Protein IDs	Majority protein IDs	Fasta headers	Peptides	Razor + unique peptides	Unique peptides	LFQ intensity 736_m_wt	LFQ intensity 736_sc_wt	LFQ intensity 737_m_midy	LFQ intensity 737_sc_midy	LFQ intensity 738_m_wt	LFQ intensity 738_sc_wt	LFQ intensity 739_m_midy	LFQ intensity 739_sc_midy	LFQ intensity 740_m_midy	LFQ intensity 740_sc_midy	LFQ intensity 741_m_wt	LFQ intensity 741_sc_wt	LFQ intensity 743_m_wt	LFQ intensity 743_sc_midy	LFQ intensity 744_m_midy	LFQ intensity 744_sc_midy	LFQ intensity 745_m_wt	LFQ intensity 745_sc_wt	Only identified by site	Reverse	Potential contaminant	gene_name	alt_gene_names	bp_annotation	bp_annotation_id	cc_annotation	cc_annotation_id	kegg_annotation	kegg_annotation_id	mf_annotation	mf_annotation_id
CON__ENSEMBL:ENSBTAP00000001528;XP_020926605.1	CON__ENSEMBL:ENSBTAP00000001528;XP_020926605.1	;XP_020926605.1 LOW QUALITY PROTEIN: intersectin-1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	ITSN1	NA;ITSN1;NA;NA;NA	regulation of small GTPase mediated signal transduction;positive regulation of protein kinase B signaling;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;membrane organization;viral process;positive regulation of kinase activity;ephrin receptor signaling pathway;negative regulation of neuron apoptotic process;G-protein coupled receptor signaling pathway;positive regulation of apoptotic process;synaptic vesicle endocytosis	GO:005105; GO:005189; GO:000726; GO:003502; GO:006102; GO:001603; GO:003367; GO:004801; GO:004352; GO:000718; GO:004306; GO:004848	plasma membrane;endocytic vesicle;clathrin-coated pit;cytosol;cell junction;presynaptic endocytic zone;calyx of Held;nuclear envelope;lamellipodium	GO:000588; GO:003013; GO:000590; GO:000582; GO:003005; GO:009883; GO:004430; GO:000563; GO:003002	"NA"	"NA"	Rho guanyl-nucleotide exchange factor activity;kinase activator activity;guanyl-nucleotide exchange factor activity;protein complex scaffold;proline-rich region binding;protein binding;calcium ion binding	GO:000508; GO:001920; GO:000508; GO:003294; GO:007006; GO:000551; GO:000550
XP_005666566.1;CON__ENSEMBL:ENSBTAP00000023055;XP_003482383.1	XP_005666566.1;CON__ENSEMBL:ENSBTAP00000023055;XP_003482383.1	XP_005666566.1 hepatocyte growth factor activator isoform X2 [Sus scrofa];;XP_003482383.1 hepatocyte growth factor activator isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	21030000	0	0	15834000	0	10097000	0	0	0	0	0	8646300	0	NA	NA	+	HGFAC	HGFAC;NA;HGFAC;NA;NA	proteolysis	GO:000650	cytosol;rough endoplasmic reticulum;extracellular region;extracellular space	GO:000582; GO:000579; GO:000557; GO:000561	"NA"	"NA"	serine-type peptidase activity;serine-type endopeptidase activity	GO:000823; GO:000425
CON__ENSEMBL:ENSBTAP00000024146	CON__ENSEMBL:ENSBTAP00000024146	NA	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39885000	+	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__ENSEMBL:ENSP00000377550;CON__P13646-1	CON__ENSEMBL:ENSP00000377550;CON__P13646-1	;	18	10	4	0	0	0	0	308700000	0	0	0	0	42072000	0	0	0	0	0	0	39950000	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P00761;XP_020934123.1;XP_020934122.1;XP_020934121.1;XP_020934120.1;XP_020934119.1;NP_001156363.1	CON__P00761;XP_020934123.1;XP_020934122.1;XP_020934121.1;XP_020934120.1;XP_020934119.1;NP_001156363.1	;XP_020934123.1 trypsinogen isoform X1 [Sus scrofa];XP_020934122.1 trypsinogen isoform X1 [Sus scrofa];XP_020934121.1 trypsinogen isoform X1 [Sus scrofa];XP_020934120.1 trypsinogen isoform X1 [Sus scrofa];XP_020934119.1 trypsinogen isoform X1 [Sus scrofa];	5	5	5	4828500000	5899500000	5612100000	6143700000	5316400000	6955700000	5695300000	5416900000	4892300000	4554800000	6192000000	1421300000	7818300000	8919200000	8764200000	5510300000	7690700000	6611000000	NA	NA	+	LOC100302368	LOC100302368;LOC100302368;LOC100302368;LOC100302368;LOC100302368	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P01030	CON__P01030	NA	6	2	2	0	37509000	28420000	49705000	48141000	97541000	46867000	43375000	0	32563000	0	74187000	0	0	0	38582000	43068000	61202000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P01966	CON__P01966	NA	7	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	379360000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P02533;XP_020922661.1;CON__Q61782;XP_020921966.1	CON__P02533;XP_020922661.1	;XP_020922661.1 keratin, type I cytoskeletal 14-like [Sus scrofa]	24	15	3	79649000	80689000	46707000	272440000	608390000	33826000	62150000	28242000	0	82551000	20612000	46804000	76040000	0	44199000	0	148080000	0	NA	NA	+	LOC110255272	NA;LOC110255272;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P02538;XP_013840212.2;CON__O95678;XP_003355445.3;XP_020947339.1;XP_020947338.1;XP_020947337.1;CON__H-INV:HIT000016045;CON__REFSEQ:XP_932229	CON__P02538	NA	32	22	1	22968000	0	0	160200000	2199200000	0	22483000	0	0	69328000	0	16293000	0	0	19653000	0	44409000	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P02662	CON__P02662	NA	3	3	3	0	0	0	0	0	0	4809000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P02754	CON__P02754	NA	1	1	1	0	0	0	0	0	0	5285600	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P02768-1	CON__P02768-1	NA	39	33	31	3486600000	4431700000	4452700000	4431400000	7061000000	6529400000	5296400000	2907800000	4072400000	2981000000	4019000000	5378800000	5254500000	6058500000	5494300000	4546500000	5089000000	6343900000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P04258	CON__P04258	NA	7	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	63859000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P04259	CON__P04259	NA	31	2	1	0	0	0	10504000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P04264	CON__P04264	NA	36	36	26	3304700000	2232000000	1899000000	3087700000	5428400000	944970000	2600300000	1390500000	1401000000	2626700000	1809900000	1907500000	3777400000	1082300000	840090000	1545400000	2459900000	987060000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P05787;CON__H-INV:HIT000292931;CON__Q9H552;CON__REFSEQ:XP_092267	CON__P05787	NA	15	2	2	0	0	0	0	16746000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P08727;CON__P05784	CON__P08727	NA	23	7	6	0	0	0	0	394350000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P08779	CON__P08779	NA	21	8	8	0	0	0	82930000	141170000	0	0	0	0	36835000	0	0	50195000	0	0	0	43322000	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P12763	CON__P12763	NA	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1792700	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P13645;XP_005668904.1;XP_003131508.1;XP_003131507.2;CON__Q148H6;CON__Q7Z3Y7;XP_020922673.1;CON__A2A5Y0;CON__Q92764;XP_020922672.1;CON__Q7Z3Z0;CON__O76015;CON__Q7Z3Y8;XP_003131480.2;NP_001231551.1;XP_003131481.2;CON__O76014;CON__REFSEQ:XP_986630;XP_003131512.1	CON__P13645	NA	35	35	22	3291200000	2186400000	1130100000	2552300000	6416200000	1043100000	2246300000	1265700000	1075400000	2231800000	1471800000	1650600000	3376600000	897750000	762750000	1326800000	1795200000	841720000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P13647;XP_003126221.1;XP_020947348.1;XP_020947347.1	CON__P13647;XP_003126221.1	;XP_003126221.1 keratin, type II cytoskeletal 5 [Sus scrofa]	26	13	5	22273000	7878400	18202000	44375000	738050000	0	15528000	0	0	22953000	16493000	7570900	5959400	0	0	0	0	0	NA	NA	+	KRT5	NA;KRT5;NA;NA;NA	cytoskeleton organization;epidermis development;keratinization;cornification;hemidesmosome assembly	GO:000701; GO:000854; GO:003142; GO:007026; GO:003158	cytosol;nucleus;cytoplasm;keratin filament;extracellular exosome;membrane;plasma membrane	GO:000582; GO:000563; GO:000573; GO:004509; GO:007006; GO:001602; GO:000588	"NA"	"NA"	scaffold protein binding;protein binding;structural constituent of cytoskeleton	GO:009711; GO:000551; GO:000520
CON__P15497	CON__P15497	NA	7	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	545610000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P19013	CON__P19013	NA	8	4	1	0	0	0	0	27546000	0	0	0	0	9851300	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P34955	CON__P34955	NA	3	2	2	0	0	0	0	0	7845700	0	0	0	0	0	0	0	0	0	0	0	3831400	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P35527	CON__P35527	NA	22	21	21	380370000	234500000	460190000	476310000	418590000	136130000	312240000	198010000	201160000	297180000	244950000	217850000	552420000	184950000	96423000	194110000	525400000	187660000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P35908v2;CON__P35908;CON__Q01546;NP_001092053.1;XP_020947353.1	CON__P35908v2;CON__P35908	;	34	32	20	805430000	652620000	338420000	1145600000	1542400000	281800000	756950000	340820000	529980000	817830000	514870000	461690000	1167200000	201720000	279790000	467910000	583420000	248560000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__P41361	CON__P41361	NA	7	2	2	109480000	0	129210000	153540000	162030000	0	172290000	0	133960000	0	139340000	0	141470000	147640000	160270000	113880000	149560000	165360000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001123442.1;CON__P62894;XP_013841086.1	NP_001123442.1;CON__P62894	NP_001123442.1 cytochrome c [Sus scrofa];	5	5	5	0	0	68364000	0	97874000	72691000	60181000	63985000	59869000	63955000	0	45013000	66394000	64510000	79551000	68951000	59546000	0	NA	NA	+	CYCS	CYCS;NA;NA;NA;NA	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c;intrinsic apoptotic signaling pathway;mitochondrial electron transport, ubiquinol to cytochrome c;mitochondrion organization;cellular respiration;protein dephosphorylation;cellular response to oxidative stress	GO:000863; GO:009719; GO:000612; GO:000700; GO:004533; GO:000647; GO:003459	mitochondrial inner membrane;respiratory chain;nucleus;mitochondrion;mitochondrial intermembrane space;protein phosphatase type 2A complex;cytosol	GO:000574; GO:007046; GO:000563; GO:000573; GO:000575; GO:000015; GO:000582	 Sulfur metabolism; p53 signaling pathway; Apoptosis; Tuberculosis; Toxoplasmosis; Influenza A; Pathways in cancer; Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Legionellosis; Metabolic pathways; Colorectal cancer; Viral myocarditis; Small cell lung cancer	hsa0092; hsa0411; hsa0421; hsa0515; hsa0514; hsa0516; hsa0520; hsa0493; hsa0501; hsa0513; hsa0110; hsa0521; hsa0541; hsa0522	protein binding;metal ion binding;heme binding;protein serine/threonine phosphatase activity;electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity	GO:000551; GO:004687; GO:002003; GO:000472; GO:004515
XP_020949552.1;XP_003355856.1;CON__P67983;XP_020949551.1	XP_020949552.1;XP_003355856.1;CON__P67983;XP_020949551.1	XP_020949552.1 metallothionein-1D isoform X2 [Sus scrofa];XP_003355856.1 metallothionein-2A [Sus scrofa];;XP_020949551.1 metallothionein-1D isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	MT1D	MT1D;MT-2B;NA;MT1D;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q04695;CON__Q9QWL7	CON__Q04695;CON__Q9QWL7	;	20	4	2	0	0	0	0	51614000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q29443;CON__Q0IIK2	CON__Q29443;CON__Q0IIK2	;	10	4	4	114790000	179720000	113380000	243200000	183930000	456710000	148740000	174650000	129870000	183600000	182820000	0	127520000	232910000	142370000	169240000	186930000	260080000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q1RMK2	CON__Q1RMK2	NA	1	1	1	95354000	0	31099000	34500000	34305000	0	43269000	0	46186000	0	41217000	0	43367000	0	77397000	13999000	50899000	9230400	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q2HJF0	CON__Q2HJF0	NA	4	1	1	0	0	0	0	0	0	0	0	0	0	0	35672000	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q2M2I5	CON__Q2M2I5	NA	3	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q32MB2;CON__Q7RTS7;XP_020947352.1;XP_020947351.1;CON__Q3SY84;XP_013840685.1	CON__Q32MB2;CON__Q7RTS7;XP_020947352.1;XP_020947351.1;CON__Q3SY84;XP_013840685.1	;;XP_020947352.1 keratin, type II cytoskeletal 73 isoform X2 [Sus scrofa];XP_020947351.1 keratin, type II cytoskeletal 73 isoform X1 [Sus scrofa];;XP_013840685.1 keratin, type II cytoskeletal 71 [Sus scrofa]	7	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	+	LOC100511079	NA;LOC100511079;LOC100511079;NA;LOC106506651	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q32PI4	CON__Q32PI4	NA	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16710000	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q3KNV1;CON__P08729;CON__Q9DCV7	CON__Q3KNV1;CON__P08729	;	11	7	5	0	0	0	0	0	0	89144000	0	46146000	0	52769000	0	111530000	0	81903000	0	139530000	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q3SX09;CON__P02070	CON__Q3SX09;CON__P02070	;	5	4	3	2994700000	478060000	495030000	1381200000	683280000	234130000	547460000	726850000	1400800000	351560000	989600000	542770000	2110900000	441340000	2169200000	284190000	752960000	234560000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q3SX14	CON__Q3SX14	NA	18	18	18	1429700000	3323200000	1507700000	2649700000	1549500000	3403400000	1733800000	2282000000	1801100000	2783300000	1801700000	2965300000	2619800000	2672700000	1707800000	2578200000	1867800000	3965000000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005660265.1;CON__Q3SX28	XP_005660265.1;CON__Q3SX28	XP_005660265.1 tropomyosin beta chain isoform X3 [Sus scrofa];	33	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	77459000	0	NA	NA	+	TPM2	TPM2;NA;NA;NA;NA	muscle contraction;actin filament organization;regulation of ATPase activity;muscle filament sliding	GO:000693; GO:000701; GO:004346; GO:003004	muscle thin filament tropomyosin;actin cytoskeleton;cytosol;actin filament	GO:000586; GO:001562; GO:000582; GO:000588	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction	hsa0541; hsa0541; hsa0426	actin filament binding;structural constituent of muscle;identical protein binding;protein heterodimerization activity;actin binding	GO:005101; GO:000830; GO:004280; GO:004698; GO:000377
CON__Q9Z2K1;CON__Q3ZAW8	CON__Q9Z2K1;CON__Q3ZAW8	;	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15409000	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
CON__Q5D862	CON__Q5D862	NA	2	2	2	6235300	6295600	0	6565100	20148000	0	8703500	5340900	0	0	0	0	0	0	0	0	3342100	0	NA	NA	+	NA	NA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001001534.1	NP_001001534.1	NP_001001534.1 ryanodine receptor 1 [Sus scrofa]	2	2	2	306580000	300620000	433320000	379400000	336330000	369340000	701270000	220600000	326650000	209080000	261860000	0	434330000	356030000	291850000	238670000	601950000	466050000	NA	NA	NA	RYR1	RYR1;NA;NA;NA;NA	ion transmembrane transport;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;protein homotetramerization;calcium ion transport;skeletal muscle fiber development;cellular response to calcium ion;regulation of cardiac conduction;ossification involved in bone maturation;response to hypoxia;skin development;release of sequestered calcium ion into cytosol;muscle contraction;response to caffeine;regulation of cytosolic calcium ion concentration;cellular response to caffeine;outflow tract morphogenesis	GO:003422; GO:001480; GO:005128; GO:000681; GO:004874; GO:007127; GO:190377; GO:004393; GO:000166; GO:004358; GO:005120; GO:000693; GO:003100; GO:005148; GO:007131; GO:000315	cell cortex;junctional sarcoplasmic reticulum membrane;Z disc;calcium channel complex;smooth endoplasmic reticulum;plasma membrane;terminal cisterna;integral component of organelle membrane;cytoplasm;sarcoplasmic reticulum membrane;junctional membrane complex;I band;sarcolemma;extracellular exosome;cytoplasmic vesicle membrane;sarcoplasmic reticulum;ryanodine receptor complex	GO:000593; GO:001470; GO:003001; GO:003470; GO:000579; GO:000588; GO:001480; GO:003130; GO:000573; GO:003301; GO:003031; GO:003167; GO:004238; GO:007006; GO:003065; GO:001652; GO:199042	 Calcium signaling pathway; Long-term depression; Oxytocin signaling pathway; Circadian entrainment	hsa0402; hsa0473; hsa0492; hsa0471	ATP binding;protease binding;protein binding;calcium-release channel activity;ryanodine-sensitive calcium-release channel activity;voltage-gated calcium channel activity;calcium channel activity;calcium-induced calcium release activity;calcium ion binding	GO:000552; GO:000202; GO:000551; GO:001527; GO:000521; GO:000524; GO:000526; GO:004876; GO:000550
NP_001001535.1;XP_020930326.1	NP_001001535.1;XP_020930326.1	NP_001001535.1 desmin [Sus scrofa];XP_020930326.1 desmin isoform X1 [Sus scrofa]	41	37	36	623000000	1963200000	1532400000	0	3257700	2506400000	17947000	434080000	1251300000	3232900000	1462400000	2475000000	1482100000	20148000	76660000	377730000	150640000	0	NA	NA	NA	DES	DES;DES;NA;NA;NA	intermediate filament organization;cytoskeleton organization;muscle filament sliding;muscle contraction;regulation of heart contraction	GO:004510; GO:000701; GO:003004; GO:000693; GO:000801	cytosol;nucleus;neuromuscular junction;Z disc;intermediate filament;sarcolemma;intercalated disc;fascia adherens;extracellular exosome;cardiac myofibril;intermediate filament cytoskeleton	GO:000582; GO:000563; GO:003159; GO:003001; GO:000588; GO:004238; GO:001470; GO:000591; GO:007006; GO:009751; GO:004511	 Dilated cardiomyopathy; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0541	cytoskeletal protein binding;protein binding;structural constituent of cytoskeleton;identical protein binding	GO:000809; GO:000551; GO:000520; GO:004280
NP_001001537.1	NP_001001537.1	NP_001001537.1 inter-alpha-trypsin inhibitor heavy chain H4 precursor [Sus scrofa]	36	2	1	0	0	0	0	48855000	54786000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ITIH4	ITIH4;NA;NA;NA;NA	acute-phase response;negative regulation of endopeptidase activity;hyaluronan metabolic process;response to cytokine;platelet degranulation	GO:000695; GO:001095; GO:003021; GO:003409; GO:000257	platelet dense granule lumen;blood microparticle;extracellular exosome;plasma membrane;extracellular region	GO:003108; GO:007256; GO:007006; GO:000588; GO:000557	"NA"	"NA"	endopeptidase inhibitor activity;protein binding;serine-type endopeptidase inhibitor activity	GO:000486; GO:000551; GO:000486
NP_001001539.1;XP_020934157.1;XP_020934156.1;XP_020919735.1;XP_020919734.1;XP_013835806.1;XP_013835805.1;NP_001038033.2	NP_001001539.1	NP_001001539.1 aldose reductase [Sus scrofa]	9	9	9	247990000	610270000	207280000	145510000	175900000	188600000	251730000	165480000	198550000	197090000	201670000	157300000	238820000	193490000	251790000	204740000	191880000	155800000	NA	NA	NA	AKR1B1	AKR1B1;NA;NA;NA;NA	daunorubicin metabolic process;naphthalene metabolic process;electron transport chain;norepinephrine metabolic process;oxidation-reduction process;renal water homeostasis;fructose biosynthetic process;regulation of urine volume;cellular response to methylglyoxal;negative regulation of apoptotic process;doxorubicin metabolic process;cellular hyperosmotic salinity response;positive regulation of smooth muscle cell proliferation;positive regulation of JAK-STAT cascade;maternal process involved in female pregnancy;response to thyroid hormone;response to water deprivation;stress-activated protein kinase signaling cascade;carbohydrate metabolic process;cellular response to peptide;inner medullary collecting duct development;tissue homeostasis;sorbitol biosynthetic process;C21-steroid hormone biosynthetic process	GO:004459; GO:001893; GO:002290; GO:004241; GO:005511; GO:000309; GO:004637; GO:003580; GO:009723; GO:004306; GO:004459; GO:007147; GO:004866; GO:004642; GO:006013; GO:009706; GO:000941; GO:003109; GO:000597; GO:190165; GO:007206; GO:000189; GO:000606; GO:000670	mast cell granule;Schmidt-Lanterman incisure;Schwann cell microvillus;extracellular exosome;nucleoplasm;paranodal junction;extracellular space;cytosol;cell projection cytoplasm;perinuclear region of cytoplasm	GO:004262; GO:004322; GO:009745; GO:007006; GO:000565; GO:003301; GO:000561; GO:000582; GO:003283; GO:004847	 Metabolic pathways; Pentose and glucuronate interconversions; Glycerolipid metabolism; Fructose and mannose metabolism	hsa0110; hsa0004; hsa0056; hsa0005	oxidoreductase activity;electron carrier activity;glyceraldehyde oxidoreductase activity;alditol:NADP+ 1-oxidoreductase activity;alcohol dehydrogenase (NADP+) activity	GO:001649; GO:000905; GO:004379; GO:000403; GO:000810
NP_001001542.1	NP_001001542.1	NP_001001542.1 sodium/potassium-transporting ATPase subunit beta-1 [Sus scrofa]	3	3	3	0	18481000	0	0	0	23504000	30482000	22070000	0	10406000	23340000	12923000	24919000	0	0	0	38581000	0	NA	NA	NA	ATP1B1	ATP1B1;NA;NA;NA;NA	cellular potassium ion homeostasis;response to hypoxia;ATP metabolic process;sodium ion export from cell;leukocyte migration;protein localization to plasma membrane;membrane repolarization during cardiac muscle cell action potential;positive regulation of potassium ion transmembrane transporter activity;positive regulation of potassium ion import;establishment or maintenance of transmembrane electrochemical gradient;relaxation of cardiac muscle;potassium ion import across plasma membrane;cellular calcium ion homeostasis;cellular sodium ion homeostasis;protein transport into plasma membrane raft;membrane repolarization;positive regulation of sodium ion export from cell;cell adhesion;regulation of gene expression;protein stabilization;regulation of cardiac muscle contraction by calcium ion signaling;positive regulation of ATPase activity;cardiac muscle contraction;cell communication by electrical coupling involved in cardiac conduction	GO:003000; GO:000166; GO:004603; GO:003637; GO:005090; GO:007265; GO:008601; GO:190101; GO:190328; GO:001024; GO:005511; GO:199057; GO:000687; GO:000688; GO:004486; GO:008600; GO:190327; GO:000715; GO:001046; GO:005082; GO:001088; GO:003278; GO:006004; GO:008606	plasma membrane;extracellular exosome;sodium:potassium-exchanging ATPase complex;extracellular vesicle;apical plasma membrane;caveola;sarcolemma;intercalated disc;membrane	GO:000588; GO:007006; GO:000589; GO:190356; GO:001632; GO:000590; GO:004238; GO:001470; GO:001602	 Thyroid hormone synthesis; Pancreatic secretion; cAMP signaling pathway; Cardiac muscle contraction; Thyroid hormone signaling pathway; Aldosterone-regulated sodium reabsorption	hsa0491; hsa0497; hsa0402; hsa0426; hsa0491; hsa0496	ATPase activity;MHC class II protein complex binding;sodium:potassium-exchanging ATPase activity;potassium ion binding;sodium ion binding;drug binding;protein binding;protein kinase binding;ATPase binding;protein C-terminus binding;ATP binding;ATPase activator activity	GO:001688; GO:002302; GO:000539; GO:003095; GO:003140; GO:000814; GO:000551; GO:001990; GO:005111; GO:000802; GO:000552; GO:000167
NP_001001546.1	NP_001001546.1	NP_001001546.1 myelin basic protein [Sus scrofa]	7	7	7	0	1213100000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MBP	MBP;NA;NA;NA;NA	chemical synaptic transmission;myelination;MAPK cascade;maintenance of permeability of blood-brain barrier;axon ensheathment;response to toxic substance;positive regulation of interleukin-6 secretion;positive regulation of metalloendopeptidase activity;sensory perception of sound;positive regulation of chemokine (C-C motif) ligand 2 secretion;negative regulation of heterotypic cell-cell adhesion;membrane organization;immune response;central nervous system development;substantia nigra development	GO:000726; GO:004255; GO:000016; GO:003563; GO:000836; GO:000963; GO:200077; GO:190468; GO:000760; GO:190420; GO:003411; GO:006102; GO:000695; GO:000741; GO:002176	plasma membrane;internode region of axon;cell surface;macromolecular complex;nucleus;myelin sheath;neuronal cell body;cell periphery;compact myelin	GO:000588; GO:003326; GO:000998; GO:003299; GO:000563; GO:004320; GO:004302; GO:007194; GO:004321	"NA"	"NA"	structural constituent of myelin sheath;protease binding;protein binding	GO:001991; GO:000202; GO:000551
XP_013842818.1;NP_001001587.1	XP_013842818.1;NP_001001587.1	XP_013842818.1 40S ribosomal protein S28 isoform X1 [Sus scrofa];NP_001001587.1 40S ribosomal protein S28 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	34487000	0	0	0	0	0	0	NA	NA	NA	RPS28	RPS28;RPS28;NA;NA;NA	rRNA processing;ribosomal small subunit assembly;cytoplasmic translation;ribosomal small subunit biogenesis;ribosome biogenesis;SRP-dependent cotranslational protein targeting to membrane;maturation of SSU-rRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000636; GO:000002; GO:000218; GO:004227; GO:004225; GO:000661; GO:003049; GO:000018; GO:000641	extracellular exosome;cytoplasmic side of rough endoplasmic reticulum membrane;cytosol;polysomal ribosome;cytosolic small ribosomal subunit;nucleoplasm;small ribosomal subunit	GO:007006; GO:009855; GO:000582; GO:004278; GO:002262; GO:000565; GO:001593	 Ribosome	hsa0301	protein binding;RNA binding;structural constituent of ribosome	GO:000551; GO:000372; GO:000373
NP_001001632.1;XP_005663430.1;XP_005663427.1;XP_020944392.1;XP_005663431.1;XP_020944391.1;XP_020944393.1;XP_013852498.1;XP_005663433.1	NP_001001632.1;XP_005663430.1;XP_005663427.1;XP_020944392.1;XP_005663431.1;XP_020944391.1	NP_001001632.1 tropomyosin alpha-3 chain [Sus scrofa];XP_005663430.1 tropomyosin alpha-3 chain isoform X18 [Sus scrofa];XP_005663427.1 tropomyosin alpha-3 chain isoform X15 [Sus scrofa];XP_020944392.1 tropomyosin alpha-3 chain isoform X11 [Sus scrofa];XP_0	25	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	72742000	NA	NA	NA	TPM3	TPM3;TPM3;TPM3;TPM3;TPM3	muscle filament sliding;actin filament organization;muscle contraction	GO:003004; GO:000701; GO:000693	stress fiber;extracellular exosome;muscle thin filament tropomyosin;actin filament;cytoskeleton;cytosol;actin cytoskeleton	GO:000172; GO:007006; GO:000586; GO:000588; GO:000585; GO:000582; GO:001562	 Cardiac muscle contraction; Pathways in cancer; Thyroid cancer; Hypertrophic cardiomyopathy (HCM); Adrenergic signaling in cardiomyocytes	hsa0426; hsa0520; hsa0521; hsa0541; hsa0426	molecular_function;protein binding;actin filament binding	GO:000367; GO:000551; GO:005101
NP_001001634.1	NP_001001634.1	NP_001001634.1 40S ribosomal protein S17 [Sus scrofa]	5	5	5	38999000	28428000	36006000	25930000	27366000	71298000	28968000	21998000	39184000	49854000	21822000	37288000	29290000	42254000	20475000	41610000	27895000	47784000	NA	NA	NA	RPS17	RPS17;NA;NA;NA;NA	rRNA processing;ribosomal small subunit biogenesis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;erythrocyte homeostasis	GO:000636; GO:004227; GO:000641; GO:000018; GO:000661; GO:003410	focal adhesion;membrane;synapse;nucleoplasm;cytosol;ribosome;cytosolic small ribosomal subunit	GO:000592; GO:001602; GO:004520; GO:000565; GO:000582; GO:000584; GO:002262	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
XP_020924241.1;NP_001001636.1	XP_020924241.1;NP_001001636.1	XP_020924241.1 60S ribosomal protein L32 isoform X1 [Sus scrofa];NP_001001636.1 60S ribosomal protein L32 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6025400	NA	NA	NA	RPL32	RPL32;RPL32;NA;NA;NA	translational initiation;cytoplasmic translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000218; GO:000018; GO:000641; GO:000661	membrane;polysomal ribosome;cytosolic large ribosomal subunit;cytosol	GO:001602; GO:004278; GO:002262; GO:000582	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
NP_001001637.1;XP_005671774.1	NP_001001637.1;XP_005671774.1	NP_001001637.1 PDZ and LIM domain protein 3 [Sus scrofa];XP_005671774.1 PDZ and LIM domain protein 3 isoform X2 [Sus scrofa]	6	6	2	0	0	0	0	0	0	0	0	0	0	0	21072000	74735000	0	0	0	0	0	NA	NA	NA	PDLIM3	PDLIM3;PDLIM3;NA;NA;NA	heart development;actin filament organization	GO:000750; GO:000701	actin cytoskeleton;Z disc	GO:001562; GO:003001	"NA"	"NA"	protein binding;cytoskeletal protein binding;metal ion binding;structural constituent of muscle	GO:000551; GO:000809; GO:004687; GO:000830
NP_001001638.1	NP_001001638.1	NP_001001638.1 60S ribosomal protein L11 [Sus scrofa]	3	3	3	0	0	73334000	57222000	60347000	70083000	62664000	52944000	0	0	61365000	0	58555000	69278000	45263000	57189000	65364000	66007000	NA	NA	NA	RPL11	RPL11;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;protein localization to nucleus;negative regulation of ubiquitin protein ligase activity;regulation of signal transduction by p53 class mediator;protein targeting;positive regulation of gene expression;positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator;cytoplasmic translation;ribosomal large subunit biogenesis;protein stabilization;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;positive regulation of protein binding;ribosomal large subunit assembly;rRNA processing;negative regulation of protein neddylation	GO:000661; GO:003450; GO:190466; GO:190179; GO:000660; GO:001062; GO:190225; GO:000218; GO:004227; GO:005082; GO:000641; GO:000018; GO:003243; GO:200005; GO:003209; GO:000002; GO:000636; GO:200043	cytoplasm;macromolecular complex;nucleoplasm;nucleolus;membrane;cytosolic large ribosomal subunit;polysomal ribosome;extracellular exosome;cytosol	GO:000573; GO:003299; GO:000565; GO:000573; GO:001602; GO:002262; GO:004278; GO:007006; GO:000582	 Ribosome	hsa0301	5S rRNA binding;RNA binding;ubiquitin protein ligase binding;structural constituent of ribosome;ubiquitin ligase inhibitor activity;protein binding	GO:000809; GO:000372; GO:003162; GO:000373; GO:199094; GO:000551
NP_001001640.1;XP_013841525.2;NP_001001864.1	NP_001001640.1	NP_001001640.1 amine oxidase [flavin-containing] A [Sus scrofa]	11	11	4	278560000	154370000	311570000	122480000	277290000	152270000	335560000	136280000	291230000	140500000	288630000	192590000	253180000	140350000	299020000	163870000	314480000	135850000	NA	NA	NA	MAOA	MAOA;NA;NA;NA;NA	cytokine-mediated signaling pathway;dopamine catabolic process;cellular biogenic amine metabolic process;neurotransmitter catabolic process;oxidation-reduction process	GO:001922; GO:004242; GO:000657; GO:004213; GO:005511	integral component of membrane;mitochondrion;mitochondrial outer membrane	GO:001602; GO:000573; GO:000574	 Dopaminergic synapse; Amphetamine addiction; Serotonergic synapse; Glycine, serine and threonine metabolism; Tyrosine metabolism; Arginine and proline metabolism; Tryptophan metabolism; Metabolic pathways; Phenylalanine metabolism; Drug metabolism - cytochrome P450; Histidine metabolism	hsa0472; hsa0503; hsa0472; hsa0026; hsa0035; hsa0033; hsa0038; hsa0110; hsa0036; hsa0098; hsa0034	primary amine oxidase activity	GO:000813
NP_001001641.1	NP_001001641.1	NP_001001641.1 bifunctional epoxide hydrolase 2 [Sus scrofa]	17	17	17	79636000	111250000	54574000	71801000	39472000	55365000	59501000	89660000	84014000	86522000	73187000	104110000	34368000	104280000	63689000	111580000	57720000	83956000	NA	NA	NA	EPHX2	EPHX2;NA;NA;NA;NA	positive regulation of gene expression;positive regulation of blood vessel diameter;protein targeting to peroxisome;epoxygenase P450 pathway;regulation of blood pressure;long-chain fatty acid biosynthetic process;phospholipid dephosphorylation;inflammatory response;reactive oxygen species metabolic process;dephosphorylation;drug metabolic process;regulation of cholesterol metabolic process;response to toxic substance;stilbene catabolic process;xenobiotic metabolic process;epoxide metabolic process;cellular calcium ion homeostasis;cholesterol homeostasis	GO:001062; GO:009775; GO:000662; GO:001937; GO:000821; GO:004275; GO:004683; GO:000695; GO:007259; GO:001631; GO:001714; GO:009018; GO:000963; GO:004627; GO:000680; GO:009717; GO:000687; GO:004263	peroxisomal matrix;cytosol;extracellular exosome;peroxisome	GO:000578; GO:000582; GO:007006; GO:000577	 Metabolic pathways; Arachidonic acid metabolism; Peroxisome	hsa0110; hsa0059; hsa0414	lipid phosphatase activity;epoxide hydrolase activity;protein homodimerization activity;toxic substance binding;phosphatase activity;magnesium ion binding;receptor binding;10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity	GO:004257; GO:000430; GO:004280; GO:001564; GO:001679; GO:000028; GO:000510; GO:003388
XP_020946860.1;XP_020946859.1;XP_005655600.1;NP_001001642.1;XP_020934280.1;XP_020934279.1;XP_020934278.1;XP_005654323.2;XP_020934277.1;XP_020934276.1;XP_020934274.1;XP_020934273.1;XP_020934272.1;XP_020934271.1;XP_020934270.1	XP_020946860.1;XP_020946859.1;XP_005655600.1;NP_001001642.1	XP_020946860.1 5-AMP-activated protein kinase subunit gamma-1 isoform X1 [Sus scrofa];XP_020946859.1 5-AMP-activated protein kinase subunit gamma-1 isoform X1 [Sus scrofa];XP_005655600.1 5-AMP-activated protein kinase subunit gamma-1 isoform X1 [Sus scr	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3851500	NA	NA	NA	PRKAG1	PRKAG1;PRKAG1;PRKAG1;PRKAG1;NA	fatty acid biosynthetic process;cell cycle arrest;protein phosphorylation;positive regulation of protein kinase activity;signal transduction;spermatogenesis;nuclear import;regulation of protein serine/threonine kinase activity;regulation of glycolytic process;positive regulation of gene expression;macroautophagy	GO:000663; GO:000705; GO:000646; GO:004586; GO:000716; GO:000728; GO:005117; GO:007190; GO:000611; GO:001062; GO:001623	nucleoplasm;membrane;cytosol;nucleotide-activated protein kinase complex	GO:000565; GO:001602; GO:000582; GO:003158	 Hypertrophic cardiomyopathy (HCM); Adipocytokine signaling pathway; Non-alcoholic fatty liver disease (NAFLD); FoxO signaling pathway; Insulin signaling pathway; AMPK signaling pathway; Circadian rhythm	hsa0541; hsa0492; hsa0493; hsa0406; hsa0491; hsa0415; hsa0471	AMP-activated protein kinase activity;cAMP-dependent protein kinase activity;ATP binding;AMP binding;protein kinase activity;protein binding;cAMP-dependent protein kinase regulator activity;protein kinase binding;ADP binding	GO:000467; GO:000469; GO:000552; GO:001620; GO:000467; GO:000551; GO:000860; GO:001990; GO:004353
NP_001001643.1	NP_001001643.1	NP_001001643.1 rab GDP dissociation inhibitor beta [Sus scrofa]	27	27	19	901990000	794800000	854470000	731660000	773150000	747170000	803870000	815480000	748620000	793280000	690310000	573000000	807130000	716170000	736110000	834520000	705700000	746380000	NA	NA	NA	GDI2	GDI2;NA;NA;NA;NA	neutrophil degranulation;protein transport;signal transduction;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;positive regulation of GTPase activity	GO:004331; GO:001503; GO:000716; GO:000726; GO:005105; GO:004354	synapse;azurophil granule lumen;vesicle;Golgi apparatus;focal adhesion;extracellular exosome;cytosol;membrane;extracellular region;secretory granule lumen;cytoplasm	GO:004520; GO:003557; GO:003198; GO:000579; GO:000592; GO:007006; GO:000582; GO:001602; GO:000557; GO:003477; GO:000573	"NA"	"NA"	protein binding;GTPase activator activity;RNA binding;small GTPase binding	GO:000551; GO:000509; GO:000372; GO:003126
NP_001001649.2	NP_001001649.2	NP_001001649.2 cadherin-5 precursor [Sus scrofa]	11	11	11	0	41764000	51296000	45087000	45444000	58507000	49046000	54552000	42050000	46279000	0	56390000	40863000	62374000	56170000	51736000	42324000	52363000	NA	NA	NA	CDH5	CDH5;NA;NA;NA;NA	cell morphogenesis;cell-cell adhesion mediated by cadherin;cell-cell junction assembly;transforming growth factor beta receptor signaling pathway;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;cell-cell adhesion;positive regulation of angiogenesis;negative regulation of inflammatory response;positive regulation of establishment of endothelial barrier;blood vessel maturation;adherens junction organization;homophilic cell adhesion via plasma membrane adhesion molecules;regulation of establishment of cell polarity	GO:000090; GO:004433; GO:000704; GO:000717; GO:001633; GO:009860; GO:004576; GO:005072; GO:190314; GO:000195; GO:003433; GO:000715; GO:200011	membrane;cell surface;cell junction;cell-cell junction;plasma membrane;integral component of membrane;bicellular tight junction;catenin complex	GO:001602; GO:000998; GO:003005; GO:000591; GO:000588; GO:001602; GO:000592; GO:001634	 Cell adhesion molecules (CAMs); Leukocyte transendothelial migration	hsa0451; hsa0467	protein binding;ion channel binding;beta-catenin binding;protein homodimerization activity;receptor binding;vascular endothelial growth factor receptor 2 binding;calcium ion binding;cadherin binding;cytoskeletal protein binding	GO:000551; GO:004432; GO:000801; GO:004280; GO:000510; GO:004318; GO:000550; GO:004529; GO:000809
NP_001001770.1	NP_001001770.1	NP_001001770.1 cytochrome b5 [Sus scrofa]	6	6	6	544090000	526990000	549530000	506230000	396260000	401050000	539770000	603280000	569160000	496920000	524660000	451610000	302700000	454700000	607830000	763900000	490770000	444100000	NA	NA	NA	CYB5A	CYB5A;NA;NA;NA;NA	L-ascorbic acid metabolic process;hydrogen ion transmembrane transport;response to cadmium ion;electron transport chain	GO:001985; GO:190260; GO:004668; GO:002290	intracellular membrane-bounded organelle;cytosol;endoplasmic reticulum membrane;integral component of membrane;mitochondrial outer membrane	GO:004323; GO:000582; GO:000578; GO:001602; GO:000574	"NA"	"NA"	metal ion binding;enzyme binding;cytochrome-c oxidase activity;heme binding;aldo-keto reductase (NADP) activity	GO:004687; GO:001989; GO:000412; GO:002003; GO:000403
NP_001001771.1;XP_013850150.2	NP_001001771.1	NP_001001771.1 fibrillin-1 precursor [Sus scrofa]	99	99	96	2032900000	20383000000	15314000000	16447000000	11494000000	20180000000	3678800000	10436000000	7520800000	10609000000	8745500000	10762000000	6214200000	12452000000	10810000000	13051000000	9144700000	24504000000	NA	NA	NA	FBN1	FBN1;NA;NA;NA;NA	extracellular matrix organization;camera-type eye development;regulation of receptor activity;negative regulation of osteoclast differentiation;negative regulation of osteoclast development;post-translational protein modification;cellular response to insulin-like growth factor stimulus;cellular response to transforming growth factor beta stimulus;post-embryonic eye morphogenesis;sequestering of BMP in extracellular matrix;metanephros development;skeletal system development;cell adhesion mediated by integrin;heart development;embryonic eye morphogenesis;cellular protein metabolic process	GO:003019; GO:004301; GO:001046; GO:004567; GO:200120; GO:004368; GO:199031; GO:007156; GO:004805; GO:003558; GO:000165; GO:000150; GO:003362; GO:000750; GO:004804; GO:004426	endoplasmic reticulum lumen;microfibril;extracellular space;basement membrane;extracellular matrix;extracellular region	GO:000578; GO:000152; GO:000561; GO:000560; GO:003101; GO:000557	"NA"	"NA"	extracellular matrix structural constituent;calcium ion binding;macromolecular complex binding;hormone activity;protein binding;identical protein binding;heparin binding;extracellular matrix constituent conferring elasticity	GO:000520; GO:000550; GO:004487; GO:000517; GO:000551; GO:004280; GO:000820; GO:003002
NP_001001862.1	NP_001001862.1	NP_001001862.1 troponin C, skeletal muscle [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32357000	0	NA	NA	NA	TNNC2	TNNC2;NA;NA;NA;NA	skeletal muscle contraction;regulation of muscle contraction;muscle filament sliding	GO:000300; GO:000693; GO:003004	troponin complex;cytosol	GO:000586; GO:000582	 Calcium signaling pathway	hsa0402	calcium ion binding;actin filament binding;protein binding;calcium-dependent protein binding;actin binding	GO:000550; GO:005101; GO:000551; GO:004830; GO:000377
XP_020937506.1;XP_020937494.1;XP_020937483.1;XP_020937474.1;XP_020937468.1;XP_020937457.1;XP_020937450.1;XP_020937440.1;XP_020937436.1;XP_020937431.1;XP_020937423.1;NP_001001863.1;XP_020949122.1;XP_020949121.1;XP_005656023.1;XP_013844159.1;XP_020949120.1;XP_020949118.1;XP_005656022.1;NP_998913.1;XP_020949117.1;XP_013844158.1;XP_020949116.1;XP_020949115.1;XP_005656021.1;XP_020949114.1;XP_020949113.1;XP_020949112.1	XP_020937506.1;XP_020937494.1;XP_020937483.1;XP_020937474.1;XP_020937468.1;XP_020937457.1;XP_020937450.1;XP_020937440.1;XP_020937436.1;XP_020937431.1;XP_020937423.1;NP_001001863.1	XP_020937506.1 troponin T, fast skeletal muscle isoform X36 [Sus scrofa];XP_020937494.1 troponin T, fast skeletal muscle isoform X34 [Sus scrofa];XP_020937483.1 troponin T, fast skeletal muscle isoform X32 [Sus scrofa];XP_020937474.1 troponin T, fast skele	8	8	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	411690000	0	NA	NA	NA	TNNT3	TNNT3;TNNT3;TNNT3;TNNT3;TNNT3	muscle filament sliding;cardiac muscle contraction;regulation of striated muscle contraction;sarcomere organization;skeletal muscle contraction;muscle contraction;regulation of ATPase activity	GO:003004; GO:006004; GO:000694; GO:004521; GO:000300; GO:000693; GO:004346	troponin complex;cytosol	GO:000586; GO:000582	"NA"	"NA"	protein binding;tropomyosin binding;calcium-dependent protein binding;troponin C binding;troponin I binding;actin binding;calcium ion binding;calcium-dependent ATPase activity	GO:000551; GO:000552; GO:004830; GO:003017; GO:003101; GO:000377; GO:000550; GO:003089
NP_001001867.1	NP_001001867.1	NP_001001867.1 galectin-1 [Sus scrofa]	10	10	10	4626000000	8296100000	6560300000	6683300000	5438700000	7030000000	5270300000	6228400000	4222600000	6145200000	6973700000	10544000000	5073800000	9298500000	6634300000	7797900000	5663600000	8670000000	NA	NA	NA	LGALS1	LGALS1;NA;NA;NA;NA	response to drug;negative regulation of neuron projection development;positive regulation of erythrocyte aggregation;post-translational protein modification;response to isolation stress;cellular protein metabolic process;plasma cell differentiation;apoptotic process;negative regulation of cell-substrate adhesion;positive regulation of I-kappaB kinase/NF-kappaB signaling;myoblast differentiation;cellular response to glucose stimulus;cellular response to organic cyclic compound;response to axon injury;positive regulation of viral entry into host cell;T cell costimulation;regulation of apoptotic process;positive regulation of dendritic cell differentiation	GO:004249; GO:001097; GO:003412; GO:004368; GO:003590; GO:004426; GO:000231; GO:000691; GO:001081; GO:004312; GO:004544; GO:007133; GO:007140; GO:004867; GO:004659; GO:003129; GO:004298; GO:200120	extracellular space;endoplasmic reticulum lumen;cytosol;nucleus;cell surface;extracellular region;extracellular exosome;cytoplasm	GO:000561; GO:000578; GO:000582; GO:000563; GO:000998; GO:000557; GO:007006; GO:000573	"NA"	"NA"	protein homodimerization activity;laminin binding;RNA binding;lactose binding;protein binding	GO:004280; GO:004323; GO:000372; GO:003039; GO:000551
NP_001001869.1	NP_001001869.1	NP_001001869.1 E3 ubiquitin-protein ligase RNF114 [Sus scrofa]	3	3	3	30574000	39480000	32653000	33505000	36239000	40344000	43619000	24617000	36167000	31348000	38848000	33131000	24432000	30422000	36308000	0	45942000	38122000	NA	NA	NA	RNF114	RNF114;NA;NA;NA;NA	multicellular organism development;protein polyubiquitination;cell differentiation;spermatogenesis	GO:000727; GO:000020; GO:003015; GO:000728	nucleus;cytosol;plasma membrane	GO:000563; GO:000582; GO:000588	"NA"	"NA"	metal ion binding;ubiquitin-protein transferase activity	GO:004687; GO:000484
XP_020957907.1;XP_020957906.1;XP_005667429.1;NP_001002801.1	XP_020957907.1;XP_020957906.1;XP_005667429.1;NP_001002801.1	XP_020957907.1 apolipoprotein C-III isoform X1 [Sus scrofa];XP_020957906.1 apolipoprotein C-III isoform X1 [Sus scrofa];XP_005667429.1 apolipoprotein C-III isoform X1 [Sus scrofa];NP_001002801.1 apolipoprotein C-III precursor [Sus scrofa]	4	4	4	121580000	51356000	91337000	100060000	203790000	195850000	117720000	66401000	119030000	86558000	116230000	51973000	108870000	114630000	156820000	90047000	157740000	85938000	NA	NA	NA	APOC3	APOC3;APOC3;APOC3;APOC3;NA	negative regulation of low-density lipoprotein particle clearance;cholesterol efflux;negative regulation of fatty acid biosynthetic process;negative regulation of cholesterol import;triglyceride catabolic process;phospholipid efflux;negative regulation of receptor-mediated endocytosis;negative regulation of lipoprotein lipase activity;triglyceride homeostasis;retinoid metabolic process;negative regulation of very-low-density lipoprotein particle clearance;regulation of Cdc42 protein signal transduction;high-density lipoprotein particle remodeling;cholesterol homeostasis;reverse cholesterol transport;negative regulation of very-low-density lipoprotein particle remodeling;chylomicron remnant clearance;lipoprotein metabolic process;triglyceride metabolic process;G-protein coupled receptor signaling pathway;negative regulation of triglyceride catabolic process;negative regulation of high-density lipoprotein particle clearance;negative regulation of lipid metabolic process;negative regulation of lipid catabolic process	GO:001098; GO:003334; GO:004571; GO:006062; GO:001943; GO:003370; GO:004826; GO:005100; GO:007032; GO:000152; GO:001091; GO:003248; GO:003437; GO:004263; GO:004369; GO:001090; GO:003438; GO:004215; GO:000664; GO:000718; GO:001089; GO:001098; GO:004583; GO:005099	spherical high-density lipoprotein particle;very-low-density lipoprotein particle;extracellular space;extracellular exosome;chylomicron;extracellular region;early endosome	GO:003436; GO:003436; GO:000561; GO:007006; GO:004262; GO:000557; GO:000576	 PPAR signaling pathway	hsa0332	phospholipid binding;cholesterol binding;lipase inhibitor activity;high-density lipoprotein particle receptor binding;enzyme regulator activity	GO:000554; GO:001548; GO:005510; GO:007065; GO:003023
NP_001002817.1	NP_001002817.1	NP_001002817.1 fatty acid-binding protein, adipocyte [Sus scrofa]	21	21	20	32458000000	30908000000	34500000000	29719000000	31020000000	28512000000	37733000000	34680000000	32783000000	32030000000	30583000000	42518000000	16586000000	37058000000	36471000000	32718000000	26668000000	31412000000	NA	NA	NA	FABP4	FABP4;NA;NA;NA;NA	negative regulation of protein kinase activity;long-chain fatty acid transport;triglyceride catabolic process;cellular response to lithium ion;response to bacterium;cholesterol homeostasis;positive regulation of inflammatory response;white fat cell differentiation;cytokine production;negative regulation of transcription, DNA-templated;cellular response to tumor necrosis factor	GO:000646; GO:001590; GO:001943; GO:007128; GO:000961; GO:004263; GO:005072; GO:005087; GO:000181; GO:004589; GO:007135	cytoplasm;nucleus;extracellular exosome;lipid particle;cytosol	GO:000573; GO:000563; GO:007006; GO:000581; GO:000582	 PPAR signaling pathway; Regulation of lipolysis in adipocytes	hsa0332; hsa0492	hormone receptor binding;fatty acid binding;long-chain fatty acid binding;long-chain fatty acid transporter activity	GO:005142; GO:000550; GO:003604; GO:000532
XP_020949255.1;NP_001003924.1	XP_020949255.1;NP_001003924.1	XP_020949255.1 complement C1q subcomponent subunit A isoform X1 [Sus scrofa];NP_001003924.1 complement C1q subcomponent subunit A precursor [Sus scrofa]	3	3	3	8722300	12298000	7188800	0	9947600	0	0	0	11017000	0	0	0	0	0	0	0	12802000	0	NA	NA	NA	C1QA	C1QA;C1QA;NA;NA;NA	complement activation;proteolysis;complement activation, classical pathway;response to iron ion;regulation of complement activation;innate immune response;cell-cell signaling	GO:000695; GO:000650; GO:000695; GO:001003; GO:003044; GO:004508; GO:000726	collagen trimer;complement component C1 complex;extracellular region	GO:000558; GO:000560; GO:000557	 Complement and coagulation cascades; Systemic lupus erythematosus; Pertussis; Staphylococcus aureus infection; Prion diseases; Chagas disease (American trypanosomiasis)	hsa0461; hsa0532; hsa0513; hsa0515; hsa0502; hsa0514	protein binding;serine-type endopeptidase activity	GO:000551; GO:000425
NP_001003925.1	NP_001003925.1	NP_001003925.1 apolipoprotein F precursor [Sus scrofa]	4	4	4	145580000	100590000	83258000	117840000	93379000	128470000	153110000	82215000	143800000	93168000	161070000	84723000	98963000	104350000	178860000	98985000	181220000	146050000	NA	NA	NA	APOF	APOF;NA;NA;NA;NA	lipid transport;cholesterol metabolic process;lipid metabolic process	GO:000686; GO:000820; GO:000662	low-density lipoprotein particle;high-density lipoprotein particle;extracellular space	GO:003436; GO:003436; GO:000561	"NA"	"NA"	receptor binding;lipid transporter activity;cholesterol binding	GO:000510; GO:000531; GO:001548
NP_001004031.1;XP_020932974.1	NP_001004031.1;XP_020932974.1	NP_001004031.1 destrin [Sus scrofa];XP_020932974.1 destrin isoform X1 [Sus scrofa]	10	10	10	106050000	177090000	249430000	91340000	77359000	323670000	82987000	145850000	157720000	423290000	259520000	330750000	515760000	114290000	96433000	109110000	83190000	100210000	NA	NA	NA	DSTN	DSTN;DSTN;NA;NA;NA	actin polymerization or depolymerization;actin filament severing;actin filament depolymerization;positive regulation of actin filament depolymerization	GO:000815; GO:005101; GO:003004; GO:003083	cortical actin cytoskeleton;actin cytoskeleton;extracellular exosome	GO:003086; GO:001562; GO:007006	"NA"	"NA"	protein binding;actin filament binding	GO:000551; GO:005101
XP_020920819.1;XP_020920818.1;XP_005668375.2;XP_005668374.2;XP_005668373.2;NP_001004034.1	XP_020920819.1;XP_020920818.1;XP_005668375.2;XP_005668374.2;XP_005668373.2;NP_001004034.1	XP_020920819.1 high mobility group protein B1 isoform X1 [Sus scrofa];XP_020920818.1 high mobility group protein B1 isoform X1 [Sus scrofa];XP_005668375.2 high mobility group protein B1 isoform X1 [Sus scrofa];XP_005668374.2 high mobility group protein B1	10	10	8	190030000	334150000	315970000	477950000	304360000	422710000	237250000	397410000	271890000	450420000	296790000	537190000	376450000	593830000	289940000	571600000	297560000	334020000	NA	NA	NA	HMGB1	HMGB1;HMGB1;HMGB1;HMGB1;HMGB1	DNA geometric change;developmental process;positive regulation of tumor necrosis factor production;positive regulation of apoptotic process;neutrophil degranulation;T-helper 1 cell differentiation;positive regulation of DNA ligation;cell chemotaxis;DNA topological change;regulation of transcription from RNA polymerase II promoter;negative regulation of RNA polymerase II transcriptional preinitiation complex assembly;positive regulation of interleukin-1 secretion;positive chemotaxis;neutrophil clearance;positive regulation of vascular endothelial cell proliferation;autophagy;positive regulation of mismatch repair;positive regulation of blood vessel endothelial cell migration;tumor necrosis factor secretion;negative regulation of apoptotic cell clearance;positive regulation of autophagy;positive regulation of interleukin-10 production;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of DNA binding;negative regulation of transcription from RNA polymerase II promoter;neuron projection development;regulation of restriction endodeoxyribonuclease activity;negative regulation of CD4-positive, alpha-beta T cell differentiation;positive regulation of innate immune response;cellular response to lipopolysaccharide;positive regulation of NIK/NF-kappaB signaling;positive regulation of dendritic cell differentiation;DNA recombination;chromatin remodeling;positive regulation of toll-like receptor 9 signaling pathway;T-helper 1 cell activation;positive regulation of activated T cell proliferation;positive regulation of interferon-alpha secretion;positive regulation of interleukin-6 secretion;myeloid dendritic cell activation;activation of innate immune response;toll-like receptor signaling pathway;dendritic cell chemotaxis;regulation of tolerance induction;inflammatory response;regulation of receptor activity;positive regulation of interleukin-6 production;V(D)J recombination;apoptotic cell clearance;positive regulation of transcription from RNA polymerase II promoter;positive regulation of ERK1 and ERK2 cascade;inflammatory response to antigenic stimulus;regulation of T cell mediated immune response to tumor cell;apoptotic DNA fragmentation;chromatin silencing;positive regulation of cytosolic calcium ion concentration;negative regulation of interferon-gamma production;positive regulation of MAPK cascade;positive regulation of JNK cascade;positive regulation of monocyte chemotaxis	GO:003239; GO:003250; GO:003276; GO:004306; GO:004331; GO:004506; GO:005110; GO:006032; GO:000626; GO:000635; GO:001705; GO:005071; GO:005091; GO:009735; GO:190556; GO:000691; GO:003242; GO:004353; GO:199077; GO:200042; GO:001050; GO:003273; GO:004328; GO:004338; GO:000012; GO:003117; GO:003207; GO:004337; GO:004508; GO:007122; GO:190122; GO:200120; GO:000631; GO:000633; GO:003416; GO:003571; GO:004210; GO:190274; GO:200077; GO:000177; GO:000221; GO:000222; GO:000240; GO:000264; GO:000695; GO:001046; GO:003275; GO:003315; GO:004327; GO:004594; GO:007037; GO:000243; GO:000284; GO:000630; GO:000634; GO:000720; GO:003268; GO:004341; GO:004633; GO:009002	nucleus;extracellular region;alphav-beta3 integrin-HMGB1 complex;endosome;endoplasmic reticulum-Golgi intermediate compartment;condensed chromosome;cell surface;nucleoplasm;extracellular space;cytoplasm;transcriptional repressor complex;secretory granule lumen;ficolin-1-rich granule lumen	GO:000563; GO:000557; GO:003586; GO:000576; GO:000579; GO:000079; GO:000998; GO:000565; GO:000561; GO:000573; GO:001705; GO:003477; GO:190481	 Base excision repair	hsa0341	phosphatidylserine binding;cytokine activity;chemoattractant activity;four-way junction DNA binding;lipopolysaccharide binding;DNA binding, bending;supercoiled DNA binding;double-stranded DNA binding;RNA binding;transcription regulatory region DNA binding;lyase activity;integrin binding;C-X-C chemokine binding;RAGE receptor binding;damaged DNA binding;transcription coactivator activity;transcription factor binding;repressing transcription factor binding;DNA polymerase binding;protein binding	GO:000178; GO:000512; GO:004205; GO:000040; GO:000153; GO:000830; GO:009710; GO:000369; GO:000372; GO:004421; GO:001682; GO:000517; GO:001995; GO:005078; GO:000368; GO:000371; GO:000813; GO:007049; GO:007018; GO:000551
NP_001004042.1	NP_001004042.1	NP_001004042.1 V-type proton ATPase catalytic subunit A [Sus scrofa]	10	10	10	48423000	52781000	56172000	42413000	43444000	48525000	48986000	57308000	55396000	57425000	50231000	44954000	40445000	58718000	46821000	48446000	39176000	48153000	NA	NA	NA	ATP6V1A	ATP6V1A;NA;NA;NA;NA	cellular iron ion homeostasis;insulin receptor signaling pathway;ion transmembrane transport;cellular response to increased oxygen levels;ATP hydrolysis coupled proton transport;ATP metabolic process;regulation of macroautophagy;transferrin transport	GO:000687; GO:000828; GO:003422; GO:003629; GO:001599; GO:004603; GO:001624; GO:003357	lysosomal membrane;extracellular exosome;vacuolar membrane;apical plasma membrane;proton-transporting two-sector ATPase complex;proton-transporting V-type ATPase, V1 domain;cytosol;plasma membrane;microvillus	GO:000576; GO:007006; GO:000577; GO:001632; GO:001646; GO:003318; GO:000582; GO:000588; GO:000590	 Synaptic vesicle cycle; Collecting duct acid secretion; Epithelial cell signaling in Helicobacter pylori infection; Rheumatoid arthritis; Phagosome; Oxidative phosphorylation; Metabolic pathways; Vibrio cholerae infection	hsa0472; hsa0496; hsa0512; hsa0532; hsa0414; hsa0019; hsa0110; hsa0511	ATP binding;proton-transporting ATPase activity, rotational mechanism	GO:000552; GO:004696
NP_001004043.1	NP_001004043.1	NP_001004043.1 cofilin-1 [Sus scrofa]	14	14	13	1092100000	1780700000	1677500000	1599100000	1193900000	1671100000	1332500000	1487400000	1403900000	1619500000	1276600000	1502800000	1844600000	1621900000	1476900000	1420600000	1394000000	1850200000	NA	NA	NA	CFL1	CFL1;NA;NA;NA;NA	neural crest cell migration;regulation of dendritic spine morphogenesis;mitotic cytokinesis;Rho protein signal transduction;interleukin-12-mediated signaling pathway;positive regulation by host of viral process;neural fold formation;response to virus;cytoskeleton organization;establishment of cell polarity;actin filament fragmentation;negative regulation of apoptotic process;response to amino acid;actin cytoskeleton organization;protein phosphorylation;regulation of cell morphogenesis;positive regulation of actin filament depolymerization	GO:000175; GO:006100; GO:000028; GO:000726; GO:003572; GO:004479; GO:000184; GO:000961; GO:000701; GO:003001; GO:003004; GO:004306; GO:004320; GO:003003; GO:000646; GO:002260; GO:003083	nuclear matrix;lamellipodium;cytoplasm;focal adhesion;nucleus;cortical actin cytoskeleton;extracellular space;cytosol;vesicle;cell-cell junction;lamellipodium membrane;membrane;extracellular exosome;ruffle membrane	GO:001636; GO:003002; GO:000573; GO:000592; GO:000563; GO:003086; GO:000561; GO:000582; GO:003198; GO:000591; GO:003125; GO:001602; GO:007006; GO:003258	 Axon guidance; Fc gamma R-mediated phagocytosis; Pertussis; Regulation of actin cytoskeleton	hsa0436; hsa0466; hsa0513; hsa0481	receptor binding;protein binding;actin filament binding	GO:000510; GO:000551; GO:005101
NP_001004045.1	NP_001004045.1	NP_001004045.1 protein S100-A11 [Sus scrofa]	2	2	2	50113000	70240000	66514000	109290000	65471000	76305000	54454000	140130000	97272000	132380000	142200000	232960000	183010000	135740000	165350000	123520000	135150000	135820000	NA	NA	NA	S100A11	S100A11;NA;NA;NA;NA	signal transduction;neutrophil degranulation;cell-cell adhesion;negative regulation of DNA replication;negative regulation of cell proliferation	GO:000716; GO:004331; GO:009860; GO:000815; GO:000828	extracellular space;extracellular region;nucleus;cell-cell adherens junction;ruffle;cytoplasm;secretory granule lumen;extracellular exosome	GO:000561; GO:000557; GO:000563; GO:000591; GO:000172; GO:000573; GO:003477; GO:007006	"NA"	"NA"	S100 protein binding;calcium ion binding;protein homodimerization activity;cadherin binding involved in cell-cell adhesion;calcium-dependent protein binding;protein binding	GO:004454; GO:000550; GO:004280; GO:009864; GO:004830; GO:000551
NP_001004049.1;XP_020944404.1	NP_001004049.1;XP_020944404.1	NP_001004049.1 3 beta-hydroxysteroid dehydrogenase/Delta 5--_4-isomerase [Sus scrofa];XP_020944404.1 3 beta-hydroxysteroid dehydrogenase/Delta 5--_4-isomerase isoform X1 [Sus scrofa]	3	3	3	33552000	0	18193000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	HSD3B1	HSD3B1;HSD3B1;NA;NA;NA	estrogen biosynthetic process;glucocorticoid biosynthetic process;steroid biosynthetic process;response to corticosterone;hippocampus development;C21-steroid hormone metabolic process;oxidation-reduction process	GO:000670; GO:000670; GO:000669; GO:005141; GO:002176; GO:000820; GO:005511	integral component of membrane;endoplasmic reticulum membrane;smooth endoplasmic reticulum membrane;intracellular membrane-bounded organelle;mitochondrial intermembrane space;mitochondrial inner membrane	GO:001602; GO:000578; GO:003086; GO:004323; GO:000575; GO:000574	 Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis; Aldosterone synthesis and secretion	hsa0014; hsa0110; hsa0491; hsa0492	3-keto sterol reductase activity;3-beta-hydroxy-delta5-steroid dehydrogenase activity;oxidoreductase activity;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;steroid delta-isomerase activity;5alpha-androstane-3beta,17beta-diol dehydrogenase activity	GO:000025; GO:000385; GO:001649; GO:001661; GO:000476; GO:004702
NP_001004050.1;XP_020939260.1	NP_001004050.1;XP_020939260.1	NP_001004050.1 prolyl endopeptidase [Sus scrofa];XP_020939260.1 prolyl endopeptidase isoform X1 [Sus scrofa]	17	17	17	50091000	44720000	45432000	43154000	47082000	35986000	48592000	44848000	53505000	45529000	57079000	61060000	57261000	43468000	45800000	53721000	42508000	43097000	NA	NA	NA	PREP	PREP;PREP;NA;NA;NA	proteolysis	GO:000650	nucleus;cytoplasm;membrane;cytosol	GO:000563; GO:000573; GO:001602; GO:000582	 Renin-angiotensin system	hsa0461	protein binding;serine-type exopeptidase activity;serine-type peptidase activity;serine-type endopeptidase activity;oligopeptidase activity;endopeptidase activity	GO:000551; GO:007000; GO:000823; GO:000425; GO:007001; GO:000417
XP_005665851.1;XP_005665850.1;NP_001005157.1;XP_005665849.1;XP_020954000.1;XP_003123418.5	XP_005665851.1;XP_005665850.1;NP_001005157.1;XP_005665849.1;XP_020954000.1;XP_003123418.5	XP_005665851.1 spliceosome RNA helicase DDX39B isoform X3 [Sus scrofa];XP_005665850.1 spliceosome RNA helicase DDX39B isoform X3 [Sus scrofa];NP_001005157.1 spliceosome RNA helicase DDX39B [Sus scrofa];XP_005665849.1 spliceosome RNA helicase DDX39B isoform	13	13	13	101290000	99630000	95238000	110130000	101200000	114330000	99565000	103760000	90073000	93550000	117910000	125330000	126070000	99107000	94211000	101500000	108160000	118790000	NA	NA	NA	DDX39B	DDX39B;DDX39B;DDX39B;DDX39B;DDX39A	RNA splicing;liver development;RNA export from nucleus;positive regulation of vascular smooth muscle cell proliferation;spliceosomal complex assembly;mRNA 3'-end processing;negative regulation of DNA damage checkpoint;positive regulation of DNA biosynthetic process;mRNA splicing, via spliceosome;RNA secondary structure unwinding;viral mRNA export from host cell nucleus;positive regulation of cell growth involved in cardiac muscle cell development;positive regulation of DNA-templated transcription, elongation;positive regulation of translation	GO:000838; GO:000188; GO:000640; GO:190470; GO:000024; GO:003112; GO:200000; GO:200057; GO:000039; GO:001050; GO:004678; GO:006105; GO:003278; GO:004572	nucleus;nuclear speck;U6 snRNP;transcription export complex;nucleoplasm;cytoplasm;nuclear matrix	GO:000563; GO:001660; GO:000568; GO:000034; GO:000565; GO:000573; GO:001636	 RNA transport; Spliceosome; mRNA surveillance pathway; Influenza A	hsa0301; hsa0304; hsa0301; hsa0516	RNA-dependent ATPase activity;ATP-dependent RNA helicase activity;macromolecular complex binding;protein binding;ATPase activity;identical protein binding;ATP-dependent protein binding;RNA binding;ATP binding;U6 snRNA binding;U4 snRNA binding	GO:000818; GO:000400; GO:004487; GO:000551; GO:001688; GO:004280; GO:004300; GO:000372; GO:000552; GO:001707; GO:003062
NP_001005208.1	NP_001005208.1	NP_001005208.1 serum albumin precursor [Sus scrofa]	92	92	74	258000000000	465960000000	288330000000	540280000000	361610000000	610530000000	368430000000	380080000000	347950000000	383280000000	416750000000	393550000000	376030000000	528460000000	366500000000	426530000000	421490000000	662210000000	NA	NA	NA	ALB	ALB;NA;NA;NA;NA	high-density lipoprotein particle remodeling;retina homeostasis;receptor-mediated endocytosis;negative regulation of apoptotic process;platelet degranulation;maintenance of mitochondrion location;cellular protein metabolic process;post-translational protein modification;cellular response to starvation;hemolysis by symbiont of host erythrocytes;cellular oxidant detoxification	GO:003437; GO:000189; GO:000689; GO:004306; GO:000257; GO:005165; GO:004426; GO:004368; GO:000926; GO:001983; GO:009886	nucleus;endoplasmic reticulum lumen;macromolecular complex;extracellular exosome;blood microparticle;Golgi apparatus;extracellular region;extracellular space;platelet alpha granule lumen	GO:000563; GO:000578; GO:003299; GO:007006; GO:007256; GO:000579; GO:000557; GO:000561; GO:003109	"NA"	"NA"	DNA binding;antioxidant activity;fatty acid binding;toxic substance binding;chaperone binding;pyridoxal phosphate binding;identical protein binding;oxygen binding;protein binding;drug binding	GO:000367; GO:001620; GO:000550; GO:001564; GO:005108; GO:003017; GO:004280; GO:001982; GO:000551; GO:000814
XP_020946776.1;XP_020946775.1;NP_001005348.1;XP_020946774.1	XP_020946776.1;XP_020946775.1;NP_001005348.1;XP_020946774.1	XP_020946776.1 bax inhibitor 1 isoform X2 [Sus scrofa];XP_020946775.1 bax inhibitor 1 isoform X2 [Sus scrofa];NP_001005348.1 bax inhibitor 1 [Sus scrofa];XP_020946774.1 bax inhibitor 1 isoform X1 [Sus scrofa]	2	2	2	26699000	27036000	30269000	14113000	26660000	28662000	20303000	19753000	21387000	20646000	21355000	10046000	13450000	21941000	21537000	21947000	26234000	12043000	NA	NA	NA	TMBIM6	TMBIM6;TMBIM6;TMBIM6;TMBIM6;NA	negative regulation of RNA splicing;negative regulation of immunoglobulin secretion;response to L-glutamate;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;negative regulation of apoptotic signaling pathway;cellular response to unfolded protein;negative regulation of endoribonuclease activity;negative regulation of apoptotic process;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;autophagy;negative regulation of calcium ion transport into cytosol;negative regulation of protein binding;endoplasmic reticulum calcium ion homeostasis;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	GO:003311; GO:005102; GO:190206; GO:190223; GO:190329; GO:200123; GO:003462; GO:006070; GO:004306; GO:199044; GO:000691; GO:001052; GO:003209; GO:003246; GO:007005	endoplasmic reticulum;cytoplasm;mitochondrial membrane;endoplasmic reticulum membrane;integral component of plasma membrane;membrane;nucleus	GO:000578; GO:000573; GO:003196; GO:000578; GO:000588; GO:001602; GO:000563	"NA"	"NA"	enzyme binding;ubiquitin protein ligase binding;endoribonuclease inhibitor activity;protein binding	GO:001989; GO:003162; GO:006069; GO:000551
XP_020946794.1;NP_001005349.1;XP_020946793.1;XP_020946791.1;XP_020946792.1	XP_020946794.1;NP_001005349.1;XP_020946793.1;XP_020946791.1;XP_020946792.1	XP_020946794.1 complement C1s subcomponent isoform X4 [Sus scrofa];NP_001005349.1 complement C1s subcomponent precursor [Sus scrofa];XP_020946793.1 complement C1s subcomponent isoform X3 [Sus scrofa];XP_020946791.1 complement C1s subcomponent isoform X1 [S	13	13	13	78472000	125750000	69042000	139470000	92613000	192310000	95542000	92350000	67336000	82317000	70861000	117960000	79870000	102470000	75079000	71549000	90664000	120970000	NA	NA	NA	C1S	C1S;C1S;C1S;C1S;C1S	regulation of complement activation;innate immune response;complement activation, classical pathway;proteolysis	GO:003044; GO:004508; GO:000695; GO:000650	extracellular region;extracellular space;blood microparticle	GO:000557; GO:000561; GO:007256	 Staphylococcus aureus infection; Complement and coagulation cascades; Pertussis; Systemic lupus erythematosus	hsa0515; hsa0461; hsa0513; hsa0532	protein binding;serine-type endopeptidase activity;calcium ion binding;identical protein binding	GO:000551; GO:000425; GO:000550; GO:004280
XP_013848366.1;XP_005659594.1;NP_001005726.1	XP_013848366.1;XP_005659594.1;NP_001005726.1	XP_013848366.1 annexin A2 isoform X1 [Sus scrofa];XP_005659594.1 annexin A2 isoform X1 [Sus scrofa];NP_001005726.1 annexin A2 [Sus scrofa]	36	36	36	11902000000	15807000000	17313000000	18935000000	12950000000	16963000000	12747000000	14693000000	13143000000	19499000000	19262000000	21372000000	12540000000	23217000000	20304000000	18782000000	19076000000	24375000000	NA	NA	NA	ANXA2	ANXA2;ANXA2;ANXA2;NA;NA	negative regulation of development of symbiont involved in interaction with host;protein heterotetramerization;cell-cell adhesion;positive regulation of low-density lipoprotein particle clearance;biomineral tissue development;fibrinolysis;positive regulation of low-density lipoprotein particle receptor binding;neutrophil degranulation;positive regulation of vacuole organization;catabolism by host of symbiont protein;protein localization to plasma membrane;angiogenesis;regulation of plasminogen activation;collagen fibril organization;interleukin-12-mediated signaling pathway;osteoclast development;negative regulation of catalytic activity;membrane budding;positive regulation by host of viral process;positive regulation of fibroblast proliferation;positive regulation of receptor-mediated endocytosis involved in cholesterol transport;positive regulation of chondrocyte differentiation;positive regulation of calcium ion transport;negative regulation by host of symbiont molecular function;response to thyroid hormone;positive regulation of vesicle fusion;negative regulation of low-density lipoprotein particle receptor catabolic process;regulation of cytosolic calcium ion concentration;endocardial cell differentiation;calcium ion transmembrane transport;positive regulation of viral life cycle;membrane raft assembly;positive regulation of receptor recycling;positive regulation of protein phosphorylation;growth plate cartilage development;body fluid secretion	GO:004414; GO:005129; GO:009860; GO:190558; GO:003121; GO:004273; GO:190559; GO:004331; GO:004409; GO:005236; GO:007265; GO:000152; GO:001075; GO:003019; GO:003572; GO:003603; GO:004308; GO:000690; GO:004479; GO:004814; GO:190560; GO:003233; GO:005192; GO:005240; GO:009706; GO:003134; GO:003280; GO:005148; GO:006095; GO:007058; GO:190390; GO:000176; GO:000192; GO:000193; GO:000341; GO:000758	plasma membrane;cytosol;nucleus;cytoplasm;endosome;lipid particle;basolateral plasma membrane;late endosome membrane;perinuclear region of cytoplasm;ruffle;midbody;vesicle;PCSK9-AnxA2 complex;membrane;cell-cell adherens junction;myelin sheath adaxonal region;sarcolemma;membrane raft;basement membrane;melanosome;extrinsic component of plasma membrane;extracellular exosome;extracellular region;extracellular space;cell cortex;azurophil granule lumen;cell surface;Schmidt-Lanterman incisure;macropinosome	GO:000588; GO:000582; GO:000563; GO:000573; GO:000576; GO:000581; GO:001632; GO:003190; GO:004847; GO:000172; GO:003049; GO:003198; GO:199066; GO:001602; GO:000591; GO:003574; GO:004238; GO:004512; GO:000560; GO:004247; GO:001989; GO:007006; GO:000557; GO:000561; GO:000593; GO:003557; GO:000998; GO:004322; GO:004435	"NA"	"NA"	RNA binding;virion binding;phosphatidylserine binding;Rab GTPase binding;cytoskeletal protein binding;calcium ion binding;protease binding;cadherin binding involved in cell-cell adhesion;calcium-dependent phospholipid binding;phospholipase A2 inhibitor activity;S100 protein binding;molecular function regulator;calcium channel activity;calcium-dependent protein binding;protein binding;identical protein binding;bone sialoprotein binding;voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels	GO:000372; GO:004679; GO:000178; GO:001713; GO:000809; GO:000550; GO:000202; GO:009864; GO:000554; GO:001983; GO:004454; GO:009877; GO:000526; GO:004830; GO:000551; GO:004280; GO:004473; GO:009951
XP_013852454.1;NP_001005730.1	XP_013852454.1;NP_001005730.1	XP_013852454.1 glucosylceramidase isoform X1 [Sus scrofa];NP_001005730.1 glucosylceramidase precursor [Sus scrofa]	3	3	3	0	8756200	0	9641500	10032000	0	0	0	0	7683800	0	0	0	0	0	8543500	0	9989800	NA	NA	NA	GBA	GBA;GBA;NA;NA;NA	positive regulation of mitophagy in response to mitochondrial depolarization;mitochondrion organization;regulation of cellular protein metabolic process;negative regulation of interleukin-6 production;regulation of water loss via skin;cellular response to tumor necrosis factor;response to thyroid hormone;positive regulation of neuronal action potential;autophagy;cellular response to starvation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;beta-glucoside catabolic process;positive regulation of proteolysis involved in cellular protein catabolic process;lipid glycosylation;regulation of TOR signaling;negative regulation of protein homooligomerization;cell death in response to oxidative stress;ceramide biosynthetic process;positive regulation of protein lipidation;regulation of lysosomal protein catabolic process;cholesterol metabolic process;regulation of macroautophagy;positive regulation of protein complex disassembly;negative regulation of MAP kinase activity;positive regulation of protein metabolic process;skin morphogenesis;response to estrogen;negative regulation of neuron death;autophagosome organization;glucosylceramide catabolic process;lysosome organization;termination of signal transduction;neuron projection development;response to testosterone;response to dexamethasone	GO:190492; GO:000700; GO:003226; GO:003271; GO:003356; GO:007135; GO:009706; GO:190445; GO:000691; GO:000926; GO:003243; GO:003530; GO:005072; GO:190180; GO:190305; GO:003025; GO:003200; GO:003246; GO:003647; GO:004651; GO:190306; GO:190516; GO:000820; GO:001624; GO:004324; GO:004340; GO:005124; GO:004358; GO:004362; GO:190121; GO:190503; GO:000668; GO:000704; GO:002302; GO:003117; GO:003357; GO:007154	extrinsic component of membrane;lysosome;extracellular exosome;lysosomal lumen	GO:001989; GO:000576; GO:007006; GO:004320	 Metabolic pathways; Lysosome; Other glycan degradation; Sphingolipid metabolism	hsa0110; hsa0414; hsa0051; hsa0060	scavenger receptor binding;steryl-beta-glucosidase activity;protein binding;glucosylceramidase activity;receptor binding;glucosyltransferase activity;hydrolase activity	GO:000512; GO:005029; GO:000551; GO:000434; GO:000510; GO:004652; GO:001678
NP_001006592.1;XP_020941551.1	NP_001006592.1;XP_020941551.1	NP_001006592.1 myosin regulatory light chain 2, skeletal muscle isoform [Sus scrofa];XP_020941551.1 myosin regulatory light chain 2, skeletal muscle isoform isoform X1 [Sus scrofa]	11	11	11	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2787300000	0	NA	NA	NA	MYLPF	MYLPF;MYLPF;NA;NA;NA	immune response;muscle contraction;skeletal muscle tissue development	GO:000695; GO:000693; GO:000751	muscle myosin complex;lysosomal membrane;cytosol	GO:000585; GO:000576; GO:000582	 Leukocyte transendothelial migration; Tight junction; Focal adhesion; Regulation of actin cytoskeleton	hsa0467; hsa0453; hsa0451; hsa0481	calcium ion binding;structural constituent of muscle	GO:000550; GO:000830
XP_020939341.1;XP_020939323.1;XP_020939313.1;XP_020939302.1;XP_020939330.1;XP_020939291.1;XP_020939289.1;NP_001007196.1;XP_020939347.1	XP_020939341.1;XP_020939323.1;XP_020939313.1;XP_020939302.1;XP_020939330.1;XP_020939291.1;XP_020939289.1;NP_001007196.1;XP_020939347.1	XP_020939341.1 protein quaking isoform X7 [Sus scrofa];XP_020939323.1 protein quaking isoform X5 [Sus scrofa];XP_020939313.1 protein quaking isoform X4 [Sus scrofa];XP_020939302.1 protein quaking isoform X3 [Sus scrofa];XP_020939330.1 protein quaking isofo	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13774000	NA	NA	NA	QKI	QKI;QKI;QKI;QKI;QKI	mRNA processing;RNA splicing;regulation of translation;multicellular organism development;mRNA transport;cell differentiation	GO:000639; GO:000838; GO:000641; GO:000727; GO:005102; GO:003015	nucleus;cytoplasm	GO:000563; GO:000573	"NA"	"NA"	protein binding;RNA binding;SH3 domain binding	GO:000551; GO:000372; GO:001712
NP_001007518.1	NP_001007518.1	NP_001007518.1 cytochrome c oxidase subunit 5B, mitochondrial precursor [Sus scrofa]	6	6	6	196490000	136190000	151290000	76912000	143450000	93496000	175680000	116800000	147710000	93831000	139080000	114760000	66224000	102560000	117630000	116270000	120450000	96726000	NA	NA	NA	COX5B	COX5B;NA;NA;NA;NA	respiratory gaseous exchange;mitochondrial electron transport, cytochrome c to oxygen;mitochondrial ATP synthesis coupled proton transport	GO:000758; GO:000612; GO:004277	mitochondrion;mitochondrial inner membrane	GO:000573; GO:000574	 Cardiac muscle contraction; Oxidative phosphorylation; Parkinson's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD)	hsa0426; hsa0019; hsa0501; hsa0110; hsa0493	protein binding;cytochrome-c oxidase activity;metal ion binding	GO:000551; GO:000412; GO:004687
NP_001007519.1	NP_001007519.1	NP_001007519.1 heat shock protein beta-1 [Sus scrofa]	19	19	17	5138400000	3187600000	5317100000	1969100000	3821900000	2917200000	4257900000	3217700000	3506300000	2566800000	4884800000	1975900000	3680300000	2945100000	3289500000	1977200000	5477100000	2857600000	NA	NA	NA	HSPB1	HSPB1;NA;NA;NA;NA	cellular response to vascular endothelial growth factor stimulus;regulation of mRNA stability;retina homeostasis;regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of blood vessel endothelial cell migration;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;regulation of autophagy;negative regulation of protein serine/threonine kinase activity;platelet aggregation;regulation of protein phosphorylation;response to virus;intracellular signal transduction;regulation of translational initiation;positive regulation of endothelial cell chemotaxis;response to unfolded protein;negative regulation of apoptotic process;positive regulation of angiogenesis;positive regulation of interleukin-1 beta production;anterograde axonal protein transport;negative regulation of protein kinase activity;positive regulation of tumor necrosis factor biosynthetic process;chaperone-mediated protein folding	GO:003592; GO:004348; GO:000189; GO:004312; GO:004353; GO:190217; GO:003803; GO:001050; GO:007190; GO:007052; GO:000193; GO:000961; GO:003555; GO:000644; GO:200102; GO:000698; GO:004306; GO:004576; GO:003273; GO:009964; GO:000646; GO:004253; GO:006107	focal adhesion;Z disc;cytoplasm;cytosol;proteasome complex;spindle;extracellular space;cytoskeleton;extracellular exosome;nucleus;axon cytoplasm;plasma membrane	GO:000592; GO:003001; GO:000573; GO:000582; GO:000050; GO:000581; GO:000561; GO:000585; GO:007006; GO:000563; GO:190411; GO:000588	 VEGF signaling pathway; Amoebiasis; MAPK signaling pathway; Epstein-Barr virus infection	hsa0437; hsa0514; hsa0401; hsa0516	protein binding;protein binding involved in protein folding;ubiquitin binding;identical protein binding;protein kinase C inhibitor activity;protein kinase binding;RNA binding;protein kinase C binding	GO:000551; GO:004418; GO:004313; GO:004280; GO:000842; GO:001990; GO:000372; GO:000508
XP_020936071.1;XP_020936067.1;XP_020936062.1;XP_013847134.2;XP_005653010.2;XP_005653009.2;NP_001008481.1;XP_020936044.1;XP_005653011.2;XP_020936035.1;XP_005653013.2;XP_005653014.2;XP_005653012.2	XP_020936071.1;XP_020936067.1;XP_020936062.1;XP_013847134.2;XP_005653010.2;XP_005653009.2;NP_001008481.1;XP_020936044.1;XP_005653011.2;XP_020936035.1;XP_005653013.2;XP_005653014.2;XP_005653012.2	XP_020936071.1 glucocorticoid receptor isoform X8 [Sus scrofa];XP_020936067.1 glucocorticoid receptor isoform X8 [Sus scrofa];XP_020936062.1 glucocorticoid receptor isoform X7 [Sus scrofa];XP_013847134.2 glucocorticoid receptor isoform X7 [Sus scrofa];XP_0	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14214000	NA	NA	NA	NR3C1	NR3C1;NR3C1;NR3C1;NR3C1;NR3C1	regulation of transcription, DNA-templated;cellular response to glucocorticoid stimulus;negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;glucocorticoid receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;chromatin organization;cellular response to dexamethasone stimulus;signal transduction;glucocorticoid mediated signaling pathway;cellular response to transforming growth factor beta stimulus;cell cycle;chromosome segregation;transcription, DNA-templated;apoptotic process;cell division	GO:000635; GO:007138; GO:000012; GO:000636; GO:004292; GO:004594; GO:000632; GO:007154; GO:000716; GO:004340; GO:007156; GO:000704; GO:000705; GO:000635; GO:000691; GO:005130	nucleus;spindle;nuclear speck;macromolecular complex;mitochondrial matrix;cytosol;cytoplasm;nucleoplasm	GO:000563; GO:000581; GO:001660; GO:003299; GO:000575; GO:000582; GO:000573; GO:000565	 Neuroactive ligand-receptor interaction	hsa0408	transcription factor activity, sequence-specific DNA binding;glucocorticoid receptor activity;Hsp90 protein binding;steroid hormone binding;RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;RNA binding;steroid binding;core promoter binding;zinc ion binding;SUMO binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;protein binding;protein kinase binding	GO:000370; GO:000488; GO:005187; GO:199023; GO:000487; GO:000122; GO:000372; GO:000549; GO:000104; GO:000827; GO:003218; GO:000097; GO:000098; GO:000551; GO:001990
XP_013840479.1;XP_013840478.1;XP_005672726.1;NP_001008687.1	XP_013840479.1;XP_013840478.1;XP_005672726.1;NP_001008687.1	XP_013840479.1 major prion protein isoform X1 [Sus scrofa];XP_013840478.1 major prion protein isoform X1 [Sus scrofa];XP_005672726.1 major prion protein isoform X1 [Sus scrofa];NP_001008687.1 major prion protein precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	16105000	0	15456000	0	14178000	0	13510000	0	16622000	0	11173000	12196000	NA	NA	NA	PRNP	PRNP;PRNP;PRNP;PRNP;NA	long-term memory;positive regulation of neuron apoptotic process;negative regulation of calcineurin-NFAT signaling cascade;cellular response to beta-amyloid;protein destabilization;cellular response to drug;positive regulation of protein tyrosine kinase activity;positive regulation of protein targeting to membrane;regulation of calcium ion import across plasma membrane;cellular copper ion homeostasis;negative regulation of apoptotic process;regulation of potassium ion transmembrane transport;response to cadmium ion;modulation of age-related behavioral decline;negative regulation of T cell receptor signaling pathway;negative regulation of long-term synaptic potentiation;positive regulation of neuron death;negative regulation of amyloid precursor protein catabolic process;cell cycle arrest;calcium-mediated signaling using intracellular calcium source;positive regulation of peptidyl-tyrosine phosphorylation;regulation of glutamate receptor signaling pathway;regulation of intracellular calcium activated chloride channel activity;positive regulation of protein localization to plasma membrane;negative regulation of protein phosphorylation;response to oxidative stress;negative regulation of protein processing;protein homooligomerization;negative regulation of catalytic activity;negative regulation of sequence-specific DNA binding transcription factor activity;negative regulation of activated T cell proliferation;cellular response to copper ion;dendritic spine maintenance;negative regulation of beta-amyloid formation;negative regulation of dendritic spine maintenance;learning or memory;activation of protein kinase activity;negative regulation of interleukin-17 production;negative regulation of interferon-gamma production;neuron projection maintenance	GO:000761; GO:004352; GO:007088; GO:190464; GO:003164; GO:003569; GO:006109; GO:009031; GO:190566; GO:000687; GO:004306; GO:190137; GO:004668; GO:009064; GO:005086; GO:190027; GO:190121; GO:190299; GO:000705; GO:003558; GO:005073; GO:190044; GO:190293; GO:190307; GO:000193; GO:000697; GO:001095; GO:005126; GO:004308; GO:004343; GO:004600; GO:007128; GO:009706; GO:190243; GO:190295; GO:000761; GO:003214; GO:003270; GO:003268; GO:199053	plasma membrane;intracellular membrane-bounded organelle;cytosol;postsynaptic density;postsynapse;extrinsic component of membrane;Golgi apparatus;endoplasmic reticulum;cell surface;membrane raft;extracellular exosome;cytoplasm;inclusion body;dendrite;anchored component of external side of plasma membrane;nuclear membrane	GO:000588; GO:004323; GO:000582; GO:001406; GO:009879; GO:001989; GO:000579; GO:000578; GO:000998; GO:004512; GO:007006; GO:000573; GO:001623; GO:003042; GO:003136; GO:003196	 Prion diseases	hsa0502	identical protein binding;cuprous ion binding;beta-amyloid binding;glycosaminoglycan binding;signaling receptor activity;type 5 metabotropic glutamate receptor binding;copper ion binding;chaperone binding;ion channel binding;macromolecular complex binding;protease binding;microtubule binding;ATP-dependent protein binding;tubulin binding;protein binding;lamin binding	GO:004280; GO:190313; GO:000154; GO:000553; GO:003802; GO:003180; GO:000550; GO:005108; GO:004432; GO:004487; GO:000202; GO:000801; GO:004300; GO:001563; GO:000551; GO:000552
NP_001008688.1	NP_001008688.1	NP_001008688.1 carbonic anhydrase 3 [Sus scrofa]	23	23	23	10093000000	11684000000	14868000000	11270000000	12285000000	9202100000	11418000000	12421000000	15544000000	13537000000	12903000000	11306000000	6678700000	9562100000	17017000000	18748000000	14050000000	9528800000	NA	NA	NA	CA3	CA3;NA;NA;NA;NA	response to bacterium;response to oxidative stress;bicarbonate transport;response to ethanol;dephosphorylation	GO:000961; GO:000697; GO:001570; GO:004547; GO:001631	cytosol	GO:000582	 Nitrogen metabolism	hsa0091	carbonate dehydratase activity;phosphatase activity;zinc ion binding;nickel cation binding	GO:000408; GO:001679; GO:000827; GO:001615
NP_001008689.1	NP_001008689.1	NP_001008689.1 GTP-binding protein SAR1b [Sus scrofa]	5	2	2	28636000	20087000	27888000	28817000	26666000	0	23315000	27033000	36448000	24406000	0	0	0	21036000	25348000	20534000	24757000	24818000	NA	NA	NA	SAR1B	SAR1B;NA;NA;NA;NA	COPII vesicle coating;regulation of COPII vesicle coating;ER to Golgi vesicle-mediated transport;membrane organization;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of exogenous peptide antigen via MHC class II;positive regulation of protein exit from endoplasmic reticulum;vesicle organization	GO:004820; GO:000340; GO:000688; GO:006102; GO:000247; GO:001988; GO:007086; GO:001605	endoplasmic reticulum membrane;endoplasmic reticulum;Golgi cisterna membrane;cytosol;ER to Golgi transport vesicle membrane;endoplasmic reticulum exit site;COPII vesicle coat	GO:000578; GO:000578; GO:003258; GO:000582; GO:001250; GO:007097; GO:003012	 Protein processing in endoplasmic reticulum; Legionellosis	hsa0414; hsa0513	GTPase activity;GTP binding;metal ion binding	GO:000392; GO:000552; GO:004687
XP_020924276.1;NP_001008692.1	XP_020924276.1;NP_001008692.1	XP_020924276.1 LIM and cysteine-rich domains protein 1 isoform X1 [Sus scrofa];NP_001008692.1 LIM and cysteine-rich domains protein 1 [Sus scrofa]	7	7	7	0	0	24762000	0	0	0	0	0	0	24425000	0	0	28431000	0	0	19183000	0	0	NA	NA	NA	LMCD1	LMCD1;LMCD1;NA;NA;NA	regulation of cardiac muscle hypertrophy;positive regulation of calcineurin-NFAT signaling cascade;negative regulation of transcription from RNA polymerase II promoter;cellular protein metabolic process	GO:001061; GO:007088; GO:000012; GO:004426	cytoplasm;nucleus;nucleoplasm	GO:000573; GO:000563; GO:000565	"NA"	"NA"	transcription corepressor activity;zinc ion binding	GO:000371; GO:000827
NP_001009576.1	NP_001009576.1	NP_001009576.1 radixin [Sus scrofa]	16	7	7	41927000	47808000	51594000	44066000	45845000	36035000	51416000	55904000	43264000	48673000	57363000	52622000	46671000	54814000	50460000	35379000	44098000	36709000	NA	NA	NA	RDX	RDX;NA;NA;NA;NA	positive regulation of cell migration;negative regulation of cell size;barbed-end actin filament capping;regulation of actin filament bundle assembly;regulation of Rap protein signal transduction;positive regulation of cellular protein catabolic process;establishment of protein localization;cellular response to thyroid hormone stimulus;regulation of cell size;negative regulation of adherens junction organization;negative regulation of homotypic cell-cell adhesion;apical protein localization;regulation of organelle assembly;microvillus assembly;regulation of GTPase activity;establishment of endothelial barrier;positive regulation of protein localization to early endosome;positive regulation of early endosome to late endosome transport;positive regulation of gene expression;protein kinase A signaling;positive regulation of G1/S transition of mitotic cell cycle;cellular response to platelet-derived growth factor stimulus;regulation of ruffle assembly;negative regulation of GTPase activity;protein localization to plasma membrane	GO:003033; GO:004579; GO:005101; GO:003223; GO:003248; GO:190336; GO:004518; GO:009706; GO:000836; GO:190339; GO:003411; GO:004517; GO:190211; GO:003003; GO:004308; GO:006102; GO:190296; GO:200064; GO:001062; GO:001073; GO:190008; GO:003612; GO:190002; GO:003426; GO:007265	ruffle;cortical actin cytoskeleton;extracellular space;cell tip;focal adhesion;plasma membrane;lamellipodium;cleavage furrow;stereocilium;cell periphery;T-tubule;cell-cell adherens junction;apical plasma membrane;microvillus;filopodium;midbody;extracellular exosome	GO:000172; GO:003086; GO:000561; GO:005128; GO:000592; GO:000588; GO:003002; GO:003215; GO:003242; GO:007194; GO:003031; GO:000591; GO:001632; GO:000590; GO:003017; GO:003049; GO:007006	 Proteoglycans in cancer; MicroRNAs in cancer; Regulation of actin cytoskeleton	hsa0520; hsa0520; hsa0481	protein domain specific binding;ATPase binding;actin binding;RNA binding;protein kinase A binding;protein binding;protein homodimerization activity;cadherin binding	GO:001990; GO:005111; GO:000377; GO:000372; GO:005101; GO:000551; GO:004280; GO:004529
XP_005665171.1;XP_005665169.1;NP_001009582.1;XP_001928591.3	XP_005665171.1;XP_005665169.1;NP_001009582.1;XP_001928591.3	XP_005665171.1 stathmin isoform X1 [Sus scrofa];XP_005665169.1 stathmin isoform X1 [Sus scrofa];NP_001009582.1 stathmin [Sus scrofa];XP_001928591.3 stathmin-2 [Sus scrofa]	2	2	2	0	31076000	0	0	0	0	0	0	0	0	0	14907000	25115000	17312000	0	0	14912000	0	NA	NA	NA	STMN1	STMN1;STMN1;STMN1;STMN2;NA	negative regulation of thrombin-activated receptor signaling pathway;negative regulation of microtubule polymerization;neuron projection development;establishment of skin barrier;negative regulation of guanyl-nucleotide exchange factor activity;response to virus;signal transduction;intracellular signal transduction;regulation of cytoskeleton organization;microtubule depolymerization;mitotic spindle organization;axonogenesis;negative regulation of Rho protein signal transduction;positive regulation of cellular component movement;brain development;hepatocyte growth factor receptor signaling pathway;mitotic cytokinesis	GO:007049; GO:003111; GO:003117; GO:006143; GO:190509; GO:000961; GO:000716; GO:003555; GO:005149; GO:000701; GO:000705; GO:000740; GO:003502; GO:005127; GO:000742; GO:004801; GO:000028	cytosol;neuron projection;microtubule;extracellular exosome;membrane;cytoplasm	GO:000582; GO:004300; GO:000587; GO:007006; GO:001602; GO:000573	 MicroRNAs in cancer; MAPK signaling pathway	hsa0520; hsa0401	protein binding;tubulin binding	GO:000551; GO:001563
NP_001011507.1	NP_001011507.1	NP_001011507.1 lysosome-associated membrane glycoprotein 1 precursor [Sus scrofa]	4	4	4	20596000	20987000	16456000	19553000	22164000	19646000	19904000	18458000	16316000	20684000	18812000	0	24629000	16799000	23921000	15795000	15274000	27310000	NA	NA	NA	LAMP1	LAMP1;NA;NA;NA;NA	autophagic cell death;granzyme-mediated apoptotic signaling pathway;positive regulation of natural killer cell degranulation;protein stabilization;Golgi to lysosome transport;regulation of organelle transport along microtubule;establishment of protein localization to organelle;neutrophil degranulation;viral entry into host cell;positive regulation of natural killer cell mediated cytotoxicity	GO:004810; GO:000862; GO:004332; GO:005082; GO:009016; GO:190251; GO:007259; GO:004331; GO:004671; GO:004595	lysosomal membrane;plasma membrane;neuronal cell body;perinuclear region of cytoplasm;alveolar lamellar body;late endosome;dendrite;melanosome;external side of plasma membrane;cytolytic granule;membrane;phagolysosome membrane;lysosome;azurophil granule membrane;cytoplasm;ficolin-1-rich granule membrane;cytosol;endosome membrane;extracellular exosome;integral component of synaptic vesicle membrane;autolysosome;sarcolemma	GO:000576; GO:000588; GO:004302; GO:004847; GO:009720; GO:000577; GO:003042; GO:004247; GO:000989; GO:004419; GO:001602; GO:006147; GO:000576; GO:003557; GO:000573; GO:010100; GO:000582; GO:001000; GO:007006; GO:003028; GO:004475; GO:004238	 Lysosome; Phagosome; Tuberculosis	hsa0414; hsa0414; hsa0515	protein binding;virus receptor activity;enzyme binding;protein domain specific binding	GO:000551; GO:000161; GO:001989; GO:001990
NP_001011509.1	NP_001011509.1	NP_001011509.1 heme-binding protein 1 [Sus scrofa]	6	6	6	95055000	83491000	76893000	80772000	86160000	77758000	67795000	86182000	66612000	82546000	70069000	96278000	61328000	61819000	66959000	75666000	70207000	71847000	NA	NA	NA	HEBP1	HEBP1;NA;NA;NA;NA	circadian rhythm;G-protein coupled receptor signaling pathway	GO:000762; GO:000718	extracellular exosome;extracellular region	GO:007006; GO:000557	"NA"	"NA"	heme binding	GO:002003
NP_001011727.1	NP_001011727.1	NP_001011727.1 adenosylhomocysteinase [Sus scrofa]	13	13	13	174360000	262960000	228820000	213660000	140120000	218460000	183900000	181520000	186990000	178010000	192190000	164990000	271850000	251060000	176950000	167890000	218060000	181300000	NA	NA	NA	AHCY	AHCY;NA;NA;NA;NA	circadian sleep/wake cycle;sulfur amino acid metabolic process;S-adenosylhomocysteine catabolic process;methylation;S-adenosylmethionine cycle;chronic inflammatory response to antigenic stimulus;response to hypoxia;one-carbon metabolic process;response to nutrient	GO:004274; GO:000009; GO:001951; GO:003225; GO:003335; GO:000243; GO:000166; GO:000673; GO:000758	nucleus;melanosome;neuron projection;cytosol;extracellular exosome	GO:000563; GO:004247; GO:004300; GO:000582; GO:007006	 Cysteine and methionine metabolism; Metabolic pathways	hsa0027; hsa0110	protein binding;NAD binding;adenosylhomocysteinase activity;identical protein binding;adenyl nucleotide binding	GO:000551; GO:005128; GO:000401; GO:004280; GO:003055
NP_001012407.1	NP_001012407.1	NP_001012407.1 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 [Sus scrofa]	4	4	4	35329000	24221000	27405000	35083000	27501000	12356000	14633000	31359000	24134000	25627000	26068000	38757000	0	19857000	27360000	42971000	0	17047000	NA	NA	NA	ABHD5	ABHD5;NA;NA;NA;NA	cell differentiation;lipid homeostasis;negative regulation of sequestering of triglyceride;positive regulation of lipoprotein lipase activity;phosphatidic acid biosynthetic process;fatty acid metabolic process	GO:003015; GO:005508; GO:001089; GO:005100; GO:000665; GO:000663	cytosol;lipid particle	GO:000582; GO:000581	 Regulation of lipolysis in adipocytes	hsa0492	carboxylic ester hydrolase activity;triglyceride lipase activity;1-acylglycerol-3-phosphate O-acyltransferase activity;lysophosphatidic acid acyltransferase activity	GO:005268; GO:000480; GO:000384; GO:004217
XP_020935215.1;XP_020935214.1;XP_020935213.1;XP_020935212.1;XP_020935210.1;NP_001012408.1;XP_020935209.1;XP_020935208.1;XP_020935207.1;XP_020935206.1;XP_020935205.1;XP_020935204.1;XP_020935203.1;XP_020935202.1;XP_020935217.1;XP_020935216.1;XP_020935218.1;XP_020935219.1;XP_020935224.1;XP_020935223.1;XP_020935221.1;XP_020935220.1	XP_020935215.1;XP_020935214.1;XP_020935213.1;XP_020935212.1;XP_020935210.1;NP_001012408.1;XP_020935209.1;XP_020935208.1;XP_020935207.1;XP_020935206.1;XP_020935205.1;XP_020935204.1;XP_020935203.1;XP_020935202.1;XP_020935217.1;XP_020935216.1;XP_020935218.1	XP_020935215.1 dystrophin isoform X13 [Sus scrofa];XP_020935214.1 dystrophin isoform X12 [Sus scrofa];XP_020935213.1 dystrophin isoform X11 [Sus scrofa];XP_020935212.1 dystrophin isoform X10 [Sus scrofa];XP_020935210.1 dystrophin isoform X9 [Sus scrofa];NP	46	45	45	52931000	135320000	57270000	70077000	26563000	62324000	49375000	97748000	45720000	117890000	64174000	203300000	45630000	90482000	37976000	117620000	35019000	76337000	NA	NA	NA	DMD	DMD;DMD;DMD;DMD;DMD	regulation of heart rate;muscle cell cellular homeostasis;cytoskeleton organization;muscle filament sliding;cellular protein localization;negative regulation of peptidyl-cysteine S-nitrosylation;positive regulation of sodium ion transmembrane transporter activity;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;cardiac muscle cell action potential;muscle organ development;negative regulation of peptidyl-serine phosphorylation;cardiac muscle contraction;regulation of ryanodine-sensitive calcium-release channel activity;regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;regulation of skeletal muscle contraction;response to muscle stretch;muscle fiber development;peptide biosynthetic process;regulation of voltage-gated calcium channel activity;cellular macromolecular complex assembly	GO:000202; GO:004671; GO:000701; GO:003004; GO:003461; GO:190208; GO:200065; GO:001088; GO:008600; GO:000751; GO:003313; GO:006004; GO:006031; GO:001480; GO:001481; GO:003599; GO:004874; GO:004304; GO:190138; GO:003462	lateral plasma membrane;dystrophin-associated glycoprotein complex;sarcolemma;membrane raft;synapse;postsynaptic membrane;cell surface;cell-substrate junction;cytosol;cytoskeleton;Z disc;costamere;macromolecular complex;neuron projection terminus;filopodium;filopodium membrane	GO:001632; GO:001601; GO:004238; GO:004512; GO:004520; GO:004521; GO:000998; GO:003005; GO:000582; GO:000585; GO:003001; GO:004303; GO:003299; GO:004430; GO:003017; GO:003152	 Hypertrophic cardiomyopathy (HCM); Arrhythmogenic right ventricular cardiomyopathy (ARVC)	hsa0541; hsa0541	zinc ion binding;structural constituent of muscle;nitric-oxide synthase binding;actin binding;protein binding;dystroglycan binding;structural constituent of cytoskeleton;myosin binding;vinculin binding	GO:000827; GO:000830; GO:005099; GO:000377; GO:000551; GO:000216; GO:000520; GO:001702; GO:001716
NP_001014971.1	NP_001014971.1	NP_001014971.1 collagen alpha-1(V) chain precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9156200	NA	NA	NA	COL5A1	COL5A1;NA;NA;NA;NA	extracellular matrix organization;cell migration;integrin biosynthetic process;skin development;tendon development;blood vessel development;regulation of cellular component organization;cell adhesion;collagen biosynthetic process;wound healing, spreading of epidermal cells;negative regulation of endodermal cell differentiation;collagen fibril organization;eye morphogenesis;heart morphogenesis;supramolecular fiber organization	GO:003019; GO:001647; GO:004511; GO:004358; GO:003598; GO:000156; GO:005112; GO:000715; GO:003296; GO:003531; GO:190322; GO:003019; GO:004859; GO:000300; GO:009743	extracellular space;collagen type V trimer;extracellular matrix;extracellular region;basement membrane;endoplasmic reticulum lumen	GO:000561; GO:000558; GO:003101; GO:000557; GO:000560; GO:000578	 Protein digestion and absorption; Platelet activation; Amoebiasis; ECM-receptor interaction; PI3K-Akt signaling pathway	hsa0497; hsa0461; hsa0514; hsa0451; hsa0415	extracellular matrix structural constituent conferring tensile strength;integrin binding;extracellular matrix structural constituent;platelet-derived growth factor binding;metal ion binding;protein binding;proteoglycan binding;heparin binding	GO:003002; GO:000517; GO:000520; GO:004840; GO:004687; GO:000551; GO:004339; GO:000820
XP_020956154.1;XP_020956153.1;XP_020956152.1;XP_020956151.1;XP_020956150.1;NP_001018042.1	XP_020956154.1;XP_020956153.1;XP_020956152.1;XP_020956151.1;XP_020956150.1;NP_001018042.1	XP_020956154.1 guanylate cyclase soluble subunit beta-1 isoform X2 [Sus scrofa];XP_020956153.1 guanylate cyclase soluble subunit beta-1 isoform X2 [Sus scrofa];XP_020956152.1 guanylate cyclase soluble subunit beta-1 isoform X1 [Sus scrofa];XP_020956151.1 g	4	4	4	10148000	9157100	10908000	0	0	10852000	0	12161000	0	9570300	0	0	12755000	10110000	0	8431200	0	8499900	NA	NA	NA	GUCY1B1	GUCY1B1;GUCY1B1;GUCY1B1;GUCY1B1;GUCY1B1	cGMP biosynthetic process;blood circulation;cellular response to nitric oxide;nitric oxide mediated signal transduction;cGMP-mediated signaling;trans-synaptic signaling by nitric oxide, modulating synaptic transmission;nitric oxide-cGMP-mediated signaling pathway	GO:000618; GO:000801; GO:007173; GO:000726; GO:001993; GO:009955; GO:003806	guanylate cyclase complex, soluble;presynaptic active zone	GO:000807; GO:004878	 Gap junction; Purine metabolism; Vascular smooth muscle contraction; Circadian entrainment; Long-term depression; Salivary secretion; Oxytocin signaling pathway; Platelet activation; cGMP-PKG signaling pathway	hsa0454; hsa0023; hsa0427; hsa0471; hsa0473; hsa0497; hsa0492; hsa0461; hsa0402	heme binding;protein binding;guanylate cyclase activity;signaling receptor activity;metal ion binding;GTP binding	GO:002003; GO:000551; GO:000438; GO:003802; GO:004687; GO:000552
XP_020956170.1;XP_020956169.1;XP_020956168.1;XP_020956167.1;XP_020956166.1;NP_001018043.1	XP_020956170.1;XP_020956169.1;XP_020956168.1;XP_020956167.1;XP_020956166.1;NP_001018043.1	XP_020956170.1 guanylate cyclase soluble subunit alpha-3 isoform X1 [Sus scrofa];XP_020956169.1 guanylate cyclase soluble subunit alpha-3 isoform X1 [Sus scrofa];XP_020956168.1 guanylate cyclase soluble subunit alpha-3 isoform X1 [Sus scrofa];XP_020956167.	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GUCY1A1	GUCY1A1;GUCY1A1;GUCY1A1;GUCY1A1;GUCY1A1	nitric oxide mediated signal transduction;regulation of blood pressure;response to defense-related host nitric oxide production;blood circulation;cGMP biosynthetic process;positive regulation of nitric oxide mediated signal transduction;relaxation of vascular smooth muscle;retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission	GO:000726; GO:000821; GO:005256; GO:000801; GO:000618; GO:001075; GO:006008; GO:009892	GABA-ergic synapse;glutamatergic synapse;guanylate cyclase complex, soluble	GO:009898; GO:009897; GO:000807	 Renin secretion; Platelet activation; Long-term depression; Vascular smooth muscle contraction; Oxytocin signaling pathway; Purine metabolism; cGMP-PKG signaling pathway; Circadian entrainment; Gap junction; Salivary secretion	hsa0492; hsa0461; hsa0473; hsa0427; hsa0492; hsa0023; hsa0402; hsa0471; hsa0454; hsa0497	GTP binding;protein binding;heme binding;signaling receptor activity;guanylate cyclase activity	GO:000552; GO:000551; GO:002003; GO:003802; GO:000438
XP_005656356.1;NP_001020386.1	XP_005656356.1;NP_001020386.1	XP_005656356.1 cofilin-2 isoform X1 [Sus scrofa];NP_001020386.1 cofilin-2 [Sus scrofa]	7	6	6	122450000	185000000	172770000	144200000	91871000	101290000	129120000	145220000	143290000	198400000	140560000	179340000	162500000	121600000	121180000	145540000	148210000	135990000	NA	NA	NA	CFL2	CFL2;CFL2;NA;NA;NA	sarcomere organization;positive regulation of actin filament depolymerization;muscle cell cellular homeostasis;skeletal muscle tissue development;actin filament depolymerization	GO:004521; GO:003083; GO:004671; GO:000751; GO:003004	Z disc;extracellular exosome;extracellular space;I band;nuclear matrix;actin cytoskeleton	GO:003001; GO:007006; GO:000561; GO:003167; GO:001636; GO:001562	 Axon guidance; Pertussis; Fc gamma R-mediated phagocytosis; Regulation of actin cytoskeleton	hsa0436; hsa0513; hsa0466; hsa0481	actin filament binding;protein binding	GO:005101; GO:000551
NP_001020387.1;XP_020954089.1	NP_001020387.1	NP_001020387.1 histone H1.2-like protein [Sus scrofa]	13	13	3	1257900000	2552600000	1806400000	1717800000	1412000000	2628600000	2064800000	1725900000	1873400000	2182100000	2056000000	2221400000	2670800000	2298900000	1652700000	2163300000	2128200000	2333600000	NA	NA	NA	LOC574051	LOC574051;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020927838.1;NP_001020393.1;XP_020927839.1	XP_020927838.1;NP_001020393.1;XP_020927839.1	XP_020927838.1 myozenin-1 isoform X1 [Sus scrofa];NP_001020393.1 myozenin-1 [Sus scrofa];XP_020927839.1 myozenin-1 isoform X2 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32643000	0	NA	NA	NA	MYOZ1	MYOZ1;MYOZ1;MYOZ1;NA;NA	skeletal muscle fiber adaptation;negative regulation of calcineurin-NFAT signaling cascade;negative regulation of phosphoprotein phosphatase activity;skeletal muscle tissue development;negative regulation of skeletal muscle tissue regeneration;sarcomere organization;myofibril assembly;negative regulation of transcription from RNA polymerase II promoter	GO:004350; GO:007088; GO:003251; GO:000751; GO:004341; GO:004521; GO:003023; GO:000012	pseudopodium;actin cytoskeleton;Z disc;nucleus	GO:003114; GO:001562; GO:003001; GO:000563	"NA"	"NA"	FATZ binding;protein binding;protein serine/threonine phosphatase inhibitor activity;actin binding;telethonin binding	GO:005137; GO:000551; GO:000486; GO:000377; GO:003143
XP_020946862.1;XP_005664187.1;NP_001025706.1;XP_005664186.1	XP_020946862.1;XP_005664187.1;NP_001025706.1;XP_005664186.1	XP_020946862.1 BH3-interacting domain death agonist isoform X1 [Sus scrofa];XP_005664187.1 BH3-interacting domain death agonist isoform X1 [Sus scrofa];NP_001025706.1 BH3-interacting domain death agonist [Sus scrofa];XP_005664186.1 BH3-interacting domain d	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16587000	0	NA	NA	NA	BID	BID;BID;BID;BID;NA	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;apoptotic mitochondrial changes;protein homooligomerization;hepatocyte apoptotic process;mitochondrial ATP synthesis coupled electron transport;positive regulation of apoptotic process;neuron apoptotic process;regulation of G1/S transition of mitotic cell cycle;regulation of cell proliferation;establishment of protein localization to membrane;positive regulation of release of cytochrome c from mitochondria;positive regulation of fibroblast apoptotic process;positive regulation of intrinsic apoptotic signaling pathway;protein targeting to mitochondrion;extrinsic apoptotic signaling pathway via death domain receptors;mitochondrial outer membrane permeabilization;positive regulation of extrinsic apoptotic signaling pathway;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of mitochondrial membrane potential;positive regulation of protein homooligomerization;regulation of apoptotic process;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;release of cytochrome c from mitochondria;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	GO:190223; GO:000863; GO:005126; GO:009728; GO:004277; GO:004306; GO:005140; GO:200004; GO:004212; GO:009015; GO:009020; GO:200027; GO:200124; GO:000662; GO:000862; GO:009734; GO:200123; GO:000691; GO:001091; GO:003246; GO:004298; GO:190103; GO:000183; GO:190074	mitochondrion;mitochondrial outer membrane;cytosol;membrane;integral component of mitochondrial membrane	GO:000573; GO:000574; GO:000582; GO:001602; GO:003259	 Pathways in cancer; Alzheimer's disease; p53 signaling pathway; Viral myocarditis; Sphingolipid signaling pathway; Apoptosis; Natural killer cell mediated cytotoxicity; Non-alcoholic fatty liver disease (NAFLD); Tuberculosis	hsa0520; hsa0501; hsa0411; hsa0541; hsa0407; hsa0421; hsa0465; hsa0493; hsa0515	protein binding;death receptor binding;ubiquitin protein ligase binding;protein heterodimerization activity	GO:000551; GO:000512; GO:003162; GO:004698
XP_020946863.1;NP_001026954.1	XP_020946863.1;NP_001026954.1	XP_020946863.1 ADP-ribosylation factor-like protein 1 isoform X1 [Sus scrofa];NP_001026954.1 ADP-ribosylation factor-like protein 1 [Sus scrofa]	4	4	4	0	11738000	16550000	18981000	0	12612000	13114000	15753000	15075000	16809000	11458000	0	0	14231000	11308000	16310000	14055000	18196000	NA	NA	NA	ARL1	ARL1;ARL1;NA;NA;NA	activation of phospholipase D activity;intracellular protein transport;Golgi organization;vesicle-mediated transport;retrograde transport, endosome to Golgi;Golgi vesicle transport;toxin metabolic process;protein localization to Golgi apparatus	GO:003158; GO:000688; GO:000703; GO:001619; GO:004214; GO:004819; GO:000940; GO:003406	cytosol;cytoplasm;trans-Golgi network;trans-Golgi network membrane;Golgi apparatus	GO:000582; GO:000573; GO:000580; GO:003258; GO:000579	"NA"	"NA"	GTPase activity;GTP binding;protein domain specific binding;metal ion binding;enzyme activator activity	GO:000392; GO:000552; GO:001990; GO:004687; GO:000804
NP_001026955.1	NP_001026955.1	NP_001026955.1 ADP-ribosylation factor-like protein 3 [Sus scrofa]	2	2	2	9972200	0	10366000	9070100	0	9115000	8970600	0	8300100	0	0	0	14006000	0	9782300	7472800	0	10827000	NA	NA	NA	ARL3	ARL3;NA;NA;NA;NA	photoreceptor cell development;post-Golgi vesicle-mediated transport;smoothened signaling pathway;cilium assembly;protein localization to ciliary membrane;small GTPase mediated signal transduction;mitotic cytokinesis;intraciliary transport;kidney development;protein localization to cilium	GO:004246; GO:000689; GO:000722; GO:006027; GO:190344; GO:000726; GO:000028; GO:004207; GO:000182; GO:006151	Golgi apparatus;extracellular exosome;photoreceptor connecting cilium;microtubule cytoskeleton;Golgi membrane;centrosome;cilium;nucleus;cytoplasmic microtubule;spindle microtubule;midbody	GO:000579; GO:007006; GO:003239; GO:001563; GO:000013; GO:000581; GO:000592; GO:000563; GO:000588; GO:000587; GO:003049	"NA"	"NA"	magnesium ion binding;GTP binding;GTPase activity;protein binding;microtubule binding;GDP binding;GTPase activating protein binding	GO:000028; GO:000552; GO:000392; GO:000551; GO:000801; GO:001900; GO:003279
XP_005657451.1;XP_005657450.1;NP_001026956.1	XP_005657451.1;XP_005657450.1;NP_001026956.1	XP_005657451.1 GTP-binding protein SAR1a isoform X1 [Sus scrofa];XP_005657450.1 GTP-binding protein SAR1a isoform X1 [Sus scrofa];NP_001026956.1 GTP-binding protein SAR1a [Sus scrofa]	9	9	6	135410000	190950000	176290000	135270000	133930000	126520000	150870000	222390000	108840000	208540000	172470000	194300000	110090000	152010000	134340000	173250000	124840000	167670000	NA	NA	NA	SAR1A	SAR1A;SAR1A;SAR1A;NA;NA	vesicle organization;intracellular protein transport;regulation of COPII vesicle coating;membrane organization;cargo loading into COPII-coated vesicle;positive regulation of protein exit from endoplasmic reticulum	GO:001605; GO:000688; GO:000340; GO:006102; GO:009011; GO:007086	endoplasmic reticulum;Golgi membrane;COPII vesicle coat;endoplasmic reticulum exit site	GO:000578; GO:000013; GO:003012; GO:007097	 Legionellosis; Protein processing in endoplasmic reticulum	hsa0513; hsa0414	GTPase activity;protein binding;GTP binding	GO:000392; GO:000551; GO:000552
NP_001026957.1	NP_001026957.1	NP_001026957.1 ras-related protein Rab-1A [Sus scrofa]	9	3	3	0	0	0	0	0	0	0	0	0	0	0	13643000	0	0	0	0	0	0	NA	NA	NA	RAB1A	RAB1A;NA;NA;NA;NA	autophagosome assembly;cell migration;establishment of endothelial intestinal barrier;endocytosis;COPII vesicle coating;cilium assembly;ER to Golgi vesicle-mediated transport;interleukin-8 secretion;cargo loading into COPII-coated vesicle;defense response to bacterium;positive regulation of glycoprotein metabolic process;virion assembly;vesicle transport along microtubule;substrate adhesion-dependent cell spreading;post-translational protein modification;Rab protein signal transduction;positive regulation of ubiquitin protein ligase activity;autophagy;Golgi organization;vesicle-mediated transport;growth hormone secretion;melanosome transport	GO:000004; GO:001647; GO:009055; GO:000689; GO:004820; GO:006027; GO:000688; GO:007260; GO:009011; GO:004274; GO:190302; GO:001906; GO:004749; GO:003444; GO:004368; GO:003248; GO:190466; GO:000691; GO:000703; GO:001619; GO:003025; GO:003240	Golgi membrane;endoplasmic reticulum membrane;transport vesicle membrane;early endosome;melanosome;cytosol;extracellular exosome;Golgi apparatus	GO:000013; GO:000578; GO:003065; GO:000576; GO:004247; GO:000582; GO:007006; GO:000579	 Legionellosis	hsa0513	GTPase activity;cadherin binding;protein binding;GTP binding	GO:000392; GO:004529; GO:000551; GO:000552
NP_001026959.1;XP_005669939.1	NP_001026959.1	NP_001026959.1 retinol-binding protein 1 [Sus scrofa]	3	3	3	52270000	0	53800000	0	0	0	72502000	0	0	0	0	0	0	0	57819000	34422000	0	0	NA	NA	NA	RBP1	RBP1;NA;NA;NA;NA	vitamin A metabolic process;lipid homeostasis;retinoic acid biosynthetic process;retinoid metabolic process	GO:000677; GO:005508; GO:000213; GO:000152	nucleoplasm;cytosol;lipid particle	GO:000565; GO:000582; GO:000581	"NA"	"NA"	retinal binding;retinoid binding;all-trans-retinol binding	GO:001691; GO:000550; GO:190476
NP_001026962.1	NP_001026962.1	NP_001026962.1 histone H1.3-like protein [Sus scrofa]	8	2	2	72497000	89764000	141680000	76381000	76486000	104300000	136730000	81458000	96942000	100500000	136130000	0	197020000	108790000	118420000	83986000	140430000	108670000	NA	NA	NA	LOC595122	LOC595122;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020957916.1;NP_001026963.1	XP_020957916.1;NP_001026963.1	XP_020957916.1 nicotinamide phosphoribosyltransferase isoform X1 [Sus scrofa];NP_001026963.1 nicotinamide phosphoribosyltransferase [Sus scrofa]	6	6	6	25303000	12476000	21572000	0	36972000	0	14736000	0	16996000	0	13158000	0	0	0	0	0	17552000	0	NA	NA	NA	NAMPT	NAMPT;NAMPT;NA;NA;NA	NAD biosynthesis via nicotinamide riboside salvage pathway;cellular response to ionizing radiation;response to D-galactose;negative regulation of cellular senescence;negative regulation of autophagy;female pregnancy;circadian regulation of gene expression;cell-cell signaling;circadian rhythm;response to organic cyclic compound;regulation of receptor activity;regulation of lung blood pressure;cellular response to beta-amyloid;signal transduction;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of nitric-oxide synthase biosynthetic process;adipose tissue development;neuron death;cellular response to oxygen-glucose deprivation;microglial cell activation;positive regulation of smooth muscle cell proliferation	GO:003435; GO:007147; GO:190537; GO:200077; GO:001050; GO:000756; GO:003292; GO:000726; GO:000762; GO:001407; GO:001046; GO:001491; GO:190464; GO:000716; GO:000828; GO:004594; GO:005177; GO:006061; GO:007099; GO:009065; GO:000177; GO:004866	cell junction;extracellular exosome;plasma membrane;nuclear speck;cytosol	GO:003005; GO:007006; GO:000588; GO:001660; GO:000582	 Metabolic pathways; Nicotinate and nicotinamide metabolism	hsa0110; hsa0076	identical protein binding;nicotinamide phosphoribosyltransferase activity;cytokine activity;protein homodimerization activity;nicotinate-nucleotide diphosphorylase (carboxylating) activity;protein binding;drug binding	GO:004280; GO:004728; GO:000512; GO:004280; GO:000451; GO:000551; GO:000814
NP_001026964.1	NP_001026964.1	NP_001026964.1 SPARC precursor [Sus scrofa]	10	10	10	102010000	197790000	100280000	221290000	0	126570000	106440000	168530000	96945000	148330000	132770000	178190000	75676000	158240000	115430000	144030000	79883000	222400000	NA	NA	NA	SPARC	SPARC;NA;NA;NA;NA	negative regulation of endothelial cell proliferation;receptor-mediated endocytosis;response to L-ascorbic acid;response to ethanol;bone development;heart development;negative regulation of angiogenesis;response to calcium ion;platelet degranulation;response to lead ion;response to cytokine;pigmentation;response to cadmium ion;response to gravity;wound healing;inner ear development;ossification;response to lipopolysaccharide;cellular response to growth factor stimulus;extracellular matrix organization;lung development;response to glucocorticoid;positive regulation of endothelial cell migration;regulation of cell morphogenesis;response to peptide hormone;regulation of synapse organization	GO:000193; GO:000689; GO:003359; GO:004547; GO:006034; GO:000750; GO:001652; GO:005159; GO:000257; GO:001028; GO:003409; GO:004347; GO:004668; GO:000962; GO:004206; GO:004883; GO:000150; GO:003249; GO:007136; GO:003019; GO:003032; GO:005138; GO:001059; GO:002260; GO:004343; GO:005080	extracellular space;platelet alpha granule membrane;endocytic vesicle lumen;nuclear matrix;plasma membrane;cytoplasm;extracellular region;glutamatergic synapse;basement membrane;cell surface	GO:000561; GO:003109; GO:007168; GO:001636; GO:000588; GO:000573; GO:000557; GO:009897; GO:000560; GO:000998	"NA"	"NA"	collagen binding;calcium ion binding;extracellular matrix binding;extracellular matrix structural constituent;protein binding	GO:000551; GO:000550; GO:005084; GO:000520; GO:000551
NP_001026966.1;XP_020927841.1	NP_001026966.1;XP_020927841.1	NP_001026966.1 2-5-oligoadenylate synthase 2 [Sus scrofa];XP_020927841.1 2-5-oligoadenylate synthase 2 isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	9756400	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OAS2	OAS2;OAS2;NA;NA;NA	defense response to virus;regulation of ribonuclease activity;interferon-gamma-mediated signaling pathway;RNA catabolic process;nucleobase-containing compound metabolic process;regulation of lactation;response to bacterium	GO:005160; GO:006070; GO:006033; GO:000640; GO:000613; GO:190348; GO:000961	membrane;nucleoplasm;perinuclear region of cytoplasm;nucleus;cytosol;intracellular membrane-bounded organelle	GO:001602; GO:000565; GO:004847; GO:000563; GO:000582; GO:004323	 Influenza A; Herpes simplex infection	hsa0516; hsa0516	double-stranded RNA binding;ATP binding;2'-5'-oligoadenylate synthetase activity;metal ion binding;protein binding	GO:000372; GO:000552; GO:000173; GO:004687; GO:000551
NP_001026967.1	NP_001026967.1	NP_001026967.1 FAS-associated death domain protein [Sus scrofa]	3	3	3	0	0	5014900	0	5760000	7426800	6482700	0	0	7634300	0	0	0	0	0	6207700	0	0	NA	NA	NA	FADD	FADD;NA;NA;NA;NA	activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of macrophage differentiation;spleen development;positive regulation of adaptive immune response;viral process;positive regulation of tumor necrosis factor production;cellular response to mechanical stimulus;toll-like receptor 3 signaling pathway;behavioral response to cocaine;necroptotic signaling pathway;positive regulation of extrinsic apoptotic signaling pathway;positive regulation of T cell mediated cytotoxicity;positive regulation of I-kappaB kinase/NF-kappaB signaling;defense response to virus;negative regulation of necroptotic process;TRIF-dependent toll-like receptor signaling pathway;negative regulation of activation-induced cell death of T cells;motor neuron apoptotic process;extrinsic apoptotic signaling pathway;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;apoptotic process;TRAIL-activated apoptotic signaling pathway;T cell homeostasis;positive regulation of apoptotic process;response to morphine;innate immune response;positive regulation of proteolysis;activation of cysteine-type endopeptidase activity;kidney development;cell surface receptor signaling pathway;extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of interleukin-8 production;positive regulation of activated T cell proliferation;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interferon-gamma production;T cell differentiation in thymus;positive regulation of transcription from RNA polymerase II promoter;death-inducing signaling complex assembly;positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation	GO:000691; GO:004565; GO:004853; GO:000282; GO:001603; GO:003276; GO:007126; GO:003413; GO:004814; GO:009752; GO:200123; GO:000191; GO:004312; GO:005160; GO:006054; GO:003566; GO:007023; GO:009704; GO:009719; GO:190204; GO:000691; GO:003646; GO:004302; GO:004306; GO:004327; GO:004508; GO:004586; GO:009720; GO:000182; GO:000716; GO:000862; GO:003275; GO:004210; GO:006034; GO:003272; GO:003307; GO:004594; GO:007155; GO:200045	neuron projection;nucleus;cytosol;CD95 death-inducing signaling complex;ripoptosome;plasma membrane;membrane raft;cell body;cytoplasm	GO:004300; GO:000563; GO:000582; GO:003126; GO:009734; GO:000588; GO:004512; GO:004429; GO:000573	 Alzheimer's disease; Herpes simplex infection; Chagas disease (American trypanosomiasis); Pathways in cancer; Apoptosis; TNF signaling pathway; Tuberculosis; Toll-like receptor signaling pathway	hsa0501; hsa0516; hsa0514; hsa0520; hsa0421; hsa0466; hsa0515; hsa0462	tumor necrosis factor receptor binding;tumor necrosis factor receptor superfamily binding;death effector domain binding;death receptor binding;protease binding;protein binding;identical protein binding;macromolecular complex binding;receptor serine/threonine kinase binding;caspase binding	GO:000516; GO:003281; GO:003587; GO:000512; GO:000202; GO:000551; GO:004280; GO:004487; GO:003361; GO:008972
NP_001027548.1;XP_020935163.1;XP_020935162.1	NP_001027548.1;XP_020935163.1;XP_020935162.1	NP_001027548.1 hypoxanthine-guanine phosphoribosyltransferase [Sus scrofa];XP_020935163.1 hypoxanthine-guanine phosphoribosyltransferase isoform X2 [Sus scrofa];XP_020935162.1 hypoxanthine-guanine phosphoribosyltransferase isoform X1 [Sus scrofa]	8	8	7	85299000	65507000	78427000	66072000	72624000	72987000	73848000	68018000	75224000	60758000	73184000	60376000	83341000	65680000	82228000	65720000	67758000	68443000	NA	NA	NA	HPRT1	HPRT1;HPRT1;HPRT1;NA;NA	locomotory behavior;GMP salvage;purine ribonucleoside salvage;hypoxanthine salvage;hypoxanthine metabolic process;guanine salvage;positive regulation of dopamine metabolic process;IMP metabolic process;grooming behavior;dopamine metabolic process;protein homotetramerization;central nervous system neuron development;lymphocyte proliferation;striatum development;cerebral cortex neuron differentiation;GMP catabolic process;T cell mediated cytotoxicity;response to amphetamine;dendrite morphogenesis	GO:000762; GO:003226; GO:000616; GO:004310; GO:004610; GO:000617; GO:004596; GO:004604; GO:000762; GO:004241; GO:005128; GO:002195; GO:004665; GO:002175; GO:002189; GO:004603; GO:000191; GO:000197; GO:004881	extracellular exosome;cytosol;cytoplasm	GO:007006; GO:000582; GO:000573	 Metabolic pathways; Purine metabolism; Drug metabolism - other enzymes	hsa0110; hsa0023; hsa0098	nucleotide binding;magnesium ion binding;hypoxanthine phosphoribosyltransferase activity;protein binding;protein homodimerization activity;guanine phosphoribosyltransferase activity	GO:000016; GO:000028; GO:000442; GO:000551; GO:004280; GO:005265
NP_001028180.1	NP_001028180.1	NP_001028180.1 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha [Sus scrofa]	6	6	6	255650000	110060000	274300000	178560000	320820000	106710000	281930000	211670000	252590000	187790000	196350000	184610000	76794000	119670000	249040000	229900000	216980000	127920000	NA	NA	NA	AGPAT1	AGPAT1;NA;NA;NA;NA	phosphatidic acid biosynthetic process;CDP-diacylglycerol biosynthetic process;positive regulation of cytokine-mediated signaling pathway;positive regulation of cytokine production;phospholipid metabolic process;positive regulation of cellular metabolic process	GO:000665; GO:001602; GO:000196; GO:000181; GO:000664; GO:003132	integral component of membrane;endoplasmic reticulum;membrane	GO:001602; GO:000578; GO:001602	 Glycerophospholipid metabolism; Metabolic pathways; Glycerolipid metabolism; Fat digestion and absorption	hsa0056; hsa0110; hsa0056; hsa0497	protein binding;1-acylglycerol-3-phosphate O-acyltransferase activity	GO:000551; GO:000384
NP_001028186.1;XP_005653783.1	NP_001028186.1;XP_005653783.1	NP_001028186.1 myosin-binding protein H [Sus scrofa];XP_005653783.1 myosin-binding protein H isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21118000	0	NA	NA	NA	MYBPH	MYBPH;MYBPH;NA;NA;NA	cell adhesion;regulation of striated muscle contraction	GO:000715; GO:000694	myosin filament	GO:003298	"NA"	"NA"	protein binding;structural constituent of muscle	GO:000551; GO:000830
NP_001032223.1;XP_020933343.1	NP_001032223.1	NP_001032223.1 40S ribosomal protein SA [Sus scrofa]	12	12	12	300970000	286160000	303720000	298250000	340990000	337180000	323990000	322330000	313290000	290420000	385140000	286450000	407720000	338190000	345280000	302950000	341210000	333800000	NA	NA	NA	RPSA	RPSA;NA;NA;NA;NA	translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cell adhesion;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosomal small subunit assembly;rRNA export from nucleus;translational initiation;viral entry into host cell;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000018; GO:000715; GO:000044; GO:000046; GO:000002; GO:000640; GO:000641; GO:004671; GO:000661	nucleus;cytosolic small ribosomal subunit;membrane;extracellular exosome;cytosol;cytoplasm;plasma membrane;nucleoplasm	GO:000563; GO:002262; GO:001602; GO:007006; GO:000582; GO:000573; GO:000588; GO:000565	 Ribosome	hsa0301	laminin receptor activity;laminin binding;virus receptor activity;protein binding;structural constituent of ribosome;RNA binding;ribosome binding	GO:000505; GO:004323; GO:000161; GO:000551; GO:000373; GO:000372; GO:004302
NP_001032228.1	NP_001032228.1	NP_001032228.1 triosephosphate isomerase [Sus scrofa]	16	16	16	2226600000	2742900000	2499200000	2055300000	2361500000	2195900000	2279300000	2082700000	2329500000	2402800000	2824900000	3413300000	2493400000	2449100000	2523500000	3028300000	3336700000	2562400000	NA	NA	NA	TPI1	TPI1;NA;NA;NA;NA	glycolytic process;methylglyoxal biosynthetic process;glyceraldehyde-3-phosphate biosynthetic process;multicellular organism development;glycerol catabolic process;gluconeogenesis;canonical glycolysis	GO:000609; GO:001924; GO:004616; GO:000727; GO:001956; GO:000609; GO:006162	extracellular space;nucleus;cytosol;extracellular exosome	GO:000561; GO:000563; GO:000582; GO:007006	 Glycolysis / Gluconeogenesis; Inositol phosphate metabolism; Biosynthesis of antibiotics; Biosynthesis of amino acids; Fructose and mannose metabolism; Metabolic pathways; Carbon metabolism	hsa0001; hsa0056; hsa0113; hsa0123; hsa0005; hsa0110; hsa0120	protein homodimerization activity;ubiquitin protein ligase binding;methylglyoxal synthase activity;triose-phosphate isomerase activity;protein binding	GO:004280; GO:003162; GO:000892; GO:000480; GO:000551
NP_001032810.1	NP_001032810.1	NP_001032810.1 cathepsin D precursor [Sus scrofa]	15	15	15	116320000	146920000	136230000	148210000	127570000	151440000	108530000	133340000	108570000	150180000	141120000	115630000	175040000	179120000	198760000	175050000	137230000	178820000	NA	NA	NA	CTSD	CTSD;NA;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;protein catabolic process;collagen catabolic process;neutrophil degranulation;proteolysis	GO:001988; GO:003016; GO:003057; GO:004331; GO:000650	ficolin-1-rich granule lumen;lysosome;tertiary granule lumen;membrane raft;extracellular exosome;specific granule lumen;melanosome;extracellular region;lysosomal lumen;extracellular space	GO:190481; GO:000576; GO:190472; GO:004512; GO:007006; GO:003558; GO:004247; GO:000557; GO:004320; GO:000561	 Sphingolipid signaling pathway; Tuberculosis; Lysosome	hsa0407; hsa0515; hsa0414	protein binding;aspartic-type endopeptidase activity;serine-type endopeptidase activity	GO:000551; GO:000419; GO:000425
NP_001033050.1	NP_001033050.1	NP_001033050.1 proteasome subunit beta type-9 [Sus scrofa]	2	2	2	0	0	12972000	0	0	0	0	0	14112000	0	14062000	0	0	0	0	0	0	0	NA	NA	NA	PSMB9	PSMB9;NA;NA;NA;NA	post-translational protein modification;viral process;protein deubiquitination;immune system process;proteasomal protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of cysteine-type endopeptidase activity	GO:004368; GO:001603; GO:001657; GO:000237; GO:001049; GO:004316; GO:200011	nucleoplasm;spermatoproteasome complex;proteasome complex;cytoplasm;nucleus;cytosol;extracellular exosome;proteasome core complex;proteasome core complex, beta-subunit complex	GO:000565; GO:199011; GO:000050; GO:000573; GO:000563; GO:000582; GO:007006; GO:000583; GO:001977	 Proteasome	hsa0305	endopeptidase activity;threonine-type endopeptidase activity;protein binding	GO:000417; GO:000429; GO:000551
NP_001033089.1;XP_020932989.1;XP_020932988.1	NP_001033089.1;XP_020932989.1;XP_020932988.1	NP_001033089.1 peptidyl-prolyl cis-trans isomerase FKBP1A [Sus scrofa];XP_020932989.1 peptidyl-prolyl cis-trans isomerase FKBP1A isoform X1 [Sus scrofa];XP_020932988.1 peptidyl-prolyl cis-trans isomerase FKBP1A isoform X1 [Sus scrofa]	4	4	4	333350000	430750000	338160000	229560000	319480000	521150000	333280000	375960000	262630000	426900000	260600000	361120000	214430000	294510000	264040000	359010000	342720000	376460000	NA	NA	NA	FKBP1A	FKBP1A;FKBP1A;FKBP1A;NA;NA	'de novo' protein folding;SMAD protein complex assembly;negative regulation of ryanodine-sensitive calcium-release channel activity;chaperone-mediated protein folding;positive regulation of protein ubiquitination;regulation of protein localization;negative regulation of release of sequestered calcium ion into cytosol;supramolecular fiber organization;calcium ion transmembrane transport;regulation of amyloid precursor protein catabolic process;positive regulation of protein binding;protein refolding;ventricular cardiac muscle tissue morphogenesis;protein folding;protein maturation by protein folding;regulation of activin receptor signaling pathway;heart morphogenesis;protein peptidyl-prolyl isomerization;heart trabecula formation;negative regulation of phosphoprotein phosphatase activity;positive regulation of I-kappaB kinase/NF-kappaB signaling;regulation of immune response;T cell activation;amyloid fibril formation	GO:000645; GO:000718; GO:006031; GO:006107; GO:003139; GO:003288; GO:005128; GO:009743; GO:007058; GO:190299; GO:003209; GO:004202; GO:005501; GO:000645; GO:002241; GO:003292; GO:000300; GO:000041; GO:006034; GO:003251; GO:004312; GO:005077; GO:004211; GO:199000	sarcoplasmic reticulum;cytoplasmic side of membrane;membrane;cytosol;terminal cisterna;Z disc;ryanodine receptor complex;extrinsic component of organelle membrane;cytoplasm	GO:001652; GO:009856; GO:001602; GO:000582; GO:001480; GO:003001; GO:199042; GO:003131; GO:000573	"NA"	"NA"	transforming growth factor beta receptor binding;macrolide binding;calcium channel inhibitor activity;ion channel binding;peptidyl-prolyl cis-trans isomerase activity;protein binding;type I transforming growth factor beta receptor binding;SMAD binding;activin binding	GO:000516; GO:000552; GO:001985; GO:004432; GO:000375; GO:000551; GO:003471; GO:004633; GO:004818
NP_001033096.1	NP_001033096.1	NP_001033096.1 serine/arginine-rich splicing factor 1 [Sus scrofa]	8	8	8	40720000	52240000	44866000	46708000	32299000	49047000	42371000	37456000	46155000	35944000	42817000	48915000	55622000	54907000	0	32060000	24913000	0	NA	NA	NA	SRSF1	SRSF1;NA;NA;NA;NA	liver regeneration;mRNA processing;mRNA splice site selection;oligodendrocyte differentiation;alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;mRNA 3'-end processing;cardiac muscle contraction;in utero embryonic development;RNA export from nucleus;positive regulation of RNA splicing	GO:009742; GO:000639; GO:000637; GO:004870; GO:000038; GO:000039; GO:004529; GO:003112; GO:006004; GO:000170; GO:000640; GO:003312	cytoplasm;exon-exon junction complex;catalytic step 2 spliceosome;nuclear speck;nucleus;nucleoplasm	GO:000573; GO:003514; GO:007101; GO:001660; GO:000563; GO:000565	 Herpes simplex infection; Spliceosome	hsa0516; hsa0304	RNA binding;RS domain binding;protein kinase B binding;protein binding;DNA topoisomerase binding;mRNA binding	GO:000372; GO:005073; GO:004342; GO:000551; GO:004454; GO:000372
NP_001033712.1	NP_001033712.1	NP_001033712.1 guanine nucleotide-binding protein G(q) subunit alpha [Sus scrofa]	9	9	6	85650000	108550000	91537000	83855000	66588000	78381000	89315000	98022000	65462000	79815000	81377000	93074000	63144000	97560000	82671000	101190000	65914000	85510000	NA	NA	NA	GNAQ	GNAQ;NA;NA;NA;NA	phototransduction, visible light;regulation of canonical Wnt signaling pathway;G-protein coupled receptor signaling pathway;entrainment of circadian clock;action potential;platelet activation;positive regulation of GTPase activity;protein stabilization;blood coagulation;negative regulation of protein kinase activity;activation of phospholipase C activity;G-protein coupled acetylcholine receptor signaling pathway	GO:000760; GO:006082; GO:000718; GO:000964; GO:000150; GO:003016; GO:004354; GO:005082; GO:000759; GO:000646; GO:000720; GO:000721	cytoplasm;nuclear membrane;photoreceptor outer segment;plasma membrane;heterotrimeric G-protein complex;lysosomal membrane;extracellular exosome	GO:000573; GO:003196; GO:000175; GO:000588; GO:000583; GO:000576; GO:007006	 Rap1 signaling pathway; Calcium signaling pathway; Circadian entrainment; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Endocrine and other factor-regulated calcium reabsorption; Gastric acid secretion; African trypanosomiasis; Platelet activation; Glucagon signaling pathway; Sphingolipid signaling pathway; Alzheimer's disease; Insulin secretion; Vascular smooth muscle contraction; Adrenergic signaling in cardiomyocytes; Long-term depression; Gap junction; Pathways in cancer	hsa0401; hsa0402; hsa0471; hsa0472; hsa0475; hsa0496; hsa0497; hsa0514; hsa0461; hsa0492; hsa0407; hsa0501; hsa0491; hsa0427; hsa0426; hsa0473; hsa0454; hsa0520	G-protein coupled receptor binding;GTP binding;protein binding;GTPase activator activity;G-protein beta/gamma-subunit complex binding;metal ion binding;type 2A serotonin receptor binding;GTPase activity	GO:000166; GO:000552; GO:000551; GO:000509; GO:003168; GO:004687; GO:003182; GO:000392
NP_001033715.2;XP_020919727.1;XP_020919736.1;XP_013835807.2;NP_001038034.1;XP_020919738.1;XP_020919737.1;XP_013835808.1;XP_005668293.1;XP_005668289.1;XP_005668288.1;XP_005668287.1;NP_001038083.1	NP_001033715.2;XP_020919727.1	NP_001033715.2 aldo-keto reductase family 1, member C-like 1 [Sus scrofa];XP_020919727.1 aldo-keto reductase family 1, member C-like 1 isoform X1 [Sus scrofa]	19	19	19	3139200000	2005700000	2143200000	2014400000	1275600000	820630000	2022500000	2044700000	1930000000	1864400000	1072200000	961300000	702080000	1592100000	1566100000	1882600000	1338300000	1323100000	NA	NA	NA	AKR1C4	AKR1C4;AKR1C4;NA;NA;NA	androgen metabolic process;cellular response to jasmonic acid stimulus;daunorubicin metabolic process;bile acid biosynthetic process;steroid metabolic process;electron transport chain;bile acid and bile salt transport;progesterone metabolic process;retinoid metabolic process	GO:000820; GO:007139; GO:004459; GO:000669; GO:000820; GO:002290; GO:001572; GO:004244; GO:000152	cytoplasm;extracellular exosome;cytosol	GO:000573; GO:007006; GO:000582	 Metabolism of xenobiotics by cytochrome P450; Steroid hormone biosynthesis; Primary bile acid biosynthesis; Metabolic pathways	hsa0098; hsa0014; hsa0012; hsa0110	electron carrier activity;androsterone dehydrogenase activity;alcohol dehydrogenase (NADP+) activity;bile acid transmembrane transporter activity;oxidoreductase activity;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;retinal dehydrogenase activity;alditol:NADP+ 1-oxidoreductase activity;ketosteroid monooxygenase activity;steroid dehydrogenase activity;chlordecone reductase activity	GO:000905; GO:004702; GO:000810; GO:001512; GO:001649; GO:001665; GO:000175; GO:000403; GO:004708; GO:001622; GO:004774
NP_001033721.1	NP_001033721.1	NP_001033721.1 deoxyribonuclease-1-like 1 precursor [Sus scrofa]	5	5	5	57116000	53848000	64785000	54362000	69836000	52792000	61221000	73105000	50548000	40665000	92068000	108860000	59496000	0	54918000	0	54206000	50932000	NA	NA	NA	DNASE1L1	DNASE1L1;NA;NA;NA;NA	neutrophil degranulation;DNA catabolic process;DNA metabolic process;DNA catabolic process, endonucleolytic	GO:004331; GO:000630; GO:000625; GO:000073	nucleus;endoplasmic reticulum;extracellular region;specific granule lumen	GO:000563; GO:000578; GO:000557; GO:003558	"NA"	"NA"	deoxyribonuclease activity;DNA binding;deoxyribonuclease I activity	GO:000453; GO:000367; GO:000453
NP_001033725.1;XP_020937733.1	NP_001033725.1;XP_020937733.1	NP_001033725.1 paralemmin-1 [Sus scrofa];XP_020937733.1 paralemmin-1 isoform X1 [Sus scrofa]	9	9	9	44989000	53606000	49227000	44403000	38035000	47794000	67231000	49546000	47333000	42001000	45868000	38691000	44626000	56540000	59833000	45245000	37916000	56130000	NA	NA	NA	PALM	PALM;PALM;NA;NA;NA	synapse maturation;negative regulation of dopamine receptor signaling pathway;cytoskeleton organization;regulation of cell shape;negative regulation of adenylate cyclase activity;protein localization to plasma membrane;positive regulation of filopodium assembly;cellular response to electrical stimulus	GO:006007; GO:006016; GO:000701; GO:000836; GO:000719; GO:007265; GO:005149; GO:007125	postsynaptic density;intrinsic component of the cytoplasmic side of the plasma membrane;dendritic spine membrane;axon;nucleus;basolateral plasma membrane;filopodium membrane;plasma membrane;intracellular membrane-bounded organelle;cytoplasmic vesicle	GO:001406; GO:003123; GO:003259; GO:003042; GO:000563; GO:001632; GO:003152; GO:000588; GO:004323; GO:003141	"NA"	"NA"	protein binding;D3 dopamine receptor binding	GO:000551; GO:003175
NP_001033727.1	NP_001033727.1	NP_001033727.1 perilipin-1 [Sus scrofa]	40	40	40	7355700000	8059400000	8496700000	9023300000	8044700000	8195400000	7513500000	8738800000	8318900000	10543000000	9677900000	10332000000	4079900000	10703000000	10822000000	13261000000	9576000000	8565700000	NA	NA	NA	PLIN1	PLIN1;NA;NA;NA;NA	lipid catabolic process;lipid metabolic process	GO:001604; GO:000662	endoplasmic reticulum;lipid particle;cytosol	GO:000578; GO:000581; GO:000582	 PPAR signaling pathway; Regulation of lipolysis in adipocytes	hsa0332; hsa0492	lipid binding	GO:000828
NP_001033734.1	NP_001033734.1	NP_001033734.1 palmdelphin [Sus scrofa]	11	11	11	30841000	39321000	38369000	31776000	33057000	26531000	32892000	42115000	31727000	33489000	34743000	0	20079000	37192000	35230000	38151000	33136000	31084000	NA	NA	NA	PALMD	PALMD;NA;NA;NA;NA	regulation of cell shape	GO:000836	dendritic spine;cytoplasm;membrane	GO:004319; GO:000573; GO:001602	"NA"	"NA"	"NA"	"NA"
NP_001034835.1	NP_001034835.1	NP_001034835.1 fatty acid-binding protein, epidermal [Sus scrofa]	16	16	16	1812300000	1316300000	1993100000	1274600000	1936700000	1711400000	1865500000	1650600000	1613500000	1451100000	1493600000	1464000000	1024600000	1329000000	1557000000	1283300000	1381500000	1125300000	NA	NA	NA	FABP5	FABP5;NA;NA;NA;NA	glucose homeostasis;triglyceride catabolic process;epidermis development;glucose metabolic process;regulation of prostaglandin biosynthetic process;positive regulation of peroxisome proliferator activated receptor signaling pathway;phosphatidylcholine biosynthetic process;neutrophil degranulation;regulation of sensory perception of pain;negative regulation of glucose transport;lipid metabolic process	GO:004259; GO:001943; GO:000854; GO:000600; GO:003139; GO:003536; GO:000665; GO:004331; GO:005193; GO:001082; GO:000662	extracellular region;extracellular exosome;nucleus;cell junction;postsynaptic density;synapse;nucleoplasm;cytoplasm;cytosol;plasma membrane;azurophil granule lumen;postsynaptic membrane;secretory granule membrane	GO:000557; GO:007006; GO:000563; GO:003005; GO:001406; GO:004520; GO:000565; GO:000573; GO:000582; GO:000588; GO:003557; GO:004521; GO:003066	 PPAR signaling pathway	hsa0332	lipid binding;fatty acid binding;protein binding;retinoic acid binding;identical protein binding	GO:000828; GO:000550; GO:000551; GO:000197; GO:004280
NP_001037992.1	NP_001037992.1	NP_001037992.1 beta-enolase [Sus scrofa]	17	11	10	0	0	0	32833000	0	0	0	0	0	87715000	0	0	9091900	5842500	0	0	2069000000	0	NA	NA	NA	ENO3	ENO3;NA;NA;NA;NA	gluconeogenesis;response to drug;canonical glycolysis;skeletal muscle tissue regeneration;aging	GO:000609; GO:004249; GO:006162; GO:004340; GO:000756	phosphopyruvate hydratase complex;extracellular space;extracellular exosome;cytosol;membrane;plasma membrane	GO:000001; GO:000561; GO:007006; GO:000582; GO:001602; GO:000588	 RNA degradation; Biosynthesis of amino acids; Glycolysis / Gluconeogenesis; Biosynthesis of antibiotics; Metabolic pathways; Carbon metabolism; HIF-1 signaling pathway	hsa0301; hsa0123; hsa0001; hsa0113; hsa0110; hsa0120; hsa0406	phosphopyruvate hydratase activity;magnesium ion binding;protein heterodimerization activity;protein homodimerization activity	GO:000463; GO:000028; GO:004698; GO:004280
NP_001038000.1;XP_005663527.1	NP_001038000.1;XP_005663527.1	NP_001038000.1 26S proteasome non-ATPase regulatory subunit 4 [Sus scrofa];XP_005663527.1 26S proteasome non-ATPase regulatory subunit 4 isoform X1 [Sus scrofa]	5	5	5	36457000	37046000	51884000	42773000	43272000	0	51412000	43405000	54413000	47190000	31300000	0	41895000	41562000	45796000	51062000	46755000	40968000	NA	NA	NA	PSMD4	PSMD4;PSMD4;NA;NA;NA	post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process;protein deubiquitination;proteasome assembly	GO:004368; GO:004316; GO:001657; GO:004324	cytosol;proteasome complex;nucleoplasm;nucleus;proteasome regulatory particle, base subcomplex;proteasome accessory complex	GO:000582; GO:000050; GO:000565; GO:000563; GO:000854; GO:002262	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	identical protein binding;protein binding;RNA binding;polyubiquitin binding	GO:004280; GO:000551; GO:000372; GO:003159
NP_001038003.1;NP_001090987.1;XP_005654564.1	NP_001038003.1	NP_001038003.1 guanine nucleotide-binding protein subunit alpha-11 [Sus scrofa]	6	3	3	0	11517000	10268000	24683000	10158000	0	10599000	21684000	8806800	11911000	0	18095000	9477800	8721100	0	11286000	0	9437000	NA	NA	NA	GNA11	GNA11;NA;NA;NA;NA	action potential;phospholipase C-activating dopamine receptor signaling pathway;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;entrainment of circadian clock;phototransduction, visible light;developmental pigmentation;cellular response to pH;skeletal system development;signal transduction;platelet activation;G-protein coupled acetylcholine receptor signaling pathway;heart development;regulation of melanocyte differentiation	GO:000150; GO:006015; GO:000718; GO:000964; GO:000760; GO:004806; GO:007146; GO:000150; GO:000716; GO:003016; GO:000721; GO:000750; GO:004563	photoreceptor outer segment;cytoplasm;plasma membrane;heterotrimeric G-protein complex;lysosomal membrane;extracellular exosome	GO:000175; GO:000573; GO:000588; GO:000583; GO:000576; GO:007006	 Chagas disease (American trypanosomiasis); Aldosterone synthesis and secretion; Long-term depression; Amoebiasis; Calcium signaling pathway; Insulin secretion; Cholinergic synapse; Vascular smooth muscle contraction; Gap junction; Pathways in cancer	hsa0514; hsa0492; hsa0473; hsa0514; hsa0402; hsa0491; hsa0472; hsa0427; hsa0454; hsa0520	G-protein coupled receptor binding;GTP binding;metal ion binding;type 2A serotonin receptor binding;GTPase activity;G-protein beta/gamma-subunit complex binding	GO:000166; GO:000552; GO:004687; GO:003182; GO:000392; GO:003168
XP_013839744.1;NP_001038006.1;XP_020930378.1	XP_013839744.1;NP_001038006.1	XP_013839744.1 metaxin-2 isoform X1 [Sus scrofa];NP_001038006.1 metaxin-2 [Sus scrofa]	3	3	3	3771900	4918300	11091000	0	0	0	10656000	0	6288700	0	0	0	0	0	5915100	0	0	0	NA	NA	NA	MTX2	MTX2;MTX2;NA;NA;NA	protein transport;mitochondrial transport	GO:001503; GO:000683	nucleolus;mitochondrial sorting and assembly machinery complex;mitochondrion;mitochondrial outer membrane	GO:000573; GO:000140; GO:000573; GO:000574	"NA"	"NA"	protein binding	GO:000551
NP_001038007.1	NP_001038007.1	NP_001038007.1 60S ribosomal protein L6 [Sus scrofa]	15	15	15	206890000	254450000	354310000	221050000	184460000	315800000	249430000	197840000	292830000	249060000	204110000	223870000	243100000	317010000	207480000	284530000	288040000	301320000	NA	NA	NA	RPL6	RPL6;NA;NA;NA;NA	ribosomal large subunit assembly;cytoplasmic translation;SRP-dependent cotranslational protein targeting to membrane;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of transcription, DNA-templated	GO:000002; GO:000218; GO:000661; GO:000641; GO:000018; GO:000635	membrane;polysomal ribosome;cytosol;postsynaptic density;rough endoplasmic reticulum;cytosolic large ribosomal subunit;cytoplasmic ribonucleoprotein granule;focal adhesion;nucleus	GO:001602; GO:004278; GO:000582; GO:001406; GO:000579; GO:002262; GO:003646; GO:000592; GO:000563	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;cadherin binding;DNA binding	GO:000372; GO:000373; GO:004529; GO:000367
NP_001038008.1;XP_003121835.2	NP_001038008.1;XP_003121835.2	NP_001038008.1 60S ribosomal protein L10 [Sus scrofa];XP_003121835.2 60S ribosomal protein L10-like [Sus scrofa]	5	5	5	33683000	37913000	65095000	0	18008000	68587000	23547000	0	55677000	43422000	32412000	8227700	0	45216000	0	43040000	56423000	40000000	NA	NA	NA	RPL10	RPL10;RPL10L;NA;NA;NA	negative regulation of apoptotic process;translational initiation;ribosomal large subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;embryonic brain development;negative regulation of transcription from RNA polymerase II promoter	GO:004306; GO:000641; GO:000002; GO:000018; GO:000661; GO:199040; GO:000012	nucleus;smooth endoplasmic reticulum;cytosol;macromolecular complex;endoplasmic reticulum;membrane;cytosolic large ribosomal subunit	GO:000563; GO:000579; GO:000582; GO:003299; GO:000578; GO:001602; GO:002262	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;protein binding;translation regulator activity	GO:000373; GO:000372; GO:000551; GO:004518
NP_001038009.1;XP_020947258.1;XP_003355423.1;XP_013843702.1	NP_001038009.1;XP_020947258.1;XP_003355423.1;XP_013843702.1	NP_001038009.1 tubulin alpha-1B chain [Sus scrofa];XP_020947258.1 tubulin alpha-1C chain isoform X3 [Sus scrofa];XP_003355423.1 tubulin alpha-1C chain isoform X2 [Sus scrofa];XP_013843702.1 tubulin alpha-1C chain isoform X1 [Sus scrofa]	25	25	0	4678300000	7231700000	5021100000	5032300000	4474000000	4908500000	4938500000	5434200000	4336100000	5218700000	4734300000	6022500000	5545200000	4877900000	4671100000	5300700000	5043200000	5978400000	NA	NA	NA	TUBA1B	TUBA1B;LOC100127131;LOC100127131;LOC100127131;NA	cellular response to interleukin-4;cell division;microtubule cytoskeleton organization;microtubule-based process;mitotic cell cycle;cytoskeleton-dependent intracellular transport	GO:007135; GO:005130; GO:000022; GO:000701; GO:000027; GO:003070	cytoplasm;microtubule;membrane raft;cytoplasmic microtubule;microtubule cytoskeleton	GO:000573; GO:000587; GO:004512; GO:000588; GO:001563	 Phagosome; Gap junction; Pathogenic Escherichia coli infection	hsa0414; hsa0454; hsa0513	structural constituent of cytoskeleton;ubiquitin protein ligase binding;protein binding;double-stranded RNA binding;GTPase activity;GTP binding;structural molecule activity	GO:000520; GO:003162; GO:000551; GO:000372; GO:000392; GO:000552; GO:000519
XP_020937947.1;NP_001038016.1;XP_020930835.1;XP_020930710.1;XP_020930647.1;XP_020930609.1;XP_020930555.1;XP_013848534.1;XP_005659733.1;XP_005659732.1;XP_003121596.1;NP_001302567.1	XP_020937947.1;NP_001038016.1	XP_020937947.1 creatine kinase S-type, mitochondrial isoform X1 [Sus scrofa];NP_001038016.1 creatine kinase S-type, mitochondrial [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13248000	0	NA	NA	NA	CKMT2	CKMT2;CKMT2;NA;NA;NA	muscle contraction;creatine metabolic process;phosphorylation	GO:000693; GO:000660; GO:001631	mitochondrial inner membrane;mitochondrion	GO:000574; GO:000573	 Metabolic pathways; Arginine and proline metabolism	hsa0110; hsa0033	ATP binding;creatine kinase activity	GO:000552; GO:000411
XP_005673463.1;NP_001038020.1;XP_020936571.1	XP_005673463.1;NP_001038020.1;XP_020936571.1	XP_005673463.1 thymosin beta-4 isoform X1 [Sus scrofa];NP_001038020.1 thymosin beta-4 [Sus scrofa];XP_020936571.1 thymosin beta-4-like [Sus scrofa]	6	6	6	668410000	1246400000	721620000	1241100000	858270000	1688500000	906530000	1499800000	670450000	1456400000	1040700000	1168000000	976950000	1355600000	960270000	1713400000	701830000	1315600000	NA	NA	NA	TMSB4X	TMSB4X;TMSB4X;LOC110257905;NA;NA	actin filament organization;negative regulation of NF-kappaB transcription factor activity;regulation of NIK/NF-kappaB signaling;negative regulation of interleukin-8 secretion;platelet degranulation;sequestering of actin monomers;regulation of cell migration;regulation of inflammatory response;negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding;positive regulation of endothelial cell chemotaxis;positive regulation of ATP biosynthetic process;tumor necrosis factor-mediated signaling pathway;positive regulation of blood vessel endothelial cell migration;positive regulation of proton-transporting ATP synthase activity, rotational mechanism;cytoplasmic sequestering of NF-kappaB	GO:000701; GO:003208; GO:190122; GO:200048; GO:000257; GO:004298; GO:003033; GO:005072; GO:190302; GO:200102; GO:200117; GO:003320; GO:004353; GO:190527; GO:000725	extracellular region;nucleus;cytoskeleton;platelet alpha granule lumen;cytosol;cytoplasm	GO:000557; GO:000563; GO:000585; GO:003109; GO:000582; GO:000573	 Regulation of actin cytoskeleton	hsa0481	enzyme binding;actin monomer binding;protein binding;RNA binding	GO:001989; GO:000378; GO:000551; GO:000372
XP_013852265.1;XP_005663204.1;NP_001038021.1	XP_013852265.1;XP_005663204.1;NP_001038021.1	XP_013852265.1 microsomal glutathione S-transferase 3 isoform X1 [Sus scrofa];XP_005663204.1 microsomal glutathione S-transferase 3 isoform X1 [Sus scrofa];NP_001038021.1 microsomal glutathione S-transferase 3 [Sus scrofa]	3	3	3	85118000	73967000	114080000	0	53847000	55088000	103500000	46788000	137560000	41118000	75850000	0	71075000	41589000	0	55432000	63633000	90098000	NA	NA	NA	MGST3	MGST3;MGST3;MGST3;NA;NA	response to organonitrogen compound;lipid metabolic process;xenobiotic metabolic process;cellular oxidant detoxification;leukotriene biosynthetic process;glutathione derivative biosynthetic process	GO:001024; GO:000662; GO:000680; GO:009886; GO:001937; GO:190168	intracellular membrane-bounded organelle;nuclear envelope;endoplasmic reticulum;organelle membrane;membrane	GO:004323; GO:000563; GO:000578; GO:003109; GO:001602	 Drug metabolism - cytochrome P450; Metabolism of xenobiotics by cytochrome P450; Glutathione metabolism; Chemical carcinogenesis	hsa0098; hsa0098; hsa0048; hsa0520	leukotriene-C4 synthase activity;protein binding;glutathione peroxidase activity;glutathione transferase activity	GO:000446; GO:000551; GO:000460; GO:000436
XP_020944412.1;XP_020944411.1;NP_001038022.1	XP_020944412.1;XP_020944411.1;NP_001038022.1	XP_020944412.1 protein S100-A6 isoform X1 [Sus scrofa];XP_020944411.1 protein S100-A6 isoform X1 [Sus scrofa];NP_001038022.1 protein S100-A6 [Sus scrofa]	4	4	4	13879000	64021000	0	23970000	0	95154000	16148000	14856000	11053000	35708000	15319000	858330000	31505000	32005000	0	13766000	0	64641000	NA	NA	NA	S100A6	S100A6;S100A6;S100A6;NA;NA	positive regulation of fibroblast proliferation;axonogenesis;ion transmembrane transport;signal transduction	GO:004814; GO:000740; GO:003422; GO:000716	extracellular region;nuclear envelope;plasma membrane;cytosol;extrinsic component of cytoplasmic side of plasma membrane;perinuclear region of cytoplasm;extracellular exosome;cytoplasm;ruffle	GO:000557; GO:000563; GO:000588; GO:000582; GO:003123; GO:004847; GO:007006; GO:000573; GO:000172	"NA"	"NA"	zinc ion binding;ion transmembrane transporter activity;calcium ion binding;protein binding;S100 protein binding;tropomyosin binding;protein homodimerization activity;calcium-dependent protein binding	GO:000827; GO:001507; GO:000550; GO:000551; GO:004454; GO:000552; GO:004280; GO:004830
NP_001038024.1	NP_001038024.1	NP_001038024.1 serine/threonine-protein phosphatase PP1-alpha catalytic subunit [Sus scrofa]	14	14	4	60601000	71196000	93136000	89889000	85482000	108420000	65933000	80003000	78561000	99968000	60302000	96782000	93833000	89907000	66482000	93460000	94454000	100840000	NA	NA	NA	PPP1CA	PPP1CA;NA;NA;NA;NA	protein dephosphorylation;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;regulation of glycogen catabolic process;cell division;regulation of canonical Wnt signaling pathway;glycogen metabolic process;circadian regulation of gene expression;regulation of translational initiation by eIF2 alpha dephosphorylation;entrainment of circadian clock by photoperiod;cell-cell adhesion;beta-catenin destruction complex disassembly;dephosphorylation;lung development;regulation of circadian rhythm;cell cycle;negative regulation of protein binding;response to lead ion;peptidyl-threonine dephosphorylation;branching morphogenesis of an epithelial tube;peptidyl-serine dephosphorylation	GO:000647; GO:200124; GO:000598; GO:005130; GO:006082; GO:000597; GO:003292; GO:003649; GO:004315; GO:009860; GO:190488; GO:001631; GO:003032; GO:004275; GO:000704; GO:003209; GO:001028; GO:003597; GO:004875; GO:007026	protein phosphatase type 1 complex;nucleus;cytoplasm;cytosol;dendritic spine;presynapse;glutamatergic synapse;glycogen granule;perikaryon;nucleoplasm;plasma membrane;extracellular exosome;nuclear chromosome, telomeric region;cell-cell adherens junction;PTW/PP1 phosphatase complex	GO:000016; GO:000563; GO:000573; GO:000582; GO:004319; GO:009879; GO:009897; GO:004258; GO:004320; GO:000565; GO:000588; GO:007006; GO:000078; GO:000591; GO:007235	 mRNA surveillance pathway; Vascular smooth muscle contraction; Oocyte meiosis; Oxytocin signaling pathway; Alcoholism; Dopaminergic synapse; Hippo signaling pathway; Insulin signaling pathway; Regulation of actin cytoskeleton; Herpes simplex infection; cAMP signaling pathway; Platelet activation; Insulin resistance; Focal adhesion; Adrenergic signaling in cardiomyocytes; Inflammatory mediator regulation of TRP channels; Proteoglycans in cancer	hsa0301; hsa0427; hsa0411; hsa0492; hsa0503; hsa0472; hsa0439; hsa0491; hsa0481; hsa0516; hsa0402; hsa0461; hsa0493; hsa0451; hsa0426; hsa0475; hsa0520	protein binding;phosphatase activity;protein serine/threonine phosphatase activity;ribonucleoprotein complex binding;protein phosphatase 1 binding;metal ion binding;cadherin binding involved in cell-cell adhesion	GO:000551; GO:001679; GO:000472; GO:004302; GO:000815; GO:004687; GO:009864
NP_001038025.1	NP_001038025.1	NP_001038025.1 serine/threonine-protein phosphatase PP1-gamma catalytic subunit [Sus scrofa]	12	2	2	0	0	0	9266500	0	0	10229000	0	0	0	0	21305000	0	0	0	0	15599000	10156000	NA	NA	NA	PPP1CC	PPP1CC;NA;NA;NA;NA	cell division;regulation of circadian rhythm;positive regulation of glial cell proliferation;neuron differentiation;protein dephosphorylation;cell cycle;circadian regulation of gene expression;entrainment of circadian clock by photoperiod;glycogen metabolic process;regulation of nucleocytoplasmic transport	GO:005130; GO:004275; GO:006025; GO:003018; GO:000647; GO:000704; GO:003292; GO:004315; GO:000597; GO:004682	cytoplasm;nucleolus;presynapse;nucleus;focal adhesion;midbody;cleavage furrow;PTW/PP1 phosphatase complex;nuclear chromosome, telomeric region;cytosol;macromolecular complex;protein phosphatase type 1 complex;nuclear speck;glutamatergic synapse;condensed chromosome kinetochore;mitochondrial outer membrane;dendritic spine	GO:000573; GO:000573; GO:009879; GO:000563; GO:000592; GO:003049; GO:003215; GO:007235; GO:000078; GO:000582; GO:003299; GO:000016; GO:001660; GO:009897; GO:000077; GO:000574; GO:004319	 Oocyte meiosis; Platelet activation; cGMP-PKG signaling pathway; Focal adhesion; Proteoglycans in cancer; Alcoholism; Inflammatory mediator regulation of TRP channels; Herpes simplex infection; Hippo signaling pathway; Regulation of actin cytoskeleton; Long-term potentiation; mRNA surveillance pathway; Vascular smooth muscle contraction; Insulin signaling pathway; Oxytocin signaling pathway; Adrenergic signaling in cardiomyocytes; Insulin resistance	hsa0411; hsa0461; hsa0402; hsa0451; hsa0520; hsa0503; hsa0475; hsa0516; hsa0439; hsa0481; hsa0472; hsa0301; hsa0427; hsa0491; hsa0492; hsa0426; hsa0493	protein serine/threonine phosphatase activity;protein phosphatase 1 binding;phosphoprotein phosphatase activity;phosphatase activity;protein N-terminus binding;protein domain specific binding;RNA binding;protein binding;protein C-terminus binding;lamin binding;macromolecular complex binding;metal ion binding	GO:000472; GO:000815; GO:000472; GO:001679; GO:004748; GO:001990; GO:000372; GO:000551; GO:000802; GO:000552; GO:004487; GO:004687
NP_001038029.1	NP_001038029.1	NP_001038029.1 14-3-3 protein sigma [Sus scrofa]	3	1	1	0	0	0	0	0	0	1700100	0	0	0	0	0	0	0	0	0	0	0	+	NA	NA	SFN	SFN;NA;NA;NA;NA	intrinsic apoptotic signaling pathway in response to DNA damage;establishment of skin barrier;keratinization;positive regulation of epidermal cell differentiation;membrane organization;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of cyclin-dependent protein serine/threonine kinase activity;release of cytochrome c from mitochondria;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;positive regulation of cell growth;positive regulation of protein export from nucleus;negative regulation of protein serine/threonine kinase activity;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;negative regulation of protein kinase activity;signal transduction;negative regulation of keratinocyte proliferation;regulation of epidermal cell division;keratinocyte development	GO:000863; GO:006143; GO:003142; GO:004560; GO:006102; GO:004315; GO:000007; GO:000183; GO:000697; GO:003030; GO:004682; GO:007190; GO:190074; GO:000646; GO:000716; GO:001083; GO:001048; GO:000333	mitochondrion;extracellular exosome;cytosol;nucleus;extracellular space	GO:000573; GO:007006; GO:000582; GO:000563; GO:000561	 Cell cycle; p53 signaling pathway; Aldosterone-regulated sodium reabsorption	hsa0411; hsa0411; hsa0496	cadherin binding;phosphoprotein binding;protein binding;identical protein binding;protein kinase binding;protein kinase C inhibitor activity	GO:004529; GO:005121; GO:000551; GO:004280; GO:001990; GO:000842
NP_001038030.1	NP_001038030.1	NP_001038030.1 proteasome subunit beta type-10 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2449900	0	NA	NA	NA	PSMB10	PSMB10;NA;NA;NA;NA	proteasomal protein catabolic process;viral process;humoral immune response;T cell proliferation;cell morphogenesis;protein deubiquitination;post-translational protein modification;proteasomal ubiquitin-independent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:001049; GO:001603; GO:000695; GO:004209; GO:000090; GO:001657; GO:004368; GO:001049; GO:004316	proteasome complex;proteasome core complex, beta-subunit complex;cytoplasm;cytosol;proteasome core complex;spermatoproteasome complex;nucleoplasm;nucleus	GO:000050; GO:001977; GO:000573; GO:000582; GO:000583; GO:199011; GO:000565; GO:000563	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000417
XP_020951792.1;XP_013854702.1;XP_003127889.1;NP_001231180.1;NP_001038037.3	XP_020951792.1;XP_013854702.1;XP_003127889.1;NP_001231180.1;NP_001038037.3	XP_020951792.1 myosin regulatory light chain 12B [Sus scrofa];XP_013854702.1 myosin regulatory light chain 12B [Sus scrofa];XP_003127889.1 myosin regulatory light chain 12B [Sus scrofa];NP_001231180.1 myosin regulatory light chain 2 protein isoform 2 [Sus	10	10	5	278490000	390910000	423440000	355140000	281950000	660490000	265960000	508550000	320890000	587380000	398090000	285130000	817250000	443530000	326500000	330650000	312600000	399440000	NA	NA	NA	MRLC2	MRLC2;MRLC2;MRLC2;LOC733637;LOC733637	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020927847.1;NP_001038039.1;XP_020927846.1	XP_020927847.1;NP_001038039.1;XP_020927846.1	XP_020927847.1 cGMP-dependent protein kinase 1 isoform X2 [Sus scrofa];NP_001038039.1 cGMP-dependent protein kinase 1 [Sus scrofa];XP_020927846.1 cGMP-dependent protein kinase 1 isoform X1 [Sus scrofa]	3	3	3	0	0	395660000	745220000	0	0	0	0	0	0	0	376590000	0	0	0	464490000	0	0	NA	NA	NA	PRKG1	PRKG1;PRKG1;PRKG1;NA;NA	dendrite development;cGMP-mediated signaling;regulation of GTPase activity;relaxation of vascular smooth muscle;signal transduction;neuron migration;forebrain development;negative regulation of platelet aggregation;negative regulation of vascular associated smooth muscle cell migration;actin cytoskeleton organization;protein phosphorylation;negative regulation of vascular smooth muscle cell proliferation	GO:001635; GO:001993; GO:004308; GO:006008; GO:000716; GO:000176; GO:003090; GO:009033; GO:190475; GO:003003; GO:000646; GO:190470	plasma membrane;cytoplasm;Golgi apparatus;cytosol	GO:000588; GO:000573; GO:000579; GO:000582	 cGMP-PKG signaling pathway; Vascular smooth muscle contraction; Olfactory transduction; Regulation of lipolysis in adipocytes; Gap junction; Circadian entrainment; Salivary secretion; Platelet activation; Long-term depression	hsa0402; hsa0427; hsa0474; hsa0492; hsa0454; hsa0471; hsa0497; hsa0461; hsa0473	protein binding;protein serine/threonine kinase activity;calcium channel regulator activity;cGMP binding;cGMP-dependent protein kinase activity;ATP binding	GO:000551; GO:000467; GO:000524; GO:003055; GO:000469; GO:000552
XP_020932991.1;NP_001038040.1	XP_020932991.1;NP_001038040.1	XP_020932991.1 isocitrate dehydrogenase [NAD] subunit beta, mitochondrial isoform X1 [Sus scrofa];NP_001038040.1 isocitrate dehydrogenase [NAD] subunit beta, mitochondrial [Sus scrofa]	5	5	5	30866000	19841000	29611000	0	25277000	19244000	0	15995000	0	16828000	0	18485000	0	0	0	27429000	0	0	NA	NA	NA	IDH3B	IDH3B;IDH3B;NA;NA;NA	tricarboxylic acid cycle;electron transport chain;isocitrate metabolic process	GO:000609; GO:002290; GO:000610	nucleus;mitochondrion;mitochondrial matrix	GO:000563; GO:000573; GO:000575	 Biosynthesis of antibiotics; Carbon metabolism; Citrate cycle (TCA cycle); Biosynthesis of amino acids; Metabolic pathways; 2-Oxocarboxylic acid metabolism	hsa0113; hsa0120; hsa0002; hsa0123; hsa0110; hsa0121	magnesium ion binding;NAD binding;isocitrate dehydrogenase (NAD+) activity;electron carrier activity	GO:000028; GO:005128; GO:000444; GO:000905
NP_001038043.1	NP_001038043.1	NP_001038043.1 granulins precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GRN	GRN;NA;NA;NA;NA	positive regulation of cell migration;signal transduction;regulation of receptor activity;neutrophil degranulation	GO:003033; GO:000716; GO:001046; GO:004331	extracellular exosome;extracellular region;lysosome;azurophil granule lumen;extracellular space;endoplasmic reticulum	GO:007006; GO:000557; GO:000576; GO:003557; GO:000561; GO:000578	"NA"	"NA"	protein binding;growth factor activity;RNA binding;cytokine activity	GO:000551; GO:000808; GO:000372; GO:000512
NP_001038045.1	NP_001038045.1	NP_001038045.1 signal transducer and activator of transcription 3 [Sus scrofa]	11	11	11	0	40906000	56121000	30220000	35775000	37721000	52283000	37043000	43038000	32035000	34786000	29054000	38373000	36166000	0	30252000	41267000	31356000	NA	NA	NA	STAT3	STAT3;NA;NA;NA;NA	eye photoreceptor cell differentiation;protein import into nucleus;negative regulation of autophagy;cytokine-mediated signaling pathway;positive regulation of cell migration;response to estradiol;negative regulation of apoptotic process;response to ethanol;positive regulation of erythrocyte differentiation;positive regulation of gene silencing by miRNA;leptin-mediated signaling pathway;interleukin-6-mediated signaling pathway;acute-phase response;negative regulation of hydrogen peroxide biosynthetic process;viral process;phosphorylation;interleukin-23-mediated signaling pathway;positive regulation of tyrosine phosphorylation of STAT protein;glucose homeostasis;eating behavior;positive regulation of angiogenesis;regulation of mitochondrial membrane permeability;growth hormone receptor signaling pathway;energy homeostasis;negative regulation of stem cell differentiation;mRNA transcription from RNA polymerase II promoter;positive regulation of interleukin-6 biosynthetic process;modulation of synaptic transmission;regulation of feeding behavior;cellular response to organic cyclic compound;negative regulation of transcription from RNA polymerase II promoter;interleukin-7-mediated signaling pathway;cellular response to leptin stimulus;radial glial cell differentiation;T-helper 17 cell lineage commitment;positive regulation of ATP biosynthetic process;negative regulation of neuron migration;regulation of transcription, DNA-templated;sexual reproduction;positive regulation of Notch signaling pathway;astrocyte differentiation;regulation of cell cycle;positive regulation of metalloendopeptidase activity;positive regulation of vascular endothelial cell proliferation;temperature homeostasis;signal transduction;cell proliferation;positive regulation of gene expression;intracellular receptor signaling pathway;somatic stem cell population maintenance;miRNA mediated inhibition of translation;interleukin-15-mediated signaling pathway;positive regulation of transcription, DNA-templated;negative regulation of neuron death;interleukin-35-mediated signaling pathway;JAK-STAT cascade;nervous system development;cellular response to hormone stimulus;negative regulation of glycolytic process;positive regulation of transcription from RNA polymerase II promoter;positive regulation of growth factor dependent skeletal muscle satellite cell proliferation;regulation of multicellular organism growth;aging;positive regulation of NF-kappaB transcription factor activity;cellular response to cytokine stimulus;positive regulation of pri-miRNA transcription from RNA polymerase II promoter;postsynapse to nucleus signaling pathway	GO:000175; GO:000660; GO:001050; GO:001922; GO:003033; GO:003235; GO:004306; GO:004547; GO:004564; GO:200063; GO:003321; GO:007010; GO:000695; GO:001073; GO:001603; GO:001631; GO:003815; GO:004253; GO:004259; GO:004275; GO:004576; GO:004690; GO:006039; GO:009700; GO:200073; GO:004278; GO:004541; GO:005080; GO:006025; GO:007140; GO:000012; GO:003811; GO:004432; GO:006001; GO:007254; GO:200117; GO:200122; GO:000635; GO:001995; GO:004574; GO:004870; GO:005172; GO:190468; GO:190556; GO:000165; GO:000716; GO:000828; GO:001062; GO:003052; GO:003501; GO:003527; GO:003572; GO:004589; GO:190121; GO:007075; GO:000725; GO:000739; GO:003287; GO:004582; GO:004594; GO:190272; GO:004001; GO:000756; GO:005109; GO:007134; GO:190289; GO:009952	postsynaptic density;glutamatergic synapse;nucleus;mitochondrial inner membrane;Schaffer collateral - CA1 synapse;RNA polymerase II transcription factor complex;nucleoplasm;cytoplasm;plasma membrane;nuclear chromatin;cytosol	GO:001406; GO:009897; GO:000563; GO:000574; GO:009868; GO:009057; GO:000565; GO:000573; GO:000588; GO:000079; GO:000582	 Chemokine signaling pathway; Pathways in cancer; Measles; HIF-1 signaling pathway; Acute myeloid leukemia; Signaling pathways regulating pluripotency of stem cells; Jak-STAT signaling pathway; Toxoplasmosis; Prolactin signaling pathway; Inflammatory bowel disease (IBD); Insulin resistance; Adipocytokine signaling pathway; Pancreatic cancer	hsa0406; hsa0520; hsa0516; hsa0406; hsa0522; hsa0455; hsa0463; hsa0514; hsa0491; hsa0532; hsa0493; hsa0492; hsa0521	CCR5 chemokine receptor binding;protein phosphatase binding;transcription factor activity, sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;protein dimerization activity;DNA binding;RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding;transcription factor binding;glucocorticoid receptor binding;protein homodimerization activity;protein binding;chromatin DNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;transcription regulatory region DNA binding;RNA polymerase II repressing transcription factor binding	GO:003173; GO:001990; GO:000370; GO:000098; GO:004698; GO:000367; GO:000487; GO:000813; GO:003525; GO:004280; GO:000551; GO:003149; GO:000097; GO:000122; GO:004421; GO:000110
XP_020949263.1;NP_001038049.1;XP_020949264.1	XP_020949263.1;NP_001038049.1;XP_020949264.1	XP_020949263.1 quinone oxidoreductase isoform X1 [Sus scrofa];NP_001038049.1 quinone oxidoreductase [Sus scrofa];XP_020949264.1 quinone oxidoreductase isoform X2 [Sus scrofa]	5	5	5	21563000	30154000	35092000	0	32420000	0	44728000	39437000	30652000	34375000	26382000	40352000	19882000	40569000	39764000	60513000	37125000	35446000	NA	NA	NA	CRYZ	CRYZ;CRYZ;CRYZ;NA;NA	oxidation-reduction process;protein homotetramerization;xenobiotic catabolic process;visual perception	GO:005511; GO:005128; GO:004217; GO:000760	extracellular exosome;cytosol	GO:007006; GO:000582	"NA"	"NA"	NADH binding;NADPH binding;mRNA 3'-UTR binding;NADPH:quinone reductase activity;zinc ion binding	GO:007040; GO:007040; GO:000373; GO:000396; GO:000827
NP_001038055.1;CON__P06868	NP_001038055.1	NP_001038055.1 plasminogen precursor [Sus scrofa]	35	35	35	680110000	668570000	707830000	916870000	1771200000	2551300000	1132500000	772790000	1032500000	806470000	883330000	692170000	766880000	891920000	793350000	754800000	1012000000	1138000000	NA	NA	NA	PLG	PLG;NA;NA;NA;NA	negative regulation of fibrinolysis;modification by host of symbiont morphology or physiology via secreted substance;interaction with symbiont;interaction with symbiont via secreted substance involved in symbiotic interaction;fibrinolysis;platelet degranulation;extracellular matrix disassembly;blood coagulation;tissue remodeling;proteolysis;negative regulation of cell-substrate adhesion;positive regulation of fibrinolysis;negative regulation of cell-cell adhesion mediated by cadherin;negative regulation of cell proliferation;cellular protein metabolic process	GO:005191; GO:005218; GO:005170; GO:005221; GO:004273; GO:000257; GO:002261; GO:000759; GO:004877; GO:000650; GO:001081; GO:005191; GO:200004; GO:000828; GO:004426	extrinsic component of external side of plasma membrane;extracellular space;platelet alpha granule lumen;other organism cell membrane;plasma membrane;extracellular region;extracellular exosome;blood microparticle;cell surface	GO:003123; GO:000561; GO:003109; GO:004421; GO:000588; GO:000557; GO:007006; GO:007256; GO:000998	 Neuroactive ligand-receptor interaction; Staphylococcus aureus infection; Complement and coagulation cascades; Influenza A	hsa0408; hsa0515; hsa0461; hsa0516	serine-type peptidase activity;proteasome core complex binding;protein antigen binding;enzyme binding;kinase binding;apolipoprotein binding;receptor binding;endopeptidase activity;protein binding;chaperone binding;serine-type endopeptidase activity	GO:000823; GO:190485; GO:199040; GO:001989; GO:001990; GO:003418; GO:000510; GO:000417; GO:000551; GO:005108; GO:000425
NP_001038057.1	NP_001038057.1	NP_001038057.1 coagulation factor X precursor [Sus scrofa]	3	3	3	0	0	0	0	0	47951000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	F10	F10;NA;NA;NA;NA	positive regulation of cell migration;ER to Golgi vesicle-mediated transport;blood coagulation, extrinsic pathway;proteolysis;positive regulation of protein kinase B signaling	GO:003033; GO:000688; GO:000759; GO:000650; GO:005189	Golgi lumen;endoplasmic reticulum lumen;plasma membrane;extracellular region;extracellular space;intrinsic component of external side of plasma membrane	GO:000579; GO:000578; GO:000588; GO:000557; GO:000561; GO:003123	 Complement and coagulation cascades	hsa0461	serine-type endopeptidase activity;protein binding;phospholipid binding;calcium ion binding	GO:000425; GO:000551; GO:000554; GO:000550
XP_020957928.1;XP_020957927.1;XP_020957926.1;NP_001038066.1	XP_020957928.1;XP_020957927.1;XP_020957926.1;NP_001038066.1	XP_020957928.1 40S ribosomal protein S3 isoform X1 [Sus scrofa];XP_020957927.1 40S ribosomal protein S3 isoform X1 [Sus scrofa];XP_020957926.1 40S ribosomal protein S3 isoform X1 [Sus scrofa];NP_001038066.1 40S ribosomal protein S3 [Sus scrofa]	13	13	13	260510000	258280000	317680000	291480000	270760000	323850000	303060000	282460000	254370000	281020000	313120000	240750000	275230000	321910000	308970000	306180000	305030000	326010000	NA	NA	NA	RPS3	RPS3;RPS3;RPS3;RPS3;NA	DNA repair;response to oxidative stress;positive regulation of microtubule polymerization;DNA damage response, detection of DNA damage;positive regulation of NF-kappaB transcription factor activity;response to TNF agonist;positive regulation of NIK/NF-kappaB signaling;regulation of apoptotic process;negative regulation of translation;positive regulation of JUN kinase activity;positive regulation of DNA N-glycosylase activity;chromosome segregation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of endodeoxyribonuclease activity;negative regulation of protein ubiquitination;spindle assembly;cell division;SRP-dependent cotranslational protein targeting to membrane;positive regulation of gene expression;negative regulation of DNA repair;cellular response to tumor necrosis factor;translational initiation;positive regulation of protein complex assembly;positive regulation of activated T cell proliferation;positive regulation of apoptotic signaling pathway;positive regulation of T cell receptor signaling pathway;positive regulation of interleukin-2 production;cellular response to hydrogen peroxide;positive regulation of base-excision repair;apoptotic process;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage;positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	GO:000628; GO:000697; GO:003111; GO:004276; GO:005109; GO:006148; GO:190122; GO:004298; GO:001714; GO:004350; GO:190254; GO:000705; GO:000018; GO:003207; GO:003139; GO:005122; GO:005130; GO:000661; GO:001062; GO:004573; GO:007135; GO:000641; GO:003133; GO:004210; GO:200123; GO:005086; GO:003274; GO:007030; GO:190505; GO:000691; GO:190223; GO:200127	focal adhesion;nucleus;cytosol;cytoplasm;polysome;ruffle membrane;plasma membrane;cytosolic small ribosomal subunit;nucleoplasm;mitochondrial matrix;postsynaptic density;extracellular exosome;membrane;mitochondrial inner membrane;mitotic spindle;ribonucleoprotein complex;endoplasmic reticulum;NF-kappaB complex	GO:000592; GO:000563; GO:000582; GO:000573; GO:000584; GO:003258; GO:000588; GO:002262; GO:000565; GO:000575; GO:001406; GO:007006; GO:001602; GO:000574; GO:007268; GO:199090; GO:000578; GO:007115	 Ribosome	hsa0301	DNA binding;RNA binding;protein kinase A binding;microtubule binding;oxidized purine DNA binding;iron-sulfur cluster binding;structural constituent of ribosome;endodeoxyribonuclease activity;tubulin binding;enzyme binding;Hsp90 protein binding;small ribosomal subunit rRNA binding;supercoiled DNA binding;damaged DNA binding;oxidized purine nucleobase lesion DNA N-glycosylase activity;DNA N-glycosylase activity;ubiquitin-like protein conjugating enzyme binding;RNA polymerase II regulatory region sequence-specific DNA binding;kinase binding;Hsp70 protein binding;protein binding;DNA-(apurinic or apyrimidinic site) lyase activity;transcription factor binding;macromolecular complex binding	GO:000367; GO:000372; GO:005101; GO:000801; GO:003235; GO:005153; GO:000373; GO:000452; GO:001563; GO:001989; GO:005187; GO:007018; GO:009710; GO:000368; GO:000853; GO:001910; GO:004439; GO:000097; GO:001990; GO:003054; GO:000551; GO:000390; GO:000813; GO:004487
NP_001038067.1	NP_001038067.1	NP_001038067.1 cystatin-C precursor [Sus scrofa]	4	4	4	24596000	37211000	29470000	49704000	43711000	46916000	30381000	41348000	0	41936000	0	66076000	18898000	28353000	29425000	39384000	41293000	37351000	NA	NA	NA	CST3	CST3;NA;NA;NA;NA	defense response;negative regulation of endopeptidase activity;regulation of tissue remodeling;negative regulation of peptidase activity;negative regulation of elastin catabolic process;negative regulation of extracellular matrix disassembly;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;negative regulation of proteolysis;supramolecular fiber organization	GO:000695; GO:001095; GO:003410; GO:001046; GO:006031; GO:001071; GO:004331; GO:004368; GO:004426; GO:004586; GO:009743	extracellular region;endoplasmic reticulum lumen;extracellular exosome;tertiary granule lumen;ficolin-1-rich granule lumen;extracellular space	GO:000557; GO:000578; GO:007006; GO:190472; GO:190481; GO:000561	 Salivary secretion	hsa0497	protein binding;endopeptidase inhibitor activity;identical protein binding;beta-amyloid binding;protease binding	GO:000551; GO:000486; GO:004280; GO:000154; GO:000202
NP_001038071.1	NP_001038071.1	NP_001038071.1 ATP synthase subunit O, mitochondrial precursor [Sus scrofa]	8	8	8	114970000	58271000	120580000	82293000	119180000	56194000	105960000	110660000	90854000	129330000	74441000	88302000	51988000	97732000	64873000	126200000	74053000	41031000	NA	NA	NA	ATP5PO	ATP5PO;NA;NA;NA;NA	ATP biosynthetic process;mitochondrial ATP synthesis coupled proton transport;ATP hydrolysis coupled cation transmembrane transport;hydrogen ion transmembrane transport;cristae formation	GO:000675; GO:004277; GO:009913; GO:190260; GO:004240	mitochondrion;mitochondrial proton-transporting ATP synthase complex;plasma membrane;mitochondrial inner membrane;nucleus	GO:000573; GO:000575; GO:000588; GO:000574; GO:000563	 Oxidative phosphorylation; Huntington's disease; Metabolic pathways	hsa0019; hsa0501; hsa0110	ATPase activity;proton-transporting ATP synthase activity, rotational mechanism;transmembrane transporter activity;protein binding;transporter activity;drug binding	GO:001688; GO:004693; GO:002285; GO:000551; GO:000521; GO:000814
XP_020949269.1;NP_001038072.1;XP_020949268.1	XP_020949269.1;NP_001038072.1;XP_020949268.1	XP_020949269.1 delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial isoform X2 [Sus scrofa];NP_001038072.1 delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial [Sus scrofa];XP_020949268.1 delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondri	8	8	8	134710000	80300000	106510000	41562000	93460000	59283000	132500000	55633000	127320000	51750000	73753000	39573000	65650000	70796000	102880000	65810000	67239000	45922000	NA	NA	NA	ECH1	ECH1;ECH1;ECH1;NA;NA	protein targeting to peroxisome;fatty acid beta-oxidation	GO:000662; GO:000663	extracellular exosome;mitochondrion;peroxisomal matrix;peroxisome;cytosol;membrane	GO:007006; GO:000573; GO:000578; GO:000577; GO:000582; GO:001602	 Peroxisome	hsa0414	protein binding;delta3,5-delta2,4-dienoyl-CoA isomerase activity;receptor binding	GO:000551; GO:005175; GO:000510
NP_001038075.1	NP_001038075.1	NP_001038075.1 nucleoside diphosphate kinase B [Sus scrofa]	8	8	5	369420000	433430000	355030000	262360000	275730000	284130000	307720000	409800000	336550000	265260000	295140000	100440000	331490000	276740000	300530000	256920000	385610000	448870000	NA	NA	NA	NME2	NME2;NA;NA;NA;NA	neutrophil degranulation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of keratinocyte differentiation;regulation of epidermis development;GTP biosynthetic process;nucleobase-containing small molecule interconversion;positive regulation of epithelial cell proliferation;CTP biosynthetic process;adenylate cyclase-activating G-protein coupled receptor signaling pathway;integrin-mediated signaling pathway;negative regulation of myeloid leukocyte differentiation;nucleoside diphosphate phosphorylation;positive regulation of neuron projection development;negative regulation of apoptotic process;protein autophosphorylation;cellular response to fatty acid;UTP biosynthetic process;cell adhesion;nucleoside triphosphate biosynthetic process;positive regulation of transcription, DNA-templated;cellular response to glucose stimulus;peptidyl-histidine phosphorylation;cellular response to oxidative stress;protein oligomerization;response to growth hormone	GO:004331; GO:004594; GO:004561; GO:004568; GO:000618; GO:001594; GO:005067; GO:000624; GO:000718; GO:000722; GO:000276; GO:000616; GO:001097; GO:004306; GO:004677; GO:007139; GO:000622; GO:000715; GO:000914; GO:004589; GO:007133; GO:001810; GO:003459; GO:005125; GO:006041	cytosol;secretory granule lumen;extracellular region;focal adhesion;lamellipodium;perinuclear region of cytoplasm;cell periphery;intermediate filament;cytoplasm;extracellular exosome;ruffle;nucleus;mitochondrial membrane;ficolin-1-rich granule lumen	GO:000582; GO:003477; GO:000557; GO:000592; GO:003002; GO:004847; GO:007194; GO:000588; GO:000573; GO:007006; GO:000172; GO:000563; GO:003196; GO:190481	 Pyrimidine metabolism; Biosynthesis of antibiotics; Purine metabolism; Metabolic pathways	hsa0024; hsa0113; hsa0023; hsa0110	ATP binding;transcription coactivator activity;protein binding;G-quadruplex DNA binding;metal ion binding;DNA binding;intermediate filament binding;enzyme binding;nucleoside diphosphate kinase activity;fatty acid binding;protein histidine kinase activity;GDP binding	GO:000552; GO:000371; GO:000551; GO:005188; GO:004687; GO:000367; GO:001921; GO:001989; GO:000455; GO:000550; GO:000467; GO:001900
NP_001038076.1	NP_001038076.1	NP_001038076.1 aldehyde dehydrogenase, mitochondrial precursor [Sus scrofa]	18	15	15	238390000	158920000	357140000	211190000	74919000	90306000	430930000	250260000	171760000	156650000	157320000	141960000	304890000	283650000	306750000	251250000	239740000	137660000	NA	NA	NA	ALDH2	ALDH2;NA;NA;NA;NA	alcohol metabolic process;ethanol oxidation;carbohydrate metabolic process;electron transport chain	GO:000606; GO:000606; GO:000597; GO:002290	mitochondrial matrix;extracellular exosome	GO:000575; GO:007006	 Metabolic pathways; Fatty acid degradation; Valine, leucine and isoleucine degradation; Histidine metabolism; Biosynthesis of antibiotics; Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Lysine degradation; Arginine and proline metabolism; beta-Alanine metabolism; Pyruvate metabolism; Glycolysis / Gluconeogenesis; Tryptophan metabolism; Glycerolipid metabolism	hsa0110; hsa0007; hsa0028; hsa0034; hsa0113; hsa0004; hsa0005; hsa0031; hsa0033; hsa0041; hsa0062; hsa0001; hsa0038; hsa0056	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;aldehyde dehydrogenase [NAD(P)+;electron carrier activity;aldehyde dehydrogenase (NAD) activity;NAD binding	GO:004387; GO:000403; GO:000905; GO:000402; GO:005128
NP_001038077.1	NP_001038077.1	NP_001038077.1 tubulin beta chain [Sus scrofa]	24	7	6	744460000	1159100000	739910000	1060700000	840480000	923580000	765960000	1208000000	709820000	1186300000	869960000	1281300000	838240000	1202700000	1038300000	1189700000	839910000	1196200000	NA	NA	NA	TUBB	TUBB;NA;NA;NA;NA	ciliary basal body docking;neutrophil degranulation;spindle assembly;cell division;mitotic cell cycle;cytoskeleton-dependent intracellular transport;natural killer cell mediated cytotoxicity;regulation of G2/M transition of mitotic cell cycle;G2/M transition of mitotic cell cycle;regulation of synapse organization;microtubule cytoskeleton organization;microtubule-based process;cellular process	GO:009771; GO:004331; GO:005122; GO:005130; GO:000027; GO:003070; GO:004226; GO:001038; GO:000008; GO:005080; GO:000022; GO:000701; GO:000998	nucleus;azurophil granule lumen;cytoskeleton;cytoplasmic ribonucleoprotein granule;nuclear envelope lumen;cell body;membrane raft;extracellular exosome;extracellular region;cytoplasm;microtubule	GO:000563; GO:003557; GO:000585; GO:003646; GO:000564; GO:004429; GO:004512; GO:007006; GO:000557; GO:000573; GO:000587	 Phagosome; Pathogenic Escherichia coli infection; Gap junction	hsa0414; hsa0513; hsa0454	structural constituent of cytoskeleton;MHC class I protein binding;GTPase activity;protein domain specific binding;macromolecular complex binding;protein binding;ubiquitin protein ligase binding;GTPase activating protein binding;GTP binding;structural molecule activity	GO:000520; GO:004228; GO:000392; GO:001990; GO:004487; GO:000551; GO:003162; GO:003279; GO:000552; GO:000519
XP_020932993.1;XP_020932992.1;XP_005672893.1;NP_001038078.1	XP_020932993.1;XP_020932992.1;XP_005672893.1;NP_001038078.1	XP_020932993.1 microtubule-associated protein RP/EB family member 1 isoform X1 [Sus scrofa];XP_020932992.1 microtubule-associated protein RP/EB family member 1 isoform X1 [Sus scrofa];XP_005672893.1 microtubule-associated protein RP/EB family member 1 isof	9	9	8	64074000	62224000	51368000	66259000	52511000	52555000	48761000	58893000	53458000	61589000	65921000	106110000	55795000	71954000	71930000	60397000	49022000	61405000	NA	NA	NA	MAPRE1	MAPRE1;MAPRE1;MAPRE1;MAPRE1;NA	ciliary basal body docking;cell migration;positive regulation of cell migration;G2/M transition of mitotic cell cycle;positive regulation of microtubule polymerization;protein localization;spindle assembly;cell division;protein localization to microtubule plus-end;regulation of G2/M transition of mitotic cell cycle;protein localization to microtubule;cell proliferation;positive regulation of microtubule plus-end binding	GO:009771; GO:001647; GO:003033; GO:000008; GO:003111; GO:000810; GO:005122; GO:005130; GO:190482; GO:001038; GO:003537; GO:000828; GO:190303	microtubule organizing center;spindle midzone;cytoplasmic microtubule;spindle;focal adhesion;Golgi apparatus;microtubule;cortical microtubule cytoskeleton;cytosol;cell projection membrane;microtubule plus-end	GO:000581; GO:005123; GO:000588; GO:000581; GO:000592; GO:000579; GO:000587; GO:003098; GO:000582; GO:003125; GO:003537	"NA"	"NA"	protein C-terminus binding;RNA binding;cadherin binding;microtubule plus-end binding;microtubule binding;protein kinase binding;protein binding;identical protein binding	GO:000802; GO:000372; GO:004529; GO:005101; GO:000801; GO:001990; GO:000551; GO:004280
NP_001038079.1	NP_001038079.1	NP_001038079.1 thioredoxin-interacting protein [Sus scrofa]	4	4	4	0	0	5360100	5103600	0	0	4852000	5102900	5069100	5145800	0	0	0	0	4431800	5179800	0	1987400	NA	NA	NA	TXNIP	TXNIP;NA;NA;NA;NA	negative regulation of catalytic activity;platelet-derived growth factor receptor signaling pathway;positive regulation of apoptotic process;protein import into nucleus;keratinocyte differentiation;cell cycle;response to mechanical stimulus;response to glucose;regulation of cell proliferation;response to calcium ion;response to progesterone;negative regulation of transcription from RNA polymerase II promoter;response to estradiol;negative regulation of cell division;response to hydrogen peroxide;cellular response to tumor cell	GO:004308; GO:004800; GO:004306; GO:000660; GO:003021; GO:000704; GO:000961; GO:000974; GO:004212; GO:005159; GO:003257; GO:000012; GO:003235; GO:005178; GO:004254; GO:007122	cytoplasm;nucleus;cytosol;mitochondrial intermembrane space	GO:000573; GO:000563; GO:000582; GO:000575	"NA"	"NA"	enzyme inhibitor activity;protein binding;ubiquitin protein ligase binding	GO:000485; GO:000551; GO:003162
NP_001038084.1	NP_001038084.1	NP_001038084.1 mannose-P-dolichol utilization defect 1 protein [Sus scrofa]	3	3	3	23001000	0	0	0	0	0	0	0	18720000	18349000	0	0	0	0	0	32538000	22629000	28191000	NA	NA	NA	MPDU1	MPDU1;NA;NA;NA;NA	dolichol-linked oligosaccharide biosynthetic process;oligosaccharide biosynthetic process;protein folding	GO:000648; GO:000931; GO:000645	integral component of membrane;endoplasmic reticulum membrane;membrane	GO:001602; GO:000578; GO:001602	"NA"	"NA"	protein binding	GO:000551
NP_001038086.3;XP_013846182.1;XP_003126308.1;XP_005671073.1;XP_005671070.1;NP_001152776.1;NP_001272394.1;XP_013834619.1;XP_005655651.1;NP_001159516.1;XP_020931853.1;XP_020931852.1;XP_020958023.1;XP_020958022.1;XP_020931851.1;XP_020931850.1;XP_020931848.1;XP_020931847.1;XP_020931846.1;XP_020958021.1;XP_020918940.1;XP_020918939.1;XP_020922712.1;XP_005653988.1;XP_020922711.1;XP_020934504.1;XP_020922710.1;XP_003358110.1;XP_005653987.1;XP_003131553.1	NP_001038086.3;XP_013846182.1	NP_001038086.3 cyclin-dependent-like kinase 5 [Sus scrofa];XP_013846182.1 cyclin-dependent-like kinase 5 isoform X1 [Sus scrofa]	3	3	2	15684000	25075000	21373000	0	0	0	14148000	17202000	0	0	0	26751000	0	22190000	19425000	0	18160000	0	NA	NA	NA	CDK5	CDK5;CDK5;NA;NA;NA	synaptic transmission, dopaminergic;phosphorylation;chemical synaptic transmission;synapse assembly;neuron projection development;negative regulation of transcription, DNA-templated;neuron differentiation;negative regulation of axon extension;oligodendrocyte differentiation;negative regulation of protein export from nucleus;regulation of synaptic plasticity;excitatory postsynaptic potential;regulation of protein localization to plasma membrane;cell division;regulation of dendritic spine morphogenesis;negative regulation of neuron death;motor neuron axon guidance;cell proliferation;skeletal muscle tissue development;rhythmic process;synaptic transmission, glutamatergic;calcium ion import;positive regulation of protein targeting to membrane;cell-matrix adhesion;regulation of apoptotic process;Schwann cell development;cerebellar cortex formation;corpus callosum development;receptor catabolic process;positive regulation of actin cytoskeleton reorganization;cellular response to beta-amyloid;mitochondrion organization;protein phosphorylation;nucleocytoplasmic transport;synaptic vesicle transport;peptidyl-serine phosphorylation;sensory perception of pain;layer formation in cerebral cortex;synapse disassembly;positive regulation of receptor activity;regulation of cell cycle arrest;receptor clustering;axonogenesis;regulation of macroautophagy;negative regulation of cell cycle;behavioral response to cocaine;dendrite morphogenesis;visual learning;response to wounding;hippocampus development;negative regulation of synaptic plasticity;protein localization to synapse;regulation of synaptic transmission, glutamatergic;induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration;positive regulation of glial cell apoptotic process;cell cycle;central nervous system neuron development;cortical actin cytoskeleton organization;negative regulation of protein ubiquitination;neuron apoptotic process;microtubule cytoskeleton organization;histone phosphorylation;synaptic vesicle exocytosis;positive regulation of protein kinase activity;intracellular protein transport;regulation of cell migration;positive regulation of neuron apoptotic process;axon extension;neuron migration;positive regulation of protein binding;serine phosphorylation of STAT protein;protein autophosphorylation;regulation of synaptic vesicle recycling	GO:000196; GO:001631; GO:000726; GO:000741; GO:003117; GO:004589; GO:003018; GO:003051; GO:004870; GO:004682; GO:004816; GO:006007; GO:190307; GO:005130; GO:006100; GO:190121; GO:000804; GO:000828; GO:000751; GO:004851; GO:003524; GO:007050; GO:009031; GO:000716; GO:004298; GO:001404; GO:002169; GO:002203; GO:003280; GO:200025; GO:190464; GO:000700; GO:000646; GO:000691; GO:004848; GO:001810; GO:001923; GO:002181; GO:009888; GO:200027; GO:007115; GO:004311; GO:000740; GO:001624; GO:004578; GO:004814; GO:004881; GO:000854; GO:000961; GO:002176; GO:003191; GO:003541; GO:005196; GO:009970; GO:003435; GO:000704; GO:002195; GO:003086; GO:003139; GO:005140; GO:000022; GO:001657; GO:001607; GO:004586; GO:000688; GO:003033; GO:004352; GO:004867; GO:000176; GO:003209; GO:004250; GO:004677; GO:190342	nucleoplasm;cytosol;postsynaptic membrane;perikaryon;glutamatergic synapse;postsynaptic density;nucleus;microtubule;neuromuscular junction;lamellipodium;neuronal cell body;axon;Schaffer collateral - CA1 synapse;plasma membrane;membrane;cyclin-dependent protein kinase 5 holoenzyme complex;neuron projection;filopodium;presynapse;cytoplasm;cell junction	GO:000565; GO:000582; GO:004521; GO:004320; GO:009897; GO:001406; GO:000563; GO:000587; GO:003159; GO:003002; GO:004302; GO:003042; GO:009868; GO:000588; GO:001602; GO:001653; GO:004300; GO:003017; GO:009879; GO:000573; GO:003005	 Cocaine addiction; Alzheimer's disease; Axon guidance	hsa0503; hsa0501; hsa0436	kinase activity;ErbB-3 class receptor binding;acetylcholine receptor activator activity;cyclin-dependent protein serine/threonine kinase activity;p53 binding;ErbB-2 class receptor binding;protein binding;protein kinase activity;ephrin receptor binding;tau-protein kinase activity;protein kinase binding;tau protein binding;microtubule binding;ATP binding;Hsp90 protein binding;voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels	GO:001630; GO:004312; GO:003054; GO:000469; GO:000203; GO:000517; GO:000551; GO:000467; GO:004687; GO:005032; GO:001990; GO:004815; GO:000801; GO:000552; GO:005187; GO:009963
XP_020957938.1;XP_020957937.1;XP_020957936.1;XP_020957935.1;XP_020957933.1;XP_020957932.1;XP_005667751.1;XP_005667750.1;XP_005667749.1;XP_005667748.1;NP_001038087.1;XP_020919149.1;XP_020919148.1	XP_020957938.1;XP_020957937.1;XP_020957936.1;XP_020957935.1;XP_020957933.1;XP_020957932.1;XP_005667751.1;XP_005667750.1;XP_005667749.1;XP_005667748.1;NP_001038087.1	XP_020957938.1 platelet glycoprotein 4 isoform X2 [Sus scrofa];XP_020957937.1 platelet glycoprotein 4 isoform X1 [Sus scrofa];XP_020957936.1 platelet glycoprotein 4 isoform X1 [Sus scrofa];XP_020957935.1 platelet glycoprotein 4 isoform X1 [Sus scrofa];XP_0	13	13	13	4732900000	4701900000	4823900000	3688300000	3533800000	3267300000	3154200000	3057600000	3487500000	3407100000	3458800000	2598800000	1851800000	4301600000	4290300000	4976100000	3521300000	3441100000	NA	NA	NA	CD36	CD36;CD36;CD36;CD36;CD36	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of cell death;regulation of lipopolysaccharide-mediated signaling pathway;negative regulation of growth of symbiont in host;toll-like receptor TLR6:TLR2 signaling pathway;neutrophil degranulation;positive regulation of phagocytosis, engulfment;response to linoleic acid;cellular response to lipopolysaccharide;energy homeostasis;regulation of action potential;positive regulation of NLRP3 inflammasome complex assembly;platelet degranulation;sensory perception of taste;cholesterol transport;receptor internalization;positive regulation of interleukin-12 production;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB signaling;long-chain fatty acid import;interleukin-1 beta secretion;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of macrophage cytokine production;cellular response to diacyl bacterial lipopeptide;positive regulation of blood microparticle formation;toll-like receptor signaling pathway;response to stilbenoid;amyloid fibril formation;regulation of removal of superoxide radicals;production of molecular mediator involved in inflammatory response;blood coagulation;fatty acid metabolic process;regulation of lipid metabolic process;intestinal cholesterol absorption;regulation of toll-like receptor signaling pathway;low-density lipoprotein particle clearance;apoptotic cell clearance;low-density lipoprotein particle mediated signaling;cellular response to beta-amyloid;positive regulation of cell-matrix adhesion;phagocytosis, recognition;nitric oxide mediated signal transduction;cytokine-mediated signaling pathway;lipid storage;triglyceride transport;negative regulation of protein import into nucleus;lipoprotein transport;positive regulation of nitric oxide biosynthetic process;cholesterol import;positive regulation of gene expression;positive regulation of macrophage derived foam cell differentiation;positive regulation of cholesterol storage;positive regulation of interleukin-6 production;cellular response to hydroperoxide;negative regulation of transcription from RNA polymerase II promoter;cell adhesion;defense response to Gram-positive bacterium;cGMP-mediated signaling;positive regulation of blood coagulation;response to lipid;intestinal absorption;cellular response to low-density lipoprotein particle stimulus;positive regulation of reactive oxygen species biosynthetic process;MyD88-dependent toll-like receptor signaling pathway;lipid metabolic process;receptor-mediated endocytosis;positive regulation of cytosolic calcium ion concentration;regulation of protein heterodimerization activity;positive regulation of ERK1 and ERK2 cascade	GO:000247; GO:001094; GO:003166; GO:004413; GO:003812; GO:004331; GO:006010; GO:007054; GO:007122; GO:009700; GO:009890; GO:190022; GO:000257; GO:005090; GO:003030; GO:003162; GO:003273; GO:003276; GO:004312; GO:004453; GO:005070; GO:005073; GO:005109; GO:006090; GO:007172; GO:200033; GO:000222; GO:003563; GO:199000; GO:200012; GO:000253; GO:000759; GO:000663; GO:001921; GO:003029; GO:003412; GO:003438; GO:004327; GO:005509; GO:190464; GO:000195; GO:000691; GO:000726; GO:001922; GO:001991; GO:003419; GO:004230; GO:004295; GO:004542; GO:007050; GO:001062; GO:001074; GO:001088; GO:003275; GO:007144; GO:000012; GO:000715; GO:005083; GO:001993; GO:003019; GO:003399; GO:005089; GO:007140; GO:190342; GO:000275; GO:000662; GO:000689; GO:000720; GO:004349; GO:007037	plasma membrane;platelet alpha granule membrane;external side of plasma membrane;apical plasma membrane;phagocytic vesicle;membrane;integral component of plasma membrane;brush border membrane;receptor complex;membrane raft;Golgi apparatus;cell surface;endocytic vesicle membrane;extracellular space;specific granule membrane	GO:000588; GO:003109; GO:000989; GO:001632; GO:004533; GO:001602; GO:000588; GO:003152; GO:004323; GO:004512; GO:000579; GO:000998; GO:003066; GO:000561; GO:003557	 Hematopoietic cell lineage; AMPK signaling pathway; Insulin resistance; Fat digestion and absorption; ECM-receptor interaction; Malaria; PPAR signaling pathway; Phagosome; Adipocytokine signaling pathway	hsa0464; hsa0415; hsa0493; hsa0497; hsa0451; hsa0514; hsa0332; hsa0414; hsa0492	beta-amyloid binding;scavenger receptor activity;Toll-like receptor binding;low-density lipoprotein particle binding;lipoteichoic acid receptor activity;protein binding;high-density lipoprotein particle binding;lipoprotein particle binding;lipid binding;transforming growth factor beta binding;thrombospondin receptor activity	GO:000154; GO:000504; GO:003532; GO:003016; GO:007089; GO:000551; GO:000803; GO:007181; GO:000828; GO:005043; GO:007005
NP_001041537.1;XP_020924286.1	NP_001041537.1;XP_020924286.1	NP_001041537.1 ADP-ribosylation factor 4 [Sus scrofa];XP_020924286.1 ADP-ribosylation factor 4 isoform X1 [Sus scrofa]	8	3	2	161400000	176370000	135010000	157540000	141440000	171240000	170400000	149880000	158130000	0	169500000	0	157250000	194510000	186170000	147970000	219850000	216160000	NA	NA	NA	ARF4	ARF4;ARF4;NA;NA;NA	Golgi to plasma membrane transport;brain development;vesicle-mediated transport;negative regulation of apoptotic process;regulation of reactive oxygen species metabolic process;intracellular protein transport;cell migration;response to axon injury;protein localization to cilium;epidermal growth factor receptor signaling pathway;activation of phospholipase D activity;establishment or maintenance of epithelial cell apical/basal polarity;dendritic spine development;protein ADP-ribosylation;retrograde vesicle-mediated transport, Golgi to ER;learning;apical protein localization;positive regulation of transcription from RNA polymerase II promoter	GO:000689; GO:000742; GO:001619; GO:004306; GO:200037; GO:000688; GO:001647; GO:004867; GO:006151; GO:000717; GO:003158; GO:004519; GO:006099; GO:000647; GO:000689; GO:000761; GO:004517; GO:004594	membrane;extracellular exosome;glutamatergic synapse;cytosol;cytoplasm;dendritic spine;Golgi apparatus;plasma membrane;ruffle membrane	GO:001602; GO:007006; GO:009897; GO:000582; GO:000573; GO:004319; GO:000579; GO:000588; GO:003258	"NA"	"NA"	epidermal growth factor receptor binding;protein binding;GTP binding;ARF guanyl-nucleotide exchange factor activity;GTPase activity	GO:000515; GO:000551; GO:000552; GO:000508; GO:000392
NP_001041538.1	NP_001041538.1	NP_001041538.1 PRA1 family protein 3 [Sus scrofa]	5	5	5	47012000	88494000	76699000	85991000	58508000	79724000	60251000	92116000	59468000	76893000	70342000	102010000	68059000	74435000	115890000	101290000	75414000	108140000	NA	NA	NA	ARL6IP5	ARL6IP5;NA;NA;NA;NA	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;L-glutamate transport;intrinsic apoptotic signaling pathway in response to oxidative stress;negative regulation of mitochondrial membrane potential;positive regulation of apoptotic process;negative regulation of L-glutamate transport;positive regulation of stress-activated MAPK cascade	GO:004328; GO:001581; GO:000863; GO:001091; GO:004306; GO:000203; GO:003287	cytoskeleton;integral component of membrane;endoplasmic reticulum membrane;plasma membrane	GO:000585; GO:001602; GO:000578; GO:000588	"NA"	"NA"	molecular_function;protein binding	GO:000367; GO:000551
NP_001070681.1	NP_001070681.1	NP_001070681.1 macrophage migration inhibitory factor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	290130000	NA	NA	NA	MIF	MIF;NA;NA;NA;NA	cell surface receptor signaling pathway;negative regulation of macrophage chemotaxis;positive regulation of MAP kinase activity;leukocyte migration;positive regulation of prostaglandin secretion involved in immune response;protein homotrimerization;negative regulation of gene expression;positive regulation of B cell proliferation;positive regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of tumor necrosis factor production;negative regulation of myeloid cell apoptotic process;interleukin-12-mediated signaling pathway;positive chemotaxis;negative regulation of mature B cell apoptotic process;inflammatory response;regulation of receptor activity;negative regulation of cellular protein metabolic process;positive regulation of fibroblast proliferation;positive regulation of chemokine (C-X-C motif) ligand 2 production;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of myeloid leukocyte cytokine production involved in immune response;prostaglandin biosynthetic process;cell proliferation;carboxylic acid metabolic process;negative regulation of apoptotic process;neutrophil degranulation;innate immune response;positive regulation of cytokine secretion;positive regulation of ERK1 and ERK2 cascade;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of protein kinase A signaling;regulation of macrophage activation;cell aging;DNA damage response, signal transduction by p53 class mediator;positive regulation of peptidyl-serine phosphorylation;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of arachidonic acid secretion;negative regulation of cell aging;positive regulation of phosphorylation;negative regulation of cell cycle arrest	GO:000716; GO:001076; GO:004340; GO:005090; GO:006107; GO:007020; GO:001062; GO:003089; GO:003166; GO:003276; GO:003303; GO:003572; GO:005091; GO:000290; GO:000695; GO:001046; GO:003226; GO:004814; GO:200034; GO:004351; GO:006108; GO:000151; GO:000828; GO:001975; GO:004306; GO:004331; GO:004508; GO:005071; GO:007037; GO:190216; GO:001073; GO:004303; GO:000756; GO:003033; GO:003313; GO:005073; GO:009023; GO:009034; GO:004232; GO:007115	cytosol;nucleoplasm;extracellular space;cell surface;vesicle;ficolin-1-rich granule lumen;extracellular region;secretory granule lumen;extracellular exosome	GO:000582; GO:000565; GO:000561; GO:000998; GO:003198; GO:190481; GO:000557; GO:003477; GO:007006	 Phenylalanine metabolism; Tyrosine metabolism	hsa0036; hsa0035	cytokine receptor binding;chemoattractant activity;protein binding;receptor binding;protease binding;cytokine activity;phenylpyruvate tautomerase activity;identical protein binding;dopachrome isomerase activity	GO:000512; GO:004205; GO:000551; GO:000510; GO:000202; GO:000512; GO:005017; GO:004280; GO:000416
NP_001070685.1;XP_020955066.1;XP_005666393.1;XP_005666392.1;XP_005666391.1;XP_020955065.1;XP_005666388.1;XP_001927469.2;XP_001927454.2;XP_020949271.1;XP_013851275.2;NP_001070684.1	NP_001070685.1	NP_001070685.1 serine/arginine-rich splicing factor 6 [Sus scrofa]	3	3	3	41439000	47876000	47592000	47130000	40615000	49271000	60531000	0	0	45885000	0	40331000	0	0	0	50257000	0	46062000	NA	NA	NA	SRSF6	SRSF6;NA;NA;NA;NA	response to insulin;mRNA cis splicing, via spliceosome;negative regulation of cell death;mRNA 3'-end processing;regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;negative regulation of mRNA splicing, via spliceosome;regulation of wound healing;negative regulation of type B pancreatic cell apoptotic process;mRNA splice site selection;regulation of keratinocyte proliferation;negative regulation of keratinocyte differentiation;positive regulation of epithelial cell proliferation involved in lung morphogenesis;RNA export from nucleus	GO:003286; GO:004529; GO:006054; GO:003112; GO:000038; GO:000039; GO:004802; GO:006104; GO:200067; GO:000637; GO:001083; GO:004561; GO:006050; GO:000640	nucleus;nuclear speck;nucleoplasm	GO:000563; GO:001660; GO:000565	 Herpes simplex infection; Spliceosome	hsa0516; hsa0304	RNA binding;pre-mRNA binding;protein binding	GO:000372; GO:003600; GO:000551
XP_005663912.1;NP_001070686.1;XP_005663911.1;XP_020922747.1	XP_005663912.1;NP_001070686.1;XP_005663911.1	XP_005663912.1 heterogeneous nuclear ribonucleoprotein A1 isoform X2 [Sus scrofa];NP_001070686.1 heterogeneous nuclear ribonucleoprotein A1 [Sus scrofa];XP_005663911.1 heterogeneous nuclear ribonucleoprotein A1 isoform X1 [Sus scrofa]	12	12	12	97540000	157280000	124840000	130090000	106240000	164080000	110650000	124640000	133040000	131420000	141200000	130130000	176860000	146010000	138700000	134260000	142800000	144960000	NA	NA	NA	HNRNPA1	HNRNPA1;HNRNPA1;HNRNPA1;NA;NA	mRNA splicing, via spliceosome;cellular response to sodium arsenite;RNA export from nucleus;positive regulation of telomere maintenance via telomerase;regulation of alternative mRNA splicing, via spliceosome;mRNA transport;fibroblast growth factor receptor signaling pathway;viral process;RNA metabolic process;cellular response to glucose starvation;nuclear import;nuclear export	GO:000039; GO:190393; GO:000640; GO:003221; GO:000038; GO:005102; GO:000854; GO:001603; GO:001607; GO:004214; GO:005117; GO:005116	spliceosomal complex;extracellular exosome;cytoplasm;ribonucleoprotein complex;membrane;nucleus;catalytic step 2 spliceosome;nucleoplasm	GO:000568; GO:007006; GO:000573; GO:199090; GO:001602; GO:000563; GO:007101; GO:000565	 Spliceosome	hsa0304	RNA binding;protein domain specific binding;telomeric repeat-containing RNA binding;protein binding;single-stranded DNA binding;pre-mRNA binding;G-rich strand telomeric DNA binding;single-stranded RNA binding;miRNA binding	GO:000372; GO:001990; GO:006175; GO:000551; GO:000369; GO:003600; GO:009850; GO:000372; GO:003519
XP_020924292.1;XP_020924291.1;NP_001070689.1;XP_020924289.1	XP_020924292.1;XP_020924291.1;NP_001070689.1;XP_020924289.1	XP_020924292.1 transformer-2 protein homolog beta isoform X2 [Sus scrofa];XP_020924291.1 transformer-2 protein homolog beta isoform X2 [Sus scrofa];NP_001070689.1 transformer-2 protein homolog beta [Sus scrofa];XP_020924289.1 transformer-2 protein homolog	5	5	5	7132100	10227000	0	8138400	0	0	10847000	10631000	14488000	12099000	0	0	14377000	9577300	0	10968000	12883000	12228000	NA	NA	NA	TRA2B	TRA2B;TRA2B;TRA2B;TRA2B;NA	regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome;cerebral cortex regionalization;mRNA splicing, via spliceosome;cellular response to glucose stimulus;regulation of RNA splicing;protein oligomerization;embryonic brain development;RNA splicing, via transesterification reactions	GO:000038; GO:004802; GO:002179; GO:000039; GO:007133; GO:004348; GO:005125; GO:199040; GO:000037	nucleus;nucleoplasm;nuclear inner membrane;spliceosomal complex;ribonucleoprotein complex	GO:000563; GO:000565; GO:000563; GO:000568; GO:199090	 Spliceosome	hsa0304	mRNA binding;identical protein binding;protein binding;protein domain specific binding;RNA binding;pre-mRNA binding	GO:000372; GO:004280; GO:000551; GO:001990; GO:000372; GO:003600
NP_001070690.1;XP_020932999.1;XP_020932998.1;XP_020932997.1;XP_020932996.1;XP_020932995.1;XP_020932994.1;NP_001070696.1	NP_001070690.1	NP_001070690.1 U1 small nuclear ribonucleoprotein A [Sus scrofa]	3	3	3	14341000	23281000	19290000	0	17687000	28565000	23365000	20585000	0	20523000	21557000	21693000	17523000	0	29804000	16951000	19430000	0	NA	NA	NA	SNRPA	SNRPA;NA;NA;NA;NA	mRNA splicing, via spliceosome;regulation of mRNA polyadenylation	GO:000039; GO:190036	nucleoplasm;U1 snRNP	GO:000565; GO:000568	 Spliceosome	hsa0304	U1 snRNP binding;protein binding;snRNA stem-loop binding;RNA binding;identical protein binding;U1 snRNA binding	GO:199044; GO:000551; GO:003561; GO:000372; GO:004280; GO:003061
XP_020921924.1;XP_020921923.1;NP_001072130.1;CON__Q95121	XP_020921924.1;XP_020921923.1;NP_001072130.1	XP_020921924.1 pigment epithelium-derived factor isoform X1 [Sus scrofa];XP_020921923.1 pigment epithelium-derived factor isoform X1 [Sus scrofa];NP_001072130.1 pigment epithelium-derived factor precursor [Sus scrofa]	16	16	16	192350000	603740000	223270000	609090000	324880000	737520000	268430000	469880000	225000000	520330000	278100000	632530000	509900000	625210000	283230000	456790000	372060000	825890000	NA	NA	NA	SERPINF1	SERPINF1;SERPINF1;SERPINF1;NA;NA	negative regulation of endopeptidase activity;positive regulation of neuron projection development;cellular response to glucose stimulus;cellular response to dexamethasone stimulus;multicellular organism development;cell proliferation;ovulation cycle;negative regulation of neuron death;negative regulation of gene expression;negative regulation of angiogenesis;positive regulation of neurogenesis;cellular response to retinoic acid;aging;negative regulation of epithelial cell proliferation involved in prostate gland development;short-term memory;response to acidic pH;negative regulation of endothelial cell migration;response to arsenic-containing substance;kidney development;negative regulation of inflammatory response;retina development in camera-type eye;cellular response to cobalt ion	GO:001095; GO:001097; GO:007133; GO:007154; GO:000727; GO:000828; GO:004269; GO:190121; GO:001062; GO:001652; GO:005076; GO:007130; GO:000756; GO:006077; GO:000761; GO:001044; GO:001059; GO:004668; GO:000182; GO:005072; GO:006004; GO:007127	extracellular region;extracellular exosome;perinuclear region of cytoplasm;extracellular space;basement membrane;melanosome;axon hillock	GO:000557; GO:007006; GO:004847; GO:000561; GO:000560; GO:004247; GO:004320	"NA"	"NA"	serine-type endopeptidase inhibitor activity;protein binding	GO:000486; GO:000551
NP_001072131.1	NP_001072131.1	NP_001072131.1 protein DJ-1 [Sus scrofa]	14	14	14	711650000	1074800000	937150000	726640000	741000000	1040100000	859760000	923290000	831010000	894650000	874770000	885570000	900940000	805230000	967270000	818350000	825640000	968840000	NA	NA	NA	PARK7	PARK7;NA;NA;NA;NA	lactate biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;negative regulation of TRAIL-activated apoptotic signaling pathway;glyoxal metabolic process;regulation of TRAIL receptor biosynthetic process;protein stabilization;regulation of mitochondrial membrane potential;negative regulation of oxidative stress-induced cell death;negative regulation of reactive oxygen species biosynthetic process;positive regulation of protein homodimerization activity;regulation of supramolecular fiber organization;negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;negative regulation of protein phosphorylation;insulin secretion;negative regulation of protein binding;regulation of inflammatory response;membrane hyperpolarization;positive regulation of oxidative phosphorylation uncoupler activity;positive regulation of sequence-specific DNA binding transcription factor activity;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;positive regulation of interleukin-8 production;glutathione deglycation;positive regulation of peptidyl-serine phosphorylation;negative regulation of cell death;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;single fertilization;methylglyoxal metabolic process;negative regulation of protein ubiquitination;positive regulation of pyrroline-5-carboxylate reductase activity;positive regulation of gene expression;cellular response to glyoxal;negative regulation of protein sumoylation;cellular response to oxidative stress;protein deglycosylation;regulation of neuron apoptotic process;dopamine uptake involved in synaptic transmission;negative regulation of neuron death;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;glucose homeostasis;positive regulation of mitophagy;peptidyl-lysine deglycation;positive regulation of protein localization to nucleus;autophagy;cellular oxidant detoxification;positive regulation of L-dopa biosynthetic process;positive regulation of acute inflammatory response to antigenic stimulus;negative regulation of ubiquitin-specific protease activity;negative regulation of protein acetylation;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;positive regulation of androgen receptor activity;negative regulation of extrinsic apoptotic signaling pathway;DNA repair;proteolysis;mitochondrion organization;Ras protein signal transduction;activation of protein kinase B activity;detoxification of mercury ion;negative regulation of ubiquitin-protein transferase activity;positive regulation of tyrosine 3-monooxygenase activity;positive regulation of protein kinase B signaling;detoxification of copper ion;cellular response to hydrogen peroxide;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;inflammatory response;negative regulation of apoptotic process;negative regulation of protein export from nucleus;negative regulation of death-inducing signaling complex assembly;hydrogen peroxide metabolic process;glycolate biosynthetic process;enzyme active site formation via L-cysteine sulfinic acid;positive regulation of NAD(P)H oxidase activity;regulation of androgen receptor signaling pathway;positive regulation of superoxide dismutase activity;positive regulation of transcription regulatory region DNA binding;negative regulation of protein kinase activity;adult locomotory behavior;negative regulation of protein K48-linked deubiquitination;negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway;positive regulation of mitochondrial electron transport, NADH to ubiquinone	GO:001924; GO:004594; GO:190312; GO:190318; GO:004556; GO:005082; GO:005188; GO:190320; GO:190342; GO:009007; GO:190290; GO:190525; GO:000193; GO:003007; GO:003209; GO:005072; GO:006008; GO:200027; GO:005109; GO:190337; GO:003275; GO:003653; GO:003313; GO:006054; GO:200126; GO:000733; GO:000943; GO:003139; GO:190316; GO:001062; GO:003647; GO:003323; GO:003459; GO:000651; GO:004352; GO:005158; GO:190121; GO:003243; GO:004259; GO:190359; GO:003652; GO:190018; GO:000691; GO:009886; GO:190319; GO:000286; GO:200015; GO:190198; GO:190217; GO:200082; GO:200123; GO:000628; GO:000650; GO:000700; GO:000726; GO:003214; GO:005078; GO:005144; GO:190317; GO:005189; GO:001027; GO:007030; GO:190223; GO:000695; GO:004306; GO:004682; GO:190307; GO:004274; GO:004629; GO:001832; GO:003386; GO:006076; GO:190167; GO:200067; GO:000646; GO:000834; GO:190309; GO:190338; GO:190295	chromatin;nucleus;nucleoplasm;mitochondrion;endoplasmic reticulum;presynapse;PML body;axon;membrane raft;mitochondrial respiratory chain complex I;mitochondrial matrix;cell-cell adherens junction;cell body;plasma membrane;extracellular exosome;cytosol;perinuclear region of cytoplasm	GO:000078; GO:000563; GO:000565; GO:000573; GO:000578; GO:009879; GO:001660; GO:003042; GO:004512; GO:000574; GO:000575; GO:000591; GO:004429; GO:000588; GO:007006; GO:000582; GO:004847	 Parkinson's disease	hsa0501	copper ion binding;protein homodimerization activity;repressing transcription factor binding;ubiquitin-like protein conjugating enzyme binding;protein deglycase activity;protein binding;superoxide dismutase copper chaperone activity;oxidoreductase activity, acting on peroxide as acceptor;cupric ion binding;cytokine binding;scaffold protein binding;kinase binding;cadherin binding;enzyme binding;mercury ion binding;core promoter binding;mRNA binding;peptidase activity;peroxiredoxin activity;ubiquitin-specific protease binding;transcription coactivator activity;receptor binding;transcription factor binding;androgen receptor binding;small protein activating enzyme binding;L-dopa decarboxylase activator activity;double-stranded DNA binding	GO:000550; GO:004280; GO:007049; GO:004439; GO:003652; GO:000551; GO:001653; GO:001668; GO:190313; GO:001995; GO:009711; GO:001990; GO:004529; GO:001989; GO:004534; GO:000104; GO:000372; GO:000823; GO:005192; GO:199038; GO:000371; GO:000510; GO:000813; GO:005068; GO:004438; GO:003647; GO:000369
NP_001072132.1	NP_001072132.1	NP_001072132.1 NAD(P)H-hydrate epimerase precursor [Sus scrofa]	3	3	3	25558000	24446000	27030000	18808000	17538000	0	30946000	21606000	31096000	22546000	26102000	35247000	24120000	0	0	0	32261000	25223000	NA	NA	NA	NAXE	NAXE;NA;NA;NA;NA	protein homotetramerization;nicotinamide nucleotide metabolic process;NAD biosynthesis via nicotinamide riboside salvage pathway	GO:005128; GO:004649; GO:003435	cell body;nucleoplasm;mitochondrion;cilium;extracellular exosome;intracellular membrane-bounded organelle;extracellular region;extracellular space;mitochondrial matrix;cytosol	GO:004429; GO:000565; GO:000573; GO:000592; GO:007006; GO:004323; GO:000557; GO:000561; GO:000575; GO:000582	"NA"	"NA"	nucleotide binding;metal ion binding;protein homodimerization activity;protein binding;NADHX epimerase activity	GO:000016; GO:004687; GO:004280; GO:000551; GO:005285
NP_001072139.1;XP_020956180.1;XP_013834060.1	NP_001072139.1	NP_001072139.1 ubiquitin-conjugating enzyme E2 K [Sus scrofa]	5	5	5	24610000	25618000	25508000	21706000	21345000	18290000	19867000	21469000	19887000	21572000	21366000	0	17468000	23549000	22208000	19742000	20629000	20428000	NA	NA	NA	UBE2K	UBE2K;NA;NA;NA;NA	protein K48-linked ubiquitination;positive regulation of type I interferon-mediated signaling pathway;cellular response to interferon-beta;positive regulation of peptidyl-threonine phosphorylation;ubiquitin-dependent protein catabolic process;regulation of proteasomal ubiquitin-dependent protein catabolic process;free ubiquitin chain polymerization;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;protein ubiquitination	GO:007093; GO:006034; GO:003545; GO:001080; GO:000651; GO:003243; GO:001099; GO:007005; GO:001656	filopodium tip;cytosol;nucleus	GO:003243; GO:000582; GO:000563	 Ubiquitin mediated proteolysis	hsa0412	protein binding;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity;ubiquitin-protein transferase activity;ATP binding;ubiquitin-ubiquitin ligase activity	GO:000551; GO:003162; GO:006163; GO:000484; GO:000552; GO:003445
XP_005661779.2;NP_001072141.1	XP_005661779.2;NP_001072141.1	XP_005661779.2 ubiquitin-conjugating enzyme E2 D2 [Sus scrofa];NP_001072141.1 ubiquitin-conjugating enzyme E2 D2 [Sus scrofa]	2	2	2	0	23107000	0	28899000	0	26572000	0	0	0	0	0	28571000	23164000	24211000	23220000	25777000	0	25993000	NA	NA	NA	UBE2D2	UBE2D2;UBE2D3;NA;NA;NA	protein targeting to peroxisome;protein ubiquitination;protein autoubiquitination;cellular protein modification process;ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination;protein polyubiquitination;protein K48-linked ubiquitination	GO:000662; GO:001656; GO:005186; GO:000646; GO:000651; GO:007097; GO:000020; GO:007093	nucleoplasm;extracellular exosome;ubiquitin ligase complex;macromolecular complex;cytosol	GO:000565; GO:007006; GO:000015; GO:003299; GO:000582	 Protein processing in endoplasmic reticulum; Ubiquitin mediated proteolysis; Shigellosis	hsa0414; hsa0412; hsa0513	ubiquitin-protein transferase activity;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity;ATP binding;protein binding	GO:000484; GO:003162; GO:006163; GO:000552; GO:000551
XP_020939992.1;XP_005659996.1;NP_001072145.1	XP_020939992.1;XP_005659996.1;NP_001072145.1	XP_020939992.1 ADP-ribosylation factor 6 isoform X1 [Sus scrofa];XP_005659996.1 ADP-ribosylation factor 6 isoform X1 [Sus scrofa];NP_001072145.1 ADP-ribosylation factor 6 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6675500	NA	NA	NA	ARF6	ARF6;ARF6;ARF6;NA;NA	liver development;myeloid cell apoptotic process;regulation of Rac protein signal transduction;maintenance of postsynaptic density structure;intracellular protein transport;negative regulation of dendrite development;vesicle-mediated transport;regulation of filopodium assembly;negative regulation of protein localization to cell surface;protein localization to cell surface;protein localization to endosome;negative regulation of receptor-mediated endocytosis;cell division;cortical actin cytoskeleton organization;ruffle assembly;hepatocyte apoptotic process;regulation of presynapse assembly;synaptic vesicle endocytosis;positive regulation of protein localization to plasma membrane;positive regulation of adherens junction organization;cell cycle;cellular response to nerve growth factor stimulus;cell adhesion;positive regulation of actin filament polymerization;endocytic recycling;positive regulation of keratinocyte migration;regulation of dendritic spine development;establishment of epithelial cell polarity	GO:000188; GO:003302; GO:003502; GO:009956; GO:000688; GO:200017; GO:001619; GO:005148; GO:200000; GO:003439; GO:003601; GO:004826; GO:005130; GO:003086; GO:009717; GO:009728; GO:190560; GO:004848; GO:190307; GO:190339; GO:000704; GO:199009; GO:000715; GO:003083; GO:003245; GO:005154; GO:006099; GO:009016	focal adhesion;filopodium membrane;Golgi apparatus;cytoplasm;cell cortex;endocytic vesicle;Flemming body;presynapse;ruffle;cleavage furrow;recycling endosome membrane;extracellular exosome;cytosol;endosome;plasma membrane;membrane;glutamatergic synapse;early endosome membrane	GO:000592; GO:003152; GO:000579; GO:000573; GO:000593; GO:003013; GO:009054; GO:009879; GO:000172; GO:003215; GO:005503; GO:007006; GO:000582; GO:000576; GO:000588; GO:001602; GO:009897; GO:003190	 Endocytosis; Ras signaling pathway; Fc gamma R-mediated phagocytosis	hsa0414; hsa0401; hsa0466	protein N-terminus binding;GTP binding;GTPase activity;protein binding;thioesterase binding	GO:004748; GO:000552; GO:000392; GO:000551; GO:003199
NP_001072147.1	NP_001072147.1	NP_001072147.1 CD81 antigen [Sus scrofa]	4	4	4	121140000	193690000	176430000	146600000	115950000	138420000	143450000	143210000	112260000	119800000	115200000	180440000	119560000	116030000	112780000	168490000	96486000	129430000	NA	NA	NA	CD81	CD81;NA;NA;NA;NA	positive regulation of cell proliferation;regulation of complement activation;positive regulation of 1-phosphatidylinositol 4-kinase activity;humoral immune response mediated by circulating immunoglobulin;positive regulation of B cell proliferation;viral entry into host cell;protein localization to plasma membrane;protein localization;receptor-mediated virion attachment to host cell;cell surface receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;positive regulation of peptidyl-tyrosine phosphorylation;activation of MAPK activity;regulation of protein stability;receptor internalization;regulation of immune response;protein localization to lysosome;cellular response to low-density lipoprotein particle stimulus;regulation of cell motility;positive regulation of protein catabolic process in the vacuole	GO:000828; GO:003044; GO:004312; GO:000245; GO:003089; GO:004671; GO:007265; GO:000810; GO:004681; GO:000716; GO:004594; GO:005073; GO:000018; GO:003164; GO:003162; GO:005077; GO:006146; GO:007140; GO:200014; GO:190435	membrane;vesicle;immunological synapse;plasma membrane;focal adhesion;basolateral plasma membrane;integral component of membrane;extracellular exosome	GO:001602; GO:003198; GO:000177; GO:000588; GO:000592; GO:001632; GO:001602; GO:007006	 B cell receptor signaling pathway; Hepatitis C; Malaria	hsa0466; hsa0516; hsa0514	MHC class II protein complex binding;transferrin receptor binding;virus receptor activity;integrin binding;protein binding;cholesterol binding	GO:002302; GO:199045; GO:000161; GO:000517; GO:000551; GO:001548
XP_020954051.1;XP_020954050.1;XP_020954049.1;XP_020954048.1;XP_020954047.1;XP_020954045.1;NP_001072151.1;XP_020954044.1;XP_020954043.1;XP_020954042.1;XP_020954041.1;XP_020954040.1;XP_020954053.1;XP_020954052.1;XP_020954054.1	XP_020954051.1;XP_020954050.1;XP_020954049.1;XP_020954048.1;XP_020954047.1;XP_020954045.1;NP_001072151.1;XP_020954044.1;XP_020954043.1;XP_020954042.1;XP_020954041.1;XP_020954040.1;XP_020954053.1;XP_020954052.1;XP_020954054.1	XP_020954051.1 protein NDRG2 isoform X2 [Sus scrofa];XP_020954050.1 protein NDRG2 isoform X2 [Sus scrofa];XP_020954049.1 protein NDRG2 isoform X2 [Sus scrofa];XP_020954048.1 protein NDRG2 isoform X2 [Sus scrofa];XP_020954047.1 protein NDRG2 isoform X2 [Sus	5	5	5	79703000	98814000	72454000	93893000	66899000	64598000	87939000	88656000	89420000	84871000	82504000	0	73015000	80371000	90688000	85520000	74382000	72316000	NA	NA	NA	NDRG2	NDRG2;NDRG2;NDRG2;NDRG2;NDRG2	cell differentiation;negative regulation of smooth muscle cell proliferation;Wnt signaling pathway;substantia nigra development;signal transduction;regulation of platelet-derived growth factor production;negative regulation of ERK1 and ERK2 cascade;regulation of vascular endothelial growth factor production;negative regulation of cytokine production	GO:003015; GO:004866; GO:001605; GO:002176; GO:000716; GO:009036; GO:007037; GO:001057; GO:000181	nucleus;growth cone;cytoplasm;cytosol;extracellular exosome;Golgi apparatus;perinuclear region of cytoplasm	GO:000563; GO:003042; GO:000573; GO:000582; GO:007006; GO:000579; GO:004847	"NA"	"NA"	protein binding;molecular_function	GO:000551; GO:000367
XP_020940032.1;XP_020940025.1;XP_020940020.1;XP_020940009.1;XP_020940006.1;NP_001073675.2;XP_020951813.1;XP_020951812.1;XP_020951811.1;XP_020951315.1;XP_020951314.1;XP_020951313.1;XP_020951312.1;XP_020951311.1;XP_020951310.1;XP_020951309.1;XP_020951308.1;XP_020951307.1;XP_020951305.1;XP_020951304.1;XP_020951303.1	XP_020940032.1;XP_020940025.1;XP_020940020.1;XP_020940009.1;XP_020940006.1;NP_001073675.2;XP_020951813.1;XP_020951812.1;XP_020951811.1;XP_020951315.1;XP_020951314.1;XP_020951313.1;XP_020951312.1;XP_020951311.1;XP_020951310.1;XP_020951309.1;XP_020951308.1;XP_020951307.1;XP_020951305.1;XP_020951304.1;XP_020951303.1	XP_020940032.1 tyrosine-protein kinase Fyn isoform X3 [Sus scrofa];XP_020940025.1 tyrosine-protein kinase Fyn isoform X2 [Sus scrofa];XP_020940020.1 tyrosine-protein kinase Fyn isoform X1 [Sus scrofa];XP_020940009.1 tyrosine-protein kinase Fyn isoform X1 [	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8909500	NA	NA	NA	YES1	YES1;YES1;YES1;FGR;FGR	positive regulation of peptidyl-tyrosine phosphorylation;cellular response to retinoic acid;regulation of vascular permeability;positive regulation of transcription from RNA polymerase II promoter;transmembrane receptor protein tyrosine kinase signaling pathway;cellular response to platelet-derived growth factor stimulus;ephrin receptor signaling pathway;leukocyte migration;Fc-gamma receptor signaling pathway involved in phagocytosis;T cell costimulation;cellular protein modification process;peptidyl-tyrosine autophosphorylation;regulation of glucose transport;cell differentiation;cellular response to transforming growth factor beta stimulus	GO:005073; GO:007130; GO:004311; GO:004594; GO:000716; GO:003612; GO:004801; GO:005090; GO:003809; GO:003129; GO:000646; GO:003808; GO:001082; GO:003015; GO:007156	cytosol;focal adhesion;microtubule organizing center;glutamatergic synapse;Golgi apparatus;plasma membrane;postsynaptic specialization, intracellular component;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome	GO:000582; GO:000592; GO:000581; GO:009897; GO:000579; GO:000588; GO:009909; GO:003123; GO:007006	 Adherens junction; Tight junction	hsa0452; hsa0453	epidermal growth factor receptor binding;phosphotyrosine binding;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding;ion channel binding;receptor binding;enzyme binding	GO:000515; GO:000178; GO:000471; GO:000551; GO:000552; GO:004432; GO:000510; GO:001989
XP_020930347.1;NP_001077401.1;XP_020930346.1;XP_020930345.1;XP_020930349.1;XP_020930348.1	XP_020930347.1;NP_001077401.1;XP_020930346.1;XP_020930345.1;XP_020930349.1;XP_020930348.1	XP_020930347.1 integrin alpha-V isoform X3 [Sus scrofa];NP_001077401.1 integrin alpha-V precursor [Sus scrofa];XP_020930346.1 integrin alpha-V isoform X2 [Sus scrofa];XP_020930345.1 integrin alpha-V isoform X1 [Sus scrofa];XP_020930349.1 integrin alpha-V i	11	11	11	14763000	28581000	17489000	24085000	13009000	19563000	13407000	19547000	13236000	25464000	15954000	34013000	26977000	19537000	14247000	21471000	15247000	32934000	NA	NA	NA	ITGAV	ITGAV;ITGAV;ITGAV;ITGAV;ITGAV	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of macrophage derived foam cell differentiation;extracellular matrix organization;positive regulation of cell migration;extrinsic apoptotic signaling pathway in absence of ligand;apoptotic cell clearance;entry of symbiont into host cell by promotion of host phagocytosis;regulation of transforming growth factor beta activation;viral entry into host cell;cell-substrate adhesion;negative regulation of lipid transport;apolipoprotein A-I-mediated signaling pathway;neutrophil degranulation;negative regulation of low-density lipoprotein particle receptor biosynthetic process;leukocyte migration;ERK1 and ERK2 cascade;positive regulation of cell proliferation;negative regulation of lipid storage;substrate adhesion-dependent cell spreading;vasculogenesis;cell adhesion;cell adhesion mediated by integrin;regulation of phagocytosis;calcium ion transmembrane transport;negative regulation of entry of bacterium into host cell;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of cytosolic calcium ion concentration;integrin-mediated signaling pathway;heterotypic cell-cell adhesion;positive regulation of cell adhesion;vascular endothelial growth factor receptor signaling pathway;negative regulation of lipoprotein metabolic process;angiogenesis;cell-matrix adhesion;positive regulation of osteoblast proliferation;transforming growth factor-beta secretion;negative chemotaxis;endodermal cell differentiation	GO:000247; GO:001074; GO:003019; GO:003033; GO:009719; GO:004327; GO:005206; GO:190138; GO:004671; GO:003158; GO:003236; GO:003802; GO:004331; GO:004571; GO:005090; GO:007037; GO:000828; GO:001088; GO:003444; GO:000157; GO:000715; GO:003362; GO:005076; GO:007058; GO:200053; GO:200123; GO:000720; GO:000722; GO:003411; GO:004578; GO:004801; GO:005074; GO:000152; GO:000716; GO:003369; GO:003804; GO:005091; GO:003598	lamellipodium membrane;specific granule membrane;focal adhesion;external side of plasma membrane;integrin alphav-beta5 complex;membrane;cell surface;cytosol;microvillus membrane;alphav-beta3 integrin-IGF-1-IGF1R complex;integral component of plasma membrane;ruffle membrane;extracellular exosome;integrin complex;phagocytic vesicle	GO:003125; GO:003557; GO:000592; GO:000989; GO:003468; GO:001602; GO:000998; GO:000582; GO:003152; GO:003586; GO:000588; GO:003258; GO:007006; GO:000830; GO:004533	 Pathways in cancer; Hypertrophic cardiomyopathy (HCM); Focal adhesion; Thyroid hormone signaling pathway; PI3K-Akt signaling pathway; Regulation of actin cytoskeleton; Phagosome; Small cell lung cancer; Proteoglycans in cancer	hsa0520; hsa0541; hsa0451; hsa0491; hsa0415; hsa0481; hsa0414; hsa0522; hsa0520	fibronectin binding;virus receptor activity;voltage-gated calcium channel activity;neuregulin binding;coreceptor activity;fibroblast growth factor binding;extracellular matrix protein binding;protein binding;opsonin binding;integrin binding;metal ion binding;transforming growth factor beta binding;protease binding;protein kinase C binding;C-X3-C chemokine binding;extracellular matrix binding;insulin-like growth factor I binding	GO:000196; GO:000161; GO:000524; GO:003813; GO:001502; GO:001713; GO:199043; GO:000551; GO:000184; GO:000517; GO:004687; GO:005043; GO:000202; GO:000508; GO:001996; GO:005084; GO:003199
NP_001077410.2;NP_001028187.3	NP_001077410.2;NP_001028187.3	NP_001077410.2 angiotensin-converting enzyme isoform 2 precursor [Sus scrofa];NP_001028187.3 angiotensin-converting enzyme isoform 1 precursor [Sus scrofa]	10	10	10	17120000	45295000	18034000	37337000	17430000	39461000	17196000	40355000	18887000	23815000	35299000	30013000	29246000	52747000	36461000	39025000	18131000	43426000	NA	NA	NA	ACE	ACE;ACE;NA;NA;NA	spermatogenesis;positive regulation of systemic arterial blood pressure;beta-amyloid metabolic process;regulation of vasoconstriction;positive regulation of protein binding;hormone catabolic process;positive regulation of blood pressure;regulation of blood pressure;negative regulation of gene expression;hematopoietic stem cell differentiation;cell proliferation in bone marrow;kidney development;peptide catabolic process;positive regulation of protein tyrosine kinase activity;antigen processing and presentation of peptide antigen via MHC class I;mononuclear cell proliferation;heart contraction;positive regulation of peptidyl-cysteine S-nitrosylation;regulation of blood vessel diameter;regulation of hematopoietic stem cell proliferation;arachidonic acid secretion;regulation of renal output by angiotensin;posttranscriptional regulation of gene expression;regulation of smooth muscle cell migration;positive regulation of peptidyl-tyrosine autophosphorylation;neutrophil mediated immunity;blood vessel remodeling;angiotensin maturation;proteolysis;negative regulation of gap junction assembly;regulation of angiotensin metabolic process	GO:000728; GO:000308; GO:005043; GO:001922; GO:003209; GO:004244; GO:004577; GO:000821; GO:001062; GO:006021; GO:007183; GO:000182; GO:004317; GO:006109; GO:000247; GO:003294; GO:006004; GO:200017; GO:009774; GO:190203; GO:005048; GO:000201; GO:001060; GO:001491; GO:190008; GO:000244; GO:000197; GO:000200; GO:000650; GO:190359; GO:006017	endosome;extracellular region;lysosome;plasma membrane;external side of plasma membrane;extracellular exosome;extracellular space;integral component of membrane	GO:000576; GO:000557; GO:000576; GO:000588; GO:000989; GO:007006; GO:000561; GO:001602	 Renin-angiotensin system; Chagas disease (American trypanosomiasis); Hypertrophic cardiomyopathy (HCM); Renin secretion	hsa0461; hsa0514; hsa0541; hsa0492	dipeptidyl-peptidase activity;metallopeptidase activity;zinc ion binding;mitogen-activated protein kinase kinase binding;carboxypeptidase activity;drug binding;metallodipeptidase activity;endopeptidase activity;chloride ion binding;bradykinin receptor binding;mitogen-activated protein kinase binding;peptidyl-dipeptidase activity	GO:000823; GO:000823; GO:000827; GO:003143; GO:000418; GO:000814; GO:007057; GO:000417; GO:003140; GO:003171; GO:005101; GO:000824
NP_001078912.1	NP_001078912.1	NP_001078912.1 selenoprotein F precursor [Sus scrofa]	3	3	3	0	9432600	9018800	0	0	9845000	8943000	0	0	8918600	9736700	0	0	12626000	0	9437700	0	0	NA	NA	NA	SELENOF	SELENOF;NA;NA;NA;NA	'de novo' posttranslational protein folding	GO:005108	endoplasmic reticulum lumen	GO:000578	"NA"	"NA"	protein binding	GO:000551
XP_020957807.1;XP_020957806.1;XP_020957805.1;XP_020957803.1;NP_001090881.1	XP_020957807.1;XP_020957806.1;XP_020957805.1;XP_020957803.1;NP_001090881.1	XP_020957807.1 porphobilinogen deaminase isoform X2 [Sus scrofa];XP_020957806.1 porphobilinogen deaminase isoform X2 [Sus scrofa];XP_020957805.1 porphobilinogen deaminase isoform X2 [Sus scrofa];XP_020957803.1 porphobilinogen deaminase isoform X1 [Sus scro	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2693900	NA	NA	NA	HMBS	HMBS;HMBS;HMBS;HMBS;HMBS	heme biosynthetic process;peptidyl-pyrromethane cofactor linkage;protoporphyrinogen IX biosynthetic process	GO:000678; GO:001816; GO:000678	cytosol;cytoplasm	GO:000582; GO:000573	 Metabolic pathways; Porphyrin and chlorophyll metabolism	hsa0110; hsa0086	hydroxymethylbilane synthase activity	GO:000441
XP_005654459.1;NP_001090887.1	XP_005654459.1;NP_001090887.1	XP_005654459.1 elongation factor 1-alpha 1 isoform X1 [Sus scrofa];NP_001090887.1 elongation factor 1-alpha 1 [Sus scrofa]	16	16	8	2441600000	1749800000	2362100000	2073400000	2227200000	1859700000	1946600000	1810200000	1657400000	2288400000	2134400000	1435900000	1861300000	2001800000	2297100000	2275700000	1862300000	2221100000	NA	NA	NA	EEF1A1	EEF1A1;EEF1A1;NA;NA;NA	cellular response to epidermal growth factor stimulus;translational elongation;neutrophil degranulation;regulation of chaperone-mediated autophagy	GO:007136; GO:000641; GO:004331; GO:190471	extracellular region;membrane;nucleus;ruffle membrane;plasma membrane;cytoplasmic side of lysosomal membrane;nucleolus;secretory granule lumen;extracellular space;cytosol;cortical actin cytoskeleton;ficolin-1-rich granule lumen;eukaryotic translation elongation factor 1 complex;extracellular exosome	GO:000557; GO:001602; GO:000563; GO:003258; GO:000588; GO:009857; GO:000573; GO:003477; GO:000561; GO:000582; GO:003086; GO:190481; GO:000585; GO:007006	 RNA transport; Legionellosis	hsa0301; hsa0513	translation elongation factor activity;protein kinase binding;RNA binding;tRNA binding;GTPase activity;protein binding;GTP binding	GO:000374; GO:001990; GO:000372; GO:000004; GO:000392; GO:000551; GO:000552
XP_020930113.1;XP_020930112.1;XP_020930111.1;XP_020930110.1;XP_020930109.1;NP_001090892.1;XP_020930108.1;XP_020930107.1	XP_020930113.1;XP_020930112.1;XP_020930111.1;XP_020930110.1;XP_020930109.1;NP_001090892.1;XP_020930108.1;XP_020930107.1	XP_020930113.1 integrin beta-6 isoform X4 [Sus scrofa];XP_020930112.1 integrin beta-6 isoform X4 [Sus scrofa];XP_020930111.1 integrin beta-6 isoform X3 [Sus scrofa];XP_020930110.1 integrin beta-6 isoform X3 [Sus scrofa];XP_020930109.1 integrin beta-6 isofo	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	139820000	NA	NA	NA	ITGB6	ITGB6;ITGB6;ITGB6;ITGB6;ITGB6	inflammatory response;viral entry into host cell;integrin-mediated signaling pathway;extracellular matrix organization;cell adhesion mediated by integrin;transforming growth factor-beta secretion;cell adhesion;regulation of transforming growth factor beta activation;cell-matrix adhesion;cell migration	GO:000695; GO:004671; GO:000722; GO:003019; GO:003362; GO:003804; GO:000715; GO:190138; GO:000716; GO:001647	centrosome;cell junction;plasma membrane;integrin complex;focal adhesion;external side of plasma membrane;receptor complex;nucleoplasm;cell surface;integrin alphav-beta6 complex	GO:000581; GO:003005; GO:000588; GO:000830; GO:000592; GO:000989; GO:004323; GO:000565; GO:000998; GO:003468	 ECM-receptor interaction; Regulation of actin cytoskeleton; Hypertrophic cardiomyopathy (HCM); Focal adhesion; PI3K-Akt signaling pathway	hsa0451; hsa0481; hsa0541; hsa0451; hsa0415	virus receptor activity;signaling receptor activity;integrin binding;protein binding	GO:000161; GO:003802; GO:000517; GO:000551
NP_001090895.1	NP_001090895.1	NP_001090895.1 D-aspartate oxidase [Sus scrofa]	3	3	3	15812000	19612000	21744000	0	18633000	0	21914000	24426000	26778000	17421000	23580000	0	0	15875000	14743000	21030000	33142000	23654000	NA	NA	NA	DDO	DDO;NA;NA;NA;NA	D-amino acid metabolic process;aspartate metabolic process;insemination;grooming behavior;hormone metabolic process;oxidation-reduction process;protein targeting to peroxisome;D-amino acid catabolic process;cellular nitrogen compound metabolic process	GO:004641; GO:000653; GO:000732; GO:000762; GO:004244; GO:005511; GO:000662; GO:001947; GO:003464	peroxisome;peroxisomal matrix;cytosol	GO:000577; GO:000578; GO:000582	 Alanine, aspartate and glutamate metabolism; Peroxisome	hsa0025; hsa0414	D-amino-acid oxidase activity;receptor binding;FAD binding;protein binding;D-aspartate oxidase activity;cofactor binding	GO:000388; GO:000510; GO:007194; GO:000551; GO:000844; GO:004803
NP_001090896.1;XP_020953509.1;XP_020953508.1;XP_020954097.1;XP_013833071.1;NP_001107175.1;XP_013833080.2;XP_005665845.2;NP_998933.1;XP_020953941.1	NP_001090896.1;XP_020953509.1;XP_020953508.1	NP_001090896.1 MHC class I antigen 3 precursor [Sus scrofa];XP_020953509.1 MHC class I antigen 3 isoform X2 [Sus scrofa];XP_020953508.1 MHC class I antigen 3 isoform X1 [Sus scrofa]	10	10	2	86030000	104780000	88659000	0	133950000	122240000	101070000	84643000	80414000	79410000	68709000	100620000	82938000	113210000	83374000	95478000	99151000	96901000	NA	NA	NA	SLA-3	SLA-3;SLA-3;SLA-3;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020932804.1;XP_005672820.1;NP_001090898.1	XP_020932804.1;XP_005672820.1;NP_001090898.1	XP_020932804.1 mitochondrial antiviral-signaling protein isoform X2 [Sus scrofa];XP_005672820.1 mitochondrial antiviral-signaling protein isoform X1 [Sus scrofa];NP_001090898.1 mitochondrial antiviral-signaling protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5300700	0	0	NA	NA	NA	MAVS	MAVS;MAVS;MAVS;NA;NA	activation of innate immune response;negative regulation of type I interferon production;positive regulation of interleukin-8 production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of response to cytokine stimulus;positive regulation of defense response to virus by host;positive regulation of protein phosphorylation;positive regulation of interferon-alpha production;positive regulation of IP-10 production;regulation of peroxisome organization;positive regulation of interferon-alpha secretion;positive regulation of tumor necrosis factor secretion;positive regulation of myeloid dendritic cell cytokine production;regulation of transcription, DNA-templated;positive regulation of type I interferon-mediated signaling pathway;positive regulation of chemokine (C-C motif) ligand 5 production;defense response to bacterium;signal transduction;viral process;positive regulation of interferon-beta secretion;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of viral genome replication;innate immune response;positive regulation of transcription from RNA polymerase II promoter;defense response to virus;positive regulation of tumor necrosis factor production;cellular response to exogenous dsRNA;positive regulation of interleukin-6 secretion	GO:000221; GO:003248; GO:003275; GO:005109; GO:006076; GO:000223; GO:000193; GO:003272; GO:007166; GO:190006; GO:190274; GO:190446; GO:000273; GO:000635; GO:006034; GO:007165; GO:004274; GO:000716; GO:001603; GO:003554; GO:004312; GO:004507; GO:004508; GO:004594; GO:005160; GO:003276; GO:007136; GO:200077	mitochondrial outer membrane;mitochondrial membrane;integral component of membrane;mitochondrion;peroxisomal membrane	GO:000574; GO:003196; GO:001602; GO:000573; GO:000577	 Cytosolic DNA-sensing pathway; Hepatitis C; RIG-I-like receptor signaling pathway	hsa0462; hsa0516; hsa0462	protein binding;protein kinase binding;signaling adaptor activity;CARD domain binding	GO:000551; GO:001990; GO:003559; GO:005070
NP_001090904.1;XP_005671109.1	NP_001090904.1;XP_005671109.1	NP_001090904.1 prolyl 4-hydroxylase subunit alpha-1 precursor [Sus scrofa];XP_005671109.1 prolyl 4-hydroxylase subunit alpha-1 isoform X1 [Sus scrofa]	8	8	8	0	24928000	29174000	0	0	22586000	31832000	26210000	29550000	0	0	0	0	0	25212000	0	30086000	33508000	NA	NA	NA	P4HA1	P4HA1;P4HA1;NA;NA;NA	peptidyl-proline hydroxylation to 4-hydroxy-L-proline;collagen fibril organization;oxidation-reduction process	GO:001840; GO:003019; GO:005511	endoplasmic reticulum lumen;endoplasmic reticulum;procollagen-proline 4-dioxygenase complex;membrane;mitochondrion;intracellular membrane-bounded organelle	GO:000578; GO:000578; GO:001622; GO:001602; GO:000573; GO:004323	 Metabolic pathways; Arginine and proline metabolism	hsa0110; hsa0033	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;L-ascorbic acid binding;identical protein binding;procollagen-proline 4-dioxygenase activity;iron ion binding;protein binding	GO:001670; GO:003141; GO:004280; GO:000465; GO:000550; GO:000551
XP_020930148.1;XP_020930147.1;XP_020930146.1;NP_001090909.1;XP_020930144.1;XP_020930143.1;XP_020930142.1;XP_020930141.1;XP_020930140.1;XP_020930139.1;XP_020930138.1;XP_020930137.1;XP_020930136.1;XP_020930135.1;XP_020930134.1;XP_020930133.1;XP_020930132.1;XP_020930131.1;XP_020930130.1;XP_020930129.1;XP_020930128.1;XP_020930127.1;XP_020930126.1;XP_020930125.1;XP_020930124.1;XP_020930123.1;XP_020930122.1;XP_020930121.1;XP_020930120.1;XP_020930119.1;XP_020930118.1;XP_020930117.1;XP_020930116.1;XP_020930115.1;XP_020930114.1;XP_020937388.1;NP_001231132.1	XP_020930148.1;XP_020930147.1;XP_020930146.1;NP_001090909.1;XP_020930144.1;XP_020930143.1;XP_020930142.1;XP_020930141.1;XP_020930140.1;XP_020930139.1;XP_020930138.1;XP_020930137.1;XP_020930136.1;XP_020930135.1;XP_020930134.1;XP_020930133.1;XP_020930132.1;XP_020930131.1;XP_020930130.1;XP_020930129.1;XP_020930128.1;XP_020930127.1;XP_020930126.1;XP_020930125.1;XP_020930124.1;XP_020930123.1;XP_020930122.1;XP_020930121.1;XP_020930120.1;XP_020930119.1;XP_020930118.1;XP_020930117.1;XP_020930116.1;XP_020930115.1;XP_020930114.1	XP_020930148.1 myc box-dependent-interacting protein 1 isoform X34 [Sus scrofa];XP_020930147.1 myc box-dependent-interacting protein 1 isoform X33 [Sus scrofa];XP_020930146.1 myc box-dependent-interacting protein 1 isoform X32 [Sus scrofa];NP_001090909.1 m	6	6	6	0	33715000	20114000	34377000	0	39028000	0	28637000	0	33892000	28370000	31956000	45442000	35903000	28701000	32628000	47918000	37030000	NA	NA	NA	BIN1	BIN1;BIN1;BIN1;BIN1;BIN1	cytoskeleton organization;endosome to lysosome transport;regulation of neuron differentiation;negative regulation of potassium ion transmembrane transport;nucleus organization;negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;positive regulation of actin filament polymerization;nucleus localization;membrane organization;T-tubule organization;positive regulation of apoptotic process;endocytosis;positive regulation of astrocyte differentiation;regulation of cell cycle arrest;negative regulation of ventricular cardiac muscle cell action potential;viral process;regulation of endocytosis;lipid tube assembly;regulation of heart rate by cardiac conduction;negative regulation of beta-amyloid formation;negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	GO:000701; GO:000833; GO:004566; GO:190138; GO:000699; GO:190487; GO:003083; GO:005164; GO:006102; GO:003329; GO:004306; GO:000689; GO:004871; GO:007115; GO:190394; GO:001603; GO:003010; GO:006098; GO:008609; GO:190243; GO:190296	nucleus;cytosol;cytoplasm;plasma membrane;membrane;nuclear envelope;cytoskeleton;axon;axon initial segment;Z disc;lipid tube;actin cytoskeleton;T-tubule;node of Ranvier;endosome;I band;synaptic vesicle	GO:000563; GO:000582; GO:000573; GO:000588; GO:001602; GO:000563; GO:000585; GO:003042; GO:004319; GO:003001; GO:006098; GO:001562; GO:003031; GO:003326; GO:000576; GO:003167; GO:000802	 Endocytosis; Fc gamma R-mediated phagocytosis	hsa0414; hsa0466	chaperone binding;actin filament binding;protease binding;clathrin binding;RNA polymerase binding;protein binding;identical protein binding;phospholipid binding;tau protein binding	GO:005108; GO:005101; GO:000202; GO:003027; GO:007006; GO:000551; GO:004280; GO:000554; GO:004815
NP_001090914.2	NP_001090914.2	NP_001090914.2 monocyte differentiation antigen CD14 precursor [Sus scrofa]	7	7	7	18040000	33232000	29008000	37384000	28903000	29516000	27672000	42673000	11311000	36377000	19839000	37641000	27425000	26530000	24886000	25770000	0	34463000	NA	NA	NA	CD14	CD14;NA;NA;NA;NA	receptor-mediated endocytosis;positive regulation of tumor necrosis factor production;MyD88-dependent toll-like receptor signaling pathway;innate immune response;positive regulation of cytokine secretion;cellular response to lipoteichoic acid;positive regulation of interleukin-8 secretion;toll-like receptor signaling pathway;positive regulation of interferon-gamma production;TRIF-dependent toll-like receptor signaling pathway;cellular response to molecule of bacterial origin;cellular response to diacyl bacterial lipopeptide;apoptotic signaling pathway;inflammatory response;cell surface receptor signaling pathway;response to magnesium ion;neutrophil degranulation;response to electrical stimulus;necroptotic process;phagocytosis;positive regulation of type I interferon production;toll-like receptor TLR1:TLR2 signaling pathway;response to ethanol;apoptotic process;I-kappaB kinase/NF-kappaB signaling;toll-like receptor 4 signaling pathway;response to tumor necrosis factor;positive regulation of endocytosis;positive regulation of NIK/NF-kappaB signaling;response to heat;lipopolysaccharide-mediated signaling pathway;negative regulation of MyD88-independent toll-like receptor signaling pathway	GO:000689; GO:003276; GO:000275; GO:004508; GO:005071; GO:007122; GO:200048; GO:000222; GO:003272; GO:003566; GO:007121; GO:007172; GO:009719; GO:000695; GO:000716; GO:003202; GO:004331; GO:005160; GO:007026; GO:000690; GO:003248; GO:003812; GO:004547; GO:000691; GO:000724; GO:003414; GO:003461; GO:004580; GO:190122; GO:000940; GO:003166; GO:003412	extracellular space;plasma membrane;secretory granule membrane;lipopolysaccharide receptor complex;extracellular exosome;external side of plasma membrane;extracellular region;cell surface;endosome membrane;anchored component of external side of plasma membrane;membrane raft;Golgi apparatus	GO:000561; GO:000588; GO:003066; GO:004669; GO:007006; GO:000989; GO:000557; GO:000998; GO:001000; GO:003136; GO:004512; GO:000579	 Toll-like receptor signaling pathway; Pathogenic Escherichia coli infection; Transcriptional misregulation in cancer; Regulation of actin cytoskeleton; Amoebiasis; NF-kappa B signaling pathway; MAPK signaling pathway; Tuberculosis; Hematopoietic cell lineage; Phagosome	hsa0462; hsa0513; hsa0520; hsa0481; hsa0514; hsa0406; hsa0401; hsa0515; hsa0464; hsa0414	lipoteichoic acid binding;opsonin receptor activity;lipopeptide binding;protein binding;peptidoglycan receptor activity;lipopolysaccharide binding	GO:007089; GO:000184; GO:007172; GO:000551; GO:001601; GO:000153
NP_001090917.1;CON__Q3MHN2	NP_001090917.1	NP_001090917.1 complement component C9 precursor [Sus scrofa]	11	11	11	74132000	70074000	62011000	64799000	125350000	197050000	94994000	58481000	64405000	59969000	59470000	54021000	74975000	77311000	60960000	53783000	78473000	77814000	NA	NA	NA	C9	C9;NA;NA;NA;NA	cytolysis;complement activation, classical pathway;regulation of complement activation;protein homooligomerization;cell killing	GO:001983; GO:000695; GO:003044; GO:005126; GO:000190	plasma membrane;extracellular region;extracellular exosome;other organism cell membrane;cytosol;extracellular space;blood microparticle	GO:000588; GO:000557; GO:007006; GO:004421; GO:000582; GO:000561; GO:007256	 Prion diseases; Amoebiasis; Systemic lupus erythematosus; Complement and coagulation cascades	hsa0502; hsa0514; hsa0532; hsa0461	"NA"	"NA"
NP_001090918.1	NP_001090918.1	NP_001090918.1 complement component C6 precursor [Sus scrofa]	7	7	7	0	0	0	0	11558000	12189000	0	0	10399000	0	0	0	0	0	0	0	9226900	0	NA	NA	NA	C6	C6;NA;NA;NA;NA	regulation of complement activation;in utero embryonic development;positive regulation of activation of membrane attack complex;complement activation;cytolysis;innate immune response;positive regulation of angiogenesis	GO:003044; GO:000170; GO:000197; GO:000695; GO:001983; GO:004508; GO:004576	extracellular exosome;extracellular region	GO:007006; GO:000557	 Complement and coagulation cascades; Prion diseases; Systemic lupus erythematosus	hsa0461; hsa0502; hsa0532	protein binding	GO:000551
NP_001090919.2;XP_020948834.1	NP_001090919.2;XP_020948834.1	NP_001090919.2 complement component C8 alpha chain precursor [Sus scrofa];XP_020948834.1 complement component C8 alpha chain isoform X1 [Sus scrofa]	8	8	8	44948000	35091000	47444000	39947000	48079000	74631000	52919000	0	34334000	38205000	35595000	31832000	49076000	47064000	52151000	31865000	52569000	55918000	NA	NA	NA	C8A	C8A;C8A;NA;NA;NA	immune response;complement activation, classical pathway;regulation of complement activation;cytolysis	GO:000695; GO:000695; GO:003044; GO:001983	membrane attack complex;extracellular exosome;extracellular region;blood microparticle;membrane;extracellular space	GO:000557; GO:007006; GO:000557; GO:007256; GO:001602; GO:000561	 Complement and coagulation cascades; Amoebiasis; Systemic lupus erythematosus; Prion diseases	hsa0461; hsa0514; hsa0532; hsa0502	macromolecular complex binding;complement binding	GO:004487; GO:000184
NP_001090920.2	NP_001090920.2	NP_001090920.2 complement component C8 beta chain precursor [Sus scrofa]	5	5	5	0	20825000	21766000	0	21718000	25037000	0	0	0	0	0	0	19876000	22698000	23839000	0	0	0	NA	NA	NA	C8B	C8B;NA;NA;NA;NA	complement activation, classical pathway;immune response;regulation of complement activation;cytolysis	GO:000695; GO:000695; GO:003044; GO:001983	membrane attack complex;membrane;extracellular exosome;extracellular vesicle;extracellular region	GO:000557; GO:001602; GO:007006; GO:190356; GO:000557	 Complement and coagulation cascades; Prion diseases; Amoebiasis; Systemic lupus erythematosus	hsa0461; hsa0502; hsa0514; hsa0532	macromolecular complex binding	GO:004487
NP_001090921.1;XP_013844502.1;XP_005652771.1;XP_013844498.1	NP_001090921.1;XP_013844502.1;XP_005652771.1;XP_013844498.1	NP_001090921.1 complement component C8 gamma chain precursor [Sus scrofa];XP_013844502.1 complement component C8 gamma chain isoform X3 [Sus scrofa];XP_005652771.1 complement component C8 gamma chain isoform X2 [Sus scrofa];XP_013844498.1 complement compon	6	6	6	54946000	40008000	39358000	49595000	50852000	87660000	49825000	30089000	47697000	57813000	59625000	44457000	62630000	53305000	66620000	46009000	58595000	53451000	NA	NA	NA	C8G	C8G;C8G;C8G;C8G;NA	regulation of complement activation;complement activation, alternative pathway;cytolysis	GO:003044; GO:000695; GO:001983	extracellular region;blood microparticle;membrane attack complex;extracellular exosome	GO:000557; GO:007256; GO:000557; GO:007006	 Complement and coagulation cascades; Prion diseases; Systemic lupus erythematosus; Amoebiasis	hsa0461; hsa0502; hsa0532; hsa0514	retinol binding	GO:001984
NP_001090923.1	NP_001090923.1	NP_001090923.1 F-actin-capping protein subunit alpha-1 [Sus scrofa]	9	7	7	72787000	95154000	93746000	72366000	70695000	93921000	84918000	66879000	79459000	77452000	74277000	75605000	113360000	97632000	92862000	83089000	107000000	109400000	NA	NA	NA	CAPZA1	CAPZA1;NA;NA;NA;NA	actin cytoskeleton organization;interleukin-12-mediated signaling pathway;innate immune response;ER to Golgi vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;barbed-end actin filament capping;macromolecular complex assembly;cell junction assembly;blood coagulation	GO:003003; GO:003572; GO:004508; GO:000688; GO:001988; GO:005101; GO:006500; GO:003432; GO:000759	cytoskeleton;cytosol;WASH complex;actin cytoskeleton;actin cortical patch;F-actin capping protein complex;extracellular exosome;extracellular region	GO:000585; GO:000582; GO:007120; GO:001562; GO:003047; GO:000829; GO:007006; GO:000557	 Endocytosis	hsa0414	actin filament binding;actin binding;protein binding;cadherin binding	GO:005101; GO:000377; GO:000551; GO:004529
NP_001090924.1	NP_001090924.1	NP_001090924.1 F-actin-capping protein subunit alpha-2 [Sus scrofa]	13	13	11	221430000	251410000	205030000	224340000	176280000	245550000	203840000	228770000	186800000	225180000	248860000	291730000	289840000	241590000	218550000	230840000	216180000	294500000	NA	NA	NA	CAPZA2	CAPZA2;NA;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;actin cytoskeleton organization;innate immune response;barbed-end actin filament capping;macromolecular complex assembly;ER to Golgi vesicle-mediated transport;blood coagulation	GO:001988; GO:003003; GO:004508; GO:005101; GO:006500; GO:000688; GO:000759	extracellular region;cytosol;membrane;actin cortical patch;actin cytoskeleton;extracellular exosome;brush border;F-actin capping protein complex	GO:000557; GO:000582; GO:001602; GO:003047; GO:001562; GO:007006; GO:000590; GO:000829	 Endocytosis	hsa0414	actin filament binding	GO:005101
XP_020927423.1;XP_020927422.1;XP_013845747.1;XP_005657324.1;XP_005657323.1;NP_001090927.1;XP_005657322.3;XP_020927424.1	XP_020927423.1;XP_020927422.1;XP_013845747.1;XP_005657324.1;XP_005657323.1;NP_001090927.1;XP_005657322.3;XP_020927424.1	XP_020927423.1 cathepsin B isoform X2 [Sus scrofa];XP_020927422.1 cathepsin B isoform X2 [Sus scrofa];XP_013845747.1 cathepsin B isoform X2 [Sus scrofa];XP_005657324.1 cathepsin B isoform X2 [Sus scrofa];XP_005657323.1 cathepsin B isoform X2 [Sus scrofa];N	7	7	7	70117000	115670000	100820000	139280000	83664000	128750000	79824000	103660000	75282000	111730000	92217000	118010000	102500000	130440000	112370000	104470000	119830000	143480000	NA	NA	NA	CTSB	CTSB;CTSB;CTSB;CTSB;CTSB	decidualization;cellular response to thyroid hormone stimulus;proteolysis;proteolysis involved in cellular protein catabolic process;epithelial cell differentiation;regulation of catalytic activity;regulation of apoptotic process;collagen catabolic process;viral entry into host cell;neutrophil degranulation	GO:004669; GO:009706; GO:000650; GO:005160; GO:003085; GO:005079; GO:004298; GO:003057; GO:004671; GO:004331	melanosome;ficolin-1-rich granule lumen;nucleolus;perinuclear region of cytoplasm;extracellular space;intracellular membrane-bounded organelle;endolysosome lumen;lysosome;extracellular region;extracellular exosome	GO:004247; GO:190481; GO:000573; GO:004847; GO:000561; GO:004323; GO:003602; GO:000576; GO:000557; GO:007006	 Renin secretion; Lysosome; Antigen processing and presentation	hsa0492; hsa0414; hsa0461	cysteine-type endopeptidase activity;protein binding;peptidase activity;proteoglycan binding;serine-type endopeptidase activity	GO:000419; GO:000551; GO:000823; GO:004339; GO:000425
NP_001090937.1;XP_013835180.1	NP_001090937.1;XP_013835180.1	NP_001090937.1 cytochrome c oxidase subunit NDUFA4 [Sus scrofa];XP_013835180.1 cytochrome c oxidase subunit NDUFA4 isoform X1 [Sus scrofa]	3	3	3	0	67177000	0	0	0	0	79179000	69439000	96295000	82172000	0	50789000	0	0	0	81858000	75613000	0	NA	NA	NA	NDUFA4	NDUFA4;NDUFA4;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;hydrogen ion transmembrane transport	GO:000612; GO:190260	mitochondrion;mitochondrial respiratory chain complex I;mitochondrial respiratory chain complex IV	GO:000573; GO:000574; GO:000575	 Oxidative phosphorylation; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways	hsa0019; hsa0501; hsa0493; hsa0110	NADH dehydrogenase (ubiquinone) activity;protein binding;cytochrome-c oxidase activity;macromolecular complex binding	GO:000813; GO:000551; GO:000412; GO:004487
XP_020928261.1;NP_001090940.1	XP_020928261.1;NP_001090940.1	XP_020928261.1 methylmalonyl-CoA epimerase, mitochondrial isoform X1 [Sus scrofa];NP_001090940.1 methylmalonyl-CoA epimerase, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13275000	0	0	NA	NA	NA	MCEE	MCEE;MCEE;NA;NA;NA	short-chain fatty acid catabolic process;L-methylmalonyl-CoA metabolic process	GO:001962; GO:004649	mitochondrial matrix	GO:000575	 Propanoate metabolism; Metabolic pathways; Carbon metabolism; Glyoxylate and dicarboxylate metabolism; Valine, leucine and isoleucine degradation	hsa0064; hsa0110; hsa0120; hsa0063; hsa0028	protein binding;methylmalonyl-CoA epimerase activity;metal ion binding	GO:000551; GO:000449; GO:004687
XP_013852024.1;NP_001090942.2;XP_005669185.1	XP_013852024.1;NP_001090942.2	XP_013852024.1 cytochrome c oxidase subunit 6C isoform X1 [Sus scrofa];NP_001090942.2 cytochrome c oxidase subunit 6C [Sus scrofa]	3	3	3	130280000	0	138840000	61948000	82907000	88643000	111040000	66266000	161850000	75678000	78540000	0	58203000	78400000	94501000	73904000	99170000	71624000	NA	NA	NA	COX6C	COX6C;COX6C;NA;NA;NA	generation of precursor metabolites and energy;electron transport chain;hydrogen ion transmembrane transport	GO:000609; GO:002290; GO:190260	mitochondrial inner membrane;mitochondrion;integral component of membrane	GO:000574; GO:000573; GO:001602	 Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation; Alzheimer's disease; Cardiac muscle contraction	hsa0110; hsa0493; hsa0019; hsa0501; hsa0426	cytochrome-c oxidase activity	GO:000412
NP_001090944.2	NP_001090944.2	NP_001090944.2 NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial [Sus scrofa]	3	3	3	39163000	22699000	30679000	21170000	33449000	15488000	37070000	27696000	29340000	27168000	24426000	26995000	0	23122000	31903000	24895000	23603000	23080000	NA	NA	NA	NDUFV2	NDUFV2;NA;NA;NA;NA	cardiac muscle tissue development;mitochondrial electron transport, NADH to ubiquinone;nervous system development;mitochondrial respiratory chain complex I assembly	GO:004873; GO:000612; GO:000739; GO:003298	mitochondrion;mitochondrial inner membrane	GO:000573; GO:000574	 Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Oxidative phosphorylation	hsa0110; hsa0493; hsa0501; hsa0019	protein binding;metal ion binding;NADH dehydrogenase (ubiquinone) activity;electron carrier activity;2 iron, 2 sulfur cluster binding;NADH dehydrogenase activity	GO:000551; GO:004687; GO:000813; GO:000905; GO:005153; GO:000395
NP_001090945.1	NP_001090945.1	NP_001090945.1 proteasome subunit beta type-7 precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	8790100	0	0	0	0	0	0	NA	NA	NA	PSMB7	PSMB7;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;viral process;proteasome-mediated ubiquitin-dependent protein catabolic process;neutrophil degranulation;proteasomal protein catabolic process;protein deubiquitination;post-translational protein modification	GO:001049; GO:001603; GO:004316; GO:004331; GO:001049; GO:001657; GO:004368	proteasome complex;nucleoplasm;proteasome core complex, beta-subunit complex;cytoplasm;proteasome core complex;extracellular region;ficolin-1-rich granule lumen;nucleus;secretory granule lumen;cytosol	GO:000050; GO:000565; GO:001977; GO:000573; GO:000583; GO:000557; GO:190481; GO:000563; GO:003477; GO:000582	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000417
XP_020953511.1;NP_001090946.2;XP_020926443.1	XP_020953511.1;NP_001090946.2	XP_020953511.1 60S ribosomal protein L10a isoform X1 [Sus scrofa];NP_001090946.2 60S ribosomal protein L10a [Sus scrofa]	6	6	6	128770000	131550000	171410000	116070000	105950000	192950000	140100000	93894000	168160000	172700000	109340000	137670000	148520000	161180000	94504000	147940000	178460000	187080000	NA	NA	NA	RPL10A	RPL10A;RPL10A;NA;NA;NA	maturation of LSU-rRNA;translation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;response to ethanol	GO:000047; GO:000641; GO:000661; GO:000018; GO:000218; GO:004547	postsynaptic density;polysomal ribosome;cytosolic large ribosomal subunit;focal adhesion;extracellular exosome;nucleus;membrane;cytosol	GO:001406; GO:004278; GO:002262; GO:000592; GO:007006; GO:000563; GO:001602; GO:000582	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;protein binding	GO:000372; GO:000373; GO:000551
XP_020923829.1;NP_001090947.1;XP_003480329.1	XP_020923829.1;NP_001090947.1	XP_020923829.1 60S ribosomal protein L14 isoform X1 [Sus scrofa];NP_001090947.1 60S ribosomal protein L14 [Sus scrofa]	3	3	3	64178000	67529000	57964000	56207000	47028000	73349000	0	40656000	67150000	77317000	0	0	79214000	65018000	0	69486000	54801000	92970000	NA	NA	NA	RPL14	RPL14;RPL14;NA;NA;NA	rRNA processing;SRP-dependent cotranslational protein targeting to membrane;ribosomal large subunit biogenesis;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000636; GO:000661; GO:004227; GO:000018; GO:000641	cytosol;extracellular exosome;cytosolic large ribosomal subunit;membrane;postsynaptic density	GO:000582; GO:007006; GO:002262; GO:001602; GO:001406	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;protein binding;cadherin binding	GO:000372; GO:000373; GO:000551; GO:004529
NP_001090948.1	NP_001090948.1	NP_001090948.1 60S ribosomal protein L27 [Sus scrofa]	5	5	5	116550000	125070000	139160000	99552000	113870000	169210000	100780000	103420000	153210000	136220000	101290000	83121000	130720000	166360000	87231000	143710000	151140000	151630000	NA	NA	NA	RPL27	RPL27;NA;NA;NA;NA	translation;translational initiation;rRNA processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000641; GO:000636; GO:000018; GO:000661	ribosome;membrane;cytosolic large ribosomal subunit;extracellular exosome;cytoplasmic side of rough endoplasmic reticulum membrane;focal adhesion;ribonucleoprotein complex;nucleus;cytosol	GO:000584; GO:001602; GO:002262; GO:007006; GO:009855; GO:000592; GO:199090; GO:000563; GO:000582	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;protein binding	GO:000373; GO:000372; GO:000551
XP_003128784.1;NP_001090949.1	XP_003128784.1;NP_001090949.1	XP_003128784.1 40S ribosomal protein S21 [Sus scrofa];NP_001090949.1 40S ribosomal protein S21 [Sus scrofa]	2	2	2	0	66643000	0	0	0	0	0	64097000	0	56543000	0	0	0	78353000	0	52317000	0	64103000	NA	NA	NA	RPS21	LOC100518848;RPS21;NA;NA;NA	translation;translational initiation;endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);cytoplasmic translation;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000641; GO:000046; GO:000018; GO:000044; GO:000218; GO:000661	cytosol;synapse;nucleoplasm;rough endoplasmic reticulum;polysomal ribosome;cytosolic small ribosomal subunit;small ribosomal subunit	GO:000582; GO:004520; GO:000565; GO:000579; GO:004278; GO:002262; GO:001593	 Ribosome	hsa0301	RNA binding;protein N-terminus binding;structural constituent of ribosome	GO:000372; GO:004748; GO:000373
NP_001090950.1	NP_001090950.1	NP_001090950.1 40S ribosomal protein S26 [Sus scrofa]	2	2	2	43690000	0	65440000	0	0	65792000	0	0	49021000	43247000	0	0	46607000	0	0	52758000	62777000	52854000	NA	NA	NA	RPS26	RPS26;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;cytoplasmic translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;negative regulation of RNA splicing	GO:000661; GO:000218; GO:000018; GO:000641; GO:003311	nucleoplasm;extracellular exosome;small ribosomal subunit;polysomal ribosome;cytoplasmic side of rough endoplasmic reticulum membrane;cytosol;cytosolic small ribosomal subunit;membrane	GO:000565; GO:007006; GO:001593; GO:004278; GO:009855; GO:000582; GO:002262; GO:001602	 Ribosome	hsa0301	protein binding;RNA binding;structural constituent of ribosome;cadherin binding	GO:000551; GO:000372; GO:000373; GO:004529
NP_001090951.1;CON__P21752	NP_001090951.1;CON__P21752	NP_001090951.1 thymosin beta-10 [Sus scrofa];	3	3	3	0	66220000	40087000	108190000	46388000	98113000	50196000	112240000	38836000	92079000	51478000	281810000	74976000	70112000	91579000	121380000	43772000	0	NA	NA	+	TMSB10	TMSB10;NA;NA;NA;NA	actin filament organization;sequestering of actin monomers;regulation of cell migration	GO:000701; GO:004298; GO:003033	cytoplasm;cytoskeleton	GO:000573; GO:000585	"NA"	"NA"	actin monomer binding;protein binding	GO:000378; GO:000551
NP_001090953.1	NP_001090953.1	NP_001090953.1 cytochrome c oxidase subunit 7A2, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12629000	NA	NA	NA	COX7A2	COX7A2;NA;NA;NA;NA	regulation of oxidative phosphorylation;mitochondrial respiratory chain supercomplex assembly;hydrogen ion transmembrane transport;electron transport chain	GO:000208; GO:009725; GO:190260; GO:002290	mitochondrial respiratory chain;integral component of membrane	GO:000574; GO:001602	 Oxidative phosphorylation; Cardiac muscle contraction; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0426; hsa0501; hsa0493	cytochrome-c oxidase activity	GO:000412
NP_001090964.1;XP_020941196.1;XP_020941197.1	NP_001090964.1;XP_020941196.1;XP_020941197.1	NP_001090964.1 ribose-5-phosphate isomerase [Sus scrofa];XP_020941196.1 ribose-5-phosphate isomerase isoform X1 [Sus scrofa];XP_020941197.1 ribose-5-phosphate isomerase isoform X2 [Sus scrofa]	7	7	7	71461000	85002000	77625000	94058000	71219000	84435000	57659000	76469000	64769000	73905000	77239000	142540000	65759000	81102000	83890000	76918000	48304000	61415000	NA	NA	NA	RPIA	RPIA;RPIA;RPIA;NA;NA	pentose-phosphate shunt, non-oxidative branch;pentose-phosphate shunt;D-ribose metabolic process	GO:000905; GO:000609; GO:000601	cytosol;intracellular membrane-bounded organelle	GO:000582; GO:004323	 Biosynthesis of amino acids; Pentose phosphate pathway; Carbon metabolism; Metabolic pathways; Biosynthesis of antibiotics	hsa0123; hsa0003; hsa0120; hsa0110; hsa0113	identical protein binding;protein binding;ribose-5-phosphate isomerase activity;monosaccharide binding	GO:004280; GO:000551; GO:000475; GO:004802
NP_001090965.1	NP_001090965.1	NP_001090965.1 cystatin-B [Sus scrofa]	4	4	4	813100000	756280000	1031500000	640410000	255260000	509380000	932560000	688650000	699760000	652000000	611110000	468280000	654950000	970010000	958910000	662500000	973260000	777310000	NA	NA	NA	CSTB	CSTB;NA;NA;NA;NA	negative regulation of endopeptidase activity;adult locomotory behavior;neutrophil degranulation;negative regulation of proteolysis;negative regulation of peptidase activity	GO:001095; GO:000834; GO:004331; GO:004586; GO:001046	nucleolus;extracellular region;tertiary granule lumen;extracellular space;cytosol;ficolin-1-rich granule lumen;cytoplasm;extracellular exosome;secretory granule lumen	GO:000573; GO:000557; GO:190472; GO:000561; GO:000582; GO:190481; GO:000573; GO:007006; GO:003477	"NA"	"NA"	endopeptidase inhibitor activity;protease binding;cysteine-type endopeptidase inhibitor activity;RNA binding	GO:000486; GO:000202; GO:000486; GO:000372
XP_005660031.1;NP_001090970.1	XP_005660031.1;NP_001090970.1	XP_005660031.1 galectin-3 isoform X1 [Sus scrofa];NP_001090970.1 galectin-3 [Sus scrofa]	6	6	6	55465000	217750000	104750000	266470000	100770000	257070000	141970000	161710000	93663000	202410000	140740000	218710000	171890000	209220000	132800000	227040000	223390000	355080000	NA	NA	NA	LGALS3	LGALS3;LGALS3;NA;NA;NA	regulation of T cell proliferation;neutrophil degranulation;negative regulation of endocytosis;eosinophil chemotaxis;regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of protein tyrosine phosphatase activity;positive regulation of calcium ion import;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;positive chemotaxis;regulation of T cell apoptotic process;positive regulation of protein localization to plasma membrane;RNA splicing;positive regulation of protein homodimerization activity;neutrophil chemotaxis;negative regulation of T cell receptor signaling pathway;mononuclear cell migration;monocyte chemotaxis;regulation of myeloid cell differentiation;negative regulation of immunological synapse formation;negative regulation of extrinsic apoptotic signaling pathway;mRNA processing;epithelial cell differentiation;innate immune response;positive regulation of dendritic cell differentiation	GO:004212; GO:004331; GO:004580; GO:004824; GO:190204; GO:190361; GO:009028; GO:200118; GO:005091; GO:007023; GO:190307; GO:000838; GO:009007; GO:003059; GO:005086; GO:007167; GO:000254; GO:004563; GO:200052; GO:200123; GO:000639; GO:003085; GO:004508; GO:200120	extracellular space;secretory granule membrane;immunological synapse;cytoplasm;plasma membrane;cell surface;extracellular region;membrane;mitochondrial inner membrane;extracellular exosome;spliceosomal complex;ficolin-1-rich granule membrane;nucleus	GO:000561; GO:003066; GO:000177; GO:000573; GO:000588; GO:000998; GO:000557; GO:001602; GO:000574; GO:007006; GO:000568; GO:010100; GO:000563	"NA"	"NA"	RNA binding;protein binding;protein phosphatase inhibitor activity;protein phosphatase binding;carbohydrate binding;chemoattractant activity;IgE binding;laminin binding	GO:000372; GO:000551; GO:000486; GO:001990; GO:003024; GO:004205; GO:001986; GO:004323
XP_020920751.1;NP_001090973.1	XP_020920751.1;NP_001090973.1	XP_020920751.1 heat shock protein 105 kDa isoform X1 [Sus scrofa];NP_001090973.1 heat shock protein 105 kDa [Sus scrofa]	4	4	4	0	0	10609000	0	0	0	0	0	0	0	0	0	0	0	0	7176500	0	0	NA	NA	NA	HSPH1	HSPH1;HSPH1;NA;NA;NA	response to unfolded protein;positive regulation of MHC class I biosynthetic process;chaperone mediated protein folding requiring cofactor;regulation of cellular response to heat;receptor-mediated endocytosis;regulation of catalytic activity;positive regulation of NK T cell activation	GO:000698; GO:004534; GO:005108; GO:190003; GO:000689; GO:005079; GO:005113	extracellular exosome;endocytic vesicle lumen;nucleus;nucleoplasm;macromolecular complex;cytosol;microtubule;extracellular region;cytoplasm	GO:007006; GO:007168; GO:000563; GO:000565; GO:003299; GO:000582; GO:000587; GO:000557; GO:000573	 Protein processing in endoplasmic reticulum	hsa0414	adenyl-nucleotide exchange factor activity;ATP binding;alpha-tubulin binding;protein binding	GO:000077; GO:000552; GO:004301; GO:000551
NP_001090978.1;XP_020937155.1;XP_020937156.1	NP_001090978.1;XP_020937155.1	NP_001090978.1 adenylosuccinate synthetase isozyme 1 [Sus scrofa];XP_020937155.1 adenylosuccinate synthetase isozyme 1 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11536000	0	NA	NA	NA	ADSSL1	ADSSL1;ADSSL1;NA;NA;NA	glutamine metabolic process;IMP metabolic process;AMP biosynthetic process;purine ribonucleoside monophosphate biosynthetic process;response to muscle activity;immune system process;aspartate metabolic process;cellular response to drug;cellular response to electrical stimulus;response to starvation;'de novo' AMP biosynthetic process	GO:000654; GO:004604; GO:000616; GO:000916; GO:001485; GO:000237; GO:000653; GO:003569; GO:007125; GO:004259; GO:004420	cytosol;cytoplasm	GO:000582; GO:000573	 Alanine, aspartate and glutamate metabolism; Metabolic pathways; Purine metabolism	hsa0025; hsa0110; hsa0023	magnesium ion binding;GTP binding;protein homodimerization activity;GTPase activity;actin filament binding;phosphate ion binding;adenylosuccinate synthase activity	GO:000028; GO:000552; GO:004280; GO:000392; GO:005101; GO:004230; GO:000401
NP_001090985.1	NP_001090985.1	NP_001090985.1 succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5610100	NA	NA	NA	SDHD	SDHD;NA;NA;NA;NA	mitochondrial electron transport, succinate to ubiquinone;tricarboxylic acid cycle	GO:000612; GO:000609	mitochondrion;mitochondrial inner membrane;integral component of membrane	GO:000573; GO:000574; GO:001602	 Alzheimer's disease; Parkinson's disease; Oxidative phosphorylation; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Citrate cycle (TCA cycle); Biosynthesis of antibiotics; Carbon metabolism	hsa0501; hsa0501; hsa0019; hsa0110; hsa0493; hsa0002; hsa0113; hsa0120	electron carrier activity;succinate dehydrogenase activity;heme binding;metal ion binding;ubiquinone binding;succinate dehydrogenase (ubiquinone) activity	GO:000905; GO:000010; GO:002003; GO:004687; GO:004803; GO:000817
NP_001090990.2	NP_001090990.2	NP_001090990.2 membrane-associated progesterone receptor component 2 [Sus scrofa]	8	7	7	251970000	215120000	248530000	218360000	235730000	154170000	226040000	225460000	205210000	183680000	237170000	250530000	110240000	187310000	223730000	202550000	228280000	199420000	NA	NA	NA	PGRMC2	PGRMC2;NA;NA;NA;NA	steroid hormone mediated signaling pathway	GO:004340	membrane;nuclear envelope;integral component of membrane	GO:001602; GO:000563; GO:001602	"NA"	"NA"	steroid binding;steroid hormone receptor activity;protein binding	GO:000549; GO:000370; GO:000551
NP_001092055.1;XP_020932130.1	NP_001092055.1;XP_020932130.1	NP_001092055.1 AP-3 complex subunit beta-1 [Sus scrofa];XP_020932130.1 AP-3 complex subunit beta-1 isoform X1 [Sus scrofa]	8	8	8	40369000	51377000	46451000	46450000	41240000	42728000	0	43774000	0	43342000	45273000	61302000	67339000	52329000	0	43909000	0	59413000	NA	NA	NA	AP3B1	AP3B1;AP3B1;NA;NA;NA	blood coagulation;positive regulation of NK T cell differentiation;synaptic vesicle budding from endosome;melanosome organization;intracellular protein transport;anterograde synaptic vesicle transport;protein targeting to lysosome;anterograde axonal transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib	GO:000759; GO:005113; GO:001618; GO:003243; GO:000688; GO:004849; GO:000662; GO:000808; GO:004800	lysosomal membrane;membrane;clathrin-coated vesicle membrane;postsynapse;axon cytoplasm;Golgi apparatus;clathrin adaptor complex;AP-3 adaptor complex	GO:000576; GO:001602; GO:003066; GO:009879; GO:190411; GO:000579; GO:003013; GO:003012	 Lysosome	hsa0414	protein phosphatase binding;GTP-dependent protein binding	GO:001990; GO:003074
XP_005666280.1;NP_001092063.1	XP_005666280.1;NP_001092063.1	XP_005666280.1 geranylgeranyl transferase type-2 subunit alpha isoform X1 [Sus scrofa];NP_001092063.1 geranylgeranyl transferase type-2 subunit alpha [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1190600	NA	NA	NA	RABGGTA	RABGGTA;RABGGTA;NA;NA;NA	protein geranylgeranylation;regulation of apoptotic process;macromolecular complex assembly;cellular protein modification process;visual perception;post-translational protein modification	GO:001834; GO:004298; GO:006500; GO:000646; GO:000760; GO:004368	nucleoplasm;cytoplasm;Rab-protein geranylgeranyltransferase complex;plasma membrane;cytosol	GO:000565; GO:000573; GO:000596; GO:000588; GO:000582	"NA"	"NA"	zinc ion binding;Rab GTPase binding;Rab geranylgeranyltransferase activity;protein heterodimerization activity	GO:000827; GO:001713; GO:000466; GO:004698
NP_001092068.1	NP_001092068.1	NP_001092068.1 60S acidic ribosomal protein P0 [Sus scrofa]	10	10	10	267770000	262300000	295750000	299400000	287740000	314540000	289030000	246790000	280980000	281710000	261610000	292430000	318360000	297240000	236080000	276240000	327210000	335580000	NA	NA	NA	RPLP0	RPLP0;NA;NA;NA;NA	ribosomal large subunit assembly;cytoplasmic translation;interleukin-12-mediated signaling pathway;SRP-dependent cotranslational protein targeting to membrane;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000002; GO:000218; GO:003572; GO:000661; GO:000641; GO:000018	cytosolic large ribosomal subunit;cytosol;postsynaptic density;membrane;ribonucleoprotein complex;postsynapse;cytoplasmic ribonucleoprotein granule;nucleus;endoplasmic reticulum;extracellular exosome;cytoplasm;focal adhesion	GO:002262; GO:000582; GO:001406; GO:001602; GO:199090; GO:009879; GO:003646; GO:000563; GO:000578; GO:007006; GO:000573; GO:000592	 Ribosome	hsa0301	RNA binding;large ribosomal subunit rRNA binding;protein binding;structural constituent of ribosome	GO:000372; GO:007018; GO:000551; GO:000373
XP_020932177.1;XP_020932172.1;XP_013843010.1;XP_020932170.1;XP_020932161.1;XP_005655035.1;XP_005655033.1;XP_005655032.1;NP_001092072.1	XP_020932177.1;XP_020932172.1;XP_013843010.1;XP_020932170.1;XP_020932161.1;XP_005655035.1;XP_005655033.1;XP_005655032.1;NP_001092072.1	XP_020932177.1 sideroflexin-1 isoform X3 [Sus scrofa];XP_020932172.1 sideroflexin-1 isoform X2 [Sus scrofa];XP_013843010.1 sideroflexin-1 isoform X2 [Sus scrofa];XP_020932170.1 sideroflexin-1 isoform X1 [Sus scrofa];XP_020932161.1 sideroflexin-1 isoform X1	4	4	4	0	8356400	7212900	9039800	17991000	0	7393800	15514000	7149100	16731000	6963900	0	0	5561800	7488800	7903200	0	0	NA	NA	NA	SFXN1	SFXN1;SFXN1;SFXN1;SFXN1;SFXN1	erythrocyte differentiation;ion transmembrane transport;iron ion homeostasis;iron ion transport	GO:003021; GO:003422; GO:005507; GO:000682	integral component of membrane;mitochondrial membrane;mitochondrion	GO:001602; GO:003196; GO:000573	"NA"	"NA"	ion transmembrane transporter activity	GO:001507
NP_001092075.1	NP_001092075.1	NP_001092075.1 patatin-like phospholipase domain-containing protein 2 [Sus scrofa]	12	12	1	272140000	161390000	151280000	125680000	107510000	62762000	172380000	139020000	224540000	144800000	162290000	197170000	94257000	153150000	128840000	159090000	136810000	155500000	NA	NA	NA	PNPLA2	PNPLA2;NA;NA;NA;NA	negative regulation of sequestering of triglyceride;lipid particle organization;post-translational protein modification;positive regulation of triglyceride catabolic process;triglyceride catabolic process;lipid homeostasis;acylglycerol acyl-chain remodeling;lipid storage;cellular protein metabolic process	GO:001089; GO:003438; GO:004368; GO:001089; GO:001943; GO:005508; GO:003615; GO:001991; GO:004426	endoplasmic reticulum lumen;lipid particle;plasma membrane;nucleoplasm;endoplasmic reticulum membrane;membrane;cytosol;cytoplasm	GO:000578; GO:000581; GO:000588; GO:000565; GO:000578; GO:001602; GO:000582; GO:000573	 Glycerolipid metabolism; Metabolic pathways; Regulation of lipolysis in adipocytes	hsa0056; hsa0110; hsa0492	triglyceride lipase activity;lipoprotein lipase activity;acylglycerol O-acyltransferase activity	GO:000480; GO:000446; GO:001641
NP_001093400.1	NP_001093400.1	NP_001093400.1 fatty acid synthase [Sus scrofa]	135	135	135	98567000000	17603000000	55567000000	12071000000	71506000000	13455000000	61207000000	21235000000	49385000000	22509000000	55044000000	4766900000	21772000000	13780000000	34979000000	21019000000	57652000000	17195000000	NA	NA	NA	FASN	FASN;NA;NA;NA;NA	macromolecule metabolic process;oxidation-reduction process;ether lipid biosynthetic process;cellular response to interleukin-4;establishment of endothelial intestinal barrier;fatty acid biosynthetic process;neutrophil differentiation;acetyl-CoA metabolic process;regulation of cholesterol biosynthetic process;positive regulation of cellular metabolic process;fatty-acyl-CoA biosynthetic process;osteoblast differentiation;mammary gland development	GO:004317; GO:005511; GO:000861; GO:007135; GO:009055; GO:000663; GO:003022; GO:000608; GO:004554; GO:003132; GO:004694; GO:000164; GO:003087	melanosome;extracellular exosome;Golgi apparatus;membrane;glycogen granule;cytosol;plasma membrane	GO:004247; GO:007006; GO:000579; GO:001602; GO:004258; GO:000582; GO:000588	 Metabolic pathways; AMPK signaling pathway; Fatty acid biosynthesis; Fatty acid metabolism; Insulin signaling pathway	hsa0110; hsa0415; hsa0006; hsa0121; hsa0491	cadherin binding;RNA binding;drug binding;phosphopantetheine binding;enoyl-[acyl-carrier-protein;protein homodimerization activity;3-oxoacyl-[acyl-carrier-protein;oleoyl-[acyl-carrier-protein;NADPH binding;protein binding;myristoyl-[acyl-carrier-protein;(3R)-hydroxymyristoyl-[acyl-carrier-protein;3-hydroxyoctanoyl-[acyl-carrier-protein;3-oxo-pimeloyl-[acp	GO:004529; GO:000372; GO:000814; GO:003117; GO:004711; GO:004280; GO:000431; GO:000432; GO:007040; GO:000551; GO:001629; GO:000865; GO:004745; GO:010213
NP_001093401.1	NP_001093401.1	NP_001093401.1 fatty acid-binding protein, heart [Sus scrofa]	13	13	13	7658100000	3278900000	5619400000	3769900000	4616100000	1951100000	6758200000	4416200000	6835900000	4879400000	5530500000	3126900000	2416200000	3434700000	4397900000	3456700000	3635500000	2518400000	NA	NA	NA	FABP3	FABP3;NA;NA;NA;NA	regulation of phosphatidylcholine biosynthetic process;negative regulation of cell proliferation;positive regulation of phospholipid biosynthetic process;response to drug;cholesterol homeostasis;fatty acid metabolic process;response to fatty acid;triglyceride catabolic process;long-chain fatty acid import;regulation of fatty acid oxidation;phospholipid homeostasis;response to insulin	GO:200124; GO:000828; GO:007107; GO:004249; GO:004263; GO:000663; GO:007054; GO:001943; GO:004453; GO:004632; GO:005509; GO:003286	cytosol;extracellular space;sarcoplasm;extracellular exosome	GO:000582; GO:000561; GO:001652; GO:007006	 PPAR signaling pathway	hsa0332	long-chain fatty acid binding;protein binding;icosatetraenoic acid binding;long-chain fatty acid transporter activity;cytoskeletal protein binding;oleic acid binding	GO:003604; GO:000551; GO:005054; GO:000532; GO:000809; GO:007053
NP_001093402.1	NP_001093402.1	NP_001093402.1 phosphoglycerate kinase 1 [Sus scrofa]	23	23	18	2185600000	2496800000	2333500000	2435800000	2253500000	1788500000	2242100000	2209900000	1976700000	2564700000	2226000000	2761100000	1885200000	2278400000	2202100000	3000300000	2706600000	2210200000	NA	NA	NA	PGK1	PGK1;NA;NA;NA;NA	positive regulation of oxidative phosphorylation;negative regulation of angiogenesis;plasminogen activation;gluconeogenesis;canonical glycolysis;cellular response to hypoxia;phosphorylation;epithelial cell differentiation	GO:190386; GO:001652; GO:003163; GO:000609; GO:006162; GO:007145; GO:001631; GO:003085	membrane raft;extracellular space;membrane;cytosol;extracellular exosome	GO:004512; GO:000561; GO:001602; GO:000582; GO:007006	 Carbon metabolism; Glycolysis / Gluconeogenesis; Metabolic pathways; HIF-1 signaling pathway; Biosynthesis of antibiotics; Biosynthesis of amino acids	hsa0120; hsa0001; hsa0110; hsa0406; hsa0113; hsa0123	phosphoglycerate kinase activity;ATP binding;protein-disulfide reductase activity;protein binding;ADP binding	GO:000461; GO:000552; GO:004713; GO:000551; GO:004353
NP_001093658.1	NP_001093658.1	NP_001093658.1 calpain-2 catalytic subunit [Sus scrofa]	23	23	23	345030000	489600000	384940000	389030000	359680000	412850000	363740000	409330000	431470000	476320000	428390000	615840000	535210000	469020000	428180000	493740000	453160000	501740000	NA	NA	NA	CAPN2	CAPN2;NA;NA;NA;NA	proteolysis;female pregnancy;positive regulation of neuron death;positive regulation of phosphatidylcholine biosynthetic process;positive regulation of cardiac muscle cell apoptotic process;behavioral response to pain;protein autoprocessing;cellular response to interferon-beta;regulation of cytoskeleton organization;cellular response to amino acid stimulus;regulation of interleukin-6 production;myoblast fusion;response to hydrogen peroxide;cellular response to lipopolysaccharide;blastocyst development;proteolysis involved in cellular protein catabolic process;positive regulation of myoblast fusion;response to hypoxia	GO:000650; GO:000756; GO:190121; GO:200124; GO:001066; GO:004826; GO:001654; GO:003545; GO:005149; GO:007123; GO:003267; GO:000752; GO:004254; GO:007122; GO:000182; GO:005160; GO:190174; GO:000166	cortical actin cytoskeleton;neuronal cell body;plasma membrane;dendrite;membrane raft;endoplasmic reticulum;pseudopodium;focal adhesion;external side of plasma membrane;chromatin;lysosome;cytoplasm;mitochondrial intermembrane space;extracellular exosome;nucleus;Golgi apparatus;cytosol;perinuclear endoplasmic reticulum	GO:003086; GO:004302; GO:000588; GO:003042; GO:004512; GO:000578; GO:003114; GO:000592; GO:000989; GO:000078; GO:000576; GO:000573; GO:000575; GO:007006; GO:000563; GO:000579; GO:000582; GO:009703	 Apoptosis; Focal adhesion; Alzheimer's disease; Protein processing in endoplasmic reticulum	hsa0421; hsa0451; hsa0501; hsa0414	protein heterodimerization activity;protein binding;cysteine-type peptidase activity;enzyme binding;cytoskeletal protein binding;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding	GO:004698; GO:000551; GO:000823; GO:001989; GO:000809; GO:000419; GO:000550
NP_001093660.1;XP_005652570.1	NP_001093660.1;XP_005652570.1	NP_001093660.1 insulin-like growth factor-binding protein 6 precursor [Sus scrofa];XP_005652570.1 insulin-like growth factor-binding protein 6 isoform X1 [Sus scrofa]	3	3	3	0	25163000	0	0	0	30611000	0	12867000	0	15414000	0	16654000	5570100	13819000	0	0	8246100	34236000	NA	NA	NA	IGFBP6	IGFBP6;IGFBP6;NA;NA;NA	regulation of insulin-like growth factor receptor signaling pathway;negative regulation of canonical Wnt signaling pathway;negative regulation of cell proliferation;cellular protein metabolic process;signal transduction	GO:004356; GO:009009; GO:000828; GO:004426; GO:000716	extracellular region;Golgi apparatus;insulin-like growth factor binary complex;extracellular space	GO:000557; GO:000579; GO:004256; GO:000561	"NA"	"NA"	fibronectin binding;insulin-like growth factor I binding;receptor binding	GO:000196; GO:003199; GO:000510
NP_001093662.1	NP_001093662.1	NP_001093662.1 serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform [Sus scrofa]	4	4	4	0	17797000	18553000	16430000	14244000	16896000	15716000	19088000	0	20606000	19398000	24914000	8861000	19454000	13056000	19606000	18106000	14315000	NA	NA	NA	PPP2R5A	PPP2R5A;NA;NA;NA;NA	positive regulation of protein dephosphorylation;regulation of phosphoprotein phosphatase activity;signal transduction;regulation of protein autophosphorylation;protein dephosphorylation;negative regulation of lipid kinase activity;negative regulation of protein localization to plasma membrane	GO:003530; GO:004366; GO:000716; GO:003195; GO:000647; GO:009021; GO:190307	cytosol;nucleus;centrosome;protein phosphatase type 2A complex;chromosome, centromeric region;cytoplasm;membrane;Z disc;M band	GO:000582; GO:000563; GO:000581; GO:000015; GO:000077; GO:000573; GO:001602; GO:003001; GO:003143	 Sphingolipid signaling pathway; AMPK signaling pathway; Adrenergic signaling in cardiomyocytes; Dopaminergic synapse; mRNA surveillance pathway; Oocyte meiosis	hsa0407; hsa0415; hsa0426; hsa0472; hsa0301; hsa0411	protein binding;protein phosphatase regulator activity;kinase binding;phosphoprotein phosphatase activity;protein phosphatase activator activity	GO:000551; GO:001988; GO:001990; GO:000472; GO:007254
NP_001093663.1	NP_001093663.1	NP_001093663.1 eukaryotic initiation factor 4A-III [Sus scrofa]	7	5	5	0	0	17531000	12659000	12444000	0	0	14020000	0	11542000	0	25150000	0	14251000	0	18682000	0	13533000	NA	NA	NA	EIF4A3	EIF4A3;NA;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;associative learning;mRNA 3'-end processing;cellular response to brain-derived neurotrophic factor stimulus;mRNA export from nucleus;negative regulation of selenocysteine incorporation;mRNA splicing, via spliceosome;negative regulation of translation;exploration behavior;rRNA processing;response to organic cyclic compound;negative regulation of excitatory postsynaptic potential;positive regulation of translation;cellular response to selenite ion;embryonic cranial skeleton morphogenesis;regulation of translation at postsynapse, modulating synaptic transmission	GO:000018; GO:000830; GO:003112; GO:199041; GO:000640; GO:190457; GO:000039; GO:001714; GO:003564; GO:000636; GO:001407; GO:009039; GO:004572; GO:007271; GO:004870; GO:009957	cytoplasm;membrane;postsynaptic cytosol;catalytic step 2 spliceosome;glutamatergic synapse;nucleoplasm;cytosol;nuclear speck;dendrite;neuronal cell body;exon-exon junction complex	GO:000573; GO:001602; GO:009952; GO:007101; GO:009897; GO:000565; GO:000582; GO:001660; GO:003042; GO:004302; GO:003514	 mRNA surveillance pathway; Spliceosome; RNA transport	hsa0301; hsa0304; hsa0301	RNA stem-loop binding;ATP-dependent RNA helicase activity;translation regulator activity;mRNA binding;protein binding;ATP binding;poly(A) binding;ribonucleoprotein complex binding;selenocysteine insertion sequence binding	GO:003561; GO:000400; GO:004518; GO:000372; GO:000551; GO:000552; GO:000814; GO:004302; GO:003536
NP_001093665.1;XP_020923835.1	NP_001093665.1;XP_020923835.1	NP_001093665.1 eukaryotic initiation factor 4A-II [Sus scrofa];XP_020923835.1 eukaryotic initiation factor 4A-II isoform X1 [Sus scrofa]	15	15	9	299080000	338580000	408140000	307500000	251600000	341930000	378880000	296100000	322230000	297860000	338800000	390500000	339420000	357910000	358750000	322520000	340950000	352150000	NA	NA	NA	EIF4A2	EIF4A2;EIF4A2;NA;NA;NA	regulation of translational initiation;cellular response to leukemia inhibitory factor;viral process;translational initiation;negative regulation of RNA-directed 5'-3' RNA polymerase activity	GO:000644; GO:199083; GO:001603; GO:000641; GO:190026	eukaryotic translation initiation factor 4F complex;cytosol;perinuclear region of cytoplasm	GO:001628; GO:000582; GO:004847	 RNA transport	hsa0301	ATP-dependent RNA helicase activity;translation initiation factor activity;ATPase activity;protein binding;ATP binding;RNA binding;helicase activity	GO:000400; GO:000374; GO:001688; GO:000551; GO:000552; GO:000372; GO:000438
XP_020921673.1;NP_001093666.1	XP_020921673.1;NP_001093666.1	XP_020921673.1 eukaryotic initiation factor 4A-I isoform X1 [Sus scrofa];NP_001093666.1 eukaryotic initiation factor 4A-I [Sus scrofa]	11	5	5	40911000	41107000	33607000	37859000	38625000	43769000	32706000	34272000	41273000	41514000	30280000	0	50139000	36906000	41098000	35678000	43722000	44613000	NA	NA	NA	EIF4A1	EIF4A1;EIF4A1;NA;NA;NA	translational initiation;viral process	GO:000641; GO:001603	nucleus;cytoplasm;cytosol;eukaryotic translation initiation factor 4F complex;extracellular exosome;membrane	GO:000563; GO:000573; GO:000582; GO:001628; GO:007006; GO:001602	 RNA transport	hsa0301	translation initiation factor activity;RNA binding;protein binding;ATP-dependent RNA helicase activity;helicase activity;ATP binding;translation factor activity, RNA binding;RNA cap binding	GO:000374; GO:000372; GO:000551; GO:000400; GO:000438; GO:000552; GO:000813; GO:000033
XP_020921674.1;NP_001094498.1;XP_020921676.1;XP_020921675.1;XP_020921679.1;XP_020921678.1;XP_020921677.1	XP_020921674.1;NP_001094498.1;XP_020921676.1;XP_020921675.1;XP_020921679.1;XP_020921678.1;XP_020921677.1	XP_020921674.1 peroxisomal acyl-coenzyme A oxidase 1 isoform X1 [Sus scrofa];NP_001094498.1 peroxisomal acyl-coenzyme A oxidase 1 [Sus scrofa];XP_020921676.1 peroxisomal acyl-coenzyme A oxidase 1 isoform X3 [Sus scrofa];XP_020921675.1 peroxisomal acyl-coen	11	11	11	70664000	43960000	122750000	25586000	102570000	42718000	127950000	59147000	189990000	75939000	90276000	41166000	35745000	25291000	77148000	41881000	87096000	27745000	NA	NA	NA	ACOX1	ACOX1;ACOX1;ACOX1;ACOX1;ACOX1	generation of precursor metabolites and energy;lipid metabolic process;fatty acid oxidation;very long-chain fatty acid metabolic process;alpha-linolenic acid metabolic process;fatty acid beta-oxidation using acyl-CoA oxidase;prostaglandin metabolic process;spermatogenesis;regulation of lipid metabolic process;lipid homeostasis	GO:000609; GO:000662; GO:001939; GO:000003; GO:003610; GO:003354; GO:000669; GO:000728; GO:001921; GO:005508	peroxisome;peroxisomal matrix;plasma membrane;cytosol;membrane;nucleolus;intracellular membrane-bounded organelle;nucleus;nucleoplasm;peroxisomal membrane	GO:000577; GO:000578; GO:000588; GO:000582; GO:001602; GO:000573; GO:004323; GO:000563; GO:000565; GO:000577	 PPAR signaling pathway; alpha-Linolenic acid metabolism; Metabolic pathways; Fatty acid metabolism; cAMP signaling pathway; Biosynthesis of unsaturated fatty acids; Fatty acid degradation; Peroxisome	hsa0332; hsa0059; hsa0110; hsa0121; hsa0402; hsa0104; hsa0007; hsa0414	acyl-CoA oxidase activity;palmitoyl-CoA oxidase activity;PDZ domain binding;flavin adenine dinucleotide binding;protein N-terminus binding;FAD binding;receptor binding;fatty acid binding	GO:000399; GO:001640; GO:003016; GO:005066; GO:004748; GO:007194; GO:000510; GO:000550
NP_001095285.1	NP_001095285.1	NP_001095285.1 complement C2 precursor [Sus scrofa]	6	6	6	0	11794000	23933000	11062000	27858000	20901000	36195000	22588000	19996000	15564000	0	0	0	12594000	17058000	11987000	0	0	NA	NA	NA	C2	C2;NA;NA;NA;NA	proteolysis;innate immune response;regulation of complement activation;complement activation;positive regulation of apoptotic cell clearance;response to nutrient	GO:000650; GO:004508; GO:003044; GO:000695; GO:200042; GO:000758	extracellular space;extracellular region;extracellular exosome	GO:000561; GO:000557; GO:007006	 Pertussis; Staphylococcus aureus infection; Complement and coagulation cascades; Systemic lupus erythematosus	hsa0513; hsa0515; hsa0461; hsa0532	serine-type endopeptidase activity;metal ion binding;protein binding	GO:000425; GO:004687; GO:000551
NP_001095287.1	NP_001095287.1	NP_001095287.1 helicase SKI2W [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1293600	NA	NA	NA	SKIV2L	SKIV2L;NA;NA;NA;NA	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay;RNA catabolic process	GO:004392; GO:007047; GO:000640	cytosol;Ski complex;nucleus	GO:000582; GO:005508; GO:000563	 RNA degradation	hsa0301	ATP binding;RNA binding;ATP-dependent RNA helicase activity	GO:000552; GO:000372; GO:000400
NP_001095290.1;XP_013840911.1	NP_001095290.1;XP_013840911.1	NP_001095290.1 dolichol-phosphate mannosyltransferase subunit 1 [Sus scrofa];XP_013840911.1 dolichol-phosphate mannosyltransferase subunit 1 isoform X1 [Sus scrofa]	5	5	5	11415000	17779000	19647000	15879000	20281000	0	14617000	18614000	20090000	15865000	16309000	15455000	15569000	16629000	0	22190000	13695000	16767000	NA	NA	NA	DPM1	DPM1;DPM1;NA;NA;NA	GPI anchor biosynthetic process;protein O-linked mannosylation;dolichol metabolic process	GO:000650; GO:003526; GO:001934	endoplasmic reticulum membrane;membrane;endoplasmic reticulum;nucleus;dolichol-phosphate-mannose synthase complex	GO:000578; GO:001602; GO:000578; GO:000563; GO:003318	 Metabolic pathways; N-Glycan biosynthesis	hsa0110; hsa0051	dolichyl-phosphate beta-D-mannosyltransferase activity;dolichyl-phosphate-mannose-protein mannosyltransferase activity;protein binding	GO:000458; GO:000416; GO:000551
NP_001095294.1;CON__Q3KUS7	NP_001095294.1	NP_001095294.1 complement factor B precursor [Sus scrofa]	26	26	2	956590000	779210000	815460000	945950000	1664800000	2534600000	1260300000	762200000	1160200000	902620000	1161800000	950270000	1091300000	877370000	1034400000	764630000	1235800000	1174600000	NA	NA	NA	CFB	CFB;NA;NA;NA;NA	complement activation;complement activation, alternative pathway;regulation of complement activation;proteolysis	GO:000695; GO:000695; GO:003044; GO:000650	blood microparticle;plasma membrane;extracellular exosome;extracellular region;extracellular space	GO:007256; GO:000588; GO:007006; GO:000557; GO:000561	 Staphylococcus aureus infection; Complement and coagulation cascades	hsa0515; hsa0461	complement binding;serine-type endopeptidase activity;protein binding	GO:000184; GO:000425; GO:000551
XP_013838851.1;XP_013838850.1;NP_001096681.1	XP_013838851.1;XP_013838850.1;NP_001096681.1	XP_013838851.1 gamma-synuclein isoform X1 [Sus scrofa];XP_013838850.1 gamma-synuclein isoform X1 [Sus scrofa];NP_001096681.1 gamma-synuclein [Sus scrofa]	9	9	9	179400000	578330000	333260000	379710000	201200000	541730000	256340000	663020000	207790000	539990000	374270000	790630000	90876000	409480000	457320000	498350000	282590000	863280000	NA	NA	NA	SNCG	SNCG;SNCG;SNCG;NA;NA	chemical synaptic transmission;adult locomotory behavior;regulation of neurotransmitter secretion;synapse organization;protein secretion;regulation of dopamine secretion	GO:000726; GO:000834; GO:004692; GO:005080; GO:000930; GO:001405	extracellular exosome;microtubule organizing center;cytoplasm;neuronal cell body;axon;perinuclear region of cytoplasm	GO:007006; GO:000581; GO:000573; GO:004302; GO:003042; GO:004847	"NA"	"NA"	protein binding	GO:000551
XP_020921683.1;NP_001098421.1;XP_020921940.1;XP_020921939.1;XP_020925485.1	XP_020921683.1;NP_001098421.1	XP_020921683.1 myosin-1 isoform X1 [Sus scrofa];NP_001098421.1 myosin-1 [Sus scrofa]	91	19	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1345500000	0	NA	NA	NA	MYH1	MYH1;MYH1;NA;NA;NA	muscle contraction	GO:000693	muscle myosin complex;intercalated disc;cytoplasmic ribonucleoprotein granule;A band;myosin filament	GO:000585; GO:001470; GO:003646; GO:003167; GO:003298	 Tight junction	hsa0453	protein binding;ATP binding;actin filament binding;motor activity;calmodulin binding	GO:000551; GO:000552; GO:005101; GO:000377; GO:000551
NP_001098423.1	NP_001098423.1	NP_001098423.1 succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial precursor [Sus scrofa]	6	6	6	198540000	108250000	174320000	108370000	179560000	103910000	167470000	134690000	174590000	128220000	143520000	108160000	107850000	108090000	136190000	146920000	131230000	108280000	NA	NA	NA	SDHB	SDHB;NA;NA;NA;NA	aerobic respiration;respiratory electron transport chain;succinate metabolic process;tricarboxylic acid cycle	GO:000906; GO:002290; GO:000610; GO:000609	nucleoplasm;mitochondrial inner membrane;plasma membrane;mitochondrial membrane;mitochondrion	GO:000565; GO:000574; GO:000588; GO:003196; GO:000573	 Alzheimer's disease; Parkinson's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation; Biosynthesis of antibiotics; Carbon metabolism; Citrate cycle (TCA cycle)	hsa0501; hsa0501; hsa0110; hsa0493; hsa0019; hsa0113; hsa0120; hsa0002	succinate dehydrogenase (ubiquinone) activity;electron carrier activity;3 iron, 4 sulfur cluster binding;ubiquinone binding;protein binding;metal ion binding	GO:000817; GO:000905; GO:005153; GO:004803; GO:000551; GO:004687
XP_020937097.1;XP_020937095.1;NP_001098758.1;XP_020937101.1	XP_020937097.1;XP_020937095.1;NP_001098758.1;XP_020937101.1	XP_020937097.1 collagen alpha-3(V) chain isoform X2 [Sus scrofa];XP_020937095.1 collagen alpha-3(V) chain isoform X1 [Sus scrofa];NP_001098758.1 collagen alpha-3(V) chain precursor [Sus scrofa];XP_020937101.1 collagen alpha-3(V) chain isoform X3 [Sus scrof	3	3	3	0	16618000	0	0	0	0	0	0	0	0	0	0	0	0	0	20972000	0	0	NA	NA	NA	COL5A3	COL5A3;COL5A3;COL5A3;COL5A3;NA	cell adhesion;extracellular matrix organization;skin development;cell-matrix adhesion	GO:000715; GO:003019; GO:004358; GO:000716	extracellular space;endoplasmic reticulum lumen;extracellular matrix;extracellular region;collagen type V trimer	GO:000561; GO:000578; GO:003101; GO:000557; GO:000558	 ECM-receptor interaction; Protein digestion and absorption; Amoebiasis; Focal adhesion; Platelet activation; PI3K-Akt signaling pathway	hsa0451; hsa0497; hsa0514; hsa0451; hsa0461; hsa0415	extracellular matrix structural constituent;heparin binding;extracellular matrix structural constituent conferring tensile strength;collagen binding;proteoglycan binding	GO:000520; GO:000820; GO:003002; GO:000551; GO:004339
XP_020930354.1;XP_020930353.1;NP_001098759.1	XP_020930354.1;XP_020930353.1;NP_001098759.1	XP_020930354.1 collagen alpha-2(V) chain isoform X1 [Sus scrofa];XP_020930353.1 collagen alpha-2(V) chain isoform X1 [Sus scrofa];NP_001098759.1 collagen alpha-2(V) chain precursor [Sus scrofa]	2	2	2	0	0	0	7094900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	COL5A2	COL5A2;COL5A2;COL5A2;NA;NA	cellular response to amino acid stimulus;skeletal system development;collagen fibril organization;notochord development;eye morphogenesis;skin development;negative regulation of endodermal cell differentiation	GO:007123; GO:000150; GO:003019; GO:003090; GO:004859; GO:004358; GO:190322	extracellular region;extracellular space;collagen trimer;endoplasmic reticulum lumen;extracellular matrix	GO:000557; GO:000561; GO:000558; GO:000578; GO:003101	 ECM-receptor interaction; PI3K-Akt signaling pathway; Protein digestion and absorption; Platelet activation; Amoebiasis; Focal adhesion	hsa0451; hsa0415; hsa0497; hsa0461; hsa0514; hsa0451	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;SMAD binding;metal ion binding	GO:000520; GO:003002; GO:004633; GO:004687
NP_001098761.1	NP_001098761.1	NP_001098761.1 leucyl-cystinyl aminopeptidase [Sus scrofa]	19	19	19	141650000	109940000	151760000	99968000	136510000	84244000	149140000	140830000	156590000	102470000	150450000	48539000	97705000	103130000	186380000	139160000	126930000	86683000	NA	NA	NA	LNPEP	LNPEP;NA;NA;NA;NA	cell-cell signaling;peptide catabolic process;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;proteolysis;female pregnancy;protein catabolic process;protein polyubiquitination;SMAD protein signal transduction	GO:000726; GO:004317; GO:000248; GO:000650; GO:000756; GO:003016; GO:000020; GO:006039	lysosomal membrane;extracellular region;cytoplasm;membrane;early endosome lumen;perinuclear region of cytoplasm;cytosol;integral component of plasma membrane;cytoplasmic vesicle membrane	GO:000576; GO:000557; GO:000573; GO:001602; GO:003190; GO:004847; GO:000582; GO:000588; GO:003065	 Renin-angiotensin system	hsa0461	aminopeptidase activity;metallopeptidase activity;protein binding;zinc ion binding;peptide binding;metalloaminopeptidase activity	GO:000417; GO:000823; GO:000551; GO:000827; GO:004227; GO:007000
NP_001098769.1	NP_001098769.1	NP_001098769.1 COP9 signalosome complex subunit 6 [Sus scrofa]	4	4	4	0	28723000	0	0	22047000	0	34065000	0	23068000	24254000	26358000	0	0	35055000	25765000	0	30790000	0	NA	NA	NA	COPS6	COPS6;NA;NA;NA;NA	protein deneddylation;transcription-coupled nucleotide-excision repair;viral process;post-translational protein modification;nucleotide-excision repair, DNA damage recognition	GO:000033; GO:000628; GO:001603; GO:004368; GO:000071	cytosol;COP9 signalosome;nucleoplasm	GO:000582; GO:000818; GO:000565	"NA"	"NA"	protein binding	GO:000551
NP_001098770.1;XP_005663091.1;XP_013852148.1	NP_001098770.1;XP_005663091.1;XP_013852148.1	NP_001098770.1 COP9 signalosome complex subunit 5 [Sus scrofa];XP_005663091.1 COP9 signalosome complex subunit 5 isoform X1 [Sus scrofa];XP_013852148.1 COP9 signalosome complex subunit 5 isoform X2 [Sus scrofa]	4	4	4	19706000	20662000	22870000	0	17548000	0	16666000	20590000	22109000	21509000	0	0	25856000	0	0	19366000	22985000	0	NA	NA	NA	COPS5	COPS5;COPS5;COPS5;NA;NA	protein deneddylation;positive regulation of sequence-specific DNA binding transcription factor activity;transcription-coupled nucleotide-excision repair;translation;exosomal secretion;protein deubiquitination;transcription from RNA polymerase II promoter;regulation of IRE1-mediated unfolded protein response;negative regulation of apoptotic process;regulation of cell cycle;post-translational protein modification;positive regulation of transcription from RNA polymerase II promoter;nucleotide-excision repair, DNA damage recognition;regulation of JNK cascade	GO:000033; GO:005109; GO:000628; GO:000641; GO:199018; GO:001657; GO:000636; GO:190389; GO:004306; GO:005172; GO:004368; GO:004594; GO:000071; GO:004632	nucleoplasm;cytoplasm;nucleus;eukaryotic translation initiation factor 3 complex;cytosol;synaptic vesicle;COP9 signalosome;cell junction;perinuclear region of cytoplasm;chromatin	GO:000565; GO:000573; GO:000563; GO:000585; GO:000582; GO:000802; GO:000818; GO:003005; GO:004847; GO:000078	"NA"	"NA"	thiol-dependent ubiquitin-specific protease activity;macrophage migration inhibitory factor binding;transcription coactivator activity;protein binding;metal ion binding;enzyme binding;metallopeptidase activity;NEDD8-specific protease activity;metalloendopeptidase activity;translation initiation factor activity	GO:000484; GO:003571; GO:000371; GO:000551; GO:004687; GO:001989; GO:000823; GO:001978; GO:000422; GO:000374
NP_001098771.1;XP_020927742.1	NP_001098771.1;XP_020927742.1	NP_001098771.1 COP9 signalosome complex subunit 2 [Sus scrofa];XP_020927742.1 COP9 signalosome complex subunit 2 isoform X1 [Sus scrofa]	8	8	8	34752000	34579000	40237000	30243000	35551000	36194000	30968000	33056000	32726000	33097000	35576000	21548000	40801000	35565000	27284000	35886000	36442000	26506000	NA	NA	NA	COPS2	COPS2;COPS2;NA;NA;NA	negative regulation of transcription, DNA-templated;protein deneddylation;nucleotide-excision repair, DNA damage recognition;negative regulation of nucleic acid-templated transcription;signal transduction;cell proliferation;protein phosphorylation;post-translational protein modification;transcription from RNA polymerase II promoter;skeletal muscle cell differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;neuron differentiation	GO:004589; GO:000033; GO:000071; GO:190350; GO:000716; GO:000828; GO:000646; GO:004368; GO:000636; GO:003591; GO:000012; GO:000628; GO:003018	cytoplasm;cytosol;nucleoplasm;COP9 signalosome	GO:000573; GO:000582; GO:000565; GO:000818	"NA"	"NA"	protein binding;transcription corepressor activity	GO:000551; GO:000371
XP_020955925.1;XP_013844865.1;NP_001098774.1;XP_005656621.1;XP_013844866.1	XP_020955925.1;XP_013844865.1;NP_001098774.1;XP_005656621.1;XP_013844866.1	XP_020955925.1 COP9 signalosome complex subunit 4 isoform X1 [Sus scrofa];XP_013844865.1 COP9 signalosome complex subunit 4 isoform X2 [Sus scrofa];NP_001098774.1 COP9 signalosome complex subunit 4 [Sus scrofa];XP_005656621.1 COP9 signalosome complex subun	10	10	10	59183000	53042000	43634000	47953000	45891000	50446000	49295000	56227000	53546000	58226000	47110000	50967000	52274000	54946000	49323000	52332000	49846000	45006000	NA	NA	NA	COPS4	COPS4;COPS4;COPS4;COPS4;COPS4	nucleotide-excision repair, DNA damage recognition;protein deneddylation;transcription-coupled nucleotide-excision repair;post-translational protein modification	GO:000071; GO:000033; GO:000628; GO:004368	cell junction;COP9 signalosome;synaptic vesicle;cytosol;nucleoplasm;nucleus;nuclear speck	GO:003005; GO:000818; GO:000802; GO:000582; GO:000565; GO:000563; GO:001660	"NA"	"NA"	NEDD8-specific protease activity;protein binding	GO:001978; GO:000551
NP_001098775.1	NP_001098775.1	NP_001098775.1 translocation protein SEC62 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	21780000	0	25742000	0	0	0	23495000	0	0	NA	NA	NA	SEC62	SEC62;NA;NA;NA;NA	cotranslational protein targeting to membrane;posttranslational protein targeting to membrane;posttranslational protein targeting to membrane, translocation	GO:000661; GO:000662; GO:003120	endoplasmic reticulum;rough endoplasmic reticulum;membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane;cytosol	GO:000578; GO:000579; GO:001602; GO:003017; GO:000578; GO:000582	 Protein processing in endoplasmic reticulum; Protein export	hsa0414; hsa0306	signaling receptor activity;protein transporter activity	GO:003802; GO:000856
NP_001098778.1	NP_001098778.1	NP_001098778.1 NAD-dependent protein deacylase sirtuin-5, mitochondrial [Sus scrofa]	2	2	2	0	0	2835000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SIRT5	SIRT5;NA;NA;NA;NA	protein ADP-ribosylation;response to nutrient levels;protein deglutarylation;protein demalonylation;negative regulation of cardiac muscle cell apoptotic process;negative regulation of reactive oxygen species metabolic process;chromatin silencing;protein deacetylation;mitochondrion organization;regulation of ketone biosynthetic process	GO:000647; GO:003166; GO:006169; GO:003604; GO:001066; GO:200037; GO:000634; GO:000647; GO:000700; GO:001056	mitochondrial inner membrane;mitochondrial intermembrane space;nucleus;cytosol;mitochondrion	GO:000574; GO:000575; GO:000563; GO:000582; GO:000573	"NA"	"NA"	NAD+ binding;NAD-dependent protein deacetylase activity;protein-succinyllysine desuccinylase activity;NAD+ ADP-ribosyltransferase activity;zinc ion binding;protein-glutaryllysine deglutarylase activity	GO:007040; GO:003497; GO:003605; GO:000395; GO:000827; GO:006169
NP_001103415.1	NP_001103415.1	NP_001103415.1 cadherin-13 precursor [Sus scrofa]	11	11	11	257080000	300860000	241740000	240370000	191080000	269790000	180140000	363000000	190280000	250110000	262860000	477360000	352630000	283020000	241150000	287820000	153970000	326210000	NA	NA	NA	CDH13	CDH13;NA;NA;NA;NA	cell morphogenesis;mitotic cell cycle;localization within membrane;negative regulation of cell proliferation;adherens junction organization;Rac protein signal transduction;regulation of epidermal growth factor receptor signaling pathway;homophilic cell adhesion via plasma membrane adhesion molecules;cell-cell adhesion;regulation of endocytosis;endothelial cell migration;Rho protein signal transduction;positive regulation of positive chemotaxis;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;positive regulation of smooth muscle cell proliferation;positive regulation of endothelial cell proliferation;sprouting angiogenesis;cell-cell junction assembly;cell-cell adhesion mediated by cadherin;positive regulation of calcium-mediated signaling;keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;low-density lipoprotein particle mediated signaling;positive regulation of cell-matrix adhesion;negative regulation of cell adhesion;lamellipodium assembly;positive regulation of cell migration	GO:000090; GO:000027; GO:005166; GO:000828; GO:003433; GO:001660; GO:004205; GO:000715; GO:009860; GO:003010; GO:004354; GO:000726; GO:005092; GO:001633; GO:004866; GO:000193; GO:000204; GO:000704; GO:004433; GO:005085; GO:004361; GO:004594; GO:005509; GO:000195; GO:000716; GO:003003; GO:003033	focal adhesion;cell surface;plasma membrane;cell-cell adherens junction;neuron projection;extracellular region;anchored component of membrane;caveola;cytoplasm;external side of plasma membrane;extracellular exosome;GABA-ergic synapse;perinuclear region of cytoplasm;extracellular space;catenin complex	GO:000592; GO:000998; GO:000588; GO:000591; GO:004300; GO:000557; GO:003122; GO:000590; GO:000573; GO:000989; GO:007006; GO:009898; GO:004847; GO:000561; GO:001634	"NA"	"NA"	low-density lipoprotein particle binding;cytoskeletal protein binding;adiponectin binding;calcium ion binding;protein homodimerization activity;cadherin binding;lipoprotein particle binding	GO:003016; GO:000809; GO:005510; GO:000550; GO:004280; GO:004529; GO:007181
NP_001103528.1	NP_001103528.1	NP_001103528.1 tumor suppressor candidate 5 [Sus scrofa]	7	7	7	647730000	665200000	949810000	620580000	397760000	369270000	650690000	688070000	582640000	667910000	467400000	490640000	0	587050000	173440000	599100000	605800000	495170000	NA	NA	NA	TRARG1	TRARG1;NA;NA;NA;NA	protein localization to plasma membrane;cellular response to insulin stimulus;endosome to plasma membrane protein transport;vesicle fusion to plasma membrane;glucose import in response to insulin stimulus	GO:007265; GO:003286; GO:009963; GO:009950; GO:004438	membrane;plasma membrane;integral component of membrane;perinuclear region of cytoplasm;endomembrane system;cytoplasmic vesicle membrane	GO:001602; GO:000588; GO:001602; GO:004847; GO:001250; GO:003065	"NA"	"NA"	"NA"	"NA"
NP_001103898.1;XP_020953525.1;XP_020953524.1	NP_001103898.1;XP_020953525.1;XP_020953524.1	NP_001103898.1 protein canopy homolog 3 precursor [Sus scrofa];XP_020953525.1 protein canopy homolog 3 isoform X2 [Sus scrofa];XP_020953524.1 protein canopy homolog 3 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CNPY3	CNPY3;CNPY3;CNPY3;NA;NA	toll-like receptor signaling pathway;innate immune response	GO:000222; GO:004508	endoplasmic reticulum lumen	GO:000578	"NA"	"NA"	receptor binding	GO:000510
NP_001104726.1;NP_999452.1	NP_001104726.1	NP_001104726.1 serpin B9 [Sus scrofa]	7	7	6	20520000	17062000	20692000	14075000	16018000	15114000	18326000	15706000	16945000	14656000	18089000	24371000	27806000	13733000	0	10343000	20409000	11873000	NA	NA	NA	SERPINB9	SERPINB9;NA;NA;NA;NA	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;apoptotic process;protection from natural killer cell mediated cytotoxicity;mast cell mediated immunity;positive regulation of gene expression;negative regulation of apoptotic process;negative regulation of endopeptidase activity;negative regulation by symbiont of host apoptotic process;immune response;cellular response to estrogen stimulus;response to bacterium	GO:004315; GO:000691; GO:004227; GO:000244; GO:001062; GO:004306; GO:001095; GO:003366; GO:000695; GO:007139; GO:000961	cytosol;membrane;extracellular exosome;extracellular space;nucleoplasm;cytoplasm;Golgi apparatus;nucleus	GO:000582; GO:001602; GO:007006; GO:000561; GO:000565; GO:000573; GO:000579; GO:000563	 Amoebiasis	hsa0514	cysteine-type endopeptidase inhibitor activity involved in apoptotic process;serine-type endopeptidase inhibitor activity;protein binding;protease binding	GO:004302; GO:000486; GO:000551; GO:000202
XP_020944105.1;XP_020944104.1;XP_020944103.1;XP_020944102.1;XP_020944101.1;XP_020944100.1;XP_020944099.1;XP_020944098.1;XP_013852415.1;XP_005663329.1;NP_001104727.2	XP_020944105.1;XP_020944104.1;XP_020944103.1;XP_020944102.1;XP_020944101.1;XP_020944100.1;XP_020944099.1;XP_020944098.1;XP_013852415.1;XP_005663329.1;NP_001104727.2	XP_020944105.1 prelamin-A/C isoform X1 [Sus scrofa];XP_020944104.1 prelamin-A/C isoform X1 [Sus scrofa];XP_020944103.1 prelamin-A/C isoform X1 [Sus scrofa];XP_020944102.1 prelamin-A/C isoform X1 [Sus scrofa];XP_020944101.1 prelamin-A/C isoform X1 [Sus scro	46	46	45	1114200000	3600100000	1976400000	2467500000	1185400000	2896900000	1596700000	2117800000	1510200000	2331100000	2023800000	2797700000	3683300000	2833200000	2239100000	2139600000	1800100000	3423700000	NA	NA	NA	LMNA	LMNA;LMNA;LMNA;LMNA;LMNA	protein import into nucleus;regulation of cell migration;establishment or maintenance of microtubule cytoskeleton polarity;negative regulation of mesenchymal cell proliferation;positive regulation of cell aging;negative regulation of cardiac muscle hypertrophy in response to stress;negative regulation of cell proliferation;positive regulation of gene expression;protein localization to nucleus;negative regulation of release of cytochrome c from mitochondria;regulation of protein stability;ventricular cardiac muscle cell development;mitotic nuclear envelope reassembly;IRE1-mediated unfolded protein response;cellular response to hypoxia;regulation of protein localization to nucleus;positive regulation of histone H3-K9 trimethylation;negative regulation of extrinsic apoptotic signaling pathway	GO:000660; GO:003033; GO:003095; GO:007220; GO:009034; GO:190324; GO:000828; GO:001062; GO:003450; GO:009020; GO:003164; GO:005501; GO:000708; GO:003649; GO:007145; GO:190018; GO:190011; GO:200123	nuclear membrane;lamin filament;nuclear speck;cytosol;nucleoplasm	GO:003196; GO:000563; GO:001660; GO:000582; GO:000565	 Dilated cardiomyopathy; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0541	protein binding;structural molecule activity	GO:000551; GO:000519
NP_001106146.1;XP_005659547.1	NP_001106146.1;XP_005659547.1	NP_001106146.1 small ubiquitin-related modifier 1 precursor [Sus scrofa];XP_005659547.1 small ubiquitin-related modifier 1-like [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23547000	0	NA	NA	NA	SUMO1	SUMO1;LOC100737265;NA;NA;NA	double-strand break repair via nonhomologous end joining;protein sumoylation;regulation of interferon-gamma-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;viral process;regulation of cardiac muscle cell contraction;negative regulation of action potential;protein stabilization;palate development;negative regulation of delayed rectifier potassium channel activity;PML body organization;cellular response to cadmium ion;positive regulation of protein complex assembly;protein localization to nuclear pore;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of protein localization;cellular response to heat;negative regulation of DNA binding;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of calcium-transporting ATPase activity;DNA repair;negative regulation of transcription, DNA-templated	GO:000630; GO:001692; GO:006033; GO:000012; GO:001603; GO:008600; GO:004575; GO:005082; GO:006002; GO:190226; GO:003057; GO:007127; GO:003133; GO:009020; GO:003243; GO:003288; GO:003460; GO:004339; GO:004343; GO:190189; GO:000628; GO:004589	nuclear speck;nuclear envelope;nuclear body;cytosol;nuclear stress granule;nuclear pore;nucleoplasm;voltage-gated potassium channel complex;heterochromatin;dendrite;nuclear membrane;fibrillar center;SUMO activating enzyme complex;plasma membrane;XY body;nucleolus;synapse	GO:001660; GO:000563; GO:001660; GO:000582; GO:009716; GO:000564; GO:000565; GO:000807; GO:000079; GO:003042; GO:003196; GO:000165; GO:003151; GO:000588; GO:000174; GO:000573; GO:004520	 RNA transport	hsa0301	protein binding;ubiquitin-like protein ligase binding;RNA binding;transcription factor binding;SUMO transferase activity;protein binding, bridging;protein C-terminus binding;enzyme binding;transcription corepressor binding;potassium channel regulator activity;protein tag;ubiquitin protein ligase binding;glucocorticoid receptor binding	GO:000551; GO:004438; GO:000372; GO:000813; GO:001978; GO:003067; GO:000802; GO:001989; GO:000122; GO:001545; GO:003138; GO:003162; GO:003525
NP_001106151.1;XP_020923847.1	NP_001106151.1;XP_020923847.1	NP_001106151.1 transketolase [Sus scrofa];XP_020923847.1 transketolase isoform X1 [Sus scrofa]	26	26	26	6150600000	3141200000	4146600000	3759400000	4694500000	2042600000	4467700000	3422000000	4231000000	3538800000	3641900000	2059400000	2211300000	2987100000	4533700000	4314100000	4204900000	2579200000	NA	NA	NA	TKT	TKT;TKT;NA;NA;NA	xylulose biosynthetic process;glyceraldehyde-3-phosphate biosynthetic process;pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch;regulation of growth	GO:000599; GO:004616; GO:000609; GO:000905; GO:004000	nucleoplasm;nuclear body;peroxisome;cytosol;vesicle;extracellular exosome	GO:000565; GO:001660; GO:000577; GO:000582; GO:003198; GO:007006	 Pentose phosphate pathway; Biosynthesis of amino acids; Metabolic pathways; Biosynthesis of antibiotics; Carbon metabolism	hsa0003; hsa0123; hsa0110; hsa0113; hsa0120	metal ion binding;transketolase activity;protein homodimerization activity;cofactor binding;protein binding	GO:004687; GO:000480; GO:004280; GO:004803; GO:000551
NP_001106165.1;XP_020932286.1	NP_001106165.1;XP_020932286.1	NP_001106165.1 heterogeneous nuclear ribonucleoprotein A/B [Sus scrofa];XP_020932286.1 heterogeneous nuclear ribonucleoprotein A/B isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6886500	NA	NA	NA	HNRNPAB	HNRNPAB;HNRNPAB;NA;NA;NA	positive regulation of transcription, DNA-templated;epithelial to mesenchymal transition	GO:004589; GO:000183	nucleus;cytoplasm;nucleoplasm;ribonucleoprotein complex;RNA polymerase II transcription factor complex	GO:000563; GO:000573; GO:000565; GO:199090; GO:009057	"NA"	"NA"	transcription factor activity, sequence-specific DNA binding;RNA binding;sequence-specific DNA binding;protein binding;sequence-specific double-stranded DNA binding	GO:000370; GO:000372; GO:004356; GO:000551; GO:199083
XP_013833453.1;NP_001309736.1;XP_020953939.1;XP_005666141.1;XP_020953937.1;XP_020953936.1;XP_013833452.1;NP_001309735.1;NP_001106484.1	XP_013833453.1;NP_001309736.1;XP_020953939.1;XP_005666141.1;XP_020953937.1;XP_020953936.1;XP_013833452.1;NP_001309735.1;NP_001106484.1	XP_013833453.1 platelet-activating factor acetylhydrolase isoform X4 [Sus scrofa];NP_001309736.1 platelet-activating factor acetylhydrolase isoform 2 [Sus scrofa];XP_020953939.1 platelet-activating factor acetylhydrolase isoform X3 [Sus scrofa];XP_00566614	4	4	4	0	9106100	0	0	0	0	0	0	0	0	0	12816000	0	0	0	0	0	0	NA	NA	NA	PLA2G7	PLA2G7;PLA2G7;PLA2G7;PLA2G7;PLA2G7	positive regulation of monocyte chemotaxis;lipid catabolic process;low-density lipoprotein particle remodeling;platelet activating factor metabolic process;lipid oxidation;positive regulation of inflammatory response	GO:009002; GO:001604; GO:003437; GO:004646; GO:003444; GO:005072	cytoplasm;extracellular region;low-density lipoprotein particle	GO:000573; GO:000557; GO:003436	 Metabolic pathways; Biosynthesis of antibiotics; Ether lipid metabolism	hsa0110; hsa0113; hsa0056	1-alkyl-2-acetylglycerophosphocholine esterase activity;hydrolase activity, acting on ester bonds;calcium-independent phospholipase A2 activity;phospholipid binding	GO:000384; GO:001678; GO:004749; GO:000554
XP_020933449.1;XP_005660542.2;NP_001106518.1;XP_020933955.1	XP_020933449.1;XP_005660542.2;NP_001106518.1;XP_020933955.1	XP_020933449.1 carnitine O-acetyltransferase isoform X1 [Sus scrofa];XP_005660542.2 carnitine O-acetyltransferase isoform X1 [Sus scrofa];NP_001106518.1 carnitine O-acetyltransferase [Sus scrofa];XP_020933955.1 carnitine O-acetyltransferase isoform X2 [Sus	5	5	5	14168000	14181000	17951000	0	14007000	0	0	0	0	13293000	13850000	15776000	14748000	11233000	0	0	0	0	NA	NA	NA	CRAT	CRAT;CRAT;CRAT;CRAT;NA	fatty acid beta-oxidation using acyl-CoA oxidase;protein targeting to peroxisome;carnitine metabolic process, CoA-linked	GO:003354; GO:000662; GO:001925	mitochondrial inner membrane;peroxisomal matrix;peroxisome;cytosol;mitochondrion	GO:000574; GO:000578; GO:000577; GO:000582; GO:000573	 Peroxisome	hsa0414	receptor binding;carnitine O-acetyltransferase activity	GO:000510; GO:000409
NP_001106688.1	NP_001106688.1	NP_001106688.1 60S ribosomal protein L7 [Sus scrofa]	8	8	8	128550000	113280000	137670000	70153000	110020000	152870000	97884000	89751000	143850000	110890000	93280000	127460000	111640000	97152000	78712000	136800000	150950000	165390000	NA	NA	NA	RPL7	RPL7;NA;NA;NA;NA	translational initiation;translation;ribosomal large subunit biogenesis;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000641; GO:000641; GO:004227; GO:000046; GO:000636; GO:000661; GO:000018	cytoplasm;postsynaptic density;membrane;nucleolus;focal adhesion;ribonucleoprotein complex;cytosol;cytosolic large ribosomal subunit;nucleus	GO:000573; GO:001406; GO:001602; GO:000573; GO:000592; GO:199090; GO:000582; GO:002262; GO:000563	 Ribosome	hsa0301	RNA binding;protein binding;DNA binding;structural constituent of ribosome;protein homodimerization activity;mRNA binding	GO:000372; GO:000551; GO:000367; GO:000373; GO:004280; GO:000372
XP_020947911.1;NP_001106758.1;XP_013843801.1;XP_020933349.1;XP_020933342.1;XP_020933337.1;NP_001182704.1	XP_020947911.1;NP_001106758.1;XP_013843801.1	XP_020947911.1 L-lactate dehydrogenase B chain isoform X2 [Sus scrofa];NP_001106758.1 L-lactate dehydrogenase B chain [Sus scrofa];XP_013843801.1 L-lactate dehydrogenase B chain isoform X1 [Sus scrofa]	17	16	16	7616700000	7866600000	8981700000	6544200000	8665300000	6007000000	7976100000	7257200000	8079800000	5997200000	8627400000	6188600000	3430700000	7818100000	8782900000	7227600000	7179800000	6672400000	NA	NA	NA	LDHB	LDHB;LDHB;LDHB;NA;NA	oxidation-reduction process;carbohydrate metabolic process;pyruvate metabolic process	GO:005511; GO:000597; GO:000609	cytoplasm;membrane raft;cytosol;membrane;extracellular exosome	GO:000573; GO:004512; GO:000582; GO:001602; GO:007006	 Metabolic pathways; Cysteine and methionine metabolism; Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis; Pyruvate metabolism; Propanoate metabolism; Glucagon signaling pathway	hsa0110; hsa0027; hsa0113; hsa0001; hsa0062; hsa0064; hsa0492	L-lactate dehydrogenase activity;identical protein binding;protein binding	GO:000445; GO:004280; GO:000551
NP_001106907.1	NP_001106907.1	NP_001106907.1 alpha-2-macroglobulin receptor-associated protein precursor [Sus scrofa]	6	6	6	25233000	48916000	46287000	46717000	33496000	40753000	37901000	44089000	26315000	0	34908000	47637000	34621000	61398000	40074000	43437000	51938000	54958000	NA	NA	NA	LRPAP1	LRPAP1;NA;NA;NA;NA	negative regulation of protein binding;positive regulation of beta-amyloid clearance;extracellular negative regulation of signal transduction;negative regulation of very-low-density lipoprotein particle clearance;negative regulation of receptor internalization;regulation of receptor-mediated endocytosis;negative regulation of cell death	GO:003209; GO:190022; GO:190011; GO:001091; GO:000209; GO:004825; GO:006054	endosome;Golgi apparatus;cell surface;rough endoplasmic reticulum lumen;cis-Golgi network;extracellular region;plasma membrane;endoplasmic reticulum;endosome lumen	GO:000576; GO:000579; GO:000998; GO:004823; GO:000580; GO:000557; GO:000588; GO:000578; GO:003190	"NA"	"NA"	heparin binding;receptor antagonist activity;protein binding;very-low-density lipoprotein particle receptor binding;receptor binding;low-density lipoprotein particle receptor binding;beta-amyloid binding;lipase binding	GO:000820; GO:004801; GO:000551; GO:007032; GO:000510; GO:005075; GO:000154; GO:003547
NP_001106914.1;XP_020953529.1	NP_001106914.1;XP_020953529.1	NP_001106914.1 enoyl-CoA delta isomerase 2, mitochondrial [Sus scrofa];XP_020953529.1 enoyl-CoA delta isomerase 2, mitochondrial isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	16790000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ECI2	ECI2;ECI2;NA;NA;NA	protein targeting to peroxisome;fatty acid beta-oxidation using acyl-CoA oxidase	GO:000662; GO:003354	peroxisomal matrix;intracellular membrane-bounded organelle;membrane;mitochondrion;cytosol;nucleoplasm;peroxisome	GO:000578; GO:004323; GO:001602; GO:000573; GO:000582; GO:000565; GO:000577	 Fatty acid degradation; Peroxisome	hsa0007; hsa0414	dodecenoyl-CoA delta-isomerase activity;fatty-acyl-CoA binding;receptor binding	GO:000416; GO:000006; GO:000510
NP_001106915.1;XP_020948867.1;XP_005656086.1;XP_020948865.1	NP_001106915.1;XP_020948867.1;XP_005656086.1;XP_020948865.1	NP_001106915.1 F-actin-capping protein subunit beta [Sus scrofa];XP_020948867.1 F-actin-capping protein subunit beta isoform X3 [Sus scrofa];XP_005656086.1 F-actin-capping protein subunit beta isoform X2 [Sus scrofa];XP_020948865.1 F-actin-capping protein	14	14	14	176910000	208590000	200140000	208500000	167610000	204470000	190490000	197480000	165780000	198790000	195930000	221690000	214950000	231970000	157660000	187090000	201680000	229000000	NA	NA	NA	CAPZB	CAPZB;CAPZB;CAPZB;CAPZB;NA	actin cytoskeleton organization;cytoskeleton organization;regulation of cell morphogenesis;blood coagulation;regulation of lamellipodium assembly;antigen processing and presentation of exogenous peptide antigen via MHC class II;barbed-end actin filament capping;negative regulation of filopodium assembly;cell morphogenesis;ER to Golgi vesicle-mediated transport	GO:003003; GO:000701; GO:002260; GO:000759; GO:001059; GO:001988; GO:005101; GO:005149; GO:000090; GO:000688	actin cytoskeleton;cytoskeleton;sarcomere;cytosol;WASH complex;F-actin capping protein complex;extracellular exosome	GO:001562; GO:000585; GO:003001; GO:000582; GO:007120; GO:000829; GO:007006	 Endocytosis	hsa0414	actin binding;cadherin binding;actin filament binding;protein binding	GO:000377; GO:004529; GO:005101; GO:000551
NP_001107167.1;NP_001302687.1;XP_020954162.1;XP_020954161.1	NP_001107167.1	NP_001107167.1 MHC class II histocompatibility antigen SLA-DRB1 precursor [Sus scrofa]	7	7	4	113180000	71068000	85205000	52383000	89640000	77664000	104320000	103160000	68632000	47988000	76967000	86220000	52673000	50214000	109190000	80884000	56749000	42083000	NA	NA	NA	SLA-DRB1	SLA-DRB1;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001107168.1;CON__ENSEMBL:ENSBTAP00000025008	NP_001107168.1;CON__ENSEMBL:ENSBTAP00000025008	NP_001107168.1 tubulin beta-1 chain [Sus scrofa];	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20867000	0	+	NA	+	TUBB1	TUBB1;NA;NA;NA;NA	microtubule cytoskeleton organization;spindle assembly;mitotic cell cycle;microtubule-based process	GO:000022; GO:005122; GO:000027; GO:000701	cytoplasm;extracellular exosome;microtubule	GO:000573; GO:007006; GO:000587	 Phagosome; Pathogenic Escherichia coli infection; Gap junction	hsa0414; hsa0513; hsa0454	GTPase activity;GTP binding;structural constituent of cytoskeleton	GO:000392; GO:000552; GO:000520
NP_001107174.1;XP_020953531.1;XP_020953534.1;XP_020953533.1;XP_020953536.1;XP_020953535.1	NP_001107174.1;XP_020953531.1;XP_020953534.1;XP_020953533.1;XP_020953536.1;XP_020953535.1	NP_001107174.1 MHC class I antigen 2 precursor [Sus scrofa];XP_020953531.1 MHC class I antigen 2 isoform X1 [Sus scrofa];XP_020953534.1 MHC class I antigen 2 isoform X3 [Sus scrofa];XP_020953533.1 MHC class I antigen 2 isoform X2 [Sus scrofa];XP_020953536.	9	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11633000	NA	NA	NA	SLA-2	SLA-2;SLA-2;SLA-2;SLA-2;SLA-2	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013833074.2;NP_001107176.1	XP_013833074.2;NP_001107176.1	XP_013833074.2 MHC class I antigen 6 isoform X1 [Sus scrofa];NP_001107176.1 MHC class I antigen 6 precursor [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SLA-6	SLA-6;SLA-6;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001107178.1	NP_001107178.1	NP_001107178.1 MHC class II DR-alpha precursor [Sus scrofa]	3	3	3	74056000	32941000	47669000	35791000	36557000	25781000	39626000	43856000	42212000	23186000	50367000	25143000	29955000	37105000	58175000	32870000	33711000	22421000	NA	NA	NA	SLA-DRA	SLA-DRA;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001107528.1	NP_001107528.1	NP_001107528.1 MHC class I antigen 5 precursor [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	3021400	0	0	0	0	0	0	0	0	NA	NA	NA	SLA-5	SLA-5;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020921888.1;XP_020921895.1;XP_020921894.1;XP_020921893.1;XP_020921892.1;XP_020921890.1;XP_020921889.1;NP_001107741.1;XP_020921886.1;XP_020921896.1;XP_020921887.1;XP_020921897.1;NP_001193328.1	XP_020921888.1;XP_020921895.1;XP_020921894.1;XP_020921893.1;XP_020921892.1;XP_020921890.1;XP_020921889.1;NP_001107741.1;XP_020921886.1;XP_020921896.1;XP_020921887.1;XP_020921897.1	XP_020921888.1 acetyl-CoA carboxylase 1 isoform X3 [Sus scrofa];XP_020921895.1 acetyl-CoA carboxylase 1 isoform X4 [Sus scrofa];XP_020921894.1 acetyl-CoA carboxylase 1 isoform X4 [Sus scrofa];XP_020921893.1 acetyl-CoA carboxylase 1 isoform X4 [Sus scrofa];	68	68	68	2442300000	1275900000	2087700000	830080000	2582900000	851180000	2335000000	1273300000	1741000000	1374300000	1943000000	463950000	800100000	962220000	2078900000	1921800000	1978000000	1266100000	NA	NA	NA	ACACA	ACACA;ACACA;ACACA;ACACA;ACACA	tissue homeostasis;acetyl-CoA metabolic process;malonyl-CoA biosynthetic process;fatty acid biosynthetic process;lipid homeostasis;cellular response to prostaglandin E stimulus;protein metabolic process;regulation of cholesterol biosynthetic process;fatty-acyl-CoA biosynthetic process;positive regulation of cellular metabolic process;protein homotetramerization;carnitine shuttle	GO:000189; GO:000608; GO:200129; GO:000663; GO:005508; GO:007138; GO:001953; GO:004554; GO:004694; GO:003132; GO:005128; GO:000685	actin cytoskeleton;cytosol;fibrillar center	GO:001562; GO:000582; GO:000165	 AMPK signaling pathway; Glucagon signaling pathway; Fatty acid biosynthesis; Propanoate metabolism; Metabolic pathways; Insulin signaling pathway; Pyruvate metabolism; Fatty acid metabolism	hsa0415; hsa0492; hsa0006; hsa0064; hsa0110; hsa0491; hsa0062; hsa0121	biotin carboxylase activity;acetyl-CoA carboxylase activity;metal ion binding;ATP binding;protein binding;identical protein binding	GO:000407; GO:000398; GO:004687; GO:000552; GO:000551; GO:004280
NP_001107743.1;XP_020948844.1	NP_001107743.1;XP_020948844.1	NP_001107743.1 NAD-dependent protein deacetylase sirtuin-2 [Sus scrofa];XP_020948844.1 NAD-dependent protein deacetylase sirtuin-2 isoform X1 [Sus scrofa]	11	11	11	71015000	78729000	59717000	62112000	51883000	50401000	66959000	71456000	49560000	50718000	56311000	58014000	44716000	63113000	59657000	76955000	54739000	58813000	NA	NA	NA	SIRT2	SIRT2;SIRT2;NA;NA;NA	chromatin silencing at rDNA;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;cellular response to hepatocyte growth factor stimulus;negative regulation of striated muscle tissue development;positive regulation of cell division;cellular response to molecule of bacterial origin;chromatin silencing at telomere;substantia nigra development;regulation of myelination;cellular response to oxidative stress;cellular response to epinephrine stimulus;histone deacetylation;myelination in peripheral nervous system;hepatocyte growth factor receptor signaling pathway;cell division;response to redox state;negative regulation of oligodendrocyte progenitor proliferation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia;negative regulation of transcription from RNA polymerase II promoter in response to hypoxia;cellular response to caloric restriction;negative regulation of defense response to bacterium;regulation of exit from mitosis;negative regulation of cell proliferation;phosphatidylinositol 3-kinase signaling;negative regulation of protein catabolic process;positive regulation of attachment of spindle microtubules to kinetochore;peptidyl-lysine deacetylation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of autophagy;gene silencing;cellular lipid catabolic process;innate immune response;negative regulation of fat cell differentiation;positive regulation of meiotic nuclear division;positive regulation of transcription from RNA polymerase II promoter;negative regulation of reactive oxygen species metabolic process;histone H4 deacetylation;protein ADP-ribosylation;regulation of phosphorylation;positive regulation of DNA binding;positive regulation of execution phase of apoptosis;negative regulation of peptidyl-threonine phosphorylation;protein kinase B signaling;negative regulation of transcription, DNA-templated;meiotic cell cycle;cellular response to hypoxia;tubulin deacetylation;autophagy;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of cell cycle;negative regulation of NLRP3 inflammasome complex assembly;positive regulation of oocyte maturation	GO:000018; GO:003243; GO:003572; GO:004584; GO:005178; GO:007121; GO:000634; GO:002176; GO:003164; GO:003459; GO:007187; GO:001657; GO:002201; GO:004801; GO:005130; GO:005177; GO:007044; GO:200077; GO:006142; GO:006143; GO:190042; GO:000709; GO:000828; GO:001406; GO:004217; GO:005198; GO:003498; GO:000012; GO:001050; GO:001645; GO:004424; GO:004508; GO:004559; GO:004583; GO:004594; GO:200037; GO:007093; GO:000647; GO:004232; GO:004338; GO:190011; GO:001080; GO:004349; GO:004589; GO:005132; GO:007145; GO:009004; GO:000691; GO:004316; GO:005172; GO:190022; GO:190019	chromatin silencing complex;spindle;lateral loop;Schmidt-Lanterman incisure;mitotic spindle;chromosome, telomeric region;nucleus;nuclear heterochromatin;nucleolus;microtubule;midbody;perikaryon;perinuclear region of cytoplasm;glial cell projection;chromosome;growth cone;juxtaparanode region of axon;plasma membrane;paranode region of axon;paranodal junction;cytosol	GO:000567; GO:000581; GO:004321; GO:004322; GO:007268; GO:000078; GO:000563; GO:000572; GO:000573; GO:000587; GO:003049; GO:004320; GO:004847; GO:009738; GO:000569; GO:003042; GO:004422; GO:000588; GO:003327; GO:003301; GO:000582	"NA"	"NA"	chromatin binding;protein binding;histone deacetylase activity;histone deacetylase binding;NAD+ ADP-ribosyltransferase activity;protein deacetylase activity;transcription factor binding;NAD-dependent histone deacetylase activity;NAD+ binding;tubulin deacetylase activity;ubiquitin binding;NAD-dependent histone deacetylase activity (H4-K16 specific);NAD-dependent protein deacetylase activity;histone acetyltransferase binding;zinc ion binding	GO:000368; GO:000551; GO:000440; GO:004282; GO:000395; GO:003355; GO:000813; GO:001713; GO:007040; GO:004290; GO:004313; GO:004697; GO:003497; GO:003503; GO:000827
NP_001107753.1	NP_001107753.1	NP_001107753.1 transcription factor p65 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8743900	NA	NA	NA	RELA	RELA;NA;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell proliferation;animal organ morphogenesis;response to progesterone;positive regulation of I-kappaB kinase/NF-kappaB signaling;response to amino acid;negative regulation of transcription, DNA-templated;positive regulation of T cell receptor signaling pathway;response to cAMP;response to interleukin-1;negative regulation of extrinsic apoptotic signaling pathway;tumor necrosis factor-mediated signaling pathway;postsynapse to nucleus signaling pathway;hair follicle development;aging;response to cobalamin;response to cytokine;negative regulation of apoptotic process;response to morphine;positive regulation of transcription from RNA polymerase II promoter;regulation of inflammatory response;cellular response to lipoteichoic acid;regulation of NIK/NF-kappaB signaling;positive regulation of miRNA metabolic process;regulation of transcription, DNA-templated;viral process;negative regulation of protein catabolic process;cellular response to hydrogen peroxide;nucleotide-binding oligomerization domain containing 2 signaling pathway;interleukin-1-mediated signaling pathway;response to organic substance;positive regulation of Schwann cell differentiation;positive regulation of chondrocyte differentiation;response to insulin;negative regulation of protein sumoylation;cellular response to interleukin-6;inflammatory response;membrane protein intracellular domain proteolysis;cellular response to hepatocyte growth factor stimulus;regulation of DNA-templated transcription in response to stress;positive regulation of pri-miRNA transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;positive regulation of leukocyte adhesion to vascular endothelial cell;chromatin organization;cytokine-mediated signaling pathway;Fc-epsilon receptor signaling pathway;positive regulation of interleukin-12 biosynthetic process;T cell receptor signaling pathway;cellular response to angiotensin;liver development;acetaldehyde metabolic process;cellular defense response;I-kappaB kinase/NF-kappaB signaling;negative regulation of insulin receptor signaling pathway;pri-miRNA transcription from RNA polymerase II promoter;cellular response to nicotine;stimulatory C-type lectin receptor signaling pathway;response to UV-B;positive regulation of type I interferon production;response to muramyl dipeptide;cellular response to vascular endothelial growth factor stimulus;response to muscle stretch;NIK/NF-kappaB signaling;positive regulation of NF-kappaB transcription factor activity;defense response to virus;cellular response to interleukin-1	GO:000012; GO:000828; GO:000988; GO:003257; GO:004312; GO:004320; GO:004589; GO:005086; GO:005159; GO:007055; GO:200123; GO:003320; GO:009952; GO:000194; GO:000756; GO:003359; GO:003409; GO:004306; GO:004327; GO:004594; GO:005072; GO:007122; GO:190122; GO:200063; GO:000635; GO:001603; GO:004217; GO:007030; GO:007043; GO:007049; GO:001003; GO:001404; GO:003233; GO:003286; GO:003323; GO:007135; GO:000695; GO:003129; GO:003572; GO:004362; GO:190289; GO:190152; GO:190499; GO:000632; GO:001922; GO:003809; GO:004508; GO:005085; GO:190438; GO:000188; GO:000611; GO:000696; GO:000724; GO:004662; GO:006161; GO:007131; GO:000222; GO:001022; GO:003248; GO:003249; GO:003592; GO:003599; GO:003806; GO:005109; GO:005160; GO:007134	nuclear chromatin;nucleolus;glutamatergic synapse;transcription factor complex;nucleus;nucleoplasm;cytosol;NF-kappaB p50/p65 complex	GO:000079; GO:000573; GO:009897; GO:000566; GO:000563; GO:000565; GO:000582; GO:003552	 cAMP signaling pathway; NF-kappa B signaling pathway; Toll-like receptor signaling pathway; Adipocytokine signaling pathway; Hepatitis C; Apoptosis; Prolactin signaling pathway; Legionellosis; Chronic myeloid leukemia; Tuberculosis; Osteoclast differentiation; Pancreatic cancer; Neurotrophin signaling pathway; Cocaine addiction; Leishmaniasis; Pathways in cancer; PI3K-Akt signaling pathway; T cell receptor signaling pathway; Insulin resistance; Epithelial cell signaling in Helicobacter pylori infection; MAPK signaling pathway; Sphingolipid signaling pathway; Inflammatory bowel disease (IBD)	hsa0402; hsa0406; hsa0462; hsa0492; hsa0516; hsa0421; hsa0491; hsa0513; hsa0522; hsa0515; hsa0438; hsa0521; hsa0472; hsa0503; hsa0514; hsa0520; hsa0415; hsa0466; hsa0493; hsa0512; hsa0401; hsa0407; hsa0532	protein binding;enzyme binding;NF-kappaB binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;transcription factor binding;protein kinase binding;protein heterodimerization activity;chromatin binding;ubiquitin protein ligase binding;protein N-terminus binding;activating transcription factor binding;identical protein binding;macromolecular complex binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;transcription factor activity, sequence-specific DNA binding;ankyrin repeat binding;DNA binding;chromatin DNA binding;transcription regulatory region DNA binding;repressing transcription factor binding;phosphate ion binding;histone deacetylase binding	GO:000551; GO:001989; GO:005105; GO:000098; GO:000813; GO:001990; GO:004698; GO:000368; GO:003162; GO:004748; GO:003361; GO:004280; GO:004487; GO:000097; GO:000122; GO:000370; GO:007153; GO:000367; GO:003149; GO:004421; GO:007049; GO:004230; GO:004282
XP_020955928.1;XP_020955927.1;XP_020955926.1;NP_001107755.1	XP_020955928.1;XP_020955927.1;XP_020955926.1;NP_001107755.1	XP_020955928.1 aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X1 [Sus scrofa];XP_020955927.1 aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X1 [Sus scrofa];XP_020955926.1 aminoacyl tRNA synthase	6	6	6	131340000	110570000	132370000	0	119590000	106890000	118490000	0	118080000	103650000	114220000	136180000	82019000	115320000	109270000	37484000	86816000	92103000	NA	NA	NA	AIMP1	AIMP1;AIMP1;AIMP1;AIMP1;NA	negative regulation of endothelial cell proliferation;cell adhesion;defense response to virus;chemotaxis;inflammatory response;apoptotic process;signal transduction;angiogenesis;tRNA aminoacylation for protein translation;regulation of receptor activity;cell-cell signaling;response to wounding;leukocyte migration;positive regulation of glucagon secretion	GO:000193; GO:000715; GO:005160; GO:000693; GO:000695; GO:000691; GO:000716; GO:000152; GO:000641; GO:001046; GO:000726; GO:000961; GO:005090; GO:007009	membrane;endoplasmic reticulum;nucleus;Golgi apparatus;aminoacyl-tRNA synthetase multienzyme complex;cytosol;extracellular space;cell surface	GO:001602; GO:000578; GO:000563; GO:000579; GO:001710; GO:000582; GO:000561; GO:000998	"NA"	"NA"	GTPase binding;protein binding;cytokine activity;protein homodimerization activity;tRNA binding	GO:005102; GO:000551; GO:000512; GO:004280; GO:000004
NP_001107756.1	NP_001107756.1	NP_001107756.1 60S ribosomal protein L5 [Sus scrofa]	5	5	5	129210000	70393000	115150000	63712000	85766000	135240000	103710000	76202000	119940000	116270000	90108000	90837000	112000000	139000000	80199000	106150000	153600000	137820000	NA	NA	NA	RPL5	RPL5;NA;NA;NA;NA	translation;translational initiation;rRNA processing;protein stabilization;regulation of signal transduction by p53 class mediator;ribosomal large subunit assembly;ribosomal large subunit biogenesis;SRP-dependent cotranslational protein targeting to membrane;negative regulation of ubiquitin protein ligase activity;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;negative regulation of protein neddylation;positive regulation of gene expression;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of translation	GO:000641; GO:000641; GO:000636; GO:005082; GO:190179; GO:000002; GO:004227; GO:000661; GO:190466; GO:200005; GO:200043; GO:001062; GO:000018; GO:004572	cytoplasm;cytosol;nucleolus;nucleoplasm;extracellular exosome;nucleus;focal adhesion;membrane;macromolecular complex;synapse;endoplasmic reticulum;cytosolic large ribosomal subunit;ribonucleoprotein complex	GO:000573; GO:000582; GO:000573; GO:000565; GO:007006; GO:000563; GO:000592; GO:001602; GO:003299; GO:004520; GO:000578; GO:002262; GO:199090	 Ribosome	hsa0301	structural constituent of ribosome;protein binding;RNA binding;ubiquitin ligase inhibitor activity;5S rRNA binding;mRNA 3'-UTR binding;mRNA 5'-UTR binding;ubiquitin protein ligase binding	GO:000373; GO:000551; GO:000372; GO:199094; GO:000809; GO:000373; GO:004802; GO:003162
NP_001107759.1	NP_001107759.1	NP_001107759.1 beta-sarcoglycan [Sus scrofa]	4	4	4	32994000	37411000	0	0	0	25833000	0	28460000	0	37858000	31397000	64259000	32589000	31877000	0	39465000	0	34392000	NA	NA	NA	SGCB	SGCB;NA;NA;NA;NA	muscle organ development;vascular smooth muscle cell development;muscle fiber development;cardiac muscle cell development	GO:000751; GO:009708; GO:004874; GO:005501	sarcolemma;cytoplasm;cytoskeleton;dystrophin-associated glycoprotein complex;integral component of plasma membrane	GO:004238; GO:000573; GO:000585; GO:001601; GO:000588	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Dilated cardiomyopathy	hsa0541; hsa0541	"NA"	"NA"
XP_020946538.1;XP_020946537.1;XP_020946536.1;XP_020946535.1;NP_001108148.1;XP_020946534.1;XP_020946533.1;XP_020946532.1;XP_020946530.1;XP_020946529.1;XP_020946528.1	XP_020946538.1;XP_020946537.1;XP_020946536.1;XP_020946535.1;NP_001108148.1;XP_020946534.1;XP_020946533.1;XP_020946532.1;XP_020946530.1;XP_020946529.1;XP_020946528.1	XP_020946538.1 LIM domain and actin-binding protein 1 isoform X5 [Sus scrofa];XP_020946537.1 LIM domain and actin-binding protein 1 isoform X4 [Sus scrofa];XP_020946536.1 LIM domain and actin-binding protein 1 isoform X4 [Sus scrofa];XP_020946535.1 LIM dom	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	7510500	0	0	0	0	NA	NA	NA	LIMA1	LIMA1;LIMA1;LIMA1;LIMA1;LIMA1	intestinal cholesterol absorption;negative regulation of actin filament depolymerization;cholesterol metabolic process;cholesterol homeostasis;actin filament bundle assembly;cell migration;ruffle organization	GO:003029; GO:003083; GO:000820; GO:004263; GO:005101; GO:001647; GO:003152	cytosol;cleavage furrow;stress fiber;brush border membrane;actin cytoskeleton;plasma membrane;focal adhesion	GO:000582; GO:003215; GO:000172; GO:003152; GO:001562; GO:000588; GO:000592	"NA"	"NA"	protein binding;cadherin binding;actin filament binding;actin monomer binding;metal ion binding	GO:000551; GO:004529; GO:005101; GO:000378; GO:004687
NP_001108627.1;NP_999051.1;NP_001131079.1	NP_001108627.1	NP_001108627.1 glutathione peroxidase 3 precursor [Sus scrofa]	7	7	7	79639000	126120000	173060000	61065000	99081000	124580000	73171000	71643000	93746000	61357000	84867000	66715000	68798000	43546000	68259000	51518000	101090000	101080000	NA	NA	NA	GPX3	GPX3;NA;NA;NA;NA	protein homotetramerization;oxidation-reduction process;hydrogen peroxide catabolic process;cellular oxidant detoxification;response to lipid hydroperoxide;cellular response to oxidative stress	GO:005128; GO:005511; GO:004274; GO:009886; GO:000698; GO:003459	extracellular exosome;extracellular region;extracellular space	GO:007006; GO:000557; GO:000561	 Arachidonic acid metabolism; Thyroid hormone synthesis; Glutathione metabolism	hsa0059; hsa0491; hsa0048	transcription factor binding;peroxidase activity;selenium binding;protein binding	GO:000813; GO:000460; GO:000843; GO:000551
NP_001116457.1;XP_020932497.1;CON__P00735	NP_001116457.1;XP_020932497.1	NP_001116457.1 prothrombin precursor [Sus scrofa];XP_020932497.1 prothrombin isoform X1 [Sus scrofa]	22	22	22	548650000	476120000	431510000	542540000	867450000	1219300000	622020000	481300000	577190000	459770000	720180000	659330000	633020000	602470000	592530000	425950000	678650000	661920000	NA	NA	NA	F2	F2;F2;NA;NA;NA	proteolysis;regulation of gene expression;cell surface receptor signaling pathway;G-protein coupled receptor signaling pathway;negative regulation of platelet activation;positive regulation of reactive oxygen species metabolic process;multicellular organism development;regulation of complement activation;fibrinolysis;positive regulation of protein localization to nucleus;cytolysis by host of symbiont cells;positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway;positive regulation of protein phosphorylation;positive regulation of cell proliferation;response to wounding;positive regulation of phosphatidylinositol 3-kinase signaling;blood coagulation, intrinsic pathway;positive regulation of cell growth;positive regulation of release of sequestered calcium ion into cytosol;negative regulation of fibrinolysis;positive regulation of collagen biosynthetic process;negative regulation of cytokine production involved in inflammatory response;ER to Golgi vesicle-mediated transport;regulation of cell shape;platelet activation;positive regulation of blood coagulation;cellular protein metabolic process;negative regulation of astrocyte differentiation;acute-phase response;negative regulation of proteolysis;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of lipid kinase activity;positive regulation of JAK-STAT cascade;regulation of cytosolic calcium ion concentration;neutrophil mediated killing of gram-negative bacterium	GO:000650; GO:001046; GO:000716; GO:000718; GO:001054; GO:200037; GO:000727; GO:003044; GO:004273; GO:190018; GO:005183; GO:190073; GO:000193; GO:000828; GO:000961; GO:001406; GO:000759; GO:003030; GO:005128; GO:005191; GO:003296; GO:190001; GO:000688; GO:000836; GO:003016; GO:003019; GO:004426; GO:004871; GO:000695; GO:004586; GO:006184; GO:009021; GO:004642; GO:005148; GO:007094	extracellular space;Golgi lumen;endoplasmic reticulum lumen;plasma membrane;external side of plasma membrane;blood microparticle;extracellular region;extracellular exosome	GO:000561; GO:000579; GO:000578; GO:000588; GO:000989; GO:007256; GO:000557; GO:007006	 Regulation of actin cytoskeleton; Complement and coagulation cascades; Neuroactive ligand-receptor interaction	hsa0481; hsa0461; hsa0408	thrombospondin receptor activity;calcium ion binding;lipopolysaccharide binding;heparin binding;serine-type endopeptidase activity;enzyme activator activity;protein binding;receptor binding;growth factor activity	GO:007005; GO:000550; GO:000153; GO:000820; GO:000425; GO:000804; GO:000551; GO:000510; GO:000808
NP_001116458.1	NP_001116458.1	NP_001116458.1 tRNA-splicing ligase RtcB homolog [Sus scrofa]	7	7	7	50388000	58594000	58203000	55029000	56029000	56257000	51943000	50912000	45711000	54608000	45335000	63354000	70923000	59623000	39130000	51592000	58075000	56089000	NA	NA	NA	RTCB	RTCB;NA;NA;NA;NA	in utero embryonic development;tRNA splicing, via endonucleolytic cleavage and ligation;tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate;placenta development	GO:000170; GO:000638; GO:000097; GO:000189	cytoplasm;cytosol;intracellular membrane-bounded organelle;nuclear envelope;tRNA-splicing ligase complex;endoplasmic reticulum membrane;nucleoplasm	GO:000573; GO:000582; GO:004323; GO:000563; GO:007266; GO:000578; GO:000565	"NA"	"NA"	ATP binding;vinculin binding;RNA binding;protein binding;metal ion binding;RNA ligase (ATP) activity	GO:000552; GO:001716; GO:000372; GO:000551; GO:004687; GO:000397
NP_001116459.1	NP_001116459.1	NP_001116459.1 hexokinase-2 [Sus scrofa]	19	17	17	127070000	49619000	115100000	0	101030000	0	134010000	56338000	97033000	58089000	80379000	0	0	20584000	81839000	84249000	83698000	0	NA	NA	NA	HK2	HK2;NA;NA;NA;NA	regulation of glucose import;response to ischemia;maintenance of protein location in mitochondrion;cellular glucose homeostasis;glycolytic process;carbohydrate phosphorylation;canonical glycolysis;lactation;apoptotic mitochondrial changes;cellular response to leukemia inhibitory factor;response to hypoxia;positive regulation of angiogenesis;glucose 6-phosphate metabolic process;negative regulation of reactive oxygen species metabolic process;positive regulation of mitophagy in response to mitochondrial depolarization;negative regulation of mitochondrial membrane permeability	GO:004632; GO:000293; GO:007265; GO:000167; GO:000609; GO:004683; GO:006162; GO:000759; GO:000863; GO:199083; GO:000166; GO:004576; GO:005115; GO:200037; GO:190492; GO:003579	sarcoplasmic reticulum;membrane;cytosol;plasma membrane;mitochondrial outer membrane	GO:001652; GO:001602; GO:000582; GO:000588; GO:000574	 Metabolic pathways; Biosynthesis of antibiotics; HIF-1 signaling pathway; Carbon metabolism; Carbohydrate digestion and absorption; Amino sugar and nucleotide sugar metabolism; Insulin signaling pathway; Fructose and mannose metabolism; Type II diabetes mellitus; Starch and sucrose metabolism; Glycolysis / Gluconeogenesis; Central carbon metabolism in cancer	hsa0110; hsa0113; hsa0406; hsa0120; hsa0497; hsa0052; hsa0491; hsa0005; hsa0493; hsa0050; hsa0001; hsa0523	protein binding;glucokinase activity;hexokinase activity;ATP binding;fructokinase activity;mannokinase activity;glucose binding	GO:000551; GO:000434; GO:000439; GO:000552; GO:000886; GO:001915; GO:000553
NP_001116541.1;XP_005653511.1;XP_005653510.1	NP_001116541.1;XP_005653511.1;XP_005653510.1	NP_001116541.1 ATP-binding cassette sub-family F member 1 [Sus scrofa];XP_005653511.1 ATP-binding cassette sub-family F member 1 isoform X2 [Sus scrofa];XP_005653510.1 ATP-binding cassette sub-family F member 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1318900	NA	NA	NA	ABCF1	ABCF1;ABCF1;ABCF1;NA;NA	translation;transmembrane transport;inflammatory response	GO:000641; GO:005508; GO:000695	nuclear envelope;cytosol;membrane;nucleoplasm;ribosome	GO:000563; GO:000582; GO:001602; GO:000565; GO:000584	"NA"	"NA"	translation factor activity, RNA binding;ATP binding;protein binding;RNA binding;ATPase activity	GO:000813; GO:000552; GO:000551; GO:000372; GO:001688
XP_020935034.1;XP_020935033.1;NP_001116542.1;XP_020935036.1;XP_020935035.1	XP_020935034.1;XP_020935033.1;NP_001116542.1;XP_020935036.1;XP_020935035.1	XP_020935034.1 angiotensin-converting enzyme 2 isoform X2 [Sus scrofa];XP_020935033.1 angiotensin-converting enzyme 2 isoform X1 [Sus scrofa];NP_001116542.1 angiotensin-converting enzyme 2 precursor [Sus scrofa];XP_020935036.1 angiotensin-converting enzyme	3	3	3	36181000	0	36566000	0	32310000	0	19477000	0	21154000	0	17000000	0	0	0	22726000	0	17960000	0	NA	NA	NA	ACE2	ACE2;ACE2;ACE2;ACE2;ACE2	regulation of vasoconstriction;positive regulation of cardiac muscle contraction;regulation of systemic arterial blood pressure by renin-angiotensin;regulation of cytokine production;viral entry into host cell;receptor-mediated virion attachment to host cell;regulation of cell proliferation;regulation of inflammatory response;positive regulation of amino acid transport;regulation of blood vessel diameter;positive regulation of gap junction assembly;receptor biosynthetic process;positive regulation of reactive oxygen species metabolic process;angiotensin maturation;angiotensin-mediated drinking behavior;tryptophan transport;regulation of cardiac conduction	GO:001922; GO:006045; GO:000308; GO:000181; GO:004671; GO:004681; GO:004212; GO:005072; GO:005195; GO:009774; GO:190359; GO:003280; GO:200037; GO:000200; GO:000305; GO:001582; GO:190377	extracellular space;extracellular region;plasma membrane;extracellular exosome;brush border membrane;integral component of membrane;cytoplasm;cell surface;membrane raft	GO:000561; GO:000557; GO:000588; GO:007006; GO:003152; GO:001602; GO:000573; GO:000998; GO:004512	 Renin-angiotensin system; Protein digestion and absorption	hsa0461; hsa0497	endopeptidase activity;zinc ion binding;protein binding;carboxypeptidase activity;exopeptidase activity;peptidyl-dipeptidase activity;virus receptor activity	GO:000417; GO:000827; GO:000551; GO:000418; GO:000823; GO:000824; GO:000161
XP_005655471.1;XP_020944091.1;NP_001116548.1;XP_020944090.1	XP_005655471.1;XP_020944091.1;NP_001116548.1;XP_020944090.1	XP_005655471.1 AMP deaminase 1 isoform X3 [Sus scrofa];XP_020944091.1 AMP deaminase 1 isoform X2 [Sus scrofa];NP_001116548.1 AMP deaminase 1 [Sus scrofa];XP_020944090.1 AMP deaminase 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8295700	0	NA	NA	NA	AMPD1	AMPD1;AMPD1;AMPD1;AMPD1;NA	AMP metabolic process;IMP biosynthetic process;IMP salvage;purine-containing compound salvage;response to organic substance	GO:004603; GO:000618; GO:003226; GO:004310; GO:001003	cytosol	GO:000582	 Metabolic pathways; Biosynthesis of antibiotics; Purine metabolism	hsa0110; hsa0113; hsa0023	AMP deaminase activity;myosin heavy chain binding;metal ion binding	GO:000387; GO:003203; GO:004687
NP_001116549.1	NP_001116549.1	NP_001116549.1 aspartoacylase [Sus scrofa]	13	13	13	141010000	227520000	162280000	204600000	128320000	162970000	209250000	234550000	202820000	216840000	145400000	267170000	68324000	185920000	162410000	210920000	102280000	187510000	NA	NA	NA	ASPA	ASPA;NA;NA;NA;NA	aspartate catabolic process;central nervous system myelination;positive regulation of oligodendrocyte differentiation;cellular amino acid biosynthetic process	GO:000653; GO:002201; GO:004871; GO:000865	nucleus;cytosol	GO:000563; GO:000582	 Alanine, aspartate and glutamate metabolism; Metabolic pathways; Histidine metabolism	hsa0025; hsa0110; hsa0034	protein binding;hydrolase activity, acting on ester bonds;identical protein binding;metal ion binding;aminoacylase activity;aspartoacylase activity	GO:000551; GO:001678; GO:004280; GO:004687; GO:000404; GO:001980
XP_020948874.1;XP_005655917.1;NP_001116555.1;XP_020948873.1	XP_020948874.1;XP_005655917.1;NP_001116555.1;XP_020948873.1	XP_020948874.1 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial isoform X2 [Sus scrofa];XP_005655917.1 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial isoform X2 [Sus scrofa];NP_001116555.1 2-oxoisovalerate dehydrogenase subunit alph	5	5	5	32390000	0	18942000	0	21914000	0	23983000	0	26415000	20477000	18925000	0	15322000	0	14032000	21082000	17370000	17272000	NA	NA	NA	BCKDHA	BCKDHA;BCKDHA;BCKDHA;BCKDHA;NA	branched-chain amino acid catabolic process;oxidation-reduction process	GO:000908; GO:005511	mitochondrial matrix;mitochondrion;mitochondrial alpha-ketoglutarate dehydrogenase complex	GO:000575; GO:000573; GO:000594	 Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of antibiotics	hsa0028; hsa0110; hsa0113	carboxy-lyase activity;protein binding;3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity;alpha-ketoacid dehydrogenase activity;metal ion binding	GO:001683; GO:000551; GO:000386; GO:000382; GO:004687
NP_001116558.1;XP_020932343.1	NP_001116558.1;XP_020932343.1	NP_001116558.1 basigin precursor [Sus scrofa];XP_020932343.1 basigin isoform X1 [Sus scrofa]	11	11	11	293180000	267990000	248800000	222120000	262520000	178590000	277040000	243670000	238550000	225660000	287300000	125640000	180120000	255310000	266770000	286010000	271800000	228760000	NA	NA	NA	BSG	BSG;BSG;NA;NA;NA	odontogenesis of dentin-containing tooth;response to peptide hormone;response to cAMP;monocarboxylic acid transport;response to mercury ion;decidualization;pyruvate metabolic process;cell surface receptor signaling pathway;axon guidance;protein localization to plasma membrane;homophilic cell adhesion via plasma membrane adhesion molecules;extracellular matrix organization;dendrite self-avoidance;leukocyte migration;embryo implantation;extracellular matrix disassembly	GO:004247; GO:004343; GO:005159; GO:001571; GO:004668; GO:004669; GO:000609; GO:000716; GO:000741; GO:007265; GO:000715; GO:003019; GO:007059; GO:005090; GO:000756; GO:002261	Golgi membrane;plasma membrane;membrane raft;acrosomal membrane;focal adhesion;membrane;melanosome;sarcolemma;mitochondrion;axon;intracellular membrane-bounded organelle;extracellular exosome	GO:000013; GO:000588; GO:004512; GO:000208; GO:000592; GO:001602; GO:004247; GO:004238; GO:000573; GO:003042; GO:004323; GO:007006	"NA"	"NA"	monocarboxylic acid transmembrane transporter activity;protein binding;protein binding involved in cell-cell adhesion;cadherin binding;mannose binding	GO:000802; GO:000551; GO:009863; GO:004529; GO:000553
NP_001116561.1;CON__ENSEMBL:ENSBTAP00000007350	NP_001116561.1	NP_001116561.1 complement C4-A precursor [Sus scrofa]	52	52	48	1150800000	826320000	515830000	1077500000	1330500000	2009100000	1302700000	871220000	970620000	740070000	920530000	1023600000	1142000000	1038900000	1015400000	661480000	1530900000	1677100000	NA	NA	NA	C4A	C4A;NA;NA;NA;NA	innate immune response;cellular protein metabolic process;proteolysis;complement activation, classical pathway;post-translational protein modification;positive regulation of apoptotic cell clearance;regulation of complement activation;negative regulation of endopeptidase activity	GO:004508; GO:004426; GO:000650; GO:000695; GO:004368; GO:200042; GO:003044; GO:001095	axon;extracellular region;dendrite;neuronal cell body;endoplasmic reticulum lumen;plasma membrane;cell junction;extracellular exosome;extracellular space;synapse;blood microparticle	GO:003042; GO:000557; GO:003042; GO:004302; GO:000578; GO:000588; GO:003005; GO:007006; GO:000561; GO:004520; GO:007256	 Systemic lupus erythematosus; Pertussis; Staphylococcus aureus infection; Complement and coagulation cascades	hsa0532; hsa0513; hsa0515; hsa0461	complement component C1q binding;endopeptidase inhibitor activity;serine-type endopeptidase activity	GO:000184; GO:000486; GO:000425
NP_001116563.1	NP_001116563.1	NP_001116563.1 caveolin-2 [Sus scrofa]	5	5	5	119260000	147280000	407160000	101970000	161560000	98595000	206040000	122180000	337330000	187730000	146540000	413240000	184250000	254110000	265810000	269320000	244060000	281350000	NA	NA	NA	CAV2	CAV2;NA;NA;NA;NA	endoplasmic reticulum organization;skeletal muscle fiber development;protein oligomerization;positive regulation of endothelial cell proliferation;mitochondrion organization;regulation of mitotic nuclear division;insulin receptor signaling pathway;positive regulation of MAPK cascade;positive regulation by host of viral release from host cell;vesicle docking;vesicle fusion;negative regulation of transforming growth factor beta receptor signaling pathway;caveola assembly;vesicle organization;cell differentiation;positive regulation of GTPase activity;receptor-mediated endocytosis of virus by host cell;positive regulation of dopamine receptor signaling pathway	GO:000702; GO:004874; GO:005125; GO:000193; GO:000700; GO:000708; GO:000828; GO:004341; GO:004479; GO:004827; GO:000690; GO:003051; GO:007083; GO:001605; GO:003015; GO:004354; GO:001906; GO:006016	acrosomal membrane;Golgi membrane;nucleus;transport vesicle;macromolecular complex;perinuclear region of cytoplasm;extrinsic component of cytoplasmic side of plasma membrane;membrane raft;plasma membrane;caveola;cytoplasmic vesicle;sarcolemma;cytoplasm;Golgi apparatus;focal adhesion	GO:000208; GO:000013; GO:000563; GO:003013; GO:003299; GO:004847; GO:003123; GO:004512; GO:000588; GO:000590; GO:003141; GO:004238; GO:000573; GO:000579; GO:000592	 Bacterial invasion of epithelial cells; Endocytosis; Proteoglycans in cancer; Focal adhesion	hsa0510; hsa0414; hsa0520; hsa0451	structural molecule activity;protein binding;protein homodimerization activity;protein heterodimerization activity;protein binding, bridging;protein complex scaffold;protein kinase binding;scaffold protein binding	GO:000519; GO:000551; GO:004280; GO:004698; GO:003067; GO:003294; GO:001990; GO:009711
NP_001116568.1;XP_020932429.1	NP_001116568.1;XP_020932429.1	NP_001116568.1 hsp90 co-chaperone Cdc37 [Sus scrofa];XP_020932429.1 hsp90 co-chaperone Cdc37 isoform X1 [Sus scrofa]	9	9	9	80491000	79395000	91250000	70877000	83361000	94545000	87814000	75473000	70819000	81521000	85992000	77697000	75134000	81083000	83037000	68113000	91946000	78998000	NA	NA	NA	CDC37	CDC37;CDC37;NA;NA;NA	regulation of cyclin-dependent protein serine/threonine kinase activity;ERBB2 signaling pathway;positive regulation of macromitophagy in response to mitochondrial depolarization;posttranscriptional regulation of gene expression;protein stabilization;regulation of type I interferon-mediated signaling pathway;protein folding;protein targeting;peptidyl-tyrosine phosphorylation	GO:000007; GO:003812; GO:009877; GO:001060; GO:005082; GO:006033; GO:000645; GO:000660; GO:001810	extracellular exosome;cytoplasm;HSP90-CDC37 chaperone complex;cytosol;chaperone complex	GO:007006; GO:000573; GO:199056; GO:000582; GO:010103	 PI3K-Akt signaling pathway	hsa0415	heat shock protein binding;chaperone binding;protein binding;Hsp90 protein binding;protein kinase regulator activity;protein kinase binding;protein tyrosine kinase activity;scaffold protein binding	GO:003107; GO:005108; GO:000551; GO:005187; GO:001988; GO:001990; GO:000471; GO:009711
NP_001116576.1	NP_001116576.1	NP_001116576.1 cathepsin Z precursor [Sus scrofa]	4	4	4	0	36716000	0	32070000	0	0	22124000	24625000	0	32966000	0	0	0	37223000	25900000	0	24600000	32231000	NA	NA	NA	CTSZ	CTSZ;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;proteolysis involved in cellular protein catabolic process;positive regulation of neuron apoptotic process;negative regulation of protein binding;negative regulation of plasminogen activation;angiotensin maturation;COPII vesicle coating;epithelial tube branching involved in lung morphogenesis;neutrophil degranulation;positive regulation of neural precursor cell proliferation;regulation of neuron death;negative regulation of neuron projection development;proteolysis	GO:000688; GO:005160; GO:004352; GO:003209; GO:001075; GO:000200; GO:004820; GO:006044; GO:004331; GO:200017; GO:190121; GO:001097; GO:000650	ER to Golgi transport vesicle;intracellular membrane-bounded organelle;cell surface;cell cortex region;ficolin-1-rich granule lumen;Golgi membrane;endoplasmic reticulum lumen;specific granule lumen;extracellular exosome;extracellular space;lysosome;plasma membrane;extracellular region;growth cone;cytoplasmic vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane	GO:003013; GO:004323; GO:000998; GO:009973; GO:190481; GO:000013; GO:000578; GO:003558; GO:007006; GO:000561; GO:000576; GO:000588; GO:000557; GO:003042; GO:003141; GO:003311	 Lysosome	hsa0414	cysteine-type peptidase activity;cysteine-type endopeptidase activity;carboxypeptidase activity;protein binding	GO:000823; GO:000419; GO:000418; GO:000551
XP_020924205.1;XP_005669625.1;NP_001116588.1;XP_005669626.1	XP_020924205.1;XP_005669625.1;NP_001116588.1;XP_005669626.1	XP_020924205.1 guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [Sus scrofa];XP_005669625.1 guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [Sus scrofa];NP_001116588.1 guanine nucleotide-binding protein G(i) subunit alp	18	18	12	970700000	1271000000	1314900000	972180000	896540000	1157100000	1071100000	1102500000	1004500000	1015100000	1042600000	1115600000	1215700000	1343300000	1010700000	1157900000	1141800000	1171700000	NA	NA	NA	GNAI2	GNAI2;GNAI2;GNAI2;GNAI2;NA	gamma-aminobutyric acid signaling pathway;positive regulation of urine volume;response to nutrient;positive regulation of NAD(P)H oxidase activity;G-protein coupled receptor signaling pathway;negative regulation of calcium ion-dependent exocytosis;positive regulation of cell proliferation;positive regulation of cell migration;adenosine receptor signaling pathway;negative regulation of apoptotic signaling pathway;signal transduction;negative regulation of synaptic transmission;cell division;positive regulation of ERK1 and ERK2 cascade;cell cycle;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;positive regulation of superoxide anion generation;positive regulation of vascular smooth muscle cell proliferation;positive regulation of neural precursor cell proliferation;protein folding;G-protein coupled acetylcholine receptor signaling pathway;positive regulation of insulin receptor signaling pathway;regulation of calcium ion transport;negative regulation of protein tyrosine phosphatase activity	GO:000721; GO:003581; GO:000758; GO:003386; GO:000718; GO:004595; GO:000828; GO:003033; GO:000197; GO:200123; GO:000716; GO:005080; GO:005130; GO:007037; GO:000704; GO:000719; GO:003293; GO:190470; GO:200017; GO:000645; GO:000721; GO:004662; GO:005192; GO:190361	cytoplasm;centrosome;heterotrimeric G-protein complex;cytosol;cell body;extracellular exosome;extracellular vesicle;membrane raft;nucleoplasm;dendrite;plasma membrane;membrane;midbody	GO:000573; GO:000581; GO:000583; GO:000582; GO:004429; GO:007006; GO:190356; GO:004512; GO:000565; GO:003042; GO:000588; GO:001602; GO:003049	 Chemokine signaling pathway; Gap junction; GABAergic synapse; Estrogen signaling pathway; cAMP signaling pathway; Axon guidance; Leukocyte transendothelial migration; Regulation of lipolysis in adipocytes; Gastric acid secretion; Cocaine addiction; Toxoplasmosis; Circadian entrainment; Rap1 signaling pathway; Long-term depression; Parkinson's disease; Pertussis; Pathways in cancer; Adrenergic signaling in cardiomyocytes; Sphingolipid signaling pathway; Tight junction; Platelet activation	hsa0406; hsa0454; hsa0472; hsa0491; hsa0402; hsa0436; hsa0467; hsa0492; hsa0497; hsa0503; hsa0514; hsa0471; hsa0401; hsa0473; hsa0501; hsa0513; hsa0520; hsa0426; hsa0407; hsa0453; hsa0461	G-protein coupled receptor binding;GTP binding;G-protein beta/gamma-subunit complex binding;protein binding;GTPase activity;metal ion binding	GO:000166; GO:000552; GO:003168; GO:000551; GO:000392; GO:004687
XP_005663643.1;NP_001116589.1	XP_005663643.1;NP_001116589.1	XP_005663643.1 guanine nucleotide-binding protein G(k) subunit alpha isoform X1 [Sus scrofa];NP_001116589.1 guanine nucleotide-binding protein G(k) subunit alpha [Sus scrofa]	15	9	9	133070000	208190000	176350000	180270000	129160000	140260000	166490000	183690000	148940000	148540000	138430000	267010000	106090000	204660000	132960000	162190000	172130000	142210000	NA	NA	NA	GNAI3	GNAI3;GNAI3;NA;NA;NA	vesicle fusion;cell cycle;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;positive regulation of macroautophagy;cell division;G-protein coupled receptor signaling pathway;protein folding;dopamine receptor signaling pathway;positive regulation of superoxide anion generation;positive regulation of vascular smooth muscle cell proliferation;brain development;positive regulation of NAD(P)H oxidase activity;GTP metabolic process;negative regulation of apoptotic signaling pathway	GO:000690; GO:000704; GO:000719; GO:001623; GO:005130; GO:000718; GO:000645; GO:000721; GO:003293; GO:190470; GO:000742; GO:003386; GO:004603; GO:200123	membrane;nucleus;lysosomal membrane;heterotrimeric G-protein complex;membrane raft;Golgi membrane;extracellular exosome;centrosome;zymogen granule;nucleolus;midbody;endoplasmic reticulum membrane;plasma membrane	GO:001602; GO:000563; GO:000576; GO:000583; GO:004512; GO:000013; GO:007006; GO:000581; GO:004258; GO:000573; GO:003049; GO:000578; GO:000588	 cGMP-PKG signaling pathway; Cholinergic synapse; Progesterone-mediated oocyte maturation; Regulation of lipolysis in adipocytes; Gastric acid secretion; Alcoholism; cAMP signaling pathway; Tight junction; Gap junction; Toxoplasmosis; Parkinson's disease; Pathways in cancer; Sphingolipid signaling pathway; Axon guidance; Adrenergic signaling in cardiomyocytes; Leukocyte transendothelial migration; Chemokine signaling pathway; Platelet activation; Circadian entrainment; Rap1 signaling pathway; Long-term depression; Pertussis	hsa0402; hsa0472; hsa0491; hsa0492; hsa0497; hsa0503; hsa0402; hsa0453; hsa0454; hsa0514; hsa0501; hsa0520; hsa0407; hsa0436; hsa0426; hsa0467; hsa0406; hsa0461; hsa0471; hsa0401; hsa0473; hsa0513	G-protein coupled receptor binding;GDP binding;GTP binding;protein domain specific binding;GTPase activating protein binding;GTPase activity;G-protein beta/gamma-subunit complex binding;G-protein coupled serotonin receptor binding;protein binding;metal ion binding	GO:000166; GO:001900; GO:000552; GO:001990; GO:003279; GO:000392; GO:003168; GO:003182; GO:000551; GO:004687
NP_001116593.1	NP_001116593.1	NP_001116593.1 beta-glucuronidase precursor [Sus scrofa]	6	6	6	0	0	0	0	0	19014000	0	0	0	15189000	16368000	17902000	18966000	0	20033000	0	18296000	16906000	NA	NA	NA	GUSB	GUSB;NA;NA;NA;NA	glycosaminoglycan catabolic process;glucuronoside catabolic process;hyaluronan catabolic process;neutrophil degranulation;carbohydrate metabolic process	GO:000602; GO:001939; GO:003021; GO:004331; GO:000597	extracellular space;membrane;lysosomal lumen;intracellular membrane-bounded organelle;ficolin-1-rich granule lumen;extracellular region;extracellular exosome;azurophil granule lumen	GO:000561; GO:001602; GO:004320; GO:004323; GO:190481; GO:000557; GO:007006; GO:003557	 Glycosaminoglycan degradation; Lysosome; Pentose and glucuronate interconversions; Drug metabolism - other enzymes; Porphyrin and chlorophyll metabolism; Metabolic pathways; Starch and sucrose metabolism	hsa0053; hsa0414; hsa0004; hsa0098; hsa0086; hsa0110; hsa0050	receptor binding;carbohydrate binding;protein domain specific binding;beta-glucuronidase activity	GO:000510; GO:003024; GO:001990; GO:000456
XP_020934317.1;NP_001116594.1	XP_020934317.1;NP_001116594.1	XP_020934317.1 histone H2A.V [Sus scrofa];NP_001116594.1 histone H2A.Z [Sus scrofa]	5	3	3	0	0	0	0	71411000	0	0	0	0	0	95285000	89739000	0	0	72962000	0	0	0	NA	NA	NA	H2AFZ	LOC100512448;H2AFZ;NA;NA;NA	chromatin organization;cellular response to estradiol stimulus;positive regulation of transcription from RNA polymerase II promoter	GO:000632; GO:007139; GO:004594	extracellular exosome;nuclear chromatin;nucleus;nuclear heterochromatin;nucleosome;Barr body;nuclear euchromatin	GO:007006; GO:000079; GO:000563; GO:000572; GO:000078; GO:000174; GO:000571	 Systemic lupus erythematosus; Alcoholism	hsa0532; hsa0503	DNA binding;nucleosomal DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;protein binding;protein heterodimerization activity	GO:000367; GO:003149; GO:000098; GO:000097; GO:000551; GO:004698
NP_001116599.1	NP_001116599.1	NP_001116599.1 heat shock 70 kDa protein [Sus scrofa]	9	2	2	766140000	218100000	375850000	483560000	546630000	346300000	594150000	286930000	830610000	293660000	860560000	0	831080000	693370000	1217000000	189660000	634360000	514640000	NA	NA	NA	HSPA6	HSPA6;NA;NA;NA;NA	protein refolding;cellular response to heat;response to unfolded protein;neutrophil degranulation;chaperone mediated protein folding requiring cofactor;cellular response to unfolded protein;cellular heat acclimation	GO:004202; GO:003460; GO:000698; GO:004331; GO:005108; GO:003462; GO:007037	extracellular region;secretory granule lumen;blood microparticle;cytoplasm;ficolin-1-rich granule lumen;macromolecular complex;cytosol;COP9 signalosome;centriole;extracellular exosome;nucleus	GO:000557; GO:003477; GO:007256; GO:000573; GO:190481; GO:003299; GO:000582; GO:000818; GO:000581; GO:007006; GO:000563	 Protein processing in endoplasmic reticulum; Epstein-Barr virus infection; Antigen processing and presentation; Estrogen signaling pathway; Legionellosis; Spliceosome; MAPK signaling pathway; Toxoplasmosis; Endocytosis	hsa0414; hsa0516; hsa0461; hsa0491; hsa0513; hsa0304; hsa0401; hsa0514; hsa0414	protein binding;heat shock protein binding;protein binding involved in protein folding;unfolded protein binding;misfolded protein binding;ATP binding;ATPase activity;enzyme binding;ATPase activity, coupled	GO:000551; GO:003107; GO:004418; GO:005108; GO:005178; GO:000552; GO:001688; GO:001989; GO:004262
XP_013838967.1;XP_020927441.1;XP_005671310.1;NP_001116606.1	XP_013838967.1;XP_020927441.1;XP_005671310.1;NP_001116606.1	XP_013838967.1 lysosomal acid lipase/cholesteryl ester hydrolase isoform X1 [Sus scrofa];XP_020927441.1 lysosomal acid lipase/cholesteryl ester hydrolase isoform X2 [Sus scrofa];XP_005671310.1 lysosomal acid lipase/cholesteryl ester hydrolase isoform X2 [S	4	4	4	0	0	16861000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LIPA	LIPA;LIPA;LIPA;LIPA;NA	inflammatory response;lipid catabolic process;lung development;low-density lipoprotein particle clearance;homeostasis of number of cells within a tissue;cell morphogenesis;tissue remodeling;cell proliferation;cytokine production;sterol metabolic process;cellular lipid metabolic process	GO:000695; GO:001604; GO:003032; GO:003438; GO:004887; GO:000090; GO:004877; GO:000828; GO:000181; GO:001612; GO:004425	fibrillar center;lysosome;intracellular membrane-bounded organelle;lysosomal lumen	GO:000165; GO:000576; GO:004323; GO:004320	 Steroid biosynthesis; Lysosome	hsa0010; hsa0414	sterol esterase activity;lipase activity	GO:000477; GO:001629
NP_001116608.1	NP_001116608.1	NP_001116608.1 U6 snRNA-associated Sm-like protein LSm2 [Sus scrofa]	2	2	2	0	8458900	0	10028000	8374200	0	9019500	0	9212700	0	9782900	0	10536000	0	0	0	0	0	NA	NA	NA	LSM2	LSM2;NA;NA;NA;NA	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;mRNA splicing, via spliceosome	GO:004392; GO:000039	nucleoplasm;U4/U6 x U5 tri-snRNP complex;U2-type precatalytic spliceosome;cytosol;Lsm1-7-Pat1 complex;catalytic step 2 spliceosome;P-body;nucleus;U6 snRNP	GO:000565; GO:004654; GO:007100; GO:000582; GO:199072; GO:007101; GO:000093; GO:000563; GO:000568	 RNA degradation; Spliceosome	hsa0301; hsa0304	RNA binding;U6 snRNA binding;Ral GTPase binding;protein binding	GO:000372; GO:001707; GO:001716; GO:000551
XP_020921695.1;XP_020921694.1;NP_001116613.1	XP_020921695.1;XP_020921694.1;NP_001116613.1	XP_020921695.1 myosin-4 isoform X1 [Sus scrofa];XP_020921694.1 myosin-4 isoform X1 [Sus scrofa];NP_001116613.1 myosin-4 [Sus scrofa]	100	99	20	0	0	0	0	0	5303100	0	4314800	4124700	0	6020600	0	10056000	0	0	0	19020000000	3750500	NA	NA	NA	MYH4	MYH4;MYH4;MYH4;NA;NA	muscle filament sliding;ATP metabolic process;muscle contraction;actin filament-based movement	GO:003004; GO:004603; GO:000693; GO:003004	myosin filament;sarcomere;muscle myosin complex	GO:003298; GO:003001; GO:000585	 Tight junction	hsa0453	ATP binding;ATPase activity;calmodulin binding;microfilament motor activity;double-stranded RNA binding;actin filament binding	GO:000552; GO:001688; GO:000551; GO:000014; GO:000372; GO:005101
XP_013840961.1;NP_001116620.1	XP_013840961.1;NP_001116620.1	XP_013840961.1 probable aminopeptidase NPEPL1 isoform X1 [Sus scrofa];NP_001116620.1 probable aminopeptidase NPEPL1 [Sus scrofa]	6	6	6	19367000	23830000	15969000	18160000	20295000	25425000	18833000	19719000	15463000	19336000	21169000	30172000	25674000	20345000	23734000	22436000	20993000	23022000	NA	NA	NA	NPEPL1	NPEPL1;NPEPL1;NA;NA;NA	proteolysis	GO:000650	nucleus;cytoplasm	GO:000563; GO:000573	"NA"	"NA"	aminopeptidase activity;metalloexopeptidase activity;manganese ion binding	GO:000417; GO:000823; GO:003014
XP_020937603.1;XP_020937602.1;XP_020937601.1;XP_020937599.1;XP_020926281.1;XP_005669554.1;NP_001116621.1;XP_020924234.1;NP_001123448.1;NP_001123437.1;XP_020926282.1;NP_999615.1	XP_020937603.1;XP_020937602.1;XP_020937601.1;XP_020937599.1;XP_020926281.1;XP_005669554.1;NP_001116621.1;XP_020924234.1;NP_001123448.1;NP_001123437.1;XP_020926282.1;NP_999615.1	XP_020937603.1 protegrin-1-like [Sus scrofa];XP_020937602.1 protegrin-3-like [Sus scrofa];XP_020937601.1 protegrin-3-like [Sus scrofa];XP_020937599.1 protegrin-1 [Sus scrofa];XP_020926281.1 protegrin-3 [Sus scrofa];XP_005669554.1 protegrin-1 [Sus scrofa];N	5	5	2	176430000	80661000	134980000	84318000	113860000	85304000	123510000	51731000	119400000	65071000	115720000	0	196590000	69638000	96550000	36795000	268830000	30987000	NA	NA	NA	LOC110258651	LOC110258651;LOC110258650;LOC110258649;LOC110258648;LOC110255221	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005673100.1;NP_001116630.1	XP_005673100.1;NP_001116630.1	XP_005673100.1 phosphoenolpyruvate carboxykinase, cytosolic [GTP] isoform X1 [Sus scrofa];NP_001116630.1 phosphoenolpyruvate carboxykinase, cytosolic [GTP] [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	6868100	0	0	0	0	0	0	NA	NA	NA	PCK1	PCK1;PCK1;NA;NA;NA	glucose metabolic process;gluconeogenesis;aging;response to lipid;hepatocyte differentiation;internal protein amino acid acetylation;response to lipopolysaccharide;glycerol biosynthetic process from pyruvate;positive regulation of transcription from RNA polymerase II promoter in response to acidic pH;cellular response to fructose stimulus;response to starvation;cellular response to interleukin-1;cellular response to hypoxia;oxaloacetate metabolic process;response to activity;cellular response to insulin stimulus;response to interleukin-6;cellular response to glucagon stimulus;cellular response to dexamethasone stimulus;cellular response to retinoic acid;cellular response to cAMP;cellular response to tumor necrosis factor;propionate catabolic process;cellular response to potassium ion starvation;response to methionine	GO:000600; GO:000609; GO:000756; GO:003399; GO:007036; GO:000647; GO:003249; GO:004632; GO:006140; GO:007133; GO:004259; GO:007134; GO:007145; GO:000610; GO:001482; GO:003286; GO:007074; GO:007137; GO:007154; GO:007130; GO:007132; GO:007135; GO:001954; GO:005136; GO:190464	cytoplasm;extracellular exosome;mitochondrion;cytosol	GO:000573; GO:007006; GO:000573; GO:000582	 Pyruvate metabolism; Metabolic pathways; Glucagon signaling pathway; FoxO signaling pathway; PI3K-Akt signaling pathway; Citrate cycle (TCA cycle); Biosynthesis of antibiotics; Insulin resistance; Insulin signaling pathway; Glycolysis / Gluconeogenesis; PPAR signaling pathway; Proximal tubule bicarbonate reclamation	hsa0062; hsa0110; hsa0492; hsa0406; hsa0415; hsa0002; hsa0113; hsa0493; hsa0491; hsa0001; hsa0332; hsa0496	manganese ion binding;magnesium ion binding;GDP binding;GTP binding;carboxylic acid binding;phosphoenolpyruvate carboxykinase (GTP) activity	GO:003014; GO:000028; GO:001900; GO:000552; GO:003140; GO:000461
NP_001116632.1	NP_001116632.1	NP_001116632.1 prefoldin subunit 4 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	100640000	0	NA	NA	NA	PFDN4	PFDN4;NA;NA;NA;NA	protein folding	GO:000645	cytosol;cytoplasm;prefoldin complex;nucleus	GO:000582; GO:000573; GO:001627; GO:000563	"NA"	"NA"	chaperone binding;protein binding;unfolded protein binding	GO:005108; GO:000551; GO:005108
NP_001116634.1;XP_001926798.4	NP_001116634.1	NP_001116634.1 D-3-phosphoglycerate dehydrogenase [Sus scrofa]	15	15	15	0	391450000	14894000	190050000	0	100450000	19370000	145160000	0	205420000	57084000	425420000	26031000	311440000	19375000	241660000	12749000	279830000	NA	NA	NA	PHGDH	PHGDH;NA;NA;NA;NA	glial cell development;brain development;neural tube development;glycine metabolic process;L-serine biosynthetic process;taurine metabolic process;gamma-aminobutyric acid metabolic process;neuron projection development;spinal cord development;G1 to G0 transition;regulation of gene expression;electron transport chain;cellular amino acid metabolic process	GO:002178; GO:000742; GO:002191; GO:000654; GO:000656; GO:001953; GO:000944; GO:003117; GO:002151; GO:007031; GO:001046; GO:002290; GO:000652	cytosol;extracellular exosome	GO:000582; GO:007006	 Biosynthesis of amino acids; Glycine, serine and threonine metabolism; Metabolic pathways; Carbon metabolism; Biosynthesis of antibiotics	hsa0123; hsa0026; hsa0110; hsa0120; hsa0113	electron carrier activity;NAD binding;phosphoglycerate dehydrogenase activity;L-malate dehydrogenase activity	GO:000905; GO:005128; GO:000461; GO:003006
NP_001116638.1	NP_001116638.1	NP_001116638.1 protein phosphatase 1 regulatory subunit 11 [Sus scrofa]	1	1	1	0	4273000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PPP1R11	PPP1R11;NA;NA;NA;NA	protein ubiquitination;negative regulation of protein dephosphorylation;negative regulation of cytokine secretion;negative regulation of phosphoprotein phosphatase activity;defense response to Gram-positive bacterium;ubiquitin-dependent protein catabolic process	GO:001656; GO:003530; GO:005071; GO:003251; GO:005083; GO:000651	cytoplasm;protein phosphatase type 1 complex;nucleus	GO:000573; GO:000016; GO:000563	"NA"	"NA"	protein serine/threonine phosphatase inhibitor activity;protein phosphatase 1 binding;protein binding;ubiquitin protein ligase activity	GO:000486; GO:000815; GO:000551; GO:006163
NP_001116644.1	NP_001116644.1	NP_001116644.1 glycogen phosphorylase, liver form [Sus scrofa]	35	35	30	823590000	740100000	961070000	752140000	719050000	535790000	839430000	821770000	867460000	642580000	814840000	633100000	531730000	713980000	917570000	987300000	821770000	660250000	NA	NA	NA	PYGL	PYGL;NA;NA;NA;NA	glucose homeostasis;necroptotic process;glycogen catabolic process;5-phosphoribose 1-diphosphate biosynthetic process;response to bacterium;glycogen metabolic process;neutrophil degranulation	GO:004259; GO:007026; GO:000598; GO:000601; GO:000961; GO:000597; GO:004331	extracellular exosome;cytosol;cytoplasm;ficolin-1-rich granule lumen;extracellular region;secretory granule lumen	GO:007006; GO:000582; GO:000573; GO:190481; GO:000557; GO:003477	 Insulin signaling pathway; Starch and sucrose metabolism; Glucagon signaling pathway; Metabolic pathways; Insulin resistance	hsa0491; hsa0050; hsa0492; hsa0110; hsa0493	AMP binding;bile acid binding;vitamin binding;ATP binding;drug binding;protein binding;pyridoxal phosphate binding;purine nucleobase binding;protein homodimerization activity;glucose binding;glycogen phosphorylase activity	GO:001620; GO:003205; GO:001984; GO:000552; GO:000814; GO:000551; GO:003017; GO:000206; GO:004280; GO:000553; GO:000818
NP_001116645.1	NP_001116645.1	NP_001116645.1 ras-related protein Rab-1B [Sus scrofa]	10	10	4	907970000	812110000	907670000	756880000	811330000	553460000	895960000	769110000	843010000	748280000	856390000	596320000	594170000	810080000	974380000	880980000	736950000	734110000	NA	NA	NA	RAB1B	RAB1B;NA;NA;NA;NA	virion assembly;post-translational protein modification;ER to Golgi vesicle-mediated transport;autophagy;COPII vesicle coating;regulation of autophagosome assembly;retrograde vesicle-mediated transport, Golgi to ER;Rab protein signal transduction;establishment of endothelial intestinal barrier;positive regulation of glycoprotein metabolic process	GO:001906; GO:004368; GO:000688; GO:000691; GO:004820; GO:200078; GO:000689; GO:003248; GO:009055; GO:190302	Golgi membrane;transport vesicle;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;pre-autophagosomal structure membrane;Golgi apparatus;cytosol;extracellular exosome	GO:000013; GO:003013; GO:000578; GO:003311; GO:003404; GO:000579; GO:000582; GO:007006	 Legionellosis	hsa0513	protein binding;GTP binding;GTPase activity	GO:000551; GO:000552; GO:000392
XP_020923851.1;XP_020923850.1;NP_001116652.1	XP_020923851.1;XP_020923850.1;NP_001116652.1	XP_020923851.1 ras-related protein Rab-5A isoform X1 [Sus scrofa];XP_020923850.1 ras-related protein Rab-5A isoform X1 [Sus scrofa];NP_001116652.1 ras-related protein Rab-5A [Sus scrofa]	7	4	4	35595000	30420000	33897000	34567000	34043000	25178000	32015000	31139000	35994000	28105000	39594000	39490000	35714000	26047000	41175000	34298000	31630000	30927000	NA	NA	NA	RAB5A	RAB5A;RAB5A;RAB5A;NA;NA	endocytosis;regulation of endocytosis;regulation of autophagosome assembly;Rab protein signal transduction;receptor internalization involved in canonical Wnt signaling pathway;phosphatidylinositol biosynthetic process;synaptic vesicle recycling;regulation of synaptic vesicle exocytosis;phagocytosis;positive regulation of exocytosis;regulation of long-term neuronal synaptic plasticity;regulation of filopodium assembly;membrane organization;intracellular protein transport;viral RNA genome replication;blood coagulation;post-translational protein modification;early endosome to late endosome transport;regulation of endosome size	GO:000689; GO:003010; GO:200078; GO:003248; GO:200028; GO:000666; GO:003646; GO:200030; GO:000690; GO:004592; GO:004816; GO:005148; GO:006102; GO:000688; GO:003969; GO:000759; GO:004368; GO:004502; GO:005103	phagocytic vesicle membrane;ruffle;early endosome;axon;somatodendritic compartment;phagocytic vesicle;extracellular exosome;clathrin-coated vesicle membrane;early phagosome;endosome membrane;early endosome membrane;melanosome;neuronal cell body;endocytic vesicle;synaptic vesicle;anchored component of synaptic vesicle membrane;plasma membrane;cytoplasm;axon terminus;cytoplasmic side of early endosome membrane;cytosol;terminal bouton;membrane raft;actin cytoskeleton;postsynaptic early endosome	GO:003067; GO:000172; GO:000576; GO:003042; GO:003647; GO:004533; GO:007006; GO:003066; GO:003200; GO:001000; GO:003190; GO:004247; GO:004302; GO:003013; GO:000802; GO:009899; GO:000588; GO:000573; GO:004367; GO:009855; GO:000582; GO:004319; GO:004512; GO:001562; GO:009884	 Ras signaling pathway; Endocytosis; Vasopressin-regulated water reabsorption; Amoebiasis; Amyotrophic lateral sclerosis (ALS); Tuberculosis	hsa0401; hsa0414; hsa0496; hsa0514; hsa0501; hsa0515	GTP binding;GDP binding;protein binding;GTPase activity	GO:000552; GO:001900; GO:000551; GO:000392
NP_001116657.1;XP_020921475.1;XP_005673977.1;XP_005673976.1	NP_001116657.1	NP_001116657.1 ras-related protein Rap-2a precursor [Sus scrofa]	6	6	6	39829000	0	35333000	29575000	36905000	31474000	32216000	36179000	0	34357000	0	0	0	0	32903000	43105000	34899000	34074000	NA	NA	NA	RAP2B	RAP2B;NA;NA;NA;NA	regulation of protein tyrosine kinase activity;microvillus assembly;Rap protein signal transduction;platelet aggregation;platelet activation;signal transduction;negative regulation of cell migration;positive regulation of protein autophosphorylation;establishment of endothelial intestinal barrier;neutrophil degranulation	GO:006109; GO:003003; GO:003248; GO:007052; GO:003016; GO:000716; GO:003033; GO:003195; GO:009055; GO:004331	specific granule membrane;recycling endosome membrane;extracellular exosome;plasma membrane;cytosol;cell-cell contact zone;membrane raft;tertiary granule membrane;bicellular tight junction;membrane	GO:003557; GO:005503; GO:007006; GO:000588; GO:000582; GO:004429; GO:004512; GO:007082; GO:000592; GO:001602	"NA"	"NA"	GTP binding;GDP binding;protein binding;GTPase activity;protein domain specific binding	GO:000552; GO:001900; GO:000551; GO:000392; GO:001990
XP_020934097.1;XP_020934096.1;XP_020934095.1;NP_001116658.1	XP_020934097.1;XP_020934096.1;XP_020934095.1;NP_001116658.1	XP_020934097.1 retinoic acid receptor responder protein 2 isoform X1 [Sus scrofa];XP_020934096.1 retinoic acid receptor responder protein 2 isoform X1 [Sus scrofa];XP_020934095.1 retinoic acid receptor responder protein 2 isoform X1 [Sus scrofa];NP_0011166	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7786200	0	NA	NA	NA	RARRES2	RARRES2;RARRES2;RARRES2;RARRES2;NA	positive regulation of protein phosphorylation;platelet degranulation;inflammatory response;innate immune response;regulation of lipid catabolic process;chemotaxis;embryonic digestive tract development;antifungal humoral response;cell differentiation;defense response to Gram-negative bacterium;positive regulation of fat cell differentiation;positive regulation of chemotaxis;defense response to Gram-positive bacterium;insulin receptor signaling pathway;antifungal innate immune response;retinoid metabolic process;in utero embryonic development;positive regulation of macrophage chemotaxis	GO:000193; GO:000257; GO:000695; GO:004508; GO:005099; GO:000693; GO:004856; GO:001973; GO:003015; GO:005082; GO:004560; GO:005092; GO:005083; GO:000828; GO:006176; GO:000152; GO:000170; GO:001075	extracellular matrix;platelet dense granule lumen;extracellular region;extracellular space	GO:003101; GO:003108; GO:000557; GO:000561	"NA"	"NA"	receptor binding;protein binding	GO:000510; GO:000551
XP_020941207.1;NP_001116661.1	XP_020941207.1;NP_001116661.1	XP_020941207.1 rho-related GTP-binding protein RhoB isoform X1 [Sus scrofa];NP_001116661.1 rho-related GTP-binding protein RhoB [Sus scrofa]	4	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6564300	0	0	NA	NA	NA	RHOB	RHOB;RHOB;NA;NA;NA	cell adhesion;negative regulation of cell cycle;cellular response to ionizing radiation;positive regulation of angiogenesis;intracellular protein transport;apoptotic process;endosome to lysosome transport;cell migration;establishment or maintenance of actin cytoskeleton polarity;regulation of small GTPase mediated signal transduction;positive regulation of endothelial cell migration;cellular response to hydrogen peroxide;Rho protein signal transduction;cell differentiation;negative regulation of cell migration;positive regulation of apoptotic process;actin filament bundle assembly;regulation of actin cytoskeleton organization;mitotic cytokinesis;regulation of cell shape;angiogenesis;actin filament organization;G-protein coupled receptor signaling pathway;endothelial tube morphogenesis	GO:000715; GO:004578; GO:007147; GO:004576; GO:000688; GO:000691; GO:000833; GO:001647; GO:003095; GO:005105; GO:001059; GO:007030; GO:000726; GO:003015; GO:003033; GO:004306; GO:005101; GO:003295; GO:000028; GO:000836; GO:000152; GO:000701; GO:000718; GO:006115	cytosol;cell division site;early endosome;endosome membrane;cytoplasm;late endosome membrane;intracellular membrane-bounded organelle;nucleus;plasma membrane;focal adhesion;extracellular exosome;cell cortex	GO:000582; GO:003215; GO:000576; GO:001000; GO:000573; GO:003190; GO:004323; GO:000563; GO:000588; GO:000592; GO:007006; GO:000593	"NA"	"NA"	protein binding;GTPase activity;protein kinase binding;GTP binding;GDP binding	GO:000551; GO:000392; GO:001990; GO:000552; GO:001900
XP_020957600.1;XP_020957599.1;XP_020957598.1;XP_020957597.1;NP_001116663.1;XP_005662632.1;XP_005659127.1	XP_020957600.1;XP_020957599.1;XP_020957598.1;XP_020957597.1;NP_001116663.1	XP_020957600.1 rho-related GTP-binding protein RhoG isoform X1 [Sus scrofa];XP_020957599.1 rho-related GTP-binding protein RhoG isoform X1 [Sus scrofa];XP_020957598.1 rho-related GTP-binding protein RhoG isoform X1 [Sus scrofa];XP_020957597.1 rho-related G	11	11	10	153790000	232900000	233420000	286010000	217870000	232230000	213450000	240030000	234240000	225870000	164280000	314310000	251240000	300040000	211490000	259710000	177850000	271810000	NA	NA	NA	RHOG	RHOG;RHOG;RHOG;RHOG;RHOG	regulation of ruffle assembly;establishment or maintenance of cell polarity;positive regulation of cell proliferation;regulation of cell shape;positive regulation of protein kinase B signaling;actin cytoskeleton organization;Rac protein signal transduction;regulation of actin cytoskeleton organization;activation of GTPase activity;positive regulation of protein localization to plasma membrane;positive regulation of transcription, DNA-templated;neutrophil degranulation;phosphatidylinositol phosphorylation;cell chemotaxis;actin filament organization;Rho protein signal transduction;regulation of small GTPase mediated signal transduction	GO:190002; GO:000716; GO:000828; GO:000836; GO:005189; GO:003003; GO:001660; GO:003295; GO:009063; GO:190307; GO:004589; GO:004331; GO:004685; GO:006032; GO:000701; GO:000726; GO:005105	endoplasmic reticulum membrane;cell cortex;cytosol;cell projection;extracellular exosome;secretory granule membrane;plasma membrane;cytoplasm;focal adhesion	GO:000578; GO:000593; GO:000582; GO:004299; GO:007006; GO:003066; GO:000588; GO:000573; GO:000592	 Bacterial invasion of epithelial cells; Shigellosis	hsa0510; hsa0513	protein binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;protein kinase binding;GTPase activity;GTP binding	GO:000551; GO:004693; GO:001990; GO:000392; GO:000552
XP_005660930.1;NP_001116666.1	XP_005660930.1;NP_001116666.1	XP_005660930.1 plasma protease C1 inhibitor isoform X1 [Sus scrofa];NP_001116666.1 plasma protease C1 inhibitor precursor [Sus scrofa]	8	8	8	123320000	100610000	83951000	111220000	127100000	221350000	104100000	89994000	118080000	91237000	129970000	86725000	183610000	115930000	115330000	114370000	188560000	176600000	NA	NA	NA	SERPING1	SERPING1;SERPING1;NA;NA;NA	blood circulation;negative regulation of endopeptidase activity;aging;complement activation, classical pathway;innate immune response;negative regulation of complement activation, lectin pathway;fibrinolysis;platelet degranulation;regulation of complement activation;blood coagulation, intrinsic pathway	GO:000801; GO:001095; GO:000756; GO:000695; GO:004508; GO:000186; GO:004273; GO:000257; GO:003044; GO:000759	extracellular region;extracellular exosome;platelet alpha granule lumen;blood microparticle;extracellular space	GO:000557; GO:007006; GO:003109; GO:007256; GO:000561	 Complement and coagulation cascades; Pertussis	hsa0461; hsa0513	serine-type endopeptidase inhibitor activity;protein binding	GO:000486; GO:000551
NP_001116672.1	NP_001116672.1	NP_001116672.1 testin [Sus scrofa]	4	4	4	0	0	31066000	20114000	0	0	0	18757000	18491000	26779000	0	0	28894000	19573000	0	0	0	0	NA	NA	NA	TES	TES;NA;NA;NA;NA	negative regulation of cell proliferation	GO:000828	focal adhesion;macromolecular complex;cytosol;nucleus;cell junction;plasma membrane	GO:000592; GO:003299; GO:000582; GO:000563; GO:003005; GO:000588	"NA"	"NA"	zinc ion binding;RNA binding;protein binding;cadherin binding	GO:000827; GO:000372; GO:000551; GO:004529
NP_001116676.1	NP_001116676.1	NP_001116676.1 tenascin-X precursor [Sus scrofa]	89	5	5	0	38609000	0	48945000	0	23966000	0	0	0	0	0	26866000	0	0	0	0	49528000	41118000	NA	NA	NA	TNXB	TNXB;NA;NA;NA;NA	cell adhesion;elastic fiber assembly;actin cytoskeleton organization;collagen metabolic process;collagen fibril organization	GO:000715; GO:004825; GO:003003; GO:003296; GO:003019	extracellular space;extracellular exosome;extracellular matrix;extracellular region	GO:000561; GO:007006; GO:003101; GO:000557	 Focal adhesion; MicroRNAs in cancer; ECM-receptor interaction; PI3K-Akt signaling pathway	hsa0451; hsa0520; hsa0451; hsa0415	collagen fibril binding;integrin binding;protein binding;extracellular matrix structural constituent;heparin binding	GO:009863; GO:000517; GO:000551; GO:000520; GO:000820
NP_001116685.1;XP_020932868.1	NP_001116685.1;XP_020932868.1	NP_001116685.1 vesicle-associated membrane protein-associated protein B [Sus scrofa];XP_020932868.1 vesicle-associated membrane protein-associated protein B isoform X1 [Sus scrofa]	6	6	5	97984000	127350000	130040000	108190000	96458000	98927000	130840000	107530000	93470000	99819000	122910000	72951000	72123000	104020000	129310000	116870000	117710000	102500000	NA	NA	NA	VAPB	VAPB;VAPB;NA;NA;NA	IRE1-mediated unfolded protein response;positive regulation of viral genome replication;COPII-coated vesicle budding;endoplasmic reticulum organization;modulation by virus of host morphology or physiology;cellular calcium ion homeostasis;endoplasmic reticulum unfolded protein response;ER to Golgi vesicle-mediated transport;sphingolipid biosynthetic process	GO:003649; GO:004507; GO:009011; GO:000702; GO:001904; GO:000687; GO:003096; GO:000688; GO:003014	cytoplasm;endoplasmic reticulum;Golgi apparatus;integral component of membrane;endoplasmic reticulum exit site;Golgi membrane	GO:000573; GO:000578; GO:000579; GO:001602; GO:007097; GO:000013	"NA"	"NA"	FFAT motif binding;protein heterodimerization activity;protein binding;beta-tubulin binding;microtubule binding;enzyme binding;protein homodimerization activity;cadherin binding	GO:003314; GO:004698; GO:000551; GO:004848; GO:000801; GO:001989; GO:004280; GO:004529
XP_020938559.1;NP_001116691.1	XP_020938559.1;NP_001116691.1	XP_020938559.1 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial isoform X1 [Sus scrofa];NP_001116691.1 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial [Sus scrofa]	5	5	5	30321000	16917000	16373000	0	30211000	0	18473000	0	24830000	0	17329000	0	15093000	20581000	0	23436000	19949000	16357000	NA	NA	NA	BCKDHB	BCKDHB;BCKDHB;NA;NA;NA	response to nutrient;branched-chain amino acid catabolic process;oxidation-reduction process	GO:000758; GO:000908; GO:005511	mitochondrion;mitochondrial alpha-ketoglutarate dehydrogenase complex;mitochondrial matrix	GO:000573; GO:000594; GO:000575	 Metabolic pathways; Valine, leucine and isoleucine degradation; Biosynthesis of antibiotics	hsa0110; hsa0028; hsa0113	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity;protein binding;alpha-ketoacid dehydrogenase activity	GO:000386; GO:000551; GO:000382
NP_001116693.1;XP_020953572.1	NP_001116693.1	NP_001116693.1 beta-hexosaminidase subunit alpha precursor [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	7433100	0	0	0	0	0	0	0	0	NA	NA	NA	HEXA	HEXA;NA;NA;NA;NA	keratan sulfate catabolic process;chondroitin sulfate catabolic process;hyaluronan catabolic process;carbohydrate metabolic process;glycosaminoglycan biosynthetic process;glycosphingolipid metabolic process	GO:004234; GO:003020; GO:003021; GO:000597; GO:000602; GO:000668	membrane;lysosomal lumen;extracellular exosome;azurophil granule	GO:001602; GO:004320; GO:007006; GO:004258	 Amino sugar and nucleotide sugar metabolism; Glycosaminoglycan degradation; Metabolic pathways; Lysosome; Other glycan degradation; Glycosphingolipid biosynthesis - globo series	hsa0052; hsa0053; hsa0110; hsa0414; hsa0051; hsa0060	beta-N-acetylhexosaminidase activity;protein binding;acetylglucosaminyltransferase activity;protein heterodimerization activity	GO:000456; GO:000551; GO:000837; GO:004698
NP_001116695.1	NP_001116695.1	NP_001116695.1 serum paraoxonase/arylesterase 2 precursor [Sus scrofa]	7	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39899000	0	0	0	NA	NA	NA	PON2	PON2;NA;NA;NA;NA	response to oxidative stress;response to toxic substance;lipoxygenase pathway;aromatic compound catabolic process	GO:000697; GO:000963; GO:001937; GO:001943	plasma membrane;extracellular region;nucleus;lysosome;mitochondrion	GO:000588; GO:000557; GO:000563; GO:000576; GO:000573	 Metabolic pathways	hsa0110	acyl-L-homoserine-lactone lactonohydrolase activity;arylesterase activity;identical protein binding;metal ion binding	GO:010200; GO:000406; GO:004280; GO:004687
NP_001121905.1	NP_001121905.1	NP_001121905.1 solute carrier family 2, facilitated glucose transporter member 4 [Sus scrofa]	5	5	5	43635000	12987000	26236000	0	0	0	23300000	13311000	18917000	9301500	30957000	11118000	0	0	22718000	11552000	39398000	0	NA	NA	NA	SLC2A4	SLC2A4;NA;NA;NA;NA	cellular response to tumor necrosis factor;glucose transmembrane transport;glucose homeostasis;glucose import in response to insulin stimulus;brown fat cell differentiation;carbohydrate metabolic process;cellular response to insulin stimulus;response to ethanol;glucose import;cellular response to osmotic stress;amylopectin biosynthetic process;cellular response to hypoxia	GO:007135; GO:190465; GO:004259; GO:004438; GO:005087; GO:000597; GO:003286; GO:004547; GO:004632; GO:007147; GO:001002; GO:007145	integral component of plasma membrane;trans-Golgi network transport vesicle;perinuclear region of cytoplasm;endomembrane system;cytoplasmic vesicle membrane;extracellular exosome;plasma membrane;clathrin-coated pit;external side of plasma membrane;membrane raft;clathrin-coated vesicle;presynapse;multivesicular body;sarcoplasmic reticulum;T-tubule;cytosol;membrane;insulin-responsive compartment	GO:000588; GO:003014; GO:004847; GO:001250; GO:003065; GO:007006; GO:000588; GO:000590; GO:000989; GO:004512; GO:003013; GO:009879; GO:000577; GO:001652; GO:003031; GO:000582; GO:001602; GO:003259	 Adipocytokine signaling pathway; FoxO signaling pathway; Insulin signaling pathway; Type II diabetes mellitus; AMPK signaling pathway	hsa0492; hsa0406; hsa0491; hsa0493; hsa0415	protein binding;glucose transmembrane transporter activity;D-glucose transmembrane transporter activity	GO:000551; GO:000535; GO:005505
NP_001121916.1	NP_001121916.1	NP_001121916.1 junctional adhesion molecule A precursor [Sus scrofa]	5	5	5	33251000	46392000	31761000	44982000	0	0	32251000	35596000	30684000	0	26779000	0	0	38462000	29910000	32742000	0	38950000	NA	NA	NA	F11R	F11R;NA;NA;NA;NA	regulation of membrane permeability;response to radiation;positive regulation of GTPase activity;positive regulation of blood pressure;intestinal absorption;protein localization to plasma membrane;regulation of cytokine production;transforming growth factor beta receptor signaling pathway;actomyosin structure organization;inflammatory response;bicellular tight junction assembly;regulation of actin cytoskeleton reorganization;extracellular matrix organization;negative regulation of GTPase activity;viral entry into host cell;cell adhesion;leukocyte migration;establishment of endothelial intestinal barrier	GO:009055; GO:000931; GO:004354; GO:004577; GO:005089; GO:007265; GO:000181; GO:000717; GO:003103; GO:000695; GO:007083; GO:200024; GO:003019; GO:003426; GO:004671; GO:000715; GO:005090; GO:009055	cell junction;plasma membrane;cytoplasmic vesicle;bicellular tight junction;slit diaphragm;cell-cell junction;extracellular exosome;integral component of membrane	GO:003005; GO:000588; GO:003141; GO:000592; GO:003605; GO:000591; GO:007006; GO:001602	 Cell adhesion molecules (CAMs); Tight junction; Epithelial cell signaling in Helicobacter pylori infection; Leukocyte transendothelial migration	hsa0451; hsa0453; hsa0512; hsa0467	virus receptor activity;protein binding;cadherin binding;PDZ domain binding	GO:000161; GO:000551; GO:004529; GO:003016
XP_020944110.1;XP_020944109.1;NP_001121917.1	XP_020944110.1;XP_020944109.1;NP_001121917.1	XP_020944110.1 monocarboxylate transporter 1 isoform X1 [Sus scrofa];XP_020944109.1 monocarboxylate transporter 1 isoform X1 [Sus scrofa];NP_001121917.1 monocarboxylate transporter 1 [Sus scrofa]	7	7	7	53828000	60213000	68367000	35615000	42625000	17742000	48123000	43257000	53669000	39080000	46831000	39724000	33892000	42764000	34765000	41205000	52847000	49868000	NA	NA	NA	SLC16A1	SLC16A1;SLC16A1;SLC16A1;NA;NA	pyruvate metabolic process;lipid metabolic process;mevalonate transport;glucose homeostasis;monocarboxylic acid transport;leukocyte migration;plasma membrane lactate transport;behavioral response to nutrient;centrosome cycle;response to food;regulation of insulin secretion;cellular response to organic cyclic compound	GO:000609; GO:000662; GO:001572; GO:004259; GO:001571; GO:005090; GO:003587; GO:005178; GO:000709; GO:003209; GO:005079; GO:007140	centrosome;integral component of membrane;synapse;extracellular exosome;plasma membrane;intracellular membrane-bounded organelle;cell junction	GO:000581; GO:001602; GO:004520; GO:007006; GO:000588; GO:004323; GO:003005	"NA"	"NA"	lactate transmembrane transporter activity;symporter activity;organic cyclic compound binding;monocarboxylic acid transmembrane transporter activity;mevalonate transmembrane transporter activity;protein homodimerization activity	GO:001512; GO:001529; GO:009715; GO:000802; GO:001513; GO:004280
XP_005671984.1;NP_001121924.1	XP_005671984.1;NP_001121924.1	XP_005671984.1 cytochrome b reductase 1 isoform X1 [Sus scrofa];NP_001121924.1 cytochrome b reductase 1 [Sus scrofa]	2	2	2	0	49916000	0	73804000	44216000	54279000	69424000	53411000	66815000	57853000	71343000	0	80849000	67710000	75454000	46094000	71016000	0	NA	NA	NA	CYBRD1	CYBRD1;CYBRD1;NA;NA;NA	response to iron ion;oxidation-reduction process;cellular iron ion homeostasis	GO:001003; GO:005511; GO:000687	lysosomal membrane;plasma membrane;brush border membrane;integral component of membrane;extracellular exosome	GO:000576; GO:000588; GO:003152; GO:001602; GO:007006	 Mineral absorption	hsa0497	oxidoreductase activity, oxidizing metal ions;protein binding;ferric-chelate reductase activity;oxidoreductase activity;metal ion binding	GO:001672; GO:000551; GO:000029; GO:001649; GO:004687
NP_001121929.1	NP_001121929.1	NP_001121929.1 pre-mRNA-processing factor 19 [Sus scrofa]	6	6	6	0	25051000	19362000	0	0	25082000	22904000	19871000	0	22796000	25104000	28623000	34492000	23073000	27930000	26827000	0	22204000	NA	NA	NA	PRPF19	PRPF19;NA;NA;NA;NA	lipid biosynthetic process;positive regulation of mRNA splicing, via spliceosome;protein polyubiquitination;inner cell mass cell proliferation;spliceosomal complex assembly;double-strand break repair via nonhomologous end joining;cellular protein localization;positive regulation of neuron differentiation;transcription-coupled nucleotide-excision repair;positive regulation of astrocyte differentiation;protein K63-linked ubiquitination;proteasomal protein catabolic process;signal transduction involved in DNA damage checkpoint;generation of catalytic spliceosome for first transesterification step;mRNA splicing, via spliceosome	GO:000861; GO:004802; GO:000020; GO:000183; GO:000024; GO:000630; GO:003461; GO:004566; GO:000628; GO:004871; GO:007053; GO:001049; GO:007242; GO:000034; GO:000039	DNA replication factor A complex;nucleoplasm;Prp19 complex;U2-type catalytic step 2 spliceosome;membrane;nuclear speck;nucleus;cytoplasm;spindle;catalytic step 2 spliceosome;site of double-strand break	GO:000566; GO:000565; GO:000097; GO:007100; GO:001602; GO:001660; GO:000563; GO:000573; GO:000581; GO:007101; GO:003586	 Ubiquitin mediated proteolysis; Spliceosome	hsa0412; hsa0304	ubiquitin protein ligase activity;ubiquitin-protein transferase activity;ubiquitin-ubiquitin ligase activity;protein binding;identical protein binding	GO:006163; GO:000484; GO:003445; GO:000551; GO:004280
NP_001121932.1	NP_001121932.1	NP_001121932.1 fat storage-inducing transmembrane protein 2 [Sus scrofa]	2	2	2	56968000	0	58855000	0	64319000	0	0	33483000	0	0	49201000	0	0	0	54356000	34038000	0	0	NA	NA	NA	FITM2	FITM2;NA;NA;NA;NA	lipid particle organization;regulation of triglyceride biosynthetic process;cytoskeleton organization;regulation of cell morphogenesis;positive regulation of sequestering of triglyceride;sequestering of triglyceride;lipid storage;cellular triglyceride homeostasis;phospholipid biosynthetic process	GO:003438; GO:001086; GO:000701; GO:002260; GO:001089; GO:003073; GO:001991; GO:003535; GO:000865	integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane	GO:003017; GO:000578	"NA"	"NA"	molecular_function	GO:000367
XP_013833055.1;XP_005665805.1;NP_001121955.1;XP_005665806.1;XP_013833054.1	XP_013833055.1;XP_005665805.1;NP_001121955.1;XP_005665806.1;XP_013833054.1	XP_013833055.1 flotillin-1 isoform X3 [Sus scrofa];XP_005665805.1 flotillin-1 isoform X1 [Sus scrofa];NP_001121955.1 flotillin-1 [Sus scrofa];XP_005665806.1 flotillin-1 isoform X4 [Sus scrofa];XP_013833054.1 flotillin-1 isoform X2 [Sus scrofa]	10	10	10	77619000	89273000	70174000	51880000	46860000	74980000	68580000	87880000	64626000	57178000	65650000	68839000	83800000	62892000	68300000	51241000	70389000	89469000	NA	NA	NA	FLOT1	FLOT1;FLOT1;FLOT1;FLOT1;FLOT1	positive regulation of toll-like receptor 3 signaling pathway;positive regulation of cell junction assembly;positive regulation of cell-cell adhesion mediated by cadherin;dsRNA transport;positive regulation of skeletal muscle tissue development;protein kinase C signaling;protein localization to plasma membrane;protein stabilization;cellular response to exogenous dsRNA;regulation of toll-like receptor 4 signaling pathway;regulation of Rho protein signal transduction;positive regulation of endocytosis;regulation of neurotransmitter uptake;membrane raft assembly;positive regulation of cytokine production;positive regulation of protein binding;positive regulation of interferon-beta production;protein localization to membrane raft;regulation of receptor internalization;positive regulation of heterotypic cell-cell adhesion;response to endoplasmic reticulum stress;protein homooligomerization;positive regulation of protein phosphorylation;positive regulation of synaptic transmission, dopaminergic;plasma membrane raft assembly;positive regulation of cell adhesion molecule production;axonogenesis;extracellular matrix disassembly;positive regulation of myoblast fusion	GO:003414; GO:190189; GO:200004; GO:003322; GO:004864; GO:007052; GO:007265; GO:005082; GO:007136; GO:003414; GO:003502; GO:004580; GO:005158; GO:000176; GO:000181; GO:003209; GO:003272; GO:190304; GO:000209; GO:003411; GO:003497; GO:005126; GO:000193; GO:003222; GO:004485; GO:006035; GO:000740; GO:002261; GO:190174	membrane;caveola;COP9 signalosome;presynaptic active zone;extracellular exosome;microtubule organizing center;external side of plasma membrane;GABA-ergic synapse;cytoplasmic vesicle;cell-cell adherens junction;plasma membrane;focal adhesion;basolateral plasma membrane;melanosome;cell-cell contact zone;lysosomal membrane;lamellipodium;flotillin complex;centriolar satellite;sarcolemma;glutamatergic synapse;uropod;cortical actin cytoskeleton;membrane raft	GO:001602; GO:000590; GO:000818; GO:004878; GO:007006; GO:000581; GO:000989; GO:009898; GO:003141; GO:000591; GO:000588; GO:000592; GO:001632; GO:004247; GO:004429; GO:000576; GO:003002; GO:001660; GO:003445; GO:004238; GO:009897; GO:000193; GO:003086; GO:004512	 Insulin signaling pathway	hsa0491	ionotropic glutamate receptor binding;protein heterodimerization activity;protein binding;protease binding	GO:003525; GO:004698; GO:000551; GO:000202
NP_001121964.1	NP_001121964.1	NP_001121964.1 cellular retinoic acid-binding protein 1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	18582000	0	0	0	0	0	0	0	0	NA	NA	NA	CRABP1	CRABP1;NA;NA;NA;NA	multicellular organism development;signal transduction;retinoic acid catabolic process	GO:000727; GO:000716; GO:003465	cytosol	GO:000582	"NA"	"NA"	protein binding;retinoid binding;retinoic acid binding;retinol binding;retinal binding	GO:000551; GO:000550; GO:000197; GO:001984; GO:001691
NP_001123419.1	NP_001123419.1	NP_001123419.1 tropomyosin beta chain [Sus scrofa]	33	22	0	486200000	828570000	2486000000	412690000	381830000	1638600000	322410000	1344300000	827200000	3076100000	1294100000	971430000	4948200000	517660000	352140000	456690000	1097300000	421910000	NA	NA	NA	TPM2	TPM2;NA;NA;NA;NA	muscle contraction;actin filament organization;regulation of ATPase activity;muscle filament sliding	GO:000693; GO:000701; GO:004346; GO:003004	muscle thin filament tropomyosin;actin cytoskeleton;cytosol;actin filament	GO:000586; GO:001562; GO:000582; GO:000588	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction	hsa0541; hsa0541; hsa0426	actin filament binding;structural constituent of muscle;identical protein binding;protein heterodimerization activity;actin binding	GO:005101; GO:000830; GO:004280; GO:004698; GO:000377
NP_001123421.1	NP_001123421.1	NP_001123421.1 creatine kinase M-type [Sus scrofa]	16	16	4	0	0	6469600	129000000	0	0	0	0	0	154930000	0	0	50537000	17992000	0	0	6236500000	0	NA	NA	NA	CKM	CKM;NA;NA;NA;NA	phosphocreatine biosynthetic process;creatine metabolic process;phosphorylation	GO:004631; GO:000660; GO:001631	cytosol;extracellular space	GO:000582; GO:000561	 Metabolic pathways; Arginine and proline metabolism	hsa0110; hsa0033	ATP binding;protein binding;creatine kinase activity	GO:000552; GO:000551; GO:000411
NP_001123422.1;XP_020953960.1;XP_013833081.1	NP_001123422.1;XP_020953960.1;XP_013833081.1	NP_001123422.1 allograft inflammatory factor 1 [Sus scrofa];XP_020953960.1 allograft inflammatory factor 1 isoform X1 [Sus scrofa];XP_013833081.1 allograft inflammatory factor 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4940500	NA	NA	NA	AIF1	AIF1;AIF1;AIF1;NA;NA	response to electrical stimulus;cellular response to interferon-gamma;ruffle assembly;microglial cell activation;negative regulation of smooth muscle cell chemotaxis;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of protein phosphorylation;phagocytosis, engulfment;inflammatory response;positive regulation of T cell proliferation;positive regulation of smooth muscle cell proliferation;positive regulation of muscle hyperplasia;Rac protein signal transduction;response to glucocorticoid;actin filament bundle assembly;cellular response to morphine;negative regulation of apoptotic process;negative regulation of gene expression;positive regulation of monocyte chemotaxis;positive regulation of T cell migration;cerebellum development;positive regulation of nitric oxide biosynthetic process;actin filament polymerization;cellular response to extracellular stimulus;cellular response to hormone stimulus;response to axon injury;cellular response to hydroperoxide	GO:005160; GO:007134; GO:009717; GO:000177; GO:007167; GO:190008; GO:000193; GO:000691; GO:000695; GO:004210; GO:004866; GO:001473; GO:001660; GO:005138; GO:005101; GO:007131; GO:004306; GO:001062; GO:009002; GO:200040; GO:002154; GO:004542; GO:003004; GO:003166; GO:003287; GO:004867; GO:007144	cytosol;actin filament;ruffle membrane;nucleus;perikaryon;cytoplasm;perinuclear region of cytoplasm;cell projection;lamellipodium;phagocytic cup	GO:000582; GO:000588; GO:003258; GO:000563; GO:004320; GO:000573; GO:004847; GO:004299; GO:003002; GO:000189	"NA"	"NA"	calcium ion binding;actin filament binding;molecular_function	GO:000550; GO:005101; GO:000367
XP_020932965.1;NP_001123424.1;XP_020932964.1	XP_020932965.1;NP_001123424.1;XP_020932964.1	XP_020932965.1 GDP-fucose protein O-fucosyltransferase 1 isoform X2 [Sus scrofa];NP_001123424.1 GDP-fucose protein O-fucosyltransferase 1 precursor [Sus scrofa];XP_020932964.1 GDP-fucose protein O-fucosyltransferase 1 isoform X1 [Sus scrofa]	4	4	4	17937000	0	16064000	0	15660000	27742000	0	17553000	0	19132000	18812000	0	0	24105000	0	25188000	0	21825000	NA	NA	NA	POFUT1	POFUT1;POFUT1;POFUT1;NA;NA	somitogenesis;fucose metabolic process;regulation of transcription, DNA-templated;nervous system development;O-glycan processing;Notch signaling pathway;angiogenesis;regulation of Notch signaling pathway;protein O-linked fucosylation;heart development;protein O-linked glycosylation	GO:000175; GO:000600; GO:000635; GO:000739; GO:001626; GO:000721; GO:000152; GO:000859; GO:003606; GO:000750; GO:000649	endoplasmic reticulum;membrane	GO:000578; GO:001602	 Other types of O-glycan biosynthesis	hsa0051	peptide-O-fucosyltransferase activity;fucosyltransferase activity	GO:004692; GO:000841
NP_001123426.1	NP_001123426.1	NP_001123426.1 40S ribosomal protein S20 [Sus scrofa]	4	4	4	120230000	137300000	157850000	157750000	157280000	189340000	147850000	156930000	143830000	159860000	157500000	175880000	126160000	207500000	149240000	170240000	131930000	200020000	NA	NA	NA	RPS20	RPS20;NA;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000018; GO:000641; GO:000661	cytosol;membrane;nucleoplasm;cytosolic small ribosomal subunit;synapse;extracellular exosome	GO:000582; GO:001602; GO:000565; GO:002262; GO:004520; GO:007006	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;protein binding	GO:000372; GO:000373; GO:000551
NP_001123427.1	NP_001123427.1	NP_001123427.1 60S ribosomal protein L23 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	55500000	54594000	0	0	58887000	0	0	NA	NA	NA	RPL23	RPL23;NA;NA;NA;NA	positive regulation of cell cycle arrest;translation;protein-DNA complex disassembly;positive regulation of signal transduction by p53 class mediator;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;negative regulation of transcription from RNA polymerase II promoter;SRP-dependent cotranslational protein targeting to membrane;positive regulation of cell proliferation;positive regulation of gene expression;negative regulation of cell cycle arrest;protein stabilization;cellular response to actinomycin D;negative regulation of ubiquitin protein ligase activity;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	GO:007115; GO:000641; GO:003298; GO:190179; GO:000018; GO:000012; GO:000661; GO:000828; GO:001062; GO:007115; GO:005082; GO:007271; GO:190466; GO:200005	nucleolus;cytosol;membrane;macromolecular complex;nucleoplasm;cytoplasm;extracellular exosome;ribosome;focal adhesion;postsynaptic density;cytosolic large ribosomal subunit	GO:000573; GO:000582; GO:001602; GO:003299; GO:000565; GO:000573; GO:007006; GO:000584; GO:000592; GO:001406; GO:002262	 Ribosome	hsa0301	protein binding;ubiquitin ligase inhibitor activity;RNA binding;large ribosomal subunit rRNA binding;ubiquitin protein ligase binding;transcription coactivator binding;structural constituent of ribosome	GO:000551; GO:199094; GO:000372; GO:007018; GO:003162; GO:000122; GO:000373
NP_001123430.1	NP_001123430.1	NP_001123430.1 antithrombin-III precursor [Sus scrofa]	21	21	16	589670000	877730000	715280000	843090000	995230000	1671200000	909300000	787920000	834090000	732960000	783130000	666110000	815890000	800350000	661870000	727120000	822180000	1060100000	NA	NA	NA	SERPINC1	SERPINC1;NA;NA;NA;NA	lactation;cellular protein metabolic process;regulation of blood coagulation, intrinsic pathway;acute inflammatory response to antigenic stimulus;blood coagulation;negative regulation of endopeptidase activity;post-translational protein modification;response to nutrient	GO:000759; GO:004426; GO:200026; GO:000243; GO:000759; GO:001095; GO:004368; GO:000758	extracellular region;plasma membrane;extracellular space;extracellular exosome;blood microparticle;endoplasmic reticulum lumen	GO:000557; GO:000588; GO:000561; GO:007006; GO:007256; GO:000578	 Complement and coagulation cascades	hsa0461	protein binding;serine-type endopeptidase inhibitor activity;protease binding;heparin binding;identical protein binding	GO:000551; GO:000486; GO:000202; GO:000820; GO:004280
NP_001123434.1	NP_001123434.1	NP_001123434.1 diamine acetyltransferase 2 [Sus scrofa]	8	8	8	0	49763000	0	52211000	41178000	38427000	47704000	50001000	0	0	55679000	52156000	56297000	0	0	59858000	52080000	53613000	NA	NA	NA	SAT2	SAT2;NA;NA;NA;NA	spermine acetylation;putrescine acetylation;putrescine catabolic process;nor-spermidine metabolic process;spermidine acetylation	GO:003291; GO:003292; GO:000944; GO:004620; GO:003291	cytoplasm;extracellular exosome	GO:000573; GO:007006	 Arginine and proline metabolism; Metabolic pathways	hsa0033; hsa0110	diamine N-acetyltransferase activity;protein binding;N-acetyltransferase activity;identical protein binding;spermidine binding	GO:000414; GO:000551; GO:000808; GO:004280; GO:001980
NP_001123435.1	NP_001123435.1	NP_001123435.1 reticulon-4 [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2570100	NA	NA	NA	RTN4	RTN4;NA;NA;NA;NA	endoplasmic reticulum tubular network membrane organization;nuclear pore complex assembly;positive regulation of protein kinase B signaling;endoplasmic reticulum tubular network organization;positive regulation of ERBB3 signaling pathway;axonal fasciculation;cerebral cortex radial glia guided migration;positive regulation of mammary gland epithelial cell proliferation;negative regulation of axonogenesis;protein stabilization;cardiac epithelial to mesenchymal transition;positive regulation of epithelial cell migration;negative regulation of axon extension;negative regulation of cell growth;blastocyst formation;regulation of apoptotic process;apoptotic process;regulation of branching morphogenesis of a nerve;positive regulation of protein localization to endoplasmic reticulum	GO:199080; GO:005129; GO:005189; GO:007178; GO:190558; GO:000741; GO:002180; GO:003360; GO:005077; GO:005082; GO:006031; GO:001063; GO:003051; GO:003030; GO:000182; GO:004298; GO:000691; GO:200017; GO:190555	endoplasmic reticulum;postsynaptic density;integral component of endoplasmic reticulum membrane;endoplasmic reticulum tubular network;nuclear envelope;endoplasmic reticulum membrane;cell projection;plasma membrane;endoplasmic reticulum tubular network membrane;neuronal cell body	GO:000578; GO:001406; GO:003017; GO:007178; GO:000563; GO:000578; GO:004299; GO:000588; GO:009882; GO:004302	"NA"	"NA"	cadherin binding;RNA binding;protein binding;ubiquitin protein ligase binding	GO:004529; GO:000372; GO:000551; GO:003162
NP_001123444.1	NP_001123444.1	NP_001123444.1 CD209 antigen [Sus scrofa]	3	3	3	0	0	33924000	59837000	0	57001000	0	0	0	0	0	0	0	51806000	0	0	0	75805000	NA	NA	NA	CD209	CD209;NA;NA;NA;NA	peptide antigen transport;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;cell-cell recognition;stimulatory C-type lectin receptor signaling pathway;adaptive immune response;virion attachment to host cell;viral genome replication;antigen processing and presentation;regulation of T cell proliferation;innate immune response;B cell adhesion;intracellular signal transduction;modulation by virus of host morphology or physiology;viral entry into host cell;intracellular transport of virus;endocytosis;positive regulation of T cell proliferation	GO:004696; GO:000715; GO:000998; GO:000222; GO:000225; GO:001906; GO:001907; GO:001988; GO:004212; GO:004508; GO:009732; GO:003555; GO:001904; GO:004671; GO:007573; GO:000689; GO:004210	membrane;extracellular region;plasma membrane;cytoplasm;host cell;cell surface;external side of plasma membrane;integral component of membrane	GO:001602; GO:000557; GO:000588; GO:000573; GO:004365; GO:000998; GO:000989; GO:001602	 Phagosome; Measles; Tuberculosis	hsa0414; hsa0516; hsa0515	protein binding;mannose binding;virion binding;metal ion binding;virus receptor activity;peptide antigen binding;carbohydrate binding	GO:000551; GO:000553; GO:004679; GO:004687; GO:000161; GO:004260; GO:003024
NP_001123450.1	NP_001123450.1	NP_001123450.1 cytochrome b-c1 complex subunit 9 [Sus scrofa]	2	2	2	113680000	0	58672000	0	51542000	0	0	0	67039000	0	0	0	0	0	0	0	48944000	0	NA	NA	NA	UQCR10	UQCR10;NA;NA;NA;NA	mitochondrial respiratory chain complex III assembly;mitochondrial electron transport, ubiquinol to cytochrome c;aerobic respiration	GO:003455; GO:000612; GO:000906	mitochondrial inner membrane;mitochondrial respiratory chain complex III	GO:000574; GO:000575	 Non-alcoholic fatty liver disease (NAFLD); Cardiac muscle contraction; Parkinson's disease; Oxidative phosphorylation; Metabolic pathways	hsa0493; hsa0426; hsa0501; hsa0019; hsa0110	ubiquinol-cytochrome-c reductase activity	GO:000812
NP_001123683.1	NP_001123683.1	NP_001123683.1 transcription factor A, mitochondrial precursor [Sus scrofa]	2	2	2	26028000	18235000	0	14377000	16578000	16902000	20897000	0	0	0	18891000	0	0	16868000	0	18949000	15524000	0	NA	NA	NA	TFAM	TFAM;NA;NA;NA;NA	transcription from mitochondrial promoter;transcription initiation from mitochondrial promoter;mitochondrion organization;mitochondrial respiratory chain complex assembly;positive regulation of transcription, DNA-templated	GO:000639; GO:000639; GO:000700; GO:003310; GO:004589	mitochondrial matrix;cytosol;nucleus;macromolecular complex;mitochondrion;mitochondrial nucleoid	GO:000575; GO:000582; GO:000563; GO:003299; GO:000573; GO:004264	 Huntington's disease	hsa0501	mitochondrial RNA polymerase regulatory region DNA binding;sequence-specific DNA binding;DNA binding, bending;chromatin binding;transcription factor activity, sequence-specific DNA binding;heat shock protein binding;transcription coactivator binding;protein binding;RNA binding	GO:000101; GO:004356; GO:000830; GO:000368; GO:000370; GO:003107; GO:000122; GO:000551; GO:000372
NP_001124003.1	NP_001124003.1	NP_001124003.1 disintegrin and metalloproteinase domain-containing protein 10 precursor [Sus scrofa]	3	3	3	15174000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ADAM10	ADAM10;NA;NA;NA;NA	membrane protein ectodomain proteolysis;post-translational protein modification;response to tumor necrosis factor;positive regulation of cell proliferation;positive regulation of cell growth;positive regulation of apoptotic process;cellular protein metabolic process;PMA-inducible membrane protein ectodomain proteolysis;extracellular matrix disassembly;Notch signaling pathway;in utero embryonic development;monocyte activation;Notch receptor processing, ligand-dependent;negative regulation of cell adhesion;integrin-mediated signaling pathway;protein phosphorylation;regulation of dendritic spine morphogenesis;beta-amyloid formation;neutrophil degranulation;positive regulation of cell migration;protein processing;positive regulation of T cell chemotaxis;spermatogenesis;cell-cell signaling;response to antineoplastic agent	GO:000650; GO:004368; GO:003461; GO:000828; GO:003030; GO:004306; GO:004426; GO:005108; GO:002261; GO:000721; GO:000170; GO:004211; GO:003533; GO:000716; GO:000722; GO:000646; GO:006100; GO:003420; GO:004331; GO:003033; GO:001648; GO:001082; GO:000728; GO:000726; GO:009732	plasma membrane;neuronal cell body;tetraspanin-enriched microdomain;Golgi-associated vesicle;cell surface;postsynaptic membrane;perinuclear endoplasmic reticulum;extracellular exosome;cytoplasm;integral component of membrane;dendritic spine;postsynaptic density;specific granule membrane;Golgi membrane;glutamatergic synapse;synaptic vesicle;tertiary granule membrane;nucleus;endoplasmic reticulum lumen;trans-Golgi network;focal adhesion	GO:000588; GO:004302; GO:009719; GO:000579; GO:000998; GO:004521; GO:009703; GO:007006; GO:000573; GO:001602; GO:004319; GO:001406; GO:003557; GO:000013; GO:009897; GO:000802; GO:007082; GO:000563; GO:000578; GO:000580; GO:000592	 Alzheimer's disease; Epithelial cell signaling in Helicobacter pylori infection	hsa0501; hsa0512	receptor binding;integrin binding;SH3 domain binding;metallopeptidase activity;protein kinase binding;endopeptidase activity;metalloendopeptidase activity;protein binding;protein homodimerization activity;metal ion binding	GO:000510; GO:000517; GO:001712; GO:000823; GO:001990; GO:000417; GO:000422; GO:000551; GO:004280; GO:004687
NP_001124204.1	NP_001124204.1	NP_001124204.1 thrombomodulin precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1165200	NA	NA	NA	THBD	THBD;NA;NA;NA;NA	response to lipopolysaccharide;negative regulation of blood coagulation;response to cAMP;female pregnancy;blood coagulation;response to X-ray;negative regulation of fibrinolysis;negative regulation of platelet activation	GO:003249; GO:003019; GO:005159; GO:000756; GO:000759; GO:001016; GO:005191; GO:001054	vacuolar membrane;plasma membrane;cell surface;extracellular space;apicolateral plasma membrane	GO:000577; GO:000588; GO:000998; GO:000561; GO:001632	 Complement and coagulation cascades	hsa0461	calcium ion binding;signaling receptor activity;transmembrane signaling receptor activity;protein binding	GO:000550; GO:003802; GO:000488; GO:000551
NP_001124205.1	NP_001124205.1	NP_001124205.1 adenylosuccinate lyase [Sus scrofa]	7	7	7	31293000	30717000	27320000	30234000	29565000	0	29932000	33260000	31212000	28520000	0	0	0	28843000	28377000	23659000	38182000	28446000	NA	NA	NA	ADSL	ADSL;NA;NA;NA;NA	'de novo' IMP biosynthetic process;response to nutrient;protein tetramerization;aerobic respiration;'de novo' AMP biosynthetic process;AMP biosynthetic process;purine ribonucleoside monophosphate biosynthetic process;response to muscle activity;response to starvation;response to hypoxia	GO:000618; GO:000758; GO:005126; GO:000906; GO:004420; GO:000616; GO:000916; GO:001485; GO:004259; GO:000166	cytosol	GO:000582	 Biosynthesis of antibiotics; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Purine metabolism	hsa0113; hsa0025; hsa0110; hsa0023	(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity;N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity	GO:007062; GO:000401
XP_020941229.1;XP_020941228.1;NP_001124206.1;XP_020941227.1;XP_020941226.1;XP_005655324.3;XP_020941224.1;XP_020941223.1;XP_020948900.1;XP_020948899.1;XP_020948898.1;NP_001135459.1;XP_020948897.1	XP_020941229.1;XP_020941228.1;NP_001124206.1;XP_020941227.1;XP_020941226.1;XP_005655324.3;XP_020941224.1;XP_020941223.1	XP_020941229.1 phosphatidate phosphatase LPIN1 isoform X4 [Sus scrofa];XP_020941228.1 phosphatidate phosphatase LPIN1 isoform X4 [Sus scrofa];NP_001124206.1 phosphatidate phosphatase LPIN1 [Sus scrofa];XP_020941227.1 phosphatidate phosphatase LPIN1 isoform	7	7	7	14502000	0	14803000	0	14361000	0	11518000	0	14098000	13092000	0	0	0	0	0	17061000	13018000	0	NA	NA	NA	LPIN1	LPIN1;LPIN1;LPIN1;LPIN1;LPIN1	mitotic nuclear envelope disassembly;dephosphorylation;animal organ regeneration;triglyceride biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;cellular response to insulin stimulus;triglyceride mobilization;phosphatidylcholine biosynthetic process;fatty acid catabolic process	GO:000707; GO:001631; GO:003110; GO:001943; GO:004594; GO:003286; GO:000664; GO:000665; GO:000906	mitochondrial outer membrane;nucleoplasm;cytoplasm;cytosol;nucleus;endoplasmic reticulum membrane;nuclear membrane	GO:000574; GO:000565; GO:000573; GO:000582; GO:000563; GO:000578; GO:003196	 Glycerophospholipid metabolism; Metabolic pathways; Glycerolipid metabolism	hsa0056; hsa0110; hsa0056	transcription coactivator activity;phosphatidate phosphatase activity	GO:000371; GO:000819
NP_001124208.1	NP_001124208.1	NP_001124208.1 bifunctional purine biosynthesis protein PURH [Sus scrofa]	17	17	17	51010000	46433000	37593000	47860000	54752000	41470000	51728000	47116000	50540000	55334000	49548000	73415000	34654000	35533000	45156000	54814000	41469000	42878000	NA	NA	NA	ATIC	ATIC;NA;NA;NA;NA	nucleobase-containing compound metabolic process;purine ribonucleoside monophosphate biosynthetic process;cerebral cortex development;response to inorganic substance;cellular response to interleukin-7;cerebellum development;tetrahydrofolate biosynthetic process;dihydrofolate metabolic process;brainstem development;animal organ regeneration;'de novo' IMP biosynthetic process;nucleoside metabolic process	GO:000613; GO:000916; GO:002198; GO:001003; GO:009876; GO:002154; GO:004665; GO:004645; GO:000336; GO:003110; GO:000618; GO:000911	cytosol;plasma membrane;extracellular exosome;membrane	GO:000582; GO:000588; GO:007006; GO:001602	 One carbon pool by folate; Metabolic pathways; Purine metabolism; Biosynthesis of antibiotics	hsa0067; hsa0110; hsa0023; hsa0113	cadherin binding;IMP cyclohydrolase activity;phosphoribosylaminoimidazolecarboxamide formyltransferase activity;protein homodimerization activity	GO:004529; GO:000393; GO:000464; GO:004280
XP_020957613.1;XP_020957612.1;XP_013854557.1;XP_020957611.1;NP_001124446.1;XP_013854542.1;XP_020957609.1;XP_020957608.1;XP_020957607.1;XP_020957606.1;XP_005653698.1;XP_020957610.1;XP_013854550.2	XP_020957613.1;XP_020957612.1;XP_013854557.1;XP_020957611.1;NP_001124446.1;XP_013854542.1;XP_020957609.1;XP_020957608.1;XP_020957607.1;XP_020957606.1;XP_005653698.1;XP_020957610.1;XP_013854550.2	XP_020957613.1 stromal interaction molecule 1 isoform X12 [Sus scrofa];XP_020957612.1 stromal interaction molecule 1 isoform X11 [Sus scrofa];XP_013854557.1 stromal interaction molecule 1 isoform X10 [Sus scrofa];XP_020957611.1 stromal interaction molecule	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	8661800	0	0	0	0	NA	NA	NA	STIM1	STIM1;STIM1;STIM1;STIM1;STIM1	regulation of cardiac conduction;detection of calcium ion;activation of store-operated calcium channel activity;positive regulation of angiogenesis;cellular calcium ion homeostasis;store-operated calcium entry;regulation of store-operated calcium entry;regulation of calcium ion transport;enamel mineralization	GO:190377; GO:000551; GO:003223; GO:004576; GO:000687; GO:000211; GO:200125; GO:005192; GO:007016	integral component of plasma membrane;endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;plasma membrane;cortical endoplasmic reticulum;sarcoplasmic reticulum membrane;microtubule;plasma membrane raft	GO:000588; GO:000578; GO:003017; GO:000588; GO:003254; GO:003301; GO:000587; GO:004485	 Platelet activation; Calcium signaling pathway	hsa0461; hsa0402	protease binding;calcium channel regulator activity;identical protein binding;microtubule plus-end binding;protein binding;calcium ion binding	GO:000202; GO:000524; GO:004280; GO:005101; GO:000551; GO:000550
NP_001124518.1	NP_001124518.1	NP_001124518.1 gamma-interferon-inducible-lysosomal thiol reductase precursor [Sus scrofa]	2	2	2	0	0	0	42908000	0	63103000	0	0	0	0	0	0	0	42784000	0	0	0	0	NA	NA	NA	IFI30	IFI30;NA;NA;NA;NA	interferon-gamma-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I;antigen processing and presentation of exogenous peptide antigen via MHC class II;oxidation-reduction process	GO:006033; GO:004259; GO:001988; GO:005511	cell junction;intracellular membrane-bounded organelle;lysosomal lumen;extracellular region;lysosome;cytosol	GO:003005; GO:004323; GO:004320; GO:000557; GO:000576; GO:000582	 Antigen processing and presentation	hsa0461	oxidoreductase activity, acting on a sulfur group of donors;protein binding	GO:001666; GO:000551
NP_001127815.1	NP_001127815.1	NP_001127815.1 actin-related protein 3 [Sus scrofa]	13	13	11	182780000	222320000	274170000	232290000	178420000	289030000	197690000	210770000	236940000	276660000	199710000	258470000	396370000	264480000	208420000	256940000	238040000	323780000	NA	NA	NA	ACTR3	ACTR3;NA;NA;NA;NA	Arp2/3 complex-mediated actin nucleation;meiotic chromosome movement towards spindle pole;establishment or maintenance of cell polarity;spindle localization;actin polymerization-dependent cell motility;positive regulation of transcription from RNA polymerase II promoter;cellular response to interferon-gamma;Fc-gamma receptor signaling pathway involved in phagocytosis;asymmetric cell division;membrane organization;meiotic cytokinesis;cilium assembly;ephrin receptor signaling pathway	GO:003431; GO:001634; GO:000716; GO:005165; GO:007035; GO:004594; GO:007134; GO:003809; GO:000835; GO:006102; GO:003320; GO:006027; GO:004801	cell-cell junction;lamellipodium;nucleus;actin cytoskeleton;cytoplasm;extracellular exosome;focal adhesion;membrane;brush border;cytosol;site of double-strand break;Arp2/3 protein complex	GO:000591; GO:003002; GO:000563; GO:001562; GO:000573; GO:007006; GO:000592; GO:001602; GO:000590; GO:000582; GO:003586; GO:000588	"NA"	"NA"	protein binding;actin filament binding;structural constituent of cytoskeleton;ATP binding	GO:000551; GO:005101; GO:000520; GO:000552
NP_001127826.1;XP_005662565.1	NP_001127826.1;XP_005662565.1	NP_001127826.1 actin-related protein 2 [Sus scrofa];XP_005662565.1 actin-related protein 2 isoform X1 [Sus scrofa]	7	7	7	92800000	104200000	110750000	106380000	71896000	110430000	73383000	84653000	87595000	98574000	78037000	96994000	133390000	97456000	117890000	86603000	86658000	104120000	NA	NA	NA	ACTR2	ACTR2;ACTR2;NA;NA;NA	Arp2/3 complex-mediated actin nucleation;response to immobilization stress;regulation of double-strand break repair via nonhomologous end joining;Fc-gamma receptor signaling pathway involved in phagocytosis;cellular response to interferon-gamma;cellular response to trichostatin A;cytosolic transport;establishment or maintenance of cell polarity;associative learning;positive regulation of transcription from RNA polymerase II promoter;spindle localization;response to ethanol;neutrophil degranulation;ephrin receptor signaling pathway;meiotic cytokinesis;cilium assembly;positive regulation of double-strand break repair via homologous recombination;meiotic chromosome movement towards spindle pole;positive regulation of dendritic spine morphogenesis;membrane organization;asymmetric cell division	GO:003431; GO:003590; GO:200103; GO:003809; GO:007134; GO:003598; GO:001648; GO:000716; GO:000830; GO:004594; GO:005165; GO:004547; GO:004331; GO:004801; GO:003320; GO:006027; GO:190516; GO:001634; GO:006100; GO:006102; GO:000835	nucleus;Arp2/3 protein complex;azurophil granule lumen;focal adhesion;invadopodium;extracellular region;actin cap;cytoplasm;lamellipodium;cytosol;membrane;site of double-strand break;extracellular exosome;actin cytoskeleton;postsynaptic density;podosome core;ficolin-1-rich granule lumen	GO:000563; GO:000588; GO:003557; GO:000592; GO:007143; GO:000557; GO:003047; GO:000573; GO:003002; GO:000582; GO:001602; GO:003586; GO:007006; GO:001562; GO:001406; GO:006182; GO:190481	"NA"	"NA"	structural constituent of cytoskeleton;ATP binding;actin filament binding	GO:000520; GO:000552; GO:005101
XP_020941233.1;XP_020941232.1;NP_001127828.1	XP_020941233.1;XP_020941232.1;NP_001127828.1	XP_020941233.1 actin-related protein 2/3 complex subunit 1B isoform X1 [Sus scrofa];XP_020941232.1 actin-related protein 2/3 complex subunit 1B isoform X1 [Sus scrofa];NP_001127828.1 actin-related protein 2/3 complex subunit 1B [Sus scrofa]	10	10	9	65957000	100100000	115020000	118170000	67370000	136340000	56614000	63271000	93546000	83251000	69235000	158160000	195730000	94999000	72880000	88606000	93446000	143300000	NA	NA	NA	ARPC1B	ARPC1B;ARPC1B;ARPC1B;NA;NA	ephrin receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;response to estrogen;response to estradiol;Arp2/3 complex-mediated actin nucleation	GO:004801; GO:003809; GO:004362; GO:003235; GO:003431	Arp2/3 protein complex;tubulobulbar complex;cytosol;focal adhesion;nucleus;actin cytoskeleton;extracellular exosome	GO:000588; GO:003628; GO:000582; GO:000592; GO:000563; GO:001562; GO:007006	 Fc gamma R-mediated phagocytosis; Salmonella infection; Endocytosis; Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells	hsa0466; hsa0513; hsa0414; hsa0481; hsa0510	structural constituent of cytoskeleton;actin filament binding;protein binding	GO:000520; GO:005101; GO:000551
NP_001127829.1	NP_001127829.1	NP_001127829.1 actin-related protein 2/3 complex subunit 5 [Sus scrofa]	3	3	3	0	92712000	0	88802000	58315000	137940000	63318000	85460000	52432000	82883000	69277000	94930000	111890000	86876000	68771000	83387000	0	98173000	NA	NA	NA	ARPC5	ARPC5;NA;NA;NA;NA	cell migration;orbitofrontal cortex development;microtubule organizing center localization;membrane organization;Fc-gamma receptor signaling pathway involved in phagocytosis;lamellipodium organization;Arp2/3 complex-mediated actin nucleation;smooth muscle cell migration;ephrin receptor signaling pathway;actin filament network formation;neutrophil degranulation;actin cytoskeleton organization;maintenance of cell polarity	GO:001647; GO:002176; GO:006184; GO:006102; GO:003809; GO:009758; GO:003431; GO:001490; GO:004801; GO:005163; GO:004331; GO:003003; GO:003001	cytosol;cytoplasm;actin cytoskeleton;secretory granule lumen;extracellular region;site of double-strand break;ficolin-1-rich granule lumen;Arp2/3 protein complex;focal adhesion;growth cone;extracellular exosome;nucleus;endosome;lamellipodium	GO:000582; GO:000573; GO:001562; GO:003477; GO:000557; GO:003586; GO:190481; GO:000588; GO:000592; GO:003042; GO:007006; GO:000563; GO:000576; GO:003002	 Shigellosis; Endocytosis; Bacterial invasion of epithelial cells; Regulation of actin cytoskeleton; Fc gamma R-mediated phagocytosis; Pathogenic Escherichia coli infection	hsa0513; hsa0414; hsa0510; hsa0481; hsa0466; hsa0513	structural constituent of cytoskeleton;protein binding;actin filament binding	GO:000520; GO:000551; GO:005101
NP_001128295.1	NP_001128295.1	NP_001128295.1 selenoprotein P precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16472000	0	0	0	NA	NA	NA	SELENOP	SELENOP;NA;NA;NA;NA	selenium compound metabolic process;locomotory behavior;platelet degranulation;regulation of growth;post-embryonic development;brain development;response to oxidative stress;response to selenium ion;sexual reproduction	GO:000188; GO:000762; GO:000257; GO:004000; GO:000979; GO:000742; GO:000697; GO:001026; GO:001995	extracellular space;extracellular exosome;platelet dense granule lumen;extracellular region	GO:000561; GO:007006; GO:003108; GO:000557	"NA"	"NA"	selenium binding	GO:000843
NP_001128296.1;XP_020941822.1	NP_001128296.1	NP_001128296.1 cytochrome P450 3A46 [Sus scrofa]	5	5	2	0	0	44672000	21817000	0	0	15089000	19282000	20466000	16391000	0	0	0	0	17214000	12369000	16649000	0	NA	NA	NA	CYP3A46	CYP3A46;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001128438.1	NP_001128438.1	NP_001128438.1 DCC-interacting protein 13-alpha [Sus scrofa]	13	13	13	45378000	71563000	57637000	61792000	38907000	55354000	49484000	49089000	57089000	50786000	48615000	49000000	70847000	49143000	53949000	57708000	47213000	67408000	NA	NA	NA	APPL1	APPL1;NA;NA;NA;NA	regulation of fibroblast migration;regulation of innate immune response;positive regulation of cytokine production involved in inflammatory response;signal transduction;positive regulation of macropinocytosis;transforming growth factor beta receptor signaling pathway;extrinsic apoptotic signaling pathway in absence of ligand;adiponectin-activated signaling pathway;regulation of glucose import;insulin receptor signaling pathway;signaling;cellular response to hepatocyte growth factor stimulus;cell cycle;regulation of toll-like receptor 4 signaling pathway;positive regulation of melanin biosynthetic process;regulation of protein localization to plasma membrane;negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis	GO:001076; GO:004508; GO:190001; GO:000716; GO:190530; GO:000717; GO:009719; GO:003321; GO:004632; GO:000828; GO:002305; GO:003572; GO:000704; GO:003414; GO:004802; GO:190307; GO:190545	plasma membrane;vesicle membrane;early phagosome;macropinosome;extracellular exosome;cytoplasm;endosome;ruffle;nucleus;membrane;cytosol;endosome membrane;early endosome membrane;cytoplasmic vesicle;intracellular vesicle	GO:000588; GO:001250; GO:003200; GO:004435; GO:007006; GO:000573; GO:000576; GO:000172; GO:000563; GO:001602; GO:000582; GO:001000; GO:003190; GO:003141; GO:009770	 Pathways in cancer; Colorectal cancer	hsa0520; hsa0521	phosphatidylinositol binding;beta-tubulin binding;protein binding;protein kinase B binding;macromolecular complex binding;phosphatidylserine binding;identical protein binding	GO:003509; GO:004848; GO:000551; GO:004342; GO:004487; GO:000178; GO:004280
XP_020934104.1;XP_020934103.1;XP_020934102.1;XP_020934101.1;NP_001128440.1	XP_020934104.1;XP_020934103.1;XP_020934102.1;XP_020934101.1;NP_001128440.1	XP_020934104.1 phosphoglycerate mutase 2 isoform X1 [Sus scrofa];XP_020934103.1 phosphoglycerate mutase 2 isoform X1 [Sus scrofa];XP_020934102.1 phosphoglycerate mutase 2 isoform X1 [Sus scrofa];XP_020934101.1 phosphoglycerate mutase 2 isoform X1 [Sus scro	8	4	4	0	0	0	21894000	0	0	0	0	0	18449000	0	0	0	0	0	0	443400000	0	NA	NA	NA	PGAM2	PGAM2;PGAM2;PGAM2;PGAM2;PGAM2	response to mercury ion;spermatogenesis;canonical glycolysis;Notch signaling pathway;striated muscle contraction;gluconeogenesis	GO:004668; GO:000728; GO:006162; GO:000721; GO:000694; GO:000609	extracellular exosome;nucleus;cytosol	GO:007006; GO:000563; GO:000582	 Glycolysis / Gluconeogenesis; Glycine, serine and threonine metabolism; Central carbon metabolism in cancer; Carbon metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Metabolic pathways; Biosynthesis of antibiotics	hsa0001; hsa0026; hsa0523; hsa0120; hsa0123; hsa0492; hsa0110; hsa0113	cofactor binding;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity;bisphosphoglycerate mutase activity;phosphoglycerate mutase activity;hydrolase activity	GO:004803; GO:004653; GO:000408; GO:000461; GO:001678
XP_020941234.1;NP_001129152.1	XP_020941234.1;NP_001129152.1	XP_020941234.1 ubiquitin carboxyl-terminal hydrolase 7 isoform X1 [Sus scrofa];NP_001129152.1 ubiquitin carboxyl-terminal hydrolase 7 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	USP7	USP7;USP7;NA;NA;NA	ubiquitin-dependent protein catabolic process;negative regulation of NF-kappaB transcription factor activity;protein K48-linked deubiquitination;regulation of protein stability;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;transcription-coupled nucleotide-excision repair;multicellular organism development;maintenance of DNA methylation;viral process;protein deubiquitination;monoubiquitinated protein deubiquitination;protein stabilization;positive regulation of DNA demethylation;histone H2B conserved C-terminal lysine deubiquitination;regulation of telomere capping;regulation of sequence-specific DNA binding transcription factor activity	GO:000651; GO:003208; GO:007110; GO:003164; GO:003243; GO:000628; GO:000727; GO:001021; GO:001603; GO:001657; GO:003552; GO:005082; GO:190153; GO:003561; GO:190435; GO:005109	nuclear body;PML body;nucleoplasm;macromolecular complex;nucleus;chromosome;cytosol	GO:001660; GO:001660; GO:000565; GO:003299; GO:000563; GO:000569; GO:000582	 FoxO signaling pathway; Epstein-Barr virus infection; Viral carcinogenesis	hsa0406; hsa0516; hsa0520	ubiquitinyl hydrolase activity;thiol-dependent ubiquitin-specific protease activity;cysteine-type endopeptidase activity;Lys48-specific deubiquitinase activity;protein C-terminus binding;transcription factor binding;p53 binding;protein binding;ubiquitin protein ligase binding;thiol-dependent ubiquitinyl hydrolase activity	GO:010100; GO:000484; GO:000419; GO:199038; GO:000802; GO:000813; GO:000203; GO:000551; GO:003162; GO:003645
NP_001131091.1	NP_001131091.1	NP_001131091.1 40S ribosomal protein S3a [Sus scrofa]	8	8	8	134370000	95252000	137140000	57030000	85714000	177470000	96674000	78001000	131980000	137630000	83670000	129530000	121150000	134090000	0	115140000	141640000	148570000	NA	NA	NA	RPS3A	RPS3A;NA;NA;NA;NA	cell differentiation;negative regulation of apoptotic process;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane	GO:003015; GO:004306; GO:000641; GO:000018; GO:000661	focal adhesion;synapse;nucleus;endoplasmic reticulum;extracellular exosome;cytosolic small ribosomal subunit;nucleolus;ribonucleoprotein complex;cytosol;nucleoplasm	GO:000592; GO:004520; GO:000563; GO:000578; GO:007006; GO:002262; GO:000573; GO:199090; GO:000582; GO:000565	 Ribosome	hsa0301	mRNA 5'-UTR binding;structural constituent of ribosome;RNA binding;protein binding	GO:004802; GO:000373; GO:000372; GO:000551
NP_001131092.1	NP_001131092.1	NP_001131092.1 40S ribosomal protein S16 [Sus scrofa]	9	9	9	151800000	119210000	151730000	147870000	150390000	149800000	127250000	126040000	125440000	165260000	134000000	177570000	105050000	205760000	115540000	184830000	155380000	175790000	NA	NA	NA	RPS16	RPS16;NA;NA;NA;NA	translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;ribosomal small subunit biogenesis;cellular response to leukemia inhibitory factor;SRP-dependent cotranslational protein targeting to membrane;translational initiation	GO:000641; GO:000018; GO:000046; GO:000636; GO:004227; GO:199083; GO:000661; GO:000641	membrane;cytosolic small ribosomal subunit;nucleoplasm;small ribosomal subunit;extracellular exosome;focal adhesion;cytosol	GO:001602; GO:002262; GO:000565; GO:001593; GO:007006; GO:000592; GO:000582	 Ribosome	hsa0301	RNA binding;protein binding;structural constituent of ribosome	GO:000372; GO:000551; GO:000373
NP_001131099.1;XP_013837080.2	NP_001131099.1	NP_001131099.1 ERO1-like protein alpha precursor [Sus scrofa]	15	15	15	113340000	136040000	112570000	154150000	115430000	111560000	99957000	145230000	101820000	117780000	127130000	139420000	71254000	153570000	123450000	137800000	109030000	141280000	NA	NA	NA	ERO1A	ERO1A;NA;NA;NA;NA	cellular protein modification process;protein folding in endoplasmic reticulum;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;chaperone mediated protein folding requiring cofactor;extracellular matrix organization;oxidation-reduction process;response to temperature stimulus;cell redox homeostasis;animal organ senescence;cellular response to hypoxia;protein folding;protein maturation by protein folding;brown fat cell differentiation;release of sequestered calcium ion into cytosol;4-hydroxyproline metabolic process;endoplasmic reticulum unfolded protein response;cellular response to oxidative stress	GO:000646; GO:003497; GO:007005; GO:005108; GO:003019; GO:005511; GO:000926; GO:004545; GO:001026; GO:007145; GO:000645; GO:002241; GO:005087; GO:005120; GO:001947; GO:003096; GO:003459	endoplasmic reticulum membrane;dendrite;intracellular membrane-bounded organelle;endoplasmic reticulum;membrane	GO:000578; GO:003042; GO:004323; GO:000578; GO:001602	 Vibrio cholerae infection; Protein processing in endoplasmic reticulum	hsa0511; hsa0414	protein disulfide isomerase activity;protein binding;disulfide oxidoreductase activity;oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor;oxidoreductase activity	GO:000375; GO:000551; GO:001503; GO:001667; GO:001649
NP_001131100.1	NP_001131100.1	NP_001131100.1 growth factor receptor-bound protein 2 [Sus scrofa]	8	8	8	31056000	43021000	47399000	34389000	35687000	36240000	37505000	41601000	39943000	30514000	35771000	52468000	41569000	32068000	40164000	28472000	33184000	32531000	NA	NA	NA	GRB2	GRB2;NA;NA;NA;NA	T cell costimulation;phosphatidylinositol-3-phosphate biosynthetic process;leukocyte migration;aging;negative regulation of epidermal growth factor receptor signaling pathway;regulation of MAPK cascade;insulin receptor signaling pathway;cellular response to ionizing radiation;Ras protein signal transduction;viral process;cytokine-mediated signaling pathway;positive regulation of actin filament polymerization;receptor internalization;ERBB2 signaling pathway;protein heterooligomerization;positive regulation of Ras protein signal transduction;MAPK cascade;fibroblast growth factor receptor signaling pathway;signal transduction in response to DNA damage;neurotrophin TRK receptor signaling pathway;positive regulation of protein kinase B signaling;positive regulation of reactive oxygen species metabolic process;entry of bacterium into host cell;Fc-gamma receptor signaling pathway involved in phagocytosis;anatomical structure formation involved in morphogenesis;axon guidance;interleukin-15-mediated signaling pathway;branching involved in labyrinthine layer morphogenesis;epidermal growth factor receptor signaling pathway;phosphatidylinositol phosphorylation;membrane organization	GO:003129; GO:003609; GO:005090; GO:000756; GO:004205; GO:004340; GO:000828; GO:007147; GO:000726; GO:001603; GO:001922; GO:003083; GO:003162; GO:003812; GO:005129; GO:004657; GO:000016; GO:000854; GO:004277; GO:004801; GO:005189; GO:200037; GO:003563; GO:003809; GO:004864; GO:000741; GO:003572; GO:006067; GO:000717; GO:004685; GO:006102	endosome;Golgi apparatus;nucleolus;Grb2-EGFR complex;cytosol;cell-cell junction;COP9 signalosome;plasma membrane;vesicle membrane;nucleus;nucleoplasm;extracellular exosome	GO:000576; GO:000579; GO:000573; GO:007043; GO:000582; GO:000591; GO:000818; GO:000588; GO:001250; GO:000563; GO:000565; GO:007006	 Focal adhesion; Proteoglycans in cancer; Chemokine signaling pathway; Dorso-ventral axis formation; B cell receptor signaling pathway; GnRH signaling pathway; Glioma; Chronic myeloid leukemia; Choline metabolism in cancer; Gap junction; Signaling pathways regulating pluripotency of stem cells; Neurotrophin signaling pathway; Jak-STAT signaling pathway; PI3K-Akt signaling pathway; Natural killer cell mediated cytotoxicity; Hepatitis C; MAPK signaling pathway; Alcoholism; Osteoclast differentiation	hsa0451; hsa0520; hsa0406; hsa0432; hsa0466; hsa0491; hsa0521; hsa0522; hsa0523; hsa0454; hsa0455; hsa0472; hsa0463; hsa0415; hsa0465; hsa0516; hsa0401; hsa0503; hsa0438	RNA binding;SH3/SH2 adaptor activity;protein binding;1-phosphatidylinositol-3-kinase activity;protein kinase binding;Ras guanyl-nucleotide exchange factor activity;phosphotyrosine binding;ephrin receptor binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;neurotrophin TRKA receptor binding;insulin receptor substrate binding;epidermal growth factor receptor binding;SH3 domain binding;identical protein binding	GO:000372; GO:000507; GO:000551; GO:001630; GO:001990; GO:000508; GO:000178; GO:004687; GO:004693; GO:000516; GO:004356; GO:000515; GO:001712; GO:004280
NP_001131101.1	NP_001131101.1	NP_001131101.1 endoplasmic reticulum resident protein 44 precursor [Sus scrofa]	9	9	9	83874000	103350000	90279000	86447000	103960000	102860000	91792000	109160000	91795000	93224000	112220000	116070000	102610000	98044000	105450000	97200000	99344000	104730000	NA	NA	NA	ERP44	ERP44;NA;NA;NA;NA	response to unfolded protein;response to endoplasmic reticulum stress;cell redox homeostasis;protein folding;neutrophil degranulation;glycoprotein metabolic process	GO:000698; GO:003497; GO:004545; GO:000645; GO:004331; GO:000910	extracellular region;cell surface;endoplasmic reticulum lumen;specific granule lumen;endoplasmic reticulum-Golgi intermediate compartment;extracellular exosome	GO:000557; GO:000998; GO:000578; GO:003558; GO:000579; GO:007006	"NA"	"NA"	protein binding;protein disulfide isomerase activity	GO:000551; GO:000375
XP_005669925.1;XP_020923975.1;XP_020923974.1;NP_001131102.1	XP_005669925.1;XP_020923975.1;XP_020923974.1;NP_001131102.1	XP_005669925.1 cytoplasmic protein NCK1 isoform X2 [Sus scrofa];XP_020923975.1 cytoplasmic protein NCK1 isoform X1 [Sus scrofa];XP_020923974.1 cytoplasmic protein NCK1 isoform X1 [Sus scrofa];NP_001131102.1 cytoplasmic protein NCK1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6496800	NA	NA	NA	NCK1	NCK1;NCK1;NCK1;NCK1;NA	response to other organism;positive regulation of cap-independent translational initiation;actin filament organization;positive regulation of actin filament polymerization;positive regulation of translation in response to endoplasmic reticulum stress;positive regulation of transcription from RNA polymerase II promoter;Fc-gamma receptor signaling pathway involved in phagocytosis;negative regulation of cell death;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;negative regulation of PERK-mediated unfolded protein response;T cell receptor signaling pathway;negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;substrate-dependent cell migration, cell extension;signal complex assembly;positive regulation of neuron projection development;lamellipodium assembly;regulation of cell migration;negative regulation of insulin receptor signaling pathway;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;positive regulation of T cell proliferation;ephrin receptor signaling pathway;negative regulation of protein kinase activity;negative regulation of peptidyl-serine phosphorylation;T cell activation;peptidyl-serine dephosphorylation	GO:005170; GO:190367; GO:000701; GO:003083; GO:003649; GO:004594; GO:003809; GO:006054; GO:199044; GO:190389; GO:005085; GO:190391; GO:000693; GO:000717; GO:001097; GO:003003; GO:003033; GO:004662; GO:190223; GO:004210; GO:004801; GO:000646; GO:003313; GO:004211; GO:007026	nucleus;cell-cell junction;vesicle membrane;cytoplasm;ribosome;protein phosphatase type 1 complex;cytosol;endoplasmic reticulum;plasma membrane	GO:000563; GO:000591; GO:001250; GO:000573; GO:000584; GO:000016; GO:000582; GO:000578; GO:000588	 Pathogenic Escherichia coli infection; Axon guidance; ErbB signaling pathway; T cell receptor signaling pathway	hsa0513; hsa0436; hsa0401; hsa0466	SH3/SH2 adaptor activity;receptor tyrosine kinase binding;cadherin binding;eukaryotic initiation factor eIF2 binding;protein domain specific binding;protein binding, bridging;receptor signaling complex scaffold activity;protein kinase inhibitor activity;cytoskeletal adaptor activity;binding, bridging;receptor binding;ephrin receptor binding;protein binding	GO:000507; GO:003097; GO:004529; GO:007107; GO:001990; GO:003067; GO:003015; GO:000486; GO:000809; GO:006009; GO:000510; GO:004687; GO:000551
NP_001131106.1	NP_001131106.1	NP_001131106.1 vacuolar protein sorting-associated protein 26B [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15793000	NA	NA	NA	VPS26B	VPS26B;NA;NA;NA;NA	regulation of macroautophagy;intracellular protein transport;cellular response to interferon-gamma;retrograde transport, endosome to Golgi	GO:001624; GO:000688; GO:007134; GO:004214	cytosol;late endosome;early endosome;phagocytic vesicle;retromer complex	GO:000582; GO:000577; GO:000576; GO:004533; GO:003090	 Endocytosis	hsa0414	protein binding;protein transporter activity	GO:000551; GO:000856
NP_001131108.1;XP_020921698.1	NP_001131108.1;XP_020921698.1	NP_001131108.1 adapter molecule crk [Sus scrofa];XP_020921698.1 adapter molecule crk isoform X2 [Sus scrofa]	8	8	1	46725000	52879000	49213000	58264000	42614000	49667000	48817000	61387000	66618000	54586000	54493000	69124000	64483000	50227000	57072000	57005000	51319000	43203000	NA	NA	NA	CRK	CRK;CRK;NA;NA;NA	hippocampus development;Fc-gamma receptor signaling pathway involved in phagocytosis;negative regulation of wound healing;response to cholecystokinin;regulation of GTPase activity;cellular response to nitric oxide;activation of GTPase activity;regulation of T cell migration;establishment of cell polarity;vascular endothelial growth factor receptor signaling pathway;cytokine-mediated signaling pathway;cellular response to insulin-like growth factor stimulus;cellular response to endothelin;regulation of signal transduction;positive regulation of smooth muscle cell migration;cerebellar neuron development;regulation of cell adhesion mediated by integrin;negative regulation of natural killer cell mediated cytotoxicity;cellular response to nerve growth factor stimulus;response to hepatocyte growth factor;regulation of protein binding;cell chemotaxis;regulation of transcription from RNA polymerase II promoter;regulation of actin cytoskeleton organization;negative regulation of cell motility;neuron migration;response to yeast;regulation of cell shape;reelin-mediated signaling pathway;lipid metabolic process;cellular response to transforming growth factor beta stimulus;activation of MAPKK activity;dendrite development;cerebral cortex development;helper T cell diapedesis;regulation of dendrite development;response to hydrogen peroxide;regulation of Rac protein signal transduction;positive regulation of substrate adhesion-dependent cell spreading	GO:002176; GO:003809; GO:006104; GO:006184; GO:004308; GO:007173; GO:009063; GO:200040; GO:003001; GO:004801; GO:001922; GO:199031; GO:199085; GO:000996; GO:001491; GO:009874; GO:003362; GO:004595; GO:199009; GO:003572; GO:004339; GO:006032; GO:000635; GO:003295; GO:200014; GO:000176; GO:000187; GO:000836; GO:003802; GO:000662; GO:007156; GO:000018; GO:001635; GO:002198; GO:003568; GO:005077; GO:004254; GO:003502; GO:190002	extracellular exosome;cytosol;macromolecular complex;nucleus;actin cytoskeleton;cytoplasm;plasma membrane;membrane raft	GO:007006; GO:000582; GO:003299; GO:000563; GO:001562; GO:000573; GO:000588; GO:004512	 Regulation of actin cytoskeleton; Focal adhesion; ErbB signaling pathway; Bacterial invasion of epithelial cells; Fc gamma R-mediated phagocytosis; Chemokine signaling pathway; Pathways in cancer; Neurotrophin signaling pathway; Insulin signaling pathway; Shigellosis; Chronic myeloid leukemia; Renal cell carcinoma	hsa0481; hsa0451; hsa0401; hsa0510; hsa0466; hsa0406; hsa0520; hsa0472; hsa0491; hsa0513; hsa0522; hsa0521	cytoskeletal protein binding;protein self-association;phosphotyrosine binding;SH2 domain binding;protein tyrosine kinase binding;insulin-like growth factor receptor binding;ephrin receptor binding;protein binding;scaffold protein binding;SH3/SH2 adaptor activity;SH3 domain binding;protein phosphorylated amino acid binding	GO:000809; GO:004362; GO:000178; GO:004216; GO:199078; GO:000515; GO:004687; GO:000551; GO:009711; GO:000507; GO:001712; GO:004530
XP_020941254.1;NP_001131111.1;XP_020941253.1	XP_020941254.1;NP_001131111.1;XP_020941253.1	XP_020941254.1 Na(+)/H(+) exchange regulatory cofactor NHE-RF2 isoform X2 [Sus scrofa];NP_001131111.1 Na(+)/H(+) exchange regulatory cofactor NHE-RF2 [Sus scrofa];XP_020941253.1 Na(+)/H(+) exchange regulatory cofactor NHE-RF2 isoform X1 [Sus scrofa]	5	5	5	16038000	0	22234000	17733000	13342000	20013000	17362000	24730000	19461000	0	0	15455000	7226400	15971000	0	22930000	14131000	14307000	NA	NA	NA	SLC9A3R2	SLC9A3R2;SLC9A3R2;SLC9A3R2;NA;NA	macromolecular complex assembly	GO:006500	extracellular exosome;endomembrane system;focal adhesion;plasma membrane;apical plasma membrane;nucleus	GO:007006; GO:001250; GO:000592; GO:000588; GO:001632; GO:000563	 Aldosterone-regulated sodium reabsorption	hsa0496	phosphatase binding;beta-catenin binding;protein C-terminus binding;protein complex scaffold;cadherin binding;receptor binding;protein binding	GO:001990; GO:000801; GO:000802; GO:003294; GO:004529; GO:000510; GO:000551
NP_001132943.1;XP_020953698.1;XP_020953697.1	NP_001132943.1;XP_020953698.1;XP_020953697.1	NP_001132943.1 DNA-(apurinic or apyrimidinic site) lyase [Sus scrofa];XP_020953698.1 DNA-(apurinic or apyrimidinic site) lyase isoform X1 [Sus scrofa];XP_020953697.1 DNA-(apurinic or apyrimidinic site) lyase isoform X1 [Sus scrofa]	9	9	9	0	20211000	12118000	24643000	25311000	20214000	24077000	21824000	24357000	18166000	17926000	32687000	18814000	18409000	24156000	32114000	25628000	24693000	NA	NA	NA	APEX1	APEX1;APEX1;APEX1;NA;NA	positive regulation of G1/S transition of mitotic cell cycle;DNA repair;negative regulation of smooth muscle cell migration;cellular response to cAMP;aging;regulation of apoptotic process;cell redox homeostasis;cellular response to hydrogen peroxide;cellular response to peptide hormone stimulus;negative regulation of nucleic acid-templated transcription;DNA demethylation;regulation of mRNA stability;oxidation-reduction process;DNA recombination;telomere maintenance;RNA phosphodiester bond hydrolysis, endonucleolytic;telomere maintenance via base-excision repair	GO:190008; GO:000628; GO:001491; GO:007132; GO:000756; GO:004298; GO:004545; GO:007030; GO:007137; GO:190350; GO:008011; GO:004348; GO:005511; GO:000631; GO:000072; GO:009050; GO:009769	transcription factor complex;endoplasmic reticulum;perinuclear region of cytoplasm;nucleolus;nuclear speck;nucleus;centrosome;ribosome;nuclear chromosome, telomeric region;nucleoplasm	GO:000566; GO:000578; GO:004847; GO:000573; GO:001660; GO:000563; GO:000581; GO:000584; GO:000078; GO:000565	 Base excision repair	hsa0341	DNA-(apurinic or apyrimidinic site) lyase activity;protein binding;metal ion binding;DNA binding;transcription corepressor activity;endonuclease activity;double-stranded telomeric DNA binding;RNA-DNA hybrid ribonuclease activity;NF-kappaB binding;damaged DNA binding;double-stranded DNA exodeoxyribonuclease activity;chromatin DNA binding;RNA binding;uracil DNA N-glycosylase activity;phosphoric diester hydrolase activity;oxidoreductase activity;macromolecular complex binding;site-specific endodeoxyribonuclease activity, specific for altered base;double-stranded DNA 3'-5' exodeoxyribonuclease activity;3'-5' exonuclease activity	GO:000390; GO:000551; GO:004687; GO:000367; GO:000371; GO:000451; GO:000369; GO:000452; GO:005105; GO:000368; GO:000830; GO:003149; GO:000372; GO:000484; GO:000808; GO:001649; GO:004487; GO:001689; GO:000831; GO:000840
NP_001132944.1	NP_001132944.1	NP_001132944.1 proteasome subunit alpha type-6 [Sus scrofa]	7	7	7	198020000	196560000	212690000	187300000	164180000	158950000	222350000	191720000	190710000	165810000	187350000	161430000	162810000	185470000	200830000	197660000	181910000	168980000	NA	NA	NA	PSMA6	PSMA6;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of NF-kappaB transcription factor activity;regulation of inflammatory response;proteasomal protein catabolic process;protein deubiquitination;proteolysis involved in cellular protein catabolic process;post-translational protein modification	GO:001049; GO:004316; GO:005109; GO:005072; GO:001049; GO:001657; GO:005160; GO:004368	proteasome complex;P-body;nucleus;polysome;cytosol;nuclear matrix;myofibril;proteasome core complex;cytoplasm;extracellular exosome;nucleoplasm;proteasome core complex, alpha-subunit complex	GO:000050; GO:000093; GO:000563; GO:000584; GO:000582; GO:001636; GO:003001; GO:000583; GO:000573; GO:007006; GO:000565; GO:001977	 Proteasome	hsa0305	RNA binding;endopeptidase activity;protein binding;NF-kappaB binding;threonine-type endopeptidase activity;purine ribonucleoside triphosphate binding	GO:000372; GO:000417; GO:000551; GO:005105; GO:000429; GO:003563
NP_001135462.1;XP_020921824.1;NP_001230387.1	NP_001135462.1;XP_020921824.1;NP_001230387.1	NP_001135462.1 60S ribosomal protein L26-like 1 [Sus scrofa];XP_020921824.1 60S ribosomal protein L26 isoform X1 [Sus scrofa];NP_001230387.1 60S ribosomal protein L26 [Sus scrofa]	4	4	4	40036000	58090000	69025000	38756000	41032000	71498000	50725000	49778000	45451000	59428000	39737000	0	43300000	59757000	33689000	51562000	52606000	57299000	NA	NA	NA	RPL26L1	RPL26L1;RPL26;RPL26;NA;NA	ribosomal large subunit biogenesis;cytoplasmic translation	GO:004227; GO:000218	cytosolic large ribosomal subunit;extracellular exosome	GO:002262; GO:007006	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
NP_001136140.1	NP_001136140.1	NP_001136140.1 H/ACA ribonucleoprotein complex subunit 4 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1466700	0	0	0	0	0	0	NA	NA	NA	DKC1	DKC1;NA;NA;NA;NA	positive regulation of telomerase RNA localization to Cajal body;mRNA pseudouridine synthesis;RNA processing;snRNA pseudouridine synthesis;scaRNA localization to Cajal body;regulation of telomerase RNA localization to Cajal body;positive regulation of telomere maintenance via telomerase;positive regulation of establishment of protein localization to telomere;box H/ACA snoRNA 3'-end processing;telomere maintenance via telomerase;rRNA pseudouridine synthesis;positive regulation of telomerase activity;enzyme-directed rRNA pseudouridine synthesis;rRNA processing	GO:190487; GO:199048; GO:000639; GO:003112; GO:009066; GO:190487; GO:003221; GO:190485; GO:000049; GO:000700; GO:003111; GO:005197; GO:000045; GO:000636	nucleus;box H/ACA scaRNP complex;telomerase holoenzyme complex;box H/ACA telomerase RNP complex;cytoplasm;box H/ACA snoRNP complex;fibrillar center;nucleoplasm	GO:000563; GO:007258; GO:000569; GO:009066; GO:000573; GO:003142; GO:000165; GO:000565	 Ribosome biogenesis in eukaryotes	hsa0300	protein binding;telomerase RNA binding;box H/ACA snoRNA binding;telomerase activity;pseudouridine synthase activity	GO:000551; GO:007003; GO:003451; GO:000372; GO:000998
XP_013840333.2;XP_005672616.2;NP_001136301.1;XP_020932183.1;XP_005672615.2	XP_013840333.2;XP_005672616.2;NP_001136301.1;XP_020932183.1;XP_005672615.2	XP_013840333.2 complement C1q tumor necrosis factor-related protein 2 isoform X3 [Sus scrofa];XP_005672616.2 complement C1q tumor necrosis factor-related protein 2 isoform X3 [Sus scrofa];NP_001136301.1 complement C1q tumor necrosis factor-related protein	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7977600	NA	NA	NA	C1QTNF2	C1QTNF2;C1QTNF2;C1QTNF2;C1QTNF2;C1QTNF2	positive regulation of glucose import;positive regulation of fatty acid oxidation;protein homooligomerization;positive regulation of glycogen biosynthetic process;protein heterotrimerization;activation of MAPK activity	GO:004632; GO:004632; GO:005126; GO:004572; GO:007020; GO:000018	collagen trimer;extracellular space	GO:000558; GO:000561	"NA"	"NA"	identical protein binding;protein binding;receptor binding	GO:004280; GO:000551; GO:000510
XP_020932184.1;NP_001136304.1	XP_020932184.1;NP_001136304.1	XP_020932184.1 methionine adenosyltransferase 2 subunit beta isoform X1 [Sus scrofa];NP_001136304.1 methionine adenosyltransferase 2 subunit beta [Sus scrofa]	3	3	3	16305000	0	0	0	17044000	0	0	0	0	0	0	0	19421000	0	16186000	0	0	17755000	NA	NA	NA	MAT2B	MAT2B;MAT2B;NA;NA;NA	S-adenosylmethionine biosynthetic process;one-carbon metabolic process;regulation of catalytic activity	GO:000655; GO:000673; GO:005079	extracellular exosome;methionine adenosyltransferase complex;cytosol;nucleus	GO:007006; GO:004826; GO:000582; GO:000563	 Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of amino acids	hsa0027; hsa0110; hsa0123	enzyme binding;methionine adenosyltransferase regulator activity;protein binding	GO:001989; GO:004827; GO:000551
NP_001136313.1	NP_001136313.1	NP_001136313.1 galactoside-binding soluble lectin 13 [Sus scrofa]	3	3	3	0	0	0	55104000	0	0	0	0	0	26794000	0	63812000	0	0	0	35514000	0	0	NA	NA	NA	LGALS13	LGALS13;NA;NA;NA;NA	positive regulation of T cell apoptotic process;phospholipid metabolic process;apoptotic process	GO:007023; GO:000664; GO:000691	cytoplasm;nuclear matrix	GO:000573; GO:001636	"NA"	"NA"	protein binding;lysophospholipase activity;carbohydrate binding	GO:000551; GO:000462; GO:003024
XP_020935074.1;NP_001137180.1;XP_005673582.1;XP_013841487.1;XP_013841486.1;XP_013841485.1;XP_005673581.2;XP_013841484.1;XP_013841483.1;XP_013841482.1	XP_020935074.1;NP_001137180.1;XP_005673582.1;XP_013841487.1;XP_013841486.1;XP_013841485.1;XP_005673581.2;XP_013841484.1;XP_013841483.1;XP_013841482.1	XP_020935074.1 glycerol kinase isoform X9 [Sus scrofa];NP_001137180.1 glycerol kinase [Sus scrofa];XP_005673582.1 glycerol kinase isoform X8 [Sus scrofa];XP_013841487.1 glycerol kinase isoform X7 [Sus scrofa];XP_013841486.1 glycerol kinase isoform X6 [Sus	9	9	9	0	17221000	57136000	0	24647000	0	38626000	0	47649000	33838000	32628000	0	26495000	0	20008000	25336000	0	0	NA	NA	NA	GK	GK;GK;GK;GK;GK	glycerol metabolic process;glycerol-3-phosphate biosynthetic process;triglyceride metabolic process;phosphorylation;glycerol catabolic process;triglyceride biosynthetic process	GO:000607; GO:004616; GO:000664; GO:001631; GO:001956; GO:001943	mitochondrial outer membrane;cytoplasm;cytosol;extracellular exosome	GO:000574; GO:000573; GO:000582; GO:007006	 Metabolic pathways; PPAR signaling pathway; Glycerolipid metabolism	hsa0110; hsa0332; hsa0056	glycerol kinase activity;ATP binding;protein binding	GO:000437; GO:000552; GO:000551
NP_001137188.1	NP_001137188.1	NP_001137188.1 dual specificity mitogen-activated protein kinase kinase 1 [Sus scrofa]	4	2	2	0	0	0	0	0	0	0	0	0	7968600	0	0	0	0	0	0	0	0	NA	NA	NA	MAP2K1	MAP2K1;NA;NA;NA;NA	epithelial cell proliferation involved in lung morphogenesis;MAPK cascade;chemotaxis;signal transduction;heart development;positive regulation of ERK1 and ERK2 cascade;regulation of Golgi inheritance;negative regulation of cell proliferation;regulation of axon regeneration;face development;positive regulation of gene expression;peptidyl-tyrosine phosphorylation;keratinocyte differentiation;thyroid gland development;stress-activated protein kinase signaling cascade;placenta blood vessel development;positive regulation of protein serine/threonine kinase activity;cerebellar cortex formation;neuron differentiation;activation of protein kinase activity;regulation of stress-activated MAPK cascade;positive regulation of axonogenesis;labyrinthine layer development;regulation of early endosome to late endosome transport;signal transduction by protein phosphorylation;positive regulation of transcription, DNA-templated;Bergmann glial cell differentiation;trachea formation;cellular senescence;cell motility;positive regulation of production of miRNAs involved in gene silencing by miRNA;activation of MAPK activity;protein phosphorylation;cell cycle arrest;thymus development	GO:006050; GO:000016; GO:000693; GO:000716; GO:000750; GO:007037; GO:009017; GO:000828; GO:004867; GO:006032; GO:001062; GO:001810; GO:003021; GO:003087; GO:003109; GO:006067; GO:007190; GO:002169; GO:003018; GO:003214; GO:003287; GO:005077; GO:006071; GO:200064; GO:002301; GO:004589; GO:006002; GO:006044; GO:009039; GO:004887; GO:190380; GO:000018; GO:000646; GO:000705; GO:004853	cytoplasm;plasma membrane;focal adhesion;mitochondrion;endoplasmic reticulum;Golgi apparatus;nucleus;microtubule organizing center;cytosol;early endosome;late endosome	GO:000573; GO:000588; GO:000592; GO:000573; GO:000578; GO:000579; GO:000563; GO:000581; GO:000582; GO:000576; GO:000577	 MAPK signaling pathway; Focal adhesion; Natural killer cell mediated cytotoxicity; Neurotrophin signaling pathway; Estrogen signaling pathway; Pathways in cancer; Thyroid cancer; Central carbon metabolism in cancer; FoxO signaling pathway; VEGF signaling pathway; Toll-like receptor signaling pathway; Rap1 signaling pathway; cAMP signaling pathway; Vascular smooth muscle contraction; Fc epsilon RI signaling pathway; Prion diseases; Alcoholism; Influenza A; Oocyte meiosis; Dorso-ventral axis formation; Osteoclast differentiation; Long-term depression; Signaling pathways regulating pluripotency of stem cells; Regulation of actin cytoskeleton; Non-small cell lung cancer; PI3K-Akt signaling pathway; Sphingolipid signaling pathway; Gap junction; Oxytocin signaling pathway	hsa0401; hsa0451; hsa0465; hsa0472; hsa0491; hsa0520; hsa0521; hsa0523; hsa0406; hsa0437; hsa0462; hsa0401; hsa0402; hsa0427; hsa0466; hsa0502; hsa0503; hsa0516; hsa0411; hsa0432; hsa0438; hsa0473; hsa0455; hsa0481; hsa0522; hsa0415; hsa0407; hsa0454; hsa0492	protein serine/threonine kinase activity;protein tyrosine kinase activity;protein N-terminus binding;MAP kinase kinase activity;protein C-terminus binding;protein kinase activity;ATP binding;scaffold protein binding;protein binding;protein serine/threonine kinase activator activity	GO:000467; GO:000471; GO:004748; GO:000470; GO:000802; GO:000467; GO:000552; GO:009711; GO:000551; GO:004353
XP_013837467.1;NP_001137190.1;XP_020923995.1;XP_013837468.2	XP_013837467.1;NP_001137190.1;XP_020923995.1;XP_013837468.2	XP_013837467.1 monoglyceride lipase isoform X1 [Sus scrofa];NP_001137190.1 monoglyceride lipase [Sus scrofa];XP_020923995.1 monoglyceride lipase isoform X2 [Sus scrofa];XP_013837468.2 monoglyceride lipase isoform X2 [Sus scrofa]	17	17	17	330030000	220790000	602360000	315010000	498960000	269490000	403770000	242080000	458480000	270370000	396490000	453910000	166770000	198040000	473930000	599760000	257350000	168810000	NA	NA	NA	MGLL	MGLL;MGLL;MGLL;MGLL;NA	regulation of inflammatory response;acylglycerol catabolic process;regulation of signal transduction;inflammatory response;triglyceride catabolic process;regulation of endocannabinoid signaling pathway;fatty acid biosynthetic process;arachidonic acid metabolic process;acylglycerol acyl-chain remodeling;lipid metabolic process;regulation of sensory perception of pain	GO:005072; GO:004646; GO:000996; GO:000695; GO:001943; GO:200012; GO:000663; GO:001936; GO:003615; GO:000662; GO:005193	extrinsic component of membrane;plasma membrane;cytosol;endoplasmic reticulum membrane;nucleoplasm;membrane	GO:001989; GO:000588; GO:000582; GO:000578; GO:000565; GO:001602	 Metabolic pathways; Glycerolipid metabolism; Retrograde endocannabinoid signaling; Regulation of lipolysis in adipocytes	hsa0110; hsa0056; hsa0472; hsa0492	lysophospholipase activity;protein homodimerization activity;acylglycerol lipase activity	GO:000462; GO:004280; GO:004737
NP_001137196.1	NP_001137196.1	NP_001137196.1 Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [Sus scrofa]	6	6	6	0	0	0	0	0	0	92873000	0	0	0	0	0	0	0	0	0	118470000	0	NA	NA	NA	SLC9A3R1	SLC9A3R1;NA;NA;NA;NA	negative regulation of protein kinase B signaling;regulation of cell size;microvillus assembly;regulation of protein kinase activity;protein localization to plasma membrane;nuclear migration;negative regulation of platelet-derived growth factor receptor signaling pathway;gland morphogenesis;negative regulation of cell migration;regulation of excretion;negative regulation of cell proliferation;cellular phosphate ion homeostasis;establishment of epithelial cell apical/basal polarity;establishment of Golgi localization;renal absorption;positive regulation of ion transmembrane transport;phospholipase C-activating dopamine receptor signaling pathway;macromolecular complex assembly;negative regulation of ERK1 and ERK2 cascade;negative regulation of canonical Wnt signaling pathway;sensory perception of sound;regulation of sodium:proton antiporter activity;renal phosphate ion absorption;adenylate cyclase-activating dopamine receptor signaling pathway;Wnt signaling pathway;bile acid secretion;negative regulation of mitotic cell cycle;auditory receptor cell stereocilium organization;renal sodium ion transport;negative regulation of phosphatidylinositol 3-kinase signaling;glutathione transport;positive regulation of intrinsic apoptotic signaling pathway	GO:005189; GO:000836; GO:003003; GO:004585; GO:007265; GO:000709; GO:001064; GO:002261; GO:003033; GO:004406; GO:000828; GO:003064; GO:004519; GO:005168; GO:007029; GO:003476; GO:006015; GO:006500; GO:007037; GO:009009; GO:000760; GO:003241; GO:009729; GO:000719; GO:001605; GO:003278; GO:004593; GO:006008; GO:000309; GO:001406; GO:003463; GO:200124	apical plasma membrane;vesicle;perinuclear region of cytoplasm;microvillus;extracellular exosome;nucleus;filopodium;microvillus membrane;endomembrane system;membrane raft;actin cytoskeleton;cell periphery;ruffle;cytoplasm;membrane;stereocilium tip;sperm midpiece	GO:001632; GO:003198; GO:004847; GO:000590; GO:007006; GO:000563; GO:003017; GO:003152; GO:001250; GO:004512; GO:001562; GO:007194; GO:000172; GO:000573; GO:001602; GO:003242; GO:009722	"NA"	"NA"	receptor binding;beta-catenin binding;myosin II binding;chloride channel regulator activity;growth factor receptor binding;phosphatase binding;PDZ domain binding;protein self-association;protein N-terminus binding;beta-2 adrenergic receptor binding;protein complex scaffold;protein binding;macromolecular complex binding;dopamine receptor binding	GO:000510; GO:000801; GO:004515; GO:001708; GO:007085; GO:001990; GO:003016; GO:004362; GO:004748; GO:003169; GO:003294; GO:000551; GO:004487; GO:005078
NP_001137199.1;XP_013836086.1;XP_020921039.1;XP_005657651.1;XP_003133853.1;XP_020931687.1;XP_020931686.1;XP_020931685.1;XP_020931684.1;XP_020931683.1;XP_020931682.1;XP_020931681.1	NP_001137199.1;XP_013836086.1;XP_020921039.1;XP_005657651.1;XP_003133853.1;XP_020931687.1;XP_020931686.1;XP_020931685.1;XP_020931684.1;XP_020931683.1;XP_020931682.1;XP_020931681.1	NP_001137199.1 serine/threonine-protein kinase 26 [Sus scrofa];XP_013836086.1 serine/threonine-protein kinase 24 isoform X2 [Sus scrofa];XP_020921039.1 serine/threonine-protein kinase 24 isoform X1 [Sus scrofa];XP_005657651.1 serine/threonine-protein kinas	2	2	2	0	0	0	0	0	0	0	0	0	0	0	11509000	0	0	0	0	0	0	NA	NA	NA	STK25	STK25;STK25;STK25;STK25;STK25	activation of protein kinase activity;protein phosphorylation;stress-activated protein kinase signaling cascade;intrinsic apoptotic signaling pathway in response to hydrogen peroxide;positive regulation of stress-activated MAPK cascade;establishment of Golgi localization;positive regulation of axonogenesis;signal transduction;signal transduction by protein phosphorylation;Golgi reassembly;response to oxidative stress;response to hydrogen peroxide;Golgi localization;protein autophosphorylation	GO:003214; GO:000646; GO:003109; GO:003648; GO:003287; GO:005168; GO:005077; GO:000716; GO:002301; GO:009016; GO:000697; GO:004254; GO:005164; GO:004677	Golgi apparatus;cytoplasm;extracellular exosome;Golgi membrane	GO:000579; GO:000573; GO:007006; GO:000013	"NA"	"NA"	metal ion binding;protein kinase activity;ATP binding;protein homodimerization activity;protein binding	GO:004687; GO:000467; GO:000552; GO:004280; GO:000551
NP_001137594.1;XP_020921703.1	NP_001137594.1;XP_020921703.1	NP_001137594.1 alpha-sarcoglycan precursor [Sus scrofa];XP_020921703.1 alpha-sarcoglycan isoform X1 [Sus scrofa]	4	4	4	0	30502000	0	21150000	0	0	0	19953000	0	16567000	0	19050000	0	21402000	0	31273000	0	0	NA	NA	NA	SGCA	SGCA;SGCA;NA;NA;NA	muscle organ development;muscle contraction	GO:000751; GO:000693	membrane raft;integral component of membrane;cell-cell junction;cytoskeleton;sarcoglycan complex;cytoplasm;sarcolemma	GO:004512; GO:001602; GO:000591; GO:000585; GO:001601; GO:000573; GO:004238	 Viral myocarditis; Dilated cardiomyopathy	hsa0541; hsa0541	protein binding;calcium ion binding	GO:000551; GO:000550
XP_020932186.1;XP_020932185.1;NP_001137595.1	XP_020932186.1;XP_020932185.1;NP_001137595.1	XP_020932186.1 delta-sarcoglycan isoform X1 [Sus scrofa];XP_020932185.1 delta-sarcoglycan isoform X1 [Sus scrofa];NP_001137595.1 delta-sarcoglycan [Sus scrofa]	8	8	8	48271000	87155000	58964000	60948000	34647000	65210000	42442000	72617000	36279000	71902000	66690000	123830000	75455000	57305000	46036000	83646000	44308000	77178000	NA	NA	NA	SGCD	SGCD;SGCD;SGCD;NA;NA	muscle organ development;cell death;cardiac muscle fiber development;heart contraction;coronary vasculature morphogenesis;calcium-mediated signaling;calcium ion homeostasis;cardiac muscle cell contraction;cellular protein complex localization	GO:000751; GO:000821; GO:004873; GO:006004; GO:006097; GO:001972; GO:005507; GO:008600; GO:003462	sarcoplasmic reticulum;dystrophin-associated glycoprotein complex;sarcolemma;plasma membrane;integral component of membrane;cytoskeleton	GO:001652; GO:001601; GO:004238; GO:000588; GO:001602; GO:000585	 Viral myocarditis; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0541	"NA"	"NA"
XP_020957638.1;NP_001137596.1;XP_020957637.1;XP_020957636.1;XP_020957635.1;XP_020957634.1;XP_020957633.1;XP_020957632.1	XP_020957638.1;NP_001137596.1;XP_020957637.1;XP_020957636.1;XP_020957635.1;XP_020957634.1;XP_020957633.1;XP_020957632.1	XP_020957638.1 epsilon-sarcoglycan isoform X7 [Sus scrofa];NP_001137596.1 epsilon-sarcoglycan [Sus scrofa];XP_020957637.1 epsilon-sarcoglycan isoform X6 [Sus scrofa];XP_020957636.1 epsilon-sarcoglycan isoform X5 [Sus scrofa];XP_020957635.1 epsilon-sarcogly	3	3	3	0	0	0	0	0	0	0	0	0	0	0	25535000	0	0	0	0	0	0	NA	NA	NA	SGCE	SGCE;SGCE;SGCE;SGCE;SGCE	cell-matrix adhesion;muscle organ development	GO:000716; GO:000751	cytoskeleton;sarcoglycan complex;sarcolemma;dendrite membrane;plasma membrane;Golgi apparatus	GO:000585; GO:001601; GO:004238; GO:003259; GO:000588; GO:000579	"NA"	"NA"	calcium ion binding	GO:000550
NP_001138313.1	NP_001138313.1	NP_001138313.1 hemoglobin subunit beta [Sus scrofa]	15	15	6	206930000000	57517000000	56929000000	103980000000	72203000000	42425000000	90914000000	73041000000	144430000000	62951000000	96480000000	62308000000	225070000000	79004000000	161160000000	45523000000	113990000000	41313000000	NA	NA	NA	HBB	HBB;NA;NA;NA;NA	blood coagulation;positive regulation of cell death;bicarbonate transport;hydrogen peroxide catabolic process;regulation of blood vessel size;platelet aggregation;oxygen transport;neutrophil degranulation;protein heterooligomerization;renal absorption;cellular oxidant detoxification;receptor-mediated endocytosis;positive regulation of nitric oxide biosynthetic process;nitric oxide transport;response to hydrogen peroxide;regulation of blood pressure	GO:000759; GO:001094; GO:001570; GO:004274; GO:005088; GO:007052; GO:001567; GO:004331; GO:005129; GO:007029; GO:009886; GO:000689; GO:004542; GO:003018; GO:004254; GO:000821	extracellular region;extracellular space;cytosol;hemoglobin complex;endocytic vesicle lumen;extracellular exosome;tertiary granule lumen;ficolin-1-rich granule lumen;haptoglobin-hemoglobin complex;blood microparticle	GO:000557; GO:000561; GO:000582; GO:000583; GO:007168; GO:007006; GO:190472; GO:190481; GO:003183; GO:007256	 Malaria; African trypanosomiasis	hsa0514; hsa0514	metal ion binding;haptoglobin binding;peroxidase activity;oxygen transporter activity;protein binding;oxygen binding;heme binding;hemoglobin binding;organic acid binding	GO:004687; GO:003172; GO:000460; GO:000534; GO:000551; GO:001982; GO:002003; GO:003049; GO:004317
NP_001138314.1	NP_001138314.1	NP_001138314.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8779300	0	0	NA	NA	NA	NDUFB8	NDUFB8;NA;NA;NA;NA	mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:000612	integral component of membrane;mitochondrial respiratory chain complex I;endoplasmic reticulum;mitochondrial matrix;mitochondrion	GO:001602; GO:000574; GO:000578; GO:000575; GO:000573	 Huntington's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Oxidative phosphorylation	hsa0501; hsa0110; hsa0493; hsa0501; hsa0019	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_020944406.1;NP_001138373.1;XP_020944407.1	XP_020944406.1;NP_001138373.1;XP_020944407.1	XP_020944406.1 proteasome subunit alpha type-5 isoform X1 [Sus scrofa];NP_001138373.1 proteasome subunit alpha type-5 [Sus scrofa];XP_020944407.1 proteasome subunit alpha type-5 isoform X2 [Sus scrofa]	8	8	8	151880000	157600000	152760000	170730000	158270000	134200000	175720000	178240000	171690000	138540000	141220000	162550000	142230000	138920000	188790000	154750000	159730000	128950000	NA	NA	NA	PSMA5	PSMA5;PSMA5;PSMA5;NA;NA	post-translational protein modification;proteasomal protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;protein deubiquitination;neutrophil degranulation	GO:004368; GO:001049; GO:004316; GO:001657; GO:004331	secretory granule lumen;cytosol;proteasome core complex;proteasome core complex, alpha-subunit complex;ficolin-1-rich granule lumen;proteasome complex;nucleus;nucleoplasm;cytoplasm;extracellular exosome;extracellular region	GO:003477; GO:000582; GO:000583; GO:001977; GO:190481; GO:000050; GO:000563; GO:000565; GO:000573; GO:007006; GO:000557	 Proteasome	hsa0305	endopeptidase activity;threonine-type endopeptidase activity;protein binding	GO:000417; GO:000429; GO:000551
NP_001138374.1	NP_001138374.1	NP_001138374.1 proteasome subunit beta type-3 [Sus scrofa]	6	6	6	99772000	52391000	68477000	79164000	76286000	37926000	82494000	72594000	82063000	59212000	84702000	32541000	73522000	54711000	82731000	64317000	66998000	58056000	NA	NA	NA	PSMB3	PSMB3;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;protein deubiquitination;viral process;proteasomal protein catabolic process	GO:001049; GO:004316; GO:004368; GO:001657; GO:001603; GO:001049	proteasome core complex;proteasome complex;nucleus;nucleoplasm;cytoplasm;proteasome core complex, beta-subunit complex;extracellular exosome;cytosol	GO:000583; GO:000050; GO:000563; GO:000565; GO:000573; GO:001977; GO:007006; GO:000582	 Proteasome	hsa0305	endopeptidase activity;threonine-type endopeptidase activity;protein binding	GO:000417; GO:000429; GO:000551
NP_001138398.2;XP_020921914.1	NP_001138398.2;XP_020921914.1	NP_001138398.2 proteasome subunit beta type-6 [Sus scrofa];XP_020921914.1 proteasome subunit beta type-6 isoform X1 [Sus scrofa]	4	4	4	103410000	71889000	84936000	84177000	58415000	64296000	81413000	63741000	84962000	61209000	66200000	97611000	60746000	78397000	86454000	40311000	65165000	36709000	NA	NA	NA	PSMB6	PSMB6;PSMB6;NA;NA;NA	proteasomal protein catabolic process;viral process;proteasomal ubiquitin-independent protein catabolic process;protein deubiquitination;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:001049; GO:001603; GO:001049; GO:001657; GO:004368; GO:004316	proteasome core complex;proteasome core complex, beta-subunit complex;extracellular exosome;nucleus;cytosol;proteasome complex;nucleoplasm;cytoplasm	GO:000583; GO:001977; GO:007006; GO:000563; GO:000582; GO:000050; GO:000565; GO:000573	 Proteasome	hsa0305	endopeptidase activity;threonine-type endopeptidase activity;cadherin binding	GO:000417; GO:000429; GO:004529
NP_001138491.1	NP_001138491.1	NP_001138491.1 glycerol-3-phosphate acyltransferase 6 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6517700	0	NA	NA	NA	GPAT4	GPAT4;NA;NA;NA;NA	acyl-CoA metabolic process;lactation;diacylglycerol metabolic process;glandular epithelial cell maturation;phosphatidylcholine biosynthetic process;triglyceride biosynthetic process;fatty acid metabolic process;lipid biosynthetic process;CDP-diacylglycerol biosynthetic process;regulation of multicellular organism growth	GO:000663; GO:000759; GO:004633; GO:000207; GO:000665; GO:001943; GO:000663; GO:000861; GO:001602; GO:004001	membrane;endoplasmic reticulum;integral component of membrane	GO:001602; GO:000578; GO:001602	 Metabolic pathways; Glycerolipid metabolism	hsa0110; hsa0056	1-acylglycerol-3-phosphate O-acyltransferase activity;glycerol-3-phosphate O-acyltransferase activity	GO:000384; GO:000436
NP_001138693.1	NP_001138693.1	NP_001138693.1 ADP-ribosylation factor 5 [Sus scrofa]	8	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3823300	+	NA	NA	ARF5	ARF5;NA;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;vesicle-mediated transport;intracellular protein transport;Golgi to plasma membrane transport	GO:000689; GO:001619; GO:000688; GO:000689	cytoplasm;perinuclear region of cytoplasm;Golgi apparatus;plasma membrane;extracellular exosome	GO:000573; GO:004847; GO:000579; GO:000588; GO:007006	 Endocytosis	hsa0414	GTPase activity;protein binding;GTP binding	GO:000392; GO:000551; GO:000552
NP_001138694.1	NP_001138694.1	NP_001138694.1 retinoid-binding protein 7 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	7542900	0	0	0	0	0	0	0	0	0	NA	NA	NA	RBP7	RBP7;NA;NA;NA;NA	"NA"	"NA"	cytoplasm	GO:000573	"NA"	"NA"	protein binding;retinal binding;retinol binding	GO:000551; GO:001691; GO:001984
XP_005665847.1;NP_001138849.1	XP_005665847.1;NP_001138849.1	XP_005665847.1 casein kinase II subunit beta isoform X1 [Sus scrofa];NP_001138849.1 casein kinase II subunit beta [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9146000	0	0	NA	NA	NA	CSNK2B	CSNK2B;CSNK2B;NA;NA;NA	response to testosterone;negative regulation of blood vessel endothelial cell migration;cellular macromolecular complex assembly;positive regulation of activin receptor signaling pathway;Wnt signaling pathway;positive regulation of pathway-restricted SMAD protein phosphorylation;liver regeneration;adiponectin-activated signaling pathway;neutrophil degranulation;regulation of protein kinase activity;endothelial tube morphogenesis;signal transduction;negative regulation of cell proliferation;regulation of DNA binding;regulation of signal transduction by p53 class mediator;peptidyl-threonine phosphorylation	GO:003357; GO:004353; GO:003462; GO:003292; GO:001605; GO:001086; GO:009742; GO:003321; GO:004331; GO:004585; GO:006115; GO:000716; GO:000828; GO:005110; GO:190179; GO:001810	plasma membrane;cytosol;cytoplasm;extracellular exosome;PcG protein complex;chromatin;nuclear matrix;secretory granule lumen;nucleoplasm;nucleus;cilium;extracellular region;protein kinase CK2 complex;ficolin-1-rich granule lumen	GO:000588; GO:000582; GO:000573; GO:007006; GO:003151; GO:000078; GO:001636; GO:003477; GO:000565; GO:000563; GO:000592; GO:000557; GO:000595; GO:190481	 Wnt signaling pathway; NF-kappa B signaling pathway; Tight junction; Herpes simplex infection; Ribosome biogenesis in eukaryotes; Adherens junction	hsa0431; hsa0406; hsa0453; hsa0516; hsa0300; hsa0452	protein binding;protein domain specific binding;metal ion binding;transcription factor binding;identical protein binding;ribonucleoprotein complex binding;chromatin binding;receptor binding;protein serine/threonine kinase activity;protein kinase regulator activity	GO:000551; GO:001990; GO:004687; GO:000813; GO:004280; GO:004302; GO:000368; GO:000510; GO:000467; GO:001988
NP_001138854.1	NP_001138854.1	NP_001138854.1 large proline-rich protein BAG6 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	2749000	0	0	0	0	0	NA	NA	NA	BAG6	BAG6;NA;NA;NA;NA	kidney development;ubiquitin-dependent ERAD pathway;negative regulation of proteolysis;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;ER-associated misfolded protein catabolic process;apoptotic process;cell differentiation;ubiquitin-dependent protein catabolic process;negative regulation of apoptotic process;regulation of embryonic development;tail-anchored membrane protein insertion into ER membrane;spermatogenesis;internal peptidyl-lysine acetylation;protein stabilization;maintenance of unfolded protein involved in ERAD pathway;synaptonemal complex assembly;brain development;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;proteasomal protein catabolic process;lung development;regulation of cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of ERAD pathway;chromatin organization;immune response-activating cell surface receptor signaling pathway;natural killer cell activation	GO:000182; GO:003043; GO:004586; GO:007005; GO:007171; GO:000691; GO:003015; GO:000651; GO:004306; GO:004599; GO:007181; GO:000728; GO:001839; GO:005082; GO:190437; GO:000713; GO:000742; GO:003243; GO:001049; GO:003032; GO:004212; GO:004277; GO:190429; GO:000632; GO:000242; GO:003010	cytoplasm;nucleoplasm;cytosol;intracellular membrane-bounded organelle;extracellular exosome;BAT3 complex;nucleus;membrane	GO:000573; GO:000565; GO:000582; GO:004323; GO:007006; GO:007181; GO:000563; GO:001602	"NA"	"NA"	receptor binding;ubiquitin protein ligase binding;ribosome binding;ubiquitin-specific protease binding;misfolded protein binding;Hsp70 protein binding;polyubiquitin binding;proteasome binding;protein binding	GO:000510; GO:003162; GO:004302; GO:199038; GO:005178; GO:003054; GO:003159; GO:007062; GO:000551
NP_001138857.1	NP_001138857.1	NP_001138857.1 dynein light chain Tctex-type 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DYNLT1	DYNLT1;NA;NA;NA;NA	establishment of mitotic spindle orientation;intracellular transport of viral protein in host cell;regulation of G-protein coupled receptor protein signaling pathway;negative regulation of neurogenesis;viral entry into host cell;cell division;microtubule-dependent intracellular transport of viral material towards nucleus;neutrophil degranulation	GO:000013; GO:001906; GO:000827; GO:005076; GO:004671; GO:005130; GO:007552; GO:004331	cytoplasmic microtubule;secretory granule lumen;host cell;spindle;cytoplasmic dynein complex;extracellular region;Golgi apparatus;ficolin-1-rich granule lumen;secretory vesicle	GO:000588; GO:003477; GO:004365; GO:000581; GO:000586; GO:000557; GO:000579; GO:190481; GO:009950	"NA"	"NA"	motor activity;identical protein binding;protein binding	GO:000377; GO:004280; GO:000551
XP_020948917.1;XP_020948916.1;XP_020948915.1;NP_001138859.1	XP_020948917.1;XP_020948916.1;XP_020948915.1;NP_001138859.1	XP_020948917.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X1 [Sus scrofa];XP_020948916.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X1 [Sus scrofa];XP_020948915.1 guanine nucleotide-binding pr	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6650000	NA	NA	NA	GNG12	GNG12;GNG12;GNG12;GNG12;NA	G-protein coupled receptor signaling pathway;response to lipopolysaccharide;signal transduction;cerebral cortex development	GO:000718; GO:003249; GO:000716; GO:002198	extracellular exosome;plasma membrane;heterotrimeric G-protein complex	GO:007006; GO:000588; GO:000583	 Ras signaling pathway; Retrograde endocannabinoid signaling; PI3K-Akt signaling pathway; Chemokine signaling pathway; Regulation of actin cytoskeleton; Pathways in cancer; MAPK signaling pathway; Morphine addiction; Circadian entrainment	hsa0401; hsa0472; hsa0415; hsa0406; hsa0481; hsa0520; hsa0401; hsa0503; hsa0471	GTPase activity;PDZ domain binding;protein binding;phosphate ion binding	GO:000392; GO:003016; GO:000551; GO:004230
XP_020921708.1;XP_020921707.1;NP_001139599.1;XP_020921706.1	XP_020921708.1;XP_020921707.1;NP_001139599.1;XP_020921706.1	XP_020921708.1 clathrin heavy chain 1 isoform X3 [Sus scrofa];XP_020921707.1 clathrin heavy chain 1 isoform X2 [Sus scrofa];NP_001139599.1 clathrin heavy chain 1 [Sus scrofa];XP_020921706.1 clathrin heavy chain 1 isoform X1 [Sus scrofa]	65	65	65	1395100000	1648700000	1515600000	1662400000	1347200000	1677900000	1460800000	1688300000	1527600000	1560200000	1408400000	1637500000	1790800000	1763400000	1504600000	1667600000	1571300000	1896900000	NA	NA	NA	CLTC	CLTC;CLTC;CLTC;CLTC;NA	intracellular protein transport;membrane organization;osteoblast differentiation;autophagy;transferrin transport;retrograde transport, endosome to Golgi;clathrin coat assembly;low-density lipoprotein particle receptor catabolic process;low-density lipoprotein particle clearance;regulation of mitotic spindle organization;receptor internalization;clathrin-dependent endocytosis;antigen processing and presentation of exogenous peptide antigen via MHC class II;cell division;Wnt signaling pathway, planar cell polarity pathway;negative regulation of protein localization to plasma membrane;mitotic cell cycle;receptor-mediated endocytosis;negative regulation of hyaluronan biosynthetic process	GO:000688; GO:006102; GO:000164; GO:000691; GO:003357; GO:004214; GO:004826; GO:003280; GO:003438; GO:006023; GO:003162; GO:007258; GO:001988; GO:005130; GO:006007; GO:190307; GO:000027; GO:000689; GO:190012	clathrin coat;clathrin coat of coated pit;clathrin-coated endocytic vesicle membrane;clathrin-coated endocytic vesicle;mitotic spindle;extracellular vesicle;membrane;intracellular membrane-bounded organelle;melanosome;focal adhesion;trans-Golgi network membrane;clathrin complex;mitotic spindle microtubule;macromolecular complex;endolysosome membrane;plasma membrane;endosome;spindle;extracellular exosome;cytosol	GO:003011; GO:003013; GO:003066; GO:004533; GO:007268; GO:190356; GO:001602; GO:004323; GO:004247; GO:000592; GO:003258; GO:007143; GO:199049; GO:003299; GO:003602; GO:000588; GO:000576; GO:000581; GO:007006; GO:000582	 Endocytosis; Huntington's disease; Lysosome; Synaptic vesicle cycle; Endocrine and other factor-regulated calcium reabsorption; Bacterial invasion of epithelial cells	hsa0414; hsa0501; hsa0414; hsa0472; hsa0496; hsa0510	double-stranded RNA binding;ubiquitin-specific protease binding;structural molecule activity;disordered domain specific binding;low-density lipoprotein particle receptor binding;RNA binding;clathrin light chain binding;protein binding;protein kinase binding	GO:000372; GO:199038; GO:000519; GO:009771; GO:005075; GO:000372; GO:003205; GO:000551; GO:001990
XP_013834901.1;XP_005667453.1;NP_001139601.1	XP_013834901.1;XP_005667453.1;NP_001139601.1	XP_013834901.1 thy-1 membrane glycoprotein isoform X1 [Sus scrofa];XP_005667453.1 thy-1 membrane glycoprotein isoform X1 [Sus scrofa];NP_001139601.1 thy-1 membrane glycoprotein precursor [Sus scrofa]	6	6	6	292820000	668590000	393480000	505130000	304460000	836690000	461550000	578330000	365720000	624130000	488490000	518670000	879550000	829130000	370580000	591430000	659180000	1167600000	NA	NA	NA	THY1	THY1;THY1;THY1;NA;NA	positive regulation of cellular extravasation;receptor clustering;focal adhesion assembly;integrin-mediated signaling pathway;regulation of Rho-dependent protein serine/threonine kinase activity;negative regulation of protein kinase activity;T cell receptor signaling pathway;positive regulation of heterotypic cell-cell adhesion;negative regulation of protein tyrosine kinase activity;cell-cell adhesion;retinal cone cell development;positive regulation of T cell activation;positive regulation of focal adhesion assembly;cytoskeleton organization;negative regulation of axonogenesis;angiogenesis;regulation of cell-matrix adhesion;cell-cell signaling;negative regulation of cell migration;negative regulation of neuron projection regeneration;positive regulation of GTPase activity;protein autophosphorylation;negative regulation of T cell receptor signaling pathway;positive regulation of release of sequestered calcium ion into cytosol	GO:000269; GO:004311; GO:004804; GO:000722; GO:200029; GO:000646; GO:005085; GO:003411; GO:006109; GO:009860; GO:004654; GO:005087; GO:005189; GO:000701; GO:005077; GO:000152; GO:000195; GO:000726; GO:003033; GO:007057; GO:004354; GO:004677; GO:005086; GO:005128	plasma membrane;cytosol;integral component of plasma membrane;neuronal cell body membrane;external side of plasma membrane;dendrite;myelin sheath;membrane raft;extracellular exosome;extracellular region;axolemma;dendrite membrane;endoplasmic reticulum;apical plasma membrane;anchored component of external side of plasma membrane;focal adhesion;cell surface	GO:000588; GO:000582; GO:000588; GO:003280; GO:000989; GO:003042; GO:004320; GO:004512; GO:007006; GO:000557; GO:003067; GO:003259; GO:000578; GO:001632; GO:003136; GO:000592; GO:000998	 Leukocyte transendothelial migration	hsa0467	protein kinase binding;GPI anchor binding;GTPase activator activity;integrin binding;protein binding	GO:001990; GO:003423; GO:000509; GO:000517; GO:000551
NP_001139772.1	NP_001139772.1	NP_001139772.1 fascin [Sus scrofa]	15	15	15	333510000	653160000	341260000	599980000	358650000	560650000	546370000	572760000	460670000	500880000	520070000	503820000	522170000	499840000	567740000	698520000	479190000	535550000	NA	NA	NA	FSCN1	FSCN1;NA;NA;NA;NA	cytokine-mediated signaling pathway;microspike assembly;cell-cell junction assembly;establishment or maintenance of cell polarity;positive regulation of extracellular matrix disassembly;regulation of microvillus assembly;actin filament bundle assembly;cell proliferation;cell migration;establishment of apical/basal cell polarity;positive regulation of lamellipodium assembly;regulation of actin cytoskeleton organization;positive regulation of filopodium assembly;positive regulation of podosome assembly;cell motility	GO:001922; GO:003003; GO:000704; GO:000716; GO:009009; GO:003253; GO:005101; GO:000828; GO:001647; GO:003508; GO:001059; GO:003295; GO:005149; GO:007180; GO:004887	cytoplasm;microspike;invadopodium;stress fiber;lamellipodium;extracellular exosome;growth cone;cell projection membrane;cytoskeleton;filopodium;podosome;cytosol;actin cytoskeleton;microvillus;cell-cell junction	GO:000573; GO:004439; GO:007143; GO:000172; GO:003002; GO:007006; GO:003042; GO:003125; GO:000585; GO:003017; GO:000210; GO:000582; GO:001562; GO:000590; GO:000591	 MicroRNAs in cancer	hsa0520	actin binding;cadherin binding;actin filament binding;protein binding;protein binding, bridging;RNA binding;drug binding	GO:000377; GO:004529; GO:005101; GO:000551; GO:003067; GO:000372; GO:000814
NP_001153064.1	NP_001153064.1	NP_001153064.1 cytochrome b5 type B [Sus scrofa]	4	4	4	372280000	255450000	241680000	200530000	332980000	147930000	275730000	368060000	223500000	111820000	354170000	241930000	122720000	210810000	415630000	212390000	223410000	174860000	NA	NA	NA	CYB5B	CYB5B;NA;NA;NA;NA	oxidation-reduction process	GO:005511	integral component of membrane;membrane;mitochondrial outer membrane	GO:001602; GO:001602; GO:000574	"NA"	"NA"	protein binding;metal ion binding;heme binding	GO:000551; GO:004687; GO:002003
NP_001153080.1;XP_020930231.1	NP_001153080.1;XP_020930231.1	NP_001153080.1 pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 1, mitochondrial [Sus scrofa];XP_020930231.1 pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 1, mitochondrial isoform X1 [Sus scrofa]	4	4	4	8578100	5021400	8803200	0	8331500	0	6463600	0	5043300	0	0	0	0	0	0	7907300	0	0	NA	NA	NA	PDK1	PDK1;PDK1;NA;NA;NA	hypoxia-inducible factor-1alpha signaling pathway;intrinsic apoptotic signaling pathway in response to oxidative stress;glucose metabolic process;protein phosphorylation;cell proliferation;regulation of acetyl-CoA biosynthetic process from pyruvate;regulation of glucose metabolic process	GO:009741; GO:000863; GO:000600; GO:000646; GO:000828; GO:001051; GO:001090	nucleus;nucleolus;mitochondrial pyruvate dehydrogenase complex;mitochondrial matrix	GO:000563; GO:000573; GO:000596; GO:000575	 HIF-1 signaling pathway; Central carbon metabolism in cancer	hsa0406; hsa0523	protein binding;protein kinase activity;ATP binding;pyruvate dehydrogenase (acetyl-transferring) kinase activity	GO:000551; GO:000467; GO:000552; GO:000474
NP_001153085.1	NP_001153085.1	NP_001153085.1 NAD(P)H dehydrogenase [quinone] 1 [Sus scrofa]	6	6	6	81286000	61612000	69198000	76757000	0	0	112940000	77857000	130060000	82521000	0	57036000	0	63065000	0	46013000	73793000	68233000	NA	NA	NA	NQO1	NQO1;NA;NA;NA;NA	response to toxic substance;electron transport chain;response to electrical stimulus;removal of superoxide radicals;xenobiotic metabolic process;response to ethanol;response to nutrient;response to hydrogen sulfide;cellular response to hydrogen peroxide;response to nitrogen compound;synaptic transmission, cholinergic;negative regulation of catalytic activity;positive regulation of neuron apoptotic process;aging;response to estradiol;negative regulation of apoptotic process;regulation of cellular amino acid metabolic process;cellular response to metal ion	GO:000963; GO:002290; GO:005160; GO:001943; GO:000680; GO:004547; GO:000758; GO:190488; GO:007030; GO:190169; GO:000727; GO:004308; GO:004352; GO:000756; GO:003235; GO:004306; GO:000652; GO:007124	dendrite;neuronal cell body;cytosol;cytoplasm	GO:003042; GO:004302; GO:000582; GO:000573	 Ubiquinone and other terpenoid-quinone biosynthesis	hsa0013	NAD(P)H dehydrogenase (quinone) activity;identical protein binding;superoxide dismutase activity;protein binding;cytochrome-b5 reductase activity, acting on NAD(P)H;RNA binding;electron carrier activity;oxidoreductase activity	GO:000395; GO:004280; GO:000478; GO:000551; GO:000412; GO:000372; GO:000905; GO:001649
NP_001153087.1	NP_001153087.1	NP_001153087.1 keratin, type II cytoskeletal 8 [Sus scrofa]	34	29	18	52208000	347870000	393700000	28267000	909240000	31122000	4445800000	64831000	901240000	54356000	3040000000	36049000	3195500000	21733000	1621500000	35109000	7162200000	13900000	NA	NA	NA	KRT8	KRT8;NA;NA;NA;NA	response to other organism;keratinization;viral process;sarcomere organization;response to hydrostatic pressure;cornification;extrinsic apoptotic signaling pathway;cell differentiation involved in embryonic placenta development;tumor necrosis factor-mediated signaling pathway;hepatocyte apoptotic process	GO:005170; GO:003142; GO:001603; GO:004521; GO:005159; GO:007026; GO:009719; GO:006070; GO:003320; GO:009728	cell-cell junction;nuclear matrix;intermediate filament cytoskeleton;extracellular exosome;cytoplasm;nucleoplasm;apicolateral plasma membrane;dystrophin-associated glycoprotein complex;costamere;nucleus;Z disc;cytosol;intermediate filament;keratin filament;sarcolemma	GO:000591; GO:001636; GO:004511; GO:007006; GO:000573; GO:000565; GO:001632; GO:001601; GO:004303; GO:000563; GO:003001; GO:000582; GO:000588; GO:004509; GO:004238	"NA"	"NA"	scaffold protein binding;structural molecule activity;protein binding;macromolecular complex binding	GO:009711; GO:000519; GO:000551; GO:004487
XP_020938111.1;NP_001153552.1;XP_003133724.2	XP_020938111.1;NP_001153552.1	XP_020938111.1 LOW QUALITY PROTEIN: diacylglycerol O-acyltransferase 2-like [Sus scrofa];NP_001153552.1 diacylglycerol O-acyltransferase 2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17159000	0	NA	NA	NA	DGAT2	LOC110259135;DGAT2;NA;NA;NA	positive regulation of gluconeogenesis;regulation of cholesterol metabolic process;triglyceride biosynthetic process;cellular response to oleic acid;lipid storage;acylglycerol acyl-chain remodeling;positive regulation of triglyceride biosynthetic process;low-density lipoprotein particle clearance;long-chain fatty-acyl-CoA metabolic process;retinol metabolic process;cholesterol homeostasis;negative regulation of fatty acid oxidation;glycerol metabolic process;diacylglycerol metabolic process;regulation of lipoprotein metabolic process;fatty acid homeostasis;fat pad development;cellular triglyceride homeostasis;regulation of plasma lipoprotein particle levels	GO:004572; GO:009018; GO:001943; GO:007140; GO:001991; GO:003615; GO:001086; GO:003438; GO:003533; GO:004257; GO:004263; GO:004632; GO:000607; GO:004633; GO:005074; GO:005508; GO:006061; GO:003535; GO:009700	mitochondrion;perinuclear endoplasmic reticulum membrane;perinuclear region of cytoplasm;integral component of membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum;lipid particle	GO:000573; GO:199057; GO:004847; GO:001602; GO:003017; GO:000578; GO:000581	 Glycerolipid metabolism; Metabolic pathways; Fat digestion and absorption	hsa0056; hsa0110; hsa0497	retinol O-fatty-acyltransferase activity;protein homodimerization activity;diacylglycerol O-acyltransferase activity;2-acylglycerol O-acyltransferase activity	GO:005025; GO:004280; GO:000414; GO:000384
NP_001153558.1;XP_020930232.1	NP_001153558.1	NP_001153558.1 prothymosin alpha [Sus scrofa]	3	3	3	0	151840000	161660000	207850000	115070000	186400000	230320000	144880000	0	130730000	239550000	0	0	261960000	251070000	113580000	0	211610000	NA	NA	NA	PTMA	PTMA;NA;NA;NA;NA	transcription, DNA-templated;histone exchange	GO:000635; GO:004348	nucleus;nucleoplasm;cytosol	GO:000563; GO:000565; GO:000582	 Epstein-Barr virus infection	hsa0516	activating transcription factor binding;histone binding;protein binding	GO:003361; GO:004239; GO:000551
XP_005659007.1;NP_001153565.1;XP_005659008.1	XP_005659007.1;NP_001153565.1;XP_005659008.1	XP_005659007.1 protein arginine N-methyltransferase 5 isoform X1 [Sus scrofa];NP_001153565.1 protein arginine N-methyltransferase 5 [Sus scrofa];XP_005659008.1 protein arginine N-methyltransferase 5 isoform X2 [Sus scrofa]	3	3	3	0	10600000	0	10701000	0	0	10448000	0	0	0	0	0	0	0	0	0	0	10843000	NA	NA	NA	PRMT5	PRMT5;PRMT5;PRMT5;NA;NA	regulation of DNA methylation;liver regeneration;regulation of mitotic nuclear division;peptidyl-arginine methylation;regulation of ERK1 and ERK2 cascade;histone arginine methylation;histone H4-R3 methylation;DNA-templated transcription, termination;cell proliferation;endothelial cell activation;Golgi ribbon formation;peptidyl-arginine methylation, to symmetrical-dimethyl arginine;peptidyl-arginine N-methylation;negative regulation of cell differentiation;spliceosomal snRNP assembly;circadian regulation of gene expression;regulation of signal transduction by p53 class mediator;positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway;positive regulation of oligodendrocyte differentiation;negative regulation of nucleic acid-templated transcription	GO:004403; GO:009742; GO:000708; GO:001821; GO:007037; GO:003496; GO:004398; GO:000635; GO:000828; GO:004211; GO:009016; GO:001991; GO:003524; GO:004559; GO:000038; GO:003292; GO:190179; GO:190499; GO:004871; GO:190350	nucleus;Golgi apparatus;histone methyltransferase complex;cytosol;methylosome;nucleoplasm;cytoplasm	GO:000563; GO:000579; GO:003509; GO:000582; GO:003470; GO:000565; GO:000573	 RNA transport	hsa0301	E-box binding;protein-arginine N-methyltransferase activity;identical protein binding;histone-arginine N-methyltransferase activity;protein binding;methyl-CpG binding;protein heterodimerization activity;protein-arginine omega-N symmetric methyltransferase activity;histone methyltransferase activity (H4-R3 specific);transcription corepressor activity;ribonucleoprotein complex binding;methyltransferase activity	GO:007088; GO:001627; GO:004280; GO:000846; GO:000551; GO:000832; GO:004698; GO:003524; GO:004402; GO:000371; GO:004302; GO:000816
NP_001153744.1	NP_001153744.1	NP_001153744.1 protein S100-A12 [Sus scrofa]	5	5	5	76136000	0	52817000	27504000	87313000	48233000	41503000	0	56088000	34630000	80254000	0	78700000	21550000	139530000	0	72940000	0	NA	NA	NA	S100A12	S100A12;NA;NA;NA;NA	monocyte chemotaxis;positive regulation of MAP kinase activity;innate immune response;defense response to fungus;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB signaling;mast cell activation;inflammatory response;killing of cells of other organism;cytokine secretion;positive regulation of inflammatory response;defense response to bacterium;xenobiotic metabolic process;neutrophil chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide;neutrophil degranulation	GO:000254; GO:004340; GO:004508; GO:005083; GO:005109; GO:004312; GO:004557; GO:000695; GO:003164; GO:005066; GO:005072; GO:004274; GO:000680; GO:003059; GO:006184; GO:004331	nucleus;plasma membrane;cytosol;secretory granule lumen;extracellular region;cytoplasm;cytoskeleton	GO:000563; GO:000588; GO:000582; GO:003477; GO:000557; GO:000573; GO:000585	"NA"	"NA"	calcium ion binding;copper ion binding;RAGE receptor binding;protein binding;zinc ion binding	GO:000550; GO:000550; GO:005078; GO:000551; GO:000827
XP_020946634.1;XP_020932909.1;XP_020932905.1;XP_020932903.1;XP_005661199.1;XP_005661198.1;NP_001153899.1;XP_020932893.1;NP_001153898.1;XP_020921705.1;XP_020921704.1;XP_020932894.1;NP_001138692.1	XP_020946634.1;XP_020932909.1;XP_020932905.1;XP_020932903.1;XP_005661199.1;XP_005661198.1;NP_001153899.1;XP_020932893.1;NP_001153898.1;XP_020921705.1;XP_020921704.1;XP_020932894.1;NP_001138692.1	XP_020946634.1 ADP-ribosylation factor 3 isoform X1 [Sus scrofa];XP_020932909.1 ADP-ribosylation factor 1 isoform X3 [Sus scrofa];XP_020932905.1 ADP-ribosylation factor 1 isoform X3 [Sus scrofa];XP_020932903.1 ADP-ribosylation factor 1 isoform X3 [Sus scro	9	9	3	251810000	225680000	243340000	238530000	204370000	173640000	193720000	210870000	250700000	238400000	212570000	86646000	215730000	223760000	194760000	237810000	256450000	234980000	NA	NA	NA	ARF3	ARF3;ARF1;ARF1;ARF1;ARF1	vesicle-mediated transport;Golgi to plasma membrane transport;intracellular protein transport;phosphatidylinositol biosynthetic process	GO:001619; GO:000689; GO:000688; GO:000666	Golgi membrane;cytoplasm;perinuclear region of cytoplasm;Golgi apparatus;plasma membrane;extracellular exosome	GO:000013; GO:000573; GO:004847; GO:000579; GO:000588; GO:007006	 Endocytosis	hsa0414	GTP binding;GTPase activity	GO:000552; GO:000392
NP_001155111.1	NP_001155111.1	NP_001155111.1 protein MAL2 [Sus scrofa]	2	2	2	229220000	139710000	200150000	132560000	146610000	67012000	208650000	173680000	185480000	166090000	129880000	132640000	0	53172000	107310000	140840000	0	58961000	NA	NA	NA	MAL2	MAL2;NA;NA;NA;NA	myelination;transcytosis	GO:004255; GO:004505	membrane raft;perinuclear region of cytoplasm;endomembrane system;integral component of membrane;extracellular exosome;apical plasma membrane	GO:004512; GO:004847; GO:001250; GO:001602; GO:007006; GO:001632	"NA"	"NA"	protein binding;structural constituent of myelin sheath	GO:000551; GO:001991
XP_020953977.1;NP_001155225.1	XP_020953977.1;NP_001155225.1	XP_020953977.1 phosphoenolpyruvate carboxykinase [GTP], mitochondrial isoform X1 [Sus scrofa];NP_001155225.1 phosphoenolpyruvate carboxykinase [GTP], mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PCK2	PCK2;PCK2;NA;NA;NA	glycerol biosynthetic process from pyruvate;cellular response to dexamethasone stimulus;cellular response to insulin stimulus;response to lipid;hepatocyte differentiation;pyruvate metabolic process;propionate catabolic process;cellular response to glucose stimulus;response to starvation	GO:004632; GO:007154; GO:003286; GO:003399; GO:007036; GO:000609; GO:001954; GO:007133; GO:004259	mitochondrion;mitochondrial matrix;cytosol	GO:000573; GO:000575; GO:000582	 AMPK signaling pathway; Insulin resistance; Biosynthesis of antibiotics; PPAR signaling pathway; Citrate cycle (TCA cycle); Pyruvate metabolism; Glycolysis / Gluconeogenesis; Adipocytokine signaling pathway; FoxO signaling pathway; Proximal tubule bicarbonate reclamation; Insulin signaling pathway; PI3K-Akt signaling pathway; Metabolic pathways	hsa0415; hsa0493; hsa0113; hsa0332; hsa0002; hsa0062; hsa0001; hsa0492; hsa0406; hsa0496; hsa0491; hsa0415; hsa0110	protein binding;phosphoenolpyruvate carboxykinase (GTP) activity;GTP binding;manganese ion binding	GO:000551; GO:000461; GO:000552; GO:003014
NP_001155875.1	NP_001155875.1	NP_001155875.1 ubiquitin thioesterase OTUB1 [Sus scrofa]	10	10	10	65376000	79997000	68102000	73813000	66899000	73123000	70552000	64075000	67595000	64706000	57992000	99383000	63401000	74784000	68234000	76014000	62508000	71940000	NA	NA	NA	OTUB1	OTUB1;NA;NA;NA;NA	DNA repair;protein deubiquitination;negative regulation of histone H2A K63-linked ubiquitination;protein K48-linked deubiquitination;cellular response to interleukin-1;cellular response to DNA damage stimulus;negative regulation of double-strand break repair;adaptive immune response	GO:000628; GO:001657; GO:190131; GO:007110; GO:007134; GO:000697; GO:200078; GO:000225	nucleoplasm;cytosol;nucleus;extracellular exosome	GO:000565; GO:000582; GO:000563; GO:007006	"NA"	"NA"	ubiquitin protein ligase binding;ubiquitin binding;thiol-dependent ubiquitin-specific protease activity;NEDD8-specific protease activity;protein binding	GO:003162; GO:004313; GO:000484; GO:001978; GO:000551
NP_001156532.1	NP_001156532.1	NP_001156532.1 cadherin-1 precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3795700	NA	NA	NA	CDH1	CDH1;NA;NA;NA;NA	negative regulation of cell migration;entry of bacterium into host cell;cell-cell adhesion;positive regulation of protein import into nucleus;positive regulation of transcription, DNA-templated;response to toxic substance;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;negative regulation of cell-cell adhesion;cellular response to lithium ion;homophilic cell adhesion via plasma membrane adhesion molecules;extracellular matrix organization;cell-cell adhesion mediated by cadherin;neuron projection development;adherens junction organization;cell-cell junction assembly;regulation of protein catabolic process at postsynapse, modulating synaptic transmission;cell morphogenesis;synapse assembly;regulation of gene expression;pituitary gland development;cellular response to indole-3-methanol;protein localization to plasma membrane	GO:003033; GO:003563; GO:009860; GO:004230; GO:004589; GO:000963; GO:001633; GO:002240; GO:007128; GO:000715; GO:003019; GO:004433; GO:003117; GO:003433; GO:000704; GO:009957; GO:000090; GO:000741; GO:001046; GO:002198; GO:007168; GO:007265	cell-cell adherens junction;cytoplasm;trans-Golgi network;cell junction;cortical actin cytoskeleton;plasma membrane;flotillin complex;extracellular exosome;cytoplasmic side of plasma membrane;cell surface;integral component of membrane;catenin complex;lamellipodium;apical junction complex;perinuclear region of cytoplasm;extracellular region;endosome;lateral plasma membrane;actin cytoskeleton;postsynapse;glutamatergic synapse	GO:000591; GO:000573; GO:000580; GO:003005; GO:003086; GO:000588; GO:001660; GO:007006; GO:000989; GO:000998; GO:001602; GO:001634; GO:003002; GO:004329; GO:004847; GO:000557; GO:000576; GO:001632; GO:001562; GO:009879; GO:009897	 Adherens junction; Bacterial invasion of epithelial cells; Thyroid cancer; Pathogenic Escherichia coli infection; Rap1 signaling pathway; Pathways in cancer; Hippo signaling pathway; Cell adhesion molecules (CAMs)	hsa0452; hsa0510; hsa0521; hsa0513; hsa0401; hsa0520; hsa0439; hsa0451	protein binding;ankyrin binding;GTPase activating protein binding;protein homodimerization activity;calcium ion binding;cell adhesion molecule binding;gamma-catenin binding;cytoskeletal protein binding;beta-catenin binding	GO:000551; GO:003050; GO:003279; GO:004280; GO:000550; GO:005083; GO:004529; GO:000809; GO:000801
XP_020932986.1;NP_001156878.1	XP_020932986.1;NP_001156878.1	XP_020932986.1 endothelial protein C receptor isoform X1 [Sus scrofa];NP_001156878.1 endothelial protein C receptor precursor [Sus scrofa]	4	4	4	0	40996000	42428000	44130000	0	60792000	0	0	0	35438000	0	0	0	29027000	0	45740000	29983000	72629000	NA	NA	NA	PROCR	PROCR;PROCR;NA;NA;NA	negative regulation of coagulation;blood coagulation	GO:005081; GO:000759	plasma membrane;integral component of plasma membrane;centrosome;focal adhesion;extracellular region;cell surface;extracellular exosome;perinuclear region of cytoplasm	GO:000588; GO:000588; GO:000581; GO:000592; GO:000557; GO:000998; GO:007006; GO:004847	"NA"	"NA"	protein binding;signaling receptor activity	GO:000551; GO:003802
NP_001157273.1	NP_001157273.1	NP_001157273.1 insulin-like growth factor-binding protein 7 precursor [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	6759800	0	0	0	0	0	NA	NA	NA	IGFBP7	IGFBP7;NA;NA;NA;NA	response to heat;response to cortisol;embryo implantation;regulation of cell growth;regulation of steroid biosynthetic process;cellular protein metabolic process;response to retinoic acid;post-translational protein modification;cell adhesion;cellular response to hormone stimulus;negative regulation of cell proliferation	GO:000940; GO:005141; GO:000756; GO:000155; GO:005081; GO:004426; GO:003252; GO:004368; GO:000715; GO:003287; GO:000828	extracellular region;extracellular exosome;endoplasmic reticulum lumen;extracellular space	GO:000557; GO:007006; GO:000578; GO:000561	"NA"	"NA"	protein binding;extracellular matrix structural constituent;insulin-like growth factor binding	GO:000551; GO:000520; GO:000552
XP_005655646.1;NP_001157469.1;XP_005655644.1;XP_020946771.1	XP_005655646.1;NP_001157469.1;XP_005655644.1;XP_020946771.1	XP_005655646.1 myosin light polypeptide 6 isoform X3 [Sus scrofa];NP_001157469.1 myosin light polypeptide 6 [Sus scrofa];XP_005655644.1 myosin light polypeptide 6 isoform X1 [Sus scrofa];XP_020946771.1 myosin light polypeptide 6 isoform X2 [Sus scrofa]	9	9	9	988050000	1621400000	1596400000	1236800000	890110000	2337600000	922890000	1909000000	1071300000	2192100000	1859200000	2623100000	3135900000	1584800000	1097600000	1194100000	1003300000	1094400000	NA	NA	NA	MYL6	MYL6;MYL6;MYL6;MYL6;NA	muscle filament sliding;skeletal muscle tissue development;muscle contraction	GO:003004; GO:000751; GO:000693	membrane;vesicle;brush border;myosin complex;cytosol;unconventional myosin complex;extracellular exosome	GO:001602; GO:003198; GO:000590; GO:001645; GO:000582; GO:001646; GO:007006	 Vascular smooth muscle contraction; Oxytocin signaling pathway	hsa0427; hsa0492	calcium ion binding;protein binding;structural constituent of muscle;motor activity;actin-dependent ATPase activity	GO:000550; GO:000551; GO:000830; GO:000377; GO:003089
NP_001157470.1	NP_001157470.1	NP_001157470.1 annexin A1 [Sus scrofa]	21	21	21	1201700000	898040000	919310000	922380000	2095500000	535320000	1074000000	778510000	903610000	717940000	1705800000	2927800000	1038800000	1117500000	1344200000	2637400000	1771200000	488610000	NA	NA	NA	ANXA1	ANXA1;NA;NA;NA;NA	neutrophil homeostasis;regulation of cell shape;actin cytoskeleton reorganization;positive regulation of interleukin-2 production;positive regulation of neutrophil apoptotic process;negative regulation of apoptotic process;cell-cell adhesion;positive regulation of G1/S transition of mitotic cell cycle;peptide cross-linking;negative regulation of interleukin-8 secretion;myoblast migration involved in skeletal muscle regeneration;keratinocyte differentiation;positive regulation of vesicle fusion;DNA duplex unwinding;response to drug;positive regulation of T-helper 1 cell differentiation;arachidonic acid secretion;neutrophil clearance;negative regulation of phospholipase A2 activity;adaptive immune response;response to X-ray;regulation of interleukin-1 production;phagocytosis;G-protein coupled receptor signaling pathway;cytokine-mediated signaling pathway;insulin secretion;positive regulation of prostaglandin biosynthetic process;negative regulation of exocytosis;response to interleukin-1;positive regulation of wound healing;estrous cycle;prolactin secretion;cell surface receptor signaling pathway;prostate gland development;hepatocyte differentiation;cellular response to glucocorticoid stimulus;positive regulation of cell migration involved in sprouting angiogenesis;monocyte chemotaxis;regulation of leukocyte migration;gliogenesis;response to peptide hormone;alpha-beta T cell differentiation;regulation of cell proliferation;innate immune response;cellular response to hydrogen peroxide;inflammatory response;endocrine pancreas development;response to estradiol;cellular response to vascular endothelial growth factor stimulus;positive regulation of T cell proliferation;regulation of hormone secretion;regulation of inflammatory response;granulocyte chemotaxis	GO:000178; GO:000836; GO:003153; GO:003274; GO:003303; GO:004306; GO:009860; GO:190008; GO:001814; GO:200048; GO:001483; GO:003021; GO:003134; GO:003250; GO:004249; GO:004562; GO:005048; GO:009735; GO:190013; GO:000225; GO:001016; GO:003265; GO:000690; GO:000718; GO:001922; GO:003007; GO:003139; GO:004592; GO:007055; GO:009030; GO:004484; GO:007045; GO:000716; GO:003085; GO:007036; GO:007138; GO:009005; GO:000254; GO:000268; GO:004206; GO:004343; GO:004663; GO:004212; GO:004508; GO:007030; GO:000695; GO:003101; GO:003235; GO:003592; GO:004210; GO:004688; GO:005072; GO:007162	phagocytic cup;extrinsic component of external side of plasma membrane;mast cell granule;focal adhesion;motile cilium;early endosome membrane;vesicle;macromolecular complex;cornified envelope;nucleoplasm;sarcolemma;cytoplasm;actin filament;mitochondrial membrane;extracellular exosome;cytosol;basolateral plasma membrane;nucleus;cell-cell adherens junction;cell surface;extracellular region;endosome;extrinsic component of membrane;extrinsic component of endosome membrane;extracellular space;synaptic membrane;cytoplasmic vesicle membrane	GO:000189; GO:003123; GO:004262; GO:000592; GO:003151; GO:003190; GO:003198; GO:003299; GO:000153; GO:000565; GO:004238; GO:000573; GO:000588; GO:003196; GO:007006; GO:000582; GO:001632; GO:000563; GO:000591; GO:000998; GO:000557; GO:000576; GO:001989; GO:003131; GO:000561; GO:009706; GO:003065	"NA"	"NA"	calcium-dependent protein binding;receptor binding;calcium-dependent phospholipid binding;phospholipase A2 inhibitor activity;cadherin binding involved in cell-cell adhesion;DNA/DNA annealing activity;structural molecule activity;protein binding;single-stranded RNA binding;protein binding, bridging;single-stranded DNA binding;protein homodimerization activity;double-stranded DNA-dependent ATPase activity;calcium ion binding	GO:004830; GO:000510; GO:000554; GO:001983; GO:009864; GO:199081; GO:000519; GO:000551; GO:000372; GO:003067; GO:000369; GO:004280; GO:003367; GO:000550
XP_020920817.1;XP_020920816.1;XP_013835877.1;NP_001157473.1	XP_020920817.1;XP_020920816.1;XP_013835877.1;NP_001157473.1	XP_020920817.1 arachidonate 5-lipoxygenase-activating protein isoform X2 [Sus scrofa];XP_020920816.1 arachidonate 5-lipoxygenase-activating protein isoform X1 [Sus scrofa];XP_013835877.1 arachidonate 5-lipoxygenase-activating protein isoform X1 [Sus scrofa	3	3	3	0	9703800	0	0	0	5963500	0	0	0	7658600	0	0	0	0	0	0	0	0	NA	NA	NA	ALOX5AP	ALOX5AP;ALOX5AP;ALOX5AP;ALOX5AP;NA	cellular oxidant detoxification;cellular response to calcium ion;leukotriene biosynthetic process;positive regulation of catalytic activity;protein homotrimerization	GO:009886; GO:007127; GO:001937; GO:004308; GO:007020	membrane;endoplasmic reticulum membrane;nuclear envelope;nuclear membrane;integral component of membrane	GO:001602; GO:000578; GO:000563; GO:003196; GO:001602	"NA"	"NA"	arachidonic acid binding;protein N-terminus binding;glutathione peroxidase activity;glutathione transferase activity;leukotriene-C4 synthase activity;enzyme activator activity;protein binding	GO:005054; GO:004748; GO:000460; GO:000436; GO:000446; GO:000804; GO:000551
NP_001157475.1;XP_020935171.1	NP_001157475.1;XP_020935171.1	NP_001157475.1 coagulation factor IX [Sus scrofa];XP_020935171.1 coagulation factor IX isoform X1 [Sus scrofa]	10	10	10	316870000	341590000	377400000	251230000	411280000	302680000	415270000	326250000	298230000	227790000	309590000	285320000	141430000	245310000	325800000	282610000	338070000	233840000	NA	NA	NA	F9	F9;F9;NA;NA;NA	blood coagulation;ER to Golgi vesicle-mediated transport;zymogen activation;proteolysis;blood coagulation, intrinsic pathway	GO:000759; GO:000688; GO:003163; GO:000650; GO:000759	plasma membrane;Golgi lumen;extracellular region;endoplasmic reticulum lumen;extracellular space;extracellular exosome	GO:000588; GO:000579; GO:000557; GO:000578; GO:000561; GO:007006	 Complement and coagulation cascades	hsa0461	protein binding;endopeptidase activity;serine-type endopeptidase activity;calcium ion binding	GO:000551; GO:000417; GO:000425; GO:000550
NP_001157478.1;XP_020938995.1;CON__P00978	NP_001157478.1;XP_020938995.1	NP_001157478.1 protein AMBP precursor [Sus scrofa];XP_020938995.1 protein AMBP isoform X1 [Sus scrofa]	7	7	7	115160000	102850000	99153000	100520000	127770000	166780000	127650000	86626000	108270000	87148000	132190000	65967000	94544000	104870000	102220000	74964000	112370000	92039000	NA	NA	NA	AMBP	AMBP;AMBP;NA;NA;NA	receptor-mediated endocytosis;viral process;protein-chromophore linkage;negative regulation of immune response;negative regulation of JNK cascade;negative regulation of endopeptidase activity;cell adhesion;female pregnancy;protein catabolic process;heme catabolic process	GO:000689; GO:001603; GO:001829; GO:005077; GO:004632; GO:001095; GO:000715; GO:000756; GO:003016; GO:004216	blood microparticle;plasma membrane;extracellular exosome;extracellular region;extracellular space;intracellular membrane-bounded organelle;cell surface	GO:007256; GO:000588; GO:007006; GO:000557; GO:000561; GO:004323; GO:000998	"NA"	"NA"	serine-type endopeptidase inhibitor activity;protein binding;calcium oxalate binding;protein homodimerization activity;heme binding;IgA binding;calcium channel inhibitor activity	GO:000486; GO:000551; GO:004690; GO:004280; GO:002003; GO:001986; GO:001985
NP_001157479.1	NP_001157479.1	NP_001157479.1 isocitrate dehydrogenase [NADP], mitochondrial [Sus scrofa]	15	14	14	93825000	52963000	104400000	47289000	62706000	62904000	67843000	55132000	94679000	70958000	64528000	87845000	123340000	57302000	36895000	48013000	74666000	45997000	NA	NA	NA	IDH2	IDH2;NA;NA;NA;NA	glyoxylate cycle;2-oxoglutarate metabolic process;NADP metabolic process;negative regulation of glial cell proliferation;tricarboxylic acid cycle;negative regulation of glial cell migration;negative regulation of matrix metallopeptidase secretion;carbohydrate metabolic process;NADP biosynthetic process	GO:000609; GO:000610; GO:000673; GO:006025; GO:000609; GO:190397; GO:190446; GO:000597; GO:000674	mitochondrial matrix;mitochondrion;extracellular exosome;peroxisome;cytosol	GO:000575; GO:000573; GO:007006; GO:000577; GO:000582	 Carbon metabolism; Citrate cycle (TCA cycle); Glutathione metabolism; Biosynthesis of antibiotics; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Peroxisome	hsa0120; hsa0002; hsa0048; hsa0113; hsa0110; hsa0121; hsa0123; hsa0414	magnesium ion binding;NAD binding;protein homodimerization activity;isocitrate dehydrogenase (NADP+) activity	GO:000028; GO:005128; GO:004280; GO:000445
NP_001157492.1;XP_005670497.1;XP_013838117.1;XP_020927755.1;XP_020927754.1;XP_013838118.1;XP_020936530.1;XP_020936529.1;XP_020936521.1;XP_020936519.1;XP_020936515.1;XP_020936508.1;XP_020936504.1;XP_020936502.1;XP_020936493.1;XP_020936487.1;XP_020936535.1;XP_020956632.1;XP_020956631.1;XP_020956629.1;NP_999190.1;XP_020956628.1	NP_001157492.1;XP_005670497.1;XP_013838117.1	NP_001157492.1 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform [Sus scrofa];XP_005670497.1 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1 [Sus scrofa];XP_013838117.1 serine/thr	9	9	9	64892000	50801000	60427000	48582000	56525000	43366000	57384000	59151000	63223000	51581000	71235000	67569000	48202000	51979000	60939000	56075000	68172000	47808000	NA	NA	NA	PPP2R2A	PPP2R2A;PPP2R2A;PPP2R2A;NA;NA	response to morphine;regulation of phosphoprotein phosphatase activity;peptidyl-serine dephosphorylation;protein dephosphorylation;mitotic cell cycle;G2/M transition of mitotic cell cycle;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:004327; GO:004366; GO:007026; GO:000647; GO:000027; GO:000008; GO:000018	protein phosphatase type 2A complex;nucleoplasm;cytosol;glutamatergic synapse	GO:000015; GO:000565; GO:000582; GO:009897	 Sphingolipid signaling pathway; Hippo signaling pathway; Tight junction; Hepatitis C; Adrenergic signaling in cardiomyocytes; mRNA surveillance pathway; AMPK signaling pathway; Dopaminergic synapse; Chagas disease (American trypanosomiasis)	hsa0407; hsa0439; hsa0453; hsa0516; hsa0426; hsa0301; hsa0415; hsa0472; hsa0514	protein binding;macromolecular complex binding;protein serine/threonine phosphatase activity;tau protein binding;protein phosphatase regulator activity;protein phosphatase 2A binding	GO:000551; GO:004487; GO:000472; GO:004815; GO:001988; GO:005172
NP_001157984.1	NP_001157984.1	NP_001157984.1 phosphate carrier protein, mitochondrial [Sus scrofa]	5	5	5	267110000	139860000	241890000	144430000	216420000	112860000	190420000	152160000	304090000	137840000	159870000	124520000	146000000	110420000	146430000	153770000	144930000	139390000	NA	NA	NA	SLC25A3	SLC25A3;NA;NA;NA;NA	phosphate ion transmembrane transport;hydrogen ion transmembrane transport	GO:003543; GO:190260	integral component of mitochondrial inner membrane;extracellular exosome;mitochondrion;integral component of plasma membrane;membrane;mitochondrial inner membrane	GO:003130; GO:007006; GO:000573; GO:000588; GO:001602; GO:000574	"NA"	"NA"	inorganic phosphate transmembrane transporter activity;phosphate:proton symporter activity;macromolecular complex binding	GO:000531; GO:001531; GO:004487
XP_020927845.1;XP_013838976.1;NP_001158122.1;XP_020943030.1	XP_020927845.1;XP_013838976.1;NP_001158122.1;XP_020943030.1	XP_020927845.1 actin, aortic smooth muscle isoform X1 [Sus scrofa];XP_013838976.1 actin, aortic smooth muscle isoform X1 [Sus scrofa];NP_001158122.1 actin, aortic smooth muscle [Sus scrofa];XP_020943030.1 actin, gamma-enteric smooth muscle [Sus scrofa]	27	27	2	9662400000	16787000000	36956000000	10584000000	7070700000	34575000000	8414800000	23679000000	14678000000	45018000000	21565000000	24301000000	82645000000	11275000000	10353000000	12706000000	20615000000	11672000000	NA	NA	NA	ACTA2	ACTA2;ACTA2;ACTA2;ACTG2;NA	vascular smooth muscle contraction;response to virus;regulation of blood pressure;mesenchyme migration;positive regulation of gene expression;positive regulation of transcription, DNA-templated;muscle contraction;glomerular mesangial cell development	GO:001482; GO:000961; GO:000821; GO:009013; GO:001062; GO:004589; GO:000693; GO:007214	smooth muscle contractile fiber;extracellular exosome;lamellipodium;actin cytoskeleton;extracellular space;macromolecular complex;cell body;cytosol;cytoplasm;filopodium	GO:003048; GO:007006; GO:003002; GO:001562; GO:000561; GO:003299; GO:004429; GO:000582; GO:000573; GO:003017	 Vascular smooth muscle contraction	hsa0427	protein kinase binding;ATP binding	GO:001990; GO:000552
XP_020932904.1;NP_001160145.1	XP_020932904.1;NP_001160145.1	XP_020932904.1 phosphatidate cytidylyltransferase 2 isoform X1 [Sus scrofa];NP_001160145.1 phosphatidate cytidylyltransferase 2 [Sus scrofa]	3	3	3	36930000	32047000	33650000	41606000	32612000	14969000	0	55791000	31183000	26101000	22716000	0	19705000	0	27831000	26210000	22267000	0	NA	NA	NA	CDS2	CDS2;CDS2;NA;NA;NA	CDP-diacylglycerol biosynthetic process;phosphatidylglycerol biosynthetic process	GO:001602; GO:000665	mitochondrial inner membrane;endoplasmic reticulum membrane;integral component of membrane	GO:000574; GO:000578; GO:001602	 Metabolic pathways; Phosphatidylinositol signaling system; Glycerophospholipid metabolism	hsa0110; hsa0407; hsa0056	phosphatidate cytidylyltransferase activity	GO:000460
NP_001161057.1	NP_001161057.1	NP_001161057.1 calcium load-activated calcium channel precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	42498000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TMCO1	TMCO1;NA;NA;NA;NA	calcium ion transmembrane transport;ER overload response;endoplasmic reticulum calcium ion homeostasis	GO:007058; GO:000698; GO:003246	Golgi membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane	GO:000013; GO:000578; GO:003017	"NA"	"NA"	calcium channel activity	GO:000526
XP_020930367.1;XP_020930366.1;XP_020930365.1;XP_020930364.1;XP_020930363.1;XP_005671766.1;XP_005671765.1;XP_005671764.1;NP_001161101.2;XP_020940402.1;XP_020940401.1;XP_020940400.1;XP_013850557.1;XP_013850556.1;XP_013850555.1;XP_003354318.1;XP_005661691.1;XP_005661690.1	XP_020930367.1;XP_020930366.1;XP_020930365.1;XP_020930364.1;XP_020930363.1;XP_005671766.1;XP_005671765.1;XP_005671764.1;NP_001161101.2	XP_020930367.1 long-chain-fatty-acid--CoA ligase 1 isoform X2 [Sus scrofa];XP_020930366.1 long-chain-fatty-acid--CoA ligase 1 isoform X2 [Sus scrofa];XP_020930365.1 long-chain-fatty-acid--CoA ligase 1 isoform X1 [Sus scrofa];XP_020930364.1 long-chain-fatty	34	34	34	2385700000	784850000	2069500000	971970000	2577100000	779240000	2071600000	1297600000	1946400000	1441300000	1602600000	662740000	635250000	897910000	1553900000	1155100000	1533200000	712750000	NA	NA	NA	ACSL1	ACSL1;ACSL1;ACSL1;ACSL1;ACSL1	regulation of lipid metabolic process;adiponectin-activated signaling pathway;xenobiotic catabolic process;linoleic acid metabolic process;positive regulation of protein serine/threonine kinase activity;alpha-linolenic acid metabolic process;lipid biosynthetic process;response to drug;response to oleic acid;long-chain fatty-acyl-CoA biosynthetic process;long-chain fatty acid import;long-chain fatty acid metabolic process;response to nutrient;response to organic cyclic compound;triglyceride biosynthetic process	GO:001921; GO:003321; GO:004217; GO:004365; GO:007190; GO:003610; GO:000861; GO:004249; GO:003420; GO:003533; GO:004453; GO:000167; GO:000758; GO:001407; GO:001943	mitochondrion;mitochondrial outer membrane;plasma membrane;integral component of membrane;endoplasmic reticulum membrane;peroxisomal membrane	GO:000573; GO:000574; GO:000588; GO:001602; GO:000578; GO:000577	 PPAR signaling pathway; Adipocytokine signaling pathway; Fatty acid metabolism; Peroxisome; Metabolic pathways; Fatty acid biosynthesis; Fatty acid degradation	hsa0332; hsa0492; hsa0121; hsa0414; hsa0110; hsa0006; hsa0007	decanoate--CoA ligase activity;ATP binding;long-chain fatty acid-CoA ligase activity	GO:010239; GO:000552; GO:000446
NP_001161104.2	NP_001161104.2	NP_001161104.2 fructose-1,6-bisphosphatase isozyme 2 [Sus scrofa]	8	8	8	58379000	101910000	27600000	62413000	32408000	47205000	72733000	94006000	67568000	94395000	52364000	137780000	0	61728000	46469000	99690000	41190000	72145000	NA	NA	NA	FBP2	FBP2;NA;NA;NA;NA	dephosphorylation;fructose metabolic process;gluconeogenesis;fructose 1,6-bisphosphate metabolic process;sucrose biosynthetic process	GO:001631; GO:000600; GO:000609; GO:003038; GO:000598	Z disc;cytoplasm;nucleoplasm;cell junction;extracellular exosome;cytosol;plasma membrane	GO:003001; GO:000573; GO:000565; GO:003005; GO:007006; GO:000582; GO:000588	 Biosynthesis of antibiotics; Pentose phosphate pathway; Glycolysis / Gluconeogenesis; Metabolic pathways; AMPK signaling pathway; Insulin signaling pathway; Fructose and mannose metabolism; Carbon metabolism	hsa0113; hsa0003; hsa0001; hsa0110; hsa0415; hsa0491; hsa0005; hsa0120	fructose 1,6-bisphosphate 1-phosphatase activity;metal ion binding;protein binding;identical protein binding	GO:004213; GO:004687; GO:000551; GO:004280
NP_001161105.1	NP_001161105.1	NP_001161105.1 5-AMP-activated protein kinase catalytic subunit alpha-1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5413600	0	0	NA	NA	NA	PRKAA1	PRKAA1;NA;NA;NA;NA	activation of MAPK activity;response to hypoxia;glucose metabolic process;Wnt signaling pathway;rhythmic process;positive regulation of skeletal muscle tissue development;regulation of vesicle-mediated transport;cellular response to ethanol;response to UV;positive regulation of glycolytic process;CAMKK-AMPK signaling cascade;negative regulation of tubulin deacetylation;positive regulation of gene expression;glucose homeostasis;regulation of circadian rhythm;negative regulation of apoptotic process;negative regulation of glucosylceramide biosynthetic process;cellular response to prostaglandin E stimulus;positive regulation of peptidyl-lysine acetylation;fatty acid biosynthetic process;cold acclimation;fatty acid oxidation;negative regulation of TOR signaling;histone-serine phosphorylation;intracellular signal transduction;fatty acid homeostasis;neuron cellular homeostasis;cellular response to glucose stimulus;energy homeostasis;protein phosphorylation;cell cycle arrest;signal transduction;lipid biosynthetic process;response to gamma radiation;positive regulation of autophagy;response to caffeine;negative regulation of insulin receptor signaling pathway;cellular response to hypoxia;cholesterol biosynthetic process;macroautophagy;cellular response to nutrient levels;cellular response to oxidative stress;negative regulation of lipid catabolic process;motor behavior;positive regulation of cell proliferation;response to activity;positive regulation of cholesterol biosynthetic process;cellular response to hydrogen peroxide;regulation of microtubule cytoskeleton organization;response to camptothecin;regulation of peptidyl-serine phosphorylation;cellular response to glucose starvation;protein heterooligomerization;cellular response to calcium ion;cellular response to organonitrogen compound;positive regulation of transcription from mitochondrial promoter;positive regulation of cellular protein localization;positive regulation of protein targeting to mitochondrion	GO:000018; GO:000166; GO:000600; GO:001605; GO:004851; GO:004864; GO:006062; GO:007136; GO:000941; GO:004582; GO:006176; GO:190442; GO:001062; GO:004259; GO:004275; GO:004306; GO:004631; GO:007138; GO:200075; GO:000663; GO:000963; GO:001939; GO:003200; GO:003540; GO:003555; GO:005508; GO:007005; GO:007133; GO:009700; GO:000646; GO:000705; GO:000716; GO:000861; GO:001033; GO:001050; GO:003100; GO:004662; GO:007145; GO:000669; GO:001623; GO:003166; GO:003459; GO:005099; GO:006174; GO:000828; GO:001482; GO:004554; GO:007030; GO:007050; GO:190156; GO:003313; GO:004214; GO:005129; GO:007127; GO:007141; GO:190310; GO:190382; GO:190395	axon;nucleotide-activated protein kinase complex;cytosol;dendrite;apical plasma membrane;nuclear speck;nucleoplasm;neuronal cell body;cytoplasm;nucleus	GO:003042; GO:003158; GO:000582; GO:003042; GO:001632; GO:001660; GO:000565; GO:004302; GO:000573; GO:000563	 Adipocytokine signaling pathway; mTOR signaling pathway; Insulin resistance; FoxO signaling pathway; Circadian rhythm; Insulin signaling pathway; Hypertrophic cardiomyopathy (HCM); Regulation of autophagy; Oxytocin signaling pathway	hsa0492; hsa0415; hsa0493; hsa0406; hsa0471; hsa0491; hsa0541; hsa0414; hsa0492	chromatin binding;AMP-activated protein kinase activity;protein binding;cAMP-dependent protein kinase activity;tau-protein kinase activity;[acetyl-CoA carboxylase;[hydroxymethylglutaryl-CoA reductase (NADPH);ATP binding;protein C-terminus binding;metal ion binding;tau protein binding;histone serine kinase activity	GO:000368; GO:000467; GO:000551; GO:000469; GO:005032; GO:005040; GO:004732; GO:000552; GO:000802; GO:004687; GO:004815; GO:003517
NP_001161107.1	NP_001161107.1	NP_001161107.1 isovaleryl-CoA dehydrogenase, mitochondrial [Sus scrofa]	14	14	14	283070000	164830000	313520000	137660000	329200000	166150000	258150000	161880000	336750000	197060000	281790000	210160000	208630000	188250000	265280000	220930000	246530000	165800000	NA	NA	NA	IVD	IVD;NA;NA;NA;NA	leucine catabolic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase;branched-chain amino acid catabolic process	GO:000655; GO:003353; GO:000908	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	isovaleryl-CoA dehydrogenase activity;protein binding;flavin adenine dinucleotide binding	GO:000847; GO:000551; GO:005066
XP_005674023.1;XP_005674022.1;NP_001161108.1	XP_005674023.1;XP_005674022.1;NP_001161108.1	XP_005674023.1 sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X1 [Sus scrofa];XP_005674022.1 sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X1 [Sus scrofa];NP_001161108.1 sterol-4-alpha-carboxylate 3-dehydrogenase,	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123370000	NA	NA	NA	NSDHL	NSDHL;NSDHL;NSDHL;NA;NA	cholesterol biosynthetic process;smoothened signaling pathway;cholesterol metabolic process;oxidation-reduction process;hair follicle development;labyrinthine layer blood vessel development	GO:000669; GO:000722; GO:000820; GO:005511; GO:000194; GO:006071	integral component of membrane;endoplasmic reticulum membrane;lipid particle	GO:001602; GO:000578; GO:000581	 Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics	hsa0010; hsa0110; hsa0113	3-beta-hydroxy-delta5-steroid dehydrogenase activity;C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity;oxidoreductase activity;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity	GO:000385; GO:000025; GO:001649; GO:001661; GO:004701
NP_001161110.1	NP_001161110.1	NP_001161110.1 3-ketoacyl-CoA thiolase, mitochondrial [Sus scrofa]	15	15	15	227610000	182420000	316140000	182010000	259030000	174740000	367750000	251300000	379610000	239620000	201850000	186910000	113430000	208710000	187780000	198560000	146670000	170500000	NA	NA	NA	ACAA2	ACAA2;NA;NA;NA;NA	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cholesterol biosynthetic process;negative regulation of mitochondrial membrane permeability involved in apoptotic process;fatty acid beta-oxidation;cellular response to hypoxia	GO:190102; GO:000669; GO:190210; GO:000663; GO:007145	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Fatty acid degradation; Metabolic pathways; Fatty acid metabolism; Biosynthesis of antibiotics; Valine, leucine and isoleucine degradation; Fatty acid elongation	hsa0007; hsa0110; hsa0121; hsa0113; hsa0028; hsa0006	acetyl-CoA C-acetyltransferase activity;RNA binding;acetyl-CoA C-acyltransferase activity;protein binding	GO:000398; GO:000372; GO:000398; GO:000551
NP_001161111.1	NP_001161111.1	NP_001161111.1 annexin A4 [Sus scrofa]	22	21	21	910590000	627280000	626940000	1040900000	1026800000	640460000	720860000	1034000000	720480000	963420000	990200000	1414600000	609410000	1260800000	1212300000	1667900000	960750000	637000000	NA	NA	NA	ANXA4	ANXA4;NA;NA;NA;NA	negative regulation of catalytic activity;epithelial cell differentiation;Notch signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of apoptotic process;regulation of transcription from RNA polymerase II promoter;negative regulation of interleukin-8 secretion;signal transduction	GO:004308; GO:003085; GO:000721; GO:003208; GO:004306; GO:000635; GO:200048; GO:000716	cytoplasm;cell surface;perinuclear region of cytoplasm;cytosol;vesicle membrane;extracellular exosome;nucleus;plasma membrane;nuclear membrane	GO:000573; GO:000998; GO:004847; GO:000582; GO:001250; GO:007006; GO:000563; GO:000588; GO:003196	"NA"	"NA"	phospholipase inhibitor activity;chondroitin sulfate binding;protein binding;calcium ion binding;heparin binding;calcium-dependent phospholipid binding;identical protein binding;NF-kappaB binding;calcium-dependent protein binding	GO:000485; GO:003537; GO:000551; GO:000550; GO:000820; GO:000554; GO:004280; GO:005105; GO:004830
NP_001161113.1	NP_001161113.1	NP_001161113.1 copper transport protein ATOX1 [Sus scrofa]	4	4	4	180400000	170430000	148750000	159900000	182590000	168860000	170630000	153550000	153360000	169710000	203830000	207320000	260630000	179810000	185740000	167040000	198830000	187890000	NA	NA	NA	ATOX1	ATOX1;NA;NA;NA;NA	copper ion transport;copper ion export;response to oxidative stress;negative regulation of apoptotic process;cellular copper ion homeostasis	GO:000682; GO:006000; GO:000697; GO:004306; GO:000687	cytosol	GO:000582	 Mineral absorption	hsa0497	metallochaperone activity;copper-dependent protein binding;copper ion binding;protein binding;ATPase binding;copper chaperone activity	GO:001653; GO:003276; GO:000550; GO:000551; GO:005111; GO:001653
NP_001161122.1;NP_001230116.1	NP_001161122.1	NP_001161122.1 S-adenosylmethionine synthase [Sus scrofa]	7	7	7	41362000	52696000	46060000	48566000	28691000	47597000	46109000	45957000	42376000	43538000	48687000	54852000	51846000	37366000	43598000	48033000	40419000	38993000	NA	NA	NA	MAT2A	MAT2A;NA;NA;NA;NA	one-carbon metabolic process;protein hexamerization;protein heterooligomerization;cellular response to leukemia inhibitory factor;S-adenosylmethionine biosynthetic process	GO:000673; GO:003421; GO:005129; GO:199083; GO:000655	methionine adenosyltransferase complex;cytosol	GO:004826; GO:000582	 Cysteine and methionine metabolism; Biosynthesis of amino acids; Metabolic pathways	hsa0027; hsa0123; hsa0110	methionine adenosyltransferase activity;protein binding;metal ion binding;ATP binding;identical protein binding	GO:000447; GO:000551; GO:004687; GO:000552; GO:004280
XP_005656819.2;NP_001161124.1	XP_005656819.2;NP_001161124.1	XP_005656819.2 acyl carrier protein, mitochondrial isoform X1 [Sus scrofa];NP_001161124.1 acyl carrier protein, mitochondrial [Sus scrofa]	2	2	2	34485000	31388000	26767000	23382000	40755000	29921000	56092000	0	33446000	46358000	27244000	0	0	28395000	30957000	35537000	43054000	31087000	NA	NA	NA	NDUFAB1	NDUFAB1;NDUFAB1;NA;NA;NA	protein lipoylation;mitochondrial electron transport, NADH to ubiquinone;fatty acid biosynthetic process;mitochondrial respiratory chain complex I assembly	GO:000924; GO:000612; GO:000663; GO:003298	nucleoplasm;mitochondrial matrix;mitochondrial membrane;mitochondrion;mitochondrial respiratory chain complex I;mitochondrial large ribosomal subunit	GO:000565; GO:000575; GO:003196; GO:000573; GO:000574; GO:000576	 Oxidative phosphorylation; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways	hsa0019; hsa0501; hsa0493; hsa0110	NADH dehydrogenase (ubiquinone) activity;acyl binding;protein binding;calcium ion binding	GO:000813; GO:000003; GO:000551; GO:000550
NP_001161887.1	NP_001161887.1	NP_001161887.1 non-specific lipid-transfer protein [Sus scrofa]	10	10	10	86875000	102320000	87299000	62555000	88442000	103840000	78261000	58883000	98581000	74963000	89544000	83651000	69293000	84727000	87171000	70138000	78910000	94421000	NA	NA	NA	SCP2	SCP2;NA;NA;NA;NA	alpha-linolenic acid metabolic process;protein targeting to peroxisome;bile acid biosynthetic process;lipid hydroperoxide transport;phospholipid transport;positive regulation of intracellular cholesterol transport;fatty acid beta-oxidation using acyl-CoA oxidase	GO:003610; GO:000662; GO:000669; GO:190137; GO:001591; GO:003238; GO:003354	nucleoplasm;mitochondrion;peroxisomal matrix;membrane;macromolecular complex;cytosol;peroxisome;intracellular membrane-bounded organelle	GO:000565; GO:000573; GO:000578; GO:001602; GO:003299; GO:000582; GO:000577; GO:004323	 Peroxisome; Primary bile acid biosynthesis; PPAR signaling pathway; Metabolic pathways	hsa0414; hsa0012; hsa0332; hsa0110	fatty-acyl-CoA binding;protein binding;cholesterol binding;long-chain fatty acyl-CoA binding;propanoyl-CoA C-acyltransferase activity;receptor binding;oleic acid binding;propionyl-CoA C2-trimethyltridecanoyltransferase activity	GO:000006; GO:000551; GO:001548; GO:003604; GO:003381; GO:000510; GO:007053; GO:005063
NP_001161893.1;XP_005663781.1;XP_005663780.1;XP_005663778.1;XP_013852888.1;XP_013852887.1	NP_001161893.1;XP_005663781.1;XP_005663780.1;XP_005663778.1;XP_013852888.1;XP_013852887.1	NP_001161893.1 endophilin-B1 [Sus scrofa];XP_005663781.1 endophilin-B1 isoform X3 [Sus scrofa];XP_005663780.1 endophilin-B1 isoform X2 [Sus scrofa];XP_005663778.1 endophilin-B1 isoform X1 [Sus scrofa];XP_013852888.1 endophilin-B1 isoform X5 [Sus scrofa];XP	12	12	12	39377000	81511000	71665000	81074000	53414000	66264000	62637000	63524000	65631000	71956000	56103000	80151000	54883000	91674000	67609000	85394000	64513000	75650000	NA	NA	NA	SH3GLB1	SH3GLB1;SH3GLB1;SH3GLB1;SH3GLB1;SH3GLB1	cellular response to amino acid starvation;regulation of macroautophagy;regulation of cytokinesis;receptor catabolic process;positive regulation of membrane tubulation;positive regulation of autophagy;protein oligomerization;membrane fission;positive regulation of protein targeting to mitochondrion;autophagy;regulation of protein stability;protein localization to vacuolar membrane;cellular response to glucose starvation;autophagic cell death;positive regulation of autophagosome assembly	GO:003419; GO:001624; GO:003246; GO:003280; GO:190352; GO:001050; GO:005125; GO:009014; GO:190395; GO:000691; GO:003164; GO:190377; GO:004214; GO:004810; GO:200078	Golgi membrane;cytoplasm;cytosol;midbody;autophagosome membrane;mitochondrial outer membrane;cytoplasmic vesicle	GO:000013; GO:000573; GO:000582; GO:003049; GO:000042; GO:000574; GO:003141	 Endocytosis	hsa0414	lipid binding;cadherin binding;protein homodimerization activity;protein binding	GO:000828; GO:004529; GO:004280; GO:000551
NP_001163991.1;XP_020946622.1	NP_001163991.1;XP_020946622.1	NP_001163991.1 T-complex protein 1 subunit beta [Sus scrofa];XP_020946622.1 T-complex protein 1 subunit beta isoform X1 [Sus scrofa]	16	16	16	301490000	216240000	262120000	208290000	287570000	206410000	251020000	190930000	279020000	241540000	256580000	223750000	320960000	219830000	247850000	210690000	271860000	227810000	NA	NA	NA	CCT2	CCT2;CCT2;NA;NA;NA	positive regulation of telomere maintenance via telomerase;protein stabilization;chaperone mediated protein folding independent of cofactor;positive regulation of establishment of protein localization to telomere;positive regulation of telomerase RNA localization to Cajal body;neutrophil degranulation;positive regulation of telomerase activity;protein folding;chaperone-mediated protein complex assembly;binding of sperm to zona pellucida;toxin transport;scaRNA localization to Cajal body	GO:003221; GO:005082; GO:005108; GO:190485; GO:190487; GO:004331; GO:005197; GO:000645; GO:005113; GO:000733; GO:190199; GO:009066	extracellular exosome;microtubule;extracellular region;cytosol;azurophil granule lumen;zona pellucida receptor complex;chaperonin-containing T-complex;cell body	GO:007006; GO:000587; GO:000557; GO:000582; GO:003557; GO:000219; GO:000583; GO:004429	"NA"	"NA"	ATP binding;unfolded protein binding;protein binding;ubiquitin protein ligase binding;protein binding involved in protein folding	GO:000552; GO:005108; GO:000551; GO:003162; GO:004418
NP_001163993.1	NP_001163993.1	NP_001163993.1 T-complex protein 1 subunit eta [Sus scrofa]	14	14	14	202370000	139620000	223770000	164640000	211330000	150370000	201130000	152230000	202960000	192420000	150100000	147240000	160360000	153910000	180680000	155230000	179470000	151660000	NA	NA	NA	CCT7	CCT7;NA;NA;NA;NA	binding of sperm to zona pellucida;toxin transport;positive regulation of telomerase RNA localization to Cajal body;protein folding;positive regulation of telomere maintenance via telomerase;protein stabilization;positive regulation of establishment of protein localization to telomere	GO:000733; GO:190199; GO:190487; GO:000645; GO:003221; GO:005082; GO:190485	cell body;cytosol;chaperonin-containing T-complex;microtubule;extracellular exosome;cytoplasm	GO:004429; GO:000582; GO:000583; GO:000587; GO:007006; GO:000573	"NA"	"NA"	identical protein binding;protein binding;unfolded protein binding;ATP binding	GO:004280; GO:000551; GO:005108; GO:000552
NP_001165456.1;NP_001165454.1;NP_999477.2;NP_001165455.1;XP_020932812.1;XP_020932811.1;XP_020932810.1;XP_020932809.1;XP_020932823.1;XP_020932822.1;XP_020932821.1;XP_020932820.1;XP_020932819.1;XP_020932817.1;XP_020932816.1;XP_020932815.1;XP_020932814.1;XP_020932813.1;XP_020951707.1;XP_020951706.1;XP_003482083.4	NP_001165456.1;NP_001165454.1;NP_999477.2;NP_001165455.1;XP_020932812.1;XP_020932811.1;XP_020932810.1;XP_020932809.1;XP_020932823.1;XP_020932822.1;XP_020932821.1;XP_020932820.1;XP_020932819.1;XP_020932817.1;XP_020932816.1;XP_020932815.1;XP_020932814.1;XP_020932813.1	NP_001165456.1 guanine nucleotide-binding protein G(s) subunit alpha isoform g [Sus scrofa];NP_001165454.1 guanine nucleotide-binding protein G(s) subunit alpha isoform GNASS [Sus scrofa];NP_999477.2 guanine nucleotide-binding protein G(s) subunit alpha is	17	16	16	256730000	262970000	294220000	231900000	214260000	191800000	210440000	232690000	199240000	205130000	217600000	259970000	164110000	236810000	221750000	251100000	236470000	215190000	NA	NA	NA	GNAS	GNAS;GNAS;GNAS;GNAS;GNAS	response to drug;positive regulation of osteoblast differentiation;embryonic cranial skeleton morphogenesis;endochondral ossification;positive regulation of catalytic activity;tissue homeostasis;platelet aggregation;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;embryonic hindlimb morphogenesis;cartilage development;energy reserve metabolic process;developmental growth;bone development;genetic imprinting;DNA methylation;multicellular organism growth;regulation of parathyroid hormone secretion;adenylate cyclase-activating dopamine receptor signaling pathway;post-embryonic body morphogenesis;skin development;positive regulation of osteoclast differentiation	GO:004249; GO:004566; GO:004870; GO:000195; GO:004308; GO:000189; GO:007052; GO:000718; GO:003511; GO:005121; GO:000611; GO:004858; GO:006034; GO:007151; GO:000630; GO:003526; GO:200082; GO:000719; GO:004003; GO:004358; GO:004567	membrane;apical plasma membrane;cytosol;dendrite;heterotrimeric G-protein complex;extracellular exosome	GO:001602; GO:001632; GO:000582; GO:003042; GO:000583; GO:007006	 Rap1 signaling pathway; Platelet activation; Ovarian steroidogenesis; Aldosterone synthesis and secretion; Salivary secretion; Cocaine addiction; cAMP signaling pathway; Circadian entrainment; Glutamatergic synapse; Long-term depression; Vasopressin-regulated water reabsorption; Amoebiasis; Dilated cardiomyopathy; Vascular smooth muscle contraction; Inflammatory mediator regulation of TRP channels; Vibrio cholerae infection; Taste transduction; Gap junction; Pathways in cancer; Adrenergic signaling in cardiomyocytes	hsa0401; hsa0461; hsa0491; hsa0492; hsa0497; hsa0503; hsa0402; hsa0471; hsa0472; hsa0473; hsa0496; hsa0514; hsa0541; hsa0427; hsa0475; hsa0511; hsa0474; hsa0454; hsa0520; hsa0426	G-protein beta/gamma-subunit complex binding;G-protein coupled receptor binding;protein binding;adenylate cyclase activator activity;GTPase activity;metal ion binding;corticotropin-releasing hormone receptor 1 binding;beta-2 adrenergic receptor binding;D1 dopamine receptor binding;ionotropic glutamate receptor binding;mu-type opioid receptor binding;insulin-like growth factor receptor binding;GTP binding	GO:003168; GO:000166; GO:000551; GO:001085; GO:000392; GO:004687; GO:005143; GO:003169; GO:003174; GO:003525; GO:003185; GO:000515; GO:000552
NP_001165837.1	NP_001165837.1	NP_001165837.1 coatomer subunit beta [Sus scrofa]	17	17	17	119050000	109500000	107830000	135510000	117930000	112090000	100960000	117770000	114850000	127310000	109620000	150790000	152210000	113150000	120060000	123360000	117670000	153860000	NA	NA	NA	COPB1	COPB1;NA;NA;NA;NA	viral process;intracellular protein transport;neutrophil degranulation;intra-Golgi vesicle-mediated transport	GO:001603; GO:000688; GO:004331; GO:000689	cytosol;membrane;transport vesicle;Golgi-associated vesicle;intracellular membrane-bounded organelle;tertiary granule membrane;COPI vesicle coat;ficolin-1-rich granule membrane;endoplasmic reticulum membrane;secretory granule membrane;Golgi membrane;plasma membrane	GO:000582; GO:001602; GO:003013; GO:000579; GO:004323; GO:007082; GO:003012; GO:010100; GO:000578; GO:003066; GO:000013; GO:000588	"NA"	"NA"	structural molecule activity;protein binding	GO:000519; GO:000551
NP_001167604.1	NP_001167604.1	NP_001167604.1 calreticulin precursor [Sus scrofa]	16	16	16	664580000	831990000	948780000	780780000	778730000	965480000	884490000	904590000	700040000	675240000	798340000	933500000	773520000	935750000	929220000	747410000	892240000	945460000	NA	NA	NA	CALR	CALR;NA;NA;NA;NA	regulation of meiotic nuclear division;negative regulation of neuron differentiation;positive regulation of phagocytosis;peptide antigen assembly with MHC class I protein complex;receptor-mediated endocytosis;positive regulation of cell proliferation;positive regulation of gene expression;negative regulation of translation;positive regulation of cell cycle;sequestering of calcium ion;cellular senescence;positive regulation of dendritic cell chemotaxis;protein export from nucleus;response to estradiol;regulation of apoptotic process;negative regulation of transcription, DNA-templated;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;regulation of transcription, DNA-templated;protein folding;spermatogenesis;positive regulation of endothelial cell migration;cortical actin cytoskeleton organization;ATF6-mediated unfolded protein response;response to drug;glucocorticoid receptor signaling pathway;negative regulation of cell cycle arrest;positive regulation of NIK/NF-kappaB signaling;negative regulation of retinoic acid receptor signaling pathway;antigen processing and presentation of peptide antigen via MHC class I;cellular calcium ion homeostasis;negative regulation of transcription from RNA polymerase II promoter;protein maturation by protein folding;negative regulation of intracellular steroid hormone receptor signaling pathway;cellular response to lithium ion;negative regulation of trophoblast cell migration;response to testosterone;protein localization to nucleus;protein folding in endoplasmic reticulum;protein stabilization;cardiac muscle cell differentiation;positive regulation of substrate adhesion-dependent cell spreading	GO:004002; GO:004566; GO:005076; GO:000250; GO:000689; GO:000828; GO:001062; GO:001714; GO:004578; GO:005120; GO:009039; GO:200051; GO:000661; GO:003235; GO:004298; GO:004589; GO:199066; GO:000635; GO:000645; GO:000728; GO:001059; GO:003086; GO:003650; GO:004249; GO:004292; GO:007115; GO:190122; GO:004838; GO:000247; GO:000687; GO:000012; GO:002241; GO:003314; GO:007128; GO:190116; GO:003357; GO:003450; GO:003497; GO:005082; GO:005500; GO:190002	nucleus;smooth endoplasmic reticulum;endoplasmic reticulum quality control compartment;extracellular region;nuclear envelope;endoplasmic reticulum lumen;polysome;endocytic vesicle lumen;extracellular space;cytosol;external side of plasma membrane;focal adhesion;cell surface;endoplasmic reticulum-Golgi intermediate compartment membrane;extracellular exosome;integral component of lumenal side of endoplasmic reticulum membrane;phagocytic vesicle membrane;sarcoplasmic reticulum lumen;acrosomal vesicle;MHC class I peptide loading complex;cytoplasm;membrane;perinuclear region of cytoplasm	GO:000563; GO:000579; GO:004432; GO:000557; GO:000563; GO:000578; GO:000584; GO:007168; GO:000561; GO:000582; GO:000989; GO:000592; GO:000998; GO:003311; GO:007006; GO:007155; GO:003067; GO:003301; GO:000166; GO:004282; GO:000573; GO:001602; GO:004847	 Protein processing in endoplasmic reticulum; Phagosome; Antigen processing and presentation; Chagas disease (American trypanosomiasis); HTLV-I infection	hsa0414; hsa0414; hsa0461; hsa0514; hsa0516	calcium ion binding;zinc ion binding;mRNA binding;integrin binding;hormone binding;androgen receptor binding;iron ion binding;unfolded protein binding;protein binding involved in protein folding;peptide binding;protein binding;ubiquitin protein ligase binding;complement component C1q binding;carbohydrate binding;DNA binding	GO:000550; GO:000827; GO:000372; GO:000517; GO:004256; GO:005068; GO:000550; GO:005108; GO:004418; GO:004227; GO:000551; GO:003162; GO:000184; GO:003024; GO:000367
XP_005653336.1;NP_001170799.1	XP_005653336.1;NP_001170799.1	XP_005653336.1 apolipoprotein C-II isoform X1 [Sus scrofa];NP_001170799.1 apolipoprotein C-II precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6231000	0	0	0	NA	NA	NA	APOC2	APOC2;APOC2;NA;NA;NA	negative regulation of cholesterol transport;chylomicron remodeling;negative regulation of catalytic activity;response to drug;negative regulation of lipid metabolic process;negative regulation of very-low-density lipoprotein particle clearance;triglyceride homeostasis;positive regulation of very-low-density lipoprotein particle remodeling;cholesterol efflux;positive regulation of fatty acid biosynthetic process;positive regulation of triglyceride catabolic process;phospholipid efflux;retinoid metabolic process;reverse cholesterol transport;negative regulation of receptor-mediated endocytosis;positive regulation of lipoprotein lipase activity;lipid catabolic process;chylomicron remnant clearance;cholesterol homeostasis;lipoprotein transport;positive regulation of phospholipid catabolic process;positive regulation of phospholipase activity	GO:003237; GO:003437; GO:004308; GO:004249; GO:004583; GO:001091; GO:007032; GO:001090; GO:003334; GO:004572; GO:001089; GO:003370; GO:000152; GO:004369; GO:004826; GO:005100; GO:001604; GO:003438; GO:004263; GO:004295; GO:006069; GO:001051	intermediate-density lipoprotein particle;chylomicron;early endosome;low-density lipoprotein particle;extracellular space;extracellular region	GO:003436; GO:004262; GO:000576; GO:003436; GO:000561; GO:000557	"NA"	"NA"	phospholipase binding;protein homodimerization activity;lipase inhibitor activity;phospholipase activator activity;lipoprotein lipase activator activity;lipid binding	GO:004327; GO:004280; GO:005510; GO:001600; GO:006023; GO:000828
XP_020944152.1;NP_001171994.1	XP_020944152.1;NP_001171994.1	XP_020944152.1 myelin P2 protein isoform X2 [Sus scrofa];NP_001171994.1 myelin P2 protein [Sus scrofa]	7	6	6	0	4584500000	0	0	0	0	0	0	0	55660000	0	0	0	0	0	0	0	0	NA	NA	NA	PMP2	PMP2;PMP2;NA;NA;NA	membrane organization	GO:006102	extracellular exosome;myelin sheath;cytoplasm	GO:007006; GO:004320; GO:000573	"NA"	"NA"	protein binding;cholesterol binding;fatty acid binding	GO:000551; GO:001548; GO:000550
XP_020946556.1;XP_005655643.1;NP_001171997.1	XP_020946556.1;XP_005655643.1;NP_001171997.1	XP_020946556.1 protein canopy homolog 2 isoform X1 [Sus scrofa];XP_005655643.1 protein canopy homolog 2 isoform X1 [Sus scrofa];NP_001171997.1 protein canopy homolog 2 precursor [Sus scrofa]	5	5	5	0	42526000	0	50499000	52025000	89774000	41432000	54529000	37939000	49607000	60520000	59532000	59094000	61340000	45526000	52908000	54262000	48788000	NA	NA	NA	CNPY2	CNPY2;CNPY2;CNPY2;NA;NA	positive regulation of low-density lipoprotein particle receptor biosynthetic process;negative regulation of gene expression;regulation of low-density lipoprotein particle clearance	GO:004571; GO:001062; GO:001098	endoplasmic reticulum	GO:000578	"NA"	"NA"	protein binding	GO:000551
NP_001171999.1;XP_005670990.1;XP_020944478.1;XP_020944470.1;XP_020944460.1;XP_020944452.1;XP_013842274.1;XP_020944446.1;XP_020944437.1	NP_001171999.1;XP_005670990.1	NP_001171999.1 ran-specific GTPase-activating protein [Sus scrofa];XP_005670990.1 ran-specific GTPase-activating protein isoform X1 [Sus scrofa]	6	6	6	79885000	78285000	68080000	65541000	70298000	90572000	87367000	72616000	67943000	80873000	77842000	74471000	80430000	80984000	82739000	75414000	75129000	73250000	NA	NA	NA	RANBP1	RANBP1;RANBP1;NA;NA;NA	positive regulation of mitotic centrosome separation;signal transduction;positive regulation of GTPase activity;viral process;intracellular transport	GO:004660; GO:000716; GO:004354; GO:001603; GO:004690	nuclear pore;cytoplasm;cytosol;nuclear envelope;centrosome	GO:000564; GO:000573; GO:000582; GO:000563; GO:000581	 HTLV-I infection; Viral carcinogenesis	hsa0516; hsa0520	GDP-dissociation inhibitor activity;Ran GTPase binding;cadherin binding;GTPase activator activity;protein binding	GO:000509; GO:000853; GO:004529; GO:000509; GO:000551
XP_005663367.1;XP_020944218.1;XP_020944216.1;NP_001172060.1;XP_020944215.1	XP_005663367.1;XP_020944218.1;XP_020944216.1;NP_001172060.1;XP_020944215.1	XP_005663367.1 farnesyl pyrophosphate synthase isoform X4 [Sus scrofa];XP_020944218.1 farnesyl pyrophosphate synthase isoform X3 [Sus scrofa];XP_020944216.1 farnesyl pyrophosphate synthase isoform X2 [Sus scrofa];NP_001172060.1 farnesyl pyrophosphate synth	8	8	8	139490000	127410000	131840000	128080000	167060000	129340000	143340000	153310000	150960000	131390000	140450000	180200000	104940000	140140000	130320000	138800000	89134000	133940000	NA	NA	NA	FDPS	FDPS;FDPS;FDPS;FDPS;FDPS	viral process;regulation of cholesterol biosynthetic process;farnesyl diphosphate biosynthetic process;cholesterol biosynthetic process;geranyl diphosphate biosynthetic process	GO:001603; GO:004554; GO:004533; GO:000669; GO:003338	cytoplasm;nucleoplasm;cytosol	GO:000573; GO:000565; GO:000582	 Metabolic pathways; Biosynthesis of antibiotics; Terpenoid backbone biosynthesis; HTLV-I infection	hsa0110; hsa0113; hsa0090; hsa0516	metal ion binding;RNA binding;geranyltranstransferase activity;dimethylallyltranstransferase activity	GO:004687; GO:000372; GO:000433; GO:000416
NP_001172061.2	NP_001172061.2	NP_001172061.2 leukotriene A-4 hydrolase [Sus scrofa]	17	17	17	177460000	201520000	256570000	213750000	185000000	242200000	250140000	212230000	243080000	218360000	190320000	188420000	273540000	224990000	231450000	243760000	234650000	211910000	NA	NA	NA	LTA4H	LTA4H;NA;NA;NA;NA	long-chain fatty acid biosynthetic process;peptide catabolic process;cellular protein metabolic process;leukotriene metabolic process;cellular lipid metabolic process;proteolysis;leukotriene biosynthetic process;neutrophil degranulation	GO:004275; GO:004317; GO:004426; GO:000669; GO:004425; GO:000650; GO:001937; GO:004331	cytosol;ficolin-1-rich granule lumen;nucleus;tertiary granule lumen;extracellular region;extracellular exosome;nucleoplasm	GO:000582; GO:190481; GO:000563; GO:190472; GO:000557; GO:007006; GO:000565	 Arachidonic acid metabolism; Metabolic pathways	hsa0059; hsa0110	epoxide hydrolase activity;leukotriene-A4 hydrolase activity;zinc ion binding;protein binding;RNA binding;peptidase activity;aminopeptidase activity;metalloaminopeptidase activity	GO:000430; GO:000446; GO:000827; GO:000551; GO:000372; GO:000823; GO:000417; GO:007000
NP_001172062.1;XP_005670934.1	NP_001172062.1;XP_005670934.1	NP_001172062.1 ubiquitin-conjugating enzyme E2 L3 [Sus scrofa];XP_005670934.1 ubiquitin-conjugating enzyme E2 L3 isoform X1 [Sus scrofa]	6	6	6	70638000	87741000	88869000	64460000	70596000	82001000	63811000	71161000	74455000	87028000	63454000	63160000	79221000	70109000	69816000	71031000	73234000	83470000	NA	NA	NA	UBE2L3	UBE2L3;UBE2L3;NA;NA;NA	protein K11-linked ubiquitination;positive regulation of protein targeting to mitochondrion;protein polyubiquitination;cellular protein modification process;ubiquitin-dependent protein catabolic process;positive regulation of protein ubiquitination;protein ubiquitination;cell proliferation;cellular response to glucocorticoid stimulus;regulation of transcription, DNA-templated;cell cycle phase transition;positive regulation of ubiquitin-protein transferase activity;positive regulation of nucleic acid-templated transcription	GO:007097; GO:190395; GO:000020; GO:000646; GO:000651; GO:003139; GO:001656; GO:000828; GO:007138; GO:000635; GO:004477; GO:005144; GO:190350	cytoplasm;nucleoplasm;ubiquitin ligase complex;nucleus;cytosol	GO:000573; GO:000565; GO:000015; GO:000563; GO:000582	 Ubiquitin mediated proteolysis; Parkinson's disease	hsa0412; hsa0501	ubiquitin-protein transferase activity;ubiquitin conjugating enzyme activity;transcription coactivator activity;RNA binding;protein binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activator activity;ATP binding	GO:000484; GO:006163; GO:000371; GO:000372; GO:000551; GO:003162; GO:001989; GO:009702; GO:000552
NP_001172063.1	NP_001172063.1	NP_001172063.1 actin-related protein 2/3 complex subunit 5-like protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	12087000	10910000	11244000	0	0	0	0	0	0	0	0	NA	NA	NA	ARPC5L	ARPC5L;NA;NA;NA;NA	biological_process;cell migration;Arp2/3 complex-mediated actin nucleation	GO:000815; GO:001647; GO:003431	cytoplasm;focal adhesion;extracellular exosome;glutamatergic synapse;Arp2/3 protein complex	GO:000573; GO:000592; GO:007006; GO:009897; GO:000588	 Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells; Pathogenic Escherichia coli infection; Fc gamma R-mediated phagocytosis; Endocytosis	hsa0481; hsa0510; hsa0513; hsa0466; hsa0414	protein binding;actin filament binding;molecular_function	GO:000551; GO:005101; GO:000367
NP_001172064.1	NP_001172064.1	NP_001172064.1 actin-related protein 2/3 complex subunit 3 [Sus scrofa]	5	5	5	65754000	81826000	79037000	89653000	67430000	95377000	77486000	77048000	81444000	93511000	71770000	129280000	146250000	95890000	78621000	92468000	95622000	82937000	NA	NA	NA	ARPC3	ARPC3;NA;NA;NA;NA	membrane organization;ephrin receptor signaling pathway;actin polymerization-dependent cell motility;Arp2/3 complex-mediated actin nucleation;Fc-gamma receptor signaling pathway involved in phagocytosis	GO:006102; GO:004801; GO:007035; GO:003431; GO:003809	focal adhesion;nucleus;extracellular exosome;cytosol;membrane;lamellipodium;site of double-strand break;actin cytoskeleton;Arp2/3 protein complex	GO:000592; GO:000563; GO:007006; GO:000582; GO:001602; GO:003002; GO:003586; GO:001562; GO:000588	 Bacterial invasion of epithelial cells; Pathogenic Escherichia coli infection; Endocytosis; Fc gamma R-mediated phagocytosis; Regulation of actin cytoskeleton	hsa0510; hsa0513; hsa0414; hsa0466; hsa0481	structural constituent of cytoskeleton;actin filament binding;protein binding	GO:000520; GO:005101; GO:000551
NP_001172068.1	NP_001172068.1	NP_001172068.1 sialic acid synthase [Sus scrofa]	3	3	3	20736000	0	33424000	0	0	0	0	35906000	0	34384000	0	0	0	0	0	31624000	37051000	0	NA	NA	NA	NANS	NANS;NA;NA;NA;NA	CMP-N-acetylneuraminate biosynthetic process;carbohydrate biosynthetic process	GO:000605; GO:001605	cytoplasm;cytosol;extracellular exosome	GO:000573; GO:000582; GO:007006	 Amino sugar and nucleotide sugar metabolism; Metabolic pathways	hsa0052; hsa0110	N-acetylneuraminate synthase activity;N-acylneuraminate cytidylyltransferase activity;N-acylneuraminate-9-phosphate synthase activity	GO:005046; GO:000878; GO:004744
NP_001172070.1;XP_020927658.1;XP_005671603.1;XP_005671605.2	NP_001172070.1;XP_020927658.1;XP_005671603.1;XP_005671605.2	NP_001172070.1 ornithine aminotransferase, mitochondrial [Sus scrofa];XP_020927658.1 ornithine aminotransferase, mitochondrial isoform X2 [Sus scrofa];XP_005671603.1 ornithine aminotransferase, mitochondrial isoform X2 [Sus scrofa];XP_005671605.2 ornithine	9	9	9	53444000	34831000	45829000	28250000	53614000	31061000	48343000	36369000	62008000	42593000	44761000	33263000	38571000	32676000	39112000	37590000	47087000	37360000	NA	NA	NA	OAT	OAT;OAT;OAT;OAT;NA	visual perception;arginine catabolic process to proline via ornithine;arginine catabolic process to glutamate;protein hexamerization;cellular amino acid biosynthetic process;L-proline biosynthetic process	GO:000760; GO:001012; GO:001954; GO:003421; GO:000865; GO:005512	nucleoplasm;cytoplasm;mitochondrial matrix	GO:000565; GO:000573; GO:000575	 Metabolic pathways; Arginine and proline metabolism; Biosynthesis of antibiotics	hsa0110; hsa0033; hsa0113	pyridoxal phosphate binding;ornithine-oxo-acid transaminase activity	GO:003017; GO:000458
NP_001172071.1	NP_001172071.1	NP_001172071.1 ATP synthase subunit alpha, mitochondrial [Sus scrofa]	31	31	31	3849100000	2198400000	3074700000	2331800000	3232500000	1838700000	3589300000	2709700000	3122600000	2684200000	2959400000	2282900000	2133800000	2517400000	3009100000	2633100000	2249800000	2062500000	NA	NA	NA	ATP5F1A	ATP5F1A;NA;NA;NA;NA	lipid metabolic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;ATP synthesis coupled proton transport;electron transport chain;positive regulation of blood vessel endothelial cell migration;ATP biosynthetic process;negative regulation of endothelial cell proliferation;response to oxidative stress;ATP metabolic process;ATP hydrolysis coupled cation transmembrane transport	GO:000662; GO:004240; GO:004277; GO:001598; GO:002290; GO:004353; GO:000675; GO:000193; GO:000697; GO:004603; GO:009913	COP9 signalosome;mitochondrion;mitochondrial inner membrane;plasma membrane;extracellular exosome;mitochondrial proton-transporting ATP synthase complex, catalytic core F(1);mitochondrial proton-transporting ATP synthase complex;proton-transporting ATP synthase complex;membrane	GO:000818; GO:000573; GO:000574; GO:000588; GO:007006; GO:000027; GO:000575; GO:004525; GO:001602	 Oxidative phosphorylation; Metabolic pathways; Parkinson's disease	hsa0019; hsa0110; hsa0501	ATPase activity;MHC class I protein binding;ADP binding;protein binding;ATP binding;proton-transporting ATP synthase activity, rotational mechanism;RNA binding;transmembrane transporter activity	GO:001688; GO:004228; GO:004353; GO:000551; GO:000552; GO:004693; GO:000372; GO:002285
NP_001172092.1	NP_001172092.1	NP_001172092.1 enhancer of rudimentary homolog [Sus scrofa]	3	3	3	0	60817000	65716000	50853000	0	73217000	62270000	59693000	52513000	49270000	59558000	0	70100000	68264000	52122000	64451000	66602000	63814000	NA	NA	NA	ERH	ERH;NA;NA;NA;NA	pyrimidine nucleoside metabolic process;cell cycle;pyrimidine nucleotide biosynthetic process;positive regulation of Notch signaling pathway;nucleobase-containing compound metabolic process	GO:000621; GO:000704; GO:000622; GO:004574; GO:000613	midbody;methylosome	GO:003049; GO:003470	"NA"	"NA"	RNA binding;methyl-CpG binding;protein binding	GO:000372; GO:000832; GO:000551
NP_001172096.1	NP_001172096.1	NP_001172096.1 signal sequence receptor, alpha [Sus scrofa]	3	3	3	0	32294000	28588000	41976000	34048000	19106000	20456000	28033000	0	36478000	22208000	0	25012000	25075000	28894000	19007000	29230000	32716000	NA	NA	NA	SSR1	SSR1;NA;NA;NA;NA	cotranslational protein targeting to membrane;positive regulation of cell proliferation;IRE1-mediated unfolded protein response	GO:000661; GO:000828; GO:003649	endoplasmic reticulum;integral component of membrane;endoplasmic reticulum membrane	GO:000578; GO:001602; GO:000578	 Protein processing in endoplasmic reticulum	hsa0414	protein binding	GO:000551
NP_001172098.1	NP_001172098.1	NP_001172098.1 secretory carrier-associated membrane protein 3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16929000	NA	NA	NA	SCAMP3	SCAMP3;NA;NA;NA;NA	protein transport;post-Golgi vesicle-mediated transport	GO:001503; GO:000689	recycling endosome membrane;extracellular exosome;integral component of membrane;intracellular membrane-bounded organelle;Golgi membrane;trans-Golgi network membrane;Golgi apparatus	GO:005503; GO:007006; GO:001602; GO:004323; GO:000013; GO:003258; GO:000579	"NA"	"NA"	ubiquitin protein ligase binding	GO:003162
XP_020944286.1;XP_020944285.1;NP_001172101.1	XP_020944286.1;XP_020944285.1;NP_001172101.1	XP_020944286.1 ubiquinol-cytochrome c reductase binding protein isoform X2 [Sus scrofa];XP_020944285.1 ubiquinol-cytochrome c reductase binding protein isoform X1 [Sus scrofa];NP_001172101.1 ubiquinol-cytochrome c reductase binding protein [Sus scrofa]	3	3	3	96920000	55314000	97924000	52945000	85538000	58985000	125480000	75168000	94363000	56976000	87408000	0	42501000	55840000	90340000	64279000	61670000	56136000	NA	NA	NA	UQCRB	UQCRB;UQCRB;UQCRB;NA;NA	oxidative phosphorylation;mitochondrial electron transport, ubiquinol to cytochrome c;oxidation-reduction process;aerobic respiration;mitochondrial respiratory chain complex III assembly	GO:000611; GO:000612; GO:005511; GO:000906; GO:003455	mitochondrial inner membrane;mitochondrial respiratory chain;mitochondrial respiratory chain complex III	GO:000574; GO:000574; GO:000575	 Metabolic pathways; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation; Cardiac muscle contraction	hsa0110; hsa0501; hsa0493; hsa0019; hsa0426	protein binding;ubiquinol-cytochrome-c reductase activity	GO:000551; GO:000812
NP_001172107.1	NP_001172107.1	NP_001172107.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 [Sus scrofa]	4	4	4	29850000	15771000	25530000	0	29029000	0	29693000	22217000	28475000	20381000	21595000	21616000	0	17399000	21774000	25197000	22677000	17496000	NA	NA	NA	NDUFA6	NDUFA6;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;response to oxidative stress;mitochondrial respiratory chain complex I assembly	GO:000612; GO:000697; GO:003298	mitochondrial respiratory chain complex I;mitochondrial inner membrane;mitochondrial membrane	GO:000574; GO:000574; GO:003196	 Metabolic pathways; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0110; hsa0501; hsa0493; hsa0019	NADH dehydrogenase (ubiquinone) activity	GO:000813
NP_001172109.1;NP_001172108.1;XP_005665938.1	NP_001172109.1;NP_001172108.1;XP_005665938.1	NP_001172109.1 prefoldin subunit 6 [Sus scrofa];NP_001172108.1 prefoldin subunit 6 [Sus scrofa];XP_005665938.1 prefoldin subunit 6 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7985600	NA	NA	NA	PFDN6	PFDN6;PFDN6;PFDN6;NA;NA	protein folding;chaperone-mediated protein complex assembly	GO:000645; GO:005113	prefoldin complex;cytoplasm	GO:001627; GO:000573	"NA"	"NA"	unfolded protein binding;chaperone binding	GO:005108; GO:005108
XP_020930183.1;XP_020930182.1;NP_001172115.1	XP_020930183.1;XP_020930182.1;NP_001172115.1	XP_020930183.1 aspartyl aminopeptidase isoform X1 [Sus scrofa];XP_020930182.1 aspartyl aminopeptidase isoform X1 [Sus scrofa];NP_001172115.1 aspartyl aminopeptidase [Sus scrofa]	4	4	4	6929300	6900000	6865600	6290000	0	0	7710800	0	9207100	0	0	5349500	0	7184900	7202100	8326200	0	0	NA	NA	NA	DNPEP	DNPEP;DNPEP;DNPEP;NA;NA	peptide metabolic process;proteolysis	GO:000651; GO:000650	cytoplasm;extracellular region;blood microparticle;cytosol;nucleus	GO:000573; GO:000557; GO:007256; GO:000582; GO:000563	"NA"	"NA"	protein binding;aminopeptidase activity;zinc ion binding;metalloaminopeptidase activity;identical protein binding	GO:000551; GO:000417; GO:000827; GO:007000; GO:004280
NP_001173223.1	NP_001173223.1	NP_001173223.1 apolipoprotein A-II precursor [Sus scrofa]	3	3	3	232980000	70518000	122470000	190670000	292670000	159680000	150570000	183730000	253080000	154630000	62179000	70655000	68548000	65692000	130630000	0	76789000	68850000	NA	NA	NA	APOA2	APOA2;NA;NA;NA;NA	regulation of lipid metabolic process;high-density lipoprotein particle remodeling;cholesterol homeostasis;positive regulation of catalytic activity;negative regulation of cholesterol transporter activity;reverse cholesterol transport;phospholipid catabolic process;negative regulation of very-low-density lipoprotein particle remodeling;regulation of protein stability;cholesterol efflux;high-density lipoprotein particle assembly;retinoid metabolic process;phosphatidylcholine biosynthetic process;cholesterol metabolic process;viral process;animal organ regeneration;protein stabilization;lipoprotein metabolic process;triglyceride metabolic process;negative regulation of cholesterol transport;diacylglycerol catabolic process;positive regulation of phagocytosis;phospholipid efflux;response to estrogen;cellular protein metabolic process;positive regulation of interleukin-8 biosynthetic process;positive regulation of lipid catabolic process;response to glucose;regulation of intestinal cholesterol absorption;negative regulation of cytokine secretion involved in immune response;peptidyl-methionine modification;acute inflammatory response;positive regulation of cholesterol esterification;protein oxidation;response to drug;post-translational protein modification;response to glucocorticoid;negative regulation of lipase activity;negative regulation of cholesterol import	GO:001921; GO:003437; GO:004263; GO:004308; GO:006069; GO:004369; GO:000939; GO:001090; GO:003164; GO:003334; GO:003438; GO:000152; GO:000665; GO:000820; GO:001603; GO:003110; GO:005082; GO:004215; GO:000664; GO:003237; GO:004634; GO:005076; GO:003370; GO:004362; GO:004426; GO:004541; GO:005099; GO:000974; GO:003030; GO:000274; GO:001820; GO:000252; GO:001087; GO:001815; GO:004249; GO:004368; GO:005138; GO:006019; GO:006062	early endosome;cytosol;spherical high-density lipoprotein particle;blood microparticle;extracellular region;extracellular exosome;endoplasmic reticulum lumen;chylomicron	GO:000576; GO:000582; GO:003436; GO:007256; GO:000557; GO:007006; GO:000578; GO:004262	 PPAR signaling pathway	hsa0332	high-density lipoprotein particle receptor binding;lipid transporter activity;lipase inhibitor activity;phosphatidylcholine-sterol O-acyltransferase activator activity;lipid binding;cholesterol binding;protein heterodimerization activity;high-density lipoprotein particle binding;cholesterol transporter activity;protein binding;phospholipid binding;phosphatidylcholine binding;apolipoprotein receptor binding;heat shock protein binding;protein homodimerization activity	GO:007065; GO:000531; GO:005510; GO:006022; GO:000828; GO:001548; GO:004698; GO:000803; GO:001712; GO:000551; GO:000554; GO:003121; GO:003419; GO:003107; GO:004280
NP_001177097.1	NP_001177097.1	NP_001177097.1 protein S100-A14 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	14784000	17577000	0	0	18637000	34451000	31125000	19312000	0	43630000	NA	NA	NA	S100A14	S100A14;NA;NA;NA;NA	calcium ion homeostasis;positive regulation of granulocyte chemotaxis;positive regulation of monocyte chemotaxis;response to lipopolysaccharide;toll-like receptor 4 signaling pathway;apoptotic process;defense response to bacterium	GO:005507; GO:007162; GO:009002; GO:003249; GO:003414; GO:000691; GO:004274	cell junction;perinuclear region of cytoplasm;cytosol;nuclear body;plasma membrane;extracellular exosome	GO:003005; GO:004847; GO:000582; GO:001660; GO:000588; GO:007006	"NA"	"NA"	chemokine receptor binding;calcium ion binding;protein binding	GO:004237; GO:000550; GO:000551
NP_001177098.1	NP_001177098.1	NP_001177098.1 4-hydroxy-2-oxoglutarate aldolase, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7598500	0	0	NA	NA	NA	HOGA1	HOGA1;NA;NA;NA;NA	glyoxylate catabolic process;4-hydroxyproline catabolic process;pyruvate biosynthetic process;glyoxylate metabolic process;oxalate metabolic process	GO:000943; GO:001947; GO:004286; GO:004648; GO:003360	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Arginine and proline metabolism; Glyoxylate and dicarboxylate metabolism; Metabolic pathways	hsa0033; hsa0063; hsa0110	protein homodimerization activity;protein binding;4-hydroxy-2-oxoglutarate aldolase activity	GO:004280; GO:000551; GO:000870
NP_001177104.1	NP_001177104.1	NP_001177104.1 enoyl-CoA hydratase, mitochondrial [Sus scrofa]	11	11	11	871920000	446070000	547670000	397520000	763920000	352680000	679220000	495630000	659850000	488570000	603550000	481620000	329510000	434140000	390410000	434010000	369940000	327330000	NA	NA	NA	ECHS1	ECHS1;NA;NA;NA;NA	fatty acid beta-oxidation	GO:000663	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Fatty acid elongation; beta-Alanine metabolism; Butanoate metabolism; Fatty acid metabolism; Metabolic pathways; Valine, leucine and isoleucine degradation; Fatty acid degradation; Carbon metabolism; Propanoate metabolism; Biosynthesis of antibiotics; Lysine degradation; Tryptophan metabolism	hsa0006; hsa0041; hsa0065; hsa0121; hsa0110; hsa0028; hsa0007; hsa0120; hsa0064; hsa0113; hsa0031; hsa0038	protein binding;enoyl-CoA hydratase activity	GO:000551; GO:000430
XP_020944244.1;NP_001177107.1	XP_020944244.1;NP_001177107.1	XP_020944244.1 60S ribosomal protein L30 isoform X1 [Sus scrofa];NP_001177107.1 60S ribosomal protein L30 [Sus scrofa]	3	3	3	84387000	50015000	91720000	62836000	58150000	96861000	42193000	35725000	83353000	80865000	41533000	54948000	75671000	69324000	31302000	90518000	89500000	99655000	NA	NA	NA	RPL30	RPL30;RPL30;NA;NA;NA	defense response to Gram-negative bacterium;killing of cells of other organism;antimicrobial humoral immune response mediated by antimicrobial peptide;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane	GO:005082; GO:003164; GO:006184; GO:000018; GO:000218; GO:000641; GO:000661	nucleus;polysomal ribosome;focal adhesion;membrane;cytosol;postsynaptic density;cytosolic large ribosomal subunit;extracellular exosome	GO:000563; GO:004278; GO:000592; GO:001602; GO:000582; GO:001406; GO:002262; GO:007006	 Ribosome	hsa0301	RNA binding;protein binding;structural constituent of ribosome	GO:000372; GO:000551; GO:000373
NP_001177109.1;XP_005672920.1;XP_020952736.1;XP_013840738.1;XP_013840737.1	NP_001177109.1	NP_001177109.1 dynein light chain roadblock-type 1 [Sus scrofa]	3	3	3	54773000	69446000	62343000	63364000	64884000	63552000	67988000	67327000	54407000	69240000	66381000	82733000	75185000	81514000	63942000	69960000	67108000	75860000	NA	NA	NA	DYNLRB1	DYNLRB1;NA;NA;NA;NA	microtubule-based movement;intraciliary transport involved in cilium assembly;visual behavior	GO:000701; GO:003573; GO:000763	cilium;membrane;cytoplasmic dynein complex;ciliary tip;centrosome;cytoplasm;microtubule;outer dynein arm	GO:000592; GO:001602; GO:000586; GO:009754; GO:000581; GO:000573; GO:000587; GO:003615	"NA"	"NA"	dynein intermediate chain binding;protein binding;microtubule motor activity	GO:004550; GO:000551; GO:000377
NP_001177118.1;XP_020927591.1	NP_001177118.1	NP_001177118.1 tricarboxylate transport protein, mitochondrial [Sus scrofa]	5	5	5	292300000	77392000	185960000	0	193930000	80376000	188430000	97353000	177850000	92596000	128210000	56627000	79562000	79887000	64734000	95016000	98304000	67584000	NA	NA	NA	SLC25A1	SLC25A1;NA;NA;NA;NA	mitochondrial citrate transport;fatty-acyl-CoA biosynthetic process;gluconeogenesis	GO:000684; GO:004694; GO:000609	nucleus;mitochondrial inner membrane;integral component of membrane;extracellular exosome	GO:000563; GO:000574; GO:001602; GO:007006	"NA"	"NA"	citrate transmembrane transporter activity;tricarboxylic acid transmembrane transporter activity	GO:001513; GO:001514
NP_001177123.1;NP_001138852.1	NP_001177123.1;NP_001138852.1	NP_001177123.1 V-type proton ATPase subunit G 1 [Sus scrofa];NP_001138852.1 V-type proton ATPase subunit G 2 [Sus scrofa]	4	4	4	0	32474000	35777000	0	26917000	27792000	24116000	23884000	24574000	29733000	25334000	22277000	19218000	23819000	23392000	24788000	27888000	27357000	NA	NA	NA	ATP6V1G1	ATP6V1G1;ATP6V1G2;NA;NA;NA	insulin receptor signaling pathway;hydrogen ion transmembrane transport;cellular iron ion homeostasis;ion transmembrane transport;transferrin transport;cellular response to increased oxygen levels;regulation of macroautophagy	GO:000828; GO:190260; GO:000687; GO:003422; GO:003357; GO:003629; GO:001624	vacuolar proton-transporting V-type ATPase complex;extracellular exosome;plasma membrane;lysosomal membrane;cytosol	GO:001647; GO:007006; GO:000588; GO:000576; GO:000582	 Epithelial cell signaling in Helicobacter pylori infection; Collecting duct acid secretion; Metabolic pathways; Rheumatoid arthritis; Phagosome; Synaptic vesicle cycle; Oxidative phosphorylation; Vibrio cholerae infection	hsa0512; hsa0496; hsa0110; hsa0532; hsa0414; hsa0472; hsa0019; hsa0511	ATPase binding;protein binding;hydrogen-exporting ATPase activity, phosphorylative mechanism	GO:005111; GO:000551; GO:000855
NP_001177124.2;XP_020923911.1;XP_020923910.1;XP_020923909.1;XP_020919644.1;XP_020919643.1;XP_020919642.1;NP_001230864.1;XP_020919641.1;XP_020919640.1;XP_020919639.1;XP_020919638.1;XP_020919637.1	NP_001177124.2;XP_020923911.1;XP_020923910.1;XP_020923909.1	NP_001177124.2 calcium/calmodulin-dependent protein kinase type 1 [Sus scrofa];XP_020923911.1 calcium/calmodulin-dependent protein kinase type 1 isoform X2 [Sus scrofa];XP_020923910.1 calcium/calmodulin-dependent protein kinase type 1 isoform X2 [Sus scrof	3	3	3	0	0	5505900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CAMK1	CAMK1;CAMK1;CAMK1;CAMK1;NA	signal transduction;positive regulation of peptidyl-serine phosphorylation;positive regulation of syncytium formation by plasma membrane fusion;regulation of protein localization;positive regulation of dendritic spine development;positive regulation of transcription from RNA polymerase II promoter;nucleocytoplasmic transport;cell cycle;negative regulation of protein binding;positive regulation of synapse structural plasticity;regulation of histone H3-K9 acetylation;regulation of muscle cell differentiation;protein phosphorylation;positive regulation of protein acetylation;regulation of protein binding;positive regulation of protein export from nucleus;positive regulation of protein serine/threonine kinase activity;positive regulation of neuron projection development	GO:000716; GO:003313; GO:006014; GO:003288; GO:006099; GO:004594; GO:000691; GO:000704; GO:003209; GO:005183; GO:200061; GO:005114; GO:000646; GO:190198; GO:004339; GO:004682; GO:007190; GO:001097	nucleus;glutamatergic synapse;cytoplasm;postsynaptic density	GO:000563; GO:009897; GO:000573; GO:001406	 Aldosterone synthesis and secretion; Oxytocin signaling pathway	hsa0492; hsa0492	calmodulin-dependent protein kinase activity;protein binding;ATP binding	GO:000468; GO:000551; GO:000552
NP_001177126.1	NP_001177126.1	NP_001177126.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 [Sus scrofa]	7	7	7	66402000	51512000	85981000	43908000	62825000	42563000	85875000	40713000	77435000	56340000	59823000	52852000	37397000	46785000	70120000	65422000	58190000	45648000	NA	NA	NA	NDUFA8	NDUFA8;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	GO:000612; GO:003298	mitochondrial respiratory chain complex I;mitochondrial inner membrane;mitochondrial intermembrane space;mitochondrion	GO:000574; GO:000574; GO:000575; GO:000573	 Oxidative phosphorylation; Metabolic pathways; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0110; hsa0501; hsa0493	macromolecular complex binding;NADH dehydrogenase (ubiquinone) activity	GO:004487; GO:000813
XP_005656433.1;NP_001177128.1;NP_001177127.1;XP_020953737.1;XP_020953736.1;XP_020953735.1	XP_005656433.1;NP_001177128.1;NP_001177127.1;XP_020953737.1;XP_020953736.1;XP_020953735.1	XP_005656433.1 acylphosphatase-1 isoform X17 [Sus scrofa];NP_001177128.1 acylphosphatase-1 isoform 2 [Sus scrofa];NP_001177127.1 acylphosphatase-1 isoform 1 [Sus scrofa];XP_020953737.1 acylphosphatase-1 isoform X14 [Sus scrofa];XP_020953736.1 acylphosphata	2	2	2	0	0	0	0	0	0	0	0	0	0	17108000	19606000	20292000	0	19147000	0	0	0	NA	NA	NA	ACYP1	ACYP1;ACYP1;ACYP1;ACYP1;ACYP1	phosphate-containing compound metabolic process	GO:000679	"NA"	"NA"	 Pyruvate metabolism	hsa0062	acylphosphatase activity	GO:000399
NP_001177132.1;XP_005656281.1	NP_001177132.1;XP_005656281.1	NP_001177132.1 U1 small nuclear ribonucleoprotein C [Sus scrofa];XP_005656281.1 U1 small nuclear ribonucleoprotein C isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SNRPC	SNRPC;SNRPC;NA;NA;NA	mRNA 5'-splice site recognition;spliceosomal snRNP assembly;mRNA splicing, via spliceosome	GO:000039; GO:000038; GO:000039	U1 snRNP;nucleoplasm;U2-type prespliceosome;Cajal body	GO:000568; GO:000565; GO:007100; GO:001503	 Spliceosome	hsa0304	RNA binding;mRNA binding;zinc ion binding;protein binding;U1 snRNA binding;pre-mRNA 5'-splice site binding;protein homodimerization activity;U1 snRNP binding	GO:000372; GO:000372; GO:000827; GO:000551; GO:003061; GO:003062; GO:004280; GO:199044
XP_020944221.1;XP_020944220.1;NP_001177134.1	XP_020944221.1;XP_020944220.1;NP_001177134.1	XP_020944221.1 V-type proton ATPase subunit C 1 isoform X1 [Sus scrofa];XP_020944220.1 V-type proton ATPase subunit C 1 isoform X1 [Sus scrofa];NP_001177134.1 V-type proton ATPase subunit C 1 [Sus scrofa]	6	6	6	8861400	14647000	13096000	13390000	14683000	10067000	13130000	14722000	16510000	12531000	11520000	12981000	0	9871200	9211600	14587000	12936000	14352000	NA	NA	NA	ATP6V1C1	ATP6V1C1;ATP6V1C1;ATP6V1C1;NA;NA	ion transmembrane transport;regulation of macroautophagy;ATP hydrolysis coupled proton transport;hydrogen ion transmembrane transport;insulin receptor signaling pathway;transferrin transport	GO:003422; GO:001624; GO:001599; GO:190260; GO:000828; GO:003357	extracellular exosome;lysosomal membrane;proton-transporting two-sector ATPase complex;apical part of cell;cytosol;vacuolar proton-transporting V-type ATPase, V1 domain;plasma membrane;cytoplasmic vesicle	GO:007006; GO:000576; GO:001646; GO:004517; GO:000582; GO:000022; GO:000588; GO:003141	 Synaptic vesicle cycle; Collecting duct acid secretion; Vibrio cholerae infection; Phagosome; Epithelial cell signaling in Helicobacter pylori infection; Oxidative phosphorylation; Metabolic pathways; Rheumatoid arthritis	hsa0472; hsa0496; hsa0511; hsa0414; hsa0512; hsa0019; hsa0110; hsa0532	proton-transporting ATPase activity, rotational mechanism;transporter activity;hydrogen-exporting ATPase activity, phosphorylative mechanism;protein binding	GO:004696; GO:000521; GO:000855; GO:000551
XP_020944224.1;XP_005663410.1;NP_001177137.1;NP_001177136.1	XP_020944224.1;XP_005663410.1;NP_001177137.1;NP_001177136.1	XP_020944224.1 protein S100-A16 isoform X1 [Sus scrofa];XP_005663410.1 protein S100-A16 isoform X1 [Sus scrofa];NP_001177137.1 protein S100-A16 [Sus scrofa];NP_001177136.1 protein S100-A16 [Sus scrofa]	3	3	3	18138000	0	0	21661000	23221000	0	21352000	18750000	19985000	23117000	32552000	24932000	0	0	30341000	26255000	27334000	32259000	NA	NA	NA	S100A16	S100A16;S100A16;S100A16;S100A16;NA	response to calcium ion	GO:005159	nucleolus;extracellular space;cytosol;plasma membrane;extracellular exosome	GO:000573; GO:000561; GO:000582; GO:000588; GO:007006	"NA"	"NA"	protein binding;RNA binding;calcium ion binding;protein homodimerization activity	GO:000551; GO:000372; GO:000550; GO:004280
NP_001177141.1	NP_001177141.1	NP_001177141.1 DDRGK domain-containing protein 1 [Sus scrofa]	1	1	1	2009300	2711700	2714200	0	2124400	0	2403700	0	2702200	0	0	5565600	0	0	2081500	0	2056700	0	NA	NA	NA	DDRGK1	DDRGK1;NA;NA;NA;NA	positive regulation of cell migration;regulation of intracellular estrogen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;positive regulation of cell cycle G1/S phase transition;positive regulation of cell proliferation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of apoptotic process;positive regulation of proteasomal protein catabolic process;positive regulation of I-kappaB phosphorylation;positive regulation of gene expression;positive regulation of metallopeptidase activity;response to endoplasmic reticulum stress;positive regulation of NF-kappaB transcription factor activity;cartilage development;positive regulation of protein localization to endoplasmic reticulum;protein K69-linked ufmylation;positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding	GO:003033; GO:003314; GO:004594; GO:190280; GO:000828; GO:003243; GO:004306; GO:190180; GO:190372; GO:001062; GO:190505; GO:003497; GO:005109; GO:005121; GO:190555; GO:199059; GO:190563	nucleolus;endoplasmic reticulum;cytoplasm	GO:000573; GO:000578; GO:000573	"NA"	"NA"	protein binding;RNA polymerase II repressing transcription factor binding;ubiquitin-like protein ligase binding	GO:000551; GO:000110; GO:004438
NP_001177142.1	NP_001177142.1	NP_001177142.1 small nuclear ribonucleoprotein F [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12275000	0	NA	NA	NA	SNRPF	SNRPF;NA;NA;NA;NA	termination of RNA polymerase II transcription;RNA splicing;histone mRNA metabolic process;nuclear import;spliceosomal snRNP assembly;mRNA splicing, via spliceosome	GO:000636; GO:000838; GO:000833; GO:005117; GO:000038; GO:000039	U4/U6 x U5 tri-snRNP complex;spliceosomal complex;SMN-Sm protein complex;U2-type precatalytic spliceosome;nucleoplasm;methylosome;cytosol;small nuclear ribonucleoprotein complex;catalytic step 2 spliceosome;nucleus;small nucleolar ribonucleoprotein complex	GO:004654; GO:000568; GO:003471; GO:007100; GO:000565; GO:003470; GO:000582; GO:003053; GO:007101; GO:000563; GO:000573	 Spliceosome	hsa0304	RNA binding;protein binding	GO:000372; GO:000551
NP_001177145.1	NP_001177145.1	NP_001177145.1 diablo homolog, mitochondrial [Sus scrofa]	2	2	2	31882000	24921000	0	0	26888000	0	34767000	0	27432000	0	0	0	0	23289000	36091000	0	0	0	NA	NA	NA	DIABLO	DIABLO;NA;NA;NA;NA	activation of cysteine-type endopeptidase activity involved in apoptotic process;intrinsic apoptotic signaling pathway in response to oxidative stress;apoptotic process;intrinsic apoptotic signaling pathway;extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of apoptotic process;neuron apoptotic process	GO:000691; GO:000863; GO:000691; GO:009719; GO:000862; GO:004306; GO:005140	mitochondrion;CD40 receptor complex;mitochondrial intermembrane space;cytoplasmic side of plasma membrane;cytosol	GO:000573; GO:003563; GO:000575; GO:000989; GO:000582	"NA"	"NA"	protein binding	GO:000551
NP_001177148.1;XP_020927613.1;XP_020927612.1	NP_001177148.1;XP_020927613.1;XP_020927612.1	NP_001177148.1 pterin-4-alpha-carbinolamine dehydratase [Sus scrofa];XP_020927613.1 pterin-4-alpha-carbinolamine dehydratase isoform X1 [Sus scrofa];XP_020927612.1 pterin-4-alpha-carbinolamine dehydratase isoform X1 [Sus scrofa]	5	5	5	121870000	113190000	118800000	84165000	102910000	88051000	99151000	80599000	61387000	65515000	97703000	0	78218000	98468000	77400000	71489000	82455000	65967000	NA	NA	NA	PCBD1	PCBD1;PCBD1;PCBD1;NA;NA	regulation of protein homodimerization activity;L-phenylalanine catabolic process;protein homotetramerization;protein heterooligomerization;positive regulation of transcription, DNA-templated;tetrahydrobiopterin biosynthetic process;oxidation-reduction process	GO:004349; GO:000655; GO:005128; GO:005129; GO:004589; GO:000672; GO:005511	nucleoplasm;extracellular exosome;nucleus;cytosol	GO:000565; GO:007006; GO:000563; GO:000582	"NA"	"NA"	protein binding;identical protein binding;phenylalanine 4-monooxygenase activity;4-alpha-hydroxytetrahydrobiopterin dehydratase activity;transcription coactivator activity	GO:000551; GO:004280; GO:000450; GO:000812; GO:000371
NP_001177150.1	NP_001177150.1	NP_001177150.1 cytochrome c oxidase subunit VIa polypeptide 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30971000	0	0	NA	NA	NA	COX6A1	COX6A1;NA;NA;NA;NA	mitochondrial electron transport, cytochrome c to oxygen;aerobic respiration;regulation of catalytic activity;generation of precursor metabolites and energy;hydrogen ion transmembrane transport	GO:000612; GO:000906; GO:005079; GO:000609; GO:190260	mitochondrion;mitochondrial inner membrane	GO:000573; GO:000574	 Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Cardiac muscle contraction; Alzheimer's disease; Oxidative phosphorylation	hsa0501; hsa0493; hsa0110; hsa0426; hsa0501; hsa0019	cytochrome-c oxidase activity;enzyme regulator activity	GO:000412; GO:003023
NP_001177156.1;NP_001177155.1	NP_001177156.1;NP_001177155.1	NP_001177156.1 NHP2-like protein 1 [Sus scrofa];NP_001177155.1 NHP2-like protein 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	30388000	0	0	19444000	26288000	0	NA	NA	NA	SNU13	SNU13;SNU13;NA;NA;NA	rRNA processing;mRNA splicing, via spliceosome;box C/D snoRNP assembly;maturation of LSU-rRNA;single fertilization	GO:000636; GO:000039; GO:000049; GO:000047; GO:000733	dense fibrillar component;box C/D snoRNP complex;small-subunit processome;nucleolus;U4/U6 x U5 tri-snRNP complex;nucleus;U4atac snRNP;U2-type precatalytic spliceosome;nucleoplasm;macromolecular complex	GO:000165; GO:003142; GO:003204; GO:000573; GO:004654; GO:000563; GO:000569; GO:007100; GO:000565; GO:003299	 Spliceosome; Ribosome biogenesis in eukaryotes	hsa0304; hsa0300	RNA binding;U4atac snRNA binding;U3 snoRNA binding;protein binding;ATPase binding;snoRNA binding	GO:000372; GO:003062; GO:003451; GO:000551; GO:005111; GO:003051
NP_001177159.1;XP_020920811.1;XP_020920810.1;XP_020920808.1	NP_001177159.1;XP_020920811.1;XP_020920810.1;XP_020920808.1	NP_001177159.1 importin subunit alpha-4 [Sus scrofa];XP_020920811.1 importin subunit alpha-4 isoform X3 [Sus scrofa];XP_020920810.1 importin subunit alpha-4 isoform X2 [Sus scrofa];XP_020920808.1 importin subunit alpha-4 isoform X1 [Sus scrofa]	7	5	5	11853000	14838000	13679000	8896600	11410000	8130800	10380000	14189000	11402000	10782000	11229000	12205000	13188000	11195000	14445000	11128000	11281000	10813000	NA	NA	NA	KPNA3	KPNA3;KPNA3;KPNA3;KPNA3;NA	NLS-bearing protein import into nucleus;viral entry into host cell;modulation by virus of host process;macromolecular complex assembly;viral penetration into host nucleus	GO:000660; GO:004671; GO:001905; GO:006500; GO:007573	cytosol;host cell;nuclear pore;nucleoplasm	GO:000582; GO:004365; GO:000564; GO:000565	"NA"	"NA"	protein transporter activity;protein binding;protein C-terminus binding;nuclear localization sequence binding;nuclear import signal receptor activity	GO:000856; GO:000551; GO:000802; GO:000813; GO:006160
NP_001177161.2	NP_001177161.2	NP_001177161.2 2,4-dienoyl-CoA reductase, mitochondrial [Sus scrofa]	11	11	11	282790000	213970000	238920000	218010000	191970000	144970000	264760000	247160000	270800000	216070000	227910000	200580000	188360000	260900000	228610000	235840000	214670000	201380000	NA	NA	NA	DECR1	DECR1;NA;NA;NA;NA	protein homotetramerization;fatty acid beta-oxidation	GO:005128; GO:000663	nucleus;mitochondrial matrix;nucleoplasm;cytosol;mitochondrion	GO:000563; GO:000575; GO:000565; GO:000582; GO:000573	"NA"	"NA"	NADPH binding;oxidoreductase activity, acting on NAD(P)H;2,4-dienoyl-CoA reductase (NADPH) activity	GO:007040; GO:001665; GO:000867
NP_001177168.1	NP_001177168.1	NP_001177168.1 actin-related protein 2/3 complex subunit 2 [Sus scrofa]	12	12	12	151500000	171470000	218680000	179100000	124250000	246410000	139380000	155230000	153080000	197350000	127530000	100300000	227080000	195760000	156260000	178120000	177610000	198930000	NA	NA	NA	ARPC2	ARPC2;NA;NA;NA;NA	ephrin receptor signaling pathway;actin filament polymerization;Arp2/3 complex-mediated actin nucleation;actin polymerization-dependent cell motility;membrane organization;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of lamellipodium assembly	GO:004801; GO:003004; GO:003431; GO:007035; GO:006102; GO:003809; GO:190002; GO:001059	cytosol;extracellular exosome;site of double-strand break;actin cytoskeleton;neuron projection;glutamatergic synapse;lamellipodium;muscle cell projection membrane;endosome;focal adhesion;nucleus;Arp2/3 protein complex	GO:000582; GO:007006; GO:003586; GO:001562; GO:004300; GO:009897; GO:003002; GO:003619; GO:000576; GO:000592; GO:000563; GO:000588	 Endocytosis; Salmonella infection; Bacterial invasion of epithelial cells; Fc gamma R-mediated phagocytosis; Regulation of actin cytoskeleton	hsa0414; hsa0513; hsa0510; hsa0466; hsa0481	structural constituent of cytoskeleton;actin filament binding;protein binding	GO:000520; GO:005101; GO:000551
XP_020946577.1;NP_001177169.1	XP_020946577.1;NP_001177169.1	XP_020946577.1 glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X1 [Sus scrofa];NP_001177169.1 glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic [Sus scrofa]	21	21	21	2338600000	1578500000	2197000000	1264300000	2836100000	1485700000	2650900000	1914800000	2652400000	2046600000	2071100000	1692700000	1026100000	1647800000	2143800000	2161100000	2332300000	1923200000	NA	NA	NA	GPD1	GPD1;GPD1;NA;NA;NA	glycerol-3-phosphate catabolic process;glycerophosphate shuttle;cellular response to cAMP;glycerol-3-phosphate metabolic process;positive regulation of glycolytic process;cellular response to tumor necrosis factor;gluconeogenesis;phosphatidic acid biosynthetic process	GO:004616; GO:000612; GO:007132; GO:000607; GO:004582; GO:007135; GO:000609; GO:000665	extracellular exosome;glycerol-3-phosphate dehydrogenase complex;cytosol	GO:007006; GO:000933; GO:000582	 Glycerophospholipid metabolism	hsa0056	glycerol-3-phosphate dehydrogenase [NAD+;glycerol-3-phosphate dehydrogenase activity;glycerol-3-phosphate dehydrogenase [NAD(P)+;protein homodimerization activity;NAD binding	GO:000436; GO:000436; GO:004795; GO:004280; GO:005128
XP_020924050.1;XP_013837431.1;XP_020924049.1;XP_020924048.1;XP_020924047.1;XP_020924046.1;XP_020924044.1;NP_001177214.1;XP_020924045.1;XP_020924042.1;XP_020924041.1;XP_020924040.1;XP_020924039.1;XP_020924038.1;XP_020924037.1;XP_020924036.1;XP_013837430.1;XP_020924059.1;XP_020924058.1;XP_020924057.1;XP_020924056.1;XP_020924055.1;XP_020924054.1;XP_020924053.1;XP_020924052.1;XP_013837433.1;XP_020924061.1;XP_020924060.1	XP_020924050.1;XP_013837431.1;XP_020924049.1;XP_020924048.1;XP_020924047.1;XP_020924046.1;XP_020924044.1;NP_001177214.1;XP_020924045.1;XP_020924042.1;XP_020924041.1;XP_020924040.1;XP_020924039.1;XP_020924038.1;XP_020924037.1;XP_020924036.1;XP_013837430.1;XP_020924059.1;XP_020924058.1;XP_020924057.1;XP_020924056.1;XP_020924055.1;XP_020924054.1;XP_020924053.1;XP_020924052.1;XP_013837433.1;XP_020924061.1;XP_020924060.1	XP_020924050.1 ubiquitin-like modifier-activating enzyme ATG7 isoform X6 [Sus scrofa];XP_013837431.1 ubiquitin-like modifier-activating enzyme ATG7 isoform X3 [Sus scrofa];XP_020924049.1 ubiquitin-like modifier-activating enzyme ATG7 isoform X2 [Sus scrofa	13	13	13	31313000	30080000	29045000	26530000	21270000	18430000	26827000	24634000	26447000	26002000	30516000	27911000	24089000	23818000	22872000	37020000	24267000	26923000	NA	NA	NA	ATG7	ATG7;ATG7;ATG7;ATG7;ATG7	protein ubiquitination;response to glucose;positive regulation of protein modification process;piecemeal microautophagy of nucleus;mitophagy;membrane fusion;cellular response to starvation;suppression by virus of host autophagy;regulation of circadian rhythm;late nucleophagy;cellular response to hyperoxia;autophagy of host cells involved in interaction with symbiont;neutrophil degranulation;cellular response to morphine;negative regulation of mitochondrial DNA replication;protein transport;C-terminal protein lipidation;positive regulation of autophagy;macroautophagy;positive regulation of protein catabolic process;rhythmic process;chaperone-mediated autophagy;protein lipidation;cellular response to nitrogen starvation;aging;protein modification by small protein conjugation;positive regulation of apoptotic process;defense response to virus;negative regulation of oxidative stress-induced neuron death;autophagosome assembly;cellular protein modification process;autophagy;response to fluoride	GO:001656; GO:000974; GO:003140; GO:003472; GO:000042; GO:006102; GO:000926; GO:003952; GO:004275; GO:004480; GO:007145; GO:007504; GO:004331; GO:007131; GO:009029; GO:001503; GO:000650; GO:001050; GO:001623; GO:004573; GO:004851; GO:006168; GO:000649; GO:000699; GO:000756; GO:003244; GO:004306; GO:005160; GO:190320; GO:000004; GO:000646; GO:000691; GO:190261	axoneme;extracellular region;cytosol;ficolin-1-rich granule lumen;axon;cytoplasm;pre-autophagosomal structure;secretory granule lumen	GO:000593; GO:000557; GO:000582; GO:190481; GO:003042; GO:000573; GO:000040; GO:003477	 Regulation of autophagy	hsa0414	protein binding;transcription factor binding;Atg8 activating enzyme activity;ubiquitin activating enzyme activity;protein homodimerization activity	GO:000551; GO:000813; GO:001977; GO:000483; GO:004280
NP_001177217.1;XP_003126907.1	NP_001177217.1;XP_003126907.1	NP_001177217.1 gamma-aminobutyric acid receptor-associated protein [Sus scrofa];XP_003126907.1 gamma-aminobutyric acid receptor-associated protein-like 2 [Sus scrofa]	2	2	1	11953000	27294000	0	0	0	17552000	0	17270000	15973000	0	17079000	15123000	0	28289000	23001000	14757000	11393000	12560000	NA	NA	NA	GABARAP	GABARAP;GABARAPL2;NA;NA;NA	autophagosome assembly;autophagosome maturation;protein targeting;extrinsic apoptotic signaling pathway via death domain receptors;microtubule cytoskeleton organization;macroautophagy;mitophagy;cellular response to nitrogen starvation;chemical synaptic transmission	GO:000004; GO:009735; GO:000660; GO:000862; GO:000022; GO:001623; GO:000042; GO:000699; GO:000726	plasma membrane;Golgi membrane;autophagosome;smooth endoplasmic reticulum;cytoplasmic vesicle;cell body;autophagosome membrane;lysosome;microtubule associated complex;axoneme;cytosol;actin cytoskeleton;perinuclear region of cytoplasm;sperm midpiece	GO:000588; GO:000013; GO:000577; GO:000579; GO:003141; GO:004429; GO:000042; GO:000576; GO:000587; GO:000593; GO:000582; GO:001562; GO:004847; GO:009722	 Regulation of autophagy; FoxO signaling pathway; GABAergic synapse	hsa0414; hsa0406; hsa0472	GABA receptor binding;beta-tubulin binding;protein binding;microtubule binding;ubiquitin protein ligase binding	GO:005081; GO:004848; GO:000551; GO:000801; GO:003162
NP_001177351.1	NP_001177351.1	NP_001177351.1 superoxide dismutase [Cu-Zn] [Sus scrofa]	11	11	11	1984300000	2248900000	2121000000	2207900000	1959800000	1487500000	2848900000	2680500000	2336300000	2236800000	1821300000	1660900000	1217700000	2150700000	2132700000	2152900000	1945200000	1877400000	NA	NA	NA	SOD1	SOD1;NA;NA;NA;NA	ovarian follicle development;sensory perception of sound;cellular response to ATP;positive regulation of cytokine production;placenta development;regulation of blood pressure;peripheral nervous system myelin maintenance;negative regulation of neuron apoptotic process;response to ethanol;negative regulation of cholesterol biosynthetic process;thymus development;neurofilament cytoskeleton organization;response to antipsychotic drug;cellular iron ion homeostasis;spermatogenesis;transmission of nerve impulse;regulation of T cell differentiation in thymus;cellular response to potassium ion;positive regulation of catalytic activity;response to copper ion;muscle cell cellular homeostasis;positive regulation of phagocytosis;cellular response to cadmium ion;response to amphetamine;myeloid cell homeostasis;embryo implantation;positive regulation of superoxide anion generation;regulation of multicellular organism growth;response to hydrogen peroxide;hydrogen peroxide biosynthetic process;heart contraction;auditory receptor cell stereocilium organization;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;superoxide metabolic process;interleukin-12-mediated signaling pathway;response to drug;superoxide anion generation;response to axon injury;negative regulation of inflammatory response;activation of MAPK activity;anterograde axonal transport;response to heat;removal of superoxide radicals;response to carbon monoxide;positive regulation of apoptotic process;regulation of protein kinase activity;regulation of organ growth;reactive oxygen species metabolic process;platelet degranulation;glutathione metabolic process;retrograde axonal transport;response to organic substance;response to superoxide;locomotory behavior;cellular response to oxidative stress;regulation of mitochondrial membrane potential;oxidation-reduction process	GO:000154; GO:000760; GO:007131; GO:000181; GO:000189; GO:000821; GO:003228; GO:004352; GO:004547; GO:004554; GO:004853; GO:006005; GO:009733; GO:000687; GO:000728; GO:001922; GO:003308; GO:003586; GO:004308; GO:004668; GO:004671; GO:005076; GO:007127; GO:000197; GO:000226; GO:000756; GO:003293; GO:004001; GO:004254; GO:005066; GO:006004; GO:006008; GO:190217; GO:000680; GO:003572; GO:004249; GO:004255; GO:004867; GO:005072; GO:000018; GO:000808; GO:000940; GO:001943; GO:003446; GO:004306; GO:004585; GO:004662; GO:007259; GO:000257; GO:000674; GO:000809; GO:001003; GO:000030; GO:000762; GO:003459; GO:005188; GO:005511	nucleoplasm;mitochondrion;mitochondrial matrix;extracellular space;cytosol;extracellular region;dendrite cytoplasm;peroxisome;plasma membrane;dense core granule;cytoplasmic vesicle;nucleus;lysosome;macromolecular complex;extracellular exosome;neuronal cell body;axon cytoplasm	GO:000565; GO:000573; GO:000575; GO:000561; GO:000582; GO:000557; GO:003283; GO:000577; GO:000588; GO:003104; GO:003141; GO:000563; GO:000576; GO:003299; GO:007006; GO:004302; GO:190411	 Huntington's disease; Prion diseases; Peroxisome; Amyotrophic lateral sclerosis (ALS)	hsa0501; hsa0502; hsa0414; hsa0501	copper ion binding;chaperone binding;protein binding;identical protein binding;Rac GTPase binding;superoxide dismutase activity;zinc ion binding;protein phosphatase 2B binding	GO:000550; GO:005108; GO:000551; GO:004280; GO:004836; GO:000478; GO:000827; GO:003034
NP_001182041.1	NP_001182041.1	NP_001182041.1 protein disulfide-isomerase A3 precursor [Sus scrofa]	35	35	35	1079400000	1480400000	1189100000	1421600000	1099600000	1435300000	1210300000	1397000000	1135500000	1315800000	1235900000	1378300000	1378600000	1602200000	1281900000	1436300000	1422100000	1450800000	NA	NA	NA	PDIA3	PDIA3;NA;NA;NA;NA	cellular response to interleukin-7;positive regulation of extrinsic apoptotic signaling pathway;antigen processing and presentation of peptide antigen via MHC class I;protein folding;proteolysis;response to endoplasmic reticulum stress;oxidation-reduction process;cell redox homeostasis	GO:009876; GO:200123; GO:000247; GO:000645; GO:000650; GO:003497; GO:005511; GO:004545	nucleus;cell surface;phagocytic vesicle;extracellular space;extracellular exosome;endoplasmic reticulum;melanosome;focal adhesion;MHC class I peptide loading complex;recycling endosome membrane	GO:000563; GO:000998; GO:004533; GO:000561; GO:007006; GO:000578; GO:004247; GO:000592; GO:004282; GO:005503	 Protein processing in endoplasmic reticulum; Antigen processing and presentation	hsa0414; hsa0461	RNA binding;identical protein binding;protein disulfide isomerase activity;cysteine-type endopeptidase activity;phospholipase C activity;peptide disulfide oxidoreductase activity;protein binding	GO:000372; GO:004280; GO:000375; GO:000419; GO:000462; GO:001503; GO:000551
NP_001182043.1	NP_001182043.1	NP_001182043.1 dynein light chain 1, cytoplasmic [Sus scrofa]	5	2	2	0	0	0	0	0	0	0	0	0	0	0	53983000	0	0	0	0	0	0	NA	NA	NA	DYNLL1	DYNLL1;NA;NA;NA;NA	apoptotic process;negative regulation of phosphorylation;positive regulation of non-motile cilium assembly;intraciliary retrograde transport;positive regulation of insulin secretion involved in cellular response to glucose stimulus;regulation of G2/M transition of mitotic cell cycle;viral process;intraciliary transport involved in cilium assembly;motile cilium assembly;neutrophil degranulation;positive regulation of ATP-dependent microtubule motor activity, plus-end-directed;G2/M transition of mitotic cell cycle;spermatid development;ER to Golgi vesicle-mediated transport;substantia nigra development;macroautophagy;antigen processing and presentation of exogenous peptide antigen via MHC class II;ciliary basal body docking	GO:000691; GO:004232; GO:190285; GO:003572; GO:003577; GO:001038; GO:001603; GO:003573; GO:004445; GO:004331; GO:200058; GO:000008; GO:000728; GO:000688; GO:002176; GO:001623; GO:001988; GO:009771	centrosome;cytoplasmic dynein complex;plasma membrane;nucleus;COP9 signalosome;dynein complex;axon cytoplasm;microtubule;mitotic spindle;cytoplasm;cytosol;cilium;membrane;tertiary granule membrane;ficolin-1-rich granule membrane;kinetochore;ciliary tip	GO:000581; GO:000586; GO:000588; GO:000563; GO:000818; GO:003028; GO:190411; GO:000587; GO:007268; GO:000573; GO:000582; GO:000592; GO:001602; GO:007082; GO:010100; GO:000077; GO:009754	 Vasopressin-regulated water reabsorption	hsa0496	protein C-terminus binding;protein homodimerization activity;dynein intermediate chain binding;ATP-dependent microtubule motor activity, plus-end-directed;protein heterodimerization activity;dynein light intermediate chain binding;nitric-oxide synthase regulator activity;scaffold protein binding;enzyme binding;protein domain specific binding;protein binding	GO:000802; GO:004280; GO:004550; GO:000857; GO:004698; GO:005195; GO:003023; GO:009711; GO:001989; GO:001990; GO:000551
NP_001182048.1	NP_001182048.1	NP_001182048.1 protein disulfide-isomerase A6 precursor [Sus scrofa]	17	17	17	234230000	317510000	283400000	316140000	324550000	358940000	298810000	333230000	248500000	259760000	297060000	366840000	335270000	317070000	341520000	298780000	374390000	329800000	NA	NA	NA	PDIA6	PDIA6;NA;NA;NA;NA	oxidation-reduction process;post-translational protein modification;cellular protein metabolic process;cell redox homeostasis;protein folding;IRE1-mediated unfolded protein response	GO:005511; GO:004368; GO:004426; GO:004545; GO:000645; GO:003649	endoplasmic reticulum lumen;endoplasmic reticulum-Golgi intermediate compartment;plasma membrane;endoplasmic reticulum chaperone complex;extracellular exosome;melanosome;extracellular space;endoplasmic reticulum membrane;cytosol	GO:000578; GO:000579; GO:000588; GO:003466; GO:007006; GO:004247; GO:000561; GO:000578; GO:000582	 Protein processing in endoplasmic reticulum	hsa0414	protein disulfide isomerase activity;protein binding;peptide disulfide oxidoreductase activity	GO:000375; GO:000551; GO:001503
NP_001182255.1;XP_020953719.1	NP_001182255.1;XP_020953719.1	NP_001182255.1 protein ABHD16A [Sus scrofa];XP_020953719.1 protein ABHD16A isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7003000	NA	NA	NA	ABHD16A	ABHD16A;ABHD16A;NA;NA;NA	prostaglandin catabolic process;monoacylglycerol catabolic process	GO:190534; GO:005265	integral component of membrane	GO:001602	"NA"	"NA"	lysophospholipase activity;protein binding;acylglycerol lipase activity	GO:000462; GO:000551; GO:004737
XP_005670994.1;XP_005670993.1;NP_001182259.1	XP_005670994.1;XP_005670993.1;NP_001182259.1	XP_005670994.1 catechol O-methyltransferase isoform X1 [Sus scrofa];XP_005670993.1 catechol O-methyltransferase isoform X1 [Sus scrofa];NP_001182259.1 catechol O-methyltransferase [Sus scrofa]	11	11	11	321590000	163980000	251670000	269710000	288750000	146950000	263940000	262350000	284770000	224810000	169370000	154380000	186240000	157040000	209430000	277550000	198390000	190000000	NA	NA	NA	COMT	COMT;COMT;COMT;NA;NA	estrogen metabolic process;negative regulation of dopamine metabolic process;negative regulation of smooth muscle cell proliferation;positive regulation of homocysteine metabolic process;regulation of sensory perception of pain;learning;response to organic cyclic compound;developmental process;response to drug;methylation;response to lipopolysaccharide;response to estrogen;multicellular organismal reproductive process;dopamine catabolic process;response to pain;female pregnancy;cellular response to phosphate starvation;neurotransmitter catabolic process;dopamine metabolic process;negative regulation of renal sodium excretion	GO:000821; GO:004596; GO:004866; GO:005066; GO:005193; GO:000761; GO:001407; GO:003250; GO:004249; GO:003225; GO:003249; GO:004362; GO:004860; GO:004242; GO:004826; GO:000756; GO:001603; GO:004213; GO:004241; GO:003581	integral component of membrane;cytosol;dendrite;postsynaptic membrane;cell body;membrane;extracellular exosome;intracellular membrane-bounded organelle;plasma membrane;dendritic spine	GO:001602; GO:000582; GO:003042; GO:004521; GO:004429; GO:001602; GO:007006; GO:004323; GO:000588; GO:004319	 Dopaminergic synapse; Tyrosine metabolism; Steroid hormone biosynthesis; Metabolic pathways	hsa0472; hsa0035; hsa0014; hsa0110	O-methyltransferase activity;catechol O-methyltransferase activity;methyltransferase activity;L-dopa O-methyltransferase activity;protein binding;magnesium ion binding	GO:000817; GO:001620; GO:000816; GO:010208; GO:000551; GO:000028
XP_020946564.1;NP_001182260.1;XP_020946563.1;XP_020946562.1;XP_020946561.1;XP_020946560.1;XP_020946559.1;XP_020946558.1	XP_020946564.1;NP_001182260.1;XP_020946563.1;XP_020946562.1;XP_020946561.1;XP_020946560.1;XP_020946559.1;XP_020946558.1	XP_020946564.1 cleavage and polyadenylation specificity factor subunit 6 isoform X4 [Sus scrofa];NP_001182260.1 cleavage and polyadenylation specificity factor subunit 6 [Sus scrofa];XP_020946563.1 cleavage and polyadenylation specificity factor subunit 6	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1766600	NA	NA	NA	CPSF6	CPSF6;CPSF6;CPSF6;CPSF6;CPSF6	mRNA processing;positive regulation of RNA export from nucleus;protein heterotetramerization;protein tetramerization;pre-mRNA cleavage required for polyadenylation;messenger ribonucleoprotein complex assembly	GO:000639; GO:004683; GO:005129; GO:005126; GO:009878; GO:199012	perichromatin fibrils;ribonucleoprotein complex;nucleus;membrane;interchromatin granule;mRNA cleavage factor complex;nucleoplasm;nuclear speck;cytoplasm;paraspeckles	GO:000572; GO:199090; GO:000563; GO:001602; GO:003506; GO:000584; GO:000565; GO:001660; GO:000573; GO:004238	 mRNA surveillance pathway	hsa0301	RNA binding;mRNA binding;exon-exon junction complex binding;protein binding;ribosomal large subunit binding	GO:000372; GO:000372; GO:199044; GO:000551; GO:004302
NP_001182263.1	NP_001182263.1	NP_001182263.1 ELAV-like protein 1 [Sus scrofa]	6	6	6	49127000	40929000	39522000	37468000	40012000	42034000	42897000	42155000	40318000	33383000	55312000	37548000	61819000	45495000	44205000	39931000	46004000	50848000	NA	NA	NA	ELAVL1	ELAVL1;NA;NA;NA;NA	mRNA splicing, via spliceosome;regulation of mRNA stability;regulation of stem cell population maintenance;positive regulation of translation;multicellular organism development;protein homooligomerization;negative regulation of gene silencing by miRNA;mRNA stabilization;3'-UTR-mediated mRNA stabilization	GO:000039; GO:004348; GO:200003; GO:004572; GO:000727; GO:005126; GO:006096; GO:004825; GO:007093	nucleoplasm;ribonucleoprotein complex;postsynapse;nucleus;cytoplasm;membrane;glutamatergic synapse;cytosol;cytoplasmic stress granule	GO:000565; GO:199090; GO:009879; GO:000563; GO:000573; GO:001602; GO:009897; GO:000582; GO:001049	 AMPK signaling pathway	hsa0415	protein binding;protein kinase binding;miRNA binding;protein homodimerization activity;AU-rich element binding;mRNA 3'-UTR AU-rich region binding;RNA binding;mRNA 3'-UTR binding	GO:000551; GO:001990; GO:003519; GO:004280; GO:001709; GO:003592; GO:000372; GO:000373
NP_001182266.1	NP_001182266.1	NP_001182266.1 peptidyl-prolyl cis-trans isomerase FKBP4 [Sus scrofa]	6	6	6	32591000	25505000	39360000	20446000	32135000	37810000	34834000	25142000	25605000	21136000	31447000	27961000	27891000	25400000	29970000	24516000	38791000	24616000	NA	NA	NA	FKBP4	FKBP4;NA;NA;NA;NA	copper ion transport;male sex differentiation;protein peptidyl-prolyl isomerization;steroid hormone receptor complex assembly;chaperone-mediated protein folding;negative regulation of microtubule polymerization;embryo implantation;negative regulation of neuron projection development;protein complex localization;regulation of cellular response to heat;protein folding;androgen receptor signaling pathway;prostate gland development	GO:000682; GO:004666; GO:000041; GO:000646; GO:006107; GO:003111; GO:000756; GO:001097; GO:003150; GO:190003; GO:000645; GO:003052; GO:003085	cytosol;neuronal cell body;macromolecular complex;cytoplasm;axonal growth cone;extracellular exosome;microtubule;nucleoplasm;perinuclear region of cytoplasm	GO:000582; GO:004302; GO:003299; GO:000573; GO:004429; GO:007006; GO:000587; GO:000565; GO:004847	 Estrogen signaling pathway	hsa0491	protein binding;GTP binding;tau protein binding;peptidyl-prolyl cis-trans isomerase activity;protein binding, bridging;RNA binding;copper-dependent protein binding;phosphoprotein binding;heat shock protein binding;glucocorticoid receptor binding	GO:000551; GO:000552; GO:004815; GO:000375; GO:003067; GO:000372; GO:003276; GO:005121; GO:003107; GO:003525
XP_005660997.1;NP_001182281.1;XP_005660996.1;XP_005660995.1	XP_005660997.1;NP_001182281.1;XP_005660996.1;XP_005660995.1	XP_005660997.1 midkine isoform X2 [Sus scrofa];NP_001182281.1 midkine precursor [Sus scrofa];XP_005660996.1 midkine isoform X1 [Sus scrofa];XP_005660995.1 midkine isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MDK	MDK;MDK;MDK;MDK;NA	dentate gyrus development;defecation;signal transduction;cerebellar granular layer development;regulation of behavior;response to glucocorticoid;nervous system development;cell migration;short-term memory;cell differentiation;behavioral fear response;Notch signaling pathway;response to wounding;adrenal gland development;response to drug;negative regulation of neuron apoptotic process;positive regulation of cell division;regulation of receptor activity;cerebral cortex development;positive regulation of transcription, DNA-templated	GO:002154; GO:003042; GO:000716; GO:002168; GO:005079; GO:005138; GO:000739; GO:001647; GO:000761; GO:003015; GO:000166; GO:000721; GO:000961; GO:003032; GO:004249; GO:004352; GO:005178; GO:001046; GO:002198; GO:004589	extracellular region;cytoplasm;cell projection	GO:000557; GO:000573; GO:004299	"NA"	"NA"	growth factor activity;heparin binding	GO:000808; GO:000820
XP_013852206.1;NP_001182297.1	XP_013852206.1;NP_001182297.1	XP_013852206.1 epidermal retinol dehydrogenase 2 isoform X1 [Sus scrofa];NP_001182297.1 epidermal retinol dehydrogenase 2 [Sus scrofa]	8	8	8	36282000	96878000	36563000	127420000	23619000	55001000	21721000	92446000	37638000	110870000	20637000	86487000	16729000	105870000	43035000	181370000	37086000	114190000	NA	NA	NA	SDR16C5	SDR16C5;SDR16C5;NA;NA;NA	negative regulation of histone acetylation;retinal metabolic process;keratinocyte proliferation;negative regulation of transcription from RNA polymerase II promoter;oxidation-reduction process;positive regulation of histone deacetylation	GO:003506; GO:004257; GO:004361; GO:000012; GO:005511; GO:003106	transcriptional repressor complex;integral component of membrane;chromatin;endoplasmic reticulum;plasma membrane;lipid particle;nucleus	GO:001705; GO:001602; GO:000078; GO:000578; GO:000588; GO:000581; GO:000563	 Retinol metabolism	hsa0083	activating transcription factor binding;transcription corepressor activity;retinol dehydrogenase activity;transcription factor binding	GO:003361; GO:000371; GO:000474; GO:000813
NP_001182307.1	NP_001182307.1	NP_001182307.1 valine--tRNA ligase [Sus scrofa]	13	13	13	52474000	49283000	47291000	46655000	53622000	44243000	51379000	52305000	47864000	43929000	58884000	63396000	52017000	50593000	56868000	50789000	59810000	56690000	NA	NA	NA	VARS	VARS;NA;NA;NA;NA	tRNA aminoacylation for protein translation;valyl-tRNA aminoacylation	GO:000641; GO:000643	cytosol	GO:000582	 Aminoacyl-tRNA biosynthesis	hsa0097	aminoacyl-tRNA editing activity;protein binding;ATP binding;valine-tRNA ligase activity	GO:000216; GO:000551; GO:000552; GO:000483
NP_001182437.1	NP_001182437.1	NP_001182437.1 glycogen [starch] synthase, muscle [Sus scrofa]	13	13	12	144470000	96557000	103180000	85427000	99462000	52522000	95474000	75263000	86468000	62095000	126070000	91647000	61462000	67625000	107180000	99213000	111910000	82541000	NA	NA	NA	GYS1	GYS1;NA;NA;NA;NA	heart development;glycogen biosynthetic process	GO:000750; GO:000597	inclusion body;membrane;cytoplasm;cytosol	GO:001623; GO:001602; GO:000573; GO:000582	 Insulin signaling pathway; Glucagon signaling pathway; Insulin resistance; Starch and sucrose metabolism; PI3K-Akt signaling pathway	hsa0491; hsa0492; hsa0493; hsa0050; hsa0415	protein binding;glucose binding;protein kinase binding;glycogen synthase activity, transferring glucose-1-phosphate;glycogen (starch) synthase activity	GO:000551; GO:000553; GO:001990; GO:006154; GO:000437
NP_001182440.1	NP_001182440.1	NP_001182440.1 glycogen [starch] synthase, liver [Sus scrofa]	4	3	3	31986000	0	16862000	0	13967000	0	0	0	11839000	0	0	0	0	0	0	0	0	0	NA	NA	NA	GYS2	GYS2;NA;NA;NA;NA	response to glucose;glycogen biosynthetic process;generation of precursor metabolites and energy	GO:000974; GO:000597; GO:000609	cytoplasm;cell cortex;cytosol;ectoplasm;cytoskeleton;cortical actin cytoskeleton	GO:000573; GO:000593; GO:000582; GO:004326; GO:000585; GO:003086	 PI3K-Akt signaling pathway; AMPK signaling pathway; Insulin signaling pathway; Glucagon signaling pathway; Insulin resistance; Starch and sucrose metabolism	hsa0415; hsa0415; hsa0491; hsa0492; hsa0493; hsa0050	glycogen (starch) synthase activity;protein homodimerization activity;glycogen synthase activity, transferring glucose-1-phosphate	GO:000437; GO:004280; GO:006154
NP_001182709.1;XP_020922766.1;XP_020922713.1;XP_020922676.1	NP_001182709.1;XP_020922766.1;XP_020922713.1;XP_020922676.1	NP_001182709.1 protein-L-isoaspartate(D-aspartate) O-methyltransferase [Sus scrofa];XP_020922766.1 protein-L-isoaspartate(D-aspartate) O-methyltransferase isoform X3 [Sus scrofa];XP_020922713.1 protein-L-isoaspartate(D-aspartate) O-methyltransferase isofor	9	9	9	303130000	273800000	313500000	235370000	217870000	184610000	257050000	212750000	257390000	231590000	280970000	203240000	195430000	214580000	329700000	289700000	289390000	203870000	NA	NA	NA	PCMT1	PCMT1;PCMT1;PCMT1;PCMT1;NA	protein methylation;protein repair	GO:000647; GO:003009	cytoplasm;extracellular exosome;cytosol;extracellular vesicle	GO:000573; GO:007006; GO:000582; GO:190356	"NA"	"NA"	cadherin binding;protein binding;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	GO:004529; GO:000551; GO:000471
XP_013835710.1;NP_001182710.1;XP_013835711.1;XP_020922721.1	XP_013835710.1;NP_001182710.1;XP_013835711.1;XP_020922721.1	XP_013835710.1 phosphatidylinositol 5-phosphate 4-kinase type-2 alpha isoform X1 [Sus scrofa];NP_001182710.1 phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [Sus scrofa];XP_013835711.1 phosphatidylinositol 5-phosphate 4-kinase type-2 alpha isoform X	4	4	4	16928000	16687000	17194000	15948000	13614000	15087000	14576000	13023000	15079000	16795000	14998000	0	17842000	13910000	14396000	14308000	14153000	18182000	NA	NA	NA	PIP4K2A	PIP4K2A;PIP4K2A;PIP4K2A;PIP4K2B;NA	positive regulation of autophagosome assembly;phospholipid metabolic process;regulation of autophagy;phosphatidylinositol biosynthetic process;regulation of phosphatidylinositol 3-kinase signaling;megakaryocyte development;phosphatidylinositol phosphorylation	GO:200078; GO:000664; GO:001050; GO:000666; GO:001406; GO:003585; GO:004685	nucleoplasm;autophagosome;plasma membrane;cytosol	GO:000565; GO:000577; GO:000588; GO:000582	 Phosphatidylinositol signaling system; Regulation of actin cytoskeleton; Inositol phosphate metabolism	hsa0407; hsa0481; hsa0056	1-phosphatidylinositol-3-phosphate 4-kinase activity;1-phosphatidylinositol-5-phosphate 4-kinase activity;ATP binding	GO:005281; GO:001630; GO:000552
NP_001183950.1;XP_020949163.1	NP_001183950.1;XP_020949163.1	NP_001183950.1 hydroxysteroid dehydrogenase-like protein 2 [Sus scrofa];XP_020949163.1 hydroxysteroid dehydrogenase-like protein 2 isoform X1 [Sus scrofa]	8	8	8	45110000	28907000	65179000	0	46996000	27287000	76670000	40589000	81780000	41865000	23926000	0	0	22448000	34557000	34446000	0	0	NA	NA	NA	HSDL2	HSDL2;HSDL2;NA;NA;NA	oxidation-reduction process;biological_process	GO:005511; GO:000815	peroxisome;membrane;mitochondrion	GO:000577; GO:001602; GO:000573	"NA"	"NA"	molecular_function;oxidoreductase activity	GO:000367; GO:001649
XP_020946587.1;XP_005663956.1;NP_001239030.1;XP_013853088.1;XP_013853087.1;XP_005663955.1;NP_001184235.1	XP_020946587.1;XP_005663956.1;NP_001239030.1;XP_013853088.1;XP_013853087.1;XP_005663955.1;NP_001184235.1	XP_020946587.1 signal transducer and activator of transcription 6 isoform X2 [Sus scrofa];XP_005663956.1 signal transducer and activator of transcription 6 isoform X2 [Sus scrofa];NP_001239030.1 signal transducer and activator of transcription 6 isoform 2	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10769000	0	11209000	NA	NA	NA	STAT6	STAT6;STAT6;STAT6;STAT6;STAT6	negative regulation of type 2 immune response;mammary gland epithelial cell proliferation;positive regulation of transcription from RNA polymerase II promoter;mammary gland morphogenesis;cellular response to hydrogen peroxide;cellular response to reactive nitrogen species;regulation of cell proliferation;regulation of transcription from RNA polymerase II promoter;signal transduction;cytokine-mediated signaling pathway;interleukin-4-mediated signaling pathway;positive regulation of isotype switching to IgE isotypes;T-helper 1 cell lineage commitment;positive regulation of type I interferon production;negative regulation of transcription from RNA polymerase II promoter	GO:000282; GO:003359; GO:004594; GO:006044; GO:007030; GO:190217; GO:004212; GO:000635; GO:000716; GO:001922; GO:003577; GO:004829; GO:000229; GO:003248; GO:000012	membrane raft;cytosol;nuclear chromatin;nuclear membrane;nucleoplasm	GO:004512; GO:000582; GO:000079; GO:003196; GO:000565	 Hepatitis B; Inflammatory bowel disease (IBD); Jak-STAT signaling pathway	hsa0516; hsa0532; hsa0463	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;identical protein binding;protein phosphatase binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;transcription factor activity, sequence-specific DNA binding;RNA polymerase II regulatory region sequence-specific DNA binding;protein binding	GO:000122; GO:004280; GO:001990; GO:000098; GO:000370; GO:000097; GO:000551
XP_020927551.1;XP_020927549.1;XP_020927548.1;NP_001185848.1;XP_020927547.1;XP_005671100.1;XP_005671099.1;XP_005671098.1	XP_020927551.1;XP_020927549.1;XP_020927548.1;NP_001185848.1;XP_020927547.1;XP_005671100.1;XP_005671099.1;XP_005671098.1	XP_020927551.1 saposin-B-Val isoform X7 [Sus scrofa];XP_020927549.1 saposin-B-Val isoform X6 [Sus scrofa];XP_020927548.1 saposin-B-Val isoform X5 [Sus scrofa];NP_001185848.1 saposin-B-Val precursor [Sus scrofa];XP_020927547.1 saposin-B-Val isoform X4 [Sus	6	6	6	0	120120000	88754000	119930000	86308000	147460000	92323000	103020000	53847000	91239000	75279000	162120000	70949000	137170000	93942000	110770000	107330000	145290000	NA	NA	NA	PSAP	PSAP;PSAP;PSAP;PSAP;PSAP	regulation of autophagy;positive regulation of hydrolase activity;cellular response to organic substance;glycosphingolipid metabolic process;regulation of lipid metabolic process;walking behavior;negative regulation of hydrogen peroxide-induced cell death;platelet degranulation;neuromuscular process controlling balance;ganglioside GM1 transport to membrane;corneocyte development;sensory perception of sound;myelination;micturition;epithelial cell differentiation involved in prostate gland development;cochlea development;lipid transport;G-protein coupled receptor signaling pathway;neutrophil degranulation;positive regulation of MAPK cascade;prostate gland growth;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;cornified envelope assembly	GO:001050; GO:005134; GO:007131; GO:000668; GO:001921; GO:009065; GO:190320; GO:000257; GO:005088; GO:190557; GO:000333; GO:000760; GO:004255; GO:006007; GO:006074; GO:009010; GO:000686; GO:000718; GO:004331; GO:004341; GO:006073; GO:000719; GO:190357	lysosome;extracellular space;lysosomal lumen;extracellular exosome;plasma membrane;azurophil granule membrane;intracellular membrane-bounded organelle;lysosomal membrane;extracellular region	GO:000576; GO:000561; GO:004320; GO:007006; GO:000588; GO:003557; GO:004323; GO:000576; GO:000557	 Lysosome	hsa0414	ganglioside GT1b binding;beta-galactosidase activity;ganglioside GP1c binding;protein homodimerization activity;protein binding;G-protein coupled receptor binding;protease binding;phospholipid binding;enzyme activator activity;lipid binding	GO:190557; GO:000456; GO:190557; GO:004280; GO:000551; GO:000166; GO:000202; GO:000554; GO:000804; GO:000828
NP_001185851.1;XP_020927581.1	NP_001185851.1;XP_020927581.1	NP_001185851.1 mitogen-activated protein kinase 1 [Sus scrofa];XP_020927581.1 mitogen-activated protein kinase 1 isoform X1 [Sus scrofa]	14	14	12	162710000	252850000	237360000	218270000	165060000	240290000	177210000	201500000	192270000	204620000	214120000	254570000	196970000	241660000	151170000	227980000	200490000	232910000	NA	NA	NA	MAPK1	MAPK1;MAPK1;NA;NA;NA	peptidyl-serine phosphorylation;sensory perception of pain;regulation of cellular pH;thyroid gland development;lipopolysaccharide-mediated signaling pathway;cellular response to reactive oxygen species;ERBB signaling pathway;neutrophil degranulation;cellular response to granulocyte macrophage colony-stimulating factor stimulus;cell cycle;regulation of gene expression;positive regulation of gene expression;regulation of phosphatidylinositol 3-kinase signaling;positive regulation of telomere maintenance via telomerase;response to estrogen;regulation of cytoskeleton organization;Bergmann glial cell differentiation;ERK1 and ERK2 cascade;response to epidermal growth factor;cellular response to organic substance;regulation of early endosome to late endosome transport;apoptotic process;fibroblast growth factor receptor signaling pathway;cytosine metabolic process;platelet activation;positive regulation of cell migration;regulation of protein stability;intracellular signal transduction;Fc-gamma receptor signaling pathway involved in phagocytosis;outer ear morphogenesis;response to exogenous dsRNA;positive regulation of translation;decidualization;B cell receptor signaling pathway;labyrinthine layer blood vessel development;regulation of Golgi inheritance;MAPK cascade;cellular response to DNA damage stimulus;signal transduction;chemical synaptic transmission;axon guidance;learning or memory;viral process;peptidyl-threonine phosphorylation;negative regulation of cell differentiation;positive regulation of cardiac muscle cell proliferation;face development;lung morphogenesis;protein phosphorylation;thymus development;long-term synaptic potentiation;cellular response to cadmium ion;caveolin-mediated endocytosis;positive regulation of telomere capping;activation of MAPK activity;aging;diadenosine tetraphosphate biosynthetic process;positive regulation of transcription, DNA-templated;stress-activated MAPK cascade;trachea formation;chemotaxis;response to nicotine;positive regulation of telomerase activity;cellular response to tumor necrosis factor;regulation of cellular response to heat;cellular response to dopamine;cardiac neural crest cell development involved in heart development;positive regulation of peptidyl-threonine phosphorylation;regulation of ossification;regulation of stress-activated MAPK cascade;mammary gland epithelial cell proliferation;cellular response to amino acid starvation;regulation of sequence-specific DNA binding transcription factor activity	GO:001810; GO:001923; GO:003064; GO:003087; GO:003166; GO:003461; GO:003812; GO:004331; GO:009701; GO:000704; GO:001046; GO:001062; GO:001406; GO:003221; GO:004362; GO:005149; GO:006002; GO:007037; GO:007084; GO:007131; GO:200064; GO:000691; GO:000854; GO:001985; GO:003016; GO:003033; GO:003164; GO:003555; GO:003809; GO:004247; GO:004333; GO:004572; GO:004669; GO:005085; GO:006071; GO:009017; GO:000016; GO:000697; GO:000716; GO:000726; GO:000741; GO:000761; GO:001603; GO:001810; GO:004559; GO:006004; GO:006032; GO:006042; GO:000646; GO:004853; GO:006029; GO:007127; GO:007258; GO:190435; GO:000018; GO:000756; GO:001596; GO:004589; GO:005140; GO:006044; GO:000693; GO:003509; GO:005197; GO:007135; GO:190003; GO:190335; GO:006130; GO:001080; GO:003027; GO:003287; GO:003359; GO:003419; GO:005109	mitochondrion;caveola;dendrite cytoplasm;macromolecular complex;microtubule organizing center;cytosol;cytoskeleton;pseudopodium;ficolin-1-rich granule lumen;late endosome;focal adhesion;postsynaptic density;azurophil granule lumen;nucleus;nucleoplasm;Golgi apparatus;plasma membrane;axon;mitotic spindle;early endosome;extracellular region;cytoplasm;perikaryon	GO:000573; GO:000590; GO:003283; GO:003299; GO:000581; GO:000582; GO:000585; GO:003114; GO:190481; GO:000577; GO:000592; GO:001406; GO:003557; GO:000563; GO:000565; GO:000579; GO:000588; GO:003042; GO:007268; GO:000576; GO:000557; GO:000573; GO:004320	 MAPK signaling pathway; HIF-1 signaling pathway; Dorso-ventral axis formation; Platelet activation; B cell receptor signaling pathway; Neurotrophin signaling pathway; Regulation of actin cytoskeleton; Chagas disease (American trypanosomiasis); Hepatitis B; Proteoglycans in cancer; Endometrial cancer; Rap1 signaling pathway; VEGF signaling pathway; Shigellosis; Axon guidance; Signaling pathways regulating pluripotency of stem cells; Insulin signaling pathway; Alzheimer's disease; Non-small cell lung cancer; Gap junction; Prion diseases; cGMP-PKG signaling pathway; mTOR signaling pathway; NOD-like receptor signaling pathway; Natural killer cell mediated cytotoxicity; Long-term depression; Oxytocin signaling pathway; Type II diabetes mellitus; Tuberculosis; Choline metabolism in cancer; Oocyte meiosis; Circadian entrainment; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; TGF-beta signaling pathway; Osteoclast differentiation; Focal adhesion; Adherens junction; Sphingolipid signaling pathway; Aldosterone-regulated sodium reabsorption; Alcoholism	hsa0401; hsa0406; hsa0432; hsa0461; hsa0466; hsa0472; hsa0481; hsa0514; hsa0516; hsa0520; hsa0521; hsa0401; hsa0437; hsa0513; hsa0436; hsa0455; hsa0491; hsa0501; hsa0522; hsa0454; hsa0502; hsa0402; hsa0415; hsa0462; hsa0465; hsa0473; hsa0492; hsa0493; hsa0515; hsa0523; hsa0411; hsa0471; hsa0426; hsa0427; hsa0435; hsa0438; hsa0451; hsa0452; hsa0407; hsa0496; hsa0503	kinase activity;double-stranded DNA binding;protein serine/threonine kinase activity;mitogen-activated protein kinase kinase kinase binding;phosphotyrosine binding;MAP kinase activity;RNA polymerase II carboxy-terminal domain kinase activity;protein binding;ATP binding;transcription factor binding;phosphatase binding;identical protein binding	GO:001630; GO:000369; GO:000467; GO:003143; GO:000178; GO:000470; GO:000835; GO:000551; GO:000552; GO:000813; GO:001990; GO:004280
NP_001185852.2;XP_003358996.2	NP_001185852.2	NP_001185852.2 chloride intracellular channel protein 5 [Sus scrofa]	7	7	7	21849000	0	21467000	0	25200000	0	86217000	0	21548000	0	49594000	0	27450000	0	32305000	0	91954000	9848200	NA	NA	NA	CLIC5	CLIC5;NA;NA;NA;NA	female pregnancy;sensory perception of sound;regulation of ion transmembrane transport;chloride transport;chloride transmembrane transport	GO:000756; GO:000760; GO:003476; GO:000682; GO:190247	Golgi apparatus;cell cortex;actin cytoskeleton;microtubule organizing center;chloride channel complex;extracellular exosome	GO:000579; GO:000593; GO:001562; GO:000581; GO:003470; GO:007006	"NA"	"NA"	chloride channel activity;protein binding;voltage-gated ion channel activity	GO:000525; GO:000551; GO:000524
NP_001186292.1	NP_001186292.1	NP_001186292.1 calcium-binding mitochondrial carrier protein SCaMC-1 [Sus scrofa]	6	6	6	0	40002000	27046000	41807000	35176000	33232000	23547000	50791000	31535000	36274000	37048000	25008000	29645000	30846000	26428000	29798000	28963000	40023000	NA	NA	NA	SLC25A24	SLC25A24;NA;NA;NA;NA	regulation of cell death;mitochondrial transport;cellular response to oxidative stress;transmembrane transport;cellular response to calcium ion;ATP transport	GO:001094; GO:000683; GO:003459; GO:005508; GO:007127; GO:001586	mitochondrial inner membrane;mitochondrion;integral component of membrane	GO:000574; GO:000573; GO:001602	"NA"	"NA"	calcium ion binding;ATP transmembrane transporter activity	GO:000550; GO:000534
XP_020957708.1;XP_020957707.1;XP_020957706.1;XP_020957705.1;XP_005667460.1;NP_001186648.1;XP_005667459.1;XP_020957704.1;XP_020957703.1;XP_005667455.1;XP_013834903.1;XP_020957701.1;XP_020957700.1;XP_020957699.1	XP_020957708.1;XP_020957707.1;XP_020957706.1;XP_020957705.1;XP_005667460.1;NP_001186648.1;XP_005667459.1;XP_020957704.1;XP_020957703.1;XP_005667455.1;XP_013834903.1;XP_020957701.1;XP_020957700.1;XP_020957699.1	XP_020957708.1 glucose-6-phosphate exchanger SLC37A4 isoform X6 [Sus scrofa];XP_020957707.1 glucose-6-phosphate exchanger SLC37A4 isoform X6 [Sus scrofa];XP_020957706.1 glucose-6-phosphate exchanger SLC37A4 isoform X6 [Sus scrofa];XP_020957705.1 glucose-6-	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7674200	0	NA	NA	NA	SLC37A4	SLC37A4;SLC37A4;SLC37A4;SLC37A4;SLC37A4	glucose metabolic process;gluconeogenesis;glucose-6-phosphate transport;phosphate ion transmembrane transport;carbohydrate transport	GO:000600; GO:000609; GO:001576; GO:003543; GO:000864	integral component of membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane;membrane	GO:001602; GO:000578; GO:003017; GO:001602	 Carbohydrate digestion and absorption	hsa0497	transporter activity;glucose-6-phosphate transmembrane transporter activity;glucose 6-phosphate:inorganic phosphate antiporter activity	GO:000521; GO:001515; GO:006151
XP_020944311.1;XP_020944310.1;NP_001188310.1;XP_020934490.1;XP_020934489.1;XP_013846266.1;XP_020934488.1;XP_020934487.1;XP_020934486.1;XP_013846264.1;XP_005657816.1;XP_005657815.1;XP_003134727.2	XP_020944311.1;XP_020944310.1;NP_001188310.1;XP_020934490.1;XP_020934489.1;XP_013846266.1;XP_020934488.1;XP_020934487.1;XP_020934486.1;XP_013846264.1;XP_005657816.1;XP_005657815.1;XP_003134727.2	XP_020944311.1 adenosylhomocysteinase 2 isoform X2 [Sus scrofa];XP_020944310.1 adenosylhomocysteinase 2 isoform X1 [Sus scrofa];NP_001188310.1 adenosylhomocysteinase 2 [Sus scrofa];XP_020934490.1 adenosylhomocysteinase 3 isoform X5 [Sus scrofa];XP_02093448	4	4	4	0	51051000	49351000	0	0	64569000	36328000	38466000	0	0	42384000	0	0	0	0	57822000	51153000	49667000	NA	NA	NA	AHCYL1	AHCYL1;AHCYL1;AHCYL2;AHCYL2;AHCYL2	positive regulation of sodium ion transport;one-carbon metabolic process;angiotensin-activated signaling pathway;response to calcium ion;mRNA polyadenylation;epithelial fluid transport;regulation of mRNA 3'-end processing;regulation of anion transport;regulation of ion transmembrane transporter activity;S-adenosylmethionine cycle;protein export from nucleus;regulation of cardiac conduction	GO:001076; GO:000673; GO:003816; GO:005159; GO:000637; GO:004204; GO:003144; GO:004407; GO:003241; GO:003335; GO:000661; GO:190377	cytosol;cytoplasm;endoplasmic reticulum membrane;apical plasma membrane;extracellular exosome	GO:000582; GO:000573; GO:000578; GO:001632; GO:007006	 Cysteine and methionine metabolism; Metabolic pathways	hsa0027; hsa0110	RNA binding;protein binding;identical protein binding;adenosylhomocysteinase activity	GO:000372; GO:000551; GO:004280; GO:000401
XP_003124283.1;XP_003354456.1;NP_001188311.1	XP_003124283.1;XP_003354456.1;NP_001188311.1	XP_003124283.1 interferon-induced transmembrane protein 1 [Sus scrofa];XP_003354456.1 interferon-induced transmembrane protein 1-like [Sus scrofa];NP_001188311.1 interferon-induced transmembrane protein 3 [Sus scrofa]	1	1	1	0	8354400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	IFITM3	LOC100519082;LOC100626247;IFITM3;NA;NA	negative regulation of viral entry into host cell;defense response to virus;immune response;response to interferon-gamma;negative regulation of viral transcription;negative regulation of viral genome replication;response to interferon-beta;response to virus;type I interferon signaling pathway	GO:004659; GO:005160; GO:000695; GO:003434; GO:003289; GO:004507; GO:003545; GO:000961; GO:006033	late endosome membrane;lysosomal membrane;integral component of membrane;macromolecular complex;plasma membrane	GO:003190; GO:000576; GO:001602; GO:003299; GO:000588	"NA"	"NA"	protein binding	GO:000551
XP_020921798.1;XP_020921797.1;NP_001188313.1;XP_020921795.1	XP_020921798.1;XP_020921797.1;NP_001188313.1;XP_020921795.1	XP_020921798.1 rho GDP-dissociation inhibitor 1 isoform X2 [Sus scrofa];XP_020921797.1 rho GDP-dissociation inhibitor 1 isoform X2 [Sus scrofa];NP_001188313.1 rho GDP-dissociation inhibitor 1 [Sus scrofa];XP_020921795.1 rho GDP-dissociation inhibitor 1 iso	8	8	8	605710000	878890000	653160000	880170000	726300000	881980000	596620000	839350000	512510000	755320000	694200000	1124900000	666050000	808860000	767910000	879460000	650000000	815720000	NA	NA	NA	ARHGDIA	ARHGDIA;ARHGDIA;ARHGDIA;ARHGDIA;NA	regulation of Rho protein signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of apoptotic process;positive regulation of GTPase activity;regulation of actin cytoskeleton reorganization;semaphorin-plexin signaling pathway;negative regulation of cell adhesion;positive regulation of axonogenesis;Rho protein signal transduction	GO:003502; GO:005105; GO:004306; GO:004354; GO:200024; GO:007152; GO:000716; GO:005077; GO:000726	cytoskeleton;membrane;cytosol;extracellular exosome	GO:000585; GO:001602; GO:000582; GO:007006	 Vasopressin-regulated water reabsorption; Neurotrophin signaling pathway	hsa0496; hsa0472	Rho GDP-dissociation inhibitor activity;protein binding;Rac GTPase binding;GTPase activator activity	GO:000509; GO:000551; GO:004836; GO:000509
NP_001188360.1	NP_001188360.1	NP_001188360.1 selenoprotein O [Sus scrofa]	3	3	3	0	15839000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SELENOO	SELENOO;NA;NA;NA;NA	"NA"	"NA"	mitochondrion	GO:000573	"NA"	"NA"	"NA"	"NA"
NP_001189469.1	NP_001189469.1	NP_001189469.1 transmembrane emp24 domain-containing protein 7 precursor [Sus scrofa]	3	3	3	34822000	34971000	34650000	29034000	34555000	49187000	33380000	0	39299000	38234000	34876000	33657000	45773000	29537000	36078000	37878000	47199000	0	NA	NA	NA	TMED7	TMED7;NA;NA;NA;NA	Golgi organization;ER to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER	GO:000703; GO:000688; GO:000689	integral component of membrane;COPII vesicle coat;transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane;Golgi apparatus;Golgi membrane	GO:001602; GO:003012; GO:003013; GO:003311; GO:000578; GO:000579; GO:000013	"NA"	"NA"	"NA"	"NA"
NP_001191110.1;XP_020943450.1;XP_020943396.1;XP_020943558.1;XP_020943497.1;XP_020943345.1;XP_020943300.1	NP_001191110.1;XP_020943450.1;XP_020943396.1;XP_020943558.1;XP_020943497.1;XP_020943345.1;XP_020943300.1	NP_001191110.1 A-kinase anchor protein 2 [Sus scrofa];XP_020943450.1 A-kinase anchor protein 2 isoform X4 [Sus scrofa];XP_020943396.1 A-kinase anchor protein 2 isoform X3 [Sus scrofa];XP_020943558.1 A-kinase anchor protein 2 isoform X5 [Sus scrofa];XP_0209	8	8	8	0	23526000	23610000	25384000	23104000	0	17590000	0	0	21988000	26228000	27799000	20519000	26838000	20292000	27681000	0	24771000	NA	NA	NA	AKAP2	AKAP2;AKAP2;AKAP2;AKAP2;AKAP2	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001191212.1;XP_020938996.1;XP_013850028.1;XP_013834333.2	NP_001191212.1	NP_001191212.1 40S ribosomal protein S4, X isoform [Sus scrofa]	16	16	16	161960000	144930000	211040000	148250000	176830000	210970000	175940000	153710000	197830000	171780000	168320000	243600000	213220000	210820000	177520000	206140000	215940000	235350000	NA	NA	NA	RPS4X	RPS4X;NA;NA;NA;NA	translation;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;positive regulation of cell proliferation;multicellular organism development;positive regulation of translation	GO:000641; GO:000641; GO:000018; GO:000661; GO:000828; GO:000727; GO:004572	nucleoplasm;extracellular exosome;small ribosomal subunit;cytosol;ribosome;cytoplasmic ribonucleoprotein granule;cytosolic small ribosomal subunit;ribonucleoprotein complex;focal adhesion;membrane	GO:000565; GO:007006; GO:001593; GO:000582; GO:000584; GO:003646; GO:002262; GO:199090; GO:000592; GO:001602	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;rRNA binding;RNA binding	GO:000551; GO:000373; GO:001984; GO:000372
NP_001191292.1;XP_020953703.1	NP_001191292.1;XP_020953703.1	NP_001191292.1 transmembrane emp24 domain-containing protein 3 precursor [Sus scrofa];XP_020953703.1 transmembrane emp24 domain-containing protein 3 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7742400	NA	NA	NA	TMED3	TMED3;TMED3;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;Golgi organization;ER to Golgi vesicle-mediated transport	GO:000689; GO:000703; GO:000688	COPI vesicle coat;Golgi membrane;endoplasmic reticulum;Golgi apparatus;integral component of membrane;Golgi cisterna membrane;transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane	GO:003012; GO:000013; GO:000578; GO:000579; GO:001602; GO:003258; GO:003013; GO:003311	"NA"	"NA"	"NA"	"NA"
XP_020941366.1;XP_020941365.1;XP_020941364.1;XP_005655190.1;XP_005655188.1;NP_001191298.1;XP_020941363.1	XP_020941366.1;XP_020941365.1;XP_020941364.1;XP_005655190.1;XP_005655188.1;NP_001191298.1;XP_020941363.1	XP_020941366.1 SUMO-conjugating enzyme UBC9 isoform X3 [Sus scrofa];XP_020941365.1 SUMO-conjugating enzyme UBC9 isoform X3 [Sus scrofa];XP_020941364.1 SUMO-conjugating enzyme UBC9 isoform X2 [Sus scrofa];XP_005655190.1 SUMO-conjugating enzyme UBC9 isoform	3	3	3	0	14879000	19905000	0	0	20287000	17997000	0	0	16588000	0	0	22062000	0	0	18907000	0	16635000	NA	NA	NA	UBE2I	UBE2I;UBE2I;UBE2I;UBE2I;UBE2I	proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of sequence-specific DNA binding transcription factor activity;negative regulation of transcription from RNA polymerase II promoter;ubiquitin-dependent protein catabolic process;cell cycle;viral process;chromosome segregation;regulation of receptor activity;positive regulation of intracellular steroid hormone receptor signaling pathway;cell division;protein ubiquitination;negative regulation of transcription, DNA-templated;cellular protein modification process;protein sumoylation;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of SUMO transferase activity	GO:004316; GO:005109; GO:000012; GO:000651; GO:000704; GO:001603; GO:000705; GO:001046; GO:003314; GO:005130; GO:001656; GO:004589; GO:000646; GO:001692; GO:004312; GO:190375	fibrillar center;cytoplasm;nuclear envelope;PML body;dendrite;sumoylated E2 ligase complex;synaptonemal complex;transferase complex;nucleoplasm;cytosol;synapse	GO:000165; GO:000573; GO:000563; GO:001660; GO:003042; GO:199035; GO:000079; GO:199023; GO:000565; GO:000582; GO:004520	 NF-kappa B signaling pathway; RNA transport; MicroRNAs in cancer; Ubiquitin mediated proteolysis	hsa0406; hsa0301; hsa0520; hsa0412	enzyme binding;bHLH transcription factor binding;SUMO conjugating enzyme activity;ATP binding;protein C-terminus binding;RNA binding;protein binding;SUMO transferase activity;small protein activating enzyme binding;RING-like zinc finger domain binding;ubiquitin-protein transferase activity;transcription factor binding;HLH domain binding	GO:001989; GO:004342; GO:006165; GO:000552; GO:000802; GO:000372; GO:000551; GO:001978; GO:004438; GO:007153; GO:000484; GO:000813; GO:004339
XP_005668988.1;NP_001191688.1	XP_005668988.1;NP_001191688.1	XP_005668988.1 nucleoside diphosphate kinase A isoform X1 [Sus scrofa];NP_001191688.1 nucleoside diphosphate kinase A [Sus scrofa]	6	3	3	57363000	82073000	90448000	64372000	66056000	75885000	70745000	72671000	75641000	66014000	63149000	31387000	72763000	61867000	85561000	57904000	71672000	71693000	NA	NA	NA	NME1	NME1;NME1;NA;NA;NA	DNA metabolic process;hippocampus development;nucleoside diphosphate phosphorylation;endocytosis;negative regulation of cell proliferation;cellular response to drug;positive regulation of DNA binding;CTP biosynthetic process;lactation;response to amine;GTP biosynthetic process;positive regulation of neuron projection development;regulation of apoptotic process;response to cAMP;negative regulation of myeloid leukocyte differentiation;nucleobase-containing small molecule interconversion;cellular response to fatty acid;UTP biosynthetic process;negative regulation of gene expression;response to testosterone;positive regulation of epithelial cell proliferation;cellular response to glucose stimulus	GO:000625; GO:002176; GO:000616; GO:000689; GO:000828; GO:003569; GO:004338; GO:000624; GO:000759; GO:001407; GO:000618; GO:001097; GO:004298; GO:005159; GO:000276; GO:001594; GO:007139; GO:000622; GO:001062; GO:003357; GO:005067; GO:007133	intermediate filament;perinuclear region of cytoplasm;extracellular exosome;ruffle membrane;mitochondrial outer membrane;cytosol;centrosome;membrane;nucleus;cytoplasm	GO:000588; GO:004847; GO:007006; GO:003258; GO:000574; GO:000582; GO:000581; GO:001602; GO:000563; GO:000573	 Pyrimidine metabolism; Purine metabolism; Biosynthesis of antibiotics; Metabolic pathways	hsa0024; hsa0023; hsa0113; hsa0110	RNA binding;single-stranded DNA binding;deoxyribonuclease activity;nucleoside diphosphate kinase activity;identical protein binding;protein binding;intermediate filament binding;RNA polymerase II regulatory region sequence-specific DNA binding;GTP binding;enzyme binding;gamma-tubulin binding;ribosomal small subunit binding;magnesium ion binding	GO:000372; GO:000369; GO:000453; GO:000455; GO:004280; GO:000551; GO:001921; GO:000097; GO:000552; GO:001989; GO:004301; GO:004302; GO:000028
NP_001191699.1	NP_001191699.1	NP_001191699.1 O-acetyl-ADP-ribose deacetylase MACROD1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	7003800	0	0	0	0	6378200	0	0	12190000	0	NA	NA	NA	MACROD1	MACROD1;NA;NA;NA;NA	cellular response to DNA damage stimulus;purine nucleoside metabolic process;protein de-ADP-ribosylation	GO:000697; GO:004227; GO:005172	nucleoplasm;nucleus	GO:000565; GO:000563	"NA"	"NA"	deacetylase activity;protein binding;hydrolase activity, acting on glycosyl bonds	GO:001921; GO:000551; GO:001679
NP_001191781.1	NP_001191781.1	NP_001191781.1 fucose-1-phosphate guanylyltransferase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4432200	0	0	0	NA	NA	NA	FPGT	FPGT;NA;NA;NA;NA	fucose metabolic process	GO:000600	cytoplasm;cytosol	GO:000573; GO:000582	 Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Fructose and mannose metabolism	hsa0052; hsa0110; hsa0005	catalytic activity;GTP binding;fucose-1-phosphate guanylyltransferase activity	GO:000382; GO:000552; GO:004734
NP_001192023.1	NP_001192023.1	NP_001192023.1 ubiquitin-conjugating enzyme E2 variant 1 [Sus scrofa]	4	4	2	125810000	135460000	99825000	105360000	88203000	111420000	93874000	125070000	92100000	104330000	118130000	72016000	122150000	114860000	138310000	125500000	76891000	115800000	NA	NA	NA	UBE2V1	UBE2V1;NA;NA;NA;NA	positive regulation of I-kappaB kinase/NF-kappaB signaling;protein polyubiquitination;cell differentiation;activation of MAPK activity;positive regulation of NF-kappaB transcription factor activity;regulation of transcription, DNA-templated;nucleotide-binding oligomerization domain containing signaling pathway;positive regulation of transcription, DNA-templated;postreplication repair;protein K63-linked ubiquitination;regulation of DNA repair;JNK cascade;interleukin-1-mediated signaling pathway	GO:004312; GO:000020; GO:003015; GO:000018; GO:005109; GO:000635; GO:007042; GO:004589; GO:000630; GO:007053; GO:000628; GO:000725; GO:007049	cytoplasm;UBC13-UEV1A complex;nucleoplasm;ubiquitin conjugating enzyme complex;cytosol;macromolecular complex;nucleus;ubiquitin ligase complex;extracellular exosome	GO:000573; GO:003537; GO:000565; GO:003137; GO:000582; GO:003299; GO:000563; GO:000015; GO:007006	"NA"	"NA"	ubiquitin conjugating enzyme activity;protein binding	GO:006163; GO:000551
NP_001192208.1;XP_005653347.1	NP_001192208.1;XP_005653347.1	NP_001192208.1 electron transfer flavoprotein subunit beta [Sus scrofa];XP_005653347.1 electron transfer flavoprotein subunit beta isoform X1 [Sus scrofa]	11	11	11	336960000	205220000	278680000	190110000	275050000	175230000	311320000	182740000	320730000	204030000	241290000	165560000	190790000	234050000	289060000	202790000	215920000	203390000	NA	NA	NA	ETFB	ETFB;ETFB;NA;NA;NA	electron transport chain;fatty acid beta-oxidation using acyl-CoA dehydrogenase	GO:002290; GO:003353	mitochondrial matrix;mitochondrion;cytosol	GO:000575; GO:000573; GO:000582	"NA"	"NA"	electron carrier activity;protein binding	GO:000905; GO:000551
NP_001192332.1	NP_001192332.1	NP_001192332.1 tubulin-folding cofactor B [Sus scrofa]	2	2	2	0	0	0	0	0	0	20194000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TBCB	TBCB;NA;NA;NA;NA	nervous system development;cell differentiation	GO:000739; GO:003015	microtubule cytoskeleton;microtubule;cytoplasm;cytosol	GO:001563; GO:000587; GO:000573; GO:000582	"NA"	"NA"	protein binding	GO:000551
NP_001192335.1;NP_001192333.1	NP_001192335.1;NP_001192333.1	NP_001192335.1 DNA-directed RNA polymerase II subunit RPB9 isoform 2 [Sus scrofa];NP_001192333.1 DNA-directed RNA polymerase II subunit RPB9 isoform 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	859050	0	NA	NA	NA	POLR2I	POLR2I;POLR2I;NA;NA;NA	mRNA cleavage;snRNA transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;7-methylguanosine mRNA capping;maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter;transcription from RNA polymerase II promoter;regulation of gene silencing by miRNA;transcription-coupled nucleotide-excision repair;RNA metabolic process	GO:000637; GO:004279; GO:000039; GO:000854; GO:000637; GO:000119; GO:000636; GO:006096; GO:000628; GO:001607	DNA-directed RNA polymerase II, core complex;nucleolus;nucleus;nucleoplasm	GO:000566; GO:000573; GO:000563; GO:000565	 Metabolic pathways; Huntington's disease; Purine metabolism; Pyrimidine metabolism; Epstein-Barr virus infection; RNA polymerase	hsa0110; hsa0501; hsa0023; hsa0024; hsa0516; hsa0302	DNA-directed 5'-3' RNA polymerase activity;nucleic acid binding;zinc ion binding	GO:000389; GO:000367; GO:000827
XP_020932208.1;NP_001192334.1	XP_020932208.1;NP_001192334.1	XP_020932208.1 ras GTPase-activating protein-binding protein 1 isoform X1 [Sus scrofa];NP_001192334.1 ras GTPase-activating protein-binding protein 1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	G3BP1	G3BP1;G3BP1;NA;NA;NA	negative regulation of canonical Wnt signaling pathway;nucleic acid phosphodiester bond hydrolysis;Ras protein signal transduction;stress granule assembly;DNA duplex unwinding	GO:009009; GO:009030; GO:000726; GO:003406; GO:003250	ribonucleoprotein complex;cytosol;perikaryon;nucleus;focal adhesion;cytoplasmic stress granule	GO:199090; GO:000582; GO:004320; GO:000563; GO:000592; GO:001049	"NA"	"NA"	ATP-dependent DNA helicase activity;ATP-dependent RNA helicase activity;protein binding;endonuclease activity;RNA binding;ATP binding;DNA binding	GO:000400; GO:000400; GO:000551; GO:000451; GO:000372; GO:000552; GO:000367
NP_001193269.1	NP_001193269.1	NP_001193269.1 cell cycle and apoptosis regulator protein 2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2755700	NA	NA	NA	CCAR2	CCAR2;NA;NA;NA;NA	cell cycle;regulation of protein stability;positive regulation of apoptotic process;negative regulation of catalytic activity;regulation of cellular response to heat;regulation of DNA-templated transcription, elongation;negative regulation of cell growth;mitochondrial fragmentation involved in apoptotic process;positive regulation of canonical Wnt signaling pathway;regulation of transcription, DNA-templated;response to UV;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of transcription, DNA-templated;regulation of protein deacetylation;positive regulation of nucleic acid-templated transcription;rhythmic process;positive regulation of DNA damage checkpoint;mRNA processing;RNA splicing;cellular response to DNA damage stimulus;Wnt signaling pathway;regulation of circadian rhythm;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	GO:000704; GO:003164; GO:004306; GO:004308; GO:190003; GO:003278; GO:003030; GO:004365; GO:009026; GO:000635; GO:000941; GO:003243; GO:004589; GO:009031; GO:190350; GO:004851; GO:200000; GO:000639; GO:000838; GO:000697; GO:001605; GO:004275; GO:190223	nucleoplasm;mitochondrial matrix;nuclear chromatin;nucleus;DBIRD complex;cytoplasm	GO:000565; GO:000575; GO:000079; GO:000563; GO:004460; GO:000573	"NA"	"NA"	RNA polymerase II core binding;protein binding;enzyme inhibitor activity;enzyme binding;ligand-dependent nuclear receptor transcription coactivator activity;RNA binding	GO:000099; GO:000551; GO:000485; GO:001989; GO:003037; GO:000372
XP_020923928.1;XP_020923927.1;XP_020923926.1;NP_001193278.1;XP_020923925.1;XP_020923924.1;XP_020923930.1;XP_020923929.1;CON__Q0V8M9	XP_020923928.1;XP_020923927.1;XP_020923926.1;NP_001193278.1;XP_020923925.1;XP_020923924.1;XP_020923930.1;XP_020923929.1;CON__Q0V8M9	XP_020923928.1 inter-alpha-trypsin inhibitor heavy chain H3 isoform X5 [Sus scrofa];XP_020923927.1 inter-alpha-trypsin inhibitor heavy chain H3 isoform X4 [Sus scrofa];XP_020923926.1 inter-alpha-trypsin inhibitor heavy chain H3 isoform X3 [Sus scrofa];NP_0	8	8	8	62691000	25275000	36583000	23611000	56685000	52619000	32392000	0	35146000	22530000	56523000	0	58358000	32164000	27500000	0	44709000	29948000	NA	NA	+	ITIH3	ITIH3;ITIH3;ITIH3;ITIH3;ITIH3	negative regulation of endopeptidase activity;hyaluronan metabolic process;platelet degranulation	GO:001095; GO:003021; GO:000257	platelet dense granule lumen;extracellular region;extracellular exosome	GO:003108; GO:000557; GO:007006	"NA"	"NA"	endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity	GO:000486; GO:000486
NP_001193288.1;XP_020946773.1	NP_001193288.1;XP_020946773.1	NP_001193288.1 glyceraldehyde-3-phosphate dehydrogenase [Sus scrofa];XP_020946773.1 glyceraldehyde-3-phosphate dehydrogenase isoform X1 [Sus scrofa]	18	18	16	3775200000	2947000000	4440100000	4560900000	3848700000	2757300000	4070900000	3339300000	4199700000	4285600000	3258600000	3396100000	2879100000	3142000000	3899200000	4061200000	6120300000	2913400000	NA	NA	NA	GAPDH	GAPDH;GAPDH;NA;NA;NA	glycolytic process;regulation of macroautophagy;neuron apoptotic process;killing by host of symbiont cells;gluconeogenesis;negative regulation of translation;positive regulation of cytokine secretion;defense response to fungus;cellular response to interferon-gamma;killing of cells of other organism;positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction;antimicrobial humoral immune response mediated by antimicrobial peptide;protein stabilization;microtubule cytoskeleton organization;negative regulation of endopeptidase activity;peptidyl-cysteine S-trans-nitrosylation;canonical glycolysis	GO:000609; GO:001624; GO:005140; GO:005187; GO:000609; GO:001714; GO:005071; GO:005083; GO:007134; GO:003164; GO:005250; GO:006184; GO:005082; GO:000022; GO:001095; GO:003560; GO:006162	intracellular membrane-bounded organelle;GAIT complex;ribonucleoprotein complex;perinuclear region of cytoplasm;nuclear membrane;extracellular exosome;lipid particle;plasma membrane;microtubule cytoskeleton;cytosol;membrane;nucleus;cytoplasm;vesicle	GO:004323; GO:009745; GO:199090; GO:004847; GO:003196; GO:007006; GO:000581; GO:000588; GO:001563; GO:000582; GO:001602; GO:000563; GO:000573; GO:003198	 Carbon metabolism; HIF-1 signaling pathway; Alzheimer's disease; Metabolic pathways; Biosynthesis of antibiotics; Biosynthesis of amino acids; Glycolysis / Gluconeogenesis	hsa0120; hsa0406; hsa0501; hsa0110; hsa0113; hsa0123; hsa0001	aspartic-type endopeptidase inhibitor activity;peptidyl-cysteine S-nitrosylase activity;microtubule binding;identical protein binding;NAD binding;protein binding;NADP binding;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity;disordered domain specific binding	GO:001982; GO:003560; GO:000801; GO:004280; GO:005128; GO:000551; GO:005066; GO:000436; GO:009771
NP_001193308.1;XP_020946726.1	NP_001193308.1;XP_020946726.1	NP_001193308.1 lipase maturation factor 2 [Sus scrofa];XP_020946726.1 lipase maturation factor 2 isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	29385000	0	0	0	19755000	0	18169000	NA	NA	NA	LMF2	LMF2;LMF2;NA;NA;NA	protein maturation	GO:005160	integral component of membrane;endoplasmic reticulum membrane;membrane	GO:001602; GO:000578; GO:001602	"NA"	"NA"	protein binding	GO:000551
NP_001193332.1	NP_001193332.1	NP_001193332.1 protein-lysine 6-oxidase precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4103700	0	NA	NA	NA	LOX	LOX;NA;NA;NA;NA	aorta development;lung development;wound healing;elastic fiber assembly;heart development;response to steroid hormone;cellular protein modification process;peptidyl-lysine oxidation;collagen fibril organization;response to drug;blood vessel morphogenesis	GO:003590; GO:003032; GO:004206; GO:004825; GO:000750; GO:004854; GO:000646; GO:001805; GO:003019; GO:004249; GO:004851	extracellular space;extracellular matrix;nucleus;extracellular region;collagen trimer	GO:000561; GO:003101; GO:000563; GO:000557; GO:000558	"NA"	"NA"	protein-lysine 6-oxidase activity;protein binding;copper ion binding	GO:000472; GO:000551; GO:000550
NP_001193358.1;XP_020936732.1;XP_005661593.1;XP_005661592.2	NP_001193358.1;XP_020936732.1;XP_005661593.1;XP_005661592.2	NP_001193358.1 versican core protein precursor [Sus scrofa];XP_020936732.1 versican core protein isoform X1 [Sus scrofa];XP_005661593.1 versican core protein isoform X3 [Sus scrofa];XP_005661592.2 versican core protein isoform X2 [Sus scrofa]	12	12	12	0	77483000	0	72300000	0	71955000	0	29972000	0	65167000	0	82615000	252360000	51600000	0	59315000	58119000	101550000	NA	NA	NA	VCAN	VCAN;VCAN;VCAN;VCAN;NA	osteoblast differentiation;multicellular organism development;central nervous system development;extracellular matrix organization;cell recognition;post-translational protein modification;cellular protein metabolic process;chondroitin sulfate catabolic process;skeletal system development;cell adhesion	GO:000164; GO:000727; GO:000741; GO:003019; GO:000803; GO:004368; GO:004426; GO:003020; GO:000150; GO:000715	lysosomal lumen;extracellular matrix;extracellular region;Golgi lumen;extracellular space;endoplasmic reticulum lumen;membrane	GO:004320; GO:003101; GO:000557; GO:000579; GO:000561; GO:000578; GO:001602	 Cell adhesion molecules (CAMs)	hsa0451	carbohydrate binding;protein binding;calcium ion binding;glycosaminoglycan binding;hyaluronic acid binding;extracellular matrix structural constituent conferring compression resistance	GO:003024; GO:000551; GO:000550; GO:000553; GO:000554; GO:003002
XP_020923906.1;NP_001193464.1;XP_020923905.1;XP_020923907.1	XP_020923906.1;NP_001193464.1;XP_020923905.1	XP_020923906.1 actin-related protein 2/3 complex subunit 4 isoform X2 [Sus scrofa];NP_001193464.1 actin-related protein 2/3 complex subunit 4 [Sus scrofa];XP_020923905.1 actin-related protein 2/3 complex subunit 4 isoform X1 [Sus scrofa]	6	6	6	163150000	186900000	191120000	202340000	164840000	206770000	163690000	174080000	174840000	216310000	142760000	203050000	282170000	189660000	184000000	189860000	182610000	190380000	NA	NA	NA	ARPC4	ARPC4;ARPC4;ARPC4;NA;NA	actin nucleation;membrane organization;ephrin receptor signaling pathway;actin filament polymerization;Arp2/3 complex-mediated actin nucleation;Fc-gamma receptor signaling pathway involved in phagocytosis	GO:004501; GO:006102; GO:004801; GO:003004; GO:003431; GO:003809	cytosol;extracellular exosome;cell projection;Arp2/3 protein complex;site of double-strand break;nucleus	GO:000582; GO:007006; GO:004299; GO:000588; GO:003586; GO:000563	 Endocytosis; Shigellosis; Bacterial invasion of epithelial cells; Fc gamma R-mediated phagocytosis; Regulation of actin cytoskeleton	hsa0414; hsa0513; hsa0510; hsa0466; hsa0481	protein binding;protein binding, bridging;actin filament binding;enzyme binding;structural constituent of cytoskeleton	GO:000551; GO:003067; GO:005101; GO:001989; GO:000520
NP_001229989.1	NP_001229989.1	NP_001229989.1 ras-related protein Rab-10 [Sus scrofa]	5	4	4	76897000	122020000	144120000	74060000	55319000	86019000	81383000	87544000	116220000	80915000	83126000	119750000	48120000	118320000	106720000	98393000	108630000	84762000	NA	NA	NA	RAB10	RAB10;NA;NA;NA;NA	antigen processing and presentation;Golgi to plasma membrane transport;axonogenesis;regulation of exocytosis;polarized epithelial cell differentiation;establishment of neuroblast polarity;establishment of protein localization to endoplasmic reticulum membrane;cell-cell adhesion;Golgi to plasma membrane protein transport;neutrophil degranulation;Rab protein signal transduction;cellular response to insulin stimulus;vesicle docking involved in exocytosis;vesicle-mediated transport;endoplasmic reticulum tubular network organization;protein localization to plasma membrane;protein localization to basolateral plasma membrane;protein secretion;intracellular protein transport;establishment of protein localization to membrane	GO:001988; GO:000689; GO:000740; GO:001715; GO:003085; GO:004520; GO:009705; GO:009860; GO:004300; GO:004331; GO:003248; GO:003286; GO:000690; GO:001619; GO:007178; GO:007265; GO:190336; GO:000930; GO:000688; GO:009015	trans-Golgi network;plasma membrane;extracellular exosome;cytosol;cilium;synaptic vesicle;secretory granule membrane;phagocytic vesicle membrane;exocyst;perinuclear region of cytoplasm;endoplasmic reticulum tubular network;endosome;insulin-responsive compartment;cell-cell adherens junction;recycling endosome;Golgi apparatus;cytoplasmic vesicle membrane;Golgi membrane;endoplasmic reticulum membrane;exocytic vesicle	GO:000580; GO:000588; GO:007006; GO:000582; GO:000592; GO:000802; GO:003066; GO:003067; GO:000014; GO:004847; GO:007178; GO:000576; GO:003259; GO:000591; GO:005503; GO:000579; GO:003065; GO:000013; GO:000578; GO:007038	 AMPK signaling pathway; Endocytosis	hsa0415; hsa0414	GTP binding;myosin V binding;protein binding;GTPase activity;cadherin binding involved in cell-cell adhesion;GDP binding	GO:000552; GO:003148; GO:000551; GO:000392; GO:009864; GO:001900
NP_001229990.1	NP_001229990.1	NP_001229990.1 alpha-actinin-1 [Sus scrofa]	52	30	27	367170000	415800000	924460000	378920000	368270000	714330000	399770000	664660000	420230000	1084100000	600870000	604360000	2221300000	449510000	352010000	371180000	509320000	457710000	NA	NA	NA	ACTN1	ACTN1;NA;NA;NA;NA	platelet activation;platelet formation;focal adhesion assembly;platelet degranulation;platelet morphogenesis;negative regulation of cellular component movement;regulation of apoptotic process;actin filament organization;actin filament bundle assembly;actin crosslink formation;platelet aggregation;actin filament network formation;positive regulation of nucleic acid-templated transcription	GO:003016; GO:003022; GO:004804; GO:000257; GO:003634; GO:005127; GO:004298; GO:000701; GO:005101; GO:005176; GO:007052; GO:005163; GO:190350	extracellular space;fascia adherens;platelet alpha granule lumen;pseudopodium;cytosol;actin filament;focal adhesion;glutamatergic synapse;extracellular region;cytoplasm;stress fiber;extracellular exosome;brush border;Z disc;cell projection	GO:000561; GO:000591; GO:003109; GO:003114; GO:000582; GO:000588; GO:000592; GO:009897; GO:000557; GO:000573; GO:000172; GO:007006; GO:000590; GO:003001; GO:004299	 Systemic lupus erythematosus; Leukocyte transendothelial migration; Amoebiasis; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Viral carcinogenesis; Adherens junction; Tight junction; Focal adhesion; Regulation of actin cytoskeleton	hsa0532; hsa0467; hsa0514; hsa0541; hsa0520; hsa0452; hsa0453; hsa0451; hsa0481	calcium ion binding;ligand-dependent nuclear receptor transcription coactivator activity;protein homodimerization activity;ion channel binding;protein binding;actin filament binding;double-stranded RNA binding;integrin binding;vinculin binding	GO:000550; GO:003037; GO:004280; GO:004432; GO:000551; GO:005101; GO:000372; GO:000517; GO:001716
XP_020921804.1;XP_020921803.1;XP_020921802.1;NP_001230112.1	XP_020921804.1;XP_020921803.1;XP_020921802.1;NP_001230112.1	XP_020921804.1 AP-2 complex subunit beta isoform X2 [Sus scrofa];XP_020921803.1 AP-2 complex subunit beta isoform X1 [Sus scrofa];XP_020921802.1 AP-2 complex subunit beta isoform X1 [Sus scrofa];NP_001230112.1 AP-2 complex subunit beta [Sus scrofa]	18	18	9	98289000	143550000	141270000	150790000	87635000	126990000	117210000	128820000	122570000	130570000	106890000	123010000	160100000	154280000	110920000	133570000	135110000	165170000	NA	NA	NA	AP2B1	AP2B1;AP2B1;AP2B1;AP2B1;NA	Wnt signaling pathway, planar cell polarity pathway;membrane organization;positive regulation of protein localization to membrane;low-density lipoprotein particle clearance;aorta development;antigen processing and presentation of exogenous peptide antigen via MHC class II;clathrin coat assembly;postsynaptic neurotransmitter receptor internalization;positive regulation of endocytosis;coronary vasculature development;negative regulation of neuron death;low-density lipoprotein particle receptor catabolic process;ephrin receptor signaling pathway;regulation of defense response to virus by virus;clathrin-dependent endocytosis;ventricular septum development	GO:006007; GO:006102; GO:190547; GO:003438; GO:003590; GO:001988; GO:004826; GO:009888; GO:004580; GO:006097; GO:190121; GO:003280; GO:004801; GO:005069; GO:007258; GO:000328	glutamatergic synapse;plasma membrane;endolysosome membrane;clathrin-coated endocytic vesicle;cytosol;postsynapse;membrane;endocytic vesicle membrane;AP-2 adaptor complex	GO:009897; GO:000588; GO:003602; GO:004533; GO:000582; GO:009879; GO:001602; GO:003066; GO:003012	 Endocytosis; Synaptic vesicle cycle; Endocrine and other factor-regulated calcium reabsorption; Huntington's disease	hsa0414; hsa0472; hsa0496; hsa0501	protein binding;clathrin binding;clathrin adaptor activity;signal sequence binding;macromolecular complex binding	GO:000551; GO:003027; GO:003561; GO:000504; GO:004487
NP_001230113.1;XP_001928917.1	NP_001230113.1	NP_001230113.1 hexokinase-1 [Sus scrofa]	34	34	32	539540000	442390000	345560000	347390000	474730000	418880000	330020000	351020000	328740000	317920000	425040000	419680000	324210000	524260000	352680000	374840000	389500000	523580000	NA	NA	NA	HK1	HK1;NA;NA;NA;NA	glycolytic process;establishment of protein localization to mitochondrion;carbohydrate phosphorylation;positive regulation of interleukin-1 beta secretion;positive regulation of cytokine secretion involved in immune response;cellular glucose homeostasis;glucose 6-phosphate metabolic process;canonical glycolysis	GO:000609; GO:007265; GO:004683; GO:005071; GO:000274; GO:000167; GO:005115; GO:006162	mitochondrial outer membrane;cytosol;mitochondrion;membrane raft	GO:000574; GO:000582; GO:000573; GO:004512	 Butirosin and neomycin biosynthesis; Biosynthesis of antibiotics; Central carbon metabolism in cancer; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Carbohydrate digestion and absorption; Glycolysis / Gluconeogenesis; HIF-1 signaling pathway; Insulin signaling pathway; Type II diabetes mellitus; Metabolic pathways; Carbon metabolism	hsa0052; hsa0113; hsa0523; hsa0005; hsa0050; hsa0052; hsa0497; hsa0001; hsa0406; hsa0491; hsa0493; hsa0110; hsa0120	peptidoglycan binding;glucose binding;identical protein binding;protein binding;fructokinase activity;hexokinase activity;ATP binding;mannokinase activity;glucokinase activity	GO:004283; GO:000553; GO:004280; GO:000551; GO:000886; GO:000439; GO:000552; GO:001915; GO:000434
XP_020934812.1;NP_001230139.1;XP_005666916.1;XP_005666915.1;NP_001230136.1	XP_020934812.1;NP_001230139.1	XP_020934812.1 calnexin isoform X1 [Sus scrofa];NP_001230139.1 calnexin precursor [Sus scrofa]	15	15	15	331240000	366530000	357490000	324800000	313280000	284800000	330500000	331400000	263880000	268900000	304550000	308490000	210850000	335540000	342890000	373580000	365650000	339040000	NA	NA	NA	CANX	CANX;CANX;NA;NA;NA	aging;protein folding in endoplasmic reticulum;interleukin-35-mediated signaling pathway;protein secretion;clathrin-dependent endocytosis;antigen processing and presentation of peptide antigen via MHC class I;protein folding;antigen processing and presentation of exogenous peptide antigen via MHC class II;synaptic vesicle endocytosis;interleukin-27-mediated signaling pathway	GO:000756; GO:003497; GO:007075; GO:000930; GO:007258; GO:000247; GO:000645; GO:001988; GO:004848; GO:007010	membrane;dendritic spine;integral component of postsynaptic membrane;endoplasmic reticulum lumen;rough endoplasmic reticulum;ER-mitochondrion membrane contact site;axon;melanosome;ribosome;neuronal cell body;endoplasmic reticulum quality control compartment;glutamatergic synapse;dendrite cytoplasm;extracellular exosome;integral component of lumenal side of endoplasmic reticulum membrane	GO:001602; GO:004319; GO:009905; GO:000578; GO:000579; GO:004423; GO:003042; GO:004247; GO:000584; GO:004302; GO:004432; GO:009897; GO:003283; GO:007006; GO:007155	 Thyroid hormone synthesis; HTLV-I infection; Phagosome; Antigen processing and presentation	hsa0491; hsa0516; hsa0414; hsa0461	ionotropic glutamate receptor binding;RNA binding;calcium ion binding;apolipoprotein binding;protein binding;carbohydrate binding;unfolded protein binding	GO:003525; GO:000372; GO:000550; GO:003418; GO:000551; GO:003024; GO:005108
NP_001230144.1	NP_001230144.1	NP_001230144.1 exportin-2 [Sus scrofa]	13	13	13	21033000	28440000	37201000	24862000	31590000	27354000	29644000	20229000	34746000	27954000	25471000	29326000	27098000	22268000	22520000	30521000	26084000	32544000	NA	NA	NA	CSE1L	CSE1L;NA;NA;NA;NA	protein export from nucleus;apoptotic process;cell proliferation;protein import into nucleus	GO:000661; GO:000691; GO:000828; GO:000660	cytoplasm;nucleoplasm;membrane;nucleus;extracellular exosome;cytosol	GO:000573; GO:000565; GO:001602; GO:000563; GO:007006; GO:000582	"NA"	"NA"	Ran GTPase binding;protein transporter activity;nuclear export signal receptor activity;protein binding	GO:000853; GO:000856; GO:000504; GO:000551
NP_001230148.1	NP_001230148.1	NP_001230148.1 protein Niban [Sus scrofa]	13	13	13	0	36071000	39512000	42051000	0	55792000	0	32158000	23520000	68241000	25907000	53889000	72541000	53571000	0	37513000	0	72732000	NA	NA	NA	FAM129A	FAM129A;NA;NA;NA;NA	positive regulation of translation;negative regulation of protein phosphorylation;response to endoplasmic reticulum stress	GO:004572; GO:000193; GO:003497	cytosol;plasma membrane;membrane;cytoplasm;extracellular exosome	GO:000582; GO:000588; GO:001602; GO:000573; GO:007006	"NA"	"NA"	molecular_function;protein binding	GO:000367; GO:000551
NP_001230149.1	NP_001230149.1	NP_001230149.1 lon protease homolog, mitochondrial [Sus scrofa]	16	16	16	101300000	75911000	96668000	77892000	112400000	62975000	105800000	95536000	117220000	100340000	88469000	116500000	56127000	89475000	88818000	106630000	76409000	75317000	NA	NA	NA	LONP1	LONP1;NA;NA;NA;NA	proteolysis involved in cellular protein catabolic process;mitochondrial genome maintenance;misfolded or incompletely synthesized protein catabolic process;response to hormone;cellular response to oxidative stress;protein homooligomerization;oxidation-dependent protein catabolic process;mitochondrion organization;response to aluminum ion;aging;mitochondrial DNA metabolic process;chaperone-mediated protein complex assembly;response to hypoxia	GO:005160; GO:000000; GO:000651; GO:000972; GO:003459; GO:005126; GO:007040; GO:000700; GO:001004; GO:000756; GO:003204; GO:005113; GO:000166	mitochondrial matrix;mitochondrial nucleoid;nucleoplasm;nucleus;mitochondrion;cytosol;membrane	GO:000575; GO:004264; GO:000565; GO:000563; GO:000573; GO:000582; GO:001602	"NA"	"NA"	single-stranded DNA binding;serine-type endopeptidase activity;sequence-specific DNA binding;ATP binding;mitochondrial RNA polymerase regulatory region DNA binding;G-quadruplex DNA binding;ATP-dependent peptidase activity;DNA polymerase binding;ADP binding;single-stranded RNA binding;protein binding	GO:000369; GO:000425; GO:004356; GO:000552; GO:000101; GO:005188; GO:000417; GO:007018; GO:004353; GO:000372; GO:000551
XP_020941291.1;XP_005662058.1;NP_001230150.1	XP_020941291.1;XP_005662058.1;NP_001230150.1	XP_020941291.1 phosphoserine phosphatase isoform X1 [Sus scrofa];XP_005662058.1 phosphoserine phosphatase isoform X1 [Sus scrofa];NP_001230150.1 phosphoserine phosphatase [Sus scrofa]	5	5	5	162220000	66434000	86507000	46399000	61638000	36535000	71823000	79884000	97425000	73240000	66652000	0	41190000	75350000	58847000	53819000	75057000	55320000	NA	NA	NA	PSPH	PSPH;PSPH;PSPH;NA;NA	response to mechanical stimulus;L-serine metabolic process;response to nutrient levels;dephosphorylation;response to testosterone	GO:000961; GO:000656; GO:003166; GO:001631; GO:003357	cytosol;neuron projection;cytoplasm	GO:000582; GO:004300; GO:000573	 Biosynthesis of amino acids; Glycine, serine and threonine metabolism; Carbon metabolism; Metabolic pathways; Biosynthesis of antibiotics	hsa0123; hsa0026; hsa0120; hsa0110; hsa0113	protein homodimerization activity;calcium ion binding;magnesium ion binding;phosphatase activity;phosphoserine phosphatase activity	GO:004280; GO:000550; GO:000028; GO:001679; GO:000464
XP_020944232.1;NP_001230198.1	XP_020944232.1;NP_001230198.1	XP_020944232.1 calsequestrin-1 isoform X1 [Sus scrofa];NP_001230198.1 calsequestrin-1 precursor [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	124930000	0	NA	NA	NA	CASQ1	CASQ1;CASQ1;NA;NA;NA	response to denervation involved in regulation of muscle adaptation;regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;positive regulation of release of sequestered calcium ion into cytosol;positive regulation of store-operated calcium channel activity;ion transmembrane transport;regulation of store-operated calcium entry;response to organic substance;skeletal muscle tissue development;sarcomere organization;protein polymerization;regulation of cardiac conduction;endoplasmic reticulum organization;response to heat	GO:001489; GO:001480; GO:005128; GO:190134; GO:003422; GO:200125; GO:001003; GO:000751; GO:004521; GO:005125; GO:190377; GO:000702; GO:000940	mitochondrion;sarcoplasmic reticulum membrane;mitochondrial matrix;endoplasmic reticulum;smooth endoplasmic reticulum;Z disc;terminal cisterna lumen;T-tubule;sarcoplasmic reticulum	GO:000573; GO:003301; GO:000575; GO:000578; GO:000579; GO:003001; GO:001480; GO:003031; GO:001652	"NA"	"NA"	identical protein binding;calcium ion binding;protein binding	GO:004280; GO:000550; GO:000551
NP_001230202.1;XP_005667153.1;XP_020957774.1;XP_003132476.1;XP_020957775.1;XP_020957773.1;XP_020918397.1;XP_003129872.1;XP_003356293.1	NP_001230202.1;XP_005667153.1;XP_020957774.1;XP_003132476.1;XP_020957775.1;XP_020957773.1	NP_001230202.1 ras-related protein Rab-6A [Sus scrofa];XP_005667153.1 ras-related protein Rab-6A isoform X3 [Sus scrofa];XP_020957774.1 ras-related protein Rab-6A isoform X2 [Sus scrofa];XP_003132476.1 ras-related protein Rab-6B [Sus scrofa];XP_020957775.1	9	9	9	360940000	394560000	404060000	371490000	293470000	332220000	344800000	337960000	316710000	293860000	362130000	287810000	321050000	374760000	369490000	391050000	333750000	391300000	NA	NA	NA	RAB6A	RAB6A;RAB6A;RAB6B;RAB6A;RAB6A	retrograde vesicle-mediated transport, Golgi to ER;protein localization to Golgi apparatus;antigen processing and presentation;early endosome to Golgi transport;retrograde transport, endosome to Golgi;intra-Golgi vesicle-mediated transport;peptidyl-cysteine methylation;minus-end-directed organelle transport along microtubule;intracellular protein transport;neutrophil degranulation;Rab protein signal transduction;viral process	GO:000689; GO:003406; GO:001988; GO:003449; GO:004214; GO:000689; GO:001812; GO:007238; GO:000688; GO:004331; GO:003248; GO:001603	cytosol;extracellular exosome;cytoplasmic vesicle;membrane;plasma membrane;trans-Golgi network membrane;Golgi membrane;trans-Golgi network;secretory granule membrane;endosome to plasma membrane transport vesicle;endoplasmic reticulum membrane;Golgi apparatus	GO:000582; GO:007006; GO:003141; GO:001602; GO:000588; GO:003258; GO:000013; GO:000580; GO:003066; GO:007038; GO:000578; GO:000579	"NA"	"NA"	GTP binding;protein domain specific binding;GTPase activity;protein binding;myosin V binding	GO:000552; GO:001990; GO:000392; GO:000551; GO:003148
NP_001230220.1	NP_001230220.1	NP_001230220.1 ras-related protein Rab-35 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	20665000	0	0	0	0	0	0	NA	NA	NA	RAB35	RAB35;NA;NA;NA;NA	mitotic cytokinesis;protein localization;endosomal transport;protein localization to endosome;neuron projection development;endocytic recycling;plasma membrane to endosome transport;intracellular protein transport;antigen processing and presentation;Rab protein signal transduction;cellular response to nerve growth factor stimulus	GO:000028; GO:000810; GO:001619; GO:003601; GO:003117; GO:003245; GO:004822; GO:000688; GO:001988; GO:003248; GO:199009	cell projection membrane;melanosome;clathrin-coated endocytic vesicle;recycling endosome membrane;extracellular exosome;intercellular bridge;plasma membrane;clathrin-coated pit;Golgi membrane;cytosol;endosome membrane;clathrin-coated vesicle membrane;anchored component of synaptic vesicle membrane	GO:003125; GO:004247; GO:004533; GO:005503; GO:007006; GO:004517; GO:000588; GO:000590; GO:000013; GO:000582; GO:001000; GO:003066; GO:009899	 Endocytosis	hsa0414	protein binding;GTPase activity;GTP binding;phosphatidylinositol-4,5-bisphosphate binding;GDP binding	GO:000551; GO:000392; GO:000552; GO:000554; GO:001900
NP_001230226.1	NP_001230226.1	NP_001230226.1 collagen alpha-1(III) chain precursor [Sus scrofa]	10	10	4	0	53425000	0	56493000	0	83483000	0	52721000	0	59444000	0	61860000	0	0	0	53597000	0	74087000	NA	NA	NA	COL3A1	COL3A1;NA;NA;NA;NA	response to radiation;response to mechanical stimulus;transforming growth factor beta receptor signaling pathway;cerebral cortex development;wound healing;negative regulation of neuron migration;skeletal system development;response to cytokine;positive regulation of Rho protein signal transduction;regulation of immune response;cellular response to amino acid stimulus;platelet activation;collagen fibril organization;supramolecular fiber organization;skin development;cell-matrix adhesion;integrin-mediated signaling pathway;heart development;peptide cross-linking;digestive tract development;aorta smooth muscle tissue morphogenesis	GO:000931; GO:000961; GO:000717; GO:002198; GO:004206; GO:200122; GO:000150; GO:003409; GO:003502; GO:005077; GO:007123; GO:003016; GO:003019; GO:009743; GO:004358; GO:000716; GO:000722; GO:000750; GO:001814; GO:004856; GO:006041	extracellular space;collagen type III trimer;endoplasmic reticulum lumen;extracellular region;extracellular matrix	GO:000561; GO:000558; GO:000578; GO:000557; GO:003101	 Focal adhesion; Platelet activation; PI3K-Akt signaling pathway; Amoebiasis; ECM-receptor interaction; Protein digestion and absorption	hsa0451; hsa0461; hsa0415; hsa0514; hsa0451; hsa0497	metal ion binding;protease binding;platelet-derived growth factor binding;integrin binding;extracellular matrix structural constituent;SMAD binding;protein binding;extracellular matrix structural constituent conferring tensile strength	GO:004687; GO:000202; GO:004840; GO:000517; GO:000520; GO:004633; GO:000551; GO:003002
NP_001230233.1	NP_001230233.1	NP_001230233.1 sterol 26-hydroxylase, mitochondrial [Sus scrofa]	7	7	7	63836000	0	47194000	0	40334000	0	42790000	19581000	61863000	0	19838000	0	0	17168000	24860000	0	16287000	0	NA	NA	NA	CYP27A1	CYP27A1;NA;NA;NA;NA	sterol metabolic process;oxidation-reduction process;bile acid biosynthetic process	GO:001612; GO:005511; GO:000669	mitochondrial membrane;mitochondrion;mitochondrial matrix	GO:003196; GO:000573; GO:000575	 PPAR signaling pathway; Metabolic pathways; Primary bile acid biosynthesis	hsa0332; hsa0110; hsa0012	heme binding;steroid hydroxylase activity;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	GO:002003; GO:000839; GO:000550; GO:001670
XP_020940136.1;NP_001230243.1	XP_020940136.1;NP_001230243.1	XP_020940136.1 four and a half LIM domains protein 5 isoform X2 [Sus scrofa];NP_001230243.1 four and a half LIM domains protein 5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	FHL5	FHL5;FHL5;NA;NA;NA	positive regulation of transcription from RNA polymerase II promoter	GO:004594	Z disc;nucleus	GO:003001; GO:000563	"NA"	"NA"	transcription coactivator activity;protein binding;metal ion binding	GO:000371; GO:000551; GO:004687
NP_001230248.1	NP_001230248.1	NP_001230248.1 immunoglobulin lambda-like polypeptide 5 precursor [Sus scrofa]	10	10	7	15357000000	17715000000	12276000000	24207000000	16601000000	24533000000	17997000000	15310000000	14831000000	14507000000	12709000000	15438000000	14805000000	19131000000	14145000000	14288000000	15650000000	19290000000	NA	NA	NA	LOC100152327	LOC100152327;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001230268.1;CON__Q05443	NP_001230268.1;CON__Q05443	NP_001230268.1 lumican precursor [Sus scrofa];	16	16	16	2223600000	11158000000	3087600000	12765000000	2810600000	14875000000	4281800000	9126400000	3272700000	8678000000	3200800000	6807700000	5565800000	11873000000	3963400000	9789200000	5419300000	14238000000	NA	NA	+	LUM	LUM;NA;NA;NA;NA	visual perception;positive regulation of transforming growth factor beta1 production;response to organic cyclic compound;cartilage development;keratan sulfate catabolic process;keratan sulfate biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;response to growth factor;extracellular matrix organization	GO:000760; GO:003291; GO:001407; GO:005121; GO:004234; GO:001814; GO:004594; GO:007084; GO:003019	extracellular space;Golgi lumen;fibrillar collagen trimer;extracellular exosome;extracellular matrix;extracellular region;lysosomal lumen	GO:000561; GO:000579; GO:000558; GO:007006; GO:003101; GO:000557; GO:004320	 Proteoglycans in cancer	hsa0520	protein binding;extracellular matrix structural constituent conferring compression resistance;collagen binding;extracellular matrix structural constituent	GO:000551; GO:003002; GO:000551; GO:000520
NP_001230269.1	NP_001230269.1	NP_001230269.1 proteasome inhibitor PI31 subunit [Sus scrofa]	2	2	2	0	0	0	0	0	13344000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PSMF1	PSMF1;NA;NA;NA;NA	post-translational protein modification;protein deubiquitination;negative regulation of proteasomal protein catabolic process;ubiquitin-dependent protein catabolic process;negative regulation of endopeptidase activity	GO:004368; GO:001657; GO:190179; GO:000651; GO:001095	perinuclear region of cytoplasm;proteasome core complex;cytosol;nucleoplasm;endoplasmic reticulum;membrane	GO:004847; GO:000583; GO:000582; GO:000565; GO:000578; GO:001602	 Proteasome	hsa0305	protein binding;endopeptidase inhibitor activity;protein homodimerization activity;proteasome binding;protein heterodimerization activity	GO:000551; GO:000486; GO:004280; GO:007062; GO:004698
XP_020924154.1;NP_001230270.1;XP_005670105.1	XP_020924154.1;NP_001230270.1;XP_005670105.1	XP_020924154.1 DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2 [Sus scrofa];NP_001230270.1 DNA-directed RNA polymerases I, II, and III subunit RPABC3 [Sus scrofa];XP_005670105.1 DNA-directed RNA polymerases I, II, and III subunit RPAB	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2573100	NA	NA	NA	POLR2H	POLR2H;POLR2H;POLR2H;NA;NA	snRNA transcription from RNA polymerase II promoter;positive regulation of gene expression, epigenetic;transcription initiation from RNA polymerase I promoter;transcription from RNA polymerase III promoter;transcription-coupled nucleotide-excision repair;RNA metabolic process;regulation of gene silencing by miRNA;7-methylguanosine mRNA capping;mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway	GO:004279; GO:004581; GO:000636; GO:000638; GO:000628; GO:001607; GO:006096; GO:000637; GO:000039; GO:000854	cytosol;nucleoplasm;DNA-directed RNA polymerase I complex;DNA-directed RNA polymerase II, core complex;protein-DNA complex;nucleus	GO:000582; GO:000565; GO:000573; GO:000566; GO:003299; GO:000563	 Purine metabolism; Huntington's disease; RNA polymerase; Pyrimidine metabolism; Cytosolic DNA-sensing pathway; Metabolic pathways; Epstein-Barr virus infection	hsa0023; hsa0501; hsa0302; hsa0024; hsa0462; hsa0110; hsa0516	RNA polymerase III activity;RNA polymerase II activity;single-stranded DNA binding	GO:000105; GO:000105; GO:000369
NP_001230274.1;XP_013849640.1	NP_001230274.1;XP_013849640.1	NP_001230274.1 60S ribosomal protein L13 [Sus scrofa];XP_013849640.1 60S ribosomal protein L13 isoform X1 [Sus scrofa]	8	8	8	96386000	125790000	140130000	105230000	80818000	165730000	98652000	94939000	129480000	138790000	99769000	134590000	109840000	132780000	88066000	157210000	132790000	157850000	NA	NA	NA	RPL13	RPL13;RPL13;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000018; GO:000641; GO:000661	endoplasmic reticulum;cytosolic ribosome;nucleus;cytosol;membrane;nucleolus	GO:000578; GO:002262; GO:000563; GO:000582; GO:001602; GO:000573	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;RNA binding	GO:000551; GO:000373; GO:000372
NP_001230275.2;XP_020946575.1;NP_001259023.1;XP_013853259.1	NP_001230275.2;XP_020946575.1;NP_001259023.1;XP_013853259.1	NP_001230275.2 ecto-ADP-ribosyltransferase 4 isoform 2 [Sus scrofa];XP_020946575.1 ecto-ADP-ribosyltransferase 4 isoform X2 [Sus scrofa];NP_001259023.1 ecto-ADP-ribosyltransferase 4 isoform 1 [Sus scrofa];XP_013853259.1 ecto-ADP-ribosyltransferase 4 isofor	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	11520000	0	0	0	0	0	NA	NA	NA	ART4	ART4;ART4;ART4;ART4;NA	protein ADP-ribosylation;arginine metabolic process;peptidyl-arginine ADP-ribosylation	GO:000647; GO:000652; GO:001812	membrane;anchored component of membrane;extracellular region;plasma membrane	GO:001602; GO:003122; GO:000557; GO:000588	"NA"	"NA"	NAD+ ADP-ribosyltransferase activity;NAD(P)+-protein-arginine ADP-ribosyltransferase activity	GO:000395; GO:000395
XP_020943044.1;XP_005660006.1;XP_013848845.1;XP_005660005.1;NP_001230305.1	XP_020943044.1;XP_005660006.1;XP_013848845.1;XP_005660005.1;NP_001230305.1	XP_020943044.1 glucosamine 6-phosphate N-acetyltransferase isoform X2 [Sus scrofa];XP_005660006.1 glucosamine 6-phosphate N-acetyltransferase isoform X2 [Sus scrofa];XP_013848845.1 glucosamine 6-phosphate N-acetyltransferase isoform X1 [Sus scrofa];XP_0056	4	4	4	19020000	20468000	17650000	0	16624000	18408000	11810000	13400000	18488000	17505000	0	18225000	0	20159000	0	17134000	13758000	17369000	NA	NA	NA	GNPNAT1	GNPNAT1;GNPNAT1;GNPNAT1;GNPNAT1;GNPNAT1	glucosamine metabolic process;liver development;N-acetylglucosamine biosynthetic process;cellular response to leukemia inhibitory factor	GO:000604; GO:000188; GO:000604; GO:199083	Golgi apparatus;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment;Golgi membrane;cytosol;endosome membrane;late endosome	GO:000579; GO:000578; GO:000579; GO:000013; GO:000582; GO:001000; GO:000577	 Amino sugar and nucleotide sugar metabolism	hsa0052	monosaccharide binding;glucosamine 6-phosphate N-acetyltransferase activity;identical protein binding	GO:004802; GO:000434; GO:004280
NP_001230336.1	NP_001230336.1	NP_001230336.1 thioredoxin-related transmembrane protein 4 precursor [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6596600	0	0	0	NA	NA	NA	TMX4	TMX4;NA;NA;NA;NA	oxidation-reduction process;cell redox homeostasis	GO:005511; GO:004545	cell;integral component of membrane	GO:000562; GO:001602	"NA"	"NA"	"NA"	"NA"
XP_020953659.1;NP_001230338.1	XP_020953659.1;NP_001230338.1	XP_020953659.1 guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase MESH1 isoform X1 [Sus scrofa];NP_001230338.1 guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase MESH1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	15570000	10738000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	HDDC3	HDDC3;HDDC3;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	 Purine metabolism	hsa0023	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity;protein binding;metal ion binding	GO:000889; GO:000551; GO:004687
NP_001230339.1	NP_001230339.1	NP_001230339.1 endoribonuclease LACTB2 [Sus scrofa]	5	5	5	0	0	16082000	0	22797000	0	23459000	15018000	0	14331000	0	0	0	0	0	15439000	0	0	NA	NA	NA	LACTB2	LACTB2;NA;NA;NA;NA	RNA phosphodiester bond hydrolysis, endonucleolytic	GO:009050	mitochondrial matrix	GO:000575	"NA"	"NA"	zinc ion binding;single-stranded RNA binding;endoribonuclease activity;protein binding	GO:000827; GO:000372; GO:000452; GO:000551
XP_005655824.1;NP_001230347.1;XP_020949091.1;XP_013835459.1;XP_013835458.1;XP_005667954.1;XP_003357655.1	XP_005655824.1;NP_001230347.1;XP_020949091.1	XP_005655824.1 vacuolar protein sorting-associated protein 4A isoform X2 [Sus scrofa];NP_001230347.1 vacuolar protein sorting-associated protein 4A [Sus scrofa];XP_020949091.1 vacuolar protein sorting-associated protein 4A isoform X1 [Sus scrofa]	4	3	3	0	21490000	19968000	0	0	15197000	18956000	20337000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	VPS4A	VPS4A;VPS4A;VPS4A;NA;NA	actomyosin contractile ring contraction;abscission;vesicle-mediated transport;endosomal vesicle fusion;vacuole organization;intracellular cholesterol transport;negative regulation of cytokinesis;cell division;positive regulation of viral life cycle;regulation of protein localization;multivesicular body assembly;mitotic cytokinesis checkpoint;late endosomal microautophagy;positive regulation of viral release from host cell;positive regulation of viral budding via host ESCRT complex;membrane budding;nuclear envelope organization;macroautophagy;nuclear envelope reassembly;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;ESCRT III complex disassembly;protein targeting to lysosome;vesicle uncoating;mitotic metaphase plate congression;regulation of protein localization to plasma membrane;viral budding via host ESCRT complex;cytoskeleton-dependent cytokinesis;viral life cycle;viral release from host cell;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;positive regulation of exosomal secretion;ESCRT complex disassembly	GO:000091; GO:000983; GO:001619; GO:003405; GO:000703; GO:003236; GO:003246; GO:005130; GO:190390; GO:003288; GO:003625; GO:004487; GO:006173; GO:190218; GO:190377; GO:000690; GO:000699; GO:001623; GO:003146; GO:009061; GO:190490; GO:000662; GO:007231; GO:000708; GO:190307; GO:003970; GO:006164; GO:001905; GO:001907; GO:004316; GO:190354; GO:190489	plasma membrane;late endosome membrane;Flemming body;nucleus;cytoplasm;lysosome;vacuolar membrane;extracellular exosome;cytosol;endosome membrane;midbody;centrosome;spindle pole;perinuclear region of cytoplasm	GO:000588; GO:003190; GO:009054; GO:000563; GO:000573; GO:000576; GO:000577; GO:007006; GO:000582; GO:001000; GO:003049; GO:000581; GO:000092; GO:004847	 Endocytosis	hsa0414	protein binding;ATP binding;macromolecular complex binding;protein C-terminus binding;ATPase activity, coupled;ATPase activity;protein domain specific binding	GO:000551; GO:000552; GO:004487; GO:000802; GO:004262; GO:001688; GO:001990
NP_001230351.1;NP_001230350.1;XP_020920752.1	NP_001230351.1;NP_001230350.1;XP_020920752.1	NP_001230351.1 ATP-dependent (S)-NAD(P)H-hydrate dehydratase isoform 2 [Sus scrofa];NP_001230350.1 ATP-dependent (S)-NAD(P)H-hydrate dehydratase isoform 1 [Sus scrofa];XP_020920752.1 ATP-dependent (S)-NAD(P)H-hydrate dehydratase isoform X1 [Sus scrofa]	11	11	11	100190000	128770000	111070000	126260000	104780000	134390000	122160000	122370000	131480000	129520000	114020000	157200000	104980000	117880000	124290000	160870000	113550000	117350000	NA	NA	NA	NAXD	NAXD;NAXD;NAXD;NA;NA	biological_process;NAD biosynthesis via nicotinamide riboside salvage pathway	GO:000815; GO:003435	cellular_component;mitochondrial matrix	GO:000557; GO:000575	"NA"	"NA"	ATP binding;molecular_function;ADP-dependent NAD(P)H-hydrate dehydratase activity;ATP-dependent NAD(P)H-hydrate dehydratase activity;protein binding	GO:000552; GO:000367; GO:005285; GO:004745; GO:000551
XP_013838560.1;XP_005670932.1;NP_001230355.1	XP_013838560.1;XP_005670932.1;NP_001230355.1	XP_013838560.1 small nuclear ribonucleoprotein Sm D3 isoform X1 [Sus scrofa];XP_005670932.1 small nuclear ribonucleoprotein Sm D3 isoform X1 [Sus scrofa];NP_001230355.1 small nuclear ribonucleoprotein Sm D3 [Sus scrofa]	2	2	2	0	45525000	41661000	47436000	44847000	50347000	33714000	54321000	36237000	46211000	53750000	58245000	37794000	56581000	51337000	52202000	0	51513000	NA	NA	NA	SNRPD3	SNRPD3;SNRPD3;SNRPD3;NA;NA	protein methylation;histone mRNA metabolic process;nuclear import;spliceosomal snRNP assembly;RNA splicing;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription	GO:000647; GO:000833; GO:005117; GO:000038; GO:000838; GO:000039; GO:000636	nuclear body;commitment complex;small nuclear ribonucleoprotein complex;nucleus;methylosome;spliceosomal complex;cytosol;telomerase holoenzyme complex;SMN-Sm protein complex;U4/U6 x U5 tri-snRNP complex;nucleoplasm;U2-type precatalytic spliceosome;catalytic step 2 spliceosome	GO:001660; GO:000024; GO:003053; GO:000563; GO:003470; GO:000568; GO:000582; GO:000569; GO:003471; GO:004654; GO:000565; GO:007100; GO:007101	 Systemic lupus erythematosus; Spliceosome	hsa0532; hsa0304	protein binding;U7 snRNA binding;telomerase RNA binding;RNA binding;U1 snRNP binding;enzyme binding	GO:000551; GO:007120; GO:007003; GO:000372; GO:199044; GO:001989
NP_001230356.1	NP_001230356.1	NP_001230356.1 T-complex protein 1 subunit alpha [Sus scrofa]	17	17	17	347280000	254300000	314070000	254500000	307300000	222040000	322090000	258310000	294680000	272280000	286470000	271170000	254920000	304180000	273190000	253050000	301950000	244150000	NA	NA	NA	TCP1	TCP1;NA;NA;NA;NA	positive regulation of telomerase activity;toxin transport;positive regulation of protein localization to Cajal body;protein folding;protein stabilization;positive regulation of establishment of protein localization to telomere;scaRNA localization to Cajal body;tubulin complex assembly;interleukin-12-mediated signaling pathway;regulation of macrophage apoptotic process;binding of sperm to zona pellucida;positive regulation of telomere maintenance via telomerase;translocation of peptides or proteins into host cell cytoplasm	GO:005197; GO:190199; GO:190487; GO:000645; GO:005082; GO:190485; GO:009066; GO:000702; GO:003572; GO:200010; GO:000733; GO:003221; GO:004405	acrosomal vesicle;Golgi apparatus;pericentriolar material;chaperonin-containing T-complex;nuclear heterochromatin;extracellular exosome;cytosol;microtubule;cell body;zona pellucida receptor complex;centrosome	GO:000166; GO:000579; GO:000024; GO:000583; GO:000572; GO:007006; GO:000582; GO:000587; GO:004429; GO:000219; GO:000581	"NA"	"NA"	RNA binding;ATP binding;unfolded protein binding;protein binding;ubiquitin protein ligase binding	GO:000372; GO:000552; GO:005108; GO:000551; GO:003162
NP_001230363.1	NP_001230363.1	NP_001230363.1 tubulin beta-2B chain [Sus scrofa]	21	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6686500	NA	NA	NA	TUBB2B	TUBB2B;NA;NA;NA;NA	mitotic cell cycle;microtubule cytoskeleton organization;modulation of synaptic transmission;neuron migration;microtubule-based process;positive regulation of axon guidance	GO:000027; GO:000022; GO:005080; GO:000176; GO:000701; GO:190266	nucleus;cytoplasm;Schaffer collateral - CA1 synapse;microtubule;microtubule cytoskeleton	GO:000563; GO:000573; GO:009868; GO:000587; GO:001563	 Gap junction; Pathogenic Escherichia coli infection; Phagosome	hsa0454; hsa0513; hsa0414	GTP binding;protein heterodimerization activity;GTPase activity;structural constituent of cytoskeleton;protein binding	GO:000552; GO:004698; GO:000392; GO:000520; GO:000551
NP_001230369.1	NP_001230369.1	NP_001230369.1 E3 UFM1-protein ligase 1 [Sus scrofa]	11	11	11	0	21528000	19325000	21730000	22614000	19310000	20924000	22009000	19743000	22900000	24656000	23436000	0	14255000	20729000	23487000	20111000	16803000	NA	NA	NA	UFL1	UFL1;NA;NA;NA;NA	protein K69-linked ufmylation;osteoblast differentiation;regulation of proteasomal ubiquitin-dependent protein catabolic process;response to L-glutamate;response to endoplasmic reticulum stress;negative regulation of apoptotic process;protein ufmylation;negative regulation of NF-kappaB transcription factor activity;positive regulation of cell proliferation;negative regulation of protein ubiquitination;regulation of protein localization;regulation of intracellular estrogen receptor signaling pathway;positive regulation of glial cell proliferation	GO:199059; GO:000164; GO:003243; GO:190206; GO:003497; GO:004306; GO:007156; GO:003208; GO:000828; GO:003139; GO:003288; GO:003314; GO:006025	macromolecular complex;endoplasmic reticulum;cytoplasm;cytosol;membrane;neuron projection	GO:003299; GO:000578; GO:000573; GO:000582; GO:001602; GO:004300	"NA"	"NA"	protein binding;UFM1 transferase activity	GO:000551; GO:007156
NP_001230371.1	NP_001230371.1	NP_001230371.1 syntaxin-12 [Sus scrofa]	6	6	6	30555000	26575000	31354000	0	26649000	21596000	23090000	25845000	28795000	25073000	0	17742000	18029000	23897000	25531000	27400000	25107000	0	NA	NA	NA	STX12	STX12;NA;NA;NA;NA	cholesterol efflux;vesicle docking;protein stabilization;intracellular protein transport;autophagosome assembly;vesicle fusion	GO:003334; GO:004827; GO:005082; GO:000688; GO:000004; GO:000690	Golgi membrane;integral component of membrane;pre-autophagosomal structure;membrane raft;postsynaptic recycling endosome;recycling endosome membrane;synaptic vesicle;endomembrane system;SNARE complex;early endosome membrane;phagocytic vesicle;integral component of synaptic vesicle membrane;BLOC-1 complex;vesicle	GO:000013; GO:001602; GO:000040; GO:004512; GO:009883; GO:005503; GO:000802; GO:001250; GO:003120; GO:003190; GO:004533; GO:003028; GO:003108; GO:003198	 Phagosome	hsa0414	SNARE binding;protein binding;SNAP receptor activity	GO:000014; GO:000551; GO:000548
NP_001230377.1;NP_001230376.1	NP_001230377.1;NP_001230376.1	NP_001230377.1 eukaryotic translation initiation factor 4H isoform 2 [Sus scrofa];NP_001230376.1 eukaryotic translation initiation factor 4H isoform 1 [Sus scrofa]	6	6	6	0	0	0	9141600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EIF4H	EIF4H;EIF4H;NA;NA;NA	regulation of translational initiation;formation of translation preinitiation complex;translational initiation;eukaryotic translation initiation factor 4F complex assembly;developmental growth;cytoplasmic translation;sexual reproduction;viral process	GO:000644; GO:000173; GO:000641; GO:009701; GO:004858; GO:000218; GO:001995; GO:001603	polysome;perinuclear region of cytoplasm;cytosol;membrane;eukaryotic translation initiation factor 4F complex	GO:000584; GO:004847; GO:000582; GO:001602; GO:001628	"NA"	"NA"	translation initiation factor activity;RNA strand annealing activity;RNA binding;protein binding;ribosomal small subunit binding;cadherin binding;RNA strand-exchange activity;translation factor activity, RNA binding	GO:000374; GO:003359; GO:000372; GO:000551; GO:004302; GO:004529; GO:003405; GO:000813
NP_001230394.1;XP_020957798.1;XP_020957797.1;XP_020939431.1;XP_005654890.3;XP_020939433.1;XP_020939432.1;XP_020939430.1	NP_001230394.1;XP_020957798.1;XP_020957797.1;XP_020939431.1;XP_005654890.3	NP_001230394.1 N-fatty-acyl-amino acid synthase/hydrolase PM20D1 [Sus scrofa];XP_020957798.1 N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X2 [Sus scrofa];XP_020957797.1 N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X1 [Sus scrofa];	4	4	4	0	20070000	0	16751000	14490000	0	12192000	22193000	11656000	17122000	10271000	21615000	0	18328000	18893000	27552000	13884000	0	NA	NA	NA	PM20D1	PM20D1;PM20D1;PM20D1;LOC100519130;LOC100519130	negative regulation of neuron death;energy homeostasis;cellular amide catabolic process;cellular amino acid metabolic process;nitrogen compound metabolic process;adaptive thermogenesis;cellular lipid metabolic process;regulation of oxidative phosphorylation uncoupler activity;proteolysis	GO:190121; GO:009700; GO:004360; GO:000652; GO:000680; GO:199084; GO:004425; GO:200027; GO:000650	extracellular exosome	GO:007006	"NA"	"NA"	lyase activity;peptidase activity;metal ion binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	GO:001682; GO:000823; GO:004687; GO:001681
XP_005663294.1;NP_001230397.1	XP_005663294.1;NP_001230397.1	XP_005663294.1 CD5 antigen-like isoform X1 [Sus scrofa];NP_001230397.1 CD5 antigen-like precursor [Sus scrofa]	4	4	4	89670000	48417000	50710000	50183000	48750000	36533000	45362000	25812000	63000000	32842000	40197000	28696000	0	52506000	97996000	40477000	64138000	0	NA	NA	NA	CD5L	CD5L;CD5L;NA;NA;NA	receptor-mediated endocytosis;cellular defense response;inflammatory response;apoptotic process;immune system process	GO:000689; GO:000696; GO:000695; GO:000691; GO:000237	extracellular region;cytoplasm;blood microparticle;membrane;extracellular space	GO:000557; GO:000573; GO:007256; GO:001602; GO:000561	"NA"	"NA"	scavenger receptor activity	GO:000504
NP_001230399.1	NP_001230399.1	NP_001230399.1 RNA 3-terminal phosphate cyclase [Sus scrofa]	3	3	3	0	5962200	11021000	0	6287600	5184700	6357600	7662100	0	9144000	6646300	8502000	0	5302800	4676000	9694900	8488500	6379200	NA	NA	NA	RTCA	RTCA;NA;NA;NA;NA	RNA processing	GO:000639	nucleus;nucleoplasm	GO:000563; GO:000565	"NA"	"NA"	ATP binding;RNA-3'-phosphate cyclase activity;RNA binding	GO:000552; GO:000396; GO:000372
NP_001230406.1	NP_001230406.1	NP_001230406.1 26S proteasome non-ATPase regulatory subunit 2 [Sus scrofa]	20	20	20	131020000	117010000	134470000	128790000	133960000	105950000	126150000	124480000	139250000	110380000	135710000	100540000	119100000	121000000	141070000	139250000	119760000	114650000	NA	NA	NA	PSMD2	PSMD2;NA;NA;NA;NA	regulation of catalytic activity;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of protein catabolic process;neutrophil degranulation	GO:005079; GO:001657; GO:004316; GO:004368; GO:004217; GO:004331	proteasome storage granule;extracellular region;proteasome regulatory particle, base subcomplex;cytosol;secretory granule lumen;nucleus;extracellular exosome;nucleoplasm;proteasome accessory complex;proteasome complex;proteasome regulatory particle;membrane;ficolin-1-rich granule lumen	GO:003451; GO:000557; GO:000854; GO:000582; GO:003477; GO:000563; GO:007006; GO:000565; GO:002262; GO:000050; GO:000583; GO:001602; GO:190481	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	protein binding;enzyme regulator activity;endopeptidase activity	GO:000551; GO:003023; GO:000417
XP_013834051.1;NP_001230410.1	XP_013834051.1;NP_001230410.1	XP_013834051.1 60S ribosomal protein L9 isoform X1 [Sus scrofa];NP_001230410.1 60S ribosomal protein L9 [Sus scrofa]	8	8	8	96519000	78355000	101070000	74020000	89860000	89771000	90691000	71462000	97586000	93501000	74103000	73373000	90793000	98250000	72972000	92573000	100630000	103800000	NA	NA	NA	RPL9	RPL9;RPL9;NA;NA;NA	cytoplasmic translation;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane	GO:000218; GO:000641; GO:000018; GO:000661	ribosome;cytosolic large ribosomal subunit;focal adhesion;cytosol;membrane;nucleus	GO:000584; GO:002262; GO:000592; GO:000582; GO:001602; GO:000563	 Ribosome	hsa0301	rRNA binding;structural constituent of ribosome;protein binding;RNA binding	GO:001984; GO:000373; GO:000551; GO:000372
NP_001230413.1	NP_001230413.1	NP_001230413.1 neutral cholesterol ester hydrolase 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4147900	0	NA	NA	NA	NCEH1	NCEH1;NA;NA;NA;NA	lipid catabolic process;low-density lipoprotein particle clearance	GO:001604; GO:003438	membrane;endoplasmic reticulum membrane;integral component of membrane	GO:001602; GO:000578; GO:001602	 Bile secretion	hsa0497	sterol esterase activity	GO:000477
NP_001230414.1	NP_001230414.1	NP_001230414.1 valacyclovir hydrolase precursor [Sus scrofa]	6	6	6	38430000	20094000	39285000	19587000	40108000	17881000	34939000	28148000	35377000	25363000	26803000	32915000	18126000	14911000	23363000	28917000	37730000	14493000	NA	NA	NA	BPHL	BPHL;NA;NA;NA;NA	cellular amino acid metabolic process;response to toxic substance;xenobiotic metabolic process	GO:000652; GO:000963; GO:000680	mitochondrion;mitochondrial outer membrane	GO:000573; GO:000574	"NA"	"NA"	alpha-amino-acid esterase activity	GO:004765
XP_005663409.1;NP_001230415.1;XP_013852495.1	XP_005663409.1;NP_001230415.1;XP_013852495.1	XP_005663409.1 SNARE-associated protein Snapin isoform X2 [Sus scrofa];NP_001230415.1 SNARE-associated protein Snapin [Sus scrofa];XP_013852495.1 SNARE-associated protein Snapin isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11702000	0	0	NA	NA	NA	SNAPIN	SNAPIN;SNAPIN;SNAPIN;NA;NA	intracellular protein transport;anterograde axonal transport;viral process;cellular protein complex localization;melanosome organization;protein maturation;late endosome to lysosome transport;anterograde synaptic vesicle transport;synaptic vesicle exocytosis;neuron projection development;synaptic vesicle fusion to presynaptic active zone membrane;synaptic vesicle transport;terminal button organization;retrograde axonal transport;endosome to lysosome transport;synaptic vesicle maturation;lysosome localization;regulation of synaptic vesicle exocytosis;neurotransmitter secretion;lysosomal lumen acidification;negative regulation of neuron projection development;regulation of protein binding;autophagosome maturation;positive regulation of late endosome to lysosome transport	GO:000688; GO:000808; GO:001603; GO:003462; GO:003243; GO:005160; GO:190277; GO:004849; GO:001607; GO:003117; GO:003162; GO:004848; GO:007255; GO:000809; GO:000833; GO:001618; GO:003241; GO:200030; GO:000726; GO:000704; GO:001097; GO:004339; GO:009735; GO:190282	BLOC-1 complex;synapse;BORC complex;axon cytoplasm;synaptic vesicle;synaptic vesicle membrane;lysosomal membrane;Golgi membrane;cell junction;secretory granule;perinuclear region of cytoplasm	GO:003108; GO:004520; GO:009907; GO:190411; GO:000802; GO:003067; GO:000576; GO:000013; GO:003005; GO:003014; GO:004847	"NA"	"NA"	protein binding;SNARE binding	GO:000551; GO:000014
NP_001230421.1;XP_005666184.1	NP_001230421.1;XP_005666184.1	NP_001230421.1 secretory carrier-associated membrane protein 2 [Sus scrofa];XP_005666184.1 secretory carrier-associated membrane protein 2 isoform X1 [Sus scrofa]	3	3	3	0	26113000	20507000	31006000	21043000	25728000	0	24525000	23699000	26133000	20921000	37536000	25679000	30937000	24608000	23579000	17817000	27286000	NA	NA	NA	SCAMP2	SCAMP2;SCAMP2;NA;NA;NA	post-Golgi vesicle-mediated transport;protein transport	GO:000689; GO:001503	integral component of membrane;intracellular membrane-bounded organelle;Golgi apparatus;trans-Golgi network membrane;recycling endosome membrane;Golgi membrane;extracellular exosome;transport vesicle	GO:001602; GO:004323; GO:000579; GO:003258; GO:005503; GO:000013; GO:007006; GO:003013	"NA"	"NA"	protein binding	GO:000551
NP_001230423.1	NP_001230423.1	NP_001230423.1 UPF0568 protein C14orf166 homolog [Sus scrofa]	6	6	6	28543000	23835000	26502000	24880000	29951000	20194000	27414000	24164000	26598000	30045000	32635000	19331000	33170000	26018000	30119000	26430000	24616000	25504000	NA	NA	NA	RTRAF	RTRAF;NA;NA;NA;NA	viral process;positive regulation of transcription from RNA polymerase II promoter;negative regulation of protein kinase activity;RNA transport;tRNA splicing, via endonucleolytic cleavage and ligation	GO:001603; GO:004594; GO:000646; GO:005065; GO:000638	cytosol;perinuclear region of cytoplasm;tRNA-splicing ligase complex;nucleus;mitotic spindle;cytoplasm;nucleoplasm;centrosome	GO:000582; GO:004847; GO:007266; GO:000563; GO:007268; GO:000573; GO:000565; GO:000581	"NA"	"NA"	RNA polymerase II core binding;identical protein binding;protein binding;RNA binding	GO:000099; GO:004280; GO:000551; GO:000372
NP_001230424.1	NP_001230424.1	NP_001230424.1 cytoplasmic dynein 1 intermediate chain 2 [Sus scrofa]	8	8	8	57450000	87006000	74407000	73934000	58621000	64938000	66519000	69857000	67558000	71810000	65147000	93752000	71394000	82144000	72936000	69977000	60142000	72153000	NA	NA	NA	DYNC1I2	DYNC1I2;NA;NA;NA;NA	ciliary basal body docking;microtubule-based movement;G2/M transition of mitotic cell cycle;ER to Golgi vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;viral process;regulation of G2/M transition of mitotic cell cycle	GO:009771; GO:000701; GO:000008; GO:000688; GO:001988; GO:001603; GO:001038	cytosol;cytoplasm;vesicle;centrosome;dynein complex;microtubule;cytoplasmic dynein complex	GO:000582; GO:000573; GO:003198; GO:000581; GO:003028; GO:000587; GO:000586	 Vasopressin-regulated water reabsorption; Phagosome; Salmonella infection	hsa0496; hsa0414; hsa0513	protein binding;microtubule motor activity;dynein light chain binding;ATP-dependent microtubule motor activity, plus-end-directed	GO:000551; GO:000377; GO:004550; GO:000857
NP_001230429.1	NP_001230429.1	NP_001230429.1 vesicle transport protein GOT1B [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1695300	NA	NA	NA	GOLT1B	GOLT1B;NA;NA;NA;NA	protein transport;vesicle-mediated transport;positive regulation of I-kappaB kinase/NF-kappaB signaling	GO:001503; GO:001619; GO:004312	macromolecular complex;membrane;endoplasmic reticulum;Golgi membrane	GO:003299; GO:001602; GO:000578; GO:000013	"NA"	"NA"	"NA"	"NA"
NP_001230432.1	NP_001230432.1	NP_001230432.1 adipogenesis regulatory factor [Sus scrofa]	5	5	5	834180000	879380000	828570000	636790000	811790000	523760000	932490000	867580000	1030900000	898900000	1457100000	5184400000	623530000	496280000	1293300000	630440000	644140000	507930000	NA	NA	NA	ADIRF	ADIRF;NA;NA;NA;NA	cell differentiation;cellular response to radiation;positive regulation of fat cell differentiation;cellular response to cisplatin;positive regulation of transcription from RNA polymerase II promoter;regulation of response to drug	GO:003015; GO:007147; GO:004560; GO:007271; GO:004594; GO:200102	cytosol;nucleoplasm;extracellular exosome;nucleus	GO:000582; GO:000565; GO:007006; GO:000563	"NA"	"NA"	molecular_function	GO:000367
XP_013838769.1;XP_005671119.1;NP_001230445.1;XP_020933401.1;XP_013846153.2;XP_005657711.2;XP_005657710.2	XP_013838769.1;XP_005671119.1;NP_001230445.1;XP_020933401.1;XP_013846153.2;XP_005657711.2;XP_005657710.2	XP_013838769.1 AP-3 complex subunit mu-1 isoform X1 [Sus scrofa];XP_005671119.1 AP-3 complex subunit mu-1 isoform X1 [Sus scrofa];NP_001230445.1 AP-3 complex subunit mu-1 [Sus scrofa];XP_020933401.1 AP-3 complex subunit mu-2 isoform X2 [Sus scrofa];XP_0138	2	2	2	0	0	0	0	0	0	0	0	0	7264400	0	0	0	0	0	0	0	0	NA	NA	NA	AP3M1	AP3M1;AP3M1;AP3M2;AP3M2;AP3M2	protein targeting to lysosome;viral process;anterograde synaptic vesicle transport;anterograde axonal transport	GO:000662; GO:001603; GO:004849; GO:000808	Golgi apparatus;clathrin adaptor complex;axon cytoplasm;lysosomal membrane;cytoplasmic vesicle membrane	GO:000579; GO:003013; GO:190411; GO:000576; GO:003065	 Lysosome	hsa0414	Rab GTPase binding;protein binding	GO:001713; GO:000551
NP_001230453.1	NP_001230453.1	NP_001230453.1 elongation factor 1-beta [Sus scrofa]	3	3	3	62222000	61751000	61923000	56423000	62067000	54517000	58610000	67125000	50512000	53202000	60348000	30226000	65982000	59729000	58913000	60396000	61511000	68227000	NA	NA	NA	EEF1B2	EEF1B2;NA;NA;NA;NA	translational elongation	GO:000641	cytosol;nucleus;endoplasmic reticulum;cytoplasm;eukaryotic translation elongation factor 1 complex	GO:000582; GO:000563; GO:000578; GO:000573; GO:000585	"NA"	"NA"	protein binding;translation elongation factor activity	GO:000551; GO:000374
NP_001230456.1	NP_001230456.1	NP_001230456.1 peptidase inhibitor 16 precursor [Sus scrofa]	3	3	3	20869000	146620000	53650000	155180000	74725000	184870000	53571000	115840000	45576000	89058000	91069000	176450000	91966000	163490000	54351000	118580000	89858000	185810000	NA	NA	NA	PI16	PI16;NA;NA;NA;NA	negative regulation of peptidase activity	GO:001046	extracellular space	GO:000561	"NA"	"NA"	peptidase inhibitor activity	GO:003041
XP_005665613.2;NP_001230474.1;XP_020953702.1	XP_005665613.2;NP_001230474.1;XP_020953702.1	XP_005665613.2 eukaryotic translation elongation factor 1 epsilon-1 isoform X2 [Sus scrofa];NP_001230474.1 eukaryotic translation elongation factor 1 epsilon-1 [Sus scrofa];XP_020953702.1 eukaryotic translation elongation factor 1 epsilon-1 isoform X1 [Sus	4	4	4	9865600	6633700	8356800	0	0	0	8163900	0	8975800	6354000	0	0	0	0	7406900	7007900	0	5842600	NA	NA	NA	EEF1E1	EEF1E1;EEF1E1;EEF1E1;NA;NA	tRNA aminoacylation for protein translation;positive regulation of cellular senescence;positive regulation of apoptotic process;negative regulation of cell proliferation;positive regulation of DNA damage response, signal transduction by p53 class mediator	GO:000641; GO:200077; GO:004306; GO:000828; GO:004351	cytoplasm;nucleoplasm;aminoacyl-tRNA synthetase multienzyme complex;cytosol;nucleus;nucleolus	GO:000573; GO:000565; GO:001710; GO:000582; GO:000563; GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_020927605.1;XP_020927604.1;XP_020927606.1;XP_020927603.1;XP_020927601.1;NP_001230484.1;XP_020927609.1;XP_020927608.1;XP_020927607.1	XP_020927605.1;XP_020927604.1;XP_020927606.1;XP_020927603.1;XP_020927601.1;NP_001230484.1;XP_020927609.1;XP_020927608.1;XP_020927607.1	XP_020927605.1 heterogeneous nuclear ribonucleoprotein H3 isoform X2 [Sus scrofa];XP_020927604.1 heterogeneous nuclear ribonucleoprotein H3 isoform X2 [Sus scrofa];XP_020927606.1 heterogeneous nuclear ribonucleoprotein H3 isoform X1 [Sus scrofa];XP_0209276	4	4	4	0	21200000	27339000	15261000	28341000	27953000	12561000	31391000	0	23968000	27194000	33492000	38525000	22775000	29573000	26437000	25326000	28382000	NA	NA	NA	HNRNPH3	HNRNPH3;HNRNPH3;HNRNPH3;HNRNPH3;HNRNPH3	mRNA splicing, via spliceosome;RNA splicing;epithelial cell differentiation;RNA processing	GO:000039; GO:000838; GO:003085; GO:000639	spliceosomal complex;nucleoplasm;nucleus	GO:000568; GO:000565; GO:000563	"NA"	"NA"	protein binding;RNA binding	GO:000551; GO:000372
NP_001230485.1	NP_001230485.1	NP_001230485.1 prohibitin-2 [Sus scrofa]	11	11	11	204340000	124530000	169370000	119560000	174530000	128740000	177260000	130520000	196870000	137100000	151530000	142060000	133060000	158060000	147230000	149050000	141210000	114250000	NA	NA	NA	PHB2	PHB2;NA;NA;NA;NA	mitochondrial calcium ion transport;response to wounding;negative regulation of intracellular estrogen receptor signaling pathway;mammary gland alveolus development;mitochondrion organization;sister chromatid cohesion;negative regulation of mammary gland epithelial cell proliferation;regulation of branching involved in mammary gland duct morphogenesis;protein stabilization;positive regulation of sequence-specific DNA binding transcription factor activity;cellular response to hypoxia;positive regulation of cell cycle G1/S phase transition;negative regulation of apoptotic process;negative regulation of transcription, DNA-templated;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of ERK1 and ERK2 cascade;cellular response to retinoic acid;regulation of complement activation;positive regulation of exit from mitosis	GO:000685; GO:000961; GO:003314; GO:006074; GO:000700; GO:000706; GO:003360; GO:006076; GO:005082; GO:005109; GO:007145; GO:190280; GO:004306; GO:004589; GO:004343; GO:007037; GO:007130; GO:003044; GO:003153	glutamatergic synapse;mitochondrion;nucleus;mitochondrial outer membrane;GABA-ergic synapse;cell surface;axon;presynaptic active zone;postsynaptic density;nuclear matrix;macromolecular complex;cell periphery	GO:009897; GO:000573; GO:000563; GO:000574; GO:009898; GO:000998; GO:003042; GO:004878; GO:001406; GO:001636; GO:003299; GO:007194	"NA"	"NA"	protein binding;protein C-terminus binding;protein N-terminus binding;estrogen receptor binding;amide binding	GO:000551; GO:000802; GO:004748; GO:003033; GO:003321
NP_001230490.1	NP_001230490.1	NP_001230490.1 NHL repeat-containing protein 2 [Sus scrofa]	8	8	8	17943000	20444000	28071000	20473000	22671000	16134000	22533000	21577000	20990000	23547000	23427000	33736000	21224000	18835000	22087000	24827000	19173000	21623000	NA	NA	NA	NHLRC2	NHLRC2;NA;NA;NA;NA	platelet degranulation;cell redox homeostasis	GO:000257; GO:004545	cytosol;platelet alpha granule lumen;extracellular region	GO:000582; GO:003109; GO:000557	"NA"	"NA"	protein binding	GO:000551
XP_020937161.1;NP_001230504.1	XP_020937161.1;NP_001230504.1	XP_020937161.1 creatine kinase B-type isoform X1 [Sus scrofa];NP_001230504.1 creatine kinase B-type [Sus scrofa]	14	14	14	637570000	756020000	479220000	728230000	567470000	721870000	651700000	873400000	680650000	1033400000	716530000	561240000	637100000	529470000	1002200000	1659800000	450360000	415280000	NA	NA	NA	CKB	CKB;CKB;NA;NA;NA	cerebellum development;cellular chloride ion homeostasis;substantia nigra development;creatine metabolic process;phosphorylation	GO:002154; GO:003064; GO:002176; GO:000660; GO:001631	neuronal cell body;extracellular exosome;extracellular space;dendrite;nucleus;cytosol	GO:004302; GO:007006; GO:000561; GO:003042; GO:000563; GO:000582	 Arginine and proline metabolism; Metabolic pathways	hsa0033; hsa0110	creatine kinase activity;ubiquitin protein ligase binding;ATP binding;protein binding	GO:000411; GO:003162; GO:000552; GO:000551
XP_020932933.1;NP_001230506.1	XP_020932933.1;NP_001230506.1	XP_020932933.1 eukaryotic translation initiation factor 6 isoform X1 [Sus scrofa];NP_001230506.1 eukaryotic translation initiation factor 6 [Sus scrofa]	6	6	6	90021000	104060000	97806000	92745000	81371000	78906000	99995000	88519000	92550000	106280000	88949000	128590000	86460000	88231000	88402000	95885000	92155000	79522000	NA	NA	NA	EIF6	EIF6;EIF6;NA;NA;NA	translational initiation;mature ribosome assembly;assembly of large subunit precursor of preribosome;regulation of glycolytic process;regulation of fatty acid biosynthetic process;regulation of megakaryocyte differentiation;positive regulation of translation;regulation of reactive oxygen species metabolic process;ribosomal subunit export from nucleus;miRNA mediated inhibition of translation;ribosomal large subunit biogenesis;response to insulin;gene silencing by miRNA	GO:000641; GO:004225; GO:190262; GO:000611; GO:004230; GO:004565; GO:004572; GO:200037; GO:000005; GO:003527; GO:004227; GO:003286; GO:003519	nucleoplasm;nucleolus;extracellular exosome;nucleus;cytosol;preribosome, large subunit precursor	GO:000565; GO:000573; GO:007006; GO:000563; GO:000582; GO:003068	 Ribosome biogenesis in eukaryotes	hsa0300	ribosomal large subunit binding;translation initiation factor activity;ribosome binding;protein binding	GO:004302; GO:000374; GO:004302; GO:000551
NP_001230514.1;XP_020941412.1;XP_020922061.1;XP_020922062.1;XP_020947184.1	NP_001230514.1;XP_020941412.1;XP_020922061.1	NP_001230514.1 ras-related C3 botulinum toxin substrate 1 [Sus scrofa];XP_020941412.1 ras-related C3 botulinum toxin substrate 1 isoform X1 [Sus scrofa];XP_020922061.1 ras-related C3 botulinum toxin substrate 3 isoform X1 [Sus scrofa]	9	8	4	337500000	326650000	358780000	373060000	281830000	325140000	278990000	253240000	343250000	322750000	305410000	507740000	329690000	409870000	369290000	360000000	339750000	319360000	NA	NA	NA	RAC1	RAC1;RAC1;RAC3;NA;NA	mast cell chemotaxis;protein phosphorylation;cell-matrix adhesion;Fc-gamma receptor signaling pathway involved in phagocytosis;negative regulation of receptor-mediated endocytosis;regulation of defense response to virus by virus;regulation of stress fiber assembly;positive regulation of substrate adhesion-dependent cell spreading;inflammatory response;Rho protein signal transduction;negative regulation of interleukin-23 production;positive regulation of Rho protein signal transduction;neutrophil degranulation;bone resorption;regulation of small GTPase mediated signal transduction;regulation of hydrogen peroxide metabolic process;substrate adhesion-dependent cell spreading;regulation of nitric oxide biosynthetic process;cell motility;cell proliferation;T cell costimulation;ephrin receptor signaling pathway;positive regulation of neutrophil chemotaxis;actin filament polymerization;cell migration;cellular response to mechanical stimulus;cell projection assembly;positive regulation of microtubule polymerization;positive regulation of DNA replication;localization within membrane;positive regulation of protein kinase B signaling;ruffle assembly;regulation of neutrophil migration;neuron migration;anatomical structure morphogenesis;motor neuron axon guidance;regulation of cell size;response to wounding;regulation of lamellipodium assembly;semaphorin-plexin signaling pathway;blood coagulation;cell adhesion;intracellular signal transduction;Rac protein signal transduction;regulation of respiratory burst;positive regulation of protein phosphorylation;positive regulation of cell-substrate adhesion;regulation of cell migration;ruffle organization;phosphatidylinositol phosphorylation;Wnt signaling pathway, planar cell polarity pathway	GO:000255; GO:000646; GO:000716; GO:003809; GO:004826; GO:005069; GO:005149; GO:190002; GO:000695; GO:000726; GO:003270; GO:003502; GO:004331; GO:004545; GO:005105; GO:001031; GO:003444; GO:004542; GO:004887; GO:000828; GO:003129; GO:004801; GO:009002; GO:003004; GO:001647; GO:007126; GO:003003; GO:003111; GO:004574; GO:005166; GO:005189; GO:009717; GO:190262; GO:000176; GO:000965; GO:000804; GO:000836; GO:000961; GO:001059; GO:007152; GO:000759; GO:000715; GO:003555; GO:001660; GO:006026; GO:000193; GO:001081; GO:003033; GO:003152; GO:004685; GO:006007	Golgi membrane;endoplasmic reticulum membrane;trans-Golgi network;secretory granule membrane;actin filament;lamellipodium;postsynapse;cytosol;cytoplasm;cytoplasmic ribonucleoprotein granule;membrane;ruffle membrane;melanosome;ficolin-1-rich granule membrane;dendritic spine;extracellular exosome;focal adhesion;cytoplasmic vesicle;cell projection;recycling endosome membrane;glutamatergic synapse	GO:000013; GO:000578; GO:000580; GO:003066; GO:000588; GO:003002; GO:009879; GO:000582; GO:000573; GO:003646; GO:001602; GO:003258; GO:004247; GO:010100; GO:004319; GO:007006; GO:000592; GO:003141; GO:004299; GO:005503; GO:009897	 Rap1 signaling pathway; Focal adhesion; Fc gamma R-mediated phagocytosis; Colorectal cancer; Viral carcinogenesis; Amyotrophic lateral sclerosis (ALS); Shigellosis; Chemokine signaling pathway; Axon guidance; VEGF signaling pathway; Adherens junction; Leukocyte transendothelial migration; MAPK signaling pathway; cAMP signaling pathway; Phagosome; Natural killer cell mediated cytotoxicity; Neurotrophin signaling pathway; Choline metabolism in cancer; Viral myocarditis; Pancreatic secretion; Osteoclast differentiation; Non-alcoholic fatty liver disease (NAFLD); Epithelial cell signaling in Helicobacter pylori infection; Sphingolipid signaling pathway; PI3K-Akt signaling pathway; Wnt signaling pathway; Toll-like receptor signaling pathway; Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells	hsa0401; hsa0451; hsa0466; hsa0521; hsa0520; hsa0501; hsa0513; hsa0406; hsa0436; hsa0437; hsa0452; hsa0467; hsa0401; hsa0402; hsa0414; hsa0465; hsa0472; hsa0523; hsa0541; hsa0497; hsa0438; hsa0493; hsa0512; hsa0407; hsa0415; hsa0431; hsa0462; hsa0481; hsa0510	GTP binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;enzyme binding;thioesterase binding;histone deacetylase binding;ATPase binding;protein serine/threonine kinase activity;GTPase activity;macromolecular complex binding;protein binding;protein kinase binding;Rab GTPase binding;Rho GDP-dissociation inhibitor binding	GO:000552; GO:004693; GO:001989; GO:003199; GO:004282; GO:005111; GO:000467; GO:000392; GO:004487; GO:000551; GO:001990; GO:001713; GO:005102
XP_020919701.1;NP_001230517.1;XP_020919703.1;XP_020919702.1;XP_020919700.1	XP_020919701.1;NP_001230517.1;XP_020919703.1;XP_020919702.1;XP_020919700.1	XP_020919701.1 fumarate hydratase, mitochondrial isoform X2 [Sus scrofa];NP_001230517.1 fumarate hydratase, mitochondrial [Sus scrofa];XP_020919703.1 fumarate hydratase, mitochondrial isoform X3 [Sus scrofa];XP_020919702.1 fumarate hydratase, mitochondrial	9	9	9	105090000	70902000	114240000	53387000	120560000	79742000	106710000	56707000	106860000	78364000	82802000	54450000	59731000	78912000	83309000	103410000	92303000	59765000	NA	NA	NA	FH	FH;FH;FH;FH;FH	fumarate metabolic process;tricarboxylic acid cycle;malate metabolic process;homeostasis of number of cells within a tissue	GO:000610; GO:000609; GO:000610; GO:004887	tricarboxylic acid cycle enzyme complex;mitochondrial matrix;extracellular exosome;cytoplasm	GO:004523; GO:000575; GO:007006; GO:000573	 Renal cell carcinoma; Citrate cycle (TCA cycle); Pyruvate metabolism; Metabolic pathways; Pathways in cancer; Biosynthesis of antibiotics; Carbon metabolism	hsa0521; hsa0002; hsa0062; hsa0110; hsa0520; hsa0113; hsa0120	fumarate hydratase activity;protein binding	GO:000433; GO:000551
NP_001230518.1;XP_013844180.1;XP_013844179.1;XP_013844178.1;XP_020950864.1;XP_013844177.1;XP_020925360.1;XP_013837608.1	NP_001230518.1	NP_001230518.1 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 [Sus scrofa]	20	20	19	131180000	224160000	143180000	208320000	146570000	172290000	144010000	214960000	163520000	181420000	152280000	235210000	138530000	218630000	184680000	231960000	152030000	198640000	NA	NA	NA	PLCD1	PLCD1;NA;NA;NA;NA	phospholipid metabolic process;inositol trisphosphate biosynthetic process;intracellular signal transduction;regulation of cell proliferation;inositol phosphate metabolic process;angiogenesis;lipid catabolic process;labyrinthine layer blood vessel development	GO:000664; GO:003295; GO:003555; GO:004212; GO:004364; GO:000152; GO:001604; GO:006071	extracellular exosome;cytoplasm;plasma membrane;cytosol	GO:007006; GO:000573; GO:000588; GO:000582	 Thyroid hormone signaling pathway; Metabolic pathways; Phosphatidylinositol signaling system; Inositol phosphate metabolism; Calcium signaling pathway	hsa0491; hsa0110; hsa0407; hsa0056; hsa0402	GTPase activating protein binding;calcium ion binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol phospholipase C activity;protein binding	GO:003279; GO:000550; GO:000554; GO:000443; GO:000551
XP_020935139.1;NP_001230522.1	XP_020935139.1;NP_001230522.1	XP_020935139.1 vesicle-associated membrane protein 7 isoform X1 [Sus scrofa];NP_001230522.1 vesicle-associated membrane protein 7 [Sus scrofa]	2	2	2	0	6058600	0	0	0	0	0	6033200	0	8050800	0	0	0	0	0	0	0	0	NA	NA	NA	VAMP7	VAMP7;VAMP7;NA;NA;NA	vesicle fusion;calcium ion regulated exocytosis;natural killer cell degranulation;positive regulation of dendrite morphogenesis;eosinophil degranulation;ER to Golgi vesicle-mediated transport;Golgi to plasma membrane protein transport;positive regulation of histamine secretion by mast cell;phagocytosis, engulfment;endosome to lysosome transport;SNARE complex assembly;regulation of protein targeting to vacuolar membrane;vesicle transport along microtubule;membrane organization;autophagosome maturation;vesicle-mediated transport;triglyceride transport;neutrophil degranulation;vesicle fusion with Golgi apparatus	GO:000690; GO:001715; GO:004332; GO:005077; GO:004330; GO:000688; GO:004300; GO:190359; GO:000691; GO:000833; GO:003549; GO:190048; GO:004749; GO:006102; GO:009735; GO:001619; GO:003419; GO:004331; GO:004828	perinuclear region of cytoplasm;endoplasmic reticulum membrane;plasma membrane;hippocampal mossy fiber to CA3 synapse;lysosomal membrane;cell junction;SNARE complex;intracellular membrane-bounded organelle;cytoplasm;trans-Golgi network;cell surface;secretory granule;clathrin-coated vesicle membrane;platelet alpha granule;azurophil granule membrane;pseudopodium;neuron projection;phagocytic vesicle;membrane;late endosome membrane;apical part of cell;lamellipodium;integral component of synaptic vesicle membrane;phagocytic vesicle membrane;extracellular exosome	GO:004847; GO:000578; GO:000588; GO:009868; GO:000576; GO:003005; GO:003120; GO:004323; GO:000573; GO:000580; GO:000998; GO:003014; GO:003066; GO:003109; GO:003557; GO:003114; GO:004300; GO:004533; GO:001602; GO:003190; GO:004517; GO:003002; GO:003028; GO:003067; GO:007006	 SNARE interactions in vesicular transport	hsa0413	SNARE binding;protein binding;syntaxin binding;SNAP receptor activity	GO:000014; GO:000551; GO:001990; GO:000548
XP_020927616.1;NP_001230528.1	XP_020927616.1;NP_001230528.1	XP_020927616.1 annexin A8 isoform X1 [Sus scrofa];NP_001230528.1 annexin A8 [Sus scrofa]	14	14	14	23099000	38002000	32913000	70620000	94984000	56871000	263940000	30827000	67309000	33987000	90888000	31983000	201330000	39612000	82999000	24903000	369870000	138380000	NA	NA	NA	ANXA8	ANXA8;ANXA8;NA;NA;NA	negative regulation of serine-type endopeptidase activity;endosome organization;negative regulation of phospholipase A2 activity;blood coagulation;endosomal transport	GO:190000; GO:000703; GO:190013; GO:000759; GO:001619	cytosol;late endosome membrane;plasma membrane	GO:000582; GO:003190; GO:000588	"NA"	"NA"	phosphatidylinositol-4,5-bisphosphate binding;calcium-dependent phospholipid binding;phosphatidylinositol-3,4-bisphosphate binding;actin filament binding;calcium ion binding	GO:000554; GO:000554; GO:004332; GO:005101; GO:000550
NP_001230536.1	NP_001230536.1	NP_001230536.1 translin-associated protein X [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	1745600	0	0	0	0	NA	NA	NA	TSNAX	TSNAX;NA;NA;NA;NA	multicellular organism development;spermatogenesis;RNA phosphodiester bond hydrolysis, endonucleolytic;protein transport;cell differentiation	GO:000727; GO:000728; GO:009050; GO:001503; GO:003015	cytoplasm;cytosol;nucleus;perinuclear region of cytoplasm;Golgi apparatus	GO:000573; GO:000582; GO:000563; GO:004847; GO:000579	"NA"	"NA"	DNA binding;RNA binding;protein binding;sequence-specific DNA binding;metal ion binding;protein transporter activity;single-stranded DNA binding;endoribonuclease activity	GO:000367; GO:000372; GO:000551; GO:004356; GO:004687; GO:000856; GO:000369; GO:000452
NP_001230537.1;XP_020927622.1	NP_001230537.1;XP_020927622.1	NP_001230537.1 phospholysine phosphohistidine inorganic pyrophosphate phosphatase [Sus scrofa];XP_020927622.1 phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X1 [Sus scrofa]	5	5	5	19247000	18285000	25940000	18758000	27668000	9001800	16598000	28245000	23444000	20703000	22885000	63576000	11127000	13252000	26937000	29302000	14039000	14067000	NA	NA	NA	LHPP	LHPP;LHPP;NA;NA;NA	phosphate-containing compound metabolic process;dephosphorylation;protein dephosphorylation;purine ribonucleoside monophosphate biosynthetic process	GO:000679; GO:001631; GO:000647; GO:000916	nucleus;nuclear speck;cytosol	GO:000563; GO:001660; GO:000582	 Oxidative phosphorylation	hsa0019	inorganic diphosphatase activity;protein homodimerization activity;magnesium ion binding;protein histidine phosphatase activity;phosphatase activity	GO:000442; GO:004280; GO:000028; GO:010100; GO:001679
NP_001230549.1;XP_020949079.1	NP_001230549.1;XP_020949079.1	NP_001230549.1 cytoplasmic dynein 1 light intermediate chain 2 [Sus scrofa];XP_020949079.1 cytoplasmic dynein 1 light intermediate chain 2 isoform X1 [Sus scrofa]	9	9	9	0	50138000	45642000	47589000	0	48370000	40748000	35930000	46257000	33360000	35464000	49919000	48040000	39604000	31257000	37002000	33468000	39141000	NA	NA	NA	DYNC1LI2	DYNC1LI2;DYNC1LI2;NA;NA;NA	cellular response to nerve growth factor stimulus;antigen processing and presentation of exogenous peptide antigen via MHC class II;ER to Golgi vesicle-mediated transport;centrosome localization;microtubule cytoskeleton organization;protein homooligomerization;microtubule-based movement	GO:199009; GO:001988; GO:000688; GO:005164; GO:000022; GO:005126; GO:000701	lysosome;centrosome;late endosome;cytoplasmic dynein complex;cytosol;kinetochore;microtubule;membrane	GO:000576; GO:000581; GO:000577; GO:000586; GO:000582; GO:000077; GO:000587; GO:001602	 Phagosome; Vasopressin-regulated water reabsorption; Salmonella infection	hsa0414; hsa0496; hsa0513	ATP binding;microtubule motor activity;dynein heavy chain binding	GO:000552; GO:000377; GO:004550
NP_001230552.1;XP_013848134.1;XP_003127849.1	NP_001230552.1;XP_013848134.1;XP_003127849.1	NP_001230552.1 ras-related GTP-binding protein D [Sus scrofa];XP_013848134.1 ras-related GTP-binding protein D isoform X1 [Sus scrofa];XP_003127849.1 ras-related GTP-binding protein C [Sus scrofa]	4	4	4	0	28851000	24536000	16462000	0	0	24866000	20108000	23786000	26527000	22634000	14170000	16218000	21809000	23133000	22750000	24268000	24390000	NA	NA	NA	RRAGD	RRAGD;RRAGD;RRAGC;NA;NA	cell cycle arrest;regulation of autophagy;regulation of macroautophagy;cellular protein localization;cellular response to starvation;cellular response to amino acid stimulus;positive regulation of TOR signaling;positive regulation of TORC1 signaling;cellular response to leucine starvation	GO:000705; GO:001050; GO:001624; GO:003461; GO:000926; GO:007123; GO:003200; GO:190426; GO:199025	cytosol;nucleus;cytoplasm;EGO complex;lysosome;nucleoplasm;Gtr1-Gtr2 GTPase complex;centrosome	GO:000582; GO:000563; GO:000573; GO:003444; GO:000576; GO:000565; GO:199013; GO:000581	 mTOR signaling pathway	hsa0415	GTP binding;GDP binding;GTPase activity;GTPase binding;protein binding;protein heterodimerization activity	GO:000552; GO:001900; GO:000392; GO:005102; GO:000551; GO:004698
NP_001230556.1	NP_001230556.1	NP_001230556.1 ragulator complex protein LAMTOR2 [Sus scrofa]	2	2	2	0	4570600	0	0	0	0	0	0	8829200	0	0	0	0	0	0	0	0	0	NA	NA	NA	LAMTOR2	LAMTOR2;NA;NA;NA;NA	MAPK cascade;activation of MAPKK activity;cellular protein localization;cellular response to amino acid stimulus;neutrophil degranulation;cell cycle arrest;regulation of macroautophagy;regulation of cell growth;positive regulation of TOR signaling	GO:000016; GO:000018; GO:003461; GO:007123; GO:004331; GO:000705; GO:001624; GO:000155; GO:003200	lysosomal membrane;tertiary granule membrane;specific granule membrane;late endosome;Ragulator complex;plasma membrane;endosome membrane	GO:000576; GO:007082; GO:003557; GO:000577; GO:007198; GO:000588; GO:001000	"NA"	"NA"	protein binding;guanyl-nucleotide exchange factor activity;protein complex scaffold	GO:000551; GO:000508; GO:003294
NP_001230558.1	NP_001230558.1	NP_001230558.1 lysosomal protective protein precursor [Sus scrofa]	3	3	3	0	0	0	0	0	9200000	7500300	0	0	10192000	0	0	0	15945000	0	13566000	0	10718000	NA	NA	NA	CTSA	CTSA;NA;NA;NA;NA	proteolysis;negative regulation of chaperone-mediated autophagy;intracellular protein transport;positive regulation of catalytic activity;glycosphingolipid metabolic process;proteolysis involved in cellular protein catabolic process;regulation of protein stability;neutrophil degranulation	GO:000650; GO:190471; GO:000688; GO:004308; GO:000668; GO:005160; GO:003164; GO:004331	nucleoplasm;lysosomal lumen;extracellular exosome;lysosome;endoplasmic reticulum;intracellular membrane-bounded organelle;lumenal side of lysosomal membrane;extracellular region;azurophil granule lumen;membrane	GO:000565; GO:004320; GO:007006; GO:000576; GO:000578; GO:004323; GO:009857; GO:000557; GO:003557; GO:001602	 Renin-angiotensin system; Lysosome	hsa0461; hsa0414	serine-type carboxypeptidase activity;exo-alpha-sialidase activity;enzyme activator activity;carboxypeptidase activity	GO:000418; GO:000430; GO:000804; GO:000418
NP_001230566.1	NP_001230566.1	NP_001230566.1 protein-glutamate O-methyltransferase [Sus scrofa]	5	5	5	0	0	12016000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ARMT1	ARMT1;NA;NA;NA;NA	cellular response to DNA damage stimulus;regulation of response to DNA damage stimulus;protein methylation;methylation	GO:000697; GO:200102; GO:000647; GO:003225	"NA"	"NA"	"NA"	"NA"	enzyme binding;S-adenosylmethionine-dependent methyltransferase activity;protein carboxyl O-methyltransferase activity;protein binding	GO:001989; GO:000875; GO:005199; GO:000551
NP_001230567.1;XP_005656487.1;XP_020953926.1;XP_013844648.1;XP_013844647.1;XP_013844646.1;XP_020953925.1	NP_001230567.1;XP_005656487.1;XP_020953926.1;XP_013844648.1;XP_013844647.1;XP_013844646.1;XP_020953925.1	NP_001230567.1 maleylacetoacetate isomerase [Sus scrofa];XP_005656487.1 maleylacetoacetate isomerase isoform X1 [Sus scrofa];XP_020953926.1 maleylacetoacetate isomerase isoform X3 [Sus scrofa];XP_013844648.1 maleylacetoacetate isomerase isoform X3 [Sus scr	5	5	5	27664000	34325000	28002000	35916000	28490000	16531000	30532000	40027000	40274000	40677000	26540000	46416000	12945000	27693000	21285000	39565000	18948000	30394000	NA	NA	NA	GSTZ1	GSTZ1;GSTZ1;GSTZ1;GSTZ1;GSTZ1	L-phenylalanine catabolic process;cellular oxidant detoxification;tyrosine catabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;glutathione derivative biosynthetic process;glutathione metabolic process	GO:000655; GO:009886; GO:000657; GO:001051; GO:190168; GO:000674	cytosol;mitochondrion;mitochondrial matrix	GO:000582; GO:000573; GO:000575	 Tyrosine metabolism; Metabolic pathways	hsa0035; hsa0110	identical protein binding;hydrolase activity, acting on acid halide bonds, in C-halide compounds;maleylacetoacetate isomerase activity;protein binding;glutathione peroxidase activity;glutathione transferase activity;protein homodimerization activity	GO:004280; GO:001912; GO:001603; GO:000551; GO:000460; GO:000436; GO:004280
XP_005670078.1;NP_001230573.1;XP_020924149.1	XP_005670078.1;NP_001230573.1;XP_020924149.1	XP_005670078.1 AP-2 complex subunit mu isoform X1 [Sus scrofa];NP_001230573.1 AP-2 complex subunit mu [Sus scrofa];XP_020924149.1 AP-2 complex subunit mu isoform X2 [Sus scrofa]	4	4	4	0	26947000	27469000	34583000	23377000	33716000	0	20324000	0	36681000	0	0	27874000	34751000	26632000	44475000	0	0	NA	NA	NA	AP2M1	AP2M1;AP2M1;AP2M1;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;receptor internalization;regulation of vesicle size;ephrin receptor signaling pathway;Wnt signaling pathway, planar cell polarity pathway;low-density lipoprotein particle clearance;membrane organization;intracellular protein transport;membrane budding;regulation of defense response to virus by virus;negative regulation of protein localization to plasma membrane;low-density lipoprotein particle receptor catabolic process;clathrin-dependent endocytosis	GO:001988; GO:003162; GO:009749; GO:004801; GO:006007; GO:003438; GO:006102; GO:000688; GO:000690; GO:005069; GO:190307; GO:003280; GO:007258	endolysosome membrane;plasma membrane;cytosol;clathrin-coated endocytic vesicle;clathrin-coated endocytic vesicle membrane;AP-2 adaptor complex;extracellular exosome;lysosomal membrane	GO:003602; GO:000588; GO:000582; GO:004533; GO:003066; GO:003012; GO:007006; GO:000576	 Endocytosis; Huntington's disease; Synaptic vesicle cycle; Endocrine and other factor-regulated calcium reabsorption	hsa0414; hsa0501; hsa0472; hsa0496	protein binding;clathrin adaptor activity;ion channel binding;low-density lipoprotein particle receptor binding;signal sequence binding;lipid binding;transporter activity	GO:000551; GO:003561; GO:004432; GO:005075; GO:000504; GO:000828; GO:000521
NP_001230576.1	NP_001230576.1	NP_001230576.1 WD repeat and FYVE domain-containing protein 1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13980000	0	0	NA	NA	NA	WDFY1	WDFY1;NA;NA;NA;NA	positive regulation of toll-like receptor 3 signaling pathway;positive regulation of toll-like receptor 4 signaling pathway	GO:003414; GO:003414	nucleus;cytosol;early endosome	GO:000563; GO:000582; GO:000576	"NA"	"NA"	protein binding;zinc ion binding;1-phosphatidylinositol binding	GO:000551; GO:000827; GO:000554
NP_001230581.1	NP_001230581.1	NP_001230581.1 proteasome subunit alpha type-7 [Sus scrofa]	11	11	6	133380000	118300000	127680000	136120000	122460000	124640000	135200000	136450000	153500000	123790000	139470000	130330000	120990000	141230000	151020000	125400000	140520000	125790000	NA	NA	NA	PSMA7	PSMA7;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;viral process;post-translational protein modification;protein deubiquitination;proteasomal protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:001049; GO:001603; GO:004368; GO:001657; GO:001049; GO:004316	nucleus;cytoplasm;extracellular exosome;nucleoplasm;proteasome core complex, alpha-subunit complex;postsynapse;proteasome core complex;proteasome complex;cytosol	GO:000563; GO:000573; GO:007006; GO:000565; GO:001977; GO:009879; GO:000583; GO:000050; GO:000582	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity;identical protein binding	GO:000551; GO:000429; GO:000417; GO:004280
NP_001230582.1;XP_020949067.1	NP_001230582.1;XP_020949067.1	NP_001230582.1 small nuclear ribonucleoprotein Sm D2 [Sus scrofa];XP_020949067.1 small nuclear ribonucleoprotein Sm D2 isoform X1 [Sus scrofa]	4	4	4	0	19753000	0	0	17391000	28466000	0	23360000	0	21404000	0	0	0	30739000	22206000	22820000	21453000	26522000	NA	NA	NA	SNRPD2	SNRPD2;SNRPD2;NA;NA;NA	spliceosomal complex assembly;RNA splicing;mRNA splicing, via spliceosome;spliceosomal snRNP assembly;nuclear import	GO:000024; GO:000838; GO:000039; GO:000038; GO:005117	U2 snRNP;pICln-Sm protein complex;U12-type spliceosomal complex;methylosome;cytosol;extracellular exosome;U2-type precatalytic spliceosome;catalytic step 2 spliceosome;nucleus;nucleoplasm;U4/U6 x U5 tri-snRNP complex;small nuclear ribonucleoprotein complex	GO:000568; GO:003471; GO:000568; GO:003470; GO:000582; GO:007006; GO:007100; GO:007101; GO:000563; GO:000565; GO:004654; GO:003053	 Spliceosome	hsa0304	protein binding;RNA binding	GO:000551; GO:000372
NP_001230584.1	NP_001230584.1	NP_001230584.1 collagen alpha-2(I) chain precursor [Sus scrofa]	8	8	8	0	106430000	37748000	310470000	35536000	104170000	0	178460000	0	75866000	52227000	103940000	59281000	234600000	0	104070000	0	102980000	NA	NA	NA	COL1A2	COL1A2;NA;NA;NA;NA	cellular response to amino acid stimulus;blood vessel development;cytokine-mediated signaling pathway;extracellular matrix organization;regulation of immune response;protein heterotrimerization;Rho protein signal transduction;skeletal system development;odontogenesis;skin morphogenesis;leukocyte migration;blood coagulation;transforming growth factor beta receptor signaling pathway;regulation of blood pressure;platelet activation	GO:007123; GO:000156; GO:001922; GO:003019; GO:005077; GO:007020; GO:000726; GO:000150; GO:004247; GO:004358; GO:005090; GO:000759; GO:000717; GO:000821; GO:003016	extracellular region;extracellular exosome;endoplasmic reticulum;collagen type I trimer;extracellular matrix;extracellular space	GO:000557; GO:007006; GO:000578; GO:000558; GO:003101; GO:000561	 ECM-receptor interaction; PI3K-Akt signaling pathway; Focal adhesion; Platelet activation; Amoebiasis; Protein digestion and absorption	hsa0451; hsa0415; hsa0451; hsa0461; hsa0514; hsa0497	platelet-derived growth factor binding;protein binding;metal ion binding;identical protein binding;protein binding, bridging;extracellular matrix structural constituent conferring tensile strength;protease binding;SMAD binding;extracellular matrix structural constituent	GO:004840; GO:000551; GO:004687; GO:004280; GO:003067; GO:003002; GO:000202; GO:004633; GO:000520
XP_020955505.1;XP_020955504.1;XP_020955500.1;XP_020955495.1;XP_020945586.1;XP_003356615.2;XP_001927974.2;XP_001927752.1;NP_001230585.1;XP_020955503.1;XP_013832959.2;XP_020954075.1;XP_020954074.1;XP_013846203.1	XP_020955505.1;XP_020955504.1;XP_020955500.1;XP_020955495.1;XP_020945586.1;XP_003356615.2;XP_001927974.2;XP_001927752.1;NP_001230585.1;XP_020955503.1;XP_013832959.2	XP_020955505.1 LOW QUALITY PROTEIN: histone H2B type 1-K [Sus scrofa];XP_020955504.1 histone H2B type 1-K [Sus scrofa];XP_020955500.1 histone H2B type 1 [Sus scrofa];XP_020955495.1 histone H2B type 1 [Sus scrofa];XP_020945586.1 histone H2B type 2-F [Sus sc	4	4	2	1836400000	2311000000	2155900000	1586200000	1854700000	4405900000	2025900000	1349000000	2583300000	3461500000	1864900000	3452200000	4436500000	3508000000	1109400000	3970900000	3548800000	3460000000	NA	NA	NA	LOC100512420	LOC100512420;LOC110261672;LOC110261669;LOC110261663;LOC110261671	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001230595.1	NP_001230595.1	NP_001230595.1 alpha-actinin-2 [Sus scrofa]	27	9	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54088000	0	NA	NA	NA	ACTN2	ACTN2;NA;NA;NA;NA	cell adhesion;negative regulation of potassium ion transport;muscle filament sliding;regulation of membrane potential;positive regulation of endocytic recycling;positive regulation of cation channel activity;sarcomere organization;negative regulation of potassium ion transmembrane transporter activity;microspike assembly;protein localization to plasma membrane;positive regulation of nucleic acid-templated transcription;MAPK cascade;platelet degranulation;actin filament uncapping;negative regulation of protein localization to cell surface;phospholipase C-activating angiotensin-activated signaling pathway;focal adhesion assembly;protein homotetramerization;regulation of apoptotic process;cardiac muscle cell development	GO:000715; GO:004326; GO:003004; GO:004239; GO:200113; GO:200125; GO:004521; GO:190101; GO:003003; GO:007265; GO:190350; GO:000016; GO:000257; GO:005169; GO:200000; GO:008609; GO:004804; GO:005128; GO:004298; GO:005501	plasma membrane;extracellular region;glutamatergic synapse;postsynaptic density, intracellular component;focal adhesion;pseudopodium;filopodium;platelet alpha granule lumen;extracellular exosome;cytoskeleton;cortical actin cytoskeleton;postsynaptic density membrane;cytosol;actin filament;Z disc;dendritic spine	GO:000588; GO:000557; GO:009897; GO:009909; GO:000592; GO:003114; GO:003017; GO:003109; GO:007006; GO:000585; GO:003086; GO:009883; GO:000582; GO:000588; GO:003001; GO:004319	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Adherens junction; Leukocyte transendothelial migration; Viral carcinogenesis; Tight junction; Focal adhesion; Regulation of actin cytoskeleton; Amoebiasis; Systemic lupus erythematosus	hsa0541; hsa0452; hsa0467; hsa0520; hsa0453; hsa0451; hsa0481; hsa0514; hsa0532	calcium ion binding;cytoskeletal protein binding;integrin binding;identical protein binding;protein binding;structural constituent of muscle;protein domain specific binding;ion channel binding;FATZ binding;actin filament binding;Ras guanyl-nucleotide exchange factor activity;titin binding;LIM domain binding;thyroid hormone receptor coactivator activity;protein dimerization activity;titin Z domain binding;phosphatidylinositol-4,5-bisphosphate binding	GO:000550; GO:000809; GO:000517; GO:004280; GO:000551; GO:000830; GO:001990; GO:004432; GO:005137; GO:005101; GO:000508; GO:003143; GO:003027; GO:003037; GO:004698; GO:007008; GO:000554
XP_005655518.1;NP_001230608.1	XP_005655518.1;NP_001230608.1	XP_005655518.1 diphthine methyl ester synthase isoform X1 [Sus scrofa];NP_001230608.1 diphthine methyl ester synthase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3042600	0	0	0	NA	NA	NA	DPH5	DPH5;DPH5;NA;NA;NA	methylation;peptidyl-diphthamide biosynthetic process from peptidyl-histidine	GO:003225; GO:001718	cytosol;cellular_component	GO:000582; GO:000557	"NA"	"NA"	diphthine synthase activity	GO:000416
NP_001230609.1;XP_005653119.1;XP_020933303.1;XP_020933302.1;XP_020933301.1;XP_020933300.1;XP_020933299.1	NP_001230609.1;XP_005653119.1	NP_001230609.1 transcription elongation factor A protein 1 [Sus scrofa];XP_005653119.1 transcription elongation factor A protein 1 isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5549300	0	0	0	NA	NA	NA	TCEA1	TCEA1;TCEA1;NA;NA;NA	regulation of transcription, DNA-templated;transcription elongation from RNA polymerase II promoter;positive regulation of exoribonuclease activity;transcription-coupled nucleotide-excision repair	GO:000635; GO:000636; GO:190191; GO:000628	nucleolus;nucleus;nucleoplasm;transcription factor TFIID complex	GO:000573; GO:000563; GO:000565; GO:000566	"NA"	"NA"	zinc ion binding;DNA binding;protein binding	GO:000827; GO:000367; GO:000551
XP_020927688.1;NP_001230619.1	XP_020927688.1;NP_001230619.1	XP_020927688.1 hyaluronan-binding protein 2 isoform X1 [Sus scrofa];NP_001230619.1 hyaluronan-binding protein 2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11385000	NA	NA	NA	HABP2	HABP2;HABP2;NA;NA;NA	cell adhesion;proteolysis	GO:000715; GO:000650	extracellular region;extracellular space	GO:000557; GO:000561	"NA"	"NA"	serine-type endopeptidase activity;glycosaminoglycan binding;calcium ion binding	GO:000425; GO:000553; GO:000550
XP_020953924.1;XP_020953923.1;XP_020953922.1;XP_020953921.1;XP_020953920.1;XP_020953919.1;XP_020953918.1;XP_020953917.1;XP_020953916.1;XP_020953915.1;XP_020953914.1;XP_020953913.1;XP_020953912.1;XP_020953911.1;XP_020953910.1;XP_020953909.1;XP_020953908.1;XP_020953907.1;NP_001230623.1;XP_020953906.1;XP_020953905.1;XP_020953904.1;XP_020953902.1;XP_020953901.1;XP_020953900.1;XP_020953899.1;XP_020953898.1;XP_020953897.1;XP_020953896.1;XP_020953895.1;XP_020953894.1;XP_020953893.1;XP_020953892.1;XP_020953891.1;XP_020953890.1;XP_020953889.1;NP_001230622.1	XP_020953924.1;XP_020953923.1;XP_020953922.1;XP_020953921.1;XP_020953920.1;XP_020953919.1;XP_020953918.1;XP_020953917.1;XP_020953916.1;XP_020953915.1;XP_020953914.1;XP_020953913.1;XP_020953912.1;XP_020953911.1;XP_020953910.1;XP_020953909.1;XP_020953908.1;XP_020953907.1;NP_001230623.1;XP_020953906.1;XP_020953905.1;XP_020953904.1;XP_020953902.1;XP_020953901.1;XP_020953900.1;XP_020953899.1;XP_020953898.1;XP_020953897.1;XP_020953896.1;XP_020953895.1;XP_020953894.1;XP_020953893.1;XP_020953892.1;XP_020953891.1;XP_020953890.1;XP_020953889.1;NP_001230622.1	XP_020953924.1 heterogeneous nuclear ribonucleoproteins C1/C2 isoform X4 [Sus scrofa];XP_020953923.1 heterogeneous nuclear ribonucleoproteins C1/C2 isoform X4 [Sus scrofa];XP_020953922.1 heterogeneous nuclear ribonucleoproteins C1/C2 isoform X4 [Sus scrofa	8	8	8	83942000	72913000	72996000	62833000	77217000	85194000	71137000	67169000	61475000	60143000	93084000	59921000	114600000	89304000	69909000	75120000	84952000	83749000	NA	NA	NA	HNRNPC	HNRNPC;HNRNPC;HNRNPC;HNRNPC;HNRNPC	osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;3'-UTR-mediated mRNA stabilization;mRNA splicing, via spliceosome;ATP-dependent chromatin remodeling	GO:000164; GO:000838; GO:001607; GO:003221; GO:007093; GO:000039; GO:004304	spliceosomal complex;nuclear chromatin;extracellular region;cytosol;nucleoplasm;actin cytoskeleton;telomerase holoenzyme complex;macromolecular complex;membrane;nucleus;extracellular exosome;catalytic step 2 spliceosome	GO:000568; GO:000079; GO:000557; GO:000582; GO:000565; GO:001562; GO:000569; GO:003299; GO:001602; GO:000563; GO:007006; GO:007101	 Spliceosome	hsa0304	RNA polymerase II distal enhancer sequence-specific DNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;telomerase RNA binding;mRNA 3'-UTR binding;poly(U) RNA binding;protein binding;RNA binding;identical protein binding;nucleosomal DNA binding;N6-methyladenosine-containing RNA binding	GO:000098; GO:000097; GO:007003; GO:000373; GO:000826; GO:000551; GO:000372; GO:004280; GO:003149; GO:199024
NP_001230624.1	NP_001230624.1	NP_001230624.1 transmembrane emp24 domain-containing protein 5 precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6808000	NA	NA	NA	TMED5	TMED5;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;Golgi ribbon formation;Golgi organization;intracellular protein transport	GO:000688; GO:009016; GO:000703; GO:000688	endoplasmic reticulum membrane;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle;cis-Golgi network;endoplasmic reticulum exit site;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment membrane	GO:000578; GO:001602; GO:000579; GO:003013; GO:000580; GO:007097; GO:000578; GO:003311	"NA"	"NA"	protein binding	GO:000551
NP_001230627.1	NP_001230627.1	NP_001230627.1 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase [Sus scrofa]	8	8	8	65874000	97103000	110180000	110270000	94339000	104560000	105470000	113560000	63802000	72703000	136090000	141280000	82266000	109800000	109510000	125200000	102220000	107270000	NA	NA	NA	ADI1	ADI1;NA;NA;NA;NA	methionine metabolic process;oxidation-reduction process;L-methionine salvage from methylthioadenosine	GO:000655; GO:005511; GO:001950	cytosol;cytoplasm;plasma membrane;nucleus	GO:000582; GO:000573; GO:000588; GO:000563	 Cysteine and methionine metabolism; Metabolic pathways	hsa0027; hsa0110	iron ion binding;oxidoreductase activity;acireductone dioxygenase [iron(II)-requiring;protein binding	GO:000550; GO:001649; GO:001030; GO:000551
XP_020937850.1;XP_020937849.1;XP_020937848.1;XP_020937847.1;XP_020937846.1;XP_020937845.1;XP_020937843.1;XP_020937842.1;XP_020937841.1;XP_020937840.1;XP_020937839.1;XP_020937838.1;XP_020937837.1;XP_020937836.1;XP_020937835.1;XP_020937834.1;XP_020937832.1;XP_020937831.1;NP_001230628.1	XP_020937850.1;XP_020937849.1;XP_020937848.1;XP_020937847.1;XP_020937846.1;XP_020937845.1;XP_020937843.1;XP_020937842.1;XP_020937841.1;XP_020937840.1;XP_020937839.1;XP_020937838.1;XP_020937837.1;XP_020937836.1;XP_020937835.1;XP_020937834.1;XP_020937832.1;XP_020937831.1;NP_001230628.1	XP_020937850.1 small nuclear ribonucleoprotein-associated protein N isoform X1 [Sus scrofa];XP_020937849.1 small nuclear ribonucleoprotein-associated protein N isoform X1 [Sus scrofa];XP_020937848.1 small nuclear ribonucleoprotein-associated protein N isof	2	2	2	0	11744000	12173000	0	11764000	12387000	7041200	10313000	0	10378000	0	20775000	0	9546400	9362900	13653000	12517000	0	NA	NA	NA	SNRPN	SNRPN;SNRPN;SNRPN;SNRPN;SNRPN	mRNA splicing, via spliceosome;response to hormone;RNA splicing	GO:000039; GO:000972; GO:000838	nucleoplasm;U5 snRNP;cytoplasm;U4/U6 x U5 tri-snRNP complex;small nuclear ribonucleoprotein complex;U2-type prespliceosome;catalytic step 2 spliceosome	GO:000565; GO:000568; GO:000573; GO:004654; GO:003053; GO:007100; GO:007101	"NA"	"NA"	protein binding;RNA binding	GO:000551; GO:000372
NP_001230634.1;XP_005663884.2;XP_020946624.1	NP_001230634.1;XP_005663884.2;XP_020946624.1	NP_001230634.1 thioredoxin, mitochondrial [Sus scrofa];XP_005663884.2 thioredoxin, mitochondrial isoform X1 [Sus scrofa];XP_020946624.1 thioredoxin, mitochondrial isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	12379000	0	7453800	0	12129000	0	8154000	0	0	0	9741500	0	0	0	NA	NA	NA	TXN2	TXN2;TXN2;TXN2;NA;NA	response to hypoxia;response to oxidative stress;glycerol ether metabolic process;response to hormone;response to glucose;cellular response to nutrient levels;response to axon injury;sulfur amino acid catabolic process;cell redox homeostasis;oxidation-reduction process;response to drug;response to organic cyclic compound	GO:000166; GO:000697; GO:000666; GO:000972; GO:000974; GO:003166; GO:004867; GO:000009; GO:004545; GO:005511; GO:004249; GO:001407	mitochondrial matrix;nucleolus;dendrite;neuronal cell body	GO:000575; GO:000573; GO:003042; GO:004302	"NA"	"NA"	protein binding;peptide-methionine (R)-S-oxide reductase activity;macromolecular complex binding;protein disulfide oxidoreductase activity;peptide-methionine (S)-S-oxide reductase activity	GO:000551; GO:003374; GO:004487; GO:001503; GO:000811
XP_020918145.1;XP_020918104.1;XP_005659874.1;NP_001230636.1	XP_020918145.1;XP_020918104.1;XP_005659874.1;NP_001230636.1	XP_020918145.1 cytosolic non-specific dipeptidase isoform X1 [Sus scrofa];XP_020918104.1 cytosolic non-specific dipeptidase isoform X1 [Sus scrofa];XP_005659874.1 cytosolic non-specific dipeptidase isoform X1 [Sus scrofa];NP_001230636.1 cytosolic non-speci	14	14	14	81813000	119560000	88900000	115040000	104560000	130790000	117920000	115770000	111100000	101650000	116620000	146160000	130280000	131240000	126970000	121310000	103510000	114700000	NA	NA	NA	CNDP2	CNDP2;CNDP2;CNDP2;CNDP2;NA	glutathione biosynthetic process;proteolysis	GO:000675; GO:000650	extracellular exosome;nucleoplasm;cytosol	GO:007006; GO:000565; GO:000582	 Histidine metabolism; Arginine and proline metabolism; beta-Alanine metabolism; Metabolic pathways	hsa0034; hsa0033; hsa0041; hsa0110	cytosolic dipeptidase activity;metal ion binding;alanylglutamate dipeptidase activity;metallopeptidase activity;carboxypeptidase activity	GO:010200; GO:004687; GO:010304; GO:000823; GO:000418
XP_020930257.1;XP_020930256.1;NP_001230722.1;XP_020930255.1;XP_020930254.1;XP_020930259.1	XP_020930257.1;XP_020930256.1;NP_001230722.1;XP_020930255.1;XP_020930254.1	XP_020930257.1 septin-2 isoform X2 [Sus scrofa];XP_020930256.1 septin-2 isoform X2 [Sus scrofa];NP_001230722.1 septin-2 [Sus scrofa];XP_020930255.1 septin-2 isoform X1 [Sus scrofa];XP_020930254.1 septin-2 isoform X1 [Sus scrofa]	14	14	14	119620000	168240000	197060000	128500000	122320000	162780000	153910000	149860000	132760000	140420000	150450000	207500000	281150000	161930000	139770000	144200000	161060000	183530000	NA	NA	NA	Sep 02	Sep 02;Sep 02;Sep 02;Sep 02;Sep 02	spermatogenesis;cilium assembly;smoothened signaling pathway;neuron projection development;cytoskeleton-dependent cytokinesis	GO:000728; GO:006027; GO:000722; GO:003117; GO:006164	septin complex;perinuclear region of cytoplasm;exocyst;cleavage furrow;cell cortex;microtubule cytoskeleton;nucleus;spindle;ciliary membrane;sperm annulus;photoreceptor connecting cilium;cytoplasm;condensed chromosome kinetochore;septin ring;midbody;non-motile cilium;extracellular exosome	GO:003110; GO:004847; GO:000014; GO:003215; GO:000593; GO:001563; GO:000563; GO:000581; GO:006017; GO:009722; GO:003239; GO:000573; GO:000077; GO:000594; GO:003049; GO:009773; GO:007006	 Bacterial invasion of epithelial cells	hsa0510	protein binding;protein complex scaffold;GTP binding;GTPase activity;cadherin binding	GO:000551; GO:003294; GO:000552; GO:000392; GO:004529
NP_001230725.1	NP_001230725.1	NP_001230725.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [Sus scrofa]	8	8	8	92198000	50366000	60768000	39981000	77033000	36932000	87256000	53850000	66624000	52128000	66966000	53441000	45736000	45967000	68252000	58351000	52804000	41304000	NA	NA	NA	NDUFS3	NDUFS3;NA;NA;NA;NA	reactive oxygen species metabolic process;mitochondrial electron transport, NADH to ubiquinone;substantia nigra development;negative regulation of cell growth;mitochondrial respiratory chain complex I assembly;negative regulation of intrinsic apoptotic signaling pathway	GO:007259; GO:000612; GO:002176; GO:003030; GO:003298; GO:200124	mitochondrial matrix;nuclear body;mitochondrial respiratory chain complex I;mitochondrion;mitochondrial membrane	GO:000575; GO:001660; GO:000574; GO:000573; GO:003196	 Huntington's disease; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Oxidative phosphorylation	hsa0501; hsa0501; hsa0493; hsa0110; hsa0019	protein binding;NADH dehydrogenase (ubiquinone) activity;electron carrier activity;NADH dehydrogenase activity	GO:000551; GO:000813; GO:000905; GO:000395
NP_001230730.1	NP_001230730.1	NP_001230730.1 ribose-phosphate pyrophosphokinase 2 [Sus scrofa]	7	3	3	0	17735000	9540400	0	12854000	15869000	19168000	12820000	12141000	14762000	16353000	0	15947000	13566000	14379000	17230000	17434000	13661000	NA	NA	NA	PRPS2	PRPS2;NA;NA;NA;NA	phosphorylation;animal organ regeneration;purine nucleotide biosynthetic process;nucleotide biosynthetic process;nucleoside metabolic process;5-phosphoribose 1-diphosphate biosynthetic process;nucleobase-containing compound metabolic process	GO:001631; GO:003110; GO:000616; GO:000916; GO:000911; GO:000601; GO:000613	ribose phosphate diphosphokinase complex;cytoplasm	GO:000218; GO:000573	 Biosynthesis of amino acids; Metabolic pathways; Carbon metabolism; Pentose phosphate pathway; Purine metabolism; Biosynthesis of antibiotics	hsa0123; hsa0110; hsa0120; hsa0003; hsa0023; hsa0113	GDP binding;ribose phosphate diphosphokinase activity;carbohydrate binding;ATP binding;protein homodimerization activity;magnesium ion binding;AMP binding;protein binding;kinase activity;ADP binding	GO:001900; GO:000474; GO:003024; GO:000552; GO:004280; GO:000028; GO:001620; GO:000551; GO:001630; GO:004353
NP_001230731.1	NP_001230731.1	NP_001230731.1 ras-related protein Rab-8A [Sus scrofa]	5	4	3	0	31050000	33161000	40317000	28374000	29517000	23851000	28849000	31714000	27251000	33327000	57725000	25334000	38890000	33340000	48126000	30685000	28365000	NA	NA	NA	RAB8A	RAB8A;NA;NA;NA;NA	cilium assembly;regulation of exocytosis;Rab protein signal transduction;neurotransmitter receptor transport to postsynaptic membrane;intracellular protein transport;regulation of autophagy;post-translational protein modification;autophagy;Golgi vesicle fusion to target membrane;vesicle docking involved in exocytosis;protein secretion;cellular response to insulin stimulus;regulation of protein transport;protein localization to plasma membrane;neurotransmitter receptor transport, endosome to postsynaptic membrane;regulation of long-term neuronal synaptic plasticity;axonogenesis;vesicle-mediated transport in synapse	GO:006027; GO:001715; GO:003248; GO:009896; GO:000688; GO:001050; GO:004368; GO:000691; GO:004821; GO:000690; GO:000930; GO:003286; GO:005122; GO:007265; GO:009888; GO:004816; GO:000740; GO:009900	phagocytic vesicle membrane;extracellular exosome;non-motile cilium;cytosol;recycling endosome membrane;plasma membrane;endosome;phagocytic vesicle;centrosome;cilium;synaptic vesicle;postsynaptic density;trans-Golgi network transport vesicle;midbody;trans-Golgi network membrane;ciliary basal body;ciliary base;neuronal cell body;Golgi membrane;dendritic spine;glutamatergic synapse	GO:003067; GO:007006; GO:009773; GO:000582; GO:005503; GO:000588; GO:000576; GO:004533; GO:000581; GO:000592; GO:000802; GO:001406; GO:003014; GO:003049; GO:003258; GO:003606; GO:009754; GO:004302; GO:000013; GO:004319; GO:009897	 Pancreatic secretion; AMPK signaling pathway; Endocytosis	hsa0497; hsa0415; hsa0414	protein kinase binding;GTP binding;myosin V binding;protein binding;GTPase activity;Rab GTPase binding;GDP binding	GO:001990; GO:000552; GO:003148; GO:000551; GO:000392; GO:001713; GO:001900
NP_001230732.1	NP_001230732.1	NP_001230732.1 nuclear migration protein nudC [Sus scrofa]	4	4	4	0	0	29654000	0	23386000	0	0	0	0	0	25308000	0	0	0	33405000	0	34144000	0	NA	NA	NA	NUDC	NUDC;NA;NA;NA;NA	cell proliferation;cell cycle;multicellular organism development;developmental process;cell division;protein folding	GO:000828; GO:000704; GO:000727; GO:003250; GO:005130; GO:000645	cytoplasm;nucleoplasm;microtubule;cytosol	GO:000573; GO:000565; GO:000587; GO:000582	"NA"	"NA"	unfolded protein binding;protein binding;cadherin binding	GO:005108; GO:000551; GO:004529
NP_001230736.1	NP_001230736.1	NP_001230736.1 peptidyl-prolyl cis-trans isomerase FKBP10 precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16200000	0	0	NA	NA	NA	FKBP10	FKBP10;NA;NA;NA;NA	protein peptidyl-prolyl isomerization	GO:000041	endoplasmic reticulum lumen	GO:000578	"NA"	"NA"	calcium ion binding;FK506 binding;peptidyl-prolyl cis-trans isomerase activity	GO:000550; GO:000552; GO:000375
NP_001230739.1	NP_001230739.1	NP_001230739.1 chitinase domain-containing protein 1 precursor [Sus scrofa]	3	3	3	0	0	0	0	10803000	0	10981000	0	0	0	0	0	0	0	15900000	0	14231000	0	NA	NA	NA	CHID1	CHID1;NA;NA;NA;NA	negative regulation of cytokine production involved in inflammatory response;carbohydrate metabolic process;platelet degranulation;innate immune response	GO:190001; GO:000597; GO:000257; GO:004508	lysosome;extracellular region;late endosome;trans-Golgi network;membrane;extracellular exosome;lysosomal lumen;nucleus;extracellular space	GO:000576; GO:000557; GO:000577; GO:000580; GO:001602; GO:007006; GO:004320; GO:000563; GO:000561	"NA"	"NA"	protein binding;oligosaccharide binding;chitin binding	GO:000551; GO:007049; GO:000806
NP_001230751.1	NP_001230751.1	NP_001230751.1 aflatoxin B1 aldehyde reductase member 2 [Sus scrofa]	4	4	4	31703000	24295000	27276000	27301000	24818000	22019000	26338000	32957000	33685000	30604000	27683000	33555000	33340000	25394000	20475000	31288000	23977000	23417000	NA	NA	NA	AKR7A2	AKR7A2;NA;NA;NA;NA	carbohydrate metabolic process;electron transport chain;xenobiotic metabolic process;daunorubicin metabolic process;cellular aldehyde metabolic process	GO:000597; GO:002290; GO:000680; GO:004459; GO:000608	cytosol;Golgi apparatus;extracellular exosome	GO:000582; GO:000579; GO:007006	 Metabolism of xenobiotics by cytochrome P450	hsa0098	phenanthrene-9,10-epoxide hydrolase activity;aldo-keto reductase (NADP) activity;protein binding;electron carrier activity	GO:001911; GO:000403; GO:000551; GO:000905
NP_001230754.1	NP_001230754.1	NP_001230754.1 protein transport protein Sec61 subunit beta [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39513000	NA	NA	NA	SEC61B	SEC61B;NA;NA;NA;NA	retrograde protein transport, ER to cytosol;posttranslational protein targeting to membrane, translocation;SRP-dependent cotranslational protein targeting to membrane, translocation;ubiquitin-dependent ERAD pathway	GO:003097; GO:003120; GO:000661; GO:003043	endoplasmic reticulum Sec complex;membrane;cytosol;Sec61 translocon complex	GO:003120; GO:001602; GO:000582; GO:000578	 Vibrio cholerae infection; Protein processing in endoplasmic reticulum; Protein export	hsa0511; hsa0414; hsa0306	epidermal growth factor binding;protein binding;ARF guanyl-nucleotide exchange factor activity;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;RNA binding	GO:004840; GO:000551; GO:000508; GO:001545; GO:000372
NP_001230759.1;XP_020955987.1;XP_013853939.1;XP_013853934.1	NP_001230759.1;XP_020955987.1;XP_013853939.1;XP_013853934.1	NP_001230759.1 enolase-phosphatase E1 [Sus scrofa];XP_020955987.1 enolase-phosphatase E1 isoform X1 [Sus scrofa];XP_013853939.1 enolase-phosphatase E1 isoform X1 [Sus scrofa];XP_013853934.1 enolase-phosphatase E1 isoform X1 [Sus scrofa]	3	3	3	0	10950000	7598400	6155600	0	5724400	0	11499000	0	10035000	5234000	0	0	6775800	7963300	9999900	0	3600300	NA	NA	NA	ENOPH1	ENOPH1;ENOPH1;ENOPH1;ENOPH1;NA	L-methionine salvage from methylthioadenosine;L-methionine salvage from S-adenosylmethionine;dephosphorylation	GO:001950; GO:001928; GO:001631	nucleus;cytosol	GO:000563; GO:000582	 Metabolic pathways; Cysteine and methionine metabolism	hsa0110; hsa0027	magnesium ion binding;acireductone synthase activity;2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity	GO:000028; GO:004387; GO:004371
NP_001230773.1	NP_001230773.1	NP_001230773.1 oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4909700	0	0	NA	NA	NA	CPOX	CPOX;NA;NA;NA;NA	heme biosynthetic process;protoporphyrinogen IX biosynthetic process from glutamate;oxidation-reduction process	GO:000678; GO:001935; GO:005511	mitochondrial intermembrane space;cytoplasm;cytosol	GO:000575; GO:000573; GO:000582	 Metabolic pathways; Porphyrin and chlorophyll metabolism	hsa0110; hsa0086	protein homodimerization activity;coproporphyrinogen oxidase activity	GO:004280; GO:000410
XP_020941305.1;NP_001230787.1;XP_005662379.1;XP_020941304.1;XP_020941303.1;XP_005662378.1;XP_005662377.1;XP_005662376.1;XP_020941301.1;XP_005662374.1	XP_020941305.1;NP_001230787.1;XP_005662379.1;XP_020941304.1;XP_020941303.1;XP_005662378.1;XP_005662377.1;XP_005662376.1;XP_020941301.1;XP_005662374.1	XP_020941305.1 LIM and senescent cell antigen-like-containing domain protein 1 isoform X8 [Sus scrofa];NP_001230787.1 LIM and senescent cell antigen-like-containing domain protein 1 [Sus scrofa];XP_005662379.1 LIM and senescent cell antigen-like-containing	9	9	6	215040000	267550000	307750000	325150000	205660000	291230000	226670000	274690000	247630000	344850000	214720000	356800000	121160000	323080000	210910000	403110000	253920000	325020000	NA	NA	NA	LIMS1	LIMS1;LIMS1;LIMS1;LIMS1;LIMS1	epithelial to mesenchymal transition;regulation of epithelial cell proliferation;cellular response to transforming growth factor beta stimulus;positive regulation of cell-substrate adhesion;establishment of protein localization;protein heterooligomerization;positive regulation of substrate adhesion-dependent cell spreading;tumor necrosis factor-mediated signaling pathway;positive regulation of GTPase activity;positive regulation of focal adhesion assembly;positive regulation of gene expression;cell junction assembly;cell aging;negative regulation of transcription, DNA-templated;positive regulation of NIK/NF-kappaB signaling	GO:000183; GO:005067; GO:007156; GO:001081; GO:004518; GO:005129; GO:190002; GO:003320; GO:004354; GO:005189; GO:001062; GO:003432; GO:000756; GO:004589; GO:190122	plasma membrane;cell-cell junction;perinuclear region of cytoplasm;focal adhesion;cytosol;macromolecular complex	GO:000588; GO:000591; GO:004847; GO:000592; GO:000582; GO:003299	"NA"	"NA"	protein binding;zinc ion binding;protein kinase binding	GO:000551; GO:000827; GO:001990
XP_020933670.1;XP_013845156.1;XP_013845153.1;XP_013845149.1;XP_013845146.1;XP_013845140.1;XP_005652818.1;NP_001230794.1	XP_020933670.1;XP_013845156.1;XP_013845153.1;XP_013845149.1;XP_013845146.1;XP_013845140.1;XP_005652818.1;NP_001230794.1	XP_020933670.1 CD151 antigen isoform X1 [Sus scrofa];XP_013845156.1 CD151 antigen isoform X1 [Sus scrofa];XP_013845153.1 CD151 antigen isoform X1 [Sus scrofa];XP_013845149.1 CD151 antigen isoform X1 [Sus scrofa];XP_013845146.1 CD151 antigen isoform X1 [Sus	2	2	2	0	0	0	0	0	0	0	0	0	0	0	55643000	0	0	0	0	0	0	NA	NA	NA	CD151	CD151;CD151;CD151;CD151;CD151	wound healing, spreading of cells;T cell proliferation;positive regulation of endocytosis;cell adhesion;positive regulation of cell migration;cell surface receptor signaling pathway;hemidesmosome assembly	GO:004431; GO:004209; GO:004580; GO:000715; GO:003033; GO:000716; GO:003158	membrane;basement membrane;integral component of plasma membrane;cytosol;focal adhesion;cell surface	GO:001602; GO:000560; GO:000588; GO:000582; GO:000592; GO:000998	"NA"	"NA"	integrin binding;protein binding	GO:000517; GO:000551
NP_001230795.1;XP_020947477.1;XP_020947476.1;XP_020947475.1;XP_020947474.1;XP_020947472.1;XP_020947471.1;XP_020947470.1;XP_020947469.1;XP_020947468.1;XP_005663952.1;XP_003355507.1;XP_020947465.1;XP_020947473.1;XP_020947467.1;XP_003355526.4	NP_001230795.1;XP_020947477.1;XP_020947476.1;XP_020947475.1;XP_020947474.1;XP_020947472.1;XP_020947471.1;XP_020947470.1;XP_020947469.1;XP_020947468.1	NP_001230795.1 retinol dehydrogenase 16 (all-trans) precursor [Sus scrofa];XP_020947477.1 retinol dehydrogenase 16 isoform X1 [Sus scrofa];XP_020947476.1 retinol dehydrogenase 16 isoform X1 [Sus scrofa];XP_020947475.1 retinol dehydrogenase 16 isoform X1 [S	11	11	11	0	0	121050000	170680000	0	0	225820000	258870000	210840000	194460000	0	0	0	20394000	73368000	75800000	0	0	NA	NA	NA	LOC100512656	LOC100512656;LOC100512656;LOC100512656;LOC100512656;LOC100626199	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005664751.1;NP_001230796.1;XP_020948957.1;XP_005664752.1	XP_005664751.1;NP_001230796.1;XP_020948957.1;XP_005664752.1	XP_005664751.1 ruvB-like 2 isoform X1 [Sus scrofa];NP_001230796.1 ruvB-like 2 [Sus scrofa];XP_020948957.1 ruvB-like 2 isoform X2 [Sus scrofa];XP_005664752.1 ruvB-like 2 isoform X2 [Sus scrofa]	12	12	12	44562000	52655000	53672000	56085000	41263000	68821000	52485000	49747000	43757000	47217000	54513000	57542000	66609000	58820000	43775000	44801000	54392000	59429000	NA	NA	NA	RUVBL2	RUVBL2;RUVBL2;RUVBL2;RUVBL2;NA	positive regulation of histone acetylation;chromatin remodeling;DNA duplex unwinding;cellular response to estradiol stimulus;box C/D snoRNP assembly;regulation of growth;positive regulation of transcription from RNA polymerase II promoter;protein folding;DNA repair;cellular response to UV;histone acetylation;histone H4 acetylation;negative regulation of nucleic acid-templated transcription;positive regulation of telomerase RNA localization to Cajal body;establishment of protein localization to chromatin;transcriptional activation by promoter-enhancer looping;negative regulation of canonical Wnt signaling pathway;DNA recombination;regulation of transcription from RNA polymerase II promoter;negative regulation of estrogen receptor binding	GO:003506; GO:000633; GO:003250; GO:007139; GO:000049; GO:004000; GO:004594; GO:000645; GO:000628; GO:003464; GO:001657; GO:004396; GO:190350; GO:190487; GO:007116; GO:007173; GO:009009; GO:000631; GO:000635; GO:007189	nuclear euchromatin;centrosome;MLL1 complex;R2TP complex;Swr1 complex;nucleus;extracellular exosome;membrane;cytosol;nuclear matrix;Ino80 complex;cytoplasm;nucleoplasm;ribonucleoprotein complex;NuA4 histone acetyltransferase complex	GO:000571; GO:000581; GO:007133; GO:009725; GO:000081; GO:000563; GO:007006; GO:001602; GO:000582; GO:001636; GO:003101; GO:000573; GO:000565; GO:199090; GO:003526	"NA"	"NA"	protein binding;ATP binding;protein homodimerization activity;TFIID-class transcription factor binding;transcription corepressor activity;TBP-class protein binding;RNA polymerase II distal enhancer sequence-specific DNA binding;chromatin DNA binding;ATP-dependent 5'-3' DNA helicase activity;ADP binding;ATPase binding;ATPase activity;unfolded protein binding;DNA helicase activity;beta-catenin binding;RNA polymerase II core promoter sequence-specific DNA binding;ATP-dependent DNA helicase activity	GO:000551; GO:000552; GO:004280; GO:000109; GO:000371; GO:001702; GO:000098; GO:003149; GO:004314; GO:004353; GO:005111; GO:001688; GO:005108; GO:000367; GO:000801; GO:000097; GO:000400
NP_001230809.1	NP_001230809.1	NP_001230809.1 PRA1 family protein 2 [Sus scrofa]	4	4	4	0	32634000	46373000	29274000	30653000	45197000	0	33732000	0	42531000	0	40790000	0	47538000	0	34093000	42056000	37927000	NA	NA	NA	PRAF2	PRAF2;NA;NA;NA;NA	L-glutamate transport;protein transport	GO:001581; GO:001503	integral component of membrane;endosome membrane	GO:001602; GO:001000	"NA"	"NA"	"NA"	"NA"
NP_001230825.1	NP_001230825.1	NP_001230825.1 glutaredoxin-3 [Sus scrofa]	10	10	10	82503000	57736000	69404000	73588000	79903000	55507000	69284000	78543000	95030000	84336000	54689000	64235000	63638000	62211000	93982000	57864000	64343000	61649000	NA	NA	NA	GLRX3	GLRX3;NA;NA;NA;NA	cellular iron ion homeostasis;protein maturation by iron-sulfur cluster transfer;regulation of the force of heart contraction;cell redox homeostasis;negative regulation of cardiac muscle hypertrophy;[2Fe-2S;electron transport chain	GO:000687; GO:009742; GO:000202; GO:004545; GO:001061; GO:004457; GO:002290	cytosol;nucleus;dendrite;Z disc;cell cortex	GO:000582; GO:000563; GO:003042; GO:003001; GO:000593	"NA"	"NA"	electron carrier activity;metal ion binding;RNA binding;iron-sulfur cluster binding;protein binding;identical protein binding;protein disulfide oxidoreductase activity;protein kinase C binding	GO:000905; GO:004687; GO:000372; GO:005153; GO:000551; GO:004280; GO:001503; GO:000508
NP_001230827.1	NP_001230827.1	NP_001230827.1 WD40 repeat-containing protein SMU1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3825100	NA	NA	NA	SMU1	SMU1;NA;NA;NA;NA	mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;RNA splicing	GO:000039; GO:000038; GO:000838	cytoplasm;nuclear speck;nucleus;U2-type precatalytic spliceosome	GO:000573; GO:001660; GO:000563; GO:007100	"NA"	"NA"	protein binding	GO:000551
XP_013837953.1;XP_005654258.1;NP_001230831.1	XP_013837953.1;XP_005654258.1;NP_001230831.1	XP_013837953.1 protein phosphatase 1 regulatory subunit 7 isoform X2 [Sus scrofa];XP_005654258.1 protein phosphatase 1 regulatory subunit 7 isoform X1 [Sus scrofa];NP_001230831.1 protein phosphatase 1 regulatory subunit 7 [Sus scrofa]	9	9	9	40537000	48397000	41577000	34371000	42155000	45371000	46431000	43082000	38955000	42381000	46428000	52630000	48942000	42928000	35643000	39302000	39261000	38177000	NA	NA	NA	PPP1R7	PPP1R7;PPP1R7;PPP1R7;NA;NA	positive regulation of protein dephosphorylation;regulation of phosphoprotein phosphatase activity	GO:003530; GO:004366	chromosome;extracellular exosome;cytoplasm;nucleus	GO:000569; GO:007006; GO:000573; GO:000563	"NA"	"NA"	protein phosphatase regulator activity;enzyme regulator activity;protein binding	GO:001988; GO:003023; GO:000551
NP_001230836.1	NP_001230836.1	NP_001230836.1 heat shock cognate 71 kDa protein [Sus scrofa]	28	26	20	1514700000	1501100000	1582700000	1298500000	1361500000	1295600000	1384600000	1322700000	1256000000	1309900000	1470900000	1432500000	1519400000	1432100000	1331000000	1311600000	1371600000	1432500000	NA	NA	NA	HSPA8	HSPA8;NA;NA;NA;NA	slow axonal transport;axo-dendritic transport;regulation of cellular response to heat;vesicle-mediated transport;regulation of protein stability;membrane organization;regulation of protein complex stability;chaperone-mediated protein transport involved in chaperone-mediated autophagy;clathrin coat disassembly;mRNA splicing, via spliceosome;cytokine-mediated signaling pathway;late endosomal microautophagy;negative regulation of supramolecular fiber organization;protein folding;cellular response to heat;cellular response to unfolded protein;regulation of mRNA stability;chaperone-mediated autophagy translocation complex disassembly;response to unfolded protein;cellular response to starvation;viral process;negative regulation of transcription, DNA-templated;regulation of protein complex assembly;protein refolding;chaperone mediated protein folding requiring cofactor;regulation of protein import;neutrophil degranulation;ATP metabolic process;chaperone-mediated autophagy	GO:199083; GO:000808; GO:190003; GO:001619; GO:003164; GO:006102; GO:006163; GO:006174; GO:007231; GO:000039; GO:001922; GO:006173; GO:190290; GO:000645; GO:003460; GO:003462; GO:004348; GO:190476; GO:000698; GO:000926; GO:001603; GO:004589; GO:004325; GO:004202; GO:005108; GO:190458; GO:004331; GO:004603; GO:006168	ubiquitin ligase complex;Prp19 complex;nucleus;cytoplasm;autophagosome;extracellular space;axon;melanosome;terminal bouton;cytosol;spliceosomal complex;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;extracellular exosome;lysosomal membrane;secretory granule lumen;ribonucleoprotein complex;plasma membrane;presynaptic cytosol;lumenal side of lysosomal membrane;membrane;chaperone complex;ficolin-1-rich granule lumen;extracellular region;nucleoplasm;focal adhesion;lysosomal lumen;blood microparticle	GO:000015; GO:000097; GO:000563; GO:000573; GO:000577; GO:000561; GO:003042; GO:004247; GO:004319; GO:000582; GO:000568; GO:006120; GO:007006; GO:000576; GO:003477; GO:199090; GO:000588; GO:009952; GO:009857; GO:001602; GO:010103; GO:190481; GO:000557; GO:000565; GO:000592; GO:004320; GO:007256	 Influenza A; Measles; Spliceosome; MAPK signaling pathway; Legionellosis; Endocytosis; Antigen processing and presentation; Estrogen signaling pathway; Toxoplasmosis	hsa0516; hsa0516; hsa0304; hsa0401; hsa0513; hsa0414; hsa0461; hsa0491; hsa0514	unfolded protein binding;protein binding;cadherin binding;C3HC4-type RING finger domain binding;G-protein coupled receptor binding;misfolded protein binding;enzyme binding;MHC class II protein complex binding;ATPase activity, coupled;RNA binding;chaperone binding;ATPase activity;clathrin-uncoating ATPase activity;protein binding, bridging;ubiquitin protein ligase binding;heat shock protein binding;protein binding involved in protein folding;ATP binding	GO:005108; GO:000551; GO:004529; GO:005513; GO:000166; GO:005178; GO:001989; GO:002302; GO:004262; GO:000372; GO:005108; GO:001688; GO:199083; GO:003067; GO:003162; GO:003107; GO:004418; GO:000552
NP_001230846.1;XP_005661254.2;XP_013850077.1;XP_013842893.2;XP_020939449.1	NP_001230846.1;XP_005661254.2;XP_013850077.1	NP_001230846.1 AP-1 complex subunit mu-1 [Sus scrofa];XP_005661254.2 AP-1 complex subunit mu-1 isoform X1 [Sus scrofa];XP_013850077.1 AP-1 complex subunit mu-1 isoform X2 [Sus scrofa]	3	3	3	0	12811000	14719000	0	0	0	0	11386000	0	0	0	0	0	0	0	0	15133000	0	NA	NA	NA	AP1M1	AP1M1;AP1M1;AP1M1;NA;NA	intracellular protein transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;melanosome organization;regulation of defense response to virus by virus;endosome to melanosome transport;neutrophil degranulation	GO:000688; GO:001988; GO:003243; GO:005069; GO:003564; GO:004331	cytosol;clathrin adaptor complex;cytoplasmic vesicle membrane;clathrin-coated vesicle membrane;plasma membrane;lysosomal membrane;trans-Golgi network membrane;Golgi membrane;membrane;specific granule membrane;extracellular exosome	GO:000582; GO:003013; GO:003065; GO:003066; GO:000588; GO:000576; GO:003258; GO:000013; GO:001602; GO:003557; GO:007006	 Lysosome	hsa0414	protein binding	GO:000551
XP_005668066.2;NP_001230847.1	XP_005668066.2;NP_001230847.1	XP_005668066.2 cytochrome b5 reductase 1 isoform X1 [Sus scrofa];NP_001230847.1 cytochrome b5 reductase 1 [Sus scrofa]	3	3	3	0	0	12613000	0	0	0	0	0	0	0	0	0	0	15112000	0	0	0	13338000	NA	NA	NA	CYB5R1	CYB5R1;CYB5R1;NA;NA;NA	platelet degranulation;oxidation-reduction process;sterol biosynthetic process;bicarbonate transport	GO:000257; GO:005511; GO:001612; GO:001570	integral component of membrane;membrane;plasma membrane;endoplasmic reticulum membrane;mitochondrion;platelet alpha granule membrane;extracellular exosome	GO:001602; GO:001602; GO:000588; GO:000578; GO:000573; GO:003109; GO:007006	 Amino sugar and nucleotide sugar metabolism	hsa0052	cytochrome-b5 reductase activity, acting on NAD(P)H;protein binding;FAD binding	GO:000412; GO:000551; GO:007194
NP_001230849.1	NP_001230849.1	NP_001230849.1 carbonic anhydrase 4 precursor [Sus scrofa]	5	5	5	71478000	41839000	107630000	32547000	61789000	36036000	69265000	26834000	58168000	32610000	32241000	38645000	0	27539000	86561000	46993000	0	0	NA	NA	NA	CA4	CA4;NA;NA;NA;NA	bicarbonate transport	GO:001570	plasma membrane;transport vesicle membrane;basolateral plasma membrane;perinuclear region of cytoplasm;secretory granule membrane;endoplasmic reticulum-Golgi intermediate compartment;anchored component of external side of plasma membrane;trans-Golgi network;cell surface;brush border membrane;extracellular exosome;membrane	GO:000588; GO:003065; GO:001632; GO:004847; GO:003066; GO:000579; GO:003136; GO:000580; GO:000998; GO:003152; GO:007006; GO:001602	 Nitrogen metabolism; Proximal tubule bicarbonate reclamation	hsa0091; hsa0496	carbonate dehydratase activity;protein binding;zinc ion binding	GO:000408; GO:000551; GO:000827
XP_005657046.1;NP_001230857.1	XP_005657046.1;NP_001230857.1	XP_005657046.1 fructose-bisphosphate aldolase C isoform X1 [Sus scrofa];NP_001230857.1 fructose-bisphosphate aldolase C [Sus scrofa]	30	30	26	3815300000	3725200000	4166200000	2904200000	3651100000	2482900000	3923200000	3146600000	4288300000	3131500000	3740300000	3765200000	1702200000	2910500000	4088600000	3813600000	3502500000	3207000000	NA	NA	NA	ALDOC	ALDOC;ALDOC;NA;NA;NA	epithelial cell differentiation;canonical glycolysis;gluconeogenesis;neutrophil degranulation;fructose metabolic process;fructose 1,6-bisphosphate metabolic process	GO:003085; GO:006162; GO:000609; GO:004331; GO:000600; GO:003038	tertiary granule lumen;ficolin-1-rich granule lumen;extracellular region;cytoskeleton;extracellular exosome;cytosol;secretory granule lumen	GO:190472; GO:190481; GO:000557; GO:000585; GO:007006; GO:000582; GO:003477	 Pentose phosphate pathway; Biosynthesis of amino acids; Fructose and mannose metabolism; Carbon metabolism; Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis; Metabolic pathways	hsa0003; hsa0123; hsa0005; hsa0120; hsa0113; hsa0001; hsa0110	fructose-bisphosphate aldolase activity;protein binding;cytoskeletal protein binding	GO:000433; GO:000551; GO:000809
NP_001230868.1	NP_001230868.1	NP_001230868.1 alcohol dehydrogenase 1C (class I), gamma polypeptide [Sus scrofa]	5	3	3	0	0	0	0	0	0	0	0	0	0	0	0	26482000	79435000	0	0	0	0	NA	NA	NA	ADH1C	ADH1C;NA;NA;NA;NA	retinoic acid metabolic process;ethanol oxidation;retinol metabolic process	GO:004257; GO:000606; GO:004257	plasma membrane;cytosol;nucleoplasm	GO:000588; GO:000582; GO:000565	 Tyrosine metabolism; Retinol metabolism; Fatty acid degradation; Drug metabolism - cytochrome P450; Metabolic pathways; Glycolysis / Gluconeogenesis; Chemical carcinogenesis	hsa0035; hsa0083; hsa0007; hsa0098; hsa0110; hsa0001; hsa0520	zinc ion binding;retinol dehydrogenase activity;alcohol dehydrogenase (NAD) activity	GO:000827; GO:000474; GO:000402
NP_001230874.1	NP_001230874.1	NP_001230874.1 heat shock protein 75 kDa, mitochondrial [Sus scrofa]	3	3	3	0	0	0	0	12025000	0	9901000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TRAP1	TRAP1;NA;NA;NA;NA	translational attenuation;negative regulation of reactive oxygen species biosynthetic process;chaperone-mediated protein folding;negative regulation of cellular respiration;negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide	GO:000938; GO:190342; GO:006107; GO:190185; GO:190375	nucleoplasm;membrane;mitochondrion;mitochondrial intermembrane space;mitochondrial inner membrane	GO:000565; GO:001602; GO:000573; GO:000575; GO:000574	"NA"	"NA"	RNA binding;tumor necrosis factor receptor binding;ATP binding;protein kinase binding;protein binding;unfolded protein binding	GO:000372; GO:000516; GO:000552; GO:001990; GO:000551; GO:005108
NP_001230992.1	NP_001230992.1	NP_001230992.1 60S ribosomal protein L3 [Sus scrofa]	9	9	9	177730000	188200000	215810000	157050000	175080000	244420000	210840000	166400000	206420000	192650000	179770000	168220000	198380000	221020000	149420000	208300000	212300000	249590000	NA	NA	NA	RPL3	RPL3;NA;NA;NA;NA	cellular response to interleukin-4;ribosomal large subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:007135; GO:000002; GO:000018; GO:000641; GO:000661	focal adhesion;synapse;cytoplasm;nucleus;extracellular exosome;cytosol;macromolecular complex;cytosolic large ribosomal subunit	GO:000592; GO:004520; GO:000573; GO:000563; GO:007006; GO:000582; GO:003299; GO:002262	 Ribosome	hsa0301	protein binding;RNA binding;5S rRNA binding;structural constituent of ribosome	GO:000551; GO:000372; GO:000809; GO:000373
XP_020924121.1;NP_001230994.1	XP_020924121.1;NP_001230994.1	XP_020924121.1 60S ribosomal protein L15 isoform X1 [Sus scrofa];NP_001230994.1 60S ribosomal protein L15 [Sus scrofa]	7	7	7	121870000	81020000	161270000	65837000	92077000	133790000	103110000	74400000	125600000	100080000	82643000	69655000	93110000	94852000	0	103070000	136010000	133610000	NA	NA	NA	RPL15	RPL15;RPL15;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translational initiation;SRP-dependent cotranslational protein targeting to membrane;cytoplasmic translation	GO:000018; GO:000641; GO:000661; GO:000218	nucleus;ribosome;cytosol;membrane;cytosolic large ribosomal subunit	GO:000563; GO:000584; GO:000582; GO:001602; GO:002262	 Ribosome	hsa0301	cadherin binding;RNA binding;protein binding;structural constituent of ribosome	GO:004529; GO:000372; GO:000551; GO:000373
NP_001230997.1;NP_001230998.1;XP_020949278.1;XP_013854097.1;XP_013854095.1;XP_013854094.1;XP_020949276.1;XP_013854096.1;XP_005664780.1	NP_001230997.1;NP_001230998.1;XP_020949278.1;XP_013854097.1;XP_013854095.1;XP_013854094.1;XP_020949276.1;XP_013854096.1	NP_001230997.1 60S ribosomal protein L13a isoform 1 [Sus scrofa];NP_001230998.1 60S ribosomal protein L13a isoform 2 [Sus scrofa];XP_020949278.1 60S ribosomal protein L13a isoform X4 [Sus scrofa];XP_013854097.1 60S ribosomal protein L13a isoform X4 [Sus sc	3	3	3	103140000	52752000	91797000	0	71431000	87352000	77132000	53183000	100280000	91571000	0	52796000	73661000	87038000	0	90459000	105050000	99752000	NA	NA	NA	RPL13A	RPL13A;RPL13A;RPL13A;RPL13A;RPL13A	translational initiation;translation;negative regulation of translation;cellular response to interferon-gamma;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;negative regulation of formation of translation preinitiation complex;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000641; GO:001714; GO:007134; GO:000018; GO:190119; GO:000661	cytoplasm;focal adhesion;ribonucleoprotein complex;ribosome;membrane;cytosol;nucleolus;GAIT complex;nucleus;large ribosomal subunit;cytosolic large ribosomal subunit	GO:000573; GO:000592; GO:199090; GO:000584; GO:001602; GO:000582; GO:000573; GO:009745; GO:000563; GO:001593; GO:002262	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;mRNA binding	GO:000372; GO:000373; GO:000372
NP_001230999.1;XP_005664771.2	NP_001230999.1;XP_005664771.2	NP_001230999.1 40S ribosomal protein S11 [Sus scrofa];XP_005664771.2 40S ribosomal protein S11 isoform X1 [Sus scrofa]	8	8	8	80233000	49973000	83897000	0	89355000	112440000	0	0	98748000	0	0	0	0	99207000	0	0	87903000	98213000	NA	NA	NA	RPS11	RPS11;RPS11;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000018; GO:000641; GO:000661	nucleolus;extracellular exosome;cytosolic small ribosomal subunit;ribosome;cytoplasm;focal adhesion;cytosol;nucleoplasm;membrane	GO:000573; GO:007006; GO:002262; GO:000584; GO:000573; GO:000592; GO:000582; GO:000565; GO:001602	 Ribosome	hsa0301	RNA binding;protein binding;structural constituent of ribosome;rRNA binding	GO:000372; GO:000551; GO:000373; GO:001984
NP_001231015.1;XP_020946699.1	NP_001231015.1;XP_020946699.1	NP_001231015.1 eukaryotic translation initiation factor 3 subunit L [Sus scrofa];XP_020946699.1 eukaryotic translation initiation factor 3 subunit L isoform X1 [Sus scrofa]	13	13	13	0	62211000	61857000	69292000	49801000	61818000	56710000	66629000	61525000	75611000	59861000	58025000	65884000	64661000	54697000	66685000	56824000	77045000	NA	NA	NA	EIF3L	EIF3L;EIF3L;NA;NA;NA	viral translational termination-reinitiation;translational initiation;formation of cytoplasmic translation initiation complex	GO:007552; GO:000641; GO:000173	nucleoplasm;eukaryotic 43S preinitiation complex;cytosol;eukaryotic translation initiation factor 3 complex;fibrillar center;membrane;eukaryotic 48S preinitiation complex	GO:000565; GO:001628; GO:000582; GO:000585; GO:000165; GO:001602; GO:003329	"NA"	"NA"	translation initiation factor activity;protein binding;RNA binding	GO:000374; GO:000551; GO:000372
XP_020927726.1;XP_020927695.1;NP_001231019.1;XP_020927656.1;XP_020925937.1	XP_020927726.1;XP_020927695.1;NP_001231019.1;XP_020927656.1	XP_020927726.1 protein SET isoform X3 [Sus scrofa];XP_020927695.1 protein SET isoform X2 [Sus scrofa];NP_001231019.1 protein SET [Sus scrofa];XP_020927656.1 protein SET isoform X1 [Sus scrofa]	4	4	4	61081000	72770000	80068000	80079000	65049000	96939000	79993000	82756000	72534000	74377000	82044000	86065000	104770000	77991000	94525000	75481000	87389000	79739000	NA	NA	NA	SET	SET;SET;SET;SET;NA	negative regulation of transcription, DNA-templated;negative regulation of histone acetylation;negative regulation of neuron apoptotic process;negative regulation of phosphoprotein phosphatase activity;nucleosome disassembly;DNA replication;viral process;regulation of mRNA stability	GO:004589; GO:003506; GO:004352; GO:003251; GO:000633; GO:000626; GO:001603; GO:004348	nucleus;cytoplasm;perinuclear region of cytoplasm;endoplasmic reticulum;nucleoplasm;lipid particle;macromolecular complex;cytosol	GO:000563; GO:000573; GO:004847; GO:000578; GO:000565; GO:000581; GO:003299; GO:000582	"NA"	"NA"	histone binding;protein phosphatase inhibitor activity;DNA binding;protein phosphatase regulator activity;protein binding	GO:004239; GO:000486; GO:000367; GO:001988; GO:000551
NP_001231022.1;XP_013850710.1	NP_001231022.1;XP_013850710.1	NP_001231022.1 glucosamine-6-phosphate isomerase 1 [Sus scrofa];XP_013850710.1 glucosamine-6-phosphate isomerase 1 isoform X1 [Sus scrofa]	5	5	4	20545000	26724000	21281000	27048000	18339000	19673000	23266000	15800000	23570000	19899000	17858000	0	0	18063000	17018000	22613000	24771000	24265000	NA	NA	NA	GNPDA1	GNPDA1;GNPDA1;NA;NA;NA	N-acetylglucosamine catabolic process;generation of precursor metabolites and energy;single fertilization;glucosamine catabolic process;carbohydrate metabolic process;N-acetylneuraminate catabolic process	GO:000604; GO:000609; GO:000733; GO:000604; GO:000597; GO:001926	cytosol;extracellular exosome;cytoplasm	GO:000582; GO:007006; GO:000573	 Amino sugar and nucleotide sugar metabolism; Metabolic pathways	hsa0052; hsa0110	glucosamine-6-phosphate deaminase activity;identical protein binding;protein binding	GO:000434; GO:004280; GO:000551
XP_020935071.1;XP_020935070.1;XP_013841909.1;NP_001231025.1	XP_020935071.1;XP_020935070.1;XP_013841909.1;NP_001231025.1	XP_020935071.1 RNA-binding motif protein, X chromosome isoform X1 [Sus scrofa];XP_020935070.1 RNA-binding motif protein, X chromosome isoform X1 [Sus scrofa];XP_013841909.1 RNA-binding motif protein, X chromosome isoform X1 [Sus scrofa];NP_001231025.1 RNA-	4	4	4	24565000	43122000	37530000	30304000	30302000	48182000	35854000	32328000	32745000	26347000	43479000	26272000	21949000	0	34771000	0	39657000	23890000	NA	NA	NA	RBMX	RBMX;RBMX;RBMX;RBMX;NA	mRNA splicing, via spliceosome;osteoblast differentiation;RNA metabolic process;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;negative regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;protein oligomerization;regulation of alternative mRNA splicing, via spliceosome;transcription from RNA polymerase II promoter;membrane protein ectodomain proteolysis	GO:000039; GO:000164; GO:001607; GO:005126; GO:004594; GO:004802; GO:007134; GO:005125; GO:000038; GO:000636; GO:000650	nuclear euchromatin;ribonucleoprotein complex;nucleoplasm;membrane;extracellular exosome;spliceosomal complex;catalytic step 2 spliceosome;extracellular space;nucleus;supraspliceosomal complex	GO:000571; GO:199090; GO:000565; GO:001602; GO:007006; GO:000568; GO:007101; GO:000561; GO:000563; GO:004453	 Spliceosome	hsa0304	identical protein binding;chromatin binding;protein binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA binding;protein domain specific binding	GO:004280; GO:000368; GO:000551; GO:000097; GO:000372; GO:001990
NP_001231034.1	NP_001231034.1	NP_001231034.1 tubulin-specific chaperone D [Sus scrofa]	11	11	11	0	11458000	10483000	9512000	11586000	0	8525400	12421000	0	11515000	14022000	14517000	0	11524000	0	14049000	9330800	13844000	NA	NA	NA	TBCD	TBCD;NA;NA;NA;NA	negative regulation of cell-substrate adhesion;cell morphogenesis involved in neuron differentiation;adherens junction assembly;post-chaperonin tubulin folding pathway;negative regulation of microtubule polymerization;positive regulation of GTPase activity;protein folding;bicellular tight junction assembly;microtubule cytoskeleton organization;mitotic cell cycle	GO:001081; GO:004866; GO:003433; GO:000702; GO:003111; GO:004354; GO:000645; GO:007083; GO:000022; GO:000027	microtubule;lateral plasma membrane;cytoplasm;centrosome;bicellular tight junction;adherens junction	GO:000587; GO:001632; GO:000573; GO:000581; GO:000592; GO:000591	"NA"	"NA"	chaperone binding;protein binding;GTPase activator activity;beta-tubulin binding	GO:005108; GO:000551; GO:000509; GO:004848
XP_005665953.2;NP_001231035.1	XP_005665953.2;NP_001231035.1	XP_005665953.2 40S ribosomal protein S10 isoform X1 [Sus scrofa];NP_001231035.1 ribosomal protein S10 [Sus scrofa]	4	4	4	34843000	30231000	39839000	46925000	35044000	42725000	37932000	41064000	45138000	39926000	39911000	35847000	31481000	42378000	38055000	44611000	43356000	44715000	NA	NA	NA	RPS10	RPS10;RPS10;NA;NA;NA	ribosomal small subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;translational initiation	GO:000002; GO:000018; GO:000661; GO:000641	cytosolic small ribosomal subunit;ribosome;focal adhesion;nucleoplasm;membrane;cytosol;nucleolus	GO:002262; GO:000584; GO:000592; GO:000565; GO:001602; GO:000582; GO:000573	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;RNA binding	GO:000551; GO:000373; GO:000372
NP_001231036.1;XP_005673514.1	NP_001231036.1	NP_001231036.1 synapse-associated protein 1 isoform 1 [Sus scrofa]	4	4	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9296900	NA	NA	NA	SYAP1	SYAP1;NA;NA;NA;NA	cellular response to platelet-derived growth factor stimulus;positive regulation of protein serine/threonine kinase activity;positive regulation of fat cell differentiation;cellular response to insulin-like growth factor stimulus;cellular response to insulin stimulus;cell differentiation;positive regulation of protein homodimerization activity;TORC2 signaling;cellular response to epidermal growth factor stimulus	GO:003612; GO:007190; GO:004560; GO:199031; GO:003286; GO:003015; GO:009007; GO:003820; GO:007136	dendrite;nucleoplasm;perinuclear region of cytoplasm;extracellular exosome;cell junction;perikaryon;postsynaptic membrane;cytosol;Golgi apparatus;axon;extrinsic component of cytoplasmic side of plasma membrane;presynaptic membrane	GO:003042; GO:000565; GO:004847; GO:007006; GO:003005; GO:004320; GO:004521; GO:000582; GO:000579; GO:003042; GO:003123; GO:004273	"NA"	"NA"	protein binding	GO:000551
NP_001231038.1	NP_001231038.1	NP_001231038.1 synapse-associated protein 1 isoform 2 [Sus scrofa]	2	1	1	0	0	0	0	0	0	0	0	0	0	0	14725000	0	0	0	0	0	0	NA	NA	NA	SYAP1	SYAP1;NA;NA;NA;NA	cellular response to platelet-derived growth factor stimulus;positive regulation of protein serine/threonine kinase activity;positive regulation of fat cell differentiation;cellular response to insulin-like growth factor stimulus;cellular response to insulin stimulus;cell differentiation;positive regulation of protein homodimerization activity;TORC2 signaling;cellular response to epidermal growth factor stimulus	GO:003612; GO:007190; GO:004560; GO:199031; GO:003286; GO:003015; GO:009007; GO:003820; GO:007136	dendrite;nucleoplasm;perinuclear region of cytoplasm;extracellular exosome;cell junction;perikaryon;postsynaptic membrane;cytosol;Golgi apparatus;axon;extrinsic component of cytoplasmic side of plasma membrane;presynaptic membrane	GO:003042; GO:000565; GO:004847; GO:007006; GO:003005; GO:004320; GO:004521; GO:000582; GO:000579; GO:003042; GO:003123; GO:004273	"NA"	"NA"	protein binding	GO:000551
NP_001231042.1;CON__P02676	NP_001231042.1	NP_001231042.1 fibrinogen beta chain precursor [Sus scrofa]	28	28	28	1479600000	957280000	1053900000	915970000	3404600000	3963500000	1465000000	890840000	1761900000	1163400000	1547600000	520420000	1423900000	871230000	1011000000	776760000	1492900000	1325000000	NA	NA	NA	FGB	FGB;NA;NA;NA;NA	cellular macromolecular complex assembly;adaptive immune response;platelet degranulation;cell-matrix adhesion;cellular response to leptin stimulus;platelet aggregation;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell apoptotic process;response to calcium ion;cellular response to interleukin-1;positive regulation of substrate adhesion-dependent cell spreading;blood coagulation;protein polymerization;positive regulation of peptide hormone secretion;toll-like receptor signaling pathway;fibrinolysis;positive regulation of exocytosis;positive regulation of heterotypic cell-cell adhesion;plasminogen activation;innate immune response;positive regulation of vasoconstriction;blood coagulation, fibrin clot formation;extracellular matrix organization;induction of bacterial agglutination;positive regulation of protein secretion;positive regulation of ERK1 and ERK2 cascade	GO:003462; GO:000225; GO:000257; GO:000716; GO:004432; GO:007052; GO:190204; GO:200035; GO:005159; GO:007134; GO:190002; GO:000759; GO:005125; GO:009027; GO:000222; GO:004273; GO:004592; GO:003411; GO:003163; GO:004508; GO:004590; GO:007237; GO:003019; GO:004315; GO:005071; GO:007037	extracellular space;plasma membrane;cell surface;extracellular vesicle;platelet alpha granule;synapse;cell cortex;blood microparticle;endoplasmic reticulum;extracellular region;external side of plasma membrane;extracellular exosome	GO:000561; GO:000588; GO:000998; GO:190356; GO:003109; GO:004520; GO:000593; GO:007256; GO:000578; GO:000557; GO:000989; GO:007006	 Platelet activation; Complement and coagulation cascades	hsa0461; hsa0461	chaperone binding;cell adhesion molecule binding;receptor binding;structural molecule activity;extracellular matrix structural constituent;protein binding	GO:005108; GO:005083; GO:000510; GO:000519; GO:000520; GO:000551
XP_013853501.1;XP_005664276.1;NP_001231058.1	XP_013853501.1;XP_005664276.1;NP_001231058.1	XP_013853501.1 inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X1 [Sus scrofa];XP_005664276.1 inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X1 [Sus scrofa];NP_001231058.1 inhibitor of nuclear factor kappa-B k	7	7	5	0	30394000	0	40712000	0	38138000	0	43219000	0	26859000	0	50462000	30940000	40812000	0	33079000	0	44662000	NA	NA	NA	IKBIP	IKBIP;IKBIP;IKBIP;NA;NA	response to X-ray	GO:001016	membrane;endoplasmic reticulum;integral component of membrane	GO:001602; GO:000578; GO:001602	"NA"	"NA"	protein binding	GO:000551
NP_001231061.1	NP_001231061.1	NP_001231061.1 serpin H1 precursor [Sus scrofa]	20	20	20	753240000	1386600000	1109000000	1695800000	1602400000	1864100000	1116800000	1740800000	867720000	1505900000	1227200000	1588000000	1179700000	1627600000	1326100000	1582600000	1027600000	1852300000	NA	NA	NA	SERPINH1	SERPINH1;NA;NA;NA;NA	protein maturation;negative regulation of endopeptidase activity;collagen fibril organization;collagen biosynthetic process;response to unfolded protein;chondrocyte development involved in endochondral bone morphogenesis	GO:005160; GO:001095; GO:003019; GO:003296; GO:000698; GO:000343	extracellular space;endoplasmic reticulum lumen;endoplasmic reticulum-Golgi intermediate compartment;membrane raft	GO:000561; GO:000578; GO:000579; GO:004512	"NA"	"NA"	unfolded protein binding;RNA binding;collagen binding;serine-type endopeptidase inhibitor activity	GO:005108; GO:000372; GO:000551; GO:000486
NP_001231066.1	NP_001231066.1	NP_001231066.1 ATP synthase subunit g, mitochondrial [Sus scrofa]	7	7	7	142860000	59118000	100510000	79247000	95374000	35331000	76656000	75831000	89332000	71626000	78755000	136170000	52802000	75046000	89345000	94317000	59021000	50784000	NA	NA	NA	ATP5MG	ATP5MG;NA;NA;NA;NA	ATP synthesis coupled proton transport;cristae formation;ATP biosynthetic process;mitochondrial ATP synthesis coupled proton transport;ATP hydrolysis coupled cation transmembrane transport	GO:001598; GO:004240; GO:000675; GO:004277; GO:009913	mitochondrial proton-transporting ATP synthase complex;mitochondrial inner membrane;mitochondrion;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)	GO:000575; GO:000574; GO:000573; GO:000027	 Oxidative phosphorylation; Metabolic pathways	hsa0019; hsa0110	transmembrane transporter activity;proton-transporting ATP synthase activity, rotational mechanism;ATPase activity	GO:002285; GO:004693; GO:001688
NP_001231072.1;NP_001231071.1	NP_001231072.1;NP_001231071.1	NP_001231072.1 sorcin isoform 2 [Sus scrofa];NP_001231071.1 sorcin isoform 1 [Sus scrofa]	8	8	8	148240000	246080000	229840000	241820000	162370000	286780000	209830000	244830000	187430000	226610000	179130000	202640000	208170000	264930000	238340000	231260000	214370000	238810000	NA	NA	NA	SRI	SRI;SRI;NA;NA;NA	regulation of heart contraction;negative regulation of heart rate;positive regulation of release of sequestered calcium ion into cytosol;regulation of relaxation of muscle;regulation of calcium ion transport;signal transduction;negative regulation of cardiac muscle contraction;regulation of cell communication by electrical coupling involved in cardiac conduction;calcium ion transport;heart development;muscle organ development;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;cytoplasmic sequestering of transcription factor;action potential;intracellular sequestering of iron ion;regulation of striated muscle contraction;regulation of cell communication by electrical coupling;positive regulation of insulin secretion involved in cellular response to glucose stimulus;negative regulation of ryanodine-sensitive calcium-release channel activity;regulation of cardiac muscle cell contraction;negative regulation of transcription regulatory region DNA binding	GO:000801; GO:001045; GO:005128; GO:190107; GO:005192; GO:000716; GO:005511; GO:190184; GO:000681; GO:000750; GO:000751; GO:001088; GO:004299; GO:000150; GO:000688; GO:000694; GO:001064; GO:003577; GO:006031; GO:008600; GO:200067	smooth endoplasmic reticulum;sarcoplasmic reticulum;Z disc;T-tubule;sarcoplasmic reticulum membrane;cytosol;dendritic spine neck;extracellular exosome;chromaffin granule membrane;cytoplasm;endoplasmic reticulum membrane;nucleoplasm;axon terminus;membrane	GO:000579; GO:001652; GO:003001; GO:003031; GO:003301; GO:000582; GO:004432; GO:007006; GO:004258; GO:000573; GO:000578; GO:000565; GO:004367; GO:001602	"NA"	"NA"	repressing transcription factor binding;ion channel binding;protein binding;protease binding;protein heterodimerization activity;calcium ion binding;receptor binding;calcium channel regulator activity	GO:007049; GO:004432; GO:000551; GO:000202; GO:004698; GO:000550; GO:000510; GO:000524
NP_001231076.1	NP_001231076.1	NP_001231076.1 translocon-associated protein subunit gamma [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5411500	0	0	0	NA	NA	NA	SSR3	SSR3;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane	GO:000661	endoplasmic reticulum membrane;integral component of membrane	GO:000578; GO:001602	 Protein processing in endoplasmic reticulum	hsa0414	"NA"	"NA"
NP_001231078.1;XP_020921748.1	NP_001231078.1;XP_020921748.1	NP_001231078.1 COP9 signalosome complex subunit 3 [Sus scrofa];XP_020921748.1 COP9 signalosome complex subunit 3 isoform X1 [Sus scrofa]	5	5	5	18720000	14420000	16990000	14686000	18933000	11222000	19552000	17414000	23060000	19580000	0	16804000	17117000	14369000	16340000	17741000	15745000	14431000	NA	NA	NA	COPS3	COPS3;COPS3;NA;NA;NA	transcription-coupled nucleotide-excision repair;response to light stimulus;nucleotide-excision repair, DNA damage recognition;in utero embryonic development;protein deneddylation;signal transduction;ubiquitin-dependent protein catabolic process;post-translational protein modification	GO:000628; GO:000941; GO:000071; GO:000170; GO:000033; GO:000716; GO:000651; GO:004368	COP9 signalosome;cytoplasm;nucleoplasm;cytosol;nucleus	GO:000818; GO:000573; GO:000565; GO:000582; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_005667427.1;NP_001231079.1;XP_005667428.1	XP_005667427.1;NP_001231079.1;XP_005667428.1	XP_005667427.1 transgelin isoform X1 [Sus scrofa];NP_001231079.1 transgelin [Sus scrofa];XP_005667428.1 transgelin isoform X2 [Sus scrofa]	21	21	21	641600000	1113300000	4928900000	638120000	419710000	3126900000	480930000	2359800000	1345400000	6381100000	1793900000	1796400000	10777000000	857180000	558220000	862570000	703290000	931560000	NA	NA	NA	TAGLN	TAGLN;TAGLN;TAGLN;NA;NA	epithelial cell differentiation;muscle organ development	GO:003085; GO:000751	cytoplasm	GO:000573	"NA"	"NA"	protein binding;actin filament binding	GO:000551; GO:005101
NP_001231080.1;XP_020953706.1	NP_001231080.1;XP_020953706.1	NP_001231080.1 26S protease regulatory subunit 4 [Sus scrofa];XP_020953706.1 26S protease regulatory subunit 4 isoform X1 [Sus scrofa]	6	6	6	82243000	80631000	77395000	83311000	67420000	60577000	86430000	87198000	83976000	86949000	81885000	72683000	73309000	87756000	85089000	83918000	75185000	81124000	NA	NA	NA	PSMC1	PSMC1;PSMC1;NA;NA;NA	protein folding;post-translational protein modification;protein deubiquitination;negative regulation of neuron death;protein catabolic process;positive regulation of proteasomal protein catabolic process	GO:000645; GO:004368; GO:001657; GO:190121; GO:003016; GO:190180	cytosol;proteasome regulatory particle, base subcomplex;membrane;nucleus;proteasome accessory complex;nucleoplasm;proteasome complex	GO:000582; GO:000854; GO:001602; GO:000563; GO:002262; GO:000565; GO:000050	 Viral carcinogenesis; Epstein-Barr virus infection; Proteasome	hsa0520; hsa0516; hsa0305	TBP-class protein binding;protein binding;ATP binding;ATPase activity;proteasome-activating ATPase activity;RNA binding	GO:001702; GO:000551; GO:000552; GO:001688; GO:003640; GO:000372
XP_020949053.1;NP_001231081.1;XP_020949056.1;XP_020949055.1;XP_020949054.1	XP_020949053.1;NP_001231081.1	XP_020949053.1 nuclear pore complex protein Nup93 isoform X1 [Sus scrofa];NP_001231081.1 nuclear pore complex protein Nup93 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	108330000	0	0	0	64912000	0	0	108940000	111010000	0	NA	NA	NA	NUP93	NUP93;NUP93;NA;NA;NA	positive regulation of SMAD protein import into nucleus;mRNA export from nucleus;viral process;protein import into nucleus;SMAD protein signal transduction;nuclear pore complex assembly;renal system development;nuclear envelope organization;poly(A)+ mRNA export from nucleus	GO:006039; GO:000640; GO:001603; GO:000660; GO:006039; GO:005129; GO:007200; GO:000699; GO:001697	nuclear envelope;nuclear membrane;membrane;nuclear pore;nuclear periphery	GO:000563; GO:003196; GO:001602; GO:000564; GO:003439	 RNA transport	hsa0301	structural constituent of nuclear pore;protein binding	GO:001705; GO:000551
NP_001231082.1	NP_001231082.1	NP_001231082.1 malate dehydrogenase, mitochondrial [Sus scrofa]	18	18	18	1259800000	742450000	1216300000	659760000	1424800000	673280000	1356200000	842410000	1249600000	827050000	974270000	877040000	839530000	703320000	926300000	906290000	892740000	677500000	NA	NA	NA	MDH2	MDH2;NA;NA;NA;NA	NADH metabolic process;oxaloacetate metabolic process;aerobic respiration;tricarboxylic acid cycle;internal protein amino acid acetylation	GO:000673; GO:000610; GO:000906; GO:000609; GO:000647	membrane;mitochondrion;nucleus;mitochondrial matrix;extracellular exosome	GO:001602; GO:000573; GO:000563; GO:000575; GO:007006	 Citrate cycle (TCA cycle); Cysteine and methionine metabolism; Glyoxylate and dicarboxylate metabolism; Carbon metabolism; Metabolic pathways; Biosynthesis of antibiotics; Pyruvate metabolism	hsa0002; hsa0027; hsa0063; hsa0120; hsa0110; hsa0113; hsa0062	malate dehydrogenase (NADP+) activity;RNA binding;protein self-association;L-malate dehydrogenase activity	GO:004655; GO:000372; GO:004362; GO:003006
NP_001231084.1;XP_005666833.1	NP_001231084.1;XP_005666833.1	NP_001231084.1 lysosome membrane protein 2 precursor [Sus scrofa];XP_005666833.1 lysosome membrane protein 2 isoform X1 [Sus scrofa]	8	8	8	25351000	53866000	41262000	52976000	34348000	54687000	53664000	49091000	41723000	50815000	35514000	45215000	53758000	54283000	53663000	52590000	52425000	63286000	NA	NA	NA	SCARB2	SCARB2;SCARB2;NA;NA;NA	regulation of glucosylceramidase activity;positive regulation of neuron projection development;aminophospholipid transport;regulation of lysosome organization;receptor-mediated endocytosis;viral entry into host cell;regulation of cellular carbohydrate catabolic process;regulation of endosome organization;protein targeting to lysosome;membrane organization	GO:190512; GO:001097; GO:001591; GO:190567; GO:000689; GO:004671; GO:004347; GO:190497; GO:000662; GO:006102	Golgi membrane;membrane;endoplasmic reticulum membrane;endosome membrane;extracellular exosome;plasma membrane;lysosomal lumen;clathrin-coated vesicle membrane;focal adhesion;lysosomal membrane;late endosome membrane	GO:000013; GO:001602; GO:000578; GO:001000; GO:007006; GO:000588; GO:004320; GO:003066; GO:000592; GO:000576; GO:003190	 Lysosome	hsa0414	transmembrane signaling receptor activity;protein transporter activity;enzyme binding;phosphatidylcholine binding;scavenger receptor activity;protein binding;phospholipid transporter activity;phosphatidylserine binding;cholesterol binding;protein homodimerization activity;virus receptor activity	GO:000488; GO:000856; GO:001989; GO:003121; GO:000504; GO:000551; GO:000554; GO:000178; GO:001548; GO:004280; GO:000161
NP_001231086.1	NP_001231086.1	NP_001231086.1 peptidyl-prolyl cis-trans isomerase FKBP3 [Sus scrofa]	5	5	5	0	54270000	51934000	62883000	58782000	55156000	42080000	58037000	0	51721000	46408000	89092000	47285000	76497000	59406000	58416000	61014000	49814000	NA	NA	NA	FKBP3	FKBP3;NA;NA;NA;NA	protein peptidyl-prolyl isomerization	GO:000041	nucleus	GO:000563	"NA"	"NA"	FK506 binding;signaling receptor activity;protein binding;RNA binding;peptidyl-prolyl cis-trans isomerase activity	GO:000552; GO:003802; GO:000551; GO:000372; GO:000375
NP_001231089.1	NP_001231089.1	NP_001231089.1 dehydrogenase/reductase SDR family member 7 [Sus scrofa]	13	13	13	657400000	340530000	473730000	278820000	540900000	297440000	504310000	420330000	513110000	394370000	627200000	408960000	322600000	540840000	490240000	429660000	555470000	373940000	NA	NA	NA	DHRS7	DHRS7;NA;NA;NA;NA	oxidation-reduction process	GO:005511	membrane	GO:001602	"NA"	"NA"	oxidoreductase activity	GO:001649
NP_001231090.1	NP_001231090.1	NP_001231090.1 serpin B10 [Sus scrofa]	2	2	2	0	0	0	0	0	0	7218400	0	0	9113200	0	0	13970000	8876300	0	0	0	0	NA	NA	NA	SERPINB10	SERPINB10;NA;NA;NA;NA	neutrophil degranulation;negative regulation of endopeptidase activity	GO:004331; GO:001095	secretory granule membrane;ficolin-1-rich granule membrane;extracellular space;plasma membrane;nucleus	GO:003066; GO:010100; GO:000561; GO:000588; GO:000563	 Amoebiasis	hsa0514	serine-type endopeptidase inhibitor activity	GO:000486
NP_001231091.1;XP_020918345.1	NP_001231091.1;XP_020918345.1	NP_001231091.1 sorbitol dehydrogenase [Sus scrofa];XP_020918345.1 sorbitol dehydrogenase isoform X1 [Sus scrofa]	7	7	7	97550000	119790000	89031000	92820000	83451000	84001000	112020000	81799000	91844000	100360000	81849000	88124000	104710000	90831000	93365000	102670000	89470000	84137000	NA	NA	NA	SORD	SORD;SORD;NA;NA;NA	oxidation-reduction process;response to cadmium ion;L-xylitol metabolic process;sorbitol catabolic process;flagellated sperm motility;response to nutrient levels;response to drug;response to hormone;glucuronate catabolic process to xylulose 5-phosphate;fructose biosynthetic process;glucose metabolic process;response to osmotic stress	GO:005511; GO:004668; GO:005116; GO:000606; GO:003031; GO:003166; GO:004249; GO:000972; GO:001964; GO:004637; GO:000600; GO:000697	cytosol;mitochondrial membrane;membrane;extracellular space;motile cilium;extracellular exosome	GO:000582; GO:003196; GO:001602; GO:000561; GO:003151; GO:007006	 Pentose and glucuronate interconversions; Fructose and mannose metabolism; Metabolic pathways	hsa0004; hsa0005; hsa0110	zinc ion binding;NAD binding;carbohydrate binding;L-iditol 2-dehydrogenase activity;identical protein binding;D-xylulose reductase activity	GO:000827; GO:005128; GO:003024; GO:000393; GO:004280; GO:004652
XP_020919646.1;NP_001231092.1	XP_020919646.1;NP_001231092.1	XP_020919646.1 dnaJ homolog subfamily A member 1 isoform X1 [Sus scrofa];NP_001231092.1 dnaJ homolog subfamily A member 1 [Sus scrofa]	4	4	4	20750000	13762000	18194000	15336000	18960000	16583000	20068000	17407000	0	0	9609800	0	0	15819000	0	16504000	20128000	16534000	NA	NA	NA	DNAJA1	DNAJA1;DNAJA1;NA;NA;NA	positive regulation of ATPase activity;positive regulation of apoptotic process;protein folding;flagellated sperm motility;androgen receptor signaling pathway;toxin transport;negative regulation of establishment of protein localization to mitochondrion;negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;negative regulation of protein ubiquitination;regulation of protein transport;DNA damage response, detection of DNA damage;negative regulation of JUN kinase activity;response to unfolded protein;spermatogenesis;response to heat;protein localization to mitochondrion	GO:003278; GO:004306; GO:000645; GO:003031; GO:003052; GO:190199; GO:190374; GO:190525; GO:003139; GO:005122; GO:004276; GO:004350; GO:000698; GO:000728; GO:000940; GO:007058	mitochondrion;nucleus;perinuclear region of cytoplasm;ubiquitin ligase complex;extracellular exosome;cytosol;microtubule cytoskeleton;cytoplasmic side of endoplasmic reticulum membrane;membrane	GO:000573; GO:000563; GO:004847; GO:000015; GO:007006; GO:000582; GO:001563; GO:009855; GO:001602	 Protein processing in endoplasmic reticulum	hsa0414	chaperone binding;ATP binding;ubiquitin protein ligase binding;unfolded protein binding;metal ion binding;low-density lipoprotein particle receptor binding;protein binding;G-protein coupled receptor binding;ATPase activator activity;Hsp70 protein binding;Tat protein binding;C3HC4-type RING finger domain binding	GO:005108; GO:000552; GO:003162; GO:005108; GO:004687; GO:005075; GO:000551; GO:000166; GO:000167; GO:003054; GO:003095; GO:005513
NP_001231105.1;XP_020934189.1;XP_020934188.1;XP_020934187.1;XP_020934186.1;XP_020934185.1;XP_020934184.1	NP_001231105.1;XP_020934189.1;XP_020934188.1;XP_020934187.1;XP_020934186.1;XP_020934185.1;XP_020934184.1	NP_001231105.1 MICOS complex subunit MIC19 [Sus scrofa];XP_020934189.1 MICOS complex subunit MIC19 isoform X6 [Sus scrofa];XP_020934188.1 MICOS complex subunit MIC19 isoform X5 [Sus scrofa];XP_020934187.1 MICOS complex subunit MIC19 isoform X4 [Sus scrofa]	2	2	2	27270000	0	29695000	0	31910000	0	29707000	25342000	27617000	0	25408000	19161000	20123000	0	25394000	0	0	0	NA	NA	NA	CHCHD3	CHCHD3;CHCHD3;CHCHD3;CHCHD3;CHCHD3	negative regulation of transcription from RNA polymerase II promoter;inner mitochondrial membrane organization;mitochondrial fusion;cristae formation	GO:000012; GO:000700; GO:000805; GO:004240	nucleus;cytoplasm;mitochondrial inner membrane;extracellular exosome;MICOS complex	GO:000563; GO:000573; GO:000574; GO:007006; GO:006161	"NA"	"NA"	phosphatase binding;protein complex scaffold;protein binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	GO:001990; GO:003294; GO:000551; GO:000122
NP_001231109.1	NP_001231109.1	NP_001231109.1 T-complex protein 1 subunit gamma [Sus scrofa]	16	16	16	266550000	185260000	279010000	190530000	272230000	186570000	229120000	184240000	253950000	232900000	226080000	223620000	223990000	250160000	208140000	229910000	241130000	193330000	NA	NA	NA	CCT3	CCT3;NA;NA;NA;NA	positive regulation of telomere maintenance via telomerase;protein folding;protein stabilization;pore complex assembly;positive regulation of establishment of protein localization to telomere;toxin transport;positive regulation of protein localization to Cajal body;binding of sperm to zona pellucida	GO:003221; GO:000645; GO:005082; GO:004693; GO:190485; GO:190199; GO:190487; GO:000733	chaperonin-containing T-complex;cell body;zona pellucida receptor complex;cytosol;cytoskeleton;extracellular exosome;plasma membrane;microtubule	GO:000583; GO:004429; GO:000219; GO:000582; GO:000585; GO:007006; GO:000588; GO:000587	"NA"	"NA"	ATP binding;unfolded protein binding;RNA binding;protein binding	GO:000552; GO:005108; GO:000372; GO:000551
XP_005656340.1;NP_001231113.1;XP_020953684.1;XP_005656339.1	XP_005656340.1;NP_001231113.1;XP_020953684.1;XP_005656339.1	XP_005656340.1 reticulocalbin-2 isoform X2 [Sus scrofa];NP_001231113.1 reticulocalbin-2 precursor [Sus scrofa];XP_020953684.1 reticulocalbin-2 isoform X3 [Sus scrofa];XP_005656339.1 reticulocalbin-2 isoform X1 [Sus scrofa]	8	8	8	51514000	75334000	57654000	83530000	63153000	76115000	70439000	95451000	65841000	69528000	70235000	111530000	73079000	87959000	82987000	78466000	83193000	87246000	NA	NA	NA	RCN2	RCN2;RCN2;RCN2;RCN2;NA	"NA"	"NA"	endoplasmic reticulum;endoplasmic reticulum lumen;nucleolus	GO:000578; GO:000578; GO:000573	"NA"	"NA"	protein binding;calcium ion binding	GO:000551; GO:000550
XP_005654424.1;NP_001231114.1;XP_020945010.1	XP_005654424.1;NP_001231114.1;XP_020945010.1	XP_005654424.1 peroxisomal biogenesis factor 3 isoform X2 [Sus scrofa];NP_001231114.1 peroxisomal biogenesis factor 3 [Sus scrofa];XP_020945010.1 peroxisomal biogenesis factor 3 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3084900	0	0	NA	NA	NA	PEX3	PEX3;PEX3;PEX3;NA;NA	peroxisome organization;protein import into peroxisome membrane;peroxisome membrane biogenesis;transmembrane transport	GO:000703; GO:004504; GO:001655; GO:005508	macromolecular complex;membrane;nucleoplasm;peroxisome;endoplasmic reticulum;cytosol;protein-lipid complex	GO:003299; GO:001602; GO:000565; GO:000577; GO:000578; GO:000582; GO:003299	 Peroxisome	hsa0414	protein binding, bridging;protein binding;protein dimerization activity;lipid binding	GO:003067; GO:000551; GO:004698; GO:000828
XP_003125211.1;NP_001231139.1;NP_001231138.1	XP_003125211.1;NP_001231139.1;NP_001231138.1	XP_003125211.1 calmodulin [Sus scrofa];NP_001231139.1 calmodulin [Sus scrofa];NP_001231138.1 calmodulin [Sus scrofa]	10	10	9	2868900000	3112100000	3221200000	2268700000	2234400000	2249300000	2746300000	2589100000	2341900000	2354100000	2782300000	1233200000	2009100000	2829300000	3133400000	3217900000	2657300000	2044800000	NA	NA	NA	CALM2	CALM2;CALM1;CALM3;NA;NA	positive regulation of DNA binding;positive regulation of cyclic-nucleotide phosphodiesterase activity;positive regulation of peptidyl-threonine phosphorylation;positive regulation of protein serine/threonine kinase activity;positive regulation by host of symbiont cAMP-mediated signal transduction;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;response to calcium ion;regulation of cytokinesis;G2/M transition of mitotic cell cycle;positive regulation of phosphoprotein phosphatase activity;positive regulation of protein dephosphorylation;negative regulation of ryanodine-sensitive calcium-release channel activity;regulation of heart rate;positive regulation of protein autophosphorylation;regulation of cell communication by electrical coupling involved in cardiac conduction;detection of calcium ion;G-protein coupled receptor signaling pathway;substantia nigra development;regulation of cardiac muscle contraction	GO:004338; GO:005134; GO:001080; GO:007190; GO:007520; GO:001088; GO:005159; GO:003246; GO:000008; GO:003251; GO:003530; GO:006031; GO:000202; GO:003195; GO:190184; GO:000551; GO:000718; GO:002176; GO:005511	plasma membrane;nucleus;cytoplasm;vesicle;catalytic complex;myelin sheath;spindle pole;centrosome;spindle microtubule;voltage-gated potassium channel complex;sarcomere;macromolecular complex;calcium channel complex	GO:000588; GO:000563; GO:000573; GO:003198; GO:190249; GO:004320; GO:000092; GO:000581; GO:000587; GO:000807; GO:003001; GO:003299; GO:003470	 Calcium signaling pathway; cGMP-PKG signaling pathway; Phosphatidylinositol signaling system; Aldosterone synthesis and secretion; Pertussis; Oocyte meiosis; Olfactory transduction; Salivary secretion; Alzheimer's disease; Alcoholism; Glioma; Adrenergic signaling in cardiomyocytes; Neurotrophin signaling pathway; Inflammatory mediator regulation of TRP channels; GnRH signaling pathway; Tuberculosis; Rap1 signaling pathway; Circadian entrainment; Vascular smooth muscle contraction	hsa0402; hsa0402; hsa0407; hsa0492; hsa0513; hsa0411; hsa0474; hsa0497; hsa0501; hsa0503; hsa0521; hsa0426; hsa0472; hsa0475; hsa0491; hsa0515; hsa0401; hsa0471; hsa0427	adenylate cyclase binding;calcium channel inhibitor activity;ion channel binding;calcium ion binding;N-terminal myristoylation domain binding;protein serine/threonine kinase activator activity;adenylate cyclase activator activity;titin binding;protein kinase binding;protein phosphatase activator activity;protein binding;disordered domain specific binding	GO:000817; GO:001985; GO:004432; GO:000550; GO:003199; GO:004353; GO:001085; GO:003143; GO:001990; GO:007254; GO:000551; GO:009771
NP_001231142.1;XP_013847326.1	NP_001231142.1;XP_013847326.1	NP_001231142.1 ADP-ribosylation factor-like protein 6-interacting protein 1 [Sus scrofa];XP_013847326.1 ADP-ribosylation factor-like protein 6-interacting protein 1 isoform X1 [Sus scrofa]	2	2	2	126970000	80909000	148130000	88792000	64851000	0	97985000	68036000	123670000	112660000	56544000	74133000	0	77678000	71534000	128690000	115860000	92527000	NA	NA	NA	ARL6IP1	ARL6IP1;ARL6IP1;NA;NA;NA	cotranslational protein targeting to membrane;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;endoplasmic reticulum tubular network formation;negative regulation of apoptotic process;positive regulation of L-glutamate transport;apoptotic process;endoplasmic reticulum tubular network membrane organization	GO:000661; GO:004315; GO:007178; GO:004306; GO:000203; GO:000691; GO:199080	Sec61 translocon complex;endoplasmic reticulum membrane;integral component of membrane;cytosol;integral component of endoplasmic reticulum membrane	GO:000578; GO:000578; GO:001602; GO:000582; GO:003017	"NA"	"NA"	protein binding;identical protein binding	GO:000551; GO:004280
NP_001231145.1;XP_020938480.1;XP_003122575.1;XP_020938479.1	NP_001231145.1	NP_001231145.1 sorting nexin-6 [Sus scrofa]	11	11	11	45104000	76556000	62508000	74332000	41008000	63472000	56176000	64655000	50264000	55777000	62883000	92282000	60174000	79373000	54102000	56731000	56982000	74845000	NA	NA	NA	SNX6	SNX6;NA;NA;NA;NA	intracellular protein transport;negative regulation of transcription, DNA-templated;negative regulation of transforming growth factor beta receptor signaling pathway;retrograde transport, endosome to Golgi;regulation of histamine secretion by mast cell;negative regulation of epidermal growth factor-activated receptor activity;regulation of macroautophagy	GO:000688; GO:004589; GO:003051; GO:004214; GO:190359; GO:000717; GO:001624	cytosol;nucleus;early endosome membrane;tubular endosome;retromer complex;cytoplasm	GO:000582; GO:000563; GO:003190; GO:009742; GO:003090; GO:000573	 Endocytosis	hsa0414	phosphatidylinositol binding;protein binding;protein heterodimerization activity;dynactin binding;protein homodimerization activity	GO:003509; GO:000551; GO:004698; GO:003445; GO:004280
NP_001231150.1	NP_001231150.1	NP_001231150.1 RNA-binding protein 14 [Sus scrofa]	3	3	3	0	0	6319900	0	0	0	0	0	10711000	0	0	0	0	0	0	0	0	0	NA	NA	NA	RBM14	RBM14;NA;NA;NA;NA	centriole assembly;DNA repair;glucocorticoid receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;DNA replication;histone deacetylation;negative regulation of centriole replication;SMAD protein signal transduction;DNA recombination;intracellular estrogen receptor signaling pathway;response to hormone;innate immune response;activation of innate immune response	GO:009853; GO:000628; GO:004292; GO:004594; GO:000626; GO:001657; GO:004660; GO:006039; GO:000631; GO:003052; GO:000972; GO:004508; GO:000221	ribonucleoprotein complex;nucleoplasm;transcription factor complex;mediator complex;nucleolus;nuclear speck;nucleus	GO:199090; GO:000565; GO:000566; GO:001659; GO:000573; GO:001660; GO:000563	"NA"	"NA"	protein binding, bridging;RNA binding;transcription cofactor activity;ligand-dependent nuclear receptor transcription coactivator activity;protein binding	GO:003067; GO:000372; GO:000371; GO:003037; GO:000551
NP_001231154.1	NP_001231154.1	NP_001231154.1 eukaryotic translation initiation factor 4E-binding protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5469700	0	0	0	NA	NA	NA	EIF4EBP1	EIF4EBP1;NA;NA;NA;NA	G1/S transition of mitotic cell cycle;negative regulation of translational initiation;lung development;response to ischemia;negative regulation of protein complex assembly;insulin receptor signaling pathway;TOR signaling;cellular response to hypoxia;cellular response to dexamethasone stimulus;response to amino acid starvation;response to ethanol;IRES-dependent translational initiation;positive regulation of mitotic cell cycle	GO:000008; GO:004594; GO:003032; GO:000293; GO:003133; GO:000828; GO:003192; GO:007145; GO:007154; GO:199092; GO:004547; GO:000219; GO:004593	cytosol;nucleus;cytoplasm;glutamatergic synapse;postsynaptic cytosol;macromolecular complex	GO:000582; GO:000563; GO:000573; GO:009897; GO:009952; GO:003299	 Acute myeloid leukemia; PI3K-Akt signaling pathway; Choline metabolism in cancer; ErbB signaling pathway; Insulin signaling pathway; RNA transport; HIF-1 signaling pathway	hsa0522; hsa0415; hsa0523; hsa0401; hsa0491; hsa0301; hsa0406	eukaryotic initiation factor 4E binding;translation repressor activity;protein phosphatase 2A binding;protein binding	GO:000819; GO:003037; GO:005172; GO:000551
NP_001231156.1;XP_020920807.1	NP_001231156.1;XP_020920807.1	NP_001231156.1 regulator of cell cycle RGCC [Sus scrofa];XP_020920807.1 regulator of cell cycle RGCC isoform X1 [Sus scrofa]	6	6	6	30354000	40073000	0	36844000	26962000	0	0	54930000	26126000	38042000	26374000	60543000	0	0	43561000	42089000	0	25300000	NA	NA	NA	RGCC	RGCC;RGCC;NA;NA;NA	positive regulation of epithelial to mesenchymal transition;positive regulation of cytokine secretion;mitotic cell cycle arrest;negative regulation of fibroblast growth factor production;positive regulation of mitotic nuclear division;fibroblast activation;positive regulation of gene expression;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of extracellular matrix assembly;negative regulation of cell-cell adhesion mediated by cadherin;positive regulation of endothelial cell apoptotic process;positive regulation of DNA biosynthetic process;negative regulation of cell proliferation;activation of protein kinase activity;positive regulation of collagen biosynthetic process;negative regulation of blood vessel endothelial cell migration;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of sequence-specific DNA binding transcription factor activity;cellular response to hypoxia;positive regulation of extracellular matrix constituent secretion;complement activation;positive regulation of cell cycle arrest;negative regulation of endothelial cell proliferation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of stress fiber assembly;negative regulation of mitotic cell cycle phase transition;negative regulation of exit from mitosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;negative regulation of angiogenesis	GO:001071; GO:005071; GO:007185; GO:009027; GO:004584; GO:007253; GO:001062; GO:004573; GO:190120; GO:200004; GO:200035; GO:200057; GO:000828; GO:003214; GO:003296; GO:004353; GO:190008; GO:005109; GO:007145; GO:000333; GO:000695; GO:007115; GO:000193; GO:004594; GO:005149; GO:190199; GO:000110; GO:000697; GO:001652	cytoplasm;cytosol;nucleus;nucleolus;centrosome	GO:000573; GO:000582; GO:000563; GO:000573; GO:000581	"NA"	"NA"	protein kinase activator activity;protein kinase binding;protein binding;R-SMAD binding	GO:003029; GO:001990; GO:000551; GO:007041
XP_020947945.1;XP_020947804.1;XP_020947727.1;XP_020947661.1;XP_020947618.1;XP_020947564.1;XP_020947489.1;XP_005659694.2;NP_001231167.1	XP_020947945.1;XP_020947804.1;XP_020947727.1;XP_020947661.1;XP_020947618.1;XP_020947564.1;XP_020947489.1;XP_005659694.2;NP_001231167.1	XP_020947945.1 sulfide:quinone oxidoreductase, mitochondrial isoform X1 [Sus scrofa];XP_020947804.1 sulfide:quinone oxidoreductase, mitochondrial isoform X1 [Sus scrofa];XP_020947727.1 sulfide:quinone oxidoreductase, mitochondrial isoform X1 [Sus scrofa];X	18	18	18	256400000	180420000	272030000	153770000	276420000	172920000	282900000	215520000	259680000	189650000	222330000	188370000	185040000	227410000	221910000	173970000	226810000	193530000	NA	NA	NA	SQOR	SQOR;SQOR;SQOR;SQOR;SQOR	hydrogen sulfide metabolic process;sulfide oxidation, using sulfide:quinone oxidoreductase	GO:007081; GO:007022	mitochondrial inner membrane	GO:000574	 Sulfur metabolism	hsa0092	quinone binding;sulfide:quinone oxidoreductase activity;FAD binding	GO:004803; GO:007022; GO:007194
XP_020941381.1;NP_001231168.1	XP_020941381.1;NP_001231168.1	XP_020941381.1 nuclear receptor-binding protein isoform X1 [Sus scrofa];NP_001231168.1 nuclear receptor-binding protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	2240900	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NRBP1	NRBP1;NRBP1;NA;NA;NA	intracellular signal transduction;ER to Golgi vesicle-mediated transport;transcription initiation from RNA polymerase II promoter;protein phosphorylation	GO:003555; GO:000688; GO:000636; GO:000646	lamellipodium;endomembrane system;membrane;cell cortex;cytoplasm;nucleoplasm	GO:003002; GO:001250; GO:001602; GO:000593; GO:000573; GO:000565	"NA"	"NA"	protein serine/threonine kinase activity;protein homodimerization activity;protein binding;ATP binding	GO:000467; GO:004280; GO:000551; GO:000552
NP_001231169.1	NP_001231169.1	NP_001231169.1 rho GDP-dissociation inhibitor 2 [Sus scrofa]	5	5	5	63682000	67324000	60056000	59073000	68562000	67683000	58961000	76287000	52725000	52673000	91504000	127920000	77707000	88337000	82910000	63937000	73999000	67201000	NA	NA	NA	ARHGDIB	ARHGDIB;NA;NA;NA;NA	cellular response to redox state;negative regulation of cell adhesion;multicellular organism development;negative regulation of trophoblast cell migration;Rho protein signal transduction;regulation of Rho protein signal transduction;regulation of actin cytoskeleton reorganization;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	GO:007146; GO:000716; GO:000727; GO:190116; GO:000726; GO:003502; GO:200024; GO:004354; GO:005105	membrane;cytoskeleton;cytoplasmic vesicle;cytosol;cytoplasm;extracellular exosome	GO:001602; GO:000585; GO:003141; GO:000582; GO:000573; GO:007006	 Neurotrophin signaling pathway; Vasopressin-regulated water reabsorption	hsa0472; hsa0496	GTPase activity;Rho GDP-dissociation inhibitor activity;protein binding;Rac GTPase binding	GO:000392; GO:000509; GO:000551; GO:004836
NP_001231176.1	NP_001231176.1	NP_001231176.1 cleavage and polyadenylation specificity factor subunit 5 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1724200	0	NA	NA	NA	NUDT21	NUDT21;NA;NA;NA;NA	positive regulation of mRNA cleavage;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA polyadenylation;protein heterotetramerization;mRNA processing;positive regulation of mRNA polyadenylation;positive regulation of stem cell differentiation;cell differentiation;positive regulation of pro-B cell differentiation;posttranscriptional regulation of gene expression;mRNA 3'-end processing;protein tetramerization;pre-mRNA cleavage required for polyadenylation;messenger ribonucleoprotein complex assembly	GO:003143; GO:000039; GO:000636; GO:000637; GO:005129; GO:000639; GO:190036; GO:200073; GO:003015; GO:200097; GO:001060; GO:003112; GO:005126; GO:009878; GO:199012	microtubule organizing center;paraspeckles;nucleoplasm;centrosome;mRNA cleavage and polyadenylation specificity factor complex;nucleus;cytoplasm;nuclear body	GO:000581; GO:004238; GO:000565; GO:000581; GO:000584; GO:000563; GO:000573; GO:001660	 mRNA surveillance pathway	hsa0301	RNA binding;protein binding;identical protein binding;histone deacetylase binding;mRNA binding;chromatin binding;hydrolase activity;AU-rich element binding	GO:000372; GO:000551; GO:004280; GO:004282; GO:000372; GO:000368; GO:001678; GO:001709
XP_020919699.1;NP_001231177.1	XP_020919699.1;NP_001231177.1	XP_020919699.1 phosphotriesterase-related protein isoform X1 [Sus scrofa];NP_001231177.1 phosphotriesterase-related protein [Sus scrofa]	6	6	6	35859000	61135000	44895000	53399000	62154000	72969000	53524000	59205000	50429000	51060000	48478000	66908000	34196000	67903000	54168000	53431000	52141000	55631000	NA	NA	NA	PTER	PTER;PTER;NA;NA;NA	epithelial cell differentiation;catabolic process	GO:003085; GO:000905	extracellular exosome	GO:007006	"NA"	"NA"	molecular_function;zinc ion binding;hydrolase activity, acting on ester bonds	GO:000367; GO:000827; GO:001678
NP_001231183.1	NP_001231183.1	NP_001231183.1 ras-related protein Rab-5C [Sus scrofa]	7	4	4	88120000	79109000	80367000	88491000	66659000	60511000	80838000	85513000	76421000	88697000	100520000	87285000	102200000	98126000	115970000	93595000	74542000	93705000	NA	NA	NA	RAB5C	RAB5C;NA;NA;NA;NA	plasma membrane to endosome transport;intracellular protein transport;Rab protein signal transduction;regulation of endocytosis;neutrophil degranulation	GO:004822; GO:000688; GO:003248; GO:003010; GO:004331	extracellular exosome;lysosomal membrane;endocytic vesicle;plasma membrane;anchored component of synaptic vesicle membrane;melanosome;early endosome membrane;lipid particle;azurophil granule membrane	GO:007006; GO:000576; GO:003013; GO:000588; GO:009899; GO:004247; GO:003190; GO:000581; GO:003557	 Vasopressin-regulated water reabsorption; Tuberculosis; Phagosome; Ras signaling pathway; Amoebiasis	hsa0496; hsa0515; hsa0414; hsa0401; hsa0514	protein binding;GTP binding;GTPase activity;GDP binding	GO:000551; GO:000552; GO:000392; GO:001900
NP_001231184.1;NP_001231185.1	NP_001231184.1;NP_001231185.1	NP_001231184.1 lysosome-associated membrane glycoprotein 2 isoform 1 precursor [Sus scrofa];NP_001231185.1 lysosome-associated membrane glycoprotein 2 isoform 2 precursor [Sus scrofa]	2	2	2	13740000	0	17416000	0	0	22074000	14678000	20661000	19477000	0	0	0	21053000	0	0	15377000	0	0	NA	NA	NA	LAMP2	LAMP2;LAMP2;NA;NA;NA	regulation of protein stability;muscle cell cellular homeostasis;chaperone-mediated autophagy;lysosomal protein catabolic process;protein import;platelet degranulation;cellular response to starvation;protein stabilization;autophagosome maturation;neutrophil degranulation;protein targeting;protein targeting to lysosome involved in chaperone-mediated autophagy	GO:003164; GO:004671; GO:006168; GO:190514; GO:001703; GO:000257; GO:000926; GO:005082; GO:009735; GO:004331; GO:000660; GO:006174	platelet dense granule membrane;membrane microdomain;membrane;extracellular exosome;lysosomal matrix;late endosome;azurophil granule membrane;autolysosome;lysosome;extracellular space;membrane raft;phagocytic vesicle membrane;integral component of autophagosome membrane;plasma membrane;late endosome membrane;lysosomal lumen;ficolin-1-rich granule membrane	GO:003108; GO:009885; GO:001602; GO:007006; GO:199083; GO:000577; GO:003557; GO:004475; GO:000576; GO:000561; GO:004512; GO:003067; GO:009763; GO:000588; GO:003190; GO:004320; GO:010100	 Phagosome; Tuberculosis; Lysosome	hsa0414; hsa0515; hsa0414	protein domain specific binding;enzyme binding;protein binding	GO:001990; GO:001989; GO:000551
NP_001231187.1;XP_020957767.1	NP_001231187.1;XP_020957767.1	NP_001231187.1 NADP-dependent malic enzyme, mitochondrial [Sus scrofa];XP_020957767.1 NADP-dependent malic enzyme, mitochondrial isoform X1 [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	633990	0	0	0	NA	NA	NA	ME3	ME3;ME3;NA;NA;NA	pyruvate metabolic process;malate metabolic process;oxygen metabolic process;oxidation-reduction process;aerobic respiration;tricarboxylic acid cycle	GO:000609; GO:000610; GO:007259; GO:005511; GO:000906; GO:000609	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Carbon metabolism; Metabolic pathways; Pyruvate metabolism	hsa0120; hsa0110; hsa0062	oxaloacetate decarboxylase activity;malic enzyme activity;cofactor binding;NAD binding;metal ion binding	GO:000894; GO:000447; GO:004803; GO:005128; GO:004687
NP_001231189.1	NP_001231189.1	NP_001231189.1 arginine--tRNA ligase, cytoplasmic [Sus scrofa]	17	17	17	61328000	62961000	75792000	54549000	62584000	55894000	61183000	56697000	63715000	73948000	64625000	91345000	23476000	59684000	60166000	68384000	59908000	68138000	NA	NA	NA	RARS	RARS;NA;NA;NA;NA	arginyl-tRNA aminoacylation;tRNA aminoacylation for protein translation	GO:000642; GO:000641	membrane;nucleoplasm;cytosol;extracellular exosome;cytoplasm;nucleus;aminoacyl-tRNA synthetase multienzyme complex	GO:001602; GO:000565; GO:000582; GO:007006; GO:000573; GO:000563; GO:001710	 Aminoacyl-tRNA biosynthesis	hsa0097	arginine-tRNA ligase activity;cadherin binding;arginine binding;tRNA binding;ATP binding;protein binding	GO:000481; GO:004529; GO:003461; GO:000004; GO:000552; GO:000551
NP_001231190.1;XP_013851600.1	NP_001231190.1;XP_013851600.1	NP_001231190.1 EGF-containing fibulin-like extracellular matrix protein 1 precursor [Sus scrofa];XP_013851600.1 EGF-containing fibulin-like extracellular matrix protein 1 isoform X1 [Sus scrofa]	14	14	14	89107000	241560000	179790000	372000000	172400000	265060000	182540000	264310000	177530000	286930000	323250000	322760000	491260000	291170000	239710000	210130000	239100000	322020000	NA	NA	NA	EFEMP1	EFEMP1;EFEMP1;NA;NA;NA	regulation of receptor activity;peptidyl-tyrosine phosphorylation;visual perception;embryonic eye morphogenesis;epidermal growth factor receptor signaling pathway;negative regulation of chondrocyte differentiation;camera-type eye development;post-embryonic eye morphogenesis;regulation of transcription, DNA-templated	GO:001046; GO:001810; GO:000760; GO:004804; GO:000717; GO:003233; GO:004301; GO:004805; GO:000635	extracellular space;extracellular exosome;extracellular region;extracellular matrix	GO:000561; GO:007006; GO:000557; GO:003101	"NA"	"NA"	epidermal growth factor-activated receptor activity;protein binding;epidermal growth factor receptor binding;extracellular matrix structural constituent;growth factor activity;calcium ion binding	GO:000500; GO:000551; GO:000515; GO:000520; GO:000808; GO:000550
XP_020930264.1;XP_020930263.1;NP_001231192.1;XP_013839740.1;XP_005672029.1	XP_020930264.1;XP_020930263.1;NP_001231192.1;XP_013839740.1;XP_005672029.1	XP_020930264.1 protein lunapark isoform X4 [Sus scrofa];XP_020930263.1 protein lunapark isoform X3 [Sus scrofa];NP_001231192.1 protein lunapark [Sus scrofa];XP_013839740.1 protein lunapark isoform X2 [Sus scrofa];XP_005672029.1 protein lunapark isoform X1	6	6	6	25817000	22438000	19918000	24694000	0	0	27214000	22905000	0	20900000	25495000	0	0	28531000	23044000	0	24875000	0	NA	NA	NA	LNPK	LNPK;LNPK;LNPK;LNPK;LNPK	endoplasmic reticulum organization;regulation of chondrocyte differentiation;positive regulation of endoplasmic reticulum tubular network organization;blood coagulation;limb development;endoplasmic reticulum tubular network maintenance;embryonic forelimb morphogenesis;embryonic digit morphogenesis	GO:000702; GO:003233; GO:190337; GO:000759; GO:006017; GO:007178; GO:003511; GO:004273	integral component of endoplasmic reticulum membrane;endoplasmic reticulum;nucleoplasm;endoplasmic reticulum tubular network;endoplasmic reticulum tubular network membrane;integral component of membrane	GO:003017; GO:000578; GO:000565; GO:007178; GO:009882; GO:001602	"NA"	"NA"	identical protein binding;metal ion binding	GO:004280; GO:004687
NP_001231205.1;XP_013840827.1	NP_001231205.1;XP_013840827.1	NP_001231205.1 thioredoxin-like protein 1 [Sus scrofa];XP_013840827.1 thioredoxin-like protein 1 isoform X1 [Sus scrofa]	8	8	8	127420000	120570000	143460000	129120000	103720000	96567000	113000000	109520000	117100000	91484000	104880000	111760000	119130000	114360000	114150000	117860000	116710000	126770000	NA	NA	NA	TXNL1	TXNL1;TXNL1;NA;NA;NA	oxidation-reduction process;cell redox homeostasis	GO:005511; GO:004545	cytoplasm;proteasome complex;nucleus;cytosol	GO:000573; GO:000050; GO:000563; GO:000582	"NA"	"NA"	disulfide oxidoreductase activity	GO:001503
NP_001231212.1;XP_020949001.1	NP_001231212.1;XP_020949001.1	NP_001231212.1 complement C1q subcomponent subunit B precursor [Sus scrofa];XP_020949001.1 complement C1q subcomponent subunit B isoform X1 [Sus scrofa]	2	2	2	29381000	44493000	38788000	36502000	31908000	52209000	22306000	21430000	23771000	0	32186000	35989000	32583000	37873000	33359000	0	47054000	29679000	NA	NA	NA	C1QB	C1QB;C1QB;NA;NA;NA	innate immune response;complement activation;regulation of complement activation;proteolysis;inner ear development	GO:004508; GO:000695; GO:003044; GO:000650; GO:004883	extracellular region;complement component C1 complex;blood microparticle;collagen trimer	GO:000557; GO:000560; GO:007256; GO:000558	 Complement and coagulation cascades; Pertussis; Staphylococcus aureus infection; Systemic lupus erythematosus; Prion diseases; Chagas disease (American trypanosomiasis)	hsa0461; hsa0513; hsa0515; hsa0532; hsa0502; hsa0514	protein homodimerization activity;serine-type endopeptidase activity;protein binding	GO:004280; GO:000425; GO:000551
XP_020949253.1;NP_001231215.1	XP_020949253.1;NP_001231215.1	XP_020949253.1 complement C1q subcomponent subunit C isoform X1 [Sus scrofa];NP_001231215.1 complement C1q subcomponent subunit C precursor [Sus scrofa]	4	4	4	0	28491000	0	22527000	0	29866000	0	0	18148000	14842000	0	0	0	0	0	19887000	0	22331000	NA	NA	NA	C1QC	C1QC;C1QC;NA;NA;NA	complement activation, classical pathway;immune response;regulation of complement activation;negative regulation of granulocyte differentiation;innate immune response;negative regulation of macrophage differentiation;proteolysis	GO:000695; GO:000695; GO:003044; GO:003085; GO:004508; GO:004565; GO:000650	extracellular region;blood microparticle;extracellular space;collagen trimer	GO:000557; GO:007256; GO:000561; GO:000558	 Pertussis; Chagas disease (American trypanosomiasis); Complement and coagulation cascades; Prion diseases; Systemic lupus erythematosus; Staphylococcus aureus infection	hsa0513; hsa0514; hsa0461; hsa0502; hsa0532; hsa0515	serine-type endopeptidase activity;protein binding	GO:000425; GO:000551
NP_001231230.1	NP_001231230.1	NP_001231230.1 importin-5 [Sus scrofa]	12	12	12	92321000	58133000	75016000	65286000	64614000	63093000	64142000	73037000	78711000	73491000	57089000	74710000	83280000	66790000	64403000	59507000	67961000	72837000	NA	NA	NA	IPO5	IPO5;NA;NA;NA;NA	viral process;positive regulation of protein import into nucleus;cellular response to amino acid stimulus;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of GTPase activity;ribosomal protein import into nucleus;NLS-bearing protein import into nucleus	GO:001603; GO:004230; GO:007123; GO:004573; GO:003426; GO:000661; GO:000660	nucleolus;nuclear membrane;membrane;nuclear pore;cytoplasm;nuclear periphery;nucleus	GO:000573; GO:003196; GO:001602; GO:000564; GO:000573; GO:003439; GO:000563	"NA"	"NA"	RNA binding;protein binding;GTPase inhibitor activity;nuclear localization sequence binding;protein transporter activity;Ran GTPase binding	GO:000372; GO:000551; GO:000509; GO:000813; GO:000856; GO:000853
XP_020932924.1;NP_001231234.1	XP_020932924.1;NP_001231234.1	XP_020932924.1 nucleolar protein 56 isoform X1 [Sus scrofa];NP_001231234.1 nucleolar protein 56 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1440400	NA	NA	NA	NOP56	NOP56;NOP56;NA;NA;NA	rRNA processing	GO:000636	cytoplasm;nucleoplasm;fibrillar center;small nucleolar ribonucleoprotein complex;small-subunit processome;pre-snoRNP complex;membrane;box C/D snoRNP complex	GO:000573; GO:000565; GO:000165; GO:000573; GO:003204; GO:007076; GO:001602; GO:003142	 Ribosome biogenesis in eukaryotes	hsa0300	snoRNA binding;protein binding;RNA binding;cadherin binding;histone methyltransferase binding	GO:003051; GO:000551; GO:000372; GO:004529; GO:199022
NP_001231236.1;XP_020935554.1	NP_001231236.1;XP_020935554.1	NP_001231236.1 dynactin subunit 4 [Sus scrofa];XP_020935554.1 dynactin subunit 4 isoform X1 [Sus scrofa]	8	8	8	18768000	15805000	15350000	13920000	0	13915000	13748000	14343000	15045000	19998000	13404000	19409000	15372000	17716000	0	14855000	15731000	16471000	NA	NA	NA	DCTN4	DCTN4;DCTN4;NA;NA;NA	nuclear migration;ER to Golgi vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II	GO:000709; GO:000688; GO:001988	cytoplasm;dynactin complex;kinetochore;cytosol;stress fiber;nucleus;sarcomere;centrosome;focal adhesion;cell cortex;spindle pole	GO:000573; GO:000586; GO:000077; GO:000582; GO:000172; GO:000563; GO:003001; GO:000581; GO:000592; GO:000593; GO:000092	 Vasopressin-regulated water reabsorption; Huntington's disease	hsa0496; hsa0501	protein binding;protein N-terminus binding	GO:000551; GO:004748
XP_005664048.1;NP_001231246.1;NP_001231245.1;XP_020946741.1;XP_020946742.1;XP_005664050.1	XP_005664048.1;NP_001231246.1;NP_001231245.1;XP_020946741.1;XP_020946742.1;XP_005664050.1	XP_005664048.1 nucleosome assembly protein 1-like 1 isoform X1 [Sus scrofa];NP_001231246.1 nucleosome assembly protein 1-like 1 [Sus scrofa];NP_001231245.1 nucleosome assembly protein 1-like 1 [Sus scrofa];XP_020946741.1 nucleosome assembly protein 1-like	9	9	7	100850000	109350000	96689000	95468000	73722000	101460000	90085000	119340000	98937000	106760000	86787000	154050000	95558000	93048000	99135000	112380000	100080000	122090000	NA	NA	NA	NAP1L1	NAP1L1;NAP1L1;NAP1L1;NAP1L1;NAP1L1	positive regulation of neural precursor cell proliferation;positive regulation of neurogenesis;nucleosome assembly;positive regulation of cell proliferation;DNA replication	GO:200017; GO:005076; GO:000633; GO:000828; GO:000626	cytoplasm;membrane;nucleus;melanosome	GO:000573; GO:001602; GO:000563; GO:004247	"NA"	"NA"	RNA binding;protein binding	GO:000372; GO:000551
XP_005660263.1;NP_001231254.1;NP_001231257.1;XP_005660262.2	XP_005660263.1;NP_001231254.1;NP_001231257.1	XP_005660263.1 histidine triad nucleotide-binding protein 2, mitochondrial isoform X2 [Sus scrofa];NP_001231254.1 histidine triad nucleotide-binding protein 2, mitochondrial isoform 1 precursor [Sus scrofa];NP_001231257.1 histidine triad nucleotide-binding	5	5	5	73056000	59681000	71586000	49402000	65761000	43554000	79264000	63793000	70529000	61484000	64207000	82215000	50524000	54060000	57308000	75802000	55406000	58577000	NA	NA	NA	HINT2	HINT2;HINT2;HINT2;NA;NA	apoptotic process;steroid biosynthetic process;lipid catabolic process;negative regulation of peptidyl-lysine acetylation	GO:000691; GO:000669; GO:001604; GO:200075	mitochondrion;nucleolus	GO:000573; GO:000573	"NA"	"NA"	hydrolase activity;nucleotide binding	GO:001678; GO:000016
NP_001231258.1;XP_005669119.2;XP_020921794.1	NP_001231258.1;XP_005669119.2;XP_020921794.1	NP_001231258.1 cytokine receptor-like factor 3 [Sus scrofa];XP_005669119.2 cytokine receptor-like factor 3 isoform X2 [Sus scrofa];XP_020921794.1 cytokine receptor-like factor 3 isoform X1 [Sus scrofa]	6	6	6	13892000	9000700	14193000	12010000	13845000	2860100	8136600	11294000	10733000	12696000	8891200	8896700	0	0	12683000	0	6045800	0	NA	NA	NA	CRLF3	CRLF3;CRLF3;CRLF3;NA;NA	negative regulation of cell growth;positive regulation of cell cycle arrest;G1/S transition of mitotic cell cycle;positive regulation of JAK-STAT cascade;positive regulation of transcription, DNA-templated;positive regulation of transcription from RNA polymerase II promoter	GO:003030; GO:007115; GO:000008; GO:004642; GO:004589; GO:004594	plasma membrane;nucleus;cytosol;cytoplasm	GO:000588; GO:000563; GO:000582; GO:000573	"NA"	"NA"	identical protein binding;DNA binding;protein binding	GO:004280; GO:000367; GO:000551
NP_001231260.1	NP_001231260.1	NP_001231260.1 neurofilament light polypeptide [Sus scrofa]	19	17	17	0	1289800000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NEFL	NEFL;NA;NA;NA;NA	microtubule cytoskeleton organization;peripheral nervous system axon regeneration;cerebral cortex development;locomotion;neuron projection morphogenesis;spinal cord development;hippocampus development;regulation of axon diameter;anterograde axonal transport;axonal transport of mitochondrion;intermediate filament organization;response to acrylamide;neurofilament bundle assembly;positive regulation of axonogenesis;neuromuscular process controlling balance;synapse maturation;protein polymerization;MAPK cascade;response to corticosterone;retrograde axonal transport;response to peptide hormone;negative regulation of neuron apoptotic process;neurofilament cytoskeleton organization	GO:000022; GO:001401; GO:002198; GO:004001; GO:004881; GO:002151; GO:002176; GO:003113; GO:000808; GO:001989; GO:004510; GO:190393; GO:003369; GO:005077; GO:005088; GO:006007; GO:005125; GO:000016; GO:005141; GO:000809; GO:004343; GO:004352; GO:006005	cytosol;neurofilament;neuromuscular junction;growth cone;Schaffer collateral - CA1 synapse;cholinergic synapse;cytoplasm;axon cytoplasm	GO:000582; GO:000588; GO:003159; GO:003042; GO:009868; GO:009898; GO:000573; GO:190411	 Amyotrophic lateral sclerosis (ALS)	hsa0501	protein binding, bridging;structural constituent of cytoskeleton;protein binding;protein C-terminus binding;identical protein binding;phospholipase binding;protein heterodimerization activity;Ras guanyl-nucleotide exchange factor activity;protein domain specific binding	GO:003067; GO:000520; GO:000551; GO:000802; GO:004280; GO:004327; GO:004698; GO:000508; GO:001990
NP_001231264.1	NP_001231264.1	NP_001231264.1 neuromodulin [Sus scrofa]	2	2	2	0	28773000	0	0	0	32779000	0	0	0	0	0	0	0	0	0	0	0	47901000	NA	NA	NA	GAP43	GAP43;NA;NA;NA;NA	cell fate commitment;response to wounding;glial cell differentiation;axon choice point recognition;regulation of growth;tissue regeneration;nervous system development;axon regeneration;regulation of filopodium assembly;protein kinase C-activating G-protein coupled receptor signaling pathway	GO:004516; GO:000961; GO:001000; GO:001619; GO:004000; GO:004224; GO:000739; GO:003110; GO:005148; GO:000720	postsynaptic density;cell junction;GABA-ergic synapse;plasma membrane;filopodium membrane;cytoplasm;growth cone membrane	GO:001406; GO:003005; GO:009898; GO:000588; GO:003152; GO:000573; GO:003258	"NA"	"NA"	lysophosphatidic acid binding;calmodulin binding;phosphatidylserine binding;phosphatidylinositol phosphate binding	GO:003572; GO:000551; GO:000178; GO:190198
XP_013845424.1;NP_001231268.1	XP_013845424.1;NP_001231268.1	XP_013845424.1 GPI transamidase component PIG-S isoform X1 [Sus scrofa];NP_001231268.1 GPI transamidase component PIG-S [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	21069000	0	0	0	0	0	0	NA	NA	NA	PIGS	PIGS;PIGS;NA;NA;NA	attachment of GPI anchor to protein	GO:001625	membrane;GPI-anchor transamidase complex;endoplasmic reticulum membrane	GO:001602; GO:004276; GO:000578	 Metabolic pathways; Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	hsa0110; hsa0056	protein binding;GPI-anchor transamidase activity	GO:000551; GO:000392
XP_020949049.1;XP_020949048.1;NP_001231270.1;XP_005659297.1;XP_003121294.1	XP_020949049.1;XP_020949048.1;NP_001231270.1;XP_005659297.1;XP_003121294.1	XP_020949049.1 protein tyrosine phosphatase type IVA 2 isoform X1 [Sus scrofa];XP_020949048.1 protein tyrosine phosphatase type IVA 2 isoform X1 [Sus scrofa];NP_001231270.1 protein tyrosine phosphatase type IVA 2 [Sus scrofa];XP_005659297.1 protein tyrosin	4	4	4	0	0	17438000	12903000	0	0	0	0	0	0	0	0	0	17438000	0	17931000	0	17392000	NA	NA	NA	PTP4A2	PTP4A2;PTP4A2;PTP4A2;PTP4A1;PTP4A1	peptidyl-tyrosine dephosphorylation;post-translational protein modification	GO:003533; GO:004368	nucleus;early endosome;cytoplasm;plasma membrane;cytosol	GO:000563; GO:000576; GO:000573; GO:000588; GO:000582	"NA"	"NA"	protein tyrosine phosphatase activity;prenylated protein tyrosine phosphatase activity	GO:000472; GO:000472
NP_001231271.1;XP_020924132.1;XP_020924134.1;XP_020924133.1	NP_001231271.1;XP_020924132.1;XP_020924134.1;XP_020924133.1	NP_001231271.1 omega-amidase NIT2 [Sus scrofa];XP_020924132.1 omega-amidase NIT2 isoform X1 [Sus scrofa];XP_020924134.1 omega-amidase NIT2 isoform X3 [Sus scrofa];XP_020924133.1 omega-amidase NIT2 isoform X2 [Sus scrofa]	17	17	17	188060000	163950000	183560000	163640000	134190000	158500000	137600000	115770000	126690000	134630000	189770000	204210000	174680000	192180000	183300000	181560000	160190000	169250000	NA	NA	NA	NIT2	NIT2;NIT2;NIT2;NIT2;NA	asparagine metabolic process;oxaloacetate metabolic process;neutrophil degranulation;glutamine metabolic process	GO:000652; GO:000610; GO:004331; GO:000654	specific granule lumen;extracellular region;extracellular exosome;cytosol;centrosome;tertiary granule lumen	GO:003558; GO:000557; GO:007006; GO:000582; GO:000581; GO:190472	 Alanine, aspartate and glutamate metabolism	hsa0025	omega-amidase activity	GO:005015
XP_020956015.1;NP_001231273.1;NP_001231272.1	XP_020956015.1;NP_001231273.1;NP_001231272.1	XP_020956015.1 transmembrane protein 33 isoform X1 [Sus scrofa];NP_001231273.1 transmembrane protein 33 [Sus scrofa];NP_001231272.1 transmembrane protein 33 [Sus scrofa]	3	3	3	14256000	16275000	14081000	17961000	19417000	12516000	0	15371000	16406000	15375000	15463000	16922000	25333000	0	13818000	16110000	14042000	15057000	NA	NA	NA	TMEM33	TMEM33;TMEM33;TMEM33;NA;NA	regulation of endoplasmic reticulum tubular network organization;positive regulation of PERK-mediated unfolded protein response;response to endoplasmic reticulum stress	GO:190337; GO:190389; GO:003497	endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum;nuclear pore;melanosome;nuclear envelope	GO:000578; GO:003017; GO:000578; GO:000564; GO:004247; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_020923876.1;XP_020923875.1;XP_020923874.1;XP_020923873.1;NP_001231276.1	XP_020923876.1;XP_020923875.1;XP_020923874.1;XP_020923873.1;NP_001231276.1	XP_020923876.1 ADP-ribosylarginine hydrolase isoform X1 [Sus scrofa];XP_020923875.1 ADP-ribosylarginine hydrolase isoform X1 [Sus scrofa];XP_020923874.1 ADP-ribosylarginine hydrolase isoform X1 [Sus scrofa];XP_020923873.1 ADP-ribosylarginine hydrolase isof	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ADPRH	ADPRH;ADPRH;ADPRH;ADPRH;ADPRH	protein de-ADP-ribosylation;activation of GTPase activity;cellular protein modification process;intracellular protein transport	GO:005172; GO:009063; GO:000646; GO:000688	cell	GO:000562	"NA"	"NA"	potassium ion binding;magnesium ion binding;ADP-ribosylarginine hydrolase activity;GTPase activator activity;Rab GTPase binding;protein binding	GO:003095; GO:000028; GO:000387; GO:000509; GO:001713; GO:000551
NP_001231279.1	NP_001231279.1	NP_001231279.1 carboxymethylenebutenolidase homolog [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3026200	0	0	0	NA	NA	NA	CMBL	CMBL;NA;NA;NA;NA	xenobiotic metabolic process	GO:000680	extracellular exosome;cytosol	GO:007006; GO:000582	 Metabolic pathways; Biosynthesis of antibiotics	hsa0110; hsa0113	hydrolase activity	GO:001678
NP_001231282.1	NP_001231282.1	NP_001231282.1 proteasome subunit beta type-1 [Sus scrofa]	7	7	7	113040000	83665000	100860000	89787000	89463000	75441000	112590000	99316000	95054000	79308000	104440000	72245000	85004000	103300000	108870000	85051000	108720000	81050000	NA	NA	NA	PSMB1	PSMB1;NA;NA;NA;NA	protein deubiquitination;proteasomal ubiquitin-independent protein catabolic process;neutrophil degranulation;viral process;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification	GO:001657; GO:001049; GO:004331; GO:001603; GO:004316; GO:004368	proteasome core complex, beta-subunit complex;secretory granule lumen;proteasome complex;extracellular region;nucleus;proteasome core complex;cytosol;cytoplasm;ficolin-1-rich granule lumen;nucleoplasm;extracellular exosome	GO:001977; GO:003477; GO:000050; GO:000557; GO:000563; GO:000583; GO:000582; GO:000573; GO:190481; GO:000565; GO:007006	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000417
XP_020923891.1;NP_001231283.1;XP_020923892.1;XP_013835765.1;XP_005668256.1;XP_003130856.1	XP_020923891.1;NP_001231283.1;XP_020923892.1;XP_013835765.1;XP_005668256.1;XP_003130856.1	XP_020923891.1 protein transport protein Sec61 subunit alpha isoform X1 [Sus scrofa];NP_001231283.1 protein transport protein Sec61 subunit alpha [Sus scrofa];XP_020923892.1 protein transport protein Sec61 subunit alpha isoform X2 [Sus scrofa];XP_013835765	6	6	6	48694000	44130000	48789000	40097000	33567000	47101000	37298000	43271000	56071000	34241000	36218000	71523000	37349000	61299000	45009000	43066000	65021000	58510000	NA	NA	NA	SEC61A1	SEC61A1;SEC61A1;SEC61A2;SEC61A2;SEC61A2	protein targeting to ER;SRP-dependent cotranslational protein targeting to membrane, translocation;posttranslational protein targeting to membrane;endoplasmic reticulum organization;response to interferon-gamma;pronephric nephron development	GO:004504; GO:000661; GO:000662; GO:000702; GO:003434; GO:003901	Sec61 translocon complex;endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;membrane;cytosol	GO:000578; GO:000578; GO:003017; GO:001602; GO:000582	 Protein export; Phagosome; Vibrio cholerae infection	hsa0306; hsa0414; hsa0511	protein transmembrane transporter activity;ribosome binding;protein binding;signal sequence binding	GO:000832; GO:004302; GO:000551; GO:000504
NP_001231289.1	NP_001231289.1	NP_001231289.1 smoothelin [Sus scrofa]	17	17	17	0	0	113640000	0	0	51653000	0	0	41521000	183390000	56614000	56881000	191750000	0	0	0	0	0	NA	NA	NA	SMTN	SMTN;NA;NA;NA;NA	smooth muscle contraction;actin cytoskeleton organization;muscle organ development	GO:000693; GO:003003; GO:000751	cytoplasm;cytoskeleton;microtubule organizing center;actin cytoskeleton;filamentous actin	GO:000573; GO:000585; GO:000581; GO:001562; GO:003194	"NA"	"NA"	actin binding;structural constituent of muscle	GO:000377; GO:000830
NP_001231300.1	NP_001231300.1	NP_001231300.1 peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PIN1	PIN1;NA;NA;NA;NA	positive regulation of protein phosphorylation;cell cycle;protein stabilization;neuron differentiation;negative regulation of type I interferon production;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of GTPase activity;negative regulation of neuron apoptotic process;regulation of protein phosphorylation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of ERK1 and ERK2 cascade;positive regulation of canonical Wnt signaling pathway;regulation of cytokinesis;negative regulation of protein catabolic process;synapse organization;regulation of pathway-restricted SMAD protein phosphorylation;regulation of signal transduction by p53 class mediator;negative regulation of cell motility;negative regulation of protein binding;microtubule polymerization;protein peptidyl-prolyl isomerization;regulation of gene expression;positive regulation of protein dephosphorylation;positive regulation of cell growth involved in cardiac muscle cell development;positive regulation of ubiquitin-protein transferase activity;regulation of protein localization to nucleus;regulation of mitotic nuclear division	GO:000193; GO:000704; GO:005082; GO:003018; GO:003248; GO:003051; GO:004354; GO:004352; GO:000193; GO:004594; GO:007037; GO:009026; GO:003246; GO:004217; GO:005080; GO:006039; GO:190179; GO:200014; GO:003209; GO:004678; GO:000041; GO:001046; GO:003530; GO:006105; GO:005144; GO:190018; GO:000708	cytoplasm;midbody;mitochondrion;cytosol;nucleus;glutamatergic synapse;nucleoplasm;neuron projection;nuclear speck;postsynaptic cytosol	GO:000573; GO:003049; GO:000573; GO:000582; GO:000563; GO:009897; GO:000565; GO:004300; GO:001660; GO:009952	 RIG-I-like receptor signaling pathway	hsa0462	mitogen-activated protein kinase kinase binding;peptidyl-prolyl cis-trans isomerase activity;GTPase activating protein binding;motor activity;protein binding;beta-catenin binding;phosphoserine binding;tau protein binding;phosphoprotein binding	GO:003143; GO:000375; GO:003279; GO:000377; GO:000551; GO:000801; GO:005081; GO:004815; GO:005121
XP_005671198.1;XP_005671197.1;NP_001231304.1;XP_005671196.1;XP_005671195.1;NP_001231303.1;NP_001231302.1;XP_005671194.1	XP_005671198.1;XP_005671197.1;NP_001231304.1;XP_005671196.1;XP_005671195.1;NP_001231303.1;NP_001231302.1;XP_005671194.1	XP_005671198.1 redox-regulatory protein FAM213A isoform X3 [Sus scrofa];XP_005671197.1 redox-regulatory protein FAM213A isoform X3 [Sus scrofa];NP_001231304.1 redox-regulatory protein FAM213A isoform 2 [Sus scrofa];XP_005671196.1 redox-regulatory protein F	15	15	15	515100000	388350000	397730000	366470000	467630000	347740000	405920000	414340000	379880000	401610000	526190000	515570000	181160000	416600000	511850000	471360000	400110000	423990000	NA	NA	NA	PRXL2A	PRXL2A;PRXL2A;PRXL2A;PRXL2A;PRXL2A	oxidation-reduction process;regulation of osteoclast differentiation;cellular oxidant detoxification	GO:005511; GO:004567; GO:009886	extracellular region;cytoplasm	GO:000557; GO:000573	"NA"	"NA"	antioxidant activity	GO:001620
NP_001231305.1;XP_020937433.1	NP_001231305.1	NP_001231305.1 thyroid hormone-inducible hepatic protein [Sus scrofa]	6	6	6	357280000	171750000	357050000	79671000	171730000	149760000	286570000	128730000	336040000	169020000	155040000	94242000	31739000	146640000	124750000	81230000	102870000	61245000	NA	NA	NA	THRSP	THRSP;NA;NA;NA;NA	regulation of lipid biosynthetic process;regulation of triglyceride biosynthetic process;response to bacterium;lipid metabolic process;carnitine shuttle	GO:004689; GO:001086; GO:000961; GO:000662; GO:000685	nucleoplasm;cytosol	GO:000565; GO:000582	"NA"	"NA"	identical protein binding;protein homodimerization activity	GO:004280; GO:004280
XP_005671209.1;XP_005671208.1;XP_005671207.1;NP_001231312.1;NP_001231311.1	XP_005671209.1;XP_005671208.1;XP_005671207.1;NP_001231312.1;NP_001231311.1	XP_005671209.1 growth hormone-inducible transmembrane protein isoform X1 [Sus scrofa];XP_005671208.1 growth hormone-inducible transmembrane protein isoform X1 [Sus scrofa];XP_005671207.1 growth hormone-inducible transmembrane protein isoform X1 [Sus scrofa	2	2	2	0	0	27091000	0	0	22822000	0	0	0	18366000	0	0	0	0	0	20959000	0	0	NA	NA	NA	GHITM	GHITM;GHITM;GHITM;GHITM;GHITM	apoptotic process;biological_process	GO:000691; GO:000815	integral component of membrane;mitochondrial inner membrane;extracellular exosome;mitochondrion	GO:001602; GO:000574; GO:007006; GO:000573	"NA"	"NA"	molecular_function;protein binding	GO:000367; GO:000551
NP_001231313.1;XP_003134345.1	NP_001231313.1	NP_001231313.1 alpha-soluble NSF attachment protein [Sus scrofa]	8	8	8	82851000	83054000	81018000	60946000	65332000	71912000	79840000	77303000	85167000	71856000	82558000	77847000	64928000	84152000	76363000	78160000	72072000	71691000	NA	NA	NA	NAPA	NAPA;NA;NA;NA;NA	synaptic vesicle priming;apical protein localization;positive regulation of ATPase activity;synaptic transmission, glutamatergic;intra-Golgi vesicle-mediated transport;COPII vesicle coating;intracellular protein transport;regulation of synaptic vesicle priming;membrane fusion;SNARE complex disassembly;brain development;neuron differentiation	GO:001608; GO:004517; GO:003278; GO:003524; GO:000689; GO:004820; GO:000688; GO:001080; GO:006102; GO:003549; GO:000742; GO:003018	postsynapse;Golgi membrane;cytosol;SNARE complex;presynapse;glutamatergic synapse;membrane;plasma membrane;extracellular exosome;vacuolar membrane;synaptobrevin 2-SNAP-25-syntaxin-1a complex	GO:009879; GO:000013; GO:000582; GO:003120; GO:009879; GO:009897; GO:001602; GO:000588; GO:007006; GO:000577; GO:007004	 Synaptic vesicle cycle	hsa0472	protein binding;soluble NSF attachment protein activity;syntaxin binding;SNARE binding;macromolecular complex binding	GO:000551; GO:000548; GO:001990; GO:000014; GO:004487
NP_001231315.1;XP_020956018.1	NP_001231315.1;XP_020956018.1	NP_001231315.1 peptidyl-prolyl cis-trans isomerase D [Sus scrofa];XP_020956018.1 peptidyl-prolyl cis-trans isomerase D isoform X1 [Sus scrofa]	7	7	7	26395000	24827000	21482000	16316000	40312000	21049000	25168000	21518000	19199000	20115000	28655000	28428000	25972000	22570000	26175000	25276000	33731000	19982000	NA	NA	NA	PPID	PPID;PPID;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;protein refolding;positive regulation of viral genome replication;positive regulation of protein secretion;macromolecular complex assembly;apoptotic process;viral release from host cell;lipid particle organization;cellular response to UV-A;protein peptidyl-prolyl isomerization;protein transport;positive regulation of apoptotic process;protein folding;chaperone-mediated protein folding	GO:000012; GO:004202; GO:004507; GO:005071; GO:006500; GO:000691; GO:001907; GO:003438; GO:007149; GO:000041; GO:001503; GO:004306; GO:000645; GO:006107	nucleus;nucleoplasm;nucleolus;cytosol	GO:000563; GO:000565; GO:000573; GO:000582	"NA"	"NA"	estrogen receptor binding;Hsp70 protein binding;transcription factor binding;unfolded protein binding;peptidyl-prolyl cis-trans isomerase activity;Hsp90 protein binding;heat shock protein binding;cyclosporin A binding;protein binding	GO:003033; GO:003054; GO:000813; GO:005108; GO:000375; GO:005187; GO:003107; GO:001601; GO:000551
NP_001231316.1;XP_020944160.1;XP_020944159.1;XP_020944158.1;XP_020944156.1;XP_020944155.1;XP_020944154.1;XP_020944161.1	NP_001231316.1;XP_020944160.1;XP_020944159.1;XP_020944158.1;XP_020944156.1;XP_020944155.1;XP_020944154.1;XP_020944161.1	NP_001231316.1 tumor protein D52 [Sus scrofa];XP_020944160.1 tumor protein D52 isoform X6 [Sus scrofa];XP_020944159.1 tumor protein D52 isoform X5 [Sus scrofa];XP_020944158.1 tumor protein D52 isoform X4 [Sus scrofa];XP_020944156.1 tumor protein D52 isofor	8	8	8	20392000	37086000	28064000	24144000	19554000	25642000	24565000	23418000	24157000	28060000	21305000	39071000	28476000	26467000	23481000	24941000	24926000	34821000	NA	NA	NA	TPD52	TPD52;TPD52;TPD52;TPD52;TPD52	secretion;B cell differentiation;anatomical structure morphogenesis	GO:004690; GO:003018; GO:000965	perinuclear region of cytoplasm;cytoplasm;endoplasmic reticulum	GO:004847; GO:000573; GO:000578	"NA"	"NA"	protein binding;calcium ion binding;protein homodimerization activity;protein heterodimerization activity	GO:000551; GO:000550; GO:004280; GO:004698
NP_001231317.1;XP_020919666.1	NP_001231317.1;XP_020919666.1	NP_001231317.1 cyclin-Y [Sus scrofa];XP_020919666.1 cyclin-Y isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2319400	NA	NA	NA	CCNY	CCNY;CCNY;NA;NA;NA	G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein serine/threonine kinase activity;Wnt signaling pathway;cell division;regulation of canonical Wnt signaling pathway	GO:000008; GO:004573; GO:001605; GO:005130; GO:006082	plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex	GO:000588; GO:000563; GO:000030	"NA"	"NA"	protein kinase binding;protein binding;cyclin-dependent protein serine/threonine kinase regulator activity	GO:001990; GO:000551; GO:001653
NP_001231318.1;XP_020919924.1;XP_020937817.1;XP_020937816.1;XP_020937815.1;XP_020937813.1;XP_020937812.1;XP_020937811.1	NP_001231318.1;XP_020919924.1	NP_001231318.1 saccharopine dehydrogenase-like oxidoreductase [Sus scrofa];XP_020919924.1 saccharopine dehydrogenase-like oxidoreductase [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	19530000	0	0	0	0	0	0	0	28382000	28568000	0	NA	NA	NA	SCCPDH	SCCPDH;LOC102162044;NA;NA;NA	platelet degranulation;glycolipid biosynthetic process;oxidation-reduction process	GO:000257; GO:000924; GO:005511	lipid particle;membrane;nucleus;midbody;plasma membrane;mitochondrion;extracellular region;platelet alpha granule lumen	GO:000581; GO:001602; GO:000563; GO:003049; GO:000588; GO:000573; GO:000557; GO:003109	"NA"	"NA"	oxidoreductase activity	GO:001649
XP_013845657.1;XP_005652865.1;NP_001231321.1	XP_013845657.1;XP_005652865.1;NP_001231321.1	XP_013845657.1 small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X1 [Sus scrofa];XP_005652865.1 small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X1 [Sus scrofa];NP_001231321.1 small glutamine-rich	7	7	7	0	24979000	38282000	0	0	23218000	33156000	19241000	30441000	20615000	18920000	29493000	20092000	24087000	0	24726000	27288000	23911000	NA	NA	NA	SGTA	SGTA;SGTA;SGTA;NA;NA	viral process;negative regulation of ER-associated ubiquitin-dependent protein catabolic process;ubiquitin-dependent ERAD pathway;positive regulation of chaperone-mediated protein folding;chaperone-mediated protein folding;tail-anchored membrane protein insertion into ER membrane;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;posttranslational protein targeting to membrane	GO:001603; GO:190307; GO:003043; GO:190364; GO:006107; GO:007181; GO:200005; GO:000662	membrane;cytosol;extrinsic component of synaptic vesicle membrane;nucleus;TRC complex;cytoplasm	GO:001602; GO:000582; GO:009885; GO:000563; GO:007238; GO:000573	"NA"	"NA"	identical protein binding;protein complex scaffold;protein self-association;protein binding;BAT3 complex binding	GO:004280; GO:003294; GO:004362; GO:000551; GO:190428
NP_001231322.1	NP_001231322.1	NP_001231322.1 ribosome maturation protein SBDS [Sus scrofa]	12	12	12	68243000	53351000	67072000	67178000	59594000	53593000	60971000	66517000	56306000	65686000	53108000	58449000	41391000	62231000	59807000	62610000	62809000	40871000	NA	NA	NA	SBDS	SBDS;NA;NA;NA;NA	cell proliferation;bone marrow development;inner cell mass cell proliferation;bone mineralization;mature ribosome assembly;rRNA processing;leukocyte chemotaxis;mitotic spindle organization	GO:000828; GO:004853; GO:000183; GO:003028; GO:004225; GO:000636; GO:003059; GO:000705	spindle pole;cytosol;nucleus;cytoplasm;nucleoplasm	GO:000092; GO:000582; GO:000563; GO:000573; GO:000565	 Ribosome biogenesis in eukaryotes	hsa0300	rRNA binding;protein binding;ribosome binding;RNA binding;microtubule binding	GO:001984; GO:000551; GO:004302; GO:000372; GO:000801
NP_001231326.1;XP_005668766.1	NP_001231326.1;XP_005668766.1	NP_001231326.1 glial fibrillary acidic protein [Sus scrofa];XP_005668766.1 glial fibrillary acidic protein isoform X1 [Sus scrofa]	2	2	2	0	8775200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GFAP	GFAP;GFAP;NA;NA;NA	Bergmann glial cell differentiation;neuron projection regeneration;long-term synaptic potentiation;response to wounding;intermediate filament organization;astrocyte development;negative regulation of neuron projection development;extracellular matrix organization;regulation of protein complex assembly;regulation of neurotransmitter uptake;positive regulation of Schwann cell proliferation;regulation of chaperone-mediated autophagy	GO:006002; GO:003110; GO:006029; GO:000961; GO:004510; GO:001400; GO:001097; GO:003019; GO:004325; GO:005158; GO:001062; GO:190471	lysosome;cytoplasm;cytoplasmic side of lysosomal membrane;cell body;astrocyte end-foot;intermediate filament;cytosol	GO:000576; GO:000573; GO:009857; GO:004429; GO:009745; GO:000588; GO:000582	"NA"	"NA"	structural constituent of cytoskeleton;kinase binding;protein binding;identical protein binding;integrin binding	GO:000520; GO:001990; GO:000551; GO:004280; GO:000517
NP_001231327.1	NP_001231327.1	NP_001231327.1 pyruvate dehydrogenase E1 component subunit beta, mitochondrial [Sus scrofa]	12	12	12	472540000	167960000	303770000	169850000	408670000	156790000	362350000	224480000	344660000	225420000	273680000	113150000	197110000	156920000	232690000	232070000	279530000	148790000	NA	NA	NA	PDHB	PDHB;NA;NA;NA;NA	tricarboxylic acid cycle;acetyl-CoA biosynthetic process from pyruvate;glucose metabolic process;mitochondrial acetyl-CoA biosynthetic process from pyruvate	GO:000609; GO:000608; GO:000600; GO:006173	nucleoplasm;nucleus;mitochondrial matrix;pyruvate dehydrogenase complex;mitochondrion	GO:000565; GO:000563; GO:000575; GO:004525; GO:000573	 Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Carbon metabolism; Glucagon signaling pathway; Central carbon metabolism in cancer; Pyruvate metabolism; HIF-1 signaling pathway; Biosynthesis of antibiotics; Metabolic pathways	hsa0001; hsa0002; hsa0120; hsa0492; hsa0523; hsa0062; hsa0406; hsa0113; hsa0110	protein binding;pyruvate dehydrogenase (acetyl-transferring) activity;pyruvate dehydrogenase (NAD+) activity	GO:000551; GO:000473; GO:003460
NP_001231332.1;XP_020953940.1	NP_001231332.1;XP_020953940.1	NP_001231332.1 electron transfer flavoprotein subunit alpha, mitochondrial [Sus scrofa];XP_020953940.1 electron transfer flavoprotein subunit alpha, mitochondrial isoform X1 [Sus scrofa]	13	13	13	265640000	135580000	239170000	134170000	235210000	125410000	234600000	139010000	332030000	177900000	152060000	144950000	172680000	157740000	148070000	202570000	158040000	139620000	NA	NA	NA	ETFA	ETFA;ETFA;NA;NA;NA	fatty acid beta-oxidation using acyl-CoA dehydrogenase;electron transport chain	GO:003353; GO:002290	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	oxidoreductase activity;protein binding;electron carrier activity;flavin adenine dinucleotide binding	GO:001649; GO:000551; GO:000905; GO:005066
NP_001231333.1	NP_001231333.1	NP_001231333.1 serine/threonine-protein phosphatase 6 catalytic subunit [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	7329400	0	11457000	0	0	0	0	0	0	NA	NA	NA	PPP6C	PPP6C;NA;NA;NA;NA	protein dephosphorylation;innate immune response;G1/S transition of mitotic cell cycle;COPII vesicle coating	GO:000647; GO:004508; GO:000008; GO:004820	mitochondrion;cytosol;Golgi membrane	GO:000573; GO:000582; GO:000013	"NA"	"NA"	metal ion binding;protein serine/threonine phosphatase activity;protein binding	GO:004687; GO:000472; GO:000551
XP_013851127.1;XP_020941479.1;XP_013851126.1;NP_001231341.1	XP_013851127.1;XP_020941479.1;XP_013851126.1;NP_001231341.1	XP_013851127.1 heme oxygenase 2 isoform X2 [Sus scrofa];XP_020941479.1 heme oxygenase 2 isoform X1 [Sus scrofa];XP_013851126.1 heme oxygenase 2 isoform X1 [Sus scrofa];NP_001231341.1 heme oxygenase 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	26136000	0	0	0	0	0	0	NA	NA	NA	HMOX2	HMOX2;HMOX2;HMOX2;HMOX2;NA	response to hypoxia;cellular iron ion homeostasis;heme catabolic process;iron ion homeostasis;heme oxidation;neutrophil degranulation;response to oxidative stress	GO:000166; GO:000687; GO:004216; GO:005507; GO:000678; GO:004331; GO:000697	plasma membrane;membrane;endoplasmic reticulum membrane;specific granule membrane	GO:000588; GO:001602; GO:000578; GO:003557	 Porphyrin and chlorophyll metabolism; Mineral absorption	hsa0086; hsa0497	heme oxygenase (decyclizing) activity;protein binding;metal ion binding;heme binding	GO:000439; GO:000551; GO:004687; GO:002003
XP_020944149.1;XP_020944143.1;NP_001231343.2;XP_020944147.1;XP_020944146.1;XP_020944145.1;XP_020944144.1	XP_020944149.1;XP_020944143.1;NP_001231343.2;XP_020944147.1;XP_020944146.1;XP_020944145.1;XP_020944144.1	XP_020944149.1 syntenin-1 isoform X1 [Sus scrofa];XP_020944143.1 syntenin-1 isoform X1 [Sus scrofa];NP_001231343.2 syntenin-1 CG9291-PB [Sus scrofa];XP_020944147.1 syntenin-1 isoform X4 [Sus scrofa];XP_020944146.1 syntenin-1 isoform X4 [Sus scrofa];XP_0209	4	4	4	10128000	8799700	9531200	0	8211900	6055700	10898000	0	5099400	0	0	6720100	0	6671200	5902400	5963600	7869000	5237800	NA	NA	NA	SDCBP	SDCBP;SDCBP;SDCBP;SDCBP;SDCBP	regulation of mitotic cell cycle;negative regulation of receptor internalization;substrate-dependent cell migration, cell extension;neutrophil degranulation;protein targeting to membrane;chemical synaptic transmission;positive regulation of cell growth;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of JNK cascade;positive regulation of pathway-restricted SMAD protein phosphorylation;positive regulation of transforming growth factor beta receptor signaling pathway;positive regulation of exosomal secretion;positive regulation of extracellular exosome assembly;positive regulation of cell migration;positive regulation of phosphorylation;positive regulation of cell proliferation;positive regulation of epithelial to mesenchymal transition;actin cytoskeleton organization;intracellular signal transduction;ephrin receptor signaling pathway	GO:000734; GO:000209; GO:000693; GO:004331; GO:000661; GO:000726; GO:003030; GO:003243; GO:004633; GO:001086; GO:003051; GO:190354; GO:190355; GO:003033; GO:004232; GO:000828; GO:001071; GO:003003; GO:003555; GO:004801	extracellular space;nucleoplasm;intracellular membrane-bounded organelle;nuclear membrane;extracellular region;interleukin-5 receptor complex;azurophil granule lumen;nucleus;melanosome;blood microparticle;extracellular vesicle;cytosol;adherens junction;membrane raft;cytoskeleton;plasma membrane;membrane;cytoplasm;focal adhesion;endoplasmic reticulum membrane;extracellular exosome	GO:000561; GO:000565; GO:004323; GO:003196; GO:000557; GO:000589; GO:003557; GO:000563; GO:004247; GO:007256; GO:190356; GO:000582; GO:000591; GO:004512; GO:000585; GO:000588; GO:001602; GO:000573; GO:000592; GO:000578; GO:007006	"NA"	"NA"	frizzled binding;phosphatidylinositol-4,5-bisphosphate binding;identical protein binding;protein N-terminus binding;protein heterodimerization activity;interleukin-5 receptor binding;protein binding;cytoskeletal adaptor activity;syndecan binding	GO:000510; GO:000554; GO:004280; GO:004748; GO:004698; GO:000513; GO:000551; GO:000809; GO:004554
NP_001231345.1;CON__P02584	NP_001231345.1;CON__P02584	NP_001231345.1 profilin-1 [Sus scrofa];	9	9	9	654340000	836240000	870110000	684000000	651900000	957700000	716430000	765430000	644300000	885480000	775470000	594030000	1055100000	732910000	656830000	763840000	763880000	809730000	NA	NA	+	PFN1	PFN1;NA;NA;NA;NA	actin cytoskeleton organization;neural tube closure;negative regulation of actin filament bundle assembly;regulation of actin filament polymerization;negative regulation of stress fiber assembly;synapse maturation;positive regulation of epithelial cell migration;protein stabilization;regulation of transcription from RNA polymerase II promoter;positive regulation of ATPase activity;modification of postsynaptic actin cytoskeleton;positive regulation of ruffle assembly	GO:003003; GO:000184; GO:003223; GO:003083; GO:005149; GO:006007; GO:001063; GO:005082; GO:000635; GO:003278; GO:009888; GO:190002	focal adhesion;cell cortex;blood microparticle;membrane;cytoplasm;extracellular exosome;nucleus;glutamatergic synapse;cytoskeleton;cytosol	GO:000592; GO:000593; GO:007256; GO:001602; GO:000573; GO:007006; GO:000563; GO:009897; GO:000585; GO:000582	 Shigellosis; Rap1 signaling pathway; Salmonella infection; Regulation of actin cytoskeleton	hsa0513; hsa0401; hsa0513; hsa0481	actin monomer binding;phosphatidylinositol-4,5-bisphosphate binding;proline-rich region binding;actin binding;protein binding;Rho GTPase binding;adenyl-nucleotide exchange factor activity;RNA binding;cadherin binding	GO:000378; GO:000554; GO:007006; GO:000377; GO:000551; GO:001704; GO:000077; GO:000372; GO:004529
NP_001231353.1	NP_001231353.1	NP_001231353.1 pre-mRNA-splicing factor SPF27 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1977800	NA	NA	NA	BCAS2	BCAS2;NA;NA;NA;NA	mRNA splicing, via spliceosome;RNA splicing;RNA splicing, via transesterification reactions	GO:000039; GO:000838; GO:000037	Prp19 complex;nucleolus;centrosome;U2-type catalytic step 2 spliceosome;spliceosomal complex;nucleoplasm;DNA replication factor A complex;nuclear speck	GO:000097; GO:000573; GO:000581; GO:007100; GO:000568; GO:000565; GO:000566; GO:001660	 Spliceosome	hsa0304	protein binding	GO:000551
NP_001231357.1;XP_020935129.1	NP_001231357.1;XP_020935129.1	NP_001231357.1 chloride intracellular channel protein 2 [Sus scrofa];XP_020935129.1 chloride intracellular channel protein 2 isoform X1 [Sus scrofa]	8	8	8	19123000	16379000	23310000	17553000	17004000	15415000	18930000	18659000	25792000	20113000	14946000	22114000	13237000	14133000	16226000	15503000	17585000	21086000	NA	NA	NA	CLIC2	CLIC2;CLIC2;NA;NA;NA	signal transduction;positive regulation of binding;negative regulation of ryanodine-sensitive calcium-release channel activity;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;cellular oxidant detoxification;chloride transmembrane transport	GO:000716; GO:005109; GO:006031; GO:001088; GO:009886; GO:190247	cytoplasm;chloride channel complex;nucleus	GO:000573; GO:003470; GO:000563	"NA"	"NA"	protein binding;chloride channel activity;glutathione transferase activity;voltage-gated ion channel activity;glutathione peroxidase activity	GO:000551; GO:000525; GO:000436; GO:000524; GO:000460
NP_001231359.1	NP_001231359.1	NP_001231359.1 dnaJ homolog subfamily B member 1 [Sus scrofa]	6	6	5	0	12334000	13633000	0	0	16165000	0	12344000	0	0	11862000	16613000	18208000	13108000	15117000	12375000	0	15722000	NA	NA	NA	DNAJB1	DNAJB1;NA;NA;NA;NA	response to unfolded protein;negative regulation of transcription from RNA polymerase II promoter;forebrain development;negative regulation of inclusion body assembly;negative regulation of transcription from RNA polymerase II promoter in response to stress;positive regulation of ATPase activity;chaperone mediated protein folding requiring cofactor;regulation of cellular response to heat	GO:000698; GO:000012; GO:003090; GO:009008; GO:009720; GO:003278; GO:005108; GO:190003	dendritic spine;postsynaptic density;nucleus;nucleolus;neuronal cell body;nucleoplasm;glutamatergic synapse;cytosol;sperm head;extracellular exosome	GO:004319; GO:001406; GO:000563; GO:000573; GO:004302; GO:000565; GO:009897; GO:000582; GO:006182; GO:007006	 Influenza A; Protein processing in endoplasmic reticulum	hsa0516; hsa0414	protein binding;unfolded protein binding;transcription corepressor activity;Hsp70 protein binding;ATPase activator activity;cadherin binding;ATPase binding	GO:000551; GO:005108; GO:000371; GO:003054; GO:000167; GO:004529; GO:005111
XP_005666120.1;NP_001231362.1	XP_005666120.1;NP_001231362.1	XP_005666120.1 heat shock protein HSP 90-beta isoform X1 [Sus scrofa];NP_001231362.1 heat shock protein HSP 90-beta [Sus scrofa]	31	16	14	506270000	360770000	517780000	290410000	508330000	355350000	507220000	330690000	439320000	267630000	487700000	276270000	389770000	311410000	459970000	252320000	468520000	300560000	NA	NA	NA	HSP90AB1	HSP90AB1;HSP90AB1;NA;NA;NA	negative regulation of apoptotic process;positive regulation of cyclin-dependent protein kinase activity;establishment of cell polarity;positive regulation of nitric oxide biosynthetic process;positive regulation of telomerase activity;negative regulation of cell cycle arrest;supramolecular fiber organization;negative regulation of transforming growth factor beta activation;protein stabilization;axon extension;regulation of cellular response to heat;xenobiotic metabolic process;central nervous system neuron axonogenesis;regulation of protein ubiquitination;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of cell differentiation;telomerase holoenzyme complex assembly;response to unfolded protein;positive regulation of phosphoprotein phosphatase activity;positive regulation of peptidyl-serine phosphorylation;negative regulation of protein metabolic process;regulation of type I interferon-mediated signaling pathway;negative regulation of proteasomal protein catabolic process;positive regulation of tau-protein kinase activity;regulation of cellular protein localization;chaperone-mediated protein complex assembly;virion attachment to host cell;positive regulation of transforming growth factor beta receptor signaling pathway;cellular response to interleukin-4;placenta development;protein folding;telomere maintenance via telomerase;Fc-gamma receptor signaling pathway involved in phagocytosis;neutrophil degranulation;positive regulation of protein kinase B signaling;positive regulation of protein localization to cell surface	GO:004306; GO:190403; GO:003001; GO:004542; GO:005197; GO:007115; GO:009743; GO:190138; GO:005082; GO:004867; GO:190003; GO:000680; GO:002195; GO:003139; GO:003243; GO:004559; GO:190532; GO:000698; GO:003251; GO:003313; GO:005124; GO:006033; GO:190179; GO:190294; GO:190382; GO:005113; GO:001906; GO:003051; GO:007135; GO:000189; GO:000645; GO:000700; GO:003809; GO:004331; GO:005189; GO:200001	secretory granule lumen;melanosome;neuronal cell body;HSP90-CDC37 chaperone complex;extracellular exosome;cytoplasm;nucleoplasm;COP9 signalosome;perinuclear region of cytoplasm;cytosol;nucleus;axonal growth cone;ficolin-1-rich granule lumen;extracellular region;plasma membrane;membrane;macromolecular complex;aryl hydrocarbon receptor complex	GO:003477; GO:004247; GO:004302; GO:199056; GO:007006; GO:000573; GO:000565; GO:000818; GO:004847; GO:000582; GO:000563; GO:004429; GO:190481; GO:000557; GO:000588; GO:001602; GO:003299; GO:003475	 Pathways in cancer; Protein processing in endoplasmic reticulum; NOD-like receptor signaling pathway; PI3K-Akt signaling pathway; Antigen processing and presentation; Prostate cancer; Progesterone-mediated oocyte maturation	hsa0520; hsa0414; hsa0462; hsa0415; hsa0461; hsa0521; hsa0491	identical protein binding;disordered domain specific binding;unfolded protein binding;MHC class II protein complex binding;TPR domain binding;protein homodimerization activity;histone deacetylase binding;DNA polymerase binding;ATPase activity, coupled;heat shock protein binding;ubiquitin protein ligase binding;ATP binding;kinase binding;cadherin binding;RNA binding;protein kinase regulator activity;histone methyltransferase binding;protein dimerization activity;nitric-oxide synthase regulator activity;peptide binding;tau protein binding;protein binding;ATP-dependent protein binding	GO:004280; GO:009771; GO:005108; GO:002302; GO:003091; GO:004280; GO:004282; GO:007018; GO:004262; GO:003107; GO:003162; GO:000552; GO:001990; GO:004529; GO:000372; GO:001988; GO:199022; GO:004698; GO:003023; GO:004227; GO:004815; GO:000551; GO:004300
XP_020944209.1;XP_020944208.1;XP_020944207.1;XP_020944206.1;XP_020944205.1;XP_020944204.1;XP_020944203.1;XP_020944202.1;XP_020944201.1;XP_020944200.1;XP_020944199.1;XP_013852317.1;XP_013852316.1;XP_005663257.1;XP_005663256.1;XP_005663255.1;XP_005663254.1;XP_005663253.1;XP_005663252.1;XP_005663251.1;XP_005663250.1;XP_005663249.1;NP_001231363.1	XP_020944209.1;XP_020944208.1;XP_020944207.1;XP_020944206.1;XP_020944205.1;XP_020944204.1;XP_020944203.1;XP_020944202.1;XP_020944201.1;XP_020944200.1;XP_020944199.1;XP_013852317.1;XP_013852316.1;XP_005663257.1;XP_005663256.1;XP_005663255.1;XP_005663254.1;XP_005663253.1;XP_005663252.1;XP_005663251.1;XP_005663250.1;XP_005663249.1;NP_001231363.1	XP_020944209.1 DDB1- and CUL4-associated factor 8 isoform X1 [Sus scrofa];XP_020944208.1 DDB1- and CUL4-associated factor 8 isoform X1 [Sus scrofa];XP_020944207.1 DDB1- and CUL4-associated factor 8 isoform X1 [Sus scrofa];XP_020944206.1 DDB1- and CUL4-asso	4	4	4	0	0	5141700	0	4718700	0	4706300	0	0	0	0	0	0	0	0	5624200	0	0	NA	NA	NA	DCAF8	DCAF8;DCAF8;DCAF8;DCAF8;DCAF8	protein ubiquitination;post-translational protein modification	GO:001656; GO:004368	mitochondrion;cytoplasm;cytosol;nucleoplasm;Cul4-RING E3 ubiquitin ligase complex;nucleus	GO:000573; GO:000573; GO:000582; GO:000565; GO:008000; GO:000563	"NA"	"NA"	protein binding	GO:000551
NP_001231364.1	NP_001231364.1	NP_001231364.1 proteolipid protein 2 [Sus scrofa]	2	2	2	158340000	139750000	231050000	128400000	169080000	116150000	137700000	146420000	168550000	163570000	186780000	170390000	113290000	162600000	181370000	176440000	214450000	132160000	NA	NA	NA	PLP2	PLP2;NA;NA;NA;NA	ion transmembrane transport;chemotaxis;ion transport;cytokine-mediated signaling pathway	GO:003422; GO:000693; GO:000681; GO:001922	endoplasmic reticulum membrane;plasma membrane;membrane;endoplasmic reticulum	GO:000578; GO:000588; GO:001602; GO:000578	"NA"	"NA"	protein binding;chemokine binding;ion transmembrane transporter activity	GO:000551; GO:001995; GO:001507
XP_020924181.1;XP_020924180.1;NP_001231366.1	XP_020924181.1;XP_020924180.1;NP_001231366.1	XP_020924181.1 transforming protein RhoA isoform X1 [Sus scrofa];XP_020924180.1 transforming protein RhoA isoform X1 [Sus scrofa];NP_001231366.1 transforming protein RhoA [Sus scrofa]	9	9	2	361810000	416280000	395350000	385750000	355450000	439520000	314960000	363160000	360110000	393620000	313220000	338670000	352770000	363780000	325790000	459020000	394480000	439110000	NA	NA	NA	RHOA	RHOA;RHOA;RHOA;NA;NA	response to hypoxia;actin filament bundle assembly;actin cytoskeleton organization;Roundabout signaling pathway;odontogenesis;positive regulation of neuron apoptotic process;vascular endothelial growth factor receptor signaling pathway;positive regulation of axonogenesis;negative chemotaxis;regulation of small GTPase mediated signal transduction;negative regulation of cell migration involved in sprouting angiogenesis;endothelial tube lumen extension;skeletal muscle satellite cell migration;cellular response to chemokine;angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure;alpha-beta T cell lineage commitment;transforming growth factor beta receptor signaling pathway;skeletal muscle tissue development;positive regulation of cell growth;actin cytoskeleton reorganization;regulation of actin cytoskeleton organization;neutrophil degranulation;positive regulation of alpha-beta T cell differentiation;response to glucocorticoid;cellular response to cytokine stimulus;positive regulation of NIK/NF-kappaB signaling;negative regulation of reactive oxygen species biosynthetic process;positive regulation of leukocyte adhesion to vascular endothelial cell;viral process;regulation of osteoblast proliferation;cell junction assembly;cleavage furrow formation;response to ethanol;positive regulation of stress fiber assembly;regulation of focal adhesion assembly;trabecula morphogenesis;regulation of cell motility;regulation of neural precursor cell proliferation;response to mechanical stimulus;G-protein coupled receptor signaling pathway;Rho protein signal transduction;negative regulation of cell-substrate adhesion;cell migration;androgen receptor signaling pathway;positive regulation of actin filament polymerization;response to amino acid;endothelial cell migration;GTP metabolic process;regulation of calcium ion transport;regulation of microtubule cytoskeleton organization;regulation of systemic arterial blood pressure by endothelin;cell-matrix adhesion;protein deubiquitination;cerebral cortex cell migration;establishment or maintenance of actin cytoskeleton polarity;apolipoprotein A-I-mediated signaling pathway;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;wound healing, spreading of cells;establishment of epithelial cell apical/basal polarity;negative regulation of cell size;Wnt signaling pathway, planar cell polarity pathway;positive regulation of lipase activity;regulation of modification of postsynaptic actin cytoskeleton;positive regulation of T cell migration;regulation of cell shape;response to glucose;positive regulation of translation;forebrain radial glial cell differentiation;positive regulation of cytokinesis;positive regulation of I-kappaB kinase/NF-kappaB signaling;ossification involved in bone maturation;mitotic cleavage furrow formation;positive regulation of vascular smooth muscle contraction;actin filament organization;stress-activated protein kinase signaling cascade;neuron projection morphogenesis;cellular response to lipopolysaccharide;regulation of transcription from RNA polymerase II promoter;substantia nigra development;regulation of cell migration;negative regulation of intracellular steroid hormone receptor signaling pathway;stress fiber assembly;apical junction assembly;beta selection;positive regulation of neuron differentiation;positive regulation of podosome assembly;positive regulation of protein serine/threonine kinase activity;mitotic spindle assembly;negative regulation of oxidative phosphorylation	GO:000166; GO:005101; GO:003003; GO:003538; GO:004247; GO:004352; GO:004801; GO:005077; GO:005091; GO:005105; GO:009005; GO:009749; GO:190276; GO:199086; GO:000199; GO:000236; GO:000717; GO:000751; GO:003030; GO:003153; GO:003295; GO:004331; GO:004663; GO:005138; GO:007134; GO:190122; GO:190342; GO:190499; GO:001603; GO:003368; GO:003432; GO:003608; GO:004547; GO:005149; GO:005189; GO:006138; GO:200014; GO:200017; GO:000961; GO:000718; GO:000726; GO:001081; GO:001647; GO:003052; GO:003083; GO:004320; GO:004354; GO:004603; GO:005192; GO:007050; GO:000310; GO:000716; GO:001657; GO:002179; GO:003095; GO:003802; GO:004328; GO:004431; GO:004519; GO:004579; GO:006007; GO:006019; GO:190527; GO:200040; GO:000836; GO:000974; GO:004572; GO:002186; GO:003246; GO:004312; GO:004393; GO:190367; GO:190469; GO:000701; GO:003109; GO:004881; GO:007122; GO:000635; GO:002176; GO:003033; GO:003314; GO:004314; GO:004329; GO:004336; GO:004566; GO:007180; GO:007190; GO:009030; GO:009032	secretory granule membrane;extrinsic component of cytoplasmic side of plasma membrane;plasma membrane;cytoskeleton;lamellipodium;cell junction;dendritic spine;postsynapse;intracellular membrane-bounded organelle;axon;cytoplasm;endosome;cell cortex;cleavage furrow;glutamatergic synapse;endoplasmic reticulum membrane;vesicle;ruffle membrane;cell periphery;ficolin-1-rich granule membrane;extracellular exosome;cytosol;nucleus;focal adhesion;midbody;apical junction complex	GO:003066; GO:003123; GO:000588; GO:000585; GO:003002; GO:003005; GO:004319; GO:009879; GO:004323; GO:003042; GO:000573; GO:000576; GO:000593; GO:003215; GO:009897; GO:000578; GO:003198; GO:003258; GO:007194; GO:010100; GO:007006; GO:000582; GO:000563; GO:000592; GO:003049; GO:004329	 Oxytocin signaling pathway; cAMP signaling pathway; Chemokine signaling pathway; Vascular smooth muscle contraction; Tight junction; Bacterial invasion of epithelial cells; Pertussis; MicroRNAs in cancer; Rap1 signaling pathway; Focal adhesion; Adherens junction; T cell receptor signaling pathway; Colorectal cancer; Sphingolipid signaling pathway; Wnt signaling pathway; TGF-beta signaling pathway; Neurotrophin signaling pathway; Tuberculosis; Endocytosis; Platelet activation; Leukocyte transendothelial migration; Regulation of actin cytoskeleton; Pancreatic secretion; Axon guidance	hsa0492; hsa0402; hsa0406; hsa0427; hsa0453; hsa0510; hsa0513; hsa0520; hsa0401; hsa0451; hsa0452; hsa0466; hsa0521; hsa0407; hsa0431; hsa0435; hsa0472; hsa0515; hsa0414; hsa0461; hsa0467; hsa0481; hsa0497; hsa0436	protein binding;GDP binding;protein kinase binding;myosin binding;GTP binding;GTPase activity;Rho GDP-dissociation inhibitor binding	GO:000551; GO:001900; GO:001990; GO:001702; GO:000552; GO:000392; GO:005102
XP_020944279.1;XP_020944278.1;XP_020944277.1;XP_020944276.1;XP_020944275.1;XP_020944274.1;XP_020944273.1;XP_020944272.1;XP_020944271.1;XP_020944270.1;XP_020944269.1;XP_020944268.1;XP_020944267.1;XP_020944266.1;XP_020944265.1;XP_020944264.1;XP_020944263.1;XP_020944262.1;NP_001231368.1;XP_020944284.1;XP_020944283.1;XP_020944282.1;XP_020944281.1;XP_020944280.1	XP_020944279.1;XP_020944278.1;XP_020944277.1;XP_020944276.1;XP_020944275.1;XP_020944274.1;XP_020944273.1;XP_020944272.1;XP_020944271.1;XP_020944270.1;XP_020944269.1;XP_020944268.1;XP_020944267.1;XP_020944266.1;XP_020944265.1;XP_020944264.1;XP_020944263.1;XP_020944262.1;NP_001231368.1;XP_020944284.1;XP_020944283.1;XP_020944282.1;XP_020944281.1;XP_020944280.1	XP_020944279.1 protein FAM49B isoform X2 [Sus scrofa];XP_020944278.1 protein FAM49B isoform X2 [Sus scrofa];XP_020944277.1 protein FAM49B isoform X2 [Sus scrofa];XP_020944276.1 protein FAM49B isoform X2 [Sus scrofa];XP_020944275.1 protein FAM49B isoform X2	2	2	2	0	0	7721800	0	0	0	4683800	0	0	0	4795500	0	6107500	0	0	0	0	0	NA	NA	NA	FAM49B	FAM49B;FAM49B;FAM49B;FAM49B;FAM49B	platelet degranulation;positive regulation of T cell mediated cytotoxicity;positive regulation of memory T cell activation;positive regulation of interferon-gamma production;positive regulation of T cell activation	GO:000257; GO:000191; GO:200056; GO:003272; GO:005087	cilium;membrane;extracellular exosome;extracellular region;platelet alpha granule lumen	GO:000592; GO:001602; GO:007006; GO:000557; GO:003109	"NA"	"NA"	protein binding;MHC class Ib protein binding, via antigen binding groove	GO:000551; GO:002303
NP_001231372.1;XP_005672864.1;XP_005672865.1	NP_001231372.1;XP_005672864.1;XP_005672865.1	NP_001231372.1 NSFL1 cofactor p47 [Sus scrofa];XP_005672864.1 NSFL1 cofactor p47 isoform X1 [Sus scrofa];XP_005672865.1 NSFL1 cofactor p47 isoform X2 [Sus scrofa]	12	12	12	70974000	77476000	83157000	62276000	67041000	62743000	83674000	69406000	72566000	58188000	79286000	79636000	63943000	72767000	80150000	70892000	73308000	84006000	NA	NA	NA	NSFL1C	NSFL1C;NSFL1C;NSFL1C;NA;NA	autophagosome assembly;negative regulation of protein localization to centrosome;proteasome-mediated ubiquitin-dependent protein catabolic process;establishment of mitotic spindle orientation;positive regulation of mitotic centrosome separation;nuclear envelope reassembly;Golgi organization;membrane fusion	GO:000004; GO:190478; GO:004316; GO:000013; GO:004660; GO:003146; GO:000703; GO:006102	spindle pole centrosome;plasma membrane;cytosol;intermediate filament cytoskeleton;nucleoplasm;VCP-NSFL1C complex;chromosome;Golgi stack	GO:003161; GO:000588; GO:000582; GO:004511; GO:000565; GO:199073; GO:000569; GO:000579	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;phospholipid binding;ubiquitin binding;ATPase binding	GO:000551; GO:000554; GO:004313; GO:005111
NP_001231379.1;NP_001231378.1;XP_013843207.1;XP_013843206.1	NP_001231379.1;NP_001231378.1;XP_013843207.1;XP_013843206.1	NP_001231379.1 nucleoside diphosphate kinase 3 isoform 2 precursor [Sus scrofa];NP_001231378.1 nucleoside diphosphate kinase 3 isoform 1 precursor [Sus scrofa];XP_013843207.1 nucleoside diphosphate kinase 3 isoform X2 [Sus scrofa];XP_013843206.1 nucleoside	2	2	2	163130000	177810000	180640000	149700000	179620000	0	185360000	155320000	140390000	148190000	164170000	116160000	170330000	176610000	212190000	183460000	165290000	141670000	NA	NA	NA	NME3	NME3;NME3;NME3;NME3;NA	GTP biosynthetic process;nucleoside diphosphate phosphorylation;CTP biosynthetic process;nucleobase-containing small molecule interconversion;UTP biosynthetic process;apoptotic process	GO:000618; GO:000616; GO:000624; GO:001594; GO:000622; GO:000691	cytosol	GO:000582	 Biosynthesis of antibiotics; Purine metabolism; Pyrimidine metabolism; Metabolic pathways	hsa0113; hsa0023; hsa0024; hsa0110	metal ion binding;nucleoside diphosphate kinase activity;protein binding;ATP binding	GO:004687; GO:000455; GO:000551; GO:000552
NP_001231382.1;XP_020948982.1;XP_020948981.1;NP_001231381.1	NP_001231382.1;XP_020948982.1;XP_020948981.1;NP_001231381.1	NP_001231382.1 AP-2 complex subunit sigma isoform 2 [Sus scrofa];XP_020948982.1 AP-2 complex subunit sigma isoform X1 [Sus scrofa];XP_020948981.1 AP-2 complex subunit sigma isoform X1 [Sus scrofa];NP_001231381.1 AP-2 complex subunit sigma isoform 1 [Sus sc	2	2	2	0	0	20679000	0	0	0	23129000	0	24882000	0	0	0	43033000	0	0	0	0	0	NA	NA	NA	AP2S1	AP2S1;AP2S1;AP2S1;AP2S1;NA	low-density lipoprotein particle receptor catabolic process;clathrin coat assembly;regulation of defense response to virus by virus;low-density lipoprotein particle clearance;antigen processing and presentation of exogenous peptide antigen via MHC class II;Wnt signaling pathway, planar cell polarity pathway;ephrin receptor signaling pathway;membrane organization;intracellular protein transport;regulation of endocytosis;clathrin-dependent endocytosis	GO:003280; GO:004826; GO:005069; GO:003438; GO:001988; GO:006007; GO:004801; GO:006102; GO:000688; GO:003010; GO:007258	endocytic vesicle membrane;clathrin-coated endocytic vesicle membrane;endolysosome membrane;plasma membrane;AP-2 adaptor complex;clathrin-coated endocytic vesicle;cytosol	GO:003066; GO:003066; GO:003602; GO:000588; GO:003012; GO:004533; GO:000582	 Endocrine and other factor-regulated calcium reabsorption; Synaptic vesicle cycle; Huntington's disease; Endocytosis	hsa0496; hsa0472; hsa0501; hsa0414	clathrin adaptor activity;transporter activity;protein transporter activity;protein binding	GO:003561; GO:000521; GO:000856; GO:000551
NP_001231384.1	NP_001231384.1	NP_001231384.1 proteasome subunit beta type-4 [Sus scrofa]	2	2	2	0	30313000	33430000	0	0	36497000	26987000	34686000	33313000	32701000	0	0	0	0	0	31443000	28734000	29369000	NA	NA	NA	PSMB4	PSMB4;NA;NA;NA;NA	protein deubiquitination;proteasomal ubiquitin-independent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;viral process;negative regulation of inflammatory response to antigenic stimulus	GO:001657; GO:001049; GO:004316; GO:004368; GO:001603; GO:000286	nucleoplasm;extracellular exosome;proteasome complex;cytosol;proteasome core complex, beta-subunit complex;cytoplasm;proteasome core complex;nucleus	GO:000565; GO:007006; GO:000050; GO:000582; GO:001977; GO:000573; GO:000583; GO:000563	 Proteasome	hsa0305	threonine-type endopeptidase activity;protein binding;lipopolysaccharide binding;endopeptidase activity	GO:000429; GO:000551; GO:000153; GO:000417
NP_001231390.1;XP_020934411.1;XP_020934462.1	NP_001231390.1;XP_020934411.1;XP_020934462.1	NP_001231390.1 glia maturation factor beta [Sus scrofa];XP_020934411.1 glia maturation factor beta isoform X1 [Sus scrofa];XP_020934462.1 glia maturation factor beta isoform X2 [Sus scrofa]	5	5	4	47775000	65096000	64352000	68054000	52582000	51030000	64582000	59372000	63140000	64271000	51875000	58133000	60428000	60706000	57285000	49510000	68135000	59603000	NA	NA	NA	GMFB	GMFB;GMFB;GMFB;NA;NA	positive regulation of catalytic activity;locomotory behavior;regulation of receptor activity;learning;protein phosphorylation;negative regulation of Arp2/3 complex-mediated actin nucleation;nervous system development;actin filament debranching	GO:004308; GO:000762; GO:001046; GO:000761; GO:000646; GO:003431; GO:000739; GO:007184	actin cortical patch	GO:003047	"NA"	"NA"	growth factor activity;protein kinase inhibitor activity;actin binding;enzyme activator activity;Arp2/3 complex binding	GO:000808; GO:000486; GO:000377; GO:000804; GO:007193
NP_001231396.1	NP_001231396.1	NP_001231396.1 succinate-semialdehyde dehydrogenase, mitochondrial [Sus scrofa]	3	3	3	13729000	0	12187000	0	0	0	17808000	13656000	17848000	0	13634000	0	0	16815000	19032000	0	13632000	14776000	NA	NA	NA	ALDH5A1	ALDH5A1;NA;NA;NA;NA	neurotransmitter catabolic process;glucose metabolic process;acetate metabolic process;succinate metabolic process;glycerophospholipid metabolic process;central nervous system development;post-embryonic development;glutamine metabolic process;glutathione metabolic process;glutamate metabolic process;glucosylceramide metabolic process;protein homotetramerization;respiratory electron transport chain;galactosylceramide metabolic process;short-chain fatty acid metabolic process;gamma-aminobutyric acid catabolic process	GO:004213; GO:000600; GO:000608; GO:000610; GO:000665; GO:000741; GO:000979; GO:000654; GO:000674; GO:000653; GO:000667; GO:005128; GO:002290; GO:000668; GO:004645; GO:000945	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Butanoate metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways	hsa0065; hsa0025; hsa0110	succinate-semialdehyde dehydrogenase [NAD(P)+;succinate-semialdehyde dehydrogenase (NAD+) activity;protein homodimerization activity	GO:000901; GO:000477; GO:004280
NP_001231397.1;XP_020953951.1	NP_001231397.1;XP_020953951.1	NP_001231397.1 proteasome subunit alpha type-4 [Sus scrofa];XP_020953951.1 proteasome subunit alpha type-4 isoform X1 [Sus scrofa]	9	9	9	142210000	139390000	133020000	137570000	117480000	109870000	131170000	137750000	135370000	131270000	144370000	123160000	126620000	118870000	137190000	123580000	131520000	112150000	NA	NA	NA	PSMA4	PSMA4;PSMA4;NA;NA;NA	post-translational protein modification;proteasomal ubiquitin-independent protein catabolic process;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;viral process	GO:004368; GO:001049; GO:001657; GO:004316; GO:001603	cytoplasm;proteasome complex;proteasome core complex;nucleoplasm;intracellular membrane-bounded organelle;proteasome core complex, alpha-subunit complex;P-body;nucleus;extracellular exosome;cytosol	GO:000573; GO:000050; GO:000583; GO:000565; GO:004323; GO:001977; GO:000093; GO:000563; GO:007006; GO:000582	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000417
NP_001231401.1	NP_001231401.1	NP_001231401.1 myosin regulatory light polypeptide 9 [Sus scrofa]	8	3	3	59207000	112070000	161670000	50617000	37926000	248900000	30313000	160900000	151760000	424510000	154510000	335840000	364820000	48051000	31601000	81324000	33237000	42338000	NA	NA	NA	MYL9	MYL9;NA;NA;NA;NA	regulation of muscle contraction;platelet aggregation;muscle contraction;regulation of megakaryocyte differentiation	GO:000693; GO:007052; GO:000693; GO:004565	stress fiber;muscle myosin complex;cytosol;Z disc	GO:000172; GO:000585; GO:000582; GO:003001	 Oxytocin signaling pathway; Tight junction; Leukocyte transendothelial migration; cAMP signaling pathway; Focal adhesion; Regulation of actin cytoskeleton; Vascular smooth muscle contraction	hsa0492; hsa0453; hsa0467; hsa0402; hsa0451; hsa0481; hsa0427	calcium ion binding;structural constituent of muscle;myosin heavy chain binding	GO:000550; GO:000830; GO:003203
NP_001231402.1	NP_001231402.1	NP_001231402.1 cation-independent mannose-6-phosphate receptor precursor [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	7509700	0	0	0	0	0	0	0	0	NA	NA	NA	IGF2R	IGF2R;NA;NA;NA;NA	lysosomal transport;positive regulation of apoptotic process;G-protein coupled receptor signaling pathway;post-embryonic development;spermatogenesis;neutrophil degranulation;post-Golgi vesicle-mediated transport;signal transduction;animal organ regeneration;membrane organization;liver development;response to retinoic acid;insulin-like growth factor receptor signaling pathway	GO:000704; GO:004306; GO:000718; GO:000979; GO:000728; GO:004331; GO:000689; GO:000716; GO:003110; GO:006102; GO:000188; GO:003252; GO:004800	lysosomal membrane;secretory granule membrane;trans-Golgi network membrane;integral component of plasma membrane;clathrin-coated vesicle;nuclear envelope lumen;late endosome;clathrin coat;perinuclear region of cytoplasm;cell surface;trans-Golgi network transport vesicle;Golgi apparatus;trans-Golgi network;focal adhesion;extracellular exosome;membrane;endosome	GO:000576; GO:003066; GO:003258; GO:000588; GO:003013; GO:000564; GO:000577; GO:003011; GO:004847; GO:000998; GO:003014; GO:000579; GO:000580; GO:000592; GO:007006; GO:001602; GO:000576	 Lysosome; Endocytosis	hsa0414; hsa0414	enzyme binding;phosphoprotein binding;insulin-like growth factor II binding;mannose binding;retinoic acid binding;identical protein binding;kringle domain binding;signaling receptor activity;protein binding;G-protein alpha-subunit binding;insulin-like growth factor-activated receptor activity;insulin-like growth factor binding	GO:001989; GO:005121; GO:003199; GO:000553; GO:000197; GO:004280; GO:003614; GO:003802; GO:000551; GO:000196; GO:000501; GO:000552
NP_001231403.1	NP_001231403.1	NP_001231403.1 peroxiredoxin-2 [Sus scrofa]	14	14	14	2986100000	2005800000	2246700000	1895100000	2247900000	1346000000	2548600000	2025100000	2546600000	1896100000	2584300000	2075800000	2379200000	2074200000	2612200000	1964000000	2527800000	1831900000	NA	NA	NA	PRDX2	PRDX2;NA;NA;NA;NA	activation of MAPK activity;homeostasis of number of cells;negative regulation of apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of blood coagulation;negative regulation of lipopolysaccharide-mediated signaling pathway;thymus development;oxidation-reduction process;cell redox homeostasis;negative regulation of NF-kappaB transcription factor activity;cellular response to oxidative stress;hydrogen peroxide catabolic process;regulation of apoptotic process;response to oxidative stress;T cell proliferation;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;regulation of hydrogen peroxide metabolic process;leukocyte activation;negative regulation of T cell differentiation;respiratory burst involved in inflammatory response;removal of superoxide radicals;response to lipopolysaccharide	GO:000018; GO:004887; GO:004306; GO:200037; GO:003019; GO:003166; GO:004853; GO:005511; GO:004545; GO:003208; GO:003459; GO:004274; GO:004298; GO:000697; GO:004209; GO:200124; GO:001031; GO:004532; GO:004558; GO:000253; GO:001943; GO:003249	cytosol;extracellular exosome;cytoplasm	GO:000582; GO:007006; GO:000573	"NA"	"NA"	antioxidant activity;thioredoxin peroxidase activity;protein binding	GO:001620; GO:000837; GO:000551
NP_001231408.1;XP_020944329.1;XP_020944328.1;XP_020944327.1	NP_001231408.1	NP_001231408.1 derlin-1 [Sus scrofa]	3	3	3	13050000	0	19421000	9434900	12981000	0	13758000	15978000	12320000	0	10507000	0	0	10362000	12361000	0	13526000	12776000	NA	NA	NA	DERL1	DERL1;NA;NA;NA;NA	endoplasmic reticulum unfolded protein response;positive regulation of protein ubiquitination;protein destabilization;protein folding;ERAD pathway;protein homooligomerization;transmembrane transport;protein ubiquitination;ubiquitin-dependent ERAD pathway;viral process;retrograde protein transport, ER to cytosol;response to unfolded protein;ER-associated misfolded protein catabolic process;positive regulation of protein binding;establishment of protein localization	GO:003096; GO:003139; GO:003164; GO:000645; GO:003650; GO:005126; GO:005508; GO:001656; GO:003043; GO:001603; GO:003097; GO:000698; GO:007171; GO:003209; GO:004518	early endosome;integral component of endoplasmic reticulum membrane;Derlin-1 retrotranslocation complex;signal recognition particle receptor complex;late endosome;Derlin-1-VIMP complex;VCP-NPL4-UFD1 AAA ATPase complex;signal recognition particle;integral component of membrane	GO:000576; GO:003017; GO:003651; GO:000578; GO:000577; GO:003650; GO:003409; GO:004850; GO:001602	 Protein processing in endoplasmic reticulum; Amyotrophic lateral sclerosis (ALS)	hsa0414; hsa0501	signaling receptor activity;ATPase binding;protein binding;protease binding;MHC class I protein binding;ubiquitin-specific protease binding;ubiquitin protein ligase binding	GO:003802; GO:005111; GO:000551; GO:000202; GO:004228; GO:199038; GO:003162
XP_020932895.1;NP_001231414.1;XP_005672834.1	XP_020932895.1;NP_001231414.1;XP_005672834.1	XP_020932895.1 receptor-type tyrosine-protein phosphatase alpha isoform X2 [Sus scrofa];NP_001231414.1 receptor-type tyrosine-protein phosphatase alpha precursor [Sus scrofa];XP_005672834.1 receptor-type tyrosine-protein phosphatase alpha isoform X1 [Sus s	2	2	2	0	8611700	0	0	0	0	0	0	0	0	0	13589000	0	0	0	0	0	0	NA	NA	NA	PTPRA	PTPRA;PTPRA;PTPRA;NA;NA	insulin receptor signaling pathway;MAPK cascade;modulation of synaptic transmission;axon guidance;peptidyl-tyrosine dephosphorylation	GO:000828; GO:000016; GO:005080; GO:000741; GO:003533	integral component of plasma membrane;Schaffer collateral - CA1 synapse;plasma membrane;receptor complex;extracellular exosome	GO:000588; GO:009868; GO:000588; GO:004323; GO:007006	"NA"	"NA"	protein tyrosine phosphatase activity;Ras guanyl-nucleotide exchange factor activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding	GO:000472; GO:000508; GO:000500; GO:000551
NP_001231417.1;XP_013854072.1	NP_001231417.1;XP_013854072.1	NP_001231417.1 nucleobindin-1 precursor [Sus scrofa];XP_013854072.1 nucleobindin-1 isoform X1 [Sus scrofa]	10	10	10	16155000	26057000	14244000	28194000	19657000	28369000	16592000	22688000	19828000	26714000	25179000	31847000	24106000	26045000	21139000	18789000	30254000	27351000	NA	NA	NA	NUCB1	NUCB1;NUCB1;NA;NA;NA	response to cisplatin;post-translational protein modification;cellular protein metabolic process;regulation of protein targeting	GO:007271; GO:004368; GO:004426; GO:190353	nucleus;rough endoplasmic reticulum;endoplasmic reticulum lumen;Golgi cisterna membrane;extracellular space;early endosome;cis-Golgi network;extrinsic component of Golgi membrane;membrane;extracellular exosome;lumenal side of Golgi membrane	GO:000563; GO:000579; GO:000578; GO:003258; GO:000561; GO:000576; GO:000580; GO:009049; GO:001602; GO:007006; GO:009854	"NA"	"NA"	G-protein alpha-subunit binding;DNA binding;protein binding;calcium ion binding	GO:000196; GO:000367; GO:000551; GO:000550
XP_020930173.1;NP_001231422.1	XP_020930173.1;NP_001231422.1	XP_020930173.1 basic leucine zipper and W2 domain-containing protein 1 isoform X1 [Sus scrofa];NP_001231422.1 basic leucine zipper and W2 domain-containing protein 1 [Sus scrofa]	7	7	6	0	27054000	27449000	29839000	27288000	30508000	14051000	36768000	21476000	23045000	19313000	29926000	0	10127000	15799000	12190000	25555000	22337000	NA	NA	NA	BZW1	BZW1;BZW1;NA;NA;NA	"NA"	"NA"	membrane;cytoplasm	GO:001602; GO:000573	"NA"	"NA"	RNA binding;cadherin binding	GO:000372; GO:004529
NP_001231430.1	NP_001231430.1	NP_001231430.1 glutamate dehydrogenase 1, mitochondrial [Sus scrofa]	18	18	18	236670000	414470000	406630000	352340000	282620000	359310000	310940000	329810000	396100000	333870000	322730000	484740000	339320000	346320000	296380000	330250000	298730000	423790000	NA	NA	NA	GLUD1	GLUD1;NA;NA;NA;NA	substantia nigra development;glutamate catabolic process;glutamine metabolic process;cellular amino acid biosynthetic process;oxidation-reduction process;positive regulation of insulin secretion;tricarboxylic acid metabolic process	GO:002176; GO:000653; GO:000654; GO:000865; GO:005511; GO:003202; GO:007235	mitochondrion;mitochondrial matrix;cytoplasm	GO:000573; GO:000575; GO:000573	 Alanine, aspartate and glutamate metabolism; Metabolic pathways; D-Glutamine and D-glutamate metabolism; Nitrogen metabolism; Arginine biosynthesis; Carbon metabolism; Proximal tubule bicarbonate reclamation	hsa0025; hsa0110; hsa0047; hsa0091; hsa0022; hsa0120; hsa0496	glutamate dehydrogenase [NAD(P)+;GTP binding;identical protein binding;glutamate dehydrogenase (NAD+) activity;protein binding;ADP binding;NAD+ binding;leucine binding	GO:000435; GO:000552; GO:004280; GO:000435; GO:000551; GO:004353; GO:007040; GO:007072
XP_020935235.1;XP_020935233.1;XP_020935222.1;XP_013843040.1;XP_020935211.1;XP_020935201.1;NP_001231434.1	XP_020935235.1;XP_020935233.1;XP_020935222.1;XP_013843040.1;XP_020935211.1;XP_020935201.1;NP_001231434.1	XP_020935235.1 tumor necrosis factor alpha-induced protein 8 isoform X5 [Sus scrofa];XP_020935233.1 tumor necrosis factor alpha-induced protein 8 isoform X5 [Sus scrofa];XP_020935222.1 tumor necrosis factor alpha-induced protein 8 isoform X3 [Sus scrofa];X	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	417920	0	NA	NA	NA	TNFAIP8	TNFAIP8;TNFAIP8;TNFAIP8;TNFAIP8;TNFAIP8	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;apoptotic process;positive regulation of apoptotic process	GO:004315; GO:000691; GO:004306	cytoplasm;nucleoplasm	GO:000573; GO:000565	"NA"	"NA"	protein binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process	GO:000551; GO:004302
XP_005661445.1;XP_005661444.1;NP_001231435.1	XP_005661445.1;XP_005661444.1;NP_001231435.1	XP_005661445.1 DAZ-associated protein 1 isoform X2 [Sus scrofa];XP_005661444.1 DAZ-associated protein 1 isoform X1 [Sus scrofa];NP_001231435.1 DAZ-associated protein 1 [Sus scrofa]	5	5	5	14834000	17011000	20405000	0	15019000	15798000	15883000	15643000	21245000	13268000	0	21936000	15265000	18287000	0	12917000	17249000	19089000	NA	NA	NA	DAZAP1	DAZAP1;DAZAP1;DAZAP1;NA;NA	cell proliferation;cell differentiation;spermatogenesis;maternal placenta development;positive regulation of mRNA splicing, via spliceosome	GO:000828; GO:003015; GO:000728; GO:000189; GO:004802	nucleoplasm;nucleus;cytosol;ribonucleoprotein complex;macromolecular complex	GO:000565; GO:000563; GO:000582; GO:199090; GO:003299	 mRNA surveillance pathway	hsa0301	poly(U) RNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;RNA stem-loop binding;poly(G) binding	GO:000826; GO:000372; GO:000373; GO:000551; GO:003561; GO:003404
XP_020946851.1;XP_020946850.1;XP_020946849.1;XP_020946848.1;XP_005652597.1;XP_005652596.1;NP_001231441.1;XP_005652593.1;XP_005652592.1;XP_013839381.1;XP_013839353.1;XP_020946853.1;XP_020946852.1;XP_005652602.1;XP_005652601.1;XP_013839644.1;XP_005652599.1;XP_005652598.1;XP_013839542.1;XP_020946847.1;XP_013839078.1;XP_005652586.1;XP_005652585.1;XP_005652584.1;XP_020946843.1;XP_005652583.1;XP_005652582.1;XP_005652581.1;XP_005652580.1;XP_005652579.1;XP_005652578.1;XP_020946842.1;XP_013838729.1;XP_020946846.1;XP_013839319.1;XP_013839282.1;XP_005652591.1;XP_020946845.1;XP_020946844.1;XP_013839239.1;XP_005652590.1;XP_005652589.1;XP_005652588.1;XP_005652587.1;XP_020926752.1;XP_020926751.1;XP_020926750.1;XP_020926749.1;XP_020926748.1;XP_020926747.1;XP_020926746.1;XP_020926745.1;XP_020926744.1;XP_013837213.1;XP_013837212.1;XP_003358505.1;XP_005669675.1	XP_020946851.1;XP_020946850.1;XP_020946849.1;XP_020946848.1;XP_005652597.1;XP_005652596.1;NP_001231441.1;XP_005652593.1;XP_005652592.1;XP_013839381.1;XP_013839353.1;XP_020946853.1;XP_020946852.1;XP_005652602.1;XP_005652601.1;XP_013839644.1;XP_005652599.1;XP_005652598.1;XP_013839542.1;XP_020946847.1;XP_013839078.1;XP_005652586.1;XP_005652585.1;XP_005652584.1;XP_020946843.1;XP_005652583.1;XP_005652582.1;XP_005652581.1;XP_005652580.1;XP_005652579.1;XP_005652578.1;XP_020946842.1;XP_013838729.1;XP_020946846.1;XP_013839319.1;XP_013839282.1;XP_005652591.1;XP_020946845.1;XP_020946844.1;XP_013839239.1;XP_005652590.1;XP_005652589.1;XP_005652588.1;XP_005652587.1	XP_020946851.1 poly(rC)-binding protein 2 isoform X35 [Sus scrofa];XP_020946850.1 poly(rC)-binding protein 2 isoform X33 [Sus scrofa];XP_020946849.1 poly(rC)-binding protein 2 isoform X32 [Sus scrofa];XP_020946848.1 poly(rC)-binding protein 2 isoform X31 [	9	6	6	65742000	74150000	81863000	72354000	71473000	65716000	75201000	68561000	75239000	61753000	66543000	72419000	101190000	62563000	70173000	69422000	86539000	79308000	NA	NA	NA	PCBP2	PCBP2;PCBP2;PCBP2;PCBP2;PCBP2	negative regulation of defense response to virus;defense response to virus;mRNA metabolic process;IRES-dependent viral translational initiation;mRNA splicing, via spliceosome;innate immune response;viral RNA genome replication;negative regulation of type I interferon production;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:005068; GO:005160; GO:001607; GO:007552; GO:000039; GO:004508; GO:003969; GO:003248; GO:004316	cytoplasm;membrane;extracellular exosome;nucleus;cytosol;nucleoplasm;focal adhesion	GO:000573; GO:001602; GO:007006; GO:000563; GO:000582; GO:000565; GO:000592	"NA"	"NA"	enzyme binding;ubiquitin protein ligase binding;C-rich single-stranded DNA binding;RNA binding;protein binding	GO:001989; GO:003162; GO:199082; GO:000372; GO:000551
XP_005660823.2;XP_005660822.2;NP_001231443.1	XP_005660823.2;XP_005660822.2;NP_001231443.1	XP_005660823.2 HRAS-like suppressor 3 isoform X1 [Sus scrofa];XP_005660822.2 HRAS-like suppressor 3 isoform X1 [Sus scrofa];NP_001231443.1 HRAS-like suppressor 3 [Sus scrofa]	3	3	3	0	34403000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PLA2G16	PLA2G16;PLA2G16;PLA2G16;NA;NA	triglyceride metabolic process;negative regulation of cell cycle;phospholipid metabolic process;peroxisome organization;phosphatidylcholine acyl-chain remodeling;phosphatidylinositol acyl-chain remodeling;regulation of adipose tissue development;phospholipid biosynthetic process;response to bacterium;lipid catabolic process;ether lipid metabolic process	GO:000664; GO:004578; GO:000664; GO:000703; GO:003615; GO:003614; GO:190417; GO:000865; GO:000961; GO:001604; GO:004648	peroxisome;perinuclear region of cytoplasm;peroxisomal membrane;endoplasmic reticulum;cellular_component;cytosol;integral component of membrane	GO:000577; GO:004847; GO:000577; GO:000578; GO:000557; GO:000582; GO:001602	 Ether lipid metabolism; Linoleic acid metabolism; Glycerophospholipid metabolism; Ras signaling pathway; Metabolic pathways; Regulation of lipolysis in adipocytes	hsa0056; hsa0059; hsa0056; hsa0401; hsa0110; hsa0492	phosphatidylserine 1-acylhydrolase activity;phosphatidylcholine 1-acylhydrolase activity;transferase activity, transferring acyl groups;protein binding;phospholipase A2 activity;1-acyl-2-lysophosphatidylserine acylhydrolase activity	GO:005273; GO:000897; GO:001674; GO:000551; GO:000462; GO:005274
NP_001231453.1;XP_005666850.1	NP_001231453.1;XP_005666850.1	NP_001231453.1 fibrinogen gamma chain precursor [Sus scrofa];XP_005666850.1 fibrinogen gamma chain isoform X1 [Sus scrofa]	16	16	16	1145800000	1018300000	943300000	919370000	2813800000	3519400000	1329200000	882790000	1554100000	999040000	1429900000	825470000	1145800000	754920000	969320000	705740000	1251500000	1131200000	NA	NA	NA	FGG	FGG;FGG;NA;NA;NA	protein secretion;positive regulation of heterotypic cell-cell adhesion;positive regulation of exocytosis;plasminogen activation;negative regulation of platelet aggregation;platelet maturation;response to calcium ion;cellular response to interleukin-6;positive regulation of peptide hormone secretion;negative regulation of endothelial cell apoptotic process;platelet degranulation;fibrinolysis;cellular protein metabolic process;positive regulation of ERK1 and ERK2 cascade;blood coagulation, fibrin clot formation;blood coagulation;extracellular matrix organization;positive regulation of substrate adhesion-dependent cell spreading;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;cell-matrix adhesion;post-translational protein modification;protein polymerization;platelet aggregation;cellular response to interleukin-1;toll-like receptor signaling pathway;cellular macromolecular complex assembly;positive regulation of vasoconstriction;positive regulation of protein secretion	GO:000930; GO:003411; GO:004592; GO:003163; GO:009033; GO:003634; GO:005159; GO:007135; GO:009027; GO:200035; GO:000257; GO:004273; GO:004426; GO:007037; GO:007237; GO:000759; GO:003019; GO:190002; GO:190204; GO:000716; GO:004368; GO:005125; GO:007052; GO:007134; GO:000222; GO:003462; GO:004590; GO:005071	cell surface;extracellular region;platelet alpha granule;endoplasmic reticulum lumen;blood microparticle;plasma membrane;external side of plasma membrane;extracellular exosome;extracellular space	GO:000998; GO:000557; GO:003109; GO:000578; GO:007256; GO:000588; GO:000989; GO:007006; GO:000561	 Platelet activation; Complement and coagulation cascades; Staphylococcus aureus infection	hsa0461; hsa0461; hsa0515	receptor binding;metal ion binding;cell adhesion molecule binding;structural molecule activity;protein binding;protein homodimerization activity;extracellular matrix structural constituent	GO:000510; GO:004687; GO:005083; GO:000519; GO:000551; GO:004280; GO:000520
XP_020944321.1;XP_020944320.1;XP_005662912.1;NP_001231454.1;XP_020944322.1	XP_020944321.1;XP_020944320.1;XP_005662912.1;NP_001231454.1;XP_020944322.1	XP_020944321.1 putative deoxyribonuclease TATDN1 isoform X2 [Sus scrofa];XP_020944320.1 putative deoxyribonuclease TATDN1 isoform X2 [Sus scrofa];XP_005662912.1 putative deoxyribonuclease TATDN1 isoform X1 [Sus scrofa];NP_001231454.1 putative deoxyribonucl	2	2	2	0	0	0	0	0	0	0	0	0	5687200	0	0	0	0	0	0	0	0	NA	NA	NA	TATDN1	TATDN1;TATDN1;TATDN1;TATDN1;TATDN1	DNA metabolic process;nucleic acid phosphodiester bond hydrolysis	GO:000625; GO:009030	nucleoplasm	GO:000565	"NA"	"NA"	3'-5'-exodeoxyribonuclease activity;metal ion binding;endodeoxyribonuclease activity, producing 5'-phosphomonoesters;protein binding	GO:000829; GO:004687; GO:001688; GO:000551
NP_001231460.1	NP_001231460.1	NP_001231460.1 thioredoxin-dependent peroxide reductase, mitochondrial [Sus scrofa]	9	9	9	803650000	299450000	865330000	256390000	638140000	173230000	824390000	405850000	919240000	432640000	489090000	241710000	300940000	245870000	519150000	438380000	442850000	242590000	NA	NA	NA	PRDX3	PRDX3;NA;NA;NA;NA	positive regulation of cell proliferation;hydrogen peroxide catabolic process;negative regulation of apoptotic process;myeloid cell differentiation;negative regulation of kinase activity;response to hydrogen peroxide;positive regulation of NF-kappaB transcription factor activity;response to lipopolysaccharide;cellular response to oxidative stress;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular oxidant detoxification;maternal placenta development;cell redox homeostasis;apoptotic process;mitochondrion organization;peptidyl-cysteine oxidation;cellular response to reactive oxygen species;regulation of mitochondrial membrane potential;response to oxidative stress	GO:000828; GO:004274; GO:004306; GO:003009; GO:003367; GO:004254; GO:005109; GO:003249; GO:003459; GO:004315; GO:009886; GO:000189; GO:004545; GO:000691; GO:000700; GO:001817; GO:003461; GO:005188; GO:000697	cytosol;cytoplasm;mitochondrial matrix;macromolecular complex;early endosome	GO:000582; GO:000573; GO:000575; GO:003299; GO:000576	"NA"	"NA"	protein binding;thioredoxin peroxidase activity;alkyl hydroperoxide reductase activity;kinase binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;identical protein binding;protein C-terminus binding	GO:000551; GO:000837; GO:000878; GO:001990; GO:004302; GO:004280; GO:000802
NP_001231461.1	NP_001231461.1	NP_001231461.1 dehydrogenase/reductase SDR family member 11 [Sus scrofa]	3	3	3	26039000	0	0	0	0	0	0	0	0	0	0	0	0	0	20957000	0	21341000	0	NA	NA	NA	DHRS11	DHRS11;NA;NA;NA;NA	oxidation-reduction process;steroid biosynthetic process;estrogen biosynthetic process	GO:005511; GO:000669; GO:000670	cellular_component;extracellular region	GO:000557; GO:000557	"NA"	"NA"	nucleotide binding;3-keto sterol reductase activity;estradiol 17-beta-dehydrogenase activity;17-beta-ketosteroid reductase activity;17-beta-hydroxysteroid dehydrogenase (NADP+) activity	GO:000016; GO:000025; GO:000430; GO:007255; GO:007258
NP_001231465.1;CON__Q28194	NP_001231465.1;CON__Q28194	NP_001231465.1 thrombospondin-1 precursor [Sus scrofa];	7	7	7	0	28869000	35632000	0	0	18700000	22834000	0	26096000	20287000	0	31175000	60415000	0	29482000	25452000	0	31378000	NA	NA	+	THBS1	THBS1;NA;NA;NA;NA	positive regulation of blood coagulation;response to progesterone;negative regulation of interleukin-12 production;response to endoplasmic reticulum stress;positive regulation of macrophage activation;negative regulation of blood vessel endothelial cell migration;regulation of megakaryocyte differentiation;positive regulation of smooth muscle cell proliferation;cellular response to tumor necrosis factor;negative regulation of sprouting angiogenesis;positive regulation of endothelial cell apoptotic process;negative regulation of extrinsic apoptotic signaling pathway;negative regulation of dendritic cell antigen processing and presentation;response to unfolded protein;positive regulation of cell migration;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;engulfment of apoptotic cell;behavioral response to pain;negative regulation of focal adhesion assembly;chronic inflammatory response;response to mechanical stimulus;positive regulation of cell proliferation;response to drug;response to glucose;positive regulation of reactive oxygen species metabolic process;negative regulation of cGMP-mediated signaling;peptide cross-linking;positive regulation of angiogenesis;negative regulation of cell-matrix adhesion;negative regulation of angiogenesis;platelet degranulation;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;cell adhesion;inflammatory response;cell cycle arrest;negative regulation of apoptotic process;negative regulation of endothelial cell migration;negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of translation;cell migration;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;response to hypoxia;positive regulation of fibroblast migration;response to magnesium ion;negative regulation of fibroblast growth factor receptor signaling pathway;positive regulation of phosphorylation;negative regulation of cell migration involved in sprouting angiogenesis;sprouting angiogenesis;positive regulation of transforming growth factor beta1 production;cellular response to heat;positive regulation of chemotaxis;response to calcium ion;negative regulation of fibrinolysis;cellular response to growth factor stimulus;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell chemotaxis;activation of MAPK activity;negative regulation of endothelial cell proliferation;extracellular matrix organization;response to testosterone;positive regulation of tumor necrosis factor biosynthetic process	GO:003019; GO:003257; GO:003269; GO:003497; GO:004303; GO:004353; GO:004565; GO:004866; GO:007135; GO:190367; GO:200035; GO:200123; GO:000260; GO:000698; GO:003033; GO:003051; GO:004315; GO:004365; GO:004826; GO:005189; GO:000254; GO:000961; GO:000828; GO:004249; GO:000974; GO:200037; GO:001075; GO:001814; GO:004576; GO:000195; GO:001652; GO:000257; GO:000258; GO:000715; GO:000695; GO:000705; GO:004306; GO:001059; GO:001074; GO:004572; GO:001647; GO:190358; GO:000166; GO:001076; GO:003202; GO:004003; GO:004232; GO:009005; GO:000204; GO:003291; GO:003460; GO:005092; GO:005159; GO:005191; GO:007136; GO:190204; GO:200102; GO:000018; GO:000193; GO:003019; GO:003357; GO:004253	cell surface;sarcoplasmic reticulum;endoplasmic reticulum;extracellular region;extracellular exosome;secretory granule;platelet alpha granule;external side of plasma membrane;extracellular matrix;extracellular space	GO:000998; GO:001652; GO:000578; GO:000557; GO:007006; GO:003014; GO:003109; GO:000989; GO:003101; GO:000561	 TGF-beta signaling pathway; ECM-receptor interaction; Malaria; Proteoglycans in cancer; PI3K-Akt signaling pathway; Rap1 signaling pathway; Phagosome; p53 signaling pathway; Bladder cancer	hsa0435; hsa0451; hsa0514; hsa0520; hsa0415; hsa0401; hsa0414; hsa0411; hsa0521	calcium ion binding;fibronectin binding;proteoglycan binding;fibrinogen binding;integrin binding;transforming growth factor beta binding;identical protein binding;protein binding;extracellular matrix structural constituent;laminin binding;heparin binding;fibroblast growth factor binding;low-density lipoprotein particle binding;phosphatidylserine binding	GO:000550; GO:000196; GO:004339; GO:007005; GO:000517; GO:005043; GO:004280; GO:000551; GO:000520; GO:004323; GO:000820; GO:001713; GO:003016; GO:000178
NP_001231470.1;XP_005669603.1	NP_001231470.1;XP_005669603.1	NP_001231470.1 mannose-1-phosphate guanyltransferase beta [Sus scrofa];XP_005669603.1 mannose-1-phosphate guanyltransferase beta isoform X1 [Sus scrofa]	6	6	6	0	35384000	34990000	39657000	33331000	0	38460000	34383000	31999000	27451000	39501000	0	39097000	35990000	0	33002000	37286000	30000000	NA	NA	NA	GMPPB	GMPPB;GMPPB;NA;NA;NA	GDP-mannose biosynthetic process	GO:000929	cytoplasm	GO:000573	 Fructose and mannose metabolism; Metabolic pathways; Amino sugar and nucleotide sugar metabolism	hsa0005; hsa0110; hsa0052	protein binding;mannose-1-phosphate guanylyltransferase activity;GTP binding	GO:000551; GO:000447; GO:000552
NP_001231473.1;XP_020953928.1;XP_020953931.1;XP_020953929.1;XP_020953927.1	NP_001231473.1;XP_020953928.1	NP_001231473.1 arpin [Sus scrofa];XP_020953928.1 arpin isoform X2 [Sus scrofa]	5	5	5	0	19519000	0	0	0	0	0	0	0	0	21690000	0	0	0	0	0	23705000	0	NA	NA	NA	ARPIN	ARPIN;ARPIN;NA;NA;NA	negative regulation of cell migration;directional locomotion;negative regulation of lamellipodium morphogenesis;negative regulation of actin nucleation	GO:003033; GO:003305; GO:200039; GO:005112	lamellipodium	GO:003002	"NA"	"NA"	protein binding	GO:000551
NP_001231479.1	NP_001231479.1	NP_001231479.1 dual specificity mitogen-activated protein kinase kinase 2 [Sus scrofa]	6	6	4	34458000	41036000	43015000	45809000	44960000	40603000	38561000	43689000	38165000	38586000	48947000	36129000	38554000	48336000	53407000	51482000	41925000	31907000	NA	NA	NA	MAP2K2	MAP2K2;NA;NA;NA;NA	positive regulation of transcription, DNA-templated;activation of protein kinase activity;positive regulation of production of miRNAs involved in gene silencing by miRNA;stress-activated protein kinase signaling cascade;regulation of stress-activated MAPK cascade;negative regulation of gene expression;peptidyl-tyrosine phosphorylation;regulation of Golgi inheritance;MAPK cascade;signal transduction by protein phosphorylation;positive regulation of protein serine/threonine kinase activity;peptidyl-serine autophosphorylation;regulation of early endosome to late endosome transport;ERK1 and ERK2 cascade;activation of MAPK activity	GO:004589; GO:003214; GO:190380; GO:003109; GO:003287; GO:001062; GO:001810; GO:009017; GO:000016; GO:002301; GO:007190; GO:003628; GO:200064; GO:007037; GO:000018	peroxisomal membrane;focal adhesion;extracellular region;cell-cell junction;mitochondrion;nucleus;Golgi apparatus;perinuclear region of cytoplasm;cytosol;microtubule;endoplasmic reticulum;early endosome;cytoplasmic side of plasma membrane;late endosome	GO:000577; GO:000592; GO:000557; GO:000591; GO:000573; GO:000563; GO:000579; GO:004847; GO:000582; GO:000587; GO:000578; GO:000576; GO:000989; GO:000577	 VEGF signaling pathway; Melanogenesis; Hepatitis B; MicroRNAs in cancer; Endometrial cancer; Gap junction; T cell receptor signaling pathway; MAPK signaling pathway; Toll-like receptor signaling pathway; Long-term potentiation; Acute myeloid leukemia; FoxO signaling pathway; Vascular smooth muscle contraction; Regulation of actin cytoskeleton; Oxytocin signaling pathway; cGMP-PKG signaling pathway; Sphingolipid signaling pathway; Natural killer cell mediated cytotoxicity; Central carbon metabolism in cancer; Long-term depression; Prion diseases; PI3K-Akt signaling pathway; Signaling pathways regulating pluripotency of stem cells	hsa0437; hsa0491; hsa0516; hsa0520; hsa0521; hsa0454; hsa0466; hsa0401; hsa0462; hsa0472; hsa0522; hsa0406; hsa0427; hsa0481; hsa0492; hsa0402; hsa0407; hsa0465; hsa0523; hsa0473; hsa0502; hsa0415; hsa0455	protein serine/threonine/tyrosine kinase activity;metal ion binding;PDZ domain binding;ATP binding;scaffold protein binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;protein serine/threonine kinase activator activity;protein binding;MAP kinase kinase activity	GO:000471; GO:004687; GO:003016; GO:000552; GO:009711; GO:000467; GO:000471; GO:004353; GO:000551; GO:000470
NP_001231485.1	NP_001231485.1	NP_001231485.1 aminoacyl tRNA synthase complex-interacting multifunctional protein 2 isoform 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17929000	NA	NA	NA	AIMP2	AIMP2;NA;NA;NA;NA	positive regulation of neuron death;apoptotic process;negative regulation of cell proliferation;positive regulation of protein ubiquitination;Type II pneumocyte differentiation;tRNA aminoacylation for protein translation;macromolecular complex assembly;positive regulation of aminoacyl-tRNA ligase activity	GO:190121; GO:000691; GO:000828; GO:003139; GO:006051; GO:000641; GO:006500; GO:190363	nucleus;membrane;aminoacyl-tRNA synthetase multienzyme complex;cytosol	GO:000563; GO:001602; GO:001710; GO:000582	"NA"	"NA"	protein binding;protein complex scaffold	GO:000551; GO:003294
XP_020933514.1;NP_001231487.1	XP_020933514.1;NP_001231487.1	XP_020933514.1 60S ribosomal protein L17 isoform X1 [Sus scrofa];NP_001231487.1 60S ribosomal protein L17 [Sus scrofa]	8	8	8	78249000	97223000	92696000	65131000	76683000	119810000	95950000	58404000	79422000	91851000	76967000	39180000	104330000	97275000	48239000	77670000	107570000	124300000	NA	NA	NA	RPL17	RPL17;RPL17;NA;NA;NA	translational initiation;SRP-dependent cotranslational protein targeting to membrane;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation	GO:000641; GO:000661; GO:000641; GO:000018; GO:000218	cytosol;cytosolic large ribosomal subunit;nucleus	GO:000582; GO:002262; GO:000563	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;protein binding	GO:000373; GO:000372; GO:000551
NP_001231489.1;XP_013836318.1;XP_005668753.1	NP_001231489.1;XP_013836318.1;XP_005668753.1	NP_001231489.1 vesicle-fusing ATPase [Sus scrofa];XP_013836318.1 vesicle-fusing ATPase isoform X2 [Sus scrofa];XP_005668753.1 vesicle-fusing ATPase isoform X1 [Sus scrofa]	6	6	6	0	21949000	21004000	19639000	0	21528000	0	0	0	0	16172000	0	0	0	18842000	0	0	15370000	NA	NA	NA	NSF	NSF;NSF;NSF;NA;NA	exocytosis;ER to Golgi vesicle-mediated transport;regulation of exocytosis;SNARE complex disassembly;Golgi vesicle docking;potassium ion transport;positive regulation of receptor recycling;plasma membrane fusion;positive regulation of protein catabolic process;COPII vesicle coating;Golgi to plasma membrane protein transport;vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER	GO:000688; GO:000688; GO:001715; GO:003549; GO:004821; GO:000681; GO:000192; GO:004502; GO:004573; GO:004820; GO:004300; GO:001619; GO:000689	postsynaptic density;cytosol;Golgi stack;Golgi membrane;plasma membrane;lysosomal membrane;dendritic shaft	GO:001406; GO:000582; GO:000579; GO:000013; GO:000588; GO:000576; GO:004319	 Synaptic vesicle cycle; Vasopressin-regulated water reabsorption; GABAergic synapse	hsa0472; hsa0496; hsa0472	ATP binding;syntaxin-1 binding;PDZ domain binding;ionotropic glutamate receptor binding;metal ion binding;ATPase activity;ATPase activity, coupled;Rab GTPase binding;SNARE binding;protein kinase binding;protein binding;macromolecular complex binding	GO:000552; GO:001707; GO:003016; GO:003525; GO:004687; GO:001688; GO:004262; GO:001713; GO:000014; GO:001990; GO:000551; GO:004487
NP_001231490.1	NP_001231490.1	NP_001231490.1 histamine N-methyltransferase [Sus scrofa]	4	4	4	0	46454000	22720000	43418000	37122000	44644000	0	37221000	26730000	39074000	0	54304000	0	37035000	28387000	59743000	30019000	47328000	NA	NA	NA	HNMT	HNMT;NA;NA;NA;NA	methylation;histamine catabolic process;histidine catabolic process;response to interleukin-1;respiratory gaseous exchange;response to immobilization stress;response to amine;response to tumor cell;hyperosmotic response;brain development;response to cocaine;response to glucocorticoid	GO:003225; GO:000169; GO:000654; GO:007055; GO:000758; GO:003590; GO:001407; GO:000234; GO:000697; GO:000742; GO:004222; GO:005138	neuron projection;extracellular exosome;cytosol;cytoplasm	GO:004300; GO:007006; GO:000582; GO:000573	 Histidine metabolism	hsa0034	histamine N-methyltransferase activity	GO:004653
XP_020934043.1;XP_020934034.1;NP_001231492.1;XP_020934024.1;XP_020934017.1;XP_020934013.1;NP_001231491.1;XP_020934004.1;XP_020933993.1;XP_020933987.1;XP_020929524.1	XP_020934043.1;XP_020934034.1;NP_001231492.1;XP_020934024.1;XP_020934017.1;XP_020934013.1;NP_001231491.1;XP_020934004.1;XP_020933993.1;XP_020933987.1	XP_020934043.1 core histone macro-H2A.1 isoform X4 [Sus scrofa];XP_020934034.1 core histone macro-H2A.1 isoform X4 [Sus scrofa];NP_001231492.1 core histone macro-H2A.1 isoform 2 [Sus scrofa];XP_020934024.1 core histone macro-H2A.1 isoform X3 [Sus scrofa];X	12	12	12	107500000	145290000	120800000	110120000	103750000	165110000	133050000	110260000	126350000	139240000	144740000	162990000	208210000	152280000	115580000	187570000	160220000	159280000	NA	NA	NA	H2AFY	H2AFY;H2AFY;H2AFY;H2AFY;H2AFY	regulation of gene expression, epigenetic;negative regulation of gene expression, epigenetic;negative regulation of histone H3-K4 methylation;negative regulation of histone H3-K27 methylation;negative regulation of transcription from RNA polymerase II promoter;nucleosome assembly;positive regulation of maintenance of mitotic sister chromatid cohesion;positive regulation of keratinocyte differentiation;dosage compensation;regulation of chromatin silencing at rDNA;negative regulation of protein serine/threonine kinase activity;negative regulation of cell cycle G2/M phase transition;negative regulation of histone phosphorylation;regulation of response to oxidative stress;negative regulation of protein localization to chromosome, telomeric region;chromatin organization;regulation of lipid metabolic process;establishment of protein localization to chromatin;negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	GO:004002; GO:004581; GO:005157; GO:006108; GO:000012; GO:000633; GO:003418; GO:004561; GO:000754; GO:006118; GO:007190; GO:190275; GO:003312; GO:190288; GO:190481; GO:000632; GO:001921; GO:007116; GO:190183	nucleosome;nuclear chromatin;nucleolus;nuclear chromosome;pericentric heterochromatin;nuclear chromosome, telomeric region;sex chromatin;nucleus;Barr body;extracellular exosome	GO:000078; GO:000079; GO:000573; GO:000022; GO:000572; GO:000078; GO:000173; GO:000563; GO:000174; GO:007006	 Alcoholism; Systemic lupus erythematosus	hsa0503; hsa0532	RNA polymerase II core promoter sequence-specific DNA binding;enzyme binding;protein serine/threonine kinase inhibitor activity;promoter-specific chromatin binding;RNA polymerase II regulatory region sequence-specific DNA binding;transcription regulatory region DNA binding;protein kinase binding;rDNA binding;nucleosomal DNA binding;protein binding;DNA binding;double-stranded methylated DNA binding;protein heterodimerization activity	GO:000097; GO:001989; GO:003029; GO:199084; GO:000097; GO:004421; GO:001990; GO:000018; GO:003149; GO:000551; GO:000367; GO:001038; GO:004698
XP_005654813.1;NP_001231527.1	XP_005654813.1;NP_001231527.1	XP_005654813.1 glucosidase 2 subunit beta isoform X1 [Sus scrofa];NP_001231527.1 glucosidase 2 subunit beta precursor [Sus scrofa]	7	7	7	62646000	101250000	92315000	87464000	64437000	85826000	86035000	86743000	67347000	71453000	102360000	65339000	64721000	107110000	96657000	91689000	91810000	92681000	NA	NA	NA	PRKCSH	PRKCSH;PRKCSH;NA;NA;NA	intracellular signal transduction;N-glycan processing;post-translational protein modification;cellular protein metabolic process	GO:003555; GO:000649; GO:004368; GO:004426	endoplasmic reticulum lumen;glucosidase II complex;intracellular membrane-bounded organelle;endoplasmic reticulum	GO:000578; GO:001717; GO:004323; GO:000578	 Protein processing in endoplasmic reticulum	hsa0414	protein kinase C binding;ion channel binding;phosphoprotein binding;calcium ion binding;protein binding	GO:000508; GO:004432; GO:005121; GO:000550; GO:000551
NP_001231549.1	NP_001231549.1	NP_001231549.1 TBC1 domain family member 20 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1469800	0	0	NA	NA	NA	TBC1D20	TBC1D20;NA;NA;NA;NA	lens fiber cell morphogenesis;positive regulation by virus of viral protein levels in host cell;regulation of cilium assembly;positive regulation by host of viral genome replication;cargo loading into COPII-coated vesicle;ER to Golgi vesicle-mediated transport;Golgi organization;virion assembly;acrosome assembly;positive regulation of GTPase activity;COPII vesicle coating;lipid particle organization;seminiferous tubule development;positive regulation of ER to Golgi vesicle-mediated transport	GO:007030; GO:004672; GO:190201; GO:004482; GO:009011; GO:000688; GO:000703; GO:001906; GO:000167; GO:004354; GO:004820; GO:003438; GO:007252; GO:190295	nuclear membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum;integral component of Golgi membrane	GO:003196; GO:003311; GO:000578; GO:003017	"NA"	"NA"	GTPase activator activity;protein binding;Rab GTPase binding	GO:000509; GO:000551; GO:001713
XP_005655405.1;NP_001231552.1;XP_005655404.1	XP_005655405.1;NP_001231552.1;XP_005655404.1	XP_005655405.1 protein LYRIC isoform X2 [Sus scrofa];NP_001231552.1 protein LYRIC [Sus scrofa];XP_005655404.1 protein LYRIC isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4299600	NA	NA	NA	MTDH	MTDH;MTDH;MTDH;NA;NA	positive regulation of autophagy;negative regulation of apoptotic process;positive regulation of protein kinase B signaling;bicellular tight junction assembly;negative regulation of transcription from RNA polymerase II promoter;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of angiogenesis;lipopolysaccharide-mediated signaling pathway;positive regulation of nucleic acid-templated transcription;positive regulation of NF-kappaB transcription factor activity	GO:001050; GO:004306; GO:005189; GO:007083; GO:000012; GO:004312; GO:004576; GO:003166; GO:190350; GO:005109	integral component of membrane;intercellular canaliculus;nuclear body;cytoplasm;endoplasmic reticulum;apical plasma membrane;perinuclear region of cytoplasm;nuclear membrane;fibrillar center;nucleus;bicellular tight junction	GO:001602; GO:004658; GO:001660; GO:000573; GO:000578; GO:001632; GO:004847; GO:003196; GO:000165; GO:000563; GO:000592	"NA"	"NA"	protein binding;RNA polymerase II transcription factor binding;double-stranded RNA binding;transcription coactivator activity;NF-kappaB binding	GO:000551; GO:000108; GO:000372; GO:000371; GO:005105
NP_001231553.1	NP_001231553.1	NP_001231553.1 eukaryotic translation initiation factor 3 subunit I [Sus scrofa]	3	3	3	0	20124000	16974000	0	0	22351000	0	0	18669000	0	17837000	20812000	0	21366000	0	0	0	0	NA	NA	NA	EIF3I	EIF3I;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;translational initiation	GO:000173; GO:000641	eukaryotic translation initiation factor 3 complex, eIF3m;cytosol;eukaryotic 43S preinitiation complex;eukaryotic 48S preinitiation complex;eukaryotic translation initiation factor 3 complex;extracellular exosome	GO:007154; GO:000582; GO:001628; GO:003329; GO:000585; GO:007006	 RNA transport	hsa0301	protein binding;translation initiation factor activity	GO:000551; GO:000374
NP_001231554.1	NP_001231554.1	NP_001231554.1 glutathione synthetase [Sus scrofa]	6	6	6	15145000	10241000	14524000	16594000	14042000	12561000	16368000	14252000	16959000	13590000	17409000	25581000	18456000	0	19012000	16408000	16093000	0	NA	NA	NA	GSS	GSS;NA;NA;NA;NA	cellular amino acid metabolic process;aging;response to cadmium ion;glutathione biosynthetic process;nervous system development;response to oxidative stress;response to tumor necrosis factor;response to amino acid;response to xenobiotic stimulus;response to nutrient levels	GO:000652; GO:000756; GO:004668; GO:000675; GO:000739; GO:000697; GO:003461; GO:004320; GO:000941; GO:003166	cytosol;extracellular exosome	GO:000582; GO:007006	 Metabolic pathways; Glutathione metabolism	hsa0110; hsa0048	ATP binding;glutathione binding;protein binding;magnesium ion binding;identical protein binding;glutathione synthase activity;glycine binding	GO:000552; GO:004329; GO:000551; GO:000028; GO:004280; GO:000436; GO:001659
NP_001231560.1	NP_001231560.1	NP_001231560.1 cytoskeleton-associated protein 4 [Sus scrofa]	19	19	19	0	84189000	42165000	125130000	0	113420000	78966000	108850000	53229000	98608000	90618000	113340000	149110000	125100000	86255000	77915000	91583000	143590000	NA	NA	NA	CKAP4	CKAP4;NA;NA;NA;NA	cellular protein metabolic process;neutrophil degranulation;post-translational protein modification	GO:004426; GO:004331; GO:004368	plasma membrane;endoplasmic reticulum;perinuclear region of cytoplasm;membrane;cytosol;specific granule membrane;lamellar body;lipid particle;rough endoplasmic reticulum;cytoskeleton;nuclear speck;cytoplasmic ribonucleoprotein granule;extracellular exosome	GO:000588; GO:000578; GO:004847; GO:001602; GO:000582; GO:003557; GO:004259; GO:000581; GO:000579; GO:000585; GO:001660; GO:003646; GO:007006	 Protein processing in endoplasmic reticulum	hsa0414	RNA binding	GO:000372
NP_001231568.1	NP_001231568.1	NP_001231568.1 histidine-rich glycoprotein precursor [Sus scrofa]	19	19	19	1585300000	1618400000	1111700000	1475700000	1646800000	2198800000	2024500000	1413300000	2427700000	1770500000	2040800000	1688600000	2157000000	2094900000	2129100000	1347700000	2519800000	2604900000	NA	NA	NA	HRG	HRG;NA;NA;NA;NA	defense response to fungus;negative regulation of cell adhesion;platelet activation;cytolysis in other organism;positive regulation of focal adhesion assembly;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of immune response to tumor cell;regulation of gene expression;regulation of actin cytoskeleton organization;negative regulation of lamellipodium assembly;platelet degranulation;regulation of protein complex assembly;negative regulation of endothelial cell chemotaxis;regulation of blood coagulation;positive regulation of apoptotic process;chemotaxis;negative regulation of endopeptidase activity;fibrinolysis;regulation of peptidyl-tyrosine phosphorylation;negative regulation of fibrinolysis;negative regulation of cell proliferation;negative regulation of cell growth;negative regulation of blood vessel endothelial cell migration;positive regulation of blood vessel remodeling;angiogenesis;regulation of platelet activation;heme transport;negative regulation of angiogenesis;negative regulation of cell adhesion mediated by integrin;negative regulation of vascular endothelial growth factor signaling pathway	GO:005083; GO:000716; GO:003016; GO:005171; GO:005189; GO:006184; GO:000283; GO:001046; GO:003295; GO:001059; GO:000257; GO:004325; GO:200102; GO:003019; GO:004306; GO:000693; GO:001095; GO:004273; GO:005073; GO:005191; GO:000828; GO:003030; GO:004353; GO:200050; GO:000152; GO:001054; GO:001588; GO:001652; GO:003362; GO:190074	cell surface;extracellular region;extracellular exosome;plasma membrane;blood microparticle;endolysosome;platelet alpha granule lumen	GO:000998; GO:000557; GO:007006; GO:000588; GO:007256; GO:003601; GO:003109	"NA"	"NA"	cysteine-type endopeptidase inhibitor activity;heparin binding;protein binding;metal ion binding;heme binding;receptor binding;serine-type endopeptidase inhibitor activity;zinc ion binding;heparan sulfate proteoglycan binding;immunoglobulin binding	GO:000486; GO:000820; GO:000551; GO:004687; GO:002003; GO:000510; GO:000486; GO:000827; GO:004339; GO:001986
NP_001231575.1	NP_001231575.1	NP_001231575.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [Sus scrofa]	2	2	2	37770000	0	31327000	21264000	28205000	0	29407000	22513000	35895000	0	27958000	28282000	0	28191000	35137000	0	28194000	20626000	NA	NA	NA	NDUFA13	NDUFA13;NA;NA;NA;NA	reactive oxygen species metabolic process;cellular response to retinoic acid;oxidation-reduction process;protein import into mitochondrial inner membrane;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of intrinsic apoptotic signaling pathway;negative regulation of transcription, DNA-templated;extrinsic apoptotic signaling pathway;positive regulation of peptidase activity;cellular response to interferon-beta;positive regulation of protein catabolic process;negative regulation of cell growth;mitochondrial respiratory chain complex I assembly	GO:007259; GO:007130; GO:005511; GO:004503; GO:004328; GO:200124; GO:004589; GO:009719; GO:001095; GO:003545; GO:004573; GO:003030; GO:003298	nucleoplasm;mitochondrial membrane;mitochondrial inner membrane;integral component of membrane;cytoplasm	GO:000565; GO:003196; GO:000574; GO:001602; GO:000573	 Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Oxidative phosphorylation; Metabolic pathways	hsa0493; hsa0501; hsa0019; hsa0110	protein binding;NADH dehydrogenase (ubiquinone) activity;ATP binding;NADH dehydrogenase activity	GO:000551; GO:000813; GO:000552; GO:000395
NP_001231582.1	NP_001231582.1	NP_001231582.1 serotransferrin precursor [Sus scrofa]	74	74	65	30291000000	49627000000	32155000000	53506000000	45765000000	83516000000	39627000000	37066000000	32574000000	35467000000	42723000000	45262000000	31453000000	43700000000	35524000000	39054000000	40232000000	60152000000	NA	NA	NA	TF	TF;NA;NA;NA;NA	regulation of protein stability;transferrin transport;regulation of iron ion transport;cellular protein metabolic process;platelet degranulation;cellular iron ion homeostasis;iron ion homeostasis;trivalent inorganic cation transport;retina homeostasis;post-translational protein modification;positive regulation of receptor-mediated endocytosis;membrane organization;cellular response to iron ion	GO:003164; GO:003357; GO:003475; GO:004426; GO:000257; GO:000687; GO:005507; GO:007251; GO:000189; GO:004368; GO:004826; GO:006102; GO:007128	late endosome;cell surface;clathrin-coated vesicle membrane;extracellular exosome;HFE-transferrin receptor complex;apical plasma membrane;perinuclear region of cytoplasm;blood microparticle;extracellular space;basal plasma membrane;recycling endosome;secretory granule lumen;early endosome;cytoplasmic vesicle;endoplasmic reticulum lumen;clathrin-coated pit;endosome membrane;extrinsic component of external side of plasma membrane;vesicle;basal part of cell;extracellular region;endocytic vesicle	GO:000577; GO:000998; GO:003066; GO:007006; GO:199071; GO:001632; GO:004847; GO:007256; GO:000561; GO:000992; GO:005503; GO:003477; GO:000576; GO:003141; GO:000578; GO:000590; GO:001000; GO:003123; GO:003198; GO:004517; GO:000557; GO:003013	 HIF-1 signaling pathway; Mineral absorption	hsa0406; hsa0497	ferric iron binding;ferric iron transmembrane transporter activity;ferrous iron binding;iron chaperone activity;protein binding;transferrin receptor binding	GO:000819; GO:001509; GO:000819; GO:003498; GO:000551; GO:199045
NP_001231584.1	NP_001231584.1	NP_001231584.1 mesencephalic astrocyte-derived neurotrophic factor precursor [Sus scrofa]	3	3	3	0	0	15795000	16950000	23248000	0	13272000	0	0	14136000	25742000	17282000	0	25210000	0	15391000	25206000	29923000	NA	NA	NA	MANF	MANF;NA;NA;NA;NA	regulation of receptor activity;response to unfolded protein;platelet degranulation;regulation of response to endoplasmic reticulum stress;neuron projection development;dopaminergic neuron differentiation	GO:001046; GO:000698; GO:000257; GO:190589; GO:003117; GO:007154	extracellular space;nucleus;endoplasmic reticulum lumen;extracellular region;sarcoplasmic reticulum lumen;cytosol	GO:000561; GO:000563; GO:000578; GO:000557; GO:003301; GO:000582	"NA"	"NA"	growth factor activity;RNA binding	GO:000808; GO:000372
NP_001231587.1;NP_001231586.1	NP_001231587.1;NP_001231586.1	NP_001231587.1 mannose-1-phosphate guanyltransferase alpha [Sus scrofa];NP_001231586.1 mannose-1-phosphate guanyltransferase alpha [Sus scrofa]	7	7	7	11071000	0	0	0	0	0	0	0	8469200	0	9775200	0	12342000	0	0	0	0	0	NA	NA	NA	GMPPA	GMPPA;GMPPA;NA;NA;NA	biosynthetic process	GO:000905	cytoplasm;extracellular exosome	GO:000573; GO:007006	 Amino sugar and nucleotide sugar metabolism; Fructose and mannose metabolism; Metabolic pathways	hsa0052; hsa0005; hsa0110	nucleotidyltransferase activity;protein binding	GO:001677; GO:000551
XP_020946648.1;XP_020946646.1;XP_020946645.1;NP_001231608.1	XP_020946648.1;XP_020946646.1;XP_020946645.1;NP_001231608.1	XP_020946648.1 microfibrillar-associated protein 5 isoform X3 [Sus scrofa];XP_020946646.1 microfibrillar-associated protein 5 isoform X2 [Sus scrofa];XP_020946645.1 microfibrillar-associated protein 5 isoform X1 [Sus scrofa];NP_001231608.1 microfibrillar-a	8	8	8	0	676310000	702170000	527000000	453110000	746910000	152350000	266830000	470310000	438980000	290990000	452110000	214030000	470700000	401430000	639690000	462020000	1016800000	NA	NA	NA	MFAP5	MFAP5;MFAP5;MFAP5;MFAP5;NA	extracellular matrix organization;definitive hemopoiesis;supramolecular fiber organization	GO:003019; GO:006021; GO:009743	extracellular region;microfibril	GO:000557; GO:000152	"NA"	"NA"	extracellular matrix structural constituent	GO:000520
XP_020921753.1;NP_001231613.1;XP_020921752.1	XP_020921753.1;NP_001231613.1;XP_020921752.1	XP_020921753.1 ATP synthase subunit d, mitochondrial isoform X2 [Sus scrofa];NP_001231613.1 ATP synthase subunit d, mitochondrial [Sus scrofa];XP_020921752.1 ATP synthase subunit d, mitochondrial isoform X1 [Sus scrofa]	9	9	9	328610000	197750000	264050000	184660000	307860000	186460000	296670000	217670000	327840000	206580000	268210000	243000000	179820000	208290000	258020000	241840000	208720000	191020000	NA	NA	NA	ATP5PD	ATP5PD;ATP5PD;ATP5PD;NA;NA	ATP biosynthetic process;ATP synthesis coupled proton transport;mitochondrial ATP synthesis coupled proton transport;ATP hydrolysis coupled cation transmembrane transport;cristae formation	GO:000675; GO:001598; GO:004277; GO:009913; GO:004240	mitochondrion;mitochondrial proton-transporting ATP synthase, stator stalk;mitochondrial proton-transporting ATP synthase complex;nucleoplasm;mitochondrial inner membrane	GO:000573; GO:000027; GO:000575; GO:000565; GO:000574	 Oxidative phosphorylation; Metabolic pathways; Parkinson's disease	hsa0019; hsa0110; hsa0501	transmembrane transporter activity;ATPase activity;proton-transporting ATP synthase activity, rotational mechanism	GO:002285; GO:001688; GO:004693
NP_001231616.1	NP_001231616.1	NP_001231616.1 60S ribosomal protein L36 [Sus scrofa]	4	4	4	0	0	0	0	0	56645000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RPL36	RPL36;NA;NA;NA;NA	translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;cytoplasmic translation;translational initiation	GO:000641; GO:000018; GO:000661; GO:000218; GO:000641	cytoplasm;cytosolic large ribosomal subunit;cytosol;membrane;polysomal ribosome;nucleolus	GO:000573; GO:002262; GO:000582; GO:001602; GO:004278; GO:000573	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
XP_020957682.1;XP_020957681.1;XP_020957680.1;XP_020957679.1;NP_001231625.1	XP_020957682.1;XP_020957681.1;XP_020957680.1;XP_020957679.1;NP_001231625.1	XP_020957682.1 ester hydrolase C11orf54 homolog isoform X1 [Sus scrofa];XP_020957681.1 ester hydrolase C11orf54 homolog isoform X1 [Sus scrofa];XP_020957680.1 ester hydrolase C11orf54 homolog isoform X1 [Sus scrofa];XP_020957679.1 ester hydrolase C11orf54	5	5	5	17645000	26372000	17101000	23465000	9517400	0	25647000	25693000	23201000	25164000	14634000	19136000	0	9369200	11300000	18214000	15422000	20453000	NA	NA	NA	C9H11orf54	C9H11orf54;C9H11orf54;C9H11orf54;C9H11orf54;C9H11orf54	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020925800.1;XP_020925734.1;XP_005659757.1;NP_001231648.1;XP_020925511.1;XP_013848566.1;XP_013848565.1;XP_013848564.1;XP_013848563.1;XP_013848562.1;NP_001231647.1	XP_020925800.1;XP_020925734.1;XP_005659757.1;NP_001231648.1;XP_020925511.1;XP_013848566.1;XP_013848565.1;XP_013848564.1;XP_013848563.1;XP_013848562.1;NP_001231647.1	XP_020925800.1 synaptosomal-associated protein 23 isoform X2 [Sus scrofa];XP_020925734.1 synaptosomal-associated protein 23 isoform X2 [Sus scrofa];XP_005659757.1 synaptosomal-associated protein 23 isoform X2 [Sus scrofa];NP_001231648.1 synaptosomal-associ	5	5	5	0	26310000	29117000	0	19490000	18277000	21463000	24073000	0	19870000	0	0	21622000	19509000	33063000	0	21225000	22409000	NA	NA	NA	SNAP23	SNAP23;SNAP23;SNAP23;SNAP23;SNAP23	synaptic vesicle priming;synaptic vesicle fusion to presynaptic active zone membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;membrane fusion;vesicle targeting;post-Golgi vesicle-mediated transport;neutrophil degranulation;histamine secretion by mast cell;exocytosis;protein transport	GO:001608; GO:003162; GO:000247; GO:006102; GO:000690; GO:000689; GO:004331; GO:000255; GO:000688; GO:001503	neuron projection;tertiary granule membrane;nucleoplasm;cell-cell adherens junction;phagocytic vesicle membrane;specific granule membrane;plasma membrane;azurophil granule;mast cell granule;cytoplasm;focal adhesion;SNARE complex;extracellular exosome;presynapse	GO:004300; GO:007082; GO:000565; GO:000591; GO:003067; GO:003557; GO:000588; GO:004258; GO:004262; GO:000573; GO:000592; GO:003120; GO:007006; GO:009879	 Platelet activation; SNARE interactions in vesicular transport	hsa0461; hsa0413	syntaxin binding;protein binding;SNAP receptor activity	GO:001990; GO:000551; GO:000548
NP_001231652.1	NP_001231652.1	NP_001231652.1 eukaryotic translation initiation factor 3 subunit D [Sus scrofa]	3	3	3	0	0	0	0	0	17210000	0	0	0	17599000	0	0	0	0	0	0	0	0	NA	NA	NA	EIF3D	EIF3D;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;positive regulation of translation;translational initiation;positive regulation of mRNA binding;cap-dependent translational initiation;viral translational termination-reinitiation	GO:000173; GO:004572; GO:000641; GO:190241; GO:000219; GO:007552	cytosol;eukaryotic translation initiation factor 3 complex;eukaryotic translation initiation factor 3 complex, eIF3m;membrane;eukaryotic 48S preinitiation complex;eukaryotic 43S preinitiation complex	GO:000582; GO:000585; GO:007154; GO:001602; GO:003329; GO:001628	 RNA transport	hsa0301	RNA binding;translation initiation factor activity;mRNA cap binding;protein binding	GO:000372; GO:000374; GO:009880; GO:000551
NP_001231661.1	NP_001231661.1	NP_001231661.1 carbonyl reductase [NADPH] 3 [Sus scrofa]	8	7	6	40762000	67176000	48888000	78314000	40374000	60363000	52598000	60171000	61570000	77629000	61732000	73567000	54969000	81579000	40629000	51135000	59653000	68915000	NA	NA	NA	CBR3	CBR3;NA;NA;NA;NA	oxidation-reduction process;xenobiotic metabolic process;phylloquinone catabolic process;cognition	GO:005511; GO:000680; GO:004237; GO:005089	nucleoplasm;extracellular space;cytosol	GO:000565; GO:000561; GO:000582	 Arachidonic acid metabolism; Metabolic pathways; Metabolism of xenobiotics by cytochrome P450	hsa0059; hsa0110; hsa0098	3-keto sterol reductase activity;carbonyl reductase (NADPH) activity;protein binding;NADPH binding	GO:000025; GO:000409; GO:000551; GO:007040
NP_001231662.1	NP_001231662.1	NP_001231662.1 indolethylamine N-methyltransferase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	INMT	INMT;NA;NA;NA;NA	response to toxic substance;methylation;amine metabolic process	GO:000963; GO:003225; GO:000930	cytosol;cytoplasm	GO:000582; GO:000573	 Selenocompound metabolism; Tryptophan metabolism	hsa0045; hsa0038	amine N-methyltransferase activity;thioether S-methyltransferase activity;protein binding	GO:003074; GO:000479; GO:000551
NP_001231672.1	NP_001231672.1	NP_001231672.1 NADH dehydrogenase [ubiquinone] 1 subunit C2 [Sus scrofa]	2	2	2	36555000	21422000	28235000	0	36915000	0	0	22991000	0	0	0	0	0	0	32926000	0	0	0	NA	NA	NA	NDUFC2	NDUFC2;NA;NA;NA;NA	mitochondrial respiratory chain complex I assembly;neutrophil degranulation;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:004331; GO:000612	azurophil granule membrane;integral component of membrane;mitochondrion;mitochondrial respiratory chain complex I;plasma membrane	GO:003557; GO:001602; GO:000573; GO:000574; GO:000588	 Alzheimer's disease; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Oxidative phosphorylation	hsa0501; hsa0501; hsa0493; hsa0110; hsa0019	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_020935121.1;XP_020935120.1;XP_020935118.1;XP_020935117.1;XP_020935116.1;XP_013841363.1;XP_013841362.1;XP_013841360.1;XP_005673484.1;XP_005673482.1;XP_005673481.1;XP_005673480.1;XP_005673479.1;XP_005673477.1;XP_005673476.1;NP_001231676.1;XP_003135320.1	XP_020935121.1;XP_020935120.1;XP_020935118.1;XP_020935117.1;XP_020935116.1;XP_013841363.1;XP_013841362.1;XP_013841360.1;XP_005673484.1;XP_005673482.1;XP_005673481.1;XP_005673480.1;XP_005673479.1;XP_005673477.1;XP_005673476.1;NP_001231676.1	XP_020935121.1 ras-related protein Rab-9A isoform X1 [Sus scrofa];XP_020935120.1 ras-related protein Rab-9A isoform X1 [Sus scrofa];XP_020935118.1 ras-related protein Rab-9A isoform X1 [Sus scrofa];XP_020935117.1 ras-related protein Rab-9A isoform X1 [Sus	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6382800	0	0	NA	NA	NA	RAB9A	RAB9A;RAB9A;RAB9A;RAB9A;RAB9A	regulation of protein localization;negative regulation by host of symbiont molecular function;intracellular protein transport;retrograde transport, endosome to Golgi;positive regulation of exocytosis;Rab protein signal transduction	GO:003288; GO:005240; GO:000688; GO:004214; GO:004592; GO:003248	extracellular exosome;plasma membrane;trans-Golgi network membrane;late endosome;transport vesicle;cytosol;melanosome;lysosome;phagocytic vesicle;endoplasmic reticulum membrane;phagocytic vesicle membrane	GO:007006; GO:000588; GO:003258; GO:000577; GO:003013; GO:000582; GO:004247; GO:000576; GO:004533; GO:000578; GO:003067	 Measles	hsa0516	identical protein binding;protein binding;GTPase activity;GTP binding;GDP binding	GO:004280; GO:000551; GO:000392; GO:000552; GO:001900
NP_001231714.1;XP_020934140.1	NP_001231714.1;XP_020934140.1	NP_001231714.1 maturin [Sus scrofa];XP_020934140.1 maturin isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1389900	0	NA	NA	NA	MTURN	MTURN;MTURN;NA;NA;NA	multicellular organism development	GO:000727	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001231740.1	NP_001231740.1	NP_001231740.1 leucine-rich repeat-containing protein 57 [Sus scrofa]	6	6	6	28685000	35604000	36041000	30239000	26702000	0	39023000	29846000	28953000	24856000	25675000	31714000	27820000	26135000	34614000	33541000	34351000	32926000	NA	NA	NA	LRRC57	LRRC57;NA;NA;NA;NA	"NA"	"NA"	extracellular exosome;membrane	GO:007006; GO:001602	"NA"	"NA"	"NA"	"NA"
NP_001231758.1;XP_013837676.1	NP_001231758.1;XP_013837676.1	NP_001231758.1 40S ribosomal protein S13 [Sus scrofa];XP_013837676.1 40S ribosomal protein S13-like [Sus scrofa]	8	8	8	107930000	110260000	130560000	70683000	93777000	139330000	103580000	77948000	140830000	135940000	80225000	94288000	145010000	143860000	58466000	148970000	143600000	185080000	NA	NA	NA	RPS13	RPS13;LOC100621400;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;translation;negative regulation of RNA splicing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000661; GO:000641; GO:003311; GO:000018	cytosolic small ribosomal subunit;extracellular exosome;nucleoplasm;membrane;cytosol;ribosome;nucleolus;postsynaptic density;nucleus;focal adhesion	GO:002262; GO:007006; GO:000565; GO:001602; GO:000582; GO:000584; GO:000573; GO:001406; GO:000563; GO:000592	 Ribosome	hsa0301	mRNA binding;mRNA 5'-UTR binding;RNA binding;structural constituent of ribosome;protein binding;small ribosomal subunit rRNA binding	GO:000372; GO:004802; GO:000372; GO:000373; GO:000551; GO:007018
NP_001231759.1	NP_001231759.1	NP_001231759.1 putative transferase CAF17, mitochondrial [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	8183700	0	0	0	0	0	0	0	0	NA	NA	NA	IBA57	IBA57;NA;NA;NA;NA	iron-sulfur cluster assembly;heme biosynthetic process	GO:001622; GO:000678	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	RNA binding;transferase activity	GO:000372; GO:001674
NP_001231762.1	NP_001231762.1	NP_001231762.1 alcohol dehydrogenase class-3 [Sus scrofa]	10	10	8	157580000	160030000	200100000	145780000	155270000	159130000	189970000	145650000	162920000	153370000	162900000	132810000	168100000	156890000	129010000	165050000	177100000	143570000	NA	NA	NA	ADH5	ADH5;NA;NA;NA;NA	response to lipopolysaccharide;response to nitrosative stress;respiratory system process;positive regulation of blood pressure;formaldehyde catabolic process;response to redox state;retinoid metabolic process;ethanol oxidation;electron transport chain;peptidyl-cysteine S-nitrosylation	GO:003249; GO:005140; GO:000301; GO:004577; GO:004629; GO:005177; GO:000152; GO:000606; GO:002290; GO:001811	mitochondrion;cytosol;extracellular exosome	GO:000573; GO:000582; GO:007006	 Metabolism of xenobiotics by cytochrome P450; Tyrosine metabolism; Carbon metabolism; Glycolysis / Gluconeogenesis; Fatty acid degradation; Chemical carcinogenesis; Drug metabolism - cytochrome P450; Metabolic pathways; Biosynthesis of antibiotics; Degradation of aromatic compounds; Retinol metabolism	hsa0098; hsa0035; hsa0120; hsa0001; hsa0007; hsa0520; hsa0098; hsa0110; hsa0113; hsa0122; hsa0083	formaldehyde dehydrogenase activity;fatty acid binding;protein homodimerization activity;alcohol dehydrogenase activity, zinc-dependent;S-(hydroxymethyl)glutathione dehydrogenase activity;zinc ion binding;electron carrier activity	GO:001846; GO:000550; GO:004280; GO:000402; GO:005190; GO:000827; GO:000905
XP_020927380.1;XP_013839807.1;NP_001231793.1	XP_020927380.1;XP_013839807.1;NP_001231793.1	XP_020927380.1 mitochondrial pyruvate carrier 1 isoform X3 [Sus scrofa];XP_013839807.1 mitochondrial pyruvate carrier 1 isoform X1 [Sus scrofa];NP_001231793.1 mitochondrial pyruvate carrier 1 [Sus scrofa]	2	2	2	40891000	0	0	0	0	0	0	0	0	0	0	0	0	0	16245000	0	0	0	NA	NA	NA	MPC1	MPC1;MPC1;MPC1;NA;NA	biological_process;mitochondrial acetyl-CoA biosynthetic process from pyruvate;cellular response to leukemia inhibitory factor;mitochondrial pyruvate transport	GO:000815; GO:006173; GO:199083; GO:000685	integral component of mitochondrial inner membrane;mitochondrion	GO:003130; GO:000573	"NA"	"NA"	pyruvate transmembrane transporter activity;molecular_function	GO:005083; GO:000367
NP_001231795.1	NP_001231795.1	NP_001231795.1 60S acidic ribosomal protein P2 [Sus scrofa]	8	8	8	440650000	498360000	501560000	451710000	446100000	508380000	516690000	466930000	454250000	404980000	569000000	399680000	573430000	419260000	585560000	415730000	438470000	512580000	NA	NA	NA	RPLP2	RPLP2;NA;NA;NA;NA	translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000018; GO:000641; GO:000661	extracellular exosome;cytosol;cytosolic large ribosomal subunit;synapse;focal adhesion;membrane	GO:007006; GO:000582; GO:002262; GO:004520; GO:000592; GO:001602	 Ribosome	hsa0301	protein binding;structural constituent of ribosome	GO:000551; GO:000373
NP_001231801.1	NP_001231801.1	NP_001231801.1 ubiquitin conjugation factor E4 A [Sus scrofa]	2	2	2	0	10738000	10364000	0	0	0	0	0	0	8192300	0	0	0	0	8849900	0	9469500	0	NA	NA	NA	UBE4A	UBE4A;NA;NA;NA;NA	ubiquitin-dependent ERAD pathway;protein polyubiquitination;ubiquitin-dependent protein catabolic process	GO:003043; GO:000020; GO:000651	ubiquitin ligase complex;cytoplasm;nucleus	GO:000015; GO:000573; GO:000563	 Ubiquitin mediated proteolysis	hsa0412	ubiquitin-ubiquitin ligase activity;protein binding	GO:003445; GO:000551
NP_001231804.1;NP_001026958.1;XP_001928392.1	NP_001231804.1;NP_001026958.1	NP_001231804.1 ras-related protein Rab-11B [Sus scrofa];NP_001026958.1 ras-related protein Rab-11A [Sus scrofa]	12	12	12	415450000	547860000	483730000	512850000	351980000	477580000	517240000	491210000	455120000	411660000	472690000	499720000	491300000	519570000	544250000	489040000	475850000	541480000	NA	NA	NA	RAB11B	RAB11B;RAB11A;NA;NA;NA	regulated exocytosis;establishment of protein localization to membrane;regulation of endocytic recycling;receptor recycling;exocytosis;insulin secretion involved in cellular response to glucose stimulus;melanosome transport;post-translational protein modification;constitutive secretory pathway;regulation of protein localization to cell surface;regulation of anion transport;cellular response to acidic pH;Rab protein signal transduction;transferrin transport;retrograde transport, endosome to plasma membrane	GO:004505; GO:009015; GO:200113; GO:000188; GO:000688; GO:003577; GO:003240; GO:004368; GO:004505; GO:200000; GO:004407; GO:007146; GO:003248; GO:003357; GO:199012	cell junction;phagocytic vesicle membrane;phagocytic vesicle;recycling endosome;extracellular exosome;anchored component of synaptic vesicle membrane;cytosol;endosome;synaptic vesicle	GO:003005; GO:003067; GO:004533; GO:005503; GO:007006; GO:009899; GO:000582; GO:000576; GO:000802	 AMPK signaling pathway; Vasopressin-regulated water reabsorption; Endocytosis	hsa0415; hsa0496; hsa0414	GDP binding;GTP binding;cadherin binding;protein binding;GTPase activity;myosin V binding	GO:001900; GO:000552; GO:004529; GO:000551; GO:000392; GO:003148
NP_001231823.1	NP_001231823.1	NP_001231823.1 layilin precursor [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13017000	NA	NA	NA	LAYN	LAYN;NA;NA;NA;NA	"NA"	"NA"	integral component of membrane;ruffle;cell surface;focal adhesion	GO:001602; GO:000172; GO:000998; GO:000592	"NA"	"NA"	carbohydrate binding;hyaluronic acid binding	GO:003024; GO:000554
NP_001231843.1	NP_001231843.1	NP_001231843.1 synaptobrevin homolog YKT6 [Sus scrofa]	7	7	7	39027000	42435000	34402000	45211000	32682000	38017000	31267000	37917000	33881000	42929000	37157000	44391000	29190000	42613000	32795000	45514000	34906000	39130000	NA	NA	NA	YKT6	YKT6;NA;NA;NA;NA	vesicle targeting;ER to Golgi vesicle-mediated transport;vesicle docking involved in exocytosis;membrane fusion;protein transport;retrograde transport, endosome to Golgi	GO:000690; GO:000688; GO:000690; GO:006102; GO:001503; GO:004214	cytosol;endoplasmic reticulum;cytoplasm;integral component of plasma membrane;transport vesicle;endosome;basilar dendrite;Golgi apparatus;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi membrane;SNARE complex;neuronal cell body;cytoplasmic vesicle membrane	GO:000582; GO:000578; GO:000573; GO:000588; GO:003013; GO:000576; GO:009744; GO:000579; GO:003311; GO:000013; GO:003120; GO:004302; GO:003065	 SNARE interactions in vesicular transport	hsa0413	cadherin binding;SNAP receptor activity;protein-cysteine S-palmitoyltransferase activity	GO:004529; GO:000548; GO:001970
NP_001231852.1	NP_001231852.1	NP_001231852.1 armadillo repeat-containing protein 10 [Sus scrofa]	7	7	7	44235000	39850000	43348000	45430000	44464000	41765000	44089000	36928000	55425000	40608000	54258000	51686000	72116000	41181000	46105000	36986000	44785000	47025000	NA	NA	NA	ARMC10	ARMC10;NA;NA;NA;NA	regulation of growth	GO:004000	mitochondrion;endoplasmic reticulum;integral component of membrane	GO:000573; GO:000578; GO:001602	"NA"	"NA"	p53 binding;DBD domain binding	GO:000203; GO:005069
NP_001231853.1	NP_001231853.1	NP_001231853.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7301500	NA	NA	NA	NDUFA11	NDUFA11;NA;NA;NA;NA	mitochondrial respiratory chain complex I assembly;oxidation-reduction process	GO:003298; GO:005511	mitochondrial respiratory chain complex I;integral component of membrane;mitochondrion;mitochondrial inner membrane	GO:000574; GO:001602; GO:000573; GO:000574	 Parkinson's disease; Metabolic pathways; Alzheimer's disease; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0501; hsa0110; hsa0501; hsa0493; hsa0019	"NA"	"NA"
XP_005655306.1;NP_001231854.1	XP_005655306.1;NP_001231854.1	XP_005655306.1 protein dpy-30 homolog isoform X1 [Sus scrofa];NP_001231854.1 protein dpy-30 homolog [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1508100	NA	NA	NA	DPY30	DPY30;DPY30;NA;NA;NA	regulation of megakaryocyte differentiation;histone H3-K4 methylation;endosomal transport	GO:004565; GO:005156; GO:001619	nucleoplasm;nucleus;Golgi apparatus;Set1C/COMPASS complex;trans-Golgi network;MLL3/4 complex;histone methyltransferase complex	GO:000565; GO:000563; GO:000579; GO:004818; GO:000580; GO:004466; GO:003509	"NA"	"NA"	histone-lysine N-methyltransferase activity;identical protein binding;protein binding	GO:001802; GO:004280; GO:000551
XP_020924081.1;NP_001231857.1	XP_020924081.1;NP_001231857.1	XP_020924081.1 U6 snRNA-associated Sm-like protein LSm3 isoform X1 [Sus scrofa];NP_001231857.1 U6 snRNA-associated Sm-like protein LSm3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4302800	0	0	NA	NA	NA	LSM3	LSM3;LSM3;NA;NA;NA	mRNA splicing, via spliceosome;mRNA processing;cytoplasmic mRNA processing body assembly;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	GO:000039; GO:000639; GO:003396; GO:004392	nucleoplasm;U6 snRNP;U4/U6 x U5 tri-snRNP complex;P-body;catalytic step 2 spliceosome;cytosol;nucleus;U2-type precatalytic spliceosome;Lsm1-7-Pat1 complex	GO:000565; GO:000568; GO:004654; GO:000093; GO:007101; GO:000582; GO:000563; GO:007100; GO:199072	 RNA degradation; Spliceosome	hsa0301; hsa0304	protein binding;RNA binding	GO:000551; GO:000372
NP_001231864.1	NP_001231864.1	NP_001231864.1 transaldolase [Sus scrofa]	15	15	15	1419800000	1271100000	1447700000	1129400000	1297000000	955200000	1428200000	1143000000	1307500000	982470000	1037600000	451770000	638040000	1080400000	1391400000	1306200000	1500100000	1219200000	NA	NA	NA	TALDO1	TALDO1;NA;NA;NA;NA	xylulose biosynthetic process;fructose 6-phosphate metabolic process;interleukin-12-mediated signaling pathway;carbohydrate metabolic process;pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch	GO:000599; GO:000600; GO:003572; GO:000597; GO:000609; GO:000905	nucleoplasm;nucleus;cytoplasm;cytosol;extracellular exosome	GO:000565; GO:000563; GO:000573; GO:000582; GO:007006	 Biosynthesis of amino acids; Pentose phosphate pathway; Carbon metabolism; Biosynthesis of antibiotics; Metabolic pathways	hsa0123; hsa0003; hsa0120; hsa0113; hsa0110	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity;monosaccharide binding;protein binding	GO:000480; GO:004802; GO:000551
NP_001231869.1	NP_001231869.1	NP_001231869.1 uroporphyrinogen decarboxylase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	UROD	UROD;NA;NA;NA;NA	protoporphyrinogen IX biosynthetic process;heme biosynthetic process	GO:000678; GO:000678	cytosol;nucleoplasm	GO:000582; GO:000565	 Porphyrin and chlorophyll metabolism; Metabolic pathways	hsa0086; hsa0110	uroporphyrinogen decarboxylase activity;protein binding	GO:000485; GO:000551
XP_020956013.1;XP_013833913.2;NP_001231877.1	XP_020956013.1;XP_013833913.2;NP_001231877.1	XP_020956013.1 LETM1 and EF-hand domain-containing protein 1, mitochondrial isoform X2 [Sus scrofa];XP_013833913.2 LETM1 and EF-hand domain-containing protein 1, mitochondrial isoform X1 [Sus scrofa];NP_001231877.1 LETM1 and EF-hand domain-containing prote	10	10	10	28631000	19653000	24696000	0	26040000	0	26246000	23094000	36462000	22536000	21163000	27134000	10333000	18719000	23944000	25108000	18506000	17653000	NA	NA	NA	LETM1	LETM1;LETM1;LETM1;NA;NA	protein hexamerization;mitochondrial calcium release;cristae formation;protein homooligomerization;mitochondrial calcium ion homeostasis;mitochondrial calcium ion transport	GO:003421; GO:009909; GO:004240; GO:005126; GO:005156; GO:000685	mitochondrion;mitochondrial inner membrane;integral component of membrane	GO:000573; GO:000574; GO:001602	"NA"	"NA"	protein binding;calcium ion binding;ribosome binding;calcium:proton antiporter activity	GO:000551; GO:000550; GO:004302; GO:001536
NP_001231880.1;XP_020921764.1	NP_001231880.1;XP_020921764.1	NP_001231880.1 leucine-rich repeat-containing protein 59 [Sus scrofa];XP_020921764.1 leucine-rich repeat-containing protein 59 isoform X1 [Sus scrofa]	6	6	6	23527000	31417000	24397000	33959000	32139000	35831000	24602000	26375000	28870000	32413000	36972000	55167000	38351000	37409000	26761000	43639000	32926000	42273000	NA	NA	NA	LRRC59	LRRC59;LRRC59;NA;NA;NA	"NA"	"NA"	cytoplasm;endoplasmic reticulum;integral component of membrane;nuclear envelope;mitochondrial nucleoid;organelle membrane	GO:000573; GO:000578; GO:001602; GO:000563; GO:004264; GO:003109	"NA"	"NA"	cadherin binding;RNA binding	GO:004529; GO:000372
XP_005674076.1;NP_001231909.1	XP_005674076.1;NP_001231909.1	XP_005674076.1 prefoldin subunit 3 isoform X1 [Sus scrofa];NP_001231909.1 prefoldin subunit 3 [Sus scrofa]	3	3	3	0	13230000	14477000	0	15104000	0	0	14505000	14732000	0	0	0	14638000	0	0	0	12524000	14172000	NA	NA	NA	VBP1	VBP1;VBP1;NA;NA;NA	microtubule-based process;protein folding;tubulin complex assembly	GO:000701; GO:000645; GO:000702	nucleus;cytoplasm;cytosol;polysome;prefoldin complex;intracellular membrane-bounded organelle	GO:000563; GO:000573; GO:000582; GO:000584; GO:001627; GO:004323	"NA"	"NA"	protein binding;tubulin binding	GO:000551; GO:001563
NP_001231917.1	NP_001231917.1	NP_001231917.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 [Sus scrofa]	3	3	3	17922000	10098000	16810000	0	19605000	0	14625000	0	16316000	14960000	0	0	0	0	0	13947000	0	0	NA	NA	NA	NDUFS5	NDUFS5;NA;NA;NA;NA	mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:000612	mitochondrial intermembrane space;mitochondrial inner membrane;mitochondrion	GO:000575; GO:000574; GO:000573	 Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Huntington's disease	hsa0019; hsa0493; hsa0110; hsa0501	NADH dehydrogenase (ubiquinone) activity	GO:000813
NP_001231920.1;XP_020953860.1	NP_001231920.1;XP_020953860.1	NP_001231920.1 synaptojanin-2-binding protein [Sus scrofa];XP_020953860.1 synaptojanin-2-binding protein isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15177000	0	NA	NA	NA	SYNJ2BP	SYNJ2BP;SYNJ2BP;NA;NA;NA	Rho protein signal transduction;regulation of Notch signaling pathway;negative regulation of endothelial cell proliferation;negative regulation of endothelial cell migration;establishment or maintenance of epithelial cell apical/basal polarity;negative regulation of ERK1 and ERK2 cascade;receptor localization to synapse;receptor clustering;negative regulation of sprouting angiogenesis;protein targeting;regulation of endocytosis;cell-cell adhesion;chemical synaptic transmission;negative regulation of angiogenesis;intracellular distribution of mitochondria	GO:000726; GO:000859; GO:000193; GO:001059; GO:004519; GO:007037; GO:009712; GO:004311; GO:190367; GO:000660; GO:003010; GO:009860; GO:000726; GO:001652; GO:004831	mitochondrion;neuron projection;cell junction;postsynaptic density membrane;basolateral plasma membrane;ionotropic glutamate receptor complex;integral component of mitochondrial outer membrane;neuromuscular junction	GO:000573; GO:004300; GO:003005; GO:009883; GO:001632; GO:000832; GO:003130; GO:003159	"NA"	"NA"	protein binding;protein C-terminus binding;ionotropic glutamate receptor binding	GO:000551; GO:000802; GO:003525
NP_001231923.1	NP_001231923.1	NP_001231923.1 vacuolar protein sorting-associated protein 45 [Sus scrofa]	3	3	3	0	0	6145600	0	0	0	0	0	0	0	0	0	10506000	0	0	7848700	0	9107300	NA	NA	NA	VPS45	VPS45;NA;NA;NA;NA	vesicle docking involved in exocytosis;blood coagulation;intracellular protein transport	GO:000690; GO:000759; GO:000688	cellular_component;Golgi apparatus;endosome membrane;integral component of membrane;Golgi membrane;synaptic vesicle	GO:000557; GO:000579; GO:001000; GO:001602; GO:000013; GO:000802	 Endocytosis	hsa0414	protein binding;molecular_function	GO:000551; GO:000367
NP_001231927.1;XP_005661536.1	NP_001231927.1;XP_005661536.1	NP_001231927.1 transcription factor BTF3 [Sus scrofa];XP_005661536.1 transcription factor BTF3 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5868700	0	0	0	NA	NA	NA	BTF3	BTF3;BTF3;NA;NA;NA	transcription from RNA polymerase II promoter;protein transport;in utero embryonic development	GO:000636; GO:001503; GO:000170	nucleus;cytosol	GO:000563; GO:000582	"NA"	"NA"	protein binding;RNA binding	GO:000551; GO:000372
XP_005664594.2;NP_001231935.1;XP_005664593.2	XP_005664594.2;NP_001231935.1;XP_005664593.2	XP_005664594.2 protein YIF1B isoform X2 [Sus scrofa];NP_001231935.1 protein YIF1B [Sus scrofa];XP_005664593.2 protein YIF1B isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	3797200	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	YIF1B	YIF1B;YIF1B;YIF1B;NA;NA	ER to Golgi vesicle-mediated transport	GO:000688	endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle;integral component of Golgi membrane	GO:000578; GO:000579; GO:003013; GO:003017	"NA"	"NA"	"NA"	"NA"
NP_001231937.1	NP_001231937.1	NP_001231937.1 26S protease regulatory subunit 7 [Sus scrofa]	14	14	14	74454000	70123000	76835000	58052000	71862000	60674000	72557000	62500000	64106000	64680000	72016000	61700000	0	72212000	74779000	68082000	60913000	40924000	NA	NA	NA	PSMC2	PSMC2;NA;NA;NA;NA	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;ubiquitin-dependent protein catabolic process;neutrophil degranulation;osteoblast differentiation;protein deubiquitination;post-translational protein modification;positive regulation of proteasomal protein catabolic process	GO:004589; GO:000651; GO:004331; GO:000164; GO:001657; GO:004368; GO:190180	membrane;ficolin-1-rich granule lumen;nucleus;dendritic spine;P-body;cytosol;cytoplasm;proteasome regulatory particle, base subcomplex;proteasome accessory complex;secretory granule lumen;extracellular region;proteasome complex;nucleoplasm;cytoplasmic ribonucleoprotein granule	GO:001602; GO:190481; GO:000563; GO:004319; GO:000093; GO:000582; GO:000573; GO:000854; GO:002262; GO:003477; GO:000557; GO:000050; GO:000565; GO:003646	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	ATPase activity;proteasome-activating ATPase activity;TBP-class protein binding;protein binding;ATP binding	GO:001688; GO:003640; GO:001702; GO:000551; GO:000552
XP_020930266.1;XP_005672090.1;XP_005672089.1;NP_001231941.1	XP_020930266.1;XP_005672090.1;XP_005672089.1;NP_001231941.1	XP_020930266.1 inositol polyphosphate 1-phosphatase isoform X1 [Sus scrofa];XP_005672090.1 inositol polyphosphate 1-phosphatase isoform X1 [Sus scrofa];XP_005672089.1 inositol polyphosphate 1-phosphatase isoform X1 [Sus scrofa];NP_001231941.1 inositol poly	3	3	3	0	15899000	8939200	18764000	10297000	22494000	12262000	15046000	11345000	16194000	0	18888000	0	22428000	0	16878000	11817000	25190000	NA	NA	NA	INPP1	INPP1;INPP1;INPP1;INPP1;NA	inositol phosphate metabolic process;signal transduction;inositol phosphate dephosphorylation;phosphate-containing compound metabolic process	GO:004364; GO:000716; GO:004685; GO:000679	cytosol	GO:000582	 Metabolic pathways; Inositol phosphate metabolism; Phosphatidylinositol signaling system	hsa0110; hsa0056; hsa0407	inositol-1,4-bisphosphate 1-phosphatase activity;inositol-1,3,4-trisphosphate 1-phosphatase activity;protein binding;metal ion binding	GO:000444; GO:005282; GO:000551; GO:004687
NP_001233132.1;XP_005673618.1;XP_013846519.1;XP_013846518.1;XP_020932240.1;XP_020932239.1;XP_020932238.1;NP_001278611.1;XP_020932237.1;XP_020932236.1	NP_001233132.1;XP_005673618.1;XP_013846519.1;XP_013846518.1	NP_001233132.1 ATP-dependent RNA helicase DDX3X [Sus scrofa];XP_005673618.1 ATP-dependent RNA helicase DDX3X isoform X1 [Sus scrofa];XP_013846519.1 ATP-dependent RNA helicase DDX3X isoform X2 [Sus scrofa];XP_013846518.1 ATP-dependent RNA helicase DDX3X iso	10	10	10	24341000	32053000	26740000	36802000	27754000	26311000	21800000	33397000	25019000	33423000	24377000	30172000	33929000	23876000	32232000	31341000	29819000	28513000	NA	NA	NA	DDX3X	DDX3X;DDX3X;LOC100624590;LOC100624590;NA	intracellular signal transduction;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of translation;positive regulation of canonical Wnt signaling pathway;cellular response to osmotic stress;negative regulation of intrinsic apoptotic signaling pathway;positive regulation of interferon-beta production;negative regulation of apoptotic process;mature ribosome assembly;neutrophil degranulation;positive regulation of viral genome replication;positive regulation of chemokine (C-C motif) ligand 5 production;translational initiation;RNA secondary structure unwinding;negative regulation of cell growth;DNA duplex unwinding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;innate immune response;positive regulation of gene expression;positive regulation of translation;intrinsic apoptotic signaling pathway;positive regulation of G1/S transition of mitotic cell cycle;response to virus;viral process;negative regulation of protein complex assembly;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of transcription from RNA polymerase II promoter;protein localization to cytoplasmic stress granule;chromosome segregation;Wnt signaling pathway;stress granule assembly;cellular response to arsenic-containing substance;positive regulation of protein serine/threonine kinase activity	GO:003555; GO:000862; GO:001714; GO:009026; GO:007147; GO:200124; GO:003272; GO:004306; GO:004225; GO:004331; GO:004507; GO:007165; GO:000641; GO:001050; GO:003030; GO:003250; GO:004315; GO:004508; GO:001062; GO:004572; GO:009719; GO:190008; GO:000961; GO:001603; GO:003133; GO:004328; GO:004594; GO:190360; GO:000705; GO:001605; GO:003406; GO:007124; GO:007190	cytosolic small ribosomal subunit;cytoplasm;nucleus;eukaryotic translation initiation factor 3 complex;cytoplasmic stress granule;nuclear speck;ficolin-1-rich granule lumen;extracellular region;mitochondrial outer membrane;extracellular exosome;cytosol;secretory granule lumen	GO:002262; GO:000573; GO:000563; GO:000585; GO:001049; GO:001660; GO:190481; GO:000557; GO:000574; GO:007006; GO:000582; GO:003477	 Hepatitis B; Viral carcinogenesis; RIG-I-like receptor signaling pathway	hsa0516; hsa0520; hsa0462	ATP binding;eukaryotic initiation factor 4E binding;translation initiation factor binding;RNA stem-loop binding;ATP-dependent RNA helicase activity;poly(A) binding;mRNA 5'-UTR binding;GTPase activity;ATPase activity;ribosomal small subunit binding;protein binding;RNA binding;transcription factor binding;nucleoside-triphosphatase activity;RNA strand annealing activity;CTPase activity;cadherin binding;DNA binding;protein serine/threonine kinase activator activity	GO:000552; GO:000819; GO:003136; GO:003561; GO:000400; GO:000814; GO:004802; GO:000392; GO:001688; GO:004302; GO:000551; GO:000372; GO:000813; GO:001711; GO:003359; GO:004327; GO:004529; GO:000367; GO:004353
NP_001233144.1	NP_001233144.1	NP_001233144.1 ubiquitin/ISG15-conjugating enzyme E2 L6 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	4382700	0	0	0	0	0	0	0	0	0	NA	NA	NA	UBE2L6	UBE2L6;NA;NA;NA;NA	cellular protein modification process;negative regulation of type I interferon production;protein ubiquitination;translesion synthesis;ISG15-protein conjugation;ubiquitin-dependent protein catabolic process;cellular protein metabolic process	GO:000646; GO:003248; GO:001656; GO:001998; GO:003202; GO:000651; GO:004426	cytosol;nucleoplasm;ubiquitin ligase complex	GO:000582; GO:000565; GO:000015	 Ubiquitin mediated proteolysis; Parkinson's disease	hsa0412; hsa0501	protein binding;ubiquitin binding;ubiquitin conjugating enzyme activity;ISG15 transferase activity;ubiquitin-protein transferase activity;ubiquitin protein ligase binding	GO:000551; GO:004313; GO:006163; GO:004229; GO:000484; GO:003162
NP_001233167.1	NP_001233167.1	NP_001233167.1 coatomer subunit gamma-2 [Sus scrofa]	5	2	2	0	0	4730000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	COPG2	COPG2;NA;NA;NA;NA	intracellular protein transport;retrograde vesicle-mediated transport, Golgi to ER;protein secretion;organelle transport along microtubule;ER to Golgi vesicle-mediated transport	GO:000688; GO:000689; GO:000930; GO:007238; GO:000688	endoplasmic reticulum-Golgi intermediate compartment;transport vesicle;Golgi apparatus;endoplasmic reticulum;membrane;cytosol;COPI vesicle coat;Golgi membrane	GO:000579; GO:003013; GO:000579; GO:000578; GO:001602; GO:000582; GO:003012; GO:000013	"NA"	"NA"	structural molecule activity	GO:000519
XP_005665742.2;NP_001233171.1	XP_005665742.2;NP_001233171.1	XP_005665742.2 patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [Sus scrofa];NP_001233171.1 patr class I histocompatibility antigen, A-126 alpha chain-like precursor [Sus scrofa]	8	3	2	0	0	0	0	0	0	0	0	0	0	0	20672000	0	0	0	0	0	0	NA	NA	NA	LOC100513601	LOC100513601;LOC100513601;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001233172.1	NP_001233172.1	NP_001233172.1 carnitine O-palmitoyltransferase 2, mitochondrial precursor [Sus scrofa]	13	13	13	78749000	58114000	88107000	61735000	65564000	40174000	104190000	69508000	96652000	76783000	51096000	59869000	63805000	73189000	61942000	60804000	52232000	41478000	NA	NA	NA	CPT2	CPT2;NA;NA;NA;NA	fatty acid beta-oxidation;carnitine shuttle;regulation of lipid metabolic process	GO:000663; GO:000685; GO:001921	nucleolus;nucleoplasm;mitochondrion;mitochondrial inner membrane	GO:000573; GO:000565; GO:000573; GO:000574	 Fatty acid metabolism; PPAR signaling pathway; Fatty acid degradation	hsa0121; hsa0332; hsa0007	carnitine O-palmitoyltransferase activity	GO:000409
XP_020924272.1;XP_020924271.1;XP_020924270.1;XP_020924269.1;XP_020924268.1;XP_005670089.1;XP_020924267.1;XP_020924266.1;XP_013837701.1;XP_020924265.1;XP_020924264.1;XP_020924263.1;XP_020924262.1;XP_020924261.1;XP_020924260.1;XP_013837698.1;XP_005670088.1;NP_001233182.1;XP_020924259.1;XP_005670087.1;XP_020924258.1;XP_005670086.1;XP_020924257.1;XP_020924256.1;XP_013837697.1;XP_005670084.1;XP_020924255.1;XP_020924254.1	XP_020924272.1;XP_020924271.1;XP_020924270.1;XP_020924269.1;XP_020924268.1;XP_005670089.1;XP_020924267.1;XP_020924266.1;XP_013837701.1;XP_020924265.1;XP_020924264.1;XP_020924263.1;XP_020924262.1;XP_020924261.1;XP_020924260.1;XP_013837698.1;XP_005670088.1;NP_001233182.1;XP_020924259.1;XP_005670087.1;XP_020924258.1;XP_005670086.1;XP_020924257.1;XP_020924256.1;XP_013837697.1;XP_005670084.1;XP_020924255.1;XP_020924254.1	XP_020924272.1 eukaryotic translation initiation factor 4 gamma 1 isoform X17 [Sus scrofa];XP_020924271.1 eukaryotic translation initiation factor 4 gamma 1 isoform X16 [Sus scrofa];XP_020924270.1 eukaryotic translation initiation factor 4 gamma 1 isoform	8	8	8	0	15023000	14277000	14084000	16760000	17365000	15119000	14199000	13798000	16069000	15976000	0	15327000	14978000	15866000	13774000	16666000	15683000	NA	NA	NA	EIF4G1	EIF4G1;EIF4G1;EIF4G1;EIF4G1;EIF4G1	cellular response to nutrient levels;positive regulation of cellular protein metabolic process;cellular macromolecule biosynthetic process;cap-dependent translational initiation;developmental process;positive regulation of peptidyl-serine phosphorylation;viral process;negative regulation of autophagy;positive regulation of neuron differentiation;translational initiation;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of eukaryotic translation initiation factor 4F complex assembly;positive regulation of cell proliferation;regulation of mRNA stability;negative regulation of neuron death;positive regulation of miRNA mediated inhibition of translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell death;regulation of cellular response to stress;regulation of polysome binding;mitochondrion organization;regulation of gene silencing by miRNA;regulation of presynapse assembly;behavioral fear response;regulation of translational initiation;negative regulation of peptidyl-threonine phosphorylation;positive regulation of cell growth;energy homeostasis	GO:003166; GO:003227; GO:003464; GO:000219; GO:003250; GO:003313; GO:001603; GO:001050; GO:004566; GO:000641; GO:190008; GO:190553; GO:000828; GO:004348; GO:190121; GO:190561; GO:000018; GO:001094; GO:008013; GO:190569; GO:000700; GO:006096; GO:190560; GO:000166; GO:000644; GO:001080; GO:003030; GO:009700	polysome;cytoplasm;eukaryotic translation initiation factor 4F complex;cytosolic small ribosomal subunit;membrane;nucleus;cytosol	GO:000584; GO:000573; GO:001628; GO:002262; GO:001602; GO:000563; GO:000582	 RNA transport; Viral myocarditis	hsa0301; hsa0541	translation factor activity, RNA binding;protein complex scaffold;RNA binding;translation initiation factor binding;protein binding;ATP binding;eukaryotic initiation factor 4E binding;identical protein binding;translation initiation factor activity	GO:000813; GO:003294; GO:000372; GO:003136; GO:000551; GO:000552; GO:000819; GO:004280; GO:000374
XP_020957748.1;XP_020957746.1;XP_020957743.1;NP_001233199.1;XP_020957737.1;XP_020957735.1;XP_020957732.1;XP_020957740.1;XP_020957749.1;XP_020957747.1;XP_020957745.1;XP_020957733.1;XP_020957744.1;XP_020957730.1;XP_020957742.1;XP_020957727.1;XP_020957741.1;XP_020957738.1;XP_020957736.1;XP_020957751.1;XP_020957734.1;XP_020957731.1;XP_020957729.1;XP_020957726.1;XP_020947457.1;XP_020947449.1;XP_020947440.1;XP_020947438.1;XP_020947435.1;XP_020947429.1;XP_020947425.1;XP_020947420.1;XP_020947413.1;XP_020947411.1;XP_020947408.1;XP_020947404.1;XP_020947400.1;XP_020947396.1;XP_020947392.1;XP_020947386.1;XP_020947381.1;XP_020947376.1;XP_020947372.1;XP_020947370.1;XP_013848248.1;XP_020947367.1;XP_020947355.1;XP_013848246.1;XP_020947340.1;XP_013848245.1;XP_013848244.1;XP_013848243.1;XP_005659462.1;XP_005659461.1	XP_020957748.1;XP_020957746.1;XP_020957743.1;NP_001233199.1;XP_020957737.1;XP_020957735.1;XP_020957732.1;XP_020957740.1;XP_020957749.1;XP_020957747.1;XP_020957745.1;XP_020957733.1;XP_020957744.1;XP_020957730.1;XP_020957742.1;XP_020957727.1;XP_020957741.1;XP_020957738.1;XP_020957736.1;XP_020957751.1;XP_020957734.1;XP_020957731.1;XP_020957729.1;XP_020957726.1	XP_020957748.1 phosphatidylinositol-binding clathrin assembly protein isoform X21 [Sus scrofa];XP_020957746.1 phosphatidylinositol-binding clathrin assembly protein isoform X19 [Sus scrofa];XP_020957743.1 phosphatidylinositol-binding clathrin assembly prot	5	5	5	25686000	20302000	26658000	24491000	15963000	31000000	33985000	28117000	24706000	27972000	26080000	19957000	37635000	24608000	22943000	27300000	19950000	24102000	NA	NA	NA	PICALM	PICALM;PICALM;PICALM;PICALM;PICALM	endosomal transport;regulation of protein localization;clathrin coat assembly;positive regulation of neuron death;negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;clathrin-coated pit assembly;negative regulation of protein localization to cell surface;endocytosis;synaptic vesicle maturation;modulation of age-related behavioral decline;membrane organization;negative regulation of protein localization to plasma membrane;vesicle-mediated transport;axonogenesis;learning or memory;positive regulation of GTPase activity;iron ion homeostasis;regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;membrane budding;regulation of endocytosis;receptor internalization;iron ion import across plasma membrane;cell proliferation;positive regulation of transcription, DNA-templated;synaptic vesicle endocytosis;clathrin-dependent endocytosis;regulation of vesicle size;membrane bending;positive regulation of beta-amyloid formation;hemopoiesis;dendrite morphogenesis;macromolecular complex assembly;negative regulation of gene expression;cargo loading into vesicle	GO:001619; GO:003288; GO:004826; GO:190121; GO:190296; GO:190522; GO:200000; GO:000689; GO:001618; GO:009064; GO:006102; GO:190307; GO:001619; GO:000740; GO:000761; GO:004354; GO:005507; GO:190295; GO:000690; GO:003010; GO:003162; GO:009871; GO:000828; GO:004589; GO:004848; GO:007258; GO:009749; GO:009775; GO:190200; GO:003009; GO:004881; GO:006500; GO:001062; GO:003545	membrane;endosome to plasma membrane transport vesicle;neurofibrillary tangle;cytosol;Golgi apparatus;clathrin coat of coated pit;postsynaptic membrane;extrinsic component of presynaptic endocytic zone membrane;intracellular membrane-bounded organelle;neuronal cell body;clathrin-coated endocytic vesicle;plasma membrane;early endosome;synaptic vesicle;perinuclear region of cytoplasm;AP-2 adaptor complex;intrinsic component of membrane;vesicle;presynaptic membrane;nucleus;clathrin-coated pit;cell surface	GO:001602; GO:007038; GO:009741; GO:000582; GO:000579; GO:003013; GO:004521; GO:009889; GO:004323; GO:004302; GO:004533; GO:000588; GO:000576; GO:000802; GO:004847; GO:003012; GO:003122; GO:003198; GO:004273; GO:000563; GO:000590; GO:000998	"NA"	"NA"	SNARE binding;beta-amyloid binding;phosphatidylinositol-4,5-bisphosphate binding;clathrin heavy chain binding;clathrin binding;low-density lipoprotein particle receptor binding;protein binding;Rab GTPase binding;tau protein binding;cadherin binding	GO:000014; GO:000154; GO:000554; GO:003205; GO:003027; GO:005075; GO:000551; GO:001713; GO:004815; GO:004529
XP_005657399.1;XP_020927664.1;NP_001238977.1;XP_005657398.1;XP_005657397.1;XP_013845832.1;XP_013845831.1;XP_005657396.1;XP_020927663.1;XP_020927662.1;XP_020927660.1;XP_020927659.1	XP_005657399.1;XP_020927664.1;NP_001238977.1;XP_005657398.1;XP_005657397.1;XP_013845832.1;XP_013845831.1;XP_005657396.1;XP_020927663.1;XP_020927662.1;XP_020927660.1;XP_020927659.1	XP_005657399.1 RNA-binding protein EWS isoform X11 [Sus scrofa];XP_020927664.1 RNA-binding protein EWS isoform X10 [Sus scrofa];NP_001238977.1 RNA-binding protein EWS [Sus scrofa];XP_005657398.1 RNA-binding protein EWS isoform X9 [Sus scrofa];XP_005657397.	3	3	3	0	0	0	0	0	0	0	0	0	19661000	0	0	0	17192000	0	0	0	19040000	NA	NA	NA	EWSR1	EWSR1;EWSR1;EWSR1;EWSR1;EWSR1	regulation of transcription, DNA-templated	GO:000635	nucleus;nucleolus;plasma membrane	GO:000563; GO:000573; GO:000588	 Transcriptional misregulation in cancer	hsa0520	metal ion binding;identical protein binding;RNA binding;protein binding	GO:004687; GO:004280; GO:000372; GO:000551
NP_001239141.1	NP_001239141.1	NP_001239141.1 pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5017800	0	0	NA	NA	NA	DHX15	DHX15;NA;NA;NA;NA	mRNA processing;mRNA splicing, via spliceosome;response to toxic substance;RNA splicing;response to alkaloid	GO:000639; GO:000039; GO:000963; GO:000838; GO:004327	nucleoplasm;nuclear speck;nucleus;U12-type spliceosomal complex;U2-type post-mRNA release spliceosomal complex;nucleolus	GO:000565; GO:001660; GO:000563; GO:000568; GO:007100; GO:000573	 Spliceosome	hsa0304	protein binding;ATP binding;RNA helicase activity;ATP-dependent 3'-5' RNA helicase activity	GO:000551; GO:000552; GO:000372; GO:003445
NP_001239142.1	NP_001239142.1	NP_001239142.1 delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial [Sus scrofa]	8	8	8	104060000	68239000	80092000	57822000	74516000	47337000	42700000	50936000	47829000	39471000	82445000	47975000	41360000	31628000	37033000	29689000	51906000	46930000	NA	NA	NA	ALDH4A1	ALDH4A1;NA;NA;NA;NA	glyoxylate metabolic process;proline catabolic process;proline catabolic process to glutamate;electron transport chain;4-hydroxyproline catabolic process	GO:004648; GO:000656; GO:001013; GO:002290; GO:001947	mitochondrial matrix	GO:000575	 Metabolic pathways; Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism	hsa0110; hsa0025; hsa0033	1-pyrroline-5-carboxylate dehydrogenase activity;electron carrier activity;identical protein binding;aldehyde dehydrogenase (NAD) activity	GO:000384; GO:000905; GO:004280; GO:000402
NP_001239143.1;XP_020924084.1	NP_001239143.1;XP_020924084.1	NP_001239143.1 ADP-ribosylation factor-like protein 8B [Sus scrofa];XP_020924084.1 ADP-ribosylation factor-like protein 8B isoform X1 [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	38379000	0	0	NA	NA	NA	ARL8B	ARL8B;ARL8B;NA;NA;NA	chromosome segregation;lysosome localization;cell division;cell cycle;anterograde axonal transport	GO:000705; GO:003241; GO:005130; GO:000704; GO:000808	membrane;synapse;axon cytoplasm;vacuolar membrane;midbody;cytoplasm;late endosome membrane;extracellular exosome;lysosomal membrane;spindle midzone	GO:001602; GO:004520; GO:190411; GO:000577; GO:003049; GO:000573; GO:003190; GO:007006; GO:000576; GO:005123	"NA"	"NA"	GDP binding;GTPase activity;alpha-tubulin binding;protein binding;GTP binding;beta-tubulin binding	GO:001900; GO:000392; GO:004301; GO:000551; GO:000552; GO:004848
NP_001239161.1	NP_001239161.1	NP_001239161.1 peptidyl-prolyl cis-trans isomerase FKBP9 precursor [Sus scrofa]	4	4	4	0	0	0	49796000	0	44709000	40986000	44916000	0	37167000	50077000	44534000	0	39478000	0	41172000	0	31269000	NA	NA	NA	FKBP9	FKBP9;NA;NA;NA;NA	protein peptidyl-prolyl isomerization;protein folding	GO:000041; GO:000645	endoplasmic reticulum	GO:000578	"NA"	"NA"	peptidyl-prolyl cis-trans isomerase activity;calcium ion binding	GO:000375; GO:000550
XP_020956028.1;XP_020956027.1;XP_020956026.1;NP_001239162.1;XP_020956025.1;XP_020956024.1;XP_020956023.1;XP_020956022.1;XP_020956021.1;XP_020956020.1;XP_020956036.1;XP_020956035.1;XP_020956034.1;XP_020956033.1;XP_020956019.1;XP_020956032.1;XP_020956031.1;XP_020956030.1;XP_020956029.1;XP_020956037.1	XP_020956028.1;XP_020956027.1;XP_020956026.1;NP_001239162.1;XP_020956025.1;XP_020956024.1;XP_020956023.1;XP_020956022.1;XP_020956021.1;XP_020956020.1;XP_020956036.1;XP_020956035.1;XP_020956034.1;XP_020956033.1;XP_020956019.1;XP_020956032.1;XP_020956031.1;XP_020956030.1;XP_020956029.1	XP_020956028.1 arfaptin-1 isoform X3 [Sus scrofa];XP_020956027.1 arfaptin-1 isoform X3 [Sus scrofa];XP_020956026.1 arfaptin-1 isoform X3 [Sus scrofa];NP_001239162.1 arfaptin-1 [Sus scrofa];XP_020956025.1 arfaptin-1 isoform X2 [Sus scrofa];XP_020956024.1 ar	5	5	5	0	0	0	0	0	0	0	0	0	16152000	0	0	0	0	0	0	0	0	NA	NA	NA	ARFIP1	ARFIP1;ARFIP1;ARFIP1;ARFIP1;ARFIP1	intracellular protein transport;regulation of protein secretion	GO:000688; GO:005070	cytosol;cytoplasm;Golgi membrane;trans-Golgi network membrane	GO:000582; GO:000573; GO:000013; GO:003258	"NA"	"NA"	phospholipid binding;phosphatidylinositol-4-phosphate binding;protein domain specific binding	GO:000554; GO:007027; GO:001990
XP_005663414.1;XP_005663413.1;NP_001239534.1;XP_013852496.1	XP_005663414.1;XP_005663413.1;NP_001239534.1;XP_013852496.1	XP_005663414.1 protein S100-A4 isoform X2 [Sus scrofa];XP_005663413.1 protein S100-A4 isoform X2 [Sus scrofa];NP_001239534.1 protein S100-A4 [Sus scrofa];XP_013852496.1 protein S100-A4 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	57588000	0	0	0	0	0	0	NA	NA	NA	S100A4	S100A4;S100A4;S100A4;S100A4;NA	positive regulation of I-kappaB kinase/NF-kappaB signaling;epithelial to mesenchymal transition	GO:004312; GO:000183	extracellular exosome;extracellular region;extracellular space;nucleus;neuron projection;perinuclear region of cytoplasm	GO:007006; GO:000557; GO:000561; GO:000563; GO:004300; GO:004847	"NA"	"NA"	calcium ion binding;identical protein binding;RNA binding;actin binding;RAGE receptor binding;calcium-dependent protein binding;protein binding;transition metal ion binding	GO:000550; GO:004280; GO:000372; GO:000377; GO:005078; GO:004830; GO:000551; GO:004691
NP_001240850.1	NP_001240850.1	NP_001240850.1 mannose-6-phosphate isomerase [Sus scrofa]	2	2	2	11351000	0	0	0	0	0	0	0	0	0	14231000	0	15804000	0	0	0	0	0	NA	NA	NA	MPI	MPI;NA;NA;NA;NA	cell wall mannoprotein biosynthetic process;GDP-mannose biosynthetic process;mannose to fructose-6-phosphate metabolic process;protein glycosylation	GO:000003; GO:000929; GO:006161; GO:000648	cytosol;extracellular exosome	GO:000582; GO:007006	 Fructose and mannose metabolism; Metabolic pathways; Amino sugar and nucleotide sugar metabolism	hsa0005; hsa0110; hsa0052	zinc ion binding;mannose-6-phosphate isomerase activity	GO:000827; GO:000447
NP_001241645.1	NP_001241645.1	NP_001241645.1 60 kDa heat shock protein, mitochondrial [Sus scrofa]	28	28	28	1639500000	904170000	1339100000	778090000	1868200000	837240000	1433500000	992670000	1535400000	957910000	1114500000	698120000	909680000	908260000	1214000000	1016900000	1039200000	769530000	NA	NA	NA	HSPD1	HSPD1;NA;NA;NA;NA	B cell cytokine production;activation of cysteine-type endopeptidase activity involved in apoptotic process;mitochondrion organization;positive regulation of interferon-gamma production;positive regulation of interleukin-10 production;MyD88-dependent toll-like receptor signaling pathway;protein refolding;positive regulation of macrophage activation;protein import into mitochondrial intermembrane space;negative regulation of apoptotic process;response to cold;response to unfolded protein;apoptotic mitochondrial changes;viral process;adhesion of symbiont to host;isotype switching to IgG isotypes;protein maturation;regulation of transcription from RNA polymerase II promoter;B cell proliferation;T cell activation;positive regulation of T cell mediated immune response to tumor cell;'de novo' protein folding;protein stabilization;positive regulation of T cell activation;chaperone-mediated protein complex assembly;positive regulation of interleukin-6 production;interaction with symbiont	GO:000236; GO:000691; GO:000700; GO:003272; GO:003273; GO:000275; GO:004202; GO:004303; GO:004504; GO:004306; GO:000940; GO:000698; GO:000863; GO:001603; GO:004440; GO:004829; GO:005160; GO:000635; GO:004210; GO:004211; GO:000284; GO:000645; GO:005082; GO:005087; GO:005113; GO:003275; GO:005170	clathrin-coated pit;extracellular exosome;cell surface;mitochondrial matrix;extracellular space;early endosome;mitochondrion;secretory granule;coated vesicle;macromolecular complex;membrane;lipopolysaccharide receptor complex;plasma membrane;cytosol;mitochondrial inner membrane	GO:000590; GO:007006; GO:000998; GO:000575; GO:000561; GO:000576; GO:000573; GO:003014; GO:003013; GO:003299; GO:001602; GO:004669; GO:000588; GO:000582; GO:000574	 Legionellosis; Tuberculosis; RNA degradation; Type I diabetes mellitus	hsa0513; hsa0515; hsa0301; hsa0494	DNA replication origin binding;protein binding;p53 binding;RNA binding;chaperone binding;ATP binding;apolipoprotein A-I binding;lipopolysaccharide binding;ubiquitin protein ligase binding;single-stranded DNA binding;ATPase activity;high-density lipoprotein particle binding;enzyme binding	GO:000368; GO:000551; GO:000203; GO:000372; GO:005108; GO:000552; GO:003418; GO:000153; GO:003162; GO:000369; GO:001688; GO:000803; GO:001989
NP_001242898.1	NP_001242898.1	NP_001242898.1 macrophage mannose receptor 1 precursor [Sus scrofa]	14	14	14	0	35359000	19987000	48414000	27168000	36470000	28114000	36561000	23601000	37506000	34145000	41404000	44076000	39203000	0	45478000	29964000	53881000	NA	NA	NA	MRC1	MRC1;NA;NA;NA;NA	viral entry into host cell;cellular response to lipopolysaccharide;cellular response to interleukin-4;receptor-mediated endocytosis;cellular response to interferon-gamma	GO:004671; GO:007122; GO:007135; GO:000689; GO:007134	cell surface;endosome membrane;plasma membrane	GO:000998; GO:001000; GO:000588	 Phagosome; Tuberculosis	hsa0414; hsa0515	transmembrane signaling receptor activity;virus receptor activity;cargo receptor activity;mannose binding;protein binding	GO:000488; GO:000161; GO:003802; GO:000553; GO:000551
XP_005673615.1;NP_001243294.1	XP_005673615.1;NP_001243294.1	XP_005673615.1 mid1-interacting protein 1 isoform X1 [Sus scrofa];NP_001243294.1 mid1-interacting protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	3253500	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MID1IP1	MID1IP1;MID1IP1;NA;NA;NA	positive regulation of fatty acid biosynthetic process;negative regulation of microtubule depolymerization;positive regulation of ligase activity;regulation of lipid biosynthetic process;carnitine shuttle;protein polymerization;lipid metabolic process	GO:004572; GO:000702; GO:005135; GO:004689; GO:000685; GO:005125; GO:000662	microtubule;microtubule cytoskeleton;nucleus;cytosol	GO:000587; GO:001563; GO:000563; GO:000582	"NA"	"NA"	protein binding;protein C-terminus binding;identical protein binding	GO:000551; GO:000802; GO:004280
NP_001243708.1;XP_020948864.1;XP_020948861.1;XP_013844017.2;XP_013844015.2;XP_013844014.2;XP_005655877.2;XP_005655876.2;XP_005655875.2;XP_020948863.1;XP_020919654.1;XP_013835505.1;XP_005668002.1;XP_005668000.1;XP_020919653.1;XP_005667999.1;NP_001243075.1	NP_001243708.1;XP_020948864.1;XP_020948861.1;XP_013844017.2;XP_013844015.2;XP_013844014.2;XP_005655877.2;XP_005655876.2;XP_005655875.2;XP_020948863.1	NP_001243708.1 RAC-beta serine/threonine-protein kinase [Sus scrofa];XP_020948864.1 RAC-beta serine/threonine-protein kinase isoform X3 [Sus scrofa];XP_020948861.1 RAC-beta serine/threonine-protein kinase isoform X1 [Sus scrofa];XP_013844017.2 RAC-beta ser	8	8	5	32405000	24833000	30120000	26042000	0	0	34066000	21541000	31825000	24142000	33309000	36026000	26667000	22364000	22848000	26908000	21578000	27087000	NA	NA	NA	AKT2	AKT2;AKT2;AKT2;AKT2;AKT2	intracellular signal transduction;regulation of translation;negative regulation of plasma membrane long-chain fatty acid transport;peripheral nervous system myelin maintenance;protein localization to plasma membrane;cellular protein modification process;positive regulation of mitochondrial membrane potential;cellular response to insulin stimulus;positive regulation of glucose import;positive regulation of cell migration;positive regulation of vesicle fusion;protein kinase B signaling;regulation of cell cycle arrest;positive regulation of protein phosphorylation;positive regulation of cell proliferation;positive regulation of glucose metabolic process;mammary gland epithelial cell differentiation;retinal rod cell apoptotic process;glycogen biosynthetic process;carbohydrate transport;fat cell differentiation;activation of GTPase activity;peptidyl-serine phosphorylation;intracellular protein transmembrane transport;signal transduction;positive regulation of fatty acid beta-oxidation;positive regulation of glycogen biosynthetic process;cellular response to high light intensity;glucose metabolic process;negative regulation of apoptotic process;positive regulation of protein targeting to membrane;positive regulation of cell motility	GO:003555; GO:000641; GO:001074; GO:003228; GO:007265; GO:000646; GO:001091; GO:003286; GO:004632; GO:003033; GO:003134; GO:004349; GO:007115; GO:000193; GO:000828; GO:001090; GO:006064; GO:009747; GO:000597; GO:000864; GO:004544; GO:009063; GO:001810; GO:006500; GO:000716; GO:003200; GO:004572; GO:007148; GO:000600; GO:004306; GO:009031; GO:200014	nucleoplasm;intracellular membrane-bounded organelle;plasma membrane;ruffle membrane;cytosol;macromolecular complex;early endosome;nucleus;cell cortex	GO:000565; GO:004323; GO:000588; GO:003258; GO:000582; GO:003299; GO:000576; GO:000563; GO:000593	 Rap1 signaling pathway; AMPK signaling pathway; VEGF signaling pathway; Toll-like receptor signaling pathway; B cell receptor signaling pathway; Dopaminergic synapse; Estrogen signaling pathway; Hepatitis C; Glioma; Acute myeloid leukemia; Central carbon metabolism in cancer; Apoptosis; Adrenergic signaling in cardiomyocytes; Osteoclast differentiation; Signaling pathways regulating pluripotency of stem cells; Insulin resistance; Carbohydrate digestion and absorption; Chagas disease (American trypanosomiasis); Jak-STAT signaling pathway; Adipocytokine signaling pathway; ErbB signaling pathway; Platelet activation; Pathways in cancer; cGMP-PKG signaling pathway; Chemokine signaling pathway; Sphingolipid signaling pathway; Tuberculosis; Tight junction; Focal adhesion	hsa0401; hsa0415; hsa0437; hsa0462; hsa0466; hsa0472; hsa0491; hsa0516; hsa0521; hsa0522; hsa0523; hsa0421; hsa0426; hsa0438; hsa0455; hsa0493; hsa0497; hsa0514; hsa0463; hsa0492; hsa0401; hsa0461; hsa0520; hsa0402; hsa0406; hsa0407; hsa0515; hsa0453; hsa0451	metal ion binding;protein serine/threonine kinase activity;ATP binding;protein binding	GO:004687; GO:000467; GO:000552; GO:000551
XP_020941741.1;XP_020941610.1;XP_020941553.1;XP_020941349.1;XP_020941322.1;XP_020941230.1;XP_020941182.1;XP_020941164.1;NP_001245232.1;XP_020941796.1;XP_020941679.1;XP_020941463.1;XP_020941410.1;XP_020941288.1;XP_020941511.1	XP_020941741.1;XP_020941610.1;XP_020941553.1;XP_020941349.1;XP_020941322.1;XP_020941230.1;XP_020941182.1;XP_020941164.1;NP_001245232.1;XP_020941796.1;XP_020941679.1;XP_020941463.1;XP_020941410.1;XP_020941288.1;XP_020941511.1	XP_020941741.1 kinectin isoform X13 [Sus scrofa];XP_020941610.1 kinectin isoform X11 [Sus scrofa];XP_020941553.1 kinectin isoform X10 [Sus scrofa];XP_020941349.1 kinectin isoform X6 [Sus scrofa];XP_020941322.1 kinectin isoform X5 [Sus scrofa];XP_020941230.	20	20	20	60316000	58609000	64540000	53422000	65704000	60628000	68561000	65708000	62516000	60926000	76617000	74463000	72802000	65539000	74254000	57856000	64503000	64109000	NA	NA	NA	KTN1	KTN1;KTN1;KTN1;KTN1;KTN1	microtubule-based movement;post-translational protein modification;cellular protein metabolic process	GO:000701; GO:004368; GO:004426	endoplasmic reticulum;integral component of membrane;endoplasmic reticulum lumen;integral component of plasma membrane	GO:000578; GO:001602; GO:000578; GO:000588	"NA"	"NA"	RNA binding;cadherin binding;protein binding;kinesin binding	GO:000372; GO:004529; GO:000551; GO:001989
NP_001245315.1	NP_001245315.1	NP_001245315.1 DNA topoisomerase 2-beta [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2076300	NA	NA	NA	TOP2B	TOP2B;NA;NA;NA;NA	neuron migration;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;resolution of meiotic recombination intermediates;sister chromatid segregation;axonogenesis;DNA topological change;forebrain development;mitotic DNA integrity checkpoint	GO:000176; GO:004587; GO:000071; GO:000081; GO:000740; GO:000626; GO:003090; GO:004477	nucleoplasm;heterochromatin;nucleolus;viral integration complex;nucleus;cytosol;ribonucleoprotein complex	GO:000565; GO:000079; GO:000573; GO:001903; GO:000563; GO:000582; GO:199090	"NA"	"NA"	protein kinase C binding;DNA binding;chromatin binding;protein C-terminus binding;protein heterodimerization activity;DNA topoisomerase type II (ATP-hydrolyzing) activity;metal ion binding;ATP binding;histone deacetylase binding;enzyme binding	GO:000508; GO:000367; GO:000368; GO:000802; GO:004698; GO:000391; GO:004687; GO:000552; GO:004282; GO:001989
NP_001245336.1	NP_001245336.1	NP_001245336.1 tubulin-specific chaperone C [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2035200	0	0	NA	NA	NA	TBCC	TBCC;NA;NA;NA;NA	protein folding;tubulin complex assembly;cell morphogenesis	GO:000645; GO:000702; GO:000090	microtubule;cytosol;cytoskeleton;cytoplasm;photoreceptor connecting cilium	GO:000587; GO:000582; GO:000585; GO:000573; GO:003239	"NA"	"NA"	tubulin binding;chaperone binding;GTPase activity	GO:001563; GO:005108; GO:000392
NP_001245364.1;XP_020933503.1;XP_020933504.1	NP_001245364.1;XP_020933503.1;XP_020933504.1	NP_001245364.1 protein diaphanous homolog 1 [Sus scrofa];XP_020933503.1 protein diaphanous homolog 1 isoform X1 [Sus scrofa];XP_020933504.1 protein diaphanous homolog 1 isoform X2 [Sus scrofa]	11	11	11	0	13537000	18079000	16505000	22256000	18660000	0	11423000	15333000	21391000	18738000	17644000	18208000	19254000	18184000	31109000	13081000	0	NA	NA	NA	DIAPH1	DIAPH1;DIAPH1;DIAPH1;NA;NA	regulation of microtubule-based process;regulation of release of sequestered calcium ion into cytosol;regulation of cell motility;sensory perception of sound;neutrophil degranulation;cytoskeleton organization;actin cytoskeleton organization;actin filament polymerization;protein localization to microtubule;regulation of cytoskeleton organization;cellular response to histamine;regulation of cell shape;positive regulation of cell migration	GO:003288; GO:005127; GO:200014; GO:000760; GO:004331; GO:000701; GO:003003; GO:003004; GO:003537; GO:005149; GO:007142; GO:000836; GO:003033	cytosol;nucleus;ruffle membrane;mitotic spindle;secretory granule membrane;microtubule organizing center;plasma membrane;cytoplasm;ficolin-1-rich granule membrane	GO:000582; GO:000563; GO:003258; GO:007268; GO:003066; GO:000581; GO:000588; GO:000573; GO:010100	 Shigellosis; Focal adhesion; Regulation of actin cytoskeleton	hsa0513; hsa0451; hsa0481	Rho GTPase binding;receptor binding;protein binding;RNA binding;ion channel binding;actin binding	GO:001704; GO:000510; GO:000551; GO:000372; GO:004432; GO:000377
XP_020948971.1;NP_001245373.1	XP_020948971.1;NP_001245373.1	XP_020948971.1 wiskott-Aldrich syndrome protein family member 2 isoform X1 [Sus scrofa];NP_001245373.1 wiskott-Aldrich syndrome protein family member 2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	15020000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	WASF2	WASF2;WASF2;NA;NA;NA	actin cytoskeleton organization;actin filament-based movement;megakaryocyte development;vascular endothelial growth factor receptor signaling pathway;angiogenesis;positive regulation of lamellipodium assembly;postsynaptic actin cytoskeleton organization;viral process;Fc-gamma receptor signaling pathway involved in phagocytosis;negative regulation of stress fiber assembly;ameboidal-type cell migration;lamellipodium assembly;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;Rac protein signal transduction;lamellipodium morphogenesis	GO:003003; GO:003004; GO:003585; GO:004801; GO:000152; GO:001059; GO:009897; GO:001603; GO:003809; GO:005149; GO:000166; GO:003003; GO:000718; GO:001660; GO:007267	macromolecular complex;lamellipodium;extracellular exosome;actin cytoskeleton;SCAR complex;ruffle;synapse;cytosol;early endosome;cell-cell junction	GO:003299; GO:003002; GO:007006; GO:001562; GO:003120; GO:000172; GO:004520; GO:000582; GO:000576; GO:000591	 Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells; Adherens junction; Salmonella infection; Choline metabolism in cancer; Fc gamma R-mediated phagocytosis	hsa0481; hsa0510; hsa0452; hsa0513; hsa0523; hsa0466	SH3 domain binding;cadherin binding;protein binding;actin binding;protein kinase A binding	GO:001712; GO:004529; GO:000551; GO:000377; GO:005101
NP_001254623.2;XP_020924233.1;XP_013847041.1;CON__ENSEMBL:ENSBTAP00000031900	NP_001254623.2;XP_020924233.1;XP_013847041.1	NP_001254623.2 ceruloplasmin precursor [Sus scrofa];XP_020924233.1 ceruloplasmin isoform X1 [Sus scrofa];XP_013847041.1 ceruloplasmin isoform X1 [Sus scrofa]	35	35	35	1438100000	1320700000	1020100000	1513600000	2928300000	3525600000	1539800000	1104200000	1524900000	1252300000	1363900000	1359300000	1560800000	1419800000	1346000000	953180000	1585700000	1692400000	NA	NA	NA	CP	CP;CP;CP;NA;NA	copper ion transport;iron ion homeostasis;cellular iron ion homeostasis;oxidation-reduction process;post-translational protein modification;cellular protein metabolic process;iron ion transport	GO:000682; GO:005507; GO:000687; GO:005511; GO:004368; GO:004426; GO:000682	extracellular exosome;extracellular space;blood microparticle;endoplasmic reticulum lumen;plasma membrane;lysosomal membrane;extracellular region	GO:007006; GO:000561; GO:007256; GO:000578; GO:000588; GO:000576; GO:000557	 Porphyrin and chlorophyll metabolism	hsa0086	ferroxidase activity;copper ion binding;oxidoreductase activity;chaperone binding	GO:000432; GO:000550; GO:001649; GO:005108
NP_001254763.1	NP_001254763.1	NP_001254763.1 protein disulfide-isomerase A4 precursor [Sus scrofa]	22	22	22	1134300000	1558400000	1647900000	1617700000	1231000000	2032700000	1645300000	1551400000	1246300000	1419000000	1550000000	1253300000	1831900000	1561800000	1791700000	1279400000	1654100000	1636200000	NA	NA	NA	PDIA4	PDIA4;NA;NA;NA;NA	response to endoplasmic reticulum stress;chaperone-mediated protein folding;oxidation-reduction process;protein secretion;protein folding;cell redox homeostasis	GO:003497; GO:006107; GO:005511; GO:000930; GO:000645; GO:004545	endoplasmic reticulum;extracellular space;endoplasmic reticulum lumen;cell surface;melanosome	GO:000578; GO:000561; GO:000578; GO:000998; GO:004247	 Thyroid hormone synthesis; Vibrio cholerae infection; Protein processing in endoplasmic reticulum	hsa0491; hsa0511; hsa0414	protein binding;RNA binding;protein disulfide isomerase activity;peptide disulfide oxidoreductase activity	GO:000551; GO:000372; GO:000375; GO:001503
NP_001258644.1	NP_001258644.1	NP_001258644.1 laminin subunit gamma-1 precursor [Sus scrofa]	77	77	75	4704600000	5926800000	5723400000	5378600000	4534500000	3829100000	5611000000	5922900000	3920300000	4583700000	4750200000	7196900000	2382500000	5648100000	5691000000	6207300000	4460500000	4880300000	NA	NA	NA	LAMC1	LAMC1;NA;NA;NA;NA	hemidesmosome assembly;endoderm development;extracellular matrix organization;positive regulation of epithelial cell proliferation;cell migration;post-translational protein modification;cellular protein metabolic process;extracellular matrix disassembly;substrate adhesion-dependent cell spreading;cell adhesion;macromolecular complex assembly	GO:003158; GO:000749; GO:003019; GO:005067; GO:001647; GO:004368; GO:004426; GO:002261; GO:003444; GO:000715; GO:006500	laminin-1 complex;laminin-10 complex;extracellular exosome;extracellular space;endoplasmic reticulum lumen;laminin-11 complex;extracellular region;basement membrane	GO:000560; GO:004325; GO:007006; GO:000561; GO:000578; GO:004326; GO:000557; GO:000560	 Focal adhesion; Prion diseases; Amoebiasis; PI3K-Akt signaling pathway; ECM-receptor interaction; Small cell lung cancer; Pathways in cancer	hsa0451; hsa0502; hsa0514; hsa0415; hsa0451; hsa0522; hsa0520	extracellular matrix structural constituent	GO:000520
NP_001265702.1	NP_001265702.1	NP_001265702.1 myosin light chain 3 [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23166000	0	NA	NA	NA	MYL3	MYL3;NA;NA;NA;NA	positive regulation of ATPase activity;regulation of the force of heart contraction;skeletal muscle tissue development;regulation of striated muscle contraction;muscle filament sliding;cardiac muscle contraction;ventricular cardiac muscle tissue morphogenesis	GO:003278; GO:000202; GO:000751; GO:000694; GO:003004; GO:006004; GO:005501	I band;cytosol;A band;muscle myosin complex;sarcomere	GO:003167; GO:000582; GO:003167; GO:000585; GO:003001	 Adrenergic signaling in cardiomyocytes; Dilated cardiomyopathy; Cardiac muscle contraction	hsa0426; hsa0541; hsa0426	calcium ion binding;structural constituent of muscle;actin monomer binding;motor activity;myosin II heavy chain binding	GO:000550; GO:000830; GO:000378; GO:000377; GO:003203
NP_001272902.1	NP_001272902.1	NP_001272902.1 enoyl-CoA delta isomerase 1, mitochondrial [Sus scrofa]	5	5	5	117240000	49598000	90175000	48771000	111160000	59251000	121690000	84047000	127430000	95205000	85857000	59603000	64859000	86987000	80609000	109540000	79791000	77989000	NA	NA	NA	ECI1	ECI1;NA;NA;NA;NA	fatty acid beta-oxidation	GO:000663	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Fatty acid degradation	hsa0007	enoyl-CoA hydratase activity;dodecenoyl-CoA delta-isomerase activity;intramolecular oxidoreductase activity	GO:000430; GO:000416; GO:001686
XP_013851035.1;NP_001274349.1;NP_001302693.1	XP_013851035.1;NP_001274349.1;NP_001302693.1	XP_013851035.1 RNA-binding protein FUS isoform X1 [Sus scrofa];NP_001274349.1 RNA-binding protein FUS [Sus scrofa];NP_001302693.1 TATA-binding protein-associated factor 2N [Sus scrofa]	4	4	4	0	40449000	0	28600000	0	32146000	25827000	0	0	28045000	28196000	0	51158000	42391000	37062000	0	0	0	NA	NA	NA	FUS	FUS;FUS;TAF15;NA;NA	mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;regulation of RNA splicing;RNA splicing;positive regulation of double-strand break repair via homologous recombination;protein homooligomerization;cellular response to calcium ion;positive regulation of nucleic acid-templated transcription	GO:000039; GO:000635; GO:004348; GO:000838; GO:190516; GO:005126; GO:007127; GO:190350	nucleoplasm;perikaryon;dendritic spine head;perinuclear region of cytoplasm;nucleus;polysome	GO:000565; GO:004320; GO:004432; GO:004847; GO:000563; GO:000584	 Transcriptional misregulation in cancer	hsa0520	ionotropic glutamate receptor binding;chromatin binding;identical protein binding;estrogen receptor binding;transcription coactivator activity;myosin V binding;protein binding;thyroid hormone receptor binding;DNA binding;RNA binding;metal ion binding	GO:003525; GO:000368; GO:004280; GO:003033; GO:000371; GO:003148; GO:000551; GO:004696; GO:000367; GO:000372; GO:004687
NP_001274775.1	NP_001274775.1	NP_001274775.1 GTP-binding protein Rheb [Sus scrofa]	3	3	3	0	33516000	27736000	0	0	27723000	31394000	25831000	26442000	25040000	35295000	35598000	0	30320000	36075000	31238000	24434000	0	NA	NA	NA	RHEB	RHEB;NA;NA;NA;NA	regulation of macroautophagy;signal transduction;positive regulation of TOR signaling;regulation of type B pancreatic cell development;cell cycle arrest;positive regulation of oligodendrocyte differentiation	GO:001624; GO:000716; GO:003200; GO:200007; GO:000705; GO:004871	Golgi membrane;cytosol;extracellular exosome;membrane;spliceosomal complex;lysosomal membrane;endoplasmic reticulum membrane;postsynaptic density	GO:000013; GO:000582; GO:007006; GO:001602; GO:000568; GO:000576; GO:000578; GO:001406	 Insulin signaling pathway; Thyroid hormone signaling pathway; AMPK signaling pathway; Choline metabolism in cancer	hsa0491; hsa0491; hsa0415; hsa0523	protein kinase binding;GTPase activity;protein binding;GTP binding;GDP binding;magnesium ion binding	GO:001990; GO:000392; GO:000551; GO:000552; GO:001900; GO:000028
NP_001278705.1	NP_001278705.1	NP_001278705.1 macrosialin precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3080600	NA	NA	NA	CD68	CD68;NA;NA;NA;NA	neutrophil degranulation	GO:004331	integral component of membrane;azurophil granule membrane;plasma membrane;endosome membrane;membrane	GO:001602; GO:003557; GO:000588; GO:001000; GO:001602	 Lysosome	hsa0414	"NA"	"NA"
XP_005663495.1;XP_005663494.1;XP_003355214.1;NP_001278853.1	XP_005663495.1;XP_005663494.1;XP_003355214.1;NP_001278853.1	XP_005663495.1 protein S100-A10 isoform X1 [Sus scrofa];XP_005663494.1 protein S100-A10 isoform X1 [Sus scrofa];XP_003355214.1 protein S100-A10 isoform X1 [Sus scrofa];NP_001278853.1 protein S100-A10 [Sus scrofa]	5	5	5	579570000	837920000	653520000	871400000	657100000	911560000	608070000	872970000	582280000	1027200000	894940000	2312900000	794590000	1199100000	1059100000	1384000000	876700000	1100100000	NA	NA	NA	S100A10	S100A10;S100A10;S100A10;S100A10;NA	protein heterotetramerization;response to drug;protein localization to plasma membrane;positive regulation of GTPase activity;positive regulation of substrate adhesion-dependent cell spreading;membrane budding;membrane raft assembly;positive regulation of binding;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly	GO:005129; GO:004249; GO:007265; GO:004354; GO:190002; GO:000690; GO:000176; GO:005109; GO:005149; GO:005189	extrinsic component of plasma membrane;extracellular region;membrane raft;endoplasmic reticulum;extracellular exosome	GO:001989; GO:000557; GO:004512; GO:000578; GO:007006	"NA"	"NA"	calcium ion binding;protein homodimerization activity;lipid binding;protein binding;ion channel binding	GO:000550; GO:004280; GO:000828; GO:000551; GO:004432
NP_001278854.1	NP_001278854.1	NP_001278854.1 proliferating cell nuclear antigen [Sus scrofa]	4	4	4	0	0	21195000	0	0	0	16037000	0	0	0	0	0	0	0	16841000	0	0	0	NA	NA	NA	PCNA	PCNA;NA;NA;NA;NA	nucleotide-excision repair, DNA incision, 5'-to lesion;heart development;translesion synthesis;positive regulation of deoxyribonuclease activity;positive regulation of DNA repair;response to dexamethasone;mismatch repair;error-prone translesion synthesis;liver regeneration;telomere maintenance;protein ubiquitination;response to cadmium ion;leading strand elongation;transcription-coupled nucleotide-excision repair;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cell proliferation;replication fork processing;telomere maintenance via semi-conservative replication;cellular response to UV;response to L-glutamate;epithelial cell differentiation;response to estradiol;DNA damage response, detection of DNA damage;regulation of transcription involved in G1/S transition of mitotic cell cycle;error-free translesion synthesis;cellular response to hydrogen peroxide;mitotic telomere maintenance via semi-conservative replication;viral process;nucleotide-excision repair, DNA incision;estrous cycle;positive regulation of DNA replication	GO:000629; GO:000750; GO:001998; GO:003207; GO:004573; GO:007154; GO:000629; GO:004227; GO:009742; GO:000072; GO:001656; GO:004668; GO:000627; GO:000628; GO:000697; GO:000828; GO:003129; GO:003220; GO:003464; GO:190206; GO:003085; GO:003235; GO:004276; GO:000008; GO:007098; GO:007030; GO:190299; GO:001603; GO:003368; GO:004484; GO:004574	nuclear body;nuclear replication fork;nuclear chromosome, telomeric region;nucleoplasm;PCNA complex;PCNA-p21 complex;nucleus;DNA replication factor C complex;extracellular exosome;centrosome;replisome	GO:001660; GO:004359; GO:000078; GO:000565; GO:004362; GO:007055; GO:000563; GO:000566; GO:007006; GO:000581; GO:003089	 Cell cycle; Nucleotide excision repair; Mismatch repair; HTLV-I infection; Base excision repair; DNA replication	hsa0411; hsa0342; hsa0343; hsa0516; hsa0341; hsa0303	protein binding;enzyme binding;MutLalpha complex binding;purine-specific mismatch base pair DNA N-glycosylase activity;damaged DNA binding;histone acetyltransferase binding;identical protein binding;dinucleotide insertion or deletion binding;DNA polymerase binding;DNA polymerase processivity factor activity;receptor tyrosine kinase binding	GO:000551; GO:001989; GO:003240; GO:000070; GO:000368; GO:003503; GO:004280; GO:003213; GO:007018; GO:003033; GO:003097
NP_001279034.1;XP_020932880.1	NP_001279034.1;XP_020932880.1	NP_001279034.1 deoxynucleoside triphosphate triphosphohydrolase SAMHD1 [Sus scrofa];XP_020932880.1 deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X1 [Sus scrofa]	6	6	6	0	0	0	0	0	0	0	12410000	0	0	0	15831000	0	0	0	0	0	0	NA	NA	NA	SAMHD1	SAMHD1;SAMHD1;NA;NA;NA	negative regulation of type I interferon-mediated signaling pathway;double-strand break repair via homologous recombination;deoxyribonucleotide catabolic process;regulation of innate immune response;dATP catabolic process;defense response to virus;dGTP catabolic process;immune response;cellular response to DNA damage stimulus;somatic hypermutation of immunoglobulin genes;protein homotetramerization;RNA phosphodiester bond hydrolysis;type I interferon signaling pathway	GO:006033; GO:000072; GO:000926; GO:004508; GO:004606; GO:005160; GO:000620; GO:000695; GO:000697; GO:001644; GO:005128; GO:009050; GO:006033	plasma membrane;nucleus;site of double-strand break;nucleoplasm	GO:000588; GO:000563; GO:003586; GO:000565	"NA"	"NA"	nucleic acid binding;single-stranded DNA binding;GTP binding;protein binding;RNA binding;zinc ion binding;identical protein binding;triphosphoric monoester hydrolase activity;ribonuclease activity;dGTP binding;dGTPase activity	GO:000367; GO:000369; GO:000552; GO:000551; GO:000372; GO:000827; GO:004280; GO:001679; GO:000454; GO:003256; GO:000883
XP_020935134.1;NP_001284561.1	XP_020935134.1;NP_001284561.1	XP_020935134.1 apoptosis-inducing factor 1, mitochondrial isoform X1 [Sus scrofa];NP_001284561.1 apoptosis-inducing factor 1, mitochondrial [Sus scrofa]	12	12	12	151220000	66657000	126710000	88520000	118060000	62106000	133940000	77805000	139160000	87428000	110540000	62246000	67927000	72319000	118250000	98570000	88535000	63407000	NA	NA	NA	AIFM1	AIFM1;AIFM1;NA;NA;NA	regulation of apoptotic DNA fragmentation;cellular response to aldosterone;oxidation-reduction process;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of apoptotic process;response to ischemia;cellular response to estradiol stimulus;chromosome condensation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cellular response to hydrogen peroxide;cellular response to oxygen-glucose deprivation;response to L-glutamate;positive regulation of neuron apoptotic process;neuron apoptotic process;cellular response to nitric oxide	GO:190251; GO:190404; GO:005511; GO:000691; GO:004306; GO:000293; GO:007139; GO:003026; GO:007005; GO:007030; GO:009065; GO:190206; GO:004352; GO:005140; GO:007173	cytosol;mitochondrial intermembrane space;mitochondrion;mitochondrial inner membrane;nucleus;perinuclear region of cytoplasm	GO:000582; GO:000575; GO:000573; GO:000574; GO:000563; GO:004847	 Apoptosis	hsa0421	FAD binding;oxidoreductase activity, acting on NAD(P)H;NAD(P)H oxidase activity;DNA binding;protein binding;protein dimerization activity	GO:007194; GO:001665; GO:001617; GO:000367; GO:000551; GO:004698
NP_001295339.1	NP_001295339.1	NP_001295339.1 diphosphoinositol polyphosphate phosphohydrolase 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	15454000	0	0	0	0	0	0	0	NA	NA	NA	NUDT3	NUDT3;NA;NA;NA;NA	diphosphoinositol polyphosphate metabolic process;diadenosine hexaphosphate catabolic process;diphosphoinositol polyphosphate catabolic process;inositol phosphate metabolic process;cell-cell signaling;diadenosine polyphosphate catabolic process;adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	GO:007154; GO:190190; GO:007154; GO:004364; GO:000726; GO:001596; GO:190191	nucleus;cytosol;cytoplasm	GO:000563; GO:000582; GO:000573	"NA"	"NA"	endopolyphosphatase activity;inositol bisdiphosphate tetrakisphosphate diphosphatase activity;bis(5'-adenosyl)-hexaphosphatase activity;diphosphoinositol-polyphosphate diphosphatase activity;m7G(5')pppN diphosphatase activity;magnesium ion binding	GO:000029; GO:005284; GO:003443; GO:000848; GO:005007; GO:000028
NP_001295402.1;NP_001295401.1;XP_020930284.1;XP_020930283.1	NP_001295402.1	NP_001295402.1 aldehyde oxidase [Sus scrofa]	26	26	26	214720000	268580000	137430000	185000000	214660000	217680000	101000000	193370000	113290000	184940000	163770000	338900000	66479000	323410000	188920000	285840000	147520000	267810000	NA	NA	NA	AOX1	AOX1;NA;NA;NA;NA	electron transport chain;oxidation-reduction process;xanthine catabolic process;drug metabolic process;vitamin B6 metabolic process	GO:002290; GO:005511; GO:000911; GO:001714; GO:004281	cytosol;extracellular exosome	GO:000582; GO:007006	 Nicotinate and nicotinamide metabolism; Tryptophan metabolism; Retinol metabolism; Valine, leucine and isoleucine degradation; Vitamin B6 metabolism; Tyrosine metabolism; Drug metabolism - cytochrome P450; Metabolic pathways	hsa0076; hsa0038; hsa0083; hsa0028; hsa0075; hsa0035; hsa0098; hsa0110	electron carrier activity;xanthine dehydrogenase activity;identical protein binding;FAD binding;molybdopterin cofactor binding;flavin adenine dinucleotide binding;2 iron, 2 sulfur cluster binding;aldehyde oxidase activity;NAD binding;iron ion binding	GO:000905; GO:000485; GO:004280; GO:007194; GO:004354; GO:005066; GO:005153; GO:000403; GO:005128; GO:000550
NP_001302503.1	NP_001302503.1	NP_001302503.1 glutathione S-transferase kappa 1 [Sus scrofa]	5	5	5	23299000	0	18993000	15195000	22772000	15266000	23170000	16235000	25761000	0	19440000	14876000	0	14017000	16102000	16923000	14621000	13368000	NA	NA	NA	GSTK1	GSTK1;NA;NA;NA;NA	epithelial cell differentiation;glutathione metabolic process;cellular oxidant detoxification;protein targeting to peroxisome;oxidation-reduction process;glutathione derivative biosynthetic process	GO:003085; GO:000674; GO:009886; GO:000662; GO:005511; GO:190168	mitochondrial matrix;peroxisome;membrane;extracellular exosome;mitochondrion;cytosol;peroxisomal matrix	GO:000575; GO:000577; GO:001602; GO:007006; GO:000573; GO:000582; GO:000578	 Drug metabolism - cytochrome P450; Peroxisome; Chemical carcinogenesis; Glutathione metabolism; Metabolism of xenobiotics by cytochrome P450	hsa0098; hsa0414; hsa0520; hsa0048; hsa0098	glutathione transferase activity;protein binding;glutathione peroxidase activity;receptor binding;protein disulfide oxidoreductase activity	GO:000436; GO:000551; GO:000460; GO:000510; GO:001503
NP_001302506.1;XP_003359965.2	NP_001302506.1;XP_003359965.2	NP_001302506.1 complement component C1q receptor precursor [Sus scrofa];XP_003359965.2 complement component C1q receptor isoform X1 [Sus scrofa]	7	7	7	22177000	0	0	0	15918000	0	16910000	0	0	0	22211000	38693000	14461000	0	17253000	22264000	0	0	NA	NA	NA	CD93	CD93;CD93;NA;NA;NA	phagocytosis;viral process;macrophage activation;neutrophil degranulation;cell-cell adhesion	GO:000690; GO:001603; GO:004211; GO:004331; GO:009860	plasma membrane;tertiary granule membrane;ficolin-1-rich granule membrane;secretory granule membrane;integral component of membrane;cell surface;specific granule membrane	GO:000588; GO:007082; GO:010100; GO:003066; GO:001602; GO:000998; GO:003557	"NA"	"NA"	protein binding;complement component C1q binding;calcium ion binding;signaling receptor activity;carbohydrate binding	GO:000551; GO:000184; GO:000550; GO:003802; GO:003024
XP_020953711.1;XP_020953709.1;XP_013833282.2;NP_001302540.1;XP_020953714.1;XP_020953712.1;XP_013833281.2;XP_020953713.1;XP_020953710.1;XP_013833287.1	XP_020953711.1;XP_020953709.1;XP_013833282.2;NP_001302540.1;XP_020953714.1;XP_020953712.1;XP_013833281.2;XP_020953713.1;XP_020953710.1;XP_013833287.1	XP_020953711.1 peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1 [Sus scrofa];XP_020953709.1 peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1 [Sus scrofa];XP_013833282.2 peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1 [Sus scrofa];NP_001302540.	4	4	4	24802000	0	17067000	0	13495000	17736000	14184000	0	20807000	0	14462000	0	13414000	15047000	18118000	16251000	17116000	0	NA	NA	NA	FKBP5	FKBP5;FKBP5;FKBP5;FKBP5;FKBP5	protein peptidyl-prolyl isomerization;protein folding;chaperone-mediated protein folding;response to bacterium	GO:000041; GO:000645; GO:006107; GO:000961	nucleoplasm;cytosol;extracellular exosome;membrane;cytoplasm	GO:000565; GO:000582; GO:007006; GO:001602; GO:000573	 Estrogen signaling pathway	hsa0491	protein binding;peptidyl-prolyl cis-trans isomerase activity;FK506 binding;heat shock protein binding	GO:000551; GO:000375; GO:000552; GO:003107
NP_001302557.1	NP_001302557.1	NP_001302557.1 tissue alpha-L-fucosidase precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7658500	0	NA	NA	NA	FUCA1	FUCA1;NA;NA;NA;NA	glycoside catabolic process;fucose metabolic process;glycosaminoglycan catabolic process;glycolipid catabolic process;neutrophil degranulation	GO:001613; GO:000600; GO:000602; GO:001937; GO:004331	extracellular exosome;azurophil granule lumen;lysosome;extracellular region;cytoplasm;lysosomal lumen	GO:007006; GO:003557; GO:000576; GO:000557; GO:000573; GO:004320	 Lysosome; Other glycan degradation	hsa0414; hsa0051	alpha-L-fucosidase activity	GO:000456
NP_001302639.1	NP_001302639.1	NP_001302639.1 tubulin alpha-1A chain [Sus scrofa]	25	2	0	0	83984000	0	0	49968000	0	0	53738000	0	67367000	0	92982000	71719000	50213000	0	56534000	0	64736000	NA	NA	NA	TUBA1A	TUBA1A;NA;NA;NA;NA	microtubule cytoskeleton organization;microtubule-based process;regulation of synapse organization;cell division;G2/M transition of mitotic cell cycle;cytoskeleton-dependent intracellular transport;regulation of G2/M transition of mitotic cell cycle;mitotic cell cycle;ciliary basal body docking	GO:000022; GO:000701; GO:005080; GO:005130; GO:000008; GO:003070; GO:001038; GO:000027; GO:009771	cytosol;nucleus;myelin sheath;cytoplasmic microtubule;microtubule cytoskeleton;cytoplasmic ribonucleoprotein granule;microtubule;cytoplasm;neuromuscular junction;membrane raft;recycling endosome;extracellular exosome	GO:000582; GO:000563; GO:004320; GO:000588; GO:001563; GO:003646; GO:000587; GO:000573; GO:003159; GO:004512; GO:005503; GO:007006	 Pathogenic Escherichia coli infection; Phagosome; Gap junction	hsa0513; hsa0414; hsa0454	protein binding;GTP binding;structural constituent of cytoskeleton;GTPase activity;protein domain specific binding;structural molecule activity	GO:000551; GO:000552; GO:000520; GO:000392; GO:001990; GO:000519
XP_020941457.1;XP_020941456.1;XP_020941455.1;XP_020941454.1;XP_020941453.1;XP_020941452.1;XP_020941451.1;XP_020941458.1;XP_020941450.1;XP_020941449.1;XP_020941448.1;XP_020941447.1;XP_020941445.1;XP_020941444.1;XP_020941443.1;XP_020941442.1;XP_020941441.1;XP_020941440.1;XP_020941439.1;XP_020941438.1;XP_020941437.1;XP_020941436.1;XP_020941434.1;XP_020941433.1;XP_020941432.1;XP_020941431.1;NP_001302653.1;XP_020941430.1	XP_020941457.1;XP_020941456.1;XP_020941455.1;XP_020941454.1;XP_020941453.1;XP_020941452.1;XP_020941451.1;XP_020941458.1;XP_020941450.1;XP_020941449.1;XP_020941448.1;XP_020941447.1;XP_020941445.1;XP_020941444.1;XP_020941443.1;XP_020941442.1;XP_020941441.1;XP_020941440.1;XP_020941439.1;XP_020941438.1;XP_020941437.1;XP_020941436.1;XP_020941434.1;XP_020941433.1;XP_020941432.1;XP_020941431.1;NP_001302653.1;XP_020941430.1	XP_020941457.1 elastin isoform X26 [Sus scrofa];XP_020941456.1 elastin isoform X25 [Sus scrofa];XP_020941455.1 elastin isoform X24 [Sus scrofa];XP_020941454.1 elastin isoform X23 [Sus scrofa];XP_020941453.1 elastin isoform X22 [Sus scrofa];XP_020941452.1 e	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	7012100	0	0	0	0	0	NA	NA	NA	ELN	ELN;ELN;ELN;ELN;ELN	outflow tract morphogenesis;animal organ morphogenesis;stress fiber assembly;respiratory gaseous exchange;blood circulation;cell proliferation;aortic valve morphogenesis;skeletal muscle tissue development;extracellular matrix organization;regulation of actin filament polymerization	GO:000315; GO:000988; GO:004314; GO:000758; GO:000801; GO:000828; GO:000318; GO:000751; GO:003019; GO:003083	elastic fiber;extracellular region;extracellular matrix	GO:007195; GO:000557; GO:003101	 Protein digestion and absorption	hsa0497	extracellular matrix binding;protein binding;extracellular matrix structural constituent;extracellular matrix constituent conferring elasticity	GO:005084; GO:000551; GO:000520; GO:003002
XP_020941477.1;XP_013851234.1;NP_001302657.1	XP_020941477.1;XP_013851234.1;NP_001302657.1	XP_020941477.1 mimecan isoform X1 [Sus scrofa];XP_013851234.1 mimecan isoform X1 [Sus scrofa];NP_001302657.1 mimecan precursor [Sus scrofa]	20	20	20	2337100000	9644000000	2271900000	10945000000	2472100000	7503100000	3244700000	7320000000	2964100000	6662900000	2917300000	8043700000	2865500000	9133500000	3558500000	6602000000	3571900000	8304200000	NA	NA	NA	OGN	OGN;OGN;OGN;NA;NA	keratan sulfate biosynthetic process;regulation of receptor activity;keratan sulfate catabolic process;negative regulation of smooth muscle cell proliferation	GO:001814; GO:001046; GO:004234; GO:004866	extracellular exosome;extracellular space;extracellular vesicle;Golgi lumen;extracellular region;lysosomal lumen	GO:007006; GO:000561; GO:190356; GO:000579; GO:000557; GO:004320	"NA"	"NA"	growth factor activity;protein binding;extracellular matrix structural constituent conferring compression resistance	GO:000808; GO:000551; GO:003002
NP_001302675.1;NP_999238.1;XP_020926619.1;XP_020926618.1	NP_001302675.1	NP_001302675.1 carbonyl reductase [NADPH] 1 [Sus scrofa]	10	10	7	115370000	116440000	97988000	85526000	86127000	99387000	137690000	115840000	106350000	79591000	127240000	129170000	166680000	131420000	100160000	84657000	124450000	117100000	NA	NA	NA	LOC100622246	LOC100622246;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_001302695.1	NP_001302695.1	NP_001302695.1 liver carboxylesterase precursor [Sus scrofa]	21	4	3	0	16784000	11265000	35054000	37590000	0	34885000	47869000	30843000	39872000	0	0	0	23237000	45315000	33290000	0	0	NA	NA	NA	LOC100736962	LOC100736962;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020941461.1;NP_001302705.1;XP_020941460.1	XP_020941461.1;NP_001302705.1;XP_020941460.1	XP_020941461.1 ribokinase isoform X2 [Sus scrofa];NP_001302705.1 ribokinase [Sus scrofa];XP_020941460.1 ribokinase isoform X1 [Sus scrofa]	3	3	3	16005000	10863000	11637000	0	0	0	11542000	14092000	11213000	0	10748000	0	0	8673600	0	15507000	0	0	NA	NA	NA	RBKS	RBKS;RBKS;RBKS;NA;NA	pentose-phosphate shunt;carbohydrate phosphorylation;D-ribose catabolic process	GO:000609; GO:004683; GO:001930	cytosol;nucleus	GO:000582; GO:000563	 Pentose phosphate pathway	hsa0003	ATP binding;metal ion binding;ribokinase activity;protein binding	GO:000552; GO:004687; GO:000474; GO:000551
NP_001302707.1	NP_001302707.1	NP_001302707.1 PDZ and LIM domain protein 1 [Sus scrofa]	15	15	15	154940000	181100000	264260000	201510000	149040000	241790000	160260000	248680000	149570000	279620000	192920000	230600000	618040000	199260000	125530000	156390000	185150000	160300000	NA	NA	NA	PDLIM1	PDLIM1;NA;NA;NA;NA	cell-cell adhesion;response to oxidative stress;positive regulation of nucleic acid-templated transcription;response to hypoxia;regulation of transcription, DNA-templated	GO:009860; GO:000697; GO:190350; GO:000166; GO:000635	transcription factor complex;focal adhesion;cell-cell adherens junction;cytoskeleton;Z disc	GO:000566; GO:000592; GO:000591; GO:000585; GO:003001	"NA"	"NA"	cadherin binding involved in cell-cell adhesion;metal ion binding;transcription coactivator activity	GO:009864; GO:004687; GO:000371
NP_001302729.1	NP_001302729.1	NP_001302729.1 toll-interacting protein [Sus scrofa]	5	5	5	48220000	47850000	39056000	41841000	37797000	26634000	41428000	44467000	37229000	37749000	45031000	46010000	35070000	44279000	53764000	51798000	37194000	55858000	NA	NA	NA	TOLLIP	TOLLIP;NA;NA;NA;NA	ubiquitin-dependent protein catabolic process;phosphorylation;cell-cell signaling;signal transduction;epithelial cell differentiation;positive regulation of protein sumoylation;neutrophil degranulation;autophagy;innate immune response;leukocyte activation;protein localization to endosome;interleukin-1-mediated signaling pathway;intracellular signal transduction;inflammatory response	GO:000651; GO:001631; GO:000726; GO:000716; GO:003085; GO:003323; GO:004331; GO:000691; GO:004508; GO:004532; GO:003601; GO:007049; GO:003555; GO:000695	extracellular exosome;cytosol;azurophil granule lumen;specific granule lumen;cytoplasm;extracellular region;nuclear body;interleukin-18 receptor complex;interleukin-1 receptor complex;perinuclear region of cytoplasm	GO:007006; GO:000582; GO:003557; GO:003558; GO:000573; GO:000557; GO:001660; GO:004509; GO:004532; GO:004847	 Toll-like receptor signaling pathway	hsa0462	interleukin-1, Type I receptor binding;kinase binding;ubiquitin conjugating enzyme binding;Toll-like receptor binding;protein binding;SUMO binding;ubiquitin binding	GO:000515; GO:001990; GO:003162; GO:003532; GO:000551; GO:003218; GO:004313
NP_001302733.1;XP_020949106.1	NP_001302733.1;XP_020949106.1	NP_001302733.1 splicing factor U2AF 65 kDa subunit [Sus scrofa];XP_020949106.1 splicing factor U2AF 65 kDa subunit isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	6353600	0	8421300	0	0	0	13848000	0	0	0	0	NA	NA	NA	U2AF2	U2AF2;U2AF2;NA;NA;NA	negative regulation of protein ubiquitination;RNA export from nucleus;mRNA processing;positive regulation of RNA splicing;mRNA splicing, via spliceosome;mRNA 3'-end processing;negative regulation of mRNA splicing, via spliceosome	GO:003139; GO:000640; GO:000639; GO:003312; GO:000039; GO:003112; GO:004802	commitment complex;U2-type prespliceosome;U2AF;nuclear speck;Prp19 complex;spliceosomal complex;nucleoplasm;nucleus	GO:000024; GO:007100; GO:008970; GO:001660; GO:000097; GO:000568; GO:000565; GO:000563	 Spliceosome	hsa0304	RNA binding;pre-mRNA 3'-splice site binding;protein binding;enzyme binding;C2H2 zinc finger domain binding;poly-pyrimidine tract binding	GO:000372; GO:003062; GO:000551; GO:001989; GO:007074; GO:000818
NP_001302738.1	NP_001302738.1	NP_001302738.1 cytochrome P450, family 20, subfamily A, polypeptide 1 [Sus scrofa]	10	10	10	0	31243000	18429000	35391000	19060000	25959000	19373000	22524000	18389000	30898000	25789000	28148000	25586000	34741000	21905000	31957000	20539000	29087000	NA	NA	NA	CYP20A1	CYP20A1;NA;NA;NA;NA	oxidation-reduction process	GO:005511	integral component of membrane;membrane	GO:001602; GO:001602	"NA"	"NA"	heme binding;iron ion binding;monooxygenase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	GO:002003; GO:000550; GO:000449; GO:001670
XP_020937608.1;NP_001335683.1;XP_020937607.1;XP_020937609.1;XP_020937606.1	XP_020937608.1;NP_001335683.1;XP_020937607.1;XP_020937609.1;XP_020937606.1	XP_020937608.1 lamina-associated polypeptide 2, isoforms beta/gamma isoform X3 [Sus scrofa];NP_001335683.1 thymopoietin [Sus scrofa];XP_020937607.1 lamina-associated polypeptide 2, isoforms beta/gamma isoform X2 [Sus scrofa];XP_020937609.1 lamina-associate	11	11	11	65767000	60238000	56903000	68173000	61980000	68978000	63483000	57483000	64386000	65466000	83304000	81718000	81740000	67024000	81527000	59823000	65149000	61653000	NA	NA	NA	TMPO	LOC100622780;TMPO;LOC100622780;LOC100622780;LOC100622780	regulation of transcription, DNA-templated	GO:000635	nuclear envelope;nucleus;chromatin	GO:000563; GO:000563; GO:000078	"NA"	"NA"	lamin binding;protein binding;DNA binding;cadherin binding	GO:000552; GO:000551; GO:000367; GO:004529
XP_005660759.1;NP_001335713.1	XP_005660759.1;NP_001335713.1	XP_005660759.1 calpain-1 catalytic subunit isoform X1 [Sus scrofa];NP_001335713.1 calpain-1 catalytic subunit [Sus scrofa]	18	18	18	95112000	130790000	118120000	133400000	100040000	127520000	119680000	105620000	108800000	138050000	141320000	148050000	153050000	153640000	118560000	133510000	137040000	148150000	NA	NA	NA	CAPN1	CAPN1;CAPN1;NA;NA;NA	neutrophil degranulation;regulation of catalytic activity;cornification;self proteolysis;regulation of NMDA receptor activity;receptor catabolic process;positive regulation of cell proliferation;proteolysis;regulation of macroautophagy;mammary gland involution	GO:004331; GO:005079; GO:007026; GO:009726; GO:200031; GO:003280; GO:000828; GO:000650; GO:001624; GO:006005	cytoplasm;ficolin-1-rich granule lumen;lysosome;cytosol;extracellular exosome;extracellular region;mitochondrion;plasma membrane;focal adhesion;membrane	GO:000573; GO:190481; GO:000576; GO:000582; GO:007006; GO:000557; GO:000573; GO:000588; GO:000592; GO:001602	 Apoptosis; Alzheimer's disease; Protein processing in endoplasmic reticulum	hsa0421; hsa0501; hsa0414	protein binding;endopeptidase activity;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding	GO:000551; GO:000417; GO:000419; GO:000550
XP_020939024.1;NP_001335832.1	XP_020939024.1;NP_001335832.1	XP_020939024.1 cartilage intermediate layer protein 1 isoform X1 [Sus scrofa];NP_001335832.1 cartilage intermediate layer protein 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	1348700	0	0	0	0	0	0	NA	NA	NA	CILP	CILP;CILP;NA;NA;NA	cellular response to transforming growth factor beta stimulus;negative regulation of gene expression;dephosphorylation;negative regulation of insulin-like growth factor receptor signaling pathway;negative regulation of SMAD protein import into nucleus	GO:007156; GO:001062; GO:001631; GO:004356; GO:006039	extracellular exosome;extracellular space	GO:007006; GO:000561	"NA"	"NA"	extracellular matrix structural constituent;nucleotide diphosphatase activity;alkaline phosphatase activity	GO:000520; GO:000455; GO:000403
NP_001335864.1;NP_999603.2;NP_001335866.1;NP_001335865.1;NP_001032226.1	NP_001335864.1;NP_999603.2;NP_001335866.1;NP_001335865.1	NP_001335864.1 caveolin-1 isoform a [Sus scrofa];NP_999603.2 caveolin-1 isoform b [Sus scrofa];NP_001335866.1 caveolin-1 isoform b [Sus scrofa];NP_001335865.1 caveolin-1 isoform b [Sus scrofa]	7	7	7	3772000000	4486800000	5148800000	2971900000	3528100000	3482300000	4120900000	4024200000	4451800000	3927900000	3733500000	3035800000	2502200000	4061300000	3824600000	4773800000	4180600000	4311200000	NA	NA	NA	CAV1	CAV1;CAV1;CAV1;CAV1;NA	triglyceride metabolic process;receptor-mediated endocytosis of virus by host cell;mammary gland development;cholesterol homeostasis;positive regulation of catalytic activity;positive regulation of vasoconstriction;leukocyte migration;negative regulation of nitric-oxide synthase activity;negative regulation of necroptotic process;cellular response to exogenous dsRNA;caveolin-mediated endocytosis;regulation of heart rate by cardiac conduction;negative regulation of canonical Wnt signaling pathway;apoptotic signaling pathway;regulation of ventricular cardiac muscle cell action potential;vasculogenesis;protein localization;lactation;response to bacterium;positive regulation of peptidase activity;cholesterol transport;negative regulation of protein ubiquitination;positive regulation of protein binding;response to progesterone;negative regulation of pinocytosis;regulation of cytosolic calcium ion concentration;calcium ion homeostasis;positive regulation of cell adhesion molecule production;positive regulation of canonical Wnt signaling pathway;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;negative regulation of inward rectifier potassium channel activity;positive regulation of extrinsic apoptotic signaling pathway;response to hypoxia;negative regulation of cytokine-mediated signaling pathway;positive regulation of gene expression;regulation of fatty acid metabolic process;negative regulation of epithelial cell differentiation;receptor internalization;positive regulation of peptidyl-serine phosphorylation;protein homooligomerization;mammary gland involution;negative regulation of protein tyrosine kinase activity;caveola assembly;cellular response to peptide hormone stimulus;negative regulation of potassium ion transmembrane transport;beta-catenin destruction complex disassembly;receptor internalization involved in canonical Wnt signaling pathway;response to ischemia;response to calcium ion;regulation of ruffle assembly;regulation of entry of bacterium into host cell;inactivation of MAPK activity;regulation of smooth muscle contraction;skeletal muscle tissue development;positive regulation of calcium ion transport into cytosol;vesicle organization;lipid storage;nitric oxide homeostasis;negative regulation of MAPK cascade;protein localization to plasma membrane raft;regulation of cardiac muscle cell action potential involved in regulation of contraction;positive regulation of intrinsic apoptotic signaling pathway;negative regulation of transcription from RNA polymerase II promoter;regulation of the force of heart contraction by chemical signal;cellular calcium ion homeostasis;positive regulation of cell migration;maintenance of protein location in cell;positive regulation of toll-like receptor 3 signaling pathway;vasoconstriction;negative regulation of tyrosine phosphorylation of STAT protein;negative regulation of nitric oxide biosynthetic process;regulation of nitric-oxide synthase activity;negative regulation of anoikis;angiogenesis;negative regulation of endothelial cell proliferation;calcium ion transport;posttranscriptional regulation of gene expression;cell differentiation;negative regulation of JAK-STAT cascade;regulation of peptidase activity;negative regulation of peptidyl-tyrosine autophosphorylation;protein localization to basolateral plasma membrane;positive regulation of gap junction assembly;regulation of blood coagulation;negative regulation of transforming growth factor beta receptor signaling pathway;T cell costimulation;response to estrogen;membrane depolarization;cellular response to hyperoxia;cellular response to transforming growth factor beta stimulus;regulation of cell communication by electrical coupling involved in cardiac conduction	GO:000664; GO:001906; GO:003087; GO:004263; GO:004308; GO:004590; GO:005090; GO:005100; GO:006054; GO:007136; GO:007258; GO:008609; GO:009009; GO:009719; GO:009891; GO:000157; GO:000810; GO:000759; GO:000961; GO:001095; GO:003030; GO:003139; GO:003209; GO:003257; GO:004855; GO:005148; GO:005507; GO:006035; GO:009026; GO:190307; GO:190360; GO:200123; GO:000166; GO:000196; GO:001062; GO:001921; GO:003085; GO:003162; GO:003313; GO:005126; GO:006005; GO:006109; GO:007083; GO:007137; GO:190138; GO:190488; GO:200028; GO:000293; GO:005159; GO:190002; GO:200053; GO:000018; GO:000694; GO:000751; GO:001052; GO:001605; GO:001991; GO:003348; GO:004340; GO:004486; GO:009890; GO:200124; GO:000012; GO:000305; GO:000687; GO:003033; GO:003250; GO:003414; GO:004231; GO:004253; GO:004501; GO:005099; GO:200081; GO:000152; GO:000193; GO:000681; GO:001060; GO:003015; GO:004642; GO:005254; GO:190008; GO:190336; GO:190359; GO:003019; GO:003051; GO:003129; GO:004362; GO:005189; GO:007145; GO:007156; GO:190184	endoplasmic reticulum;cytoplasm;endoplasmic reticulum membrane;caveola;cell cortex;cilium;early endosome membrane;sarcolemma;membrane;lipid particle;membrane raft;integral component of plasma membrane;Golgi membrane;endocytic vesicle membrane;acrosomal membrane;endosome;Golgi apparatus;macromolecular complex;cytoplasmic vesicle;VCP-NPL4-UFD1 AAA ATPase complex;perinuclear region of cytoplasm	GO:000578; GO:000573; GO:000578; GO:000590; GO:000593; GO:000592; GO:003190; GO:004238; GO:001602; GO:000581; GO:004512; GO:000588; GO:000013; GO:003066; GO:000208; GO:000576; GO:000579; GO:003299; GO:003141; GO:003409; GO:004847	 Viral myocarditis; Proteoglycans in cancer; Endocytosis; Focal adhesion; Bacterial invasion of epithelial cells	hsa0541; hsa0520; hsa0414; hsa0451; hsa0510	protein binding;receptor binding;structural molecule activity;enzyme binding;protein binding, bridging;nitric-oxide synthase binding;protein complex scaffold;patched binding;identical protein binding;protein heterodimerization activity;Rac GTPase binding;cholesterol binding;peptidase activator activity;protein kinase binding;inward rectifier potassium channel inhibitor activity;ion channel binding;ATPase binding	GO:000551; GO:000510; GO:000519; GO:001989; GO:003067; GO:005099; GO:003294; GO:000511; GO:004280; GO:004698; GO:004836; GO:001548; GO:001650; GO:001990; GO:007032; GO:004432; GO:005111
NP_999560.2;NP_001335871.1;XP_020955327.1;XP_020955326.1;XP_020955325.1;XP_020955324.1;XP_020955323.1	NP_999560.2;NP_001335871.1	NP_999560.2 alpha-1-antitrypsin precursor [Sus scrofa];NP_001335871.1 alpha-1-antitrypsin precursor [Sus scrofa]	15	15	14	1310900000	1665700000	856510000	1510700000	1579700000	2644400000	1338200000	1486500000	1257400000	1229600000	1120600000	1325400000	1206600000	1215200000	1285600000	1488700000	1107700000	1903000000	NA	NA	NA	SERPINA1	SERPINA1;SERPINA1;NA;NA;NA	platelet degranulation;blood coagulation;negative regulation of endopeptidase activity;ER to Golgi vesicle-mediated transport;COPII vesicle coating;acute-phase response;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process	GO:000257; GO:000759; GO:001095; GO:000688; GO:004820; GO:000695; GO:004331; GO:004368; GO:004426	ficolin-1-rich granule lumen;Golgi membrane;intracellular membrane-bounded organelle;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum lumen;extracellular exosome;extracellular region;Golgi apparatus;platelet alpha granule lumen;extracellular space;ER to Golgi transport vesicle	GO:190481; GO:000013; GO:004323; GO:003311; GO:000578; GO:007006; GO:000557; GO:000579; GO:003109; GO:000561; GO:003013	 Complement and coagulation cascades	hsa0461	protease binding;protein binding;identical protein binding;serine-type endopeptidase inhibitor activity	GO:000202; GO:000551; GO:004280; GO:000486
NP_001335890.1;XP_020957898.1;XP_020957897.1;XP_020957896.1;XP_020957894.1;XP_020957893.1;NP_999413.2	NP_001335890.1;XP_020957898.1;XP_020957897.1;XP_020957896.1;XP_020957894.1;XP_020957893.1;NP_999413.2	NP_001335890.1 corticosteroid 11-beta-dehydrogenase isozyme 1 isoform 2 [Sus scrofa];XP_020957898.1 corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X1 [Sus scrofa];XP_020957897.1 corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X1 [Sus scrofa]	4	4	4	11396000	9541700	8689200	0	16319000	6315900	12398000	5947300	12508000	6190300	9282500	0	13650000	4002100	13296000	4968800	14083000	6202200	NA	NA	NA	HSD11B1	HSD11B1;HSD11B1;HSD11B1;HSD11B1;HSD11B1	glucocorticoid biosynthetic process;lung development;oxidation-reduction process	GO:000670; GO:003032; GO:005511	endoplasmic reticulum membrane;membrane	GO:000578; GO:001602	 Metabolism of xenobiotics by cytochrome P450; Steroid hormone biosynthesis; Chemical carcinogenesis; Metabolic pathways	hsa0098; hsa0014; hsa0520; hsa0110	11-beta-hydroxysteroid dehydrogenase (NADP+) activity;steroid binding;11-beta-hydroxysteroid dehydrogenase [NAD(P)	GO:007052; GO:000549; GO:000384
NP_001335901.1	NP_001335901.1	NP_001335901.1 trifunctional enzyme subunit beta, mitochondrial [Sus scrofa]	14	14	14	266020000	186920000	304710000	188970000	226170000	166030000	357790000	239870000	383270000	219210000	240470000	207270000	185600000	175440000	266170000	213680000	160710000	182340000	NA	NA	NA	HADHB	HADHB;NA;NA;NA;NA	fatty acid beta-oxidation	GO:000663	mitochondrial outer membrane;endoplasmic reticulum;mitochondrial envelope;mitochondrion;mitochondrial nucleoid	GO:000574; GO:000578; GO:000574; GO:000573; GO:004264	 Fatty acid degradation; Fatty acid elongation; Biosynthesis of antibiotics; Valine, leucine and isoleucine degradation; Fatty acid metabolism; Metabolic pathways	hsa0007; hsa0006; hsa0113; hsa0028; hsa0121; hsa0110	protein binding;3-hydroxyacyl-CoA dehydrogenase activity;acetyl-CoA C-acyltransferase activity;RNA binding;long-chain-3-hydroxyacyl-CoA dehydrogenase activity;enoyl-CoA hydratase activity	GO:000551; GO:000385; GO:000398; GO:000372; GO:001650; GO:000430
NP_008636.1	NP_008636.1	NP_008636.1 cytochrome c oxidase subunit I (mitochondrion) [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	4368900	0	0	0	0	0	0	0	0	NA	NA	NA	COX1	COX1;NA;NA;NA;NA	electron transport coupled proton transport;response to oxidative stress;mitochondrial electron transport, cytochrome c to oxygen;cerebellum development;aerobic respiration;response to copper ion;aging;response to electrical stimulus	GO:001599; GO:000697; GO:000612; GO:002154; GO:000906; GO:004668; GO:000756; GO:005160	integral component of membrane;mitochondrial respiratory chain complex III;respiratory chain complex IV;mitochondrial inner membrane	GO:001602; GO:000575; GO:004527; GO:000574	 Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Cardiac muscle contraction; Oxidative phosphorylation; Alzheimer's disease; Metabolic pathways	hsa0501; hsa0493; hsa0426; hsa0019; hsa0501; hsa0110	metal ion binding;protein binding;cytochrome-c oxidase activity;heme binding	GO:004687; GO:000551; GO:000412; GO:002003
NP_008637.1	NP_008637.1	NP_008637.1 cytochrome c oxidase subunit II (mitochondrion) [Sus scrofa]	3	3	3	0	0	107100000	0	0	0	99362000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	COX2	COX2;NA;NA;NA;NA	lactation;positive regulation of ATP biosynthetic process;response to cold;mitochondrial electron transport, cytochrome c to oxygen;positive regulation of hydrogen peroxide biosynthetic process;hydrogen ion transmembrane transport;ATP synthesis coupled electron transport;positive regulation of necrotic cell death	GO:000759; GO:200117; GO:000940; GO:000612; GO:001072; GO:190260; GO:004277; GO:001094	mitochondrion;respiratory chain complex IV;membrane;mitochondrial inner membrane	GO:000573; GO:004527; GO:001602; GO:000574	 Cardiac muscle contraction; Parkinson's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0426; hsa0501; hsa0110; hsa0493; hsa0019	protein binding;cytochrome-c oxidase activity;copper ion binding	GO:000551; GO:000412; GO:000550
NP_008638.1	NP_008638.1	NP_008638.1 ATP synthase F0 subunit 8 (mitochondrion) [Sus scrofa]	2	2	2	0	0	0	0	51432000	34568000	0	0	0	0	43508000	25924000	40570000	27050000	12769000	43538000	39862000	43528000	NA	NA	NA	ATP8	ATP8;NA;NA;NA;NA	cristae formation;mitochondrial ATP synthesis coupled proton transport;ATP biosynthetic process	GO:004240; GO:004277; GO:000675	mitochondrial proton-transporting ATP synthase complex;integral component of membrane;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)	GO:000575; GO:001602; GO:000574; GO:000027	 Oxidative phosphorylation; Metabolic pathways; Huntington's disease	hsa0019; hsa0110; hsa0501	ATPase activity;transmembrane transporter activity;hydrogen ion transmembrane transporter activity	GO:001688; GO:002285; GO:001507
NP_008639.1	NP_008639.1	NP_008639.1 ATP synthase F0 subunit 6 (mitochondrion) [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1459500	0	NA	NA	NA	ATP6	ATP6;NA;NA;NA;NA	cristae formation;aging;mitochondrial ATP synthesis coupled proton transport;response to hyperoxia;ATP biosynthetic process;ATP synthesis coupled proton transport;ATP hydrolysis coupled cation transmembrane transport	GO:004240; GO:000756; GO:004277; GO:005509; GO:000675; GO:001598; GO:009913	proton-transporting ATP synthase complex;mitochondrial inner membrane;integral component of membrane;proton-transporting ATP synthase complex, coupling factor F(o);mitochondrial proton-transporting ATP synthase complex	GO:004525; GO:000574; GO:001602; GO:004526; GO:000575	 Oxidative phosphorylation; Alzheimer's disease; Metabolic pathways	hsa0019; hsa0501; hsa0110	protein binding;transmembrane transporter activity;ATPase activity;proton-transporting ATP synthase activity, rotational mechanism	GO:000551; GO:002285; GO:001688; GO:004693
NP_008646.1	NP_008646.1	NP_008646.1 cytochrome b (mitochondrion) [Sus scrofa]	2	2	2	0	0	16403000	0	0	0	0	0	14017000	0	0	0	0	0	0	0	0	0	NA	NA	NA	CYTB	CYTB;NA;NA;NA;NA	response to hypoxia;animal organ regeneration;response to calcium ion;response to glucagon;mitochondrial electron transport, ubiquinol to cytochrome c;response to cobalamin;hyperosmotic salinity response;electron transport coupled proton transport;response to cadmium ion;response to ethanol;response to hyperoxia;response to heat	GO:000166; GO:003110; GO:005159; GO:003376; GO:000612; GO:003359; GO:004253; GO:001599; GO:004668; GO:004547; GO:005509; GO:000940	mitochondrial inner membrane;mitochondrion;mitochondrial respiratory chain complex III;integral component of mitochondrial inner membrane	GO:000574; GO:000573; GO:000575; GO:003130	 Metabolic pathways; Oxidative phosphorylation; Cardiac muscle contraction; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0019; hsa0426; hsa0501; hsa0493	ubiquinol-cytochrome-c reductase activity;metal ion binding;macromolecular complex binding	GO:000812; GO:004687; GO:004487
NP_998908.1	NP_998908.1	NP_998908.1 FUN14 domain-containing protein 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3835000	NA	NA	NA	FUNDC2	FUNDC2;NA;NA;NA;NA	mitophagy	GO:000042	integral component of mitochondrial outer membrane;mitochondrion;nucleus	GO:003130; GO:000573; GO:000563	"NA"	"NA"	"NA"	"NA"
NP_998918.1	NP_998918.1	NP_998918.1 translocator protein [Sus scrofa]	2	2	2	0	9813100	9517100	10039000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TSPO	TSPO;NA;NA;NA;NA	C21-steroid hormone biosynthetic process;response to manganese ion;peripheral nervous system axon regeneration;positive regulation of apoptotic process;cellular response to lipopolysaccharide;heme biosynthetic process;cell proliferation;positive regulation of necrotic cell death;adrenal gland development;response to progesterone;negative regulation of ATP metabolic process;protein targeting to mitochondrion;regulation of cholesterol transport;anion transport;negative regulation of tumor necrosis factor production;behavioral response to pain;contact inhibition;positive regulation of glial cell proliferation;maintenance of protein location in mitochondrion;apoptotic process;negative regulation of nitric oxide biosynthetic process;positive regulation of calcium ion transport;cellular hypotonic response;aging;glial cell migration;positive regulation of mitochondrial depolarization;negative regulation of mitophagy;regulation of steroid biosynthetic process;steroid metabolic process;cholesterol transport;cellular response to zinc ion;response to vitamin B1;positive regulation of reactive oxygen species metabolic process;negative regulation of protein ubiquitination;response to testosterone	GO:000670; GO:001004; GO:001401; GO:004306; GO:007122; GO:000678; GO:000828; GO:001094; GO:003032; GO:003257; GO:190357; GO:000662; GO:003237; GO:000682; GO:003272; GO:004826; GO:006024; GO:006025; GO:007265; GO:000691; GO:004501; GO:005192; GO:007147; GO:000756; GO:000834; GO:005190; GO:190314; GO:005081; GO:000820; GO:003030; GO:007129; GO:001026; GO:200037; GO:003139; GO:003357	endoplasmic reticulum;integral component of membrane;extracellular exosome;mitochondrial outer membrane	GO:000578; GO:001602; GO:007006; GO:000574	 HTLV-I infection; Neuroactive ligand-receptor interaction	hsa0516; hsa0408	protein binding;benzodiazepine receptor activity;cholesterol transporter activity;androgen binding;ion channel binding;cholesterol binding	GO:000551; GO:000850; GO:001712; GO:000549; GO:004432; GO:001548
NP_998928.1	NP_998928.1	NP_998928.1 ubiquitin carboxyl-terminal hydrolase isozyme L1 [Sus scrofa]	7	7	7	62841000	436630000	170690000	153250000	0	41167000	86756000	121920000	83800000	292170000	0	45113000	63183000	110200000	0	103090000	68794000	93240000	NA	NA	NA	UCHL1	UCHL1;NA;NA;NA;NA	negative regulation of MAP kinase activity;axon target recognition;regulation of macroautophagy;neuromuscular process;cell proliferation;muscle fiber development;eating behavior;axonal transport of mitochondrion;response to ischemia;adult walking behavior;protein deubiquitination;sensory perception of pain;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:004340; GO:000741; GO:001624; GO:005090; GO:000828; GO:004874; GO:004275; GO:001989; GO:000293; GO:000762; GO:001657; GO:001923; GO:004316	neuronal cell body;nucleoplasm;plasma membrane;cytosol;cytoplasm;endoplasmic reticulum membrane;neuron projection terminus;axon cytoplasm	GO:004302; GO:000565; GO:000588; GO:000582; GO:000573; GO:000578; GO:004430; GO:190411	 Parkinson's disease	hsa0501	thiol-dependent ubiquitin-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity;omega peptidase activity;ligase activity;ubiquitin protein ligase binding;protein binding;cysteine-type endopeptidase activity;alpha-2A adrenergic receptor binding;ubiquitin binding	GO:000484; GO:003645; GO:000824; GO:001687; GO:003162; GO:000551; GO:000419; GO:003169; GO:004313
NP_998929.1;XP_020919937.1	NP_998929.1	NP_998929.1 40S ribosomal protein S23 [Sus scrofa]	4	4	4	28483000	14346000	43295000	25307000	35242000	71004000	17659000	16321000	37837000	24923000	16193000	0	0	27426000	19271000	27894000	22028000	23943000	NA	NA	NA	RPS23	RPS23;NA;NA;NA;NA	translational initiation;SRP-dependent cotranslational protein targeting to membrane;maintenance of translational fidelity;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;stress granule assembly;translation	GO:000641; GO:000661; GO:199014; GO:000018; GO:000218; GO:003406; GO:000641	cytosol;membrane;rough endoplasmic reticulum;ribosome;polysomal ribosome;synapse;endoplasmic reticulum;cytosolic small ribosomal subunit;nucleoplasm	GO:000582; GO:001602; GO:000579; GO:000584; GO:004278; GO:004520; GO:000578; GO:002262; GO:000565	 Ribosome	hsa0301	structural constituent of ribosome;protein binding;RNA binding	GO:000373; GO:000551; GO:000372
NP_998930.1	NP_998930.1	NP_998930.1 sulfotransferase 1A3 [Sus scrofa]	9	9	9	71425000	82457000	66992000	122330000	68841000	195610000	93047000	107070000	106620000	172470000	49150000	123740000	82261000	115520000	85346000	116390000	69102000	132820000	NA	NA	NA	SULT1A3	SULT1A3;NA;NA;NA;NA	IRE1-mediated unfolded protein response;ERK1 and ERK2 cascade;calcineurin-mediated signaling;dopamine receptor signaling pathway;steroid metabolic process;NMDA selective glutamate receptor signaling pathway;ethanol catabolic process;xenobiotic metabolic process;flavonoid metabolic process;dopamine catabolic process;negative regulation of neuron death;cellular response to dopamine;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfation	GO:003649; GO:007037; GO:009772; GO:000721; GO:000820; GO:009898; GO:000606; GO:000680; GO:000981; GO:004242; GO:190121; GO:190335; GO:005042; GO:005192	cytosol	GO:000582	 Chemical carcinogenesis	hsa0520	protein binding;sulfate binding;aryl sulfotransferase activity;amine sulfotransferase activity;sulfotransferase activity	GO:000551; GO:004319; GO:000406; GO:004768; GO:000814
NP_998931.1	NP_998931.1	NP_998931.1 heat shock 70 kDa protein 1B [Sus scrofa]	28	28	17	2042800000	2241000000	2831500000	1851700000	3344200000	3239800000	2646400000	2059600000	2454400000	2170400000	2446800000	2802600000	2309100000	2524300000	2516900000	2461600000	3178400000	2541600000	NA	NA	NA	HSP70.2	HSP70.2;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020930322.1;XP_020930321.1;XP_020930318.1;XP_020930319.1;NP_998934.1;XP_020930317.1;XP_020930316.1;XP_020930323.1;XP_020930315.1;XP_020930314.1	XP_020930322.1;XP_020930321.1;XP_020930318.1;XP_020930319.1;NP_998934.1;XP_020930317.1;XP_020930316.1;XP_020930323.1;XP_020930315.1;XP_020930314.1	XP_020930322.1 signal transducer and activator of transcription 1 isoform X3 [Sus scrofa];XP_020930321.1 signal transducer and activator of transcription 1 isoform X3 [Sus scrofa];XP_020930318.1 signal transducer and activator of transcription 1 isoform X3	10	10	10	44950000	34918000	32701000	31959000	43747000	32790000	35267000	34523000	37573000	32206000	31973000	35969000	46000000	27869000	29936000	30826000	32133000	28789000	NA	NA	NA	STAT1	STAT1;STAT1;STAT1;STAT1;STAT1	response to mechanical stimulus;negative regulation of I-kappaB kinase/NF-kappaB signaling;response to peptide hormone;positive regulation of erythrocyte differentiation;metanephric mesenchymal cell proliferation involved in metanephros development;negative regulation of endothelial cell proliferation;blood circulation;cytokine-mediated signaling pathway;type I interferon signaling pathway;cellular response to organic cyclic compound;regulation of apoptotic process;response to interferon-beta;positive regulation of smooth muscle cell proliferation;metanephric mesenchymal cell differentiation;negative regulation of transcription from RNA polymerase II promoter;JAK-STAT cascade;negative regulation of angiogenesis;interleukin-9-mediated signaling pathway;response to hydrogen peroxide;negative regulation by virus of viral protein levels in host cell;macrophage derived foam cell differentiation;interleukin-35-mediated signaling pathway;negative regulation of metanephric nephron tubule epithelial cell differentiation;positive regulation of transcription of Notch receptor target;positive regulation of interferon-alpha production;cellular response to insulin stimulus;response to cytokine;positive regulation of transcription from RNA polymerase II promoter;renal tubule development;interleukin-6-mediated signaling pathway;cellular response to interferon-gamma;viral process;tumor necrosis factor-mediated signaling pathway;endothelial cell migration;positive regulation of nitric-oxide synthase biosynthetic process;positive regulation of mesenchymal cell proliferation;positive regulation of defense response to virus by host;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;response to nutrient;positive regulation of transcription, DNA-templated;response to cAMP;defense response to virus	GO:000961; GO:004312; GO:004343; GO:004564; GO:007213; GO:000193; GO:000801; GO:001922; GO:006033; GO:007140; GO:004298; GO:003545; GO:004866; GO:007216; GO:000012; GO:000725; GO:001652; GO:003811; GO:004254; GO:004672; GO:001074; GO:007075; GO:007230; GO:000722; GO:003272; GO:003286; GO:003409; GO:004594; GO:006132; GO:007010; GO:007134; GO:001603; GO:003320; GO:004354; GO:005177; GO:000205; GO:000223; GO:000334; GO:000758; GO:004589; GO:005159; GO:005160	macromolecular complex;nucleus;nucleolus;axon;perinuclear region of cytoplasm;nuclear chromatin;cytosol;nucleoplasm	GO:003299; GO:000563; GO:000573; GO:003042; GO:004847; GO:000079; GO:000582; GO:000565	 Osteoclast differentiation; Prolactin signaling pathway; Tuberculosis; Inflammatory bowel disease (IBD); Influenza A; Pancreatic cancer; Jak-STAT signaling pathway; Pathways in cancer; Toll-like receptor signaling pathway; Chemokine signaling pathway; Toxoplasmosis	hsa0438; hsa0491; hsa0515; hsa0532; hsa0516; hsa0521; hsa0463; hsa0520; hsa0462; hsa0406; hsa0514	tumor necrosis factor receptor binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;transcription factor activity, sequence-specific DNA binding;identical protein binding;CCR5 chemokine receptor binding;nuclear hormone receptor binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;histone binding;protein phosphatase 2A binding;repressing transcription factor binding;double-stranded DNA binding;enzyme binding;histone acetyltransferase binding;cadherin binding;protein binding;ubiquitin-like protein ligase binding;promoter-specific chromatin binding	GO:000516; GO:000097; GO:000370; GO:004280; GO:003173; GO:003525; GO:000098; GO:004239; GO:005172; GO:007049; GO:000369; GO:001989; GO:003503; GO:004529; GO:000551; GO:004438; GO:199084
NP_998939.1;XP_020935941.1;XP_020935937.1;XP_020935935.1	NP_998939.1;XP_020935941.1;XP_020935937.1;XP_020935935.1	NP_998939.1 CD74 antigen [Sus scrofa];XP_020935941.1 CD74 antigen isoform X3 [Sus scrofa];XP_020935937.1 CD74 antigen isoform X2 [Sus scrofa];XP_020935935.1 CD74 antigen isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	11916000	0	0	0	0	0	0	0	0	0	10734000	0	0	NA	NA	NA	CD74	CD74;CD74;CD74;CD74;NA	immunoglobulin mediated immune response;antigen processing and presentation of endogenous antigen;negative regulation of peptide secretion;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of macrophage cytokine production;prostaglandin biosynthetic process;positive regulation of B cell proliferation;positive regulation of kinase activity;positive regulation of MAPK cascade;chaperone mediated protein folding requiring cofactor;positive regulation of protein phosphorylation;positive regulation of transcription, DNA-templated;positive regulation of I-kappaB kinase/NF-kappaB signaling;leukocyte migration;positive regulation of neutrophil chemotaxis;positive regulation of cytokine-mediated signaling pathway;signal transduction;regulation of macrophage activation;positive regulation of monocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;protein heterotetramerization;protein trimerization;positive regulation of ERK1 and ERK2 cascade;activation of MAPK activity;positive regulation of dendritic cell antigen processing and presentation;positive regulation of type 2 immune response;negative regulation of mature B cell apoptotic process;defense response;positive regulation of T cell differentiation;positive regulation of viral entry into host cell;positive regulation of fibroblast proliferation;intracellular protein transport;negative regulation of apoptotic process;cell proliferation;macrophage migration inhibitory factor signaling pathway;T cell selection;negative thymic T cell selection;macromolecular complex assembly;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of chemokine (C-X-C motif) ligand 2 production	GO:001606; GO:001988; GO:000279; GO:004351; GO:006090; GO:000151; GO:003089; GO:003367; GO:004341; GO:005108; GO:000193; GO:004589; GO:004312; GO:005090; GO:009002; GO:000196; GO:000716; GO:004303; GO:004565; GO:005073; GO:005129; GO:007020; GO:007037; GO:000018; GO:000260; GO:000283; GO:000290; GO:000695; GO:004558; GO:004659; GO:004814; GO:000688; GO:004306; GO:000828; GO:003569; GO:004505; GO:004506; GO:006500; GO:190216; GO:200034	membrane;trans-Golgi network membrane;extracellular exosome;multivesicular body;NOS2-CD74 complex;lysosomal membrane;integral component of membrane;cell surface;ER to Golgi transport vesicle membrane;MHC class II protein complex;transport vesicle membrane;endocytic vesicle membrane;lysosomal lumen;plasma membrane;Golgi membrane;integral component of lumenal side of endoplasmic reticulum membrane;external side of plasma membrane	GO:001602; GO:003258; GO:007006; GO:000577; GO:003569; GO:000576; GO:001602; GO:000998; GO:001250; GO:004261; GO:003065; GO:003066; GO:004320; GO:000588; GO:000013; GO:007155; GO:000989	 Tuberculosis; Herpes simplex infection; Antigen processing and presentation	hsa0515; hsa0516; hsa0461	protein binding involved in protein folding;MHC class II protein complex binding;nitric-oxide synthase binding;protein binding;cytokine receptor activity;beta-amyloid binding;MHC class II protein binding, via antigen binding groove;CD4 receptor binding;MHC class II protein binding;identical protein binding;cytokine binding;macrophage migration inhibitory factor binding	GO:004418; GO:002302; GO:005099; GO:000551; GO:000489; GO:000154; GO:004265; GO:004260; GO:004228; GO:004280; GO:001995; GO:003571
NP_998946.1;XP_020927729.1	NP_998946.1;XP_020927729.1	NP_998946.1 acyl-CoA desaturase [Sus scrofa];XP_020927729.1 acyl-CoA desaturase isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	14149000	0	26460000	24706000	80716000	0	0	0	0	0	48586000	0	0	NA	NA	NA	SCD	SCD;SCD;NA;NA;NA	unsaturated fatty acid biosynthetic process;regulation of cholesterol biosynthetic process;oxidation-reduction process;response to fatty acid;monounsaturated fatty acid biosynthetic process;fatty-acyl-CoA biosynthetic process	GO:000663; GO:004554; GO:005511; GO:007054; GO:190396; GO:004694	membrane;integral component of endoplasmic reticulum membrane;integral component of membrane;endoplasmic reticulum;nucleolus	GO:001602; GO:003017; GO:001602; GO:000578; GO:000573	 Biosynthesis of unsaturated fatty acids; PPAR signaling pathway; Fatty acid metabolism; AMPK signaling pathway	hsa0104; hsa0332; hsa0121; hsa0415	protein binding;palmitoyl-CoA 9-desaturase activity;iron ion binding;oxidoreductase activity;stearoyl-CoA 9-desaturase activity	GO:000551; GO:003289; GO:000550; GO:001649; GO:000476
NP_998947.1	NP_998947.1	NP_998947.1 phosphoglycerate kinase 2 [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	0	0	68374000	0	0	0	0	0	0	NA	NA	NA	PGK2	PGK2;NA;NA;NA;NA	positive regulation of oxidative phosphorylation;glycolytic process;phosphorylation	GO:190386; GO:000609; GO:001631	nucleus;sperm fibrous sheath;extracellular exosome;cytosol	GO:000563; GO:003568; GO:007006; GO:000582	 Glycolysis / Gluconeogenesis; Carbon metabolism; Metabolic pathways; Biosynthesis of antibiotics; Biosynthesis of amino acids	hsa0001; hsa0120; hsa0110; hsa0113; hsa0123	phosphoglycerate kinase activity;ATP binding;ADP binding	GO:000461; GO:000552; GO:004353
NP_998952.1	NP_998952.1	NP_998952.1 alpha-1-antichymotrypsin 2 precursor [Sus scrofa]	21	17	14	985960000	1013900000	761120000	1476600000	1685000000	1707300000	1124100000	1158300000	1134200000	803550000	929670000	389080000	931390000	717650000	993370000	859550000	864510000	1287900000	NA	NA	NA	SERPINA3-2	SERPINA3-2;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013836385.1;NP_998954.1;XP_020921841.1;XP_020921840.1	XP_013836385.1;NP_998954.1;XP_020921841.1;XP_020921840.1	XP_013836385.1 bifunctional coenzyme A synthase isoform X3 [Sus scrofa];NP_998954.1 bifunctional coenzyme A synthase precursor [Sus scrofa];XP_020921841.1 bifunctional coenzyme A synthase isoform X2 [Sus scrofa];XP_020921840.1 bifunctional coenzyme A synth	4	4	4	0	0	0	0	0	0	0	3180400	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	COASY	COASY;COASY;COASY;COASY;NA	phosphorylation;coenzyme A biosynthetic process;coenzyme biosynthetic process	GO:001631; GO:001593; GO:000910	mitochondrial outer membrane;nucleoplasm;mitochondrial matrix;extracellular exosome;cytosol	GO:000574; GO:000565; GO:000575; GO:007006; GO:000582	 Pantothenate and CoA biosynthesis; Metabolic pathways	hsa0077; hsa0110	protein binding;pantetheine-phosphate adenylyltransferase activity;dephospho-CoA kinase activity;ATP binding	GO:000551; GO:000459; GO:000414; GO:000552
NP_998955.1;XP_020957818.1	NP_998955.1;XP_020957818.1	NP_998955.1 m7GpppX diphosphatase [Sus scrofa];XP_020957818.1 m7GpppX diphosphatase isoform X1 [Sus scrofa]	7	7	7	0	14629000	13723000	0	12477000	13747000	10719000	17377000	12058000	16669000	12206000	16714000	19711000	16025000	15326000	15307000	12617000	14630000	NA	NA	NA	DCPS	DCPS;DCPS;NA;NA;NA	mRNA cis splicing, via spliceosome;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;cellular response to menadione;RNA phosphodiester bond hydrolysis, exonucleolytic;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;deadenylation-dependent decapping of nuclear-transcribed mRNA;negative regulation of programmed cell death	GO:004529; GO:004392; GO:003624; GO:009050; GO:000028; GO:000029; GO:004306	mitochondrion;nucleoplasm;P-body;cytoplasm;nucleus;cytosol	GO:000573; GO:000565; GO:000093; GO:000573; GO:000563; GO:000582	 RNA degradation	hsa0301	m7G(5')pppN diphosphatase activity;protein binding;exoribonuclease activity;RNA 7-methylguanosine cap binding	GO:005007; GO:000551; GO:000453; GO:000034
NP_998960.1	NP_998960.1	NP_998960.1 lymphocyte function-associated antigen 3 precursor [Sus scrofa]	4	4	4	28080000	31760000	23949000	27823000	22538000	21059000	27270000	32959000	28415000	26245000	31388000	23829000	19018000	25589000	24238000	27383000	29569000	23203000	NA	NA	NA	CD58	CD58;NA;NA;NA;NA	leukocyte migration;neutrophil degranulation;cell-cell adhesion;heterotypic cell-cell adhesion;cellular response to interferon-gamma;cellular response to tumor necrosis factor;positive regulation of interleukin-8 secretion	GO:005090; GO:004331; GO:009860; GO:003411; GO:007134; GO:007135; GO:200048	cell surface;extracellular exosome;plasma membrane;membrane;secretory granule membrane;ficolin-1-rich granule membrane	GO:000998; GO:007006; GO:000588; GO:001602; GO:003066; GO:010100	 Epstein-Barr virus infection; Cell adhesion molecules (CAMs)	hsa0516; hsa0451	protein binding;receptor binding	GO:000551; GO:000510
NP_998977.1;XP_013833848.1;XP_013833849.1	NP_998977.1;XP_013833848.1;XP_013833849.1	NP_998977.1 corticosteroid-binding globulin precursor [Sus scrofa];XP_013833848.1 corticosteroid-binding globulin isoform X1 [Sus scrofa];XP_013833849.1 corticosteroid-binding globulin isoform X2 [Sus scrofa]	4	4	4	21198000	14348000	12209000	12709000	18338000	16578000	15994000	12843000	18905000	15096000	0	0	13706000	10301000	18630000	11826000	14330000	13501000	NA	NA	NA	SERPINA6	SERPINA6;SERPINA6;SERPINA6;NA;NA	negative regulation of endopeptidase activity;glucocorticoid metabolic process	GO:001095; GO:000821	extracellular space;extracellular exosome	GO:000561; GO:007006	"NA"	"NA"	serine-type endopeptidase inhibitor activity;steroid binding	GO:000486; GO:000549
NP_998981.1	NP_998981.1	NP_998981.1 intercellular adhesion molecule 1 precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	6013600	0	0	0	0	0	NA	NA	NA	ICAM1	ICAM1;NA;NA;NA;NA	regulation of leukocyte mediated cytotoxicity;T cell antigen processing and presentation;cytokine-mediated signaling pathway;response to insulin;positive regulation of nitric oxide biosynthetic process;regulation of immune response;leukocyte migration;cellular response to beta-amyloid;positive regulation of leukocyte adhesion to vascular endothelial cell;cell aging;cell adhesion mediated by integrin;response to gonadotropin;response to amino acid;response to copper ion;response to ethanol;T cell extravasation;cellular response to leukemia inhibitory factor;cellular response to nutrient levels;positive regulation of ERK1 and ERK2 cascade;cellular response to glucose stimulus;cellular response to hypoxia;establishment of Sertoli cell barrier;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell apoptotic process;adhesion of symbiont to host;cellular response to lipopolysaccharide;cellular response to interleukin-1;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;positive regulation of cellular extravasation;sensory perception of sound;positive regulation of NF-kappaB transcription factor activity;negative regulation of calcium ion transport;cellular response to alkaloid;cellular response to interleukin-6;T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;regulation of cell shape;extracellular matrix organization;receptor-mediated virion attachment to host cell;establishment of endothelial barrier;cellular response to dexamethasone stimulus;regulation of ruffle assembly;ovarian follicle development;response to amphetamine;response to ionizing radiation;response to sulfur dioxide;membrane to membrane docking;positive regulation of actin filament polymerization;positive regulation of vasoconstriction;acute inflammatory response to antigenic stimulus;viral entry into host cell;positive regulation of GTPase activity;positive regulation of peptidyl-tyrosine phosphorylation;interferon-gamma-mediated signaling pathway;establishment of endothelial intestinal barrier	GO:000191; GO:000245; GO:001922; GO:003286; GO:004542; GO:005077; GO:005090; GO:190464; GO:190499; GO:000756; GO:003362; GO:003469; GO:004320; GO:004668; GO:004547; GO:007268; GO:199083; GO:003166; GO:007037; GO:007133; GO:007145; GO:009736; GO:190204; GO:200035; GO:004440; GO:007122; GO:007134; GO:000715; GO:000269; GO:000760; GO:005109; GO:005192; GO:007131; GO:007135; GO:000229; GO:000836; GO:003019; GO:004681; GO:006102; GO:007154; GO:190002; GO:000154; GO:000197; GO:001021; GO:001047; GO:002261; GO:003083; GO:004590; GO:000243; GO:004671; GO:004354; GO:005073; GO:006033; GO:009055	extracellular exosome;extracellular space;immunological synapse;membrane raft;plasma membrane;membrane;focal adhesion;external side of plasma membrane;cell surface	GO:007006; GO:000561; GO:000177; GO:004512; GO:000588; GO:001602; GO:000592; GO:000989; GO:000998	 Cell adhesion molecules (CAMs); TNF signaling pathway; Staphylococcus aureus infection; Natural killer cell mediated cytotoxicity; HTLV-I infection; Leukocyte transendothelial migration; NF-kappa B signaling pathway; Rheumatoid arthritis; Viral myocarditis; Malaria	hsa0451; hsa0466; hsa0515; hsa0465; hsa0516; hsa0467; hsa0406; hsa0532; hsa0541; hsa0514	virus receptor activity;signaling receptor activity;protein binding;transmembrane signaling receptor activity;integrin binding	GO:000161; GO:003802; GO:000551; GO:000488; GO:000517
NP_998992.1	NP_998992.1	NP_998992.1 carbonyl reductase [NADPH] 2 [Sus scrofa]	6	6	6	0	111000000	0	266090000	0	328850000	0	155270000	0	120870000	0	131440000	0	160430000	0	106410000	0	89094000	NA	NA	NA	CBR2	CBR2;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_998993.1;CON__ENSEMBL:ENSBTAP00000024466;CON__ENSEMBL:ENSBTAP00000024462	NP_998993.1	NP_998993.1 IgG heavy chain precursor [Sus scrofa]	21	21	20	21563000000	26981000000	15419000000	31037000000	46268000000	67883000000	26357000000	20666000000	17469000000	18031000000	20694000000	17426000000	29924000000	30799000000	27566000000	24077000000	33732000000	41189000000	NA	NA	NA	LOC396781	LOC396781;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005653704.1;NP_998995.1;XP_013854598.1;XP_013854644.1;NP_999476.1;XP_020957834.1	XP_005653704.1;NP_998995.1;XP_013854598.1;XP_013854644.1;NP_999476.1;XP_020957834.1	XP_005653704.1 folate receptor 1 isoform X3 [Sus scrofa];NP_998995.1 folate receptor gamma precursor [Sus scrofa];XP_013854598.1 folate receptor 1 isoform X2 [Sus scrofa];XP_013854644.1 folate receptor alpha isoform X1 [Sus scrofa];NP_999476.1 folate recep	2	2	2	0	20529000	9997800	0	0	22909000	0	15602000	0	0	0	0	0	0	0	15221000	11021000	27381000	NA	NA	NA	FOLR3	FOLR3;FOLR3;FOLR1;FOLR1;FOLR3	sperm-egg recognition;cell adhesion;folic acid transport;neutrophil degranulation;fusion of sperm to egg plasma membrane	GO:003503; GO:000715; GO:001588; GO:004331; GO:000734	extracellular region;anchored component of external side of plasma membrane;tertiary granule lumen;membrane;extrinsic component of membrane;specific granule lumen	GO:000557; GO:003136; GO:190472; GO:001602; GO:001989; GO:003558	 Endocytosis	hsa0414	signaling receptor activity;folic acid binding	GO:003802; GO:000554
NP_999009.1	NP_999009.1	NP_999009.1 C-reactive protein precursor [Sus scrofa]	4	4	4	0	0	0	0	16232000	34582000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CRP	CRP;NA;NA;NA;NA	innate immune response;positive regulation of gene expression;positive regulation of superoxide anion generation;negative regulation of blood vessel diameter;regulation of interleukin-8 secretion;negative regulation of lipid storage;defense response to Gram-positive bacterium;complement activation, classical pathway;opsonization;negative regulation of macrophage derived foam cell differentiation	GO:004508; GO:001062; GO:003293; GO:009775; GO:200048; GO:001088; GO:005083; GO:000695; GO:000822; GO:001074	extracellular space;extracellular region	GO:000561; GO:000557	"NA"	"NA"	protein binding;low-density lipoprotein particle binding;complement component C1q binding;choline binding;virion binding;low-density lipoprotein particle receptor binding;calcium ion binding;identical protein binding	GO:000551; GO:003016; GO:000184; GO:003326; GO:004679; GO:005075; GO:000550; GO:004280
NP_999012.2	NP_999012.2	NP_999012.2 inhibitor of carbonic anhydrase precursor [Sus scrofa]	39	38	4	820630000	1177400000	668950000	1035400000	862610000	1355400000	852510000	670100000	769560000	762870000	920700000	903380000	740670000	865390000	741690000	811560000	900770000	1183400000	NA	NA	NA	TF	TF;NA;NA;NA;NA	regulation of protein stability;transferrin transport;regulation of iron ion transport;cellular protein metabolic process;platelet degranulation;cellular iron ion homeostasis;iron ion homeostasis;trivalent inorganic cation transport;retina homeostasis;post-translational protein modification;positive regulation of receptor-mediated endocytosis;membrane organization;cellular response to iron ion	GO:003164; GO:003357; GO:003475; GO:004426; GO:000257; GO:000687; GO:005507; GO:007251; GO:000189; GO:004368; GO:004826; GO:006102; GO:007128	late endosome;cell surface;clathrin-coated vesicle membrane;extracellular exosome;HFE-transferrin receptor complex;apical plasma membrane;perinuclear region of cytoplasm;blood microparticle;extracellular space;basal plasma membrane;recycling endosome;secretory granule lumen;early endosome;cytoplasmic vesicle;endoplasmic reticulum lumen;clathrin-coated pit;endosome membrane;extrinsic component of external side of plasma membrane;vesicle;basal part of cell;extracellular region;endocytic vesicle	GO:000577; GO:000998; GO:003066; GO:007006; GO:199071; GO:001632; GO:004847; GO:007256; GO:000561; GO:000992; GO:005503; GO:003477; GO:000576; GO:003141; GO:000578; GO:000590; GO:001000; GO:003123; GO:003198; GO:004517; GO:000557; GO:003013	 HIF-1 signaling pathway; Mineral absorption	hsa0406; hsa0497	ferric iron binding;ferric iron transmembrane transporter activity;ferrous iron binding;iron chaperone activity;protein binding;transferrin receptor binding	GO:000819; GO:001509; GO:000819; GO:003498; GO:000551; GO:199045
XP_020957836.1;XP_005653711.1;XP_005653710.1;XP_005653709.1;XP_005653708.1;XP_005653707.1;NP_999018.1;XP_005653705.1	XP_020957836.1;XP_005653711.1;XP_005653710.1;XP_005653709.1;XP_005653708.1;XP_005653707.1;NP_999018.1;XP_005653705.1	XP_020957836.1 folate receptor 2 isoform X1 [Sus scrofa];XP_005653711.1 folate receptor 2 isoform X1 [Sus scrofa];XP_005653710.1 folate receptor 2 isoform X1 [Sus scrofa];XP_005653709.1 folate receptor 2 isoform X1 [Sus scrofa];XP_005653708.1 folate recept	7	7	7	29908000	110070000	84147000	64483000	72310000	74261000	85467000	62515000	43977000	67745000	67976000	0	51984000	83611000	76572000	118580000	105770000	137720000	NA	NA	NA	FOLR2	FOLR2;FOLR2;FOLR2;FOLR2;FOLR2	receptor-mediated endocytosis;folic acid metabolic process;folic acid import into cell;positive regulation of cell proliferation;regulation of thymidylate synthase biosynthetic process;cellular response to folic acid;cell adhesion;fusion of sperm to egg plasma membrane;monocyte chemotaxis;inflammatory response;folic acid transport;sperm-egg recognition	GO:000689; GO:004665; GO:190444; GO:000828; GO:005075; GO:007123; GO:000715; GO:000734; GO:000254; GO:000695; GO:001588; GO:003503	plasma membrane;anchored component of external side of plasma membrane;extracellular region;cell surface	GO:000588; GO:003136; GO:000557; GO:000998	 Endocytosis	hsa0414	drug binding;folic acid binding;folic acid receptor activity;signaling receptor activity;methotrexate binding	GO:000814; GO:000554; GO:006171; GO:003802; GO:005187
NP_999020.2;XP_020943626.1	NP_999020.2	NP_999020.2 myosin-7 [Sus scrofa]	19	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8273900	0	NA	NA	NA	MYH7	MYH7;NA;NA;NA;NA	muscle contraction;regulation of slow-twitch skeletal muscle fiber contraction;muscle filament sliding;ventricular cardiac muscle tissue morphogenesis;skeletal muscle contraction;cardiac muscle contraction;adult heart development;regulation of the force of skeletal muscle contraction;ATP metabolic process;striated muscle contraction;cardiac muscle hypertrophy in response to stress;regulation of heart rate;transition between fast and slow fiber	GO:000693; GO:003144; GO:003004; GO:005501; GO:000300; GO:006004; GO:000751; GO:001472; GO:004603; GO:000694; GO:001489; GO:000202; GO:001488	myosin complex;Z disc;muscle myosin complex;stress fiber;myosin filament	GO:001645; GO:003001; GO:000585; GO:000172; GO:003298	 Adrenergic signaling in cardiomyocytes; cGMP-PKG signaling pathway; Cardiac muscle contraction; Hypertrophic cardiomyopathy (HCM); Tight junction	hsa0426; hsa0402; hsa0426; hsa0541; hsa0453	protein binding;ATP binding;actin-dependent ATPase activity;actin filament binding;ATPase activity;calmodulin binding;microfilament motor activity	GO:000551; GO:000552; GO:003089; GO:005101; GO:001688; GO:000551; GO:000014
NP_999028.1;XP_020924182.1	NP_999028.1;XP_020924182.1	NP_999028.1 protegrin-4 precursor [Sus scrofa];XP_020924182.1 protegrin-4 isoform X1 [Sus scrofa]	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15191000	0	NA	NA	NA	NPG4	NPG4;NPG4;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_999030.1;XP_020927734.1	NP_999030.1;XP_020927734.1	NP_999030.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [Sus scrofa];XP_020927734.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 2 isoform X1 [Sus scrofa]	17	10	9	41544000	50424000	43751000	46498000	38138000	44409000	43010000	50276000	49582000	47801000	68767000	59328000	61737000	50509000	61938000	51993000	37901000	54024000	NA	NA	NA	ATP2A2	ATP2A2;ATP2A2;NA;NA;NA	skeletal muscle contraction;ER-nucleus signaling pathway;organelle organization;epidermis development;cardiac muscle hypertrophy in response to stress;relaxation of cardiac muscle;regulation of the force of heart contraction;positive regulation of heart rate;cellular response to heat;sarcoplasmic reticulum calcium ion transport;cell adhesion;transition between fast and slow fiber;endoplasmic reticulum calcium ion homeostasis;response to endoplasmic reticulum stress;positive regulation of endoplasmic reticulum calcium ion concentration;calcium ion transmembrane transport;hydrogen ion transmembrane transport;regulation of calcium ion-dependent exocytosis of neurotransmitter;calcium ion transport from cytosol to endoplasmic reticulum;regulation of cardiac conduction;regulation of cardiac muscle contraction by calcium ion signaling;T-tubule organization;ion transmembrane transport;regulation of cardiac muscle cell action potential involved in regulation of contraction;calcium ion import into sarcoplasmic reticulum;cellular calcium ion homeostasis;response to lipopolysaccharide;cellular response to oxidative stress;negative regulation of heart contraction;regulation of cardiac muscle cell membrane potential;ATP hydrolysis coupled cation transmembrane transport	GO:000300; GO:000698; GO:000699; GO:000854; GO:001489; GO:005511; GO:000202; GO:001046; GO:003460; GO:007029; GO:000715; GO:001488; GO:003246; GO:003497; GO:003247; GO:007058; GO:190260; GO:190323; GO:190351; GO:190377; GO:001088; GO:003329; GO:003422; GO:009890; GO:199003; GO:000687; GO:003249; GO:003459; GO:004582; GO:008603; GO:009913	endoplasmic reticulum;membrane;vesicle membrane;platelet dense tubular network membrane;perinuclear region of cytoplasm;endoplasmic reticulum membrane;macromolecular complex;extrinsic component of cytoplasmic side of plasma membrane;sarcoplasmic reticulum;sarcoplasmic reticulum membrane;ribbon synapse;apical ectoplasmic specialization;integral component of plasma membrane;nucleoplasm	GO:000578; GO:001602; GO:001250; GO:003109; GO:004847; GO:000578; GO:003299; GO:003123; GO:001652; GO:003301; GO:009747; GO:006183; GO:000588; GO:000565	 Thyroid hormone signaling pathway; Hypertrophic cardiomyopathy (HCM); Pancreatic secretion; Alzheimer's disease; cGMP-PKG signaling pathway; Cardiac muscle contraction	hsa0491; hsa0541; hsa0497; hsa0501; hsa0402; hsa0426	S100 protein binding;hydrogen-exporting ATPase activity, phosphorylative mechanism;calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential;calcium ion binding;calcium-transporting ATPase activity;enzyme binding;ATP binding;lutropin-choriogonadotropic hormone receptor binding;protein binding	GO:004454; GO:000855; GO:008603; GO:000550; GO:000538; GO:001989; GO:000552; GO:003177; GO:000551
NP_999033.1	NP_999033.1	NP_999033.1 ficolin-2 precursor [Sus scrofa]	7	7	3	166810000	513550000	125110000	170850000	74132000	75706000	237770000	120700000	189180000	147770000	38837000	0	38741000	64263000	273890000	151640000	48142000	73329000	NA	NA	NA	FCN2	FCN2;NA;NA;NA;NA	proteolysis;opsonization;defense response to Gram-positive bacterium;recognition of apoptotic cell;complement activation;defense response to Gram-negative bacterium;complement activation, lectin pathway	GO:000650; GO:000822; GO:005083; GO:004365; GO:000695; GO:005082; GO:000186	extracellular exosome;extracellular region;blood microparticle;collagen trimer	GO:007006; GO:000557; GO:007256; GO:000558	"NA"	"NA"	calcium-dependent protein binding;antigen binding;metal ion binding;mannan binding;protein binding;proteoglycan binding;serine-type endopeptidase activity	GO:004830; GO:000382; GO:004687; GO:200106; GO:000551; GO:004339; GO:000425
NP_999039.1	NP_999039.1	NP_999039.1 malate dehydrogenase, cytoplasmic [Sus scrofa]	16	16	16	2816600000	2734100000	2299600000	2785900000	2789100000	2458400000	3058400000	2686900000	2695300000	3117700000	3020900000	3148000000	1441700000	3407500000	2230300000	2635600000	2182800000	3666700000	NA	NA	NA	MDH1	MDH1;NA;NA;NA;NA	NADH metabolic process;tricarboxylic acid cycle;oxaloacetate metabolic process	GO:000673; GO:000609; GO:000610	cytosol;extracellular exosome;extracellular space	GO:000582; GO:007006; GO:000561	 Glyoxylate and dicarboxylate metabolism; Cysteine and methionine metabolism; Pyruvate metabolism; Proximal tubule bicarbonate reclamation; Citrate cycle (TCA cycle); Carbon metabolism; Metabolic pathways; Biosynthesis of antibiotics	hsa0063; hsa0027; hsa0062; hsa0496; hsa0002; hsa0120; hsa0110; hsa0113	NAD binding;malic enzyme activity;diiodophenylpyruvate reductase activity;protein binding;L-malate dehydrogenase activity	GO:005128; GO:000447; GO:004786; GO:000551; GO:003006
NP_999043.1;XP_020936224.1;XP_013842817.1	NP_999043.1;XP_020936224.1;XP_013842817.1	NP_999043.1 calponin-1 [Sus scrofa];XP_020936224.1 calponin-1 isoform X1 [Sus scrofa];XP_013842817.1 calponin-1 isoform X1 [Sus scrofa]	12	12	11	57189000	146730000	847110000	0	0	396580000	0	316180000	120270000	1783800000	252880000	170930000	1902600000	32872000	8180900	85674000	23212000	63305000	NA	NA	NA	CNN1	CNN1;CNN1;CNN1;NA;NA	regulation of smooth muscle contraction;actomyosin structure organization;negative regulation of vascular smooth muscle cell proliferation	GO:000694; GO:003103; GO:190470	cytoskeleton;focal adhesion	GO:000585; GO:000592	"NA"	"NA"	protein binding;calmodulin binding;actin binding	GO:000551; GO:000551; GO:000377
NP_999046.1	NP_999046.1	NP_999046.1 lambda-crystallin homolog [Sus scrofa]	9	9	1	36572000	54263000	39625000	57873000	29093000	49321000	40933000	44842000	43132000	54717000	42013000	52899000	57252000	42791000	41341000	50146000	35652000	51836000	NA	NA	NA	CRYL1	CRYL1;NA;NA;NA;NA	oxidation-reduction process;glucuronate catabolic process to xylulose 5-phosphate;fatty acid metabolic process	GO:005511; GO:001964; GO:000663	extracellular exosome;cytosol	GO:007006; GO:000582	 Pentose and glucuronate interconversions; Metabolic pathways	hsa0004; hsa0110	3-hydroxyacyl-CoA dehydrogenase activity;protein homodimerization activity;L-gulonate 3-dehydrogenase activity;NAD+ binding	GO:000385; GO:004280; GO:005010; GO:007040
NP_999052.1	NP_999052.1	NP_999052.1 serum amyloid P-component precursor [Sus scrofa]	3	3	3	0	0	8336200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	APCS	APCS;NA;NA;NA;NA	negative regulation by host of viral exo-alpha-sialidase activity;cellular protein metabolic process;negative regulation by host of viral glycoprotein metabolic process;negative regulation of wound healing;protein folding;negative regulation of viral entry into host cell;acute-phase response;innate immune response;chaperone-mediated protein complex assembly;negative regulation of glycoprotein metabolic process;negative regulation of acute inflammatory response;negative regulation of monocyte differentiation;negative regulation of viral process	GO:004486; GO:004426; GO:004487; GO:006104; GO:000645; GO:004659; GO:000695; GO:004508; GO:005113; GO:190301; GO:000267; GO:004565; GO:004852	extracellular region;extracellular space;nucleus;extracellular exosome;blood microparticle	GO:000557; GO:000561; GO:000563; GO:007006; GO:007256	"NA"	"NA"	carbohydrate binding;calcium ion binding;complement component C1q binding;low-density lipoprotein particle binding;unfolded protein binding;identical protein binding;virion binding	GO:003024; GO:000550; GO:000184; GO:003016; GO:005108; GO:004280; GO:004679
NP_999056.1	NP_999056.1	NP_999056.1 vascular cell adhesion protein 1 precursor [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4181700	0	0	NA	NA	NA	VCAM1	VCAM1;NA;NA;NA;NA	extracellular matrix organization;positive regulation of T cell proliferation;response to ethanol;cell adhesion;oxidation-reduction process;response to ionizing radiation;B cell differentiation;response to hypoxia;acute inflammatory response;response to nutrient;response to zinc ion;heterotypic cell-cell adhesion;cell chemotaxis;innervation;cellular response to tumor necrosis factor;aging;regulation of immune response;interferon-gamma-mediated signaling pathway;membrane to membrane docking;response to nicotine;cellular response to beta-amyloid;chronic inflammatory response;cell-matrix adhesion;response to lipopolysaccharide;leukocyte tethering or rolling;cardiac neuron differentiation;amine metabolic process;cytokine-mediated signaling pathway;calcium-mediated signaling using intracellular calcium source;cellular response to vascular endothelial growth factor stimulus	GO:003019; GO:004210; GO:004547; GO:000715; GO:005511; GO:001021; GO:003018; GO:000166; GO:000252; GO:000758; GO:001004; GO:003411; GO:006032; GO:006038; GO:007135; GO:000756; GO:005077; GO:006033; GO:002261; GO:003509; GO:190464; GO:000254; GO:000716; GO:003249; GO:005090; GO:006094; GO:000930; GO:001922; GO:003558; GO:003592	extracellular space;early endosome;microvillus;external side of plasma membrane;filopodium;Golgi apparatus;cell surface;alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;plasma membrane;apical part of cell;podosome;endoplasmic reticulum;sarcolemma;extracellular exosome	GO:000561; GO:000576; GO:000590; GO:000989; GO:003017; GO:000579; GO:000998; GO:007106; GO:000588; GO:004517; GO:000210; GO:000578; GO:004238; GO:007006	 Cell adhesion molecules (CAMs); HTLV-I infection; African trypanosomiasis; Leukocyte transendothelial migration; NF-kappa B signaling pathway; TNF signaling pathway	hsa0451; hsa0516; hsa0514; hsa0467; hsa0406; hsa0466	cell adhesion molecule binding;primary amine oxidase activity;integrin binding	GO:005083; GO:000813; GO:000517
NP_999061.1;XP_020924186.1	NP_999061.1;XP_020924186.1	NP_999061.1 aminoacylase-1 [Sus scrofa];XP_020924186.1 aminoacylase-1 isoform X1 [Sus scrofa]	17	17	17	224270000	202690000	162890000	223260000	196720000	145410000	216820000	248500000	178980000	179600000	222250000	213860000	145140000	217540000	207790000	206500000	205390000	184430000	NA	NA	NA	ACY1	ACY1;ACY1;NA;NA;NA	proteolysis;xenobiotic metabolic process;cellular amino acid metabolic process	GO:000650; GO:000680; GO:000652	cytosol;extracellular exosome	GO:000582; GO:007006	 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Arginine biosynthesis; Metabolic pathways; Biosynthesis of antibiotics	hsa0121; hsa0123; hsa0022; hsa0110; hsa0113	aminoacylase activity;protein binding;metallopeptidase activity;metal ion binding;identical protein binding	GO:000404; GO:000551; GO:000823; GO:004687; GO:004280
NP_999062.1	NP_999062.1	NP_999062.1 long-chain specific acyl-CoA dehydrogenase, mitochondrial precursor [Sus scrofa]	15	15	15	362640000	344440000	372590000	221320000	268020000	202220000	395690000	311350000	395100000	289150000	297610000	274960000	164330000	273300000	296960000	293720000	265260000	292380000	NA	NA	NA	ACADL	ACADL;NA;NA;NA;NA	fatty acid beta-oxidation;carnitine catabolic process;negative regulation of fatty acid oxidation;fatty acid beta-oxidation using acyl-CoA dehydrogenase;cellular lipid catabolic process;temperature homeostasis;negative regulation of fatty acid biosynthetic process;carnitine metabolic process, CoA-linked;oxidation-reduction process;long-chain fatty acid catabolic process;protein homotetramerization;regulation of cholesterol metabolic process	GO:000663; GO:004241; GO:004632; GO:003353; GO:004424; GO:000165; GO:004571; GO:001925; GO:005511; GO:004275; GO:005128; GO:009018	mitochondrion;mitochondrial membrane;mitochondrial matrix	GO:000573; GO:003196; GO:000575	 Metabolic pathways; Fatty acid degradation; Fatty acid metabolism; PPAR signaling pathway	hsa0110; hsa0007; hsa0121; hsa0332	fatty-acyl-CoA binding;long-chain-acyl-CoA dehydrogenase activity;palmitoyl-CoA oxidase activity;flavin adenine dinucleotide binding;acyl-CoA dehydrogenase activity	GO:000006; GO:000446; GO:001640; GO:005066; GO:000399
NP_999063.1;XP_005670765.1	NP_999063.1;XP_005670765.1	NP_999063.1 short-chain specific acyl-CoA dehydrogenase, mitochondrial precursor [Sus scrofa];XP_005670765.1 short-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X1 [Sus scrofa]	9	9	9	130770000	70620000	112440000	63823000	91882000	62124000	120740000	67955000	102470000	77341000	85746000	71997000	0	77994000	89235000	76529000	82233000	62151000	NA	NA	NA	ACADS	ACADS;ACADS;NA;NA;NA	fatty acid beta-oxidation using acyl-CoA dehydrogenase;fatty acid beta-oxidation;butyrate catabolic process	GO:003353; GO:000663; GO:004635	nucleus;nucleoplasm;mitochondrial matrix;mitochondrion	GO:000563; GO:000565; GO:000575; GO:000573	 Fatty acid degradation; Carbon metabolism; Butanoate metabolism; Valine, leucine and isoleucine degradation; Fatty acid metabolism; Metabolic pathways	hsa0007; hsa0120; hsa0065; hsa0028; hsa0121; hsa0110	flavin adenine dinucleotide binding;butyryl-CoA dehydrogenase activity;acyl-CoA dehydrogenase activity	GO:005066; GO:000408; GO:000399
NP_999065.1	NP_999065.1	NP_999065.1 N-acylglucosamine 2-epimerase [Sus scrofa]	9	9	9	51713000	74018000	40840000	76148000	26880000	56460000	37303000	73638000	51594000	56091000	56946000	105880000	46516000	84360000	40208000	77569000	45268000	75207000	NA	NA	NA	RENBP	RENBP;NA;NA;NA;NA	N-acetylneuraminate catabolic process;N-acetylglucosamine metabolic process;regulation of blood pressure;negative regulation of endopeptidase activity;N-acetylmannosamine metabolic process	GO:001926; GO:000604; GO:000821; GO:001095; GO:000605	cytosol;extracellular exosome	GO:000582; GO:007006	 Amino sugar and nucleotide sugar metabolism	hsa0052	protein homodimerization activity;N-acylglucosamine 2-epimerase activity;ATP binding;peptidase inhibitor activity;endopeptidase inhibitor activity	GO:004280; GO:005012; GO:000552; GO:003041; GO:000486
NP_999066.1	NP_999066.1	NP_999066.1 propionyl-CoA carboxylase beta chain, mitochondrial precursor [Sus scrofa]	14	14	14	112570000	50287000	118620000	48325000	114400000	42345000	111930000	90513000	125920000	80641000	87732000	81726000	22651000	50669000	68996000	80982000	62978000	34257000	NA	NA	NA	PCCB	PCCB;NA;NA;NA;NA	biotin metabolic process	GO:000676	mitochondrial matrix;mitochondrion;cytosol	GO:000575; GO:000573; GO:000582	 Metabolic pathways; Valine, leucine and isoleucine degradation; Carbon metabolism; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Biosynthesis of antibiotics	hsa0110; hsa0028; hsa0120; hsa0063; hsa0064; hsa0113	protein binding;propionyl-CoA carboxylase activity;ATP binding	GO:000551; GO:000465; GO:000552
NP_999068.1;CON__Q9TRI1	NP_999068.1	NP_999068.1 inter-alpha-trypsin inhibitor heavy chain H2 precursor [Sus scrofa]	16	16	16	532750000	202790000	269490000	333550000	409520000	418690000	480030000	208900000	544120000	247960000	467080000	178860000	522440000	281260000	522600000	174690000	428340000	162610000	NA	NA	NA	ITIH2	ITIH2;NA;NA;NA;NA	hyaluronan metabolic process;negative regulation of endopeptidase activity;cellular protein metabolic process;post-translational protein modification	GO:003021; GO:001095; GO:004426; GO:004368	endoplasmic reticulum lumen;extracellular region;extracellular exosome;blood microparticle	GO:000578; GO:000557; GO:007006; GO:007256	"NA"	"NA"	serine-type endopeptidase inhibitor activity;endopeptidase inhibitor activity	GO:000486; GO:000486
NP_999069.1;XP_020936328.1;XP_020936333.1	NP_999069.1;XP_020936328.1;XP_020936333.1	NP_999069.1 neutral alpha-glucosidase AB precursor [Sus scrofa];XP_020936328.1 neutral alpha-glucosidase AB isoform X2 [Sus scrofa];XP_020936333.1 neutral alpha-glucosidase AB isoform X4 [Sus scrofa]	32	1	1	0	0	0	0	0	0	0	0	0	75390000	0	135420000	0	0	0	117390000	0	0	NA	NA	NA	GANAB	GANAB;GANAB;GANAB;NA;NA	carbohydrate metabolic process;N-glycan processing	GO:000597; GO:000649	Golgi apparatus;melanosome;endoplasmic reticulum lumen;extracellular exosome;glucosidase II complex;membrane;intracellular membrane-bounded organelle	GO:000579; GO:004247; GO:000578; GO:007006; GO:001717; GO:001602; GO:004323	 Protein processing in endoplasmic reticulum; N-Glycan biosynthesis; Metabolic pathways	hsa0414; hsa0051; hsa0110	glucan 1,3-alpha-glucosidase activity;protein binding;RNA binding;carbohydrate binding	GO:003391; GO:000551; GO:000372; GO:003024
XP_013836290.2;NP_999072.1;XP_013836291.2;XP_005668737.2	XP_013836290.2;NP_999072.1;XP_013836291.2;XP_005668737.2	XP_013836290.2 platelet endothelial cell adhesion molecule isoform X1 [Sus scrofa];NP_999072.1 platelet endothelial cell adhesion molecule precursor [Sus scrofa];XP_013836291.2 platelet endothelial cell adhesion molecule isoform X3 [Sus scrofa];XP_00566873	16	16	16	87064000	103460000	94584000	91279000	87309000	101070000	83451000	107370000	76774000	73217000	99263000	116420000	104760000	121740000	117820000	96051000	75445000	82453000	NA	NA	NA	PECAM1	PECAM1;PECAM1;PECAM1;PECAM1;NA	platelet degranulation;signal transduction;neutrophil extravasation;angiogenesis;Rho protein signal transduction;monocyte extravasation;endothelial cell migration;leukocyte migration;homophilic cell adhesion via plasma membrane adhesion molecules;extracellular matrix organization;cell-cell adhesion via plasma-membrane adhesion molecules;neutrophil degranulation;glomerular endothelium development;regulation of cell migration;endothelial cell morphogenesis;phagocytosis;wound healing;endothelial cell-matrix adhesion;cell recognition;positive regulation of tyrosine phosphorylation of STAT protein	GO:000257; GO:000716; GO:007267; GO:000152; GO:000726; GO:003569; GO:004354; GO:005090; GO:000715; GO:003019; GO:009874; GO:004331; GO:007201; GO:003033; GO:000188; GO:000690; GO:004206; GO:009067; GO:000803; GO:004253	platelet alpha granule membrane;cell-cell contact zone;extracellular exosome;plasma membrane;smooth muscle contractile fiber;integral component of membrane;extracellular space;external side of plasma membrane;membrane raft;secretory granule membrane	GO:003109; GO:004429; GO:007006; GO:000588; GO:003048; GO:001602; GO:000561; GO:000989; GO:004512; GO:003066	 Leukocyte transendothelial migration; Cell adhesion molecules (CAMs); Malaria	hsa0467; hsa0451; hsa0514	protein binding;protein homodimerization activity	GO:000551; GO:004280
NP_999073.1	NP_999073.1	NP_999073.1 integrin beta-2 precursor [Sus scrofa]	4	4	4	0	0	0	0	137150000	0	0	0	0	0	0	0	0	119300000	0	0	0	0	NA	NA	NA	ITGB2	ITGB2;NA;NA;NA;NA	microglial cell activation;receptor internalization;receptor clustering;neutrophil degranulation;cellular response to low-density lipoprotein particle stimulus;leukocyte migration involved in inflammatory response;apoptotic process;leukocyte cell-cell adhesion;heterotypic cell-cell adhesion;toll-like receptor 4 signaling pathway;negative regulation of dopamine metabolic process;positive regulation of protein targeting to membrane;inflammatory response;cell-matrix adhesion;extracellular matrix organization;endothelial cell migration;cell-cell signaling;integrin-mediated signaling pathway;aging;leukocyte migration;positive regulation of microglial cell activation;positive regulation of prostaglandin-E synthase activity;cell migration;neutrophil chemotaxis;endodermal cell differentiation;regulation of immune response;neutrophil migration;cell-cell adhesion;positive regulation of neuron death;receptor-mediated endocytosis;regulation of cell shape;natural killer cell activation;positive regulation of superoxide anion generation;positive regulation of nitric oxide biosynthetic process;positive regulation of angiogenesis;beta-amyloid clearance;cytokine-mediated signaling pathway;cell adhesion mediated by integrin;cellular extravasation;regulation of peptidyl-tyrosine phosphorylation;positive regulation of NF-kappaB transcription factor activity;cell-cell adhesion via plasma-membrane adhesion molecules	GO:000177; GO:003162; GO:004311; GO:004331; GO:007140; GO:000252; GO:000691; GO:000715; GO:003411; GO:003414; GO:004596; GO:009031; GO:000695; GO:000716; GO:003019; GO:004354; GO:000726; GO:000722; GO:000756; GO:005090; GO:190398; GO:200036; GO:001647; GO:003059; GO:003598; GO:005077; GO:199026; GO:009860; GO:190121; GO:000689; GO:000836; GO:003010; GO:003293; GO:004542; GO:004576; GO:009724; GO:001922; GO:003362; GO:004512; GO:005073; GO:005109; GO:009874	receptor complex;integrin complex;cell surface;specific granule membrane;plasma membrane raft;cytoplasmic region;external side of plasma membrane;integrin alphaL-beta2 complex;extracellular vesicle;ficolin-1-rich granule membrane;plasma membrane;membrane;focal adhesion;tertiary granule membrane;extracellular exosome	GO:004323; GO:000830; GO:000998; GO:003557; GO:004485; GO:009956; GO:000989; GO:003468; GO:190356; GO:010100; GO:000588; GO:001602; GO:000592; GO:007082; GO:007006	 Leukocyte transendothelial migration; Rheumatoid arthritis; Cell adhesion molecules (CAMs); HTLV-I infection; Regulation of actin cytoskeleton; Tuberculosis; Legionellosis; Phagosome; Hippo signaling pathway; Viral myocarditis; Natural killer cell mediated cytotoxicity; Leishmaniasis; Rap1 signaling pathway	hsa0467; hsa0532; hsa0451; hsa0516; hsa0481; hsa0515; hsa0513; hsa0414; hsa0439; hsa0541; hsa0465; hsa0514; hsa0401	cell adhesion molecule binding;complement component C3b binding;protein binding;protein kinase binding;protein heterodimerization activity;beta-amyloid binding;integrin binding;heat shock protein binding;metal ion binding;ICAM-3 receptor activity;cargo receptor activity	GO:005083; GO:000185; GO:000551; GO:001990; GO:004698; GO:000154; GO:000517; GO:003107; GO:004687; GO:003036; GO:003802
NP_999074.1;XP_020957861.1;XP_020957860.1;XP_020957859.1	NP_999074.1;XP_020957861.1;XP_020957860.1;XP_020957859.1	NP_999074.1 glutamine synthetase [Sus scrofa];XP_020957861.1 glutamine synthetase isoform X1 [Sus scrofa];XP_020957860.1 glutamine synthetase isoform X1 [Sus scrofa];XP_020957859.1 glutamine synthetase isoform X1 [Sus scrofa]	10	10	10	54075000	97589000	71630000	127810000	144730000	239700000	103310000	219700000	123030000	140690000	35013000	135300000	34244000	169470000	71532000	108820000	0	78608000	NA	NA	NA	GLUL	GLUL;GLUL;GLUL;GLUL;NA	ammonia assimilation cycle;protein homooligomerization;neurotransmitter uptake;angiogenesis;cellular response to starvation;protein palmitoylation;positive regulation of epithelial cell proliferation;glutamine biosynthetic process;response to glucose;regulation of endothelial cell migration;regulation of sprouting angiogenesis;glutamate catabolic process;cell proliferation;cellular amino acid biosynthetic process;positive regulation of insulin secretion;positive regulation of synaptic transmission, glutamatergic	GO:001967; GO:005126; GO:000150; GO:000152; GO:000926; GO:001834; GO:005067; GO:000654; GO:000974; GO:001059; GO:190367; GO:000653; GO:000828; GO:000865; GO:003202; GO:005196	axon terminus;extracellular exosome;mitochondrion;cytosol;plasma membrane;rough endoplasmic reticulum;myelin sheath;macromolecular complex;nucleus;glial cell projection	GO:004367; GO:007006; GO:000573; GO:000582; GO:000588; GO:000579; GO:004320; GO:003299; GO:000563; GO:009738	 Arginine biosynthesis; Metabolic pathways; GABAergic synapse; Glyoxylate and dicarboxylate metabolism; Nitrogen metabolism; Biosynthesis of amino acids; Alanine, aspartate and glutamate metabolism	hsa0022; hsa0110; hsa0472; hsa0063; hsa0091; hsa0123; hsa0025	identical protein binding;dynein light chain binding;manganese ion binding;ATP binding;protein binding;magnesium ion binding;glutamate-ammonia ligase activity;protein-cysteine S-palmitoyltransferase activity;glutamate binding	GO:004280; GO:004550; GO:003014; GO:000552; GO:000551; GO:000028; GO:000435; GO:001970; GO:001659
NP_999076.1	NP_999076.1	NP_999076.1 membrane-associated progesterone receptor component 1 [Sus scrofa]	9	9	8	138450000	140880000	157050000	123220000	137450000	146500000	157900000	154670000	133850000	114520000	149040000	198230000	93174000	153950000	151830000	133930000	160910000	124530000	NA	NA	NA	PGRMC1	PGRMC1;NA;NA;NA;NA	neutrophil degranulation	GO:004331	membrane;specific granule membrane;cell body;plasma membrane;neuron projection;endoplasmic reticulum;neuronal cell body;smooth endoplasmic reticulum membrane;synapse	GO:001602; GO:003557; GO:004429; GO:000588; GO:004300; GO:000578; GO:004302; GO:003086; GO:004520	"NA"	"NA"	protein binding;beta-amyloid binding;steroid binding	GO:000551; GO:000154; GO:000549
NP_999079.1;XP_013854872.1;XP_020952376.1	NP_999079.1;XP_013854872.1	NP_999079.1 fatty-acid amide hydrolase 1 [Sus scrofa];XP_013854872.1 fatty-acid amide hydrolase 1 isoform X1 [Sus scrofa]	9	9	9	16138000	15342000	13114000	13850000	25948000	15150000	11603000	23188000	15662000	15304000	18472000	38460000	0	19852000	20889000	30520000	18633000	18700000	NA	NA	NA	FAAH	FAAH;FAAH;NA;NA;NA	arachidonic acid metabolic process;fatty acid catabolic process	GO:001936; GO:000906	cytoskeleton;integral component of membrane;endoplasmic reticulum membrane;organelle membrane	GO:000585; GO:001602; GO:000578; GO:003109	 Retrograde endocannabinoid signaling	hsa0472	oleamide hydrolase activity;acylglycerol lipase activity;protein binding;amidase activity;anandamide amidohydrolase activity;fatty acid amide hydrolase activity	GO:010207; GO:004737; GO:000551; GO:000404; GO:010307; GO:001706
NP_999080.2	NP_999080.2	NP_999080.2 ATP synthase subunit e, mitochondrial [Sus scrofa]	4	4	4	163240000	94100000	118120000	84435000	120960000	76115000	163350000	87718000	137110000	69493000	128090000	56060000	84375000	96942000	140330000	81440000	127830000	113690000	NA	NA	NA	ATP5ME	ATP5ME;NA;NA;NA;NA	cristae formation;mitochondrial ATP synthesis coupled proton transport;ATP biosynthetic process	GO:004240; GO:004277; GO:000675	mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);mitochondrion;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex	GO:000027; GO:000573; GO:000574; GO:000575	 Metabolic pathways; Oxidative phosphorylation	hsa0110; hsa0019	transmembrane transporter activity;hydrogen ion transmembrane transporter activity;macromolecular complex binding;ATPase activity	GO:002285; GO:001507; GO:004487; GO:001688
NP_999082.1;XP_020935325.1	NP_999082.1;XP_020935325.1	NP_999082.1 60S ribosomal protein L36a [Sus scrofa];XP_020935325.1 60S ribosomal protein L36a [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30225000	NA	NA	NA	RPL36AL	RPL36AL;RPL36A;NA;NA;NA	translation	GO:000641	cytosol;plasma membrane;nucleus;cytosolic large ribosomal subunit;endoplasmic reticulum	GO:000582; GO:000588; GO:000563; GO:002262; GO:000578	 Ribosome	hsa0301	structural constituent of ribosome;protein binding	GO:000373; GO:000551
XP_005671687.1;NP_999083.1;XP_005671686.1;XP_013839424.1;XP_020930331.1;XP_020930330.1;XP_020930332.1;XP_013839425.1	XP_005671687.1;NP_999083.1;XP_005671686.1;XP_013839424.1;XP_020930331.1;XP_020930330.1;XP_020930332.1;XP_013839425.1	XP_005671687.1 vitamin K-dependent protein C isoform X5 [Sus scrofa];NP_999083.1 vitamin K-dependent protein C precursor [Sus scrofa];XP_005671686.1 vitamin K-dependent protein C isoform X4 [Sus scrofa];XP_013839424.1 vitamin K-dependent protein C isoform	10	10	10	100790000	96098000	101540000	81511000	79233000	149980000	74894000	64817000	73378000	53937000	77821000	63066000	87369000	84256000	87654000	55146000	82385000	63886000	NA	NA	NA	PROC	PROC;PROC;PROC;PROC;PROC	proteolysis;positive regulation of establishment of endothelial barrier;negative regulation of coagulation;negative regulation of inflammatory response;blood coagulation;cellular protein metabolic process;ER to Golgi vesicle-mediated transport;negative regulation of apoptotic process;post-translational protein modification;negative regulation of blood coagulation	GO:000650; GO:190314; GO:005081; GO:005072; GO:000759; GO:004426; GO:000688; GO:004306; GO:004368; GO:003019	endoplasmic reticulum;extracellular space;Golgi apparatus;extracellular region;endoplasmic reticulum lumen	GO:000578; GO:000561; GO:000579; GO:000557; GO:000578	 Complement and coagulation cascades	hsa0461	serine-type endopeptidase activity;calcium ion binding;protein binding	GO:000425; GO:000550; GO:000551
NP_999085.1	NP_999085.1	NP_999085.1 decorin precursor [Sus scrofa]	23	23	23	3142900000	13977000000	3572800000	18159000000	3417400000	17094000000	5818200000	10400000000	4054700000	9742800000	4618300000	13026000000	6602400000	15974000000	5343000000	11764000000	7206700000	15700000000	NA	NA	NA	DCN	DCN;NA;NA;NA;NA	placenta development;animal organ morphogenesis;positive regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;chondroitin sulfate biosynthetic process;positive regulation of mitochondrial fission;response to lipopolysaccharide;aging;extracellular matrix organization;wound healing;response to mechanical stimulus;skeletal muscle tissue development;negative regulation of endothelial cell migration;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of mitochondrial depolarization;negative regulation of vascular endothelial growth factor signaling pathway;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;kidney development;positive regulation of macroautophagy;negative regulation of angiogenesis	GO:000189; GO:000988; GO:004594; GO:001050; GO:003020; GO:009014; GO:003249; GO:000756; GO:003019; GO:004206; GO:000961; GO:000751; GO:001059; GO:001406; GO:005190; GO:190074; GO:001980; GO:000182; GO:001623; GO:001652	Golgi lumen;collagen type VI trimer;extracellular space;lysosomal lumen;extracellular region	GO:000579; GO:000558; GO:000561; GO:004320; GO:000557	 Proteoglycans in cancer; TGF-beta signaling pathway	hsa0520; hsa0435	glycosaminoglycan binding;collagen binding;RNA binding;extracellular matrix structural constituent conferring compression resistance;protein N-terminus binding;extracellular matrix binding	GO:000553; GO:000551; GO:000372; GO:003002; GO:004748; GO:005084
NP_999088.1;XP_005669617.1	NP_999088.1;XP_005669617.1	NP_999088.1 acylamino-acid-releasing enzyme [Sus scrofa];XP_005669617.1 acylamino-acid-releasing enzyme isoform X1 [Sus scrofa]	12	12	12	96423000	78099000	66762000	78313000	68903000	55338000	90800000	73600000	75917000	70656000	71233000	59716000	87912000	74669000	90243000	65167000	70226000	70808000	NA	NA	NA	APEH	APEH;APEH;NA;NA;NA	beta-amyloid metabolic process;neutrophil degranulation;translational termination;proteolysis	GO:005043; GO:004331; GO:000641; GO:000650	nuclear membrane;ficolin-1-rich granule lumen;cytosol;extracellular region;extracellular exosome	GO:003196; GO:190481; GO:000582; GO:000557; GO:007006	"NA"	"NA"	serine-type endopeptidase activity;RNA binding;protein binding;omega peptidase activity;identical protein binding	GO:000425; GO:000372; GO:000551; GO:000824; GO:004280
NP_999089.2;CON__Q0VCM5	NP_999089.2	NP_999089.2 inter-alpha-trypsin inhibitor heavy chain H1 precursor [Sus scrofa]	24	24	24	547860000	230080000	336920000	356590000	480200000	433540000	581510000	191490000	567490000	277050000	546350000	250910000	606490000	373660000	536680000	197220000	492860000	279930000	NA	NA	NA	ITIH1	ITIH1;NA;NA;NA;NA	hyaluronan metabolic process;negative regulation of endopeptidase activity	GO:003021; GO:001095	blood microparticle;extracellular region;extracellular exosome	GO:007256; GO:000557; GO:007006	"NA"	"NA"	calcium ion binding;serine-type endopeptidase inhibitor activity	GO:000550; GO:000486
NP_999092.1	NP_999092.1	NP_999092.1 aspartate aminotransferase, cytoplasmic [Sus scrofa]	14	14	14	293390000	267870000	307990000	215890000	370580000	196970000	310540000	252300000	315560000	279740000	303820000	238370000	226040000	212860000	347350000	289590000	289510000	202210000	NA	NA	NA	GOT1	GOT1;NA;NA;NA;NA	glutamate catabolic process to 2-oxoglutarate;response to immobilization stress;fatty acid homeostasis;transdifferentiation;negative regulation of cytosolic calcium ion concentration;negative regulation of mitochondrial depolarization;response to transition metal nanoparticle;cellular amino acid biosynthetic process;response to cadmium ion;oxaloacetate metabolic process;glycerol biosynthetic process;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of collagen biosynthetic process;aspartate metabolic process;glutamate catabolic process to aspartate;cellular response to insulin stimulus;response to glucocorticoid;gluconeogenesis;Notch signaling pathway;response to carbohydrate;cellular response to mechanical stimulus	GO:001955; GO:003590; GO:005508; GO:006029; GO:005148; GO:005190; GO:199026; GO:000865; GO:004668; GO:000610; GO:000611; GO:003051; GO:003296; GO:000653; GO:001955; GO:003286; GO:005138; GO:000609; GO:000721; GO:000974; GO:007126	nucleus;lysosome;cytosol;nucleoplasm;extracellular exosome;cytoplasm;axon terminus	GO:000563; GO:000576; GO:000582; GO:000565; GO:007006; GO:000573; GO:004367	 Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Cysteine and methionine metabolism; Arginine and proline metabolism; Tyrosine metabolism; Biosynthesis of amino acids; Metabolic pathways; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism	hsa0022; hsa0025; hsa0036; hsa0040; hsa0027; hsa0033; hsa0035; hsa0123; hsa0110; hsa0113; hsa0120; hsa0121	L-cysteine:2-oxoglutarate aminotransferase activity;phosphatidylserine decarboxylase activity;L-aspartate:2-oxoglutarate aminotransferase activity;pyridoxal phosphate binding;carboxylic acid binding	GO:004780; GO:000460; GO:000406; GO:003017; GO:003140
NP_999093.1	NP_999093.1	NP_999093.1 aspartate aminotransferase, mitochondrial precursor [Sus scrofa]	20	20	20	951630000	657720000	836790000	469050000	682280000	479010000	847350000	605380000	900420000	592200000	846170000	613930000	578830000	640340000	712530000	706750000	775980000	613740000	NA	NA	NA	GOT2	GOT2;NA;NA;NA;NA	2-oxoglutarate metabolic process;lactation;fatty acid transport;glutamate catabolic process to 2-oxoglutarate;response to ethanol;glyoxylate metabolic process;L-kynurenine metabolic process;glutamate metabolic process;female pregnancy;response to muscle activity;response to insulin;oxaloacetate metabolic process;4-hydroxyproline catabolic process;response to morphine;cellular amino acid biosynthetic process;gluconeogenesis	GO:000610; GO:000759; GO:001590; GO:001955; GO:004547; GO:004648; GO:009705; GO:000653; GO:000756; GO:001485; GO:003286; GO:000610; GO:001947; GO:004327; GO:000865; GO:000609	cell surface;macromolecular complex;perikaryon;mitochondrion;mitochondrial matrix;mitochondrial inner membrane;T-tubule;plasma membrane;extracellular exosome	GO:000998; GO:003299; GO:004320; GO:000573; GO:000575; GO:000574; GO:003031; GO:000588; GO:007006	 Arginine and proline metabolism; Tyrosine metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Fat digestion and absorption; Metabolic pathways; Alanine, aspartate and glutamate metabolism; Cysteine and methionine metabolism; Biosynthesis of antibiotics; Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Carbon metabolism; Arginine biosynthesis	hsa0033; hsa0035; hsa0121; hsa0123; hsa0497; hsa0110; hsa0025; hsa0027; hsa0113; hsa0036; hsa0040; hsa0120; hsa0022	pyridoxal phosphate binding;enzyme binding;RNA binding;protein homodimerization activity;L-aspartate:2-oxoglutarate aminotransferase activity;amino acid binding;4-hydroxyglutamate transaminase activity;kynurenine-oxoglutarate transaminase activity;phospholipid binding	GO:003017; GO:001989; GO:000372; GO:004280; GO:000406; GO:001659; GO:004757; GO:001621; GO:000554
XP_003131242.1;NP_999095.1;XP_020955659.1	XP_003131242.1;NP_999095.1;XP_020955659.1	XP_003131242.1 histone H3.3 [Sus scrofa];NP_999095.1 histone H3.3 [Sus scrofa];XP_020955659.1 histone H3.3-like [Sus scrofa]	6	1	1	0	0	0	0	0	0	0	0	0	0	0	13577000	0	0	0	0	0	0	NA	NA	NA	H3F3A	LOC100521680;H3F3A;LOC100627410;NA;NA	nucleosome assembly;DNA replication-independent nucleosome assembly;telomere organization;cellular protein metabolic process;negative regulation of gene expression, epigenetic;chromatin silencing at rDNA;regulation of megakaryocyte differentiation;regulation of gene silencing by miRNA;blood coagulation;positive regulation of cell growth	GO:000633; GO:000633; GO:003220; GO:004426; GO:004581; GO:000018; GO:004565; GO:006096; GO:000759; GO:003030	nuclear nucleosome;nucleosome;nucleus;nucleoplasm;extracellular region;macromolecular complex;extracellular exosome;nuclear chromosome	GO:000078; GO:000078; GO:000563; GO:000565; GO:000557; GO:003299; GO:007006; GO:000022	 Systemic lupus erythematosus; Alcoholism; Transcriptional misregulation in cancer	hsa0532; hsa0503; hsa0520	protein binding;RNA polymerase II core promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;nucleosomal DNA binding;protein heterodimerization activity	GO:000551; GO:000097; GO:000098; GO:003149; GO:004698
XP_005671131.1;NP_999099.1;XP_005671130.1;XP_020927737.1	XP_005671131.1;NP_999099.1;XP_005671130.1;XP_020927737.1	XP_005671131.1 vinculin isoform X3 [Sus scrofa];NP_999099.1 vinculin [Sus scrofa];XP_005671130.1 vinculin isoform X2 [Sus scrofa];XP_020927737.1 vinculin isoform X1 [Sus scrofa]	56	56	56	2100900000	3033700000	3288700000	2713100000	1985000000	3224600000	2176000000	3447900000	2260800000	3783400000	2987500000	3856300000	4197800000	3318600000	2777800000	3485300000	2024700000	2707300000	NA	NA	NA	VCL	VCL;VCL;VCL;VCL;NA	protein localization to cell surface;adherens junction assembly;neutrophil degranulation;negative regulation of cell migration;epithelial cell-cell adhesion;axon extension;muscle contraction;cell adhesion;apical junction assembly;lamellipodium assembly;platelet aggregation;morphogenesis of an epithelium;platelet degranulation;cell-matrix adhesion	GO:003439; GO:003433; GO:004331; GO:003033; GO:009013; GO:004867; GO:000693; GO:000715; GO:004329; GO:003003; GO:007052; GO:000200; GO:000257; GO:000716	cell-cell junction;adherens junction;extracellular exosome;cell-substrate junction;secretory granule lumen;specific granule lumen;ficolin-1-rich granule lumen;macromolecular complex;sarcolemma;extracellular region;focal adhesion;costamere;podosome;cytosol;cytoskeleton;extracellular vesicle	GO:000591; GO:000591; GO:007006; GO:003005; GO:003477; GO:003558; GO:190481; GO:003299; GO:004238; GO:000557; GO:000592; GO:004303; GO:000210; GO:000582; GO:000585; GO:190356	 Focal adhesion; Amoebiasis; Leukocyte transendothelial migration; Shigellosis; Adherens junction; Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells	hsa0451; hsa0514; hsa0467; hsa0513; hsa0452; hsa0481; hsa0510	dystroglycan binding;structural molecule activity;ubiquitin protein ligase binding;actin binding;protein binding;alpha-catenin binding;beta-catenin binding	GO:000216; GO:000519; GO:003162; GO:000377; GO:000551; GO:004529; GO:000801
NP_999100.2	NP_999100.2	NP_999100.2 proteasome subunit beta type-8 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3688600	0	NA	NA	NA	PSMB8	PSMB8;NA;NA;NA;NA	regulation of endopeptidase activity;type I interferon signaling pathway;proteasomal protein catabolic process;protein deubiquitination;post-translational protein modification;fat cell differentiation;viral process;antigen processing and presentation;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:005254; GO:006033; GO:001049; GO:001657; GO:004368; GO:004544; GO:001603; GO:001988; GO:004316	proteasome complex;nucleus;proteasome core complex, beta-subunit complex;extracellular exosome;nucleoplasm;proteasome core complex;cytosol;spermatoproteasome complex;cytoplasm	GO:000050; GO:000563; GO:001977; GO:007006; GO:000565; GO:000583; GO:000582; GO:199011; GO:000573	 Proteasome	hsa0305	protein binding;endopeptidase activity;threonine-type endopeptidase activity	GO:000551; GO:000417; GO:000429
NP_999101.1	NP_999101.1	NP_999101.1 ribonuclease 4 precursor [Sus scrofa]	4	4	4	0	102320000	54655000	101490000	45353000	133640000	55215000	72660000	60546000	100270000	48637000	86594000	70887000	116000000	67232000	97321000	88377000	130540000	NA	NA	NA	RNASE4	RNASE4;NA;NA;NA;NA	RNA phosphodiester bond hydrolysis, endonucleolytic;mRNA cleavage	GO:009050; GO:000637	extracellular region	GO:000557	"NA"	"NA"	nucleic acid binding;ribonuclease A activity;ribonuclease activity	GO:000367; GO:000452; GO:000454
NP_999103.1	NP_999103.1	NP_999103.1 succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial precursor [Sus scrofa]	20	20	20	1045200000	1154100000	579140000	780080000	695970000	691550000	589250000	907280000	940790000	1130800000	968800000	1297000000	414550000	1300800000	761470000	972390000	657340000	913560000	NA	NA	NA	OXCT1	OXCT1;NA;NA;NA;NA	cellular ketone body metabolic process;positive regulation of insulin secretion involved in cellular response to glucose stimulus;response to hormone;ketone catabolic process;response to starvation;response to ethanol;heart development;response to nutrient;response to activity;brain development;ketone body catabolic process;adipose tissue development	GO:004695; GO:003577; GO:000972; GO:004218; GO:004259; GO:004547; GO:000750; GO:000758; GO:001482; GO:000742; GO:004695; GO:006061	nucleoplasm;mitochondrial matrix;mitochondrion	GO:000565; GO:000575; GO:000573	 Valine, leucine and isoleucine degradation; Synthesis and degradation of ketone bodies; Butanoate metabolism	hsa0028; hsa0007; hsa0065	protein homodimerization activity;3-oxoacid CoA-transferase activity	GO:004280; GO:000826
NP_999105.1	NP_999105.1	NP_999105.1 40S ribosomal protein S18 [Sus scrofa]	7	7	7	122400000	114570000	122310000	101860000	92530000	176760000	104880000	74069000	121940000	128370000	92847000	105340000	123770000	159650000	114160000	125810000	139890000	183250000	NA	NA	NA	RPS18	RPS18;NA;NA;NA;NA	translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;translational initiation	GO:000641; GO:000018; GO:000661; GO:000641	postsynaptic density;cytosol;ribosome;small ribosomal subunit;cytosolic small ribosomal subunit;membrane;extracellular exosome;nucleus;nucleoplasm;focal adhesion	GO:001406; GO:000582; GO:000584; GO:001593; GO:002262; GO:001602; GO:007006; GO:000563; GO:000565; GO:000592	 Ribosome	hsa0301	RNA binding;rRNA binding;protein binding;structural constituent of ribosome	GO:000372; GO:001984; GO:000551; GO:000373
NP_999107.1	NP_999107.1	NP_999107.1 apolipoprotein R precursor [Sus scrofa]	7	4	4	0	27243000	0	39918000	20200000	49146000	0	27197000	0	41323000	26528000	29197000	25490000	13416000	24464000	0	32043000	61912000	NA	NA	NA	C4BPA	C4BPA;NA;NA;NA;NA	negative regulation of complement activation, classical pathway;regulation of complement activation;regulation of opsonization;innate immune response;positive regulation of protein catabolic process;complement activation, classical pathway	GO:004595; GO:003044; GO:190302; GO:004508; GO:004573; GO:000695	extracellular region;blood microparticle;extracellular space;plasma membrane;other organism cell	GO:000557; GO:007256; GO:000561; GO:000588; GO:004421	 Pertussis; Complement and coagulation cascades	hsa0513; hsa0461	RNA binding;protein binding	GO:000372; GO:000551
NP_999108.1	NP_999108.1	NP_999108.1 pyridoxal kinase [Sus scrofa]	6	6	6	0	22955000	26604000	30888000	21313000	20505000	26647000	28508000	28296000	26404000	28538000	24174000	22952000	23430000	36738000	32739000	28144000	28824000	NA	NA	NA	PDXK	PDXK;NA;NA;NA;NA	pyridoxal 5'-phosphate salvage;phosphorylation;cell proliferation;pyridoxal phosphate biosynthetic process;vitamin B6 metabolic process;neutrophil degranulation	GO:000944; GO:001631; GO:000828; GO:004282; GO:004281; GO:004331	secretory granule lumen;nucleoplasm;extracellular region;extracellular exosome;nucleus;specific granule lumen;cytosol	GO:003477; GO:000565; GO:000557; GO:007006; GO:000563; GO:003558; GO:000582	 Vitamin B6 metabolism; Metabolic pathways	hsa0075; hsa0110	pyridoxal kinase activity;potassium ion binding;pyridoxal phosphate binding;sodium ion binding;zinc ion binding;ATP binding;protein homodimerization activity;magnesium ion binding	GO:000847; GO:003095; GO:003017; GO:003140; GO:000827; GO:000552; GO:004280; GO:000028
NP_999109.1	NP_999109.1	NP_999109.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 [Sus scrofa]	2	2	2	50401000	47054000	45027000	46449000	48845000	43917000	53410000	60674000	43105000	41438000	51401000	24004000	33915000	50514000	46068000	49555000	47706000	52624000	NA	NA	NA	DAD1	DAD1;NA;NA;NA;NA	protein N-linked glycosylation;response to drug;apoptotic process;blastocyst development;protein N-linked glycosylation via asparagine;response to nutrient;protein glycosylation;negative regulation of apoptotic process	GO:000648; GO:004249; GO:000691; GO:000182; GO:001827; GO:000758; GO:000648; GO:004306	endoplasmic reticulum membrane;oligosaccharyltransferase complex;membrane	GO:000578; GO:000825; GO:001602	 Protein processing in endoplasmic reticulum; N-Glycan biosynthesis; Metabolic pathways	hsa0414; hsa0051; hsa0110	dolichyl-diphosphooligosaccharide-protein glycotransferase activity;oligosaccharyl transferase activity	GO:000457; GO:000457
XP_005669619.1;NP_999115.1	XP_005669619.1;NP_999115.1	XP_005669619.1 60S ribosomal protein L29 isoform X1 [Sus scrofa];NP_999115.1 60S ribosomal protein L29 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16205000	0	NA	NA	NA	RPL29	RPL29;RPL29;NA;NA;NA	translational initiation;embryo implantation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;SRP-dependent cotranslational protein targeting to membrane;translation	GO:000641; GO:000756; GO:000018; GO:000218; GO:000661; GO:000641	cytosol;cytosolic large ribosomal subunit;membrane	GO:000582; GO:002262; GO:001602	 Ribosome	hsa0301	heparin binding;cadherin binding;RNA binding;structural constituent of ribosome	GO:000820; GO:004529; GO:000372; GO:000373
NP_999118.1;XP_020957866.1	NP_999118.1;XP_020957866.1	NP_999118.1 hemopexin precursor [Sus scrofa];XP_020957866.1 hemopexin isoform X1 [Sus scrofa]	22	22	22	4515100000	7616300000	4619000000	9509200000	8275000000	12526000000	6119200000	7821400000	6044800000	6662600000	6836100000	8616100000	5547900000	7343400000	5929400000	7721900000	5778100000	9648600000	NA	NA	NA	HPX	HPX;HPX;NA;NA;NA	positive regulation of humoral immune response mediated by circulating immunoglobulin;proteolysis;positive regulation of interferon-gamma-mediated signaling pathway;cellular iron ion homeostasis;receptor-mediated endocytosis;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of immunoglobulin production;viral process;heme transport;heme metabolic process	GO:000292; GO:000650; GO:006033; GO:000687; GO:000689; GO:004253; GO:000263; GO:001603; GO:001588; GO:004216	endocytic vesicle lumen;extracellular exosome;blood microparticle;extracellular region;extracellular space	GO:007168; GO:007006; GO:007256; GO:000557; GO:000561	"NA"	"NA"	metal ion binding;heme transporter activity;protein binding	GO:004687; GO:001523; GO:000551
NP_999119.1	NP_999119.1	NP_999119.1 aconitate hydratase, mitochondrial precursor [Sus scrofa]	28	28	28	1443900000	718140000	1257500000	589830000	1270100000	595120000	1378400000	760870000	1401600000	852370000	923790000	545050000	640220000	665500000	992390000	881940000	942880000	664150000	NA	NA	NA	ACO2	ACO2;NA;NA;NA;NA	tricarboxylic acid cycle;isocitrate metabolic process;generation of precursor metabolites and energy;response to isolation stress;liver development	GO:000609; GO:000610; GO:000609; GO:003590; GO:000188	mitochondrial matrix;cytosol;mitochondrion	GO:000575; GO:000582; GO:000573	 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Citrate cycle (TCA cycle); Metabolic pathways; Carbon metabolism; Glyoxylate and dicarboxylate metabolism; Biosynthesis of antibiotics	hsa0121; hsa0123; hsa0002; hsa0110; hsa0120; hsa0063; hsa0113	4 iron, 4 sulfur cluster binding;aconitate hydratase activity;3 iron, 4 sulfur cluster binding;iron ion binding	GO:005153; GO:000399; GO:005153; GO:000550
XP_020936424.1;XP_005653007.1;XP_005653006.1;XP_005653005.1;NP_999125.1	XP_020936424.1;XP_005653007.1;XP_005653006.1;XP_005653005.1;NP_999125.1	XP_020936424.1 voltage-dependent anion-selective channel protein 1 isoform X1 [Sus scrofa];XP_005653007.1 voltage-dependent anion-selective channel protein 1 isoform X1 [Sus scrofa];XP_005653006.1 voltage-dependent anion-selective channel protein 1 isoform	16	16	16	1547100000	1008500000	1230400000	751470000	1064200000	588540000	1280600000	907100000	1119700000	809150000	1049500000	743090000	557060000	875940000	932880000	912520000	1055800000	946350000	NA	NA	NA	VDAC1	VDAC1;VDAC1;VDAC1;VDAC1;VDAC1	pyruvate metabolic process;neuron-neuron synaptic transmission;viral process;macroautophagy;epithelial cell differentiation;anion transmembrane transport;anion transport;regulation of mitophagy;inorganic anion transport;behavioral fear response;mitochondrial calcium ion transport;apoptotic process;learning;negative regulation of reactive oxygen species metabolic process	GO:000609; GO:000727; GO:001603; GO:001623; GO:003085; GO:009865; GO:000682; GO:190314; GO:001569; GO:000166; GO:000685; GO:000691; GO:000761; GO:200037	mitochondrial permeability transition pore complex;membrane;nucleus;synaptic vesicle;mitochondrion;plasma membrane;extracellular exosome;mitochondrial outer membrane;membrane raft;pore complex;mitochondrial nucleoid	GO:000575; GO:001602; GO:000563; GO:000802; GO:000573; GO:000588; GO:007006; GO:000574; GO:004512; GO:004693; GO:004264	 Influenza A; Parkinson's disease; HTLV-I infection; cGMP-PKG signaling pathway	hsa0516; hsa0501; hsa0516; hsa0402	protein binding;macromolecular complex binding;voltage-gated anion channel activity;protein kinase binding;porin activity;ion channel binding;identical protein binding	GO:000551; GO:004487; GO:000830; GO:001990; GO:001528; GO:004432; GO:004280
XP_013845204.1;XP_013845203.1;XP_005656885.1;XP_005656884.1;NP_999126.1	XP_013845204.1;XP_013845203.1;XP_005656885.1;XP_005656884.1;NP_999126.1	XP_013845204.1 optineurin isoform X4 [Sus scrofa];XP_013845203.1 optineurin isoform X3 [Sus scrofa];XP_005656885.1 optineurin isoform X2 [Sus scrofa];XP_005656884.1 optineurin isoform X1 [Sus scrofa];NP_999126.1 optineurin [Sus scrofa]	10	10	10	40255000	35079000	30629000	22076000	31438000	27587000	32062000	29258000	39442000	28876000	24088000	31370000	0	19710000	31033000	27433000	21084000	29337000	NA	NA	NA	OPTN	OPTN;OPTN;OPTN;OPTN;OPTN	defense response to Gram-negative bacterium;Golgi ribbon formation;negative regulation of receptor recycling;protein localization to Golgi apparatus;positive regulation of xenophagy;autophagy;negative regulation of I-kappaB kinase/NF-kappaB signaling;G2/M transition of mitotic cell cycle;cellular response to unfolded protein;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;Golgi organization;innate immune response;signal transduction;cell death;positive regulation of autophagy;Golgi to plasma membrane protein transport	GO:005082; GO:009016; GO:000192; GO:003406; GO:190441; GO:000691; GO:004312; GO:000008; GO:003462; GO:006173; GO:000703; GO:004508; GO:000716; GO:000821; GO:001050; GO:004300	cytosol;autophagosome;Golgi apparatus;perinuclear region of cytoplasm;nucleoplasm;Golgi membrane;recycling endosome membrane;cytoplasm;trans-Golgi network;nucleus	GO:000582; GO:000577; GO:000579; GO:004847; GO:000565; GO:000013; GO:005503; GO:000573; GO:000580; GO:000563	"NA"	"NA"	identical protein binding;protein binding;metal ion binding;K63-linked polyubiquitin binding;protein binding, bridging;protein C-terminus binding;Rab GTPase binding;polyubiquitin binding	GO:004280; GO:000551; GO:004687; GO:007053; GO:003067; GO:000802; GO:001713; GO:003159
NP_999127.1	NP_999127.1	NP_999127.1 trifunctional enzyme subunit alpha, mitochondrial [Sus scrofa]	18	18	18	765180000	460620000	913680000	515650000	620830000	467230000	974770000	591030000	1232000000	753300000	595670000	513330000	506410000	554150000	645970000	675910000	543180000	489420000	NA	NA	NA	HADHA	HADHA;NA;NA;NA;NA	fatty acid beta-oxidation;response to drug;response to insulin	GO:000663; GO:004249; GO:003286	mitochondrial fatty acid beta-oxidation multienzyme complex;mitochondrial nucleoid;mitochondrial inner membrane;mitochondrion	GO:001650; GO:004264; GO:000574; GO:000573	 Tryptophan metabolism; Butanoate metabolism; Fatty acid metabolism; Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of unsaturated fatty acids; Biosynthesis of antibiotics; Fatty acid elongation; Fatty acid degradation; Lysine degradation; Propanoate metabolism; Carbon metabolism; beta-Alanine metabolism	hsa0038; hsa0065; hsa0121; hsa0028; hsa0110; hsa0104; hsa0113; hsa0006; hsa0007; hsa0031; hsa0064; hsa0120; hsa0041	fatty-acyl-CoA binding;protein binding;acetyl-CoA C-acetyltransferase activity;3-hydroxyacyl-CoA dehydrogenase activity;enoyl-CoA hydratase activity;long-chain-enoyl-CoA hydratase activity;NAD binding;macromolecular complex binding	GO:000006; GO:000551; GO:000398; GO:000385; GO:000430; GO:001650; GO:005128; GO:004487
XP_020956106.1;XP_020956105.1;XP_020956104.1;XP_013833955.2;NP_999129.1	XP_020956106.1;XP_020956105.1;XP_020956104.1;XP_013833955.2;NP_999129.1	XP_020956106.1 huntingtin isoform X4 [Sus scrofa];XP_020956105.1 huntingtin isoform X3 [Sus scrofa];XP_020956104.1 huntingtin isoform X2 [Sus scrofa];XP_013833955.2 huntingtin isoform X1 [Sus scrofa];NP_999129.1 huntingtin [Sus scrofa]	2	2	2	0	491550000	0	416140000	0	0	225280000	261600000	401860000	370840000	0	0	350120000	443240000	433460000	382620000	406980000	490500000	NA	NA	NA	HTT	HTT;HTT;HTT;HTT;HTT	retrograde vesicle-mediated transport, Golgi to ER;vocal learning;positive regulation of aggrephagy;protein destabilization;regulation of phosphoprotein phosphatase activity;regulation of cAMP-dependent protein kinase activity;establishment of mitotic spindle orientation;positive regulation of cilium assembly;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;positive regulation of apoptotic process;vesicle transport along microtubule;apoptotic process;Golgi organization;positive regulation of mitophagy;positive regulation of lipophagy;regulation of CAMKK-AMPK signaling cascade;negative regulation of extrinsic apoptotic signaling pathway	GO:000689; GO:004229; GO:190533; GO:003164; GO:004366; GO:200047; GO:000013; GO:004572; GO:003158; GO:004306; GO:004749; GO:000691; GO:000703; GO:190359; GO:190450; GO:190528; GO:200123	endoplasmic reticulum;nucleoplasm;cytoplasm;inclusion body;cytoplasmic vesicle membrane;macromolecular complex;perinuclear region of cytoplasm;autophagosome;axon;postsynaptic cytosol;cytosol;nucleus;centriole;Golgi apparatus	GO:000578; GO:000565; GO:000573; GO:001623; GO:003065; GO:003299; GO:004847; GO:000577; GO:003042; GO:009952; GO:000582; GO:000563; GO:000581; GO:000579	 Huntington's disease	hsa0501	p53 binding;profilin binding;heat shock protein binding;dynein intermediate chain binding;kinase binding;dynactin binding;protein binding;identical protein binding;ion channel binding;beta-tubulin binding	GO:000203; GO:000552; GO:003107; GO:004550; GO:001990; GO:003445; GO:000551; GO:004280; GO:004432; GO:004848
NP_999133.1;XP_013835739.1;XP_020919724.1	NP_999133.1;XP_013835739.1;XP_020919724.1	NP_999133.1 integrin beta-1 precursor [Sus scrofa];XP_013835739.1 integrin beta-1 isoform X2 [Sus scrofa];XP_020919724.1 integrin beta-1 isoform X1 [Sus scrofa]	19	19	19	542790000	861630000	703560000	810320000	536100000	643990000	571200000	884440000	632770000	769370000	692420000	1041600000	504600000	832670000	715410000	893130000	571150000	721970000	NA	NA	NA	ITGB1	ITGB1;ITGB1;ITGB1;NA;NA	G1/S transition of mitotic cell cycle;cell-matrix adhesion;viral entry into host cell;stress fiber assembly;mesodermal cell differentiation;positive regulation of protein localization to plasma membrane;integrin-mediated signaling pathway;cell-substrate adhesion;dendrite morphogenesis;cellular response to low-density lipoprotein particle stimulus;cell migration involved in sprouting angiogenesis;phagocytosis;leukocyte cell-cell adhesion;transforming growth factor beta receptor signaling pathway;regulation of collagen catabolic process;leukocyte migration;positive regulation of protein kinase B signaling;visual learning;cell migration;B cell differentiation;receptor internalization;negative regulation of Rho protein signal transduction;negative regulation of cell differentiation;modulation of synaptic transmission;cytokine-mediated signaling pathway;formation of radial glial scaffolds;cell projection organization;cell adhesion mediated by integrin;cell-cell adhesion mediated by integrin;positive regulation of angiogenesis;in utero embryonic development;cellular defense response;germ cell migration;heterotypic cell-cell adhesion;positive regulation of apoptotic process;regulation of immune response;positive regulation of receptor activity;regulation of cell cycle;positive regulation of cell proliferation;extracellular matrix organization;positive regulation of GTPase activity;sarcomere organization;axon extension;basement membrane organization;negative regulation of anoikis;cardiac muscle cell differentiation	GO:000008; GO:000716; GO:004671; GO:004314; GO:004833; GO:190307; GO:000722; GO:003158; GO:004881; GO:007140; GO:000204; GO:000690; GO:000715; GO:000717; GO:001071; GO:005090; GO:005189; GO:000854; GO:001647; GO:003018; GO:003162; GO:003502; GO:004559; GO:005080; GO:001922; GO:002194; GO:003003; GO:003362; GO:003363; GO:004576; GO:000170; GO:000696; GO:000835; GO:003411; GO:004306; GO:005077; GO:200027; GO:005172; GO:000828; GO:003019; GO:004354; GO:004521; GO:004867; GO:007171; GO:200081; GO:005500	cytoplasm;lamellipodium;neuromuscular junction;integrin alpha8-beta1 complex;integrin alpha10-beta1 complex;membrane raft;myelin sheath abaxonal region;melanosome;dendritic spine;integrin complex;focal adhesion;intercalated disc;sarcolemma;receptor complex;glial cell projection;integrin alpha1-beta1 complex;Schaffer collateral - CA1 synapse;plasma membrane;glutamatergic synapse;ruffle;membrane;perinuclear region of cytoplasm;extracellular exosome;cleavage furrow;ruffle membrane;external side of plasma membrane;cell surface;filopodium;recycling endosome;invadopodium membrane	GO:000573; GO:003002; GO:003159; GO:003467; GO:003468; GO:004512; GO:003574; GO:004247; GO:004319; GO:000830; GO:000592; GO:001470; GO:004238; GO:004323; GO:009738; GO:003466; GO:009868; GO:000588; GO:009897; GO:000172; GO:001602; GO:004847; GO:007006; GO:003215; GO:003258; GO:000989; GO:000998; GO:003017; GO:005503; GO:007143	 Focal adhesion; Leukocyte transendothelial migration; Shigellosis; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Regulation of actin cytoskeleton; Rap1 signaling pathway; Cell adhesion molecules (CAMs); Pathways in cancer; Bacterial invasion of epithelial cells; Small cell lung cancer; PI3K-Akt signaling pathway; Leishmaniasis; Axon guidance; Platelet activation; Phagosome	hsa0451; hsa0467; hsa0513; hsa0541; hsa0481; hsa0401; hsa0451; hsa0520; hsa0510; hsa0522; hsa0415; hsa0514; hsa0436; hsa0461; hsa0414	cadherin binding;collagen binding involved in cell-matrix adhesion;laminin binding;protease binding;metal ion binding;protein heterodimerization activity;actin binding;integrin binding;macromolecular complex binding;fibronectin binding;coreceptor activity;protein binding;virus receptor activity;cell adhesion molecule binding;C-X3-C chemokine binding	GO:004529; GO:009863; GO:004323; GO:000202; GO:004687; GO:004698; GO:000377; GO:000517; GO:004487; GO:000196; GO:001502; GO:000551; GO:000161; GO:005083; GO:001996
XP_020927747.1;XP_020927746.1;XP_020927745.1;XP_020927744.1;XP_020927743.1;XP_020927741.1;XP_020927740.1;NP_999136.1;XP_020927739.1;CON__P17697	XP_020927747.1;XP_020927746.1;XP_020927745.1;XP_020927744.1;XP_020927743.1;XP_020927741.1;XP_020927740.1;NP_999136.1;XP_020927739.1	XP_020927747.1 clusterin isoform X2 [Sus scrofa];XP_020927746.1 clusterin isoform X2 [Sus scrofa];XP_020927745.1 clusterin isoform X2 [Sus scrofa];XP_020927744.1 clusterin isoform X2 [Sus scrofa];XP_020927743.1 clusterin isoform X2 [Sus scrofa];XP_02092774	15	15	15	238010000	185070000	200060000	206860000	233800000	282240000	240050000	146530000	256030000	195650000	231800000	164970000	226300000	143110000	205870000	134320000	238810000	190710000	NA	NA	NA	CLU	CLU;CLU;CLU;CLU;CLU	cell morphogenesis;platelet degranulation;protein stabilization;positive regulation of protein homooligomerization;positive regulation of receptor-mediated endocytosis;regulation of neuron death;negative regulation of cellular response to thapsigargin;release of cytochrome c from mitochondria;innate immune response;response to misfolded protein;response to virus;central nervous system myelin maintenance;reverse cholesterol transport;positive regulation of nitric oxide biosynthetic process;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of beta-amyloid formation;negative regulation of response to endoplasmic reticulum stress;negative regulation of amyloid fibril formation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of tau-protein kinase activity;microglial cell activation;complement activation, classical pathway;protein import;regulation of cell proliferation;positive regulation of neurofibrillary tangle assembly;chaperone-mediated protein complex assembly;positive regulation of gene expression;regulation of complement activation;positive regulation of tumor necrosis factor production;positive regulation of apoptotic process;positive regulation of NF-kappaB transcription factor activity;negative regulation of cell death;microglial cell proliferation;chaperone-mediated protein transport involved in chaperone-mediated autophagy;positive regulation of beta-amyloid formation;chaperone-mediated protein folding;negative regulation of release of cytochrome c from mitochondria;regulation of beta-amyloid clearance;regulation of neuronal signal transduction;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;antimicrobial humoral response;lipid metabolic process	GO:000090; GO:000257; GO:005082; GO:003246; GO:004826; GO:190121; GO:190589; GO:000183; GO:004508; GO:005178; GO:000961; GO:003228; GO:004369; GO:004542; GO:190223; GO:190243; GO:190357; GO:190590; GO:003243; GO:190294; GO:000177; GO:000695; GO:001703; GO:004212; GO:190299; GO:005113; GO:001062; GO:003044; GO:003276; GO:004306; GO:005109; GO:006054; GO:006151; GO:006174; GO:190200; GO:006107; GO:009020; GO:190022; GO:190284; GO:200006; GO:001973; GO:000662	extracellular region;intracellular membrane-bounded organelle;cell periphery;neurofibrillary tangle;extracellular space;Golgi apparatus;synapse;perinuclear region of cytoplasm;platelet alpha granule lumen;blood microparticle;perinuclear endoplasmic reticulum lumen;membrane;cytoskeleton;cell surface;nucleus;apical dendrite;mitochondrion;cytosol;macromolecular complex;chromaffin granule;mitochondrial inner membrane;spherical high-density lipoprotein particle;extracellular exosome	GO:000557; GO:004323; GO:007194; GO:009741; GO:000561; GO:000579; GO:004520; GO:004847; GO:003109; GO:007256; GO:009902; GO:001602; GO:000585; GO:000998; GO:000563; GO:009744; GO:000573; GO:000582; GO:003299; GO:004258; GO:000574; GO:003436; GO:007006	"NA"	"NA"	protein binding;chaperone binding;low-density lipoprotein particle receptor binding;ATPase activity;misfolded protein binding;macromolecular complex binding;ubiquitin protein ligase binding;tau protein binding;beta-amyloid binding	GO:000551; GO:005108; GO:005075; GO:001688; GO:005178; GO:004487; GO:003162; GO:004815; GO:000154
NP_999138.1	NP_999138.1	NP_999138.1 heat shock protein HSP 90-alpha [Sus scrofa]	35	35	20	3518400000	2680400000	3579300000	2054600000	3463200000	2746700000	3273400000	2444600000	2980000000	2105000000	3434800000	2431200000	3444100000	2418100000	2952400000	2108500000	3322500000	2453200000	NA	NA	NA	HSP90AA1	HSP90AA1;NA;NA;NA;NA	regulation of protein ubiquitination;positive regulation of tau-protein kinase activity;positive regulation of cellular protein catabolic process;positive regulation of protein phosphorylation;chaperone-mediated protein complex assembly;mitochondrial transport;receptor-mediated endocytosis;regulation of G2/M transition of mitotic cell cycle;positive regulation of peptidyl-serine phosphorylation;protein unfolding;vascular endothelial growth factor receptor signaling pathway;regulation of nitric-oxide synthase activity;ciliary basal body docking;response to antibiotic;cytokine-mediated signaling pathway;cellular response to heat;telomerase holoenzyme complex assembly;response to unfolded protein;central nervous system neuron axonogenesis;telomere maintenance via telomerase;neutrophil degranulation;response to heat;protein stabilization;positive regulation of nitric oxide biosynthetic process;positive regulation of protein kinase B signaling;positive regulation of telomerase activity;regulation of cellular response to heat;regulation of cellular protein localization;protein refolding;establishment of cell polarity;peptidyl-tyrosine phosphorylation;Fc-gamma receptor signaling pathway involved in phagocytosis;ERBB2 signaling pathway;protein import into mitochondrial outer membrane;axon extension;cofactor metabolic process;chaperone-mediated autophagy;G2/M transition of mitotic cell cycle;signal transduction;positive regulation of protein polymerization;regulation of protein complex assembly	GO:003139; GO:190294; GO:190336; GO:000193; GO:005113; GO:000683; GO:000689; GO:001038; GO:003313; GO:004333; GO:004801; GO:005099; GO:009771; GO:004667; GO:001922; GO:003460; GO:190532; GO:000698; GO:002195; GO:000700; GO:004331; GO:000940; GO:005082; GO:004542; GO:005189; GO:005197; GO:190003; GO:190382; GO:004202; GO:003001; GO:001810; GO:003809; GO:003812; GO:004504; GO:004867; GO:005118; GO:006168; GO:000008; GO:000716; GO:003227; GO:004325	plasma membrane;nucleus;lysosomal lumen;axonal growth cone;extracellular exosome;cytoplasm;secretory granule lumen;ficolin-1-rich granule lumen;extracellular region;nucleoplasm;cell surface;melanosome;membrane;neuronal cell body;endocytic vesicle lumen;cytosol;macromolecular complex;perinuclear region of cytoplasm	GO:000588; GO:000563; GO:004320; GO:004429; GO:007006; GO:000573; GO:003477; GO:190481; GO:000557; GO:000565; GO:000998; GO:004247; GO:001602; GO:004302; GO:007168; GO:000582; GO:003299; GO:004847	 Protein processing in endoplasmic reticulum; Progesterone-mediated oocyte maturation; PI3K-Akt signaling pathway; NOD-like receptor signaling pathway; Pathways in cancer; Antigen processing and presentation; Prostate cancer	hsa0414; hsa0491; hsa0415; hsa0462; hsa0520; hsa0461; hsa0521	histone deacetylase binding;ATPase activity, coupled;ATP binding;identical protein binding;GTPase binding;scaffold protein binding;unfolded protein binding;DNA polymerase binding;protein tyrosine kinase activity;TPR domain binding;ubiquitin protein ligase binding;nucleotide binding;ATPase activity;nitric-oxide synthase regulator activity;disordered domain specific binding;MHC class II protein complex binding;tau protein binding;protein binding;RNA binding;protein tyrosine kinase binding	GO:004282; GO:004262; GO:000552; GO:004280; GO:005102; GO:009711; GO:005108; GO:007018; GO:000471; GO:003091; GO:003162; GO:000016; GO:001688; GO:003023; GO:009771; GO:002302; GO:004815; GO:000551; GO:000372; GO:199078
NP_999139.1	NP_999139.1	NP_999139.1 myelin proteolipid protein [Sus scrofa]	3	3	3	0	73502000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PLP1	PLP1;NA;NA;NA;NA	astrocyte development;neuron projection development;myelination;long-chain fatty acid biosynthetic process;axon ensheathment;axon development;inflammatory response;integrin-mediated signaling pathway;positive regulation of gene expression;substantia nigra development;central nervous system myelination;chemical synaptic transmission;glial cell differentiation	GO:001400; GO:003117; GO:004255; GO:004275; GO:000836; GO:006156; GO:000695; GO:000722; GO:001062; GO:002176; GO:002201; GO:000726; GO:001000	plasma membrane;myelin sheath;integral component of membrane	GO:000588; GO:004320; GO:001602	"NA"	"NA"	protein binding;structural molecule activity;structural constituent of myelin sheath	GO:000551; GO:000519; GO:001991
XP_020952021.1;NP_999143.1	XP_020952021.1;NP_999143.1	XP_020952021.1 beta-2-microglobulin [Sus scrofa];NP_999143.1 beta-2-microglobulin precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12164000	0	NA	NA	NA	B2M	B2M;B2M;NA;NA;NA	response to molecule of bacterial origin;positive regulation of T cell cytokine production;antigen processing and presentation of endogenous peptide antigen via MHC class I;positive regulation of receptor-mediated endocytosis;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;cellular protein metabolic process;innate immune response;positive regulation of transferrin receptor binding;regulation of iron ion transport;positive regulation of protein binding;regulation of immune response;positive regulation of T cell mediated cytotoxicity;iron ion transport;response to drug;response to cadmium ion;positive regulation of receptor binding;retina homeostasis;antigen processing and presentation of peptide antigen via MHC class I;regulation of erythrocyte differentiation;regulation of defense response to virus by virus;interferon-gamma-mediated signaling pathway;cellular response to iron ion;negative regulation of neuron projection development;T cell differentiation in thymus;protein refolding;neutrophil degranulation;iron ion homeostasis	GO:000223; GO:000272; GO:001988; GO:004826; GO:000248; GO:004426; GO:004508; GO:190443; GO:003475; GO:003209; GO:005077; GO:000191; GO:000682; GO:004249; GO:004668; GO:190012; GO:000189; GO:000247; GO:004564; GO:005069; GO:006033; GO:007128; GO:001097; GO:003307; GO:004202; GO:004331; GO:005507	MHC class I protein complex;cytosol;extracellular space;endoplasmic reticulum lumen;Golgi apparatus;phagocytic vesicle membrane;external side of plasma membrane;ER to Golgi transport vesicle membrane;HFE-transferrin receptor complex;plasma membrane;early endosome membrane;specific granule lumen;tertiary granule lumen;Golgi membrane;membrane;recycling endosome membrane;focal adhesion;extracellular exosome;extracellular region	GO:004261; GO:000582; GO:000561; GO:000578; GO:000579; GO:003067; GO:000989; GO:001250; GO:199071; GO:000588; GO:003190; GO:003558; GO:190472; GO:000013; GO:001602; GO:005503; GO:000592; GO:007006; GO:000557	 Antigen processing and presentation	hsa0461	protein binding;identical protein binding	GO:000551; GO:004280
NP_999144.1	NP_999144.1	NP_999144.1 fructose-1,6-bisphosphatase 1 [Sus scrofa]	9	9	9	91826000	113530000	88186000	121080000	121390000	151740000	83915000	77368000	107010000	85942000	110770000	126760000	151500000	125590000	91733000	71010000	123320000	152420000	NA	NA	NA	FBP1	FBP1;NA;NA;NA;NA	regulation of gluconeogenesis;fructose 6-phosphate metabolic process;sucrose biosynthetic process;gluconeogenesis;cellular response to drug;dephosphorylation;fructose 1,6-bisphosphate metabolic process;negative regulation of transcription from RNA polymerase II promoter;negative regulation of cell growth;negative regulation of glycolytic process;protein homotetramerization;cellular response to magnesium ion;negative regulation of Ras protein signal transduction	GO:000611; GO:000600; GO:000598; GO:000609; GO:003569; GO:001631; GO:003038; GO:000012; GO:003030; GO:004582; GO:005128; GO:007128; GO:004658	nucleus;cytoplasm;cytosol;extracellular exosome	GO:000563; GO:000573; GO:000582; GO:007006	 Pentose phosphate pathway; Glycolysis / Gluconeogenesis; Fructose and mannose metabolism; Biosynthesis of antibiotics; AMPK signaling pathway; Insulin signaling pathway; Carbon metabolism; Metabolic pathways; Glucagon signaling pathway	hsa0003; hsa0001; hsa0005; hsa0113; hsa0415; hsa0491; hsa0120; hsa0110; hsa0492	identical protein binding;fructose 1,6-bisphosphate 1-phosphatase activity;metal ion binding;monosaccharide binding;protein binding;AMP binding	GO:004280; GO:004213; GO:004687; GO:004802; GO:000551; GO:001620
NP_999147.1;XP_020924189.1;XP_020924188.1;XP_020924187.1	NP_999147.1;XP_020924189.1;XP_020924188.1;XP_020924187.1	NP_999147.1 leukocyte surface antigen CD47 precursor [Sus scrofa];XP_020924189.1 leukocyte surface antigen CD47 isoform X3 [Sus scrofa];XP_020924188.1 leukocyte surface antigen CD47 isoform X2 [Sus scrofa];XP_020924187.1 leukocyte surface antigen CD47 isof	5	5	5	91905000	98101000	92513000	93528000	90147000	93022000	87500000	100590000	100730000	126570000	103960000	101460000	118570000	88290000	104060000	143260000	93076000	90554000	NA	NA	NA	CD47	CD47;CD47;CD47;CD47;NA	response to bacterium;regulation of interleukin-6 production;regulation of nitric oxide biosynthetic process;positive regulation of inflammatory response;cellular response to interferon-gamma;positive regulation of phagocytosis;heterotypic cell-cell adhesion;neutrophil degranulation;positive regulation of cell proliferation;regulation of interleukin-12 production;positive regulation of cell-cell adhesion;regulation of interferon-gamma production;positive regulation of T cell activation;opsonization;extracellular matrix organization;monocyte extravasation;positive regulation of stress fiber assembly;integrin-mediated signaling pathway;regulation of tumor necrosis factor production;negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;cell migration;leukocyte migration	GO:000961; GO:003267; GO:004542; GO:005072; GO:007134; GO:005076; GO:003411; GO:004331; GO:000828; GO:003265; GO:002240; GO:003264; GO:005087; GO:000822; GO:003019; GO:003569; GO:005149; GO:000722; GO:003268; GO:190545; GO:001647; GO:005090	extracellular exosome;plasma membrane;specific granule membrane;cell surface;tertiary granule membrane	GO:007006; GO:000588; GO:003557; GO:000998; GO:007082	 ECM-receptor interaction	hsa0451	protein binding involved in heterotypic cell-cell adhesion;protein binding;protein binding involved in cell-cell adhesion;thrombospondin receptor activity	GO:008608; GO:000551; GO:009863; GO:007005
XP_013836293.1;NP_999148.1;XP_020921870.1;XP_020921869.1;XP_005668738.1;XP_020921868.1;XP_020921867.1;NP_001171384.1	XP_013836293.1;NP_999148.1;XP_020921870.1;XP_020921869.1;XP_005668738.1;XP_020921868.1;XP_020921867.1	XP_013836293.1 26S protease regulatory subunit 8 isoform X5 [Sus scrofa];NP_999148.1 26S proteasome regulatory subunit 8 [Sus scrofa];XP_020921870.1 26S protease regulatory subunit 8 isoform X3 [Sus scrofa];XP_020921869.1 26S protease regulatory subunit 8	10	10	10	51344000	31340000	40639000	47496000	52997000	34121000	41829000	36283000	43683000	49451000	48709000	61517000	41589000	40764000	43984000	42412000	36573000	31962000	NA	NA	NA	PSMC5	PSMC5;PSMC5;PSMC5;PSMC5;PSMC5	modulation of synaptic transmission;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-templated;positive regulation of proteasomal protein catabolic process;protein deubiquitination;positive regulation of inclusion body assembly;negative regulation of programmed cell death	GO:005080; GO:004316; GO:004368; GO:000635; GO:004589; GO:190180; GO:001657; GO:009026; GO:004306	nucleoplasm;proteasome accessory complex;blood microparticle;nucleus;inclusion body;membrane;nuclear proteasome complex;postsynapse;cytosol;proteasome complex;proteasome regulatory particle, base subcomplex;cytoplasmic vesicle;extracellular exosome;cytoplasm	GO:000565; GO:002262; GO:007256; GO:000563; GO:001623; GO:001602; GO:003159; GO:009879; GO:000582; GO:000050; GO:000854; GO:003141; GO:007006; GO:000573	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	transcription factor binding;ATP binding;TBP-class protein binding;ATPase activity;protein binding;proteasome-activating ATPase activity;thyrotropin-releasing hormone receptor binding	GO:000813; GO:000552; GO:001702; GO:001688; GO:000551; GO:003640; GO:003153
NP_999149.1;XP_003359058.1	NP_999149.1;XP_003359058.1	NP_999149.1 small ubiquitin-related modifier 2 precursor [Sus scrofa];XP_003359058.1 small ubiquitin-related modifier 3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76250000	NA	NA	NA	SUMO2	SUMO2;SUMO3;NA;NA;NA	protein sumoylation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of transcription from RNA polymerase II promoter	GO:001692; GO:003243; GO:004594	PML body;nucleus;nucleoplasm	GO:001660; GO:000563; GO:000565	 RNA transport	hsa0301	ubiquitin protein ligase binding;protein tag;ubiquitin-like protein ligase binding;RNA binding;protein binding;transcription corepressor binding;SUMO transferase activity	GO:003162; GO:003138; GO:004438; GO:000372; GO:000551; GO:000122; GO:001978
NP_999151.1;XP_013833090.2	NP_999151.1;XP_013833090.2	NP_999151.1 myocilin precursor [Sus scrofa];XP_013833090.2 myocilin isoform X1 [Sus scrofa]	8	8	8	0	98143000	0	42927000	0	37838000	0	50352000	0	66907000	0	32908000	0	0	0	0	0	53804000	NA	NA	NA	MYOC	MYOC;MYOC;NA;NA;NA	positive regulation of focal adhesion assembly;positive regulation of substrate adhesion-dependent cell spreading;osteoblast differentiation;negative regulation of cell-matrix adhesion;negative regulation of Rho protein signal transduction;positive regulation of stress fiber assembly;positive regulation of mitochondrial depolarization;bone development;skeletal muscle hypertrophy;non-canonical Wnt signaling pathway via JNK cascade;regulation of MAPK cascade;positive regulation of cell migration;ERBB2-ERBB3 signaling pathway;clustering of voltage-gated sodium channels;positive regulation of protein kinase B signaling;positive regulation of phosphatidylinositol 3-kinase signaling;myelination in peripheral nervous system;neuron projection development	GO:005189; GO:190002; GO:000164; GO:000195; GO:003502; GO:005149; GO:005190; GO:006034; GO:001473; GO:003803; GO:004340; GO:003033; GO:003813; GO:004516; GO:005189; GO:001406; GO:002201; GO:003117	cilium;mitochondrial inner membrane;endoplasmic reticulum;cytoplasmic vesicle;node of Ranvier;mitochondrial intermembrane space;extracellular exosome;Golgi apparatus;extracellular space	GO:000592; GO:000574; GO:000578; GO:003141; GO:003326; GO:000575; GO:007006; GO:000579; GO:000561	"NA"	"NA"	myosin light chain binding;fibronectin binding;receptor tyrosine kinase binding;frizzled binding;protein binding;metal ion binding	GO:003202; GO:000196; GO:003097; GO:000510; GO:000551; GO:004687
NP_999152.1;XP_003358728.2	NP_999152.1	NP_999152.1 60S ribosomal protein L22 [Sus scrofa]	6	6	6	52592000	93830000	102540000	116430000	84605000	87373000	68998000	90312000	50516000	107340000	90768000	81036000	49490000	149430000	74606000	114780000	83606000	104370000	NA	NA	NA	RPL22	RPL22;NA;NA;NA;NA	translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000641; GO:000641; GO:000661; GO:000018	cytosolic large ribosomal subunit;focal adhesion;cytosol;cytoplasm;extracellular exosome;nucleus;ribonucleoprotein complex	GO:002262; GO:000592; GO:000582; GO:000573; GO:007006; GO:000563; GO:199090	 Ribosome	hsa0301	heparin binding;RNA binding;protein binding;structural constituent of ribosome	GO:000820; GO:000372; GO:000551; GO:000373
NP_999159.1	NP_999159.1	NP_999159.1 dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor [Sus scrofa]	17	17	17	538850000	242650000	368330000	222070000	450490000	159120000	455000000	282320000	419650000	243970000	340980000	187280000	218600000	207640000	329330000	297900000	325250000	196990000	NA	NA	NA	DLAT	DLAT;NA;NA;NA;NA	sleep;glucose metabolic process;tricarboxylic acid cycle;acetyl-CoA biosynthetic process from pyruvate	GO:003043; GO:000600; GO:000609; GO:000608	mitochondrial matrix;mitochondrion;pyruvate dehydrogenase complex;mitochondrial pyruvate dehydrogenase complex	GO:000575; GO:000573; GO:004525; GO:000596	 Glycolysis / Gluconeogenesis; Pyruvate metabolism; Metabolic pathways; Carbon metabolism; Biosynthesis of antibiotics; Citrate cycle (TCA cycle)	hsa0001; hsa0062; hsa0110; hsa0120; hsa0113; hsa0002	pyruvate dehydrogenase (NAD+) activity;dihydrolipoyllysine-residue acetyltransferase activity;protein binding;identical protein binding	GO:003460; GO:000474; GO:000551; GO:004280
NP_999165.1;XP_005664416.1	NP_999165.1;XP_005664416.1	NP_999165.1 haptoglobin precursor [Sus scrofa];XP_005664416.1 haptoglobin isoform X1 [Sus scrofa]	20	20	20	1972500000	1572600000	1945400000	3200500000	10742000000	12732000000	2980300000	1785200000	1423900000	1097900000	3075800000	2558900000	2276500000	2154000000	2677300000	1549200000	1823700000	1808200000	NA	NA	NA	HP	HP;HP;NA;NA;NA	acute inflammatory response;defense response to bacterium;neutrophil degranulation;negative regulation of hydrogen peroxide catabolic process;response to organic substance;defense response;response to hydrogen peroxide;receptor-mediated endocytosis;negative regulation of oxidoreductase activity;cellular oxidant detoxification;proteolysis;positive regulation of cell death	GO:000252; GO:004274; GO:004331; GO:200029; GO:001003; GO:000695; GO:004254; GO:000689; GO:005135; GO:009886; GO:000650; GO:001094	specific granule lumen;haptoglobin-hemoglobin complex;extracellular exosome;blood microparticle;extracellular region;endocytic vesicle lumen;tertiary granule lumen;extracellular space	GO:003558; GO:003183; GO:007006; GO:007256; GO:000557; GO:007168; GO:190472; GO:000561	"NA"	"NA"	antioxidant activity;hemoglobin binding;protein binding;serine-type endopeptidase activity	GO:001620; GO:003049; GO:000551; GO:000425
NP_999166.1	NP_999166.1	NP_999166.1 transferrin receptor protein 1 [Sus scrofa]	5	5	5	0	0	5780900	0	4706700	0	2734100	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TFRC	TFRC;NA;NA;NA;NA	cellular iron ion homeostasis;viral entry into host cell;receptor internalization;transferrin transport;positive regulation of bone resorption;regulation of cell growth;regulation of cell proliferation;cellular response to leukemia inhibitory factor;positive regulation of B cell proliferation;iron ion transport;cellular response to drug;positive regulation of T cell proliferation;osteoclast differentiation;positive regulation of isotype switching;membrane organization	GO:000687; GO:004671; GO:003162; GO:003357; GO:004578; GO:000155; GO:004212; GO:199083; GO:003089; GO:000682; GO:003569; GO:004210; GO:003031; GO:004583; GO:006102	membrane;endosome membrane;clathrin-coated pit;extracellular region;endosome;external side of plasma membrane;basolateral plasma membrane;melanosome;extracellular exosome;HFE-transferrin receptor complex;plasma membrane;perinuclear region of cytoplasm;cell surface;cytoplasmic vesicle;recycling endosome;extracellular space;clathrin-coated vesicle membrane;blood microparticle;extracellular vesicle	GO:001602; GO:001000; GO:000590; GO:000557; GO:000576; GO:000989; GO:001632; GO:004247; GO:007006; GO:199071; GO:000588; GO:004847; GO:000998; GO:003141; GO:005503; GO:000561; GO:003066; GO:007256; GO:190356	 Hematopoietic cell lineage; Endocytosis; HIF-1 signaling pathway	hsa0464; hsa0414; hsa0406	virus receptor activity;transferrin receptor activity;transferrin transmembrane transporter activity;RNA binding;protein binding;protein homodimerization activity	GO:000161; GO:000499; GO:003357; GO:000372; GO:000551; GO:004280
NP_999170.1	NP_999170.1	NP_999170.1 osteoclast-stimulating factor 1 [Sus scrofa]	3	3	3	0	40149000	41691000	34116000	41342000	37471000	34148000	37081000	40786000	40130000	32308000	30292000	41681000	0	35457000	37439000	36540000	44785000	NA	NA	NA	OSTF1	OSTF1;NA;NA;NA;NA	neutrophil degranulation;ossification;signal transduction	GO:004331; GO:000150; GO:000716	secretory granule lumen;ficolin-1-rich granule lumen;extracellular region	GO:003477; GO:190481; GO:000557	"NA"	"NA"	protein binding;SH3 domain binding	GO:000551; GO:001712
NP_999171.1	NP_999171.1	NP_999171.1 CD9 antigen [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	157110000	NA	NA	NA	CD9	CD9;NA;NA;NA;NA	cell adhesion;fusion of sperm to egg plasma membrane;negative regulation of cell proliferation;oligodendrocyte development;response to water deprivation;sperm-egg recognition;cellular response to low-density lipoprotein particle stimulus;platelet degranulation;cell surface receptor signaling pathway;brain development;paranodal junction assembly;platelet activation;negative regulation of cellular component movement;receptor internalization;negative regulation of platelet aggregation	GO:000715; GO:000734; GO:000828; GO:001400; GO:000941; GO:003503; GO:007140; GO:000257; GO:000716; GO:000742; GO:003091; GO:003016; GO:005127; GO:003162; GO:009033	platelet alpha granule membrane;plasma membrane;membrane;extracellular vesicle;extracellular space;external side of plasma membrane;endocytic vesicle membrane;extracellular exosome;apical plasma membrane;focal adhesion	GO:003109; GO:000588; GO:001602; GO:190356; GO:000561; GO:000989; GO:003066; GO:007006; GO:001632; GO:000592	 Hematopoietic cell lineage	hsa0464	integrin binding;protein binding	GO:000517; GO:000551
NP_999172.1	NP_999172.1	NP_999172.1 epidermal growth factor receptor precursor [Sus scrofa]	6	6	6	0	0	0	8472400	0	0	0	7435900	0	0	0	12813000	9230300	10373000	0	10143000	0	11435000	NA	NA	NA	EGFR	EGFR;NA;NA;NA;NA	ossification;embryonic placenta development;positive regulation of protein phosphorylation;transmembrane receptor protein tyrosine kinase signaling pathway;epidermal growth factor receptor signaling pathway;learning or memory;diterpenoid metabolic process;viral entry into host cell;cellular response to amino acid stimulus;cell differentiation;positive regulation of peptidyl-serine phosphorylation;cellular response to reactive oxygen species;peptidyl-tyrosine autophosphorylation;ovulation cycle;positive regulation of bone resorption;protein autophosphorylation;astrocyte activation;positive regulation of epithelial cell proliferation;liver regeneration;cell-cell adhesion;activation of MAPKK activity;positive regulation of blood vessel diameter;peptidyl-tyrosine phosphorylation;positive regulation of superoxide anion generation;ERBB2 signaling pathway;positive regulation of MAP kinase activity;negative regulation of mitotic cell cycle;regulation of peptidyl-tyrosine phosphorylation;cellular response to dexamethasone stimulus;positive regulation of canonical Wnt signaling pathway;negative regulation of cardiocyte differentiation;translation;magnesium ion homeostasis;lung development;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of DNA replication;positive regulation of smooth muscle cell proliferation;response to calcium ion;eyelid development in camera-type eye;positive regulation of ERK1 and ERK2 cascade;cellular response to epidermal growth factor stimulus;cellular response to estradiol stimulus;negative regulation of ERBB signaling pathway;positive regulation of NIK/NF-kappaB signaling;salivary gland morphogenesis;response to cobalamin;wound healing;tongue development;regulation of JNK cascade;phosphatidylinositol phosphorylation;protein insertion into membrane;positive regulation of protein kinase C activity;positive regulation of G1/S transition of mitotic cell cycle;regulation of cell motility;regulation of transcription from RNA polymerase II promoter;activation of phospholipase C activity;negative regulation of apoptotic process;positive regulation of nitric oxide mediated signal transduction;regulation of phosphatidylinositol 3-kinase signaling;cerebral cortex cell migration;positive regulation of cell growth;positive regulation of transcription from RNA polymerase II promoter;cellular response to cadmium ion;positive regulation of production of miRNAs involved in gene silencing by miRNA;positive regulation of cell migration;positive regulation of DNA repair;positive regulation of vasoconstriction;positive regulation of protein kinase B signaling;morphogenesis of an epithelial fold;response to UV-A;positive regulation of protein localization to plasma membrane;hair follicle development;response to osmotic stress;circadian rhythm;cell proliferation;cellular response to mechanical stimulus;positive regulation of phosphorylation;hydrogen peroxide metabolic process;activation of phospholipase A2 activity by calcium-mediated signaling;digestive tract morphogenesis;neuron projection morphogenesis;positive regulation of inflammatory response;regulation of nitric-oxide synthase activity;positive regulation of prolactin secretion;MAPK cascade;midgut development;positive regulation of transcription, DNA-templated;negative regulation of protein catabolic process;positive regulation of synaptic transmission, glutamatergic	GO:000150; GO:000189; GO:000193; GO:000716; GO:000717; GO:000761; GO:001610; GO:004671; GO:007123; GO:003015; GO:003313; GO:003461; GO:003808; GO:004269; GO:004578; GO:004677; GO:004814; GO:005067; GO:009742; GO:009860; GO:000018; GO:009775; GO:001810; GO:003293; GO:003812; GO:004340; GO:004593; GO:005073; GO:007154; GO:009026; GO:190520; GO:000641; GO:001096; GO:003032; GO:004205; GO:004574; GO:004866; GO:005159; GO:006102; GO:007037; GO:007136; GO:007139; GO:190118; GO:190122; GO:000743; GO:003359; GO:004206; GO:004358; GO:004632; GO:004685; GO:005120; GO:190002; GO:190008; GO:200014; GO:000635; GO:000720; GO:004306; GO:001075; GO:001406; GO:002179; GO:003030; GO:004594; GO:007127; GO:190380; GO:003033; GO:004573; GO:004590; GO:005189; GO:006057; GO:007014; GO:190307; GO:000194; GO:000697; GO:000762; GO:000828; GO:007126; GO:004232; GO:004274; GO:004300; GO:004854; GO:004881; GO:005072; GO:005099; GO:190272; GO:000016; GO:000749; GO:004589; GO:004217; GO:005196	membrane;nucleus;cytoplasm;endosome;basolateral plasma membrane;nuclear membrane;synapse;Golgi membrane;clathrin-coated vesicle membrane;Shc-EGFR complex;multivesicular body, internal vesicle lumen;focal adhesion;early endosome membrane;perinuclear region of cytoplasm;integral component of plasma membrane;endosome membrane;endocytic vesicle;macromolecular complex;membrane raft;extracellular space;basal plasma membrane;cell surface;receptor complex;endoplasmic reticulum membrane	GO:001602; GO:000563; GO:000573; GO:000576; GO:001632; GO:003196; GO:004520; GO:000013; GO:003066; GO:007043; GO:009748; GO:000592; GO:003190; GO:004847; GO:000588; GO:001000; GO:003013; GO:003299; GO:004512; GO:000561; GO:000992; GO:000998; GO:004323; GO:000578	 Central carbon metabolism in cancer; MAPK signaling pathway; Estrogen signaling pathway; Endometrial cancer; FoxO signaling pathway; PI3K-Akt signaling pathway; Pathways in cancer; Choline metabolism in cancer; Epithelial cell signaling in Helicobacter pylori infection; Hepatitis C; Endocytosis; Regulation of actin cytoskeleton; Calcium signaling pathway; Dorso-ventral axis formation; Focal adhesion; Gap junction; Oxytocin signaling pathway; Adherens junction; Non-small cell lung cancer	hsa0523; hsa0401; hsa0491; hsa0521; hsa0406; hsa0415; hsa0520; hsa0523; hsa0512; hsa0516; hsa0414; hsa0481; hsa0402; hsa0432; hsa0451; hsa0454; hsa0492; hsa0452; hsa0522	protein binding;chromatin binding;actin filament binding;identical protein binding;enzyme binding;protein phosphatase binding;epidermal growth factor-activated receptor activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;epidermal growth factor binding;ubiquitin protein ligase binding;calmodulin binding;protein heterodimerization activity;MAP kinase kinase kinase activity;integrin binding;protein tyrosine kinase activity;virus receptor activity;double-stranded DNA binding;nitric-oxide synthase regulator activity;cadherin binding;transmembrane signaling receptor activity;Ras guanyl-nucleotide exchange factor activity;ATP binding	GO:000551; GO:000368; GO:005101; GO:004280; GO:001989; GO:001990; GO:000500; GO:004693; GO:004840; GO:003162; GO:000551; GO:004698; GO:000470; GO:000517; GO:000471; GO:000161; GO:000369; GO:003023; GO:004529; GO:000488; GO:000508; GO:000552
NP_999184.2	NP_999184.2	NP_999184.2 dehydrogenase/reductase SDR family member 4 [Sus scrofa]	10	10	10	499090000	175790000	914580000	244560000	217860000	161660000	363130000	218250000	804660000	288930000	249090000	186420000	147140000	207890000	216930000	180530000	198550000	175220000	NA	NA	NA	DHRS4	DHRS4;NA;NA;NA;NA	oxidation-reduction process;cellular ketone metabolic process;alcohol metabolic process;steroid metabolic process;protein targeting to peroxisome;protein tetramerization;retinol metabolic process	GO:005511; GO:004218; GO:000606; GO:000820; GO:000662; GO:005126; GO:004257	peroxisome;endoplasmic reticulum membrane;cytosol;nucleus;peroxisomal membrane;mitochondrion	GO:000577; GO:000578; GO:000582; GO:000563; GO:000577; GO:000573	 Metabolic pathways; Peroxisome; Retinol metabolism	hsa0110; hsa0414; hsa0083	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;NADP-retinol dehydrogenase activity;3-keto sterol reductase activity;receptor binding;alcohol dehydrogenase [NAD(P)+;carbonyl reductase (NADPH) activity	GO:001665; GO:005265; GO:000025; GO:000510; GO:001845; GO:000409
XP_020938343.1;XP_020938333.1;XP_020938322.1;XP_005659487.1;XP_005659486.1;NP_999186.1;XP_013848266.1;XP_020938293.1;XP_005659485.1;XP_013848265.1;XP_020938274.1;XP_013848264.1;XP_020938260.1;XP_020938253.1;XP_005659483.1;XP_020938238.1	XP_020938343.1;XP_020938333.1;XP_020938322.1;XP_005659487.1;XP_005659486.1;NP_999186.1;XP_013848266.1;XP_020938293.1;XP_005659485.1;XP_013848265.1;XP_020938274.1;XP_013848264.1;XP_020938260.1;XP_020938253.1;XP_005659483.1;XP_020938238.1	XP_020938343.1 unconventional myosin-VI isoform X9 [Sus scrofa];XP_020938333.1 unconventional myosin-VI isoform X9 [Sus scrofa];XP_020938322.1 unconventional myosin-VI isoform X8 [Sus scrofa];XP_005659487.1 unconventional myosin-VI isoform X8 [Sus scrofa];	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9297900	0	0	NA	NA	NA	MYO6	MYO6;MYO6;MYO6;MYO6;MYO6	endocytosis;DNA damage response, signal transduction by p53 class mediator;actin filament-based movement;regulation of secretion;positive regulation of transcription from RNA polymerase II promoter;intracellular protein transport;sensory perception of sound;response to drug	GO:000689; GO:003033; GO:003004; GO:005104; GO:004594; GO:000688; GO:000760; GO:004249	lysosomal membrane;plasma membrane;unconventional myosin complex;extracellular exosome;nucleus;cell cortex;membrane;clathrin-coated vesicle membrane;cytoplasmic vesicle;nuclear membrane;microvillus;filamentous actin;clathrin-coated endocytic vesicle;cytosol;nucleoplasm;Golgi apparatus;apical part of cell;endocytic vesicle;ruffle membrane;perinuclear region of cytoplasm;ruffle;cytoplasm;DNA-directed RNA polymerase II, holoenzyme	GO:000576; GO:000588; GO:001646; GO:007006; GO:000563; GO:000593; GO:001602; GO:003066; GO:003141; GO:003196; GO:000590; GO:003194; GO:004533; GO:000582; GO:000565; GO:000579; GO:004517; GO:003013; GO:003258; GO:004847; GO:000172; GO:000573; GO:001659	"NA"	"NA"	actin binding;minus-end directed microfilament motor activity;calmodulin binding;ATP binding;motor activity;ADP binding;actin filament binding	GO:000377; GO:006000; GO:000551; GO:000552; GO:000377; GO:004353; GO:005101
NP_999189.1	NP_999189.1	NP_999189.1 serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform [Sus scrofa]	19	19	14	288550000	292460000	254820000	212900000	270900000	248860000	209580000	267240000	290480000	260150000	221840000	316700000	273880000	260000000	229810000	255640000	241760000	274190000	NA	NA	NA	PPP2R1A	PPP2R1A;NA;NA;NA;NA	apoptotic process;protein dephosphorylation;female meiotic division;negative regulation of cell growth;regulation of growth;mitotic sister chromatid separation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;macromolecular complex assembly;RNA splicing;regulation of phosphoprotein phosphatase activity;G2/M transition of mitotic cell cycle;regulation of transcription, DNA-templated;regulation of meiotic cell cycle process involved in oocyte maturation;chromosome segregation;ceramide metabolic process;response to organic substance;regulation of G2/M transition of mitotic cell cycle;second-messenger-mediated signaling;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;meiotic sister chromatid cohesion, centromeric;peptidyl-serine dephosphorylation;regulation of DNA replication;regulation of Wnt signaling pathway;ciliary basal body docking;regulation of cell adhesion;negative regulation of tyrosine phosphorylation of STAT protein;regulation of cell differentiation;meiotic spindle elongation	GO:000691; GO:000647; GO:000714; GO:003030; GO:004000; GO:005130; GO:000018; GO:006500; GO:000838; GO:004366; GO:000008; GO:000635; GO:190353; GO:000705; GO:000667; GO:001003; GO:001038; GO:001993; GO:200124; GO:005175; GO:007026; GO:000627; GO:003011; GO:009771; GO:003015; GO:004253; GO:004559; GO:005123	nucleus;cytoplasm;chromosome, centromeric region;protein phosphatase type 2A complex;cytosol;extracellular exosome;dendrite;membrane;microtubule cytoskeleton;lateral plasma membrane;glutamatergic synapse	GO:000563; GO:000573; GO:000077; GO:000015; GO:000582; GO:007006; GO:003042; GO:001602; GO:001563; GO:001632; GO:009897	 Dopaminergic synapse; Oocyte meiosis; PI3K-Akt signaling pathway; Adrenergic signaling in cardiomyocytes; Sphingolipid signaling pathway; Chagas disease (American trypanosomiasis); Tight junction; Long-term depression; mRNA surveillance pathway; TGF-beta signaling pathway; Hippo signaling pathway; Hepatitis C	hsa0472; hsa0411; hsa0415; hsa0426; hsa0407; hsa0514; hsa0453; hsa0473; hsa0301; hsa0435; hsa0439; hsa0516	protein serine/threonine phosphatase activity;protein antigen binding;protein binding;protein heterodimerization activity;protein phosphatase regulator activity	GO:000472; GO:199040; GO:000551; GO:004698; GO:001988
XP_020921872.1;XP_005656989.1;NP_999191.1	XP_020921872.1;XP_005656989.1;NP_999191.1	XP_020921872.1 cAMP-dependent protein kinase type I-alpha regulatory subunit isoform X1 [Sus scrofa];XP_005656989.1 cAMP-dependent protein kinase type I-alpha regulatory subunit isoform X1 [Sus scrofa];NP_999191.1 cAMP-dependent protein kinase type I-alpha	8	8	8	0	28235000	22585000	21114000	19468000	27079000	15883000	25412000	18282000	24930000	26604000	27957000	39577000	18756000	0	27703000	19024000	21611000	NA	NA	NA	PRKAR1A	PRKAR1A;PRKAR1A;PRKAR1A;NA;NA	cGMP-mediated signaling;negative regulation of activated T cell proliferation;renal water homeostasis;female meiotic division;sarcomere organization;negative regulation of meiotic nuclear division;negative regulation of cAMP-dependent protein kinase activity;blood coagulation;activation of protein kinase A activity;cellular response to glucagon stimulus;intracellular signal transduction;regulation of transcription from RNA polymerase II promoter;cardiac muscle cell proliferation;mesoderm formation	GO:001993; GO:004600; GO:000309; GO:000714; GO:004521; GO:004583; GO:200048; GO:000759; GO:003419; GO:007137; GO:003555; GO:000635; GO:006003; GO:000170	immunological synapse;membrane;nucleotide-activated protein kinase complex;ciliary base;cAMP-dependent protein kinase complex;plasma membrane raft;cytosol;cytoplasm;neuromuscular junction;macromolecular complex;axoneme;glutamatergic synapse	GO:000177; GO:001602; GO:003158; GO:009754; GO:000595; GO:004485; GO:000582; GO:000573; GO:003159; GO:003299; GO:000593; GO:009897	 Apoptosis; Insulin signaling pathway	hsa0421; hsa0491	protein kinase A catalytic subunit binding;3',5'-cyclic-GMP phosphodiesterase activity;protein binding;cAMP-dependent protein kinase regulator activity;cAMP-dependent protein kinase inhibitor activity;protein domain specific binding;cAMP binding;ubiquitin protein ligase binding	GO:003423; GO:004755; GO:000551; GO:000860; GO:000486; GO:001990; GO:003055; GO:003162
XP_020927759.1;XP_020927758.1;XP_020927757.1;XP_020927756.1;XP_005670939.1;NP_999195.1	XP_020927759.1;XP_020927758.1;XP_020927757.1;XP_020927756.1;XP_005670939.1;NP_999195.1	XP_020927759.1 gamma-glutamyltranspeptidase 1 isoform X2 [Sus scrofa];XP_020927758.1 gamma-glutamyltranspeptidase 1 isoform X1 [Sus scrofa];XP_020927757.1 gamma-glutamyltranspeptidase 1 isoform X1 [Sus scrofa];XP_020927756.1 gamma-glutamyltranspeptidase 1	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27240000	0	NA	NA	NA	GGT1	GGT1;GGT1;GGT1;GGT1;GGT1	spermatogenesis;regulation of inflammatory response;regulation of immune system process;proteolysis;fatty acid metabolic process;response to estradiol;leukotriene D4 biosynthetic process;glutathione biosynthetic process;xenobiotic metabolic process;peptide modification;translation;cellular amino acid metabolic process;glutamate metabolic process;cysteine biosynthetic process;glutathione metabolic process;leukotriene metabolic process;zymogen activation;response to tumor necrosis factor;response to lipopolysaccharide	GO:000728; GO:005072; GO:000268; GO:000650; GO:000663; GO:003235; GO:190175; GO:000675; GO:000680; GO:003117; GO:000641; GO:000652; GO:000653; GO:001934; GO:000674; GO:000669; GO:003163; GO:003461; GO:003249	integral component of membrane;plasma membrane;extracellular space;extracellular exosome	GO:001602; GO:000588; GO:000561; GO:007006	 Metabolic pathways; Glutathione metabolism; Arachidonic acid metabolism; Taurine and hypotaurine metabolism; Cyanoamino acid metabolism	hsa0110; hsa0048; hsa0059; hsa0043; hsa0046	glutathione hydrolase activity;protein binding;leukotriene-C(4) hydrolase;peptidyltransferase activity	GO:003637; GO:000551; GO:000295; GO:000004
NP_999204.1	NP_999204.1	NP_999204.1 medium-chain specific acyl-CoA dehydrogenase, mitochondrial precursor [Sus scrofa]	10	10	10	151030000	67849000	90666000	59060000	121050000	48809000	96214000	70785000	103040000	77275000	51381000	65280000	50123000	68252000	87293000	69167000	73526000	60195000	NA	NA	NA	ACADM	ACADM;NA;NA;NA;NA	carnitine metabolic process, CoA-linked;fatty acid beta-oxidation;medium-chain fatty acid catabolic process;oxidation-reduction process;regulation of lipid metabolic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase;carnitine biosynthetic process	GO:001925; GO:000663; GO:005179; GO:005511; GO:001921; GO:003353; GO:004532	nucleus;nuclear speck;axon;mitochondrial membrane;mitochondrial matrix;mitochondrion	GO:000563; GO:001660; GO:003042; GO:003196; GO:000575; GO:000573	 Propanoate metabolism; beta-Alanine metabolism; Fatty acid metabolism; Carbon metabolism; PPAR signaling pathway; Fatty acid degradation; Metabolic pathways; Biosynthesis of antibiotics; Valine, leucine and isoleucine degradation	hsa0064; hsa0041; hsa0121; hsa0120; hsa0332; hsa0007; hsa0110; hsa0113; hsa0028	identical protein binding;medium-chain-acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding;acyl-CoA dehydrogenase activity	GO:004280; GO:007099; GO:005066; GO:000399
NP_999209.1;XP_020944355.1	NP_999209.1;XP_020944355.1	NP_999209.1 dihydropyrimidine dehydrogenase [NADP(+)] precursor [Sus scrofa];XP_020944355.1 dihydropyrimidine dehydrogenase [NADP(+)] isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24368000	0	0	NA	NA	NA	DPYD	DPYD;DPYD;NA;NA;NA	oxidation-reduction process;uracil catabolic process;purine nucleobase catabolic process;pyrimidine nucleobase catabolic process;beta-alanine biosynthetic process;pyrimidine nucleoside catabolic process	GO:005511; GO:000621; GO:000614; GO:000620; GO:001948; GO:004613	cytosol;cytoplasm	GO:000582; GO:000573	 Drug metabolism - other enzymes; Pantothenate and CoA biosynthesis; Metabolic pathways; beta-Alanine metabolism; Pyrimidine metabolism	hsa0098; hsa0077; hsa0110; hsa0041; hsa0024	metal ion binding;protein homodimerization activity;flavin adenine dinucleotide binding;uracil binding;dihydrouracil dehydrogenase (NAD+) activity;dihydropyrimidine dehydrogenase (NADP+) activity;4 iron, 4 sulfur cluster binding;protein binding;NADH dehydrogenase activity	GO:004687; GO:004280; GO:005066; GO:000205; GO:000415; GO:001711; GO:005153; GO:000551; GO:000395
NP_999215.1	NP_999215.1	NP_999215.1 glutathione S-transferase omega-1 [Sus scrofa]	13	13	13	325530000	228170000	273790000	229930000	310640000	218640000	246690000	210620000	293090000	216270000	302100000	248410000	266250000	218370000	283370000	228870000	259280000	247640000	NA	NA	NA	GSTO1	GSTO1;NA;NA;NA;NA	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;glutathione derivative biosynthetic process;xenobiotic catabolic process;oxidation-reduction process;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;methylation;interleukin-12-mediated signaling pathway;positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;L-ascorbic acid metabolic process;negative regulation of ryanodine-sensitive calcium-release channel activity;cellular response to arsenic-containing substance;cellular oxidant detoxification	GO:001088; GO:190168; GO:004217; GO:005511; GO:001088; GO:003225; GO:003572; GO:001481; GO:001985; GO:006031; GO:007124; GO:009886	cytoplasm;extracellular exosome;cytosol	GO:000573; GO:007006; GO:000582	 Glutathione metabolism; Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis	hsa0048; hsa0098; hsa0520	protein binding;oxidoreductase activity;methylarsonate reductase activity;glutathione transferase activity;glutathione dehydrogenase (ascorbate) activity	GO:000551; GO:001649; GO:005061; GO:000436; GO:004517
NP_999219.1	NP_999219.1	NP_999219.1 tissue-type plasminogen activator precursor [Sus scrofa]	7	7	7	0	0	0	0	0	0	0	0	0	0	0	0	0	20480000	0	20174000	0	15757000	NA	NA	NA	PLAT	PLAT;NA;NA;NA;NA	smooth muscle cell migration;response to hypoxia;platelet-derived growth factor receptor signaling pathway;blood coagulation;cellular protein modification process;plasminogen activation;proteolysis;fibrinolysis;negative regulation of proteolysis	GO:001490; GO:000166; GO:004800; GO:000759; GO:000646; GO:003163; GO:000650; GO:004273; GO:004586	apical part of cell;extracellular exosome;cytoplasm;secretory granule;glutamatergic synapse;Schaffer collateral - CA1 synapse;extracellular region;extracellular space;cell surface	GO:004517; GO:007006; GO:000573; GO:003014; GO:009897; GO:009868; GO:000557; GO:000561; GO:000998	 Transcriptional misregulation in cancer; Complement and coagulation cascades	hsa0520; hsa0461	protein binding;receptor binding;phosphoprotein binding;serine-type endopeptidase activity	GO:000551; GO:000510; GO:005121; GO:000425
NP_999223.1;XP_020935154.1;CON__Q9TT36	NP_999223.1;XP_020935154.1	NP_999223.1 thyroxine-binding globulin precursor [Sus scrofa];XP_020935154.1 thyroxine-binding globulin isoform X1 [Sus scrofa]	4	4	4	0	17819000	0	22339000	0	30525000	14390000	17106000	20090000	19901000	24492000	28872000	18678000	15120000	18941000	18486000	0	22578000	NA	NA	NA	SERPINA7	SERPINA7;SERPINA7;NA;NA;NA	negative regulation of endopeptidase activity;thyroid hormone transport	GO:001095; GO:007032	extracellular region;extracellular space;extracellular exosome	GO:000557; GO:000561; GO:007006	"NA"	"NA"	serine-type endopeptidase inhibitor activity	GO:000486
XP_005668471.1;NP_999225.1	XP_005668471.1;NP_999225.1	XP_005668471.1 S-formylglutathione hydrolase isoform X1 [Sus scrofa];NP_999225.1 S-formylglutathione hydrolase [Sus scrofa]	12	12	12	280920000	357700000	359260000	258330000	241980000	282870000	266500000	233010000	392550000	342050000	245520000	310530000	233970000	333370000	246930000	384170000	320450000	302450000	NA	NA	NA	ESD	ESD;ESD;NA;NA;NA	biological_process;glutathione derivative biosynthetic process;formaldehyde catabolic process	GO:000815; GO:190168; GO:004629	endoplasmic reticulum lumen;extracellular exosome;cytosol;cytoplasmic vesicle	GO:000578; GO:007006; GO:000582; GO:003141	 Carbon metabolism	hsa0120	identical protein binding;hydrolase activity, acting on ester bonds;methylumbelliferyl-acetate deacetylase activity;protein binding;S-formylglutathione hydrolase activity;carboxylic ester hydrolase activity	GO:004280; GO:001678; GO:004737; GO:000551; GO:001873; GO:005268
NP_999227.1	NP_999227.1	NP_999227.1 dihydrolipoyl dehydrogenase, mitochondrial precursor [Sus scrofa]	13	13	13	459780000	323530000	433750000	314300000	444860000	272960000	409390000	353970000	417690000	330680000	370920000	295450000	253630000	276820000	301970000	389110000	278670000	275200000	NA	NA	NA	DLD	DLD;NA;NA;NA;NA	cell redox homeostasis;mitochondrial acetyl-CoA biosynthetic process from pyruvate;2-oxoglutarate metabolic process;lipoate metabolic process;dihydrolipoamide metabolic process;proteolysis;aging;regulation of membrane potential;gastrulation;mitochondrial electron transport, NADH to ubiquinone;sperm capacitation	GO:004545; GO:006173; GO:000610; GO:000910; GO:005106; GO:000650; GO:000756; GO:004239; GO:000736; GO:000612; GO:004824	nucleoplasm;acrosomal matrix;nucleus;oxoglutarate dehydrogenase complex;mitochondrion;motile cilium;mitochondrial matrix	GO:000565; GO:004315; GO:000563; GO:004525; GO:000573; GO:003151; GO:000575	 Biosynthesis of antibiotics; Metabolic pathways; Glyoxylate and dicarboxylate metabolism; Valine, leucine and isoleucine degradation; Citrate cycle (TCA cycle); Pyruvate metabolism; Carbon metabolism; Glycolysis / Gluconeogenesis; Glycine, serine and threonine metabolism	hsa0113; hsa0110; hsa0063; hsa0028; hsa0002; hsa0062; hsa0120; hsa0001; hsa0026	electron carrier activity;pyruvate dehydrogenase (NAD+) activity;NAD binding;dihydrolipoyl dehydrogenase activity;protein binding;lipoamide binding;flavin adenine dinucleotide binding	GO:000905; GO:003460; GO:005128; GO:000414; GO:000551; GO:004354; GO:005066
XP_020927764.1;XP_020927763.1;NP_999228.1	XP_020927764.1;XP_020927763.1;NP_999228.1	XP_020927764.1 high mobility group protein B2 isoform X1 [Sus scrofa];XP_020927763.1 high mobility group protein B2 isoform X1 [Sus scrofa];NP_999228.1 high mobility group protein B2 [Sus scrofa]	5	3	3	0	32097000	30949000	28834000	27947000	46503000	22551000	25843000	28526000	27253000	26237000	19949000	31718000	0	23452000	27704000	34729000	30859000	NA	NA	NA	HMGB2	HMGB2;HMGB2;HMGB2;NA;NA	nucleosome assembly;response to drug;positive regulation of erythrocyte differentiation;response to steroid hormone;positive chemotaxis;DNA ligation involved in DNA repair;regulation of stem cell proliferation;regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;DNA topological change;spermatid nucleus differentiation;defense response to Gram-positive bacterium;positive regulation of transcription, DNA-templated;positive regulation of DNA binding;innate immune response;cell chemotaxis;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;male gonad development;DNA geometric change;positive regulation of megakaryocyte differentiation;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;regulation of neurogenesis;positive regulation of endothelial cell proliferation;apoptotic DNA fragmentation;DNA recombination;inflammatory response to antigenic stimulus;chromatin organization;defense response to Gram-negative bacterium;positive regulation of nuclease activity;response to lipopolysaccharide;V(D)J recombination;cellular response to lipopolysaccharide	GO:000633; GO:004249; GO:004564; GO:004854; GO:005091; GO:005110; GO:007209; GO:000635; GO:003272; GO:000626; GO:000728; GO:005083; GO:004589; GO:004338; GO:004508; GO:006032; GO:190204; GO:000858; GO:003239; GO:004565; GO:000633; GO:004594; GO:005076; GO:000193; GO:000630; GO:000631; GO:000243; GO:000632; GO:005082; GO:003207; GO:003249; GO:003315; GO:007122	extracellular space;cell;macromolecular complex;perinuclear region of cytoplasm;nucleus;cytoplasm;nucleoplasm;condensed chromosome	GO:000561; GO:000562; GO:003299; GO:004847; GO:000563; GO:000573; GO:000565; GO:000079	"NA"	"NA"	single-stranded DNA binding;RNA binding;damaged DNA binding;DNA binding, bending;four-way junction DNA binding;enhancer sequence-specific DNA binding;drug binding;transcription regulatory region DNA binding;protein binding;double-stranded DNA binding;transcription coactivator activity;transcription factor binding;chemoattractant activity;non-sequence-specific DNA binding, bending;RAGE receptor binding;supercoiled DNA binding;DNA binding;protein domain specific binding	GO:000369; GO:000372; GO:000368; GO:000830; GO:000040; GO:000115; GO:000814; GO:004421; GO:000551; GO:000369; GO:000371; GO:000813; GO:004205; GO:004437; GO:005078; GO:009710; GO:000367; GO:001990
XP_005656702.1;NP_999229.1	XP_005656702.1;NP_999229.1	XP_005656702.1 dimethylaniline monooxygenase [N-oxide-forming] 1 isoform X1 [Sus scrofa];NP_999229.1 dimethylaniline monooxygenase [N-oxide-forming] 1 [Sus scrofa]	7	7	7	27780000	0	30389000	0	17048000	21586000	21367000	0	36851000	0	15657000	18239000	0	30847000	18512000	0	15863000	14602000	NA	NA	NA	FMO1	FMO1;FMO1;NA;NA;NA	organic acid metabolic process;response to lipopolysaccharide;response to osmotic stress;toxin metabolic process;drug metabolic process;NADPH oxidation;xenobiotic metabolic process	GO:000608; GO:003249; GO:000697; GO:000940; GO:001714; GO:007099; GO:000680	organelle membrane;endoplasmic reticulum lumen;integral component of membrane	GO:003109; GO:000578; GO:001602	 Drug metabolism - cytochrome P450	hsa0098	monooxygenase activity;flavin adenine dinucleotide binding;protein binding;N,N-dimethylaniline monooxygenase activity	GO:000449; GO:005066; GO:000551; GO:000449
XP_020936669.1;XP_020936666.1;XP_020936664.1;XP_020936660.1;XP_020936657.1;XP_020936653.1;XP_020936648.1;XP_020936645.1;XP_020936638.1;XP_020936635.1;XP_020936607.1;XP_020936631.1;XP_020936587.1;XP_020936582.1;XP_020936580.1;XP_020936578.1;XP_020936575.1;XP_020936628.1;XP_020936625.1;XP_020936619.1;XP_020936614.1;XP_020936568.1;NP_999232.1;XP_020936561.1;XP_020936555.1;XP_020936548.1;XP_020936600.1;XP_020936589.1	XP_020936669.1;XP_020936666.1;XP_020936664.1;XP_020936660.1;XP_020936657.1;XP_020936653.1;XP_020936648.1;XP_020936645.1;XP_020936638.1;XP_020936635.1;XP_020936607.1;XP_020936631.1;XP_020936587.1;XP_020936582.1;XP_020936580.1;XP_020936578.1;XP_020936575.1;XP_020936628.1;XP_020936625.1;XP_020936619.1;XP_020936614.1;XP_020936568.1;NP_999232.1;XP_020936561.1;XP_020936555.1;XP_020936548.1;XP_020936600.1;XP_020936589.1	XP_020936669.1 calpastatin isoform X27 [Sus scrofa];XP_020936666.1 calpastatin isoform X26 [Sus scrofa];XP_020936664.1 calpastatin isoform X25 [Sus scrofa];XP_020936660.1 calpastatin isoform X24 [Sus scrofa];XP_020936657.1 calpastatin isoform X23 [Sus scro	14	14	14	49924000	167530000	113530000	117050000	100420000	160740000	88814000	120840000	96663000	134480000	112560000	156180000	130650000	148970000	156320000	154400000	151790000	161980000	NA	NA	NA	CAST	CAST;CAST;CAST;CAST;CAST	presynaptic active zone organization;negative regulation of type B pancreatic cell apoptotic process;inhibition of cysteine-type endopeptidase activity	GO:199070; GO:200067; GO:009734	membrane;cytosol;endoplasmic reticulum	GO:001602; GO:000582; GO:000578	"NA"	"NA"	protease binding;endopeptidase inhibitor activity;protein binding;RNA binding;calcium-dependent cysteine-type endopeptidase inhibitor activity;cadherin binding	GO:000202; GO:000486; GO:000551; GO:000372; GO:001085; GO:004529
NP_999239.1	NP_999239.1	NP_999239.1 plasma kallikrein [Sus scrofa]	6	6	6	60973000	28253000	44791000	49836000	75375000	84016000	0	0	54519000	24046000	43423000	0	38289000	0	59670000	31834000	55127000	39203000	NA	NA	NA	KLKB1	KLKB1;NA;NA;NA;NA	Factor XII activation;zymogen activation;blood coagulation, intrinsic pathway;extracellular matrix disassembly;fibrinolysis;positive regulation of fibrinolysis;proteolysis	GO:000254; GO:003163; GO:000759; GO:002261; GO:004273; GO:005191; GO:000650	plasma membrane;extracellular region;extracellular exosome;extracellular space	GO:000588; GO:000557; GO:007006; GO:000561	 Complement and coagulation cascades	hsa0461	serine-type endopeptidase activity;protein binding	GO:000425; GO:000551
XP_020946788.1;NP_999268.1	XP_020946788.1;NP_999268.1	XP_020946788.1 endoplasmin isoform X1 [Sus scrofa];NP_999268.1 endoplasmin precursor [Sus scrofa]	29	27	27	629530000	829860000	798590000	814870000	777840000	874720000	866740000	837250000	730830000	737330000	896830000	739530000	886120000	931200000	978220000	822370000	925860000	878070000	NA	NA	NA	HSP90B1	HSP90B1;HSP90B1;NA;NA;NA	receptor-mediated endocytosis;actin rod assembly;response to hypoxia;ubiquitin-dependent ERAD pathway;response to endoplasmic reticulum stress;negative regulation of apoptotic process;toll-like receptor signaling pathway;regulation of phosphoprotein phosphatase activity;post-translational protein modification;retrograde protein transport, ER to cytosol;cellular response to ATP;protein transport;cellular protein metabolic process;sequestering of calcium ion;cytokine-mediated signaling pathway;ATF6-mediated unfolded protein response	GO:000689; GO:003124; GO:000166; GO:003043; GO:003497; GO:004306; GO:000222; GO:004366; GO:004368; GO:003097; GO:007131; GO:001503; GO:004426; GO:005120; GO:001922; GO:003650	plasma membrane;perinuclear region of cytoplasm;endocytic vesicle lumen;endoplasmic reticulum;extracellular exosome;membrane;midbody;extracellular region;nucleus;cytosol;melanosome;focal adhesion;macromolecular complex;endoplasmic reticulum chaperone complex	GO:000588; GO:004847; GO:007168; GO:000578; GO:007006; GO:001602; GO:003049; GO:000557; GO:000563; GO:000582; GO:004247; GO:000592; GO:003299; GO:003466	 Thyroid hormone synthesis; Pathways in cancer; Estrogen signaling pathway; PI3K-Akt signaling pathway; Prostate cancer; NOD-like receptor signaling pathway; Protein processing in endoplasmic reticulum	hsa0491; hsa0520; hsa0491; hsa0415; hsa0521; hsa0462; hsa0414	low-density lipoprotein particle receptor binding;RNA binding;protein phosphatase binding;unfolded protein binding;ATP binding;calcium ion binding;protein binding	GO:005075; GO:000372; GO:001990; GO:005108; GO:000552; GO:000550; GO:000551
NP_999269.1;CON__Q3ZBS7	NP_999269.1	NP_999269.1 vitronectin precursor [Sus scrofa]	11	11	11	211590000	158490000	120980000	151840000	176760000	202530000	175980000	145320000	161040000	129110000	216390000	203150000	140770000	149780000	184680000	156790000	131130000	178110000	NA	NA	NA	VTN	VTN;NA;NA;NA;NA	negative regulation of blood coagulation;positive regulation of protein binding;positive regulation of receptor-mediated endocytosis;cell adhesion;receptor-mediated endocytosis;cell adhesion mediated by integrin;endodermal cell differentiation;positive regulation of peptidyl-tyrosine phosphorylation;liver regeneration;cell-matrix adhesion;positive regulation of smooth muscle cell migration;positive regulation of vascular endothelial growth factor receptor signaling pathway;oligodendrocyte differentiation;smooth muscle cell-matrix adhesion;positive regulation of wound healing;immune response;cell proliferation;negative regulation of endopeptidase activity;protein polymerization;cell migration;positive regulation of cell-substrate adhesion;extracellular matrix organization;regulation of complement activation	GO:003019; GO:003209; GO:004826; GO:000715; GO:000689; GO:003362; GO:003598; GO:005073; GO:009742; GO:000716; GO:001491; GO:003094; GO:004870; GO:006130; GO:009030; GO:000695; GO:000828; GO:001095; GO:005125; GO:001647; GO:001081; GO:003019; GO:003044	extracellular region;basement membrane;extracellular exosome;endoplasmic reticulum;intracellular membrane-bounded organelle;blood microparticle;extracellular space;Golgi lumen;rough endoplasmic reticulum lumen;alphav-beta3 integrin-vitronectin complex	GO:000557; GO:000560; GO:007006; GO:000578; GO:004323; GO:007256; GO:000561; GO:000579; GO:004823; GO:007106	 PI3K-Akt signaling pathway; ECM-receptor interaction; Proteoglycans in cancer	hsa0415; hsa0451; hsa0520	scavenger receptor activity;heparin binding;identical protein binding;polysaccharide binding;extracellular matrix structural constituent;collagen binding;extracellular matrix binding;integrin binding	GO:000504; GO:000820; GO:004280; GO:003024; GO:000520; GO:000551; GO:005084; GO:000517
NP_999279.1;XP_020949197.1;XP_020949196.1;XP_020949195.1;XP_020949194.1;XP_020949193.1;XP_020949192.1;XP_020949191.1;XP_020949190.1;XP_020949189.1;XP_020949187.1;XP_020949186.1;XP_020949185.1	NP_999279.1;XP_020949197.1;XP_020949196.1;XP_020949195.1;XP_020949194.1;XP_020949193.1;XP_020949192.1;XP_020949191.1;XP_020949190.1;XP_020949189.1;XP_020949187.1;XP_020949186.1;XP_020949185.1	NP_999279.1 tyrosine-protein kinase JAK1 [Sus scrofa];XP_020949197.1 tyrosine-protein kinase JAK1 isoform X1 [Sus scrofa];XP_020949196.1 tyrosine-protein kinase JAK1 isoform X1 [Sus scrofa];XP_020949195.1 tyrosine-protein kinase JAK1 isoform X1 [Sus scrofa	2	2	2	114380000	126020000	144100000	0	180670000	155200000	0	156990000	133370000	130100000	0	0	0	150730000	214950000	167040000	159890000	157330000	NA	NA	NA	JAK1	JAK1;JAK1;JAK1;JAK1;JAK1	interferon-gamma-mediated signaling pathway;interleukin-2-mediated signaling pathway;type I interferon signaling pathway;interleukin-6-mediated signaling pathway;interleukin-35-mediated signaling pathway;interleukin-12-mediated signaling pathway;MAPK cascade;intracellular signal transduction;protein phosphorylation;response to antibiotic;peptidyl-tyrosine phosphorylation;cytokine-mediated signaling pathway;positive regulation of sprouting angiogenesis	GO:006033; GO:003811; GO:006033; GO:007010; GO:007075; GO:003572; GO:000016; GO:003555; GO:000646; GO:004667; GO:001810; GO:001922; GO:190367	nucleus;cytosol;membrane;cytoskeleton;focal adhesion;endosome;cytoplasm	GO:000563; GO:000582; GO:001602; GO:000585; GO:000592; GO:000576; GO:000573	 Signaling pathways regulating pluripotency of stem cells; Hepatitis B; Viral carcinogenesis; Osteoclast differentiation; Jak-STAT signaling pathway; Toxoplasmosis; PI3K-Akt signaling pathway; Pancreatic cancer; Tuberculosis	hsa0455; hsa0516; hsa0520; hsa0438; hsa0463; hsa0514; hsa0415; hsa0521; hsa0515	protein binding;ubiquitin protein ligase binding;ATP binding;Ras guanyl-nucleotide exchange factor activity;metal ion binding;CCR5 chemokine receptor binding;protein tyrosine kinase activity;growth hormone receptor binding;protein phosphatase binding	GO:000551; GO:003162; GO:000552; GO:000508; GO:004687; GO:003173; GO:000471; GO:000513; GO:001990
NP_999281.1	NP_999281.1	NP_999281.1 matrix Gla protein precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13047000	NA	NA	NA	MGP	MGP;NA;NA;NA;NA	cartilage condensation;cell differentiation;regulation of bone mineralization;ossification	GO:000150; GO:003015; GO:003050; GO:000150	extracellular exosome;extracellular matrix	GO:007006; GO:003101	"NA"	"NA"	structural constituent of bone;protein binding;calcium ion binding;extracellular matrix structural constituent	GO:000814; GO:000551; GO:000550; GO:000520
NP_999284.1	NP_999284.1	NP_999284.1 acyl-CoA-binding protein [Sus scrofa]	11	11	11	7738100000	5452700000	9044800000	5871300000	6357900000	4065300000	9284200000	8478700000	8375800000	7454400000	6913400000	14063000000	2581300000	4786900000	8388300000	8472900000	4515700000	3897300000	NA	NA	NA	DBI	DBI;NA;NA;NA;NA	acyl-CoA metabolic process;protein palmitoylation;phosphatidylcholine acyl-chain remodeling	GO:000663; GO:001834; GO:003615	endoplasmic reticulum lumen;extracellular exosome;Golgi apparatus	GO:000578; GO:007006; GO:000579	 PPAR signaling pathway	hsa0332	benzodiazepine receptor binding;long-chain fatty acyl-CoA binding;lipid binding;protein dimerization activity	GO:003015; GO:003604; GO:000828; GO:004698
NP_999292.2	NP_999292.2	NP_999292.2 superoxide dismutase [Mn], mitochondrial [Sus scrofa]	8	8	8	748870000	397840000	1183300000	251150000	527840000	261400000	824650000	387330000	991340000	408970000	629300000	377400000	430860000	344910000	731160000	293780000	537650000	304510000	NA	NA	NA	SOD2	SOD2;NA;NA;NA;NA	age-dependent response to reactive oxygen species;release of cytochrome c from mitochondria;negative regulation of cell proliferation;oxygen homeostasis;cellular response to oxidative stress;interleukin-12-mediated signaling pathway;protein homotetramerization;acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure;superoxide metabolic process;removal of superoxide radicals;regulation of blood pressure;positive regulation of cell migration;oxidation-reduction process;regulation of transcription from RNA polymerase II promoter;negative regulation of neuron apoptotic process;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;positive regulation of vascular associated smooth muscle cell apoptotic process;positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching;response to superoxide;negative regulation of vascular smooth muscle cell proliferation	GO:000131; GO:000183; GO:000828; GO:003236; GO:003459; GO:003572; GO:005128; GO:000306; GO:000680; GO:001943; GO:000821; GO:003033; GO:005511; GO:000635; GO:004352; GO:190217; GO:190546; GO:190593; GO:000030; GO:190470	mitochondrion;extracellular exosome;mitochondrial matrix	GO:000573; GO:007006; GO:000575	 Peroxisome; Huntington's disease; FoxO signaling pathway	hsa0414; hsa0501; hsa0406	metal ion binding;identical protein binding;manganese ion binding;superoxide dismutase activity	GO:004687; GO:004280; GO:003014; GO:000478
NP_999296.1	NP_999296.1	NP_999296.1 caspase-3 [Sus scrofa]	3	3	3	0	16247000	0	0	0	0	0	0	0	10235000	0	0	0	0	0	0	0	0	NA	NA	NA	CASP3	CASP3;NA;NA;NA;NA	response to hypoxia;B cell homeostasis;response to amino acid;positive regulation of neuron apoptotic process;neuron apoptotic process;execution phase of apoptosis;axonal fasciculation;sensory perception of sound;keratinocyte differentiation;negative regulation of B cell proliferation;response to estradiol;glial cell apoptotic process;hippo signaling;positive regulation of beta-amyloid formation;proteolysis;learning or memory;negative regulation of apoptotic process;response to glucose;regulation of protein stability;wound healing;response to glucocorticoid;leukocyte apoptotic process;luteolysis;apoptotic process;heart development;response to X-ray;cytokine-mediated signaling pathway;neurotrophin TRK receptor signaling pathway;intrinsic apoptotic signaling pathway in response to osmotic stress;regulation of macroautophagy;platelet formation;response to nicotine;response to hydrogen peroxide;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of activated T cell proliferation;protein processing;cellular response to DNA damage stimulus;response to UV;hippocampus development;neuron differentiation;T cell homeostasis;cellular response to staurosporine;apoptotic DNA fragmentation;response to lipopolysaccharide;response to tumor necrosis factor;cell fate commitment;striated muscle cell differentiation;response to cobalt ion	GO:000166; GO:000178; GO:004320; GO:004352; GO:005140; GO:009719; GO:000741; GO:000760; GO:003021; GO:003088; GO:003235; GO:003434; GO:003532; GO:190200; GO:000650; GO:000761; GO:004306; GO:000974; GO:003164; GO:004206; GO:005138; GO:007188; GO:000155; GO:000691; GO:000750; GO:001016; GO:001922; GO:004801; GO:000862; GO:001624; GO:003022; GO:003509; GO:004254; GO:004573; GO:004600; GO:001648; GO:000697; GO:000941; GO:002176; GO:003018; GO:004302; GO:007273; GO:000630; GO:003249; GO:003461; GO:004516; GO:005114; GO:003202	nucleus;cytoplasm;death-inducing signaling complex;nucleoplasm;neuronal cell body;cytosol;membrane raft	GO:000563; GO:000573; GO:003126; GO:000565; GO:004302; GO:000582; GO:004512	 Pertussis; Proteoglycans in cancer; p53 signaling pathway; Natural killer cell mediated cytotoxicity; Alzheimer's disease; Legionellosis; Hepatitis B; Viral myocarditis; Colorectal cancer; MAPK signaling pathway; Apoptosis; TNF signaling pathway; Serotonergic synapse; Non-alcoholic fatty liver disease (NAFLD); Epithelial cell signaling in Helicobacter pylori infection; Tuberculosis; Amoebiasis	hsa0513; hsa0520; hsa0411; hsa0465; hsa0501; hsa0513; hsa0516; hsa0541; hsa0521; hsa0401; hsa0421; hsa0466; hsa0472; hsa0493; hsa0512; hsa0515; hsa0514	macromolecular complex binding;cysteine-type endopeptidase activity;protease binding;protein binding;peptidase activity;cysteine-type endopeptidase activator activity involved in apoptotic process;cysteine-type endopeptidase activity involved in apoptotic process;cyclin-dependent protein serine/threonine kinase inhibitor activity;death receptor binding;cysteine-type endopeptidase activity involved in execution phase of apoptosis;phospholipase A2 activator activity;cysteine-type endopeptidase activity involved in apoptotic signaling pathway	GO:004487; GO:000419; GO:000202; GO:000551; GO:000823; GO:000865; GO:009715; GO:000486; GO:000512; GO:009720; GO:001600; GO:009719
XP_020921876.1;XP_020921875.1;NP_999301.1	XP_020921876.1;XP_020921875.1;NP_999301.1	XP_020921876.1 myosin-2 isoform X1 [Sus scrofa];XP_020921875.1 myosin-2 isoform X1 [Sus scrofa];NP_999301.1 myosin-2 [Sus scrofa]	73	5	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	619510000	0	NA	NA	NA	MYH2	MYH2;MYH2;MYH2;NA;NA	muscle contraction;Fc-gamma receptor signaling pathway involved in phagocytosis;muscle filament sliding	GO:000693; GO:003809; GO:003004	myosin filament;cytosol;myofibril;muscle myosin complex;macromolecular complex	GO:003298; GO:000582; GO:003001; GO:000585; GO:003299	 Tight junction	hsa0453	protein binding;ATP binding;actin filament binding;calmodulin binding;microfilament motor activity	GO:000551; GO:000552; GO:005101; GO:000551; GO:000014
NP_999309.1	NP_999309.1	NP_999309.1 peroxiredoxin-5, mitochondrial [Sus scrofa]	12	12	12	267400000	162050000	274790000	171020000	367250000	157320000	410490000	235730000	331590000	202860000	298290000	151730000	230390000	190750000	324680000	225940000	283720000	184780000	NA	NA	NA	PRDX5	PRDX5;NA;NA;NA;NA	inflammatory response;response to oxidative stress;hydrogen peroxide catabolic process;cell redox homeostasis;negative regulation of transcription from RNA polymerase III promoter;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;oxidation-reduction process;negative regulation of apoptotic process;cellular response to reactive oxygen species;cellular oxidant detoxification;apoptotic process;cellular response to oxidative stress	GO:000695; GO:000697; GO:004274; GO:004545; GO:001648; GO:004315; GO:005511; GO:004306; GO:003461; GO:009886; GO:000691; GO:003459	mitochondrial matrix;peroxisome;nucleus;cytosol;extracellular space;cytoplasmic vesicle;perinuclear region of cytoplasm;mitochondrion;peroxisomal matrix;intracellular membrane-bounded organelle;extracellular exosome	GO:000575; GO:000577; GO:000563; GO:000582; GO:000561; GO:003141; GO:004847; GO:000573; GO:000578; GO:004323; GO:007006	 Peroxisome	hsa0414	peroxidase activity;protein dimerization activity;protein binding;RNA polymerase III regulatory region DNA binding;receptor binding;thioredoxin peroxidase activity;cysteine-type endopeptidase inhibitor activity involved in apoptotic process	GO:000460; GO:004698; GO:000551; GO:000101; GO:000510; GO:000837; GO:004302
NP_999318.1;XP_013839039.1;XP_005671361.1;XP_005671360.1;XP_005671358.1	NP_999318.1;XP_013839039.1;XP_005671361.1;XP_005671360.1;XP_005671358.1	NP_999318.1 ectonucleoside triphosphate diphosphohydrolase 1 [Sus scrofa];XP_013839039.1 ectonucleoside triphosphate diphosphohydrolase 1 isoform X1 [Sus scrofa];XP_005671361.1 ectonucleoside triphosphate diphosphohydrolase 1 isoform X1 [Sus scrofa];XP_005	3	3	3	15927000	0	24377000	0	0	0	22243000	0	18799000	25264000	0	0	0	0	0	0	0	0	NA	NA	NA	ENTPD1	ENTPD1;ENTPD1;ENTPD1;ENTPD1;ENTPD1	nucleobase-containing small molecule catabolic process;blood coagulation;cell adhesion	GO:003465; GO:000759; GO:000715	plasma membrane;extracellular exosome;integral component of plasma membrane;membrane	GO:000588; GO:007006; GO:000588; GO:001602	 Epstein-Barr virus infection; Purine metabolism; Pyrimidine metabolism	hsa0516; hsa0023; hsa0024	protein binding;nucleoside-diphosphatase activity;8-oxo-dGTP phosphohydrolase activity;ATP binding	GO:000551; GO:001711; GO:010249; GO:000552
NP_999319.2	NP_999319.2	NP_999319.2 thioredoxin reductase 1, cytoplasmic [Sus scrofa]	10	10	10	157220000	81210000	123610000	94436000	93968000	64486000	117300000	80529000	112410000	84536000	76874000	61294000	66632000	68081000	102160000	65932000	108360000	79196000	NA	NA	NA	TXNRD1	TXNRD1;NA;NA;NA;NA	regulation of lipid metabolic process;cell proliferation;cellular response to oxidative stress;nucleobase-containing small molecule interconversion;mesoderm formation;selenium compound metabolic process;cell redox homeostasis;cellular oxidant detoxification;signal transduction;electron transport chain	GO:001921; GO:000828; GO:003459; GO:001594; GO:000170; GO:000188; GO:004545; GO:009886; GO:000716; GO:002290	nucleoplasm;fibrillar center;extracellular exosome;cytoplasm;cytosol	GO:000565; GO:000165; GO:007006; GO:000573; GO:000582	 Pyrimidine metabolism; Selenocompound metabolism	hsa0024; hsa0045	protein binding;electron carrier activity;flavin adenine dinucleotide binding;methylseleninic acid reductase activity;protein disulfide oxidoreductase activity;thioredoxin-disulfide reductase activity	GO:000551; GO:000905; GO:005066; GO:009862; GO:001503; GO:000479
NP_999331.1	NP_999331.1	NP_999331.1 trans-1,2-dihydrobenzene-1,2-diol dehydrogenase [Sus scrofa]	6	6	6	244320000	285200000	222380000	331840000	188290000	0	287060000	306750000	297540000	336540000	227880000	341820000	270150000	255200000	204220000	353850000	236240000	307670000	NA	NA	NA	DHDH	DHDH;NA;NA;NA;NA	electron transport chain;D-xylose catabolic process;carbohydrate metabolic process	GO:002290; GO:004284; GO:000597	"NA"	"NA"	 Metabolism of xenobiotics by cytochrome P450; Pentose and glucuronate interconversions	hsa0098; hsa0004	NAD(P)+ transhydrogenase activity;D-xylose 1-dehydrogenase (NADP+) activity;trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;electron carrier activity	GO:000874; GO:004783; GO:004711; GO:000905
XP_005661088.1;NP_999335.1	XP_005661088.1;NP_999335.1	XP_005661088.1 CD59 glycoprotein isoform X1 [Sus scrofa];NP_999335.1 CD59 glycoprotein precursor [Sus scrofa]	2	2	2	384440000	496580000	601800000	365990000	391560000	354280000	576960000	297790000	422820000	397300000	570810000	454700000	345040000	398410000	401040000	474560000	661000000	434620000	NA	NA	NA	CD59	CD59;CD59;NA;NA;NA	ER to Golgi vesicle-mediated transport;blood coagulation;neutrophil degranulation;COPII vesicle coating;cell surface receptor signaling pathway;regulation of complement activation;negative regulation of activation of membrane attack complex	GO:000688; GO:000759; GO:004331; GO:004820; GO:000716; GO:003044; GO:000197	transport vesicle;vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi membrane;extracellular space;plasma membrane;endoplasmic reticulum membrane;focal adhesion;cell surface;tertiary granule membrane;ER to Golgi transport vesicle membrane;anchored component of external side of plasma membrane;extracellular exosome;membrane;specific granule membrane	GO:003013; GO:003198; GO:003311; GO:000013; GO:000561; GO:000588; GO:000578; GO:000592; GO:000998; GO:007082; GO:001250; GO:003136; GO:007006; GO:001602; GO:003557	 Hematopoietic cell lineage; Complement and coagulation cascades	hsa0464; hsa0461	complement binding;protein binding	GO:000184; GO:000551
XP_020941516.1;XP_020941515.1;NP_999349.1	XP_020941516.1;XP_020941515.1;NP_999349.1	XP_020941516.1 serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X1 [Sus scrofa];XP_020941515.1 serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X1 [Sus scrofa];NP_999349.1 serine/threonine-protein phosphatase P	12	3	3	0	38449000	41829000	27391000	31021000	43463000	29542000	34549000	25863000	41447000	36648000	45674000	35438000	42759000	0	41388000	32324000	29810000	NA	NA	NA	PPP1CB	PPP1CB;PPP1CB;PPP1CB;NA;NA	cell cycle;regulation of cell adhesion;regulation of glycogen biosynthetic process;protein dephosphorylation;regulation of glycogen catabolic process;circadian regulation of gene expression;regulation of circadian rhythm;entrainment of circadian clock by photoperiod;cell division	GO:000704; GO:003015; GO:000597; GO:000647; GO:000598; GO:003292; GO:004275; GO:004315; GO:005130	cytoplasm;glycogen granule;cytosol;plasma membrane;nucleoplasm;focal adhesion;extracellular exosome;protein phosphatase type 1 complex;nuclear chromosome, telomeric region;nucleus;nucleolus;PTW/PP1 phosphatase complex	GO:000573; GO:004258; GO:000582; GO:000588; GO:000565; GO:000592; GO:007006; GO:000016; GO:000078; GO:000563; GO:000573; GO:007235	 Oxytocin signaling pathway; mRNA surveillance pathway; Long-term potentiation; Regulation of actin cytoskeleton; Herpes simplex infection; Vascular smooth muscle contraction; Focal adhesion; Inflammatory mediator regulation of TRP channels; Insulin resistance; Hippo signaling pathway; Amphetamine addiction; cAMP signaling pathway; Insulin signaling pathway; Oocyte meiosis; Platelet activation; Proteoglycans in cancer; Adrenergic signaling in cardiomyocytes	hsa0492; hsa0301; hsa0472; hsa0481; hsa0516; hsa0427; hsa0451; hsa0475; hsa0493; hsa0439; hsa0503; hsa0402; hsa0491; hsa0411; hsa0461; hsa0520; hsa0426	myosin-light-chain-phosphatase activity;protein binding;protein serine/threonine phosphatase activity;myosin phosphatase activity;protein kinase binding;metal ion binding;phosphatase activity	GO:005011; GO:000551; GO:000472; GO:001701; GO:001990; GO:004687; GO:001679
NP_999353.1	NP_999353.1	NP_999353.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit precursor [Sus scrofa]	7	7	7	424490000	467600000	441600000	397420000	397900000	424120000	408690000	375430000	401050000	373540000	476640000	423200000	491720000	431690000	419600000	474370000	451070000	506840000	NA	NA	NA	DDOST	DDOST;NA;NA;NA;NA	protein glycosylation;protein N-linked glycosylation;protein N-linked glycosylation via asparagine;response to cytokine;T cell activation;neutrophil degranulation	GO:000648; GO:000648; GO:001827; GO:003409; GO:004211; GO:004331	macromolecular complex;plasma membrane;integral component of membrane;endoplasmic reticulum;azurophil granule membrane;oligosaccharyltransferase complex;intracellular membrane-bounded organelle	GO:003299; GO:000588; GO:001602; GO:000578; GO:003557; GO:000825; GO:004323	 N-Glycan biosynthesis; Metabolic pathways; Protein processing in endoplasmic reticulum	hsa0051; hsa0110; hsa0414	protein binding;oligosaccharyl transferase activity	GO:000551; GO:000457
XP_020941518.1;NP_999356.1;XP_020941517.1;XP_020942523.1	XP_020941518.1;NP_999356.1;XP_020941517.1;XP_020942523.1	XP_020941518.1 tryptase isoform X2 [Sus scrofa];NP_999356.1 tryptase precursor [Sus scrofa];XP_020941517.1 tryptase isoform X1 [Sus scrofa];XP_020942523.1 tryptase-like [Sus scrofa]	3	3	3	0	0	143850000	0	0	0	0	0	0	0	113020000	0	0	0	78381000	0	0	0	NA	NA	NA	MCT7	MCT7;MCT7;MCT7;LOC110255206;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_999357.2	NP_999357.2	NP_999357.2 72 kDa type IV collagenase precursor [Sus scrofa]	6	6	6	0	21187000	0	0	0	22051000	0	20048000	0	26199000	0	36844000	0	0	0	23068000	0	23153000	NA	NA	NA	MMP2	MMP2;NA;NA;NA;NA	ephrin receptor signaling pathway;tissue remodeling;proteolysis;extracellular matrix organization;embryo implantation;cytokine-mediated signaling pathway;blood vessel maturation;endodermal cell differentiation;face morphogenesis;bone trabecula formation;extracellular matrix disassembly;cellular response to amino acid stimulus;collagen catabolic process;cellular protein metabolic process;angiogenesis;response to hypoxia;positive regulation of vascular smooth muscle cell proliferation	GO:004801; GO:004877; GO:000650; GO:003019; GO:000756; GO:001922; GO:000195; GO:003598; GO:006032; GO:006034; GO:002261; GO:007123; GO:003057; GO:004426; GO:000152; GO:000166; GO:190470	extracellular region;mitochondrion;extracellular space;plasma membrane;nucleus;sarcomere	GO:000557; GO:000573; GO:000561; GO:000588; GO:000563; GO:003001	 Leukocyte transendothelial migration; Pathways in cancer; GnRH signaling pathway; Bladder cancer	hsa0467; hsa0520; hsa0491; hsa0521	protein binding;serine-type endopeptidase activity;metalloendopeptidase activity;zinc ion binding;metallopeptidase activity	GO:000551; GO:000425; GO:000422; GO:000827; GO:000823
XP_020927778.1;XP_020927777.1;XP_020927776.1;XP_005671145.1;XP_020927773.1;XP_020927772.1;XP_020927771.1;XP_005671144.1;XP_005671143.1;XP_005671142.1;XP_020927769.1;XP_005671140.1;NP_999358.1;XP_013838776.1;XP_013838775.1;XP_005671138.1;XP_005671137.1;XP_020927768.1;XP_005671135.1;XP_013838773.1;XP_005671134.1;XP_005671133.1;XP_020927779.1;XP_005671139.1;XP_020927774.1;XP_020927770.1;XP_020927767.1;XP_020934309.1;XP_020934308.1;XP_020934307.1;XP_020934306.1;XP_020934305.1;XP_020934304.1;XP_020934303.1;XP_020934302.1;XP_020934301.1;XP_020934300.1;XP_020934299.1;XP_020934297.1;XP_020934296.1;XP_020934295.1;XP_020934294.1;XP_020940680.1;XP_020940679.1;XP_005653018.1;XP_003354404.1;XP_020940678.1;XP_005653019.1;XP_020940677.1;XP_020940676.1	XP_020927778.1;XP_020927777.1;XP_020927776.1;XP_005671145.1;XP_020927773.1;XP_020927772.1;XP_020927771.1;XP_005671144.1;XP_005671143.1;XP_005671142.1;XP_020927769.1;XP_005671140.1;NP_999358.1;XP_013838776.1;XP_013838775.1;XP_005671138.1;XP_005671137.1;XP_020927768.1;XP_005671135.1;XP_013838773.1;XP_005671134.1;XP_005671133.1;XP_020927779.1;XP_005671139.1;XP_020927774.1;XP_020927770.1;XP_020927767.1;XP_020934309.1;XP_020934308.1;XP_020934307.1;XP_020934306.1;XP_020934305.1;XP_020934304.1;XP_020934303.1;XP_020934302.1;XP_020934301.1;XP_020934300.1;XP_020934299.1;XP_020934297.1;XP_020934296.1;XP_020934295.1;XP_020934294.1	XP_020927778.1 calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X24 [Sus scrofa];XP_020927777.1 calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X23 [Sus scrofa];XP_020927776.1 calcium/calmodulin-dependent	7	7	5	26321000	44489000	44808000	32195000	24927000	43080000	24135000	37298000	25349000	52853000	36941000	52177000	57004000	43910000	27002000	42303000	33802000	38669000	NA	NA	NA	CAMK2B	CAMK2B;CAMK2B;CAMK2B;CAMK2B;CAMK2B	regulation of synapse structural plasticity;positive regulation of neuron projection development;regulation of skeletal muscle adaptation;protein autophosphorylation;regulation of long-term neuronal synaptic plasticity;positive regulation of synapse maturation;regulation of neuron migration;interferon-gamma-mediated signaling pathway;regulation of dendritic spine development;protein phosphorylation;regulation of calcium ion transport;MAPK cascade;signal transduction;positive regulation of dendritic spine morphogenesis	GO:005182; GO:001097; GO:001473; GO:004677; GO:004816; GO:009012; GO:200122; GO:006033; GO:006099; GO:000646; GO:005192; GO:000016; GO:000716; GO:006100	cytoplasm;microtubule organizing center;plasma membrane;nucleoplasm;endocytic vesicle membrane;synapse;cell junction;cytosol;neuron projection;sarcoplasmic reticulum membrane	GO:000573; GO:000581; GO:000588; GO:000565; GO:003066; GO:004520; GO:003005; GO:000582; GO:004300; GO:003301	 cAMP signaling pathway; Oocyte meiosis; Neurotrophin signaling pathway; Olfactory transduction; GnRH signaling pathway; Oxytocin signaling pathway; Amphetamine addiction; Circadian entrainment; Adrenergic signaling in cardiomyocytes; Inflammatory mediator regulation of TRP channels; Calcium signaling pathway; Tuberculosis; Proteoglycans in cancer; ErbB signaling pathway; HIF-1 signaling pathway; Wnt signaling pathway; Glioma; Gastric acid secretion	hsa0402; hsa0411; hsa0472; hsa0474; hsa0491; hsa0492; hsa0503; hsa0471; hsa0426; hsa0475; hsa0402; hsa0515; hsa0520; hsa0401; hsa0406; hsa0431; hsa0521; hsa0497	calmodulin binding;ATP binding;protein homodimerization activity;protein binding;protein serine/threonine kinase activity;actin binding;Ras guanyl-nucleotide exchange factor activity;calmodulin-dependent protein kinase activity	GO:000551; GO:000552; GO:004280; GO:000551; GO:000467; GO:000377; GO:000508; GO:000468
XP_020949213.1;XP_013854093.1;XP_013854091.1;XP_013854090.1;XP_013854089.1;NP_999362.2;XP_020949211.1	XP_020949213.1;XP_013854093.1;XP_013854091.1;XP_013854090.1;XP_013854089.1;NP_999362.2;XP_020949211.1	XP_020949213.1 IgG receptor FcRn large subunit p51 isoform X2 [Sus scrofa];XP_013854093.1 IgG receptor FcRn large subunit p51 isoform X2 [Sus scrofa];XP_013854091.1 IgG receptor FcRn large subunit p51 isoform X2 [Sus scrofa];XP_013854090.1 IgG receptor FcR	5	5	5	0	13366000	0	21719000	0	13811000	0	16885000	0	12925000	0	0	0	0	0	10362000	10921000	17559000	NA	NA	NA	FCGRT	FCGRT;FCGRT;FCGRT;FCGRT;FCGRT	immune response;IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor	GO:000695; GO:000241	plasma membrane;integral component of membrane;extracellular space;external side of plasma membrane	GO:000588; GO:001602; GO:000561; GO:000989	"NA"	"NA"	beta-2-microglobulin binding;IgG binding;peptide antigen binding	GO:003088; GO:001986; GO:004260
NP_999366.1	NP_999366.1	NP_999366.1 glutathione peroxidase 1 [Sus scrofa]	13	13	13	412940000	310500000	237410000	309390000	329590000	280400000	365440000	308610000	320880000	345190000	249980000	265320000	507960000	427290000	556250000	404870000	461180000	389490000	NA	NA	NA	GPX1	GPX1;NA;NA;NA;NA	purine nucleotide catabolic process;regulation of mammary gland epithelial cell proliferation;regulation of neuron apoptotic process;fat cell differentiation;negative regulation of release of cytochrome c from mitochondria;UV protection;blood vessel endothelial cell migration;cellular oxidant detoxification;response to xenobiotic stimulus;response to gamma radiation;lipoxygenase pathway;cellular response to oxidative stress;positive regulation of protein kinase B signaling;negative regulation of inflammatory response to antigenic stimulus;glutathione metabolic process;intrinsic apoptotic signaling pathway in response to oxidative stress;response to selenium ion;response to hydrogen peroxide;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;skeletal muscle fiber development;myoblast proliferation;positive regulation of supramolecular fiber organization;triglyceride metabolic process;sensory perception of sound;response to hydroperoxide;regulation of gene expression, epigenetic;endothelial cell development;cell redox homeostasis;response to symbiotic bacterium;interaction with symbiont;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;temperature homeostasis;vasodilation;heart contraction;angiogenesis involved in wound healing;regulation of proteasomal protein catabolic process;protein oxidation;hydrogen peroxide catabolic process;skeletal muscle tissue regeneration;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	GO:000619; GO:003359; GO:004352; GO:004544; GO:009020; GO:000965; GO:004353; GO:009886; GO:000941; GO:001033; GO:001937; GO:003459; GO:005189; GO:000286; GO:000674; GO:000863; GO:001026; GO:004254; GO:004315; GO:004874; GO:005145; GO:190290; GO:000664; GO:000760; GO:003319; GO:004002; GO:000188; GO:004545; GO:000960; GO:005170; GO:190217; GO:000165; GO:004231; GO:006004; GO:006005; GO:006113; GO:001815; GO:004274; GO:004340; GO:190204	mitochondrion;cytoplasm;mitochondrial matrix;cytosol;Lewy body	GO:000573; GO:000573; GO:000575; GO:000582; GO:009741	 Huntington's disease; Arachidonic acid metabolism; Amyotrophic lateral sclerosis (ALS); Thyroid hormone synthesis; Glutathione metabolism	hsa0501; hsa0059; hsa0501; hsa0491; hsa0048	peroxidase activity;SH3 domain binding;glutathione peroxidase activity	GO:000460; GO:001712; GO:000460
NP_999377.1	NP_999377.1	NP_999377.1 transthyretin precursor [Sus scrofa]	8	8	8	242280000	355280000	271900000	230940000	254030000	702250000	331880000	268080000	400920000	401060000	246370000	349790000	308820000	270500000	117970000	231210000	411620000	637240000	NA	NA	NA	TTR	TTR;NA;NA;NA;NA	retinoid metabolic process;neutrophil degranulation;extracellular matrix organization;purine nucleobase metabolic process;regulation of receptor activity;cellular protein metabolic process;thyroid hormone transport;retinol metabolic process	GO:000152; GO:004331; GO:003019; GO:000614; GO:001046; GO:004426; GO:007032; GO:004257	extracellular space;extracellular exosome;extracellular region;macromolecular complex;azurophil granule lumen	GO:000561; GO:007006; GO:000557; GO:003299; GO:003557	"NA"	"NA"	identical protein binding;protein heterodimerization activity;protein binding;thyroid hormone binding;hormone activity	GO:004280; GO:004698; GO:000551; GO:007032; GO:000517
NP_999380.2	NP_999380.2	NP_999380.2 gastrotropin [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	42783000	0	0	0	0	0	0	0	NA	NA	NA	FABP6	FABP6;NA;NA;NA;NA	negative regulation of cell proliferation;triglyceride catabolic process;lipid metabolic process;lipid transport	GO:000828; GO:001943; GO:000662; GO:000686	cytosol;membrane;cytoplasm	GO:000582; GO:001602; GO:000573	 PPAR signaling pathway	hsa0332	lipid binding;bile acid binding	GO:000828; GO:003205
XP_020944374.1;XP_020944373.1;XP_020944372.1;NP_999381.1	XP_020944374.1;XP_020944373.1;XP_020944372.1;NP_999381.1	XP_020944374.1 inositol monophosphatase 1 isoform X1 [Sus scrofa];XP_020944373.1 inositol monophosphatase 1 isoform X1 [Sus scrofa];XP_020944372.1 inositol monophosphatase 1 isoform X1 [Sus scrofa];NP_999381.1 inositol monophosphatase 1 [Sus scrofa]	5	5	5	35637000	0	34936000	32190000	26572000	30082000	22237000	27600000	28939000	31044000	34443000	48274000	44541000	24441000	25479000	29093000	25502000	28903000	NA	NA	NA	IMPA1	IMPA1;IMPA1;IMPA1;IMPA1;NA	phosphatidylinositol biosynthetic process;phosphatidylinositol phosphorylation;inositol biosynthetic process;signal transduction;inositol phosphate metabolic process;phosphate-containing compound metabolic process	GO:000666; GO:004685; GO:000602; GO:000716; GO:004364; GO:000679	cytosol;cytoplasm	GO:000582; GO:000573	 Phosphatidylinositol signaling system; Metabolic pathways; Inositol phosphate metabolism	hsa0407; hsa0110; hsa0056	inositol monophosphate 1-phosphatase activity;protein binding;identical protein binding;inositol monophosphate 3-phosphatase activity;manganese ion binding;lithium ion binding;magnesium ion binding	GO:000893; GO:000551; GO:004280; GO:005283; GO:003014; GO:003140; GO:000028
NP_999388.1	NP_999388.1	NP_999388.1 thimet oligopeptidase [Sus scrofa]	6	6	6	0	32380000	24720000	0	0	26410000	25114000	22354000	24274000	35611000	20896000	32869000	26005000	30211000	0	24752000	23014000	26918000	NA	NA	NA	THOP1	THOP1;NA;NA;NA;NA	protein polyubiquitination;proteolysis;peptide metabolic process	GO:000020; GO:000650; GO:000651	cytosol;mitochondrial intermembrane space	GO:000582; GO:000575	 Renin-angiotensin system; African trypanosomiasis	hsa0461; hsa0514	metalloendopeptidase activity;metal ion binding;peptide binding	GO:000422; GO:004687; GO:004227
XP_005661470.1;NP_999396.2;XP_020936997.1;XP_020936988.1;XP_020936977.1;XP_020936969.1;XP_005660386.1;NP_001070683.1;XP_020939972.1;XP_013849207.1;XP_013849206.1;XP_013849205.1	XP_005661470.1;NP_999396.2;XP_020936997.1;XP_020936988.1;XP_020936977.1;XP_020936969.1	XP_005661470.1 polypyrimidine tract-binding protein 1 isoform X5 [Sus scrofa];NP_999396.2 polypyrimidine tract-binding protein 1 [Sus scrofa];XP_020936997.1 polypyrimidine tract-binding protein 1 isoform X4 [Sus scrofa];XP_020936988.1 polypyrimidine tract-	11	11	11	123480000	120510000	122000000	125490000	108640000	140920000	115590000	122470000	123990000	127100000	133530000	124380000	158480000	124930000	146070000	143320000	130250000	135840000	NA	NA	NA	PTBP1	PTBP1;PTBP1;PTBP1;PTBP1;PTBP1	mRNA splicing, via spliceosome;positive regulation of protein dephosphorylation;negative regulation of mRNA splicing, via spliceosome;negative regulation of muscle cell differentiation;positive regulation of calcineurin-NFAT signaling cascade;regulation of alternative mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;negative regulation of RNA splicing;mRNA processing;IRES-dependent viral translational initiation;RNA splicing;RNA metabolic process	GO:000039; GO:003530; GO:004802; GO:005114; GO:007088; GO:000038; GO:000854; GO:003311; GO:000639; GO:007552; GO:000838; GO:001607	nucleolus;nucleoplasm;membrane;extracellular exosome	GO:000573; GO:000565; GO:001602; GO:007006	"NA"	"NA"	poly-pyrimidine tract binding;pre-mRNA binding;protein binding;RNA binding	GO:000818; GO:003600; GO:000551; GO:000372
XP_005655046.1;NP_999398.1	XP_005655046.1;NP_999398.1	XP_005655046.1 glutaredoxin-1 isoform X1 [Sus scrofa];NP_999398.1 glutaredoxin-1 [Sus scrofa]	4	4	4	104160000	101350000	148420000	124450000	59639000	63237000	104480000	99975000	147090000	141750000	81321000	120370000	70757000	111100000	79683000	98527000	85622000	79485000	NA	NA	NA	GLRX	GLRX;GLRX;NA;NA;NA	positive regulation of membrane potential;positive regulation of sodium ion transmembrane transporter activity;cell redox homeostasis;protein deglutathionylation;nucleobase-containing small molecule interconversion;electron transport chain	GO:004583; GO:200065; GO:004545; GO:008005; GO:001594; GO:002290	cytosol;nucleus;extracellular exosome	GO:000582; GO:000563; GO:007006	"NA"	"NA"	glutathione disulfide oxidoreductase activity;glutathione oxidoreductase activity;electron carrier activity;protein N-terminus binding	GO:001503; GO:009757; GO:000905; GO:004748
NP_999404.2;XP_020953962.1	NP_999404.2;XP_020953962.1	NP_999404.2 matrix metalloproteinase-14 precursor [Sus scrofa];XP_020953962.1 matrix metalloproteinase-14 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10184000	NA	NA	NA	MMP14	MMP14;MMP14;NA;NA;NA	response to oxidative stress;astrocyte cell migration;tissue remodeling;protein processing;response to organic cyclic compound;collagen catabolic process;response to estrogen;cell motility;lung development;craniofacial suture morphogenesis;angiogenesis;endochondral ossification;proteolysis;positive regulation of myotube differentiation;extracellular matrix disassembly;endodermal cell differentiation;ovarian follicle development;endothelial cell proliferation;response to hormone;positive regulation of macrophage migration;skeletal system development;response to mechanical stimulus;male gonad development;extracellular matrix organization;positive regulation of cell growth;zymogen activation;embryonic cranial skeleton morphogenesis;regulation of protein localization to plasma membrane;positive regulation of protein processing;negative regulation of focal adhesion assembly;head development;response to hypoxia;positive regulation of cell migration;positive regulation of B cell differentiation;negative regulation of Notch signaling pathway;branching morphogenesis of an epithelial tube;response to odorant	GO:000697; GO:004361; GO:004877; GO:001648; GO:001407; GO:003057; GO:004362; GO:004887; GO:003032; GO:009709; GO:000152; GO:000195; GO:000650; GO:001083; GO:002261; GO:003598; GO:000154; GO:000193; GO:000972; GO:190552; GO:000150; GO:000961; GO:000858; GO:003019; GO:003030; GO:003163; GO:004870; GO:190307; GO:001095; GO:005189; GO:006032; GO:000166; GO:003033; GO:004557; GO:004574; GO:004875; GO:199083	integral component of plasma membrane;plasma membrane;extracellular space;focal adhesion;extracellular matrix;macropinosome;intermediate filament cytoskeleton;cytoplasm;Golgi lumen;nucleus;cytoplasmic vesicle;melanosome;cytosol	GO:000588; GO:000588; GO:000561; GO:000592; GO:003101; GO:004435; GO:004511; GO:000573; GO:000579; GO:000563; GO:003141; GO:004247; GO:000582	 GnRH signaling pathway; TNF signaling pathway	hsa0491; hsa0466	zinc ion binding;protein binding;serine-type endopeptidase activity;endopeptidase activity;metalloaminopeptidase activity;metalloendopeptidase activity;integrin binding	GO:000827; GO:000551; GO:000425; GO:000417; GO:007000; GO:000422; GO:000517
XP_005653120.2;XP_013848694.2;NP_999405.1;XP_013848698.2	XP_005653120.2;XP_013848694.2;NP_999405.1;XP_013848698.2	XP_005653120.2 V-type proton ATPase subunit H isoform X3 [Sus scrofa];XP_013848694.2 V-type proton ATPase subunit H isoform X1 [Sus scrofa];NP_999405.1 V-type proton ATPase subunit H [Sus scrofa];XP_013848698.2 V-type proton ATPase subunit H isoform X2 [Su	2	2	2	0	6481900	0	0	8539600	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ATP6V1H	ATP6V1H;ATP6V1H;ATP6V1H;ATP6V1H;NA	vacuolar acidification;ion transmembrane transport;regulation of catalytic activity;endocytosis;ATP hydrolysis coupled proton transport;regulation of defense response to virus by virus;regulation of macroautophagy;insulin receptor signaling pathway;transferrin transport	GO:000703; GO:003422; GO:005079; GO:000689; GO:001599; GO:005069; GO:001624; GO:000828; GO:003357	extracellular exosome;vacuolar proton-transporting V-type ATPase, V1 domain;plasma membrane;lysosomal membrane;cytosol	GO:007006; GO:000022; GO:000588; GO:000576; GO:000582	 Phagosome; Oxidative phosphorylation; Synaptic vesicle cycle; Rheumatoid arthritis; Epithelial cell signaling in Helicobacter pylori infection; Metabolic pathways; Lysosome; Vibrio cholerae infection; Tuberculosis	hsa0414; hsa0019; hsa0472; hsa0532; hsa0512; hsa0110; hsa0414; hsa0511; hsa0515	proton-transporting ATPase activity, rotational mechanism;protein binding;enzyme regulator activity;ATPase activity	GO:004696; GO:000551; GO:003023; GO:001688
XP_020937027.1;NP_999407.1;XP_020937021.1;XP_020937048.1;XP_020937043.1;XP_020937035.1	XP_020937027.1;NP_999407.1;XP_020937021.1;XP_020937048.1;XP_020937043.1;XP_020937035.1	XP_020937027.1 coagulation factor XII isoform X2 [Sus scrofa];NP_999407.1 coagulation factor XII precursor [Sus scrofa];XP_020937021.1 coagulation factor XII isoform X1 [Sus scrofa];XP_020937048.1 coagulation factor XII isoform X5 [Sus scrofa];XP_020937043	7	7	7	0	34306000	0	0	43141000	99133000	37632000	23253000	0	33926000	0	52327000	0	37108000	46864000	0	43606000	64332000	NA	NA	NA	F12	F12;F12;F12;F12;F12	plasma kallikrein-kinin cascade;fibrinolysis;Factor XII activation;positive regulation of fibrinolysis;positive regulation of plasminogen activation;positive regulation of blood coagulation;response to misfolded protein;blood coagulation, intrinsic pathway;protein autoprocessing;zymogen activation;protein processing;innate immune response;proteolysis	GO:000235; GO:004273; GO:000254; GO:005191; GO:001075; GO:003019; GO:005178; GO:000759; GO:001654; GO:003163; GO:001648; GO:004508; GO:000650	extracellular region;extracellular space;rough endoplasmic reticulum;plasma membrane;extracellular exosome	GO:000557; GO:000561; GO:000579; GO:000588; GO:007006	 Complement and coagulation cascades	hsa0461	misfolded protein binding;calcium ion binding;protein binding;serine-type endopeptidase activity	GO:005178; GO:000550; GO:000551; GO:000425
XP_013845457.1;XP_005657075.1;XP_005657074.1;NP_999415.1	XP_013845457.1;XP_005657075.1;XP_005657074.1;NP_999415.1	XP_013845457.1 platelet-activating factor acetylhydrolase IB subunit alpha isoform X1 [Sus scrofa];XP_005657075.1 platelet-activating factor acetylhydrolase IB subunit alpha isoform X1 [Sus scrofa];XP_005657074.1 platelet-activating factor acetylhydrolase	9	9	9	71349000	101110000	101250000	80069000	69115000	84158000	82782000	91238000	80269000	74012000	87237000	93074000	78290000	95930000	81389000	92153000	95914000	98404000	NA	NA	NA	PAFAH1B1	PAFAH1B1;PAFAH1B1;PAFAH1B1;PAFAH1B1;NA	G2/M transition of mitotic cell cycle;neuron migration;positive regulation of cytokine-mediated signaling pathway;chemical synaptic transmission;protein secretion;lipid catabolic process;cerebral cortex development;positive regulation of embryonic development;negative regulation of JNK cascade;regulation of microtubule cytoskeleton organization;cochlea development;microtubule cytoskeleton organization;regulation of G2/M transition of mitotic cell cycle;stem cell division;transmission of nerve impulse;vesicle transport along microtubule;regulation of microtubule motor activity;acrosome assembly;neuroblast proliferation;hippocampus development;establishment of planar polarity of embryonic epithelium;auditory receptor cell development;microtubule-based process;actin cytoskeleton organization;nuclear migration;microtubule organizing center organization;neuromuscular process controlling balance;ameboidal-type cell migration;adult locomotory behavior;corpus callosum morphogenesis;osteoclast development;brain morphogenesis;nuclear envelope disassembly;establishment of centrosome localization;establishment of mitotic spindle orientation;regulation of GTPase activity;cortical microtubule organization;platelet activating factor metabolic process;positive regulation of dendritic spine morphogenesis;microtubule cytoskeleton organization involved in establishment of planar polarity;ciliary basal body docking;retrograde axonal transport;positive regulation of mitotic cell cycle;learning or memory;negative regulation of neuron projection development;layer formation in cerebral cortex;cerebral cortex neuron differentiation;positive regulation of axon extension;microtubule sliding	GO:000008; GO:000176; GO:000196; GO:000726; GO:000930; GO:001604; GO:002198; GO:004001; GO:004632; GO:007050; GO:009010; GO:000022; GO:001038; GO:001714; GO:001922; GO:004749; GO:200057; GO:000167; GO:000740; GO:002176; GO:004224; GO:006011; GO:000701; GO:003003; GO:000709; GO:003102; GO:005088; GO:000166; GO:000834; GO:002154; GO:003603; GO:004885; GO:005108; GO:005166; GO:000013; GO:004308; GO:004362; GO:004646; GO:006100; GO:009017; GO:009771; GO:000809; GO:004593; GO:000761; GO:001097; GO:002181; GO:002189; GO:004577; GO:005101	stereocilium;astral microtubule;neuronal cell body;microtubule associated complex;extracellular exosome;axon cytoplasm;cytosol;centrosome;central region of growth cone;cell cortex;motile cilium;kinetochore;nuclear envelope;neuron projection;cell leading edge;cytoplasmic microtubule;nuclear membrane;perinuclear region of cytoplasm	GO:003242; GO:000023; GO:004302; GO:000587; GO:007006; GO:190411; GO:000582; GO:000581; GO:009072; GO:000593; GO:003151; GO:000077; GO:000563; GO:004300; GO:003125; GO:000588; GO:003196; GO:004847	 Metabolic pathways; Ether lipid metabolism	hsa0110; hsa0056	protein homodimerization activity;phospholipase binding;microtubule plus-end binding;heparin binding;dynactin binding;dynein intermediate chain binding;phosphoprotein binding;phospholipase A2 activity;microtubule binding;protein binding;dynein complex binding	GO:004280; GO:004327; GO:005101; GO:000820; GO:003445; GO:004550; GO:005121; GO:000462; GO:000801; GO:000551; GO:007084
NP_999423.2	NP_999423.2	NP_999423.2 cAMP-dependent protein kinase type II-alpha regulatory subunit [Sus scrofa]	11	9	9	135240000	136890000	160800000	145180000	111640000	120510000	165020000	161330000	149040000	132730000	144380000	132000000	123330000	155730000	147190000	157490000	133840000	120830000	NA	NA	NA	PRKAR2A	PRKAR2A;NA;NA;NA;NA	activation of protein kinase A activity;intracellular signal transduction;negative regulation of cAMP-dependent protein kinase activity;renal water homeostasis;blood coagulation;cGMP-mediated signaling;cellular response to glucagon stimulus	GO:003419; GO:003555; GO:200048; GO:000309; GO:000759; GO:001993; GO:007137	membrane;axoneme;cytosol;focal adhesion;cAMP-dependent protein kinase complex;nucleotide-activated protein kinase complex;plasma membrane;cytoplasm;macromolecular complex;centrosome;plasma membrane raft;extracellular exosome;ciliary base	GO:001602; GO:000593; GO:000582; GO:000592; GO:000595; GO:003158; GO:000588; GO:000573; GO:003299; GO:000581; GO:004485; GO:007006; GO:009754	 Insulin signaling pathway; Apoptosis	hsa0491; hsa0421	cAMP binding;protein binding;cAMP-dependent protein kinase regulator activity;protein domain specific binding;cAMP-dependent protein kinase inhibitor activity;3',5'-cyclic-GMP phosphodiesterase activity;ubiquitin protein ligase binding;protein kinase A catalytic subunit binding	GO:003055; GO:000551; GO:000860; GO:001990; GO:000486; GO:004755; GO:003162; GO:003423
XP_020946803.1;NP_999441.1;XP_020946802.1;XP_020946806.1;XP_020946804.1	XP_020946803.1;NP_999441.1;XP_020946802.1;XP_020946806.1;XP_020946804.1	XP_020946803.1 citrate synthase, mitochondrial isoform X2 [Sus scrofa];NP_999441.1 citrate synthase, mitochondrial precursor [Sus scrofa];XP_020946802.1 citrate synthase, mitochondrial isoform X1 [Sus scrofa];XP_020946806.1 citrate synthase, mitochondrial	12	12	12	1204300000	607900000	1182100000	518740000	994900000	509080000	1295500000	800920000	1133300000	666070000	889350000	558050000	489820000	613640000	853790000	800550000	706480000	516910000	NA	NA	NA	CS	CS;CS;CS;CS;CS	tricarboxylic acid cycle;carbohydrate metabolic process	GO:000609; GO:000597	nucleus;mitochondrial matrix;mitochondrion;extracellular exosome	GO:000563; GO:000575; GO:000573; GO:007006	 Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of antibiotics; Biosynthesis of amino acids; Citrate cycle (TCA cycle); Carbon metabolism; Glyoxylate and dicarboxylate metabolism	hsa0110; hsa0121; hsa0113; hsa0123; hsa0002; hsa0120; hsa0063	citrate (Si)-synthase activity;RNA binding	GO:000410; GO:000372
NP_999444.1;XP_013833613.1	NP_999444.1;XP_013833613.1	NP_999444.1 proteasome activator complex subunit 2 [Sus scrofa];XP_013833613.1 proteasome activator complex subunit 2 isoform X1 [Sus scrofa]	7	7	7	98301000	55425000	94476000	61019000	120400000	75321000	78459000	66232000	105700000	63471000	84877000	91202000	90869000	61709000	72797000	64731000	79342000	61808000	NA	NA	NA	PSME2	PSME2;PSME2;NA;NA;NA	regulation of proteasomal protein catabolic process;interleukin-12-mediated signaling pathway;regulation of G1/S transition of mitotic cell cycle;positive regulation of endopeptidase activity;post-translational protein modification;protein deubiquitination	GO:006113; GO:003572; GO:200004; GO:001095; GO:004368; GO:001657	nucleoplasm;cytoplasm;membrane;proteasome activator complex;proteasome complex;extracellular exosome;cytosol	GO:000565; GO:000573; GO:001602; GO:000853; GO:000050; GO:007006; GO:000582	 Antigen processing and presentation; Proteasome	hsa0461; hsa0305	endopeptidase activator activity;identical protein binding;protein binding	GO:006113; GO:004280; GO:000551
NP_999445.1	NP_999445.1	NP_999445.1 transitional endoplasmic reticulum ATPase [Sus scrofa]	28	28	3	927170000	907440000	948030000	802570000	951700000	672510000	950210000	877600000	903120000	850240000	886650000	898130000	876860000	896780000	949340000	880950000	899290000	779690000	NA	NA	NA	VCP	VCP;NA;NA;NA;NA	protein ubiquitination;ubiquitin-dependent ERAD pathway;cellular response to heat;transmembrane transport;regulation of apoptotic process;positive regulation of protein complex assembly;protein hexamerization;DNA repair;proteasomal protein catabolic process;macroautophagy;protein deubiquitination;endoplasmic reticulum unfolded protein response;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;ERAD pathway;ATP metabolic process;mitotic spindle disassembly;positive regulation of canonical Wnt signaling pathway;autophagosome maturation;positive regulation of Lys63-specific deubiquitinase activity;cellular response to arsenite ion;NADH metabolic process;ER to Golgi vesicle-mediated transport;positive regulation of mitochondrial membrane potential;protein homooligomerization;error-free translesion synthesis;establishment of protein localization;ER-associated misfolded protein catabolic process;positive regulation of ubiquitin-specific protease activity;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to DNA damage stimulus;viral genome replication;retrograde protein transport, ER to cytosol;proteasome-mediated ubiquitin-dependent protein catabolic process;neutrophil degranulation;flavin adenine dinucleotide catabolic process;positive regulation of ATP biosynthetic process;translesion synthesis;protein folding;double-strand break repair;protein N-linked glycosylation via asparagine;regulation of synapse organization;regulation of aerobic respiration;positive regulation of oxidative phosphorylation;endosome to lysosome transport via multivesicular body sorting pathway;stress granule disassembly;positive regulation of protein catabolic process;aggresome assembly	GO:001656; GO:003043; GO:003460; GO:005508; GO:004298; GO:003133; GO:003421; GO:000628; GO:001049; GO:001623; GO:001657; GO:003096; GO:003243; GO:003650; GO:004603; GO:005122; GO:009026; GO:009735; GO:190300; GO:190384; GO:000673; GO:000688; GO:001091; GO:005126; GO:007098; GO:004518; GO:007171; GO:200015; GO:000691; GO:000697; GO:001907; GO:003097; GO:004316; GO:004331; GO:007238; GO:200117; GO:001998; GO:000645; GO:000630; GO:001827; GO:005080; GO:190371; GO:190386; GO:003251; GO:003561; GO:004573; GO:007084	cytoplasmic stress granule;azurophil granule lumen;proteasome complex;Derlin-1 retrotranslocation complex;ficolin-1-rich granule lumen;VCP-NSFL1C complex;nucleus;site of double-strand break;extracellular exosome;glutamatergic synapse;extracellular region;endoplasmic reticulum membrane;VCP-NPL4-UFD1 AAA ATPase complex;ATPase complex;cytosol;cytoplasm;macromolecular complex;nucleoplasm;lipid particle;secretory granule lumen;intracellular membrane-bounded organelle;perinuclear region of cytoplasm	GO:001049; GO:003557; GO:000050; GO:003651; GO:190481; GO:199073; GO:000563; GO:003586; GO:007006; GO:009897; GO:000557; GO:000578; GO:003409; GO:190494; GO:000582; GO:000573; GO:003299; GO:000565; GO:000581; GO:003477; GO:004323; GO:004847	 Legionellosis; Protein processing in endoplasmic reticulum	hsa0513; hsa0414	identical protein binding;protein phosphatase binding;deubiquitinase activator activity;ubiquitin-specific protease binding;ubiquitin protein ligase binding;protein binding;ADP binding;BAT3 complex binding;ATP binding;K48-linked polyubiquitin binding;ubiquitin-like protein ligase binding;ATPase activity;lipid binding;RNA binding;polyubiquitin binding;MHC class I protein binding	GO:004280; GO:001990; GO:003580; GO:199038; GO:003162; GO:000551; GO:004353; GO:190428; GO:000552; GO:003643; GO:004438; GO:001688; GO:000828; GO:000372; GO:003159; GO:004228
NP_999447.1;CON__Q29RQ1	NP_999447.1	NP_999447.1 complement component C7 precursor [Sus scrofa]	11	11	11	60411000	40918000	35798000	36747000	66773000	83677000	62303000	0	60418000	0	51159000	0	70363000	39610000	45250000	40419000	55273000	56119000	NA	NA	NA	C7	C7;NA;NA;NA;NA	complement activation, classical pathway;cytolysis;complement activation;regulation of complement activation;cellular sodium ion homeostasis	GO:000695; GO:001983; GO:000695; GO:003044; GO:000688	extracellular region;membrane attack complex;extracellular exosome	GO:000557; GO:000557; GO:007006	 Complement and coagulation cascades; Prion diseases; Systemic lupus erythematosus	hsa0461; hsa0502; hsa0532	"NA"	"NA"
XP_020927833.1;NP_999451.1	XP_020927833.1;NP_999451.1	XP_020927833.1 lipoprotein lipase isoform X1 [Sus scrofa];NP_999451.1 lipoprotein lipase precursor [Sus scrofa]	8	8	8	87680000	82810000	69897000	35313000	56803000	49560000	50888000	60594000	39282000	53183000	116390000	68111000	37127000	58722000	92437000	66606000	74890000	63004000	NA	NA	NA	LPL	LPL;LPL;NA;NA;NA	positive regulation of macrophage derived foam cell differentiation;very-low-density lipoprotein particle remodeling;cholesterol homeostasis;triglyceride biosynthetic process;negative regulation of cellular response to insulin stimulus;fatty acid biosynthetic process;phospholipid metabolic process;response to drug;response to bacterium;regulation of lipoprotein lipase activity;response to glucose;positive regulation of sequestering of triglyceride;triglyceride homeostasis;response to cold;low-density lipoprotein particle mediated signaling;positive regulation of cholesterol storage;positive regulation of inflammatory response;positive regulation of chemokine secretion	GO:001074; GO:003437; GO:004263; GO:001943; GO:190007; GO:000663; GO:000664; GO:004249; GO:000961; GO:005100; GO:000974; GO:001089; GO:007032; GO:000940; GO:005509; GO:001088; GO:005072; GO:009019	cell surface;anchored component of membrane;extracellular space;extracellular region;very-low-density lipoprotein particle;plasma membrane;chylomicron	GO:000998; GO:003122; GO:000561; GO:000557; GO:003436; GO:000588; GO:004262	 Glycerolipid metabolism; Alzheimer's disease; PPAR signaling pathway	hsa0056; hsa0501; hsa0332	receptor binding;phospholipase activity;triglyceride lipase activity;lipoprotein lipase activity;triglyceride binding;apolipoprotein binding;protein binding;heparin binding	GO:000510; GO:000462; GO:000480; GO:000446; GO:001712; GO:003418; GO:000551; GO:000820
XP_020921906.1;NP_999455.1	XP_020921906.1;NP_999455.1	XP_020921906.1 signal transducer and activator of transcription 5A isoform X1 [Sus scrofa];NP_999455.1 signal transducer and activator of transcription 5A [Sus scrofa]	12	1	1	0	0	0	0	0	0	0	0	0	0	0	2885800	0	0	0	0	0	0	NA	NA	NA	STAT5A	STAT5A;STAT5A;NA;NA;NA	positive regulation of blood vessel endothelial cell migration;taurine metabolic process;JAK-STAT cascade;reelin-mediated signaling pathway;interleukin-9-mediated signaling pathway;positive regulation of endothelial cell proliferation;regulation of transcription from RNA polymerase II promoter;lactation;peptidyl-tyrosine phosphorylation;JAK-STAT cascade involved in growth hormone signaling pathway;cytokine-mediated signaling pathway;interleukin-15-mediated signaling pathway;regulation of multicellular organism growth	GO:004353; GO:001953; GO:000725; GO:003802; GO:003811; GO:000193; GO:000635; GO:000759; GO:001810; GO:006039; GO:001922; GO:003572; GO:004001	nucleoplasm;cytosol	GO:000565; GO:000582	 Acute myeloid leukemia; ErbB signaling pathway; Prolactin signaling pathway; HTLV-I infection; Chronic myeloid leukemia; Pathways in cancer; Jak-STAT signaling pathway	hsa0522; hsa0401; hsa0491; hsa0516; hsa0522; hsa0520; hsa0463	RNA polymerase II transcription factor activity, sequence-specific DNA binding;DNA binding;transcription factor activity, sequence-specific DNA binding;protein tyrosine kinase activity;protein binding	GO:000098; GO:000367; GO:000370; GO:000471; GO:000551
NP_999459.1	NP_999459.1	NP_999459.1 tropomodulin-3 [Sus scrofa]	10	10	10	64193000	92259000	75280000	81032000	68514000	88286000	71384000	93340000	63106000	75894000	79906000	109280000	124510000	103140000	88253000	85941000	79270000	102140000	NA	NA	NA	TMOD3	TMOD3;NA;NA;NA;NA	myofibril assembly;cell-cell adhesion;muscle contraction;erythrocyte development;pointed-end actin filament capping;positive regulation of mitotic cell cycle phase transition	GO:003023; GO:009860; GO:000693; GO:004882; GO:005169; GO:190199	striated muscle thin filament;cell-cell adherens junction;myofibril	GO:000586; GO:000591; GO:003001	"NA"	"NA"	tropomyosin binding;actin binding;cadherin binding involved in cell-cell adhesion	GO:000552; GO:000377; GO:009864
NP_999460.1	NP_999460.1	NP_999460.1 nitric oxide synthase, endothelial [Sus scrofa]	2	2	2	130250000	0	0	0	0	0	0	0	68299000	0	0	0	57114000	0	33823000	0	0	0	NA	NA	NA	NOS3	NOS3;NA;NA;NA;NA	endocardial cushion morphogenesis;cell redox homeostasis;regulation of blood pressure;response to heat;negative regulation of muscle hyperplasia;positive regulation of guanylate cyclase activity;positive regulation of blood vessel endothelial cell migration;negative regulation of calcium ion transport;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of potassium ion transport;oxidation-reduction process;arginine catabolic process;regulation of sodium ion transport;regulation of systemic arterial blood pressure by endothelin;nitric oxide mediated signal transduction;negative regulation of platelet activation;removal of superoxide radicals;vasodilation;positive regulation of angiogenesis;regulation of blood vessel size;regulation of nitric-oxide synthase activity;regulation of the force of heart contraction by chemical signal;endothelial cell migration;cofactor metabolic process;in utero embryonic development;aortic valve morphogenesis;negative regulation of blood pressure;homeostasis of number of cells within a tissue;ventricular septum morphogenesis;ovulation from ovarian follicle;negative regulation of cell proliferation;response to hormone;lung development;response to fluid shear stress;negative regulation of hydrolase activity;negative regulation of biomineral tissue development;angiogenesis;nitric oxide biosynthetic process;mitochondrion organization;positive regulation of gene expression;lipopolysaccharide-mediated signaling pathway;response to lipopolysaccharide;blood vessel remodeling;smooth muscle hyperplasia	GO:000320; GO:004545; GO:000821; GO:000940; GO:001474; GO:003128; GO:004353; GO:005192; GO:190204; GO:004326; GO:005511; GO:000652; GO:000202; GO:000310; GO:000726; GO:001054; GO:001943; GO:004231; GO:004576; GO:005088; GO:005099; GO:000305; GO:004354; GO:005118; GO:000170; GO:000318; GO:004577; GO:004887; GO:006041; GO:000154; GO:000828; GO:000972; GO:003032; GO:003440; GO:005134; GO:007016; GO:000152; GO:000680; GO:000700; GO:001062; GO:003166; GO:003249; GO:000197; GO:001480	plasma membrane;nucleus;Golgi apparatus;cytoplasm;cytoskeleton;vesicle membrane;Golgi membrane;endocytic vesicle membrane;cytosol;caveola	GO:000588; GO:000563; GO:000579; GO:000573; GO:000585; GO:001250; GO:000013; GO:003066; GO:000582; GO:000590	 PI3K-Akt signaling pathway; Estrogen signaling pathway; Oxytocin signaling pathway; Insulin resistance; Metabolic pathways; HIF-1 signaling pathway; cGMP-PKG signaling pathway; VEGF signaling pathway; Arginine and proline metabolism; Sphingolipid signaling pathway; Arginine biosynthesis; Platelet activation	hsa0415; hsa0491; hsa0492; hsa0493; hsa0110; hsa0406; hsa0402; hsa0437; hsa0033; hsa0407; hsa0022; hsa0461	heme binding;scaffold protein binding;protein binding;actin monomer binding;tetrahydrobiopterin binding;nitric-oxide synthase activity;cadmium ion binding;FMN binding;oxidoreductase activity;NADP binding;NADPH-hemoprotein reductase activity	GO:002003; GO:009711; GO:000551; GO:000378; GO:003461; GO:000451; GO:004687; GO:001018; GO:001649; GO:005066; GO:000395
XP_020946830.1;XP_020946829.1;XP_020946828.1;NP_999465.1	XP_020946830.1;XP_020946829.1;XP_020946828.1;NP_999465.1	XP_020946830.1 microsomal glutathione S-transferase 1 isoform X1 [Sus scrofa];XP_020946829.1 microsomal glutathione S-transferase 1 isoform X1 [Sus scrofa];XP_020946828.1 microsomal glutathione S-transferase 1 isoform X1 [Sus scrofa];NP_999465.1 microsomal	6	6	6	479750000	392460000	520200000	326760000	411890000	320040000	480960000	376870000	507610000	298600000	443290000	297290000	207960000	403110000	333370000	308830000	600050000	425340000	NA	NA	NA	MGST1	MGST1;MGST1;MGST1;MGST1;NA	glutathione derivative biosynthetic process;glutathione metabolic process;oxidation-reduction process;cellular response to lipid hydroperoxide;response to organonitrogen compound;prostaglandin biosynthetic process;xenobiotic metabolic process;Leydig cell differentiation;response to lipopolysaccharide;protein homotrimerization;response to drug;neutrophil degranulation;cellular oxidant detoxification	GO:190168; GO:000674; GO:005511; GO:007144; GO:001024; GO:000151; GO:000680; GO:003332; GO:003249; GO:007020; GO:004249; GO:004331; GO:009886	mitochondrial outer membrane;peroxisomal membrane;endoplasmic reticulum;plasma membrane;apical part of cell;nucleus;azurophil granule membrane;integral component of membrane;mitochondrion	GO:000574; GO:000577; GO:000578; GO:000588; GO:004517; GO:000563; GO:003557; GO:001602; GO:000573	 Metabolism of xenobiotics by cytochrome P450; Drug metabolism - cytochrome P450; Glutathione metabolism; Chemical carcinogenesis	hsa0098; hsa0098; hsa0048; hsa0520	protein binding;protein homodimerization activity;glutathione peroxidase activity;glutathione transferase activity;prostaglandin-E synthase activity;glutathione binding	GO:000551; GO:004280; GO:000460; GO:000436; GO:005022; GO:004329
NP_999466.2;XP_020937157.1	NP_999466.2;XP_020937157.1	NP_999466.2 catalase [Sus scrofa];XP_020937157.1 catalase isoform X1 [Sus scrofa]	31	31	31	4189500000	5265600000	5057700000	4301200000	4361000000	3761800000	4814500000	4659500000	5019600000	4582400000	4557600000	6466000000	3112600000	4340200000	5504200000	4646600000	3978500000	4066700000	NA	NA	NA	CAT	CAT;CAT;NA;NA;NA	cholesterol metabolic process;aerobic respiration;response to ozone;response to hyperoxia;ureteric bud development;protein targeting to peroxisome;triglyceride metabolic process;response to cadmium ion;response to insulin;positive regulation of NF-kappaB transcription factor activity;aging;cellular response to oxidative stress;response to hydrogen peroxide;neutrophil degranulation;response to reactive oxygen species;response to hypoxia;UV protection;response to inactivity;hydrogen peroxide catabolic process;response to fatty acid;response to phenylpropanoid;negative regulation of apoptotic process;response to lead ion;protein tetramerization;positive regulation of cell division;negative regulation of NF-kappaB transcription factor activity;response to vitamin A;response to vitamin E;response to L-ascorbic acid;cellular oxidant detoxification;osteoblast differentiation;response to light intensity;positive regulation of phosphatidylinositol 3-kinase signaling;protein homotetramerization;response to activity;hemoglobin metabolic process;response to estradiol;response to ethanol;cellular response to growth factor stimulus	GO:000820; GO:000906; GO:001019; GO:005509; GO:000165; GO:000662; GO:000664; GO:004668; GO:003286; GO:005109; GO:000756; GO:003459; GO:004254; GO:004331; GO:000030; GO:000166; GO:000965; GO:001485; GO:004274; GO:007054; GO:008018; GO:004306; GO:001028; GO:005126; GO:005178; GO:003208; GO:003318; GO:003319; GO:003359; GO:009886; GO:000164; GO:000964; GO:001406; GO:005128; GO:001482; GO:002002; GO:003235; GO:004547; GO:007136	plasma membrane;extracellular region;Golgi apparatus;secretory granule lumen;endoplasmic reticulum;peroxisomal membrane;mitochondrial intermembrane space;intracellular membrane-bounded organelle;extracellular exosome;cytosol;ficolin-1-rich granule lumen;membrane;lysosome;focal adhesion	GO:000588; GO:000557; GO:000579; GO:003477; GO:000578; GO:000577; GO:000575; GO:004323; GO:007006; GO:000582; GO:190481; GO:001602; GO:000576; GO:000592	 Glyoxylate and dicarboxylate metabolism; Biosynthesis of antibiotics; Peroxisome; Amyotrophic lateral sclerosis (ALS); Tryptophan metabolism; Carbon metabolism; FoxO signaling pathway	hsa0063; hsa0113; hsa0414; hsa0501; hsa0038; hsa0120; hsa0406	receptor binding;NADP binding;identical protein binding;antioxidant activity;heme binding;aminoacylase activity;catalase activity;metal ion binding;oxidoreductase activity, acting on peroxide as acceptor;enzyme binding	GO:000510; GO:005066; GO:004280; GO:001620; GO:002003; GO:000404; GO:000409; GO:004687; GO:001668; GO:001989
NP_999469.1	NP_999469.1	NP_999469.1 proteasome activator complex subunit 1 [Sus scrofa]	10	10	10	197430000	119740000	173290000	112590000	187280000	138590000	165630000	137620000	168820000	110160000	179340000	152940000	196650000	142180000	155070000	120890000	154350000	130390000	NA	NA	NA	PSME1	PSME1;NA;NA;NA;NA	regulation of G1/S transition of mitotic cell cycle;protein deubiquitination;post-translational protein modification;regulation of proteasomal protein catabolic process;antigen processing and presentation of exogenous antigen;positive regulation of endopeptidase activity	GO:200004; GO:001657; GO:004368; GO:006113; GO:001988; GO:001095	cytosol;cytoplasm;proteasome complex;proteasome activator complex;extracellular exosome;nucleoplasm	GO:000582; GO:000573; GO:000050; GO:000853; GO:007006; GO:000565	 Proteasome; Antigen processing and presentation	hsa0305; hsa0461	protein binding;endopeptidase activator activity	GO:000551; GO:006113
NP_999471.1;XP_020937169.1;XP_020937173.1	NP_999471.1;XP_020937169.1;XP_020937173.1	NP_999471.1 peroxisomal multifunctional enzyme type 2 [Sus scrofa];XP_020937169.1 peroxisomal multifunctional enzyme type 2 isoform X1 [Sus scrofa];XP_020937173.1 peroxisomal multifunctional enzyme type 2 isoform X2 [Sus scrofa]	27	27	27	793850000	506330000	941480000	393760000	816770000	431290000	990380000	512070000	1251000000	584610000	824040000	467430000	278490000	470620000	643770000	480650000	762970000	594000000	NA	NA	NA	HSD17B4	HSD17B4;HSD17B4;HSD17B4;NA;NA	osteoblast differentiation;fatty acid beta-oxidation;androgen metabolic process;estrogen metabolic process;Sertoli cell development;fatty acid beta-oxidation using acyl-CoA oxidase;very long-chain fatty-acyl-CoA metabolic process;protein targeting to peroxisome;bile acid biosynthetic process;alpha-linolenic acid metabolic process;very long-chain fatty acid metabolic process	GO:000164; GO:000663; GO:000820; GO:000821; GO:006000; GO:003354; GO:003611; GO:000662; GO:000669; GO:003610; GO:000003	cytosol;peroxisomal matrix;membrane;peroxisomal membrane	GO:000582; GO:000578; GO:001602; GO:000577	 Primary bile acid biosynthesis; Metabolic pathways; Peroxisome	hsa0012; hsa0110; hsa0414	protein homodimerization activity;3-hydroxyacyl-CoA dehydrogenase activity;17-beta-hydroxysteroid dehydrogenase (NAD+) activity;receptor binding;long-chain-enoyl-CoA hydratase activity;isomerase activity;3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity	GO:004280; GO:000385; GO:004459; GO:000510; GO:001650; GO:001685; GO:003398
NP_999472.1	NP_999472.1	NP_999472.1 10 kDa heat shock protein, mitochondrial [Sus scrofa]	6	6	6	567010000	274830000	565330000	199910000	714730000	255700000	433280000	311250000	424140000	275150000	474910000	346680000	304340000	272840000	395110000	308200000	405850000	274500000	NA	NA	NA	HSPE1	HSPE1;NA;NA;NA;NA	activation of cysteine-type endopeptidase activity involved in apoptotic process;osteoblast differentiation;protein folding;response to unfolded protein;chaperone mediated protein folding requiring cofactor	GO:000691; GO:000164; GO:000645; GO:000698; GO:005108	membrane;mitochondrial matrix;extracellular exosome;mitochondrion	GO:001602; GO:000575; GO:007006; GO:000573	"NA"	"NA"	RNA binding;chaperone binding;metal ion binding;ATP binding;protein binding	GO:000372; GO:005108; GO:004687; GO:000552; GO:000551
NP_999473.1;CON__Q03247	NP_999473.1	NP_999473.1 apolipoprotein E precursor [Sus scrofa]	9	9	9	307500000	343510000	299100000	448830000	299040000	532250000	293130000	409620000	315730000	301390000	352920000	606710000	250080000	424830000	295120000	293650000	296250000	390810000	NA	NA	NA	APOE	APOE;NA;NA;NA;NA	cytoskeleton organization;positive regulation of transcription, DNA-templated;regulation of axon extension;regulation of Cdc42 protein signal transduction;chylomicron remodeling;positive regulation by host of viral process;regulation of neuronal synaptic plasticity;maintenance of location in cell;response to caloric restriction;positive regulation of ERK1 and ERK2 cascade;intermediate-density lipoprotein particle clearance;negative regulation of triglyceride metabolic process;cellular oxidant detoxification;negative regulation of long-term synaptic potentiation;positive regulation of heparan sulfate binding;positive regulation of heparan sulfate proteoglycan binding;regulation of cellular response to very-low-density lipoprotein particle stimulus;retinoid metabolic process;cholesterol biosynthetic process;synaptic transmission, cholinergic;regulation of proteasomal protein catabolic process;positive regulation of cholesterol efflux;regulation of protein homooligomerization;lipoprotein catabolic process;vasodilation;negative regulation of MAP kinase activity;negative regulation of blood vessel endothelial cell migration;reverse cholesterol transport;negative regulation of inflammatory response;regulation of cholesterol metabolic process;regulation of behavioral fear response;G-protein coupled receptor signaling pathway;long-term memory;negative regulation of platelet activation;positive regulation of lipid biosynthetic process;virion assembly;neuron projection development;phospholipid efflux;positive regulation of dendritic spine development;AMPA glutamate receptor clustering;positive regulation of dendritic spine maintenance;response to dietary excess;cholesterol catabolic process;chylomicron remnant clearance;intracellular transport;positive regulation of nitric-oxide synthase activity;positive regulation of phospholipid efflux;negative regulation of endothelial cell proliferation;nitric oxide mediated signal transduction;negative regulation of neuron projection development;negative regulation of blood coagulation;regulation of cholesterol transport;cholesterol efflux;locomotory exploration behavior;post-translational protein modification;cellular protein metabolic process;positive regulation of endocytosis;regulation of beta-amyloid clearance;regulation of amyloid fibril formation;triglyceride metabolic process;negative regulation of gene expression;cGMP-mediated signaling;cholesterol homeostasis;negative regulation of canonical Wnt signaling pathway;positive regulation of postsynaptic membrane organization;negative regulation of presynaptic membrane organization;negative regulation of beta-amyloid formation;positive regulation of lipid transport across blood brain barrier;response to reactive oxygen species;regulation of transcription from RNA polymerase II promoter;receptor-mediated endocytosis;cholesterol metabolic process;long-chain fatty acid transport;protein import;positive regulation of low-density lipoprotein particle receptor catabolic process;amyloid precursor protein metabolic process;regulation of innate immune response;negative regulation of cholesterol biosynthetic process;fatty acid homeostasis;negative regulation of neuron death;cellular calcium ion homeostasis;triglyceride catabolic process;negative regulation of cellular protein metabolic process;very-low-density lipoprotein particle clearance;negative regulation of neuron apoptotic process;artery morphogenesis;positive regulation of membrane protein ectodomain proteolysis;regulation of protein metabolic process;triglyceride homeostasis	GO:000701; GO:004589; GO:003051; GO:003248; GO:003437; GO:004479; GO:004816; GO:005165; GO:006177; GO:007037; GO:007183; GO:009020; GO:009886; GO:190027; GO:190585; GO:190586; GO:190589; GO:000152; GO:000669; GO:000727; GO:006113; GO:001087; GO:003246; GO:004215; GO:004231; GO:004340; GO:004353; GO:004369; GO:005072; GO:009018; GO:200082; GO:000718; GO:000761; GO:001054; GO:004688; GO:001906; GO:003117; GO:003370; GO:006099; GO:009711; GO:190295; GO:000202; GO:000670; GO:003438; GO:004690; GO:005100; GO:190299; GO:000193; GO:000726; GO:001097; GO:003019; GO:003237; GO:003334; GO:003564; GO:004368; GO:004426; GO:004580; GO:190022; GO:190590; GO:000664; GO:001062; GO:001993; GO:004263; GO:009009; GO:190162; GO:190163; GO:190243; GO:190300; GO:000030; GO:000635; GO:000689; GO:000820; GO:001590; GO:001703; GO:003280; GO:004298; GO:004508; GO:004554; GO:005508; GO:190121; GO:000687; GO:001943; GO:003226; GO:003444; GO:004352; GO:004884; GO:005104; GO:005124; GO:007032	plasma membrane;extracellular region;cytoplasm;neuronal cell body;synaptic cleft;extracellular vesicle;discoidal high-density lipoprotein particle;endocytic vesicle lumen;glutamatergic synapse;Golgi apparatus;dendrite;blood microparticle;clathrin-coated endocytic vesicle membrane;lipoprotein particle;membrane;extracellular space;extracellular matrix;nucleus;early endosome;endoplasmic reticulum lumen;chylomicron;extracellular exosome	GO:000588; GO:000557; GO:000573; GO:004302; GO:004308; GO:190356; GO:003436; GO:007168; GO:009897; GO:000579; GO:003042; GO:007256; GO:003066; GO:199077; GO:001602; GO:000561; GO:003101; GO:000563; GO:000576; GO:000578; GO:004262; GO:007006	 Alzheimer's disease	hsa0501	protein binding;lipid binding;cholesterol transporter activity;protein dimerization activity;cholesterol binding;macromolecular complex binding;tau protein binding;lipoprotein particle binding;heparin binding;protein homodimerization activity;heparan sulfate proteoglycan binding;low-density lipoprotein particle receptor binding;lipid transporter activity;antioxidant activity;phosphatidylcholine-sterol O-acyltransferase activator activity;beta-amyloid binding;very-low-density lipoprotein particle receptor binding;structural molecule activity;phospholipid binding;metal chelating activity	GO:000551; GO:000828; GO:001712; GO:004698; GO:001548; GO:004487; GO:004815; GO:007181; GO:000820; GO:004280; GO:004339; GO:005075; GO:000531; GO:001620; GO:006022; GO:000154; GO:007032; GO:000519; GO:000554; GO:004691
NP_999478.1;XP_020938922.1	NP_999478.1;XP_020938922.1	NP_999478.1 thioredoxin [Sus scrofa];XP_020938922.1 thioredoxin isoform X1 [Sus scrofa]	9	9	9	994050000	614220000	731740000	489510000	674910000	471010000	692020000	507750000	720440000	559500000	681820000	501680000	718380000	637730000	755260000	456700000	652920000	482330000	NA	NA	NA	TXN	TXN;TXN;NA;NA;NA	cell proliferation;response to radiation;positive regulation of DNA binding;negative regulation of transcription from RNA polymerase II promoter;oxidation-reduction process;glycerol ether metabolic process;negative regulation of hydrogen peroxide-induced cell death;signal transduction;activation of protein kinase B activity;cell-cell signaling;positive regulation of peptidyl-serine phosphorylation;positive regulation of protein kinase B signaling;cell redox homeostasis;negative regulation of protein export from nucleus	GO:000828; GO:000931; GO:004338; GO:000012; GO:005511; GO:000666; GO:190320; GO:000716; GO:003214; GO:000726; GO:003313; GO:005189; GO:004545; GO:004682	extracellular exosome;cytosol;nucleus	GO:007006; GO:000582; GO:000563	"NA"	"NA"	protein binding;RNA binding;protein disulfide oxidoreductase activity	GO:000551; GO:000372; GO:001503
NP_999483.1;XP_013850079.1	NP_999483.1	NP_999483.1 calpain small subunit 1 [Sus scrofa]	7	7	7	170920000	281620000	206070000	200680000	163220000	244950000	213800000	218760000	182900000	229040000	205590000	184390000	220230000	183940000	235890000	202200000	245830000	248600000	NA	NA	NA	CAPNS1	CAPNS1;NA;NA;NA;NA	proteolysis;positive regulation of cell proliferation;regulation of macroautophagy;cornification	GO:000650; GO:000828; GO:001624; GO:007026	cytosol;plasma membrane;membrane;extracellular exosome	GO:000582; GO:000588; GO:001602; GO:007006	"NA"	"NA"	protein binding;calcium ion binding;calcium-dependent cysteine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000550; GO:000419; GO:000417
NP_999488.1	NP_999488.1	NP_999488.1 junction plakoglobin [Sus scrofa]	10	10	9	0	9588800	11421000	12901000	41831000	0	0	13374000	0	20478000	0	20319000	0	0	0	24894000	0	19002000	NA	NA	NA	JUP	JUP;NA;NA;NA;NA	positive regulation of protein import into nucleus;regulation of ventricular cardiac muscle cell action potential;regulation of cell proliferation;cell migration;detection of mechanical stimulus;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of canonical Wnt signaling pathway;keratinization;adherens junction organization;negative regulation of blood vessel endothelial cell migration;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;neutrophil degranulation;positive regulation of angiogenesis;positive regulation of transcription from RNA polymerase II promoter;protein heterooligomerization;cellular response to indole-3-methanol;cytoskeletal anchoring at plasma membrane;cornification;endothelial cell-cell adhesion;protein localization to plasma membrane;positive regulation of cell-matrix adhesion;desmosome assembly;regulation of heart rate by cardiac conduction;cell-cell adhesion	GO:004230; GO:009891; GO:004212; GO:001647; GO:005098; GO:005109; GO:009026; GO:003142; GO:003433; GO:004353; GO:008607; GO:004331; GO:004576; GO:004594; GO:005129; GO:007168; GO:000701; GO:007026; GO:007160; GO:007265; GO:000195; GO:000215; GO:008609; GO:009860	extracellular region;apicolateral plasma membrane;desmosome;specific granule lumen;intermediate filament;actin cytoskeleton;gamma-catenin-TCF7L2 complex;cytosol;cytoplasm;fascia adherens;focal adhesion;Z disc;intercalated disc;protein-DNA complex;cornified envelope;extracellular exosome;ficolin-1-rich granule lumen;nucleus;cytoskeleton;cytoplasmic side of plasma membrane;catenin complex	GO:000557; GO:001632; GO:003005; GO:003558; GO:000588; GO:001562; GO:007166; GO:000582; GO:000573; GO:000591; GO:000592; GO:003001; GO:001470; GO:003299; GO:000153; GO:007006; GO:190481; GO:000563; GO:000585; GO:000989; GO:001634	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Acute myeloid leukemia; Transcriptional misregulation in cancer	hsa0541; hsa0522; hsa0520	cell adhesion molecule binding;structural molecule activity;alpha-catenin binding;nuclear hormone receptor binding;cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication;transcription coactivator activity;protein homodimerization activity;protein binding;protein kinase binding	GO:005083; GO:000519; GO:004529; GO:003525; GO:008608; GO:000371; GO:004280; GO:000551; GO:001990
NP_999491.1	NP_999491.1	NP_999491.1 60S ribosomal protein L35 [Sus scrofa]	4	4	4	73414000	93824000	117770000	52394000	65314000	115660000	68349000	44641000	91523000	85128000	58840000	65014000	83038000	116470000	0	115620000	106760000	131290000	NA	NA	NA	RPL35	RPL35;NA;NA;NA;NA	maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);SRP-dependent cotranslational protein targeting to membrane;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000046; GO:000661; GO:000641; GO:000018	cytosolic large ribosomal subunit;membrane;cytosol;nucleolus	GO:002262; GO:001602; GO:000582; GO:000573	 Ribosome	hsa0301	structural constituent of ribosome;mRNA binding	GO:000373; GO:000372
NP_999495.1;CON__Q3ZBD7	NP_999495.1;CON__Q3ZBD7	NP_999495.1 glucose-6-phosphate isomerase [Sus scrofa];	18	18	18	1013300000	1022600000	1074100000	1027600000	842220000	784120000	952340000	924420000	1109300000	946590000	973390000	806730000	782240000	1028700000	1037700000	1007100000	1552800000	900830000	NA	NA	+	GPI	GPI;NA;NA;NA;NA	in utero embryonic development;carbohydrate metabolic process;hemostasis;response to muscle stretch;glucose homeostasis;gluconeogenesis;neutrophil degranulation;aldehyde catabolic process;response to testosterone;negative regulation of neuron apoptotic process;mesoderm formation;regulation of receptor activity;positive regulation of endothelial cell migration;response to progesterone;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;response to morphine;methylglyoxal biosynthetic process;response to cadmium ion;response to estradiol;erythrocyte homeostasis;response to immobilization stress;positive regulation of immunoglobulin secretion;canonical glycolysis;humoral immune response;learning or memory;glucose 6-phosphate metabolic process	GO:000170; GO:000597; GO:000759; GO:003599; GO:004259; GO:000609; GO:004331; GO:004618; GO:003357; GO:004352; GO:000170; GO:001046; GO:001059; GO:003257; GO:004315; GO:004327; GO:001924; GO:004668; GO:003235; GO:003410; GO:003590; GO:005102; GO:006162; GO:000695; GO:000761; GO:005115	plasma membrane;extracellular region;neuron projection;membrane;secretory granule lumen;extracellular exosome;ciliary membrane;ficolin-1-rich granule lumen;nucleoplasm;cytosol	GO:000588; GO:000557; GO:004300; GO:001602; GO:003477; GO:007006; GO:006017; GO:190481; GO:000565; GO:000582	 Pentose phosphate pathway; Starch and sucrose metabolism; Glycolysis / Gluconeogenesis; Metabolic pathways; Carbon metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of antibiotics	hsa0003; hsa0050; hsa0001; hsa0110; hsa0120; hsa0052; hsa0113	ubiquitin protein ligase binding;intramolecular transferase activity;growth factor activity;monosaccharide binding;glucose-6-phosphate isomerase activity;cytokine activity	GO:003162; GO:001686; GO:000808; GO:004802; GO:000434; GO:000512
NP_999496.1	NP_999496.1	NP_999496.1 hydroxyacyl-coenzyme A dehydrogenase, mitochondrial precursor [Sus scrofa]	10	10	10	1188800000	579870000	849660000	565180000	948720000	318250000	899910000	771630000	1014100000	612130000	896750000	911350000	487590000	566140000	993900000	795570000	681090000	598980000	NA	NA	NA	HADH	HADH;NA;NA;NA;NA	negative regulation of insulin secretion;fatty acid beta-oxidation;response to insulin;response to activity;response to drug	GO:004667; GO:000663; GO:003286; GO:001482; GO:004249	nucleoplasm;cytoplasm;mitochondrial matrix	GO:000565; GO:000573; GO:000575	 Lysine degradation; Butanoate metabolism; Metabolic pathways; Biosynthesis of antibiotics; Fatty acid elongation; Fatty acid metabolism; Valine, leucine and isoleucine degradation; Fatty acid degradation; Tryptophan metabolism	hsa0031; hsa0065; hsa0110; hsa0113; hsa0006; hsa0121; hsa0028; hsa0007; hsa0038	3-hydroxyacyl-CoA dehydrogenase activity;NAD+ binding	GO:000385; GO:007040
NP_999497.1	NP_999497.1	NP_999497.1 receptor of activated protein C kinase 1 [Sus scrofa]	14	14	14	309420000	340680000	372200000	266240000	313750000	367800000	326080000	274700000	329160000	286380000	310320000	309870000	400260000	311600000	308580000	314420000	366610000	373200000	NA	NA	NA	RACK1	RACK1;NA;NA;NA;NA	apoptotic process;protein ubiquitination;activation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of gene expression;negative regulation of Wnt signaling pathway;positive regulation of cell migration;rhythmic process;positive regulation of mitochondrial depolarization;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein homooligomerization;regulation of protein localization;pigmentation;negative regulation of phagocytosis;negative regulation of endoplasmic reticulum unfolded protein response;regulation of establishment of cell polarity;negative regulation of translation;negative regulation of protein tyrosine kinase activity;cell cycle;positive regulation of Golgi to plasma membrane protein transport;cellular response to glucose stimulus;rescue of stalled ribosome;positive regulation of ceramide biosynthetic process;regulation of cell cycle;positive regulation of apoptotic process;cellular response to growth factor stimulus;negative regulation of hydrogen peroxide-induced neuron death;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of protein phosphorylation;negative regulation of peptidyl-serine phosphorylation;positive regulation of cyclic-nucleotide phosphodiesterase activity;positive regulation of gastrulation;viral process;regulation of tumor necrosis factor-mediated signaling pathway;negative regulation of cell growth;positive regulation of GTPase activity;negative regulation of protein kinase B signaling;gastrulation;regulation of cell division	GO:000691; GO:001656; GO:000691; GO:001062; GO:003017; GO:003033; GO:004851; GO:005190; GO:003243; GO:003246; GO:003288; GO:004347; GO:005076; GO:190010; GO:200011; GO:001714; GO:006109; GO:000704; GO:004299; GO:007133; GO:007234; GO:200030; GO:005172; GO:004306; GO:007136; GO:190320; GO:200124; GO:000193; GO:003313; GO:005134; GO:200054; GO:001603; GO:001080; GO:003030; GO:004354; GO:005189; GO:000736; GO:005130	mitochondrion;dendrite;phagocytic cup;cytosol;nucleoplasm;midbody;cytosolic small ribosomal subunit;neuronal cell body;perikaryon;IRE1-RACK1-PP2A complex;small ribosomal subunit;nucleus;cytoplasm;perinuclear region of cytoplasm;extracellular exosome	GO:000573; GO:003042; GO:000189; GO:000582; GO:000565; GO:003049; GO:002262; GO:004302; GO:004320; GO:199063; GO:001593; GO:000563; GO:000573; GO:004847; GO:007006	 Measles	hsa0516	protein binding;enzyme binding;protein tyrosine kinase inhibitor activity;cadherin binding;protein kinase C binding;signaling adaptor activity;ion channel inhibitor activity;cyclin binding;protein homodimerization activity;ribosome binding;RNA binding;receptor binding;receptor tyrosine kinase binding;SH2 domain binding;cysteine-type endopeptidase activator activity involved in apoptotic process;protein phosphatase binding;protein complex scaffold	GO:000551; GO:001989; GO:003029; GO:004529; GO:000508; GO:003559; GO:000820; GO:003033; GO:004280; GO:004302; GO:000372; GO:000510; GO:003097; GO:004216; GO:000865; GO:001990; GO:003294
NP_999498.1	NP_999498.1	NP_999498.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 precursor [Sus scrofa]	26	26	26	327730000	392550000	378870000	409890000	410690000	410180000	415540000	426690000	384900000	367220000	448940000	527480000	477850000	464530000	455620000	464260000	444060000	511000000	NA	NA	NA	RPN1	RPN1;NA;NA;NA;NA	cellular protein modification process;protein N-linked glycosylation via asparagine	GO:000646; GO:001827	oligosaccharyltransferase complex;melanosome;integral component of membrane;endoplasmic reticulum membrane;rough endoplasmic reticulum;cytosol	GO:000825; GO:004247; GO:001602; GO:000578; GO:000579; GO:000582	 Protein processing in endoplasmic reticulum; N-Glycan biosynthesis; Metabolic pathways	hsa0414; hsa0051; hsa0110	RNA binding;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;protein binding	GO:000372; GO:000457; GO:000551
NP_999500.1;XP_020937225.1	NP_999500.1	NP_999500.1 tropomyosin alpha-4 chain [Sus scrofa]	30	20	10	606430000	752320000	628230000	733600000	530270000	814180000	674280000	887330000	565280000	733140000	761300000	642640000	1262500000	828590000	826440000	704950000	736210000	723180000	NA	NA	NA	TPM4	TPM4;NA;NA;NA;NA	actin filament organization;osteoblast differentiation;muscle filament sliding;muscle contraction	GO:000701; GO:000164; GO:003004; GO:000693	actin filament;cytosol;stress fiber;membrane;extracellular exosome;muscle thin filament tropomyosin;focal adhesion;cytoskeleton	GO:000588; GO:000582; GO:000172; GO:001602; GO:007006; GO:000586; GO:000592; GO:000585	 Dilated cardiomyopathy; Adrenergic signaling in cardiomyocytes; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0426; hsa0541	protein binding;protein heterodimerization activity;protein homodimerization activity;calcium ion binding;actin filament binding;structural constituent of muscle	GO:000551; GO:004698; GO:004280; GO:000550; GO:005101; GO:000830
XP_020924209.1;NP_999507.1	XP_020924209.1;NP_999507.1	XP_020924209.1 serine/threonine-protein kinase OSR1 isoform X1 [Sus scrofa];NP_999507.1 serine/threonine-protein kinase OSR1 [Sus scrofa]	8	8	7	37851000	44426000	44472000	50560000	35451000	36593000	53465000	48618000	51516000	36758000	47420000	0	38813000	41521000	47442000	45840000	48800000	46082000	NA	NA	NA	OXSR1	OXSR1;OXSR1;NA;NA;NA	chemokine (C-X-C motif) ligand 12 signaling pathway;signal transduction by trans-phosphorylation;protein autophosphorylation;cellular response to chemokine;osmosensory signaling pathway;peptidyl-threonine phosphorylation;activation of protein kinase activity;negative regulation of potassium ion transmembrane transporter activity;response to oxidative stress;intracellular signal transduction;positive regulation of T cell chemotaxis;stress-activated protein kinase signaling cascade;chemokine (C-C motif) ligand 21 signaling pathway;cellular hypotonic response;protein phosphorylation	GO:003814; GO:002301; GO:004677; GO:199086; GO:000723; GO:001810; GO:003214; GO:190101; GO:000697; GO:003555; GO:001082; GO:003109; GO:003811; GO:007147; GO:000646	cytoplasm;cytosol;extracellular exosome	GO:000573; GO:000582; GO:007006	"NA"	"NA"	ATP binding;protein kinase binding;identical protein binding;magnesium ion binding;protein serine/threonine kinase activity;protein binding	GO:000552; GO:001990; GO:004280; GO:000028; GO:000467; GO:000551
NP_999508.1	NP_999508.1	NP_999508.1 dihydropteridine reductase [Sus scrofa]	11	11	11	373010000	514290000	348210000	352080000	418240000	484080000	364620000	432450000	297750000	274770000	572800000	814970000	314510000	449940000	287510000	335860000	343850000	296610000	NA	NA	NA	QDPR	QDPR;NA;NA;NA;NA	response to glucagon;liver development;L-phenylalanine catabolic process;response to lead ion;electron transport chain;cellular amino acid metabolic process;dihydrobiopterin metabolic process;tetrahydrobiopterin biosynthetic process;cellular response to drug;response to aluminum ion	GO:003376; GO:000188; GO:000655; GO:001028; GO:002290; GO:000652; GO:005106; GO:000672; GO:003569; GO:001004	cytoplasm;neuron projection;extracellular exosome;cytosol	GO:000573; GO:004300; GO:007006; GO:000582	 Folate biosynthesis; Metabolic pathways	hsa0079; hsa0110	electron carrier activity;NADPH binding;protein homodimerization activity;6,7-dihydropteridine reductase activity	GO:000905; GO:007040; GO:004280; GO:000415
NP_999514.1	NP_999514.1	NP_999514.1 pyruvate carboxylase, mitochondrial [Sus scrofa]	58	58	58	7999400000	4032400000	7037700000	3511400000	6183100000	2656100000	8352000000	5174100000	8971300000	5764800000	5247400000	4329000000	2420900000	3632600000	5487900000	6320600000	4343500000	3329600000	NA	NA	NA	PC	PC;NA;NA;NA;NA	positive regulation by host of viral process;lipid metabolic process;pyruvate metabolic process;viral RNA genome packaging;negative regulation of gene expression;positive regulation by host of viral release from host cell;biotin metabolic process	GO:004479; GO:000662; GO:000609; GO:001907; GO:001062; GO:004479; GO:000676	mitochondrial matrix;mitochondrion;cytosol	GO:000575; GO:000573; GO:000582	 Biosynthesis of amino acids; Citrate cycle (TCA cycle); Pyruvate metabolism; Metabolic pathways; Carbon metabolism	hsa0123; hsa0002; hsa0062; hsa0110; hsa0120	pyruvate carboxylase activity;metal ion binding;protein binding;identical protein binding;biotin binding;ATP binding	GO:000473; GO:004687; GO:000551; GO:004280; GO:000937; GO:000552
NP_999518.1;XP_020934178.1;XP_013841254.1;XP_005665315.1;XP_013854654.1;XP_003127865.1;XP_020951649.1;XP_013854652.1;XP_013854651.1;XP_005665314.2;XP_005665312.1;XP_013854653.2;XP_013854649.1	NP_999518.1;XP_020934178.1;XP_013841254.1	NP_999518.1 peptidyl-prolyl cis-trans isomerase A [Sus scrofa];XP_020934178.1 peptidyl-prolyl cis-trans isomerase A isoform X2 [Sus scrofa];XP_013841254.1 peptidyl-prolyl cis-trans isomerase A isoform X1 [Sus scrofa]	13	13	13	3092600000	2989900000	2730900000	3078900000	2800400000	2682300000	2973900000	3013200000	2517900000	3417700000	2738900000	4668800000	2098900000	2767900000	2934000000	3312400000	2463200000	2837200000	NA	NA	NA	PPIA	PPIA;PPIA;PPIA;NA;NA	viral release from host cell;positive regulation of viral genome replication;entry into host cell;protein refolding;viral life cycle;interleukin-12-mediated signaling pathway;uncoating of virus;regulation of viral genome replication;leukocyte migration;RNA-dependent DNA biosynthetic process;positive regulation of protein secretion;protein peptidyl-prolyl isomerization;lipid particle organization;neutrophil degranulation;establishment of integrated proviral latency;protein folding	GO:001907; GO:004507; GO:003026; GO:004202; GO:001905; GO:003572; GO:001906; GO:004506; GO:005090; GO:000627; GO:005071; GO:000041; GO:003438; GO:004331; GO:007571; GO:000645	extracellular region;cytosol;secretory granule lumen;nucleus;vesicle;extracellular exosome;membrane;focal adhesion;macromolecular complex;ficolin-1-rich granule lumen;extracellular space	GO:000557; GO:000582; GO:003477; GO:000563; GO:003198; GO:007006; GO:001602; GO:000592; GO:003299; GO:190481; GO:000561	"NA"	"NA"	virion binding;cyclosporin A binding;unfolded protein binding;protein binding;peptidyl-prolyl cis-trans isomerase activity;RNA binding	GO:004679; GO:001601; GO:005108; GO:000551; GO:000375; GO:000372
NP_999520.1	NP_999520.1	NP_999520.1 epoxide hydrolase 1 precursor [Sus scrofa]	17	17	17	383390000	311520000	296990000	315420000	276910000	238070000	267510000	311710000	338660000	372090000	294090000	401770000	171380000	427360000	243550000	338880000	360120000	403730000	NA	NA	NA	EPHX1	EPHX1;NA;NA;NA;NA	diol biosynthetic process;aromatic compound catabolic process;cellular response to glucocorticoid stimulus;xenobiotic metabolic process;response to toxic substance;liver development;epoxide metabolic process	GO:003431; GO:001943; GO:007138; GO:000680; GO:000963; GO:000188; GO:009717	plasma membrane;endoplasmic reticulum membrane;organelle membrane;integral component of membrane	GO:000588; GO:000578; GO:003109; GO:001602	 Metabolism of xenobiotics by cytochrome P450; Bile secretion; Chemical carcinogenesis	hsa0098; hsa0497; hsa0520	enzyme binding;cis-stilbene-oxide hydrolase activity;epoxide hydrolase activity	GO:001989; GO:003396; GO:000430
NP_999527.2;XP_020924222.1	NP_999527.2;XP_020924222.1	NP_999527.2 lactotransferrin precursor [Sus scrofa];XP_020924222.1 lactotransferrin isoform X1 [Sus scrofa]	6	5	5	0	0	14768000	0	52685000	0	21249000	0	0	0	0	0	30847000	0	31369000	0	33027000	0	NA	NA	NA	LTF	LTF;LTF;NA;NA;NA	innate immune response in mucosa;humoral immune response;negative regulation of apoptotic process;ossification;antimicrobial humoral response;regulation of tumor necrosis factor production;positive regulation of osteoblast proliferation;cellular protein metabolic process;positive regulation of osteoblast differentiation;negative regulation of tumor necrosis factor (ligand) superfamily member 11 production;regulation of cytokine production;defense response to Gram-negative bacterium;neutrophil degranulation;positive regulation of chondrocyte proliferation;negative regulation of cysteine-type endopeptidase activity;negative regulation of osteoclast development;positive regulation of protein serine/threonine kinase activity;proteolysis;negative regulation of ATPase activity;positive regulation of toll-like receptor 4 signaling pathway;negative regulation of viral genome replication;positive regulation of NF-kappaB transcription factor activity;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of bone mineralization involved in bone maturation;killing of cells of other organism;negative regulation of lipopolysaccharide-mediated signaling pathway;membrane disruption in other organism;bone morphogenesis;retina homeostasis;iron assimilation by chelation and transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation by host of viral process;negative regulation of viral process;negative regulation of single-species biofilm formation in or on host organism	GO:000222; GO:000695; GO:004306; GO:000150; GO:001973; GO:003268; GO:003369; GO:004426; GO:004566; GO:200030; GO:000181; GO:005082; GO:004331; GO:190273; GO:200011; GO:200120; GO:007190; GO:000650; GO:003278; GO:003414; GO:004507; GO:005109; GO:006184; GO:190015; GO:003164; GO:003166; GO:005167; GO:006034; GO:000189; GO:003321; GO:004312; GO:004479; GO:004852; GO:190022	nucleus;tertiary granule lumen;cytoplasm;cell surface;other organism cell membrane;extracellular space;secretory granule;specific granule;macromolecular complex;extracellular exosome;phagocytic vesicle lumen;specific granule lumen;extracellular region	GO:000563; GO:190472; GO:000573; GO:000998; GO:004421; GO:000561; GO:003014; GO:004258; GO:003299; GO:007006; GO:009701; GO:003558; GO:000557	"NA"	"NA"	lipopolysaccharide binding;serine-type endopeptidase activity;cysteine-type endopeptidase inhibitor activity;heparin binding;DNA binding;protein serine/threonine kinase activator activity;protein binding;iron ion binding	GO:000153; GO:000425; GO:000486; GO:000820; GO:000367; GO:004353; GO:000551; GO:000550
NP_999528.1	NP_999528.1	NP_999528.1 40S ribosomal protein S12 [Sus scrofa]	7	7	7	183590000	196500000	215680000	204650000	231080000	297490000	255980000	203890000	180870000	238320000	218940000	255880000	241580000	220090000	191060000	201610000	232660000	263550000	NA	NA	NA	RPS12	RPS12;NA;NA;NA;NA	translational initiation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000641; GO:000661; GO:000018; GO:000641	cytosolic small ribosomal subunit;Golgi apparatus;nucleoplasm;cytosol;membrane;intracellular membrane-bounded organelle	GO:002262; GO:000579; GO:000565; GO:000582; GO:001602; GO:004323	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
XP_020924225.1;XP_020924224.1;XP_020924223.1;XP_013836946.1;XP_005669434.1;NP_999532.1	XP_020924225.1;XP_020924224.1;XP_020924223.1;XP_013836946.1;XP_005669434.1;NP_999532.1	XP_020924225.1 catenin beta-1 isoform X1 [Sus scrofa];XP_020924224.1 catenin beta-1 isoform X1 [Sus scrofa];XP_020924223.1 catenin beta-1 isoform X1 [Sus scrofa];XP_013836946.1 catenin beta-1 isoform X1 [Sus scrofa];XP_005669434.1 catenin beta-1 isoform X1	8	7	7	0	20943000	15412000	23821000	15716000	20218000	17179000	21705000	14852000	17275000	19863000	29838000	0	28836000	14864000	21862000	0	19379000	NA	NA	NA	CTNNB1	CTNNB1;CTNNB1;CTNNB1;CTNNB1;CTNNB1	embryonic axis specification;branching involved in ureteric bud morphogenesis;neuron migration;lens morphogenesis in camera-type eye;negative regulation of cell proliferation;dorsal/ventral axis specification;central nervous system vasculogenesis;androgen receptor signaling pathway;negative regulation of protein sumoylation;embryonic skeletal limb joint morphogenesis;embryonic hindlimb morphogenesis;canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition;bone resorption;positive regulation of histone H3-K4 methylation;regulation of timing of anagen;lung-associated mesenchyme development;endothelial tube morphogenesis;positive regulation of core promoter binding;beta-catenin-TCF complex assembly;beta-catenin destruction complex disassembly;branching involved in blood vessel morphogenesis;chromatin-mediated maintenance of transcription;chemical synaptic transmission;male genitalia development;hindbrain development;positive regulation of apoptotic process;embryonic foregut morphogenesis;regulation of smooth muscle cell proliferation;epithelial tube branching involved in lung morphogenesis;lung induction;dorsal root ganglion development;positive regulation of DNA-templated transcription, initiation;negative regulation of apoptotic signaling pathway;cell morphogenesis involved in differentiation;cell-matrix adhesion;protein localization to cell surface;embryonic heart tube development;positive regulation of MAPK cascade;negative regulation of mitotic cell cycle, embryonic;negative regulation of oligodendrocyte differentiation;lung cell differentiation;positive regulation of epithelial cell proliferation involved in prostate gland development;mesenchymal cell proliferation involved in lung development;fungiform papilla formation;cellular response to growth factor stimulus;cellular response to indole-3-methanol;endodermal cell fate commitment;positive regulation of neuroblast proliferation;Wnt signaling pathway, calcium modulating pathway;response to drug;positive regulation of epithelial to mesenchymal transition;osteoclast differentiation;regulation of myelination;positive regulation of telomere maintenance via telomerase;entry of bacterium into host cell;embryonic digit morphogenesis;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of neuron apoptotic process;positive regulation of osteoblast differentiation;negative regulation of osteoclast differentiation;positive regulation of skeletal muscle tissue development;oviduct development;epithelial cell differentiation involved in prostate gland development;renal vesicle formation;regulation of calcium ion import;midbrain dopaminergic neuron differentiation;neuron projection extension;in utero embryonic development;viral process;anterior/posterior axis specification;positive regulation of heparan sulfate proteoglycan biosynthetic process;positive regulation of transcription, DNA-templated;hair follicle morphogenesis;positive regulation of type I interferon production;adherens junction assembly;hair cell differentiation;positive regulation of endothelial cell differentiation;positive regulation of fibroblast growth factor receptor signaling pathway;cell maturation;regulation of neurogenesis;synapse organization;positive regulation of muscle cell differentiation;regulation of centromeric sister chromatid cohesion;renal inner medulla development;synaptic vesicle clustering;cell-cell adhesion;embryonic brain development;metanephros morphogenesis;cell adhesion;response to estradiol;T cell differentiation in thymus;positive regulation of transcription from RNA polymerase II promoter;thymus development;positive regulation of sequence-specific DNA binding transcription factor activity;canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation;regulation of secondary heart field cardioblast proliferation;ectoderm development;stem cell population maintenance;layer formation in cerebral cortex;pancreas development;negative regulation of chondrocyte differentiation;regulation of T cell proliferation;odontogenesis of dentin-containing tooth;regulation of fibroblast proliferation;synaptic vesicle transport;oocyte development;canonical Wnt signaling pathway;hair follicle placode formation;cranial ganglion development;nephron tubule formation;regulation of nephron tubule epithelial cell differentiation;positive regulation of chromatin-mediated maintenance of transcription;canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;positive regulation of determination of dorsal identity;negative regulation of transcription from RNA polymerase II promoter;epithelial to mesenchymal transition;neural plate development;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;Wnt signaling pathway;glial cell fate determination;negative regulation of angiogenesis;regulation of centriole-centriole cohesion;regulation of angiogenesis;positive regulation of telomerase activity;regulation of canonical Wnt signaling pathway;sympathetic ganglion development;negative regulation of oxidative stress-induced neuron death;regulation of protein localization to cell surface	GO:000057; GO:000165; GO:000176; GO:000208; GO:000828; GO:000995; GO:002200; GO:003052; GO:003323; GO:003602; GO:003511; GO:004433; GO:004545; GO:005157; GO:005188; GO:006048; GO:006115; GO:190479; GO:190483; GO:190488; GO:000156; GO:004809; GO:000726; GO:003053; GO:003090; GO:004306; GO:004861; GO:004866; GO:006044; GO:006049; GO:199079; GO:200014; GO:200123; GO:000090; GO:000716; GO:003439; GO:003505; GO:004341; GO:004597; GO:004871; GO:006047; GO:006076; GO:006091; GO:006119; GO:007136; GO:007168; GO:000171; GO:000205; GO:000722; GO:004249; GO:001071; GO:003031; GO:003164; GO:003221; GO:003563; GO:004273; GO:004312; GO:004352; GO:004566; GO:004567; GO:004864; GO:006006; GO:006074; GO:007203; GO:009027; GO:190494; GO:199013; GO:000170; GO:001603; GO:000994; GO:001090; GO:004589; GO:003106; GO:003248; GO:003433; GO:003531; GO:004560; GO:004574; GO:004846; GO:005076; GO:005080; GO:005114; GO:007060; GO:007205; GO:009709; GO:009860; GO:199040; GO:000333; GO:000715; GO:003235; GO:003307; GO:004594; GO:004853; GO:005109; GO:006132; GO:000326; GO:000739; GO:001982; GO:002181; GO:003101; GO:003233; GO:004212; GO:004247; GO:004814; GO:004848; GO:004859; GO:006007; GO:006078; GO:006155; GO:007207; GO:007218; GO:190450; GO:190495; GO:200001; GO:000012; GO:000183; GO:000184; GO:000334; GO:001605; GO:000740; GO:001652; GO:003099; GO:004576; GO:005197; GO:006082; GO:006154; GO:190320; GO:200000	centrosome;microvillus membrane;apical part of cell;postsynaptic density, intracellular component;membrane;flotillin complex;Z disc;extracellular exosome;beta-catenin-TCF7L2 complex;beta-catenin-TCF complex;transcription factor complex;bicellular tight junction;lateral plasma membrane;lamellipodium;protein-DNA complex;perinuclear region of cytoplasm;Schaffer collateral - CA1 synapse;cytoplasm;cell-cell junction;cell cortex;cell junction;Scrib-APC-beta-catenin complex;synapse;plasma membrane;nuclear euchromatin;beta-catenin destruction complex;postsynaptic membrane;cytosol;nucleus;catenin complex;spindle pole;nucleoplasm;presynaptic membrane;cell periphery;presynaptic active zone cytoplasmic component	GO:000581; GO:003152; GO:004517; GO:009909; GO:001602; GO:001660; GO:003001; GO:007006; GO:007036; GO:199090; GO:000566; GO:000592; GO:001632; GO:003002; GO:003299; GO:004847; GO:009868; GO:000573; GO:000591; GO:000593; GO:003005; GO:003475; GO:004520; GO:000588; GO:000571; GO:003087; GO:004521; GO:000582; GO:000563; GO:001634; GO:000092; GO:000565; GO:004273; GO:007194; GO:009883	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Hippo signaling pathway; Focal adhesion; HTLV-I infection; Thyroid hormone signaling pathway; Thyroid cancer; Rap1 signaling pathway; Adherens junction; Bacterial invasion of epithelial cells; Pathogenic Escherichia coli infection; Tight junction; Leukocyte transendothelial migration; Pathways in cancer; Wnt signaling pathway; Signaling pathways regulating pluripotency of stem cells	hsa0541; hsa0439; hsa0451; hsa0516; hsa0491; hsa0521; hsa0401; hsa0452; hsa0510; hsa0513; hsa0453; hsa0467; hsa0520; hsa0431; hsa0455	chromatin binding;enzyme binding;transcription factor activity, sequence-specific DNA binding;protein kinase binding;RNA polymerase II transcription factor binding;RNA polymerase II activating transcription factor binding;estrogen receptor binding;alpha-catenin binding;protein heterodimerization activity;protein C-terminus binding;transcription coactivator activity;transcription factor binding;SMAD binding;repressing transcription factor binding;disordered domain specific binding;nuclear hormone receptor binding;ion channel binding;androgen receptor binding;protein binding;I-SMAD binding	GO:000368; GO:001989; GO:000370; GO:001990; GO:000108; GO:000110; GO:003033; GO:004529; GO:004698; GO:000802; GO:000371; GO:000813; GO:004633; GO:007049; GO:009771; GO:003525; GO:004432; GO:005068; GO:000551; GO:007041
NP_999535.1;CON__Q3Y5Z3	NP_999535.1	NP_999535.1 adiponectin precursor [Sus scrofa]	6	6	6	1912100000	2766100000	1516100000	2030300000	1547200000	2163200000	2029900000	1636700000	1653000000	1641600000	1733100000	1381700000	1009500000	2111600000	1785100000	2707200000	1669600000	2239600000	NA	NA	NA	ADIPOQ	ADIPOQ;NA;NA;NA;NA	regulation of receptor activity;response to activity;positive regulation of glucose import;negative regulation of granulocyte differentiation;cellular response to insulin stimulus;negative regulation of heterotypic cell-cell adhesion;negative regulation of MAP kinase activity;negative regulation of gluconeogenesis;positive regulation of fatty acid metabolic process;protein heterotrimerization;detection of oxidative stress;negative regulation of intracellular protein transport;positive regulation of glycogen (starch) synthase activity;response to hypoxia;circadian rhythm;positive regulation of signal transduction;positive regulation of protein kinase A signaling;negative regulation of tumor necrosis factor-mediated signaling pathway;response to tumor necrosis factor;cellular response to drug;negative regulation of fat cell differentiation;negative regulation of blood pressure;negative regulation of hormone secretion;negative regulation of DNA biosynthetic process;negative regulation of protein autophosphorylation;negative regulation of low-density lipoprotein particle receptor biosynthetic process;brown fat cell differentiation;negative regulation of receptor binding;negative regulation of vascular associated smooth muscle cell migration;negative regulation of metanephric mesenchymal cell migration;positive regulation of cholesterol efflux;positive regulation of myeloid cell apoptotic process;low-density lipoprotein particle clearance;response to ethanol;negative regulation of ERK1 and ERK2 cascade;response to linoleic acid;cellular response to cAMP;cellular response to epinephrine stimulus;positive regulation of metanephric glomerular visceral epithelial cell development;regulation of fatty acid biosynthetic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of renal albumin absorption;positive regulation of protein phosphorylation;glucose metabolic process;response to sucrose;regulation of glucose metabolic process;negative regulation of transcription, DNA-templated;negative regulation of cell migration;negative regulation of tumor necrosis factor production;glucose homeostasis;negative regulation of macrophage differentiation;negative regulation of phagocytosis;negative regulation of synaptic transmission;response to glucocorticoid;negative regulation of vascular smooth muscle cell proliferation;negative regulation of platelet-derived growth factor receptor-alpha signaling pathway;response to nutrient;response to bacterium;protein homooligomerization;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of monocyte chemotactic protein-1 production;positive regulation of cAMP-dependent protein kinase activity;generation of precursor metabolites and energy;fatty acid beta-oxidation;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of macrophage derived foam cell differentiation;fatty acid oxidation;positive regulation of cellular protein metabolic process;positive regulation of interleukin-8 production;negative regulation of inflammatory response;protein localization to plasma membrane	GO:001046; GO:001482; GO:004632; GO:003085; GO:003286; GO:003411; GO:004340; GO:004572; GO:004592; GO:007020; GO:007099; GO:009031; GO:200046; GO:000166; GO:000762; GO:000996; GO:001073; GO:001080; GO:003461; GO:003569; GO:004559; GO:004577; GO:004688; GO:200027; GO:003195; GO:004571; GO:005087; GO:190012; GO:190475; GO:200059; GO:001087; GO:003303; GO:003438; GO:004547; GO:007037; GO:007054; GO:007132; GO:007187; GO:200047; GO:004230; GO:004312; GO:200053; GO:000193; GO:000600; GO:000974; GO:001090; GO:004589; GO:003033; GO:003272; GO:004259; GO:004565; GO:005076; GO:005080; GO:005138; GO:190470; GO:200058; GO:000758; GO:000961; GO:005126; GO:005073; GO:007163; GO:200048; GO:000609; GO:000663; GO:001064; GO:001074; GO:001939; GO:003227; GO:003275; GO:005072; GO:007265	collagen trimer;endoplasmic reticulum;extracellular region;extracellular space;cell surface	GO:000558; GO:000578; GO:000557; GO:000561; GO:000998	 Adipocytokine signaling pathway; Non-alcoholic fatty liver disease (NAFLD); PPAR signaling pathway; AMPK signaling pathway	hsa0492; hsa0493; hsa0332; hsa0415	receptor binding;sialic acid binding;extracellular matrix structural constituent;protein homodimerization activity;cytokine activity;hormone activity;protein binding	GO:000510; GO:003369; GO:000520; GO:004280; GO:000512; GO:000517; GO:000551
XP_005670361.1;XP_005670360.1;XP_005670359.1;NP_999537.1;XP_005670363.1;XP_005670362.1;XP_020924227.1;XP_020924226.1	XP_005670361.1;XP_005670360.1;XP_005670359.1;NP_999537.1;XP_005670363.1;XP_005670362.1;XP_020924227.1;XP_020924226.1	XP_005670361.1 amyloid beta A4 protein isoform X3 [Sus scrofa];XP_005670360.1 amyloid beta A4 protein isoform X2 [Sus scrofa];XP_005670359.1 amyloid beta A4 protein isoform X1 [Sus scrofa];NP_999537.1 amyloid-beta A4 protein precursor [Sus scrofa];XP_00567	4	4	4	0	0	0	12503000	0	0	0	11122000	0	6290100	0	0	0	0	0	9164600	0	0	NA	NA	NA	APP	APP;APP;APP;APP;APP	positive regulation of protein phosphorylation;regulation of translation;Notch signaling pathway;positive regulation of G2/M transition of mitotic cell cycle;regulation of Wnt signaling pathway;positive regulation of phosphorylation;innate immune response;collateral sprouting in absence of injury;synapse organization;cell adhesion;response to oxidative stress;cellular process;forebrain development;negative regulation of neuron differentiation;positive regulation of mitotic cell cycle;positive regulation of transcription from RNA polymerase II promoter;astrocyte activation;cognition;positive regulation of NF-kappaB transcription factor activity;neuron apoptotic process;positive regulation of ERK1 and ERK2 cascade;regulation of presynapse assembly;astrocyte activation involved in immune response;platelet degranulation;mRNA polyadenylation;protein phosphorylation;axo-dendritic transport;response to lead ion;positive regulation of peptidyl-serine phosphorylation;positive regulation of interleukin-1 beta biosynthetic process;cellular response to cAMP;positive regulation of NIK/NF-kappaB signaling;cellular response to beta-amyloid;negative regulation of low-density lipoprotein receptor activity;endocytosis;learning or memory;locomotory behavior;positive regulation of peptidyl-threonine phosphorylation;positive regulation of peptidase activity;dendrite development;regulation of multicellular organism growth;smooth endoplasmic reticulum calcium ion homeostasis;positive regulation of amyloid fibril formation;neuron projection maintenance;suckling behavior;cellular copper ion homeostasis;adult locomotory behavior;microglia development;neuron projection development;positive regulation of interleukin-6 biosynthetic process;regulation of peptidyl-tyrosine phosphorylation;cellular response to copper ion;amyloid fibril formation;cellular response to nerve growth factor stimulus;G-protein coupled receptor signaling pathway;visual learning;positive regulation of gene expression;neuron remodeling;positive regulation of protein binding;tumor necrosis factor production;ionotropic glutamate receptor signaling pathway;positive regulation of tumor necrosis factor biosynthetic process;cellular protein metabolic process;synaptic growth at neuromuscular junction;negative regulation of long-term synaptic potentiation;positive regulation of beta-amyloid formation;positive regulation of T cell migration;axonogenesis;cholesterol metabolic process;negative regulation of cell proliferation;extracellular matrix organization;modulation of age-related behavioral decline;regulation of long-term neuronal synaptic plasticity;positive regulation of protein metabolic process;cellular response to norepinephrine stimulus;modulation of excitatory postsynaptic potential;positive regulation of microglial cell activation;regulation of epidermal growth factor-activated receptor activity;regulation of gene expression;axon midline choice point recognition;post-translational protein modification;positive regulation of JNK cascade;neuromuscular process controlling balance;positive regulation of receptor activity;regulation of NMDA receptor activity	GO:000193; GO:000641; GO:000721; GO:001097; GO:003011; GO:004232; GO:004508; GO:004866; GO:005080; GO:000715; GO:000697; GO:000998; GO:003090; GO:004566; GO:004593; GO:004594; GO:004814; GO:005089; GO:005109; GO:005140; GO:007037; GO:190560; GO:000226; GO:000257; GO:000637; GO:000646; GO:000808; GO:001028; GO:003313; GO:005072; GO:007132; GO:190122; GO:190464; GO:190559; GO:000689; GO:000761; GO:000762; GO:001080; GO:001095; GO:001635; GO:004001; GO:005156; GO:190590; GO:199053; GO:000196; GO:000687; GO:000834; GO:001400; GO:003117; GO:004541; GO:005073; GO:007128; GO:199000; GO:199009; GO:000718; GO:000854; GO:001062; GO:001632; GO:003209; GO:003264; GO:003523; GO:004253; GO:004426; GO:005112; GO:190027; GO:190200; GO:200040; GO:000740; GO:000820; GO:000828; GO:003019; GO:009064; GO:004816; GO:005124; GO:007187; GO:009881; GO:190398; GO:000717; GO:001046; GO:001619; GO:004368; GO:004633; GO:005088; GO:200027; GO:200031	Golgi apparatus;perikaryon;membrane raft;astrocyte projection;integral component of membrane;clathrin-coated pit;recycling endosome;neuromuscular junction;ciliary rootlet;apical part of cell;synapse;perinuclear region of cytoplasm;extracellular exosome;Golgi-associated vesicle;endosome lumen;integral component of plasma membrane;platelet alpha granule lumen;dendritic spine;main axon;extracellular region;cytosol;nuclear envelope lumen;cytoplasm;endosome;cell-cell junction;trans-Golgi network membrane;receptor complex;spindle midzone;extracellular space;endoplasmic reticulum lumen;ER to Golgi transport vesicle;cell surface;presynaptic active zone;growth cone lamellipodium;growth cone filopodium;axon	GO:000579; GO:004320; GO:004512; GO:009744; GO:001602; GO:000590; GO:005503; GO:003159; GO:003525; GO:004517; GO:004520; GO:004847; GO:007006; GO:000579; GO:003190; GO:000588; GO:003109; GO:004319; GO:004430; GO:000557; GO:000582; GO:000564; GO:000573; GO:000576; GO:000591; GO:003258; GO:004323; GO:005123; GO:000561; GO:000578; GO:003013; GO:000998; GO:004878; GO:199076; GO:199081; GO:003042	 Serotonergic synapse; Alzheimer's disease	hsa0472; hsa0501	heparin binding;transition metal ion binding;serine-type endopeptidase inhibitor activity;growth factor receptor binding;protein binding;peptidase activator activity;receptor binding;receptor activator activity;DNA binding;identical protein binding;enzyme binding;PTB domain binding	GO:000820; GO:004691; GO:000486; GO:007085; GO:000551; GO:001650; GO:000510; GO:003054; GO:000367; GO:004280; GO:001989; GO:005142
NP_999538.1	NP_999538.1	NP_999538.1 translationally-controlled tumor protein [Sus scrofa]	4	4	4	65229000	47921000	40226000	48375000	58434000	51030000	60488000	47575000	63020000	54270000	49727000	0	44027000	44347000	49654000	39582000	54177000	49315000	NA	NA	NA	TPT1	TPT1;NA;NA;NA;NA	negative regulation of apoptotic process;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;cellular calcium ion homeostasis;regulation of apoptotic process;response to virus;calcium ion transport	GO:004306; GO:190223; GO:000687; GO:004298; GO:000961; GO:000681	cytoplasm;cytoplasmic microtubule;spindle pole;extracellular space;nucleus;multivesicular body;cytosol;extracellular exosome	GO:000573; GO:000588; GO:000092; GO:000561; GO:000563; GO:000577; GO:000582; GO:007006	"NA"	"NA"	RNA binding;calcium ion binding;protein binding	GO:000372; GO:000550; GO:000551
NP_999539.2;XP_013845373.1;XP_020922453.1;XP_013845371.1;XP_003131354.1	NP_999539.2	NP_999539.2 myosin light chain 1/3, skeletal muscle isoform [Sus scrofa]	10	10	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1887200000	0	NA	NA	NA	MYL1	MYL1;NA;NA;NA;NA	muscle filament sliding;muscle contraction;cardiac muscle contraction	GO:003004; GO:000693; GO:006004	myofibril;sarcomere;muscle myosin complex;cytosol	GO:003001; GO:003001; GO:000585; GO:000582	"NA"	"NA"	structural constituent of muscle;calcium ion binding	GO:000830; GO:000550
NP_999546.1	NP_999546.1	NP_999546.1 calcium/calmodulin-dependent protein kinase type II subunit delta [Sus scrofa]	5	3	3	0	12853000	0	12430000	13571000	11656000	12174000	12659000	0	13315000	12695000	0	0	0	11982000	11439000	15820000	0	NA	NA	NA	CAMK2D	CAMK2D;NA;NA;NA;NA	MAPK cascade;cellular response to calcium ion;regulation of heart rate by cardiac conduction;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;negative regulation of sodium ion transmembrane transporter activity;positive regulation of cardiac muscle cell apoptotic process;peptidyl-threonine phosphorylation;protein autophosphorylation;relaxation of cardiac muscle;negative regulation of sodium ion transmembrane transport;regulation of cardiac muscle cell action potential;regulation of relaxation of cardiac muscle;regulation of membrane depolarization;regulation of cell communication by electrical coupling;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;protein oligomerization;cardiac muscle cell contraction;regulation of cell growth;interferon-gamma-mediated signaling pathway;regulation of the force of heart contraction;regulation of heart contraction;positive regulation of cardiac muscle hypertrophy;protein phosphorylation;endoplasmic reticulum calcium ion homeostasis;regulation of cell communication by electrical coupling involved in cardiac conduction;regulation of transcription from RNA polymerase II promoter;regulation of ryanodine-sensitive calcium-release channel activity;regulation of cellular localization;regulation of histone deacetylase activity	GO:000016; GO:007127; GO:008609; GO:190251; GO:200065; GO:001066; GO:001810; GO:004677; GO:005511; GO:190230; GO:009890; GO:190189; GO:000325; GO:001064; GO:001088; GO:005125; GO:008600; GO:000155; GO:006033; GO:000202; GO:000801; GO:001061; GO:000646; GO:003246; GO:190184; GO:000635; GO:006031; GO:006034; GO:190172	nucleus;neuron projection;cytosol;cytoplasm;plasma membrane;sarcolemma;nucleoplasm;endocytic vesicle membrane;membrane;sarcoplasmic reticulum membrane	GO:000563; GO:004300; GO:000582; GO:000573; GO:000588; GO:004238; GO:000565; GO:003066; GO:001602; GO:003301	 Adrenergic signaling in cardiomyocytes; Melanogenesis; Glucagon signaling pathway; Tuberculosis; HIF-1 signaling pathway; Neurotrophin signaling pathway; Gastric acid secretion; Circadian entrainment; ErbB signaling pathway; Oocyte meiosis; Wnt signaling pathway; Proteoglycans in cancer; Calcium signaling pathway; Olfactory transduction; Glioma; Amphetamine addiction; Inflammatory mediator regulation of TRP channels	hsa0426; hsa0491; hsa0492; hsa0515; hsa0406; hsa0472; hsa0497; hsa0471; hsa0401; hsa0411; hsa0431; hsa0520; hsa0402; hsa0474; hsa0521; hsa0503; hsa0475	calmodulin binding;identical protein binding;ATP binding;sodium channel inhibitor activity;calmodulin-dependent protein kinase activity;ion channel binding;protein binding;protein serine/threonine kinase activity;Ras guanyl-nucleotide exchange factor activity;titin binding	GO:000551; GO:004280; GO:000552; GO:001987; GO:000468; GO:004432; GO:000551; GO:000467; GO:000508; GO:003143
XP_020939044.1;NP_999550.1;XP_020939049.1	XP_020939044.1;NP_999550.1;XP_020939049.1	XP_020939044.1 prostaglandin reductase 1 isoform X1 [Sus scrofa];NP_999550.1 prostaglandin reductase 1 [Sus scrofa];XP_020939049.1 prostaglandin reductase 1 isoform X2 [Sus scrofa]	12	12	12	1540300000	849390000	1630800000	717160000	1328800000	517590000	1424100000	875130000	1507300000	997240000	1113800000	670730000	611750000	866780000	1377800000	1153700000	1258900000	632310000	NA	NA	NA	PTGR1	PTGR1;PTGR1;PTGR1;NA;NA	prostaglandin metabolic process;response to antineoplastic agent;oxidation-reduction process;leukotriene metabolic process	GO:000669; GO:009732; GO:005511; GO:000669	cytoplasm;extracellular exosome	GO:000573; GO:007006	"NA"	"NA"	13-prostaglandin reductase activity;15-oxoprostaglandin 13-oxidase activity;2-alkenal reductase [NAD(P)	GO:003613; GO:004752; GO:003244
NP_999553.1	NP_999553.1	NP_999553.1 apolipoprotein A-IV precursor [Sus scrofa]	22	22	18	152590000	246190000	228120000	375500000	182220000	369740000	418990000	474610000	333000000	342850000	194340000	138720000	188430000	216120000	223020000	280750000	275130000	302910000	NA	NA	NA	APOA4	APOA4;NA;NA;NA;NA	lipid transport;cholesterol metabolic process;cholesterol efflux;phosphatidylcholine metabolic process;retinoid metabolic process;positive regulation of lipid biosynthetic process;phospholipid efflux;cellular protein metabolic process;triglyceride homeostasis;triglyceride catabolic process;regulation of cholesterol transport;very-low-density lipoprotein particle remodeling;lipoprotein metabolic process;innate immune response in mucosa;cholesterol biosynthetic process;positive regulation of cholesterol esterification;positive regulation of triglyceride catabolic process;lipid catabolic process;negative regulation of plasma lipoprotein oxidation;hydrogen peroxide catabolic process;reverse cholesterol transport;positive regulation of fatty acid biosynthetic process;lipid homeostasis;leukocyte cell-cell adhesion;regulation of intestinal cholesterol absorption;response to lipid hydroperoxide;response to stilbenoid;cholesterol homeostasis;positive regulation of lipoprotein lipase activity;high-density lipoprotein particle assembly;protein-lipid complex assembly	GO:000686; GO:000820; GO:003334; GO:004647; GO:000152; GO:004688; GO:003370; GO:004426; GO:007032; GO:001943; GO:003237; GO:003437; GO:004215; GO:000222; GO:000669; GO:001087; GO:001089; GO:001604; GO:003444; GO:004274; GO:004369; GO:004572; GO:005508; GO:000715; GO:003030; GO:000698; GO:003563; GO:004263; GO:005100; GO:003438; GO:006500	extracellular region;extracellular exosome;early endosome;endoplasmic reticulum lumen;very-low-density lipoprotein particle;cytosol;chylomicron;extracellular space;cell surface;blood microparticle	GO:000557; GO:007006; GO:000576; GO:000578; GO:003436; GO:000582; GO:004262; GO:000561; GO:000998; GO:007256	 Fat digestion and absorption; Vitamin digestion and absorption	hsa0497; hsa0497	antioxidant activity;phospholipid binding;cholesterol transporter activity;phosphatidylcholine-sterol O-acyltransferase activator activity;lipid binding;identical protein binding;cholesterol binding;copper ion binding;phosphatidylcholine binding;lipid transporter activity;protein binding	GO:001620; GO:000554; GO:001712; GO:006022; GO:000828; GO:004280; GO:001548; GO:000550; GO:003121; GO:000531; GO:000551
NP_999562.1	NP_999562.1	NP_999562.1 dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor [Sus scrofa]	8	8	8	109120000	82470000	113870000	80683000	99952000	63127000	108890000	87734000	104620000	74099000	102440000	77113000	93309000	73027000	103840000	79977000	91908000	70426000	NA	NA	NA	DLST	DLST;NA;NA;NA;NA	tricarboxylic acid cycle;L-lysine catabolic process to acetyl-CoA via saccharopine;2-oxoglutarate metabolic process;generation of precursor metabolites and energy	GO:000609; GO:003351; GO:000610; GO:000609	oxoglutarate dehydrogenase complex;membrane;mitochondrion;nucleus;mitochondrial matrix	GO:004525; GO:001602; GO:000573; GO:000563; GO:000575	 Metabolic pathways; Carbon metabolism; Citrate cycle (TCA cycle); Lysine degradation; Biosynthesis of antibiotics	hsa0110; hsa0120; hsa0002; hsa0031; hsa0113	protein binding;dihydrolipoyllysine-residue succinyltransferase activity	GO:000551; GO:000414
NP_999563.1	NP_999563.1	NP_999563.1 apolipoprotein A-I preproprotein [Sus scrofa]	21	21	15	3687900000	2661700000	3052600000	3247500000	3516300000	4636400000	4761100000	2506900000	4536600000	3049600000	3063700000	466490000	4199600000	2641200000	3347900000	2122000000	4852200000	3614400000	NA	NA	NA	APOA1	APOA1;NA;NA;NA;NA	endothelial cell proliferation;transforming growth factor beta receptor signaling pathway;vitamin transport;lipid storage;chylomicron assembly;response to estrogen;post-translational protein modification;cellular protein metabolic process;positive regulation of cholesterol efflux;peptidyl-methionine modification;regulation of lipid metabolic process;lipoprotein biosynthetic process;negative regulation of inflammatory response;phospholipid homeostasis;triglyceride homeostasis;cholesterol import;positive regulation of phospholipid efflux;retinoid metabolic process;cholesterol metabolic process;negative regulation of tumor necrosis factor-mediated signaling pathway;positive regulation of hydrolase activity;negative regulation of response to cytokine stimulus;positive regulation of substrate adhesion-dependent cell spreading;platelet degranulation;phosphatidylcholine biosynthetic process;receptor-mediated endocytosis;regulation of cholesterol transport;regulation of Cdc42 protein signal transduction;phospholipid efflux;positive regulation of Rho protein signal transduction;negative chemotaxis;negative regulation of lipase activity;ERK1 and ERK2 cascade;regulation of protein phosphorylation;response to drug;cholesterol homeostasis;reverse cholesterol transport;negative regulation of cytokine secretion involved in immune response;glucocorticoid metabolic process;peripheral nervous system axon regeneration;protein stabilization;high-density lipoprotein particle assembly;positive regulation of phagocytosis;cholesterol biosynthetic process;G-protein coupled receptor signaling pathway;integrin-mediated signaling pathway;protein oxidation;regulation of intestinal cholesterol absorption;adrenal gland development;animal organ regeneration;cholesterol efflux;negative regulation of heterotypic cell-cell adhesion;blood vessel endothelial cell migration;positive regulation of stress fiber assembly;negative regulation of cell adhesion molecule production;response to nutrient;negative regulation of very-low-density lipoprotein particle remodeling;positive regulation of lipid biosynthetic process;triglyceride catabolic process;negative regulation of interleukin-1 beta secretion	GO:000193; GO:000717; GO:005118; GO:001991; GO:003437; GO:004362; GO:004368; GO:004426; GO:001087; GO:001820; GO:001921; GO:004215; GO:005072; GO:005509; GO:007032; GO:007050; GO:190299; GO:000152; GO:000820; GO:001080; GO:005134; GO:006076; GO:190002; GO:000257; GO:000665; GO:000689; GO:003237; GO:003248; GO:003370; GO:003502; GO:005091; GO:006019; GO:007037; GO:000193; GO:004249; GO:004263; GO:004369; GO:000274; GO:000821; GO:001401; GO:005082; GO:003438; GO:005076; GO:000669; GO:000718; GO:000722; GO:001815; GO:003030; GO:003032; GO:003110; GO:003334; GO:003411; GO:004353; GO:005149; GO:006035; GO:000758; GO:001090; GO:004688; GO:001943; GO:005071	nucleus;discoidal high-density lipoprotein particle;endocytic vesicle;secretory granule lumen;early endosome;blood microparticle;cytoplasmic vesicle;extracellular exosome;plasma membrane;endoplasmic reticulum lumen;chylomicron;extracellular region;cytosol;cell surface;endocytic vesicle lumen;extracellular vesicle;extracellular space	GO:000563; GO:003436; GO:003013; GO:003477; GO:000576; GO:007256; GO:003141; GO:007006; GO:000588; GO:000578; GO:004262; GO:000557; GO:000582; GO:000998; GO:007168; GO:190356; GO:000561	 Fat digestion and absorption; PPAR signaling pathway; Vitamin digestion and absorption; African trypanosomiasis	hsa0497; hsa0332; hsa0497; hsa0514	protein binding;heat shock protein binding;cholesterol transporter activity;identical protein binding;enzyme binding;beta-amyloid binding;phosphatidylcholine-sterol O-acyltransferase activator activity;phospholipid binding;high-density lipoprotein particle binding;cholesterol binding;apolipoprotein receptor binding;chemorepellent activity;lipase inhibitor activity;high-density lipoprotein particle receptor binding	GO:000551; GO:003107; GO:001712; GO:004280; GO:001989; GO:000154; GO:006022; GO:000554; GO:000803; GO:001548; GO:003419; GO:004549; GO:005510; GO:007065
NP_999570.1	NP_999570.1	NP_999570.1 methylmalonyl-CoA mutase, mitochondrial precursor [Sus scrofa]	9	9	9	44760000	26945000	40684000	0	61281000	26830000	45650000	38409000	42113000	29372000	43703000	42468000	20200000	29566000	51545000	31937000	30925000	25989000	NA	NA	NA	MMUT	MMUT;NA;NA;NA;NA	positive regulation of GTPase activity;post-embryonic development;homocysteine metabolic process;cobalamin metabolic process	GO:004354; GO:000979; GO:005066; GO:000923	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Metabolic pathways; Valine, leucine and isoleucine degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Carbon metabolism	hsa0110; hsa0028; hsa0063; hsa0064; hsa0120	identical protein binding;methylmalonyl-CoA mutase activity;metal ion binding;cobalamin binding;GTPase activity;protein homodimerization activity;modified amino acid binding;protein binding	GO:004280; GO:000449; GO:004687; GO:003141; GO:000392; GO:004280; GO:007234; GO:000551
NP_999571.1	NP_999571.1	NP_999571.1 aldose 1-epimerase [Sus scrofa]	11	11	11	189890000	234370000	242760000	222010000	187940000	193480000	262490000	227520000	226820000	229430000	216090000	256010000	169920000	213880000	236320000	262950000	223590000	203870000	NA	NA	NA	GALM	GALM;NA;NA;NA;NA	galactose metabolic process;glucose metabolic process;galactose catabolic process via UDP-galactose	GO:000601; GO:000600; GO:003349	cytoplasm;extracellular exosome	GO:000573; GO:007006	 Metabolic pathways; Biosynthesis of antibiotics; Galactose metabolism; Glycolysis / Gluconeogenesis	hsa0110; hsa0113; hsa0005; hsa0001	carbohydrate binding;aldose 1-epimerase activity	GO:003024; GO:000403
NP_999572.1	NP_999572.1	NP_999572.1 phospholipid hydroperoxide glutathione peroxidase, mitochondrial precursor [Sus scrofa]	4	4	4	267730000	215980000	201940000	184980000	212730000	112360000	207090000	163750000	192050000	192550000	196760000	247740000	132550000	194280000	207760000	250580000	208550000	154700000	NA	NA	NA	GPX4	GPX4;NA;NA;NA;NA	lipoxygenase pathway;oxidation-reduction process;chromatin organization;phospholipid metabolic process;cellular oxidant detoxification;glutathione metabolic process;multicellular organism development;spermatogenesis;aging;protein polymerization;long-chain fatty acid biosynthetic process;regulation of inflammatory response;response to oxidative stress;response to estradiol	GO:001937; GO:005511; GO:000632; GO:000664; GO:009886; GO:000674; GO:000727; GO:000728; GO:000756; GO:005125; GO:004275; GO:005072; GO:000697; GO:003235	nucleoplasm;nucleus;macromolecular complex;extracellular exosome;mitochondrion;cytosol	GO:000565; GO:000563; GO:003299; GO:007006; GO:000573; GO:000582	 Glutathione metabolism	hsa0048	phospholipid-hydroperoxide glutathione peroxidase activity;glutathione peroxidase activity;protein binding;selenium binding;identical protein binding	GO:004706; GO:000460; GO:000551; GO:000843; GO:004280
NP_999573.1	NP_999573.1	NP_999573.1 peroxiredoxin-6 [Sus scrofa]	17	17	17	1967900000	1786300000	1758300000	1348400000	1705600000	994070000	1913300000	1506400000	1429700000	1240000000	2129100000	1263700000	1107600000	1514200000	2080600000	1497300000	1927200000	1452100000	NA	NA	NA	PRDX6	PRDX6;NA;NA;NA;NA	cell redox homeostasis;glycerophospholipid catabolic process;positive regulation of mRNA splicing, via spliceosome;cellular oxidant detoxification;cellular response to oxidative stress;neutrophil degranulation;oxidation-reduction process;response to oxidative stress;hydrogen peroxide catabolic process	GO:004545; GO:004647; GO:004802; GO:009886; GO:003459; GO:004331; GO:005511; GO:000697; GO:004274	extracellular space;azurophil granule lumen;extracellular region;cytosol;membrane;cytoplasm;extracellular exosome;nucleus;perinuclear region of cytoplasm	GO:000561; GO:003557; GO:000557; GO:000582; GO:001602; GO:000573; GO:007006; GO:000563; GO:004847	 Metabolic pathways	hsa0110	ubiquitin protein ligase binding;protein binding;peroxidase activity;peroxiredoxin activity;calcium-independent phospholipase A2 activity;protein homodimerization activity;cadherin binding	GO:003162; GO:000551; GO:000460; GO:005192; GO:004749; GO:004280; GO:004529
NP_999576.1	NP_999576.1	NP_999576.1 cytochrome c oxidase subunit 7A1, mitochondrial precursor [Sus scrofa]	1	1	1	145520000	0	108630000	0	89546000	0	110960000	0	85595000	0	74137000	0	0	0	0	0	69445000	0	NA	NA	NA	COX7A1	COX7A1;NA;NA;NA;NA	regulation of oxidative phosphorylation;hydrogen ion transmembrane transport;generation of precursor metabolites and energy;electron transport chain;mitochondrial respiratory chain supercomplex assembly	GO:000208; GO:190260; GO:000609; GO:002290; GO:009725	mitochondrion;integral component of membrane	GO:000573; GO:001602	 Cardiac muscle contraction; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0426; hsa0501; hsa0493; hsa0019	cytochrome-c oxidase activity	GO:000412
NP_999578.1	NP_999578.1	NP_999578.1 cytochrome P450 2B22 precursor [Sus scrofa]	13	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	763950	0	0	0	NA	NA	NA	CYP2B22	CYP2B22;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_999582.1	NP_999582.1	NP_999582.1 cytochrome P450 2A19 [Sus scrofa]	9	9	9	0	4906400	0	22083000	0	0	0	33566000	8021200	24782000	0	30945000	0	3903200	0	35294000	0	12574000	NA	NA	NA	CYP2A19	CYP2A19;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
NP_999583.1;XP_003129255.3	NP_999583.1	NP_999583.1 ADP/ATP translocase 3 [Sus scrofa]	10	3	3	49091000	44279000	60415000	56358000	50352000	47497000	47249000	52872000	70000000	59020000	44260000	52682000	43467000	55871000	0	57744000	48738000	45450000	NA	NA	NA	SLC25A6	SLC25A6;NA;NA;NA;NA	regulation of insulin secretion;ATP transport;apoptotic process;active induction of host immune response by virus;protein targeting to mitochondrion;adenine transport;transmembrane transport	GO:005079; GO:001586; GO:000691; GO:004673; GO:000662; GO:001585; GO:005508	nucleus;mitochondrial inner membrane presequence translocase complex;integral component of membrane;mitochondrion	GO:000563; GO:000574; GO:001602; GO:000573	 Huntington's disease; cGMP-PKG signaling pathway; HTLV-I infection; Parkinson's disease	hsa0501; hsa0402; hsa0516; hsa0501	ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity	GO:000547; GO:000551; GO:001520
NP_999602.1	NP_999602.1	NP_999602.1 vesicle transport through interaction with t-SNAREs homolog 1B [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7906600	0	0	NA	NA	NA	VTI1B	VTI1B;NA;NA;NA;NA	membrane fusion;ER to Golgi vesicle-mediated transport;vesicle docking involved in exocytosis;vesicle-mediated transport;protein targeting to vacuole;Golgi to vacuole transport;cell proliferation;vesicle fusion with Golgi apparatus;autophagosome maturation;regulation of protein localization to plasma membrane;platelet degranulation;retrograde transport, endosome to Golgi	GO:006102; GO:000688; GO:000690; GO:001619; GO:000662; GO:000689; GO:000828; GO:004828; GO:009735; GO:190307; GO:000257; GO:004214	integral component of membrane;extracellular region;perinuclear region of cytoplasm;cytosol;endoplasmic reticulum membrane;Golgi apparatus;recycling endosome membrane;ER to Golgi transport vesicle membrane;SNARE complex;vesicle;platelet alpha granule lumen;neuronal cell body;lysosomal membrane;intracellular membrane-bounded organelle;synaptic vesicle;early endosome membrane	GO:001602; GO:000557; GO:004847; GO:000582; GO:000578; GO:000579; GO:005503; GO:001250; GO:003120; GO:003198; GO:003109; GO:004302; GO:000576; GO:004323; GO:000802; GO:003190	 SNARE interactions in vesicular transport	hsa0413	protein binding;SNARE binding;chloride channel inhibitor activity;SNAP receptor activity	GO:000551; GO:000014; GO:001986; GO:000548
NP_999612.1	NP_999612.1	NP_999612.1 hemoglobin subunit epsilon [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123600000	NA	NA	NA	HBE1	HBE1;NA;NA;NA;NA	blood coagulation;response to organic cyclic compound;protein heterooligomerization;hydrogen peroxide catabolic process;oxygen transport;cellular oxidant detoxification	GO:000759; GO:001407; GO:005129; GO:004274; GO:001567; GO:009886	hemoglobin complex;haptoglobin-hemoglobin complex;cytosol;blood microparticle	GO:000583; GO:003183; GO:000582; GO:007256	"NA"	"NA"	protein binding;oxygen transporter activity;oxygen binding;heme binding;organic acid binding;peroxidase activity;haptoglobin binding;metal ion binding	GO:000551; GO:000534; GO:001982; GO:002003; GO:004317; GO:000460; GO:003172; GO:004687
XP_020934183.1;NP_999619.1	XP_020934183.1;NP_999619.1	XP_020934183.1 aquaporin-1 isoform X1 [Sus scrofa];NP_999619.1 aquaporin-1 [Sus scrofa]	1	1	1	0	0	0	0	0	20229000	0	0	0	0	16204000	0	15333000	0	0	0	28504000	25025000	NA	NA	NA	AQP1	AQP1;AQP1;NA;NA;NA	cGMP-mediated signaling;positive regulation of saliva secretion;cellular response to hydrogen peroxide;cellular response to mercury ion;hyperosmotic response;cellular homeostasis;carbon dioxide transmembrane transport;response to drug;positive regulation of angiogenesis;cellular response to hypoxia;cellular response to dexamethasone stimulus;maintenance of symbiont-containing vacuole by host;bicarbonate transport;glycerol transport;cellular response to UV;ammonium transmembrane transport;potassium ion transport;water transport;carbon dioxide transport;lateral ventricle development;pancreatic juice secretion;establishment or maintenance of actin cytoskeleton polarity;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of fibroblast proliferation;cellular response to inorganic substance;cellular response to nitric oxide;nitric oxide transport;renal water transport;cell volume homeostasis;ammonium transport;odontogenesis;multicellular organismal water homeostasis;cellular response to mechanical stimulus;cellular response to retinoic acid;cellular response to salt stress;potassium ion transmembrane transport;cerebrospinal fluid secretion;negative regulation of apoptotic process;cellular response to cAMP	GO:001993; GO:004687; GO:007030; GO:007128; GO:000697; GO:001972; GO:003537; GO:004249; GO:004576; GO:007145; GO:007154; GO:008501; GO:001570; GO:001579; GO:003464; GO:007248; GO:000681; GO:000683; GO:001567; GO:002167; GO:003015; GO:003095; GO:004315; GO:004814; GO:007124; GO:007173; GO:003018; GO:000309; GO:000688; GO:001569; GO:004247; GO:005089; GO:007126; GO:007130; GO:007147; GO:007180; GO:003332; GO:004306; GO:007132	nucleus;brush border;symbiont-containing vacuole;plasma membrane;basal plasma membrane;nuclear membrane;sarcolemma;integral component of membrane;basolateral plasma membrane;apical part of cell;cytoplasm;brush border membrane;extracellular exosome	GO:000563; GO:000590; GO:002000; GO:000588; GO:000992; GO:003196; GO:004238; GO:001602; GO:001632; GO:004517; GO:000573; GO:003152; GO:007006	 Bile secretion; Renin secretion; Proximal tubule bicarbonate reclamation	hsa0497; hsa0492; hsa0496	glycerol transmembrane transporter activity;nitric oxide transmembrane transporter activity;identical protein binding;protein binding;water channel activity;potassium channel activity;ammonium transmembrane transporter activity;potassium ion transmembrane transporter activity;intracellular cGMP activated cation channel activity;carbon dioxide transmembrane transporter activity;water transmembrane transporter activity;transmembrane transporter activity	GO:001516; GO:003018; GO:004280; GO:000551; GO:001525; GO:000526; GO:000851; GO:001507; GO:000522; GO:003537; GO:000537; GO:002285
REV__CON__Q7Z3Y8;REV__XP_003131532.3;REV__NP_001231551.1;REV__XP_003131530.1	REV__CON__Q7Z3Y8;REV__XP_003131532.3;REV__NP_001231551.1;REV__XP_003131530.1	;XP_003131532.3 keratin, type I cytoskeletal 25 [Sus scrofa];NP_001231551.1 keratin, type I cytoskeletal 27 [Sus scrofa];XP_003131530.1 keratin, type I cytoskeletal 26 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	43194000	0	0	0	0	0	NA	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_005673100.1;REV__NP_001116630.1	REV__XP_005673100.1;REV__NP_001116630.1	XP_005673100.1 phosphoenolpyruvate carboxykinase, cytosolic [GTP] isoform X1 [Sus scrofa];NP_001116630.1 phosphoenolpyruvate carboxykinase, cytosolic [GTP] [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	59219000	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__NP_001138313.1	REV__NP_001138313.1	NP_001138313.1 hemoglobin subunit beta [Sus scrofa]	1	1	1	73637000	109840000	134120000	85723000	82659000	80016000	112980000	86653000	122680000	71684000	93404000	133990000	0	84609000	126550000	92383000	82329000	73040000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__NP_001230554.1	REV__NP_001230554.1	NP_001230554.1 carboxylesterase 3 precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7666600	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__NP_999004.1	REV__NP_999004.1	NP_999004.1 tumor necrosis factor receptor superfamily member 6 precursor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	25881000	0	0	0	0	0	0	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020933921.1;REV__XP_020933920.1;REV__XP_020933919.1;REV__XP_020933918.1;REV__XP_020933917.1;REV__XP_020933916.1;REV__XP_013840763.1;REV__XP_020933915.1;REV__XP_013840761.1;REV__XP_013840760.1;REV__XP_001929443.1	REV__XP_020933921.1;REV__XP_020933920.1;REV__XP_020933919.1;REV__XP_020933918.1;REV__XP_020933917.1;REV__XP_020933916.1;REV__XP_013840763.1;REV__XP_020933915.1;REV__XP_013840761.1;REV__XP_013840760.1;REV__XP_001929443.1	XP_020933921.1 centrosome-associated protein CEP250 isoform X9 [Sus scrofa];XP_020933920.1 centrosome-associated protein CEP250 isoform X8 [Sus scrofa];XP_020933919.1 centrosome-associated protein CEP250 isoform X7 [Sus scrofa];XP_020933918.1 centrosome-as	2	2	2	0	0	0	0	0	0	0	37186000	37715000	39724000	40948000	0	0	40176000	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_003122117.1	REV__XP_003122117.1	XP_003122117.1 uncharacterized protein C9orf152 homolog [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10238000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_013853529.2;REV__XP_005664311.1;REV__XP_005664310.1;REV__XP_003126756.1	REV__XP_013853529.2;REV__XP_005664311.1;REV__XP_005664310.1;REV__XP_003126756.1	XP_013853529.2 nuclear receptor subfamily 2 group C member 1 isoform X3 [Sus scrofa];XP_005664311.1 nuclear receptor subfamily 2 group C member 1 isoform X2 [Sus scrofa];XP_005664310.1 nuclear receptor subfamily 2 group C member 1 isoform X1 [Sus scrofa];X	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34375000	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_003130443.4	REV__XP_003130443.4	XP_003130443.4 LOW QUALITY PROTEIN: centromere protein F [Sus scrofa]	2	2	2	0	0	51915000	0	58557000	0	0	0	0	79998000	0	144500000	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_003131484.1	REV__XP_003131484.1	XP_003131484.1 keratin, type I cytoskeletal 13 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	63201000	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020936528.1;REV__XP_020936527.1;REV__XP_020936526.1;REV__XP_020936525.1;REV__XP_020936523.1;REV__XP_013846467.1;REV__XP_020936522.1;REV__XP_013846466.1;REV__XP_013846465.1;REV__XP_020936520.1;REV__XP_013846464.1;REV__XP_003135467.1;REV__XP_013846463.1;REV__XP_013846462.1;REV__XP_013846461.1;REV__XP_013846460.1	REV__XP_020936528.1;REV__XP_020936527.1;REV__XP_020936526.1;REV__XP_020936525.1;REV__XP_020936523.1;REV__XP_013846467.1;REV__XP_020936522.1;REV__XP_013846466.1;REV__XP_013846465.1;REV__XP_020936520.1;REV__XP_013846464.1;REV__XP_003135467.1;REV__XP_013846463.1;REV__XP_013846462.1;REV__XP_013846461.1;REV__XP_013846460.1	XP_020936528.1 integrator complex subunit 6-like isoform X16 [Sus scrofa];XP_020936527.1 integrator complex subunit 6-like isoform X15 [Sus scrofa];XP_020936526.1 integrator complex subunit 6-like isoform X14 [Sus scrofa];XP_020936525.1 integrator complex	2	2	2	0	0	0	0	0	0	0	0	0	0	38487000	0	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_013851016.1;REV__XP_013851015.1;REV__XP_013851014.1;REV__XP_003354560.2	REV__XP_013851016.1;REV__XP_013851015.1;REV__XP_013851014.1;REV__XP_003354560.2	XP_013851016.1 general transcription factor II-I repeat domain-containing protein 2 isoform X4 [Sus scrofa];XP_013851015.1 general transcription factor II-I repeat domain-containing protein 2 isoform X3 [Sus scrofa];XP_013851014.1 general transcription fac	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52710000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020930028.1;REV__XP_005657428.1;REV__XP_020930023.1;REV__XP_013845844.1;REV__XP_020930029.1;REV__XP_005657430.1;REV__XP_020930027.1;REV__XP_020930026.1;REV__XP_020930024.1;REV__XP_013845845.1;REV__XP_020930022.1;REV__XP_013845843.1;REV__XP_005657422.2;REV__XP_020921804.1;REV__XP_020921803.1;REV__XP_020921802.1;REV__NP_001230112.1	REV__XP_020930028.1;REV__XP_005657428.1;REV__XP_020930023.1;REV__XP_013845844.1;REV__XP_020930029.1;REV__XP_005657430.1;REV__XP_020930027.1;REV__XP_020930026.1;REV__XP_020930024.1;REV__XP_013845845.1;REV__XP_020930022.1;REV__XP_013845843.1;REV__XP_005657422.2	XP_020930028.1 AP-1 complex subunit beta-1 isoform X4 [Sus scrofa];XP_005657428.1 AP-1 complex subunit beta-1 isoform X4 [Sus scrofa];XP_020930023.1 AP-1 complex subunit beta-1 isoform X2 [Sus scrofa];XP_013845844.1 AP-1 complex subunit beta-1 isoform X2 [	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40568000	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_005659164.2	REV__XP_005659164.2	XP_005659164.2 dapper homolog 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	73113000	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020929405.1;REV__XP_013839331.1;REV__XP_020929404.1;REV__XP_020929402.1;REV__XP_020929401.1;REV__XP_020929400.1;REV__XP_020929399.1;REV__XP_020929398.1;REV__XP_020929397.1;REV__XP_020929406.1	REV__XP_020929405.1;REV__XP_013839331.1;REV__XP_020929404.1;REV__XP_020929402.1;REV__XP_020929401.1;REV__XP_020929400.1;REV__XP_020929399.1;REV__XP_020929398.1;REV__XP_020929397.1;REV__XP_020929406.1	XP_020929405.1 proliferation marker protein Ki-67 isoform X7 [Sus scrofa];XP_013839331.1 proliferation marker protein Ki-67 isoform X8 [Sus scrofa];XP_020929404.1 proliferation marker protein Ki-67 isoform X6 [Sus scrofa];XP_020929402.1 proliferation marke	2	2	2	192110000	0	224910000	394100000	0	0	0	294620000	778470000	341490000	0	125760000	375480000	232150000	0	199200000	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020922648.1;REV__XP_020922647.1;REV__XP_020922646.1;REV__XP_020922645.1;REV__XP_020922644.1	REV__XP_020922648.1;REV__XP_020922647.1;REV__XP_020922646.1;REV__XP_020922645.1;REV__XP_020922644.1	XP_020922648.1 tetratricopeptide repeat protein 25 isoform X5 [Sus scrofa];XP_020922647.1 tetratricopeptide repeat protein 25 isoform X4 [Sus scrofa];XP_020922646.1 tetratricopeptide repeat protein 25 isoform X3 [Sus scrofa];XP_020922645.1 tetratricopeptid	1	1	1	0	0	0	0	0	0	47771000	0	0	0	0	0	0	0	0	0	0	0	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020924726.1;REV__XP_020924725.1;REV__XP_020924724.1;REV__XP_020924723.1;REV__XP_020924722.1;REV__XP_020924721.1;REV__XP_020924720.1	REV__XP_020924726.1;REV__XP_020924725.1;REV__XP_020924724.1;REV__XP_020924723.1;REV__XP_020924722.1;REV__XP_020924721.1;REV__XP_020924720.1	XP_020924726.1 filamin-B isoform X7 [Sus scrofa];XP_020924725.1 filamin-B isoform X6 [Sus scrofa];XP_020924724.1 filamin-B isoform X5 [Sus scrofa];XP_020924723.1 filamin-B isoform X4 [Sus scrofa];XP_020924722.1 filamin-B isoform X3 [Sus scrofa];XP_02092472	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50945000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020925936.1;REV__XP_020925935.1	REV__XP_020925936.1;REV__XP_020925935.1	XP_020925936.1 F-box only protein 40 [Sus scrofa];XP_020925935.1 F-box only protein 40 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	26824000	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020928723.1	REV__XP_020928723.1	XP_020928723.1 retinitis pigmentosa 1-like 1 protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6337500	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020931560.1	REV__XP_020931560.1	XP_020931560.1 LOW QUALITY PROTEIN: titin [Sus scrofa]	6	6	6	0	0	0	0	60538000	0	91849000	42290000	60672000	0	0	0	0	0	75214000	0	108490000	36619000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020933131.1	REV__XP_020933131.1	XP_020933131.1 uncharacterized protein LOC110257362 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22650000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020935862.1;REV__XP_020935861.1;REV__XP_020935860.1;REV__XP_020935859.1;REV__XP_020935858.1;REV__XP_020935857.1;REV__XP_020935856.1;REV__XP_020935855.1;REV__XP_020935853.1	REV__XP_020935862.1;REV__XP_020935861.1;REV__XP_020935860.1;REV__XP_020935859.1;REV__XP_020935858.1;REV__XP_020935857.1;REV__XP_020935856.1;REV__XP_020935855.1;REV__XP_020935853.1	XP_020935862.1 phospholipid-transporting ATPase IG isoform X9 [Sus scrofa];XP_020935861.1 phospholipid-transporting ATPase IG isoform X8 [Sus scrofa];XP_020935860.1 phospholipid-transporting ATPase IG isoform X7 [Sus scrofa];XP_020935859.1 phospholipid-tra	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40188000	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020938932.1	REV__XP_020938932.1	XP_020938932.1 LOW QUALITY PROTEIN: otogelin [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	104450000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020938969.1	REV__XP_020938969.1	XP_020938969.1 ras association domain-containing protein 10 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14690000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020940568.1	REV__XP_020940568.1	XP_020940568.1 protocadherin beta-6 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23898000	+	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020941194.1	REV__XP_020941194.1	XP_020941194.1 uncharacterized protein LOC110259813 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	18229000	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020942968.1;REV__XP_020942967.1;REV__XP_020942966.1;REV__XP_020942965.1;REV__XP_020942964.1	REV__XP_020942968.1;REV__XP_020942967.1;REV__XP_020942966.1;REV__XP_020942965.1;REV__XP_020942964.1	XP_020942968.1 dynein heavy chain 6, axonemal isoform X5 [Sus scrofa];XP_020942967.1 dynein heavy chain 6, axonemal isoform X4 [Sus scrofa];XP_020942966.1 dynein heavy chain 6, axonemal isoform X3 [Sus scrofa];XP_020942965.1 dynein heavy chain 6, axonemal	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25260000	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020946052.1;REV__XP_020946051.1;REV__XP_020946050.1;REV__XP_020946049.1;REV__XP_020946048.1;REV__XP_020946047.1;REV__XP_020946046.1;REV__XP_020946045.1;REV__XP_020946044.1;REV__XP_020946037.1;REV__XP_020946043.1;REV__XP_020946035.1;REV__XP_020946042.1;REV__XP_020946041.1;REV__XP_020946040.1;REV__XP_020946034.1;REV__XP_020946039.1;REV__XP_020946033.1;REV__XP_020946038.1;REV__XP_020946036.1;REV__XP_020946024.1;REV__XP_020946023.1;REV__XP_020946022.1;REV__XP_020946032.1;REV__XP_020946031.1;REV__XP_020946030.1;REV__XP_020946029.1;REV__XP_020946028.1;REV__XP_020946027.1;REV__XP_020946026.1	REV__XP_020946052.1;REV__XP_020946051.1;REV__XP_020946050.1;REV__XP_020946049.1;REV__XP_020946048.1;REV__XP_020946047.1;REV__XP_020946046.1;REV__XP_020946045.1;REV__XP_020946044.1;REV__XP_020946037.1;REV__XP_020946043.1;REV__XP_020946035.1;REV__XP_020946042.1;REV__XP_020946041.1;REV__XP_020946040.1;REV__XP_020946034.1;REV__XP_020946039.1;REV__XP_020946033.1;REV__XP_020946038.1;REV__XP_020946036.1;REV__XP_020946024.1;REV__XP_020946023.1;REV__XP_020946022.1;REV__XP_020946032.1;REV__XP_020946031.1;REV__XP_020946030.1;REV__XP_020946029.1;REV__XP_020946028.1;REV__XP_020946027.1;REV__XP_020946026.1	XP_020946052.1 plectin isoform X29 [Sus scrofa];XP_020946051.1 plectin isoform X28 [Sus scrofa];XP_020946050.1 plectin isoform X27 [Sus scrofa];XP_020946049.1 plectin isoform X26 [Sus scrofa];XP_020946048.1 plectin isoform X25 [Sus scrofa];XP_020946047.1 p	3	3	3	0	0	0	0	55977000	0	0	24447000	0	0	0	0	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020946341.1;REV__XP_020946310.1;REV__XP_020946346.1;REV__XP_020946345.1;REV__XP_020946344.1;REV__XP_020946343.1;REV__XP_020946342.1;REV__XP_020946340.1;REV__XP_020946339.1;REV__XP_020946338.1;REV__XP_020946337.1;REV__XP_020946336.1;REV__XP_020946334.1;REV__XP_020946333.1;REV__XP_020946332.1;REV__XP_020946331.1;REV__XP_020946330.1;REV__XP_020946329.1;REV__XP_020946328.1;REV__XP_020946327.1;REV__XP_020946326.1;REV__XP_020946347.1;REV__XP_020946325.1;REV__XP_020946324.1;REV__XP_020946323.1;REV__XP_020946322.1;REV__XP_020946335.1;REV__XP_020946321.1;REV__XP_020946320.1;REV__XP_020946319.1;REV__XP_020946318.1;REV__XP_020946317.1;REV__XP_020946316.1;REV__XP_020946315.1;REV__XP_020946314.1;REV__XP_020946313.1;REV__XP_020946312.1;REV__XP_020946311.1;REV__XP_020946308.1;REV__XP_020946307.1;REV__XP_020946306.1;REV__XP_020946305.1;REV__XP_020946304.1;REV__XP_020946303.1	REV__XP_020946341.1;REV__XP_020946310.1;REV__XP_020946346.1;REV__XP_020946345.1;REV__XP_020946344.1;REV__XP_020946343.1;REV__XP_020946342.1;REV__XP_020946340.1;REV__XP_020946339.1;REV__XP_020946338.1;REV__XP_020946337.1;REV__XP_020946336.1;REV__XP_020946334.1;REV__XP_020946333.1;REV__XP_020946332.1;REV__XP_020946331.1;REV__XP_020946330.1;REV__XP_020946329.1;REV__XP_020946328.1;REV__XP_020946327.1;REV__XP_020946326.1;REV__XP_020946347.1;REV__XP_020946325.1;REV__XP_020946324.1;REV__XP_020946323.1;REV__XP_020946322.1;REV__XP_020946335.1;REV__XP_020946321.1;REV__XP_020946320.1;REV__XP_020946319.1;REV__XP_020946318.1;REV__XP_020946317.1;REV__XP_020946316.1;REV__XP_020946315.1;REV__XP_020946314.1;REV__XP_020946313.1;REV__XP_020946312.1;REV__XP_020946311.1;REV__XP_020946308.1;REV__XP_020946307.1;REV__XP_020946306.1;REV__XP_020946305.1;REV__XP_020946304.1;REV__XP_020946303.1	XP_020946341.1 myomegalin isoform X38 [Sus scrofa];XP_020946310.1 myomegalin isoform X7 [Sus scrofa];XP_020946346.1 myomegalin isoform X43 [Sus scrofa];XP_020946345.1 myomegalin isoform X42 [Sus scrofa];XP_020946344.1 myomegalin isoform X41 [Sus scrofa];XP	3	3	3	0	171090000	0	211870000	0	153010000	197620000	0	166650000	175070000	0	263640000	0	229550000	0	238380000	0	161790000	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020950313.1;REV__XP_020950312.1;REV__XP_020950311.1;REV__XP_020950310.1;REV__XP_020950309.1	REV__XP_020950313.1;REV__XP_020950312.1;REV__XP_020950311.1;REV__XP_020950310.1;REV__XP_020950309.1	XP_020950313.1 zinc finger protein 114 [Sus scrofa];XP_020950312.1 zinc finger protein 114 [Sus scrofa];XP_020950311.1 zinc finger protein 114 [Sus scrofa];XP_020950310.1 zinc finger protein 114 [Sus scrofa];XP_020950309.1 zinc finger protein 114 [Sus scro	1	1	1	0	0	0	0	0	19677000	0	0	0	0	0	0	0	0	0	0	0	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020950359.1	REV__XP_020950359.1	XP_020950359.1 60S ribosomal protein L18 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6026800	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REV__XP_020951581.1	REV__XP_020951581.1	XP_020951581.1 claspin isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8274600	0	NA	+	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
XP_005671204.1;XP_020929657.1;XP_013838831.1;XP_001924213.1;XP_013851954.1;XP_020944616.1;XP_020944615.1	XP_005671204.1;XP_020929657.1;XP_013838831.1;XP_001924213.1	XP_005671204.1 annexin A11 isoform X2 [Sus scrofa];XP_020929657.1 annexin A11 isoform X1 [Sus scrofa];XP_013838831.1 annexin A11 isoform X1 [Sus scrofa];XP_001924213.1 annexin A11 isoform X1 [Sus scrofa]	17	17	17	173160000	172690000	212120000	184600000	180120000	232140000	157540000	170640000	158640000	176380000	216430000	291590000	334940000	211840000	180950000	238530000	219110000	165300000	NA	NA	NA	ANXA11	ANXA11;ANXA11;ANXA11;ANXA11;NA	response to calcium ion;cytokinetic process;phagocytosis	GO:005159; GO:003250; GO:000690	extracellular exosome;melanosome;cytosol;cytoplasm;spindle;membrane;nucleoplasm;azurophil granule;phagocytic vesicle;nuclear envelope;midbody	GO:007006; GO:004247; GO:000582; GO:000573; GO:000581; GO:001602; GO:000565; GO:004258; GO:004533; GO:000563; GO:003049	"NA"	"NA"	RNA binding;calcium-dependent protein binding;S100 protein binding;protein binding;calcium ion binding;phosphatidylethanolamine binding;calcium-dependent phospholipid binding;MHC class II protein complex binding	GO:000372; GO:004830; GO:004454; GO:000551; GO:000550; GO:000842; GO:000554; GO:002302
XP_001924218.1	XP_001924218.1	XP_001924218.1 carbonic anhydrase 1 [Sus scrofa]	13	13	13	1510100000	353590000	354660000	609550000	471520000	166550000	698910000	561550000	1372800000	521710000	762440000	477420000	1784800000	660340000	1622200000	352470000	963580000	245120000	NA	NA	NA	LOC100153915	LOC100153915;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_001924224.1;XP_005666194.1	XP_001924224.1;XP_005666194.1	XP_001924224.1 alpha-mannosidase 2C1 isoform X1 [Sus scrofa];XP_005666194.1 alpha-mannosidase 2C1 isoform X2 [Sus scrofa]	6	6	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8684000	0	0	NA	NA	NA	MAN2C1	MAN2C1;MAN2C1;NA;NA;NA	oligosaccharide catabolic process;mannose metabolic process	GO:000931; GO:000601	nucleoplasm;cytosol	GO:000565; GO:000582	 Other glycan degradation	hsa0051	alpha-mannosidase activity;carbohydrate binding;metal ion binding	GO:000455; GO:003024; GO:004687
XP_001924364.2;XP_020955572.1	XP_001924364.2;XP_020955572.1	XP_001924364.2 C-1-tetrahydrofolate synthase, cytoplasmic isoform X1 [Sus scrofa];XP_020955572.1 C-1-tetrahydrofolate synthase, cytoplasmic isoform X2 [Sus scrofa]	20	20	20	192210000	167410000	176680000	158610000	191170000	168660000	184570000	158270000	194630000	158100000	217590000	175090000	136550000	206160000	191160000	201440000	172840000	181490000	NA	NA	NA	MTHFD1	MTHFD1;MTHFD1;NA;NA;NA	heart development;folic acid metabolic process;oxidation-reduction process;one-carbon metabolic process;somite development;neural tube closure;purine nucleotide biosynthetic process;serine family amino acid metabolic process;methionine metabolic process;serine family amino acid biosynthetic process;purine nucleobase biosynthetic process;embryonic neurocranium morphogenesis;10-formyltetrahydrofolate biosynthetic process;transsulfuration;histidine biosynthetic process;neutrophil homeostasis;methionine biosynthetic process;tetrahydrofolate interconversion	GO:000750; GO:004665; GO:005511; GO:000673; GO:006105; GO:000184; GO:000616; GO:000906; GO:000655; GO:000907; GO:000911; GO:004870; GO:000925; GO:001934; GO:000010; GO:000178; GO:000908; GO:003599	membrane;mitochondrion;cytosol;extracellular exosome	GO:001602; GO:000573; GO:000582; GO:007006	 One carbon pool by folate; Metabolic pathways	hsa0067; hsa0110	protein binding;methylenetetrahydrofolate dehydrogenase (NAD+) activity;ATP binding;methenyltetrahydrofolate cyclohydrolase activity;formate-tetrahydrofolate ligase activity	GO:000551; GO:000448; GO:000552; GO:000447; GO:000432
XP_001924368.2	XP_001924368.2	XP_001924368.2 NADP-dependent malic enzyme [Sus scrofa]	25	25	24	2456000000	635420000	1472500000	933590000	1894500000	304610000	1781600000	919460000	1454900000	1020800000	1213600000	276180000	748590000	611410000	1132100000	907450000	1119300000	488310000	NA	NA	NA	ME1	ME1;NA;NA;NA;NA	pyruvate metabolic process;malate metabolic process;protein tetramerization;regulation of NADP metabolic process;NADP biosynthetic process;regulation of lipid metabolic process;carbohydrate metabolic process;response to carbohydrate;electron transport chain;response to hormone	GO:000609; GO:000610; GO:005126; GO:190203; GO:000674; GO:001921; GO:000597; GO:000974; GO:002290; GO:000972	cytosol;mitochondrion	GO:000582; GO:000573	 Pyruvate metabolism; Metabolic pathways; Carbon metabolism; PPAR signaling pathway	hsa0062; hsa0110; hsa0120; hsa0332	malate dehydrogenase (decarboxylating) (NADP+) activity;NADP binding;malic enzyme activity;manganese ion binding;NAD binding;ADP binding;electron carrier activity;oxaloacetate decarboxylase activity	GO:000447; GO:005066; GO:000447; GO:003014; GO:005128; GO:004353; GO:000905; GO:000894
XP_020924861.1;XP_013837333.1;XP_020924860.1;XP_003358544.1;XP_001924412.2	XP_020924861.1;XP_013837333.1;XP_020924860.1;XP_003358544.1;XP_001924412.2	XP_020924861.1 NEDD8-activating enzyme E1 catalytic subunit isoform X5 [Sus scrofa];XP_013837333.1 NEDD8-activating enzyme E1 catalytic subunit isoform X4 [Sus scrofa];XP_020924860.1 NEDD8-activating enzyme E1 catalytic subunit isoform X3 [Sus scrofa];XP_0	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3589400	NA	NA	NA	UBA3	UBA3;UBA3;UBA3;UBA3;UBA3	endomitotic cell cycle;protein modification by small protein conjugation;cellular protein modification process;protein neddylation;negative regulation of transcription, DNA-templated;proteolysis;post-translational protein modification;regulation of cell cycle	GO:000711; GO:003244; GO:000646; GO:004511; GO:004589; GO:000650; GO:004368; GO:005172	cytoplasm;nucleus;macromolecular complex;cytosol	GO:000573; GO:000563; GO:003299; GO:000582	 Ubiquitin mediated proteolysis	hsa0412	protein binding;ligand-dependent nuclear receptor binding;ATP binding;NEDD8 transferase activity;identical protein binding;protein heterodimerization activity	GO:000551; GO:001692; GO:000552; GO:001978; GO:004280; GO:004698
XP_001924424.2	XP_001924424.2	XP_001924424.2 COMM domain-containing protein 4 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	5329800	0	0	0	0	0	NA	NA	NA	COMMD4	COMMD4;NA;NA;NA;NA	"NA"	"NA"	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_001924454.3	XP_001924454.3	XP_001924454.3 LOW QUALITY PROTEIN: phosphoacetylglucosamine mutase [Sus scrofa]	10	10	10	134360000	258100000	202620000	187390000	164460000	172870000	182450000	200650000	192210000	198840000	193080000	249620000	128500000	251060000	164340000	195850000	196410000	217010000	NA	NA	NA	PGM3	PGM3;NA;NA;NA;NA	UDP-N-acetylglucosamine biosynthetic process;carbohydrate metabolic process;hemopoiesis;protein O-linked glycosylation;glucosamine metabolic process;protein N-linked glycosylation;glucose 1-phosphate metabolic process;spermatogenesis	GO:000604; GO:000597; GO:003009; GO:000649; GO:000604; GO:000648; GO:001925; GO:000728	cytosol;cellular_component	GO:000582; GO:000557	 Amino sugar and nucleotide sugar metabolism; Biosynthesis of antibiotics	hsa0052; hsa0113	phosphoglucomutase activity;magnesium ion binding;phosphoacetylglucosamine mutase activity	GO:000461; GO:000028; GO:000461
XP_001924480.2	XP_001924480.2	XP_001924480.2 proteasome subunit beta type-5 [Sus scrofa]	11	11	11	165370000	118780000	138440000	155900000	121230000	93248000	149040000	143210000	150110000	126120000	137530000	106420000	93313000	134530000	165030000	136530000	119100000	138010000	NA	NA	NA	PSMB5	PSMB5;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;response to oxidative stress;protein deubiquitination;proteolysis;proteasome-mediated ubiquitin-dependent protein catabolic process;viral process;proteasomal protein catabolic process;post-translational protein modification	GO:001049; GO:000697; GO:001657; GO:000650; GO:004316; GO:001603; GO:001049; GO:004368	proteasome complex;nucleoplasm;proteasome core complex, beta-subunit complex;nucleus;centrosome;cytoplasm;proteasome core complex;cytosol;extracellular exosome	GO:000050; GO:000565; GO:001977; GO:000563; GO:000581; GO:000573; GO:000583; GO:000582; GO:007006	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;peptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000823; GO:000417
XP_013852409.2;XP_001924678.3;XP_020955446.1	XP_013852409.2;XP_001924678.3	XP_013852409.2 hepatoma-derived growth factor isoform X1 [Sus scrofa];XP_001924678.3 hepatoma-derived growth factor isoform X2 [Sus scrofa]	4	4	4	0	31273000	24748000	0	48444000	44273000	33264000	0	35740000	30002000	47056000	0	39910000	34850000	0	30287000	30480000	39402000	NA	NA	NA	HDGF	HDGF;HDGF;NA;NA;NA	regulation of receptor activity;IRE1-mediated unfolded protein response;signal transduction;cellular response to interleukin-7;negative regulation of transcription from RNA polymerase II promoter;cell proliferation	GO:001046; GO:003649; GO:000716; GO:009876; GO:000012; GO:000828	extracellular region;extracellular space;transcriptional repressor complex;cytoplasm;nucleoplasm	GO:000557; GO:000561; GO:001705; GO:000573; GO:000565	"NA"	"NA"	heparin binding;transcription corepressor binding;DNA binding;RNA binding;transcription corepressor activity;nucleotide binding;growth factor activity	GO:000820; GO:000122; GO:000367; GO:000372; GO:000371; GO:000016; GO:000808
XP_001924714.2;XP_020919791.1;XP_020919789.1	XP_001924714.2;XP_020919791.1;XP_020919789.1	XP_001924714.2 GTP:AMP phosphotransferase AK3, mitochondrial isoform X1 [Sus scrofa];XP_020919791.1 GTP:AMP phosphotransferase AK3, mitochondrial isoform X2 [Sus scrofa];XP_020919789.1 GTP:AMP phosphotransferase AK3, mitochondrial isoform X2 [Sus scrofa]	7	7	7	48223000	43365000	41038000	45177000	45134000	51967000	34064000	42696000	47500000	35384000	0	48300000	42428000	46392000	38191000	46942000	35375000	35794000	NA	NA	NA	AK3	AK3;AK3;AK3;NA;NA	UTP metabolic process;nucleoside monophosphate phosphorylation;ADP biosynthetic process;AMP metabolic process;blood coagulation;phosphorylation;ITP metabolic process	GO:004605; GO:004694; GO:000617; GO:004603; GO:000759; GO:001631; GO:004604	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Biosynthesis of antibiotics; Purine metabolism	hsa0113; hsa0023	protein binding;GTP binding;nucleoside triphosphate adenylate kinase activity;adenylate kinase activity	GO:000551; GO:000552; GO:004689; GO:000401
XP_003359413.1;XP_001924864.1;XP_020928854.1;XP_020928853.1;XP_020928851.1;XP_020928850.1;XP_013839175.1;XP_013839174.1;XP_005671506.1;XP_005671505.1;XP_001924773.1;XP_020928855.1	XP_003359413.1;XP_001924864.1;XP_020928854.1;XP_020928853.1;XP_020928851.1;XP_020928850.1;XP_013839175.1;XP_013839174.1;XP_005671506.1;XP_005671505.1;XP_001924773.1;XP_020928855.1	XP_003359413.1 gamma-adducin isoform X2 [Sus scrofa];XP_001924864.1 gamma-adducin isoform X2 [Sus scrofa];XP_020928854.1 gamma-adducin isoform X1 [Sus scrofa];XP_020928853.1 gamma-adducin isoform X1 [Sus scrofa];XP_020928851.1 gamma-adducin isoform X1 [Sus	18	18	18	29259000	114280000	82503000	116120000	58051000	95074000	74673000	90314000	68199000	103400000	96348000	146270000	102720000	140030000	110990000	118350000	100450000	105110000	NA	NA	NA	ADD3	ADD3;ADD3;ADD3;ADD3;ADD3	barbed-end actin filament capping;actin filament bundle assembly;transmembrane transport	GO:005101; GO:005101; GO:005508	brush border;cell cortex;nucleoplasm;membrane;cell-cell junction;cytosol;plasma membrane;postsynaptic density;cytoskeleton;plasma membrane raft;condensed nuclear chromosome	GO:000590; GO:000593; GO:000565; GO:001602; GO:000591; GO:000582; GO:000588; GO:001406; GO:000585; GO:004485; GO:000079	"NA"	"NA"	structural molecule activity;structural constituent of cytoskeleton;actin filament binding;calmodulin binding;spectrin binding	GO:000519; GO:000520; GO:005101; GO:000551; GO:003050
XP_005671982.1;XP_001925033.2	XP_005671982.1;XP_001925033.2	XP_005671982.1 lupus La protein [Sus scrofa];XP_001925033.2 lupus La protein [Sus scrofa]	10	10	10	46714000	61003000	55036000	61999000	41889000	80215000	47566000	44281000	52942000	66251000	0	57182000	58740000	71705000	30740000	80616000	75645000	78834000	NA	NA	NA	SSB	SSB;SSB;NA;NA;NA	histone mRNA metabolic process;nuclear histone mRNA catabolic process;tRNA 3'-end processing;IRES-dependent viral translational initiation;protein localization to cytoplasmic stress granule;tRNA export from nucleus;tRNA 5'-leader removal;tRNA processing	GO:000833; GO:007104; GO:004278; GO:007552; GO:190360; GO:000640; GO:000168; GO:000803	ribonucleoprotein complex;cytoplasm;nuclear chromosome, telomeric region;nucleus	GO:199090; GO:000573; GO:000078; GO:000563	 Systemic lupus erythematosus	hsa0532	RNA binding;mRNA binding;protein binding;poly(U) RNA binding;tRNA binding;sequence-specific mRNA binding;protein homodimerization activity	GO:000372; GO:000372; GO:000551; GO:000826; GO:000004; GO:199082; GO:004280
XP_001925038.3	XP_001925038.3	XP_001925038.3 LOW QUALITY PROTEIN: myelin protein P0 [Sus scrofa]	7	7	7	0	10013000000	0	0	0	0	0	0	0	130220000	0	0	0	0	0	0	0	0	NA	NA	NA	MPZ	MPZ;NA;NA;NA;NA	chemical synaptic transmission;negative regulation of apoptotic process;cell-cell adhesion via plasma-membrane adhesion molecules;myelination	GO:000726; GO:004306; GO:009874; GO:004255	plasma membrane;rough endoplasmic reticulum;lysosome;basolateral plasma membrane;myelin sheath;integral component of plasma membrane	GO:000588; GO:000579; GO:000576; GO:001632; GO:004320; GO:000588	 Cell adhesion molecules (CAMs)	hsa0451	structural molecule activity	GO:000519
XP_001925115.3	XP_001925115.3	XP_001925115.3 inorganic pyrophosphatase [Sus scrofa]	6	6	6	0	43139000	46776000	39442000	50066000	51763000	47510000	44402000	49465000	48186000	36804000	47151000	41387000	53543000	41264000	40580000	37222000	46926000	NA	NA	NA	PPA1	PPA1;NA;NA;NA;NA	diphosphate metabolic process;tRNA aminoacylation for protein translation;phosphate-containing compound metabolic process	GO:007134; GO:000641; GO:000679	extracellular exosome;cytosol;cytoplasm	GO:007006; GO:000582; GO:000573	 Oxidative phosphorylation	hsa0019	magnesium ion binding;inorganic diphosphatase activity	GO:000028; GO:000442
XP_013854562.2;XP_020951465.1;XP_005654450.1;XP_005654449.1;XP_001925247.4;NP_001156877.1	XP_013854562.2;XP_020951465.1;XP_005654450.1;XP_005654449.1;XP_001925247.4;NP_001156877.1	XP_013854562.2 importin subunit alpha-7 isoform X2 [Sus scrofa];XP_020951465.1 importin subunit alpha-7 isoform X1 [Sus scrofa];XP_005654450.1 importin subunit alpha-6 isoform X3 [Sus scrofa];XP_005654449.1 importin subunit alpha-6 isoform X1 [Sus scrofa];	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2004700	NA	NA	NA	KPNA6	KPNA6;KPNA6;KPNA5;KPNA5;KPNA5	NLS-bearing protein import into nucleus;maternal process involved in female pregnancy;positive regulation of transcription from RNA polymerase II promoter	GO:000660; GO:006013; GO:004594	nuclear pore;membrane;cytosol;nucleoplasm	GO:000564; GO:001602; GO:000582; GO:000565	"NA"	"NA"	nuclear localization sequence binding;nuclear import signal receptor activity;protein binding;protein transporter activity	GO:000813; GO:006160; GO:000551; GO:000856
XP_001925287.3	XP_001925287.3	XP_001925287.3 integrin alpha-5 [Sus scrofa]	5	5	5	0	21906000	0	17601000	0	21471000	0	0	0	25641000	0	25134000	0	25535000	0	21476000	0	18515000	NA	NA	NA	ITGA5	ITGA5;NA;NA;NA;NA	positive regulation of cell migration;cell-substrate adhesion;integrin-mediated signaling pathway;female pregnancy;positive regulation of cell-substrate adhesion;positive regulation of vascular endothelial growth factor receptor signaling pathway;cell adhesion mediated by integrin;heterotypic cell-cell adhesion;negative regulation of anoikis;cell-substrate junction assembly;wound healing, spreading of epidermal cells;leukocyte migration;angiogenesis;cell adhesion;memory;viral entry into host cell;extracellular matrix organization;positive regulation of sprouting angiogenesis;endodermal cell differentiation;cell-cell adhesion mediated by integrin;positive regulation of peptidyl-tyrosine phosphorylation	GO:003033; GO:003158; GO:000722; GO:000756; GO:001081; GO:003094; GO:003362; GO:003411; GO:200081; GO:000704; GO:003531; GO:005090; GO:000152; GO:000715; GO:000761; GO:004671; GO:003019; GO:190367; GO:003598; GO:003363; GO:005073	focal adhesion;ruffle;integrin complex;cell-cell junction;external side of plasma membrane;endoplasmic reticulum;Golgi apparatus;cell surface;synapse;ruffle membrane;cytoplasmic vesicle;alphav-beta3 integrin-vitronectin complex;plasma membrane	GO:000592; GO:000172; GO:000830; GO:000591; GO:000989; GO:000578; GO:000579; GO:000998; GO:004520; GO:003258; GO:003141; GO:007106; GO:000588	 Shigellosis; Hypertrophic cardiomyopathy (HCM); Regulation of actin cytoskeleton; Phagosome; ECM-receptor interaction; Hematopoietic cell lineage; Proteoglycans in cancer; Bacterial invasion of epithelial cells; PI3K-Akt signaling pathway; Pertussis	hsa0513; hsa0541; hsa0481; hsa0414; hsa0451; hsa0464; hsa0520; hsa0510; hsa0415; hsa0513	epidermal growth factor receptor binding;platelet-derived growth factor receptor binding;protein binding;integrin binding;vascular endothelial growth factor receptor 2 binding;metal ion binding;virus receptor activity	GO:000515; GO:000516; GO:000551; GO:000517; GO:004318; GO:004687; GO:000161
XP_001925371.1;XP_003355565.1	XP_001925371.1;XP_003355565.1	XP_001925371.1 TBC1 domain family member 15 isoform X2 [Sus scrofa];XP_003355565.1 TBC1 domain family member 15 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3497500	NA	NA	NA	TBC1D15	TBC1D15;TBC1D15;NA;NA;NA	regulation of GTPase activity;regulation of cilium assembly;activation of GTPase activity;intracellular protein transport	GO:004308; GO:190201; GO:009063; GO:000688	extracellular region;cytoplasm	GO:000557; GO:000573	"NA"	"NA"	GTPase activator activity;Rab GTPase binding;protein binding	GO:000509; GO:001713; GO:000551
XP_001925384.4	XP_001925384.4	XP_001925384.4 U2 small nuclear ribonucleoprotein A [Sus scrofa]	3	3	3	0	0	13015000	0	0	0	0	0	0	0	19713000	0	0	0	0	0	0	0	NA	NA	NA	SNRPA1	SNRPA1;NA;NA;NA;NA	spermatogenesis;RNA splicing;mRNA splicing, via spliceosome;interleukin-12-mediated signaling pathway	GO:000728; GO:000838; GO:000039; GO:003572	nucleus;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome;small nuclear ribonucleoprotein complex;U2 snRNP;nucleoplasm;nuclear speck	GO:000563; GO:007100; GO:007101; GO:003053; GO:000568; GO:000565; GO:001660	 Spliceosome	hsa0304	protein binding;RNA binding;U2 snRNA binding	GO:000551; GO:000372; GO:003062
XP_001925390.4;XP_013838239.1;XP_005670643.1;XP_013838237.1;XP_013838240.1;XP_020927925.1	XP_001925390.4;XP_013838239.1;XP_005670643.1;XP_013838237.1	XP_001925390.4 RILP-like protein 1 isoform X2 [Sus scrofa];XP_013838239.1 RILP-like protein 1 isoform X4 [Sus scrofa];XP_005670643.1 RILP-like protein 1 isoform X3 [Sus scrofa];XP_013838237.1 RILP-like protein 1 isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	8949500	0	6096700	0	6664500	0	0	NA	NA	NA	RILPL1	RILPL1;RILPL1;RILPL1;RILPL1;NA	protein transport from ciliary membrane to plasma membrane;epithelial cell morphogenesis;regulation of neuron death;cilium assembly	GO:190344; GO:000338; GO:190121; GO:006027	nucleoplasm;ciliary basal body;cytosol;plasma membrane;cilium;cytoplasm;centrosome	GO:000565; GO:003606; GO:000582; GO:000588; GO:000592; GO:000573; GO:000581	"NA"	"NA"	protein dimerization activity;dynein light intermediate chain binding;small GTPase binding	GO:004698; GO:005195; GO:003126
XP_001925399.1;XP_003129998.3;XP_020945584.1	XP_001925399.1;XP_003129998.3;XP_020945584.1	XP_001925399.1 histone H2A type 1-A [Sus scrofa];XP_003129998.3 histone H2AX [Sus scrofa];XP_020945584.1 histone H2A type 2-B [Sus scrofa]	5	2	2	22041000	28915000	23164000	37417000	41006000	24161000	32958000	30769000	23325000	34118000	27958000	18055000	23930000	21568000	26848000	25837000	19227000	29538000	NA	NA	NA	LOC100522201	LOC100153329;LOC100522201;LOC100154181;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_001925420.4;XP_013840041.1	XP_001925420.4;XP_013840041.1	XP_001925420.4 EF-hand domain-containing protein D1 isoform X1 [Sus scrofa];XP_013840041.1 EF-hand domain-containing protein D1 isoform X2 [Sus scrofa]	4	3	3	0	0	0	0	0	0	0	0	0	0	0	0	14447000	0	0	0	0	0	NA	NA	NA	EFHD1	EFHD1;EFHD1;NA;NA;NA	neuron projection development	GO:003117	mitochondrial inner membrane	GO:000574	"NA"	"NA"	calcium ion binding	GO:000550
XP_020946438.1;XP_001925514.4	XP_020946438.1;XP_001925514.4	XP_020946438.1 translocation protein SEC63 homolog isoform X2 [Sus scrofa];XP_001925514.4 translocation protein SEC63 homolog isoform X1 [Sus scrofa]	3	3	3	0	0	0	11598000	10834000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SEC63	SEC63;SEC63;NA;NA;NA	protein targeting to membrane;multicellular organism aging;renal system development;nitrogen compound metabolic process;posttranslational protein targeting to membrane, translocation;liver development;SRP-dependent cotranslational protein targeting to membrane;posttranslational protein targeting to membrane	GO:000661; GO:001025; GO:007200; GO:000680; GO:003120; GO:000188; GO:000661; GO:000662	cytosol;endoplasmic reticulum membrane;Sec62/Sec63 complex;membrane	GO:000582; GO:000578; GO:003120; GO:001602	 Protein export; Protein processing in endoplasmic reticulum	hsa0306; hsa0414	protein transporter activity;signaling receptor activity;RNA binding;protein binding	GO:000856; GO:003802; GO:000372; GO:000551
XP_001925589.5;XP_020929371.1;XP_020929364.1;XP_005659686.2;XP_013848481.2;XP_003121567.4;XP_005659685.2;XP_020929361.1	XP_001925589.5;XP_020929371.1;XP_020929364.1;XP_005659686.2;XP_013848481.2;XP_003121567.4;XP_005659685.2;XP_020929361.1	XP_001925589.5 N-acetylgalactosamine kinase isoform X1 [Sus scrofa];XP_020929371.1 N-acetylgalactosamine kinase isoform X6 [Sus scrofa];XP_020929364.1 N-acetylgalactosamine kinase isoform X6 [Sus scrofa];XP_005659686.2 N-acetylgalactosamine kinase isoform	5	5	5	0	46731000	32752000	48274000	28184000	37407000	32796000	45074000	0	40784000	36581000	39454000	32506000	44253000	0	55858000	40577000	42586000	NA	NA	NA	GALK2	GALK2;GALK2;GALK2;GALK2;GALK2	galactose catabolic process via UDP-galactose;carbohydrate metabolic process;carbohydrate phosphorylation	GO:003349; GO:000597; GO:004683	cytosol;cytoplasm	GO:000582; GO:000573	"NA"	"NA"	galactokinase activity;ATP binding;galactose binding;N-acetylgalactosamine kinase activity	GO:000433; GO:000552; GO:000553; GO:003385
XP_005652655.1;XP_003355646.1;XP_003126576.1;XP_001925656.2	XP_005652655.1;XP_003355646.1;XP_003126576.1;XP_001925656.2	XP_005652655.1 COP9 signalosome complex subunit 7a [Sus scrofa];XP_003355646.1 COP9 signalosome complex subunit 7a [Sus scrofa];XP_003126576.1 COP9 signalosome complex subunit 7a [Sus scrofa];XP_001925656.2 COP9 signalosome complex subunit 7a [Sus scrofa]	5	5	5	0	11047000	12416000	12764000	0	10912000	11202000	14212000	0	15588000	12599000	15566000	12781000	0	14671000	12063000	10421000	11484000	NA	NA	NA	COPS7A	COPS7A;COPS7A;COPS7A;COPS7A;NA	viral process;protein deneddylation;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, DNA damage recognition;post-translational protein modification	GO:001603; GO:000033; GO:000628; GO:000071; GO:004368	nucleoplasm;COP9 signalosome;cytosol	GO:000565; GO:000818; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_001925705.4	XP_001925705.4	XP_001925705.4 serine--tRNA ligase, cytoplasmic [Sus scrofa]	15	15	15	168260000	169350000	196330000	155500000	164580000	135140000	158280000	153850000	175580000	197110000	164470000	224300000	167460000	153720000	175340000	185670000	160050000	152600000	NA	NA	NA	SARS	SARS;NA;NA;NA;NA	tRNA processing;negative regulation of transcription from RNA polymerase II promoter;selenocysteinyl-tRNA(Sec) biosynthetic process;negative regulation of vascular endothelial growth factor production;negative regulation of angiogenesis;tRNA aminoacylation for protein translation;selenocysteine metabolic process;seryl-tRNA aminoacylation	GO:000803; GO:000012; GO:009705; GO:190404; GO:001652; GO:000641; GO:001625; GO:000643	nucleus;cytosol;extracellular exosome;cytoplasm	GO:000563; GO:000582; GO:007006; GO:000573	 Aminoacyl-tRNA biosynthesis	hsa0097	protein binding;ATP binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA binding;serine-tRNA ligase activity;selenocysteine-tRNA ligase activity;protein homodimerization activity	GO:000551; GO:000552; GO:000097; GO:000372; GO:000482; GO:009861; GO:004280
XP_001925742.2;XP_020933799.1	XP_001925742.2;XP_020933799.1	XP_001925742.2 regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2 [Sus scrofa];XP_020933799.1 regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1 [Sus scrofa]	3	3	3	0	0	3733000	0	4368800	0	0	4909600	3746300	4809100	0	8871800	0	0	0	0	4192700	3072700	NA	NA	NA	RPRD1B	RPRD1B;RPRD1B;NA;NA;NA	regulation of cell cycle process;mRNA 3'-end processing;snRNA transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;dephosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation	GO:001056; GO:003112; GO:004279; GO:004594; GO:007094; GO:000828	nucleus;cytosol;DNA-directed RNA polymerase II, holoenzyme;nucleoplasm;centrosome	GO:000563; GO:000582; GO:001659; GO:000565; GO:000581	"NA"	"NA"	RNA polymerase II core binding;identical protein binding;protein binding	GO:000099; GO:004280; GO:000551
XP_001925819.3;XP_003355644.1;XP_020948070.1;XP_013837679.2;XP_020926871.1	XP_001925819.3;XP_003355644.1;XP_020948070.1	XP_001925819.3 ubiquitin carboxyl-terminal hydrolase 5 isoform X3 [Sus scrofa];XP_003355644.1 ubiquitin carboxyl-terminal hydrolase 5 isoform X2 [Sus scrofa];XP_020948070.1 ubiquitin carboxyl-terminal hydrolase 5 isoform X1 [Sus scrofa]	22	22	22	265930000	287380000	239860000	260300000	248160000	208330000	253340000	269810000	247240000	250040000	240860000	294460000	235810000	261330000	260690000	275860000	232470000	254980000	NA	NA	NA	USP5	USP5;USP5;USP5;NA;NA	ubiquitin-dependent protein catabolic process;protein deubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein K48-linked deubiquitination	GO:000651; GO:001657; GO:003243; GO:007110	lysosome;cytosol	GO:000576; GO:000582	"NA"	"NA"	zinc ion binding;cysteine-type endopeptidase activity;protein binding;thiol-dependent ubiquitin-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity;ubiquitin binding	GO:000827; GO:000419; GO:000551; GO:000484; GO:003645; GO:004313
XP_001925937.3	XP_001925937.3	XP_001925937.3 26S proteasome non-ATPase regulatory subunit 1 [Sus scrofa]	13	13	13	116260000	70770000	84709000	92465000	79830000	58037000	84292000	82681000	86938000	81832000	73553000	77654000	88081000	67998000	84991000	83777000	86384000	76197000	NA	NA	NA	PSMD1	PSMD1;NA;NA;NA;NA	proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of catalytic activity;regulation of protein catabolic process;post-translational protein modification;protein deubiquitination;neutrophil degranulation	GO:004316; GO:005079; GO:004217; GO:004368; GO:001657; GO:004331	membrane;nucleoplasm;proteasome storage granule;proteasome complex;extracellular region;azurophil granule lumen;proteasome accessory complex;nucleus;cytosol;proteasome regulatory particle;proteasome regulatory particle, base subcomplex	GO:001602; GO:000565; GO:003451; GO:000050; GO:000557; GO:003557; GO:002262; GO:000563; GO:000582; GO:000583; GO:000854	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	protein binding;endopeptidase activity;ubiquitin protein ligase binding;enzyme regulator activity	GO:000551; GO:000417; GO:003162; GO:003023
XP_001925948.1	XP_001925948.1	XP_001925948.1 3-ketodihydrosphingosine reductase [Sus scrofa]	3	3	3	0	30646000	33520000	35443000	0	0	0	22064000	0	30666000	0	39222000	0	43563000	0	32854000	0	38280000	NA	NA	NA	KDSR	KDSR;NA;NA;NA;NA	oxidation-reduction process;sphingolipid biosynthetic process;3-keto-sphinganine metabolic process	GO:005511; GO:003014; GO:000666	membrane;endoplasmic reticulum;extracellular space;integral component of membrane	GO:001602; GO:000578; GO:000561; GO:001602	 Metabolic pathways; Sphingolipid metabolism	hsa0110; hsa0060	3-dehydrosphinganine reductase activity	GO:004756
XP_013839531.1;XP_005671831.1;XP_005671830.1;XP_001925958.2	XP_013839531.1;XP_005671831.1;XP_005671830.1;XP_001925958.2	XP_013839531.1 phospholipase DDHD2 [Sus scrofa];XP_005671831.1 phospholipase DDHD2 [Sus scrofa];XP_005671830.1 phospholipase DDHD2 [Sus scrofa];XP_001925958.2 phospholipase DDHD2 [Sus scrofa]	5	5	5	0	10292000	11727000	0	12056000	0	0	0	0	0	0	0	0	0	0	11507000	9462500	0	NA	NA	NA	DDHD2	DDHD2;DDHD2;DDHD2;DDHD2;NA	ER to Golgi vesicle-mediated transport;lipid particle organization;visual learning;triglyceride catabolic process;positive regulation of mitochondrial fission;locomotory behavior;macromolecule metabolic process	GO:000688; GO:003438; GO:000854; GO:001943; GO:009014; GO:000762; GO:004317	endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle;cytosol;membrane;Golgi apparatus;microtubule organizing center	GO:000579; GO:003013; GO:000582; GO:001602; GO:000579; GO:000581	"NA"	"NA"	triglyceride lipase activity;phospholipase activity;metal ion binding	GO:000480; GO:000462; GO:004687
XP_013839835.1;XP_005672126.1;XP_005672125.1;XP_005672124.1;XP_001926016.1;XP_001925960.1;XP_020930611.1	XP_013839835.1;XP_005672126.1;XP_005672125.1;XP_005672124.1;XP_001926016.1;XP_001925960.1	XP_013839835.1 peptidyl-prolyl cis-trans isomerase-like 3 isoform X1 [Sus scrofa];XP_005672126.1 peptidyl-prolyl cis-trans isomerase-like 3 isoform X1 [Sus scrofa];XP_005672125.1 peptidyl-prolyl cis-trans isomerase-like 3 isoform X1 [Sus scrofa];XP_0056721	5	5	5	0	15924000	12182000	13014000	0	12731000	0	12876000	0	0	0	0	0	0	0	13782000	0	14033000	NA	NA	NA	PPIL3	PPIL3;PPIL3;PPIL3;PPIL3;PPIL3	mRNA splicing, via spliceosome;protein folding;protein peptidyl-prolyl isomerization	GO:000039; GO:000645; GO:000041	catalytic step 2 spliceosome	GO:007101	"NA"	"NA"	peptidyl-prolyl cis-trans isomerase activity;protein binding	GO:000375; GO:000551
XP_001925971.4;XP_020925236.1;XP_020925235.1;XP_020925233.1;XP_020925232.1;XP_020925231.1	XP_001925971.4	XP_001925971.4 LOW QUALITY PROTEIN: plastin-3 [Sus scrofa]	28	28	21	298460000	377190000	333800000	299460000	245760000	299650000	300760000	335070000	301030000	275510000	246450000	367940000	268730000	303310000	228130000	326140000	207310000	329340000	NA	NA	NA	PLS3	PLS3;NA;NA;NA;NA	bone development;actin filament bundle assembly;actin filament network formation	GO:006034; GO:005101; GO:005163	plasma membrane;cytoplasm;actin filament;actin filament bundle;cytosol	GO:000588; GO:000573; GO:000588; GO:003243; GO:000582	"NA"	"NA"	calcium ion binding;actin filament binding	GO:000550; GO:005101
XP_005657902.1;XP_001926000.1	XP_005657902.1;XP_001926000.1	XP_005657902.1 MICOS complex subunit MIC27 isoform X2 [Sus scrofa];XP_001926000.1 MICOS complex subunit MIC27 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4063500	0	0	NA	NA	NA	APOOL	APOOL;APOOL;NA;NA;NA	cristae formation;platelet degranulation	GO:004240; GO:000257	mitochondrion;platelet alpha granule lumen;MICOS complex;extracellular region	GO:000573; GO:003109; GO:006161; GO:000557	"NA"	"NA"	protein binding	GO:000551
XP_001926034.2;XP_005657447.1;XP_020929421.1	XP_001926034.2;XP_005657447.1;XP_020929421.1	XP_001926034.2 vacuolar protein sorting-associated protein 26A isoform X1 [Sus scrofa];XP_005657447.1 vacuolar protein sorting-associated protein 26A isoform X3 [Sus scrofa];XP_020929421.1 vacuolar protein sorting-associated protein 26A isoform X2 [Sus scr	10	10	8	102090000	105430000	114840000	84788000	81837000	79297000	93201000	74943000	105690000	89233000	66997000	92476000	83947000	84868000	101700000	85894000	98286000	84602000	NA	NA	NA	VPS26A	VPS26A;VPS26A;VPS26A;NA;NA	Wnt signaling pathway;intracellular protein transport;retrograde transport, endosome to plasma membrane;regulation of macroautophagy;retrograde transport, endosome to Golgi	GO:001605; GO:000688; GO:199012; GO:001624; GO:004214	retromer, cargo-selective complex;endosome;endosome membrane;vesicle;tubular endosome;cytosol;retromer complex	GO:003090; GO:000576; GO:001000; GO:003198; GO:009742; GO:000582; GO:003090	 Endocytosis	hsa0414	protein binding;protein transporter activity	GO:000551; GO:000856
XP_020925746.1;XP_020925745.1;XP_001926098.2	XP_020925746.1;XP_020925745.1;XP_001926098.2	XP_020925746.1 apolipoprotein D [Sus scrofa];XP_020925745.1 apolipoprotein D [Sus scrofa];XP_001926098.2 apolipoprotein D [Sus scrofa]	4	4	4	0	145700000	0	0	0	0	0	0	0	0	0	0	0	26612000	0	0	0	0	NA	NA	NA	APOD	APOD;APOD;APOD;NA;NA	negative regulation of smooth muscle cell proliferation;negative regulation of monocyte chemotactic protein-1 production;negative regulation of T cell migration;lipid transport;negative regulation of lipoprotein lipid oxidation;negative regulation of cytokine production involved in inflammatory response;lipid metabolic process;tissue regeneration;negative regulation of focal adhesion assembly;glucose metabolic process;brain development;negative regulation of protein import into nucleus;response to axon injury;aging;response to drug;angiogenesis;peripheral nervous system axon regeneration;response to reactive oxygen species;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of smooth muscle cell-matrix adhesion	GO:004866; GO:007163; GO:200040; GO:000686; GO:006058; GO:190001; GO:000662; GO:004224; GO:005189; GO:000600; GO:000742; GO:004230; GO:004867; GO:000756; GO:004249; GO:000152; GO:001401; GO:000030; GO:001064; GO:200009	endoplasmic reticulum;neuronal cell body;cytosolic ribosome;dendrite;perinuclear region of cytoplasm;extracellular region;extracellular space;cytoplasm;extracellular exosome	GO:000578; GO:004302; GO:002262; GO:003042; GO:004847; GO:000557; GO:000561; GO:000573; GO:007006	"NA"	"NA"	lipid transporter activity;cholesterol binding;protein binding	GO:000531; GO:001548; GO:000551
XP_005660570.2;XP_001926112.3;XP_020925618.1	XP_005660570.2;XP_001926112.3;XP_020925618.1	XP_005660570.2 serine/threonine-protein phosphatase 2A activator isoform X2 [Sus scrofa];XP_001926112.3 serine/threonine-protein phosphatase 2A activator isoform X1 [Sus scrofa];XP_020925618.1 serine/threonine-protein phosphatase 2A activator isoform X3 [S	6	6	6	31097000	44975000	43842000	46189000	31937000	32337000	40790000	43587000	52357000	49720000	34954000	63132000	47900000	33835000	31142000	43720000	31594000	38843000	NA	NA	NA	PTPA	PTPA;PTPA;PTPA;NA;NA	positive regulation of protein dephosphorylation;negative regulation of protein dephosphorylation;positive regulation of apoptotic process;positive regulation of phosphoprotein phosphatase activity;regulation of phosphoprotein phosphatase activity;protein peptidyl-prolyl isomerization;mitotic spindle organization	GO:003530; GO:003530; GO:004306; GO:003251; GO:004366; GO:000041; GO:000705	nucleus;calcium channel complex;nucleoplasm;extracellular exosome;cytoplasm;protein phosphatase type 2A complex	GO:000563; GO:003470; GO:000565; GO:007006; GO:000573; GO:000015	 Insulin resistance	hsa0493	protein phosphatase regulator activity;protein heterodimerization activity;peptidyl-prolyl cis-trans isomerase activity;protein binding;protein homodimerization activity;receptor binding;protein tyrosine phosphatase activator activity;ATPase activity;ATP binding;protein phosphatase 2A binding	GO:001988; GO:004698; GO:000375; GO:000551; GO:004280; GO:000510; GO:000816; GO:001688; GO:000552; GO:005172
XP_020944897.1;XP_020944896.1;XP_001926150.2	XP_020944897.1;XP_020944896.1;XP_001926150.2	XP_020944897.1 transient receptor potential cation channel subfamily A member 1 isoform X2 [Sus scrofa];XP_020944896.1 transient receptor potential cation channel subfamily A member 1 isoform X1 [Sus scrofa];XP_001926150.2 transient receptor potential cati	1	1	1	0	0	0	0	0	0	0	0	0	0	0	168880000	0	0	0	0	0	0	NA	NA	NA	TRPA1	TRPA1;TRPA1;TRPA1;NA;NA	response to organic cyclic compound;thermoception;calcium ion transmembrane transport;response to organic substance;response to pain;response to cold;sensory perception of pain;cell surface receptor signaling pathway;response to hydrogen peroxide;detection of mechanical stimulus involved in sensory perception of pain;ion transport;protein homotetramerization;release of sequestered calcium ion into cytosol	GO:001407; GO:005095; GO:007058; GO:001003; GO:004826; GO:000940; GO:001923; GO:000716; GO:004254; GO:005096; GO:000681; GO:005128; GO:005120	stereocilium bundle;plasma membrane	GO:003242; GO:000588	 Inflammatory mediator regulation of TRP channels	hsa0475	channel activity;identical protein binding;calcium channel activity;calcium-release channel activity;temperature-gated cation channel activity	GO:001526; GO:004280; GO:000526; GO:001527; GO:009760
XP_001926164.2	XP_001926164.2	XP_001926164.2 prostaglandin G/H synthase 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	12748000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PTGS1	PTGS1;NA;NA;NA;NA	inflammatory response;xenobiotic metabolic process;regulation of cell proliferation;prostaglandin biosynthetic process;oxidation-reduction process;response to oxidative stress;cellular oxidant detoxification;cyclooxygenase pathway;regulation of blood pressure	GO:000695; GO:000680; GO:004212; GO:000151; GO:005511; GO:000697; GO:009886; GO:001937; GO:000821	endoplasmic reticulum membrane;intracellular membrane-bounded organelle;photoreceptor outer segment;extracellular exosome;cytoplasm;organelle membrane;Golgi apparatus	GO:000578; GO:004323; GO:000175; GO:007006; GO:000573; GO:003109; GO:000579	 Platelet activation; Arachidonic acid metabolism; Metabolic pathways; Regulation of lipolysis in adipocytes; Serotonergic synapse	hsa0461; hsa0059; hsa0110; hsa0492; hsa0472	peroxidase activity;prostaglandin-endoperoxide synthase activity;heme binding;metal ion binding;dioxygenase activity	GO:000460; GO:000466; GO:002003; GO:004687; GO:005121
XP_005664105.1;XP_001926213.3;XP_020947956.1;XP_005664106.1	XP_005664105.1;XP_001926213.3;XP_020947956.1;XP_005664106.1	XP_005664105.1 deoxyribose-phosphate aldolase isoform X2 [Sus scrofa];XP_001926213.3 deoxyribose-phosphate aldolase isoform X1 [Sus scrofa];XP_020947956.1 deoxyribose-phosphate aldolase isoform X4 [Sus scrofa];XP_005664106.1 deoxyribose-phosphate aldolase	4	4	4	0	0	9350400	0	0	0	0	0	0	0	0	0	0	0	0	6944500	0	6198700	NA	NA	NA	DERA	DERA;DERA;DERA;DERA;NA	neutrophil degranulation;carbohydrate catabolic process;deoxyribonucleotide catabolic process;deoxyribonucleoside catabolic process;pentose-phosphate shunt;deoxyribose phosphate catabolic process	GO:004331; GO:001605; GO:000926; GO:004612; GO:000609; GO:004638	nucleus;cytosol;ficolin-1-rich granule lumen;extracellular region;secretory granule lumen	GO:000563; GO:000582; GO:190481; GO:000557; GO:003477	 Pentose phosphate pathway	hsa0003	deoxyribose-phosphate aldolase activity	GO:000413
XP_001926332.2	XP_001926332.2	XP_001926332.2 short/branched chain specific acyl-CoA dehydrogenase, mitochondrial [Sus scrofa]	15	15	15	344770000	276590000	260060000	175600000	450810000	293350000	438940000	336920000	403380000	309030000	247460000	298360000	158500000	253430000	221380000	300360000	227860000	233930000	NA	NA	NA	ACADSB	ACADSB;NA;NA;NA;NA	oxidation-reduction process;fatty acid metabolic process;branched-chain amino acid catabolic process	GO:005511; GO:000663; GO:000908	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Fatty acid metabolism; Fatty acid degradation; Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0121; hsa0007; hsa0028; hsa0110	acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding	GO:000399; GO:005066
XP_001926413.2	XP_001926413.2	XP_001926413.2 glutamate--cysteine ligase regulatory subunit [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9311500	NA	NA	NA	GCLM	GCLM;NA;NA;NA;NA	glutamate metabolic process;glutathione biosynthetic process;response to drug;hepatic stellate cell activation;negative regulation of extrinsic apoptotic signaling pathway;response to human chorionic gonadotropin;cysteine metabolic process;response to nitrosative stress;response to oxidative stress;cellular response to follicle-stimulating hormone stimulus;cellular response to leukemia inhibitory factor;positive regulation of glutamate-cysteine ligase activity;cellular response to fibroblast growth factor stimulus;regulation of mitochondrial depolarization;aging;response to activity;cellular response to glucose stimulus;response to nutrient;apoptotic mitochondrial changes;cellular response to hepatocyte growth factor stimulus;negative regulation of neuron apoptotic process;cellular response to thyroxine stimulus;regulation of blood vessel size	GO:000653; GO:000675; GO:004249; GO:003573; GO:200123; GO:004475; GO:000653; GO:005140; GO:000697; GO:007137; GO:199083; GO:003522; GO:004434; GO:005190; GO:000756; GO:001482; GO:007133; GO:000758; GO:000863; GO:003572; GO:004352; GO:009706; GO:005088	glutamate-cysteine ligase complex;cytosol	GO:001710; GO:000582	 Metabolic pathways; Glutathione metabolism	hsa0110; hsa0048	glutamate-cysteine ligase activity;protein heterodimerization activity;enzyme regulator activity;glutamate-cysteine ligase catalytic subunit binding	GO:000435; GO:004698; GO:003023; GO:003522
XP_001926511.1	XP_001926511.1	XP_001926511.1 syntaxin-7 [Sus scrofa]	6	6	6	0	18362000	15342000	12095000	0	0	18911000	14599000	17206000	0	0	0	0	17732000	0	22592000	20449000	21396000	NA	NA	NA	STX7	STX7;NA;NA;NA;NA	organelle localization;vesicle docking;organelle assembly;positive regulation of T cell mediated cytotoxicity;intracellular protein transport;positive regulation of receptor localization to synapse;vesicle fusion;regulation of protein localization to plasma membrane	GO:005164; GO:004827; GO:007092; GO:000191; GO:000688; GO:190268; GO:000690; GO:190307	plasma membrane;lysosomal membrane;SNARE complex;recycling endosome;late endosome;integral component of membrane;immunological synapse;endomembrane system;early endosome membrane;azurophil granule;perinuclear region of cytoplasm;extracellular exosome;endocytic vesicle;synaptic vesicle;vesicle;tertiary granule	GO:000588; GO:000576; GO:003120; GO:005503; GO:000577; GO:001602; GO:000177; GO:001250; GO:003190; GO:004258; GO:004847; GO:007006; GO:003013; GO:000802; GO:003198; GO:007082	 SNARE interactions in vesicular transport; Phagosome	hsa0413; hsa0414	SNAP receptor activity;protein binding;SNARE binding;chloride channel inhibitor activity;syntaxin binding	GO:000548; GO:000551; GO:000014; GO:001986; GO:001990
XP_001926622.4	XP_001926622.4	XP_001926622.4 LOW QUALITY PROTEIN: mitochondrial 10-formyltetrahydrofolate dehydrogenase [Sus scrofa]	37	31	31	266590000	233980000	204400000	231120000	249490000	164200000	236970000	285520000	261610000	252990000	190850000	259310000	185410000	229990000	205240000	282520000	159350000	241190000	NA	NA	NA	ALDH1L2	ALDH1L2;NA;NA;NA;NA	oxidation-reduction process;10-formyltetrahydrofolate catabolic process;biosynthetic process;one-carbon metabolic process;folic acid metabolic process	GO:005511; GO:000925; GO:000905; GO:000673; GO:004665	mitochondrion;nucleus;extracellular exosome;mitochondrial matrix	GO:000573; GO:000563; GO:007006; GO:000575	 One carbon pool by folate	hsa0067	aldehyde dehydrogenase (NAD) activity;formyltetrahydrofolate dehydrogenase activity;hydroxymethyl-, formyl- and related transferase activity	GO:000402; GO:001615; GO:001674
XP_020930070.1;XP_020930069.1;XP_020930068.1;XP_020930067.1;XP_020930066.1;XP_020930065.1;XP_020930064.1;XP_020930063.1;XP_013838836.1;XP_001926637.1	XP_020930070.1;XP_020930069.1;XP_020930068.1;XP_020930067.1;XP_020930066.1;XP_020930065.1;XP_020930064.1;XP_020930063.1;XP_013838836.1;XP_001926637.1	XP_020930070.1 tetraspanin-14 [Sus scrofa];XP_020930069.1 tetraspanin-14 [Sus scrofa];XP_020930068.1 tetraspanin-14 [Sus scrofa];XP_020930067.1 tetraspanin-14 [Sus scrofa];XP_020930066.1 tetraspanin-14 [Sus scrofa];XP_020930065.1 tetraspanin-14 [Sus scrofa	2	2	2	0	0	0	0	0	0	11240000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TSPAN14	TSPAN14;TSPAN14;TSPAN14;TSPAN14;TSPAN14	protein localization to plasma membrane;protein maturation;cellular protein metabolic process;neutrophil degranulation;positive regulation of Notch signaling pathway;cell surface receptor signaling pathway	GO:007265; GO:005160; GO:004426; GO:004331; GO:004574; GO:000716	integral component of plasma membrane;specific granule membrane;tertiary granule membrane;tetraspanin-enriched microdomain;cell surface;endoplasmic reticulum lumen;plasma membrane	GO:000588; GO:003557; GO:007082; GO:009719; GO:000998; GO:000578; GO:000588	"NA"	"NA"	enzyme binding	GO:001989
XP_001926664.3;XP_005669579.1;XP_020926297.1;XP_020926296.1	XP_001926664.3;XP_005669579.1;XP_020926297.1;XP_020926296.1	XP_001926664.3 cytochrome b-c1 complex subunit 1, mitochondrial isoform X4 [Sus scrofa];XP_005669579.1 cytochrome b-c1 complex subunit 1, mitochondrial isoform X3 [Sus scrofa];XP_020926297.1 cytochrome b-c1 complex subunit 1, mitochondrial isoform X2 [Sus	13	13	13	519440000	274650000	419910000	218930000	479390000	190570000	493860000	323670000	477870000	314340000	326110000	249570000	212930000	256470000	365290000	279070000	298370000	229760000	NA	NA	NA	LOC100156879	LOC100156879;LOC100156879;LOC100156879;LOC100156879;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_001926739.2	XP_001926739.2	XP_001926739.2 ras-related protein Rab-2A [Sus scrofa]	13	13	5	285010000	270590000	280830000	221310000	246760000	228630000	256540000	219510000	263670000	244890000	242310000	203020000	274570000	221390000	209160000	280730000	247750000	253720000	NA	NA	NA	RAB2A	RAB2A;NA;NA;NA;NA	intracellular protein transport;Golgi organization;post-translational protein modification;Rab protein signal transduction;ER to Golgi vesicle-mediated transport	GO:000688; GO:000703; GO:004368; GO:003248; GO:000688	nucleus;lysosomal membrane;Golgi apparatus;Golgi membrane;cytosol;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;melanosome;extracellular exosome	GO:000563; GO:000576; GO:000579; GO:000013; GO:000582; GO:000578; GO:003311; GO:004247; GO:007006	 AMPK signaling pathway	hsa0415	GTPase activity;GTP binding;protein binding;GDP binding	GO:000392; GO:000552; GO:000551; GO:001900
XP_001926746.1	XP_001926746.1	XP_001926746.1 transmembrane emp24 domain-containing protein 10 [Sus scrofa]	7	7	7	164250000	124090000	131720000	121890000	124280000	144760000	130820000	119510000	110050000	130250000	153670000	144880000	146200000	119190000	165730000	129590000	139980000	134820000	NA	NA	NA	TMED10	TMED10;NA;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;response to alkaloid;ER to Golgi vesicle-mediated transport;COPII vesicle coating;protein oligomerization;kidney development;COPI-coated vesicle budding;Golgi organization;regulation of beta-amyloid formation;cargo loading into vesicle;regulated exocytosis;vesicle targeting, to, from or within Golgi	GO:000689; GO:004327; GO:000688; GO:004820; GO:005125; GO:000182; GO:003596; GO:000703; GO:190200; GO:003545; GO:004505; GO:004819	plasma membrane;Golgi membrane;endoplasmic reticulum;ER to Golgi transport vesicle membrane;trans-Golgi network transport vesicle;ER to Golgi transport vesicle;secretory granule membrane;gamma-secretase complex;endoplasmic reticulum-Golgi intermediate compartment;endoplasmic reticulum-Golgi intermediate compartment membrane;cis-Golgi network;zymogen granule membrane;integral component of membrane;melanosome	GO:000588; GO:000013; GO:000578; GO:001250; GO:003014; GO:003013; GO:003066; GO:007076; GO:000579; GO:003311; GO:000580; GO:004258; GO:001602; GO:004247	"NA"	"NA"	macromolecular complex binding;syntaxin binding;protein binding	GO:004487; GO:001990; GO:000551
XP_001926892.3;XP_020928946.1	XP_001926892.3;XP_020928946.1	XP_001926892.3 protein phosphatase 1F isoform X1 [Sus scrofa];XP_020928946.1 protein phosphatase 1F isoform X2 [Sus scrofa]	6	6	6	19689000	38610000	30398000	27108000	21363000	27753000	24918000	32210000	22747000	32609000	23805000	34984000	29551000	27120000	27872000	29932000	22250000	24965000	NA	NA	NA	PPM1F	PPM1F;PPM1F;NA;NA;NA	peptidyl-threonine dephosphorylation;positive regulation of cell-substrate adhesion;negative regulation of protein transport;positive regulation of gene expression;histone dephosphorylation;positive regulation of cell migration;negative regulation of protein kinase activity by regulation of protein phosphorylation;negative regulation of peptidyl-serine phosphorylation;cellular response to drug;positive regulation of epithelial cell migration;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of stress fiber assembly;positive regulation of growth;peptidyl-serine dephosphorylation;negative regulation of cell-cell adhesion mediated by cadherin;negative regulation of protein kinase activity;positive regulation of chemotaxis;positive regulation of focal adhesion assembly;intrinsic apoptotic signaling pathway;regulation of cellular protein localization;negative regulation of transcription, DNA-templated	GO:003597; GO:001081; GO:005122; GO:001062; GO:001657; GO:003033; GO:004438; GO:003313; GO:003569; GO:001063; GO:004328; GO:005149; GO:004592; GO:007026; GO:200004; GO:000646; GO:005092; GO:005189; GO:009719; GO:190382; GO:004589	macromolecular complex;cytosol;perinuclear region of cytoplasm	GO:003299; GO:000582; GO:004847	"NA"	"NA"	protein binding;protein serine/threonine phosphatase activity;calmodulin-dependent protein phosphatase activity;metal ion binding;protein tyrosine/serine/threonine phosphatase activity	GO:000551; GO:000472; GO:003319; GO:004687; GO:000813
XP_001927037.1;XP_013844436.1	XP_001927037.1;XP_013844436.1	XP_001927037.1 WD repeat-containing protein 61 isoform X1 [Sus scrofa];XP_013844436.1 WD repeat-containing protein 61 isoform X2 [Sus scrofa]	5	5	5	7946600	6741600	6877200	0	5853000	6649200	5736500	6582000	0	0	7670100	0	0	0	0	6601000	6326100	6571800	NA	NA	NA	WDR61	WDR61;WDR61;NA;NA;NA	positive regulation of histone H3-K4 methylation;Wnt signaling pathway;protein ubiquitination;positive regulation of histone H3-K79 methylation;positive regulation of transcription elongation from RNA polymerase II promoter;transcription from RNA polymerase II promoter;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;negative regulation of myeloid cell differentiation;positive regulation of transcription from RNA polymerase II promoter;histone H3-K4 trimethylation	GO:005157; GO:001605; GO:001656; GO:200116; GO:003296; GO:000636; GO:004392; GO:004563; GO:004594; GO:008018	cytosol;Cdc73/Paf1 complex;nucleus;cytoplasm;transcriptionally active chromatin;nucleoplasm;Ski complex	GO:000582; GO:001659; GO:000563; GO:000573; GO:003532; GO:000565; GO:005508	 RNA degradation	hsa0301	protein binding	GO:000551
XP_020928876.1;XP_020928875.1;XP_001927084.1	XP_020928876.1;XP_020928875.1;XP_001927084.1	XP_020928876.1 programmed cell death protein 4 [Sus scrofa];XP_020928875.1 programmed cell death protein 4 [Sus scrofa];XP_001927084.1 programmed cell death protein 4 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16227000	0	0	NA	NA	NA	PDCD4	PDCD4;PDCD4;PDCD4;NA;NA	negative regulation of cytokine production involved in inflammatory response;positive regulation of NIK/NF-kappaB signaling;positive regulation of endothelial cell apoptotic process;BMP signaling pathway;epithelial to mesenchymal transition involved in cardiac fibroblast development;negative regulation of vascular smooth muscle cell proliferation;negative regulation of vascular smooth muscle cell differentiation;negative regulation of transcription, DNA-templated;cellular response to lipopolysaccharide;cell aging;positive regulation of vascular associated smooth muscle cell apoptotic process;negative regulation of myofibroblast differentiation;apoptotic process;negative regulation of apoptotic process;positive regulation of inflammatory response;interleukin-12-mediated signaling pathway;negative regulation of JUN kinase activity;negative regulation of cell cycle	GO:190001; GO:190122; GO:200035; GO:003050; GO:006094; GO:190470; GO:190506; GO:004589; GO:007122; GO:000756; GO:190546; GO:190476; GO:000691; GO:004306; GO:005072; GO:003572; GO:004350; GO:004578	nucleus;cytoplasm;cytosol	GO:000563; GO:000573; GO:000582	 MicroRNAs in cancer; Proteoglycans in cancer	hsa0520; hsa0520	protein binding;RNA binding	GO:000551; GO:000372
XP_020929094.1;XP_001927093.2;XP_020929095.1	XP_020929094.1;XP_001927093.2;XP_020929095.1	XP_020929094.1 methionine synthase isoform X2 [Sus scrofa];XP_001927093.2 methionine synthase isoform X1 [Sus scrofa];XP_020929095.1 methionine synthase isoform X3 [Sus scrofa]	12	12	12	0	0	15526000	0	0	0	0	0	21108000	0	0	0	0	0	0	0	0	0	NA	NA	NA	MTR	MTR;MTR;MTR;NA;NA	response to axon injury;axon regeneration;cellular response to nitric oxide;cobalamin metabolic process;methylation;methionine biosynthetic process;pteridine-containing compound metabolic process;nervous system development	GO:004867; GO:003110; GO:007173; GO:000923; GO:003225; GO:000908; GO:004255; GO:000739	cytosol	GO:000582	 Cysteine and methionine metabolism; Metabolic pathways; Selenocompound metabolism; One carbon pool by folate; Biosynthesis of amino acids	hsa0027; hsa0110; hsa0045; hsa0067; hsa0123	protein binding;zinc ion binding;methionine synthase activity;cobalamin binding	GO:000551; GO:000827; GO:000870; GO:003141
XP_005656508.1;XP_001927117.4	XP_005656508.1;XP_001927117.4	XP_005656508.1 legumain [Sus scrofa];XP_001927117.4 legumain [Sus scrofa]	5	5	5	0	32790000	40119000	60940000	37937000	74267000	32091000	31198000	23123000	34618000	27560000	0	54632000	45716000	43253000	31580000	49001000	52030000	NA	NA	NA	LGMN	LGMN;LGMN;NA;NA;NA	positive regulation of cell proliferation;antigen processing and presentation of exogenous peptide antigen via MHC class II;dendritic spine organization;proteolysis;vacuolar protein processing;memory;receptor catabolic process;positive regulation of mitotic cell cycle;positive regulation of long-term synaptic potentiation;negative regulation of ERBB signaling pathway;positive regulation of endothelial cell chemotaxis;negative regulation of gene expression;associative learning;negative regulation of neuron apoptotic process;cellular response to beta-amyloid;response to acidic pH;positive regulation of monocyte chemotaxis;activation of cysteine-type endopeptidase activity;renal system process;cellular response to calcium ion;self proteolysis;cellular response to hepatocyte growth factor stimulus;negative regulation of multicellular organism growth;vitamin D metabolic process;proteolysis involved in cellular protein catabolic process	GO:000828; GO:001988; GO:009706; GO:000650; GO:000662; GO:000761; GO:003280; GO:004593; GO:190027; GO:190118; GO:200102; GO:001062; GO:000830; GO:004352; GO:190464; GO:001044; GO:009002; GO:009720; GO:000301; GO:007127; GO:009726; GO:003572; GO:004001; GO:004235; GO:005160	endolysosome lumen;lysosomal lumen;lysosome;late endosome;perinuclear region of cytoplasm;extracellular region;cytoplasm;apical part of cell;extracellular exosome	GO:003602; GO:004320; GO:000576; GO:000577; GO:004847; GO:000557; GO:000573; GO:004517; GO:007006	 Lysosome; Antigen processing and presentation	hsa0414; hsa0461	cysteine-type endopeptidase activity;peptidase activity;tau protein binding	GO:000419; GO:000823; GO:004815
XP_005657341.2;XP_020928516.1;XP_001927120.1	XP_005657341.2;XP_020928516.1;XP_001927120.1	XP_005657341.2 carbonyl reductase family member 4 isoform X3 [Sus scrofa];XP_020928516.1 carbonyl reductase family member 4 isoform X2 [Sus scrofa];XP_001927120.1 carbonyl reductase family member 4 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	4997400	0	5947400	0	9744900	0	4467100	0	0	0	0	0	0	0	NA	NA	NA	CBR4	CBR4;CBR4;CBR4;NA;NA	doxorubicin metabolic process;protein homotetramerization;daunorubicin metabolic process;protein heterotetramerization;oxidation-reduction process;fatty acid biosynthetic process	GO:004459; GO:005128; GO:004459; GO:005129; GO:005511; GO:000663	mitochondrial matrix;oxidoreductase complex	GO:000575; GO:199020	"NA"	"NA"	protein binding;NAD(P)H dehydrogenase (quinone) activity;NADPH dehydrogenase (quinone) activity;quinone binding;3-oxoacyl-[acyl-carrier-protein;NADPH binding	GO:000551; GO:000395; GO:000875; GO:004803; GO:004702; GO:007040
XP_001927122.3	XP_001927122.3	XP_001927122.3 adipocyte plasma membrane-associated protein [Sus scrofa]	17	17	17	395940000	356930000	342750000	402260000	349490000	279500000	365760000	373630000	286990000	300450000	382340000	338020000	228270000	451320000	371140000	400730000	361920000	361900000	NA	NA	NA	APMAP	APMAP;NA;NA;NA;NA	biological_process;biosynthetic process	GO:000815; GO:000905	cell surface;integral component of membrane;endoplasmic reticulum	GO:000998; GO:001602; GO:000578	"NA"	"NA"	arylesterase activity;strictosidine synthase activity	GO:000406; GO:001684
XP_001927130.1	XP_001927130.1	XP_001927130.1 5-nucleotidase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3292900	NA	NA	NA	NT5E	NT5E;NA;NA;NA;NA	NAD metabolic process;dephosphorylation;adenosine biosynthetic process;pyrimidine nucleoside catabolic process;AMP catabolic process;leukocyte cell-cell adhesion;negative regulation of inflammatory response;DNA metabolic process	GO:001967; GO:001631; GO:004608; GO:004613; GO:000619; GO:000715; GO:005072; GO:000625	extracellular exosome;anchored component of membrane;cytosol;plasma membrane;nucleoplasm;membrane;cell surface	GO:007006; GO:003122; GO:000582; GO:000588; GO:000565; GO:001602; GO:000998	 Nicotinate and nicotinamide metabolism; Purine metabolism; Pyrimidine metabolism; Metabolic pathways	hsa0076; hsa0023; hsa0024; hsa0110	5'-nucleotidase activity;metal ion binding;nucleotide binding	GO:000825; GO:004687; GO:000016
XP_005672818.2;XP_001927148.3;XP_020933733.1	XP_005672818.2;XP_001927148.3;XP_020933733.1	XP_005672818.2 acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X3 [Sus scrofa];XP_001927148.3 acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X2 [Sus scrofa];XP_020933733.1 acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ACSS1	ACSS1;ACSS1;ACSS1;NA;NA	ethanol oxidation;propionate biosynthetic process;acetyl-CoA biosynthetic process;acetate biosynthetic process;acetyl-CoA biosynthetic process from acetate	GO:000606; GO:001954; GO:000608; GO:001941; GO:001942	mitochondrial matrix	GO:000575	 Carbon metabolism; Propanoate metabolism; Biosynthesis of antibiotics; Metabolic pathways; Glycolysis / Gluconeogenesis; Pyruvate metabolism	hsa0120; hsa0064; hsa0113; hsa0110; hsa0001; hsa0062	acetate-CoA ligase activity;AMP binding;protein binding;ATP binding	GO:000398; GO:001620; GO:000551; GO:000552
XP_001927240.2	XP_001927240.2	XP_001927240.2 keratin, type II cytoskeletal 79 [Sus scrofa]	10	3	2	15320000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	KRT79	KRT79;NA;NA;NA;NA	cornification;keratinization	GO:007026; GO:003142	extracellular exosome;keratin filament;cytosol	GO:007006; GO:004509; GO:000582	"NA"	"NA"	enzyme binding;protein binding;structural molecule activity	GO:001989; GO:000551; GO:000519
XP_020944416.1;XP_020944415.1;XP_005663006.1;XP_001927263.3;NP_001302655.1	XP_020944416.1;XP_020944415.1;XP_005663006.1;XP_001927263.3;NP_001302655.1	XP_020944416.1 14-3-3 protein zeta/delta isoform X1 [Sus scrofa];XP_020944415.1 14-3-3 protein zeta/delta isoform X1 [Sus scrofa];XP_005663006.1 14-3-3 protein zeta/delta isoform X1 [Sus scrofa];XP_001927263.3 14-3-3 protein zeta/delta isoform X1 [Sus scro	19	19	17	3912000000	5114500000	5082400000	4127300000	3602000000	3859300000	5093900000	4858200000	4702800000	4898800000	4095200000	4304400000	3161900000	4390200000	4325500000	5058800000	4515700000	4139800000	NA	NA	NA	YWHAZ	YWHAZ;YWHAZ;YWHAZ;YWHAZ;YWHAZ	signal transduction;membrane organization;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;establishment of Golgi localization;regulation of mRNA stability;regulation of synapse maturation;Golgi reassembly;cytokine-mediated signaling pathway;platelet activation;negative regulation of apoptotic process	GO:000716; GO:006102; GO:190074; GO:005168; GO:004348; GO:009012; GO:009016; GO:001922; GO:003016; GO:004306	vesicle;nucleus;extracellular space;mitochondrion;blood microparticle;glutamatergic synapse;nucleoplasm;cytosol;focal adhesion;extracellular exosome;melanosome	GO:003198; GO:000563; GO:000561; GO:000573; GO:007256; GO:009897; GO:000565; GO:000582; GO:000592; GO:007006; GO:004247	 Oocyte meiosis; Epstein-Barr virus infection; PI3K-Akt signaling pathway; Pathogenic Escherichia coli infection; Cell cycle; Viral carcinogenesis; Hippo signaling pathway	hsa0411; hsa0516; hsa0415; hsa0513; hsa0411; hsa0520; hsa0439	protein binding;ubiquitin protein ligase binding;ion channel binding;RNA binding;transcription factor binding;protein domain specific binding;cadherin binding;identical protein binding	GO:000551; GO:003162; GO:004432; GO:000372; GO:000813; GO:001990; GO:004529; GO:004280
XP_001927288.1	XP_001927288.1	XP_001927288.1 developmentally-regulated GTP-binding protein 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DRG1	DRG1;NA;NA;NA;NA	transcription, DNA-templated;cytoplasmic translation;multicellular organism development	GO:000635; GO:000218; GO:000727	membrane;polysome;cytoplasm;cytosol;nuclear body	GO:001602; GO:000584; GO:000573; GO:000582; GO:001660	"NA"	"NA"	transcription factor binding;GTP binding;identical protein binding;protein binding	GO:000813; GO:000552; GO:004280; GO:000551
XP_001927300.5	XP_001927300.5	XP_001927300.5 LOW QUALITY PROTEIN: A-kinase anchor protein 12 [Sus scrofa]	50	50	50	880960000	1685300000	979450000	1528800000	958140000	1314600000	1295000000	1691400000	922280000	1316400000	1149100000	1389300000	1036400000	1557400000	1375500000	1540800000	1221200000	1523200000	NA	NA	NA	AKAP12	AKAP12;NA;NA;NA;NA	modulation of synaptic transmission;regulation of protein kinase C signaling;G-protein coupled receptor signaling pathway;protein targeting;regulation of protein kinase A signaling;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	GO:005080; GO:009003; GO:000718; GO:000660; GO:001073; GO:000719	cytoplasm;cell cortex;plasma membrane;cytoskeleton;cytosol;Schaffer collateral - CA1 synapse;focal adhesion	GO:000573; GO:000593; GO:000588; GO:000585; GO:000582; GO:009868; GO:000592	"NA"	"NA"	protein kinase A binding;protein binding;adenylate cyclase binding	GO:005101; GO:000551; GO:000817
XP_001927308.2;XP_020931453.1	XP_001927308.2;XP_020931453.1	XP_001927308.2 coiled-coil domain-containing protein 93 isoform X2 [Sus scrofa];XP_020931453.1 coiled-coil domain-containing protein 93 isoform X1 [Sus scrofa]	4	4	4	0	13681000	9824500	12261000	0	0	0	0	0	0	0	0	0	9137000	0	0	0	0	NA	NA	NA	CCDC93	CCDC93;CCDC93;NA;NA;NA	Golgi to plasma membrane transport;protein transport	GO:000689; GO:001503	early endosome;intracellular membrane-bounded organelle	GO:000576; GO:004323	"NA"	"NA"	protein binding	GO:000551
XP_020944849.1;XP_003355080.1;XP_001927356.3	XP_020944849.1;XP_003355080.1;XP_001927356.3	XP_020944849.1 elongin-C [Sus scrofa];XP_003355080.1 elongin-C [Sus scrofa];XP_001927356.3 elongin-C [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	40113000	0	0	0	0	0	0	NA	NA	NA	ELOC	ELOC;ELOC;ELOC;NA;NA	positive regulation of transcription elongation from RNA polymerase II promoter;post-translational protein modification;transcription from RNA polymerase II promoter;viral process;regulation of transcription from RNA polymerase II promoter in response to hypoxia;regulation of transcription from RNA polymerase II promoter;ubiquitin-dependent protein catabolic process;protein ubiquitination	GO:003296; GO:004368; GO:000636; GO:001603; GO:006141; GO:000635; GO:000651; GO:001656	nucleoplasm;elongin complex;cytosol	GO:000565; GO:007044; GO:000582	 HIF-1 signaling pathway; Ubiquitin mediated proteolysis; Pathways in cancer; Renal cell carcinoma	hsa0406; hsa0412; hsa0520; hsa0521	ubiquitin-protein transferase activity;protein binding	GO:000484; GO:000551
XP_001927358.1	XP_001927358.1	XP_001927358.1 prefoldin subunit 2 [Sus scrofa]	3	3	3	0	28818000	27760000	16165000	0	0	26131000	26320000	0	0	22051000	29455000	0	0	23585000	0	0	23391000	NA	NA	NA	PFDN2	PFDN2;NA;NA;NA;NA	positive regulation of cytoskeleton organization;protein folding	GO:005149; GO:000645	prefoldin complex;nucleus;mitochondrion;cytosol	GO:001627; GO:000563; GO:000573; GO:000582	"NA"	"NA"	protein binding involved in protein folding;unfolded protein binding;protein binding	GO:004418; GO:005108; GO:000551
XP_001927373.4	XP_001927373.4	XP_001927373.4 isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial [Sus scrofa]	10	10	10	124880000	108550000	117340000	87914000	97874000	80461000	132910000	84199000	125110000	91347000	107470000	71629000	101200000	104300000	86093000	94938000	113210000	95969000	NA	NA	NA	IDH3A	IDH3A;NA;NA;NA;NA	carbohydrate metabolic process;tricarboxylic acid cycle	GO:000597; GO:000609	nucleus;mitochondrial matrix;mitochondrion	GO:000563; GO:000575; GO:000573	 Biosynthesis of antibiotics; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Citrate cycle (TCA cycle); Carbon metabolism; Biosynthesis of amino acids	hsa0113; hsa0110; hsa0121; hsa0002; hsa0120; hsa0123	magnesium ion binding;isocitrate dehydrogenase (NAD+) activity;NAD binding	GO:000028; GO:000444; GO:005128
XP_001927404.1;XP_005673553.1	XP_001927404.1;XP_005673553.1	XP_001927404.1 peroxiredoxin-4 isoform X1 [Sus scrofa];XP_005673553.1 peroxiredoxin-4 isoform X2 [Sus scrofa]	10	8	8	312900000	286570000	305330000	355080000	313240000	282340000	270560000	313650000	319970000	295210000	314470000	239220000	338490000	361820000	270130000	295480000	321130000	274740000	NA	NA	NA	PRDX4	PRDX4;PRDX4;NA;NA;NA	I-kappaB phosphorylation;male gonad development;negative regulation of male germ cell proliferation;cell redox homeostasis;protein maturation by protein folding;hydrogen peroxide catabolic process;oxidation-reduction process;neutrophil degranulation;extracellular matrix organization;spermatogenesis;4-hydroxyproline metabolic process;response to oxidative stress;cellular oxidant detoxification	GO:000725; GO:000858; GO:200025; GO:004545; GO:002241; GO:004274; GO:005511; GO:004331; GO:003019; GO:000728; GO:001947; GO:000697; GO:009886	extracellular exosome;endoplasmic reticulum;smooth endoplasmic reticulum;ficolin-1-rich granule lumen;extracellular region;cytoplasm;nucleus;cytosol;secretory granule lumen	GO:007006; GO:000578; GO:000579; GO:190481; GO:000557; GO:000573; GO:000563; GO:000582; GO:003477	"NA"	"NA"	protein binding;protein homodimerization activity;thioredoxin peroxidase activity	GO:000551; GO:004280; GO:000837
XP_001927405.1	XP_001927405.1	XP_001927405.1 immunoglobulin-binding protein 1 [Sus scrofa]	2	2	2	0	19653000	18391000	0	13735000	0	17323000	16665000	0	18836000	0	0	0	0	0	0	0	16177000	NA	NA	NA	IGBP1	IGBP1;NA;NA;NA;NA	response to tumor necrosis factor;B cell activation;regulation of phosphoprotein phosphatase activity;response to interleukin-1;regulation of microtubule-based movement;negative regulation of stress-activated MAPK cascade;negative regulation of transcription from RNA polymerase II promoter;signal transduction;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	GO:003461; GO:004211; GO:004366; GO:007055; GO:006063; GO:003287; GO:000012; GO:000716; GO:004315	cytosol;cytoplasm	GO:000582; GO:000573	"NA"	"NA"	protein phosphatase regulator activity;protein phosphatase 2A binding;protein binding	GO:001988; GO:005172; GO:000551
XP_001927475.1	XP_001927475.1	XP_001927475.1 ADP/ATP translocase 2 [Sus scrofa]	12	5	4	72674000	38098000	69676000	36410000	78490000	38463000	66569000	43695000	65761000	41912000	52003000	28211000	47626000	0	40263000	45059000	46502000	41112000	NA	NA	NA	SLC25A5	SLC25A5;NA;NA;NA;NA	positive regulation of cell proliferation;transmembrane transport;ATP transport;regulation of insulin secretion;cellular response to leukemia inhibitory factor;viral process;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;adenine transport;chromosome segregation	GO:000828; GO:005508; GO:001586; GO:005079; GO:199083; GO:001603; GO:190102; GO:001585; GO:000705	mitochondrial inner membrane;membrane;integral component of plasma membrane;nucleus;MMXD complex;mitochondrion;mitochondrial nucleoid;membrane raft	GO:000574; GO:001602; GO:000588; GO:000563; GO:007181; GO:000573; GO:004264; GO:004512	 Calcium signaling pathway; Huntington's disease; cGMP-PKG signaling pathway; HTLV-I infection	hsa0402; hsa0501; hsa0402; hsa0516	adenine transmembrane transporter activity;ATP:ADP antiporter activity;protein binding;RNA binding;ubiquitin protein ligase binding	GO:001520; GO:000547; GO:000551; GO:000372; GO:003162
XP_001927515.2	XP_001927515.2	XP_001927515.2 8-oxo-dGDP phosphatase NUDT18 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1582200	NA	NA	NA	NUDT18	NUDT18;NA;NA;NA;NA	GDP catabolic process;dGDP catabolic process;nucleobase-containing small molecule catabolic process;dADP catabolic process	GO:004671; GO:004606; GO:003465; GO:004605	cytosol	GO:000582	"NA"	"NA"	protein binding;magnesium ion binding;8-oxo-dGDP phosphatase activity	GO:000551; GO:000028; GO:004471
XP_005663081.2;XP_001927531.2	XP_005663081.2;XP_001927531.2	XP_005663081.2 transmembrane protein 70, mitochondrial isoform X2 [Sus scrofa];XP_001927531.2 transmembrane protein 70, mitochondrial isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1735700	0	0	NA	NA	NA	TMEM70	TMEM70;TMEM70;NA;NA;NA	mitochondrial proton-transporting ATP synthase complex assembly	GO:003361	mitochondrion;integral component of mitochondrial membrane;nucleoplasm;mitochondrial inner membrane	GO:000573; GO:003259; GO:000565; GO:000574	"NA"	"NA"	molecular_function	GO:000367
XP_005671393.1;XP_001927564.2	XP_005671393.1;XP_001927564.2	XP_005671393.1 delta-1-pyrroline-5-carboxylate synthase isoform X2 [Sus scrofa];XP_001927564.2 delta-1-pyrroline-5-carboxylate synthase isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ALDH18A1	ALDH18A1;ALDH18A1;NA;NA;NA	oxidation-reduction process;proline biosynthetic process;ornithine biosynthetic process;citrulline biosynthetic process;glutamate metabolic process;cellular amino acid biosynthetic process;phosphorylation;L-proline biosynthetic process	GO:005511; GO:000656; GO:000659; GO:001924; GO:000653; GO:000865; GO:001631; GO:005512	cytosol;mitochondrion;mitochondrial inner membrane	GO:000582; GO:000573; GO:000574	 Metabolic pathways; Biosynthesis of amino acids; Arginine and proline metabolism	hsa0110; hsa0123; hsa0033	protein binding;delta1-pyrroline-5-carboxylate synthetase activity;RNA binding;glutamate 5-kinase activity;ATP binding;identical protein binding;glutamate-5-semialdehyde dehydrogenase activity	GO:000551; GO:001708; GO:000372; GO:000434; GO:000552; GO:004280; GO:000435
XP_001927580.3;XP_020948046.1	XP_001927580.3;XP_020948046.1	XP_001927580.3 CD109 antigen isoform X1 [Sus scrofa];XP_020948046.1 CD109 antigen isoform X2 [Sus scrofa]	10	10	10	0	17868000	18221000	23489000	16527000	22769000	0	27929000	20346000	22755000	16321000	27594000	47788000	23111000	22814000	27053000	21963000	21030000	NA	NA	NA	CD109	CD109;CD109;NA;NA;NA	negative regulation of protein phosphorylation;negative regulation of endopeptidase activity;platelet degranulation;regulation of keratinocyte differentiation;osteoclast fusion;negative regulation of transforming growth factor beta receptor signaling pathway;hair follicle development;negative regulation of keratinocyte proliferation;negative regulation of wound healing	GO:000193; GO:001095; GO:000257; GO:004561; GO:007267; GO:003051; GO:000194; GO:001083; GO:006104	extracellular space;anchored component of membrane;plasma membrane;cell surface;platelet alpha granule membrane;extracellular region	GO:000561; GO:003122; GO:000588; GO:000998; GO:003109; GO:000557	"NA"	"NA"	transforming growth factor beta binding;serine-type endopeptidase inhibitor activity	GO:005043; GO:000486
XP_001927584.1;XP_013853037.1	XP_001927584.1;XP_013853037.1	XP_001927584.1 coatomer subunit zeta-1 isoform X2 [Sus scrofa];XP_013853037.1 coatomer subunit zeta-1 isoform X1 [Sus scrofa]	4	4	4	0	20035000	18445000	0	15723000	11147000	15720000	0	0	15856000	0	0	0	0	0	0	0	0	NA	NA	NA	COPZ1	COPZ1;COPZ1;NA;NA;NA	intra-Golgi vesicle-mediated transport;intracellular protein transport;retrograde vesicle-mediated transport, Golgi to ER;toxin transport	GO:000689; GO:000688; GO:000689; GO:190199	endoplasmic reticulum membrane;COPI vesicle coat;transport vesicle;Golgi membrane;cytosol	GO:000578; GO:003012; GO:003013; GO:000013; GO:000582	"NA"	"NA"	"NA"	"NA"
XP_001927665.3	XP_001927665.3	XP_001927665.3 coagulation factor XIII A chain [Sus scrofa]	15	15	15	61814000	197140000	109050000	286260000	87785000	185970000	74549000	176210000	117600000	221520000	94465000	173240000	158020000	237390000	139690000	256870000	114180000	277730000	NA	NA	NA	F13A1	F13A1;NA;NA;NA;NA	blood coagulation;cytokine-mediated signaling pathway;peptide cross-linking;platelet degranulation;blood coagulation, fibrin clot formation	GO:000759; GO:001922; GO:001814; GO:000257; GO:007237	platelet alpha granule lumen;blood microparticle;extracellular region	GO:003109; GO:007256; GO:000557	 Complement and coagulation cascades	hsa0461	protein-glutamine gamma-glutamyltransferase activity;metal ion binding	GO:000381; GO:004687
XP_020955499.1;XP_001928592.1;XP_013853268.2;XP_013852658.1;XP_020955498.1;XP_020955497.1;XP_013832958.1;XP_013832957.1;XP_003356618.1;XP_001927727.1;XP_005663563.1;XP_003355263.3	XP_020955499.1;XP_001928592.1;XP_013853268.2;XP_013852658.1;XP_020955498.1;XP_020955497.1;XP_013832958.1;XP_013832957.1;XP_003356618.1;XP_001927727.1;XP_005663563.1;XP_003355263.3	XP_020955499.1 histone H2A type 1-H [Sus scrofa];XP_001928592.1 histone H2A type 1-H [Sus scrofa];XP_013853268.2 histone H2A.J [Sus scrofa];XP_013852658.1 histone H2A type 2-C [Sus scrofa];XP_020955498.1 histone H2A type 1 [Sus scrofa];XP_020955497.1 histo	6	6	2	2977600000	3605200000	2656700000	4343000000	3698600000	4206600000	3418300000	3822900000	3237200000	4241100000	5447700000	8931000000	5592300000	4360000000	4029300000	4970100000	3653800000	3888900000	NA	NA	NA	LOC110261668	LOC110261668;LOC100625850;LOC106510170;LOC110261666;LOC110261665	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_001927782.1;XP_013854647.1;XP_005665310.1;XP_020951647.1;XP_020951646.1;XP_005665309.1;XP_013854646.1;XP_003127861.2;XP_005665308.1;XP_005665307.1;XP_005665306.1;XP_003482078.1;XP_005674625.2	XP_001927782.1	XP_001927782.1 polyadenylate-binding protein 1 [Sus scrofa]	14	14	14	74860000	77903000	73481000	84680000	62338000	74487000	75522000	77844000	57019000	78769000	77485000	92628000	82617000	68117000	69349000	68805000	66797000	68846000	NA	NA	NA	PABPC1	PABPC1;NA;NA;NA;NA	mRNA polyadenylation;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of mRNA stability;mRNA stabilization;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translational initiation;gene silencing by RNA;positive regulation of translation;positive regulation of viral genome replication;mRNA splicing, via spliceosome	GO:000637; GO:006021; GO:200062; GO:004348; GO:004825; GO:190015; GO:000018; GO:000641; GO:003104; GO:004572; GO:004507; GO:000039	cytosol;cytoplasmic ribonucleoprotein granule;synapse;messenger ribonucleoprotein complex;nucleus;cytoplasm;focal adhesion;catalytic step 2 spliceosome;ribonucleoprotein complex;membrane;cytoplasmic stress granule;dendrite;extracellular exosome	GO:000582; GO:003646; GO:004520; GO:199012; GO:000563; GO:000573; GO:000592; GO:007101; GO:199090; GO:001602; GO:001049; GO:003042; GO:007006	 mRNA surveillance pathway; RNA transport	hsa0301; hsa0301	mRNA 3'-UTR binding;protein C-terminus binding;translation activator activity;RNA binding;protein binding;poly(A) binding;poly(U) RNA binding	GO:000373; GO:000802; GO:000849; GO:000372; GO:000551; GO:000814; GO:000826
XP_001927816.1;XP_005657393.1	XP_001927816.1;XP_005657393.1	XP_001927816.1 phosphatidylinositol transfer protein beta isoform isoform X2 [Sus scrofa];XP_005657393.1 phosphatidylinositol transfer protein beta isoform isoform X1 [Sus scrofa]	7	7	6	60678000	63610000	65186000	59732000	50578000	54662000	61991000	61988000	65311000	55964000	66484000	69978000	76560000	68257000	53000000	71952000	54479000	60284000	NA	NA	NA	PITPNB	PITPNB;PITPNB;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;phospholipid transport;nucleus organization;lipid metabolic process	GO:000689; GO:001591; GO:000699; GO:000662	cytoplasm;Golgi membrane;endoplasmic reticulum membrane	GO:000573; GO:000013; GO:000578	"NA"	"NA"	phosphatidylcholine transporter activity;phosphatidylcholine binding;phosphatidylinositol binding;phosphatidylinositol transporter activity	GO:000852; GO:003121; GO:003509; GO:000852
XP_001927830.4;XP_020924489.1	XP_001927830.4;XP_020924489.1	XP_001927830.4 78 kDa glucose-regulated protein isoform X2 [Sus scrofa];XP_020924489.1 78 kDa glucose-regulated protein isoform X1 [Sus scrofa]	35	35	34	1532300000	1430000000	1650100000	1473000000	1502100000	1480300000	1720200000	1409100000	1329500000	1316200000	1641200000	1209500000	1535000000	1478700000	1802500000	1392900000	1800900000	1404700000	NA	NA	NA	HSPA5	HSPA5;HSPA5;NA;NA;NA	protein refolding;cerebellar Purkinje cell layer development;cellular response to unfolded protein;cellular response to calcium ion;cellular response to cAMP;toxin transport;regulation of IRE1-mediated unfolded protein response;maintenance of protein localization in endoplasmic reticulum;cellular response to drug;neuron apoptotic process;positive regulation of neuron projection development;chaperone mediated protein folding requiring cofactor;regulation of protein folding in endoplasmic reticulum;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;negative regulation of apoptotic process;cerebellum structural organization;ubiquitin-dependent ERAD pathway;endoplasmic reticulum unfolded protein response;IRE1-mediated unfolded protein response;ATF6-mediated unfolded protein response;cellular response to gamma radiation;negative regulation of protein homodimerization activity;stress response to metal ion;response to methamphetamine hydrochloride;positive regulation of protein ubiquitination;cellular response to glucose starvation;response to cocaine;luteolysis;neuron differentiation;positive regulation of cell migration;protein folding in endoplasmic reticulum;cellular response to manganese ion;response to unfolded protein;negative regulation of transforming growth factor beta receptor signaling pathway;cellular response to antibiotic;cellular response to nerve growth factor stimulus;substantia nigra development;cellular response to heat;cellular response to interleukin-4	GO:004202; GO:002168; GO:003462; GO:007127; GO:007132; GO:190199; GO:190389; GO:003543; GO:003569; GO:005140; GO:001097; GO:005108; GO:006090; GO:199044; GO:004306; GO:002158; GO:003043; GO:003096; GO:003649; GO:003650; GO:007148; GO:009007; GO:009750; GO:190431; GO:003139; GO:004214; GO:004222; GO:000155; GO:003018; GO:003033; GO:003497; GO:007128; GO:000698; GO:003051; GO:007123; GO:199009; GO:002176; GO:003460; GO:007135	plasma membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane;membrane;mitochondrion;cytosol;intracellular membrane-bounded organelle;endoplasmic reticulum-Golgi intermediate compartment;midbody;nucleus;endoplasmic reticulum chaperone complex;melanosome;extracellular exosome;macromolecular complex;COP9 signalosome;focal adhesion;cell surface	GO:000588; GO:000578; GO:003017; GO:001602; GO:000573; GO:000582; GO:004323; GO:000579; GO:003049; GO:000563; GO:003466; GO:004247; GO:007006; GO:003299; GO:000818; GO:000592; GO:000998	 Protein processing in endoplasmic reticulum; Prion diseases; Antigen processing and presentation; Protein export; Thyroid hormone synthesis	hsa0414; hsa0502; hsa0461; hsa0306; hsa0491	misfolded protein binding;protein domain specific binding;unfolded protein binding;enzyme binding;ribosome binding;protein binding;heat shock protein binding;ATPase activity;ATPase activity, coupled;ATP binding;protein binding involved in protein folding;calcium ion binding;ubiquitin protein ligase binding;cadherin binding	GO:005178; GO:001990; GO:005108; GO:001989; GO:004302; GO:000551; GO:003107; GO:001688; GO:004262; GO:000552; GO:004418; GO:000550; GO:003162; GO:004529
XP_020929234.1;XP_001927831.1;XP_001927836.1	XP_020929234.1;XP_001927831.1;XP_001927836.1	XP_020929234.1 dihydropyrimidinase-related protein 2 isoform X2 [Sus scrofa];XP_001927831.1 dihydropyrimidinase-related protein 2 isoform X3 [Sus scrofa];XP_001927836.1 dihydropyrimidinase-related protein 2 isoform X1 [Sus scrofa]	25	25	23	653630000	1657500000	783420000	788390000	785960000	1550100000	651540000	885280000	709620000	1188600000	743350000	1796500000	870720000	1264400000	1004000000	1414600000	797770000	1981800000	NA	NA	NA	DPYSL2	DPYSL2;DPYSL2;DPYSL2;NA;NA	regulation of axon extension;cytoskeleton organization;brain development;nucleobase-containing compound metabolic process;axon guidance;signal transduction;endocytosis;nervous system development	GO:003051; GO:000701; GO:000742; GO:000613; GO:000741; GO:000716; GO:000689; GO:000739	extracellular exosome;plasma membrane;cytosol;membrane;microtubule	GO:007006; GO:000588; GO:000582; GO:001602; GO:000587	 Axon guidance	hsa0436	dihydropyrimidinase activity;protein binding;identical protein binding;microtubule binding	GO:000415; GO:000551; GO:004280; GO:000801
XP_005656359.1;XP_001927834.3	XP_005656359.1;XP_001927834.3	XP_005656359.1 signal recognition particle 54 kDa protein [Sus scrofa];XP_001927834.3 signal recognition particle 54 kDa protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1592400	NA	NA	NA	SRP54	SRP54;SRP54;NA;NA;NA	response to drug;protein targeting to ER;SRP-dependent cotranslational protein targeting to membrane	GO:004249; GO:004504; GO:000661	nucleolus;cytoplasm;cytosol;nucleus;signal recognition particle, endoplasmic reticulum targeting;nuclear speck	GO:000573; GO:000573; GO:000582; GO:000563; GO:000578; GO:001660	 Protein export	hsa0306	GTPase activity;endoplasmic reticulum signal peptide binding;ribonucleoprotein complex binding;RNA binding;GTP binding;drug binding;GDP binding;7S RNA binding;protein binding	GO:000392; GO:003094; GO:004302; GO:000372; GO:000552; GO:000814; GO:001900; GO:000831; GO:000551
XP_001927837.1;XP_005671157.1	XP_001927837.1;XP_005671157.1	XP_001927837.1 annexin A7 isoform X2 [Sus scrofa];XP_005671157.1 annexin A7 isoform X1 [Sus scrofa]	10	10	10	121740000	125740000	108570000	112600000	107790000	140220000	126080000	114250000	119820000	117920000	137030000	173650000	187710000	122910000	132020000	124980000	129060000	126230000	NA	NA	NA	ANXA7	ANXA7;ANXA7;NA;NA;NA	hemostasis;response to salt stress;response to organic cyclic compound;cellular water homeostasis;cell proliferation;social behavior;response to calcium ion;autophagy;regulation of cell shape;membrane fusion;negative regulation of gene expression;cellular calcium ion homeostasis;epithelial cell differentiation	GO:000759; GO:000965; GO:001407; GO:000999; GO:000828; GO:003517; GO:005159; GO:000691; GO:000836; GO:006102; GO:001062; GO:000687; GO:003085	plasma membrane;cytosol;extracellular exosome;nuclear envelope;endoplasmic reticulum membrane;chromaffin granule membrane;membrane	GO:000588; GO:000582; GO:007006; GO:000563; GO:000578; GO:004258; GO:001602	"NA"	"NA"	RNA binding;calcium ion binding;protein binding;integrin binding;calcium-dependent protein binding;calcium-dependent phospholipid binding;identical protein binding	GO:000372; GO:000550; GO:000551; GO:000517; GO:004830; GO:000554; GO:004280
XP_001927840.1	XP_001927840.1	XP_001927840.1 carbonic anhydrase 2 [Sus scrofa]	7	7	7	395600000	63819000	68946000	160290000	98668000	0	85838000	128880000	178100000	85176000	113500000	101090000	272100000	123660000	195380000	61758000	139030000	30741000	NA	NA	NA	LOC100154873	LOC100154873;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005673502.1;XP_003360278.1;XP_005673501.1;XP_020935251.1;XP_005673500.1;XP_020935250.1;XP_003360279.1;XP_013841372.1;XP_001927851.3	XP_005673502.1;XP_003360278.1;XP_005673501.1;XP_020935251.1;XP_005673500.1;XP_020935250.1;XP_003360279.1;XP_013841372.1;XP_001927851.3	XP_005673502.1 neuronal membrane glycoprotein M6-b isoform X9 [Sus scrofa];XP_003360278.1 neuronal membrane glycoprotein M6-b isoform X8 [Sus scrofa];XP_005673501.1 neuronal membrane glycoprotein M6-b isoform X7 [Sus scrofa];XP_020935251.1 neuronal membran	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5421400	NA	NA	NA	GPM6B	GPM6B;GPM6B;GPM6B;GPM6B;GPM6B	protein transport;positive regulation of bone mineralization;nervous system development;regulation of actin cytoskeleton organization;ossification;regulation of focal adhesion assembly;negative regulation of protein localization to cell surface;neuron projection development;negative regulation of serotonin uptake;extracellular matrix assembly	GO:001503; GO:003050; GO:000739; GO:003295; GO:000150; GO:005189; GO:200000; GO:003117; GO:005161; GO:008502	integral component of membrane;plasma membrane;membrane raft	GO:001602; GO:000588; GO:004512	"NA"	"NA"	molecular_function	GO:000367
XP_005663582.1;XP_001927895.1	XP_005663582.1;XP_001927895.1	XP_005663582.1 RNA-binding protein 8A isoform X2 [Sus scrofa];XP_001927895.1 RNA-binding protein 8A isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6635800	NA	NA	NA	RBM8A	RBM8A;RBM8A;NA;NA;NA	regulation of translation;mRNA 3'-end processing;regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;RNA export from nucleus;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000641; GO:003112; GO:000038; GO:000039; GO:000640; GO:000018	nucleoplasm;nuclear speck;dendrite;nucleus;exon-exon junction complex;cytoplasm;cytosol;neuronal cell body;catalytic step 2 spliceosome	GO:000565; GO:001660; GO:003042; GO:000563; GO:003514; GO:000573; GO:000582; GO:004302; GO:007101	 RNA transport; mRNA surveillance pathway; Spliceosome	hsa0301; hsa0301; hsa0304	RNA binding;mRNA binding;protein binding	GO:000372; GO:000372; GO:000551
XP_001927901.1	XP_001927901.1	XP_001927901.1 UV excision repair protein RAD23 homolog B [Sus scrofa]	10	10	10	121440000	126940000	142440000	138740000	113270000	118860000	143280000	123490000	115500000	117150000	132740000	71356000	108550000	130490000	138510000	122990000	115550000	116250000	NA	NA	NA	RAD23B	RAD23B;NA;NA;NA;NA	embryonic organ development;global genome nucleotide-excision repair;regulation of proteasomal ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;nucleotide-excision repair, DNA damage recognition;protein folding;nucleotide-excision repair, preincision complex assembly;spermatogenesis;nucleotide-excision repair;protein deubiquitination;cellular response to interleukin-7	GO:004856; GO:007091; GO:003243; GO:004316; GO:000071; GO:000645; GO:000629; GO:000728; GO:000628; GO:001657; GO:009876	cytosol;XPC complex;proteasome complex;nucleus;nucleoplasm	GO:000582; GO:007194; GO:000050; GO:000563; GO:000565	 Protein processing in endoplasmic reticulum; Nucleotide excision repair	hsa0414; hsa0342	protein binding;damaged DNA binding;polyubiquitin binding;single-stranded DNA binding;proteasome binding;ubiquitin binding	GO:000551; GO:000368; GO:003159; GO:000369; GO:007062; GO:004313
XP_020955891.1;XP_005665664.1;XP_001927944.1	XP_020955891.1;XP_005665664.1;XP_001927944.1	XP_020955891.1 protein DEK [Sus scrofa];XP_005665664.1 protein DEK [Sus scrofa];XP_001927944.1 protein DEK [Sus scrofa]	5	5	5	0	15832000	13963000	0	0	24676000	0	0	13778000	22201000	14143000	13577000	20961000	21204000	0	21252000	18643000	18520000	NA	NA	NA	DEK	DEK;DEK;DEK;NA;NA	regulation of double-strand break repair;transcription from RNA polymerase II promoter;regulation of transcription from RNA polymerase II promoter;chromatin organization;regulation of double-strand break repair via nonhomologous end joining;viral genome replication;signal transduction;positive regulation of gene expression, epigenetic	GO:200077; GO:000636; GO:000635; GO:000632; GO:200103; GO:001907; GO:000716; GO:004581	contractile fiber;nucleoplasm;nucleus	GO:004329; GO:000565; GO:000563	"NA"	"NA"	DNA binding;RNA binding;histone binding	GO:000367; GO:000372; GO:004239
XP_001927971.1	XP_001927971.1	XP_001927971.1 prostaglandin E synthase 2 [Sus scrofa]	2	2	2	0	0	9569200	0	9207400	0	0	8090600	0	0	0	0	0	0	0	7607000	0	0	NA	NA	NA	PTGES2	PTGES2;NA;NA;NA;NA	neutrophil degranulation;cell redox homeostasis;electron transport chain;cyclooxygenase pathway;positive regulation of transcription, DNA-templated	GO:004331; GO:004545; GO:002290; GO:001937; GO:004589	integral component of membrane;perinuclear region of cytoplasm;cytosol;Golgi membrane;mitochondrion;extracellular region;azurophil granule lumen;nucleus	GO:001602; GO:004847; GO:000582; GO:000013; GO:000573; GO:000557; GO:003557; GO:000563	 Arachidonic acid metabolism; Metabolic pathways	hsa0059; hsa0110	prostaglandin-E synthase activity;protein binding;DNA binding;protein disulfide oxidoreductase activity;glutathione binding;electron carrier activity;lyase activity;heme binding	GO:005022; GO:000551; GO:000367; GO:001503; GO:004329; GO:000905; GO:001682; GO:002003
XP_001927992.1	XP_001927992.1	XP_001927992.1 lactoylglutathione lyase [Sus scrofa]	12	12	12	247300000	250250000	247490000	258640000	181920000	200070000	228130000	225260000	232200000	189020000	231500000	204040000	182970000	258110000	274080000	197850000	228310000	161610000	NA	NA	NA	GLO1	GLO1;NA;NA;NA;NA	methylglyoxal metabolic process;carbohydrate metabolic process;glutathione metabolic process;osteoclast differentiation;pyruvate metabolic process;regulation of transcription from RNA polymerase II promoter;negative regulation of apoptotic process	GO:000943; GO:000597; GO:000674; GO:003031; GO:000609; GO:000635; GO:004306	plasma membrane;extracellular exosome;cytoplasm;nucleus;cytosol	GO:000588; GO:007006; GO:000573; GO:000563; GO:000582	 Pyruvate metabolism	hsa0062	zinc ion binding;lactoylglutathione lyase activity	GO:000827; GO:000446
XP_001928025.1	XP_001928025.1	XP_001928025.1 proteasome subunit alpha type-3 [Sus scrofa]	10	10	10	132440000	124780000	137110000	125930000	128560000	116010000	159580000	133730000	133520000	110520000	147680000	119430000	115690000	130400000	159840000	126560000	126930000	119580000	NA	NA	NA	PSMA3	PSMA3;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;proteasomal protein catabolic process;post-translational protein modification;regulation of endopeptidase activity;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;viral process	GO:001049; GO:001049; GO:004368; GO:005254; GO:001657; GO:004316; GO:001603	cytosol;cytoplasm;proteasome core complex, alpha-subunit complex;proteasome complex;synapse;extracellular exosome;nucleoplasm;proteasome core complex;nucleus	GO:000582; GO:000573; GO:001977; GO:000050; GO:004520; GO:007006; GO:000565; GO:000583; GO:000563	 Proteasome	hsa0305	threonine-type endopeptidase activity;endopeptidase activity;ubiquitin protein ligase binding;protein binding	GO:000429; GO:000417; GO:003162; GO:000551
XP_020954868.1;XP_001928049.1;XP_020954871.1;XP_001929155.3	XP_020954868.1;XP_001928049.1;XP_020954871.1	XP_020954868.1 GMP reductase 2 isoform X1 [Sus scrofa];XP_001928049.1 GMP reductase 2 isoform X1 [Sus scrofa];XP_020954871.1 GMP reductase 2 isoform X2 [Sus scrofa]	5	5	5	0	0	18299000	24935000	0	20192000	0	24795000	18022000	20763000	0	0	0	19800000	18700000	23893000	23503000	19789000	NA	NA	NA	GMPR2	GMPR2;GMPR2;GMPR2;NA;NA	purine nucleobase metabolic process;purine-containing compound salvage;GMP metabolic process;purine ribonucleotide interconversion;oxidation-reduction process	GO:000614; GO:004310; GO:004603; GO:001595; GO:005511	GMP reductase complex;cytosol	GO:190256; GO:000582	 Purine metabolism	hsa0023	GMP reductase activity;metal ion binding	GO:000392; GO:004687
XP_005671167.1;XP_001928060.1;XP_005671165.1;XP_001928050.2;XP_005671164.1;XP_020928242.1;XP_020928240.1;XP_020928239.1;XP_020928238.1;XP_020928237.1;XP_020928236.1;XP_020928235.1;XP_020928234.1;XP_020928233.1;XP_005671163.1;XP_020956132.1;XP_020956131.1;NP_999293.1;XP_020956130.1;XP_020956129.1;XP_020956128.1;XP_001928198.4;XP_005657294.1;XP_005657293.1;XP_003483429.1;XP_005657295.1	XP_005671167.1;XP_001928060.1;XP_005671165.1;XP_001928050.2;XP_005671164.1;XP_020928242.1;XP_020928240.1;XP_020928239.1;XP_020928238.1;XP_020928237.1;XP_020928236.1;XP_020928235.1;XP_020928234.1;XP_020928233.1;XP_005671163.1;XP_020956132.1;XP_020956131.1;NP_999293.1;XP_020956130.1;XP_020956129.1;XP_020956128.1	XP_005671167.1 serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X6 [Sus scrofa];XP_001928060.1 serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X5 [Sus scrofa];XP_005671165.1 serine/threonine-prot	5	5	5	0	0	0	22490000	14935000	0	0	0	25536000	0	0	0	17226000	21047000	0	22897000	25414000	25981000	NA	NA	NA	PPP3CA	PPP3CA;PPP3CA;PPP3CA;PPP3CA;PPP3CA	calcineurin-NFAT signaling cascade;G1/S transition of mitotic cell cycle;positive regulation of cell adhesion;calcineurin-mediated signaling;T cell activation;positive regulation of endocytosis;positive regulation of transcription from RNA polymerase II promoter;positive regulation of calcineurin-NFAT signaling cascade;cellular response to glucose stimulus;brain development;multicellular organismal response to stress;skeletal muscle fiber development;positive regulation of sequence-specific DNA binding transcription factor activity;response to calcium ion;protein import into nucleus;calcium ion transport;negative regulation of dendrite morphogenesis;excitatory postsynaptic potential;Wnt signaling pathway, calcium modulating pathway;protein dephosphorylation;positive regulation of cell migration;cellular response to drug;Fc-epsilon receptor signaling pathway;positive regulation of cardiac muscle hypertrophy in response to stress;response to amphetamine;transition between fast and slow fiber;cardiac muscle hypertrophy in response to stress;dephosphorylation;negative regulation of chromatin binding;skeletal muscle tissue regeneration;negative regulation of insulin secretion;negative regulation of production of miRNAs involved in gene silencing by miRNA;positive regulation of connective tissue replacement	GO:003317; GO:000008; GO:004578; GO:009772; GO:004211; GO:004580; GO:004594; GO:007088; GO:007133; GO:000742; GO:003355; GO:004874; GO:005109; GO:005159; GO:000660; GO:000681; GO:005077; GO:006007; GO:000722; GO:000647; GO:003033; GO:003569; GO:003809; GO:190324; GO:000197; GO:001488; GO:001489; GO:001631; GO:003556; GO:004340; GO:004667; GO:190379; GO:190520	mitochondrion;slit diaphragm;Z disc;Schaffer collateral - CA1 synapse;calcineurin complex;dendritic spine;glutamatergic synapse;cytoplasmic side of plasma membrane;cytoplasm;nucleoplasm;sarcolemma;cytosol	GO:000573; GO:003605; GO:003001; GO:009868; GO:000595; GO:004319; GO:009897; GO:000989; GO:000573; GO:000565; GO:004238; GO:000582	 Axon guidance; B cell receptor signaling pathway; Glutamatergic synapse; Oxytocin signaling pathway; Amyotrophic lateral sclerosis (ALS); Oocyte meiosis; VEGF signaling pathway; Natural killer cell mediated cytotoxicity; MAPK signaling pathway; Apoptosis; Amphetamine addiction; Calcium signaling pathway; Tuberculosis; Wnt signaling pathway; Osteoclast differentiation; HTLV-I infection	hsa0436; hsa0466; hsa0472; hsa0492; hsa0501; hsa0411; hsa0437; hsa0465; hsa0401; hsa0421; hsa0503; hsa0402; hsa0515; hsa0431; hsa0438; hsa0516	calmodulin-dependent protein phosphatase activity;protein binding;calcium ion binding;protein serine/threonine phosphatase activity;drug binding;cyclosporin A binding;protein dimerization activity;enzyme binding	GO:003319; GO:000551; GO:000550; GO:000472; GO:000814; GO:001601; GO:004698; GO:001989
XP_001928080.1;XP_005671576.1	XP_001928080.1;XP_005671576.1	XP_001928080.1 mitotic checkpoint protein BUB3 isoform X2 [Sus scrofa];XP_005671576.1 mitotic checkpoint protein BUB3 isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	8656000	0	0	0	0	0	0	NA	NA	NA	BUB3	BUB3;BUB3;NA;NA;NA	mitotic sister chromatid segregation;mitotic spindle assembly checkpoint;protein localization to kinetochore;meiotic cell cycle;regulation of mitotic cell cycle phase transition;attachment of spindle microtubules to kinetochore;anaphase-promoting complex-dependent catabolic process;cell division	GO:000007; GO:000709; GO:003450; GO:005132; GO:190199; GO:000860; GO:003114; GO:005130	condensed chromosome kinetochore;nucleoplasm;kinetochore;cytosol;mitotic checkpoint complex;bub1-bub3 complex	GO:000077; GO:000565; GO:000077; GO:000582; GO:003359; GO:199029	 HTLV-I infection; Cell cycle	hsa0516; hsa0411	ubiquitin binding;protein binding	GO:004313; GO:000551
XP_001928105.1	XP_001928105.1	XP_001928105.1 sorting nexin-12 [Sus scrofa]	8	8	7	0	31678000	30739000	30800000	0	35110000	24949000	28841000	25639000	22508000	25589000	35632000	0	0	28754000	21692000	0	34480000	NA	NA	NA	SNX12	SNX12;NA;NA;NA;NA	negative regulation of protein processing;regulation of endocytosis;negative regulation of protein transport;negative regulation of gene expression;negative regulation of early endosome to late endosome transport;protein transport;negative regulation of protein catabolic process	GO:001095; GO:003010; GO:005122; GO:001062; GO:200064; GO:001503; GO:004217	membrane;early endosome	GO:001602; GO:000576	 Endocytosis	hsa0414	phosphatidylinositol binding;protein binding;enzyme binding	GO:003509; GO:000551; GO:001989
XP_001928111.1	XP_001928111.1	XP_001928111.1 14-3-3 protein eta [Sus scrofa]	15	13	13	211340000	276610000	353450000	284880000	221370000	279120000	279120000	248060000	288640000	253810000	220640000	158500000	256540000	314080000	248560000	223160000	297320000	288250000	NA	NA	NA	YWHAH	YWHAH;NA;NA;NA;NA	intracellular protein transport;positive regulation of transcription, DNA-templated;membrane organization;regulation of synaptic plasticity;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;substantia nigra development;negative regulation of dendrite morphogenesis;regulation of sodium ion transport;glucocorticoid catabolic process;glucocorticoid receptor signaling pathway;regulation of neuron differentiation;membrane depolarization during action potential;regulation of sodium ion transmembrane transporter activity	GO:000688; GO:004589; GO:006102; GO:004816; GO:190074; GO:002176; GO:005077; GO:000202; GO:000671; GO:004292; GO:004566; GO:008601; GO:200064	glutamatergic synapse;plasma membrane;mitochondrion;presynapse;intercalated disc;cytosol;extracellular exosome	GO:009897; GO:000588; GO:000573; GO:009879; GO:001470; GO:000582; GO:007006	 Oocyte meiosis; PI3K-Akt signaling pathway; Viral carcinogenesis; Epstein-Barr virus infection; Cell cycle; Hippo signaling pathway	hsa0411; hsa0415; hsa0520; hsa0516; hsa0411; hsa0439	protein binding;glucocorticoid receptor binding;ion channel binding;protein heterodimerization activity;actin binding;identical protein binding;sodium channel regulator activity;protein domain specific binding;enzyme binding;insulin-like growth factor receptor binding	GO:000551; GO:003525; GO:004432; GO:004698; GO:000377; GO:004280; GO:001708; GO:001990; GO:001989; GO:000515
XP_001928120.2	XP_001928120.2	XP_001928120.2 ribonuclease T2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RNASET2	RNASET2;NA;NA;NA;NA	RNA catabolic process;neutrophil degranulation;RNA phosphodiester bond hydrolysis, endonucleolytic	GO:000640; GO:004331; GO:009050	extracellular exosome;azurophil granule lumen;lysosome;extracellular region;endoplasmic reticulum lumen;extracellular space;lysosomal lumen	GO:007006; GO:003557; GO:000576; GO:000557; GO:000578; GO:000561; GO:004320	"NA"	"NA"	endoribonuclease activity;ribonuclease T2 activity;ribonuclease activity;RNA binding	GO:000452; GO:003389; GO:000454; GO:000372
XP_020954724.1;XP_013833541.1;XP_005666216.1;XP_005666215.1;XP_001928183.1	XP_020954724.1;XP_013833541.1;XP_005666216.1;XP_005666215.1;XP_001928183.1	XP_020954724.1 stimulated by retinoic acid gene 6 protein homolog [Sus scrofa];XP_013833541.1 stimulated by retinoic acid gene 6 protein homolog [Sus scrofa];XP_005666216.1 stimulated by retinoic acid gene 6 protein homolog [Sus scrofa];XP_005666215.1 stim	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	3888400	0	0	0	0	0	NA	NA	NA	STRA6	STRA6;STRA6;STRA6;STRA6;STRA6	retinoid metabolic process;lung development;embryonic digestive tract development;artery morphogenesis;pulmonary valve morphogenesis;camera-type eye development;lung alveolus development;developmental growth;pulmonary artery morphogenesis;vitamin A import;feeding behavior;ear development;neuromuscular process;paramesonephric duct development;heart development;learning;positive regulation of behavior;female genitalia development;face morphogenesis;diaphragm development;embryonic camera-type eye formation;alveolar primary septum development;vocal learning;digestive tract morphogenesis;cognition;eyelid development in camera-type eye;ductus arteriosus closure;blood vessel development;retinol transport;smooth muscle tissue development;lung vasculature development;kidney development;ventricular septum development;uterus morphogenesis	GO:000152; GO:003032; GO:004856; GO:004884; GO:000318; GO:004301; GO:004828; GO:004858; GO:006115; GO:007193; GO:000763; GO:004358; GO:005090; GO:006120; GO:000750; GO:000761; GO:004852; GO:003054; GO:006032; GO:006053; GO:006090; GO:006114; GO:004229; GO:004854; GO:005089; GO:006102; GO:009707; GO:000156; GO:003463; GO:004874; GO:006042; GO:000182; GO:000328; GO:006103	plasma membrane;integral component of plasma membrane;macromolecular complex	GO:000588; GO:000588; GO:003299	"NA"	"NA"	retinol binding;signaling receptor activity;retinol transporter activity;retinal binding	GO:001984; GO:003802; GO:003463; GO:001691
XP_020954725.1;XP_001928209.1;XP_005666212.1;XP_013833544.1	XP_020954725.1;XP_001928209.1;XP_005666212.1;XP_013833544.1	XP_020954725.1 immunoglobulin superfamily containing leucine-rich repeat protein isoform X3 [Sus scrofa];XP_001928209.1 immunoglobulin superfamily containing leucine-rich repeat protein isoform X3 [Sus scrofa];XP_005666212.1 immunoglobulin superfamily cont	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12466000	NA	NA	NA	ISLR	ISLR;ISLR;ISLR;ISLR;NA	platelet degranulation;cell adhesion	GO:000257; GO:000715	extracellular region;platelet alpha granule lumen;extracellular exosome	GO:000557; GO:003109; GO:007006	"NA"	"NA"	"NA"	"NA"
XP_001928233.2	XP_001928233.2	XP_001928233.2 LOW QUALITY PROTEIN: tubulin alpha-1D chain [Sus scrofa]	23	2	1	291160000	516330000	310540000	219950000	217780000	230980000	257260000	209900000	282480000	274000000	245190000	116120000	326960000	314730000	317410000	290410000	342020000	354470000	NA	NA	NA	LOC100158003	LOC100158003;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020957466.1;XP_001928284.1	XP_020957466.1;XP_001928284.1	XP_020957466.1 thioredoxin-related transmembrane protein 1 isoform X2 [Sus scrofa];XP_001928284.1 thioredoxin-related transmembrane protein 1 isoform X1 [Sus scrofa]	3	3	3	21339000	23015000	22021000	0	21244000	25019000	17443000	22058000	17164000	24235000	0	0	27555000	23022000	0	23788000	25150000	25454000	NA	NA	NA	TMX1	TMX1;TMX1;NA;NA;NA	oxidation-reduction process;response to endoplasmic reticulum stress;cell redox homeostasis	GO:005511; GO:003497; GO:004545	endoplasmic reticulum membrane;integral component of membrane	GO:000578; GO:001602	"NA"	"NA"	disulfide oxidoreductase activity	GO:001503
XP_001928370.3	XP_001928370.3	XP_001928370.3 tubulin alpha-4A chain [Sus scrofa]	23	3	3	141890000	158570000	153970000	167100000	121030000	79442000	137070000	133580000	160320000	150960000	135660000	160330000	90264000	179150000	180930000	202150000	163510000	158460000	NA	NA	NA	TUBA4A	TUBA4A;NA;NA;NA;NA	microtubule cytoskeleton organization;mitotic cell cycle;ciliary basal body docking;microtubule-based process;G2/M transition of mitotic cell cycle;platelet degranulation;regulation of G2/M transition of mitotic cell cycle	GO:000022; GO:000027; GO:009771; GO:000701; GO:000008; GO:000257; GO:001038	extracellular region;microtubule cytoskeleton;cytoplasm;cytoskeleton;extracellular exosome;cytosol;microtubule	GO:000557; GO:001563; GO:000573; GO:000585; GO:007006; GO:000582; GO:000587	 Pathogenic Escherichia coli infection; Gap junction; Phagosome	hsa0513; hsa0454; hsa0414	GTP binding;protein kinase binding;protein binding;structural constituent of cytoskeleton;GTPase activity	GO:000552; GO:001990; GO:000551; GO:000520; GO:000392
XP_001928374.1	XP_001928374.1	XP_001928374.1 eukaryotic translation initiation factor 2 subunit 1 [Sus scrofa]	6	6	6	0	28439000	26877000	36679000	0	31648000	34987000	0	0	42317000	37403000	0	0	27513000	32612000	29539000	32956000	31392000	NA	NA	NA	EIF2S1	EIF2S1;NA;NA;NA;NA	transmembrane transport;negative regulation of guanyl-nucleotide exchange factor activity;cellular response to heat;cellular response to UV;PERK-mediated unfolded protein response;positive regulation of neuron death;positive regulation of type B pancreatic cell apoptotic process;translational initiation;negative regulation of translational initiation in response to stress;cellular response to amino acid starvation;cellular response to oxidative stress;response to endoplasmic reticulum stress;aging;stress granule assembly;protein autophosphorylation;response to manganese-induced endoplasmic reticulum stress	GO:005508; GO:190509; GO:003460; GO:003464; GO:003649; GO:190121; GO:200067; GO:000641; GO:003205; GO:003419; GO:003459; GO:003497; GO:000756; GO:003406; GO:004677; GO:199073	eukaryotic translation initiation factor 2 complex;eukaryotic 48S preinitiation complex;translation initiation ternary complex;cytosol;eukaryotic translation initiation factor 2B complex;membrane;nucleus;cytoplasmic stress granule;polysome;synapse;extracellular exosome;multi-eIF complex;glial limiting end-foot	GO:000585; GO:003329; GO:004420; GO:000582; GO:000585; GO:001602; GO:000563; GO:001049; GO:000584; GO:004520; GO:007006; GO:004361; GO:009745	 RNA transport; Non-alcoholic fatty liver disease (NAFLD); Protein processing in endoplasmic reticulum; Influenza A	hsa0301; hsa0493; hsa0414; hsa0516	ribosome binding;RNA binding;translation initiation factor activity;protein binding	GO:004302; GO:000372; GO:000374; GO:000551
XP_001928377.1	XP_001928377.1	XP_001928377.1 eukaryotic translation initiation factor 3 subunit A [Sus scrofa]	9	9	9	0	32072000	36406000	38427000	24293000	31183000	29464000	35228000	61514000	38760000	36014000	33594000	29931000	33948000	0	34213000	0	42366000	NA	NA	NA	EIF3A	EIF3A;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;translation reinitiation;negative regulation of ERK1 and ERK2 cascade;IRES-dependent viral translational initiation;translational initiation	GO:000173; GO:000218; GO:007037; GO:007552; GO:000641	cytosol;eukaryotic 43S preinitiation complex;nucleus;eukaryotic translation initiation factor 3 complex;eukaryotic 48S preinitiation complex;multi-eIF complex;nucleolus;postsynaptic density;eukaryotic translation initiation factor 3 complex, eIF3m;membrane;microtubule	GO:000582; GO:001628; GO:000563; GO:000585; GO:003329; GO:004361; GO:000573; GO:001406; GO:007154; GO:001602; GO:000587	 RNA transport	hsa0301	receptor tyrosine kinase binding;RNA binding;protein binding;translation initiation factor activity;structural molecule activity	GO:003097; GO:000372; GO:000551; GO:000374; GO:000519
XP_001928380.1	XP_001928380.1	XP_001928380.1 acetyl-CoA acetyltransferase, cytosolic [Sus scrofa]	9	9	9	182390000	117660000	149810000	82385000	171130000	58258000	152060000	105020000	149610000	108780000	108920000	52416000	36958000	82418000	151510000	107480000	103250000	74396000	NA	NA	NA	ACAT2	ACAT2;NA;NA;NA;NA	fatty acid beta-oxidation;lipid metabolic process;cholesterol biosynthetic process	GO:000663; GO:000662; GO:000669	cytosol;nucleolus;nucleus;extracellular exosome	GO:000582; GO:000573; GO:000563; GO:007006	 Valine, leucine and isoleucine degradation; Glyoxylate and dicarboxylate metabolism; Carbon metabolism; Fatty acid degradation; Fat digestion and absorption; Butanoate metabolism; Tryptophan metabolism; Pyruvate metabolism; Terpenoid backbone biosynthesis; Metabolic pathways; Propanoate metabolism; Biosynthesis of antibiotics; Fatty acid metabolism; Lysine degradation	hsa0028; hsa0063; hsa0120; hsa0007; hsa0497; hsa0065; hsa0038; hsa0062; hsa0090; hsa0110; hsa0064; hsa0113; hsa0121; hsa0031	acetyl-CoA C-acetyltransferase activity;protein binding;acetyl-CoA C-acyltransferase activity	GO:000398; GO:000551; GO:000398
XP_001928514.1	XP_001928514.1	XP_001928514.1 protein Dr1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3857200	NA	NA	NA	DR1	DR1;NA;NA;NA;NA	positive regulation of transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;regulation of RNA polymerase II transcriptional preinitiation complex assembly;transcription from RNA polymerase II promoter;histone H3 acetylation	GO:004594; GO:000012; GO:000633; GO:004589; GO:000636; GO:004396	nucleus;Ada2/Gcn5/Ada3 transcription activator complex;negative cofactor 2 complex	GO:000563; GO:000567; GO:001705	"NA"	"NA"	transcription coactivator activity;transcription corepressor activity;protein heterodimerization activity;TBP-class protein binding;protein binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;core promoter binding;transcription factor binding;DNA binding	GO:000371; GO:000371; GO:004698; GO:001702; GO:000551; GO:000098; GO:000104; GO:000813; GO:000367
XP_020945107.1;XP_020945106.1;XP_020945105.1;XP_001928558.1	XP_020945107.1;XP_020945106.1;XP_020945105.1;XP_001928558.1	XP_020945107.1 TIP41-like protein isoform X4 [Sus scrofa];XP_020945106.1 TIP41-like protein isoform X3 [Sus scrofa];XP_020945105.1 TIP41-like protein isoform X2 [Sus scrofa];XP_001928558.1 TIP41-like protein isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7632300	NA	NA	NA	TIPRL	TIPRL;TIPRL;TIPRL;TIPRL;NA	signal transduction;DNA damage checkpoint;TOR signaling;negative regulation of phosphoprotein phosphatase activity	GO:000716; GO:000007; GO:003192; GO:003251	cytosol	GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_001928597.3;XP_005659235.2	XP_001928597.3;XP_005659235.2	XP_001928597.3 heme-binding protein 2 isoform X2 [Sus scrofa];XP_005659235.2 heme-binding protein 2 isoform X1 [Sus scrofa]	3	3	3	0	8277000	0	6221600	0	0	0	6334700	0	0	0	0	6525100	6102600	0	7306400	0	0	NA	NA	NA	HEBP2	HEBP2;HEBP2;NA;NA;NA	positive regulation of mitochondrial membrane permeability;regulation of response to reactive oxygen species;positive regulation of necrotic cell death;neutrophil degranulation;negative regulation of mitochondrial membrane potential	GO:003579; GO:190103; GO:001094; GO:004331; GO:001091	azurophil granule lumen;mitochondrion;extracellular exosome;extracellular region	GO:003557; GO:000573; GO:007006; GO:000557	"NA"	"NA"	protein binding;heme binding	GO:000551; GO:002003
XP_005666478.1;XP_005666477.1;XP_001928604.1	XP_005666478.1;XP_005666477.1;XP_001928604.1	XP_005666478.1 plasma serine protease inhibitor [Sus scrofa];XP_005666477.1 plasma serine protease inhibitor [Sus scrofa];XP_001928604.1 plasma serine protease inhibitor [Sus scrofa]	4	4	4	0	0	12852000	0	0	12591000	14216000	0	13330000	0	0	0	0	0	12680000	0	0	12868000	NA	NA	NA	SERPINA5	SERPINA5;SERPINA5;SERPINA5;NA;NA	negative regulation of endopeptidase activity;seminal vesicle development;fusion of sperm to egg plasma membrane;blood coagulation;spermatogenesis;lipid transport;negative regulation of hydrolase activity	GO:001095; GO:006110; GO:000734; GO:000759; GO:000728; GO:000686; GO:005134	platelet dense tubular network;protein C inhibitor-TMPRSS7 complex;extracellular region;protein C inhibitor-coagulation factor XI complex;extracellular space;extracellular exosome;external side of plasma membrane;protein C inhibitor-plasma kallikrein complex;acrosomal membrane;membrane;platelet alpha granule;macromolecular complex	GO:003109; GO:003602; GO:000557; GO:009718; GO:000561; GO:007006; GO:000989; GO:003603; GO:000208; GO:001602; GO:003109; GO:003299	 Complement and coagulation cascades	hsa0461	serine-type endopeptidase inhibitor activity;protein binding;retinoic acid binding;acrosin binding;phosphatidylcholine binding;protease binding;glycosaminoglycan binding;heparin binding	GO:000486; GO:000551; GO:000197; GO:003219; GO:003121; GO:000202; GO:000553; GO:000820
XP_020945161.1;XP_001928678.3;XP_005663209.1;XP_005663206.1	XP_020945161.1;XP_001928678.3;XP_005663209.1;XP_005663206.1	XP_020945161.1 UDP-N-acetylhexosamine pyrophosphorylase isoform X3 [Sus scrofa];XP_001928678.3 UDP-N-acetylhexosamine pyrophosphorylase isoform X3 [Sus scrofa];XP_005663209.1 UDP-N-acetylhexosamine pyrophosphorylase isoform X2 [Sus scrofa];XP_005663206.1 U	6	6	5	13211000	13127000	15672000	37936000	0	21857000	10848000	22019000	19680000	17327000	0	13699000	0	0	0	21258000	13579000	27144000	NA	NA	NA	UAP1	UAP1;UAP1;UAP1;UAP1;NA	UDP-N-acetylglucosamine biosynthetic process	GO:000604	nucleoplasm;cytosol;plasma membrane	GO:000565; GO:000582; GO:000588	 Biosynthesis of antibiotics; Amino sugar and nucleotide sugar metabolism; Metabolic pathways	hsa0113; hsa0052; hsa0110	identical protein binding;carbohydrate binding;UDP-N-acetylglucosamine diphosphorylase activity	GO:004280; GO:003024; GO:000397
XP_020945693.1;XP_020945692.1;XP_020945691.1;XP_020945690.1;XP_020945689.1;XP_020945688.1;XP_003355289.1;XP_001928684.1;XP_013852718.1;XP_020945694.1	XP_020945693.1;XP_020945692.1;XP_020945691.1;XP_020945690.1;XP_020945689.1;XP_020945688.1;XP_003355289.1;XP_001928684.1;XP_013852718.1;XP_020945694.1	XP_020945693.1 ras-related protein Rap-1A isoform X1 [Sus scrofa];XP_020945692.1 ras-related protein Rap-1A isoform X1 [Sus scrofa];XP_020945691.1 ras-related protein Rap-1A isoform X1 [Sus scrofa];XP_020945690.1 ras-related protein Rap-1A isoform X1 [Sus	10	10	2	690260000	730880000	805140000	881270000	545030000	677820000	632890000	837060000	679950000	826700000	698700000	888130000	465780000	783630000	704830000	857710000	598380000	652710000	NA	NA	NA	RAP1A	RAP1A;RAP1A;RAP1A;RAP1A;RAP1A	protein transport;positive regulation of protein kinase activity;positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;cellular response to drug;nerve growth factor signaling pathway;regulation of insulin secretion;establishment of endothelial barrier;cellular response to glucose stimulus;liver regeneration;microvillus assembly;positive regulation of glucose import;cellular response to cAMP;response to antineoplastic agent;regulation of cell junction assembly;negative regulation of synaptic vesicle exocytosis;positive regulation of neuron projection development;cellular response to nerve growth factor stimulus;Rap protein signal transduction;negative regulation of collagen biosynthetic process;positive regulation of GTPase activity;positive regulation of vasculogenesis;signal transduction;neutrophil degranulation;positive regulation of ERK1 and ERK2 cascade	GO:001503; GO:004586; GO:190545; GO:003569; GO:003818; GO:005079; GO:006102; GO:007133; GO:009742; GO:003003; GO:004632; GO:007132; GO:009732; GO:190188; GO:200030; GO:001097; GO:199009; GO:003248; GO:003296; GO:004354; GO:200121; GO:000716; GO:004331; GO:007037	cytoplasm;guanyl-nucleotide exchange factor complex;phagocytic vesicle;specific granule membrane;glutamatergic synapse;plasma membrane;neuron projection;perinuclear region of cytoplasm;cytosol;extracellular exosome;early endosome;late endosome;cell junction	GO:000573; GO:003204; GO:004533; GO:003557; GO:009897; GO:000588; GO:004300; GO:004847; GO:000582; GO:007006; GO:000576; GO:000577; GO:003005	 Focal adhesion; Long-term potentiation; Rap1 signaling pathway; Platelet activation; cAMP signaling pathway; Leukocyte transendothelial migration; Pancreatic secretion; Chemokine signaling pathway; Renal cell carcinoma	hsa0451; hsa0472; hsa0401; hsa0461; hsa0402; hsa0467; hsa0497; hsa0406; hsa0521	GTPase activity;macromolecular complex binding;protein binding;Rap guanyl-nucleotide exchange factor activity;GTP binding;protein transporter activity	GO:000392; GO:004487; GO:000551; GO:001703; GO:000552; GO:000856
XP_001928729.1	XP_001928729.1	XP_001928729.1 malectin [Sus scrofa]	5	5	5	34853000	64591000	71177000	49848000	50775000	76940000	42326000	55006000	51560000	56169000	64186000	46770000	30661000	75186000	60744000	55062000	70252000	54967000	NA	NA	NA	MLEC	MLEC;NA;NA;NA;NA	neutrophil degranulation;carbohydrate metabolic process;protein folding	GO:004331; GO:000597; GO:000645	membrane;specific granule membrane;plasma membrane;endoplasmic reticulum membrane;integral component of membrane	GO:001602; GO:003557; GO:000588; GO:000578; GO:001602	"NA"	"NA"	carbohydrate binding;enzyme binding	GO:003024; GO:001989
XP_001928742.1;XP_001928732.1	XP_001928742.1;XP_001928732.1	XP_001928742.1 coatomer subunit alpha isoform X2 [Sus scrofa];XP_001928732.1 coatomer subunit alpha isoform X1 [Sus scrofa]	28	28	28	169730000	184050000	175780000	181240000	162720000	184540000	165980000	172870000	149090000	173830000	161480000	186970000	191200000	187640000	135930000	198810000	167010000	208230000	NA	NA	NA	COPA	COPA;COPA;NA;NA;NA	intra-Golgi vesicle-mediated transport;ER to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER;pancreatic juice secretion;regulation of receptor activity	GO:000689; GO:000688; GO:000689; GO:003015; GO:001046	extracellular space;extracellular exosome;membrane;cytoplasm;endoplasmic reticulum membrane;COPI vesicle coat;transport vesicle;Golgi membrane;cytosol	GO:000561; GO:007006; GO:001602; GO:000573; GO:000578; GO:003012; GO:003013; GO:000013; GO:000582	"NA"	"NA"	structural molecule activity;hormone activity	GO:000519; GO:000517
XP_020954882.1;XP_013833657.1;XP_001928758.1	XP_020954882.1;XP_013833657.1;XP_001928758.1	XP_020954882.1 thiamine-triphosphatase [Sus scrofa];XP_013833657.1 thiamine-triphosphatase [Sus scrofa];XP_001928758.1 thiamine-triphosphatase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	THTPA	THTPA;THTPA;THTPA;NA;NA	thiamine metabolic process;generation of precursor metabolites and energy;thiamine diphosphate metabolic process;dephosphorylation;thiamine-containing compound metabolic process	GO:000677; GO:000609; GO:004235; GO:001631; GO:004272	cytosol	GO:000582	 Thiamine metabolism; Metabolic pathways	hsa0073; hsa0110	magnesium ion binding;hydrolase activity;thiamin-triphosphatase activity	GO:000028; GO:001678; GO:005033
XP_001928763.2	XP_001928763.2	XP_001928763.2 histidine triad nucleotide-binding protein 3 [Sus scrofa]	3	3	3	0	0	18612000	0	0	0	15807000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	HINT3	HINT3;NA;NA;NA;NA	"NA"	"NA"	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	nucleotide binding;hydrolase activity	GO:000016; GO:001678
XP_001928782.2	XP_001928782.2	XP_001928782.2 26S protease regulatory subunit 10B [Sus scrofa]	11	11	11	71605000	59708000	73584000	72329000	60861000	49969000	73482000	63645000	70748000	67067000	65431000	70968000	68191000	68807000	54430000	74803000	64576000	65573000	NA	NA	NA	PSMC6	PSMC6;NA;NA;NA;NA	ubiquitin-dependent protein catabolic process;post-translational protein modification;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;ubiquitin-dependent ERAD pathway;positive regulation of proteasomal protein catabolic process;protein deubiquitination	GO:000651; GO:004368; GO:004589; GO:003043; GO:190180; GO:001657	nucleoplasm;cytosolic proteasome complex;extracellular exosome;membrane;proteasome regulatory particle, base subcomplex;nucleus;proteasome complex;proteasome accessory complex;cytosol	GO:000565; GO:003159; GO:007006; GO:001602; GO:000854; GO:000563; GO:000050; GO:002262; GO:000582	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	protein binding;protein binding, bridging;ATP binding;identical protein binding;ATPase activity;proteasome-activating ATPase activity	GO:000551; GO:003067; GO:000552; GO:004280; GO:001688; GO:003640
XP_001928802.1;XP_020955054.1;XP_005656404.1;XP_020955053.1	XP_001928802.1;XP_020955054.1;XP_005656404.1;XP_020955053.1	XP_001928802.1 retinol dehydrogenase 11 isoform X4 [Sus scrofa];XP_020955054.1 retinol dehydrogenase 11 isoform X3 [Sus scrofa];XP_005656404.1 retinol dehydrogenase 11 isoform X2 [Sus scrofa];XP_020955053.1 retinol dehydrogenase 11 isoform X1 [Sus scrofa]	3	3	3	28173000	18643000	26853000	22782000	15655000	18036000	19017000	18773000	21926000	19109000	18832000	18657000	0	0	18814000	28098000	20144000	12488000	NA	NA	NA	RDH11	RDH11;RDH11;RDH11;RDH11;NA	retinol metabolic process;adaptation of rhodopsin mediated signaling;retinal metabolic process;oxidation-reduction process;retinoid metabolic process;visual perception	GO:004257; GO:001606; GO:004257; GO:005511; GO:000152; GO:000760	integral component of membrane;photoreceptor inner segment;endoplasmic reticulum membrane	GO:001602; GO:000191; GO:000578	 Retinol metabolism; Metabolic pathways	hsa0083; hsa0110	protein binding;aldehyde dehydrogenase (NADP+) activity;retinol dehydrogenase activity;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;NADP-retinol dehydrogenase activity	GO:000551; GO:003372; GO:000474; GO:001661; GO:005265
XP_013845695.1;XP_001928827.3	XP_013845695.1;XP_001928827.3	XP_013845695.1 methylglutaconyl-CoA hydratase, mitochondrial isoform X2 [Sus scrofa];XP_001928827.3 methylglutaconyl-CoA hydratase, mitochondrial isoform X1 [Sus scrofa]	6	6	6	40169000	25983000	24985000	17776000	28734000	0	27263000	22436000	30330000	19051000	29447000	23221000	0	20326000	21006000	28646000	22370000	0	NA	NA	NA	AUH	AUH;AUH;NA;NA;NA	fatty acid beta-oxidation;leucine catabolic process;branched-chain amino acid catabolic process	GO:000663; GO:000655; GO:000908	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	mRNA 3'-UTR binding;itaconyl-CoA hydratase activity;enoyl-CoA hydratase activity;methylglutaconyl-CoA hydratase activity	GO:000373; GO:005001; GO:000430; GO:000449
XP_020931174.1;XP_020931173.1;XP_001928829.1	XP_020931174.1;XP_020931173.1;XP_001928829.1	XP_020931174.1 splicing factor 3B subunit 1 isoform X2 [Sus scrofa];XP_020931173.1 splicing factor 3B subunit 1 isoform X2 [Sus scrofa];XP_001928829.1 splicing factor 3B subunit 1 isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	12763000	0	0	0	13143000	13827000	0	0	0	0	0	0	0	NA	NA	NA	SF3B1	SF3B1;SF3B1;SF3B1;NA;NA	RNA splicing, via transesterification reactions;mRNA splicing, via spliceosome;positive regulation of gene expression, epigenetic	GO:000037; GO:000039; GO:004581	nuclear speck;U2 snRNP;U2-type precatalytic spliceosome;catalytic step 2 spliceosome;nucleus;U11/U12 snRNP;nucleoplasm	GO:001660; GO:000568; GO:007100; GO:007101; GO:000563; GO:003469; GO:000565	 Spliceosome	hsa0304	RNA binding;protein binding;mRNA binding	GO:000372; GO:000551; GO:000372
XP_020955330.1;XP_001928857.4	XP_020955330.1;XP_001928857.4	XP_020955330.1 serpin A3-8 [Sus scrofa];XP_001928857.4 serpin A3-8 [Sus scrofa]	19	14	10	517760000	566880000	568150000	1087000000	5061400000	5653600000	521270000	639800000	358240000	344860000	640800000	755200000	536540000	632730000	477640000	539840000	603150000	743700000	NA	NA	NA	LOC100153899	LOC100153899;LOC100153899;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013849376.1;XP_001928876.1	XP_013849376.1;XP_001928876.1	XP_013849376.1 phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X2 [Sus scrofa];XP_001928876.1 phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X1 [Sus scrofa]	3	3	3	0	0	16190000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PHYHD1	PHYHD1;PHYHD1;NA;NA;NA	oxidation-reduction process	GO:005511	"NA"	"NA"	"NA"	"NA"	dioxygenase activity;protein binding;metal ion binding	GO:005121; GO:000551; GO:004687
XP_001928879.1;CON__Q9TTE1;CON__A2I7N1;CON__A2I7N0	XP_001928879.1	XP_001928879.1 serpin A3-6 [Sus scrofa]	21	7	5	0	0	122780000	361370000	508120000	619110000	0	0	121070000	167700000	213260000	502860000	352580000	139940000	68745000	0	0	54948000	NA	NA	NA	LOC100156325	LOC100156325;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_001928883.1	XP_001928883.1	XP_001928883.1 density-regulated protein [Sus scrofa]	2	2	2	0	0	11671000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DENR	DENR;NA;NA;NA;NA	ribosome disassembly;formation of translation preinitiation complex;translation reinitiation;IRES-dependent viral translational initiation	GO:003279; GO:000173; GO:000218; GO:007552	cellular_component	GO:000557	"NA"	"NA"	protein binding;translation initiation factor activity;molecular_function;mRNA binding	GO:000551; GO:000374; GO:000367; GO:000372
XP_001928898.1	XP_001928898.1	XP_001928898.1 LDLR chaperone MESD [Sus scrofa]	7	7	7	51739000	52514000	56327000	49810000	47107000	70492000	62100000	64699000	53710000	31701000	0	84328000	0	54028000	55825000	57539000	61863000	45892000	NA	NA	NA	MESD	MESD;NA;NA;NA;NA	phagocytosis;protein folding;Wnt signaling pathway;mesoderm development;protein localization to cell surface;positive regulation of skeletal muscle acetylcholine-gated channel clustering	GO:000690; GO:000645; GO:001605; GO:000749; GO:003439; GO:190439	endoplasmic reticulum;cellular_component;plasma membrane	GO:000578; GO:000557; GO:000588	"NA"	"NA"	identical protein binding;molecular_function;low-density lipoprotein particle receptor binding	GO:004280; GO:000367; GO:005075
XP_020945233.1;XP_001928904.2;XP_013852328.1	XP_020945233.1;XP_001928904.2;XP_013852328.1	XP_020945233.1 peroxisomal biogenesis factor 19 isoform X2 [Sus scrofa];XP_001928904.2 peroxisomal biogenesis factor 19 isoform X1 [Sus scrofa];XP_013852328.1 peroxisomal biogenesis factor 19 isoform X3 [Sus scrofa]	8	8	8	24573000	40866000	36700000	25501000	32831000	27169000	39796000	31374000	40006000	30774000	37660000	0	0	36152000	41650000	38013000	34137000	0	NA	NA	NA	PEX19	PEX19;PEX19;PEX19;NA;NA	peroxisome fission;transmembrane transport;peroxisome organization;chaperone-mediated protein folding;chaperone-mediated protein transport;protein targeting to peroxisome;protein import into peroxisome membrane;protein stabilization;establishment of protein localization to peroxisome;negative regulation of lipid binding	GO:001655; GO:005508; GO:000703; GO:006107; GO:007232; GO:000662; GO:004504; GO:005082; GO:007266; GO:190013	brush border membrane;peroxisome;macromolecular complex;cytoplasm;nucleoplasm;cytosol	GO:003152; GO:000577; GO:003299; GO:000573; GO:000565; GO:000582	 Peroxisome	hsa0414	protein binding;peroxisome membrane class-1 targeting sequence binding;protein N-terminus binding;ATPase binding	GO:000551; GO:003610; GO:004748; GO:005111
XP_001928912.1	XP_001928912.1	XP_001928912.1 alpha-centractin [Sus scrofa]	9	9	4	175660000	148890000	165040000	146340000	146960000	119810000	140360000	135650000	158620000	149110000	145110000	140310000	167420000	176790000	177200000	143230000	149510000	159700000	NA	NA	NA	ACTR1A	ACTR1A;NA;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;spermatogenesis;vesicle-mediated transport;ER to Golgi vesicle-mediated transport;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body docking	GO:001988; GO:000728; GO:001619; GO:000688; GO:000008; GO:001038; GO:009771	extracellular exosome;centriole;cell cortex region;COPI-coated vesicle;microtubule cytoskeleton;cytoplasm;microtubule associated complex;manchette;cytosol;dynactin complex	GO:007006; GO:000581; GO:009973; GO:003013; GO:001563; GO:000573; GO:000587; GO:000217; GO:000582; GO:000586	"NA"	"NA"	protein binding;ATP binding	GO:000551; GO:000552
XP_001928925.1	XP_001928925.1	XP_001928925.1 activator of 90 kDa heat shock protein ATPase homolog 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	33089000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	AHSA1	AHSA1;NA;NA;NA;NA	positive regulation of ATPase activity	GO:003278	extracellular exosome;endoplasmic reticulum;cytosol	GO:007006; GO:000578; GO:000582	"NA"	"NA"	Hsp90 protein binding;cadherin binding;chaperone binding;ATPase activator activity;protein binding	GO:005187; GO:004529; GO:005108; GO:000167; GO:000551
XP_001928927.2	XP_001928927.2	XP_001928927.2 LOW QUALITY PROTEIN: cysteine-rich with EGF-like domain protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5055900	NA	NA	NA	CRELD1	CRELD1;NA;NA;NA;NA	endocardial cushion development;cardiac septum development	GO:000319; GO:000327	integral component of membrane	GO:001602	"NA"	"NA"	extracellular matrix structural constituent;calcium ion binding	GO:000520; GO:000550
XP_001928957.1;XP_005660567.1;XP_020925552.1;XP_005660568.1;XP_005660566.1;XP_020925545.1;XP_020925523.1;XP_005660569.1;XP_020925563.1;XP_005660565.1;XP_005660563.1;XP_020925522.1	XP_001928957.1;XP_005660567.1;XP_020925552.1;XP_005660568.1;XP_005660566.1;XP_020925545.1;XP_020925523.1;XP_005660569.1;XP_020925563.1;XP_005660565.1;XP_005660563.1;XP_020925522.1	XP_001928957.1 endophilin-B2 isoform X11 [Sus scrofa];XP_005660567.1 endophilin-B2 isoform X9 [Sus scrofa];XP_020925552.1 endophilin-B2 isoform X6 [Sus scrofa];XP_005660568.1 endophilin-B2 isoform X10 [Sus scrofa];XP_005660566.1 endophilin-B2 isoform X7 [S	13	13	13	29426000	57985000	39364000	50214000	31597000	35207000	40172000	61685000	47307000	50350000	42230000	60489000	42162000	68453000	44303000	52175000	45731000	51815000	NA	NA	NA	SH3GLB2	SH3GLB2;SH3GLB2;SH3GLB2;SH3GLB2;SH3GLB2	"NA"	"NA"	cytoplasm;cytosol;nucleoplasm	GO:000573; GO:000582; GO:000565	 Endocytosis	hsa0414	cadherin binding;identical protein binding;protein binding	GO:004529; GO:004280; GO:000551
XP_001928988.1	XP_001928988.1	XP_001928988.1 ribonuclease UK114 [Sus scrofa]	7	7	7	88371000	66689000	83042000	50880000	60148000	29330000	95410000	66371000	77724000	51439000	50611000	0	32645000	58713000	82605000	56665000	47211000	44865000	NA	NA	NA	RIDA	RIDA;NA;NA;NA;NA	brain development;negative regulation of translation;response to salt;L-threonine catabolic process to glycine;negative regulation of epithelial cell proliferation;RNA phosphodiester bond hydrolysis, endonucleolytic;organonitrogen compound catabolic process;kidney development;lung development;response to lipid;G1 to G0 transition	GO:000742; GO:001714; GO:190207; GO:001951; GO:005068; GO:009050; GO:190156; GO:000182; GO:003032; GO:003399; GO:007031	cytosol;cytoplasm;mitochondrial matrix;peroxisome;extracellular exosome;nucleus	GO:000582; GO:000573; GO:000575; GO:000577; GO:007006; GO:000563	"NA"	"NA"	transition metal ion binding;xenon atom binding;endoribonuclease activity, producing 3'-phosphomonoesters;deaminase activity;long-chain fatty acid binding;protein homodimerization activity;RNA binding	GO:004691; GO:190401; GO:001689; GO:001923; GO:003604; GO:004280; GO:000372
XP_001928995.1	XP_001928995.1	XP_001928995.1 astrocytic phosphoprotein PEA-15 [Sus scrofa]	8	8	8	67558000	122370000	121770000	135680000	78184000	99328000	98600000	142390000	118060000	117610000	62096000	99267000	85195000	125090000	85169000	107950000	110390000	111980000	NA	NA	NA	PEA15	PEA15;NA;NA;NA;NA	apoptotic process;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of glucose import;DNA damage checkpoint;MAPK cascade;activation of MAPK activity;response to morphine;carbohydrate transport	GO:000691; GO:190204; GO:004632; GO:000007; GO:000016; GO:000018; GO:004327; GO:000864	microtubule associated complex;nucleus;cytosol	GO:000587; GO:000563; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_020945135.1;XP_001929021.1;XP_001929017.1	XP_020945135.1;XP_001929021.1;XP_001929017.1	XP_020945135.1 protein CREG1 isoform X3 [Sus scrofa];XP_001929021.1 protein CREG1 isoform X2 [Sus scrofa];XP_001929017.1 protein CREG1 isoform X1 [Sus scrofa]	3	3	3	0	20810000	20230000	17228000	0	23096000	16829000	14920000	0	19081000	0	18308000	0	20553000	25490000	0	0	28184000	NA	NA	NA	CREG1	CREG1;CREG1;CREG1;NA;NA	regulation of transcription from RNA polymerase II promoter;neutrophil degranulation;regulation of growth;negative regulation of nucleic acid-templated transcription;multicellular organism development	GO:000635; GO:004331; GO:004000; GO:190350; GO:000727	azurophil granule lumen;extracellular region;transcription factor complex;extracellular exosome;extracellular space	GO:003557; GO:000557; GO:000566; GO:007006; GO:000561	"NA"	"NA"	cofactor binding;transcription factor binding;transcription corepressor activity	GO:004803; GO:000813; GO:000371
XP_001929028.1	XP_001929028.1	XP_001929028.1 glutaredoxin-related protein 5, mitochondrial [Sus scrofa]	2	2	2	0	0	9260100	0	0	0	13508000	0	0	9488300	0	0	0	0	0	0	0	0	NA	NA	NA	GLRX5	GLRX5;NA;NA;NA;NA	protein lipoylation;small molecule metabolic process;cell redox homeostasis;hemopoiesis;electron transport chain	GO:000924; GO:004428; GO:004545; GO:003009; GO:002290	nucleus;mitochondrial matrix;dendrite;neuronal cell body;mitochondrion	GO:000563; GO:000575; GO:003042; GO:004302; GO:000573	"NA"	"NA"	protein binding;metal ion binding;glutathione disulfide oxidoreductase activity;2 iron, 2 sulfur cluster binding;electron carrier activity	GO:000551; GO:004687; GO:001503; GO:005153; GO:000905
XP_020929278.1;XP_001929050.3	XP_020929278.1;XP_001929050.3	XP_020929278.1 BRISC complex subunit Abro1 [Sus scrofa];XP_001929050.3 BRISC complex subunit Abro1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3271800	0	0	NA	NA	NA	ABRAXAS2	ABRAXAS2;ABRAXAS2;NA;NA;NA	chromosome segregation;response to ischemia;protein K63-linked deubiquitination;mitotic cell cycle;attachment of spindle microtubules to kinetochore;cell division;protein deubiquitination;mitotic spindle assembly	GO:000705; GO:000293; GO:007053; GO:000027; GO:000860; GO:005130; GO:001657; GO:009030	cytosol;BRISC complex;cytoplasm;spindle pole centrosome;microtubule minus-end;centrosome;midbody	GO:000582; GO:007055; GO:000573; GO:003161; GO:003644; GO:000581; GO:003049	"NA"	"NA"	microtubule binding;protein binding;polyubiquitin binding	GO:000801; GO:000551; GO:003159
XP_001929053.1	XP_001929053.1	XP_001929053.1 putative acyl-coenzyme A thioesterase 6 [Sus scrofa]	4	2	2	69587000	69337000	76510000	0	73006000	54499000	113410000	83362000	95405000	54130000	79638000	74676000	0	68550000	95244000	65509000	65043000	77783000	NA	NA	NA	ACOT6	ACOT6;NA;NA;NA;NA	fatty acid metabolic process;acyl-CoA metabolic process	GO:000663; GO:000663	peroxisomal matrix;cytosol	GO:000578; GO:000582	"NA"	"NA"	acyl-CoA hydrolase activity;carboxylic ester hydrolase activity	GO:004761; GO:005268
XP_001929062.1;XP_005656504.1;XP_020955282.1	XP_001929062.1;XP_005656504.1;XP_020955282.1	XP_001929062.1 fibulin-5 isoform X3 [Sus scrofa];XP_005656504.1 fibulin-5 isoform X2 [Sus scrofa];XP_020955282.1 fibulin-5 isoform X1 [Sus scrofa]	7	7	7	103520000	78459000	103580000	148440000	96573000	107970000	144390000	154910000	163640000	207790000	211810000	127800000	583510000	144920000	171950000	88714000	143680000	125040000	NA	NA	NA	FBLN5	FBLN5;FBLN5;FBLN5;NA;NA	protein localization to cell surface;elastic fiber assembly;regulation of cell growth;extracellular matrix organization;cell-matrix adhesion;secretion;regulation of removal of superoxide radicals	GO:003439; GO:004825; GO:000155; GO:003019; GO:000716; GO:004690; GO:200012	extracellular region;extracellular space;extracellular matrix;extracellular exosome;elastic fiber	GO:000557; GO:000561; GO:003101; GO:007006; GO:007195	"NA"	"NA"	integrin binding;protein C-terminus binding;extracellular matrix constituent conferring elasticity;protein homodimerization activity;protein binding;calcium ion binding	GO:000517; GO:000802; GO:003002; GO:004280; GO:000551; GO:000550
XP_001929064.4;XP_013852534.1;XP_020955042.1;XP_003128025.1;XP_003359827.2;XP_003483878.1	XP_001929064.4;XP_013852534.1	XP_001929064.4 ras-related protein Rab-8B [Sus scrofa];XP_013852534.1 ras-related protein Rab-13 [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	14332000	5051000	0	0	0	0	0	0	0	NA	NA	NA	RAB8B	RAB8B;RAB13;NA;NA;NA	cilium assembly;antigen processing and presentation;adherens junction organization;protein secretion;protein localization to plasma membrane;protein import into peroxisome membrane;intracellular protein transport;regulation of exocytosis;Golgi vesicle fusion to target membrane;positive regulation of corticotropin secretion;positive regulation of cell projection organization;Rab protein signal transduction;cellular response to insulin stimulus;vesicle docking involved in exocytosis	GO:006027; GO:001988; GO:003433; GO:000930; GO:007265; GO:004504; GO:000688; GO:001715; GO:004821; GO:005146; GO:003134; GO:003248; GO:003286; GO:000690	perinuclear region of cytoplasm;plasma membrane;endosome;intracellular membrane-bounded organelle;recycling endosome membrane;phagocytic vesicle;extracellular exosome;peroxisomal membrane;nucleoplasm;synaptic vesicle;nuclear body;phagocytic vesicle membrane;cell tip;trans-Golgi network transport vesicle	GO:004847; GO:000588; GO:000576; GO:004323; GO:005503; GO:004533; GO:007006; GO:000577; GO:000565; GO:000802; GO:001660; GO:003067; GO:005128; GO:003014	"NA"	"NA"	GTP binding;receptor binding;GDP binding;protein binding;GTPase activity;TPR domain binding	GO:000552; GO:000510; GO:001900; GO:000551; GO:000392; GO:003091
XP_020929556.1;XP_020929555.1;XP_020929554.1;XP_020929553.1;XP_020929551.1;XP_013838718.1;XP_013838717.1;XP_005671058.1;XP_005671057.1;XP_005671056.1;XP_001929089.1	XP_020929556.1;XP_020929555.1;XP_020929554.1;XP_020929553.1;XP_020929551.1;XP_013838718.1;XP_013838717.1;XP_005671058.1;XP_005671057.1;XP_005671056.1;XP_001929089.1	XP_020929556.1 heterogeneous nuclear ribonucleoprotein F [Sus scrofa];XP_020929555.1 heterogeneous nuclear ribonucleoprotein F [Sus scrofa];XP_020929554.1 heterogeneous nuclear ribonucleoprotein F [Sus scrofa];XP_020929553.1 heterogeneous nuclear ribonucle	8	8	6	106550000	133340000	125130000	145900000	107530000	139770000	129680000	144540000	124110000	125920000	128590000	174900000	163260000	132080000	132250000	140370000	142010000	143970000	NA	NA	NA	HNRNPF	HNRNPF;HNRNPF;HNRNPF;HNRNPF;HNRNPF	mRNA splicing, via spliceosome;interleukin-12-mediated signaling pathway;RNA metabolic process;RNA processing;regulation of RNA splicing;fibroblast growth factor receptor signaling pathway	GO:000039; GO:003572; GO:001607; GO:000639; GO:004348; GO:000854	cytosol;nucleoplasm;membrane;nucleus;catalytic step 2 spliceosome;plasma membrane	GO:000582; GO:000565; GO:001602; GO:000563; GO:007101; GO:000588	"NA"	"NA"	protein binding;single-stranded RNA binding;TBP-class protein binding	GO:000551; GO:000372; GO:001702
XP_020954784.1;XP_020954783.1;XP_001929104.1;XP_020954766.1;XP_020945383.1;XP_020945382.1;XP_020945381.1;XP_020945380.1	XP_020954784.1;XP_020954783.1;XP_001929104.1;XP_020954766.1	XP_020954784.1 pyruvate kinase PKM isoform X8 [Sus scrofa];XP_020954783.1 pyruvate kinase PKM isoform X8 [Sus scrofa];XP_001929104.1 pyruvate kinase PKM isoform X8 [Sus scrofa];XP_020954766.1 poly [ADP-ribose] polymerase 6 isoform X2 [Sus scrofa]	33	33	5	1545800000	1363200000	1532400000	1637800000	1401400000	1379700000	1613000000	1115700000	1442900000	1480500000	1531800000	1159900000	2201000000	1185100000	1018200000	1306700000	3380300000	1431700000	NA	NA	NA	PKM	PKM;PKM;PKM;PKM;NA	response to hypoxia;programmed cell death;skeletal muscle tissue regeneration;canonical glycolysis;response to gravity;cellular response to insulin stimulus;liver development;response to muscle inactivity;neutrophil degranulation;positive regulation of sprouting angiogenesis;glycolytic process;response to nutrient;animal organ regeneration;protein homotetramerization	GO:000166; GO:001250; GO:004340; GO:006162; GO:000962; GO:003286; GO:000188; GO:001487; GO:004331; GO:190367; GO:000609; GO:000758; GO:003110; GO:005128	nucleus;cilium;cytosol;vesicle;extracellular exosome;cytoplasm;extracellular region;ficolin-1-rich granule lumen;secretory granule lumen;pyruvate kinase complex;extracellular vesicle	GO:000563; GO:000592; GO:000582; GO:003198; GO:007006; GO:000573; GO:000557; GO:190481; GO:003477; GO:190291; GO:190356	 Purine metabolism; Glucagon signaling pathway; Carbon metabolism; Biosynthesis of antibiotics; Viral carcinogenesis; Glycolysis / Gluconeogenesis; Metabolic pathways; Pyruvate metabolism; Biosynthesis of amino acids; Type II diabetes mellitus; Central carbon metabolism in cancer	hsa0023; hsa0492; hsa0120; hsa0113; hsa0520; hsa0001; hsa0110; hsa0062; hsa0123; hsa0493; hsa0523	RNA binding;identical protein binding;magnesium ion binding;ATP binding;MHC class II protein complex binding;thyroid hormone binding;protein binding;cadherin binding;pyruvate kinase activity;kinase activity;potassium ion binding;ADP binding	GO:000372; GO:004280; GO:000028; GO:000552; GO:002302; GO:007032; GO:000551; GO:004529; GO:000474; GO:001630; GO:003095; GO:004353
XP_020955157.1;XP_005656444.1;XP_003128705.1;XP_001929109.1	XP_020955157.1;XP_005656444.1;XP_003128705.1;XP_001929109.1	XP_020955157.1 prostaglandin reductase 2 isoform X2 [Sus scrofa];XP_005656444.1 prostaglandin reductase 2 isoform X2 [Sus scrofa];XP_003128705.1 prostaglandin reductase 2 isoform X1 [Sus scrofa];XP_001929109.1 prostaglandin reductase 2 isoform X1 [Sus scro	3	3	3	0	0	24553000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PTGR2	PTGR2;PTGR2;PTGR2;PTGR2;NA	prostaglandin metabolic process;oxidation-reduction process	GO:000669; GO:005511	cytoplasm	GO:000573	"NA"	"NA"	zinc ion binding;15-oxoprostaglandin 13-oxidase activity;13-prostaglandin reductase activity	GO:000827; GO:004752; GO:003613
XP_020933471.1;XP_020933470.1;XP_005672925.1;XP_003134451.1;XP_020933468.1;XP_013840755.1;XP_020933467.1;XP_020933466.1;XP_020933465.1;XP_003359995.1;XP_001929139.2;XP_013840752.1;XP_005672922.1;XP_020933464.1;XP_020933463.1;XP_020933462.1;XP_020933461.1;XP_020933460.1;XP_020933459.1;XP_020933458.1;XP_020933473.1;XP_020933472.1	XP_020933471.1;XP_020933470.1;XP_005672925.1;XP_003134451.1;XP_020933468.1;XP_013840755.1;XP_020933467.1;XP_020933466.1;XP_020933465.1;XP_003359995.1;XP_001929139.2;XP_013840752.1;XP_005672922.1;XP_020933464.1;XP_020933463.1;XP_020933462.1;XP_020933461.1;XP_020933460.1;XP_020933459.1;XP_020933458.1	XP_020933471.1 RNA-binding protein Raly isoform X7 [Sus scrofa];XP_020933470.1 RNA-binding protein Raly isoform X7 [Sus scrofa];XP_005672925.1 RNA-binding protein Raly isoform X7 [Sus scrofa];XP_003134451.1 RNA-binding protein Raly isoform X7 [Sus scrofa];	3	3	3	0	0	0	0	0	11477000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RALY	RALY;RALY;RALY;RALY;RALY	cholesterol homeostasis;mRNA splicing, via spliceosome;regulation of nucleic acid-templated transcription	GO:004263; GO:000039; GO:190350	catalytic step 2 spliceosome;nucleus	GO:007101; GO:000563	"NA"	"NA"	transcription cofactor activity;protein binding;RNA binding	GO:000371; GO:000551; GO:000372
XP_001929141.1	XP_001929141.1	XP_001929141.1 ubiquinone biosynthesis monooxygenase COQ6, mitochondrial [Sus scrofa]	3	3	3	0	0	0	0	11059000	0	15456000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	COQ6	COQ6;NA;NA;NA;NA	oxidation-reduction process;ubiquinone biosynthetic process	GO:005511; GO:000674	mitochondrion;Golgi apparatus;extrinsic component of mitochondrial inner membrane;cell projection	GO:000573; GO:000579; GO:003131; GO:004299	 Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways	hsa0013; hsa0110	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;FAD binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;protein binding;oxidoreductase activity	GO:001671; GO:007194; GO:001670; GO:000551; GO:001649
XP_005668474.1;XP_001929173.1	XP_005668474.1;XP_001929173.1	XP_005668474.1 plastin-2 [Sus scrofa];XP_001929173.1 plastin-2 [Sus scrofa]	20	13	13	112020000	118110000	106840000	103420000	102600000	94348000	85096000	97648000	84103000	80520000	95520000	115640000	166150000	107490000	135170000	92739000	94301000	109570000	NA	NA	NA	LCP1	LCP1;LCP1;NA;NA;NA	animal organ regeneration;actin filament network formation;positive regulation of podosome assembly;actin filament bundle assembly;cell migration;interleukin-12-mediated signaling pathway;protein kinase A signaling;extracellular matrix disassembly;T cell activation involved in immune response;regulation of intracellular protein transport;wound healing, spreading of cells	GO:003110; GO:005163; GO:007180; GO:005101; GO:001647; GO:003572; GO:001073; GO:002261; GO:000228; GO:003315; GO:004431	plasma membrane;perinuclear region of cytoplasm;cytosol;filopodium;actin cytoskeleton;ruffle membrane;extracellular exosome;cell junction;ruffle;podosome;actin filament;cytoplasm;focal adhesion;actin filament bundle;extracellular space;phagocytic cup	GO:000588; GO:004847; GO:000582; GO:003017; GO:001562; GO:003258; GO:007006; GO:003005; GO:000172; GO:000210; GO:000588; GO:000573; GO:000592; GO:003243; GO:000561; GO:000189	"NA"	"NA"	calcium ion binding;identical protein binding;actin binding;integrin binding;actin filament binding;GTPase binding	GO:000550; GO:004280; GO:000377; GO:000517; GO:005101; GO:005102
XP_001929181.1;CON__Q2KIG3	XP_001929181.1	XP_001929181.1 carboxypeptidase B2 [Sus scrofa]	9	9	9	79514000	61082000	64783000	78401000	83840000	121610000	79005000	64079000	69211000	53447000	62520000	48053000	56511000	78269000	47679000	42023000	63448000	87336000	NA	NA	NA	CPB2	CPB2;NA;NA;NA;NA	liver regeneration;cellular response to glucose stimulus;response to drug;blood coagulation;proteolysis;negative regulation of plasminogen activation;regulation of complement activation;negative regulation of hepatocyte proliferation;response to heat;fibrinolysis;positive regulation of extracellular matrix constituent secretion;negative regulation of fibrinolysis	GO:009742; GO:007133; GO:004249; GO:000759; GO:000650; GO:001075; GO:003044; GO:200034; GO:000940; GO:004273; GO:000333; GO:005191	extracellular space;cell;extracellular region;extracellular exosome	GO:000561; GO:000562; GO:000557; GO:007006	 Pancreatic secretion; Complement and coagulation cascades; Protein digestion and absorption	hsa0497; hsa0461; hsa0497	metallocarboxypeptidase activity;zinc ion binding	GO:000418; GO:000827
XP_001929185.1	XP_001929185.1	XP_001929185.1 eukaryotic translation initiation factor 2 subunit 2 [Sus scrofa]	4	4	4	7443300	0	9061800	0	8711100	0	0	0	0	10787000	0	0	0	0	0	0	0	0	NA	NA	NA	EIF2S2	EIF2S2;NA;NA;NA;NA	translational initiation;male gonad development;transmembrane transport;in utero embryonic development;male germ cell proliferation	GO:000641; GO:000858; GO:005508; GO:000170; GO:000217	nucleus;cytosol;eukaryotic translation initiation factor 2 complex;cytoplasm	GO:000563; GO:000582; GO:000585; GO:000573	 RNA transport	hsa0301	protein binding;translation factor activity, RNA binding;RNA binding;translation initiation factor activity;metal ion binding	GO:000551; GO:000813; GO:000372; GO:000374; GO:004687
XP_020948512.1;XP_020948511.1;XP_020948510.1;XP_020948509.1;XP_001929203.4;XP_020948508.1;XP_020948507.1;XP_005655682.1;XP_003481667.1;XP_005655681.1;XP_005655680.1;XP_020924390.1	XP_020948512.1;XP_020948511.1;XP_020948510.1;XP_020948509.1;XP_001929203.4;XP_020948508.1;XP_020948507.1;XP_005655682.1;XP_003481667.1;XP_005655681.1;XP_005655680.1	XP_020948512.1 SWI/SNF complex subunit SMARCC2 isoform X11 [Sus scrofa];XP_020948511.1 SWI/SNF complex subunit SMARCC2 isoform X10 [Sus scrofa];XP_020948510.1 SWI/SNF complex subunit SMARCC2 isoform X9 [Sus scrofa];XP_020948509.1 SWI/SNF complex subunit SM	3	3	3	0	0	0	4413900	0	0	0	0	0	0	0	10913000	0	0	0	0	0	5986500	NA	NA	NA	SMARCC2	SMARCC2;SMARCC2;SMARCC2;SMARCC2;SMARCC2	regulation of transcription from RNA polymerase II promoter;nucleosome disassembly;nervous system development;ATP-dependent chromatin remodeling;positive regulation of transcription, DNA-templated	GO:000635; GO:000633; GO:000739; GO:004304; GO:004589	npBAF complex;nucleoplasm;nBAF complex;SWI/SNF complex;nuclear chromatin;macromolecular complex	GO:007156; GO:000565; GO:007156; GO:001651; GO:000079; GO:003299	"NA"	"NA"	RNA polymerase II distal enhancer sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;transcription coactivator activity;nucleosomal DNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;protein binding	GO:000098; GO:000098; GO:000371; GO:003149; GO:000097; GO:000551
XP_003481475.2;XP_001929212.4	XP_003481475.2;XP_001929212.4	XP_003481475.2 cell adhesion molecule 3 isoform X2 [Sus scrofa];XP_001929212.4 cell adhesion molecule 3 isoform X1 [Sus scrofa]	4	4	4	0	33762000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CADM3	CADM3;CADM3;NA;NA;NA	adherens junction organization;homophilic cell adhesion via plasma membrane adhesion molecules;protein localization	GO:003433; GO:000715; GO:000810	cell-cell junction;integral component of presynaptic membrane;plasma membrane;parallel fiber to Purkinje cell synapse	GO:000591; GO:009905; GO:000588; GO:009868	 Cell adhesion molecules (CAMs)	hsa0451	protein homodimerization activity	GO:004280
XP_001929258.1;XP_020954981.1;XP_013844518.2	XP_001929258.1;XP_020954981.1;XP_013844518.2	XP_001929258.1 purine nucleoside phosphorylase isoform X3 [Sus scrofa];XP_020954981.1 purine nucleoside phosphorylase isoform X2 [Sus scrofa];XP_013844518.2 purine nucleoside phosphorylase isoform X1 [Sus scrofa]	6	6	6	23536000	11770000	11704000	19884000	0	12406000	0	18505000	25784000	0	21637000	11117000	34199000	12223000	14103000	19108000	13242000	0	NA	NA	NA	PNP	PNP;PNP;PNP;NA;NA	inosine catabolic process;nicotinamide riboside catabolic process;NAD biosynthesis via nicotinamide riboside salvage pathway;urate biosynthetic process;purine nucleotide catabolic process;purine-containing compound salvage;interleukin-2 secretion;positive regulation of alpha-beta T cell differentiation;positive regulation of T cell proliferation;immune response;response to drug;neutrophil degranulation;nucleobase-containing compound metabolic process	GO:000614; GO:000673; GO:003435; GO:003441; GO:000619; GO:004310; GO:007097; GO:004663; GO:004210; GO:000695; GO:004249; GO:004331; GO:000613	extracellular region;cytoskeleton;cytosol;secretory granule lumen;ficolin-1-rich granule lumen;cytoplasm;extracellular exosome;nucleus	GO:000557; GO:000585; GO:000582; GO:003477; GO:190481; GO:000573; GO:007006; GO:000563	 Pyrimidine metabolism; Nicotinate and nicotinamide metabolism; Purine metabolism; Metabolic pathways	hsa0024; hsa0076; hsa0023; hsa0110	nucleoside binding;purine-nucleoside phosphorylase activity;purine nucleobase binding;phosphate ion binding;drug binding	GO:000188; GO:000473; GO:000206; GO:004230; GO:000814
XP_013844520.1;XP_001929285.1	XP_013844520.1;XP_001929285.1	XP_013844520.1 probable tRNA N6-adenosine threonylcarbamoyltransferase isoform X2 [Sus scrofa];XP_001929285.1 probable tRNA N6-adenosine threonylcarbamoyltransferase isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	5728300	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OSGEP	OSGEP;OSGEP;NA;NA;NA	tRNA threonylcarbamoyladenosine modification	GO:000294	nucleus;nucleoplasm;EKC/KEOPS complex;plasma membrane;cytoplasm;nuclear speck	GO:000563; GO:000565; GO:000040; GO:000588; GO:000573; GO:001660	"NA"	"NA"	protein binding;N(6)-L-threonylcarbamoyladenine synthase;metal ion binding	GO:000551; GO:006171; GO:004687
XP_001929313.3	XP_001929313.3	XP_001929313.3 cytosolic purine 5-nucleotidase [Sus scrofa]	2	2	2	0	0	0	0	0	9611000	11932000	0	0	0	0	0	0	0	0	13723000	0	0	NA	NA	NA	NT5C2	NT5C2;NA;NA;NA;NA	adenosine metabolic process;purine nucleotide catabolic process;dephosphorylation;IMP metabolic process;drug metabolic process	GO:004608; GO:000619; GO:001631; GO:004604; GO:001714	cytosol	GO:000582	 Pyrimidine metabolism; Purine metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways	hsa0024; hsa0023; hsa0076; hsa0110	nucleotide binding;metal ion binding;5'-nucleotidase activity;protein binding;nucleoside phosphotransferase activity	GO:000016; GO:004687; GO:000825; GO:000551; GO:005014
XP_020948766.1;XP_001929315.4;CON__P12035	XP_020948766.1;XP_001929315.4;CON__P12035	XP_020948766.1 keratin, type II cytoskeletal 3 isoform X2 [Sus scrofa];XP_001929315.4 keratin, type II cytoskeletal 3 isoform X1 [Sus scrofa];	13	2	0	0	0	0	0	0	0	0	0	0	2461500	0	0	0	0	0	0	0	0	NA	NA	+	KRT3	KRT3;KRT3;NA;NA;NA	keratinization;cornification;epithelial cell differentiation;intermediate filament cytoskeleton organization	GO:003142; GO:007026; GO:003085; GO:004510	keratin filament;cytosol;extracellular exosome;intermediate filament	GO:004509; GO:000582; GO:007006; GO:000588	"NA"	"NA"	structural molecule activity	GO:000519
XP_005663384.1;XP_001929318.1	XP_005663384.1;XP_001929318.1	XP_005663384.1 dolichol-phosphate mannosyltransferase subunit 3 [Sus scrofa];XP_001929318.1 dolichol-phosphate mannosyltransferase subunit 3 [Sus scrofa]	2	2	2	0	21294000	0	23519000	24261000	21637000	23886000	21233000	0	0	0	29510000	0	30246000	0	27342000	25283000	0	NA	NA	NA	DPM3	DPM3;DPM3;NA;NA;NA	regulation of protein stability;protein O-linked mannosylation;protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;GPI anchor biosynthetic process;carbohydrate metabolic process	GO:003164; GO:003526; GO:001840; GO:000650; GO:000597	integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane;membrane;mannosyltransferase complex;dolichol-phosphate-mannose synthase complex	GO:003017; GO:000578; GO:001602; GO:003150; GO:003318	 Metabolic pathways; N-Glycan biosynthesis	hsa0110; hsa0051	dolichyl-phosphate beta-D-mannosyltransferase activity;protein binding	GO:000458; GO:000551
XP_020930037.1;XP_013838585.1;XP_001929353.3;XP_020930036.1;XP_013838583.1;XP_013838582.1	XP_020930037.1;XP_013838585.1;XP_001929353.3;XP_020930036.1;XP_013838583.1;XP_013838582.1	XP_020930037.1 gamma-glutamyltransferase 5 isoform X5 [Sus scrofa];XP_013838585.1 gamma-glutamyltransferase 5 isoform X4 [Sus scrofa];XP_001929353.3 gamma-glutamyltransferase 5 isoform X3 [Sus scrofa];XP_020930036.1 gamma-glutamyltransferase 5 isoform X2 [	3	3	3	0	12965000	0	0	0	0	0	10418000	0	0	0	18141000	12833000	0	0	0	0	0	NA	NA	NA	GGT5	GGT5;GGT5;GGT5;GGT5;GGT5	glutathione metabolic process;glutathione biosynthetic process;glutamate metabolic process;fatty acid metabolic process;cellular amino acid metabolic process;proteolysis;cysteine biosynthetic process;translation;leukotriene metabolic process;inflammatory response;leukotriene D4 biosynthetic process	GO:000674; GO:000675; GO:000653; GO:000663; GO:000652; GO:000650; GO:001934; GO:000641; GO:000669; GO:000695; GO:190175	intrinsic component of plasma membrane;plasma membrane;integral component of membrane	GO:003122; GO:000588; GO:001602	 Taurine and hypotaurine metabolism; Metabolic pathways; Cyanoamino acid metabolism; Arachidonic acid metabolism; Glutathione metabolism	hsa0043; hsa0110; hsa0046; hsa0059; hsa0048	peptidyltransferase activity;leukotriene-C(4) hydrolase;glutathione hydrolase activity	GO:000004; GO:000295; GO:003637
XP_001929355.3	XP_001929355.3	XP_001929355.3 alpha-internexin [Sus scrofa]	5	2	2	0	3364100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	INA	INA;NA;NA;NA;NA	postsynaptic actin cytoskeleton organization;cell differentiation;cellular response to leukemia inhibitory factor;substantia nigra development;neurofilament cytoskeleton organization	GO:009897; GO:003015; GO:199083; GO:002176; GO:006005	cytoplasmic ribonucleoprotein granule;nucleoplasm;postsynapse;neurofilament;nuclear membrane;intermediate filament cytoskeleton;extracellular space;Schaffer collateral - CA1 synapse	GO:003646; GO:000565; GO:009879; GO:000588; GO:003196; GO:004511; GO:000561; GO:009868	"NA"	"NA"	structural constituent of cytoskeleton;structural constituent of postsynaptic actin cytoskeleton	GO:000520; GO:009897
XP_005670809.2;XP_001929380.1;XP_020923176.1	XP_005670809.2;XP_001929380.1	XP_005670809.2 coronin-1C [Sus scrofa];XP_001929380.1 coronin-1C [Sus scrofa]	10	10	10	42612000	67893000	69327000	60768000	39466000	71942000	40834000	64252000	56930000	95390000	66815000	80917000	145960000	57363000	42476000	53185000	43741000	71364000	NA	NA	NA	CORO1C	CORO1C;CORO1C;NA;NA;NA	regulation of protein phosphorylation;regulation of epithelial cell migration;regulation of ruffle assembly;neural crest cell migration;negative regulation of protein kinase activity by regulation of protein phosphorylation;regulation of focal adhesion assembly;activation of GTPase activity;negative regulation of protein phosphorylation;actin cytoskeleton organization;establishment of protein localization;endosome membrane tubulation;endosomal transport;signal transduction;regulation of fibroblast migration;positive regulation of lamellipodium morphogenesis;membrane fission;phagocytosis	GO:000193; GO:001063; GO:190002; GO:000175; GO:004438; GO:005189; GO:009063; GO:000193; GO:003003; GO:004518; GO:009775; GO:001619; GO:000716; GO:001076; GO:200039; GO:009014; GO:000690	cell cortex;lateral plasma membrane;vesicle;lamellipodium;sarcolemma;endosome membrane;actin cytoskeleton;synapse;focal adhesion;flotillin complex;sarcomere;ruffle membrane	GO:000593; GO:001632; GO:003198; GO:003002; GO:004238; GO:001000; GO:001562; GO:004520; GO:000592; GO:001660; GO:003001; GO:003258	"NA"	"NA"	protein binding;actin filament binding;Rac GTPase binding	GO:000551; GO:005101; GO:004836
XP_001929396.1	XP_001929396.1	XP_001929396.1 vacuolar protein sorting-associated protein 18 homolog isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	968820	NA	NA	NA	VPS18	VPS18;NA;NA;NA;NA	lysosome organization;regulation of synaptic vesicle exocytosis;autophagy;endosome organization;regulation of SNARE complex assembly;endosome to lysosome transport;vesicle docking involved in exocytosis;viral entry into host cell;intracellular protein transport	GO:000704; GO:200030; GO:000691; GO:000703; GO:003554; GO:000833; GO:000690; GO:004671; GO:000688	actin filament;HOPS complex;lysosomal membrane;presynapse;autophagosome;clathrin-coated vesicle;late endosome membrane;CORVET complex;AP-3 adaptor complex;glutamatergic synapse	GO:000588; GO:003089; GO:000576; GO:009879; GO:000577; GO:003013; GO:003190; GO:003326; GO:003012; GO:009897	"NA"	"NA"	metal ion binding;protein binding, bridging;actin binding;protein binding;syntaxin binding	GO:004687; GO:003067; GO:000377; GO:000551; GO:001990
XP_020945990.1;XP_020945988.1;XP_020945987.1;XP_020945986.1;XP_020945985.1;XP_020945984.1;XP_020945983.1;XP_013852880.1;XP_013852879.1;XP_013852878.1;XP_013852876.1;XP_020945982.1;XP_020945981.1;XP_005663770.1;XP_003125974.1;XP_001929419.2;XP_020945980.1	XP_020945990.1;XP_020945988.1;XP_020945987.1;XP_020945986.1;XP_020945985.1;XP_020945984.1;XP_020945983.1;XP_013852880.1;XP_013852879.1;XP_013852878.1;XP_013852876.1;XP_020945982.1;XP_020945981.1;XP_005663770.1;XP_003125974.1;XP_001929419.2;XP_020945980.1	XP_020945990.1 kynurenine--oxoglutarate transaminase 3 isoform X4 [Sus scrofa];XP_020945988.1 kynurenine--oxoglutarate transaminase 3 isoform X4 [Sus scrofa];XP_020945987.1 kynurenine--oxoglutarate transaminase 3 isoform X4 [Sus scrofa];XP_020945986.1 kynu	10	10	10	196640000	160530000	184950000	122290000	157120000	118780000	190110000	137710000	169790000	166580000	144630000	131020000	113430000	149350000	124670000	220200000	154370000	140140000	NA	NA	NA	KYAT3	KYAT3;KYAT3;KYAT3;KYAT3;KYAT3	2-oxoglutarate metabolic process;biosynthetic process;L-kynurenine metabolic process;cellular amino acid metabolic process;kynurenine metabolic process	GO:000610; GO:000905; GO:009705; GO:000652; GO:007018	cytoplasm;mitochondrion	GO:000573; GO:000573	 Tryptophan metabolism; Metabolic pathways; Selenocompound metabolism; Chemical carcinogenesis	hsa0038; hsa0110; hsa0045; hsa0520	protein homodimerization activity;pyridoxal phosphate binding;kynurenine-glyoxylate transaminase activity;RNA binding;kynurenine-oxoglutarate transaminase activity;cysteine-S-conjugate beta-lyase activity	GO:004280; GO:003017; GO:004731; GO:000372; GO:001621; GO:004780
XP_003359292.1;XP_005671187.1;XP_001929420.2;XP_005671186.1;XP_003359295.1	XP_003359292.1;XP_005671187.1;XP_001929420.2;XP_005671186.1;XP_003359295.1	XP_003359292.1 40S ribosomal protein S24 isoform X5 [Sus scrofa];XP_005671187.1 40S ribosomal protein S24 isoform X4 [Sus scrofa];XP_001929420.2 40S ribosomal protein S24 isoform X3 [Sus scrofa];XP_005671186.1 40S ribosomal protein S24 isoform X2 [Sus scro	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5437600	NA	NA	NA	RPS24	RPS24;RPS24;RPS24;RPS24;RPS24	rRNA processing;translational initiation;SRP-dependent cotranslational protein targeting to membrane;erythrocyte homeostasis;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;ribosomal small subunit biogenesis	GO:000636; GO:000641; GO:000661; GO:003410; GO:000018; GO:004227	small ribosomal subunit;cytosolic small ribosomal subunit;nucleus;cytosol;nucleoplasm;membrane	GO:001593; GO:002262; GO:000563; GO:000582; GO:000565; GO:001602	 Ribosome	hsa0301	RNA binding;translation initiation factor binding;structural constituent of ribosome	GO:000372; GO:003136; GO:000373
XP_001929445.4	XP_001929445.4	XP_001929445.4 ATP synthase subunit beta, mitochondrial [Sus scrofa]	22	22	22	2747300000	1608000000	2119100000	1490800000	2353000000	1448200000	2500600000	1991500000	2430200000	1871100000	1978700000	1764600000	1687800000	1382600000	2100300000	1793200000	1652500000	1461100000	NA	NA	NA	ATP5F1B	ATP5F1B;NA;NA;NA;NA	hydrogen ion transmembrane transport;negative regulation of cell adhesion involved in substrate-bound cell migration;mitochondrion organization;lipid metabolic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;generation of precursor metabolites and energy;cellular response to interleukin-7;regulation of intracellular pH;angiogenesis;osteoblast differentiation;ATP biosynthetic process;positive regulation of blood vessel endothelial cell migration;ATP hydrolysis coupled cation transmembrane transport	GO:190260; GO:000693; GO:000700; GO:000662; GO:004240; GO:004277; GO:000609; GO:009876; GO:005145; GO:000152; GO:000164; GO:000675; GO:004353; GO:009913	mitochondrial proton-transporting ATP synthase complex;cell surface;plasma membrane;mitochondrial proton-transporting ATP synthase, catalytic core;mitochondrial nucleoid;nucleus;proton-transporting ATP synthase complex;membrane;mitochondrion;extracellular exosome;mitochondrial membrane	GO:000575; GO:000998; GO:000588; GO:000575; GO:004264; GO:000563; GO:004525; GO:001602; GO:000573; GO:007006; GO:003196	 Alzheimer's disease; Metabolic pathways; Oxidative phosphorylation; Huntington's disease	hsa0501; hsa0110; hsa0019; hsa0501	ATPase activity;ATP binding;proton-transporting ATPase activity, rotational mechanism;proton-transporting ATP synthase activity, rotational mechanism;transmembrane transporter activity;MHC class I protein binding;angiostatin binding;transporter activity;protein binding	GO:001688; GO:000552; GO:004696; GO:004693; GO:002285; GO:004228; GO:004353; GO:000521; GO:000551
XP_005663949.1;XP_001929448.3	XP_005663949.1;XP_001929448.3	XP_005663949.1 prostaglandin E synthase 3 isoform X2 [Sus scrofa];XP_001929448.3 prostaglandin E synthase 3 isoform X1 [Sus scrofa]	5	5	5	58044000	0	70639000	0	63220000	0	0	0	62370000	71515000	0	0	66701000	0	0	0	0	0	NA	NA	NA	PTGES3	PTGES3;PTGES3;NA;NA;NA	protein folding;telomere maintenance;telomere maintenance via telomerase;chaperone mediated protein folding requiring cofactor;xenobiotic metabolic process;signal transduction;protein stabilization;positive regulation of telomerase activity;chaperone-mediated protein complex assembly;positive regulation of phosphorylation;cyclooxygenase pathway;regulation of cellular response to heat;telomerase holoenzyme complex assembly;prostaglandin biosynthetic process	GO:000645; GO:000072; GO:000700; GO:005108; GO:000680; GO:000716; GO:005082; GO:005197; GO:005113; GO:004232; GO:001937; GO:190003; GO:190532; GO:000151	cytosol;nucleus;macromolecular complex;chaperone complex;chromosome, telomeric region;telomerase holoenzyme complex;cytoplasm;nucleoplasm	GO:000582; GO:000563; GO:003299; GO:010103; GO:000078; GO:000569; GO:000573; GO:000565	 Metabolic pathways; Arachidonic acid metabolism	hsa0110; hsa0059	telomerase activity;chaperone binding;prostaglandin-E synthase activity;Hsp90 protein binding;DNA polymerase binding;protein binding	GO:000372; GO:005108; GO:005022; GO:005187; GO:007018; GO:000551
XP_005671492.1;XP_001929465.1	XP_005671492.1;XP_001929465.1	XP_005671492.1 STE20-like serine/threonine-protein kinase isoform X2 [Sus scrofa];XP_001929465.1 STE20-like serine/threonine-protein kinase isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2640900	0	0	NA	NA	NA	SLK	SLK;SLK;NA;NA;NA	apoptotic process;regulation of apoptotic process;stress-activated protein kinase signaling cascade;signal transduction by protein phosphorylation;activation of protein kinase activity;cytoplasmic microtubule organization;protein autophosphorylation;regulation of focal adhesion assembly;regulation of cell migration	GO:000691; GO:004298; GO:003109; GO:002301; GO:003214; GO:003112; GO:004677; GO:005189; GO:003033	perinuclear region of cytoplasm;extracellular exosome;cell leading edge;cytoplasm	GO:004847; GO:007006; GO:003125; GO:000573	 Oocyte meiosis	hsa0411	protein homodimerization activity;protein binding;ATP binding;identical protein binding;protein serine/threonine kinase activity;cadherin binding	GO:004280; GO:000551; GO:000552; GO:004280; GO:000467; GO:004529
XP_020947463.1;XP_005663951.1;XP_005663950.1;XP_001929467.3;XP_020947462.1;XP_020947461.1;XP_020947460.1	XP_020947463.1;XP_005663951.1;XP_005663950.1;XP_001929467.3;XP_020947462.1;XP_020947461.1;XP_020947460.1	XP_020947463.1 nascent polypeptide-associated complex subunit alpha isoform X2 [Sus scrofa];XP_005663951.1 nascent polypeptide-associated complex subunit alpha isoform X2 [Sus scrofa];XP_005663950.1 nascent polypeptide-associated complex subunit alpha isof	2	2	2	0	0	0	0	0	0	0	0	0	0	48841000	0	0	0	0	0	0	0	NA	NA	NA	NACA	NACA;NACA;NACA;NACA;NACA	translation;positive regulation of transcription from RNA polymerase II promoter involved in heart development;skeletal muscle tissue regeneration;positive regulation of cell proliferation involved in heart morphogenesis;regulation of skeletal muscle fiber development;positive regulation of skeletal muscle tissue growth;protein transport;cardiac ventricle development;negative regulation of striated muscle cell apoptotic process;heart trabecula morphogenesis	GO:000641; GO:190122; GO:004340; GO:200013; GO:004874; GO:004863; GO:001503; GO:000323; GO:001066; GO:006138	nascent polypeptide-associated complex;nucleus	GO:000585; GO:000563	"NA"	"NA"	DNA binding	GO:000367
XP_020929294.1;XP_001929518.1	XP_020929294.1;XP_001929518.1	XP_020929294.1 peptidyl-prolyl cis-trans isomerase F, mitochondrial isoform X2 [Sus scrofa];XP_001929518.1 peptidyl-prolyl cis-trans isomerase F, mitochondrial isoform X1 [Sus scrofa]	2	1	1	13601000	0	0	0	13273000	0	12766000	0	11468000	0	0	0	0	0	0	0	0	0	NA	NA	NA	PPIF	PPIF;PPIF;NA;NA;NA	regulation of necrotic cell death;cellular response to hydrogen peroxide;protein peptidyl-prolyl isomerization;cellular response to arsenic-containing substance;negative regulation of release of cytochrome c from mitochondria;negative regulation of oxidative phosphorylation;negative regulation of oxidative phosphorylation uncoupler activity;regulation of mitochondrial membrane permeability;apoptotic mitochondrial changes;regulation of proton-transporting ATPase activity, rotational mechanism;protein refolding;cellular response to calcium ion;negative regulation of ATPase activity;negative regulation of intrinsic apoptotic signaling pathway;response to ischemia;negative regulation of apoptotic process;necroptotic process;regulation of mitochondrial membrane permeability involved in programmed necrotic cell death;mitochondrial outer membrane permeabilization involved in programmed cell death	GO:001093; GO:007030; GO:000041; GO:007124; GO:009020; GO:009032; GO:200027; GO:004690; GO:000863; GO:001084; GO:004202; GO:007127; GO:003278; GO:200124; GO:000293; GO:004306; GO:007026; GO:190244; GO:190268	mitochondrial permeability transition pore complex;membrane;mitochondrial proton-transporting ATP synthase complex;mitochondrion	GO:000575; GO:001602; GO:000575; GO:000573	 Calcium signaling pathway; Parkinson's disease; cGMP-PKG signaling pathway; Toxoplasmosis	hsa0402; hsa0501; hsa0402; hsa0514	cyclosporin A binding;unfolded protein binding;protein binding;peptidyl-prolyl cis-trans isomerase activity	GO:001601; GO:005108; GO:000551; GO:000375
XP_013833296.1;XP_003356663.1;XP_001929525.3	XP_013833296.1;XP_003356663.1;XP_001929525.3	XP_013833296.1 mitogen-activated protein kinase 14 isoform X3 [Sus scrofa];XP_003356663.1 mitogen-activated protein kinase 14 isoform X2 [Sus scrofa];XP_001929525.3 mitogen-activated protein kinase 14 isoform X1 [Sus scrofa]	2	2	2	0	0	14526000	0	0	0	23266000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MAPK14	MAPK14;MAPK14;MAPK14;NA;NA	DNA damage checkpoint;chondrocyte differentiation;fatty acid oxidation;signal transduction in response to DNA damage;neutrophil degranulation;positive regulation of cardiac muscle cell proliferation;cellular response to lipoteichoic acid;positive regulation of gene expression;positive regulation of reactive oxygen species metabolic process;positive regulation of macrophage chemotaxis;peptidyl-serine phosphorylation;positive regulation of myoblast fusion;cartilage condensation;placenta development;positive regulation of cytokine secretion involved in immune response;regulation of transcription from RNA polymerase II promoter;positive regulation of myotube differentiation;positive regulation of metallopeptidase activity;cell morphogenesis;angiogenesis;signal transduction;chemotaxis;skeletal muscle tissue development;lipopolysaccharide-mediated signaling pathway;response to muramyl dipeptide;positive regulation of myoblast differentiation;cellular response to ionizing radiation;regulation of cytokine production involved in inflammatory response;positive regulation of interleukin-12 secretion;positive regulation of transcription from RNA polymerase II promoter;positive regulation of muscle cell differentiation;3'-UTR-mediated mRNA stabilization;positive regulation of brown fat cell differentiation;stress-induced premature senescence;cellular response to virus;transmembrane receptor protein serine/threonine kinase signaling pathway;response to muscle stretch;p38MAPK cascade;positive regulation of blood vessel endothelial cell migration;vascular endothelial growth factor receptor signaling pathway;cellular response to tumor necrosis factor;negative regulation of canonical Wnt signaling pathway;activation of MAPK activity;glucose metabolic process;positive regulation of glucose import;cellular response to vascular endothelial growth factor stimulus;positive regulation of protein import into nucleus;regulation of signal transduction by p53 class mediator;apoptotic process;intracellular signal transduction;regulation of gene expression;regulation of ossification;osteoclast differentiation;positive regulation of cyclase activity;positive regulation of erythrocyte differentiation;cellular response to organic substance	GO:000007; GO:000206; GO:001939; GO:004277; GO:004331; GO:006004; GO:007122; GO:001062; GO:200037; GO:001075; GO:001810; GO:190174; GO:000150; GO:000189; GO:000274; GO:000635; GO:001083; GO:190505; GO:000090; GO:000152; GO:000716; GO:000693; GO:000751; GO:003166; GO:003249; GO:004566; GO:007147; GO:190001; GO:200118; GO:004594; GO:005114; GO:007093; GO:009033; GO:009040; GO:009858; GO:000717; GO:003599; GO:003806; GO:004353; GO:004801; GO:007135; GO:009009; GO:000018; GO:000600; GO:004632; GO:003592; GO:004230; GO:190179; GO:000691; GO:003555; GO:001046; GO:003027; GO:003031; GO:003128; GO:004564; GO:007131	nuclear speck;extracellular region;secretory granule lumen;mitochondrion;glutamatergic synapse;spindle pole;nucleoplasm;ficolin-1-rich granule lumen;cytosol;nucleus	GO:001660; GO:000557; GO:003477; GO:000573; GO:009897; GO:000092; GO:000565; GO:190481; GO:000582; GO:000563	 FoxO signaling pathway; Signaling pathways regulating pluripotency of stem cells; Progesterone-mediated oocyte maturation; Shigellosis; Toxoplasmosis; Epstein-Barr virus infection; Osteoclast differentiation; RIG-I-like receptor signaling pathway; T cell receptor signaling pathway; Tuberculosis; Rap1 signaling pathway; VEGF signaling pathway; Proteoglycans in cancer; Inflammatory mediator regulation of TRP channels; Leukocyte transendothelial migration; Amyotrophic lateral sclerosis (ALS); Sphingolipid signaling pathway; Dopaminergic synapse; Epithelial cell signaling in Helicobacter pylori infection; Adrenergic signaling in cardiomyocytes; Platelet activation	hsa0406; hsa0455; hsa0491; hsa0513; hsa0514; hsa0516; hsa0438; hsa0462; hsa0466; hsa0515; hsa0401; hsa0437; hsa0520; hsa0475; hsa0467; hsa0501; hsa0407; hsa0472; hsa0512; hsa0426; hsa0461	MAP kinase kinase activity;MAP kinase activity;ATP binding;protein phosphatase binding;mitogen-activated protein kinase p38 binding;protein binding;enzyme binding;NFAT protein binding;protein serine/threonine kinase activity	GO:000470; GO:000470; GO:000552; GO:001990; GO:004827; GO:000551; GO:001989; GO:005152; GO:000467
XP_001929601.1	XP_001929601.1	XP_001929601.1 heparin cofactor 2 [Sus scrofa]	15	15	15	281490000	321790000	213650000	252980000	415070000	644210000	301650000	232350000	328390000	275970000	328260000	289250000	278670000	256620000	311470000	311130000	296220000	329290000	NA	NA	NA	SERPIND1	SERPIND1;NA;NA;NA;NA	post-translational protein modification;cellular protein metabolic process;blood coagulation;negative regulation of endopeptidase activity;chemotaxis	GO:004368; GO:004426; GO:000759; GO:001095; GO:000693	extracellular region;extracellular space;endoplasmic reticulum lumen;extracellular exosome	GO:000557; GO:000561; GO:000578; GO:007006	 Complement and coagulation cascades	hsa0461	serine-type endopeptidase inhibitor activity;endopeptidase inhibitor activity;heparin binding	GO:000486; GO:000486; GO:000820
XP_013838635.2;XP_020929120.1;XP_020929118.1;XP_013838633.2;XP_001929604.6	XP_013838635.2;XP_020929120.1;XP_020929118.1;XP_013838633.2;XP_001929604.6	XP_013838635.2 phosphatidylinositol 4-kinase alpha isoform X5 [Sus scrofa];XP_020929120.1 phosphatidylinositol 4-kinase alpha isoform X4 [Sus scrofa];XP_020929118.1 phosphatidylinositol 4-kinase alpha isoform X3 [Sus scrofa];XP_013838633.2 phosphatidylinos	10	10	10	0	0	0	0	0	0	0	20793000	22622000	26366000	19821000	0	0	29889000	26441000	0	0	0	NA	NA	NA	PI4KA	PI4KA;PI4KA;PI4KA;PI4KA;PI4KA	signal transduction;viral replication complex formation and maintenance;viral RNA genome replication;phosphatidylinositol-mediated signaling;phosphatidylinositol biosynthetic process;phosphorylation;multi-organism membrane organization;phosphatidylinositol phosphorylation	GO:000716; GO:004678; GO:003969; GO:004801; GO:000666; GO:001631; GO:004480; GO:004685	cytoplasm;membrane;focal adhesion;extracellular exosome;cytosol;viral replication complex;Golgi-associated vesicle membrane;plasma membrane	GO:000573; GO:001602; GO:000592; GO:007006; GO:000582; GO:001903; GO:003066; GO:000588	 Inositol phosphate metabolism; Phosphatidylinositol signaling system; Metabolic pathways	hsa0056; hsa0407; hsa0110	1-phosphatidylinositol 4-kinase activity;ATP binding;protein binding;cadherin binding;kinase activity	GO:000443; GO:000552; GO:000551; GO:004529; GO:001630
XP_001929657.6;XP_020929784.1	XP_001929657.6;XP_020929784.1	XP_001929657.6 ubiquitin fusion degradation protein 1 homolog isoform X2 [Sus scrofa];XP_020929784.1 ubiquitin fusion degradation protein 1 homolog isoform X1 [Sus scrofa]	2	2	2	0	0	6318300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	UFD1	UFD1;UFD1;NA;NA;NA	negative regulation of type I interferon production;negative regulation of RIG-I signaling pathway;error-free translesion synthesis;ubiquitin-dependent protein catabolic process;protein deubiquitination;ER-associated misfolded protein catabolic process;skeletal system development;retrograde protein transport, ER to cytosol;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:003248; GO:003953; GO:007098; GO:000651; GO:001657; GO:007171; GO:000150; GO:003097; GO:004316	cytosol;nucleoplasm;endoplasmic reticulum;UFD1-NPL4 complex;nucleus;VCP-NPL4-UFD1 AAA ATPase complex	GO:000582; GO:000565; GO:000578; GO:003650; GO:000563; GO:003409	 Protein processing in endoplasmic reticulum	hsa0414	macromolecular complex binding;ATPase binding;receptor binding;K48-linked polyubiquitin binding;thiol-dependent ubiquitin-specific protease activity;protein binding	GO:004487; GO:005111; GO:000510; GO:003643; GO:000484; GO:000551
XP_020954219.1;XP_001929671.1	XP_020954219.1;XP_001929671.1	XP_020954219.1 ras-related protein Rab-23 [Sus scrofa];XP_001929671.1 ras-related protein Rab-23 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13293000	NA	NA	NA	RAB23	RAB23;RAB23;NA;NA;NA	negative regulation of protein import into nucleus;intracellular protein transport;Rab protein signal transduction;cellular defense response;GTP metabolic process;craniofacial suture morphogenesis;autophagosome assembly;cilium assembly	GO:004230; GO:000688; GO:003248; GO:000696; GO:004603; GO:009709; GO:000004; GO:006027	plasma membrane;centrosome;phagocytic vesicle membrane;endosome membrane;autophagosome;cytosol;cytoplasm;cell junction;phagocytic vesicle	GO:000588; GO:000581; GO:003067; GO:001000; GO:000577; GO:000582; GO:000573; GO:003005; GO:004533	 Hedgehog signaling pathway	hsa0434	GTP binding;GTPase activity;protein binding	GO:000552; GO:000392; GO:000551
XP_020928443.1;XP_013838662.1;XP_013838661.1;XP_020928442.1;XP_005671003.1;XP_020928441.1;XP_001929677.1	XP_020928443.1;XP_013838662.1;XP_013838661.1;XP_020928442.1;XP_005671003.1;XP_020928441.1;XP_001929677.1	XP_020928443.1 armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X7 [Sus scrofa];XP_013838662.1 armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X6 [Sus scrofa];XP_013838661.1 armadillo repeat protein deleted in	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ARVCF	ARVCF;ARVCF;ARVCF;ARVCF;ARVCF	cell adhesion;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;cell-cell adhesion;cell-cell junction assembly;multicellular organism development	GO:000715; GO:001633; GO:009860; GO:000704; GO:000727	cytoplasm;nucleus;cell-cell junction;plasma membrane	GO:000573; GO:000563; GO:000591; GO:000588	"NA"	"NA"	cadherin binding;protein binding	GO:004529; GO:000551
XP_013852605.1;XP_001929678.1;XP_020945522.1;XP_013852604.1	XP_013852605.1;XP_001929678.1;XP_020945522.1;XP_013852604.1	XP_013852605.1 selenium-binding protein 1 isoform X4 [Sus scrofa];XP_001929678.1 selenium-binding protein 1 isoform X3 [Sus scrofa];XP_020945522.1 selenium-binding protein 1 isoform X1 [Sus scrofa];XP_013852604.1 selenium-binding protein 1 isoform X2 [Sus	26	26	26	1378500000	1191800000	1344200000	1280100000	1152500000	1361500000	1678100000	1145200000	1339700000	836940000	1545600000	1423500000	1398600000	1341000000	1359500000	1057900000	1379200000	1306900000	NA	NA	NA	SELENBP1	SELENBP1;SELENBP1;SELENBP1;SELENBP1;NA	protein transport;oxidation-reduction process	GO:001503; GO:005511	extracellular exosome;extracellular space;nucleolus;cytosol;membrane;fibrillar center	GO:007006; GO:000561; GO:000573; GO:000582; GO:001602; GO:000165	"NA"	"NA"	selenium binding;protein binding;methanethiol oxidase activity	GO:000843; GO:000551; GO:001854
XP_013838663.1;XP_001929679.1;XP_020928444.1;XP_013838664.1	XP_013838663.1;XP_001929679.1;XP_020928444.1;XP_013838664.1	XP_013838663.1 transport and Golgi organization protein 2 homolog isoform X3 [Sus scrofa];XP_001929679.1 transport and Golgi organization protein 2 homolog isoform X2 [Sus scrofa];XP_020928444.1 transport and Golgi organization protein 2 homolog isoform X1	2	2	2	0	0	4820100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TANGO2	TANGO2;TANGO2;TANGO2;TANGO2;NA	Golgi organization;protein secretion	GO:000703; GO:000930	Golgi apparatus	GO:000579	"NA"	"NA"	"NA"	"NA"
XP_020945550.1;XP_020945549.1;XP_001929700.1	XP_020945550.1;XP_020945549.1;XP_001929700.1	XP_020945550.1 ubiquitin carboxyl-terminal hydrolase MINDY-1 isoform X3 [Sus scrofa];XP_020945549.1 ubiquitin carboxyl-terminal hydrolase MINDY-1 isoform X2 [Sus scrofa];XP_001929700.1 ubiquitin carboxyl-terminal hydrolase MINDY-1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2640500	0	NA	NA	NA	MINDY1	MINDY1;MINDY1;MINDY1;NA;NA	biological_process;protein K48-linked deubiquitination	GO:000815; GO:007110	cytosol;nucleus;nucleoplasm;nuclear body	GO:000582; GO:000563; GO:000565; GO:001660	"NA"	"NA"	cysteine-type carboxypeptidase activity;K48-linked polyubiquitin binding;protein binding;thiol-dependent ubiquitin-specific protease activity;Lys48-specific deubiquitinase activity	GO:001680; GO:003643; GO:000551; GO:000484; GO:199038
XP_020944217.1;XP_020944214.1;XP_003121262.3;XP_013843913.1;XP_005652739.1	XP_020944217.1;XP_020944214.1;XP_003121262.3	XP_020944217.1 ethylmalonyl-CoA decarboxylase isoform X1 [Sus scrofa];XP_020944214.1 ethylmalonyl-CoA decarboxylase isoform X1 [Sus scrofa];XP_003121262.3 ethylmalonyl-CoA decarboxylase isoform X1 [Sus scrofa]	15	15	15	1170700000	114160000	417850000	200910000	431800000	81156000	510390000	177340000	484250000	201520000	190220000	44103000	90226000	88782000	227180000	229810000	125540000	44480000	NA	NA	NA	ECHDC1	ECHDC1;ECHDC1;ECHDC1;NA;NA	fatty acid beta-oxidation	GO:000663	cytosol	GO:000582	 Propanoate metabolism	hsa0064	enoyl-CoA hydratase activity;carboxy-lyase activity	GO:000430; GO:001683
XP_003121320.4	XP_003121320.4	XP_003121320.4 LOW QUALITY PROTEIN: collagen alpha-1(XIX) chain [Sus scrofa]	2	2	2	0	0	0	79586000	16258000	0	38224000	23743000	0	19239000	0	0	0	0	42450000	19436000	0	42840000	NA	NA	NA	COL19A1	COL19A1;NA;NA;NA;NA	cell-cell adhesion;skeletal system development;collagen catabolic process;skeletal muscle tissue development;cell differentiation;extracellular matrix organization;cell adhesion	GO:009860; GO:000150; GO:003057; GO:000751; GO:003015; GO:003019; GO:000715	collagen trimer;endoplasmic reticulum lumen;extracellular region;extracellular matrix;extracellular space	GO:000558; GO:000578; GO:000557; GO:003101; GO:000561	"NA"	"NA"	protein binding, bridging;extracellular matrix structural constituent	GO:003067; GO:000520
XP_005659544.1;XP_020949363.1;XP_003121503.3	XP_005659544.1;XP_020949363.1;XP_003121503.3	XP_005659544.1 asparagine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa];XP_020949363.1 asparagine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_003121503.3 asparagine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa]	6	6	6	32691000	32573000	33061000	28819000	33142000	28231000	27759000	29504000	28879000	33115000	28600000	28696000	32555000	0	27162000	33551000	26787000	33037000	NA	NA	NA	NARS	NARS;NARS;NARS;NA;NA	tRNA aminoacylation for protein translation;asparaginyl-tRNA aminoacylation	GO:000641; GO:000642	cytosol;cytoplasm;extracellular exosome	GO:000582; GO:000573; GO:007006	 Aminoacyl-tRNA biosynthesis	hsa0097	nucleic acid binding;asparagine-tRNA ligase activity;ATP binding	GO:000367; GO:000481; GO:000552
XP_003121581.3	XP_003121581.3	XP_003121581.3 eukaryotic translation initiation factor 3 subunit J [Sus scrofa]	5	5	5	0	16506000	18290000	0	18556000	0	21643000	15451000	0	18157000	16992000	0	0	20861000	20154000	18037000	15883000	19729000	NA	NA	NA	EIF3J	EIF3J;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;translational initiation	GO:000173; GO:000641	cytosol;eukaryotic translation initiation factor 3 complex;eukaryotic 43S preinitiation complex;eukaryotic 48S preinitiation complex	GO:000582; GO:000585; GO:001628; GO:003329	 RNA transport	hsa0301	protein binding;translation initiation factor activity	GO:000551; GO:000374
XP_013848606.1;XP_003121631.2	XP_013848606.1;XP_003121631.2	XP_013848606.1 protein Mis18-beta isoform X2 [Sus scrofa];XP_003121631.2 protein Mis18-beta isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	22368000	0	0	0	0	0	0	0	0	+	NA	NA	OIP5	OIP5;OIP5;NA;NA;NA	cell division;cell cycle;chromosome segregation;cell communication;CENP-A containing nucleosome assembly	GO:005130; GO:000704; GO:000705; GO:000715; GO:003408	chromosome, centromeric region;cytosol;Cajal body;chromocenter;nucleoplasm;nucleus;nuclear speck;chromatin	GO:000077; GO:000582; GO:001503; GO:001036; GO:000565; GO:000563; GO:001660; GO:000078	"NA"	"NA"	metal ion binding;identical protein binding;protein binding	GO:004687; GO:004280; GO:000551
XP_003121650.1	XP_003121650.1	XP_003121650.1 signal recognition particle 14 kDa protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	11409000	0	0	0	9134100	0	0	0	0	NA	NA	NA	SRP14	SRP14;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;response to drug;neutrophil degranulation;cotranslational protein targeting to membrane;protein targeting to ER	GO:000661; GO:004249; GO:004331; GO:000661; GO:004504	extracellular region;cytosol;cytoplasm;ficolin-1-rich granule lumen;nucleus;signal recognition particle, endoplasmic reticulum targeting;secretory granule lumen	GO:000557; GO:000582; GO:000573; GO:190481; GO:000563; GO:000578; GO:003477	 Protein export	hsa0306	protein binding;RNA binding;endoplasmic reticulum signal peptide binding;7S RNA binding	GO:000551; GO:000372; GO:003094; GO:000831
XP_003121747.3	XP_003121747.3	XP_003121747.3 vacuolar protein sorting-associated protein 4B [Sus scrofa]	9	9	8	32537000	41949000	42328000	42388000	35578000	38108000	37105000	41323000	39782000	37372000	37578000	58082000	40959000	38156000	32603000	44945000	37682000	43643000	NA	NA	NA	VPS4B	VPS4B;NA;NA;NA;NA	cholesterol transport;regulation of mitotic spindle assembly;positive regulation of exosomal secretion;positive regulation of centriole elongation;mitotic metaphase plate congression;endosomal transport;macroautophagy;endosome to lysosome transport via multivesicular body sorting pathway;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;regulation of centrosome duplication;viral budding via host ESCRT complex;regulation of viral process;potassium ion transport;nucleus organization;positive regulation of G2/M transition of mitotic cell cycle;protein transport;protein depolymerization;negative regulation of cell death;late endosomal microautophagy;ESCRT III complex disassembly;multivesicular body assembly;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;viral life cycle;viral release from host cell;response to lipid;vacuole organization;positive regulation of viral process;positive regulation of viral release from host cell;positive regulation of viral life cycle	GO:003030; GO:190167; GO:190354; GO:190372; GO:000708; GO:001619; GO:001623; GO:003251; GO:004316; GO:001082; GO:003970; GO:005079; GO:000681; GO:000699; GO:001097; GO:001503; GO:005126; GO:006054; GO:006173; GO:190490; GO:003625; GO:009061; GO:001905; GO:001907; GO:003399; GO:000703; GO:004852; GO:190218; GO:190390	cytosol;endosome;endosome membrane;Flemming body;cytoplasm;spindle pole;late endosome membrane;centrosome;nucleus;extracellular exosome	GO:000582; GO:000576; GO:001000; GO:009054; GO:000573; GO:000092; GO:003190; GO:000581; GO:000563; GO:007006	 Endocytosis	hsa0414	protein binding;protein homodimerization activity;ATPase activity, coupled;ATP binding;ATPase activity;protein C-terminus binding	GO:000551; GO:004280; GO:004262; GO:000552; GO:001688; GO:000802
XP_003121777.2	XP_003121777.2	XP_003121777.2 very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 [Sus scrofa]	4	4	4	0	0	0	0	14381000	0	13976000	17193000	19214000	17189000	0	0	17091000	14382000	15462000	16915000	0	23597000	NA	NA	NA	HACD3	HACD3;NA;NA;NA;NA	sphingolipid biosynthetic process;fatty acid elongation;positive regulation of GTPase activity;activation of JUN kinase activity;small GTPase mediated signal transduction;I-kappaB kinase/NF-kappaB signaling;positive regulation of viral genome replication;very long-chain fatty acid biosynthetic process;positive regulation by virus of viral protein levels in host cell;Rac protein signal transduction	GO:003014; GO:003049; GO:004354; GO:000725; GO:000726; GO:000724; GO:004507; GO:004276; GO:004672; GO:001660	cytosol;integral component of membrane;mitochondrion;focal adhesion;nuclear membrane;endoplasmic reticulum	GO:000582; GO:001602; GO:000573; GO:000592; GO:003196; GO:000578	 Fatty acid elongation; Biosynthesis of unsaturated fatty acids; Fatty acid metabolism	hsa0006; hsa0104; hsa0121	GTPase activator activity;protein binding;enzyme binding;3-hydroxy-behenoyl-CoA dehydratase activity;3-hydroxyacyl-CoA dehydratase activity	GO:000509; GO:000551; GO:001989; GO:010234; GO:001881
XP_003121807.3	XP_003121807.3	XP_003121807.3 acidic leucine-rich nuclear phosphoprotein 32 family member A [Sus scrofa]	9	9	8	80329000	89620000	85287000	88215000	92618000	100240000	83979000	93093000	96295000	91231000	76936000	84205000	111680000	103100000	73905000	88651000	97142000	106210000	NA	NA	NA	ANP32A	ANP32A;NA;NA;NA;NA	nucleocytoplasmic transport;regulation of mRNA stability;intracellular signal transduction	GO:000691; GO:004348; GO:003555	endoplasmic reticulum;cytoplasm;nucleoplasm;perinuclear region of cytoplasm;nucleus	GO:000578; GO:000573; GO:000565; GO:004847; GO:000563	"NA"	"NA"	histone binding;protein binding;RNA binding	GO:004239; GO:000551; GO:000372
XP_003121866.1;XP_020957939.1;XP_020957934.1	XP_003121866.1;XP_020957939.1;XP_020957934.1	XP_003121866.1 MAPK-interacting and spindle-stabilizing protein-like isoform X2 [Sus scrofa];XP_020957939.1 MAPK-interacting and spindle-stabilizing protein-like isoform X1 [Sus scrofa];XP_020957934.1 MAPK-interacting and spindle-stabilizing protein-like i	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7169400	NA	NA	NA	MAPK1IP1L	MAPK1IP1L;MAPK1IP1L;MAPK1IP1L;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	protein binding	GO:000551
XP_020918378.1;XP_020918375.1;XP_013841474.1;XP_003121921.1	XP_020918378.1;XP_020918375.1;XP_013841474.1;XP_003121921.1	XP_020918378.1 phospholipase A-2-activating protein isoform X4 [Sus scrofa];XP_020918375.1 phospholipase A-2-activating protein isoform X3 [Sus scrofa];XP_013841474.1 phospholipase A-2-activating protein isoform X2 [Sus scrofa];XP_003121921.1 phospholipase	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10537000	0	0	NA	NA	NA	PLAA	PLAA;PLAA;PLAA;PLAA;NA	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;signal transduction;inflammatory response;positive regulation of dendrite extension;phospholipid metabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin homeostasis;macroautophagy;positive regulation of synaptic vesicle recycling;positive regulation of phospholipase A2 activity;prostaglandin metabolic process;cellular response to lipopolysaccharide;negative regulation of protein K63-linked ubiquitination;positive regulation of neuron migration	GO:004316; GO:000716; GO:000695; GO:190386; GO:000664; GO:004316; GO:001099; GO:001623; GO:190342; GO:003243; GO:000669; GO:007122; GO:190004; GO:200122	cytoplasm;cell junction;extracellular exosome;nucleus;synapse	GO:000573; GO:003005; GO:007006; GO:000563; GO:004520	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;phospholipase A2 activator activity;ubiquitin binding	GO:000551; GO:001600; GO:004313
XP_003121927.3	XP_003121927.3	XP_003121927.3 S-methyl-5-thioadenosine phosphorylase [Sus scrofa]	8	8	8	118010000	125450000	117800000	108530000	116130000	126880000	111510000	102830000	125950000	99547000	122520000	110720000	115350000	113730000	105850000	137340000	122930000	111090000	NA	NA	NA	MTAP	MTAP;NA;NA;NA;NA	nicotinamide riboside catabolic process;methylation;interleukin-12-mediated signaling pathway;L-methionine salvage from methylthioadenosine;purine ribonucleoside salvage;nucleobase-containing compound metabolic process;response to testosterone	GO:000673; GO:003225; GO:003572; GO:001950; GO:000616; GO:000613; GO:003357	cytosol;cytoplasm;nucleus;extracellular exosome	GO:000582; GO:000573; GO:000563; GO:007006	 Metabolic pathways; Cysteine and methionine metabolism	hsa0110; hsa0027	S-methyl-5-thioadenosine phosphorylase activity;phosphorylase activity;protein binding	GO:001706; GO:000464; GO:000551
XP_003121938.1;XP_020918852.1;XP_005660140.1	XP_003121938.1;XP_020918852.1;XP_005660140.1	XP_003121938.1 40S ribosomal protein S6 isoform X1 [Sus scrofa];XP_020918852.1 40S ribosomal protein S6 isoform X2 [Sus scrofa];XP_005660140.1 40S ribosomal protein S6 isoform X2 [Sus scrofa]	6	6	6	104370000	68246000	123840000	57873000	68569000	156970000	78169000	45124000	77921000	111050000	54901000	95731000	91438000	90026000	60895000	106590000	125510000	126440000	NA	NA	NA	RPS6	RPS6;RPS6;RPS6;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;ribosomal small subunit biogenesis;translation;glucose homeostasis;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane;TOR signaling	GO:000018; GO:004227; GO:000641; GO:004259; GO:004306; GO:000636; GO:000661; GO:003192	cytosolic small ribosomal subunit;nucleoplasm;nucleolus;dendrite;cytosol;endoplasmic reticulum;nucleus;small ribosomal subunit;cytoplasmic ribonucleoprotein granule;membrane;ribonucleoprotein complex;cell body	GO:002262; GO:000565; GO:000573; GO:003042; GO:000582; GO:000578; GO:000563; GO:001593; GO:003646; GO:001602; GO:199090; GO:004429	 mTOR signaling pathway; HIF-1 signaling pathway; Ribosome; Insulin signaling pathway; Proteoglycans in cancer; PI3K-Akt signaling pathway	hsa0415; hsa0406; hsa0301; hsa0491; hsa0520; hsa0415	protein kinase binding;protein binding;RNA binding;structural constituent of ribosome	GO:001990; GO:000551; GO:000372; GO:000373
XP_003121981.4	XP_003121981.4	XP_003121981.4 phosphoglucomutase-like protein 5 [Sus scrofa]	21	21	21	99134000	152480000	270280000	75407000	56536000	231590000	97714000	151920000	148710000	284970000	180330000	167920000	398010000	92753000	56796000	112910000	125050000	92699000	NA	NA	NA	PGM5	PGM5;NA;NA;NA;NA	cell adhesion;myofibril assembly;glucose metabolic process;striated muscle tissue development	GO:000715; GO:003023; GO:000600; GO:001470	Z disc;sarcolemma;cell-cell adherens junction;focal adhesion;cytosol;cytoplasmic side of plasma membrane;stress fiber;dystrophin-associated glycoprotein complex;costamere;intercalated disc	GO:003001; GO:004238; GO:000591; GO:000592; GO:000582; GO:000989; GO:000172; GO:001601; GO:004303; GO:001470	"NA"	"NA"	phosphoglucomutase activity;structural molecule activity;magnesium ion binding	GO:000461; GO:000519; GO:000028
XP_003122046.1	XP_003122046.1	XP_003122046.1 Golgi-associated plant pathogenesis-related protein 1 [Sus scrofa]	5	5	5	104390000	125080000	164310000	146180000	117900000	119600000	134970000	111050000	110510000	131450000	140070000	144680000	108980000	161200000	181000000	150320000	129350000	161370000	NA	NA	NA	GLIPR2	GLIPR2;NA;NA;NA;NA	positive regulation of epithelial to mesenchymal transition;positive regulation of epithelial cell migration;positive regulation of ERK1 and ERK2 cascade	GO:001071; GO:001063; GO:007037	extracellular exosome;extracellular space;Golgi membrane	GO:007006; GO:000561; GO:000013	"NA"	"NA"	protein homodimerization activity	GO:004280
XP_003122217.3;XP_005660500.1	XP_003122217.3;XP_005660500.1	XP_003122217.3 syntaxin-binding protein 1 isoform X2 [Sus scrofa];XP_005660500.1 syntaxin-binding protein 1 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5882400	NA	NA	NA	STXBP1	STXBP1;STXBP1;NA;NA;NA	protein transport;synaptic vesicle priming;developmental process involved in reproduction;regulation of synaptic vesicle priming;negative regulation of synaptic transmission, GABAergic;response to estradiol;axon target recognition;platelet aggregation;protein localization to plasma membrane;platelet degranulation;synaptic vesicle maturation;protein stabilization;regulation of SNARE complex assembly;positive regulation of mast cell degranulation;negative regulation of neuron apoptotic process;positive regulation of calcium ion-dependent exocytosis;regulation of synaptic vesicle fusion to presynaptic membrane;cellular response to interferon-gamma;neuromuscular synaptic transmission;negative regulation of protein complex assembly;long term synaptic depression;vesicle docking involved in exocytosis;presynaptic dense core vesicle exocytosis;positive regulation of glutamate secretion, neurotransmission	GO:001503; GO:001608; GO:000300; GO:001080; GO:003222; GO:003235; GO:000741; GO:007052; GO:007265; GO:000257; GO:001618; GO:005082; GO:003554; GO:004330; GO:004352; GO:004595; GO:003163; GO:007134; GO:000727; GO:003133; GO:006029; GO:000690; GO:009952; GO:190329	mitochondrion;axon;presynaptic active zone membrane;glutamatergic synapse;nucleoplasm;extracellular exosome;cytosol;platelet alpha granule;perinuclear region of cytoplasm;plasma membrane;cytoplasm;macromolecular complex;phagocytic vesicle;postsynapse;cytoskeleton	GO:000573; GO:003042; GO:004878; GO:009897; GO:000565; GO:007006; GO:000582; GO:003109; GO:004847; GO:000588; GO:000573; GO:003299; GO:004533; GO:009879; GO:000585	 Synaptic vesicle cycle	hsa0472	protein domain specific binding;RNA binding;identical protein binding;syntaxin-1 binding;syntaxin binding;protein binding;phospholipase binding;SNARE binding;protein N-terminus binding	GO:001990; GO:000372; GO:004280; GO:001707; GO:001990; GO:000551; GO:004327; GO:000014; GO:004748
XP_005660509.1;XP_003122225.3;XP_020952119.1;XP_013851623.2;XP_003127969.4	XP_005660509.1;XP_003122225.3	XP_005660509.1 adenylate kinase isoenzyme 1 [Sus scrofa];XP_003122225.3 adenylate kinase isoenzyme 1 [Sus scrofa]	6	6	6	101030000	124120000	88258000	138050000	132980000	122020000	143720000	129510000	124800000	142090000	119020000	129970000	135930000	134400000	110560000	133200000	379360000	121650000	NA	NA	NA	AK1	AK1;AK1;NA;NA;NA	nucleoside triphosphate biosynthetic process;nucleobase-containing small molecule interconversion;AMP metabolic process;nucleoside diphosphate phosphorylation;ADP biosynthetic process;nucleoside monophosphate phosphorylation	GO:000914; GO:001594; GO:004603; GO:000616; GO:000617; GO:004694	extracellular exosome;cytosol	GO:007006; GO:000582	 Metabolic pathways; Purine metabolism; Biosynthesis of antibiotics	hsa0110; hsa0023; hsa0113	nucleoside diphosphate kinase activity;adenylate kinase activity;ATP binding	GO:000455; GO:000401; GO:000552
XP_020948431.1;XP_020948423.1;XP_020948415.1;XP_020948410.1;XP_005652532.1;XP_005652531.1;XP_013833896.1;XP_013833868.1;XP_013833845.1;XP_013833815.1;XP_013833777.1;XP_005652530.1;XP_005652529.1;XP_003122339.1	XP_020948431.1;XP_020948423.1;XP_020948415.1;XP_020948410.1;XP_005652532.1;XP_005652531.1;XP_013833896.1;XP_013833868.1;XP_013833845.1;XP_013833815.1;XP_013833777.1;XP_005652530.1;XP_005652529.1;XP_003122339.1	XP_020948431.1 haloacid dehalogenase-like hydrolase domain-containing protein 2 isoform X2 [Sus scrofa];XP_020948423.1 haloacid dehalogenase-like hydrolase domain-containing protein 2 isoform X2 [Sus scrofa];XP_020948415.1 haloacid dehalogenase-like hydrol	4	4	4	21158000	15503000	15213000	9823400	16045000	0	13396000	12297000	16925000	14182000	18753000	20001000	8726800	11320000	0	20354000	12511000	11665000	NA	NA	NA	HDHD2	HDHD2;HDHD2;HDHD2;HDHD2;HDHD2	dephosphorylation;biological_process	GO:001631; GO:000815	extracellular exosome	GO:007006	"NA"	"NA"	protein binding;phosphatase activity;enzyme binding;metal ion binding	GO:000551; GO:001679; GO:001989; GO:004687
XP_003122400.2	XP_003122400.2	XP_003122400.2 tubulin beta-4B chain [Sus scrofa]	24	24	1	1817400000	3263400000	2443500000	2390600000	2197200000	2256000000	2084200000	2694900000	1994700000	2965700000	2149200000	2798000000	2466700000	2927500000	2174500000	2681900000	2401500000	2777100000	NA	NA	NA	TUBB4B	TUBB4B;NA;NA;NA;NA	microtubule cytoskeleton organization;regulation of G2/M transition of mitotic cell cycle;natural killer cell mediated cytotoxicity;neutrophil degranulation;microtubule-based process;ciliary basal body docking;G2/M transition of mitotic cell cycle;mitotic cell cycle	GO:000022; GO:001038; GO:004226; GO:004331; GO:000701; GO:009771; GO:000008; GO:000027	cytosol;azurophil granule lumen;cytoplasm;cytoskeleton;extracellular region;nucleus;extracellular exosome;microtubule;extracellular vesicle	GO:000582; GO:003557; GO:000573; GO:000585; GO:000557; GO:000563; GO:007006; GO:000587; GO:190356	 Phagosome; Gap junction; Pathogenic Escherichia coli infection	hsa0414; hsa0454; hsa0513	MHC class I protein binding;GTPase activity;GTP binding;unfolded protein binding;structural constituent of cytoskeleton;double-stranded RNA binding	GO:004228; GO:000392; GO:000552; GO:005108; GO:000520; GO:000372
XP_005652838.1;XP_005652837.1;XP_005652836.1;XP_005652835.1;XP_003122446.2	XP_005652838.1;XP_005652837.1;XP_005652836.1;XP_005652835.1;XP_003122446.2	XP_005652838.1 mitochondrial glutamate carrier 1 [Sus scrofa];XP_005652837.1 mitochondrial glutamate carrier 1 [Sus scrofa];XP_005652836.1 mitochondrial glutamate carrier 1 [Sus scrofa];XP_005652835.1 mitochondrial glutamate carrier 1 [Sus scrofa];XP_00312	4	4	4	32136000	0	62835000	0	44235000	0	64208000	27470000	54362000	0	34747000	0	0	0	44342000	32552000	34308000	0	NA	NA	NA	SLC25A22	SLC25A22;SLC25A22;SLC25A22;SLC25A22;SLC25A22	malate-aspartate shuttle;L-glutamate transport;L-aspartate transport;ion transport;hydrogen ion transmembrane transport	GO:004349; GO:001581; GO:007077; GO:000681; GO:190260	mitochondrial inner membrane;integral component of membrane	GO:000574; GO:001602	"NA"	"NA"	L-aspartate transmembrane transporter activity;L-glutamate transmembrane transporter activity;hydrogen:amino acid symporter activity	GO:001518; GO:000531; GO:000528
XP_020938399.1;XP_005660672.1;XP_003122483.3;XP_003122482.1	XP_020938399.1;XP_005660672.1;XP_003122483.3;XP_003122482.1	XP_020938399.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial isoform X2 [Sus scrofa];XP_005660672.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial isoform X2 [Sus scrofa];XP_003122483.3 NADH dehydrogenase [ubiqu	2	2	2	0	0	0	0	14808000	0	0	0	0	0	0	0	0	0	0	12967000	0	0	NA	NA	NA	NDUFS8	NDUFS8;NDUFS8;NDUFS8;NDUFS8;NA	aerobic respiration;response to oxidative stress;mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	GO:000906; GO:000697; GO:000612; GO:003298	mitochondrial matrix;mitochondrion;mitochondrial respiratory chain complex I	GO:000575; GO:000573; GO:000574	 Oxidative phosphorylation; Metabolic pathways; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0110; hsa0501; hsa0493	4 iron, 4 sulfur cluster binding;metal ion binding;NADH dehydrogenase activity;NADH dehydrogenase (ubiquinone) activity	GO:005153; GO:004687; GO:000395; GO:000813
XP_003122486.1	XP_003122486.1	XP_003122486.1 NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial [Sus scrofa]	19	19	19	117620000	57869000	90284000	44303000	99806000	31976000	125810000	62573000	125690000	63181000	69051000	26338000	0	51642000	74855000	80171000	83791000	68145000	NA	NA	NA	NDUFV1	NDUFV1;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;mitochondrial ATP synthesis coupled electron transport;cellular respiration	GO:000612; GO:003298; GO:004277; GO:004533	mitochondrion;mitochondrial respiratory chain complex I;cytosol	GO:000573; GO:000574; GO:000582	 Oxidative phosphorylation; Alzheimer's disease; Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways	hsa0019; hsa0501; hsa0493; hsa0110	NAD binding;metal ion binding;FMN binding;NADH dehydrogenase activity;NADH dehydrogenase (ubiquinone) activity;4 iron, 4 sulfur cluster binding	GO:005128; GO:004687; GO:001018; GO:000395; GO:000813; GO:005153
XP_003122504.1;XP_013849480.1	XP_003122504.1;XP_013849480.1	XP_003122504.1 AH receptor-interacting protein isoform X1 [Sus scrofa];XP_013849480.1 AH receptor-interacting protein isoform X2 [Sus scrofa]	6	6	6	0	19615000	21990000	15168000	14820000	0	17516000	0	14203000	13274000	16954000	20064000	17784000	0	15649000	14027000	17487000	17371000	NA	NA	NA	AIP	AIP;AIP;NA;NA;NA	regulation of protein kinase A signaling;positive regulation of nucleic acid-templated transcription;protein maturation by protein folding;xenobiotic metabolic process;interleukin-12-mediated signaling pathway;negative regulation of cyclic-nucleotide phosphodiesterase activity;protein targeting to mitochondrion	GO:001073; GO:190350; GO:002241; GO:000680; GO:003572; GO:005134; GO:000662	cytosol;aryl hydrocarbon receptor complex;cytoplasm;plasma membrane;nucleoplasm	GO:000582; GO:003475; GO:000573; GO:000588; GO:000565	"NA"	"NA"	transcription factor binding;aryl hydrocarbon receptor binding;unfolded protein binding;protein binding;transcription coactivator activity;GAF domain binding	GO:000813; GO:001716; GO:005108; GO:000551; GO:000371; GO:003600
XP_003122540.1;XP_005660702.1	XP_003122540.1;XP_005660702.1	XP_003122540.1 alpha-actinin-3 isoform X2 [Sus scrofa];XP_005660702.1 alpha-actinin-3 isoform X1 [Sus scrofa]	35	23	22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	864090000	0	NA	NA	NA	ACTN3	ACTN3;ACTN3;NA;NA;NA	regulation of aerobic respiration;transition between fast and slow fiber;regulation of apoptotic process;response to denervation involved in regulation of muscle adaptation;muscle filament sliding;focal adhesion assembly;positive regulation of skeletal muscle tissue growth;negative regulation of glycolytic process;negative regulation of calcineurin-NFAT signaling cascade;regulation of the force of skeletal muscle contraction;skeletal muscle atrophy;negative regulation of oxidative phosphorylation;positive regulation of glucose catabolic process to lactate via pyruvate	GO:190371; GO:001488; GO:004298; GO:001489; GO:003004; GO:004804; GO:004863; GO:004582; GO:007088; GO:001472; GO:001473; GO:009032; GO:190402	cytosol;extracellular exosome;focal adhesion;actin filament;pseudopodium	GO:000582; GO:007006; GO:000592; GO:000588; GO:003114	 Amoebiasis; Tight junction; Viral carcinogenesis; Adherens junction; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Leukocyte transendothelial migration; Focal adhesion; Systemic lupus erythematosus; Regulation of actin cytoskeleton	hsa0514; hsa0453; hsa0520; hsa0452; hsa0541; hsa0467; hsa0451; hsa0532; hsa0481	structural constituent of muscle;calcium ion binding;actin binding;integrin binding;ion channel binding;protein binding;protein homodimerization activity	GO:000830; GO:000550; GO:000377; GO:000517; GO:004432; GO:000551; GO:004280
XP_005660730.1;XP_003122562.1;XP_003122561.1;XP_003122559.1;XP_003122558.1	XP_005660730.1;XP_003122562.1;XP_003122561.1;XP_003122559.1;XP_003122558.1	XP_005660730.1 barrier-to-autointegration factor [Sus scrofa];XP_003122562.1 barrier-to-autointegration factor [Sus scrofa];XP_003122561.1 barrier-to-autointegration factor [Sus scrofa];XP_003122559.1 barrier-to-autointegration factor [Sus scrofa];XP_00312	4	4	4	31748000	57453000	50639000	70784000	38988000	61506000	52699000	57067000	55379000	58863000	65758000	40875000	95701000	49991000	61080000	61874000	61435000	64474000	NA	NA	NA	BANF1	BANF1;BANF1;BANF1;BANF1;BANF1	mitotic nuclear envelope reassembly;nuclear transport;establishment of integrated proviral latency;DNA integration;response to virus;negative regulation of viral genome replication	GO:000708; GO:005116; GO:007571; GO:001507; GO:000961; GO:004507	nucleoplasm;nuclear envelope;condensed chromosome;cytosol;cytoplasm	GO:000565; GO:000563; GO:000079; GO:000582; GO:000573	"NA"	"NA"	DNA binding;protein homodimerization activity;protein C-terminus binding;protein binding;LEM domain binding;enzyme binding;protein N-terminus binding	GO:000367; GO:004280; GO:000802; GO:000551; GO:009772; GO:001989; GO:004748
XP_003122563.1	XP_003122563.1	XP_003122563.1 endosialin [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7500300	NA	NA	NA	CD248	CD248;NA;NA;NA;NA	lymph node development;anatomical structure regression;positive regulation of cell proliferation;cell migration;biological_process;positive regulation of endothelial cell apoptotic process	GO:004853; GO:006003; GO:000828; GO:001647; GO:000815; GO:200035	extracellular exosome;cytoplasm;integral component of membrane;external side of plasma membrane;extracellular matrix	GO:007006; GO:000573; GO:001602; GO:000989; GO:003101	"NA"	"NA"	carbohydrate binding;calcium ion binding;molecular_function;extracellular matrix binding;extracellular matrix protein binding	GO:003024; GO:000550; GO:000367; GO:005084; GO:199043
XP_003122597.4;XP_013849576.1	XP_003122597.4;XP_013849576.1	XP_003122597.4 ADP-ribosylation factor-like protein 2 isoform X2 [Sus scrofa];XP_013849576.1 ADP-ribosylation factor-like protein 2 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	7053300	0	0	0	0	0	0	0	0	NA	NA	NA	ARL2	ARL2;ARL2;NA;NA;NA	centrosome cycle;regulation of insulin secretion;maintenance of protein location in nucleus;tubulin complex assembly;regulation of microtubule polymerization;negative regulation of GTPase activity;bicellular tight junction assembly;positive regulation of cell-substrate adhesion	GO:000709; GO:005079; GO:005145; GO:000702; GO:003111; GO:003426; GO:007083; GO:001081	nucleus;cilium;mitochondrial matrix;Golgi apparatus;lateral plasma membrane;nucleolus;centrosome;cytosol	GO:000563; GO:000592; GO:000575; GO:000579; GO:001632; GO:000573; GO:000581; GO:000582	"NA"	"NA"	GTPase activity;GTP binding;GTPase inhibitor activity;GDP binding;protein binding	GO:000392; GO:000552; GO:000509; GO:001900; GO:000551
XP_003122620.3	XP_003122620.3	XP_003122620.3 multifunctional methyltransferase subunit TRM112-like protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5699600	NA	NA	NA	TRMT112	TRMT112;NA;NA;NA;NA	positive regulation of rRNA processing;tRNA methylation;peptidyl-glutamine methylation;rRNA (guanine-N7)-methylation	GO:200023; GO:003048; GO:001836; GO:007047	perinuclear region of cytoplasm;nucleoplasm;cytosol;macromolecular complex	GO:004847; GO:000565; GO:000582; GO:003299	"NA"	"NA"	protein binding;rRNA (guanine) methyltransferase activity;protein methyltransferase activity;protein heterodimerization activity	GO:000551; GO:001643; GO:000827; GO:004698
XP_005660807.1;XP_005660806.1;XP_003353837.1;XP_003122628.1	XP_005660807.1;XP_005660806.1;XP_003353837.1;XP_003122628.1	XP_005660807.1 peptidyl-prolyl cis-trans isomerase FKBP2 isoform X2 [Sus scrofa];XP_005660806.1 peptidyl-prolyl cis-trans isomerase FKBP2 isoform X2 [Sus scrofa];XP_003353837.1 peptidyl-prolyl cis-trans isomerase FKBP2 isoform X2 [Sus scrofa];XP_003122628.	4	4	4	100910000	68998000	76939000	72441000	108840000	57008000	78415000	84246000	64770000	64136000	74168000	72239000	49594000	72979000	79748000	70563000	80731000	79903000	NA	NA	NA	FKBP2	FKBP2;FKBP2;FKBP2;FKBP2;NA	protein peptidyl-prolyl isomerization	GO:000041	endoplasmic reticulum;endoplasmic reticulum membrane	GO:000578; GO:000578	"NA"	"NA"	FK506 binding;protein binding;peptidyl-prolyl cis-trans isomerase activity	GO:000552; GO:000551; GO:000375
XP_003122635.3	XP_003122635.3	XP_003122635.3 LOW QUALITY PROTEIN: splicing factor 1 [Sus scrofa]	3	3	3	0	10311000	0	0	0	0	0	10924000	0	0	0	16027000	0	0	0	0	0	0	NA	NA	NA	SF1	SF1;NA;NA;NA;NA	mRNA splicing, via spliceosome;regulation of steroid biosynthetic process;mRNA 3'-splice site recognition;nuclear body organization;Leydig cell differentiation;negative regulation of smooth muscle cell proliferation;male sex determination;negative regulation of nucleic acid-templated transcription;spliceosomal complex assembly	GO:000039; GO:005081; GO:000038; GO:003057; GO:003332; GO:004866; GO:003023; GO:190350; GO:000024	spliceosomal complex;nuclear body;ribosome;nucleus;nucleoplasm	GO:000568; GO:001660; GO:000584; GO:000563; GO:000565	"NA"	"NA"	zinc ion binding;pre-mRNA branch point binding;transcription corepressor activity;protein binding;RNA binding;identical protein binding	GO:000827; GO:004513; GO:000371; GO:000551; GO:000372; GO:004280
XP_003122636.2	XP_003122636.2	XP_003122636.2 glycogen phosphorylase, muscle form [Sus scrofa]	32	29	27	2235400	1879200	1421000	0	0	10388000	0	0	2000100	7069800	1908800	16694000	3908200	0	0	0	2002800000	0	NA	NA	NA	PYGM	PYGM;NA;NA;NA;NA	glycogen metabolic process;glycogen catabolic process	GO:000597; GO:000598	extracellular exosome;cytoplasm;cytosol	GO:007006; GO:000573; GO:000582	 Starch and sucrose metabolism; Insulin signaling pathway; Glucagon signaling pathway; Metabolic pathways; Insulin resistance	hsa0050; hsa0491; hsa0492; hsa0110; hsa0493	glycogen phosphorylase activity;protein binding;nucleotide binding;pyridoxal phosphate binding	GO:000818; GO:000551; GO:000016; GO:003017
XP_003122642.2	XP_003122642.2	XP_003122642.2 fermitin family homolog 3 [Sus scrofa]	5	5	5	14521000	11724000	11580000	14280000	0	11252000	11379000	11109000	0	11528000	0	11452000	0	11923000	0	0	11036000	11559000	NA	NA	NA	FERMT3	FERMT3;NA;NA;NA;NA	integrin activation;regulation of cell-cell adhesion mediated by integrin;leukocyte cell-cell adhesion;platelet aggregation;integrin-mediated signaling pathway;positive regulation of cell migration;substrate adhesion-dependent cell spreading;platelet degranulation	GO:003362; GO:003363; GO:000715; GO:007052; GO:000722; GO:003033; GO:003444; GO:000257	membrane;cell junction;cell projection;extracellular exosome;extracellular region;platelet alpha granule lumen;podosome	GO:001602; GO:003005; GO:004299; GO:007006; GO:000557; GO:003109; GO:000210	 Platelet activation	hsa0461	integrin binding	GO:000517
XP_005660857.1;XP_003122673.2	XP_005660857.1;XP_003122673.2	XP_005660857.1 isoaspartyl peptidase/L-asparaginase isoform X2 [Sus scrofa];XP_003122673.2 isoaspartyl peptidase/L-asparaginase isoform X1 [Sus scrofa]	9	9	9	56651000	75034000	67805000	67795000	40893000	61980000	47379000	60789000	71299000	59627000	64790000	81712000	77750000	74738000	62715000	63471000	77239000	56676000	NA	NA	NA	ASRGL1	ASRGL1;ASRGL1;NA;NA;NA	asparagine catabolic process via L-aspartate;L-phenylalanine catabolic process;protein maturation;proteolysis	GO:003334; GO:000655; GO:005160; GO:000650	photoreceptor inner segment;nucleus;cytoplasm;cytosol	GO:000191; GO:000563; GO:000573; GO:000582	"NA"	"NA"	beta-aspartyl-peptidase activity;hydrolase activity;asparaginase activity;N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity	GO:000879; GO:001678; GO:000406; GO:000394
XP_020938600.1;XP_003122689.1	XP_020938600.1;XP_003122689.1	XP_020938600.1 triokinase/FMN cyclase [Sus scrofa];XP_003122689.1 triokinase/FMN cyclase [Sus scrofa]	9	9	9	25649000	28571000	22728000	24987000	20900000	22268000	29186000	29010000	21060000	26938000	29961000	39983000	31704000	26713000	18220000	31299000	17215000	25218000	NA	NA	NA	TKFC	TKFC;TKFC;NA;NA;NA	glycerol catabolic process;regulation of innate immune response;cellular carbohydrate metabolic process;negative regulation of MDA-5 signaling pathway;carbohydrate phosphorylation;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate	GO:001956; GO:004508; GO:004426; GO:003953; GO:004683; GO:006162	cytosol;nucleus;extracellular exosome	GO:000582; GO:000563; GO:007006	 RIG-I-like receptor signaling pathway; Glycerolipid metabolism; Metabolic pathways; Carbon metabolism	hsa0462; hsa0056; hsa0110; hsa0120	protein binding;ATP binding;metal ion binding;glycerone kinase activity;FAD-AMP lyase (cyclizing) activity;triokinase activity	GO:000551; GO:000552; GO:004687; GO:000437; GO:003401; GO:005035
XP_003122699.2	XP_003122699.2	XP_003122699.2 LOW QUALITY PROTEIN: DNA damage-binding protein 1 [Sus scrofa]	25	25	25	147040000	186830000	174850000	183370000	163160000	169230000	176070000	183320000	199910000	172400000	183090000	198480000	177800000	176160000	166120000	211990000	167430000	166710000	NA	NA	NA	DDB1	DDB1;NA;NA;NA;NA	nucleotide-excision repair, DNA incision, 5'-to lesion;UV-damage excision repair;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, preincision complex stabilization;proteasomal protein catabolic process;nucleotide-excision repair, DNA incision;histone H2A monoubiquitination;positive regulation of viral release from host cell;negative regulation of apoptotic process;post-translational protein modification;regulation of mitotic cell cycle phase transition;nucleotide-excision repair, DNA damage recognition;Wnt signaling pathway;viral process;DNA damage response, detection of DNA damage;proteasome-mediated ubiquitin-dependent protein catabolic process;interaction with symbiont;cellular response to DNA damage stimulus;positive regulation of viral genome replication;positive regulation by virus of viral protein levels in host cell;protein ubiquitination;ubiquitin-dependent protein catabolic process;positive regulation of protein catabolic process	GO:000629; GO:007091; GO:000628; GO:000629; GO:001049; GO:003368; GO:003551; GO:190218; GO:004306; GO:004368; GO:190199; GO:000071; GO:001605; GO:001603; GO:004276; GO:004316; GO:005170; GO:000697; GO:004507; GO:004672; GO:001656; GO:000651; GO:004573	Cul4B-RING E3 ubiquitin ligase complex;extracellular space;nucleus;Cul4-RING E3 ubiquitin ligase complex;cytoplasm;nucleoplasm;extracellular exosome;Cul4A-RING E3 ubiquitin ligase complex;macromolecular complex;nuclear chromosome, telomeric region	GO:003146; GO:000561; GO:000563; GO:008000; GO:000573; GO:000565; GO:007006; GO:003146; GO:003299; GO:000078	 Viral carcinogenesis; Nucleotide excision repair; Ubiquitin mediated proteolysis; Hepatitis B	hsa0520; hsa0342; hsa0412; hsa0516	cullin family protein binding;protein binding;macromolecular complex binding;protein binding, bridging;WD40-repeat domain binding;damaged DNA binding;DNA binding	GO:009760; GO:000551; GO:004487; GO:003067; GO:007198; GO:000368; GO:000367
XP_003122718.1	XP_003122718.1	XP_003122718.1 transmembrane protein 109 [Sus scrofa]	3	3	3	48700000	0	0	0	56170000	0	43025000	0	0	0	64385000	36814000	53296000	0	45859000	0	61125000	0	NA	NA	NA	TMEM109	TMEM109;NA;NA;NA;NA	ion transmembrane transport;negative regulation of cell death;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of ion transmembrane transport;cellular response to gamma radiation	GO:003422; GO:006054; GO:004277; GO:003476; GO:007148	integral component of membrane;nuclear outer membrane;extracellular exosome;sarcoplasmic reticulum membrane	GO:001602; GO:000564; GO:007006; GO:003301	"NA"	"NA"	voltage-gated ion channel activity;protein binding;molecular_function	GO:000524; GO:000551; GO:000367
XP_003122837.1;XP_003122836.1;XP_003122834.1;XP_005654732.2	XP_003122837.1;XP_003122836.1;XP_003122834.1;XP_005654732.2	XP_003122837.1 olfactory receptor 4X2-like [Sus scrofa];XP_003122836.1 olfactory receptor 4X2-like [Sus scrofa];XP_003122834.1 olfactory receptor 4X2-like [Sus scrofa];XP_005654732.2 olfactory receptor 4X2-like [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	492240000	0	NA	NA	NA	LOC100523356	LOC100523356;LOC100523167;LOC100522784;LOC102160149;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005673920.1;XP_005662165.1;XP_003122846.1	XP_005673920.1;XP_005662165.1;XP_003122846.1	XP_005673920.1 60S ribosomal protein L39 [Sus scrofa];XP_005662165.1 60S ribosomal protein L39 [Sus scrofa];XP_003122846.1 60S ribosomal protein L39 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27341000	NA	NA	NA	RPL39	RPL39;LOC100623540;LOC100525679;NA;NA	SRP-dependent cotranslational protein targeting to membrane;cytoplasmic translation;antimicrobial humoral immune response mediated by antimicrobial peptide;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;defense response to Gram-positive bacterium;antibacterial humoral response;innate immune response in mucosa	GO:000661; GO:000218; GO:006184; GO:000018; GO:000641; GO:005083; GO:001973; GO:000222	cytosolic large ribosomal subunit;extracellular space;cytosol;polysomal ribosome	GO:002262; GO:000561; GO:000582; GO:004278	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
XP_005660979.1;XP_003122857.1	XP_005660979.1;XP_003122857.1	XP_005660979.1 26S protease regulatory subunit 6A isoform X2 [Sus scrofa];XP_003122857.1 26S protease regulatory subunit 6A isoform X1 [Sus scrofa]	8	8	8	73516000	48456000	63733000	57700000	75723000	38591000	63742000	69220000	65420000	57078000	61943000	55846000	60934000	44855000	60238000	59933000	56915000	52200000	NA	NA	NA	PSMC3	PSMC3;PSMC3;NA;NA;NA	viral process;modulation by host of viral transcription;neutrophil degranulation;protein deubiquitination;post-translational protein modification;positive regulation of transcription from RNA polymerase II promoter;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;blastocyst development;protein catabolic process;positive regulation of proteasomal protein catabolic process	GO:001603; GO:004392; GO:004331; GO:001657; GO:004368; GO:004594; GO:004589; GO:000182; GO:003016; GO:190180	P-body;proteasome complex;extracellular region;nucleus;nucleoplasm;cytosol;membrane;proteasome regulatory particle, base subcomplex;secretory granule lumen;ficolin-1-rich granule lumen;proteasome accessory complex	GO:000093; GO:000050; GO:000557; GO:000563; GO:000565; GO:000582; GO:001602; GO:000854; GO:003477; GO:190481; GO:002262	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	identical protein binding;ATPase activity;ATP binding;protein binding;proteasome-activating ATPase activity	GO:004280; GO:001688; GO:000552; GO:000551; GO:003640
XP_020940888.1;XP_020940887.1;XP_020940886.1;XP_020940884.1;XP_020940883.1;XP_020940882.1;XP_020940881.1;XP_020940880.1;XP_013849813.1;XP_013849812.1;XP_003122859.1	XP_020940888.1;XP_020940887.1;XP_020940886.1;XP_020940884.1;XP_020940883.1;XP_020940882.1;XP_020940881.1;XP_020940880.1;XP_013849813.1;XP_013849812.1;XP_003122859.1	XP_020940888.1 protein kinase C and casein kinase substrate in neurons protein 3 [Sus scrofa];XP_020940887.1 protein kinase C and casein kinase substrate in neurons protein 3 [Sus scrofa];XP_020940886.1 protein kinase C and casein kinase substrate in neuro	3	3	3	0	0	0	0	0	14021000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PACSIN3	PACSIN3;PACSIN3;PACSIN3;PACSIN3;PACSIN3	positive regulation of membrane protein ectodomain proteolysis;plasma membrane tubulation;endocytosis;cytoskeleton organization;negative regulation of calcium ion transport;negative regulation of endocytosis	GO:005104; GO:009732; GO:000689; GO:000701; GO:005192; GO:004580	cytoplasm;extracellular exosome;cytoskeleton;cytosol;plasma membrane	GO:000573; GO:007006; GO:000585; GO:000582; GO:000588	"NA"	"NA"	cytoskeletal protein binding;calcium channel inhibitor activity;protein binding;phospholipid binding;lipid binding	GO:000809; GO:001985; GO:000551; GO:000554; GO:000828
XP_020940899.1;XP_020940898.1;XP_003122873.2;XP_013849822.1;XP_005661009.1	XP_020940899.1;XP_020940898.1;XP_003122873.2;XP_013849822.1;XP_005661009.1	XP_020940899.1 rho GTPase-activating protein 1 isoform X2 [Sus scrofa];XP_020940898.1 rho GTPase-activating protein 1 isoform X2 [Sus scrofa];XP_003122873.2 rho GTPase-activating protein 1 isoform X2 [Sus scrofa];XP_013849822.1 rho GTPase-activating protei	13	13	13	91759000	144340000	156160000	152470000	114570000	163620000	121970000	151090000	142100000	146230000	139400000	218970000	165700000	173020000	144380000	142630000	146350000	160920000	NA	NA	NA	ARHGAP1	ARHGAP1;ARHGAP1;ARHGAP1;ARHGAP1;ARHGAP1	endosomal transport;small GTPase mediated signal transduction;transferrin transport;regulation of small GTPase mediated signal transduction;negative regulation of endocytic recycling;positive regulation of GTPase activity;positive regulation of signal transduction	GO:001619; GO:000726; GO:003357; GO:005105; GO:200113; GO:004354; GO:000996	cytoplasm;cytosol;sorting endosome;extracellular exosome;endosome membrane;perinuclear region of cytoplasm	GO:000573; GO:000582; GO:009744; GO:007006; GO:001000; GO:004847	"NA"	"NA"	SH3 domain binding;GTPase activator activity;Rab GTPase binding;SH3/SH2 adaptor activity;protein binding;cadherin binding	GO:001712; GO:000509; GO:001713; GO:000507; GO:000551; GO:004529
XP_005661041.1;XP_003122904.1	XP_005661041.1;XP_003122904.1	XP_005661041.1 apoptosis inhibitor 5 isoform X2 [Sus scrofa];XP_003122904.1 apoptosis inhibitor 5 isoform X1 [Sus scrofa]	5	5	5	0	0	11027000	0	0	12017000	0	12126000	0	14391000	0	0	0	12194000	0	15730000	12624000	11777000	NA	NA	NA	API5	API5;API5;NA;NA;NA	negative regulation of fibroblast apoptotic process;apoptotic process;negative regulation of apoptotic process	GO:200027; GO:000691; GO:004306	membrane;spliceosomal complex;nucleus;nuclear speck;cytoplasm	GO:001602; GO:000568; GO:000563; GO:001660; GO:000573	"NA"	"NA"	protein binding;RNA binding;fibroblast growth factor binding	GO:000551; GO:000372; GO:001713
XP_003122917.2	XP_003122917.2	XP_003122917.2 LOW QUALITY PROTEIN: pyruvate dehydrogenase protein X component, mitochondrial [Sus scrofa]	6	6	6	79070000	32874000	55742000	32517000	49711000	27391000	56988000	36317000	51489000	35727000	39246000	34068000	35956000	33391000	36250000	43554000	39200000	24958000	NA	NA	NA	PDHX	PDHX;NA;NA;NA;NA	mitochondrial acetyl-CoA biosynthetic process from pyruvate	GO:006173	mitochondrial matrix;pyruvate dehydrogenase complex	GO:000575; GO:004525	 Metabolic pathways	hsa0110	transferase activity, transferring acyl groups;protein binding;pyruvate dehydrogenase (NAD+) activity	GO:001674; GO:000551; GO:003460
XP_003122918.2	XP_003122918.2	XP_003122918.2 LOW QUALITY PROTEIN: methylthioribulose-1-phosphate dehydratase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13270000	0	0	NA	NA	NA	APIP	APIP;NA;NA;NA;NA	regulation of ERK1 and ERK2 cascade;protein homotetramerization;pyroptosis;apoptotic process;negative regulation of apoptotic process;L-methionine salvage from S-adenosylmethionine;L-methionine salvage from methylthioadenosine	GO:007037; GO:005128; GO:007026; GO:000691; GO:004306; GO:001928; GO:001950	cytoplasm	GO:000573	 Cysteine and methionine metabolism; Metabolic pathways	hsa0027; hsa0110	identical protein binding;methylthioribulose 1-phosphate dehydratase activity;zinc ion binding;protein binding	GO:004280; GO:004657; GO:000827; GO:000551
XP_003122952.1;XP_020948722.1;XP_020948721.1;XP_020948720.1;XP_020948719.1;XP_020948717.1	XP_003122952.1	XP_003122952.1 protein lin-7 homolog C [Sus scrofa]	3	3	3	0	19070000	14743000	0	0	0	17921000	0	0	15799000	0	15335000	15393000	0	0	12578000	0	14462000	NA	NA	NA	LIN7C	LIN7C;NA;NA;NA;NA	maintenance of epithelial cell apical/basal polarity;exocytosis;neurotransmitter secretion;protein transport;protein localization to basolateral plasma membrane;morphogenesis of an epithelial sheet	GO:004519; GO:000688; GO:000726; GO:001503; GO:190336; GO:000201	presynapse;postsynaptic membrane;cytoplasm;MPP7-DLG1-LIN7 complex;synapse;bicellular tight junction;neuron projection;glutamatergic synapse;cell-cell junction;basolateral plasma membrane;plasma membrane;postsynaptic density	GO:009879; GO:004521; GO:000573; GO:009702; GO:004520; GO:000592; GO:004300; GO:009897; GO:000591; GO:001632; GO:000588; GO:001406	"NA"	"NA"	cytoskeletal protein binding;PDZ domain binding;protein domain specific binding;L27 domain binding	GO:000809; GO:003016; GO:001990; GO:009701
XP_003123013.1	XP_003123013.1	XP_003123013.1 proteasome subunit alpha type-1 [Sus scrofa]	10	10	10	147890000	126090000	152400000	139660000	116020000	106300000	162140000	136080000	138400000	123540000	157100000	139480000	141500000	156840000	157380000	140650000	142160000	117150000	NA	NA	NA	PSMA1	PSMA1;NA;NA;NA;NA	post-translational protein modification;immune system process;negative regulation of inflammatory response to antigenic stimulus;protein deubiquitination;proteasomal protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:004368; GO:000237; GO:000286; GO:001657; GO:001049; GO:004316	proteasome core complex, alpha-subunit complex;proteasome complex;cytoplasm;proteasome core complex;cytosol;extracellular exosome;centrosome;nucleus;polysome;nucleoplasm	GO:001977; GO:000050; GO:000573; GO:000583; GO:000582; GO:007006; GO:000581; GO:000563; GO:000584; GO:000565	 Proteasome	hsa0305	lipopolysaccharide binding;threonine-type endopeptidase activity;protein binding;RNA binding;endopeptidase activity	GO:000153; GO:000429; GO:000551; GO:000372; GO:000417
XP_003123029.2	XP_003123029.2	XP_003123029.2 switch-associated protein 70 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	18161000	0	0	0	0	0	0	0	0	0	NA	NA	NA	SWAP70	SWAP70;NA;NA;NA;NA	actin filament bundle assembly;positive regulation of mast cell chemotaxis;positive regulation of cytosolic calcium ion concentration;negative regulation of actin filament depolymerization;negative regulation of cell-cell adhesion mediated by integrin;regulation of protein localization;isotype switching;negative regulation of peptidyl-serine dephosphorylation;positive regulation of actin filament bundle assembly	GO:005101; GO:006075; GO:000720; GO:003083; GO:003363; GO:003288; GO:004519; GO:190230; GO:003223	cytoplasm;plasma membrane;lamellipodium;nucleus;cytoskeleton	GO:000573; GO:000588; GO:003002; GO:000563; GO:000585	"NA"	"NA"	cadherin binding;calcium ion binding;DNA binding;protein binding;ATP binding	GO:004529; GO:000550; GO:000367; GO:000551; GO:000552
XP_003123039.1	XP_003123039.1	XP_003123039.1 ATP synthase subunit delta, mitochondrial [Sus scrofa]	4	4	4	238820000	125820000	172680000	150930000	177490000	125810000	276420000	144120000	262600000	124620000	228120000	91097000	113380000	177580000	271340000	147630000	146550000	0	NA	NA	NA	ATP5F1D	ATP5F1D;NA;NA;NA;NA	ATP synthesis coupled proton transport;cristae formation;response to copper ion;mitochondrial ATP synthesis coupled proton transport;oxidative phosphorylation;ATP hydrolysis coupled cation transmembrane transport;ATP biosynthetic process	GO:001598; GO:004240; GO:004668; GO:004277; GO:000611; GO:009913; GO:000675	mitochondrion;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex, catalytic core F(1);mitochondrial proton-transporting ATP synthase complex	GO:000573; GO:000574; GO:000027; GO:000575	 Parkinson's disease; Huntington's disease; Oxidative phosphorylation; Metabolic pathways	hsa0501; hsa0501; hsa0019; hsa0110	transmembrane transporter activity;ADP binding;ATP binding;transporter activity;proton-transporting ATP synthase activity, rotational mechanism;ATPase activity	GO:002285; GO:004353; GO:000552; GO:000521; GO:004693; GO:001688
XP_005654770.1;XP_003123084.1;XP_020939794.1;XP_005654769.1;XP_005654768.1;XP_020939793.1	XP_005654770.1;XP_003123084.1;XP_020939794.1;XP_005654769.1;XP_005654768.1;XP_020939793.1	XP_005654770.1 nicalin isoform X6 [Sus scrofa];XP_003123084.1 nicalin isoform X5 [Sus scrofa];XP_020939794.1 nicalin isoform X4 [Sus scrofa];XP_005654769.1 nicalin isoform X3 [Sus scrofa];XP_005654768.1 nicalin isoform X2 [Sus scrofa];XP_020939793.1 nicali	5	5	5	0	0	7707100	0	9835000	6595500	0	8941100	0	6624900	8799500	0	6348100	6619200	0	6644900	7795800	6473000	NA	NA	NA	NCLN	NCLN;NCLN;NCLN;NCLN;NCLN	regulation of signal transduction;regulation of protein complex stability;regulation of protein complex assembly;protein stabilization	GO:000996; GO:006163; GO:004325; GO:005082	membrane;integral component of membrane;macromolecular complex;endoplasmic reticulum membrane	GO:001602; GO:001602; GO:003299; GO:000578	"NA"	"NA"	protein binding	GO:000551
XP_003123114.1;XP_005661386.1;XP_020918921.1;XP_001925192.2	XP_003123114.1;XP_005661386.1	XP_003123114.1 endophilin-A2 isoform X2 [Sus scrofa];XP_005661386.1 endophilin-A2 isoform X1 [Sus scrofa]	6	6	6	0	35937000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SH3GL1	SH3GL1;SH3GL1;NA;NA;NA	signal transduction;synaptic vesicle uncoating;positive regulation of synaptic vesicle endocytosis;central nervous system development;modulation of excitatory postsynaptic potential	GO:000716; GO:001619; GO:190024; GO:000741; GO:009881	early endosome membrane;Schaffer collateral - CA1 synapse;cytoplasm;postsynaptic density, intracellular component;podosome;cytosol;cell projection;presynapse;cell junction;glutamatergic synapse	GO:003190; GO:009868; GO:000573; GO:009909; GO:000210; GO:000582; GO:004299; GO:009879; GO:003005; GO:009897	 Endocytosis	hsa0414	protein binding;protein C-terminus binding;ion channel binding;SH3 domain binding;phosphatase binding;beta-1 adrenergic receptor binding;cadherin binding;GTPase binding;lipid binding;identical protein binding	GO:000551; GO:000802; GO:004432; GO:001712; GO:001990; GO:003169; GO:004529; GO:005102; GO:000828; GO:004280
XP_003123119.1;CON__Q2KIF2	XP_003123119.1	XP_003123119.1 leucine-rich alpha-2-glycoprotein [Sus scrofa]	7	7	7	30824000	33920000	18882000	40155000	74409000	133020000	25012000	23080000	21785000	26653000	34630000	17637000	37201000	33105000	20660000	23904000	16089000	24628000	NA	NA	NA	LRG1	LRG1;NA;NA;NA;NA	positive regulation of angiogenesis;brown fat cell differentiation;response to bacterium;neutrophil degranulation;biological_process;positive regulation of transforming growth factor beta receptor signaling pathway;positive regulation of endothelial cell proliferation	GO:004576; GO:005087; GO:000961; GO:004331; GO:000815; GO:003051; GO:000193	extracellular region;specific granule lumen;extracellular space;intracellular membrane-bounded organelle;extracellular exosome;membrane;ficolin-1-rich granule lumen;tertiary granule lumen	GO:000557; GO:003558; GO:000561; GO:004323; GO:007006; GO:001602; GO:190481; GO:190472	"NA"	"NA"	transforming growth factor beta receptor binding;protein binding;molecular_function	GO:000516; GO:000551; GO:000367
XP_003123210.1;XP_020939551.1	XP_003123210.1;XP_020939551.1	XP_003123210.1 KN motif and ankyrin repeat domain-containing protein 3 isoform X1 [Sus scrofa];XP_020939551.1 KN motif and ankyrin repeat domain-containing protein 3 isoform X2 [Sus scrofa]	3	3	3	0	0	9948700	0	0	0	0	0	6879300	0	0	0	0	0	0	0	0	0	NA	NA	NA	KANK3	KANK3;KANK3;NA;NA;NA	negative regulation of actin filament polymerization	GO:003083	cytoplasm	GO:000573	"NA"	"NA"	"NA"	"NA"
XP_003123223.1;XP_003123222.1;XP_003123224.2	XP_003123223.1;XP_003123222.1;XP_003123224.2	XP_003123223.1 transmembrane protein 205 isoform X2 [Sus scrofa];XP_003123222.1 transmembrane protein 205 isoform X2 [Sus scrofa];XP_003123224.2 transmembrane protein 205 isoform X1 [Sus scrofa]	2	2	2	52696000	0	32925000	43038000	31608000	0	42209000	0	46311000	0	42040000	0	18879000	56951000	42923000	0	61243000	42749000	NA	NA	NA	TMEM205	TMEM205;TMEM205;TMEM205;NA;NA	"NA"	"NA"	integral component of membrane	GO:001602	"NA"	"NA"	"NA"	"NA"
XP_003123225.2;XP_005654944.1;NP_001116651.1	XP_003123225.2;XP_005654944.1;NP_001116651.1	XP_003123225.2 ras-related protein Rab-3D [Sus scrofa];XP_005654944.1 ras-related protein Rab-3A isoform X1 [Sus scrofa];NP_001116651.1 ras-related protein Rab-3A [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	2239700	0	0	0	0	0	NA	NA	NA	RAB3D	RAB3D;RAB3A;RAB3A;NA;NA	protein localization to plasma membrane;regulation of exocytosis;intracellular protein transport;peptidyl-cysteine methylation;Rab protein signal transduction;neutrophil degranulation;vesicle docking involved in exocytosis;positive regulation of regulated secretory pathway;protein secretion;bone resorption	GO:007265; GO:001715; GO:000688; GO:001812; GO:003248; GO:004331; GO:000690; GO:190330; GO:000930; GO:004545	endosome;cytoplasmic microtubule;vesicle;extracellular exosome;synaptic vesicle;zymogen granule;secretory vesicle;azurophil granule membrane	GO:000576; GO:000588; GO:003198; GO:007006; GO:000802; GO:004258; GO:009950; GO:003557	 Pancreatic secretion	hsa0497	GTPase activity;myosin V binding;GTP binding;GTP-dependent protein binding	GO:000392; GO:003148; GO:000552; GO:003074
XP_003123233.2	XP_003123233.2	XP_003123233.2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 [Sus scrofa]	4	4	4	4630800	0	0	0	12823000	0	0	5448900	0	10537000	0	0	0	0	0	9288100	0	4831400	NA	NA	NA	NDUFA7	NDUFA7;NA;NA;NA;NA	mitochondrial translation;mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone	GO:003254; GO:003298; GO:000612	mitochondrial respiratory chain complex I;mitochondrial ribosome;mitochondrion;mitochondrial inner membrane	GO:000574; GO:000576; GO:000573; GO:000574	 Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Oxidative phosphorylation; Huntington's disease	hsa0493; hsa0110; hsa0019; hsa0501	structural constituent of ribosome;NADH dehydrogenase (ubiquinone) activity	GO:000373; GO:000813
XP_003123248.1	XP_003123248.1	XP_003123248.1 mitochondrial import inner membrane translocase subunit TIM44 [Sus scrofa]	5	5	5	0	0	13493000	0	16238000	0	0	0	14953000	7917700	0	16323000	0	0	9513800	0	0	0	NA	NA	NA	TIMM44	TIMM44;NA;NA;NA;NA	protein targeting to mitochondrion;protein import into mitochondrial matrix	GO:000662; GO:003015	mitochondrion;mitochondrial inner membrane;mitochondrial matrix	GO:000573; GO:000574; GO:000575	"NA"	"NA"	ATP binding;protein binding;chaperone binding	GO:000552; GO:000551; GO:005108
XP_003123252.1;XP_020939484.1	XP_003123252.1;XP_020939484.1	XP_003123252.1 protein YIPF2 isoform X3 [Sus scrofa];XP_020939484.1 protein YIPF2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1448400	NA	NA	NA	YIPF2	YIPF2;YIPF2;NA;NA;NA	vesicle-mediated transport	GO:001619	Golgi apparatus;integral component of membrane;transport vesicle;Golgi medial cisterna;trans-Golgi network;Golgi trans cisterna;late endosome membrane	GO:000579; GO:001602; GO:003013; GO:000579; GO:000580; GO:000013; GO:003190	"NA"	"NA"	protein binding;Rab GTPase binding	GO:000551; GO:001713
XP_020939451.1;XP_003123258.1;XP_005654920.1;XP_020939450.1	XP_020939451.1;XP_003123258.1;XP_005654920.1;XP_020939450.1	XP_020939451.1 choline transporter-like protein 2 isoform X4 [Sus scrofa];XP_003123258.1 choline transporter-like protein 2 isoform X3 [Sus scrofa];XP_005654920.1 choline transporter-like protein 2 isoform X2 [Sus scrofa];XP_020939450.1 choline transporter	3	3	3	27476000	38997000	29441000	22122000	24441000	41143000	30665000	23669000	31232000	24119000	27942000	25040000	29943000	35918000	0	28939000	37083000	33068000	NA	NA	NA	SLC44A2	SLC44A2;SLC44A2;SLC44A2;SLC44A2;NA	phosphatidylcholine biosynthetic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;transmembrane transport;neutrophil degranulation;choline transport	GO:000665; GO:004312; GO:005508; GO:004331; GO:001587	plasma membrane;specific granule membrane;extracellular exosome;lysosomal membrane;integral component of membrane	GO:000588; GO:003557; GO:007006; GO:000576; GO:001602	 Choline metabolism in cancer	hsa0523	choline transmembrane transporter activity	GO:001522
XP_003123362.2;XP_013846058.2	XP_003123362.2;XP_013846058.2	XP_003123362.2 lysosomal alpha-mannosidase isoform X2 [Sus scrofa];XP_013846058.2 lysosomal alpha-mannosidase isoform X1 [Sus scrofa]	8	8	8	0	40361000	38216000	53490000	29744000	48740000	30811000	27612000	28147000	38119000	28640000	0	54164000	30584000	29369000	44182000	34399000	37500000	NA	NA	NA	MAN2B1	MAN2B1;MAN2B1;NA;NA;NA	cellular protein modification process;oligosaccharide catabolic process;protein deglycosylation;mannose metabolic process;neutrophil degranulation	GO:000646; GO:000931; GO:000651; GO:000601; GO:004331	extracellular region;extracellular space;lysosomal lumen;azurophil granule lumen;extracellular exosome;vacuolar membrane	GO:000557; GO:000561; GO:004320; GO:003557; GO:007006; GO:000577	 Other glycan degradation; Lysosome	hsa0051; hsa0414	alpha-mannosidase activity;metal ion binding;carbohydrate binding	GO:000455; GO:004687; GO:003024
XP_003123372.1	XP_003123372.1	XP_003123372.1 ATPase ASNA1 [Sus scrofa]	7	7	7	44770000	58233000	61382000	47239000	48090000	41685000	47875000	46332000	52346000	45138000	54324000	41310000	55492000	61259000	56807000	51945000	58272000	50793000	NA	NA	NA	ASNA1	ASNA1;NA;NA;NA;NA	arsenite transport;posttranslational protein targeting to membrane;tail-anchored membrane protein insertion into ER membrane;IRE1-mediated unfolded protein response	GO:001570; GO:000662; GO:007181; GO:003649	cytoplasm;endoplasmic reticulum membrane;GET complex;extracellular exosome;nucleus;nucleolus	GO:000573; GO:000578; GO:004352; GO:007006; GO:000563; GO:000573	"NA"	"NA"	metal ion binding;ATP binding;transporter activity;ATPase activity;protein binding;arsenite transmembrane transporter activity	GO:004687; GO:000552; GO:000521; GO:001688; GO:000551; GO:001510
XP_003123385.1;XP_020939373.1	XP_003123385.1;XP_020939373.1	XP_003123385.1 phenylalanine--tRNA ligase alpha subunit isoform X2 [Sus scrofa];XP_020939373.1 phenylalanine--tRNA ligase alpha subunit isoform X1 [Sus scrofa]	11	11	11	36350000	24646000	34300000	25419000	28838000	26349000	34708000	32912000	29250000	25930000	31976000	39806000	24353000	30546000	31363000	28085000	28876000	26878000	NA	NA	NA	FARSA	FARSA;FARSA;NA;NA;NA	protein heterotetramerization;phenylalanyl-tRNA aminoacylation	GO:005129; GO:000643	membrane;cytosol;cytoplasm;phenylalanine-tRNA ligase complex	GO:001602; GO:000582; GO:000573; GO:000932	 Aminoacyl-tRNA biosynthesis	hsa0097	ATP binding;tRNA binding;RNA binding;phenylalanine-tRNA ligase activity;protein binding	GO:000552; GO:000004; GO:000372; GO:000482; GO:000551
XP_003123387.1	XP_003123387.1	XP_003123387.1 growth arrest and DNA damage-inducible proteins-interacting protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19931000	+	NA	NA	GADD45GIP1	GADD45GIP1;NA;NA;NA;NA	viral process;mitotic cell cycle arrest;mitochondrial translational termination	GO:001603; GO:007185; GO:007012	ribosome;mitochondrion;mitochondrial matrix;nucleus	GO:000584; GO:000573; GO:000575; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_003123394.3	XP_003123394.3	XP_003123394.3 methylthioribose-1-phosphate isomerase [Sus scrofa]	8	8	8	43798000	32304000	33711000	0	42833000	37835000	0	37218000	32026000	33766000	32668000	35355000	42663000	0	35903000	36989000	39554000	43304000	NA	NA	NA	MRI1	MRI1;NA;NA;NA;NA	L-methionine salvage from S-adenosylmethionine;L-methionine salvage from methylthioadenosine	GO:001928; GO:001950	nucleoplasm;cell projection;fibrillar center;cytosol	GO:000565; GO:004299; GO:000165; GO:000582	 Cysteine and methionine metabolism; Metabolic pathways	hsa0027; hsa0110	S-methyl-5-thioribose-1-phosphate isomerase activity;identical protein binding	GO:004652; GO:004280
XP_003123401.1;XP_003354151.1	XP_003123401.1;XP_003354151.1	XP_003123401.1 cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [Sus scrofa];XP_003354151.1 cAMP-dependent protein kinase catalytic subunit alpha isoform X2 [Sus scrofa]	12	12	5	283990000	223920000	262590000	259030000	288510000	252760000	216990000	305560000	239030000	238890000	283190000	352200000	221870000	251780000	256290000	347820000	222900000	248030000	NA	NA	NA	PRKACA	PRKACA;PRKACA;NA;NA;NA	mRNA processing;cytokine-mediated signaling pathway;regulation of cytosolic calcium ion concentration;cellular response to parathyroid hormone stimulus;neural tube closure;stimulatory C-type lectin receptor signaling pathway;renal water homeostasis;regulation of proteasomal protein catabolic process;protein kinase A signaling;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;regulation of heart rate;blood coagulation;positive regulation of cell cycle arrest;cellular response to epinephrine stimulus;G2/M transition of mitotic cell cycle;mesoderm formation;regulation of G2/M transition of mitotic cell cycle;modulation of synaptic transmission;regulation of ryanodine-sensitive calcium-release channel activity;regulation of cardiac conduction;protein phosphorylation;regulation of macroautophagy;activation of protein kinase A activity;calcium-mediated signaling using intracellular calcium source;sperm capacitation;regulation of protein processing;cell communication by electrical coupling involved in cardiac conduction;peptidyl-threonine phosphorylation;high-density lipoprotein particle assembly;cellular response to heat;protein autophosphorylation;regulation of cardiac muscle contraction;ciliary basal body docking;regulation of bicellular tight junction assembly;regulation of osteoblast differentiation;negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;regulation of protein binding;positive regulation of protein export from nucleus;cellular response to glucose stimulus	GO:000639; GO:001922; GO:005148; GO:007137; GO:000184; GO:000222; GO:000309; GO:006113; GO:001073; GO:001088; GO:000202; GO:000759; GO:007115; GO:007187; GO:000008; GO:000170; GO:001038; GO:005080; GO:006031; GO:190377; GO:000646; GO:001624; GO:003419; GO:003558; GO:004824; GO:007061; GO:008606; GO:001810; GO:003438; GO:003460; GO:004677; GO:005511; GO:009771; GO:200081; GO:004566; GO:190162; GO:004339; GO:004682; GO:007133	cAMP-dependent protein kinase complex;sperm flagellum;extracellular exosome;cytosol;nuclear speck;dendritic spine;plasma membrane raft;intercellular bridge;acrosomal vesicle;membrane;cytoplasm;centrosome;calcium channel complex;ciliary base;axoneme;nucleus;neuromuscular junction;nucleoplasm;perinuclear region of cytoplasm	GO:000595; GO:003612; GO:007006; GO:000582; GO:001660; GO:004319; GO:004485; GO:004517; GO:000166; GO:001602; GO:000573; GO:000581; GO:003470; GO:009754; GO:000593; GO:000563; GO:003159; GO:000565; GO:004847	 Calcium signaling pathway; GABAergic synapse; GnRH signaling pathway; Oxytocin signaling pathway; MAPK signaling pathway; cAMP signaling pathway; Oocyte meiosis; Inflammatory mediator regulation of TRP channels; Endocrine and other factor-regulated calcium reabsorption; Salivary secretion; Parkinson's disease; Cocaine addiction; Pathways in cancer; Wnt signaling pathway; HTLV-I infection; Adrenergic signaling in cardiomyocytes; Platelet activation; Circadian entrainment; Taste transduction; Dilated cardiomyopathy; Chemokine signaling pathway; Apoptosis; Hedgehog signaling pathway; Prion diseases; Vascular smooth muscle contraction; Gap junction; Vibrio cholerae infection; Amoebiasis	hsa0402; hsa0472; hsa0491; hsa0492; hsa0401; hsa0402; hsa0411; hsa0475; hsa0496; hsa0497; hsa0501; hsa0503; hsa0520; hsa0431; hsa0516; hsa0426; hsa0461; hsa0471; hsa0474; hsa0541; hsa0406; hsa0421; hsa0434; hsa0502; hsa0427; hsa0454; hsa0511; hsa0514	protein serine/threonine kinase activity;manganese ion binding;protein serine/threonine/tyrosine kinase activity;ATP binding;protein binding;ubiquitin protein ligase binding;protein kinase binding;protein kinase A regulatory subunit binding;magnesium ion binding;protein kinase activity;cAMP-dependent protein kinase activity	GO:000467; GO:003014; GO:000471; GO:000552; GO:000551; GO:003162; GO:001990; GO:003423; GO:000028; GO:000467; GO:000469
XP_005652964.1;XP_003123501.2;XP_005652963.1	XP_005652964.1;XP_003123501.2;XP_005652963.1	XP_005652964.1 acetolactate synthase-like protein isoform X2 [Sus scrofa];XP_003123501.2 acetolactate synthase-like protein isoform X2 [Sus scrofa];XP_005652963.1 acetolactate synthase-like protein isoform X1 [Sus scrofa]	6	6	6	0	0	17265000	15418000	15102000	0	18538000	15997000	0	18095000	0	15506000	0	12866000	0	17632000	13424000	14346000	NA	NA	NA	ILVBL	ILVBL;ILVBL;ILVBL;NA;NA	biological_process	GO:000815	membrane;integral component of membrane	GO:001602; GO:001602	"NA"	"NA"	magnesium ion binding;molecular_function;transferase activity;thiamine pyrophosphate binding;protein binding	GO:000028; GO:000367; GO:001674; GO:003097; GO:000551
XP_005661273.2;XP_020939255.1;XP_020939254.1;XP_005661270.2;XP_020939253.1;XP_005661267.2;XP_020939251.1;XP_020939250.1;XP_003123529.3;XP_020939247.1;XP_020939246.1;XP_013850083.2;XP_020939248.1;XP_020939252.1;XP_020939249.1;XP_020939245.1	XP_005661273.2;XP_020939255.1;XP_020939254.1;XP_005661270.2;XP_020939253.1;XP_005661267.2;XP_020939251.1;XP_020939250.1;XP_003123529.3;XP_020939247.1;XP_020939246.1;XP_013850083.2;XP_020939248.1	XP_005661273.2 epidermal growth factor receptor substrate 15-like 1 isoform X16 [Sus scrofa];XP_020939255.1 epidermal growth factor receptor substrate 15-like 1 isoform X15 [Sus scrofa];XP_020939254.1 epidermal growth factor receptor substrate 15-like 1 is	5	5	5	0	0	0	0	0	0	0	8156100	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EPS15L1	EPS15L1;EPS15L1;EPS15L1;EPS15L1;EPS15L1	negative regulation of epidermal growth factor receptor signaling pathway;membrane organization;endocytosis	GO:004205; GO:006102; GO:000689	cytosol;clathrin coat of coated pit;membrane;plasma membrane;nucleus	GO:000582; GO:003013; GO:001602; GO:000588; GO:000563	 Endocytosis	hsa0414	calcium ion binding;cadherin binding;protein binding	GO:000550; GO:004529; GO:000551
XP_003123541.1	XP_003123541.1	XP_003123541.1 procollagen galactosyltransferase 1 [Sus scrofa]	3	3	3	0	20070000	0	0	0	18843000	0	0	17127000	0	16874000	0	17379000	0	0	17248000	0	21126000	NA	NA	NA	COLGALT1	COLGALT1;NA;NA;NA;NA	positive regulation of collagen fibril organization	GO:190402	membrane;endoplasmic reticulum lumen	GO:001602; GO:000578	 Other types of O-glycan biosynthesis; Lysine degradation	hsa0051; hsa0031	procollagen galactosyltransferase activity	GO:005021
XP_003123542.1;XP_005661239.1;XP_020939215.1	XP_003123542.1;XP_005661239.1;XP_020939215.1	XP_003123542.1 6-phosphogluconolactonase isoform X1 [Sus scrofa];XP_005661239.1 6-phosphogluconolactonase isoform X3 [Sus scrofa];XP_020939215.1 6-phosphogluconolactonase isoform X2 [Sus scrofa]	8	8	8	84822000	94045000	84743000	85161000	76323000	65667000	85645000	96402000	86973000	80994000	80638000	107670000	100670000	81503000	90136000	97235000	99707000	87101000	NA	NA	NA	PGLS	PGLS;PGLS;PGLS;NA;NA	pentose-phosphate shunt, oxidative branch;carbohydrate metabolic process;pentose-phosphate shunt	GO:000905; GO:000597; GO:000609	extracellular exosome;cytosol	GO:007006; GO:000582	 Carbon metabolism; Pentose phosphate pathway; Metabolic pathways; Biosynthesis of antibiotics	hsa0120; hsa0003; hsa0110; hsa0113	6-phosphogluconolactonase activity;protein binding	GO:001705; GO:000551
XP_020939193.1;XP_020939192.1;XP_003123559.4	XP_020939193.1;XP_020939192.1;XP_003123559.4	XP_020939193.1 60S ribosomal protein L18a isoform X2 [Sus scrofa];XP_020939192.1 60S ribosomal protein L18a isoform X2 [Sus scrofa];XP_003123559.4 60S ribosomal protein L18a isoform X1 [Sus scrofa]	5	5	5	94135000	67533000	108020000	71261000	66889000	101340000	68454000	56975000	95331000	89197000	55056000	74899000	91048000	94979000	52745000	99945000	107290000	105580000	NA	NA	NA	RPL18A	RPL18A;RPL18A;RPL18A;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;SRP-dependent cotranslational protein targeting to membrane;response to antineoplastic agent	GO:000018; GO:000218; GO:000641; GO:000661; GO:009732	postsynaptic density;cytosolic large ribosomal subunit;polysomal ribosome;cytosol;membrane	GO:001406; GO:002262; GO:004278; GO:000582; GO:001602	 Ribosome	hsa0301	RNA binding;protein binding;structural constituent of ribosome	GO:000372; GO:000551; GO:000373
XP_005652984.1;XP_020939137.1;XP_003123564.1	XP_005652984.1;XP_020939137.1;XP_003123564.1	XP_005652984.1 peptidyl-prolyl cis-trans isomerase FKBP8 isoform X2 [Sus scrofa];XP_020939137.1 peptidyl-prolyl cis-trans isomerase FKBP8 isoform X1 [Sus scrofa];XP_003123564.1 peptidyl-prolyl cis-trans isomerase FKBP8 isoform X1 [Sus scrofa]	3	3	3	0	10414000	11188000	10119000	10008000	8063000	0	8394000	10021000	10522000	11789000	17940000	0	0	0	14050000	9336300	12524000	NA	NA	NA	FKBP8	FKBP8;FKBP8;FKBP8;NA;NA	apoptotic process;multicellular organism growth;smoothened signaling pathway;negative regulation of apoptotic process;negative regulation of protein phosphorylation;dorsal/ventral neural tube patterning;intracellular signal transduction;cell fate specification;viral process;positive regulation of BMP signaling pathway;camera-type eye development;protein peptidyl-prolyl isomerization	GO:000691; GO:003526; GO:000722; GO:004306; GO:000193; GO:002190; GO:003555; GO:000170; GO:001603; GO:003051; GO:004301; GO:000041	endoplasmic reticulum;cytosol;membrane;integral component of endoplasmic reticulum membrane;macromolecular complex;mitochondrial membrane;mitochondrion	GO:000578; GO:000582; GO:001602; GO:003017; GO:003299; GO:003196; GO:000573	"NA"	"NA"	protein binding;identical protein binding;peptidyl-prolyl cis-trans isomerase activity;metal ion binding;disordered domain specific binding	GO:000551; GO:004280; GO:000375; GO:004687; GO:009771
XP_003123584.1	XP_003123584.1	XP_003123584.1 coatomer subunit epsilon [Sus scrofa]	5	5	5	0	20730000	17580000	18604000	0	0	0	20867000	0	18543000	22580000	23043000	23384000	0	19780000	0	0	0	NA	NA	NA	COPE	COPE;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER;protein transport	GO:000688; GO:000689; GO:001503	transport vesicle;cytosol;COPI vesicle coat;endoplasmic reticulum membrane;nucleoplasm;Golgi apparatus;Golgi membrane	GO:003013; GO:000582; GO:003012; GO:000578; GO:000565; GO:000579; GO:000013	"NA"	"NA"	protein binding;structural molecule activity	GO:000551; GO:000519
XP_003123686.3	XP_003123686.3	XP_003123686.3 glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 [Sus scrofa]	11	8	8	0	0	0	19019000	0	20985000	0	0	0	10632000	0	0	11532000	0	0	0	0	19505000	NA	NA	NA	GFPT2	GFPT2;NA;NA;NA;NA	UDP-N-acetylglucosamine metabolic process;cellular response to leukemia inhibitory factor;protein N-linked glycosylation;glutamine metabolic process;fructose 6-phosphate metabolic process;UDP-N-acetylglucosamine biosynthetic process;energy reserve metabolic process	GO:000604; GO:199083; GO:000648; GO:000654; GO:000600; GO:000604; GO:000611	cytosol	GO:000582	 Biosynthesis of antibiotics; Insulin resistance; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Amino sugar and nucleotide sugar metabolism	hsa0113; hsa0493; hsa0025; hsa0110; hsa0052	protein binding;carbohydrate derivative binding;glutamine-fructose-6-phosphate transaminase (isomerizing) activity	GO:000551; GO:009736; GO:000436
XP_005654993.2;XP_003123687.4	XP_005654993.2;XP_003123687.4	XP_005654993.2 sequestosome-1 isoform X2 [Sus scrofa];XP_003123687.4 sequestosome-1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6440900	NA	NA	NA	SQSTM1	SQSTM1;SQSTM1;NA;NA;NA	immune system process;protein localization;negative regulation of apoptotic process;negative regulation of growth of symbiont in host;positive regulation of long-term synaptic potentiation;response to ischemia;autophagy;endosome organization;macromitophagy;macroautophagy;cell differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;protein phosphorylation;regulation of Ras protein signal transduction;positive regulation of protein localization to plasma membrane;mitochondrion organization;regulation of mitochondrion organization;response to mitochondrial depolarisation;ubiquitin-dependent protein catabolic process;endosomal transport;regulation of I-kappaB kinase/NF-kappaB signaling;protein heterooligomerization;regulation of protein complex stability;interleukin-1-mediated signaling pathway;positive regulation of protein phosphorylation;aggrephagy;intracellular signal transduction;protein localization to perinuclear region of cytoplasm	GO:000237; GO:000810; GO:004306; GO:004413; GO:190027; GO:000293; GO:000691; GO:000703; GO:000042; GO:001623; GO:003015; GO:004594; GO:000012; GO:000646; GO:004657; GO:190307; GO:000700; GO:001082; GO:009878; GO:000651; GO:001619; GO:004312; GO:005129; GO:006163; GO:007049; GO:000193; GO:003597; GO:003555; GO:190571	aggresome;amphisome;autophagosome;Lewy body;P-body;nucleoplasm;mitochondrion;PML body;sarcomere;extracellular exosome;cytosol;pre-autophagosomal structure;inclusion body;sperm midpiece;endoplasmic reticulum;intracellular membrane-bounded organelle	GO:001623; GO:004475; GO:000577; GO:009741; GO:000093; GO:000565; GO:000573; GO:001660; GO:003001; GO:007006; GO:000582; GO:000040; GO:001623; GO:009722; GO:000578; GO:004323	 Osteoclast differentiation	hsa0438	ubiquitin protein ligase binding;protein serine/threonine kinase activity;receptor tyrosine kinase binding;ionotropic glutamate receptor binding;protein homodimerization activity;K63-linked polyubiquitin binding;SH2 domain binding;protein kinase C binding;enzyme binding;zinc ion binding;ubiquitin binding;protein binding;protein kinase binding	GO:003162; GO:000467; GO:003097; GO:003525; GO:004280; GO:007053; GO:004216; GO:000508; GO:001989; GO:000827; GO:004313; GO:000551; GO:001990
XP_003123690.1;XP_020939983.1;XP_005655002.1;XP_020939984.1;XP_003357017.2;XP_005656574.1;XP_005656572.1;XP_020957077.1;XP_003129124.2;XP_020929180.1;XP_005656571.1;XP_013844767.1;XP_013844766.1;XP_005656570.1	XP_003123690.1;XP_020939983.1;XP_005655002.1;XP_020939984.1	XP_003123690.1 RUN and FYVE domain-containing protein 1 isoform X2 [Sus scrofa];XP_020939983.1 RUN and FYVE domain-containing protein 1 isoform X1 [Sus scrofa];XP_005655002.1 RUN and FYVE domain-containing protein 1 isoform X4 [Sus scrofa];XP_020939984.1 R	8	8	8	0	19979000	10622000	18189000	0	16802000	0	13902000	12475000	14539000	0	0	0	21334000	0	18151000	12691000	15806000	NA	NA	NA	RUFY1	RUFY1;RUFY1;RUFY1;RUFY1;NA	regulation of endocytosis;endocytosis;phosphatidylinositol biosynthetic process;protein transport	GO:003010; GO:000689; GO:000666; GO:001503	endosome;nuclear speck;cytosol;cytoplasm;nucleus;intracellular membrane-bounded organelle;early endosome membrane	GO:000576; GO:001660; GO:000582; GO:000573; GO:000563; GO:004323; GO:003190	 Endocytosis	hsa0414	SH3 domain binding;protein binding;lipid binding;metal ion binding;SH2 domain binding;protein transporter activity	GO:001712; GO:000551; GO:000828; GO:004687; GO:004216; GO:000856
XP_020939989.1;XP_020939988.1;XP_020939987.1;XP_003123691.1;XP_020939985.1;XP_005654998.1;XP_005654997.1;XP_005654996.1;XP_020939991.1;XP_020939990.1;XP_020939986.1;XP_013842977.1;XP_013842975.1;XP_013842978.1;XP_013842976.1;XP_020935324.1;XP_020935323.1	XP_020939989.1;XP_020939988.1;XP_020939987.1;XP_003123691.1;XP_020939985.1;XP_005654998.1;XP_005654997.1;XP_005654996.1;XP_020939991.1;XP_020939990.1;XP_020939986.1;XP_013842977.1;XP_013842975.1;XP_013842978.1;XP_013842976.1;XP_020935324.1;XP_020935323.1	XP_020939989.1 heterogeneous nuclear ribonucleoprotein H isoform X7 [Sus scrofa];XP_020939988.1 heterogeneous nuclear ribonucleoprotein H isoform X7 [Sus scrofa];XP_020939987.1 heterogeneous nuclear ribonucleoprotein H isoform X7 [Sus scrofa];XP_003123691.	7	5	5	100370000	114460000	131070000	111570000	107660000	135640000	133180000	110890000	116750000	116200000	111050000	132650000	165440000	117720000	147640000	117660000	138800000	133350000	NA	NA	NA	HNRNPH1	HNRNPH1;HNRNPH1;HNRNPH1;HNRNPH1;HNRNPH1	mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;RNA metabolic process;RNA processing;regulation of RNA splicing	GO:000039; GO:000854; GO:001607; GO:000639; GO:004348	cytosol;nucleus;nucleoplasm;membrane;catalytic step 2 spliceosome	GO:000582; GO:000563; GO:000565; GO:001602; GO:007101	"NA"	"NA"	protein binding;RNA binding;poly(U) RNA binding	GO:000551; GO:000372; GO:000826
XP_003123695.1;XP_003123696.1	XP_003123695.1;XP_003123696.1	XP_003123695.1 TBC1 domain family member 9B isoform X2 [Sus scrofa];XP_003123696.1 TBC1 domain family member 9B isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	9797800	0	0	0	0	0	6989300	0	9308700	0	0	NA	NA	NA	TBC1D9B	TBC1D9B;TBC1D9B;NA;NA;NA	regulation of cilium assembly;intracellular protein transport;activation of GTPase activity	GO:190201; GO:000688; GO:009063	integral component of membrane;cell	GO:001602; GO:000562	"NA"	"NA"	protein binding;calcium ion binding;GTPase activator activity;Rab GTPase binding	GO:000551; GO:000550; GO:000509; GO:001713
XP_005661525.1;XP_005661524.1;XP_003123708.1	XP_005661525.1;XP_005661524.1;XP_003123708.1	XP_005661525.1 FAS-associated factor 2 isoform X2 [Sus scrofa];XP_005661524.1 FAS-associated factor 2 isoform X2 [Sus scrofa];XP_003123708.1 FAS-associated factor 2 isoform X1 [Sus scrofa]	2	2	2	0	0	5807000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	FAF2	FAF2;FAF2;FAF2;NA;NA	ubiquitin-dependent ERAD pathway;retrograde protein transport, ER to cytosol;negative regulation of catalytic activity;response to unfolded protein;lipid particle organization;neutrophil degranulation	GO:003043; GO:003097; GO:004308; GO:000698; GO:003438; GO:004331	endoplasmic reticulum;extracellular region;VCP-NPL4-UFD1 AAA ATPase complex;lipid particle;azurophil granule lumen	GO:000578; GO:000557; GO:003409; GO:000581; GO:003557	"NA"	"NA"	protein binding;lipase binding;lipase inhibitor activity;ubiquitin binding;ubiquitin protein ligase binding	GO:000551; GO:003547; GO:005510; GO:004313; GO:003162
XP_003123722.1	XP_003123722.1	XP_003123722.1 transmembrane emp24 domain-containing protein 9 [Sus scrofa]	4	4	4	60739000	64858000	84659000	85720000	74545000	76022000	97369000	73176000	71007000	62293000	80664000	81374000	84426000	77364000	89471000	80918000	77066000	80416000	NA	NA	NA	TMED9	TMED9;NA;NA;NA;NA	protein exit from endoplasmic reticulum;positive regulation of organelle organization;ER to Golgi vesicle-mediated transport;COPI coating of Golgi vesicle;early endosome to Golgi transport;retrograde vesicle-mediated transport, Golgi to ER;Golgi organization	GO:003252; GO:001063; GO:000688; GO:004820; GO:003449; GO:000689; GO:000703	ER to Golgi transport vesicle;integral component of membrane;Golgi membrane;cytosol;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment membrane;extracellular exosome;Golgi apparatus;transport vesicle;trans-Golgi network transport vesicle	GO:003013; GO:001602; GO:000013; GO:000582; GO:000578; GO:003311; GO:007006; GO:000579; GO:003013; GO:003014	"NA"	"NA"	protein binding;syntaxin binding	GO:000551; GO:001990
XP_003123896.3	XP_003123896.3	XP_003123896.3 geranylgeranyl transferase type-1 subunit beta [Sus scrofa]	3	3	3	0	0	0	0	0	3851200	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PGGT1B	PGGT1B;NA;NA;NA;NA	protein geranylgeranylation;positive regulation of cell cycle;response to cytokine;negative regulation of nitric-oxide synthase biosynthetic process;positive regulation of cell proliferation;protein prenylation	GO:001834; GO:004578; GO:003409; GO:005177; GO:000828; GO:001834	CAAX-protein geranylgeranyltransferase complex	GO:000595	"NA"	"NA"	drug binding;peptide binding;zinc ion binding;CAAX-protein geranylgeranyltransferase activity;isoprenoid binding	GO:000814; GO:004227; GO:000827; GO:000466; GO:001984
XP_013850500.1;XP_003123900.2;XP_013850499.1	XP_013850500.1;XP_003123900.2;XP_013850499.1	XP_013850500.1 aminopeptidase Q isoform X3 [Sus scrofa];XP_003123900.2 aminopeptidase Q isoform X1 [Sus scrofa];XP_013850499.1 aminopeptidase Q isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1177300	NA	NA	NA	LVRN	LVRN;LVRN;LVRN;NA;NA	proteolysis;peptide catabolic process	GO:000650; GO:004317	plasma membrane;integral component of membrane;cytoplasm	GO:000588; GO:001602; GO:000573	"NA"	"NA"	peptide binding;metalloaminopeptidase activity;zinc ion binding	GO:004227; GO:007000; GO:000827
XP_003123930.2	XP_003123930.2	XP_003123930.2 lamin-B1 [Sus scrofa]	14	12	12	55530000	103300000	81923000	53776000	84850000	92263000	85342000	0	77665000	52273000	78927000	59201000	180910000	49753000	100340000	0	141190000	77363000	NA	NA	NA	LMNB1	LMNB1;NA;NA;NA;NA	interleukin-12-mediated signaling pathway	GO:003572	lamin filament;nucleoplasm;membrane;nuclear matrix;nuclear inner membrane;nuclear membrane	GO:000563; GO:000565; GO:001602; GO:001636; GO:000563; GO:003196	"NA"	"NA"	structural molecule activity;phospholipase binding;protein binding;sequence-specific double-stranded DNA binding	GO:000519; GO:004327; GO:000551; GO:199083
XP_003123949.1	XP_003123949.1	XP_003123949.1 isochorismatase domain-containing protein 1 [Sus scrofa]	10	10	10	138430000	108840000	148470000	125030000	150500000	82273000	135800000	135460000	142560000	115130000	145540000	130280000	84175000	115670000	126820000	123230000	96548000	101680000	NA	NA	NA	ISOC1	ISOC1;NA;NA;NA;NA	biological_process	GO:000815	cytoplasm;peroxisome	GO:000573; GO:000577	"NA"	"NA"	protein binding;molecular_function;catalytic activity	GO:000551; GO:000367; GO:000382
XP_003124018.1	XP_003124018.1	XP_003124018.1 heterogeneous nuclear ribonucleoprotein A0 [Sus scrofa]	3	3	3	0	26253000	0	0	0	0	0	0	0	0	23932000	0	30649000	0	0	0	25954000	0	NA	NA	NA	HNRNPA0	HNRNPA0;NA;NA;NA;NA	mRNA splicing, via spliceosome;inflammatory response;3'-UTR-mediated mRNA stabilization;mRNA processing;RNA metabolic process;response to lipopolysaccharide	GO:000039; GO:000695; GO:007093; GO:000639; GO:001607; GO:003249	nucleoplasm;nucleus;ribonucleoprotein complex	GO:000565; GO:000563; GO:199090	"NA"	"NA"	AU-rich element binding;mRNA binding;protein kinase binding	GO:001709; GO:000372; GO:001990
XP_003124023.1;XP_005661751.1	XP_003124023.1;XP_005661751.1	XP_003124023.1 eukaryotic peptide chain release factor subunit 1 isoform X1 [Sus scrofa];XP_005661751.1 eukaryotic peptide chain release factor subunit 1 isoform X2 [Sus scrofa]	6	6	6	0	0	16532000	0	0	0	0	0	19202000	0	0	0	0	0	0	18977000	0	0	NA	NA	NA	ETF1	ETF1;ETF1;NA;NA;NA	regulation of translational termination;protein methylation;cytoplasmic translational termination;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000644; GO:000647; GO:000218; GO:000018	nucleus;cytosol;translation release factor complex;cytoplasm	GO:000563; GO:000582; GO:001844; GO:000573	 mRNA surveillance pathway	hsa0301	ribosome binding;translation release factor activity, codon specific;RNA binding;translation release factor activity;protein binding;translation termination factor activity;sequence-specific mRNA binding	GO:004302; GO:001614; GO:000372; GO:000374; GO:000551; GO:000807; GO:199082
XP_003124036.3;XP_020943863.1;XP_020943864.1	XP_003124036.3	XP_003124036.3 catenin alpha-1 [Sus scrofa]	20	20	15	71549000	98934000	104100000	115550000	100850000	144800000	102270000	133870000	94405000	118460000	123260000	186740000	115870000	152990000	109350000	136980000	94024000	118870000	NA	NA	NA	CTNNA1	CTNNA1;NA;NA;NA;NA	ovarian follicle development;negative regulation of cell motility;establishment or maintenance of cell polarity;epithelial cell-cell adhesion;negative regulation of integrin-mediated signaling pathway;response to estrogen;cellular response to indole-3-methanol;cell adhesion;aging;gap junction assembly;apical junction assembly;positive regulation of muscle cell differentiation;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;axon regeneration;cellular protein localization;odontogenesis of dentin-containing tooth;positive regulation of smoothened signaling pathway;protein heterooligomerization;male gonad development;adherens junction organization;actin filament organization;negative regulation of neuroblast proliferation	GO:000154; GO:200014; GO:000716; GO:009013; GO:200104; GO:004362; GO:007168; GO:000715; GO:000756; GO:001626; GO:004329; GO:005114; GO:200124; GO:003110; GO:003461; GO:004247; GO:004588; GO:005129; GO:000858; GO:003433; GO:000701; GO:000740	cell-cell junction;catenin complex;Golgi apparatus;flotillin complex;intracellular membrane-bounded organelle;zonula adherens;intercalated disc;acrosomal vesicle;cytosol;lamellipodium;plasma membrane;focal adhesion;actin cytoskeleton;cell junction	GO:000591; GO:001634; GO:000579; GO:001660; GO:004323; GO:000591; GO:001470; GO:000166; GO:000582; GO:003002; GO:000588; GO:000592; GO:001562; GO:003005	 Hippo signaling pathway; Adherens junction; Leukocyte transendothelial migration; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Tight junction; Pathways in cancer; Endometrial cancer; Bacterial invasion of epithelial cells	hsa0439; hsa0452; hsa0467; hsa0541; hsa0453; hsa0520; hsa0521; hsa0510	identical protein binding;RNA binding;gamma-catenin binding;protein heterodimerization activity;protein binding;structural molecule activity;beta-catenin binding;actin filament binding;vinculin binding	GO:004280; GO:000372; GO:004529; GO:004698; GO:000551; GO:000519; GO:000801; GO:005101; GO:001716
XP_003124081.1;XP_020940550.1	XP_003124081.1;XP_020940550.1	XP_003124081.1 histidine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_020940550.1 histidine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa]	16	16	12	53200000	55790000	56646000	45820000	48457000	37898000	55458000	43797000	60798000	43994000	54343000	52669000	61055000	55818000	52268000	55622000	53622000	48185000	NA	NA	NA	HARS	HARS;HARS;NA;NA;NA	tRNA aminoacylation for protein translation;translation;histidyl-tRNA aminoacylation;mitochondrial translation	GO:000641; GO:000641; GO:000642; GO:003254	mitochondrion;cytoplasm;cytosol	GO:000573; GO:000573; GO:000582	 Aminoacyl-tRNA biosynthesis	hsa0097	histidine-tRNA ligase activity;identical protein binding;ATP binding	GO:000482; GO:004280; GO:000552
XP_003124094.3;XP_013843252.2	XP_003124094.3;XP_013843252.2	XP_003124094.3 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [Sus scrofa];XP_013843252.2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2-like [Sus scrofa]	3	3	3	43227000	29260000	35007000	0	38929000	0	34103000	30334000	30602000	21232000	40642000	22843000	0	0	38651000	26333000	0	26437000	NA	NA	NA	NDUFA2	NDUFA2;LOC106507363;NA;NA;NA	mitochondrial respiratory chain complex I assembly;blastocyst hatching;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:000183; GO:000612	mitochondrial inner membrane;mitochondrial respiratory chain complex I;mitochondrial membrane	GO:000574; GO:000574; GO:003196	 Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Metabolic pathways; Oxidative phosphorylation	hsa0493; hsa0501; hsa0110; hsa0019	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_003124114.4;XP_013852013.1;XP_020944687.1;XP_001925286.2	XP_003124114.4	XP_003124114.4 LOW QUALITY PROTEIN: dihydropyrimidinase-related protein 3 [Sus scrofa]	18	17	16	34237000	206120000	124200000	61793000	63376000	186010000	118450000	77108000	102710000	340790000	128120000	152840000	756420000	92549000	120730000	102950000	203660000	331730000	NA	NA	NA	DPYSL3	DPYSL3;NA;NA;NA;NA	actin filament bundle assembly;positive regulation of filopodium assembly;cellular response to cytokine stimulus;neuron development;negative regulation of cell migration;response to axon injury;negative regulation of neuron projection development;protein homooligomerization;actin crosslink formation	GO:005101; GO:005149; GO:007134; GO:004866; GO:003033; GO:004867; GO:001097; GO:005126; GO:005176	extracellular space;cell body;cytosol;filamentous actin;exocytic vesicle;growth cone;synapse;lamellipodium	GO:000561; GO:004429; GO:000582; GO:003194; GO:007038; GO:003042; GO:004520; GO:003002	"NA"	"NA"	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;filamin binding;protein binding;SH3 domain binding;chondroitin sulfate binding	GO:001681; GO:003100; GO:000551; GO:001712; GO:003537
XP_020940674.1;XP_013850786.2;XP_003124148.5	XP_020940674.1;XP_013850786.2;XP_003124148.5	XP_020940674.1 macrophage colony-stimulating factor 1 receptor isoform X2 [Sus scrofa];XP_013850786.2 macrophage colony-stimulating factor 1 receptor isoform X3 [Sus scrofa];XP_003124148.5 macrophage colony-stimulating factor 1 receptor isoform X1 [Sus scr	2	2	2	0	0	0	0	0	0	0	0	0	9692100	0	0	0	0	0	0	0	0	NA	NA	NA	CSF1R	CSF1R;CSF1R;CSF1R;NA;NA	axon guidance;forebrain neuron differentiation;monocyte differentiation;ruffle organization;macrophage colony-stimulating factor signaling pathway;positive regulation of MAPK cascade;cell-cell junction maintenance;positive regulation of protein tyrosine kinase activity;regulation of cell shape;hematopoietic progenitor cell differentiation;cytokine-mediated signaling pathway;positive regulation of cell migration;positive regulation of protein serine/threonine kinase activity;positive regulation of chemokine secretion;regulation of actin cytoskeleton reorganization;inflammatory response;innate immune response;protein autophosphorylation;positive regulation of cell motility;transmembrane receptor protein tyrosine kinase signaling pathway;positive regulation of cell proliferation;olfactory bulb development;cellular response to macrophage colony-stimulating factor stimulus;regulation of bone resorption;mammary gland duct morphogenesis;cellular response to cytokine stimulus;hemopoiesis;phosphatidylinositol-mediated signaling;positive regulation of ERK1 and ERK2 cascade;osteoclast differentiation;negative regulation of apoptotic process;positive regulation of protein phosphorylation;multicellular organism development;peptidyl-tyrosine phosphorylation;positive regulation of tyrosine phosphorylation of STAT protein;phosphatidylinositol metabolic process	GO:000741; GO:002187; GO:003022; GO:003152; GO:003814; GO:004341; GO:004521; GO:006109; GO:000836; GO:000224; GO:001922; GO:003033; GO:007190; GO:009019; GO:200024; GO:000695; GO:004508; GO:004677; GO:200014; GO:000716; GO:000828; GO:002177; GO:003600; GO:004512; GO:006060; GO:007134; GO:003009; GO:004801; GO:007037; GO:003031; GO:004306; GO:000193; GO:000727; GO:001810; GO:004253; GO:004648	cell surface;CSF1-CSF1R complex;nucleoplasm;plasma membrane;receptor complex	GO:000998; GO:199068; GO:000565; GO:000588; GO:004323	 Transcriptional misregulation in cancer; PI3K-Akt signaling pathway; Pathways in cancer; Osteoclast differentiation; Hematopoietic cell lineage; Endocytosis; Rap1 signaling pathway; Cytokine-cytokine receptor interaction	hsa0520; hsa0415; hsa0520; hsa0438; hsa0464; hsa0414; hsa0401; hsa0406	ATP binding;protein homodimerization activity;transmembrane receptor protein tyrosine kinase activity;macrophage colony-stimulating factor receptor activity;protein phosphatase binding;cytokine binding;protein binding	GO:000552; GO:004280; GO:000471; GO:000501; GO:001990; GO:001995; GO:000551
XP_003124275.1	XP_003124275.1	XP_003124275.1 26S proteasome non-ATPase regulatory subunit 13 [Sus scrofa]	9	9	9	25253000	31839000	37098000	26908000	29381000	0	27400000	30092000	28343000	37877000	27234000	22564000	30363000	28600000	32647000	30536000	33435000	33777000	NA	NA	NA	PSMD13	PSMD13;NA;NA;NA;NA	neutrophil degranulation;meiosis I;ubiquitin-dependent protein catabolic process;post-translational protein modification;proteasome assembly;protein deubiquitination	GO:004331; GO:000712; GO:000651; GO:004368; GO:004324; GO:001657	nucleus;proteasome regulatory particle, lid subcomplex;secretory granule lumen;cytosol;proteasome regulatory particle;proteasome complex;membrane;extracellular region;nucleoplasm;proteasome accessory complex;ficolin-1-rich granule lumen	GO:000563; GO:000854; GO:003477; GO:000582; GO:000583; GO:000050; GO:001602; GO:000557; GO:000565; GO:002262; GO:190481	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	structural molecule activity	GO:000519
XP_020941706.1;XP_003124328.1	XP_020941706.1;XP_003124328.1	XP_020941706.1 actin, cytoplasmic 1 [Sus scrofa];XP_003124328.1 actin, cytoplasmic 1 [Sus scrofa]	26	13	1	7878300000	14168000000	11942000000	12732000000	8842200000	18849000000	10511000000	15100000000	10720000000	14427000000	10158000000	14784000000	18837000000	13235000000	11047000000	12081000000	12378000000	16219000000	NA	NA	NA	ACTB	ACTB;ACTB;NA;NA;NA	protein deubiquitination;Fc-gamma receptor signaling pathway involved in phagocytosis;cell motility;cellular response to cytochalasin B;ATP-dependent chromatin remodeling;membrane organization;postsynaptic actin cytoskeleton organization;retina homeostasis;ephrin receptor signaling pathway;regulation of transmembrane transporter activity;synaptic vesicle endocytosis;regulation of norepinephrine uptake;regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of gene expression, epigenetic;platelet aggregation;substantia nigra development;negative regulation of protein binding;cell junction assembly;regulation of protein localization to plasma membrane	GO:001657; GO:003809; GO:004887; GO:007274; GO:004304; GO:006102; GO:009897; GO:000189; GO:004801; GO:002289; GO:004848; GO:005162; GO:000007; GO:004581; GO:007052; GO:002176; GO:003209; GO:003432; GO:190307	extracellular space;membrane;cortical cytoskeleton;vesicle;Schaffer collateral - CA1 synapse;nuclear chromatin;nucleoplasm;cytoskeleton;calyx of Held;extracellular exosome;focal adhesion;actin cytoskeleton;NuA4 histone acetyltransferase complex;postsynaptic actin cytoskeleton;glutamatergic synapse;nucleus;cytoplasm;cytosol;macromolecular complex;dense body;presynapse;plasma membrane;cytoplasmic ribonucleoprotein granule;blood microparticle;ribonucleoprotein complex	GO:000561; GO:001602; GO:003086; GO:003198; GO:009868; GO:000079; GO:000565; GO:000585; GO:004430; GO:007006; GO:000592; GO:001562; GO:003526; GO:009887; GO:009897; GO:000563; GO:000573; GO:000582; GO:003299; GO:009743; GO:009879; GO:000588; GO:003646; GO:007256; GO:199090	 Thyroid hormone signaling pathway; Influenza A; Hypertrophic cardiomyopathy (HCM); Regulation of actin cytoskeleton; Oxytocin signaling pathway; Vibrio cholerae infection; Hippo signaling pathway; Adherens junction; Leukocyte transendothelial migration; Pathogenic Escherichia coli infection; Rap1 signaling pathway; Focal adhesion; Proteoglycans in cancer; Bacterial invasion of epithelial cells; Gastric acid secretion; Phagosome; Tight junction; Platelet activation	hsa0491; hsa0516; hsa0541; hsa0481; hsa0492; hsa0511; hsa0439; hsa0452; hsa0467; hsa0513; hsa0401; hsa0451; hsa0520; hsa0510; hsa0497; hsa0414; hsa0453; hsa0461	nucleosomal DNA binding;identical protein binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;structural constituent of cytoskeleton;kinesin binding;tau protein binding;structural constituent of postsynaptic actin cytoskeleton;Tat protein binding;protein binding;ATP binding;RNA polymerase II distal enhancer sequence-specific DNA binding;protein kinase binding;nitric-oxide synthase binding	GO:003149; GO:004280; GO:000097; GO:000520; GO:001989; GO:004815; GO:009897; GO:003095; GO:000551; GO:000552; GO:000098; GO:001990; GO:005099
XP_003124493.1	XP_003124493.1	XP_003124493.1 vitamin K epoxide reductase complex subunit 1-like protein 1 [Sus scrofa]	4	4	4	57142000	59923000	53796000	39854000	40578000	43639000	34782000	51228000	36718000	37705000	44061000	0	30277000	52990000	34474000	55658000	53069000	64025000	NA	NA	NA	VKORC1L1	VKORC1L1;NA;NA;NA;NA	vitamin K metabolic process;oxidation-reduction process;peptidyl-glutamic acid carboxylation;cellular response to oxidative stress	GO:004237; GO:005511; GO:001718; GO:003459	integral component of membrane;endoplasmic reticulum membrane	GO:001602; GO:000578	 Ubiquinone and other terpenoid-quinone biosynthesis	hsa0013	vitamin-K-epoxide reductase (warfarin-sensitive) activity;quinone binding	GO:004705; GO:004803
XP_003124496.1	XP_003124496.1	XP_003124496.1 coiled-coil-helix-coiled-coil-helix domain-containing protein 2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15520000	NA	NA	NA	CHCHD2	CHCHD2;NA;NA;NA;NA	positive regulation of transcription from RNA polymerase II promoter;mitochondrion organization;regulation of cellular response to hypoxia	GO:004594; GO:000700; GO:190003	mitochondrion;mitochondrial intermembrane space;nucleus	GO:000573; GO:000575; GO:000563	"NA"	"NA"	transcription factor binding;sequence-specific DNA binding;protein binding	GO:000813; GO:004356; GO:000551
XP_003124519.2	XP_003124519.2	XP_003124519.2 LOW QUALITY PROTEIN: 3-methyl-2-oxobutanoate dehydrogenase [lipoamide] kinase, mitochondrial [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	12434000	0	0	0	0	0	0	0	0	0	NA	NA	NA	BCKDK	BCKDK;NA;NA;NA;NA	phosphorylation;protein phosphorylation;branched-chain amino acid catabolic process;cellular amino acid catabolic process	GO:001631; GO:000646; GO:000908; GO:000906	mitochondrion;mitochondrial alpha-ketoglutarate dehydrogenase complex;mitochondrial matrix	GO:000573; GO:000594; GO:000575	"NA"	"NA"	protein serine/threonine kinase activity;ATP binding;kinase activity;protein binding;[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)	GO:000467; GO:000552; GO:001630; GO:000551; GO:004732
XP_020942062.1;XP_003124521.1	XP_020942062.1;XP_003124521.1	XP_020942062.1 vitamin K epoxide reductase complex subunit 1 isoform X2 [Sus scrofa];XP_003124521.1 vitamin K epoxide reductase complex subunit 1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61572000	NA	NA	NA	VKORC1	VKORC1;VKORC1;NA;NA;NA	vitamin K metabolic process;blood coagulation;oxidation-reduction process;peptidyl-glutamic acid carboxylation;bone development;drug metabolic process	GO:004237; GO:000759; GO:005511; GO:001718; GO:006034; GO:001714	endoplasmic reticulum membrane;endoplasmic reticulum;integral component of membrane	GO:000578; GO:000578; GO:001602	 Ubiquinone and other terpenoid-quinone biosynthesis	hsa0013	vitamin-K-epoxide reductase (warfarin-sensitive) activity;quinone binding	GO:004705; GO:004803
XP_003124542.3	XP_003124542.3	XP_003124542.3 tripartite motif-containing protein 72 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5706700	0	NA	NA	NA	TRIM72	TRIM72;NA;NA;NA;NA	negative regulation of insulin-like growth factor receptor signaling pathway;proteasome-mediated ubiquitin-dependent protein catabolic process;muscle system process;protein ubiquitination;muscle organ development;muscle contraction;exocytosis;protein homooligomerization;negative regulation of insulin receptor signaling pathway;plasma membrane repair;negative regulation of myotube differentiation	GO:004356; GO:004316; GO:000301; GO:001656; GO:000751; GO:000693; GO:000688; GO:005126; GO:004662; GO:000177; GO:001083	cytoplasmic vesicle membrane;sarcolemma	GO:003065; GO:004238	"NA"	"NA"	zinc ion binding;phosphatidylserine binding;protein binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity	GO:000827; GO:000178; GO:000551; GO:003162; GO:006163
XP_003124563.3	XP_003124563.3	XP_003124563.3 elongation factor Tu, mitochondrial [Sus scrofa]	16	16	16	201990000	158440000	207690000	140450000	234960000	128680000	192730000	163700000	232760000	146920000	172300000	193100000	167780000	169290000	180230000	183330000	165080000	130470000	NA	NA	NA	TUFM	TUFM;NA;NA;NA;NA	response to ethanol;translational elongation;mitochondrial translational elongation	GO:004547; GO:000641; GO:007012	synapse;membrane;mitochondrial nucleoid;extracellular exosome;mitochondrion	GO:004520; GO:001602; GO:004264; GO:007006; GO:000573	"NA"	"NA"	GTPase activity;GTP binding;protein binding;RNA binding;translation elongation factor activity	GO:000392; GO:000552; GO:000551; GO:000372; GO:000374
XP_020943713.1;XP_003124567.2;XP_020943711.1;XP_020943710.1;XP_020943709.1;XP_020943708.1	XP_020943713.1;XP_003124567.2;XP_020943711.1;XP_020943710.1;XP_020943709.1;XP_020943708.1	XP_020943713.1 rab GTPase-binding effector protein 2 isoform X6 [Sus scrofa];XP_003124567.2 rab GTPase-binding effector protein 2 isoform X5 [Sus scrofa];XP_020943711.1 rab GTPase-binding effector protein 2 isoform X4 [Sus scrofa];XP_020943710.1 rab GTPase	3	3	3	0	0	0	0	0	0	91015000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RABEP2	RABEP2;RABEP2;RABEP2;RABEP2;RABEP2	regulation of receptor activity;endocytosis;positive regulation of GTPase activity;protein transport	GO:001046; GO:000689; GO:004354; GO:001503	early endosome;cytosol;intracellular membrane-bounded organelle	GO:000576; GO:000582; GO:004323	"NA"	"NA"	GTPase activator activity;growth factor activity	GO:000509; GO:000808
XP_003124603.3	XP_003124603.3	XP_003124603.3 cytochrome b-c1 complex subunit 2, mitochondrial [Sus scrofa]	8	8	8	289290000	161140000	263690000	151080000	230870000	151890000	298790000	213930000	310250000	200850000	204940000	150950000	124420000	152750000	182740000	199930000	189150000	138800000	NA	NA	NA	LOC100524613	LOC100524613;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003124605.2;XP_020942160.1	XP_003124605.2;XP_020942160.1	XP_003124605.2 ketimine reductase mu-crystallin isoform X1 [Sus scrofa];XP_020942160.1 ketimine reductase mu-crystallin isoform X2 [Sus scrofa]	5	5	5	10370000	32066000	12150000	72051000	0	14707000	0	95863000	9110700	72716000	10002000	48849000	7326500	8548600	0	31114000	0	11248000	NA	NA	NA	CRYM	CRYM;CRYM;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;lysine catabolic process;sensory perception of sound;thyroid hormone metabolic process;oxidation-reduction process;thyroid hormone transport	GO:000012; GO:000655; GO:000760; GO:004240; GO:005511; GO:007032	extracellular exosome;cytosol;nucleus;cytoplasm;peroxisomal matrix	GO:007006; GO:000582; GO:000563; GO:000573; GO:000578	"NA"	"NA"	NADP binding;thyroid hormone binding;protein binding;oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor;hormone binding;thiomorpholine-carboxylate dehydrogenase activity;transcription corepressor activity;protein homodimerization activity	GO:005066; GO:007032; GO:000551; GO:001663; GO:004256; GO:004712; GO:000371; GO:004280
XP_013851113.2;XP_005662204.1;XP_003124656.3	XP_013851113.2;XP_005662204.1;XP_003124656.3	XP_013851113.2 calcium-regulated heat-stable protein 1 [Sus scrofa];XP_005662204.1 calcium-regulated heat-stable protein 1 [Sus scrofa];XP_003124656.3 calcium-regulated heat-stable protein 1 [Sus scrofa]	3	3	3	121950000	112360000	112100000	125230000	114320000	87754000	131150000	108290000	104080000	99704000	138990000	125450000	99525000	123010000	130780000	142000000	107990000	94851000	NA	NA	NA	CARHSP1	CARHSP1;CARHSP1;CARHSP1;NA;NA	intracellular signal transduction;regulation of transcription from RNA polymerase II promoter;regulation of mRNA stability	GO:003555; GO:000635; GO:004348	P granule;cytosol;cytoplasm;P-body;cytoplasmic exosome (RNase complex)	GO:004318; GO:000582; GO:000573; GO:000093; GO:000017	"NA"	"NA"	phosphatase binding;mRNA 3'-UTR binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;protein binding	GO:001990; GO:000373; GO:000098; GO:000551
XP_013851124.1;XP_003124688.4	XP_013851124.1;XP_003124688.4	XP_013851124.1 periplakin isoform X2 [Sus scrofa];XP_003124688.4 periplakin isoform X1 [Sus scrofa]	21	21	21	0	25924000	0	35535000	29016000	36698000	23372000	21764000	0	22407000	25161000	36582000	11479000	34541000	30412000	29194000	39653000	64895000	NA	NA	NA	PPL	PPL;PPL;NA;NA;NA	intermediate filament cytoskeleton organization;cornification;wound healing;response to mechanical stimulus	GO:004510; GO:007026; GO:004206; GO:000961	intermediate filament;nucleus;cytoskeleton;cornified envelope;mitochondrion;desmosome;extracellular exosome;membrane;cytosol	GO:000588; GO:000563; GO:000585; GO:000153; GO:000573; GO:003005; GO:007006; GO:001602; GO:000582	"NA"	"NA"	structural constituent of cytoskeleton;protein binding;structural molecule activity;cadherin binding	GO:000520; GO:000551; GO:000519; GO:004529
XP_003124743.2	XP_003124743.2	XP_003124743.2 mesothelin [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	23209000	0	0	0	37321000	0	NA	NA	NA	LOC100524016	LOC100524016;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003124756.2	XP_003124756.2	XP_003124756.2 E3 ubiquitin-protein ligase CHIP [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3043400	0	NA	NA	NA	STUB1	STUB1;NA;NA;NA;NA	endoplasmic reticulum unfolded protein response;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;cellular response to misfolded protein;protein polyubiquitination;ERBB2 signaling pathway;protein maturation;regulation of protein stability;cellular response to heat;positive regulation of ubiquitin-protein transferase activity;misfolded or incompletely synthesized protein catabolic process;positive regulation of protein ubiquitination;ubiquitin-dependent SMAD protein catabolic process;protein autoubiquitination;regulation of glucocorticoid metabolic process;positive regulation of chaperone-mediated protein complex assembly;protein ubiquitination;negative regulation of transforming growth factor beta receptor signaling pathway;protein K63-linked ubiquitination;cellular response to hypoxia;response to ischemia;DNA repair;ubiquitin-dependent ERAD pathway;negative regulation of protein binding;chaperone-mediated autophagy	GO:003096; GO:003243; GO:004316; GO:007121; GO:000020; GO:003812; GO:005160; GO:003164; GO:003460; GO:005144; GO:000651; GO:003139; GO:003057; GO:005186; GO:003194; GO:009003; GO:001656; GO:003051; GO:007053; GO:007145; GO:000293; GO:000628; GO:003043; GO:003209; GO:006168	ubiquitin ligase complex;endoplasmic reticulum;nucleus;chaperone complex;ubiquitin conjugating enzyme complex;nuclear inclusion body;cytosol;cytoplasm;Z disc;nucleoplasm	GO:000015; GO:000578; GO:000563; GO:010103; GO:003137; GO:004240; GO:000582; GO:000573; GO:003001; GO:000565	 Ubiquitin mediated proteolysis; Protein processing in endoplasmic reticulum	hsa0412; hsa0414	chaperone binding;protein binding, bridging;ubiquitin protein ligase binding;ubiquitin-ubiquitin ligase activity;tau protein binding;G-protein coupled receptor binding;enzyme binding;SMAD binding;protein binding;ubiquitin-protein transferase activity;Hsp90 protein binding;heat shock protein binding;protein homodimerization activity;ubiquitin protein ligase activity;misfolded protein binding;kinase binding;Hsp70 protein binding;TPR domain binding	GO:005108; GO:003067; GO:003162; GO:003445; GO:004815; GO:000166; GO:001989; GO:004633; GO:000551; GO:000484; GO:005187; GO:003107; GO:004280; GO:006163; GO:005178; GO:001990; GO:003054; GO:003091
XP_003124794.2	XP_003124794.2	XP_003124794.2 elongin-B [Sus scrofa]	8	8	8	83045000	107620000	95314000	80436000	78749000	80922000	93997000	83749000	91164000	86537000	93186000	65610000	87520000	80552000	114540000	90642000	92426000	89446000	NA	NA	NA	ELOB	ELOB;NA;NA;NA;NA	regulation of transcription from RNA polymerase II promoter in response to hypoxia;protein ubiquitination;post-translational protein modification;transcription elongation from RNA polymerase II promoter;macromolecular complex assembly	GO:006141; GO:001656; GO:004368; GO:000636; GO:006500	Cul5-RING ubiquitin ligase complex;elongin complex;cytosol;VCB complex;Cul2-RING ubiquitin ligase complex;nucleoplasm	GO:003146; GO:007044; GO:000582; GO:003089; GO:003146; GO:000565	 Ubiquitin mediated proteolysis; HIF-1 signaling pathway; Renal cell carcinoma; Pathways in cancer	hsa0412; hsa0406; hsa0521; hsa0520	protein binding;ubiquitin protein ligase binding	GO:000551; GO:003162
XP_003124992.1	XP_003124992.1	XP_003124992.1 all-trans-retinol 13,14-reductase [Sus scrofa]	17	17	17	333000000	260440000	270470000	340750000	535260000	281600000	289030000	238190000	340480000	336620000	215480000	204990000	62524000	232270000	608400000	615140000	236260000	242490000	NA	NA	NA	RETSAT	RETSAT;NA;NA;NA;NA	oxidation-reduction process;retinol metabolic process	GO:005511; GO:004257	endoplasmic reticulum membrane;nuclear outer membrane;membrane;nuclear membrane	GO:000578; GO:000564; GO:001602; GO:003196	 Retinol metabolism	hsa0083	oxidoreductase activity;all-trans-retinol 13,14-reductase activity	GO:001649; GO:005178
XP_020942956.1;XP_013843340.1;XP_013843339.1;XP_003124998.1;XP_003124997.1;XP_003124996.1;XP_003124995.1	XP_020942956.1;XP_013843340.1;XP_013843339.1;XP_003124998.1;XP_003124997.1;XP_003124996.1;XP_003124995.1	XP_020942956.1 macrophage-capping protein [Sus scrofa];XP_013843340.1 macrophage-capping protein [Sus scrofa];XP_013843339.1 macrophage-capping protein [Sus scrofa];XP_003124998.1 macrophage-capping protein [Sus scrofa];XP_003124997.1 macrophage-capping pr	6	6	6	0	77851000	70188000	122330000	63650000	106810000	44587000	86389000	45277000	87465000	51435000	90439000	113080000	84182000	87315000	86516000	59518000	92455000	NA	NA	NA	CAPG	CAPG;CAPG;CAPG;CAPG;CAPG	macromolecular complex assembly;barbed-end actin filament capping;extracellular matrix disassembly;positive regulation of podosome assembly	GO:006500; GO:005101; GO:002261; GO:007180	nucleus;nucleolus;F-actin capping protein complex;centriole;melanosome;extracellular exosome;nucleoplasm;mitotic spindle;Flemming body	GO:000563; GO:000573; GO:000829; GO:000581; GO:004247; GO:007006; GO:000565; GO:007268; GO:009054	"NA"	"NA"	protein binding;cadherin binding;protein domain specific binding;actin filament binding;macromolecular complex binding	GO:000551; GO:004529; GO:001990; GO:005101; GO:004487
XP_003125060.1	XP_003125060.1	XP_003125060.1 SET and MYND domain-containing protein 5 [Sus scrofa]	4	4	4	0	0	15182000	11646000	0	9150500	0	10231000	11577000	0	11887000	0	0	10911000	10454000	0	10440000	9432900	NA	NA	NA	SMYD5	SMYD5;NA;NA;NA;NA	biological_process;methylation	GO:000815; GO:003225	cellular_component	GO:000557	"NA"	"NA"	molecular_function;metal ion binding;methyltransferase activity	GO:000367; GO:004687; GO:000816
XP_003125080.1	XP_003125080.1	XP_003125080.1 sepiapterin reductase [Sus scrofa]	15	15	15	475630000	438290000	478280000	501890000	590330000	393900000	513410000	574050000	461910000	520330000	493850000	598470000	415180000	488130000	527290000	513130000	418700000	449160000	NA	NA	NA	SPR	SPR;NA;NA;NA;NA	regulation of nitric-oxide synthase activity;tetrahydrobiopterin biosynthetic process;nitric oxide biosynthetic process;cofactor metabolic process;oxidation-reduction process	GO:005099; GO:000672; GO:000680; GO:005118; GO:005511	cytosol;nucleoplasm;extracellular exosome	GO:000582; GO:000565; GO:007006	 Metabolic pathways; Folate biosynthesis	hsa0110; hsa0079	aldo-keto reductase (NADP) activity;sepiapterin reductase activity;NADP binding	GO:000403; GO:000475; GO:005066
XP_003125091.3;XP_020943049.1;XP_005662537.1;XP_005662536.1	XP_003125091.3;XP_020943049.1;XP_005662537.1;XP_005662536.1	XP_003125091.3 N-acetyl-D-glucosamine kinase isoform X1 [Sus scrofa];XP_020943049.1 N-acetyl-D-glucosamine kinase isoform X2 [Sus scrofa];XP_005662537.1 N-acetyl-D-glucosamine kinase isoform X2 [Sus scrofa];XP_005662536.1 N-acetyl-D-glucosamine kinase isof	9	9	9	40652000	69158000	49922000	55950000	36398000	45977000	49236000	62230000	41049000	60389000	58362000	78986000	51886000	56944000	55778000	53053000	59419000	56779000	NA	NA	NA	NAGK	NAGK;NAGK;NAGK;NAGK;NA	N-acetylglucosamine metabolic process;N-acetylneuraminate catabolic process;UDP-N-acetylglucosamine biosynthetic process;N-acetylmannosamine metabolic process;carbohydrate phosphorylation	GO:000604; GO:001926; GO:000604; GO:000605; GO:004683	extracellular exosome;cytosol	GO:007006; GO:000582	 Amino sugar and nucleotide sugar metabolism	hsa0052	ATP binding;protein binding;N-acetylglucosamine kinase activity	GO:000552; GO:000551; GO:004512
XP_003125105.1	XP_003125105.1	XP_003125105.1 poly(rC)-binding protein 1 [Sus scrofa]	11	11	8	235680000	294480000	248430000	302370000	231350000	260820000	261110000	260880000	252670000	271570000	216470000	347980000	330990000	254050000	235880000	286890000	261280000	298670000	NA	NA	NA	PCBP1	PCBP1;NA;NA;NA;NA	viral RNA genome replication;RNA metabolic process;mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter	GO:003969; GO:001607; GO:000039; GO:004594	extracellular exosome;cytoplasm;cytoplasmic ribonucleoprotein granule;nucleoplasm;membrane;cytosol;nuclear speck	GO:007006; GO:000573; GO:003646; GO:000565; GO:001602; GO:000582; GO:001660	 Spliceosome	hsa0304	single-stranded DNA binding;cadherin binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;mRNA binding;sequence-specific single stranded DNA binding;protein binding	GO:000369; GO:004529; GO:000098; GO:000372; GO:009884; GO:000551
XP_003125148.1	XP_003125148.1	XP_003125148.1 T-complex protein 1 subunit delta [Sus scrofa]	14	14	14	129430000	89547000	156410000	114660000	133610000	93224000	118070000	93182000	160790000	140940000	105480000	106070000	123260000	120940000	86847000	139240000	129560000	111110000	NA	NA	NA	CCT4	CCT4;NA;NA;NA;NA	toxin transport;scaRNA localization to Cajal body;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;protein folding;binding of sperm to zona pellucida;protein stabilization;positive regulation of telomerase activity;positive regulation of telomere maintenance via telomerase	GO:190199; GO:009066; GO:190485; GO:190487; GO:000645; GO:000733; GO:005082; GO:005197; GO:003221	cytosol;nucleoplasm;centrosome;chaperonin-containing T-complex;extracellular exosome;cell body;zona pellucida receptor complex;microtubule;melanosome;cell projection	GO:000582; GO:000565; GO:000581; GO:000583; GO:007006; GO:004429; GO:000219; GO:000587; GO:004247; GO:004299	"NA"	"NA"	protein binding;unfolded protein binding;ATP binding;RNA binding	GO:000551; GO:005108; GO:000552; GO:000372
XP_003125182.3	XP_003125182.3	XP_003125182.3 prolyl-tRNA synthetase associated domain-containing protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10432000	0	0	NA	NA	NA	LOC100514282	LOC100514282;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003125184.3;XP_013846730.1;XP_013846724.1;XP_005652973.1;NP_999376.1;XP_005654051.1;NP_001098779.1;XP_020929677.1;XP_020929676.1;XP_003483459.2	XP_003125184.3;XP_013846730.1;XP_013846724.1;XP_005652973.1;NP_999376.1;XP_005654051.1;NP_001098779.1;XP_020929677.1;XP_020929676.1;XP_003483459.2	XP_003125184.3 ubiquitin-40S ribosomal protein S27a [Sus scrofa];XP_013846730.1 ubiquitin-60S ribosomal protein L40 isoform X1 [Sus scrofa];XP_013846724.1 ubiquitin-60S ribosomal protein L40 isoform X1 [Sus scrofa];XP_005652973.1 ubiquitin-60S ribosomal pr	6	6	6	552460000	384760000	414680000	584130000	513390000	314800000	415810000	536840000	399970000	392830000	571580000	220810000	389890000	522150000	650300000	500330000	446470000	332650000	NA	NA	NA	UBA52	UBA52;UBA52;UBB;UBC;UBC	cellular protein modification process;JNK cascade;negative regulation of apoptotic process;cytokine-mediated signaling pathway;translesion synthesis;anaphase-promoting complex-dependent catabolic process;interstrand cross-link repair;negative regulation of transcription from RNA polymerase II promoter;protein ubiquitination;protein targeting to peroxisome;transcription-coupled nucleotide-excision repair;transforming growth factor beta receptor signaling pathway;protein deubiquitination;negative regulation of transforming growth factor beta receptor signaling pathway;error-free translesion synthesis;positive regulation of transcription from RNA polymerase II promoter;positive regulation of NF-kappaB transcription factor activity;global genome nucleotide-excision repair;interleukin-1-mediated signaling pathway;activation of MAPK activity;MyD88-dependent toll-like receptor signaling pathway;endosomal transport;error-prone translesion synthesis;membrane organization;translational initiation;I-kappaB kinase/NF-kappaB signaling;virion assembly;cellular protein metabolic process;modification-dependent protein catabolic process;nucleotide-excision repair, DNA gap filling;nucleotide-excision repair, DNA incision;regulation of mRNA stability;regulation of transcription from RNA polymerase II promoter in response to hypoxia;nucleotide-excision repair, DNA damage recognition;Wnt signaling pathway;stress-activated MAPK cascade;intracellular transport of virus;protein polyubiquitination;SRP-dependent cotranslational protein targeting to membrane;viral life cycle;TRIF-dependent toll-like receptor signaling pathway;DNA damage response, detection of DNA damage;transmembrane transport;nucleotide-binding oligomerization domain containing signaling pathway	GO:000646; GO:000725; GO:004306; GO:001922; GO:001998; GO:003114; GO:003629; GO:000012; GO:001656; GO:000662; GO:000628; GO:000717; GO:001657; GO:003051; GO:007098; GO:004594; GO:005109; GO:007091; GO:007049; GO:000018; GO:000275; GO:001619; GO:004227; GO:006102; GO:000641; GO:000724; GO:001906; GO:004426; GO:001994; GO:000629; GO:003368; GO:004348; GO:006141; GO:000071; GO:001605; GO:005140; GO:007573; GO:000020; GO:000661; GO:001905; GO:003566; GO:004276; GO:005508; GO:007042	cytoplasm;lysosomal membrane;endosome membrane;synapse;plasma membrane;nucleus;cytosol;extracellular space;nucleoplasm;cytosolic small ribosomal subunit;vesicle;host cell;mitochondrial outer membrane;endoplasmic reticulum membrane;endocytic vesicle membrane;extracellular exosome	GO:000573; GO:000576; GO:001000; GO:004520; GO:000588; GO:000563; GO:000582; GO:000561; GO:000565; GO:002262; GO:003198; GO:004365; GO:000574; GO:000578; GO:003066; GO:007006	 Ribosome	hsa0301	protein binding;protein tag;ubiquitin protein ligase binding;structural constituent of ribosome	GO:000551; GO:003138; GO:003162; GO:000373
XP_003125231.4	XP_003125231.4	XP_003125231.4 leucine-rich PPR motif-containing protein, mitochondrial [Sus scrofa]	12	12	12	17696000	0	20404000	0	39201000	0	21824000	7128200	21590000	9669900	0	0	6403800	6768000	10176000	13172000	12899000	0	NA	NA	NA	LRPPRC	LRPPRC;NA;NA;NA;NA	negative regulation of mitochondrial RNA catabolic process;mRNA transport;mitochondrion transport along microtubule;regulation of mitochondrial translation	GO:000096; GO:005102; GO:004749; GO:007012	nucleoplasm;condensed nuclear chromosome;microtubule;perinuclear region of cytoplasm;cytoskeleton;mitochondrial nucleoid;membrane;nuclear inner membrane;mitochondrion;nuclear outer membrane;ribonucleoprotein complex	GO:000565; GO:000079; GO:000587; GO:004847; GO:000585; GO:004264; GO:001602; GO:000563; GO:000573; GO:000564; GO:199090	"NA"	"NA"	beta-tubulin binding;protein binding;RNA binding;actin filament binding;single-stranded DNA binding;microtubule binding;ubiquitin protein ligase binding	GO:004848; GO:000551; GO:000372; GO:005101; GO:000369; GO:000801; GO:003162
XP_020943239.1;XP_003125251.2;XP_005662643.1;XP_020943238.1;XP_020943237.1	XP_020943239.1;XP_003125251.2;XP_005662643.1;XP_020943238.1;XP_020943237.1	XP_020943239.1 cytochrome c oxidase subunit 7A-related protein, mitochondrial isoform X5 [Sus scrofa];XP_003125251.2 cytochrome c oxidase subunit 7A-related protein, mitochondrial isoform X4 [Sus scrofa];XP_005662643.1 cytochrome c oxidase subunit 7A-relat	2	2	2	0	0	0	0	0	0	0	0	0	0	0	10273000	0	0	0	0	0	0	NA	NA	NA	LOC100516606	LOC100516606;LOC100516606;LOC100516606;LOC100516606;LOC100516606	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020943263.1;XP_005662658.1;XP_003125259.1;XP_020943262.1;XP_005662656.1;XP_003125258.1	XP_020943263.1;XP_005662658.1;XP_003125259.1;XP_020943262.1;XP_005662656.1;XP_003125258.1	XP_020943263.1 serine/arginine-rich splicing factor 7 isoform X6 [Sus scrofa];XP_005662658.1 serine/arginine-rich splicing factor 7 isoform X5 [Sus scrofa];XP_003125259.1 serine/arginine-rich splicing factor 7 isoform X4 [Sus scrofa];XP_020943262.1 serine/	5	5	4	20934000	38387000	31953000	32946000	27369000	42614000	31540000	38655000	27450000	33445000	36113000	0	41897000	0	33670000	37887000	38587000	41745000	NA	NA	NA	SRSF7	SRSF7;SRSF7;SRSF7;SRSF7;SRSF7	regulation of alternative mRNA splicing, via spliceosome;negative regulation of mRNA splicing, via spliceosome;RNA export from nucleus;RNA splicing;mRNA splicing, via spliceosome;mRNA processing;mRNA cis splicing, via spliceosome;mRNA 3'-end processing;cellular response to leukemia inhibitory factor	GO:000038; GO:004802; GO:000640; GO:000838; GO:000039; GO:000639; GO:004529; GO:003112; GO:199083	nucleoplasm;nucleus;cytoplasm;nuclear speck;extracellular exosome	GO:000565; GO:000563; GO:000573; GO:001660; GO:007006	 Spliceosome; Herpes simplex infection	hsa0304; hsa0516	protein binding;protein domain specific binding;zinc ion binding;RNA binding	GO:000551; GO:001990; GO:000827; GO:000372
XP_005662732.2;XP_003125351.2	XP_005662732.2;XP_003125351.2	XP_005662732.2 EMILIN-1 isoform X2 [Sus scrofa];XP_003125351.2 EMILIN-1 isoform X1 [Sus scrofa]	2	2	2	0	0	6915000	10673000	0	0	8649600	0	0	0	0	0	6523000	0	0	4300500	0	0	NA	NA	NA	EMILIN1	EMILIN1;EMILIN1;NA;NA;NA	positive regulation of gene expression;negative regulation of collagen biosynthetic process;negative regulation of cell activation;negative regulation of collagen fibril organization;negative regulation of macrophage migration;cell migration;negative regulation of angiogenesis;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of vascular endothelial growth factor receptor signaling pathway;aortic valve morphogenesis;negative regulation of gene expression;cell-matrix adhesion;negative regulation of pathway-restricted SMAD protein phosphorylation;cell adhesion;positive regulation of cell-substrate adhesion;elastic fiber assembly;protein homotrimerization;negative regulation of ERK1 and ERK2 cascade;positive regulation of extracellular matrix assembly	GO:001062; GO:003296; GO:005086; GO:190402; GO:190552; GO:001647; GO:001652; GO:003051; GO:003094; GO:000318; GO:001062; GO:000716; GO:006039; GO:000715; GO:001081; GO:004825; GO:007020; GO:007037; GO:190120	extracellular region;extracellular matrix;collagen trimer;extracellular exosome;EMILIN complex;extracellular space;integrin alpha4-beta1 complex	GO:000557; GO:003101; GO:000558; GO:007006; GO:199097; GO:000561; GO:003466	"NA"	"NA"	protein binding;identical protein binding;integrin binding involved in cell-matrix adhesion;extracellular matrix constituent conferring elasticity	GO:000551; GO:004280; GO:009864; GO:003002
XP_003125380.1	XP_003125380.1	XP_003125380.1 putative peptidyl-tRNA hydrolase PTRHD1 [Sus scrofa]	2	2	2	0	20572000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PTRHD1	PTRHD1;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	aminoacyl-tRNA hydrolase activity	GO:000404
XP_013851790.1;XP_005662795.1;XP_003125393.1	XP_013851790.1;XP_005662795.1;XP_003125393.1	XP_013851790.1 protein FAM49A [Sus scrofa];XP_005662795.1 protein FAM49A [Sus scrofa];XP_003125393.1 protein FAM49A [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6127300	0	0	0	NA	NA	NA	FAM49A	FAM49A;FAM49A;FAM49A;NA;NA	"NA"	"NA"	intracellular	GO:000562	"NA"	"NA"	"NA"	"NA"
XP_005662846.3;XP_005662844.1;XP_003125453.6;XP_020943611.1	XP_005662846.3;XP_005662844.1;XP_003125453.6;XP_020943611.1	XP_005662846.3 peroxidasin homolog isoform X3 [Sus scrofa];XP_005662844.1 peroxidasin homolog isoform X1 [Sus scrofa];XP_003125453.6 peroxidasin homolog isoform X2 [Sus scrofa];XP_020943611.1 peroxidasin homolog isoform X4 [Sus scrofa]	5	5	5	6370400	8906000	8878500	8119700	0	8713900	0	11423000	0	0	0	10639000	0	0	0	9233200	0	0	NA	NA	NA	PXDN	PXDN;PXDN;PXDN;PXDN;NA	immune response;response to oxidative stress;extracellular matrix organization;cellular oxidant detoxification;oxidation-reduction process;negative regulation of cytokine-mediated signaling pathway;hydrogen peroxide catabolic process	GO:000695; GO:000697; GO:003019; GO:009886; GO:005511; GO:000196; GO:004274	endoplasmic reticulum;extracellular exosome;extracellular space;extracellular region	GO:000578; GO:007006; GO:000561; GO:000557	"NA"	"NA"	extracellular matrix structural constituent;peroxidase activity;heme binding;interleukin-1 receptor antagonist activity;metal ion binding	GO:000520; GO:000460; GO:002003; GO:000515; GO:004687
XP_003125478.1	XP_003125478.1	XP_003125478.1 COMM domain-containing protein 5 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	10851000	0	11309000	0	0	NA	NA	NA	COMMD5	COMMD5;NA;NA;NA;NA	"NA"	"NA"	cytosol;nucleoplasm	GO:000582; GO:000565	"NA"	"NA"	protein binding	GO:000551
XP_020946138.1;XP_013851848.1;XP_013851846.1;XP_005662863.1;XP_005662865.1;XP_003125488.2;XP_020946136.1;XP_013853737.1;XP_003127043.1	XP_020946138.1;XP_013851848.1;XP_013851846.1;XP_005662863.1;XP_005662865.1;XP_003125488.2;XP_020946136.1	XP_020946138.1 alanine aminotransferase 1 isoform X4 [Sus scrofa];XP_013851848.1 alanine aminotransferase 1 isoform X4 [Sus scrofa];XP_013851846.1 alanine aminotransferase 1 isoform X4 [Sus scrofa];XP_005662863.1 alanine aminotransferase 1 isoform X4 [Sus	10	10	10	0	17832000	24938000	0	34886000	24237000	20176000	16971000	34313000	0	67240000	19297000	0	32956000	33367000	38548000	31245000	30377000	NA	NA	NA	GPT	GPT;GPT;GPT;GPT;GPT	cellular amino acid biosynthetic process;L-alanine catabolic process	GO:000865; GO:004285	cytosol;extracellular exosome	GO:000582; GO:007006	 Arginine biosynthesis; Carbon metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of amino acids; 2-Oxocarboxylic acid metabolism	hsa0022; hsa0120; hsa0025; hsa0110; hsa0123; hsa0121	pyridoxal phosphate binding;L-alanine:2-oxoglutarate aminotransferase activity	GO:003017; GO:000402
XP_003125491.1	XP_003125491.1	XP_003125491.1 cytochrome c1, heme protein, mitochondrial [Sus scrofa]	5	5	5	199440000	136070000	196170000	124120000	189290000	121680000	192910000	121200000	216440000	143740000	116140000	117510000	110530000	119290000	93568000	154590000	143600000	104610000	NA	NA	NA	LOC100525869	LOC100525869;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003125563.2;XP_005662949.1	XP_003125563.2;XP_005662949.1	XP_003125563.2 eukaryotic translation initiation factor 3 subunit H isoform X1 [Sus scrofa];XP_005662949.1 eukaryotic translation initiation factor 3 subunit H isoform X2 [Sus scrofa]	3	3	3	0	0	5013100	0	0	10147000	0	0	8432500	0	0	0	10352000	0	8966900	6910600	7560500	0	NA	NA	NA	EIF3H	EIF3H;EIF3H;NA;NA;NA	translational initiation;formation of cytoplasmic translation initiation complex;proteolysis;regulation of translational initiation	GO:000641; GO:000173; GO:000650; GO:000644	membrane;eukaryotic translation initiation factor 3 complex, eIF3m;eukaryotic 48S preinitiation complex;extracellular exosome;cytosol;eukaryotic translation initiation factor 3 complex;eukaryotic 43S preinitiation complex;polysomal ribosome	GO:001602; GO:007154; GO:003329; GO:007006; GO:000582; GO:000585; GO:001628; GO:004278	 RNA transport; Measles	hsa0301; hsa0516	RNA binding;translation initiation factor activity;metallopeptidase activity;protein binding	GO:000372; GO:000374; GO:000823; GO:000551
XP_003125622.1	XP_003125622.1	XP_003125622.1 LOW QUALITY PROTEIN: OTU domain-containing protein 6B [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OTUD6B	OTUD6B;NA;NA;NA;NA	cell proliferation;protein deubiquitination;proteasome assembly	GO:000828; GO:001657; GO:004324	eukaryotic translation initiation factor 4F complex	GO:001628	"NA"	"NA"	thiol-dependent ubiquitinyl hydrolase activity;thiol-dependent ubiquitin-specific protease activity	GO:003645; GO:000484
XP_003125629.1	XP_003125629.1	XP_003125629.1 V-type proton ATPase subunit d 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ATP6V0D2	ATP6V0D2;NA;NA;NA;NA	transferrin transport;ion transmembrane transport;vacuolar acidification;ATP hydrolysis coupled proton transport;insulin receptor signaling pathway;regulation of macroautophagy	GO:003357; GO:003422; GO:000703; GO:001599; GO:000828; GO:001624	membrane;early endosome;phagocytic vesicle membrane;apical plasma membrane;vacuolar proton-transporting V-type ATPase complex;proton-transporting V-type ATPase, V0 domain;endosome membrane;extracellular exosome;plasma membrane proton-transporting V-type ATPase complex	GO:001602; GO:000576; GO:003067; GO:001632; GO:001647; GO:003317; GO:001000; GO:007006; GO:003318	 Rheumatoid arthritis; Oxidative phosphorylation; Metabolic pathways; Tuberculosis; Vibrio cholerae infection; Lysosome; Collecting duct acid secretion; Epithelial cell signaling in Helicobacter pylori infection; Synaptic vesicle cycle; Viral carcinogenesis	hsa0532; hsa0019; hsa0110; hsa0515; hsa0511; hsa0414; hsa0496; hsa0512; hsa0472; hsa0520	hydrogen-exporting ATPase activity, phosphorylative mechanism;proton-transporting ATPase activity, rotational mechanism;protein binding	GO:000855; GO:004696; GO:000551
XP_003125636.1	XP_003125636.1	XP_003125636.1 hypoxia-inducible factor 1-alpha inhibitor [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1062800	NA	NA	NA	HIF1AN	HIF1AN;NA;NA;NA;NA	positive regulation of myoblast differentiation;regulation of transcription from RNA polymerase II promoter in response to hypoxia;negative regulation of transcription from RNA polymerase II promoter in response to hypoxia;peptidyl-aspartic acid hydroxylation;positive regulation of vasculogenesis;oxidation-reduction process;peptidyl-histidine hydroxylation;negative regulation of Notch signaling pathway	GO:004566; GO:006141; GO:006142; GO:004226; GO:200121; GO:005511; GO:003613; GO:004574	cytosol;nucleus;perinuclear region of cytoplasm;cytoplasm;nucleoplasm	GO:000582; GO:000563; GO:004847; GO:000573; GO:000565	"NA"	"NA"	Notch binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;oxygen sensor activity;peptidyl-asparagine 3-dioxygenase activity;protein binding;NF-kappaB binding;zinc ion binding;carboxylic acid binding;cofactor binding;protein homodimerization activity;ankyrin repeat binding;iron ion binding;peptidyl-histidine dioxygenase activity	GO:000511; GO:001670; GO:001982; GO:003614; GO:000551; GO:005105; GO:000827; GO:003140; GO:004803; GO:004280; GO:007153; GO:000550; GO:003613
XP_003125651.1	XP_003125651.1	XP_003125651.1 hydroxyacid-oxoacid transhydrogenase, mitochondrial [Sus scrofa]	10	10	10	165310000	102860000	136910000	86126000	178190000	79742000	180510000	122700000	148980000	116400000	141000000	90591000	57867000	95344000	106490000	139810000	96204000	87189000	NA	NA	NA	ADHFE1	ADHFE1;NA;NA;NA;NA	2-oxoglutarate metabolic process;oxidation-reduction process;glutamate catabolic process via 2-oxoglutarate	GO:000610; GO:005511; GO:000653	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	hydroxyacid-oxoacid transhydrogenase activity;alcohol dehydrogenase (NAD) activity;metal ion binding	GO:004798; GO:000402; GO:004687
XP_003125697.1	XP_003125697.1	XP_003125697.1 dermatopontin [Sus scrofa]	7	7	7	203190000	390100000	224590000	836460000	184060000	501900000	400870000	432700000	223020000	258350000	310310000	433720000	0	778560000	302920000	481070000	390830000	643780000	NA	NA	NA	DPT	DPT;NA;NA;NA;NA	cell adhesion;negative regulation of cell proliferation;collagen fibril organization	GO:000715; GO:000828; GO:003019	extracellular space	GO:000561	"NA"	"NA"	extracellular matrix structural constituent	GO:000520
XP_020945194.1;XP_003125703.1;XP_003125702.1	XP_020945194.1;XP_003125703.1;XP_003125702.1	XP_020945194.1 ubiquitin-fold modifier-conjugating enzyme 1 [Sus scrofa];XP_003125703.1 ubiquitin-fold modifier-conjugating enzyme 1 [Sus scrofa];XP_003125702.1 ubiquitin-fold modifier-conjugating enzyme 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	12460000	0	0	0	10519000	0	0	NA	NA	NA	UFC1	UFC1;UFC1;UFC1;NA;NA	protein ufmylation;protein K69-linked ufmylation;brain development;response to endoplasmic reticulum stress	GO:007156; GO:199059; GO:000742; GO:003497	extracellular exosome	GO:007006	"NA"	"NA"	protein binding;UFM1 transferase activity	GO:000551; GO:007156
XP_003125707.2	XP_003125707.2	XP_003125707.2 succinate dehydrogenase cytochrome b560 subunit, mitochondrial [Sus scrofa]	3	3	3	105330000	38496000	88966000	44524000	60812000	40757000	57033000	46525000	75091000	49735000	38688000	0	44010000	37580000	38103000	53491000	51200000	50582000	NA	NA	NA	SDHC	SDHC;NA;NA;NA;NA	aerobic respiration;tricarboxylic acid cycle;oxidation-reduction process;mitochondrial electron transport, succinate to ubiquinone	GO:000906; GO:000609; GO:005511; GO:000612	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);respiratory chain complex II;mitochondrial inner membrane;integral component of membrane;mitochondrion	GO:000574; GO:004527; GO:000574; GO:001602; GO:000573	 Oxidative phosphorylation; Metabolic pathways; Biosynthesis of antibiotics; Citrate cycle (TCA cycle); Parkinson's disease; Carbon metabolism; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0110; hsa0113; hsa0002; hsa0501; hsa0120; hsa0493	electron carrier activity;succinate dehydrogenase (ubiquinone) activity;heme binding;metal ion binding	GO:000905; GO:000817; GO:002003; GO:004687
XP_020945244.1;XP_020945242.1;XP_013852337.1;XP_005663269.1;XP_003355153.1;XP_003125720.2	XP_020945244.1;XP_020945242.1;XP_013852337.1;XP_005663269.1;XP_003355153.1;XP_003125720.2	XP_020945244.1 transgelin-2 [Sus scrofa];XP_020945242.1 transgelin-2 [Sus scrofa];XP_013852337.1 transgelin-2 [Sus scrofa];XP_005663269.1 transgelin-2 [Sus scrofa];XP_003355153.1 transgelin-2 [Sus scrofa];XP_003125720.2 transgelin-2 [Sus scrofa]	13	13	13	192690000	363190000	279590000	363820000	254630000	424420000	245340000	353350000	233290000	351480000	257160000	411540000	524250000	329820000	235850000	310400000	429750000	424140000	NA	NA	NA	TAGLN2	TAGLN2;TAGLN2;TAGLN2;TAGLN2;TAGLN2	platelet degranulation;epithelial cell differentiation	GO:000257; GO:003085	extracellular region;extracellular exosome;cytosol;vesicle	GO:000557; GO:007006; GO:000582; GO:003198	"NA"	"NA"	protein binding;cadherin binding	GO:000551; GO:004529
XP_020945450.1;XP_013852533.1;XP_020945449.1;XP_013852532.1;XP_020945448.1;XP_020945447.1;XP_020945446.1;XP_020945445.1;XP_020945444.1;XP_020945443.1;XP_020945442.1;XP_013852531.1;XP_020945441.1;XP_020945440.1;XP_020945439.1;XP_020945438.1;XP_020945437.1;XP_020945435.1;XP_020945436.1;XP_013852528.1;XP_020945433.1;XP_020945432.1;XP_020945431.1;XP_020945430.1;XP_020945429.1;XP_013852527.1;XP_013852526.1;XP_020945428.1;XP_020945427.1;XP_020945426.1;XP_020945425.1;XP_020945424.1;XP_005663448.1;XP_003125776.4;XP_020945423.1;XP_020945422.1;XP_020945421.1;XP_013852524.1;XP_020945420.1;XP_020945419.1;XP_013852523.1;XP_013852521.1;XP_020945418.1;XP_013852520.1;XP_013852519.1;XP_005663439.1;XP_005663438.1;XP_013852518.1;XP_013852514.1;XP_013852513.1	XP_020945450.1;XP_013852533.1;XP_020945449.1;XP_013852532.1;XP_020945448.1;XP_020945447.1;XP_020945446.1;XP_020945445.1;XP_020945444.1;XP_020945443.1;XP_020945442.1;XP_013852531.1;XP_020945441.1;XP_020945440.1;XP_020945439.1;XP_020945438.1;XP_020945437.1;XP_020945435.1;XP_020945436.1;XP_013852528.1;XP_020945433.1;XP_020945432.1;XP_020945431.1;XP_020945430.1;XP_020945429.1;XP_013852527.1;XP_013852526.1;XP_020945428.1;XP_020945427.1;XP_020945426.1;XP_020945425.1;XP_020945424.1;XP_005663448.1;XP_003125776.4;XP_020945423.1;XP_020945422.1;XP_020945421.1;XP_013852524.1;XP_020945420.1;XP_020945419.1;XP_013852523.1;XP_013852521.1;XP_020945418.1;XP_013852520.1;XP_013852519.1;XP_005663439.1;XP_005663438.1;XP_013852518.1;XP_013852514.1;XP_013852513.1	XP_020945450.1 ubiquitin-associated protein 2-like isoform X30 [Sus scrofa];XP_013852533.1 ubiquitin-associated protein 2-like isoform X30 [Sus scrofa];XP_020945449.1 ubiquitin-associated protein 2-like isoform X29 [Sus scrofa];XP_013852532.1 ubiquitin-ass	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2604300	NA	NA	NA	UBAP2L	UBAP2L;UBAP2L;UBAP2L;UBAP2L;UBAP2L	binding of sperm to zona pellucida;hematopoietic stem cell homeostasis	GO:000733; GO:006148	Ada2/Gcn5/Ada3 transcription activator complex;PcG protein complex;nucleus;cytoplasm	GO:000567; GO:003151; GO:000563; GO:000573	"NA"	"NA"	RNA binding;protein binding	GO:000372; GO:000551
XP_020958334.1;XP_003125783.1;XP_020945453.1;XP_020957985.1;XP_020932079.1	XP_020958334.1;XP_003125783.1	XP_020958334.1 40S ribosomal protein S27-like [Sus scrofa];XP_003125783.1 40S ribosomal protein S27 isoform X1 [Sus scrofa]	4	2	2	0	0	10172000	0	6520600	0	0	0	0	0	0	20496000	0	0	0	5650400	5182300	0	NA	NA	NA	RPS27	LOC110262272;RPS27;NA;NA;NA	ribosomal small subunit assembly;rRNA processing;translational initiation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cell proliferation	GO:000002; GO:000636; GO:000641; GO:000661; GO:000018; GO:000828	nucleus;cytosolic small ribosomal subunit;nucleoplasm;ribosome;postsynaptic density;cytosol	GO:000563; GO:002262; GO:000565; GO:000584; GO:001406; GO:000582	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;DNA binding;zinc ion binding;RNA binding	GO:000551; GO:000373; GO:000367; GO:000827; GO:000372
XP_013852593.1;XP_020945514.1;XP_003125809.1	XP_013852593.1;XP_020945514.1;XP_003125809.1	XP_013852593.1 sorting nexin-27 isoform X3 [Sus scrofa];XP_020945514.1 sorting nexin-27 isoform X2 [Sus scrofa];XP_003125809.1 sorting nexin-27 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9246600	NA	NA	NA	SNX27	SNX27;SNX27;SNX27;NA;NA	signal transduction;endosomal transport;retrograde transport, endosome to plasma membrane;establishment of natural killer cell polarity;intracellular protein transport;endosome to lysosome transport	GO:000716; GO:001619; GO:199012; GO:000177; GO:000688; GO:000833	WASH complex;nucleoplasm;early endosome membrane;immunological synapse;cytosol;endosome;retromer complex	GO:007120; GO:000565; GO:003190; GO:000177; GO:000582; GO:000576; GO:003090	"NA"	"NA"	protein binding;phosphatidylinositol binding;phosphatidylinositol-3-phosphate binding	GO:000551; GO:003509; GO:003226
XP_003125894.1;XP_020946420.1	XP_003125894.1;XP_020946420.1	XP_003125894.1 rho-related GTP-binding protein RhoC isoform X2 [Sus scrofa];XP_020946420.1 rho-related GTP-binding protein RhoC isoform X1 [Sus scrofa]	9	2	2	30586000	0	0	0	23994000	0	0	26056000	0	24587000	0	0	0	0	0	0	0	0	NA	NA	NA	RHOC	RHOC;RHOC;NA;NA;NA	actin filament bundle assembly;cell migration;skeletal muscle satellite cell migration;Rho protein signal transduction;regulation of cell migration;positive regulation of I-kappaB kinase/NF-kappaB signaling;mitotic cytokinesis;establishment or maintenance of actin cytoskeleton polarity;positive regulation of protein homooligomerization;wound healing, spreading of cells;actin filament organization;G-protein coupled receptor signaling pathway;regulation of cell shape;apical junction assembly;regulation of small GTPase mediated signal transduction;positive regulation of lipase activity;positive regulation of stress fiber assembly;regulation of actin cytoskeleton organization	GO:005101; GO:001647; GO:190276; GO:000726; GO:003033; GO:004312; GO:000028; GO:003095; GO:003246; GO:004431; GO:000701; GO:000718; GO:000836; GO:004329; GO:005105; GO:006019; GO:005149; GO:003295	cytosol;cytoplasm;cell cortex;intracellular membrane-bounded organelle;cell division site;plasma membrane;extracellular exosome;stereocilium	GO:000582; GO:000573; GO:000593; GO:004323; GO:003215; GO:000588; GO:007006; GO:003242	"NA"	"NA"	protein binding;GTPase activity;GTP binding;protein kinase binding	GO:000551; GO:000392; GO:000552; GO:001990
XP_003125950.3	XP_003125950.3	XP_003125950.3 LOW QUALITY PROTEIN: calponin-3 [Sus scrofa]	4	3	3	0	44539000	42818000	23105000	20973000	44485000	26126000	30038000	0	40241000	24393000	0	91342000	26744000	18755000	0	34525000	49319000	NA	NA	NA	CNN3	CNN3;NA;NA;NA;NA	actomyosin structure organization;cell-cell adhesion;negative regulation of ATPase activity;epithelial cell differentiation	GO:003103; GO:009860; GO:003278; GO:003085	focal adhesion;dendritic spine;postsynaptic density;cytosol;cell-cell adherens junction;actin cytoskeleton;neuronal cell body	GO:000592; GO:004319; GO:001406; GO:000582; GO:000591; GO:001562; GO:004302	"NA"	"NA"	cadherin binding involved in cell-cell adhesion;calmodulin binding;microtubule binding;actin binding	GO:009864; GO:000551; GO:000801; GO:000377
XP_003125999.3;XP_020947036.1;XP_013843636.1;XP_013843637.1	XP_003125999.3;XP_020947036.1;XP_013843636.1;XP_013843637.1	XP_003125999.3 tetratricopeptide repeat protein 38 isoform X3 [Sus scrofa];XP_020947036.1 tetratricopeptide repeat protein 38 isoform X2 [Sus scrofa];XP_013843636.1 tetratricopeptide repeat protein 38 isoform X1 [Sus scrofa];XP_013843637.1 tetratricopeptid	7	7	7	19689000	14920000	15683000	19101000	17909000	13167000	15384000	18523000	18477000	19368000	16209000	14977000	15354000	15979000	18550000	25333000	18259000	20400000	NA	NA	NA	TTC38	TTC38;TTC38;TTC38;TTC38;NA	"NA"	"NA"	extracellular exosome	GO:007006	"NA"	"NA"	"NA"	"NA"
XP_003126003.3;CON__ENSEMBL:ENSBTAP00000016046	XP_003126003.3;CON__ENSEMBL:ENSBTAP00000016046	XP_003126003.3 fibulin-1 isoform X1 [Sus scrofa];	16	16	5	175060000	245380000	318630000	318420000	219160000	311340000	520550000	292400000	317710000	274780000	230810000	265900000	430430000	251740000	357220000	272260000	324740000	252980000	NA	NA	+	FBLN1	FBLN1;NA;NA;NA;NA	negative regulation of ERK1 and ERK2 cascade;negative regulation of stem cell proliferation;positive regulation of peptidase activity;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of protein phosphorylation;negative regulation of cell adhesion;embryo implantation;negative regulation of cell motility;integrin-mediated signaling pathway;viral process;extracellular matrix organization;blood coagulation, fibrin clot formation	GO:007037; GO:200064; GO:001095; GO:190002; GO:000193; GO:000716; GO:000756; GO:200014; GO:000722; GO:001603; GO:003019; GO:007237	extracellular region;basement membrane;elastic fiber;extracellular space;extracellular matrix;extracellular exosome	GO:000557; GO:000560; GO:007195; GO:000561; GO:003101; GO:007006	"NA"	"NA"	extracellular matrix structural constituent;protein C-terminus binding;identical protein binding;macromolecular complex binding;fibronectin binding;fibrinogen binding;calcium ion binding;peptidase activator activity	GO:000520; GO:000802; GO:004280; GO:004487; GO:000196; GO:007005; GO:000550; GO:001650
XP_003126030.2	XP_003126030.2	XP_003126030.2 LOW QUALITY PROTEIN: NADH-cytochrome b5 reductase 3-like [Sus scrofa]	15	15	15	588590000	1464300000	862390000	1221400000	529740000	1201200000	612270000	1024000000	720880000	783680000	937200000	1240900000	624890000	1619500000	942650000	1226400000	1073500000	1435600000	NA	NA	NA	LOC100524254	LOC100524254;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003126064.4	XP_003126064.4	XP_003126064.4 mitochondrial import receptor subunit TOM22 homolog [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	10151000	0	0	0	0	NA	NA	NA	TOMM22	TOMM22;NA;NA;NA;NA	protein transmembrane transport;protein import into mitochondrial outer membrane;positive regulation of apoptotic process;protein targeting to mitochondrion	GO:007180; GO:004504; GO:004306; GO:000662	integral component of membrane;membrane;mitochondrial outer membrane;mitochondrion	GO:001602; GO:001602; GO:000574; GO:000573	"NA"	"NA"	protein binding;protein transmembrane transporter activity	GO:000551; GO:000832
XP_003126085.1	XP_003126085.1	XP_003126085.1 histone H1.0 [Sus scrofa]	2	2	2	0	0	0	0	0	187130000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC100510904	LOC100510904;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003126145.1	XP_003126145.1	XP_003126145.1 peptidyl-prolyl cis-trans isomerase FKBP11 [Sus scrofa]	5	5	5	0	20774000	18058000	27438000	0	24781000	21171000	24862000	0	26524000	31728000	49867000	26374000	38263000	32065000	30416000	0	31317000	NA	NA	NA	FKBP11	FKBP11;NA;NA;NA;NA	protein peptidyl-prolyl isomerization	GO:000041	membrane;integral component of membrane	GO:001602; GO:001602	"NA"	"NA"	peptidyl-prolyl cis-trans isomerase activity	GO:000375
XP_003126153.1;XP_020947259.1	XP_003126153.1;XP_020947259.1	XP_003126153.1 peripherin isoform X2 [Sus scrofa];XP_020947259.1 peripherin isoform X1 [Sus scrofa]	19	15	15	0	631550000	7340600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PRPH	PRPH;PRPH;NA;NA;NA	"NA"	"NA"	type III intermediate filament;intermediate filament;membrane;extracellular exosome	GO:004509; GO:000588; GO:001602; GO:007006	 Amyotrophic lateral sclerosis (ALS)	hsa0501	structural molecule activity;protein binding	GO:000519; GO:000551
XP_013853072.1;XP_013853071.1;XP_003126302.1	XP_013853072.1;XP_013853071.1;XP_003126302.1	XP_013853072.1 11-cis retinol dehydrogenase [Sus scrofa];XP_013853071.1 11-cis retinol dehydrogenase [Sus scrofa];XP_003126302.1 11-cis retinol dehydrogenase [Sus scrofa]	8	8	8	78646000	21647000	58321000	47502000	27714000	0	42518000	42832000	43611000	46408000	19412000	36762000	0	14153000	17323000	54320000	21787000	12777000	NA	NA	NA	RDH5	RDH5;RDH5;RDH5;NA;NA	visual perception;response to stimulus;oxidation-reduction process;retinol metabolic process;retinoid metabolic process	GO:000760; GO:005089; GO:005511; GO:004257; GO:000152	endoplasmic reticulum membrane;cell body;endoplasmic reticulum lumen	GO:000578; GO:004429; GO:000578	 Retinol metabolism	hsa0083	retinol dehydrogenase activity	GO:000474
XP_003126310.2	XP_003126310.2	XP_003126310.2 LOW QUALITY PROTEIN: extended synaptotagmin-1 [Sus scrofa]	25	25	25	137440000	249850000	208690000	203690000	178650000	213730000	177050000	217710000	179790000	221150000	213170000	266750000	190610000	205140000	219900000	261550000	185000000	206410000	NA	NA	NA	ESYT1	ESYT1;NA;NA;NA;NA	lipid transport;endoplasmic reticulum-plasma membrane tethering	GO:000686; GO:006181	endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;extrinsic component of cytoplasmic side of plasma membrane;membrane;intrinsic component of endoplasmic reticulum membrane;endoplasmic reticulum	GO:000578; GO:003017; GO:003123; GO:001602; GO:003122; GO:000578	"NA"	"NA"	identical protein binding;protein binding;calcium-dependent phospholipid binding;phosphatidylethanolamine binding;phosphatidylcholine binding;calcium ion binding;phosphatidylinositol binding	GO:004280; GO:000551; GO:000554; GO:000842; GO:003121; GO:000550; GO:003509
XP_003126410.2	XP_003126410.2	XP_003126410.2 LOW QUALITY PROTEIN: cullin-associated NEDD8-dissociated protein 1 [Sus scrofa]	27	27	25	218220000	179200000	213570000	177670000	199060000	162910000	189620000	191960000	208530000	186750000	185380000	114360000	266140000	180860000	166860000	175150000	193710000	187260000	NA	NA	NA	CAND1	CAND1;NA;NA;NA;NA	cellular iron ion homeostasis;negative regulation of catalytic activity;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;protein ubiquitination;neutrophil degranulation;cell differentiation;post-translational protein modification;SCF complex assembly	GO:000687; GO:004308; GO:004589; GO:001656; GO:004331; GO:003015; GO:004368; GO:001026	secretory granule lumen;ubiquitin ligase complex;nucleoplasm;Golgi apparatus;ficolin-1-rich granule lumen;extracellular region;nucleus;cytoplasm;extracellular exosome;cullin-RING ubiquitin ligase complex;membrane;cytosol	GO:003477; GO:000015; GO:000565; GO:000579; GO:190481; GO:000557; GO:000563; GO:000573; GO:007006; GO:003146; GO:001602; GO:000582	"NA"	"NA"	protein binding;TBP-class protein binding	GO:000551; GO:001702
XP_005653209.1;XP_003126475.1;XP_013849234.1;XP_005653208.1;XP_013849247.1	XP_005653209.1;XP_003126475.1;XP_013849234.1;XP_005653208.1;XP_013849247.1	XP_005653209.1 GTPase KRas isoform X2 [Sus scrofa];XP_003126475.1 GTPase KRas isoform X2 [Sus scrofa];XP_013849234.1 GTPase KRas isoform X1 [Sus scrofa];XP_005653208.1 GTPase KRas isoform X1 [Sus scrofa];XP_013849247.1 GTPase KRas isoform X3 [Sus scrofa]	5	2	2	0	0	0	0	0	0	0	6874800	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	KRAS	KRAS;KRAS;KRAS;KRAS;KRAS	stimulatory C-type lectin receptor signaling pathway;Ras protein signal transduction;regulation of protein stability;response to isolation stress;response to glucocorticoid;positive regulation of cellular senescence;MAPK cascade;forebrain astrocyte development;regulation of synaptic transmission, GABAergic;positive regulation of cell proliferation;visual learning;positive regulation of gene expression;actin cytoskeleton organization;negative regulation of cell differentiation;positive regulation of nitric-oxide synthase activity;striated muscle cell differentiation;epithelial tube branching involved in lung morphogenesis;negative regulation of neuron apoptotic process;positive regulation of NF-kappaB transcription factor activity;positive regulation of Rac protein signal transduction;endocrine signaling;liver development;positive regulation of protein phosphorylation;cytokine-mediated signaling pathway;female pregnancy;positive regulation of MAP kinase activity;regulation of long-term neuronal synaptic plasticity;homeostasis of number of cells within a tissue	GO:000222; GO:000726; GO:003164; GO:003590; GO:005138; GO:200077; GO:000016; GO:002189; GO:003222; GO:000828; GO:000854; GO:001062; GO:003003; GO:004559; GO:005100; GO:005114; GO:006044; GO:004352; GO:005109; GO:003502; GO:003800; GO:000188; GO:000193; GO:001922; GO:000756; GO:004340; GO:004816; GO:004887	extrinsic component of cytoplasmic side of plasma membrane;membrane;plasma membrane;cytosol;cytoplasm;membrane raft;focal adhesion	GO:003123; GO:001602; GO:000588; GO:000582; GO:000573; GO:004512; GO:000592	 ErbB signaling pathway; FoxO signaling pathway; Natural killer cell mediated cytotoxicity; Long-term potentiation; Insulin signaling pathway; Oxytocin signaling pathway; Viral carcinogenesis; Choline metabolism in cancer; Ras signaling pathway; Axon guidance; HTLV-I infection; Thyroid cancer; Acute myeloid leukemia; VEGF signaling pathway; Sphingolipid signaling pathway; PI3K-Akt signaling pathway; Signaling pathways regulating pluripotency of stem cells; B cell receptor signaling pathway; Aldosterone-regulated sodium reabsorption; Dorso-ventral axis formation; Tight junction; Gap junction; Long-term depression; Regulation of actin cytoskeleton; Alcoholism	hsa0401; hsa0406; hsa0465; hsa0472; hsa0491; hsa0492; hsa0520; hsa0523; hsa0401; hsa0436; hsa0516; hsa0521; hsa0522; hsa0437; hsa0407; hsa0415; hsa0455; hsa0466; hsa0496; hsa0432; hsa0453; hsa0454; hsa0473; hsa0481; hsa0503	GTPase activity;protein binding;macromolecular complex binding;GMP binding;LRR domain binding;GTP binding	GO:000392; GO:000551; GO:004487; GO:001900; GO:003027; GO:000552
XP_003126481.1	XP_003126481.1	XP_003126481.1 N-acylneuraminate cytidylyltransferase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3830300	0	0	NA	NA	NA	CMAS	CMAS;NA;NA;NA;NA	N-acetylneuraminate metabolic process	GO:000605	nucleoplasm;nucleus;membrane	GO:000565; GO:000563; GO:001602	 Metabolic pathways; Amino sugar and nucleotide sugar metabolism	hsa0110; hsa0052	N-acylneuraminate cytidylyltransferase activity	GO:000878
XP_003355623.1;XP_003126523.1	XP_003355623.1;XP_003126523.1	XP_003355623.1 Y-box-binding protein 3 isoform X2 [Sus scrofa];XP_003126523.1 Y-box-binding protein 3 isoform X1 [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	YBX3	YBX3;YBX3;NA;NA;NA	in utero embryonic development;positive regulation of organ growth;cellular hyperosmotic response;negative regulation of necroptotic process;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cytoplasmic translation;response to cold;fertilization;3'-UTR-mediated mRNA stabilization;negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;male gonad development;negative regulation of skeletal muscle tissue development;spermatogenesis;cellular response to tumor necrosis factor	GO:000170; GO:004662; GO:007147; GO:006054; GO:000012; GO:200076; GO:000940; GO:000956; GO:007093; GO:190221; GO:000858; GO:004864; GO:000728; GO:007135	perinuclear region of cytoplasm;nucleus;bicellular tight junction;cytoplasm;cytosol	GO:004847; GO:000563; GO:000592; GO:000573; GO:000582	 Tight junction	hsa0453	mRNA 3'-UTR binding;protein binding;polysome binding;RNA polymerase II regulatory region sequence-specific DNA binding;transcription factor activity, sequence-specific DNA binding;Rho GTPase binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;double-stranded DNA binding;transcription corepressor activity;RNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding	GO:000373; GO:000551; GO:190553; GO:000097; GO:000370; GO:001704; GO:000122; GO:000369; GO:000371; GO:000372; GO:000098
XP_003126608.2	XP_003126608.2	XP_003126608.2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial [Sus scrofa]	10	10	10	52790000	35696000	46676000	30709000	49455000	30591000	41310000	36190000	51801000	39859000	44016000	31799000	33002000	38909000	34462000	42601000	31772000	25922000	NA	NA	NA	NDUFA9	NDUFA9;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;sodium ion transport;circadian rhythm;ubiquinone-6 biosynthetic process;response to glucose;mitochondrial respiratory chain complex I assembly	GO:000612; GO:000681; GO:000762; GO:190100; GO:000974; GO:003298	nucleus;mitochondrial respiratory chain complex I;mitochondrial membrane;mitochondrion;mitochondrial matrix;nucleoplasm	GO:000563; GO:000574; GO:003196; GO:000573; GO:000575; GO:000565	 Alzheimer's disease; Parkinson's disease; Oxidative phosphorylation; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD)	hsa0501; hsa0501; hsa0019; hsa0110; hsa0493	protein binding;macromolecular complex binding;NADH dehydrogenase (ubiquinone) activity;NADH dehydrogenase activity;coenzyme binding	GO:000551; GO:004487; GO:000813; GO:000395; GO:005066
XP_003126641.3	XP_003126641.3	XP_003126641.3 V-type proton ATPase subunit E 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3288900	0	NA	NA	NA	ATP6V1E1	ATP6V1E1;NA;NA;NA;NA	insulin receptor signaling pathway;ion transmembrane transport;ATP hydrolysis coupled proton transport;regulation of macroautophagy;hydrogen ion transmembrane transport;transferrin transport	GO:000828; GO:003422; GO:001599; GO:001624; GO:190260; GO:003357	proton-transporting two-sector ATPase complex, catalytic domain;microvillus;extracellular exosome;lysosomal membrane;apical plasma membrane;cytosol;proton-transporting two-sector ATPase complex	GO:003317; GO:000590; GO:007006; GO:000576; GO:001632; GO:000582; GO:001646	 Synaptic vesicle cycle; Phagosome; Collecting duct acid secretion; Rheumatoid arthritis; Oxidative phosphorylation; Metabolic pathways; Vibrio cholerae infection; Epithelial cell signaling in Helicobacter pylori infection	hsa0472; hsa0414; hsa0496; hsa0532; hsa0019; hsa0110; hsa0511; hsa0512	protein binding;proton-transporting ATPase activity, rotational mechanism;hydrogen-exporting ATPase activity, phosphorylative mechanism;ATPase binding	GO:000551; GO:004696; GO:000855; GO:005111
XP_020948164.1;XP_020948163.1;XP_013853375.2;XP_003126643.4	XP_020948164.1;XP_020948163.1;XP_013853375.2;XP_003126643.4	XP_020948164.1 bcl-2-like protein 13 [Sus scrofa];XP_020948163.1 bcl-2-like protein 13 [Sus scrofa];XP_013853375.2 bcl-2-like protein 13 [Sus scrofa];XP_003126643.4 bcl-2-like protein 13 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16357000	0	NA	NA	NA	BCL2L13	BCL2L13;BCL2L13;BCL2L13;BCL2L13;NA	apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process	GO:000691; GO:000691	mitochondrial membrane;nucleus;integral component of membrane;mitochondrion	GO:003196; GO:000563; GO:001602; GO:000573	 Legionellosis	hsa0513	protein binding;cysteine-type endopeptidase activator activity involved in apoptotic process	GO:000551; GO:000865
XP_003126645.3	XP_003126645.3	XP_003126645.3 tubulin alpha-8 chain [Sus scrofa]	15	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4937100	0	0	0	+	NA	NA	TUBA8	TUBA8;NA;NA;NA;NA	microtubule-based process;microtubule cytoskeleton organization;mitotic cell cycle	GO:000701; GO:000022; GO:000027	cytoplasm;microtubule;microtubule cytoskeleton	GO:000573; GO:000587; GO:001563	 Phagosome; Pathogenic Escherichia coli infection; Gap junction	hsa0414; hsa0513; hsa0454	GTPase activity;GTP binding;structural constituent of cytoskeleton	GO:000392; GO:000552; GO:000520
XP_003126759.3;XP_005664304.1	XP_003126759.3;XP_005664304.1	XP_003126759.3 methionine aminopeptidase 2 isoform X1 [Sus scrofa];XP_005664304.1 methionine aminopeptidase 2 isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12025000	0	0	0	NA	NA	NA	METAP2	METAP2;METAP2;NA;NA;NA	N-terminal protein amino acid modification;protein processing;regulation of rhodopsin mediated signaling pathway;protein initiator methionine removal;peptidyl-methionine modification	GO:003136; GO:001648; GO:002240; GO:007008; GO:001820	cytosol;cytoplasm;plasma membrane	GO:000582; GO:000573; GO:000588	"NA"	"NA"	metalloexopeptidase activity;metalloaminopeptidase activity;metal ion binding;RNA binding;aminopeptidase activity	GO:000823; GO:007000; GO:004687; GO:000372; GO:000417
XP_003126763.1	XP_003126763.1	XP_003126763.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 [Sus scrofa]	3	3	3	0	8139400	0	0	0	0	9934000	10947000	0	0	9383400	0	0	0	12145000	0	0	0	NA	NA	NA	NDUFA12	NDUFA12;NA;NA;NA;NA	response to oxidative stress;respiratory gaseous exchange;mitochondrial respiratory chain complex I assembly;mitochondrial ATP synthesis coupled electron transport	GO:000697; GO:000758; GO:003298; GO:004277	mitochondrion;mitochondrial inner membrane;cytosol	GO:000573; GO:000574; GO:000582	 Metabolic pathways; Huntington's disease; Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0501; hsa0019; hsa0493	NADH dehydrogenase (ubiquinone) activity;electron carrier activity	GO:000813; GO:000905
XP_020946999.1;XP_020946996.1;XP_020946995.1;XP_005653241.1;XP_020946994.1;XP_003126824.1;XP_005653239.1;XP_020946998.1;XP_020946997.1	XP_020946999.1;XP_020946996.1;XP_020946995.1;XP_005653241.1;XP_020946994.1;XP_003126824.1;XP_005653239.1;XP_020946998.1;XP_020946997.1	XP_020946999.1 histone deacetylase 10 isoform X9 [Sus scrofa];XP_020946996.1 histone deacetylase 10 isoform X6 [Sus scrofa];XP_020946995.1 histone deacetylase 10 isoform X5 [Sus scrofa];XP_005653241.1 histone deacetylase 10 isoform X4 [Sus scrofa];XP_02094	3	3	3	0	0	4011200	6621700	0	3365700	0	5440800	4088600	6001200	3958200	0	0	3902100	0	3734700	3580700	4307400	NA	NA	NA	HDAC10	HDAC10;HDAC10;HDAC10;HDAC10;HDAC10	negative regulation of transcription from RNA polymerase II promoter;macroautophagy;positive regulation of mismatch repair;oligodendrocyte development;peptidyl-lysine deacetylation;regulation of transcription, DNA-templated;histone deacetylation;reciprocal DNA recombination;negative regulation of transcription, DNA-templated;chromatin organization;protein deacetylation	GO:000012; GO:001623; GO:003242; GO:001400; GO:003498; GO:000635; GO:001657; GO:003582; GO:004589; GO:000632; GO:000647	histone deacetylase complex;nucleus;nucleoplasm;cytoplasm	GO:000011; GO:000563; GO:000565; GO:000573	 Alcoholism; Viral carcinogenesis	hsa0503; hsa0520	deacetylase activity;acetylspermidine deacetylase activity;histone deacetylase activity;protein deacetylase activity;enzyme binding;acetylputrescine deacetylase activity;protein binding;zinc ion binding;histone deacetylase binding	GO:001921; GO:004761; GO:000440; GO:003355; GO:001989; GO:004760; GO:000551; GO:000827; GO:004282
XP_003126898.3	XP_003126898.3	XP_003126898.3 synaptic vesicle membrane protein VAT-1 homolog-like [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	VAT1L	VAT1L;NA;NA;NA;NA	oxidation-reduction process	GO:005511	"NA"	"NA"	"NA"	"NA"	protein binding;zinc ion binding;oxidoreductase activity	GO:000551; GO:000827; GO:001649
XP_003126904.2;XP_003355791.1	XP_003126904.2;XP_003355791.1	XP_003126904.2 lysine--tRNA ligase isoform X2 [Sus scrofa];XP_003355791.1 lysine--tRNA ligase isoform X1 [Sus scrofa]	8	8	8	13329000	13858000	17864000	9450600	20453000	16560000	8143700	15297000	14961000	15088000	14612000	18130000	13002000	11406000	13406000	11935000	13813000	6809500	NA	NA	NA	KARS	KARS;KARS;NA;NA;NA	positive regulation of transcription, DNA-templated;positive regulation of cytokine production involved in inflammatory response;basophil activation involved in immune response;viral process;positive regulation of ERK1 and ERK2 cascade;lysyl-tRNA aminoacylation;positive regulation of p38MAPK cascade;activation of MAPK activity;negative regulation of cell proliferation;positive regulation of cytokine secretion involved in immune response;tRNA processing;diadenosine tetraphosphate biosynthetic process;positive regulation of macrophage activation;tRNA aminoacylation for protein translation;response to X-ray;positive regulation of macrophage chemotaxis;tumor necrosis factor-mediated signaling pathway;positive regulation of metallopeptidase activity	GO:004589; GO:190001; GO:000227; GO:001603; GO:007037; GO:000643; GO:190074; GO:000018; GO:000828; GO:000274; GO:000803; GO:001596; GO:004303; GO:000641; GO:001016; GO:001075; GO:003320; GO:190505	cytosol;extracellular space;mitochondrion;nucleus;plasma membrane;mitochondrial matrix;aminoacyl-tRNA synthetase multienzyme complex	GO:000582; GO:000561; GO:000573; GO:000563; GO:000588; GO:000575; GO:001710	 Aminoacyl-tRNA biosynthesis	hsa0097	identical protein binding;protein binding;protein homodimerization activity;tRNA binding;ATP binding;amino acid binding;ATP adenylyltransferase activity;lysine-tRNA ligase activity	GO:004280; GO:000551; GO:004280; GO:000004; GO:000552; GO:001659; GO:000387; GO:000482
XP_003126917.1;XP_003126920.1;XP_005653299.1	XP_003126917.1;XP_003126920.1;XP_005653299.1	XP_003126917.1 ATP-dependent RNA helicase DDX19A [Sus scrofa];XP_003126920.1 ATP-dependent RNA helicase DDX19B isoform X1 [Sus scrofa];XP_005653299.1 ATP-dependent RNA helicase DDX19B isoform X2 [Sus scrofa]	5	5	5	0	24807000	23078000	18641000	0	24612000	22944000	0	22980000	18736000	0	0	0	0	0	26111000	27288000	0	NA	NA	NA	DDX19A	DDX19A;DDX19B;DDX19B;NA;NA	protein transport;mRNA transport;biological_process	GO:001503; GO:005102; GO:000815	nuclear membrane;cytoplasm;nuclear pore;membrane	GO:003196; GO:000573; GO:000564; GO:001602	"NA"	"NA"	protein binding;molecular_function;RNA binding;ATP binding;helicase activity	GO:000551; GO:000367; GO:000372; GO:000552; GO:000438
XP_003481845.1;XP_020949486.1;XP_003126945.3	XP_003481845.1;XP_020949486.1;XP_003126945.3	XP_003481845.1 AP-1 complex subunit gamma-1 isoform X2 [Sus scrofa];XP_020949486.1 AP-1 complex subunit gamma-1 isoform X1 [Sus scrofa];XP_003126945.3 AP-1 complex subunit gamma-1 isoform X1 [Sus scrofa]	7	7	7	0	0	0	0	0	0	0	0	0	10584000	0	0	0	0	0	0	0	0	NA	NA	NA	AP1G1	AP1G1;AP1G1;AP1G1;NA;NA	positive regulation of natural killer cell degranulation;regulation of defense response to virus by virus;melanosome organization;endosome to melanosome transport;positive regulation of natural killer cell mediated cytotoxicity;intracellular protein transport;Golgi to lysosome transport;antigen processing and presentation of exogenous peptide antigen via MHC class II	GO:004332; GO:005069; GO:003243; GO:003564; GO:004595; GO:000688; GO:009016; GO:001988	Golgi membrane;clathrin-coated vesicle;intracellular membrane-bounded organelle;recycling endosome;cytoplasmic vesicle membrane;Golgi apparatus;membrane;lysosomal membrane;cytoplasm;AP-type membrane coat adaptor complex;trans-Golgi network membrane;cytosol;AP-1 adaptor complex;clathrin-coated vesicle membrane	GO:000013; GO:003013; GO:004323; GO:005503; GO:003065; GO:000579; GO:001602; GO:000576; GO:000573; GO:003011; GO:003258; GO:000582; GO:003012; GO:003066	 Lysosome	hsa0414	GTP-dependent protein binding;Rab GTPase binding;protein binding;transporter activity;kinesin binding	GO:003074; GO:001713; GO:000551; GO:000521; GO:001989
XP_003126970.2	XP_003126970.2	XP_003126970.2 nuclear transport factor 2 [Sus scrofa]	3	3	3	0	128840000	28733000	0	0	165010000	0	0	78982000	0	0	0	312080000	0	357100000	132050000	167930000	171850000	NA	NA	NA	NUTF2	NUTF2;NA;NA;NA;NA	protein export from nucleus;protein import into nucleus;nucleocytoplasmic transport;protein localization to nuclear pore;mRNA transport	GO:000661; GO:000660; GO:000691; GO:009020; GO:005102	nucleoplasm;extracellular exosome;nuclear membrane;nuclear outer membrane;cytosol;nuclear pore central transport channel;nuclear inner membrane	GO:000565; GO:007006; GO:003196; GO:000564; GO:000582; GO:004461; GO:000563	"NA"	"NA"	identical protein binding;structural constituent of nuclear pore;protein binding;protein transporter activity;Ran GTPase binding	GO:004280; GO:001705; GO:000551; GO:000856; GO:000853
XP_020949745.1;XP_013853721.1;XP_003126976.1;XP_003126975.1	XP_020949745.1;XP_013853721.1;XP_003126976.1;XP_003126975.1	XP_020949745.1 tubulin polymerization-promoting protein family member 3 [Sus scrofa];XP_013853721.1 tubulin polymerization-promoting protein family member 3 [Sus scrofa];XP_003126976.1 tubulin polymerization-promoting protein family member 3 [Sus scrofa];X	9	9	9	72592000	173850000	127850000	176090000	121050000	224600000	120100000	130280000	76448000	162430000	154690000	255690000	165030000	176690000	152930000	164080000	186850000	239280000	NA	NA	NA	TPPP3	TPPP3;TPPP3;TPPP3;TPPP3;NA	microtubule polymerization;microtubule bundle formation;positive regulation of protein polymerization	GO:004678; GO:000157; GO:003227	microtubule;perinuclear region of cytoplasm;microtubule bundle	GO:000587; GO:004847; GO:009742	"NA"	"NA"	tubulin binding	GO:001563
XP_003126994.1	XP_003126994.1	XP_003126994.1 V-type proton ATPase subunit d 1 [Sus scrofa]	4	4	4	0	7635700	0	0	0	0	0	0	0	0	0	0	0	0	0	8292600	8596300	8506600	NA	NA	NA	ATP6V0D1	ATP6V0D1;NA;NA;NA;NA	vacuolar acidification;cellular response to increased oxygen levels;cellular iron ion homeostasis;IRE1-mediated unfolded protein response;cilium assembly;insulin receptor signaling pathway;transferrin transport;vacuolar transport;ion transmembrane transport;ATP hydrolysis coupled proton transport;regulation of macroautophagy;brain development;hydrogen ion transmembrane transport	GO:000703; GO:003629; GO:000687; GO:003649; GO:006027; GO:000828; GO:003357; GO:000703; GO:003422; GO:001599; GO:001624; GO:000742; GO:190260	extracellular exosome;synaptic vesicle;proton-transporting V-type ATPase, V0 domain;lysosomal membrane;membrane;phagocytic vesicle membrane;centrosome;endosome membrane;apical plasma membrane;vacuolar proton-transporting V-type ATPase complex;plasma membrane proton-transporting V-type ATPase complex;axon terminus	GO:007006; GO:000802; GO:003317; GO:000576; GO:001602; GO:003067; GO:000581; GO:001000; GO:001632; GO:001647; GO:003318; GO:004367	 Phagosome; Viral carcinogenesis; Oxidative phosphorylation; Metabolic pathways; Synaptic vesicle cycle; Epithelial cell signaling in Helicobacter pylori infection; Tuberculosis; Collecting duct acid secretion; Lysosome; Vibrio cholerae infection; Rheumatoid arthritis	hsa0414; hsa0520; hsa0019; hsa0110; hsa0472; hsa0512; hsa0515; hsa0496; hsa0414; hsa0511; hsa0532	protein binding;hydrogen-exporting ATPase activity, phosphorylative mechanism;proton-transporting ATPase activity, rotational mechanism;macromolecular complex binding	GO:000551; GO:000855; GO:004696; GO:004487
XP_003127021.2	XP_003127021.2	XP_003127021.2 plasmolipin [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	10564000	0	0	0	0	0	0	0	0	NA	NA	NA	PLLP	PLLP;NA;NA;NA;NA	response to wounding;myelination;ion transport	GO:000961; GO:004255; GO:000681	compact myelin;integral component of membrane;membrane raft	GO:004321; GO:001602; GO:004512	"NA"	"NA"	protein binding;structural constituent of myelin sheath	GO:000551; GO:001991
XP_003127042.1	XP_003127042.1	XP_003127042.1 dnaJ homolog subfamily A member 2 [Sus scrofa]	6	6	6	26324000	48588000	35000000	0	23891000	0	33825000	29215000	30446000	33158000	21792000	37685000	28665000	29420000	20456000	35011000	32903000	30638000	NA	NA	NA	DNAJA2	DNAJA2;NA;NA;NA;NA	positive regulation of cell proliferation;response to heat;positive regulation of ATPase activity;protein refolding	GO:000828; GO:000940; GO:003278; GO:004202	membrane;extracellular exosome;cytosol	GO:001602; GO:007006; GO:000582	 Protein processing in endoplasmic reticulum	hsa0414	chaperone binding;ATP binding;metal ion binding;heat shock protein binding;protein binding;ATPase activator activity;unfolded protein binding	GO:005108; GO:000552; GO:004687; GO:003107; GO:000551; GO:000167; GO:005108
XP_003127050.1	XP_003127050.1	XP_003127050.1 cytochrome b-c1 complex subunit Rieske, mitochondrial [Sus scrofa]	7	7	7	114500000	53473000	71022000	49191000	67996000	39783000	104800000	75457000	95997000	72857000	73646000	62842000	54011000	45551000	86577000	70147000	55516000	44911000	NA	NA	NA	LOC100522678	LOC100522678;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005653317.1;XP_003127051.1	XP_005653317.1;XP_003127051.1	XP_005653317.1 pleckstrin homology domain-containing family F member 1 [Sus scrofa];XP_003127051.1 pleckstrin homology domain-containing family F member 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	9403000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PLEKHF1	PLEKHF1;PLEKHF1;NA;NA;NA	endosome organization;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of autophagy;vesicle organization;apoptotic process;protein localization to plasma membrane	GO:000703; GO:200124; GO:001050; GO:001605; GO:000691; GO:007265	perinuclear region of cytoplasm;lysosome;endosome membrane;nucleus	GO:004847; GO:000576; GO:001000; GO:000563	"NA"	"NA"	metal ion binding;protein binding;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol binding;phosphatidylinositol-4-phosphate binding	GO:004687; GO:000551; GO:001031; GO:003226; GO:003509; GO:007027
XP_003127107.1	XP_003127107.1	XP_003127107.1 heat shock protein beta-6 [Sus scrofa]	10	10	10	495570000	937740000	573370000	943110000	416560000	599420000	521480000	954040000	517030000	924200000	699440000	1124400000	730090000	914880000	645840000	766920000	690070000	867740000	NA	NA	NA	HSPB6	HSPB6;NA;NA;NA;NA	regulation of muscle contraction;chaperone-mediated protein folding;negative regulation of cardiac muscle cell apoptotic process;positive regulation of angiogenesis	GO:000693; GO:006107; GO:001066; GO:004576	extracellular region;nucleus;cytoplasm	GO:000557; GO:000563; GO:000573	"NA"	"NA"	unfolded protein binding;protein homodimerization activity;protein binding;structural constituent of eye lens;chaperone binding	GO:005108; GO:004280; GO:000551; GO:000521; GO:005108
XP_003127167.2;XP_005664652.1	XP_003127167.2;XP_005664652.1	XP_003127167.2 eukaryotic translation initiation factor 3 subunit K isoform X2 [Sus scrofa];XP_005664652.1 eukaryotic translation initiation factor 3 subunit K isoform X1 [Sus scrofa]	3	3	3	0	22615000	16930000	0	18550000	21993000	21980000	13659000	17043000	0	0	19489000	0	21387000	0	17596000	23148000	25696000	NA	NA	NA	EIF3K	EIF3K;EIF3K;NA;NA;NA	formation of cytoplasmic translation initiation complex;translational initiation;regulation of translational initiation	GO:000173; GO:000641; GO:000644	nucleus;eukaryotic translation initiation factor 3 complex;cytosol;eukaryotic 48S preinitiation complex;membrane;eukaryotic 43S preinitiation complex	GO:000563; GO:000585; GO:000582; GO:003329; GO:001602; GO:001628	"NA"	"NA"	protein binding;ribosome binding;translation initiation factor activity	GO:000551; GO:004302; GO:000374
XP_005655941.1;XP_003127220.1	XP_005655941.1;XP_003127220.1	XP_005655941.1 platelet-activating factor acetylhydrolase IB subunit gamma isoform X2 [Sus scrofa];XP_003127220.1 platelet-activating factor acetylhydrolase IB subunit gamma isoform X1 [Sus scrofa]	4	4	4	30547000	34933000	35777000	32576000	0	36985000	0	22693000	28331000	0	37112000	33778000	52353000	29513000	0	28861000	49273000	33379000	NA	NA	NA	PAFAH1B3	PAFAH1B3;PAFAH1B3;NA;NA;NA	lipid metabolic process;spermatogenesis;lipid catabolic process;nervous system development;brain development	GO:000662; GO:000728; GO:001604; GO:000739; GO:000742	cytosol;membrane;cytoplasm	GO:000582; GO:001602; GO:000573	 Ether lipid metabolism; Metabolic pathways	hsa0056; hsa0110	protein heterodimerization activity;phospholipase A2 activity;identical protein binding;platelet-activating factor acetyltransferase activity;protein binding;1-alkyl-2-acetylglycerophosphocholine esterase activity	GO:004698; GO:000462; GO:004280; GO:004717; GO:000551; GO:000384
XP_003481921.1;XP_003127229.3;XP_005655963.1	XP_003481921.1;XP_003127229.3;XP_005655963.1	XP_003481921.1 40S ribosomal protein S19 isoform X2 [Sus scrofa];XP_003127229.3 40S ribosomal protein S19 isoform X2 [Sus scrofa];XP_005655963.1 40S ribosomal protein S19 isoform X1 [Sus scrofa]	8	8	8	143200000	148860000	170360000	159910000	167350000	171210000	144570000	156970000	119690000	148610000	179050000	224800000	105230000	198970000	147430000	175430000	159780000	183840000	NA	NA	NA	RPS19	RPS19;RPS19;RPS19;NA;NA	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;SRP-dependent cotranslational protein targeting to membrane;positive regulation of cellular component movement;translation;Notch signaling pathway;response to extracellular stimulus;maturation of SSU-rRNA;killing of cells of other organism;positive regulation of respiratory burst involved in inflammatory response;protein tetramerization;ribosomal small subunit biogenesis;ribosomal small subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;monocyte chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide;nucleolus organization;erythrocyte differentiation;defense response to Gram-negative bacterium	GO:000046; GO:000636; GO:000661; GO:005127; GO:000641; GO:000721; GO:000999; GO:003049; GO:003164; GO:006026; GO:005126; GO:004227; GO:000002; GO:000018; GO:000254; GO:006184; GO:000700; GO:003021; GO:005082	cytosolic small ribosomal subunit;nucleolus;cytosol;extracellular exosome;focal adhesion;nucleoplasm;membrane;postsynaptic density;ribosome	GO:002262; GO:000573; GO:000582; GO:007006; GO:000592; GO:000565; GO:001602; GO:001406; GO:000584	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;fibroblast growth factor binding;protein kinase binding;protein homodimerization activity;protein binding	GO:000372; GO:000373; GO:001713; GO:001990; GO:004280; GO:000551
XP_003127286.3;XP_003356032.3	XP_003127286.3;XP_003356032.3	XP_003127286.3 neutral amino acid transporter B(0) isoform X1 [Sus scrofa];XP_003356032.3 neutral amino acid transporter B(0) isoform X2 [Sus scrofa]	6	6	6	22176000	26235000	24672000	16763000	21355000	16998000	17351000	15843000	25744000	19589000	25857000	0	16588000	13406000	21016000	21011000	20727000	23782000	NA	NA	NA	SLC1A5	SLC1A5;SLC1A5;NA;NA;NA	amino acid transport;glutamine secretion;protein homotrimerization;viral entry into host cell;L-serine transport;neutral amino acid transport;glutamine transport;L-glutamine import into cell	GO:000686; GO:001058; GO:007020; GO:004671; GO:001582; GO:001580; GO:000686; GO:190380	melanosome;integral component of membrane;plasma membrane;extracellular exosome	GO:004247; GO:001602; GO:000588; GO:007006	 Protein digestion and absorption; Central carbon metabolism in cancer	hsa0497; hsa0523	protein binding;L-serine transmembrane transporter activity;L-glutamine transmembrane transporter activity;amino acid transmembrane transporter activity;metal ion binding;signaling receptor activity;virus receptor activity;symporter activity	GO:000551; GO:001519; GO:001518; GO:001517; GO:004687; GO:003802; GO:000161; GO:001529
XP_013853985.1;XP_003127291.1	XP_013853985.1;XP_003127291.1	XP_013853985.1 SUMO-activating enzyme subunit 1 isoform X2 [Sus scrofa];XP_003127291.1 SUMO-activating enzyme subunit 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	3158200	0	0	0	3242600	0	0	0	4915500	0	0	0	2851000	0	0	NA	NA	NA	SAE1	SAE1;SAE1;NA;NA;NA	protein sumoylation;positive regulation of catalytic activity;protein modification by small protein conjugation;protein ubiquitination;positive regulation of protein targeting to mitochondrion	GO:001692; GO:004308; GO:003244; GO:001656; GO:190395	nucleoplasm;SUMO activating enzyme complex;nucleus;cytoplasm	GO:000565; GO:003151; GO:000563; GO:000573	 Ubiquitin mediated proteolysis	hsa0412	protein C-terminus binding;small protein activating enzyme binding;protein binding;ubiquitin activating enzyme activity;enzyme activator activity;SUMO activating enzyme activity;protein heterodimerization activity;ATP-dependent protein binding	GO:000802; GO:004438; GO:000551; GO:000483; GO:000804; GO:001994; GO:004698; GO:004300
XP_005664745.1;XP_003127326.2;XP_013854062.1;XP_013854064.1;XP_020950362.1;XP_013854063.1;XP_020950361.1	XP_005664745.1;XP_003127326.2;XP_013854062.1;XP_013854064.1;XP_020950362.1;XP_013854063.1;XP_020950361.1	XP_005664745.1 branched-chain-amino-acid aminotransferase, mitochondrial isoform X7 [Sus scrofa];XP_003127326.2 branched-chain-amino-acid aminotransferase, mitochondrial isoform X3 [Sus scrofa];XP_013854062.1 branched-chain-amino-acid aminotransferase, mit	5	5	5	122100000	49524000	87916000	45745000	113210000	78071000	106360000	67796000	92430000	66045000	76528000	52693000	49961000	68187000	79586000	72543000	74760000	48635000	NA	NA	NA	BCAT2	BCAT2;BCAT2;BCAT2;BCAT2;BCAT2	isoleucine catabolic process;regulation of hormone levels;leucine biosynthetic process;cellular response to leukemia inhibitory factor;branched-chain amino acid catabolic process	GO:000655; GO:001081; GO:000909; GO:199083; GO:000908	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Pantothenate and CoA biosynthesis; Biosynthesis of antibiotics; Metabolic pathways; Biosynthesis of amino acids; Valine, leucine and isoleucine biosynthesis; 2-Oxocarboxylic acid metabolism; Valine, leucine and isoleucine degradation	hsa0077; hsa0113; hsa0110; hsa0123; hsa0029; hsa0121; hsa0028	branched-chain-amino-acid transaminase activity;L-leucine transaminase activity	GO:000408; GO:005265
XP_013854105.1;XP_003127376.1	XP_013854105.1;XP_003127376.1	XP_013854105.1 reticulocalbin-3 [Sus scrofa];XP_003127376.1 reticulocalbin-3 [Sus scrofa]	6	6	6	0	37048000	18358000	40727000	20989000	42812000	25923000	35691000	0	37697000	27420000	40490000	62540000	41864000	30920000	24230000	34015000	44238000	NA	NA	NA	RCN3	RCN3;RCN3;NA;NA;NA	collagen biosynthetic process;regulation of protein kinase B signaling;lung epithelium development;protein secretion;protein transport;phospholipid homeostasis;ERAD pathway;positive regulation of peptidase activity;surfactant homeostasis	GO:003296; GO:005189; GO:006042; GO:000930; GO:001503; GO:005509; GO:003650; GO:001095; GO:004312	endoplasmic reticulum lumen;endoplasmic reticulum	GO:000578; GO:000578	"NA"	"NA"	protein binding;calcium ion binding	GO:000551; GO:000550
XP_003127419.3	XP_003127419.3	XP_003127419.3 LOW QUALITY PROTEIN: myosin-binding protein C, fast-type [Sus scrofa]	22	22	22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	443450000	0	NA	NA	NA	MYBPC2	MYBPC2;NA;NA;NA;NA	skeletal muscle myosin thick filament assembly;sarcomere organization;cardiac muscle tissue morphogenesis;muscle contraction;cell adhesion;muscle filament sliding;skeletal muscle thin filament assembly;cardiac muscle fiber development;striated muscle myosin thick filament assembly	GO:003024; GO:004521; GO:005500; GO:000693; GO:000715; GO:003004; GO:003024; GO:004873; GO:007168	Z disc;cytosol;striated muscle thin filament;myosin filament;M band;sarcomere	GO:003001; GO:000582; GO:000586; GO:003298; GO:003143; GO:003001	"NA"	"NA"	protein binding;structural constituent of muscle;muscle alpha-actinin binding;actin filament binding	GO:000551; GO:000830; GO:005137; GO:005101
XP_020950568.1;XP_020950567.1;XP_003127453.1;XP_003127452.1	XP_020950568.1;XP_020950567.1;XP_003127453.1;XP_003127452.1	XP_020950568.1 myeloid-associated differentiation marker [Sus scrofa];XP_020950567.1 myeloid-associated differentiation marker [Sus scrofa];XP_003127453.1 myeloid-associated differentiation marker [Sus scrofa];XP_003127452.1 myeloid-associated differentiat	4	4	4	85916000	127730000	106820000	95929000	67332000	87054000	83695000	96127000	76287000	99957000	99106000	60168000	127560000	84777000	80784000	87959000	126420000	114630000	NA	NA	NA	MYADM	MYADM;MYADM;MYADM;MYADM;NA	positive regulation of cell migration;cell-cell junction maintenance;negative regulation of protein kinase C signaling;regulation of cell-substrate adhesion;negative regulation of heterotypic cell-cell adhesion;membrane raft organization;positive regulation of substrate adhesion-dependent cell spreading;protein localization to plasma membrane;negative regulation of gene expression;establishment of endothelial barrier;negative regulation of protein phosphorylation;negative regulation of actin filament polymerization	GO:003033; GO:004521; GO:009003; GO:001081; GO:003411; GO:003157; GO:190002; GO:007265; GO:001062; GO:006102; GO:000193; GO:003083	cortical actin cytoskeleton;plasma membrane;ruffle;cell-cell junction;integral component of membrane;membrane raft	GO:003086; GO:000588; GO:000172; GO:000591; GO:001602; GO:004512	"NA"	"NA"	molecular_function	GO:000367
XP_013854212.1;XP_003127465.1	XP_013854212.1;XP_003127465.1	XP_013854212.1 lysophospholipid acyltransferase 7 isoform X2 [Sus scrofa];XP_003127465.1 lysophospholipid acyltransferase 7 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7588300	0	NA	NA	NA	MBOAT7	MBOAT7;MBOAT7;NA;NA;NA	phospholipid biosynthetic process;layer formation in cerebral cortex;phosphatidylinositol acyl-chain remodeling;ventricular system development	GO:000865; GO:002181; GO:003614; GO:002159	integral component of membrane;membrane;endoplasmic reticulum membrane	GO:001602; GO:001602; GO:000578	 Glycerophospholipid metabolism	hsa0056	1-acylglycerol-3-phosphate O-acyltransferase activity;lysophospholipid acyltransferase activity;2-acylglycerol-3-phosphate O-acyltransferase activity;protein binding	GO:000384; GO:007161; GO:004714; GO:000551
XP_005656031.1;XP_003127516.2	XP_005656031.1;XP_003127516.2	XP_005656031.1 hsp70-binding protein 1 [Sus scrofa];XP_003127516.2 hsp70-binding protein 1 [Sus scrofa]	2	2	2	0	0	4657000	0	4131800	0	3765900	3276500	4290400	0	0	0	0	0	3300200	3822400	3937200	0	NA	NA	NA	HSPBP1	HSPBP1;HSPBP1;NA;NA;NA	positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein folding;negative regulation of catalytic activity;positive regulation of protein ubiquitination	GO:003243; GO:000645; GO:004308; GO:003139	cytoplasm;endoplasmic reticulum	GO:000573; GO:000578	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;adenyl-nucleotide exchange factor activity;enzyme inhibitor activity;ubiquitin protein ligase binding	GO:000551; GO:000077; GO:000485; GO:003162
XP_003127552.3	XP_003127552.3	XP_003127552.3 LOW QUALITY PROTEIN: ATPase family AAA domain-containing protein 3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC100525876	LOC100525876;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003127605.2	XP_003127605.2	XP_003127605.2 LOW QUALITY PROTEIN: 6-phosphogluconate dehydrogenase, decarboxylating [Sus scrofa]	26	26	26	2190600000	1523500000	1770400000	1732100000	1742600000	1004600000	1840000000	1566000000	1792200000	1419400000	1403000000	802830000	946120000	1455700000	1625200000	1817700000	1592200000	1434200000	NA	NA	NA	PGD	PGD;NA;NA;NA;NA	pentose-phosphate shunt;pentose-phosphate shunt, oxidative branch;oxidation-reduction process;pentose biosynthetic process;D-gluconate metabolic process	GO:000609; GO:000905; GO:005511; GO:001932; GO:001952	nucleus;cytosol;extracellular exosome	GO:000563; GO:000582; GO:007006	 Glutathione metabolism; Metabolic pathways; Carbon metabolism; Pentose phosphate pathway; Biosynthesis of antibiotics	hsa0048; hsa0110; hsa0120; hsa0003; hsa0113	phosphogluconate dehydrogenase (decarboxylating) activity;NADP binding	GO:000461; GO:005066
XP_005665053.1;XP_005665052.1;XP_003127622.1;XP_020951005.1;XP_020951004.1;XP_020951003.1;XP_003127623.1;XP_020951002.1;XP_020951001.1	XP_005665053.1;XP_005665052.1;XP_003127622.1;XP_020951005.1;XP_020951004.1;XP_020951003.1;XP_003127623.1;XP_020951002.1;XP_020951001.1	XP_005665053.1 methylenetetrahydrofolate reductase isoform X5 [Sus scrofa];XP_005665052.1 methylenetetrahydrofolate reductase isoform X5 [Sus scrofa];XP_003127622.1 methylenetetrahydrofolate reductase isoform X5 [Sus scrofa];XP_020951005.1 methylenetetrahy	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2223200	NA	NA	NA	MTHFR	MTHFR;MTHFR;MTHFR;MTHFR;MTHFR	one-carbon metabolic process;methionine biosynthetic process;regulation of histone methylation;response to interleukin-1;cellular amino acid metabolic process;blood circulation;folic acid metabolic process;heterochromatin maintenance;response to hypoxia;response to vitamin B2;response to folic acid;methionine metabolic process;homocysteine metabolic process;neural tube closure;oxidation-reduction process;response to amino acid;tetrahydrofolate interconversion;S-adenosylmethionine metabolic process	GO:000673; GO:000908; GO:003106; GO:007055; GO:000652; GO:000801; GO:004665; GO:007082; GO:000166; GO:003327; GO:005159; GO:000655; GO:005066; GO:000184; GO:005511; GO:004320; GO:003599; GO:004650	synapse;cytosol	GO:004520; GO:000582	 One carbon pool by folate; Metabolic pathways; Carbon metabolism	hsa0067; hsa0110; hsa0120	macromolecular complex binding;modified amino acid binding;flavin adenine dinucleotide binding;methylenetetrahydrofolate reductase (NAD(P)H) activity;FAD binding	GO:004487; GO:007234; GO:005066; GO:000448; GO:007194
XP_003127676.1	XP_003127676.1	XP_003127676.1 EF-hand domain-containing protein D2 [Sus scrofa]	13	13	12	78719000	126330000	117320000	122630000	79124000	178650000	73576000	119180000	87762000	100970000	107450000	99448000	144910000	108000000	90408000	89830000	104880000	125740000	NA	NA	NA	EFHD2	EFHD2;NA;NA;NA;NA	"NA"	"NA"	membrane raft	GO:004512	"NA"	"NA"	calcium ion binding;cadherin binding	GO:000550; GO:004529
XP_005665104.1;XP_003127692.1	XP_005665104.1;XP_003127692.1	XP_005665104.1 microfibrillar-associated protein 2 isoform X2 [Sus scrofa];XP_003127692.1 microfibrillar-associated protein 2 isoform X1 [Sus scrofa]	1	1	1	0	215170000	73819000	240560000	0	196790000	0	152560000	0	118430000	0	31750000	0	140300000	55178000	134490000	0	137910000	NA	NA	NA	MFAP2	MFAP2;MFAP2;NA;NA;NA	extracellular matrix organization;embryonic eye morphogenesis;post-embryonic eye morphogenesis	GO:003019; GO:004804; GO:004805	microfibril;extracellular region	GO:000152; GO:000557	"NA"	"NA"	extracellular matrix structural constituent	GO:000520
XP_020951258.1;XP_020951257.1;XP_020951256.1;XP_020951255.1;XP_003127758.1	XP_020951258.1;XP_020951257.1;XP_020951256.1;XP_020951255.1;XP_003127758.1	XP_020951258.1 mitochondrial fission regulator 1-like isoform X2 [Sus scrofa];XP_020951257.1 mitochondrial fission regulator 1-like isoform X2 [Sus scrofa];XP_020951256.1 mitochondrial fission regulator 1-like isoform X1 [Sus scrofa];XP_020951255.1 mitocho	2	2	2	0	0	0	0	0	6713200	0	0	0	0	0	8709200	0	0	0	0	0	0	NA	NA	NA	MTFR1L	MTFR1L;MTFR1L;MTFR1L;MTFR1L;MTFR1L	mitochondrial fission;aerobic respiration	GO:000026; GO:000906	mitochondrion	GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_003127816.2;XP_020951433.1	XP_003127816.2;XP_020951433.1	XP_003127816.2 peflin isoform X2 [Sus scrofa];XP_020951433.1 peflin isoform X1 [Sus scrofa]	3	3	3	0	6918300	6241600	0	6185000	6570000	0	6776200	6789700	7733500	0	0	0	0	0	0	6459200	0	NA	NA	NA	PEF1	PEF1;PEF1;NA;NA;NA	positive regulation of protein monoubiquitination;neural crest formation;ER to Golgi vesicle-mediated transport;response to calcium ion;neural crest cell development;COPII vesicle coating	GO:190252; GO:001402; GO:000688; GO:005159; GO:001403; GO:004820	endoplasmic reticulum;COPII vesicle coat;Cul3-RING ubiquitin ligase complex;Golgi membrane;cytoplasm;extracellular exosome	GO:000578; GO:003012; GO:003146; GO:000013; GO:000573; GO:007006	"NA"	"NA"	binding, bridging;calcium ion binding;RNA binding;protein dimerization activity;calcium-dependent protein binding;protein binding	GO:006009; GO:000550; GO:000372; GO:004698; GO:004830; GO:000551
XP_003127836.1	XP_003127836.1	XP_003127836.1 poly(ADP-ribose) glycohydrolase ARH3 [Sus scrofa]	4	4	4	0	15329000	13316000	0	0	0	17029000	21016000	0	15691000	0	22120000	0	0	0	12349000	10812000	15143000	NA	NA	NA	ADPRHL2	ADPRHL2;NA;NA;NA;NA	DNA repair;cellular response to superoxide	GO:000628; GO:007145	nucleoplasm;site of DNA damage;mitochondrion;nuclear body;nucleus;mitochondrial matrix	GO:000565; GO:009073; GO:000573; GO:001660; GO:000563; GO:000575	"NA"	"NA"	O-acetyl-ADP-ribose deacetylase activity;poly(ADP-ribose) glycohydrolase activity;magnesium ion binding;hydrolase activity, hydrolyzing O-glycosyl compounds	GO:006146; GO:000464; GO:000028; GO:000455
XP_003127843.1	XP_003127843.1	XP_003127843.1 splicing factor 3A subunit 3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	6073000	0	0	0	0	0	NA	NA	NA	SF3A3	SF3A3;NA;NA;NA;NA	RNA splicing, via transesterification reactions;RNA splicing;U2-type prespliceosome assembly;mRNA 3'-splice site recognition;mRNA splicing, via spliceosome;mRNA processing	GO:000037; GO:000838; GO:190324; GO:000038; GO:000039; GO:000639	nucleoplasm;U2-type precatalytic spliceosome;nucleus;spliceosomal complex;nuclear speck;catalytic step 2 spliceosome	GO:000565; GO:007100; GO:000563; GO:000568; GO:001660; GO:007101	 Spliceosome	hsa0304	protein binding;RNA binding;zinc ion binding	GO:000551; GO:000372; GO:000827
XP_003127871.2	XP_003127871.2	XP_003127871.2 palmitoyl-protein thioesterase 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7627500	NA	NA	NA	PPT1	PPT1;NA;NA;NA;NA	associative learning;negative regulation of apoptotic process;cofactor transport;receptor-mediated endocytosis;lysosomal lumen acidification;negative regulation of neuron apoptotic process;cellular protein catabolic process;protein depalmitoylation;brain development;sphingolipid catabolic process;neuron development;response to stimulus;nervous system development;protein catabolic process;visual perception;fatty-acyl-CoA biosynthetic process;positive regulation of receptor-mediated endocytosis;regulation of synapse structure or activity;neurotransmitter secretion;lipid catabolic process;negative regulation of cell growth;membrane raft organization;pinocytosis;grooming behavior;adult locomotory behavior;protein transport;regulation of phospholipase A2 activity;positive regulation of pinocytosis	GO:000830; GO:004306; GO:005118; GO:000689; GO:000704; GO:004352; GO:004425; GO:000208; GO:000742; GO:003014; GO:004866; GO:005089; GO:000739; GO:003016; GO:000760; GO:004694; GO:004826; GO:005080; GO:000726; GO:001604; GO:003030; GO:003157; GO:000690; GO:000762; GO:000834; GO:001503; GO:003242; GO:004854	synaptic vesicle;axon;lysosomal lumen;neuronal cell body;membrane;cytosol;Golgi apparatus;membrane raft;extracellular region;lysosome;nucleus;extracellular exosome	GO:000802; GO:003042; GO:004320; GO:004302; GO:001602; GO:000582; GO:000579; GO:004512; GO:000557; GO:000576; GO:000563; GO:007006	 Lysosome; Fatty acid metabolism; Fatty acid elongation; Metabolic pathways	hsa0414; hsa0121; hsa0006; hsa0110	palmitoyl-CoA hydrolase activity;protein binding;palmitoyl-(protein) hydrolase activity	GO:001629; GO:000551; GO:000847
XP_020951657.1;XP_020951656.1;XP_020951655.1;XP_003127872.5;XP_020951665.1;XP_020951664.1;XP_020951663.1;XP_020951662.1	XP_020951657.1;XP_020951656.1;XP_020951655.1;XP_003127872.5;XP_020951665.1;XP_020951664.1;XP_020951663.1;XP_020951662.1	XP_020951657.1 adenylyl cyclase-associated protein 1 isoform X1 [Sus scrofa];XP_020951656.1 adenylyl cyclase-associated protein 1 isoform X1 [Sus scrofa];XP_020951655.1 adenylyl cyclase-associated protein 1 isoform X1 [Sus scrofa];XP_003127872.5 adenylyl c	20	20	1	634300000	754150000	829660000	692310000	602320000	736260000	597830000	782680000	676990000	826460000	626830000	938100000	912140000	749760000	629930000	741140000	706400000	740380000	NA	NA	NA	CAP1	CAP1;CAP1;CAP1;CAP1;CAP1	receptor-mediated endocytosis;actin polymerization or depolymerization;cell morphogenesis;activation of adenylate cyclase activity;ameboidal-type cell migration;signal transduction;neutrophil degranulation	GO:000689; GO:000815; GO:000090; GO:000719; GO:000166; GO:000716; GO:004331	extracellular region;focal adhesion;plasma membrane;cortical actin cytoskeleton;azurophil granule lumen;extracellular exosome	GO:000557; GO:000592; GO:000588; GO:003086; GO:003557; GO:007006	"NA"	"NA"	adenylate cyclase binding;actin binding	GO:000817; GO:000377
XP_005665357.1;XP_003127892.2	XP_005665357.1;XP_003127892.2	XP_005665357.1 myomesin-1 isoform X1 [Sus scrofa];XP_003127892.2 myomesin-1 isoform X2 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49315000	0	NA	NA	NA	MYOM1	MYOM1;MYOM1;NA;NA;NA	extraocular skeletal muscle development;skeletal muscle thin filament assembly;cardiac muscle fiber development;positive regulation of protein secretion;cardiac myofibril assembly;muscle contraction;striated muscle myosin thick filament assembly;positive regulation of gene expression;sarcomere organization;protein kinase A signaling	GO:000207; GO:003024; GO:004873; GO:005071; GO:005500; GO:000693; GO:007168; GO:001062; GO:004521; GO:001073	sarcomere;striated muscle myosin thick filament;Z disc;M band	GO:003001; GO:000586; GO:003001; GO:003143	"NA"	"NA"	identical protein binding;actin filament binding;structural constituent of muscle;kinase binding;protein homodimerization activity;protein binding;muscle alpha-actinin binding	GO:004280; GO:005101; GO:000830; GO:001990; GO:004280; GO:000551; GO:005137
XP_020951826.1;XP_005653461.1;XP_003127902.1	XP_020951826.1;XP_005653461.1;XP_003127902.1	XP_020951826.1 small nuclear ribonucleoprotein Sm D1 isoform X2 [Sus scrofa];XP_005653461.1 small nuclear ribonucleoprotein Sm D1 isoform X2 [Sus scrofa];XP_003127902.1 small nuclear ribonucleoprotein Sm D1 isoform X1 [Sus scrofa]	3	3	3	18484000	12670000	11942000	0	34039000	13700000	10035000	36434000	14406000	18505000	19673000	64803000	0	12504000	14520000	14956000	14762000	12802000	NA	NA	NA	SNRPD1	SNRPD1;SNRPD1;SNRPD1;NA;NA	spliceosomal snRNP assembly;nuclear import;mRNA splicing, via spliceosome;RNA splicing;spliceosomal complex assembly	GO:000038; GO:005117; GO:000039; GO:000838; GO:000024	small nuclear ribonucleoprotein complex;nucleoplasm;U1 snRNP;U2-type precatalytic spliceosome;commitment complex;nucleus;catalytic step 2 spliceosome;cytosol;SMN-Sm protein complex;methylosome;U4/U6 x U5 tri-snRNP complex	GO:003053; GO:000565; GO:000568; GO:007100; GO:000024; GO:000563; GO:007101; GO:000582; GO:003471; GO:003470; GO:004654	 Systemic lupus erythematosus; Spliceosome	hsa0532; hsa0304	RNA binding;protein binding;U1 snRNP binding	GO:000372; GO:000551; GO:199044
XP_020952097.1;XP_020952096.1;XP_013854792.1;XP_020952095.1;XP_020952093.1;XP_020952092.1;XP_020952091.1;XP_003127965.2;XP_020952090.1;XP_020952089.1;XP_020952088.1;XP_020952087.1;XP_013854788.1;XP_005665424.1;XP_020952085.1;XP_013854785.1;XP_020932834.1;XP_020932775.1;XP_020932733.1;XP_005660579.1;NP_001231214.1;XP_013849385.1;XP_005660577.1;XP_013849380.1;XP_020932634.1;XP_020932513.1;XP_020932494.1	XP_020952097.1;XP_020952096.1;XP_013854792.1;XP_020952095.1;XP_020952093.1;XP_020952092.1;XP_020952091.1;XP_003127965.2;XP_020952090.1;XP_020952089.1;XP_020952088.1;XP_020952087.1;XP_013854788.1;XP_005665424.1;XP_020952085.1;XP_013854785.1	XP_020952097.1 far upstream element-binding protein 1 isoform X16 [Sus scrofa];XP_020952096.1 far upstream element-binding protein 1 isoform X15 [Sus scrofa];XP_013854792.1 far upstream element-binding protein 1 isoform X14 [Sus scrofa];XP_020952095.1 far	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3303900	NA	NA	NA	FUBP1	FUBP1;FUBP1;FUBP1;FUBP1;FUBP1	transcription from RNA polymerase II promoter;positive regulation of gene expression;regulation of transcription, DNA-templated	GO:000636; GO:001062; GO:000635	nucleoplasm;nucleus	GO:000565; GO:000563	"NA"	"NA"	transcription factor activity, sequence-specific DNA binding;RNA binding;protein binding;single-stranded DNA binding	GO:000370; GO:000372; GO:000551; GO:000369
XP_020952080.1;XP_003127967.3;XP_020952079.1	XP_020952080.1;XP_003127967.3;XP_020952079.1	XP_020952080.1 interferon-induced protein 44-like isoform X2 [Sus scrofa];XP_003127967.3 interferon-induced protein 44-like isoform X2 [Sus scrofa];XP_020952079.1 interferon-induced protein 44-like isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	7271800	0	0	0	0	0	0	0	NA	NA	NA	IFI44L	IFI44L;IFI44L;IFI44L;NA;NA	immune response;defense response to virus	GO:000695; GO:005160	cellular_component;cytoplasm	GO:000557; GO:000573	"NA"	"NA"	GTP binding;molecular_function	GO:000552; GO:000367
XP_003127982.1;XP_003356484.1;XP_003127983.1;XP_003127984.1	XP_003127982.1;XP_003356484.1;XP_003127983.1;XP_003127984.1	XP_003127982.1 plasminogen activator inhibitor 1 RNA-binding protein isoform X4 [Sus scrofa];XP_003356484.1 plasminogen activator inhibitor 1 RNA-binding protein isoform X3 [Sus scrofa];XP_003127983.1 plasminogen activator inhibitor 1 RNA-binding protein i	5	5	5	0	25888000	33192000	20667000	29336000	25093000	31799000	23762000	29935000	27713000	32071000	0	33623000	21631000	40402000	0	33721000	30193000	NA	NA	NA	SERBP1	SERBP1;SERBP1;SERBP1;SERBP1;NA	regulation of mRNA stability;regulation of apoptotic process;PML body organization	GO:004348; GO:004298; GO:003057	nucleus;cytosol;cytoplasm;extracellular exosome;perinuclear region of cytoplasm;plasma membrane;membrane	GO:000563; GO:000582; GO:000573; GO:007006; GO:004847; GO:000588; GO:001602	"NA"	"NA"	RNA binding;mRNA 3'-UTR binding;cadherin binding;protein binding;SUMO binding	GO:000372; GO:000373; GO:004529; GO:000551; GO:003218
XP_005665445.1;XP_003128019.3	XP_005665445.1;XP_003128019.3	XP_005665445.1 phospholipid phosphatase 3 isoform X2 [Sus scrofa];XP_003128019.3 phospholipid phosphatase 3 isoform X1 [Sus scrofa]	3	3	3	0	0	0	16349000	0	26224000	0	0	0	0	0	0	0	0	0	12791000	0	17464000	NA	NA	NA	PLPP3	PLPP3;PLPP3;NA;NA;NA	homotypic cell-cell adhesion;negative regulation of protein phosphorylation;phospholipid metabolic process;regulation of Wnt signaling pathway;canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration;canonical Wnt signaling pathway;germ cell migration;sphingolipid biosynthetic process;canonical Wnt signaling pathway involved in positive regulation of wound healing;phospholipid dephosphorylation;protein dephosphorylation;lipid metabolic process;protein stabilization;positive regulation of sequence-specific DNA binding transcription factor activity	GO:003410; GO:000193; GO:000664; GO:003011; GO:004432; GO:006007; GO:000835; GO:003014; GO:004433; GO:004683; GO:000647; GO:000662; GO:005082; GO:005109	plasma membrane;membrane;Golgi apparatus;adherens junction;integral component of plasma membrane	GO:000588; GO:001602; GO:000579; GO:000591; GO:000588	 Ether lipid metabolism; Glycerolipid metabolism; Metabolic pathways; Fc gamma R-mediated phagocytosis; Fat digestion and absorption; Sphingolipid metabolism; Choline metabolism in cancer	hsa0056; hsa0056; hsa0110; hsa0466; hsa0497; hsa0060; hsa0523	phosphatase activity;lipid phosphatase activity;phosphoprotein phosphatase activity;phosphatidate phosphatase activity;sphingosine-1-phosphate phosphatase activity;protein binding	GO:001679; GO:004257; GO:000472; GO:000819; GO:004239; GO:000551
XP_003128033.2	XP_003128033.2	XP_003128033.2 UPF0587 protein C1orf123 homolog [Sus scrofa]	5	5	5	37563000	43742000	42544000	37448000	42647000	54764000	50810000	42215000	39836000	38708000	38075000	47524000	47598000	53925000	45972000	43470000	40493000	37544000	NA	NA	NA	CZIB	CZIB;NA;NA;NA;NA	biological_process	GO:000815	"NA"	"NA"	"NA"	"NA"	zinc ion binding	GO:000827
XP_013843826.1;XP_003128047.2;XP_013843825.1	XP_013843826.1;XP_003128047.2;XP_013843825.1	XP_013843826.1 protein mago nashi homolog 2 isoform X2 [Sus scrofa];XP_003128047.2 protein mago nashi homolog [Sus scrofa];XP_013843825.1 protein mago nashi homolog 2 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	8573100	0	0	0	0	0	0	NA	NA	NA	MAGOHB	MAGOHB;MAGOH;MAGOHB;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;RNA splicing;mRNA export from nucleus;mRNA splicing, via spliceosome;mRNA 3'-end processing	GO:000018; GO:000838; GO:000640; GO:000039; GO:003112	exon-exon junction complex;neuronal cell body;catalytic step 2 spliceosome;nucleoplasm	GO:003514; GO:004302; GO:007101; GO:000565	 mRNA surveillance pathway; RNA transport; Spliceosome	hsa0301; hsa0301; hsa0304	RNA binding;protein binding	GO:000372; GO:000551
XP_003128059.3	XP_003128059.3	XP_003128059.3 UMP-CMP kinase [Sus scrofa]	7	7	7	88826000	100530000	101090000	92818000	81314000	71349000	94707000	96373000	74431000	78060000	97927000	115990000	92825000	90511000	91073000	94044000	86132000	95036000	NA	NA	NA	CMPK1	CMPK1;NA;NA;NA;NA	pyrimidine ribonucleotide biosynthetic process;nucleoside triphosphate biosynthetic process;'de novo' pyrimidine nucleobase biosynthetic process;UMP biosynthetic process;nucleoside diphosphate phosphorylation;nucleobase-containing small molecule interconversion;nucleoside monophosphate phosphorylation	GO:000922; GO:000914; GO:000620; GO:000622; GO:000616; GO:001594; GO:004694	cytosol;extracellular exosome;nucleus;nucleolus	GO:000582; GO:007006; GO:000563; GO:000573	 Pyrimidine metabolism; Metabolic pathways	hsa0024; hsa0110	ATP binding;nucleoside phosphate kinase activity;nucleoside diphosphate kinase activity;uridylate kinase activity;cytidylate kinase activity;uridine kinase activity	GO:000552; GO:005014; GO:000455; GO:000904; GO:000412; GO:000484
XP_003128108.1	XP_003128108.1	XP_003128108.1 40S ribosomal protein S8 [Sus scrofa]	11	11	11	103000000	73299000	108630000	85065000	100230000	84386000	89706000	78762000	100360000	107400000	87849000	73209000	97040000	111950000	82599000	103170000	97432000	112370000	NA	NA	NA	RPS8	RPS8;NA;NA;NA;NA	translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	GO:000641; GO:000641; GO:000661; GO:000018; GO:000046	cytosolic small ribosomal subunit;extracellular exosome;nucleus;membrane;cytosol;endoplasmic reticulum;ribonucleoprotein complex;nucleoplasm;focal adhesion	GO:002262; GO:007006; GO:000563; GO:001602; GO:000582; GO:000578; GO:199090; GO:000565; GO:000592	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome	GO:000372; GO:000373
XP_013844371.2;XP_003128111.2;XP_005656251.2;XP_013844372.2;XP_003128112.2	XP_013844371.2;XP_003128111.2;XP_005656251.2;XP_013844372.2;XP_003128112.2	XP_013844371.2 putative hydroxypyruvate isomerase isoform X2 [Sus scrofa];XP_003128111.2 putative hydroxypyruvate isomerase isoform X1 [Sus scrofa];XP_005656251.2 putative hydroxypyruvate isomerase isoform X5 [Sus scrofa];XP_013844372.2 putative hydroxypyr	5	5	5	0	0	0	23867000	0	27269000	21292000	0	19260000	18237000	26339000	21516000	38069000	32775000	25777000	26463000	0	0	NA	NA	NA	HYI	HYI;HYI;HYI;HYI;HYI	biological_process	GO:000815	cellular_component	GO:000557	 Metabolic pathways; Glyoxylate and dicarboxylate metabolism	hsa0110; hsa0063	racemase and epimerase activity, acting on carbohydrates and derivatives;hydroxypyruvate isomerase activity;protein binding;molecular_function	GO:001685; GO:000890; GO:000551; GO:000367
XP_003128148.2;XP_003128147.2;XP_003128146.2;XP_020952579.1	XP_003128148.2;XP_003128147.2;XP_003128146.2;XP_020952579.1	XP_003128148.2 peptidyl-prolyl cis-trans isomerase H isoform X4 [Sus scrofa];XP_003128147.2 peptidyl-prolyl cis-trans isomerase H isoform X4 [Sus scrofa];XP_003128146.2 peptidyl-prolyl cis-trans isomerase H isoform X4 [Sus scrofa];XP_020952579.1 peptidyl-p	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1490200	0	0	NA	NA	NA	PPIH	PPIH;PPIH;PPIH;PPIH;NA	protein refolding;angiogenesis;protein folding;mRNA splicing, via spliceosome;protein peptidyl-prolyl isomerization;positive regulation of viral genome replication;macromolecular complex assembly	GO:004202; GO:000152; GO:000645; GO:000039; GO:000041; GO:004507; GO:006500	spliceosomal complex;nuclear speck;U4/U6 x U5 tri-snRNP complex;cytoplasm;U4/U6 snRNP;nucleoplasm	GO:000568; GO:001660; GO:004654; GO:000573; GO:007100; GO:000565	 Spliceosome	hsa0304	protein binding;unfolded protein binding;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;ribonucleoprotein complex binding	GO:000551; GO:005108; GO:000375; GO:001601; GO:004302
XP_003128149.1;XP_013832832.1;XP_013832831.1;XP_013832830.1	XP_003128149.1;XP_013832832.1;XP_013832831.1;XP_013832830.1	XP_003128149.1 phosphopantothenate--cysteine ligase isoform X1 [Sus scrofa];XP_013832832.1 phosphopantothenate--cysteine ligase isoform X3 [Sus scrofa];XP_013832831.1 phosphopantothenate--cysteine ligase isoform X3 [Sus scrofa];XP_013832830.1 phosphopantot	7	7	7	23532000	21990000	24306000	24232000	27270000	21176000	24706000	22748000	27011000	27991000	26047000	29689000	17962000	24610000	24954000	29874000	24883000	18394000	NA	NA	NA	PPCS	PPCS;PPCS;PPCS;PPCS;NA	coenzyme A biosynthetic process;coenzyme biosynthetic process	GO:001593; GO:000910	cytosol	GO:000582	 Pantothenate and CoA biosynthesis; Metabolic pathways	hsa0077; hsa0110	phosphopantothenate--cysteine ligase activity	GO:000463
XP_003128180.1;CON__Q2KJF1	XP_003128180.1	XP_003128180.1 alpha-1B-glycoprotein [Sus scrofa]	22	22	22	1219000000	1244700000	651150000	1476100000	1558700000	1826800000	1236100000	1122800000	1131800000	1060400000	1456200000	1682900000	1474400000	1337400000	1493300000	1305200000	1349400000	1981500000	NA	NA	NA	A1BG	A1BG;NA;NA;NA;NA	neutrophil degranulation;platelet degranulation;biological_process	GO:004331; GO:000257; GO:000815	platelet alpha granule lumen;secretory granule lumen;blood microparticle;extracellular space;extracellular exosome;ficolin-1-rich granule lumen;extracellular region	GO:003109; GO:003477; GO:007256; GO:000561; GO:007006; GO:190481; GO:000557	"NA"	"NA"	molecular_function	GO:000367
XP_003128181.1	XP_003128181.1	XP_003128181.1 40S ribosomal protein S5 [Sus scrofa]	5	5	5	111160000	57315000	123260000	61234000	90701000	87281000	82960000	62476000	108880000	96637000	68784000	52640000	83691000	78396000	49713000	101510000	114980000	90267000	NA	NA	NA	RPS5	RPS5;NA;NA;NA;NA	translation;SRP-dependent cotranslational protein targeting to membrane;translational initiation;regulation of translational fidelity;ribosomal small subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000641; GO:000661; GO:000641; GO:000645; GO:000002; GO:000018	membrane;cytosolic small ribosomal subunit;cytosol;nucleoplasm;focal adhesion;extracellular exosome;ribonucleoprotein complex	GO:001602; GO:002262; GO:000582; GO:000565; GO:000592; GO:007006; GO:199090	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;RNA binding;rRNA binding	GO:000551; GO:000373; GO:000372; GO:001984
XP_020955762.1;XP_020955757.1;XP_020955756.1;XP_020955755.1;XP_020955754.1;XP_020955753.1;XP_003128194.1;XP_013844390.1;XP_013844389.1;XP_013844388.1;XP_020955764.1;XP_020955763.1;XP_020955761.1;XP_020955760.1;XP_020955759.1;XP_020955758.1	XP_020955762.1;XP_020955757.1;XP_020955756.1;XP_020955755.1;XP_020955754.1;XP_020955753.1;XP_003128194.1;XP_013844390.1;XP_013844389.1;XP_013844388.1;XP_020955764.1;XP_020955763.1;XP_020955761.1;XP_020955760.1;XP_020955759.1;XP_020955758.1	XP_020955762.1 exocyst complex component 2 isoform X7 [Sus scrofa];XP_020955757.1 exocyst complex component 2 isoform X4 [Sus scrofa];XP_020955756.1 exocyst complex component 2 isoform X4 [Sus scrofa];XP_020955755.1 exocyst complex component 2 isoform X3 [	3	3	3	0	0	0	0	0	0	0	0	0	5127400	0	0	0	0	0	0	0	0	NA	NA	NA	EXOC2	EXOC2;EXOC2;EXOC2;EXOC2;EXOC2	vesicle-mediated transport;Golgi to plasma membrane transport;exocytosis;regulation of entry of bacterium into host cell;protein transport	GO:001619; GO:000689; GO:000688; GO:200053; GO:001503	plasma membrane;Flemming body;exocyst;membrane;cytosol	GO:000588; GO:009054; GO:000014; GO:001602; GO:000582	 Ras signaling pathway	hsa0401	Ral GTPase binding;protein kinase binding;protein N-terminus binding;protein binding	GO:001716; GO:001990; GO:004748; GO:000551
XP_003128384.1	XP_003128384.1	XP_003128384.1 BAG family molecular chaperone regulator 2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1899400	NA	NA	NA	BAG2	BAG2;NA;NA;NA;NA	positive regulation of protein processing;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin protein ligase activity;protein folding;negative regulation of protein ubiquitination;positive regulation of proteasomal protein catabolic process;negative regulation of protein binding;regulation of cellular response to heat;protein stabilization;protein metabolic process	GO:001095; GO:003243; GO:190466; GO:000645; GO:003139; GO:190180; GO:003209; GO:190003; GO:005082; GO:001953	microtubule;cytosol;dendrite;chaperone complex;dendritic microtubule	GO:000587; GO:000582; GO:003042; GO:010103; GO:190158	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;adenyl-nucleotide exchange factor activity;identical protein binding;heat shock protein binding;ubiquitin protein ligase binding;chaperone binding;tau protein binding;ion channel binding	GO:000551; GO:000077; GO:004280; GO:003107; GO:003162; GO:005108; GO:004815; GO:004432
XP_003128488.1	XP_003128488.1	XP_003128488.1 ammonium transporter Rh type A [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6600700	0	NA	NA	NA	RHAG	RHAG;NA;NA;NA;NA	carbon dioxide transmembrane transport;cellular ion homeostasis;carbon dioxide transport;erythrocyte development;ammonium transmembrane transport;ammonium transport;multicellular organismal iron ion homeostasis;bicarbonate transport	GO:003537; GO:000687; GO:001567; GO:004882; GO:007248; GO:001569; GO:006058; GO:001570	plasma membrane;membrane;integral component of plasma membrane	GO:000588; GO:001602; GO:000588	"NA"	"NA"	leak channel activity;ammonium transmembrane transporter activity;ankyrin binding;carbon dioxide transmembrane transporter activity	GO:002284; GO:000851; GO:003050; GO:003537
XP_020954686.1;XP_003128529.1	XP_020954686.1;XP_003128529.1	XP_020954686.1 tyrosine-protein phosphatase non-receptor type 9 isoform X2 [Sus scrofa];XP_003128529.1 tyrosine-protein phosphatase non-receptor type 9 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4441100	NA	NA	NA	PTPN9	PTPN9;PTPN9;NA;NA;NA	peptidyl-tyrosine dephosphorylation;positive regulation of protein localization to plasma membrane;protein dephosphorylation;cellular response to cytokine stimulus;negative regulation of neuron projection development	GO:003533; GO:190307; GO:000647; GO:007134; GO:001097	cytoplasm;neuron projection terminus;nucleoplasm	GO:000573; GO:004430; GO:000565	"NA"	"NA"	non-membrane spanning protein tyrosine phosphatase activity;protein binding;protein tyrosine phosphatase activity	GO:000472; GO:000551; GO:000472
XP_003128533.4	XP_003128533.4	XP_003128533.4 chondroitin sulfate proteoglycan 4 [Sus scrofa]	24	24	24	13390000	59314000	127780000	53878000	136640000	73241000	83615000	97740000	109760000	74197000	130070000	77263000	15405000	66002000	138800000	77600000	0	70412000	NA	NA	NA	CSPG4	CSPG4;NA;NA;NA;NA	chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;tissue remodeling;activation of MAPK activity;angiogenesis;transmembrane receptor protein tyrosine kinase signaling pathway;intracellular signal transduction;cell proliferation;glial cell migration;positive regulation of peptidyl-tyrosine phosphorylation	GO:003020; GO:003020; GO:004877; GO:000018; GO:000152; GO:000716; GO:003555; GO:000828; GO:000834; GO:005073	focal adhesion;lysosomal lumen;Golgi lumen;extracellular region;integral component of plasma membrane;apical plasma membrane;cell surface;extracellular exosome;lamellipodium membrane	GO:000592; GO:004320; GO:000579; GO:000557; GO:000588; GO:001632; GO:000998; GO:007006; GO:003125	"NA"	"NA"	protein kinase binding	GO:001990
XP_003128571.2;XP_013833588.1	XP_003128571.2;XP_013833588.1	XP_003128571.2 probable D-tyrosyl-tRNA(Tyr) deacylase 2 isoform X2 [Sus scrofa];XP_013833588.1 probable D-tyrosyl-tRNA(Tyr) deacylase 2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1892900	NA	NA	NA	DTD2	DTD2;DTD2;NA;NA;NA	tRNA metabolic process	GO:000639	cytoplasm	GO:000573	"NA"	"NA"	D-tyrosyl-tRNA(Tyr) deacylase activity;aminoacyl-tRNA editing activity;tRNA binding;protein binding	GO:005150; GO:000216; GO:000004; GO:000551
XP_003128591.1;XP_005666291.1	XP_003128591.1;XP_005666291.1	XP_003128591.1 dehydrogenase/reductase SDR family member 1 isoform X2 [Sus scrofa];XP_005666291.1 dehydrogenase/reductase SDR family member 1 isoform X1 [Sus scrofa]	7	7	7	13027000	18784000	22730000	21188000	0	11494000	15911000	19920000	23907000	24146000	11274000	23754000	0	17243000	13512000	27014000	0	12757000	NA	NA	NA	DHRS1	DHRS1;DHRS1;NA;NA;NA	oxidation-reduction process	GO:005511	endoplasmic reticulum	GO:000578	"NA"	"NA"	protein binding;oxidoreductase activity	GO:000551; GO:001649
XP_003128592.1	XP_003128592.1	XP_003128592.1 NEDD8 [Sus scrofa]	2	2	2	0	0	0	0	0	39109000	0	0	0	64758000	0	58576000	0	0	0	37760000	0	0	NA	NA	NA	NEDD8	NEDD8;NA;NA;NA;NA	regulation of transcription from RNA polymerase II promoter;cellular iron ion homeostasis;anatomical structure morphogenesis;regulation of proteolysis;protein ubiquitination;proteolysis;post-translational protein modification;cellular protein modification process;response to organic cyclic compound;protein deubiquitination;modification-dependent protein catabolic process;protein neddylation;ubiquitin-dependent protein catabolic process;protein localization	GO:000635; GO:000687; GO:000965; GO:003016; GO:001656; GO:000650; GO:004368; GO:000646; GO:001407; GO:001657; GO:001994; GO:004511; GO:000651; GO:000810	nucleoplasm;cytoplasm;cytosol;nucleus;extracellular exosome	GO:000565; GO:000573; GO:000582; GO:000563; GO:007006	"NA"	"NA"	protein tag;protein binding;ubiquitin protein ligase binding	GO:003138; GO:000551; GO:003162
XP_013844693.1;XP_005656526.1;XP_003128776.3	XP_013844693.1;XP_005656526.1;XP_003128776.3	XP_013844693.1 tryptophan--tRNA ligase, cytoplasmic [Sus scrofa];XP_005656526.1 tryptophan--tRNA ligase, cytoplasmic [Sus scrofa];XP_003128776.3 tryptophan--tRNA ligase, cytoplasmic [Sus scrofa]	8	8	8	34029000	36604000	23581000	27212000	27282000	24599000	22669000	25040000	28137000	29582000	19366000	31348000	44325000	22850000	31335000	32927000	22953000	30620000	NA	NA	NA	WARS	WARS;WARS;WARS;NA;NA	translation;tryptophanyl-tRNA aminoacylation;negative regulation of cell proliferation;positive regulation of gene expression;tRNA aminoacylation for protein translation;regulation of angiogenesis;angiogenesis;negative regulation of protein phosphorylation;negative regulation of protein kinase activity;regulation of protein ADP-ribosylation;positive regulation of protein complex assembly	GO:000641; GO:000643; GO:000828; GO:001062; GO:000641; GO:004576; GO:000152; GO:000193; GO:000646; GO:001083; GO:003133	extracellular exosome;cytoplasm;macromolecular complex;cytosol;nucleus	GO:007006; GO:000573; GO:003299; GO:000582; GO:000563	 Aminoacyl-tRNA biosynthesis	hsa0097	protein domain specific binding;protein binding;ATP binding;protein kinase binding;kinase inhibitor activity;protein homodimerization activity;tryptophan-tRNA ligase activity	GO:001990; GO:000551; GO:000552; GO:001990; GO:001921; GO:004280; GO:000483
XP_003128958.1	XP_003128958.1	XP_003128958.1 phosphoglucomutase-2 [Sus scrofa]	12	12	12	56788000	71192000	70379000	64255000	63983000	59853000	58129000	57910000	67428000	60129000	63282000	76090000	91523000	76505000	69433000	65513000	82006000	57768000	NA	NA	NA	PGM2	PGM2;NA;NA;NA;NA	glycogen biosynthetic process;pentose-phosphate shunt;galactose catabolic process;glycogen catabolic process;glucose metabolic process;neutrophil degranulation;deoxyribose phosphate catabolic process	GO:000597; GO:000609; GO:001938; GO:000598; GO:000600; GO:004331; GO:004638	cytosol;secretory granule lumen;extracellular exosome;extracellular region;ficolin-1-rich granule lumen	GO:000582; GO:003477; GO:007006; GO:000557; GO:190481	 Glycolysis / Gluconeogenesis; Metabolic pathways; Biosynthesis of antibiotics; Purine metabolism; Pentose phosphate pathway; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism	hsa0001; hsa0110; hsa0113; hsa0023; hsa0003; hsa0005; hsa0050; hsa0052	phosphoglucomutase activity;protein binding;phosphopentomutase activity;magnesium ion binding	GO:000461; GO:000551; GO:000897; GO:000028
XP_003128969.2	XP_003128969.2	XP_003128969.2 LOW QUALITY PROTEIN: protein NOXP20 [Sus scrofa]	9	9	9	36971000	53140000	45150000	46484000	38765000	0	40796000	48276000	0	45464000	41416000	58032000	61498000	43464000	35184000	44993000	42305000	51049000	NA	NA	NA	FAM114A1	FAM114A1;NA;NA;NA;NA	"NA"	"NA"	cytosol;nucleoplasm;nucleus;Golgi apparatus	GO:000582; GO:000565; GO:000563; GO:000579	"NA"	"NA"	protein binding	GO:000551
XP_003128997.3;XP_003128996.1;XP_013834096.1	XP_003128997.3;XP_003128996.1	XP_003128997.3 glucosamine-6-phosphate isomerase 2 isoform X1 [Sus scrofa];XP_003128996.1 glucosamine-6-phosphate isomerase 2 isoform X1 [Sus scrofa]	5	4	4	0	0	0	0	17784000	0	0	0	0	7529200	5949700	0	0	0	0	0	0	0	NA	NA	NA	GNPDA2	GNPDA2;GNPDA2;NA;NA;NA	N-acetylneuraminate catabolic process;UDP-N-acetylglucosamine biosynthetic process;carbohydrate metabolic process	GO:001926; GO:000604; GO:000597	cytosol;nucleus;cytoplasm	GO:000582; GO:000563; GO:000573	 Amino sugar and nucleotide sugar metabolism; Metabolic pathways	hsa0052; hsa0110	identical protein binding;protein binding;glucosamine-6-phosphate deaminase activity	GO:004280; GO:000551; GO:000434
XP_003129004.1;XP_020956223.1;XP_020956222.1	XP_003129004.1;XP_020956223.1;XP_020956222.1	XP_003129004.1 COMM domain-containing protein 8 isoform X3 [Sus scrofa];XP_020956223.1 COMM domain-containing protein 8 isoform X2 [Sus scrofa];XP_020956222.1 COMM domain-containing protein 8 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3008100	NA	NA	NA	COMMD8	COMMD8;COMMD8;COMMD8;NA;NA	"NA"	"NA"	nucleoplasm;cytosol	GO:000565; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_003129051.1;XP_005666725.1;XP_005666726.1	XP_003129051.1;XP_005666725.1;XP_005666726.1	XP_003129051.1 electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X1 [Sus scrofa];XP_005666725.1 electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X2 [Sus scrofa];XP_005666726.1 electron transfer f	17	17	17	420780000	218360000	367790000	192350000	298150000	160630000	401510000	235960000	414750000	245660000	262280000	216170000	143510000	205710000	303270000	258790000	227290000	205100000	NA	NA	NA	ETFDH	ETFDH;ETFDH;ETFDH;NA;NA	respiratory electron transport chain;electron transport chain;fatty acid beta-oxidation using acyl-CoA dehydrogenase;response to oxidative stress	GO:002290; GO:002290; GO:003353; GO:000697	integral component of mitochondrial inner membrane;mitochondrial membrane;mitochondrial matrix	GO:003130; GO:003196; GO:000575	"NA"	"NA"	oxidoreductase activity;quinone binding;electron carrier activity;electron-transferring-flavoprotein dehydrogenase activity;metal ion binding;oxidoreductase activity, oxidizing metal ions with flavin as acceptor;4 iron, 4 sulfur cluster binding;flavin adenine dinucleotide binding	GO:001649; GO:004803; GO:000905; GO:000417; GO:004687; GO:004378; GO:005153; GO:005066
XP_003129089.2	XP_003129089.2	XP_003129089.2 peptidyl-prolyl cis-trans isomerase C [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	3075300	0	0	0	0	0	0	0	NA	NA	NA	PPIC	PPIC;NA;NA;NA;NA	protein peptidyl-prolyl isomerization;protein refolding	GO:000041; GO:004202	cytoplasm;extracellular exosome	GO:000573; GO:007006	"NA"	"NA"	peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;unfolded protein binding;protein binding	GO:000375; GO:001601; GO:005108; GO:000551
XP_003129135.1	XP_003129135.1	XP_003129135.1 N-acylethanolamine-hydrolyzing acid amidase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	12463000	0	0	0	12604000	0	0	NA	NA	NA	NAAA	NAAA;NA;NA;NA;NA	lipid metabolic process;biological_process;neurotransmitter secretion	GO:000662; GO:000815; GO:000726	extracellular exosome;presynapse;cytoplasm;lysosomal lumen	GO:007006; GO:009879; GO:000573; GO:004320	"NA"	"NA"	transcription factor binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	GO:000813; GO:001681
XP_003129141.2	XP_003129141.2	XP_003129141.2 starch-binding domain-containing protein 1 [Sus scrofa]	11	11	11	186550000	115580000	185140000	121200000	177200000	76169000	205880000	123170000	118000000	144640000	143440000	45523000	58245000	82246000	188890000	172120000	184840000	100350000	NA	NA	NA	STBD1	STBD1;NA;NA;NA;NA	glycophagy;intracellular transport;glycogen catabolic process;neutrophil degranulation	GO:006172; GO:004690; GO:000598; GO:004331	plasma membrane;perinuclear region of cytoplasm;endoplasmic reticulum;ficolin-1-rich granule membrane;tertiary granule membrane;T-tubule;pre-autophagosomal structure membrane;membrane;cytosol;integral component of plasma membrane	GO:000588; GO:004847; GO:000578; GO:010100; GO:007082; GO:003031; GO:003404; GO:001602; GO:000582; GO:000588	"NA"	"NA"	enzyme binding;protein binding;polysaccharide binding;glycogen binding;starch binding	GO:001989; GO:000551; GO:003024; GO:200106; GO:200107
XP_005666843.1;XP_005666842.1;XP_003129144.1;XP_013834262.1;XP_005666839.1;XP_005666838.1;XP_020957132.1;XP_020957131.1;XP_020957130.1;XP_020957128.1;XP_020957135.1;XP_020957133.1;XP_020957136.1;XP_020935910.1;XP_020935909.1;XP_013841828.2;XP_005673925.1;XP_003135392.1;XP_020935908.1;XP_020935907.1;XP_013841827.2;XP_020935906.1;XP_020935904.1;XP_013841826.2;XP_013841831.1;XP_013841825.2;XP_005673924.1;XP_020935912.1;XP_020935911.1	XP_005666843.1;XP_005666842.1;XP_003129144.1;XP_013834262.1;XP_005666839.1;XP_005666838.1;XP_020957132.1;XP_020957131.1;XP_020957130.1;XP_020957128.1;XP_020957135.1;XP_020957133.1	XP_005666843.1 septin-11 isoform X8 [Sus scrofa];XP_005666842.1 septin-11 isoform X7 [Sus scrofa];XP_003129144.1 septin-11 isoform X6 [Sus scrofa];XP_013834262.1 septin-11 isoform X5 [Sus scrofa];XP_005666839.1 septin-11 isoform X5 [Sus scrofa];XP_00566683	14	12	12	96445000	130190000	170390000	93101000	89308000	163010000	110150000	103640000	95824000	99702000	119610000	120420000	180890000	120730000	126080000	95627000	122820000	102210000	NA	NA	NA	Sep 11	Sep 11;Sep 11;Sep 11;Sep 11;Sep 11	regulation of synapse organization;protein heterooligomerization;cytoskeleton-dependent cytokinesis	GO:005080; GO:005129; GO:006164	axon;stress fiber;septin ring;septin complex;dendritic spine;glutamatergic synapse;GABA-ergic synapse;postsynaptic specialization of symmetric synapse;cell junction;microtubule cytoskeleton	GO:003042; GO:000172; GO:000594; GO:003110; GO:004319; GO:009897; GO:009898; GO:009962; GO:003005; GO:001563	 Bacterial invasion of epithelial cells	hsa0510	GTPase activity;protein complex scaffold;protein binding;GTP binding	GO:000392; GO:003294; GO:000551; GO:000552
XP_003129218.4;XP_020956322.1	XP_003129218.4;XP_020956322.1	XP_003129218.4 ATP-binding cassette sub-family E member 1 isoform X2 [Sus scrofa];XP_020956322.1 ATP-binding cassette sub-family E member 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9394400	0	NA	NA	NA	ABCE1	ABCE1;ABCE1;NA;NA;NA	translational initiation;negative regulation of endoribonuclease activity;ribosomal subunit export from nucleus;translational termination;defense response to virus;viral process;regulation of type I interferon-mediated signaling pathway	GO:000641; GO:006070; GO:000005; GO:000641; GO:005160; GO:001603; GO:006033	mitochondrion;cytoplasm;membrane;cytosol;mitochondrial matrix	GO:000573; GO:000573; GO:001602; GO:000582; GO:000575	"NA"	"NA"	ATPase activity;iron ion binding;endoribonuclease inhibitor activity;protein binding;ribosomal small subunit binding;ATP binding	GO:001688; GO:000550; GO:006069; GO:000551; GO:004302; GO:000552
XP_003129266.2	XP_003129266.2	XP_003129266.2 annexin A5 [Sus scrofa]	33	33	32	8609500000	9520800000	11224000000	9489200000	10127000000	7502600000	11049000000	11796000000	11327000000	10918000000	9192100000	10974000000	7473300000	11152000000	10530000000	9976600000	8697600000	8652000000	NA	NA	NA	ANXA5	ANXA5;NA;NA;NA;NA	blood coagulation;signal transduction;response to organic substance;ATP hydrolysis coupled cation transmembrane transport;regulation of flagellated sperm motility;negative regulation of prolactin secretion;platelet degranulation;protein homooligomerization;positive regulation of apoptotic process;calcium ion transmembrane transport;cellular response to lead ion;negative regulation of blood coagulation;cellular response to gonadotropin-releasing hormone;negative regulation of sequestering of calcium ion;response to thyroid hormone;negative regulation of catalytic activity;response to calcium ion	GO:000759; GO:000716; GO:001003; GO:009913; GO:190131; GO:190272; GO:000257; GO:005126; GO:004306; GO:007058; GO:007128; GO:003019; GO:009721; GO:005128; GO:009706; GO:004308; GO:005159	extracellular exosome;membrane;focal adhesion;endothelial microparticle;external side of plasma membrane;extracellular region;cytosol;cytoplasm	GO:007006; GO:001602; GO:000592; GO:007256; GO:000989; GO:000557; GO:000582; GO:000573	"NA"	"NA"	peptide hormone binding;protein binding;calcium-transporting ATPase activity;binding, bridging;calcium-dependent phospholipid binding;heparin binding;calcium ion binding;phospholipase inhibitor activity;receptor tyrosine kinase binding	GO:001704; GO:000551; GO:000538; GO:006009; GO:000554; GO:000820; GO:000550; GO:000485; GO:003097
XP_003129306.1	XP_003129306.1	XP_003129306.1 oligosaccharyltransferase complex subunit OSTC [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11974000	NA	NA	NA	OSTC	OSTC;NA;NA;NA;NA	protein N-linked glycosylation via asparagine	GO:001827	integral component of membrane;oligosaccharyltransferase complex	GO:001602; GO:000825	"NA"	"NA"	protein binding;dolichyl-diphosphooligosaccharide-protein glycotransferase activity	GO:000551; GO:000457
XP_013844819.1;XP_003357106.1;XP_003129333.2	XP_013844819.1;XP_003357106.1;XP_003129333.2	XP_013844819.1 3-hydroxybutyrate dehydrogenase type 2 [Sus scrofa];XP_003357106.1 3-hydroxybutyrate dehydrogenase type 2 [Sus scrofa];XP_003129333.2 3-hydroxybutyrate dehydrogenase type 2 [Sus scrofa]	11	11	11	198420000	220120000	251380000	213020000	241770000	211220000	222000000	221200000	261650000	224940000	294290000	316090000	172570000	255330000	292810000	272380000	252450000	225240000	NA	NA	NA	BDH2	BDH2;BDH2;BDH2;NA;NA	siderophore biosynthetic process;iron ion homeostasis;epithelial cell differentiation;heme metabolic process;ketone body biosynthetic process;fatty acid beta-oxidation	GO:001929; GO:005507; GO:003085; GO:004216; GO:004695; GO:000663	mitochondrion;cytosol;cytoplasm;extracellular exosome	GO:000573; GO:000582; GO:000573; GO:007006	 Synthesis and degradation of ketone bodies; Metabolic pathways; Butanoate metabolism	hsa0007; hsa0110; hsa0065	NAD binding;3-hydroxybutyrate dehydrogenase activity;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor	GO:005128; GO:000385; GO:001662
XP_003129349.1;XP_020957385.1;XP_020957386.1	XP_003129349.1;XP_020957385.1;XP_020957386.1	XP_003129349.1 ragulator complex protein LAMTOR3 isoform X2 [Sus scrofa];XP_020957385.1 ragulator complex protein LAMTOR3 isoform X1 [Sus scrofa];XP_020957386.1 ragulator complex protein LAMTOR3 isoform X3 [Sus scrofa]	2	2	2	22295000	0	0	0	18527000	0	15584000	15662000	15094000	19304000	0	12641000	0	0	0	18669000	0	0	NA	NA	NA	LAMTOR3	LAMTOR3;LAMTOR3;LAMTOR3;NA;NA	cellular response to amino acid stimulus;activation of MAPKK activity;neutrophil degranulation;MAPK cascade;regulation of macroautophagy;positive regulation of TOR signaling;cell cycle arrest;cellular protein localization	GO:007123; GO:000018; GO:004331; GO:000016; GO:001624; GO:003200; GO:000705; GO:003461	endosome membrane;specific granule membrane;extracellular exosome;Ragulator complex;tertiary granule membrane;focal adhesion;plasma membrane;lysosomal membrane	GO:001000; GO:003557; GO:007006; GO:007198; GO:007082; GO:000592; GO:000588; GO:000576	 MAPK signaling pathway	hsa0401	protein binding;protein complex scaffold;guanyl-nucleotide exchange factor activity;kinase activator activity	GO:000551; GO:003294; GO:000508; GO:001920
XP_003129362.1;XP_005656612.1	XP_003129362.1;XP_005656612.1	XP_003129362.1 eukaryotic translation initiation factor 4E isoform X2 [Sus scrofa];XP_005656612.1 eukaryotic translation initiation factor 4E isoform X1 [Sus scrofa]	2	2	2	0	22154000	27068000	0	0	0	19825000	0	0	0	0	0	0	25666000	0	18296000	0	28536000	NA	NA	NA	EIF4E	EIF4E;EIF4E;NA;NA;NA	behavioral fear response;negative regulation of neuron differentiation;stem cell population maintenance;lung development;positive regulation of mitotic cell cycle;G1/S transition of mitotic cell cycle;mRNA export from nucleus;cellular response to dexamethasone stimulus;regulation of translation;viral process;negative regulation of autophagy;negative regulation of translation;regulation of translation at postsynapse, modulating synaptic transmission	GO:000166; GO:004566; GO:001982; GO:003032; GO:004593; GO:000008; GO:000640; GO:007154; GO:000641; GO:001603; GO:001050; GO:001714; GO:009957	cytoplasmic stress granule;postsynaptic cytosol;cytosol;cytoplasm;glutamatergic synapse;mRNA cap binding complex;eukaryotic translation initiation factor 4F complex;RISC complex;chromatoid body;cytoplasmic ribonucleoprotein granule;perinuclear region of cytoplasm;P-body;extracellular exosome	GO:001049; GO:009952; GO:000582; GO:000573; GO:009897; GO:000584; GO:001628; GO:001644; GO:003339; GO:003646; GO:004847; GO:000093; GO:007006	 RNA transport; Insulin signaling pathway; mTOR signaling pathway; HIF-1 signaling pathway	hsa0301; hsa0491; hsa0415; hsa0406	RNA binding;repressing transcription factor binding;enzyme binding;RNA 7-methylguanosine cap binding;translation regulator activity;protein binding;RNA cap binding;translation initiation factor activity;eukaryotic initiation factor 4G binding	GO:000372; GO:007049; GO:001989; GO:000034; GO:004518; GO:000551; GO:000033; GO:000374; GO:003137
XP_003129639.1	XP_003129639.1	XP_003129639.1 ragulator complex protein LAMTOR1 [Sus scrofa]	4	4	4	28374000	21497000	21839000	19151000	23769000	18915000	19141000	21334000	18918000	18418000	16845000	30246000	0	18455000	0	19802000	17921000	17281000	NA	NA	NA	LAMTOR1	LAMTOR1;NA;NA;NA;NA	endosomal transport;positive regulation of MAPK cascade;lysosome organization;cell cycle arrest;regulation of macroautophagy;cellular response to amino acid stimulus;cholesterol homeostasis;neutrophil degranulation;regulation of receptor recycling;regulation of cholesterol efflux;positive regulation of TOR signaling;regulation of cell growth;endosome organization;cellular protein localization;regulation of cholesterol import;lysosome localization	GO:001619; GO:004341; GO:000704; GO:000705; GO:001624; GO:007123; GO:004263; GO:004331; GO:000191; GO:001087; GO:003200; GO:000155; GO:000703; GO:003461; GO:006062; GO:003241	Ragulator complex;lysosomal membrane;specific granule membrane;plasma membrane;late endosome membrane;membrane raft;ficolin-1-rich granule membrane;extracellular exosome	GO:007198; GO:000576; GO:003557; GO:000588; GO:003190; GO:004512; GO:010100; GO:007006	"NA"	"NA"	protein complex scaffold;guanyl-nucleotide exchange factor activity;protein binding;GTPase binding	GO:003294; GO:000508; GO:000551; GO:005102
XP_020918175.1;XP_020918174.1;XP_020918173.1;XP_020918172.1;XP_003357246.1;XP_003129712.1;XP_013834595.1;XP_013834594.1;XP_020918176.1	XP_020918175.1;XP_020918174.1;XP_020918173.1;XP_020918172.1;XP_003357246.1;XP_003129712.1;XP_013834595.1;XP_013834594.1;XP_020918176.1	XP_020918175.1 beta-arrestin-1 isoform X8 [Sus scrofa];XP_020918174.1 beta-arrestin-1 isoform X7 [Sus scrofa];XP_020918173.1 beta-arrestin-1 isoform X6 [Sus scrofa];XP_020918172.1 beta-arrestin-1 isoform X5 [Sus scrofa];XP_003357246.1 beta-arrestin-1 isofo	4	4	4	0	0	13887000	0	0	0	0	0	0	0	0	0	0	0	0	0	28092000	0	NA	NA	NA	ARRB1	ARRB1;ARRB1;ARRB1;ARRB1;ARRB1	positive regulation of cell proliferation;positive regulation of protein phosphorylation;positive regulation of smooth muscle cell apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;apoptotic process;negative regulation of NF-kappaB transcription factor activity;positive regulation of histone acetylation;positive regulation of insulin secretion involved in cellular response to glucose stimulus;follicle-stimulating hormone signaling pathway;positive regulation of histone H4 acetylation;positive regulation of receptor internalization;protein ubiquitination;response to drug;negative regulation of GTPase activity;negative regulation of protein ubiquitination;positive regulation of Rho protein signal transduction;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of Notch signaling pathway;activation of MAPK activity;negative regulation of interleukin-6 production;stress fiber assembly;negative regulation of ERK1 and ERK2 cascade;G-protein coupled receptor internalization;ubiquitin-dependent protein catabolic process;G-protein coupled receptor signaling pathway;protein transport;positive regulation of protein binding;positive regulation of transcription from RNA polymerase II promoter;phototransduction;histone acetylation;platelet activation;positive regulation of GTPase activity;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of neuron apoptotic process;membrane organization;transcription from RNA polymerase II promoter;positive regulation of peptidyl-serine phosphorylation	GO:000828; GO:000193; GO:003439; GO:004316; GO:000691; GO:003208; GO:003506; GO:003577; GO:004269; GO:009024; GO:000209; GO:001656; GO:004249; GO:003426; GO:003139; GO:003502; GO:004315; GO:004574; GO:000018; GO:003271; GO:004314; GO:007037; GO:000203; GO:000651; GO:000718; GO:001503; GO:003209; GO:004594; GO:000760; GO:001657; GO:003016; GO:004354; GO:004328; GO:004352; GO:006102; GO:000636; GO:003313	postsynaptic density;lysosomal membrane;postsynaptic membrane;Golgi membrane;nuclear body;pseudopodium;chromatin;cytosol;nucleoplasm;clathrin-coated pit;basolateral plasma membrane;dendritic spine;nucleus;cytoplasm;plasma membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle	GO:001406; GO:000576; GO:004521; GO:000013; GO:001660; GO:003114; GO:000078; GO:000582; GO:000565; GO:000590; GO:001632; GO:004319; GO:000563; GO:000573; GO:000588; GO:003065; GO:003141	 MAPK signaling pathway; Endocytosis; Phototransduction; Morphine addiction; Chemokine signaling pathway	hsa0401; hsa0414; hsa0474; hsa0503; hsa0406	GTPase activator activity;histone acetyltransferase activity;mitogen-activated protein kinase kinase binding;clathrin adaptor activity;protein phosphorylated amino acid binding;enzyme inhibitor activity;arrestin family protein binding;insulin-like growth factor receptor binding;estrogen receptor binding;alpha-1B adrenergic receptor binding;angiotensin receptor binding;follicle-stimulating hormone receptor binding;V2 vasopressin receptor binding;ion channel binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;protein binding;transcription factor binding;ubiquitin protein ligase binding;transcription regulatory region DNA binding	GO:000509; GO:000440; GO:003143; GO:003561; GO:004530; GO:000485; GO:199076; GO:000515; GO:003033; GO:003169; GO:003170; GO:003176; GO:003189; GO:004432; GO:004302; GO:000551; GO:000813; GO:003162; GO:004421
XP_003129789.1;XP_013834695.1	XP_003129789.1	XP_003129789.1 dipeptidyl peptidase 1 isoform X1 [Sus scrofa]	4	4	4	0	0	22059000	23547000	19308000	0	29453000	0	25227000	0	0	0	25695000	19931000	28927000	0	24146000	21130000	NA	NA	NA	CTSC	CTSC;NA;NA;NA;NA	proteolysis involved in cellular protein catabolic process;apoptotic process;proteolysis;immune response;neutrophil degranulation;COPII vesicle coating;ER to Golgi vesicle-mediated transport;T cell mediated cytotoxicity;aging;response to organic substance;positive regulation of proteolysis involved in cellular protein catabolic process;positive regulation of apoptotic signaling pathway	GO:005160; GO:000691; GO:000650; GO:000695; GO:004331; GO:004820; GO:000688; GO:000191; GO:000756; GO:001003; GO:190305; GO:200123	azurophil granule lumen;Golgi membrane;centrosome;membrane;extracellular exosome;extracellular region;endoplasmic reticulum-Golgi intermediate compartment membrane;lysosome;extracellular space;endoplasmic reticulum lumen;intracellular membrane-bounded organelle;ER to Golgi transport vesicle;nucleoplasm	GO:003557; GO:000013; GO:000581; GO:001602; GO:007006; GO:000557; GO:003311; GO:000576; GO:000561; GO:000578; GO:004323; GO:003013; GO:000565	 Lysosome	hsa0414	serine-type endopeptidase activity;cysteine-type peptidase activity;protein binding;peptidase activator activity involved in apoptotic process;chloride ion binding;chaperone binding;identical protein binding;protein self-association;cysteine-type endopeptidase activity;phosphatase binding	GO:000425; GO:000823; GO:000551; GO:001650; GO:003140; GO:005108; GO:004280; GO:004362; GO:000419; GO:001990
XP_003129882.1;XP_020918408.1	XP_003129882.1;XP_020918408.1	XP_003129882.1 KDEL motif-containing protein 2 isoform X9 [Sus scrofa];XP_020918408.1 KDEL motif-containing protein 2 isoform X8 [Sus scrofa]	14	14	14	58299000	135590000	68527000	124810000	49316000	104090000	88549000	163030000	50943000	102030000	85301000	149340000	93410000	159700000	107710000	132810000	107280000	154210000	NA	NA	NA	LOC100512977	LOC100512977;LOC100512977;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003129926.1	XP_003129926.1	XP_003129926.1 oligoribonuclease, mitochondrial [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	8664600	0	0	0	0	0	0	NA	NA	NA	REXO2	REXO2;NA;NA;NA;NA	RNA phosphodiester bond hydrolysis, exonucleolytic;nucleobase-containing compound metabolic process;nucleotide metabolic process	GO:009050; GO:000613; GO:000911	mitochondrial matrix;focal adhesion;nucleus;mitochondrion;mitochondrial intermembrane space	GO:000575; GO:000592; GO:000563; GO:000573; GO:000575	 Ribosome biogenesis in eukaryotes	hsa0300	nucleic acid binding;3'-5' exonuclease activity;3'-5'-exoribonuclease activity	GO:000367; GO:000840; GO:000017
XP_020918606.1;XP_013834909.1;XP_013834908.1;XP_005667467.1;XP_005667466.1;XP_005667465.1;XP_003129962.1	XP_020918606.1;XP_013834909.1;XP_013834908.1;XP_005667467.1;XP_005667466.1;XP_005667465.1;XP_003129962.1	XP_020918606.1 probable ATP-dependent RNA helicase DDX6 isoform X2 [Sus scrofa];XP_013834909.1 probable ATP-dependent RNA helicase DDX6 isoform X2 [Sus scrofa];XP_013834908.1 probable ATP-dependent RNA helicase DDX6 isoform X1 [Sus scrofa];XP_005667467.1 p	3	3	3	0	0	16286000	0	0	14712000	17431000	16282000	0	20527000	18448000	21747000	0	17056000	0	0	0	0	NA	NA	NA	DDX6	DDX6;DDX6;DDX6;DDX6;DDX6	stem cell population maintenance;spermatid differentiation;negative regulation of neuron differentiation;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;cytoplasmic mRNA processing body assembly;viral RNA genome packaging	GO:001982; GO:004851; GO:004566; GO:004392; GO:003396; GO:001907	P-body;cytoplasmic ribonucleoprotein granule;cytosol;RISC complex;cytoplasm;concave side of sperm head;heterochromatin;outer dense fiber;cell-cell adherens junction;nucleus;chromatoid body;perinuclear region of cytoplasm;sperm annulus;membrane;cytoplasmic stress granule	GO:000093; GO:003646; GO:000582; GO:001644; GO:000573; GO:006183; GO:000079; GO:000152; GO:000591; GO:000563; GO:003339; GO:004847; GO:009722; GO:001602; GO:001049	 RNA degradation	hsa0301	protein binding;ATP binding;helicase activity;RNA helicase activity;cadherin binding;protein domain specific binding	GO:000551; GO:000552; GO:000438; GO:000372; GO:004529; GO:001990
XP_003129966.2;XP_013834915.2;XP_020918608.1	XP_003129966.2;XP_013834915.2;XP_020918608.1	XP_003129966.2 trafficking protein particle complex subunit 4 isoform X2 [Sus scrofa];XP_013834915.2 trafficking protein particle complex subunit 4 isoform X1 [Sus scrofa];XP_020918608.1 trafficking protein particle complex subunit 4 isoform X3 [Sus scrofa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7048700	NA	NA	NA	TRAPPC4	TRAPPC4;TRAPPC4;TRAPPC4;NA;NA	dendrite development;COPII vesicle coating;ER to Golgi vesicle-mediated transport	GO:001635; GO:004820; GO:000688	cytosol;TRAPP complex;Golgi membrane;synapse;synaptic vesicle;endoplasmic reticulum;Golgi stack;dendrite	GO:000582; GO:003000; GO:000013; GO:004520; GO:000802; GO:000578; GO:000579; GO:003042	"NA"	"NA"	Rab guanyl-nucleotide exchange factor activity;protein binding	GO:001711; GO:000551
XP_003129968.1;XP_003129967.1	XP_003129968.1;XP_003129967.1	XP_003129968.1 40S ribosomal protein S25 [Sus scrofa];XP_003129967.1 40S ribosomal protein S25 [Sus scrofa]	4	4	4	127890000	103630000	117800000	64566000	103000000	157150000	79074000	66412000	100520000	132560000	73106000	56703000	129330000	128210000	54406000	135830000	111960000	175050000	NA	NA	NA	RPS25	RPS25;RPS25;NA;NA;NA	translation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translational initiation	GO:000641; GO:000661; GO:000018; GO:000641	cytosolic small ribosomal subunit;nucleus;nucleoplasm;extracellular exosome;small ribosomal subunit;cytosol;postsynaptic density;nucleolus;ribosome	GO:002262; GO:000563; GO:000565; GO:007006; GO:001593; GO:000582; GO:001406; GO:000573; GO:000584	 Ribosome	hsa0301	protein binding;RNA binding	GO:000551; GO:000372
XP_020918614.1;XP_020918613.1;XP_005667477.2;XP_020918612.1;XP_020918611.1;XP_005667476.2;XP_020918610.1;XP_020918609.1;XP_013834917.2;XP_003129970.2;XP_005667473.2;XP_020918615.1	XP_020918614.1;XP_020918613.1;XP_005667477.2;XP_020918612.1;XP_020918611.1;XP_005667476.2;XP_020918610.1;XP_020918609.1;XP_013834917.2;XP_003129970.2;XP_005667473.2;XP_020918615.1	XP_020918614.1 hypoxia up-regulated protein 1 isoform X7 [Sus scrofa];XP_020918613.1 hypoxia up-regulated protein 1 isoform X6 [Sus scrofa];XP_005667477.2 hypoxia up-regulated protein 1 isoform X6 [Sus scrofa];XP_020918612.1 hypoxia up-regulated protein 1	14	14	14	33356000	68274000	61819000	73952000	63005000	73274000	64416000	74219000	57734000	62551000	63219000	90005000	57659000	62492000	61443000	70993000	81451000	78005000	NA	NA	NA	HYOU1	HYOU1;HYOU1;HYOU1;HYOU1;HYOU1	response to endoplasmic reticulum stress;cellular response to hypoxia;negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway;response to ischemia;ER to Golgi vesicle-mediated transport;receptor-mediated endocytosis;IRE1-mediated unfolded protein response;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway	GO:003497; GO:007145; GO:190338; GO:000293; GO:000688; GO:000689; GO:003649; GO:190329	smooth endoplasmic reticulum;endocytic vesicle lumen;membrane;extracellular exosome;focal adhesion;endoplasmic reticulum chaperone complex;extracellular region;endoplasmic reticulum	GO:000579; GO:007168; GO:001602; GO:007006; GO:000592; GO:003466; GO:000557; GO:000578	 Protein processing in endoplasmic reticulum	hsa0414	ATP binding;chaperone binding	GO:000552; GO:005108
XP_005667487.1;XP_003129983.1;XP_005667486.1;XP_005667488.1	XP_005667487.1;XP_003129983.1;XP_005667486.1;XP_005667488.1	XP_005667487.1 cell surface glycoprotein MUC18 isoform X4 [Sus scrofa];XP_003129983.1 cell surface glycoprotein MUC18 isoform X3 [Sus scrofa];XP_005667486.1 cell surface glycoprotein MUC18 isoform X2 [Sus scrofa];XP_005667488.1 cell surface glycoprotein MU	7	7	7	43281000	64443000	57638000	43758000	55391000	65080000	34865000	62009000	38834000	65240000	44464000	52888000	64692000	63340000	37307000	39676000	23867000	36651000	NA	NA	NA	MCAM	MCAM;MCAM;MCAM;MCAM;NA	vascular wound healing;anatomical structure morphogenesis;angiogenesis;glomerular filtration;cell adhesion;positive regulation of cell migration	GO:006104; GO:000965; GO:000152; GO:000309; GO:000715; GO:003033	plasma membrane;focal adhesion;integral component of membrane;extracellular region;nucleus;external side of plasma membrane;extracellular space	GO:000588; GO:000592; GO:001602; GO:000557; GO:000563; GO:000989; GO:000561	"NA"	"NA"	"NA"	"NA"
XP_020918849.1;XP_003130152.1;XP_013844986.1;XP_020918850.1;XP_020918848.1	XP_020918849.1;XP_003130152.1;XP_013844986.1;XP_020918850.1;XP_020918848.1	XP_020918849.1 dimethylaniline monooxygenase [N-oxide-forming] 2 isoform X3 [Sus scrofa];XP_003130152.1 dimethylaniline monooxygenase [N-oxide-forming] 2 isoform X1 [Sus scrofa];XP_013844986.1 dimethylaniline monooxygenase [N-oxide-forming] 2 isoform X5 [S	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	8283900	0	0	0	0	NA	NA	NA	FMO2	FMO2;FMO2;FMO2;FMO2;FMO2	NADP metabolic process;xenobiotic metabolic process;oxygen metabolic process;organic acid metabolic process;drug metabolic process;toxin metabolic process;NADPH oxidation	GO:000673; GO:000680; GO:007259; GO:000608; GO:001714; GO:000940; GO:007099	membrane;endoplasmic reticulum membrane;organelle membrane	GO:001602; GO:000578; GO:003109	 Drug metabolism - cytochrome P450	hsa0098	N,N-dimethylaniline monooxygenase activity;NADP binding;monooxygenase activity	GO:000449; GO:005066; GO:000449
XP_003130153.1	XP_003130153.1	XP_003130153.1 fibromodulin [Sus scrofa]	4	4	4	31744000	116710000	29235000	99573000	34520000	121770000	100410000	61475000	42156000	85466000	68992000	191030000	713340000	72402000	65520000	83826000	140570000	269460000	NA	NA	NA	FMOD	FMOD;NA;NA;NA;NA	transforming growth factor beta receptor complex assembly;keratan sulfate biosynthetic process;collagen fibril organization;keratan sulfate catabolic process	GO:000718; GO:001814; GO:003019; GO:004234	extracellular space;extracellular matrix;lysosomal lumen;Golgi lumen;extracellular region	GO:000561; GO:003101; GO:004320; GO:000579; GO:000557	"NA"	"NA"	extracellular matrix structural constituent conferring compression resistance	GO:003002
XP_005656706.1;XP_003130154.1	XP_005656706.1;XP_003130154.1	XP_005656706.1 prolargin [Sus scrofa];XP_003130154.1 prolargin [Sus scrofa]	19	19	19	802120000	4780200000	911600000	5547200000	892410000	4316400000	1473300000	2840400000	962840000	3260200000	1342800000	3698600000	3293200000	4571200000	1377300000	3907300000	1608200000	7306200000	NA	NA	NA	PRELP	PRELP;PRELP;NA;NA;NA	skeletal system development;keratan sulfate catabolic process;keratan sulfate biosynthetic process;cell aging	GO:000150; GO:004234; GO:001814; GO:000756	Golgi lumen;extracellular exosome;extracellular vesicle;extracellular matrix;extracellular region;lysosomal lumen	GO:000579; GO:007006; GO:190356; GO:003101; GO:000557; GO:004320	"NA"	"NA"	extracellular matrix structural constituent;heparin binding;extracellular matrix structural constituent conferring compression resistance	GO:000520; GO:000820; GO:003002
XP_020958059.1;XP_003130208.3;XP_005667683.2;XP_020958058.1;XP_020958057.1;XP_020958062.1;XP_020958060.1	XP_020958059.1;XP_003130208.3;XP_005667683.2;XP_020958058.1;XP_020958057.1;XP_020958062.1;XP_020958060.1	XP_020958059.1 calcium-binding mitochondrial carrier protein Aralar2 isoform X5 [Sus scrofa];XP_003130208.3 calcium-binding mitochondrial carrier protein Aralar2 isoform X4 [Sus scrofa];XP_005667683.2 calcium-binding mitochondrial carrier protein Aralar2 i	12	12	10	37950000	28053000	38877000	25213000	37709000	19019000	44106000	35384000	47518000	24922000	32610000	24372000	25630000	25141000	25688000	29350000	32006000	22650000	NA	NA	NA	SLC25A13	SLC25A13;SLC25A13;SLC25A13;SLC25A13;SLC25A13	L-aspartate transport;aspartate transport;mitochondrial transport;cellular respiration;malate-aspartate shuttle;response to calcium ion;gluconeogenesis;ATP biosynthetic process	GO:007077; GO:001581; GO:000683; GO:004533; GO:004349; GO:005159; GO:000609; GO:000675	mitochondrion;integral component of plasma membrane;mitochondrial inner membrane	GO:000573; GO:000588; GO:000574	"NA"	"NA"	transporter activity;identical protein binding;acidic amino acid transmembrane transporter activity;calcium ion binding;L-glutamate transmembrane transporter activity;L-aspartate transmembrane transporter activity	GO:000521; GO:004280; GO:001517; GO:000550; GO:000531; GO:001518
XP_003130289.1	XP_003130289.1	XP_003130289.1 mitochondrial-processing peptidase subunit beta [Sus scrofa]	3	3	3	13811000	0	11066000	0	0	0	0	0	0	0	0	0	0	0	13188000	11097000	10929000	0	NA	NA	NA	PMPCB	PMPCB;NA;NA;NA;NA	protein processing involved in protein targeting to mitochondrion;mitochondrial calcium ion transport	GO:000662; GO:000685	mitochondrial inner membrane;mitochondrion;mitochondrial processing peptidase complex	GO:000574; GO:000573; GO:001708	"NA"	"NA"	metalloendopeptidase activity;metal ion binding;endopeptidase activity	GO:000422; GO:004687; GO:000417
XP_003130317.3	XP_003130317.3	XP_003130317.3 LOW QUALITY PROTEIN: laminin subunit beta-1 [Sus scrofa]	69	69	69	2844800000	3251700000	3554700000	2691600000	2891300000	2010200000	3473500000	3564100000	2600400000	2443000000	2412100000	3497700000	1105700000	3142000000	3757800000	3182700000	2410700000	2534000000	NA	NA	NA	LAMB1	LAMB1;NA;NA;NA;NA	neuron projection development;post-translational protein modification;neuronal-glial interaction involved in cerebral cortex radial glia guided migration;odontogenesis;substrate adhesion-dependent cell spreading;positive regulation of epithelial cell proliferation;positive regulation of cell migration;cellular protein metabolic process;extracellular matrix organization;endodermal cell differentiation;cell adhesion	GO:003117; GO:004368; GO:002181; GO:004247; GO:003444; GO:005067; GO:003033; GO:004426; GO:003019; GO:003598; GO:000715	extracellular exosome;perinuclear region of cytoplasm;laminin-1 complex;laminin-8 complex;endoplasmic reticulum lumen;extracellular region;extracellular space	GO:007006; GO:004847; GO:000560; GO:004325; GO:000578; GO:000557; GO:000561	 Pathways in cancer; Focal adhesion; Toxoplasmosis; PI3K-Akt signaling pathway; Small cell lung cancer	hsa0520; hsa0451; hsa0514; hsa0415; hsa0522	extracellular matrix structural constituent;protein binding;structural molecule activity	GO:000520; GO:000551; GO:000519
XP_003130369.3;XP_013845074.1;XP_013845073.1	XP_003130369.3;XP_013845074.1;XP_013845073.1	XP_003130369.3 calcyclin-binding protein isoform X1 [Sus scrofa];XP_013845074.1 calcyclin-binding protein isoform X2 [Sus scrofa];XP_013845073.1 calcyclin-binding protein isoform X2 [Sus scrofa]	5	5	5	19758000	22834000	29437000	0	25866000	19472000	21958000	15515000	22843000	14666000	20579000	10607000	19363000	15938000	24230000	16525000	23222000	14385000	NA	NA	NA	CACYBP	CACYBP;CACYBP;CACYBP;NA;NA	aging;cellular response to leukemia inhibitory factor;negative regulation of cell death;cardiac muscle cell differentiation;response to growth hormone;cellular response to calcium ion;heart development;positive regulation of DNA replication	GO:000756; GO:199083; GO:006054; GO:005500; GO:006041; GO:007127; GO:000750; GO:004574	SCF ubiquitin ligase complex;nucleus;extracellular exosome;nucleoplasm;cytosol;neuron projection;beta-catenin destruction complex;nuclear envelope lumen;cell body	GO:001900; GO:000563; GO:007006; GO:000565; GO:000582; GO:004300; GO:003087; GO:000564; GO:004429	 Wnt signaling pathway	hsa0431	protein binding;protein homodimerization activity;tubulin binding;ubiquitin protein ligase binding;protein domain specific binding;S100 protein binding	GO:000551; GO:004280; GO:001563; GO:003162; GO:001990; GO:004454
XP_013835097.1;XP_003130503.1	XP_013835097.1;XP_003130503.1	XP_013835097.1 C4b-binding protein beta chain [Sus scrofa];XP_003130503.1 C4b-binding protein beta chain [Sus scrofa]	2	2	2	0	0	0	0	0	0	13601000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	C4BPB	C4BPB;C4BPB;NA;NA;NA	blood coagulation;complement activation, classical pathway;innate immune response;regulation of opsonization;negative regulation of complement activation, classical pathway;regulation of complement activation;positive regulation of protein catabolic process	GO:000759; GO:000695; GO:004508; GO:190302; GO:004595; GO:003044; GO:004573	other organism cell;extracellular space;plasma membrane;extracellular region	GO:004421; GO:000561; GO:000588; GO:000557	 Complement and coagulation cascades; Pertussis	hsa0461; hsa0513	protein binding	GO:000551
XP_020919982.1;XP_020919981.1;XP_020919980.1;XP_003130551.1;XP_020919978.1;XP_005656837.1;XP_020919977.1;XP_020919976.1;XP_020919975.1;XP_013845145.1	XP_020919982.1;XP_020919981.1;XP_020919980.1;XP_003130551.1;XP_020919978.1;XP_005656837.1;XP_020919977.1;XP_020919976.1;XP_020919975.1;XP_013845145.1	XP_020919982.1 3(2),5-bisphosphate nucleotidase 1 isoform X4 [Sus scrofa];XP_020919981.1 3(2),5-bisphosphate nucleotidase 1 isoform X4 [Sus scrofa];XP_020919980.1 3(2),5-bisphosphate nucleotidase 1 isoform X4 [Sus scrofa];XP_003130551.1 3(2),5-	4	4	4	0	21748000	0	0	15801000	21399000	23482000	19241000	20162000	0	18212000	17642000	0	19635000	0	21648000	21160000	28061000	NA	NA	NA	BPNT1	BPNT1;BPNT1;BPNT1;BPNT1;BPNT1	nervous system development;nucleobase-containing compound metabolic process;dephosphorylation;phosphatidylinositol phosphorylation;3'-phosphoadenosine 5'-phosphosulfate metabolic process	GO:000739; GO:000613; GO:001631; GO:004685; GO:005042	cytosol	GO:000582	 Biosynthesis of antibiotics; Sulfur metabolism; Metabolic pathways	hsa0113; hsa0092; hsa0110	metal ion binding;3'(2'),5'-bisphosphate nucleotidase activity	GO:004687; GO:000844
XP_003130588.1	XP_003130588.1	XP_003130588.1 signal recognition particle 9 kDa protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SRP9	SRP9;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane, translocation;SRP-dependent cotranslational protein targeting to membrane;negative regulation of translational elongation	GO:000661; GO:000661; GO:004590	cytosol;signal recognition particle receptor complex	GO:000582; GO:000578	 Protein export	hsa0306	signal recognition particle binding;protein binding;RNA binding;7S RNA binding	GO:000504; GO:000551; GO:000372; GO:000831
XP_003130704.1;XP_005668106.1	XP_003130704.1;XP_005668106.1	XP_003130704.1 dynactin subunit 3 isoform X2 [Sus scrofa];XP_005668106.1 dynactin subunit 3 isoform X1 [Sus scrofa]	2	2	2	0	28610000	0	0	0	26691000	0	25675000	40674000	25753000	0	0	0	28820000	0	0	0	0	NA	NA	NA	DCTN3	DCTN3;DCTN3;NA;NA;NA	mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class II;ER to Golgi vesicle-mediated transport;ciliary basal body docking;G2/M transition of mitotic cell cycle;microtubule-based process;cytoskeleton-dependent cytokinesis	GO:000027; GO:001038; GO:001988; GO:000688; GO:009771; GO:000008; GO:000701; GO:006164	midbody;perinuclear region of cytoplasm;condensed chromosome kinetochore;microtubule;cytosol;spindle;nucleolus;dynactin complex;cleavage furrow	GO:003049; GO:004847; GO:000077; GO:000587; GO:000582; GO:000581; GO:000573; GO:000586; GO:003215	"NA"	"NA"	structural molecule activity;protein binding	GO:000519; GO:000551
XP_020920548.1;XP_020920547.1;XP_013835703.1;XP_003130802.2;XP_005668196.1;XP_020920546.1;XP_020920545.1;XP_013835702.1;XP_013835701.1;XP_020920544.1;XP_005668194.1;XP_013835700.1;XP_013835699.1	XP_020920548.1;XP_020920547.1;XP_013835703.1;XP_003130802.2;XP_005668196.1;XP_020920546.1;XP_020920545.1;XP_013835702.1;XP_013835701.1;XP_020920544.1;XP_005668194.1;XP_013835700.1;XP_013835699.1	XP_020920548.1 acyl-CoA-binding domain-containing protein 5 isoform X13 [Sus scrofa];XP_020920547.1 acyl-CoA-binding domain-containing protein 5 isoform X12 [Sus scrofa];XP_013835703.1 acyl-CoA-binding domain-containing protein 5 isoform X11 [Sus scrofa];X	3	3	3	0	0	0	0	0	0	0	0	0	0	8666000	0	0	0	0	0	0	0	NA	NA	NA	ACBD5	ACBD5;ACBD5;ACBD5;ACBD5;ACBD5	aggrephagy;fatty acid catabolic process;macroautophagy;pexophagy	GO:003597; GO:000906; GO:001623; GO:003024	nucleoplasm;peroxisome;membrane;nucleus	GO:000565; GO:000577; GO:001602; GO:000563	"NA"	"NA"	fatty-acyl-CoA binding;molecular_function;lipid binding	GO:000006; GO:000367; GO:000828
XP_003130816.5;XP_013845185.2	XP_003130816.5;XP_013845185.2	XP_003130816.5 phosphoribosyltransferase domain-containing protein 1 isoform X1 [Sus scrofa];XP_013845185.2 phosphoribosyltransferase domain-containing protein 1 isoform X2 [Sus scrofa]	4	3	3	0	0	0	0	0	0	0	0	0	0	0	21808000	0	0	0	0	0	0	NA	NA	NA	PRTFDC1	PRTFDC1;PRTFDC1;NA;NA;NA	GMP catabolic process;purine ribonucleoside salvage;guanine salvage	GO:004603; GO:000616; GO:000617	cytoplasm	GO:000573	"NA"	"NA"	hypoxanthine phosphoribosyltransferase activity;protein homodimerization activity;nucleotide binding;protein binding;magnesium ion binding	GO:000442; GO:004280; GO:000016; GO:000551; GO:000028
XP_020920636.1;XP_020920635.1;XP_005668236.1;XP_005668235.1;XP_020920633.1;XP_020920632.1;XP_020920631.1;XP_020920630.1;XP_003130846.1;XP_020920629.1;XP_005668234.1;XP_005668233.1;XP_020920637.1	XP_020920636.1;XP_020920635.1;XP_005668236.1;XP_005668235.1;XP_020920633.1;XP_020920632.1;XP_020920631.1;XP_020920630.1;XP_003130846.1;XP_020920629.1;XP_005668234.1;XP_005668233.1;XP_020920637.1	XP_020920636.1 neuropilin-1 isoform X4 [Sus scrofa];XP_020920635.1 neuropilin-1 isoform X4 [Sus scrofa];XP_005668236.1 neuropilin-1 isoform X4 [Sus scrofa];XP_005668235.1 neuropilin-1 isoform X3 [Sus scrofa];XP_020920633.1 neuropilin-1 isoform X2 [Sus scro	5	5	5	21943000	0	19970000	0	0	0	15831000	0	19360000	0	0	0	17131000	0	19166000	19780000	15797000	17849000	NA	NA	NA	NRP1	NRP1;NRP1;NRP1;NRP1;NRP1	angiogenesis;cell migration involved in sprouting angiogenesis;signal transduction;positive regulation of endothelial cell migration;platelet-derived growth factor receptor signaling pathway;positive regulation of cytokine activity;coronary artery morphogenesis;sensory neuron axon guidance;positive regulation of actin cytoskeleton reorganization;substrate-dependent cell migration, cell extension;regulation of Cdc42 protein signal transduction;substrate adhesion-dependent cell spreading;negative regulation of axon extension involved in axon guidance;positive regulation of filopodium assembly;regulation of vesicle-mediated transport;trigeminal ganglion development;sympathetic neuron projection guidance;positive regulation of substrate adhesion-dependent cell spreading;VEGF-activated neuropilin signaling pathway involved in axon guidance;protein localization to early endosome;facioacoustic ganglion development;branching involved in blood vessel morphogenesis;cell-cell signaling;axonal fasciculation;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;retinal ganglion cell axon guidance;ventral trunk neural crest cell migration;positive regulation of focal adhesion assembly;motor neuron migration;integrin-mediated signaling pathway;positive regulation of smooth muscle cell migration;positive regulation of GTPase activity;sympathetic ganglion development;commissural neuron axon guidance;positive regulation of cell migration involved in sprouting angiogenesis;positive regulation of retinal ganglion cell axon guidance;neuron migration;cellular response to hepatocyte growth factor stimulus;negative regulation of neuron apoptotic process;hepatocyte growth factor receptor signaling pathway;dichotomous subdivision of terminal units involved in salivary gland branching;semaphorin-plexin signaling pathway involved in axon guidance;positive regulation of endothelial cell proliferation;outflow tract septum morphogenesis;response to wounding;facial nerve structural organization;vestibulocochlear nerve structural organization;nerve development;branchiomotor neuron axon guidance;VEGF-activated neuropilin signaling pathway;positive regulation of peptidyl-tyrosine phosphorylation;angiogenesis involved in coronary vascular morphogenesis;retina vasculature morphogenesis in camera-type eye;positive regulation of ERK1 and ERK2 cascade;semaphorin-plexin signaling pathway;regulation of retinal ganglion cell axon guidance;dorsal root ganglion morphogenesis;trigeminal nerve structural organization;endothelial cell chemotaxis;cellular response to vascular endothelial growth factor stimulus;axonogenesis involved in innervation;renal artery morphogenesis;otic placode development;animal organ morphogenesis;actin cytoskeleton reorganization;neuropilin signaling pathway;positive regulation of phosphorylation;positive chemotaxis;endothelial tip cell fate specification;neural crest cell migration involved in autonomic nervous system development;toxin transport;negative regulation of extrinsic apoptotic signaling pathway	GO:000152; GO:000204; GO:000716; GO:001059; GO:004800; GO:006030; GO:006098; GO:009737; GO:200025; GO:000693; GO:003248; GO:003444; GO:004884; GO:005149; GO:006062; GO:006155; GO:009749; GO:190002; GO:190237; GO:190294; GO:190337; GO:000156; GO:000726; GO:000741; GO:002182; GO:003129; GO:003648; GO:005189; GO:009747; GO:000722; GO:001491; GO:004354; GO:006154; GO:007167; GO:009005; GO:190233; GO:000176; GO:003572; GO:004352; GO:004801; GO:006066; GO:190228; GO:000193; GO:000314; GO:000961; GO:002161; GO:002164; GO:002167; GO:002178; GO:003819; GO:005073; GO:006097; GO:006129; GO:007037; GO:007152; GO:009025; GO:190483; GO:002163; GO:003576; GO:003592; GO:006038; GO:006144; GO:190504; GO:000988; GO:003153; GO:003818; GO:004232; GO:005091; GO:009710; GO:190116; GO:190199; GO:200123	plasma membrane;cytosol;neurofilament;axon;cell surface;early endosome;neuron projection;sorting endosome;semaphorin receptor complex;extracellular space;glutamatergic synapse;integral component of postsynaptic membrane;receptor complex;focal adhesion;cytoplasmic vesicle;neuronal cell body	GO:000588; GO:000582; GO:000588; GO:003042; GO:000998; GO:000576; GO:004300; GO:009744; GO:000211; GO:000561; GO:009897; GO:009905; GO:004323; GO:000592; GO:003141; GO:004302	 HTLV-I infection; Axon guidance	hsa0516; hsa0436	metal ion binding;coreceptor activity;protein kinase binding;GTPase activator activity;semaphorin receptor activity;growth factor binding;cytokine binding;protein binding;vascular endothelial growth factor-activated receptor activity;heparin binding;vascular endothelial growth factor binding	GO:004687; GO:001502; GO:001990; GO:000509; GO:001715; GO:001983; GO:001995; GO:000551; GO:000502; GO:000820; GO:003808
XP_003130868.2	XP_003130868.2	XP_003130868.2 inter-alpha-trypsin inhibitor heavy chain H5 [Sus scrofa]	21	21	21	171210000	195280000	149140000	242420000	94223000	134270000	97899000	221790000	100480000	196540000	92122000	349410000	148600000	219460000	166350000	339060000	98224000	172140000	NA	NA	NA	ITIH5	ITIH5;NA;NA;NA;NA	hyaluronan metabolic process;negative regulation of endopeptidase activity	GO:003021; GO:001095	"NA"	"NA"	"NA"	"NA"	serine-type endopeptidase inhibitor activity	GO:000486
XP_020921232.1;XP_013835927.1;XP_013835926.1;XP_003130995.1;XP_005668433.1	XP_020921232.1;XP_013835927.1;XP_013835926.1;XP_003130995.1;XP_005668433.1	XP_020921232.1 vacuolar protein-sorting-associated protein 36 isoform X3 [Sus scrofa];XP_013835927.1 vacuolar protein-sorting-associated protein 36 isoform X3 [Sus scrofa];XP_013835926.1 vacuolar protein-sorting-associated protein 36 isoform X3 [Sus scrofa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5025800	NA	NA	NA	VPS36	VPS36;VPS36;VPS36;VPS36;VPS36	multivesicular body assembly;macroautophagy;protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;endosomal transport	GO:003625; GO:001623; GO:004332; GO:001619	late endosome membrane;lysosome;nucleus;ESCRT II complex;cytosol;extracellular exosome	GO:003190; GO:000576; GO:000563; GO:000081; GO:000582; GO:007006	 Endocytosis	hsa0414	phosphatidylinositol-3-phosphate binding;protein C-terminus binding;protein binding;ubiquitin binding	GO:003226; GO:000802; GO:000551; GO:004313
XP_003131149.1	XP_003131149.1	XP_003131149.1 cullin-4A [Sus scrofa]	3	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4510000	0	0	NA	NA	NA	CUL4A	CUL4A;NA;NA;NA;NA	in utero embryonic development;nucleotide-excision repair, preincision complex stabilization;cellular response to DNA damage stimulus;cell cycle arrest;DNA damage response, detection of DNA damage;post-translational protein modification;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of cell proliferation;viral process;hemopoiesis;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of granulocyte differentiation;nucleotide-excision repair, DNA incision;somatic stem cell population maintenance;regulation of protein metabolic process;intrinsic apoptotic signaling pathway;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;global genome nucleotide-excision repair;transcription-coupled nucleotide-excision repair;regulation of nucleotide-excision repair;nucleotide-excision repair, DNA damage recognition;ubiquitin-dependent protein catabolic process;regulation of DNA damage checkpoint;G1/S transition of mitotic cell cycle;protein ubiquitination	GO:000170; GO:000629; GO:000697; GO:000705; GO:004276; GO:004368; GO:190008; GO:000828; GO:001603; GO:003009; GO:004316; GO:003085; GO:003368; GO:003501; GO:005124; GO:009719; GO:003114; GO:007091; GO:000628; GO:200081; GO:000071; GO:000651; GO:200000; GO:000008; GO:001656	Cul4A-RING E3 ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;SCF ubiquitin ligase complex;Cul4-RING E3 ubiquitin ligase complex;nucleoplasm	GO:003146; GO:003146; GO:001900; GO:008000; GO:000565	 Nucleotide excision repair; Ubiquitin mediated proteolysis	hsa0342; hsa0412	ubiquitin protein ligase binding;protein binding;ubiquitin protein ligase activity	GO:003162; GO:000551; GO:006163
XP_003131177.2	XP_003131177.2	XP_003131177.2 LOW QUALITY PROTEIN: ketosamine-3-kinase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	6784900	0	0	0	0	NA	NA	NA	FN3KRP	FN3KRP;NA;NA;NA;NA	post-translational protein modification;phosphorylation	GO:004368; GO:001631	cytosol	GO:000582	"NA"	"NA"	kinase activity	GO:001630
XP_003131222.1;XP_020922254.1;XP_005656978.1	XP_003131222.1;XP_020922254.1;XP_005656978.1	XP_003131222.1 phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X1 [Sus scrofa];XP_020922254.1 phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X2 [Sus scrofa];XP_005656978.1 phosphoribosyl pyrophosphate synthase-associa	6	6	5	0	20034000	18900000	0	16755000	0	23923000	0	15535000	14088000	0	22672000	0	0	16426000	19499000	0	0	NA	NA	NA	PRPSAP1	PRPSAP1;PRPSAP1;PRPSAP1;NA;NA	nucleotide biosynthetic process;5-phosphoribose 1-diphosphate biosynthetic process;nucleobase-containing compound metabolic process;purine nucleotide biosynthetic process;negative regulation of catalytic activity	GO:000916; GO:000601; GO:000613; GO:000616; GO:004308	cytoplasm;ribose phosphate diphosphokinase complex	GO:000573; GO:000218	"NA"	"NA"	enzyme inhibitor activity;protein binding;magnesium ion binding;ribose phosphate diphosphokinase activity;identical protein binding	GO:000485; GO:000551; GO:000028; GO:000474; GO:004280
XP_003131227.2;XP_020922233.1	XP_003131227.2;XP_020922233.1	XP_003131227.2 cytoglobin isoform X2 [Sus scrofa];XP_020922233.1 cytoglobin isoform X1 [Sus scrofa]	4	4	4	22717000	37156000	21379000	0	0	31969000	17331000	23724000	21788000	20719000	0	0	32402000	0	28199000	23199000	18931000	24480000	NA	NA	NA	CYGB	CYGB;CYGB;NA;NA;NA	regulation of nitric-oxide synthase activity;negative regulation of hepatic stellate cell activation;fatty acid oxidation;oxygen transport;cellular oxidant detoxification;negative regulation of fibroblast migration;negative regulation of collagen biosynthetic process;response to hypoxia;response to oxidative stress	GO:005099; GO:200049; GO:001939; GO:001567; GO:009886; GO:001076; GO:003296; GO:000166; GO:000697	neuronal cell body;cytosol;nuclear speck;neuron projection	GO:004302; GO:000582; GO:001660; GO:004300	"NA"	"NA"	oxygen transporter activity;nitric oxide dioxygenase activity;oxygen binding;protein binding;peroxidase activity;fatty acid peroxidase activity;catalase activity;iron ion binding;heme binding	GO:000534; GO:000894; GO:001982; GO:000551; GO:000460; GO:004788; GO:000409; GO:000550; GO:002003
XP_003131238.1	XP_003131238.1	XP_003131238.1 tripartite motif-containing protein 47 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11532000	NA	NA	NA	TRIM47	TRIM47;NA;NA;NA;NA	protein ubiquitination	GO:001656	cytosol;nucleus	GO:000582; GO:000563	"NA"	"NA"	zinc ion binding;ubiquitin-protein transferase activity;ligase activity	GO:000827; GO:000484; GO:001687
XP_003131241.1	XP_003131241.1	XP_003131241.1 galactokinase [Sus scrofa]	11	11	11	51122000	46860000	38181000	49016000	40216000	45614000	49305000	43570000	39775000	40285000	44027000	68513000	58396000	45618000	61667000	52393000	48525000	43629000	NA	NA	NA	GALK1	GALK1;NA;NA;NA;NA	galactose metabolic process;carbohydrate phosphorylation;galactose catabolic process via UDP-galactose;galactitol metabolic process;galactose catabolic process;glycolytic process from galactose	GO:000601; GO:004683; GO:003349; GO:001940; GO:001938; GO:006162	cytoplasm;extracellular exosome;membrane;cytosol	GO:000573; GO:007006; GO:001602; GO:000582	 Amino sugar and nucleotide sugar metabolism; Galactose metabolism; Metabolic pathways	hsa0052; hsa0005; hsa0110	galactokinase activity;ATP binding;galactose binding	GO:000433; GO:000552; GO:000553
XP_003131314.1;XP_005668719.1;CON__P17690	XP_003131314.1;XP_005668719.1	XP_003131314.1 beta-2-glycoprotein 1 isoform X1 [Sus scrofa];XP_005668719.1 beta-2-glycoprotein 1 isoform X2 [Sus scrofa]	11	11	11	90263000	114500000	111360000	171330000	235660000	303840000	164950000	113490000	126470000	131880000	237600000	186030000	194120000	166770000	204840000	184390000	154160000	238770000	NA	NA	NA	APOH	APOH;APOH;NA;NA;NA	positive regulation of lipoprotein lipase activity;regulation of fibrinolysis;plasminogen activation;negative regulation of myeloid cell apoptotic process;negative regulation of blood coagulation;triglyceride transport;negative regulation of angiogenesis;triglyceride metabolic process;blood coagulation, intrinsic pathway;negative regulation of smooth muscle cell apoptotic process;negative regulation of endothelial cell proliferation;platelet degranulation;negative regulation of endothelial cell migration	GO:005100; GO:005191; GO:003163; GO:003303; GO:003019; GO:003419; GO:001652; GO:000664; GO:000759; GO:003439; GO:000193; GO:000257; GO:001059	chylomicron;cell surface;platelet dense granule lumen;very-low-density lipoprotein particle;extracellular space;extracellular exosome;extracellular region	GO:004262; GO:000998; GO:003108; GO:003436; GO:000561; GO:007006; GO:000557	"NA"	"NA"	lipid binding;protein binding;phospholipid binding;heparin binding;identical protein binding;lipoprotein lipase activator activity	GO:000828; GO:000551; GO:000554; GO:000820; GO:004280; GO:006023
XP_020922487.1;XP_003131364.1	XP_020922487.1;XP_003131364.1	XP_020922487.1 Golgi SNAP receptor complex member 2 isoform X2 [Sus scrofa];XP_003131364.1 Golgi SNAP receptor complex member 2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8682200	0	NA	NA	NA	GOSR2	GOSR2;GOSR2;NA;NA;NA	ER to Golgi vesicle-mediated transport;protein targeting to vacuole;IRE1-mediated unfolded protein response;retrograde transport, endosome to Golgi;intra-Golgi vesicle-mediated transport;COPII vesicle coating;vesicle fusion with Golgi apparatus	GO:000688; GO:000662; GO:003649; GO:004214; GO:000689; GO:004820; GO:004828	Golgi membrane;endoplasmic reticulum membrane;integral component of membrane;Golgi apparatus;endoplasmic reticulum-Golgi intermediate compartment membrane;cytosol;ER to Golgi transport vesicle membrane;SNARE complex;late endosome membrane	GO:000013; GO:000578; GO:001602; GO:000579; GO:003311; GO:000582; GO:001250; GO:003120; GO:003190	 SNARE interactions in vesicular transport	hsa0413	SNAP receptor activity;protein binding;SNARE binding	GO:000548; GO:000551; GO:000014
XP_005668786.1;XP_005668785.1;XP_005668784.1;XP_003131375.1;XP_003131374.1;XP_005668787.1	XP_005668786.1;XP_005668785.1;XP_005668784.1;XP_003131375.1;XP_003131374.1;XP_005668787.1	XP_005668786.1 dephospho-CoA kinase domain-containing protein isoform X1 [Sus scrofa];XP_005668785.1 dephospho-CoA kinase domain-containing protein isoform X1 [Sus scrofa];XP_005668784.1 dephospho-CoA kinase domain-containing protein isoform X1 [Sus scrofa	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14948000	0	0	NA	NA	NA	DCAKD	DCAKD;DCAKD;DCAKD;DCAKD;DCAKD	coenzyme A biosynthetic process;phosphorylation	GO:001593; GO:001631	membrane	GO:001602	"NA"	"NA"	dephospho-CoA kinase activity;ATP binding	GO:000414; GO:000552
XP_003131380.1	XP_003131380.1	XP_003131380.1 116 kDa U5 small nuclear ribonucleoprotein component [Sus scrofa]	6	5	5	0	0	8442100	0	0	8497400	0	0	0	0	0	0	0	0	9523800	12324000	0	9050700	NA	NA	NA	EFTUD2	EFTUD2;NA;NA;NA;NA	RNA splicing;response to cocaine;mRNA splicing, via spliceosome;cellular response to drug;mRNA processing	GO:000838; GO:004222; GO:000039; GO:003569; GO:000639	nucleoplasm;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome;ribonucleoprotein complex;membrane;cytosol;spliceosomal complex;Cajal body;nuclear speck;U4/U6 x U5 tri-snRNP complex	GO:000565; GO:007100; GO:007101; GO:199090; GO:001602; GO:000582; GO:000568; GO:001503; GO:001660; GO:004654	 Spliceosome	hsa0304	GTP binding;protein binding;GTPase activity;RNA binding;U5 snRNA binding	GO:000552; GO:000551; GO:000392; GO:000372; GO:003062
XP_003131408.3	XP_003131408.3	XP_003131408.3 dual specificity protein phosphatase 3 [Sus scrofa]	5	5	5	42176000	56398000	61334000	36531000	28427000	42662000	50513000	44601000	38724000	47066000	23621000	57973000	63727000	38635000	32047000	36954000	35008000	54407000	NA	NA	NA	DUSP3	DUSP3;NA;NA;NA;NA	negative regulation of T cell activation;dephosphorylation;regulation of focal adhesion assembly;cellular response to epidermal growth factor stimulus;negative regulation of MAPK cascade;negative regulation of ERK1 and ERK2 cascade;inactivation of MAPK activity;negative regulation of T cell receptor signaling pathway;negative regulation of cell migration;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of mitotic cell cycle;negative regulation of JNK cascade;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity;peptidyl-tyrosine dephosphorylation;negative regulation of chemotaxis	GO:005086; GO:001631; GO:005189; GO:007136; GO:004340; GO:007037; GO:000018; GO:005086; GO:003033; GO:004205; GO:004593; GO:004632; GO:199026; GO:003533; GO:005092	nucleoplasm;nucleus;cytosol;immunological synapse	GO:000565; GO:000563; GO:000582; GO:000177	 MAPK signaling pathway	hsa0401	protein tyrosine phosphatase activity;protein tyrosine/serine/threonine phosphatase activity;protein tyrosine kinase binding;receptor tyrosine kinase binding;cytoskeletal protein binding;protein kinase binding;phosphatase activity;MAP kinase phosphatase activity	GO:000472; GO:000813; GO:199078; GO:003097; GO:000809; GO:001990; GO:001679; GO:003354
XP_003131429.1	XP_003131429.1	XP_003131429.1 cytochrome c oxidase assembly factor 3 homolog, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	8504900	0	0	0	0	0	0	0	NA	NA	NA	LOC100518575	LOC100518575;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020922651.1;XP_020922650.1;XP_003131468.2	XP_020922651.1;XP_020922650.1;XP_003131468.2	XP_020922651.1 2,3-cyclic-nucleotide 3-phosphodiesterase isoform X2 [Sus scrofa];XP_020922650.1 2,3-cyclic-nucleotide 3-phosphodiesterase isoform X2 [Sus scrofa];XP_003131468.2 2,3-cyclic-nucleotide 3-phosphodiesterase isoform X1 [Sus scrofa]	20	20	20	231950000	603760000	397610000	255570000	489200000	339690000	364690000	298770000	314310000	304590000	249140000	238540000	197110000	384080000	287230000	448770000	263340000	206220000	NA	NA	NA	CNP	CNP;CNP;CNP;NA;NA	adult locomotory behavior;response to toxic substance;forebrain development;oligodendrocyte differentiation;chemical synaptic transmission;axonogenesis;substantia nigra development;regulation of mitochondrial membrane permeability;aging;microtubule cytoskeleton organization;cyclic nucleotide catabolic process;response to lipopolysaccharide	GO:000834; GO:000963; GO:003090; GO:004870; GO:000726; GO:000740; GO:002176; GO:004690; GO:000756; GO:000022; GO:000921; GO:003249	mitochondrial inner membrane;plasma membrane;membrane;myelin sheath abaxonal region;melanosome;cytosol;nucleus;mitochondrial outer membrane;cytoplasm;nucleoplasm;microvillus;pseudopodium;perinuclear region of cytoplasm;extracellular exosome;extracellular space	GO:000574; GO:000588; GO:001602; GO:003574; GO:004247; GO:000582; GO:000563; GO:000574; GO:000573; GO:000565; GO:000590; GO:003114; GO:004847; GO:007006; GO:000561	"NA"	"NA"	cyclic nucleotide binding;2',3'-cyclic-nucleotide 3'-phosphodiesterase activity;RNA binding	GO:003055; GO:000411; GO:000372
XP_003131485.1;CON__P35900;XP_003131510.1;XP_003131478.3;CON__Q14525;NP_001231824.1;CON__Q9UE12;CON__Q15323;CON__Q9D312;XP_003131482.3;XP_020922678.1;XP_020922677.1;CON__Q8N1A0;CON__O76011;CON__Q6NTB9;CON__O76009;XP_020921967.1;CON__Q9C075;CON__Q6IFU5;CON__Q8IUT8	XP_003131485.1	XP_003131485.1 keratin, type I cytoskeletal 19 [Sus scrofa]	34	33	14	95915000	162410000	618090000	59049000	1727500000	7844700	6263200000	19235000	1076300000	56539000	3810000000	0	3062200000	0	2409100000	6161400	8874100000	2822900	NA	NA	NA	KRT19	KRT19;NA;NA;NA;NA	sarcomere organization;response to estrogen;keratinization;cell differentiation involved in embryonic placenta development;viral process;Notch signaling pathway;cornification	GO:004521; GO:004362; GO:003142; GO:006070; GO:001603; GO:000721; GO:007026	plasma membrane;terminal web;dystrophin-associated glycoprotein complex;sarcolemma;cell periphery;cytosol;Z disc;extracellular exosome;intermediate filament;costamere;apicolateral plasma membrane	GO:000588; GO:199035; GO:001601; GO:004238; GO:007194; GO:000582; GO:003001; GO:007006; GO:000588; GO:004303; GO:001632	"NA"	"NA"	structural constituent of muscle;macromolecular complex binding;structural constituent of cytoskeleton;protein binding	GO:000830; GO:004487; GO:000520; GO:000551
XP_003131544.1	XP_003131544.1	XP_003131544.1 26S proteasome non-ATPase regulatory subunit 3 [Sus scrofa]	17	17	17	94265000	62079000	88152000	86670000	80391000	63017000	82770000	81149000	83904000	82365000	85107000	105750000	104930000	66796000	86817000	81337000	79411000	73781000	NA	NA	NA	PSMD3	PSMD3;NA;NA;NA;NA	ubiquitin-dependent protein catabolic process;protein deubiquitination;regulation of protein catabolic process;neutrophil degranulation;regulation of catalytic activity;post-translational protein modification	GO:000651; GO:001657; GO:004217; GO:004331; GO:005079; GO:004368	proteasome regulatory particle, lid subcomplex;extracellular region;cytosol;proteasome complex;proteasome accessory complex;extracellular exosome;ficolin-1-rich granule lumen;membrane;nucleus;nucleoplasm;secretory granule lumen	GO:000854; GO:000557; GO:000582; GO:000050; GO:002262; GO:007006; GO:190481; GO:001602; GO:000563; GO:000565; GO:003477	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	protein binding;enzyme regulator activity	GO:000551; GO:003023
XP_020922692.1;XP_020922691.1;XP_020922690.1;XP_013835142.1;XP_013835139.1;XP_005653978.1;XP_003131546.1;XP_003126305.1;XP_001928873.1;XP_001926384.1	XP_020922692.1;XP_020922691.1;XP_020922690.1;XP_013835142.1;XP_013835139.1;XP_005653978.1;XP_003131546.1;XP_003126305.1;XP_001928873.1;XP_001926384.1	XP_020922692.1 ORM1-like protein 3 [Sus scrofa];XP_020922691.1 ORM1-like protein 3 [Sus scrofa];XP_020922690.1 ORM1-like protein 3 [Sus scrofa];XP_013835142.1 ORM1-like protein 3 [Sus scrofa];XP_013835139.1 ORM1-like protein 3 [Sus scrofa];XP_005653978.1 O	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	60265000	50548000	0	0	40506000	NA	NA	NA	ORMDL3	ORMDL3;ORMDL3;ORMDL3;ORMDL3;ORMDL3	cellular sphingolipid homeostasis;ceramide metabolic process;neutrophil degranulation;negative regulation of ceramide biosynthetic process	GO:009015; GO:000667; GO:004331; GO:190006	endoplasmic reticulum;secretory granule membrane;SPOTS complex;integral component of membrane;plasma membrane;specific granule membrane	GO:000578; GO:003066; GO:003533; GO:001602; GO:000588; GO:003557	"NA"	"NA"	protein binding	GO:000551
XP_003131557.1	XP_003131557.1	XP_003131557.1 60S ribosomal protein L19 [Sus scrofa]	2	2	2	77856000	68159000	96923000	45522000	45822000	119560000	77302000	49488000	67098000	87194000	0	49192000	58803000	72946000	58081000	104300000	89695000	92447000	NA	NA	NA	RPL19	RPL19;NA;NA;NA;NA	liver regeneration;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;cytoplasmic translation;SRP-dependent cotranslational protein targeting to membrane	GO:009742; GO:000018; GO:000641; GO:000218; GO:000661	cytosolic large ribosomal subunit;membrane;cytosol;focal adhesion;polysomal ribosome	GO:002262; GO:001602; GO:000582; GO:000592; GO:004278	 Ribosome	hsa0301	RNA binding;protein binding;structural constituent of ribosome;5.8S rRNA binding;large ribosomal subunit rRNA binding	GO:000372; GO:000551; GO:000373; GO:199093; GO:007018
XP_003131565.4;XP_013835160.1	XP_003131565.4;XP_013835160.1	XP_003131565.4 migration and invasion enhancer 1 isoform X2 [Sus scrofa];XP_013835160.1 migration and invasion enhancer 1 isoform X1 [Sus scrofa]	5	5	5	19335000	31678000	21789000	30417000	24421000	0	18696000	26543000	30009000	21345000	16601000	18725000	0	18781000	0	0	19824000	21848000	NA	NA	NA	MIEN1	MIEN1;MIEN1;NA;NA;NA	positive regulation of filopodium assembly;negative regulation of apoptotic process;positive regulation of cell migration;apoptotic process;response to selenium ion	GO:005149; GO:004306; GO:003033; GO:000691; GO:001026	cytosol;intrinsic component of the cytoplasmic side of the plasma membrane	GO:000582; GO:003123	"NA"	"NA"	protein binding	GO:000551
XP_003131575.2	XP_003131575.2	XP_003131575.2 puromycin-sensitive aminopeptidase [Sus scrofa]	28	28	28	353920000	341270000	417070000	320090000	322100000	321050000	422310000	355470000	405560000	315970000	407510000	352650000	406730000	341440000	400650000	349460000	391320000	367600000	NA	NA	NA	NPEPPS	NPEPPS;NA;NA;NA;NA	proteolysis;peptide catabolic process;positive regulation of protein targeting to mitochondrion;cellular response to hypoxia;protein polyubiquitination	GO:000650; GO:004317; GO:190395; GO:007145; GO:000020	cytosol;extracellular exosome;nucleus;cytoplasm	GO:000582; GO:007006; GO:000563; GO:000573	"NA"	"NA"	zinc ion binding;metalloaminopeptidase activity;aminopeptidase activity;peptide binding	GO:000827; GO:007000; GO:000417; GO:004227
XP_003131576.3	XP_003131576.3	XP_003131576.3 importin subunit beta-1 [Sus scrofa]	17	17	17	168100000	211620000	192120000	234390000	178180000	211010000	188720000	220580000	190090000	195670000	167580000	221930000	187290000	239710000	225120000	221850000	186210000	195200000	NA	NA	NA	KPNB1	KPNB1;NA;NA;NA;NA	mitotic metaphase plate congression;astral microtubule organization;intracellular transport of virus;mitotic spindle assembly;neutrophil degranulation;establishment of protein localization;regulation of cholesterol biosynthetic process;apoptotic DNA fragmentation;Ran protein signal transduction;establishment of mitotic spindle localization;mitotic chromosome movement towards spindle pole;modulation by virus of host process;ribosomal protein import into nucleus;protein import into nucleus	GO:000708; GO:003095; GO:007573; GO:009030; GO:004331; GO:004518; GO:004554; GO:000630; GO:003129; GO:004000; GO:000707; GO:001905; GO:000661; GO:000660	extracellular region;cytosol;nuclear envelope;nucleoplasm;nuclear periphery;host cell;endoplasmic reticulum tubular network;nuclear membrane;extracellular exosome;ficolin-1-rich granule lumen;nuclear pore;cytoplasm;specific granule lumen;cytoplasmic stress granule;membrane	GO:000557; GO:000582; GO:000563; GO:000565; GO:003439; GO:004365; GO:007178; GO:003196; GO:007006; GO:190481; GO:000564; GO:000573; GO:003558; GO:001049; GO:001602	 RNA transport	hsa0301	protein transporter activity;RNA binding;protein domain specific binding;nuclear localization sequence binding;zinc ion binding;protein binding;Hsp90 protein binding;Ran GTPase binding;enzyme binding	GO:000856; GO:000372; GO:001990; GO:000813; GO:000827; GO:000551; GO:005187; GO:000853; GO:001989
XP_013835446.1;XP_003131586.1;XP_020922767.1;XP_020922765.1;XP_020922764.1;XP_020922763.1	XP_013835446.1;XP_003131586.1;XP_020922767.1;XP_020922765.1;XP_020922764.1;XP_020922763.1	XP_013835446.1 chromobox protein homolog 1 isoform X2 [Sus scrofa];XP_003131586.1 chromobox protein homolog 1 isoform X2 [Sus scrofa];XP_020922767.1 chromobox protein homolog 1 isoform X1 [Sus scrofa];XP_020922765.1 chromobox protein homolog 1 isoform X1 [	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9489600	0	0	NA	NA	NA	CBX1	CBX1;CBX1;CBX1;CBX1;CBX1	cellular response to DNA damage stimulus	GO:000697	nucleoplasm;nuclear chromosome, telomeric region;nuclear heterochromatin;chromosome, centromeric region;spindle;site of DNA damage;nucleus	GO:000565; GO:000078; GO:000572; GO:000077; GO:000581; GO:009073; GO:000563	"NA"	"NA"	chromatin binding;histone methyltransferase binding;protein binding;enzyme binding	GO:000368; GO:199022; GO:000551; GO:001989
XP_020922794.1;XP_013836451.2;XP_005668921.2;XP_003131608.4	XP_020922794.1;XP_013836451.2;XP_005668921.2;XP_003131608.4	XP_020922794.1 prohibitin [Sus scrofa];XP_013836451.2 prohibitin [Sus scrofa];XP_005668921.2 prohibitin [Sus scrofa];XP_003131608.4 prohibitin [Sus scrofa]	14	14	14	269240000	220090000	235470000	201840000	292590000	144440000	284380000	241320000	280750000	219480000	265950000	274280000	228700000	215430000	256130000	233480000	202550000	188920000	NA	NA	NA	PHB	PHB;PHB;PHB;PHB;NA	signal transduction;negative regulation of transcription by competitive promoter binding;progesterone receptor signaling pathway;positive regulation of ERK1 and ERK2 cascade;regulation of transcription, DNA-templated;mitochondrion organization;osteoblast differentiation;negative regulation of protein catabolic process;positive regulation of G-protein coupled receptor protein signaling pathway;mitochondrial calcium ion transport;positive regulation of transcription, DNA-templated;histone deacetylation;positive regulation of complement activation;cellular response to interleukin-6;negative regulation of transcription from RNA polymerase II promoter;negative regulation of glucocorticoid receptor signaling pathway;positive regulation of gene expression;regulation of apoptotic process;negative regulation of androgen receptor signaling pathway;negative regulation of cell proliferation;protein stabilization;negative regulation of cell growth;DNA biosynthetic process	GO:000716; GO:001094; GO:005084; GO:007037; GO:000635; GO:000700; GO:000164; GO:004217; GO:004574; GO:000685; GO:004589; GO:001657; GO:004591; GO:007135; GO:000012; GO:200032; GO:001062; GO:004298; GO:006076; GO:000828; GO:005082; GO:003030; GO:007189	plasma membrane;cell surface;mitochondrion;nucleus;extracellular exosome;integral component of plasma membrane;mitochondrial inner membrane;membrane;nucleoplasm;early endosome	GO:000588; GO:000998; GO:000573; GO:000563; GO:007006; GO:000588; GO:000574; GO:001602; GO:000565; GO:000576	"NA"	"NA"	protein C-terminus binding;proteinase activated receptor binding;complement component C3a binding;protein binding;histone deacetylase binding;transcription regulatory region DNA binding;enzyme binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding	GO:000802; GO:003187; GO:000185; GO:000551; GO:004282; GO:004421; GO:001989; GO:000098
XP_003131621.3;XP_020922821.1;XP_020922823.1;XP_020922822.1	XP_003131621.3;XP_020922821.1	XP_003131621.3 acyl-CoA synthetase family member 2, mitochondrial isoform X1 [Sus scrofa];XP_020922821.1 acyl-CoA synthetase family member 2, mitochondrial isoform X2 [Sus scrofa]	10	10	10	128040000	53334000	87477000	56959000	73873000	50800000	76461000	54116000	90613000	64915000	69073000	66891000	87951000	53937000	65854000	58506000	89958000	74062000	NA	NA	NA	ACSF2	ACSF2;ACSF2;NA;NA;NA	acyl-CoA metabolic process;fatty acid metabolic process	GO:000663; GO:000663	mitochondrial matrix	GO:000575	"NA"	"NA"	ATP binding;protein binding;acyl-CoA ligase activity	GO:000552; GO:000551; GO:000399
XP_003131623.4	XP_003131623.4	XP_003131623.4 LOW QUALITY PROTEIN: canalicular multispecific organic anion transporter 2 [Sus scrofa]	3	3	3	0	7666200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14989000	0	NA	NA	NA	ABCC3	ABCC3;NA;NA;NA;NA	transmembrane transport;ATP hydrolysis coupled anion transmembrane transport;bile acid and bile salt transport	GO:005508; GO:009913; GO:001572	integral component of plasma membrane;plasma membrane;vacuolar membrane;membrane	GO:000588; GO:000588; GO:000577; GO:001602	 ABC transporters; Bile secretion	hsa0201; hsa0497	ATPase-coupled anion transmembrane transporter activity;bile acid-exporting ATPase activity;ATP binding;organic anion transmembrane transporter activity;ATPase activity, coupled to transmembrane movement of substances	GO:004322; GO:001543; GO:000552; GO:000851; GO:004262
XP_020922930.1;XP_003131683.1	XP_020922930.1;XP_003131683.1	XP_020922930.1 dynein light chain 2, cytoplasmic [Sus scrofa];XP_003131683.1 dynein light chain 2, cytoplasmic [Sus scrofa]	5	5	2	107710000	120410000	88533000	87748000	75198000	104780000	84064000	99017000	96925000	91915000	79196000	176500000	148800000	94525000	85188000	81800000	94325000	88386000	NA	NA	NA	DYNLL2	DYNLL2;DYNLL2;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;intraciliary transport involved in cilium assembly;positive regulation of ATP-dependent microtubule motor activity, plus-end-directed;ER to Golgi vesicle-mediated transport;macroautophagy	GO:001988; GO:003573; GO:200058; GO:000688; GO:001623	dynein complex;ciliary tip;cytosol;nucleus;centrosome;glutamatergic synapse;cytoplasmic dynein complex;membrane;postsynaptic density;microtubule;myosin V complex;plasma membrane;postsynapse;cilium	GO:003028; GO:009754; GO:000582; GO:000563; GO:000581; GO:009897; GO:000586; GO:001602; GO:001406; GO:000587; GO:003147; GO:000588; GO:009879; GO:000592	 Vasopressin-regulated water reabsorption	hsa0496	protein binding;dynein intermediate chain binding;dynein light intermediate chain binding;ATP-dependent microtubule motor activity, plus-end-directed;protein heterodimerization activity;protein homodimerization activity;scaffold protein binding	GO:000551; GO:004550; GO:005195; GO:000857; GO:004698; GO:004280; GO:009711
XP_003131703.3	XP_003131703.3	XP_003131703.3 LOW QUALITY PROTEIN: myeloperoxidase [Sus scrofa]	2	2	2	0	0	0	0	59769000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MPO	MPO;NA;NA;NA;NA	negative regulation of apoptotic process;neutrophil degranulation;respiratory burst involved in defense response;defense response to fungus;oxidation-reduction process;aging;defense response to bacterium;response to oxidative stress;hypochlorous acid biosynthetic process;defense response;response to mechanical stimulus;removal of superoxide radicals;low-density lipoprotein particle remodeling;response to gold nanoparticle;response to food;response to lipopolysaccharide;response to yeast;negative regulation of growth of symbiont in host	GO:004306; GO:004331; GO:000267; GO:005083; GO:005511; GO:000756; GO:004274; GO:000697; GO:000214; GO:000695; GO:000961; GO:001943; GO:003437; GO:199026; GO:003209; GO:003249; GO:000187; GO:004413	extracellular region;azurophil granule;extracellular exosome;azurophil granule lumen;nucleus;intracellular membrane-bounded organelle;extracellular space;cytoplasm;lysosome;secretory granule	GO:000557; GO:004258; GO:007006; GO:003557; GO:000563; GO:004323; GO:000561; GO:000573; GO:000576; GO:003014	 Phagosome; Transcriptional misregulation in cancer	hsa0414; hsa0520	chromatin binding;metal ion binding;heparin binding;heme binding;peroxidase activity	GO:000368; GO:004687; GO:000820; GO:002003; GO:000460
XP_005669059.1;XP_005669058.1;XP_003131717.1;XP_003131714.1	XP_005669059.1;XP_005669058.1;XP_003131717.1;XP_003131714.1	XP_005669059.1 peptidyl-tRNA hydrolase 2, mitochondrial [Sus scrofa];XP_005669058.1 peptidyl-tRNA hydrolase 2, mitochondrial [Sus scrofa];XP_003131717.1 peptidyl-tRNA hydrolase 2, mitochondrial [Sus scrofa];XP_003131714.1 peptidyl-tRNA hydrolase 2, mitocho	3	3	3	8429000	8194800	7783500	7502900	9073500	5545300	8668300	6529000	8196400	8545200	0	0	0	0	8648900	8754200	0	7455000	NA	NA	NA	PTRH2	PTRH2;PTRH2;PTRH2;PTRH2;NA	positive regulation of anoikis;negative regulation of anoikis;apoptotic process;negative regulation of gene expression	GO:200021; GO:200081; GO:000691; GO:001062	mitochondrion;cytosol;membrane	GO:000573; GO:000582; GO:001602	"NA"	"NA"	aminoacyl-tRNA hydrolase activity;protein binding	GO:000404; GO:000551
XP_003483108.2;XP_013845415.2;XP_005657043.2;XP_013845413.2;XP_013845412.2;XP_003131790.5	XP_003483108.2;XP_013845415.2;XP_005657043.2;XP_013845413.2;XP_013845412.2;XP_003131790.5	XP_003483108.2 mitochondrial Rho GTPase 1 isoform X6 [Sus scrofa];XP_013845415.2 mitochondrial Rho GTPase 1 isoform X5 [Sus scrofa];XP_005657043.2 mitochondrial Rho GTPase 1 isoform X4 [Sus scrofa];XP_013845413.2 mitochondrial Rho GTPase 1 isoform X3 [Sus	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1262800	0	NA	NA	NA	RHOT1	RHOT1;RHOT1;RHOT1;RHOT1;RHOT1	regulation of small GTPase mediated signal transduction;protein deubiquitination;mitochondrial outer membrane permeabilization;regulation of organelle transport along microtubule;Rho protein signal transduction;cellular homeostasis;regulation of mitochondrion organization;regulation of neurotransmitter secretion;mitochondrion transport along microtubule;establishment of mitochondrion localization by microtubule attachment;mitochondrion organization	GO:005105; GO:001657; GO:009734; GO:190251; GO:000726; GO:001972; GO:001082; GO:004692; GO:004749; GO:003464; GO:000700	mitochondrion;membrane;integral component of mitochondrial outer membrane;mitochondrial outer membrane;cytosol;plasma membrane	GO:000573; GO:001602; GO:003130; GO:000574; GO:000582; GO:000588	"NA"	"NA"	molecular_function;calcium ion binding;GTPase activity;protein binding;GTP binding	GO:000367; GO:000550; GO:000392; GO:000551; GO:000552
XP_003131820.1	XP_003131820.1	XP_003131820.1 60S ribosomal protein L23a [Sus scrofa]	8	8	8	101700000	144000000	165830000	92745000	91773000	144180000	124940000	119420000	146320000	107820000	110480000	54997000	143050000	131730000	106050000	84848000	141380000	136220000	NA	NA	NA	RPL23A	RPL23A;NA;NA;NA;NA	translation;ribosomal large subunit assembly;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translational initiation;SRP-dependent cotranslational protein targeting to membrane;cell proliferation	GO:000641; GO:000002; GO:000018; GO:000641; GO:000661; GO:000828	cytosolic large ribosomal subunit;nucleolus;nucleus;extracellular exosome;cytosol	GO:002262; GO:000573; GO:000563; GO:007006; GO:000582	 Ribosome	hsa0301	TORC2 complex binding;protein binding;RNA binding;structural constituent of ribosome;cadherin binding;rRNA binding	GO:190484; GO:000551; GO:000372; GO:000373; GO:004529; GO:001984
XP_005669162.1;XP_003131835.2	XP_005669162.1;XP_003131835.2	XP_005669162.1 Golgi SNAP receptor complex member 1 isoform X2 [Sus scrofa];XP_003131835.2 Golgi SNAP receptor complex member 1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	5020700	0	0	0	0	0	0	0	0	0	NA	NA	NA	GOSR1	GOSR1;GOSR1;NA;NA;NA	intra-Golgi vesicle-mediated transport;protein transport;retrograde transport, endosome to Golgi;vesicle fusion;ER to Golgi vesicle-mediated transport;regulation of vesicle targeting, to, from or within Golgi	GO:000689; GO:001503; GO:004214; GO:000690; GO:000688; GO:004820	Golgi membrane;membrane;cytosol;Golgi apparatus;SNARE complex;cis-Golgi network;transport vesicle	GO:000013; GO:001602; GO:000582; GO:000579; GO:003120; GO:000580; GO:003013	 SNARE interactions in vesicular transport	hsa0413	SNAP receptor activity	GO:000548
XP_013835617.1;XP_003131863.2	XP_013835617.1;XP_003131863.2	XP_013835617.1 glyoxalase domain-containing protein 4 [Sus scrofa];XP_003131863.2 glyoxalase domain-containing protein 4 [Sus scrofa]	8	8	8	151520000	156550000	158270000	162320000	173170000	145210000	169790000	157410000	133640000	114920000	194320000	142140000	126010000	150580000	175120000	160440000	162080000	145120000	NA	NA	NA	GLOD4	GLOD4;GLOD4;NA;NA;NA	"NA"	"NA"	extracellular exosome;mitochondrion	GO:007006; GO:000573	"NA"	"NA"	cadherin binding	GO:004529
XP_003131870.1	XP_003131870.1	XP_003131870.1 replication protein A 70 kDa DNA-binding subunit [Sus scrofa]	3	3	3	0	0	4862400	0	0	0	0	0	0	3657300	0	0	0	0	0	0	0	0	NA	NA	NA	RPA1	RPA1;NA;NA;NA;NA	DNA replication;G1/S transition of mitotic cell cycle;telomere maintenance;protein localization to chromosome;interstrand cross-link repair;nucleotide-excision repair;DNA-dependent DNA replication;nucleotide-excision repair, preincision complex assembly;cellular response to DNA damage stimulus;telomere maintenance via telomerase;error-prone translesion synthesis;nucleotide-excision repair, DNA incision;error-free translesion synthesis;meiotic cell cycle;regulation of cellular response to heat;DNA recombination;DNA damage response, detection of DNA damage;translesion synthesis;telomere maintenance via semi-conservative replication	GO:000626; GO:000008; GO:000072; GO:003450; GO:003629; GO:000628; GO:000626; GO:000629; GO:000697; GO:000700; GO:004227; GO:003368; GO:007098; GO:005132; GO:190003; GO:000631; GO:004276; GO:001998; GO:003220	PML body;site of DNA damage;nuclear chromosome, telomeric region;nucleus;nucleoplasm;DNA replication factor A complex	GO:001660; GO:009073; GO:000078; GO:000563; GO:000565; GO:000566	 Fanconi anemia pathway; Nucleotide excision repair; Mismatch repair; DNA replication; Homologous recombination	hsa0346; hsa0342; hsa0343; hsa0303; hsa0344	single-stranded DNA binding;G-rich strand telomeric DNA binding;metal ion binding;damaged DNA binding;single-stranded telomeric DNA binding;sequence-specific DNA binding;protein binding	GO:000369; GO:009850; GO:004687; GO:000368; GO:004304; GO:004356; GO:000551
XP_003131896.1	XP_003131896.1	XP_003131896.1 tax1-binding protein 3 [Sus scrofa]	2	2	2	0	27937000	0	0	0	0	0	0	0	14929000	0	22165000	0	0	0	25942000	0	0	NA	NA	NA	TAX1BP3	TAX1BP3;NA;NA;NA;NA	activation of GTPase activity;negative regulation of Wnt signaling pathway;negative regulation of protein localization to cell surface;Rho protein signal transduction;negative regulation of cell proliferation;Wnt signaling pathway	GO:009063; GO:003017; GO:200000; GO:000726; GO:000828; GO:001605	actin cytoskeleton;cytosol;plasma membrane;cytoplasm;extracellular exosome;intracellular membrane-bounded organelle;fibrillar center	GO:001562; GO:000582; GO:000588; GO:000573; GO:007006; GO:004323; GO:000165	"NA"	"NA"	beta-catenin binding;protein C-terminus binding;protein binding	GO:000801; GO:000802; GO:000551
XP_003131925.1	XP_003131925.1	XP_003131925.1 thioredoxin domain-containing protein 17 [Sus scrofa]	4	4	4	48931000	58064000	62511000	32214000	42262000	43224000	51784000	34717000	43405000	41909000	55441000	55114000	42836000	46300000	39355000	50488000	52063000	48329000	NA	NA	NA	TXNDC17	TXNDC17;NA;NA;NA;NA	tumor necrosis factor-mediated signaling pathway;oxidation-reduction process;cellular oxidant detoxification	GO:003320; GO:005511; GO:009886	cytosol;extracellular exosome	GO:000582; GO:007006	"NA"	"NA"	peroxidase activity;protein binding;protein-disulfide reductase activity	GO:000460; GO:000551; GO:004713
XP_020923476.1;XP_013843405.1;XP_003131980.1;XP_003131979.1;XP_020923474.1;XP_020925458.1;XP_020925457.1	XP_020923476.1;XP_013843405.1;XP_003131980.1;XP_003131979.1;XP_020923474.1	XP_020923476.1 eukaryotic translation initiation factor 5A-1 isoform X2 [Sus scrofa];XP_013843405.1 eukaryotic translation initiation factor 5A-1 isoform X2 [Sus scrofa];XP_003131980.1 eukaryotic translation initiation factor 5A-1 isoform X2 [Sus scrofa];X	11	11	11	373980000	276780000	310640000	308110000	334620000	287330000	283850000	333210000	320060000	320260000	302780000	143950000	253400000	274620000	326860000	266780000	282820000	302460000	NA	NA	NA	EIF5A	EIF5A;EIF5A;EIF5A;EIF5A;EIF5A	positive regulation of cell proliferation;positive regulation of translational termination;nucleocytoplasmic transport;translational frameshifting;protein export from nucleus;mRNA export from nucleus	GO:000828; GO:004590; GO:000691; GO:000645; GO:000661; GO:000640	membrane;annulate lamellae;cytosol;nucleus;cytoplasm;endoplasmic reticulum membrane	GO:001602; GO:000564; GO:000582; GO:000563; GO:000573; GO:000578	"NA"	"NA"	U6 snRNA binding;protein binding;protein N-terminus binding;translation elongation factor activity;ribosome binding;RNA binding	GO:001707; GO:000551; GO:004748; GO:000374; GO:004302; GO:000372
XP_005669252.1;XP_003131983.3	XP_005669252.1;XP_003131983.3	XP_005669252.1 chromatin complexes subunit BAP18 isoform X3 [Sus scrofa];XP_003131983.3 chromatin complexes subunit BAP18 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	21775000	0	0	0	0	0	0	NA	NA	NA	C12H17orf49	C12H17orf49;C12H17orf49;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020923468.1;XP_005655336.1;XP_003131991.2;XP_020923466.1	XP_020923468.1;XP_005655336.1;XP_003131991.2;XP_020923466.1	XP_020923468.1 very long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X4 [Sus scrofa];XP_005655336.1 very long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_003131991.2 very long-chain specific acyl-CoA deh	15	15	15	148340000	92233000	158820000	84343000	132610000	69161000	146970000	83219000	188410000	118090000	103000000	85777000	106190000	69415000	122280000	106630000	97520000	78823000	NA	NA	NA	ACADVL	ACADVL;ACADVL;ACADVL;ACADVL;NA	negative regulation of fatty acid oxidation;energy derivation by oxidation of organic compounds;IRE1-mediated unfolded protein response;negative regulation of fatty acid biosynthetic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase;epithelial cell differentiation;regulation of cholesterol metabolic process;temperature homeostasis;fatty acid beta-oxidation;response to cold	GO:004632; GO:001598; GO:003649; GO:004571; GO:003353; GO:003085; GO:009018; GO:000165; GO:000663; GO:000940	mitochondrial inner membrane;mitochondrial matrix;nucleolus;mitochondrial nucleoid;cytosol;nucleus;mitochondrial membrane	GO:000574; GO:000575; GO:000573; GO:004264; GO:000582; GO:000563; GO:003196	 Fatty acid metabolism; Fatty acid degradation; Metabolic pathways	hsa0121; hsa0007; hsa0110	fatty-acyl-CoA binding;long-chain-acyl-CoA dehydrogenase activity;very-long-chain-acyl-CoA dehydrogenase activity;acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding	GO:000006; GO:000446; GO:001709; GO:000399; GO:005066
XP_003132080.1;XP_020923604.1;XP_020935789.1;NP_001302522.1;XP_013836817.1;XP_020938397.1;XP_020938396.1;XP_020938395.1;XP_020938394.1;XP_020935785.1;XP_020935783.1;XP_020935782.1;XP_013849471.2	XP_003132080.1;XP_020923604.1	XP_003132080.1 fatty aldehyde dehydrogenase isoform X2 [Sus scrofa];XP_020923604.1 fatty aldehyde dehydrogenase isoform X1 [Sus scrofa]	16	16	16	192480000	297590000	200860000	240590000	260330000	324920000	184430000	272480000	210730000	270050000	301010000	395110000	135360000	298640000	358740000	398640000	275680000	360890000	NA	NA	NA	ALDH3A2	ALDH3A2;ALDH3A2;NA;NA;NA	peripheral nervous system development;hexadecanal metabolic process;epidermis development;oxidation-reduction process;central nervous system development;sphingolipid biosynthetic process;phytol metabolic process;fatty acid alpha-oxidation;cellular aldehyde metabolic process	GO:000742; GO:004645; GO:000854; GO:005511; GO:000741; GO:003014; GO:003330; GO:000156; GO:000608	peroxisomal membrane;intracellular membrane-bounded organelle;endoplasmic reticulum membrane;integral component of membrane	GO:000577; GO:004323; GO:000578; GO:001602	 beta-Alanine metabolism; Glycolysis / Gluconeogenesis; Pentose and glucuronate interconversions; Valine, leucine and isoleucine degradation; Glycerolipid metabolism; Pyruvate metabolism; Ascorbate and aldarate metabolism; Lysine degradation; Arginine and proline metabolism; Tryptophan metabolism; Metabolic pathways; Biosynthesis of antibiotics; Histidine metabolism; Fatty acid degradation	hsa0041; hsa0001; hsa0004; hsa0028; hsa0056; hsa0062; hsa0005; hsa0031; hsa0033; hsa0038; hsa0110; hsa0113; hsa0034; hsa0007	aldehyde dehydrogenase (NAD) activity;protein homodimerization activity;long-chain-aldehyde dehydrogenase activity;protein binding;3-chloroallyl aldehyde dehydrogenase activity;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;long-chain-alcohol oxidase activity;medium-chain-aldehyde dehydrogenase activity	GO:000402; GO:004280; GO:005006; GO:000551; GO:000402; GO:004387; GO:004657; GO:005281
XP_003132136.3	XP_003132136.3	XP_003132136.3 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B [Sus scrofa]	4	4	4	23810000	0	19082000	25744000	24992000	24179000	24357000	23984000	23316000	22518000	26657000	0	22214000	24293000	0	21881000	27101000	25139000	NA	NA	NA	STT3B	STT3B;NA;NA;NA;NA	co-translational protein modification;glycoprotein catabolic process;response to unfolded protein;protein N-linked glycosylation via asparagine;ubiquitin-dependent ERAD pathway;post-translational protein modification	GO:004368; GO:000651; GO:000698; GO:001827; GO:003043; GO:004368	integral component of membrane;endoplasmic reticulum;oligosaccharyltransferase complex;macromolecular complex;oligosaccharyltransferase I complex;membrane	GO:001602; GO:000578; GO:000825; GO:003299; GO:003499; GO:001602	 N-Glycan biosynthesis; Protein processing in endoplasmic reticulum; Metabolic pathways	hsa0051; hsa0414; hsa0110	metal ion binding;dolichyl-diphosphooligosaccharide-protein glycotransferase activity	GO:004687; GO:000457
XP_003132151.1;XP_020927323.1	XP_003132151.1;XP_020927323.1	XP_003132151.1 3-ketoacyl-CoA thiolase, peroxisomal isoform X1 [Sus scrofa];XP_020927323.1 3-ketoacyl-CoA thiolase, peroxisomal isoform X2 [Sus scrofa]	16	16	16	551100000	289540000	705650000	278230000	583580000	172650000	799010000	328030000	961960000	361640000	452740000	298040000	194810000	259200000	454610000	327790000	416880000	262330000	NA	NA	NA	ACAA1	ACAA1;ACAA1;NA;NA;NA	very long-chain fatty acid metabolic process;protein targeting to peroxisome;fatty acid beta-oxidation;phenylacetate catabolic process;fatty acid beta-oxidation using acyl-CoA oxidase;neutrophil degranulation;bile acid metabolic process;alpha-linolenic acid metabolic process	GO:000003; GO:000662; GO:000663; GO:001012; GO:003354; GO:004331; GO:000820; GO:003610	peroxisome;membrane;peroxisomal matrix;specific granule lumen;extracellular region;intracellular membrane-bounded organelle;cytosol	GO:000577; GO:001602; GO:000578; GO:003558; GO:000557; GO:004323; GO:000582	 Fatty acid degradation; Biosynthesis of unsaturated fatty acids; Fatty acid metabolism; Biosynthesis of antibiotics; Valine, leucine and isoleucine degradation; Metabolic pathways; PPAR signaling pathway; alpha-Linolenic acid metabolism; Peroxisome	hsa0007; hsa0104; hsa0121; hsa0113; hsa0028; hsa0110; hsa0332; hsa0059; hsa0414	acetate CoA-transferase activity;palmitoyl-CoA oxidase activity;protein binding;acetyl-CoA C-acyltransferase activity	GO:000877; GO:001640; GO:000551; GO:000398
XP_003132249.2;XP_005669590.1	XP_003132249.2;XP_005669590.1	XP_003132249.2 inosine-5-monophosphate dehydrogenase 2 isoform X2 [Sus scrofa];XP_005669590.1 inosine-5-monophosphate dehydrogenase 2 isoform X1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	14922000	0	0	13969000	0	16529000	0	NA	NA	NA	IMPDH2	IMPDH2;IMPDH2;NA;NA;NA	lymphocyte proliferation;protein homotetramerization;GTP biosynthetic process;retina development in camera-type eye;cellular response to interleukin-4;circadian rhythm;purine ribonucleoside monophosphate biosynthetic process;oxidation-reduction process;GMP biosynthetic process;neutrophil degranulation	GO:004665; GO:005128; GO:000618; GO:006004; GO:007135; GO:000762; GO:000916; GO:005511; GO:000617; GO:004331	cytosol;cytoplasm;nucleus;secretory granule lumen;peroxisomal membrane;extracellular exosome;ficolin-1-rich granule lumen;membrane;extracellular region	GO:000582; GO:000573; GO:000563; GO:003477; GO:000577; GO:007006; GO:190481; GO:001602; GO:000557	 Drug metabolism - other enzymes; Purine metabolism; Metabolic pathways	hsa0098; hsa0023; hsa0110	RNA binding;nucleotide binding;IMP dehydrogenase activity;metal ion binding;DNA binding;protein binding	GO:000372; GO:000016; GO:000393; GO:004687; GO:000367; GO:000551
XP_003132263.2;XP_013837152.2;XP_020924435.1;XP_020924434.1;XP_020924433.1;XP_020924432.1	XP_003132263.2;XP_013837152.2;XP_020924435.1;XP_020924434.1;XP_020924433.1;XP_020924432.1	XP_003132263.2 hepatocyte growth factor-like protein isoform X6 [Sus scrofa];XP_013837152.2 hepatocyte growth factor-like protein isoform X5 [Sus scrofa];XP_020924435.1 hepatocyte growth factor-like protein isoform X4 [Sus scrofa];XP_020924434.1 hepatocyte	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1188600	NA	NA	NA	MST1	MST1;MST1;MST1;MST1;MST1	proteolysis;negative regulation of gluconeogenesis;regulation of cAMP-dependent protein kinase activity;regulation of macrophage chemotaxis;positive regulation of mammary gland epithelial cell proliferation;hepatocyte growth factor receptor signaling pathway	GO:000650; GO:004572; GO:200047; GO:001075; GO:003360; GO:004801	extracellular space;extracellular region	GO:000561; GO:000557	"NA"	"NA"	protein binding;receptor tyrosine kinase binding;serine-type endopeptidase activity	GO:000551; GO:003097; GO:000425
XP_003132276.1	XP_003132276.1	XP_003132276.1 cytochrome b561 domain-containing protein 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5552400	0	NA	NA	NA	LOC100517372	LOC100517372;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003132357.4;XP_020926487.1	XP_003132357.4;XP_020926487.1	XP_003132357.4 succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X1 [Sus scrofa];XP_020926487.1 succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X2 [Sus scrofa]	13	13	12	144870000	100840000	145020000	99809000	133960000	79914000	162790000	110000000	132940000	112880000	140970000	102720000	130980000	114800000	148850000	113550000	139840000	97502000	NA	NA	NA	SUCLG2	SUCLG2;SUCLG2;NA;NA;NA	tricarboxylic acid cycle;succinyl-CoA metabolic process	GO:000609; GO:000610	mitochondrial matrix;succinate-CoA ligase complex (GDP-forming);plasma membrane;mitochondrion	GO:000575; GO:004524; GO:000588; GO:000573	 Carbon metabolism; Metabolic pathways; Citrate cycle (TCA cycle); Propanoate metabolism; Biosynthesis of antibiotics	hsa0120; hsa0110; hsa0002; hsa0064; hsa0113	magnesium ion binding;GTP binding;protein heterodimerization activity;succinate-CoA ligase (GDP-forming) activity;GDP binding;protein binding	GO:000028; GO:000552; GO:004698; GO:000477; GO:001900; GO:000551
XP_003132451.1	XP_003132451.1	XP_003132451.1 histone H1x [Sus scrofa]	5	5	5	24558000	59373000	49680000	16179000	23011000	69281000	34857000	57829000	35163000	85776000	68185000	48516000	121720000	57800000	35063000	25381000	64119000	83468000	NA	NA	NA	LOC100516295	LOC100516295;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003132469.4	XP_003132469.4	XP_003132469.4 ubiquitin-like modifier-activating enzyme 5 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18700000	NA	NA	NA	UBA5	UBA5;NA;NA;NA;NA	neuromuscular process;protein ufmylation;protein K69-linked ufmylation;regulation of intracellular estrogen receptor signaling pathway;protein modification by small protein conjugation;response to endoplasmic reticulum stress	GO:005090; GO:007156; GO:199059; GO:003314; GO:003244; GO:003497	cytosol;nucleus;intracellular membrane-bounded organelle;cytoplasm;Golgi apparatus	GO:000582; GO:000563; GO:004323; GO:000573; GO:000579	"NA"	"NA"	metal ion binding;ATP binding;UFM1 activating enzyme activity;protein binding	GO:004687; GO:000552; GO:007156; GO:000551
XP_003132530.1	XP_003132530.1	XP_003132530.1 COMM domain-containing protein 2 [Sus scrofa]	4	4	4	0	16204000	12382000	12953000	0	0	10955000	17460000	11691000	14102000	0	14471000	0	14411000	13031000	14138000	10611000	17392000	NA	NA	NA	COMMD2	COMMD2;NA;NA;NA;NA	"NA"	"NA"	cytoplasm	GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_020925331.1;XP_020925330.1;XP_020925328.1;XP_020925327.1;XP_020925322.1;XP_020925321.1;XP_020925320.1;XP_020925319.1;XP_020925318.1;XP_020925317.1;XP_020925316.1;XP_005669991.1;XP_020925315.1;XP_020925313.1;XP_020925312.1;XP_020925311.1;XP_020925310.1;XP_020925309.1;XP_003132543.1;XP_020925308.1;XP_020925307.1;XP_020925306.1;XP_003132542.1;XP_020925305.1;XP_020925304.1;XP_020925303.1;XP_020925302.1;XP_020925301.1;XP_005669990.1;XP_020925300.1;XP_020925299.1;XP_005669989.1;XP_020925298.1;XP_020925297.1;XP_020925295.1;XP_020925294.1;XP_020925293.1;XP_020925292.1;XP_005669987.1;XP_020921474.1;XP_020921473.1;XP_020921472.1;XP_020921471.1;XP_020921470.1;XP_020921469.1;XP_020921468.1;XP_020921467.1;XP_020921466.1;XP_020921465.1;XP_020921464.1;XP_020921463.1;XP_020921462.1;XP_020921461.1;XP_020921460.1;XP_020921459.1;XP_020921458.1;XP_020921457.1;XP_020921456.1;XP_020921455.1;XP_020921454.1	XP_020925331.1;XP_020925330.1;XP_020925328.1;XP_020925327.1;XP_020925322.1;XP_020925321.1;XP_020925320.1;XP_020925319.1;XP_020925318.1;XP_020925317.1;XP_020925316.1;XP_005669991.1;XP_020925315.1;XP_020925313.1;XP_020925312.1;XP_020925311.1;XP_020925310.1;XP_020925309.1;XP_003132543.1;XP_020925308.1;XP_020925307.1;XP_020925306.1;XP_003132542.1;XP_020925305.1;XP_020925304.1;XP_020925303.1;XP_020925302.1;XP_020925301.1;XP_005669990.1;XP_020925300.1;XP_020925299.1;XP_005669989.1;XP_020925298.1;XP_020925297.1;XP_020925295.1;XP_020925294.1;XP_020925293.1;XP_020925292.1;XP_005669987.1	XP_020925331.1 muscleblind-like protein 1 isoform X22 [Sus scrofa];XP_020925330.1 muscleblind-like protein 1 isoform X22 [Sus scrofa];XP_020925328.1 muscleblind-like protein 1 isoform X20 [Sus scrofa];XP_020925327.1 muscleblind-like protein 1 isoform X19 [	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18221000	NA	NA	NA	MBNL1	MBNL1;MBNL1;MBNL1;MBNL1;MBNL1	nervous system development;embryonic limb morphogenesis;RNA splicing;regulation of alternative mRNA splicing, via spliceosome;mRNA processing;in utero embryonic development;myoblast differentiation;regulation of RNA splicing	GO:000739; GO:003032; GO:000838; GO:000038; GO:000639; GO:000170; GO:004544; GO:004348	cytosol;cytoplasm;cytoplasmic stress granule;nucleus;nucleoplasm	GO:000582; GO:000573; GO:001049; GO:000563; GO:000565	"NA"	"NA"	regulatory region RNA binding;metal ion binding;double-stranded RNA binding;protein binding	GO:000106; GO:004687; GO:000372; GO:000551
XP_020925355.1;XP_020925354.1;XP_020925353.1;XP_020925352.1;XP_020925351.1;XP_013837598.1;XP_003132549.1	XP_020925355.1;XP_020925354.1;XP_020925353.1;XP_020925352.1;XP_020925351.1;XP_013837598.1;XP_003132549.1	XP_020925355.1 neprilysin [Sus scrofa];XP_020925354.1 neprilysin [Sus scrofa];XP_020925353.1 neprilysin [Sus scrofa];XP_020925352.1 neprilysin [Sus scrofa];XP_020925351.1 neprilysin [Sus scrofa];XP_013837598.1 neprilysin [Sus scrofa];XP_003132549.1 neprily	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MME	MME;MME;MME;MME;MME	proteolysis;neuropeptide processing;cellular response to UV-B;replicative senescence;positive regulation of neurogenesis;cellular response to cytokine stimulus;peptide metabolic process;creatinine metabolic process;beta-amyloid metabolic process;angiotensin maturation;aging;positive regulation of long-term synaptic potentiation;kidney development;lung development;beta-amyloid clearance;learning or memory;sensory perception of pain;placenta development;neutrophil degranulation	GO:000650; GO:006183; GO:007149; GO:009039; GO:005076; GO:007134; GO:000651; GO:004644; GO:005043; GO:000200; GO:000756; GO:190027; GO:000182; GO:003032; GO:009724; GO:000761; GO:001923; GO:000189; GO:004331	integral component of plasma membrane;secretory granule membrane;axon;membrane raft;neuronal cell body;cell surface;cytoplasmic vesicle;presynapse;integral component of membrane;cytoplasm;extracellular exosome;plasma membrane;brush border;early endosome;trans-Golgi network;synaptic vesicle;neuron projection terminus;synapse;focal adhesion	GO:000588; GO:003066; GO:003042; GO:004512; GO:004302; GO:000998; GO:003141; GO:009879; GO:001602; GO:000573; GO:007006; GO:000588; GO:000590; GO:000576; GO:000580; GO:000802; GO:004430; GO:004520; GO:000592	 Renin-angiotensin system; Hematopoietic cell lineage; Alzheimer's disease; Protein digestion and absorption	hsa0461; hsa0464; hsa0501; hsa0497	zinc ion binding;metallopeptidase activity;peptide binding;metalloendopeptidase activity;phosphatidylserine binding;endopeptidase activity;protein homodimerization activity;oligopeptidase activity;protein binding;cardiolipin binding	GO:000827; GO:000823; GO:004227; GO:000422; GO:000178; GO:000417; GO:004280; GO:007001; GO:000551; GO:190161
XP_020926870.1;XP_020926869.1;XP_020926868.1;XP_020926867.1;XP_020935929.1;XP_003360272.5;XP_020926866.1;XP_020926865.1;XP_020926864.1;XP_020926863.1;XP_020926862.1;XP_020926861.1;XP_020926860.1;XP_020926859.1;XP_020926858.1;XP_020926857.1;XP_020926856.1;XP_020926855.1;XP_003132590.3;XP_020936646.1;XP_020935928.1;XP_020935927.1;XP_020935926.1	XP_020926870.1;XP_020926869.1;XP_020926868.1;XP_020926867.1;XP_020935929.1;XP_003360272.5;XP_020926866.1;XP_020926865.1;XP_020926864.1;XP_020926863.1;XP_020926862.1;XP_020926861.1;XP_020926860.1;XP_020926859.1;XP_020926858.1;XP_020926857.1;XP_020926856.1;XP_020926855.1;XP_003132590.3;XP_020936646.1;XP_020935928.1;XP_020935927.1;XP_020935926.1	XP_020926870.1 F-box-like/WD repeat-containing protein TBL1XR1 isoform X2 [Sus scrofa];XP_020926869.1 F-box-like/WD repeat-containing protein TBL1XR1 isoform X2 [Sus scrofa];XP_020926868.1 F-box-like/WD repeat-containing protein TBL1XR1 isoform X2 [Sus scr	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	5030500	0	0	0	0	0	NA	NA	NA	TBL1X	TBL1X;LOC100624648;TBL1X;TBL1X;TBL1X	proteasome-mediated ubiquitin-dependent protein catabolic process;histone deacetylation;regulation of lipid metabolic process;positive regulation of transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;proteolysis;regulation of transcription from RNA polymerase II promoter;protein stabilization;positive regulation of canonical Wnt signaling pathway;sensory perception of sound;positive regulation of transcription, DNA-templated	GO:004316; GO:001657; GO:001921; GO:004594; GO:000012; GO:000650; GO:000635; GO:005082; GO:009026; GO:000760; GO:004589	nucleoplasm;mitotic spindle;histone deacetylase complex;transcriptional repressor complex;nucleus	GO:000565; GO:007268; GO:000011; GO:001705; GO:000563	 Wnt signaling pathway	hsa0431	histone binding;beta-catenin binding;transcription regulatory region DNA binding;protein domain specific binding;protein C-terminus binding;transcription corepressor activity;protein binding;transcription factor binding	GO:004239; GO:000801; GO:004421; GO:001990; GO:000802; GO:000371; GO:000551; GO:000813
XP_003132593.1;XP_005670065.1	XP_003132593.1;XP_005670065.1	XP_003132593.1 actin-like protein 6A isoform X1 [Sus scrofa];XP_005670065.1 actin-like protein 6A isoform X2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21816000	NA	NA	NA	ACTL6A	ACTL6A;ACTL6A;NA;NA;NA	protein deubiquitination;blastocyst formation;neural retina development;regulation of growth;positive regulation of nucleic acid-templated transcription;histone H4 acetylation;DNA recombination;regulation of transcription from RNA polymerase II promoter;ATP-dependent chromatin remodeling;signal transduction;DNA repair;chromatin remodeling;spinal cord development	GO:001657; GO:000182; GO:000340; GO:004000; GO:190350; GO:004396; GO:000631; GO:000635; GO:004304; GO:000716; GO:000628; GO:000633; GO:002151	NuA4 histone acetyltransferase complex;plasma membrane;Ino80 complex;nuclear chromatin;nucleus;SWI/SNF complex;npBAF complex;macromolecular complex;nucleoplasm	GO:003526; GO:000588; GO:003101; GO:000079; GO:000563; GO:001651; GO:007156; GO:003299; GO:000565	"NA"	"NA"	RNA polymerase II core promoter proximal region sequence-specific DNA binding;protein binding;RNA polymerase II distal enhancer sequence-specific DNA binding;chromatin binding;nucleosomal DNA binding;transcription coactivator activity	GO:000097; GO:000551; GO:000098; GO:000368; GO:003149; GO:000371
XP_003358742.1;XP_020926902.1;XP_020926901.1;XP_020926899.1;XP_003132601.1;XP_005670074.1;XP_020926898.1;XP_020926897.1	XP_003358742.1;XP_020926902.1;XP_020926901.1;XP_020926899.1;XP_003132601.1;XP_005670074.1;XP_020926898.1;XP_020926897.1	XP_003358742.1 fragile X mental retardation syndrome-related protein 1 isoform X8 [Sus scrofa];XP_020926902.1 fragile X mental retardation syndrome-related protein 1 isoform X7 [Sus scrofa];XP_020926901.1 fragile X mental retardation syndrome-related prote	3	3	1	0	34565000	0	42590000	0	0	0	0	0	24415000	0	30593000	0	0	0	0	0	39959000	NA	NA	NA	FXR1	FXR1;FXR1;FXR1;FXR1;FXR1	apoptotic process;muscle organ development;cell differentiation;positive regulation of gene silencing by miRNA;negative regulation of translation;positive regulation of translation;regulation of mRNA stability	GO:000691; GO:000751; GO:003015; GO:200063; GO:001714; GO:004572; GO:004348	cytoplasm;dendritic spine;nucleolus;cytoplasmic ribonucleoprotein granule;polysome;costamere;membrane;ribonucleoprotein granule;perinuclear region of cytoplasm;glutamatergic synapse;nucleus;cytosol;postsynaptic density;axon;neuronal cell body	GO:000573; GO:004319; GO:000573; GO:003646; GO:000584; GO:004303; GO:001602; GO:003577; GO:004847; GO:009897; GO:000563; GO:000582; GO:001406; GO:003042; GO:004302	 RNA transport	hsa0301	translation regulator activity;protein heterodimerization activity;mRNA binding;mRNA 3'-UTR binding;protein binding;protein homodimerization activity;RNA strand annealing activity	GO:004518; GO:004698; GO:000372; GO:000373; GO:000551; GO:004280; GO:003359
XP_003132625.1;CON__Q58D62	XP_003132625.1	XP_003132625.1 fetuin-B [Sus scrofa]	10	10	10	39206000	55056000	41342000	46882000	70087000	101510000	66553000	54795000	80022000	74841000	76769000	65153000	68398000	81992000	70680000	62717000	79886000	105440000	NA	NA	NA	FETUB	FETUB;NA;NA;NA;NA	single fertilization;negative regulation of endopeptidase activity;binding of sperm to zona pellucida;biological_process	GO:000733; GO:001095; GO:000733; GO:000815	extracellular region;extracellular exosome	GO:000557; GO:007006	"NA"	"NA"	molecular_function;metalloendopeptidase inhibitor activity;cysteine-type endopeptidase inhibitor activity	GO:000367; GO:000819; GO:000486
XP_003483344.1;XP_013837749.1;XP_003132638.3;XP_013837748.1	XP_003483344.1;XP_013837749.1;XP_003132638.3;XP_013837748.1	XP_003483344.1 coiled-coil domain-containing protein 50 isoform X4 [Sus scrofa];XP_013837749.1 coiled-coil domain-containing protein 50 isoform X3 [Sus scrofa];XP_003132638.3 coiled-coil domain-containing protein 50 isoform X1 [Sus scrofa];XP_013837748.1 c	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7327000	0	NA	NA	NA	CCDC50	CCDC50;CCDC50;CCDC50;CCDC50;NA	sensory perception of sound	GO:000760	cytosol	GO:000582	"NA"	"NA"	ubiquitin protein ligase binding;protein binding	GO:003162; GO:000551
XP_003132681.3	XP_003132681.3	XP_003132681.3 protein disulfide-isomerase A5 [Sus scrofa]	3	3	3	0	14057000	0	0	0	20268000	0	15185000	0	11663000	0	17698000	0	18047000	10511000	14396000	14514000	16544000	NA	NA	NA	PDIA5	PDIA5;NA;NA;NA;NA	cell redox homeostasis;protein folding;IRE1-mediated unfolded protein response;oxidation-reduction process	GO:004545; GO:000645; GO:003649; GO:005511	endoplasmic reticulum membrane;endoplasmic reticulum lumen	GO:000578; GO:000578	"NA"	"NA"	oxidoreductase activity;protein disulfide isomerase activity;protein binding;peptide disulfide oxidoreductase activity	GO:001649; GO:000375; GO:000551; GO:001503
XP_003132730.3	XP_003132730.3	XP_003132730.3 ubiquitin-like-conjugating enzyme ATG3 [Sus scrofa]	5	5	5	0	19399000	17196000	0	15608000	15874000	15185000	15443000	14763000	12549000	14904000	0	0	0	14654000	15258000	14241000	0	NA	NA	NA	ATG3	ATG3;NA;NA;NA;NA	mitochondrial fragmentation involved in apoptotic process;regulation of cilium assembly;autophagosome assembly;protein ubiquitination;mitophagy;protein targeting to membrane;cellular protein modification process;macroautophagy;negative regulation of phagocytosis	GO:004365; GO:190201; GO:000004; GO:001656; GO:000042; GO:000661; GO:000646; GO:001623; GO:005076	cytosol;cytoplasmic ubiquitin ligase complex	GO:000582; GO:000015	 Regulation of autophagy	hsa0414	Atg8 ligase activity;ubiquitin-like protein transferase activity;protein binding;Atg12 transferase activity;enzyme binding	GO:001977; GO:001978; GO:000551; GO:001977; GO:001989
XP_003132745.1	XP_003132745.1	XP_003132745.1 60S ribosomal protein L24 [Sus scrofa]	4	4	4	48764000	45182000	62628000	27449000	35278000	67173000	38084000	40387000	60296000	49413000	33948000	26424000	39639000	38992000	38715000	41678000	59294000	65484000	NA	NA	NA	RPL24	RPL24;NA;NA;NA;NA	cytoplasmic translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;exit from mitosis;retina development in camera-type eye;assembly of large subunit precursor of preribosome;optic nerve development;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;ribosomal large subunit assembly;retinal ganglion cell axon guidance;mitotic cell cycle checkpoint	GO:000218; GO:000641; GO:000661; GO:001045; GO:006004; GO:190262; GO:002155; GO:000018; GO:000002; GO:003129; GO:000709	cytosol;cytoplasm;extracellular exosome;cytosolic large ribosomal subunit;synapse;polysomal ribosome;membrane;endoplasmic reticulum	GO:000582; GO:000573; GO:007006; GO:002262; GO:004520; GO:004278; GO:001602; GO:000578	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;cadherin binding;protein binding	GO:000373; GO:000372; GO:004529; GO:000551
XP_003132922.1	XP_003132922.1	XP_003132922.1 26S proteasome non-ATPase regulatory subunit 9 [Sus scrofa]	5	5	5	46830000	55496000	47183000	47441000	43788000	37700000	50179000	51775000	54900000	43470000	63971000	72120000	61095000	50406000	55178000	48517000	53712000	55299000	NA	NA	NA	PSMD9	PSMD9;NA;NA;NA;NA	ubiquitin-dependent protein catabolic process;positive regulation of insulin secretion;positive regulation of transcription, DNA-templated;protein deubiquitination;post-translational protein modification;negative regulation of insulin secretion;proteasome regulatory particle assembly	GO:000651; GO:003202; GO:004589; GO:001657; GO:004368; GO:004667; GO:007068	nucleoplasm;proteasome regulatory particle;proteasome regulatory particle, base subcomplex;cytosol;cytoplasm;nucleus	GO:000565; GO:000583; GO:000854; GO:000582; GO:000573; GO:000563	"NA"	"NA"	transcription coactivator activity;protein binding;bHLH transcription factor binding	GO:000371; GO:000551; GO:004342
XP_020928898.1;XP_003132924.1;XP_020928897.1;XP_020928895.1;XP_020928894.1;XP_020928896.1;XP_020928893.1;XP_020928892.1	XP_020928898.1;XP_003132924.1;XP_020928897.1;XP_020928895.1;XP_020928894.1;XP_020928896.1;XP_020928893.1;XP_020928892.1	XP_020928898.1 transmembrane protein 120B isoform X7 [Sus scrofa];XP_003132924.1 transmembrane protein 120B isoform X7 [Sus scrofa];XP_020928897.1 transmembrane protein 120B isoform X6 [Sus scrofa];XP_020928895.1 transmembrane protein 120B isoform X4 [Sus	2	2	2	0	0	23180000	0	25994000	0	0	0	0	0	30216000	0	0	0	14018000	23153000	26063000	18812000	NA	NA	NA	TMEM120B	TMEM120B;TMEM120B;TMEM120B;TMEM120B;TMEM120B	biological_process;fat cell differentiation;protein heterooligomerization	GO:000815; GO:004544; GO:005129	nuclear inner membrane;integral component of membrane;cellular_component	GO:000563; GO:001602; GO:000557	"NA"	"NA"	protein binding;molecular_function	GO:000551; GO:000367
XP_003132938.1;XP_020928716.1	XP_003132938.1;XP_020928716.1	XP_003132938.1 phosphatidylethanolamine-binding protein 1 isoform X1 [Sus scrofa];XP_020928716.1 phosphatidylethanolamine-binding protein 1 isoform X2 [Sus scrofa]	15	15	15	2693700000	3421800000	2674000000	3037500000	2684000000	2781900000	3060700000	3380000000	2626700000	2730000000	2672700000	2934300000	2365400000	3689000000	2990900000	3521500000	2505400000	3029700000	NA	NA	NA	PEBP1	PEBP1;PEBP1;NA;NA;NA	response to heat;response to calcium ion;aging;response to wounding;positive regulation of mitotic nuclear division;response to activity;sperm capacitation;regulation of neurotransmitter levels;response to oxidative stress;hippocampus development;negative regulation of MAPK cascade;response to ethanol;response to corticosterone;positive regulation of acetylcholine metabolic process;MAPK cascade;regulation of the force of heart contraction;response to organonitrogen compound;positive regulation of cAMP-mediated signaling;response to toxic substance;negative regulation of endopeptidase activity	GO:000940; GO:005159; GO:000756; GO:000961; GO:004584; GO:001482; GO:004824; GO:000150; GO:000697; GO:002176; GO:004340; GO:004547; GO:005141; GO:006040; GO:000016; GO:000202; GO:001024; GO:004395; GO:000963; GO:001095	mitochondrial outer membrane;neuronal cell body;apical part of cell;synaptic vesicle;extracellular space;extracellular exosome;cytosol;myelin sheath;axon terminus;mitochondrion;cell surface;nucleus;Golgi apparatus	GO:000574; GO:004302; GO:004517; GO:000802; GO:000561; GO:007006; GO:000582; GO:004320; GO:004367; GO:000573; GO:000998; GO:000563; GO:000579	"NA"	"NA"	phosphatidylethanolamine binding;serine-type endopeptidase inhibitor activity;mitogen-activated protein kinase binding;enzyme binding;protein kinase binding;protein binding;RNA binding;receptor binding;ATP binding	GO:000842; GO:000486; GO:005101; GO:001989; GO:001990; GO:000551; GO:000372; GO:000510; GO:000552
XP_003133034.2;XP_005670968.2	XP_003133034.2;XP_005670968.2	XP_003133034.2 immunoglobulin lambda-like polypeptide 5 isoform X2 [Sus scrofa];XP_005670968.2 immunoglobulin lambda-like polypeptide 5 isoform X1 [Sus scrofa]	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	215640000	NA	NA	NA	LOC100523213	LOC100523213;LOC100523213;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003133041.1	XP_003133041.1	XP_003133041.1 synaptosomal-associated protein 29 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	4974900	0	0	0	0	0	0	NA	NA	NA	SNAP29	SNAP29;NA;NA;NA;NA	vesicle fusion;cilium assembly;protein transport;synaptic vesicle priming;membrane fusion;exocytosis;vesicle targeting;autophagosome maturation;autophagosome docking;synaptic vesicle fusion to presynaptic active zone membrane;neutrophil degranulation	GO:000690; GO:006027; GO:001503; GO:001608; GO:006102; GO:000688; GO:000690; GO:009735; GO:001624; GO:003162; GO:004331	ciliary pocket membrane;azurophil granule membrane;cytoplasm;Golgi membrane;autophagosome;cytosol;presynapse;nucleoplasm;autophagosome membrane;plasma membrane;centrosome;SNARE complex	GO:002001; GO:003557; GO:000573; GO:000013; GO:000577; GO:000582; GO:009879; GO:000565; GO:000042; GO:000588; GO:000581; GO:003120	 SNARE interactions in vesicular transport	hsa0413	syntaxin binding;SNAP receptor activity;protein binding	GO:001990; GO:000548; GO:000551
XP_003133042.1	XP_003133042.1	XP_003133042.1 crk-like protein [Sus scrofa]	4	4	4	11399000	8756100	10085000	0	0	10761000	0	0	8955800	9355800	0	8417500	10726000	10227000	9807500	16222000	0	10323000	NA	NA	NA	CRKL	CRKL;NA;NA;NA;NA	urogenital system development;neuron migration;outflow tract morphogenesis;JNK cascade;fibroblast growth factor receptor signaling pathway;anterior/posterior pattern specification;retinoic acid receptor signaling pathway;thymus development;B cell apoptotic process;negative regulation of protein phosphorylation;intracellular signal transduction;pharynx development;endothelin receptor signaling pathway;cellular response to interleukin-7;regulation of skeletal muscle acetylcholine-gated channel clustering;cranial skeletal system development;regulation of T cell migration;blood vessel development;single fertilization;positive regulation of Ras protein signal transduction;positive regulation of ERK1 and ERK2 cascade;activation of MAPKK activity;regulation of cell growth;Ras protein signal transduction;spermatogenesis;hippocampus development;parathyroid gland development;acetylcholine receptor signaling pathway;male gonad development;cellular response to transforming growth factor beta stimulus;positive regulation of cell proliferation;helper T cell diapedesis;activation of GTPase activity;cerebellar neuron development;positive regulation of substrate adhesion-dependent cell spreading;synapse assembly;negative regulation of gene expression;cerebral cortex development;establishment of cell polarity;cell chemotaxis;lipid metabolic process;dendrite development;cytokine-mediated signaling pathway;regulation of cell adhesion mediated by integrin;reelin-mediated signaling pathway;regulation of dendrite development;T cell receptor signaling pathway;positive regulation of glial cell migration	GO:000165; GO:000176; GO:000315; GO:000725; GO:000854; GO:000995; GO:004838; GO:004853; GO:000178; GO:000193; GO:003555; GO:006046; GO:008610; GO:009876; GO:190439; GO:190488; GO:200040; GO:000156; GO:000733; GO:004657; GO:007037; GO:000018; GO:000155; GO:000726; GO:000728; GO:002176; GO:006001; GO:009550; GO:000858; GO:007156; GO:000828; GO:003568; GO:009063; GO:009874; GO:190002; GO:000741; GO:001062; GO:002198; GO:003001; GO:006032; GO:000662; GO:001635; GO:001922; GO:003362; GO:003802; GO:005077; GO:005085; GO:190397	nucleoplasm;macromolecular complex;cytosol;neuromuscular junction;extrinsic component of postsynaptic membrane	GO:000565; GO:003299; GO:000582; GO:003159; GO:009889	 Fc gamma R-mediated phagocytosis; Shigellosis; Renal cell carcinoma; Neurotrophin signaling pathway; Insulin signaling pathway; Pathways in cancer; MAPK signaling pathway; Chemokine signaling pathway; Focal adhesion; Chronic myeloid leukemia; Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells	hsa0466; hsa0513; hsa0521; hsa0472; hsa0491; hsa0520; hsa0401; hsa0406; hsa0451; hsa0522; hsa0481; hsa0510	protein binding;identical protein binding;phosphotyrosine binding;cadherin binding;SH3/SH2 adaptor activity;RNA binding	GO:000551; GO:004280; GO:000178; GO:004529; GO:000507; GO:000372
XP_020928849.1;XP_020928848.1;XP_005671503.1;XP_013839173.1;XP_003133228.3	XP_020928849.1;XP_020928848.1;XP_005671503.1;XP_013839173.1;XP_003133228.3	XP_020928849.1 xaa-Pro aminopeptidase 1 isoform X4 [Sus scrofa];XP_020928848.1 xaa-Pro aminopeptidase 1 isoform X4 [Sus scrofa];XP_005671503.1 xaa-Pro aminopeptidase 1 isoform X3 [Sus scrofa];XP_013839173.1 xaa-Pro aminopeptidase 1 isoform X2 [Sus scrofa];	5	5	5	0	9561200	12271000	0	0	14172000	0	0	0	15422000	0	16720000	0	0	0	16176000	0	15600000	NA	NA	NA	XPNPEP1	XPNPEP1;XPNPEP1;XPNPEP1;XPNPEP1;XPNPEP1	proteolysis;bradykinin catabolic process	GO:000650; GO:001081	cytoplasm;extracellular exosome;cytosol	GO:000573; GO:007006; GO:000582	"NA"	"NA"	metalloaminopeptidase activity;aminopeptidase activity;manganese ion binding;protein homodimerization activity	GO:007000; GO:000417; GO:003014; GO:004280
XP_020929229.1;XP_020929227.1;XP_020929226.1;XP_003483614.1;XP_003133249.3;XP_020929224.1;XP_005671568.1;XP_013839271.1;XP_020929225.1;XP_013839268.1;XP_005671569.1;XP_020929223.1;XP_013839264.1	XP_020929229.1;XP_020929227.1;XP_020929226.1;XP_003483614.1;XP_003133249.3;XP_020929224.1;XP_005671568.1	XP_020929229.1 arginyl-tRNA--protein transferase 1 isoform X13 [Sus scrofa];XP_020929227.1 arginyl-tRNA--protein transferase 1 isoform X11 [Sus scrofa];XP_020929226.1 arginyl-tRNA--protein transferase 1 isoform X10 [Sus scrofa];XP_003483614.1 arginyl-tRNA-	3	3	3	0	6395200	0	0	0	0	0	0	5146200	0	0	0	0	5553300	0	7077800	0	0	NA	NA	NA	ATE1	ATE1;ATE1;ATE1;ATE1;ATE1	protein arginylation;proteasomal protein catabolic process	GO:001659; GO:001049	nucleus;cytoplasm	GO:000563; GO:000573	"NA"	"NA"	protein binding;arginyltransferase activity	GO:000551; GO:000405
XP_003133258.2;XP_013845962.1	XP_003133258.2;XP_013845962.1	XP_003133258.2 glia maturation factor gamma isoform X1 [Sus scrofa];XP_013845962.1 glia maturation factor gamma isoform X2 [Sus scrofa]	4	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5379100	0	0	NA	NA	NA	GMFG	GMFG;GMFG;NA;NA;NA	positive regulation of catalytic activity;neutrophil degranulation;negative regulation of Arp2/3 complex-mediated actin nucleation;actin filament debranching;protein phosphorylation;regulation of receptor activity;regulation of actin cytoskeleton reorganization	GO:004308; GO:004331; GO:003431; GO:007184; GO:000646; GO:001046; GO:200024	extracellular region;actin cortical patch;secretory granule lumen;ficolin-1-rich granule lumen	GO:000557; GO:003047; GO:003477; GO:190481	"NA"	"NA"	growth factor activity;enzyme activator activity;protein kinase inhibitor activity;actin binding;Arp2/3 complex binding	GO:000808; GO:000804; GO:000486; GO:000377; GO:007193
XP_020931502.1;XP_003133314.1	XP_020931502.1;XP_003133314.1	XP_020931502.1 aspartate--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_003133314.1 aspartate--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa]	11	11	11	78063000	89695000	92682000	86688000	69240000	84911000	86004000	81068000	83170000	67194000	82555000	72493000	81575000	88449000	80398000	81337000	97319000	86767000	NA	NA	NA	DARS	DARS;DARS;NA;NA;NA	translation;tRNA aminoacylation for protein translation;macromolecular complex assembly;aspartyl-tRNA aminoacylation	GO:000641; GO:000641; GO:006500; GO:000642	synapse;cytosol;cytoplasm;aminoacyl-tRNA synthetase multienzyme complex;membrane;extracellular exosome	GO:004520; GO:000582; GO:000573; GO:001710; GO:001602; GO:007006	 Aminoacyl-tRNA biosynthesis	hsa0097	aminoacylase activity;aspartate-tRNA ligase activity;ATP binding;protein binding;RNA binding	GO:000404; GO:000481; GO:000552; GO:000551; GO:000372
XP_003133368.1	XP_003133368.1	XP_003133368.1 signal peptidase complex subunit 3 [Sus scrofa]	3	3	3	0	29101000	31803000	34070000	28480000	32508000	29408000	30241000	33441000	32474000	34305000	0	0	39483000	28263000	41793000	33052000	36827000	NA	NA	NA	SPCS3	SPCS3;NA;NA;NA;NA	signal peptide processing;protein targeting to ER;proteolysis	GO:000646; GO:004504; GO:000650	organelle membrane;integral component of membrane;endoplasmic reticulum	GO:003109; GO:001602; GO:000578	 Protein export	hsa0306	peptidase activity	GO:000823
XP_003133393.1	XP_003133393.1	XP_003133393.1 ADP/ATP translocase 1 [Sus scrofa]	12	12	5	637150000	303730000	586040000	236580000	495770000	237640000	425130000	303150000	473660000	269790000	399840000	253330000	357460000	270320000	334860000	328960000	406810000	250820000	NA	NA	NA	SLC25A4	SLC25A4;NA;NA;NA;NA	ATP transport;generation of precursor metabolites and energy;adenine transport;regulation of insulin secretion;mitochondrial genome maintenance;ADP transport;transmembrane transport;apoptotic mitochondrial changes;negative regulation of necroptotic process;viral process	GO:001586; GO:000609; GO:001585; GO:005079; GO:000000; GO:001586; GO:005508; GO:000863; GO:006054; GO:001603	integral component of plasma membrane;mitochondrion;mitochondrial inner membrane;integral component of mitochondrial membrane	GO:000588; GO:000573; GO:000574; GO:003259	 Calcium signaling pathway; HTLV-I infection; cGMP-PKG signaling pathway; Huntington's disease	hsa0402; hsa0516; hsa0402; hsa0501	ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity	GO:000547; GO:000551; GO:001520
XP_003133417.1;XP_013839538.1	XP_003133417.1;XP_013839538.1	XP_003133417.1 proline synthase co-transcribed bacterial homolog protein isoform X1 [Sus scrofa];XP_013839538.1 proline synthase co-transcribed bacterial homolog protein isoform X2 [Sus scrofa]	5	5	5	27358000	45275000	39564000	31752000	35455000	26965000	40931000	41162000	39249000	42474000	26028000	35978000	28727000	43280000	28762000	47807000	37605000	37615000	NA	NA	NA	PLPBP	PLPBP;PLPBP;NA;NA;NA	biological_process	GO:000815	cytoplasm	GO:000573	"NA"	"NA"	pyridoxal phosphate binding	GO:003017
XP_020930531.1;XP_003133441.3;XP_020930526.1;XP_020930534.1;XP_020930533.1;XP_020930532.1;XP_020930530.1;XP_020930529.1;XP_020930528.1;XP_020930527.1;XP_020930525.1;XP_020930524.1;XP_020930523.1;XP_020930522.1	XP_020930531.1;XP_003133441.3;XP_020930526.1;XP_020930534.1;XP_020930533.1;XP_020930532.1;XP_020930530.1;XP_020930529.1;XP_020930528.1;XP_020930527.1;XP_020930525.1;XP_020930524.1;XP_020930523.1;XP_020930522.1	XP_020930531.1 RNA-binding protein with multiple splicing isoform X10 [Sus scrofa];XP_003133441.3 RNA-binding protein with multiple splicing isoform X9 [Sus scrofa];XP_020930526.1 RNA-binding protein with multiple splicing isoform X5 [Sus scrofa];XP_020930	3	3	3	0	14597000	15999000	0	0	12347000	15978000	15010000	14865000	0	0	18935000	0	13981000	0	0	12655000	0	NA	NA	NA	RBPMS	RBPMS;RBPMS;RBPMS;RBPMS;RBPMS	response to oxidative stress;mRNA splicing, via spliceosome;positive regulation of pathway-restricted SMAD protein phosphorylation;RNA processing;positive regulation of nucleic acid-templated transcription;positive regulation of SMAD protein import into nucleus	GO:000697; GO:000039; GO:001086; GO:000639; GO:190350; GO:006039	cytoplasmic stress granule;P-body;cytosol;nucleoplasm	GO:001049; GO:000093; GO:000582; GO:000565	"NA"	"NA"	protein binding;RNA binding;poly(A) binding;protein homodimerization activity;transcription coactivator activity;snRNA stem-loop binding	GO:000551; GO:000372; GO:000814; GO:004280; GO:000371; GO:003561
XP_020931816.1;XP_020931817.1;XP_013839580.1;XP_020931815.1;XP_003133450.3;XP_020931814.1	XP_020931816.1;XP_020931817.1;XP_013839580.1;XP_020931815.1;XP_003133450.3;XP_020931814.1	XP_020931816.1 LIM and senescent cell antigen-like-containing domain protein 2 isoform X5 [Sus scrofa];XP_020931817.1 LIM and senescent cell antigen-like-containing domain protein 2 isoform X6 [Sus scrofa];XP_013839580.1 LIM and senescent cell antigen-like	7	4	4	0	14715000	0	0	0	20479000	0	15275000	0	24902000	0	18976000	14777000	0	0	13688000	0	0	NA	NA	NA	LIMS2	LIMS2;LIMS2;LIMS2;LIMS2;LIMS2	cell junction assembly;positive regulation of integrin-mediated signaling pathway;negative regulation of neural precursor cell proliferation;negative regulation of hepatocyte proliferation;cell-cell junction organization;cell-cell adhesion;negative regulation of apoptotic process	GO:003432; GO:200104; GO:200017; GO:200034; GO:004521; GO:009860; GO:004306	focal adhesion;nucleus;plasma membrane;cytosol	GO:000592; GO:000563; GO:000588; GO:000582	"NA"	"NA"	metal ion binding	GO:004687
XP_003133502.3	XP_003133502.3	XP_003133502.3 STE20/SPS1-related proline-alanine-rich protein kinase [Sus scrofa]	6	5	5	83725000	0	84447000	0	0	0	89637000	67747000	99126000	73855000	0	0	0	0	0	83897000	66347000	0	NA	NA	NA	STK39	STK39;NA;NA;NA;NA	signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;maintenance of lens transparency;chemokine (C-X-C motif) ligand 12 signaling pathway;negative regulation of pancreatic juice secretion;peptidyl-serine phosphorylation;negative regulation of creatine transmembrane transporter activity;protein phosphorylation;intracellular signal transduction;cellular response to chemokine;negative regulation of sodium ion transmembrane transporter activity;positive regulation of T cell chemotaxis;signal transduction by trans-phosphorylation;protein autophosphorylation;negative regulation of potassium ion transmembrane transport;activation of MAPK activity;regulation of inflammatory response;cellular hypotonic response;regulation of blood pressure;positive regulation of ion transmembrane transporter activity;positive regulation of potassium ion transport;ion homeostasis;negative regulation of potassium ion transmembrane transporter activity	GO:002301; GO:003109; GO:003214; GO:003643; GO:003814; GO:009018; GO:001810; GO:190540; GO:000646; GO:003555; GO:199086; GO:200065; GO:001082; GO:002301; GO:004677; GO:190138; GO:000018; GO:005072; GO:007147; GO:000821; GO:003241; GO:004326; GO:005080; GO:190101	cytoplasm;cytosol;cytoskeleton;apical plasma membrane;extrinsic component of membrane;nucleoplasm;intracellular membrane-bounded organelle	GO:000573; GO:000582; GO:000585; GO:001632; GO:001989; GO:000565; GO:004323	"NA"	"NA"	protein binding;kinase activity;protein serine/threonine kinase activity;ATP binding;protein kinase binding	GO:000551; GO:001630; GO:000467; GO:000552; GO:001990
XP_020930797.1;XP_020930793.1;XP_005672037.1;XP_005672036.1;XP_003133549.1;XP_020930796.1;XP_020930795.1;XP_020930794.1;XP_003359613.1	XP_020930797.1;XP_020930793.1;XP_005672037.1;XP_005672036.1;XP_003133549.1;XP_020930796.1;XP_020930795.1;XP_020930794.1;XP_003359613.1	XP_020930797.1 heterogeneous nuclear ribonucleoprotein A3 isoform X5 [Sus scrofa];XP_020930793.1 heterogeneous nuclear ribonucleoprotein A3 isoform X2 [Sus scrofa];XP_005672037.1 heterogeneous nuclear ribonucleoprotein A3 isoform X2 [Sus scrofa];XP_0056720	13	13	13	75029000	166400000	128070000	168250000	125460000	195660000	116490000	133080000	129890000	149860000	122800000	74496000	188930000	173480000	127460000	130060000	156240000	211750000	NA	NA	NA	HNRNPA3	HNRNPA3;HNRNPA3;HNRNPA3;HNRNPA3;HNRNPA3	mRNA splicing, via spliceosome;mRNA transport;RNA metabolic process	GO:000039; GO:005102; GO:001607	postsynaptic density;neuron projection;cytoplasm;ribonucleoprotein granule;messenger ribonucleoprotein complex;nucleus;nucleoplasm;catalytic step 2 spliceosome;ribonucleoprotein complex	GO:001406; GO:004300; GO:000573; GO:003577; GO:199012; GO:000563; GO:000565; GO:007101; GO:199090	 Spliceosome	hsa0304	RNA binding;RNA transmembrane transporter activity;mRNA binding;protein binding	GO:000372; GO:005103; GO:000372; GO:000551
XP_020931513.1;XP_020931512.1;XP_020931511.1;XP_020931510.1;XP_020931509.1;XP_020931508.1;XP_020931507.1;XP_020931506.1;XP_005652507.1;XP_005652506.1;XP_005652505.1;XP_003133626.1;XP_013852426.1	XP_020931513.1;XP_020931512.1;XP_020931511.1;XP_020931510.1;XP_020931509.1;XP_020931508.1;XP_020931507.1;XP_020931506.1;XP_005652507.1;XP_005652506.1;XP_005652505.1;XP_003133626.1;XP_013852426.1	XP_020931513.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 isoform X2 [Sus scrofa];XP_020931512.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 isoform X2 [Sus scrofa];XP_020931511.1 NADH dehydrogenase [ubiquinone] 1 beta subc	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23424000	0	NA	NA	NA	NDUFB3	NDUFB3;NDUFB3;NDUFB3;NDUFB3;NDUFB3	mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:000612	mitochondrial inner membrane;integral component of membrane;mitochondrial respiratory chain complex I	GO:000574; GO:001602; GO:000574	 Oxidative phosphorylation; Parkinson's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0501; hsa0110; hsa0493	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_020930610.1;XP_020930608.1;XP_020930607.1;XP_020930606.1;XP_020930605.1;XP_013839833.1;XP_013839832.1;XP_013839831.1;XP_013839830.1;XP_005672133.2;XP_005672132.2;XP_003133631.5;XP_013839829.1	XP_020930610.1;XP_020930608.1;XP_020930607.1;XP_020930606.1;XP_020930605.1;XP_013839833.1;XP_013839832.1;XP_013839831.1;XP_013839830.1;XP_005672133.2;XP_005672132.2;XP_003133631.5;XP_013839829.1	XP_020930610.1 NIF3-like protein 1 isoform X2 [Sus scrofa];XP_020930608.1 NIF3-like protein 1 isoform X2 [Sus scrofa];XP_020930607.1 NIF3-like protein 1 isoform X2 [Sus scrofa];XP_020930606.1 NIF3-like protein 1 isoform X2 [Sus scrofa];XP_020930605.1 NIF3-	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8171600	0	0	0	NA	NA	NA	NIF3L1	NIF3L1;NIF3L1;NIF3L1;NIF3L1;NIF3L1	negative regulation of nucleic acid-templated transcription;neuron differentiation;positive regulation of transcription, DNA-templated	GO:190350; GO:003018; GO:004589	cytoplasm;mitochondrion;nucleus	GO:000573; GO:000573; GO:000563	"NA"	"NA"	protein binding;transcription factor binding;identical protein binding	GO:000551; GO:000813; GO:004280
XP_005672173.1;XP_003133651.1	XP_005672173.1;XP_003133651.1	XP_005672173.1 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial [Sus scrofa];XP_003133651.1 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial [Sus scrofa]	16	16	16	195380000	111260000	156930000	98298000	166060000	85167000	159920000	134500000	164040000	116250000	160440000	113300000	114020000	112930000	163800000	137510000	132560000	113770000	NA	NA	NA	NDUFS1	NDUFS1;NDUFS1;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;apoptotic mitochondrial changes;reactive oxygen species metabolic process;cellular respiration;regulation of mitochondrial membrane potential;ATP metabolic process;mitochondrial respiratory chain complex I assembly	GO:000612; GO:000863; GO:007259; GO:004533; GO:005188; GO:004603; GO:003298	mitochondrial intermembrane space;mitochondrial matrix;mitochondrion;mitochondrial respiratory chain complex I;plasma membrane respiratory chain complex I	GO:000575; GO:000575; GO:000573; GO:000574; GO:004527	 Non-alcoholic fatty liver disease (NAFLD); Metabolic pathways; Huntington's disease; Oxidative phosphorylation	hsa0493; hsa0110; hsa0501; hsa0019	protein binding;metal ion binding;4 iron, 4 sulfur cluster binding;electron carrier activity;NADH dehydrogenase activity;NADH dehydrogenase (ubiquinone) activity	GO:000551; GO:004687; GO:005153; GO:000905; GO:000395; GO:000813
XP_003133677.1;XP_013839908.1;XP_013839907.1;XP_020931394.1;XP_013839909.1	XP_003133677.1;XP_013839908.1;XP_013839907.1;XP_020931394.1;XP_013839909.1	XP_003133677.1 ribulose-phosphate 3-epimerase isoform X3 [Sus scrofa];XP_013839908.1 ribulose-phosphate 3-epimerase isoform X2 [Sus scrofa];XP_013839907.1 ribulose-phosphate 3-epimerase isoform X1 [Sus scrofa];XP_020931394.1 ribulose-phosphate 3-epimerase	2	2	2	25210000	21043000	26796000	22897000	25425000	19813000	26558000	24283000	30304000	22119000	27350000	28611000	30314000	23171000	29865000	23110000	24636000	24773000	NA	NA	NA	RPE	RPE;RPE;RPE;RPE;RPE	carbohydrate metabolic process;cellular carbohydrate metabolic process;pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch;pentose catabolic process	GO:000597; GO:004426; GO:000609; GO:000905; GO:001932	extracellular exosome;cytosol	GO:007006; GO:000582	 Pentose and glucuronate interconversions; Biosynthesis of antibiotics; Biosynthesis of amino acids; Carbon metabolism; Pentose phosphate pathway; Metabolic pathways	hsa0004; hsa0113; hsa0123; hsa0120; hsa0003; hsa0110	protein homodimerization activity;ribulose-phosphate 3-epimerase activity;metal ion binding;identical protein binding	GO:004280; GO:000475; GO:004687; GO:004280
XP_003133690.2	XP_003133690.2	XP_003133690.2 LOW QUALITY PROTEIN: fibronectin [Sus scrofa]	62	62	62	636490000	1088000000	554750000	1035100000	644270000	979570000	712560000	971370000	686600000	1290600000	496830000	1406400000	920100000	880020000	817010000	718440000	822930000	1499800000	NA	NA	NA	FN1	FN1;NA;NA;NA;NA	cell-substrate junction assembly;interaction with other organism via secreted substance involved in symbiotic interaction;regulation of protein phosphorylation;cytokine-mediated signaling pathway;integrin activation;positive regulation of fibroblast proliferation;interaction with symbiont;negative regulation of transforming growth factor-beta secretion;angiogenesis;platelet degranulation;acute-phase response;regulation of cell shape;positive regulation of peptidase activity;cell adhesion;positive regulation of gene expression;wound healing;leukocyte migration;positive regulation of substrate-dependent cell migration, cell attachment to substrate;response to wounding;peptide cross-linking;substrate adhesion-dependent cell spreading;positive regulation of cell proliferation;endodermal cell differentiation;cellular protein metabolic process;calcium-independent cell-matrix adhesion;extracellular matrix organization;post-translational protein modification;positive regulation of axon extension;regulation of ERK1 and ERK2 cascade;neural crest cell migration involved in autonomic nervous system development	GO:000704; GO:005204; GO:000193; GO:001922; GO:003362; GO:004814; GO:005170; GO:200120; GO:000152; GO:000257; GO:000695; GO:000836; GO:001095; GO:000715; GO:001062; GO:004206; GO:005090; GO:190423; GO:000961; GO:001814; GO:003444; GO:000828; GO:003598; GO:004426; GO:000716; GO:003019; GO:004368; GO:004577; GO:007037; GO:190116	fibrinogen complex;endoplasmic reticulum-Golgi intermediate compartment;blood microparticle;extracellular region;platelet alpha granule lumen;basement membrane;endoplasmic reticulum lumen;extracellular matrix;apical plasma membrane;extracellular space;extracellular exosome	GO:000557; GO:000579; GO:007256; GO:000557; GO:003109; GO:000560; GO:000578; GO:003101; GO:001632; GO:000561; GO:007006	 Bacterial invasion of epithelial cells; PI3K-Akt signaling pathway; Regulation of actin cytoskeleton; Focal adhesion; Pathways in cancer; Small cell lung cancer; Amoebiasis	hsa0510; hsa0415; hsa0481; hsa0451; hsa0520; hsa0522; hsa0514	protease binding;receptor binding;protein C-terminus binding;peptidase activator activity;extracellular matrix structural constituent;identical protein binding;chaperone binding;heparin binding;proteoglycan binding;collagen binding;integrin binding;disordered domain specific binding;enzyme binding	GO:000202; GO:000510; GO:000802; GO:001650; GO:000520; GO:004280; GO:005108; GO:000820; GO:004339; GO:000551; GO:000517; GO:009771; GO:001989
XP_020931936.1;XP_013839924.2;XP_003133697.3;XP_005672234.2	XP_020931936.1;XP_013839924.2;XP_003133697.3;XP_005672234.2	XP_020931936.1 X-ray repair cross-complementing protein 5 isoform X4 [Sus scrofa];XP_013839924.2 X-ray repair cross-complementing protein 5 isoform X3 [Sus scrofa];XP_003133697.3 X-ray repair cross-complementing protein 5 isoform X1 [Sus scrofa];XP_0056722	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	XRCC5	XRCC5;XRCC5;XRCC5;XRCC5;NA	telomere maintenance;cellular response to DNA damage stimulus;neutrophil degranulation;positive regulation of telomerase activity;positive regulation of telomere maintenance via telomerase;cellular response to fatty acid;response to drug;negative regulation of transcription, DNA-templated;regulation of telomere maintenance;cellular response to leukemia inhibitory factor;DNA recombination;cell proliferation;innate immune response;positive regulation of neurogenesis;hematopoietic stem cell differentiation;cellular hyperosmotic salinity response;cellular response to gamma radiation;establishment of integrated proviral latency;activation of innate immune response;double-strand break repair via nonhomologous end joining;brain development;protein localization to chromosome, telomeric region;positive regulation of type I interferon production;positive regulation of catalytic activity;regulation of smooth muscle cell proliferation;negative regulation of t-circle formation;DNA duplex unwinding;positive regulation of protein kinase activity	GO:000072; GO:000697; GO:004331; GO:005197; GO:003221; GO:007139; GO:004249; GO:004589; GO:003220; GO:199083; GO:000631; GO:000828; GO:004508; GO:005076; GO:006021; GO:007147; GO:007148; GO:007571; GO:000221; GO:000630; GO:000742; GO:007019; GO:003248; GO:004308; GO:004866; GO:190443; GO:003250; GO:004586	nuclear telomere cap complex;macromolecular complex;secretory granule lumen;nonhomologous end joining complex;membrane;nucleolus;plasma membrane;ribonucleoprotein complex;extracellular region;nucleoplasm;nuclear chromosome, telomeric region;cytosol;nucleus;Ku70:Ku80 complex;site of DNA damage	GO:000078; GO:003299; GO:003477; GO:007041; GO:001602; GO:000573; GO:000588; GO:199090; GO:000557; GO:000565; GO:000078; GO:000582; GO:000563; GO:004356; GO:009073	 Non-homologous end-joining	hsa0345	transcription regulatory region DNA binding;ubiquitin protein ligase binding;double-stranded DNA binding;protein C-terminus binding;DNA end binding;enzyme activator activity;DNA binding;RNA binding;telomeric DNA binding;macromolecular complex binding;5'-deoxyribose-5-phosphate lyase activity;ATP-dependent DNA helicase activity;protein binding;damaged DNA binding;ATP binding	GO:004421; GO:003162; GO:000369; GO:000802; GO:004502; GO:000804; GO:000367; GO:000372; GO:004216; GO:004487; GO:005157; GO:000400; GO:000551; GO:000368; GO:000552
XP_020930633.1;XP_020930632.1;XP_003133716.2;XP_005672293.1;XP_005672292.1;XP_020930631.1;XP_020930630.1;XP_020930629.1;XP_013839980.2;XP_020925098.1;XP_020934935.1;XP_020934934.1;XP_020934933.1;XP_020934932.1;XP_020934931.1;XP_020934930.1;XP_020934929.1;XP_020934928.1;XP_020934927.1	XP_020930633.1;XP_020930632.1;XP_003133716.2;XP_005672293.1;XP_005672292.1;XP_020930631.1;XP_020930630.1;XP_020930629.1;XP_013839980.2	XP_020930633.1 dnaJ homolog subfamily B member 2 isoform X7 [Sus scrofa];XP_020930632.1 dnaJ homolog subfamily B member 2 isoform X6 [Sus scrofa];XP_003133716.2 dnaJ homolog subfamily B member 2 isoform X6 [Sus scrofa];XP_005672293.1 dnaJ homolog subfamily	3	3	3	0	0	9600900	0	0	6247100	7276600	8756300	0	0	5701800	0	0	0	0	7776900	9182500	0	NA	NA	NA	DNAJB2	DNAJB2;DNAJB2;DNAJB2;DNAJB2;DNAJB2	response to unfolded protein;positive regulation of ATPase activity;protein refolding;negative regulation of inclusion body assembly;negative regulation of cell proliferation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;neuron cellular homeostasis;regulation of chaperone-mediated protein folding;ubiquitin-dependent ERAD pathway;negative regulation of cell growth;chaperone-mediated protein folding;regulation of protein ubiquitination;negative regulation of protein binding	GO:000698; GO:003278; GO:004202; GO:009008; GO:000828; GO:003243; GO:007005; GO:190364; GO:003043; GO:003030; GO:006107; GO:003139; GO:003209	cytosol;nucleus;intrinsic component of endoplasmic reticulum membrane;nuclear membrane;proteasome complex	GO:000582; GO:000563; GO:003122; GO:003196; GO:000050	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;ubiquitin binding;chaperone binding;ATPase activator activity;Hsp70 protein binding	GO:000551; GO:004313; GO:005108; GO:000167; GO:003054
XP_003133809.1	XP_003133809.1	XP_003133809.1 COP9 signalosome complex subunit 8 [Sus scrofa]	4	4	4	0	0	17901000	0	22396000	0	18652000	0	0	0	15481000	0	0	0	0	0	0	0	NA	NA	NA	COPS8	COPS8;NA;NA;NA;NA	COP9 signalosome assembly;post-translational protein modification;protein deneddylation;transcription-coupled nucleotide-excision repair;protein phosphorylation;nucleotide-excision repair, DNA damage recognition;negative regulation of cell proliferation;activation of NF-kappaB-inducing kinase activity	GO:001038; GO:004368; GO:000033; GO:000628; GO:000646; GO:000071; GO:000828; GO:000725	COP9 signalosome;perinuclear region of cytoplasm;nucleoplasm;extracellular exosome;nucleus;cytosol	GO:000818; GO:004847; GO:000565; GO:007006; GO:000563; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_003133833.1	XP_003133833.1	XP_003133833.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial [Sus scrofa]	7	7	7	63579000	32546000	56286000	34044000	59195000	29060000	58065000	43349000	58815000	55739000	42493000	0	34734000	30603000	56437000	32684000	43662000	42788000	NA	NA	NA	NDUFA10	NDUFA10;NA;NA;NA;NA	mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone	GO:003298; GO:000612	mitochondrion;mitochondrial matrix;mitochondrial respiratory chain complex I;cytoplasm	GO:000573; GO:000575; GO:000574; GO:000573	 Metabolic pathways; Huntington's disease; Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0501; hsa0019; hsa0493	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_003133941.2	XP_003133941.2	XP_003133941.2 nuclear pore complex protein Nup155 [Sus scrofa]	2	2	2	0	0	0	0	9381300	0	0	0	0	0	0	0	9808200	0	0	0	0	0	NA	NA	NA	NUP155	NUP155;NA;NA;NA;NA	mRNA export from nucleus;viral process;nuclear envelope organization;transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery;protein targeting to nuclear inner membrane;protein import into nucleus;atrial cardiac muscle cell action potential	GO:000640; GO:001603; GO:000699; GO:000097; GO:003622; GO:000660; GO:008601	nuclear membrane;nuclear pore inner ring;nuclear envelope;membrane	GO:003196; GO:004461; GO:000563; GO:001602	 RNA transport	hsa0301	structural constituent of nuclear pore;transporter activity;protein binding	GO:001705; GO:000521; GO:000551
XP_003133963.1	XP_003133963.1	XP_003133963.1 UPF0600 protein C5orf51 homolog [Sus scrofa]	3	3	3	0	0	12611000	0	0	0	0	0	0	0	0	0	0	0	0	0	12331000	0	NA	NA	NA	C16H5orf51	C16H5orf51;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005657674.1;XP_005657673.1;XP_005657672.1;XP_003133969.3;XP_003483866.1	XP_005657674.1;XP_005657673.1;XP_005657672.1;XP_003133969.3;XP_003483866.1	XP_005657674.1 polyadenylate-binding protein-interacting protein 1 isoform X3 [Sus scrofa];XP_005657673.1 polyadenylate-binding protein-interacting protein 1 isoform X3 [Sus scrofa];XP_005657672.1 polyadenylate-binding protein-interacting protein 1 isoform	3	3	3	0	0	9436900	0	0	0	0	0	0	0	0	0	0	0	0	7838000	0	0	NA	NA	NA	PAIP1	PAIP1;PAIP1;PAIP1;PAIP1;PAIP1	regulation of translational initiation;translational initiation;positive regulation of translation;mRNA stabilization	GO:000644; GO:000641; GO:004572; GO:004825	cytoplasm;cytosol	GO:000573; GO:000582	 RNA transport	hsa0301	translation activator activity;protein binding;RNA binding	GO:000849; GO:000551; GO:000372
XP_003134014.3;XP_020932615.1	XP_003134014.3;XP_020932615.1	XP_003134014.3 sorting nexin-18 isoform X2 [Sus scrofa];XP_020932615.1 sorting nexin-18 isoform X1 [Sus scrofa]	4	4	4	0	5971400	0	0	0	0	0	0	0	9564800	6676300	0	0	0	0	0	0	0	NA	NA	NA	SNX18	SNX18;SNX18;NA;NA;NA	mitotic cytokinesis;protein transport;cleavage furrow formation;endocytosis;endosomal transport;positive regulation of GTPase activity	GO:000028; GO:001503; GO:003608; GO:000689; GO:001619; GO:004354	extracellular exosome;clathrin-coated vesicle;endosome membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;extrinsic component of cytoplasmic side of plasma membrane	GO:007006; GO:003013; GO:001000; GO:003065; GO:003141; GO:003123	"NA"	"NA"	phosphatidylinositol-4,5-bisphosphate binding;protein binding	GO:000554; GO:000551
XP_013840227.1;XP_003134018.1;XP_005672503.1	XP_013840227.1;XP_003134018.1;XP_005672503.1	XP_013840227.1 probable glutathione peroxidase 8 isoform X3 [Sus scrofa];XP_003134018.1 probable glutathione peroxidase 8 isoform X1 [Sus scrofa];XP_005672503.1 probable glutathione peroxidase 8 isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3513900	NA	NA	NA	GPX8	GPX8;GPX8;GPX8;NA;NA	oxidation-reduction process;cellular oxidant detoxification;cellular response to oxidative stress	GO:005511; GO:009886; GO:003459	integral component of membrane;endoplasmic reticulum lumen	GO:001602; GO:000578	 Glutathione metabolism; Arachidonic acid metabolism; Thyroid hormone synthesis	hsa0048; hsa0059; hsa0491	glutathione peroxidase activity;peroxidase activity	GO:000460; GO:000460
XP_003134070.2	XP_003134070.2	XP_003134070.2 28S ribosomal protein S36, mitochondrial [Sus scrofa]	2	2	2	0	0	19913000	0	19264000	0	23219000	12460000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MRPS36	MRPS36;NA;NA;NA;NA	mitochondrial translational termination;mitochondrial translational elongation;2-oxoglutarate metabolic process;translation;oxidation-reduction process	GO:007012; GO:007012; GO:000610; GO:000641; GO:005511	mitochondrion;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial oxoglutarate dehydrogenase complex	GO:000573; GO:000576; GO:000574; GO:000935	"NA"	"NA"	structural constituent of ribosome;oxoglutarate dehydrogenase (succinyl-transferring) activity	GO:000373; GO:000459
XP_003134080.1;XP_005672590.1;XP_020952325.1;XP_005659735.3	XP_003134080.1;XP_005672590.1	XP_003134080.1 microtubule-associated protein 1B isoform X1 [Sus scrofa];XP_005672590.1 microtubule-associated protein 1B isoform X2 [Sus scrofa]	17	17	17	0	185380000	5415800	0	0	18413000	0	9483900	0	21761000	12805000	0	54698000	19371000	0	4768600	13911000	16148000	NA	NA	NA	MAP1B	MAP1B;MAP1B;NA;NA;NA	negative regulation of intracellular transport;axonogenesis;mitochondrion transport along microtubule;regulation of microtubule depolymerization;establishment of monopolar cell polarity;microtubule cytoskeleton organization;neuron migration;cellular process;dendrite development;positive regulation of axon extension;microtubule bundle formation;axon extension	GO:003238; GO:000740; GO:004749; GO:003111; GO:006116; GO:000022; GO:000176; GO:000998; GO:001635; GO:004577; GO:000157; GO:004867	plasma membrane;microtubule associated complex;neuronal cell body;dendritic spine;somatodendritic compartment;apical dendrite;hippocampal mossy fiber;photoreceptor outer segment;postsynaptic density;dendrite;synapse;cell junction;cytosol;cell projection	GO:000588; GO:000587; GO:004302; GO:004319; GO:003647; GO:009744; GO:009745; GO:000175; GO:001406; GO:003042; GO:004520; GO:003005; GO:000582; GO:004299	"NA"	"NA"	actin binding;structural molecule activity;microtubule binding;protein binding;tubulin binding	GO:000377; GO:000519; GO:000801; GO:000551; GO:001563
XP_003134100.4;XP_013846102.1	XP_003134100.4;XP_013846102.1	XP_003134100.4 endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X2 [Sus scrofa];XP_013846102.1 endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X1 [Sus scrofa]	8	8	8	37920000	41408000	49643000	44571000	42780000	48886000	46744000	44950000	40721000	42508000	47733000	55791000	41632000	46427000	42728000	39349000	47166000	42459000	NA	NA	NA	ERGIC1	ERGIC1;ERGIC1;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;ER to Golgi vesicle-mediated transport	GO:000689; GO:000688	membrane;nucleoplasm;endoplasmic reticulum-Golgi intermediate compartment membrane;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment;Golgi membrane;endoplasmic reticulum membrane;intracellular membrane-bounded organelle	GO:001602; GO:000565; GO:003311; GO:001602; GO:000579; GO:000013; GO:000578; GO:004323	"NA"	"NA"	protein binding	GO:000551
XP_003134131.1	XP_003134131.1	XP_003134131.1 nudC domain-containing protein 2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6948700	0	NA	NA	NA	NUDCD2	NUDCD2;NA;NA;NA;NA	developmental process;protein folding	GO:003250; GO:000645	spindle pole;cytoplasm;condensed chromosome kinetochore;microtubule organizing center	GO:000092; GO:000573; GO:000077; GO:000581	"NA"	"NA"	protein binding;unfolded protein binding	GO:000551; GO:005108
XP_020932763.1;XP_013840376.2;XP_003134191.4;XP_020932762.1;XP_020932761.1;XP_020932764.1	XP_020932763.1;XP_013840376.2;XP_003134191.4;XP_020932762.1;XP_020932761.1;XP_020932764.1	XP_020932763.1 coiled-coil domain-containing protein 69 isoform X4 [Sus scrofa];XP_013840376.2 coiled-coil domain-containing protein 69 isoform X4 [Sus scrofa];XP_003134191.4 coiled-coil domain-containing protein 69 isoform X3 [Sus scrofa];XP_020932762.1 c	6	6	6	23160000	35755000	26652000	19399000	21064000	19385000	25318000	27283000	23787000	32820000	28873000	25234000	20020000	31538000	31700000	36333000	30221000	36032000	NA	NA	NA	CCDC69	CCDC69;CCDC69;CCDC69;CCDC69;CCDC69	spindle midzone assembly	GO:005125	microtubule cytoskeleton;midbody;nucleus;cytoplasm;spindle midzone	GO:001563; GO:003049; GO:000563; GO:000573; GO:005123	"NA"	"NA"	microtubule binding	GO:000801
XP_003134215.1	XP_003134215.1	XP_003134215.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial [Sus scrofa]	4	4	4	47810000	0	41347000	0	39991000	0	47512000	33067000	48420000	0	37883000	36002000	22084000	33346000	43840000	0	39019000	0	NA	NA	NA	NDUFS6	NDUFS6;NA;NA;NA;NA	muscle contraction;multicellular organism growth;mitochondrial electron transport, NADH to ubiquinone;cardiovascular system development;reproductive system development;fatty acid metabolic process;mitochondrial respiratory chain complex I assembly;mitochondrion morphogenesis;multicellular organism aging	GO:000693; GO:003526; GO:000612; GO:007235; GO:006145; GO:000663; GO:003298; GO:007058; GO:001025	mitochondrial inner membrane;mitochondrial respiratory chain complex I	GO:000574; GO:000574	 Metabolic pathways; Alzheimer's disease; Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0501; hsa0019; hsa0493	NADH dehydrogenase (ubiquinone) activity;electron carrier activity	GO:000813; GO:000905
XP_003134235.3	XP_003134235.3	XP_003134235.3 acid ceramidase [Sus scrofa]	4	4	4	37103000	22840000	33722000	37143000	36188000	37279000	36183000	23882000	31412000	27176000	26694000	19788000	33083000	31974000	26428000	27545000	33769000	26528000	NA	NA	NA	ASAH1	ASAH1;NA;NA;NA;NA	ceramide catabolic process;neutrophil degranulation;glycosphingolipid metabolic process;sphingosine biosynthetic process	GO:004651; GO:004331; GO:000668; GO:004651	early endosome;ficolin-1-rich granule lumen;extracellular exosome;tertiary granule lumen;lysosomal lumen;lysosome;extracellular space;extracellular region;endoplasmic reticulum	GO:000576; GO:190481; GO:007006; GO:190472; GO:004320; GO:000576; GO:000561; GO:000557; GO:000578	 Metabolic pathways; Lysosome; Sphingolipid metabolism; Sphingolipid signaling pathway	hsa0110; hsa0414; hsa0060; hsa0407	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;ceramidase activity	GO:001681; GO:001704
XP_003134284.1	XP_003134284.1	XP_003134284.1 arylamine N-acetyltransferase 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	762670	0	NA	NA	NA	LOC100511905	LOC100511905;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013840614.1;XP_003134376.1	XP_013840614.1;XP_003134376.1	XP_013840614.1 vacuolar protein sorting-associated protein 16 homolog isoform X2 [Sus scrofa];XP_003134376.1 vacuolar protein sorting-associated protein 16 homolog isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3161900	NA	NA	NA	VPS16	VPS16;VPS16;NA;NA;NA	autophagosome maturation;endosomal transport;endosome to lysosome transport;regulation of vacuole fusion, non-autophagic;vacuole organization;regulation of SNARE complex assembly;intracellular protein transport	GO:009735; GO:001619; GO:000833; GO:003288; GO:000703; GO:003554; GO:000688	endosome;early endosome;clathrin-coated vesicle;autophagosome;axon;HOPS complex;neuronal cell body;late endosome membrane;recycling endosome	GO:000576; GO:000576; GO:003013; GO:000577; GO:003042; GO:003089; GO:004302; GO:003190; GO:005503	"NA"	"NA"	protein binding;actin binding;actin filament binding	GO:000551; GO:000377; GO:005101
XP_003134381.1;XP_020933444.1	XP_003134381.1;XP_020933444.1	XP_003134381.1 probable carboxypeptidase X1 isoform X2 [Sus scrofa];XP_020933444.1 probable carboxypeptidase X1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CPXM1	CPXM1;CPXM1;NA;NA;NA	protein processing;peptide metabolic process	GO:001648; GO:000651	extracellular space	GO:000561	"NA"	"NA"	metallocarboxypeptidase activity;zinc ion binding	GO:000418; GO:000827
XP_020933851.1;XP_005672877.1;XP_003134407.1	XP_020933851.1;XP_005672877.1;XP_003134407.1	XP_020933851.1 casein kinase II subunit alpha [Sus scrofa];XP_005672877.1 casein kinase II subunit alpha [Sus scrofa];XP_003134407.1 casein kinase II subunit alpha [Sus scrofa]	5	5	5	0	10149000	10258000	0	12598000	0	0	0	0	0	12743000	0	0	0	0	0	0	0	NA	NA	NA	CSNK2A1	CSNK2A1;CSNK2A1;CSNK2A1;NA;NA	positive regulation of Wnt signaling pathway;regulation of signal transduction by p53 class mediator;signal transduction;Wnt signaling pathway;negative regulation of apoptotic signaling pathway;positive regulation of protein catabolic process;regulation of chromosome separation;protein phosphorylation;cell cycle;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;chaperone-mediated protein folding;positive regulation of cell growth;apoptotic process;peptidyl-serine phosphorylation;rhythmic process;positive regulation of cell proliferation;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	GO:003017; GO:190179; GO:000716; GO:001605; GO:200123; GO:004573; GO:190581; GO:000646; GO:000704; GO:004315; GO:006107; GO:003030; GO:000691; GO:001810; GO:004851; GO:000828; GO:200005	nucleus;plasma membrane;Sin3 complex;PcG protein complex;cytosol;nucleoplasm;protein kinase CK2 complex	GO:000563; GO:000588; GO:001658; GO:003151; GO:000582; GO:000565; GO:000595	 NF-kappa B signaling pathway; Ribosome biogenesis in eukaryotes; Herpes simplex infection; Adherens junction; Tight junction; Wnt signaling pathway	hsa0406; hsa0300; hsa0516; hsa0452; hsa0453; hsa0431	protein binding;kinase activity;protein serine/threonine kinase activity;identical protein binding;Hsp90 protein binding;ATP binding;protein N-terminus binding	GO:000551; GO:001630; GO:000467; GO:004280; GO:005187; GO:000552; GO:004748
XP_003134450.6	XP_003134450.6	XP_003134450.6 charged multivesicular body protein 4b [Sus scrofa]	4	4	4	0	17303000	13033000	0	13503000	0	14942000	13518000	0	0	13331000	0	0	0	0	0	0	0	NA	NA	NA	CHMP4B	CHMP4B;NA;NA;NA;NA	nuclear envelope reassembly;multivesicular body assembly;negative regulation of cell death;negative regulation of autophagosome assembly;nucleus organization;endosomal transport;macroautophagy;positive regulation of viral release from host cell;exit from mitosis;negative regulation of neuron death;mitotic cytokinesis;viral life cycle;maintenance of lens transparency;viral budding;regulation of viral process;vacuolar transport;viral budding via host ESCRT complex;membrane fission;regulation of centrosome duplication;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;mitotic metaphase plate congression;regulation of mitotic spindle assembly;posttranslational protein targeting to membrane;autophagy;protein homooligomerization	GO:003146; GO:003625; GO:006054; GO:190290; GO:000699; GO:001619; GO:001623; GO:190218; GO:001045; GO:190121; GO:000028; GO:001905; GO:003643; GO:004675; GO:005079; GO:000703; GO:003970; GO:009014; GO:001082; GO:009061; GO:000708; GO:190167; GO:000662; GO:000691; GO:005126	cytoplasmic side of plasma membrane;late endosome membrane;vesicle;membrane coat;cytoplasm;endosome;extracellular exosome;cytosol;nucleus;ESCRT III complex;midbody	GO:000989; GO:003190; GO:003198; GO:003011; GO:000573; GO:000576; GO:007006; GO:000582; GO:000563; GO:000081; GO:003049	 Endocytosis	hsa0414	identical protein binding;protein binding;protein homodimerization activity;cadherin binding	GO:004280; GO:000551; GO:004280; GO:004529
XP_003134532.1	XP_003134532.1	XP_003134532.1 TP53-regulating kinase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6911800	0	0	0	NA	NA	NA	TP53RK	TP53RK;NA;NA;NA;NA	protein phosphorylation;tRNA processing;tRNA threonylcarbamoyladenosine metabolic process;regulation of signal transduction by p53 class mediator	GO:000646; GO:000803; GO:007052; GO:190179	nucleus;nucleoplasm;EKC/KEOPS complex;cytosol;cytoplasm	GO:000563; GO:000565; GO:000040; GO:000582; GO:000573	"NA"	"NA"	p53 binding;ATP binding;protein binding;protein serine/threonine kinase activity;hydrolase activity	GO:000203; GO:000552; GO:000551; GO:000467; GO:001678
XP_005657776.1;XP_003134640.2	XP_005657776.1;XP_003134640.2	XP_005657776.1 zyxin [Sus scrofa];XP_003134640.2 zyxin [Sus scrofa]	12	12	12	0	63113000	63383000	59383000	0	111480000	0	78176000	31893000	98607000	50559000	59611000	141960000	68002000	41085000	41181000	0	71119000	NA	NA	NA	ZYX	ZYX;ZYX;NA;NA;NA	viral process;cell-matrix adhesion;transforming growth factor beta receptor signaling pathway;stress fiber assembly;cellular response to interferon-gamma;integrin-mediated signaling pathway;cell-cell signaling;regulation of inflammatory response	GO:001603; GO:000716; GO:000717; GO:004314; GO:007134; GO:000722; GO:000726; GO:005072	stress fiber;cytosol;cell-cell adherens junction;focal adhesion;phagocytic vesicle;nucleus	GO:000172; GO:000582; GO:000591; GO:000592; GO:004533; GO:000563	 Focal adhesion	hsa0451	protein binding;metal ion binding;RNA binding	GO:000551; GO:004687; GO:000372
XP_020934829.1;XP_020934824.1;XP_003134701.1;XP_005673205.1;XP_005673201.1;XP_005673200.1;XP_020934833.1;XP_020934832.1;XP_020934831.1;XP_020934828.1;XP_005673207.1;XP_020934827.1;XP_020934826.1;XP_020934825.1;XP_005673203.1;XP_005673202.1	XP_020934829.1;XP_020934824.1;XP_003134701.1;XP_005673205.1;XP_005673201.1;XP_005673200.1;XP_020934833.1;XP_020934832.1;XP_020934831.1;XP_020934828.1;XP_005673207.1;XP_020934827.1;XP_020934826.1;XP_020934825.1;XP_005673203.1;XP_005673202.1	XP_020934829.1 caldesmon isoform X8 [Sus scrofa];XP_020934824.1 caldesmon isoform X4 [Sus scrofa];XP_003134701.1 caldesmon isoform X2 [Sus scrofa];XP_005673205.1 caldesmon isoform X7 [Sus scrofa];XP_005673201.1 caldesmon isoform X3 [Sus scrofa];XP_00567320	19	19	19	246620000	663110000	558520000	524580000	288970000	686450000	423860000	660680000	426980000	581760000	508810000	589900000	1115300000	581560000	441310000	461170000	402340000	568890000	NA	NA	NA	CALD1	CALD1;CALD1;CALD1;CALD1;CALD1	muscle contraction	GO:000693	cytoskeleton;intracellular membrane-bounded organelle;cytosol;plasma membrane;myofibril;actin cap;actin cytoskeleton	GO:000585; GO:004323; GO:000582; GO:000588; GO:003001; GO:003047; GO:001562	 Vascular smooth muscle contraction	hsa0427	actin binding;myosin binding;tropomyosin binding;cadherin binding;calmodulin binding	GO:000377; GO:001702; GO:000552; GO:004529; GO:000551
XP_003134717.3	XP_003134717.3	XP_003134717.3 podocalyxin [Sus scrofa]	2	2	2	16945000	0	29085000	0	0	15763000	39482000	0	0	0	0	0	30265000	0	0	0	32294000	23061000	NA	NA	NA	PODXL	PODXL;NA;NA;NA;NA	regulation of microvillus assembly;positive regulation of cell-cell adhesion mediated by integrin;negative regulation of cell-cell adhesion;cell adhesion;negative regulation of cell adhesion;cell migration;epithelial tube formation;positive regulation of cell migration;glomerular visceral epithelial cell development	GO:003253; GO:003363; GO:002240; GO:000715; GO:000716; GO:001647; GO:007217; GO:003033; GO:007201	nucleolus;filopodium;slit diaphragm;microtubule organizing center;ruffle;lamellipodium;extracellular space;cytoplasm;membrane raft;extracellular exosome;plasma membrane;intracellular membrane-bounded organelle;apical plasma membrane;microvillus membrane	GO:000573; GO:003017; GO:003605; GO:000581; GO:000172; GO:003002; GO:000561; GO:000573; GO:004512; GO:007006; GO:000588; GO:004323; GO:001632; GO:003152	"NA"	"NA"	protein binding	GO:000551
XP_003134746.1	XP_003134746.1	XP_003134746.1 V-type proton ATPase subunit F [Sus scrofa]	3	3	3	0	6216300	7895900	6877200	12906000	5793800	6567100	0	0	5139100	6846700	0	6715700	5216300	7212200	7054200	6664900	5508300	NA	NA	NA	ATP6V1F	ATP6V1F;NA;NA;NA;NA	hydrogen ion transmembrane transport;ion transmembrane transport;transferrin transport;ATP hydrolysis coupled proton transport;insulin receptor signaling pathway	GO:190260; GO:003422; GO:003357; GO:001599; GO:000828	cytosol;proton-transporting two-sector ATPase complex;extracellular exosome;vacuolar proton-transporting V-type ATPase complex;proton-transporting V-type ATPase, V1 domain;membrane	GO:000582; GO:001646; GO:007006; GO:001647; GO:003318; GO:001602	 Synaptic vesicle cycle; Oxidative phosphorylation; Phagosome; Rheumatoid arthritis; Metabolic pathways; Epithelial cell signaling in Helicobacter pylori infection; Vibrio cholerae infection; Collecting duct acid secretion	hsa0472; hsa0019; hsa0414; hsa0532; hsa0110; hsa0512; hsa0511; hsa0496	proton-transporting ATPase activity, rotational mechanism;protein binding;ATPase activity, uncoupled;hydrogen ion transmembrane transporter activity	GO:004696; GO:000551; GO:004262; GO:001507
XP_003134748.1;XP_003134747.1;XP_020934610.1;XP_005657826.1;XP_020934609.1;XP_020934608.1	XP_003134748.1;XP_003134747.1;XP_020934610.1;XP_005657826.1;XP_020934609.1;XP_020934608.1	XP_003134748.1 filamin-C isoform X6 [Sus scrofa];XP_003134747.1 filamin-C isoform X4 [Sus scrofa];XP_020934610.1 filamin-C isoform X3 [Sus scrofa];XP_005657826.1 filamin-C isoform X5 [Sus scrofa];XP_020934609.1 filamin-C isoform X2 [Sus scrofa];XP_02093460	55	45	45	0	100360000	94135000	41182000	0	305010000	17928000	64452000	25685000	171560000	192060000	220170000	382030000	39572000	0	52945000	127080000	74088000	NA	NA	NA	FLNC	FLNC;FLNC;FLNC;FLNC;FLNC	cell junction assembly;muscle fiber development	GO:003432; GO:004874	plasma membrane;Z disc;cytoskeleton;costamere;sarcolemma;focal adhesion;sarcoplasm;cytosol;cytoplasm	GO:000588; GO:003001; GO:000585; GO:004303; GO:004238; GO:000592; GO:001652; GO:000582; GO:000573	 Salmonella infection; Focal adhesion; Proteoglycans in cancer; MAPK signaling pathway	hsa0513; hsa0451; hsa0520; hsa0401	cytoskeletal protein binding;protein binding;actin filament binding;ankyrin binding	GO:000809; GO:000551; GO:005101; GO:003050
XP_003134753.1;XP_020934967.1	XP_003134753.1;XP_020934967.1	XP_003134753.1 calumenin isoform X2 [Sus scrofa];XP_020934967.1 calumenin isoform X3 [Sus scrofa]	10	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56879000	NA	NA	NA	CALU	CALU;CALU;NA;NA;NA	post-translational protein modification;biological_process;cellular protein metabolic process	GO:004368; GO:000815; GO:004426	endoplasmic reticulum membrane;melanosome;endoplasmic reticulum;membrane;Golgi apparatus;sarcoplasmic reticulum lumen;extracellular region	GO:000578; GO:004247; GO:000578; GO:001602; GO:000579; GO:003301; GO:000557	"NA"	"NA"	protein binding;calcium ion binding	GO:000551; GO:000550
XP_003134775.1	XP_003134775.1	XP_003134775.1 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 isoform X1 [Sus scrofa]	3	3	3	29914000	22414000	0	0	37826000	0	30266000	24498000	25752000	0	0	21336000	0	20592000	18021000	0	23448000	0	NA	NA	NA	NDUFA5	NDUFA5;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	GO:000612; GO:003298	mitochondrial respiratory chain complex I;mitochondrial inner membrane	GO:000574; GO:000574	 Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation; Huntington's disease	hsa0110; hsa0493; hsa0019; hsa0501	NADH dehydrogenase (ubiquinone) activity;protein binding	GO:000813; GO:000551
XP_003134801.1	XP_003134801.1	XP_003134801.1 LSM8 homolog, U6 small nuclear RNA associated [Sus scrofa]	3	3	3	0	10150000	0	0	0	0	0	10460000	0	8885500	0	12674000	14594000	0	0	10540000	0	0	NA	NA	NA	LSM8	LSM8;NA;NA;NA;NA	RNA metabolic process;mRNA splicing, via spliceosome	GO:001607; GO:000039	nucleus;U2-type precatalytic spliceosome;nucleoplasm;U4/U6 x U5 tri-snRNP complex;U6 snRNP	GO:000563; GO:007100; GO:000565; GO:004654; GO:000568	 RNA degradation; Spliceosome	hsa0301; hsa0304	U6 snRNA binding;RNA binding;protein binding	GO:001707; GO:000372; GO:000551
XP_003134854.3	XP_003134854.3	XP_003134854.3 glycine--tRNA ligase [Sus scrofa]	8	8	8	15632000	10291000	15508000	13389000	15578000	15603000	12727000	17808000	13369000	15992000	11125000	18366000	15951000	0	9178000	15834000	11795000	14615000	NA	NA	NA	GARS	GARS;NA;NA;NA;NA	tRNA aminoacylation for protein translation;diadenosine tetraphosphate biosynthetic process;glycyl-tRNA aminoacylation;mitochondrial glycyl-tRNA aminoacylation	GO:000641; GO:001596; GO:000642; GO:007015	cytosol;mitochondrion;extracellular exosome;mitochondrial matrix;secretory granule;axon	GO:000582; GO:000573; GO:007006; GO:000575; GO:003014; GO:003042	 Aminoacyl-tRNA biosynthesis	hsa0097	ATP binding;identical protein binding;protein dimerization activity;bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity;glycine-tRNA ligase activity;protein binding	GO:000552; GO:004280; GO:004698; GO:000408; GO:000482; GO:000551
XP_003134934.1;XP_013839281.1;XP_020929265.1;XP_020929264.1;XP_013839280.2	XP_003134934.1	XP_003134934.1 adipocyte enhancer-binding protein 1 [Sus scrofa]	7	7	7	0	49963000	20922000	36365000	0	30440000	28723000	39920000	0	35766000	24470000	41267000	56588000	49718000	25613000	0	47758000	47976000	NA	NA	NA	AEBP1	AEBP1;NA;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;protein processing;regulation of collagen fibril organization;peptide metabolic process	GO:000012; GO:001648; GO:190402; GO:000651	cytoplasm;extracellular exosome;nucleus;extracellular region;extracellular space	GO:000573; GO:007006; GO:000563; GO:000557; GO:000561	"NA"	"NA"	collagen binding;calmodulin binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;metallocarboxypeptidase activity;RNA polymerase II regulatory region sequence-specific DNA binding;zinc ion binding;transcription corepressor activity;extracellular matrix structural constituent	GO:000551; GO:000551; GO:000122; GO:000418; GO:000097; GO:000827; GO:000371; GO:000520
XP_020934310.1;XP_003134937.1	XP_020934310.1;XP_003134937.1	XP_020934310.1 biliverdin reductase A [Sus scrofa];XP_003134937.1 biliverdin reductase A [Sus scrofa]	6	6	6	22903000	23936000	16610000	17401000	15482000	0	19375000	16490000	20139000	11303000	20017000	0	20248000	19177000	17265000	16828000	24138000	15209000	NA	NA	NA	BLVRA	BLVRA;BLVRA;NA;NA;NA	oxidation-reduction process;heme catabolic process	GO:005511; GO:004216	cytosol;extracellular exosome	GO:000582; GO:007006	 Porphyrin and chlorophyll metabolism	hsa0086	biliverdin reductase activity;protein binding;zinc ion binding	GO:000407; GO:000551; GO:000827
XP_020935792.1;XP_013841373.1;XP_005673505.1;XP_005673504.1;XP_003134991.1	XP_020935792.1;XP_013841373.1;XP_005673505.1;XP_005673504.1;XP_003134991.1	XP_020935792.1 pirin [Sus scrofa];XP_013841373.1 pirin [Sus scrofa];XP_005673505.1 pirin [Sus scrofa];XP_005673504.1 pirin [Sus scrofa];XP_003134991.1 pirin [Sus scrofa]	4	4	4	29814000	62768000	39111000	69500000	0	44716000	0	74768000	0	48260000	0	0	0	38603000	32626000	0	37249000	0	NA	NA	NA	PIR	PIR;PIR;PIR;PIR;PIR	transcription from RNA polymerase II promoter;oxidation-reduction process;digestion;regulation of nucleic acid-templated transcription;monocyte differentiation	GO:000636; GO:005511; GO:000758; GO:190350; GO:003022	cytosol;nucleus;nucleoplasm;cytoplasm	GO:000582; GO:000563; GO:000565; GO:000573	"NA"	"NA"	transcription cofactor activity;quercetin 2,3-dioxygenase activity;metal ion binding;protein binding	GO:000371; GO:000812; GO:004687; GO:000551
XP_020936181.1;XP_003135028.3;XP_005658004.1;XP_020936588.1	XP_020936181.1;XP_003135028.3;XP_005658004.1;XP_020936588.1	XP_020936181.1 eukaryotic translation initiation factor 2 subunit 3 [Sus scrofa];XP_003135028.3 eukaryotic translation initiation factor 2 subunit 3 [Sus scrofa];XP_005658004.1 eukaryotic translation initiation factor 2 subunit 3 isoform X2 [Sus scrofa];XP	13	13	13	60722000	57361000	76501000	77160000	86138000	75992000	62235000	70464000	74178000	74698000	56380000	75080000	61384000	72502000	67486000	77925000	72153000	68486000	NA	NA	NA	EIF2S3	EIF2S3;EIF2S3;LOC100624149;LOC100624149;NA	formation of translation preinitiation complex;translational initiation;transmembrane transport	GO:000173; GO:000641; GO:005508	nucleus;cytosol;eukaryotic translation initiation factor 2 complex;cytoplasm;extracellular exosome	GO:000563; GO:000582; GO:000585; GO:000573; GO:007006	 RNA transport	hsa0301	translation initiation factor activity;protein binding;GTPase activity;translation factor activity, RNA binding;GTP binding;cadherin binding	GO:000374; GO:000551; GO:000392; GO:000813; GO:000552; GO:004529
XP_003135056.1	XP_003135056.1	XP_003135056.1 dynein light chain Tctex-type 3 [Sus scrofa]	2	2	2	0	0	22694000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DYNLT3	DYNLT3;NA;NA;NA;NA	regulation of mitotic cell cycle;positive regulation of mitotic cell cycle;cell cycle;cell division	GO:000734; GO:004593; GO:000704; GO:005130	mitotic spindle astral microtubule;condensed chromosome kinetochore;nucleus;cytoplasmic dynein complex	GO:006167; GO:000077; GO:000563; GO:000586	"NA"	"NA"	protein binding;motor activity;identical protein binding	GO:000551; GO:000377; GO:004280
XP_003135101.1;XP_013846341.1	XP_003135101.1;XP_013846341.1	XP_003135101.1 properdin isoform X1 [Sus scrofa];XP_013846341.1 properdin isoform X2 [Sus scrofa]	4	4	4	0	0	0	0	0	25372000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CFP	CFP;CFP;NA;NA;NA	proteolysis;complement activation, alternative pathway;defense response to bacterium;regulation of complement activation;neutrophil degranulation	GO:000650; GO:000695; GO:004274; GO:003044; GO:004331	extracellular space;specific granule lumen;tertiary granule lumen;endoplasmic reticulum lumen;extracellular region	GO:000561; GO:003558; GO:190472; GO:000578; GO:000557	 Herpes simplex infection	hsa0516	serine-type endopeptidase activity;protein binding	GO:000425; GO:000551
XP_003135104.1;XP_020936066.1	XP_003135104.1;XP_020936066.1	XP_003135104.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial isoform X2 [Sus scrofa];XP_020936066.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial isoform X1 [Sus scrofa]	2	2	2	0	0	33972000	0	27564000	0	34978000	23823000	29432000	25973000	0	0	0	26350000	0	0	0	0	NA	NA	NA	NDUFB11	NDUFB11;NDUFB11;NA;NA;NA	oxidation-reduction process;mitochondrial respiratory chain complex I assembly	GO:005511; GO:003298	mitochondrion;integral component of membrane;mitochondrial inner membrane	GO:000573; GO:001602; GO:000574	 Alzheimer's disease; Metabolic pathways; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0501; hsa0110; hsa0501; hsa0493; hsa0019	protein binding	GO:000551
XP_003135131.2	XP_003135131.2	XP_003135131.2 coiled-coil domain-containing protein 22 [Sus scrofa]	10	10	10	0	15349000	0	0	0	0	14248000	15609000	15173000	0	17353000	0	0	13503000	0	14453000	0	15396000	NA	NA	NA	CCDC22	CCDC22;NA;NA;NA;NA	cellular copper ion homeostasis;Golgi to plasma membrane transport;post-translational protein modification;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;cytoplasmic sequestering of NF-kappaB	GO:000687; GO:000689; GO:004368; GO:200006; GO:001503; GO:004312; GO:000725	nucleoplasm;endosome;cellular_component;cytosol	GO:000565; GO:000576; GO:000557; GO:000582	"NA"	"NA"	cullin family protein binding;protein binding	GO:009760; GO:000551
XP_005673707.1;XP_003135172.3;XP_020936265.1	XP_005673707.1;XP_003135172.3;XP_020936265.1	XP_005673707.1 structural maintenance of chromosomes protein 1A isoform X3 [Sus scrofa];XP_003135172.3 structural maintenance of chromosomes protein 1A isoform X2 [Sus scrofa];XP_020936265.1 structural maintenance of chromosomes protein 1A isoform X1 [Sus	5	5	5	0	17914000	0	0	0	16548000	0	0	0	16423000	0	19221000	0	16553000	27789000	18330000	0	0	NA	NA	NA	SMC1A	SMC1A;SMC1A;SMC1A;NA;NA	stem cell population maintenance;regulation of mitotic spindle assembly;meiotic cell cycle;mitotic sister chromatid segregation;response to radiation;DNA repair;cell division;sister chromatid cohesion;negative regulation of DNA endoreduplication;response to DNA damage checkpoint signaling	GO:001982; GO:190167; GO:005132; GO:000007; GO:000931; GO:000628; GO:005130; GO:000706; GO:003287; GO:007242	chromosome;meiotic cohesin complex;nuclear matrix;chromosome, centromeric region;mitotic spindle pole;condensed nuclear chromosome;cytosol;nucleus;cohesin complex;nucleoplasm	GO:000569; GO:003089; GO:001636; GO:000077; GO:009743; GO:000079; GO:000582; GO:000563; GO:000827; GO:000565	 Cell cycle; Oocyte meiosis	hsa0411; hsa0411	protein binding;mediator complex binding;ATP binding;chromatin binding;protein heterodimerization activity;RNA binding	GO:000551; GO:003603; GO:000552; GO:000368; GO:004698; GO:000372
XP_003135174.1;XP_003135175.1;XP_020936270.1	XP_003135174.1;XP_003135175.1;XP_020936270.1	XP_003135174.1 3-hydroxyacyl-CoA dehydrogenase type-2 isoform X2 [Sus scrofa];XP_003135175.1 3-hydroxyacyl-CoA dehydrogenase type-2 isoform X1 [Sus scrofa];XP_020936270.1 3-hydroxyacyl-CoA dehydrogenase type-2 isoform X3 [Sus scrofa]	11	11	11	435110000	213010000	370960000	188830000	363590000	178470000	368410000	247680000	397560000	226360000	311310000	186780000	210590000	210480000	280000000	238160000	288130000	178220000	NA	NA	NA	HSD17B10	HSD17B10;HSD17B10;HSD17B10;NA;NA	mitochondrial tRNA processing;lipid metabolic process;mitochondrion organization;protein homotetramerization;mitochondrial tRNA 5'-end processing;oxidation-reduction process;mitochondrial tRNA methylation;mitochondrial tRNA 3'-end processing;branched-chain amino acid catabolic process	GO:009064; GO:000662; GO:000700; GO:005128; GO:009774; GO:005511; GO:007090; GO:199018; GO:000908	mitochondrion;mitochondrial ribonuclease P complex;plasma membrane;mitochondrial matrix;cytoplasm	GO:000573; GO:003067; GO:000588; GO:000575; GO:000573	 Biosynthesis of antibiotics; Metabolic pathways; Valine, leucine and isoleucine degradation; Alzheimer's disease	hsa0113; hsa0110; hsa0028; hsa0501	RNA binding;testosterone dehydrogenase [NAD(P);3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity;cholate 7-alpha-dehydrogenase activity;tRNA binding;protein binding;3-hydroxyacyl-CoA dehydrogenase activity	GO:000372; GO:003028; GO:004701; GO:000870; GO:000004; GO:000551; GO:000385
XP_003135253.4	XP_003135253.4	XP_003135253.4 magnesium transporter protein 1 [Sus scrofa]	1	1	1	16419000	0	18785000	17849000	16092000	0	21190000	0	0	17265000	19242000	19783000	0	0	24018000	0	0	0	NA	NA	NA	MAGT1	MAGT1;NA;NA;NA;NA	neutrophil degranulation;transmembrane transport;cognition;magnesium ion transmembrane transport;protein N-linked glycosylation;magnesium ion transport;protein N-linked glycosylation via asparagine	GO:004331; GO:005508; GO:005089; GO:190383; GO:000648; GO:001569; GO:001827	plasma membrane;oligosaccharyltransferase complex;endoplasmic reticulum;azurophil granule membrane;integral component of plasma membrane;membrane	GO:000588; GO:000825; GO:000578; GO:003557; GO:000588; GO:001602	"NA"	"NA"	dolichyl-diphosphooligosaccharide-protein glycotransferase activity;magnesium ion transmembrane transporter activity	GO:000457; GO:001509
XP_003135287.1	XP_003135287.1	XP_003135287.1 mitochondrial import inner membrane translocase subunit Tim8 A [Sus scrofa]	2	2	2	0	0	12714000	0	0	10363000	15107000	0	0	0	13467000	11918000	0	0	10931000	0	0	0	NA	NA	NA	TIMM8A	TIMM8A;NA;NA;NA;NA	chaperone-mediated protein transport;nervous system development	GO:007232; GO:000739	mitochondrion;mitochondrial inner membrane;mitochondrial intermembrane space	GO:000573; GO:000574; GO:000575	"NA"	"NA"	protein binding;metal ion binding	GO:000551; GO:004687
XP_003135349.1;XP_003130238.1	XP_003135349.1;XP_003130238.1	XP_003135349.1 ribose-phosphate pyrophosphokinase 1 [Sus scrofa];XP_003130238.1 ribose-phosphate pyrophosphokinase 3 [Sus scrofa]	8	8	4	61628000	52263000	46095000	41662000	48812000	40285000	38122000	37641000	56748000	47894000	50634000	53022000	47106000	39748000	38764000	49671000	43047000	53326000	NA	NA	NA	PRPS1	PRPS1;PRPS1L1;NA;NA;NA	purine nucleobase metabolic process;phosphorylation;urate biosynthetic process;5-phosphoribose 1-diphosphate biosynthetic process;hypoxanthine biosynthetic process;pyrimidine nucleotide biosynthetic process;nervous system development;ribonucleoside monophosphate biosynthetic process;nucleoside metabolic process;nucleotide biosynthetic process;purine nucleotide biosynthetic process	GO:000614; GO:001631; GO:003441; GO:000601; GO:004610; GO:000622; GO:000739; GO:000915; GO:000911; GO:000916; GO:000616	ribose phosphate diphosphokinase complex;cytosol;cytoplasm	GO:000218; GO:000582; GO:000573	 Purine metabolism; Biosynthesis of antibiotics; Pentose phosphate pathway; Carbon metabolism; Metabolic pathways; Biosynthesis of amino acids	hsa0023; hsa0113; hsa0003; hsa0120; hsa0110; hsa0123	ribose phosphate diphosphokinase activity;kinase activity;identical protein binding;magnesium ion binding;ATP binding;protein binding	GO:000474; GO:001630; GO:004280; GO:000028; GO:000552; GO:000551
XP_020936170.1;XP_020936169.1;XP_013846503.1;XP_003135514.1;XP_003135515.1	XP_020936170.1;XP_020936169.1;XP_013846503.1;XP_003135514.1;XP_003135515.1	XP_020936170.1 CD99 antigen-like protein 2 isoform X4 [Sus scrofa];XP_020936169.1 CD99 antigen-like protein 2 isoform X4 [Sus scrofa];XP_013846503.1 CD99 antigen-like protein 2 isoform X4 [Sus scrofa];XP_003135514.1 CD99 antigen-like protein 2 isoform X3 [	1	1	1	0	6328900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CD99L2	CD99L2;CD99L2;CD99L2;CD99L2;CD99L2	positive regulation of neutrophil extravasation;positive regulation of T cell extravasation;cell adhesion;diapedesis	GO:200039; GO:200040; GO:000715; GO:005090	cell-cell adherens junction;cell surface;plasma membrane;focal adhesion;integral component of membrane	GO:000591; GO:000998; GO:000588; GO:000592; GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_003135523.1;XP_013841982.2	XP_003135523.1;XP_013841982.2	XP_003135523.1 biglycan isoform X2 [Sus scrofa];XP_013841982.2 biglycan isoform X1 [Sus scrofa]	19	19	19	304080000	1577500000	571510000	837950000	466960000	1543900000	371540000	961580000	445700000	1627300000	762940000	2033700000	3402600000	1547500000	526200000	1320600000	518160000	2354200000	NA	NA	NA	BGN	BGN;BGN;NA;NA;NA	chondroitin sulfate biosynthetic process;biological_process;chondroitin sulfate catabolic process;blood vessel remodeling;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization	GO:003020; GO:000815; GO:003020; GO:000197; GO:001980; GO:003019	Golgi lumen;lysosomal lumen;extracellular matrix;sarcolemma;extracellular exosome;extracellular region;cell surface;transport vesicle	GO:000579; GO:004320; GO:003101; GO:004238; GO:007006; GO:000557; GO:000998; GO:003013	"NA"	"NA"	extracellular matrix structural constituent conferring compression resistance;extracellular matrix binding;extracellular matrix structural constituent;glycosaminoglycan binding	GO:003002; GO:005084; GO:000520; GO:000553
XP_005674061.1;XP_005674060.1;XP_003135528.2;XP_020935331.1	XP_005674061.1;XP_005674060.1;XP_003135528.2;XP_020935331.1	XP_005674061.1 B-cell receptor-associated protein 31 isoform X2 [Sus scrofa];XP_005674060.1 B-cell receptor-associated protein 31 isoform X2 [Sus scrofa];XP_003135528.2 B-cell receptor-associated protein 31 isoform X2 [Sus scrofa];XP_020935331.1 B-cell rec	10	10	10	289420000	397880000	360060000	269490000	322860000	307540000	331150000	314600000	318150000	313440000	383390000	175650000	308550000	345730000	351080000	268360000	363720000	366870000	NA	NA	NA	BCAP31	BCAP31;BCAP31;BCAP31;BCAP31;NA	positive regulation of cytosolic calcium ion concentration;spermatogenesis;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;apoptotic process;ER to Golgi vesicle-mediated transport;positive regulation of intrinsic apoptotic signaling pathway;antigen processing and presentation of peptide antigen via MHC class I;calcium-mediated signaling using intracellular calcium source;positive regulation of retrograde protein transport, ER to cytosol;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of mitochondrial calcium ion concentration;protein localization to endoplasmic reticulum exit site	GO:000720; GO:000728; GO:003247; GO:190307; GO:000691; GO:000688; GO:200124; GO:000247; GO:003558; GO:190415; GO:004328; GO:005156; GO:007097	endoplasmic reticulum membrane;Sec61 translocon complex;lipid particle;membrane;Golgi cisterna membrane;integral component of lumenal side of endoplasmic reticulum membrane;mitochondrion;clathrin-coated vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;perinuclear endoplasmic reticulum;cytosol;integral component of plasma membrane	GO:000578; GO:000578; GO:000581; GO:001602; GO:003258; GO:007155; GO:000573; GO:003013; GO:003311; GO:009703; GO:000582; GO:000588	 Protein processing in endoplasmic reticulum	hsa0414	macromolecular complex binding;protein binding;MHC class I protein binding	GO:004487; GO:000551; GO:004228
XP_005674066.1;XP_003135530.1	XP_005674066.1;XP_003135530.1	XP_005674066.1 translocon-associated protein subunit delta isoform X2 [Sus scrofa];XP_003135530.1 translocon-associated protein subunit delta isoform X1 [Sus scrofa]	2	2	2	0	19454000	14651000	21942000	17836000	17364000	19715000	20962000	0	22003000	22247000	25215000	0	24524000	0	20833000	19131000	23927000	NA	NA	NA	SSR4	SSR4;SSR4;NA;NA;NA	"NA"	"NA"	extracellular exosome;integral component of membrane;Sec61 translocon complex	GO:007006; GO:001602; GO:000578	 Protein processing in endoplasmic reticulum	hsa0414	"NA"	"NA"
XP_003135546.1;XP_003135545.1;XP_020935333.1	XP_003135546.1;XP_003135545.1;XP_020935333.1	XP_003135546.1 isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial isoform X2 [Sus scrofa];XP_003135545.1 isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial isoform X1 [Sus scrofa];XP_020935333.1 isocitrate dehydrogenase [NAD] subunit gamm	4	4	4	33096000	20279000	25174000	0	0	0	24159000	25251000	22788000	23044000	21165000	29698000	19488000	0	20198000	21589000	0	0	NA	NA	NA	IDH3G	IDH3G;IDH3G;IDH3G;NA;NA	tricarboxylic acid cycle;carbohydrate metabolic process;isocitrate metabolic process	GO:000609; GO:000597; GO:000610	mitochondrial matrix;nucleoplasm;nucleolus	GO:000575; GO:000565; GO:000573	 Carbon metabolism; Citrate cycle (TCA cycle); Biosynthesis of antibiotics; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids	hsa0120; hsa0002; hsa0113; hsa0110; hsa0121; hsa0123	isocitrate dehydrogenase (NAD+) activity;NAD binding;magnesium ion binding;ATP binding	GO:000444; GO:005128; GO:000028; GO:000552
XP_020936185.1;XP_003135572.1	XP_020936185.1;XP_003135572.1	XP_020936185.1 55 kDa erythrocyte membrane protein isoform X2 [Sus scrofa];XP_003135572.1 55 kDa erythrocyte membrane protein isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7046700	0	0	0	NA	NA	NA	MPP1	MPP1;MPP1;NA;NA;NA	signal transduction;GMP metabolic process;regulation of neutrophil chemotaxis;GDP metabolic process	GO:000716; GO:004603; GO:009002; GO:004671	plasma membrane;nuclear speck;stereocilium;cytosol;membrane;cortical cytoskeleton	GO:000588; GO:001660; GO:003242; GO:000582; GO:001602; GO:003086	"NA"	"NA"	protein binding;guanylate kinase activity	GO:000551; GO:000438
XP_003353219.1;XP_020942100.1	XP_003353219.1;XP_020942100.1	XP_003353219.1 sorting nexin-9 isoform X2 [Sus scrofa];XP_020942100.1 sorting nexin-9 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4930400	NA	NA	NA	SNX9	SNX9;SNX9;NA;NA;NA	endosomal transport;positive regulation of GTPase activity;membrane organization;positive regulation of protein kinase activity;plasma membrane tubulation;positive regulation of protein oligomerization;positive regulation of membrane protein ectodomain proteolysis;intracellular protein transport;receptor-mediated endocytosis;lipid tube assembly;mitotic cytokinesis;cleavage furrow formation	GO:001619; GO:004354; GO:006102; GO:004586; GO:009732; GO:003246; GO:005104; GO:000688; GO:000689; GO:006098; GO:000028; GO:003608	extrinsic component of cytoplasmic side of plasma membrane;cytoplasmic vesicle;ruffle;trans-Golgi network;cytosol;clathrin-coated vesicle;plasma membrane;cytoplasmic vesicle membrane;cytoplasm;extracellular exosome	GO:003123; GO:003141; GO:000172; GO:000580; GO:000582; GO:003013; GO:000588; GO:003065; GO:000573; GO:007006	"NA"	"NA"	phosphatidylinositol binding;Arp2/3 complex binding;protein binding;1-phosphatidylinositol binding;ubiquitin protein ligase binding;protein homodimerization activity;cadherin binding	GO:003509; GO:007193; GO:000551; GO:000554; GO:003162; GO:004280; GO:004529
XP_020929171.1;XP_003353391.2	XP_020929171.1;XP_003353391.2	XP_020929171.1 unconventional myosin-Ie isoform X2 [Sus scrofa];XP_003353391.2 unconventional myosin-Ie isoform X1 [Sus scrofa]	4	4	3	0	0	0	0	0	0	0	0	0	0	0	0	0	126660000	0	0	0	0	NA	NA	NA	MYO1E	MYO1E;MYO1E;NA;NA;NA	nitrogen compound metabolic process;glomerular basement membrane development;actin filament-based movement;endocytosis;glomerular visceral epithelial cell development;vasculogenesis;in utero embryonic development;glomerular filtration;post-embryonic hemopoiesis;platelet-derived growth factor receptor signaling pathway	GO:000680; GO:003283; GO:003004; GO:000689; GO:007201; GO:000157; GO:000170; GO:000309; GO:003516; GO:004800	brush border;extracellular exosome;cytoskeleton;cell-cell junction;clathrin-coated endocytic vesicle;myosin complex;cytoplasm;actin cytoskeleton	GO:000590; GO:007006; GO:000585; GO:000591; GO:004533; GO:001645; GO:000573; GO:001562	"NA"	"NA"	motor activity;actin filament binding;calmodulin binding;ATPase activity, coupled;ATP binding;microfilament motor activity;phosphatidylinositol binding	GO:000377; GO:005101; GO:000551; GO:004262; GO:000552; GO:000014; GO:003509
XP_003353540.1	XP_003353540.1	XP_003353540.1 actin-related protein 10 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6366500	0	NA	NA	NA	ACTR10	ACTR10;NA;NA;NA;NA	microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II;ER to Golgi vesicle-mediated transport;neutrophil degranulation	GO:000701; GO:001988; GO:000688; GO:004331	azurophil granule lumen;dynactin complex;extracellular region;cytosol;ficolin-1-rich granule lumen	GO:003557; GO:000586; GO:000557; GO:000582; GO:190481	"NA"	"NA"	protein binding	GO:000551
XP_003353634.1	XP_003353634.1	XP_003353634.1 aldehyde dehydrogenase X, mitochondrial [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3706100	0	0	NA	NA	NA	ALDH1B1	ALDH1B1;NA;NA;NA;NA	ethanol catabolic process;ethanol oxidation;carbohydrate metabolic process	GO:000606; GO:000606; GO:000597	mitochondrion;mitochondrial matrix;intracellular membrane-bounded organelle;nucleoplasm	GO:000573; GO:000575; GO:004323; GO:000565	 Ascorbate and aldarate metabolism; Valine, leucine and isoleucine degradation; Biosynthesis of antibiotics; Fatty acid degradation; Tryptophan metabolism; beta-Alanine metabolism; Glycerolipid metabolism; Metabolic pathways; Arginine and proline metabolism; Pyruvate metabolism; Glycolysis / Gluconeogenesis; Lysine degradation; Histidine metabolism; Pentose and glucuronate interconversions	hsa0005; hsa0028; hsa0113; hsa0007; hsa0038; hsa0041; hsa0056; hsa0110; hsa0033; hsa0062; hsa0001; hsa0031; hsa0034; hsa0004	aldehyde dehydrogenase (NAD) activity;NAD binding;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity	GO:000402; GO:005128; GO:004387
XP_003353736.2	XP_003353736.2	XP_003353736.2 LOW QUALITY PROTEIN: allograft inflammatory factor 1-like [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	11301000	0	0	0	0	0	NA	NA	NA	AIF1L	AIF1L;NA;NA;NA;NA	ruffle assembly;actin filament bundle assembly	GO:009717; GO:005101	actin filament;actin cytoskeleton;cytoplasm;macromolecular complex;focal adhesion;cell projection;extracellular exosome;ruffle membrane	GO:000588; GO:001562; GO:000573; GO:003299; GO:000592; GO:004299; GO:007006; GO:003258	"NA"	"NA"	actin filament binding;calcium ion binding	GO:005101; GO:000550
XP_003353762.1	XP_003353762.1	XP_003353762.1 immediate early response 3-interacting protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3172500	0	0	NA	NA	NA	IER3IP1	IER3IP1;NA;NA;NA;NA	regulation of fibroblast apoptotic process;ER to Golgi vesicle-mediated transport	GO:200026; GO:000688	ER to Golgi transport vesicle;integral component of Golgi membrane;endoplasmic reticulum;Golgi apparatus;membrane	GO:003013; GO:003017; GO:000578; GO:000579; GO:001602	"NA"	"NA"	"NA"	"NA"
XP_020938452.1;XP_020938451.1;XP_005654715.1;XP_005654713.1;XP_003353801.2;XP_005654712.1;XP_005654711.1	XP_020938452.1;XP_020938451.1;XP_005654715.1;XP_005654713.1;XP_003353801.2;XP_005654712.1;XP_005654711.1	XP_020938452.1 dipeptidyl peptidase 3 isoform X3 [Sus scrofa];XP_020938451.1 dipeptidyl peptidase 3 isoform X3 [Sus scrofa];XP_005654715.1 dipeptidyl peptidase 3 isoform X3 [Sus scrofa];XP_005654713.1 dipeptidyl peptidase 3 isoform X3 [Sus scrofa];XP_00335	6	6	6	0	0	0	0	0	0	0	0	0	10864000	0	0	0	0	0	0	0	0	NA	NA	NA	DPP3	DPP3;DPP3;DPP3;DPP3;DPP3	proteolysis	GO:000650	nuclear speck;extracellular exosome;cytosol;plasma membrane	GO:001660; GO:007006; GO:000582; GO:000588	"NA"	"NA"	zinc ion binding;protein binding;metallopeptidase activity	GO:000827; GO:000551; GO:000823
XP_003353842.1	XP_003353842.1	XP_003353842.1 stress-induced-phosphoprotein 1 [Sus scrofa]	17	17	17	168750000	165300000	184800000	106570000	168480000	143090000	209820000	140340000	148330000	133440000	162170000	144000000	148800000	132570000	162020000	116150000	174100000	148410000	NA	NA	NA	STIP1	STIP1;NA;NA;NA;NA	cellular response to interleukin-7	GO:009876	macromolecular complex;Golgi apparatus;cytosol;nucleus;chaperone complex	GO:003299; GO:000579; GO:000582; GO:000563; GO:010103	 Prion diseases	hsa0502	RNA binding;Hsp90 protein binding;chaperone binding;protein binding;Hsp70 protein binding;protein C-terminus binding	GO:000372; GO:005187; GO:005108; GO:000551; GO:003054; GO:000802
XP_003353857.2	XP_003353857.2	XP_003353857.2 LOW QUALITY PROTEIN: 4F2 cell-surface antigen heavy chain [Sus scrofa]	7	7	7	0	9118900	7792700	8867600	0	8449600	0	10734000	0	9106900	0	10466000	0	7071800	7953200	9541300	0	11736000	NA	NA	NA	SLC3A2	SLC3A2;NA;NA;NA;NA	carbohydrate metabolic process;tryptophan transport;response to exogenous dsRNA;calcium ion transport;amino acid transport;sodium ion transmembrane transport;leukocyte migration;L-leucine import into cell	GO:000597; GO:001582; GO:004333; GO:000681; GO:000686; GO:003572; GO:005090; GO:190380	nucleus;membrane;cytosol;extracellular exosome;plasma membrane;cell surface;melanosome;apical plasma membrane	GO:000563; GO:001602; GO:000582; GO:007006; GO:000588; GO:000998; GO:004247; GO:001632	 Protein digestion and absorption	hsa0497	protein binding;neutral amino acid transmembrane transporter activity;RNA binding;catalytic activity;calcium:sodium antiporter activity;cadherin binding	GO:000551; GO:001517; GO:000372; GO:000382; GO:000543; GO:004529
XP_003353868.2	XP_003353868.2	XP_003353868.2 LOW QUALITY PROTEIN: LRRN4 C-terminal-like protein [Sus scrofa]	5	5	5	75566000	177880000	194800000	161300000	116500000	188880000	203480000	191500000	187640000	172720000	194430000	296350000	88534000	247670000	159130000	192390000	184880000	172410000	NA	NA	NA	LRRN4CL	LRRN4CL;NA;NA;NA;NA	"NA"	"NA"	integral component of membrane	GO:001602	"NA"	"NA"	"NA"	"NA"
XP_003353912.1;XP_020938703.1	XP_003353912.1;XP_020938703.1	XP_003353912.1 FACT complex subunit SSRP1 isoform X2 [Sus scrofa];XP_020938703.1 FACT complex subunit SSRP1 isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	4588300	0	0	0	0	0	0	NA	NA	NA	SSRP1	SSRP1;SSRP1;NA;NA;NA	regulation of signal transduction by p53 class mediator;regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;DNA replication;DNA repair	GO:190179; GO:000635; GO:000636; GO:000626; GO:000628	nucleoplasm;nucleolus;chromosome	GO:000565; GO:000573; GO:000569	"NA"	"NA"	RNA polymerase II transcription factor activity, sequence-specific DNA binding;chromatin binding;RNA binding;protein binding;DNA binding	GO:000098; GO:000368; GO:000372; GO:000551; GO:000367
XP_003353925.2	XP_003353925.2	XP_003353925.2 mitochondrial carrier homolog 2 [Sus scrofa]	8	8	8	88141000	47600000	84261000	49371000	67427000	53254000	52735000	55261000	75108000	61684000	60511000	56691000	50522000	48641000	35023000	66659000	52234000	71924000	NA	NA	NA	MTCH2	MTCH2;NA;NA;NA;NA	positive regulation of apoptotic process;protein localization to mitochondrion	GO:004306; GO:007058	nucleus;mitochondrion;membrane;mitochondrial inner membrane	GO:000563; GO:000573; GO:001602; GO:000574	"NA"	"NA"	"NA"	"NA"
XP_003353965.2	XP_003353965.2	XP_003353965.2 reticulocalbin-1 [Sus scrofa]	9	9	9	0	101120000	48121000	69965000	37281000	68166000	49723000	76634000	28723000	73687000	52923000	140520000	75318000	87838000	46168000	63189000	54215000	86464000	NA	NA	NA	RCN1	RCN1;NA;NA;NA;NA	post-translational protein modification;cellular protein metabolic process	GO:004368; GO:004426	endoplasmic reticulum;endoplasmic reticulum lumen	GO:000578; GO:000578	"NA"	"NA"	calcium ion binding;protein binding	GO:000550; GO:000551
XP_003354007.2	XP_003354007.2	XP_003354007.2 LOW QUALITY PROTEIN: calponin-2 [Sus scrofa]	4	4	3	0	0	43862000	35123000	43355000	28433000	36628000	49590000	0	40392000	35672000	61138000	70975000	0	56657000	35552000	0	42555000	NA	NA	NA	CNN2	CNN2;NA;NA;NA;NA	actomyosin structure organization;regulation of actin filament-based process;cellular response to mechanical stimulus;interleukin-12-mediated signaling pathway;neutrophil degranulation;cytoskeleton organization	GO:003103; GO:003297; GO:007126; GO:003572; GO:004331; GO:000701	cell-cell junction;tertiary granule lumen;stress fiber;cytoskeleton;extracellular region;specific granule lumen;focal adhesion;membrane	GO:000591; GO:190472; GO:000172; GO:000585; GO:000557; GO:003558; GO:000592; GO:001602	"NA"	"NA"	calmodulin binding;cadherin binding;actin binding	GO:000551; GO:004529; GO:000377
XP_005661458.2;XP_003354019.2;XP_020939912.1;XP_020939911.1	XP_005661458.2;XP_003354019.2;XP_020939912.1;XP_020939911.1	XP_005661458.2 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial isoform X4 [Sus scrofa];XP_003354019.2 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial isoform X3 [Sus scrofa];XP_020939912.1 NADH dehydrogenase [ubiqu	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10545000	0	NA	NA	NA	NDUFS7	NDUFS7;NDUFS7;NDUFS7;NDUFS7;NA	mitochondrial respiratory chain complex I assembly;mitochondrial electron transport, NADH to ubiquinone;electron transport coupled proton transport;aerobic respiration	GO:003298; GO:000612; GO:001599; GO:000906	neuron projection;neuronal cell body;mitochondrial matrix;synaptic membrane;mitochondrial respiratory chain complex I	GO:004300; GO:004302; GO:000575; GO:009706; GO:000574	 Parkinson's disease; Oxidative phosphorylation; Metabolic pathways; Alzheimer's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0501; hsa0019; hsa0110; hsa0501; hsa0493	quinone binding;protein binding;NADH dehydrogenase (ubiquinone) activity;protease binding;4 iron, 4 sulfur cluster binding;NADH dehydrogenase activity;metal ion binding;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	GO:004803; GO:000551; GO:000813; GO:000202; GO:005153; GO:000395; GO:004687; GO:001665
XP_003354024.1;XP_003354025.1;XP_020939909.1;XP_003354023.1;XP_005661457.1;XP_005661456.1;XP_005661455.1;XP_020939908.1;XP_005661454.1;XP_005661453.1;XP_005661452.1;XP_005661451.1	XP_003354024.1;XP_003354025.1;XP_020939909.1;XP_003354023.1;XP_005661457.1;XP_005661456.1;XP_005661455.1;XP_020939908.1;XP_005661454.1;XP_005661453.1;XP_005661452.1;XP_005661451.1	XP_003354024.1 guanidinoacetate N-methyltransferase isoform X12 [Sus scrofa];XP_003354025.1 guanidinoacetate N-methyltransferase isoform X11 [Sus scrofa];XP_020939909.1 guanidinoacetate N-methyltransferase isoform X10 [Sus scrofa];XP_003354023.1 guanidinoa	2	2	2	0	8695000	0	0	0	0	0	0	0	0	0	0	0	8110000	0	0	7775900	0	NA	NA	NA	GAMT	GAMT;GAMT;GAMT;GAMT;GAMT	animal organ morphogenesis;regulation of multicellular organism growth;creatine biosynthetic process;muscle contraction;S-adenosylmethionine metabolic process;S-adenosylhomocysteine metabolic process;spermatogenesis;methylation	GO:000988; GO:004001; GO:000660; GO:000693; GO:004650; GO:004649; GO:000728; GO:003225	cytoplasm;cytosol;nucleus	GO:000573; GO:000582; GO:000563	 Arginine and proline metabolism; Glycine, serine and threonine metabolism; Metabolic pathways	hsa0033; hsa0026; hsa0110	guanidinoacetate N-methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity;methyltransferase activity	GO:003073; GO:000875; GO:000816
XP_003354038.1	XP_003354038.1	XP_003354038.1 mitochondrial import inner membrane translocase subunit Tim13 [Sus scrofa]	2	2	2	0	0	21840000	0	12127000	0	11207000	0	0	0	12851000	0	0	0	0	0	0	0	NA	NA	NA	TIMM13	TIMM13;NA;NA;NA;NA	protein targeting to mitochondrion;protein import into mitochondrial inner membrane;sensory perception of sound;chaperone-mediated protein transport	GO:000662; GO:004503; GO:000760; GO:007232	mitochondrial intermembrane space protein transporter complex;mitochondrion;mitochondrial inner membrane;fibrillar center	GO:004271; GO:000573; GO:000574; GO:000165	"NA"	"NA"	protein transporter activity;zinc ion binding	GO:000856; GO:000827
XP_003354039.2	XP_003354039.2	XP_003354039.2 lamin-B2 [Sus scrofa]	14	13	12	44893000	61443000	54039000	0	0	53377000	62029000	38275000	47516000	42979000	59105000	0	71862000	60075000	56043000	41484000	58781000	47616000	NA	NA	NA	LMNB2	LMNB2;NA;NA;NA;NA	biological_process	GO:000815	nuclear membrane;nuclear inner membrane	GO:003196; GO:000563	"NA"	"NA"	protein binding;molecular_function;structural molecule activity	GO:000551; GO:000367; GO:000519
XP_003354050.1;XP_020939748.1	XP_003354050.1;XP_020939748.1	XP_003354050.1 elongation factor 2 isoform X1 [Sus scrofa];XP_020939748.1 elongation factor 2 isoform X2 [Sus scrofa]	34	34	33	979480000	923620000	1211000000	970670000	1114500000	1036500000	1152900000	929670000	1151500000	989110000	953160000	984130000	1026500000	1055600000	990190000	947850000	1114900000	1110100000	NA	NA	NA	EEF2	EEF2;EEF2;NA;NA;NA	glial cell proliferation;response to endoplasmic reticulum stress;aging;response to estradiol;neutrophil degranulation;hematopoietic progenitor cell differentiation;response to hydrogen peroxide;positive regulation of cytoplasmic translation;skeletal muscle contraction;skeletal muscle cell differentiation;positive regulation of translation;translational elongation;response to ethanol;response to folic acid;cellular response to brain-derived neurotrophic factor stimulus;response to ischemia	GO:001400; GO:003497; GO:000756; GO:003235; GO:004331; GO:000224; GO:004254; GO:200076; GO:000300; GO:003591; GO:004572; GO:000641; GO:004547; GO:005159; GO:199041; GO:000293	secretory granule lumen;membrane raft;synapse;extracellular region;cytoplasm;ficolin-1-rich granule lumen;nucleus;extracellular exosome;cytosol;plasma membrane;aggresome;polysomal ribosome;membrane;ribonucleoprotein complex	GO:003477; GO:004512; GO:004520; GO:000557; GO:000573; GO:190481; GO:000563; GO:007006; GO:000582; GO:000588; GO:001623; GO:004278; GO:001602; GO:199090	 AMPK signaling pathway; Oxytocin signaling pathway	hsa0415; hsa0492	translation elongation factor activity;actin filament binding;GTP binding;5S rRNA binding;p53 binding;RNA binding;GTPase activity;ribosome binding;cadherin binding;protein kinase binding;protein binding	GO:000374; GO:005101; GO:000552; GO:000809; GO:000203; GO:000372; GO:000392; GO:004302; GO:004529; GO:001990; GO:000551
XP_003354108.1;XP_020939478.1;XP_020939479.1	XP_003354108.1;XP_020939478.1;XP_020939479.1	XP_003354108.1 transmembrane emp24 domain-containing protein 1 isoform X2 [Sus scrofa];XP_020939478.1 transmembrane emp24 domain-containing protein 1 isoform X1 [Sus scrofa];XP_020939479.1 transmembrane emp24 domain-containing protein 1 isoform X3 [Sus scr	4	4	4	0	0	13193000	0	11386000	14815000	14176000	13729000	0	14885000	0	15859000	0	0	16019000	15159000	0	14517000	NA	NA	NA	TMED1	TMED1;TMED1;TMED1;NA;NA	signal transduction;cell-cell signaling;Golgi organization;intracellular protein transport	GO:000716; GO:000726; GO:000703; GO:000688	Golgi apparatus;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;ER to Golgi transport vesicle	GO:000579; GO:001602; GO:000578; GO:000579; GO:000588; GO:003311; GO:003013	"NA"	"NA"	receptor binding;protein binding	GO:000510; GO:000551
XP_003354219.1;XP_013850316.1;XP_005661501.1;XP_005661498.1;XP_005661497.1;XP_005661496.1;XP_020939976.1;XP_020939975.1;XP_020956436.1;XP_020956435.1;XP_020956434.1;XP_020956433.1;XP_020956432.1;XP_003357146.1;XP_013834518.2;XP_020956430.1;XP_020956429.1;XP_020956428.1;XP_003129389.1;XP_020956427.1;XP_013834516.2	XP_003354219.1;XP_013850316.1;XP_005661501.1;XP_005661498.1;XP_005661497.1;XP_005661496.1;XP_020939976.1;XP_020939975.1;XP_020956436.1;XP_020956435.1;XP_020956434.1;XP_020956433.1;XP_020956432.1;XP_003357146.1;XP_013834518.2;XP_020956430.1;XP_020956429.1;XP_020956428.1;XP_003129389.1;XP_020956427.1;XP_013834516.2	XP_003354219.1 mitogen-activated protein kinase 9 isoform X4 [Sus scrofa];XP_013850316.1 mitogen-activated protein kinase 9 isoform X3 [Sus scrofa];XP_005661501.1 mitogen-activated protein kinase 9 isoform X3 [Sus scrofa];XP_005661498.1 mitogen-activated p	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	986260	NA	NA	NA	MAPK10	MAPK10;MAPK10;MAPK10;MAPK10;MAPK10	activation of MAPK activity;JUN phosphorylation;negative regulation of transcription from RNA polymerase II promoter;regulation of gene expression;cellular response to organic substance;vesicle-mediated transport in synapse;signal transduction;response to water deprivation;rhythmic process;cellular hyperosmotic response;regulation of circadian rhythm;protein phosphorylation;intracellular signal transduction;Fc-epsilon receptor signaling pathway;neurotransmitter receptor transport to postsynaptic membrane	GO:000018; GO:000725; GO:000012; GO:001046; GO:007131; GO:009900; GO:000716; GO:000941; GO:004851; GO:007147; GO:004275; GO:000646; GO:003555; GO:003809; GO:009896	nucleus;cytoplasm;perikaryon;cytosol;glutamatergic synapse;nucleoplasm;plasma membrane;neuron projection	GO:000563; GO:000573; GO:004320; GO:000582; GO:009897; GO:000565; GO:000588; GO:004300	 FoxO signaling pathway; Prolactin signaling pathway; Influenza A; Pathways in cancer; Wnt signaling pathway; Adipocytokine signaling pathway; Pertussis; Choline metabolism in cancer; ErbB signaling pathway; cAMP signaling pathway; Neurotrophin signaling pathway; Inflammatory mediator regulation of TRP channels; Type II diabetes mellitus; Sphingolipid signaling pathway; RIG-I-like receptor signaling pathway; Chagas disease (American trypanosomiasis); Tuberculosis; Colorectal cancer; Osteoclast differentiation; Focal adhesion; Fc epsilon RI signaling pathway; Epithelial cell signaling in Helicobacter pylori infection; Protein processing in endoplasmic reticulum	hsa0406; hsa0491; hsa0516; hsa0520; hsa0431; hsa0492; hsa0513; hsa0523; hsa0401; hsa0402; hsa0472; hsa0475; hsa0493; hsa0407; hsa0462; hsa0514; hsa0515; hsa0521; hsa0438; hsa0451; hsa0466; hsa0512; hsa0414	ATP binding;MAP kinase activity;protein binding	GO:000552; GO:000470; GO:000551
XP_005661707.1;XP_003354326.1;XP_003354325.1	XP_005661707.1;XP_003354326.1;XP_003354325.1	XP_005661707.1 cytochrome b-c1 complex subunit 8 [Sus scrofa];XP_003354326.1 cytochrome b-c1 complex subunit 8 [Sus scrofa];XP_003354325.1 cytochrome b-c1 complex subunit 8 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14774000	0	0	NA	NA	NA	LOC100524308	LOC100524308;LOC100524308;LOC100524308;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013850661.1;XP_005661787.1;XP_003354345.1;XP_003354344.1	XP_013850661.1;XP_005661787.1;XP_003354345.1;XP_003354344.1	XP_013850661.1 transcriptional activator protein Pur-alpha [Sus scrofa];XP_005661787.1 transcriptional activator protein Pur-alpha [Sus scrofa];XP_003354345.1 transcriptional activator protein Pur-alpha [Sus scrofa];XP_003354344.1 transcriptional activator	6	6	6	51019000	57998000	50770000	60796000	55670000	51580000	51592000	68709000	55087000	59628000	49263000	77116000	70295000	53439000	62733000	59406000	52235000	55967000	NA	NA	NA	PURA	PURA;PURA;PURA;PURA;NA	cell differentiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell proliferation;DNA replication initiation;nervous system development;negative regulation of translation;dendritic transport of messenger ribonucleoprotein complex;DNA unwinding involved in DNA replication	GO:003015; GO:000012; GO:000828; GO:000627; GO:000739; GO:001714; GO:009896; GO:000626	nucleus;DNA replication factor A complex;neuronal cell body;postsynapse;nuclear chromosome, telomeric region;glutamatergic synapse;dendrite cytoplasm	GO:000563; GO:000566; GO:004302; GO:009879; GO:000078; GO:009897; GO:003283	"NA"	"NA"	translation repressor activity, nucleic acid binding;double-stranded DNA binding;RNA polymerase II regulatory region sequence-specific DNA binding;SMAD binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;protein binding;RNA binding;transcription factor binding;purine-rich negative regulatory element binding	GO:000090; GO:000369; GO:000097; GO:004633; GO:000122; GO:004356; GO:000098; GO:000551; GO:000372; GO:000813; GO:003242
XP_020939066.1;XP_020939065.1;XP_020939064.1;XP_003354442.1	XP_020939066.1;XP_020939065.1;XP_020939064.1;XP_003354442.1	XP_020939066.1 butyrophilin-like protein 9 isoform X2 [Sus scrofa];XP_020939065.1 butyrophilin-like protein 9 isoform X1 [Sus scrofa];XP_020939064.1 butyrophilin-like protein 9 isoform X1 [Sus scrofa];XP_003354442.1 butyrophilin-like protein 9 isoform X1 [	3	3	3	5501200	0	8767900	0	6391500	0	6745200	0	7282900	0	0	0	0	0	0	0	0	0	NA	NA	NA	BTNL9	BTNL9;BTNL9;BTNL9;BTNL9;NA	regulation of immune response;T cell receptor signaling pathway	GO:005077; GO:005085	external side of plasma membrane;plasma membrane;integral component of membrane	GO:000989; GO:000588; GO:001602	"NA"	"NA"	receptor binding	GO:000510
XP_003354522.1	XP_003354522.1	XP_003354522.1 procollagen C-endopeptidase enhancer 1 [Sus scrofa]	16	16	16	0	292640000	23741000	195080000	24547000	409430000	0	206430000	0	253430000	33961000	418830000	103770000	254130000	0	254040000	50083000	457540000	NA	NA	NA	PCOLCE	PCOLCE;NA;NA;NA;NA	positive regulation of peptidase activity;proteolysis;multicellular organism development;cellular response to leukemia inhibitory factor	GO:001095; GO:000650; GO:000727; GO:199083	extracellular region;extracellular space;extracellular exosome	GO:000557; GO:000561; GO:007006	"NA"	"NA"	protein binding;collagen binding;peptidase activator activity;heparin binding;extracellular matrix structural constituent	GO:000551; GO:000551; GO:001650; GO:000820; GO:000520
XP_003354782.3;XP_013851438.1	XP_003354782.3;XP_013851438.1	XP_003354782.3 charged multivesicular body protein 3 isoform X1 [Sus scrofa];XP_013851438.1 charged multivesicular body protein 3 isoform X2 [Sus scrofa]	3	3	3	0	0	18821000	0	0	0	21759000	14910000	0	22720000	17211000	0	0	20940000	0	23385000	0	0	NA	NA	NA	CHMP3	CHMP3;CHMP3;NA;NA;NA	endosomal transport;endosome transport via multivesicular body sorting pathway;multivesicular body assembly;multivesicular body-lysosome fusion;macroautophagy;late endosome to vacuole transport;multivesicular body sorting pathway;regulation of exosomal secretion;regulation of mitotic spindle assembly;negative regulation of viral release from host cell;mitotic metaphase plate congression;protein transport;viral life cycle;viral budding via host ESCRT complex;regulation of viral process;protein heterooligomerization;autophagosome maturation;apoptotic process;nucleus organization;regulation of centrosome duplication;regulation of early endosome to late endosome transport;protein polymerization	GO:001619; GO:003250; GO:003625; GO:006176; GO:001623; GO:004532; GO:007198; GO:190354; GO:190167; GO:190218; GO:000708; GO:001503; GO:001905; GO:003970; GO:005079; GO:005129; GO:009735; GO:000691; GO:000699; GO:001082; GO:200064; GO:005125	ESCRT III complex;multivesicular body;late endosome membrane;plasma membrane;extracellular exosome;cytoplasmic vesicle;cytosol	GO:000081; GO:000577; GO:003190; GO:000588; GO:007006; GO:003141; GO:000582	 Endocytosis	hsa0414	protein binding;ubiquitin-specific protease binding;protein homodimerization activity;phosphatidylcholine binding	GO:000551; GO:199038; GO:004280; GO:003121
XP_003354791.1	XP_003354791.1	XP_003354791.1 vesicle-associated membrane protein 8 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20689000	0	NA	NA	NA	VAMP8	VAMP8;NA;NA;NA;NA	positive regulation of histamine secretion by mast cell;membrane organization;autophagosome maturation;autophagosome docking;negative regulation of secretion by cell;mucus secretion;regulation of protein localization to plasma membrane;neutrophil degranulation;viral entry into host cell;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;protein transport;eosinophil degranulation	GO:190359; GO:006102; GO:009735; GO:001624; GO:190353; GO:007025; GO:190307; GO:004331; GO:004671; GO:000247; GO:001503; GO:004330	early endosome membrane;recycling endosome;mucin granule;vesicle;extracellular exosome;late endosome membrane;cytoplasm;membrane;SNARE complex;specific granule membrane;plasma membrane;secretory granule membrane;tertiary granule membrane;lysosomal membrane;cytosol;phagocytic vesicle membrane;perinuclear region of cytoplasm	GO:003190; GO:005503; GO:009859; GO:003198; GO:007006; GO:003190; GO:000573; GO:001602; GO:003120; GO:003557; GO:000588; GO:003066; GO:007082; GO:000576; GO:000582; GO:003067; GO:004847	 SNARE interactions in vesicular transport; Platelet activation	hsa0413; hsa0461	chloride channel inhibitor activity;protein binding	GO:001986; GO:000551
XP_003354827.1	XP_003354827.1	XP_003354827.1 prenylcysteine oxidase 1 [Sus scrofa]	13	13	13	1183600000	1040000000	944150000	1049500000	1162100000	655280000	995690000	1030000000	929440000	1018200000	1535900000	1040100000	688560000	1056900000	1603800000	1409600000	1280600000	984150000	NA	NA	NA	PCYOX1	PCYOX1;NA;NA;NA;NA	prenylated protein catabolic process;chloride transmembrane transport;prenylcysteine catabolic process;oxidation-reduction process;ATP hydrolysis coupled anion transmembrane transport	GO:003032; GO:190247; GO:003032; GO:005511; GO:009913	extracellular exosome;very-low-density lipoprotein particle;lysosome;plasma membrane	GO:007006; GO:003436; GO:000576; GO:000588	 Terpenoid backbone biosynthesis; Biosynthesis of antibiotics	hsa0090; hsa0113	prenylcysteine oxidase activity;chloride-transporting ATPase activity	GO:000173; GO:000855
XP_013851765.2;XP_003354961.3	XP_013851765.2;XP_003354961.3	XP_013851765.2 HCLS1-binding protein 3 isoform X2 [Sus scrofa];XP_003354961.3 HCLS1-binding protein 3 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1190600	0	NA	NA	NA	HS1BP3	HS1BP3;HS1BP3;NA;NA;NA	negative regulation of autophagy;regulation of apoptotic process	GO:001050; GO:004298	endoplasmic reticulum;mitochondrion	GO:000578; GO:000573	"NA"	"NA"	phosphatidylinositol binding;protein binding	GO:003509; GO:000551
XP_003355118.1	XP_003355118.1	XP_003355118.1 mitochondrial pyruvate carrier 2 [Sus scrofa]	4	4	4	176990000	98340000	213240000	74179000	169150000	96925000	174730000	122510000	165810000	122920000	106060000	85298000	0	111960000	101720000	144810000	138370000	120720000	NA	NA	NA	MPC2	MPC2;NA;NA;NA;NA	mitochondrial pyruvate transport;positive regulation of insulin secretion involved in cellular response to glucose stimulus;mitochondrial acetyl-CoA biosynthetic process from pyruvate	GO:000685; GO:003577; GO:006173	nucleus;integral component of mitochondrial inner membrane;mitochondrion	GO:000563; GO:003130; GO:000573	"NA"	"NA"	pyruvate transmembrane transporter activity	GO:005083
XP_020945512.1;XP_020945511.1;XP_020945510.1;XP_020945509.1;XP_020945508.1;XP_020945507.1;XP_003355219.1;XP_020945505.1;XP_013852582.1;XP_020945504.1;XP_013852581.1;XP_013852580.1;XP_013852579.1	XP_020945512.1;XP_020945511.1;XP_020945510.1;XP_020945509.1;XP_020945508.1;XP_020945507.1;XP_003355219.1;XP_020945505.1;XP_013852582.1;XP_020945504.1;XP_013852581.1;XP_013852580.1;XP_013852579.1	XP_020945512.1 nuclear receptor ROR-gamma isoform X12 [Sus scrofa];XP_020945511.1 nuclear receptor ROR-gamma isoform X11 [Sus scrofa];XP_020945510.1 nuclear receptor ROR-gamma isoform X10 [Sus scrofa];XP_020945509.1 nuclear receptor ROR-gamma isoform X10 [	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	3627300	0	0	0	0	NA	NA	NA	RORC	RORC;RORC;RORC;RORC;RORC	transcription initiation from RNA polymerase II promoter;T-helper 17 cell differentiation;cellular response to sterol;steroid hormone mediated signaling pathway;positive regulation of transcription, DNA-templated;adipose tissue development;circadian regulation of gene expression;regulation of glucose metabolic process;regulation of steroid metabolic process;positive regulation of circadian rhythm;regulation of transcription involved in cell fate commitment;xenobiotic metabolic process;cytokine-mediated signaling pathway;intracellular receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;regulation of fat cell differentiation	GO:000636; GO:007253; GO:003631; GO:004340; GO:004589; GO:006061; GO:003292; GO:001090; GO:001921; GO:004275; GO:006085; GO:000680; GO:001922; GO:003052; GO:000012; GO:004559	nucleus;nuclear body;nucleoplasm	GO:000563; GO:001660; GO:000565	 Circadian rhythm; Inflammatory bowel disease (IBD)	hsa0471; hsa0532	protein binding;transcription factor activity, direct ligand regulated sequence-specific DNA binding;transcription coactivator binding;zinc ion binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;oxysterol binding;transcription factor activity, sequence-specific DNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	GO:000551; GO:009853; GO:000122; GO:000827; GO:000098; GO:000814; GO:000370; GO:000097; GO:000487
XP_020955502.1;XP_020954093.1;XP_020945588.1;XP_020939042.1;XP_013852659.1;XP_003355262.2	XP_020955502.1;XP_020954093.1;XP_020945588.1;XP_020939042.1;XP_013852659.1;XP_003355262.2	XP_020955502.1 histone H2B type 1-J [Sus scrofa];XP_020954093.1 histone H2B type 1-B [Sus scrofa];XP_020945588.1 histone H2B type 2-E [Sus scrofa];XP_020939042.1 histone H2B type 3-B [Sus scrofa];XP_013852659.1 histone H2B type 2-E [Sus scrofa];XP_00335526	4	2	2	410340000	481070000	715390000	167860000	192550000	692570000	220880000	200180000	463960000	644320000	281000000	812470000	537700000	786420000	0	1026200000	0	842210000	NA	NA	NA	LOC110261670	LOC110261670;LOC110261486;LOC100738744;LOC100515302;LOC102162202	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003355292.1	XP_003355292.1	XP_003355292.1 ATP synthase F(0) complex subunit B1, mitochondrial [Sus scrofa]	8	8	8	248050000	92501000	178330000	139480000	210680000	117490000	168220000	185370000	225890000	142240000	133830000	185620000	131350000	121410000	188580000	160540000	153640000	120090000	NA	NA	NA	ATP5PB	ATP5PB;NA;NA;NA;NA	ATP synthesis coupled proton transport;substantia nigra development;cristae formation;ATP hydrolysis coupled cation transmembrane transport;mitochondrial ATP synthesis coupled proton transport;ATP biosynthetic process	GO:001598; GO:002176; GO:004240; GO:009913; GO:004277; GO:000675	mitochondrion;mitochondrial matrix;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);nucleus;nucleoplasm;mitochondrial inner membrane;membrane	GO:000573; GO:000575; GO:000027; GO:000563; GO:000565; GO:000574; GO:001602	 Huntington's disease; Alzheimer's disease; Oxidative phosphorylation; Metabolic pathways	hsa0501; hsa0501; hsa0019; hsa0110	protein binding;proton-transporting ATP synthase activity, rotational mechanism;ATPase activity;transmembrane transporter activity	GO:000551; GO:004693; GO:001688; GO:002285
XP_020945699.1;XP_003355293.2	XP_020945699.1;XP_003355293.2	XP_020945699.1 methylosome protein 50 isoform X2 [Sus scrofa];XP_003355293.2 methylosome protein 50 isoform X1 [Sus scrofa]	2	2	2	0	0	14532000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	WDR77	WDR77;WDR77;NA;NA;NA	positive regulation of cell proliferation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;regulation of transcription from RNA polymerase II promoter;peptidyl-arginine N-methylation;negative regulation of epithelial cell proliferation involved in prostate gland development;positive regulation of nucleic acid-templated transcription	GO:000828; GO:006052; GO:000635; GO:003524; GO:006077; GO:190350	cytoplasm;cytosol;methylosome;nucleoplasm;Golgi apparatus;nucleus	GO:000573; GO:000582; GO:003470; GO:000565; GO:000579; GO:000563	"NA"	"NA"	protein binding;protein-arginine N-methyltransferase activity;methyl-CpG binding;ligand-dependent nuclear receptor transcription coactivator activity	GO:000551; GO:001627; GO:000832; GO:003037
XP_003355612.1	XP_003355612.1	XP_003355612.1 serine-threonine kinase receptor-associated protein [Sus scrofa]	7	7	7	0	29188000	23459000	30351000	0	28153000	28582000	0	28604000	26890000	0	28962000	25673000	24903000	27081000	25744000	0	30125000	NA	NA	NA	STRAP	STRAP;NA;NA;NA;NA	negative regulation of epithelial to mesenchymal transition;negative regulation of pathway-restricted SMAD protein phosphorylation;maintenance of gastrointestinal epithelium;negative regulation of transcription from RNA polymerase II promoter;negative regulation of transforming growth factor beta receptor signaling pathway;spliceosomal snRNP assembly;negative regulation of epithelial cell migration;negative regulation of epithelial cell proliferation	GO:001071; GO:006039; GO:003027; GO:000012; GO:003051; GO:000038; GO:001063; GO:005068	cytoplasm;SMN-Sm protein complex;nucleoplasm;cytosol;SMN complex	GO:000573; GO:003471; GO:000565; GO:000582; GO:003279	 RNA transport	hsa0301	protein binding;RNA binding;receptor binding	GO:000551; GO:000372; GO:000510
XP_003355641.2	XP_003355641.2	XP_003355641.2 lysophospholipid acyltransferase 5 [Sus scrofa]	3	3	3	0	11106000	20617000	7818800	21556000	10864000	24438000	0	0	7000800	11486000	0	0	8991900	11515000	9314100	11180000	9062800	NA	NA	NA	LPCAT3	LPCAT3;NA;NA;NA;NA	phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;phospholipid biosynthetic process;regulation of plasma lipoprotein particle levels	GO:003615; GO:003615; GO:000865; GO:009700	membrane;integral component of membrane;endoplasmic reticulum membrane	GO:001602; GO:001602; GO:000578	 Glycerophospholipid metabolism	hsa0056	1-acylglycerophosphocholine O-acyltransferase activity;1-acylglycerol-3-phosphate O-acyltransferase activity;2-acylglycerol-3-phosphate O-acyltransferase activity	GO:004718; GO:000384; GO:004714
XP_003355772.1;XP_020949303.1;XP_020949302.1;XP_020949301.1	XP_003355772.1;XP_020949303.1;XP_020949302.1;XP_020949301.1	XP_003355772.1 adenine phosphoribosyltransferase isoform X4 [Sus scrofa];XP_020949303.1 adenine phosphoribosyltransferase isoform X3 [Sus scrofa];XP_020949302.1 adenine phosphoribosyltransferase isoform X2 [Sus scrofa];XP_020949301.1 adenine phosphoribosyl	9	9	9	0	25427000	25952000	35736000	21671000	21582000	31291000	26622000	40111000	27217000	19479000	25421000	22349000	30002000	0	30755000	33508000	25785000	NA	NA	NA	APRT	APRT;APRT;APRT;APRT;NA	purine ribonucleoside salvage;neutrophil degranulation;grooming behavior;cellular response to insulin stimulus;AMP salvage;adenine salvage;lactation;purine-containing compound salvage	GO:000616; GO:004331; GO:000762; GO:003286; GO:004420; GO:000616; GO:000759; GO:004310	nucleoplasm;extracellular region;cytoplasm;cytosol;secretory granule lumen;extracellular exosome	GO:000565; GO:000557; GO:000573; GO:000582; GO:003477; GO:007006	 Metabolic pathways; Purine metabolism	hsa0110; hsa0023	AMP binding;adenine phosphoribosyltransferase activity;adenine binding	GO:001620; GO:000399; GO:000205
XP_003355849.1	XP_003355849.1	XP_003355849.1 DNA-directed RNA polymerase II subunit RPB3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	2819000	0	0	0	0	0	0	NA	NA	NA	POLR2C	POLR2C;NA;NA;NA;NA	RNA metabolic process;snRNA transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;mRNA splicing, via spliceosome;transcription initiation from RNA polymerase II promoter;fibroblast growth factor receptor signaling pathway;7-methylguanosine mRNA capping;regulation of gene silencing by miRNA	GO:001607; GO:004279; GO:000628; GO:000039; GO:000636; GO:000854; GO:000637; GO:006096	nucleoplasm;nucleus;microtubule cytoskeleton;DNA-directed RNA polymerase II, core complex;cytosol	GO:000565; GO:000563; GO:001563; GO:000566; GO:000582	 Pyrimidine metabolism; Epstein-Barr virus infection; RNA polymerase; Metabolic pathways; Huntington's disease; Purine metabolism	hsa0024; hsa0516; hsa0302; hsa0110; hsa0501; hsa0023	RNA polymerase II activity;DNA binding;protein binding;protein dimerization activity	GO:000105; GO:000367; GO:000551; GO:004698
XP_003355850.1	XP_003355850.1	XP_003355850.1 ubiquinone biosynthesis protein COQ9, mitochondrial [Sus scrofa]	2	2	2	22394000	19712000	32834000	0	0	18877000	21661000	14606000	26390000	0	19106000	0	0	0	19921000	0	19035000	17390000	NA	NA	NA	COQ9	COQ9;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;ubiquinone biosynthetic process	GO:000612; GO:000674	mitochondrial inner membrane;mitochondrion	GO:000574; GO:000573	"NA"	"NA"	protein homodimerization activity;protein binding;lipid binding	GO:004280; GO:000551; GO:000828
XP_020949568.1;XP_003355851.3	XP_020949568.1;XP_003355851.3	XP_020949568.1 anamorsin [Sus scrofa];XP_003355851.3 anamorsin [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5110100	0	0	0	NA	NA	NA	CIAPIN1	CIAPIN1;CIAPIN1;NA;NA;NA	electron transport chain;methylation;apoptotic process;iron-sulfur cluster assembly;hemopoiesis;negative regulation of apoptotic process	GO:002290; GO:003225; GO:000691; GO:001622; GO:003009; GO:004306	nucleolus;mitochondrial intermembrane space;mitochondrion;nucleoplasm	GO:000573; GO:000575; GO:000573; GO:000565	"NA"	"NA"	electron carrier activity;methyltransferase activity;protein binding;2 iron, 2 sulfur cluster binding;metal ion binding	GO:000905; GO:000816; GO:000551; GO:005153; GO:004687
XP_003355931.2;XP_003127168.2;XP_020950003.1;XP_003355932.1;XP_005664653.1;XP_003355933.1;XP_020950054.1;XP_020950053.1	XP_003355931.2;XP_003127168.2;XP_020950003.1;XP_003355932.1;XP_005664653.1;XP_003355933.1	XP_003355931.2 alpha-actinin-4 isoform X3 [Sus scrofa];XP_003127168.2 alpha-actinin-4 isoform X1 [Sus scrofa];XP_020950003.1 alpha-actinin-4 isoform X4 [Sus scrofa];XP_003355932.1 alpha-actinin-4 isoform X5 [Sus scrofa];XP_005664653.1 alpha-actinin-4 isofo	58	58	36	1668600000	1779200000	2784200000	1495800000	1702000000	2202600000	2033200000	2406200000	1657500000	2633300000	1997300000	2002900000	3838600000	1844700000	1548200000	1645400000	1835800000	1644200000	NA	NA	NA	ACTN4	ACTN4;ACTN4;ACTN4;ACTN4;ACTN4	protein transport;vesicle transport along actin filament;peroxisome proliferator activated receptor signaling pathway;retinoic acid receptor signaling pathway;negative regulation of cellular component movement;regulation of nucleic acid-templated transcription;positive regulation of cell migration;platelet degranulation;tumor necrosis factor-mediated signaling pathway;regulation of apoptotic process;positive regulation of NIK/NF-kappaB signaling;positive regulation of sodium:proton antiporter activity;negative regulation of substrate adhesion-dependent cell spreading;positive regulation of pinocytosis;actin filament bundle assembly;bicellular tight junction assembly;protein localization to bicellular tight junction;response to hypoxia	GO:001503; GO:003005; GO:003535; GO:004838; GO:005127; GO:190350; GO:003033; GO:000257; GO:003320; GO:004298; GO:190122; GO:003241; GO:190002; GO:004854; GO:005101; GO:007083; GO:190239; GO:000166	extracellular region;brush border;macromolecular complex;ribonucleoprotein complex;pseudopodium;perinuclear region of cytoplasm;extracellular exosome;cytosol;nuclear body;Z disc;cytoplasm;cortical cytoskeleton;neuron projection;extracellular space;nucleus;cell-cell junction;platelet alpha granule lumen;stress fiber;focal adhesion;actin cytoskeleton	GO:000557; GO:000590; GO:003299; GO:199090; GO:003114; GO:004847; GO:007006; GO:000582; GO:001660; GO:003001; GO:000573; GO:003086; GO:004300; GO:000561; GO:000563; GO:000591; GO:003109; GO:000172; GO:000592; GO:001562	 Adherens junction; Tight junction; Amoebiasis; Systemic lupus erythematosus; Leukocyte transendothelial migration; Focal adhesion; Viral carcinogenesis; Regulation of actin cytoskeleton; Arrhythmogenic right ventricular cardiomyopathy (ARVC)	hsa0452; hsa0453; hsa0514; hsa0532; hsa0467; hsa0451; hsa0520; hsa0481; hsa0541	RNA binding;integrin binding;protein binding;chromatin DNA binding;actin binding;calcium ion binding;actin filament binding;RNA polymerase II regulatory region sequence-specific DNA binding;retinoic acid receptor binding;nuclear hormone receptor binding;protein homodimerization activity;ion channel binding;protein N-terminus binding;nucleoside binding;transcription coactivator activity;ligand-dependent nuclear receptor transcription coactivator activity	GO:000372; GO:000517; GO:000551; GO:003149; GO:000377; GO:000550; GO:005101; GO:000097; GO:004297; GO:003525; GO:004280; GO:004432; GO:004748; GO:000188; GO:000371; GO:003037
XP_003355965.1	XP_003355965.1	XP_003355965.1 flavin reductase (NADPH) [Sus scrofa]	10	10	10	1008400000	335000000	346660000	513470000	385530000	222270000	573520000	416780000	790370000	332620000	487740000	309760000	967800000	384420000	919500000	269940000	524520000	227900000	NA	NA	NA	BLVRB	BLVRB;NA;NA;NA;NA	oxidation-reduction process;heme catabolic process	GO:005511; GO:004216	nucleoplasm;plasma membrane;extracellular exosome;terminal bouton;cytosol	GO:000565; GO:000588; GO:007006; GO:004319; GO:000582	 Riboflavin metabolism; Porphyrin and chlorophyll metabolism	hsa0074; hsa0086	biliverdin reductase activity;riboflavin reductase (NADPH) activity	GO:000407; GO:004260
XP_003355972.2;XP_003134119.1	XP_003355972.2	XP_003355972.2 rRNA 2-O-methyltransferase fibrillarin [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	14147000	0	0	0	21759000	0	0	0	0	10129000	NA	NA	NA	FBL	FBL;NA;NA;NA;NA	box C/D snoRNA 3'-end processing;histone glutamine methylation;rRNA processing;snoRNA localization;rRNA methylation;osteoblast differentiation	GO:000049; GO:199025; GO:000636; GO:004825; GO:003116; GO:000164	dense fibrillar component;Cajal body;box C/D snoRNP complex;chromosome;nucleus;nucleoplasm;membrane;small-subunit processome;granular component;nucleolus;extracellular exosome	GO:000165; GO:001503; GO:003142; GO:000569; GO:000563; GO:000565; GO:001602; GO:003204; GO:000165; GO:000573; GO:007006	 Ribosome biogenesis in eukaryotes	hsa0300	histone-glutamine methyltransferase activity;ATPase binding;rRNA methyltransferase activity;RNA binding;protein binding;TFIID-class transcription factor binding	GO:199025; GO:005111; GO:000864; GO:000372; GO:000551; GO:000109
XP_003355974.3	XP_003355974.3	XP_003355974.3 LOW QUALITY PROTEIN: periaxin [Sus scrofa]	33	33	33	0	1672900000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PRX	PRX;NA;NA;NA;NA	regulation of RNA splicing;axon ensheathment	GO:004348; GO:000836	T-tubule;nucleus;cytoplasm;plasma membrane;cell junction	GO:003031; GO:000563; GO:000573; GO:000588; GO:003005	"NA"	"NA"	protein binding;molecular_function	GO:000551; GO:000367
XP_003356000.1	XP_003356000.1	XP_003356000.1 prostacyclin receptor [Sus scrofa]	2	2	2	0	0	0	0	0	53737000	0	31783000	0	46424000	0	101530000	0	0	0	0	0	0	NA	NA	NA	PTGIR	PTGIR;NA;NA;NA;NA	negative regulation of platelet-derived growth factor receptor signaling pathway;inflammatory response;positive regulation of cytosolic calcium ion concentration;G-protein coupled receptor signaling pathway;cell-cell signaling;response to lipopolysaccharide;negative regulation of smooth muscle cell proliferation	GO:001064; GO:000695; GO:000720; GO:000718; GO:000726; GO:003249; GO:004866	plasma membrane;integral component of plasma membrane;cytosol	GO:000588; GO:000588; GO:000582	 Platelet activation; Vascular smooth muscle contraction; Neuroactive ligand-receptor interaction	hsa0461; hsa0427; hsa0408	G-protein coupled receptor activity;guanyl-nucleotide exchange factor activity	GO:000493; GO:000508
XP_013854004.1;XP_003356007.1	XP_013854004.1;XP_003356007.1	XP_013854004.1 EH domain-containing protein 2 [Sus scrofa];XP_003356007.1 EH domain-containing protein 2 [Sus scrofa]	44	44	40	9766500000	7315100000	9878400000	7499100000	8159200000	5855000000	7551200000	8339900000	8301600000	8611300000	7683900000	10467000000	4163900000	7850300000	9346600000	10923000000	7639100000	7044600000	NA	NA	NA	EHD2	EHD2;EHD2;NA;NA;NA	endocytosis;positive regulation of endocytic recycling;cortical actin cytoskeleton organization;blood coagulation;protein localization to plasma membrane;endocytic recycling;positive regulation of myoblast fusion;plasma membrane tubulation	GO:000689; GO:200113; GO:003086; GO:000759; GO:007265; GO:003245; GO:190174; GO:009732	intercellular bridge;microtubule cytoskeleton;extracellular exosome;perinuclear region of cytoplasm;extrinsic component of membrane;endosome membrane;recycling endosome membrane;plasma membrane;cytosol;nucleus;caveola	GO:004517; GO:001563; GO:007006; GO:004847; GO:001989; GO:001000; GO:005503; GO:000588; GO:000582; GO:000563; GO:000590	 Endocytosis	hsa0414	ATP binding;hydrolase activity;calcium ion binding;identical protein binding;protein binding;GTP binding;protein domain specific binding;nucleic acid binding	GO:000552; GO:001678; GO:000550; GO:004280; GO:000551; GO:000552; GO:001990; GO:000367
XP_003356046.1	XP_003356046.1	XP_003356046.1 ras-related protein R-Ras [Sus scrofa]	11	11	9	467310000	635950000	636600000	542990000	426460000	517830000	450220000	616340000	449350000	554080000	530130000	610380000	346550000	719860000	519000000	606690000	464710000	506160000	NA	NA	NA	RRAS	RRAS;NA;NA;NA;NA	leukocyte differentiation;negative regulation of cell migration;Ras protein signal transduction;face morphogenesis;regulation of ERK1 and ERK2 cascade;regulation of protein kinase B signaling;positive regulation of angiogenesis	GO:000252; GO:003033; GO:000726; GO:006032; GO:007037; GO:005189; GO:004576	extracellular exosome;plasma membrane;focal adhesion	GO:007006; GO:000588; GO:000592	 Rap1 signaling pathway; Proteoglycans in cancer; Tight junction; Regulation of actin cytoskeleton; MAPK signaling pathway; cAMP signaling pathway; HTLV-I infection	hsa0401; hsa0520; hsa0453; hsa0481; hsa0401; hsa0402; hsa0516	GTPase activity;GDP binding;protein binding;macromolecular complex binding;GTP binding	GO:000392; GO:001900; GO:000551; GO:004487; GO:000552
XP_020950415.1;XP_020950414.1;XP_003356047.1;XP_003356049.1	XP_020950415.1;XP_020950414.1;XP_003356047.1;XP_003356049.1	XP_020950415.1 protein arginine N-methyltransferase 1 isoform X4 [Sus scrofa];XP_020950414.1 protein arginine N-methyltransferase 1 isoform X3 [Sus scrofa];XP_003356047.1 protein arginine N-methyltransferase 1 isoform X2 [Sus scrofa];XP_003356049.1 protein	4	4	4	0	0	20997000	0	0	0	0	0	0	0	0	0	0	0	0	25730000	0	0	NA	NA	NA	PRMT1	PRMT1;PRMT1;PRMT1;PRMT1;NA	histone arginine methylation;protein homooligomerization;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;histone H4-R3 methylation;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;protein methylation;positive regulation of cell proliferation;in utero embryonic development;regulation of transcription, DNA-templated;cell surface receptor signaling pathway;peptidyl-arginine methylation;negative regulation of megakaryocyte differentiation;positive regulation of hemoglobin biosynthetic process;neuron projection development;positive regulation of erythrocyte differentiation;positive regulation of p38MAPK cascade;histone methylation	GO:003496; GO:005126; GO:000697; GO:004398; GO:001991; GO:000647; GO:000828; GO:000170; GO:000635; GO:000716; GO:001821; GO:004565; GO:004698; GO:003117; GO:004564; GO:190074; GO:001657	cytosol;nucleoplasm;nucleus;methylosome;cytoplasm	GO:000582; GO:000565; GO:000563; GO:003470; GO:000573	 Glucagon signaling pathway; FoxO signaling pathway	hsa0492; hsa0406	enzyme binding;RNA binding;protein methyltransferase activity;protein-arginine omega-N asymmetric methyltransferase activity;protein binding;methyl-CpG binding;histone methyltransferase activity (H4-R3 specific);S-adenosyl-L-methionine binding;histone-arginine N-methyltransferase activity;histone methyltransferase activity;mitogen-activated protein kinase p38 binding;N-methyltransferase activity;identical protein binding;methyltransferase activity;protein-arginine N-methyltransferase activity	GO:001989; GO:000372; GO:000827; GO:003524; GO:000551; GO:000832; GO:004402; GO:190404; GO:000846; GO:004205; GO:004827; GO:000817; GO:004280; GO:000816; GO:001627
XP_003356244.1	XP_003356244.1	XP_003356244.1 PITH domain-containing protein 1 [Sus scrofa]	4	4	4	19894000	19199000	15913000	0	19417000	13479000	18707000	19238000	21617000	18389000	17469000	12150000	0	0	17567000	18305000	18220000	16195000	NA	NA	NA	PITHD1	PITHD1;NA;NA;NA;NA	"NA"	"NA"	nucleus	GO:000563	"NA"	"NA"	"NA"	"NA"
XP_003356343.3;XP_020951476.1;XP_013854573.1	XP_003356343.3;XP_020951476.1;XP_013854573.1	XP_003356343.3 tyrosine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa];XP_020951476.1 tyrosine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_013854573.1 tyrosine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa]	7	7	7	14362000	14511000	11111000	15526000	0	14238000	0	0	0	15791000	14735000	0	0	0	0	18358000	0	14775000	NA	NA	NA	YARS	YARS;YARS;YARS;NA;NA	apoptotic process;tRNA aminoacylation for protein translation;tyrosyl-tRNA aminoacylation	GO:000691; GO:000641; GO:000643	extracellular space;aminoacyl-tRNA synthetase multienzyme complex;cytoplasm;cytosol;nuclear body	GO:000561; GO:001710; GO:000573; GO:000582; GO:001660	 Aminoacyl-tRNA biosynthesis	hsa0097	tRNA binding;RNA binding;ATP binding;tyrosine-tRNA ligase activity;interleukin-8 receptor binding;protein binding	GO:000004; GO:000372; GO:000552; GO:000483; GO:000515; GO:000551
XP_003356657.1;XP_005665946.2	XP_003356657.1;XP_005665946.2	XP_003356657.1 protein CutA isoform X2 [Sus scrofa];XP_005665946.2 protein CutA isoform X1 [Sus scrofa]	4	4	4	26584000	18064000	24469000	0	31371000	0	22886000	28100000	18705000	15229000	22343000	28621000	18314000	17468000	25367000	15525000	22719000	18517000	NA	NA	NA	CUTA	CUTA;CUTA;NA;NA;NA	response to metal ion;protein localization	GO:001003; GO:000810	membrane;extracellular exosome	GO:001602; GO:007006	"NA"	"NA"	protein binding;enzyme binding;copper ion binding	GO:000551; GO:001989; GO:000550
XP_003356696.1	XP_003356696.1	XP_003356696.1 fumarylacetoacetase [Sus scrofa]	15	15	15	499490000	348280000	512340000	430760000	519350000	309310000	420590000	344460000	568300000	403730000	720530000	537560000	319460000	592220000	522820000	427710000	390820000	405040000	NA	NA	NA	FAH	FAH;NA;NA;NA;NA	L-phenylalanine catabolic process;arginine catabolic process;tyrosine catabolic process;homogentisate catabolic process	GO:000655; GO:000652; GO:000657; GO:190200	extracellular exosome;cytosol	GO:007006; GO:000582	 Tyrosine metabolism; Metabolic pathways	hsa0035; hsa0110	protein binding;fumarylacetoacetase activity;metal ion binding	GO:000551; GO:000433; GO:004687
XP_003356782.2	XP_003356782.2	XP_003356782.2 LOW QUALITY PROTEIN: heat shock-related 70 kDa protein 2 [Sus scrofa]	19	13	13	42185000	196790000	70812000	155700000	36822000	148220000	81340000	146720000	42755000	129860000	108290000	235670000	113930000	148420000	58425000	158310000	63037000	194420000	NA	NA	NA	HSPA2	HSPA2;NA;NA;NA;NA	male meiosis;chaperone mediated protein folding requiring cofactor;response to cold;spermatogenesis;positive regulation of calcium-transporting ATPase activity;vesicle-mediated transport;synaptonemal complex disassembly;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of protein phosphorylation;protein refolding;negative regulation of inclusion body assembly;response to unfolded protein;cellular response to heat;male meiosis I;cellular response to unfolded protein	GO:000714; GO:005108; GO:000940; GO:000728; GO:190189; GO:001619; GO:007019; GO:001097; GO:000193; GO:004202; GO:009008; GO:000698; GO:003460; GO:000714; GO:003462	membrane;synaptonemal complex;CatSper complex;extracellular exosome;meiotic spindle;male germ cell nucleus;cytoplasm;nucleus;cytosol;plasma membrane;blood microparticle;cell surface	GO:001602; GO:000079; GO:003612; GO:007006; GO:007268; GO:000167; GO:000573; GO:000563; GO:000582; GO:000588; GO:007256; GO:000998	 Spliceosome; Endocytosis; Measles; Legionellosis; MAPK signaling pathway; Estrogen signaling pathway; Antigen processing and presentation; Toxoplasmosis	hsa0304; hsa0414; hsa0516; hsa0513; hsa0401; hsa0491; hsa0461; hsa0514	protein binding;protein binding involved in protein folding;disordered domain specific binding;ATPase activity;heat shock protein binding;unfolded protein binding;enzyme binding;glycolipid binding;ATP binding;ATPase activity, coupled;misfolded protein binding;tau protein binding	GO:000551; GO:004418; GO:009771; GO:001688; GO:003107; GO:005108; GO:001989; GO:005186; GO:000552; GO:004262; GO:005178; GO:004815
XP_003356800.1	XP_003356800.1	XP_003356800.1 serine/threonine-protein kinase Nek9 [Sus scrofa]	2	2	2	0	19308000	15878000	15207000	0	0	15328000	16074000	0	14423000	16203000	0	26476000	12721000	0	14101000	0	18124000	NA	NA	NA	NEK9	NEK9;NA;NA;NA;NA	protein phosphorylation;mitotic nuclear envelope disassembly;cell division	GO:000646; GO:000707; GO:005130	nucleus;cytosol;centrosome	GO:000563; GO:000582; GO:000581	"NA"	"NA"	protein serine/threonine kinase activity;metal ion binding;protein kinase binding;protein binding;ATP binding	GO:000467; GO:004687; GO:001990; GO:000551; GO:000552
XP_003356881.2	XP_003356881.2	XP_003356881.2 major facilitator superfamily domain-containing protein 10 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1841900	NA	NA	NA	MFSD10	MFSD10;NA;NA;NA;NA	apoptotic process;tetracycline transport;sodium-independent organic anion transport;transmembrane transport	GO:000691; GO:001590; GO:004325; GO:005508	integral component of membrane;cytoplasmic vesicle membrane;brush border membrane	GO:001602; GO:003065; GO:003152	"NA"	"NA"	tetracycline transporter activity;organic anion transmembrane transporter activity	GO:000849; GO:000851
XP_003356895.2	XP_003356895.2	XP_003356895.2 LOW QUALITY PROTEIN: grpE protein homolog 1, mitochondrial [Sus scrofa]	3	3	3	26630000	11796000	17170000	7190400	26337000	0	20985000	10909000	22871000	0	0	0	12866000	0	18291000	13596000	15060000	13080000	NA	NA	NA	GRPEL1	GRPEL1;NA;NA;NA;NA	protein import into mitochondrial matrix;regulation of catalytic activity;protein folding	GO:003015; GO:005079; GO:000645	presequence translocase-associated import motor;nucleus;mitochondrial matrix;mitochondrion	GO:000140; GO:000563; GO:000575; GO:000573	"NA"	"NA"	chaperone binding;adenyl-nucleotide exchange factor activity;unfolded protein binding;protein homodimerization activity	GO:005108; GO:000077; GO:005108; GO:004280
XP_003356909.2	XP_003356909.2	XP_003356909.2 LOW QUALITY PROTEIN: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 [Sus scrofa]	3	3	3	15509000	24033000	26204000	15351000	15484000	26399000	19440000	19719000	19040000	20538000	26445000	32400000	40820000	22024000	10596000	0	25912000	25314000	NA	NA	NA	BST1	BST1;NA;NA;NA;NA	regulation of cell-matrix adhesion;regulation of cellular extravasation;positive regulation of cell proliferation;signal transduction;regulation of peptidyl-tyrosine phosphorylation;regulation of inflammatory response;regulation of superoxide metabolic process;positive regulation of B cell proliferation;regulation of actin cytoskeleton organization;regulation of neutrophil chemotaxis;NAD metabolic process;neutrophil degranulation;regulation of calcium-mediated signaling;regulation of integrin-mediated signaling pathway;humoral immune response	GO:000195; GO:000269; GO:000828; GO:000716; GO:005073; GO:005072; GO:009032; GO:003089; GO:003295; GO:009002; GO:001967; GO:004331; GO:005084; GO:200104; GO:000695	anchored component of membrane;uropod;integrin complex;extrinsic component of membrane;extracellular region;plasma membrane;specific granule membrane;extracellular exosome	GO:003122; GO:000193; GO:000830; GO:001989; GO:000557; GO:000588; GO:003557; GO:007006	 Metabolic pathways; Nicotinate and nicotinamide metabolism; Salivary secretion	hsa0110; hsa0076; hsa0497	phosphorus-oxygen lyase activity;cyclic ADP-ribose hydrolase;NAD(P)+ nucleosidase activity;transferase activity;NAD+ nucleotidase, cyclic ADP-ribose generating;NAD+ nucleosidase activity	GO:001684; GO:006181; GO:005013; GO:001674; GO:006180; GO:000395
XP_003356918.4;XP_020956716.1	XP_003356918.4;XP_020956716.1	XP_003356918.4 cytosol aminopeptidase isoform X2 [Sus scrofa];XP_020956716.1 cytosol aminopeptidase isoform X1 [Sus scrofa]	25	25	25	899730000	788150000	933610000	653730000	855150000	853480000	913730000	722490000	889690000	831690000	933600000	966090000	942300000	944690000	1049400000	1053100000	1056400000	896880000	NA	NA	NA	LAP3	LAP3;LAP3;NA;NA;NA	proteolysis	GO:000650	nucleus;cytosol;focal adhesion;midbody;trans-Golgi network;extracellular exosome;nucleoplasm	GO:000563; GO:000582; GO:000592; GO:003049; GO:000580; GO:007006; GO:000565	 Glutathione metabolism; Arginine and proline metabolism; Metabolic pathways	hsa0048; hsa0033; hsa0110	aminopeptidase activity;metalloexopeptidase activity;manganese ion binding	GO:000417; GO:000823; GO:003014
XP_013834053.1;XP_003356947.1	XP_013834053.1;XP_003356947.1	XP_013834053.1 UDP-glucose 6-dehydrogenase [Sus scrofa];XP_003356947.1 UDP-glucose 6-dehydrogenase [Sus scrofa]	22	22	22	89092000	182990000	107700000	267830000	102290000	227360000	60720000	139890000	105730000	173700000	116000000	192840000	101940000	209900000	138360000	186390000	98498000	310580000	NA	NA	NA	UGDH	UGDH;UGDH;NA;NA;NA	gastrulation with mouth forming second;UDP-glucuronate biosynthetic process;heparan sulfate proteoglycan biosynthetic process;oxidation-reduction process;protein hexamerization;glycosaminoglycan biosynthetic process;chondroitin sulfate biosynthetic process	GO:000170; GO:000606; GO:001501; GO:005511; GO:003421; GO:000602; GO:003020	cytosol;nucleus;nucleoplasm;extracellular exosome	GO:000582; GO:000563; GO:000565; GO:007006	 Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Starch and sucrose metabolism	hsa0004; hsa0005; hsa0052; hsa0110; hsa0050	UDP-glucose 6-dehydrogenase activity;NAD binding	GO:000397; GO:005128
XP_020957004.1;XP_005666764.1;XP_005666763.1;XP_003356994.1;XP_020957001.1;XP_005666762.1;XP_005666761.1;XP_020956999.1;XP_020956998.1;XP_013834186.1;XP_005666759.1;XP_020957008.1;XP_020957007.1;XP_020957005.1;XP_020957003.1;XP_020957002.1	XP_020957004.1;XP_005666764.1;XP_005666763.1;XP_003356994.1;XP_020957001.1;XP_005666762.1;XP_005666761.1;XP_020956999.1;XP_020956998.1;XP_013834186.1;XP_005666759.1;XP_020957008.1;XP_020957007.1;XP_020957005.1;XP_020957003.1;XP_020957002.1	XP_020957004.1 exocyst complex component 1 isoform X13 [Sus scrofa];XP_005666764.1 exocyst complex component 1 isoform X10 [Sus scrofa];XP_005666763.1 exocyst complex component 1 isoform X9 [Sus scrofa];XP_003356994.1 exocyst complex component 1 isoform X8	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9297000	0	0	0	NA	NA	NA	EXOC1	EXOC1;EXOC1;EXOC1;EXOC1;EXOC1	Golgi to plasma membrane transport;phosphatidylinositol-mediated signaling;positive regulation of protein secretion;defense response to virus;exocytosis;regulation of macroautophagy;protein transport;viral process	GO:000689; GO:004801; GO:005071; GO:005160; GO:000688; GO:001624; GO:001503; GO:001603	cytoplasmic side of apical plasma membrane;cytosol;cytoplasm;perinuclear region of cytoplasm;plasma membrane;membrane;Flemming body;exocyst	GO:009859; GO:000582; GO:000573; GO:004847; GO:000588; GO:001602; GO:009054; GO:000014	"NA"	"NA"	GTP-Rho binding;protein binding;phosphatidylinositol-4,5-bisphosphate binding	GO:001704; GO:000551; GO:000554
XP_003357009.1	XP_003357009.1	XP_003357009.1 immunoglobulin J chain [Sus scrofa]	5	5	5	211390000	136230000	138380000	140520000	151030000	110360000	151480000	70826000	172430000	94973000	118470000	49385000	119760000	123370000	229030000	117010000	184760000	67990000	NA	NA	NA	JCHAIN	JCHAIN;NA;NA;NA;NA	retina homeostasis;positive regulation of respiratory burst;adaptive immune response;antibacterial humoral response;immune response;innate immune response;glomerular filtration;receptor-mediated endocytosis;positive regulation of protein oligomerization;leukocyte migration	GO:000189; GO:006026; GO:000225; GO:001973; GO:000695; GO:004508; GO:000309; GO:000689; GO:003246; GO:005090	extracellular region;dimeric IgA immunoglobulin complex;extracellular space;extracellular exosome;blood microparticle;monomeric IgA immunoglobulin complex	GO:000557; GO:007175; GO:000561; GO:007006; GO:007256; GO:007174	"NA"	"NA"	IgA binding;protein binding, bridging;antigen binding;protein homodimerization activity;peptidoglycan binding;single-stranded DNA binding;immunoglobulin receptor binding;phosphatidylcholine binding	GO:001986; GO:003067; GO:000382; GO:004280; GO:004283; GO:000369; GO:003498; GO:003121
XP_003357019.1;CON__ENSEMBL:ENSBTAP00000018229;CON__Q3MHN5	XP_003357019.1	XP_003357019.1 vitamin D-binding protein [Sus scrofa]	27	27	27	1695300000	2761800000	1482500000	2443500000	3063000000	5530600000	2262900000	2184100000	1971800000	2258200000	2561700000	2893800000	2036400000	2604600000	2260100000	2345900000	2292300000	3733700000	NA	NA	NA	GC	GC;NA;NA;NA;NA	vitamin D metabolic process;vitamin transmembrane transport;vitamin transport	GO:004235; GO:003546; GO:005118	blood microparticle;extracellular exosome;cytosol;lysosomal lumen;extracellular region;extracellular space	GO:007256; GO:007006; GO:000582; GO:004320; GO:000557; GO:000561	"NA"	"NA"	actin binding;vitamin D binding;calcidiol binding;vitamin transmembrane transporter activity	GO:000377; GO:000549; GO:190211; GO:009048
XP_005666796.1;XP_003357020.1;XP_005666795.1;CON__REFSEQ:XP_585019	XP_005666796.1;XP_003357020.1;XP_005666795.1	XP_005666796.1 afamin isoform X3 [Sus scrofa];XP_003357020.1 afamin isoform X1 [Sus scrofa];XP_005666795.1 afamin isoform X2 [Sus scrofa]	26	26	26	169020000	173600000	116450000	188830000	287510000	465530000	168320000	145420000	191960000	165420000	296840000	327750000	320420000	285590000	259080000	247340000	308360000	375280000	NA	NA	NA	AFM	AFM;AFM;AFM;NA;NA	protein stabilization;vitamin transport;protein transport within extracellular region	GO:005082; GO:005118; GO:007169	blood microparticle;extracellular space;extracellular exosome;extracellular region	GO:007256; GO:000561; GO:007006; GO:000557	"NA"	"NA"	protein binding;vitamin E binding	GO:000551; GO:000843
XP_003357065.1	XP_003357065.1	XP_003357065.1 LOW QUALITY PROTEIN: short coiled-coil protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2080200	NA	NA	NA	SCOC	SCOC;NA;NA;NA;NA	regulation of protein complex stability;positive regulation of macroautophagy	GO:006163; GO:001623	cytosol;nucleoplasm;Golgi apparatus;trans-Golgi network;endosome;Golgi membrane	GO:000582; GO:000565; GO:000579; GO:000580; GO:000576; GO:000013	"NA"	"NA"	protein binding	GO:000551
XP_005667074.1;XP_003357135.1;XP_003357134.1	XP_005667074.1;XP_003357135.1;XP_003357134.1	XP_005667074.1 ADP-ribose pyrophosphatase, mitochondrial isoform X2 [Sus scrofa];XP_003357135.1 ADP-ribose pyrophosphatase, mitochondrial isoform X2 [Sus scrofa];XP_003357134.1 ADP-ribose pyrophosphatase, mitochondrial isoform X1 [Sus scrofa]	2	2	2	9433900	5281200	6382600	4767100	0	0	6097800	0	0	0	0	7059200	7257800	0	0	6183200	0	0	NA	NA	NA	NUDT9	NUDT9;NUDT9;NUDT9;NA;NA	ADP catabolic process;nucleobase-containing small molecule catabolic process;IDP catabolic process	GO:004603; GO:003465; GO:004670	mitochondrial matrix;extracellular exosome	GO:000575; GO:007006	 Purine metabolism	hsa0023	ADP-ribose diphosphatase activity;ADP-sugar diphosphatase activity;adenosine-diphosphatase activity	GO:004763; GO:001914; GO:004326
XP_005656654.1;XP_005656653.1;XP_003357179.1;XP_020917995.1;XP_020917994.1;XP_020917993.1	XP_005656654.1;XP_005656653.1;XP_003357179.1;XP_020917995.1;XP_020917994.1;XP_020917993.1	XP_005656654.1 integrin-linked protein kinase isoform X2 [Sus scrofa];XP_005656653.1 integrin-linked protein kinase isoform X2 [Sus scrofa];XP_003357179.1 integrin-linked protein kinase isoform X2 [Sus scrofa];XP_020917995.1 integrin-linked protein kinase	16	16	16	157380000	258710000	242900000	274230000	152220000	282940000	173280000	258410000	201650000	333970000	202840000	478180000	164800000	309820000	187470000	397730000	193990000	254300000	NA	NA	NA	ILK	ILK;ILK;ILK;ILK;ILK	positive regulation of protein phosphorylation;positive regulation of cell-matrix adhesion;protein phosphorylation;protein kinase B signaling;positive regulation of axon extension;cell-matrix adhesion;integrin-mediated signaling pathway;cell proliferation;fibroblast migration;negative regulation of smooth muscle cell migration;positive regulation of cell migration;myelin assembly;cell junction assembly;negative regulation of neural precursor cell proliferation;MAPK cascade;branching involved in ureteric bud morphogenesis;nerve development;regulation of actin cytoskeleton organization;positive regulation of MAP kinase activity;negative regulation of smooth muscle cell proliferation;neuron projection morphogenesis;positive regulation of dendrite morphogenesis;cell cycle arrest;myelination in peripheral nervous system;positive regulation of BMP signaling pathway;protein heterooligomerization;supramolecular fiber organization;positive regulation of signal transduction;tumor necrosis factor-mediated signaling pathway;platelet aggregation;positive regulation of canonical Wnt signaling pathway;outflow tract morphogenesis;negative regulation of cardiac muscle cell apoptotic process;positive regulation of phosphorylation;negative regulation of neuron apoptotic process;establishment or maintenance of epithelial cell apical/basal polarity;positive regulation of NIK/NF-kappaB signaling;cell aging;substrate adhesion-dependent cell spreading;positive regulation of myoblast differentiation;positive regulation of transcription, DNA-templated;positive regulation of protein kinase B signaling;peptidyl-serine phosphorylation	GO:000193; GO:000195; GO:000646; GO:004349; GO:004577; GO:000716; GO:000722; GO:000828; GO:001076; GO:001491; GO:003033; GO:003228; GO:003432; GO:200017; GO:000016; GO:000165; GO:002167; GO:003295; GO:004340; GO:004866; GO:004881; GO:005077; GO:000705; GO:002201; GO:003051; GO:005129; GO:009743; GO:000996; GO:003320; GO:007052; GO:009026; GO:000315; GO:001066; GO:004232; GO:004352; GO:004519; GO:190122; GO:000756; GO:003444; GO:004566; GO:004589; GO:005189; GO:001810	membrane;stress fiber;nucleoplasm;costamere;cytosol;dendritic shaft;macromolecular complex;neuronal cell body;sarcomere;plasma membrane;cell junction;cell-cell junction;focal adhesion;lamellipodium	GO:001602; GO:000172; GO:000565; GO:004303; GO:000582; GO:004319; GO:003299; GO:004302; GO:003001; GO:000588; GO:003005; GO:000591; GO:000592; GO:003002	 PPAR signaling pathway; Bacterial invasion of epithelial cells; Endometrial cancer; Focal adhesion	hsa0332; hsa0510; hsa0521; hsa0451	protein kinase binding;protein serine/threonine kinase activity;protein binding;ATP binding;integrin binding;SH3 domain binding	GO:001990; GO:000467; GO:000551; GO:000552; GO:000517; GO:001712
XP_013844908.1;XP_003357180.1	XP_013844908.1;XP_003357180.1	XP_013844908.1 tripeptidyl-peptidase 1 isoform X2 [Sus scrofa];XP_003357180.1 tripeptidyl-peptidase 1 isoform X1 [Sus scrofa]	4	4	4	22305000	19013000	24853000	26420000	12684000	0	21622000	24972000	24357000	23683000	25094000	13582000	21803000	17860000	13303000	0	29067000	25001000	NA	NA	NA	TPP1	TPP1;TPP1;NA;NA;NA	lysosome organization;central nervous system development;bone resorption;IRE1-mediated unfolded protein response;nervous system development;protein catabolic process;epithelial cell differentiation;proteolysis;peptide catabolic process;lipid metabolic process;neuromuscular process controlling balance	GO:000704; GO:000741; GO:004545; GO:003649; GO:000739; GO:003016; GO:003085; GO:000650; GO:004317; GO:000662; GO:005088	lysosome;lysosomal lumen;melanosome;extracellular exosome	GO:000576; GO:004320; GO:004247; GO:007006	 Lysosome	hsa0414	serine-type endopeptidase activity;endopeptidase activity;peptidase activity;peptide binding;protein binding;tripeptidyl-peptidase activity;metal ion binding	GO:000425; GO:000417; GO:000823; GO:004227; GO:000551; GO:000824; GO:004687
XP_003357187.1	XP_003357187.1	XP_003357187.1 protein kinase C delta-binding protein [Sus scrofa]	15	15	15	1750300000	2594900000	2891900000	1975800000	1520300000	1752300000	1742500000	2061800000	1985700000	2008100000	1862400000	2361600000	1343300000	2396700000	2334300000	2616700000	1927800000	1836000000	NA	NA	NA	CAVIN3	CAVIN3;NA;NA;NA;NA	cortical actin cytoskeleton organization;positive regulation of ERK1 and ERK2 cascade;negative regulation of protein kinase B signaling;negative regulation of fermentation;circadian regulation of gene expression	GO:003086; GO:007037; GO:005189; GO:190100; GO:003292	caveola;macromolecular complex;cytoplasm;cytosol	GO:000590; GO:003299; GO:000573; GO:000582	"NA"	"NA"	protein binding;protein kinase C binding	GO:000551; GO:000508
XP_003357238.3	XP_003357238.3	XP_003357238.3 LOW QUALITY PROTEIN: protein phosphatase methylesterase 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	7368100	0	0	0	0	0	0	0	0	NA	NA	NA	PPME1	PPME1;NA;NA;NA;NA	protein demethylation;negative regulation of phosphoprotein phosphatase activity;G2/M transition of mitotic cell cycle	GO:000648; GO:003251; GO:000008	nucleoplasm	GO:000565	"NA"	"NA"	protein kinase binding;cadherin binding;protein phosphatase binding;protein phosphatase inhibitor activity;protein binding;protein phosphatase regulator activity;protein C-terminal methylesterase activity	GO:001990; GO:004529; GO:001990; GO:000486; GO:000551; GO:001988; GO:005172
XP_003357333.1;XP_020918432.1;XP_005667373.1;XP_013834822.2	XP_003357333.1;XP_020918432.1;XP_005667373.1;XP_013834822.2	XP_003357333.1 serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X3 [Sus scrofa];XP_020918432.1 serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X2 [Sus scrofa];XP_005667373.1 s	6	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PPP2R1B	PPP2R1B;PPP2R1B;PPP2R1B;PPP2R1B;NA	apoptotic process involved in morphogenesis;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;regulation of phosphoprotein phosphatase activity;protein dephosphorylation	GO:006056; GO:200124; GO:004366; GO:000647	protein phosphatase type 2A complex;extracellular exosome;membrane raft;cytoplasm	GO:000015; GO:007006; GO:004512; GO:000573	 mRNA surveillance pathway; Long-term depression; Oocyte meiosis; PI3K-Akt signaling pathway; TGF-beta signaling pathway; Tight junction; Hippo signaling pathway; Hepatitis C; Sphingolipid signaling pathway; Adrenergic signaling in cardiomyocytes; Dopaminergic synapse; Chagas disease (American trypanosomiasis)	hsa0301; hsa0473; hsa0411; hsa0415; hsa0435; hsa0453; hsa0439; hsa0516; hsa0407; hsa0426; hsa0472; hsa0514	protein binding;protein serine/threonine phosphatase activity;protein phosphatase regulator activity	GO:000551; GO:000472; GO:001988
XP_003357366.1	XP_003357366.1	XP_003357366.1 coatomer subunit delta [Sus scrofa]	11	11	11	26666000	49338000	34804000	47378000	36555000	29749000	29909000	47648000	31014000	41014000	37974000	57539000	40606000	49760000	38295000	50826000	29303000	37891000	NA	NA	NA	ARCN1	ARCN1;NA;NA;NA;NA	adult locomotory behavior;cerebellar Purkinje cell layer maturation;intracellular protein transport;retrograde vesicle-mediated transport, Golgi to ER;pigmentation;Golgi localization	GO:000834; GO:002169; GO:000688; GO:000689; GO:004347; GO:005164	transport vesicle;COPI-coated vesicle;endoplasmic reticulum membrane;cytosol;COPI vesicle coat;Golgi membrane;membrane	GO:003013; GO:003013; GO:000578; GO:000582; GO:003012; GO:000013; GO:001602	"NA"	"NA"	RNA binding	GO:000372
XP_013835072.1;XP_003357449.1;XP_003357448.1;XP_003357447.1;XP_003482633.1;NP_001116648.1	XP_013835072.1;XP_003357449.1;XP_003357448.1;XP_003357447.1	XP_013835072.1 ras-related protein Rab-7L1 [Sus scrofa];XP_003357449.1 ras-related protein Rab-7L1 [Sus scrofa];XP_003357448.1 ras-related protein Rab-7L1 [Sus scrofa];XP_003357447.1 ras-related protein Rab-7L1 [Sus scrofa]	3	3	3	42099000	43823000	39103000	47367000	25933000	32966000	38185000	49368000	33628000	0	36827000	0	0	50163000	0	0	41069000	32436000	NA	NA	NA	RAB29	RAB29;RAB29;RAB29;RAB29;NA	retrograde transport, endosome to Golgi;protein localization to membrane;regulation of retrograde transport, endosome to Golgi;positive regulation of T cell receptor signaling pathway;Rab protein signal transduction;positive regulation of receptor recycling;viral RNA genome replication;intracellular protein transport;mitochondrion organization;synapse assembly;response to bacterium;regulation of neuron death;multi-organism toxin transport;negative regulation of neuron projection development;Golgi organization;T cell activation;positive regulation of intracellular protein transport;protein localization to ciliary membrane	GO:004214; GO:007265; GO:190527; GO:005086; GO:003248; GO:000192; GO:003969; GO:000688; GO:000700; GO:000741; GO:000961; GO:190121; GO:199096; GO:001097; GO:000703; GO:004211; GO:009031; GO:190344	early endosome;cis-Golgi network;cytoskeleton;melanosome;recycling endosome;plasma membrane;cytoplasm;intracellular vesicle;symbiont-containing vacuole;cytosol;Golgi apparatus;perinuclear region of cytoplasm;extracellular exosome;vacuole	GO:000576; GO:000580; GO:000585; GO:004247; GO:005503; GO:000588; GO:000573; GO:009770; GO:002000; GO:000582; GO:000579; GO:004847; GO:007006; GO:000577	"NA"	"NA"	kinesin binding;GTPase activity;Rab GTPase binding;dynein complex binding;protein binding;GTP binding;GDP binding	GO:001989; GO:000392; GO:001713; GO:007084; GO:000551; GO:000552; GO:001900
XP_005656744.1;XP_013845033.1;XP_003357521.1	XP_005656744.1;XP_013845033.1;XP_003357521.1	XP_005656744.1 hyccin isoform X2 [Sus scrofa];XP_013845033.1 hyccin isoform X1 [Sus scrofa];XP_003357521.1 hyccin isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	31132000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	FAM126A	FAM126A;FAM126A;FAM126A;NA;NA	myelination;protein localization to plasma membrane;phosphatidylinositol phosphorylation	GO:004255; GO:007265; GO:004685	cytosol;neuron projection;plasma membrane	GO:000582; GO:004300; GO:000588	"NA"	"NA"	protein binding	GO:000551
XP_003357689.2	XP_003357689.2	XP_003357689.2 LOW QUALITY PROTEIN: poly [ADP-ribose] polymerase 1 [Sus scrofa]	6	6	6	19605000	16944000	17653000	16387000	0	17444000	16772000	17078000	0	17210000	21873000	17290000	14321000	16609000	0	0	16571000	15149000	NA	NA	NA	PARP1	PARP1;NA;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;nucleotide-excision repair, DNA damage recognition;protein ADP-ribosylation;mitochondrion organization;transforming growth factor beta receptor signaling pathway;macrophage differentiation;positive regulation of intracellular estrogen receptor signaling pathway;protein auto-ADP-ribosylation;cellular response to zinc ion;double-strand break repair;DNA damage response, detection of DNA damage;positive regulation of transcription from RNA polymerase II promoter;global genome nucleotide-excision repair;response to aldosterone;positive regulation of transcription regulatory region DNA binding;telomere maintenance;positive regulation of cardiac muscle hypertrophy;peptidyl-glutamic acid poly-ADP-ribosylation;nucleotide-excision repair, DNA incision;protein modification process;positive regulation of mitochondrial depolarization;nucleotide-excision repair, preincision complex stabilization;protein autoprocessing;mitochondrial DNA metabolic process;cellular response to insulin stimulus;apoptotic process;cellular response to DNA damage stimulus;regulation of SMAD protein complex assembly;cellular response to oxidative stress;regulation of catalytic activity;positive regulation of neuron death;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;positive regulation of myofibroblast differentiation;ATP generation from poly-ADP-D-ribose;transcription from RNA polymerase II promoter;peptidyl-serine ADP-ribosylation;DNA ADP-ribosylation;cellular response to UV;mitochondrial DNA repair;regulation of DNA methylation;positive regulation of protein localization to nucleus;cellular response to beta-amyloid;negative regulation of ATP biosynthetic process;DNA repair;response to gamma radiation;signal transduction involved in regulation of gene expression;positive regulation of SMAD protein import into nucleus;positive regulation of single strand break repair;regulation of cellular protein localization;negative regulation of telomere maintenance via telomere lengthening;positive regulation of double-strand break repair via homologous recombination	GO:000012; GO:000071; GO:000647; GO:000700; GO:000717; GO:003022; GO:003314; GO:007021; GO:007129; GO:000630; GO:004276; GO:004594; GO:007091; GO:190404; GO:200067; GO:000072; GO:001061; GO:001842; GO:003368; GO:003621; GO:005190; GO:000629; GO:001654; GO:003204; GO:003286; GO:000691; GO:000697; GO:001099; GO:003459; GO:005079; GO:190121; GO:190337; GO:190476; GO:199096; GO:000636; GO:001831; GO:003059; GO:003464; GO:004350; GO:004403; GO:190018; GO:190464; GO:200117; GO:000628; GO:001033; GO:002301; GO:006039; GO:190351; GO:190382; GO:190435; GO:190516	nuclear envelope;nucleolus;protein-DNA complex;nucleus;site of double-strand break;site of DNA damage;membrane;nucleoplasm;nuclear chromosome, telomeric region;transcription factor complex	GO:000563; GO:000573; GO:003299; GO:000563; GO:003586; GO:009073; GO:001602; GO:000565; GO:000078; GO:000566	 NF-kappa B signaling pathway; Base excision repair	hsa0406; hsa0341	estrogen receptor binding;NAD binding;NAD+ ADP-ribosyltransferase activity;transcription factor binding;zinc ion binding;histone deacetylase binding;RNA polymerase II regulatory region sequence-specific DNA binding;protein N-terminus binding;protein kinase binding;RNA binding;protein binding;R-SMAD binding;DNA binding;identical protein binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;enzyme binding;protein ADP-ribosylase activity	GO:003033; GO:005128; GO:000395; GO:000813; GO:000827; GO:004282; GO:000097; GO:004748; GO:001990; GO:000372; GO:000551; GO:007041; GO:000367; GO:004280; GO:000122; GO:001989; GO:199040
XP_003357724.1	XP_003357724.1	XP_003357724.1 cysteine and glycine-rich protein 1 [Sus scrofa]	9	9	9	389300000	545970000	1850500000	357150000	201200000	1105400000	355630000	501730000	620480000	2871000000	501650000	725760000	3233200000	436990000	224470000	617040000	414070000	496330000	NA	NA	NA	CSRP1	CSRP1;NA;NA;NA;NA	platelet aggregation	GO:007052	focal adhesion;nucleus;extracellular exosome	GO:000592; GO:000563; GO:007006	"NA"	"NA"	RNA binding;zinc ion binding	GO:000372; GO:000827
XP_003357755.2;XP_020920311.1;XP_020920310.1	XP_003357755.2;XP_020920311.1;XP_020920310.1	XP_003357755.2 UPF0553 protein C9orf64 homolog isoform X2 [Sus scrofa];XP_020920311.1 UPF0553 protein C9orf64 homolog isoform X1 [Sus scrofa];XP_020920310.1 UPF0553 protein C9orf64 homolog isoform X1 [Sus scrofa]	7	7	7	0	0	0	0	17411000	0	0	0	15634000	0	0	0	19439000	0	14414000	0	15338000	0	NA	NA	NA	C10H9orf64	C10H9orf64;C10H9orf64;C10H9orf64;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003357765.1;XP_005668101.1;XP_005668100.1	XP_003357765.1;XP_005668101.1;XP_005668100.1	XP_003357765.1 galactose-1-phosphate uridylyltransferase isoform X1 [Sus scrofa];XP_005668101.1 galactose-1-phosphate uridylyltransferase isoform X3 [Sus scrofa];XP_005668100.1 galactose-1-phosphate uridylyltransferase isoform X2 [Sus scrofa]	3	3	3	0	0	9394200	7834700	0	0	13758000	0	15313000	14623000	0	0	8220200	8750900	12947000	0	0	0	NA	NA	NA	GALT	GALT;GALT;GALT;NA;NA	galactose metabolic process;UDP-glucose catabolic process;UDP-glucose metabolic process;galactose catabolic process;galactose catabolic process via UDP-galactose	GO:000601; GO:000625; GO:000601; GO:001938; GO:003349	cytosol;cytoplasm;Golgi apparatus	GO:000582; GO:000573; GO:000579	 Prolactin signaling pathway; Metabolic pathways; Amino sugar and nucleotide sugar metabolism; Galactose metabolism	hsa0491; hsa0110; hsa0052; hsa0005	UDP-glucose:hexose-1-phosphate uridylyltransferase activity;zinc ion binding;protein binding	GO:000810; GO:000827; GO:000551
XP_003357777.1	XP_003357777.1	XP_003357777.1 cytoplasmic aconitate hydratase [Sus scrofa]	42	42	42	965100000	587080000	1211300000	855120000	1437200000	816890000	1016800000	778350000	1019000000	817580000	897750000	720670000	715350000	878160000	1257900000	1356600000	1122300000	848610000	NA	NA	NA	ACO1	ACO1;NA;NA;NA;NA	tricarboxylic acid cycle;cellular iron ion homeostasis;regulation of translation;citrate metabolic process;post-embryonic development;response to iron(II) ion;intestinal absorption	GO:000609; GO:000687; GO:000641; GO:000610; GO:000979; GO:001004; GO:005089	mitochondrion;endoplasmic reticulum;Golgi apparatus;cytoplasm;cytosol;extracellular exosome	GO:000573; GO:000578; GO:000579; GO:000573; GO:000582; GO:007006	 Metabolic pathways; Citrate cycle (TCA cycle); Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; 2-Oxocarboxylic acid metabolism; Glyoxylate and dicarboxylate metabolism	hsa0110; hsa0002; hsa0113; hsa0120; hsa0123; hsa0121; hsa0063	metal ion binding;4 iron, 4 sulfur cluster binding;iron-responsive element binding;RNA binding;aconitate hydratase activity;protein binding	GO:004687; GO:005153; GO:003035; GO:000372; GO:000399; GO:000551
XP_003357800.1;XP_020920369.1;XP_020919947.1	XP_003357800.1;XP_020920369.1	XP_003357800.1 ras-related protein Rab-18 isoform X1 [Sus scrofa];XP_020920369.1 ras-related protein Rab-18 isoform X2 [Sus scrofa]	9	9	9	133060000	96016000	121070000	79224000	107690000	82951000	132180000	99502000	109190000	96123000	89816000	87639000	70065000	88529000	83300000	90724000	94989000	82694000	NA	NA	NA	RAB18	RAB18;RAB18;NA;NA;NA	small GTPase mediated signal transduction;Rab protein signal transduction;brain development;lipid particle organization;intracellular protein transport;neutrophil degranulation;eye development;endoplasmic reticulum tubular network organization	GO:000726; GO:003248; GO:000742; GO:003438; GO:000688; GO:004331; GO:000165; GO:007178	synapse;endoplasmic reticulum membrane;secretory granule membrane;Golgi apparatus;cytosol;plasma membrane;endoplasmic reticulum tubular network	GO:004520; GO:000578; GO:003066; GO:000579; GO:000582; GO:000588; GO:007178	"NA"	"NA"	GTPase activity;GTP binding;protein binding;GDP binding	GO:000392; GO:000552; GO:000551; GO:001900
XP_003357976.1	XP_003357976.1	XP_003357976.1 actin, cytoplasmic 2 [Sus scrofa]	26	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25420000	NA	NA	NA	ACTG1	ACTG1;NA;NA;NA;NA	response to mechanical stimulus;cell junction assembly;cellular response to interferon-gamma;postsynaptic actin cytoskeleton organization;ephrin receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;retina homeostasis;sarcomere organization;synaptic vesicle endocytosis;response to calcium ion;membrane organization;platelet aggregation	GO:000961; GO:003432; GO:007134; GO:009897; GO:004801; GO:003809; GO:000189; GO:004521; GO:004848; GO:005159; GO:006102; GO:007052	extracellular space;cytosol;plasma membrane;calyx of Held;phagocytic vesicle;focal adhesion;blood microparticle;postsynaptic actin cytoskeleton;membrane;myofibril;filamentous actin;cytoskeleton;nucleus;extracellular exosome;Schaffer collateral - CA1 synapse;dense body	GO:000561; GO:000582; GO:000588; GO:004430; GO:004533; GO:000592; GO:007256; GO:009887; GO:001602; GO:003001; GO:003194; GO:000585; GO:000563; GO:007006; GO:009868; GO:009743	 Phagosome; Platelet activation; Oxytocin signaling pathway; Focal adhesion; Dilated cardiomyopathy; Shigellosis; Hippo signaling pathway; Regulation of actin cytoskeleton; Leukocyte transendothelial migration; Bacterial invasion of epithelial cells; Tight junction; Thyroid hormone signaling pathway; Influenza A; Rap1 signaling pathway; Adherens junction; Vibrio cholerae infection; Proteoglycans in cancer	hsa0414; hsa0461; hsa0492; hsa0451; hsa0541; hsa0513; hsa0439; hsa0481; hsa0467; hsa0510; hsa0453; hsa0491; hsa0516; hsa0401; hsa0452; hsa0511; hsa0520	protein binding;ubiquitin protein ligase binding;identical protein binding;ATP binding;structural constituent of cytoskeleton;structural constituent of postsynaptic actin cytoskeleton	GO:000551; GO:003162; GO:004280; GO:000552; GO:000520; GO:009897
XP_003358009.3;XP_005656981.2;XP_003358008.3;XP_003358012.3;XP_020922260.1	XP_003358009.3;XP_005656981.2;XP_003358008.3;XP_003358012.3;XP_020922260.1	XP_003358009.3 exocyst complex component 7 isoform X4 [Sus scrofa];XP_005656981.2 exocyst complex component 7 isoform X3 [Sus scrofa];XP_003358008.3 exocyst complex component 7 isoform X2 [Sus scrofa];XP_003358012.3 exocyst complex component 7 isoform X1 [	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7851200	NA	NA	NA	EXOC7	EXOC7;EXOC7;EXOC7;EXOC7;EXOC7	protein transport;regulation of macroautophagy;exocytosis;regulation of entry of bacterium into host cell	GO:001503; GO:001624; GO:000688; GO:200053	growth cone membrane;Flemming body;microtubule organizing center;plasma membrane;exocyst;membrane;cytosol;centriolar satellite	GO:003258; GO:009054; GO:000581; GO:000588; GO:000014; GO:001602; GO:000582; GO:003445	 Insulin signaling pathway	hsa0491	protein binding	GO:000551
XP_020922347.1;XP_005668697.1;XP_003358038.1	XP_020922347.1;XP_005668697.1;XP_003358038.1	XP_020922347.1 60S ribosomal protein L38 [Sus scrofa];XP_005668697.1 60S ribosomal protein L38 [Sus scrofa];XP_003358038.1 60S ribosomal protein L38 [Sus scrofa]	3	3	3	0	27594000	38113000	38291000	26765000	31140000	0	0	27182000	41649000	36184000	30431000	0	0	0	0	0	56151000	NA	NA	NA	RPL38	RPL38;RPL38;RPL38;NA;NA	translation;sensory perception of sound;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;90S preribosome assembly;cytoplasmic translation;regulation of translation;SRP-dependent cotranslational protein targeting to membrane;axial mesoderm development;skeletal system development;middle ear morphogenesis	GO:000641; GO:000760; GO:000018; GO:003446; GO:000218; GO:000641; GO:000661; GO:004831; GO:000150; GO:004247	cytosolic large ribosomal subunit;polysomal ribosome;cytosol;focal adhesion;eukaryotic 80S initiation complex;postsynaptic density	GO:002262; GO:004278; GO:000582; GO:000592; GO:003329; GO:001406	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding	GO:000373; GO:000372
XP_003358046.1	XP_003358046.1	XP_003358046.1 guanine nucleotide-binding protein subunit alpha-13 [Sus scrofa]	10	10	10	56928000	72584000	61038000	58751000	0	33639000	52174000	66500000	53639000	57969000	57105000	72238000	43875000	61393000	49920000	68861000	62309000	53773000	NA	NA	NA	GNA13	GNA13;NA;NA;NA;NA	positive regulation of cytosolic calcium ion concentration;regulation of cell shape;platelet activation;signal transduction;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;regulation of small GTPase mediated signal transduction;in utero embryonic development;positive regulation of apoptotic process;branching involved in blood vessel morphogenesis;Rho protein signal transduction;regulation of cell migration;activation of phospholipase D activity;cell differentiation	GO:000720; GO:000836; GO:003016; GO:000716; GO:000718; GO:005105; GO:000170; GO:004306; GO:000156; GO:000726; GO:003033; GO:003158; GO:003015	focal adhesion;membrane;extracellular exosome;melanosome;heterotrimeric G-protein complex;plasma membrane;nucleus;brush border membrane;cytosol	GO:000592; GO:001602; GO:007006; GO:004247; GO:000583; GO:000588; GO:000563; GO:003152; GO:000582	 Vascular smooth muscle contraction; Long-term depression; Sphingolipid signaling pathway; cGMP-PKG signaling pathway; Platelet activation; Regulation of actin cytoskeleton; Pathways in cancer	hsa0427; hsa0473; hsa0407; hsa0402; hsa0461; hsa0481; hsa0520	GTP binding;protein binding;G-protein beta/gamma-subunit complex binding;G-protein coupled receptor binding;GTPase activity;D5 dopamine receptor binding;guanyl-nucleotide exchange factor activity;metal ion binding	GO:000552; GO:000551; GO:003168; GO:000166; GO:000392; GO:003175; GO:000508; GO:004687
XP_003358222.2	XP_003358222.2	XP_003358222.2 polymerase delta-interacting protein 2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	7344600	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	POLDIP2	POLDIP2;NA;NA;NA;NA	positive regulation of mitotic cell cycle;mitochondrion morphogenesis;negative regulation of macroautophagy	GO:004593; GO:007058; GO:001624	nucleus;mitochondrion;mitochondrial nucleoid	GO:000563; GO:000573; GO:004264	"NA"	"NA"	protein binding;DNA binding	GO:000551; GO:000367
XP_003358324.3	XP_003358324.3	XP_003358324.3 LOW QUALITY PROTEIN: phosphoribosylformylglycinamidine synthase [Sus scrofa]	3	3	3	0	0	17986000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PFAS	PFAS;NA;NA;NA;NA	response to drug;purine ribonucleoside monophosphate biosynthetic process;anterior head development;'de novo' IMP biosynthetic process;glutamine metabolic process	GO:004249; GO:000916; GO:009706; GO:000618; GO:000654	extracellular exosome;cytosol;cytoplasm	GO:007006; GO:000582; GO:000573	 Metabolic pathways; Purine metabolism; Biosynthesis of antibiotics	hsa0110; hsa0023; hsa0113	metal ion binding;phosphoribosylformylglycinamidine synthase activity;ATP binding	GO:004687; GO:000464; GO:000552
XP_003358453.3;XP_020924300.1	XP_003358453.3;XP_020924300.1	XP_003358453.3 phosphatidylinositide phosphatase SAC1 isoform X1 [Sus scrofa];XP_020924300.1 phosphatidylinositide phosphatase SAC1 isoform X2 [Sus scrofa]	12	12	12	57580000	52994000	63273000	49471000	51004000	45397000	55500000	50996000	51357000	46739000	58517000	43458000	47287000	57485000	53392000	57519000	68034000	48299000	NA	NA	NA	SACM1L	SACM1L;SACM1L;NA;NA;NA	phosphatidylinositol dephosphorylation;phosphatidylinositol biosynthetic process	GO:004685; GO:000666	Golgi membrane;endoplasmic reticulum membrane;AMPA glutamate receptor complex;Golgi apparatus;integral component of endoplasmic reticulum membrane	GO:000013; GO:000578; GO:003228; GO:000579; GO:003017	"NA"	"NA"	phosphatidylinositol-3-phosphatase activity;phosphatidylinositol-4-phosphate phosphatase activity;phosphatidylinositol phosphate 4-phosphatase activity;protein binding;phosphatase activity	GO:000443; GO:004381; GO:003459; GO:000551; GO:001679
XP_020924534.1;XP_005669680.1;XP_005669679.1;XP_003358507.1	XP_020924534.1;XP_005669680.1;XP_005669679.1;XP_003358507.1	XP_020924534.1 protein ABHD14B [Sus scrofa];XP_005669680.1 protein ABHD14B [Sus scrofa];XP_005669679.1 protein ABHD14B [Sus scrofa];XP_003358507.1 protein ABHD14B [Sus scrofa]	7	7	7	297800000	324590000	262800000	231720000	398430000	326450000	477670000	460760000	430420000	372350000	370520000	547140000	280940000	276930000	438180000	464210000	259440000	310810000	NA	NA	NA	ABHD14B	ABHD14B;ABHD14B;ABHD14B;ABHD14B;NA	3'-phosphoadenosine 5'-phosphosulfate metabolic process;positive regulation of transcription from RNA polymerase II promoter	GO:005042; GO:004594	cytoplasm;extracellular exosome;nucleus;cytosol;nucleolus	GO:000573; GO:007006; GO:000563; GO:000582; GO:000573	"NA"	"NA"	protein binding;hydrolase activity	GO:000551; GO:001678
XP_003358655.1;XP_005654087.1	XP_003358655.1;XP_005654087.1	XP_003358655.1 profilin-2 isoform X2 [Sus scrofa];XP_005654087.1 profilin-2 isoform X1 [Sus scrofa]	3	3	3	35664000	71236000	66462000	50381000	47127000	61344000	52217000	54442000	53800000	62473000	43930000	64936000	57097000	49277000	60998000	61905000	51004000	60262000	NA	NA	NA	PFN2	PFN2;PFN2;NA;NA;NA	actin cytoskeleton organization;positive regulation of stress fiber assembly;positive regulation of actin filament bundle assembly;positive regulation of ATPase activity;positive regulation of peptidyl-serine phosphorylation;protein stabilization;regulation of synaptic vesicle exocytosis;regulation of actin filament polymerization;negative regulation of ruffle assembly;negative regulation of epithelial cell migration;modification of postsynaptic actin cytoskeleton	GO:003003; GO:005149; GO:003223; GO:003278; GO:003313; GO:005082; GO:200030; GO:003083; GO:190002; GO:001063; GO:009888	cytoplasm;extracellular exosome;Schaffer collateral - CA1 synapse;cytoskeleton;postsynapse;glutamatergic synapse	GO:000573; GO:007006; GO:009868; GO:000585; GO:009879; GO:009897	 Rap1 signaling pathway; Shigellosis; Regulation of actin cytoskeleton	hsa0401; hsa0513; hsa0481	ATPase activity;actin binding;actin monomer binding;phosphatidylinositol-4,5-bisphosphate binding;protein binding	GO:001688; GO:000377; GO:000378; GO:000554; GO:000551
XP_013837621.1;XP_003358691.1	XP_013837621.1;XP_003358691.1	XP_013837621.1 elongation factor G, mitochondrial isoform X2 [Sus scrofa];XP_003358691.1 elongation factor G, mitochondrial isoform X1 [Sus scrofa]	2	2	2	0	0	3664900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GFM1	GFM1;GFM1;NA;NA;NA	mitochondrial translational elongation	GO:007012	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	"NA"	"NA"	translation elongation factor activity;RNA binding;protein binding;GTP binding;GTPase activity	GO:000374; GO:000372; GO:000551; GO:000552; GO:000392
XP_003358692.1	XP_003358692.1	XP_003358692.1 latexin [Sus scrofa]	2	2	2	0	38670000	0	20925000	0	36626000	0	28586000	0	24015000	55638000	40114000	0	27874000	35776000	54568000	0	27097000	NA	NA	NA	LXN	LXN;NA;NA;NA;NA	detection of temperature stimulus involved in sensory perception of pain;negative regulation of endopeptidase activity;inflammatory response	GO:005096; GO:001095; GO:000695	cytoplasm	GO:000573	"NA"	"NA"	protein binding;metalloendopeptidase inhibitor activity;heparin binding	GO:000551; GO:000819; GO:000820
XP_020925544.1;XP_003358743.1	XP_020925544.1;XP_003358743.1	XP_020925544.1 DCN1-like protein 1 isoform X2 [Sus scrofa];XP_003358743.1 DCN1-like protein 1 isoform X1 [Sus scrofa]	2	2	2	3474100	0	3713200	0	0	0	0	4495200	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DCUN1D1	DCUN1D1;DCUN1D1;NA;NA;NA	positive regulation of ubiquitin-protein transferase activity;post-translational protein modification;positive regulation of protein neddylation;protein neddylation	GO:005144; GO:004368; GO:200043; GO:004511	ubiquitin ligase complex;cytosol;nucleus	GO:000015; GO:000582; GO:000563	"NA"	"NA"	protein binding;cullin family protein binding;ubiquitin-like protein binding;ubiquitin conjugating enzyme binding	GO:000551; GO:009760; GO:003218; GO:003162
XP_003358841.2	XP_003358841.2	XP_003358841.2 coiled-coil domain-containing protein 58 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	5520900	0	0	0	0	NA	NA	NA	CCDC58	CCDC58;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005670287.1;XP_003358857.1;XP_005670286.1;XP_020926044.1;XP_020926043.1;XP_020926042.1	XP_005670287.1;XP_003358857.1;XP_005670286.1;XP_020926044.1;XP_020926043.1;XP_020926042.1	XP_005670287.1 OX-2 membrane glycoprotein isoform X4 [Sus scrofa];XP_003358857.1 OX-2 membrane glycoprotein isoform X2 [Sus scrofa];XP_005670286.1 OX-2 membrane glycoprotein isoform X1 [Sus scrofa];XP_020926044.1 OX-2 membrane glycoprotein isoform X6 [Sus	3	3	3	0	16579000	0	0	0	0	0	0	0	0	0	0	0	0	10536000	0	0	0	NA	NA	NA	CD200	CD200;CD200;CD200;CD200;CD200	heterotypic cell-cell adhesion;negative regulation of macrophage activation;positive regulation of transforming growth factor beta production;cell-cell adhesion;negative regulation of T cell migration;negative regulation of leukocyte activation;regulation of immune response;negative regulation of interleukin-6 secretion;negative regulation of macrophage migration;negative regulation of cell proliferation;negative regulation of neuron death;negative regulation of matrix metallopeptidase secretion;negative regulation of NF-kappaB transcription factor activity;positive regulation of CREB transcription factor activity	GO:003411; GO:004303; GO:007163; GO:009860; GO:200040; GO:000269; GO:005077; GO:190016; GO:190552; GO:000828; GO:190121; GO:190446; GO:003208; GO:003279	plasma membrane;cell surface;cell body;axon;integral component of plasma membrane;neuron projection;neuronal cell body;membrane	GO:000588; GO:000998; GO:004429; GO:003042; GO:000588; GO:004300; GO:004302; GO:001602	"NA"	"NA"	protein binding;protein binding involved in heterotypic cell-cell adhesion	GO:000551; GO:008608
XP_013837936.1;XP_020926157.1;XP_020926156.1;XP_003358875.3	XP_013837936.1;XP_020926157.1;XP_020926156.1;XP_003358875.3	XP_013837936.1 CD166 antigen isoform X2 [Sus scrofa];XP_020926157.1 CD166 antigen isoform X1 [Sus scrofa];XP_020926156.1 CD166 antigen isoform X1 [Sus scrofa];XP_003358875.3 CD166 antigen isoform X1 [Sus scrofa]	2	2	2	0	22531000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ALCAM	ALCAM;ALCAM;ALCAM;ALCAM;NA	axon extension involved in axon guidance;adaptive immune response;motor neuron axon guidance;neuron projection extension;cell adhesion;signal transduction;retinal ganglion cell axon guidance	GO:004884; GO:000225; GO:000804; GO:199013; GO:000715; GO:000716; GO:003129	axon;extracellular exosome;neuronal cell body;external side of plasma membrane;dendrite;intrinsic component of plasma membrane;focal adhesion;immunological synapse;integral component of plasma membrane;T cell receptor complex	GO:003042; GO:007006; GO:004302; GO:000989; GO:003042; GO:003122; GO:000592; GO:000177; GO:000588; GO:004210	 Cell adhesion molecules (CAMs)	hsa0451	receptor binding;protein binding;identical protein binding	GO:000510; GO:000551; GO:004280
XP_003358947.2	XP_003358947.2	XP_003358947.2 LOW QUALITY PROTEIN: T-complex protein 1 subunit theta [Sus scrofa]	20	20	20	284730000	255740000	248490000	203790000	254730000	207970000	253700000	208230000	242500000	203930000	245690000	216220000	218500000	230560000	286520000	201170000	268350000	202590000	NA	NA	NA	CCT8	CCT8;NA;NA;NA;NA	binding of sperm to zona pellucida;protein folding;positive regulation of telomerase RNA localization to Cajal body;protein stabilization;positive regulation of establishment of protein localization to telomere;pore complex assembly;positive regulation of telomere maintenance via telomerase;toxin transport;neutrophil degranulation	GO:000733; GO:000645; GO:190487; GO:005082; GO:190485; GO:004693; GO:003221; GO:190199; GO:004331	centrosome;microtubule;zona pellucida receptor complex;ficolin-1-rich granule lumen;cytoplasm;chaperonin-containing T-complex;cilium;extracellular exosome;cell body;azurophil granule lumen;nucleoplasm;cytosol;intermediate filament cytoskeleton;secretory granule lumen;extracellular region	GO:000581; GO:000587; GO:000219; GO:190481; GO:000573; GO:000583; GO:000592; GO:007006; GO:004429; GO:003557; GO:000565; GO:000582; GO:004511; GO:003477; GO:000557	"NA"	"NA"	protein binding;ATPase activity, coupled;unfolded protein binding;cadherin binding;ATP binding	GO:000551; GO:004262; GO:005108; GO:004529; GO:000552
XP_003359029.4	XP_003359029.4	XP_003359029.4 NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X1 [Sus scrofa]	8	8	8	26960000	44787000	30422000	36007000	41179000	34655000	37632000	39747000	32739000	29755000	40992000	50852000	0	32063000	42343000	41709000	30759000	34591000	NA	NA	NA	NDUFV3	NDUFV3;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;mitochondrial ATP synthesis coupled electron transport	GO:000612; GO:003298; GO:004277	mitochondrial respiratory chain complex I;mitochondrial inner membrane;mitochondrion;nucleoplasm	GO:000574; GO:000574; GO:000573; GO:000565	 Metabolic pathways; Huntington's disease; Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0501; hsa0019; hsa0493	RNA binding;NADH dehydrogenase (ubiquinone) activity	GO:000372; GO:000813
XP_003359054.1	XP_003359054.1	XP_003359054.1 ES1 protein homolog, mitochondrial [Sus scrofa]	9	9	9	175110000	157490000	184510000	140960000	161080000	146550000	188990000	162970000	171090000	151210000	198990000	144080000	205110000	142660000	186600000	157410000	143760000	135300000	NA	NA	NA	GATD3A	GATD3A;NA;NA;NA;NA	"NA"	"NA"	mitochondrion	GO:000573	"NA"	"NA"	"NA"	"NA"
XP_020928302.1;XP_003359097.3;XP_020928297.1;XP_020928290.1;XP_020928300.1;XP_020928299.1;XP_020928298.1;XP_020928296.1;XP_020928294.1;XP_020928293.1;XP_020928292.1;XP_020928295.1	XP_020928302.1;XP_003359097.3;XP_020928297.1;XP_020928290.1;XP_020928300.1;XP_020928299.1;XP_020928298.1;XP_020928296.1;XP_020928294.1;XP_020928293.1;XP_020928292.1	XP_020928302.1 mitochondrial peptide methionine sulfoxide reductase isoform X11 [Sus scrofa];XP_003359097.3 mitochondrial peptide methionine sulfoxide reductase isoform X8 [Sus scrofa];XP_020928297.1 mitochondrial peptide methionine sulfoxide reductase iso	5	5	5	0	21603000	22203000	19149000	16175000	20684000	0	17744000	0	17646000	0	19002000	0	17176000	0	18220000	16578000	0	NA	NA	NA	MSRA	MSRA;MSRA;MSRA;MSRA;MSRA	protein repair;oxidation-reduction process;cellular protein modification process;cellular response to oxidative stress;methionine metabolic process;response to oxidative stress	GO:003009; GO:005511; GO:000646; GO:003459; GO:000655; GO:000697	mitochondrion;cytosol;membrane;actin cytoskeleton;cytoplasm;nucleoplasm;extracellular exosome	GO:000573; GO:000582; GO:001602; GO:001562; GO:000573; GO:000565; GO:007006	"NA"	"NA"	L-methionine-(S)-S-oxide reductase activity;peptide-methionine (S)-S-oxide reductase activity	GO:003645; GO:000811
XP_003359136.2	XP_003359136.2	XP_003359136.2 LOW QUALITY PROTEIN: transmembrane emp24 domain-containing protein 2 [Sus scrofa]	2	2	2	0	0	0	0	0	10098000	0	0	5065500	7813300	0	0	5509300	0	0	0	0	0	NA	NA	NA	TMED2	TMED2;NA;NA;NA;NA	neural tube closure;positive regulation of gene expression;somite rostral/caudal axis specification;post-anal tail morphogenesis;COPI coating of Golgi vesicle;negative regulation of GTPase activity;cargo loading into vesicle;protein localization to plasma membrane;retrograde vesicle-mediated transport, Golgi to ER;maternal placenta development;ER to Golgi vesicle-mediated transport;multicellular organism growth;heart looping;labyrinthine layer blood vessel development;Golgi organization	GO:000184; GO:001062; GO:003252; GO:003634; GO:004820; GO:003426; GO:003545; GO:007265; GO:000689; GO:000189; GO:000688; GO:003526; GO:000194; GO:006071; GO:000703	endoplasmic reticulum-Golgi intermediate compartment;COPI-coated vesicle membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;zymogen granule membrane;ER to Golgi transport vesicle;Golgi apparatus;ER to Golgi transport vesicle membrane;endoplasmic reticulum;intracellular membrane-bounded organelle;integral component of membrane;Golgi membrane;Golgi cisterna membrane	GO:000579; GO:003066; GO:003311; GO:004258; GO:003013; GO:000579; GO:001250; GO:000578; GO:004323; GO:001602; GO:000013; GO:003258	"NA"	"NA"	protein binding	GO:000551
XP_003359288.1;XP_003359289.1;XP_020928247.1	XP_003359288.1;XP_003359289.1;XP_020928247.1	XP_003359288.1 adenosine kinase isoform X1 [Sus scrofa];XP_003359289.1 adenosine kinase isoform X3 [Sus scrofa];XP_020928247.1 adenosine kinase isoform X2 [Sus scrofa]	3	3	3	0	22770000	0	21133000	14321000	0	19756000	21170000	0	0	0	0	19769000	0	0	0	0	0	NA	NA	NA	ADK	ADK;ADK;ADK;NA;NA	ribonucleoside monophosphate biosynthetic process;AMP salvage;phosphorylation;purine ribonucleoside salvage;dATP biosynthetic process;purine-containing compound salvage	GO:000915; GO:004420; GO:001631; GO:000616; GO:000617; GO:004310	nucleoplasm;nucleus;cytosol	GO:000565; GO:000563; GO:000582	 Purine metabolism; Metabolic pathways	hsa0023; hsa0110	RNA binding;metal ion binding;ATP binding;adenosine kinase activity	GO:000372; GO:004687; GO:000552; GO:000400
XP_020930416.1;XP_020930415.1;XP_020930414.1;XP_020930413.1;XP_020930412.1;XP_005654231.1;XP_005654230.1;XP_003359496.1;XP_003359495.1	XP_020930416.1;XP_020930415.1;XP_020930414.1;XP_020930413.1;XP_020930412.1;XP_005654231.1;XP_005654230.1;XP_003359496.1;XP_003359495.1	XP_020930416.1 ras-related protein Ral-B [Sus scrofa];XP_020930415.1 ras-related protein Ral-B [Sus scrofa];XP_020930414.1 ras-related protein Ral-B [Sus scrofa];XP_020930413.1 ras-related protein Ral-B [Sus scrofa];XP_020930412.1 ras-related protein Ral-B	6	3	3	0	0	19699000	0	0	0	17950000	19269000	0	0	0	0	0	26468000	21663000	19702000	0	21236000	NA	NA	NA	RALB	RALB;RALB;RALB;RALB;RALB	positive regulation of protein phosphorylation;Ras protein signal transduction;positive regulation of protein binding;positive regulation of protein serine/threonine kinase activity;cell division;regulation of exocyst localization;signal transduction;cell cycle;cellular response to starvation;cellular response to exogenous dsRNA;positive regulation of autophagosome assembly;regulation of exocyst assembly;apoptotic process	GO:000193; GO:000726; GO:003209; GO:007190; GO:005130; GO:006017; GO:000716; GO:000704; GO:000926; GO:007136; GO:200078; GO:000192; GO:000691	extracellular exosome;midbody;plasma membrane	GO:007006; GO:003049; GO:000588	 Ras signaling pathway; Pathways in cancer; Rap1 signaling pathway; Pancreatic cancer	hsa0401; hsa0520; hsa0401; hsa0521	GDP binding;ATPase binding;GTP binding;ubiquitin protein ligase binding;GTPase activity;protein binding	GO:001900; GO:005111; GO:000552; GO:003162; GO:000392; GO:000551
XP_013839642.1;XP_003359584.2	XP_013839642.1;XP_003359584.2	XP_013839642.1 26S proteasome non-ATPase regulatory subunit 14 [Sus scrofa];XP_003359584.2 26S proteasome non-ATPase regulatory subunit 14 [Sus scrofa]	2	2	2	24458000	28342000	34001000	22409000	26473000	27073000	34987000	30516000	25115000	28406000	31955000	20563000	26010000	25354000	30402000	27868000	27126000	30914000	NA	NA	NA	PSMD14	PSMD14;PSMD14;NA;NA;NA	ubiquitin-dependent protein catabolic process;positive regulation of endopeptidase activity;post-translational protein modification;double-strand break repair via homologous recombination;response to ethanol;protein deubiquitination;neutrophil degranulation;protein K63-linked deubiquitination;regulation of proteasomal protein catabolic process;double-strand break repair via nonhomologous end joining;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:000651; GO:001095; GO:004368; GO:000072; GO:004547; GO:001657; GO:004331; GO:007053; GO:006113; GO:000630; GO:004316	cytosolic proteasome complex;extracellular region;cytosol;ficolin-1-rich granule lumen;nucleoplasm;proteasome complex;nucleus;secretory granule lumen;proteasome regulatory particle, lid subcomplex;proteasome accessory complex	GO:003159; GO:000557; GO:000582; GO:190481; GO:000565; GO:000050; GO:000563; GO:003477; GO:000854; GO:002262	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	metal ion binding;thiol-dependent ubiquitin-specific protease activity;Lys63-specific deubiquitinase activity;proteasome binding;thiol-dependent ubiquitinyl hydrolase activity;endopeptidase activator activity;protein binding;metallopeptidase activity	GO:004687; GO:000484; GO:006157; GO:007062; GO:003645; GO:006113; GO:000551; GO:000823
XP_003359629.1;XP_003359630.1;XP_020931473.1;XP_020931472.1;XP_020931471.1	XP_003359629.1;XP_003359630.1;XP_020931473.1;XP_020931472.1;XP_020931471.1	XP_003359629.1 nck-associated protein 1 isoform X3 [Sus scrofa];XP_003359630.1 nck-associated protein 1 isoform X1 [Sus scrofa];XP_020931473.1 nck-associated protein 1 isoform X5 [Sus scrofa];XP_020931472.1 nck-associated protein 1 isoform X4 [Sus scrofa];	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	6195500	0	0	0	0	NA	NA	NA	NCKAP1	NCKAP1;NCKAP1;NCKAP1;NCKAP1;NCKAP1	vascular endothelial growth factor receptor signaling pathway;viral process;cell projection assembly;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of actin filament polymerization;positive regulation of Arp2/3 complex-mediated actin nucleation;central nervous system development;cell migration;cortical actin cytoskeleton organization;neuron projection morphogenesis;cell morphogenesis;apoptotic process;positive regulation of lamellipodium assembly;Rac protein signal transduction	GO:004801; GO:001603; GO:003003; GO:003809; GO:003083; GO:200060; GO:000741; GO:001647; GO:003086; GO:004881; GO:000090; GO:000691; GO:001059; GO:001660	focal adhesion;ruffle;integral component of membrane;SCAR complex;lamellipodium membrane;lamellipodium;filamentous actin;extracellular exosome;cytosol	GO:000592; GO:000172; GO:001602; GO:003120; GO:003125; GO:003002; GO:003194; GO:007006; GO:000582	 Regulation of actin cytoskeleton	hsa0481	Rac GTPase binding;protein binding	GO:004836; GO:000551
XP_003359859.2;XP_020932373.1;XP_020939388.1;XP_005652908.1;XP_013846056.1;XP_003123364.2;XP_013846052.1	XP_003359859.2;XP_020932373.1	XP_003359859.2 transportin-1 isoform X2 [Sus scrofa];XP_020932373.1 transportin-1 isoform X1 [Sus scrofa]	10	10	10	34566000	35233000	44096000	42877000	36186000	36233000	41422000	29846000	32680000	35076000	38130000	39992000	48807000	39754000	28246000	41947000	36056000	43197000	NA	NA	NA	TNPO1	TNPO1;TNPO1;NA;NA;NA	protein import into nucleus;viral process;NLS-bearing protein import into nucleus;ribosomal protein import into nucleus;regulation of mRNA stability;intraciliary transport involved in cilium assembly	GO:000660; GO:001603; GO:000660; GO:000661; GO:004348; GO:003573	cytoplasm;extracellular exosome;nucleus;nuclear periphery;cilium;cytosol;nuclear membrane	GO:000573; GO:007006; GO:000563; GO:003439; GO:000592; GO:000582; GO:003196	"NA"	"NA"	protein transporter activity;protein binding;Ran GTPase binding;RNA binding;nuclear localization sequence binding	GO:000856; GO:000551; GO:000853; GO:000372; GO:000813
XP_013838238.2;XP_020932754.1;XP_003359898.2;XP_020932753.1	XP_013838238.2;XP_020932754.1;XP_003359898.2;XP_020932753.1	XP_013838238.2 tRNA (cytosine(34)-C(5))-methyltransferase isoform X4 [Sus scrofa];XP_020932754.1 tRNA (cytosine(34)-C(5))-methyltransferase isoform X3 [Sus scrofa];XP_003359898.2 tRNA (cytosine(34)-C(5))-methyltransferase isoform X2 [Sus scrofa];XP_0209327	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2575200	0	0	NA	NA	NA	NSUN2	NSUN2;NSUN2;NSUN2;NSUN2;NA	tRNA methylation;cell division;spermatid development;hair follicle maturation;tRNA modification;meiotic cell cycle checkpoint	GO:003048; GO:005130; GO:000728; GO:004882; GO:000640; GO:003331	chromatoid body;nucleoplasm;spindle;cytoplasm;nucleus	GO:003339; GO:000565; GO:000581; GO:000573; GO:000563	"NA"	"NA"	tRNA binding;tRNA (cytosine-5-)-methyltransferase activity;methyltransferase activity;RNA binding	GO:000004; GO:001642; GO:000816; GO:000372
XP_020933942.1;XP_020933941.1;XP_020933940.1;XP_020933939.1;XP_020933938.1;XP_020933937.1;XP_020933935.1;XP_020933934.1;XP_020933933.1;XP_020933932.1;XP_020933931.1;XP_020933930.1;XP_020933929.1;XP_020933928.1;XP_020933927.1;XP_020933926.1;XP_005672955.1;XP_003360013.1;XP_013840781.1;XP_005672954.1;XP_003360012.1	XP_020933942.1;XP_020933941.1;XP_020933940.1;XP_020933939.1;XP_020933938.1;XP_020933937.1;XP_020933935.1;XP_020933934.1;XP_020933933.1;XP_020933932.1;XP_020933931.1;XP_020933930.1;XP_020933929.1;XP_020933928.1;XP_020933927.1;XP_020933926.1;XP_005672955.1;XP_003360013.1;XP_013840781.1;XP_005672954.1;XP_003360012.1	XP_020933942.1 RNA-binding protein 39 isoform X7 [Sus scrofa];XP_020933941.1 RNA-binding protein 39 isoform X7 [Sus scrofa];XP_020933940.1 RNA-binding protein 39 isoform X7 [Sus scrofa];XP_020933939.1 RNA-binding protein 39 isoform X7 [Sus scrofa];XP_02093	3	3	3	0	0	0	0	0	0	0	0	0	0	6735800	7510600	0	0	0	0	0	0	NA	NA	NA	RBM39	RBM39;RBM39;RBM39;RBM39;RBM39	RNA splicing;RNA processing	GO:000838; GO:000639	nucleoplasm;microtubule cytoskeleton;microtubule organizing center;macromolecular complex;nuclear speck	GO:000565; GO:001563; GO:000581; GO:003299; GO:001660	"NA"	"NA"	protein binding;RNA binding	GO:000551; GO:000372
XP_003360037.3;XP_013848561.1;XP_013848555.2	XP_003360037.3	XP_003360037.3 protein-glutamine gamma-glutamyltransferase 2 [Sus scrofa]	36	36	36	2104400000	771830000	3157400000	514360000	1781100000	1716300000	1220900000	641940000	1183800000	898880000	1311100000	715130000	1636100000	1304800000	1455400000	597360000	1480000000	359930000	NA	NA	NA	TGM2	TGM2;NA;NA;NA;NA	positive regulation of inflammatory response;positive regulation of mitochondrial calcium ion concentration;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;blood vessel remodeling;salivary gland cavitation;protein homooligomerization;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;apoptotic cell clearance;positive regulation of smooth muscle cell proliferation;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of apoptotic process;branching involved in salivary gland morphogenesis;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of cell adhesion	GO:005072; GO:005156; GO:001815; GO:000197; GO:006066; GO:005126; GO:005148; GO:004327; GO:004866; GO:003247; GO:004306; GO:006044; GO:004312; GO:004578	mitochondrion;cytosol;focal adhesion;intrinsic component of plasma membrane;endoplasmic reticulum;extracellular exosome	GO:000573; GO:000582; GO:000592; GO:003122; GO:000578; GO:007006	 Huntington's disease	hsa0501	protein-glutamine gamma-glutamyltransferase activity;metal ion binding;GTP binding;protein domain specific binding;protein binding	GO:000381; GO:004687; GO:000552; GO:001990; GO:000551
XP_020933253.1;XP_003360061.3	XP_020933253.1;XP_003360061.3	XP_020933253.1 GPI transamidase component PIG-T isoform X2 [Sus scrofa];XP_003360061.3 GPI transamidase component PIG-T isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6308400	0	0	NA	NA	NA	PIGT	PIGT;PIGT;NA;NA;NA	neuron differentiation;attachment of GPI anchor to protein;neuron apoptotic process	GO:003018; GO:001625; GO:005140	integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane;membrane;cytoplasmic vesicle;GPI-anchor transamidase complex	GO:003017; GO:000578; GO:001602; GO:003141; GO:004276	 Metabolic pathways; Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	hsa0110; hsa0056	protein binding;GPI-anchor transamidase activity	GO:000551; GO:000392
XP_013846190.2;XP_003360127.3	XP_013846190.2;XP_003360127.3	XP_013846190.2 ATP-binding cassette sub-family B member 8, mitochondrial isoform X2 [Sus scrofa];XP_003360127.3 ATP-binding cassette sub-family B member 8, mitochondrial isoform X1 [Sus scrofa]	6	6	6	0	0	13990000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ABCB8	ABCB8;ABCB8;NA;NA;NA	transmembrane transport	GO:005508	ATP-binding cassette (ABC) transporter complex;nucleus;mitochondrial envelope;nucleolus;membrane	GO:004319; GO:000563; GO:000574; GO:000573; GO:001602	 ABC transporters	hsa0201	ATPase activity, coupled to transmembrane movement of substances;transporter activity;ATP binding	GO:004262; GO:000521; GO:000552
XP_020934455.1;XP_020934454.1;XP_003360186.3;XP_020934453.1	XP_020934455.1;XP_020934454.1;XP_003360186.3;XP_020934453.1	XP_020934455.1 ubiquitin-conjugating enzyme E2 H isoform X4 [Sus scrofa];XP_020934454.1 ubiquitin-conjugating enzyme E2 H isoform X3 [Sus scrofa];XP_003360186.3 ubiquitin-conjugating enzyme E2 H isoform X2 [Sus scrofa];XP_020934453.1 ubiquitin-conjugating	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2338900	NA	NA	NA	UBE2H	UBE2H;UBE2H;UBE2H;UBE2H;NA	protein ubiquitination;protein K48-linked ubiquitination;ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination	GO:001656; GO:007093; GO:000651; GO:004316; GO:007097	cytosol	GO:000582	 Ubiquitin mediated proteolysis	hsa0412	ATP binding;ubiquitin-protein transferase activity;ubiquitin conjugating enzyme activity;protein binding	GO:000552; GO:000484; GO:006163; GO:000551
XP_020934645.1;XP_020955569.1;XP_005673368.1;XP_005673367.1;XP_003360239.3	XP_020934645.1;XP_020955569.1;XP_005673368.1;XP_005673367.1;XP_003360239.3	XP_020934645.1 chromobox protein homolog 3 isoform X2 [Sus scrofa];XP_020955569.1 chromobox protein homolog 3 [Sus scrofa];XP_005673368.1 chromobox protein homolog 3 isoform X1 [Sus scrofa];XP_005673367.1 chromobox protein homolog 3 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10822000	0	NA	NA	NA	CBX3	CBX3;LOC110261685;CBX3;CBX3;CBX3	chromatin remodeling;cellular response to DNA damage stimulus;negative regulation of transcription, DNA-templated;negative regulation of G0 to G1 transition;rhythmic process	GO:000633; GO:000697; GO:004589; GO:007031; GO:004851	nuclear envelope;nucleoplasm;spindle;nuclear chromosome, telomeric region;nuclear pericentric heterochromatin;chromosome, centromeric region;nucleus;nuclear euchromatin;site of DNA damage;nuclear heterochromatin	GO:000563; GO:000565; GO:000581; GO:000078; GO:003161; GO:000077; GO:000563; GO:000571; GO:009073; GO:000572	"NA"	"NA"	histone methyltransferase binding;enzyme binding;protein binding;identical protein binding;protein domain specific binding	GO:199022; GO:001989; GO:000551; GO:004280; GO:001990
XP_003360255.2	XP_003360255.2	XP_003360255.2 proteasome subunit alpha type-2 [Sus scrofa]	6	6	6	100480000	68404000	84162000	91105000	88769000	50226000	90217000	94156000	108740000	70478000	80090000	58090000	80713000	67767000	97122000	71666000	76618000	73616000	NA	NA	NA	PSMA2	PSMA2;NA;NA;NA;NA	response to virus;protein deubiquitination;proteasomal ubiquitin-independent protein catabolic process;neutrophil degranulation;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:000961; GO:001657; GO:001049; GO:004331; GO:004368; GO:004316	cytosol;proteasome core complex;secretory granule lumen;proteasome complex;P-body;nucleoplasm;extracellular exosome;nucleus;cytoplasm;ficolin-1-rich granule lumen;extracellular region;proteasome core complex, alpha-subunit complex	GO:000582; GO:000583; GO:003477; GO:000050; GO:000093; GO:000565; GO:007006; GO:000563; GO:000573; GO:190481; GO:000557; GO:001977	 Proteasome	hsa0305	threonine-type endopeptidase activity;endopeptidase activity;protein binding	GO:000429; GO:000417; GO:000551
XP_003360292.2	XP_003360292.2	XP_003360292.2 pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial [Sus scrofa]	14	14	14	333140000	138910000	294550000	144850000	263590000	132630000	251980000	163030000	287600000	205580000	183030000	92958000	113650000	133540000	164200000	210000000	171080000	139930000	NA	NA	NA	PDHA1	PDHA1;NA;NA;NA;NA	acetyl-CoA biosynthetic process from pyruvate;mitochondrial acetyl-CoA biosynthetic process from pyruvate;tricarboxylic acid cycle;glucose metabolic process	GO:000608; GO:006173; GO:000609; GO:000600	nucleus;mitochondrial matrix;nucleolus;pyruvate dehydrogenase complex	GO:000563; GO:000575; GO:000573; GO:004525	 Metabolic pathways; Biosynthesis of antibiotics; Glucagon signaling pathway; Pyruvate metabolism; Carbon metabolism; Glycolysis / Gluconeogenesis; Central carbon metabolism in cancer; Citrate cycle (TCA cycle); HIF-1 signaling pathway	hsa0110; hsa0113; hsa0492; hsa0062; hsa0120; hsa0001; hsa0523; hsa0002; hsa0406	pyruvate dehydrogenase (NAD+) activity;pyruvate dehydrogenase (acetyl-transferring) activity;protein binding	GO:003460; GO:000473; GO:000551
XP_003360318.2	XP_003360318.2	XP_003360318.2 LOW QUALITY PROTEIN: peripheral plasma membrane protein CASK [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4400400	0	0	NA	NA	NA	CASK	CASK;NA;NA;NA;NA	neurotransmitter secretion;negative regulation of cell-matrix adhesion;negative regulation of keratinocyte proliferation;negative regulation of wound healing;negative regulation of cellular response to growth factor stimulus;regulation of synaptic vesicle exocytosis;positive regulation of transcription from RNA polymerase II promoter;GDP metabolic process;calcium ion import;protein phosphorylation;cell adhesion;GMP metabolic process	GO:000726; GO:000195; GO:001083; GO:006104; GO:009028; GO:200030; GO:004594; GO:004671; GO:007050; GO:000646; GO:000715; GO:004603	basement membrane;cytosol;actin cytoskeleton;vesicle;basolateral plasma membrane;Schaffer collateral - CA1 synapse;plasma membrane;cell-cell junction;ciliary membrane;nuclear lamina;nucleolus;nuclear matrix;focal adhesion;presynaptic membrane	GO:000560; GO:000582; GO:001562; GO:003198; GO:001632; GO:009868; GO:000588; GO:000591; GO:006017; GO:000565; GO:000573; GO:001636; GO:000592; GO:004273	 Tight junction	hsa0453	calmodulin binding;guanylate kinase activity;neurexin family protein binding;protein binding;protein serine/threonine kinase activity;ATP binding	GO:000551; GO:000438; GO:004204; GO:000551; GO:000467; GO:000552
XP_003360530.1	XP_003360530.1	XP_003360530.1 vacuolar ATPase assembly integral membrane protein VMA21 isoform X2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10369000	NA	NA	NA	VMA21	VMA21;NA;NA;NA;NA	vacuolar proton-transporting V-type ATPase complex assembly;regulation of ATPase activity	GO:007007; GO:004346	ER to Golgi transport vesicle membrane;lysosome;endoplasmic reticulum membrane;vacuole;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment membrane	GO:001250; GO:000576; GO:000578; GO:000577; GO:001602; GO:003311	"NA"	"NA"	"NA"	"NA"
XP_003360563.5;XP_020936403.1;REV__XP_013838484.1;REV__XP_003483494.1	XP_003360563.5;XP_020936403.1	XP_003360563.5 glucose-6-phosphate 1-dehydrogenase isoform X2 [Sus scrofa];XP_020936403.1 glucose-6-phosphate 1-dehydrogenase isoform X1 [Sus scrofa]	21	21	21	1255500000	424420000	649550000	497410000	786710000	304070000	815620000	484490000	730060000	464490000	534740000	304540000	377370000	400410000	635730000	538180000	579700000	377100000	NA	NA	NA	G6PD	G6PD;G6PD;NA;NA;NA	positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;NADP metabolic process;pentose-phosphate shunt, oxidative branch;lipid metabolic process;response to iron(III) ion;pentose biosynthetic process;substantia nigra development;regulation of neuron apoptotic process;glucose 6-phosphate metabolic process;oxidation-reduction process;negative regulation of reactive oxygen species metabolic process;cellular response to oxidative stress;negative regulation of cell growth involved in cardiac muscle cell development;response to ethanol;glucose metabolic process;pentose-phosphate shunt;cholesterol biosynthetic process;response to organic cyclic compound;response to food;erythrocyte maturation;NADPH regeneration;negative regulation of protein glutathionylation;ribose phosphate biosynthetic process	GO:190487; GO:000673; GO:000905; GO:000662; GO:001004; GO:001932; GO:002176; GO:004352; GO:005115; GO:005511; GO:200037; GO:003459; GO:006105; GO:004547; GO:000600; GO:000609; GO:000669; GO:001407; GO:003209; GO:004324; GO:000674; GO:001073; GO:004639	cytoplasmic side of plasma membrane;membrane;nucleus;cytosol;cytoplasm;extracellular exosome	GO:000989; GO:001602; GO:000563; GO:000582; GO:000573; GO:007006	 Pentose phosphate pathway; Central carbon metabolism in cancer; Metabolic pathways; Carbon metabolism; Glutathione metabolism; Biosynthesis of antibiotics	hsa0003; hsa0523; hsa0110; hsa0120; hsa0048; hsa0113	protein binding;NADP binding;protein homodimerization activity;glucose-6-phosphate dehydrogenase activity;glucose binding	GO:000551; GO:005066; GO:004280; GO:000434; GO:000553
XP_020936412.1;XP_003360570.1	XP_020936412.1;XP_003360570.1	XP_020936412.1 rab GDP dissociation inhibitor alpha isoform X2 [Sus scrofa];XP_003360570.1 rab GDP dissociation inhibitor alpha isoform X1 [Sus scrofa]	20	12	12	210300000	225390000	218630000	166960000	169640000	186650000	190690000	149560000	199420000	181060000	188450000	142700000	224810000	184250000	207380000	173650000	192840000	178560000	NA	NA	NA	GDI1	GDI1;GDI1;NA;NA;NA	Rab protein signal transduction;positive regulation of axon extension;regulation of small GTPase mediated signal transduction;negative regulation of axonogenesis;response to calcium ion;negative regulation of protein targeting to membrane;signal transduction;protein transport;positive regulation of GTPase activity	GO:003248; GO:004577; GO:005105; GO:005077; GO:005159; GO:009031; GO:000716; GO:001503; GO:004354	macromolecular complex;myelin sheath;midbody;cytosol;neuronal cell body;Golgi apparatus;cytoplasm;axon	GO:003299; GO:004320; GO:003049; GO:000582; GO:004302; GO:000579; GO:000573; GO:003042	"NA"	"NA"	protein binding;GTPase activator activity;Rab GTPase binding	GO:000551; GO:000509; GO:001713
XP_005658616.1;XP_003361422.1	XP_005658616.1;XP_003361422.1	XP_005658616.1 gamma-glutamylcyclotransferase isoform X2 [Sus scrofa];XP_003361422.1 gamma-glutamylcyclotransferase isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	12953000	0	0	0	0	0	17980000	0	0	0	0	0	0	0	NA	NA	NA	GGCT	GGCT;GGCT;NA;NA;NA	glutathione biosynthetic process;release of cytochrome c from mitochondria	GO:000675; GO:000183	cytosol;extracellular exosome	GO:000582; GO:007006	 Glutathione metabolism	hsa0048	protein homodimerization activity;gamma-glutamylcyclotransferase activity	GO:004280; GO:000383
XP_003361781.2	XP_003361781.2	XP_003361781.2 coactosin-like protein [Sus scrofa]	7	7	7	39969000	52475000	51428000	45284000	25850000	41419000	42728000	43560000	45575000	40719000	52681000	0	76092000	54904000	57143000	50266000	49503000	54295000	NA	NA	NA	COTL1	COTL1;NA;NA;NA;NA	biological_process;neutrophil degranulation;defense response to fungus	GO:000815; GO:004331; GO:005083	ficolin-1-rich granule lumen;cytoskeleton;secretory granule lumen;extracellular region;nucleus;extracellular exosome	GO:190481; GO:000585; GO:003477; GO:000557; GO:000563; GO:007006	"NA"	"NA"	protein binding;enzyme binding;actin binding	GO:000551; GO:001989; GO:000377
XP_003361930.1	XP_003361930.1	XP_003361930.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 [Sus scrofa]	5	5	5	66360000	46413000	54733000	32883000	60773000	27447000	66756000	42768000	53624000	42610000	59400000	52756000	36015000	42169000	55317000	39522000	47071000	44049000	NA	NA	NA	NDUFB4	NDUFB4;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;response to oxidative stress;mitochondrial respiratory chain complex I assembly	GO:000612; GO:000697; GO:003298	integral component of membrane;mitochondrial inner membrane;mitochondrion;nuclear membrane	GO:001602; GO:000574; GO:000573; GO:003196	 Metabolic pathways; Oxidative phosphorylation; Huntington's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0019; hsa0501; hsa0493	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_003480386.1	XP_003480386.1	XP_003480386.1 40S ribosomal protein S27-like [Sus scrofa]	4	4	2	0	36887000	38411000	28106000	30594000	39926000	37049000	31904000	35336000	38500000	29421000	0	0	42201000	38463000	0	35327000	45575000	NA	NA	NA	RPS27L	RPS27L;NA;NA;NA;NA	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;mitotic G1 DNA damage checkpoint;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of translation;activation of cysteine-type endopeptidase activity involved in apoptotic process;translation;ribosomal small subunit assembly	GO:000697; GO:003157; GO:004277; GO:004572; GO:000691; GO:000641; GO:000002	nucleus;cytosolic small ribosomal subunit	GO:000563; GO:002262	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;translation activator activity;metal ion binding;protein binding;cysteine-type endopeptidase activator activity involved in apoptotic process	GO:000373; GO:000372; GO:000849; GO:004687; GO:000551; GO:000865
XP_020954555.1;XP_020954550.1;XP_020954545.1;XP_020954542.1;XP_020954537.1;XP_003480471.3;XP_020954525.1;XP_020954519.1;XP_020954515.1;XP_020954507.1;XP_020954504.1;XP_020954502.1;XP_020954495.1;XP_020954492.1;XP_020954486.1	XP_020954555.1;XP_020954550.1;XP_020954545.1;XP_020954542.1;XP_020954537.1;XP_003480471.3;XP_020954525.1;XP_020954519.1;XP_020954515.1;XP_020954507.1;XP_020954504.1;XP_020954502.1;XP_020954495.1;XP_020954492.1;XP_020954486.1	XP_020954555.1 tight junction protein ZO-1 isoform X15 [Sus scrofa];XP_020954550.1 tight junction protein ZO-1 isoform X14 [Sus scrofa];XP_020954545.1 tight junction protein ZO-1 isoform X13 [Sus scrofa];XP_020954542.1 tight junction protein ZO-1 isoform X	17	17	17	0	83849000	53634000	65845000	56793000	86999000	87524000	79071000	62634000	66152000	77198000	86491000	76153000	64709000	0	57750000	81555000	50075000	NA	NA	NA	TJP1	TJP1;TJP1;TJP1;TJP1;TJP1	cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;regulation of bicellular tight junction assembly;establishment of endothelial intestinal barrier;hippo signaling	GO:190135; GO:000704; GO:200081; GO:009055; GO:003532	cytoplasm;cell-cell adherens junction;basolateral plasma membrane;cell projection;plasma membrane;cell junction;gap junction;podosome;apical junction complex;apical part of cell;cytosol	GO:000573; GO:000591; GO:001632; GO:004299; GO:000588; GO:003005; GO:000592; GO:000210; GO:004329; GO:004517; GO:000582	 Epithelial cell signaling in Helicobacter pylori infection; Gap junction; Adherens junction; Tight junction; Vibrio cholerae infection; Salmonella infection	hsa0512; hsa0454; hsa0452; hsa0453; hsa0511; hsa0513	protein binding;calmodulin binding;cadherin binding	GO:000551; GO:000551; GO:004529
XP_020922671.1;XP_003480607.1	XP_020922671.1;XP_003480607.1	XP_020922671.1 protein NipSnap homolog 3A [Sus scrofa];XP_003480607.1 protein NipSnap homolog 3A [Sus scrofa]	3	3	3	22123000	18249000	18865000	0	19012000	0	20701000	14694000	19584000	14997000	20263000	0	12943000	0	21521000	15674000	17707000	21667000	NA	NA	NA	LOC100154081	LOC100154081;LOC100154081;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_003480758.1;XP_020940942.1;XP_020940941.1;XP_013849881.2;XP_020940940.1;XP_013849880.1;XP_020940945.1;XP_020940939.1;XP_020940938.1;XP_013849879.1;XP_020940944.1;XP_020940943.1	XP_003480758.1;XP_020940942.1;XP_020940941.1;XP_013849881.2;XP_020940940.1;XP_013849880.1;XP_020940945.1;XP_020940939.1;XP_020940938.1;XP_013849879.1;XP_020940944.1;XP_020940943.1	XP_003480758.1 CD44 antigen isoform X9 [Sus scrofa];XP_020940942.1 CD44 antigen isoform X8 [Sus scrofa];XP_020940941.1 CD44 antigen isoform X7 [Sus scrofa];XP_013849881.2 CD44 antigen isoform X6 [Sus scrofa];XP_020940940.1 CD44 antigen isoform X5 [Sus scro	3	3	3	0	0	0	28391000	0	47568000	0	0	0	0	21421000	42490000	0	34182000	0	34663000	25232000	51499000	NA	NA	NA	CD44	CD44;CD44;CD44;CD44;CD44	positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of heterotypic cell-cell adhesion;negative regulation of DNA damage response, signal transduction by p53 class mediator;leukocyte migration;positive regulation of ERK1 and ERK2 cascade;monocyte aggregation;cell-matrix adhesion;extracellular matrix disassembly;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;wound healing, spreading of cells;cellular response to fibroblast growth factor stimulus;hyaluronan catabolic process;neutrophil degranulation;positive regulation of monocyte aggregation;inflammatory response;positive regulation of peptidyl-serine phosphorylation;interferon-gamma-mediated signaling pathway;regulation of lamellipodium morphogenesis;cell adhesion;extracellular matrix organization;cartilage development;negative regulation of apoptotic process;cell-cell adhesion;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	GO:005073; GO:003411; GO:004351; GO:005090; GO:007037; GO:007048; GO:000716; GO:002261; GO:004315; GO:004431; GO:004434; GO:003021; GO:004331; GO:190062; GO:000695; GO:003313; GO:006033; GO:200039; GO:000715; GO:003019; GO:005121; GO:004306; GO:009860; GO:190216	cell surface;basolateral plasma membrane;plasma membrane;Golgi apparatus;extracellular exosome;cytosol;secretory granule membrane;lamellipodium membrane;macrophage migration inhibitory factor receptor complex;focal adhesion;microvillus;cell projection	GO:000998; GO:001632; GO:000588; GO:000579; GO:007006; GO:000582; GO:003066; GO:003125; GO:003569; GO:000592; GO:000590; GO:004299	 ECM-receptor interaction; Epstein-Barr virus infection; MicroRNAs in cancer; Hematopoietic cell lineage; Shigellosis	hsa0451; hsa0516; hsa0520; hsa0464; hsa0513	cytokine receptor activity;collagen binding;hyaluronic acid binding;transmembrane signaling receptor activity	GO:000489; GO:000551; GO:000554; GO:000488
XP_003480784.2;XP_005661187.1	XP_003480784.2;XP_005661187.1	XP_003480784.2 lymphatic vessel endothelial hyaluronic acid receptor 1 isoform X2 [Sus scrofa];XP_005661187.1 lymphatic vessel endothelial hyaluronic acid receptor 1 isoform X1 [Sus scrofa]	2	2	2	0	21122000	0	28477000	0	0	0	0	0	0	0	0	0	26049000	0	0	0	37215000	NA	NA	NA	LYVE1	LYVE1;LYVE1;NA;NA;NA	response to wounding;cell-matrix adhesion;anatomical structure morphogenesis;hyaluronan catabolic process	GO:000961; GO:000716; GO:000965; GO:003021	extracellular exosome;plasma membrane;membrane	GO:007006; GO:000588; GO:001602	"NA"	"NA"	transmembrane signaling receptor activity;signaling receptor activity;protein binding;hyaluronic acid binding	GO:000488; GO:003802; GO:000551; GO:000554
XP_003480823.2	XP_003480823.2	XP_003480823.2 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3313100	0	NA	NA	NA	NDUFB7	NDUFB7;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	GO:000612; GO:003298	mitochondrion;mitochondrial respiratory chain complex I;mitochondrial intermembrane space	GO:000573; GO:000574; GO:000575	 Metabolic pathways; Huntington's disease; Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD)	hsa0110; hsa0501; hsa0019; hsa0493	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_003480860.1	XP_003480860.1	XP_003480860.1 tubulin beta-4A chain [Sus scrofa]	21	3	2	0	37255000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TUBB4A	TUBB4A;NA;NA;NA;NA	microtubule cytoskeleton organization;microtubule-based process;G2/M transition of mitotic cell cycle;ciliary basal body docking;negative regulation of microtubule polymerization;mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle	GO:000022; GO:000701; GO:000008; GO:009771; GO:003111; GO:000027; GO:001038	cytoplasm;myelin sheath;neuronal cell body;nucleus;internode region of axon;cytosol;microtubule;axoneme;extracellular exosome	GO:000573; GO:004320; GO:004302; GO:000563; GO:003326; GO:000582; GO:000587; GO:000593; GO:007006	 Phagosome; Pathogenic Escherichia coli infection; Gap junction	hsa0414; hsa0513; hsa0454	structural constituent of cytoskeleton;calcium ion binding;GTPase activity;protein binding;GTP binding	GO:000520; GO:000550; GO:000392; GO:000551; GO:000552
XP_003480935.1	XP_003480935.1	XP_003480935.1 receptor expression-enhancing protein 5 [Sus scrofa]	8	8	8	665150000	631800000	630150000	534250000	484260000	503820000	537070000	554630000	517940000	516660000	460370000	416680000	329310000	589590000	489280000	542360000	464750000	567870000	NA	NA	NA	REEP5	REEP5;NA;NA;NA;NA	biological_process	GO:000815	integral component of membrane;endoplasmic reticulum tubular network	GO:001602; GO:007178	"NA"	"NA"	protein binding;molecular_function	GO:000551; GO:000367
XP_020941908.1;XP_003481037.1;XP_013842734.1;XP_013842725.1;NP_001230422.1	XP_020941908.1;XP_003481037.1	XP_020941908.1 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [Sus scrofa];XP_003481037.1 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [Sus scrofa]	13	8	5	303320000	392600000	400530000	324600000	314020000	283500000	352900000	349510000	327580000	305810000	342170000	381350000	345810000	395020000	316110000	300790000	352190000	349990000	NA	NA	NA	GNB2	GNB2;GNB2;NA;NA;NA	protein folding;G-protein coupled receptor signaling pathway	GO:000645; GO:000718	macromolecular complex;cell body;membrane;extracellular space;lysosomal membrane;vesicle;focal adhesion;cytosol;plasma membrane;perinuclear region of cytoplasm;extracellular exosome	GO:003299; GO:004429; GO:001602; GO:000561; GO:000576; GO:003198; GO:000592; GO:000582; GO:000588; GO:004847; GO:007006	 Ras signaling pathway; Cholinergic synapse; Alcoholism; Chemokine signaling pathway; Pathways in cancer; PI3K-Akt signaling pathway; Circadian entrainment	hsa0401; hsa0472; hsa0503; hsa0406; hsa0520; hsa0415; hsa0471	calcium channel regulator activity;protein binding;GTPase binding;GTPase activity;macromolecular complex binding	GO:000524; GO:000551; GO:005102; GO:000392; GO:004487
XP_020934517.1;XP_020934516.1;XP_020934515.1;XP_020934514.1;XP_020942607.1;XP_020942606.1;XP_020942605.1;XP_013843192.1;XP_013843191.1;XP_020934513.1;XP_020934512.1;XP_020934511.1;XP_020934510.1;XP_020934509.1;XP_020934508.1;XP_013846235.1;XP_013846234.1;XP_013846233.1;XP_013846232.1;XP_013846231.1;XP_005657801.1;XP_005657799.1;XP_003481128.1;XP_020934507.1;XP_020934506.1;XP_013846230.1;XP_005657795.1;XP_005657794.1;XP_013846229.1;XP_020934505.1	XP_020934517.1;XP_020934516.1;XP_020934515.1;XP_020934514.1;XP_020942607.1;XP_020942606.1;XP_020942605.1;XP_013843192.1;XP_013843191.1;XP_020934513.1;XP_020934512.1;XP_020934511.1;XP_020934510.1;XP_020934509.1;XP_020934508.1;XP_013846235.1;XP_013846234.1;XP_013846233.1;XP_013846232.1;XP_013846231.1;XP_005657801.1;XP_005657799.1;XP_003481128.1;XP_020934507.1;XP_020934506.1;XP_013846230.1;XP_005657795.1;XP_005657794.1;XP_013846229.1;XP_020934505.1	XP_020934517.1 putative RNA-binding protein Luc7-like 2 isoform X9 [Sus scrofa];XP_020934516.1 putative RNA-binding protein Luc7-like 2 isoform X9 [Sus scrofa];XP_020934515.1 putative RNA-binding protein Luc7-like 2 isoform X9 [Sus scrofa];XP_020934514.1 p	2	2	2	0	0	29614000	0	0	30669000	0	0	0	0	0	0	37145000	0	0	0	0	0	NA	NA	NA	LUC7L	LOC102162486;LOC102162486;LUC7L;LUC7L;LUC7L	mRNA splice site selection;negative regulation of striated muscle tissue development	GO:000637; GO:004584	U2-type prespliceosome;U1 snRNP	GO:007100; GO:000568	"NA"	"NA"	protein binding;mRNA binding;RS domain binding;identical protein binding	GO:000551; GO:000372; GO:005073; GO:004280
XP_003481157.2	XP_003481157.2	XP_003481157.2 glycerol-3-phosphate phosphatase [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	8844800	0	0	0	0	0	0	0	0	9053200	NA	NA	NA	PGP	PGP;NA;NA;NA;NA	glycerol biosynthetic process;glycerophospholipid metabolic process;peptidyl-tyrosine dephosphorylation;negative regulation of gluconeogenesis;dephosphorylation	GO:000611; GO:000665; GO:003533; GO:004572; GO:001631	cytoplasm	GO:000573	 Glyoxylate and dicarboxylate metabolism; Biosynthesis of antibiotics; Metabolic pathways; Carbon metabolism	hsa0063; hsa0113; hsa0110; hsa0120	nucleotide phosphatase activity, acting on free nucleotides;phosphatase activity;glycerol-1-phosphatase activity;phosphoglycolate phosphatase activity;magnesium ion binding;glycerol-3-phosphatase activity;protein tyrosine phosphatase activity	GO:009851; GO:001679; GO:000012; GO:000896; GO:000028; GO:004313; GO:000472
XP_020942944.1;XP_003481218.3;XP_020942946.1;XP_020942945.1;XP_020942943.1;XP_020942942.1;XP_020942941.1	XP_020942944.1;XP_003481218.3;XP_020942946.1;XP_020942945.1;XP_020942943.1;XP_020942942.1;XP_020942941.1	XP_020942944.1 MICOS complex subunit MIC60 isoform X5 [Sus scrofa];XP_003481218.3 MICOS complex subunit MIC60 isoform X2 [Sus scrofa];XP_020942946.1 MICOS complex subunit MIC60 isoform X7 [Sus scrofa];XP_020942945.1 MICOS complex subunit MIC60 isoform X6 [	10	10	10	84164000	70130000	77510000	50007000	81808000	65811000	83052000	66701000	76151000	55331000	69936000	64029000	64540000	64833000	69876000	67921000	69335000	69469000	NA	NA	NA	IMMT	IMMT;IMMT;IMMT;IMMT;IMMT	mitochondrial calcium ion homeostasis;cristae formation	GO:005156; GO:004240	membrane;mitochondrial inner membrane;mitochondrion;MICOS complex	GO:001602; GO:000574; GO:000573; GO:006161	"NA"	"NA"	RNA binding;protein binding	GO:000372; GO:000551
XP_003481247.1	XP_003481247.1	XP_003481247.1 CB1 cannabinoid receptor-interacting protein 1 [Sus scrofa]	4	4	4	0	32341000	33917000	28724000	0	0	30950000	28846000	0	28219000	33777000	0	0	31282000	38450000	32143000	37510000	37012000	NA	NA	NA	CNRIP1	CNRIP1;NA;NA;NA;NA	negative regulation of receptor activity;regulation of receptor activity	GO:200027; GO:001046	cytoplasm;plasma membrane	GO:000573; GO:000588	"NA"	"NA"	protein C-terminus binding;type 1 cannabinoid receptor binding	GO:000802; GO:003171
XP_003481250.1;XP_013851559.1	XP_003481250.1;XP_013851559.1	XP_003481250.1 galectin-related protein isoform X2 [Sus scrofa];XP_013851559.1 galectin-related protein isoform X1 [Sus scrofa]	3	3	3	11576000	0	0	0	10773000	0	0	0	0	0	11656000	0	15708000	0	0	0	0	0	NA	NA	NA	LGALSL	LGALSL;LGALSL;NA;NA;NA	"NA"	"NA"	intracellular	GO:000562	"NA"	"NA"	protein binding;carbohydrate binding	GO:000551; GO:003024
XP_020943278.1;XP_020943277.1;XP_020943276.1;XP_020943272.1;XP_020943270.1;XP_003481284.1;XP_020943275.1;XP_020943274.1;XP_020943273.1;XP_020943271.1;XP_005662670.1;XP_020943269.1;XP_005662669.1	XP_020943278.1;XP_020943277.1;XP_020943276.1;XP_020943272.1;XP_020943270.1;XP_003481284.1;XP_020943275.1;XP_020943274.1;XP_020943273.1;XP_020943271.1;XP_005662670.1;XP_020943269.1;XP_005662669.1	XP_020943278.1 atlastin-2 isoform X9 [Sus scrofa];XP_020943277.1 atlastin-2 isoform X9 [Sus scrofa];XP_020943276.1 atlastin-2 isoform X9 [Sus scrofa];XP_020943272.1 atlastin-2 isoform X7 [Sus scrofa];XP_020943270.1 atlastin-2 isoform X5 [Sus scrofa];XP_003	4	4	4	23062000	13928000	18497000	13032000	15006000	0	20143000	13858000	15050000	0	0	0	0	0	0	16867000	19848000	0	NA	NA	NA	ATL2	ATL2;ATL2;ATL2;ATL2;ATL2	endoplasmic reticulum organization;ER to Golgi vesicle-mediated transport;endoplasmic reticulum tubular network membrane organization;protein homooligomerization;Golgi organization	GO:000702; GO:000688; GO:199080; GO:005126; GO:000703	integral component of membrane;endoplasmic reticulum tubular network membrane;endoplasmic reticulum;membrane	GO:001602; GO:009882; GO:000578; GO:001602	"NA"	"NA"	GTPase activity;identical protein binding;GTP binding;protein binding	GO:000392; GO:004280; GO:000552; GO:000551
XP_005662805.1;XP_003481337.1	XP_005662805.1;XP_003481337.1	XP_005662805.1 isoamyl acetate-hydrolyzing esterase 1 homolog isoform X2 [Sus scrofa];XP_003481337.1 isoamyl acetate-hydrolyzing esterase 1 homolog isoform X1 [Sus scrofa]	4	4	4	11418000	10630000	10465000	13006000	0	0	14024000	14525000	12903000	0	0	0	0	0	14036000	0	0	0	NA	NA	NA	IAH1	IAH1;IAH1;NA;NA;NA	lipid catabolic process	GO:001604	"NA"	"NA"	"NA"	"NA"	hydrolase activity, acting on ester bonds	GO:001678
XP_003481357.1;XP_003481358.1;XP_020943613.1	XP_003481357.1;XP_003481358.1;XP_020943613.1	XP_003481357.1 low molecular weight phosphotyrosine protein phosphatase isoform X1 [Sus scrofa];XP_003481358.1 low molecular weight phosphotyrosine protein phosphatase isoform X2 [Sus scrofa];XP_020943613.1 low molecular weight phosphotyrosine protein phos	5	5	5	53012000	48915000	41872000	42214000	37021000	36796000	49196000	40325000	50810000	40039000	41695000	0	42282000	51982000	32409000	41238000	47746000	43885000	NA	NA	NA	ACP1	ACP1;ACP1;ACP1;NA;NA	peptidyl-tyrosine dephosphorylation	GO:003533	cytoplasm;extracellular exosome;cytoplasmic side of plasma membrane	GO:000573; GO:007006; GO:000989	 Adherens junction	hsa0452	acid phosphatase activity;protein tyrosine phosphatase activity;protein binding	GO:000399; GO:000472; GO:000551
XP_020946254.1;XP_020946253.1;XP_020946252.1;XP_020946251.1;XP_005662963.1;XP_005662962.1;XP_003481410.1;XP_013852009.1;XP_020946249.1;XP_013852008.1;XP_005662959.1;XP_013852007.1;XP_020946248.1;XP_003481412.1;XP_003481411.1	XP_020946254.1;XP_020946253.1;XP_020946252.1;XP_020946251.1;XP_005662963.1;XP_005662962.1;XP_003481410.1;XP_013852009.1;XP_020946249.1;XP_013852008.1;XP_005662959.1;XP_013852007.1;XP_020946248.1;XP_003481412.1;XP_003481411.1	XP_020946254.1 oxidation resistance protein 1 isoform X11 [Sus scrofa];XP_020946253.1 oxidation resistance protein 1 isoform X10 [Sus scrofa];XP_020946252.1 oxidation resistance protein 1 isoform X9 [Sus scrofa];XP_020946251.1 oxidation resistance protein	3	3	3	0	0	10367000	0	10556000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OXR1	OXR1;OXR1;OXR1;OXR1;OXR1	neuron apoptotic process;oxidation-reduction process;negative regulation of peptidyl-cysteine S-nitrosylation;adult walking behavior;negative regulation of neuron apoptotic process;response to oxidative stress;negative regulation of oxidative stress-induced neuron death;cellular response to hydroperoxide	GO:005140; GO:005511; GO:190208; GO:000762; GO:004352; GO:000697; GO:190320; GO:007144	nucleolus;intracellular membrane-bounded organelle;mitochondrion;nucleoplasm	GO:000573; GO:004323; GO:000573; GO:000565	"NA"	"NA"	molecular_function;oxidoreductase activity	GO:000367; GO:001649
XP_020945664.1;XP_005655474.1;XP_005655473.1;XP_005655472.1;XP_020945663.1;XP_003481532.1	XP_020945664.1;XP_005655474.1;XP_005655473.1;XP_005655472.1;XP_020945663.1;XP_003481532.1	XP_020945664.1 cold shock domain-containing protein E1 isoform X4 [Sus scrofa];XP_005655474.1 cold shock domain-containing protein E1 isoform X4 [Sus scrofa];XP_005655473.1 cold shock domain-containing protein E1 isoform X3 [Sus scrofa];XP_005655472.1 cold	6	6	6	0	21305000	19812000	18827000	0	20436000	16398000	17665000	15075000	15002000	17097000	27992000	0	19687000	0	19184000	14806000	18103000	NA	NA	NA	CSDE1	CSDE1;CSDE1;CSDE1;CSDE1;CSDE1	nuclear-transcribed mRNA catabolic process, no-go decay;male gonad development	GO:007096; GO:000858	CRD-mediated mRNA stability complex;Golgi apparatus;cytosol;plasma membrane	GO:007093; GO:000579; GO:000582; GO:000588	"NA"	"NA"	RNA binding;protein binding	GO:000372; GO:000551
XP_003481553.2;XP_013852803.2	XP_003481553.2;XP_013852803.2	XP_003481553.2 lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial isoform X2 [Sus scrofa];XP_013852803.2 lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mi	7	7	7	30746000	19489000	24784000	0	27582000	0	23486000	20187000	30499000	24688000	30392000	23518000	0	0	24832000	32780000	19777000	21085000	NA	NA	NA	DBT	DBT;DBT;NA;NA;NA	"NA"	"NA"	mitochondrion;mitochondrial nucleoid;cytoplasm;mitochondrial alpha-ketoglutarate dehydrogenase complex;mitochondrial matrix	GO:000573; GO:004264; GO:000573; GO:000594; GO:000575	 Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of antibiotics	hsa0028; hsa0110; hsa0113	ubiquitin protein ligase binding;lipoic acid binding;dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity;acetyltransferase activity	GO:003162; GO:003140; GO:004375; GO:001640
XP_003481579.1	XP_003481579.1	XP_003481579.1 hsc70-interacting protein [Sus scrofa]	6	6	6	440450000	383250000	594800000	344460000	478980000	412560000	527360000	362810000	456800000	361630000	468170000	345370000	424830000	439040000	417880000	361500000	550660000	409380000	NA	NA	NA	ST13	ST13;NA;NA;NA;NA	negative regulation of protein refolding;protein folding;protein homotetramerization;response to bacterium;chaperone mediated protein folding requiring cofactor	GO:006108; GO:000645; GO:005128; GO:000961; GO:005108	extracellular exosome;cytosol;cytoplasm;macromolecular complex	GO:007006; GO:000582; GO:000573; GO:003299	"NA"	"NA"	dATP binding;chaperone binding;protein binding;protein dimerization activity;Hsp70 protein binding;protein domain specific binding;protein binding, bridging;identical protein binding;macromolecular complex binding	GO:003256; GO:005108; GO:000551; GO:004698; GO:003054; GO:001990; GO:003067; GO:004280; GO:004487
XP_003481707.1	XP_003481707.1	XP_003481707.1 ras-related protein Rab-21 [Sus scrofa]	8	8	8	23725000	32271000	28555000	24728000	23259000	28370000	26502000	30363000	22370000	24355000	19451000	30659000	22678000	24739000	16074000	28927000	29573000	27917000	NA	NA	NA	RAB21	RAB21;NA;NA;NA;NA	regulation of exocytosis;Rab protein signal transduction;positive regulation of dendrite morphogenesis;positive regulation of early endosome to late endosome transport;intracellular protein transport;regulation of axon extension;anterograde axonal transport;positive regulation of receptor-mediated endocytosis	GO:001715; GO:003248; GO:005077; GO:200064; GO:000688; GO:003051; GO:000808; GO:004826	endosome;cleavage furrow;endoplasmic reticulum membrane;trans-Golgi network;vesicle membrane;cytoplasmic vesicle membrane;extracellular exosome;early endosome;cytoplasmic side of plasma membrane;synapse;cytoplasmic side of early endosome membrane;cytosol;focal adhesion;Golgi cisterna membrane;axon cytoplasm;early endosome membrane	GO:000576; GO:003215; GO:000578; GO:000580; GO:001250; GO:003065; GO:007006; GO:000576; GO:000989; GO:004520; GO:009855; GO:000582; GO:000592; GO:003258; GO:190411; GO:003190	"NA"	"NA"	protein binding;GDP binding;GTPase activity;GTP binding	GO:000551; GO:001900; GO:000392; GO:000552
XP_003481811.2;XP_020948715.1;XP_020948716.1	XP_003481811.2;XP_020948715.1;XP_020948716.1	XP_003481811.2 acyl-CoA synthetase short-chain family member 3, mitochondrial isoform X1 [Sus scrofa];XP_020948715.1 acyl-CoA synthetase short-chain family member 3, mitochondrial isoform X2 [Sus scrofa];XP_020948716.1 acyl-CoA synthetase short-chain famil	12	12	12	35114000	13660000	78276000	21125000	42470000	19398000	51340000	43309000	61916000	9446100	15840000	20140000	29676000	31920000	34904000	27443000	27609000	17053000	NA	NA	NA	ACSS3	ACSS3;ACSS3;ACSS3;NA;NA	ketone body biosynthetic process	GO:004695	mitochondrial matrix	GO:000575	 Propanoate metabolism; Metabolic pathways	hsa0064; hsa0110	acetate-CoA ligase activity;ATP binding	GO:000398; GO:000552
XP_020950067.1;XP_003481903.1;XP_020930072.1;XP_020930071.1;XP_001925518.2	XP_020950067.1;XP_003481903.1	XP_020950067.1 ras-related protein Rab-4B [Sus scrofa];XP_003481903.1 ras-related protein Rab-4B [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5170800	0	0	NA	NA	NA	RAB4B	RAB4B;RAB4B;NA;NA;NA	intracellular protein transport;neutrophil degranulation;Rab protein signal transduction;glucose import;regulation of endocytosis	GO:000688; GO:004331; GO:003248; GO:004632; GO:003010	perinuclear region of cytoplasm;secretory granule membrane;recycling endosome;insulin-responsive compartment;endosome;plasma membrane	GO:004847; GO:003066; GO:005503; GO:003259; GO:000576; GO:000588	"NA"	"NA"	molecular_function;GTPase activity;GTP binding;protein binding	GO:000367; GO:000392; GO:000552; GO:000551
XP_003481932.1;XP_013850432.1	XP_003481932.1;XP_013850432.1	XP_003481932.1 basal cell adhesion molecule isoform X1 [Sus scrofa];XP_013850432.1 basal cell adhesion molecule isoform X2 [Sus scrofa]	27	27	27	3551600000	2837900000	3701500000	2408000000	2601300000	1679600000	3231700000	2656700000	2492000000	1973900000	2985500000	2113800000	1336300000	2535600000	4077600000	3103700000	3065900000	2415400000	NA	NA	NA	BCAM	BCAM;BCAM;NA;NA;NA	cell adhesion;signal transduction	GO:000715; GO:000716	integral component of plasma membrane;external side of plasma membrane;extracellular exosome;plasma membrane;extracellular region	GO:000588; GO:000989; GO:007006; GO:000588; GO:000557	"NA"	"NA"	transmembrane signaling receptor activity;protein C-terminus binding;laminin receptor activity;laminin binding;protein binding	GO:000488; GO:000802; GO:000505; GO:004323; GO:000551
XP_003482090.3;XP_020951845.1;XP_003482093.2	XP_003482090.3;XP_020951845.1	XP_003482090.3 laminin subunit alpha-3 isoform X1 [Sus scrofa];XP_020951845.1 laminin subunit alpha-3 isoform X2 [Sus scrofa]	4	3	3	0	11668000	9560900	0	10897000	9027200	0	12811000	0	0	0	0	0	11891000	10400000	0	12383000	0	NA	NA	NA	LAMA3	LAMA3;LAMA3;NA;NA;NA	cell adhesion;extracellular matrix organization;regulation of cell adhesion;epidermis development;endodermal cell differentiation;regulation of cell migration;hemidesmosome assembly;regulation of embryonic development	GO:000715; GO:003019; GO:003015; GO:000854; GO:003598; GO:003033; GO:003158; GO:004599	basement membrane;laminin-5 complex;extracellular exosome;extracellular region;endoplasmic reticulum	GO:000560; GO:000561; GO:007006; GO:000557; GO:000578	 PI3K-Akt signaling pathway; ECM-receptor interaction; Small cell lung cancer; Toxoplasmosis; Pathways in cancer	hsa0415; hsa0451; hsa0522; hsa0514; hsa0520	extracellular matrix structural constituent;receptor binding;structural molecule activity	GO:000520; GO:000510; GO:000519
XP_003482167.1;XP_003132567.1	XP_003482167.1	XP_003482167.1 leukocyte elastase inhibitor [Sus scrofa]	14	14	13	153180000	224040000	160430000	212220000	144420000	195700000	145490000	176250000	153650000	198760000	174760000	214760000	259390000	169230000	154440000	195210000	170350000	210370000	NA	NA	NA	SERPINB1	SERPINB1;NA;NA;NA;NA	neutrophil degranulation;negative regulation of endopeptidase activity	GO:004331; GO:001095	extracellular exosome;extracellular region;extracellular space;secretory granule lumen;membrane	GO:007006; GO:000557; GO:000561; GO:003477; GO:001602	 Amoebiasis	hsa0514	serine-type endopeptidase inhibitor activity	GO:000486
XP_003482336.1	XP_003482336.1	XP_003482336.1 iron-sulfur cluster assembly 2 homolog, mitochondrial [Sus scrofa]	3	3	3	0	0	0	0	0	0	8311100	0	8771500	0	0	0	0	0	0	0	0	0	NA	NA	NA	ISCA2	ISCA2;NA;NA;NA;NA	protein maturation;iron-sulfur cluster assembly;small molecule metabolic process	GO:005160; GO:001622; GO:004428	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	structural molecule activity;protein binding;2 iron, 2 sulfur cluster binding;iron ion binding	GO:000519; GO:000551; GO:005153; GO:000550
XP_020956360.1;XP_020956359.1;XP_003482499.3	XP_020956360.1;XP_020956359.1;XP_003482499.3	XP_020956360.1 protein transport protein Sec24D [Sus scrofa];XP_020956359.1 protein transport protein Sec24D [Sus scrofa];XP_003482499.3 protein transport protein Sec24D [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	5859100	0	0	0	5486900	0	6640000	0	0	NA	NA	NA	SEC24D	SEC24D;SEC24D;SEC24D;NA;NA	intracellular protein transport;in utero embryonic development;ER to Golgi vesicle-mediated transport;COPII vesicle coating;cargo loading into COPII-coated vesicle;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of exogenous peptide antigen via MHC class II	GO:000688; GO:000170; GO:000688; GO:004820; GO:009011; GO:000247; GO:001988	Golgi membrane;cytosol;ER to Golgi transport vesicle membrane;endoplasmic reticulum membrane;COPII vesicle coat	GO:000013; GO:000582; GO:001250; GO:000578; GO:003012	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;SNARE binding;zinc ion binding	GO:000551; GO:000014; GO:000827
XP_003482544.2	XP_003482544.2	XP_003482544.2 60S ribosomal protein L27a [Sus scrofa]	3	3	3	87141000	63631000	127810000	0	84789000	110650000	76484000	0	74341000	100590000	61663000	0	0	109600000	67598000	72956000	116550000	121350000	NA	NA	NA	RPL27A	RPL27A;NA;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;translation	GO:000018; GO:000661; GO:000641	membrane;endoplasmic reticulum;cytosol;cytosolic large ribosomal subunit	GO:001602; GO:000578; GO:000582; GO:002262	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding;protein binding	GO:000373; GO:000372; GO:000551
XP_003482611.2	XP_003482611.2	XP_003482611.2 signal peptidase complex subunit 2 [Sus scrofa]	4	4	4	0	37644000	0	31336000	25025000	0	0	27450000	0	0	0	0	0	0	25933000	30632000	0	31532000	NA	NA	NA	SPCS2	SPCS2;NA;NA;NA;NA	protein targeting to ER;signal peptide processing	GO:004504; GO:000646	signal peptidase complex;endoplasmic reticulum membrane;integral component of membrane;organelle membrane	GO:000578; GO:000578; GO:001602; GO:003109	 Protein export	hsa0306	peptidase activity	GO:000823
XP_003482845.1;XP_020920222.1;XP_020920221.1;XP_013835581.2;XP_020920220.1;XP_020920219.1;XP_020920218.1;XP_020920216.1;XP_020920217.1;XP_020920208.1;XP_020920207.1;XP_020920206.1	XP_003482845.1;XP_020920222.1;XP_020920221.1;XP_013835581.2;XP_020920220.1;XP_020920219.1;XP_020920218.1;XP_020920216.1;XP_020920217.1;XP_020920208.1;XP_020920207.1;XP_020920206.1	XP_003482845.1 protein phosphatase 1 regulatory subunit 12B isoform X12 [Sus scrofa];XP_020920222.1 protein phosphatase 1 regulatory subunit 12B isoform X11 [Sus scrofa];XP_020920221.1 protein phosphatase 1 regulatory subunit 12B isoform X11 [Sus scrofa];X	2	1	1	0	0	0	0	0	0	0	0	0	0	0	0	13970000	0	0	0	0	0	NA	NA	NA	PPP1R12B	PPP1R12B;PPP1R12B;PPP1R12B;PPP1R12B;PPP1R12B	regulation of muscle contraction;signal transduction;positive regulation of catalytic activity	GO:000693; GO:000716; GO:004308	nucleoplasm;cytosol;cytoskeleton;cytoplasm;Z disc;A band	GO:000565; GO:000582; GO:000585; GO:000573; GO:003001; GO:003167	 Oxytocin signaling pathway; Vascular smooth muscle contraction; Proteoglycans in cancer; Focal adhesion; Regulation of actin cytoskeleton	hsa0492; hsa0427; hsa0520; hsa0451; hsa0481	enzyme inhibitor activity;enzyme activator activity;protein binding;phosphatase regulator activity;protein kinase binding	GO:000485; GO:000804; GO:000551; GO:001920; GO:001990
XP_020920649.1;XP_020920648.1;XP_013835762.1;XP_005668255.1;XP_005668254.1;XP_003482884.1;XP_020920650.1	XP_020920649.1;XP_020920648.1;XP_013835762.1;XP_005668255.1;XP_005668254.1;XP_003482884.1;XP_020920650.1	XP_020920649.1 ADP-sugar pyrophosphatase isoform X1 [Sus scrofa];XP_020920648.1 ADP-sugar pyrophosphatase isoform X1 [Sus scrofa];XP_013835762.1 ADP-sugar pyrophosphatase isoform X1 [Sus scrofa];XP_005668255.1 ADP-sugar pyrophosphatase isoform X1 [Sus scro	6	6	6	38151000	43619000	40671000	39297000	31988000	33366000	42366000	43510000	37572000	32065000	38751000	42445000	41238000	38443000	37990000	41811000	34686000	34106000	NA	NA	NA	NUDT5	NUDT5;NUDT5;NUDT5;NUDT5;NUDT5	nucleoside phosphate metabolic process;ATP generation from poly-ADP-D-ribose;D-ribose catabolic process;ribose phosphate metabolic process;nucleobase-containing small molecule catabolic process;ribonucleoside diphosphate catabolic process;chromatin remodeling;nucleotide metabolic process	GO:000675; GO:199096; GO:001930; GO:001969; GO:003465; GO:000919; GO:000633; GO:000911	nucleus;cytosol;extracellular exosome	GO:000563; GO:000582; GO:007006	 Purine metabolism	hsa0023	magnesium ion binding;protein homodimerization activity;ADP-ribose diphosphatase activity;protein binding;snoRNA binding;m7G(5')pppN diphosphatase activity;ADP-sugar diphosphatase activity;nucleotidyltransferase activity;8-oxo-dGDP phosphatase activity	GO:000028; GO:004280; GO:004763; GO:000551; GO:003051; GO:005007; GO:001914; GO:001677; GO:004471
XP_020921175.1;XP_020921174.1;XP_020921173.1;XP_003482913.1;XP_003482912.1	XP_020921175.1;XP_020921174.1;XP_020921173.1;XP_003482913.1;XP_003482912.1	XP_020921175.1 60S ribosomal protein L21 [Sus scrofa];XP_020921174.1 60S ribosomal protein L21 [Sus scrofa];XP_020921173.1 60S ribosomal protein L21 [Sus scrofa];XP_003482913.1 60S ribosomal protein L21 [Sus scrofa];XP_003482912.1 60S ribosomal protein L21	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	53621000	NA	NA	NA	RPL21	RPL21;RPL21;RPL21;RPL21;RPL21	SRP-dependent cotranslational protein targeting to membrane;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000661; GO:000641; GO:000018	cytosolic large ribosomal subunit;membrane;endoplasmic reticulum;cytosol	GO:002262; GO:001602; GO:000578; GO:000582	 Ribosome	hsa0301	structural constituent of ribosome;protein binding;RNA binding	GO:000373; GO:000551; GO:000372
XP_003483009.1	XP_003483009.1	XP_003483009.1 26S proteasome non-ATPase regulatory subunit 12 [Sus scrofa]	8	8	8	26813000	26634000	29998000	19890000	27111000	19374000	34213000	22427000	26282000	22064000	27311000	30593000	20913000	21325000	26441000	26835000	28005000	18920000	NA	NA	NA	PSMD12	PSMD12;NA;NA;NA;NA	protein deubiquitination;post-translational protein modification;neutrophil degranulation;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:001657; GO:004368; GO:004331; GO:004316	proteasome complex;proteasome regulatory particle;extracellular region;nucleoplasm;secretory granule lumen;cytosol;membrane;extracellular exosome;cytoplasm;nuclear proteasome complex;ficolin-1-rich granule lumen;proteasome regulatory particle, lid subcomplex;proteasome accessory complex	GO:000050; GO:000583; GO:000557; GO:000565; GO:003477; GO:000582; GO:001602; GO:007006; GO:000573; GO:003159; GO:190481; GO:000854; GO:002262	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	"NA"	"NA"
XP_003483030.1;NP_001001635.1	XP_003483030.1	XP_003483030.1 eukaryotic translation initiation factor 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	4210800	0	0	0	0	0	0	NA	NA	NA	EIF1	EIF1;NA;NA;NA;NA	dosage compensation by inactivation of X chromosome;translational initiation;regulation of translational initiation	GO:000904; GO:000641; GO:000644	cytoplasm;nucleus;eukaryotic 43S preinitiation complex	GO:000573; GO:000563; GO:001628	 RNA transport	hsa0301	translation initiation factor activity;RNA binding;protein binding;translation factor activity, RNA binding;ribosomal small subunit binding	GO:000374; GO:000372; GO:000551; GO:000813; GO:004302
XP_020927004.1;XP_020927003.1;XP_020927002.1;XP_020927001.1;XP_020927000.1;XP_013836836.1;XP_013836835.1;XP_013836834.1;XP_013836832.1;XP_013836831.1;XP_005669341.1;XP_005669339.1;XP_005669335.1;XP_020926999.1;XP_003483176.1;XP_020926998.1;XP_020927005.1	XP_020927004.1;XP_020927003.1;XP_020927002.1;XP_020927001.1;XP_020927000.1;XP_013836836.1;XP_013836835.1;XP_013836834.1;XP_013836832.1;XP_013836831.1;XP_005669341.1;XP_005669339.1;XP_005669335.1;XP_020926999.1;XP_003483176.1;XP_020926998.1;XP_020927005.1	XP_020927004.1 biotinidase isoform X4 [Sus scrofa];XP_020927003.1 biotinidase isoform X4 [Sus scrofa];XP_020927002.1 biotinidase isoform X4 [Sus scrofa];XP_020927001.1 biotinidase isoform X4 [Sus scrofa];XP_020927000.1 biotinidase isoform X4 [Sus scrofa];X	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3718800	NA	NA	NA	BTD	BTD;BTD;BTD;BTD;BTD	biotin metabolic process;central nervous system development	GO:000676; GO:000741	extracellular region;mitochondrial matrix;extracellular exosome;extracellular space	GO:000557; GO:000575; GO:007006; GO:000561	 Biotin metabolism; Metabolic pathways; Vitamin digestion and absorption	hsa0078; hsa0110; hsa0497	biotinidase activity	GO:004770
XP_003483187.1	XP_003483187.1	XP_003483187.1 glycerol-3-phosphate dehydrogenase 1-like protein [Sus scrofa]	12	12	12	78280000	74874000	88924000	51800000	78079000	69815000	80682000	58393000	99925000	69345000	81610000	82710000	50664000	65726000	86085000	88439000	79434000	67912000	NA	NA	NA	GPD1L	GPD1L;NA;NA;NA;NA	NAD metabolic process;ventricular cardiac muscle cell action potential;action potential;negative regulation of peptidyl-serine phosphorylation;regulation of ventricular cardiac muscle cell membrane depolarization;positive regulation of protein localization to cell surface;oxidation-reduction process;regulation of sodium ion transmembrane transporter activity;carbohydrate metabolic process;glycerol-3-phosphate catabolic process;regulation of heart rate;NADH metabolic process;positive regulation of sodium ion transport;negative regulation of protein kinase C signaling;phosphatidic acid biosynthetic process	GO:001967; GO:008600; GO:000150; GO:003313; GO:006037; GO:200001; GO:005511; GO:200064; GO:000597; GO:004616; GO:000202; GO:000673; GO:001076; GO:009003; GO:000665	glycerol-3-phosphate dehydrogenase complex;extracellular exosome;cytosol;plasma membrane	GO:000933; GO:007006; GO:000582; GO:000588	 Glycerophospholipid metabolism	hsa0056	ion channel binding;sodium channel regulator activity;protein homodimerization activity;NAD binding;glycerol-3-phosphate dehydrogenase [NAD+	GO:004432; GO:001708; GO:004280; GO:005128; GO:000436
XP_003483226.1	XP_003483226.1	XP_003483226.1 mitochondrial carnitine/acylcarnitine carrier protein [Sus scrofa]	3	3	3	41652000	25027000	58201000	0	0	0	76994000	46636000	73777000	53386000	0	0	0	0	0	0	0	0	NA	NA	NA	SLC25A20	SLC25A20;NA;NA;NA;NA	acyl carnitine transmembrane transport;carnitine shuttle	GO:190261; GO:000685	mitochondrion;mitochondrial inner membrane;cytosol;integral component of membrane	GO:000573; GO:000574; GO:000582; GO:001602	"NA"	"NA"	acyl carnitine transmembrane transporter activity	GO:001522
XP_003483406.1;XP_005670390.1	XP_003483406.1;XP_005670390.1	XP_003483406.1 Down syndrome critical region protein 3 isoform X1 [Sus scrofa];XP_005670390.1 Down syndrome critical region protein 3 isoform X2 [Sus scrofa]	5	5	5	0	47370000	0	44956000	0	41445000	0	39448000	0	0	0	0	0	41964000	0	0	0	0	NA	NA	NA	VPS26C	VPS26C;VPS26C;NA;NA;NA	biological_process;intracellular protein transport	GO:000815; GO:000688	endosome;nucleus	GO:000576; GO:000563	"NA"	"NA"	molecular_function;protein transporter activity	GO:000367; GO:000856
XP_003483426.1	XP_003483426.1	XP_003483426.1 serine palmitoyltransferase 1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	7178300	0	0	0	0	0	0	NA	NA	NA	SPTLC1	SPTLC1;NA;NA;NA;NA	sphingolipid metabolic process;sphingolipid biosynthetic process;sphingosine biosynthetic process;positive regulation of lipophagy;sphingomyelin biosynthetic process	GO:000666; GO:003014; GO:004651; GO:190450; GO:000668	integral component of membrane;endoplasmic reticulum membrane;serine C-palmitoyltransferase complex;SPOTS complex	GO:001602; GO:000578; GO:001705; GO:003533	 Metabolic pathways; Sphingolipid signaling pathway; Sphingolipid metabolism	hsa0110; hsa0407; hsa0060	protein binding;serine C-palmitoyltransferase activity;pyridoxal phosphate binding	GO:000551; GO:000475; GO:003017
XP_003483427.1;XP_020943051.1	XP_003483427.1	XP_003483427.1 V-type proton ATPase subunit B, brain isoform [Sus scrofa]	9	9	9	0	32625000	21844000	27280000	28531000	25750000	26982000	27160000	27436000	26441000	28119000	35451000	31452000	27163000	0	29175000	23816000	28841000	NA	NA	NA	ATP6V1B2	ATP6V1B2;NA;NA;NA;NA	transferrin transport;regulation of macroautophagy;ATP metabolic process;insulin receptor signaling pathway;hydrogen ion transmembrane transport;ATP hydrolysis coupled proton transport;ion transmembrane transport	GO:003357; GO:001624; GO:004603; GO:000828; GO:190260; GO:001599; GO:003422	cytosol;intracellular membrane-bounded organelle;extracellular exosome;microvillus;endomembrane system;proton-transporting V-type ATPase, V1 domain;ruffle;plasma membrane;lysosomal membrane;integral component of membrane;melanosome	GO:000582; GO:004323; GO:007006; GO:000590; GO:001250; GO:003318; GO:000172; GO:000588; GO:000576; GO:001602; GO:004247	 Oxidative phosphorylation; Metabolic pathways; Epithelial cell signaling in Helicobacter pylori infection; Rheumatoid arthritis; Synaptic vesicle cycle; Phagosome; Collecting duct acid secretion; Vibrio cholerae infection	hsa0019; hsa0110; hsa0512; hsa0532; hsa0472; hsa0414; hsa0496; hsa0511	ATP binding;hydrogen ion transmembrane transporter activity;protein binding;proton-transporting ATPase activity, rotational mechanism	GO:000552; GO:001507; GO:000551; GO:004696
XP_003483474.1;XP_003483475.1	XP_003483474.1;XP_003483475.1	XP_003483474.1 vacuolar protein sorting-associated protein 29 isoform X2 [Sus scrofa];XP_003483475.1 vacuolar protein sorting-associated protein 29 isoform X1 [Sus scrofa]	6	6	6	188540000	170760000	191240000	140980000	149030000	129770000	187450000	129070000	198180000	145550000	150500000	168560000	151470000	175660000	187320000	141430000	186700000	164820000	NA	NA	NA	VPS29	VPS29;VPS29;NA;NA;NA	Wnt signaling pathway;intracellular protein transport;viral process;regulation of autophagy;retrograde transport, endosome to Golgi;retrograde transport, endosome to plasma membrane	GO:001605; GO:000688; GO:001603; GO:001050; GO:004214; GO:199012	intracellular membrane-bounded organelle;endosome membrane;retromer complex;cytosol;endosome;late endosome	GO:004323; GO:001000; GO:003090; GO:000582; GO:000576; GO:000577	 Endocytosis	hsa0414	protein transporter activity;metal ion binding;protein binding	GO:000856; GO:004687; GO:000551
XP_003483480.1	XP_003483480.1	XP_003483480.1 endoplasmic reticulum resident protein 29 [Sus scrofa]	6	6	6	94686000	75519000	78573000	79514000	0	80624000	81464000	96654000	0	61927000	87436000	107080000	61203000	74484000	73052000	77417000	74665000	87036000	NA	NA	NA	ERP29	ERP29;NA;NA;NA;NA	negative regulation of gene expression;positive regulation of gene expression;protein folding;protein secretion;protein unfolding;negative regulation of protein secretion;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;activation of MAPK activity;intracellular protein transport;positive regulation of protein phosphorylation	GO:001062; GO:001062; GO:000645; GO:000930; GO:004333; GO:005070; GO:190223; GO:000018; GO:000688; GO:000193	endoplasmic reticulum lumen;transport vesicle;cell surface;endoplasmic reticulum;smooth endoplasmic reticulum;membrane;melanosome	GO:000578; GO:003013; GO:000998; GO:000578; GO:000579; GO:001602; GO:004247	 Protein processing in endoplasmic reticulum	hsa0414	protein disulfide isomerase activity;protein homodimerization activity;chaperone binding	GO:000375; GO:004280; GO:005108
XP_003483483.2	XP_003483483.2	XP_003483483.2 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	7210800	0	0	0	0	0	0	0	NA	NA	NA	COQ5	COQ5;NA;NA;NA;NA	ubiquinone biosynthetic process;methylation	GO:000674; GO:003225	mitochondrion;mitochondrial inner membrane;mitochondrial matrix;extrinsic component of mitochondrial inner membrane;macromolecular complex	GO:000573; GO:000574; GO:000575; GO:003131; GO:003299	 Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways	hsa0013; hsa0110	protein binding;2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;2-octaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity	GO:000551; GO:004343; GO:004333
XP_003483500.1	XP_003483500.1	XP_003483500.1 splicing factor 3A subunit 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6644500	0	NA	NA	NA	SF3A1	SF3A1;NA;NA;NA;NA	mRNA splicing, via spliceosome;U2-type prespliceosome assembly;mRNA 3'-splice site recognition;mRNA processing	GO:000039; GO:190324; GO:000038; GO:000639	nucleoplasm;U2-type prespliceosome;catalytic step 2 spliceosome;U2-type spliceosomal complex;nucleus;nuclear speck	GO:000565; GO:007100; GO:007101; GO:000568; GO:000563; GO:001660	 Spliceosome	hsa0304	protein binding;RNA binding	GO:000551; GO:000372
XP_020929189.1;XP_020929188.1;XP_020929187.1;XP_020929186.1;XP_003483533.3;XP_020929185.1;XP_020929184.1;XP_020929183.1;XP_020929182.1;XP_020929181.1	XP_020929189.1;XP_020929188.1;XP_020929187.1;XP_020929186.1;XP_003483533.3;XP_020929185.1;XP_020929184.1;XP_020929183.1;XP_020929182.1;XP_020929181.1	XP_020929189.1 phenazine biosynthesis-like domain-containing protein isoform X3 [Sus scrofa];XP_020929188.1 phenazine biosynthesis-like domain-containing protein isoform X3 [Sus scrofa];XP_020929187.1 phenazine biosynthesis-like domain-containing protein i	4	4	4	0	32639000	26264000	0	0	0	30279000	0	0	0	0	32170000	0	0	0	35795000	33405000	0	NA	NA	NA	PBLD	PBLD;PBLD;PBLD;PBLD;PBLD	negative regulation of epithelial cell proliferation;negative regulation of SMAD protein import into nucleus;biosynthetic process;negative regulation of epithelial to mesenchymal transition;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of epithelial cell migration;maintenance of gastrointestinal epithelium	GO:005068; GO:006039; GO:000905; GO:001071; GO:003051; GO:001063; GO:003027	extracellular exosome;cytoplasm	GO:007006; GO:000573	"NA"	"NA"	identical protein binding;isomerase activity;protein binding;molecular_function	GO:004280; GO:001685; GO:000551; GO:000367
XP_020928244.1;XP_003483550.1;XP_013838801.1	XP_020928244.1;XP_003483550.1;XP_013838801.1	XP_020928244.1 protein transport protein Sec24C isoform X2 [Sus scrofa];XP_003483550.1 protein transport protein Sec24C isoform X2 [Sus scrofa];XP_013838801.1 protein transport protein Sec24C isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4536400	NA	NA	NA	SEC24C	SEC24C;SEC24C;SEC24C;NA;NA	cargo loading into COPII-coated vesicle;COPII vesicle coating;ER to Golgi vesicle-mediated transport;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of exogenous peptide antigen via MHC class II;in utero embryonic development	GO:009011; GO:004820; GO:000688; GO:000247; GO:001988; GO:000170	ER to Golgi transport vesicle membrane;COPII vesicle coat;endoplasmic reticulum membrane;Golgi membrane;cytosol	GO:001250; GO:003012; GO:000578; GO:000013; GO:000582	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;SNARE binding;zinc ion binding	GO:000551; GO:000014; GO:000827
XP_003483583.1	XP_003483583.1	XP_003483583.1 phosphoglycerate mutase 1 [Sus scrofa]	15	15	11	1150500000	1034100000	1473700000	935670000	1108200000	838980000	1317600000	917470000	1216100000	904090000	1013800000	959870000	896320000	944030000	1190700000	1037600000	1378300000	829500000	NA	NA	NA	PGAM1	PGAM1;NA;NA;NA;NA	respiratory burst;glycolytic process;neutrophil degranulation;regulation of glycolytic process;regulation of pentose-phosphate shunt;canonical glycolysis	GO:004573; GO:000609; GO:004331; GO:000611; GO:004345; GO:006162	ficolin-1-rich granule lumen;cytosol;cytoplasm;secretory granule lumen;extracellular exosome;membrane;extracellular region	GO:190481; GO:000582; GO:000573; GO:003477; GO:007006; GO:001602; GO:000557	 Biosynthesis of amino acids; Glucagon signaling pathway; Carbon metabolism; Glycolysis / Gluconeogenesis; Glycine, serine and threonine metabolism; Metabolic pathways; Biosynthesis of antibiotics; Central carbon metabolism in cancer	hsa0123; hsa0492; hsa0120; hsa0001; hsa0026; hsa0110; hsa0113; hsa0523	bisphosphoglycerate mutase activity;phosphoglycerate mutase activity;hydrolase activity;protein binding;protein kinase binding	GO:000408; GO:000461; GO:001678; GO:000551; GO:001990
XP_003483683.2	XP_003483683.2	XP_003483683.2 glutathione reductase, mitochondrial [Sus scrofa]	8	8	8	33244000	35520000	31893000	33675000	31779000	32848000	44611000	32420000	37544000	28073000	33879000	34260000	38843000	35396000	38127000	33047000	38339000	26906000	NA	NA	NA	GSR	GSR;NA;NA;NA;NA	glutathione metabolic process;nucleobase-containing small molecule interconversion;electron transport chain;cellular oxidant detoxification;cell redox homeostasis;cellular response to oxidative stress	GO:000674; GO:001594; GO:002290; GO:009886; GO:004545; GO:003459	mitochondrial matrix;extracellular exosome;external side of plasma membrane;cytosol;mitochondrion	GO:000575; GO:007006; GO:000989; GO:000582; GO:000573	 Thyroid hormone synthesis; Glutathione metabolism	hsa0491; hsa0048	glutathione-disulfide reductase activity;electron carrier activity;flavin adenine dinucleotide binding	GO:000436; GO:000905; GO:005066
XP_013840158.1;XP_003483854.1	XP_013840158.1;XP_003483854.1	XP_013840158.1 brain acid soluble protein 1 [Sus scrofa];XP_003483854.1 brain acid soluble protein 1 [Sus scrofa]	12	12	12	262350000	172780000	272890000	121810000	58396000	58408000	103090000	47542000	216620000	112950000	124010000	52149000	318910000	111800000	86206000	49022000	225970000	60316000	NA	NA	NA	BASP1	BASP1;BASP1;NA;NA;NA	thorax and anterior abdomen determination;positive regulation of heart growth;diaphragm development;metanephric mesenchyme development;glomerular visceral epithelial cell differentiation;positive regulation of metanephric ureteric bud development;substantia nigra development;negative regulation of transcription, DNA-templated;gonad development;mesenchymal to epithelial transition	GO:000735; GO:006042; GO:006053; GO:007207; GO:007211; GO:200107; GO:002176; GO:004589; GO:000840; GO:006023	cytoplasm;cytoskeleton;COP9 signalosome;vesicle;extracellular exosome;nuclear speck;nucleus;growth cone;plasma membrane;cell junction	GO:000573; GO:000585; GO:000818; GO:003198; GO:007006; GO:001660; GO:000563; GO:003042; GO:000588; GO:003005	"NA"	"NA"	protein binding;transcription regulatory region DNA binding;protein domain specific binding;transcription corepressor activity	GO:000551; GO:004421; GO:001990; GO:000371
XP_003483948.1	XP_003483948.1	XP_003483948.1 putative hydrolase RBBP9 [Sus scrofa]	3	3	3	0	0	15744000	0	0	0	0	0	14504000	17463000	0	0	0	0	0	0	14536000	0	NA	NA	NA	RBBP9	RBBP9;NA;NA;NA;NA	regulation of cell proliferation	GO:004212	cytoplasm;nucleoplasm	GO:000573; GO:000565	"NA"	"NA"	hydrolase activity;protein binding	GO:001678; GO:000551
XP_003484071.1	XP_003484071.1	XP_003484071.1 calumenin isoform X1 [Sus scrofa]	12	12	3	368750000	471830000	366800000	452760000	327450000	360410000	438980000	478070000	355850000	363370000	428020000	560950000	287070000	481650000	426610000	467490000	464140000	435770000	NA	NA	NA	CALU	CALU;NA;NA;NA;NA	post-translational protein modification;biological_process;cellular protein metabolic process	GO:004368; GO:000815; GO:004426	endoplasmic reticulum membrane;melanosome;endoplasmic reticulum;membrane;Golgi apparatus;sarcoplasmic reticulum lumen;extracellular region	GO:000578; GO:004247; GO:000578; GO:001602; GO:000579; GO:003301; GO:000557	"NA"	"NA"	protein binding;calcium ion binding	GO:000551; GO:000550
XP_003484266.1	XP_003484266.1	XP_003484266.1 vesicle-trafficking protein SEC22b [Sus scrofa]	12	12	12	171720000	188810000	160070000	214160000	187190000	193580000	170360000	189530000	145680000	194550000	213310000	238830000	128060000	228560000	208670000	218690000	197700000	187950000	NA	NA	NA	LOC100157002	LOC100157002;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005652426.1	XP_005652426.1	XP_005652426.1 alpha-2-HS-glycoprotein [Sus scrofa]	14	14	14	3939800000	5945700000	3107800000	5156700000	7961200000	12853000000	4915300000	4586600000	3562500000	3577700000	5191700000	4127200000	3797800000	4032500000	4943800000	4824300000	3889400000	5411500000	NA	NA	NA	AHSG	AHSG;NA;NA;NA;NA	skeletal system development;negative regulation of kinase activity;platelet degranulation;pinocytosis;negative regulation of insulin receptor signaling pathway;regulation of inflammatory response;negative regulation of bone mineralization;post-translational protein modification;ossification;neutrophil degranulation;positive regulation of phagocytosis;negative regulation of endopeptidase activity;cellular protein metabolic process;acute-phase response	GO:000150; GO:003367; GO:000257; GO:000690; GO:004662; GO:005072; GO:003050; GO:004368; GO:000150; GO:004331; GO:005076; GO:001095; GO:004426; GO:000695	secretory granule lumen;blood microparticle;platelet alpha granule lumen;extracellular space;Golgi apparatus;extracellular exosome;extracellular region;endoplasmic reticulum lumen	GO:003477; GO:007256; GO:003109; GO:000561; GO:000579; GO:007006; GO:000557; GO:000578	"NA"	"NA"	cysteine-type endopeptidase inhibitor activity;kinase inhibitor activity	GO:000486; GO:001921
XP_005652497.1	XP_005652497.1	XP_005652497.1 serum deprivation-response protein [Sus scrofa]	14	14	14	443020000	631050000	533340000	444840000	419720000	428120000	497600000	542090000	582870000	536370000	437420000	189310000	266590000	620930000	427800000	582350000	426560000	517650000	NA	NA	NA	CAVIN2	CAVIN2;NA;NA;NA;NA	plasma membrane tubulation	GO:009732	cytosol;cytoplasm;actin cytoskeleton;nucleoplasm;plasma membrane;caveola;membrane raft	GO:000582; GO:000573; GO:001562; GO:000565; GO:000588; GO:000590; GO:004512	"NA"	"NA"	protein binding;phosphatidylserine binding;phospholipid binding;protein kinase C binding	GO:000551; GO:000178; GO:000554; GO:000508
XP_005652622.1	XP_005652622.1	XP_005652622.1 prefoldin subunit 5 [Sus scrofa]	3	3	3	18332000	20553000	15690000	0	22766000	20451000	20082000	0	22123000	0	20017000	0	14135000	14591000	16022000	17431000	24940000	13474000	NA	NA	NA	PFDN5	PFDN5;NA;NA;NA;NA	negative regulation of transcription, DNA-templated;negative regulation of canonical Wnt signaling pathway;protein folding;regulation of transcription, DNA-templated;retina development in camera-type eye	GO:004589; GO:009009; GO:000645; GO:000635; GO:006004	cytoplasm;prefoldin complex;nucleus	GO:000573; GO:001627; GO:000563	"NA"	"NA"	unfolded protein binding;protein binding;transcription corepressor activity	GO:005108; GO:000551; GO:000371
XP_005652636.3	XP_005652636.3	XP_005652636.3 keratin, type I cytoskeletal 18 [Sus scrofa]	9	7	7	652130000	178790000	163530000	440660000	607940000	0	193330000	0	197690000	0	0	0	400470000	0	407360000	0	266850000	0	NA	NA	NA	KRT18	KRT18;NA;NA;NA;NA	Golgi to plasma membrane CFTR protein transport;tumor necrosis factor-mediated signaling pathway;intermediate filament cytoskeleton organization;cell-cell adhesion;hepatocyte apoptotic process;viral process;cornification;keratinization;negative regulation of apoptotic process;extrinsic apoptotic signaling pathway;cell cycle;anatomical structure morphogenesis	GO:004300; GO:003320; GO:004510; GO:009860; GO:009728; GO:001603; GO:007026; GO:003142; GO:004306; GO:009719; GO:000704; GO:000965	cytoplasm;keratin filament;cell-cell adherens junction;perinuclear region of cytoplasm;microtubule organizing center;nucleolus;intermediate filament;cytosol;centriolar satellite;extracellular exosome;cell periphery	GO:000573; GO:004509; GO:000591; GO:004847; GO:000581; GO:000573; GO:000588; GO:000582; GO:003445; GO:007006; GO:007194	 Pathogenic Escherichia coli infection	hsa0513	structural molecule activity;protein binding;RNA binding;cadherin binding involved in cell-cell adhesion;scaffold protein binding	GO:000519; GO:000551; GO:000372; GO:009864; GO:009711
XP_005652652.1;XP_020948071.1	XP_005652652.1;XP_020948071.1	XP_005652652.1 gamma-enolase isoform X1 [Sus scrofa];XP_020948071.1 gamma-enolase isoform X2 [Sus scrofa]	8	4	4	0	24353000	0	0	0	0	0	0	0	0	0	0	16942000	0	0	0	0	0	NA	NA	NA	ENO2	ENO2;ENO2;NA;NA;NA	glycolytic process;canonical glycolysis;gluconeogenesis	GO:000609; GO:006162; GO:000609	extracellular space;cytosol;plasma membrane;phosphopyruvate hydratase complex;photoreceptor inner segment;membrane;perikaryon;extracellular exosome	GO:000561; GO:000582; GO:000588; GO:000001; GO:000191; GO:001602; GO:004320; GO:007006	 Glycolysis / Gluconeogenesis; Biosynthesis of antibiotics; Biosynthesis of amino acids; Carbon metabolism; HIF-1 signaling pathway; Metabolic pathways; RNA degradation	hsa0001; hsa0113; hsa0123; hsa0120; hsa0406; hsa0110; hsa0301	phosphopyruvate hydratase activity;protein binding;magnesium ion binding	GO:000463; GO:000551; GO:000028
XP_005652934.1;XP_003123386.2	XP_005652934.1;XP_003123386.2	XP_005652934.1 UV excision repair protein RAD23 homolog A isoform X2 [Sus scrofa];XP_003123386.2 UV excision repair protein RAD23 homolog A isoform X1 [Sus scrofa]	4	4	4	0	0	21421000	0	0	0	0	13823000	29310000	8847000	20052000	0	0	0	20749000	20159000	0	0	NA	NA	NA	RAD23A	RAD23A;RAD23A;NA;NA;NA	protein destabilization;nucleotide-excision repair;viral process;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of cell cycle;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of viral genome replication	GO:003164; GO:000628; GO:001603; GO:003243; GO:004578; GO:001657; GO:004316; GO:004507	cytoplasm;microtubule organizing center;macromolecular complex;intracellular membrane-bounded organelle;proteasome complex;nucleus;nucleoplasm;cytosol	GO:000573; GO:000581; GO:003299; GO:004323; GO:000050; GO:000563; GO:000565; GO:000582	 Nucleotide excision repair; Protein processing in endoplasmic reticulum	hsa0342; hsa0414	proteasome binding;damaged DNA binding;single-stranded DNA binding;kinase binding;ubiquitin binding;protein binding;ubiquitin-specific protease binding;polyubiquitin binding	GO:007062; GO:000368; GO:000369; GO:001990; GO:004313; GO:000551; GO:199038; GO:003159
XP_020942367.1;XP_020942366.1;XP_020942365.1;XP_013848158.1;XP_020942364.1;XP_005653093.1;XP_020942363.1;XP_020942362.1;XP_020942361.1	XP_020942367.1;XP_020942366.1;XP_020942365.1;XP_013848158.1;XP_020942364.1;XP_005653093.1;XP_020942363.1;XP_020942362.1;XP_020942361.1	XP_020942367.1 sarcalumenin isoform X7 [Sus scrofa];XP_020942366.1 sarcalumenin isoform X7 [Sus scrofa];XP_020942365.1 sarcalumenin isoform X7 [Sus scrofa];XP_013848158.1 sarcalumenin isoform X6 [Sus scrofa];XP_020942364.1 sarcalumenin isoform X5 [Sus scro	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16540000	0	NA	NA	NA	SRL	SRL;SRL;SRL;SRL;SRL	"NA"	"NA"	sarcoplasmic reticulum lumen	GO:003301	"NA"	"NA"	GTP binding	GO:000552
XP_005653330.2	XP_005653330.2	XP_005653330.2 xaa-Pro dipeptidase [Sus scrofa]	16	16	16	312240000	471790000	374600000	855820000	288190000	582930000	393050000	661320000	455220000	661520000	389660000	565020000	604740000	737720000	455160000	706930000	379590000	800710000	NA	NA	NA	PEPD	PEPD;NA;NA;NA;NA	proteolysis;cellular amino acid metabolic process;collagen catabolic process	GO:000650; GO:000652; GO:003057	nucleus;nucleoplasm;extracellular exosome	GO:000563; GO:000565; GO:007006	"NA"	"NA"	aminopeptidase activity;protein binding;proline dipeptidase activity;manganese ion binding;metallocarboxypeptidase activity	GO:000417; GO:000551; GO:010200; GO:003014; GO:000418
XP_005653410.1;XP_003127549.1	XP_005653410.1;XP_003127549.1	XP_005653410.1 von Willebrand factor A domain-containing protein 1 isoform X2 [Sus scrofa];XP_003127549.1 von Willebrand factor A domain-containing protein 1 isoform X1 [Sus scrofa]	7	7	7	35781000	59278000	28073000	39955000	30266000	23741000	34333000	50371000	22958000	33606000	44126000	50115000	41274000	47542000	36807000	57378000	30283000	28153000	NA	NA	NA	VWA1	VWA1;VWA1;NA;NA;NA	cellular protein metabolic process;growth plate cartilage chondrocyte morphogenesis;extracellular matrix organization;behavioral response to pain;post-translational protein modification	GO:004426; GO:000342; GO:003019; GO:004826; GO:004368	extracellular space;extracellular exosome;interstitial matrix;extracellular matrix;basement membrane;endoplasmic reticulum lumen	GO:000561; GO:007006; GO:000561; GO:003101; GO:000560; GO:000578	"NA"	"NA"	extracellular matrix structural constituent;identical protein binding	GO:000520; GO:004280
XP_005653457.2	XP_005653457.2	XP_005653457.2 rho-associated protein kinase 1 [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	69975000	0	0	0	0	0	NA	NA	NA	ROCK1	ROCK1;NA;NA;NA;NA	bleb assembly;protein localization to plasma membrane;aortic valve morphogenesis;peptidyl-serine phosphorylation;cortical actin cytoskeleton organization;vascular endothelial growth factor receptor signaling pathway;regulation of stress fiber assembly;regulation of synaptic vesicle endocytosis;negative regulation of amyloid precursor protein catabolic process;regulation of cell motility;regulation of autophagy;negative regulation of protein binding;neutrophil degranulation;negative regulation of membrane protein ectodomain proteolysis;protein phosphorylation;neuron projection development;regulation of neuron differentiation;leukocyte tethering or rolling;positive regulation of connective tissue replacement;regulation of establishment of cell polarity;apical constriction;apoptotic process;leukocyte cell-cell adhesion;signal transduction;membrane to membrane docking;regulation of cell adhesion;response to transforming growth factor beta;negative regulation of bicellular tight junction assembly;response to angiotensin;G-protein coupled receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;Rho protein signal transduction;negative regulation of angiogenesis;negative regulation of myosin-light-chain-phosphatase activity;regulation of keratinocyte differentiation;positive regulation of beta-amyloid clearance;regulation of establishment of endothelial barrier;positive regulation of gene expression;actin cytoskeleton organization;regulation of actin cytoskeleton organization;myoblast migration;regulation of focal adhesion assembly;negative regulation of beta-amyloid formation;smooth muscle contraction;positive regulation of cardiac muscle hypertrophy;positive regulation of MAPK cascade;negative regulation of neuron apoptotic process;negative regulation of biomineral tissue development;regulation of beta-amyloid formation	GO:003206; GO:007265; GO:000318; GO:001810; GO:003086; GO:004801; GO:005149; GO:190024; GO:190299; GO:200014; GO:001050; GO:003209; GO:004331; GO:005104; GO:000646; GO:003117; GO:004566; GO:005090; GO:190520; GO:200011; GO:000338; GO:000691; GO:000715; GO:000716; GO:002261; GO:003015; GO:007155; GO:190334; GO:199077; GO:000718; GO:000724; GO:000726; GO:001652; GO:003550; GO:004561; GO:190022; GO:190314; GO:001062; GO:003003; GO:003295; GO:005145; GO:005189; GO:190243; GO:000693; GO:001061; GO:004341; GO:004352; GO:007016; GO:190200	Golgi membrane;centriole;extracellular region;lamellipodium;bleb;cytosol;secretory granule lumen;ruffle;cytoskeleton;plasma membrane;cytoplasmic stress granule	GO:000013; GO:000581; GO:000557; GO:003002; GO:003205; GO:000582; GO:003477; GO:000172; GO:000585; GO:000588; GO:001049	 Platelet activation; Pathways in cancer; Sphingolipid signaling pathway; Shigellosis; Vascular smooth muscle contraction; TGF-beta signaling pathway; Focal adhesion; Chemokine signaling pathway; Oxytocin signaling pathway; cGMP-PKG signaling pathway; Regulation of actin cytoskeleton; Leukocyte transendothelial migration; Axon guidance	hsa0461; hsa0520; hsa0407; hsa0513; hsa0427; hsa0435; hsa0451; hsa0406; hsa0492; hsa0402; hsa0481; hsa0467; hsa0436	protein binding;tau protein binding;protein kinase activity;ATP binding;metal ion binding;tau-protein kinase activity;Rho-dependent protein serine/threonine kinase activity;GTP-Rho binding	GO:000551; GO:004815; GO:000467; GO:000552; GO:004687; GO:005032; GO:007251; GO:001704
XP_005653559.1;NP_001171998.1;XP_020953641.1;XP_020953642.1	XP_005653559.1;NP_001171998.1;XP_020953641.1;XP_020953642.1	XP_005653559.1 protein unc-45 homolog A isoform X2 [Sus scrofa];NP_001171998.1 protein unc-45 homolog A [Sus scrofa];XP_020953641.1 protein unc-45 homolog A isoform X1 [Sus scrofa];XP_020953642.1 protein unc-45 homolog A isoform X3 [Sus scrofa]	10	10	10	0	0	16400000	0	0	10325000	0	12218000	15123000	20903000	15666000	0	0	11710000	0	0	14201000	0	NA	NA	NA	UNC45A	UNC45A;UNC45A;UNC45A;UNC45A;NA	muscle organ development;chaperone-mediated protein folding;cell differentiation	GO:000751; GO:006107; GO:003015	cytosol;nuclear speck;Golgi apparatus;perinuclear region of cytoplasm	GO:000582; GO:001660; GO:000579; GO:004847	"NA"	"NA"	cadherin binding;protein binding;Hsp90 protein binding	GO:004529; GO:000551; GO:005187
XP_005653581.1;XP_005653580.1;NP_999442.1;XP_020953963.1	XP_005653581.1;XP_005653580.1;NP_999442.1;XP_020953963.1	XP_005653581.1 aminopeptidase N isoform X2 [Sus scrofa];XP_005653580.1 aminopeptidase N isoform X2 [Sus scrofa];NP_999442.1 aminopeptidase N [Sus scrofa];XP_020953963.1 aminopeptidase N isoform X1 [Sus scrofa]	14	14	14	42340000	76022000	28893000	110840000	25203000	161830000	45123000	142760000	40864000	85079000	61622000	103020000	216430000	127330000	29598000	85667000	68836000	74130000	NA	NA	NA	ANPEP	ANPEP;ANPEP;ANPEP;ANPEP;NA	angiogenesis;cell differentiation;peptide catabolic process;neutrophil degranulation;proteolysis;viral entry into host cell	GO:000152; GO:003015; GO:004317; GO:004331; GO:000650; GO:004671	external side of plasma membrane;cytoplasm;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment;extracellular exosome;extracellular space;lysosomal membrane;plasma membrane;secretory granule membrane	GO:000989; GO:000573; GO:001602; GO:000579; GO:007006; GO:000561; GO:000576; GO:000588; GO:003066	 Metabolic pathways; Hematopoietic cell lineage; Glutathione metabolism; Renin-angiotensin system	hsa0110; hsa0464; hsa0048; hsa0461	signaling receptor activity;peptide binding;virus receptor activity;aminopeptidase activity;zinc ion binding;metallopeptidase activity;metalloaminopeptidase activity	GO:003802; GO:004227; GO:000161; GO:000417; GO:000827; GO:000823; GO:007000
XP_020918085.1;XP_013854694.1;XP_020918084.1;XP_005653725.1;XP_005653724.1;XP_005653723.1;XP_005653722.1;XP_005653721.1	XP_020918085.1;XP_013854694.1;XP_020918084.1;XP_005653725.1;XP_005653724.1;XP_005653723.1;XP_005653722.1;XP_005653721.1	XP_020918085.1 nuclear mitotic apparatus protein 1 isoform X2 [Sus scrofa];XP_013854694.1 nuclear mitotic apparatus protein 1 isoform X2 [Sus scrofa];XP_020918084.1 nuclear mitotic apparatus protein 1 isoform X1 [Sus scrofa];XP_005653725.1 nuclear mitotic	12	12	12	0	24937000	23019000	0	27108000	30782000	29441000	26729000	28145000	26955000	30302000	30513000	28524000	28432000	26086000	22811000	21805000	24930000	NA	NA	NA	NUMA1	NUMA1;NUMA1;NUMA1;NUMA1;NUMA1	cell division;anastral spindle assembly;regulation of mitotic spindle organization;positive regulation of chromosome separation;chromosome segregation;positive regulation of hair follicle development;positive regulation of mitotic spindle elongation;positive regulation of intracellular transport;regulation of metaphase plate congression;establishment of mitotic spindle orientation;positive regulation of BMP signaling pathway;positive regulation of microtubule polymerization;positive regulation of keratinocyte differentiation;positive regulation of chromosome segregation;nucleus organization;microtubule bundle formation;positive regulation of protein localization to cell cortex;astral microtubule organization;meiotic cell cycle;positive regulation of protein localization to spindle pole body;positive regulation of spindle assembly	GO:005130; GO:005504; GO:006023; GO:190582; GO:000705; GO:005179; GO:190284; GO:003238; GO:009023; GO:000013; GO:003051; GO:003111; GO:004561; GO:005198; GO:000699; GO:000157; GO:190477; GO:003095; GO:005132; GO:190236; GO:190583	Golgi membrane;chromosome;spindle microtubule;neuronal cell body;mitotic spindle pole;spindle pole;cytosol;microtubule plus-end;extracellular exosome;lateral plasma membrane;macromolecular complex;microtubule bundle;cytoplasm;nucleoplasm;cell cortex;spindle pole centrosome;microtubule minus-end;mitotic spindle astral microtubule;cytoplasmic microtubule bundle;mitotic spindle midzone;dendrite;lateral cell cortex;cell cortex region;spindle;nuclear matrix;cortical microtubule;nucleus;extrinsic component of plasma membrane;mitotic spindle	GO:000013; GO:000569; GO:000587; GO:004302; GO:009743; GO:000092; GO:000582; GO:003537; GO:007006; GO:001632; GO:003299; GO:009742; GO:000573; GO:000565; GO:000593; GO:003161; GO:003644; GO:006167; GO:190572; GO:199002; GO:003042; GO:009757; GO:009973; GO:000581; GO:001636; GO:005502; GO:000563; GO:001989; GO:007268	"NA"	"NA"	protein C-terminus binding;microtubule binding;protein domain specific binding;structural molecule activity;tubulin binding;dynein complex binding;microtubule minus-end binding;protein binding;phosphatidylinositol binding;disordered domain specific binding;macromolecular complex binding	GO:000802; GO:000801; GO:001990; GO:000519; GO:001563; GO:007084; GO:005101; GO:000551; GO:003509; GO:009771; GO:004487
XP_005653913.2	XP_005653913.2	XP_005653913.2 LOW QUALITY PROTEIN: septin-9 [Sus scrofa]	11	11	11	33724000	65327000	37305000	47778000	37442000	72587000	34352000	49740000	27182000	54302000	45039000	104060000	65758000	66948000	39187000	59390000	41399000	72044000	NA	NA	NA	Sep 09	Sep 09;NA;NA;NA;NA	protein heterooligomerization;cytoskeleton-dependent cytokinesis;positive regulation of non-motile cilium assembly	GO:005129; GO:006164; GO:190285	microtubule cytoskeleton;non-motile cilium;septin complex;stress fiber;septin ring;perinuclear region of cytoplasm;cytoplasm;microtubule;axoneme;actin cytoskeleton	GO:001563; GO:009773; GO:003110; GO:000172; GO:000594; GO:004847; GO:000573; GO:000587; GO:000593; GO:001562	 Bacterial invasion of epithelial cells	hsa0510	protein binding;GTP binding;GTPase activity;cadherin binding;protein complex scaffold	GO:000551; GO:000552; GO:000392; GO:004529; GO:003294
XP_005653924.2	XP_005653924.2	XP_005653924.2 signal recognition particle subunit SRP68 [Sus scrofa]	4	4	4	0	4994900	4577000	0	0	0	3910800	5293900	0	0	0	11523000	0	0	4965600	0	0	0	NA	NA	NA	SRP68	SRP68;NA;NA;NA;NA	response to drug;SRP-dependent cotranslational protein targeting to membrane	GO:004249; GO:000661	endoplasmic reticulum;signal recognition particle;nucleolus;ribosome;focal adhesion;signal recognition particle, endoplasmic reticulum targeting;cytosol	GO:000578; GO:004850; GO:000573; GO:000584; GO:000592; GO:000578; GO:000582	 Protein export	hsa0306	endoplasmic reticulum signal peptide binding;signal recognition particle binding;protein binding;7S RNA binding;protein domain specific binding;RNA binding;ribosome binding	GO:003094; GO:000504; GO:000551; GO:000831; GO:001990; GO:000372; GO:004302
XP_020930454.1;XP_005654217.2	XP_020930454.1;XP_005654217.2	XP_020930454.1 UBX domain-containing protein 4 isoform X2 [Sus scrofa];XP_005654217.2 UBX domain-containing protein 4 isoform X1 [Sus scrofa]	4	4	4	24214000	0	27721000	32332000	22115000	0	26795000	31352000	26550000	34392000	19480000	0	0	31636000	34123000	30807000	21256000	0	NA	NA	NA	UBXN4	UBXN4;UBXN4;NA;NA;NA	ubiquitin-dependent ERAD pathway;response to unfolded protein	GO:003043; GO:000698	cytosol;nuclear envelope;endoplasmic reticulum membrane	GO:000582; GO:000563; GO:000578	"NA"	"NA"	protein binding	GO:000551
XP_005654305.1;XP_005654304.1	XP_005654305.1;XP_005654304.1	XP_005654305.1 prostacyclin synthase isoform X2 [Sus scrofa];XP_005654304.1 prostacyclin synthase isoform X1 [Sus scrofa]	16	16	16	157970000	150760000	328640000	171170000	141260000	154250000	219820000	171010000	128290000	123790000	210870000	163120000	318810000	134030000	233270000	130050000	273370000	164670000	NA	NA	NA	PTGIS	PTGIS;PTGIS;NA;NA;NA	cellular response to interleukin-6;apoptotic signaling pathway;positive regulation of execution phase of apoptosis;cyclooxygenase pathway;negative regulation of NF-kappaB transcription factor activity;decidualization;negative regulation of inflammatory response;cellular response to hypoxia;negative regulation of nitric oxide biosynthetic process;prostaglandin biosynthetic process;oxidation-reduction process;embryo implantation;positive regulation of peroxisome proliferator activated receptor signaling pathway;NAD biosynthesis via nicotinamide riboside salvage pathway;positive regulation of angiogenesis;icosanoid metabolic process;cellular response to interleukin-1	GO:007135; GO:009719; GO:190011; GO:001937; GO:003208; GO:004669; GO:005072; GO:007145; GO:004501; GO:000151; GO:005511; GO:000756; GO:003536; GO:003435; GO:004576; GO:000669; GO:007134	endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;caveola;nucleus;extracellular space	GO:000578; GO:000578; GO:001602; GO:000590; GO:000563; GO:000561	 Arachidonic acid metabolism; Metabolic pathways	hsa0059; hsa0110	prostaglandin-I synthase activity;monooxygenase activity;iron ion binding;protein binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding	GO:000811; GO:000449; GO:000550; GO:000551; GO:001670; GO:002003
XP_020955030.1;XP_005654535.1	XP_020955030.1;XP_005654535.1	XP_020955030.1 protein disulfide-isomerase TMX3 isoform X2 [Sus scrofa];XP_005654535.1 protein disulfide-isomerase TMX3 isoform X1 [Sus scrofa]	7	7	7	34685000	38840000	35117000	46293000	36737000	34753000	27181000	46367000	37762000	33067000	41943000	33488000	0	41649000	52371000	48310000	38378000	38908000	NA	NA	NA	TMX3	TMX3;TMX3;NA;NA;NA	cell redox homeostasis;platelet degranulation;peptidyl-cysteine oxidation	GO:004545; GO:000257; GO:001817	plasma membrane;endoplasmic reticulum membrane;cell surface;integral component of membrane;platelet alpha granule membrane	GO:000588; GO:000578; GO:000998; GO:001602; GO:003109	"NA"	"NA"	protein disulfide isomerase activity;protein binding;thiol oxidase activity	GO:000375; GO:000551; GO:001697
XP_005654787.1;XP_003123174.3	XP_005654787.1;XP_003123174.3	XP_005654787.1 cdc42-interacting protein 4 isoform X1 [Sus scrofa];XP_003123174.3 cdc42-interacting protein 4 isoform X2 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	13728000	0	0	0	0	0	NA	NA	NA	TRIP10	TRIP10;TRIP10;NA;NA;NA	actin cytoskeleton organization;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;membrane organization;cell communication;endocytosis;signal transduction	GO:003003; GO:004354; GO:005105; GO:006102; GO:000715; GO:000689; GO:000716	cell projection;perinuclear region of cytoplasm;cytoplasm;phagocytic cup;nucleoplasm;cytoskeleton;Golgi apparatus;cytosol;cell cortex;intracellular membrane-bounded organelle;lysosome;extracellular exosome	GO:004299; GO:004847; GO:000573; GO:000189; GO:000565; GO:000585; GO:000579; GO:000582; GO:000593; GO:004323; GO:000576; GO:007006	 Insulin signaling pathway	hsa0491	GTPase activator activity;protein binding;identical protein binding;lipid binding	GO:000509; GO:000551; GO:004280; GO:000828
XP_020934397.1;XP_005654811.2;XP_005654810.2;NP_001231859.1;XP_020934430.1;XP_020934422.1;XP_020934412.1;XP_020934405.1;XP_020934400.1;XP_013842803.1;XP_013842802.1;XP_005654812.2;XP_020934436.1;XP_020934407.1;XP_020934452.1;XP_013842805.1;XP_020934444.1;XP_013842804.1;XP_020934459.1;XP_020934448.1	XP_020934397.1;XP_005654811.2;XP_005654810.2;NP_001231859.1;XP_020934430.1;XP_020934422.1;XP_020934412.1;XP_020934405.1;XP_020934400.1;XP_013842803.1;XP_013842802.1;XP_005654812.2;XP_020934436.1;XP_020934407.1;XP_020934452.1;XP_013842805.1;XP_020934444.1;XP_013842804.1	XP_020934397.1 heterogeneous nuclear ribonucleoprotein M isoform X6 [Sus scrofa];XP_005654811.2 heterogeneous nuclear ribonucleoprotein M isoform X2 [Sus scrofa];XP_005654810.2 heterogeneous nuclear ribonucleoprotein M isoform X1 [Sus scrofa];NP_001231859.	12	12	12	82926000	98442000	91249000	103270000	99298000	140830000	112700000	99469000	88341000	103000000	120920000	84835000	107390000	116750000	117710000	109180000	108820000	101330000	NA	NA	NA	HNRNPM	HNRNPM;HNRNPM;HNRNPM;HNRNPM;HNRNPM	alternative mRNA splicing, via spliceosome;regulation of mRNA stability involved in response to oxidative stress;RNA metabolic process;mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway	GO:000038; GO:200081; GO:001607; GO:000039; GO:000854	spliceosomal complex;post-mRNA release spliceosomal complex;ribonucleoprotein complex;nuclear matrix;paraspeckles;nucleus;nucleoplasm;extracellular exosome;membrane;nucleolus	GO:000568; GO:007101; GO:199090; GO:001636; GO:004238; GO:000563; GO:000565; GO:007006; GO:001602; GO:000573	 Spliceosome	hsa0304	mRNA binding;protein domain specific binding;RNA binding;protein binding	GO:000372; GO:001990; GO:000372; GO:000551
XP_005654909.1	XP_005654909.1	XP_005654909.1 complement C3 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6656000	0	0	0	NA	NA	NA	LOC100517145	LOC100517145;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005655282.2;XP_020941544.1;NP_999574.1	XP_005655282.2;XP_020941544.1;NP_999574.1	XP_005655282.2 succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial isoform X2 [Sus scrofa];XP_020941544.1 succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial isoform X1 [Sus scrofa];NP_999574.1 succinate--CoA ligase [ADP/G	7	7	7	127840000	67687000	113210000	87977000	103230000	72635000	108330000	70666000	126450000	82886000	85057000	96540000	117710000	90791000	83521000	98750000	94031000	86131000	NA	NA	NA	SUCLG1	SUCLG1;SUCLG1;SUCLG1;NA;NA	succinyl-CoA metabolic process;succinate metabolic process;nucleoside triphosphate biosynthetic process;nucleoside diphosphate phosphorylation;tricarboxylic acid cycle	GO:000610; GO:000610; GO:000914; GO:000616; GO:000609	mitochondrial matrix;cytosol;mitochondrion;plasma membrane	GO:000575; GO:000582; GO:000573; GO:000588	 Carbon metabolism; Metabolic pathways; Propanoate metabolism; Citrate cycle (TCA cycle); Biosynthesis of antibiotics	hsa0120; hsa0110; hsa0064; hsa0002; hsa0113	nucleoside diphosphate kinase activity;cofactor binding;succinate-CoA ligase (ADP-forming) activity;RNA binding	GO:000455; GO:004803; GO:000477; GO:000372
XP_005655354.1	XP_005655354.1	XP_005655354.1 60S ribosomal protein L8 [Sus scrofa]	8	8	8	49302000	47085000	50218000	0	46114000	60205000	0	0	55373000	71786000	0	0	0	48471000	0	0	44616000	70903000	NA	NA	NA	RPL8	RPL8;NA;NA;NA;NA	translational initiation;cytoplasmic translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000218; GO:000018; GO:000641; GO:000661	polysomal ribosome;membrane;cytosolic large ribosomal subunit;focal adhesion;cytosol;postsynapse;postsynaptic density	GO:004278; GO:001602; GO:002262; GO:000592; GO:000582; GO:009879; GO:001406	 Ribosome	hsa0301	structural constituent of ribosome;rRNA binding;RNA binding	GO:000373; GO:001984; GO:000372
XP_005655478.1;XP_020945682.1;XP_020945681.1	XP_005655478.1;XP_020945682.1;XP_020945681.1	XP_005655478.1 olfactomedin-like protein 3 isoform X1 [Sus scrofa];XP_020945682.1 olfactomedin-like protein 3 isoform X2 [Sus scrofa];XP_020945681.1 olfactomedin-like protein 3 isoform X2 [Sus scrofa]	10	10	10	0	220430000	16700000	167180000	22409000	214220000	41225000	162030000	0	170920000	60588000	266210000	119270000	203040000	45186000	206470000	48448000	308700000	NA	NA	NA	OLFML3	OLFML3;OLFML3;OLFML3;NA;NA	multicellular organism development	GO:000727	extracellular vesicle	GO:190356	"NA"	"NA"	"NA"	"NA"
XP_005655606.1;XP_013836898.1;XP_003133048.1;XP_020929709.1;XP_020929069.1	XP_005655606.1;XP_013836898.1;XP_003133048.1;XP_020929709.1;XP_020929069.1	XP_005655606.1 tubulin alpha-1A chain isoform X1 [Sus scrofa];XP_013836898.1 tubulin alpha-3 chain isoform X2 [Sus scrofa];XP_003133048.1 tubulin alpha-3 chain isoform X2 [Sus scrofa];XP_020929709.1 tubulin alpha-3 chain isoform X1 [Sus scrofa];XP_02092906	25	1	1	63960000	96462000	27825000	49145000	34658000	21631000	26756000	52962000	30856000	23371000	33382000	20146000	78805000	17667000	53167000	19988000	30433000	57077000	NA	NA	NA	TUBA1A	TUBA1A;LOC100155138;LOC100510930;LOC100510930;LOC100155138	microtubule cytoskeleton organization;microtubule-based process;regulation of synapse organization;cell division;G2/M transition of mitotic cell cycle;cytoskeleton-dependent intracellular transport;regulation of G2/M transition of mitotic cell cycle;mitotic cell cycle;ciliary basal body docking	GO:000022; GO:000701; GO:005080; GO:005130; GO:000008; GO:003070; GO:001038; GO:000027; GO:009771	cytosol;nucleus;myelin sheath;cytoplasmic microtubule;microtubule cytoskeleton;cytoplasmic ribonucleoprotein granule;microtubule;cytoplasm;neuromuscular junction;membrane raft;recycling endosome;extracellular exosome	GO:000582; GO:000563; GO:004320; GO:000588; GO:001563; GO:003646; GO:000587; GO:000573; GO:003159; GO:004512; GO:005503; GO:007006	 Pathogenic Escherichia coli infection; Phagosome; Gap junction	hsa0513; hsa0414; hsa0454	protein binding;GTP binding;structural constituent of cytoskeleton;GTPase activity;protein domain specific binding;structural molecule activity	GO:000551; GO:000552; GO:000520; GO:000392; GO:001990; GO:000519
XP_005655770.2	XP_005655770.2	XP_005655770.2 LOW QUALITY PROTEIN: anoctamin-6 [Sus scrofa]	6	6	6	0	14342000	18486000	0	0	16505000	0	16462000	0	12921000	0	18585000	0	0	0	16544000	0	0	NA	NA	NA	ANO6	ANO6;NA;NA;NA;NA	purinergic nucleotide receptor signaling pathway;chloride transmembrane transport;activation of blood coagulation via clotting cascade;chloride transport;positive regulation of bone mineralization;sodium ion transmembrane transport;positive regulation of apoptotic process;calcium activated phosphatidylcholine scrambling;phosphatidylserine exposure on blood platelet;positive regulation of potassium ion export across plasma membrane;dendritic cell chemotaxis;bleb assembly;positive regulation of ion transmembrane transport;pore complex assembly;calcium ion transmembrane transport;positive regulation of endothelial cell apoptotic process;blood coagulation;cation transport;negative regulation of cell volume;positive regulation of phagocytosis, engulfment;phospholipid scrambling;ion transmembrane transport;neutrophil degranulation;bone mineralization involved in bone maturation;calcium activated phosphatidylserine scrambling;positive regulation of monocyte chemotaxis	GO:003559; GO:190247; GO:000254; GO:000682; GO:003050; GO:003572; GO:004306; GO:006159; GO:009704; GO:190376; GO:000240; GO:003206; GO:003476; GO:004693; GO:007058; GO:200035; GO:000759; GO:000681; GO:004579; GO:006010; GO:001712; GO:003422; GO:004331; GO:003563; GO:006158; GO:009002	plasma membrane;membrane;specific granule membrane;extracellular exosome;cell surface;chloride channel complex;tertiary granule membrane;cytosol	GO:000588; GO:001602; GO:003557; GO:007006; GO:000998; GO:003470; GO:007082; GO:000582	"NA"	"NA"	voltage-gated chloride channel activity;calcium activated cation channel activity;protein homodimerization activity;phospholipid scramblase activity;voltage-gated ion channel activity;protein binding	GO:000524; GO:000522; GO:004280; GO:001712; GO:000524; GO:000551
XP_005655861.2	XP_005655861.2	XP_005655861.2 programmed cell death protein 5 [Sus scrofa]	5	5	5	50940000	57392000	52974000	39179000	60265000	48336000	55588000	49489000	45197000	46077000	51518000	63438000	64268000	48496000	59723000	50372000	50432000	43025000	NA	NA	NA	PDCD5	PDCD5;NA;NA;NA;NA	negative regulation of cell proliferation;positive regulation of apoptotic process;positive regulation of gene expression;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of release of cytochrome c from mitochondria;apoptotic process;cellular response to transforming growth factor beta stimulus;negative regulation of chaperone-mediated protein folding;positive regulation of protein import into mitochondrial outer membrane	GO:000828; GO:004306; GO:001062; GO:004328; GO:009020; GO:000691; GO:007156; GO:190364; GO:190363	extracellular exosome;nucleus;cytoplasm;cytosol	GO:007006; GO:000563; GO:000573; GO:000582	"NA"	"NA"	DNA binding;protein binding;acetyltransferase activator activity;beta-tubulin binding;heparin binding	GO:000367; GO:000551; GO:001069; GO:004848; GO:000820
XP_005655974.2	XP_005655974.2	XP_005655974.2 LOW QUALITY PROTEIN: persulfide dioxygenase ETHE1, mitochondrial [Sus scrofa]	7	7	7	147760000	107450000	100460000	87983000	161400000	116490000	124790000	110930000	141940000	90034000	111300000	99875000	143870000	94415000	113200000	103450000	107920000	117770000	NA	NA	NA	ETHE1	ETHE1;NA;NA;NA;NA	sulfide oxidation, using sulfide:quinone oxidoreductase;glutathione metabolic process;hydrogen sulfide metabolic process	GO:007022; GO:000674; GO:007081	cytoplasm;mitochondrion;mitochondrial matrix;nucleoplasm	GO:000573; GO:000573; GO:000575; GO:000565	 Sulfur metabolism	hsa0092	hydrolase activity, acting on ester bonds;iron ion binding;sulfur dioxygenase activity	GO:001678; GO:000550; GO:005031
XP_005655982.2	XP_005655982.2	XP_005655982.2 LOW QUALITY PROTEIN: immunity-related GTPase family Q protein [Sus scrofa]	2	2	2	0	0	0	0	0	4405400	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	IRGQ	IRGQ;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	GTP binding	GO:000552
XP_020950862.1;XP_013844186.1;XP_005656043.1	XP_020950862.1;XP_013844186.1;XP_005656043.1	XP_020950862.1 protein RER1 [Sus scrofa];XP_013844186.1 protein RER1 [Sus scrofa];XP_005656043.1 protein RER1 [Sus scrofa]	2	2	2	0	0	0	30026000	0	0	0	0	34687000	0	38640000	22222000	25122000	28041000	37496000	35928000	44002000	0	NA	NA	NA	RER1	RER1;RER1;RER1;NA;NA	skeletal muscle acetylcholine-gated channel clustering;protein retention in ER lumen;retrograde vesicle-mediated transport, Golgi to ER;positive regulation of protein localization to plasma membrane	GO:007134; GO:000662; GO:000689; GO:190307	Golgi apparatus;endoplasmic reticulum-Golgi intermediate compartment;cell surface;endoplasmic reticulum;plasma membrane;integral component of Golgi membrane	GO:000579; GO:000579; GO:000998; GO:000578; GO:000588; GO:003017	"NA"	"NA"	molecular_function;acetylcholine receptor binding	GO:000367; GO:003313
XP_005656096.1;XP_005656097.1;NP_001072148.1	XP_005656096.1;XP_005656097.1;NP_001072148.1	XP_005656096.1 cell division control protein 42 homolog isoform X1 [Sus scrofa];XP_005656097.1 cell division control protein 42 homolog isoform X2 [Sus scrofa];NP_001072148.1 cell division control protein 42 homolog [Sus scrofa]	6	5	5	273150000	272870000	257050000	295940000	257370000	190430000	275850000	286950000	289100000	271030000	232100000	402520000	242990000	231190000	283040000	270140000	262050000	245630000	NA	NA	NA	CDC42	CDC42;CDC42;CDC42;NA;NA	protein ubiquitination;positive regulation of cytokinesis;regulation of actin cytoskeleton organization;Fc-gamma receptor signaling pathway involved in phagocytosis;establishment of epithelial cell apical/basal polarity;organelle transport along microtubule;phagocytosis, engulfment;actin filament organization;Golgi organization;actin cytoskeleton organization;interleukin-12-mediated signaling pathway;positive regulation of muscle cell differentiation;positive regulation of pseudopodium assembly;regulation of filopodium assembly;establishment of Golgi localization;regulation of attachment of spindle microtubules to kinetochore;positive regulation of actin cytoskeleton reorganization;establishment or maintenance of cell polarity;regulation of lamellipodium assembly;negative regulation of epidermal growth factor receptor signaling pathway;ephrin receptor signaling pathway;regulation of small GTPase mediated signal transduction;regulation of stress fiber assembly;Wnt signaling pathway, planar cell polarity pathway;protein phosphorylation;integrin-mediated signaling pathway;substantia nigra development;T cell costimulation;negative regulation of protein complex assembly;neuropilin signaling pathway;endocytosis;positive regulation of cell growth;Cdc42 protein signal transduction;cell junction assembly;macrophage differentiation;viral RNA genome replication;dendritic spine morphogenesis;Rho protein signal transduction;blood coagulation;regulation of cell shape;modification of synaptic structure;positive regulation of substrate adhesion-dependent cell spreading	GO:001656; GO:003246; GO:003295; GO:003809; GO:004519; GO:007238; GO:000691; GO:000701; GO:000703; GO:003003; GO:003572; GO:005114; GO:003127; GO:005148; GO:005168; GO:005198; GO:200025; GO:000716; GO:001059; GO:004205; GO:004801; GO:005105; GO:005149; GO:006007; GO:000646; GO:000722; GO:002176; GO:003129; GO:003133; GO:003818; GO:000689; GO:003030; GO:003248; GO:003432; GO:003022; GO:003969; GO:006099; GO:000726; GO:000759; GO:000836; GO:009956; GO:190002	cytoplasmic ribonucleoprotein granule;dendritic spine;macromolecular complex;membrane;cell projection;cytoplasm;centrosome;cell cortex;spindle midzone;Golgi membrane;cytosol;plasma membrane;Golgi transport complex;midbody;endoplasmic reticulum membrane;focal adhesion;filopodium;neuronal cell body;extracellular exosome;mitotic spindle;neuron projection	GO:003646; GO:004319; GO:003299; GO:001602; GO:004299; GO:000573; GO:000581; GO:000593; GO:005123; GO:000013; GO:000582; GO:000588; GO:001711; GO:003049; GO:000578; GO:000592; GO:003017; GO:004302; GO:007006; GO:007268; GO:004300	 Rap1 signaling pathway; Axon guidance; Neurotrophin signaling pathway; Epithelial cell signaling in Helicobacter pylori infection; Renal cell carcinoma; Ras signaling pathway; Adherens junction; T cell receptor signaling pathway; Non-alcoholic fatty liver disease (NAFLD); Bacterial invasion of epithelial cells; Shigellosis; VEGF signaling pathway; Focal adhesion; Tight junction; Proteoglycans in cancer; Regulation of actin cytoskeleton; GnRH signaling pathway; Leukocyte transendothelial migration; Chemokine signaling pathway; Endocytosis	hsa0401; hsa0436; hsa0472; hsa0512; hsa0521; hsa0401; hsa0452; hsa0466; hsa0493; hsa0510; hsa0513; hsa0437; hsa0451; hsa0453; hsa0520; hsa0481; hsa0491; hsa0467; hsa0406; hsa0414	protein kinase binding;GBD domain binding;identical protein binding;ubiquitin protein ligase activity;protein serine/threonine kinase activity;protein binding;thioesterase binding;GTPase activity;apolipoprotein A-I receptor binding;GTP binding	GO:001990; GO:003242; GO:004280; GO:006163; GO:000467; GO:000551; GO:003199; GO:000392; GO:003419; GO:000552
XP_005656212.1;XP_005656211.1;XP_020949266.1;NP_001038062.1	XP_005656212.1;XP_005656211.1;XP_020949266.1;NP_001038062.1	XP_005656212.1 adenylate kinase 4, mitochondrial isoform X1 [Sus scrofa];XP_005656211.1 adenylate kinase 4, mitochondrial isoform X1 [Sus scrofa];XP_020949266.1 adenylate kinase 4, mitochondrial isoform X2 [Sus scrofa];NP_001038062.1 adenylate kinase 4, mi	12	12	12	555620000	361420000	484230000	356480000	560930000	134950000	446270000	428420000	477510000	371860000	466650000	509240000	230320000	415560000	437150000	553160000	338150000	319940000	NA	NA	NA	AK4	AK4;AK4;AK4;AK4;NA	ATP metabolic process;nucleobase-containing small molecule interconversion;AMP metabolic process;nucleoside triphosphate biosynthetic process;ADP biosynthetic process;response to drug;nucleoside monophosphate phosphorylation;liver development;brain development;nucleoside diphosphate phosphorylation	GO:004603; GO:001594; GO:004603; GO:000914; GO:000617; GO:004249; GO:004694; GO:000188; GO:000742; GO:000616	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Biosynthesis of antibiotics; Purine metabolism; Metabolic pathways	hsa0113; hsa0023; hsa0110	nucleoside triphosphate adenylate kinase activity;ATP binding;nucleoside diphosphate kinase activity;adenylate kinase activity;nucleoside phosphate kinase activity	GO:004689; GO:000552; GO:000455; GO:000401; GO:005014
XP_005656456.1;XP_020955158.1	XP_005656456.1;XP_020955158.1	XP_005656456.1 methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial isoform X1 [Sus scrofa];XP_020955158.1 methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial isoform X2 [Sus scrofa]	15	15	15	420890000	294020000	312340000	210630000	378440000	194610000	370640000	283910000	372530000	262870000	383340000	320610000	200970000	250740000	332260000	311960000	306270000	230490000	NA	NA	NA	ALDH6A1	ALDH6A1;ALDH6A1;NA;NA;NA	valine metabolic process;oxidation-reduction process;branched-chain amino acid catabolic process;thymine catabolic process;valine catabolic process;thymine metabolic process;brown fat cell differentiation	GO:000657; GO:005511; GO:000908; GO:000621; GO:000657; GO:001985; GO:005087	mitochondrial matrix;mitochondrion;nucleoplasm	GO:000575; GO:000573; GO:000565	 Carbon metabolism; Valine, leucine and isoleucine degradation; beta-Alanine metabolism; Propanoate metabolism; Metabolic pathways; Inositol phosphate metabolism	hsa0120; hsa0028; hsa0041; hsa0064; hsa0110; hsa0056	malonate-semialdehyde dehydrogenase (acetylating) activity;methylmalonate-semialdehyde dehydrogenase (acylating) activity;fatty-acyl-CoA binding;RNA binding	GO:001847; GO:000449; GO:000006; GO:000372
XP_020955179.1;XP_020955178.1;XP_020955177.1;XP_013844616.1;XP_020955176.1;XP_005656461.1	XP_020955179.1;XP_020955178.1;XP_020955177.1;XP_013844616.1;XP_020955176.1;XP_005656461.1	XP_020955179.1 latent-transforming growth factor beta-binding protein 2 isoform X5 [Sus scrofa];XP_020955178.1 latent-transforming growth factor beta-binding protein 2 isoform X4 [Sus scrofa];XP_020955177.1 latent-transforming growth factor beta-binding pr	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	47196000	0	0	0	0	0	NA	NA	NA	LTBP2	LTBP2;LTBP2;LTBP2;LTBP2;LTBP2	supramolecular fiber organization;protein secretion;transforming growth factor beta receptor signaling pathway;protein targeting	GO:009743; GO:000930; GO:000717; GO:000660	extracellular matrix;extracellular exosome;extracellular space;cell;extracellular region	GO:003101; GO:007006; GO:000561; GO:000562; GO:000557	"NA"	"NA"	protein binding;growth factor binding;extracellular matrix structural constituent;heparin binding;calcium ion binding	GO:000551; GO:001983; GO:000520; GO:000820; GO:000550
XP_005656590.2;XP_020957218.1;XP_020957219.1	XP_005656590.2;XP_020957218.1;XP_020957219.1	XP_005656590.2 histone-lysine N-methyltransferase SETD7 isoform X3 [Sus scrofa];XP_020957218.1 histone-lysine N-methyltransferase SETD7 isoform X1 [Sus scrofa];XP_020957219.1 histone-lysine N-methyltransferase SETD7 isoform X2 [Sus scrofa]	4	4	4	26878000	34570000	32164000	28608000	19670000	25727000	30016000	29695000	32682000	29720000	28173000	28244000	0	33846000	35084000	31094000	29512000	34971000	NA	NA	NA	SETD7	SETD7;SETD7;SETD7;NA;NA	response to ethanol;peptidyl-lysine dimethylation;positive regulation of transcription, DNA-templated;histone lysine methylation;heterochromatin organization;chromatin organization;cellular response to DNA damage stimulus;regulation of histone H3-K9 methylation	GO:004547; GO:001802; GO:004589; GO:003496; GO:007082; GO:000632; GO:000697; GO:005157	nucleoplasm;chromosome;nucleolus	GO:000565; GO:000569; GO:000573	 Lysine degradation; FoxO signaling pathway	hsa0031; hsa0406	chromatin binding;protein binding;histone-lysine N-methyltransferase activity;protein-lysine N-methyltransferase activity;p53 binding	GO:000368; GO:000551; GO:001802; GO:001627; GO:000203
XP_020957516.1;XP_020957515.1;XP_020957514.1;XP_020957513.1;XP_020957512.1;XP_020957509.1;XP_020957508.1;XP_020957507.1;XP_020957506.1;XP_020957505.1;XP_005656639.3;XP_020957504.1;XP_020957503.1;XP_020957502.1;XP_020957501.1;XP_020957499.1;XP_020957498.1;XP_020957497.1;XP_020957496.1;XP_020957495.1;XP_020957494.1;XP_020957493.1;XP_020957492.1;XP_020957491.1;XP_020957490.1;XP_020957489.1;XP_013844900.2;XP_005656636.3;XP_005656635.3;XP_020957488.1;XP_020957487.1;XP_020957486.1;XP_020957485.1;XP_020957484.1;XP_020957483.1;XP_020957482.1;XP_020957481.1;XP_020957480.1;XP_020957479.1;XP_020957478.1;XP_020957477.1;XP_020957476.1;XP_020957475.1;XP_020957474.1;XP_020957473.1;XP_020957472.1;XP_020957471.1;XP_020957470.1;XP_020957469.1;XP_020957468.1	XP_020957516.1;XP_020957515.1;XP_020957514.1;XP_020957513.1;XP_020957512.1;XP_020957509.1;XP_020957508.1;XP_020957507.1;XP_020957506.1;XP_020957505.1;XP_005656639.3;XP_020957504.1;XP_020957503.1;XP_020957502.1;XP_020957501.1;XP_020957499.1;XP_020957498.1;XP_020957497.1;XP_020957496.1;XP_020957495.1;XP_020957494.1;XP_020957493.1;XP_020957492.1;XP_020957491.1;XP_020957490.1;XP_020957489.1;XP_013844900.2;XP_005656636.3;XP_005656635.3;XP_020957488.1;XP_020957487.1;XP_020957486.1;XP_020957485.1;XP_020957484.1;XP_020957483.1;XP_020957482.1;XP_020957481.1;XP_020957480.1;XP_020957479.1;XP_020957478.1;XP_020957477.1;XP_020957476.1;XP_020957475.1;XP_020957474.1;XP_020957473.1;XP_020957472.1;XP_020957471.1;XP_020957470.1;XP_020957469.1;XP_020957468.1	XP_020957516.1 protein transport protein Sec31A isoform X26 [Sus scrofa];XP_020957515.1 protein transport protein Sec31A isoform X26 [Sus scrofa];XP_020957514.1 protein transport protein Sec31A isoform X25 [Sus scrofa];XP_020957513.1 protein transport prot	10	10	10	44546000	54617000	41210000	54677000	35366000	55318000	33871000	46511000	38669000	55279000	52489000	46855000	79106000	53562000	42095000	53449000	46392000	67225000	NA	NA	NA	SEC31A	SEC31A;SEC31A;SEC31A;SEC31A;SEC31A	endoplasmic reticulum organization;response to calcium ion;intracellular protein transport;cargo loading into COPII-coated vesicle;COPII vesicle coating;antigen processing and presentation of exogenous peptide antigen via MHC class II;IRE1-mediated unfolded protein response;antigen processing and presentation of peptide antigen via MHC class I	GO:000702; GO:005159; GO:000688; GO:009011; GO:004820; GO:001988; GO:003649; GO:000247	cytosol;vesicle coat;Golgi membrane;endoplasmic reticulum membrane;cytoplasm;ER to Golgi transport vesicle;ER to Golgi transport vesicle membrane;endoplasmic reticulum exit site;intracellular membrane-bounded organelle;perinuclear region of cytoplasm	GO:000582; GO:003012; GO:000013; GO:000578; GO:000573; GO:003013; GO:001250; GO:007097; GO:004323; GO:004847	 Protein processing in endoplasmic reticulum	hsa0414	structural molecule activity;protein binding;calcium-dependent protein binding	GO:000519; GO:000551; GO:004830
XP_005656840.2	XP_005656840.2	XP_005656840.2 isoleucine--tRNA ligase, mitochondrial [Sus scrofa]	7	7	7	17686000	12190000	14949000	14317000	0	0	0	16674000	0	15561000	0	0	0	0	0	15837000	0	0	NA	NA	NA	IARS2	IARS2;NA;NA;NA;NA	tRNA aminoacylation for protein translation;isoleucyl-tRNA aminoacylation;mitochondrial translation	GO:000641; GO:000642; GO:003254	mitochondrial matrix;mitochondrion;cytosol	GO:000575; GO:000573; GO:000582	 Aminoacyl-tRNA biosynthesis	hsa0097	tRNA binding;isoleucine-tRNA ligase activity;ATP binding;aminoacyl-tRNA editing activity	GO:000004; GO:000482; GO:000552; GO:000216
XP_005657006.1	XP_005657006.1	XP_005657006.1 synaptic vesicle membrane protein VAT-1 homolog [Sus scrofa]	22	22	22	682110000	754250000	760800000	599630000	609540000	870870000	625380000	648070000	653920000	608310000	640380000	618230000	647820000	799530000	582380000	665440000	686880000	761530000	NA	NA	NA	VAT1	VAT1;NA;NA;NA;NA	negative regulation of mitochondrial fusion;neutrophil degranulation;oxidation-reduction process	GO:001063; GO:004331; GO:005511	integral component of membrane;extracellular exosome;extracellular region;azurophil granule lumen;mitochondrial outer membrane	GO:001602; GO:007006; GO:000557; GO:003557; GO:000574	"NA"	"NA"	oxidoreductase activity;zinc ion binding	GO:001649; GO:000827
XP_005657025.1	XP_005657025.1	XP_005657025.1 retinoid-inducible serine carboxypeptidase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	816290	NA	NA	NA	SCPEP1	SCPEP1;NA;NA;NA;NA	negative regulation of blood pressure;positive regulation of blood vessel diameter;retinoic acid metabolic process;proteolysis involved in cellular protein catabolic process	GO:004577; GO:009775; GO:004257; GO:005160	extracellular exosome;cytosol	GO:007006; GO:000582	"NA"	"NA"	serine-type carboxypeptidase activity	GO:000418
XP_005657028.3	XP_005657028.3	XP_005657028.3 E3 ubiquitin/ISG15 ligase TRIM25 [Sus scrofa]	12	12	12	0	40310000	33381000	53948000	43255000	57187000	36520000	50116000	33580000	52072000	41002000	68732000	41254000	46344000	38834000	49988000	37128000	47005000	NA	NA	NA	TRIM25	TRIM25;NA;NA;NA;NA	negative regulation of viral entry into host cell;negative regulation of viral release from host cell;protein monoubiquitination;viral process;translesion synthesis;cellular response to leukemia inhibitory factor;innate immune response;regulation of viral entry into host cell;defense response to virus;interferon-gamma-mediated signaling pathway;ubiquitin-dependent ERAD pathway;response to estrogen;positive regulation of NF-kappaB transcription factor activity;negative regulation of type I interferon production;response to vitamin D;positive regulation of I-kappaB kinase/NF-kappaB signaling	GO:004659; GO:190218; GO:000651; GO:001603; GO:001998; GO:199083; GO:004508; GO:004659; GO:005160; GO:006033; GO:003043; GO:004362; GO:005109; GO:003248; GO:003328; GO:004312	nucleoplasm;nuclear body;cytosol	GO:000565; GO:001660; GO:000582	 NF-kappa B signaling pathway; RIG-I-like receptor signaling pathway; Influenza A	hsa0406; hsa0462; hsa0516	zinc ion binding;RNA binding;ligase activity;cadherin binding;protein binding;ubiquitin protein ligase activity;ubiquitin-protein transferase activity	GO:000827; GO:000372; GO:001687; GO:004529; GO:000551; GO:006163; GO:000484
XP_020923221.1;XP_020923220.1;XP_005657071.1	XP_020923221.1;XP_020923220.1;XP_005657071.1	XP_020923221.1 phosphatidylinositol transfer protein alpha isoform isoform X3 [Sus scrofa];XP_020923220.1 phosphatidylinositol transfer protein alpha isoform isoform X2 [Sus scrofa];XP_005657071.1 phosphatidylinositol transfer protein alpha isoform isoform	7	6	6	26243000	0	29267000	26143000	0	0	24860000	29354000	0	23216000	0	22963000	0	0	32723000	28404000	13162000	0	NA	NA	NA	PITPNA	PITPNA;PITPNA;PITPNA;NA;NA	axonogenesis;lipid metabolic process;visual perception;interleukin-12-mediated signaling pathway;phospholipid transport	GO:000740; GO:000662; GO:000760; GO:003572; GO:001591	cytoplasm;extracellular exosome;cytosol	GO:000573; GO:007006; GO:000582	"NA"	"NA"	phosphatidylcholine transporter activity;phosphatidylinositol binding;phosphatidylglycerol binding;phosphatidylinositol transporter activity;phosphatidylcholine binding	GO:000852; GO:003509; GO:190161; GO:000852; GO:003121
XP_005657073.1;XP_020923217.1;XP_020923216.1;XP_020923215.1;XP_020923214.1	XP_005657073.1;XP_020923217.1;XP_020923216.1;XP_020923215.1;XP_020923214.1	XP_005657073.1 unconventional myosin-Ic isoform X6 [Sus scrofa];XP_020923217.1 unconventional myosin-Ic isoform X3 [Sus scrofa];XP_020923216.1 unconventional myosin-Ic isoform X3 [Sus scrofa];XP_020923215.1 unconventional myosin-Ic isoform X3 [Sus scrofa];	62	1	1	0	0	0	0	0	0	0	0	0	0	0	2550000	0	0	0	0	0	0	+	NA	NA	MYO1C	MYO1C;MYO1C;MYO1C;MYO1C;MYO1C	positive regulation of cell migration;mRNA transport;positive regulation of gene expression, epigenetic;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of protein targeting to membrane;regulation of bicellular tight junction assembly;positive regulation of actin filament polymerization;positive regulation of cellular response to insulin stimulus;positive regulation of vascular endothelial growth factor signaling pathway;protein targeting to membrane;vesicle transport along actin filament;cellular response to interferon-gamma;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;protein targeting	GO:003033; GO:005102; GO:004581; GO:003809; GO:009031; GO:200081; GO:003083; GO:190007; GO:190074; GO:000661; GO:003005; GO:007134; GO:003808; GO:000660	plasma membrane;filamentous actin;lateral plasma membrane;stress fiber;cytoplasm;membrane raft;ruffle membrane;phagocytic vesicle;extracellular exosome;cytosol;basal plasma membrane;membrane;unconventional myosin complex;stereocilium membrane;nucleoplasm;microvillus;nuclear body;nuclear pore;cytoplasmic vesicle membrane	GO:000588; GO:003194; GO:001632; GO:000172; GO:000573; GO:004512; GO:003258; GO:004533; GO:007006; GO:000582; GO:000992; GO:001602; GO:001646; GO:006017; GO:000565; GO:000590; GO:001660; GO:000564; GO:003065	"NA"	"NA"	protein C-terminus binding;microfilament motor activity;protein binding;Ral GTPase binding;actin filament binding;receptor binding;ATP binding;actin-dependent ATPase activity	GO:000802; GO:000014; GO:000551; GO:001716; GO:005101; GO:000510; GO:000552; GO:003089
XP_020923511.1;XP_020923510.1;XP_005657092.1	XP_020923511.1;XP_020923510.1;XP_005657092.1	XP_020923511.1 trafficking protein particle complex subunit 1 isoform X2 [Sus scrofa];XP_020923510.1 trafficking protein particle complex subunit 1 isoform X1 [Sus scrofa];XP_005657092.1 trafficking protein particle complex subunit 1 isoform X1 [Sus scrofa	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1799300	0	NA	NA	NA	TRAPPC1	TRAPPC1;TRAPPC1;TRAPPC1;NA;NA	COPII vesicle coating;ER to Golgi vesicle-mediated transport;neutrophil degranulation	GO:004820; GO:000688; GO:004331	TRAPP complex;Golgi membrane;endoplasmic reticulum;cytosol;azurophil granule lumen;extracellular region	GO:003000; GO:000013; GO:000578; GO:000582; GO:003557; GO:000557	"NA"	"NA"	Rab guanyl-nucleotide exchange factor activity	GO:001711
XP_020928384.1;XP_020928383.1;XP_013845715.1;XP_005657282.1;XP_005657281.1;XP_005657280.1;XP_020928386.1;XP_020928385.1;XP_005657288.1;XP_013845716.1;XP_005657287.1;XP_005657286.1	XP_020928384.1;XP_020928383.1;XP_013845715.1;XP_005657282.1;XP_005657281.1;XP_005657280.1;XP_020928386.1;XP_020928385.1;XP_005657288.1;XP_013845716.1;XP_005657287.1;XP_005657286.1	XP_020928384.1 dematin isoform X3 [Sus scrofa];XP_020928383.1 dematin isoform X2 [Sus scrofa];XP_013845715.1 dematin isoform X1 [Sus scrofa];XP_005657282.1 dematin isoform X1 [Sus scrofa];XP_005657281.1 dematin isoform X1 [Sus scrofa];XP_005657280.1 demati	4	4	4	0	0	15956000	0	0	0	16436000	25378000	0	0	18773000	18805000	0	0	28519000	0	0	0	NA	NA	NA	DMTN	DMTN;DMTN;DMTN;DMTN;DMTN	negative regulation of peptidyl-serine phosphorylation;erythrocyte development;cellular response to calcium ion;regulation of cell shape;regulation of lamellipodium assembly;calcium-mediated signaling using extracellular calcium source;negative regulation of protein targeting to membrane;actin filament reorganization;positive regulation of platelet aggregation;actin filament bundle assembly;negative regulation of cell-substrate adhesion;positive regulation of wound healing;actin cytoskeleton organization;negative regulation of focal adhesion assembly;cellular response to cAMP;negative regulation of substrate adhesion-dependent cell spreading;transmembrane transport;macromolecular complex assembly;protein secretion by platelet;positive regulation of fibroblast migration;regulation of filopodium assembly;actin filament capping;cytoskeleton organization;negative regulation of peptidyl-threonine phosphorylation;positive regulation of blood coagulation;regulation of actin cytoskeleton organization;negative regulation of peptidyl-tyrosine phosphorylation;positive regulation of integrin-mediated signaling pathway	GO:003313; GO:004882; GO:007127; GO:000836; GO:001059; GO:003558; GO:009031; GO:009052; GO:190173; GO:005101; GO:001081; GO:009030; GO:003003; GO:005189; GO:007132; GO:190002; GO:005508; GO:006500; GO:007056; GO:001076; GO:005148; GO:005169; GO:000701; GO:001080; GO:003019; GO:003295; GO:005073; GO:200104	endomembrane system;platelet dense tubular network membrane;postsynaptic density;perinuclear region of cytoplasm;spectrin-associated cytoskeleton;actin filament;actin cytoskeleton;cytosol;cytoplasmic vesicle;cortical cytoskeleton;cell projection membrane	GO:001250; GO:003109; GO:001406; GO:004847; GO:001473; GO:000588; GO:001562; GO:000582; GO:003141; GO:003086; GO:003125	"NA"	"NA"	protein self-association;actin binding;spectrin binding;protein binding;receptor binding;actin filament binding	GO:004362; GO:000377; GO:003050; GO:000551; GO:000510; GO:005101
XP_020930028.1;XP_005657428.1;XP_020930027.1;XP_020930026.1;XP_020930024.1;XP_013845845.1;XP_020930023.1;XP_013845844.1;XP_020930022.1;XP_013845843.1;XP_005657422.2;XP_020930029.1;XP_005657430.1	XP_020930028.1;XP_005657428.1;XP_020930027.1;XP_020930026.1;XP_020930024.1;XP_013845845.1;XP_020930023.1;XP_013845844.1;XP_020930022.1;XP_013845843.1;XP_005657422.2;XP_020930029.1;XP_005657430.1	XP_020930028.1 AP-1 complex subunit beta-1 isoform X4 [Sus scrofa];XP_005657428.1 AP-1 complex subunit beta-1 isoform X4 [Sus scrofa];XP_020930027.1 AP-1 complex subunit beta-1 isoform X3 [Sus scrofa];XP_020930026.1 AP-1 complex subunit beta-1 isoform X3 [	17	8	8	21063000	23218000	26507000	30174000	24654000	26619000	20068000	21773000	30165000	23036000	0	25414000	21416000	0	23052000	25103000	22359000	24151000	NA	NA	NA	AP1B1	AP1B1;AP1B1;AP1B1;AP1B1;AP1B1	antigen processing and presentation of exogenous peptide antigen via MHC class II;determination of left/right symmetry;vesicle-mediated transport;regulation of defense response to virus by virus;intracellular protein transport;heart development	GO:001988; GO:000736; GO:001619; GO:005069; GO:000688; GO:000750	cytoplasmic vesicle membrane;trans-Golgi network membrane;lysosomal membrane;Golgi apparatus;intracellular membrane-bounded organelle;clathrin-coated vesicle membrane;cytosol;Golgi membrane;clathrin adaptor complex	GO:003065; GO:003258; GO:000576; GO:000579; GO:004323; GO:003066; GO:000582; GO:000013; GO:003013	 Lysosome	hsa0414	protein binding;transporter activity;protein kinase binding;clathrin binding	GO:000551; GO:000521; GO:001990; GO:003027
XP_020929523.1;XP_020929522.1;XP_013845885.2;XP_020929520.1;XP_020929519.1;XP_005657457.2;XP_005657456.2;XP_013845884.2;XP_005657455.2;XP_005657454.2;XP_005657453.2	XP_020929523.1;XP_020929522.1;XP_013845885.2;XP_020929520.1;XP_020929519.1;XP_005657457.2;XP_005657456.2;XP_013845884.2;XP_005657455.2;XP_005657454.2;XP_005657453.2	XP_020929523.1 apoptosis-inducing factor 2 isoform X6 [Sus scrofa];XP_020929522.1 apoptosis-inducing factor 2 isoform X5 [Sus scrofa];XP_013845885.2 apoptosis-inducing factor 2 isoform X5 [Sus scrofa];XP_020929520.1 apoptosis-inducing factor 2 isoform X4 [	4	4	4	0	53807000	51120000	55361000	55108000	46945000	47633000	61483000	41907000	53149000	35285000	32459000	34299000	64920000	37976000	55475000	49506000	39519000	NA	NA	NA	AIFM2	AIFM2;AIFM2;AIFM2;AIFM2;AIFM2	positive regulation of apoptotic process;respiratory electron transport chain;regulation of apoptotic process;apoptotic mitochondrial changes	GO:004306; GO:002290; GO:004298; GO:000863	cytoplasm;integral component of membrane;mitochondrion;extracellular space;mitochondrial outer membrane;cytosol;lipid particle	GO:000573; GO:001602; GO:000573; GO:000561; GO:000574; GO:000582; GO:000581	"NA"	"NA"	electron-transferring-flavoprotein dehydrogenase activity;DNA binding;flavin adenine dinucleotide binding	GO:000417; GO:000367; GO:005066
XP_005657482.2	XP_005657482.2	XP_005657482.2 LOW QUALITY PROTEIN: LIM domain-binding protein 3 [Sus scrofa]	7	7	7	0	0	0	0	0	0	0	0	0	26896000	0	0	24800000	0	0	0	86149000	0	NA	NA	NA	LDB3	LDB3;NA;NA;NA;NA	sarcomere organization	GO:004521	perinuclear region of cytoplasm;Z disc;pseudopodium;cytoskeleton	GO:004847; GO:003001; GO:003114; GO:000585	"NA"	"NA"	cytoskeletal protein binding;protein kinase C binding;muscle alpha-actinin binding;metal ion binding;protein binding	GO:000809; GO:000508; GO:005137; GO:004687; GO:000551
XP_005657832.1;XP_003360219.1;XP_020934288.1;XP_013846294.1;XP_003134838.1;XP_020934289.1;XP_013846295.1;XP_020942024.1;XP_020942025.1	XP_005657832.1;XP_003360219.1;XP_020934288.1;XP_013846294.1;XP_003134838.1;XP_020934289.1;XP_013846295.1	XP_005657832.1 septin-7 isoform X5 [Sus scrofa];XP_003360219.1 septin-7 isoform X4 [Sus scrofa];XP_020934288.1 septin-7 isoform X2 [Sus scrofa];XP_013846294.1 septin-7 isoform X3 [Sus scrofa];XP_003134838.1 septin-7 isoform X1 [Sus scrofa];XP_020934289.1 s	12	12	12	89893000	142090000	160430000	116730000	84249000	151260000	131260000	99978000	124880000	118440000	97086000	148560000	226940000	144250000	95640000	116310000	143850000	172470000	NA	NA	NA	Sep 07	Sep 07;Sep 07;Sep 07;Sep 07;Sep 07	negative regulation of cell migration;cytoskeleton-dependent cytokinesis;negative regulation of G1/S transition of mitotic cell cycle;spermatogenesis;positive regulation of apoptotic process;protein heterooligomerization;regulation of embryonic cell shape;positive regulation of non-motile cilium assembly;cell differentiation;cilium assembly	GO:003033; GO:006164; GO:200013; GO:000728; GO:004306; GO:005129; GO:001647; GO:190285; GO:003015; GO:006027	condensed chromosome kinetochore;axoneme;septin complex;microtubule cytoskeleton;nucleus;septin ring;apical plasma membrane;cleavage furrow;stress fiber;extracellular exosome;spindle;cytosol;non-motile cilium;midbody;sperm annulus	GO:000077; GO:000593; GO:003110; GO:001563; GO:000563; GO:000594; GO:001632; GO:003215; GO:000172; GO:007006; GO:000581; GO:000582; GO:009773; GO:003049; GO:009722	"NA"	"NA"	GTP binding;protein complex scaffold;protein binding;identical protein binding;cadherin binding;GTPase activity;structural molecule activity	GO:000552; GO:003294; GO:000551; GO:004280; GO:004529; GO:000392; GO:000519
XP_005657854.1;XP_005657853.1;XP_005657852.1;NP_001230348.1	XP_005657854.1;XP_005657853.1;XP_005657852.1;NP_001230348.1	XP_005657854.1 RNA-binding protein 3 isoform X2 [Sus scrofa];XP_005657853.1 RNA-binding protein 3 isoform X2 [Sus scrofa];XP_005657852.1 RNA-binding protein 3 isoform X1 [Sus scrofa];NP_001230348.1 RNA-binding protein 3 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	25748000	0	0	0	0	0	0	NA	NA	NA	RBM3	RBM3;RBM3;RBM3;RBM3;NA	response to cold;positive regulation of translation;negative regulation of translation;regulation of translation;RNA processing;positive regulation of mRNA splicing, via spliceosome	GO:000940; GO:004572; GO:001714; GO:000641; GO:000639; GO:004802	cytoplasm;spliceosomal complex;dendrite;ribonucleoprotein complex;nucleus;nucleoplasm;large ribosomal subunit;nucleolus	GO:000573; GO:000568; GO:003042; GO:199090; GO:000563; GO:000565; GO:001593; GO:000573	"NA"	"NA"	mRNA 3'-UTR binding;ribosomal large subunit binding;protein binding;translation repressor activity;small ribosomal subunit rRNA binding;RNA binding;poly(U) RNA binding	GO:000373; GO:004302; GO:000551; GO:003037; GO:007018; GO:000372; GO:000826
XP_013846388.1;XP_005657895.2	XP_013846388.1;XP_005657895.2	XP_013846388.1 protein PBDC1 isoform X2 [Sus scrofa];XP_005657895.2 protein PBDC1 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	4525000	0	0	0	0	0	NA	NA	NA	LOC100515118	LOC100515118;LOC100515118;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005658198.1	XP_005658198.1	XP_005658198.1 endogenous retrovirus group V member 2 Env polyprotein [Sus scrofa]	2	2	2	0	0	0	19354000	0	18843000	0	0	0	0	0	0	0	15286000	0	16054000	11788000	19084000	NA	NA	NA	LOC100624077	LOC100624077;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005659175.2	XP_005659175.2	XP_005659175.2 LOW QUALITY PROTEIN: fibronectin type III domain-containing protein 1 [Sus scrofa]	9	9	9	0	19576000	0	0	0	15751000	0	0	0	0	0	23968000	0	14978000	0	0	0	27237000	NA	NA	NA	FNDC1	FNDC1;NA;NA;NA;NA	"NA"	"NA"	extracellular region;nuclear speck	GO:000557; GO:001660	"NA"	"NA"	"NA"	"NA"
XP_005659575.1;XP_005659583.1;XP_020940582.1;XP_005659581.1;XP_020945784.1;XP_020941374.1	XP_005659575.1;XP_005659583.1;XP_020940582.1;XP_005659581.1;XP_020945784.1;XP_020941374.1	XP_005659575.1 tropomyosin alpha-1 chain isoform X7 [Sus scrofa];XP_005659583.1 tropomyosin alpha-1 chain isoform X14 [Sus scrofa];XP_020940582.1 tropomyosin alpha-1 chain isoform X4 [Sus scrofa];XP_005659581.1 tropomyosin alpha-1 chain isoform X12 [Sus sc	32	2	0	0	0	0	0	0	0	0	0	0	0	0	0	102000000	0	0	0	0	0	NA	NA	NA	TPM1	TPM1;TPM1;TPM1;TPM1;TPM1	positive regulation of stress fiber assembly;ventricular cardiac muscle tissue morphogenesis;muscle contraction;actin filament organization;positive regulation of ATPase activity;in utero embryonic development;ruffle organization;sarcomere organization;negative regulation of vascular associated smooth muscle cell migration;positive regulation of heart rate by epinephrine;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell migration;cellular response to reactive oxygen species;positive regulation of cell adhesion;regulation of heart contraction;regulation of cell shape;wound healing;muscle filament sliding;cardiac muscle contraction	GO:005149; GO:005501; GO:000693; GO:000701; GO:003278; GO:000170; GO:003152; GO:004521; GO:190475; GO:000306; GO:190470; GO:003033; GO:003461; GO:004578; GO:000801; GO:000836; GO:004206; GO:003004; GO:006004	actin cytoskeleton;sarcomere;cytosol;cytoskeleton;bleb;ruffle membrane;actin filament;stress fiber;muscle thin filament tropomyosin	GO:001562; GO:003001; GO:000582; GO:000585; GO:003205; GO:003258; GO:000588; GO:000172; GO:000586	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction; MicroRNAs in cancer	hsa0541; hsa0541; hsa0426; hsa0520	structural constituent of cytoskeleton;actin filament binding;identical protein binding;cytoskeletal protein binding;protein heterodimerization activity;actin binding;structural constituent of muscle;protein binding	GO:000520; GO:005101; GO:004280; GO:000809; GO:004698; GO:000377; GO:000830; GO:000551
XP_005659580.1;XP_005659582.1	XP_005659580.1;XP_005659582.1	XP_005659580.1 tropomyosin alpha-1 chain isoform X11 [Sus scrofa];XP_005659582.1 tropomyosin alpha-1 chain isoform X13 [Sus scrofa]	35	5	0	0	0	491990000	0	0	0	0	290890000	181550000	874200000	322400000	526150000	687310000	0	0	75069000	0	0	NA	NA	NA	TPM1	TPM1;TPM1;NA;NA;NA	positive regulation of stress fiber assembly;ventricular cardiac muscle tissue morphogenesis;muscle contraction;actin filament organization;positive regulation of ATPase activity;in utero embryonic development;ruffle organization;sarcomere organization;negative regulation of vascular associated smooth muscle cell migration;positive regulation of heart rate by epinephrine;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell migration;cellular response to reactive oxygen species;positive regulation of cell adhesion;regulation of heart contraction;regulation of cell shape;wound healing;muscle filament sliding;cardiac muscle contraction	GO:005149; GO:005501; GO:000693; GO:000701; GO:003278; GO:000170; GO:003152; GO:004521; GO:190475; GO:000306; GO:190470; GO:003033; GO:003461; GO:004578; GO:000801; GO:000836; GO:004206; GO:003004; GO:006004	actin cytoskeleton;sarcomere;cytosol;cytoskeleton;bleb;ruffle membrane;actin filament;stress fiber;muscle thin filament tropomyosin	GO:001562; GO:003001; GO:000582; GO:000585; GO:003205; GO:003258; GO:000588; GO:000172; GO:000586	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction; MicroRNAs in cancer	hsa0541; hsa0541; hsa0426; hsa0520	structural constituent of cytoskeleton;actin filament binding;identical protein binding;cytoskeletal protein binding;protein heterodimerization activity;actin binding;structural constituent of muscle;protein binding	GO:000520; GO:005101; GO:004280; GO:000809; GO:004698; GO:000377; GO:000830; GO:000551
XP_005659586.1;XP_005659589.1	XP_005659586.1;XP_005659589.1	XP_005659586.1 tropomyosin alpha-1 chain isoform X18 [Sus scrofa];XP_005659589.1 tropomyosin alpha-1 chain isoform X21 [Sus scrofa]	26	4	0	40796000	59907000	51462000	55206000	31845000	46870000	51320000	50787000	53808000	36515000	49862000	0	56580000	64273000	56019000	33970000	64632000	36242000	NA	NA	NA	TPM1	TPM1;TPM1;NA;NA;NA	positive regulation of stress fiber assembly;ventricular cardiac muscle tissue morphogenesis;muscle contraction;actin filament organization;positive regulation of ATPase activity;in utero embryonic development;ruffle organization;sarcomere organization;negative regulation of vascular associated smooth muscle cell migration;positive regulation of heart rate by epinephrine;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell migration;cellular response to reactive oxygen species;positive regulation of cell adhesion;regulation of heart contraction;regulation of cell shape;wound healing;muscle filament sliding;cardiac muscle contraction	GO:005149; GO:005501; GO:000693; GO:000701; GO:003278; GO:000170; GO:003152; GO:004521; GO:190475; GO:000306; GO:190470; GO:003033; GO:003461; GO:004578; GO:000801; GO:000836; GO:004206; GO:003004; GO:006004	actin cytoskeleton;sarcomere;cytosol;cytoskeleton;bleb;ruffle membrane;actin filament;stress fiber;muscle thin filament tropomyosin	GO:001562; GO:003001; GO:000582; GO:000585; GO:003205; GO:003258; GO:000588; GO:000172; GO:000586	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction; MicroRNAs in cancer	hsa0541; hsa0541; hsa0426; hsa0520	structural constituent of cytoskeleton;actin filament binding;identical protein binding;cytoskeletal protein binding;protein heterodimerization activity;actin binding;structural constituent of muscle;protein binding	GO:000520; GO:005101; GO:004280; GO:000809; GO:004698; GO:000377; GO:000830; GO:000551
XP_005659821.1	XP_005659821.1	XP_005659821.1 protein FAM98B [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2535800	NA	NA	NA	FAM98B	FAM98B;NA;NA;NA;NA	positive regulation of cell proliferation;positive regulation of gene expression;protein methylation	GO:000828; GO:001062; GO:000647	cytoplasm;tRNA-splicing ligase complex;intracellular membrane-bounded organelle;nucleus;nucleoplasm	GO:000573; GO:007266; GO:004323; GO:000563; GO:000565	"NA"	"NA"	protein methyltransferase activity;RNA binding;identical protein binding;protein binding	GO:000827; GO:000372; GO:004280; GO:000551
XP_005659919.2;XP_013849961.1	XP_005659919.2	XP_005659919.2 60S ribosomal protein L4 [Sus scrofa]	18	18	18	250680000	244790000	277410000	143400000	159600000	387260000	197360000	169600000	277230000	276390000	185100000	151680000	283480000	311440000	152870000	307800000	200550000	433300000	NA	NA	NA	RPL4	RPL4;NA;NA;NA;NA	translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000641; GO:000641; GO:000661; GO:000018	nucleus;cytoplasm;rough endoplasmic reticulum;cytosol;focal adhesion;extracellular exosome;ribonucleoprotein complex;cytosolic large ribosomal subunit;membrane	GO:000563; GO:000573; GO:000579; GO:000582; GO:000592; GO:007006; GO:199090; GO:002262; GO:001602	 Ribosome	hsa0301	structural constituent of ribosome;protein binding;RNA binding	GO:000373; GO:000551; GO:000372
XP_020935470.1;XP_005660144.1;XP_020935466.1	XP_020935470.1;XP_005660144.1;XP_020935466.1	XP_020935470.1 ras-related GTP-binding protein B isoform X5 [Sus scrofa];XP_005660144.1 ras-related GTP-binding protein A [Sus scrofa];XP_020935466.1 ras-related GTP-binding protein B isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	8989400	0	0	0	0	0	0	NA	NA	NA	RRAGB	RRAGB;RRAGA;RRAGB;NA;NA	cellular response to amino acid starvation;cellular response to amino acid stimulus;positive regulation of TOR signaling;cellular response to leucine starvation;regulation of macroautophagy;cell cycle arrest;cellular protein localization;positive regulation of TORC1 signaling;regulation of autophagy;cellular response to starvation	GO:003419; GO:007123; GO:003200; GO:199025; GO:001624; GO:000705; GO:003461; GO:190426; GO:001050; GO:000926	EGO complex;lysosome;cytosol;nucleus;cytoplasm;Gtr1-Gtr2 GTPase complex	GO:003444; GO:000576; GO:000582; GO:000563; GO:000573; GO:199013	 mTOR signaling pathway	hsa0415	protein binding;GTP binding;protein heterodimerization activity;guanyl ribonucleotide binding;GTPase activity;GTPase binding	GO:000551; GO:000552; GO:004698; GO:003256; GO:000392; GO:005102
XP_005660264.1	XP_005660264.1	XP_005660264.1 tropomyosin beta chain isoform X2 [Sus scrofa]	31	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	245060000	0	NA	NA	NA	TPM2	TPM2;NA;NA;NA;NA	muscle contraction;actin filament organization;regulation of ATPase activity;muscle filament sliding	GO:000693; GO:000701; GO:004346; GO:003004	muscle thin filament tropomyosin;actin cytoskeleton;cytosol;actin filament	GO:000586; GO:001562; GO:000582; GO:000588	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction	hsa0541; hsa0541; hsa0426	actin filament binding;structural constituent of muscle;identical protein binding;protein heterodimerization activity;actin binding	GO:005101; GO:000830; GO:004280; GO:004698; GO:000377
XP_020922926.1;XP_005660377.1	XP_020922926.1;XP_005660377.1	XP_020922926.1 transmembrane protein 245 isoform X2 [Sus scrofa];XP_005660377.1 transmembrane protein 245 isoform X1 [Sus scrofa]	4	4	4	20072000	19580000	34080000	25497000	15821000	24750000	15594000	18832000	18297000	0	25109000	0	0	23411000	20974000	22678000	40177000	29486000	NA	NA	NA	TMEM245	TMEM245;TMEM245;NA;NA;NA	biological_process	GO:000815	integral component of membrane	GO:001602	"NA"	"NA"	molecular_function	GO:000367
XP_005660429.1;XP_020923626.1;XP_005660428.1	XP_005660429.1;XP_020923626.1;XP_005660428.1	XP_005660429.1 alpha-1-acid glycoprotein isoform X2 [Sus scrofa];XP_020923626.1 alpha-1-acid glycoprotein isoform X3 [Sus scrofa];XP_005660428.1 alpha-1-acid glycoprotein isoform X1 [Sus scrofa]	15	15	15	954430000	1340500000	825490000	1548600000	2615400000	4247100000	1316200000	1547000000	1173600000	1044300000	1740600000	900760000	1555600000	2029500000	1470400000	1585300000	1762800000	2950200000	NA	NA	NA	ORM1	ORM1;ORM1;ORM1;NA;NA	regulation of immune system process;positive regulation of interleukin-1 beta secretion;positive regulation of tumor necrosis factor secretion;negative regulation of interleukin-6 production;neutrophil degranulation;platelet degranulation;acute-phase response;negative regulation of tumor necrosis factor production	GO:000268; GO:005071; GO:190446; GO:003271; GO:004331; GO:000257; GO:000695; GO:003272	extracellular space;extracellular region;specific granule lumen;extracellular exosome;platelet alpha granule lumen;blood microparticle;tertiary granule lumen	GO:000561; GO:000557; GO:003558; GO:007006; GO:003109; GO:007256; GO:190472	"NA"	"NA"	protein binding	GO:000551
XP_005660460.1;NP_001026953.1	XP_005660460.1;NP_001026953.1	XP_005660460.1 ras-related protein Rab-14 isoform X1 [Sus scrofa];NP_001026953.1 ras-related protein Rab-14 [Sus scrofa]	12	12	12	278800000	332920000	286390000	255330000	263710000	245880000	314830000	268650000	271400000	272580000	286310000	314160000	244660000	296370000	253360000	295860000	262700000	297140000	NA	NA	NA	RAB14	RAB14;RAB14;NA;NA;NA	intracellular protein transport;regulation of protein localization;phagolysosome assembly involved in apoptotic cell clearance;endocytic recycling;neutrophil degranulation;intracellular transport;Golgi to endosome transport;fibroblast growth factor receptor signaling pathway;vesicle-mediated transport;defense response to bacterium;phosphatidylinositol biosynthetic process;Rab protein signal transduction;regulation of embryonic development	GO:000688; GO:003288; GO:009038; GO:003245; GO:004331; GO:004690; GO:000689; GO:000854; GO:001619; GO:004274; GO:000666; GO:003248; GO:004599	early endosome membrane;phagocytic vesicle;recycling endosome membrane;extracellular exosome;Golgi membrane;lysosomal membrane;late endosome;rough endoplasmic reticulum;cytosol;cilium;perinuclear region of cytoplasm;trans-Golgi network;tertiary granule membrane;trans-Golgi network transport vesicle;plasma membrane;nuclear outer membrane-endoplasmic reticulum membrane network;intracellular membrane-bounded organelle	GO:003190; GO:004533; GO:005503; GO:007006; GO:000013; GO:000576; GO:000577; GO:000579; GO:000582; GO:000592; GO:004847; GO:000580; GO:007082; GO:003014; GO:000588; GO:004217; GO:004323	 AMPK signaling pathway	hsa0415	myosin V binding;GTPase activity;GTP binding;protein binding;GDP binding	GO:003148; GO:000392; GO:000552; GO:000551; GO:001900
XP_005660499.1	XP_005660499.1	XP_005660499.1 60S ribosomal protein L12 [Sus scrofa]	7	7	7	162630000	160210000	167290000	163410000	178840000	171340000	206080000	134970000	168830000	171220000	163970000	156660000	223700000	189610000	186530000	158210000	178480000	176120000	NA	NA	NA	RPL12	RPL12;NA;NA;NA;NA	translational initiation;translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;ribosomal large subunit assembly;SRP-dependent cotranslational protein targeting to membrane	GO:000641; GO:000641; GO:000018; GO:000002; GO:000661	large ribosomal subunit;extracellular exosome;cytosolic large ribosomal subunit;membrane;cytosol;focal adhesion;postsynaptic density;nucleolus	GO:001593; GO:007006; GO:002262; GO:001602; GO:000582; GO:000592; GO:001406; GO:000573	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;large ribosomal subunit rRNA binding;RNA binding;rRNA binding	GO:000551; GO:000373; GO:007018; GO:000372; GO:001984
XP_020925240.1;XP_020925234.1;XP_020925227.1;XP_020925219.1;XP_020925208.1;XP_005660524.2;XP_005660522.2;XP_005660528.2;XP_005660531.2;XP_005660529.2;XP_020925181.1;XP_020925171.1	XP_020925240.1;XP_020925234.1;XP_020925227.1;XP_020925219.1;XP_020925208.1;XP_005660524.2;XP_005660522.2;XP_005660528.2;XP_005660531.2;XP_005660529.2;XP_020925181.1;XP_020925171.1	XP_020925240.1 dynamin-1 isoform X11 [Sus scrofa];XP_020925234.1 dynamin-1 isoform X11 [Sus scrofa];XP_020925227.1 dynamin-1 isoform X10 [Sus scrofa];XP_020925219.1 dynamin-1 isoform X9 [Sus scrofa];XP_020925208.1 dynamin-1 isoform X8 [Sus scrofa];XP_00566	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2267300	0	NA	NA	NA	DNM1	DNM1;DNM1;DNM1;DNM1;DNM1	endosome organization;toxin transport;endocytosis;regulation of synapse structure or activity;clathrin-dependent endocytosis;synaptic vesicle budding from presynaptic endocytic zone membrane;positive regulation of synaptic vesicle endocytosis;postsynaptic neurotransmitter receptor internalization;receptor internalization;G-protein coupled receptor internalization;ephrin receptor signaling pathway;response to beta-amyloid	GO:000703; GO:190199; GO:000689; GO:005080; GO:007258; GO:001618; GO:190024; GO:009888; GO:003162; GO:000203; GO:004801; GO:190464	synapse;extracellular exosome;Golgi apparatus;postsynaptic endocytic zone membrane;nucleoplasm;microtubule;postsynaptic density;membrane;nucleus;axon;varicosity;presynaptic endocytic zone membrane;synaptic vesicle;cytoplasmic vesicle;dendritic spine head;glutamatergic synapse;plasma membrane;membrane coat;photoreceptor inner segment;postsynaptic membrane;cytoplasm;photoreceptor ribbon synapse	GO:004520; GO:007006; GO:000579; GO:009884; GO:000565; GO:000587; GO:001406; GO:001602; GO:000563; GO:003042; GO:004319; GO:009883; GO:000802; GO:003141; GO:004432; GO:009897; GO:000588; GO:003011; GO:000191; GO:004521; GO:000573; GO:009868	 Endocytosis; Endocrine and other factor-regulated calcium reabsorption; Synaptic vesicle cycle; Bacterial invasion of epithelial cells	hsa0414; hsa0496; hsa0472; hsa0510	RNA binding;GTP binding;SH3 domain binding;protein kinase binding;D2 dopamine receptor binding;GTPase activity;protein C-terminus binding;nitric-oxide synthase binding;protein binding;microtubule binding;identical protein binding;macromolecular complex binding	GO:000372; GO:000552; GO:001712; GO:001990; GO:003174; GO:000392; GO:000802; GO:005099; GO:000551; GO:000801; GO:004280; GO:004487
XP_020935759.1;XP_013849443.2;XP_013849442.2;XP_005660644.3;XP_020935771.1;XP_013849444.2;NP_001272905.1	XP_020935759.1;XP_013849443.2;XP_013849442.2;XP_005660644.3;XP_020935771.1;XP_013849444.2;NP_001272905.1	XP_020935759.1 nucleosome assembly protein 1-like 4 isoform X2 [Sus scrofa];XP_013849443.2 nucleosome assembly protein 1-like 4 isoform X2 [Sus scrofa];XP_013849442.2 nucleosome assembly protein 1-like 4 isoform X1 [Sus scrofa];XP_005660644.3 nucleosome as	9	7	7	30431000	38266000	43486000	37926000	31873000	26665000	40346000	46544000	48515000	39363000	34619000	48206000	0	26808000	27701000	33426000	30137000	0	NA	NA	NA	NAP1L4	NAP1L4;NAP1L4;NAP1L4;NAP1L4;NAP1L4	nucleosome assembly	GO:000633	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	protein binding;RNA binding;unfolded protein binding;nucleosome binding	GO:000551; GO:000372; GO:005108; GO:003149
XP_005660736.1	XP_005660736.1	XP_005660736.1 EGF-containing fibulin-like extracellular matrix protein 2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	17444000	0	0	0	0	0	NA	NA	NA	EFEMP2	EFEMP2;NA;NA;NA;NA	elastic fiber assembly	GO:004825	extracellular region;extracellular exosome;basement membrane;extracellular vesicle	GO:000557; GO:007006; GO:000560; GO:190356	"NA"	"NA"	extracellular matrix structural constituent;calcium ion binding;protein binding	GO:000520; GO:000550; GO:000551
XP_005660829.1;XP_020936320.1	XP_005660829.1;XP_020936320.1	XP_005660829.1 neutral alpha-glucosidase AB isoform X3 [Sus scrofa];XP_020936320.1 neutral alpha-glucosidase AB isoform X1 [Sus scrofa]	32	32	1	570670000	639310000	572450000	590480000	561330000	540140000	640920000	636510000	497380000	506300000	649540000	798170000	516450000	670260000	652300000	641510000	602310000	636380000	NA	NA	NA	GANAB	GANAB;GANAB;NA;NA;NA	carbohydrate metabolic process;N-glycan processing	GO:000597; GO:000649	Golgi apparatus;melanosome;endoplasmic reticulum lumen;extracellular exosome;glucosidase II complex;membrane;intracellular membrane-bounded organelle	GO:000579; GO:004247; GO:000578; GO:007006; GO:001717; GO:001602; GO:004323	 Protein processing in endoplasmic reticulum; N-Glycan biosynthesis; Metabolic pathways	hsa0414; hsa0051; hsa0110	glucan 1,3-alpha-glucosidase activity;protein binding;RNA binding;carbohydrate binding	GO:003391; GO:000551; GO:000372; GO:003024
XP_005660840.2	XP_005660840.2	XP_005660840.2 LOW QUALITY PROTEIN: heterogeneous nuclear ribonucleoprotein U-like protein 2 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	21293000	0	0	0	0	25830000	0	0	30352000	28892000	NA	NA	NA	HNRNPUL2	HNRNPUL2;NA;NA;NA;NA	biological_process	GO:000815	nucleus;nucleoplasm;membrane	GO:000563; GO:000565; GO:001602	"NA"	"NA"	RNA binding	GO:000372
XP_005660855.3	XP_005660855.3	XP_005660855.3 LOW QUALITY PROTEIN: elongation factor 1-gamma [Sus scrofa]	13	13	13	309560000	318530000	325750000	295420000	293360000	323160000	297180000	293810000	268470000	285920000	305020000	396140000	360470000	320780000	314370000	302980000	314240000	312900000	NA	NA	NA	EEF1G	EEF1G;NA;NA;NA;NA	response to virus;translational elongation	GO:000961; GO:000641	cytoplasm;cytosol;extracellular exosome;endoplasmic reticulum;membrane;nucleus	GO:000573; GO:000582; GO:007006; GO:000578; GO:001602; GO:000563	 Legionellosis	hsa0513	protein binding;translation elongation factor activity;cadherin binding	GO:000551; GO:000374; GO:004529
XP_005660860.1	XP_005660860.1	XP_005660860.1 ferritin heavy chain isoform X1 [Sus scrofa]	2	2	2	12588000	0	0	0	0	13585000	10052000	0	0	10716000	0	0	19933000	10485000	0	0	0	0	NA	NA	NA	FTH1	FTH1;NA;NA;NA;NA	cellular iron ion homeostasis;oxidation-reduction process;negative regulation of necrotic cell death;negative regulation of fibroblast proliferation;intracellular sequestering of iron ion;immune response;negative regulation of cell proliferation;neutrophil degranulation	GO:000687; GO:005511; GO:006054; GO:004814; GO:000688; GO:000695; GO:000828; GO:004331	extracellular exosome;intracellular ferritin complex;ficolin-1-rich granule lumen;nucleus;autolysosome;cytoplasm;cytosol;tertiary granule lumen;extracellular region	GO:007006; GO:000804; GO:190481; GO:000563; GO:004475; GO:000573; GO:000582; GO:190472; GO:000557	 Mineral absorption	hsa0497	iron ion binding;ferric iron binding;ferroxidase activity;protein binding;identical protein binding	GO:000550; GO:000819; GO:000432; GO:000551; GO:004280
XP_020938681.1;XP_020938680.1;XP_020938679.1;XP_005660950.1;XP_020938678.1;XP_005660949.1;XP_020938676.1;XP_020938675.1;XP_005660948.1;XP_020938674.1;XP_020938673.1;XP_005660947.1;XP_020938672.1;XP_013849763.1;XP_005660946.1;XP_020938684.1;XP_020938683.1;XP_020938682.1;XP_005660952.1	XP_020938681.1;XP_020938680.1;XP_020938679.1;XP_005660950.1;XP_020938678.1;XP_005660949.1;XP_020938676.1;XP_020938675.1;XP_005660948.1;XP_020938674.1;XP_020938673.1;XP_005660947.1;XP_020938672.1;XP_013849763.1;XP_005660946.1;XP_020938684.1;XP_020938683.1;XP_020938682.1;XP_005660952.1	XP_020938681.1 catenin delta-1 isoform X9 [Sus scrofa];XP_020938680.1 catenin delta-1 isoform X9 [Sus scrofa];XP_020938679.1 catenin delta-1 isoform X9 [Sus scrofa];XP_005660950.1 catenin delta-1 isoform X8 [Sus scrofa];XP_020938678.1 catenin delta-1 isofo	15	15	15	56504000	53453000	52359000	43680000	57939000	57438000	50108000	52927000	54230000	52560000	45378000	84966000	65323000	66786000	39761000	62678000	51354000	49699000	NA	NA	NA	CTNND1	CTNND1;CTNND1;CTNND1;CTNND1;CTNND1	negative regulation of canonical Wnt signaling pathway;cell-cell junction assembly;adherens junction organization;regulation of postsynaptic specialization membrane neurotransmitter receptor levels;entry of bacterium into host cell;cell-cell adhesion;cell adhesion;brain development;Wnt signaling pathway	GO:009009; GO:000704; GO:003433; GO:009907; GO:003563; GO:009860; GO:000715; GO:000742; GO:001605	nucleus;cell-cell adherens junction;lamellipodium;presynaptic active zone cytoplasmic component;cytosol;plasma membrane;dendritic spine;catenin complex;growth cone;hippocampal mossy fiber to CA3 synapse;postsynaptic density, intracellular component;cytoplasm;midbody;extracellular exosome;glutamatergic synapse	GO:000563; GO:000591; GO:003002; GO:009883; GO:000582; GO:000588; GO:004319; GO:001634; GO:003042; GO:009868; GO:009909; GO:000573; GO:003049; GO:007006; GO:009897	 Leukocyte transendothelial migration; Rap1 signaling pathway; Adherens junction	hsa0467; hsa0401; hsa0452	receptor binding;protein kinase binding;protein binding;cadherin binding	GO:000510; GO:001990; GO:000551; GO:004529
XP_020938820.1;XP_020938819.1;XP_013849846.1;XP_005661034.1	XP_020938820.1;XP_020938819.1;XP_013849846.1;XP_005661034.1	XP_020938820.1 1-aminocyclopropane-1-carboxylate synthase-like protein 1 isoform X3 [Sus scrofa];XP_020938819.1 1-aminocyclopropane-1-carboxylate synthase-like protein 1 isoform X2 [Sus scrofa];XP_013849846.1 1-aminocyclopropane-1-carboxylate synthase-like	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ACCS	ACCS;ACCS;ACCS;ACCS;NA	1-aminocyclopropane-1-carboxylate biosynthetic process	GO:004221	"NA"	"NA"	"NA"	"NA"	identical protein binding;protein binding;1-aminocyclopropane-1-carboxylate synthase activity;pyridoxal phosphate binding;protein homodimerization activity	GO:004280; GO:000551; GO:001684; GO:003017; GO:004280
XP_005661078.1	XP_005661078.1	XP_005661078.1 caprin-1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12636000	0	0	0	NA	NA	NA	CAPRIN1	CAPRIN1;NA;NA;NA;NA	negative regulation of translation;positive regulation of dendritic spine morphogenesis;positive regulation of dendrite morphogenesis	GO:001714; GO:006100; GO:005077	P-body;dendrite;membrane;synapse;cytosol;cytoplasmic stress granule	GO:000093; GO:003042; GO:001602; GO:004520; GO:000582; GO:001049	"NA"	"NA"	RNA binding;protein binding	GO:000372; GO:000551
XP_005661108.1	XP_005661108.1	XP_005661108.1 eukaryotic translation initiation factor 3 subunit M [Sus scrofa]	3	3	3	0	0	0	0	3567600	0	0	4245100	3622800	3828100	4406000	8568600	3650900	0	3580600	3502900	0	0	NA	NA	NA	EIF3M	EIF3M;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;translational initiation;cytoplasmic translational initiation	GO:000173; GO:000641; GO:000218	cytosol;eukaryotic 48S preinitiation complex;eukaryotic translation initiation factor 3 complex, eIF3m;eukaryotic translation initiation factor 3 complex;eukaryotic 43S preinitiation complex	GO:000582; GO:003329; GO:007154; GO:000585; GO:001628	"NA"	"NA"	protein binding;translation initiation factor binding;translation initiation factor activity	GO:000551; GO:003136; GO:000374
XP_005661255.1	XP_005661255.1	XP_005661255.1 tropomyosin alpha-4 chain isoform X1 [Sus scrofa]	24	4	4	0	0	0	0	0	0	0	0	0	0	0	0	76876000	0	0	0	0	0	NA	NA	NA	TPM4	TPM4;NA;NA;NA;NA	actin filament organization;osteoblast differentiation;muscle filament sliding;muscle contraction	GO:000701; GO:000164; GO:003004; GO:000693	actin filament;cytosol;stress fiber;membrane;extracellular exosome;muscle thin filament tropomyosin;focal adhesion;cytoskeleton	GO:000588; GO:000582; GO:000172; GO:001602; GO:007006; GO:000586; GO:000592; GO:000585	 Dilated cardiomyopathy; Adrenergic signaling in cardiomyocytes; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0426; hsa0541	protein binding;protein heterodimerization activity;protein homodimerization activity;calcium ion binding;actin filament binding;structural constituent of muscle	GO:000551; GO:004698; GO:004280; GO:000550; GO:005101; GO:000830
XP_020935064.1;XP_020935057.1;XP_020935051.1;XP_020935048.1;XP_020935043.1;XP_020935031.1;XP_005661436.1;NP_001233126.1;XP_020935072.1;XP_020935069.1;XP_005661439.1;XP_005661438.1;XP_020935028.1;XP_020935021.1;XP_020935010.1;XP_013850269.1;XP_005661435.1;XP_005661434.1;XP_005661432.1	XP_020935064.1;XP_020935057.1;XP_020935051.1;XP_020935048.1;XP_020935043.1;XP_020935031.1;XP_005661436.1;NP_001233126.1;XP_020935072.1;XP_020935069.1;XP_005661439.1;XP_005661438.1;XP_020935028.1;XP_020935021.1;XP_020935010.1;XP_013850269.1;XP_005661435.1;XP_005661434.1;XP_005661432.1	XP_020935064.1 cold-inducible RNA-binding protein isoform X2 [Sus scrofa];XP_020935057.1 cold-inducible RNA-binding protein isoform X2 [Sus scrofa];XP_020935051.1 cold-inducible RNA-binding protein isoform X2 [Sus scrofa];XP_020935048.1 cold-inducible RNA-	3	3	3	0	15066000	0	23027000	0	0	0	15063000	0	19209000	0	13247000	0	9872900	0	18741000	0	16564000	NA	NA	NA	CIRBP	CIRBP;CIRBP;CIRBP;CIRBP;CIRBP	stress granule assembly;positive regulation of mRNA splicing, via spliceosome;mRNA stabilization;response to UV;positive regulation of translation;response to cold;negative regulation of translation	GO:003406; GO:004802; GO:004825; GO:000941; GO:004572; GO:000940; GO:001714	cytoplasm;nucleoplasm;spliceosomal complex;nucleus;nucleolus;cytoplasmic stress granule;ribonucleoprotein complex	GO:000573; GO:000565; GO:000568; GO:000563; GO:000573; GO:001049; GO:199090	"NA"	"NA"	mRNA 3'-UTR binding;poly(U) RNA binding;translation repressor activity;RNA binding;protein binding;small ribosomal subunit rRNA binding	GO:000373; GO:000826; GO:003037; GO:000372; GO:000551; GO:007018
XP_005661508.1;XP_013850319.1	XP_005661508.1;XP_013850319.1	XP_005661508.1 vesicular integral-membrane protein VIP36 isoform X1 [Sus scrofa];XP_013850319.1 vesicular integral-membrane protein VIP36 isoform X2 [Sus scrofa]	5	5	5	142940000	91661000	156920000	88786000	145000000	108580000	139000000	135160000	158620000	103420000	143130000	112630000	0	109740000	195070000	125470000	146610000	109260000	NA	NA	NA	LMAN2	LMAN2;LMAN2;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;Golgi organization;ER to Golgi vesicle-mediated transport;protein transport;endoplasmic reticulum organization;positive regulation of phagocytosis	GO:000689; GO:000703; GO:000688; GO:001503; GO:000702; GO:005076	Golgi membrane;extracellular space;ER to Golgi transport vesicle;cell surface;endoplasmic reticulum membrane;Golgi apparatus;endoplasmic reticulum-Golgi intermediate compartment membrane;integral component of plasma membrane;extracellular exosome	GO:000013; GO:000561; GO:003013; GO:000998; GO:000578; GO:000579; GO:003311; GO:000588; GO:007006	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;mannose binding;heat shock protein binding;carbohydrate binding;metal ion binding	GO:000551; GO:000553; GO:003107; GO:003024; GO:004687
XP_005661680.1	XP_005661680.1	XP_005661680.1 histidine triad nucleotide-binding protein 1 [Sus scrofa]	4	4	4	111900000	107240000	98794000	116310000	99713000	96516000	99285000	125380000	70240000	119950000	86608000	144660000	125180000	101540000	99500000	102640000	120930000	94263000	NA	NA	NA	HINT1	HINT1;NA;NA;NA;NA	signal transduction;positive regulation of calcium-mediated signaling;purine ribonucleotide catabolic process;intrinsic apoptotic signaling pathway by p53 class mediator;regulation of transcription, DNA-templated	GO:000716; GO:005085; GO:000915; GO:007233; GO:000635	cytoskeleton;nucleus;histone deacetylase complex;extracellular exosome;cytosol;plasma membrane	GO:000585; GO:000563; GO:000011; GO:007006; GO:000582; GO:000588	"NA"	"NA"	hydrolase activity;nucleotide binding;protein kinase C binding	GO:001678; GO:000016; GO:000508
XP_005661704.1;XP_013850577.1;XP_005661703.1;XP_020941100.1;XP_013850576.1;XP_013850575.1;XP_020941101.1	XP_005661704.1;XP_013850577.1;XP_005661703.1;XP_020941100.1;XP_013850576.1;XP_013850575.1;XP_020941101.1	XP_005661704.1 septin-8 isoform X7 [Sus scrofa];XP_013850577.1 septin-8 isoform X5 [Sus scrofa];XP_005661703.1 septin-8 isoform X4 [Sus scrofa];XP_020941100.1 septin-8 isoform X3 [Sus scrofa];XP_013850576.1 septin-8 isoform X2 [Sus scrofa];XP_013850575.1 s	15	15	13	48487000	75605000	70405000	58387000	48255000	81258000	78210000	58406000	56193000	53468000	59391000	73474000	124830000	76360000	59072000	39745000	87226000	83546000	NA	NA	NA	Sep 08	Sep 08;Sep 08;Sep 08;Sep 08;Sep 08	regulation of SNARE complex assembly;cytoskeleton-dependent cytokinesis	GO:003554; GO:006164	septin ring;synaptic vesicle membrane;septin complex;cell junction;microtubule cytoskeleton;presynapse;axon	GO:000594; GO:003067; GO:003110; GO:003005; GO:001563; GO:009879; GO:003042	 Bacterial invasion of epithelial cells	hsa0510	GTP binding;protein complex scaffold;GTPase activity;protein binding	GO:000552; GO:003294; GO:000392; GO:000551
XP_005661711.1;XP_020957268.1	XP_005661711.1	XP_005661711.1 heat shock 70 kDa protein 4 [Sus scrofa]	19	19	19	101500000	112920000	149680000	103730000	124540000	95206000	129840000	119760000	127370000	108320000	113150000	105470000	107640000	104950000	117680000	105520000	123020000	112690000	NA	NA	NA	HSPA4	HSPA4;NA;NA;NA;NA	response to unfolded protein;chaperone-mediated protein complex assembly;protein import into mitochondrial outer membrane	GO:000698; GO:005113; GO:004504	nucleus;extracellular exosome;cytosol	GO:000563; GO:007006; GO:000582	 Antigen processing and presentation	hsa0461	ATP binding;protein binding	GO:000552; GO:000551
XP_005661752.1	XP_005661752.1	XP_005661752.1 stress-70 protein, mitochondrial [Sus scrofa]	19	19	19	626260000	312600000	490740000	247930000	564320000	277710000	523980000	349290000	490780000	311470000	415800000	302210000	267880000	271030000	470110000	333240000	334100000	263970000	NA	NA	NA	HSPA9	HSPA9;NA;NA;NA;NA	interleukin-12-mediated signaling pathway;protein refolding;erythrocyte differentiation;cellular response to heat;cellular response to unfolded protein;chaperone mediated protein folding requiring cofactor;negative regulation of apoptotic process;regulation of erythrocyte differentiation;iron-sulfur cluster assembly;response to unfolded protein	GO:003572; GO:004202; GO:003021; GO:003460; GO:003462; GO:005108; GO:004306; GO:004564; GO:001622; GO:000698	mitochondrial nucleoid;mitochondrion;extracellular exosome;mitochondrial matrix;focal adhesion	GO:004264; GO:000573; GO:007006; GO:000575; GO:000592	 RNA degradation; Tuberculosis	hsa0301; hsa0515	RNA binding;ATPase activity;protein binding;misfolded protein binding;ATP binding;protein binding involved in protein folding;ATPase activity, coupled;unfolded protein binding;heat shock protein binding;ubiquitin protein ligase binding	GO:000372; GO:001688; GO:000551; GO:005178; GO:000552; GO:004418; GO:004262; GO:005108; GO:003107; GO:003162
XP_020940518.1;XP_020940517.1;XP_020940516.1;XP_020940515.1;XP_020940514.1;XP_013850634.1;XP_020940513.1;XP_020940512.1;XP_020940511.1;XP_020940510.1;XP_013850633.1;XP_020940509.1;XP_020940508.1;XP_020940507.1;XP_020940506.1;XP_005661770.1;XP_005661768.1;XP_005661767.1;XP_005661766.1;XP_005661765.1;XP_005661764.1;XP_020940525.1;XP_020940524.1;XP_020940523.1;XP_020940522.1;XP_020940526.1;XP_020940521.1;XP_020940520.1;XP_020940519.1;XP_005661773.1	XP_020940518.1;XP_020940517.1;XP_020940516.1;XP_020940515.1;XP_020940514.1;XP_013850634.1;XP_020940513.1;XP_020940512.1;XP_020940511.1;XP_020940510.1;XP_013850633.1;XP_020940509.1;XP_020940508.1;XP_020940507.1;XP_020940506.1;XP_005661770.1;XP_005661768.1;XP_005661767.1;XP_005661766.1;XP_005661765.1;XP_005661764.1	XP_020940518.1 matrin-3 isoform X4 [Sus scrofa];XP_020940517.1 matrin-3 isoform X4 [Sus scrofa];XP_020940516.1 matrin-3 isoform X4 [Sus scrofa];XP_020940515.1 matrin-3 isoform X4 [Sus scrofa];XP_020940514.1 matrin-3 isoform X4 [Sus scrofa];XP_013850634.1 m	10	10	10	26177000	36365000	36241000	36925000	36434000	53230000	33684000	35307000	43928000	39119000	37307000	50128000	53529000	40815000	62211000	46267000	42041000	42572000	NA	NA	NA	MATR3	MATR3;MATR3;MATR3;MATR3;MATR3	activation of innate immune response;innate immune response;posttranscriptional regulation of gene expression	GO:000221; GO:004508; GO:001060	nuclear inner membrane;membrane;nuclear matrix	GO:000563; GO:001602; GO:001636	"NA"	"NA"	miRNA binding;identical protein binding;protein binding;RNA binding;structural molecule activity;zinc ion binding	GO:003519; GO:004280; GO:000551; GO:000372; GO:000519; GO:000827
XP_005661793.1	XP_005661793.1	XP_005661793.1 prefoldin subunit 1 [Sus scrofa]	2	2	2	0	29555000	0	25463000	25171000	0	0	0	0	0	0	0	29627000	0	0	0	0	0	NA	NA	NA	PFDN1	PFDN1;NA;NA;NA;NA	regulation of transcription, DNA-templated;protein folding	GO:000635; GO:000645	prefoldin complex	GO:001627	"NA"	"NA"	protein binding involved in protein folding;unfolded protein binding;transcription factor activity, sequence-specific DNA binding	GO:004418; GO:005108; GO:000370
XP_005661912.1;NP_001127827.1	XP_005661912.1;NP_001127827.1	XP_005661912.1 actin-related protein 2/3 complex subunit 1A isoform X1 [Sus scrofa];NP_001127827.1 actin-related protein 2/3 complex subunit 1A [Sus scrofa]	9	8	8	41894000	34871000	30907000	27156000	31582000	32295000	28914000	23324000	31910000	26538000	28482000	46589000	42118000	27113000	24786000	21502000	28896000	28815000	NA	NA	NA	ARPC1A	ARPC1A;ARPC1A;NA;NA;NA	membrane organization;ephrin receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;actin cytoskeleton organization;Arp2/3 complex-mediated actin nucleation	GO:006102; GO:004801; GO:003809; GO:003003; GO:003431	extracellular exosome;nucleus;actin cytoskeleton;Arp2/3 protein complex;site of double-strand break;cytosol	GO:007006; GO:000563; GO:001562; GO:000588; GO:003586; GO:000582	 Bacterial invasion of epithelial cells; Pathogenic Escherichia coli infection; Endocytosis; Regulation of actin cytoskeleton; Fc gamma R-mediated phagocytosis	hsa0510; hsa0513; hsa0414; hsa0481; hsa0466	actin binding;actin filament binding	GO:000377; GO:005101
XP_005662019.1	XP_005662019.1	XP_005662019.1 14-3-3 protein gamma [Sus scrofa]	12	10	10	1230800000	1062700000	1302600000	997190000	1053400000	746280000	1263300000	1040300000	1232900000	1098000000	994800000	1174500000	578700000	937960000	1111300000	983020000	1023700000	785370000	NA	NA	NA	YWHAG	YWHAG;NA;NA;NA;NA	regulation of synaptic plasticity;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;protein targeting;cellular response to insulin stimulus;G2/M transition of mitotic cell cycle;membrane organization;regulation of signal transduction;regulation of neuron differentiation;regulation of G2/M transition of mitotic cell cycle;ciliary basal body docking;negative regulation of protein kinase activity;negative regulation of protein serine/threonine kinase activity	GO:004816; GO:190074; GO:000660; GO:003286; GO:000008; GO:006102; GO:000996; GO:004566; GO:001038; GO:009771; GO:000646; GO:007190	membrane;focal adhesion;mitochondrion;extracellular exosome;presynapse;cytosol	GO:001602; GO:000592; GO:000573; GO:007006; GO:009879; GO:000582	 Hippo signaling pathway; Epstein-Barr virus infection; Cell cycle; PI3K-Akt signaling pathway; Viral carcinogenesis	hsa0439; hsa0516; hsa0411; hsa0415; hsa0520	insulin-like growth factor receptor binding;protein kinase C inhibitor activity;protein kinase C binding;receptor tyrosine kinase binding;protein domain specific binding;RNA binding;identical protein binding;protein binding	GO:000515; GO:000842; GO:000508; GO:003097; GO:001990; GO:000372; GO:004280; GO:000551
XP_020942003.1;XP_005662051.1;XP_005662050.1;XP_005662049.1;XP_005662048.1;XP_005662047.1;XP_005662046.1	XP_020942003.1;XP_005662051.1;XP_005662050.1;XP_005662049.1;XP_005662048.1;XP_005662047.1;XP_005662046.1	XP_020942003.1 general transcription factor II-I isoform X6 [Sus scrofa];XP_005662051.1 general transcription factor II-I isoform X6 [Sus scrofa];XP_005662050.1 general transcription factor II-I isoform X4 [Sus scrofa];XP_005662049.1 general transcription	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2035800	0	0	NA	NA	NA	GTF2I	GTF2I;GTF2I;GTF2I;GTF2I;GTF2I	regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;negative regulation of angiogenesis;negative regulation of cytosolic calcium ion concentration;signal transduction	GO:000635; GO:000636; GO:001652; GO:005148; GO:000716	cytoplasm;nucleoplasm;membrane;nucleus	GO:000573; GO:000565; GO:001602; GO:000563	 Herpes simplex infection; Basal transcription factors; cGMP-PKG signaling pathway	hsa0516; hsa0302; hsa0402	DNA binding;protein binding;transcription factor activity, sequence-specific DNA binding	GO:000367; GO:000551; GO:000370
XP_005662075.1;XP_005674660.3	XP_005662075.1	XP_005662075.1 T-complex protein 1 subunit zeta [Sus scrofa]	16	16	16	175540000	124280000	171670000	177290000	202580000	118960000	164960000	141810000	164190000	155300000	173130000	142610000	144390000	147300000	179390000	136360000	127600000	114860000	NA	NA	NA	CCT6A	CCT6A;NA;NA;NA;NA	positive regulation of protein localization to Cajal body;positive regulation of establishment of protein localization to telomere;protein folding;positive regulation of telomere maintenance via telomerase;protein stabilization;positive regulation of telomerase RNA localization to Cajal body	GO:190487; GO:190485; GO:000645; GO:003221; GO:005082; GO:190487	extracellular exosome;cytosol;cytoplasm;chaperonin-containing T-complex;microtubule	GO:007006; GO:000582; GO:000573; GO:000583; GO:000587	"NA"	"NA"	RNA binding;protein binding;WD40-repeat domain binding;unfolded protein binding;ATP binding	GO:000372; GO:000551; GO:007198; GO:005108; GO:000552
XP_013851147.1;XP_005662231.1;XP_005662230.1;XP_020942355.1	XP_013851147.1;XP_005662231.1;XP_005662230.1;XP_020942355.1	XP_013851147.1 vasorin isoform X2 [Sus scrofa];XP_005662231.1 vasorin isoform X2 [Sus scrofa];XP_005662230.1 vasorin isoform X2 [Sus scrofa];XP_020942355.1 vasorin isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4199700	NA	NA	NA	VASN	VASN;VASN;VASN;VASN;NA	cellular response to hypoxia;cellular response to redox state;negative regulation of epithelial to mesenchymal transition;negative regulation of transforming growth factor beta receptor signaling pathway	GO:007145; GO:007146; GO:001071; GO:003051	mitochondrion;cell surface;plasma membrane;extracellular matrix;integral component of membrane;extracellular space;extracellular exosome;lysosomal membrane	GO:000573; GO:000998; GO:000588; GO:003101; GO:001602; GO:000561; GO:007006; GO:000576	"NA"	"NA"	transforming growth factor beta binding;cadherin binding;protein binding	GO:005043; GO:004529; GO:000551
XP_005662305.1;NP_001230818.1	XP_005662305.1;NP_001230818.1	XP_005662305.1 asporin isoform X1 [Sus scrofa];NP_001230818.1 asporin precursor [Sus scrofa]	16	16	16	445180000	2256400000	517800000	2573800000	475880000	2403100000	791990000	1558200000	756670000	1730800000	604530000	2680600000	2776700000	2998700000	621740000	3255700000	789950000	4198200000	NA	NA	NA	ASPN	ASPN;ASPN;NA;NA;NA	negative regulation of tooth mineralization;bone mineralization;negative regulation of transforming growth factor beta receptor signaling pathway	GO:007017; GO:003028; GO:003051	extracellular matrix	GO:003101	"NA"	"NA"	extracellular matrix structural constituent conferring compression resistance;collagen binding;calcium ion binding	GO:003002; GO:000551; GO:000550
XP_013851302.1;XP_005662358.1	XP_013851302.1;XP_005662358.1	XP_013851302.1 fumarylacetoacetate hydrolase domain-containing protein 2 [Sus scrofa];XP_005662358.1 fumarylacetoacetate hydrolase domain-containing protein 2 [Sus scrofa]	8	8	8	67533000	63590000	65802000	67896000	69342000	55454000	80520000	81412000	88985000	67312000	62556000	75358000	63667000	61190000	53172000	79858000	59431000	67517000	NA	NA	NA	LOC100522130	LOC100522130;LOC100522130;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005662419.1	XP_005662419.1	XP_005662419.1 60S ribosomal protein L31 [Sus scrofa]	4	4	4	0	0	0	0	0	0	77047000	0	0	0	0	68508000	0	0	64181000	0	0	0	NA	NA	NA	RPL31	RPL31;NA;NA;NA;NA	cytoplasmic translation;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane	GO:000218; GO:000641; GO:000018; GO:000661	polysomal ribosome;extracellular exosome;membrane;cytosolic large ribosomal subunit;cytosol;focal adhesion	GO:004278; GO:007006; GO:001602; GO:002262; GO:000582; GO:000592	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;protein binding	GO:000372; GO:000373; GO:000551
XP_005662547.2;NP_001181908.1	XP_005662547.2;NP_001181908.1	XP_005662547.2 glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1 [Sus scrofa];NP_001181908.1 glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 [Sus scrofa]	17	17	14	105310000	133200000	159610000	136250000	114480000	118490000	130190000	132130000	125580000	135810000	131340000	131540000	81344000	120160000	140300000	120500000	101200000	114620000	NA	NA	NA	GFPT1	GFPT1;GFPT1;NA;NA;NA	circadian regulation of gene expression;UDP-N-acetylglucosamine biosynthetic process;energy reserve metabolic process;glutamine metabolic process;protein N-linked glycosylation;IRE1-mediated unfolded protein response;fructose 6-phosphate metabolic process	GO:003292; GO:000604; GO:000611; GO:000654; GO:000648; GO:003649; GO:000600	cytosol;extracellular exosome	GO:000582; GO:007006	 Insulin resistance; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of antibiotics; Amino sugar and nucleotide sugar metabolism	hsa0493; hsa0025; hsa0110; hsa0113; hsa0052	glutamine-fructose-6-phosphate transaminase (isomerizing) activity;carbohydrate derivative binding	GO:000436; GO:009736
XP_005662598.1;XP_005662597.1;XP_020941217.1;XP_020941218.1;XP_005662601.1	XP_005662598.1;XP_005662597.1;XP_020941217.1;XP_020941218.1	XP_005662598.1 reticulon-4 isoform X3 [Sus scrofa];XP_005662597.1 reticulon-4 isoform X1 [Sus scrofa];XP_020941217.1 reticulon-4 isoform X2 [Sus scrofa];XP_020941218.1 reticulon-4 isoform X4 [Sus scrofa]	28	28	19	873370000	1273600000	873830000	1056900000	865330000	1000600000	922290000	1176200000	884030000	917140000	741410000	1012200000	469040000	1176200000	811570000	1072500000	882140000	1077300000	NA	NA	NA	RTN4	RTN4;RTN4;RTN4;RTN4;NA	endoplasmic reticulum tubular network membrane organization;nuclear pore complex assembly;positive regulation of protein kinase B signaling;endoplasmic reticulum tubular network organization;positive regulation of ERBB3 signaling pathway;axonal fasciculation;cerebral cortex radial glia guided migration;positive regulation of mammary gland epithelial cell proliferation;negative regulation of axonogenesis;protein stabilization;cardiac epithelial to mesenchymal transition;positive regulation of epithelial cell migration;negative regulation of axon extension;negative regulation of cell growth;blastocyst formation;regulation of apoptotic process;apoptotic process;regulation of branching morphogenesis of a nerve;positive regulation of protein localization to endoplasmic reticulum	GO:199080; GO:005129; GO:005189; GO:007178; GO:190558; GO:000741; GO:002180; GO:003360; GO:005077; GO:005082; GO:006031; GO:001063; GO:003051; GO:003030; GO:000182; GO:004298; GO:000691; GO:200017; GO:190555	endoplasmic reticulum;postsynaptic density;integral component of endoplasmic reticulum membrane;endoplasmic reticulum tubular network;nuclear envelope;endoplasmic reticulum membrane;cell projection;plasma membrane;endoplasmic reticulum tubular network membrane;neuronal cell body	GO:000578; GO:001406; GO:003017; GO:007178; GO:000563; GO:000578; GO:004299; GO:000588; GO:009882; GO:004302	"NA"	"NA"	cadherin binding;RNA binding;protein binding;ubiquitin protein ligase binding	GO:004529; GO:000372; GO:000551; GO:003162
XP_005662602.1	XP_005662602.1	XP_005662602.1 reticulon-4 isoform X6 [Sus scrofa]	10	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8474100	NA	NA	NA	RTN4	RTN4;NA;NA;NA;NA	endoplasmic reticulum tubular network membrane organization;nuclear pore complex assembly;positive regulation of protein kinase B signaling;endoplasmic reticulum tubular network organization;positive regulation of ERBB3 signaling pathway;axonal fasciculation;cerebral cortex radial glia guided migration;positive regulation of mammary gland epithelial cell proliferation;negative regulation of axonogenesis;protein stabilization;cardiac epithelial to mesenchymal transition;positive regulation of epithelial cell migration;negative regulation of axon extension;negative regulation of cell growth;blastocyst formation;regulation of apoptotic process;apoptotic process;regulation of branching morphogenesis of a nerve;positive regulation of protein localization to endoplasmic reticulum	GO:199080; GO:005129; GO:005189; GO:007178; GO:190558; GO:000741; GO:002180; GO:003360; GO:005077; GO:005082; GO:006031; GO:001063; GO:003051; GO:003030; GO:000182; GO:004298; GO:000691; GO:200017; GO:190555	endoplasmic reticulum;postsynaptic density;integral component of endoplasmic reticulum membrane;endoplasmic reticulum tubular network;nuclear envelope;endoplasmic reticulum membrane;cell projection;plasma membrane;endoplasmic reticulum tubular network membrane;neuronal cell body	GO:000578; GO:001406; GO:003017; GO:007178; GO:000563; GO:000578; GO:004299; GO:000588; GO:009882; GO:004302	"NA"	"NA"	cadherin binding;RNA binding;protein binding;ubiquitin protein ligase binding	GO:004529; GO:000372; GO:000551; GO:003162
XP_005662840.1	XP_005662840.1	XP_005662840.1 40S ribosomal protein S7 [Sus scrofa]	9	9	9	96943000	89043000	126030000	109270000	103670000	95493000	104110000	94825000	136320000	108190000	94368000	152480000	99677000	112840000	97303000	108290000	112040000	122290000	NA	NA	NA	RPS7	RPS7;NA;NA;NA;NA	translation;negative regulation of ubiquitin protein ligase activity;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cell differentiation;positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;neural tube closure;SRP-dependent cotranslational protein targeting to membrane;ribosomal small subunit biogenesis;translational initiation;positive regulation of gene expression;rRNA processing;protein stabilization	GO:000641; GO:190466; GO:000018; GO:003015; GO:190225; GO:200005; GO:000184; GO:000661; GO:004227; GO:000641; GO:001062; GO:000636; GO:005082	centrosome;cytosol;nucleus;cytosolic small ribosomal subunit;ribonucleoprotein complex;nucleoplasm;ribosome;membrane;nucleolus;macromolecular complex;synapse;focal adhesion;small-subunit processome	GO:000581; GO:000582; GO:000563; GO:002262; GO:199090; GO:000565; GO:000584; GO:001602; GO:000573; GO:003299; GO:004520; GO:000592; GO:003204	 Ribosome	hsa0301	poly(U) RNA binding;protein kinase binding;RNA binding;mRNA 5'-UTR binding;structural constituent of ribosome;protein binding;ubiquitin ligase inhibitor activity	GO:000826; GO:001990; GO:000372; GO:004802; GO:000373; GO:000551; GO:199094
XP_020946209.1;XP_005662937.1	XP_020946209.1;XP_005662937.1	XP_020946209.1 collagen alpha-1(XIV) chain isoform X4 [Sus scrofa];XP_005662937.1 collagen alpha-1(XIV) chain isoform X2 [Sus scrofa]	66	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	+	NA	NA	COL14A1	COL14A1;COL14A1;NA;NA;NA	extracellular matrix organization;growth plate cartilage chondrocyte morphogenesis;cell-cell adhesion;collagen fibril organization	GO:003019; GO:000342; GO:009860; GO:003019	collagen type XIV trimer;endoplasmic reticulum lumen;extracellular region;extracellular space;extracellular matrix;collagen trimer	GO:000559; GO:000578; GO:000557; GO:000561; GO:003101; GO:000558	 Protein digestion and absorption	hsa0497	extracellular matrix structural constituent conferring tensile strength;RNA binding;protein binding, bridging;extracellular matrix structural constituent;collagen binding	GO:003002; GO:000372; GO:003067; GO:000520; GO:000551
XP_005662946.1	XP_005662946.1	XP_005662946.1 double-strand-break repair protein rad21 homolog [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3516300	0	0	NA	NA	NA	RAD21	RAD21;NA;NA;NA;NA	apoptotic process;cell division;meiotic cell cycle;DNA recombination;negative regulation of G2/M transition of mitotic cell cycle;negative regulation of mitotic metaphase/anaphase transition;protein localization to chromatin;reciprocal meiotic recombination;positive regulation of sister chromatid cohesion;regulation of transcription from RNA polymerase II promoter;double-strand break repair;sister chromatid cohesion	GO:000691; GO:005130; GO:005132; GO:000631; GO:001097; GO:004584; GO:007116; GO:000713; GO:004587; GO:000635; GO:000630; GO:000706	chromatin;condensed nuclear chromosome;nucleoplasm;nuclear matrix;meiotic cohesin complex;membrane;chromosome;chromosome, centromeric region;cytosol;cohesin complex	GO:000078; GO:000079; GO:000565; GO:001636; GO:003089; GO:001602; GO:000569; GO:000077; GO:000582; GO:000827	 Cell cycle	hsa0411	protein binding;chromatin binding	GO:000551; GO:000368
XP_020944818.1;XP_020944817.1;XP_020944816.1;XP_020944815.1;XP_020944814.1;XP_020944813.1;XP_005663052.1;XP_020944811.1;XP_020944810.1;XP_020944809.1;XP_020954307.1;XP_020924959.1;XP_020948183.1;XP_020924958.1;XP_020924957.1;XP_020924956.1;XP_020926980.1;XP_020949560.1;XP_020924955.1;XP_020924954.1;XP_020954880.1;XP_020926979.1;XP_013833316.1;XP_020926981.1;XP_013853380.1;XP_001927623.2;XP_013833313.1;XP_020924953.1	XP_020944818.1;XP_020944817.1;XP_020944816.1;XP_020944815.1;XP_020944814.1;XP_020944813.1;XP_005663052.1;XP_020944811.1;XP_020944810.1;XP_020944809.1	XP_020944818.1 copine-3 isoform X4 [Sus scrofa];XP_020944817.1 copine-3 isoform X4 [Sus scrofa];XP_020944816.1 copine-3 isoform X4 [Sus scrofa];XP_020944815.1 copine-3 isoform X4 [Sus scrofa];XP_020944814.1 copine-3 isoform X4 [Sus scrofa];XP_020944813.1 c	13	13	12	79154000	88409000	92022000	84013000	75766000	87392000	71811000	64322000	76171000	93682000	77533000	107960000	92925000	86299000	60542000	105890000	69171000	91945000	NA	NA	NA	CPNE3	CPNE3;CPNE3;CPNE3;CPNE3;CPNE3	ERBB2 signaling pathway;neutrophil degranulation;cellular response to growth factor stimulus;protein phosphorylation;glycerophospholipid biosynthetic process;cellular response to calcium ion;lipid metabolic process;positive regulation of cell migration;vesicle-mediated transport	GO:003812; GO:004331; GO:007136; GO:000646; GO:004647; GO:007127; GO:000662; GO:003033; GO:001619	azurophil granule membrane;nucleus;nucleolus;plasma membrane;cell junction;focal adhesion;extracellular exosome;cytosol	GO:003557; GO:000563; GO:000573; GO:000588; GO:003005; GO:000592; GO:007006; GO:000582	"NA"	"NA"	protein binding;protein serine/threonine kinase activity;transporter activity;calcium-dependent protein binding;RNA binding;receptor tyrosine kinase binding;calcium-dependent phospholipid binding	GO:000551; GO:000467; GO:000521; GO:004830; GO:000372; GO:003097; GO:000554
XP_005663205.1;XP_020945146.1;XP_020933986.1	XP_005663205.1;XP_020945146.1	XP_005663205.1 4-trimethylaminobutyraldehyde dehydrogenase isoform X1 [Sus scrofa];XP_020945146.1 4-trimethylaminobutyraldehyde dehydrogenase isoform X2 [Sus scrofa]	23	23	23	3721600000	2192100000	4114100000	2258900000	3633900000	2105000000	4759600000	2320900000	4205000000	2826600000	3751700000	2280000000	2123700000	2806400000	3972900000	2702000000	3659500000	2330600000	NA	NA	NA	ALDH9A1	ALDH9A1;ALDH9A1;NA;NA;NA	neurotransmitter biosynthetic process;oxidation-reduction process;hormone metabolic process;carnitine biosynthetic process;cellular aldehyde metabolic process	GO:004213; GO:005511; GO:004244; GO:004532; GO:000608	extracellular exosome;cytoplasm;cytosol	GO:007006; GO:000573; GO:000582	 Valine, leucine and isoleucine degradation; beta-Alanine metabolism; Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis; Arginine and proline metabolism; Ascorbate and aldarate metabolism; Glycerolipid metabolism; Pyruvate metabolism; Fatty acid degradation; Tryptophan metabolism; Lysine degradation; Histidine metabolism; Metabolic pathways	hsa0028; hsa0041; hsa0113; hsa0001; hsa0033; hsa0005; hsa0056; hsa0062; hsa0007; hsa0038; hsa0031; hsa0034; hsa0110	aminobutyraldehyde dehydrogenase activity;4-trimethylammoniobutyraldehyde dehydrogenase activity;1-pyrroline dehydrogenase activity;3-chloroallyl aldehyde dehydrogenase activity;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity	GO:001914; GO:004710; GO:003373; GO:000402; GO:004387
XP_005663224.1;XP_005663223.1	XP_005663224.1;XP_005663223.1	XP_005663224.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial isoform X2 [Sus scrofa];XP_005663223.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial isoform X1 [Sus scrofa]	7	7	7	31802000	23384000	26129000	23397000	35600000	0	31942000	21271000	30700000	25688000	34894000	29133000	18031000	25590000	31382000	28363000	29634000	27716000	NA	NA	NA	NDUFS2	NDUFS2;NDUFS2;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;response to oxidative stress;mitochondrial ATP synthesis coupled electron transport	GO:000612; GO:003298; GO:000697; GO:004277	nucleoplasm;mitochondrion;mitochondrial matrix;mitochondrial respiratory chain complex I	GO:000565; GO:000573; GO:000575; GO:000574	 Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD); Alzheimer's disease; Metabolic pathways	hsa0019; hsa0493; hsa0501; hsa0110	NAD binding;NADH dehydrogenase activity;electron carrier activity;metal ion binding;ubiquitin protein ligase binding;4 iron, 4 sulfur cluster binding;NADH dehydrogenase (ubiquinone) activity;quinone binding;protein binding	GO:005128; GO:000395; GO:000905; GO:004687; GO:003162; GO:005153; GO:000813; GO:004803; GO:000551
XP_005663231.1;XP_005663229.1;XP_005663227.1;XP_005663232.1	XP_005663231.1;XP_005663229.1;XP_005663227.1;XP_005663232.1	XP_005663231.1 nitrilase homolog 1 isoform X3 [Sus scrofa];XP_005663229.1 nitrilase homolog 1 isoform X3 [Sus scrofa];XP_005663227.1 nitrilase homolog 1 isoform X2 [Sus scrofa];XP_005663232.1 nitrilase homolog 1 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	11972000	0	0	0	0	0	0	0	0	0	NA	NA	NA	NIT1	NIT1;NIT1;NIT1;NIT1;NA	biological_process;nitrogen compound metabolic process	GO:000815; GO:000680	nucleus;mitochondrion	GO:000563; GO:000573	"NA"	"NA"	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;nitrilase activity	GO:001681; GO:000025
XP_005663276.2	XP_005663276.2	XP_005663276.2 spectrin alpha chain, erythrocytic 1 [Sus scrofa]	33	33	33	185320000	14528000	33073000	56661000	46745000	26390000	49044000	55711000	131820000	61939000	78845000	42358000	273760000	30724000	41720000	38527000	87064000	29330000	NA	NA	NA	SPTA1	SPTA1;NA;NA;NA;NA	actin filament organization;hemopoiesis;lymphocyte homeostasis;axon guidance;positive regulation of protein binding;actin filament capping;porphyrin-containing compound biosynthetic process;plasma membrane organization;regulation of cell shape;positive regulation of T cell proliferation;MAPK cascade;ER to Golgi vesicle-mediated transport	GO:000701; GO:003009; GO:000226; GO:000741; GO:003209; GO:005169; GO:000677; GO:000700; GO:000836; GO:004210; GO:000016; GO:000688	spectrin-associated cytoskeleton;intrinsic component of the cytoplasmic side of the plasma membrane;actin cytoskeleton;spectrin;cuticular plate;cytosol;axon	GO:001473; GO:003123; GO:001562; GO:000809; GO:003243; GO:000582; GO:003042	"NA"	"NA"	protein binding;structural constituent of cytoskeleton;actin filament binding;protein heterodimerization activity;Ras guanyl-nucleotide exchange factor activity;calcium ion binding	GO:000551; GO:000520; GO:005101; GO:004698; GO:000508; GO:000550
XP_005663322.1	XP_005663322.1	XP_005663322.1 nestin [Sus scrofa]	13	13	13	0	0	0	0	0	18336000	0	20865000	0	12527000	0	0	0	22597000	0	0	0	0	NA	NA	NA	NES	NES;NA;NA;NA;NA	negative regulation of protein binding;cell projection morphogenesis;embryonic camera-type eye development;negative regulation of catalytic activity;negative regulation of neuron apoptotic process;G2/M transition of mitotic cell cycle;central nervous system development;brain development;positive regulation of intermediate filament depolymerization;stem cell proliferation;positive regulation of neural precursor cell proliferation	GO:003209; GO:004885; GO:003107; GO:004308; GO:004352; GO:000008; GO:000741; GO:000742; GO:003084; GO:007208; GO:200017	intermediate filament cytoskeleton;intermediate filament;cytoplasm	GO:004511; GO:000588; GO:000573	"NA"	"NA"	molecular_function;structural molecule activity;intermediate filament binding	GO:000367; GO:000519; GO:001921
XP_005663418.1;XP_005663417.1;XP_020944389.1;XP_005663420.1	XP_005663418.1;XP_005663417.1;XP_020944389.1;XP_005663420.1	XP_005663418.1 tropomyosin alpha-3 chain isoform X7 [Sus scrofa];XP_005663417.1 tropomyosin alpha-3 chain isoform X6 [Sus scrofa];XP_020944389.1 tropomyosin alpha-3 chain isoform X4 [Sus scrofa];XP_005663420.1 tropomyosin alpha-3 chain isoform X3 [Sus scro	17	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	109900000	0	0	0	0	NA	NA	NA	TPM3	TPM3;TPM3;TPM3;TPM3;NA	muscle filament sliding;actin filament organization;muscle contraction	GO:003004; GO:000701; GO:000693	stress fiber;extracellular exosome;muscle thin filament tropomyosin;actin filament;cytoskeleton;cytosol;actin cytoskeleton	GO:000172; GO:007006; GO:000586; GO:000588; GO:000585; GO:000582; GO:001562	 Cardiac muscle contraction; Pathways in cancer; Thyroid cancer; Hypertrophic cardiomyopathy (HCM); Adrenergic signaling in cardiomyocytes	hsa0426; hsa0520; hsa0521; hsa0541; hsa0426	molecular_function;protein binding;actin filament binding	GO:000367; GO:000551; GO:005101
XP_005663425.1;XP_005663424.1;XP_005663429.1;XP_005663428.1	XP_005663425.1;XP_005663424.1;XP_005663429.1;XP_005663428.1	XP_005663425.1 tropomyosin alpha-3 chain isoform X16 [Sus scrofa];XP_005663424.1 tropomyosin alpha-3 chain isoform X14 [Sus scrofa];XP_005663429.1 tropomyosin alpha-3 chain isoform X13 [Sus scrofa];XP_005663428.1 tropomyosin alpha-3 chain isoform X12 [Sus	25	16	0	315720000	536260000	424100000	497760000	340810000	467360000	448450000	433410000	407000000	375430000	479120000	318820000	528700000	509730000	560320000	442620000	551160000	507790000	NA	NA	NA	TPM3	TPM3;TPM3;TPM3;TPM3;NA	muscle filament sliding;actin filament organization;muscle contraction	GO:003004; GO:000701; GO:000693	stress fiber;extracellular exosome;muscle thin filament tropomyosin;actin filament;cytoskeleton;cytosol;actin cytoskeleton	GO:000172; GO:007006; GO:000586; GO:000588; GO:000585; GO:000582; GO:001562	 Cardiac muscle contraction; Pathways in cancer; Thyroid cancer; Hypertrophic cardiomyopathy (HCM); Adrenergic signaling in cardiomyocytes	hsa0426; hsa0520; hsa0521; hsa0541; hsa0426	molecular_function;protein binding;actin filament binding	GO:000367; GO:000551; GO:005101
XP_005663466.1	XP_005663466.1	XP_005663466.1 interleukin enhancer-binding factor 2 [Sus scrofa]	9	9	9	69927000	72242000	67056000	82581000	82647000	91374000	79530000	72262000	58972000	73590000	88830000	77545000	121510000	88647000	62322000	87160000	69746000	87145000	NA	NA	NA	ILF2	ILF2;NA;NA;NA;NA	neutrophil degranulation;positive regulation of transcription, DNA-templated;transcription, DNA-templated	GO:004331; GO:004589; GO:000635	nucleolus;ficolin-1-rich granule lumen;tertiary granule lumen;ribonucleoprotein complex;extracellular region;membrane;nucleus;specific granule lumen	GO:000573; GO:190481; GO:190472; GO:199090; GO:000557; GO:001602; GO:000563; GO:003558	"NA"	"NA"	protein binding;double-stranded RNA binding;transferase activity;DNA binding;ATP binding	GO:000551; GO:000372; GO:001674; GO:000367; GO:000552
XP_013852639.1;XP_013852637.1;XP_005663542.1	XP_013852639.1;XP_013852637.1;XP_005663542.1	XP_013852639.1 protein prune homolog isoform X3 [Sus scrofa];XP_013852637.1 protein prune homolog isoform X2 [Sus scrofa];XP_005663542.1 protein prune homolog isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1587000	NA	NA	NA	PRUNE1	PRUNE1;PRUNE1;PRUNE1;NA;NA	dephosphorylation;regulation of microtubule polymerization;regulation of neurogenesis;polyphosphate catabolic process	GO:001631; GO:003111; GO:005076; GO:000679	cytosol;cytoplasm;nucleus;focal adhesion	GO:000582; GO:000573; GO:000563; GO:000592	 Purine metabolism	hsa0023	inorganic diphosphatase activity;protein binding;exopolyphosphatase activity;tubulin binding;metal ion binding;phosphatase activity	GO:000442; GO:000551; GO:000430; GO:001563; GO:004687; GO:001679
XP_020945764.1;XP_005663660.3;XP_020945763.1;XP_020945761.1;XP_013852759.2;XP_005663662.2;XP_005663661.2;XP_020945760.1;XP_020945759.1;XP_013852758.2	XP_020945764.1;XP_005663660.3;XP_020945763.1;XP_020945761.1;XP_013852759.2;XP_005663662.2;XP_005663661.2;XP_020945760.1;XP_020945759.1;XP_013852758.2	XP_020945764.1 chloride channel CLIC-like protein 1 isoform X6 [Sus scrofa];XP_005663660.3 chloride channel CLIC-like protein 1 isoform X5 [Sus scrofa];XP_020945763.1 chloride channel CLIC-like protein 1 isoform X4 [Sus scrofa];XP_020945761.1 chloride chan	3	3	3	0	0	0	0	0	0	0	18799000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CLCC1	CLCC1;CLCC1;CLCC1;CLCC1;CLCC1	chloride transmembrane transport	GO:190247	nucleus;endoplasmic reticulum;intracellular membrane-bounded organelle;membrane;chloride channel complex;Golgi apparatus	GO:000563; GO:000578; GO:004323; GO:001602; GO:003470; GO:000579	"NA"	"NA"	chloride channel activity	GO:000525
XP_005663793.1	XP_005663793.1	XP_005663793.1 fibulin-1 isoform X2 [Sus scrofa]	13	2	2	0	19081000	25377000	26089000	0	0	24846000	27798000	32663000	0	0	0	0	0	26302000	0	25077000	0	NA	NA	NA	FBLN1	FBLN1;NA;NA;NA;NA	negative regulation of ERK1 and ERK2 cascade;negative regulation of stem cell proliferation;positive regulation of peptidase activity;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of protein phosphorylation;negative regulation of cell adhesion;embryo implantation;negative regulation of cell motility;integrin-mediated signaling pathway;viral process;extracellular matrix organization;blood coagulation, fibrin clot formation	GO:007037; GO:200064; GO:001095; GO:190002; GO:000193; GO:000716; GO:000756; GO:200014; GO:000722; GO:001603; GO:003019; GO:007237	extracellular region;basement membrane;elastic fiber;extracellular space;extracellular matrix;extracellular exosome	GO:000557; GO:000560; GO:007195; GO:000561; GO:003101; GO:007006	"NA"	"NA"	extracellular matrix structural constituent;protein C-terminus binding;identical protein binding;macromolecular complex binding;fibronectin binding;fibrinogen binding;calcium ion binding;peptidase activator activity	GO:000520; GO:000802; GO:004280; GO:004487; GO:000196; GO:007005; GO:000550; GO:001650
XP_005663867.1;XP_005663866.1	XP_005663867.1;XP_005663866.1	XP_005663867.1 thiosulfate sulfurtransferase isoform X2 [Sus scrofa];XP_005663866.1 thiosulfate sulfurtransferase isoform X1 [Sus scrofa]	12	12	12	465850000	360320000	494090000	256680000	608900000	429180000	430270000	328150000	393730000	252130000	283340000	278320000	171530000	269340000	314590000	313750000	280980000	257270000	NA	NA	NA	TST	TST;TST;NA;NA;NA	cyanate catabolic process;sulfur amino acid catabolic process;epithelial cell differentiation;rRNA transport;rRNA import into mitochondrion	GO:000944; GO:000009; GO:003085; GO:005102; GO:003592	mitochondrion;extracellular space;mitochondrial matrix	GO:000573; GO:000561; GO:000575	 Cysteine and methionine metabolism; Metabolic pathways; Sulfur metabolism; Sulfur relay system	hsa0027; hsa0110; hsa0092; hsa0412	thiosulfate sulfurtransferase activity;5S rRNA binding	GO:000479; GO:000809
XP_013853164.1;XP_005664026.1	XP_013853164.1;XP_005664026.1	XP_013853164.1 ras-related protein Rap-1b [Sus scrofa];XP_005664026.1 ras-related protein Rap-1b [Sus scrofa]	10	2	2	0	0	0	0	37432000	0	54933000	0	0	0	0	0	0	0	33422000	0	65633000	0	NA	NA	NA	RAP1B	RAP1B;RAP1B;NA;NA;NA	interleukin-12-mediated signaling pathway;response to carbohydrate;microvillus assembly;cellular response to drug;positive regulation of ERK1 and ERK2 cascade;regulation of establishment of cell polarity;cell proliferation;cellular response to gonadotropin-releasing hormone;neutrophil degranulation;establishment of endothelial barrier;cellular response to cAMP;Rap protein signal transduction;regulation of cell junction assembly;negative regulation of synaptic vesicle exocytosis	GO:003572; GO:000974; GO:003003; GO:003569; GO:007037; GO:200011; GO:000828; GO:009721; GO:004331; GO:006102; GO:007132; GO:003248; GO:190188; GO:200030	membrane;cell-cell junction;membrane raft;extracellular exosome;lipid particle;plasma membrane;cytosol;azurophil granule membrane	GO:001602; GO:000591; GO:004512; GO:007006; GO:000581; GO:000588; GO:000582; GO:003557	 Ras signaling pathway; cAMP signaling pathway; Long-term potentiation; Rap1 signaling pathway; Pancreatic secretion; Renal cell carcinoma; Chemokine signaling pathway; Leukocyte transendothelial migration; Focal adhesion; Platelet activation	hsa0401; hsa0402; hsa0472; hsa0401; hsa0497; hsa0521; hsa0406; hsa0467; hsa0451; hsa0461	GTPase activity;macromolecular complex binding;protein binding;GTP binding;GDP binding	GO:000392; GO:004487; GO:000551; GO:000552; GO:001900
XP_020947808.1;XP_020947807.1;XP_020947806.1;XP_020947805.1;XP_020947803.1;XP_020947797.1;XP_020947802.1;XP_020947801.1;XP_020947800.1;XP_013853230.2;XP_020947798.1;XP_020947796.1;XP_005664081.2;XP_020947795.1;XP_020947794.1;XP_020947793.1;XP_020947792.1;XP_013853229.2;XP_013853227.2;XP_020947791.1;XP_020947790.1;XP_020947789.1	XP_020947808.1;XP_020947807.1;XP_020947806.1;XP_020947805.1;XP_020947803.1;XP_020947797.1;XP_020947802.1;XP_020947801.1;XP_020947800.1;XP_013853230.2;XP_020947798.1;XP_020947796.1;XP_005664081.2;XP_020947795.1;XP_020947794.1;XP_020947793.1;XP_020947792.1;XP_013853229.2;XP_013853227.2;XP_020947791.1;XP_020947790.1;XP_020947789.1	XP_020947808.1 liprin-beta-1 isoform X17 [Sus scrofa];XP_020947807.1 liprin-beta-1 isoform X16 [Sus scrofa];XP_020947806.1 liprin-beta-1 isoform X15 [Sus scrofa];XP_020947805.1 liprin-beta-1 isoform X9 [Sus scrofa];XP_020947803.1 liprin-beta-1 isoform X9 [	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6051000	NA	NA	NA	PPFIBP1	PPFIBP1;PPFIBP1;PPFIBP1;PPFIBP1;PPFIBP1	cell adhesion	GO:000715	cytosol;plasma membrane;focal adhesion	GO:000582; GO:000588; GO:000592	"NA"	"NA"	cadherin binding	GO:004529
XP_005664212.1	XP_005664212.1	XP_005664212.1 twinfilin-1 [Sus scrofa]	5	5	5	25602000	27233000	20676000	28880000	0	27403000	0	27951000	28216000	26675000	21246000	48318000	21543000	32927000	0	30586000	24609000	22540000	NA	NA	NA	TWF1	TWF1;NA;NA;NA;NA	positive regulation of cardiac muscle hypertrophy;peptidyl-tyrosine phosphorylation;actin filament depolymerization;negative regulation of actin filament polymerization;regulation of lamellipodium assembly;positive regulation of neuron projection development;sequestering of actin monomers;regulation of actin phosphorylation;barbed-end actin filament capping	GO:001061; GO:001810; GO:003004; GO:003083; GO:001059; GO:001097; GO:004298; GO:004353; GO:005101	actin filament;cytosol;focal adhesion;actin cytoskeleton;cell-cell junction;filopodium;ruffle membrane;cytoplasm;myofibril;perinuclear region of cytoplasm	GO:000588; GO:000582; GO:000592; GO:001562; GO:000591; GO:003017; GO:003258; GO:000573; GO:003001; GO:004847	"NA"	"NA"	actin binding;actin monomer binding;phosphatidylinositol-4,5-bisphosphate binding;cadherin binding;protein tyrosine kinase activity;protein binding;ATP binding;actin filament binding	GO:000377; GO:000378; GO:000554; GO:004529; GO:000471; GO:000551; GO:000552; GO:005101
XP_005664278.2;XP_005664277.2	XP_005664278.2;XP_005664277.2	XP_005664278.2 inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X2 [Sus scrofa];XP_005664277.2 inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X2 [Sus scrofa]	6	4	4	0	0	0	8957200	0	0	0	8334600	0	0	0	0	0	0	0	6194100	0	0	NA	NA	NA	IKBIP	IKBIP;IKBIP;NA;NA;NA	response to X-ray	GO:001016	membrane;endoplasmic reticulum;integral component of membrane	GO:001602; GO:000578; GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_005664319.2;XP_013847980.1	XP_005664319.2	XP_005664319.2 LOW QUALITY PROTEIN: ubiquitin-conjugating enzyme E2 N [Sus scrofa]	8	8	8	117740000	129060000	124170000	128930000	117950000	95981000	106950000	122990000	142540000	133240000	128790000	79643000	158080000	136980000	148990000	129830000	129180000	129560000	NA	NA	NA	UBE2N	UBE2N;NA;NA;NA;NA	JNK cascade;positive regulation of DNA repair;double-strand break repair via nonhomologous end joining;T cell receptor signaling pathway;positive regulation of ubiquitin-protein transferase activity;protein K63-linked ubiquitination;protein ubiquitination;positive regulation of histone modification;positive regulation of I-kappaB kinase/NF-kappaB signaling;histone ubiquitination;activation of MAPK activity;double-strand break repair via homologous recombination;regulation of DNA repair;cellular protein modification process;proteolysis;interleukin-1-mediated signaling pathway;regulation of histone ubiquitination;positive regulation of NF-kappaB transcription factor activity;nucleotide-binding oligomerization domain containing signaling pathway	GO:000725; GO:004573; GO:000630; GO:005085; GO:005144; GO:007053; GO:001656; GO:003105; GO:004312; GO:001657; GO:000018; GO:000072; GO:000628; GO:000646; GO:000650; GO:007049; GO:003318; GO:005109; GO:007042	UBC13-UEV1A complex;extracellular exosome;cytosol;nucleus;cytoplasm;macromolecular complex;ubiquitin ligase complex;fibrillar center;nucleoplasm;UBC13-MMS2 complex	GO:003537; GO:007006; GO:000582; GO:000563; GO:000573; GO:003299; GO:000015; GO:000165; GO:000565; GO:003137	 Ubiquitin mediated proteolysis	hsa0412	RNA binding;ubiquitin-protein transferase activity;ATP binding;ubiquitin binding;protein binding;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity	GO:000372; GO:000484; GO:000552; GO:004313; GO:000551; GO:003162; GO:006163
XP_005664408.2	XP_005664408.2	XP_005664408.2 LOW QUALITY PROTEIN: Golgi apparatus protein 1 [Sus scrofa]	15	15	15	12400000	27574000	21760000	35667000	21056000	30641000	22269000	32158000	23910000	40623000	25524000	40107000	29930000	27394000	26952000	31253000	27000000	38304000	NA	NA	NA	GLG1	GLG1;NA;NA;NA;NA	negative regulation of transforming growth factor beta receptor signaling pathway;regulation of chondrocyte differentiation;leukocyte migration;negative regulation of protein processing;bone morphogenesis	GO:003051; GO:003233; GO:005090; GO:001095; GO:006034	Golgi membrane;Golgi apparatus;extracellular matrix;plasma membrane;membrane;extracellular exosome	GO:000013; GO:000579; GO:003101; GO:000588; GO:001602; GO:007006	 Cell adhesion molecules (CAMs)	hsa0451	fibroblast growth factor binding;receptor binding	GO:001713; GO:000510
XP_005664555.1;XP_005664554.1;NP_001090966.1;XP_020949835.1	XP_005664555.1;XP_005664554.1;NP_001090966.1	XP_005664555.1 cytochrome c oxidase subunit 6B1 isoform X1 [Sus scrofa];XP_005664554.1 cytochrome c oxidase subunit 6B1 isoform X1 [Sus scrofa];NP_001090966.1 cytochrome c oxidase subunit 6B1 [Sus scrofa]	6	6	6	181560000	109280000	182960000	0	151050000	82110000	161350000	0	161640000	100980000	100580000	0	63194000	99547000	86764000	106500000	127960000	90433000	NA	NA	NA	COX6B	COX6B;COX6B;COX6B;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005664641.1	XP_005664641.1	XP_005664641.1 26S proteasome non-ATPase regulatory subunit 8 [Sus scrofa]	5	5	5	39514000	49832000	56428000	58181000	43691000	42716000	52474000	50245000	46500000	47554000	50562000	38721000	40671000	53883000	52610000	50964000	59043000	47238000	NA	NA	NA	PSMD8	PSMD8;NA;NA;NA;NA	protein deubiquitination;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process	GO:001657; GO:004368; GO:004316	nucleus;cytosol;proteasome accessory complex;proteasome complex;nucleoplasm;proteasome regulatory particle;proteasome regulatory particle, lid subcomplex	GO:000563; GO:000582; GO:002262; GO:000050; GO:000565; GO:000583; GO:000854	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	"NA"	"NA"
XP_005664792.3;XP_005664790.2;XP_020950403.1;XP_020950401.1;XP_020950399.1;XP_013854103.1;XP_020950398.1;XP_020950397.1;XP_020950400.1;XP_013854104.1;XP_013854102.1	XP_005664792.3;XP_005664790.2;XP_020950403.1;XP_020950401.1;XP_020950399.1;XP_013854103.1;XP_020950398.1;XP_020950397.1;XP_020950400.1;XP_013854104.1;XP_013854102.1	XP_005664792.3 aldehyde dehydrogenase family 16 member A1 isoform X10 [Sus scrofa];XP_005664790.2 aldehyde dehydrogenase family 16 member A1 isoform X4 [Sus scrofa];XP_020950403.1 aldehyde dehydrogenase family 16 member A1 isoform X11 [Sus scrofa];XP_02095	6	6	6	13894000	17947000	12284000	0	0	11670000	19909000	17103000	12996000	12007000	13816000	18783000	13493000	0	13213000	0	11627000	10381000	NA	NA	NA	ALDH16A1	ALDH16A1;ALDH16A1;ALDH16A1;ALDH16A1;ALDH16A1	oxidation-reduction process	GO:005511	membrane	GO:001602	"NA"	"NA"	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	GO:001662
XP_020950426.1;XP_005664809.1;XP_005664808.1	XP_020950426.1;XP_005664809.1;XP_005664808.1	XP_020950426.1 proline-rich AKT1 substrate 1 isoform X3 [Sus scrofa];XP_005664809.1 proline-rich AKT1 substrate 1 isoform X3 [Sus scrofa];XP_005664808.1 proline-rich AKT1 substrate 1 isoform X3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1580600	0	0	NA	NA	NA	AKT1S1	AKT1S1;AKT1S1;AKT1S1;NA;NA	negative regulation of protein kinase activity;neurotrophin TRK receptor signaling pathway;regulation of apoptotic process;regulation of neuron apoptotic process;negative regulation of cell size;regulation of cellular response to heat;negative regulation of TOR signaling	GO:000646; GO:004801; GO:004298; GO:004352; GO:004579; GO:190003; GO:003200	nucleoplasm;cytosol;cytoplasm;TORC1 complex	GO:000565; GO:000582; GO:000573; GO:003193	 mTOR signaling pathway; AMPK signaling pathway	hsa0415; hsa0415	protein binding	GO:000551
XP_005665216.2;XP_005665215.2;XP_005665217.1	XP_005665216.2;XP_005665215.2;XP_005665217.1	XP_005665216.2 tubulointerstitial nephritis antigen-like isoform X1 [Sus scrofa];XP_005665215.2 tubulointerstitial nephritis antigen-like isoform X1 [Sus scrofa];XP_005665217.1 tubulointerstitial nephritis antigen-like isoform X2 [Sus scrofa]	13	13	13	205090000	271690000	221510000	330810000	163340000	174490000	251960000	351060000	169800000	181640000	212930000	471690000	116650000	269090000	147560000	235480000	237370000	155870000	NA	NA	NA	TINAGL1	TINAGL1;TINAGL1;TINAGL1;NA;NA	proteolysis;receptor-mediated endocytosis;immune response;cell adhesion;endosomal transport	GO:000650; GO:000689; GO:000695; GO:000715; GO:001619	extracellular exosome;extracellular region;extracellular space;cytoplasm	GO:007006; GO:000557; GO:000561; GO:000573	"NA"	"NA"	polysaccharide binding;extracellular matrix structural constituent;protein binding;cysteine-type peptidase activity;laminin binding;scavenger receptor activity	GO:003024; GO:000520; GO:000551; GO:000823; GO:004323; GO:000504
XP_020951473.1;XP_020951472.1;XP_005665243.2	XP_020951473.1;XP_020951472.1;XP_005665243.2	XP_020951473.1 protein archease isoform X3 [Sus scrofa];XP_020951472.1 protein archease isoform X2 [Sus scrofa];XP_005665243.2 protein archease isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2858000	NA	NA	NA	ZBTB8OS	ZBTB8OS;ZBTB8OS;ZBTB8OS;NA;NA	tRNA splicing, via endonucleolytic cleavage and ligation	GO:000638	nucleoplasm;tRNA-splicing ligase complex	GO:000565; GO:007266	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_005665276.1;XP_020947249.1	XP_005665276.1	XP_005665276.1 trafficking protein particle complex subunit 3 [Sus scrofa]	5	5	5	31465000	29701000	0	0	0	31502000	25671000	0	26047000	0	39803000	0	0	37192000	0	0	26493000	31028000	NA	NA	NA	TRAPPC3	TRAPPC3;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;intra-Golgi vesicle-mediated transport;COPII vesicle coating	GO:000688; GO:000689; GO:004820	endoplasmic reticulum;cis-Golgi network membrane;Golgi membrane;cytosol;Golgi apparatus;TRAPP complex	GO:000578; GO:003310; GO:000013; GO:000582; GO:000579; GO:003000	"NA"	"NA"	protein binding;Rab guanyl-nucleotide exchange factor activity	GO:000551; GO:001711
XP_020951924.1;XP_005665400.2;XP_020951923.1	XP_020951924.1;XP_005665400.2;XP_020951923.1	XP_020951924.1 microtubule-associated protein RP/EB family member 2 isoform X3 [Sus scrofa];XP_005665400.2 microtubule-associated protein RP/EB family member 2 isoform X2 [Sus scrofa];XP_020951923.1 microtubule-associated protein RP/EB family member 2 isof	6	6	5	28185000	51231000	29956000	0	29036000	0	0	31499000	30456000	0	36828000	44614000	36114000	36549000	0	33072000	37537000	33597000	NA	NA	NA	MAPRE2	MAPRE2;MAPRE2;MAPRE2;NA;NA	positive regulation of GTPase activity;signal transduction;positive regulation of ARF protein signal transduction;cell proliferation;regulation of microtubule polymerization or depolymerization;protein localization to microtubule;spindle assembly;cell division;positive regulation of keratinocyte migration;positive regulation of adherens junction organization;protein localization to microtubule plus-end	GO:004354; GO:000716; GO:003201; GO:000828; GO:003111; GO:003537; GO:005122; GO:005130; GO:005154; GO:190339; GO:190482	microtubule;microtubule organizing center;cytoplasmic microtubule;spindle midzone;cytoplasm;focal adhesion;microtubule plus-end;microtubule cytoskeleton	GO:000587; GO:000581; GO:000588; GO:005123; GO:000573; GO:000592; GO:003537; GO:001563	"NA"	"NA"	protein binding;microtubule binding;identical protein binding;microtubule plus-end binding;protein kinase binding	GO:000551; GO:000801; GO:004280; GO:005101; GO:001990
XP_020952309.1;XP_013854844.1;XP_020952308.1;XP_005665477.1;XP_005665476.1	XP_020952309.1;XP_013854844.1;XP_020952308.1;XP_005665477.1;XP_005665476.1	XP_020952309.1 origin recognition complex subunit 1 isoform X2 [Sus scrofa];XP_013854844.1 origin recognition complex subunit 1 isoform X2 [Sus scrofa];XP_020952308.1 origin recognition complex subunit 1 isoform X1 [Sus scrofa];XP_005665477.1 origin recogn	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4709100	0	+	NA	NA	ORC1	ORC1;ORC1;ORC1;ORC1;ORC1	mitotic cell cycle;DNA replication;regulation of transcription involved in G1/S transition of mitotic cell cycle;mitotic DNA replication checkpoint;DNA replication initiation	GO:000027; GO:000626; GO:000008; GO:003331; GO:000627	nucleolus;nuclear chromosome, telomeric region;origin recognition complex;cytosol;nuclear origin of replication recognition complex;plasma membrane;nucleoplasm;nucleus	GO:000573; GO:000078; GO:000080; GO:000582; GO:000566; GO:000588; GO:000565; GO:000563	 Cell cycle	hsa0411	protein binding;metal ion binding;chromatin binding;DNA binding;ATP binding	GO:000551; GO:004687; GO:000368; GO:000367; GO:000552
XP_020952328.1;XP_020952327.1;XP_013854861.1;XP_020952326.1;XP_013854860.1;XP_005665495.1;XP_013854859.1	XP_020952328.1;XP_020952327.1;XP_013854861.1;XP_020952326.1;XP_013854860.1;XP_005665495.1;XP_013854859.1	XP_020952328.1 epidermal growth factor receptor substrate 15 isoform X7 [Sus scrofa];XP_020952327.1 epidermal growth factor receptor substrate 15 isoform X6 [Sus scrofa];XP_013854861.1 epidermal growth factor receptor substrate 15 isoform X4 [Sus scrofa];X	5	5	5	0	6531700	5420700	5959500	0	4319800	0	6342100	0	0	0	6674700	0	7033200	0	0	0	0	NA	NA	NA	EPS15	EPS15;EPS15;EPS15;EPS15;EPS15	Golgi to endosome transport;epidermal growth factor receptor signaling pathway;viral entry into host cell;endocytic recycling;negative regulation of epidermal growth factor receptor signaling pathway;clathrin coat assembly;postsynaptic neurotransmitter receptor internalization;vesicle organization;regulation of cell proliferation;membrane organization;positive regulation of receptor recycling;cell proliferation;receptor-mediated endocytosis of virus by host cell	GO:000689; GO:000717; GO:004671; GO:003245; GO:004205; GO:004826; GO:009888; GO:001605; GO:004212; GO:006102; GO:000192; GO:000828; GO:001906	basal plasma membrane;aggresome;intracellular membrane-bounded organelle;AP-2 adaptor complex;apical plasma membrane;glutamatergic synapse;ciliary membrane;plasma membrane;early endosome membrane;cytosol;clathrin-coated pit;postsynapse;membrane	GO:000992; GO:001623; GO:004323; GO:003012; GO:001632; GO:009897; GO:006017; GO:000588; GO:003190; GO:000582; GO:000590; GO:009879; GO:001602	 Endocytosis	hsa0414	protein binding;cargo receptor activity;cadherin binding;SH3 domain binding;polyubiquitin binding;calcium ion binding;identical protein binding	GO:000551; GO:003802; GO:004529; GO:001712; GO:003159; GO:000550; GO:004280
XP_013854888.1;XP_005665516.1	XP_013854888.1;XP_005665516.1	XP_013854888.1 cytochrome b-c1 complex subunit 6, mitochondrial isoform X2 [Sus scrofa];XP_005665516.1 cytochrome b-c1 complex subunit 6, mitochondrial isoform X1 [Sus scrofa]	2	2	2	0	33623000	56489000	0	62234000	0	67740000	45810000	77892000	39330000	0	0	0	0	55793000	49198000	0	0	NA	NA	NA	LOC100524873	LOC100524873;LOC100524873;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005665814.2	XP_005665814.2	XP_005665814.2 diffuse panbronchiolitis critical region protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15522000	NA	NA	NA	MUCL3	MUCL3;NA;NA;NA;NA	"NA"	"NA"	plasma membrane;integral component of membrane;cytoplasm	GO:000588; GO:001602; GO:000573	"NA"	"NA"	"NA"	"NA"
XP_005665911.1;NP_001124202.1	XP_005665911.1;NP_001124202.1	XP_005665911.1 estradiol 17-beta-dehydrogenase 8 isoform X1 [Sus scrofa];NP_001124202.1 estradiol 17-beta-dehydrogenase 8 [Sus scrofa]	3	3	3	0	0	0	0	18463000	0	22768000	0	22588000	0	14912000	0	0	0	0	0	13760000	0	NA	NA	NA	HSD17B8	HSD17B8;HSD17B8;NA;NA;NA	protein heterotetramerization;androgen metabolic process;fatty acid biosynthetic process;estrogen biosynthetic process;oxidation-reduction process	GO:005129; GO:000820; GO:000663; GO:000670; GO:005511	plasma membrane;mitochondrial envelope;mitochondrial matrix	GO:000588; GO:000574; GO:000575	 Steroid hormone biosynthesis; Metabolic pathways	hsa0014; hsa0110	NADH binding;protein binding;3-hydroxyacyl-CoA dehydrogenase activity;3-oxoacyl-[acyl-carrier-protein;estradiol 17-beta-dehydrogenase activity;testosterone dehydrogenase (NAD+) activity	GO:007040; GO:000551; GO:000385; GO:004702; GO:000430; GO:004703
XP_005665941.1	XP_005665941.1	XP_005665941.1 tapasin [Sus scrofa]	3	3	3	0	13896000	12889000	0	0	0	0	0	13931000	0	0	15215000	0	0	14453000	0	0	0	NA	NA	NA	TAPBP	TAPBP;NA;NA;NA;NA	amide transport;regulation of protein complex stability;MHC class Ib protein complex assembly;retrograde vesicle-mediated transport, Golgi to ER;immune response;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;regulation of gene expression;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of endogenous peptide antigen via MHC class I;macromolecular complex assembly;peptide antigen stabilization	GO:004288; GO:006163; GO:000239; GO:000689; GO:000695; GO:199066; GO:001046; GO:000247; GO:001988; GO:006500; GO:005082	endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment membrane;integral component of lumenal side of endoplasmic reticulum membrane;endoplasmic reticulum membrane;phagocytic vesicle membrane;Golgi membrane;integral component of membrane;MHC class I peptide loading complex	GO:000578; GO:003311; GO:007155; GO:000578; GO:003067; GO:000013; GO:001602; GO:004282	 Antigen processing and presentation	hsa0461	peptide antigen binding;TAP2 binding;peptide antigen-transporting ATPase activity;MHC class I protein binding;unfolded protein binding;protein binding	GO:004260; GO:004697; GO:001543; GO:004228; GO:005108; GO:000551
XP_005665949.1	XP_005665949.1	XP_005665949.1 LEM domain-containing protein 2 [Sus scrofa]	3	3	3	0	12144000	0	0	0	11179000	0	0	0	0	0	0	0	0	0	13693000	0	10888000	NA	NA	NA	LEMD2	LEMD2;NA;NA;NA;NA	nuclear envelope organization;negative regulation of BMP signaling pathway;negative regulation of protein kinase B signaling;protein localization to chromatin;heart formation;neurogenesis;skeletal muscle cell differentiation;negative regulation of MAPK cascade	GO:000699; GO:003051; GO:005189; GO:007116; GO:006091; GO:002200; GO:003591; GO:004340	nuclear inner membrane;membrane;endoplasmic reticulum;integral component of nuclear inner membrane;chromatin;nuclear membrane	GO:000563; GO:001602; GO:000578; GO:000563; GO:000078; GO:003196	"NA"	"NA"	protein binding	GO:000551
XP_005666094.2	XP_005666094.2	XP_005666094.2 exportin-5 [Sus scrofa]	11	11	11	15615000	23915000	26376000	9597500	18804000	19409000	26832000	23021000	15900000	20875000	10005000	13137000	21968000	14677000	14662000	25807000	23005000	21743000	NA	NA	NA	XPO5	XPO5;NA;NA;NA;NA	miRNA metabolic process;positive regulation of RNA interference;pre-miRNA export from nucleus;protein export from nucleus;regulation of protein export from nucleus	GO:001058; GO:190037; GO:003528; GO:000661; GO:004682	micro-ribonucleoprotein complex;nucleus;nuclear RNA export factor complex;cytosol;nucleoplasm;cytoplasm;RNA nuclear export complex	GO:003506; GO:000563; GO:004227; GO:000582; GO:000565; GO:000573; GO:004256	 RNA transport	hsa0301	RNA binding;nuclear export signal receptor activity;protein transporter activity;protein binding;mRNA binding;tRNA binding;pre-miRNA binding;Ran GTPase binding	GO:000372; GO:000504; GO:000856; GO:000551; GO:000372; GO:000004; GO:007088; GO:000853
XP_005666204.1	XP_005666204.1	XP_005666204.1 cytochrome c oxidase subunit 5A, mitochondrial [Sus scrofa]	3	3	3	276650000	178390000	248900000	143370000	245240000	143240000	265630000	148950000	302460000	155420000	203350000	125290000	120340000	178120000	269790000	184190000	207670000	120040000	NA	NA	NA	LOC100156967	LOC100156967;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020954782.1;XP_020954781.1;XP_020954780.1;XP_020954778.1;XP_020954777.1;XP_013833562.1;XP_005666245.1;XP_005666244.1;XP_020954765.1	XP_020954782.1;XP_020954781.1;XP_020954780.1;XP_020954778.1;XP_020954777.1;XP_013833562.1;XP_005666245.1;XP_005666244.1;XP_020954765.1	XP_020954782.1 pyruvate kinase PKM isoform X7 [Sus scrofa];XP_020954781.1 pyruvate kinase PKM isoform X7 [Sus scrofa];XP_020954780.1 pyruvate kinase PKM isoform X7 [Sus scrofa];XP_020954778.1 pyruvate kinase PKM isoform X7 [Sus scrofa];XP_020954777.1 pyruv	31	3	3	35058000	30958000	38484000	48787000	24975000	22279000	32118000	23163000	31480000	35226000	36669000	30362000	63400000	21993000	17894000	21228000	212540000	30084000	NA	NA	NA	PKM	PKM;PKM;PKM;PKM;PKM	response to hypoxia;programmed cell death;skeletal muscle tissue regeneration;canonical glycolysis;response to gravity;cellular response to insulin stimulus;liver development;response to muscle inactivity;neutrophil degranulation;positive regulation of sprouting angiogenesis;glycolytic process;response to nutrient;animal organ regeneration;protein homotetramerization	GO:000166; GO:001250; GO:004340; GO:006162; GO:000962; GO:003286; GO:000188; GO:001487; GO:004331; GO:190367; GO:000609; GO:000758; GO:003110; GO:005128	nucleus;cilium;cytosol;vesicle;extracellular exosome;cytoplasm;extracellular region;ficolin-1-rich granule lumen;secretory granule lumen;pyruvate kinase complex;extracellular vesicle	GO:000563; GO:000592; GO:000582; GO:003198; GO:007006; GO:000573; GO:000557; GO:190481; GO:003477; GO:190291; GO:190356	 Purine metabolism; Glucagon signaling pathway; Carbon metabolism; Biosynthesis of antibiotics; Viral carcinogenesis; Glycolysis / Gluconeogenesis; Metabolic pathways; Pyruvate metabolism; Biosynthesis of amino acids; Type II diabetes mellitus; Central carbon metabolism in cancer	hsa0023; hsa0492; hsa0120; hsa0113; hsa0520; hsa0001; hsa0110; hsa0062; hsa0123; hsa0493; hsa0523	RNA binding;identical protein binding;magnesium ion binding;ATP binding;MHC class II protein complex binding;thyroid hormone binding;protein binding;cadherin binding;pyruvate kinase activity;kinase activity;potassium ion binding;ADP binding	GO:000372; GO:004280; GO:000028; GO:000552; GO:002302; GO:007032; GO:000551; GO:004529; GO:000474; GO:001630; GO:003095; GO:004353
XP_005666247.1	XP_005666247.1	XP_005666247.1 protein transport protein Sec23A [Sus scrofa]	9	9	7	31175000	33412000	31504000	35304000	30851000	34978000	34292000	37404000	33145000	31895000	35943000	31759000	49317000	38731000	27677000	34527000	30364000	36154000	NA	NA	NA	SEC23A	SEC23A;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;positive regulation of GTPase activity;protein localization to plasma membrane;COPII vesicle coating;intracellular protein transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;cargo loading into COPII-coated vesicle;antigen processing and presentation of peptide antigen via MHC class I	GO:000688; GO:004354; GO:007265; GO:004820; GO:000688; GO:001988; GO:009011; GO:000247	extrinsic component of membrane;cytosol;endoplasmic reticulum membrane;COPII vesicle coat;endoplasmic reticulum exit site;ER to Golgi transport vesicle membrane	GO:001989; GO:000582; GO:000578; GO:003012; GO:007097; GO:001250	 Protein processing in endoplasmic reticulum	hsa0414	GTPase activator activity;zinc ion binding;protein binding	GO:000509; GO:000827; GO:000551
XP_005666250.1	XP_005666250.1	XP_005666250.1 C-type lectin domain family 14 member A [Sus scrofa]	4	4	4	0	9951200	0	0	0	11279000	0	0	0	0	0	0	0	0	0	10573000	0	0	NA	NA	NA	CLEC14A	CLEC14A;NA;NA;NA;NA	cell migration involved in sprouting angiogenesis;cell migration	GO:000204; GO:001647	integral component of membrane;external side of plasma membrane	GO:001602; GO:000989	"NA"	"NA"	carbohydrate binding;extracellular matrix protein binding;extracellular matrix binding	GO:003024; GO:199043; GO:005084
XP_020956717.1;XP_005666605.1	XP_020956717.1;XP_005666605.1	XP_020956717.1 condensin complex subunit 3 [Sus scrofa];XP_005666605.1 condensin complex subunit 3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30021000	0	+	NA	NA	NCAPG	NCAPG;NCAPG;NA;NA;NA	cell division;mitotic chromosome condensation	GO:005130; GO:000707	condensin complex;cytosol;nucleus;cytoplasm;condensed chromosome;membrane;condensed chromosome, centromeric region	GO:000079; GO:000582; GO:000563; GO:000573; GO:000079; GO:001602; GO:000077	"NA"	"NA"	protein binding	GO:000551
XP_005666819.2	XP_005666819.2	XP_005666819.2 LOW QUALITY PROTEIN: general vesicular transport factor p115 [Sus scrofa]	18	18	18	74440000	65170000	68837000	47347000	73315000	62595000	53259000	57308000	52333000	66092000	75296000	80785000	77564000	53003000	75075000	57701000	56242000	54973000	NA	NA	NA	USO1	USO1;NA;NA;NA;NA	intracellular protein transport;vesicle fusion with Golgi apparatus;ER to Golgi vesicle-mediated transport;COPII vesicle coating;membrane fusion;Golgi organization;transcytosis;Golgi vesicle docking	GO:000688; GO:004828; GO:000688; GO:004820; GO:006102; GO:000703; GO:004505; GO:004821	Golgi stack;transport vesicle;ER to Golgi transport vesicle membrane;perinuclear region of cytoplasm;Golgi membrane;cytosol;Golgi apparatus;fibrillar center;membrane;endoplasmic reticulum	GO:000579; GO:003013; GO:001250; GO:004847; GO:000013; GO:000582; GO:000579; GO:000165; GO:001602; GO:000578	"NA"	"NA"	protein transporter activity;cadherin binding;RNA binding;protein binding	GO:000856; GO:004529; GO:000372; GO:000551
XP_013834419.1;XP_013834418.1;XP_005667000.1;XP_005666999.1	XP_013834419.1;XP_013834418.1;XP_005667000.1;XP_005666999.1	XP_013834419.1 60S ribosomal protein L34 [Sus scrofa];XP_013834418.1 60S ribosomal protein L34 [Sus scrofa];XP_005667000.1 60S ribosomal protein L34 [Sus scrofa];XP_005666999.1 60S ribosomal protein L34 [Sus scrofa]	3	3	3	0	0	0	0	31349000	0	60731000	80271000	88576000	93134000	54538000	66812000	0	0	0	0	113510000	0	NA	NA	NA	RPL34	RPL34;RPL34;RPL34;RPL34;NA	SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000661; GO:000018; GO:000641	cytosol;cytosolic large ribosomal subunit;endoplasmic reticulum;extracellular exosome	GO:000582; GO:002262; GO:000578; GO:007006	 Ribosome	hsa0301	RNA binding;cadherin binding;structural constituent of ribosome	GO:000372; GO:004529; GO:000373
XP_005667226.2	XP_005667226.2	XP_005667226.2 mth938 domain-containing protein [Sus scrofa]	2	2	2	0	38686000	0	0	0	34431000	0	0	0	32628000	0	0	0	34882000	0	33927000	0	32548000	NA	NA	NA	AAMDC	AAMDC;NA;NA;NA;NA	positive regulation of fat cell differentiation	GO:004560	cytoplasm	GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_005667307.1	XP_005667307.1	XP_005667307.1 endonuclease domain-containing 1 protein [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	7829600	0	0	0	0	0	0	NA	NA	NA	ENDOD1	ENDOD1;NA;NA;NA;NA	platelet degranulation;nucleic acid phosphodiester bond hydrolysis	GO:000257; GO:009030	membrane;extracellular region;extracellular exosome;cytosol	GO:001602; GO:000557; GO:007006; GO:000582	"NA"	"NA"	endonuclease activity;metal ion binding;nucleic acid binding	GO:000451; GO:004687; GO:000367
XP_005667356.1;XP_005667355.1;XP_020918398.1	XP_005667356.1;XP_005667355.1	XP_005667356.1 cullin-5 isoform X3 [Sus scrofa];XP_005667355.1 cullin-5 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	12699000	0	0	0	0	0	NA	NA	NA	CUL5	CUL5;CUL5;NA;NA;NA	intrinsic apoptotic signaling pathway;viral process;ERBB2 signaling pathway;protein ubiquitination;cell cycle arrest;cell proliferation;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;calcium ion transmembrane transport;ubiquitin-dependent protein catabolic process	GO:009719; GO:001603; GO:003812; GO:001656; GO:000705; GO:000828; GO:004368; GO:004316; GO:000008; GO:003114; GO:007058; GO:000651	SCF ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;cytosol	GO:001900; GO:003146; GO:000582	 Ubiquitin mediated proteolysis	hsa0412	protein binding;ubiquitin protein ligase activity;ubiquitin-protein transferase activity;ubiquitin protein ligase binding;signaling receptor activity;calcium channel activity	GO:000551; GO:006163; GO:000484; GO:003162; GO:003802; GO:000526
XP_005667358.1;XP_005667359.1	XP_005667358.1;XP_005667359.1	XP_005667358.1 acetyl-CoA acetyltransferase, mitochondrial isoform X1 [Sus scrofa];XP_005667359.1 acetyl-CoA acetyltransferase, mitochondrial isoform X2 [Sus scrofa]	12	12	12	244360000	143190000	168260000	107640000	186690000	120610000	260510000	144290000	248220000	161590000	129260000	121590000	147400000	126500000	146370000	146910000	140900000	119880000	NA	NA	NA	ACAT1	ACAT1;ACAT1;NA;NA;NA	brain development;fatty acid beta-oxidation;metanephric proximal convoluted tubule development;response to hormone;coenzyme A metabolic process;adipose tissue development;propionyl-CoA biosynthetic process;response to organic cyclic compound;acetyl-CoA biosynthetic process;isoleucine catabolic process;acetyl-CoA catabolic process;response to starvation;ketone body catabolic process;liver development;branched-chain amino acid catabolic process;protein homooligomerization;ketone body metabolic process	GO:000742; GO:000663; GO:007222; GO:000972; GO:001593; GO:006061; GO:190286; GO:001407; GO:000608; GO:000655; GO:004635; GO:004259; GO:004695; GO:000188; GO:000908; GO:005126; GO:190222	mitochondrion;mitochondrial matrix;extracellular exosome	GO:000573; GO:000575; GO:007006	 Metabolic pathways; Pyruvate metabolism; Lysine degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Fatty acid degradation; Butanoate metabolism; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism; Valine, leucine and isoleucine degradation; Tryptophan metabolism; Terpenoid backbone biosynthesis	hsa0110; hsa0062; hsa0031; hsa0063; hsa0064; hsa0007; hsa0065; hsa0113; hsa0120; hsa0121; hsa0028; hsa0038; hsa0090	enzyme binding;acetyl-CoA C-acetyltransferase activity;metal ion binding;coenzyme binding;protein homodimerization activity;carbon-carbon lyase activity;ligase activity, forming carbon-carbon bonds	GO:001989; GO:000398; GO:004687; GO:005066; GO:004280; GO:001683; GO:001688
XP_020918438.1;XP_020918437.1;XP_005667376.1	XP_020918438.1;XP_020918437.1;XP_005667376.1	XP_020918438.1 alpha-crystallin B chain [Sus scrofa];XP_020918437.1 alpha-crystallin B chain [Sus scrofa];XP_005667376.1 alpha-crystallin B chain [Sus scrofa]	15	13	13	656630000	777250000	832240000	683060000	638860000	575170000	347310000	778090000	371700000	538870000	457590000	281550000	427400000	592110000	462250000	408550000	711650000	502560000	NA	NA	NA	CRYAB	CRYAB;CRYAB;CRYAB;NA;NA	negative regulation of reactive oxygen species metabolic process;protein homooligomerization;lens development in camera-type eye;muscle contraction;negative regulation of gene expression;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;muscle organ development;microtubule polymerization or depolymerization;apoptotic process involved in morphogenesis;regulation of cellular response to heat;tubulin complex assembly;negative regulation of apoptotic process;regulation of cell death;negative regulation of amyloid fibril formation;response to hypoxia;protein stabilization;response to estradiol;multicellular organism aging;negative regulation of cell growth;negative regulation of protein homooligomerization;response to hydrogen peroxide;protein folding;negative regulation of intracellular transport;stress-activated MAPK cascade;cellular response to gamma radiation	GO:200037; GO:005126; GO:000208; GO:000693; GO:001062; GO:004315; GO:000751; GO:003110; GO:006056; GO:190003; GO:000702; GO:004306; GO:001094; GO:190590; GO:000166; GO:005082; GO:003235; GO:001025; GO:003030; GO:003246; GO:004254; GO:000645; GO:003238; GO:005140; GO:007148	M band;nucleus;cytoplasm;Z disc;cardiac myofibril;cytosol;nucleoplasm;Golgi apparatus;cell surface;microtubule cytoskeleton;dendritic spine;synaptic membrane;postsynaptic density;extracellular exosome;actin filament bundle;axon;perikaryon	GO:003143; GO:000563; GO:000573; GO:003001; GO:009751; GO:000582; GO:000565; GO:000579; GO:000998; GO:001563; GO:004319; GO:009706; GO:001406; GO:007006; GO:003243; GO:003042; GO:004320	 Protein processing in endoplasmic reticulum	hsa0414	microtubule binding;macromolecular complex binding;protein binding;structural constituent of eye lens;metal ion binding;identical protein binding;unfolded protein binding;beta-amyloid binding	GO:000801; GO:004487; GO:000551; GO:000521; GO:004687; GO:004280; GO:005108; GO:000154
XP_020918494.1;XP_020918492.1;XP_020918491.1;XP_020918490.1;XP_020918489.1;XP_020918488.1;XP_020918487.1;XP_020918486.1;XP_020918485.1;XP_020918484.1;XP_020918483.1;XP_020918481.1;XP_020918480.1;XP_020918479.1;XP_020918478.1;XP_020918477.1;XP_020918476.1;XP_020918475.1;XP_020918474.1;XP_020918473.1;XP_005667401.1;XP_020918471.1;XP_020918470.1;XP_020918469.1;XP_020918468.1;XP_020918467.1;XP_020918466.1;XP_020918465.1;XP_020918464.1;XP_020918463.1;XP_020918462.1;XP_020918460.1;XP_020918459.1;XP_020918458.1;XP_020918457.1;XP_013834839.2;XP_020918456.1;XP_020918455.1;XP_020918454.1;XP_020918453.1;XP_020918452.1	XP_020918494.1;XP_020918492.1;XP_020918491.1;XP_020918490.1;XP_020918489.1;XP_020918488.1;XP_020918487.1;XP_020918486.1;XP_020918485.1;XP_020918484.1;XP_020918483.1;XP_020918481.1;XP_020918480.1;XP_020918479.1;XP_020918478.1;XP_020918477.1;XP_020918476.1;XP_020918475.1;XP_020918474.1;XP_020918473.1;XP_005667401.1;XP_020918471.1;XP_020918470.1;XP_020918469.1;XP_020918468.1;XP_020918467.1;XP_020918466.1;XP_020918465.1;XP_020918464.1;XP_020918463.1;XP_020918462.1;XP_020918460.1;XP_020918459.1;XP_020918458.1;XP_020918457.1;XP_013834839.2;XP_020918456.1;XP_020918455.1;XP_020918454.1;XP_020918453.1;XP_020918452.1	XP_020918494.1 neural cell adhesion molecule 1 isoform X41 [Sus scrofa];XP_020918492.1 neural cell adhesion molecule 1 isoform X40 [Sus scrofa];XP_020918491.1 neural cell adhesion molecule 1 isoform X39 [Sus scrofa];XP_020918490.1 neural cell adhesion mole	5	5	5	0	45583000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NCAM1	NCAM1;NCAM1;NCAM1;NCAM1;NCAM1	viral entry into host cell;interferon-gamma-mediated signaling pathway;cell adhesion;axon guidance;commissural neuron axon guidance;regulation of semaphorin-plexin signaling pathway;MAPK cascade	GO:004671; GO:006033; GO:000715; GO:000741; GO:007167; GO:200126; GO:000016	plasma membrane;cytosol;anchored component of membrane;integral component of membrane;external side of plasma membrane;Golgi membrane;cell surface	GO:000588; GO:000582; GO:003122; GO:001602; GO:000989; GO:000013; GO:000998	 Prion diseases; Cell adhesion molecules (CAMs)	hsa0502; hsa0451	virus receptor activity;Ras guanyl-nucleotide exchange factor activity	GO:000161; GO:000508
XP_005667518.1	XP_005667518.1	XP_005667518.1 endothelial cell-selective adhesion molecule [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12673000	0	NA	NA	NA	ESAM	ESAM;NA;NA;NA;NA	homophilic cell adhesion via plasma membrane adhesion molecules;leukocyte migration	GO:000715; GO:005090	plasma membrane;bicellular tight junction;integral component of membrane;adherens junction	GO:000588; GO:000592; GO:001602; GO:000591	 Leukocyte transendothelial migration; Cell adhesion molecules (CAMs)	hsa0467; hsa0451	"NA"	"NA"
XP_020918981.1;XP_013835101.2;XP_005667608.2;XP_005667607.2;XP_020918984.1;XP_020918983.1	XP_020918981.1;XP_013835101.2;XP_005667608.2;XP_005667607.2;XP_020918984.1;XP_020918983.1	XP_020918981.1 C4b-binding protein alpha chain isoform X2 [Sus scrofa];XP_013835101.2 C4b-binding protein alpha chain isoform X2 [Sus scrofa];XP_005667608.2 C4b-binding protein alpha chain isoform X2 [Sus scrofa];XP_005667607.2 C4b-binding protein alpha ch	11	11	8	119170000	63514000	101470000	93781000	209310000	176700000	162150000	84983000	118260000	77555000	110510000	0	141670000	94578000	142050000	63330000	163190000	98809000	NA	NA	NA	C4BPA	C4BPA;C4BPA;C4BPA;C4BPA;C4BPA	negative regulation of complement activation, classical pathway;regulation of complement activation;regulation of opsonization;innate immune response;positive regulation of protein catabolic process;complement activation, classical pathway	GO:004595; GO:003044; GO:190302; GO:004508; GO:004573; GO:000695	extracellular region;blood microparticle;extracellular space;plasma membrane;other organism cell	GO:000557; GO:007256; GO:000561; GO:000588; GO:004421	 Pertussis; Complement and coagulation cascades	hsa0513; hsa0461	RNA binding;protein binding	GO:000372; GO:000551
XP_005667670.1	XP_005667670.1	XP_005667670.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [Sus scrofa]	2	2	2	0	0	38246000	17999000	19354000	0	0	25542000	17658000	19432000	24827000	35644000	0	25815000	0	0	21423000	20711000	NA	NA	NA	GNG11	GNG11;NA;NA;NA;NA	G-protein coupled receptor signaling pathway;signal transduction	GO:000718; GO:000716	plasma membrane;heterotrimeric G-protein complex	GO:000588; GO:000583	 Retrograde endocannabinoid signaling; Serotonergic synapse; Chemokine signaling pathway; PI3K-Akt signaling pathway; Alcoholism; Circadian entrainment; Ras signaling pathway; Pathways in cancer	hsa0472; hsa0472; hsa0406; hsa0415; hsa0503; hsa0471; hsa0401; hsa0520	protein binding;GTPase activity	GO:000551; GO:000392
XP_020957890.1;XP_020957889.1;XP_020957888.1;XP_020957887.1;XP_005667741.1;XP_005667740.1;XP_020957885.1;XP_020957883.1;XP_020957880.1;XP_013835239.1;XP_020957879.1;XP_020957886.1;XP_005667739.1;XP_020957884.1;NP_999348.1;XP_020957882.1;XP_020957881.1;XP_013835237.1;XP_020957878.1;XP_020957877.1;XP_020957892.1;XP_020924480.1;XP_020924479.1;XP_020924478.1;XP_020924477.1	XP_020957890.1;XP_020957889.1;XP_020957888.1;XP_020957887.1;XP_005667741.1;XP_005667740.1;XP_020957885.1;XP_020957883.1;XP_020957880.1;XP_013835239.1;XP_020957879.1;XP_020957886.1;XP_005667739.1;XP_020957884.1;NP_999348.1;XP_020957882.1;XP_020957881.1;XP_013835237.1;XP_020957878.1;XP_020957877.1;XP_020957892.1	XP_020957890.1 voltage-dependent calcium channel subunit alpha-2/delta-1 isoform X19 [Sus scrofa];XP_020957889.1 voltage-dependent calcium channel subunit alpha-2/delta-1 isoform X18 [Sus scrofa];XP_020957888.1 voltage-dependent calcium channel subunit alp	22	22	22	40869000	83608000	45049000	53300000	48972000	58868000	38807000	58028000	45108000	62568000	52350000	80181000	46227000	58496000	46083000	68926000	58470000	42656000	NA	NA	NA	CACNA2D1	CACNA2D1;CACNA2D1;CACNA2D1;CACNA2D1;CACNA2D1	regulation of heart rate by cardiac conduction;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;calcium ion transport into cytosol;calcium ion transmembrane transport via high voltage-gated calcium channel;cardiac muscle cell action potential involved in contraction;membrane depolarization during bundle of His cell action potential;cellular response to beta-amyloid;calcium ion transport;positive regulation of high voltage-gated calcium channel activity;regulation of calcium ion transport;regulation of ventricular cardiac muscle cell membrane repolarization;calcium ion import across plasma membrane;regulation of membrane repolarization during action potential	GO:008609; GO:190251; GO:006040; GO:006157; GO:008600; GO:008604; GO:190464; GO:000681; GO:190184; GO:005192; GO:006030; GO:009870; GO:009890	sarcoplasmic reticulum;extracellular exosome;plasma membrane;voltage-gated calcium channel complex;L-type voltage-gated calcium channel complex	GO:001652; GO:007006; GO:000588; GO:000589; GO:199045	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Cardiac muscle contraction; Oxytocin signaling pathway; Dilated cardiomyopathy; MAPK signaling pathway	hsa0541; hsa0426; hsa0492; hsa0541; hsa0401	metal ion binding;voltage-gated calcium channel activity;voltage-gated calcium channel activity involved in cardiac muscle cell action potential;voltage-gated calcium channel activity involved in bundle of His cell action potential	GO:004687; GO:000524; GO:008600; GO:008605
XP_013835387.1;XP_005667885.1;XP_005667884.1	XP_013835387.1;XP_005667885.1;XP_005667884.1	XP_013835387.1 transcriptional protein SWT1 [Sus scrofa];XP_005667885.1 transcriptional protein SWT1 [Sus scrofa];XP_005667884.1 transcriptional protein SWT1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11015000	NA	NA	NA	SWT1	SWT1;SWT1;SWT1;NA;NA	transcription, DNA-templated	GO:000635	nucleus	GO:000563	"NA"	"NA"	"NA"	"NA"
XP_013835486.1;XP_013835485.1;XP_005667986.2	XP_013835486.1;XP_013835485.1;XP_005667986.2	XP_013835486.1 BRO1 domain-containing protein BROX [Sus scrofa];XP_013835485.1 BRO1 domain-containing protein BROX [Sus scrofa];XP_005667986.2 BRO1 domain-containing protein BROX [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	7964300	0	0	0	0	0	0	NA	NA	NA	BROX	BROX;BROX;BROX;NA;NA	"NA"	"NA"	extracellular exosome;membrane	GO:007006; GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_005668163.1;XP_005668164.1	XP_005668163.1;XP_005668164.1	XP_005668163.1 vimentin isoform X1 [Sus scrofa];XP_005668164.1 vimentin isoform X2 [Sus scrofa]	64	64	56	28887000000	40798000000	40778000000	39626000000	32521000000	38117000000	36876000000	44223000000	39934000000	42819000000	39195000000	45695000000	38378000000	44314000000	45359000000	37826000000	35097000000	38214000000	NA	NA	NA	VIM	VIM;VIM;NA;NA;NA	intermediate filament organization;astrocyte development;cytokine-mediated signaling pathway;muscle filament sliding;regulation of mRNA stability;SMAD protein signal transduction;positive regulation of collagen biosynthetic process;viral process;positive regulation of translation;cellular response to lipopolysaccharide;lens fiber cell development;negative regulation of neuron projection development;Bergmann glial cell differentiation;cellular response to interferon-gamma	GO:004510; GO:001400; GO:001922; GO:003004; GO:004348; GO:006039; GO:003296; GO:001603; GO:004572; GO:007122; GO:007030; GO:001097; GO:006002; GO:007134	phagocytic vesicle;peroxisome;cytoskeleton;nuclear matrix;cell leading edge;cytoplasm;polysome;neuron projection;intermediate filament;cytosol;focal adhesion;extracellular exosome;ribonucleoprotein complex	GO:004533; GO:000577; GO:000585; GO:001636; GO:003125; GO:000573; GO:000584; GO:004300; GO:000588; GO:000582; GO:000592; GO:007006; GO:199090	 MicroRNAs in cancer; Epstein-Barr virus infection	hsa0520; hsa0516	structural constituent of eye lens;identical protein binding;protein domain specific binding;keratin filament binding;double-stranded RNA binding;structural constituent of cytoskeleton;protein C-terminus binding;protein binding;scaffold protein binding	GO:000521; GO:004280; GO:001990; GO:199025; GO:000372; GO:000520; GO:000802; GO:000551; GO:009711
XP_005668216.1	XP_005668216.1	XP_005668216.1 COMM domain-containing protein 3 [Sus scrofa]	2	2	2	16396000	10037000	8987000	10949000	8883600	7162900	10214000	10042000	10841000	11076000	9558400	13603000	8241100	11823000	11468000	10738000	9210800	11317000	NA	NA	NA	COMMD3	COMMD3;NA;NA;NA;NA	sodium ion transport;neutrophil degranulation	GO:000681; GO:004331	extracellular region;ficolin-1-rich granule lumen;nucleus	GO:000557; GO:190481; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_005668259.3	XP_005668259.3	XP_005668259.3 LOW QUALITY PROTEIN: enoyl-CoA hydratase domain-containing protein 3, mitochondrial [Sus scrofa]	5	5	5	47490000	0	67892000	0	37171000	0	44811000	34248000	78510000	40686000	53633000	0	0	0	70943000	46247000	0	0	NA	NA	NA	ECHDC3	ECHDC3;NA;NA;NA;NA	"NA"	"NA"	mitochondrion	GO:000573	"NA"	"NA"	catalytic activity	GO:000382
XP_005668301.1;XP_013835817.1	XP_005668301.1	XP_005668301.1 isopentenyl-diphosphate Delta-isomerase 1 isoform X2 [Sus scrofa]	3	3	3	30282000	11761000	21352000	0	26965000	0	17844000	12221000	21884000	15852000	15202000	0	10282000	9585700	15374000	11315000	0	8153300	NA	NA	NA	LOC100625049	LOC100625049;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_005668394.1;XP_020920870.1;XP_020920869.1;XP_020920868.1;XP_020920867.1	XP_005668394.1;XP_020920870.1;XP_020920869.1;XP_020920868.1;XP_020920867.1	XP_005668394.1 serine/threonine-protein kinase DCLK1 isoform X6 [Sus scrofa];XP_020920870.1 serine/threonine-protein kinase DCLK1 isoform X3 [Sus scrofa];XP_020920869.1 serine/threonine-protein kinase DCLK1 isoform X2 [Sus scrofa];XP_020920868.1 serine/thr	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9562400	NA	NA	NA	DCLK1	DCLK1;DCLK1;DCLK1;DCLK1;DCLK1	neuron migration;response to virus;central nervous system projection neuron axonogenesis;central nervous system development;dendrite morphogenesis;nervous system development;peptidyl-serine phosphorylation;axon extension;protein phosphorylation;endosomal transport;intracellular signal transduction;forebrain development;negative regulation of protein localization to nucleus	GO:000176; GO:000961; GO:002195; GO:000741; GO:004881; GO:000739; GO:001810; GO:004867; GO:000646; GO:001619; GO:003555; GO:003090; GO:190018	integral component of plasma membrane;postsynaptic density	GO:000588; GO:001406	"NA"	"NA"	protein kinase activity;ATP binding;protein serine/threonine kinase activity	GO:000467; GO:000552; GO:000467
XP_005668408.1;NP_001193276.1;NP_001193280.1;XP_005668407.1;CON__Q2KJC7	XP_005668408.1;NP_001193276.1;NP_001193280.1;XP_005668407.1	XP_005668408.1 periostin isoform X2 [Sus scrofa];NP_001193276.1 periostin isoform 1 precursor [Sus scrofa];NP_001193280.1 periostin isoform 2 precursor [Sus scrofa];XP_005668407.1 periostin isoform X1 [Sus scrofa]	33	33	33	116920000	77549000	26741000	230700000	5325400	203900000	335340000	369220000	156980000	440620000	149240000	785370000	311320000	165180000	204320000	783700000	244480000	255660000	NA	NA	NA	POSTN	POSTN;POSTN;POSTN;POSTN;NA	cellular response to vitamin K;cellular response to transforming growth factor beta stimulus;neuron projection extension;extracellular matrix organization;response to estradiol;cellular response to fibroblast growth factor stimulus;positive regulation of chemokine (C-C motif) ligand 2 secretion;negative regulation of substrate adhesion-dependent cell spreading;cellular response to tumor necrosis factor;response to muscle activity;positive regulation of smooth muscle cell migration;regulation of Notch signaling pathway;response to hypoxia;negative regulation of cell-matrix adhesion;regulation of systemic arterial blood pressure;cell adhesion;skeletal system development;response to mechanical stimulus;bone regeneration	GO:007130; GO:007156; GO:199013; GO:003019; GO:003235; GO:004434; GO:190420; GO:190002; GO:007135; GO:001485; GO:001491; GO:000859; GO:000166; GO:000195; GO:000307; GO:000715; GO:000150; GO:000961; GO:199052	extracellular matrix;neuromuscular junction;extracellular space;trans-Golgi network	GO:003101; GO:003159; GO:000561; GO:000580	"NA"	"NA"	heparin binding;protein binding;metal ion binding;extracellular matrix structural constituent;cell adhesion molecule binding	GO:000820; GO:000551; GO:004687; GO:000520; GO:005083
XP_005668506.1	XP_005668506.1	XP_005668506.1 protein SGT1 homolog [Sus scrofa]	6	6	6	18840000	34662000	40888000	0	26649000	32072000	33364000	25803000	20889000	0	21067000	31444000	0	24973000	24486000	22938000	37097000	31115000	NA	NA	NA	SUGT1	SUGT1;NA;NA;NA;NA	regulation of protein stability;mitotic cell cycle;positive regulation by host of symbiont catalytic activity;protein stabilization	GO:003164; GO:000027; GO:004394; GO:005082	macromolecular complex;ubiquitin ligase complex;kinetochore;nucleus;cytosol	GO:003299; GO:000015; GO:000077; GO:000563; GO:000582	 NOD-like receptor signaling pathway	hsa0462	protein binding	GO:000551
XP_005668813.2;XP_020922529.1	XP_005668813.2;XP_020922529.1	XP_005668813.2 band 3 anion transport protein isoform X1 [Sus scrofa];XP_020922529.1 band 3 anion transport protein isoform X2 [Sus scrofa]	14	14	14	355320000	120710000	93345000	156430000	123740000	59849000	127790000	143520000	263720000	144650000	184200000	37543000	417740000	123050000	154350000	81607000	196480000	59511000	NA	NA	NA	SLC4A1	SLC4A1;SLC4A1;NA;NA;NA	bicarbonate transport;anion transport;regulation of intracellular pH;chloride transmembrane transport;cellular ion homeostasis	GO:001570; GO:000682; GO:005145; GO:190247; GO:000687	basolateral plasma membrane;Z disc;cortical cytoskeleton;integral component of membrane;integral component of plasma membrane;extracellular exosome;blood microparticle	GO:001632; GO:003001; GO:003086; GO:001602; GO:000588; GO:007006; GO:007256	 Collecting duct acid secretion	hsa0496	anion:anion antiporter activity;ankyrin binding;protein homodimerization activity;inorganic anion exchanger activity;anion transmembrane transporter activity;bicarbonate transmembrane transporter activity;protein binding;protein anchor	GO:001530; GO:003050; GO:004280; GO:000545; GO:000850; GO:001510; GO:000551; GO:004349
XP_005669175.1	XP_005669175.1	XP_005669175.1 sedoheptulokinase [Sus scrofa]	1	1	1	0	0	2306200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SHPK	SHPK;NA;NA;NA;NA	pentose-phosphate shunt;cellular response to interleukin-4;carbohydrate metabolic process;phosphorylation;pentose-phosphate shunt, non-oxidative branch;cellular response to interleukin-13;regulation of inflammatory response;cellular response to lipopolysaccharide;regulation of macrophage activation	GO:000609; GO:007135; GO:000597; GO:001631; GO:000905; GO:003596; GO:005072; GO:007122; GO:004303	cytosol;cytoplasm	GO:000582; GO:000573	"NA"	"NA"	ATP binding;sedoheptulokinase activity	GO:000552; GO:005027
XP_005669190.1;XP_020923361.1	XP_005669190.1;XP_020923361.1	XP_005669190.1 myb-binding protein 1A isoform X2 [Sus scrofa];XP_020923361.1 myb-binding protein 1A isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1991100	0	NA	NA	NA	MYBBP1A	MYBBP1A;MYBBP1A;NA;NA;NA	positive regulation of cell cycle arrest;positive regulation of gene expression, epigenetic;positive regulation of anoikis;ribosome biogenesis;cellular response to glucose starvation;respiratory electron transport chain;negative regulation of transcription, DNA-templated;circadian regulation of gene expression;regulation of transcription, DNA-templated;intrinsic apoptotic signaling pathway by p53 class mediator;osteoblast differentiation	GO:007115; GO:004581; GO:200021; GO:004225; GO:004214; GO:002290; GO:004589; GO:003292; GO:000635; GO:007233; GO:000164	nucleolus;intracellular membrane-bounded organelle;membrane;nucleus;NLS-dependent protein nuclear import complex;nucleoplasm;cytoplasm	GO:000573; GO:004323; GO:001602; GO:000563; GO:004256; GO:000565; GO:000573	"NA"	"NA"	RNA binding;transcription factor binding;sequence-specific DNA binding;E-box binding;transcription corepressor activity	GO:000372; GO:000813; GO:004356; GO:007088; GO:000371
XP_020923483.1;XP_005669265.1;XP_005669264.1	XP_020923483.1;XP_005669265.1;XP_005669264.1	XP_020923483.1 phospholipid scramblase 3 [Sus scrofa];XP_005669265.1 phospholipid scramblase 3 [Sus scrofa];XP_005669264.1 phospholipid scramblase 3 [Sus scrofa]	3	3	3	15055000	0	11851000	12991000	0	13635000	17294000	18484000	16359000	17166000	13721000	12930000	0	0	15812000	13110000	0	13013000	NA	NA	NA	PLSCR3	PLSCR3;PLSCR3;PLSCR3;NA;NA	apoptotic process;cholesterol homeostasis;phospholipid scrambling;cellular response to lipopolysaccharide;glucose homeostasis	GO:000691; GO:004263; GO:001712; GO:007122; GO:004259	mitochondrion;integral component of membrane;mitochondrial membrane;plasma membrane	GO:000573; GO:001602; GO:003196; GO:000588	"NA"	"NA"	calcium ion binding;protein binding;calcium-dependent protein binding;SH3 domain binding	GO:000550; GO:000551; GO:004830; GO:001712
XP_005669322.2;XP_020926996.1;XP_013836822.2;XP_005669321.2;XP_020926995.1;XP_020926994.1;XP_005669320.2	XP_005669322.2;XP_020926996.1;XP_013836822.2;XP_005669321.2;XP_020926995.1;XP_020926994.1;XP_005669320.2	XP_005669322.2 collagen alpha-5(VI) chain isoform X5 [Sus scrofa];XP_020926996.1 collagen alpha-5(VI) chain isoform X4 [Sus scrofa];XP_013836822.2 collagen alpha-5(VI) chain isoform X3 [Sus scrofa];XP_005669321.2 collagen alpha-5(VI) chain isoform X2 [Sus	11	9	9	0	0	84274000	0	101510000	0	136830000	0	94402000	0	132350000	0	46710000	0	110680000	0	143940000	0	NA	NA	NA	COL6A5	COL6A5;COL6A5;COL6A5;COL6A5;COL6A5	cell adhesion	GO:000715	extracellular region;collagen trimer	GO:000557; GO:000558	 PI3K-Akt signaling pathway; Focal adhesion; Protein digestion and absorption	hsa0415; hsa0451; hsa0497	extracellular matrix structural constituent conferring tensile strength;protein binding	GO:003002; GO:000551
XP_005669508.1;CON__Q2KIS7	XP_005669508.1;CON__Q2KIS7	XP_005669508.1 tetranectin [Sus scrofa];	12	12	12	292470000	1148200000	311360000	1035600000	351770000	1257300000	355040000	970370000	312710000	864930000	429780000	1506200000	458080000	1232000000	398030000	1009800000	468610000	1705900000	NA	NA	+	CLEC3B	CLEC3B;NA;NA;NA;NA	bone mineralization;positive regulation of plasminogen activation;cellular response to organic substance;cellular response to transforming growth factor beta stimulus;ossification;platelet degranulation	GO:003028; GO:001075; GO:007131; GO:007156; GO:000150; GO:000257	extracellular region;extracellular exosome;granular component;extracellular space;platelet dense granule lumen;cytoplasm	GO:000557; GO:007006; GO:000165; GO:000561; GO:003108; GO:000573	"NA"	"NA"	calcium ion binding;carbohydrate binding;heparin binding;kringle domain binding	GO:000550; GO:003024; GO:000820; GO:003614
XP_020926252.1;XP_020926251.1;XP_020926242.1;XP_005669550.1;XP_020926253.1;XP_020926249.1;XP_020926244.1;XP_020926246.1;XP_020926245.1;XP_020926241.1;XP_020926238.1;XP_013837073.1;XP_013837068.1;XP_005669546.1;XP_020926261.1;XP_020926258.1;XP_020926257.1;XP_020926255.1;XP_020926231.1;XP_020926229.1;XP_020926228.1;XP_020926227.1;XP_020926260.1;XP_020926254.1;XP_020926237.1;XP_020926235.1;XP_020926233.1;XP_020926264.1;XP_020926262.1;XP_020926265.1;XP_020926268.1;XP_020926270.1	XP_020926252.1;XP_020926251.1;XP_020926242.1;XP_005669550.1;XP_020926253.1;XP_020926249.1;XP_020926244.1;XP_020926246.1;XP_020926245.1;XP_020926241.1;XP_020926238.1;XP_013837073.1;XP_013837068.1;XP_005669546.1;XP_020926261.1;XP_020926258.1;XP_020926257.1;XP_020926255.1;XP_020926231.1;XP_020926229.1;XP_020926228.1;XP_020926227.1;XP_020926260.1;XP_020926254.1;XP_020926237.1;XP_020926235.1;XP_020926233.1;XP_020926264.1	XP_020926252.1 microtubule-associated protein 4 isoform X26 [Sus scrofa];XP_020926251.1 microtubule-associated protein 4 isoform X26 [Sus scrofa];XP_020926242.1 microtubule-associated protein 4 isoform X18 [Sus scrofa];XP_005669550.1 microtubule-associated	25	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12382000	NA	NA	NA	MAP4	MAP4;MAP4;MAP4;MAP4;MAP4	cell division;establishment of spindle orientation;negative regulation of non-motile cilium assembly;microtubule cytoskeleton organization;neuron projection development;mitotic spindle organization;microtubule sliding	GO:005130; GO:005129; GO:190285; GO:000022; GO:003117; GO:000705; GO:005101	neuron projection;mitotic spindle;plasma membrane;microtubule associated complex;axon;axoneme;cytosol;microtubule cytoskeleton	GO:004300; GO:007268; GO:000588; GO:000587; GO:003042; GO:000593; GO:000582; GO:001563	"NA"	"NA"	RNA binding;protein binding;microtubule binding;structural molecule activity	GO:000372; GO:000551; GO:000801; GO:000519
XP_013837221.1;XP_005669621.2	XP_013837221.1;XP_005669621.2	XP_013837221.1 twinfilin-2 [Sus scrofa];XP_005669621.2 toll-like receptor 9 isoform X1 [Sus scrofa]	8	8	8	19118000	31785000	26456000	27217000	24181000	33505000	24313000	34251000	21299000	28389000	20984000	44770000	24130000	30051000	24252000	34080000	27882000	30670000	NA	NA	NA	TWF2	TWF2;TLR9;NA;NA;NA	positive regulation of neuron projection development;actin filament depolymerization;positive regulation of lamellipodium assembly;negative regulation of actin filament polymerization;cell projection organization;cellular response to retinoic acid;cellular response to growth factor stimulus;barbed-end actin filament capping;sequestering of actin monomers;regulation of microvillus length;positive regulation of axon extension;regulation of actin cytoskeleton organization	GO:001097; GO:003004; GO:001059; GO:003083; GO:003003; GO:007130; GO:007136; GO:005101; GO:004298; GO:003253; GO:004577; GO:003295	myofibril;growth cone;lamellipodium;filopodium;actin filament;perinuclear region of cytoplasm;extracellular exosome;cytoplasm;stereocilium	GO:003001; GO:003042; GO:003002; GO:003017; GO:000588; GO:004847; GO:007006; GO:000573; GO:003242	"NA"	"NA"	protein kinase C binding;actin monomer binding;phosphatidylinositol-4,5-bisphosphate binding;protein binding;RNA binding;ATP binding;actin filament binding;cadherin binding	GO:000508; GO:000378; GO:000554; GO:000551; GO:000372; GO:000552; GO:005101; GO:004529
XP_020924647.1;XP_020924644.1;XP_020924643.1;XP_013837255.1;XP_020924642.1;XP_005669721.1;XP_020924641.1;XP_020924640.1;XP_020924646.1;XP_005669724.1;XP_020924645.1	XP_020924647.1;XP_020924644.1;XP_020924643.1;XP_013837255.1;XP_020924642.1;XP_005669721.1;XP_020924641.1;XP_020924640.1;XP_020924646.1;XP_005669724.1;XP_020924645.1	XP_020924647.1 coiled-coil domain-containing protein 66 isoform X10 [Sus scrofa];XP_020924644.1 coiled-coil domain-containing protein 66 isoform X7 [Sus scrofa];XP_020924643.1 coiled-coil domain-containing protein 66 isoform X6 [Sus scrofa];XP_013837255.1	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	+	NA	NA	CCDC66	CCDC66;CCDC66;CCDC66;CCDC66;CCDC66	retinal rod cell development;cilium assembly;microtubule bundle formation;regulation of protein localization to cilium;retina homeostasis;detection of light stimulus involved in visual perception	GO:004654; GO:006027; GO:000157; GO:190356; GO:000189; GO:005090	photoreceptor outer segment;ciliary basal body;centrosome;cilium;centriolar satellite;ciliary transition zone;photoreceptor inner segment;microtubule	GO:000175; GO:003606; GO:000581; GO:000592; GO:003445; GO:003586; GO:000191; GO:000587	"NA"	"NA"	protein binding;microtubule binding;protein homodimerization activity	GO:000551; GO:000801; GO:004280
XP_020925190.1;XP_005669941.1	XP_020925190.1;XP_005669941.1	XP_020925190.1 coatomer subunit beta [Sus scrofa];XP_005669941.1 coatomer subunit beta [Sus scrofa]	19	19	19	102440000	144700000	107660000	131140000	113220000	140330000	128790000	127600000	107420000	122890000	127540000	130380000	125140000	138920000	130510000	122480000	122340000	146000000	NA	NA	NA	COPB2	COPB2;COPB2;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;ER to Golgi vesicle-mediated transport;toxin transport;intra-Golgi vesicle-mediated transport	GO:000689; GO:000688; GO:190199; GO:000689	endoplasmic reticulum membrane;cytosol;transport vesicle;COPI vesicle coat;Golgi membrane	GO:000578; GO:000582; GO:003013; GO:003012; GO:000013	"NA"	"NA"	protein binding;structural molecule activity	GO:000551; GO:000519
XP_005669974.1	XP_005669974.1	XP_005669974.1 procollagen C-endopeptidase enhancer 2 [Sus scrofa]	2	2	2	0	15780000	0	0	0	16830000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PCOLCE2	PCOLCE2;NA;NA;NA;NA	positive regulation of peptidase activity;cellular response to leukemia inhibitory factor	GO:001095; GO:199083	extracellular region	GO:000557	"NA"	"NA"	peptidase activator activity;collagen binding;heparin binding	GO:001650; GO:000551; GO:000820
XP_013837638.1;XP_005670043.1;XP_005670042.1;XP_005670041.1	XP_013837638.1;XP_005670043.1;XP_005670042.1;XP_005670041.1	XP_013837638.1 Golgi integral membrane protein 4 isoform X4 [Sus scrofa];XP_005670043.1 Golgi integral membrane protein 4 isoform X3 [Sus scrofa];XP_005670042.1 Golgi integral membrane protein 4 isoform X2 [Sus scrofa];XP_005670041.1 Golgi integral membran	2	2	2	0	11005000	8308600	8568700	0	10865000	9452900	0	0	0	0	0	0	0	0	9331200	0	10220000	NA	NA	NA	GOLIM4	GOLIM4;GOLIM4;GOLIM4;GOLIM4;NA	"NA"	"NA"	transport vesicle;endosome membrane;Golgi membrane;Golgi lumen;endocytic vesicle;integral component of membrane;cis-Golgi network;Golgi cisterna membrane	GO:003013; GO:001000; GO:000013; GO:000579; GO:003013; GO:001602; GO:000580; GO:003258	"NA"	"NA"	"NA"	"NA"
XP_005670470.1	XP_005670470.1	XP_005670470.1 PDZ and LIM domain protein 2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PDLIM2	PDLIM2;NA;NA;NA;NA	"NA"	"NA"	cytoskeleton;nucleus;cytoplasm	GO:000585; GO:000563; GO:000573	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_020930031.1;XP_020930030.1;XP_005670496.2	XP_020930031.1;XP_020930030.1;XP_005670496.2	XP_020930031.1 neurofilament medium polypeptide isoform X3 [Sus scrofa];XP_020930030.1 neurofilament medium polypeptide isoform X2 [Sus scrofa];XP_005670496.2 neurofilament medium polypeptide isoform X1 [Sus scrofa]	19	17	16	0	1007000000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NEFM	NEFM;NEFM;NEFM;NA;NA	neurofilament bundle assembly;axon development	GO:003369; GO:006156	axon;intermediate filament cytoskeleton;neurofibrillary tangle;neurofilament	GO:003042; GO:004511; GO:009741; GO:000588	 Amyotrophic lateral sclerosis (ALS)	hsa0501	protein binding;structural constituent of cytoskeleton;microtubule binding	GO:000551; GO:000520; GO:000801
XP_005670506.2	XP_005670506.2	XP_005670506.2 LOW QUALITY PROTEIN: scavenger receptor class A member 5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	6009300	0	0	0	0	0	NA	NA	NA	SCARA5	SCARA5;NA;NA;NA;NA	iron ion transmembrane transport;protein homotrimerization;cellular iron ion homeostasis;endocytosis;cellular response to heat	GO:003475; GO:007020; GO:000687; GO:000689; GO:003460	cell surface;integral component of plasma membrane	GO:000998; GO:000588	"NA"	"NA"	scavenger receptor activity;ferritin receptor activity	GO:000504; GO:007028
XP_005670835.2	XP_005670835.2	XP_005670835.2 LOW QUALITY PROTEIN: neurofilament heavy polypeptide [Sus scrofa]	17	14	14	0	651470000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NEFH	NEFH;NA;NA;NA;NA	cell projection assembly;axon development;axonogenesis;neurofilament bundle assembly;microtubule cytoskeleton organization;neurofilament cytoskeleton organization;regulation of organelle transport along microtubule;cellular response to leukemia inhibitory factor;peripheral nervous system neuron axonogenesis	GO:003003; GO:006156; GO:000740; GO:003369; GO:000022; GO:006005; GO:190251; GO:199083; GO:004893	neurofilament;axon;postsynaptic density;neurofibrillary tangle;cytoskeleton;cytoplasm;Schaffer collateral - CA1 synapse	GO:000588; GO:003042; GO:001406; GO:009741; GO:000585; GO:000573; GO:009868	 Amyotrophic lateral sclerosis (ALS)	hsa0501	protein binding, bridging;microtubule binding;structural molecule activity;structural constituent of cytoskeleton;kinesin binding;protein kinase binding;dynein complex binding	GO:003067; GO:000801; GO:000519; GO:000520; GO:001989; GO:001990; GO:007084
XP_005671239.2	XP_005671239.2	XP_005671239.2 LOW QUALITY PROTEIN: multimerin-2 [Sus scrofa]	7	7	7	19351000	0	23996000	0	20595000	18935000	12662000	17815000	17090000	0	17273000	0	0	0	0	25381000	0	0	NA	NA	NA	MMRN2	MMRN2;NA;NA;NA;NA	positive regulation of cell-substrate adhesion;cell migration involved in sprouting angiogenesis;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of cell migration involved in sprouting angiogenesis	GO:001081; GO:000204; GO:003094; GO:009005	extracellular matrix;extracellular exosome;extracellular space;basement membrane	GO:003101; GO:007006; GO:000561; GO:000560	"NA"	"NA"	extracellular matrix structural constituent;protein binding	GO:000520; GO:000551
XP_005671423.1	XP_005671423.1	XP_005671423.1 transmembrane 9 superfamily member 3 [Sus scrofa]	3	3	3	0	0	0	12082000	0	0	0	12417000	0	0	0	0	0	0	0	0	0	16474000	NA	NA	NA	TM9SF3	TM9SF3;NA;NA;NA;NA	protein localization to membrane	GO:007265	integral component of membrane;membrane	GO:001602; GO:001602	"NA"	"NA"	"NA"	"NA"
XP_005671509.1	XP_005671509.1	XP_005671509.1 structural maintenance of chromosomes protein 3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	7658300	0	0	0	0	NA	NA	NA	SMC3	SMC3;NA;NA;NA;NA	positive regulation by host of viral release from host cell;mitotic cell cycle;regulation of mitotic spindle assembly;DNA repair;sister chromatid cohesion;negative regulation of DNA endoreduplication;interaction with symbiont;stem cell population maintenance;cell division;regulation of DNA replication;meiotic cell cycle	GO:004479; GO:000027; GO:190167; GO:000628; GO:000706; GO:003287; GO:005170; GO:001982; GO:005130; GO:000627; GO:005132	cytosol;chromosome;nuclear matrix;meiotic cohesin complex;mitotic spindle pole;chromatin;nucleus;nucleoplasm;nuclear meiotic cohesin complex;chromosome, centromeric region;lateral element;basement membrane;cohesin complex	GO:000582; GO:000569; GO:001636; GO:003089; GO:009743; GO:000078; GO:000563; GO:000565; GO:003499; GO:000077; GO:000080; GO:000560; GO:000827	 Oocyte meiosis; Cell cycle	hsa0411; hsa0411	mediator complex binding;chromatin binding;beta-tubulin binding;microtubule motor activity;ATP binding;protein binding;dynein complex binding;protein heterodimerization activity	GO:003603; GO:000368; GO:004848; GO:000377; GO:000552; GO:000551; GO:007084; GO:004698
XP_005671533.1;XP_020929031.1;XP_020929030.1;XP_020929026.1;XP_020929024.1;XP_005671532.2;XP_020929023.1;XP_020929020.1;XP_020929019.1;XP_020929018.1;XP_020929017.1;XP_020929016.1;XP_020929013.1;XP_020929011.1;XP_020929010.1;XP_013839210.1;XP_020929009.1;XP_013839207.1;XP_020929008.1;XP_020929007.1;XP_020929006.1;XP_013839209.2;XP_020929038.1;XP_020929037.1;XP_020929036.1;XP_020929034.1;XP_020929033.1;XP_020929032.1;XP_020929029.1;XP_020929028.1;XP_020929022.1;XP_020929021.1;XP_020929012.1;XP_020929039.1;XP_020929027.1;XP_020929041.1;XP_020929040.1;XP_020929043.1;XP_020929042.1	XP_005671533.1;XP_020929031.1;XP_020929030.1;XP_020929026.1;XP_020929024.1;XP_005671532.2;XP_020929023.1;XP_020929020.1;XP_020929019.1;XP_020929018.1;XP_020929017.1;XP_020929016.1;XP_020929013.1;XP_020929011.1;XP_020929010.1;XP_013839210.1;XP_020929009.1;XP_013839207.1;XP_020929008.1;XP_020929007.1;XP_020929006.1;XP_013839209.2;XP_020929038.1;XP_020929037.1;XP_020929036.1;XP_020929034.1;XP_020929033.1;XP_020929032.1;XP_020929029.1;XP_020929028.1;XP_020929022.1;XP_020929021.1;XP_020929012.1;XP_020929039.1;XP_020929027.1;XP_020929041.1;XP_020929040.1;XP_020929043.1;XP_020929042.1	XP_005671533.1 actin-binding LIM protein 1 isoform X28 [Sus scrofa];XP_020929031.1 actin-binding LIM protein 1 isoform X27 [Sus scrofa];XP_020929030.1 actin-binding LIM protein 1 isoform X26 [Sus scrofa];XP_020929026.1 actin-binding LIM protein 1 isoform X	10	10	10	0	28456000	17616000	0	0	21931000	14877000	18536000	0	19462000	21313000	0	0	30210000	18847000	17888000	19844000	18912000	NA	NA	NA	ABLIM1	ABLIM1;ABLIM1;ABLIM1;ABLIM1;ABLIM1	lamellipodium assembly;animal organ morphogenesis;visual perception;cytoskeleton organization;cilium assembly	GO:003003; GO:000988; GO:000760; GO:000701; GO:006027	stress fiber;actin cytoskeleton;lamellipodium;cytoplasm	GO:000172; GO:001562; GO:003002; GO:000573	 Axon guidance	hsa0436	metal ion binding;actin filament binding;actin binding;protein binding	GO:004687; GO:005101; GO:000377; GO:000551
XP_020929102.1;XP_020929101.1;XP_020929100.1;XP_020929099.1;XP_020929098.1;XP_013839249.1;XP_013839248.1;XP_020929097.1;XP_005671560.1	XP_020929102.1;XP_020929101.1;XP_020929100.1;XP_020929099.1;XP_020929098.1;XP_013839249.1;XP_013839248.1;XP_020929097.1;XP_005671560.1	XP_020929102.1 protein FAM45A isoform X3 [Sus scrofa];XP_020929101.1 protein FAM45A isoform X3 [Sus scrofa];XP_020929100.1 protein FAM45A isoform X3 [Sus scrofa];XP_020929099.1 protein FAM45A isoform X3 [Sus scrofa];XP_020929098.1 protein FAM45A isoform X3	4	4	4	0	12425000	0	0	0	0	0	0	13507000	12928000	0	0	0	0	0	12830000	0	15336000	NA	NA	NA	FAM45A	FAM45A;FAM45A;FAM45A;FAM45A;FAM45A	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020932267.1;XP_005671677.2	XP_020932267.1;XP_005671677.2	XP_020932267.1 activated RNA polymerase II transcriptional coactivator p15 [Sus scrofa];XP_005671677.2 activated RNA polymerase II transcriptional coactivator p15 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	4668000	0	0	0	0	0	0	NA	NA	NA	SUB1	SUB1;LOC100512195;NA;NA;NA	regulation of transcription from RNA polymerase II promoter;SMAD protein signal transduction;positive regulation of transcription initiation from RNA polymerase II promoter	GO:000635; GO:006039; GO:006026	transcription factor complex;nucleus;extracellular exosome;nucleolus	GO:000566; GO:000563; GO:007006; GO:000573	"NA"	"NA"	sequence-specific double-stranded DNA binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;single-stranded DNA binding;transcription coactivator activity;RNA binding;protein binding;identical protein binding	GO:199083; GO:000122; GO:000369; GO:000371; GO:000372; GO:000551; GO:004280
XP_005671695.2;XP_020932080.1	XP_005671695.2	XP_005671695.2 translin isoform X1 [Sus scrofa]	6	6	6	37284000	39392000	29957000	47928000	29524000	35000000	30388000	41385000	25980000	40739000	41375000	0	42818000	41717000	42550000	47907000	29445000	42292000	NA	NA	NA	TSN	TSN;NA;NA;NA;NA	RNA phosphodiester bond hydrolysis, endonucleolytic;DNA recombination	GO:009050; GO:000631	nucleus;cytoplasm;cytosol	GO:000563; GO:000573; GO:000582	"NA"	"NA"	single-stranded DNA binding;sequence-specific DNA binding;macromolecular complex binding;DNA binding;endoribonuclease activity;identical protein binding;protein binding;mRNA binding	GO:000369; GO:004356; GO:004487; GO:000367; GO:000452; GO:004280; GO:000551; GO:000372
XP_005671773.1	XP_005671773.1	XP_005671773.1 PDZ and LIM domain protein 3 isoform X1 [Sus scrofa]	6	2	2	0	0	0	0	0	0	0	0	0	0	0	0	9536700	0	0	0	0	0	NA	NA	NA	PDLIM3	PDLIM3;NA;NA;NA;NA	heart development;actin filament organization	GO:000750; GO:000701	actin cytoskeleton;Z disc	GO:001562; GO:003001	"NA"	"NA"	protein binding;cytoskeletal protein binding;metal ion binding;structural constituent of muscle	GO:000551; GO:000809; GO:004687; GO:000830
XP_020931242.1;XP_005671789.1;XP_020931241.1;XP_020931240.1;XP_020931238.1;XP_020931239.1;XP_020931237.1;XP_020931234.1;XP_020931233.1;XP_020931232.1;XP_005671785.1;XP_020931226.1;XP_020931225.1;XP_020931223.1	XP_020931242.1;XP_005671789.1;XP_020931241.1;XP_020931240.1;XP_020931238.1;XP_020931239.1;XP_020931237.1;XP_020931234.1;XP_020931233.1;XP_020931232.1;XP_005671785.1;XP_020931226.1;XP_020931225.1;XP_020931223.1	XP_020931242.1 sorbin and SH3 domain-containing protein 2 isoform X20 [Sus scrofa];XP_005671789.1 sorbin and SH3 domain-containing protein 2 isoform X20 [Sus scrofa];XP_020931241.1 sorbin and SH3 domain-containing protein 2 isoform X22 [Sus scrofa];XP_0209	14	1	1	0	0	0	0	0	0	0	0	0	0	0	0	20160000	0	0	0	0	0	NA	NA	NA	SORBS2	SORBS2;SORBS2;SORBS2;SORBS2;SORBS2	actin filament organization;Notch signaling pathway;biological_process;cell growth involved in cardiac muscle cell development	GO:000701; GO:000721; GO:000815; GO:006104	lamellipodium;perinuclear region of cytoplasm;plasma membrane;nucleus;apical plasma membrane;focal adhesion;Z disc;actin cytoskeleton;nucleoplasm	GO:003002; GO:004847; GO:000588; GO:000563; GO:001632; GO:000592; GO:003001; GO:001562; GO:000565	"NA"	"NA"	protein binding;structural constituent of cytoskeleton;cytoskeletal adaptor activity;structural constituent of muscle;RNA binding	GO:000551; GO:000520; GO:000809; GO:000830; GO:000372
XP_005671790.1;XP_020931236.1;XP_020931235.1;XP_020931231.1;XP_020931230.1;XP_020931229.1;XP_005671787.1;XP_005671786.1;XP_020931228.1;XP_020931227.1;XP_020931224.1	XP_005671790.1;XP_020931236.1;XP_020931235.1;XP_020931231.1;XP_020931230.1;XP_020931229.1;XP_005671787.1;XP_005671786.1;XP_020931228.1;XP_020931227.1;XP_020931224.1	XP_005671790.1 sorbin and SH3 domain-containing protein 2 isoform X21 [Sus scrofa];XP_020931236.1 sorbin and SH3 domain-containing protein 2 isoform X17 [Sus scrofa];XP_020931235.1 sorbin and SH3 domain-containing protein 2 isoform X15 [Sus scrofa];XP_0209	14	13	0	0	28680000	164450000	0	29982000	53210000	0	103620000	0	215380000	77520000	43347000	407850000	0	26012000	24504000	23809000	42417000	NA	NA	NA	SORBS2	SORBS2;SORBS2;SORBS2;SORBS2;SORBS2	actin filament organization;Notch signaling pathway;biological_process;cell growth involved in cardiac muscle cell development	GO:000701; GO:000721; GO:000815; GO:006104	lamellipodium;perinuclear region of cytoplasm;plasma membrane;nucleus;apical plasma membrane;focal adhesion;Z disc;actin cytoskeleton;nucleoplasm	GO:003002; GO:004847; GO:000588; GO:000563; GO:001632; GO:000592; GO:003001; GO:001562; GO:000565	"NA"	"NA"	protein binding;structural constituent of cytoskeleton;cytoskeletal adaptor activity;structural constituent of muscle;RNA binding	GO:000551; GO:000520; GO:000809; GO:000830; GO:000372
XP_005671835.1	XP_005671835.1	XP_005671835.1 U6 snRNA-associated Sm-like protein LSm1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2927100	0	0	NA	NA	NA	LSM1	LSM1;NA;NA;NA;NA	RNA metabolic process;stem cell population maintenance;RNA splicing, via transesterification reactions;RNA splicing;negative regulation of neuron differentiation;mRNA processing;histone mRNA catabolic process;deadenylation-dependent decapping of nuclear-transcribed mRNA;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	GO:001607; GO:001982; GO:000037; GO:000838; GO:004566; GO:000639; GO:007104; GO:000029; GO:004392	nucleus;axon;messenger ribonucleoprotein complex;Lsm1-7-Pat1 complex;P-body;cytoplasm;neuronal cell body;cytosol	GO:000563; GO:003042; GO:199012; GO:199072; GO:000093; GO:000573; GO:004302; GO:000582	 RNA degradation	hsa0301	RNA binding;mRNA binding;pre-mRNA binding;RNA cap binding;protein binding	GO:000372; GO:000372; GO:003600; GO:000033; GO:000551
XP_020930230.1;XP_013839537.1;XP_005671839.1;XP_005671838.1;XP_005671837.1;NP_001137178.1	XP_020930230.1;XP_013839537.1;XP_005671839.1;XP_005671838.1;XP_005671837.1;NP_001137178.1	XP_020930230.1 erlin-2 isoform X2 [Sus scrofa];XP_013839537.1 erlin-2 isoform X2 [Sus scrofa];XP_005671839.1 erlin-2 isoform X2 [Sus scrofa];XP_005671838.1 erlin-2 isoform X2 [Sus scrofa];XP_005671837.1 erlin-2 isoform X1 [Sus scrofa];NP_001137178.1 erlin-	8	8	8	69257000	96280000	81985000	114640000	82525000	98436000	96009000	112470000	80081000	79238000	94400000	109130000	65216000	104730000	94601000	106120000	89817000	120680000	NA	NA	NA	ERLIN2	ERLIN2;ERLIN2;ERLIN2;ERLIN2;ERLIN2	cholesterol metabolic process;SREBP signaling pathway;negative regulation of fatty acid biosynthetic process;ubiquitin-dependent ERAD pathway;peptidyl-tyrosine phosphorylation;transmembrane transport;negative regulation of cholesterol biosynthetic process	GO:000820; GO:003293; GO:004571; GO:003043; GO:001810; GO:005508; GO:004554	cytosol;plasma membrane;membrane raft;endoplasmic reticulum;macromolecular complex;integral component of membrane	GO:000582; GO:000588; GO:004512; GO:000578; GO:003299; GO:001602	"NA"	"NA"	protein binding;ubiquitin protein ligase binding;protein tyrosine kinase activity;cholesterol binding	GO:000551; GO:003162; GO:000471; GO:001548
XP_005671905.2;XP_020947275.1;XP_020947274.1;XP_020947273.1;XP_020947272.1;XP_020947276.1;XP_020947271.1;XP_020947270.1;XP_020947269.1;XP_020947268.1;XP_020947267.1;XP_020947266.1;XP_020947265.1;XP_020947264.1	XP_005671905.2;XP_020947275.1;XP_020947274.1;XP_020947273.1;XP_020947272.1;XP_020947276.1;XP_020947271.1;XP_020947270.1;XP_020947269.1;XP_020947268.1;XP_020947267.1;XP_020947266.1;XP_020947265.1;XP_020947264.1	XP_005671905.2 LOW QUALITY PROTEIN: formin-like protein 2 [Sus scrofa];XP_020947275.1 formin-like protein 3 isoform X12 [Sus scrofa];XP_020947274.1 formin-like protein 3 isoform X11 [Sus scrofa];XP_020947273.1 formin-like protein 3 isoform X10 [Sus scrofa]	2	2	2	171720000	224020000	335570000	115570000	107050000	153760000	179160000	126640000	0	200280000	111210000	72145000	132160000	236020000	81935000	245320000	234540000	215540000	NA	NA	NA	FMNL3	FMNL3;FMNL3;FMNL3;FMNL3;FMNL3	cell migration;angiogenesis;actin cytoskeleton organization;cytoskeleton organization;regulation of cell shape	GO:001647; GO:000152; GO:003003; GO:000701; GO:000836	intracellular membrane-bounded organelle;plasma membrane;cytosol;Golgi apparatus;cytoplasm	GO:004323; GO:000588; GO:000582; GO:000579; GO:000573	"NA"	"NA"	Rho GTPase binding;GTPase activating protein binding;actin binding	GO:001704; GO:003279; GO:000377
XP_020930559.1;XP_005671941.2	XP_020930559.1;XP_005671941.2	XP_020930559.1 prolyl endopeptidase FAP isoform X2 [Sus scrofa];XP_005671941.2 prolyl endopeptidase FAP isoform X1 [Sus scrofa]	13	13	13	0	28654000	0	0	0	0	0	26970000	24125000	33725000	0	36150000	0	27350000	0	30238000	0	34930000	NA	NA	NA	FAP	FAP;FAP;NA;NA;NA	proteolysis involved in cellular protein catabolic process;regulation of collagen catabolic process;endothelial cell migration;regulation of fibrinolysis;melanocyte apoptotic process;cell adhesion;negative regulation of extracellular matrix organization;negative regulation of cell proliferation involved in contact inhibition;angiogenesis;melanocyte proliferation;mitotic cell cycle arrest;proteolysis;positive regulation of cell cycle arrest;positive regulation of execution phase of apoptosis	GO:005160; GO:001071; GO:004354; GO:005191; GO:190236; GO:000715; GO:190305; GO:006024; GO:000152; GO:009732; GO:007185; GO:000650; GO:007115; GO:190011	lamellipodium;basal part of cell;integral component of membrane;cell surface;invadopodium membrane;plasma membrane;extracellular space;cytoplasm;lamellipodium membrane;focal adhesion;ruffle membrane	GO:003002; GO:004517; GO:001602; GO:000998; GO:007143; GO:000588; GO:000561; GO:000573; GO:003125; GO:000592; GO:003258	"NA"	"NA"	peptidase activity;protein binding;dipeptidyl-peptidase activity;metalloendopeptidase activity;protease binding;serine-type endopeptidase activity;integrin binding;endopeptidase activity;protein homodimerization activity;protein dimerization activity	GO:000823; GO:000551; GO:000823; GO:000422; GO:000202; GO:000425; GO:000517; GO:000417; GO:004280; GO:004698
XP_013839887.1;XP_013839886.1;XP_005672194.1;XP_005672193.1;XP_020930567.1	XP_013839887.1;XP_013839886.1;XP_005672194.1;XP_005672193.1;XP_020930567.1	XP_013839887.1 isocitrate dehydrogenase [NADP] cytoplasmic isoform X2 [Sus scrofa];XP_013839886.1 isocitrate dehydrogenase [NADP] cytoplasmic isoform X2 [Sus scrofa];XP_005672194.1 isocitrate dehydrogenase [NADP] cytoplasmic isoform X2 [Sus scrofa];XP_0056	23	23	22	2595700000	1581200000	2333700000	1494500000	2014500000	1316300000	2363400000	1755800000	2443100000	1983300000	1985800000	1970800000	981290000	1209800000	1580300000	1824200000	1588400000	1424300000	NA	NA	NA	IDH1	IDH1;IDH1;IDH1;IDH1;IDH1	2-oxoglutarate metabolic process;regulation of phospholipid catabolic process;glyoxylate cycle;NADPH regeneration;protein targeting to peroxisome;response to oxidative stress;neutrophil degranulation;NADP metabolic process;isocitrate metabolic process;female gonad development;response to steroid hormone;regulation of phospholipid biosynthetic process	GO:000610; GO:006069; GO:000609; GO:000674; GO:000662; GO:000697; GO:004331; GO:000673; GO:000610; GO:000858; GO:004854; GO:007107	peroxisome;mitochondrion;extracellular region;secretory granule lumen;ficolin-1-rich granule lumen;extracellular exosome;cytosol;peroxisomal matrix;tertiary granule lumen	GO:000577; GO:000573; GO:000557; GO:003477; GO:190481; GO:007006; GO:000582; GO:000578; GO:190472	 Biosynthesis of amino acids; Peroxisome; Citrate cycle (TCA cycle); Biosynthesis of antibiotics; Metabolic pathways; Central carbon metabolism in cancer; Glutathione metabolism; Carbon metabolism; 2-Oxocarboxylic acid metabolism	hsa0123; hsa0414; hsa0002; hsa0113; hsa0110; hsa0523; hsa0048; hsa0120; hsa0121	identical protein binding;protein homodimerization activity;NADP binding;cadherin binding;receptor binding;isocitrate dehydrogenase (NADP+) activity;NAD binding;(R)-2-hydroxyglutarate dehydrogenase activity;magnesium ion binding	GO:004280; GO:004280; GO:005066; GO:004529; GO:000510; GO:000445; GO:005128; GO:005199; GO:000028
XP_020931159.1;XP_020931158.1;XP_005672377.1;XP_020931157.1;XP_005672376.1;XP_020931156.1;XP_020931155.1;XP_005672375.1;XP_020931154.1;XP_020931153.1;XP_005672372.1;XP_020931152.1;XP_020931151.1;XP_020931150.1;XP_005672371.1;XP_020931149.1;XP_020931148.1;XP_020931147.1;XP_020931146.1;XP_020931145.1;XP_020931144.1;XP_020931143.1;XP_020931142.1;XP_020931141.1;XP_020931140.1;XP_013840087.1;XP_020931139.1;XP_020931138.1;XP_020931137.1;XP_013840085.1;XP_020931136.1;XP_020931135.1;XP_020931134.1;XP_020931133.1;XP_013840084.1;XP_020931132.1;XP_005672380.1;XP_020931168.1;XP_020931167.1;XP_020931166.1;XP_020931165.1;XP_020931164.1;XP_020931163.1;XP_020931162.1;XP_020931161.1;XP_020931160.1	XP_020931159.1;XP_020931158.1;XP_005672377.1;XP_020931157.1;XP_005672376.1;XP_020931156.1;XP_020931155.1;XP_005672375.1;XP_020931154.1;XP_020931153.1;XP_005672372.1;XP_020931152.1;XP_020931151.1;XP_020931150.1;XP_005672371.1;XP_020931149.1;XP_020931148.1;XP_020931147.1;XP_020931146.1;XP_020931145.1;XP_020931144.1;XP_020931143.1;XP_020931142.1;XP_020931141.1;XP_020931140.1;XP_013840087.1;XP_020931139.1;XP_020931138.1;XP_020931137.1;XP_013840085.1;XP_020931136.1;XP_020931135.1;XP_020931134.1;XP_020931133.1;XP_013840084.1;XP_020931132.1;XP_005672380.1;XP_020931168.1;XP_020931167.1;XP_020931166.1;XP_020931165.1;XP_020931164.1;XP_020931163.1;XP_020931162.1;XP_020931161.1;XP_020931160.1	XP_020931159.1 leucine-rich repeat flightless-interacting protein 1 isoform X36 [Sus scrofa];XP_020931158.1 leucine-rich repeat flightless-interacting protein 1 isoform X35 [Sus scrofa];XP_005672377.1 leucine-rich repeat flightless-interacting protein 1 is	3	3	3	0	0	5939700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LRRFIP1	LRRFIP1;LRRFIP1;LRRFIP1;LRRFIP1;LRRFIP1	negative regulation of transcription from RNA polymerase II promoter;regulation of transcription from RNA polymerase II promoter;positive regulation of NF-kappaB transcription factor activity;negative regulation of transcription, DNA-templated;positive regulation of type I interferon production	GO:000012; GO:000635; GO:005109; GO:004589; GO:003248	cytosol;cytoplasm;cytoskeleton;plasma membrane;nucleus	GO:000582; GO:000573; GO:000585; GO:000588; GO:000563	"NA"	"NA"	RNA polymerase II transcription factor activity, sequence-specific DNA binding;cadherin binding;protein binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;DNA binding;double-stranded RNA binding;protein homodimerization activity	GO:000098; GO:004529; GO:000551; GO:000097; GO:000122; GO:000367; GO:000372; GO:004280
XP_005672502.2;XP_020932714.1;XP_020932713.1	XP_005672502.2;XP_020932714.1;XP_020932713.1	XP_005672502.2 NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X1 [Sus scrofa];XP_020932714.1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X3 [Sus scrofa];XP_020932713.1 NADH dehydrogenase [ubiqu	3	3	3	0	17703000	24504000	0	22763000	0	24883000	18967000	20602000	17001000	0	0	0	19902000	23035000	22137000	0	0	NA	NA	NA	NDUFS4	NDUFS4;NDUFS4;NDUFS4;NA;NA	mitochondrial respiratory chain complex I assembly;response to cAMP;mitochondrial electron transport, NADH to ubiquinone;brain development;cAMP-mediated signaling;regulation of protein phosphorylation;positive regulation of fibroblast proliferation;cellular respiration;reactive oxygen species metabolic process	GO:003298; GO:005159; GO:000612; GO:000742; GO:001993; GO:000193; GO:004814; GO:004533; GO:007259	mitochondrial inner membrane;mitochondrial respiratory chain complex I;mitochondrion	GO:000574; GO:000574; GO:000573	 Oxidative phosphorylation; Metabolic pathways; Parkinson's disease; Non-alcoholic fatty liver disease (NAFLD)	hsa0019; hsa0110; hsa0501; hsa0493	NADH dehydrogenase (ubiquinone) activity	GO:000813
XP_005672588.2	XP_005672588.2	XP_005672588.2 methylcrotonoyl-CoA carboxylase beta chain, mitochondrial [Sus scrofa]	15	15	15	168610000	105240000	131240000	77087000	156170000	66697000	141320000	103150000	114370000	96059000	148080000	127720000	73500000	89213000	87604000	106990000	104670000	104160000	NA	NA	NA	MCCC2	MCCC2;NA;NA;NA;NA	biotin metabolic process;protein heterooligomerization;coenzyme A metabolic process;leucine catabolic process	GO:000676; GO:005129; GO:001593; GO:000655	cytosol;mitochondrial matrix;methylcrotonoyl-CoA carboxylase complex;3-methylcrotonyl-CoA carboxylase complex, mitochondrial;mitochondrion	GO:000582; GO:000575; GO:190520; GO:000216; GO:000573	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	ATP binding;protein binding;methylcrotonoyl-CoA carboxylase activity	GO:000552; GO:000551; GO:000448
XP_005672670.3	XP_005672670.3	XP_005672670.3 LOW QUALITY PROTEIN: annexin A6 [Sus scrofa]	40	40	40	660550000	818840000	773460000	816200000	801660000	1163600000	787410000	703000000	766070000	1093900000	909740000	983640000	1340300000	803810000	752310000	1037800000	828980000	879270000	NA	NA	NA	ANXA6	ANXA6;NA;NA;NA;NA	mitochondrial calcium ion homeostasis;biomineral tissue development;calcium ion transmembrane transport;apoptotic signaling pathway;ion transmembrane transport;protein homooligomerization;calcium ion import;negative regulation of sequestering of calcium ion;growth plate cartilage chondrocyte differentiation;neural crest cell migration;plasma membrane repair;regulation of muscle contraction	GO:005156; GO:003121; GO:007058; GO:009719; GO:003422; GO:005126; GO:007050; GO:005128; GO:000341; GO:000175; GO:000177; GO:000693	late endosome membrane;mitochondrion;lysosomal membrane;perinuclear region of cytoplasm;focal adhesion;melanosome;extracellular exosome;membrane	GO:003190; GO:000573; GO:000576; GO:004847; GO:000592; GO:004247; GO:007006; GO:001602	"NA"	"NA"	protein binding;GTP binding;cholesterol binding;actin filament binding;calcium-dependent phospholipid binding;heparin binding;ligand-gated ion channel activity;phosphatidylserine binding;chondroitin sulfate binding;calcium-dependent protein binding;calcium ion binding;calcium channel activity;protein homodimerization activity;lipid binding;enzyme binding;signaling receptor activity;macromolecular complex binding	GO:000551; GO:000552; GO:001548; GO:005101; GO:000554; GO:000820; GO:001527; GO:000178; GO:003537; GO:004830; GO:000550; GO:000526; GO:004280; GO:000828; GO:001989; GO:003802; GO:004487
XP_020933039.1;XP_013840604.1;XP_005672829.1;XP_020933038.1	XP_020933039.1;XP_013840604.1;XP_005672829.1;XP_020933038.1	XP_020933039.1 heat shock 70 kDa protein 12B isoform X2 [Sus scrofa];XP_013840604.1 heat shock 70 kDa protein 12B isoform X2 [Sus scrofa];XP_005672829.1 heat shock 70 kDa protein 12B isoform X2 [Sus scrofa];XP_020933038.1 heat shock 70 kDa protein 12B isof	16	14	14	63135000	66155000	74619000	79097000	68301000	79516000	74726000	67164000	77317000	62363000	88704000	75985000	95397000	78259000	67096000	72743000	89882000	82906000	NA	NA	NA	HSPA12B	HSPA12B;HSPA12B;HSPA12B;HSPA12B;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	ATP binding;protein binding	GO:000552; GO:000551
XP_005672882.2;XP_020933800.1	XP_005672882.2;XP_020933800.1	XP_005672882.2 transmembrane 9 superfamily member 4 isoform X1 [Sus scrofa];XP_020933800.1 transmembrane 9 superfamily member 4 isoform X2 [Sus scrofa]	3	3	3	0	0	10328000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TM9SF4	TM9SF4;TM9SF4;NA;NA;NA	phagocytosis;positive regulation of protein exit from endoplasmic reticulum;vacuolar proton-transporting V-type ATPase complex assembly;cell adhesion;positive regulation of protein localization to cell surface;response to hypoxia;regulation of intracellular pH;protein localization to membrane	GO:000690; GO:007086; GO:007007; GO:000715; GO:200001; GO:000166; GO:005145; GO:007265	Golgi apparatus;membrane;early endosome	GO:000579; GO:001602; GO:000576	"NA"	"NA"	protein binding	GO:000551
XP_005672919.1;NP_001137167.1	XP_005672919.1;NP_001137167.1	XP_005672919.1 acetyl-coenzyme A synthetase, cytoplasmic isoform X1 [Sus scrofa];NP_001137167.1 acetyl-coenzyme A synthetase, cytoplasmic [Sus scrofa]	16	16	16	523300000	168370000	356240000	158690000	439990000	159740000	345080000	206250000	374230000	219400000	300800000	127840000	181730000	179170000	232560000	204560000	311650000	175770000	NA	NA	NA	ACSS2	ACSS2;ACSS2;NA;NA;NA	acetate biosynthetic process;propionate biosynthetic process;acetyl-CoA biosynthetic process from acetate;ethanol oxidation;lipid biosynthetic process	GO:001941; GO:001954; GO:001942; GO:000606; GO:000861	cytoplasm;nucleoplasm;mitochondrial matrix;cytosol;intracellular membrane-bounded organelle	GO:000573; GO:000565; GO:000575; GO:000582; GO:004323	 Metabolic pathways; Carbon metabolism; Pyruvate metabolism; Propanoate metabolism; Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis	hsa0110; hsa0120; hsa0062; hsa0064; hsa0113; hsa0001	AMP binding;acetate-CoA ligase activity;ATP binding	GO:001620; GO:000398; GO:000552
XP_005673018.1	XP_005673018.1	XP_005673018.1 14-3-3 protein beta/alpha [Sus scrofa]	13	11	11	542390000	627490000	869990000	586360000	614090000	579010000	795220000	628420000	744550000	666350000	561030000	415670000	500820000	648240000	638200000	680740000	689660000	666400000	NA	NA	NA	YWHAB	YWHAB;NA;NA;NA;NA	viral process;hippo signaling;positive regulation of catalytic activity;protein heterooligomerization;negative regulation of transcription, DNA-templated;negative regulation of protein dephosphorylation;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;regulation of mRNA stability;MAPK cascade;protein targeting;negative regulation of G-protein coupled receptor protein signaling pathway;cytoplasmic sequestering of protein;membrane organization	GO:001603; GO:003532; GO:004308; GO:005129; GO:004589; GO:003530; GO:190074; GO:004348; GO:000016; GO:000660; GO:004574; GO:005122; GO:006102	perinuclear region of cytoplasm;cytosol;transcriptional repressor complex;mitochondrion;focal adhesion;melanosome;membrane;nucleus;extracellular exosome	GO:004847; GO:000582; GO:001705; GO:000573; GO:000592; GO:004247; GO:001602; GO:000563; GO:007006	 Cell cycle; Hepatitis B; Oocyte meiosis; Hippo signaling pathway; PI3K-Akt signaling pathway; Viral carcinogenesis	hsa0411; hsa0516; hsa0411; hsa0439; hsa0415; hsa0520	protein domain specific binding;macromolecular complex binding;protein binding;enzyme binding;phosphoserine binding;histone deacetylase binding;protein C-terminus binding;identical protein binding;cadherin binding;phosphoprotein binding	GO:001990; GO:004487; GO:000551; GO:001989; GO:005081; GO:004282; GO:000802; GO:004280; GO:004529; GO:005121
XP_005673164.2	XP_005673164.2	XP_005673164.2 LOW QUALITY PROTEIN: prolactin-inducible protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PIP	PIP;NA;NA;NA;NA	proteolysis;retina homeostasis;detection of chemical stimulus involved in sensory perception of bitter taste;positive regulation of gene expression;negative regulation of T cell apoptotic process;transmembrane transport	GO:000650; GO:000189; GO:000158; GO:001062; GO:007023; GO:005508	extracellular space;extracellular region;nucleus;extracellular exosome	GO:000561; GO:000557; GO:000563; GO:007006	"NA"	"NA"	aspartic-type endopeptidase activity;IgG binding;protein dimerization activity;protein binding;actin binding	GO:000419; GO:001986; GO:004698; GO:000551; GO:000377
XP_020934641.1;XP_020934637.1;XP_005673365.1;XP_020934643.1;XP_020934642.1;XP_020934640.1;XP_020934639.1;XP_020934638.1	XP_020934641.1;XP_020934637.1;XP_005673365.1;XP_020934643.1;XP_020934642.1;XP_020934640.1;XP_020934639.1;XP_020934638.1	XP_020934641.1 heterogeneous nuclear ribonucleoproteins A2/B1 isoform X3 [Sus scrofa];XP_020934637.1 heterogeneous nuclear ribonucleoproteins A2/B1 isoform X1 [Sus scrofa];XP_005673365.1 heterogeneous nuclear ribonucleoproteins A2/B1 isoform X1 [Sus scrofa	17	17	17	619100000	726840000	666650000	635950000	625880000	772730000	677220000	680090000	592140000	700180000	706460000	656840000	848970000	723290000	711170000	693230000	780450000	731960000	NA	NA	NA	HNRNPA2B1	HNRNPA2B1;HNRNPA2B1;HNRNPA2B1;HNRNPA2B1;HNRNPA2B1	negative regulation of mRNA splicing, via spliceosome;positive regulation of telomerase RNA reverse transcriptase activity;RNA metabolic process;RNA transport;miRNA transport;negative regulation of transcription from RNA polymerase II promoter;interleukin-12-mediated signaling pathway;primary miRNA processing;G-quadruplex DNA unwinding;positive regulation of telomere maintenance via telomere lengthening;mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA processing	GO:004802; GO:190566; GO:001607; GO:005065; GO:199042; GO:000012; GO:003572; GO:003105; GO:004480; GO:190435; GO:000039; GO:000640; GO:000639	chromosome, telomeric region;cytoplasm;nucleus;Cajal body;extracellular exosome;ribonucleoprotein complex;nucleoplasm;spliceosomal complex;membrane;nuclear matrix;catalytic step 2 spliceosome	GO:000078; GO:000573; GO:000563; GO:001503; GO:007006; GO:199090; GO:000565; GO:000568; GO:001602; GO:001636; GO:007101	"NA"	"NA"	mRNA 3'-UTR binding;miRNA binding;protein binding;single-stranded telomeric DNA binding;G-rich strand telomeric DNA binding;N6-methyladenosine-containing RNA binding;pre-mRNA intronic binding;RNA binding	GO:000373; GO:003519; GO:000551; GO:004304; GO:009850; GO:199024; GO:009715; GO:000372
XP_005673383.1;XP_005673382.1	XP_005673383.1;XP_005673382.1	XP_005673383.1 drebrin-like protein isoform X2 [Sus scrofa];XP_005673382.1 drebrin-like protein isoform X1 [Sus scrofa]	4	4	4	0	44138000	26497000	24358000	0	30592000	27336000	0	0	22431000	23161000	26624000	35530000	0	0	25995000	0	0	NA	NA	NA	DBNL	DBNL;DBNL;NA;NA;NA	neuron projection morphogenesis;activation of JUN kinase activity;ruffle assembly;receptor-mediated endocytosis;neutrophil degranulation;adaptive immune response;podosome assembly;Rac protein signal transduction;synapse assembly	GO:004881; GO:000725; GO:009717; GO:000689; GO:004331; GO:000225; GO:007180; GO:001660; GO:000741	ruffle;podosome;cell junction;cytosol;cytoplasm;clathrin-coated vesicle membrane;extracellular exosome;extracellular region;secretory granule lumen;Golgi membrane;lamellipodium;plasma membrane;early endosome;tertiary granule lumen;cell cortex;dendrite;postsynaptic density;ficolin-1-rich granule lumen	GO:000172; GO:000210; GO:003005; GO:000582; GO:000573; GO:003066; GO:007006; GO:000557; GO:003477; GO:000013; GO:003002; GO:000588; GO:000576; GO:190472; GO:000593; GO:003042; GO:001406; GO:190481	"NA"	"NA"	protein C-terminus binding;protein domain specific binding;actin filament binding;cadherin binding;actin binding;enzyme activator activity;protein binding	GO:000802; GO:001990; GO:005101; GO:004529; GO:000377; GO:000804; GO:000551
XP_020935795.1;XP_020935794.1;XP_020935793.1;XP_005673506.1	XP_020935795.1;XP_020935794.1;XP_020935793.1;XP_005673506.1	XP_020935795.1 cytoplasmic tyrosine-protein kinase BMX isoform X4 [Sus scrofa];XP_020935794.1 cytoplasmic tyrosine-protein kinase BMX isoform X3 [Sus scrofa];XP_020935793.1 cytoplasmic tyrosine-protein kinase BMX isoform X2 [Sus scrofa];XP_005673506.1 cyto	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	95354000	NA	NA	NA	BMX	BMX;BMX;BMX;BMX;NA	apoptotic process;intracellular signal transduction;protein autophosphorylation;peptidyl-tyrosine autophosphorylation;cell adhesion;phosphatidylinositol biosynthetic process;B cell receptor signaling pathway;mesoderm development;adaptive immune response;signal transduction;protein phosphorylation	GO:000691; GO:003555; GO:004677; GO:003808; GO:000715; GO:000666; GO:005085; GO:000749; GO:000225; GO:000716; GO:000646	ruffle membrane;plasma membrane;cytosol;nucleoplasm	GO:003258; GO:000588; GO:000582; GO:000565	"NA"	"NA"	protein tyrosine kinase activity;ATP binding;protein binding;metal ion binding;non-membrane spanning protein tyrosine kinase activity	GO:000471; GO:000552; GO:000551; GO:004687; GO:000471
XP_020935797.1;XP_005673507.1;XP_020935803.1;XP_003360283.2;XP_020935802.1;XP_020935801.1;XP_020935800.1	XP_020935797.1;XP_005673507.1	XP_020935797.1 carbonic anhydrase 5B, mitochondrial [Sus scrofa];XP_005673507.1 carbonic anhydrase 5B, mitochondrial [Sus scrofa]	5	5	5	84302000	41773000	64171000	34069000	64671000	0	73738000	47692000	51466000	50987000	42583000	0	0	30563000	62918000	75240000	54977000	32427000	NA	NA	NA	CA5B	CA5B;CA5B;NA;NA;NA	bicarbonate transport;response to bacterium	GO:001570; GO:000961	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Nitrogen metabolism	hsa0091	carbonate dehydratase activity;zinc ion binding	GO:000408; GO:000827
XP_005673540.1;XP_020935921.1;XP_020935920.1;XP_020935919.1;XP_020935918.1;XP_020935917.1;XP_020935916.1;XP_013841437.1;XP_020935915.1;XP_013841436.1;XP_020935914.1;XP_020935913.1;XP_013841435.1;XP_005673539.1	XP_005673540.1;XP_020935921.1;XP_020935920.1;XP_020935919.1;XP_020935918.1;XP_020935917.1;XP_020935916.1;XP_013841437.1;XP_020935915.1;XP_013841436.1;XP_020935914.1;XP_020935913.1;XP_013841435.1;XP_005673539.1	XP_005673540.1 SH3 domain-containing kinase-binding protein 1 isoform X14 [Sus scrofa];XP_020935921.1 SH3 domain-containing kinase-binding protein 1 isoform X13 [Sus scrofa];XP_020935920.1 SH3 domain-containing kinase-binding protein 1 isoform X12 [Sus scr	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1468200	NA	NA	NA	SH3KBP1	SH3KBP1;SH3KBP1;SH3KBP1;SH3KBP1;SH3KBP1	cytoskeleton organization;endocytosis;apoptotic process;cell-cell signaling;membrane organization;axon guidance;regulation of cell shape;cell migration;negative regulation of epidermal growth factor receptor signaling pathway	GO:000701; GO:000689; GO:000691; GO:000726; GO:006102; GO:000741; GO:000836; GO:001647; GO:004205	neuron projection;cytoplasmic vesicle membrane;endocytic vesicle;plasma membrane;synapse;cytosol;cytoplasm;cytoskeleton;cell-cell junction;focal adhesion	GO:004300; GO:003065; GO:003013; GO:000588; GO:004520; GO:000582; GO:000573; GO:000585; GO:000591; GO:000592	 Endocytosis	hsa0414	protein binding;SH3 domain binding	GO:000551; GO:001712
XP_005673555.2;XP_013841465.1;XP_020936491.1;XP_013841464.2	XP_005673555.2;XP_013841465.1;XP_020936491.1;XP_013841464.2	XP_005673555.2 acyl-coenzyme A thioesterase 9, mitochondrial isoform X3 [Sus scrofa];XP_013841465.1 acyl-coenzyme A thioesterase 9, mitochondrial isoform X2 [Sus scrofa];XP_020936491.1 acyl-coenzyme A thioesterase 9, mitochondrial isoform X1 [Sus scrofa];X	8	8	8	21722000	26853000	24320000	22960000	0	25530000	0	23121000	18729000	21143000	19023000	25007000	22905000	24727000	20169000	20219000	21932000	24539000	NA	NA	NA	ACOT9	ACOT9;ACOT9;ACOT9;ACOT9;NA	acyl-CoA metabolic process	GO:000663	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	acetyl-CoA hydrolase activity;acyl-CoA hydrolase activity;carboxylic ester hydrolase activity	GO:000398; GO:004761; GO:005268
XP_020935191.1;XP_005673626.1	XP_020935191.1;XP_005673626.1	XP_020935191.1 amine oxidase [flavin-containing] A isoform X1 [Sus scrofa];XP_005673626.1 amine oxidase [flavin-containing] A isoform X1 [Sus scrofa]	8	1	1	61840000	74759000	137500000	53210000	78182000	67951000	103670000	50696000	90030000	60134000	77365000	48155000	62483000	64904000	78375000	83275000	148890000	55189000	NA	NA	NA	MAOA	MAOA;MAOA;NA;NA;NA	cytokine-mediated signaling pathway;dopamine catabolic process;cellular biogenic amine metabolic process;neurotransmitter catabolic process;oxidation-reduction process	GO:001922; GO:004242; GO:000657; GO:004213; GO:005511	integral component of membrane;mitochondrion;mitochondrial outer membrane	GO:001602; GO:000573; GO:000574	 Dopaminergic synapse; Amphetamine addiction; Serotonergic synapse; Glycine, serine and threonine metabolism; Tyrosine metabolism; Arginine and proline metabolism; Tryptophan metabolism; Metabolic pathways; Phenylalanine metabolism; Drug metabolism - cytochrome P450; Histidine metabolism	hsa0472; hsa0503; hsa0472; hsa0026; hsa0035; hsa0033; hsa0038; hsa0110; hsa0036; hsa0098; hsa0034	primary amine oxidase activity	GO:000813
XP_013841614.1;XP_020935845.1;XP_013841613.1;XP_020935844.1;XP_020935843.1;XP_013841612.1;XP_020935841.1;XP_020935840.1;XP_020935839.1;XP_005673709.1;XP_013841611.1;XP_013841610.1;XP_013841609.1;XP_013841608.1;XP_013841607.1;XP_013841606.1	XP_013841614.1;XP_020935845.1;XP_013841613.1;XP_020935844.1;XP_020935843.1;XP_013841612.1;XP_020935841.1;XP_020935840.1;XP_020935839.1;XP_005673709.1;XP_013841611.1;XP_013841610.1;XP_013841609.1;XP_013841608.1;XP_013841607.1;XP_013841606.1	XP_013841614.1 E3 ubiquitin-protein ligase HUWE1 isoform X11 [Sus scrofa];XP_020935845.1 E3 ubiquitin-protein ligase HUWE1 isoform X10 [Sus scrofa];XP_013841613.1 E3 ubiquitin-protein ligase HUWE1 isoform X9 [Sus scrofa];XP_020935844.1 E3 ubiquitin-protein	10	10	10	8165800	0	6137700	0	0	0	0	5051100	0	5611100	8752400	0	0	0	0	0	0	7216000	NA	NA	NA	HUWE1	HUWE1;HUWE1;HUWE1;HUWE1;HUWE1	protein ubiquitination;base-excision repair;cell differentiation;positive regulation of protein targeting to mitochondrion;histone ubiquitination;neutrophil degranulation;ubiquitin-dependent protein catabolic process;protein polyubiquitination	GO:001656; GO:000628; GO:003015; GO:190395; GO:001657; GO:004331; GO:000651; GO:000020	ficolin-1-rich granule lumen;nucleus;cytoplasm;extracellular exosome;nucleoplasm;secretory granule lumen;cytosol;extracellular region;membrane	GO:190481; GO:000563; GO:000573; GO:007006; GO:000565; GO:003477; GO:000582; GO:000557; GO:001602	 Ubiquitin mediated proteolysis	hsa0412	DNA binding;RNA binding;ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase activity	GO:000367; GO:000372; GO:000484; GO:000551; GO:006163
XP_005674521.2	XP_005674521.2	XP_005674521.2 MICOS complex subunit MIC26 [Sus scrofa]	2	2	2	0	0	28133000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	APOO	APOO;NA;NA;NA;NA	lipid transport;cristae formation	GO:000686; GO:004240	extracellular space;low-density lipoprotein particle;mitochondrion;endoplasmic reticulum membrane;integral component of mitochondrial inner membrane;extracellular region;MICOS complex;Golgi membrane;cytosol	GO:000561; GO:003436; GO:000573; GO:000578; GO:003130; GO:000557; GO:006161; GO:000013; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_005674537.3	XP_005674537.3	XP_005674537.3 beta-actin-like protein 2 [Sus scrofa]	9	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5365600000	0	0	NA	NA	NA	ACTBL2	ACTBL2;NA;NA;NA;NA	biological_process	GO:000815	cytoskeleton;cytoplasm;extracellular exosome;glutamatergic synapse;extracellular space	GO:000585; GO:000573; GO:007006; GO:009897; GO:000561	"NA"	"NA"	protein binding;ATP binding;molecular_function	GO:000551; GO:000552; GO:000367
XP_020954096.1;XP_013833010.1	XP_020954096.1;XP_013833010.1	XP_020954096.1 MHC class I antigen 1 isoform X1 [Sus scrofa];XP_013833010.1 MHC class I antigen 1 isoform X2 [Sus scrofa]	7	1	1	0	0	5011800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	SLA-1	SLA-1;SLA-1;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013833699.1;XP_013833700.1	XP_013833699.1;XP_013833700.1	XP_013833699.1 ras-related protein Rab-2B isoform X1 [Sus scrofa];XP_013833700.1 ras-related protein Rab-2B isoform X2 [Sus scrofa]	10	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17101000	0	0	NA	NA	NA	RAB2B	RAB2B;RAB2B;NA;NA;NA	intracellular protein transport;Rab protein signal transduction;positive regulation of exocytosis;vesicle-mediated transport	GO:000688; GO:003248; GO:004592; GO:001619	endoplasmic reticulum membrane;Golgi membrane;plasma membrane;extracellular exosome;presynapse	GO:000578; GO:000013; GO:000588; GO:007006; GO:009879	"NA"	"NA"	protein binding;GTP binding;GTPase activity	GO:000551; GO:000552; GO:000392
XP_020955035.1;XP_013833746.2;XP_013833745.2;XP_013833744.2	XP_020955035.1;XP_013833746.2;XP_013833745.2;XP_013833744.2	XP_020955035.1 spectrin beta chain, erythrocytic [Sus scrofa];XP_013833746.2 spectrin beta chain, erythrocytic [Sus scrofa];XP_013833745.2 spectrin beta chain, erythrocytic [Sus scrofa];XP_013833744.2 spectrin beta chain, erythrocytic [Sus scrofa]	27	24	24	145920000	17781000	0	33770000	33520000	0	18734000	33709000	63532000	30968000	53422000	5869700	164860000	21488000	42667000	0	45683000	0	NA	NA	NA	SPTB	SPTB;SPTB;SPTB;SPTB;NA	actin filament capping;MAPK cascade;axon guidance;cytoskeleton organization;ER to Golgi vesicle-mediated transport	GO:005169; GO:000016; GO:000741; GO:000701; GO:000688	cytosol;actin cytoskeleton;spectrin;spectrin-associated cytoskeleton;Golgi apparatus;intrinsic component of the cytoplasmic side of the plasma membrane;macromolecular complex	GO:000582; GO:001562; GO:000809; GO:001473; GO:000579; GO:003123; GO:003299	"NA"	"NA"	actin binding;actin filament binding;Ras guanyl-nucleotide exchange factor activity;ankyrin binding;protein binding;structural constituent of cytoskeleton	GO:000377; GO:005101; GO:000508; GO:003050; GO:000551; GO:000520
XP_013833854.1	XP_013833854.1	XP_013833854.1 serpin A3-8 [Sus scrofa]	22	22	9	5334000000	7103800000	4933600000	8198400000	12262000000	18217000000	7247500000	6438900000	5550500000	4716000000	9389600000	6509800000	7734600000	8445700000	7657900000	6965700000	8649600000	11539000000	NA	NA	NA	LOC396685	LOC396685;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013833856.2	XP_013833856.2	XP_013833856.2 LOW QUALITY PROTEIN: serpin A3-5 [Sus scrofa]	22	21	11	1402600000	1554400000	1344400000	2323600000	5755300000	6846400000	825340000	726810000	1619100000	1431500000	2125300000	2134400000	1740200000	1772300000	880890000	781630000	1055400000	1525400000	NA	NA	NA	LOC396684	LOC396684;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013833946.2	XP_013833946.2	XP_013833946.2 LOW QUALITY PROTEIN: alpha-adducin [Sus scrofa]	15	15	15	107730000	206260000	139300000	200350000	107050000	198910000	147340000	207490000	119710000	182170000	161710000	244470000	172490000	211150000	177220000	196600000	152280000	222490000	NA	NA	NA	ADD1	ADD1;NA;NA;NA;NA	barbed-end actin filament capping;cell morphogenesis;cellular response to calcium ion;hemoglobin metabolic process;IRE1-mediated unfolded protein response;positive regulation of adherens junction organization;actin filament bundle assembly;cell volume homeostasis;erythrocyte differentiation;homeostasis of number of cells within a tissue;positive regulation of establishment of endothelial barrier;actin cytoskeleton organization;positive regulation of protein binding;in utero embryonic development;multicellular organism growth;transmembrane transport	GO:005101; GO:000090; GO:007127; GO:002002; GO:003649; GO:190339; GO:005101; GO:000688; GO:003021; GO:004887; GO:190314; GO:003003; GO:003209; GO:000170; GO:003526; GO:005508	F-actin capping protein complex;nucleus;nucleoplasm;nuclear body;plasma membrane raft;cell-cell adherens junction;cytoplasm;focal adhesion;plasma membrane;cytosol;cytoskeleton;postsynaptic density	GO:000829; GO:000563; GO:000565; GO:001660; GO:004485; GO:000591; GO:000573; GO:000592; GO:000588; GO:000582; GO:000585; GO:001406	"NA"	"NA"	actin binding;RNA binding;transcription factor binding;protein heterodimerization activity;structural molecule activity;protein homodimerization activity;actin filament binding;calmodulin binding;cadherin binding;spectrin binding	GO:000377; GO:000372; GO:000813; GO:004698; GO:000519; GO:004280; GO:005101; GO:000551; GO:004529; GO:003050
XP_013834226.1	XP_013834226.1	XP_013834226.1 platelet factor 4 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17988000	0	NA	NA	NA	LOC100520680	LOC100520680;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020957293.1;XP_020957292.1;XP_020957290.1;XP_020957289.1;XP_020957288.1;XP_013834374.2;XP_020957287.1;XP_020957286.1;XP_020957285.1;XP_020957284.1;XP_020957283.1;XP_020957282.1;XP_020957280.1;XP_020957279.1;XP_020957278.1;XP_020957277.1	XP_020957293.1;XP_020957292.1;XP_020957290.1;XP_020957289.1;XP_020957288.1;XP_013834374.2;XP_020957287.1;XP_020957286.1;XP_020957285.1;XP_020957284.1;XP_020957283.1;XP_020957282.1;XP_020957280.1;XP_020957279.1;XP_020957278.1;XP_020957277.1	XP_020957293.1 uncharacterized protein KIAA1109 homolog isoform X15 [Sus scrofa];XP_020957292.1 uncharacterized protein KIAA1109 homolog isoform X14 [Sus scrofa];XP_020957290.1 uncharacterized protein KIAA1109 homolog isoform X13 [Sus scrofa];XP_020957289.	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13760000	NA	NA	NA	KIAA1109	KIAA1109;KIAA1109;KIAA1109;KIAA1109;KIAA1109	synaptic vesicle endocytosis;regulation of epithelial cell differentiation;regulation of cell growth	GO:004848; GO:003085; GO:000155	presynapse;membrane;nucleus	GO:009879; GO:001602; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_013834405.2	XP_013834405.2	XP_013834405.2 uncharacterized protein C4orf32 homolog [Sus scrofa]	2	2	2	0	32028000	37291000	0	0	0	0	0	28510000	0	0	0	0	0	48944000	0	36918000	0	NA	NA	NA	FAM241A	FAM241A;NA;NA;NA;NA	"NA"	"NA"	Golgi apparatus;integral component of membrane;intracellular membrane-bounded organelle	GO:000579; GO:001602; GO:004323	"NA"	"NA"	"NA"	"NA"
XP_020917907.1;XP_013834519.2;XP_005664066.1;XP_003126448.2	XP_020917907.1;XP_013834519.2	XP_020917907.1 importin-7 isoform X2 [Sus scrofa];XP_013834519.2 importin-7 isoform X1 [Sus scrofa]	8	8	8	52675000	49803000	46271000	35491000	40857000	35492000	47532000	37374000	44287000	38824000	45576000	34901000	38215000	34463000	41885000	41651000	36819000	41321000	NA	NA	NA	IPO7	IPO7;IPO7;NA;NA;NA	innate immune response;signal transduction;viral process;protein import into nucleus;negative regulation of cyclin-dependent protein serine/threonine kinase activity	GO:004508; GO:000716; GO:001603; GO:000660; GO:004573	membrane;nucleoplasm;nuclear envelope;nuclear pore;cytosol	GO:001602; GO:000565; GO:000563; GO:000564; GO:000582	"NA"	"NA"	histone binding;SMAD binding;Ran GTPase binding;transporter activity;protein transporter activity;GTPase regulator activity;protein binding	GO:004239; GO:004633; GO:000853; GO:000521; GO:000856; GO:003069; GO:000551
XP_020918233.1;XP_020918232.1;XP_020918231.1;XP_020918230.1;XP_013834644.1;XP_013834643.1	XP_020918233.1;XP_020918232.1;XP_020918231.1;XP_020918230.1;XP_013834644.1;XP_013834643.1	XP_020918233.1 lysosomal Pro-X carboxypeptidase [Sus scrofa];XP_020918232.1 lysosomal Pro-X carboxypeptidase [Sus scrofa];XP_020918231.1 lysosomal Pro-X carboxypeptidase [Sus scrofa];XP_020918230.1 lysosomal Pro-X carboxypeptidase [Sus scrofa];XP_013834644	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2213600	0	NA	NA	NA	PRCP	PRCP;PRCP;PRCP;PRCP;PRCP	regulation of blood vessel endothelial cell migration;regulation of thyroid hormone mediated signaling pathway;plasma kallikrein-kinin cascade;negative regulation of systemic arterial blood pressure;neutrophil degranulation;angiogenesis involved in wound healing;regulation of reactive oxygen species metabolic process;energy homeostasis;glucose homeostasis;proteolysis;blood coagulation, intrinsic pathway	GO:004353; GO:000215; GO:000235; GO:000308; GO:004331; GO:006005; GO:200037; GO:009700; GO:004259; GO:000650; GO:000759	extracellular exosome;ficolin-1-rich granule membrane;azurophil granule membrane;basal part of cell;plasma membrane	GO:007006; GO:010100; GO:003557; GO:004517; GO:000588	 Protein digestion and absorption; Renin-angiotensin system	hsa0497; hsa0461	dipeptidyl-peptidase activity;protein binding;serine-type carboxypeptidase activity	GO:000823; GO:000551; GO:000418
XP_013834712.2;XP_020918288.1;NP_999549.1	XP_013834712.2;XP_020918288.1	XP_013834712.2 N-acetylated-alpha-linked acidic dipeptidase 2 isoform X1 [Sus scrofa];XP_020918288.1 N-acetylated-alpha-linked acidic dipeptidase 2 isoform X2 [Sus scrofa]	16	16	16	23797000	32558000	43061000	44400000	9141100	26959000	25514000	71963000	24259000	41265000	27771000	37437000	29265000	30417000	14963000	27585000	27170000	33444000	NA	NA	NA	NAALAD2	NAALAD2;NAALAD2;NA;NA;NA	proteolysis;neurotransmitter catabolic process;cellular amino acid biosynthetic process	GO:000650; GO:004213; GO:000865	integral component of membrane;plasma membrane	GO:001602; GO:000588	"NA"	"NA"	carboxypeptidase activity;dipeptidyl-peptidase activity;metal ion binding;dipeptidase activity;N-formylglutamate deformylase activity	GO:000418; GO:000823; GO:004687; GO:001680; GO:005012
XP_013834996.1;NP_001230781.1	XP_013834996.1;NP_001230781.1	XP_013834996.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X1 [Sus scrofa];NP_001230781.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A [Sus scrofa]	8	8	8	34765000	42768000	38711000	0	36978000	39330000	39351000	41821000	41224000	36519000	43731000	0	46008000	51603000	39400000	0	51339000	45387000	NA	NA	NA	STT3A	STT3A;STT3A;NA;NA;NA	protein N-linked glycosylation via asparagine;co-translational protein modification	GO:001827; GO:004368	oligosaccharyltransferase complex;endoplasmic reticulum membrane;oligosaccharyltransferase III complex;integral component of membrane	GO:000825; GO:000578; GO:003500; GO:001602	 Protein processing in endoplasmic reticulum; N-Glycan biosynthesis; Metabolic pathways	hsa0414; hsa0051; hsa0110	protein binding;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;metal ion binding	GO:000551; GO:000457; GO:004687
XP_013835161.1	XP_013835161.1	XP_013835161.1 serum paraoxonase/arylesterase 2 isoform X1 [Sus scrofa]	8	8	2	161900000	191540000	155060000	192380000	210460000	123650000	148310000	182120000	152450000	159850000	178940000	233520000	68011000	131590000	138370000	158700000	117820000	161310000	NA	NA	NA	PON2	PON2;NA;NA;NA;NA	response to oxidative stress;response to toxic substance;lipoxygenase pathway;aromatic compound catabolic process	GO:000697; GO:000963; GO:001937; GO:001943	plasma membrane;extracellular region;nucleus;lysosome;mitochondrion	GO:000588; GO:000557; GO:000563; GO:000576; GO:000573	 Metabolic pathways	hsa0110	acyl-L-homoserine-lactone lactonohydrolase activity;arylesterase activity;identical protein binding;metal ion binding	GO:010200; GO:000406; GO:004280; GO:004687
XP_013836273.2;XP_020923774.1;XP_020923760.1;XP_020923759.1;XP_020923758.1;XP_020923757.1;XP_020923747.1;XP_020923755.1;XP_020923753.1;XP_020923756.1;XP_020923754.1;XP_020923746.1;XP_020923745.1;XP_020923744.1;XP_020923743.1;XP_020923752.1;XP_020923751.1;XP_020923742.1;XP_020923741.1;XP_020923740.1;XP_020923739.1;XP_020923750.1;XP_020923749.1;XP_020923748.1	XP_013836273.2;XP_020923774.1	XP_013836273.2 ATP-binding cassette sub-family A member 9 isoform X1 [Sus scrofa];XP_020923774.1 ATP-binding cassette sub-family A member 9 isoform X2 [Sus scrofa]	5	5	5	0	21442000	10198000	15640000	0	12236000	14270000	15524000	11473000	14824000	12664000	18733000	20290000	14069000	12852000	18114000	15107000	17007000	NA	NA	NA	LOC100520216	LOC100520216;LOC100520216;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013836417.1	XP_013836417.1	XP_013836417.1 hematopoietic lineage cell-specific protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7511500	0	0	0	NA	NA	NA	HCLS1	HCLS1;NA;NA;NA;NA	positive regulation of cell proliferation;regulation of actin filament polymerization;positive regulation of sequence-specific DNA binding transcription factor activity;negative regulation of transcription from RNA polymerase II promoter;intracellular signal transduction;regulation of transcription, DNA-templated;negative regulation of leukocyte apoptotic process;actin filament polymerization;positive regulation of transcription from RNA polymerase II promoter;positive regulation of peptidyl-serine phosphorylation;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of protein kinase B signaling;response to hormone;positive regulation of phosphatidylinositol 3-kinase signaling;erythrocyte differentiation;positive regulation of granulocyte differentiation;positive regulation of protein import into nucleus;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of macrophage differentiation;cellular response to cytokine stimulus;positive regulation of actin cytoskeleton reorganization	GO:000828; GO:003083; GO:005109; GO:000012; GO:003555; GO:000635; GO:200010; GO:003004; GO:004594; GO:003313; GO:004253; GO:005189; GO:000972; GO:001406; GO:003021; GO:003085; GO:004230; GO:005073; GO:004565; GO:007134; GO:200025	cytoplasm;transcription factor complex;plasma membrane;mitochondrion;nucleus;cytosol	GO:000573; GO:000566; GO:000588; GO:000573; GO:000563; GO:000582	 Bacterial invasion of epithelial cells; Tight junction; Proteoglycans in cancer; Pathogenic Escherichia coli infection	hsa0510; hsa0453; hsa0520; hsa0513	protein kinase binding;actin binding;RNA polymerase II transcription factor binding;protein binding;SH3 domain binding;macromolecular complex binding	GO:001990; GO:000377; GO:000108; GO:000551; GO:001712; GO:004487
XP_020923353.1;XP_013836683.2	XP_020923353.1;XP_013836683.2	XP_020923353.1 rabankyrin-5 isoform X2 [Sus scrofa];XP_013836683.2 rabankyrin-5 isoform X1 [Sus scrofa]	8	8	8	0	12890000	13346000	15948000	0	16739000	16370000	15161000	14365000	0	0	0	16560000	0	17811000	14493000	14450000	16191000	NA	NA	NA	ANKFY1	ANKFY1;ANKFY1;NA;NA;NA	endosomal transport;retrograde transport, endosome to Golgi;positive regulation of pinocytosis;endosomal vesicle fusion;endocytosis;Golgi to lysosome transport	GO:001619; GO:004214; GO:004854; GO:003405; GO:000689; GO:009016	membrane;endosome;macropinosome;cytosol;retromer complex;endosome membrane;extracellular exosome;intracellular membrane-bounded organelle	GO:001602; GO:000576; GO:004435; GO:000582; GO:003090; GO:001000; GO:007006; GO:004323	"NA"	"NA"	Rab GTPase binding;metal ion binding;phosphatidylinositol phosphate binding;protein binding	GO:001713; GO:004687; GO:190198; GO:000551
XP_013836740.2;NP_999096.1	XP_013836740.2;NP_999096.1	XP_013836740.2 arachidonate 15-lipoxygenase isoform X1 [Sus scrofa];NP_999096.1 arachidonate 15-lipoxygenase [Sus scrofa]	26	26	26	114440000	0	88167000	0	347870000	0	1628900000	0	385600000	0	813860000	0	1933800000	0	661210000	0	2217600000	0	NA	NA	NA	ALOX15	ALOX15;ALOX15;NA;NA;NA	positive regulation of cell-substrate adhesion;regulation of peroxisome proliferator activated receptor signaling pathway;wound healing;ossification;leukotriene metabolic process;inflammatory response;long-chain fatty acid biosynthetic process;apoptotic cell clearance;regulation of engulfment of apoptotic cell;arachidonic acid metabolic process;positive regulation of actin filament polymerization;cellular response to calcium ion;negative regulation of adaptive immune response;cytokine-mediated signaling pathway;lipoxygenase pathway;positive regulation of heterotypic cell-cell adhesion;oxidation-reduction process;phosphatidylethanolamine biosynthetic process;hepoxilin biosynthetic process;positive regulation of ERK1 and ERK2 cascade;lipoxin A4 biosynthetic process;response to endoplasmic reticulum stress;bone mineralization;cellular response to interleukin-13	GO:001081; GO:003535; GO:004206; GO:000150; GO:000669; GO:000695; GO:004275; GO:004327; GO:190107; GO:001936; GO:003083; GO:007127; GO:000282; GO:001922; GO:001937; GO:003411; GO:005511; GO:000664; GO:005112; GO:007037; GO:200130; GO:003497; GO:003028; GO:003596	membrane;cytosol;extrinsic component of cytoplasmic side of plasma membrane;plasma membrane;lipid particle	GO:001602; GO:000582; GO:003123; GO:000588; GO:000581	 Metabolic pathways; Linoleic acid metabolism; Serotonergic synapse	hsa0110; hsa0059; hsa0472	iron ion binding;arachidonate 12-lipoxygenase activity;arachidonate 15-lipoxygenase activity;protein binding;phosphatidylinositol-4,5-bisphosphate binding;hepoxilin A3 synthase activity;eoxin A4 synthase activity;hepoxilin-epoxide hydrolase activity	GO:000550; GO:000405; GO:005047; GO:000551; GO:000554; GO:005112; GO:009726; GO:004797
XP_013836784.2;XP_020933208.1;XP_013840743.1;XP_020933207.1;XP_013840742.1;XP_013840741.1;XP_013840744.1	XP_013836784.2	XP_013836784.2 LOW QUALITY PROTEIN: myosin-3 [Sus scrofa]	33	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	380860000	0	NA	NA	NA	MYH3	MYH3;NA;NA;NA;NA	actin filament-based movement;ATP metabolic process;muscle filament sliding;embryonic limb morphogenesis;protein dephosphorylation;face morphogenesis;skeletal muscle contraction;sarcomere organization;muscle organ development	GO:003004; GO:004603; GO:003004; GO:003032; GO:000647; GO:006032; GO:000300; GO:004521; GO:000751	cytosol;muscle myosin complex;sarcomere;extracellular exosome;myosin filament	GO:000582; GO:000585; GO:003001; GO:007006; GO:003298	 Tight junction	hsa0453	ATPase activity, coupled;ATP binding;microfilament motor activity;calmodulin binding;myosin phosphatase activity;actin filament binding	GO:004262; GO:000552; GO:000014; GO:000551; GO:001701; GO:005101
XP_013836876.2;XP_020927097.1;XP_020927096.1	XP_013836876.2;XP_020927097.1	XP_013836876.2 peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase isoform X1 [Sus scrofa];XP_020927097.1 peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase isoform X3 [Sus scrofa]	3	3	3	0	0	3529100	0	0	0	0	3523800	0	0	0	0	0	0	0	9232600	0	0	NA	NA	NA	NGLY1	NGLY1;NGLY1;NA;NA;NA	protein deglycosylation;misfolded or incompletely synthesized protein catabolic process;protein folding	GO:000651; GO:000651; GO:000645	cytoplasm;cytosol;nucleus	GO:000573; GO:000582; GO:000563	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;metal ion binding;peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity	GO:000551; GO:004687; GO:000022
XP_020927378.1;XP_020927377.1;XP_020927376.1;XP_013836985.2;XP_020927379.1;XP_013836984.2	XP_020927378.1;XP_020927377.1;XP_020927376.1;XP_013836985.2;XP_020927379.1;XP_013836984.2	XP_020927378.1 anoctamin-10 isoform X1 [Sus scrofa];XP_020927377.1 anoctamin-10 isoform X1 [Sus scrofa];XP_020927376.1 anoctamin-10 isoform X1 [Sus scrofa];XP_013836985.2 anoctamin-10 isoform X1 [Sus scrofa];XP_020927379.1 anoctamin-10 isoform X3 [Sus scro	6	6	6	0	19223000	17741000	18680000	16620000	16714000	20482000	27436000	15626000	21986000	0	0	0	17797000	13276000	20671000	13974000	18615000	NA	NA	NA	ANO10	ANO10;ANO10;ANO10;ANO10;ANO10	ion transmembrane transport;chloride transport;cation transport	GO:003422; GO:000682; GO:000681	plasma membrane;membrane	GO:000588; GO:001602	"NA"	"NA"	intracellular calcium activated chloride channel activity;calcium activated cation channel activity	GO:000522; GO:000522
XP_020924924.1;XP_020924918.1;XP_020924923.1;XP_020924922.1;XP_020924921.1;XP_020924920.1;XP_020924919.1;XP_020924917.1;XP_020924916.1;XP_020924915.1;XP_020924914.1;XP_020924901.1;XP_020924912.1;XP_020924911.1;XP_020924910.1;XP_020924909.1;XP_020924908.1;XP_020924907.1;XP_020924906.1;XP_020924905.1;XP_020924903.1;XP_020924902.1;XP_020924900.1;XP_013837357.1;XP_013837355.1	XP_020924924.1;XP_020924918.1;XP_020924923.1;XP_020924922.1;XP_020924921.1;XP_020924920.1;XP_020924919.1;XP_020924917.1;XP_020924916.1;XP_020924915.1;XP_020924914.1;XP_020924901.1;XP_020924912.1;XP_020924911.1;XP_020924910.1;XP_020924909.1;XP_020924908.1;XP_020924907.1;XP_020924906.1;XP_020924905.1;XP_020924903.1;XP_020924902.1;XP_020924900.1;XP_013837357.1;XP_013837355.1	XP_020924924.1 neural cell adhesion molecule L1-like protein isoform X4 [Sus scrofa];XP_020924918.1 neural cell adhesion molecule L1-like protein isoform X4 [Sus scrofa];XP_020924923.1 neural cell adhesion molecule L1-like protein isoform X3 [Sus scrofa];X	1	1	1	0	0	0	0	8347600	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CHL1	CHL1;CHL1;CHL1;CHL1;CHL1	cell adhesion;axon guidance;exploration behavior;cognition;neuron migration;signal transduction;adult locomotory behavior;negative regulation of neuron apoptotic process	GO:000715; GO:000741; GO:003564; GO:005089; GO:000176; GO:000716; GO:000834; GO:004352	integral component of membrane;dendrite;extracellular exosome;plasma membrane;apical part of cell	GO:001602; GO:003042; GO:007006; GO:000588; GO:004517	"NA"	"NA"	protease binding	GO:000202
XP_020925209.1;XP_013837554.1	XP_020925209.1;XP_013837554.1	XP_020925209.1 sodium/potassium-transporting ATPase subunit beta-3 isoform X2 [Sus scrofa];XP_013837554.1 sodium/potassium-transporting ATPase subunit beta-3 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	8580200	0	0	7986400	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ATP1B3	ATP1B3;ATP1B3;NA;NA;NA	protein stabilization;establishment or maintenance of transmembrane electrochemical gradient;cellular potassium ion homeostasis;leukocyte migration;cellular sodium ion homeostasis;sodium ion export from cell;positive regulation of potassium ion import;positive regulation of ATPase activity;membrane repolarization;potassium ion import across plasma membrane;protein localization to plasma membrane;positive regulation of sodium ion export from cell;positive regulation of potassium ion transmembrane transporter activity	GO:005082; GO:001024; GO:003000; GO:005090; GO:000688; GO:003637; GO:190328; GO:003278; GO:008600; GO:199057; GO:007265; GO:190327; GO:190101	plasma membrane;caveola;melanosome;sodium:potassium-exchanging ATPase complex;extracellular exosome	GO:000588; GO:000590; GO:004247; GO:000589; GO:007006	 Adrenergic signaling in cardiomyocytes; Thyroid hormone signaling pathway; Carbohydrate digestion and absorption; Endocrine and other factor-regulated calcium reabsorption; cGMP-PKG signaling pathway; Cardiac muscle contraction	hsa0426; hsa0491; hsa0497; hsa0496; hsa0402; hsa0426	sodium:potassium-exchanging ATPase activity;ATPase activator activity;ATPase binding	GO:000539; GO:000167; GO:005111
XP_013837756.2	XP_013837756.2	XP_013837756.2 carboxypeptidase N subunit 2 [Sus scrofa]	1	1	1	0	0	0	0	3193000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CPN2	CPN2;NA;NA;NA;NA	regulation of catalytic activity;protein stabilization;regulation of complement activation;proteolysis	GO:005079; GO:005082; GO:003044; GO:000650	extracellular region;blood microparticle;extracellular matrix;extracellular exosome;extracellular space	GO:000557; GO:007256; GO:003101; GO:007006; GO:000561	"NA"	"NA"	enzyme regulator activity;metallocarboxypeptidase activity	GO:003023; GO:000418
XP_013837830.2	XP_013837830.2	XP_013837830.2 very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 [Sus scrofa]	1	1	1	175710000	173480000	139430000	166820000	169690000	124790000	192910000	206840000	166570000	146450000	202400000	189580000	76743000	182400000	238870000	199200000	177380000	125510000	NA	NA	NA	HACD2	HACD2;NA;NA;NA;NA	sphingolipid biosynthetic process;fatty acid elongation;very long-chain fatty acid biosynthetic process;long-chain fatty-acyl-CoA biosynthetic process	GO:003014; GO:003049; GO:004276; GO:003533	endoplasmic reticulum membrane;endoplasmic reticulum;integral component of membrane	GO:000578; GO:000578; GO:001602	 Fatty acid elongation; Fatty acid metabolism; Biosynthesis of unsaturated fatty acids	hsa0006; hsa0121; hsa0104	protein binding;3-hydroxy-lignoceroyl-CoA dehydratase activity;3-hydroxyacyl-CoA dehydratase activity;3R-hydroxyacyl-CoA dehydratase activity;protein tyrosine phosphatase activity;enzyme binding	GO:000551; GO:010234; GO:001881; GO:008002; GO:000472; GO:001989
XP_020926624.1;XP_013838036.2	XP_020926624.1;XP_013838036.2	XP_020926624.1 biotin--protein ligase isoform X2 [Sus scrofa];XP_013838036.2 biotin--protein ligase isoform X1 [Sus scrofa]	9	9	9	44417000	29505000	41936000	20405000	23182000	0	31919000	18976000	43150000	26257000	26615000	0	0	31444000	27630000	30161000	32237000	32016000	NA	NA	NA	HLCS	HLCS;HLCS;NA;NA;NA	histone modification;biotin metabolic process;histone biotinylation;response to biotin;protein biotinylation;cell proliferation	GO:001657; GO:000676; GO:007111; GO:007078; GO:000930; GO:000828	nuclear matrix;chromatin;nuclear lamina;mitochondrion;cytosol	GO:001636; GO:000078; GO:000565; GO:000573; GO:000582	 Biotin metabolism; Metabolic pathways	hsa0078; hsa0110	biotin-[methylmalonyl-CoA-carboxytransferase;protein binding;biotin-[acetyl-CoA-carboxylase;ATP binding;protein homodimerization activity;enzyme binding;biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing);biotin binding;biotin-protein ligase activity	GO:000407; GO:000551; GO:000407; GO:000552; GO:004280; GO:001989; GO:000408; GO:000937; GO:001827
XP_013840053.1;XP_005672351.1;NP_001265679.1;XP_005672350.1;XP_013840056.1	XP_013840053.1;XP_005672351.1;NP_001265679.1;XP_005672350.1;XP_013840056.1	XP_013840053.1 UDP glucuronosyltransferase 1 family, polypeptide A6 isoform X3 [Sus scrofa];XP_005672351.1 UDP glucuronosyltransferase 1 family, polypeptide A6 isoform X2 [Sus scrofa];NP_001265679.1 UDP glucuronosyltransferase 1 family, polypeptide A6 prec	5	5	5	0	9117100	0	0	0	0	0	15317000	0	8483700	0	0	0	0	0	10998000	0	0	NA	NA	NA	UGT1A6	UGT1A6;UGT1A6;UGT1A6;UGT1A6;UGT1A6	cellular glucuronidation;xenobiotic metabolic process;flavonoid glucuronidation	GO:005269; GO:000680; GO:005269	endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;intracellular membrane-bounded organelle	GO:000578; GO:000578; GO:001602; GO:004323	 Drug metabolism - cytochrome P450; Ascorbate and aldarate metabolism; Metabolic pathways; Porphyrin and chlorophyll metabolism; Pentose and glucuronate interconversions; Metabolism of xenobiotics by cytochrome P450; Steroid hormone biosynthesis; Chemical carcinogenesis; Starch and sucrose metabolism; Retinol metabolism	hsa0098; hsa0005; hsa0110; hsa0086; hsa0004; hsa0098; hsa0014; hsa0520; hsa0050; hsa0083	protein homodimerization activity;protein heterodimerization activity;UDP-glycosyltransferase activity;retinoic acid binding;glucuronosyltransferase activity	GO:004280; GO:004698; GO:000819; GO:000197; GO:001502
XP_020932468.1;XP_013840275.2;XP_020932467.1;XP_020932466.1;XP_020932465.1;XP_020932463.1;XP_020932464.1;XP_020932462.1;XP_020932461.1;XP_020932460.1;XP_020932459.1;XP_020932458.1;XP_020932457.1;XP_020932456.1;XP_020932455.1;XP_020932454.1;XP_020932453.1;XP_020932452.1;XP_020932451.1;XP_020932450.1;XP_020932449.1;XP_020932448.1;XP_020932447.1	XP_020932468.1;XP_013840275.2;XP_020932467.1;XP_020932466.1;XP_020932465.1;XP_020932463.1;XP_020932464.1;XP_020932462.1;XP_020932461.1;XP_020932460.1;XP_020932459.1;XP_020932458.1;XP_020932457.1;XP_020932456.1;XP_020932455.1;XP_020932454.1;XP_020932453.1;XP_020932452.1;XP_020932451.1;XP_020932450.1;XP_020932449.1;XP_020932448.1;XP_020932447.1	XP_020932468.1 erbin isoform X21 [Sus scrofa];XP_013840275.2 erbin isoform X20 [Sus scrofa];XP_020932467.1 erbin isoform X19 [Sus scrofa];XP_020932466.1 erbin isoform X18 [Sus scrofa];XP_020932465.1 erbin isoform X17 [Sus scrofa];XP_020932463.1 erbin isofo	2	2	2	180670000	42364000	75812000	67717000	56240000	0	41691000	41247000	131180000	0	81674000	0	95350000	32845000	70663000	0	193340000	0	NA	NA	NA	ERBIN	ERBIN;ERBIN;ERBIN;ERBIN;ERBIN	cell adhesion;protein targeting;integrin-mediated signaling pathway;basal protein localization;regulation of postsynaptic specialization membrane neurotransmitter receptor levels;intermediate filament cytoskeleton organization;ERBB2 signaling pathway;establishment or maintenance of epithelial cell apical/basal polarity;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;cellular response to tumor necrosis factor;epidermal growth factor receptor signaling pathway;signal transduction;negative regulation of NF-kappaB transcription factor activity;response to muramyl dipeptide;negative regulation of monocyte chemotactic protein-1 production	GO:000715; GO:000660; GO:000722; GO:004517; GO:009907; GO:004510; GO:003812; GO:004519; GO:007043; GO:007135; GO:000717; GO:000716; GO:003208; GO:003249; GO:007163	postsynapse;basal plasma membrane;plasma membrane;nucleus;cytoplasm;nuclear speck;cell junction;glutamatergic synapse;basement membrane;basolateral plasma membrane;nuclear membrane	GO:009879; GO:000992; GO:000588; GO:000563; GO:000573; GO:001660; GO:003005; GO:009897; GO:000560; GO:001632; GO:003196	 NOD-like receptor signaling pathway	hsa0462	structural constituent of cytoskeleton;receptor binding;ErbB-2 class receptor binding;protein binding	GO:000520; GO:000510; GO:000517; GO:000551
XP_013841174.2	XP_013841174.2	XP_013841174.2 endonuclease/exonuclease/phosphatase family domain-containing protein 1 [Sus scrofa]	3	3	3	0	6869000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EEPD1	EEPD1;NA;NA;NA;NA	DNA repair	GO:000628	"NA"	"NA"	"NA"	"NA"	DNA binding	GO:000367
XP_013841261.2	XP_013841261.2	XP_013841261.2 transcriptional activator protein Pur-beta [Sus scrofa]	4	4	4	0	15148000	12208000	0	0	9262700	0	0	14260000	15252000	12568000	14470000	11237000	0	14264000	0	11028000	0	NA	NA	NA	PURB	PURB;NA;NA;NA;NA	cell proliferation;negative regulation of transcription from RNA polymerase II promoter;cell differentiation;regulation of myeloid cell differentiation	GO:000828; GO:000012; GO:003015; GO:004563	nucleus;DNA replication factor A complex	GO:000563; GO:000566	"NA"	"NA"	RNA polymerase II regulatory region sequence-specific DNA binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;purine-rich negative regulatory element binding;mRNA binding;transcription factor binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;SMAD binding;double-stranded DNA binding;sequence-specific DNA binding	GO:000097; GO:000122; GO:003242; GO:000372; GO:000813; GO:000098; GO:004633; GO:000369; GO:004356
XP_020936368.1;XP_020936367.1;XP_013841392.1;XP_020936366.1;XP_020936365.1;XP_020952627.1;XP_013844381.1;XP_005656256.1;XP_003128153.1	XP_020936368.1;XP_020936367.1;XP_013841392.1;XP_020936366.1;XP_020936365.1;XP_020952627.1;XP_013844381.1;XP_005656256.1;XP_003128153.1	XP_020936368.1 CTP synthase 2 isoform X2 [Sus scrofa];XP_020936367.1 CTP synthase 2 isoform X2 [Sus scrofa];XP_013841392.1 CTP synthase 2 isoform X2 [Sus scrofa];XP_020936366.1 CTP synthase 2 isoform X1 [Sus scrofa];XP_020936365.1 CTP synthase 2 isoform X1	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1924800	0	0	NA	NA	NA	CTPS2	CTPS2;CTPS2;CTPS2;CTPS2;CTPS1	glutamine metabolic process;pyrimidine nucleobase biosynthetic process;'de novo' CTP biosynthetic process;nucleobase-containing small molecule interconversion;CTP biosynthetic process;pyrimidine nucleotide metabolic process	GO:000654; GO:001985; GO:004421; GO:001594; GO:000624; GO:000622	cytoplasm;cytosol;cytoophidium	GO:000573; GO:000582; GO:009726	 Metabolic pathways; Pyrimidine metabolism	hsa0110; hsa0024	CTP synthase activity;ATP binding;identical protein binding;protein binding	GO:000388; GO:000552; GO:004280; GO:000551
XP_013841434.1;XP_020936010.1;XP_020936009.1;XP_020936008.1;XP_020936007.1;XP_020936006.1;XP_020936005.1;XP_020936004.1;XP_020936003.1;XP_020936002.1;XP_013846397.1;NP_001230143.1;XP_020949007.1;XP_003135263.2;XP_005657901.1;XP_020941768.1;XP_020949006.1;XP_013846399.1;XP_020935567.1;XP_013846398.1	XP_013841434.1;XP_020936010.1;XP_020936009.1;XP_020936008.1;XP_020936007.1;XP_020936006.1;XP_020936005.1;XP_020936004.1;XP_020936003.1;XP_020936002.1;XP_013846397.1;NP_001230143.1;XP_020949007.1;XP_003135263.2;XP_005657901.1;XP_020941768.1;XP_020949006.1	XP_013841434.1 ribosomal protein S6 kinase alpha-3 isoform X4 [Sus scrofa];XP_020936010.1 ribosomal protein S6 kinase alpha-3 isoform X3 [Sus scrofa];XP_020936009.1 ribosomal protein S6 kinase alpha-3 isoform X3 [Sus scrofa];XP_020936008.1 ribosomal protei	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RPS6KA3	RPS6KA3;RPS6KA3;RPS6KA1;RPS6KA2;RPS6KA1	regulation of DNA-templated transcription in response to stress;positive regulation of cell differentiation;regulation of translation in response to stress;signal transduction;peptidyl-serine phosphorylation;skeletal system development;intracellular signal transduction;cell cycle;negative regulation of apoptotic process;response to lipopolysaccharide;positive regulation of transcription from RNA polymerase II promoter;apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;toll-like receptor signaling pathway;central nervous system development;positive regulation of cell growth	GO:004362; GO:004559; GO:004355; GO:000716; GO:001810; GO:000150; GO:003555; GO:000704; GO:004306; GO:003249; GO:004594; GO:000691; GO:004315; GO:000222; GO:000741; GO:003030	cytosol;nucleoplasm	GO:000582; GO:000565	 Insulin resistance; MAPK signaling pathway; Oocyte meiosis; Long-term potentiation; Progesterone-mediated oocyte maturation; mTOR signaling pathway	hsa0493; hsa0401; hsa0411; hsa0472; hsa0491; hsa0415	protein serine/threonine kinase activity;ATP binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;magnesium ion binding;protein kinase binding;protein kinase activity;protein binding;ribosomal protein S6 kinase activity;kinase activity	GO:000467; GO:000552; GO:004302; GO:000028; GO:001990; GO:000467; GO:000551; GO:000471; GO:001630
XP_013841673.1;NP_001009578.1	XP_013841673.1;NP_001009578.1	XP_013841673.1 moesin isoform X1 [Sus scrofa];NP_001009578.1 moesin [Sus scrofa]	34	34	26	804920000	760030000	825810000	922170000	898460000	830500000	834330000	1049400000	859210000	960210000	961090000	1155400000	900020000	921810000	1007500000	1137700000	906780000	826630000	NA	NA	NA	MSN	MSN;MSN;NA;NA;NA	T cell proliferation;positive regulation of protein localization to early endosome;immunological synapse formation;regulation of cell shape;gland morphogenesis;cellular response to testosterone stimulus;positive regulation of cellular protein catabolic process;cytoskeleton organization;establishment of epithelial cell apical/basal polarity;positive regulation of early endosome to late endosome transport;T cell migration;establishment of endothelial barrier;positive regulation of podosome assembly;regulation of organelle assembly;leukocyte cell-cell adhesion;positive regulation of gene expression;T cell aggregation;interleukin-12-mediated signaling pathway;leukocyte migration;regulation of lymphocyte migration	GO:004209; GO:190296; GO:000177; GO:000836; GO:002261; GO:007139; GO:190336; GO:000701; GO:004519; GO:200064; GO:007267; GO:006102; GO:007180; GO:190211; GO:000715; GO:001062; GO:007048; GO:003572; GO:005090; GO:200040	extracellular space;blood microparticle;apical plasma membrane;cell periphery;cytosol;microvillus membrane;invadopodium;microvillus;focal adhesion;cell surface;filopodium;cytoskeleton;vesicle;plasma membrane;uropod;apical part of cell;nucleus;cytoplasm;pseudopodium;perinuclear region of cytoplasm;extracellular exosome	GO:000561; GO:007256; GO:001632; GO:007194; GO:000582; GO:003152; GO:007143; GO:000590; GO:000592; GO:000998; GO:003017; GO:000585; GO:003198; GO:000588; GO:000193; GO:004517; GO:000563; GO:000573; GO:003114; GO:004847; GO:007006	 Leukocyte transendothelial migration; Proteoglycans in cancer; Regulation of actin cytoskeleton; Measles	hsa0467; hsa0520; hsa0481; hsa0516	cell adhesion molecule binding;structural constituent of cytoskeleton;receptor binding;protein binding;double-stranded RNA binding;protein kinase binding;enzyme binding;actin binding	GO:005083; GO:000520; GO:000510; GO:000551; GO:000372; GO:001990; GO:001989; GO:000377
XP_013841770.2	XP_013841770.2	XP_013841770.2 stomatin-like protein 2, mitochondrial [Sus scrofa]	4	4	4	9958500	10398000	15089000	0	0	0	0	0	0	8153800	0	17218000	0	7994100	12538000	9402300	3316600	0	NA	NA	NA	STOML2	STOML2;NA;NA;NA;NA	stress-induced mitochondrial fusion;mitochondrial protein processing;cellular calcium ion homeostasis;mitochondrion organization;CD4-positive, alpha-beta T cell activation;positive regulation of cardiolipin metabolic process;lipid localization;positive regulation of mitochondrial DNA replication;T cell receptor signaling pathway;mitochondrial ATP synthesis coupled proton transport;protein oligomerization;mitochondrial calcium ion transport;positive regulation of mitochondrial membrane potential;interleukin-2 production	GO:199004; GO:003498; GO:000687; GO:000700; GO:003571; GO:190021; GO:001087; GO:009029; GO:005085; GO:004277; GO:005125; GO:000685; GO:001091; GO:003262	cytoskeleton;COP9 signalosome;membrane raft;mitochondrial inner membrane;mitochondrial intermembrane space;extrinsic component of plasma membrane;immunological synapse;actin cytoskeleton;T cell receptor complex	GO:000585; GO:000818; GO:004512; GO:000574; GO:000575; GO:001989; GO:000177; GO:001562; GO:004210	"NA"	"NA"	cardiolipin binding;protein binding;receptor binding;GTPase binding	GO:190161; GO:000551; GO:000510; GO:005102
XP_020936464.1;XP_020936463.1;XP_020936462.1;XP_013841812.2;XP_013841811.2	XP_020936464.1;XP_020936463.1;XP_020936462.1;XP_013841812.2;XP_013841811.2	XP_020936464.1 cullin-4B isoform X5 [Sus scrofa];XP_020936463.1 cullin-4B isoform X4 [Sus scrofa];XP_020936462.1 cullin-4B isoform X2 [Sus scrofa];XP_013841812.2 cullin-4B isoform X1 [Sus scrofa];XP_013841811.2 cullin-4B isoform X3 [Sus scrofa]	2	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3496600	NA	NA	NA	CUL4B	CUL4B;CUL4B;CUL4B;CUL4B;CUL4B	nucleotide-excision repair, DNA damage recognition;ubiquitin-dependent protein catabolic process;neuron projection development;nucleotide-excision repair, preincision complex stabilization;histone H2A monoubiquitination;transcription-coupled nucleotide-excision repair;protein ubiquitination;DNA damage response, detection of DNA damage;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;global genome nucleotide-excision repair;positive regulation of G1/S transition of mitotic cell cycle;G1/S transition of mitotic cell cycle;proteasome-mediated ubiquitin-dependent protein catabolic process;proteasomal protein catabolic process;post-translational protein modification;positive regulation of protein catabolic process;cellular response to DNA damage stimulus;nucleotide-excision repair, DNA incision	GO:000071; GO:000651; GO:003117; GO:000629; GO:003551; GO:000628; GO:001656; GO:004276; GO:003114; GO:007091; GO:190008; GO:000008; GO:004316; GO:001049; GO:004368; GO:004573; GO:000697; GO:003368	nucleoplasm;SCF ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;cytosol;Cul4-RING E3 ubiquitin ligase complex;extracellular exosome	GO:000565; GO:001900; GO:003146; GO:000582; GO:008000; GO:007006	 Nucleotide excision repair; Ubiquitin mediated proteolysis	hsa0342; hsa0412	damaged DNA binding;ubiquitin protein ligase activity;protein binding;ubiquitin protein ligase binding	GO:000368; GO:006163; GO:000551; GO:003162
XP_013842153.1;XP_020940341.1	XP_013842153.1;XP_020940341.1	XP_013842153.1 sorting nexin-2 isoform X2 [Sus scrofa];XP_020940341.1 sorting nexin-2 isoform X1 [Sus scrofa]	13	13	11	67257000	162770000	109630000	154310000	81810000	150050000	98600000	132810000	84037000	105790000	109010000	148560000	118400000	127600000	96156000	149880000	115940000	153310000	NA	NA	NA	SNX2	SNX2;SNX2;NA;NA;NA	retrograde transport, endosome to Golgi;endocytosis;protein oligomerization;lamellipodium morphogenesis;intracellular protein transport;early endosome to Golgi transport	GO:004214; GO:000689; GO:005125; GO:007267; GO:000688; GO:003449	endosome membrane;macromolecular complex;cytosol;endosome;early endosome membrane;cytoplasm;lamellipodium;retromer, tubulation complex;membrane	GO:001000; GO:003299; GO:000582; GO:000576; GO:003190; GO:000573; GO:003002; GO:003090; GO:001602	 Endocytosis	hsa0414	insulin receptor binding;protein binding;protein heterodimerization activity;cadherin binding;phosphatidylinositol binding;protein homodimerization activity;leptin receptor binding;transferrin receptor binding;epidermal growth factor receptor binding	GO:000515; GO:000551; GO:004698; GO:004529; GO:003509; GO:004280; GO:199046; GO:199045; GO:000515
XP_013842872.1	XP_013842872.1	XP_013842872.1 parathymosin [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	147820000	NA	NA	NA	PTMS	PTMS;NA;NA;NA;NA	DNA replication;immune system process	GO:000626; GO:000237	nucleus	GO:000563	"NA"	"NA"	"NA"	"NA"
XP_013843303.1;XP_020942411.1;XP_013843302.1	XP_013843303.1;XP_020942411.1;XP_013843302.1	XP_013843303.1 N-acetylglucosamine-6-phosphate deacetylase isoform X3 [Sus scrofa];XP_020942411.1 N-acetylglucosamine-6-phosphate deacetylase isoform X2 [Sus scrofa];XP_013843302.1 N-acetylglucosamine-6-phosphate deacetylase isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	6544700	0	10467000	0	0	0	8815200	0	6128900	0	6597400	0	0	NA	NA	NA	AMDHD2	AMDHD2;AMDHD2;AMDHD2;NA;NA	carbohydrate metabolic process;N-acetylglucosamine catabolic process;N-acetylneuraminate catabolic process	GO:000597; GO:000604; GO:001926	nucleus;cytosol	GO:000563; GO:000582	 Amino sugar and nucleotide sugar metabolism; Biosynthesis of antibiotics	hsa0052; hsa0113	N-acetylglucosamine-6-phosphate deacetylase activity;N-acetylgalactosamine-6-phosphate deacetylase activity;metal ion binding;protein binding	GO:000844; GO:004741; GO:004687; GO:000551
XP_020943496.1;XP_020943495.1;XP_020943494.1;XP_020943493.1;XP_020943492.1;XP_020943491.1;XP_020943490.1;XP_013843390.2	XP_020943496.1;XP_020943495.1;XP_020943494.1;XP_020943493.1;XP_020943492.1;XP_020943491.1;XP_020943490.1;XP_013843390.2	XP_020943496.1 rho-associated protein kinase 2 isoform X8 [Sus scrofa];XP_020943495.1 rho-associated protein kinase 2 isoform X7 [Sus scrofa];XP_020943494.1 rho-associated protein kinase 2 isoform X6 [Sus scrofa];XP_020943493.1 rho-associated protein kinas	7	7	6	0	25013000	23701000	15734000	23225000	20876000	18372000	18536000	0	18435000	14093000	0	22715000	21442000	16537000	0	17131000	19742000	NA	NA	NA	ROCK2	ROCK2;ROCK2;ROCK2;ROCK2;ROCK2	Rho protein signal transduction;regulation of actin cytoskeleton organization;negative regulation of myosin-light-chain-phosphatase activity;viral RNA genome replication;regulation of protein metabolic process;positive regulation of cell migration;positive regulation of MAPK cascade;regulation of keratinocyte differentiation;response to transforming growth factor beta;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;aortic valve morphogenesis;smooth muscle contraction;G-protein coupled receptor signaling pathway;positive regulation of centrosome duplication;regulation of establishment of cell polarity;regulation of cell motility;protein phosphorylation;positive regulation of cardiac muscle hypertrophy;peptidyl-threonine phosphorylation;rhythmic process;negative regulation of biomineral tissue development;positive regulation of amyloid precursor protein catabolic process;I-kappaB kinase/NF-kappaB signaling;cortical actin cytoskeleton organization;protein localization to plasma membrane;positive regulation of protein phosphorylation;positive regulation of gene expression;negative regulation of angiogenesis;regulation of circadian rhythm;regulation of stress fiber assembly;cellular response to testosterone stimulus;positive regulation of fibroblast growth factor production;negative regulation of bicellular tight junction assembly;response to angiotensin;positive regulation of endothelial cell migration;regulation of cell adhesion;vascular endothelial growth factor receptor signaling pathway;centrosome duplication;regulation of focal adhesion assembly;regulation of establishment of endothelial barrier;positive regulation of connective tissue replacement;positive regulation of connective tissue growth factor production;positive regulation of beta-amyloid formation	GO:000726; GO:003295; GO:003550; GO:003969; GO:005124; GO:003033; GO:004341; GO:004561; GO:007155; GO:190296; GO:000318; GO:000693; GO:000718; GO:001082; GO:200011; GO:200014; GO:000646; GO:001061; GO:001810; GO:004851; GO:007016; GO:190299; GO:000724; GO:003086; GO:007265; GO:000193; GO:001062; GO:001652; GO:004275; GO:005149; GO:007139; GO:009027; GO:190334; GO:199077; GO:001059; GO:003015; GO:004801; GO:005129; GO:005189; GO:190314; GO:190520; GO:003272; GO:190200	cytoplasmic ribonucleoprotein granule;cytosol;nucleus;centrosome;plasma membrane	GO:003646; GO:000582; GO:000563; GO:000581; GO:000588	 Chemokine signaling pathway; Shigellosis; cGMP-PKG signaling pathway; Vascular smooth muscle contraction; Regulation of actin cytoskeleton; Proteoglycans in cancer; Leukocyte transendothelial migration; Focal adhesion; Sphingolipid signaling pathway; Wnt signaling pathway; Axon guidance; Platelet activation; Oxytocin signaling pathway	hsa0406; hsa0513; hsa0402; hsa0427; hsa0481; hsa0520; hsa0467; hsa0451; hsa0407; hsa0431; hsa0436; hsa0461; hsa0492	structural molecule activity;metal ion binding;Rho GTPase binding;Rho-dependent protein serine/threonine kinase activity;protein serine/threonine kinase activity;RNA binding;protein binding;ATP binding;tau protein binding;tau-protein kinase activity	GO:000519; GO:004687; GO:001704; GO:007251; GO:000467; GO:000372; GO:000551; GO:000552; GO:004815; GO:005032
XP_020947137.1;XP_020947136.1;XP_013843647.1;XP_013843646.1;XP_020947138.1;XP_013843648.1	XP_020947137.1;XP_020947136.1;XP_013843647.1;XP_013843646.1;XP_020947138.1;XP_013843648.1	XP_020947137.1 SUN domain-containing protein 2 isoform X1 [Sus scrofa];XP_020947136.1 SUN domain-containing protein 2 isoform X1 [Sus scrofa];XP_013843647.1 SUN domain-containing protein 2 isoform X1 [Sus scrofa];XP_013843646.1 SUN domain-containing protei	5	5	5	10595000	10398000	0	0	17764000	25728000	15881000	17545000	0	32003000	12478000	0	13385000	17174000	0	14583000	15955000	18505000	NA	NA	NA	SUN2	SUN2;SUN2;SUN2;SUN2;SUN2	nuclear migration along microfilament;mitotic spindle organization;meiotic cell cycle;cytoskeletal anchoring at nuclear membrane;nuclear envelope organization;positive regulation of cell migration;centrosome localization;nuclear migration;nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration;nuclear matrix anchoring at nuclear membrane	GO:003102; GO:000705; GO:005132; GO:009028; GO:000699; GO:003033; GO:005164; GO:000709; GO:002181; GO:009029	endosome membrane;LINC complex;condensed nuclear chromosome;nuclear chromosome, telomeric region;integral component of nuclear inner membrane;nuclear membrane	GO:001000; GO:003499; GO:000079; GO:000078; GO:000563; GO:003196	"NA"	"NA"	microtubule binding;identical protein binding;protein binding;lamin binding;protein anchor	GO:000801; GO:004280; GO:000551; GO:000552; GO:004349
XP_013843662.2;XP_003483336.1;XP_005652427.1;CON__P01045-1;CON__Q2KJ62;CON__P01044-1	XP_013843662.2;XP_003483336.1;XP_005652427.1	XP_013843662.2 kininogen-1 isoform X1 [Sus scrofa];XP_003483336.1 kininogen-1 isoform X2 [Sus scrofa];XP_005652427.1 kininogen-1 isoform X3 [Sus scrofa]	17	17	17	112090000	116210000	107210000	144350000	165650000	256390000	132870000	103820000	174800000	122280000	120580000	89882000	161380000	133640000	151270000	113930000	137380000	142500000	NA	NA	NA	KNG1	KNG1;KNG1;KNG1;NA;NA	platelet degranulation;negative regulation of blood coagulation;negative regulation of cell adhesion;G-protein coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;negative regulation of endopeptidase activity;blood coagulation, intrinsic pathway;cellular protein metabolic process;post-translational protein modification;negative regulation of proteolysis;vasodilation;positive regulation of apoptotic process;inflammatory response	GO:000257; GO:003019; GO:000716; GO:000718; GO:000720; GO:001095; GO:000759; GO:004426; GO:004368; GO:004586; GO:004231; GO:004306; GO:000695	blood microparticle;plasma membrane;extracellular space;platelet alpha granule lumen;extracellular region;endoplasmic reticulum lumen;extracellular exosome	GO:007256; GO:000588; GO:000561; GO:003109; GO:000557; GO:000578; GO:007006	 Complement and coagulation cascades	hsa0461	heparin binding;protein binding;receptor binding;cysteine-type endopeptidase inhibitor activity;zinc ion binding	GO:000820; GO:000551; GO:000510; GO:000486; GO:000827
XP_013843758.1;XP_020947459.1	XP_013843758.1;XP_020947459.1	XP_013843758.1 proliferation-associated protein 2G4 isoform X1 [Sus scrofa];XP_020947459.1 proliferation-associated protein 2G4 isoform X2 [Sus scrofa]	13	13	13	110140000	123660000	131130000	109700000	83268000	134600000	126660000	106800000	115400000	95037000	90839000	90859000	104900000	135770000	120490000	119600000	137590000	125690000	NA	NA	NA	PA2G4	PA2G4;PA2G4;NA;NA;NA	negative regulation of apoptotic process;rRNA processing;neutrophil degranulation;cell proliferation;negative regulation of transcription, DNA-templated;regulation of translation;cell cycle arrest;positive regulation of cell differentiation	GO:004306; GO:000636; GO:004331; GO:000828; GO:004589; GO:000641; GO:000705; GO:004559	nucleus;cytoplasm;extracellular region;azurophil granule lumen;membrane;extracellular exosome	GO:000563; GO:000573; GO:000557; GO:003557; GO:001602; GO:007006	"NA"	"NA"	nucleic acid binding;protein binding;DNA binding;transcription factor activity, sequence-specific DNA binding;ubiquitin protein ligase binding;RNA binding	GO:000367; GO:000551; GO:000367; GO:000370; GO:003162; GO:000372
XP_020948035.1;XP_013843850.2	XP_020948035.1;XP_013843850.2	XP_020948035.1 alpha-2-macroglobulin isoform X2 [Sus scrofa];XP_013843850.2 alpha-2-macroglobulin isoform X1 [Sus scrofa]	67	67	64	8715600000	4030300000	3538500000	4753900000	7922100000	5055100000	7072000000	3565000000	6025000000	3423300000	5988300000	2876400000	7833700000	4946100000	7272200000	3129000000	7750100000	3128400000	NA	NA	NA	A2M	A2M;A2M;NA;NA;NA	blood coagulation, intrinsic pathway;regulation of small GTPase mediated signal transduction;negative regulation of complement activation, lectin pathway;platelet degranulation;extracellular matrix disassembly;stem cell differentiation;positive regulation of GTPase activity;negative regulation of endopeptidase activity	GO:000759; GO:005105; GO:000186; GO:000257; GO:002261; GO:004886; GO:004354; GO:001095	cytosol;platelet alpha granule lumen;extracellular exosome;extracellular region;blood microparticle	GO:000582; GO:003109; GO:007006; GO:000557; GO:007256	 Complement and coagulation cascades	hsa0461	receptor binding;calcium-dependent protein binding;protease binding;serine-type endopeptidase inhibitor activity;growth factor binding;GTPase activator activity;interleukin-1 binding;interleukin-8 binding;tumor necrosis factor binding;enzyme binding;protein binding	GO:000510; GO:004830; GO:000202; GO:000486; GO:001983; GO:000509; GO:001996; GO:001995; GO:004312; GO:001989; GO:000551
XP_013844801.1	XP_013844801.1	XP_013844801.1 complement factor I [Sus scrofa]	18	18	15	88481000	89086000	103320000	86912000	156360000	242410000	132500000	72204000	111690000	97627000	90228000	73310000	96307000	90410000	95082000	76010000	153190000	142830000	NA	NA	NA	CFI	CFI;NA;NA;NA;NA	innate immune response;complement activation, classical pathway;regulation of complement activation;proteolysis;receptor-mediated endocytosis	GO:004508; GO:000695; GO:003044; GO:000650; GO:000689	membrane;extracellular space;extracellular region;extracellular exosome	GO:001602; GO:000561; GO:000557; GO:007006	 Staphylococcus aureus infection; Complement and coagulation cascades	hsa0515; hsa0461	scavenger receptor activity;serine-type endopeptidase activity;protein binding;metal ion binding	GO:000504; GO:000425; GO:000551; GO:004687
XP_013844843.1	XP_013844843.1	XP_013844843.1 CDGSH iron-sulfur domain-containing protein 2 [Sus scrofa]	7	7	7	44069000	55833000	57833000	52230000	52470000	50335000	42163000	54478000	35845000	45580000	55409000	0	0	63850000	47512000	68779000	59612000	71053000	NA	NA	NA	CISD2	CISD2;NA;NA;NA;NA	mitophagy;multicellular organism aging;regulation of autophagy	GO:000042; GO:001025; GO:001050	macromolecular complex;integral component of membrane;mitochondrial outer membrane;endoplasmic reticulum;perinuclear endoplasmic reticulum	GO:003299; GO:001602; GO:000574; GO:000578; GO:009703	"NA"	"NA"	RNA binding;2 iron, 2 sulfur cluster binding;protein homodimerization activity;protein binding;metal ion binding	GO:000372; GO:005153; GO:004280; GO:000551; GO:004687
XP_013845109.2	XP_013845109.2	XP_013845109.2 sulfhydryl oxidase 1 [Sus scrofa]	12	12	12	42033000	45447000	39886000	45773000	49720000	75222000	51154000	31071000	52407000	47198000	31091000	55638000	48393000	39329000	37852000	34288000	44655000	44419000	NA	NA	NA	QSOX1	QSOX1;NA;NA;NA;NA	platelet degranulation;neutrophil degranulation;post-translational protein modification;negative regulation of macroautophagy;oxidation-reduction process;cellular protein metabolic process;cell redox homeostasis	GO:000257; GO:004331; GO:004368; GO:001624; GO:005511; GO:004426; GO:004545	endoplasmic reticulum lumen;Golgi apparatus;integral component of Golgi membrane;extracellular space;intracellular membrane-bounded organelle;platelet alpha granule lumen;extracellular exosome;extracellular region;specific granule lumen;intercellular bridge;tertiary granule lumen	GO:000578; GO:000579; GO:003017; GO:000561; GO:004323; GO:003109; GO:007006; GO:000557; GO:003558; GO:004517; GO:190472	"NA"	"NA"	flavin-linked sulfhydryl oxidase activity;protein disulfide isomerase activity	GO:001697; GO:000375
XP_020922012.1;XP_020922011.1;XP_013845273.1;XP_013845272.1;XP_013845271.1;XP_013845269.1;XP_020922010.1;XP_020922009.1	XP_020922012.1;XP_020922011.1;XP_013845273.1;XP_013845272.1;XP_013845271.1;XP_013845269.1;XP_020922010.1;XP_020922009.1	XP_020922012.1 uncharacterized protein C17orf62 homolog isoform X3 [Sus scrofa];XP_020922011.1 uncharacterized protein C17orf62 homolog isoform X4 [Sus scrofa];XP_013845273.1 uncharacterized protein C17orf62 homolog isoform X3 [Sus scrofa];XP_013845272.1 u	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4869000	NA	NA	NA	C12H17orf62	C12H17orf62;C12H17orf62;C12H17orf62;C12H17orf62;C12H17orf62	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013845450.2	XP_013845450.2	XP_013845450.2 LOW QUALITY PROTEIN: protein ABHD15 [Sus scrofa]	4	4	4	0	0	0	0	6964300	0	0	0	0	0	0	0	0	0	0	5982100	0	0	NA	NA	NA	ABHD15	ABHD15;NA;NA;NA;NA	cellular lipid metabolic process	GO:004425	membrane;extracellular region	GO:001602; GO:000557	"NA"	"NA"	hydrolase activity	GO:001678
XP_013845612.2	XP_013845612.2	XP_013845612.2 LOW QUALITY PROTEIN: COMM domain-containing protein 9 [Sus scrofa]	4	4	4	0	21550000	0	0	16406000	0	0	0	0	0	19752000	28356000	0	18115000	25145000	19885000	20044000	20990000	NA	NA	NA	COMMD9	COMMD9;NA;NA;NA;NA	sodium ion transport;neutrophil degranulation;cholesterol homeostasis	GO:000681; GO:004331; GO:004263	Golgi apparatus;cytosol;nucleus;secretory granule lumen;extracellular region;ficolin-1-rich granule lumen	GO:000579; GO:000582; GO:000563; GO:003477; GO:000557; GO:190481	"NA"	"NA"	protein binding	GO:000551
XP_020929222.1;XP_013845818.1;XP_013845816.1;XP_020929221.1;XP_013845815.1	XP_020929222.1;XP_013845818.1;XP_013845816.1;XP_020929221.1;XP_013845815.1	XP_020929222.1 tyrosine-protein phosphatase non-receptor type 11 isoform X4 [Sus scrofa];XP_013845818.1 tyrosine-protein phosphatase non-receptor type 11 isoform X3 [Sus scrofa];XP_013845816.1 tyrosine-protein phosphatase non-receptor type 11 isoform X2 [S	9	9	9	32341000	57585000	65428000	59612000	43664000	52001000	55655000	73690000	51592000	52902000	60426000	43582000	0	55523000	57085000	70352000	0	48561000	NA	NA	NA	PTPN11	PTPN11;PTPN11;PTPN11;PTPN11;PTPN11	T cell costimulation;regulation of cell adhesion mediated by integrin;regulation of multicellular organism growth;phosphatidylinositol phosphorylation;interleukin-6-mediated signaling pathway;epidermal growth factor receptor signaling pathway;heart development;abortive mitotic cell cycle;phosphatidylinositol-3-phosphate biosynthetic process;platelet-derived growth factor receptor signaling pathway;integrin-mediated signaling pathway;brain development;positive regulation of glucose import;positive regulation of hormone secretion;cellular response to mechanical stimulus;microvillus organization;positive regulation of tumor necrosis factor production;peptidyl-tyrosine dephosphorylation;ERBB signaling pathway;neurotrophin TRK receptor signaling pathway;homeostasis of number of cells within a tissue;cellular response to epidermal growth factor stimulus;axon guidance;fibroblast growth factor receptor signaling pathway;platelet formation;multicellular organismal reproductive process;positive regulation of protein kinase B signaling;face morphogenesis;activation of MAPK activity;hormone-mediated signaling pathway;positive regulation of interferon-beta production;atrioventricular canal development;glucose homeostasis;negative regulation of insulin secretion;inner ear development;regulation of type I interferon-mediated signaling pathway;DNA damage checkpoint;cerebellar cortex formation;multicellular organism growth;regulation of protein complex assembly;genitalia development;platelet activation;megakaryocyte development;regulation of protein export from nucleus;cellular response to cytokine stimulus;triglyceride metabolic process;cytokine-mediated signaling pathway;positive regulation of interleukin-6 production;hormone metabolic process;positive regulation of mitotic cell cycle;positive regulation of insulin receptor signaling pathway;leukocyte migration;negative regulation of cortisol secretion;Bergmann glial cell differentiation;negative regulation of growth hormone secretion;intestinal epithelial cell migration;positive regulation of ERK1 and ERK2 cascade	GO:003129; GO:003362; GO:004001; GO:004685; GO:007010; GO:000717; GO:000750; GO:003327; GO:003609; GO:004800; GO:000722; GO:000742; GO:004632; GO:004688; GO:007126; GO:003252; GO:003276; GO:003533; GO:003812; GO:004801; GO:004887; GO:007136; GO:000741; GO:000854; GO:003022; GO:004860; GO:005189; GO:006032; GO:000018; GO:000975; GO:003272; GO:003630; GO:004259; GO:004667; GO:004883; GO:006033; GO:000007; GO:002169; GO:003526; GO:004325; GO:004880; GO:003016; GO:003585; GO:004682; GO:007134; GO:000664; GO:001922; GO:003275; GO:004244; GO:004593; GO:004662; GO:005090; GO:005146; GO:006002; GO:006012; GO:006158; GO:007037	cytoplasm;nucleoplasm;cytosol;mitochondrion;macromolecular complex;nucleus	GO:000573; GO:000565; GO:000582; GO:000573; GO:003299; GO:000563	 Ras signaling pathway; Neurotrophin signaling pathway; Chronic myeloid leukemia; Insulin resistance; Epithelial cell signaling in Helicobacter pylori infection; Proteoglycans in cancer; Jak-STAT signaling pathway; Leukocyte transendothelial migration; Natural killer cell mediated cytotoxicity; Herpes simplex infection; Adipocytokine signaling pathway; Renal cell carcinoma	hsa0401; hsa0472; hsa0522; hsa0493; hsa0512; hsa0520; hsa0463; hsa0467; hsa0465; hsa0516; hsa0492; hsa0521	phospholipase binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;protein kinase binding;peptide hormone receptor binding;protein binding;phosphotyrosine binding;1-phosphatidylinositol-3-kinase activity;D1 dopamine receptor binding;non-membrane spanning protein tyrosine phosphatase activity;insulin receptor substrate binding;SH3/SH2 adaptor activity;insulin receptor binding;receptor tyrosine kinase binding;cell adhesion molecule binding	GO:004327; GO:004693; GO:001990; GO:005142; GO:000551; GO:000178; GO:001630; GO:003174; GO:000472; GO:004356; GO:000507; GO:000515; GO:003097; GO:005083
XP_020930861.1;XP_020930860.1;XP_020930859.1;XP_020930858.1;XP_020930857.1;XP_013846037.2	XP_020930861.1;XP_020930860.1;XP_020930859.1;XP_020930858.1;XP_020930857.1;XP_013846037.2	XP_020930861.1 mitogen-activated protein kinase kinase kinase MLT isoform X2 [Sus scrofa];XP_020930860.1 mitogen-activated protein kinase kinase kinase MLT isoform X2 [Sus scrofa];XP_020930859.1 mitogen-activated protein kinase kinase kinase MLT isoform X2	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	7336500	0	0	0	0	0	NA	NA	NA	MAP3K20	MAP3K20;MAP3K20;MAP3K20;MAP3K20;MAP3K20	DNA damage checkpoint;positive regulation of apoptotic process;stress-activated MAPK cascade;limb development;cellular response to gamma radiation;activation of MAPKK activity;cell death;cell cycle arrest;cell proliferation;cell differentiation;cytoskeleton organization;mitotic cell cycle checkpoint;activation of JUN kinase activity;protein phosphorylation;embryonic digit morphogenesis	GO:000007; GO:004306; GO:005140; GO:006017; GO:007148; GO:000018; GO:000821; GO:000705; GO:000828; GO:003015; GO:000701; GO:000709; GO:000725; GO:000646; GO:004273	cytosol;nucleus;cytoplasm	GO:000582; GO:000563; GO:000573	 MAPK signaling pathway; Tight junction	hsa0401; hsa0453	MAP kinase kinase kinase activity;RNA binding;protein serine/threonine kinase activity;protein binding;ATP binding;magnesium ion binding	GO:000470; GO:000372; GO:000467; GO:000551; GO:000552; GO:000028
XP_013846116.1	XP_013846116.1	XP_013846116.1 nucleophosmin [Sus scrofa]	4	4	4	0	55793000	0	51376000	0	55992000	42000000	0	39832000	0	0	64511000	0	0	56815000	0	56620000	0	NA	NA	NA	NPM1	NPM1;NA;NA;NA;NA	protein localization;nucleocytoplasmic transport;negative regulation of cell proliferation;DNA repair;regulation of centrosome duplication;negative regulation of protein kinase activity by regulation of protein phosphorylation;ribosomal large subunit export from nucleus;chromatin remodeling;negative regulation of apoptotic process;ribosomal large subunit biogenesis;intracellular protein transport;cell aging;positive regulation of transcription, DNA-templated;regulation of endoribonuclease activity;regulation of eIF2 alpha phosphorylation by dsRNA;rRNA export from nucleus;positive regulation of NF-kappaB transcription factor activity;positive regulation of cell cycle G2/M phase transition;regulation of endodeoxyribonuclease activity;CENP-A containing nucleosome assembly;centrosome cycle;positive regulation of translation;cellular response to UV;regulation of centriole replication;protein oligomerization;signal transduction;regulation of transcription from RNA polymerase II promoter;viral process;ribosome assembly;positive regulation of transcription from RNA polymerase II promoter;regulation of mRNA stability involved in cellular response to UV	GO:000810; GO:000691; GO:000828; GO:000628; GO:001082; GO:004438; GO:000005; GO:000633; GO:004306; GO:004227; GO:000688; GO:000756; GO:004589; GO:006069; GO:006073; GO:000640; GO:005109; GO:190275; GO:003207; GO:003408; GO:000709; GO:004572; GO:003464; GO:004659; GO:005125; GO:000716; GO:000635; GO:001603; GO:004225; GO:004594; GO:190262	cytoplasm;spindle pole centrosome;focal adhesion;protein-DNA complex;membrane;ribonucleoprotein complex;cytosol;nucleolus;centrosome;nucleus;nucleoplasm	GO:000573; GO:003161; GO:000592; GO:003299; GO:001602; GO:199090; GO:000582; GO:000573; GO:000581; GO:000563; GO:000565	 Pathways in cancer; Transcriptional misregulation in cancer; Acute myeloid leukemia	hsa0520; hsa0520; hsa0522	protein binding;histone binding;transcription factor binding;ribosomal small subunit binding;unfolded protein binding;core promoter binding;protein kinase inhibitor activity;Tat protein binding;protein homodimerization activity;NF-kappaB binding;protein kinase binding;activating transcription factor binding;chromatin binding;transcription coactivator activity;RNA binding;protein heterodimerization activity	GO:000551; GO:004239; GO:000813; GO:004302; GO:005108; GO:000104; GO:000486; GO:003095; GO:004280; GO:005105; GO:001990; GO:003361; GO:000368; GO:000371; GO:000372; GO:004698
XP_020934881.1;XP_020934880.1;XP_020934879.1;XP_013846191.1	XP_020934881.1;XP_020934880.1;XP_020934879.1;XP_013846191.1	XP_020934881.1 NEDD8 ultimate buster 1 isoform X2 [Sus scrofa];XP_020934880.1 NEDD8 ultimate buster 1 isoform X2 [Sus scrofa];XP_020934879.1 NEDD8 ultimate buster 1 isoform X2 [Sus scrofa];XP_013846191.1 NEDD8 ultimate buster 1 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1178800	NA	NA	NA	NUB1	NUB1;NUB1;NUB1;NUB1;NA	response to interferon-gamma;response to tumor necrosis factor;post-translational protein modification;ubiquitin-dependent protein catabolic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein ubiquitination	GO:003434; GO:003461; GO:004368; GO:000651; GO:003243; GO:001656	cytosol;nucleus	GO:000582; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_020934572.1;XP_013846200.2	XP_020934572.1;XP_013846200.2	XP_020934572.1 GTPase IMAP family member 4 [Sus scrofa];XP_013846200.2 GTPase IMAP family member 4 [Sus scrofa]	8	8	8	0	24184000	33135000	28655000	21003000	43161000	20431000	19193000	25048000	37797000	20998000	34818000	35573000	45022000	29726000	42731000	28699000	46170000	NA	NA	NA	GIMAP4	GIMAP4;GIMAP4;NA;NA;NA	"NA"	"NA"	cytosol	GO:000582	"NA"	"NA"	GTP binding	GO:000552
XP_020936016.1;XP_020936015.1;XP_020936014.1;XP_020936013.1;XP_013846320.2;XP_020936576.1	XP_020936016.1;XP_020936015.1;XP_020936014.1;XP_020936013.1;XP_013846320.2	XP_020936016.1 ubiquitin-like modifier-activating enzyme 1 [Sus scrofa];XP_020936015.1 ubiquitin-like modifier-activating enzyme 1 [Sus scrofa];XP_020936014.1 ubiquitin-like modifier-activating enzyme 1 [Sus scrofa];XP_020936013.1 ubiquitin-like modifier-a	30	30	30	473560000	524530000	528650000	491140000	475320000	566290000	505420000	512460000	481760000	517910000	544510000	698600000	646620000	517600000	488950000	547920000	469140000	531790000	NA	NA	NA	UBA1	UBA1;UBA1;UBA1;UBA1;UBA1	protein modification by small protein conjugation;cellular response to DNA damage stimulus;protein ubiquitination	GO:003244; GO:000697; GO:001656	extracellular exosome;nucleoplasm;endosome membrane;heterochromatin;mitochondrion;desmosome;rough endoplasmic reticulum membrane;lysosomal membrane;cytosol;nucleus	GO:007006; GO:000565; GO:001000; GO:000079; GO:000573; GO:003005; GO:003086; GO:000576; GO:000582; GO:000563	 Parkinson's disease; Ubiquitin mediated proteolysis	hsa0501; hsa0412	RNA binding;protein binding;ATP binding;ubiquitin activating enzyme activity	GO:000372; GO:000551; GO:000552; GO:000483
XP_013847913.2	XP_013847913.2	XP_013847913.2 ezrin [Sus scrofa]	23	15	14	79901000	73326000	152340000	107270000	273430000	70212000	467020000	77109000	170600000	75117000	343200000	100520000	375790000	50701000	252720000	68964000	693490000	79163000	NA	NA	NA	EZR	EZR;NA;NA;NA;NA	actin cytoskeleton reorganization;receptor internalization;establishment of centrosome localization;negative regulation of interleukin-2 secretion;sphingosine-1-phosphate signaling pathway;cytoskeletal anchoring at plasma membrane;gland morphogenesis;regulation of microvillus length;cellular protein complex localization;negative regulation of T cell receptor signaling pathway;regulation of actin cytoskeleton organization;phosphatidylinositol-mediated signaling;positive regulation of protein secretion;negative regulation of transcription from RNA polymerase II promoter;actin filament bundle assembly;regulation of cell shape;microvillus assembly;astral microtubule organization;positive regulation of multicellular organism growth;establishment of endothelial barrier;negative regulation of ERK1 and ERK2 cascade;positive regulation of gene expression;protein kinase A signaling;positive regulation of protein localization to plasma membrane;positive regulation of cellular protein catabolic process;leukocyte cell-cell adhesion;axon guidance;filopodium assembly;protein localization to plasma membrane;regulation of NIK/NF-kappaB signaling;terminal web assembly;positive regulation of protein localization to early endosome;cortical microtubule organization;establishment of epithelial cell apical/basal polarity;cellular response to cAMP;regulation of organelle assembly;negative regulation of p38MAPK cascade;positive regulation of early endosome to late endosome transport;intestinal D-glucose absorption;protein localization to cell cortex	GO:003153; GO:003162; GO:005166; GO:190004; GO:000337; GO:000701; GO:002261; GO:003253; GO:003462; GO:005086; GO:003295; GO:004801; GO:005071; GO:000012; GO:005101; GO:000836; GO:003003; GO:003095; GO:004001; GO:006102; GO:007037; GO:001062; GO:001073; GO:190307; GO:190336; GO:000715; GO:000741; GO:004684; GO:007265; GO:190122; GO:190289; GO:190296; GO:004362; GO:004519; GO:007132; GO:190211; GO:190375; GO:200064; GO:000195; GO:007269	immunological synapse;microvillus;apical plasma membrane;vesicle;astrocyte projection;extrinsic component of membrane;actin cytoskeleton;ciliary basal body;cell periphery;ruffle;uropod;cytosol;extracellular space;endosome;filopodium;T-tubule;apical part of cell;membrane;invadopodium;macromolecular complex;cell body;Schwann cell microvillus;microvillus membrane;ruffle membrane;extracellular exosome;fibrillar center;cytoplasm;actin filament;microspike;cell projection;perinuclear region of cytoplasm;focal adhesion;cortical cytoskeleton;plasma membrane raft;cell tip;cytoplasmic side of apical plasma membrane	GO:000177; GO:000590; GO:001632; GO:003198; GO:009744; GO:001989; GO:001562; GO:003606; GO:007194; GO:000172; GO:000193; GO:000582; GO:000561; GO:000576; GO:003017; GO:003031; GO:004517; GO:001602; GO:007143; GO:003299; GO:004429; GO:009745; GO:003152; GO:003258; GO:007006; GO:000165; GO:000573; GO:000588; GO:004439; GO:004299; GO:004847; GO:000592; GO:003086; GO:004485; GO:005128; GO:009859	 Regulation of actin cytoskeleton; MicroRNAs in cancer; Pathogenic Escherichia coli infection; Gastric acid secretion; Leukocyte transendothelial migration	hsa0481; hsa0520; hsa0513; hsa0497; hsa0467	actin filament binding;protein kinase A binding;actin binding;identical protein binding;protein kinase A catalytic subunit binding;disordered domain specific binding;protein binding;protein C-terminus binding;cadherin binding;cell adhesion molecule binding;microtubule binding;protein domain specific binding;ATPase binding;RNA binding;S100 protein binding	GO:005101; GO:005101; GO:000377; GO:004280; GO:003423; GO:009771; GO:000551; GO:000802; GO:004529; GO:005083; GO:000801; GO:001990; GO:005111; GO:000372; GO:004454
XP_013848069.2	XP_013848069.2	XP_013848069.2 serine incorporator 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4271900	0	0	NA	NA	NA	SERINC1	SERINC1;NA;NA;NA;NA	sphingolipid metabolic process;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;phosphatidylserine metabolic process;phospholipid biosynthetic process;membrane biogenesis;positive regulation of serine C-palmitoyltransferase activity	GO:000666; GO:190421; GO:000665; GO:000865; GO:004409; GO:190422	integral component of membrane;endoplasmic reticulum membrane;plasma membrane	GO:001602; GO:000578; GO:000588	"NA"	"NA"	enzyme binding;protein binding;protein binding, bridging	GO:001989; GO:000551; GO:003067
XP_013848215.2	XP_013848215.2	XP_013848215.2 LOW QUALITY PROTEIN: laminin subunit alpha-4 [Sus scrofa]	65	65	65	3431400000	3932500000	3880400000	3633500000	3378200000	2270400000	3806100000	4096400000	3163100000	3134000000	3290100000	4780700000	1829700000	3913500000	4256800000	4384100000	3259400000	3367000000	NA	NA	NA	LAMA4	LAMA4;NA;NA;NA;NA	cell adhesion;extracellular matrix organization;regulation of embryonic development;regulation of cell adhesion;regulation of cell migration	GO:000715; GO:003019; GO:004599; GO:003015; GO:003033	extracellular region;basement membrane;extracellular exosome	GO:000557; GO:000560; GO:007006	 ECM-receptor interaction; PI3K-Akt signaling pathway; Focal adhesion; African trypanosomiasis; Pathways in cancer; Small cell lung cancer	hsa0451; hsa0415; hsa0451; hsa0514; hsa0520; hsa0522	receptor binding;protein binding;extracellular matrix structural constituent	GO:000510; GO:000551; GO:000520
XP_020943888.1;XP_020943887.1;XP_013848230.2	XP_020943888.1;XP_020943887.1;XP_013848230.2	XP_020943888.1 acylphosphatase-2 isoform X2 [Sus scrofa];XP_020943887.1 acylphosphatase-2 isoform X2 [Sus scrofa];XP_013848230.2 acylphosphatase-2 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3480500	0	NA	NA	NA	ACYP2	ACYP2;ACYP2;ACYP2;NA;NA	phosphate-containing compound metabolic process	GO:000679	"NA"	"NA"	 Pyruvate metabolism	hsa0062	protein binding;acylphosphatase activity;identical protein binding	GO:000551; GO:000399; GO:004280
XP_013848274.2;XP_020948019.1;XP_013848273.2;XP_020948033.1;XP_020948029.1;XP_020948028.1	XP_013848274.2;XP_020948019.1;XP_013848273.2;XP_020948033.1;XP_020948029.1;XP_020948028.1	XP_013848274.2 collagen alpha-1(XII) chain isoform X2 [Sus scrofa];XP_020948019.1 collagen alpha-1(XII) chain isoform X1 [Sus scrofa];XP_013848273.2 collagen alpha-1(XII) chain isoform X1 [Sus scrofa];XP_020948033.1 collagen alpha-1(XII) chain isoform X4 [	57	57	57	305920000	237730000	139270000	93381000	179210000	172070000	515400000	92591000	187970000	140220000	379160000	407030000	2065900000	193570000	295910000	267910000	624240000	532250000	NA	NA	NA	COL12A1	COL12A1;COL12A1;COL12A1;COL12A1;COL12A1	collagen fibril organization;endodermal cell differentiation;growth plate cartilage chondrocyte morphogenesis;cell adhesion;skeletal system development	GO:003019; GO:003598; GO:000342; GO:000715; GO:000150	extracellular exosome;collagen type XII trimer;extracellular matrix;extracellular region;extracellular space;endoplasmic reticulum lumen;extracellular vesicle	GO:007006; GO:000559; GO:003101; GO:000557; GO:000561; GO:000578; GO:190356	 Protein digestion and absorption	hsa0497	extracellular matrix structural constituent conferring tensile strength	GO:003002
XP_013848345.1	XP_013848345.1	XP_013848345.1 pleckstrin homology domain-containing family O member 2 [Sus scrofa]	3	3	3	0	10132000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PLEKHO2	PLEKHO2;NA;NA;NA;NA	neutrophil degranulation	GO:004331	extracellular region;ficolin-1-rich granule lumen	GO:000557; GO:190481	 Cytokine-cytokine receptor interaction	hsa0406	"NA"	"NA"
XP_020952703.1;XP_020952692.1;XP_013848556.1	XP_020952703.1;XP_020952692.1;XP_013848556.1	XP_020952703.1 erythrocyte membrane protein band 4.2 isoform X3 [Sus scrofa];XP_020952692.1 erythrocyte membrane protein band 4.2 isoform X2 [Sus scrofa];XP_013848556.1 erythrocyte membrane protein band 4.2 isoform X1 [Sus scrofa]	3	3	3	44481000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EPB42	EPB42;EPB42;EPB42;NA;NA	spleen development;cytoskeleton organization;hemoglobin metabolic process;erythrocyte maturation;regulation of cell shape;peptide cross-linking;iron ion homeostasis;cell morphogenesis	GO:004853; GO:000701; GO:002002; GO:004324; GO:000836; GO:001814; GO:005507; GO:000090	plasma membrane;cortical cytoskeleton;cytoskeleton	GO:000588; GO:003086; GO:000585	"NA"	"NA"	ATP binding;protein binding;protein-glutamine gamma-glutamyltransferase activity;structural constituent of cytoskeleton	GO:000552; GO:000551; GO:000381; GO:000520
XP_013848623.1	XP_013848623.1	XP_013848623.1 calcineurin B homologous protein 1 [Sus scrofa]	8	8	8	43825000	36948000	63085000	39918000	50036000	34986000	58979000	36517000	47023000	0	39268000	0	32534000	0	64491000	48525000	41251000	0	NA	NA	NA	CHP1	CHP1;NA;NA;NA;NA	protein export from nucleus;negative regulation of NF-kappaB transcription factor activity;negative regulation of protein import into nucleus;protein stabilization;negative regulation of protein autophosphorylation;positive regulation of sodium:proton antiporter activity;regulation of intracellular pH;positive regulation of protein targeting to membrane;regulation of neuron death;membrane docking;cytoplasmic microtubule organization;potassium ion transport;membrane fusion;negative regulation of phosphatase activity;negative regulation of protein ubiquitination;negative regulation of protein phosphorylation;negative regulation of protein kinase activity;calcium ion regulated exocytosis;protein oligomerization;positive regulation of protein glycosylation;negative regulation of calcineurin-NFAT signaling cascade;small GTPase mediated signal transduction;cellular response to acidic pH;microtubule bundle formation;hyaluronan catabolic process;positive regulation of protein transport	GO:000661; GO:003208; GO:004230; GO:005082; GO:003195; GO:003241; GO:005145; GO:009031; GO:190121; GO:002240; GO:003112; GO:000681; GO:006102; GO:001092; GO:003139; GO:000193; GO:000646; GO:001715; GO:005125; GO:006005; GO:007088; GO:000726; GO:007146; GO:000157; GO:003021; GO:005122	plasma membrane;transport vesicle;focal adhesion;cytosol;endoplasmic reticulum;extracellular exosome;nucleus;endoplasmic reticulum-Golgi intermediate compartment;Golgi membrane;cytoplasm;microtubule cytoskeleton	GO:000588; GO:003013; GO:000592; GO:000582; GO:000578; GO:007006; GO:000563; GO:000579; GO:000013; GO:000573; GO:001563	"NA"	"NA"	calcium ion binding;protein kinase inhibitor activity;calcium-dependent protein binding;transporter activity;protein binding;potassium channel regulator activity;microtubule binding;kinase binding	GO:000550; GO:000486; GO:004830; GO:000521; GO:000551; GO:001545; GO:000801; GO:001990
XP_013848820.1	XP_013848820.1	XP_013848820.1 trafficking protein particle complex subunit 6B [Sus scrofa]	2	2	2	0	0	16879000	0	0	0	12787000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TRAPPC6B	TRAPPC6B;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;nervous system development;regulation of GTPase activity;COPII vesicle coating	GO:000688; GO:000739; GO:004308; GO:004820	cytosol;trans-Golgi network;Golgi membrane;endoplasmic reticulum	GO:000582; GO:000580; GO:000013; GO:000578	"NA"	"NA"	protein binding;Rab guanyl-nucleotide exchange factor activity	GO:000551; GO:001711
XP_020918007.1;XP_020918000.1;XP_013848913.1;XP_020917991.1	XP_020918007.1;XP_020918000.1;XP_013848913.1;XP_020917991.1	XP_020918007.1 protein phosphatase 1A isoform X1 [Sus scrofa];XP_020918000.1 protein phosphatase 1A isoform X1 [Sus scrofa];XP_013848913.1 protein phosphatase 1A isoform X1 [Sus scrofa];XP_020917991.1 protein phosphatase 1A isoform X2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	6274500	0	0	0	0	0	0	0	0	0	NA	NA	NA	PPM1A	PPM1A;PPM1A;PPM1A;PPM1A;NA	negative regulation of NIK/NF-kappaB signaling;cell cycle arrest;negative regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to transforming growth factor beta stimulus;negative regulation of transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-templated;peptidyl-threonine dephosphorylation;positive regulation of canonical Wnt signaling pathway;protein dephosphorylation;negative regulation of BMP signaling pathway;positive regulation of protein export from nucleus;negative regulation of SMAD protein complex assembly;dephosphorylation;N-terminal protein myristoylation	GO:190122; GO:000705; GO:004312; GO:007156; GO:000012; GO:004589; GO:003597; GO:009026; GO:000647; GO:003051; GO:004682; GO:001099; GO:001631; GO:000649	membrane;nucleus;nucleoplasm;cytosol;plasma membrane	GO:001602; GO:000563; GO:000565; GO:000582; GO:000588	 MAPK signaling pathway	hsa0401	manganese ion binding;magnesium ion binding;protein binding;magnesium-dependent protein serine/threonine phosphatase activity;R-SMAD binding;calmodulin-dependent protein phosphatase activity	GO:003014; GO:000028; GO:000551; GO:000472; GO:007041; GO:003319
XP_013849361.2	XP_013849361.2	XP_013849361.2 LOW QUALITY PROTEIN: spectrin alpha chain, non-erythrocytic 1 [Sus scrofa]	137	137	137	3770800000	6713800000	4757900000	5688100000	3863700000	5144500000	5178800000	6338500000	4054500000	4957600000	4993600000	6385100000	4113500000	6013800000	5212200000	6031800000	4987600000	5561500000	NA	NA	NA	SPTAN1	SPTAN1;NA;NA;NA;NA	axon guidance;ER to Golgi vesicle-mediated transport;actin filament capping;MAPK cascade;neutrophil degranulation;cytoskeleton organization	GO:000741; GO:000688; GO:005169; GO:000016; GO:004331; GO:000701	specific granule lumen;extracellular exosome;tertiary granule lumen;cytosol;intracellular membrane-bounded organelle;extracellular vesicle;extracellular region;spectrin;membrane;microtubule cytoskeleton	GO:003558; GO:007006; GO:190472; GO:000582; GO:004323; GO:190356; GO:000557; GO:000809; GO:001602; GO:001563	 Tight junction	hsa0453	Ras guanyl-nucleotide exchange factor activity;protein binding;actin binding;structural constituent of cytoskeleton;calcium ion binding;cadherin binding	GO:000508; GO:000551; GO:000377; GO:000520; GO:000550; GO:004529
XP_013849639.1;XP_020938563.1	XP_013849639.1;XP_020938563.1	XP_013849639.1 atlastin-3 isoform X2 [Sus scrofa];XP_020938563.1 atlastin-3 isoform X1 [Sus scrofa]	13	13	13	230260000	203970000	198280000	188180000	181970000	170350000	212660000	199470000	222600000	203270000	251880000	158120000	283900000	198950000	193160000	206090000	226040000	248470000	NA	NA	NA	ATL3	ATL3;ATL3;NA;NA;NA	endoplasmic reticulum organization;positive regulation of endoplasmic reticulum tubular network organization;Golgi organization;protein homooligomerization;ER to Golgi vesicle-mediated transport	GO:000702; GO:190337; GO:000703; GO:005126; GO:000688	endoplasmic reticulum;endoplasmic reticulum tubular network;membrane;endoplasmic reticulum tubular network membrane	GO:000578; GO:007178; GO:001602; GO:009882	"NA"	"NA"	GTP binding;GTPase activity;protein binding;identical protein binding	GO:000552; GO:000392; GO:000551; GO:004280
XP_013849669.2	XP_013849669.2	XP_013849669.2 LOW QUALITY PROTEIN: neuroblast differentiation-associated protein AHNAK [Sus scrofa]	188	188	188	3094300000	6771400000	3805700000	4813800000	3323400000	5699400000	3331700000	4044700000	2935200000	4681600000	5538200000	5578100000	5481500000	5819500000	6220600000	5017900000	5262100000	6786900000	NA	NA	NA	AHNAK	AHNAK;NA;NA;NA;NA	regulation of RNA splicing;protein oligomerization;regulation of voltage-gated calcium channel activity	GO:004348; GO:005125; GO:190138	sarcolemma;vesicle;membrane raft;nucleus;costamere;extracellular exosome;cell-cell contact zone;plasma membrane;lysosomal membrane;focal adhesion;T-tubule;membrane;cytoplasm;cytosol;actin cytoskeleton	GO:004238; GO:003198; GO:004512; GO:000563; GO:004303; GO:007006; GO:004429; GO:000588; GO:000576; GO:000592; GO:003031; GO:001602; GO:000573; GO:000582; GO:001562	"NA"	"NA"	cadherin binding;protein binding;RNA binding;structural molecule activity conferring elasticity;S100 protein binding	GO:004529; GO:000551; GO:000372; GO:009749; GO:004454
XP_020938921.1;XP_020938920.1;XP_013849947.2	XP_020938921.1;XP_020938920.1;XP_013849947.2	XP_020938921.1 ubiquitin-conjugating enzyme E2 variant 3 isoform X3 [Sus scrofa];XP_020938920.1 ubiquitin-conjugating enzyme E2 variant 3 isoform X2 [Sus scrofa];XP_013849947.2 ubiquitin-conjugating enzyme E2 variant 3 isoform X1 [Sus scrofa]	4	4	4	79123000	60214000	64248000	0	0	0	53515000	0	0	0	0	43438000	0	0	45891000	52139000	39930000	0	NA	NA	NA	UEVLD	UEVLD;UEVLD;UEVLD;NA;NA	biological_process;carbohydrate metabolic process;carboxylic acid metabolic process;protein transport;cellular protein modification process;oxidation-reduction process	GO:000815; GO:000597; GO:001975; GO:001503; GO:000646; GO:005511	extracellular exosome	GO:007006	"NA"	"NA"	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;molecular_function	GO:001661; GO:000367
XP_013850255.1	XP_013850255.1	XP_013850255.1 complement factor D [Sus scrofa]	6	6	6	0	57970000	0	48096000	0	54404000	0	35350000	0	37242000	0	53507000	0	48327000	0	42714000	0	59061000	NA	NA	NA	CFD	CFD;NA;NA;NA;NA	complement activation, alternative pathway;proteolysis;platelet degranulation;neutrophil degranulation;complement activation	GO:000695; GO:000650; GO:000257; GO:004331; GO:000695	ficolin-1-rich granule lumen;secretory granule lumen;extracellular region;extracellular exosome;platelet alpha granule lumen	GO:190481; GO:003477; GO:000557; GO:007006; GO:003109	 Staphylococcus aureus infection; Complement and coagulation cascades	hsa0515; hsa0461	serine-type endopeptidase activity;serine-type peptidase activity	GO:000425; GO:000823
XP_013850349.1	XP_013850349.1	XP_013850349.1 major allergen I polypeptide chain 1-like [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	11607000	0	0	0	0	0	0	0	0	NA	NA	NA	LOC100739644	LOC100739644;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020941054.1;XP_013850452.2;XP_003123849.6	XP_020941054.1;XP_013850452.2;XP_003123849.6	XP_020941054.1 endoplasmic reticulum aminopeptidase 2 isoform X3 [Sus scrofa];XP_013850452.2 endoplasmic reticulum aminopeptidase 2 isoform X1 [Sus scrofa];XP_003123849.6 endoplasmic reticulum aminopeptidase 2 isoform X2 [Sus scrofa]	3	3	3	0	0	0	0	43418000	0	20400000	0	16686000	0	26414000	0	0	0	0	0	13067000	0	NA	NA	NA	ERAP2	ERAP2;ERAP2;ERAP2;NA;NA	adaptive immune response;proteolysis;regulation of blood pressure;peptide catabolic process;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of endogenous peptide antigen via MHC class I	GO:000225; GO:000650; GO:000821; GO:004317; GO:000247; GO:001988	cytoplasm;integral component of membrane;endoplasmic reticulum lumen	GO:000573; GO:001602; GO:000578	"NA"	"NA"	endopeptidase activity;peptide binding;metalloaminopeptidase activity;aminopeptidase activity;metallopeptidase activity;zinc ion binding	GO:000417; GO:004227; GO:007000; GO:000417; GO:000823; GO:000827
XP_013850496.2;XP_005661648.2;XP_020934988.1;XP_020934981.1;XP_013850497.2;NP_001254769.1;XP_020934964.1;XP_020934951.1;XP_013850494.2;XP_020934926.1;XP_020934918.1;XP_020934908.1;XP_020934905.1	XP_013850496.2;XP_005661648.2;XP_020934988.1;XP_020934981.1;XP_013850497.2;NP_001254769.1;XP_020934964.1;XP_020934951.1;XP_013850494.2;XP_020934926.1;XP_020934918.1;XP_020934908.1;XP_020934905.1	XP_013850496.2 COMM domain-containing protein 10 isoform X6 [Sus scrofa];XP_005661648.2 COMM domain-containing protein 10 isoform X11 [Sus scrofa];XP_020934988.1 COMM domain-containing protein 10 isoform X10 [Sus scrofa];XP_020934981.1 COMM domain-containi	2	2	2	48213000	0	27966000	0	0	0	0	0	0	0	39386000	0	0	0	45197000	0	36711000	0	NA	NA	NA	COMMD10	COMMD10;COMMD10;COMMD10;COMMD10;COMMD10	"NA"	"NA"	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_013850523.2	XP_013850523.2	XP_013850523.2 alpha-aminoadipic semialdehyde dehydrogenase [Sus scrofa]	17	17	17	460760000	494710000	378530000	329970000	343330000	276470000	594540000	459730000	526160000	393150000	463830000	510040000	309510000	445110000	401630000	441580000	431660000	387260000	NA	NA	NA	ALDH7A1	ALDH7A1;NA;NA;NA;NA	glycine betaine biosynthetic process from choline;lysine catabolic process;cellular aldehyde metabolic process;sensory perception of sound;choline catabolic process;oxidation-reduction process	GO:001928; GO:000655; GO:000608; GO:000760; GO:004242; GO:005511	cytosol;mitochondrial matrix;mitochondrion;extracellular exosome;nucleus	GO:000582; GO:000575; GO:000573; GO:007006; GO:000563	 Glycine, serine and threonine metabolism; beta-Alanine metabolism; Biosynthesis of amino acids; Lysine biosynthesis; Glycerolipid metabolism; Lysine degradation; Ascorbate and aldarate metabolism; Histidine metabolism; Tryptophan metabolism; Biosynthesis of antibiotics; Valine, leucine and isoleucine degradation; Glycolysis / Gluconeogenesis; Fatty acid degradation; Arginine and proline metabolism; Pyruvate metabolism; Metabolic pathways	hsa0026; hsa0041; hsa0123; hsa0030; hsa0056; hsa0031; hsa0005; hsa0034; hsa0038; hsa0113; hsa0028; hsa0001; hsa0007; hsa0033; hsa0062; hsa0110	protein binding;aldehyde dehydrogenase (NAD) activity;betaine-aldehyde dehydrogenase activity;L-aminoadipate-semialdehyde dehydrogenase activity;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity	GO:000551; GO:000402; GO:000880; GO:000404; GO:004387
XP_013850664.1	XP_013850664.1	XP_013850664.1 cysteine-rich and transmembrane domain-containing protein 1 isoform X2 [Sus scrofa]	2	2	2	0	20286000	0	23107000	21748000	0	0	23935000	0	0	21311000	0	0	0	0	0	0	0	NA	NA	NA	CYSTM1	CYSTM1;NA;NA;NA;NA	biological_process;neutrophil degranulation	GO:000815; GO:004331	extracellular exosome;tertiary granule membrane;plasma membrane;integral component of membrane	GO:007006; GO:007082; GO:000588; GO:001602	"NA"	"NA"	molecular_function	GO:000367
XP_020951375.1;XP_020951373.1;XP_020951371.1;XP_020951369.1;XP_020951355.1;XP_020951353.1;XP_020951351.1;XP_020951364.1;XP_020951363.1;XP_020951361.1;XP_020951356.1;XP_020951348.1;XP_013851284.2;XP_020951379.1;XP_020951378.1;XP_020951377.1;XP_020951374.1;XP_020951372.1;XP_020951358.1;XP_020951354.1;XP_020951352.1;XP_020951350.1;XP_020951368.1;XP_020951367.1;XP_013851332.1;XP_020951362.1;XP_020951359.1;XP_005653449.2;XP_003127793.3;XP_005653448.2;XP_013851313.2;XP_013851308.2;XP_013851299.2;XP_013851288.2;XP_013851280.1;XP_020951347.1;XP_020951380.1;XP_020951376.1;XP_020951357.1;XP_020951370.1;XP_005653450.1;XP_020951366.1;XP_020951365.1;XP_005653447.1;XP_020951349.1;XP_013851349.2;XP_013851341.2;XP_013851335.2	XP_020951375.1;XP_020951373.1;XP_020951371.1;XP_020951369.1;XP_020951355.1;XP_020951353.1;XP_020951351.1;XP_020951364.1;XP_020951363.1;XP_020951361.1;XP_020951356.1;XP_020951348.1;XP_013851284.2;XP_020951379.1;XP_020951378.1;XP_020951377.1;XP_020951374.1;XP_020951372.1;XP_020951358.1;XP_020951354.1;XP_020951352.1;XP_020951350.1;XP_020951368.1;XP_020951367.1;XP_013851332.1;XP_020951362.1;XP_020951359.1;XP_005653449.2;XP_003127793.3;XP_005653448.2;XP_013851313.2;XP_013851308.2;XP_013851299.2;XP_013851288.2;XP_013851280.1;XP_020951347.1;XP_020951380.1;XP_020951376.1;XP_020951357.1;XP_020951370.1;XP_005653450.1;XP_020951366.1;XP_020951365.1;XP_005653447.1;XP_020951349.1;XP_013851349.2;XP_013851341.2;XP_013851335.2	XP_020951375.1 protein 4.1 isoform X43 [Sus scrofa];XP_020951373.1 protein 4.1 isoform X41 [Sus scrofa];XP_020951371.1 protein 4.1 isoform X39 [Sus scrofa];XP_020951369.1 protein 4.1 isoform X37 [Sus scrofa];XP_020951355.1 protein 4.1 isoform X17 [Sus scro	10	10	10	79852000	51927000	45538000	42612000	48736000	31484000	44908000	42859000	49712000	59707000	53587000	49119000	57579000	46702000	53851000	62656000	54665000	41206000	NA	NA	NA	EPB41	EPB41;EPB41;EPB41;EPB41;EPB41	macromolecular complex assembly;positive regulation of protein binding;regulation of cell shape;positive regulation of protein localization to cell cortex;cortical actin cytoskeleton organization;actin cytoskeleton organization;cell cycle;actomyosin structure organization;cell division	GO:006500; GO:003209; GO:000836; GO:190477; GO:003086; GO:003003; GO:000704; GO:003103; GO:005130	spectrin-associated cytoskeleton;cell cortex region;plasma membrane;nucleus;cell junction;cortical cytoskeleton;cytoplasmic side of plasma membrane;macromolecular complex;cytosol;postsynaptic density	GO:001473; GO:009973; GO:000588; GO:000563; GO:003005; GO:003086; GO:000989; GO:003299; GO:000582; GO:001406	 Tight junction	hsa0453	calmodulin binding;protein binding;actin binding;structural constituent of cytoskeleton;protein N-terminus binding;1-phosphatidylinositol binding;phosphoprotein binding;protein C-terminus binding;spectrin binding	GO:000551; GO:000551; GO:000377; GO:000520; GO:004748; GO:000554; GO:005121; GO:000802; GO:003050
XP_013851496.2	XP_013851496.2	XP_013851496.2 LOW QUALITY PROTEIN: dysferlin [Sus scrofa]	30	30	30	58125000	89006000	102180000	70903000	66859000	68302000	64021000	101940000	72841000	80747000	82363000	112180000	60295000	95634000	67997000	91086000	73295000	88571000	NA	NA	NA	DYSF	DYSF;NA;NA;NA;NA	monocyte activation involved in immune response;muscle contraction;glycerol metabolic process;lipid storage;muscle fiber development;cellular response to osmotic stress;positive regulation of endothelial cell proliferation;vesicle fusion;negative regulation of protein catabolic process;negative regulation of high voltage-gated calcium channel activity;negative regulation of protein polyubiquitination;angiogenesis;macrophage activation involved in immune response;skeletal muscle tissue regeneration;cytokine secretion;plasma membrane repair;T-tubule organization;positive regulation of neutrophil chemotaxis;positive regulation of cell adhesion;negative regulation of gene expression;fat cell differentiation;negative regulation of phagocytosis;regulation of calcium ion import	GO:000228; GO:000693; GO:000607; GO:001991; GO:004874; GO:007147; GO:000193; GO:000690; GO:004217; GO:190184; GO:190291; GO:000152; GO:000228; GO:004340; GO:005066; GO:000177; GO:003329; GO:009002; GO:004578; GO:001062; GO:004544; GO:005076; GO:009027	membrane microdomain;nucleus;Golgi apparatus;T-tubule;extracellular exosome;cytoplasmic vesicle membrane;late endosome;early endosome;microtubule organizing center;lamellipodium;endocytic vesicle;microtubule;plasma membrane;integral component of membrane;sarcolemma	GO:009885; GO:000563; GO:000579; GO:003031; GO:007006; GO:003065; GO:000577; GO:000576; GO:000581; GO:003002; GO:003013; GO:000587; GO:000588; GO:001602; GO:004238	"NA"	"NA"	calcium ion binding;protein binding;alpha-tubulin binding;calcium-dependent phospholipid binding;microtubule binding	GO:000550; GO:000551; GO:004301; GO:000554; GO:000801
XP_013851951.1	XP_013851951.1	XP_013851951.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 [Sus scrofa]	3	3	3	43391000	29474000	45337000	22520000	40440000	28805000	49815000	30811000	45189000	31599000	39749000	36742000	0	24746000	37394000	36400000	39172000	28873000	NA	NA	NA	NDUFB9	NDUFB9;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;sensory perception of sound;mitochondrial respiratory chain complex I assembly	GO:000612; GO:000760; GO:003298	mitochondrion;mitochondrial inner membrane	GO:000573; GO:000574	 Oxidative phosphorylation; Non-alcoholic fatty liver disease (NAFLD); Alzheimer's disease; Metabolic pathways	hsa0019; hsa0493; hsa0501; hsa0110	protein binding;NADH dehydrogenase (ubiquinone) activity	GO:000551; GO:000813
XP_013851968.1;XP_013851966.1	XP_013851968.1;XP_013851966.1	XP_013851968.1 collagen alpha-1(XIV) chain isoform X3 [Sus scrofa];XP_013851966.1 collagen alpha-1(XIV) chain isoform X1 [Sus scrofa]	66	66	1	1751800000	3819700000	1755000000	4608900000	2570600000	7474700000	4469100000	3316300000	3041000000	4198700000	4133200000	3740400000	7458800000	5669100000	4754400000	3195600000	4428600000	6847300000	NA	NA	NA	COL14A1	COL14A1;COL14A1;NA;NA;NA	extracellular matrix organization;growth plate cartilage chondrocyte morphogenesis;cell-cell adhesion;collagen fibril organization	GO:003019; GO:000342; GO:009860; GO:003019	collagen type XIV trimer;endoplasmic reticulum lumen;extracellular region;extracellular space;extracellular matrix;collagen trimer	GO:000559; GO:000578; GO:000557; GO:000561; GO:003101; GO:000558	 Protein digestion and absorption	hsa0497	extracellular matrix structural constituent conferring tensile strength;RNA binding;protein binding, bridging;extracellular matrix structural constituent;collagen binding	GO:003002; GO:000372; GO:003067; GO:000520; GO:000551
XP_020945289.1;XP_020945288.1;XP_020945287.1;XP_013852393.1;XP_020945286.1;XP_020945285.1;XP_020945284.1	XP_020945289.1;XP_020945288.1;XP_020945287.1;XP_013852393.1;XP_020945286.1;XP_020945285.1;XP_020945284.1	XP_020945289.1 SLAM family member 9 isoform X4 [Sus scrofa];XP_020945288.1 SLAM family member 9 isoform X4 [Sus scrofa];XP_020945287.1 SLAM family member 9 isoform X3 [Sus scrofa];XP_013852393.1 SLAM family member 9 isoform X3 [Sus scrofa];XP_020945286.1 S	2	2	2	0	0	0	0	0	0	7014200	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC100525572	LOC100525572;LOC100525572;LOC100525572;LOC100525572;LOC100525572	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_013852472.2	XP_013852472.2	XP_013852472.2 thrombospondin-3 [Sus scrofa]	6	5	5	0	0	0	27670000	0	0	0	14442000	0	25183000	0	23402000	0	0	0	0	22407000	35962000	NA	NA	NA	THBS3	THBS3;NA;NA;NA;NA	ossification involved in bone maturation;cell-matrix adhesion;bone trabecula formation	GO:004393; GO:000716; GO:006034	perinuclear region of cytoplasm;extracellular region	GO:004847; GO:000557	 ECM-receptor interaction; Malaria; Phagosome; PI3K-Akt signaling pathway; Focal adhesion	hsa0451; hsa0514; hsa0414; hsa0415; hsa0451	extracellular matrix structural constituent;calcium ion binding;heparin binding	GO:000520; GO:000550; GO:000820
XP_013852550.2;XP_020945464.1	XP_013852550.2;XP_020945464.1	XP_013852550.2 long-chain fatty acid transport protein 3 isoform X1 [Sus scrofa];XP_020945464.1 long-chain fatty acid transport protein 3 isoform X2 [Sus scrofa]	6	6	6	0	0	0	0	0	0	0	0	11186000	0	0	30536000	0	0	0	0	0	0	NA	NA	NA	SLC27A3	SLC27A3;SLC27A3;NA;NA;NA	long-chain fatty acid metabolic process;long-chain fatty acid transport	GO:000167; GO:001590	membrane;integral component of membrane;mitochondrial membrane;endoplasmic reticulum;mitochondrion	GO:001602; GO:001602; GO:003196; GO:000578; GO:000573	 Insulin resistance	hsa0493	nucleotide binding;long-chain fatty acid transporter activity;long-chain fatty acid-CoA ligase activity;very long-chain fatty acid-CoA ligase activity	GO:000016; GO:000532; GO:000446; GO:003195
XP_013852691.2	XP_013852691.2	XP_013852691.2 prostaglandin F2 receptor negative regulator [Sus scrofa]	11	11	11	0	0	12310000	20905000	0	16633000	0	0	0	19848000	18245000	23503000	9783000	18403000	23487000	15667000	13382000	26124000	NA	NA	NA	PTGFRN	PTGFRN;NA;NA;NA;NA	lipid particle organization	GO:003438	integral component of membrane;cell surface;endoplasmic reticulum membrane;Golgi apparatus	GO:001602; GO:000998; GO:000578; GO:000579	"NA"	"NA"	protein binding	GO:000551
XP_013852731.2	XP_013852731.2	XP_013852731.2 ragulator complex protein LAMTOR5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18658000	NA	NA	NA	LAMTOR5	LAMTOR5;NA;NA;NA;NA	cellular response to amino acid stimulus;protein localization to lysosome;regulation of macroautophagy;negative regulation of apoptotic process;regulation of cell size;cell cycle arrest;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of TOR signaling;response to virus;viral genome replication	GO:007123; GO:006146; GO:001624; GO:004306; GO:000836; GO:000705; GO:004315; GO:003200; GO:000961; GO:001907	cytosol;Ragulator complex;lysosome	GO:000582; GO:007198; GO:000576	 Hepatitis B	hsa0516	protein binding;protein complex scaffold;guanyl-nucleotide exchange factor activity	GO:000551; GO:003294; GO:000508
XP_020947045.1;XP_013852916.2;XP_013852917.2	XP_020947045.1;XP_013852916.2;XP_013852917.2	XP_020947045.1 ataxin-10 isoform X3 [Sus scrofa];XP_013852916.2 ataxin-10 isoform X1 [Sus scrofa];XP_013852917.2 ataxin-10 isoform X2 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	3289700	0	0	0	0	0	NA	NA	NA	ATXN10	ATXN10;ATXN10;ATXN10;NA;NA	nervous system development;cilium assembly;neuron projection development;protein homotrimerization	GO:000739; GO:006027; GO:003117; GO:007020	neuronal cell body;plasma membrane;dendrite;perinuclear region of cytoplasm;extracellular space;membrane;cytoplasm;cytosol	GO:004302; GO:000588; GO:003042; GO:004847; GO:000561; GO:001602; GO:000573; GO:000582	"NA"	"NA"	enzyme binding;protein binding;identical protein binding	GO:001989; GO:000551; GO:004280
XP_020948340.1;XP_020948339.1;XP_013853477.1	XP_020948340.1;XP_020948339.1;XP_013853477.1	XP_020948340.1 cholinephosphotransferase 1 isoform X3 [Sus scrofa];XP_020948339.1 cholinephosphotransferase 1 isoform X2 [Sus scrofa];XP_013853477.1 cholinephosphotransferase 1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18318000	NA	NA	NA	CHPT1	CHPT1;CHPT1;CHPT1;NA;NA	lipid metabolic process;phosphatidylcholine biosynthetic process;platelet activating factor biosynthetic process;regulation of cell growth	GO:000662; GO:000665; GO:000666; GO:000155	membrane;endoplasmic reticulum membrane;integral component of membrane;Golgi membrane;intracellular membrane-bounded organelle;Golgi apparatus	GO:001602; GO:000578; GO:001602; GO:000013; GO:004323; GO:000579	 Ether lipid metabolism; Glycerophospholipid metabolism; Choline metabolism in cancer; Metabolic pathways	hsa0056; hsa0056; hsa0523; hsa0110	diacylglycerol cholinephosphotransferase activity;diacylglycerol binding;phosphotransferase activity, for other substituted phosphate groups;metal ion binding	GO:000414; GO:001999; GO:001678; GO:004687
XP_020949896.1;XP_020949895.1;XP_013853733.2;XP_013853732.2;XP_020949897.1;XP_020949894.1	XP_020949896.1;XP_020949895.1;XP_013853733.2;XP_013853732.2;XP_020949897.1;XP_020949894.1	XP_020949896.1 phosphorylase b kinase regulatory subunit beta isoform X4 [Sus scrofa];XP_020949895.1 phosphorylase b kinase regulatory subunit beta isoform X4 [Sus scrofa];XP_013853733.2 phosphorylase b kinase regulatory subunit beta isoform X3 [Sus scrofa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1191000	NA	NA	NA	PHKB	PHKB;PHKB;PHKB;PHKB;PHKB	generation of precursor metabolites and energy;protein phosphorylation;glycogen metabolic process	GO:000609; GO:000646; GO:000597	plasma membrane;phosphorylase kinase complex;cytosol	GO:000588; GO:000596; GO:000582	 Glucagon signaling pathway; Calcium signaling pathway; Insulin signaling pathway	hsa0492; hsa0402; hsa0491	phosphorylase kinase activity;protein binding	GO:000468; GO:000551
XP_020951030.1;XP_020951029.1;XP_020951028.1;XP_020951027.1;XP_020951026.1;XP_020951025.1;XP_020951024.1;XP_020951007.1;XP_020951023.1;XP_020951022.1;XP_020951021.1;XP_020951019.1;XP_020951018.1;XP_020951017.1;XP_020951016.1;XP_020951015.1;XP_020951014.1;XP_020951013.1;XP_020951012.1;XP_020951011.1;XP_020951010.1;XP_020951009.1;XP_020951008.1;XP_013854441.2	XP_020951030.1;XP_020951029.1;XP_020951028.1;XP_020951027.1;XP_020951026.1;XP_020951025.1;XP_020951024.1;XP_020951007.1;XP_020951023.1;XP_020951022.1;XP_020951021.1;XP_020951019.1;XP_020951018.1;XP_020951017.1;XP_020951016.1;XP_020951015.1;XP_020951014.1;XP_020951013.1;XP_020951012.1;XP_020951011.1;XP_020951010.1;XP_020951009.1;XP_020951008.1;XP_013854441.2	XP_020951030.1 mitofusin-2 isoform X1 [Sus scrofa];XP_020951029.1 mitofusin-2 isoform X1 [Sus scrofa];XP_020951028.1 mitofusin-2 isoform X1 [Sus scrofa];XP_020951027.1 mitofusin-2 isoform X1 [Sus scrofa];XP_020951026.1 mitofusin-2 isoform X1 [Sus scrofa];X	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5642400	0	0	0	NA	NA	NA	MFN2	MFN2;MFN2;MFN2;MFN2;MFN2	blastocyst formation;blood coagulation;negative regulation of smooth muscle cell proliferation;mitochondrion localization;apoptotic process;protein localization to pre-autophagosomal structure;response to unfolded protein;protein targeting to mitochondrion;mitochondrial membrane organization;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;positive regulation of vascular associated smooth muscle cell apoptotic process;negative regulation of Ras protein signal transduction;mitochondrial fusion;macroautophagy;positive regulation of vascular smooth muscle cell proliferation;cell cycle arrest;camera-type eye morphogenesis	GO:000182; GO:000759; GO:004866; GO:005164; GO:000691; GO:003449; GO:000698; GO:000662; GO:000700; GO:006173; GO:190546; GO:004658; GO:000805; GO:001623; GO:190470; GO:000705; GO:004859	integral component of membrane;cytosol;mitochondrial outer membrane;mitochondrion;microtubule cytoskeleton;intrinsic component of mitochondrial outer membrane	GO:001602; GO:000582; GO:000574; GO:000573; GO:001563; GO:003130	"NA"	"NA"	protein binding;GTPase activity;ubiquitin protein ligase binding;GTP binding	GO:000551; GO:000392; GO:003162; GO:000552
XP_020953293.1;XP_020953292.1;XP_020953291.1;XP_020953290.1;XP_013854502.1;XP_020953297.1;XP_020953296.1;XP_020953295.1;XP_020953294.1	XP_020953293.1;XP_020953292.1;XP_020953291.1;XP_020953290.1;XP_013854502.1;XP_020953297.1;XP_020953296.1;XP_020953295.1;XP_020953294.1	XP_020953293.1 heterochromatin protein 1-binding protein 3 isoform X2 [Sus scrofa];XP_020953292.1 heterochromatin protein 1-binding protein 3 isoform X1 [Sus scrofa];XP_020953291.1 heterochromatin protein 1-binding protein 3 isoform X1 [Sus scrofa];XP_0209	10	10	10	69636000	100110000	98955000	72112000	74418000	132910000	93550000	77289000	97928000	113270000	99858000	122410000	173160000	101160000	87222000	116860000	113110000	110270000	NA	NA	NA	HP1BP3	HP1BP3;HP1BP3;HP1BP3;HP1BP3;HP1BP3	regulation of transcription, DNA-templated;regulation of cell proliferation;nucleosome assembly;regulation of nucleus size;cellular response to hypoxia;heterochromatin organization	GO:000635; GO:004212; GO:000633; GO:009729; GO:007145; GO:007082	nucleus;nuclear speck;chromosome;nucleosome	GO:000563; GO:001660; GO:000569; GO:000078	"NA"	"NA"	protein binding;nucleosome binding;DNA binding	GO:000551; GO:003149; GO:000367
XP_013854580.1;XP_005673516.1;XP_003135004.1;XP_005673515.1;XP_003360284.1	XP_013854580.1;XP_005673516.1;XP_003135004.1;XP_005673515.1;XP_003360284.1	XP_013854580.1 histone-binding protein RBBP4 [Sus scrofa];XP_005673516.1 histone-binding protein RBBP7 isoform X4 [Sus scrofa];XP_003135004.1 histone-binding protein RBBP7 isoform X3 [Sus scrofa];XP_005673515.1 histone-binding protein RBBP7 isoform X2 [Sus	6	6	6	0	39722000	38153000	0	39043000	46286000	0	34405000	36427000	38502000	55027000	43776000	43115000	0	44409000	34999000	38825000	0	NA	NA	NA	RBBP4	RBBP4;RBBP7;RBBP7;RBBP7;RBBP7	CENP-A containing nucleosome assembly;negative regulation of G0 to G1 transition;ATP-dependent chromatin remodeling;negative regulation of gene expression, epigenetic;DNA replication-dependent nucleosome assembly;cell cycle;DNA replication;regulation of cell cycle;chromatin assembly;histone deacetylation;response to growth hormone;negative regulation of cell proliferation	GO:003408; GO:007031; GO:004304; GO:004581; GO:000633; GO:000704; GO:000626; GO:005172; GO:003149; GO:001657; GO:006041; GO:000828	nuclear chromatin;CAF-1 complex;cytosol;NuRD complex;ESC/E(Z) complex;nucleoplasm;nucleus;macromolecular complex	GO:000079; GO:003318; GO:000582; GO:001658; GO:003509; GO:000565; GO:000563; GO:003299	"NA"	"NA"	protein binding;histone deacetylase binding;DNA-dependent ATPase activity;histone deacetylase activity;RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;histone binding;nucleosomal DNA binding	GO:000551; GO:004282; GO:000809; GO:000440; GO:000097; GO:000098; GO:004239; GO:003149
XP_013854793.2;XP_020952106.1;XP_020952105.1	XP_013854793.2;XP_020952106.1;XP_020952105.1	XP_013854793.2 dnaJ homolog subfamily B member 4 isoform X1 [Sus scrofa];XP_020952106.1 dnaJ homolog subfamily B member 4 isoform X2 [Sus scrofa];XP_020952105.1 dnaJ homolog subfamily B member 4 isoform X2 [Sus scrofa]	4	3	3	0	0	0	0	0	0	0	10990000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DNAJB4	DNAJB4;DNAJB4;DNAJB4;NA;NA	response to heat;negative regulation of transcription from RNA polymerase II promoter;positive regulation of ATPase activity;chaperone mediated protein folding requiring cofactor;response to unfolded protein	GO:000940; GO:000012; GO:003278; GO:005108; GO:000698	nucleoplasm;cytosol;plasma membrane	GO:000565; GO:000582; GO:000588	"NA"	"NA"	chaperone binding;unfolded protein binding;ATPase activator activity;protein binding	GO:005108; GO:005108; GO:000167; GO:000551
XP_013854830.1;XP_013854829.1	XP_013854830.1;XP_013854829.1	XP_013854830.1 podocan [Sus scrofa];XP_013854829.1 podocan [Sus scrofa]	16	16	16	0	87167000	0	150350000	0	109160000	0	77446000	0	105380000	0	80014000	96841000	105300000	0	103270000	50267000	108890000	NA	NA	NA	PODN	PODN;PODN;NA;NA;NA	negative regulation of cell proliferation;negative regulation of cell migration	GO:000828; GO:003033	extracellular space;cytoplasm	GO:000561; GO:000573	"NA"	"NA"	collagen binding;extracellular matrix structural constituent conferring compression resistance	GO:000551; GO:003002
XP_020917931.1	XP_020917931.1	XP_020917931.1 LOW QUALITY PROTEIN: eukaryotic translation initiation factor 3 subunit F [Sus scrofa]	4	4	4	19852000	25936000	20547000	26210000	20668000	17360000	18624000	27220000	23610000	27524000	19909000	25943000	34676000	21721000	21905000	0	19396000	23834000	NA	NA	NA	EIF3F	EIF3F;NA;NA;NA;NA	IRES-dependent viral translational initiation;formation of cytoplasmic translation initiation complex;translational initiation;protein deubiquitination	GO:007552; GO:000173; GO:000641; GO:001657	eukaryotic 43S preinitiation complex;eukaryotic translation initiation factor 3 complex, eIF3m;cytosol;membrane;eukaryotic translation initiation factor 3 complex;eukaryotic 48S preinitiation complex	GO:001628; GO:007154; GO:000582; GO:001602; GO:000585; GO:003329	 RNA transport	hsa0301	thiol-dependent ubiquitin-specific protease activity;translation initiation factor binding;protein binding;translation initiation factor activity	GO:000484; GO:003136; GO:000551; GO:000374
XP_020917965.1	XP_020917965.1	XP_020917965.1 LOW QUALITY PROTEIN: olfactomedin-like protein 1 [Sus scrofa]	11	11	11	28126000	256020000	48414000	393330000	12953000	332590000	53288000	238270000	29328000	257580000	85042000	284630000	166030000	444660000	65499000	266350000	61218000	314170000	NA	NA	NA	OLFML1	OLFML1;NA;NA;NA;NA	"NA"	"NA"	extracellular region	GO:000557	"NA"	"NA"	"NA"	"NA"
XP_020918037.1	XP_020918037.1	XP_020918037.1 hemoglobin subunit beta-like [Sus scrofa]	10	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	70648000	NA	NA	NA	LOC100515788	LOC100515788;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020918365.1	XP_020918365.1	XP_020918365.1 LOW QUALITY PROTEIN: transcriptional coactivator YAP1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8782700	NA	NA	NA	YAP1	YAP1;NA;NA;NA;NA	positive regulation of transcription, DNA-templated;negative regulation of epithelial cell differentiation;response to progesterone;cardiac muscle tissue regeneration;regulation of stem cell proliferation;negative regulation of stem cell differentiation;vasculogenesis;transcription initiation from RNA polymerase II promoter;somatic stem cell population maintenance;embryonic heart tube morphogenesis;cell proliferation;hippo signaling;paraxial mesoderm development;cellular response to retinoic acid;cellular response to DNA damage stimulus;progesterone receptor signaling pathway;contact inhibition;cellular response to gamma radiation;regulation of hematopoietic stem cell differentiation;cell morphogenesis;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;regulation of neurogenesis;positive regulation of cardiac muscle cell proliferation;lung epithelial cell differentiation;macromolecular complex assembly;regulation of metanephric nephron tubule epithelial cell differentiation;heart process;positive regulation of stem cell population maintenance;negative regulation of nucleic acid-templated transcription;tissue homeostasis;notochord development;lateral mesoderm development;bud elongation involved in lung branching;regulation of keratinocyte proliferation;positive regulation of intracellular estrogen receptor signaling pathway;positive regulation of canonical Wnt signaling pathway;negative regulation of extrinsic apoptotic signaling pathway	GO:004589; GO:003085; GO:003257; GO:006102; GO:007209; GO:200073; GO:000157; GO:000636; GO:003501; GO:000314; GO:000828; GO:003532; GO:004833; GO:007130; GO:000697; GO:005084; GO:006024; GO:007148; GO:190203; GO:000090; GO:003021; GO:004594; GO:005076; GO:006004; GO:006048; GO:006500; GO:007230; GO:000301; GO:190245; GO:190350; GO:000189; GO:003090; GO:004836; GO:006044; GO:001083; GO:003314; GO:009026; GO:200123	nucleus;nucleoplasm;cytosol;TEAD-1-YAP complex;membrane;cytoplasm	GO:000563; GO:000565; GO:000582; GO:007114; GO:001602; GO:000573	 Hippo signaling pathway	hsa0439	protein heterodimerization activity;proline-rich region binding;protein binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding;transcription regulatory region DNA binding;activating transcription factor binding;transcription coactivator activity;chromatin binding;protein C-terminus binding	GO:004698; GO:007006; GO:000551; GO:000097; GO:004421; GO:003361; GO:000371; GO:000368; GO:000802
XP_020918376.1	XP_020918376.1	XP_020918376.1 LOW QUALITY PROTEIN: cytoplasmic dynein 2 heavy chain 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	163150000	0	NA	NA	NA	DYNC2H1	DYNC2H1;NA;NA;NA;NA	Golgi organization;intraciliary retrograde transport;multicellular organism development;cilium assembly;intraciliary transport involved in cilium assembly;microtubule-based movement	GO:000703; GO:003572; GO:000727; GO:006027; GO:003573; GO:000701	plasma membrane;dynein complex;microtubule;cilium;cytoplasmic dynein complex;Golgi apparatus;extracellular exosome;axoneme;motile cilium;ciliary tip	GO:000588; GO:003028; GO:000587; GO:000592; GO:000586; GO:000579; GO:007006; GO:000593; GO:003151; GO:009754	 Salmonella infection; Vasopressin-regulated water reabsorption; Phagosome	hsa0513; hsa0496; hsa0414	ATP binding;dynein light chain binding;motor activity;dynein light intermediate chain binding;ATP-dependent microtubule motor activity, minus-end-directed	GO:000552; GO:004550; GO:000377; GO:005195; GO:000856
XP_020918499.1	XP_020918499.1	XP_020918499.1 centromere/kinetochore protein zw10 homolog [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	5051400	0	0	0	0	0	0	0	6094300	0	0	NA	NA	NA	ZW10	ZW10;NA;NA;NA;NA	mitotic metaphase plate congression;macromolecular complex assembly;ER to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER;regulation of exit from mitosis;protein transport;cell division;protein localization to kinetochore;mitotic sister chromatid segregation;establishment of mitotic spindle orientation;Golgi organization;meiotic cell cycle	GO:000708; GO:006500; GO:000688; GO:000689; GO:000709; GO:001503; GO:005130; GO:003450; GO:000007; GO:000013; GO:000703; GO:005132	kinetochore;condensed chromosome kinetochore;membrane;Dsl1/NZR complex;nucleus;kinetochore microtubule;spindle pole;endoplasmic reticulum;RZZ complex	GO:000077; GO:000077; GO:001602; GO:007093; GO:000563; GO:000582; GO:000092; GO:000578; GO:199042	"NA"	"NA"	centromeric DNA binding;protein binding	GO:001923; GO:000551
XP_020918529.1;XP_020918528.1;XP_020918527.1	XP_020918529.1;XP_020918528.1;XP_020918527.1	XP_020918529.1 zinc finger and BTB domain-containing protein 16 [Sus scrofa];XP_020918528.1 zinc finger and BTB domain-containing protein 16 [Sus scrofa];XP_020918527.1 zinc finger and BTB domain-containing protein 16 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	30161000	0	0	0	0	0	0	NA	NA	NA	ZBTB16	ZBTB16;ZBTB16;ZBTB16;NA;NA	protein ubiquitination;embryonic pattern specification;negative regulation of cell proliferation;post-translational protein modification;cartilage development;positive regulation of cartilage development;embryonic hindlimb morphogenesis;positive regulation of apoptotic process;male germ-line stem cell asymmetric division;apoptotic process;positive regulation of chondrocyte differentiation;embryonic digit morphogenesis;negative regulation of transcription, DNA-templated;positive regulation of fat cell differentiation;positive regulation of ossification;positive regulation of NK T cell differentiation;mesonephros development;anterior/posterior pattern specification;protein localization to nucleus;forelimb morphogenesis;negative regulation of transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;central nervous system development;hemopoiesis;negative regulation of myeloid cell differentiation	GO:001656; GO:000988; GO:000828; GO:004368; GO:005121; GO:006103; GO:003511; GO:004306; GO:004813; GO:000691; GO:003233; GO:004273; GO:004589; GO:004560; GO:004577; GO:005113; GO:000182; GO:000995; GO:003450; GO:003513; GO:000012; GO:004594; GO:000741; GO:003009; GO:004563	nuclear speck;plasma membrane;cytosol;transcriptional repressor complex;PML body;macromolecular complex;nucleoplasm;nucleus	GO:001660; GO:000588; GO:000582; GO:001705; GO:001660; GO:003299; GO:000565; GO:000563	 Acute myeloid leukemia; Transcriptional misregulation in cancer	hsa0522; hsa0520	metal ion binding;protein homodimerization activity;protein binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;RNA polymerase II distal enhancer sequence-specific DNA binding;protein C-terminus binding;DNA binding;transcription factor activity, sequence-specific DNA binding;protein domain specific binding;sequence-specific DNA binding	GO:004687; GO:004280; GO:000551; GO:000122; GO:000098; GO:000802; GO:000367; GO:000370; GO:001990; GO:004356
XP_020918538.1	XP_020918538.1	XP_020918538.1 platelet-activating factor acetylhydrolase IB subunit beta [Sus scrofa]	4	4	4	28680000	26983000	25821000	25564000	24431000	25787000	25443000	30158000	32860000	24076000	28549000	34236000	44844000	0	27566000	28165000	31506000	28813000	NA	NA	NA	PAFAH1B2	PAFAH1B2;NA;NA;NA;NA	spermatogenesis;brain development;neutrophil degranulation;positive regulation of macroautophagy;lipid catabolic process;lipid metabolic process	GO:000728; GO:000742; GO:004331; GO:001623; GO:001604; GO:000662	fibrillar center;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen;cytosol;nucleolus;plasma membrane;extracellular region	GO:000165; GO:003477; GO:007006; GO:190481; GO:000582; GO:000573; GO:000588; GO:000557	 Ether lipid metabolism; Metabolic pathways	hsa0056; hsa0110	platelet-activating factor acetyltransferase activity;1-alkyl-2-acetylglycerophosphocholine esterase activity;protein heterodimerization activity;protein binding;phospholipase A2 activity;protein homodimerization activity	GO:004717; GO:000384; GO:004698; GO:000551; GO:000462; GO:004280
XP_020918603.1;XP_020918602.1;XP_020918601.1;XP_020918600.1;XP_020918599.1;XP_020918598.1;XP_020918597.1;XP_020918596.1;XP_020918595.1;XP_020918594.1;XP_020918593.1;XP_020918592.1;XP_020918591.1;XP_020918590.1;XP_020918589.1;XP_020918588.1;XP_020918587.1;XP_020918586.1;XP_020918585.1;XP_020918584.1	XP_020918603.1;XP_020918602.1;XP_020918601.1;XP_020918600.1;XP_020918599.1;XP_020918598.1;XP_020918597.1;XP_020918596.1;XP_020918595.1;XP_020918594.1;XP_020918593.1;XP_020918592.1;XP_020918591.1;XP_020918590.1;XP_020918589.1;XP_020918588.1;XP_020918587.1;XP_020918586.1;XP_020918585.1;XP_020918584.1	XP_020918603.1 pleckstrin homology-like domain family B member 1 isoform X19 [Sus scrofa];XP_020918602.1 pleckstrin homology-like domain family B member 1 isoform X18 [Sus scrofa];XP_020918601.1 pleckstrin homology-like domain family B member 1 isoform X17	5	5	5	0	0	0	0	0	0	0	0	0	0	0	13746000	0	0	0	0	0	0	NA	NA	NA	PHLDB1	PHLDB1;PHLDB1;PHLDB1;PHLDB1;PHLDB1	regulation of microtubule cytoskeleton organization;regulation of gastrulation;regulation of epithelial to mesenchymal transition;positive regulation of basement membrane assembly involved in embryonic body morphogenesis	GO:007050; GO:001047; GO:001071; GO:190426	basal cortex	GO:004518	"NA"	"NA"	"NA"	"NA"
XP_020918819.1;XP_020918818.1;XP_020918817.1;XP_020918816.1	XP_020918819.1;XP_020918818.1;XP_020918817.1;XP_020918816.1	XP_020918819.1 amyloid-like protein 2 isoform X4 [Sus scrofa];XP_020918818.1 amyloid-like protein 2 isoform X3 [Sus scrofa];XP_020918817.1 amyloid-like protein 2 isoform X2 [Sus scrofa];XP_020918816.1 amyloid-like protein 2 isoform X1 [Sus scrofa]	2	2	2	0	12366000	10754000	0	0	12473000	0	11537000	0	0	0	13366000	0	0	0	8947200	0	0	NA	NA	NA	APLP2	APLP2;APLP2;APLP2;APLP2;NA	cellular protein metabolic process;negative regulation of endopeptidase activity;platelet degranulation;G-protein coupled receptor signaling pathway;post-translational protein modification	GO:004426; GO:001095; GO:000257; GO:000718; GO:004368	plasma membrane;integral component of membrane;nucleus;platelet alpha granule membrane;extracellular exosome;endoplasmic reticulum lumen	GO:000588; GO:001602; GO:000563; GO:003109; GO:007006; GO:000578	"NA"	"NA"	DNA binding;heparin binding;transition metal ion binding;protein binding;serine-type endopeptidase inhibitor activity;identical protein binding	GO:000367; GO:000820; GO:004691; GO:000551; GO:000486; GO:004280
XP_020918855.1;XP_020918854.1;XP_020918853.1;XP_020918859.1;XP_020918858.1;XP_020918857.1;XP_020918856.1;XP_020946841.1;XP_020946840.1;XP_020946839.1;XP_020946837.1;NP_999517.1;XP_020946836.1;XP_020946835.1;XP_020946834.1;XP_020935326.1;XP_020924995.1;XP_020924994.1;XP_020924993.1;XP_020924992.1;XP_020924991.1;XP_020924990.1;XP_020924989.1;XP_020924988.1;XP_020924987.1;XP_020924985.1;XP_020924984.1;XP_020924983.1;XP_020924982.1;XP_020924981.1;XP_020924980.1	XP_020918855.1;XP_020918854.1;XP_020918853.1;XP_020918859.1;XP_020918858.1;XP_020918857.1;XP_020918856.1;XP_020946841.1;XP_020946840.1;XP_020946839.1;XP_020946837.1;NP_999517.1;XP_020946836.1;XP_020946835.1;XP_020946834.1	XP_020918855.1 plasma membrane calcium-transporting ATPase 4 isoform X2 [Sus scrofa];XP_020918854.1 plasma membrane calcium-transporting ATPase 4 isoform X1 [Sus scrofa];XP_020918853.1 plasma membrane calcium-transporting ATPase 4 isoform X1 [Sus scrofa];X	16	16	16	71243000	107530000	85498000	100220000	70705000	106350000	76257000	92720000	79029000	98315000	87053000	95488000	106460000	88925000	75240000	96426000	101160000	112370000	NA	NA	NA	ATP2B1	ATP2B1;ATP2B1;ATP2B1;ATP2B1;ATP2B1	cellular calcium ion homeostasis;response to cold;cellular response to vitamin D;cellular response to corticosterone stimulus;regulation of presynaptic cytosolic calcium ion concentration;calcium ion export from cell;regulation of cardiac conduction;regulation of cytosolic calcium ion concentration;ATP hydrolysis coupled cation transmembrane transport;calcium ion transmembrane transport;neural retina development;aging;ion transmembrane transport;brain development	GO:000687; GO:000940; GO:007130; GO:007138; GO:009950; GO:199003; GO:190377; GO:005148; GO:009913; GO:007058; GO:000340; GO:000756; GO:003422; GO:000742	nucleus;dendritic spine membrane;cytoplasmic side of plasma membrane;neuronal cell body membrane;GABA-ergic synapse;membrane;glutamatergic synapse;plasma membrane;basolateral plasma membrane;membrane raft;extracellular exosome;integral component of presynaptic active zone membrane	GO:000563; GO:003259; GO:000989; GO:003280; GO:009898; GO:001602; GO:009897; GO:000588; GO:001632; GO:004512; GO:007006; GO:009905	 cAMP signaling pathway; Pancreatic secretion; Calcium signaling pathway; Adrenergic signaling in cardiomyocytes; Endocrine and other factor-regulated calcium reabsorption	hsa0402; hsa0497; hsa0402; hsa0426; hsa0496	calcium-transporting ATPase activity;metal ion binding;calcium ion transmembrane transporter activity;calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration;protein binding;PDZ domain binding;ATP binding	GO:000538; GO:004687; GO:001508; GO:190505; GO:000551; GO:003016; GO:000552
XP_020919153.1;XP_020924465.1;XP_020924464.1;XP_013837188.1;XP_020919152.1;XP_020924462.1;XP_020924461.1;XP_020919151.1	XP_020919153.1	XP_020919153.1 guanine nucleotide-binding protein G(i) subunit alpha-1 [Sus scrofa]	15	9	9	335070000	290780000	428390000	233860000	275460000	178850000	336210000	267450000	363310000	284360000	275020000	334320000	147180000	247730000	319680000	304260000	279230000	202150000	NA	NA	NA	GNAI1	GNAI1;NA;NA;NA;NA	G-protein coupled receptor signaling pathway;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;regulation of mitotic spindle organization;protein folding;cell cycle;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;positive regulation of protein localization to cell cortex;response to peptide hormone;cell division;cellular response to forskolin;regulation of cAMP-mediated signaling	GO:000718; GO:000719; GO:006023; GO:000645; GO:000704; GO:000718; GO:190477; GO:004343; GO:005130; GO:190432; GO:004394	nucleus;plasma membrane;nucleolus;centrosome;heterotrimeric G-protein complex;midbody;extracellular exosome;lysosomal membrane;cell cortex region	GO:000563; GO:000588; GO:000573; GO:000581; GO:000583; GO:003049; GO:007006; GO:000576; GO:009973	 Axon guidance; Retrograde endocannabinoid signaling; Oxytocin signaling pathway; Toxoplasmosis; cGMP-PKG signaling pathway; Tight junction; Circadian entrainment; Gastric acid secretion; Sphingolipid signaling pathway; Gap junction; Progesterone-mediated oocyte maturation; Parkinson's disease; Morphine addiction; Chemokine signaling pathway; Long-term depression; Adrenergic signaling in cardiomyocytes; Rap1 signaling pathway; Pertussis; Pathways in cancer; Platelet activation; Leukocyte transendothelial migration	hsa0436; hsa0472; hsa0492; hsa0514; hsa0402; hsa0453; hsa0471; hsa0497; hsa0407; hsa0454; hsa0491; hsa0501; hsa0503; hsa0406; hsa0473; hsa0426; hsa0401; hsa0513; hsa0520; hsa0461; hsa0467	G-protein coupled receptor binding;GTP binding;GTPase activity;G-protein beta/gamma-subunit complex binding;protein binding;GDP binding;G-protein coupled serotonin receptor binding;magnesium ion binding	GO:000166; GO:000552; GO:000392; GO:003168; GO:000551; GO:001900; GO:003182; GO:000028
XP_020919174.1	XP_020919174.1	XP_020919174.1 synaptophysin-like protein 1 [Sus scrofa]	6	6	6	204600000	190310000	247480000	144110000	160240000	148800000	202200000	148160000	216930000	158750000	206210000	149850000	148320000	181780000	210950000	169840000	215250000	171600000	NA	NA	NA	SYPL1	SYPL1;NA;NA;NA;NA	chemical synaptic transmission	GO:000726	integral component of membrane;integral component of synaptic vesicle membrane;integral component of plasma membrane;secretory granule;melanosome;extracellular exosome	GO:001602; GO:003028; GO:000588; GO:003014; GO:004247; GO:007006	"NA"	"NA"	"NA"	"NA"
XP_020919247.1;XP_020919246.1;XP_020919245.1;XP_020919244.1;XP_020919243.1;XP_020919242.1;XP_020919241.1	XP_020919247.1;XP_020919246.1;XP_020919245.1;XP_020919244.1;XP_020919243.1;XP_020919242.1;XP_020919241.1	XP_020919247.1 cullin-1 [Sus scrofa];XP_020919246.1 cullin-1 [Sus scrofa];XP_020919245.1 cullin-1 [Sus scrofa];XP_020919244.1 cullin-1 [Sus scrofa];XP_020919243.1 cullin-1 [Sus scrofa];XP_020919242.1 cullin-1 [Sus scrofa];XP_020919241.1 cullin-1 [Sus scrof	4	4	4	0	0	54537000	0	0	0	0	0	0	0	0	0	0	0	71789000	0	0	0	NA	NA	NA	CUL1	CUL1;CUL1;CUL1;CUL1;CUL1	cell proliferation;G1/S transition of mitotic cell cycle;Wnt signaling pathway;ubiquitin-dependent protein catabolic process;negative regulation of cell proliferation;viral process;SCF complex assembly;negative regulation of G2/M transition of mitotic cell cycle;protein polyubiquitination;cell cycle arrest;protein ubiquitination;cellular iron ion homeostasis;stress-activated MAPK cascade;interleukin-1-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;animal organ morphogenesis;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway;post-translational protein modification;regulation of mitotic cell cycle phase transition	GO:000828; GO:000008; GO:001605; GO:000651; GO:000828; GO:001603; GO:001026; GO:001097; GO:000020; GO:000705; GO:001656; GO:000687; GO:005140; GO:007049; GO:003806; GO:004316; GO:000988; GO:003114; GO:009719; GO:004368; GO:190199	SCF ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;Parkin-FBXW7-Cul1 ubiquitin ligase complex;cytosol;nucleoplasm	GO:001900; GO:003146; GO:199045; GO:000582; GO:000565	 Cell cycle; Oocyte meiosis; Wnt signaling pathway; Circadian rhythm; Ubiquitin mediated proteolysis; TGF-beta signaling pathway; Herpes simplex infection; Protein processing in endoplasmic reticulum	hsa0411; hsa0411; hsa0431; hsa0471; hsa0412; hsa0435; hsa0516; hsa0414	protein binding;ubiquitin-protein transferase activity;ubiquitin protein ligase binding;ubiquitin protein ligase activity	GO:000551; GO:000484; GO:003162; GO:006163
XP_020919403.1;XP_020957802.1;XP_020957801.1;NP_001230318.1;XP_020957800.1;XP_020957799.1	XP_020919403.1	XP_020919403.1 LOW QUALITY PROTEIN: torsin-1A-interacting protein 1 [Sus scrofa]	4	4	4	0	12006000	0	0	0	0	0	0	0	0	0	0	0	12176000	0	11381000	0	0	NA	NA	NA	TOR1AIP1	TOR1AIP1;NA;NA;NA;NA	positive regulation of ATPase activity;protein localization to nucleus;nuclear membrane organization	GO:003278; GO:003450; GO:007176	nuclear membrane;nucleus;integral component of membrane	GO:003196; GO:000563; GO:001602	"NA"	"NA"	cytoskeletal protein binding;lamin binding;protein binding;ATPase activator activity;ATPase binding	GO:000809; GO:000552; GO:000551; GO:000167; GO:005111
XP_020919438.1;XP_020919437.1;XP_020919442.1;XP_020919441.1;XP_020919440.1	XP_020919438.1;XP_020919437.1;XP_020919442.1;XP_020919441.1;XP_020919440.1	XP_020919438.1 ATP-dependent RNA helicase A isoform X1 [Sus scrofa];XP_020919437.1 ATP-dependent RNA helicase A isoform X1 [Sus scrofa];XP_020919442.1 ATP-dependent RNA helicase A isoform X2 [Sus scrofa];XP_020919441.1 ATP-dependent RNA helicase A isoform	26	26	26	108280000	126860000	121780000	140530000	104040000	153110000	121990000	134230000	134140000	120420000	131160000	166380000	147790000	147900000	133630000	142490000	116070000	138880000	NA	NA	NA	DHX9	DHX9;DHX9;DHX9;DHX9;DHX9	DNA duplex unwinding;innate immune response;CRD-mediated mRNA stabilization;protein localization to cytoplasmic stress granule;positive regulation of tumor necrosis factor secretion;regulation of cytoplasmic translation;DNA replication;alternative mRNA splicing, via spliceosome;osteoblast differentiation;RNA secondary structure unwinding;positive regulation of DNA replication;positive regulation of interleukin-6 secretion;DNA-templated transcription, termination;positive regulation of type I interferon production;positive regulation of DNA repair;positive regulation of gene silencing by miRNA;inflammatory response;regulation of mRNA processing;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;DNA-templated viral transcription;mRNA splicing, via spliceosome;positive regulation of interleukin-18 production;G-quadruplex DNA unwinding;positive regulation of transcription from RNA polymerase II promoter;positive regulation of fibroblast proliferation;positive regulation of viral transcription;mRNA transport;positive regulation of NF-kappaB transcription factor activity;positive regulation of interferon-alpha secretion;targeting of mRNA for destruction involved in RNA interference;positive regulation of interferon-beta secretion;positive regulation of inflammatory response;positive regulation of response to cytokine stimulus;positive regulation of viral translation;positive regulation of polysome binding;positive regulation of RNA export from nucleus;rhythmic process;regulation of defense response to virus by host;pyroptosis;small RNA loading onto RISC;cellular response to tumor necrosis factor;cellular response to exogenous dsRNA	GO:003250; GO:004508; GO:007093; GO:190360; GO:190446; GO:200076; GO:000626; GO:000038; GO:000164; GO:001050; GO:004574; GO:200077; GO:000635; GO:003248; GO:004573; GO:200063; GO:000695; GO:005068; GO:200037; GO:003969; GO:000039; GO:003274; GO:004480; GO:004594; GO:004814; GO:005043; GO:005102; GO:005109; GO:190274; GO:003042; GO:003554; GO:005072; GO:006076; GO:190497; GO:190569; GO:004683; GO:004851; GO:005069; GO:007026; GO:007092; GO:007135; GO:007136	cytosol;perichromatin fibrils;nuclear body;micro-ribonucleoprotein complex;cytoplasmic ribonucleoprotein granule;membrane;polysome;polysomal ribosome;nucleus;centrosome;RISC-loading complex;ribonucleoprotein complex;nucleolus;nucleoplasm;actin cytoskeleton;macromolecular complex;CRD-mediated mRNA stability complex;nuclear stress granule	GO:000582; GO:000572; GO:001660; GO:003506; GO:003646; GO:001602; GO:000584; GO:004278; GO:000563; GO:000581; GO:007057; GO:199090; GO:000573; GO:000565; GO:001562; GO:003299; GO:007093; GO:009716	"NA"	"NA"	RNA polymerase II transcription factor binding;DNA replication origin binding;transcription coactivator activity;ATP-dependent 3'-5' RNA helicase activity;triplex DNA binding;polysome binding;sequence-specific mRNA binding;DNA binding;RNA polymerase binding;double-stranded DNA binding;ATPase activity;siRNA binding;RISC complex binding;single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity;RNA polymerase II core promoter proximal region sequence-specific DNA binding;single-stranded RNA binding;ATP-dependent DNA helicase activity;nucleoside-triphosphatase activity;ATP binding;nucleoside-triphosphate diphosphatase activity;promoter-specific chromatin binding;RNA polymerase II core binding;importin-alpha family protein binding;protein binding;metal ion binding;chromatin DNA binding;regulatory region RNA binding;ATP-dependent 3'-5' DNA/RNA helicase activity;RNA stem-loop binding;ATP-dependent 3'-5' DNA helicase activity	GO:000108; GO:000368; GO:000371; GO:003445; GO:004514; GO:190553; GO:199082; GO:000367; GO:007006; GO:000369; GO:001688; GO:003519; GO:190517; GO:199051; GO:000097; GO:000372; GO:000400; GO:001711; GO:000552; GO:004742; GO:199084; GO:000099; GO:006167; GO:000551; GO:004687; GO:003149; GO:000106; GO:003368; GO:003561; GO:004314
XP_020919475.1;XP_013833352.2	XP_020919475.1;XP_013833352.2	XP_020919475.1 nucleoprotein TPR isoform X1 [Sus scrofa];XP_013833352.2 nucleoprotein TPR isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2830100	NA	NA	NA	TPR	TPR;TPR;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;RNA import into nucleus;nuclear pore organization;negative regulation of translational initiation;cell division;mitotic spindle assembly checkpoint;positive regulation of protein import into nucleus;nuclear matrix organization;regulation of mRNA export from nucleus;cellular response to interferon-alpha;protein import into nucleus;protein export from nucleus;response to epidermal growth factor;regulation of mitotic sister chromatid separation;cellular response to heat;positive regulation of mitotic cell cycle spindle assembly checkpoint;positive regulation of intracellular protein transport;mRNA export from nucleus in response to heat stress;regulation of protein stability;negative regulation of RNA export from nucleus;viral process;positive regulation of heterochromatin assembly;regulation of protein localization;regulation of protein export from nucleus;nuclear pore complex assembly;regulation of mitotic spindle assembly	GO:000012; GO:000640; GO:000699; GO:004594; GO:005130; GO:000709; GO:004230; GO:004357; GO:001079; GO:003545; GO:000660; GO:000661; GO:007084; GO:001096; GO:003460; GO:009026; GO:009031; GO:003199; GO:003164; GO:004683; GO:001603; GO:003145; GO:003288; GO:004682; GO:005129; GO:190167	nucleus;nuclear envelope;nuclear membrane;nuclear periphery;nuclear pore nuclear basket;nuclear pore;nucleoplasm;cytoplasmic dynein complex;cytoplasm;extrinsic component of membrane;nuclear inclusion body;mitotic spindle;kinetochore	GO:000563; GO:000563; GO:003196; GO:003439; GO:004461; GO:000564; GO:000565; GO:000586; GO:000573; GO:001989; GO:004240; GO:007268; GO:000077	 RNA transport; Pathways in cancer; Thyroid cancer	hsa0301; hsa0520; hsa0521	RNA binding;protein binding;mitogen-activated protein kinase binding;tubulin binding;dynein complex binding;heat shock protein binding;protein homodimerization activity;protein anchor;chromatin binding;mRNA binding;transporter activity;structural constituent of nuclear pore	GO:000372; GO:000551; GO:005101; GO:001563; GO:007084; GO:003107; GO:004280; GO:004349; GO:000368; GO:000372; GO:000521; GO:001705
XP_020919515.1	XP_020919515.1	XP_020919515.1 neudesin [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1527900	0	0	0	NA	NA	NA	NENF	NENF;NA;NA;NA;NA	negative regulation of appetite;regulation of receptor activity;positive regulation of MAPK cascade	GO:003209; GO:001046; GO:004341	nucleoplasm;nucleus;extracellular space	GO:000565; GO:000563; GO:000561	"NA"	"NA"	growth factor activity;metal ion binding	GO:000808; GO:004687
XP_020919632.1;NP_001106918.1	XP_020919632.1;NP_001106918.1	XP_020919632.1 phytanoyl-CoA dioxygenase, peroxisomal isoform X1 [Sus scrofa];NP_001106918.1 phytanoyl-CoA dioxygenase, peroxisomal [Sus scrofa]	5	5	5	0	25971000	33264000	0	26138000	0	38955000	25963000	0	25313000	0	0	0	0	0	0	0	17399000	NA	NA	NA	PHYH	PHYH;PHYH;NA;NA;NA	fatty acid alpha-oxidation;2-oxoglutarate metabolic process;methyl-branched fatty acid metabolic process;protein targeting to peroxisome;isoprenoid metabolic process	GO:000156; GO:000610; GO:009708; GO:000662; GO:000672	peroxisomal matrix;cytosol;peroxisome	GO:000578; GO:000582; GO:000577	 Peroxisome	hsa0414	cofactor binding;ferrous iron binding;phytanoyl-CoA dioxygenase activity;protein binding;carboxylic acid binding;L-ascorbic acid binding	GO:004803; GO:000819; GO:004824; GO:000551; GO:003140; GO:003141
XP_020919690.1;XP_020919689.1;XP_020919688.1;XP_020919687.1;XP_020919686.1;XP_020919685.1;XP_020919684.1;XP_020919683.1	XP_020919690.1;XP_020919689.1;XP_020919688.1;XP_020919687.1;XP_020919686.1;XP_020919685.1;XP_020919684.1;XP_020919683.1	XP_020919690.1 heterogeneous nuclear ribonucleoprotein K isoform X4 [Sus scrofa];XP_020919689.1 heterogeneous nuclear ribonucleoprotein K isoform X4 [Sus scrofa];XP_020919688.1 heterogeneous nuclear ribonucleoprotein K isoform X4 [Sus scrofa];XP_020919687.	18	18	1	326580000	462360000	417320000	438810000	400530000	533850000	421200000	400210000	400890000	446640000	403680000	403120000	511330000	487720000	417600000	505350000	443430000	556970000	NA	NA	NA	HNRNPK	HNRNPK;HNRNPK;HNRNPK;HNRNPK;HNRNPK	viral process;positive regulation of receptor-mediated endocytosis;positive regulation of transcription from RNA polymerase II promoter;RNA processing;RNA metabolic process;regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of low-density lipoprotein particle clearance;positive regulation of low-density lipoprotein particle receptor biosynthetic process;mRNA splicing, via spliceosome;signal transduction;negative regulation of apoptotic process;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;negative regulation of mRNA splicing, via spliceosome	GO:001603; GO:004826; GO:004594; GO:000639; GO:001607; GO:190216; GO:001098; GO:004571; GO:000039; GO:000716; GO:004306; GO:007236; GO:004802	cytoplasm;nucleus;cell projection;extracellular exosome;nucleoplasm;focal adhesion;cytoplasmic stress granule;membrane;podosome;catalytic step 2 spliceosome;nuclear chromatin	GO:000573; GO:000563; GO:004299; GO:007006; GO:000565; GO:000592; GO:001049; GO:001602; GO:000210; GO:007101; GO:000079	 MicroRNAs in cancer; Herpes simplex infection; Viral carcinogenesis; Spliceosome	hsa0520; hsa0516; hsa0520; hsa0304	identical protein binding;protein domain specific binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;single-stranded DNA binding;cadherin binding;protein binding;RNA binding;RNA polymerase II core promoter proximal region sequence-specific DNA binding	GO:004280; GO:001990; GO:000122; GO:000369; GO:004529; GO:000551; GO:000372; GO:000097
XP_020919796.1;XP_020919795.1;XP_020919794.1;XP_020919793.1;XP_020919792.1	XP_020919796.1;XP_020919795.1;XP_020919794.1;XP_020919793.1;XP_020919792.1	XP_020919796.1 melanoma inhibitory activity protein 3 isoform X5 [Sus scrofa];XP_020919795.1 melanoma inhibitory activity protein 3 isoform X4 [Sus scrofa];XP_020919794.1 melanoma inhibitory activity protein 3 isoform X3 [Sus scrofa];XP_020919793.1 melanom	2	2	2	0	0	0	0	0	0	0	40840000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MIA3	MIA3;MIA3;MIA3;MIA3;MIA3	positive regulation of leukocyte migration;cargo loading into vesicle;wound healing;protein localization to endoplasmic reticulum exit site;cargo loading into COPII-coated vesicle;cellular protein metabolic process;protein secretion;cell migration involved in sprouting angiogenesis;exocytosis;endoplasmic reticulum organization;negative regulation of cell migration;post-translational protein modification;negative regulation of lymphocyte migration;protein transport;lipoprotein transport;negative regulation of leukocyte cell-cell adhesion;negative regulation of cell adhesion	GO:000268; GO:003545; GO:004206; GO:007097; GO:009011; GO:004426; GO:000930; GO:000204; GO:000688; GO:000702; GO:003033; GO:004368; GO:200040; GO:001503; GO:004295; GO:190303; GO:000716	intracellular membrane-bounded organelle;membrane;endoplasmic reticulum membrane;Golgi membrane;endoplasmic reticulum exit site	GO:004323; GO:001602; GO:000578; GO:000013; GO:007097	"NA"	"NA"	protein binding;lipoprotein transporter activity	GO:000551; GO:004295
XP_020919888.1	XP_020919888.1	XP_020919888.1 LOW QUALITY PROTEIN: sickle tail protein homolog [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	KIAA1217	KIAA1217;NA;NA;NA;NA	embryonic skeletal system development	GO:004870	cytoplasm	GO:000573	"NA"	"NA"	molecular_function	GO:000367
XP_020919974.1;XP_020919973.1	XP_020919974.1;XP_020919973.1	XP_020919974.1 bifunctional glutamate/proline--tRNA ligase isoform X2 [Sus scrofa];XP_020919973.1 bifunctional glutamate/proline--tRNA ligase isoform X1 [Sus scrofa]	27	27	27	52407000	70655000	89641000	60248000	80317000	83589000	90606000	72704000	76020000	77789000	96357000	59125000	71455000	82052000	66766000	69224000	86002000	77953000	NA	NA	NA	EPRS	EPRS;EPRS;NA;NA;NA	cellular response to interferon-gamma;long-chain fatty acid import;cellular response to insulin stimulus;tRNA aminoacylation for protein translation;prolyl-tRNA aminoacylation;glutamyl-tRNA aminoacylation;macromolecular complex assembly;negative regulation of translation	GO:007134; GO:004453; GO:003286; GO:000641; GO:000643; GO:000642; GO:006500; GO:001714	cytosol;aminoacyl-tRNA synthetase multienzyme complex;membrane;GAIT complex;plasma membrane;ribonucleoprotein complex;cytoplasm	GO:000582; GO:001710; GO:001602; GO:009745; GO:000588; GO:199090; GO:000573	 Metabolic pathways; Aminoacyl-tRNA biosynthesis; Porphyrin and chlorophyll metabolism	hsa0110; hsa0097; hsa0086	glutamate-tRNA ligase activity;identical protein binding;ATP binding;proline-tRNA ligase activity;GTPase binding;zinc ion binding;RNA stem-loop binding;protein binding	GO:000481; GO:004280; GO:000552; GO:000482; GO:005102; GO:000827; GO:003561; GO:000551
XP_020920002.1;XP_020920001.1;XP_020920000.1;XP_020919998.1;XP_020919997.1;XP_020919996.1	XP_020920002.1;XP_020920001.1;XP_020920000.1;XP_020919998.1;XP_020919997.1;XP_020919996.1	XP_020920002.1 mitochondrial amidoxime-reducing component 1 isoform X6 [Sus scrofa];XP_020920001.1 mitochondrial amidoxime-reducing component 1 isoform X5 [Sus scrofa];XP_020920000.1 mitochondrial amidoxime-reducing component 1 isoform X4 [Sus scrofa];XP_0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25077000	NA	NA	NA	MARC1	MARC1;MARC1;MARC1;MARC1;MARC1	detoxification of nitrogen compound;nitrate metabolic process;oxidation-reduction process	GO:005141; GO:004212; GO:005511	integral component of membrane;mitochondrion;mitochondrial outer membrane	GO:001602; GO:000573; GO:000574	"NA"	"NA"	nitrate reductase activity;molybdenum ion binding;molybdopterin cofactor binding;pyridoxal phosphate binding	GO:000894; GO:003015; GO:004354; GO:003017
XP_020920069.1;XP_020920068.1;XP_020920067.1;XP_020920066.1;XP_020920065.1;XP_020920064.1;XP_020920056.1;XP_020920055.1;XP_020920054.1;XP_020920053.1;XP_020920052.1;XP_020920050.1;XP_020920049.1;XP_020920063.1;XP_020920062.1;XP_020920061.1;XP_020920060.1;XP_020920058.1;XP_020920057.1;XP_020920051.1	XP_020920069.1;XP_020920068.1;XP_020920067.1;XP_020920066.1;XP_020920065.1;XP_020920064.1;XP_020920056.1;XP_020920055.1;XP_020920054.1;XP_020920053.1;XP_020920052.1;XP_020920050.1;XP_020920049.1;XP_020920063.1;XP_020920062.1;XP_020920061.1;XP_020920060.1;XP_020920058.1;XP_020920057.1;XP_020920051.1	XP_020920069.1 protein enabled homolog isoform X20 [Sus scrofa];XP_020920068.1 protein enabled homolog isoform X19 [Sus scrofa];XP_020920067.1 protein enabled homolog isoform X18 [Sus scrofa];XP_020920066.1 protein enabled homolog isoform X17 [Sus scrofa];	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	6532200	0	0	0	0	0	NA	NA	NA	ENAH	ENAH;ENAH;ENAH;ENAH;ENAH	axon guidance	GO:000741	plasma membrane;cytoskeleton;synapse;focal adhesion;cytosol;lamellipodium;cell junction;filopodium	GO:000588; GO:000585; GO:004520; GO:000592; GO:000582; GO:003002; GO:003005; GO:003017	 Regulation of actin cytoskeleton	hsa0481	protein binding;SH3 domain binding;WW domain binding;actin binding	GO:000551; GO:001712; GO:005069; GO:000377
XP_020920078.1;XP_020920077.1;XP_020920076.1;XP_020920075.1	XP_020920078.1;XP_020920077.1;XP_020920076.1;XP_020920075.1	XP_020920078.1 atypical kinase COQ8A, mitochondrial [Sus scrofa];XP_020920077.1 atypical kinase COQ8A, mitochondrial [Sus scrofa];XP_020920076.1 atypical kinase COQ8A, mitochondrial [Sus scrofa];XP_020920075.1 atypical kinase COQ8A, mitochondrial [Sus scro	4	4	4	18011000	0	16608000	0	0	0	18990000	0	16281000	0	14426000	0	0	0	17680000	11624000	0	0	NA	NA	NA	COQ8A	COQ8A;COQ8A;COQ8A;COQ8A;NA	ubiquinone biosynthetic process;phosphorylation;protein phosphorylation	GO:000674; GO:001631; GO:000646	mitochondrion;extrinsic component of mitochondrial inner membrane;integral component of membrane	GO:000573; GO:003131; GO:001602	"NA"	"NA"	ADP binding;protein binding;ATP binding;protein kinase activity;kinase activity	GO:004353; GO:000551; GO:000552; GO:000467; GO:001630
XP_020920183.1	XP_020920183.1	XP_020920183.1 leiomodin-1 [Sus scrofa]	6	6	6	0	0	35468000	0	0	16021000	0	17930000	13184000	36979000	16687000	23085000	48440000	0	0	0	0	0	NA	NA	NA	LMOD1	LMOD1;NA;NA;NA;NA	myofibril assembly;positive regulation of actin filament polymerization;actin nucleation;pointed-end actin filament capping;muscle contraction	GO:003023; GO:003083; GO:004501; GO:005169; GO:000693	myofibril;cytosol;striated muscle thin filament;membrane;actin filament;sarcomere	GO:003001; GO:000582; GO:000586; GO:001602; GO:000588; GO:003001	"NA"	"NA"	actin binding;tropomyosin binding	GO:000377; GO:000552
XP_020920186.1	XP_020920186.1	XP_020920186.1 aminopeptidase B [Sus scrofa]	10	10	10	21811000	20041000	21293000	20851000	25979000	22431000	17395000	18180000	15648000	18772000	0	30443000	31338000	18800000	17317000	24110000	23738000	23039000	NA	NA	NA	RNPEP	RNPEP;NA;NA;NA;NA	negative regulation of blood pressure;proteolysis	GO:004577; GO:000650	secretory granule;plasma membrane;extracellular region;extracellular exosome	GO:003014; GO:000588; GO:000557; GO:007006	"NA"	"NA"	epoxide hydrolase activity;metalloexopeptidase activity;zinc ion binding;aminopeptidase activity	GO:000430; GO:000823; GO:000827; GO:000417
XP_020920192.1	XP_020920192.1	XP_020920192.1 ADP-ribosylation factor-like protein 8A [Sus scrofa]	7	7	2	71653000	52128000	61623000	41203000	65007000	38207000	40674000	51291000	76151000	59356000	32777000	63191000	55470000	43746000	37060000	59242000	43015000	52831000	NA	NA	NA	ARL8A	ARL8A;NA;NA;NA;NA	anterograde axonal transport;neutrophil degranulation;cell division;cell cycle;chromosome segregation	GO:000808; GO:004331; GO:005130; GO:000704; GO:000705	lysosomal membrane;ficolin-1-rich granule membrane;spindle midzone;extracellular exosome;membrane;azurophil granule membrane;axon cytoplasm;midbody;plasma membrane;vacuolar membrane;cytoplasm;late endosome membrane	GO:000576; GO:010100; GO:005123; GO:007006; GO:001602; GO:003557; GO:190411; GO:003049; GO:000588; GO:000577; GO:000573; GO:003190	"NA"	"NA"	beta-tubulin binding;GTPase activity;alpha-tubulin binding;GTP binding;protein binding	GO:004848; GO:000392; GO:004301; GO:000552; GO:000551
XP_020920318.1;XP_020920317.1;XP_003125749.1	XP_020920318.1;XP_020920317.1;XP_003125749.1	XP_020920318.1 ubiquilin-1 isoform X2 [Sus scrofa];XP_020920317.1 ubiquilin-1 isoform X1 [Sus scrofa];XP_003125749.1 ubiquilin-4 [Sus scrofa]	5	5	3	13571000	7986900	12345000	7845400	0	0	13379000	8139900	5391000	0	9713100	0	12346000	9079300	14916000	0	9996100	0	NA	NA	NA	UBQLN1	UBQLN1;UBQLN1;UBQLN4;NA;NA	cellular response to hypoxia;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;regulation of protein ubiquitination;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;macroautophagy;regulation of macroautophagy;ubiquitin-dependent ERAD pathway;negative regulation of toll-like receptor 3 signaling pathway;autophagosome maturation;aggrephagy;negative regulation of store-operated calcium channel activity;autophagosome assembly;ubiquitin-dependent protein catabolic process;response to endoplasmic reticulum stress	GO:007145; GO:190307; GO:003139; GO:190217; GO:001623; GO:001624; GO:003043; GO:003414; GO:009735; GO:003597; GO:190134; GO:000004; GO:000651; GO:003497	macromolecular complex;cytosol;autophagosome;plasma membrane;aggresome;proteasome complex;nucleoplasm;endoplasmic reticulum;cytoplasm;cytoplasmic vesicle;perinuclear region of cytoplasm	GO:003299; GO:000582; GO:000577; GO:000588; GO:001623; GO:000050; GO:000565; GO:000578; GO:000573; GO:003141; GO:004847	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;polyubiquitin binding;identical protein binding;kinase binding	GO:000551; GO:003159; GO:004280; GO:001990
XP_020920411.1;XP_020920403.1;XP_020920400.1	XP_020920411.1;XP_020920403.1;XP_020920400.1	XP_020920411.1 structural maintenance of chromosomes protein 5 isoform X3 [Sus scrofa];XP_020920403.1 structural maintenance of chromosomes protein 5 isoform X2 [Sus scrofa];XP_020920400.1 structural maintenance of chromosomes protein 5 isoform X1 [Sus scr	3	3	3	0	0	0	0	0	0	0	0	0	19628000	0	0	0	0	0	0	0	0	NA	NA	NA	SMC5	SMC5;SMC5;SMC5;NA;NA	cellular response to DNA damage stimulus;sister chromatid cohesion;telomere maintenance via recombination;cell division;positive regulation of chromosome segregation;cellular senescence;double-strand break repair via nonhomologous end joining;positive regulation of maintenance of mitotic sister chromatid cohesion	GO:000697; GO:000706; GO:000072; GO:005130; GO:005198; GO:009039; GO:000630; GO:003418	nuclear speck;Smc5-Smc6 complex;sex chromosome;chromosome, telomeric region;nucleus;cell junction;nucleoplasm;PML body;site of double-strand break;interchromatin granule	GO:001660; GO:003091; GO:000080; GO:000078; GO:000563; GO:003005; GO:000565; GO:001660; GO:003586; GO:003506	"NA"	"NA"	protein binding;ATP binding	GO:000551; GO:000552
XP_020920464.1	XP_020920464.1	XP_020920464.1 kinesin-1 heavy chain [Sus scrofa]	15	15	12	21621000	55098000	38302000	36861000	34713000	45904000	31114000	35201000	29458000	32983000	25694000	72668000	0	45501000	40730000	41438000	36412000	35727000	NA	NA	NA	KIF5B	KIF5B;NA;NA;NA;NA	hippocampus development;microtubule-based movement;positive regulation of insulin secretion involved in cellular response to glucose stimulus;vesicle transport along microtubule;centrosome localization;plus-end-directed vesicle transport along microtubule;retrograde neuronal dense core vesicle transport;regulation of membrane potential;anterograde axonal protein transport;positive regulation of protein localization to plasma membrane;positive regulation of voltage-gated sodium channel activity;positive regulation of potassium ion transport;positive regulation of synaptic transmission, GABAergic;cellular response to interferon-gamma;positive regulation of intracellular protein transport;cytoplasm organization;positive regulation of vesicle fusion;stress granule disassembly	GO:002176; GO:000701; GO:003577; GO:004749; GO:005164; GO:007238; GO:199004; GO:004239; GO:009964; GO:190307; GO:190515; GO:004326; GO:003223; GO:007134; GO:009031; GO:000702; GO:003134; GO:003561	microtubule;axonal growth cone;kinesin complex;vesicle;phagocytic vesicle;perinuclear region of cytoplasm;axon cytoplasm;membrane;microtubule organizing center;ciliary rootlet;cytosol	GO:000587; GO:004429; GO:000587; GO:003198; GO:004533; GO:004847; GO:190411; GO:001602; GO:000581; GO:003525; GO:000582	 Endocytosis; Dopaminergic synapse	hsa0414; hsa0472	protein binding;JUN kinase binding;cadherin binding;microtubule motor activity;ATP binding;ATPase activity;microtubule binding;identical protein binding;microtubule lateral binding	GO:000551; GO:000843; GO:004529; GO:000377; GO:000552; GO:001688; GO:000801; GO:004280; GO:009960
XP_020920472.1;XP_020932147.1;XP_020932146.1;XP_013852807.1;XP_013852782.1	XP_020920472.1	XP_020920472.1 LOW QUALITY PROTEIN: signal transducing adapter molecule 1 [Sus scrofa]	3	3	3	0	15657000	8860500	0	0	12043000	0	0	0	0	0	0	0	0	0	10189000	0	0	NA	NA	NA	STAM	STAM;NA;NA;NA;NA	macroautophagy;negative regulation of epidermal growth factor receptor signaling pathway;intracellular protein transport;membrane organization;signal transduction;positive regulation of signal transduction;regulation of extracellular exosome assembly;protein deubiquitination;multivesicular body assembly;positive regulation of exosomal secretion;endosomal transport	GO:001623; GO:004205; GO:000688; GO:006102; GO:000716; GO:000996; GO:190355; GO:001657; GO:003625; GO:190354; GO:001619	ESCRT-0 complex;cytosol;early endosome membrane	GO:003356; GO:000582; GO:003190	 Endocytosis; Jak-STAT signaling pathway	hsa0414; hsa0463	protein binding;SH3/SH2 adaptor activity;ubiquitin-like protein ligase binding	GO:000551; GO:000507; GO:004438
XP_020920488.1;XP_020920486.1;XP_020920487.1	XP_020920488.1;XP_020920486.1;XP_020920487.1	XP_020920488.1 ras suppressor protein 1 isoform X3 [Sus scrofa];XP_020920486.1 ras suppressor protein 1 isoform X1 [Sus scrofa];XP_020920487.1 ras suppressor protein 1 isoform X2 [Sus scrofa]	9	9	9	157200000	233700000	200290000	290650000	193930000	174280000	153010000	296770000	176390000	287320000	207010000	410700000	184550000	264090000	179430000	331550000	137500000	189740000	NA	NA	NA	RSU1	RSU1;RSU1;RSU1;NA;NA	positive regulation of cell-substrate adhesion;regulation of cell-substrate adhesion;positive regulation of GTPase activity;signal transduction	GO:001081; GO:001081; GO:004354; GO:000716	extracellular exosome;cytosol;focal adhesion	GO:007006; GO:000582; GO:000592	"NA"	"NA"	protein binding	GO:000551
XP_020920570.1	XP_020920570.1	XP_020920570.1 retinal dehydrogenase 1 [Sus scrofa]	28	28	23	1488400000	1622800000	1350300000	1666200000	1251600000	1294000000	2204800000	1760200000	1469800000	1656200000	1190100000	1263300000	649320000	1443600000	1218000000	2082000000	1428100000	1621900000	NA	NA	NA	ALDH1A1	ALDH1A1;NA;NA;NA;NA	positive regulation of GTPase activity;ethanol oxidation;retinoid metabolic process;retinol metabolic process;oxidation-reduction process;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate;cellular aldehyde metabolic process	GO:004354; GO:000606; GO:000152; GO:004257; GO:005511; GO:006162; GO:000608	cytoplasm;extracellular exosome;cytosol	GO:000573; GO:007006; GO:000582	 Retinol metabolism; Metabolic pathways	hsa0083; hsa0110	benzaldehyde dehydrogenase (NAD+) activity;aldehyde dehydrogenase (NAD) activity;NAD binding;GTPase activator activity;androgen binding;retinal dehydrogenase activity	GO:001847; GO:000402; GO:005128; GO:000509; GO:000549; GO:000175
XP_020920622.1;XP_020920621.1;XP_020920620.1	XP_020920622.1;XP_020920621.1;XP_020920620.1	XP_020920622.1 plexin domain-containing protein 2 [Sus scrofa];XP_020920621.1 plexin domain-containing protein 2 [Sus scrofa];XP_020920620.1 plexin domain-containing protein 2 [Sus scrofa]	5	5	5	20711000	32551000	46035000	0	17931000	0	17201000	17966000	32562000	14853000	0	22853000	31787000	0	26016000	30955000	38051000	0	NA	NA	NA	PLXDC2	PLXDC2;PLXDC2;PLXDC2;NA;NA	"NA"	"NA"	integral component of membrane	GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_020920642.1;XP_020920641.1;XP_020920640.1;XP_020920639.1	XP_020920642.1;XP_020920641.1;XP_020920640.1;XP_020920639.1	XP_020920642.1 cullin-2 [Sus scrofa];XP_020920641.1 cullin-2 [Sus scrofa];XP_020920640.1 cullin-2 [Sus scrofa];XP_020920639.1 cullin-2 [Sus scrofa]	3	3	3	0	0	97989000	87847000	113840000	0	0	0	0	0	0	0	0	76031000	99438000	89883000	0	0	NA	NA	NA	CUL2	CUL2;CUL2;CUL2;CUL2;NA	cell cycle arrest;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway;protein ubiquitination;ubiquitin-dependent protein catabolic process;viral process;negative regulation of cell proliferation;G1/S transition of mitotic cell cycle;regulation of transcription from RNA polymerase II promoter in response to hypoxia	GO:000705; GO:003114; GO:004368; GO:004316; GO:009719; GO:001656; GO:000651; GO:001603; GO:000828; GO:000008; GO:006141	VCB complex;Cul2-RING ubiquitin ligase complex;SCF ubiquitin ligase complex;nucleolus;cytosol;nucleoplasm	GO:003089; GO:003146; GO:001900; GO:000573; GO:000582; GO:000565	 HIF-1 signaling pathway; Pathways in cancer; Ubiquitin mediated proteolysis; Renal cell carcinoma	hsa0406; hsa0520; hsa0412; hsa0521	protein binding;ubiquitin protein ligase binding;ubiquitin protein ligase activity;macromolecular complex binding	GO:000551; GO:003162; GO:006163; GO:004487
XP_020920661.1	XP_020920661.1	XP_020920661.1 ATP synthase subunit gamma, mitochondrial isoform X1 [Sus scrofa]	8	8	1	383370000	185330000	360940000	221300000	339320000	215600000	362160000	271160000	363950000	273600000	277660000	225820000	191760000	261160000	279680000	268900000	270770000	197910000	NA	NA	NA	ATP5F1C	ATP5F1C;NA;NA;NA;NA	oxidative phosphorylation;ATP synthesis coupled proton transport;mitochondrial ATP synthesis coupled proton transport;cristae formation;ATP biosynthetic process;ATP hydrolysis coupled cation transmembrane transport	GO:000611; GO:001598; GO:004277; GO:004240; GO:000675; GO:009913	mitochondrion;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex;membrane;mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)	GO:000573; GO:000574; GO:000575; GO:001602; GO:000027	 Alzheimer's disease; Parkinson's disease; Oxidative phosphorylation; Metabolic pathways	hsa0501; hsa0501; hsa0019; hsa0110	proton-transporting ATP synthase activity, rotational mechanism;ATPase activity;proton-transporting ATPase activity, rotational mechanism;transmembrane transporter activity;RNA binding	GO:004693; GO:001688; GO:004696; GO:002285; GO:000372
XP_020920663.1;XP_020920662.1	XP_020920663.1;XP_020920662.1	XP_020920663.1 ATP synthase subunit gamma, mitochondrial isoform X3 [Sus scrofa];XP_020920662.1 ATP synthase subunit gamma, mitochondrial isoform X2 [Sus scrofa]	8	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2763600	NA	NA	NA	ATP5F1C	ATP5F1C;ATP5F1C;NA;NA;NA	oxidative phosphorylation;ATP synthesis coupled proton transport;mitochondrial ATP synthesis coupled proton transport;cristae formation;ATP biosynthetic process;ATP hydrolysis coupled cation transmembrane transport	GO:000611; GO:001598; GO:004277; GO:004240; GO:000675; GO:009913	mitochondrion;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex;membrane;mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)	GO:000573; GO:000574; GO:000575; GO:001602; GO:000027	 Alzheimer's disease; Parkinson's disease; Oxidative phosphorylation; Metabolic pathways	hsa0501; hsa0501; hsa0019; hsa0110	proton-transporting ATP synthase activity, rotational mechanism;ATPase activity;proton-transporting ATPase activity, rotational mechanism;transmembrane transporter activity;RNA binding	GO:004693; GO:001688; GO:004696; GO:002285; GO:000372
XP_020920702.1;XP_020920701.1;XP_020920700.1;XP_020920711.1;XP_020920710.1;XP_020920709.1;XP_020920708.1;XP_020920707.1;XP_020920706.1;XP_020920705.1;XP_020920704.1;XP_020920703.1	XP_020920702.1;XP_020920701.1;XP_020920700.1;XP_020920711.1;XP_020920710.1;XP_020920709.1;XP_020920708.1;XP_020920707.1;XP_020920706.1;XP_020920705.1;XP_020920704.1;XP_020920703.1	XP_020920702.1 protein FAM208B isoform X3 [Sus scrofa];XP_020920701.1 protein FAM208B isoform X2 [Sus scrofa];XP_020920700.1 protein FAM208B isoform X1 [Sus scrofa];XP_020920711.1 protein FAM208B isoform X9 [Sus scrofa];XP_020920710.1 protein FAM208B isofo	2	2	2	56324000	0	78734000	0	57411000	0	132460000	0	0	0	0	0	0	0	0	0	121740000	0	NA	NA	NA	TASOR2	TASOR2;TASOR2;TASOR2;TASOR2;TASOR2	"NA"	"NA"	cytosol;nucleoplasm;nucleus	GO:000582; GO:000565; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_020920725.1	XP_020920725.1	XP_020920725.1 ATP-dependent 6-phosphofructokinase, platelet type [Sus scrofa]	11	11	11	0	59724000	42188000	70409000	0	86442000	29550000	57799000	28128000	55730000	27603000	67682000	50885000	54284000	29855000	55374000	37537000	66272000	NA	NA	NA	PFKP	PFKP;NA;NA;NA;NA	fructose 6-phosphate metabolic process;cellular response to leukemia inhibitory factor;canonical glycolysis;fructose 1,6-bisphosphate metabolic process;glucose catabolic process	GO:000600; GO:199083; GO:006162; GO:003038; GO:000600	cytoplasm;extracellular exosome;membrane;cytosol;6-phosphofructokinase complex;nucleus	GO:000573; GO:007006; GO:001602; GO:000582; GO:000594; GO:000563	 Glycolysis / Gluconeogenesis; RNA degradation; Pentose phosphate pathway; AMPK signaling pathway; Central carbon metabolism in cancer; Metabolic pathways; Thyroid hormone signaling pathway; Biosynthesis of amino acids; Fructose and mannose metabolism; Biosynthesis of antibiotics; Carbon metabolism	hsa0001; hsa0301; hsa0003; hsa0415; hsa0523; hsa0110; hsa0491; hsa0123; hsa0005; hsa0113; hsa0120	metal ion binding;ATP binding;fructose-6-phosphate binding;cadherin binding;AMP binding;macromolecular complex binding;6-phosphofructokinase activity;monosaccharide binding	GO:004687; GO:000552; GO:007009; GO:004529; GO:001620; GO:004487; GO:000387; GO:004802
XP_020920809.1	XP_020920809.1	XP_020920809.1 LOW QUALITY PROTEIN: phosphoserine aminotransferase [Sus scrofa]	14	14	14	441020000	380090000	329030000	347140000	217020000	208960000	391060000	335580000	299460000	350840000	266700000	275370000	164330000	335050000	314610000	384920000	423990000	391860000	NA	NA	NA	PSAT1	PSAT1;NA;NA;NA;NA	pyridoxine biosynthetic process;L-serine biosynthetic process	GO:000861; GO:000656	cytosol;extracellular exosome	GO:000582; GO:007006	 Metabolic pathways; Vitamin B6 metabolism; Glycine, serine and threonine metabolism; Carbon metabolism; Biosynthesis of antibiotics; Biosynthesis of amino acids	hsa0110; hsa0075; hsa0026; hsa0120; hsa0113; hsa0123	O-phospho-L-serine:2-oxoglutarate aminotransferase activity	GO:000464
XP_020920826.1;NP_001070695.1	XP_020920826.1;NP_001070695.1	XP_020920826.1 ubiquitin carboxyl-terminal hydrolase isozyme L3 isoform X1 [Sus scrofa];NP_001070695.1 ubiquitin carboxyl-terminal hydrolase isozyme L3 [Sus scrofa]	3	3	3	0	0	27194000	0	0	0	21944000	22770000	23710000	23450000	0	0	0	0	0	31396000	0	0	NA	NA	NA	UCHL3	UCHL3;UCHL3;NA;NA;NA	ubiquitin-dependent protein catabolic process;protein deubiquitination;protein catabolic process;post-translational protein modification	GO:000651; GO:001657; GO:003016; GO:004368	nucleus;cytoplasm;cytosol	GO:000563; GO:000573; GO:000582	"NA"	"NA"	thiol-dependent ubiquitinyl hydrolase activity;thiol-dependent ubiquitin-specific protease activity;ubiquitin binding;NEDD8-specific protease activity;protein binding;peptidase activity	GO:003645; GO:000484; GO:004313; GO:001978; GO:000551; GO:000823
XP_020920924.1	XP_020920924.1	XP_020920924.1 ubiquitin-fold modifier 1 isoform X2 [Sus scrofa]	5	5	5	0	48094000	42312000	39509000	45043000	43625000	38524000	47972000	39766000	40319000	46990000	49992000	39989000	47610000	45592000	49432000	48856000	46834000	NA	NA	NA	UFM1	UFM1;NA;NA;NA;NA	protein K69-linked ufmylation;regulation of intracellular estrogen receptor signaling pathway;brain development;response to endoplasmic reticulum stress;negative regulation of apoptotic process;protein ufmylation	GO:199059; GO:003314; GO:000742; GO:003497; GO:004306; GO:007156	nucleus;endoplasmic reticulum;cytoplasm	GO:000563; GO:000578; GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_020920960.1;XP_020920962.1;XP_020920961.1	XP_020920960.1;XP_020920962.1;XP_020920961.1	XP_020920960.1 WD repeat and FYVE domain-containing protein 2 isoform X1 [Sus scrofa];XP_020920962.1 WD repeat and FYVE domain-containing protein 2 isoform X3 [Sus scrofa];XP_020920961.1 WD repeat and FYVE domain-containing protein 2 isoform X2 [Sus scrofa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	13373000	0	0	0	0	0	0	NA	NA	NA	WDFY2	WDFY2;WDFY2;WDFY2;NA;NA	positive regulation of fat cell differentiation;positive regulation of protein phosphorylation	GO:004560; GO:000193	vesicle;early endosome	GO:003198; GO:000576	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_020921031.1;XP_020921030.1	XP_020921031.1;XP_020921030.1	XP_020921031.1 glypican-6 isoform X2 [Sus scrofa];XP_020921030.1 glypican-6 isoform X1 [Sus scrofa]	3	3	3	0	22851000	13639000	15285000	12042000	14768000	0	15492000	9211300	18038000	12256000	25849000	14838000	18889000	17443000	28275000	13366000	18785000	NA	NA	NA	GPC6	GPC6;GPC6;NA;NA;NA	retinoid metabolic process;glycosaminoglycan biosynthetic process;regulation of signal transduction;Wnt signaling pathway, planar cell polarity pathway;cell migration	GO:000152; GO:000602; GO:000996; GO:006007; GO:001647	plasma membrane;anchored component of plasma membrane;Golgi lumen;nucleus;glutamatergic synapse;extracellular space;lysosomal lumen	GO:000588; GO:004665; GO:000579; GO:000563; GO:009897; GO:000561; GO:004320	"NA"	"NA"	coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway;protein binding	GO:190492; GO:000551
XP_020921081.1;XP_020921080.1;XP_020921078.1;XP_020921077.1	XP_020921081.1;XP_020921080.1;XP_020921078.1;XP_020921077.1	XP_020921081.1 paraspeckle component 1 isoform X4 [Sus scrofa];XP_020921080.1 paraspeckle component 1 isoform X3 [Sus scrofa];XP_020921078.1 paraspeckle component 1 isoform X2 [Sus scrofa];XP_020921077.1 paraspeckle component 1 isoform X1 [Sus scrofa]	4	4	4	0	0	0	9021100	0	0	8513300	10630000	0	11236000	0	11345000	9374600	9892900	0	9533500	0	0	NA	NA	NA	PSPC1	PSPC1;PSPC1;PSPC1;PSPC1;NA	rhythmic process;regulation of transcription from RNA polymerase II promoter;innate immune response;negative regulation of transcription, DNA-templated;regulation of circadian rhythm;activation of innate immune response	GO:004851; GO:000635; GO:004508; GO:004589; GO:004275; GO:000221	fibrillar center;paraspeckles;cytoplasm;nucleus;nucleoplasm;nuclear matrix;nuclear speck	GO:000165; GO:004238; GO:000573; GO:000563; GO:000565; GO:001636; GO:001660	"NA"	"NA"	protein binding;RNA binding;transcription regulatory region sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;E-box binding	GO:000551; GO:000372; GO:000097; GO:000098; GO:007088
XP_020921120.1;XP_020921119.1;XP_020921118.1;XP_020921116.1;XP_020921115.1;XP_013835848.2;XP_020921114.1;XP_020921113.1;XP_020921117.1	XP_020921120.1;XP_020921119.1;XP_020921118.1;XP_020921116.1;XP_020921115.1;XP_013835848.2;XP_020921114.1;XP_020921113.1;XP_020921117.1	XP_020921120.1 gamma-sarcoglycan isoform X8 [Sus scrofa];XP_020921119.1 gamma-sarcoglycan isoform X7 [Sus scrofa];XP_020921118.1 gamma-sarcoglycan isoform X6 [Sus scrofa];XP_020921116.1 gamma-sarcoglycan isoform X4 [Sus scrofa];XP_020921115.1 gamma-sarcogl	5	5	5	19288000	21044000	0	19894000	0	0	0	23414000	0	19826000	0	36572000	0	19619000	17002000	23943000	0	28919000	NA	NA	NA	SGCG	SGCG;SGCG;SGCG;SGCG;SGCG	cardiac muscle tissue development;heart contraction;muscle organ development	GO:004873; GO:006004; GO:000751	cytoplasm;sarcoglycan complex;integral component of membrane;nucleoplasm;plasma membrane;cytoskeleton;sarcolemma	GO:000573; GO:001601; GO:001602; GO:000565; GO:000588; GO:000585; GO:004238	 Arrhythmogenic right ventricular cardiomyopathy (ARVC); Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0541	protein binding	GO:000551
XP_020921244.1;XP_020921243.1	XP_020921244.1;XP_020921243.1	XP_020921244.1 succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial isoform X2 [Sus scrofa];XP_020921243.1 succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial isoform X1 [Sus scrofa]	10	9	9	89111000	68519000	101010000	67804000	123400000	60458000	87860000	61309000	89923000	81628000	82178000	54439000	46467000	64446000	87269000	93243000	60700000	59385000	NA	NA	NA	SUCLA2	SUCLA2;SUCLA2;NA;NA;NA	tricarboxylic acid cycle;succinate metabolic process;succinyl-CoA pathway	GO:000609; GO:000610; GO:000678	mitochondrion;extracellular exosome;mitochondrial matrix	GO:000573; GO:007006; GO:000575	 Biosynthesis of antibiotics; Metabolic pathways; Carbon metabolism; Citrate cycle (TCA cycle); Propanoate metabolism	hsa0113; hsa0110; hsa0120; hsa0002; hsa0064	ATP binding;protein binding;succinate-CoA ligase (ADP-forming) activity;magnesium ion binding	GO:000552; GO:000551; GO:000477; GO:000028
XP_020921358.1;XP_020921347.1;XP_020921336.1;XP_020921327.1;XP_020921321.1;XP_020921315.1;XP_020921311.1	XP_020921358.1;XP_020921347.1;XP_020921336.1;XP_020921327.1;XP_020921321.1;XP_020921315.1;XP_020921311.1	XP_020921358.1 talin-1 isoform X5 [Sus scrofa];XP_020921347.1 talin-1 isoform X5 [Sus scrofa];XP_020921336.1 talin-1 isoform X4 [Sus scrofa];XP_020921327.1 talin-1 isoform X3 [Sus scrofa];XP_020921321.1 talin-1 isoform X2 [Sus scrofa];XP_020921315.1 talin-	118	118	106	3721100000	4690400000	4314100000	4649000000	3365200000	4738000000	3621400000	4848400000	3656100000	5641400000	3832200000	6739400000	4174800000	5427100000	3352900000	5727600000	3545300000	4357400000	NA	NA	NA	TLN1	TLN1;TLN1;TLN1;TLN1;TLN1	cortical actin cytoskeleton organization;integrin activation;cell-substrate junction assembly;integrin-mediated signaling pathway;muscle contraction;platelet aggregation;viral process;platelet degranulation;cytoskeletal anchoring at plasma membrane;IRE1-mediated unfolded protein response	GO:003086; GO:003362; GO:000704; GO:000722; GO:000693; GO:007052; GO:001603; GO:000257; GO:000701; GO:003649	extracellular region;focal adhesion;cytosol;extracellular exosome;cell surface;ruffle;cytoskeleton;ruffle membrane	GO:000557; GO:000592; GO:000582; GO:007006; GO:000998; GO:000172; GO:000585; GO:003258	 Platelet activation; HTLV-I infection; Focal adhesion; Rap1 signaling pathway	hsa0461; hsa0516; hsa0451; hsa0401	integrin binding;LIM domain binding;cadherin binding;actin filament binding;structural constituent of cytoskeleton;phosphatidylserine binding;protein binding;phosphatidylinositol binding;vinculin binding	GO:000517; GO:003027; GO:004529; GO:005101; GO:000520; GO:000178; GO:000551; GO:003509; GO:001716
XP_020921390.1;XP_020940614.1;XP_020940613.1;XP_020940612.1;XP_020940611.1;XP_020940610.1;XP_020940609.1;XP_020956820.1;XP_020956819.1	XP_020921390.1	XP_020921390.1 BTB/POZ domain-containing protein KCTD12 [Sus scrofa]	13	13	13	66611000	113750000	98669000	115070000	74500000	131510000	86821000	117440000	87063000	101720000	101070000	151650000	139850000	126510000	96762000	119240000	87518000	164260000	NA	NA	NA	KCTD12	KCTD12;NA;NA;NA;NA	protein homooligomerization	GO:005126	presynaptic membrane;cell junction;postsynaptic membrane	GO:004273; GO:003005; GO:004521	"NA"	"NA"	identical protein binding;RNA binding	GO:004280; GO:000372
XP_020921440.1;XP_020921441.1	XP_020921440.1;XP_020921441.1	XP_020921440.1 SLIT and NTRK-like protein 6 isoform X1 [Sus scrofa];XP_020921441.1 SLIT and NTRK-like protein 6 isoform X2 [Sus scrofa]	2	2	2	0	0	0	0	0	0	86843000	0	0	0	0	120810000	65810000	0	0	0	0	0	NA	NA	NA	SLITRK6	SLITRK6;SLITRK6;NA;NA;NA	startle response;lens development in camera-type eye;sensory perception of sound;adult locomotory behavior;innervation;cochlea development;multicellular organism growth;auditory receptor cell morphogenesis;axonogenesis;positive regulation of synapse assembly;synapse assembly;vestibulocochlear nerve development;auditory behavior;linear vestibuloocular reflex	GO:000196; GO:000208; GO:000760; GO:000834; GO:006038; GO:009010; GO:003526; GO:000209; GO:000740; GO:005196; GO:000741; GO:002156; GO:003122; GO:006000	cell surface;plasma membrane	GO:000998; GO:000588	"NA"	"NA"	"NA"	"NA"
XP_020921513.1	XP_020921513.1	XP_020921513.1 transmembrane 9 superfamily member 2 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	7865000	0	0	0	0	0	0	0	0	NA	NA	NA	TM9SF2	TM9SF2;NA;NA;NA;NA	protein localization to membrane	GO:007265	integral component of plasma membrane;membrane;extracellular exosome;endosome membrane;endosome	GO:000588; GO:001602; GO:007006; GO:001000; GO:000576	"NA"	"NA"	"NA"	"NA"
XP_020921522.1;XP_020921521.1;XP_020921520.1;XP_020921519.1;XP_020921518.1;XP_020921517.1;XP_020921516.1;XP_020921514.1	XP_020921522.1;XP_020921521.1;XP_020921520.1;XP_020921519.1;XP_020921518.1;XP_020921517.1;XP_020921516.1;XP_020921514.1	XP_020921522.1 citrate lyase subunit beta-like protein, mitochondrial isoform X2 [Sus scrofa];XP_020921521.1 citrate lyase subunit beta-like protein, mitochondrial isoform X1 [Sus scrofa];XP_020921520.1 citrate lyase subunit beta-like protein, mitochondria	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	5914500	0	0	0	0	0	NA	NA	NA	CLYBL	CLYBL;CLYBL;CLYBL;CLYBL;CLYBL	protein homotrimerization	GO:007020	mitochondrion	GO:000573	"NA"	"NA"	magnesium ion binding;(3S)-citramalyl-CoA lyase activity;malate synthase activity	GO:000028; GO:004777; GO:000447
XP_020921526.1;XP_020921525.1	XP_020921526.1;XP_020921525.1	XP_020921526.1 propionyl-CoA carboxylase alpha chain, mitochondrial isoform X2 [Sus scrofa];XP_020921525.1 propionyl-CoA carboxylase alpha chain, mitochondrial isoform X1 [Sus scrofa]	19	19	19	133880000	87703000	103710000	65110000	132360000	79407000	112970000	95782000	113900000	95812000	99743000	76297000	46646000	75572000	96484000	102320000	72746000	67633000	NA	NA	NA	PCCA	PCCA;PCCA;NA;NA;NA	biotin metabolic process	GO:000676	cytosol;mitochondrial matrix	GO:000582; GO:000575	 Propanoate metabolism; Glyoxylate and dicarboxylate metabolism; Metabolic pathways; Biosynthesis of antibiotics; Carbon metabolism; Valine, leucine and isoleucine degradation	hsa0064; hsa0063; hsa0110; hsa0113; hsa0120; hsa0028	metal ion binding;protein binding;propionyl-CoA carboxylase activity;ATP binding;biotin binding;enzyme binding	GO:004687; GO:000551; GO:000465; GO:000552; GO:000937; GO:001989
XP_020921568.1;XP_020921567.1	XP_020921568.1;XP_020921567.1	XP_020921568.1 collagen alpha-2(IV) chain [Sus scrofa];XP_020921567.1 collagen alpha-2(IV) chain [Sus scrofa]	6	6	6	77415000	89617000	57089000	155200000	57213000	45070000	68598000	124840000	70127000	69364000	71870000	140440000	82092000	141180000	65361000	94116000	53104000	55082000	NA	NA	NA	COL4A2	COL4A2;COL4A2;NA;NA;NA	aging;collagen-activated tyrosine kinase receptor signaling pathway;cellular response to transforming growth factor beta stimulus;angiogenesis;transcription, DNA-templated;response to activity;negative regulation of angiogenesis;endodermal cell differentiation;extracellular matrix organization	GO:000756; GO:003806; GO:007156; GO:000152; GO:000635; GO:001482; GO:001652; GO:003598; GO:003019	extracellular exosome;collagen type IV trimer;extracellular space;endoplasmic reticulum lumen;extracellular region;extracellular matrix	GO:007006; GO:000558; GO:000561; GO:000578; GO:000557; GO:003101	 Protein digestion and absorption; Focal adhesion; Pathways in cancer; Small cell lung cancer; PI3K-Akt signaling pathway; Amoebiasis	hsa0497; hsa0451; hsa0520; hsa0522; hsa0415; hsa0514	extracellular matrix structural constituent conferring tensile strength;protein binding;extracellular matrix structural constituent	GO:003002; GO:000551; GO:000520
XP_020921569.1;XP_020936439.1;XP_020936438.1;XP_020936437.1	XP_020921569.1;XP_020936439.1;XP_020936438.1;XP_020936437.1	XP_020921569.1 LOW QUALITY PROTEIN: collagen alpha-1(IV) chain [Sus scrofa];XP_020936439.1 collagen alpha-5(IV) chain isoform X3 [Sus scrofa];XP_020936438.1 collagen alpha-5(IV) chain isoform X2 [Sus scrofa];XP_020936437.1 collagen alpha-5(IV) chain isofor	4	4	4	76846000	135690000	104780000	232820000	63301000	57690000	115560000	221050000	69989000	98773000	81018000	287950000	65669000	165020000	101960000	155330000	68048000	81775000	NA	NA	NA	COL4A1	COL4A1;COL4A5;COL4A5;COL4A5;NA	epithelial cell differentiation;blood vessel morphogenesis;retinal blood vessel morphogenesis;cellular response to amino acid stimulus;basement membrane organization;brain development;branching involved in blood vessel morphogenesis;renal tubule morphogenesis;neuromuscular junction development;extracellular matrix organization;collagen-activated tyrosine kinase receptor signaling pathway	GO:003085; GO:004851; GO:006130; GO:007123; GO:007171; GO:000742; GO:000156; GO:006133; GO:000752; GO:003019; GO:003806	extracellular region;collagen type IV trimer;extracellular space;basement membrane;extracellular matrix;endoplasmic reticulum lumen	GO:000557; GO:000558; GO:000561; GO:000560; GO:003101; GO:000578	 Amoebiasis; Protein digestion and absorption; Focal adhesion; PI3K-Akt signaling pathway; Pathways in cancer; Small cell lung cancer	hsa0514; hsa0497; hsa0451; hsa0415; hsa0520; hsa0522	extracellular matrix structural constituent conferring tensile strength;platelet-derived growth factor binding;protein binding;extracellular matrix structural constituent	GO:003002; GO:004840; GO:000551; GO:000520
XP_020921647.1;NP_001163994.1	XP_020921647.1;NP_001163994.1	XP_020921647.1 ferrochelatase, mitochondrial isoform X1 [Sus scrofa];NP_001163994.1 ferrochelatase, mitochondrial [Sus scrofa]	5	5	5	0	23242000	29043000	0	30832000	36698000	32987000	32575000	0	27820000	30108000	38509000	32272000	0	32234000	38012000	32470000	40651000	NA	NA	NA	FECH	FECH;FECH;NA;NA;NA	response to insecticide;response to ethanol;response to methylmercury;cellular response to dexamethasone stimulus;heme biosynthetic process;generation of precursor metabolites and energy;response to arsenic-containing substance;protoporphyrinogen IX metabolic process;response to platinum ion;response to light stimulus;response to lead ion	GO:001708; GO:004547; GO:005159; GO:007154; GO:000678; GO:000609; GO:004668; GO:004650; GO:007054; GO:000941; GO:001028	mitochondrion;mitochondrial inner membrane;mitochondrial matrix	GO:000573; GO:000574; GO:000575	 Porphyrin and chlorophyll metabolism; Metabolic pathways	hsa0086; hsa0110	ferrous iron binding;2 iron, 2 sulfur cluster binding;protein binding;ferrochelatase activity	GO:000819; GO:005153; GO:000551; GO:000432
XP_020921680.1;XP_020921672.1;XP_020921669.1;XP_020921668.1	XP_020921680.1;XP_020921672.1;XP_020921669.1;XP_020921668.1	XP_020921680.1 clathrin light chain A isoform X4 [Sus scrofa];XP_020921672.1 clathrin light chain A isoform X3 [Sus scrofa];XP_020921669.1 clathrin light chain A isoform X2 [Sus scrofa];XP_020921668.1 clathrin light chain A isoform X1 [Sus scrofa]	7	7	7	69843000	105970000	93814000	82928000	99795000	118450000	98220000	105200000	100520000	91015000	106160000	122910000	106830000	112270000	110160000	110090000	109300000	113440000	NA	NA	NA	CLTA	CLTA;CLTA;CLTA;CLTA;NA	cell cycle;clathrin coat assembly;membrane organization;clathrin-dependent endocytosis;intracellular protein transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;low-density lipoprotein particle clearance;low-density lipoprotein particle receptor catabolic process;cell division	GO:000704; GO:004826; GO:006102; GO:007258; GO:000688; GO:001988; GO:003438; GO:003280; GO:005130	synaptic vesicle membrane;endolysosome membrane;cytosol;clathrin coat of trans-Golgi network vesicle;membrane;postsynaptic endocytic zone cytoplasmic component;clathrin complex;plasma membrane;clathrin coat;clathrin vesicle coat;clathrin-coated endocytic vesicle;spindle;cytoplasmic vesicle;trans-Golgi network membrane;presynaptic endocytic zone membrane	GO:003067; GO:003602; GO:000582; GO:003013; GO:001602; GO:009963; GO:007143; GO:000588; GO:003011; GO:003012; GO:004533; GO:000581; GO:003141; GO:003258; GO:009883	 Synaptic vesicle cycle; Huntington's disease; Bacterial invasion of epithelial cells; Lysosome; Endocrine and other factor-regulated calcium reabsorption	hsa0472; hsa0501; hsa0510; hsa0414; hsa0496	peptide binding;GTPase binding;molecular_function;protein binding;structural molecule activity;clathrin heavy chain binding;macromolecular complex binding	GO:004227; GO:005102; GO:000367; GO:000551; GO:000519; GO:003205; GO:004487
XP_020921685.1;XP_020921684.1;XP_020921687.1;XP_020921686.1;NP_001244205.1;NP_001098772.1	XP_020921685.1;XP_020921684.1;XP_020921687.1;XP_020921686.1;NP_001244205.1;NP_001098772.1	XP_020921685.1 ATP-citrate synthase isoform X1 [Sus scrofa];XP_020921684.1 ATP-citrate synthase isoform X1 [Sus scrofa];XP_020921687.1 ATP-citrate synthase isoform X2 [Sus scrofa];XP_020921686.1 ATP-citrate synthase isoform X2 [Sus scrofa];NP_001244205.1 A	52	52	52	13467000000	2841000000	6243400000	3110200000	6585600000	1486800000	8883000000	4435900000	4553800000	2723400000	5751200000	817120000	2610000000	2174500000	3116500000	2735200000	4954700000	2087200000	NA	NA	NA	ACLY	ACLY;ACLY;ACLY;ACLY;ACLY	coenzyme A metabolic process;neutrophil degranulation;oxaloacetate metabolic process;lipid biosynthetic process;fatty-acyl-CoA biosynthetic process;acetyl-CoA biosynthetic process;fatty acid biosynthetic process;cholesterol biosynthetic process;positive regulation of cellular metabolic process	GO:001593; GO:004331; GO:000610; GO:000861; GO:004694; GO:000608; GO:000663; GO:000669; GO:003132	plasma membrane;citrate lyase complex;extracellular exosome;extracellular region;ficolin-1-rich granule lumen;membrane;cytosol;nucleoplasm;azurophil granule lumen	GO:000588; GO:000934; GO:007006; GO:000557; GO:190481; GO:001602; GO:000582; GO:000565; GO:003557	 Biosynthesis of antibiotics; Metabolic pathways; Citrate cycle (TCA cycle)	hsa0113; hsa0110; hsa0002	cofactor binding;protein binding;metal ion binding;ATP citrate synthase activity;ATP binding	GO:004803; GO:000551; GO:004687; GO:000387; GO:000552
XP_020921697.1	XP_020921697.1	XP_020921697.1 adapter molecule crk isoform X1 [Sus scrofa]	8	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7602000	NA	NA	NA	CRK	CRK;NA;NA;NA;NA	hippocampus development;Fc-gamma receptor signaling pathway involved in phagocytosis;negative regulation of wound healing;response to cholecystokinin;regulation of GTPase activity;cellular response to nitric oxide;activation of GTPase activity;regulation of T cell migration;establishment of cell polarity;vascular endothelial growth factor receptor signaling pathway;cytokine-mediated signaling pathway;cellular response to insulin-like growth factor stimulus;cellular response to endothelin;regulation of signal transduction;positive regulation of smooth muscle cell migration;cerebellar neuron development;regulation of cell adhesion mediated by integrin;negative regulation of natural killer cell mediated cytotoxicity;cellular response to nerve growth factor stimulus;response to hepatocyte growth factor;regulation of protein binding;cell chemotaxis;regulation of transcription from RNA polymerase II promoter;regulation of actin cytoskeleton organization;negative regulation of cell motility;neuron migration;response to yeast;regulation of cell shape;reelin-mediated signaling pathway;lipid metabolic process;cellular response to transforming growth factor beta stimulus;activation of MAPKK activity;dendrite development;cerebral cortex development;helper T cell diapedesis;regulation of dendrite development;response to hydrogen peroxide;regulation of Rac protein signal transduction;positive regulation of substrate adhesion-dependent cell spreading	GO:002176; GO:003809; GO:006104; GO:006184; GO:004308; GO:007173; GO:009063; GO:200040; GO:003001; GO:004801; GO:001922; GO:199031; GO:199085; GO:000996; GO:001491; GO:009874; GO:003362; GO:004595; GO:199009; GO:003572; GO:004339; GO:006032; GO:000635; GO:003295; GO:200014; GO:000176; GO:000187; GO:000836; GO:003802; GO:000662; GO:007156; GO:000018; GO:001635; GO:002198; GO:003568; GO:005077; GO:004254; GO:003502; GO:190002	extracellular exosome;cytosol;macromolecular complex;nucleus;actin cytoskeleton;cytoplasm;plasma membrane;membrane raft	GO:007006; GO:000582; GO:003299; GO:000563; GO:001562; GO:000573; GO:000588; GO:004512	 Regulation of actin cytoskeleton; Focal adhesion; ErbB signaling pathway; Bacterial invasion of epithelial cells; Fc gamma R-mediated phagocytosis; Chemokine signaling pathway; Pathways in cancer; Neurotrophin signaling pathway; Insulin signaling pathway; Shigellosis; Chronic myeloid leukemia; Renal cell carcinoma	hsa0481; hsa0451; hsa0401; hsa0510; hsa0466; hsa0406; hsa0520; hsa0472; hsa0491; hsa0513; hsa0522; hsa0521	cytoskeletal protein binding;protein self-association;phosphotyrosine binding;SH2 domain binding;protein tyrosine kinase binding;insulin-like growth factor receptor binding;ephrin receptor binding;protein binding;scaffold protein binding;SH3/SH2 adaptor activity;SH3 domain binding;protein phosphorylated amino acid binding	GO:000809; GO:004362; GO:000178; GO:004216; GO:199078; GO:000515; GO:004687; GO:000551; GO:009711; GO:000507; GO:001712; GO:004530
XP_020921780.1	XP_020921780.1	XP_020921780.1 glyoxylate reductase/hydroxypyruvate reductase [Sus scrofa]	8	8	8	161300000	84430000	108520000	101500000	190040000	93879000	101660000	106650000	117920000	99465000	112050000	102130000	95742000	102390000	103270000	135270000	146740000	110730000	NA	NA	NA	GRHPR	GRHPR;NA;NA;NA;NA	oxidation-reduction process;protein oligomerization;dicarboxylic acid metabolic process;glyoxylate metabolic process;excretion;cellular nitrogen compound metabolic process	GO:005511; GO:005125; GO:004364; GO:004648; GO:000758; GO:003464	cytoplasm;cytosol;peroxisomal matrix;extracellular exosome	GO:000573; GO:000582; GO:000578; GO:007006	 Metabolic pathways; Pyruvate metabolism; Glycine, serine and threonine metabolism; Glyoxylate and dicarboxylate metabolism	hsa0110; hsa0062; hsa0026; hsa0063	hydroxypyruvate reductase activity;protein homodimerization activity;carboxylic acid binding;NADPH binding;NAD binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;glyoxylate reductase (NADP) activity;glycerate dehydrogenase activity	GO:001661; GO:004280; GO:003140; GO:007040; GO:005128; GO:001661; GO:003026; GO:000846
XP_020921899.1;XP_020921898.1;XP_020921901.1;XP_020921900.1;NP_999333.1	XP_020921899.1;XP_020921898.1;XP_020921901.1;XP_020921900.1;NP_999333.1	XP_020921899.1 signal transducer and activator of transcription 5B isoform X1 [Sus scrofa];XP_020921898.1 signal transducer and activator of transcription 5B isoform X1 [Sus scrofa];XP_020921901.1 signal transducer and activator of transcription 5B isoform	13	13	2	38393000	57631000	53078000	42932000	51418000	50285000	60133000	45366000	56471000	45209000	43801000	62802000	32953000	52939000	43930000	56136000	55944000	58315000	NA	NA	NA	STAT5B	STAT5B;STAT5B;STAT5B;STAT5B;STAT5B	regulation of transcription from RNA polymerase II promoter;JAK-STAT cascade;cellular response to hormone stimulus;T cell differentiation in thymus;positive regulation of transcription from RNA polymerase II promoter;interleukin-2-mediated signaling pathway;regulation of multicellular organism growth;negative regulation of erythrocyte differentiation;response to interleukin-4;lactation;lipid storage;regulation of epithelial cell differentiation;positive regulation of gamma-delta T cell differentiation;positive regulation of natural killer cell mediated cytotoxicity;Peyer's patch development;positive regulation of inflammatory response;cellular response to growth factor stimulus;natural killer cell differentiation;female pregnancy;response to estradiol;progesterone metabolic process;T cell homeostasis;mast cell migration;peptidyl-tyrosine phosphorylation;positive regulation of activated T cell proliferation;regulation of steroid metabolic process;luteinization;cytokine-mediated signaling pathway;taurine metabolic process;positive regulation of natural killer cell proliferation;interleukin-15-mediated signaling pathway;positive regulation of B cell differentiation;positive regulation of mitotic cell cycle;negative regulation of apoptotic process;positive regulation of natural killer cell differentiation;positive regulation of interleukin-2 biosynthetic process;development of secondary female sexual characteristics;JAK-STAT cascade involved in growth hormone signaling pathway	GO:000635; GO:000725; GO:003287; GO:003307; GO:004594; GO:003811; GO:004001; GO:004564; GO:007067; GO:000759; GO:001991; GO:003085; GO:004558; GO:004595; GO:004854; GO:005072; GO:007136; GO:000177; GO:000756; GO:003235; GO:004244; GO:004302; GO:009753; GO:001810; GO:004210; GO:001921; GO:000155; GO:001922; GO:001953; GO:003281; GO:003572; GO:004557; GO:004593; GO:004306; GO:003282; GO:004508; GO:004654; GO:006039	nucleoplasm;nucleus;cytoplasm;cytosol	GO:000565; GO:000563; GO:000573; GO:000582	 Prolactin signaling pathway; Jak-STAT signaling pathway; Measles; Viral carcinogenesis; Acute myeloid leukemia; Chemokine signaling pathway; ErbB signaling pathway	hsa0491; hsa0463; hsa0516; hsa0520; hsa0522; hsa0406; hsa0401	RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;chromatin binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;protein tyrosine kinase activity;protein dimerization activity;transcription factor activity, sequence-specific DNA binding;protein binding;glucocorticoid receptor binding	GO:000097; GO:000098; GO:000368; GO:000122; GO:000471; GO:004698; GO:000370; GO:000551; GO:003525
XP_020921929.1;XP_020921928.1;XP_020921930.1	XP_020921929.1;XP_020921928.1;XP_020921930.1	XP_020921929.1 myosin-8 isoform X1 [Sus scrofa];XP_020921928.1 myosin-8 isoform X1 [Sus scrofa];XP_020921930.1 myosin-8 isoform X2 [Sus scrofa]	60	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	574120000	0	NA	NA	NA	LOC110255887	LOC110255887;LOC110255887;LOC110255887;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020921943.1	XP_020921943.1	XP_020921943.1 myosin-13 [Sus scrofa]	18	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	356800000	0	+	NA	NA	LOC100736982	LOC100736982;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020921946.1;XP_020921945.1	XP_020921946.1;XP_020921945.1	XP_020921946.1 centromere protein V isoform X2 [Sus scrofa];XP_020921945.1 centromere protein V isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1529600	NA	NA	NA	CENPV	CENPV;CENPV;NA;NA;NA	cell division;ameboidal-type cell migration;pericentric heterochromatin assembly;cell cycle;regulation of chromosome organization;centromere complex assembly;positive regulation of cytokinesis	GO:005130; GO:000166; GO:003150; GO:000704; GO:003304; GO:003450; GO:003246	condensed chromosome kinetochore;cytoplasm;nucleus;microtubule cytoskeleton;spindle midzone;kinetochore	GO:000077; GO:000573; GO:000563; GO:001563; GO:005123; GO:000077	"NA"	"NA"	carbon-sulfur lyase activity;molecular_function	GO:001684; GO:000367
XP_020922039.1;XP_020922036.1;XP_020922035.1	XP_020922039.1;XP_020922036.1;XP_020922035.1	XP_020922039.1 tether containing UBX domain for GLUT4 isoform X4 [Sus scrofa];XP_020922036.1 tether containing UBX domain for GLUT4 isoform X2 [Sus scrofa];XP_020922035.1 tether containing UBX domain for GLUT4 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4657600	0	0	NA	NA	NA	ASPSCR1	ASPSCR1;ASPSCR1;ASPSCR1;NA;NA	intracellular protein transport;positive regulation of protein modification process;regulation of glucose import;glucose homeostasis	GO:000688; GO:003140; GO:004632; GO:004259	vesicle membrane;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;perinuclear region of cytoplasm;intracellular membrane-bounded organelle;endomembrane system;cytosol;extrinsic component of membrane;cytoplasmic side of plasma membrane;nucleoplasm	GO:001250; GO:000588; GO:003311; GO:004847; GO:004323; GO:001250; GO:000582; GO:001989; GO:000989; GO:000565	 Transcriptional misregulation in cancer	hsa0520	protein binding	GO:000551
XP_020922048.1;XP_020922040.1;XP_020922045.1;XP_020922043.1;XP_020922046.1;XP_020922041.1;XP_020922044.1;XP_020922047.1;XP_020922042.1	XP_020922048.1;XP_020922040.1;XP_020922045.1;XP_020922043.1;XP_020922046.1;XP_020922041.1;XP_020922044.1;XP_020922047.1;XP_020922042.1	XP_020922048.1 COP9 signalosome complex subunit 1 isoform X1 [Sus scrofa];XP_020922040.1 COP9 signalosome complex subunit 1 isoform X1 [Sus scrofa];XP_020922045.1 COP9 signalosome complex subunit 1 isoform X6 [Sus scrofa];XP_020922043.1 COP9 signalosome co	5	5	5	17766000	17894000	22676000	0	0	17270000	17817000	25009000	23517000	19598000	17330000	0	20563000	25239000	17211000	23311000	26877000	21241000	NA	NA	NA	GPS1	GPS1;GPS1;GPS1;GPS1;GPS1	post-translational protein modification;nucleotide-excision repair, DNA damage recognition;transcription-coupled nucleotide-excision repair;inactivation of MAPK activity;protein deneddylation;JNK cascade;negative regulation of GTPase activity	GO:004368; GO:000071; GO:000628; GO:000018; GO:000033; GO:000725; GO:003426	cytosol;COP9 signalosome;nucleoplasm	GO:000582; GO:000818; GO:000565	"NA"	"NA"	GTPase inhibitor activity;protein binding	GO:000509; GO:000551
XP_020922060.1	XP_020922060.1	XP_020922060.1 L-xylulose reductase [Sus scrofa]	9	9	9	424880000	367440000	286420000	354250000	458740000	328820000	346560000	358860000	314190000	277790000	466220000	435150000	227290000	473520000	375720000	408360000	345810000	349100000	NA	NA	NA	LOC110255927	LOC110255927;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020922076.1;XP_020922075.1;XP_020922074.1;XP_020922072.1;XP_020922071.1;XP_020922069.1;XP_020922068.1;XP_020920070.1;XP_005653842.1;XP_003130590.1;XP_020922073.1;XP_020922067.1	XP_020922076.1;XP_020922075.1;XP_020922074.1;XP_020922072.1;XP_020922071.1;XP_020922069.1;XP_020922068.1;XP_020920070.1;XP_005653842.1;XP_003130590.1	XP_020922076.1 pyrroline-5-carboxylate reductase 1, mitochondrial isoform X3 [Sus scrofa];XP_020922075.1 pyrroline-5-carboxylate reductase 1, mitochondrial isoform X3 [Sus scrofa];XP_020922074.1 pyrroline-5-carboxylate reductase 1, mitochondrial isoform X3	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	12390000	0	0	0	0	NA	NA	NA	PYCR1	PYCR1;PYCR1;PYCR1;PYCR1;PYCR1	proline biosynthetic process;oxidation-reduction process;cellular response to oxidative stress;L-proline biosynthetic process;cellular amino acid biosynthetic process;regulation of mitochondrial membrane potential;negative regulation of hydrogen peroxide-induced cell death	GO:000656; GO:005511; GO:003459; GO:005512; GO:000865; GO:005188; GO:190320	mitochondrial matrix;mitochondrion	GO:000575; GO:000573	 Metabolic pathways; Arginine and proline metabolism; Biosynthesis of antibiotics; Biosynthesis of amino acids	hsa0110; hsa0033; hsa0113; hsa0123	protein binding;pyrroline-5-carboxylate reductase activity;identical protein binding	GO:000551; GO:000473; GO:004280
XP_020922086.1	XP_020922086.1	XP_020922086.1 protein disulfide-isomerase [Sus scrofa]	28	28	28	1092000000	1274800000	1341700000	1534400000	1228500000	1190900000	1239100000	1465000000	993860000	1231000000	1357500000	1440900000	1036400000	1419600000	1627200000	1338300000	1281700000	1462300000	NA	NA	NA	P4HB	P4HB;NA;NA;NA;NA	cell redox homeostasis;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;post-translational protein modification;cellular protein metabolic process;cellular response to interleukin-7;chylomicron assembly;positive regulation of viral entry into host cell;protein folding;response to endoplasmic reticulum stress;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;interleukin-12-mediated signaling pathway;cellular response to hypoxia;oxidation-reduction process;interleukin-23-mediated signaling pathway	GO:004545; GO:001840; GO:004368; GO:004426; GO:009876; GO:003437; GO:004659; GO:000645; GO:003497; GO:190217; GO:003572; GO:007145; GO:005511; GO:003815	focal adhesion;endoplasmic reticulum;procollagen-proline 4-dioxygenase complex;endoplasmic reticulum chaperone complex;extracellular region;endoplasmic reticulum-Golgi intermediate compartment;melanosome;external side of plasma membrane;extracellular exosome	GO:000592; GO:000578; GO:001622; GO:003466; GO:000557; GO:000579; GO:004247; GO:000989; GO:007006	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;integrin binding;protein heterodimerization activity;procollagen-proline 4-dioxygenase activity;RNA binding;peptide disulfide oxidoreductase activity;enzyme binding;protein disulfide isomerase activity	GO:000551; GO:000517; GO:004698; GO:000465; GO:000372; GO:001503; GO:001989; GO:000375
XP_020922088.1;XP_020922087.1	XP_020922088.1;XP_020922087.1	XP_020922088.1 ethanolamine-phosphate cytidylyltransferase isoform X2 [Sus scrofa];XP_020922087.1 ethanolamine-phosphate cytidylyltransferase isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	640530	NA	NA	NA	PCYT2	PCYT2;PCYT2;NA;NA;NA	phosphatidylethanolamine biosynthetic process;phospholipid biosynthetic process	GO:000664; GO:000865	cellular_component;endoplasmic reticulum membrane	GO:000557; GO:000578	 Glycerophospholipid metabolism; Metabolic pathways	hsa0056; hsa0110	ethanolamine-phosphate cytidylyltransferase activity	GO:000430
XP_020922091.1;XP_020922089.1	XP_020922091.1;XP_020922089.1	XP_020922091.1 THO complex subunit 4 isoform X2 [Sus scrofa];XP_020922089.1 THO complex subunit 4 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15428000	NA	NA	NA	ALYREF	ALYREF;ALYREF;NA;NA;NA	replication fork processing;regulation of DNA recombination;RNA export from nucleus;viral process;mRNA 3'-end processing;mRNA splicing, via spliceosome;positive regulation of DNA-templated transcription, elongation;viral mRNA export from host cell nucleus;osteoblast differentiation	GO:003129; GO:000001; GO:000640; GO:001603; GO:003112; GO:000039; GO:003278; GO:004678; GO:000164	transcription export complex;cytosol;nuclear chromosome, telomeric region;catalytic step 2 spliceosome;extracellular exosome;nuclear speck;exon-exon junction complex;membrane;nucleoplasm	GO:000034; GO:000582; GO:000078; GO:007101; GO:007006; GO:001660; GO:003514; GO:001602; GO:000565	 Spliceosome; mRNA surveillance pathway; Herpes simplex infection	hsa0304; hsa0301; hsa0516	RNA binding;protein binding	GO:000372; GO:000551
XP_020922099.1;XP_020922096.1;XP_020922098.1;XP_020922095.1	XP_020922099.1;XP_020922096.1;XP_020922098.1;XP_020922095.1	XP_020922099.1 hepatocyte growth factor-regulated tyrosine kinase substrate isoform X4 [Sus scrofa];XP_020922096.1 hepatocyte growth factor-regulated tyrosine kinase substrate isoform X2 [Sus scrofa];XP_020922098.1 hepatocyte growth factor-regulated tyrosi	4	4	4	0	0	31564000	0	0	0	0	23093000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	HGS	HGS;HGS;HGS;HGS;NA	signal transduction;protein targeting to lysosome;negative regulation of platelet-derived growth factor receptor signaling pathway;macroautophagy;negative regulation of vascular endothelial growth factor receptor signaling pathway;multivesicular body assembly;membrane organization;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of JAK-STAT cascade;negative regulation of cell proliferation;regulation of protein catabolic process;positive regulation of gene expression;regulation of MAP kinase activity;positive regulation of exosomal secretion;membrane invagination;endosomal transport;negative regulation of angiogenesis;protein localization to membrane	GO:000716; GO:000662; GO:001064; GO:001623; GO:003094; GO:003625; GO:006102; GO:004205; GO:004642; GO:000828; GO:004217; GO:001062; GO:004340; GO:190354; GO:001032; GO:001619; GO:001652; GO:007265	early endosome;endosome;intracellular membrane-bounded organelle;multivesicular body membrane;extracellular exosome;early endosome membrane;ESCRT-0 complex;cytosol	GO:000576; GO:000576; GO:004323; GO:003258; GO:007006; GO:003190; GO:003356; GO:000582	 Phagosome; Endocytosis	hsa0414; hsa0414	protein domain specific binding;ubiquitin-like protein ligase binding;protein binding;metal ion binding	GO:001990; GO:004438; GO:000551; GO:004687
XP_020922127.1	XP_020922127.1	XP_020922127.1 LOW QUALITY PROTEIN: mitochondrial dicarboxylate carrier [Sus scrofa]	5	5	5	148710000	0	81268000	31935000	105630000	0	97260000	56677000	78229000	44407000	51477000	0	32144000	31006000	57950000	62830000	52434000	0	NA	NA	NA	SLC25A10	SLC25A10;NA;NA;NA;NA	phosphate ion transmembrane transport;mitochondrial transport;thiosulfate transport;oxaloacetate(2-) transmembrane transport;gluconeogenesis;ion transport;sulfide oxidation, using sulfide:quinone oxidoreductase;succinate transmembrane transport;sulfate transport;oxaloacetate transport	GO:003543; GO:000683; GO:001570; GO:190235; GO:000609; GO:000681; GO:007022; GO:007142; GO:000827; GO:001572	mitochondrial inner membrane;nucleus;mitochondrion;nucleoplasm;integral component of membrane	GO:000574; GO:000563; GO:000573; GO:000565; GO:001602	 Proximal tubule bicarbonate reclamation	hsa0496	succinate transmembrane transporter activity;protein binding;malate transmembrane transporter activity;sulfate transmembrane transporter activity;antiporter activity;dicarboxylic acid transmembrane transporter activity;oxaloacetate transmembrane transporter activity	GO:001514; GO:000551; GO:001514; GO:001511; GO:001529; GO:000531; GO:001513
XP_020922135.1	XP_020922135.1	XP_020922135.1 nuclear protein localization protein 4 homolog [Sus scrofa]	7	7	7	0	0	0	0	0	0	0	0	0	39653000	0	0	0	0	0	0	0	0	NA	NA	NA	NPLOC4	NPLOC4;NA;NA;NA;NA	negative regulation of RIG-I signaling pathway;Golgi organization;error-free translesion synthesis;ubiquitin-dependent ERAD pathway;ubiquitin-dependent protein catabolic process;retrograde protein transport, ER to cytosol;negative regulation of type I interferon production	GO:003953; GO:000703; GO:007098; GO:003043; GO:000651; GO:003097; GO:003248	UFD1-NPL4 complex;VCP-NPL4-UFD1 AAA ATPase complex;nucleoplasm;endoplasmic reticulum;nucleus;cytosol;nuclear outer membrane-endoplasmic reticulum membrane network	GO:003650; GO:003409; GO:000565; GO:000578; GO:000563; GO:000582; GO:004217	 Protein processing in endoplasmic reticulum	hsa0414	protein binding;metal ion binding;ubiquitin protein ligase binding;ubiquitin binding	GO:000551; GO:004687; GO:003162; GO:004313
XP_020922136.1	XP_020922136.1	XP_020922136.1 acidic leucine-rich nuclear phosphoprotein 32 family member B [Sus scrofa]	3	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7942900	0	0	NA	NA	NA	ANP32B	ANP32B;NA;NA;NA;NA	negative regulation of cell differentiation;positive regulation of protein export from nucleus;inner ear development;nucleosome assembly;palate development;activation of cysteine-type endopeptidase activity involved in apoptotic process;ventricular system development;vasculature development	GO:004559; GO:004682; GO:004883; GO:000633; GO:006002; GO:000691; GO:002159; GO:000194	nucleus;nucleolus;extracellular exosome	GO:000563; GO:000573; GO:007006	"NA"	"NA"	protein binding;histone binding;RNA polymerase binding	GO:000551; GO:004239; GO:007006
XP_020922158.1	XP_020922158.1	XP_020922158.1 charged multivesicular body protein 6 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	24181000	0	0	0	0	0	0	NA	NA	NA	CHMP6	CHMP6;NA;NA;NA;NA	endosomal transport;mitotic metaphase plate congression;macroautophagy;viral life cycle;ESCRT III complex assembly;nucleus organization;multivesicular body assembly;viral budding via host ESCRT complex;regulation of protein catabolic process;protein transport;vacuolar transport;negative regulation of epidermal growth factor-activated receptor activity;regulation of exosomal secretion	GO:001619; GO:000708; GO:001623; GO:001905; GO:190490; GO:000699; GO:003625; GO:003970; GO:004217; GO:001503; GO:000703; GO:000717; GO:190354	endosome membrane;cytosol;membrane;extracellular exosome;ESCRT III complex;late endosome membrane	GO:001000; GO:000582; GO:001602; GO:007006; GO:000081; GO:003190	 Endocytosis	hsa0414	protein binding;protein N-terminus binding;macromolecular complex binding	GO:000551; GO:004748; GO:004487
XP_020922164.1	XP_020922164.1	XP_020922164.1 LOW QUALITY PROTEIN: lysosomal alpha-glucosidase [Sus scrofa]	5	5	5	0	0	15631000	15016000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GAA	GAA;NA;NA;NA;NA	diaphragm contraction;regulation of the force of heart contraction;neutrophil degranulation;sucrose metabolic process;vacuolar sequestering;cardiac muscle contraction;heart morphogenesis;glucose metabolic process;lysosome organization;muscle cell cellular homeostasis;neuromuscular process controlling posture;tissue development;maltose metabolic process;locomotory behavior	GO:000208; GO:000202; GO:004331; GO:000598; GO:004318; GO:006004; GO:000300; GO:000600; GO:000704; GO:004671; GO:005088; GO:000988; GO:000002; GO:000762	membrane;azurophil granule membrane;ficolin-1-rich granule membrane;lysosomal lumen;extracellular exosome;lysosome;tertiary granule membrane;plasma membrane	GO:001602; GO:003557; GO:010100; GO:004320; GO:007006; GO:000576; GO:007082; GO:000588	 Metabolic pathways; Starch and sucrose metabolism; Galactose metabolism; Lysosome	hsa0110; hsa0050; hsa0005; hsa0414	alpha-1,4-glucosidase activity;carbohydrate binding;maltose alpha-glucosidase activity;alpha-glucosidase activity	GO:000455; GO:003024; GO:003245; GO:009059
XP_020922175.1	XP_020922175.1	XP_020922175.1 LOW QUALITY PROTEIN: galectin-3-binding protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	3296700	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LGALS3BP	LGALS3BP;NA;NA;NA;NA	cell adhesion;cellular defense response;platelet degranulation;signal transduction;receptor-mediated endocytosis	GO:000715; GO:000696; GO:000257; GO:000716; GO:000689	extracellular region;extracellular space;platelet dense granule lumen;extracellular exosome;membrane;blood microparticle	GO:000557; GO:000561; GO:003108; GO:007006; GO:001602; GO:007256	"NA"	"NA"	protein binding;scavenger receptor activity	GO:000551; GO:000504
XP_020922213.1	XP_020922213.1	XP_020922213.1 synaptogyrin-2 [Sus scrofa]	3	3	3	19963000	20248000	17927000	0	0	0	15598000	0	0	0	18536000	0	31708000	22959000	20659000	19548000	19603000	22471000	NA	NA	NA	SYNGR2	SYNGR2;NA;NA;NA;NA	synaptic vesicle membrane organization;regulated exocytosis	GO:004849; GO:004505	cell junction;synaptic vesicle membrane;integral component of membrane;lipid particle;extracellular exosome;neuromuscular junction	GO:003005; GO:003067; GO:001602; GO:000581; GO:007006; GO:003159	"NA"	"NA"	protein binding	GO:000551
XP_020922228.1;XP_020922227.1;XP_020922226.1;XP_020922225.1;XP_020922224.1;XP_020922223.1;XP_020922222.1	XP_020922228.1;XP_020922227.1;XP_020922226.1;XP_020922225.1;XP_020922224.1;XP_020922223.1;XP_020922222.1	XP_020922228.1 matrix-remodeling-associated protein 7 isoform X5 [Sus scrofa];XP_020922227.1 matrix-remodeling-associated protein 7 isoform X4 [Sus scrofa];XP_020922226.1 matrix-remodeling-associated protein 7 isoform X3 [Sus scrofa];XP_020922225.1 matrix-	2	2	2	0	0	0	6318700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MXRA7	MXRA7;MXRA7;MXRA7;MXRA7;MXRA7	"NA"	"NA"	integral component of membrane	GO:001602	"NA"	"NA"	"NA"	"NA"
XP_020922253.1	XP_020922253.1	XP_020922253.1 LOW QUALITY PROTEIN: collagen alpha-1(XV) chain [Sus scrofa]	17	17	17	879250000	1285500000	899030000	975180000	864760000	762870000	919450000	1045300000	799810000	799060000	1237700000	1657200000	896970000	1227300000	1099800000	1367800000	931810000	1001900000	NA	NA	NA	COL15A1	COL15A1;NA;NA;NA;NA	extracellular matrix organization;cell differentiation;collagen catabolic process;signal transduction;cell adhesion;angiogenesis	GO:003019; GO:003015; GO:003057; GO:000716; GO:000715; GO:000152	extracellular matrix;extracellular exosome;integral component of membrane;extracellular region;extracellular space;collagen type XV trimer;endoplasmic reticulum lumen	GO:003101; GO:007006; GO:001602; GO:000557; GO:000561; GO:000558; GO:000578	 Protein digestion and absorption	hsa0497	extracellular matrix structural constituent conferring tensile strength;extracellular matrix structural constituent	GO:003002; GO:000520
XP_020922281.1	XP_020922281.1	XP_020922281.1 LOW QUALITY PROTEIN: integrin beta-4 [Sus scrofa]	10	10	10	0	66909000	0	0	0	31483000	0	36489000	0	0	0	27272000	0	20160000	0	0	0	0	NA	NA	NA	ITGB4	ITGB4;NA;NA;NA;NA	autophagy;mesodermal cell differentiation;cell-matrix adhesion;hemidesmosome assembly;nail development;response to wounding;cell migration;cell adhesion mediated by integrin;cell adhesion;integrin-mediated signaling pathway;skin development;cell motility;renal system development;amelogenesis;extracellular matrix organization;digestive tract development	GO:000691; GO:004833; GO:000716; GO:003158; GO:003587; GO:000961; GO:001647; GO:003362; GO:000715; GO:000722; GO:004358; GO:004887; GO:007200; GO:009718; GO:003019; GO:004856	cell surface;cell leading edge;receptor complex;focal adhesion;cell junction;extracellular exosome;plasma membrane;integrin complex	GO:000998; GO:003125; GO:004323; GO:000592; GO:003005; GO:007006; GO:000588; GO:000830	 Focal adhesion; Hypertrophic cardiomyopathy (HCM); Regulation of actin cytoskeleton; PI3K-Akt signaling pathway; ECM-receptor interaction	hsa0451; hsa0541; hsa0481; hsa0415; hsa0451	insulin-like growth factor I binding;protein binding;integrin binding;neuregulin binding;G-protein coupled receptor binding	GO:003199; GO:000551; GO:000517; GO:003813; GO:000166
XP_020922431.1;XP_020922430.1	XP_020922431.1;XP_020922430.1	XP_020922431.1 coiled-coil domain-containing protein 47 [Sus scrofa];XP_020922430.1 coiled-coil domain-containing protein 47 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8077800	0	0	NA	NA	NA	CCDC47	CCDC47;CCDC47;NA;NA;NA	osteoblast differentiation;calcium ion homeostasis;ER overload response;endoplasmic reticulum organization;post-embryonic development;ubiquitin-dependent ERAD pathway	GO:000164; GO:005507; GO:000698; GO:000702; GO:000979; GO:003043	endoplasmic reticulum;integral component of membrane;rough endoplasmic reticulum	GO:000578; GO:001602; GO:000579	"NA"	"NA"	protein binding;RNA binding;calcium ion binding	GO:000551; GO:000372; GO:000550
XP_020922505.1;XP_020920496.1;XP_020920495.1	XP_020922505.1	XP_020922505.1 glycylpeptide N-tetradecanoyltransferase 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4997300	0	NA	NA	NA	NMT1	NMT1;NA;NA;NA;NA	cellular ketone metabolic process;in utero embryonic development;regulation of rhodopsin mediated signaling pathway;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;N-terminal protein myristoylation;N-terminal peptidyl-glycine N-myristoylation	GO:004218; GO:000170; GO:002240; GO:190074; GO:000649; GO:001800	plasma membrane;mitochondrion;extrinsic component of membrane;cytosol	GO:000588; GO:000573; GO:001989; GO:000582	"NA"	"NA"	glycylpeptide N-tetradecanoyltransferase activity;myristoyltransferase activity	GO:000437; GO:001910
XP_020922574.1;XP_020922573.1;XP_020922571.1;XP_020922570.1;XP_020922569.1;XP_020922568.1;XP_020922567.1;XP_020922566.1	XP_020922574.1;XP_020922573.1;XP_020922571.1;XP_020922570.1;XP_020922569.1;XP_020922568.1;XP_020922567.1;XP_020922566.1	XP_020922574.1 CMRF35-like molecule 9 isoform X8 [Sus scrofa];XP_020922573.1 CMRF35-like molecule 9 isoform X7 [Sus scrofa];XP_020922571.1 CMRF35-like molecule 9 isoform X6 [Sus scrofa];XP_020922570.1 CMRF35-like molecule 9 isoform X5 [Sus scrofa];XP_02092	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3294200	0	NA	NA	NA	CD300LG	CD300LG;CD300LG;CD300LG;CD300LG;CD300LG	regulation of immune response;immune system process	GO:005077; GO:000237	plasma membrane;basolateral plasma membrane;multivesicular body membrane;integral component of membrane	GO:000588; GO:001632; GO:003258; GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_020922627.1	XP_020922627.1	XP_020922627.1 alanyl-tRNA editing protein Aarsd1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2557000	NA	NA	NA	AARSD1	AARSD1;NA;NA;NA;NA	regulation of translational fidelity;alanyl-tRNA aminoacylation;biological_process	GO:000645; GO:000641; GO:000815	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	Ser-tRNA(Ala) hydrolase activity;ATP binding;nucleic acid binding;alanine-tRNA ligase activity;metal ion binding	GO:000219; GO:000552; GO:000367; GO:000481; GO:004687
XP_020922632.1;XP_003131441.2	XP_020922632.1	XP_020922632.1 LOW QUALITY PROTEIN: membrane primary amine oxidase [Sus scrofa]	30	30	16	10143000000	17879000000	11885000000	11226000000	10645000000	10734000000	9496000000	14235000000	10558000000	14261000000	11371000000	16539000000	7561500000	13840000000	14968000000	16735000000	10749000000	13662000000	NA	NA	NA	LOC100520329	LOC100520329;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020922633.1;XP_020922634.1	XP_020922633.1;XP_020922634.1	XP_020922633.1 membrane primary amine oxidase-like isoform X1 [Sus scrofa];XP_020922634.1 membrane primary amine oxidase-like isoform X2 [Sus scrofa]	19	5	5	70036000	54844000	55383000	110230000	115820000	158300000	105520000	69383000	104090000	75168000	66418000	62306000	87946000	63434000	58037000	32202000	61092000	65237000	NA	NA	NA	LOC110256000	LOC110256000;LOC110256000;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020922637.1	XP_020922637.1	XP_020922637.1 vacuolar protein-sorting-associated protein 25 [Sus scrofa]	2	2	2	0	0	6835100	0	0	0	0	7252100	0	0	0	0	0	0	0	5945500	0	0	NA	NA	NA	VPS25	VPS25;NA;NA;NA;NA	protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;negative regulation of epidermal growth factor-activated receptor activity;endosomal transport;multivesicular body assembly;macroautophagy	GO:004332; GO:000717; GO:001619; GO:003625; GO:001623	ESCRT II complex;nucleus;endosome membrane;nucleoplasm;extracellular exosome;cytosol;cytoplasm	GO:000081; GO:000563; GO:001000; GO:000565; GO:007006; GO:000582; GO:000573	 Endocytosis	hsa0414	protein binding;structural molecule activity;protein homodimerization activity;protein N-terminus binding	GO:000551; GO:000519; GO:004280; GO:004748
XP_020922642.1	XP_020922642.1	XP_020922642.1 polymerase I and transcript release factor [Sus scrofa]	17	17	17	5491000000	7265400000	7199600000	4477600000	4419500000	5875000000	5272800000	5516000000	5777100000	6622800000	5078700000	6612900000	4087800000	6058700000	5719800000	7328600000	5303700000	6358100000	NA	NA	NA	CAVIN1	CAVIN1;NA;NA;NA;NA	transcription initiation from RNA polymerase I promoter;positive regulation of cell motility;rRNA transcription;termination of RNA polymerase I transcription	GO:000636; GO:200014; GO:000930; GO:000636	mitochondrion;cytosol;macromolecular complex;nucleoplasm;nucleus;cytoplasm;caveola;membrane raft;intracellular membrane-bounded organelle;plasma membrane;endoplasmic reticulum	GO:000573; GO:000582; GO:003299; GO:000565; GO:000563; GO:000573; GO:000590; GO:004512; GO:004323; GO:000588; GO:000578	"NA"	"NA"	RNA binding;identical protein binding;rRNA primary transcript binding;protein binding	GO:000372; GO:004280; GO:004213; GO:000551
XP_020922704.1;XP_020922703.1	XP_020922704.1;XP_020922703.1	XP_020922704.1 protein phosphatase 1 regulatory subunit 1B isoform X2 [Sus scrofa];XP_020922703.1 protein phosphatase 1 regulatory subunit 1B isoform X1 [Sus scrofa]	8	8	2	51741000	89093000	101250000	84093000	77630000	67068000	90420000	73742000	93373000	85437000	77019000	138790000	39624000	68582000	118360000	113630000	66444000	78048000	NA	NA	NA	PPP1R1B	PPP1R1B;PPP1R1B;NA;NA;NA	negative regulation of female receptivity;locomotory behavior;behavioral response to cocaine;visual learning;intracellular signal transduction;transcription, DNA-templated;response to morphine;negative regulation of protein serine/threonine kinase activity;response to amphetamine;memory;negative regulation of phosphoprotein phosphatase activity;response to nicotine;signal transduction	GO:000762; GO:000762; GO:004814; GO:000854; GO:003555; GO:000635; GO:004327; GO:007190; GO:000197; GO:000761; GO:003251; GO:003509; GO:000716	neuronal cell body;glutamatergic synapse;dendritic spine neck;cytosol;cytoplasm;nucleus	GO:004302; GO:009897; GO:004432; GO:000582; GO:000573; GO:000563	 cAMP signaling pathway; Dopaminergic synapse; Amphetamine addiction	hsa0402; hsa0472; hsa0503	protein phosphatase regulator activity;D3 dopamine receptor binding;cAMP-dependent protein kinase inhibitor activity;D2 dopamine receptor binding;protein binding	GO:001988; GO:003175; GO:000486; GO:003174; GO:000551
XP_020922706.1;XP_020922705.1	XP_020922706.1;XP_020922705.1	XP_020922706.1 protein phosphatase 1 regulatory subunit 1B isoform X4 [Sus scrofa];XP_020922705.1 protein phosphatase 1 regulatory subunit 1B isoform X3 [Sus scrofa]	7	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18600000	NA	NA	NA	PPP1R1B	PPP1R1B;PPP1R1B;NA;NA;NA	negative regulation of female receptivity;locomotory behavior;behavioral response to cocaine;visual learning;intracellular signal transduction;transcription, DNA-templated;response to morphine;negative regulation of protein serine/threonine kinase activity;response to amphetamine;memory;negative regulation of phosphoprotein phosphatase activity;response to nicotine;signal transduction	GO:000762; GO:000762; GO:004814; GO:000854; GO:003555; GO:000635; GO:004327; GO:007190; GO:000197; GO:000761; GO:003251; GO:003509; GO:000716	neuronal cell body;glutamatergic synapse;dendritic spine neck;cytosol;cytoplasm;nucleus	GO:004302; GO:009897; GO:004432; GO:000582; GO:000573; GO:000563	 cAMP signaling pathway; Dopaminergic synapse; Amphetamine addiction	hsa0402; hsa0472; hsa0503	protein phosphatase regulator activity;D3 dopamine receptor binding;cAMP-dependent protein kinase inhibitor activity;D2 dopamine receptor binding;protein binding	GO:001988; GO:003175; GO:000486; GO:003174; GO:000551
XP_020922719.1;XP_020922720.1	XP_020922719.1	XP_020922719.1 LIM and SH3 domain protein 1 isoform X1 [Sus scrofa]	7	7	7	103210000	96205000	90840000	143640000	0	154180000	0	105330000	136080000	126300000	130060000	184220000	218510000	156570000	118370000	78654000	77796000	99419000	NA	NA	NA	LASP1	LASP1;NA;NA;NA;NA	ion transport;ion transmembrane transport;positive regulation of signal transduction	GO:000681; GO:003422; GO:000996	focal adhesion;cytoplasm;cortical actin cytoskeleton	GO:000592; GO:000573; GO:003086	"NA"	"NA"	ion transmembrane transporter activity;protein binding;SH3/SH2 adaptor activity;metal ion binding;actin filament binding;cadherin binding	GO:001507; GO:000551; GO:000507; GO:004687; GO:005101; GO:004529
XP_020922744.1;XP_020922746.1;XP_020922745.1	XP_020922744.1;XP_020922746.1;XP_020922745.1	XP_020922744.1 pyridoxine-5-phosphate oxidase isoform X1 [Sus scrofa];XP_020922746.1 pyridoxine-5-phosphate oxidase isoform X3 [Sus scrofa];XP_020922745.1 pyridoxine-5-phosphate oxidase isoform X2 [Sus scrofa]	5	5	5	27451000	29836000	37198000	49117000	37840000	0	43569000	37417000	36021000	52769000	0	46399000	35696000	42359000	0	40730000	28122000	0	NA	NA	NA	PNPO	PNPO;PNPO;PNPO;NA;NA	pyridoxal phosphate biosynthetic process;pyridoxine biosynthetic process;oxidation-reduction process;vitamin B6 metabolic process	GO:004282; GO:000861; GO:005511; GO:004281	nucleoplasm;cytosol	GO:000565; GO:000582	 Vitamin B6 metabolism; Metabolic pathways	hsa0075; hsa0110	pyridoxamine-phosphate oxidase activity;protein homodimerization activity;pyridoxal phosphate binding;FMN binding;protein binding	GO:000473; GO:004280; GO:003017; GO:001018; GO:000551
XP_020922750.1	XP_020922750.1	XP_020922750.1 CDK5 regulatory subunit-associated protein 3 [Sus scrofa]	4	4	4	12387000	11348000	11747000	0	0	0	13553000	11256000	0	12009000	0	17707000	0	0	13092000	11632000	14230000	0	NA	NA	NA	CDK5RAP3	CDK5RAP3;NA;NA;NA;NA	regulation of phosphatase activity;negative regulation of protein kinase activity by regulation of protein phosphorylation;mitotic G2 DNA damage checkpoint;positive regulation of protein ubiquitination;mitotic G2/M transition checkpoint;negative regulation of protein phosphorylation;positive regulation of signal transduction by p53 class mediator;brain development;regulation of neuron differentiation;protein ufmylation;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;positive regulation of transcription from RNA polymerase II promoter;regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of mitotic cell cycle;endoplasmic reticulum unfolded protein response;negative regulation of MAP kinase activity;negative regulation of protein serine/threonine kinase activity;positive regulation of protein localization to nucleus;cell proliferation;apoptotic nuclear changes;negative regulation of NF-kappaB transcription factor activity;negative regulation of cellular protein catabolic process	GO:001092; GO:004438; GO:000709; GO:003139; GO:004481; GO:000193; GO:190179; GO:000742; GO:004566; GO:007156; GO:200006; GO:004594; GO:000007; GO:000734; GO:003096; GO:004340; GO:007190; GO:190018; GO:000828; GO:003026; GO:003208; GO:190336	microtubule;membrane;macromolecular complex;cytosol;cytoplasm;centrosome;nucleus	GO:000587; GO:001602; GO:003299; GO:000582; GO:000573; GO:000581; GO:000563	"NA"	"NA"	mitogen-activated protein kinase binding;protein kinase binding;cyclin binding;NF-kappaB binding;MDM2/MDM4 family protein binding;protein binding;ubiquitin-like protein ligase binding	GO:005101; GO:001990; GO:003033; GO:005105; GO:009737; GO:000551; GO:004438
XP_020922751.1	XP_020922751.1	XP_020922751.1 coatomer subunit zeta-2 [Sus scrofa]	4	4	4	44267000	74392000	38382000	59255000	34017000	46929000	33699000	57557000	34152000	47236000	58583000	75404000	47047000	58272000	58633000	53680000	55108000	63209000	NA	NA	NA	COPZ2	COPZ2;NA;NA;NA;NA	retrograde vesicle-mediated transport, Golgi to ER;intracellular protein transport;intra-Golgi vesicle-mediated transport	GO:000689; GO:000688; GO:000689	transport vesicle;endoplasmic reticulum membrane;COPI vesicle coat;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi membrane;cytosol;cis-Golgi network	GO:003013; GO:000578; GO:003012; GO:003311; GO:000013; GO:000582; GO:000580	"NA"	"NA"	"NA"	"NA"
XP_020922810.1;XP_020922808.1;XP_020922807.1;XP_020922811.1	XP_020922810.1;XP_020922808.1;XP_020922807.1;XP_020922811.1	XP_020922810.1 pyruvate dehydrogenase kinase, isozyme 2 isoform X2 [Sus scrofa];XP_020922808.1 pyruvate dehydrogenase kinase, isozyme 2 isoform X2 [Sus scrofa];XP_020922807.1 pyruvate dehydrogenase kinase, isozyme 2 isoform X1 [Sus scrofa];XP_020922811.1 p	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	1954900	0	0	0	0	NA	NA	NA	PDK2	PDK2;PDK2;PDK2;PDK2;NA	cellular response to reactive oxygen species;insulin receptor signaling pathway;regulation of cellular ketone metabolic process;protein phosphorylation;regulation of pH;regulation of acetyl-CoA biosynthetic process from pyruvate;cellular response to nutrient;glucose metabolic process;regulation of glucose metabolic process;regulation of calcium-mediated signaling;intrinsic apoptotic signaling pathway by p53 class mediator;regulation of gluconeogenesis;glucose homeostasis	GO:003461; GO:000828; GO:001056; GO:000646; GO:000688; GO:001051; GO:003167; GO:000600; GO:001090; GO:005084; GO:007233; GO:000611; GO:004259	mitochondrion;mitochondrial pyruvate dehydrogenase complex;cytosol;nucleoplasm;mitochondrial matrix	GO:000573; GO:000596; GO:000582; GO:000565; GO:000575	"NA"	"NA"	protein homodimerization activity;protein kinase activity;ATP binding;pyruvate dehydrogenase (acetyl-transferring) kinase activity	GO:004280; GO:000467; GO:000552; GO:000474
XP_020922814.1;XP_020922813.1;XP_020922812.1;CON__Q862S4;XP_020948270.1	XP_020922814.1;XP_020922813.1;XP_020922812.1	XP_020922814.1 collagen alpha-1(I) chain isoform X3 [Sus scrofa];XP_020922813.1 collagen alpha-1(I) chain isoform X2 [Sus scrofa];XP_020922812.1 collagen alpha-1(I) chain isoform X1 [Sus scrofa]	11	11	11	236060000	696290000	205880000	2483900000	183200000	566550000	306390000	1110600000	126140000	388330000	352640000	336700000	302070000	936520000	226680000	496650000	349300000	487700000	NA	NA	NA	COL1A1	COL1A1;COL1A1;COL1A1;NA;NA	blood coagulation;response to corticosteroid;protein localization to nucleus;leukocyte migration;bone trabecula formation;intramembranous ossification;positive regulation of transcription, DNA-templated;collagen-activated tyrosine kinase receptor signaling pathway;response to cAMP;response to hyperoxia;skeletal system development;blood vessel development;sensory perception of sound;positive regulation of epithelial to mesenchymal transition;protein transport;cellular response to amino acid stimulus;cartilage development involved in endochondral bone morphogenesis;protein heterotrimerization;cellular response to tumor necrosis factor;osteoblast differentiation;response to mechanical stimulus;skin development;regulation of immune response;cellular response to retinoic acid;collagen fibril organization;collagen biosynthetic process;tooth eruption;positive regulation of canonical Wnt signaling pathway;negative regulation of cell-substrate adhesion;platelet activation;response to peptide hormone;cellular response to fibroblast growth factor stimulus;embryonic skeletal system development;cellular response to transforming growth factor beta stimulus;positive regulation of cell migration;response to estradiol;response to hydrogen peroxide;face morphogenesis;cellular response to fluoride;cellular response to mechanical stimulus;cellular response to epidermal growth factor stimulus	GO:000759; GO:003196; GO:003450; GO:005090; GO:006034; GO:000195; GO:004589; GO:003806; GO:005159; GO:005509; GO:000150; GO:000156; GO:000760; GO:001071; GO:001503; GO:007123; GO:006035; GO:007020; GO:007135; GO:000164; GO:000961; GO:004358; GO:005077; GO:007130; GO:003019; GO:003296; GO:004469; GO:009026; GO:001081; GO:003016; GO:004343; GO:004434; GO:004870; GO:007156; GO:003033; GO:003235; GO:004254; GO:006032; GO:190261; GO:007126; GO:007136	collagen type I trimer;Golgi apparatus;secretory granule;extracellular matrix;cytoplasm;extracellular region;extracellular space;endoplasmic reticulum lumen	GO:000558; GO:000579; GO:003014; GO:003101; GO:000573; GO:000557; GO:000561; GO:000578	 Amoebiasis; PI3K-Akt signaling pathway; Focal adhesion; Protein digestion and absorption; Platelet activation	hsa0514; hsa0415; hsa0451; hsa0497; hsa0461	protease binding;identical protein binding;platelet-derived growth factor binding;metal ion binding;protein binding;extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength	GO:000202; GO:004280; GO:004840; GO:004687; GO:000551; GO:000520; GO:003002
XP_020922865.1;XP_020922864.1;XP_020922863.1;XP_020922862.1;XP_020922860.1;XP_020922859.1;XP_020922858.1;XP_020922857.1;XP_020922856.1;XP_020922855.1;XP_020922854.1;XP_020922853.1;XP_020922874.1;XP_020922873.1;XP_020922871.1;XP_020922869.1;XP_020922870.1;XP_020922868.1;XP_020922867.1;XP_020922866.1	XP_020922865.1;XP_020922864.1;XP_020922863.1;XP_020922862.1;XP_020922860.1;XP_020922859.1;XP_020922858.1;XP_020922857.1;XP_020922856.1;XP_020922855.1;XP_020922854.1;XP_020922853.1;XP_020922874.1;XP_020922873.1;XP_020922871.1;XP_020922869.1;XP_020922870.1;XP_020922868.1;XP_020922867.1;XP_020922866.1	XP_020922865.1 C-Jun-amino-terminal kinase-interacting protein 4 isoform X12 [Sus scrofa];XP_020922864.1 C-Jun-amino-terminal kinase-interacting protein 4 isoform X11 [Sus scrofa];XP_020922863.1 C-Jun-amino-terminal kinase-interacting protein 4 isoform X10	8	8	7	0	18896000	0	0	0	16503000	0	0	0	18510000	0	0	0	0	0	0	0	20925000	NA	NA	NA	SPAG9	SPAG9;SPAG9;SPAG9;SPAG9;SPAG9	positive regulation of cell migration;positive regulation of muscle cell differentiation;vesicle-mediated transport;retrograde transport, endosome to Golgi;protein homooligomerization;activation of JUN kinase activity;positive regulation of neuron differentiation	GO:003033; GO:005114; GO:001619; GO:004214; GO:005126; GO:000725; GO:004566	cytoplasm;perinuclear region of cytoplasm;acrosomal vesicle;microtubule organizing center;extracellular exosome;cytosol	GO:000573; GO:004847; GO:000166; GO:000581; GO:007006; GO:000582	"NA"	"NA"	MAP-kinase scaffold activity;kinesin binding;JUN kinase binding;receptor signaling complex scaffold activity;protein binding	GO:000507; GO:001989; GO:000843; GO:003015; GO:000551
XP_020923027.1;XP_020923033.1;XP_020923017.1;XP_020923007.1;XP_020922998.1;XP_020922993.1;XP_020922986.1	XP_020923027.1;XP_020923033.1;XP_020923017.1;XP_020923007.1;XP_020922998.1;XP_020922993.1;XP_020922986.1	XP_020923027.1 tyrosine-protein phosphatase non-receptor type 3 isoform X5 [Sus scrofa];XP_020923033.1 tyrosine-protein phosphatase non-receptor type 3 isoform X6 [Sus scrofa];XP_020923017.1 tyrosine-protein phosphatase non-receptor type 3 isoform X4 [Sus	2	2	2	48024000	0	0	0	0	0	0	0	0	0	0	0	44548000	0	0	0	0	0	NA	NA	NA	PTPN3	PTPN3;PTPN3;PTPN3;PTPN3;PTPN3	peptidyl-tyrosine dephosphorylation;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of mitotic cell cycle;negative regulation of membrane protein ectodomain proteolysis;regulation of sodium ion transmembrane transporter activity;regulation of membrane depolarization during action potential;liver regeneration;protein dephosphorylation	GO:003533; GO:004205; GO:004593; GO:005104; GO:200064; GO:009890; GO:009742; GO:000647	cytoplasm;cytoskeleton;plasma membrane;cytoplasmic side of plasma membrane	GO:000573; GO:000585; GO:000588; GO:000989	"NA"	"NA"	phosphotyrosine binding;protein binding;ATPase binding;cytoskeletal protein binding;protein tyrosine phosphatase activity;sodium channel regulator activity	GO:000178; GO:000551; GO:005111; GO:000809; GO:000472; GO:001708
XP_020923053.1;XP_020923047.1;XP_020923045.1;XP_020923055.1;XP_020923054.1;XP_020923052.1;XP_020923051.1;XP_020923050.1;XP_020923049.1;XP_020923048.1;XP_020923046.1;XP_020923044.1;XP_020923043.1;XP_020923042.1;XP_020923040.1;XP_020923039.1;XP_020923038.1;XP_020923037.1;XP_020923036.1;XP_020923035.1	XP_020923053.1;XP_020923047.1;XP_020923045.1;XP_020923055.1;XP_020923054.1;XP_020923052.1;XP_020923051.1;XP_020923050.1;XP_020923049.1;XP_020923048.1;XP_020923046.1;XP_020923044.1;XP_020923043.1;XP_020923042.1;XP_020923040.1;XP_020923039.1;XP_020923038.1;XP_020923037.1;XP_020923036.1;XP_020923035.1	XP_020923053.1 keratin-associated protein 5-1-like isoform X18 [Sus scrofa];XP_020923047.1 keratin-associated protein 5-1-like isoform X12 [Sus scrofa];XP_020923045.1 keratin-associated protein 5-1-like isoform X10 [Sus scrofa];XP_020923055.1 keratin-assoc	4	4	4	0	0	0	0	0	46809000	0	0	0	0	0	0	0	0	0	17422000	0	0	NA	NA	NA	LOC110256043	LOC110256043;LOC110256043;LOC110256043;LOC110256043;LOC110256043	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020923108.1;XP_020923106.1;XP_020923105.1;XP_020923104.1	XP_020923108.1;XP_020923106.1;XP_020923105.1;XP_020923104.1	XP_020923108.1 unconventional myosin-Id isoform X4 [Sus scrofa];XP_020923106.1 unconventional myosin-Id isoform X3 [Sus scrofa];XP_020923105.1 unconventional myosin-Id isoform X2 [Sus scrofa];XP_020923104.1 unconventional myosin-Id isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	10206000	0	0	0	0	0	NA	NA	NA	MYO1D	MYO1D;MYO1D;MYO1D;MYO1D;NA	negative regulation of phosphatase activity;cellular localization;early endosome to recycling endosome transport;forebrain development	GO:001092; GO:005164; GO:006150; GO:003090	brush border;myosin complex;axolemma;extracellular exosome;axon;smooth endoplasmic reticulum;basolateral plasma membrane;neuronal cell body;cytosol;endosome;cytoplasmic vesicle;myelin sheath;apical dendrite;plasma membrane raft;neuron projection	GO:000590; GO:001645; GO:003067; GO:007006; GO:003042; GO:000579; GO:001632; GO:004302; GO:000582; GO:000576; GO:003141; GO:004320; GO:009744; GO:004485; GO:004300	"NA"	"NA"	protein domain specific binding;actin-dependent ATPase activity;calmodulin binding;ATP binding;actin filament binding;calcium-dependent protein binding;microfilament motor activity	GO:001990; GO:003089; GO:000551; GO:000552; GO:005101; GO:004830; GO:000014
XP_020923109.1	XP_020923109.1	XP_020923109.1 LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 11 [Sus scrofa]	15	15	15	254450000	272870000	266120000	248980000	252040000	218500000	282000000	264660000	249390000	255310000	260630000	226250000	304700000	237400000	258840000	268040000	251660000	239250000	NA	NA	NA	PSMD11	PSMD11;NA;NA;NA;NA	post-translational protein modification;ubiquitin-dependent protein catabolic process;proteasome assembly;stem cell differentiation;protein deubiquitination;neutrophil degranulation	GO:004368; GO:000651; GO:004324; GO:004886; GO:001657; GO:004331	nucleus;proteasome regulatory particle, lid subcomplex;cytosol;nucleoplasm;proteasome accessory complex;membrane;extracellular region;secretory granule lumen;ficolin-1-rich granule lumen;proteasome complex	GO:000563; GO:000854; GO:000582; GO:000565; GO:002262; GO:001602; GO:000557; GO:003477; GO:190481; GO:000050	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	structural molecule activity;protein binding	GO:000519; GO:000551
XP_020923132.1;XP_020923129.1;XP_020923123.1;XP_020923120.1;XP_020923117.1	XP_020923132.1;XP_020923129.1;XP_020923123.1;XP_020923120.1;XP_020923117.1	XP_020923132.1 proteasome-associated protein ECM29 homolog isoform X4 [Sus scrofa];XP_020923129.1 proteasome-associated protein ECM29 homolog isoform X4 [Sus scrofa];XP_020923123.1 proteasome-associated protein ECM29 homolog isoform X3 [Sus scrofa];XP_0209	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	23593000	0	0	0	0	NA	NA	NA	ECPAS	ECPAS;ECPAS;ECPAS;ECPAS;ECPAS	ubiquitin-dependent ERAD pathway;proteasome assembly	GO:003043; GO:004324	nucleus;cytoplasmic vesicle;membrane;early endosome;trans-Golgi network;endocytic vesicle;centrosome;endoplasmic reticulum;multivesicular body;endoplasmic reticulum-Golgi intermediate compartment;proteasome complex	GO:000563; GO:003141; GO:001602; GO:000576; GO:000580; GO:003013; GO:000581; GO:000578; GO:000577; GO:000579; GO:000050	"NA"	"NA"	protein binding;proteasome binding;protein complex scaffold	GO:000551; GO:007062; GO:003294
XP_020923161.1;XP_020923153.1;XP_020923146.1	XP_020923161.1;XP_020923153.1	XP_020923161.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 isoform X2 [Sus scrofa];XP_020923153.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 isoform X2 [Sus scrofa]	3	3	3	43250000	51156000	47844000	43730000	39124000	27562000	34568000	50135000	39088000	39920000	43960000	32817000	26988000	39703000	44175000	39497000	33550000	40068000	NA	NA	NA	GNG10	GNG10;GNG10;NA;NA;NA	signal transduction;G-protein coupled receptor signaling pathway	GO:000716; GO:000718	plasma membrane;heterotrimeric G-protein complex	GO:000588; GO:000583	 Retrograde endocannabinoid signaling; Glutamatergic synapse; PI3K-Akt signaling pathway; Circadian entrainment; Ras signaling pathway; Morphine addiction; Chemokine signaling pathway; Pathways in cancer	hsa0472; hsa0472; hsa0415; hsa0471; hsa0401; hsa0503; hsa0406; hsa0520	GTPase activity;protein binding	GO:000392; GO:000551
XP_020923160.1;XP_020923159.1;XP_020923158.1;XP_020923157.1;XP_020923156.1;XP_020923155.1	XP_020923160.1;XP_020923159.1;XP_020923158.1;XP_020923157.1;XP_020923156.1;XP_020923155.1	XP_020923160.1 flotillin-2 isoform X5 [Sus scrofa];XP_020923159.1 flotillin-2 isoform X4 [Sus scrofa];XP_020923158.1 flotillin-2 isoform X3 [Sus scrofa];XP_020923157.1 flotillin-2 isoform X3 [Sus scrofa];XP_020923156.1 flotillin-2 isoform X2 [Sus scrofa];X	10	10	10	44236000	47699000	30318000	0	0	35774000	43952000	38555000	30578000	31533000	34434000	27553000	60963000	36281000	38501000	23871000	38771000	48376000	NA	NA	NA	FLOT2	FLOT2;FLOT2;FLOT2;FLOT2;FLOT2	regulation of toll-like receptor 3 signaling pathway;cell adhesion;membrane raft assembly;negative regulation of gene expression;regulation of postsynaptic specialization membrane neurotransmitter receptor levels;negative regulation of amyloid precursor protein catabolic process;epidermis development;regulation of myoblast differentiation;anterograde dendritic transport;protein localization to plasma membrane;positive regulation of establishment of T cell polarity;protein stabilization;regulation of heterotypic cell-cell adhesion;protein localization to plasma membrane raft	GO:003413; GO:000715; GO:000176; GO:001062; GO:009907; GO:190299; GO:000854; GO:004566; GO:009893; GO:007265; GO:190390; GO:005082; GO:003411; GO:004486	cell-cell adherens junction;basolateral plasma membrane;endosome;endocytic vesicle;cytoplasmic vesicle;perinuclear region of cytoplasm;membrane;caveola;focal adhesion;plasma membrane;acrosomal membrane;cell-cell contact zone;flotillin complex;cortical actin cytoskeleton;vesicle;dendrite cytoplasm;glutamatergic synapse;uropod;lamellipodium;extracellular exosome;anchored component of presynaptic active zone membrane	GO:000591; GO:001632; GO:000576; GO:003013; GO:003141; GO:004847; GO:001602; GO:000590; GO:000592; GO:000588; GO:000208; GO:004429; GO:001660; GO:003086; GO:003198; GO:003283; GO:009897; GO:000193; GO:003002; GO:007006; GO:009902	 Insulin signaling pathway	hsa0491	protein binding;protease binding;ionotropic glutamate receptor binding;protein heterodimerization activity	GO:000551; GO:000202; GO:003525; GO:004698
XP_020923182.1	XP_020923182.1	XP_020923182.1 LOW QUALITY PROTEIN: bleomycin hydrolase [Sus scrofa]	7	7	7	26022000	27640000	27691000	25002000	22289000	28544000	29606000	24641000	30967000	26658000	22646000	41651000	22000000	0	0	22583000	31332000	24766000	NA	NA	NA	BLMH	BLMH;NA;NA;NA;NA	protein polyubiquitination;response to toxic substance;proteolysis;response to drug;homocysteine catabolic process	GO:000020; GO:000963; GO:000650; GO:004249; GO:004341	cytosol;nucleus;cytoplasm;extracellular exosome	GO:000582; GO:000563; GO:000573; GO:007006	"NA"	"NA"	identical protein binding;carboxypeptidase activity;aminopeptidase activity;protein binding;cysteine-type endopeptidase activity;cysteine-type peptidase activity	GO:004280; GO:000418; GO:000417; GO:000551; GO:000419; GO:000823
XP_020923187.1	XP_020923187.1	XP_020923187.1 nucleoredoxin [Sus scrofa]	3	3	3	0	2874900000	0	0	0	0	0	0	0	432270000	0	0	0	0	0	0	0	0	NA	NA	NA	NXN	NXN;NA;NA;NA;NA	cell redox homeostasis;cellular oxidant detoxification;Wnt signaling pathway;oxidation-reduction process;cardiovascular system development;negative regulation of protein ubiquitination;cell differentiation;negative regulation of Wnt signaling pathway	GO:004545; GO:009886; GO:001605; GO:005511; GO:007235; GO:003139; GO:003015; GO:003017	nucleus;cytosol	GO:000563; GO:000582	"NA"	"NA"	thioredoxin-disulfide reductase activity;protein-disulfide reductase activity	GO:000479; GO:004713
XP_020923210.1;XP_020923211.1	XP_020923210.1;XP_020923211.1	XP_020923210.1 14-3-3 protein epsilon isoform X1 [Sus scrofa];XP_020923211.1 14-3-3 protein epsilon isoform X2 [Sus scrofa]	18	16	16	1023400000	1256800000	1609900000	1020100000	1089700000	1066400000	1458900000	1145700000	1432500000	1136800000	1088200000	525760000	1014700000	1291400000	1324800000	1136500000	1439600000	995840000	NA	NA	NA	YWHAE	YWHAE;YWHAE;NA;NA;NA	hippo signaling;membrane organization;G2/M transition of mitotic cell cycle;neuron migration;viral process;membrane repolarization during cardiac muscle cell action potential;protein targeting;regulation of G2/M transition of mitotic cell cycle;hippocampus development;regulation of heart rate by cardiac conduction;ciliary basal body docking;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;positive regulation of protein export from nucleus;negative regulation of calcium ion export from cell;MAPK cascade;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of cytosolic calcium ion concentration;regulation of heart rate by hormone;intracellular signal transduction;cerebral cortex development;protein localization to nucleus;cellular response to heat;regulation of postsynaptic specialization membrane neurotransmitter receptor levels;regulation of membrane repolarization;regulation of cellular response to heat;regulation of potassium ion transmembrane transporter activity;negative regulation of calcium ion transmembrane transporter activity;negative regulation of peptidyl-serine dephosphorylation	GO:003532; GO:006102; GO:000008; GO:000176; GO:001603; GO:008601; GO:000660; GO:001038; GO:002176; GO:008609; GO:009771; GO:190074; GO:004682; GO:190591; GO:000016; GO:004315; GO:005148; GO:000306; GO:003555; GO:002198; GO:003450; GO:003460; GO:009907; GO:006030; GO:190003; GO:190101; GO:190102; GO:190230	glutamatergic synapse;plasma membrane;mitochondrion;nucleus;cytosol;extracellular exosome;focal adhesion;melanosome;central region of growth cone;membrane;kinesin complex	GO:009897; GO:000588; GO:000573; GO:000563; GO:000582; GO:007006; GO:000592; GO:004247; GO:009072; GO:001602; GO:000587	 Viral carcinogenesis; Cell cycle; Hippo signaling pathway; Epstein-Barr virus infection; PI3K-Akt signaling pathway; Neurotrophin signaling pathway	hsa0520; hsa0411; hsa0439; hsa0516; hsa0415; hsa0472	identical protein binding;potassium channel regulator activity;MHC class II protein complex binding;calcium channel regulator activity;histone deacetylase binding;phosphoprotein binding;Rab guanyl-nucleotide exchange factor activity;cadherin binding;scaffold protein binding;protein binding;ion channel binding;RNA binding;enzyme binding;protein domain specific binding;phosphoserine binding;protein heterodimerization activity;ubiquitin protein ligase binding	GO:004280; GO:001545; GO:002302; GO:000524; GO:004282; GO:005121; GO:001711; GO:004529; GO:009711; GO:000551; GO:004432; GO:000372; GO:001989; GO:001990; GO:005081; GO:004698; GO:003162
XP_020923218.1;XP_020923219.1;XP_020923212.1;XP_020923213.1	XP_020923218.1;XP_020923219.1;XP_020923212.1;XP_020923213.1	XP_020923218.1 unconventional myosin-Ic isoform X4 [Sus scrofa];XP_020923219.1 unconventional myosin-Ic isoform X5 [Sus scrofa];XP_020923212.1 unconventional myosin-Ic isoform X1 [Sus scrofa];XP_020923213.1 unconventional myosin-Ic isoform X2 [Sus scrofa]	64	64	3	4787100000	3238800000	4257600000	3347600000	4016800000	2675700000	3501500000	3287400000	3770900000	3542600000	3945800000	4353700000	2438000000	3913700000	4348900000	4899100000	3525500000	2981200000	NA	NA	NA	MYO1C	MYO1C;MYO1C;MYO1C;MYO1C;NA	positive regulation of cell migration;mRNA transport;positive regulation of gene expression, epigenetic;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of protein targeting to membrane;regulation of bicellular tight junction assembly;positive regulation of actin filament polymerization;positive regulation of cellular response to insulin stimulus;positive regulation of vascular endothelial growth factor signaling pathway;protein targeting to membrane;vesicle transport along actin filament;cellular response to interferon-gamma;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;protein targeting	GO:003033; GO:005102; GO:004581; GO:003809; GO:009031; GO:200081; GO:003083; GO:190007; GO:190074; GO:000661; GO:003005; GO:007134; GO:003808; GO:000660	plasma membrane;filamentous actin;lateral plasma membrane;stress fiber;cytoplasm;membrane raft;ruffle membrane;phagocytic vesicle;extracellular exosome;cytosol;basal plasma membrane;membrane;unconventional myosin complex;stereocilium membrane;nucleoplasm;microvillus;nuclear body;nuclear pore;cytoplasmic vesicle membrane	GO:000588; GO:003194; GO:001632; GO:000172; GO:000573; GO:004512; GO:003258; GO:004533; GO:007006; GO:000582; GO:000992; GO:001602; GO:001646; GO:006017; GO:000565; GO:000590; GO:001660; GO:000564; GO:003065	"NA"	"NA"	protein C-terminus binding;microfilament motor activity;protein binding;Ral GTPase binding;actin filament binding;receptor binding;ATP binding;actin-dependent ATPase activity	GO:000802; GO:000014; GO:000551; GO:001716; GO:005101; GO:000510; GO:000552; GO:003089
XP_020923228.1;XP_020923227.1	XP_020923228.1;XP_020923227.1	XP_020923228.1 pre-mRNA-processing-splicing factor 8 [Sus scrofa];XP_020923227.1 pre-mRNA-processing-splicing factor 8 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1795700	NA	NA	NA	PRPF8	PRPF8;PRPF8;NA;NA;NA	RNA splicing, via transesterification reactions;RNA splicing;spliceosomal tri-snRNP complex assembly;mRNA splicing, via spliceosome;cellular response to lipopolysaccharide;mRNA processing;cellular response to tumor necrosis factor	GO:000037; GO:000838; GO:000024; GO:000039; GO:007122; GO:000639; GO:007135	U2-type precatalytic spliceosome;nuclear speck;catalytic step 2 spliceosome;membrane;nucleus;U4/U6 x U5 tri-snRNP complex;nucleoplasm;U5 snRNP;U2-type catalytic step 2 spliceosome	GO:007100; GO:001660; GO:007101; GO:001602; GO:000563; GO:004654; GO:000565; GO:000568; GO:007100	 Spliceosome	hsa0304	U5 snRNA binding;second spliceosomal transesterification activity;U2 snRNA binding;protein binding;RNA binding;U1 snRNA binding;K63-linked polyubiquitin binding;U6 snRNA binding;pre-mRNA intronic binding	GO:003062; GO:000038; GO:003062; GO:000551; GO:000372; GO:003061; GO:007053; GO:001707; GO:009715
XP_020923232.1;XP_020923231.1	XP_020923232.1;XP_020923231.1	XP_020923232.1 WD repeat-containing protein 81 isoform X2 [Sus scrofa];XP_020923231.1 WD repeat-containing protein 81 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1426700	0	NA	NA	NA	WDR81	WDR81;WDR81;NA;NA;NA	ubiquitin-dependent protein catabolic process;negative regulation of phosphatase activity;early endosome to late endosome transport;regulation of phosphatidylinositol 3-kinase activity;mitochondrion organization;protein stabilization;aggrephagy	GO:000651; GO:001092; GO:004502; GO:004355; GO:000700; GO:005082; GO:003597	mitochondrion;extrinsic component of endosome membrane;autophagosome membrane;early endosome membrane;lysosomal membrane;endoplasmic reticulum membrane;cytosol;Golgi apparatus	GO:000573; GO:003131; GO:000042; GO:003190; GO:000576; GO:000578; GO:000582; GO:000579	"NA"	"NA"	phosphatidylinositol 3-kinase regulator activity;K63-linked polyubiquitin binding;protein binding	GO:003501; GO:007053; GO:000551
XP_020923238.1;CON__P28800	XP_020923238.1	XP_020923238.1 alpha-2-antiplasmin [Sus scrofa]	8	8	8	137510000	156700000	107650000	158580000	204040000	338540000	144480000	124280000	158310000	136720000	168140000	173920000	152250000	129540000	125520000	142130000	154490000	205280000	NA	NA	NA	SERPINF2	SERPINF2;NA;NA;NA;NA	positive regulation of stress fiber assembly;platelet degranulation;response to organic substance;negative regulation of endopeptidase activity;positive regulation of transforming growth factor beta production;positive regulation of cell differentiation;positive regulation of smooth muscle cell proliferation;regulation of blood vessel diameter by renin-angiotensin;positive regulation of collagen biosynthetic process;blood vessel morphogenesis;fibrinolysis;collagen fibril organization;positive regulation of cell-cell adhesion mediated by cadherin;positive regulation of transcription from RNA polymerase II promoter;positive regulation of JNK cascade;negative regulation of fibrinolysis;positive regulation of ERK1 and ERK2 cascade;acute-phase response;negative regulation of plasminogen activation	GO:005149; GO:000257; GO:001003; GO:001095; GO:007163; GO:004559; GO:004866; GO:000203; GO:003296; GO:004851; GO:004273; GO:003019; GO:200004; GO:004594; GO:004633; GO:005191; GO:007037; GO:000695; GO:001075	extracellular space;cell surface;extracellular region;platelet alpha granule lumen;blood microparticle;extracellular exosome	GO:000561; GO:000998; GO:000557; GO:003109; GO:007256; GO:007006	 Complement and coagulation cascades	hsa0461	protein binding;protease binding;serine-type endopeptidase inhibitor activity;protein homodimerization activity	GO:000551; GO:000202; GO:000486; GO:004280
XP_020923285.1;XP_020923284.1;XP_020923287.1;XP_020923282.1;XP_020923283.1	XP_020923285.1;XP_020923284.1;XP_020923287.1;XP_020923282.1;XP_020923283.1	XP_020923285.1 clustered mitochondria protein homolog isoform X4 [Sus scrofa];XP_020923284.1 clustered mitochondria protein homolog isoform X3 [Sus scrofa];XP_020923287.1 clustered mitochondria protein homolog isoform X5 [Sus scrofa];XP_020923282.1 cluster	6	6	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1223500	0	NA	NA	NA	CLUH	CLUH;CLUH;CLUH;CLUH;CLUH	intracellular distribution of mitochondria;mitochondrion organization	GO:004831; GO:000700	cytoplasm	GO:000573	"NA"	"NA"	mRNA binding	GO:000372
XP_020923352.1;XP_020923351.1	XP_020923352.1;XP_020923351.1	XP_020923352.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X2 [Sus scrofa];XP_020923351.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1 [Sus scrofa]	5	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	97505000	0	NA	NA	NA	ATP2A3	ATP2A3;ATP2A3;NA;NA;NA	ATP hydrolysis coupled cation transmembrane transport;ion transmembrane transport;cellular calcium ion homeostasis;hydrogen ion transmembrane transport;calcium ion transport;calcium ion transmembrane transport;regulation of cardiac conduction	GO:009913; GO:003422; GO:000687; GO:190260; GO:000681; GO:007058; GO:190377	sarcoplasmic reticulum;integral component of membrane;nuclear membrane;sarcoplasmic reticulum membrane;platelet dense tubular network membrane;endoplasmic reticulum	GO:001652; GO:001602; GO:003196; GO:003301; GO:003109; GO:000578	 Alzheimer's disease; Pancreatic secretion; cGMP-PKG signaling pathway	hsa0501; hsa0497; hsa0402	ATP binding;metal ion binding;hydrogen-exporting ATPase activity, phosphorylative mechanism;calcium-transporting ATPase activity	GO:000552; GO:004687; GO:000855; GO:000538
XP_020923395.1;XP_020923394.1;XP_020923393.1;XP_020923392.1;XP_020923391.1;XP_020923390.1;XP_020923389.1;XP_020923396.1;XP_020923398.1	XP_020923395.1;XP_020923394.1;XP_020923393.1;XP_020923392.1;XP_020923391.1;XP_020923390.1;XP_020923389.1;XP_020923396.1;XP_020923398.1	XP_020923395.1 rab GTPase-binding effector protein 1 isoform X7 [Sus scrofa];XP_020923394.1 rab GTPase-binding effector protein 1 isoform X6 [Sus scrofa];XP_020923393.1 rab GTPase-binding effector protein 1 isoform X5 [Sus scrofa];XP_020923392.1 rab GTPase	9	9	9	32885000	30698000	26026000	33599000	42744000	22215000	24534000	34525000	30797000	32834000	43506000	52564000	0	40003000	36736000	33359000	29172000	0	NA	NA	NA	RABEP1	RABEP1;RABEP1;RABEP1;RABEP1;RABEP1	apoptotic process;Golgi to plasma membrane transport;positive regulation of GTPase activity;membrane fusion;protein transport;vesicle-mediated transport;regulation of receptor activity;protein localization to ciliary membrane	GO:000691; GO:000689; GO:004354; GO:006102; GO:001503; GO:001619; GO:001046; GO:190344	recycling endosome;endosome;macromolecular complex;intracellular membrane-bounded organelle;endocytic vesicle;early endosome membrane	GO:005503; GO:000576; GO:003299; GO:004323; GO:003013; GO:003190	 Endocytosis	hsa0414	protein domain specific binding;growth factor activity;protein binding;protein homodimerization activity;GTPase activator activity	GO:001990; GO:000808; GO:000551; GO:004280; GO:000509
XP_020923415.1;XP_020923408.1;XP_020923405.1;XP_020923397.1	XP_020923415.1;XP_020923408.1;XP_020923405.1;XP_020923397.1	XP_020923415.1 haloacid dehalogenase-like hydrolase domain-containing protein 3 [Sus scrofa];XP_020923408.1 haloacid dehalogenase-like hydrolase domain-containing protein 3 [Sus scrofa];XP_020923405.1 haloacid dehalogenase-like hydrolase domain-containing	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5325300	0	0	NA	NA	NA	HDHD3	HDHD3;HDHD3;HDHD3;HDHD3;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	hydrolase activity;protein binding	GO:001678; GO:000551
XP_020923404.1	XP_020923404.1	XP_020923404.1 complement component 1 Q subcomponent-binding protein, mitochondrial [Sus scrofa]	3	3	3	68541000	42415000	65246000	34323000	58280000	37368000	76297000	52742000	82149000	51717000	51263000	25159000	46606000	50399000	46046000	50257000	56838000	41987000	NA	NA	NA	C1QBP	C1QBP;NA;NA;NA;NA	negative regulation of transcription from RNA polymerase II promoter;apoptotic process;mature ribosome assembly;positive regulation of apoptotic process;negative regulation of mRNA splicing, via spliceosome;mRNA processing;RNA splicing;viral process;positive regulation of neutrophil chemotaxis;complement activation, classical pathway;blood coagulation, intrinsic pathway;negative regulation of RIG-I signaling pathway;negative regulation of interleukin-12 production;positive regulation of trophoblast cell migration;phosphatidylinositol 3-kinase signaling;positive regulation of mitochondrial translation;positive regulation of substrate adhesion-dependent cell spreading;innate immune response;positive regulation of cell adhesion;regulation of complement activation;negative regulation of interferon-gamma production;negative regulation of defense response to virus;positive regulation of protein kinase B signaling;positive regulation of dendritic cell chemotaxis	GO:000012; GO:000691; GO:004225; GO:004306; GO:004802; GO:000639; GO:000838; GO:001603; GO:009002; GO:000695; GO:000759; GO:003953; GO:003269; GO:190116; GO:001406; GO:007013; GO:190002; GO:004508; GO:004578; GO:003044; GO:003268; GO:005068; GO:005189; GO:200051	cytoplasm;mitochondrial matrix;presynaptic active zone;nucleus;cytosol;plasma membrane;membrane;extracellular space;glutamatergic synapse;nucleolus;cell surface;GABA-ergic synapse	GO:000573; GO:000575; GO:004878; GO:000563; GO:000582; GO:000588; GO:001602; GO:000561; GO:009897; GO:000573; GO:000998; GO:009898	 Herpes simplex infection	hsa0516	mRNA binding;transcription factor binding;translation activator activity;transcription corepressor activity;kininogen binding;adrenergic receptor binding;protein kinase C binding;mitochondrial ribosome binding;protein binding;complement component C1q binding;hyaluronic acid binding	GO:000372; GO:000813; GO:000849; GO:000371; GO:003098; GO:003169; GO:000508; GO:009717; GO:000551; GO:000184; GO:000554
XP_020923424.1	XP_020923424.1	XP_020923424.1 LOW QUALITY PROTEIN: delta-aminolevulinic acid dehydratase [Sus scrofa]	8	8	8	114990000	115670000	80843000	114720000	127520000	96473000	120740000	123690000	86949000	89173000	141840000	131160000	108100000	116930000	146240000	114610000	117380000	105060000	NA	NA	NA	ALAD	ALAD;NA;NA;NA;NA	response to activity;response to mercury ion;response to glucocorticoid;protoporphyrinogen IX biosynthetic process;response to aluminum ion;response to vitamin B1;cellular response to lead ion;response to hypoxia;response to iron ion;neutrophil degranulation;response to oxidative stress;response to ionizing radiation;response to lipopolysaccharide;response to amino acid;response to fatty acid;response to cobalt ion;response to vitamin E;protein homooligomerization;response to methylmercury;response to herbicide;response to ethanol;cellular response to interleukin-4;negative regulation of proteasomal protein catabolic process	GO:001482; GO:004668; GO:005138; GO:000678; GO:001004; GO:001026; GO:007128; GO:000166; GO:001003; GO:004331; GO:000697; GO:001021; GO:003249; GO:004320; GO:007054; GO:003202; GO:003319; GO:005126; GO:005159; GO:000963; GO:004547; GO:007135; GO:190179	extracellular region;cytosol;secretory granule lumen;extracellular exosome;nucleus;ficolin-1-rich granule lumen	GO:000557; GO:000582; GO:003477; GO:007006; GO:000563; GO:190481	 Metabolic pathways; Porphyrin and chlorophyll metabolism	hsa0110; hsa0086	proteasome core complex binding;catalytic activity;identical protein binding;porphobilinogen synthase activity;zinc ion binding	GO:190485; GO:000382; GO:004280; GO:000465; GO:000827
XP_020923425.1;XP_020923426.1	XP_020923425.1;XP_020923426.1	XP_020923425.1 mitochondrial 2-oxoglutarate/malate carrier protein isoform X1 [Sus scrofa];XP_020923426.1 mitochondrial 2-oxoglutarate/malate carrier protein isoform X2 [Sus scrofa]	8	8	8	117660000	50238000	89460000	35048000	84405000	35337000	67923000	56358000	80677000	55100000	70335000	0	62234000	42278000	58110000	71743000	64689000	56204000	NA	NA	NA	SLC25A11	SLC25A11;SLC25A11;NA;NA;NA	transmembrane transport;alpha-ketoglutarate transport;gluconeogenesis	GO:005508; GO:001574; GO:000609	mitochondrion;nucleus;mitochondrial inner membrane;integral component of plasma membrane	GO:000573; GO:000563; GO:000574; GO:000588	"NA"	"NA"	RNA binding;oxoglutarate:malate antiporter activity	GO:000372; GO:001536
XP_020923522.1	XP_020923522.1	XP_020923522.1 LOW QUALITY PROTEIN: myosin-10 [Sus scrofa]	83	61	59	299210000	756680000	461900000	676360000	377560000	694520000	510030000	781890000	400170000	588520000	503990000	974030000	1270100000	958850000	512930000	710750000	550470000	804570000	NA	NA	NA	MYH10	MYH10;NA;NA;NA;NA	substrate-dependent cell migration, cell extension;cell proliferation;regulation of cell shape;actin filament-based movement;lateral ventricle development;ventricular cardiac muscle cell development;retina development in camera-type eye;modification of postsynaptic actin cytoskeleton;nuclear migration;cardiac septum development;fourth ventricle development;in utero embryonic development;adult heart development;neuromuscular process controlling balance;cell adhesion;axon guidance;aorta development;postsynaptic actin cytoskeleton organization;plasma membrane repair;cardiac myofibril assembly;coronary vasculature development;mitotic cytokinesis;neuron migration;exocytosis;cerebellar Purkinje cell layer development;actomyosin structure organization;positive regulation of protein secretion	GO:000693; GO:000828; GO:000836; GO:003004; GO:002167; GO:005501; GO:006004; GO:009888; GO:000709; GO:000327; GO:002159; GO:000170; GO:000751; GO:005088; GO:000715; GO:000741; GO:003590; GO:009897; GO:000177; GO:005500; GO:006097; GO:000028; GO:000176; GO:000688; GO:002168; GO:003103; GO:005071	neuromuscular junction;actomyosin;brush border;cell cortex;myosin complex;myosin II complex;neuronal cell body;cytosol;nucleus;polysome;lamellipodium;growth cone;midbody;extracellular exosome;myosin II filament;glutamatergic synapse;stress fiber;cytoplasm;spindle;cleavage furrow;dendritic spine	GO:003159; GO:004264; GO:000590; GO:000593; GO:001645; GO:001646; GO:004302; GO:000582; GO:000563; GO:000584; GO:003002; GO:003042; GO:003049; GO:007006; GO:009751; GO:009897; GO:000172; GO:000573; GO:000581; GO:003215; GO:004319	 Regulation of actin cytoskeleton; Tight junction; Salmonella infection	hsa0481; hsa0453; hsa0513	calmodulin binding;ADP binding;mRNA 5'-UTR binding;ATPase activity;microfilament motor activity;protein binding;actin filament binding;ATP binding;actin binding;actin-dependent ATPase activity;RNA stem-loop binding	GO:000551; GO:004353; GO:004802; GO:001688; GO:000014; GO:000551; GO:005101; GO:000552; GO:000377; GO:003089; GO:003561
XP_020923614.1	XP_020923614.1	XP_020923614.1 microfibril-associated glycoprotein 4 [Sus scrofa]	5	5	5	62106000	58512000	149640000	204850000	36810000	57979000	52977000	129020000	105960000	170790000	46946000	104150000	146890000	45639000	53676000	39003000	40417000	110930000	NA	NA	NA	MFAP4	MFAP4;NA;NA;NA;NA	supramolecular fiber organization;UV protection;elastic fiber assembly;cellular response to UV-B;cell adhesion;regulation of collagen metabolic process	GO:009743; GO:000965; GO:004825; GO:007149; GO:000715; GO:001071	extracellular region;elastic fiber;microfibril	GO:000557; GO:007195; GO:000152	"NA"	"NA"	extracellular matrix structural constituent;protein binding	GO:000520; GO:000551
XP_020923635.1;XP_020923634.1;XP_020923633.1;XP_020923632.1;XP_020923631.1;XP_020923630.1;XP_020923639.1;XP_020923638.1;XP_020923637.1;XP_020923636.1	XP_020923635.1;XP_020923634.1;XP_020923633.1;XP_020923632.1;XP_020923631.1;XP_020923630.1;XP_020923639.1;XP_020923638.1;XP_020923637.1;XP_020923636.1	XP_020923635.1 phosphoribosyl pyrophosphate synthase-associated protein 2 isoform X2 [Sus scrofa];XP_020923634.1 phosphoribosyl pyrophosphate synthase-associated protein 2 isoform X2 [Sus scrofa];XP_020923633.1 phosphoribosyl pyrophosphate synthase-associa	5	4	4	0	27919000	20925000	25577000	23238000	21535000	17476000	26269000	0	26772000	0	25998000	0	20649000	0	33047000	26646000	20920000	NA	NA	NA	PRPSAP2	PRPSAP2;PRPSAP2;PRPSAP2;PRPSAP2;PRPSAP2	nucleobase-containing compound metabolic process;5-phosphoribose 1-diphosphate biosynthetic process;nucleoside metabolic process;negative regulation of catalytic activity;bone development;purine nucleotide biosynthetic process;nucleotide biosynthetic process	GO:000613; GO:000601; GO:000911; GO:004308; GO:006034; GO:000616; GO:000916	cytoplasm;ribose phosphate diphosphokinase complex	GO:000573; GO:000218	"NA"	"NA"	protein binding;ribose phosphate diphosphokinase activity;enzyme inhibitor activity;magnesium ion binding	GO:000551; GO:000474; GO:000485; GO:000028
XP_020923642.1;XP_020923641.1	XP_020923642.1;XP_020923641.1	XP_020923642.1 protein flightless-1 homolog isoform X2 [Sus scrofa];XP_020923641.1 protein flightless-1 homolog isoform X1 [Sus scrofa]	5	5	5	183040000	73970000	111060000	33978000	0	50753000	137500000	51399000	168560000	91570000	0	33791000	195330000	0	127690000	44328000	188360000	0	NA	NA	NA	FLII	FLII;FLII;NA;NA;NA	actin filament severing;multicellular organism development;actin cytoskeleton organization	GO:005101; GO:000727; GO:003003	microtubule organizing center;brush border;cytosol;focal adhesion;nucleoplasm	GO:000581; GO:000590; GO:000582; GO:000592; GO:000565	"NA"	"NA"	protein binding;actin filament binding;actin binding	GO:000551; GO:005101; GO:000377
XP_020923652.1;XP_020923651.1;XP_020923649.1;XP_020923648.1	XP_020923652.1;XP_020923651.1;XP_020923649.1;XP_020923648.1	XP_020923652.1 serine hydroxymethyltransferase, cytosolic [Sus scrofa];XP_020923651.1 serine hydroxymethyltransferase, cytosolic [Sus scrofa];XP_020923649.1 serine hydroxymethyltransferase, cytosolic [Sus scrofa];XP_020923648.1 serine hydroxymethyltransfer	12	11	11	0	51619000	82863000	0	62645000	67042000	70762000	51252000	102150000	84381000	67720000	52241000	0	47407000	0	67665000	47185000	37801000	NA	NA	NA	SHMT1	SHMT1;SHMT1;SHMT1;SHMT1;NA	dTMP biosynthetic process;one-carbon metabolic process;glycine metabolic process;glycine biosynthetic process from serine;folic acid metabolic process;protein tetramerization;cellular response to leukemia inhibitory factor;tetrahydrofolate interconversion;carnitine biosynthetic process;L-serine metabolic process;purine nucleobase biosynthetic process;cellular response to tetrahydrofolate;negative regulation of translation;protein homotetramerization	GO:000623; GO:000673; GO:000654; GO:001926; GO:004665; GO:005126; GO:199083; GO:003599; GO:004532; GO:000656; GO:000911; GO:190448; GO:001714; GO:005128	cytosol;nucleus;extracellular exosome	GO:000582; GO:000563; GO:007006	 Cyanoamino acid metabolism; Carbon metabolism; One carbon pool by folate; Biosynthesis of antibiotics; Metabolic pathways; Glyoxylate and dicarboxylate metabolism; Glycine, serine and threonine metabolism; Biosynthesis of amino acids	hsa0046; hsa0120; hsa0067; hsa0113; hsa0110; hsa0063; hsa0026; hsa0123	protein binding;identical protein binding;translation repressor activity, nucleic acid binding;pyridoxal phosphate binding;mRNA 5'-UTR binding;cobalt ion binding;zinc ion binding;serine binding;glycine hydroxymethyltransferase activity;L-allo-threonine aldolase activity;amino acid binding	GO:000551; GO:004280; GO:000090; GO:003017; GO:004802; GO:005089; GO:000827; GO:007090; GO:000437; GO:000873; GO:001659
XP_020923674.1;XP_020923671.1;XP_020923668.1;XP_020923667.1;XP_020923665.1;XP_020923664.1;XP_020923672.1;XP_020923669.1;XP_020923673.1;XP_020923670.1;XP_020923676.1	XP_020923674.1;XP_020923671.1;XP_020923668.1;XP_020923667.1;XP_020923665.1;XP_020923664.1;XP_020923672.1;XP_020923669.1;XP_020923673.1;XP_020923670.1	XP_020923674.1 TOM1-like protein 2 isoform X10 [Sus scrofa];XP_020923671.1 TOM1-like protein 2 isoform X7 [Sus scrofa];XP_020923668.1 TOM1-like protein 2 isoform X4 [Sus scrofa];XP_020923667.1 TOM1-like protein 2 isoform X3 [Sus scrofa];XP_020923665.1 TOM1	4	4	4	0	0	16255000	0	0	0	13912000	0	0	0	0	0	0	0	0	15002000	0	0	NA	NA	NA	TOM1L2	TOM1L2;TOM1L2;TOM1L2;TOM1L2;TOM1L2	negative regulation of mitotic nuclear division;signal transduction;intracellular protein transport	GO:004583; GO:000716; GO:000688	extracellular exosome;cell	GO:007006; GO:000562	"NA"	"NA"	protein binding;protein kinase binding;clathrin binding	GO:000551; GO:001990; GO:003027
XP_020923708.1;XP_020923707.1;XP_020923706.1;XP_020923705.1;XP_020923709.1	XP_020923708.1;XP_020923707.1;XP_020923706.1;XP_020923705.1;XP_020923709.1	XP_020923708.1 dehydrogenase/reductase SDR family member 7B isoform X2 [Sus scrofa];XP_020923707.1 dehydrogenase/reductase SDR family member 7B isoform X2 [Sus scrofa];XP_020923706.1 dehydrogenase/reductase SDR family member 7B isoform X2 [Sus scrofa];XP_0	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11280000	0	0	0	NA	NA	NA	DHRS7B	DHRS7B;DHRS7B;DHRS7B;DHRS7B;DHRS7B	neutrophil differentiation;macromolecule metabolic process;ether lipid biosynthetic process;biological_process;oxidation-reduction process	GO:003022; GO:004317; GO:000861; GO:000815; GO:005511	integral component of membrane;membrane;endoplasmic reticulum membrane	GO:001602; GO:001602; GO:000578	"NA"	"NA"	molecular_function;oxidoreductase activity	GO:000367; GO:001649
XP_020923800.1	XP_020923800.1	XP_020923800.1 LOW QUALITY PROTEIN: C-type mannose receptor 2 [Sus scrofa]	15	15	15	0	57263000	0	88780000	0	68134000	0	52334000	0	67348000	0	77910000	35881000	61595000	0	46387000	0	94219000	NA	NA	NA	MRC2	MRC2;NA;NA;NA;NA	endocytosis;collagen catabolic process;osteoblast differentiation	GO:000689; GO:003057; GO:000164	membrane;focal adhesion;integral component of membrane	GO:001602; GO:000592; GO:001602	 Phagosome; Tuberculosis	hsa0414; hsa0515	transmembrane signaling receptor activity;protein binding;carbohydrate binding	GO:000488; GO:000551; GO:003024
XP_020923822.1	XP_020923822.1	XP_020923822.1 26S proteasome non-ATPase regulatory subunit 5 [Sus scrofa]	16	16	16	210470000	145530000	229510000	176280000	178180000	111500000	204230000	169750000	225090000	189790000	173200000	171470000	158790000	118410000	172500000	186950000	164550000	131420000	NA	NA	NA	PSMD5	PSMD5;NA;NA;NA;NA	protein deubiquitination;post-translational protein modification;proteasome regulatory particle assembly	GO:001657; GO:004368; GO:007068	nucleoplasm;proteasome regulatory particle, base subcomplex;proteasome complex;proteasome accessory complex;cytosol	GO:000565; GO:000854; GO:000050; GO:002262; GO:000582	"NA"	"NA"	protein binding	GO:000551
XP_020923940.1	XP_020923940.1	XP_020923940.1 erythrocyte band 7 integral membrane protein [Sus scrofa]	8	8	8	139970000	214080000	167290000	127710000	131950000	212000000	163390000	167500000	116690000	161880000	162160000	174980000	200960000	148410000	144140000	140530000	135960000	134950000	NA	NA	NA	STOM	STOM;NA;NA;NA;NA	positive regulation of protein targeting to membrane;protein homooligomerization;neutrophil degranulation;positive regulation by host of viral genome replication;regulation of acid-sensing ion channel activity	GO:009031; GO:005126; GO:004331; GO:004482; GO:190158	mitochondrion;perinuclear region of cytoplasm;plasma membrane;membrane;melanosome;membrane raft;cytoskeleton;azurophil granule membrane;vesicle;endoplasmic reticulum;tertiary granule membrane;blood microparticle;extracellular exosome;extracellular space	GO:000573; GO:004847; GO:000588; GO:001602; GO:004247; GO:004512; GO:000585; GO:003557; GO:003198; GO:000578; GO:007082; GO:007256; GO:007006; GO:000561	"NA"	"NA"	protein binding;protein homodimerization activity;RNA polymerase binding	GO:000551; GO:004280; GO:007006
XP_020924178.1;XP_020924175.1;XP_020924172.1;XP_020924170.1	XP_020924178.1;XP_020924175.1;XP_020924172.1;XP_020924170.1	XP_020924178.1 inter-alpha-trypsin inhibitor heavy chain H4 isoform X11 [Sus scrofa];XP_020924175.1 inter-alpha-trypsin inhibitor heavy chain H4 isoform X8 [Sus scrofa];XP_020924172.1 inter-alpha-trypsin inhibitor heavy chain H4 isoform X5 [Sus scrofa];XP_	44	44	1	1116100000	704890000	642010000	866270000	9185500000	9489000000	858220000	530600000	755260000	517450000	910810000	600040000	1160400000	844380000	810730000	519690000	1100100000	955880000	NA	NA	NA	ITIH4	ITIH4;ITIH4;ITIH4;ITIH4;NA	acute-phase response;negative regulation of endopeptidase activity;hyaluronan metabolic process;response to cytokine;platelet degranulation	GO:000695; GO:001095; GO:003021; GO:003409; GO:000257	platelet dense granule lumen;blood microparticle;extracellular exosome;plasma membrane;extracellular region	GO:003108; GO:007256; GO:007006; GO:000588; GO:000557	"NA"	"NA"	endopeptidase inhibitor activity;protein binding;serine-type endopeptidase inhibitor activity	GO:000486; GO:000551; GO:000486
XP_020924177.1;XP_020924176.1	XP_020924177.1;XP_020924176.1	XP_020924177.1 inter-alpha-trypsin inhibitor heavy chain H4 isoform X10 [Sus scrofa];XP_020924176.1 inter-alpha-trypsin inhibitor heavy chain H4 isoform X9 [Sus scrofa]	43	1	1	0	0	0	0	0	166230000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ITIH4	ITIH4;ITIH4;NA;NA;NA	acute-phase response;negative regulation of endopeptidase activity;hyaluronan metabolic process;response to cytokine;platelet degranulation	GO:000695; GO:001095; GO:003021; GO:003409; GO:000257	platelet dense granule lumen;blood microparticle;extracellular exosome;plasma membrane;extracellular region	GO:003108; GO:007256; GO:007006; GO:000588; GO:000557	"NA"	"NA"	endopeptidase inhibitor activity;protein binding;serine-type endopeptidase inhibitor activity	GO:000486; GO:000551; GO:000486
XP_020924419.1;XP_020924418.1;XP_020924417.1;XP_020924416.1;XP_020924414.1;XP_020924413.1;XP_020924412.1;XP_020924411.1;XP_020924410.1;XP_020924409.1;XP_020924408.1;XP_020924407.1;XP_020924406.1;XP_020924405.1;XP_020924403.1;XP_020924402.1;XP_020924401.1;XP_020924400.1;XP_020924399.1	XP_020924419.1;XP_020924418.1;XP_020924417.1;XP_020924416.1;XP_020924414.1;XP_020924413.1;XP_020924412.1;XP_020924411.1;XP_020924410.1;XP_020924409.1;XP_020924408.1;XP_020924407.1;XP_020924406.1;XP_020924405.1;XP_020924403.1;XP_020924402.1;XP_020924401.1;XP_020924400.1;XP_020924399.1	XP_020924419.1 dystroglycan [Sus scrofa];XP_020924418.1 dystroglycan [Sus scrofa];XP_020924417.1 dystroglycan [Sus scrofa];XP_020924416.1 dystroglycan [Sus scrofa];XP_020924414.1 dystroglycan [Sus scrofa];XP_020924413.1 dystroglycan [Sus scrofa];XP_0209244	10	10	10	60228000	103890000	76609000	81927000	60065000	53182000	79422000	71160000	50169000	75882000	63560000	96045000	59381000	83809000	67452000	87095000	57931000	64666000	NA	NA	NA	DAG1	DAG1;DAG1;DAG1;DAG1;DAG1	regulation of embryonic cell shape;extracellular matrix organization;positive regulation of oligodendrocyte differentiation;regulation of synapse organization;cellular response to cholesterol;skeletal muscle tissue regeneration;positive regulation of cell-matrix adhesion;cytoskeletal anchoring at plasma membrane;calcium-dependent cell-matrix adhesion;modulation by virus of host morphology or physiology;negative regulation of cell migration;branching involved in salivary gland morphogenesis;aging;response to denervation involved in regulation of muscle adaptation;cellular response to mechanical stimulus;positive regulation of basement membrane assembly involved in embryonic body morphogenesis;regulation of gastrulation;regulation of epithelial to mesenchymal transition;viral entry into host cell;axon regeneration;response to peptide hormone;retrograde trans-synaptic signaling by trans-synaptic protein complex;membrane protein ectodomain proteolysis;positive regulation of myelination;microtubule anchoring;angiogenesis involved in wound healing;myelination in peripheral nervous system;positive regulation of protein kinase activity;commissural neuron axon guidance;basement membrane organization;morphogenesis of an epithelial sheet;nerve maturation;negative regulation of protein kinase B signaling	GO:001647; GO:003019; GO:004871; GO:005080; GO:007139; GO:004340; GO:000195; GO:000701; GO:001634; GO:001904; GO:003033; GO:006044; GO:000756; GO:001489; GO:007126; GO:190426; GO:001047; GO:001071; GO:004671; GO:003110; GO:004343; GO:009894; GO:000650; GO:003164; GO:003445; GO:006005; GO:002201; GO:004586; GO:007167; GO:007171; GO:000201; GO:002168; GO:005189	extracellular space;Golgi lumen;postsynaptic membrane;integral component of membrane;endoplasmic reticulum lumen;cytoskeleton;cell-cell adherens junction;external side of plasma membrane;lamellipodium;sarcolemma;contractile ring;glutamatergic synapse;cytosol;basement membrane;nucleoplasm;focal adhesion;dystrophin-associated glycoprotein complex;basolateral plasma membrane;nuclear periphery;costamere;postsynaptic cytosol;plasma membrane;node of Ranvier;plasma membrane raft;extracellular region;extracellular exosome;cytoplasm;filopodium;GABA-ergic synapse	GO:000561; GO:000579; GO:004521; GO:001602; GO:000578; GO:000585; GO:000591; GO:000989; GO:003002; GO:004238; GO:007093; GO:009897; GO:000582; GO:000560; GO:000565; GO:000592; GO:001601; GO:001632; GO:003439; GO:004303; GO:009952; GO:000588; GO:003326; GO:004485; GO:000557; GO:007006; GO:000573; GO:003017; GO:009898	 ECM-receptor interaction; Hypertrophic cardiomyopathy (HCM)	hsa0451; hsa0541	protein binding;dystroglycan binding;laminin-1 binding;calcium ion binding;alpha-actinin binding;actin binding;structural constituent of muscle;tubulin binding;SH2 domain binding;virus receptor activity;vinculin binding	GO:000551; GO:000216; GO:004323; GO:000550; GO:005139; GO:000377; GO:000830; GO:001563; GO:004216; GO:000161; GO:001716
XP_020924555.1;XP_020924554.1;XP_020924553.1;XP_020924552.1;XP_020924551.1;XP_020924550.1;XP_020924549.1	XP_020924555.1;XP_020924554.1;XP_020924553.1;XP_020924552.1;XP_020924551.1;XP_020924550.1;XP_020924549.1	XP_020924555.1 stabilin-1 isoform X7 [Sus scrofa];XP_020924554.1 stabilin-1 isoform X6 [Sus scrofa];XP_020924553.1 stabilin-1 isoform X5 [Sus scrofa];XP_020924552.1 stabilin-1 isoform X4 [Sus scrofa];XP_020924551.1 stabilin-1 isoform X3 [Sus scrofa];XP_020	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7791500	NA	NA	NA	STAB1	STAB1;STAB1;STAB1;STAB1;STAB1	cell adhesion;cell-cell signaling;defense response to bacterium;negative regulation of angiogenesis;receptor-mediated endocytosis;oxidation-reduction process;inflammatory response	GO:000715; GO:000726; GO:004274; GO:001652; GO:000689; GO:005511; GO:000695	endocytic vesicle membrane;integral component of plasma membrane	GO:003066; GO:000588	"NA"	"NA"	low-density lipoprotein particle binding;protein binding;hyaluronic acid binding;protein disulfide oxidoreductase activity;low-density lipoprotein receptor activity;calcium ion binding	GO:003016; GO:000551; GO:000554; GO:001503; GO:000504; GO:000550
XP_020924610.1	XP_020924610.1	XP_020924610.1 store-operated calcium entry regulator STIMATE isoform X2 [Sus scrofa]	2	2	2	0	0	77218000	0	0	61004000	0	0	0	114610000	52450000	0	100530000	0	0	0	0	0	NA	NA	NA	LOC100153598	LOC100153598;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020924676.1;XP_020924674.1;XP_020924673.1;XP_020924672.1;XP_020924703.1;XP_020924701.1;XP_020924700.1;XP_020924699.1;XP_020924694.1;XP_020924692.1;XP_020924691.1;XP_020924690.1;XP_020924689.1;XP_020924688.1;XP_020924687.1;XP_020924685.1;XP_020924684.1;XP_020924683.1;XP_020924682.1;XP_020924681.1;XP_020924680.1;XP_020924679.1;XP_020924678.1;XP_020924677.1;XP_020924698.1;XP_020924696.1;XP_020924695.1;XP_020924693.1;XP_020924718.1;XP_020924717.1;XP_020924716.1;XP_020924715.1;XP_020924714.1;XP_020924713.1;XP_020924712.1;XP_020924711.1;XP_020924710.1;XP_020924707.1;XP_020924706.1;XP_020924705.1;XP_020924704.1;XP_020924702.1	XP_020924676.1;XP_020924674.1;XP_020924673.1;XP_020924672.1;XP_020924703.1;XP_020924701.1;XP_020924700.1;XP_020924699.1;XP_020924694.1;XP_020924692.1;XP_020924691.1;XP_020924690.1;XP_020924689.1;XP_020924688.1;XP_020924687.1;XP_020924685.1;XP_020924684.1;XP_020924683.1;XP_020924682.1;XP_020924681.1;XP_020924680.1;XP_020924679.1;XP_020924678.1;XP_020924677.1;XP_020924698.1;XP_020924696.1;XP_020924695.1;XP_020924693.1;XP_020924718.1;XP_020924717.1;XP_020924716.1;XP_020924715.1;XP_020924714.1;XP_020924713.1;XP_020924712.1;XP_020924711.1;XP_020924710.1;XP_020924707.1;XP_020924706.1;XP_020924705.1;XP_020924704.1;XP_020924702.1	XP_020924676.1 sarcolemmal membrane-associated protein isoform X4 [Sus scrofa];XP_020924674.1 sarcolemmal membrane-associated protein isoform X3 [Sus scrofa];XP_020924673.1 sarcolemmal membrane-associated protein isoform X2 [Sus scrofa];XP_020924672.1 sarc	8	8	8	0	0	333050000	0	0	467810000	322700000	0	0	0	403020000	0	0	0	0	0	0	0	NA	NA	NA	SLMAP	SLMAP;SLMAP;SLMAP;SLMAP;SLMAP	regulation of sodium ion transmembrane transport;regulation of membrane depolarization during cardiac muscle cell action potential;muscle contraction;protein localization to plasma membrane;regulation of voltage-gated sodium channel activity	GO:190230; GO:190082; GO:000693; GO:007265; GO:190515	smooth endoplasmic reticulum;sarcolemma;microtubule organizing center;integral component of plasma membrane	GO:000579; GO:004238; GO:000581; GO:000588	"NA"	"NA"	protein binding	GO:000551
XP_020924726.1;XP_020924725.1;XP_020924724.1;XP_020924723.1;XP_020924722.1;XP_020924721.1;XP_020924720.1	XP_020924726.1;XP_020924725.1;XP_020924724.1;XP_020924723.1;XP_020924722.1;XP_020924721.1;XP_020924720.1	XP_020924726.1 filamin-B isoform X7 [Sus scrofa];XP_020924725.1 filamin-B isoform X6 [Sus scrofa];XP_020924724.1 filamin-B isoform X5 [Sus scrofa];XP_020924723.1 filamin-B isoform X4 [Sus scrofa];XP_020924722.1 filamin-B isoform X3 [Sus scrofa];XP_02092472	90	84	82	1078500000	1114600000	1190300000	1085500000	829830000	1082800000	899450000	1249600000	990890000	930170000	915270000	1001700000	1209100000	1205600000	1012200000	856790000	989050000	961770000	NA	NA	NA	FLNB	FLNB;FLNB;FLNB;FLNB;FLNB	keratinocyte development;actin cytoskeleton organization;cellular response to interferon-gamma;epithelial cell morphogenesis;signal transduction;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development	GO:000333; GO:003003; GO:007134; GO:000338; GO:000716; GO:000701; GO:000751	neuronal cell body;phagocytic vesicle;stress fiber;cytoplasm;cell cortex;integral component of membrane;brush border;focal adhesion;Z disc;nucleus;neuron projection;extracellular exosome;plasma membrane;cytosol;actin cytoskeleton	GO:004302; GO:004533; GO:000172; GO:000573; GO:000593; GO:001602; GO:000590; GO:000592; GO:003001; GO:000563; GO:004300; GO:007006; GO:000588; GO:000582; GO:001562	 MAPK signaling pathway; Focal adhesion; Salmonella infection; Proteoglycans in cancer	hsa0401; hsa0451; hsa0513; hsa0520	cadherin binding;identical protein binding;RNA binding;protein binding;actin binding	GO:004529; GO:004280; GO:000372; GO:000551; GO:000377
XP_020924841.1	XP_020924841.1	XP_020924841.1 26S proteasome non-ATPase regulatory subunit 6 [Sus scrofa]	12	12	12	78880000	60166000	70228000	54909000	64891000	44624000	61915000	61096000	57704000	49509000	66448000	63335000	47506000	61781000	54830000	57970000	59914000	63046000	NA	NA	NA	PSMD6	PSMD6;NA;NA;NA;NA	protein deubiquitination;neutrophil degranulation;proteolysis;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of catalytic activity;post-translational protein modification	GO:001657; GO:004331; GO:000650; GO:004316; GO:005079; GO:004368	extracellular region;proteasome complex;cytosol;nucleoplasm;proteasome regulatory particle;proteasome accessory complex;secretory granule lumen;ficolin-1-rich granule lumen	GO:000557; GO:000050; GO:000582; GO:000565; GO:000583; GO:002262; GO:003477; GO:190481	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	ATPase activity;enzyme regulator activity;protein binding	GO:001688; GO:003023; GO:000551
XP_020924904.1;XP_020924913.1	XP_020924904.1;XP_020924913.1	XP_020924904.1 niban-like protein 1 isoform X1 [Sus scrofa];XP_020924913.1 niban-like protein 1 isoform X2 [Sus scrofa]	11	11	11	40912000	43204000	43946000	48888000	49552000	48307000	39518000	54922000	47406000	50000000	43710000	61872000	64394000	39851000	39061000	48694000	47595000	43131000	NA	NA	NA	FAM129B	FAM129B;FAM129B;NA;NA;NA	negative regulation of apoptotic process;negative regulation of vascular endothelial growth factor receptor signaling pathway;hypomethylation of CpG island;negative regulation of Notch signaling pathway;positive regulation of transcription regulatory region DNA binding;axon guidance;negative regulation of cell proliferation;negative regulation of angiogenesis;positive regulation of transcription, DNA-templated;cell differentiation;positive regulation of embryonic development;gonadotropin secretion;positive regulation of skeletal muscle fiber development;negative regulation of DNA biosynthetic process	GO:004306; GO:003094; GO:004402; GO:004574; GO:200067; GO:000741; GO:000828; GO:001652; GO:004589; GO:003015; GO:004001; GO:003227; GO:004874; GO:200027	adherens junction;plasma membrane;cytoplasm;nucleoplasm;nucleus;cytosol;extracellular exosome	GO:000591; GO:000588; GO:000573; GO:000565; GO:000563; GO:000582; GO:007006	"NA"	"NA"	transcription coactivator activity;cadherin binding	GO:000371; GO:004529
XP_020924979.1	XP_020924979.1	XP_020924979.1 protein SEC13 homolog [Sus scrofa]	5	5	5	0	29039000	31343000	0	0	28234000	0	28783000	28082000	30721000	27190000	40519000	30041000	36600000	25755000	32473000	26876000	39858000	NA	NA	NA	SEC13	SEC13;NA;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;protein exit from endoplasmic reticulum;positive regulation of TORC1 signaling;COPII vesicle coating;mRNA transport;cargo loading into COPII-coated vesicle;intracellular protein transport;antigen processing and presentation of peptide antigen via MHC class I;positive regulation of TOR signaling	GO:001988; GO:003252; GO:190426; GO:004820; GO:005102; GO:009011; GO:000688; GO:000247; GO:003200	GATOR2 complex;extracellular exosome;cytosol;Golgi membrane;endoplasmic reticulum membrane;nuclear pore outer ring;lysosomal membrane;kinetochore;intracellular membrane-bounded organelle;nucleoplasm;COPII vesicle coat;nuclear envelope;ER to Golgi transport vesicle membrane	GO:006170; GO:007006; GO:000582; GO:000013; GO:000578; GO:003108; GO:000576; GO:000077; GO:004323; GO:000565; GO:003012; GO:000563; GO:001250	 RNA transport; Protein processing in endoplasmic reticulum	hsa0301; hsa0414	identical protein binding;protein binding;structural molecule activity	GO:004280; GO:000551; GO:000519
XP_020925016.1;XP_013837448.1;XP_013837447.1;XP_020925017.1;XP_013837449.1	XP_020925016.1;XP_013837448.1;XP_013837447.1;XP_020925017.1;XP_013837449.1	XP_020925016.1 cullin-associated NEDD8-dissociated protein 2 isoform X1 [Sus scrofa];XP_013837448.1 cullin-associated NEDD8-dissociated protein 2 isoform X3 [Sus scrofa];XP_013837447.1 cullin-associated NEDD8-dissociated protein 2 isoform X3 [Sus scrofa];X	4	2	2	488430000	537180000	418720000	850410000	457850000	935340000	617620000	429710000	464120000	517980000	430590000	374650000	598810000	926840000	0	570330000	660920000	1067800000	NA	NA	NA	CAND2	CAND2;CAND2;CAND2;CAND2;CAND2	SCF complex assembly;positive regulation of transcription, DNA-templated;protein ubiquitination	GO:001026; GO:004589; GO:001656	nucleus	GO:000563	"NA"	"NA"	protein binding;TBP-class protein binding	GO:000551; GO:001702
XP_020925039.1	XP_020925039.1	XP_020925039.1 transmembrane protein 43 [Sus scrofa]	14	14	14	430810000	616020000	650210000	532130000	507990000	596110000	665480000	590860000	601620000	602040000	656570000	850470000	433240000	501860000	695630000	808110000	638520000	575780000	NA	NA	NA	TMEM43	TMEM43;NA;NA;NA;NA	nuclear membrane organization	GO:007176	integral component of nuclear inner membrane;endoplasmic reticulum lumen;Golgi apparatus	GO:000563; GO:000578; GO:000579	"NA"	"NA"	protein binding;protein self-association	GO:000551; GO:004362
XP_020925042.1;XP_020925041.1	XP_020925042.1;XP_020925041.1	XP_020925042.1 fibulin-2 isoform X2 [Sus scrofa];XP_020925041.1 fibulin-2 isoform X1 [Sus scrofa]	14	14	14	0	59684000	35389000	93653000	23301000	81325000	0	63228000	23234000	80840000	16842000	83413000	67295000	57417000	23363000	45209000	21138000	118950000	NA	NA	NA	FBLN2	FBLN2;FBLN2;NA;NA;NA	extracellular matrix organization;positive regulation of cell-substrate adhesion	GO:003019; GO:001081	extracellular region;extracellular matrix;extracellular vesicle	GO:000557; GO:003101; GO:190356	"NA"	"NA"	extracellular matrix constituent conferring elasticity;extracellular matrix structural constituent;extracellular matrix binding;calcium ion binding	GO:003002; GO:000520; GO:005084; GO:000550
XP_020925065.1;XP_020925064.1	XP_020925065.1;XP_020925064.1	XP_020925065.1 acyl-CoA dehydrogenase family member 9, mitochondrial isoform X2 [Sus scrofa];XP_020925064.1 acyl-CoA dehydrogenase family member 9, mitochondrial isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	2215800	0	0	0	0	0	NA	NA	NA	ACAD9	ACAD9;ACAD9;NA;NA;NA	mitochondrial respiratory chain complex I assembly;oxidation-reduction process;medium-chain fatty acid metabolic process;long-chain fatty acid metabolic process	GO:003298; GO:005511; GO:005179; GO:000167	nucleus;mitochondrion;mitochondrial membrane;mitochondrial inner membrane;dendrite	GO:000563; GO:000573; GO:003196; GO:000574; GO:003042	"NA"	"NA"	protein binding;long-chain-acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding;very-long-chain-acyl-CoA dehydrogenase activity;medium-chain-acyl-CoA dehydrogenase activity;fatty-acyl-CoA binding	GO:000551; GO:000446; GO:005066; GO:001709; GO:007099; GO:000006
XP_020925076.1	XP_020925076.1	XP_020925076.1 LOW QUALITY PROTEIN: coatomer subunit gamma-1 [Sus scrofa]	19	19	16	114150000	112010000	100670000	118740000	116940000	108070000	91255000	117760000	100760000	120200000	95485000	108640000	113830000	109470000	85771000	121660000	100620000	125460000	NA	NA	NA	COPG1	COPG1;NA;NA;NA;NA	organelle transport along microtubule;ER to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to ER;protein secretion;establishment of Golgi localization	GO:007238; GO:000688; GO:000689; GO:000930; GO:005168	cytosol;endoplasmic reticulum;Golgi apparatus;Golgi membrane;COPI vesicle coat;transport vesicle;membrane	GO:000582; GO:000578; GO:000579; GO:000013; GO:003012; GO:003013; GO:001602	"NA"	"NA"	protein binding;structural molecule activity	GO:000551; GO:000519
XP_020925087.1;XP_020925086.1;XP_020925085.1;XP_020925084.1;XP_020925080.1;XP_020925079.1;XP_020925078.1;XP_020925077.1;XP_020925089.1;XP_020925088.1	XP_020925087.1;XP_020925086.1;XP_020925085.1;XP_020925084.1;XP_020925080.1;XP_020925079.1;XP_020925078.1;XP_020925077.1;XP_020925089.1;XP_020925088.1	XP_020925087.1 cellular nucleic acid-binding protein isoform X6 [Sus scrofa];XP_020925086.1 cellular nucleic acid-binding protein isoform X6 [Sus scrofa];XP_020925085.1 cellular nucleic acid-binding protein isoform X6 [Sus scrofa];XP_020925084.1 cellular n	2	2	1	0	0	20731000	17956000	19467000	0	21312000	0	0	0	0	0	0	0	0	20136000	0	0	NA	NA	NA	CNBP	CNBP;CNBP;CNBP;CNBP;CNBP	cholesterol biosynthetic process;positive regulation of transcription, DNA-templated;negative regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-templated;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter	GO:000669; GO:004589; GO:000012; GO:000635; GO:000828; GO:004594	cytosol;endoplasmic reticulum;nucleus	GO:000582; GO:000578; GO:000563	"NA"	"NA"	RNA polymerase II regulatory region sequence-specific DNA binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;transcription factor activity, sequence-specific DNA binding;RNA binding;zinc ion binding;protein binding	GO:000097; GO:000122; GO:000370; GO:000372; GO:000827; GO:000551
XP_020925095.1;XP_020925094.1;XP_020925093.1;XP_020925092.1;XP_020925090.1;XP_020925096.1;XP_020925097.1	XP_020925095.1;XP_020925094.1;XP_020925093.1;XP_020925092.1;XP_020925090.1;XP_020925096.1;XP_020925097.1	XP_020925095.1 ras-related protein Rab-7a isoform X1 [Sus scrofa];XP_020925094.1 ras-related protein Rab-7a isoform X1 [Sus scrofa];XP_020925093.1 ras-related protein Rab-7a isoform X1 [Sus scrofa];XP_020925092.1 ras-related protein Rab-7a isoform X1 [Sus	15	15	15	389070000	393470000	373380000	380430000	334420000	276680000	361450000	382670000	347270000	363660000	336520000	469180000	353790000	400020000	352280000	372750000	376220000	393800000	NA	NA	NA	RAB7A	RAB7A;RAB7A;RAB7A;RAB7A;RAB7A	phagosome-lysosome fusion;epidermal growth factor catabolic process;positive regulation of exosomal secretion;phagosome maturation;multi-organism intracellular transport;negative regulation of intralumenal vesicle formation;protein targeting to lysosome;intracellular protein transport;protein transport;protein to membrane docking;Rab protein signal transduction;positive regulation of protein catabolic process;endocytosis;retrograde transport, endosome to Golgi;neutrophil degranulation;positive regulation of viral process;autophagosome assembly;lipid catabolic process;antigen processing and presentation of exogenous peptide antigen via MHC class II;endosome to lysosome transport;early endosome to late endosome transport;lipophagy;viral release from host cell	GO:009038; GO:000717; GO:190354; GO:009038; GO:190258; GO:190536; GO:000662; GO:000688; GO:001503; GO:002261; GO:003248; GO:004573; GO:000689; GO:004214; GO:004331; GO:004852; GO:000004; GO:001604; GO:001988; GO:000833; GO:004502; GO:006172; GO:001907	plasma membrane;Golgi apparatus;lipid particle;vacuolar membrane;pre-autophagosomal structure membrane;extracellular exosome;autophagosome membrane;lysosome;phagocytic vesicle;cytosol;phagocytic vesicle membrane;melanosome membrane;retromer complex;secretory granule membrane;endosome membrane;late endosome membrane;extrinsic component of lysosome membrane	GO:000588; GO:000579; GO:000581; GO:000577; GO:003404; GO:007006; GO:000042; GO:000576; GO:004533; GO:000582; GO:003067; GO:003316; GO:003090; GO:003066; GO:001000; GO:003190; GO:003241	 Endocytosis; Phagosome; Salmonella infection; Tuberculosis; Amoebiasis	hsa0414; hsa0414; hsa0513; hsa0515; hsa0514	GTP binding;protein binding;GTPase activity;retromer complex binding;GDP binding	GO:000552; GO:000551; GO:000392; GO:190539; GO:001900
XP_020925101.1;XP_020925102.1	XP_020925101.1;XP_020925102.1	XP_020925101.1 ruvB-like 1 isoform X1 [Sus scrofa];XP_020925102.1 ruvB-like 1 isoform X2 [Sus scrofa]	11	11	11	39851000	50906000	48564000	48933000	37095000	52466000	51587000	46515000	43971000	44720000	56684000	57856000	81786000	47045000	40142000	49837000	48946000	57220000	NA	NA	NA	RUVBL1	RUVBL1;RUVBL1;NA;NA;NA	DNA repair;chromatin remodeling;histone acetylation;cell division;DNA duplex unwinding;cell cycle;spermatogenesis;histone H4 acetylation;box C/D snoRNP assembly;DNA recombination;CENP-A containing nucleosome assembly;positive regulation of nucleic acid-templated transcription;regulation of growth;positive regulation of canonical Wnt signaling pathway;beta-catenin-TCF complex assembly;positive regulation of telomerase RNA localization to Cajal body;regulation of transcription from RNA polymerase II promoter	GO:000628; GO:000633; GO:001657; GO:005130; GO:003250; GO:000704; GO:000728; GO:004396; GO:000049; GO:000631; GO:003408; GO:190350; GO:004000; GO:009026; GO:190483; GO:190487; GO:000635	membrane;cytosol;nucleus;nuclear matrix;Ino80 complex;MLL1 complex;ribonucleoprotein complex;microtubule organizing center;Swr1 complex;extracellular exosome;R2TP complex;nucleoplasm;NuA4 histone acetyltransferase complex	GO:001602; GO:000582; GO:000563; GO:001636; GO:003101; GO:007133; GO:199090; GO:000581; GO:000081; GO:007006; GO:009725; GO:000565; GO:003526	 Wnt signaling pathway	hsa0431	cadherin binding;ATP-dependent DNA helicase activity;protein binding;ATPase activity;ADP binding;ATPase binding;TFIID-class transcription factor binding;transcription coactivator activity;ATP binding;TBP-class protein binding;ATP-dependent 5'-3' DNA helicase activity;DNA helicase activity	GO:004529; GO:000400; GO:000551; GO:001688; GO:004353; GO:005111; GO:000109; GO:000371; GO:000552; GO:001702; GO:004314; GO:000367
XP_020925123.1	XP_020925123.1	XP_020925123.1 LOW QUALITY PROTEIN: protein CDV3 homolog [Sus scrofa]	3	3	3	0	9273000	30993000	25157000	0	8539800	11268000	0	0	0	12110000	0	0	11688000	18738000	0	0	0	NA	NA	NA	CDV3	CDV3;NA;NA;NA;NA	cell proliferation	GO:000828	plasma membrane;cytosol	GO:000588; GO:000582	"NA"	"NA"	molecular_function	GO:000367
XP_020925129.1	XP_020925129.1	XP_020925129.1 signal recognition particle receptor subunit beta [Sus scrofa]	6	6	6	64402000	75368000	47944000	66231000	66243000	60765000	50027000	53591000	47266000	68204000	61742000	68685000	0	82672000	71351000	72848000	59251000	85360000	NA	NA	NA	SRPRB	SRPRB;NA;NA;NA;NA	IRE1-mediated unfolded protein response	GO:003649	integral component of membrane;membrane;cytoplasmic microtubule;endoplasmic reticulum membrane;cytoplasm	GO:001602; GO:001602; GO:000588; GO:000578; GO:000573	 Protein export	hsa0306	GTP binding	GO:000552
XP_020925180.1;XP_020925179.1;XP_020925178.1;XP_020925177.1;XP_020925176.1;XP_020925175.1;XP_020925174.1;XP_020925173.1;XP_020925172.1;XP_020925170.1	XP_020925180.1;XP_020925179.1;XP_020925178.1;XP_020925177.1;XP_020925176.1;XP_020925175.1;XP_020925174.1;XP_020925173.1;XP_020925172.1;XP_020925170.1	XP_020925180.1 ras-related protein M-Ras isoform X2 [Sus scrofa];XP_020925179.1 ras-related protein M-Ras isoform X2 [Sus scrofa];XP_020925178.1 ras-related protein M-Ras isoform X2 [Sus scrofa];XP_020925177.1 ras-related protein M-Ras isoform X1 [Sus scro	5	5	5	0	19581000	13335000	16566000	12876000	0	0	21296000	16162000	20504000	18017000	17744000	0	20283000	18246000	0	16780000	13301000	NA	NA	NA	MRAS	MRAS;MRAS;MRAS;MRAS;MRAS	Ras protein signal transduction;cellular response to leukemia inhibitory factor;actin cytoskeleton organization;muscle organ development;multicellular organism development	GO:000726; GO:199083; GO:003003; GO:000751; GO:000727	plasma membrane	GO:000588	 MAPK signaling pathway; Rap1 signaling pathway; Regulation of actin cytoskeleton; HTLV-I infection; Tight junction; Proteoglycans in cancer	hsa0401; hsa0401; hsa0481; hsa0516; hsa0453; hsa0520	GTPase activity;protein binding;GTP-dependent protein binding;GTP binding	GO:000392; GO:000551; GO:003074; GO:000552
XP_020925256.1;XP_020925258.1;XP_020925254.1;XP_020925257.1	XP_020925256.1;XP_020925258.1;XP_020925254.1	XP_020925256.1 glycogenin-1 isoform X2 [Sus scrofa];XP_020925258.1 glycogenin-1 isoform X4 [Sus scrofa];XP_020925254.1 glycogenin-1 isoform X1 [Sus scrofa]	5	4	4	0	0	10952000	0	0	0	9618000	0	18234000	10414000	10046000	0	0	9130500	0	0	9316200	0	NA	NA	NA	GYG1	GYG1;GYG1;GYG1;NA;NA	glycogen biosynthetic process;neutrophil degranulation	GO:000597; GO:004331	membrane;secretory granule lumen;cytosol;lysosomal lumen;extracellular region;ficolin-1-rich granule lumen	GO:001602; GO:003477; GO:000582; GO:004320; GO:000557; GO:190481	"NA"	"NA"	glycogenin glucosyltransferase activity;manganese ion binding;protein homodimerization activity;protein binding	GO:000846; GO:003014; GO:004280; GO:000551
XP_020925392.1	XP_020925392.1	XP_020925392.1 TBC1 domain family member 13 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	4423800	0	0	0	0	0	0	NA	NA	NA	TBC1D13	TBC1D13;NA;NA;NA;NA	intracellular protein transport;regulation of cilium assembly;activation of GTPase activity	GO:000688; GO:190201; GO:009063	membrane;cytosol	GO:001602; GO:000582	"NA"	"NA"	GTPase activator activity;Rab GTPase binding	GO:000509; GO:001713
XP_020925394.1;XP_020925395.1	XP_020925394.1;XP_020925395.1	XP_020925394.1 importin subunit alpha-3 isoform X1 [Sus scrofa];XP_020925395.1 importin subunit alpha-3 isoform X2 [Sus scrofa]	9	9	7	48402000	29871000	33604000	26795000	29408000	18693000	24122000	25279000	30904000	27237000	28627000	0	31379000	26787000	28497000	21247000	27616000	24793000	NA	NA	NA	KPNA4	KPNA4;KPNA4;NA;NA;NA	modulation by virus of host process;response to hydrogen peroxide;NLS-bearing protein import into nucleus	GO:001905; GO:004254; GO:000660	cytosol;nucleoplasm;nucleus;nuclear membrane	GO:000582; GO:000565; GO:000563; GO:003196	"NA"	"NA"	nuclear import signal receptor activity;protein binding;protein transporter activity	GO:006160; GO:000551; GO:000856
XP_020925519.1	XP_020925519.1	XP_020925519.1 guanine nucleotide-binding protein subunit beta-4 [Sus scrofa]	9	4	4	24467000	71323000	57906000	80364000	40244000	53447000	43305000	81928000	62822000	65654000	31408000	65636000	33717000	56746000	31393000	52325000	26898000	67108000	NA	NA	NA	GNB4	GNB4;NA;NA;NA;NA	protein folding;signal transduction;substantia nigra development	GO:000645; GO:000716; GO:002176	extracellular exosome;cytosol;lysosomal membrane	GO:007006; GO:000582; GO:000576	 Ras signaling pathway; Circadian entrainment; Dopaminergic synapse; Alcoholism; Pathways in cancer; PI3K-Akt signaling pathway; Chemokine signaling pathway	hsa0401; hsa0471; hsa0472; hsa0503; hsa0520; hsa0415; hsa0406	macromolecular complex binding	GO:004487
XP_020925548.1;XP_020925546.1;XP_020925547.1	XP_020925548.1;XP_020925546.1;XP_020925547.1	XP_020925548.1 methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial isoform X3 [Sus scrofa];XP_020925546.1 methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial isoform X1 [Sus scrofa];XP_020925547.1 methylcrotonoyl-CoA carboxylase subunit a	9	9	9	109110000	59325000	73650000	38131000	76784000	28664000	85071000	63993000	64821000	41726000	89505000	40167000	47165000	54776000	59352000	58355000	68791000	47068000	NA	NA	NA	MCCC1	MCCC1;MCCC1;MCCC1;NA;NA	protein heterooligomerization;biotin metabolic process;leucine catabolic process	GO:005129; GO:000676; GO:000655	3-methylcrotonyl-CoA carboxylase complex, mitochondrial;cytosol;methylcrotonoyl-CoA carboxylase complex;mitochondrion;mitochondrial matrix	GO:000216; GO:000582; GO:190520; GO:000573; GO:000575	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	metal ion binding;protein binding;biotin binding;biotin carboxylase activity;methylcrotonoyl-CoA carboxylase activity;ATP binding	GO:004687; GO:000551; GO:000937; GO:000407; GO:000448; GO:000552
XP_020925602.1	XP_020925602.1	XP_020925602.1 translation initiation factor eIF-2B subunit epsilon [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	4792300	0	0	0	0	0	0	0	NA	NA	NA	EIF2B5	EIF2B5;NA;NA;NA;NA	astrocyte development;oligodendrocyte development;T cell receptor signaling pathway;response to endoplasmic reticulum stress;myelination;positive regulation of apoptotic process;positive regulation of translational initiation;response to glucose;response to lithium ion;astrocyte differentiation;aging;ovarian follicle development;response to heat;hippocampus development;translational initiation;response to peptide hormone	GO:001400; GO:001400; GO:005085; GO:003497; GO:004255; GO:004306; GO:004594; GO:000974; GO:001022; GO:004870; GO:000756; GO:000154; GO:000940; GO:002176; GO:000641; GO:004343	cytosol;nucleus;eukaryotic translation initiation factor 2B complex;cytoplasm	GO:000582; GO:000563; GO:000585; GO:000573	 RNA transport	hsa0301	guanyl-nucleotide exchange factor activity;protein binding;translation initiation factor activity;translation initiation factor binding	GO:000508; GO:000551; GO:000374; GO:003136
XP_020925638.1	XP_020925638.1	XP_020925638.1 peroxisomal bifunctional enzyme [Sus scrofa]	6	6	6	0	0	0	0	9277800	0	12653000	9191300	12748000	0	11703000	0	0	0	13975000	8594500	7044700	0	NA	NA	NA	EHHADH	EHHADH;NA;NA;NA;NA	fatty acid beta-oxidation using acyl-CoA oxidase;protein targeting to peroxisome;internal protein amino acid acetylation;fatty acid beta-oxidation	GO:003354; GO:000662; GO:000647; GO:000663	peroxisome;peroxisomal matrix;cytosol	GO:000577; GO:000578; GO:000582	 Biosynthesis of antibiotics; Fatty acid metabolism; Metabolic pathways; PPAR signaling pathway; Carbon metabolism; Fatty acid degradation; Lysine degradation; Valine, leucine and isoleucine degradation; Propanoate metabolism; Butanoate metabolism; Tryptophan metabolism; beta-Alanine metabolism; Peroxisome	hsa0113; hsa0121; hsa0110; hsa0332; hsa0120; hsa0007; hsa0031; hsa0028; hsa0064; hsa0065; hsa0038; hsa0041; hsa0414	protein binding;long-chain-enoyl-CoA hydratase activity;receptor binding;enzyme binding;3-hydroxyacyl-CoA dehydrogenase activity;dodecenoyl-CoA delta-isomerase activity;enoyl-CoA hydratase activity	GO:000551; GO:001650; GO:000510; GO:001989; GO:000385; GO:000416; GO:000430
XP_020925725.1;XP_020925724.1;XP_020925723.1;XP_020925722.1	XP_020925725.1;XP_020925724.1;XP_020925723.1;XP_020925722.1	XP_020925725.1 dynamin-like 120 kDa protein, mitochondrial isoform X4 [Sus scrofa];XP_020925724.1 dynamin-like 120 kDa protein, mitochondrial isoform X3 [Sus scrofa];XP_020925723.1 dynamin-like 120 kDa protein, mitochondrial isoform X2 [Sus scrofa];XP_0209	8	8	8	19421000	17501000	17573000	0	19218000	18400000	17480000	19117000	15800000	15278000	18890000	24240000	0	18806000	14896000	16183000	18351000	19166000	NA	NA	NA	OPA1	OPA1;OPA1;OPA1;OPA1;NA	cochlea development;response to curcumin;negative regulation of apoptotic process;GTP metabolic process;mitochondrion morphogenesis;cellular response to L-glutamate;dynamin family protein polymerization involved in mitochondrial fission;apoptotic process;mitochondrial fusion;response to muscle activity;axonal transport of mitochondrion;intracellular distribution of mitochondria;protein oligomerization;mitochondrial calcium uptake;retina development in camera-type eye;visual perception;negative regulation of release of cytochrome c from mitochondria;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;mitochondrial fission;membrane fusion;positive regulation of mitochondrial fusion;positive regulation of insulin receptor signaling pathway;response to electrical stimulus;cellular response to glucose stimulus;cellular response to hypoxia;cellular senescence;membrane tubulation;mitochondrial genome maintenance;mitochondrion organization;positive regulation of neuron maturation;positive regulation of dendritic spine morphogenesis	GO:009010; GO:190464; GO:004306; GO:004603; GO:007058; GO:190523; GO:000337; GO:000691; GO:000805; GO:001485; GO:001989; GO:004831; GO:005125; GO:003644; GO:006004; GO:000760; GO:009020; GO:190223; GO:000026; GO:006102; GO:001063; GO:004662; GO:005160; GO:007133; GO:007145; GO:009039; GO:009774; GO:000000; GO:000700; GO:001404; GO:006100	integral component of membrane;membrane;nucleoplasm;mitochondrial outer membrane;mitochondrial membrane;axon cytoplasm;mitochondrion;cytosol;mitochondrial intermembrane space;mitochondrial crista;dendrite;extrinsic component of mitochondrial inner membrane	GO:001602; GO:001602; GO:000565; GO:000574; GO:003196; GO:190411; GO:000573; GO:000582; GO:000575; GO:003006; GO:003042; GO:003131	"NA"	"NA"	protein binding;GTPase activity;GTP binding;microtubule binding;phosphatidic acid binding;cardiolipin binding;kinase binding;magnesium ion binding	GO:000551; GO:000392; GO:000552; GO:000801; GO:007030; GO:190161; GO:001990; GO:000028
XP_020925743.1;XP_020925742.1;XP_020925741.1;XP_020925739.1;XP_020925738.1;XP_020925737.1;XP_020925736.1;XP_020925740.1	XP_020925743.1;XP_020925742.1;XP_020925741.1;XP_020925739.1;XP_020925738.1;XP_020925737.1;XP_020925736.1;XP_020925740.1	XP_020925743.1 arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X8 [Sus scrofa];XP_020925742.1 arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X7 [Sus scrofa];XP_020925741.1 arf-GAP with coiled	5	5	5	0	0	0	0	0	0	0	0	0	0	0	8506900	0	0	0	0	0	0	NA	NA	NA	ACAP2	ACAP2;ACAP2;ACAP2;ACAP2;ACAP2	positive regulation of GTPase activity;cellular response to nerve growth factor stimulus;endocytic recycling	GO:004354; GO:199009; GO:003245	endosome membrane;membrane	GO:001000; GO:001602	 Endocytosis	hsa0414	GTPase activator activity;metal ion binding;Rab GTPase binding;phosphatidylinositol-3,5-bisphosphate binding	GO:000509; GO:004687; GO:001713; GO:008002
XP_020925797.1;XP_020925796.1;XP_020925795.1;XP_020936348.1;XP_020936347.1;XP_020936346.1;XP_020936345.1;XP_020936344.1;XP_020936343.1;XP_020936342.1;XP_020936341.1;XP_020936340.1;XP_020936339.1;XP_020936338.1;XP_020936337.1;XP_020936336.1;XP_020936335.1;XP_020936334.1;XP_020936349.1;XP_020918220.1;XP_020918219.1;XP_020918218.1;XP_020918217.1;XP_013834631.2;XP_013834629.2;XP_013834628.2;XP_013834627.2;XP_005667221.2	XP_020925797.1;XP_020925796.1;XP_020925795.1;XP_020936348.1;XP_020936347.1;XP_020936346.1;XP_020936345.1;XP_020936344.1;XP_020936343.1;XP_020936342.1;XP_020936341.1;XP_020936340.1;XP_020936339.1;XP_020936338.1;XP_020936337.1;XP_020936336.1;XP_020936335.1;XP_020936334.1;XP_020936349.1	XP_020925797.1 serine/threonine-protein kinase PAK 2 [Sus scrofa];XP_020925796.1 serine/threonine-protein kinase PAK 2 [Sus scrofa];XP_020925795.1 serine/threonine-protein kinase PAK 2 [Sus scrofa];XP_020936348.1 serine/threonine-protein kinase PAK 3 isofo	5	5	5	10736000	24662000	18829000	24265000	19051000	0	14942000	23583000	13981000	17619000	23921000	28969000	15197000	18232000	20986000	25990000	12133000	18174000	NA	NA	NA	PAK3	PAK3;PAK3;PAK3;PAK3;PAK3	T cell costimulation;synapse organization;regulation of axonogenesis;positive regulation of dendritic spine morphogenesis;cellular response to organic cyclic compound;activation of MAPK activity;stimulatory C-type lectin receptor signaling pathway;positive regulation of fibroblast migration;dendrite development;cell migration;T cell receptor signaling pathway;stress-activated protein kinase signaling cascade;positive regulation of DNA biosynthetic process;activation of protein kinase activity;regulation of MAPK cascade;dendritic spine morphogenesis;axonogenesis;positive regulation of neuron apoptotic process;ephrin receptor signaling pathway;MAPK cascade;signal transduction by protein phosphorylation;regulation of actin filament polymerization	GO:003129; GO:005080; GO:005077; GO:006100; GO:007140; GO:000018; GO:000222; GO:001076; GO:001635; GO:001647; GO:005085; GO:003109; GO:200057; GO:003214; GO:004340; GO:006099; GO:000740; GO:004352; GO:004801; GO:000016; GO:002301; GO:003083	endosome;cytosol;cytoplasm;plasma membrane;postsynaptic density;glutamatergic synapse	GO:000576; GO:000582; GO:000573; GO:000588; GO:001406; GO:009897	 ErbB signaling pathway; Ras signaling pathway; Focal adhesion; Regulation of actin cytoskeleton; Renal cell carcinoma; T cell receptor signaling pathway; Axon guidance	hsa0401; hsa0401; hsa0451; hsa0481; hsa0521; hsa0466; hsa0436	MAP kinase kinase activity;Rac GTPase binding;ATP binding;protein binding;SH3 domain binding;protein serine/threonine kinase activity;metal ion binding	GO:000470; GO:004836; GO:000552; GO:000551; GO:001712; GO:000467; GO:004687
XP_020925820.1	XP_020925820.1	XP_020925820.1 UBX domain-containing protein 7 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2867300	NA	NA	NA	UBXN7	UBXN7;NA;NA;NA;NA	post-translational protein modification	GO:004368	nuclear body;cytosol;nucleoplasm;VCP-NPL4-UFD1 AAA ATPase complex	GO:001660; GO:000582; GO:000565; GO:003409	"NA"	"NA"	ubiquitin protein ligase binding;ubiquitin binding;transcription factor binding;protein binding	GO:003162; GO:004313; GO:000813; GO:000551
XP_020925865.1;XP_020925863.1;XP_020925862.1;XP_020925866.1	XP_020925865.1;XP_020925863.1;XP_020925862.1;XP_020925866.1	XP_020925865.1 sorting nexin-4 isoform X3 [Sus scrofa];XP_020925863.1 sorting nexin-4 isoform X2 [Sus scrofa];XP_020925862.1 sorting nexin-4 isoform X1 [Sus scrofa];XP_020925866.1 sorting nexin-4 isoform X4 [Sus scrofa]	2	2	2	0	6382200	0	0	0	0	0	0	0	0	0	0	0	5172200	0	0	0	0	NA	NA	NA	SNX4	SNX4;SNX4;SNX4;SNX4;NA	positive regulation of histamine secretion by mast cell;protein transport;endocytic recycling	GO:190359; GO:001503; GO:003245	macromolecular complex;plasma membrane;cytoplasmic dynein complex;membrane;cytoplasm;SNARE complex;early endosome membrane	GO:003299; GO:000588; GO:000586; GO:001602; GO:000573; GO:003120; GO:003190	 Endocytosis	hsa0414	transferrin receptor binding;leptin receptor binding;insulin receptor binding;phosphatidylinositol binding;protein binding	GO:199045; GO:199046; GO:000515; GO:003509; GO:000551
XP_020925899.1;XP_020925898.1;XP_020925897.1;XP_020925896.1;XP_020925895.1;XP_020925894.1;XP_020925893.1;XP_020925892.1;XP_020925891.1;XP_020925890.1;XP_020925900.1;XP_001929113.6	XP_020925899.1;XP_020925898.1;XP_020925897.1;XP_020925896.1;XP_020925895.1;XP_020925894.1;XP_020925893.1;XP_020925892.1;XP_020925891.1;XP_020925890.1;XP_020925900.1	XP_020925899.1 myosin light chain kinase, smooth muscle isoform X5 [Sus scrofa];XP_020925898.1 myosin light chain kinase, smooth muscle isoform X4 [Sus scrofa];XP_020925897.1 myosin light chain kinase, smooth muscle isoform X3 [Sus scrofa];XP_020925896.1 m	17	17	17	30474000	70223000	90014000	9424300	0	179650000	0	76583000	57659000	220450000	88610000	198300000	252250000	36703000	0	52688000	0	43502000	NA	NA	NA	MYLK	MYLK;MYLK;MYLK;MYLK;MYLK	protein phosphorylation;bleb assembly;cardiovascular system development;tonic smooth muscle contraction;aorta smooth muscle tissue morphogenesis;positive regulation of wound healing;muscle contraction;positive regulation of calcium ion transport;cellular hypotonic response;positive regulation of cell migration	GO:000646; GO:003206; GO:007235; GO:001482; GO:006041; GO:009030; GO:000693; GO:005192; GO:007147; GO:003033	stress fiber;cytoplasm;lamellipodium;cytosol;plasma membrane;actin cytoskeleton;cleavage furrow	GO:000172; GO:000573; GO:003002; GO:000582; GO:000588; GO:001562; GO:003215	 Calcium signaling pathway; Regulation of actin cytoskeleton; Gastric acid secretion; Vascular smooth muscle contraction; Focal adhesion; cGMP-PKG signaling pathway; Platelet activation; Oxytocin signaling pathway	hsa0402; hsa0481; hsa0497; hsa0427; hsa0451; hsa0402; hsa0461; hsa0492	calmodulin binding;protein kinase activity;myosin light chain kinase activity;actin binding;metal ion binding;protein binding;ATP binding	GO:000551; GO:000467; GO:000468; GO:000377; GO:004687; GO:000551; GO:000552
XP_020925966.1;XP_020925965.1	XP_020925966.1;XP_020925965.1	XP_020925966.1 follistatin-related protein 1 isoform X2 [Sus scrofa];XP_020925965.1 follistatin-related protein 1 isoform X1 [Sus scrofa]	4	4	4	0	29795000	20499000	34723000	22399000	40728000	19002000	26109000	15146000	23236000	23032000	34933000	16059000	29704000	18214000	31535000	18114000	34804000	NA	NA	NA	FSTL1	FSTL1;FSTL1;NA;NA;NA	BMP signaling pathway;cellular protein metabolic process;response to starvation;post-translational protein modification	GO:003050; GO:004426; GO:004259; GO:004368	extracellular exosome;endoplasmic reticulum lumen;extracellular space;extracellular region	GO:007006; GO:000578; GO:000561; GO:000557	"NA"	"NA"	calcium ion binding;protein binding;heparin binding	GO:000550; GO:000551; GO:000820
XP_020925985.1;XP_020925984.1;XP_020925987.1;XP_020925986.1	XP_020925985.1;XP_020925984.1;XP_020925987.1;XP_020925986.1	XP_020925985.1 protein O-glucosyltransferase 1 isoform X2 [Sus scrofa];XP_020925984.1 protein O-glucosyltransferase 1 isoform X1 [Sus scrofa];XP_020925987.1 protein O-glucosyltransferase 1 isoform X4 [Sus scrofa];XP_020925986.1 protein O-glucosyltransferas	2	2	2	0	0	8028500	0	6831500	0	7581500	7884400	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	POGLUT1	POGLUT1;POGLUT1;POGLUT1;POGLUT1;NA	muscle tissue development;paraxial mesoderm development;somitogenesis;cardiovascular system development;protein O-linked glycosylation;regulation of gastrulation;gastrulation;protein O-linked glycosylation via serine;axial mesoderm development;positive regulation of Notch signaling pathway	GO:006053; GO:004833; GO:000175; GO:007235; GO:000649; GO:001047; GO:000736; GO:001824; GO:004831; GO:004574	endoplasmic reticulum lumen	GO:000578	 Other types of O-glycan biosynthesis	hsa0051	glucosyltransferase activity;protein xylosyltransferase activity;UDP-xylosyltransferase activity	GO:004652; GO:003015; GO:003525
XP_020925989.1;XP_020925988.1	XP_020925989.1;XP_020925988.1	XP_020925989.1 rho GTPase-activating protein 31 isoform X2 [Sus scrofa];XP_020925988.1 rho GTPase-activating protein 31 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	57939000	0	0	0	0	0	0	NA	NA	NA	ARHGAP31	ARHGAP31;ARHGAP31;NA;NA;NA	positive regulation of GTPase activity;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction	GO:004354; GO:000726; GO:005105	lamellipodium;cytosol;focal adhesion	GO:003002; GO:000582; GO:000592	"NA"	"NA"	GTPase activator activity;SH3 domain binding	GO:000509; GO:001712
XP_020926052.1;XP_020926051.1	XP_020926052.1;XP_020926051.1	XP_020926052.1 mycophenolic acid acyl-glucuronide esterase, mitochondrial isoform X2 [Sus scrofa];XP_020926051.1 mycophenolic acid acyl-glucuronide esterase, mitochondrial isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6942600	0	NA	NA	NA	ABHD10	ABHD10;ABHD10;NA;NA;NA	glucuronoside catabolic process;cellular glucuronidation	GO:001939; GO:005269	mitochondrion;cytosol;mitochondrial matrix	GO:000573; GO:000582; GO:000575	"NA"	"NA"	hydrolase activity, hydrolyzing O-glycosyl compounds;mycophenolic acid acyl-glucuronide esterase activity	GO:000455; GO:010239
XP_020926218.1;XP_020926217.1;XP_020926216.1;XP_020926215.1;XP_020926214.1;XP_020926213.1;XP_020926212.1;XP_020926211.1;XP_020926210.1;XP_020926209.1;XP_020926208.1;XP_020926207.1;XP_020926206.1;XP_020926205.1;XP_020926204.1;XP_020926203.1;XP_020926202.1;XP_020926201.1;XP_020926200.1;XP_020926199.1;XP_020926198.1;XP_020926197.1;XP_020926196.1;XP_020926195.1;XP_020926194.1;XP_020926193.1;XP_020926192.1;XP_020926219.1;XP_020926191.1;XP_020926190.1;XP_020926189.1;XP_020926188.1;XP_020926187.1;XP_020926186.1;XP_020926185.1;XP_020926184.1;XP_020926183.1;XP_020926182.1;XP_020926181.1;XP_020926180.1;XP_020926179.1;XP_020926177.1;XP_020926176.1;XP_020926175.1;XP_020926174.1;XP_020926173.1;XP_020926172.1;XP_020926171.1;XP_020926170.1;XP_020926169.1	XP_020926218.1;XP_020926217.1;XP_020926216.1;XP_020926215.1;XP_020926214.1;XP_020926213.1;XP_020926212.1;XP_020926211.1;XP_020926210.1;XP_020926209.1;XP_020926208.1;XP_020926207.1;XP_020926206.1;XP_020926205.1;XP_020926204.1;XP_020926203.1;XP_020926202.1;XP_020926201.1;XP_020926200.1;XP_020926199.1;XP_020926198.1;XP_020926197.1;XP_020926196.1;XP_020926195.1;XP_020926194.1;XP_020926193.1;XP_020926192.1;XP_020926219.1;XP_020926191.1;XP_020926190.1;XP_020926189.1;XP_020926188.1;XP_020926187.1;XP_020926186.1;XP_020926185.1;XP_020926184.1;XP_020926183.1;XP_020926182.1;XP_020926181.1;XP_020926180.1;XP_020926179.1;XP_020926177.1;XP_020926176.1;XP_020926175.1;XP_020926174.1;XP_020926173.1;XP_020926172.1;XP_020926171.1;XP_020926170.1;XP_020926169.1	XP_020926218.1 target of Nesh-SH3 isoform X49 [Sus scrofa];XP_020926217.1 target of Nesh-SH3 isoform X48 [Sus scrofa];XP_020926216.1 target of Nesh-SH3 isoform X47 [Sus scrofa];XP_020926215.1 target of Nesh-SH3 isoform X46 [Sus scrofa];XP_020926214.1 targe	15	15	15	0	534030000	24437000	462190000	61168000	518340000	66218000	267360000	57023000	349640000	78620000	368920000	187710000	369190000	71118000	364570000	80023000	601000000	NA	NA	NA	ABI3BP	ABI3BP;ABI3BP;ABI3BP;ABI3BP;ABI3BP	extracellular matrix organization;positive regulation of cell-substrate adhesion	GO:003019; GO:001081	extracellular space;extracellular region;interstitial matrix	GO:000561; GO:000557; GO:000561	"NA"	"NA"	collagen binding;extracellular matrix structural constituent;heparin binding	GO:000551; GO:000520; GO:000820
XP_020926223.1;XP_020926222.1;XP_020926221.1;XP_020926220.1	XP_020926223.1;XP_020926222.1;XP_020926221.1;XP_020926220.1	XP_020926223.1 protein TFG isoform X4 [Sus scrofa];XP_020926222.1 protein TFG isoform X3 [Sus scrofa];XP_020926221.1 protein TFG isoform X2 [Sus scrofa];XP_020926220.1 protein TFG isoform X1 [Sus scrofa]	7	7	7	0	0	0	0	0	0	39736000	47664000	0	47734000	0	0	0	0	0	38002000	0	0	NA	NA	NA	TFG	TFG;TFG;TFG;TFG;NA	positive regulation of I-kappaB kinase/NF-kappaB signaling;ER to Golgi vesicle-mediated transport;COPII vesicle coating	GO:004312; GO:000688; GO:004820	Golgi membrane;endoplasmic reticulum exit site;cytoplasm;cytosol	GO:000013; GO:007097; GO:000573; GO:000582	 Thyroid cancer; Pathways in cancer	hsa0521; hsa0520	protein binding;identical protein binding	GO:000551; GO:004280
XP_020926243.1;XP_020926250.1;XP_020926248.1;XP_020926247.1;XP_020926226.1;XP_020926259.1;XP_020926256.1;XP_020926232.1;XP_020926230.1;XP_020926236.1;XP_020926234.1;XP_020926240.1;XP_020926239.1;XP_020926263.1;XP_020926266.1;XP_020926269.1;XP_020926267.1;XP_020926271.1	XP_020926243.1;XP_020926250.1;XP_020926248.1;XP_020926247.1;XP_020926226.1;XP_020926259.1;XP_020926256.1;XP_020926232.1;XP_020926230.1;XP_020926236.1;XP_020926234.1;XP_020926240.1;XP_020926239.1	XP_020926243.1 microtubule-associated protein 4 isoform X19 [Sus scrofa];XP_020926250.1 microtubule-associated protein 4 isoform X25 [Sus scrofa];XP_020926248.1 microtubule-associated protein 4 isoform X23 [Sus scrofa];XP_020926247.1 microtubule-associated	25	25	1	252720000	742310000	479390000	476380000	257110000	407810000	382490000	457520000	344700000	465160000	344050000	430730000	361130000	520770000	525570000	388660000	434940000	542040000	NA	NA	NA	MAP4	MAP4;MAP4;MAP4;MAP4;MAP4	cell division;establishment of spindle orientation;negative regulation of non-motile cilium assembly;microtubule cytoskeleton organization;neuron projection development;mitotic spindle organization;microtubule sliding	GO:005130; GO:005129; GO:190285; GO:000022; GO:003117; GO:000705; GO:005101	neuron projection;mitotic spindle;plasma membrane;microtubule associated complex;axon;axoneme;cytosol;microtubule cytoskeleton	GO:004300; GO:007268; GO:000588; GO:000587; GO:003042; GO:000593; GO:000582; GO:001563	"NA"	"NA"	RNA binding;protein binding;microtubule binding;structural molecule activity	GO:000372; GO:000551; GO:000801; GO:000519
XP_020926311.1	XP_020926311.1	XP_020926311.1 glutamine--tRNA ligase [Sus scrofa]	14	14	14	45908000	39823000	37210000	32039000	48016000	38299000	36081000	41833000	27427000	37017000	31197000	34313000	28393000	32370000	33533000	40623000	30645000	35286000	NA	NA	NA	QARS	QARS;NA;NA;NA;NA	glutaminyl-tRNA aminoacylation;negative regulation of stress-activated MAPK cascade;brain development;negative regulation of transcription, DNA-templated;negative regulation of apoptotic signaling pathway;tRNA aminoacylation for protein translation;negative regulation of protein kinase activity	GO:000642; GO:003287; GO:000742; GO:004589; GO:200123; GO:000641; GO:000646	cytosol;cytoplasm;macromolecular complex;mitochondrial matrix;aminoacyl-tRNA synthetase multienzyme complex	GO:000582; GO:000573; GO:003299; GO:000575; GO:001710	 Aminoacyl-tRNA biosynthesis; Metabolic pathways	hsa0097; hsa0110	glutamine-tRNA ligase activity;protein kinase binding;protein kinase inhibitor activity;ATP binding;protein binding	GO:000481; GO:001990; GO:000486; GO:000552; GO:000551
XP_020926319.1	XP_020926319.1	XP_020926319.1 laminin subunit beta-2 [Sus scrofa]	69	69	69	1371000000	2573000000	1723100000	2605000000	1165400000	1565300000	1644200000	2153400000	1160400000	1974900000	2007900000	3131800000	1255400000	2457500000	1645500000	2790300000	2054500000	2011300000	NA	NA	NA	LAMB2	LAMB2;NA;NA;NA;NA	neuromuscular junction development;axon extension involved in regeneration;retina development in camera-type eye;metanephric glomerular basement membrane development;extracellular matrix organization;visual perception;cellular protein metabolic process;metanephric glomerular visceral epithelial cell development;axon guidance;cell adhesion;post-translational protein modification;astrocyte development;Schwann cell development	GO:000752; GO:004867; GO:006004; GO:007227; GO:003019; GO:000760; GO:004426; GO:007224; GO:000741; GO:000715; GO:004368; GO:001400; GO:001404	laminin-11 complex;extracellular exosome;endoplasmic reticulum lumen;laminin-3 complex;neuromuscular junction;synaptic cleft;extracellular region	GO:004326; GO:007006; GO:000578; GO:000560; GO:003159; GO:004308; GO:000557	 Small cell lung cancer; PI3K-Akt signaling pathway; Focal adhesion; Toxoplasmosis; Pathways in cancer	hsa0522; hsa0415; hsa0451; hsa0514; hsa0520	integrin binding;structural molecule activity;extracellular matrix structural constituent	GO:000517; GO:000519; GO:000520
XP_020926395.1;CON__P07224	XP_020926395.1	XP_020926395.1 vitamin K-dependent protein S [Sus scrofa]	7	7	7	40706000	41492000	39254000	53898000	54446000	74243000	59810000	45991000	46651000	45390000	41526000	52787000	51330000	50962000	47651000	52828000	51220000	54794000	NA	NA	NA	PROS1	PROS1;NA;NA;NA;NA	ER to Golgi vesicle-mediated transport;platelet degranulation;regulation of complement activation;fibrinolysis;leukocyte migration;blood coagulation;negative regulation of endopeptidase activity	GO:000688; GO:000257; GO:003044; GO:004273; GO:005090; GO:000759; GO:001095	platelet alpha granule lumen;extracellular exosome;extracellular space;plasma membrane;extracellular region;blood microparticle;endoplasmic reticulum membrane;Golgi membrane;Golgi lumen	GO:003109; GO:007006; GO:000561; GO:000588; GO:000557; GO:007256; GO:000578; GO:000013; GO:000579	 Complement and coagulation cascades	hsa0461	calcium ion binding;endopeptidase inhibitor activity	GO:000550; GO:000486
XP_020926424.1;XP_020926423.1;XP_020926421.1;XP_020926420.1;XP_020926419.1;XP_020926418.1;XP_020926417.1;XP_020926416.1;XP_020926415.1;XP_020926414.1;XP_020926413.1	XP_020926424.1;XP_020926423.1;XP_020926421.1;XP_020926420.1;XP_020926419.1;XP_020926418.1;XP_020926417.1;XP_020926416.1;XP_020926415.1;XP_020926414.1;XP_020926413.1	XP_020926424.1 bis(5-adenosyl)-triphosphatase isoform X4 [Sus scrofa];XP_020926423.1 bis(5-adenosyl)-triphosphatase isoform X3 [Sus scrofa];XP_020926421.1 bis(5-adenosyl)-triphosphatase isoform X3 [Sus scrofa];XP_020926420.1 bis(5-adenosyl)-triphosphat	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3531700	0	NA	NA	NA	FHIT	FHIT;FHIT;FHIT;FHIT;FHIT	intrinsic apoptotic signaling pathway by p53 class mediator;purine nucleotide metabolic process;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;nucleotide metabolic process	GO:007233; GO:000616; GO:003243; GO:000911	plasma membrane;cytoplasm;fibrillar center;cytosol	GO:000588; GO:000573; GO:000165; GO:000582	 Purine metabolism; Small cell lung cancer	hsa0023; hsa0522	bis(5'-adenosyl)-triphosphatase activity;catalytic activity;identical protein binding;ubiquitin protein ligase binding;protein binding;hydrolase activity;nucleotide binding	GO:004771; GO:000382; GO:004280; GO:003162; GO:000551; GO:001678; GO:000016
XP_020926435.1;XP_020926434.1;XP_020926433.1;XP_020926432.1;XP_020926431.1;XP_020926430.1;XP_020926428.1;XP_020926427.1;XP_020926426.1	XP_020926435.1;XP_020926434.1;XP_020926433.1;XP_020926432.1;XP_020926431.1;XP_020926430.1;XP_020926428.1;XP_020926427.1;XP_020926426.1	XP_020926435.1 receptor-type tyrosine-protein phosphatase gamma isoform X7 [Sus scrofa];XP_020926434.1 receptor-type tyrosine-protein phosphatase gamma isoform X7 [Sus scrofa];XP_020926433.1 receptor-type tyrosine-protein phosphatase gamma isoform X7 [Sus	2	2	2	0	0	0	0	0	0	0	0	0	0	0	6317200	0	0	0	0	0	0	NA	NA	NA	PTPRG	PTPRG;PTPRG;PTPRG;PTPRG;PTPRG	negative regulation of neuron projection development;negative regulation of epithelial cell migration;brain development;transmembrane receptor protein tyrosine kinase signaling pathway;regulation of homophilic cell adhesion;peptidyl-tyrosine dephosphorylation	GO:001097; GO:001063; GO:000742; GO:000716; GO:190338; GO:003533	integral component of plasma membrane;extracellular exosome	GO:000588; GO:007006	"NA"	"NA"	transmembrane receptor protein tyrosine phosphatase activity;protein tyrosine phosphatase activity;identical protein binding;protein binding	GO:000500; GO:000472; GO:004280; GO:000551
XP_020926442.1	XP_020926442.1	XP_020926442.1 1,4-alpha-glucan-branching enzyme [Sus scrofa]	27	27	27	1081300000	1659200000	1236500000	1430600000	1271600000	1402100000	1337200000	1817200000	1189700000	1650300000	1173400000	1551000000	546860000	1708900000	1275700000	2078200000	1074100000	1665400000	NA	NA	NA	GBE1	GBE1;NA;NA;NA;NA	glycogen biosynthetic process;generation of precursor metabolites and energy;carbohydrate metabolic process	GO:000597; GO:000609; GO:000597	extracellular exosome;cytosol	GO:007006; GO:000582	 Starch and sucrose metabolism; Metabolic pathways	hsa0050; hsa0110	1,4-alpha-glucan branching enzyme activity;hydrolase activity, hydrolyzing O-glycosyl compounds;cation binding;protein binding	GO:000384; GO:000455; GO:004316; GO:000551
XP_020926755.1;XP_020926754.1;XP_020926753.1	XP_020926755.1;XP_020926754.1;XP_020926753.1	XP_020926755.1 collagen alpha-1(VI) chain [Sus scrofa];XP_020926754.1 collagen alpha-1(VI) chain [Sus scrofa];XP_020926753.1 collagen alpha-1(VI) chain [Sus scrofa]	35	35	35	954180000	3560300000	1658800000	4675700000	1544200000	2738400000	2451300000	3670800000	1697500000	2700700000	2206400000	3681000000	3542300000	3735200000	2337700000	4306900000	2596000000	3284100000	NA	NA	NA	LOC100623720	LOC100623720;LOC100623720;LOC100623720;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020926783.1;XP_020926778.1;XP_020926771.1	XP_020926783.1;XP_020926778.1;XP_020926771.1	XP_020926783.1 surfeit locus protein 1 isoform X3 [Sus scrofa];XP_020926778.1 surfeit locus protein 1 isoform X2 [Sus scrofa];XP_020926771.1 surfeit locus protein 1 isoform X1 [Sus scrofa]	2	2	2	0	0	9502800	0	0	0	10582000	0	9162100	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC110256505	LOC110256505;LOC110256505;LOC110256505;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020926787.1	XP_020926787.1	XP_020926787.1 surfeit locus protein 4 [Sus scrofa]	1	1	1	26848000	0	27872000	0	28930000	0	18942000	0	25342000	20546000	16693000	0	14285000	10771000	13547000	0	39811000	14891000	NA	NA	NA	SURF4	SURF4;NA;NA;NA;NA	neutrophil degranulation;Golgi organization;retrograde vesicle-mediated transport, Golgi to ER;positive regulation of organelle organization;protein exit from endoplasmic reticulum;early endosome to Golgi transport	GO:004331; GO:000703; GO:000689; GO:001063; GO:003252; GO:003449	plasma membrane;endoplasmic reticulum membrane;azurophil granule membrane;cytosol;Golgi membrane;integral component of membrane;transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum-Golgi intermediate compartment	GO:000588; GO:000578; GO:003557; GO:000582; GO:000013; GO:001602; GO:003013; GO:003311; GO:000579	"NA"	"NA"	protein binding	GO:000551
XP_020926795.1;XP_003125024.2	XP_020926795.1;XP_003125024.2	XP_020926795.1 60S ribosomal protein L7a [Sus scrofa];XP_003125024.2 60S ribosomal protein L7a [Sus scrofa]	12	12	12	224740000	227660000	244670000	160300000	178620000	292720000	203570000	154650000	224830000	251020000	194780000	226020000	260690000	248370000	143600000	243460000	236480000	309150000	NA	NA	NA	RPL7A	RPL7A;LOC100525692;NA;NA;NA	maturation of LSU-rRNA;translation;SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000047; GO:000641; GO:000661; GO:000018	membrane;cytoplasm;cytosol;nucleus;cytosolic large ribosomal subunit;focal adhesion;polysomal ribosome	GO:001602; GO:000573; GO:000582; GO:000563; GO:002262; GO:000592; GO:004278	 Ribosome	hsa0301	RNA binding;cadherin binding;structural constituent of ribosome;protein binding	GO:000372; GO:004529; GO:000373; GO:000551
XP_020926910.1;XP_020926909.1;XP_020926908.1;XP_020926907.1;XP_020926906.1;XP_020926905.1	XP_020926910.1;XP_020926909.1;XP_020926908.1;XP_020926907.1;XP_020926906.1;XP_020926905.1	XP_020926910.1 lipoma-preferred partner [Sus scrofa];XP_020926909.1 lipoma-preferred partner [Sus scrofa];XP_020926908.1 lipoma-preferred partner [Sus scrofa];XP_020926907.1 lipoma-preferred partner [Sus scrofa];XP_020926906.1 lipoma-preferred partner [Sus	15	15	15	72171000	103730000	137000000	97946000	60957000	140250000	58911000	144230000	70537000	193410000	93442000	169950000	246860000	108510000	71462000	104490000	60013000	103840000	NA	NA	NA	LPP	LPP;LPP;LPP;LPP;LPP	cell adhesion;biological_process	GO:000715; GO:000815	plasma membrane;focal adhesion;cytosol;nucleus	GO:000588; GO:000592; GO:000582; GO:000563	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_020926912.1	XP_020926912.1	XP_020926912.1 uridine 5-monophosphate synthase [Sus scrofa]	6	6	6	9235200	12294000	0	12969000	0	0	11070000	27731000	10762000	0	0	20975000	14084000	12452000	10710000	6926900	9286300	9360300	NA	NA	NA	UMPS	UMPS;NA;NA;NA;NA	UMP biosynthetic process;pyrimidine nucleoside biosynthetic process;female pregnancy;'de novo' UMP biosynthetic process;'de novo' pyrimidine nucleobase biosynthetic process;cellular response to drug;lactation	GO:000622; GO:004613; GO:000756; GO:004420; GO:000620; GO:003569; GO:000759	nucleus;cytosol;cytoplasm	GO:000563; GO:000582; GO:000573	 Drug metabolism - other enzymes; Metabolic pathways; Pyrimidine metabolism	hsa0098; hsa0110; hsa0024	orotate phosphoribosyltransferase activity;orotidine-5'-phosphate decarboxylase activity	GO:000458; GO:000459
XP_020926968.1	XP_020926968.1	XP_020926968.1 mitochondrial import receptor subunit TOM70 [Sus scrofa]	9	9	9	75450000	88199000	117360000	26277000	95088000	0	76677000	72255000	81822000	94446000	79054000	105350000	39718000	61384000	57845000	88956000	62855000	69959000	NA	NA	NA	TOMM70	TOMM70;NA;NA;NA;NA	protein targeting to mitochondrion;protein transmembrane transport	GO:000662; GO:007180	integral component of membrane;mitochondrial outer membrane;membrane;extracellular exosome;mitochondrion	GO:001602; GO:000574; GO:001602; GO:007006; GO:000573	"NA"	"NA"	protein binding;protein transmembrane transporter activity	GO:000551; GO:000832
XP_020926982.1	XP_020926982.1	XP_020926982.1 U8 snoRNA-decapping enzyme [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	8500600	0	0	0	0	0	NA	NA	NA	NUDT16	NUDT16;NA;NA;NA;NA	snoRNA catabolic process;proteolysis;positive regulation of cell proliferation;RNA phosphodiester bond hydrolysis, endonucleolytic;adenosine to inosine editing;dephosphorylation;dITP catabolic process;positive regulation of double-strand break repair;IDP catabolic process;nucleobase-containing small molecule catabolic process;XDP catabolic process;negative regulation of rRNA processing;mRNA catabolic process;positive regulation of cell cycle process	GO:001607; GO:000650; GO:000828; GO:009050; GO:000638; GO:001631; GO:003586; GO:200078; GO:004670; GO:003465; GO:190163; GO:200023; GO:000640; GO:009006	nucleolus;nucleus;nucleoplasm;cytoplasm	GO:000573; GO:000563; GO:000565; GO:000573	 Purine metabolism; RNA degradation	hsa0023; hsa0301	magnesium ion binding;chloride ion binding;ITP binding;identical protein binding;manganese ion binding;m7G(5')pppN diphosphatase activity;phosphodiesterase decapping endonuclease activity;snoRNA binding;cobalt ion binding;IDP phosphatase activity;mRNA binding;dIDP diphosphatase activity;GTP binding;nucleotide phosphatase activity, acting on free nucleotides;dITP diphosphatase activity;metalloexopeptidase activity	GO:000028; GO:003140; GO:190164; GO:004280; GO:003014; GO:005007; GO:199017; GO:003051; GO:005089; GO:199000; GO:000372; GO:009738; GO:000552; GO:009851; GO:003587; GO:000823
XP_020926990.1	XP_020926990.1	XP_020926990.1 LOW QUALITY PROTEIN: collagen alpha-6(VI) chain [Sus scrofa]	37	37	35	0	268220000	0	455500000	150530000	316710000	181210000	446700000	88890000	301140000	156180000	353440000	185760000	347550000	157620000	437960000	193600000	383530000	NA	NA	NA	COL6A6	COL6A6;NA;NA;NA;NA	cell adhesion	GO:000715	extracellular region;extracellular matrix;collagen trimer	GO:000557; GO:003101; GO:000558	 ECM-receptor interaction; PI3K-Akt signaling pathway; Protein digestion and absorption; Focal adhesion	hsa0451; hsa0415; hsa0497; hsa0451	extracellular matrix structural constituent conferring tensile strength	GO:003002
XP_020927016.1	XP_020927016.1	XP_020927016.1 raftlin [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2348200	NA	NA	NA	RFTN1	RFTN1;NA;NA;NA;NA	dsRNA transport;protein transport into membrane raft;response to exogenous dsRNA;protein localization to membrane raft;positive regulation of growth rate;B cell receptor signaling pathway;membrane raft assembly;T cell antigen processing and presentation;toll-like receptor 3 signaling pathway;interleukin-17 production	GO:003322; GO:003259; GO:004333; GO:190304; GO:004001; GO:005085; GO:000176; GO:000245; GO:003413; GO:003262	plasma membrane;cytoplasm;endosome;extracellular exosome;macromolecular complex;membrane raft	GO:000588; GO:000573; GO:000576; GO:007006; GO:003299; GO:004512	"NA"	"NA"	double-stranded RNA binding	GO:000372
XP_020927098.1	XP_020927098.1	XP_020927098.1 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	6345500	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OXSM	OXSM;NA;NA;NA;NA	fatty acid biosynthetic process;medium-chain fatty acid biosynthetic process;acyl-CoA metabolic process	GO:000663; GO:005179; GO:000663	mitochondrion;cytosol	GO:000573; GO:000582	 Biotin metabolism; Metabolic pathways; Fatty acid metabolism; Fatty acid biosynthesis	hsa0078; hsa0110; hsa0121; hsa0006	3-oxoacyl-[acyl-carrier-protein	GO:000431
XP_020927108.1;XP_020927107.1;XP_020927106.1;XP_020927104.1;XP_020927103.1;XP_020927102.1	XP_020927108.1;XP_020927107.1;XP_020927106.1;XP_020927104.1;XP_020927103.1;XP_020927102.1	XP_020927108.1 ATP synthase-coupling factor 6, mitochondrial [Sus scrofa];XP_020927107.1 ATP synthase-coupling factor 6, mitochondrial [Sus scrofa];XP_020927106.1 ATP synthase-coupling factor 6, mitochondrial [Sus scrofa];XP_020927104.1 ATP synthase-coupli	4	4	4	108050000	0	69455000	48708000	71768000	0	87106000	53694000	79286000	58975000	64156000	88736000	61051000	46801000	79037000	60234000	51412000	43919000	NA	NA	NA	ATP5PF	ATP5PF;ATP5PF;ATP5PF;ATP5PF;ATP5PF	ATP biosynthetic process;substantia nigra development;cristae formation;positive regulation of blood pressure;response to muscle activity;mitochondrial ATP synthesis coupled proton transport;negative regulation of arachidonic acid secretion;negative regulation of prostaglandin secretion;positive regulation of heart rate	GO:000675; GO:002176; GO:004240; GO:004577; GO:001485; GO:004277; GO:190013; GO:003230; GO:001046	cell surface;extracellular space;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);mitochondrial proton-transporting ATP synthase complex;mitochondrion	GO:000998; GO:000561; GO:000574; GO:000027; GO:000575; GO:000573	 Oxidative phosphorylation; Metabolic pathways; Alzheimer's disease	hsa0019; hsa0110; hsa0501	transmembrane transporter activity;macromolecular complex binding;ATPase activity;hydrogen ion transmembrane transporter activity;transporter activity	GO:002285; GO:004487; GO:001688; GO:001507; GO:000521
XP_020927169.1	XP_020927169.1	XP_020927169.1 ATP-dependent 6-phosphofructokinase, liver type [Sus scrofa]	15	15	14	128420000	120600000	131730000	125960000	138130000	112680000	141310000	136490000	140340000	122840000	114000000	136580000	124760000	115040000	113950000	150020000	145500000	169420000	NA	NA	NA	PFKL	PFKL;NA;NA;NA;NA	response to glucose;protein homotetramerization;fructose 6-phosphate metabolic process;canonical glycolysis;protein oligomerization;negative regulation of insulin secretion;glycolytic process;fructose 1,6-bisphosphate metabolic process;neutrophil degranulation	GO:000974; GO:005128; GO:000600; GO:006162; GO:005125; GO:004667; GO:000609; GO:003038; GO:004331	cytosol;secretory granule lumen;6-phosphofructokinase complex;extracellular region;extracellular exosome;ficolin-1-rich granule lumen;membrane	GO:000582; GO:003477; GO:000594; GO:000557; GO:007006; GO:190481; GO:001602	 HIF-1 signaling pathway; AMPK signaling pathway; Glycolysis / Gluconeogenesis; Galactose metabolism; Metabolic pathways; Glucagon signaling pathway; Biosynthesis of antibiotics; Pentose phosphate pathway; Carbon metabolism; Biosynthesis of amino acids; RNA degradation; Central carbon metabolism in cancer	hsa0406; hsa0415; hsa0001; hsa0005; hsa0110; hsa0492; hsa0113; hsa0003; hsa0120; hsa0123; hsa0301; hsa0523	ATP binding;identical protein binding;6-phosphofructokinase activity;fructose-6-phosphate binding;kinase binding;AMP binding;protein binding;metal ion binding;monosaccharide binding;fructose binding	GO:000552; GO:004280; GO:000387; GO:007009; GO:001990; GO:001620; GO:000551; GO:004687; GO:004802; GO:007006
XP_020927197.1;XP_020927196.1;XP_020927195.1;XP_020927193.1;XP_020927192.1;XP_020927190.1;XP_020927194.1;XP_020927189.1;XP_020927188.1	XP_020927197.1;XP_020927196.1;XP_020927195.1;XP_020927193.1;XP_020927192.1;XP_020927190.1;XP_020927194.1;XP_020927189.1;XP_020927188.1	XP_020927197.1 collagen alpha-1(XVIII) chain isoform X9 [Sus scrofa];XP_020927196.1 collagen alpha-1(XVIII) chain isoform X8 [Sus scrofa];XP_020927195.1 collagen alpha-1(XVIII) chain isoform X7 [Sus scrofa];XP_020927193.1 collagen alpha-1(XVIII) chain isof	19	19	19	273810000	444080000	425490000	352400000	234190000	335950000	326670000	418670000	289330000	359280000	403030000	370560000	651940000	336740000	340990000	331350000	414480000	311880000	NA	NA	NA	COL18A1	COL18A1;COL18A1;COL18A1;COL18A1;COL18A1	response to drug;negative regulation of cell proliferation;extracellular matrix organization;positive regulation of cell migration;response to hydrostatic pressure;positive regulation of endothelial cell apoptotic process;cell adhesion;angiogenesis;endothelial cell morphogenesis;animal organ morphogenesis;visual perception	GO:004249; GO:000828; GO:003019; GO:003033; GO:005159; GO:200035; GO:000715; GO:000152; GO:000188; GO:000988; GO:000760	extracellular region;extracellular matrix;extracellular space;endoplasmic reticulum lumen;collagen trimer;basement membrane;extracellular exosome	GO:000557; GO:003101; GO:000561; GO:000578; GO:000558; GO:000560; GO:007006	 Protein digestion and absorption	hsa0497	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;metal ion binding	GO:000520; GO:003002; GO:004687
XP_020927199.1	XP_020927199.1	XP_020927199.1 LOW QUALITY PROTEIN: CKLF-like MARVEL transmembrane domain-containing protein 6 [Sus scrofa]	2	2	2	14308000	16301000	13088000	14063000	0	0	13858000	0	0	0	0	0	0	0	0	0	14075000	0	NA	NA	NA	CMTM6	CMTM6;NA;NA;NA;NA	neutrophil degranulation;endocytic recycling;regulation of protein stability;protein transport	GO:004331; GO:003245; GO:003164; GO:001503	plasma membrane;integral component of membrane;early endosome membrane;specific granule membrane;recycling endosome membrane	GO:000588; GO:001602; GO:003190; GO:003557; GO:005503	"NA"	"NA"	protein binding	GO:000551
XP_020930841.1;XP_020930840.1;XP_020930839.1;XP_020927279.1;XP_020927278.1;XP_020927277.1;XP_020927276.1;XP_020927275.1;XP_020927274.1;XP_020927272.1;XP_020930838.1;XP_020927271.1;XP_020927270.1;XP_020927269.1;XP_020927268.1;XP_020927267.1;XP_020927266.1;XP_020930837.1;XP_020927265.1;XP_020927264.1;XP_020927263.1;XP_020927261.1;XP_020927260.1;XP_020927259.1;XP_020927258.1;XP_020927257.1;XP_020927256.1;XP_020930836.1;XP_020930834.1;XP_020930833.1;XP_020930832.1;XP_020930831.1;XP_020930830.1;XP_020930829.1;XP_020930828.1;XP_020930827.1;XP_020930826.1;XP_020930825.1;XP_020930824.1;XP_020930823.1;XP_020930822.1;XP_020930821.1;XP_020930820.1;XP_020930819.1;XP_020927255.1;XP_020927254.1;XP_020927253.1;XP_020930818.1;XP_020930817.1;XP_020927252.1;XP_020930816.1;XP_020927250.1;XP_020930815.1;XP_020927249.1;XP_020927248.1;XP_020927247.1;XP_020930814.1;XP_020930813.1;XP_020930812.1;XP_020927246.1;XP_020927245.1;XP_020927244.1;XP_020930811.1;XP_020927243.1;XP_020927242.1;XP_020927241.1;XP_020930810.1;XP_020930809.1;XP_020927239.1;XP_020927238.1;XP_020927237.1;XP_020927236.1;XP_020927235.1;XP_020930842.1;XP_020927234.1;XP_020927233.1;XP_020927232.1;XP_020927231.1;XP_020930808.1;XP_020927230.1;XP_020927228.1;XP_020930807.1;XP_020927227.1;XP_020927226.1;XP_020927225.1;XP_020930806.1	XP_020930841.1;XP_020930840.1;XP_020930839.1;XP_020927279.1;XP_020927278.1;XP_020927277.1;XP_020927276.1;XP_020927275.1;XP_020927274.1;XP_020927272.1;XP_020930838.1;XP_020927271.1;XP_020927270.1;XP_020927269.1;XP_020927268.1;XP_020927267.1;XP_020927266.1;XP_020930837.1;XP_020927265.1;XP_020927264.1;XP_020927263.1;XP_020927261.1;XP_020927260.1;XP_020927259.1;XP_020927258.1;XP_020927257.1;XP_020927256.1;XP_020930836.1;XP_020930834.1;XP_020930833.1;XP_020930832.1;XP_020930831.1;XP_020930830.1;XP_020930829.1;XP_020930828.1;XP_020930827.1;XP_020930826.1;XP_020930825.1;XP_020930824.1;XP_020930823.1;XP_020930822.1;XP_020930821.1;XP_020930820.1;XP_020930819.1;XP_020927255.1;XP_020927254.1;XP_020927253.1;XP_020930818.1;XP_020930817.1;XP_020927252.1;XP_020930816.1;XP_020927250.1;XP_020930815.1;XP_020927249.1;XP_020927248.1;XP_020927247.1;XP_020930814.1;XP_020930813.1;XP_020930812.1;XP_020927246.1;XP_020927245.1;XP_020927244.1;XP_020930811.1;XP_020927243.1;XP_020927242.1;XP_020927241.1;XP_020930810.1;XP_020930809.1;XP_020927239.1;XP_020927238.1;XP_020927237.1;XP_020927236.1;XP_020927235.1;XP_020930842.1;XP_020927234.1;XP_020927233.1;XP_020927232.1;XP_020927231.1;XP_020930808.1;XP_020927230.1;XP_020927228.1;XP_020930807.1;XP_020927227.1;XP_020927226.1;XP_020927225.1;XP_020930806.1	XP_020930841.1 CLIP-associating protein 1 isoform X34 [Sus scrofa];XP_020930840.1 CLIP-associating protein 1 isoform X33 [Sus scrofa];XP_020930839.1 CLIP-associating protein 1 isoform X32 [Sus scrofa];XP_020927279.1 CLIP-associating protein 2 isoform X50 [	2	2	2	0	2433200	0	0	0	0	0	0	0	0	0	0	0	0	0	3631400	0	2642200	NA	NA	NA	CLASP1	CLASP1;CLASP1;CLASP1;CLASP1;CLASP1	G2/M transition of mitotic cell cycle;mitotic spindle organization;establishment or maintenance of cell polarity;establishment of mitotic spindle localization;establishment of epithelial cell polarity;ciliary basal body docking;astral microtubule organization;positive regulation of exocytosis;positive regulation of basement membrane assembly involved in embryonic body morphogenesis;microtubule bundle formation;vesicle targeting;negative regulation of stress fiber assembly;microtubule cytoskeleton organization;Golgi organization;microtubule anchoring;establishment of spindle orientation;regulation of microtubule cytoskeleton organization;negative regulation of microtubule depolymerization;positive regulation of epithelial cell migration;regulation of epithelial to mesenchymal transition;positive regulation of microtubule polymerization;cell division;negative regulation of wound healing, spreading of epidermal cells;regulation of gastrulation;positive regulation of extracellular matrix disassembly;exit from mitosis;microtubule organizing center organization;regulation of focal adhesion assembly;regulation of G2/M transition of mitotic cell cycle;mitotic spindle assembly	GO:000008; GO:000705; GO:000716; GO:004000; GO:009016; GO:009771; GO:003095; GO:004592; GO:190426; GO:000157; GO:000690; GO:005149; GO:000022; GO:000703; GO:003445; GO:005129; GO:007050; GO:000702; GO:001063; GO:001071; GO:003111; GO:005130; GO:190369; GO:001047; GO:009009; GO:001045; GO:003102; GO:005189; GO:001038; GO:009030	spindle microtubule;microtubule plus-end;membrane;cytosol;Golgi apparatus;centrosome;kinetochore;focal adhesion;cell cortex;cortical microtubule cytoskeleton;centrosomal corona;cytoplasmic microtubule;basal cortex	GO:000587; GO:003537; GO:001602; GO:000582; GO:000579; GO:000581; GO:000077; GO:000592; GO:000593; GO:003098; GO:003159; GO:000588; GO:004518	"NA"	"NA"	protein binding;dystroglycan binding;microtubule binding;kinetochore binding;microtubule plus-end binding	GO:000551; GO:000216; GO:000801; GO:004351; GO:005101
XP_020927281.1;XP_020927280.1	XP_020927281.1;XP_020927280.1	XP_020927281.1 programmed cell death 6-interacting protein isoform X2 [Sus scrofa];XP_020927280.1 programmed cell death 6-interacting protein isoform X1 [Sus scrofa]	30	30	30	311100000	284340000	352620000	303690000	256160000	221580000	334400000	262350000	375630000	289540000	313650000	290610000	296900000	274610000	331980000	282090000	276650000	247080000	NA	NA	NA	PDCD6IP	PDCD6IP;PDCD6IP;NA;NA;NA	mitotic cytokinesis;multivesicular body assembly;mitotic metaphase plate congression;viral budding via host ESCRT complex;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;protein homooligomerization;apoptotic process;nucleus organization;protein transport;regulation of centrosome duplication;maintenance of epithelial cell apical/basal polarity;bicellular tight junction assembly;viral budding;positive regulation of exosomal secretion;actomyosin contractile ring assembly;viral life cycle;regulation of membrane permeability;regulation of mitotic spindle assembly;regulation of extracellular exosome assembly	GO:000028; GO:003625; GO:000708; GO:003970; GO:009061; GO:005126; GO:000691; GO:000699; GO:001503; GO:001082; GO:004519; GO:007083; GO:004675; GO:190354; GO:000091; GO:001905; GO:009055; GO:190167; GO:190355	cytosol;focal adhesion;immunological synapse;microtubule organizing center;Flemming body;membrane;endoplasmic reticulum exit site;melanosome;actomyosin;extracellular exosome;extracellular vesicle	GO:000582; GO:000592; GO:000177; GO:000581; GO:009054; GO:001602; GO:007097; GO:004247; GO:004264; GO:007006; GO:190356	 Endocytosis	hsa0414	proteinase activated receptor binding;protein binding;calcium-dependent protein binding;protein homodimerization activity	GO:003187; GO:000551; GO:004830; GO:004280
XP_020927753.1;XP_020927748.1;XP_020927738.1;XP_020927736.1;XP_020927733.1;XP_020927731.1;XP_020927728.1;XP_020927720.1;XP_020927719.1;XP_020927716.1;XP_020927725.1	XP_020927753.1;XP_020927748.1;XP_020927738.1;XP_020927736.1;XP_020927733.1;XP_020927731.1;XP_020927728.1;XP_020927720.1;XP_020927719.1;XP_020927716.1;XP_020927725.1	XP_020927753.1 SAM and SH3 domain-containing protein 1 isoform X10 [Sus scrofa];XP_020927748.1 SAM and SH3 domain-containing protein 1 isoform X9 [Sus scrofa];XP_020927738.1 SAM and SH3 domain-containing protein 1 isoform X9 [Sus scrofa];XP_020927736.1 SAM	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34509000	0	NA	NA	NA	SASH1	SASH1;SASH1;SASH1;SASH1;SASH1	positive regulation of endothelial cell migration;positive regulation of p38MAPK cascade;positive regulation of NIK/NF-kappaB signaling;positive regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of JUN kinase activity;regulation of protein K63-linked ubiquitination;protein polyubiquitination;positive regulation of angiogenesis;regulation of protein autoubiquitination	GO:001059; GO:190074; GO:190122; GO:003166; GO:004350; GO:190004; GO:000020; GO:004576; GO:190249	macromolecular complex	GO:003299	"NA"	"NA"	protein C-terminus binding;protein kinase binding;mitogen-activated protein kinase kinase kinase binding;protein complex scaffold	GO:000802; GO:001990; GO:003143; GO:003294
XP_020927762.1;NP_999222.1	XP_020927762.1;NP_999222.1	XP_020927762.1 retinol-binding protein 4 isoform X1 [Sus scrofa];NP_999222.1 retinol-binding protein 4 precursor [Sus scrofa]	6	6	6	131040000	139530000	116670000	115160000	148190000	198950000	150570000	137650000	166600000	143270000	196860000	211940000	86635000	118550000	203970000	105710000	148970000	146440000	NA	NA	NA	RBP4	RBP4;RBP4;NA;NA;NA	maintenance of gastrointestinal epithelium;positive regulation of insulin secretion;retinol metabolic process;glucose homeostasis;embryonic skeletal system development;embryonic retina morphogenesis in camera-type eye;urinary bladder development;retinoid metabolic process;visual perception;embryonic organ morphogenesis;female genitalia morphogenesis;heart trabecula formation;gluconeogenesis;lung development;response to ethanol;cardiac muscle tissue development;response to retinoic acid;positive regulation of immunoglobulin secretion;negative regulation of cardiac muscle cell proliferation;eye development;heart development;retinol transport;uterus development	GO:003027; GO:003202; GO:004257; GO:004259; GO:004870; GO:006005; GO:006015; GO:000152; GO:000760; GO:004856; GO:004880; GO:006034; GO:000609; GO:003032; GO:004547; GO:004873; GO:003252; GO:005102; GO:006004; GO:000165; GO:000750; GO:003463; GO:006006	cytosol;extracellular exosome;extracellular region;macromolecular complex;extracellular space	GO:000582; GO:007006; GO:000557; GO:003299; GO:000561	"NA"	"NA"	retinol binding;protein binding;retinal binding;retinol transporter activity;protein heterodimerization activity	GO:001984; GO:000551; GO:001691; GO:003463; GO:004698
XP_020927834.1;NP_999534.1	XP_020927834.1;NP_999534.1	XP_020927834.1 voltage-dependent anion-selective channel protein 2 isoform X1 [Sus scrofa];NP_999534.1 voltage-dependent anion-selective channel protein 2 [Sus scrofa]	12	12	12	891360000	691010000	813790000	473170000	753350000	558880000	854930000	579420000	826620000	572100000	682580000	492980000	512650000	586880000	637610000	641860000	665450000	575590000	NA	NA	NA	VDAC2	VDAC2;VDAC2;NA;NA;NA	binding of sperm to zona pellucida;anion transport;inorganic anion transport;negative regulation of protein polymerization;negative regulation of intrinsic apoptotic signaling pathway;anion transmembrane transport	GO:000733; GO:000682; GO:001569; GO:003227; GO:200124; GO:009865	nucleus;pore complex;mitochondrion;mitochondrial nucleoid;synaptic vesicle;acrosomal vesicle;mitochondrial outer membrane	GO:000563; GO:004693; GO:000573; GO:004264; GO:000802; GO:000166; GO:000574	 cGMP-PKG signaling pathway; HTLV-I infection; Parkinson's disease; Calcium signaling pathway	hsa0402; hsa0516; hsa0501; hsa0402	nucleotide binding;protein binding;porin activity;voltage-gated anion channel activity	GO:000016; GO:000551; GO:001528; GO:000830
XP_020927969.1;XP_020927964.1;XP_020927962.1;XP_020927957.1;XP_020927948.1;XP_020927942.1;XP_020927939.1;XP_020927932.1;XP_020927926.1;XP_020927920.1;XP_020927918.1;XP_020927913.1;XP_020927911.1;XP_020927986.1;XP_020927985.1;XP_020927979.1	XP_020927969.1;XP_020927964.1;XP_020927962.1;XP_020927957.1;XP_020927948.1;XP_020927942.1;XP_020927939.1;XP_020927932.1;XP_020927926.1;XP_020927920.1;XP_020927918.1;XP_020927913.1;XP_020927911.1	XP_020927969.1 utrophin isoform X11 [Sus scrofa];XP_020927964.1 utrophin isoform X10 [Sus scrofa];XP_020927962.1 utrophin isoform X10 [Sus scrofa];XP_020927957.1 utrophin isoform X9 [Sus scrofa];XP_020927948.1 utrophin isoform X8 [Sus scrofa];XP_020927942.	81	81	80	569020000	686400000	528400000	556880000	503270000	484950000	545130000	654270000	532100000	580580000	566150000	695980000	414010000	596440000	556950000	661210000	506650000	569510000	NA	NA	NA	UTRN	UTRN;UTRN;UTRN;UTRN;UTRN	positive regulation of cell-matrix adhesion;neuromuscular junction development;muscle organ development;response to denervation involved in regulation of muscle adaptation;regulation of sodium ion transmembrane transporter activity;muscle contraction	GO:000195; GO:000752; GO:000751; GO:001489; GO:200064; GO:000693	cytoskeleton;dystrophin-associated glycoprotein complex;contractile ring;plasma membrane;sarcolemma;membrane;cell junction;neuromuscular junction;macromolecular complex;extracellular exosome;cytoplasm;filopodium;growth cone;filopodium membrane;nucleoplasm;cortical actin cytoskeleton;postsynaptic membrane	GO:000585; GO:001601; GO:007093; GO:000588; GO:004238; GO:001602; GO:003005; GO:003159; GO:003299; GO:007006; GO:000573; GO:003017; GO:003042; GO:003152; GO:000565; GO:003086; GO:004521	"NA"	"NA"	protein binding;integrin binding;actin filament binding;zinc ion binding;vinculin binding;protein kinase binding;actin binding	GO:000551; GO:000517; GO:005101; GO:000827; GO:001716; GO:001990; GO:000377
XP_020927997.1;XP_020927993.1	XP_020927997.1;XP_020927993.1	XP_020927997.1 plasma alpha-L-fucosidase isoform X2 [Sus scrofa];XP_020927993.1 plasma alpha-L-fucosidase isoform X1 [Sus scrofa]	5	5	5	6539800	5703600	5763300	0	8175600	5834900	0	7744200	9946400	5777300	5807500	6984700	0	0	0	0	6812400	7820900	NA	NA	NA	FUCA2	FUCA2;FUCA2;NA;NA;NA	post-translational protein modification;cellular protein metabolic process;glycoside catabolic process;regulation of entry of bacterium into host cell;fucose metabolic process;response to bacterium;neutrophil degranulation	GO:004368; GO:004426; GO:001613; GO:200053; GO:000600; GO:000961; GO:004331	endoplasmic reticulum lumen;extracellular space;azurophil granule lumen;lysosome;extracellular region;extracellular exosome	GO:000578; GO:000561; GO:003557; GO:000576; GO:000557; GO:007006	 Other glycan degradation	hsa0051	alpha-L-fucosidase activity;protein binding	GO:000456; GO:000551
XP_020928065.1	XP_020928065.1	XP_020928065.1 LOW QUALITY PROTEIN: kinesin-like protein KIF13B [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	12678000	0	0	0	11975000	0	0	NA	NA	NA	KIF13B	KIF13B;NA;NA;NA;NA	protein targeting;signal transduction;T cell activation;regulation of axonogenesis;microtubule-based movement	GO:000660; GO:000716; GO:004211; GO:005077; GO:000701	axon;cytoplasm;kinesin complex;paranode region of axon;microvillus;cytosol	GO:003042; GO:000573; GO:000587; GO:003327; GO:000590; GO:000582	"NA"	"NA"	protein binding;ATP binding;microtubule binding;protein kinase binding;ATPase activity;microtubule motor activity;14-3-3 protein binding	GO:000551; GO:000552; GO:000801; GO:001990; GO:001688; GO:000377; GO:007188
XP_020928146.1	XP_020928146.1	XP_020928146.1 acetoacetyl-CoA synthetase [Sus scrofa]	8	8	8	112400000	0	71327000	0	104350000	0	97796000	74209000	94438000	64149000	73274000	64379000	0	0	65520000	69723000	52390000	54102000	NA	NA	NA	AACS	AACS;NA;NA;NA;NA	cellular response to glucose stimulus;response to oleic acid;white fat cell differentiation;cellular response to testosterone stimulus;liver development;response to nutrient;response to purine-containing compound;adipose tissue development;response to starvation;fatty acid metabolic process;ketone body biosynthetic process;positive regulation of insulin secretion;response to ethanol	GO:007133; GO:003420; GO:005087; GO:007139; GO:000188; GO:000758; GO:001407; GO:006061; GO:004259; GO:000663; GO:004695; GO:003202; GO:004547	cytosol	GO:000582	 Butanoate metabolism; Valine, leucine and isoleucine degradation	hsa0065; hsa0028	butyrate-CoA ligase activity;ATP binding;protein binding;acetoacetate-CoA ligase activity	GO:004776; GO:000552; GO:000551; GO:003072
XP_020928176.1	XP_020928176.1	XP_020928176.1 TP53-regulated inhibitor of apoptosis 1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5532300	0	0	0	NA	NA	NA	TRIAP1	TRIAP1;NA;NA;NA;NA	regulation of apoptotic process;positive regulation of phospholipid transport;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator;cellular response to UV;regulation of membrane lipid distribution;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of apoptotic process;phospholipid transport;positive regulation of transcription from RNA polymerase II promoter;negative regulation of release of cytochrome c from mitochondria	GO:004298; GO:200114; GO:000697; GO:003033; GO:003464; GO:009703; GO:190216; GO:000691; GO:004315; GO:004306; GO:001591; GO:004594; GO:009020	mitochondrion;perinuclear region of cytoplasm;mitochondrial intermembrane space;macromolecular complex;nucleoplasm	GO:000573; GO:004847; GO:000575; GO:003299; GO:000565	"NA"	"NA"	p53 binding;phosphatidic acid transporter activity;protein binding	GO:000203; GO:199005; GO:000551
XP_020928338.1	XP_020928338.1	XP_020928338.1 sideroflexin-3 [Sus scrofa]	7	7	7	98324000	105770000	85439000	96071000	80563000	87698000	90385000	91179000	78340000	82253000	86943000	123680000	93092000	104820000	99128000	105620000	92854000	118340000	NA	NA	NA	SFXN3	SFXN3;NA;NA;NA;NA	iron ion homeostasis;ion transmembrane transport	GO:005507; GO:003422	mitochondrial membrane;mitochondrion;integral component of membrane	GO:003196; GO:000573; GO:001602	"NA"	"NA"	ion transmembrane transporter activity	GO:001507
XP_020928360.1	XP_020928360.1	XP_020928360.1 GTP-binding nuclear protein Ran [Sus scrofa]	9	9	9	255360000	193320000	262910000	246330000	231900000	230790000	233900000	233650000	300150000	258760000	222270000	302540000	273650000	292100000	242200000	275820000	241990000	215140000	NA	NA	NA	RAN	RAN;NA;NA;NA;NA	mitotic cell cycle;tRNA export from nucleus;protein export from nucleus;positive regulation of transcription, DNA-templated;ribosomal small subunit export from nucleus;cell division;positive regulation of protein binding;protein localization to nucleolus;protein import into nucleus;mitotic spindle organization;androgen receptor signaling pathway;pre-miRNA export from nucleus;DNA metabolic process;viral process;mitotic sister chromatid segregation;GTP metabolic process;snRNA import into nucleus;miRNA metabolic process;regulation of cholesterol biosynthetic process;intracellular transport of virus	GO:000027; GO:000640; GO:000661; GO:004589; GO:000005; GO:005130; GO:003209; GO:190257; GO:000660; GO:000705; GO:003052; GO:003528; GO:000625; GO:001603; GO:000007; GO:004603; GO:006101; GO:001058; GO:004554; GO:007573	nucleus;macromolecular complex;extracellular exosome;Flemming body;nucleolus;midbody;melanosome;cytosol;host cell;nucleoplasm;recycling endosome;nuclear pore;RNA nuclear export complex;membrane;centriole;chromatin;nuclear envelope	GO:000563; GO:003299; GO:007006; GO:009054; GO:000573; GO:003049; GO:004247; GO:000582; GO:004365; GO:000565; GO:005503; GO:000564; GO:004256; GO:001602; GO:000581; GO:000078; GO:000563	 RNA transport; Epstein-Barr virus infection; Ribosome biogenesis in eukaryotes	hsa0301; hsa0516; hsa0300	protein heterodimerization activity;GTPase activity;RNA binding;androgen receptor binding;pre-miRNA binding;protein binding;chromatin binding;nuclear export signal receptor activity;GDP binding;cadherin binding;magnesium ion binding;GTP binding	GO:004698; GO:000392; GO:000372; GO:005068; GO:007088; GO:000551; GO:000368; GO:000504; GO:001900; GO:004529; GO:000028; GO:000552
XP_020928536.1;XP_020928535.1;XP_020928532.1;XP_020928531.1;XP_020928530.1;XP_020928534.1;XP_020928533.1	XP_020928536.1;XP_020928535.1;XP_020928532.1;XP_020928531.1;XP_020928530.1;XP_020928534.1;XP_020928533.1	XP_020928536.1 probable E3 ubiquitin-protein ligase HERC4 isoform X6 [Sus scrofa];XP_020928535.1 probable E3 ubiquitin-protein ligase HERC4 isoform X5 [Sus scrofa];XP_020928532.1 probable E3 ubiquitin-protein ligase HERC4 isoform X2 [Sus scrofa];XP_0209285	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18617000	NA	NA	NA	HERC4	HERC4;HERC4;HERC4;HERC4;HERC4	protein ubiquitination;cell differentiation;spermatogenesis	GO:001656; GO:003015; GO:000728	fibrillar center;cytosol	GO:000165; GO:000582	 Ubiquitin mediated proteolysis	hsa0412	ubiquitin-protein transferase activity	GO:000484
XP_020928659.1	XP_020928659.1	XP_020928659.1 LOW QUALITY PROTEIN: vinexin [Sus scrofa]	7	7	7	0	0	0	17756000	0	0	0	0	0	21641000	0	23218000	20384000	0	0	0	0	0	NA	NA	NA	SORBS3	SORBS3;NA;NA;NA;NA	muscle contraction;actin filament organization;positive regulation of cytoskeleton organization;cell-substrate adhesion;negative regulation of transcription from RNA polymerase II promoter;cell adhesion;positive regulation of MAPK cascade	GO:000693; GO:000701; GO:005149; GO:003158; GO:000012; GO:000715; GO:004341	focal adhesion;nucleus;cytoskeleton;cytosol	GO:000592; GO:000563; GO:000585; GO:000582	"NA"	"NA"	protein binding;vinculin binding;transcription factor binding;structural constituent of cytoskeleton	GO:000551; GO:001716; GO:000813; GO:000520
XP_020928793.1	XP_020928793.1	XP_020928793.1 eIF-2-alpha kinase activator GCN1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	3563500	0	0	0	0	0	NA	NA	NA	GCN1	GCN1;NA;NA;NA;NA	translation;positive regulation of kinase activity;positive regulation of transcription from RNA polymerase II promoter in response to stress;cellular response to leucine starvation;cellular response to amino acid starvation;regulation of translation;regulation of protein kinase activity	GO:000641; GO:003367; GO:003600; GO:199025; GO:003419; GO:000641; GO:004585	cytosol;membrane;cytoplasm;polysome	GO:000582; GO:001602; GO:000573; GO:000584	"NA"	"NA"	translation factor activity, RNA binding;cadherin binding;protein kinase regulator activity;RNA binding;ribosome binding;protein kinase binding	GO:000813; GO:004529; GO:001988; GO:000372; GO:004302; GO:001990
XP_020928802.1;XP_020928801.1;XP_020928800.1;XP_020928799.1;XP_020928795.1;XP_020928794.1;XP_020928803.1;XP_020928798.1;XP_020928797.1;XP_020928796.1	XP_020928802.1;XP_020928801.1;XP_020928800.1;XP_020928799.1;XP_020928795.1;XP_020928794.1;XP_020928803.1;XP_020928798.1;XP_020928797.1;XP_020928796.1	XP_020928802.1 paxillin isoform X7 [Sus scrofa];XP_020928801.1 paxillin isoform X6 [Sus scrofa];XP_020928800.1 paxillin isoform X5 [Sus scrofa];XP_020928799.1 paxillin isoform X4 [Sus scrofa];XP_020928795.1 paxillin isoform X2 [Sus scrofa];XP_020928794.1 p	5	5	5	20410000	22214000	21693000	0	19255000	0	24424000	0	20883000	0	29091000	0	0	0	27361000	0	26813000	23899000	NA	NA	NA	PXN	PXN;PXN;PXN;PXN;PXN	growth hormone receptor signaling pathway;cell-matrix adhesion;transforming growth factor beta receptor signaling pathway;endothelial cell migration;cell adhesion;vascular endothelial growth factor receptor signaling pathway;positive regulation of stress fiber assembly;muscle contraction;cellular response to reactive oxygen species	GO:006039; GO:000716; GO:000717; GO:004354; GO:000715; GO:004801; GO:005149; GO:000693; GO:003461	focal adhesion;plasma membrane;microtubule associated complex;cell cortex;cytosol;lamellipodium;stress fiber	GO:000592; GO:000588; GO:000587; GO:000593; GO:000582; GO:003002; GO:000172	 Chemokine signaling pathway; Leukocyte transendothelial migration; Focal adhesion; Regulation of actin cytoskeleton; Bacterial invasion of epithelial cells; VEGF signaling pathway; Viral carcinogenesis	hsa0406; hsa0467; hsa0451; hsa0481; hsa0510; hsa0437; hsa0520	integrin binding;vinculin binding;metal ion binding;neuropilin binding;protein binding;protein kinase binding;beta-catenin binding;ubiquitin protein ligase binding	GO:000517; GO:001716; GO:004687; GO:003819; GO:000551; GO:001990; GO:000801; GO:003162
XP_020928809.1	XP_020928809.1	XP_020928809.1 catechol O-methyltransferase domain-containing protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	6482300	0	0	0	0	0	0	0	0	0	NA	NA	NA	COMTD1	COMTD1;NA;NA;NA;NA	methylation	GO:003225	integral component of membrane	GO:001602	"NA"	"NA"	protein binding;O-methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity	GO:000551; GO:000817; GO:000875
XP_020928882.1	XP_020928882.1	XP_020928882.1 CDGSH iron-sulfur domain-containing protein 1 [Sus scrofa]	2	2	2	50852000	49865000	66870000	0	47404000	0	58087000	50551000	57610000	45936000	0	0	0	30080000	0	55616000	44509000	0	NA	NA	NA	CISD1	CISD1;NA;NA;NA;NA	regulation of cellular respiration	GO:004345	mitochondrion;integral component of membrane;cytoplasmic side of mitochondrial outer membrane	GO:000573; GO:001602; GO:003247	"NA"	"NA"	identical protein binding;metal ion binding;2 iron, 2 sulfur cluster binding	GO:004280; GO:004687; GO:005153
XP_020928973.1;XP_020928969.1;XP_020928972.1;XP_020928971.1;XP_020928968.1;XP_020928970.1;XP_020928154.1;XP_020928153.1;XP_020928152.1;XP_020928151.1;XP_020928150.1;XP_020928149.1;XP_020928148.1;XP_013838752.1	XP_020928973.1;XP_020928969.1;XP_020928972.1;XP_020928971.1;XP_020928968.1;XP_020928970.1	XP_020928973.1 palladin isoform X5 [Sus scrofa];XP_020928969.1 palladin isoform X2 [Sus scrofa];XP_020928972.1 palladin isoform X4 [Sus scrofa];XP_020928971.1 palladin isoform X4 [Sus scrofa];XP_020928968.1 palladin isoform X1 [Sus scrofa];XP_020928970.1 p	16	16	16	0	75382000	94709000	39419000	0	105560000	0	83328000	14273000	220250000	64013000	128290000	338580000	53498000	18051000	55446000	34738000	39730000	NA	NA	NA	PALLD	PALLD;PALLD;PALLD;PALLD;PALLD	dendrite self-avoidance;actin cytoskeleton organization;cell migration;cytoskeleton organization;axon guidance;keratinocyte development;epithelial cell morphogenesis;homophilic cell adhesion via plasma membrane adhesion molecules	GO:007059; GO:003003; GO:001647; GO:000701; GO:000741; GO:000333; GO:000338; GO:000715	actin filament;actin cytoskeleton;plasma membrane;cytosol;nucleus;axon;Z disc;podosome;focal adhesion;ruffle;lamellipodium	GO:000588; GO:001562; GO:000588; GO:000582; GO:000563; GO:003042; GO:003001; GO:000210; GO:000592; GO:000172; GO:003002	"NA"	"NA"	muscle alpha-actinin binding;protein binding;actin binding;protein binding involved in cell-cell adhesion	GO:005137; GO:000551; GO:000377; GO:009863
XP_020929060.1;XP_020929058.1;XP_013839241.2;XP_020929056.1;XP_020929057.1	XP_020929060.1;XP_020929058.1;XP_013839241.2;XP_020929056.1;XP_020929057.1	XP_020929060.1 heat shock 70 kDa protein 12A isoform X4 [Sus scrofa];XP_020929058.1 heat shock 70 kDa protein 12A isoform X3 [Sus scrofa];XP_013839241.2 heat shock 70 kDa protein 12A isoform X5 [Sus scrofa];XP_020929056.1 heat shock 70 kDa protein 12A isof	24	24	22	547060000	760970000	534170000	532940000	472660000	381090000	610670000	679070000	476160000	517840000	548520000	457050000	247530000	586090000	519960000	667890000	552090000	499920000	NA	NA	NA	HSPA12A	HSPA12A;HSPA12A;HSPA12A;HSPA12A;HSPA12A	biological_process	GO:000815	extracellular exosome	GO:007006	"NA"	"NA"	ATP binding;molecular_function	GO:000552; GO:000367
XP_020929117.1	XP_020929117.1	XP_020929117.1 LOW QUALITY PROTEIN: BAG family molecular chaperone regulator 3 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	15090000	0	0	0	0	0	0	0	0	NA	NA	NA	BAG3	BAG3;NA;NA;NA;NA	extrinsic apoptotic signaling pathway via death domain receptors;regulation of catalytic activity;regulation of cellular response to heat;cellular response to unfolded protein;positive regulation of protein export from nucleus;positive regulation of aggrephagy;autophagosome assembly;negative regulation of apoptotic process;protein stabilization;cellular response to mechanical stimulus;chaperone-mediated protein transport;cellular response to heat;brain development;protein folding;spinal cord development;positive regulation of protein import into nucleus;chaperone-mediated autophagy;negative regulation of transcription from RNA polymerase II promoter in response to stress;protein transport along microtubule;muscle cell cellular homeostasis;extrinsic apoptotic signaling pathway in absence of ligand;negative regulation of striated muscle cell apoptotic process;aggresome assembly;negative regulation of protein targeting to mitochondrion	GO:000862; GO:005079; GO:190003; GO:003462; GO:004682; GO:190533; GO:000004; GO:004306; GO:005082; GO:007126; GO:007232; GO:003460; GO:000742; GO:000645; GO:002151; GO:004230; GO:006168; GO:009720; GO:009884; GO:004671; GO:009719; GO:001066; GO:007084; GO:190321	chaperone complex;plasma membrane;nucleus;neuron projection;cytoplasm;cytosol;aggresome;stress fiber;Z disc	GO:010103; GO:000588; GO:000563; GO:004300; GO:000573; GO:000582; GO:001623; GO:000172; GO:003001	"NA"	"NA"	chaperone binding;protein transporter activity;protein binding;adenyl-nucleotide exchange factor activity;cadherin binding;macromolecular complex binding;dynein intermediate chain binding	GO:005108; GO:000856; GO:000551; GO:000077; GO:004529; GO:004487; GO:004550
XP_020929150.1	XP_020929150.1	XP_020929150.1 up-regulated during skeletal muscle growth protein 5 [Sus scrofa]	2	2	2	121880000	0	0	0	69872000	0	66226000	0	72909000	0	47055000	0	0	0	0	0	0	0	NA	NA	NA	ATP5MD	ATP5MD;NA;NA;NA;NA	"NA"	"NA"	integral component of membrane;mitochondrion;mitochondrial proton-transporting ATP synthase complex	GO:001602; GO:000573; GO:000575	"NA"	"NA"	"NA"	"NA"
XP_020929231.1;XP_013845712.1;XP_013845711.1;XP_020929232.1	XP_020929231.1;XP_013845712.1;XP_013845711.1;XP_020929232.1	XP_020929231.1 exportin-7 isoform X3 [Sus scrofa];XP_013845712.1 exportin-7 isoform X2 [Sus scrofa];XP_013845711.1 exportin-7 isoform X1 [Sus scrofa];XP_020929232.1 exportin-7 isoform X4 [Sus scrofa]	5	5	5	0	0	12543000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	XPO7	XPO7;XPO7;XPO7;XPO7;NA	protein export from nucleus;mRNA transport	GO:000661; GO:005102	nuclear pore;cytoplasm;nucleus	GO:000564; GO:000573; GO:000563	"NA"	"NA"	nuclear export signal receptor activity;protein binding;Ran GTPase binding	GO:000504; GO:000551; GO:000853
XP_020929339.1	XP_020929339.1	XP_020929339.1 LOW QUALITY PROTEIN: 2-5-oligoadenylate synthase 1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	14541000	0	0	0	0	0	0	0	0	0	NA	NA	NA	OAS1	OAS1;NA;NA;NA;NA	negative regulation of viral genome replication;regulation of ribonuclease activity;response to virus;glucose metabolic process;interferon-gamma-mediated signaling pathway;defense response to virus;glucose homeostasis	GO:004507; GO:006070; GO:000961; GO:000600; GO:006033; GO:005160; GO:004259	nucleus;mitochondrion;extracellular region;endoplasmic reticulum;nucleoplasm;cytosol	GO:000563; GO:000573; GO:000557; GO:000578; GO:000565; GO:000582	 Hepatitis C; Influenza A	hsa0516; hsa0516	ATP binding;metal ion binding;protein binding;2'-5'-oligoadenylate synthetase activity;double-stranded RNA binding	GO:000552; GO:004687; GO:000551; GO:000173; GO:000372
XP_020929374.1	XP_020929374.1	XP_020929374.1 pancreatic lipase-related protein 3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14786000	0	NA	NA	NA	PNLIPRP3	PNLIPRP3;NA;NA;NA;NA	lipid catabolic process	GO:001604	extracellular region	GO:000557	 Glycerolipid metabolism; Metabolic pathways	hsa0056; hsa0110	triglyceride lipase activity	GO:000480
XP_020929418.1;XP_020929417.1	XP_020929418.1;XP_020929417.1	XP_020929418.1 nidogen-1 isoform X2 [Sus scrofa];XP_020929417.1 nidogen-1 isoform X1 [Sus scrofa]	49	48	48	2438500000	2545900000	2544200000	2518200000	2190200000	1575500000	2585600000	2873000000	2092000000	2130900000	2516400000	3857600000	1230200000	2434400000	2689800000	2953200000	1953800000	2026300000	NA	NA	NA	NID1	NID1;NID1;NA;NA;NA	positive regulation of cell-substrate adhesion;cell-matrix adhesion;extracellular matrix organization;glomerular basement membrane development;basement membrane organization	GO:001081; GO:000716; GO:003019; GO:003283; GO:007171	cell periphery;basement membrane;extracellular exosome;extracellular region	GO:007194; GO:000560; GO:007006; GO:000557	"NA"	"NA"	collagen binding;calcium ion binding;extracellular matrix structural constituent;laminin binding;proteoglycan binding	GO:000551; GO:000550; GO:000520; GO:004323; GO:004339
XP_020929498.1;XP_020929497.1;XP_020929496.1;XP_020929495.1;XP_020929494.1;XP_020929493.1;XP_020929492.1;XP_020929491.1;XP_020929490.1	XP_020929498.1;XP_020929497.1;XP_020929496.1;XP_020929495.1;XP_020929494.1;XP_020929493.1;XP_020929492.1;XP_020929491.1;XP_020929490.1	XP_020929498.1 acyl-CoA dehydrogenase family member 10 isoform X7 [Sus scrofa];XP_020929497.1 acyl-CoA dehydrogenase family member 10 isoform X6 [Sus scrofa];XP_020929496.1 acyl-CoA dehydrogenase family member 10 isoform X5 [Sus scrofa];XP_020929495.1 acyl	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ACAD10	ACAD10;ACAD10;ACAD10;ACAD10;ACAD10	fatty acid beta-oxidation	GO:000663	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	"NA"	"NA"	acyl-CoA dehydrogenase activity;hydrolase activity;flavin adenine dinucleotide binding	GO:000399; GO:001678; GO:005066
XP_020929515.1;XP_020929514.1;XP_020929513.1;XP_020929512.1;XP_020929511.1	XP_020929515.1;XP_020929514.1;XP_020929513.1;XP_020929512.1;XP_020929511.1	XP_020929515.1 myoferlin isoform X5 [Sus scrofa];XP_020929514.1 myoferlin isoform X4 [Sus scrofa];XP_020929513.1 myoferlin isoform X3 [Sus scrofa];XP_020929512.1 myoferlin isoform X2 [Sus scrofa];XP_020929511.1 myoferlin isoform X1 [Sus scrofa]	21	21	21	16420000	78187000	38371000	60799000	0	137560000	38509000	57578000	0	64680000	26197000	45256000	73831000	66715000	0	53967000	11610000	130610000	NA	NA	NA	MYOF	MYOF;MYOF;MYOF;MYOF;MYOF	muscle fiber development;blood circulation;T-tubule organization;cellular response to heat;plasma membrane repair;muscle contraction;glycerol metabolic process;regulation of vascular endothelial growth factor receptor signaling pathway;myoblast fusion	GO:004874; GO:000801; GO:003329; GO:003460; GO:000177; GO:000693; GO:000607; GO:003094; GO:000752	cytoplasmic vesicle membrane;intracellular membrane-bounded organelle;nuclear membrane;integral component of membrane;nuclear envelope;caveola;cytoplasmic vesicle;plasma membrane;extracellular exosome	GO:003065; GO:004323; GO:003196; GO:001602; GO:000563; GO:000590; GO:003141; GO:000588; GO:007006	"NA"	"NA"	phospholipid binding;protein binding	GO:000554; GO:000551
XP_020929600.1;XP_020929599.1	XP_020929600.1;XP_020929599.1	XP_020929600.1 serine/threonine-protein phosphatase PGAM5, mitochondrial isoform X2 [Sus scrofa];XP_020929599.1 serine/threonine-protein phosphatase PGAM5, mitochondrial isoform X1 [Sus scrofa]	5	5	5	0	0	27567000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PGAM5	PGAM5;PGAM5;NA;NA;NA	necroptotic process;macroautophagy;positive regulation of GTPase activity;protein dephosphorylation	GO:007026; GO:001623; GO:004354; GO:000647	mitochondrial outer membrane;mitochondrion;integral component of membrane	GO:000574; GO:000573; GO:001602	 TNF signaling pathway	hsa0466	protein binding;phosphatase activity;macromolecular complex binding;GTPase activator activity;protein serine/threonine phosphatase activity	GO:000551; GO:001679; GO:004487; GO:000509; GO:000472
XP_020929649.1	XP_020929649.1	XP_020929649.1 angiotensinogen [Sus scrofa]	22	22	22	497970000	732520000	232100000	460130000	484190000	727610000	314260000	412870000	315460000	380730000	471800000	663790000	348510000	640190000	349080000	516600000	521850000	832590000	NA	NA	NA	AGT	AGT;NA;NA;NA;NA	regulation of cell growth;renin-angiotensin regulation of aldosterone production;phospholipase C-activating G-protein coupled receptor signaling pathway;positive regulation of macrophage derived foam cell differentiation;positive regulation of transcription, DNA-templated;cellular response to mechanical stimulus;low-density lipoprotein particle remodeling;positive regulation of blood pressure;regulation of long-term neuronal synaptic plasticity;positive regulation of L-lysine import into cell;positive regulation of cytokine production;blood vessel remodeling;regulation of blood vessel diameter by renin-angiotensin;renal system process;regulation of renal sodium excretion;positive regulation of endothelial cell migration;positive regulation of neuron projection development;negative regulation of angiogenesis;regulation of vasoconstriction;cytokine secretion;regulation of transmission of nerve impulse;kidney development;cell surface receptor signaling pathway;nitric oxide mediated signal transduction;associative learning;positive regulation of cardiac muscle hypertrophy;positive regulation of cardiac muscle cell apoptotic process;negative regulation of tissue remodeling;positive regulation of insulin receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;angiotensin-mediated drinking behavior;aging;artery smooth muscle contraction;regulation of lipid metabolic process;response to estradiol;positive regulation of superoxide anion generation;operant conditioning;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of neurotrophin TRK receptor signaling pathway;regulation of calcium ion transport;positive regulation of protein tyrosine kinase activity;positive regulation of gap junction assembly;cellular response to angiotensin;regulation of heart rate;positive regulation of extracellular matrix constituent secretion;G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger;regulation of blood pressure;positive regulation of activation of Janus kinase activity;positive regulation of NAD(P)H oxidase activity;fibroblast proliferation;smooth muscle cell proliferation;uterine smooth muscle contraction;regulation of cardiac conduction;protein import into nucleus;positive regulation of reactive oxygen species metabolic process;negative regulation of endopeptidase activity;regulation of norepinephrine secretion;response to muscle activity involved in regulation of muscle adaptation;positive regulation of epidermal growth factor receptor signaling pathway;regulation of extracellular matrix assembly;positive regulation of vascular associated smooth muscle cell migration;positive regulation of L-arginine import across plasma membrane;cellular sodium ion homeostasis;regulation of receptor activity;positive regulation of cholesterol esterification;vasodilation;positive regulation of nitric oxide biosynthetic process;positive regulation of inflammatory response;cell growth involved in cardiac muscle cell development;ERK1 and ERK2 cascade;positive regulation of extrinsic apoptotic signaling pathway;G-protein coupled receptor signaling pathway;negative regulation of cell growth;positive regulation of cellular protein metabolic process;regulation of cell proliferation;stress-activated MAPK cascade;positive regulation of branching involved in ureteric bud morphogenesis;positive regulation of vascular smooth muscle cell proliferation	GO:000155; GO:000201; GO:000720; GO:001074; GO:004589; GO:007126; GO:003437; GO:004577; GO:004816; GO:190501; GO:000181; GO:000197; GO:000203; GO:000301; GO:003581; GO:001059; GO:001097; GO:001652; GO:001922; GO:005066; GO:005196; GO:000182; GO:000716; GO:000726; GO:000830; GO:001061; GO:001066; GO:003410; GO:004662; GO:005109; GO:000305; GO:000756; GO:001482; GO:001921; GO:003235; GO:003293; GO:003510; GO:005073; GO:005138; GO:005192; GO:006109; GO:190359; GO:190438; GO:000202; GO:000333; GO:000719; GO:000821; GO:001053; GO:003386; GO:004814; GO:004865; GO:007047; GO:190377; GO:000660; GO:200037; GO:001095; GO:001406; GO:001487; GO:004574; GO:190120; GO:190475; GO:190558; GO:000688; GO:001046; GO:001087; GO:004231; GO:004542; GO:005072; GO:006104; GO:007037; GO:200123; GO:000718; GO:003030; GO:003227; GO:004212; GO:005140; GO:009019; GO:190470	cytosol;blood microparticle;extracellular space;extracellular exosome;extracellular region	GO:000582; GO:007256; GO:000561; GO:007006; GO:000557	 Renin secretion; Renin-angiotensin system	hsa0492; hsa0461	serine-type endopeptidase inhibitor activity;type 2 angiotensin receptor binding;growth factor activity;protein binding;hormone activity	GO:000486; GO:003170; GO:000808; GO:000551; GO:000517
XP_020929774.1;XP_020929773.1	XP_020929774.1;XP_020929773.1	XP_020929774.1 lysyl oxidase homolog 2 [Sus scrofa];XP_020929773.1 lysyl oxidase homolog 2 [Sus scrofa]	3	3	3	9697300	16064000	0	0	13559000	0	0	14003000	0	10714000	0	22256000	0	0	0	16530000	0	0	NA	NA	NA	LOXL2	LOXL2;LOXL2;NA;NA;NA	positive regulation of epithelial to mesenchymal transition;collagen fibril organization;aging;negative regulation of transcription, DNA-templated;peptidyl-lysine oxidation;negative regulation of transcription from RNA polymerase II promoter;response to hypoxia;receptor-mediated endocytosis;endothelial cell migration;response to copper ion;cell adhesion;electron transport chain;cellular protein modification process;negative regulation of stem cell population maintenance;epithelial to mesenchymal transition;sprouting angiogenesis;positive regulation of chondrocyte differentiation;endothelial cell proliferation;heterochromatin organization	GO:001071; GO:003019; GO:000756; GO:004589; GO:001805; GO:000012; GO:000166; GO:000689; GO:004354; GO:004668; GO:000715; GO:002290; GO:000646; GO:190245; GO:000183; GO:000204; GO:003233; GO:000193; GO:007082	membrane;basement membrane;chromatin;nucleus;nucleoplasm;endoplasmic reticulum;extracellular space	GO:001602; GO:000560; GO:000078; GO:000563; GO:000565; GO:000578; GO:000561	"NA"	"NA"	protein binding;calcium ion binding;scavenger receptor activity;protein-lysine 6-oxidase activity;electron carrier activity;oligosaccharide binding	GO:000551; GO:000550; GO:000504; GO:000472; GO:000905; GO:007049
XP_020929831.1;XP_020929818.1;XP_020929809.1;XP_020929832.1;XP_020929817.1;XP_020929816.1;XP_020929815.1;XP_020929813.1;XP_020929812.1;XP_020929811.1;XP_020929810.1;XP_020929808.1;XP_020929807.1;XP_020929805.1;XP_020929803.1;XP_020929828.1;XP_020929827.1;XP_020929826.1;XP_020929825.1;XP_020929823.1;XP_020929821.1;XP_020929820.1;XP_020929802.1;XP_020929800.1;XP_020929799.1;XP_020929796.1;XP_020929794.1;XP_020929792.1;XP_020929791.1;XP_020929793.1;XP_020929790.1;XP_020929789.1;XP_020929787.1;XP_020929786.1;XP_020929785.1;XP_020929834.1;XP_005671391.2;XP_020929829.1;XP_020929824.1;XP_020929801.1;XP_020929798.1;XP_020929795.1;XP_020929833.1;XP_020929797.1;XP_020929806.1;XP_020929804.1;XP_020929814.1;XP_020929822.1;XP_020929835.1;XP_005671392.2	XP_020929831.1;XP_020929818.1;XP_020929809.1;XP_020929832.1;XP_020929817.1;XP_020929816.1;XP_020929815.1;XP_020929813.1;XP_020929812.1;XP_020929811.1;XP_020929810.1;XP_020929808.1;XP_020929807.1;XP_020929805.1;XP_020929803.1;XP_020929828.1;XP_020929827.1;XP_020929826.1;XP_020929825.1;XP_020929823.1;XP_020929821.1;XP_020929820.1;XP_020929802.1;XP_020929800.1;XP_020929799.1;XP_020929796.1;XP_020929794.1;XP_020929792.1;XP_020929791.1;XP_020929793.1;XP_020929790.1;XP_020929789.1;XP_020929787.1;XP_020929786.1;XP_020929785.1;XP_020929834.1;XP_005671391.2;XP_020929829.1;XP_020929824.1;XP_020929801.1;XP_020929798.1;XP_020929795.1;XP_020929833.1;XP_020929797.1;XP_020929806.1;XP_020929804.1;XP_020929814.1;XP_020929822.1;XP_020929835.1;XP_005671392.2	XP_020929831.1 sorbin and SH3 domain-containing protein 1 isoform X43 [Sus scrofa];XP_020929818.1 sorbin and SH3 domain-containing protein 1 isoform X32 [Sus scrofa];XP_020929809.1 sorbin and SH3 domain-containing protein 1 isoform X23 [Sus scrofa];XP_0209	32	32	31	281190000	645660000	345580000	549050000	209330000	384240000	297550000	649660000	296650000	550930000	340920000	865720000	311040000	510020000	391430000	709990000	254100000	573580000	NA	NA	NA	SORBS1	SORBS1;SORBS1;SORBS1;SORBS1;SORBS1	positive regulation of lipid biosynthetic process;muscle contraction;cell-matrix adhesion;positive regulation of glycogen biosynthetic process;cellular response to insulin stimulus;positive regulation of insulin receptor signaling pathway;positive regulation of glucose import;insulin receptor signaling pathway;stress fiber assembly;focal adhesion assembly;positive regulation of protein localization to plasma membrane	GO:004688; GO:000693; GO:000716; GO:004572; GO:003286; GO:004662; GO:004632; GO:000828; GO:004314; GO:004804; GO:190307	nucleus;centrosome;cell-cell adherens junction;insulin receptor complex;nuclear matrix;stress fiber;membrane raft;plasma membrane;cytosol;cell-substrate adherens junction	GO:000563; GO:000581; GO:000591; GO:000589; GO:001636; GO:000172; GO:004512; GO:000588; GO:000582; GO:000592	 Insulin signaling pathway; PPAR signaling pathway; Adherens junction	hsa0491; hsa0332; hsa0452	protein binding;cytoskeletal protein binding;actin binding;SH3/SH2 adaptor activity;insulin receptor binding	GO:000551; GO:000809; GO:000377; GO:000507; GO:000515
XP_020930056.1;XP_020930054.1	XP_020930056.1;XP_020930054.1	XP_020930056.1 tubulin-specific chaperone E isoform X2 [Sus scrofa];XP_020930054.1 tubulin-specific chaperone E isoform X1 [Sus scrofa]	4	4	4	6170800	6173000	7016100	7336300	5042800	0	0	6728000	0	6864300	0	0	0	0	5154100	5400800	0	0	NA	NA	NA	TBCE	TBCE;TBCE;NA;NA;NA	mitotic spindle organization;post-chaperonin tubulin folding pathway;microtubule cytoskeleton organization;protein folding	GO:000705; GO:000702; GO:000022; GO:000645	microtubule;cytoplasm	GO:000587; GO:000573	"NA"	"NA"	protein binding;chaperone binding	GO:000551; GO:005108
XP_020930478.1;XP_020930479.1;XP_020951555.1	XP_020930478.1;XP_020930479.1;XP_020951555.1	XP_020930478.1 phenylalanine--tRNA ligase beta subunit isoform X1 [Sus scrofa];XP_020930479.1 phenylalanine--tRNA ligase beta subunit isoform X2 [Sus scrofa];XP_020951555.1 LOW QUALITY PROTEIN: phenylalanine--tRNA ligase beta subunit-like [Sus scrofa]	14	14	14	66094000	60865000	69428000	75286000	72619000	75344000	71761000	53375000	74291000	80817000	66358000	99313000	69948000	72224000	64540000	57871000	73897000	72955000	NA	NA	NA	FARSB	FARSB;FARSB;LOC110261142;NA;NA	protein heterotetramerization;translation;phenylalanyl-tRNA aminoacylation	GO:005129; GO:000641; GO:000643	cytoplasm;cytosol;membrane;phenylalanine-tRNA ligase complex	GO:000573; GO:000582; GO:001602; GO:000932	 Aminoacyl-tRNA biosynthesis	hsa0097	phenylalanine-tRNA ligase activity;RNA binding;protein binding;ATP binding;magnesium ion binding	GO:000482; GO:000372; GO:000551; GO:000552; GO:000028
XP_020930480.1	XP_020930480.1	XP_020930480.1 LOW QUALITY PROTEIN: D-2-hydroxyglutarate dehydrogenase, mitochondrial [Sus scrofa]	4	4	4	8754700	8183900	6873600	0	0	0	8315300	8458000	9041400	0	8772700	8472300	0	0	0	7785300	0	7798100	NA	NA	NA	D2HGDH	D2HGDH;NA;NA;NA;NA	cellular protein metabolic process;2-oxoglutarate metabolic process;respiratory electron transport chain;response to magnesium ion;response to zinc ion;lactate oxidation;response to calcium ion	GO:004426; GO:000610; GO:002290; GO:003202; GO:001004; GO:001951; GO:005159	extrinsic component of cytoplasmic side of plasma membrane;mitochondrion;mitochondrial matrix	GO:003123; GO:000573; GO:000575	"NA"	"NA"	(R)-2-hydroxyglutarate dehydrogenase activity;FAD binding;D-lactate dehydrogenase (cytochrome) activity	GO:005199; GO:007194; GO:000445
XP_020930487.1	XP_020930487.1	XP_020930487.1 LOW QUALITY PROTEIN: Golgi reassembly-stacking protein 2 [Sus scrofa]	3	3	3	18446000	0	24105000	24514000	0	16765000	22787000	0	0	0	0	34365000	0	0	0	0	0	23666000	NA	NA	NA	GORASP2	GORASP2;NA;NA;NA;NA	response to endoplasmic reticulum stress;organelle organization;Golgi organization;organelle assembly;spermatogenesis;cell differentiation	GO:003497; GO:000699; GO:000703; GO:007092; GO:000728; GO:003015	Golgi apparatus;membrane;Golgi membrane;endoplasmic reticulum membrane	GO:000579; GO:001602; GO:000013; GO:000578	"NA"	"NA"	protein binding	GO:000551
XP_020930619.1;XP_020930618.1;REV__XP_020945375.1;REV__XP_020945374.1;REV__XP_020945373.1;REV__XP_020945372.1;REV__XP_020945371.1;REV__XP_020945370.1;REV__XP_020945369.1;REV__XP_020945368.1	XP_020930619.1;XP_020930618.1	XP_020930619.1 nucleolin isoform X2 [Sus scrofa];XP_020930618.1 nucleolin isoform X1 [Sus scrofa]	18	18	18	54769000	237220000	133330000	152580000	117020000	189700000	99860000	135920000	174730000	112690000	163460000	136270000	226900000	145560000	222190000	121000000	151140000	237330000	NA	NA	NA	NCL	NCL;NCL;NA;NA;NA	cellular response to epidermal growth factor stimulus;angiogenesis;negative regulation of translation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter;cellular response to leukemia inhibitory factor	GO:007136; GO:000152; GO:001714; GO:004594; GO:190183; GO:199083	nucleus;nucleoplasm;cytoplasmic ribonucleoprotein granule;extracellular exosome;ribonucleoprotein complex;membrane;cell cortex;nucleolus	GO:000563; GO:000565; GO:003646; GO:007006; GO:199090; GO:001602; GO:000593; GO:000573	 Pathogenic Escherichia coli infection	hsa0513	protein binding;identical protein binding;mRNA 5'-UTR binding;protein C-terminus binding;telomeric DNA binding;DNA topoisomerase binding;RNA binding	GO:000551; GO:004280; GO:004802; GO:000802; GO:004216; GO:004454; GO:000372
XP_020930641.1;XP_020930640.1;XP_020930639.1;XP_020930638.1;XP_020930637.1;XP_020930636.1;XP_020930635.1	XP_020930641.1;XP_020930640.1;XP_020930639.1;XP_020930638.1;XP_020930637.1;XP_020930636.1;XP_020930635.1	XP_020930641.1 secernin-3 isoform X3 [Sus scrofa];XP_020930640.1 secernin-3 isoform X3 [Sus scrofa];XP_020930639.1 secernin-3 isoform X2 [Sus scrofa];XP_020930638.1 secernin-3 isoform X2 [Sus scrofa];XP_020930637.1 secernin-3 isoform X2 [Sus scrofa];XP_020	3	3	3	20448000	17151000	10956000	11070000	10472000	11372000	17876000	11875000	12261000	0	7915500	10770000	11479000	13187000	16391000	0	16252000	13665000	NA	NA	NA	SCRN3	SCRN3;SCRN3;SCRN3;SCRN3;SCRN3	proteolysis;exocytosis	GO:000650; GO:000688	"NA"	"NA"	"NA"	"NA"	dipeptidase activity	GO:001680
XP_020930776.1	XP_020930776.1	XP_020930776.1 peroxisomal trans-2-enoyl-CoA reductase [Sus scrofa]	6	6	6	82292000	0	16854000	0	28414000	0	21765000	0	49973000	14974000	0	0	0	0	12978000	15588000	0	0	NA	NA	NA	PECR	PECR;NA;NA;NA;NA	oxidation-reduction process;protein targeting to peroxisome;fatty acid biosynthetic process;phytol metabolic process;fatty acid alpha-oxidation	GO:005511; GO:000662; GO:000663; GO:003330; GO:000156	cytosol;peroxisome;mitochondrion	GO:000582; GO:000577; GO:000573	 Biosynthesis of unsaturated fatty acids; Peroxisome; Fatty acid metabolism	hsa0104; hsa0414; hsa0121	receptor binding;2,4-dienoyl-CoA reductase (NADPH) activity;trans-2-enoyl-CoA reductase (NADPH) activity	GO:000510; GO:000867; GO:001916
XP_020930866.1;XP_020935019.1;XP_020935018.1;XP_020935017.1;XP_020935016.1;XP_020935015.1;XP_020935013.1;XP_013841250.2;XP_020935014.1;XP_020935012.1;XP_020935011.1	XP_020930866.1	XP_020930866.1 LOW QUALITY PROTEIN: tensin-1 [Sus scrofa]	54	54	52	969040000	1603800000	880870000	1438900000	547390000	994230000	837690000	1636500000	802400000	1487500000	945130000	1888000000	846440000	1355200000	972040000	1653200000	802330000	1174000000	NA	NA	NA	TNS1	TNS1;NA;NA;NA;NA	fibroblast migration;cell-substrate junction assembly	GO:001076; GO:000704	cytoplasm;cell surface;focal adhesion;cytoskeleton	GO:000573; GO:000998; GO:000592; GO:000585	"NA"	"NA"	protein binding;actin binding;RNA binding	GO:000551; GO:000377; GO:000372
XP_020930925.1;XP_020930924.1;XP_020930923.1;XP_020930922.1;XP_020930921.1;XP_020930920.1;XP_020930919.1;XP_020930918.1;XP_020930917.1;XP_020930916.1;XP_020930915.1	XP_020930925.1;XP_020930924.1;XP_020930923.1;XP_020930922.1;XP_020930921.1;XP_020930920.1;XP_020930919.1;XP_020930918.1;XP_020930917.1;XP_020930916.1;XP_020930915.1	XP_020930925.1 vigilin [Sus scrofa];XP_020930924.1 vigilin [Sus scrofa];XP_020930923.1 vigilin [Sus scrofa];XP_020930922.1 vigilin [Sus scrofa];XP_020930921.1 vigilin [Sus scrofa];XP_020930920.1 vigilin [Sus scrofa];XP_020930919.1 vigilin [Sus scrofa];XP_0	14	14	14	19201000	28983000	18477000	37527000	18431000	29182000	23990000	26939000	23535000	36080000	26254000	34620000	36363000	28895000	23860000	21378000	24928000	40838000	NA	NA	NA	HDLBP	HDLBP;HDLBP;HDLBP;HDLBP;HDLBP	cholesterol metabolic process;high-density lipoprotein particle clearance;lipid transport	GO:000820; GO:003438; GO:000686	nucleus;plasma membrane;high-density lipoprotein particle;cytosol	GO:000563; GO:000588; GO:003436; GO:000582	"NA"	"NA"	protein binding;RNA binding;cadherin binding;lipid binding	GO:000551; GO:000372; GO:004529; GO:000828
XP_020930960.1;XP_020930959.1;XP_020930958.1	XP_020930960.1;XP_020930959.1;XP_020930958.1	XP_020930960.1 neuronal membrane glycoprotein M6-a isoform X3 [Sus scrofa];XP_020930959.1 neuronal membrane glycoprotein M6-a isoform X2 [Sus scrofa];XP_020930958.1 neuronal membrane glycoprotein M6-a isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	12928000	0	20919000	0	0	0	16674000	0	14377000	0	0	0	41804000	0	NA	NA	NA	GPM6A	GPM6A;GPM6A;GPM6A;NA;NA	neuron projection development;neural retina development;stem cell differentiation;neuron projection morphogenesis;response to bacterium;calcium ion transmembrane transport;neuron migration;synapse assembly;regulation of synapse organization;positive regulation of filopodium assembly	GO:003117; GO:000340; GO:004886; GO:004881; GO:000961; GO:007058; GO:000176; GO:000741; GO:005080; GO:005149	filopodium;neuronal cell body;extracellular exosome;integral component of presynaptic active zone membrane;axonal growth cone;plasma membrane;extracellular vesicle;neuron projection;dendritic spine;glutamatergic synapse	GO:003017; GO:004302; GO:007006; GO:009905; GO:004429; GO:000588; GO:190356; GO:004300; GO:004319; GO:009897	"NA"	"NA"	calcium channel activity;protein binding	GO:000526; GO:000551
XP_020931125.1	XP_020931125.1	XP_020931125.1 LOW QUALITY PROTEIN: nebulin [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	26185000	0	NA	NA	NA	NEB	NEB;NA;NA;NA;NA	regulation of actin filament length;somatic muscle development;cardiac muscle thin filament assembly;muscle organ development;muscle fiber development;muscle filament sliding	GO:003083; GO:000752; GO:007169; GO:000751; GO:004874; GO:003004	cytosol;actin cytoskeleton;Z disc;extracellular exosome	GO:000582; GO:001562; GO:003001; GO:007006	"NA"	"NA"	actin filament binding;structural constituent of muscle;protein binding	GO:005101; GO:000830; GO:000551
XP_020931180.1;XP_020931179.1;XP_020931178.1;XP_020931177.1;XP_020931181.1	XP_020931180.1;XP_020931179.1;XP_020931178.1;XP_020931177.1;XP_020931181.1	XP_020931180.1 calcium-binding mitochondrial carrier protein Aralar1 isoform X3 [Sus scrofa];XP_020931179.1 calcium-binding mitochondrial carrier protein Aralar1 isoform X3 [Sus scrofa];XP_020931178.1 calcium-binding mitochondrial carrier protein Aralar1 i	5	3	3	0	0	10940000	0	0	0	0	0	0	0	0	0	15973000	0	0	0	10836000	0	NA	NA	NA	SLC25A12	SLC25A12;SLC25A12;SLC25A12;SLC25A12;SLC25A12	gluconeogenesis;positive regulation of ATP biosynthetic process;glutamate biosynthetic process;L-glutamate transport;positive regulation of myelination;malate-aspartate shuttle;response to calcium ion;negative regulation of glucose catabolic process to lactate via pyruvate;positive regulation of glucose metabolic process;L-aspartate transport	GO:000609; GO:200117; GO:000653; GO:001581; GO:003164; GO:004349; GO:005159; GO:190402; GO:001090; GO:007077	mitochondrion;integral component of membrane;mitochondrial inner membrane	GO:000573; GO:001602; GO:000574	"NA"	"NA"	calcium ion binding;L-aspartate transmembrane transporter activity;acidic amino acid transmembrane transporter activity;L-glutamate transmembrane transporter activity;identical protein binding	GO:000550; GO:001518; GO:001517; GO:000531; GO:004280
XP_020931244.1;XP_020931245.1	XP_020931244.1;XP_020931245.1	XP_020931244.1 cytochrome P450 4V2 isoform X1 [Sus scrofa];XP_020931245.1 cytochrome P450 4V2 isoform X2 [Sus scrofa]	13	13	13	19323000	45326000	26315000	36406000	30698000	27119000	24704000	61994000	47100000	46907000	50773000	57887000	0	83648000	43686000	66545000	41573000	47634000	NA	NA	NA	CYP4V2	CYP4V2;CYP4V2;NA;NA;NA	response to stimulus;fatty acid omega-oxidation;retinoid metabolic process;sterol metabolic process;visual perception	GO:005089; GO:001043; GO:000152; GO:001612; GO:000760	integral component of membrane;endoplasmic reticulum membrane	GO:001602; GO:000578	"NA"	"NA"	iron ion binding;heme binding;monooxygenase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	GO:000550; GO:002003; GO:000449; GO:001670
XP_020931266.1	XP_020931266.1	XP_020931266.1 LOW QUALITY PROTEIN: cytoplasmic FMR1-interacting protein 1 [Sus scrofa]	20	20	11	45522000	63068000	65498000	60441000	61058000	70812000	51699000	68606000	53549000	56505000	44429000	77148000	60677000	55792000	60659000	61223000	47841000	61749000	NA	NA	NA	CYFIP1	CYFIP1;NA;NA;NA;NA	axon guidance;Fc-gamma receptor signaling pathway involved in phagocytosis;dendrite extension;ruffle organization;negative regulation of synaptic vesicle recycling;lamellipodium assembly;regulation of translation at postsynapse, modulating synaptic transmission;positive regulation of dendrite development;positive regulation of Arp2/3 complex-mediated actin nucleation;cell morphogenesis;regulation of translation;Rac protein signal transduction;neutrophil degranulation;positive regulation of neurotrophin TRK receptor signaling pathway;modification of synaptic structure;regulation of modification of postsynaptic actin cytoskeleton;positive regulation of axon extension;vascular endothelial growth factor receptor signaling pathway;response to electrical stimulus;axon extension;regulation of cell shape;cellular response to insulin stimulus;cognition;positive regulation of ruffle assembly	GO:000741; GO:003809; GO:009748; GO:003152; GO:190342; GO:003003; GO:009957; GO:190000; GO:200060; GO:000090; GO:000641; GO:001660; GO:004331; GO:005138; GO:009956; GO:190527; GO:004577; GO:004801; GO:005160; GO:004867; GO:000836; GO:003286; GO:005089; GO:190002	extracellular region;filopodium tip;terminal bouton;dendritic growth cone;ruffle;cytosol;SCAR complex;extracellular exosome;neuron projection;tertiary granule lumen;lamellipodium;neuronal cell body;perinuclear region of cytoplasm;excitatory synapse;mRNA cap binding complex;specific granule lumen;synapse;peripheral region of growth cone;focal adhesion;secretory granule lumen	GO:000557; GO:003243; GO:004319; GO:004429; GO:000172; GO:000582; GO:003120; GO:007006; GO:004300; GO:190472; GO:003002; GO:004302; GO:004847; GO:006007; GO:000584; GO:003558; GO:004520; GO:009072; GO:000592; GO:003477	 RNA transport; Regulation of actin cytoskeleton	hsa0301; hsa0481	protein binding;translation regulator activity;actin filament binding;RNA 7-methylguanosine cap binding;Rac GTPase binding	GO:000551; GO:004518; GO:005101; GO:000034; GO:004836
XP_020931393.1;XP_020931392.1;XP_020920979.1;XP_005668469.1;XP_020920977.1;XP_020920976.1;XP_020920975.1;XP_013835969.1;XP_013835968.1;XP_013835967.1;XP_005668468.1;XP_005668467.1;XP_005668466.1;XP_005668464.1;XP_003131019.2	XP_020931393.1;XP_020931392.1	XP_020931393.1 calcium-binding protein 39 [Sus scrofa];XP_020931392.1 calcium-binding protein 39 [Sus scrofa]	7	7	7	18482000	18378000	19971000	19603000	17140000	18029000	13968000	20636000	17485000	24758000	25159000	0	21918000	22500000	16998000	22463000	20712000	20858000	NA	NA	NA	CAB39	CAB39;CAB39;NA;NA;NA	positive regulation of peptidyl-threonine phosphorylation;positive regulation of protein serine/threonine kinase activity;negative regulation of potassium ion transmembrane transport;activation of protein kinase activity;intracellular signal transduction;signal transduction by protein phosphorylation;cellular hypotonic response;negative regulation of potassium ion transmembrane transporter activity;cell cycle arrest;neutrophil degranulation;peptidyl-serine phosphorylation;protein heterooligomerization	GO:001080; GO:007190; GO:190138; GO:003214; GO:003555; GO:002301; GO:007147; GO:190101; GO:000705; GO:004331; GO:001810; GO:005129	extracellular region;cytosol;extracellular exosome;ficolin-1-rich granule lumen;secretory granule lumen;serine/threonine protein kinase complex	GO:000557; GO:000582; GO:007006; GO:190481; GO:003477; GO:190255	 mTOR signaling pathway; AMPK signaling pathway	hsa0415; hsa0415	protein kinase activator activity;kinase binding;protein serine/threonine kinase activator activity;protein binding;protein serine/threonine kinase activity	GO:003029; GO:001990; GO:004353; GO:000551; GO:000467
XP_020931395.1;XP_020931397.1;XP_020931396.1	XP_020931395.1;XP_020931397.1;XP_020931396.1	XP_020931395.1 cullin-3 isoform X1 [Sus scrofa];XP_020931397.1 cullin-3 isoform X3 [Sus scrofa];XP_020931396.1 cullin-3 isoform X2 [Sus scrofa]	5	5	5	0	8436500	8102100	0	0	0	0	7788800	0	8038200	0	0	0	0	0	8551000	0	0	NA	NA	NA	CUL3	CUL3;CUL3;CUL3;NA;NA	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;COPII vesicle coating;ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome;trophectodermal cellular morphogenesis;ER to Golgi vesicle-mediated transport;cell projection organization;anaphase-promoting complex-dependent catabolic process;protein destabilization;fibroblast apoptotic process;intrinsic apoptotic signaling pathway;protein polyubiquitination;positive regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;MAPK cascade;gastrulation;embryonic cleavage;proteasome-mediated ubiquitin-dependent protein catabolic process;liver morphogenesis;protein ubiquitination;negative regulation of canonical Wnt signaling pathway;integrin-mediated signaling pathway;stem cell division;positive regulation of mitotic metaphase/anaphase transition;mitotic metaphase plate congression;cell migration;post-translational protein modification;G1/S transition of mitotic cell cycle;Wnt signaling pathway;ubiquitin-dependent protein catabolic process;cell cycle arrest;positive regulation of protein ubiquitination;positive regulation of cytokinesis;negative regulation of Rho protein signal transduction;stress fiber assembly	GO:003114; GO:004820; GO:007163; GO:000183; GO:000688; GO:003003; GO:003114; GO:003164; GO:004434; GO:009719; GO:000020; GO:000828; GO:000012; GO:000016; GO:000736; GO:004001; GO:004316; GO:007257; GO:001656; GO:009009; GO:000722; GO:001714; GO:004584; GO:000708; GO:001647; GO:004368; GO:000008; GO:001605; GO:000651; GO:000705; GO:003139; GO:003246; GO:003502; GO:004314	Cul3-RING ubiquitin ligase complex;cytoplasm;polar microtubule;sperm flagellum;nucleoplasm;cullin-RING ubiquitin ligase complex;SCF ubiquitin ligase complex;extracellular exosome;Golgi membrane;membrane	GO:003146; GO:000573; GO:000582; GO:003612; GO:000565; GO:003146; GO:001900; GO:007006; GO:000013; GO:001602	 Ubiquitin mediated proteolysis	hsa0412	protein binding;Notch binding;protein homodimerization activity;protein heterodimerization activity;ubiquitin-protein transferase activity;cyclin binding;POZ domain binding;ubiquitin protein ligase activity;ubiquitin protein ligase binding	GO:000551; GO:000511; GO:004280; GO:004698; GO:000484; GO:003033; GO:003120; GO:006163; GO:003162
XP_020931400.1	XP_020931400.1	XP_020931400.1 LOW QUALITY PROTEIN: collagen alpha-3(VI) chain [Sus scrofa]	117	117	117	3464900000	9143500000	4292900000	13983000000	3836000000	6855600000	6312500000	10584000000	4999600000	7458700000	5967100000	13083000000	10133000000	10488000000	6529900000	11086000000	6331900000	8322900000	NA	NA	NA	COL6A3	COL6A3;NA;NA;NA;NA	negative regulation of endopeptidase activity;extracellular matrix organization;growth plate cartilage chondrocyte morphogenesis;cell adhesion;muscle organ development	GO:001095; GO:003019; GO:000342; GO:000715; GO:000751	extracellular space;extracellular matrix;extracellular exosome;endoplasmic reticulum lumen;extracellular vesicle;extracellular region;collagen type VI trimer;sarcolemma	GO:000561; GO:003101; GO:007006; GO:000578; GO:190356; GO:000557; GO:000558; GO:004238	 PI3K-Akt signaling pathway; Focal adhesion; Protein digestion and absorption	hsa0415; hsa0451; hsa0497	serine-type endopeptidase inhibitor activity;extracellular matrix structural constituent conferring tensile strength	GO:000486; GO:003002
XP_020931433.1;XP_020931432.1	XP_020931433.1;XP_020931432.1	XP_020931433.1 grancalcin isoform X2 [Sus scrofa];XP_020931432.1 grancalcin isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	7700400	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GCA	GCA;GCA;NA;NA;NA	neutrophil degranulation;membrane fusion	GO:004331; GO:006102	plasma membrane;cytosol;azurophil granule lumen;extracellular exosome;extracellular region;cytoplasm	GO:000588; GO:000582; GO:003557; GO:007006; GO:000557; GO:000573	"NA"	"NA"	calcium ion binding;protein heterodimerization activity;protein binding;protein homodimerization activity	GO:000550; GO:004698; GO:000551; GO:004280
XP_020931439.1;XP_020931438.1;XP_020931437.1;XP_020931436.1;XP_020931435.1;XP_020931434.1	XP_020931439.1;XP_020931438.1;XP_020931437.1;XP_020931436.1;XP_020931435.1;XP_020931434.1	XP_020931439.1 glycerol-3-phosphate dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020931438.1 glycerol-3-phosphate dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020931437.1 glycerol-3-phosphate dehydrogenase, mitochondrial isoform X4 [S	12	12	12	49780000	40404000	33730000	24113000	37312000	19488000	50538000	38833000	36956000	34524000	43107000	29980000	34530000	28171000	24977000	31681000	47157000	25543000	NA	NA	NA	GPD2	GPD2;GPD2;GPD2;GPD2;GPD2	gluconeogenesis;glycerophosphate shuttle;multicellular organism growth;glycerol catabolic process;camera-type eye development;glycerol-3-phosphate catabolic process	GO:000609; GO:000612; GO:003526; GO:001956; GO:004301; GO:004616	mitochondrial inner membrane;glycerol-3-phosphate dehydrogenase complex;mitochondrion	GO:000574; GO:000933; GO:000573	 Glycerophospholipid metabolism	hsa0056	calcium ion binding;glycerol-3-phosphate dehydrogenase activity;sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity	GO:000550; GO:000436; GO:005259
XP_020931456.1	XP_020931456.1	XP_020931456.1 LOW QUALITY PROTEIN: nck-associated protein 5 [Sus scrofa]	1	1	1	0	26487000	0	0	0	46672000	0	0	0	24739000	0	0	0	0	0	0	0	0	NA	NA	NA	NCKAP5	NCKAP5;NA;NA;NA;NA	biological_process;microtubule bundle formation;microtubule depolymerization	GO:000815; GO:000157; GO:000701	cellular_component;microtubule plus-end	GO:000557; GO:003537	"NA"	"NA"	"NA"	"NA"
XP_020931469.1;XP_020931470.1;NP_999531.1;XP_020943680.1	XP_020931469.1;XP_020931470.1;NP_999531.1	XP_020931469.1 serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X1 [Sus scrofa];XP_020931470.1 serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X2 [Sus scrofa];NP_999531.1 serine/threonine-protein	7	7	7	62975000	68001000	53326000	56949000	59692000	44650000	51474000	57433000	56655000	48076000	62090000	67559000	44341000	56014000	64358000	52792000	56775000	62102000	NA	NA	NA	PPP2CB	PPP2CB;PPP2CB;PPP2CA;NA;NA	response to lead ion;regulation of gene expression;response to endoplasmic reticulum stress;peptidyl-threonine dephosphorylation;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of Ras protein signal transduction;apoptotic mitochondrial changes;protein dephosphorylation;peptidyl-serine dephosphorylation;response to hydrogen peroxide;positive regulation of microtubule binding	GO:001028; GO:001046; GO:003497; GO:003597; GO:004316; GO:004658; GO:000863; GO:000647; GO:007026; GO:004254; GO:190452	spindle pole;nucleus;chromosome, centromeric region;protein phosphatase type 2A complex;cytosol	GO:000092; GO:000563; GO:000077; GO:000015; GO:000582	 AMPK signaling pathway; Dopaminergic synapse; Chagas disease (American trypanosomiasis); TGF-beta signaling pathway; Tight junction; Hepatitis C; Hippo signaling pathway; Long-term depression; Oocyte meiosis; mRNA surveillance pathway; PI3K-Akt signaling pathway; Sphingolipid signaling pathway; Adrenergic signaling in cardiomyocytes	hsa0415; hsa0472; hsa0514; hsa0435; hsa0453; hsa0516; hsa0439; hsa0473; hsa0411; hsa0301; hsa0415; hsa0407; hsa0426	metal ion binding;protein binding;protein serine/threonine phosphatase activity;protein C-terminus binding;tau protein binding	GO:004687; GO:000551; GO:000472; GO:000802; GO:004815
XP_020931560.1	XP_020931560.1	XP_020931560.1 LOW QUALITY PROTEIN: titin [Sus scrofa]	6	6	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60571000	0	NA	NA	NA	TTN	TTN;NA;NA;NA;NA	mitotic chromosome condensation;protein kinase A signaling;skeletal muscle thin filament assembly;regulation of protein kinase activity;cardiac muscle fiber development;striated muscle myosin thick filament assembly;muscle contraction;cardiac muscle hypertrophy;positive regulation of gene expression;detection of muscle stretch;sarcomerogenesis;cardiac muscle contraction;muscle filament sliding;platelet degranulation;cardiac myofibril assembly;striated muscle contraction;response to calcium ion;peptidyl-tyrosine phosphorylation;sarcomere organization;positive regulation of protein secretion;regulation of catalytic activity	GO:000707; GO:001073; GO:003024; GO:004585; GO:004873; GO:007168; GO:000693; GO:000330; GO:001062; GO:003599; GO:004876; GO:006004; GO:003004; GO:000257; GO:005500; GO:000694; GO:005159; GO:001810; GO:004521; GO:005071; GO:005079	cytosol;sarcomere;extracellular region;M band;I band;condensed nuclear chromosome;striated muscle thin filament;extracellular exosome	GO:000582; GO:003001; GO:000557; GO:003143; GO:003167; GO:000079; GO:000586; GO:007006	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy	hsa0541; hsa0541	protein tyrosine kinase activity;protein self-association;protein binding;protein serine/threonine kinase activity;ATP binding;enzyme binding;telethonin binding;actin filament binding;muscle alpha-actinin binding;protease binding;identical protein binding;calcium ion binding;protein kinase binding;structural molecule activity conferring elasticity;structural constituent of muscle	GO:000471; GO:004362; GO:000551; GO:000467; GO:000552; GO:001989; GO:003143; GO:005101; GO:005137; GO:000202; GO:004280; GO:000550; GO:001990; GO:009749; GO:000830
XP_020931561.1	XP_020931561.1	XP_020931561.1 LOW QUALITY PROTEIN: myomesin-2 [Sus scrofa]	27	27	27	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	294510000	0	NA	NA	NA	MYOM2	MYOM2;NA;NA;NA;NA	extraocular skeletal muscle development;muscle contraction;sarcomere organization;cardiac muscle tissue morphogenesis;skeletal muscle myosin thick filament assembly;cardiac muscle fiber development;striated muscle myosin thick filament assembly	GO:000207; GO:000693; GO:004521; GO:005500; GO:003024; GO:004873; GO:007168	M band;mitochondrion;striated muscle thin filament;sarcomere;myosin filament	GO:003143; GO:000573; GO:000586; GO:003001; GO:003298	"NA"	"NA"	structural constituent of muscle;kinase binding;protein binding;muscle alpha-actinin binding;actin filament binding	GO:000830; GO:001990; GO:000551; GO:005137; GO:005101
XP_020931601.1;XP_020931600.1	XP_020931601.1;XP_020931600.1	XP_020931601.1 UDP-glucose:glycoprotein glucosyltransferase 1 isoform X2 [Sus scrofa];XP_020931600.1 UDP-glucose:glycoprotein glucosyltransferase 1 isoform X1 [Sus scrofa]	16	16	16	64676000	75259000	69154000	72940000	79798000	61971000	64107000	74218000	59895000	62111000	62293000	129660000	84144000	82876000	68055000	79416000	72187000	85204000	NA	NA	NA	UGGT1	UGGT1;UGGT1;NA;NA;NA	protein N-linked glycosylation via asparagine;ER-associated misfolded protein catabolic process;'de novo' posttranslational protein folding;UDP-glucosylation;endoplasmic reticulum mannose trimming	GO:001827; GO:007171; GO:005108; GO:009735; GO:190438	macromolecular complex;endoplasmic reticulum;extracellular exosome;endoplasmic reticulum-Golgi intermediate compartment;endoplasmic reticulum quality control compartment	GO:003299; GO:000578; GO:007006; GO:000579; GO:004432	 Protein processing in endoplasmic reticulum	hsa0414	UDP-glucose:glycoprotein glucosyltransferase activity;unfolded protein binding;protein binding	GO:000398; GO:005108; GO:000551
XP_020931603.1;XP_005654255.1	XP_020931603.1;XP_005654255.1	XP_020931603.1 glypican-1 isoform X1 [Sus scrofa];XP_005654255.1 glypican-1 isoform X2 [Sus scrofa]	7	7	7	0	32933000	30355000	0	32471000	26872000	27671000	35857000	0	28995000	30715000	31512000	23095000	27673000	39913000	49569000	28682000	33283000	NA	NA	NA	GPC1	GPC1;GPC1;NA;NA;NA	glycosaminoglycan catabolic process;positive regulation of skeletal muscle cell differentiation;retinoid metabolic process;myelin assembly;glycosaminoglycan biosynthetic process;axon guidance;Schwann cell differentiation;leukocyte migration;negative regulation of fibroblast growth factor receptor signaling pathway;heparan sulfate proteoglycan catabolic process	GO:000602; GO:200101; GO:000152; GO:003228; GO:000602; GO:000741; GO:001403; GO:005090; GO:004003; GO:003020	synapse;extracellular matrix;intrinsic component of plasma membrane;lysosomal lumen;plasma membrane;extracellular space;Golgi lumen;anchored component of plasma membrane;cytosol;nucleoplasm;endosome;extracellular exosome;extracellular region;membrane raft	GO:004520; GO:003101; GO:003122; GO:004320; GO:000588; GO:000561; GO:000579; GO:004665; GO:000582; GO:000565; GO:000576; GO:007006; GO:000557; GO:004512	 Proteoglycans in cancer	hsa0520	laminin binding;fibroblast growth factor binding;copper ion binding	GO:004323; GO:001713; GO:000550
XP_020931625.1;XP_020931623.1;XP_020931622.1;XP_020931621.1;XP_020931620.1;XP_020931619.1;XP_020931618.1;XP_020931617.1;XP_020931616.1;XP_020931615.1	XP_020931625.1;XP_020931623.1;XP_020931622.1;XP_020931621.1;XP_020931620.1;XP_020931619.1;XP_020931618.1;XP_020931617.1;XP_020931616.1;XP_020931615.1	XP_020931625.1 unconventional myosin-Ib isoform X6 [Sus scrofa];XP_020931623.1 unconventional myosin-Ib isoform X6 [Sus scrofa];XP_020931622.1 unconventional myosin-Ib isoform X5 [Sus scrofa];XP_020931621.1 unconventional myosin-Ib isoform X4 [Sus scrofa];	10	10	9	0	27025000	20760000	24639000	17727000	22988000	20007000	22591000	0	17807000	0	25836000	0	26613000	0	23329000	0	25341000	NA	NA	NA	MYO1B	MYO1B;MYO1B;MYO1B;MYO1B;MYO1B	actin filament bundle assembly;actin filament organization;actin filament-based movement;post-Golgi vesicle-mediated transport	GO:005101; GO:000701; GO:003004; GO:000689	early endosome;brush border;myosin complex;filopodium;cell periphery;plasma membrane;endosome membrane;perinuclear region of cytoplasm;extracellular exosome;cytoplasm;trans-Golgi network membrane;apical part of cell	GO:000576; GO:000590; GO:001645; GO:003017; GO:007194; GO:000588; GO:001000; GO:004847; GO:007006; GO:000573; GO:003258; GO:004517	"NA"	"NA"	phosphatidylinositol-4,5-bisphosphate binding;actin filament binding;cadherin binding;calmodulin binding;ATP binding;actin-dependent ATPase activity;microfilament motor activity;phosphatidylinositol-3,4,5-trisphosphate binding	GO:000554; GO:005101; GO:004529; GO:000551; GO:000552; GO:003089; GO:000014; GO:000554
XP_020931738.1	XP_020931738.1	XP_020931738.1 LOW QUALITY PROTEIN: integrin alpha-6 [Sus scrofa]	11	11	11	17147000	43814000	16996000	0	0	24163000	16194000	19811000	16052000	0	0	26088000	21834000	19725000	0	26778000	20035000	0	NA	NA	NA	ITGA6	ITGA6;NA;NA;NA;NA	positive regulation of cell-cell adhesion;cellular response to extracellular stimulus;digestive tract development;cell-substrate junction assembly;hemidesmosome assembly;positive regulation of GTPase activity;integrin-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;filopodium assembly;cellular response to organic cyclic compound;ectodermal cell differentiation;positive regulation of cell migration;cell-cell adhesion;extracellular matrix organization;positive regulation of phosphorylation;positive regulation of apoptotic process;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of cell-substrate adhesion;nail development;brown fat cell differentiation;amelogenesis;cell-matrix adhesion;renal system development;skin development;leukocyte migration	GO:002240; GO:003166; GO:004856; GO:000704; GO:003158; GO:004354; GO:000722; GO:004594; GO:004684; GO:007140; GO:001066; GO:003033; GO:009860; GO:003019; GO:004232; GO:004306; GO:200123; GO:001081; GO:003587; GO:005087; GO:009718; GO:000716; GO:007200; GO:004358; GO:005090	cell-cell adherens junction;basal plasma membrane;basement membrane;cell surface;integrin alpha6-beta4 complex;plasma membrane;external side of plasma membrane;hemidesmosome;filopodium;focal adhesion	GO:000591; GO:000992; GO:000560; GO:000998; GO:003467; GO:000588; GO:000989; GO:003005; GO:003017; GO:000592	 Hematopoietic cell lineage; Focal adhesion; Dilated cardiomyopathy; Small cell lung cancer; PI3K-Akt signaling pathway; Toxoplasmosis; Regulation of actin cytoskeleton; Pathways in cancer	hsa0464; hsa0451; hsa0541; hsa0522; hsa0415; hsa0514; hsa0481; hsa0520	neuregulin binding;protein binding;cadherin binding;metal ion binding;insulin-like growth factor I binding;macromolecular complex binding;laminin binding	GO:003813; GO:000551; GO:004529; GO:004687; GO:003199; GO:004487; GO:004323
XP_020931811.1	XP_020931811.1	XP_020931811.1 LOW QUALITY PROTEIN: obg-like ATPase 1 [Sus scrofa]	8	8	8	57455000	48402000	66565000	70914000	59370000	54280000	49463000	61845000	49809000	69273000	54406000	70163000	36980000	69284000	61602000	72859000	54228000	41411000	NA	NA	NA	OLA1	OLA1;NA;NA;NA;NA	ATP metabolic process;platelet degranulation	GO:004603; GO:000257	cytosol;extracellular region;cytoplasm;extracellular exosome;membrane;centrosome;platelet alpha granule lumen	GO:000582; GO:000557; GO:000573; GO:007006; GO:001602; GO:000581; GO:003109	"NA"	"NA"	protein binding;ribosome binding;ATP binding;ATPase activity;metal ion binding;cadherin binding	GO:000551; GO:004302; GO:000552; GO:001688; GO:004687; GO:004529
XP_020931861.1	XP_020931861.1	XP_020931861.1 protein lifeguard 3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21159000	NA	NA	NA	TMBIM1	TMBIM1;NA;NA;NA;NA	positive regulation of blood vessel remodeling;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of protein localization to plasma membrane;negative regulation of catalytic activity;neutrophil degranulation	GO:200050; GO:190204; GO:190307; GO:004308; GO:004331	endosome membrane;extracellular exosome;specific granule membrane;Golgi apparatus;plasma membrane;lysosomal membrane;integral component of membrane;intracellular membrane-bounded organelle	GO:001000; GO:007006; GO:003557; GO:000579; GO:000588; GO:000576; GO:001602; GO:004323	"NA"	"NA"	death receptor binding	GO:000512
XP_020931905.1;XP_020931904.1;XP_003133167.1	XP_020931905.1;XP_020931904.1;XP_003133167.1	XP_020931905.1 60S ribosomal protein L37a isoform X2 [Sus scrofa];XP_020931904.1 60S ribosomal protein L37a isoform X1 [Sus scrofa];XP_003133167.1 60S ribosomal protein L37a [Sus scrofa]	2	2	2	0	0	24462000	0	0	23037000	0	0	0	20722000	0	0	0	14398000	0	20657000	19503000	19100000	NA	NA	NA	RPL37A	RPL37A;RPL37A;LOC100524282;NA;NA	SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000661; GO:000018; GO:000641	cytosolic large ribosomal subunit;extracellular exosome;focal adhesion;cytosol;nucleus	GO:002262; GO:007006; GO:000592; GO:000582; GO:000563	 Ribosome	hsa0301	protein binding;structural constituent of ribosome;RNA binding;metal ion binding	GO:000551; GO:000373; GO:000372; GO:004687
XP_020931923.1;XP_020931922.1;XP_020931924.1	XP_020931923.1;XP_020931922.1;XP_020931924.1	XP_020931923.1 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X2 [Sus scrofa];XP_020931922.1 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X1 [Sus scrofa];XP_020931924.1 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X3 [Sus	5	5	5	0	22141000	32460000	0	22625000	26816000	14098000	27233000	25246000	27854000	29199000	0	0	28289000	0	21389000	22935000	27355000	NA	NA	NA	HIBCH	HIBCH;HIBCH;HIBCH;NA;NA	fatty acid beta-oxidation;branched-chain amino acid catabolic process;valine catabolic process	GO:000663; GO:000908; GO:000657	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 beta-Alanine metabolism; Valine, leucine and isoleucine degradation; Carbon metabolism; Metabolic pathways; Propanoate metabolism	hsa0041; hsa0028; hsa0120; hsa0110; hsa0064	3-hydroxyisobutyryl-CoA hydrolase activity	GO:000386
XP_020932070.1;XP_020932069.1;XP_020932068.1;XP_020932067.1	XP_020932070.1;XP_020932069.1;XP_020932068.1;XP_020932067.1	XP_020932070.1 lanC-like protein 1 isoform X2 [Sus scrofa];XP_020932069.1 lanC-like protein 1 isoform X2 [Sus scrofa];XP_020932068.1 lanC-like protein 1 isoform X2 [Sus scrofa];XP_020932067.1 lanC-like protein 1 isoform X1 [Sus scrofa]	10	10	10	124390000	175960000	171350000	136100000	146220000	158970000	152900000	143080000	165390000	185370000	120160000	182140000	184180000	167690000	124660000	186490000	160760000	186920000	NA	NA	NA	LANCL1	LANCL1;LANCL1;LANCL1;LANCL1;NA	regulation of neuron apoptotic process;regulation of oxidative stress-induced neuron death;G-protein coupled receptor signaling pathway	GO:004352; GO:190320; GO:000718	integral component of plasma membrane;cytoplasm;plasma membrane	GO:000588; GO:000573; GO:000588	"NA"	"NA"	G-protein coupled receptor activity;protein binding;zinc ion binding;SH3 domain binding;glutathione transferase activity;glutathione binding;low-density lipoprotein particle receptor binding	GO:000493; GO:000551; GO:000827; GO:001712; GO:000436; GO:004329; GO:005075
XP_020932192.1	XP_020932192.1	XP_020932192.1 patatin-like phospholipase domain-containing protein 2 isoform X1 [Sus scrofa]	12	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6764300	0	0	NA	NA	NA	PNPLA2	PNPLA2;NA;NA;NA;NA	negative regulation of sequestering of triglyceride;lipid particle organization;post-translational protein modification;positive regulation of triglyceride catabolic process;triglyceride catabolic process;lipid homeostasis;acylglycerol acyl-chain remodeling;lipid storage;cellular protein metabolic process	GO:001089; GO:003438; GO:004368; GO:001089; GO:001943; GO:005508; GO:003615; GO:001991; GO:004426	endoplasmic reticulum lumen;lipid particle;plasma membrane;nucleoplasm;endoplasmic reticulum membrane;membrane;cytosol;cytoplasm	GO:000578; GO:000581; GO:000588; GO:000565; GO:000578; GO:001602; GO:000582; GO:000573	 Glycerolipid metabolism; Metabolic pathways; Regulation of lipolysis in adipocytes	hsa0056; hsa0110; hsa0492	triglyceride lipase activity;lipoprotein lipase activity;acylglycerol O-acyltransferase activity	GO:000480; GO:000446; GO:001641
XP_020932218.1;XP_020932217.1	XP_020932218.1;XP_020932217.1	XP_020932218.1 carboxymethylenebutenolidase homolog isoform X1 [Sus scrofa];XP_020932217.1 carboxymethylenebutenolidase homolog isoform X1 [Sus scrofa]	7	7	2	57356000	69663000	84828000	87005000	82964000	57849000	92629000	84089000	59735000	59412000	82639000	97418000	62340000	61295000	45717000	63244000	96336000	87125000	NA	NA	NA	CMBL	CMBL;CMBL;NA;NA;NA	xenobiotic metabolic process	GO:000680	extracellular exosome;cytosol	GO:007006; GO:000582	 Metabolic pathways; Biosynthesis of antibiotics	hsa0110; hsa0113	hydrolase activity	GO:001678
XP_020932224.1;NP_001265708.1	XP_020932224.1;NP_001265708.1	XP_020932224.1 T-complex protein 1 subunit epsilon isoform X1 [Sus scrofa];NP_001265708.1 T-complex protein 1 subunit epsilon [Sus scrofa]	16	16	16	184560000	151030000	205690000	141070000	179020000	156590000	175250000	162150000	185050000	149810000	179060000	145210000	137540000	172710000	137460000	167600000	186060000	159390000	NA	NA	NA	CCT5	CCT5;CCT5;NA;NA;NA	positive regulation of establishment of protein localization to telomere;protein folding;binding of sperm to zona pellucida;positive regulation of telomere maintenance via telomerase;positive regulation of protein localization to Cajal body;response to virus;protein stabilization;toxin transport	GO:190485; GO:000645; GO:000733; GO:003221; GO:190487; GO:000961; GO:005082; GO:190199	chaperonin-containing T-complex;cell body;microtubule;cytosol;nucleolus;extracellular exosome;centrosome	GO:000583; GO:004429; GO:000587; GO:000582; GO:000573; GO:007006; GO:000581	"NA"	"NA"	mRNA 3'-UTR binding;protein binding;G-protein beta-subunit binding;unfolded protein binding;beta-tubulin binding;ATP binding;mRNA 5'-UTR binding	GO:000373; GO:000551; GO:003168; GO:005108; GO:004848; GO:000552; GO:004802
XP_020932303.1	XP_020932303.1	XP_020932303.1 LOW QUALITY PROTEIN: threonine--tRNA ligase, cytoplasmic [Sus scrofa]	2	2	2	0	12768000	0	10708000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TARS	TARS;NA;NA;NA;NA	translation;tRNA aminoacylation for protein translation;threonyl-tRNA aminoacylation	GO:000641; GO:000641; GO:000643	extracellular exosome;cytosol;cytoplasm;actin cytoskeleton	GO:007006; GO:000582; GO:000573; GO:001562	 Aminoacyl-tRNA biosynthesis	hsa0097	protein binding;tRNA binding;threonine-tRNA ligase activity;ATP binding;protein homodimerization activity	GO:000551; GO:000004; GO:000482; GO:000552; GO:004280
XP_020932305.1	XP_020932305.1	XP_020932305.1 LOW QUALITY PROTEIN: dynein heavy chain 5, axonemal [Sus scrofa]	3	3	3	68130000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DNAH5	DNAH5;NA;NA;NA;NA	microtubule-based movement;determination of left/right symmetry;outer dynein arm assembly;cilium assembly;lateral ventricle development;cilium movement;heart development;flagellated sperm motility	GO:000701; GO:000736; GO:003615; GO:006027; GO:002167; GO:000334; GO:000750; GO:003031	microtubule;dynein complex;9+2 motile cilium;axoneme;outer dynein arm	GO:000587; GO:003028; GO:009772; GO:000593; GO:003615	 Huntington's disease	hsa0501	dynein light intermediate chain binding;dynein light chain binding;ATP-dependent microtubule motor activity, minus-end-directed;ATP binding	GO:005195; GO:004550; GO:000856; GO:000552
XP_020932312.1;XP_020932311.1;XP_020932310.1;XP_020932309.1;XP_020932308.1	XP_020932312.1;XP_020932311.1;XP_020932310.1;XP_020932309.1;XP_020932308.1	XP_020932312.1 disabled homolog 2 isoform X2 [Sus scrofa];XP_020932311.1 disabled homolog 2 isoform X1 [Sus scrofa];XP_020932310.1 disabled homolog 2 isoform X1 [Sus scrofa];XP_020932309.1 disabled homolog 2 isoform X1 [Sus scrofa];XP_020932308.1 disabled	4	4	4	0	0	0	14545000	0	11240000	0	11511000	0	11850000	0	0	15421000	9763200	7847900	13502000	0	14301000	NA	NA	NA	DAB2	DAB2;DAB2;DAB2;DAB2;DAB2	Wnt signaling pathway;receptor-mediated endocytosis;multicellular organism development;positive regulation of SMAD protein import into nucleus;protein transport;leading edge cell differentiation;negative regulation of androgen receptor signaling pathway;positive regulation of clathrin-dependent endocytosis;positive regulation of epithelial to mesenchymal transition;negative regulation of protein binding;positive regulation of endocytosis;positive regulation of early endosome to late endosome transport;apoptotic process;integrin-mediated signaling pathway;positive regulation of transforming growth factor beta receptor signaling pathway;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of apoptotic process;positive regulation of pathway-restricted SMAD protein phosphorylation;positive regulation of transcription, DNA-templated;positive regulation of cell migration;cell proliferation;membrane organization;negative regulation of protein localization to plasma membrane;positive regulation of protein phosphorylation;negative regulation of canonical Wnt signaling pathway;positive regulation of Wnt signaling pathway, planar cell polarity pathway	GO:001605; GO:000689; GO:000727; GO:006039; GO:001503; GO:003502; GO:006076; GO:200037; GO:001071; GO:003209; GO:004580; GO:200064; GO:000691; GO:000722; GO:003051; GO:003243; GO:004306; GO:001086; GO:004589; GO:003033; GO:000828; GO:006102; GO:190307; GO:000193; GO:009009; GO:200009	cytosol;clathrin-coated vesicle;plasma membrane;fibrillar center;lysosomal membrane;focal adhesion;clathrin-coated pit;intracellular membrane-bounded organelle;clathrin-coated vesicle membrane	GO:000582; GO:003013; GO:000588; GO:000165; GO:000576; GO:000592; GO:000590; GO:004323; GO:003066	 Endocytosis	hsa0414	SMAD binding;protein binding;clathrin adaptor activity;cargo receptor activity;protein C-terminus binding	GO:004633; GO:000551; GO:003561; GO:003802; GO:000802
XP_020932355.1;XP_020932354.1;XP_020932353.1;XP_020932352.1;XP_020932351.1	XP_020932355.1;XP_020932354.1;XP_020932353.1;XP_020932352.1;XP_020932351.1	XP_020932355.1 cytoplasmic FMR1-interacting protein 2 isoform X2 [Sus scrofa];XP_020932354.1 cytoplasmic FMR1-interacting protein 2 isoform X2 [Sus scrofa];XP_020932353.1 cytoplasmic FMR1-interacting protein 2 isoform X2 [Sus scrofa];XP_020932352.1 cytopla	12	3	3	0	0	0	0	31355000	0	0	8723200	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CYFIP2	CYFIP2;CYFIP2;CYFIP2;CYFIP2;CYFIP2	Fc-gamma receptor signaling pathway involved in phagocytosis;cell morphogenesis;axon guidance;cell-cell adhesion;cell projection assembly;positive regulation of neurotrophin TRK receptor signaling pathway;apoptotic process;dendrite extension;positive regulation of proteolysis;vascular endothelial growth factor receptor signaling pathway;activation of cysteine-type endopeptidase activity	GO:003809; GO:000090; GO:000741; GO:009860; GO:003003; GO:005138; GO:000691; GO:009748; GO:004586; GO:004801; GO:009720	cell junction;nucleus;cytoplasm;neuron projection;cytosol;synapse;SCAR complex;perinuclear region of cytoplasm;membrane;extracellular exosome	GO:003005; GO:000563; GO:000573; GO:004300; GO:000582; GO:004520; GO:003120; GO:004847; GO:001602; GO:007006	 RNA transport; Regulation of actin cytoskeleton	hsa0301; hsa0481	protein binding;RNA 7-methylguanosine cap binding	GO:000551; GO:000034
XP_020932428.1	XP_020932428.1	XP_020932428.1 LOW QUALITY PROTEIN: integrin alpha-1 [Sus scrofa]	9	9	9	29715000	26285000	61230000	0	0	17099000	30859000	36978000	36363000	23701000	24041000	25597000	70837000	0	17189000	28615000	0	0	NA	NA	NA	ITGA1	ITGA1;NA;NA;NA;NA	extracellular matrix organization;vasodilation;negative regulation of cell proliferation;positive regulation of neuron apoptotic process;muscle contraction;cellular extravasation;integrin-mediated signaling pathway;positive regulation of phosphoprotein phosphatase activity;negative regulation of epidermal growth factor receptor signaling pathway;activation of MAPK activity;cell-matrix adhesion;neutrophil chemotaxis;neuron projection morphogenesis	GO:003019; GO:004231; GO:000828; GO:004352; GO:000693; GO:004512; GO:000722; GO:003251; GO:004205; GO:000018; GO:000716; GO:003059; GO:004881	plasma membrane;acrosomal vesicle;focal adhesion;basal part of cell;extracellular exosome;integrin alpha1-beta1 complex;membrane;external side of plasma membrane;membrane raft;integrin complex;cell surface;neuron projection;perikaryon	GO:000588; GO:000166; GO:000592; GO:004517; GO:007006; GO:003466; GO:001602; GO:000989; GO:004512; GO:000830; GO:000998; GO:004300; GO:004320	 PI3K-Akt signaling pathway; Dilated cardiomyopathy; Regulation of actin cytoskeleton; ECM-receptor interaction; Hematopoietic cell lineage	hsa0415; hsa0541; hsa0481; hsa0451; hsa0464	metal ion binding;receptor binding;protein phosphatase binding;collagen binding involved in cell-matrix adhesion;protein binding	GO:004687; GO:000510; GO:001990; GO:009863; GO:000551
XP_020932485.1	XP_020932485.1	XP_020932485.1 LOW QUALITY PROTEIN: pleckstrin homology domain-containing family G member 4B [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	27248000	0	0	0	0	0	0	NA	NA	NA	PLEKHG4B	PLEKHG4B;NA;NA;NA;NA	regulation of Rho protein signal transduction	GO:003502	"NA"	"NA"	"NA"	"NA"	protein binding;Rho guanyl-nucleotide exchange factor activity	GO:000551; GO:000508
XP_020932553.1;XP_020932552.1	XP_020932553.1;XP_020932552.1	XP_020932553.1 clathrin interactor 1 isoform X2 [Sus scrofa];XP_020932552.1 clathrin interactor 1 isoform X1 [Sus scrofa]	4	4	4	0	0	16671000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CLINT1	CLINT1;CLINT1;NA;NA;NA	endocytosis;clathrin coat assembly	GO:000689; GO:004826	nucleoplasm;membrane;intracellular membrane-bounded organelle;cytosol;perinuclear region of cytoplasm;Golgi apparatus;clathrin-coated vesicle	GO:000565; GO:001602; GO:004323; GO:000582; GO:004847; GO:000579; GO:003013	"NA"	"NA"	clathrin binding;cadherin binding;lipid binding;protein binding	GO:003027; GO:004529; GO:000828; GO:000551
XP_020932567.1	XP_020932567.1	XP_020932567.1 PWWP domain-containing protein 2A isoform X2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42846000	+	NA	NA	PWWP2A	PWWP2A;NA;NA;NA;NA	"NA"	"NA"	nucleus	GO:000563	"NA"	"NA"	histone binding;protein binding;chromatin binding	GO:004239; GO:000551; GO:000368
XP_020932590.1;XP_020932589.1	XP_020932590.1;XP_020932589.1	XP_020932590.1 succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X2 [Sus scrofa];XP_020932589.1 succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X1 [Sus scrofa]	17	17	17	761310000	457410000	680580000	441150000	693400000	439980000	738790000	469150000	743100000	491330000	568210000	477640000	358910000	503920000	541360000	546130000	529850000	386610000	NA	NA	NA	SDHA	SDHA;SDHA;NA;NA;NA	oxidation-reduction process;respiratory electron transport chain;mitochondrial electron transport, succinate to ubiquinone;nervous system development;tricarboxylic acid cycle;succinate metabolic process	GO:005511; GO:002290; GO:000612; GO:000739; GO:000609; GO:000610	mitochondrion;nucleolus;mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);plasma membrane succinate dehydrogenase complex	GO:000573; GO:000573; GO:000574; GO:004528	 Biosynthesis of antibiotics; Non-alcoholic fatty liver disease (NAFLD); Parkinson's disease; Oxidative phosphorylation; Metabolic pathways; Carbon metabolism; Citrate cycle (TCA cycle)	hsa0113; hsa0493; hsa0501; hsa0019; hsa0110; hsa0120; hsa0002	electron carrier activity;succinate dehydrogenase activity;flavin adenine dinucleotide binding;protein binding;succinate dehydrogenase (ubiquinone) activity	GO:000905; GO:000010; GO:005066; GO:000551; GO:000817
XP_020932594.1;XP_020932592.1;XP_020932593.1	XP_020932594.1;XP_020932592.1;XP_020932593.1	XP_020932594.1 programmed cell death protein 6 isoform X3 [Sus scrofa];XP_020932592.1 programmed cell death protein 6 isoform X1 [Sus scrofa];XP_020932593.1 programmed cell death protein 6 isoform X2 [Sus scrofa]	5	5	5	182310000	191380000	120180000	149950000	160950000	163710000	112000000	129000000	139400000	116670000	117360000	118980000	160470000	145500000	131900000	167130000	137750000	198460000	NA	NA	NA	PDCD6	PDCD6;PDCD6;PDCD6;NA;NA	activation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of vascular endothelial growth factor receptor signaling pathway;angiogenesis;positive regulation of angiogenesis;positive regulation of endothelial cell proliferation;cellular response to heat;vascular endothelial growth factor receptor-2 signaling pathway;response to calcium ion;negative regulation of protein kinase B signaling;COPII vesicle coating;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of protein monoubiquitination;intracellular protein transport;neural crest cell development;positive regulation of endothelial cell migration;neural crest formation;negative regulation of TOR signaling;apoptotic signaling pathway	GO:000691; GO:003094; GO:000152; GO:004576; GO:000193; GO:003460; GO:003632; GO:005159; GO:005189; GO:004820; GO:004328; GO:190252; GO:000688; GO:001403; GO:001059; GO:001402; GO:003200; GO:009719	Golgi membrane;endosome;nucleus;cytoplasmic vesicle;endoplasmic reticulum;Cul3-RING ubiquitin ligase complex;cytoplasm;COPII vesicle coat;extracellular exosome;endoplasmic reticulum exit site	GO:000013; GO:000576; GO:000563; GO:003141; GO:000578; GO:003146; GO:000573; GO:003012; GO:007006; GO:007097	"NA"	"NA"	protein dimerization activity;identical protein binding;protein anchor;calcium-dependent protein binding;calcium ion binding;magnesium ion binding;binding, bridging;protein binding	GO:004698; GO:004280; GO:004349; GO:004830; GO:000550; GO:000028; GO:006009; GO:000551
XP_020932660.1;XP_020932659.1;XP_020932658.1;XP_020932657.1;XP_020932656.1;XP_020932655.1;XP_020932653.1;XP_020932652.1;XP_020932661.1	XP_020932660.1;XP_020932659.1;XP_020932658.1;XP_020932657.1;XP_020932656.1;XP_020932655.1;XP_020932653.1;XP_020932652.1;XP_020932661.1	XP_020932660.1 NAD(P) transhydrogenase, mitochondrial isoform X1 [Sus scrofa];XP_020932659.1 NAD(P) transhydrogenase, mitochondrial isoform X1 [Sus scrofa];XP_020932658.1 NAD(P) transhydrogenase, mitochondrial isoform X1 [Sus scrofa];XP_020932657.1 NAD(P)	10	10	10	85984000	44575000	48139000	39158000	54471000	30634000	49257000	44916000	53081000	36957000	45390000	39791000	52334000	38428000	45976000	42214000	47222000	41439000	NA	NA	NA	NNT	NNT;NNT;NNT;NNT;NNT	negative regulation of apoptotic process;response to vitamin;NADPH regeneration;reactive oxygen species metabolic process;oxygen homeostasis;negative regulation of protein phosphorylation;tricarboxylic acid cycle;hydrogen ion transmembrane transport;positive regulation of hydrogen peroxide catabolic process;oxidation-reduction process;positive regulation of mitochondrial membrane potential;cell redox homeostasis;cellular oxidant detoxification	GO:004306; GO:003327; GO:000674; GO:007259; GO:003236; GO:000193; GO:000609; GO:190260; GO:190328; GO:005511; GO:001091; GO:004545; GO:009886	integral component of membrane;membrane;mitochondrial inner membrane;mitochondrion	GO:001602; GO:001602; GO:000574; GO:000573	 Metabolic pathways; Nicotinate and nicotinamide metabolism	hsa0110; hsa0076	NADP binding;NAD(P)+ transhydrogenase activity;NAD binding;NAD(P)+ transhydrogenase (B-specific) activity	GO:005066; GO:000874; GO:005128; GO:000395
XP_020932879.1;XP_020932876.1;XP_020932878.1;XP_020932875.1;NP_999106.1	XP_020932879.1;XP_020932876.1;XP_020932878.1;XP_020932875.1;NP_999106.1	XP_020932879.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X4 [Sus scrofa];XP_020932876.1 dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2 [Sus scrofa];XP_020932878.1 dolichyl-diphosph	18	18	18	310380000	331330000	304120000	337110000	316520000	279450000	367250000	375660000	335440000	335570000	344350000	392250000	323940000	357170000	355820000	374180000	363540000	340500000	NA	NA	NA	RPN2	RPN2;RPN2;RPN2;RPN2;RPN2	response to drug;cellular protein modification process;protein N-linked glycosylation via asparagine;protein N-linked glycosylation;aging	GO:004249; GO:000646; GO:001827; GO:000648; GO:000756	integral component of membrane;oligosaccharyltransferase complex;endoplasmic reticulum membrane;membrane;autophagosome membrane;rough endoplasmic reticulum	GO:001602; GO:000825; GO:000578; GO:001602; GO:000042; GO:000579	 N-Glycan biosynthesis; Metabolic pathways; Protein processing in endoplasmic reticulum	hsa0051; hsa0110; hsa0414	dolichyl-diphosphooligosaccharide-protein glycotransferase activity;protein binding;ribosome binding	GO:000457; GO:000551; GO:004302
XP_020932949.1;XP_020932948.1;NP_999448.1	XP_020932949.1;XP_020932948.1;NP_999448.1	XP_020932949.1 phospholipid transfer protein isoform X1 [Sus scrofa];XP_020932948.1 phospholipid transfer protein isoform X1 [Sus scrofa];NP_999448.1 phospholipid transfer protein precursor [Sus scrofa]	3	3	3	0	19777000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PLTP	PLTP;PLTP;PLTP;NA;NA	lipid metabolic process;lipid transport;high-density lipoprotein particle remodeling;positive regulation of cholesterol efflux;ceramide transport;vitamin E biosynthetic process;phospholipid transport;flagellated sperm motility	GO:000662; GO:000686; GO:003437; GO:001087; GO:003562; GO:001018; GO:001591; GO:003031	high-density lipoprotein particle;extracellular region;extracellular space	GO:003436; GO:000557; GO:000561	 PPAR signaling pathway	hsa0332	lipid transporter activity;phospholipid transporter activity;phosphatidylethanolamine transporter activity;diacylglycerol binding;phosphatidylcholine binding;phosphatidic acid binding;ceramide binding;phosphatidylglycerol binding;phosphatidylethanolamine binding;phosphatidylcholine transporter activity;phosphatidic acid transporter activity;ceramide transporter activity	GO:000531; GO:000554; GO:190412; GO:001999; GO:003121; GO:007030; GO:009700; GO:190161; GO:000842; GO:000852; GO:199005; GO:003562
XP_020932967.1;NP_999529.1;XP_020932966.1	XP_020932967.1;NP_999529.1;XP_020932966.1	XP_020932967.1 voltage-dependent anion-selective channel protein 3 isoform X2 [Sus scrofa];NP_999529.1 voltage-dependent anion-selective channel protein 3 [Sus scrofa];XP_020932966.1 voltage-dependent anion-selective channel protein 3 isoform X1 [Sus scrof	7	7	7	48500000	42806000	66307000	35167000	42166000	52295000	50467000	39687000	51492000	49562000	0	34112000	0	38312000	38468000	45959000	41155000	47114000	NA	NA	NA	VDAC3	VDAC3;VDAC3;VDAC3;NA;NA	regulation of cilium assembly;anion transmembrane transport;neuron-neuron synaptic transmission;inorganic anion transport;adenine transport;behavioral fear response;learning	GO:190201; GO:009865; GO:000727; GO:001569; GO:001585; GO:000166; GO:000761	mitochondrion;mitochondrial outer membrane;pore complex;extracellular exosome;nucleus	GO:000573; GO:000574; GO:004693; GO:007006; GO:000563	 Viral carcinogenesis; Huntington's disease; Calcium signaling pathway; Hepatitis B	hsa0520; hsa0501; hsa0402; hsa0516	nucleotide binding;voltage-gated anion channel activity;porin activity	GO:000016; GO:000830; GO:001528
XP_020933019.1;XP_020933018.1;XP_020933017.1;XP_020933016.1;XP_020933015.1;XP_020933014.1;XP_020933013.1;XP_020933012.1	XP_020933019.1;XP_020933018.1;XP_020933017.1;XP_020933016.1;XP_020933015.1;XP_020933014.1;XP_020933013.1;XP_020933012.1	XP_020933019.1 protein NDRG3 isoform X8 [Sus scrofa];XP_020933018.1 protein NDRG3 isoform X7 [Sus scrofa];XP_020933017.1 protein NDRG3 isoform X6 [Sus scrofa];XP_020933016.1 protein NDRG3 isoform X5 [Sus scrofa];XP_020933015.1 protein NDRG3 isoform X4 [Sus	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4235600	NA	NA	NA	NDRG3	NDRG3;NDRG3;NDRG3;NDRG3;NDRG3	negative regulation of cell growth;signal transduction;spermatogenesis;cell differentiation	GO:003030; GO:000716; GO:000728; GO:003015	extracellular exosome;cytoplasm	GO:007006; GO:000573	"NA"	"NA"	molecular_function	GO:000367
XP_020933043.1;XP_020933042.1;XP_020933041.1;XP_020933040.1	XP_020933043.1;XP_020933042.1;XP_020933041.1;XP_020933040.1	XP_020933043.1 UPF0687 protein C20orf27 homolog isoform X1 [Sus scrofa];XP_020933042.1 UPF0687 protein C20orf27 homolog isoform X1 [Sus scrofa];XP_020933041.1 UPF0687 protein C20orf27 homolog isoform X1 [Sus scrofa];XP_020933040.1 UPF0687 protein C20orf27	3	3	3	50196000	51649000	61277000	51680000	52921000	39549000	69735000	55168000	60876000	47682000	68853000	50480000	27965000	38383000	57706000	54591000	51573000	43561000	NA	NA	NA	C17H20orf27	C17H20orf27;C17H20orf27;C17H20orf27;C17H20orf27;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020933104.1;XP_020933103.1;XP_020933099.1;XP_020933098.1;XP_020933097.1;XP_020933095.1;XP_020933094.1;XP_020933101.1;XP_020933100.1;XP_020933096.1;XP_020933093.1;XP_020933092.1;XP_020933091.1	XP_020933104.1;XP_020933103.1;XP_020933099.1;XP_020933098.1;XP_020933097.1;XP_020933095.1;XP_020933094.1;XP_020933101.1;XP_020933100.1;XP_020933096.1;XP_020933093.1;XP_020933092.1;XP_020933091.1	XP_020933104.1 COMM domain-containing protein 7 isoform X13 [Sus scrofa];XP_020933103.1 COMM domain-containing protein 7 isoform X12 [Sus scrofa];XP_020933099.1 COMM domain-containing protein 7 isoform X9 [Sus scrofa];XP_020933098.1 COMM domain-containing	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1987700	0	NA	NA	NA	COMMD7	COMMD7;COMMD7;COMMD7;COMMD7;COMMD7	negative regulation of NF-kappaB transcription factor activity;negative regulation of transcription, DNA-templated;tumor necrosis factor-mediated signaling pathway	GO:003208; GO:004589; GO:003320	cytoplasmic vesicle;intracellular membrane-bounded organelle	GO:003141; GO:004323	"NA"	"NA"	protein binding;NF-kappaB binding	GO:000551; GO:005105
XP_020933197.1	XP_020933197.1	XP_020933197.1 protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha [Sus scrofa]	5	5	5	10694000	9728000	12454000	12718000	11143000	9118500	8160700	13282000	11819000	13593000	7954100	0	9461200	8434000	8190800	12006000	7947900	13685000	NA	NA	NA	FNTA	FNTA;NA;NA;NA;NA	transforming growth factor beta receptor signaling pathway;neurotransmitter receptor metabolic process;skeletal muscle acetylcholine-gated channel clustering;regulation of neurotransmitter receptor activity;positive regulation of tubulin deacetylation;protein farnesylation	GO:000717; GO:004521; GO:007134; GO:009960; GO:009004; GO:001834	cytosol;cytoplasm;plasma membrane;CAAX-protein geranylgeranyltransferase complex;protein farnesyltransferase complex;microtubule associated complex	GO:000582; GO:000573; GO:000588; GO:000595; GO:000596; GO:000587	 Terpenoid backbone biosynthesis; Biosynthesis of antibiotics	hsa0090; hsa0113	protein geranylgeranyltransferase activity;Rab geranylgeranyltransferase activity;protein binding;microtubule binding;acetylcholine receptor regulator activity;receptor tyrosine kinase binding;alpha-tubulin binding	GO:000466; GO:000466; GO:000551; GO:000801; GO:003054; GO:003097; GO:004301
XP_020933264.1;XP_020933262.1;XP_020933261.1;XP_020933265.1;XP_020933263.1	XP_020933264.1;XP_020933262.1;XP_020933261.1;XP_020933265.1;XP_020933263.1	XP_020933264.1 tumor protein D54 isoform X4 [Sus scrofa];XP_020933262.1 tumor protein D54 isoform X2 [Sus scrofa];XP_020933261.1 tumor protein D54 isoform X1 [Sus scrofa];XP_020933265.1 tumor protein D54 isoform X5 [Sus scrofa];XP_020933263.1 tumor protein	5	5	5	0	36231000	38997000	20492000	0	0	29342000	21615000	0	29014000	51480000	0	49218000	37967000	41144000	20572000	38699000	37533000	NA	NA	NA	TPD52L2	TPD52L2;TPD52L2;TPD52L2;TPD52L2;TPD52L2	regulation of cell proliferation	GO:004212	perinuclear region of cytoplasm;cytoplasm	GO:004847; GO:000573	"NA"	"NA"	RNA binding;catalytic activity	GO:000372; GO:000382
XP_020933437.1;XP_003129826.2;XP_005656114.2	XP_020933437.1;XP_003129826.2;XP_005656114.2	XP_020933437.1 elongation factor 1-alpha 2 [Sus scrofa];XP_003129826.2 elongation factor 1-alpha, oocyte form-like [Sus scrofa];XP_005656114.2 LOW QUALITY PROTEIN: elongation factor 1-alpha, somatic form-like [Sus scrofa]	10	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	66047000	0	NA	NA	NA	EEF1A2	EEF1A2;LOC100514912;LOC100620900;NA;NA	response to inorganic substance;positive regulation of apoptotic process;positive regulation of lipid kinase activity;regulation of chaperone-mediated autophagy;translation;response to electrical stimulus	GO:001003; GO:004306; GO:009021; GO:190471; GO:000641; GO:005160	cytoplasm;nucleus;eukaryotic translation elongation factor 1 complex;neuronal cell body;synapse;cytoplasmic side of lysosomal membrane	GO:000573; GO:000563; GO:000585; GO:004302; GO:004520; GO:009857	 RNA transport; Legionellosis	hsa0301; hsa0513	protein binding;GTP binding;GTPase activity;protein kinase binding;translation elongation factor activity;translation factor activity, RNA binding	GO:000551; GO:000552; GO:000392; GO:001990; GO:000374; GO:000813
XP_020933637.1	XP_020933637.1	XP_020933637.1 LOW QUALITY PROTEIN: adenosine deaminase [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	23111000	0	0	0	0	0	NA	NA	NA	ADA	ADA;NA;NA;NA;NA	adenosine catabolic process;positive regulation of B cell proliferation;positive regulation of T cell differentiation in thymus;purine-containing compound salvage;Peyer's patch development;liver development;positive regulation of smooth muscle contraction;negative regulation of mucus secretion;positive regulation of heart rate;T cell activation;positive regulation of alpha-beta T cell differentiation;lung alveolus development;negative regulation of inflammatory response;response to hypoxia;trophectodermal cell differentiation;placenta development;aging;response to vitamin E;negative regulation of adenosine receptor signaling pathway;cell adhesion;purine nucleotide salvage;response to hydrogen peroxide;negative regulation of mature B cell apoptotic process;inosine biosynthetic process;positive regulation of calcium-mediated signaling;positive regulation of germinal center formation;negative regulation of leukocyte migration;deoxyadenosine catabolic process;dATP catabolic process;xanthine biosynthetic process;positive regulation of T cell receptor signaling pathway;regulation of cell-cell adhesion mediated by integrin;negative regulation of circadian sleep/wake cycle, non-REM sleep;negative regulation of penile erection;germinal center B cell differentiation;purine ribonucleoside monophosphate biosynthetic process;response to morphine;embryonic digestive tract development;negative regulation of thymocyte apoptotic process	GO:000615; GO:003089; GO:003308; GO:004310; GO:004854; GO:000188; GO:004598; GO:007025; GO:001046; GO:004211; GO:004663; GO:004828; GO:005072; GO:000166; GO:000182; GO:000189; GO:000756; GO:003319; GO:006016; GO:000715; GO:003226; GO:004254; GO:000290; GO:004610; GO:005085; GO:000263; GO:000268; GO:000615; GO:004606; GO:004611; GO:005086; GO:003363; GO:004232; GO:006040; GO:000231; GO:000916; GO:004327; GO:004856; GO:007024	lysosome;dendrite cytoplasm;extracellular space;external side of plasma membrane;cell junction;plasma membrane;cytoplasmic vesicle lumen;membrane;cytosol;cell surface;neuronal cell body	GO:000576; GO:003283; GO:000561; GO:000989; GO:003005; GO:000588; GO:006020; GO:001602; GO:000582; GO:000998; GO:004302	 Metabolic pathways; Purine metabolism; Primary immunodeficiency	hsa0110; hsa0023; hsa0534	protein binding;zinc ion binding;adenosine deaminase activity;purine nucleoside binding	GO:000551; GO:000827; GO:000400; GO:000188
XP_020933696.1;XP_020933695.1	XP_020933696.1;XP_020933695.1	XP_020933696.1 ribosome-binding protein 1 isoform X2 [Sus scrofa];XP_020933695.1 ribosome-binding protein 1 isoform X1 [Sus scrofa]	10	10	10	0	31385000	30479000	35504000	30382000	42029000	26475000	27018000	0	35330000	35958000	36752000	46295000	41714000	43783000	25942000	34878000	35129000	NA	NA	NA	RRBP1	RRBP1;RRBP1;NA;NA;NA	osteoblast differentiation;translation;protein transport	GO:000164; GO:000641; GO:001503	ribosome;membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane	GO:000584; GO:001602; GO:000578; GO:003017	 Protein processing in endoplasmic reticulum	hsa0414	RNA binding;signaling receptor activity	GO:000372; GO:003802
XP_020933877.1;XP_020933876.1	XP_020933877.1;XP_020933876.1	XP_020933877.1 laminin subunit alpha-5 isoform X2 [Sus scrofa];XP_020933876.1 laminin subunit alpha-5 isoform X1 [Sus scrofa]	46	46	45	94179000	211680000	98550000	310040000	38059000	168870000	55256000	291860000	82463000	155710000	150730000	775650000	169580000	325990000	57968000	274260000	101850000	125500000	NA	NA	NA	LAMA5	LAMA5;LAMA5;NA;NA;NA	hair follicle development;cell proliferation;regulation of cell adhesion;substrate adhesion-dependent cell spreading;odontogenesis of dentin-containing tooth;cilium assembly;muscle organ development;cell recognition;cytokine-mediated signaling pathway;morphogenesis of a polarized epithelium;neural crest cell migration;cell migration;regulation of cell migration;angiogenesis;branching involved in ureteric bud morphogenesis;integrin-mediated signaling pathway;morphogenesis of embryonic epithelium;extracellular matrix organization;regulation of cell proliferation;endothelial cell differentiation;cytoskeleton organization;lung development;regulation of embryonic development;focal adhesion assembly;branching involved in salivary gland morphogenesis;protein localization to plasma membrane	GO:000194; GO:000828; GO:003015; GO:003444; GO:004247; GO:006027; GO:000751; GO:000803; GO:001922; GO:000173; GO:000175; GO:001647; GO:003033; GO:000152; GO:000165; GO:000722; GO:001633; GO:003019; GO:004212; GO:004544; GO:000701; GO:003032; GO:004599; GO:004804; GO:006044; GO:007265	extracellular region;extracellular space;nucleus;synaptic cleft;laminin-11 complex;neuromuscular junction;laminin-10 complex;basement membrane;extracellular exosome	GO:000557; GO:000561; GO:000563; GO:004308; GO:004326; GO:003159; GO:004325; GO:000560; GO:007006	 Focal adhesion; PI3K-Akt signaling pathway; Amoebiasis; Pathways in cancer; Small cell lung cancer; ECM-receptor interaction	hsa0451; hsa0415; hsa0514; hsa0520; hsa0522; hsa0451	extracellular matrix structural constituent;integrin binding	GO:000520; GO:000517
XP_020933879.1;XP_020933878.1	XP_020933879.1;XP_020933878.1	XP_020933879.1 proteasomal ubiquitin receptor ADRM1 isoform X2 [Sus scrofa];XP_020933878.1 proteasomal ubiquitin receptor ADRM1 isoform X1 [Sus scrofa]	4	4	4	9385100	10878000	13409000	10129000	11505000	9303700	12744000	0	12655000	9687100	10589000	12197000	9440300	9302600	12292000	11758000	9153800	7476300	NA	NA	NA	ADRM1	ADRM1;ADRM1;NA;NA;NA	positive regulation of endopeptidase activity;proteasome assembly;protein deubiquitination;ubiquitin-dependent protein catabolic process;transcription elongation from RNA polymerase II promoter	GO:001095; GO:004324; GO:001657; GO:000651; GO:000636	nucleoplasm;proteasome complex;proteasome regulatory particle, lid subcomplex;cytosol;plasma membrane	GO:000565; GO:000050; GO:000854; GO:000582; GO:000588	"NA"	"NA"	protease binding;ubiquitin binding;protein binding;proteasome binding;endopeptidase activator activity	GO:000202; GO:004313; GO:000551; GO:007062; GO:006113
XP_020933911.1	XP_020933911.1	XP_020933911.1 glycogen phosphorylase, brain form [Sus scrofa]	10	3	3	0	0	0	0	0	0	0	0	0	3354000	0	9489300	0	0	0	0	0	0	NA	NA	NA	PYGB	PYGB;NA;NA;NA;NA	glycogen catabolic process;neutrophil degranulation	GO:000598; GO:004331	extracellular region;cytoplasm;extracellular exosome;azurophil granule lumen;membrane	GO:000557; GO:000573; GO:007006; GO:003557; GO:001602	 Metabolic pathways; Insulin signaling pathway; Glucagon signaling pathway; Insulin resistance; Starch and sucrose metabolism	hsa0110; hsa0491; hsa0492; hsa0493; hsa0050	glycogen phosphorylase activity;protein binding;pyridoxal phosphate binding	GO:000818; GO:000551; GO:003017
XP_020933972.1	XP_020933972.1	XP_020933972.1 LOW QUALITY PROTEIN: ankyrin-1 [Sus scrofa]	15	15	14	102210000	0	0	5335400	0	36623000	9888500	8207600	20252000	8667300	20006000	0	108650000	9039100	9867900	0	16889000	0	NA	NA	NA	ANK1	ANK1;NA;NA;NA;NA	exocytosis;cytoskeleton organization;maintenance of epithelial cell apical/basal polarity;ER to Golgi vesicle-mediated transport;positive regulation of organelle organization;signal transduction;protein localization to plasma membrane	GO:000688; GO:000701; GO:004519; GO:000688; GO:001063; GO:000716; GO:007265	sarcolemma;cytoplasmic side of plasma membrane;nucleus;membrane;sarcoplasmic reticulum;cytosol;spectrin-associated cytoskeleton;Z disc;plasma membrane;basolateral plasma membrane;axolemma;M band;axon initial segment;postsynaptic membrane;cytoskeleton	GO:004238; GO:000989; GO:000563; GO:001602; GO:001652; GO:000582; GO:001473; GO:003001; GO:000588; GO:001632; GO:003067; GO:003143; GO:004319; GO:004521; GO:000585	 Proteoglycans in cancer	hsa0520	structural constituent of cytoskeleton;enzyme binding;spectrin binding;structural molecule activity;cytoskeletal adaptor activity;ATPase binding;protein binding;protein phosphatase binding;ion channel binding	GO:000520; GO:001989; GO:003050; GO:000519; GO:000809; GO:005111; GO:000551; GO:001990; GO:004432
XP_020933989.1;XP_020933988.1;XP_020933990.1;XP_020933991.1;XP_013840551.2	XP_020933989.1;XP_020933988.1;XP_020933990.1;XP_020933991.1;XP_013840551.2	XP_020933989.1 sorting nexin-5 isoform X1 [Sus scrofa];XP_020933988.1 sorting nexin-5 isoform X1 [Sus scrofa];XP_020933990.1 sorting nexin-5 isoform X2 [Sus scrofa];XP_020933991.1 sorting nexin-5 isoform X3 [Sus scrofa];XP_013840551.2 sorting nexin-5 isofo	10	10	10	0	50958000	38036000	52989000	32524000	63328000	36515000	43008000	38813000	58052000	36161000	66446000	49134000	57508000	36930000	59294000	43954000	57154000	NA	NA	NA	SNX5	SNX5;SNX5;SNX5;SNX5;SNX5	regulation of macroautophagy;negative regulation of blood pressure;intracellular protein transport;pinocytosis;epidermal growth factor catabolic process;retrograde transport, endosome to Golgi;positive regulation of renal sodium excretion	GO:001624; GO:004577; GO:000688; GO:000690; GO:000717; GO:004214; GO:003581	extrinsic component of endosome membrane;cytoplasmic vesicle membrane;ruffle;retromer complex;phagocytic cup;brush border;extrinsic component of cytoplasmic side of plasma membrane;early endosome membrane;tubular endosome;cytosol;macropinocytic cup	GO:003131; GO:003065; GO:000172; GO:003090; GO:000189; GO:000590; GO:003123; GO:003190; GO:009742; GO:000582; GO:007068	 Endocytosis	hsa0414	phosphatidylinositol-3,5-bisphosphate binding;phosphatidylinositol-5-phosphate binding;cadherin binding;protein heterodimerization activity;D1 dopamine receptor binding;protein binding;dynactin binding;phosphatidylinositol binding;phosphatidylinositol-4-phosphate binding	GO:008002; GO:001031; GO:004529; GO:004698; GO:003174; GO:000551; GO:003445; GO:003509; GO:007027
XP_020934146.1;NP_001243707.1	XP_020934146.1	XP_020934146.1 myotrophin isoform X1 [Sus scrofa]	5	5	5	66039000	0	74082000	0	71135000	78037000	86029000	65532000	58443000	65095000	77977000	101980000	78597000	71122000	70984000	67014000	75719000	84631000	NA	NA	NA	MTPN	MTPN;NA;NA;NA;NA	regulation of striated muscle tissue development;cerebellar granule cell differentiation;positive regulation of cell growth;catecholamine metabolic process;regulation of cell size;positive regulation of protein metabolic process;regulation of barbed-end actin filament capping;positive regulation of macromolecule biosynthetic process;striated muscle cell differentiation;skeletal muscle tissue regeneration;regulation of translation;positive regulation of cardiac muscle hypertrophy;neuron differentiation;cellular response to mechanical stimulus;positive regulation of NF-kappaB transcription factor activity	GO:001620; GO:002170; GO:003030; GO:000658; GO:000836; GO:005124; GO:200081; GO:001055; GO:005114; GO:004340; GO:000641; GO:001061; GO:003018; GO:007126; GO:005109	axon;F-actin capping protein complex;nucleus;cytosol;perinuclear region of cytoplasm	GO:003042; GO:000829; GO:000563; GO:000582; GO:004847	"NA"	"NA"	sequence-specific DNA binding	GO:004356
XP_020934259.1;XP_020934258.1;XP_020934257.1;XP_020934256.1;XP_020934255.1;XP_020934260.1;XP_020934254.1;XP_020934253.1	XP_020934259.1;XP_020934258.1;XP_020934257.1;XP_020934256.1;XP_020934255.1;XP_020934260.1;XP_020934254.1;XP_020934253.1	XP_020934259.1 single-stranded DNA-binding protein, mitochondrial isoform X3 [Sus scrofa];XP_020934258.1 single-stranded DNA-binding protein, mitochondrial isoform X3 [Sus scrofa];XP_020934257.1 single-stranded DNA-binding protein, mitochondrial isoform X3	2	2	2	0	0	10769000	0	0	0	0	0	0	0	0	0	0	0	13255000	0	11715000	0	NA	NA	NA	SSBP1	SSBP1;SSBP1;SSBP1;SSBP1;SSBP1	mitochondrion morphogenesis;positive regulation of helicase activity;mitochondrial DNA replication;mitochondrion organization	GO:007058; GO:005109; GO:000626; GO:000700	nucleoid;extracellular exosome;nucleus;mitochondrion;mitochondrial nucleoid;mitochondrial matrix	GO:000929; GO:007006; GO:000563; GO:000573; GO:004264; GO:000575	 Mismatch repair; Homologous recombination; DNA replication	hsa0343; hsa0344; hsa0303	protein binding;chromatin binding;single-stranded DNA binding;RNA binding	GO:000551; GO:000368; GO:000369; GO:000372
XP_020934292.1	XP_020934292.1	XP_020934292.1 staphylococcal nuclease domain-containing protein 1 [Sus scrofa]	19	19	19	103270000	92483000	89823000	104570000	98610000	94824000	89362000	107310000	85599000	98798000	91059000	96216000	104510000	95505000	99014000	94349000	101760000	107480000	NA	NA	NA	SND1	SND1;NA;NA;NA;NA	osteoblast differentiation;RNA catabolic process;RNA phosphodiester bond hydrolysis, endonucleolytic;miRNA catabolic process;regulation of nucleic acid-templated transcription;regulation of cell cycle process;gene silencing by RNA;viral process	GO:000164; GO:000640; GO:009050; GO:001058; GO:190350; GO:001056; GO:003104; GO:001603	nucleus;cytosol;RISC complex;melanosome;membrane;extracellular exosome;dense body;cytoplasm	GO:000563; GO:000582; GO:001644; GO:004247; GO:001602; GO:007006; GO:009743; GO:000573	 Viral carcinogenesis; Epstein-Barr virus infection	hsa0520; hsa0516	endonuclease activity;transcription cofactor activity;cadherin binding;nuclease activity;endoribonuclease activity;RISC complex binding;RNA binding;protein binding	GO:000451; GO:000371; GO:004529; GO:000451; GO:000452; GO:190517; GO:000372; GO:000551
XP_020934449.1;XP_020934447.1;XP_020932122.1;XP_020932121.1	XP_020934449.1;XP_020934447.1	XP_020934449.1 uridine phosphorylase 1 [Sus scrofa];XP_020934447.1 uridine phosphorylase 1 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14242000	0	36262000	NA	NA	NA	UPP1	UPP1;UPP1;NA;NA;NA	pyrimidine nucleoside salvage;nucleotide catabolic process;nucleobase-containing compound metabolic process;UMP salvage;pyrimidine nucleoside catabolic process;uridine catabolic process;cellular response to glucose starvation	GO:004309; GO:000916; GO:000613; GO:004420; GO:004613; GO:000621; GO:004214	nucleus;nucleoplasm;cytosol	GO:000563; GO:000565; GO:000582	 Metabolic pathways; Pyrimidine metabolism; Drug metabolism - other enzymes	hsa0110; hsa0024; hsa0098	uridine phosphorylase activity	GO:000485
XP_020934480.1	XP_020934480.1	XP_020934480.1 exocyst complex component 4 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9150600	NA	NA	NA	EXOC4	EXOC4;NA;NA;NA;NA	exocytosis;protein targeting to membrane;vesicle docking involved in exocytosis;vesicle tethering involved in exocytosis;regulation of macroautophagy;chemical synaptic transmission;Golgi to plasma membrane transport;paraxial mesoderm formation	GO:000688; GO:000661; GO:000690; GO:009052; GO:001624; GO:000726; GO:000689; GO:004834	cytoplasm;plasma membrane;membrane;myelin sheath abaxonal region;cytosol;exocyst;microvillus;synapse;Flemming body;growth cone membrane	GO:000573; GO:000588; GO:001602; GO:003574; GO:000582; GO:000014; GO:000590; GO:004520; GO:009054; GO:003258	 Tight junction	hsa0453	protein N-terminus binding;PDZ domain binding;Ral GTPase binding;protein binding	GO:004748; GO:003016; GO:001716; GO:000551
XP_020934689.1;XP_020934688.1;XP_020934687.1	XP_020934689.1;XP_020934688.1;XP_020934687.1	XP_020934689.1 extended synaptotagmin-2 isoform X3 [Sus scrofa];XP_020934688.1 extended synaptotagmin-2 isoform X2 [Sus scrofa];XP_020934687.1 extended synaptotagmin-2 isoform X1 [Sus scrofa]	12	12	12	26847000	47108000	38255000	24857000	20298000	42724000	26129000	32747000	25460000	37593000	33391000	52995000	39530000	32253000	25813000	33611000	30387000	37327000	NA	NA	NA	ESYT2	ESYT2;ESYT2;ESYT2;NA;NA	lipid transport;endocytosis;endoplasmic reticulum-plasma membrane tethering	GO:000686; GO:000689; GO:006181	endoplasmic reticulum membrane;intrinsic component of endoplasmic reticulum membrane;organelle membrane contact site;extrinsic component of cytoplasmic side of plasma membrane;membrane;integral component of plasma membrane	GO:000578; GO:003122; GO:004423; GO:003123; GO:001602; GO:000588	"NA"	"NA"	calcium-dependent phospholipid binding;phosphatidylinositol binding;cadherin binding;phosphatidylethanolamine binding;phosphatidylcholine binding;identical protein binding;calcium ion binding;protein binding	GO:000554; GO:003509; GO:004529; GO:000842; GO:003121; GO:004280; GO:000550; GO:000551
XP_020934722.1;XP_020934720.1;XP_020934718.1;XP_020934717.1;XP_003134939.5;XP_020934725.1;XP_020934723.1;XP_020934721.1;XP_020934719.1;XP_020928655.1	XP_020934722.1;XP_020934720.1;XP_020934718.1;XP_020934717.1;XP_003134939.5;XP_020934725.1;XP_020934723.1;XP_020934721.1;XP_020934719.1	XP_020934722.1 2-oxoglutarate dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020934720.1 2-oxoglutarate dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020934718.1 2-oxoglutarate dehydrogenase, mitochondrial isoform X1 [Sus scrofa];XP_0209	29	29	29	260600000	216580000	246550000	178300000	272970000	157180000	250780000	207190000	262270000	208040000	202650000	218970000	214480000	179650000	154210000	215200000	197710000	183400000	NA	NA	NA	OGDH	OGDH;OGDH;OGDH;OGDH;OGDH	thalamus development;tricarboxylic acid cycle;2-oxoglutarate metabolic process;striatum development;NADH metabolic process;hippocampus development;pyramidal neuron development;cerebellar cortex development;tangential migration from the subventricular zone to the olfactory bulb;olfactory bulb mitral cell layer development	GO:002179; GO:000609; GO:000610; GO:002175; GO:000673; GO:002176; GO:002186; GO:002169; GO:002202; GO:006103	oxoglutarate dehydrogenase complex;mitochondrion;mitochondrial matrix;mitochondrial membrane;nucleus	GO:004525; GO:000573; GO:000575; GO:003196; GO:000563	 Citrate cycle (TCA cycle); Tryptophan metabolism; Biosynthesis of antibiotics; Lysine degradation; Carbon metabolism; Metabolic pathways	hsa0002; hsa0038; hsa0113; hsa0031; hsa0120; hsa0110	thiamine pyrophosphate binding;chaperone binding;oxoglutarate dehydrogenase (NAD+) activity;oxoglutarate dehydrogenase (succinyl-transferring) activity;heat shock protein binding;metal ion binding	GO:003097; GO:005108; GO:003460; GO:000459; GO:003107; GO:004687
XP_020934757.1;XP_020934756.1;XP_020934755.1	XP_020934757.1;XP_020934756.1;XP_020934755.1	XP_020934757.1 maltase-glucoamylase, intestinal [Sus scrofa];XP_020934756.1 maltase-glucoamylase, intestinal [Sus scrofa];XP_020934755.1 maltase-glucoamylase, intestinal [Sus scrofa]	18	18	18	76290000	37663000	35534000	60848000	55716000	51996000	103420000	54736000	56711000	37525000	67251000	58624000	46905000	40702000	89273000	50998000	71655000	42525000	NA	NA	NA	MGAM	MGAM;MGAM;MGAM;NA;NA	starch catabolic process;neutrophil degranulation;polysaccharide digestion;maltose metabolic process	GO:000598; GO:004331; GO:004424; GO:000002	integral component of membrane;extracellular exosome;tertiary granule membrane;plasma membrane;apical plasma membrane;ficolin-1-rich granule membrane	GO:001602; GO:007006; GO:007082; GO:000588; GO:001632; GO:010100	 Galactose metabolism; Starch and sucrose metabolism; Metabolic pathways; Carbohydrate digestion and absorption	hsa0005; hsa0050; hsa0110; hsa0497	catalytic activity;carbohydrate binding;glucan 1,4-alpha-glucosidase activity;alpha-1,4-glucosidase activity;maltose alpha-glucosidase activity;amylase activity	GO:000382; GO:003024; GO:000433; GO:000455; GO:003245; GO:001616
XP_020934809.1;XP_020934808.1;XP_020934807.1;XP_020934806.1;XP_020934805.1;XP_020934804.1;XP_020934803.1;XP_020934802.1;XP_020934801.1;XP_020934800.1	XP_020934809.1;XP_020934808.1;XP_020934807.1;XP_020934806.1;XP_020934805.1;XP_020934804.1;XP_020934803.1;XP_020934802.1;XP_020934801.1;XP_020934800.1	XP_020934809.1 E3 ubiquitin-protein ligase HECW1 isoform X6 [Sus scrofa];XP_020934808.1 E3 ubiquitin-protein ligase HECW1 isoform X5 [Sus scrofa];XP_020934807.1 E3 ubiquitin-protein ligase HECW1 isoform X4 [Sus scrofa];XP_020934806.1 E3 ubiquitin-protein l	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15450000	NA	NA	NA	HECW1	HECW1;HECW1;HECW1;HECW1;HECW1	protein polyubiquitination;regulation of dendrite morphogenesis;ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;protein ubiquitination;positive regulation of protein catabolic process;negative regulation of canonical Wnt signaling pathway;negative regulation of sodium ion transmembrane transporter activity	GO:000020; GO:004881; GO:000651; GO:004316; GO:001656; GO:004573; GO:009009; GO:200065	cytoplasm;cytosol	GO:000573; GO:000582	"NA"	"NA"	ubiquitin protein ligase activity	GO:006163
XP_020934835.1	XP_020934835.1	XP_020934835.1 bisphosphoglycerate mutase [Sus scrofa]	3	3	3	30519000	0	0	0	0	0	0	0	0	0	0	0	27807000	0	0	0	20545000	0	NA	NA	NA	BPGM	BPGM;NA;NA;NA;NA	carbohydrate metabolic process;respiratory gaseous exchange;canonical glycolysis;erythrocyte development	GO:000597; GO:000758; GO:006162; GO:004882	cytosol;extracellular exosome	GO:000582; GO:007006	 Biosynthesis of antibiotics; Metabolic pathways; Glycine, serine and threonine metabolism; Glycolysis / Gluconeogenesis	hsa0113; hsa0110; hsa0026; hsa0001	bisphosphoglycerate mutase activity;hydrolase activity;phosphoglycerate mutase activity	GO:000408; GO:001678; GO:000461
XP_020934839.1	XP_020934839.1	XP_020934839.1 PDZ and LIM domain protein 4 isoform X1 [Sus scrofa]	6	6	1	0	0	19161000	0	0	22026000	0	0	15249000	0	0	0	0	0	0	0	0	0	NA	NA	NA	PDLIM4	PDLIM4;NA;NA;NA;NA	excitatory chemical synaptic transmission;actin cytoskeleton reorganization	GO:009897; GO:003153	nucleus;cytoplasm;perinuclear region of cytoplasm;stress fiber;cytoskeleton;early endosome lumen;dendritic spine;cell junction;recycling endosome lumen;postsynaptic membrane;filamentous actin;lamellipodium;recycling endosome membrane	GO:000563; GO:000573; GO:004847; GO:000172; GO:000585; GO:003190; GO:004319; GO:003005; GO:003477; GO:004521; GO:003194; GO:003002; GO:005503	"NA"	"NA"	protein binding;metal ion binding;protein phosphatase binding;alpha-actinin binding;protein homodimerization activity	GO:000551; GO:004687; GO:001990; GO:005139; GO:004280
XP_020934876.1	XP_020934876.1	XP_020934876.1 3-hydroxyisobutyrate dehydrogenase, mitochondrial [Sus scrofa]	6	6	6	131990000	92871000	90527000	64699000	106340000	57331000	92157000	103400000	104660000	84070000	65815000	91131000	41761000	48702000	80972000	107300000	72033000	52795000	NA	NA	NA	HIBADH	HIBADH;NA;NA;NA;NA	valine catabolic process;oxidation-reduction process;branched-chain amino acid catabolic process	GO:000657; GO:005511; GO:000908	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;NAD binding;3-hydroxyisobutyrate dehydrogenase activity;NADP binding	GO:001661; GO:005128; GO:000844; GO:005066
XP_020934878.1;XP_020934877.1;XP_013841295.1	XP_020934878.1;XP_020934877.1;XP_013841295.1	XP_020934878.1 ras-related protein Ral-A isoform X1 [Sus scrofa];XP_020934877.1 ras-related protein Ral-A isoform X1 [Sus scrofa];XP_013841295.1 ras-related protein Ral-A isoform X2 [Sus scrofa]	6	6	3	0	30645000	47415000	67969000	58246000	39759000	47458000	56547000	38445000	38969000	39959000	52797000	36218000	58246000	81145000	51415000	40586000	31102000	NA	NA	NA	RALA	RALA;RALA;RALA;NA;NA	neural tube closure;cell cycle;signal transduction;positive regulation of filopodium assembly;membrane raft localization;membrane organization;regulation of exocytosis;Ras protein signal transduction;chemotaxis;interleukin-12-mediated signaling pathway;cell division;exocytosis;actin cytoskeleton reorganization	GO:000184; GO:000704; GO:000716; GO:005149; GO:005166; GO:006102; GO:001715; GO:000726; GO:000693; GO:003572; GO:005130; GO:000688; GO:003153	cell surface;plasma membrane;cleavage furrow;Flemming body;endocytic vesicle;extracellular exosome;focal adhesion;cytoplasmic vesicle membrane	GO:000998; GO:000588; GO:003215; GO:009054; GO:003013; GO:007006; GO:000592; GO:003065	 Ras signaling pathway; Pathways in cancer; Rap1 signaling pathway; Pancreatic cancer	hsa0401; hsa0520; hsa0401; hsa0521	ATPase binding;GTPase activity;GTP binding;protein binding;ubiquitin protein ligase binding;myosin binding;GDP binding;Edg-2 lysophosphatidic acid receptor binding	GO:005111; GO:000392; GO:000552; GO:000551; GO:003162; GO:001702; GO:001900; GO:003175
XP_020935003.1;XP_020935001.1;XP_020935002.1	XP_020935003.1;XP_020935001.1;XP_020935002.1	XP_020935003.1 lanC-like protein 2 isoform X3 [Sus scrofa];XP_020935001.1 lanC-like protein 2 isoform X1 [Sus scrofa];XP_020935002.1 lanC-like protein 2 isoform X2 [Sus scrofa]	6	6	6	0	26633000	39616000	30161000	33630000	34582000	25592000	36499000	36962000	35378000	35414000	0	0	38598000	27653000	35995000	42201000	35418000	NA	NA	NA	LANCL2	LANCL2;LANCL2;LANCL2;NA;NA	negative regulation of transcription, DNA-templated;positive regulation of abscisic acid-activated signaling pathway	GO:004589; GO:000978	nucleus;plasma membrane;cytosol;cortical actin cytoskeleton	GO:000563; GO:000588; GO:000582; GO:003086	"NA"	"NA"	GTP binding;ATP binding;catalytic activity;phosphatidylinositol-4-phosphate binding;protein binding;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding	GO:000552; GO:000552; GO:000382; GO:007027; GO:000551; GO:001031; GO:003226
XP_020935185.1;XP_020935184.1;XP_020935183.1;XP_020935182.1;XP_020935181.1;NP_999540.1;XP_020935180.1;XP_020935179.1;XP_020935178.1;XP_013846457.1;XP_005657973.1;XP_005657972.1;XP_005657971.1;XP_013846455.1;XP_020935188.1;XP_013846458.1;XP_020935187.1	XP_020935185.1;XP_020935184.1;XP_020935183.1;XP_020935182.1;XP_020935181.1;NP_999540.1;XP_020935180.1;XP_020935179.1;XP_020935178.1;XP_013846457.1;XP_005657973.1;XP_005657972.1;XP_005657971.1;XP_013846455.1;XP_020935188.1;XP_013846458.1;XP_020935187.1	XP_020935185.1 four and a half LIM domains protein 1 isoform X5 [Sus scrofa];XP_020935184.1 four and a half LIM domains protein 1 isoform X5 [Sus scrofa];XP_020935183.1 four and a half LIM domains protein 1 isoform X5 [Sus scrofa];XP_020935182.1 four and a	26	26	26	2405500000	8207200000	7412200000	4736700000	2543200000	4513900000	4321400000	3863300000	4637200000	7441600000	4263300000	7364600000	4627500000	4865900000	3735400000	6900800000	5835400000	6487200000	NA	NA	NA	FHL1	FHL1;FHL1;FHL1;FHL1;FHL1	regulation of membrane depolarization;cell differentiation;positive regulation of potassium ion transport;negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell growth;negative regulation of G2/M transition of mitotic cell cycle;muscle organ development;animal organ morphogenesis;regulation of potassium ion transmembrane transporter activity	GO:000325; GO:003015; GO:004326; GO:200013; GO:003030; GO:001097; GO:000751; GO:000988; GO:190101	plasma membrane;nucleus;cytoplasm;cytosol;focal adhesion	GO:000588; GO:000563; GO:000573; GO:000582; GO:000592	"NA"	"NA"	metal ion binding;molecular_function;protein binding;ion channel binding	GO:004687; GO:000367; GO:000551; GO:004432
XP_020935312.1	XP_020935312.1	XP_020935312.1 spermine synthase [Sus scrofa]	6	6	6	16705000	14258000	15310000	0	22865000	12363000	15670000	16302000	27583000	19410000	21236000	0	13760000	17131000	17012000	16986000	20789000	16292000	NA	NA	NA	SMS	SMS;NA;NA;NA;NA	polyamine metabolic process;methionine metabolic process;spermine biosynthetic process	GO:000659; GO:000655; GO:000659	extracellular exosome;cytosol	GO:007006; GO:000582	 Arginine and proline metabolism; Metabolic pathways; Cysteine and methionine metabolism; beta-Alanine metabolism; Glutathione metabolism	hsa0033; hsa0110; hsa0027; hsa0041; hsa0048	spermine synthase activity	GO:001676
XP_020935424.1;XP_020935429.1;XP_020935427.1;XP_020935423.1;XP_020935422.1;XP_020935421.1;XP_020935420.1;XP_020935419.1;XP_020935426.1;XP_020935425.1	XP_020935424.1;XP_020935429.1;XP_020935427.1;XP_020935423.1;XP_020935422.1;XP_020935421.1;XP_020935420.1;XP_020935419.1;XP_020935426.1;XP_020935425.1	XP_020935424.1 glycogenin-2 isoform X2 [Sus scrofa];XP_020935429.1 glycogenin-2 isoform X1 [Sus scrofa];XP_020935427.1 glycogenin-2 isoform X1 [Sus scrofa];XP_020935423.1 glycogenin-2 isoform X1 [Sus scrofa];XP_020935422.1 glycogenin-2 isoform X1 [Sus scro	6	6	5	60046000	54448000	49234000	27032000	49813000	19347000	50588000	32619000	56084000	31475000	63179000	26450000	22479000	24361000	55271000	41211000	48847000	30699000	NA	NA	NA	GYG2	GYG2;GYG2;GYG2;GYG2;GYG2	glycogen biosynthetic process	GO:000597	cytosol	GO:000582	"NA"	"NA"	glycogenin glucosyltransferase activity	GO:000846
XP_020935490.1	XP_020935490.1	XP_020935490.1 ubiquilin-2 [Sus scrofa]	5	3	3	0	0	0	0	0	0	0	0	0	8482100	0	0	0	0	0	0	6181100	0	NA	NA	NA	UBQLN2	UBQLN2;NA;NA;NA;NA	autophagosome assembly;negative regulation of clathrin-dependent endocytosis;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;negative regulation of G-protein coupled receptor internalization;autophagy;regulation of macroautophagy;regulation of autophagosome assembly;ubiquitin-dependent protein catabolic process;ubiquitin-dependent ERAD pathway	GO:000004; GO:190018; GO:190307; GO:190402; GO:000691; GO:001624; GO:200078; GO:000651; GO:003043	cytoplasm;nucleus;autophagosome;cytosol;cytoplasmic vesicle;plasma membrane	GO:000573; GO:000563; GO:000577; GO:000582; GO:003141; GO:000588	 Protein processing in endoplasmic reticulum	hsa0414	polyubiquitin binding;protein binding	GO:003159; GO:000551
XP_020935506.1	XP_020935506.1	XP_020935506.1 cylicin-1 [Sus scrofa]	1	1	1	0	252050000	186750000	0	0	0	0	165630000	0	124720000	0	0	0	234040000	0	0	0	0	NA	NA	NA	CYLC1	CYLC1;NA;NA;NA;NA	multicellular organism development;cell differentiation;cytoskeleton organization;spermatogenesis	GO:000727; GO:003015; GO:000701; GO:000728	acrosomal matrix;nucleus;cytoskeletal calyx	GO:004315; GO:000563; GO:003315	"NA"	"NA"	structural constituent of cytoskeleton;structural molecule activity	GO:000520; GO:000519
XP_020935811.1;XP_020935810.1;XP_020935809.1;XP_020935808.1;XP_020935807.1;XP_020935806.1;XP_003484218.1;XP_020936613.1;XP_020936612.1;XP_020936611.1	XP_020935811.1;XP_020935810.1;XP_020935809.1;XP_020935808.1;XP_020935807.1;XP_020935806.1	XP_020935811.1 probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X4 [Sus scrofa];XP_020935810.1 probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X3 [Sus scrofa];XP_020935809.1 probable ubiquitin carboxyl-terminal hydrolase FAF-X isof	10	10	10	0	20797000	21215000	18889000	0	0	16158000	0	0	21938000	0	0	17476000	0	0	15976000	18427000	15421000	NA	NA	NA	USP9X	USP9X;USP9X;USP9X;USP9X;USP9X	transforming growth factor beta receptor signaling pathway;BMP signaling pathway;rhythmic process;protein K48-linked deubiquitination;chromosome segregation;neuron migration;cellular protein metabolic process;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;positive regulation of DNA demethylation;female gamete generation;protein deubiquitination;protein stabilization;axon extension;protein targeting to peroxisome;cell division;negative regulation of transcription from RNA polymerase II promoter;cell cycle;regulation of circadian rhythm	GO:000717; GO:003050; GO:004851; GO:007110; GO:000705; GO:000176; GO:004426; GO:007194; GO:190153; GO:000729; GO:001657; GO:005082; GO:004867; GO:000662; GO:005130; GO:000012; GO:000704; GO:004275	cytoplasm;growth cone;membrane;cytosol	GO:000573; GO:003042; GO:001602; GO:000582	"NA"	"NA"	protein binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitinyl hydrolase activity;Lys48-specific deubiquitinase activity;ubiquitinyl hydrolase activity;co-SMAD binding;cysteine-type peptidase activity;thiol-dependent ubiquitin-specific protease activity	GO:000551; GO:000419; GO:003645; GO:199038; GO:010100; GO:007041; GO:000823; GO:000484
XP_020936173.1;XP_020936172.1;XP_020936171.1	XP_020936173.1;XP_020936172.1;XP_020936171.1	XP_020936173.1 Fanconi anemia group B protein [Sus scrofa];XP_020936172.1 Fanconi anemia group B protein [Sus scrofa];XP_020936171.1 Fanconi anemia group B protein [Sus scrofa]	1	1	1	0	76425000	55835000	108160000	48751000	199540000	0	126900000	49780000	0	60227000	138460000	39036000	0	45650000	88288000	68504000	116230000	NA	NA	NA	FANCB	FANCB;FANCB;FANCB;NA;NA	positive regulation of double-strand break repair via homologous recombination;replication-born double-strand break repair via sister chromatid exchange;interstrand cross-link repair;negative regulation of double-strand break repair via homologous recombination	GO:190516; GO:199041; GO:003629; GO:200004	nucleoplasm;Fanconi anaemia nuclear complex	GO:000565; GO:004324	 Fanconi anemia pathway	hsa0346	protein binding	GO:000551
XP_020936361.1;XP_020936360.1	XP_020936361.1;XP_020936360.1	XP_020936361.1 SH3 domain-binding glutamic acid-rich-like protein isoform X2 [Sus scrofa];XP_020936360.1 SH3 domain-binding glutamic acid-rich-like protein isoform X1 [Sus scrofa]	8	8	8	91338000	166100000	148050000	172580000	95183000	186160000	150930000	168790000	135720000	231170000	162080000	213400000	259630000	146730000	134090000	175800000	114010000	155900000	NA	NA	NA	SH3BGRL	SH3BGRL;SH3BGRL;NA;NA;NA	positive regulation of signal transduction	GO:000996	nucleus;extracellular space;cytoplasm;extracellular exosome	GO:000563; GO:000561; GO:000573; GO:007006	"NA"	"NA"	SH3/SH2 adaptor activity;SH3 domain binding	GO:000507; GO:001712
XP_020936397.1;XP_020936396.1;XP_020936395.1;XP_020936390.1;XP_020936389.1;XP_020936387.1;XP_020936394.1;XP_020936393.1;XP_020936392.1;XP_020936388.1;XP_020936386.1;XP_020936385.1;XP_020936384.1;XP_020936383.1;XP_020936382.1;XP_020936398.1	XP_020936397.1;XP_020936396.1;XP_020936395.1;XP_020936390.1;XP_020936389.1;XP_020936387.1;XP_020936394.1;XP_020936393.1;XP_020936392.1;XP_020936388.1;XP_020936386.1;XP_020936385.1;XP_020936384.1;XP_020936383.1;XP_020936382.1;XP_020936398.1	XP_020936397.1 filamin-A isoform X10 [Sus scrofa];XP_020936396.1 filamin-A isoform X10 [Sus scrofa];XP_020936395.1 filamin-A isoform X10 [Sus scrofa];XP_020936390.1 filamin-A isoform X8 [Sus scrofa];XP_020936389.1 filamin-A isoform X7 [Sus scrofa];XP_02093	124	124	115	2749800000	4990300000	9367500000	3459200000	2113500000	9345100000	2610400000	8007600000	4231500000	16432000000	6186000000	9393500000	20670000000	3869000000	2551500000	4037500000	2840600000	3774500000	NA	NA	NA	FLNA	FLNA;FLNA;FLNA;FLNA;FLNA	positive regulation of protein import into nucleus;receptor clustering;negative regulation of sequence-specific DNA binding transcription factor activity;defense response to virus;protein localization to plasma membrane;establishment of Sertoli cell barrier;positive regulation of integrin-mediated signaling pathway;adenylate cyclase-inhibiting dopamine receptor signaling pathway;negative regulation of apoptotic process;platelet activation;actin cytoskeleton reorganization;negative regulation of protein catabolic process;positive regulation of potassium ion transmembrane transport;positive regulation of neural precursor cell proliferation;actin crosslink formation;regulation of membrane repolarization during atrial cardiac muscle cell action potential;positive regulation of neuron migration;negative regulation of transcription from RNA polymerase I promoter;formation of radial glial scaffolds;establishment of protein localization;cytoplasmic sequestering of protein;mitotic spindle assembly;regulation of membrane repolarization during cardiac muscle cell action potential;cilium assembly;mRNA transcription from RNA polymerase II promoter;positive regulation of I-kappaB kinase/NF-kappaB signaling;regulation of cell migration;cell junction assembly;protein localization to cell surface;positive regulation of actin filament bundle assembly;wound healing, spreading of cells;platelet degranulation;protein stabilization;cerebral cortex development;platelet aggregation;semaphorin-plexin signaling pathway;positive regulation of substrate adhesion-dependent cell spreading;protein localization to bicellular tight junction	GO:004230; GO:004311; GO:004343; GO:005160; GO:007265; GO:009736; GO:200104; GO:000719; GO:004306; GO:003016; GO:003153; GO:004217; GO:190138; GO:200017; GO:005176; GO:190500; GO:200122; GO:001647; GO:002194; GO:004518; GO:005122; GO:009030; GO:190503; GO:006027; GO:004278; GO:004312; GO:003033; GO:003432; GO:003439; GO:003223; GO:004431; GO:000257; GO:005082; GO:002198; GO:007052; GO:007152; GO:190002; GO:190239	membrane;cytosol;nucleolus;cortical cytoskeleton;dendritic shaft;postsynapse;nucleus;filamentous actin;plasma membrane;cell-cell junction;focal adhesion;apical dendrite;actin cytoskeleton;perinuclear region of cytoplasm;extracellular region;Z disc;extracellular exosome;Myb complex;neuronal cell body;glutamatergic synapse	GO:001602; GO:000582; GO:000573; GO:003086; GO:004319; GO:009879; GO:000563; GO:003194; GO:000588; GO:000591; GO:000592; GO:009744; GO:001562; GO:004847; GO:000557; GO:003001; GO:007006; GO:003152; GO:004302; GO:009897	 Salmonella infection; Proteoglycans in cancer; MAPK signaling pathway; Focal adhesion	hsa0513; hsa0520; hsa0401; hsa0451	potassium channel regulator activity;cadherin binding;G-protein coupled receptor binding;RNA binding;GTPase binding;Ral GTPase binding;SMAD binding;Fc-gamma receptor I complex binding;ion channel binding;protein binding;kinase binding;Rac GTPase binding;actin filament binding;small GTPase binding;protein homodimerization activity;transcription factor binding;Rho GTPase binding;mu-type opioid receptor binding	GO:001545; GO:004529; GO:000166; GO:000372; GO:005102; GO:001716; GO:004633; GO:003498; GO:004432; GO:000551; GO:001990; GO:004836; GO:005101; GO:003126; GO:004280; GO:000813; GO:001704; GO:003185
XP_020936417.1;XP_020936416.1	XP_020936417.1	XP_020936417.1 emerin isoform X2 [Sus scrofa]	11	11	11	47168000	100380000	80996000	99370000	64597000	106730000	84084000	109060000	83092000	88477000	72949000	120510000	98853000	105510000	69839000	99752000	85077000	101350000	NA	NA	NA	EMD	EMD;NA;NA;NA;NA	negative regulation of fibroblast proliferation;mitotic nuclear envelope reassembly;negative regulation of canonical Wnt signaling pathway;cellular response to growth factor stimulus;muscle organ development;positive regulation of protein export from nucleus;muscle contraction;skeletal muscle cell differentiation;regulation of canonical Wnt signaling pathway	GO:004814; GO:000708; GO:009009; GO:007136; GO:000751; GO:004682; GO:000693; GO:003591; GO:006082	cytoplasm;nuclear membrane;membrane;nucleoplasm;nuclear inner membrane;cortical endoplasmic reticulum;microtubule;endoplasmic reticulum;spindle pole centrosome;nuclear outer membrane;spindle	GO:000573; GO:003196; GO:001602; GO:000565; GO:000563; GO:003254; GO:000587; GO:000578; GO:003161; GO:000564; GO:000581	 Dilated cardiomyopathy; Hypertrophic cardiomyopathy (HCM)	hsa0541; hsa0541	beta-tubulin binding;cadherin binding;protein binding;actin binding	GO:004848; GO:004529; GO:000551; GO:000377
XP_020936461.1	XP_020936461.1	XP_020936461.1 LOW QUALITY PROTEIN: methyl-CpG-binding protein 2 [Sus scrofa]	5	5	5	0	18928000	0	0	0	21555000	17557000	0	22450000	19040000	16297000	24425000	22376000	0	0	0	0	19927000	NA	NA	NA	MECP2	MECP2;NA;NA;NA;NA	transcription initiation from RNA polymerase II promoter;visual learning;histone acetylation;positive regulation of transcription, DNA-templated;negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation;behavioral fear response;startle response;neurological system process involved in regulation of systemic arterial blood pressure;cellular biogenic amine metabolic process;dendrite development;catecholamine secretion;inositol metabolic process;sensory perception of pain;neuron maturation;synapse assembly;glucocorticoid metabolic process;phosphatidylcholine metabolic process;adult locomotory behavior;post-embryonic development;negative regulation of gene expression;social behavior;negative regulation of blood vessel endothelial cell migration;positive regulation of synapse assembly;mitochondrial electron transport, ubiquinol to cytochrome c;long-term memory;protein localization;negative regulation of angiogenesis;negative regulation of histone methylation;cardiolipin metabolic process;negative regulation of smooth muscle cell differentiation;regulation of gene expression by genetic imprinting;mitotic spindle organization;respiratory gaseous exchange;positive regulation of G2/M transition of mitotic cell cycle;negative regulation of histone acetylation;excitatory postsynaptic potential;long-term synaptic potentiation;positive regulation of histone H3-K9 trimethylation;negative regulation of transcription from RNA polymerase II promoter;regulation of respiratory gaseous exchange by neurological system process;glutamine metabolic process;positive regulation of cell proliferation;response to radiation;pathogenesis;cerebellum development;ventricular system development;negative regulation of neuron apoptotic process;positive regulation of microtubule nucleation;positive regulation of DNA methylation	GO:000636; GO:000854; GO:001657; GO:004589; GO:200082; GO:000166; GO:000196; GO:000197; GO:000657; GO:001635; GO:005043; GO:000602; GO:001923; GO:004255; GO:000741; GO:000821; GO:004647; GO:000834; GO:000979; GO:001062; GO:003517; GO:004353; GO:005196; GO:000612; GO:000761; GO:000810; GO:001652; GO:003106; GO:003204; GO:005115; GO:000634; GO:000705; GO:000758; GO:001097; GO:003506; GO:006007; GO:006029; GO:190011; GO:000012; GO:000208; GO:000654; GO:000828; GO:000931; GO:000940; GO:002154; GO:002159; GO:004352; GO:009006; GO:190564	heterochromatin;mitochondrion;extracellular space;nucleus;chromatin;centrosome;postsynapse;nucleoplasm;cytosol	GO:000079; GO:000573; GO:000561; GO:000563; GO:000078; GO:000581; GO:009879; GO:000565; GO:000582	"NA"	"NA"	DNA binding;RNA binding;methyl-CpG binding;siRNA binding;transcription factor binding;double-stranded methylated DNA binding;protein domain specific binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;transcription corepressor activity;protein binding;protein N-terminus binding	GO:000367; GO:000372; GO:000832; GO:003519; GO:000813; GO:001038; GO:001990; GO:000122; GO:000371; GO:000551; GO:004748
XP_020936478.1;NP_999174.1;CON__Q2UVX4	XP_020936478.1;NP_999174.1	XP_020936478.1 complement C3 isoform X1 [Sus scrofa];NP_999174.1 complement C3 precursor [Sus scrofa]	88	88	88	5088700000	2241400000	3223900000	3287400000	7773700000	6676700000	5838700000	2231100000	5128800000	2859800000	4000300000	1892800000	5401900000	3106800000	3788900000	1603100000	4978800000	2430500000	NA	NA	NA	C3	C3;C3;NA;NA;NA	complement activation, classical pathway;neutrophil degranulation;positive regulation of vascular endothelial growth factor production;beta-amyloid clearance;complement activation, alternative pathway;positive regulation of glucose transport;regulation of triglyceride biosynthetic process;positive regulation of lipid storage;positive regulation of phagocytosis, engulfment;regulation of complement activation;G-protein coupled receptor signaling pathway;negative regulation of endopeptidase activity;positive regulation of G-protein coupled receptor protein signaling pathway;regulation of immune response;positive regulation of activation of membrane attack complex;proteolysis;response to bacterium;positive regulation of angiogenesis;positive regulation of type IIa hypersensitivity;positive regulation of protein phosphorylation;fatty acid metabolic process;post-translational protein modification;positive regulation of receptor-mediated endocytosis;cell surface receptor signaling pathway involved in cell-cell signaling;signal transduction;cellular protein metabolic process;positive regulation of apoptotic cell clearance	GO:000695; GO:004331; GO:001057; GO:009724; GO:000695; GO:001082; GO:001086; GO:001088; GO:006010; GO:003044; GO:000718; GO:001095; GO:004574; GO:005077; GO:000197; GO:000650; GO:000961; GO:004576; GO:000179; GO:000193; GO:000663; GO:004368; GO:004826; GO:190511; GO:000716; GO:004426; GO:200042	extracellular region;azurophil granule lumen;plasma membrane;extracellular space;endoplasmic reticulum lumen;macromolecular complex;extracellular exosome;blood microparticle;secretory granule lumen	GO:000557; GO:003557; GO:000588; GO:000561; GO:000578; GO:003299; GO:007006; GO:007256; GO:003477	 Complement and coagulation cascades; Viral carcinogenesis; Tuberculosis; Legionellosis; Systemic lupus erythematosus; Chagas disease (American trypanosomiasis); Phagosome; Herpes simplex infection	hsa0461; hsa0520; hsa0515; hsa0513; hsa0532; hsa0514; hsa0414; hsa0516	serine-type endopeptidase activity;C5L2 anaphylatoxin chemotactic receptor binding;endopeptidase inhibitor activity;receptor binding;protein binding	GO:000425; GO:003171; GO:000486; GO:000510; GO:000551
XP_020936483.1	XP_020936483.1	XP_020936483.1 TSC22 domain family protein 3 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	TSC22D3	TSC22D3;NA;NA;NA;NA	regulation of transcription from RNA polymerase II promoter;negative regulation of activation-induced cell death of T cells;regulation of transcription, DNA-templated;ion transmembrane transport;response to osmotic stress	GO:000635; GO:007023; GO:000635; GO:003422; GO:000697	nucleus;cytosol	GO:000563; GO:000582	"NA"	"NA"	transcription factor activity, sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding	GO:000370; GO:000098
XP_020936711.1;XP_020936710.1	XP_020936711.1;XP_020936710.1	XP_020936711.1 dipeptidyl peptidase 2 isoform X2 [Sus scrofa];XP_020936710.1 dipeptidyl peptidase 2 isoform X1 [Sus scrofa]	5	5	5	19900000	24014000	21226000	43061000	21083000	24369000	26184000	42475000	28811000	28576000	26915000	22999000	40355000	32160000	27316000	24713000	25271000	30905000	NA	NA	NA	DPP7	DPP7;DPP7;NA;NA;NA	neutrophil degranulation;proteolysis	GO:004331; GO:000650	extracellular exosome;vesicle;Golgi apparatus;cytosol;extracellular region;azurophil granule lumen;intracellular membrane-bounded organelle	GO:007006; GO:003198; GO:000579; GO:000582; GO:000557; GO:003557; GO:004323	"NA"	"NA"	serine-type peptidase activity;dipeptidyl-peptidase activity	GO:000823; GO:000823
XP_020936714.1	XP_020936714.1	XP_020936714.1 UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 [Sus scrofa]	5	4	4	0	5043400	5628900	6579100	0	5156400	3031100	6279600	4176600	5166600	0	6424900	0	6426600	0	4745300	0	4771400	NA	NA	NA	UAP1L1	UAP1L1;NA;NA;NA;NA	UDP-N-acetylglucosamine biosynthetic process	GO:000604	"NA"	"NA"	 Amino sugar and nucleotide sugar metabolism; Biosynthesis of antibiotics; Metabolic pathways	hsa0052; hsa0113; hsa0110	UDP-N-acetylglucosamine diphosphorylase activity	GO:000397
XP_020936813.1	XP_020936813.1	XP_020936813.1 LOW QUALITY PROTEIN: mitochondrial-processing peptidase subunit alpha [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	192150	NA	NA	NA	PMPCA	PMPCA;NA;NA;NA;NA	proteolysis;mitochondrial calcium ion transport;protein processing involved in protein targeting to mitochondrion	GO:000650; GO:000685; GO:000662	extracellular space;mitochondrial processing peptidase complex;mitochondrial inner membrane;mitochondrion;mitochondrial matrix	GO:000561; GO:001708; GO:000574; GO:000573; GO:000575	"NA"	"NA"	metal ion binding;endopeptidase activity;metalloendopeptidase activity	GO:004687; GO:000417; GO:000422
XP_020936881.1;XP_020936880.1	XP_020936881.1;XP_020936880.1	XP_020936881.1 14 kDa phosphohistidine phosphatase isoform X8 [Sus scrofa];XP_020936880.1 14 kDa phosphohistidine phosphatase isoform X8 [Sus scrofa]	3	3	3	104740000	97920000	91329000	71459000	75627000	53207000	104540000	77491000	99290000	79474000	93741000	105790000	63109000	68675000	109840000	68598000	97896000	53441000	NA	NA	NA	LOC100513261	LOC100513261;LOC100513261;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020936903.1	XP_020936903.1	XP_020936903.1 chloride intracellular channel protein 3 [Sus scrofa]	3	3	3	0	0	0	0	12126000	0	15874000	0	0	0	0	0	0	0	0	0	17301000	0	NA	NA	NA	CLIC3	CLIC3;NA;NA;NA;NA	signal transduction;regulation of ion transmembrane transport;chloride transport;chloride transmembrane transport	GO:000716; GO:003476; GO:000682; GO:190247	chloride channel complex;cytoplasm;extracellular exosome;nucleus;nuclear body	GO:003470; GO:000573; GO:007006; GO:000563; GO:001660	"NA"	"NA"	voltage-gated ion channel activity;protein binding;chloride channel activity	GO:000524; GO:000551; GO:000525
XP_020937004.1;XP_020937003.1;XP_020937002.1;XP_020937001.1;XP_020937000.1;XP_020936999.1	XP_020937004.1;XP_020937003.1;XP_020937002.1;XP_020937001.1;XP_020937000.1;XP_020936999.1	XP_020937004.1 rho GTPase-activating protein 17 isoform X6 [Sus scrofa];XP_020937003.1 rho GTPase-activating protein 17 isoform X5 [Sus scrofa];XP_020937002.1 rho GTPase-activating protein 17 isoform X4 [Sus scrofa];XP_020937001.1 rho GTPase-activating pro	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2713400	0	0	NA	NA	NA	ARHGAP17	ARHGAP17;ARHGAP17;ARHGAP17;ARHGAP17;ARHGAP17	actin filament organization;regulation of small GTPase mediated signal transduction;calcium ion regulated exocytosis;signal transduction;regulation of actin cytoskeleton organization;positive regulation of GTPase activity	GO:000701; GO:005105; GO:001715; GO:000716; GO:003295; GO:004354	cytosol;nucleus;plasma membrane;bicellular tight junction;cytoplasm	GO:000582; GO:000563; GO:000588; GO:000592; GO:000573	"NA"	"NA"	SH3 domain binding;Rac GTPase binding;protein binding;GTPase activator activity	GO:001712; GO:004836; GO:000551; GO:000509
XP_020937133.1	XP_020937133.1	XP_020937133.1 hibernation-associated plasma protein HP-27-like [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	27945000	0	0	0	0	0	0	NA	NA	NA	LOC110258310	LOC110258310;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937134.1	XP_020937134.1	XP_020937134.1 protein HP-25 homolog 1-like [Sus scrofa]	2	2	2	0	0	0	0	67205000	52322000	54388000	0	0	0	44059000	36170000	0	0	74956000	0	39994000	0	NA	NA	NA	LOC110258312	LOC110258312;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937147.1;XP_020937146.1;XP_020937145.1;XP_020937148.1	XP_020937147.1;XP_020937146.1;XP_020937145.1;XP_020937148.1	XP_020937147.1 target of Myb protein 1 isoform X3 [Sus scrofa];XP_020937146.1 target of Myb protein 1 isoform X2 [Sus scrofa];XP_020937145.1 target of Myb protein 1 isoform X1 [Sus scrofa];XP_020937148.1 target of Myb protein 1 isoform X4 [Sus scrofa]	12	12	12	76836000	77922000	75436000	65639000	57161000	52112000	64079000	64101000	50401000	60070000	71349000	44833000	53996000	62256000	82339000	77803000	67689000	64847000	NA	NA	NA	TOM1	TOM1;TOM1;TOM1;TOM1;NA	endocytosis;neutrophil degranulation;intracellular protein transport;protein transport;endosomal transport	GO:000689; GO:004331; GO:000688; GO:001503; GO:001619	extracellular exosome;endosome;specific granule membrane;cytoplasm;plasma membrane;membrane;cytosol	GO:007006; GO:000576; GO:003557; GO:000573; GO:000588; GO:001602; GO:000582	"NA"	"NA"	protein binding;clathrin binding	GO:000551; GO:003027
XP_020938149.1;XP_020938148.1;XP_020937154.1	XP_020938149.1;XP_020938148.1;XP_020937154.1	XP_020938149.1 protein S100-B [Sus scrofa];XP_020938148.1 protein S100-B [Sus scrofa];XP_020937154.1 protein S100-B-like [Sus scrofa]	2	2	2	35249000	165260000	41537000	52790000	31823000	34599000	45873000	54853000	43414000	49008000	71556000	112090000	102360000	68049000	34527000	43334000	38440000	50337000	NA	NA	NA	S100B	S100B;S100B;LOC110258323;NA;NA	memory;regulation of cell shape;innate immune response;learning or memory;positive regulation of myelination;regulation of neuronal synaptic plasticity;astrocyte differentiation;long-term synaptic potentiation;cell proliferation;response to glucocorticoid;central nervous system development;positive regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to hypoxia;axonogenesis;response to methylmercury;negative regulation of skeletal muscle cell differentiation;positive regulation of apoptotic process	GO:000761; GO:000836; GO:004508; GO:000761; GO:003164; GO:004816; GO:004870; GO:006029; GO:000828; GO:005138; GO:000741; GO:004312; GO:007145; GO:000740; GO:005159; GO:200101; GO:004306	cytoplasm;perinuclear region of cytoplasm;extracellular space;ruffle;nucleus;extracellular region;neuronal cell body	GO:000573; GO:004847; GO:000561; GO:000172; GO:000563; GO:000557; GO:004302	"NA"	"NA"	calcium ion binding;protein binding;S100 protein binding;calcium-dependent protein binding;zinc ion binding;protein homodimerization activity;tau protein binding;RAGE receptor binding	GO:000550; GO:000551; GO:004454; GO:004830; GO:000827; GO:004280; GO:004815; GO:005078
XP_020937162.1	XP_020937162.1	XP_020937162.1 protein AHNAK2 [Sus scrofa]	7	7	7	0	138310000	40010000	59472000	25663000	113090000	38651000	51901000	44289000	57894000	47504000	0	74079000	100640000	70966000	65752000	59342000	93367000	NA	NA	NA	AHNAK2	AHNAK2;NA;NA;NA;NA	plasma membrane repair;regulation of RNA splicing	GO:000177; GO:004348	plasma membrane;nucleus;costamere;cytoplasm;cytoplasmic vesicle membrane;cytosol;Z disc;T-tubule;sarcolemma	GO:000588; GO:000563; GO:004303; GO:000573; GO:003065; GO:000582; GO:003001; GO:003031; GO:004238	"NA"	"NA"	protein binding	GO:000551
XP_020937174.1	XP_020937174.1	XP_020937174.1 LOW QUALITY PROTEIN: inverted formin-2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1665600	0	0	NA	NA	NA	INF2	INF2;NA;NA;NA;NA	actin cytoskeleton organization;regulation of mitochondrial fission	GO:003003; GO:009014	perinuclear region of cytoplasm	GO:004847	"NA"	"NA"	actin binding;Rho GTPase binding	GO:000377; GO:001704
XP_020937195.1;XP_020937193.1;XP_005653595.2;XP_005653594.2;XP_005653593.2;XP_020937197.1;XP_020937196.1;XP_020937194.1;XP_020937192.1;XP_013833405.1;XP_020954394.1;XP_013833404.1;XP_005666074.1;XP_001929257.1;XP_005660722.1;XP_005660721.1;XP_003122551.1	XP_020937195.1;XP_020937193.1;XP_005653595.2;XP_005653594.2;XP_005653593.2;XP_020937197.1;XP_020937196.1;XP_020937194.1;XP_020937192.1	XP_020937195.1 kinesin light chain 1 isoform X4 [Sus scrofa];XP_020937193.1 kinesin light chain 1 isoform X2 [Sus scrofa];XP_005653595.2 kinesin light chain 1 isoform X9 [Sus scrofa];XP_005653594.2 kinesin light chain 1 isoform X8 [Sus scrofa];XP_005653593	7	7	7	0	28798000	22389000	21198000	0	18433000	0	23699000	17235000	21255000	20206000	23395000	0	23094000	22256000	20163000	0	22197000	NA	NA	NA	KLC1	KLC1;KLC1;KLC1;KLC1;KLC1	antigen processing and presentation of exogenous peptide antigen via MHC class II;stress granule disassembly;microtubule-based movement;viral process;retrograde vesicle-mediated transport, Golgi to ER	GO:001988; GO:003561; GO:000701; GO:001603; GO:000689	cytosol;microtubule;membrane;growth cone;cytoplasmic vesicle	GO:000582; GO:000587; GO:001602; GO:003042; GO:003141	 Salmonella infection	hsa0513	motor activity;microtubule motor activity;protein binding	GO:000377; GO:000377; GO:000551
XP_020937243.1	XP_020937243.1	XP_020937243.1 LOW QUALITY PROTEIN: cytoplasmic dynein 1 heavy chain 1 [Sus scrofa]	117	117	117	812250000	938850000	898420000	844790000	786150000	863690000	742350000	917210000	802590000	844550000	756310000	923670000	865460000	891200000	783550000	885770000	846880000	904520000	NA	NA	NA	DYNC1H1	DYNC1H1;NA;NA;NA;NA	regulation of G2/M transition of mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class II;G2/M transition of mitotic cell cycle;mitotic spindle organization;regulation of mitotic spindle organization;minus-end-directed vesicle transport along microtubule;cytoplasmic microtubule organization;neutrophil degranulation;cytoplasmic mRNA processing body assembly;establishment of spindle localization;cell division;positive regulation of intracellular transport;stress granule assembly;regulation of metaphase plate congression;positive regulation of spindle assembly;ER to Golgi vesicle-mediated transport;microtubule-based movement;ciliary basal body docking	GO:001038; GO:001988; GO:000008; GO:000705; GO:006023; GO:007238; GO:003112; GO:004331; GO:003396; GO:005129; GO:005130; GO:003238; GO:003406; GO:009023; GO:190583; GO:000688; GO:000701; GO:009771	microtubule;extracellular region;extracellular exosome;membrane;azurophil granule lumen;centrosome;dynein complex;cytosol;cytoplasmic dynein complex;filopodium	GO:000587; GO:000557; GO:007006; GO:001602; GO:003557; GO:000581; GO:003028; GO:000582; GO:000586; GO:003017	 Phagosome; Salmonella infection; Vasopressin-regulated water reabsorption	hsa0414; hsa0513; hsa0496	dynein intermediate chain binding;RNA binding;ATP-dependent microtubule motor activity, minus-end-directed;protein binding;ATP binding;dynein light chain binding;dynein light intermediate chain binding	GO:004550; GO:000372; GO:000856; GO:000551; GO:000552; GO:004550; GO:005195
XP_020937308.1;XP_020937307.1	XP_020937308.1;XP_020937307.1	XP_020937308.1 cysteine-rich protein 2 isoform X2 [Sus scrofa];XP_020937307.1 cysteine-rich protein 2 isoform X1 [Sus scrofa]	6	6	6	62562000	100950000	117760000	101080000	107560000	164380000	71008000	134710000	74462000	216090000	71932000	188750000	195410000	132850000	79835000	135870000	177790000	167300000	NA	NA	NA	CRIP2	CRIP2;CRIP2;NA;NA;NA	positive regulation of cell proliferation;hemopoiesis	GO:000828; GO:003009	cell cortex	GO:000593	"NA"	"NA"	zinc ion binding;protein binding	GO:000827; GO:000551
XP_020937309.1	XP_020937309.1	XP_020937309.1 cysteine-rich protein 1 [Sus scrofa]	3	3	3	0	117670000	128650000	94553000	108700000	143340000	185410000	0	108350000	140050000	108970000	74081000	212430000	0	0	109020000	422410000	144860000	NA	NA	NA	LOC110258364	LOC110258364;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937318.1;XP_020937314.1;NP_001165834.1;XP_020937310.1;XP_013849955.2	XP_020937318.1;XP_020937314.1;NP_001165834.1;XP_020937310.1;XP_013849955.2	XP_020937318.1 L-lactate dehydrogenase A chain isoform X3 [Sus scrofa];XP_020937314.1 L-lactate dehydrogenase A chain isoform X3 [Sus scrofa];NP_001165834.1 L-lactate dehydrogenase A chain [Sus scrofa];XP_020937310.1 L-lactate dehydrogenase A chain isoform	20	20	19	1893700000	2028600000	2751100000	2381700000	2266700000	1718100000	3452300000	2187000000	2525000000	2530200000	2503300000	2487100000	2952700000	1587000000	1947600000	1842300000	9840000000	1689200000	NA	NA	NA	LDHA	LDHA;LDHA;LDHA;LDHA;LDHA	pyruvate metabolic process;response to nutrient;oxidation-reduction process;lactate metabolic process;response to glucose;post-embryonic animal organ development;NAD metabolic process;positive regulation of apoptotic process;response to hypoxia;glycolytic process;response to hydrogen peroxide;response to estrogen;response to cAMP	GO:000609; GO:000758; GO:005511; GO:000608; GO:000974; GO:004856; GO:001967; GO:004306; GO:000166; GO:000609; GO:004254; GO:004362; GO:005159	cytosol;membrane;nucleus;extracellular exosome	GO:000582; GO:001602; GO:000563; GO:007006	 HIF-1 signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer; Propanoate metabolism; Pyruvate metabolism; Glycolysis / Gluconeogenesis; Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of antibiotics	hsa0406; hsa0492; hsa0523; hsa0064; hsa0062; hsa0001; hsa0027; hsa0110; hsa0113	protein binding;cadherin binding;NAD binding;L-lactate dehydrogenase activity;kinase binding;identical protein binding	GO:000551; GO:004529; GO:005128; GO:000445; GO:001990; GO:004280
XP_020937324.1;XP_020937323.1;XP_020937322.1;XP_020937321.1;XP_020937320.1;XP_020953279.1	XP_020937324.1;XP_020937323.1;XP_020937322.1;XP_020937321.1;XP_020937320.1;XP_020953279.1	XP_020937324.1 eukaryotic translation initiation factor 5 [Sus scrofa];XP_020937323.1 eukaryotic translation initiation factor 5 [Sus scrofa];XP_020937322.1 eukaryotic translation initiation factor 5 [Sus scrofa];XP_020937321.1 eukaryotic translation initi	5	5	5	16083000	17131000	15649000	16688000	21315000	21637000	16892000	0	16323000	17761000	20989000	21400000	18413000	19925000	22544000	22208000	17195000	20292000	NA	NA	NA	EIF5	EIF5;EIF5;EIF5;EIF5;LOC100522498	formation of translation preinitiation complex;regulation of translational initiation;translational initiation;activation of GTPase activity	GO:000173; GO:000644; GO:000641; GO:009063	cytoplasm;cytosol;plasma membrane;nucleus	GO:000573; GO:000582; GO:000588; GO:000563	 RNA transport	hsa0301	GTPase activity;cadherin binding;protein binding;translation factor activity, RNA binding;translation initiation factor activity;RNA binding;GTP binding;eukaryotic initiation factor eIF2 binding	GO:000392; GO:004529; GO:000551; GO:000813; GO:000374; GO:000372; GO:000552; GO:007107
XP_020937502.1;XP_020937501.1;XP_020937504.1;XP_020937503.1;XP_020937505.1;XP_020937507.1;XP_020937508.1;CON__Q28085	XP_020937502.1;XP_020937501.1;XP_020937504.1;XP_020937503.1;XP_020937505.1	XP_020937502.1 complement factor H isoform X2 [Sus scrofa];XP_020937501.1 complement factor H isoform X1 [Sus scrofa];XP_020937504.1 complement factor H isoform X4 [Sus scrofa];XP_020937503.1 complement factor H isoform X3 [Sus scrofa];XP_020937505.1 compl	28	28	1	195710000	95061000	155340000	197700000	347100000	430040000	275280000	125530000	240500000	167460000	259430000	182590000	229880000	182430000	269150000	132230000	283140000	158780000	NA	NA	NA	CFH	CFH;CFH;CFH;CFH;CFH	viral process;complement activation, alternative pathway;regulation of complement activation	GO:001603; GO:000695; GO:003044	extracellular space;extracellular region;extracellular exosome;blood microparticle	GO:000561; GO:000557; GO:007006; GO:007256	 Staphylococcus aureus infection; Complement and coagulation cascades	hsa0515; hsa0461	heparin binding;protein binding;heparan sulfate proteoglycan binding	GO:000820; GO:000551; GO:004339
XP_020937679.1;XP_020937675.1;XP_020937671.1;XP_020937668.1;XP_020937666.1;NP_001026948.1	XP_020937679.1;XP_020937675.1;XP_020937671.1;XP_020937668.1;XP_020937666.1;NP_001026948.1	XP_020937679.1 perilipin-3 isoform X4 [Sus scrofa];XP_020937675.1 perilipin-3 isoform X3 [Sus scrofa];XP_020937671.1 perilipin-3 isoform X2 [Sus scrofa];XP_020937668.1 perilipin-3 isoform X2 [Sus scrofa];XP_020937666.1 perilipin-3 isoform X1 [Sus scrofa];N	5	5	5	0	28865000	22591000	26748000	0	0	0	31951000	0	32367000	20830000	42577000	0	39225000	0	35776000	26758000	26683000	NA	NA	NA	PLIN3	PLIN3;PLIN3;PLIN3;PLIN3;PLIN3	vesicle-mediated transport	GO:001619	Golgi apparatus;lipid particle;cytoplasm;membrane;cytosol;endosome;transport vesicle;endosome membrane	GO:000579; GO:000581; GO:000573; GO:001602; GO:000582; GO:000576; GO:003013; GO:001000	"NA"	"NA"	protein binding;cadherin binding	GO:000551; GO:004529
XP_020937678.1;XP_020938705.1	XP_020937678.1	XP_020937678.1 LOW QUALITY PROTEIN: 182 kDa tankyrase-1-binding protein [Sus scrofa]	14	14	14	0	23313000	29310000	0	29347000	53518000	38842000	59811000	0	41625000	54951000	49101000	0	50946000	51709000	45471000	35234000	43936000	NA	NA	NA	LOC100625088	LOC100625088;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937728.1;XP_020937730.1;XP_020937729.1	XP_020937728.1;XP_020937730.1;XP_020937729.1	XP_020937728.1 LOW QUALITY PROTEIN: Ig heavy chain V region 914 [Sus scrofa];XP_020937730.1 uncharacterized protein LOC110258822 [Sus scrofa];XP_020937729.1 uncharacterized protein LOC110258821 [Sus scrofa]	2	1	1	0	0	0	0	0	59343000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC110258822	LOC445536;LOC110258822;LOC110258821;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937731.1;XP_020937611.1;XP_020937732.1	XP_020937731.1;XP_020937611.1;XP_020937732.1	XP_020937731.1 uncharacterized protein LOC110258824 [Sus scrofa];XP_020937611.1 immunoglobulin heavy variable 3-23 [Sus scrofa];XP_020937732.1 uncharacterized protein LOC110258825 [Sus scrofa]	3	2	1	7198400000	8593200000	5348900000	11721000000	7406300000	12070000000	7462800000	5997900000	5768500000	6536500000	6992700000	5755300000	8739000000	9965600000	9949500000	7577600000	8385100000	10619000000	NA	NA	NA	LOC100038329	LOC110258824;LOC100038329;LOC110258825;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937734.1	XP_020937734.1	XP_020937734.1 immunoglobulin heavy variable 3-23 [Sus scrofa]	3	2	2	9422400	6192500	3562500	5798100	12467000	0	0	0	6553700	6080300	0	0	7019600	6138200	0	7789700	0	8431300	NA	NA	NA	LOC100038328	LOC100038328;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020937735.1	XP_020937735.1	XP_020937735.1 immunoglobulin heavy variable 3-23 [Sus scrofa]	3	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LOC100125542	LOC100125542;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020938146.1;XP_020938243.1	XP_020938146.1;XP_020938243.1	XP_020938146.1 LOW QUALITY PROTEIN: mucin-5B [Sus scrofa];XP_020938243.1 LOW QUALITY PROTEIN: mucin-2 [Sus scrofa]	2	1	1	0	0	0	0	11650000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MUC5B	MUC5B;MUC2;NA;NA;NA	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	GO:000222; GO:001626	Golgi lumen;extracellular exosome;extracellular space;plasma membrane;intracellular membrane-bounded organelle	GO:000579; GO:007006; GO:000561; GO:000588; GO:004323	 Salivary secretion	hsa0497	protein binding	GO:000551
XP_020938158.1	XP_020938158.1	XP_020938158.1 LOW QUALITY PROTEIN: collagen alpha-2(VI) chain [Sus scrofa]	27	27	27	1067800000	3155900000	1546000000	4437900000	1371700000	2297900000	2098400000	3452900000	1661400000	2329800000	2070200000	3893000000	3269600000	3432200000	2164300000	3821200000	2387700000	2823400000	NA	NA	NA	COL6A2	COL6A2;NA;NA;NA;NA	response to glucose;growth plate cartilage chondrocyte morphogenesis;cell adhesion;extracellular matrix organization;protein heterotrimerization	GO:000974; GO:000342; GO:000715; GO:003019; GO:007020	collagen trimer;extracellular space;sarcolemma;endoplasmic reticulum lumen;extracellular vesicle;extracellular region;extracellular matrix;macromolecular complex;extracellular exosome	GO:000558; GO:000561; GO:004238; GO:000578; GO:190356; GO:000557; GO:003101; GO:003299; GO:007006	 PI3K-Akt signaling pathway; Focal adhesion; Protein digestion and absorption	hsa0415; hsa0451; hsa0497	protein binding;extracellular matrix structural constituent conferring tensile strength	GO:000551; GO:003002
XP_020938159.1	XP_020938159.1	XP_020938159.1 lanosterol synthase [Sus scrofa]	17	17	17	362040000	292020000	161360000	317400000	204920000	179780000	242270000	324380000	180850000	251490000	219210000	210190000	82674000	364770000	180650000	337440000	166100000	228180000	NA	NA	NA	LSS	LSS;NA;NA;NA;NA	cholesterol biosynthetic process;steroid biosynthetic process;regulation of protein stability;regulation of cholesterol biosynthetic process	GO:000669; GO:000669; GO:003164; GO:004554	endoplasmic reticulum membrane;membrane;lipid particle	GO:000578; GO:001602; GO:000581	 Biosynthesis of antibiotics; Steroid biosynthesis; Metabolic pathways	hsa0113; hsa0010; hsa0110	lanosterol synthase activity	GO:000025
XP_020938202.1;XP_020938201.1;XP_020938200.1;XP_020938199.1;XP_020938198.1	XP_020938202.1;XP_020938201.1;XP_020938200.1;XP_020938199.1;XP_020938198.1	XP_020938202.1 ribonuclease inhibitor isoform X3 [Sus scrofa];XP_020938201.1 ribonuclease inhibitor isoform X3 [Sus scrofa];XP_020938200.1 ribonuclease inhibitor isoform X3 [Sus scrofa];XP_020938199.1 ribonuclease inhibitor isoform X2 [Sus scrofa];XP_02093	20	20	20	383840000	606820000	571240000	516690000	497140000	628920000	586680000	495000000	553930000	586690000	605720000	735740000	584890000	619870000	510520000	606130000	615010000	674210000	NA	NA	NA	RNH1	RNH1;RNH1;RNH1;RNH1;RNH1	mRNA catabolic process;negative regulation of catalytic activity;regulation of angiogenesis	GO:000640; GO:004308; GO:004576	nucleoplasm;cytosol;angiogenin-PRI complex;extracellular exosome	GO:000565; GO:000582; GO:003231; GO:007006	"NA"	"NA"	ribonuclease inhibitor activity;protein binding	GO:000842; GO:000551
XP_020938212.1;XP_020938213.1;NP_001038002.1	XP_020938212.1;XP_020938213.1;NP_001038002.1	XP_020938212.1 GTPase HRas isoform X1 [Sus scrofa];XP_020938213.1 GTPase HRas isoform X2 [Sus scrofa];NP_001038002.1 GTPase NRas precursor [Sus scrofa]	6	6	3	23117000	30215000	30419000	27572000	23475000	21768000	26708000	22231000	35863000	24309000	27811000	31880000	28636000	33613000	28094000	27159000	25053000	22237000	NA	NA	NA	HRAS	HRAS;HRAS;NRAS;NA;NA	positive regulation of interferon-gamma production;negative regulation of neuron apoptotic process;T cell receptor signaling pathway;cell proliferation;positive regulation of phospholipase C activity;positive regulation of cell migration;response to isolation stress;chemotaxis;cell cycle arrest;signal transduction;T-helper 1 type immune response;ephrin receptor signaling pathway;positive regulation of protein targeting to membrane;cellular senescence;animal organ morphogenesis;negative regulation of gene expression;positive regulation of MAP kinase activity;positive regulation of wound healing;positive regulation of miRNA metabolic process;MAPK cascade;positive regulation of protein phosphorylation;stimulatory C-type lectin receptor signaling pathway;endocytosis;protein heterooligomerization;positive regulation of ruffle assembly;negative regulation of GTPase activity;defense response to protozoan;positive regulation of GTPase activity;cellular response to gamma radiation;intrinsic apoptotic signaling pathway;positive regulation of actin cytoskeleton reorganization;mitotic cell cycle checkpoint;Ras protein signal transduction;positive regulation of MAPK cascade;positive regulation of DNA replication;positive regulation of transcription from RNA polymerase II promoter;positive regulation of JNK cascade;positive regulation of Ras protein signal transduction;regulation of long-term neuronal synaptic plasticity;positive regulation of epithelial cell proliferation;positive regulation of ERK1 and ERK2 cascade	GO:003272; GO:004352; GO:005085; GO:000828; GO:001086; GO:003033; GO:003590; GO:000693; GO:000705; GO:000716; GO:004208; GO:004801; GO:009031; GO:009039; GO:000988; GO:001062; GO:004340; GO:009030; GO:200063; GO:000016; GO:000193; GO:000222; GO:000689; GO:005129; GO:190002; GO:003426; GO:004283; GO:004354; GO:007148; GO:009719; GO:200025; GO:000709; GO:000726; GO:004341; GO:004574; GO:004594; GO:004633; GO:004657; GO:004816; GO:005067; GO:007037	nucleus;Golgi membrane;Golgi apparatus;plasma membrane;perinuclear region of cytoplasm;glutamatergic synapse;cytoplasm;cytosol	GO:000563; GO:000013; GO:000579; GO:000588; GO:004847; GO:009897; GO:000573; GO:000582	 Focal adhesion; Natural killer cell mediated cytotoxicity; Neurotrophin signaling pathway; Insulin signaling pathway; Oxytocin signaling pathway; HTLV-I infection; Renal cell carcinoma; Ras signaling pathway; VEGF signaling pathway; Signaling pathways regulating pluripotency of stem cells; B cell receptor signaling pathway; Long-term depression; FoxO signaling pathway; Tight junction; Endocytosis; MicroRNAs in cancer; Chronic myeloid leukemia; Sphingolipid signaling pathway; Axon guidance; Gap junction; Regulation of actin cytoskeleton; Central carbon metabolism in cancer; PI3K-Akt signaling pathway; Alcoholism	hsa0451; hsa0465; hsa0472; hsa0491; hsa0492; hsa0516; hsa0521; hsa0401; hsa0437; hsa0455; hsa0466; hsa0473; hsa0406; hsa0453; hsa0414; hsa0520; hsa0522; hsa0407; hsa0436; hsa0454; hsa0481; hsa0523; hsa0415; hsa0503	GTPase activity;protein binding;GDP binding;protein C-terminus binding;GTP binding	GO:000392; GO:000551; GO:001900; GO:000802; GO:000552
XP_020938240.1;XP_020938239.1;XP_020938241.1	XP_020938240.1;XP_020938239.1;XP_020938241.1	XP_020938240.1 AP-2 complex subunit alpha-2 isoform X2 [Sus scrofa];XP_020938239.1 AP-2 complex subunit alpha-2 isoform X1 [Sus scrofa];XP_020938241.1 AP-2 complex subunit alpha-2 isoform X3 [Sus scrofa]	23	23	18	86875000	110260000	94119000	125830000	69761000	125210000	91460000	122800000	86102000	109190000	92304000	107150000	121850000	113330000	67709000	123950000	89173000	134520000	NA	NA	NA	AP2A2	AP2A2;AP2A2;AP2A2;NA;NA	low-density lipoprotein particle receptor catabolic process;Wnt signaling pathway, planar cell polarity pathway;clathrin-dependent endocytosis;intracellular protein transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;neutrophil degranulation;regulation of defense response to virus by virus;membrane organization;low-density lipoprotein particle clearance;ephrin receptor signaling pathway	GO:003280; GO:006007; GO:007258; GO:000688; GO:001988; GO:004331; GO:005069; GO:006102; GO:003438; GO:004801	cytosol;endolysosome membrane;ficolin-1-rich granule membrane;AP-2 adaptor complex;cytoplasmic vesicle;plasma membrane;secretory granule membrane;clathrin-coated endocytic vesicle	GO:000582; GO:003602; GO:010100; GO:003012; GO:003141; GO:000588; GO:003066; GO:004533	 Endocytosis; Synaptic vesicle cycle; Endocrine and other factor-regulated calcium reabsorption; Huntington's disease	hsa0414; hsa0472; hsa0496; hsa0501	disordered domain specific binding;clathrin adaptor activity;molecular_function;protein kinase binding;protein binding;lipid binding	GO:009771; GO:003561; GO:000367; GO:001990; GO:000551; GO:000828
XP_020938242.1	XP_020938242.1	XP_020938242.1 LOW QUALITY PROTEIN: mucin-5AC [Sus scrofa]	3	3	2	0	0	0	0	48113000	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MUC5AC	MUC5AC;NA;NA;NA;NA	O-glycan processing;stimulatory C-type lectin receptor signaling pathway;phosphatidylinositol-mediated signaling	GO:001626; GO:000222; GO:004801	Golgi lumen;extracellular exosome;mucus layer;extracellular space;plasma membrane;cytoplasm	GO:000579; GO:007006; GO:007070; GO:000561; GO:000588; GO:000573	 Salivary secretion	hsa0497	extracellular matrix structural constituent	GO:000520
XP_020938264.1;XP_020938263.1;XP_020938262.1;XP_020938261.1;XP_020938259.1	XP_020938264.1;XP_020938263.1;XP_020938262.1;XP_020938261.1;XP_020938259.1	XP_020938264.1 lymphocyte-specific protein 1 isoform X5 [Sus scrofa];XP_020938263.1 lymphocyte-specific protein 1 isoform X4 [Sus scrofa];XP_020938262.1 lymphocyte-specific protein 1 isoform X3 [Sus scrofa];XP_020938261.1 lymphocyte-specific protein 1 isof	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12956000	NA	NA	NA	LSP1	LSP1;LSP1;LSP1;LSP1;LSP1	cellular defense response;signal transduction	GO:000696; GO:000716	actin cytoskeleton;extracellular exosome;membrane;plasma membrane	GO:001562; GO:007006; GO:001602; GO:000588	 Tuberculosis	hsa0515	actin binding	GO:000377
XP_020938291.1;XP_020938290.1	XP_020938291.1;XP_020938290.1	XP_020938291.1 cysteine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_020938290.1 cysteine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	11587000	0	0	0	0	0	0	NA	NA	NA	CARS	CARS;CARS;NA;NA;NA	tRNA aminoacylation for protein translation;cysteinyl-tRNA aminoacylation	GO:000641; GO:000642	cytoplasm;cytosol	GO:000573; GO:000582	 Aminoacyl-tRNA biosynthesis	hsa0097	tRNA binding;ATP binding;protein binding;protein homodimerization activity;metal ion binding;cysteine-tRNA ligase activity	GO:000004; GO:000552; GO:000551; GO:004280; GO:004687; GO:000481
XP_020938314.1;XP_020938313.1;XP_020938310.1;XP_020938309.1;XP_020938308.1;XP_020938307.1;XP_020938306.1;XP_020938316.1;XP_020938311.1;XP_020938318.1;XP_020938317.1;XP_020938315.1;XP_020938312.1	XP_020938314.1;XP_020938313.1;XP_020938310.1;XP_020938309.1;XP_020938308.1;XP_020938307.1;XP_020938306.1;XP_020938316.1;XP_020938311.1;XP_020938318.1;XP_020938317.1;XP_020938315.1;XP_020938312.1	XP_020938314.1 src substrate cortactin isoform X2 [Sus scrofa];XP_020938313.1 src substrate cortactin isoform X2 [Sus scrofa];XP_020938310.1 src substrate cortactin isoform X2 [Sus scrofa];XP_020938309.1 src substrate cortactin isoform X1 [Sus scrofa];XP_0	14	14	14	55581000	100490000	66039000	83780000	36941000	91395000	52490000	82537000	53150000	85355000	65555000	68947000	82392000	71220000	56728000	68332000	74261000	99372000	NA	NA	NA	CTTN	CTTN;CTTN;CTTN;CTTN;CTTN	cell motility;substrate-dependent cell migration, cell extension;actin filament polymerization;neuron projection morphogenesis;membrane organization;regulation of mitophagy;intracellular protein transport;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of smooth muscle contraction;focal adhesion assembly;lamellipodium organization;receptor-mediated endocytosis;regulation of axon extension;positive regulation of actin filament polymerization;actin cytoskeleton reorganization;dendritic spine maintenance	GO:004887; GO:000693; GO:003004; GO:004881; GO:006102; GO:190314; GO:000688; GO:200123; GO:004598; GO:004804; GO:009758; GO:000689; GO:003051; GO:003083; GO:003153; GO:009706	ruffle;podosome;lamellipodium;cortical cytoskeleton;dendritic spine;mitotic spindle midzone;Golgi apparatus;cytoskeleton;cell cortex;voltage-gated potassium channel complex;clathrin-coated pit;intracellular membrane-bounded organelle;cytoplasm;plasma membrane;cytosol;focal adhesion;growth cone	GO:000172; GO:000210; GO:003002; GO:003086; GO:004319; GO:199002; GO:000579; GO:000585; GO:000593; GO:000807; GO:000590; GO:004323; GO:000573; GO:000588; GO:000582; GO:000592; GO:003042	 Tight junction; Bacterial invasion of epithelial cells; Proteoglycans in cancer; Pathogenic Escherichia coli infection	hsa0453; hsa0510; hsa0520; hsa0513	profilin binding;protein binding;cadherin binding	GO:000552; GO:000551; GO:004529
XP_020938403.1;XP_020938402.1;XP_020938401.1;XP_005660678.3	XP_020938403.1;XP_020938402.1;XP_020938401.1	XP_020938403.1 glutathione S-transferase P-like isoform X3 [Sus scrofa];XP_020938402.1 glutathione S-transferase P-like isoform X2 [Sus scrofa];XP_020938401.1 glutathione S-transferase P-like isoform X1 [Sus scrofa]	14	14	14	565740000	1064200000	860540000	1103100000	674240000	1328800000	645420000	1002700000	667870000	1073400000	773380000	1994300000	801050000	877210000	818730000	1201000000	583170000	1104400000	NA	NA	NA	LOC100739163	LOC100739163;LOC100739163;LOC100739163;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020938415.1	XP_020938415.1	XP_020938415.1 coronin-1B [Sus scrofa]	14	14	14	125030000	211810000	166470000	192450000	116290000	191530000	120920000	202400000	139500000	176860000	124100000	217030000	206200000	173920000	140180000	190380000	137040000	200330000	NA	NA	NA	CORO1B	CORO1B;NA;NA;NA;NA	actin cytoskeleton organization;actin filament bundle assembly;cell migration;negative regulation of Arp2/3 complex-mediated actin nucleation;negative regulation of smooth muscle cell chemotaxis;protein localization to cell leading edge;ruffle organization;actin filament branching;cellular response to platelet-derived growth factor stimulus;endothelial cell chemotaxis;wound healing;positive regulation of lamellipodium morphogenesis	GO:003003; GO:005101; GO:001647; GO:003431; GO:007167; GO:190246; GO:003152; GO:009013; GO:003612; GO:003576; GO:004206; GO:200039	plasma membrane;extracellular exosome;actin filament;focal adhesion;cell periphery;perinuclear region of cytoplasm;stress fiber;lamellipodium;cell leading edge;cytosol;cytoplasm	GO:000588; GO:007006; GO:000588; GO:000592; GO:007194; GO:004847; GO:000172; GO:003002; GO:003125; GO:000582; GO:000573	"NA"	"NA"	cadherin binding;Arp2/3 complex binding;protein binding;identical protein binding;actin filament binding	GO:004529; GO:007193; GO:000551; GO:004280; GO:005101
XP_020952596.1;XP_020938525.1	XP_020952596.1;XP_020938525.1	XP_020952596.1 ubiquitin-like protein FUBI [Sus scrofa];XP_020938525.1 ubiquitin-like protein FUBI [Sus scrofa]	3	3	3	0	0	23670000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	FAU	LOC110261249;FAU;NA;NA;NA	biological_process	GO:000815	cellular_component	GO:000557	 Ribosome	hsa0301	RNA binding	GO:000372
XP_020938530.1	XP_020938530.1	XP_020938530.1 EH domain-containing protein 1 [Sus scrofa]	26	25	18	464950000	365190000	426550000	301850000	431500000	320120000	326450000	329830000	368940000	359250000	404020000	421960000	303730000	399090000	387940000	417710000	420350000	318880000	NA	NA	NA	EHD1	EHD1;NA;NA;NA;NA	protein homooligomerization;positive regulation of endocytic recycling;endocytic recycling;positive regulation of myoblast fusion;endocytosis;low-density lipoprotein particle clearance;intracellular protein transport;neuron projection development;cellular response to nerve growth factor stimulus;blood coagulation;positive regulation of cholesterol storage;protein localization to cilium;cholesterol homeostasis;cilium assembly	GO:005126; GO:200113; GO:003245; GO:190174; GO:000689; GO:003438; GO:000688; GO:003117; GO:199009; GO:000759; GO:001088; GO:006151; GO:004263; GO:006027	extracellular exosome;early endosome membrane;lipid particle;ciliary pocket membrane;plasma membrane;endosome membrane;platelet dense tubular network membrane;recycling endosome membrane;membrane	GO:007006; GO:003190; GO:000581; GO:002001; GO:000588; GO:001000; GO:003109; GO:005503; GO:001602	 Endocytosis	hsa0414	protein binding;cadherin binding;calcium ion binding;identical protein binding;ATP binding;Rab GTPase binding	GO:000551; GO:004529; GO:000550; GO:004280; GO:000552; GO:001713
XP_020938543.1	XP_020938543.1	XP_020938543.1 LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5643000	0	0	NA	NA	NA	PLCB3	PLCB3;NA;NA;NA;NA	regulation of systemic arterial blood pressure;release of sequestered calcium ion into cytosol;intracellular signal transduction;inositol phosphate metabolic process;Wnt signaling pathway, calcium modulating pathway;inositol trisphosphate biosynthetic process;lipid catabolic process;phosphatidylinositol-mediated signaling;G-protein coupled receptor signaling pathway	GO:000307; GO:005120; GO:003555; GO:004364; GO:000722; GO:003295; GO:001604; GO:004801; GO:000718	cytosol;nucleoplasm;membrane;macromolecular complex;postsynaptic cytosol	GO:000582; GO:000565; GO:001602; GO:003299; GO:009952	 Calcium signaling pathway; Vascular smooth muscle contraction; Cholinergic synapse; Phosphatidylinositol signaling system; Gastric acid secretion; Huntington's disease; Amoebiasis; Circadian entrainment; GnRH signaling pathway; Pathways in cancer; Metabolic pathways; Adrenergic signaling in cardiomyocytes; Wnt signaling pathway; Gap junction; Endocrine and other factor-regulated calcium reabsorption; Inositol phosphate metabolism; Platelet activation; Long-term depression; Chemokine signaling pathway; Oxytocin signaling pathway; Rap1 signaling pathway; cGMP-PKG signaling pathway; Inflammatory mediator regulation of TRP channels	hsa0402; hsa0427; hsa0472; hsa0407; hsa0497; hsa0501; hsa0514; hsa0471; hsa0491; hsa0520; hsa0110; hsa0426; hsa0431; hsa0454; hsa0496; hsa0056; hsa0461; hsa0473; hsa0406; hsa0492; hsa0401; hsa0402; hsa0475	calmodulin binding;cadherin binding;phosphatidylinositol phospholipase C activity;calcium ion binding;protein binding;phospholipase C activity	GO:000551; GO:004529; GO:000443; GO:000550; GO:000551; GO:000462
XP_020938562.1	XP_020938562.1	XP_020938562.1 LOW QUALITY PROTEIN: reticulon-3 [Sus scrofa]	3	3	3	529720000	601760000	789580000	338590000	621680000	566420000	687600000	538160000	750870000	563250000	469000000	328130000	276310000	537980000	549630000	634630000	570200000	470180000	NA	NA	NA	RTN3	RTN3;NA;NA;NA;NA	viral process;apoptotic process;vesicle-mediated transport;endoplasmic reticulum tubular network formation	GO:001603; GO:000691; GO:001619; GO:007178	plasma membrane;integral component of membrane;synapse;extracellular space;endoplasmic reticulum;Golgi membrane	GO:000588; GO:001602; GO:004520; GO:000561; GO:000578; GO:000013	"NA"	"NA"	protein binding	GO:000551
XP_020938654.1;XP_020928608.1	XP_020938654.1	XP_020938654.1 oxysterol-binding protein 1 [Sus scrofa]	7	7	7	379710000	365750000	395260000	346700000	0	382590000	359680000	432070000	309690000	304120000	0	0	0	363530000	387070000	412910000	306570000	355370000	NA	NA	NA	OSBP	OSBP;NA;NA;NA;NA	sterol transport;intracellular cholesterol transport;bile acid biosynthetic process;positive regulation of growth of symbiont in host	GO:001591; GO:003236; GO:000669; GO:004412	cytosol;intracellular membrane-bounded organelle;nucleoplasm;cytoplasm;Golgi membrane;Golgi apparatus;trans-Golgi network;plasma membrane;cell junction;endoplasmic reticulum membrane;membrane;perinuclear region of cytoplasm;perinuclear endoplasmic reticulum;nucleus	GO:000582; GO:004323; GO:000565; GO:000573; GO:000013; GO:000579; GO:000580; GO:000588; GO:003005; GO:000578; GO:001602; GO:004847; GO:009703; GO:000563	"NA"	"NA"	oxysterol binding;lipid binding;sterol transporter activity;sterol binding;phosphatidylinositol-4-phosphate binding;protein binding;protein domain specific binding	GO:000814; GO:000828; GO:001524; GO:003293; GO:007027; GO:000551; GO:001990
XP_020938706.1	XP_020938706.1	XP_020938706.1 182 kDa tankyrase-1-binding protein-like [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9105100	NA	NA	NA	LOC110259265	LOC110259265;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020938823.1;XP_020938824.1	XP_020938823.1;XP_020938824.1	XP_020938823.1 very-long-chain 3-oxoacyl-CoA reductase isoform X1 [Sus scrofa];XP_020938824.1 very-long-chain 3-oxoacyl-CoA reductase isoform X2 [Sus scrofa]	15	15	15	1337500000	817780000	1071800000	850110000	1352800000	989600000	975470000	951780000	1062600000	1127800000	1000400000	1168000000	479390000	1264800000	905310000	1267400000	1103700000	972460000	NA	NA	NA	HSD17B12	HSD17B12;HSD17B12;NA;NA;NA	estrogen biosynthetic process;positive regulation of cell-substrate adhesion;oxidation-reduction process;long-chain fatty-acyl-CoA biosynthetic process;fatty acid biosynthetic process;extracellular matrix organization	GO:000670; GO:001081; GO:005511; GO:003533; GO:000663; GO:003019	endoplasmic reticulum membrane;extracellular matrix;integral component of membrane	GO:000578; GO:003101; GO:001602	 Metabolic pathways; Fatty acid elongation; Steroid hormone biosynthesis; Biosynthesis of unsaturated fatty acids; Fatty acid metabolism	hsa0110; hsa0006; hsa0014; hsa0104; hsa0121	fibronectin binding;protein binding;estradiol 17-beta-dehydrogenase activity;3-oxo-cerotoyl-CoA reductase activity;heparin binding;long-chain-3-hydroxyacyl-CoA dehydrogenase activity;3-oxo-arachidoyl-CoA reductase activity	GO:000196; GO:000551; GO:000430; GO:010234; GO:000820; GO:001650; GO:010233
XP_020938897.1;XP_020938896.1	XP_020938897.1;XP_020938896.1	XP_020938897.1 transitional endoplasmic reticulum ATPase isoform X1 [Sus scrofa];XP_020938896.1 transitional endoplasmic reticulum ATPase isoform X1 [Sus scrofa]	27	2	2	84307000	100010000	75081000	76756000	0	0	71716000	72072000	67488000	64478000	92887000	101780000	81673000	0	88524000	77884000	87232000	0	NA	NA	NA	VCP	VCP;VCP;NA;NA;NA	protein ubiquitination;ubiquitin-dependent ERAD pathway;cellular response to heat;transmembrane transport;regulation of apoptotic process;positive regulation of protein complex assembly;protein hexamerization;DNA repair;proteasomal protein catabolic process;macroautophagy;protein deubiquitination;endoplasmic reticulum unfolded protein response;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;ERAD pathway;ATP metabolic process;mitotic spindle disassembly;positive regulation of canonical Wnt signaling pathway;autophagosome maturation;positive regulation of Lys63-specific deubiquitinase activity;cellular response to arsenite ion;NADH metabolic process;ER to Golgi vesicle-mediated transport;positive regulation of mitochondrial membrane potential;protein homooligomerization;error-free translesion synthesis;establishment of protein localization;ER-associated misfolded protein catabolic process;positive regulation of ubiquitin-specific protease activity;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to DNA damage stimulus;viral genome replication;retrograde protein transport, ER to cytosol;proteasome-mediated ubiquitin-dependent protein catabolic process;neutrophil degranulation;flavin adenine dinucleotide catabolic process;positive regulation of ATP biosynthetic process;translesion synthesis;protein folding;double-strand break repair;protein N-linked glycosylation via asparagine;regulation of synapse organization;regulation of aerobic respiration;positive regulation of oxidative phosphorylation;endosome to lysosome transport via multivesicular body sorting pathway;stress granule disassembly;positive regulation of protein catabolic process;aggresome assembly	GO:001656; GO:003043; GO:003460; GO:005508; GO:004298; GO:003133; GO:003421; GO:000628; GO:001049; GO:001623; GO:001657; GO:003096; GO:003243; GO:003650; GO:004603; GO:005122; GO:009026; GO:009735; GO:190300; GO:190384; GO:000673; GO:000688; GO:001091; GO:005126; GO:007098; GO:004518; GO:007171; GO:200015; GO:000691; GO:000697; GO:001907; GO:003097; GO:004316; GO:004331; GO:007238; GO:200117; GO:001998; GO:000645; GO:000630; GO:001827; GO:005080; GO:190371; GO:190386; GO:003251; GO:003561; GO:004573; GO:007084	cytoplasmic stress granule;azurophil granule lumen;proteasome complex;Derlin-1 retrotranslocation complex;ficolin-1-rich granule lumen;VCP-NSFL1C complex;nucleus;site of double-strand break;extracellular exosome;glutamatergic synapse;extracellular region;endoplasmic reticulum membrane;VCP-NPL4-UFD1 AAA ATPase complex;ATPase complex;cytosol;cytoplasm;macromolecular complex;nucleoplasm;lipid particle;secretory granule lumen;intracellular membrane-bounded organelle;perinuclear region of cytoplasm	GO:001049; GO:003557; GO:000050; GO:003651; GO:190481; GO:199073; GO:000563; GO:003586; GO:007006; GO:009897; GO:000557; GO:000578; GO:003409; GO:190494; GO:000582; GO:000573; GO:003299; GO:000565; GO:000581; GO:003477; GO:004323; GO:004847	 Legionellosis; Protein processing in endoplasmic reticulum	hsa0513; hsa0414	identical protein binding;protein phosphatase binding;deubiquitinase activator activity;ubiquitin-specific protease binding;ubiquitin protein ligase binding;protein binding;ADP binding;BAT3 complex binding;ATP binding;K48-linked polyubiquitin binding;ubiquitin-like protein ligase binding;ATPase activity;lipid binding;RNA binding;polyubiquitin binding;MHC class I protein binding	GO:004280; GO:001990; GO:003580; GO:199038; GO:003162; GO:000551; GO:004353; GO:190428; GO:000552; GO:003643; GO:004438; GO:001688; GO:000828; GO:000372; GO:003159; GO:004228
XP_020938923.1	XP_020938923.1	XP_020938923.1 LOW QUALITY PROTEIN: tumor susceptibility gene 101 protein [Sus scrofa]	2	2	2	0	11268000	10971000	0	10998000	0	9250100	0	0	8780700	0	0	0	0	0	0	0	0	NA	NA	NA	TSG101	TSG101;NA;NA;NA;NA	cell cycle arrest;protein transport;regulation of MAP kinase activity;positive regulation of viral release from host cell;regulation of extracellular exosome assembly;negative regulation of epidermal growth factor-activated receptor activity;multivesicular body assembly;negative regulation of transcription, DNA-templated;autophagosome maturation;extracellular transport;endosome to lysosome transport;negative regulation of cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of exosomal secretion;exosomal secretion;keratinocyte differentiation;viral budding via host ESCRT complex;viral budding;positive regulation of nucleic acid-templated transcription;protein monoubiquitination;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;positive regulation of viral budding via host ESCRT complex;regulation of cell growth;endosomal transport;macroautophagy;viral life cycle;cell division;positive regulation of ubiquitin-dependent endocytosis	GO:000705; GO:001503; GO:004340; GO:190218; GO:190355; GO:000717; GO:003625; GO:004589; GO:009735; GO:000685; GO:000833; GO:000828; GO:004205; GO:190354; GO:199018; GO:003021; GO:003970; GO:004675; GO:190350; GO:000651; GO:004316; GO:190377; GO:000155; GO:001619; GO:001623; GO:001905; GO:005130; GO:200039	nucleolus;plasma membrane;multivesicular body;cytoplasm;cytosol;microtubule organizing center;endosome membrane;ESCRT I complex;endosome;early endosome membrane;extracellular exosome;Flemming body	GO:000573; GO:000588; GO:000577; GO:000573; GO:000582; GO:000581; GO:001000; GO:000081; GO:000576; GO:003190; GO:007006; GO:009054	 Endocytosis	hsa0414	DNA binding;ubiquitin binding;ligand-dependent nuclear receptor transcription coactivator activity;virion binding;macromolecular complex binding;calcium-dependent protein binding;protein homodimerization activity;transcription corepressor activity;ubiquitin protein ligase binding;protein binding	GO:000367; GO:004313; GO:003037; GO:004679; GO:004487; GO:004830; GO:004280; GO:000371; GO:003162; GO:000551
XP_020938935.1	XP_020938935.1	XP_020938935.1 LOW QUALITY PROTEIN: nucleobindin-2 [Sus scrofa]	4	4	4	0	5576300	0	0	0	0	0	0	0	7185200	6500700	0	0	7510100	0	6219100	11616000	7824500	NA	NA	NA	NUCB2	NUCB2;NA;NA;NA;NA	negative regulation of appetite	GO:003209	nuclear outer membrane;extracellular space;plasma membrane;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment;cytosol;extracellular exosome	GO:000564; GO:000561; GO:000588; GO:000578; GO:000579; GO:000582; GO:007006	"NA"	"NA"	DNA binding;protein binding;calcium ion binding	GO:000367; GO:000551; GO:000550
XP_020938958.1	XP_020938958.1	XP_020938958.1 LOW QUALITY PROTEIN: cGMP-inhibited 3,5-cyclic phosphodiesterase B [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	4061700	0	0	0	0	0	0	0	NA	NA	NA	PDE3B	PDE3B;NA;NA;NA;NA	negative regulation of angiogenesis;negative regulation of cAMP-mediated signaling;negative regulation of cell adhesion;G-protein coupled receptor signaling pathway;angiogenesis;negative regulation of lipid catabolic process;cellular response to insulin stimulus;negative regulation of cell adhesion mediated by integrin	GO:001652; GO:004395; GO:000716; GO:000718; GO:000152; GO:005099; GO:003286; GO:003362	cytosol;membrane;Golgi apparatus;endoplasmic reticulum;guanyl-nucleotide exchange factor complex	GO:000582; GO:001602; GO:000579; GO:000578; GO:003204	 Renin secretion; cAMP signaling pathway; Insulin signaling pathway; Regulation of lipolysis in adipocytes; Purine metabolism; Morphine addiction	hsa0492; hsa0402; hsa0491; hsa0492; hsa0023; hsa0503	cGMP-inhibited cyclic-nucleotide phosphodiesterase activity;protein binding;metal ion binding;protein kinase B binding;3',5'-cyclic-AMP phosphodiesterase activity;3',5'-cyclic-GMP phosphodiesterase activity	GO:000411; GO:000551; GO:004687; GO:004342; GO:000411; GO:004755
XP_020938962.1;XP_020938964.1;XP_020938961.1;XP_020938960.1;XP_020938963.1;XP_013849179.1	XP_020938962.1;XP_020938964.1;XP_020938961.1;XP_020938960.1	XP_020938962.1 ras-related protein R-Ras2 isoform X3 [Sus scrofa];XP_020938964.1 ras-related protein R-Ras2 isoform X5 [Sus scrofa];XP_020938961.1 ras-related protein R-Ras2 isoform X2 [Sus scrofa];XP_020938960.1 ras-related protein R-Ras2 isoform X1 [Sus	9	7	7	49319000	77180000	81856000	79974000	43185000	48643000	49439000	57627000	55073000	63603000	45488000	65297000	0	57188000	47381000	61534000	54383000	57279000	NA	NA	NA	RRAS2	RRAS2;RRAS2;RRAS2;RRAS2;NA	regulation of neuron death;Ras protein signal transduction;positive regulation of cell migration;osteoblast differentiation	GO:190121; GO:000726; GO:003033; GO:000164	endoplasmic reticulum;focal adhesion;plasma membrane;extracellular exosome;membrane	GO:000578; GO:000592; GO:000588; GO:007006; GO:001602	 MAPK signaling pathway; Ras signaling pathway; Regulation of actin cytoskeleton; Proteoglycans in cancer; Tight junction; HTLV-I infection; cAMP signaling pathway	hsa0401; hsa0401; hsa0481; hsa0520; hsa0453; hsa0516; hsa0402	GTPase activity;protein binding;GTP binding	GO:000392; GO:000551; GO:000552
XP_020938970.1;XP_013840602.1	XP_020938970.1	XP_020938970.1 LOW QUALITY PROTEIN: alpha-parvin [Sus scrofa]	16	16	15	295060000	390530000	345030000	446240000	288830000	365010000	309410000	464790000	286510000	455720000	359420000	283740000	253890000	493030000	337820000	563070000	267190000	386970000	NA	NA	NA	PARVA	PARVA;NA;NA;NA;NA	establishment or maintenance of cell polarity;heterotypic cell-cell adhesion;actin cytoskeleton reorganization;sprouting angiogenesis;cell projection assembly;actin-mediated cell contraction;regulation of cell shape;substrate adhesion-dependent cell spreading;smooth muscle cell chemotaxis;cilium assembly;outflow tract septum morphogenesis	GO:000716; GO:003411; GO:003153; GO:000204; GO:003003; GO:007025; GO:000836; GO:003444; GO:007167; GO:006027; GO:000314	Z disc;cytoplasm;focal adhesion;cytosol;actin cytoskeleton;plasma membrane	GO:003001; GO:000573; GO:000592; GO:000582; GO:001562; GO:000588	 Focal adhesion	hsa0451	actin binding;protein binding;cadherin binding	GO:000377; GO:000551; GO:004529
XP_020938978.1	XP_020938978.1	XP_020938978.1 eukaryotic translation initiation factor 4 gamma 2, partial [Sus scrofa]	3	3	3	0	7013900	0	0	0	8835900	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EIF4G2	EIF4G2;NA;NA;NA;NA	regulation of translational initiation;positive regulation of cell growth;cell cycle arrest;cellular macromolecule biosynthetic process;cell death;negative regulation of autophagy;translational initiation	GO:000644; GO:003030; GO:000705; GO:003464; GO:000821; GO:001050; GO:000641	membrane;cell-cell adherens junction;cytosol;eukaryotic translation initiation factor 4F complex	GO:001602; GO:000591; GO:000582; GO:001628	 Viral myocarditis; RNA transport	hsa0541; hsa0301	RNA binding;mRNA binding;cadherin binding;translation initiation factor activity;translation factor activity, RNA binding;protein binding	GO:000372; GO:000372; GO:004529; GO:000374; GO:000813; GO:000551
XP_020939002.1;XP_020939001.1;XP_005661211.1;XP_020939000.1;XP_003123661.1	XP_020939002.1;XP_020939001.1;XP_005661211.1;XP_020939000.1;XP_003123661.1	XP_020939002.1 guanylate kinase isoform X3 [Sus scrofa];XP_020939001.1 guanylate kinase isoform X3 [Sus scrofa];XP_005661211.1 guanylate kinase isoform X4 [Sus scrofa];XP_020939000.1 guanylate kinase isoform X2 [Sus scrofa];XP_003123661.1 guanylate kinase	3	3	3	15503000	0	0	0	0	0	0	0	0	0	0	0	13969000	0	0	0	10515000	0	NA	NA	NA	GUK1	GUK1;GUK1;GUK1;GUK1;GUK1	GDP biosynthetic process;GDP-mannose metabolic process;purine nucleotide metabolic process;ATP metabolic process;dGDP biosynthetic process;nucleobase-containing small molecule interconversion;dATP metabolic process;nucleotide phosphorylation;dGMP metabolic process;glycoprotein transport	GO:004671; GO:001967; GO:000616; GO:004603; GO:000618; GO:001594; GO:004606; GO:004693; GO:004605; GO:003443	cytosol	GO:000582	 Purine metabolism; Metabolic pathways	hsa0023; hsa0110	ATP binding;guanylate kinase activity	GO:000552; GO:000438
XP_020954092.1;XP_020954091.1;XP_020954090.1;XP_020939041.1	XP_020954092.1;XP_020954091.1;XP_020954090.1;XP_020939041.1	XP_020954092.1 histone H2A type 1 [Sus scrofa];XP_020954091.1 histone H2A type 1-C [Sus scrofa];XP_020954090.1 histone H2A type 1 [Sus scrofa];XP_020939041.1 histone H2A type 3 [Sus scrofa]	6	2	2	0	0	0	0	0	0	0	0	0	0	0	686590000	41969000	0	0	0	0	0	NA	NA	NA	LOC110261483	LOC110261483;LOC110261482;LOC100155734;LOC100621538;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020939099.1	XP_020939099.1	XP_020939099.1 nuclear receptor 2C2-associated protein [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NR2C2AP	NR2C2AP;NA;NA;NA;NA	transcription initiation from RNA polymerase II promoter	GO:000636	nucleoplasm	GO:000565	"NA"	"NA"	protein binding	GO:000551
XP_020939130.1;XP_020939129.1;XP_020939128.1;XP_020939127.1	XP_020939130.1;XP_020939129.1;XP_020939128.1;XP_020939127.1	XP_020939130.1 regulator of nonsense transcripts 1 isoform X4 [Sus scrofa];XP_020939129.1 regulator of nonsense transcripts 1 isoform X3 [Sus scrofa];XP_020939128.1 regulator of nonsense transcripts 1 isoform X2 [Sus scrofa];XP_020939127.1 regulator of non	9	9	9	0	0	19068000	0	0	15536000	0	0	0	0	0	16406000	0	0	0	0	0	0	NA	NA	NA	UPF1	UPF1;UPF1;UPF1;UPF1;NA	nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay;nuclear-transcribed mRNA catabolic process;telomere maintenance via semi-conservative replication;histone mRNA catabolic process;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;viral process;positive regulation of mRNA catabolic process;3'-UTR-mediated mRNA destabilization;mRNA export from nucleus;dosage compensation by inactivation of X chromosome;cell cycle phase transition;cellular response to lipopolysaccharide;cellular response to interleukin-1;DNA repair;regulation of translational termination;DNA replication	GO:000029; GO:000095; GO:003220; GO:007104; GO:000018; GO:001603; GO:006101; GO:006115; GO:000640; GO:000904; GO:004477; GO:007122; GO:007134; GO:000628; GO:000644; GO:000626	nuclear chromosome, telomeric region;nucleoplasm;supraspliceosomal complex;cytoplasm;nucleus;cytosol;P-body;chromatin;exon-exon junction complex	GO:000078; GO:000565; GO:004453; GO:000573; GO:000563; GO:000582; GO:000093; GO:000078; GO:003514	 RNA transport; mRNA surveillance pathway	hsa0301; hsa0301	RNA binding;ATP binding;telomeric DNA binding;chromatin binding;helicase activity;zinc ion binding;protein binding;ATP-dependent RNA helicase activity	GO:000372; GO:000552; GO:004216; GO:000368; GO:000438; GO:000827; GO:000551; GO:000400
XP_020939216.1;NP_001001646.1	XP_020939216.1;NP_001001646.1	XP_020939216.1 complement C5a anaphylatoxin isoform X1 [Sus scrofa];NP_001001646.1 complement C5a anaphylatoxin precursor [Sus scrofa]	21	21	21	77441000	30520000	48123000	24848000	133780000	152400000	86032000	20929000	52676000	27321000	42613000	0	51245000	58962000	61603000	0	80576000	37808000	NA	NA	NA	C5	C5;C5;NA;NA;NA	inflammatory response;complement activation, alternative pathway;G-protein coupled receptor signaling pathway;negative regulation of endopeptidase activity;in utero embryonic development;positive regulation of angiogenesis;chemotaxis;regulation of complement activation;cell surface receptor signaling pathway;negative regulation of macrophage chemotaxis;cytolysis;positive regulation of vascular endothelial growth factor production;cell chemotaxis;positive regulation of chemokine secretion;activation of MAPK activity	GO:000695; GO:000695; GO:000718; GO:001095; GO:000170; GO:004576; GO:000693; GO:003044; GO:000716; GO:001076; GO:001983; GO:001057; GO:006032; GO:009019; GO:000018	membrane attack complex;extracellular region;extracellular exosome;extracellular space	GO:000557; GO:000557; GO:007006; GO:000561	 Complement and coagulation cascades; Systemic lupus erythematosus; Prion diseases; Pertussis; Herpes simplex infection; Staphylococcus aureus infection	hsa0461; hsa0532; hsa0502; hsa0513; hsa0516; hsa0515	protein binding;endopeptidase inhibitor activity;chemokine activity;receptor binding	GO:000551; GO:000486; GO:000800; GO:000510
XP_020939219.1;XP_020939218.1	XP_020939219.1;XP_020939218.1	XP_020939219.1 plasmalemma vesicle-associated protein [Sus scrofa];XP_020939218.1 plasmalemma vesicle-associated protein [Sus scrofa]	5	5	5	28906000	29255000	23492000	30812000	0	26602000	26133000	37559000	15980000	0	15235000	34338000	23088000	33998000	20981000	24935000	18207000	0	NA	NA	NA	PLVAP	PLVAP;PLVAP;NA;NA;NA	MAPK cascade;protein kinase C signaling;positive regulation of cellular extravasation;tumor necrosis factor-mediated signaling pathway	GO:000016; GO:007052; GO:000269; GO:003320	caveola;cell surface;perinuclear region of cytoplasm;extracellular exosome;integral component of membrane	GO:000590; GO:000998; GO:004847; GO:007006; GO:001602	"NA"	"NA"	protein homodimerization activity;protein binding	GO:004280; GO:000551
XP_020939272.1;XP_020939271.1;XP_020939269.1;XP_020939270.1;XP_020935451.1;XP_020935444.1;XP_020935436.1;XP_020935431.1;XP_020935418.1;XP_020939264.1;XP_020935412.1;NP_001231565.1;XP_020935409.1;XP_020935402.1;XP_020935397.1;XP_020935394.1;XP_020935393.1;XP_020935390.1;XP_020935383.1;XP_020939263.1;XP_020939262.1;XP_020935428.1;XP_020939259.1;XP_020939258.1;XP_020939267.1;XP_020939266.1;XP_003123482.1;XP_003123481.1;XP_020939257.1;XP_020939265.1;XP_020939261.1;XP_020939268.1	XP_020939272.1;XP_020939271.1;XP_020939269.1;XP_020939270.1;XP_020935451.1;XP_020935444.1;XP_020935436.1;XP_020935431.1;XP_020935418.1;XP_020939264.1;XP_020935412.1;NP_001231565.1;XP_020935409.1;XP_020935402.1;XP_020935397.1;XP_020935394.1;XP_020935393.1;XP_020935390.1;XP_020935383.1;XP_020939263.1;XP_020939262.1;XP_020935428.1	XP_020939272.1 cytochrome P450 4F6-like [Sus scrofa];XP_020939271.1 cytochrome P450 4F6-like [Sus scrofa];XP_020939269.1 cytochrome P450 4F6-like isoform X1 [Sus scrofa];XP_020939270.1 cytochrome P450 4F6-like isoform X2 [Sus scrofa];XP_020935451.1 cytochr	7	7	7	6651800	4352800	5942100	0	0	0	5809100	6129800	0	6417800	7168800	0	0	5120400	0	6504300	0	6178300	NA	NA	NA	LOC102167481	LOC102167481;LOC102167481;LOC100739101;LOC100739101;LOC110255237	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020939350.1;XP_020939349.1	XP_020939350.1;XP_020939349.1	XP_020939350.1 very-long-chain enoyl-CoA reductase isoform X2 [Sus scrofa];XP_020939349.1 very-long-chain enoyl-CoA reductase isoform X1 [Sus scrofa]	12	12	12	1224300000	939400000	1030100000	922980000	902070000	884970000	874940000	882310000	1089800000	862530000	938830000	924560000	431650000	991170000	770640000	1332500000	1081900000	1077500000	NA	NA	NA	TECR	TECR;TECR;NA;NA;NA	very long-chain fatty acid biosynthetic process;fatty acid elongation;long-chain fatty-acyl-CoA biosynthetic process;oxidation-reduction process	GO:004276; GO:003049; GO:003533; GO:005511	nucleus;endoplasmic reticulum;integral component of endoplasmic reticulum membrane	GO:000563; GO:000578; GO:003017	 Fatty acid metabolism; Fatty acid elongation; Biosynthesis of unsaturated fatty acids	hsa0121; hsa0006; hsa0104	oxidoreductase activity;protein binding;very-long-chain-acyl-CoA dehydrogenase activity	GO:001649; GO:000551; GO:001709
XP_020939375.1;XP_020939374.1;XP_003123376.1	XP_020939375.1;XP_020939374.1;XP_003123376.1	XP_020939375.1 glutaryl-CoA dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020939374.1 glutaryl-CoA dehydrogenase, mitochondrial isoform X2 [Sus scrofa];XP_003123376.1 glutaryl-CoA dehydrogenase, mitochondrial isoform X1 [Sus scrofa]	3	3	3	24347000	0	0	0	33475000	0	25900000	0	0	0	21321000	0	0	0	0	0	22498000	0	NA	NA	NA	GCDH	GCDH;GCDH;GCDH;NA;NA	tryptophan metabolic process;lysine catabolic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase;fatty-acyl-CoA biosynthetic process	GO:000656; GO:000655; GO:003353; GO:004694	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Biosynthesis of antibiotics; Lysine degradation; Tryptophan metabolism; Fatty acid degradation; Metabolic pathways	hsa0113; hsa0031; hsa0038; hsa0007; hsa0110	flavin adenine dinucleotide binding;fatty-acyl-CoA binding;glutaryl-CoA dehydrogenase activity	GO:005066; GO:000006; GO:000436
XP_020939442.1	XP_020939442.1	XP_020939442.1 eukaryotic translation initiation factor 3 subunit G [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4300300	NA	NA	NA	EIF3G	EIF3G;NA;NA;NA;NA	translational initiation;formation of cytoplasmic translation initiation complex;viral translational termination-reinitiation	GO:000641; GO:000173; GO:007552	nucleus;eukaryotic 43S preinitiation complex;perinuclear region of cytoplasm;cytoplasm;cytosol;eukaryotic translation initiation factor 3 complex;eukaryotic 48S preinitiation complex	GO:000563; GO:001628; GO:004847; GO:000573; GO:000582; GO:000585; GO:003329	 RNA transport	hsa0301	protein binding;translation initiation factor activity;RNA binding	GO:000551; GO:000374; GO:000372
XP_020939457.1;XP_020939456.1;XP_020939455.1;XP_020939454.1;XP_020939453.1;XP_020939452.1	XP_020939457.1;XP_020939456.1;XP_020939455.1;XP_020939454.1;XP_020939453.1;XP_020939452.1	XP_020939457.1 interleukin enhancer-binding factor 3 isoform X4 [Sus scrofa];XP_020939456.1 interleukin enhancer-binding factor 3 isoform X4 [Sus scrofa];XP_020939455.1 interleukin enhancer-binding factor 3 isoform X3 [Sus scrofa];XP_020939454.1 interleuki	12	12	11	50232000	53659000	60606000	44139000	53393000	73852000	66102000	57326000	40806000	58031000	53214000	72094000	68203000	67990000	51753000	61649000	54653000	52158000	NA	NA	NA	ILF3	ILF3;ILF3;ILF3;ILF3;ILF3	negative regulation of viral genome replication;negative regulation of transcription, DNA-templated;protein phosphorylation;negative regulation of translation;defense response to virus	GO:004507; GO:004589; GO:000646; GO:001714; GO:005160	nucleoplasm;nucleolus;membrane;extracellular region;ribonucleoprotein complex;nucleus	GO:000565; GO:000573; GO:001602; GO:000557; GO:199090; GO:000563	"NA"	"NA"	protein binding;single-stranded RNA binding;DNA binding;AU-rich element binding	GO:000551; GO:000372; GO:000367; GO:001709
XP_020939477.1;XP_020939476.1;XP_020939475.1;XP_020939474.1;XP_020939473.1;XP_020939472.1;XP_020939471.1;XP_020939470.1;XP_020939469.1;XP_020939468.1;XP_020939467.1;XP_020939466.1;XP_020939465.1;XP_020939464.1;XP_020939463.1;XP_020939462.1;XP_020939461.1;XP_020939460.1;XP_020939459.1	XP_020939477.1;XP_020939476.1;XP_020939475.1;XP_020939474.1;XP_020939473.1;XP_020939472.1;XP_020939471.1;XP_020939470.1;XP_020939469.1;XP_020939468.1;XP_020939467.1;XP_020939466.1;XP_020939465.1;XP_020939464.1;XP_020939463.1;XP_020939462.1;XP_020939461.1;XP_020939460.1;XP_020939459.1	XP_020939477.1 dynamin-2 isoform X19 [Sus scrofa];XP_020939476.1 dynamin-2 isoform X18 [Sus scrofa];XP_020939475.1 dynamin-2 isoform X17 [Sus scrofa];XP_020939474.1 dynamin-2 isoform X16 [Sus scrofa];XP_020939473.1 dynamin-2 isoform X15 [Sus scrofa];XP_020	13	13	8	37613000	39380000	32763000	51340000	39021000	35566000	32767000	41737000	42016000	43426000	40647000	58696000	40027000	46379000	36112000	52053000	38398000	48615000	NA	NA	NA	DNM2	DNM2;DNM2;DNM2;DNM2;DNM2	Golgi to plasma membrane transport;phagocytosis;transferrin transport;regulation of Rac protein signal transduction;positive regulation of apoptotic process;positive regulation of phagocytosis;positive regulation of clathrin-dependent endocytosis;signal transduction;antigen processing and presentation of exogenous peptide antigen via MHC class II;positive regulation of nitric oxide biosynthetic process;neuron projection morphogenesis;postsynaptic neurotransmitter receptor internalization;negative regulation of non-motile cilium assembly;cellular response to dopamine;G2/M transition of mitotic cell cycle;spermatogenesis;regulation of nitric-oxide synthase activity;positive regulation of sodium:potassium-exchanging ATPase activity;negative regulation of membrane tubulation;receptor-mediated endocytosis;synaptic vesicle budding from presynaptic endocytic zone membrane;negative regulation of transforming growth factor beta receptor signaling pathway;receptor internalization;aorta development;coronary vasculature development;cellular response to carbon monoxide;cellular response to X-ray;G-protein coupled receptor internalization;regulation of transcription, DNA-templated;macropinocytosis;positive regulation of transcription, DNA-templated;response to light stimulus;positive regulation of lamellipodium assembly;response to cocaine;synaptic vesicle transport;cellular response to nitric oxide;positive regulation of substrate adhesion-dependent cell spreading;regulation of synapse structure or activity;membrane organization;ventricular septum development	GO:000689; GO:000690; GO:003357; GO:003502; GO:004306; GO:005076; GO:200037; GO:000716; GO:001988; GO:004542; GO:004881; GO:009888; GO:190285; GO:190335; GO:000008; GO:000728; GO:005099; GO:190340; GO:190352; GO:000689; GO:001618; GO:003051; GO:003162; GO:003590; GO:006097; GO:007124; GO:007148; GO:000203; GO:000635; GO:004435; GO:004589; GO:000941; GO:001059; GO:004222; GO:004848; GO:007173; GO:190002; GO:005080; GO:006102; GO:000328	lamellipodium;endocytic vesicle membrane;phagocytic vesicle membrane;dendritic spine head;synapse;photoreceptor inner segment;glutamatergic synapse;trans-Golgi network;plasma membrane;postsynaptic density;macromolecular complex;clathrin-coated endocytic vesicle;Golgi membrane;cytoplasm;ruffle membrane;perinuclear region of cytoplasm;extracellular exosome;presynapse;microtubule;membrane;nucleus;clathrin-coated pit;cytoplasmic vesicle;postsynaptic density, intracellular component;endosome;Golgi apparatus;cytosol;focal adhesion;growth cone;midbody;postsynaptic endocytic zone membrane;phagocytic cup;centrosome;dendritic spine;postsynaptic membrane	GO:003002; GO:003066; GO:003067; GO:004432; GO:004520; GO:000191; GO:009897; GO:000580; GO:000588; GO:001406; GO:003299; GO:004533; GO:000013; GO:000573; GO:003258; GO:004847; GO:007006; GO:009879; GO:000587; GO:001602; GO:000563; GO:000590; GO:003141; GO:009909; GO:000576; GO:000579; GO:000582; GO:000592; GO:003042; GO:003049; GO:009884; GO:000189; GO:000581; GO:004319; GO:004521	 Endocrine and other factor-regulated calcium reabsorption; Bacterial invasion of epithelial cells; Endocytosis; Synaptic vesicle cycle; Fc gamma R-mediated phagocytosis	hsa0496; hsa0510; hsa0414; hsa0472; hsa0466	phosphatidylinositol 3-kinase regulatory subunit binding;protein binding;macromolecular complex binding;enzyme binding;SH3 domain binding;WW domain binding;nitric-oxide synthase binding;GTP binding;microtubule binding;D2 dopamine receptor binding;protein kinase binding;GTPase activity	GO:003631; GO:000551; GO:004487; GO:001989; GO:001712; GO:005069; GO:005099; GO:000552; GO:000801; GO:003174; GO:001990; GO:000392
XP_020939482.1;XP_020939481.1;XP_020939480.1;XP_020939483.1	XP_020939482.1;XP_020939481.1;XP_020939480.1;XP_020939483.1	XP_020939482.1 histone-arginine methyltransferase CARM1 isoform X3 [Sus scrofa];XP_020939481.1 histone-arginine methyltransferase CARM1 isoform X2 [Sus scrofa];XP_020939480.1 histone-arginine methyltransferase CARM1 isoform X1 [Sus scrofa];XP_020939483.1 h	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3184300	NA	NA	NA	CARM1	CARM1;CARM1;CARM1;CARM1;NA	histone arginine methylation;positive regulation of transcription from RNA polymerase II promoter;response to cAMP;viral process;negative regulation of protein binding;regulation of intracellular estrogen receptor signaling pathway;positive regulation of fat cell differentiation;endochondral bone morphogenesis;protein localization to chromatin;negative regulation of dendrite development;aging;positive regulation of cell proliferation;regulation of growth plate cartilage chondrocyte proliferation;regulation of lipid metabolic process;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;intracellular estrogen receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;regulation of mRNA binding;histone methylation;histone H3-R2 methylation;regulation of transcription, DNA-templated;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	GO:003496; GO:004594; GO:005159; GO:001603; GO:003209; GO:003314; GO:004560; GO:006035; GO:007116; GO:200017; GO:000756; GO:000828; GO:000342; GO:001921; GO:001991; GO:003052; GO:005109; GO:190241; GO:001657; GO:003497; GO:000635; GO:000697	RNA polymerase II transcription factor complex;nucleoplasm;nucleus;cytoplasm;cytosol	GO:009057; GO:000565; GO:000563; GO:000573; GO:000582	"NA"	"NA"	histone methyltransferase activity (H3-R17 specific);transcription regulatory region DNA binding;beta-catenin binding;ligand-dependent nuclear receptor transcription coactivator activity;histone-arginine N-methyltransferase activity;protein homodimerization activity;protein binding;protein methyltransferase activity;histone methyltransferase activity;protein-arginine N-methyltransferase activity;protein-arginine omega-N asymmetric methyltransferase activity;transcription coactivator activity;lysine-acetylated histone binding	GO:003564; GO:004421; GO:000801; GO:003037; GO:000846; GO:004280; GO:000551; GO:000827; GO:004205; GO:001627; GO:003524; GO:000371; GO:007057
XP_020939516.1;XP_020939515.1;XP_020939514.1;XP_020939513.1;XP_020939512.1;XP_020939511.1;XP_020939520.1;XP_020939519.1;XP_020939518.1;XP_020939517.1	XP_020939516.1;XP_020939515.1;XP_020939514.1;XP_020939513.1;XP_020939512.1;XP_020939511.1;XP_020939520.1;XP_020939519.1;XP_020939518.1;XP_020939517.1	XP_020939516.1 KN motif and ankyrin repeat domain-containing protein 2 isoform X2 [Sus scrofa];XP_020939515.1 KN motif and ankyrin repeat domain-containing protein 2 isoform X1 [Sus scrofa];XP_020939514.1 KN motif and ankyrin repeat domain-containing prote	19	19	19	25356000	102350000	65571000	86661000	38696000	80392000	64295000	106220000	48767000	83525000	55190000	137780000	86811000	95245000	39182000	79325000	56416000	103810000	NA	NA	NA	KANK2	KANK2;KANK2;KANK2;KANK2;KANK2	apoptotic process;glomerular visceral epithelial cell migration;negative regulation of transcription from RNA polymerase II promoter;negative regulation of vitamin D receptor signaling pathway;regulation of Rho protein signal transduction;kidney epithelium development;negative regulation of cell proliferation;negative regulation of intracellular estrogen receptor signaling pathway;negative regulation of programmed cell death;negative regulation of G1/S transition of mitotic cell cycle	GO:000691; GO:009052; GO:000012; GO:007056; GO:003502; GO:007207; GO:000828; GO:003314; GO:004306; GO:200013	cytoplasm;mitochondrion	GO:000573; GO:000573	"NA"	"NA"	protein binding	GO:000551
XP_020939594.1;XP_020939057.1;NP_001090952.1	XP_020939594.1;XP_020939057.1;NP_001090952.1	XP_020939594.1 tropomyosin alpha-1 chain isoform X2 [Sus scrofa];XP_020939057.1 tropomyosin alpha-1 chain isoform X1 [Sus scrofa];NP_001090952.1 tropomyosin alpha-1 chain [Sus scrofa]	36	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	193470000	0	NA	NA	NA	TPM1	TPM1;TPM1;TPM1;NA;NA	positive regulation of stress fiber assembly;ventricular cardiac muscle tissue morphogenesis;muscle contraction;actin filament organization;positive regulation of ATPase activity;in utero embryonic development;ruffle organization;sarcomere organization;negative regulation of vascular associated smooth muscle cell migration;positive regulation of heart rate by epinephrine;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell migration;cellular response to reactive oxygen species;positive regulation of cell adhesion;regulation of heart contraction;regulation of cell shape;wound healing;muscle filament sliding;cardiac muscle contraction	GO:005149; GO:005501; GO:000693; GO:000701; GO:003278; GO:000170; GO:003152; GO:004521; GO:190475; GO:000306; GO:190470; GO:003033; GO:003461; GO:004578; GO:000801; GO:000836; GO:004206; GO:003004; GO:006004	actin cytoskeleton;sarcomere;cytosol;cytoskeleton;bleb;ruffle membrane;actin filament;stress fiber;muscle thin filament tropomyosin	GO:001562; GO:003001; GO:000582; GO:000585; GO:003205; GO:003258; GO:000588; GO:000172; GO:000586	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction; MicroRNAs in cancer	hsa0541; hsa0541; hsa0426; hsa0520	structural constituent of cytoskeleton;actin filament binding;identical protein binding;cytoskeletal protein binding;protein heterodimerization activity;actin binding;structural constituent of muscle;protein binding	GO:000520; GO:005101; GO:004280; GO:000809; GO:004698; GO:000377; GO:000830; GO:000551
XP_020939646.1;XP_020939644.1	XP_020939646.1;XP_020939644.1	XP_020939646.1 far upstream element-binding protein 2 isoform X2 [Sus scrofa];XP_020939644.1 far upstream element-binding protein 2 isoform X1 [Sus scrofa]	9	9	9	42093000	54053000	40271000	52237000	34458000	48452000	50846000	51925000	41524000	43211000	49605000	68398000	54446000	53605000	46067000	48265000	42965000	53086000	NA	NA	NA	KHSRP	KHSRP;KHSRP;NA;NA;NA	RNA splicing, via transesterification reactions;regulation of transcription, DNA-templated;negative regulation of nitric oxide biosynthetic process;positive regulation of mRNA catabolic process;cellular response to cytokine stimulus;miRNA metabolic process;regulation of mRNA stability;mRNA transport;3'-UTR-mediated mRNA destabilization;regulation of miRNA metabolic process;negative regulation of low-density lipoprotein particle clearance;mRNA processing;mRNA catabolic process;RNA splicing	GO:000037; GO:000635; GO:004501; GO:006101; GO:007134; GO:001058; GO:004348; GO:005102; GO:006115; GO:200062; GO:001098; GO:000639; GO:000640; GO:000838	cytosol;cytoplasmic stress granule;membrane;exosome (RNase complex);nucleoplasm	GO:000582; GO:001049; GO:001602; GO:000017; GO:000565	"NA"	"NA"	DNA binding;mRNA 3'-UTR AU-rich region binding;protein binding;RNA binding	GO:000367; GO:003592; GO:000551; GO:000372
XP_020939706.1	XP_020939706.1	XP_020939706.1 myeloid-derived growth factor [Sus scrofa]	3	3	3	0	46780000	0	0	37715000	33861000	0	48196000	0	42080000	0	47982000	0	56965000	0	47711000	44259000	0	NA	NA	NA	MYDGF	MYDGF;NA;NA;NA;NA	positive regulation of protein phosphorylation;angiogenesis;positive regulation of endothelial cell proliferation;apoptotic process;positive regulation of angiogenesis;positive regulation of protein kinase B signaling;positive regulation of phosphatidylinositol 3-kinase signaling;IRE1-mediated unfolded protein response;negative regulation of apoptotic process;positive regulation of MAPK cascade;positive regulation of transcription from RNA polymerase II promoter	GO:000193; GO:000152; GO:000193; GO:000691; GO:004576; GO:005189; GO:001406; GO:003649; GO:004306; GO:004341; GO:004594	endoplasmic reticulum lumen;extracellular space;endoplasmic reticulum-Golgi intermediate compartment	GO:000578; GO:000561; GO:000579	"NA"	"NA"	protein binding	GO:000551
XP_020939716.1;XP_020939714.1;XP_020939713.1;XP_020939715.1;XP_020939717.1	XP_020939716.1;XP_020939714.1;XP_020939713.1;XP_020939715.1;XP_020939717.1	XP_020939716.1 perilipin-4 isoform X3 [Sus scrofa];XP_020939714.1 perilipin-4 isoform X1 [Sus scrofa];XP_020939713.1 perilipin-4 isoform X1 [Sus scrofa];XP_020939715.1 perilipin-4 isoform X2 [Sus scrofa];XP_020939717.1 perilipin-4 isoform X4 [Sus scrofa]	41	41	41	1292100000	2783500000	2073600000	2631200000	1197000000	1636000000	2012800000	2357000000	2791700000	3609800000	3010800000	4792000000	1251200000	3091500000	2958800000	3462400000	1871800000	3861000000	NA	NA	NA	PLIN4	PLIN4;PLIN4;PLIN4;PLIN4;PLIN4	"NA"	"NA"	intracellular membrane-bounded organelle;plasma membrane;lipid particle;cytosol	GO:004323; GO:000588; GO:000581; GO:000582	"NA"	"NA"	"NA"	"NA"
XP_020939792.1;XP_020939791.1;XP_020939789.1;XP_020939788.1;XP_020939786.1;XP_020939785.1;XP_020939784.1;XP_020939790.1;XP_020939783.1	XP_020939792.1;XP_020939791.1;XP_020939789.1;XP_020939788.1;XP_020939786.1;XP_020939785.1;XP_020939784.1;XP_020939790.1;XP_020939783.1	XP_020939792.1 nuclear factor 1 C-type isoform X9 [Sus scrofa];XP_020939791.1 nuclear factor 1 C-type isoform X8 [Sus scrofa];XP_020939789.1 nuclear factor 1 C-type isoform X6 [Sus scrofa];XP_020939788.1 nuclear factor 1 C-type isoform X5 [Sus scrofa];XP_0	3	3	2	0	0	0	0	0	0	0	0	0	20389000	0	0	0	0	0	18580000	0	0	NA	NA	NA	NFIC	NFIC;NFIC;NFIC;NFIC;NFIC	negative regulation of transcription from RNA polymerase II promoter;DNA replication;transcription from RNA polymerase II promoter;odontogenesis of dentin-containing tooth;positive regulation of transcription from RNA polymerase II promoter	GO:000012; GO:000626; GO:000636; GO:004247; GO:004594	fibrillar center;nucleus	GO:000165; GO:000563	"NA"	"NA"	RNA polymerase II core promoter proximal region sequence-specific DNA binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;transcription factor activity, sequence-specific DNA binding	GO:000097; GO:000098; GO:000122; GO:000370
XP_020939840.1;XP_020939839.1;XP_020939838.1;XP_020939837.1	XP_020939840.1;XP_020939839.1;XP_020939838.1;XP_020939837.1	XP_020939840.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [Sus scrofa];XP_020939839.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [Sus scrofa];XP_020939838.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) sub	2	2	2	32568000	0	33710000	39903000	35516000	0	60025000	0	40345000	0	42431000	0	32863000	0	45528000	0	42779000	45251000	NA	NA	NA	GNG7	GNG7;GNG7;GNG7;GNG7;NA	locomotory behavior;regulation of G-protein coupled receptor protein signaling pathway;G-protein coupled receptor signaling pathway;receptor guanylyl cyclase signaling pathway;behavioral fear response;regulation of adenylate cyclase activity	GO:000762; GO:000827; GO:000718; GO:000716; GO:000166; GO:004576	plasma membrane;extracellular exosome;heterotrimeric G-protein complex	GO:000588; GO:007006; GO:000583	 Circadian entrainment; Morphine addiction; Glutamatergic synapse; Ras signaling pathway; PI3K-Akt signaling pathway; Pathways in cancer; Chemokine signaling pathway	hsa0471; hsa0503; hsa0472; hsa0401; hsa0415; hsa0520; hsa0406	GTPase activity	GO:000392
XP_020939856.1;XP_020939855.1;XP_020939857.1	XP_020939856.1;XP_020939855.1;XP_020939857.1	XP_020939856.1 AP-3 complex subunit delta-1 isoform X2 [Sus scrofa];XP_020939855.1 AP-3 complex subunit delta-1 isoform X1 [Sus scrofa];XP_020939857.1 AP-3 complex subunit delta-1 isoform X3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8087100	0	0	0	NA	NA	NA	AP3D1	AP3D1;AP3D1;AP3D1;NA;NA	protein targeting to vacuole;Golgi to vacuole transport;regulation of sequestering of zinc ion;protein localization to membrane;neurotransmitter receptor transport, postsynaptic endosome to lysosome;anterograde axonal transport;synaptic vesicle budding from endosome;melanosome organization;anterograde synaptic vesicle transport;eye pigment biosynthetic process;positive regulation of NK T cell differentiation;intracellular protein transport;endosome to melanosome transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib	GO:000662; GO:000689; GO:006108; GO:007265; GO:009894; GO:000808; GO:001618; GO:003243; GO:004849; GO:000672; GO:005113; GO:000688; GO:003564; GO:004800	plasma membrane;Golgi membrane;AP-3 adaptor complex;axon cytoplasm;endosome membrane;presynaptic endosome;Golgi apparatus;glutamatergic synapse;lysosomal membrane;membrane;terminal bouton;postsynapse	GO:000588; GO:000013; GO:003012; GO:190411; GO:001000; GO:009883; GO:000579; GO:009897; GO:000576; GO:001602; GO:004319; GO:009879	 Lysosome	hsa0414	transporter activity	GO:000521
XP_020940028.1;XP_020940026.1;XP_020940029.1;XP_020940027.1	XP_020940028.1;XP_020940026.1;XP_020940029.1;XP_020940027.1	XP_020940028.1 drebrin isoform X3 [Sus scrofa];XP_020940026.1 drebrin isoform X1 [Sus scrofa];XP_020940029.1 drebrin isoform X4 [Sus scrofa];XP_020940027.1 drebrin isoform X2 [Sus scrofa]	9	9	9	0	147640000	65336000	136740000	48550000	189320000	43616000	113370000	34989000	117630000	0	150090000	78113000	137410000	0	108970000	68813000	198970000	NA	NA	NA	DBN1	DBN1;DBN1;DBN1;DBN1;NA	cell communication by chemical coupling;maintenance of protein location in cell;actin filament organization;regulation of neuronal synaptic plasticity;positive regulation of synaptic plasticity;regulation of dendrite development;positive regulation of dendritic spine morphogenesis;neural precursor cell proliferation;cell communication by electrical coupling;cytoplasmic sequestering of protein;positive regulation of receptor localization to synapse	GO:001064; GO:003250; GO:000701; GO:004816; GO:003191; GO:005077; GO:006100; GO:006135; GO:001064; GO:005122; GO:190268	cortical cytoskeleton;postsynaptic cytosol;actin cytoskeleton;dendrite;actomyosin;postsynaptic membrane;glutamatergic synapse;gap junction;cytoplasm;cytoskeleton;postsynaptic density	GO:003086; GO:009952; GO:001562; GO:003042; GO:004264; GO:004521; GO:009897; GO:000592; GO:000573; GO:000585; GO:001406	"NA"	"NA"	actin binding;protein binding;profilin binding;cadherin binding	GO:000377; GO:000551; GO:000552; GO:004529
XP_020940039.1;XP_020940038.1;XP_020940036.1;XP_020940035.1;XP_020940050.1;XP_020940049.1;XP_020940048.1;XP_020940046.1;XP_020940045.1;XP_020940044.1;XP_020940043.1;XP_020940042.1;XP_020940041.1	XP_020940039.1;XP_020940038.1;XP_020940036.1;XP_020940035.1;XP_020940050.1	XP_020940039.1 PDZ and LIM domain protein 7 isoform X5 [Sus scrofa];XP_020940038.1 PDZ and LIM domain protein 7 isoform X4 [Sus scrofa];XP_020940036.1 PDZ and LIM domain protein 7 isoform X2 [Sus scrofa];XP_020940035.1 PDZ and LIM domain protein 7 isoform	9	9	1	44830000	64987000	105140000	38891000	0	106080000	0	66691000	40819000	210120000	86311000	116930000	260570000	42418000	63178000	66199000	72615000	22744000	NA	NA	NA	PDLIM7	PDLIM7;PDLIM7;PDLIM7;PDLIM7;PDLIM7	axon guidance;receptor-mediated endocytosis;ossification;actin cytoskeleton organization;positive regulation of osteoblast differentiation	GO:000741; GO:000689; GO:000150; GO:003003; GO:004566	nucleus;actin cytoskeleton;ruffle;cytosol;cell-cell adherens junction;focal adhesion	GO:000563; GO:001562; GO:000172; GO:000582; GO:000591; GO:000592	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_020940040.1;XP_020940037.1	XP_020940040.1;XP_020940037.1	XP_020940040.1 PDZ and LIM domain protein 7 isoform X6 [Sus scrofa];XP_020940037.1 PDZ and LIM domain protein 7 isoform X3 [Sus scrofa]	9	1	1	0	0	0	0	0	0	0	0	0	0	0	44072000	66371000	0	0	0	0	0	NA	NA	NA	PDLIM7	PDLIM7;PDLIM7;NA;NA;NA	axon guidance;receptor-mediated endocytosis;ossification;actin cytoskeleton organization;positive regulation of osteoblast differentiation	GO:000741; GO:000689; GO:000150; GO:003003; GO:004566	nucleus;actin cytoskeleton;ruffle;cytosol;cell-cell adherens junction;focal adhesion	GO:000563; GO:001562; GO:000172; GO:000582; GO:000591; GO:000592	"NA"	"NA"	metal ion binding;protein binding	GO:004687; GO:000551
XP_020940069.1	XP_020940069.1	XP_020940069.1 LOW QUALITY PROTEIN: nesprin-1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	5326800	0	0	10783000	0	0	0	0	0	0	0	0	NA	NA	NA	SYNE1	SYNE1;NA;NA;NA;NA	nucleus organization;nuclear matrix anchoring at nuclear membrane;cytoskeletal anchoring at nuclear membrane;Golgi organization;muscle cell differentiation;spermatogenesis	GO:000699; GO:009029; GO:009028; GO:000703; GO:004269; GO:000728	cytoplasm;nucleoplasm;nucleolus;LINC complex;Golgi apparatus;cytoskeleton;sarcomere;P-body;nuclear membrane;nuclear envelope;nuclear outer membrane;integral component of membrane;postsynaptic membrane	GO:000573; GO:000565; GO:000573; GO:003499; GO:000579; GO:000585; GO:003001; GO:000093; GO:003196; GO:000563; GO:000564; GO:001602; GO:004521	"NA"	"NA"	actin binding;lamin binding;RNA binding;enzyme binding;protein homodimerization activity;protein binding;actin filament binding	GO:000377; GO:000552; GO:000372; GO:001989; GO:004280; GO:000551; GO:005101
XP_020940092.1;XP_020940091.1;XP_020940090.1;XP_005661527.2	XP_020940092.1;XP_020940091.1;XP_020940090.1;XP_005661527.2	XP_020940092.1 clathrin light chain B isoform X4 [Sus scrofa];XP_020940091.1 clathrin light chain B isoform X3 [Sus scrofa];XP_020940090.1 clathrin light chain B isoform X2 [Sus scrofa];XP_005661527.2 clathrin light chain B isoform X1 [Sus scrofa]	7	7	7	42629000	60326000	47910000	60414000	45892000	70177000	59560000	60566000	64600000	48150000	57608000	50966000	71305000	69954000	77734000	45491000	65952000	80158000	NA	NA	NA	CLTB	CLTB;CLTB;CLTB;CLTB;NA	clathrin coat assembly;membrane organization;clathrin-dependent endocytosis;intracellular protein transport	GO:004826; GO:006102; GO:007258; GO:000688	postsynaptic endocytic zone cytoplasmic component;clathrin coat;synaptic vesicle membrane;intracellular membrane-bounded organelle;clathrin coat of coated pit;plasma membrane;clathrin vesicle coat;presynaptic endocytic zone membrane;trans-Golgi network;cytosol;clathrin-coated endocytic vesicle;ciliary membrane	GO:009963; GO:003011; GO:003067; GO:004323; GO:003013; GO:000588; GO:003012; GO:009883; GO:000580; GO:000582; GO:004533; GO:006017	 Lysosome; Synaptic vesicle cycle; Endocytosis; Bacterial invasion of epithelial cells; Huntington's disease; Endocrine and other factor-regulated calcium reabsorption	hsa0414; hsa0472; hsa0414; hsa0510; hsa0501; hsa0496	protein binding;clathrin heavy chain binding;peptide binding;structural molecule activity	GO:000551; GO:003205; GO:004227; GO:000519
XP_020940121.1	XP_020940121.1	XP_020940121.1 LOW QUALITY PROTEIN: ras GTPase-activating-like protein IQGAP2 [Sus scrofa]	7	6	6	0	29853000	0	34800000	0	28473000	0	34417000	0	37538000	0	0	0	44909000	29501000	31201000	0	35976000	NA	NA	NA	IQGAP2	IQGAP2;NA;NA;NA;NA	negative regulation of GTPase activity;Arp2/3 complex-mediated actin nucleation;neutrophil degranulation;signal transduction;thrombin-activated receptor signaling pathway	GO:003426; GO:003431; GO:004331; GO:000716; GO:007049	plasma membrane;extracellular exosome;cytoplasm;cytosol;microvillus;filopodium;secretory granule membrane;lamellipodium;cell surface;actin cytoskeleton	GO:000588; GO:007006; GO:000573; GO:000582; GO:000590; GO:003017; GO:003066; GO:003002; GO:000998; GO:001562	 Regulation of actin cytoskeleton	hsa0481	actin binding;Arp2/3 complex binding;GTPase inhibitor activity;calmodulin binding;Rac GTPase binding;Rho GTPase binding;actin filament binding;phosphatidylinositol-3,4,5-trisphosphate binding	GO:000377; GO:007193; GO:000509; GO:000551; GO:004836; GO:001704; GO:005101; GO:000554
XP_020940122.1	XP_020940122.1	XP_020940122.1 LOW QUALITY PROTEIN: laminin subunit alpha-2 [Sus scrofa]	10	10	10	0	24805000	8743000	5479200	10040000	0	0	0	0	8557800	11818000	0	0	0	0	19743000	0	0	NA	NA	NA	LAMA2	LAMA2;NA;NA;NA;NA	regulation of embryonic development;regulation of cell adhesion;cell adhesion;extracellular matrix organization;regulation of cell migration;axon guidance;Schwann cell differentiation;positive regulation of synaptic transmission, cholinergic;muscle organ development	GO:004599; GO:003015; GO:000715; GO:003019; GO:003033; GO:000741; GO:001403; GO:003222; GO:000751	sarcolemma;synaptic cleft;dendritic spine;extracellular region;basement membrane;neuromuscular junction	GO:004238; GO:004308; GO:004319; GO:000557; GO:000560; GO:003159	 Amoebiasis; Arrhythmogenic right ventricular cardiomyopathy (ARVC); PI3K-Akt signaling pathway; Small cell lung cancer; Pathways in cancer; Focal adhesion; Toxoplasmosis	hsa0514; hsa0541; hsa0415; hsa0522; hsa0520; hsa0451; hsa0514	structural molecule activity;extracellular matrix structural constituent;receptor binding	GO:000519; GO:000520; GO:000510
XP_020940134.1	XP_020940134.1	XP_020940134.1 tubulin-specific chaperone A [Sus scrofa]	2	2	2	30258000	41494000	42760000	25590000	0	0	37144000	31850000	30657000	0	36631000	0	0	41527000	41444000	0	37233000	25952000	NA	NA	NA	TBCA	TBCA;NA;NA;NA;NA	tubulin complex assembly;protein folding;post-chaperonin tubulin folding pathway	GO:000702; GO:000645; GO:000702	nucleolus;microtubule;cytoplasm;microtubule cytoskeleton	GO:000573; GO:000587; GO:000573; GO:001563	"NA"	"NA"	RNA binding;beta-tubulin binding;chaperone binding;protein binding	GO:000372; GO:004848; GO:005108; GO:000551
XP_020940135.1	XP_020940135.1	XP_020940135.1 tropomyosin alpha-1 chain isoform X3 [Sus scrofa]	37	37	0	1805000000	2501100000	5976800000	1922100000	1264600000	4062300000	1469000000	4137700000	2212200000	8467100000	4146200000	4738200000	14601000000	1755100000	1419800000	1959900000	3486000000	1691200000	NA	NA	NA	TPM1	TPM1;NA;NA;NA;NA	positive regulation of stress fiber assembly;ventricular cardiac muscle tissue morphogenesis;muscle contraction;actin filament organization;positive regulation of ATPase activity;in utero embryonic development;ruffle organization;sarcomere organization;negative regulation of vascular associated smooth muscle cell migration;positive regulation of heart rate by epinephrine;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell migration;cellular response to reactive oxygen species;positive regulation of cell adhesion;regulation of heart contraction;regulation of cell shape;wound healing;muscle filament sliding;cardiac muscle contraction	GO:005149; GO:005501; GO:000693; GO:000701; GO:003278; GO:000170; GO:003152; GO:004521; GO:190475; GO:000306; GO:190470; GO:003033; GO:003461; GO:004578; GO:000801; GO:000836; GO:004206; GO:003004; GO:006004	actin cytoskeleton;sarcomere;cytosol;cytoskeleton;bleb;ruffle membrane;actin filament;stress fiber;muscle thin filament tropomyosin	GO:001562; GO:003001; GO:000582; GO:000585; GO:003205; GO:003258; GO:000588; GO:000172; GO:000586	 Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Cardiac muscle contraction; MicroRNAs in cancer	hsa0541; hsa0541; hsa0426; hsa0520	structural constituent of cytoskeleton;actin filament binding;identical protein binding;cytoskeletal protein binding;protein heterodimerization activity;actin binding;structural constituent of muscle;protein binding	GO:000520; GO:005101; GO:004280; GO:000809; GO:004698; GO:000377; GO:000830; GO:000551
XP_020940149.1;CON__ENSEMBL:ENSBTAP00000006074;XP_003123575.2	XP_020940149.1	XP_020940149.1 LOW QUALITY PROTEIN: thrombospondin-4 [Sus scrofa]	12	12	11	0	20082000	0	20914000	0	20370000	0	14514000	0	32331000	0	42427000	44727000	0	0	18135000	0	59182000	NA	NA	NA	THBS4	THBS4;NA;NA;NA;NA	positive regulation of cell division;positive regulation of neutrophil chemotaxis;regulation of receptor activity;behavioral response to pain;tissue remodeling;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of endothelial cell proliferation;response to unfolded protein;negative regulation of angiogenesis;response to endoplasmic reticulum stress;endothelial cell-cell adhesion;regulation of tissue remodeling;myoblast migration	GO:005178; GO:009002; GO:001046; GO:004826; GO:004877; GO:005073; GO:000193; GO:000698; GO:001652; GO:003497; GO:007160; GO:003410; GO:005145	extracellular exosome;basement membrane;extracellular region;sarcoplasmic reticulum;endoplasmic reticulum;extracellular space	GO:007006; GO:000560; GO:000557; GO:001652; GO:000578; GO:000561	 Phagosome; Malaria; PI3K-Akt signaling pathway; Focal adhesion	hsa0414; hsa0514; hsa0415; hsa0451	integrin binding;growth factor activity;calcium ion binding;protein binding;heparin binding	GO:000517; GO:000808; GO:000550; GO:000551; GO:000820
XP_020940379.1	XP_020940379.1	XP_020940379.1 LOW QUALITY PROTEIN: fibrillin-2 [Sus scrofa]	4	1	1	0	0	0	0	0	0	0	25695000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	FBN2	FBN2;NA;NA;NA;NA	positive regulation of osteoblast differentiation;extracellular matrix organization;bone trabecula formation;embryonic limb morphogenesis;camera-type eye development;positive regulation of bone mineralization;sequestering of TGFbeta in extracellular matrix;embryonic eye morphogenesis	GO:004566; GO:003019; GO:006034; GO:003032; GO:004301; GO:003050; GO:003558; GO:004804	microfibril;extracellular region;extracellular matrix	GO:000152; GO:000557; GO:003101	"NA"	"NA"	extracellular matrix structural constituent;extracellular matrix constituent conferring elasticity;calcium ion binding;protein binding	GO:000520; GO:003002; GO:000550; GO:000551
XP_020940420.1;XP_013850604.1	XP_020940420.1	XP_020940420.1 S-phase kinase-associated protein 1 [Sus scrofa]	6	6	6	57052000	65828000	66667000	47297000	51935000	77742000	65363000	45507000	53505000	44355000	60117000	0	65062000	51816000	63642000	49128000	66906000	48569000	NA	NA	NA	SKP1	SKP1;NA;NA;NA;NA	post-translational protein modification;interleukin-1-mediated signaling pathway;histone H2A monoubiquitination;cellular iron ion homeostasis;Wnt signaling pathway;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;G2/M transition of mitotic cell cycle;maintenance of protein location in nucleus;NIK/NF-kappaB signaling;protein ubiquitination;stress-activated MAPK cascade;SCF complex assembly;negative regulation of G2/M transition of mitotic cell cycle;protein polyubiquitination;viral process;regulation of mitotic cell cycle phase transition	GO:004368; GO:007049; GO:003551; GO:000687; GO:001605; GO:003114; GO:000008; GO:005145; GO:003806; GO:001656; GO:005140; GO:001026; GO:001097; GO:000020; GO:001603; GO:190199	nucleus;nucleoplasm;cytosol;cytoplasm;SCF ubiquitin ligase complex;PcG protein complex;centrosome;Cul7-RING ubiquitin ligase complex	GO:000563; GO:000565; GO:000582; GO:000573; GO:001900; GO:003151; GO:000581; GO:003146	 Oocyte meiosis; Circadian rhythm; Cell cycle; Ubiquitin mediated proteolysis; Protein processing in endoplasmic reticulum; Herpes simplex infection; Wnt signaling pathway; TGF-beta signaling pathway	hsa0411; hsa0471; hsa0411; hsa0412; hsa0414; hsa0516; hsa0431; hsa0435	protein binding;ubiquitin protein ligase activity;ubiquitin-protein transferase activity;beta-catenin binding;protein domain specific binding;cullin family protein binding	GO:000551; GO:006163; GO:000484; GO:000801; GO:001990; GO:009760
XP_020940437.1	XP_020940437.1	XP_020940437.1 pterin-4-alpha-carbinolamine dehydratase 2 [Sus scrofa]	2	2	2	22105000	0	23275000	0	20532000	8926100	22358000	16550000	24967000	8614900	15850000	0	15562000	0	17705000	14137000	18978000	0	NA	NA	NA	PCBD2	PCBD2;NA;NA;NA;NA	tetrahydrobiopterin biosynthetic process;protein heterooligomerization;positive regulation of transcription, DNA-templated;protein homotetramerization;oxidation-reduction process	GO:000672; GO:005129; GO:004589; GO:005128; GO:005511	nucleus;cellular_component	GO:000563; GO:000557	"NA"	"NA"	phenylalanine 4-monooxygenase activity;protein binding;4-alpha-hydroxytetrahydrobiopterin dehydratase activity	GO:000450; GO:000551; GO:000812
XP_020940443.1	XP_020940443.1	XP_020940443.1 LOW QUALITY PROTEIN: transforming growth factor-beta-induced protein ig-h3 [Sus scrofa]	25	25	25	138230000	331840000	196590000	358340000	186850000	296030000	167910000	182570000	198410000	303630000	242710000	511970000	351430000	263660000	218140000	490370000	298950000	355900000	NA	NA	NA	TGFBI	TGFBI;NA;NA;NA;NA	angiogenesis;negative regulation of cell adhesion;visual perception;response to stimulus;extracellular matrix organization;chondrocyte differentiation;cell proliferation;cell adhesion;cellular protein metabolic process	GO:000152; GO:000716; GO:000760; GO:005089; GO:003019; GO:000206; GO:000828; GO:000715; GO:004426	extracellular exosome;extracellular region;plasma membrane;extracellular matrix;extracellular space;trans-Golgi network;basement membrane	GO:007006; GO:000557; GO:000588; GO:003101; GO:000561; GO:000580; GO:000560	"NA"	"NA"	integrin binding;protein binding;extracellular matrix binding;cell adhesion molecule binding;extracellular matrix structural constituent	GO:000517; GO:000551; GO:005084; GO:005083; GO:000520
XP_020940620.1	XP_020940620.1	XP_020940620.1 LOW QUALITY PROTEIN: leucine--tRNA ligase, cytoplasmic [Sus scrofa]	5	5	5	5113000	0	8857100	0	0	0	0	0	0	0	0	0	4788000	0	0	0	0	0	NA	NA	NA	LARS	LARS;NA;NA;NA;NA	cellular response to amino acid stimulus;tRNA aminoacylation for protein translation;regulation of cell size;cellular response to leucine starvation;positive regulation of GTPase activity;cellular response to leucine;positive regulation of TORC1 signaling;protein targeting to lysosome;cellular response to amino acid starvation;glutaminyl-tRNA aminoacylation;negative regulation of autophagy	GO:007123; GO:000641; GO:000836; GO:199025; GO:004354; GO:007123; GO:190426; GO:000662; GO:003419; GO:000642; GO:001050	cytoplasm;lysosome;cytosol;endomembrane system;aminoacyl-tRNA synthetase multienzyme complex;endoplasmic reticulum;nuclear body	GO:000573; GO:000576; GO:000582; GO:001250; GO:001710; GO:000578; GO:001660	 Aminoacyl-tRNA biosynthesis	hsa0097	GTPase activator activity;aminoacyl-tRNA editing activity;leucine-tRNA ligase activity;protein binding;ATP binding;glutamine-tRNA ligase activity	GO:000509; GO:000216; GO:000482; GO:000551; GO:000552; GO:000481
XP_020940673.1;XP_020940672.1	XP_020940673.1;XP_020940672.1	XP_020940673.1 platelet-derived growth factor receptor beta [Sus scrofa];XP_020940672.1 platelet-derived growth factor receptor beta [Sus scrofa]	7	7	7	0	0	0	0	0	0	0	42291000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PDGFRB	PDGFRB;PDGFRB;NA;NA;NA	transmembrane receptor protein tyrosine kinase signaling pathway;positive regulation of cell proliferation;positive regulation of phosphatidylinositol 3-kinase signaling;peptidyl-tyrosine phosphorylation;response to retinoic acid;regulation of actin cytoskeleton organization;positive regulation of collagen biosynthetic process;positive regulation of apoptotic process;positive regulation of MAPK cascade;protein autophosphorylation;phosphatidylinositol phosphorylation;positive regulation of protein kinase B signaling;cell chemotaxis;metanephric glomerular capillary formation;signal transduction;G-protein coupled receptor signaling pathway;positive regulation of phospholipase C activity;cell migration involved in vasculogenesis;aorta morphogenesis;positive regulation of phosphatidylinositol 3-kinase activity;platelet-derived growth factor receptor signaling pathway;positive regulation of smooth muscle cell proliferation;metanephric mesenchyme development;glycosaminoglycan biosynthetic process;cell migration;positive regulation of phosphoprotein phosphatase activity;positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway;positive regulation of mitotic nuclear division;cardiac myofibril assembly;metanephric glomerular mesangial cell proliferation involved in metanephros development;metanephric S-shaped body morphogenesis;positive regulation of cell migration;platelet-derived growth factor receptor-beta signaling pathway;inner ear development;positive regulation of DNA biosynthetic process;hematopoietic progenitor cell differentiation;male gonad development;positive regulation of smooth muscle cell migration;positive regulation of Rho protein signal transduction;metanephric mesenchymal cell migration;cellular response to platelet-derived growth factor stimulus;response to hydrogen peroxide;positive regulation of MAP kinase activity;positive regulation of fibroblast proliferation;lung growth;cell migration involved in coronary angiogenesis;retina vasculature development in camera-type eye;positive regulation of calcium ion import;MAPK cascade;response to estradiol;phosphatidylinositol-mediated signaling;positive regulation of chemotaxis;smooth muscle cell chemotaxis;positive regulation of reactive oxygen species metabolic process;aging;phosphatidylinositol metabolic process;positive regulation of ERK1 and ERK2 cascade;positive regulation of hepatic stellate cell activation;response to fluid shear stress;wound healing;response to estrogen;response to hyperoxia	GO:000716; GO:000828; GO:001406; GO:001810; GO:003252; GO:003295; GO:003296; GO:004306; GO:004341; GO:004677; GO:004685; GO:005189; GO:006032; GO:007227; GO:000716; GO:000718; GO:001086; GO:003544; GO:003590; GO:004355; GO:004800; GO:004866; GO:007207; GO:000602; GO:001647; GO:003251; GO:003809; GO:004584; GO:005500; GO:007226; GO:007228; GO:003033; GO:003579; GO:004883; GO:200057; GO:000224; GO:000858; GO:001491; GO:003502; GO:003578; GO:003612; GO:004254; GO:004340; GO:004814; GO:006043; GO:006098; GO:006129; GO:009028; GO:000016; GO:003235; GO:004801; GO:005092; GO:007167; GO:200037; GO:000756; GO:004648; GO:007037; GO:200049; GO:003440; GO:004206; GO:004362; GO:005509	cytoplasm;cell surface;membrane;apical plasma membrane;integral component of plasma membrane;lysosomal lumen;intrinsic component of plasma membrane;intracellular membrane-bounded organelle;nucleus;Golgi apparatus;focal adhesion;cytoplasmic vesicle	GO:000573; GO:000998; GO:001602; GO:001632; GO:000588; GO:004320; GO:003122; GO:004323; GO:000563; GO:000579; GO:000592; GO:003141	 Ras signaling pathway; Rap1 signaling pathway; Pathways in cancer; Choline metabolism in cancer; Calcium signaling pathway; Cytokine-cytokine receptor interaction; Focal adhesion; Gap junction; Glioma; HTLV-I infection; PI3K-Akt signaling pathway; Regulation of actin cytoskeleton	hsa0401; hsa0401; hsa0520; hsa0523; hsa0402; hsa0406; hsa0451; hsa0454; hsa0521; hsa0516; hsa0415; hsa0481	protein binding;ATP binding;protein kinase binding;platelet-derived growth factor-activated receptor activity;platelet-derived growth factor receptor binding;protein tyrosine kinase activity;platelet-derived growth factor binding;platelet activating factor receptor activity;receptor binding;vascular endothelial growth factor binding;Ras guanyl-nucleotide exchange factor activity;enzyme binding;phosphatidylinositol 3-kinase binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	GO:000551; GO:000552; GO:001990; GO:000501; GO:000516; GO:000471; GO:004840; GO:000499; GO:000510; GO:003808; GO:000508; GO:001989; GO:004354; GO:004693
XP_020940687.1;XP_020940686.1;XP_020940685.1	XP_020940687.1;XP_020940686.1;XP_020940685.1	XP_020940687.1 40S ribosomal protein S14 [Sus scrofa];XP_020940686.1 40S ribosomal protein S14 [Sus scrofa];XP_020940685.1 40S ribosomal protein S14 [Sus scrofa]	5	5	5	71997000	104570000	78846000	89464000	69153000	62976000	50039000	100580000	55686000	79780000	99872000	71649000	48572000	127420000	98737000	77248000	62053000	119840000	NA	NA	NA	RPS14	RPS14;RPS14;RPS14;NA;NA	negative regulation of transcription from RNA polymerase II promoter;SRP-dependent cotranslational protein targeting to membrane;maturation of SSU-rRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);erythrocyte differentiation;rRNA processing;translation;ribosomal small subunit assembly	GO:000012; GO:000661; GO:003049; GO:000018; GO:000046; GO:003021; GO:000636; GO:000641; GO:000002	focal adhesion;membrane;extracellular exosome;nucleoplasm;nucleolus;cytosol;cytosolic small ribosomal subunit;postsynaptic density	GO:000592; GO:001602; GO:007006; GO:000565; GO:000573; GO:000582; GO:002262; GO:001406	 Ribosome	hsa0301	protein binding;translation regulator activity;RNA binding;structural constituent of ribosome;mRNA 5'-UTR binding;small ribosomal subunit rRNA binding	GO:000551; GO:004518; GO:000372; GO:000373; GO:004802; GO:007018
XP_020940820.1	XP_020940820.1	XP_020940820.1 SLC35A4 upstream open reading frame protein [Sus scrofa]	4	4	4	16460000	0	0	0	15683000	0	18552000	15987000	0	12328000	0	0	0	12478000	0	0	0	0	NA	NA	NA	LOC102167522	LOC102167522;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020941055.1	XP_020941055.1	XP_020941055.1 LOW QUALITY PROTEIN: endoplasmic reticulum aminopeptidase 1 [Sus scrofa]	7	7	7	0	0	8209000	0	0	0	0	0	11213000	0	12408000	11084000	12749000	9031600	0	0	14377000	10465000	NA	NA	NA	ERAP1	ERAP1;NA;NA;NA;NA	antigen processing and presentation of endogenous peptide antigen via MHC class I;peptide catabolic process;regulation of innate immune response;fat cell differentiation;angiogenesis;regulation of blood pressure;membrane protein ectodomain proteolysis;response to bacterium;antigen processing and presentation of peptide antigen via MHC class I;positive regulation of angiogenesis;adaptive immune response	GO:001988; GO:004317; GO:004508; GO:004544; GO:000152; GO:000821; GO:000650; GO:000961; GO:000247; GO:004576; GO:000225	cytosol;membrane;endoplasmic reticulum lumen;extracellular exosome;extracellular space;extracellular region;cytoplasm	GO:000582; GO:001602; GO:000578; GO:007006; GO:000561; GO:000557; GO:000573	"NA"	"NA"	interleukin-6 receptor binding;protein binding;metalloaminopeptidase activity;endopeptidase activity;metalloexopeptidase activity;peptide binding;interleukin-1, Type II receptor binding;zinc ion binding	GO:000513; GO:000551; GO:007000; GO:000417; GO:000823; GO:004227; GO:000515; GO:000827
XP_020941195.1;NP_001090933.1	XP_020941195.1;NP_001090933.1	XP_020941195.1 ATP synthase subunit f, mitochondrial isoform X1 [Sus scrofa];NP_001090933.1 ATP synthase subunit f, mitochondrial [Sus scrofa]	3	3	3	137470000	70920000	105530000	65622000	102580000	60627000	110840000	78436000	102600000	83353000	158130000	76049000	59843000	73111000	0	97291000	82012000	52541000	NA	NA	NA	ATP5MF	ATP5MF;ATP5MF;NA;NA;NA	mitochondrial ATP synthesis coupled proton transport;hydrogen ion transmembrane transport;ATP biosynthetic process;cristae formation	GO:004277; GO:190260; GO:000675; GO:004240	mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);mitochondrion;mitochondrial inner membrane;integral component of membrane;mitochondrial proton-transporting ATP synthase complex;nucleus	GO:000027; GO:000573; GO:000574; GO:001602; GO:000575; GO:000563	 Oxidative phosphorylation; Metabolic pathways	hsa0019; hsa0110	ATPase activity;transmembrane transporter activity	GO:001688; GO:002285
XP_020941216.1;XP_020941215.1;XP_020941214.1;XP_020941213.1;XP_020941212.1;XP_020941211.1;NP_001123431.1	XP_020941216.1;XP_020941215.1;XP_020941214.1;XP_020941213.1;XP_020941212.1;XP_020941211.1;NP_001123431.1	XP_020941216.1 NADPH--cytochrome P450 reductase isoform X2 [Sus scrofa];XP_020941215.1 NADPH--cytochrome P450 reductase isoform X2 [Sus scrofa];XP_020941214.1 NADPH--cytochrome P450 reductase isoform X2 [Sus scrofa];XP_020941213.1 NADPH--cytochrome P450 re	24	24	24	253130000	193450000	260600000	226100000	283270000	182350000	260120000	222720000	235550000	188170000	230130000	229730000	178310000	216010000	320770000	294450000	233850000	184130000	NA	NA	NA	POR	POR;POR;POR;POR;POR	response to nutrient;regulation of growth plate cartilage chondrocyte proliferation;electron transport chain;demethylation;cellular organofluorine metabolic process;carnitine metabolic process;fatty acid oxidation;positive regulation of monooxygenase activity;positive regulation of cholesterol biosynthetic process;response to drug;positive regulation of steroid hormone biosynthetic process;response to hormone;nitric oxide catabolic process;internal peptidyl-lysine acetylation;positive regulation of smoothened signaling pathway;negative regulation of lipase activity;positive regulation of chondrocyte differentiation;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;oxidation-reduction process;xenobiotic metabolic process;flavonoid metabolic process;nitrate catabolic process;cellular response to follicle-stimulating hormone stimulus	GO:000758; GO:000342; GO:002290; GO:007098; GO:009034; GO:000943; GO:001939; GO:003277; GO:004554; GO:004249; GO:009003; GO:000972; GO:004621; GO:001839; GO:004588; GO:006019; GO:003233; GO:004315; GO:005511; GO:000680; GO:000981; GO:004360; GO:007137	membrane;integral component of membrane;intracellular membrane-bounded organelle;mitochondrion;endoplasmic reticulum membrane;cytosol	GO:001602; GO:001602; GO:004323; GO:000573; GO:000578; GO:000582	"NA"	"NA"	electron carrier activity;flavin adenine dinucleotide binding;cytochrome-b5 reductase activity, acting on NAD(P)H;nitric oxide dioxygenase activity;FMN binding;oxidoreductase activity;iron-cytochrome-c reductase activity;hydrolase activity;protein binding;enzyme binding;NADPH-hemoprotein reductase activity	GO:000905; GO:005066; GO:000412; GO:000894; GO:001018; GO:001649; GO:004772; GO:001678; GO:000551; GO:001989; GO:000395
XP_020941340.1;NP_001191322.1	XP_020941340.1;NP_001191322.1	XP_020941340.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform X1 [Sus scrofa];NP_001191322.1 sarcoplasmic/endoplasmic reticulum calcium ATPase 1 [Sus scrofa]	23	23	15	0	18721000	3425600	5110200	0	18607000	0	0	0	17320000	0	0	0	0	0	0	1161900000	14963000	NA	NA	NA	ATP2A1	ATP2A1;ATP2A1;NA;NA;NA	positive regulation of endoplasmic reticulum calcium ion concentration;regulation of cardiac conduction;calcium ion transport;ion transmembrane transport;calcium ion transmembrane transport;relaxation of skeletal muscle;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of mitochondrial calcium ion concentration;maintenance of mitochondrion location;ATP hydrolysis coupled cation transmembrane transport;cellular calcium ion homeostasis;apoptotic mitochondrial changes;positive regulation of fast-twitch skeletal muscle fiber contraction;response to endoplasmic reticulum stress;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;calcium ion import;hydrogen ion transmembrane transport	GO:003247; GO:190377; GO:000681; GO:003422; GO:007058; GO:009007; GO:003247; GO:005156; GO:005165; GO:009913; GO:000687; GO:000863; GO:003144; GO:003497; GO:007005; GO:007050; GO:190260	integral component of membrane;endoplasmic reticulum membrane;sarcoplasmic reticulum;platelet dense tubular network membrane;mitochondrion;calcium channel complex;sarcoplasmic reticulum membrane	GO:001602; GO:000578; GO:001652; GO:003109; GO:000573; GO:003470; GO:003301	 Alzheimer's disease; Calcium signaling pathway; Pancreatic secretion	hsa0501; hsa0402; hsa0497	hydrogen-exporting ATPase activity, phosphorylative mechanism;protein homodimerization activity;calcium-transporting ATPase activity;ATP binding;calcium ion binding;protein binding	GO:000855; GO:004280; GO:000538; GO:000552; GO:000550; GO:000551
XP_020941351.1;CON__ENSEMBL:ENSBTAP00000032840	XP_020941351.1	XP_020941351.1 apolipoprotein B-100 isoform X1 [Sus scrofa]	22	22	9	111390000	47747000	43158000	59482000	83646000	60172000	75092000	40452000	96347000	64511000	66903000	56038000	106220000	60344000	67814000	52857000	85224000	20613000	NA	NA	NA	APOB	APOB;NA;NA;NA;NA	triglyceride mobilization;post-embryonic development;response to estradiol;chylomicron assembly;very-low-density lipoprotein particle clearance;lipoprotein transport;leukocyte migration;cellular response to prostaglandin stimulus;cholesterol metabolic process;flagellated sperm motility;cholesterol homeostasis;artery morphogenesis;receptor-mediated endocytosis;spermatogenesis;nervous system development;response to virus;response to selenium ion;chylomicron remnant clearance;lipoprotein biosynthetic process;post-translational protein modification;retinoid metabolic process;fertilization;positive regulation of cholesterol storage;cholesterol transport;response to lipopolysaccharide;cholesterol efflux;membrane organization;positive regulation of gene expression;cellular protein metabolic process;regulation of cholesterol biosynthetic process;in utero embryonic development;toll-like receptor signaling pathway;response to carbohydrate;triglyceride catabolic process;positive regulation of macrophage derived foam cell differentiation;cellular response to tumor necrosis factor	GO:000664; GO:000979; GO:003235; GO:003437; GO:003444; GO:004295; GO:005090; GO:007137; GO:000820; GO:003031; GO:004263; GO:004884; GO:000689; GO:000728; GO:000739; GO:000961; GO:001026; GO:003438; GO:004215; GO:004368; GO:000152; GO:000956; GO:001088; GO:003030; GO:003249; GO:003334; GO:006102; GO:001062; GO:004426; GO:004554; GO:000170; GO:000222; GO:000974; GO:001943; GO:001074; GO:007135	neuronal cell body;endoplasmic reticulum exit site;early endosome;plasma membrane;cytoplasm;endoplasmic reticulum lumen;endosome lumen;low-density lipoprotein particle;lysosomal lumen;extracellular exosome;extracellular space;clathrin-coated endocytic vesicle membrane;mature chylomicron;cytosol;smooth endoplasmic reticulum;chylomicron;intracellular membrane-bounded organelle;extracellular region;endosome membrane;endocytic vesicle lumen	GO:004302; GO:007097; GO:000576; GO:000588; GO:000573; GO:000578; GO:003190; GO:003436; GO:004320; GO:007006; GO:000561; GO:003066; GO:003435; GO:000582; GO:000579; GO:004262; GO:004323; GO:000557; GO:001000; GO:007168	 Vitamin digestion and absorption; Fat digestion and absorption	hsa0497; hsa0497	phospholipid binding;lipase binding;low-density lipoprotein particle receptor binding;heparin binding;cholesterol transporter activity;protein binding	GO:000554; GO:003547; GO:005075; GO:000820; GO:001712; GO:000551
XP_020941497.1;XP_020941496.1;XP_020941495.1;XP_020941494.1;NP_999145.1	XP_020941497.1;XP_020941496.1;XP_020941495.1;XP_020941494.1;NP_999145.1	XP_020941497.1 UTP--glucose-1-phosphate uridylyltransferase isoform X1 [Sus scrofa];XP_020941496.1 UTP--glucose-1-phosphate uridylyltransferase isoform X1 [Sus scrofa];XP_020941495.1 UTP--glucose-1-phosphate uridylyltransferase isoform X1 [Sus scrofa];XP_0	17	17	17	194440000	155470000	209570000	154620000	203360000	164460000	223240000	177610000	226460000	181390000	226410000	173370000	163540000	172120000	187080000	145390000	196710000	162750000	NA	NA	NA	UGP2	UGP2;UGP2;UGP2;UGP2;UGP2	UDP-glucuronate biosynthetic process;glycogen biosynthetic process;glucose 1-phosphate metabolic process;UDP-glucose metabolic process	GO:000606; GO:000597; GO:001925; GO:000601	extracellular exosome;cytosol;nucleus;cytoplasm	GO:007006; GO:000582; GO:000563; GO:000573	 Metabolic pathways; Starch and sucrose metabolism; Biosynthesis of antibiotics; Pentose and glucuronate interconversions; Galactose metabolism; Amino sugar and nucleotide sugar metabolism	hsa0110; hsa0050; hsa0113; hsa0004; hsa0005; hsa0052	identical protein binding;UTP:glucose-1-phosphate uridylyltransferase activity;pyrimidine ribonucleotide binding;glucose binding;protein binding;metal ion binding	GO:004280; GO:000398; GO:003255; GO:000553; GO:000551; GO:004687
XP_020941824.1	XP_020941824.1	XP_020941824.1 LOW QUALITY PROTEIN: myosin-11 [Sus scrofa]	132	132	115	2366100000	4469100000	5764200000	1200900000	832190000	9833900000	905940000	4776400000	3557300000	12036000000	6549600000	10178000000	14708000000	1705000000	1083000000	2372900000	1062000000	1463000000	NA	NA	NA	MYH11	MYH11;NA;NA;NA;NA	smooth muscle contraction;elastic fiber assembly;skeletal muscle myosin thick filament assembly;cardiac muscle fiber development;muscle contraction	GO:000693; GO:004825; GO:003024; GO:004873; GO:000693	melanosome;cytosol;muscle myosin complex;extracellular exosome;myosin filament	GO:004247; GO:000582; GO:000585; GO:007006; GO:003298	 Vascular smooth muscle contraction; Tight junction	hsa0427; hsa0453	ATP binding;protein binding;motor activity;structural constituent of muscle;actin filament binding	GO:000552; GO:000551; GO:000377; GO:000830; GO:005101
XP_020941844.1	XP_020941844.1	XP_020941844.1 LOW QUALITY PROTEIN: zinc-alpha-2-glycoprotein [Sus scrofa]	5	5	5	21684000	33707000	12045000	22953000	23360000	69580000	20016000	22533000	15842000	19407000	18393000	27378000	18720000	0	15052000	14204000	21410000	19821000	NA	NA	NA	AZGP1	AZGP1;NA;NA;NA;NA	retina homeostasis;negative regulation of cell proliferation;protein transmembrane transport;RNA phosphodiester bond hydrolysis;detection of chemical stimulus involved in sensory perception of bitter taste;immune response;transmembrane transport;cell adhesion	GO:000189; GO:000828; GO:007180; GO:009050; GO:000158; GO:000695; GO:005508; GO:000715	external side of plasma membrane;extracellular region;extracellular space;extracellular exosome;nucleus;plasma membrane	GO:000989; GO:000557; GO:000561; GO:007006; GO:000563; GO:000588	"NA"	"NA"	protein transmembrane transporter activity;protein binding;ribonuclease activity	GO:000832; GO:000551; GO:000454
XP_020941869.1	XP_020941869.1	XP_020941869.1 protein canopy homolog 4 [Sus scrofa]	6	6	6	0	14714000	0	0	21893000	0	17510000	23528000	0	0	22478000	0	0	18773000	27348000	16466000	15528000	22099000	NA	NA	NA	CNPY4	CNPY4;NA;NA;NA;NA	positive regulation of protein localization to plasma membrane	GO:190307	extracellular region	GO:000557	"NA"	"NA"	molecular_function;receptor binding	GO:000367; GO:000510
XP_020941920.1;XP_020941919.1	XP_020941920.1;XP_020941919.1	XP_020941920.1 procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 isoform X2 [Sus scrofa];XP_020941919.1 procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	745910	0	NA	NA	NA	PLOD3	PLOD3;PLOD3;NA;NA;NA	protein O-linked glycosylation;epidermis morphogenesis;collagen metabolic process;lung morphogenesis;basement membrane assembly;endothelial cell morphogenesis;protein localization;peptidyl-lysine hydroxylation;collagen fibril organization;oxidation-reduction process;in utero embryonic development;neural tube development;cellular response to hormone stimulus;vasodilation;hydroxylysine biosynthetic process	GO:000649; GO:004873; GO:003296; GO:006042; GO:007083; GO:000188; GO:000810; GO:001718; GO:003019; GO:005511; GO:000170; GO:002191; GO:003287; GO:004231; GO:004694	rough endoplasmic reticulum;trans-Golgi network;endoplasmic reticulum;Golgi apparatus;extracellular space;extracellular exosome	GO:000579; GO:000580; GO:000578; GO:000579; GO:000561; GO:007006	 Other types of O-glycan biosynthesis; Lysine degradation	hsa0051; hsa0031	procollagen-lysine 5-dioxygenase activity;L-ascorbic acid binding;procollagen galactosyltransferase activity;iron ion binding;protein binding;procollagen glucosyltransferase activity	GO:000847; GO:003141; GO:005021; GO:000550; GO:000551; GO:003382
XP_020941922.1	XP_020941922.1	XP_020941922.1 mitochondrial fission 1 protein [Sus scrofa]	6	6	6	77462000	77795000	77903000	64617000	71773000	51338000	73388000	66190000	78123000	71499000	70148000	128200000	69736000	67482000	71644000	68485000	77410000	79476000	NA	NA	NA	FIS1	FIS1;NA;NA;NA;NA	mitophagy;positive regulation of cytosolic calcium ion concentration;mitochondrial fusion;regulation of mitochondrion organization;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of protein targeting to membrane;response to hypobaric hypoxia;release of cytochrome c from mitochondria;negative regulation of endoplasmic reticulum calcium ion concentration;mitochondrial fragmentation involved in apoptotic process;cellular response to toxic substance;response to muscle activity;peroxisome fission;positive regulation of mitochondrial calcium ion concentration;response to flavonoid;positive regulation of intrinsic apoptotic signaling pathway;protein targeting to mitochondrion;response to nutrient levels;mitochondrion morphogenesis;response to fluoride;protein homooligomerization;cellular response to glucose stimulus;positive regulation of mitochondrial fission;cellular response to thapsigargin;apoptotic process;cellular response to peptide;mitochondrial fission;calcium-mediated signaling using intracellular calcium source;positive regulation of neuron apoptotic process	GO:000042; GO:000720; GO:000805; GO:001082; GO:004328; GO:009031; GO:199091; GO:000183; GO:003247; GO:004365; GO:009723; GO:001485; GO:001655; GO:005156; GO:190539; GO:200124; GO:000662; GO:003166; GO:007058; GO:190261; GO:005126; GO:007133; GO:009014; GO:190457; GO:000691; GO:190165; GO:000026; GO:003558; GO:004352	endoplasmic reticulum;mitochondrial outer membrane;integral component of mitochondrial outer membrane;peroxisome;membrane;macromolecular complex;mitochondrion	GO:000578; GO:000574; GO:003130; GO:000577; GO:001602; GO:003299; GO:000573	"NA"	"NA"	macromolecular complex binding;protein binding;receptor binding	GO:004487; GO:000551; GO:000510
XP_020941951.1;XP_020941950.1	XP_020941951.1;XP_020941950.1	XP_020941951.1 scavenger receptor cysteine-rich domain-containing group B protein isoform X2 [Sus scrofa];XP_020941950.1 scavenger receptor cysteine-rich domain-containing group B protein isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	165590000	+	NA	NA	SSC4D	SSC4D;SSC4D;NA;NA;NA	receptor-mediated endocytosis	GO:000689	external side of plasma membrane;extracellular region	GO:000989; GO:000557	"NA"	"NA"	scavenger receptor activity	GO:000504
XP_020941954.1	XP_020941954.1	XP_020941954.1 transmembrane protein 120A [Sus scrofa]	2	2	2	0	16038000	17904000	0	0	11383000	13820000	0	0	0	0	0	0	21898000	0	0	8265600	16708000	NA	NA	NA	TMEM120A	TMEM120A;NA;NA;NA;NA	fat cell differentiation;protein homooligomerization;protein heterooligomerization	GO:004544; GO:005126; GO:005129	cellular_component;integral component of membrane;nuclear inner membrane	GO:000557; GO:001602; GO:000563	"NA"	"NA"	molecular_function	GO:000367
XP_020941973.1	XP_020941973.1	XP_020941973.1 LOW QUALITY PROTEIN: huntingtin-interacting protein 1 [Sus scrofa]	8	8	8	0	0	0	0	0	0	0	0	0	0	0	7875800	0	0	0	6370000	0	0	NA	NA	NA	HIP1	HIP1;NA;NA;NA;NA	apoptotic signaling pathway;regulation of endocytosis;membrane organization;actin filament organization;regulation of apoptotic process;positive regulation of protein kinase B signaling;positive regulation of epidermal growth factor receptor signaling pathway;clathrin-dependent endocytosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;cell differentiation;positive regulation of receptor-mediated endocytosis;protein stabilization;neurotransmitter receptor transport;positive regulation of platelet-derived growth factor receptor-beta signaling pathway	GO:009719; GO:003010; GO:006102; GO:000701; GO:004298; GO:005189; GO:004574; GO:007258; GO:000691; GO:003015; GO:004826; GO:005082; GO:009963; GO:200058	nucleus;cytoskeleton;clathrin-coated vesicle;actin cortical patch;postsynapse;glutamatergic synapse;extrinsic component of cytoplasmic side of plasma membrane;Golgi apparatus;cytosol;cytoplasm;membrane;AP-2 adaptor complex;intracellular membrane-bounded organelle;extrinsic component of presynaptic membrane;extrinsic component of postsynaptic membrane	GO:000563; GO:000585; GO:003013; GO:003047; GO:009879; GO:009897; GO:003123; GO:000579; GO:000582; GO:000573; GO:001602; GO:003012; GO:004323; GO:009888; GO:009889	 Huntington's disease	hsa0501	phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3-phosphate binding;AP-2 adaptor complex binding;phosphatidylinositol-3,4-bisphosphate binding;glutamate receptor binding;structural constituent of cytoskeleton;clathrin binding;phosphatidylinositol binding;epidermal growth factor receptor binding;protein heterodimerization activity;actin filament binding;protein binding;clathrin light chain binding;protein homodimerization activity;phosphatidylinositol-3,5-bisphosphate binding	GO:000554; GO:003226; GO:003561; GO:004332; GO:003525; GO:000520; GO:003027; GO:003509; GO:000515; GO:004698; GO:005101; GO:000551; GO:003205; GO:004280; GO:008002
XP_020942019.1	XP_020942019.1	XP_020942019.1 argininosuccinate lyase [Sus scrofa]	8	8	8	0	23925000	17773000	17119000	16433000	19891000	16011000	0	16069000	22769000	20895000	22377000	16220000	30026000	17999000	28604000	22272000	17853000	NA	NA	NA	ASL	ASL;NA;NA;NA;NA	urea cycle;ammonia assimilation cycle;post-embryonic development;locomotory behavior;arginine biosynthetic process via ornithine	GO:000005; GO:001967; GO:000979; GO:000762; GO:004245	cytoplasm;cytosol;extracellular exosome	GO:000573; GO:000582; GO:007006	 Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of amino acids; Arginine biosynthesis; Biosynthesis of antibiotics	hsa0025; hsa0110; hsa0123; hsa0022; hsa0113	argininosuccinate lyase activity;identical protein binding;protein binding	GO:000405; GO:004280; GO:000551
XP_020942022.1	XP_020942022.1	XP_020942022.1 protein NipSnap homolog 2 [Sus scrofa]	3	3	3	0	0	37412000	21766000	27640000	36077000	0	0	0	29359000	0	0	0	35471000	0	33368000	32998000	32632000	NA	NA	NA	NIPSNAP2	NIPSNAP2;NA;NA;NA;NA	oxidative phosphorylation;positive regulation of high voltage-gated calcium channel activity;mitochondrion organization	GO:000611; GO:190184; GO:000700	mitochondrion;mitochondrial outer membrane	GO:000573; GO:000574	"NA"	"NA"	protein binding	GO:000551
XP_020942052.1;XP_020942051.1;XP_020942050.1;XP_020942049.1;XP_020942048.1	XP_020942052.1;XP_020942051.1;XP_020942050.1;XP_020942049.1;XP_020942048.1	XP_020942052.1 transforming growth factor beta-1-induced transcript 1 protein isoform X2 [Sus scrofa];XP_020942051.1 transforming growth factor beta-1-induced transcript 1 protein isoform X2 [Sus scrofa];XP_020942050.1 transforming growth factor beta-1-ind	11	11	11	0	32389000	40346000	18099000	6960500	30705000	12151000	34311000	29598000	48637000	35449000	30741000	78409000	23862000	0	14527000	17512000	29069000	NA	NA	NA	TGFB1I1	TGFB1I1;TGFB1I1;TGFB1I1;TGFB1I1;TGFB1I1	negative regulation of transforming growth factor beta receptor signaling pathway;cell fate commitment;positive regulation of transcription, DNA-templated;response to heat;transcription from RNA polymerase II promoter;Wnt signaling pathway;ubiquitin-dependent SMAD protein catabolic process;epithelial cell differentiation;negative regulation of fat cell differentiation;positive regulation of epithelial to mesenchymal transition;androgen receptor signaling pathway;morphogenesis of embryonic epithelium;negative regulation of cell proliferation;cell adhesion;positive regulation of transforming growth factor beta receptor signaling pathway	GO:003051; GO:004516; GO:004589; GO:000940; GO:000636; GO:001605; GO:003057; GO:003085; GO:004559; GO:001071; GO:003052; GO:001633; GO:000828; GO:000715; GO:003051	focal adhesion;cytoplasm;nuclear matrix;cytoskeleton	GO:000592; GO:000573; GO:001636; GO:000585	"NA"	"NA"	androgen receptor binding;Roundabout binding;I-SMAD binding;transcription coactivator activity;protein binding;metal ion binding	GO:005068; GO:004849; GO:007041; GO:000371; GO:000551; GO:004687
XP_020942063.1	XP_020942063.1	XP_020942063.1 syntaxin-4 [Sus scrofa]	5	5	5	25055000	0	26665000	28832000	0	0	0	26126000	0	0	24849000	0	26085000	29620000	0	27121000	25606000	24777000	NA	NA	NA	STX4	STX4;NA;NA;NA;NA	cellular response to interferon-gamma;exocytosis;vesicle docking;positive regulation of cell migration;SNARE complex assembly;positive regulation of cell adhesion;long-term synaptic potentiation;regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of protein localization to cell surface;cytokine-mediated signaling pathway;response to hydroperoxide;positive regulation of cell proliferation;positive regulation of catalytic activity;positive regulation of protein localization to plasma membrane;positive regulation of insulin secretion involved in cellular response to glucose stimulus;positive regulation of eosinophil degranulation;vesicle fusion;organelle fusion;positive regulation of immunoglobulin secretion;regulation of exocytosis;synaptic vesicle fusion to presynaptic active zone membrane;positive regulation of chemotaxis;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	GO:007134; GO:000688; GO:004827; GO:003033; GO:003549; GO:004578; GO:006029; GO:190204; GO:200001; GO:001922; GO:003319; GO:000828; GO:004308; GO:190307; GO:003577; GO:004331; GO:000690; GO:004828; GO:005102; GO:001715; GO:003162; GO:005092; GO:199066	storage vacuole;synaptic vesicle;glutamatergic synapse;trans-Golgi network;cell surface;integral component of membrane;synapse;endosome;lamellipodium;lateral loop;extracellular exosome;vacuole;basolateral plasma membrane;specific granule;extracellular space;plasma membrane;endomembrane system;SNARE complex;myelin sheath adaxonal region;presynaptic membrane;cytosol;presynaptic active zone membrane;postsynapse;phagocytic vesicle membrane;somatodendritic compartment;dendritic spine;perinuclear region of cytoplasm	GO:000032; GO:000802; GO:009897; GO:000580; GO:000998; GO:001602; GO:004520; GO:000576; GO:003002; GO:004321; GO:007006; GO:000577; GO:001632; GO:004258; GO:000561; GO:000588; GO:001250; GO:003120; GO:003574; GO:004273; GO:000582; GO:004878; GO:009879; GO:003067; GO:003647; GO:004319; GO:004847	 SNARE interactions in vesicular transport; Vasopressin-regulated water reabsorption	hsa0413; hsa0496	SNARE binding;SNAP receptor activity;sphingomyelin phosphodiesterase activator activity;protein binding	GO:000014; GO:000548; GO:001623; GO:000551
XP_020942084.1;XP_020942083.1	XP_020942084.1;XP_020942083.1	XP_020942084.1 major vault protein [Sus scrofa];XP_020942083.1 major vault protein [Sus scrofa]	26	26	26	69999000	115020000	91659000	100090000	68828000	83131000	112790000	99205000	74913000	78778000	89750000	111820000	132160000	90435000	79903000	65597000	123690000	105450000	NA	NA	NA	MVP	MVP;MVP;NA;NA;NA	negative regulation of protein tyrosine kinase activity;protein transport;mRNA transport;negative regulation of signaling;neutrophil degranulation;negative regulation of protein autophosphorylation;ERBB signaling pathway	GO:006109; GO:001503; GO:005102; GO:002305; GO:004331; GO:003195; GO:003812	extracellular exosome;nucleus;cytoskeleton;ficolin-1-rich granule lumen;perinuclear region of cytoplasm;cytosol;cytoplasm;membrane;secretory granule lumen;extracellular region;nuclear pore	GO:007006; GO:000563; GO:000585; GO:190481; GO:004847; GO:000582; GO:000573; GO:001602; GO:003477; GO:000557; GO:000564	"NA"	"NA"	protein binding;protein phosphatase binding;identical protein binding	GO:000551; GO:001990; GO:004280
XP_020942213.1;XP_020942212.1;XP_013840698.1	XP_020942213.1;XP_020942212.1	XP_020942213.1 40S ribosomal protein S15a isoform X2 [Sus scrofa];XP_020942212.1 40S ribosomal protein S15a isoform X1 [Sus scrofa]	4	4	4	64175000	0	0	65680000	64838000	0	0	0	69669000	0	60598000	0	61217000	0	0	88999000	76784000	0	NA	NA	NA	RPS15A	RPS15A;RPS15A;NA;NA;NA	positive regulation of cell proliferation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane;response to virus;positive regulation of cell cycle	GO:000828; GO:000018; GO:000641; GO:000661; GO:000961; GO:004578	nucleoplasm;cytoplasm;extracellular exosome;membrane;cytosol;cytosolic small ribosomal subunit	GO:000565; GO:000573; GO:007006; GO:001602; GO:000582; GO:002262	 Ribosome	hsa0301	RNA binding;structural constituent of ribosome;protein binding	GO:000372; GO:000373; GO:000551
XP_020942217.1	XP_020942217.1	XP_020942217.1 nodal modulator 1 [Sus scrofa]	13	13	13	64262000	39487000	40213000	52035000	60737000	34074000	46302000	50541000	47054000	46311000	56648000	61239000	51657000	38505000	57905000	58191000	48495000	48151000	NA	NA	NA	LOC100626015	LOC100626015;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020942250.1;XP_020942248.1;XP_013841597.1;XP_003135149.3	XP_020942250.1;XP_020942248.1;XP_013841597.1;XP_003135149.3	XP_020942250.1 eukaryotic peptide chain release factor GTP-binding subunit ERF3A isoform X2 [Sus scrofa];XP_020942248.1 eukaryotic peptide chain release factor GTP-binding subunit ERF3A isoform X1 [Sus scrofa];XP_013841597.1 eukaryotic peptide chain releas	7	7	7	0	22436000	19367000	17913000	18957000	0	24728000	16658000	0	15468000	19844000	23015000	22201000	15996000	24853000	17679000	18527000	0	NA	NA	NA	GSPT1	GSPT1;GSPT1;GSPT2;GSPT2;NA	protein methylation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;G1/S transition of mitotic cell cycle;cytoplasmic translational termination;translation	GO:000647; GO:000018; GO:000008; GO:000218; GO:000641	cytosol;translation release factor complex	GO:000582; GO:001844	 mRNA surveillance pathway	hsa0301	RNA binding;translation release factor activity;protein binding;GTPase activity;GTP binding	GO:000372; GO:000374; GO:000551; GO:000392; GO:000552
XP_020942313.1;XP_020942317.1;XP_020942316.1;XP_020942315.1;XP_020942314.1;NP_001171824.1	XP_020942313.1;XP_020942317.1;XP_020942316.1;XP_020942315.1;XP_020942314.1	XP_020942313.1 phosphomannomutase 2 isoform X1 [Sus scrofa];XP_020942317.1 phosphomannomutase 2 isoform X5 [Sus scrofa];XP_020942316.1 phosphomannomutase 2 isoform X4 [Sus scrofa];XP_020942315.1 phosphomannomutase 2 isoform X3 [Sus scrofa];XP_020942314.1 p	5	5	5	0	18242000	24653000	0	15727000	0	18368000	23562000	16334000	13944000	20726000	0	0	19394000	0	23799000	19717000	0	NA	NA	NA	PMM2	PMM2;PMM2;PMM2;PMM2;PMM2	protein glycosylation;protein targeting to ER;mannose metabolic process;protein N-linked glycosylation;GDP-mannose biosynthetic process	GO:000648; GO:004504; GO:000601; GO:000648; GO:000929	cytosol;nucleus;neuronal cell body	GO:000582; GO:000563; GO:004302	 Metabolic pathways; Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism	hsa0110; hsa0005; hsa0052	protein binding;phosphomannomutase activity	GO:000551; GO:000461
XP_020942354.1;XP_020942352.1;XP_020942351.1;XP_005662233.1;XP_005662232.1;XP_020942353.1	XP_020942354.1;XP_020942352.1;XP_020942351.1;XP_005662233.1;XP_005662232.1	XP_020942354.1 coronin-7 isoform X6 [Sus scrofa];XP_020942352.1 coronin-7 isoform X4 [Sus scrofa];XP_020942351.1 coronin-7 isoform X3 [Sus scrofa];XP_005662233.1 coronin-7 isoform X2 [Sus scrofa];XP_005662232.1 coronin-7 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	7473000	0	0	0	0	NA	NA	NA	LOC100513346	LOC100513346;LOC100513346;LOC100513346;LOC100513346;LOC100513346	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020942455.1	XP_020942455.1	XP_020942455.1 40S ribosomal protein S2 [Sus scrofa]	10	10	10	133660000	131160000	180430000	108520000	118830000	196220000	131270000	103620000	186740000	182550000	110650000	118670000	153180000	173630000	70875000	186590000	176030000	218430000	NA	NA	NA	RPS2	RPS2;NA;NA;NA;NA	positive regulation of ubiquitin-protein transferase activity;rRNA processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;SRP-dependent cotranslational protein targeting to membrane	GO:005144; GO:000636; GO:000018; GO:000641; GO:000661	extracellular exosome;cytosolic small ribosomal subunit;nucleoplasm;nucleolus;cytosol;focal adhesion;membrane;nucleus	GO:007006; GO:002262; GO:000565; GO:000573; GO:000582; GO:000592; GO:001602; GO:000563	 Ribosome	hsa0301	structural constituent of ribosome;protein binding;enzyme binding;fibroblast growth factor binding;cadherin binding;mRNA binding	GO:000373; GO:000551; GO:001989; GO:001713; GO:004529; GO:000372
XP_020942457.1	XP_020942457.1	XP_020942457.1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 [Sus scrofa]	6	6	6	42336000	29371000	40158000	24284000	42147000	24467000	49634000	40099000	41344000	28443000	35332000	29803000	30168000	31643000	35955000	33455000	39576000	27406000	NA	NA	NA	NDUFB10	NDUFB10;NA;NA;NA;NA	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	GO:000612; GO:003298	mitochondrial respiratory chain complex I;mitochondrial inner membrane	GO:000574; GO:000574	 Alzheimer's disease; Parkinson's disease; Metabolic pathways; Non-alcoholic fatty liver disease (NAFLD); Oxidative phosphorylation	hsa0501; hsa0501; hsa0110; hsa0493; hsa0019	NADH dehydrogenase (ubiquinone) activity;protein binding	GO:000813; GO:000551
XP_020942490.1;XP_020942489.1;XP_020942488.1;XP_020942487.1;XP_020942486.1;XP_020942485.1;XP_020942484.1;XP_020942483.1	XP_020942490.1;XP_020942489.1;XP_020942488.1;XP_020942487.1;XP_020942486.1;XP_020942485.1;XP_020942484.1;XP_020942483.1	XP_020942490.1 hydroxyacylglutathione hydrolase, mitochondrial isoform X8 [Sus scrofa];XP_020942489.1 hydroxyacylglutathione hydrolase, mitochondrial isoform X7 [Sus scrofa];XP_020942488.1 hydroxyacylglutathione hydrolase, mitochondrial isoform X6 [Sus scr	5	5	5	63432000	47038000	39776000	0	37677000	29006000	43723000	35429000	36211000	36401000	45059000	30587000	60922000	35525000	48766000	38992000	40521000	38786000	NA	NA	NA	HAGH	HAGH;HAGH;HAGH;HAGH;HAGH	glutathione biosynthetic process;pyruvate metabolic process;methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione	GO:000675; GO:000609; GO:001924	cytosol;mitochondrial matrix	GO:000582; GO:000575	 Pyruvate metabolism	hsa0062	hydroxyacylglutathione hydrolase activity;protein binding;metal ion binding	GO:000441; GO:000551; GO:004687
XP_020942626.1;XP_020942625.1;XP_003481141.1;XP_003481130.1	XP_020942626.1;XP_020942625.1	XP_020942626.1 hemoglobin subunit alpha-like [Sus scrofa];XP_020942625.1 hemoglobin subunit alpha [Sus scrofa]	14	14	9	170990000000	50663000000	45013000000	81192000000	57452000000	31379000000	68187000000	54412000000	117080000000	50958000000	66104000000	28897000000	183640000000	63165000000	118400000000	37198000000	85817000000	29748000000	NA	NA	NA	LOC110259958	LOC100737768;LOC110259958;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020942646.1;XP_020942645.1;XP_020942644.1;XP_020942643.1	XP_020942646.1;XP_020942645.1;XP_020942644.1;XP_020942643.1	XP_020942646.1 isoleucine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_020942645.1 isoleucine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_020942644.1 isoleucine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa];XP_020942643.1 isoleucine--t	5	5	5	0	0	9155900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	IARS	IARS;IARS;IARS;IARS;NA	isoleucyl-tRNA aminoacylation;tRNA aminoacylation for protein translation;osteoblast differentiation	GO:000642; GO:000641; GO:000164	aminoacyl-tRNA synthetase multienzyme complex;cytosol;cytoplasm;membrane;extracellular exosome	GO:001710; GO:000582; GO:000573; GO:001602; GO:007006	 Aminoacyl-tRNA biosynthesis	hsa0097	aminoacyl-tRNA editing activity;isoleucine-tRNA ligase activity;protein binding;tRNA binding;ATP binding;GTPase binding	GO:000216; GO:000482; GO:000551; GO:000004; GO:000552; GO:005102
XP_020942683.1	XP_020942683.1	XP_020942683.1 coiled-coil-helix-coiled-coil-helix domain-containing protein 5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CHCHD5	CHCHD5;NA;NA;NA;NA	"NA"	"NA"	mitochondrial intermembrane space	GO:000575	"NA"	"NA"	"NA"	"NA"
XP_020942748.1;XP_020942749.1	XP_020942748.1;XP_020942749.1	XP_020942748.1 septin-10 isoform X1 [Sus scrofa];XP_020942749.1 septin-10 isoform X2 [Sus scrofa]	5	4	4	0	0	0	0	0	8461700	0	0	0	0	7353400	11059000	11227000	0	7463700	6513400	7586000	9824400	NA	NA	NA	Sep 10	Sep 10;Sep 10;NA;NA;NA	cytoskeleton-dependent cytokinesis	GO:006164	septin complex;septin ring;microtubule cytoskeleton	GO:003110; GO:000594; GO:001563	"NA"	"NA"	protein binding;GTPase activity;GTP binding;protein complex scaffold	GO:000551; GO:000392; GO:000552; GO:003294
XP_020942758.1;XP_020942757.1	XP_020942758.1;XP_020942757.1	XP_020942758.1 U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X2 [Sus scrofa];XP_020942757.1 U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1251300	0	NA	NA	NA	SNRNP200	SNRNP200;SNRNP200;NA;NA;NA	cis assembly of pre-catalytic spliceosome;spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);mRNA splicing, via spliceosome;osteoblast differentiation	GO:000035; GO:000038; GO:000039; GO:000164	spliceosomal complex;U4/U6 x U5 tri-snRNP complex;nucleus;nucleoplasm;membrane;U5 snRNP;catalytic step 2 spliceosome	GO:000568; GO:004654; GO:000563; GO:000565; GO:001602; GO:000568; GO:007101	 Spliceosome	hsa0304	protein binding;ATP binding;ATP-dependent helicase activity;ATP-dependent RNA helicase activity;RNA binding;identical protein binding	GO:000551; GO:000552; GO:000802; GO:000400; GO:000372; GO:004280
XP_020942919.1	XP_020942919.1	XP_020942919.1 LOW QUALITY PROTEIN: beta-centractin [Sus scrofa]	7	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8257400	NA	NA	NA	ACTR1B	ACTR1B;NA;NA;NA;NA	antigen processing and presentation of exogenous peptide antigen via MHC class II;neutrophil degranulation	GO:001988; GO:004331	extracellular region;centrosome;microtubule cytoskeleton;membrane;cytoplasm;cytosol;secretory granule lumen;extracellular exosome;dynactin complex;ficolin-1-rich granule lumen	GO:000557; GO:000581; GO:001563; GO:001602; GO:000573; GO:000582; GO:003477; GO:007006; GO:000586; GO:190481	"NA"	"NA"	protein binding;ATP binding	GO:000551; GO:000552
XP_020942934.1;XP_020942935.1	XP_020942934.1;XP_020942935.1	XP_020942934.1 vacuolar protein sorting-associated protein VTA1 homolog isoform X1 [Sus scrofa];XP_020942935.1 vacuolar protein sorting-associated protein VTA1 homolog isoform X2 [Sus scrofa]	5	5	5	18986000	16323000	18821000	13869000	19184000	19663000	18537000	12135000	19284000	15983000	18515000	0	19130000	13884000	15065000	18611000	16476000	14677000	NA	NA	NA	VTA1	VTA1;VTA1;NA;NA;NA	macroautophagy;viral life cycle;protein transport;viral budding;multivesicular body sorting pathway;ESCRT III complex disassembly;multivesicular body assembly	GO:001623; GO:001905; GO:001503; GO:004675; GO:007198; GO:190490; GO:003625	extracellular exosome;nucleoplasm;endosome membrane;intracellular membrane-bounded organelle;cytosol	GO:007006; GO:000565; GO:001000; GO:004323; GO:000582	 Endocytosis	hsa0414	protein binding;protein C-terminus binding	GO:000551; GO:000802
XP_020942936.1	XP_020942936.1	XP_020942936.1 LOW QUALITY PROTEIN: threonine synthase-like 2 [Sus scrofa]	5	5	5	0	9221600	9615100	0	0	0	0	0	17719000	0	10174000	0	0	15064000	12692000	21537000	12390000	0	NA	NA	NA	THNSL2	THNSL2;NA;NA;NA;NA	dephosphorylation;regulation of receptor activity;biological_process;serine family amino acid catabolic process;2-oxobutyrate biosynthetic process	GO:001631; GO:001046; GO:000815; GO:000907; GO:004636	extracellular space;cellular_component	GO:000561; GO:000557	"NA"	"NA"	molecular_function;pyridoxal phosphate binding;cytokine activity;serine binding;threonine synthase activity	GO:000367; GO:003017; GO:000512; GO:007090; GO:000479
XP_020943018.1;XP_020943016.1;XP_020943017.1;XP_020943015.1;XP_020943014.1;XP_020943012.1;XP_020943011.1;XP_020943009.1;XP_020943019.1;XP_020943013.1;XP_020943010.1;XP_020943008.1	XP_020943018.1;XP_020943016.1;XP_020943017.1;XP_020943015.1;XP_020943014.1;XP_020943012.1;XP_020943011.1;XP_020943009.1;XP_020943019.1;XP_020943013.1;XP_020943010.1;XP_020943008.1	XP_020943018.1 dynactin subunit 1 isoform X11 [Sus scrofa];XP_020943016.1 dynactin subunit 1 isoform X9 [Sus scrofa];XP_020943017.1 dynactin subunit 1 isoform X10 [Sus scrofa];XP_020943015.1 dynactin subunit 1 isoform X8 [Sus scrofa];XP_020943014.1 dynacti	24	24	24	132910000	188820000	162110000	176200000	125460000	154920000	144700000	137800000	127930000	160870000	141610000	177980000	153560000	168270000	177280000	183480000	159120000	147660000	NA	NA	NA	DCTN1	DCTN1;DCTN1;DCTN1;DCTN1;DCTN1	centriole-centriole cohesion;motor behavior;ER to Golgi vesicle-mediated transport;IRE1-mediated unfolded protein response;retrograde transport, endosome to Golgi;regulation of mitotic spindle organization;neuron cellular homeostasis;nervous system development;neuromuscular junction development;ventral spinal cord development;axonal transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;nuclear envelope disassembly;maintenance of synapse structure;positive regulation of microtubule nucleation;neuromuscular process;positive regulation of neuromuscular junction development;non-motile cilium assembly;G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;microtubule anchoring at centrosome;cell division;neuron projection maintenance;mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;positive regulation of microtubule polymerization;ciliary basal body docking	GO:001045; GO:006174; GO:000688; GO:003649; GO:004214; GO:006023; GO:007005; GO:000739; GO:000752; GO:002151; GO:009893; GO:001988; GO:005108; GO:009955; GO:009006; GO:005090; GO:190439; GO:190551; GO:000008; GO:000013; GO:003445; GO:005130; GO:199053; GO:000027; GO:001038; GO:003111; GO:009771	cytosol;nuclear envelope;microtubule;axon;cell cortex region;spindle;cell cortex;kinetochore;spindle pole;dynactin complex;retromer complex;intermediate filament cytoskeleton;neuron projection;membrane;dynein complex;microtubule plus-end;neuronal cell body;cytoplasm	GO:000582; GO:000563; GO:000587; GO:003042; GO:009973; GO:000581; GO:000593; GO:000077; GO:000092; GO:000586; GO:003090; GO:004511; GO:004300; GO:001602; GO:003028; GO:003537; GO:004302; GO:000573	 Huntington's disease; Vasopressin-regulated water reabsorption	hsa0501; hsa0496	dynein complex binding;motor activity;microtubule binding;protein binding;tubulin binding;tau protein binding;protein kinase binding	GO:007084; GO:000377; GO:000801; GO:000551; GO:001563; GO:004815; GO:001990
XP_020943022.1;XP_003129121.1;XP_020956251.1;XP_020956253.1;XP_020956252.1	XP_020943022.1;XP_003129121.1;XP_020956251.1	XP_020943022.1 MOB kinase activator 1A [Sus scrofa];XP_003129121.1 MOB kinase activator 1B isoform X2 [Sus scrofa];XP_020956251.1 MOB kinase activator 1B isoform X1 [Sus scrofa]	3	3	3	0	0	0	9607900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MOB1A	MOB1A;MOB1B;MOB1B;NA;NA	hippo signaling	GO:003532	extracellular exosome;cytosol;nucleus;nucleolus	GO:007006; GO:000582; GO:000563; GO:000573	 Hippo signaling pathway	hsa0439	protein binding;metal ion binding	GO:000551; GO:004687
XP_020943073.1;XP_020943072.1;XP_020943071.1;XP_020943074.1	XP_020943073.1;XP_020943072.1;XP_020943071.1;XP_020943074.1	XP_020943073.1 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X3 [Sus scrofa];XP_020943072.1 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X2 [Sus scrofa];XP_020943071.1 NFU1 iron-sulfur cluster scaffold homolog, mitoch	2	2	2	10576000	0	11187000	0	0	0	4612000	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NFU1	NFU1;NFU1;NFU1;NFU1;NA	iron-sulfur cluster assembly;protein maturation by iron-sulfur cluster transfer	GO:001622; GO:009742	cytosol;nucleoplasm;mitochondrion;nucleus	GO:000582; GO:000565; GO:000573; GO:000563	"NA"	"NA"	iron ion binding;protein binding;4 iron, 4 sulfur cluster binding	GO:000550; GO:000551; GO:005153
XP_020943136.1;XP_020943135.1;XP_020943134.1;XP_020943131.1;XP_020943137.1;XP_020943133.1;XP_020943132.1;XP_020943130.1;XP_020943129.1;XP_020943128.1	XP_020943136.1;XP_020943135.1;XP_020943134.1;XP_020943131.1;XP_020943137.1;XP_020943133.1;XP_020943132.1;XP_020943130.1;XP_020943129.1;XP_020943128.1	XP_020943136.1 EH domain-binding protein 1 isoform X7 [Sus scrofa];XP_020943135.1 EH domain-binding protein 1 isoform X6 [Sus scrofa];XP_020943134.1 EH domain-binding protein 1 isoform X6 [Sus scrofa];XP_020943131.1 EH domain-binding protein 1 isoform X3 [	10	10	10	9519100	12276000	9222900	12268000	16609000	6924000	13349000	20884000	9531600	15944000	0	40974000	0	8380600	0	16245000	0	0	NA	NA	NA	EHBP1	EHBP1;EHBP1;EHBP1;EHBP1;EHBP1	endocytosis;protein transport	GO:000689; GO:001503	plasma membrane;endosome;cytosol	GO:000588; GO:000576; GO:000582	"NA"	"NA"	"NA"	"NA"
XP_020943143.1;XP_020943144.1;XP_020943147.1;XP_020943146.1;XP_020943145.1;XP_013851564.2	XP_020943143.1;XP_020943144.1;XP_020943147.1;XP_020943146.1;XP_020943145.1;XP_013851564.2	XP_020943143.1 exportin-1 isoform X1 [Sus scrofa];XP_020943144.1 exportin-1 isoform X2 [Sus scrofa];XP_020943147.1 exportin-1 isoform X3 [Sus scrofa];XP_020943146.1 exportin-1 isoform X3 [Sus scrofa];XP_020943145.1 exportin-1 isoform X3 [Sus scrofa];XP_013	9	9	9	78411000	48968000	55578000	64299000	59987000	61518000	42043000	50700000	45090000	52188000	44032000	51460000	53120000	50524000	49761000	51406000	60472000	58046000	NA	NA	NA	XPO1	XPO1;XPO1;XPO1;XPO1;XPO1	ribosomal small subunit export from nucleus;intracellular transport of virus;ribosomal large subunit export from nucleus;protein export from nucleus;regulation of mRNA stability;regulation of protein catabolic process;mRNA transport;viral process;response to drug;protein localization to nucleus;negative regulation of transcription from RNA polymerase II promoter;regulation of centrosome duplication;ribosome biogenesis;regulation of protein export from nucleus;nucleocytoplasmic transport	GO:000005; GO:007573; GO:000005; GO:000661; GO:004348; GO:004217; GO:005102; GO:001603; GO:004249; GO:003450; GO:000012; GO:001082; GO:004225; GO:004682; GO:000691	membrane;nuclear envelope;nucleoplasm;Cajal body;intracellular membrane-bounded organelle;cytoplasm;nuclear membrane;cytosol;macromolecular complex;ribonucleoprotein complex;kinetochore;annulate lamellae;host cell	GO:001602; GO:000563; GO:000565; GO:001503; GO:004323; GO:000573; GO:003196; GO:000582; GO:003299; GO:199090; GO:000077; GO:000564; GO:004365	 Ribosome biogenesis in eukaryotes; RNA transport; Epstein-Barr virus infection	hsa0300; hsa0301; hsa0516	transporter activity;RNA binding;protein binding;protein domain specific binding;nuclear export signal receptor activity;Ran GTPase binding;protein transporter activity	GO:000521; GO:000372; GO:000551; GO:001990; GO:000504; GO:000853; GO:000856
XP_020943216.1;XP_020943215.1	XP_020943216.1;XP_020943215.1	XP_020943216.1 multiple coagulation factor deficiency protein 2 isoform X2 [Sus scrofa];XP_020943215.1 multiple coagulation factor deficiency protein 2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6763800	0	0	NA	NA	NA	MCFD2	MCFD2;MCFD2;NA;NA;NA	protein transport;COPII vesicle coating;ER to Golgi vesicle-mediated transport	GO:001503; GO:004820; GO:000688	endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane;Golgi membrane;ER to Golgi transport vesicle membrane	GO:003311; GO:000578; GO:000013; GO:001250	"NA"	"NA"	calcium ion binding;protein binding	GO:000550; GO:000551
XP_020943348.1	XP_020943348.1	XP_020943348.1 LOW QUALITY PROTEIN: sorting nexin-17 [Sus scrofa]	3	3	3	0	5806900	4709700	0	0	4519300	3366100	5356400	4263100	6787300	0	6861300	6924000	0	0	4570000	0	0	NA	NA	NA	SNX17	SNX17;NA;NA;NA;NA	endosomal transport;regulation of endocytosis;aorta development;intracellular protein transport;coronary vasculature development;retrograde transport, endosome to plasma membrane;receptor-mediated endocytosis;signal transduction;cardiac septum development;cholesterol catabolic process	GO:001619; GO:003010; GO:003590; GO:000688; GO:006097; GO:199012; GO:000689; GO:000716; GO:000327; GO:000670	macromolecular complex;cytosol;early endosome;endosome membrane;cytoplasmic vesicle;Golgi apparatus;cytoplasmic vesicle membrane;membrane;intracellular membrane-bounded organelle	GO:003299; GO:000582; GO:000576; GO:001000; GO:003141; GO:000579; GO:003065; GO:001602; GO:004323	"NA"	"NA"	receptor binding;protein C-terminus binding;phosphatidylinositol binding;protein binding;low-density lipoprotein particle receptor binding	GO:000510; GO:000802; GO:003509; GO:000551; GO:005075
XP_020943355.1	XP_020943355.1	XP_020943355.1 LOW QUALITY PROTEIN: CAD protein [Sus scrofa]	3	3	3	7873700	0	0	0	0	0	7553200	6045900	0	0	7645700	0	0	0	0	0	0	0	NA	NA	NA	CAD	CAD;NA;NA;NA;NA	liver development;response to amine;citrulline biosynthetic process;animal organ regeneration;female pregnancy;'de novo' pyrimidine nucleobase biosynthetic process;drug metabolic process;response to caffeine;response to insulin;cellular response to drug;cellular response to epidermal growth factor stimulus;lactation;protein autophosphorylation;'de novo' UMP biosynthetic process;pyrimidine nucleoside biosynthetic process;heart development;glutamine metabolic process;nitrogen compound metabolic process;response to starvation;UTP biosynthetic process;peptidyl-threonine phosphorylation	GO:000188; GO:001407; GO:001924; GO:003110; GO:000756; GO:000620; GO:001714; GO:003100; GO:003286; GO:003569; GO:007136; GO:000759; GO:004677; GO:004420; GO:004613; GO:000750; GO:000654; GO:000680; GO:004259; GO:000622; GO:001810	cytosol;neuronal cell body;macromolecular complex;terminal bouton;nuclear matrix;nucleoplasm;cytoplasm;nucleus;cell projection;membrane;extracellular exosome	GO:000582; GO:004302; GO:003299; GO:004319; GO:001636; GO:000565; GO:000573; GO:000563; GO:004299; GO:001602; GO:007006	 Alanine, aspartate and glutamate metabolism; Metabolic pathways; Pyrimidine metabolism	hsa0025; hsa0110; hsa0024	zinc ion binding;aspartate carbamoyltransferase activity;carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity;dihydroorotase activity;ATP binding;protein kinase activity;identical protein binding;enzyme binding;aspartate binding	GO:000827; GO:000407; GO:000408; GO:000415; GO:000552; GO:000467; GO:004280; GO:001989; GO:007033
XP_020943481.1	XP_020943481.1	XP_020943481.1 LOW QUALITY PROTEIN: ATP-dependent RNA helicase DDX1 [Sus scrofa]	18	18	18	74403000	75120000	80484000	74868000	61927000	72563000	73817000	86184000	67383000	82503000	74663000	69785000	99905000	80053000	64484000	82197000	65650000	86463000	NA	NA	NA	DDX1	DDX1;NA;NA;NA;NA	response to exogenous dsRNA;nucleic acid phosphodiester bond hydrolysis;protein localization to cytoplasmic stress granule;defense response to virus;spliceosomal complex assembly;double-strand break repair;regulation of translational initiation;multicellular organism development;regulation of nucleic acid-templated transcription;positive regulation of myeloid dendritic cell cytokine production;tRNA splicing, via endonucleolytic cleavage and ligation;DNA duplex unwinding;innate immune response;positive regulation of I-kappaB kinase/NF-kappaB signaling	GO:004333; GO:009030; GO:190360; GO:005160; GO:000024; GO:000630; GO:000644; GO:000727; GO:190350; GO:000273; GO:000638; GO:003250; GO:004508; GO:004312	ribonucleoprotein complex;nucleoplasm;cytoplasmic stress granule;cytoplasm;nucleus;membrane;cytosol;cleavage body;tRNA-splicing ligase complex	GO:199090; GO:000565; GO:001049; GO:000573; GO:000563; GO:001602; GO:000582; GO:007192; GO:007266	"NA"	"NA"	DNA binding;RNA helicase activity;transcription cofactor activity;ATP-dependent helicase activity;DNA/RNA helicase activity;chromatin binding;nuclease activity;exonuclease activity;protein binding;ATP binding;poly(A) binding	GO:000367; GO:000372; GO:000371; GO:000802; GO:003367; GO:000368; GO:000451; GO:000452; GO:000551; GO:000552; GO:000814
XP_020943521.1	XP_020943521.1	XP_020943521.1 14-3-3 protein theta [Sus scrofa]	15	13	13	246500000	381480000	407970000	372050000	258240000	411220000	385140000	361550000	376050000	360110000	314080000	329480000	432170000	401380000	300340000	329360000	416090000	397000000	NA	NA	NA	YWHAQ	YWHAQ;NA;NA;NA;NA	negative regulation of transcription, DNA-templated;membrane organization;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;negative regulation of ion transmembrane transport;substantia nigra development	GO:004589; GO:006102; GO:190074; GO:003476; GO:002176	synapse;cytoplasm;membrane;extracellular exosome;cytosol;focal adhesion;macromolecular complex	GO:004520; GO:000573; GO:001602; GO:007006; GO:000582; GO:000592; GO:003299	 Pathogenic Escherichia coli infection; Cell cycle; PI3K-Akt signaling pathway; Epstein-Barr virus infection; Hippo signaling pathway; Viral carcinogenesis	hsa0513; hsa0411; hsa0415; hsa0516; hsa0439; hsa0520	ion channel binding;protein binding;protein C-terminus binding;protein N-terminus binding;protein domain specific binding;identical protein binding;14-3-3 protein binding	GO:004432; GO:000551; GO:000802; GO:004748; GO:001990; GO:004280; GO:007188
XP_020943566.1	XP_020943566.1	XP_020943566.1 UMP-CMP kinase 2, mitochondrial [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1568300	NA	NA	NA	CMPK2	CMPK2;NA;NA;NA;NA	dTTP biosynthetic process;nucleoside triphosphate biosynthetic process;nucleoside monophosphate phosphorylation;nucleoside diphosphate phosphorylation;dTDP biosynthetic process;dUDP biosynthetic process;cellular response to lipopolysaccharide	GO:000623; GO:000914; GO:004694; GO:000616; GO:000623; GO:000622; GO:007122	mitochondrion;cytoplasm	GO:000573; GO:000573	 Metabolic pathways; Pyrimidine metabolism	hsa0110; hsa0024	thymidylate kinase activity;ATP binding;UMP kinase activity;cytidylate kinase activity;uridylate kinase activity;nucleoside diphosphate kinase activity	GO:000479; GO:000552; GO:003386; GO:000412; GO:000904; GO:000455
XP_020943592.1;XP_020943603.1	XP_020943592.1;XP_020943603.1	XP_020943592.1 ectonucleotide pyrophosphatase/phosphodiesterase family member 1 isoform X1 [Sus scrofa];XP_020943603.1 ectonucleotide pyrophosphatase/phosphodiesterase family member 1 isoform X2 [Sus scrofa]	4	4	4	0	0	86738000	0	0	62678000	118650000	0	0	0	171810000	0	0	70701000	114910000	0	144050000	0	NA	NA	NA	ENPP1	ENPP1;ENPP1;NA;NA;NA	immune response;negative regulation of cell growth;cellular phosphate ion homeostasis;negative regulation of protein autophosphorylation;negative regulation of glycogen biosynthetic process;3'-phosphoadenosine 5'-phosphosulfate metabolic process;generation of precursor metabolites and energy;regulation of bone mineralization;negative regulation of fat cell differentiation;negative regulation of glucose import;riboflavin metabolic process;phosphate-containing compound metabolic process;receptor-mediated endocytosis;ATP metabolic process;nucleoside triphosphate catabolic process;cellular response to insulin stimulus;negative regulation of insulin receptor signaling pathway;nucleic acid phosphodiester bond hydrolysis;biomineral tissue development;sequestering of triglyceride	GO:000695; GO:003030; GO:003064; GO:003195; GO:004571; GO:005042; GO:000609; GO:003050; GO:004559; GO:004632; GO:000677; GO:000679; GO:000689; GO:004603; GO:000914; GO:003286; GO:004662; GO:009030; GO:003121; GO:003073	lysosomal membrane;integral component of plasma membrane;basolateral plasma membrane;cell surface;extracellular space;integral component of membrane	GO:000576; GO:000588; GO:001632; GO:000998; GO:000561; GO:001602	 Nicotinate and nicotinamide metabolism; Pantothenate and CoA biosynthesis; Purine metabolism; Metabolic pathways; Starch and sucrose metabolism	hsa0076; hsa0077; hsa0023; hsa0110; hsa0050	protein homodimerization activity;3'-phosphoadenosine 5'-phosphosulfate binding;nucleic acid binding;calcium ion binding;protein binding;phosphodiesterase I activity;zinc ion binding;NADH pyrophosphatase activity;polysaccharide binding;nucleotide diphosphatase activity;scavenger receptor activity;insulin receptor binding;ATP binding;nucleoside-triphosphate diphosphatase activity	GO:004280; GO:005065; GO:000367; GO:000550; GO:000551; GO:000452; GO:000827; GO:003552; GO:003024; GO:000455; GO:000504; GO:000515; GO:000552; GO:004742
XP_020943663.1;XP_020943661.1;XP_020943660.1;XP_020943659.1;XP_020943658.1;XP_020943657.1;XP_020943656.1;XP_020943655.1;XP_020943654.1;XP_020922513.1	XP_020943663.1;XP_020943661.1;XP_020943660.1;XP_020943659.1;XP_020943658.1;XP_020943657.1;XP_020943656.1;XP_020943655.1;XP_020943654.1	XP_020943663.1 fructose-bisphosphate aldolase A isoform X4 [Sus scrofa];XP_020943661.1 fructose-bisphosphate aldolase A isoform X4 [Sus scrofa];XP_020943660.1 fructose-bisphosphate aldolase A isoform X4 [Sus scrofa];XP_020943659.1 fructose-bisphosphate ald	25	21	21	1527000000	2363100000	2477900000	2476600000	1725200000	2250500000	1912200000	1825700000	1873100000	2417700000	1620100000	1982600000	1765300000	2198600000	2031300000	2314000000	7006400000	2100600000	NA	NA	NA	ALDOA	ALDOA;ALDOA;ALDOA;ALDOA;ALDOA	platelet degranulation;striated muscle contraction;glycolytic process;regulation of cell shape;fructose metabolic process;binding of sperm to zona pellucida;fructose 1,6-bisphosphate metabolic process;muscle cell cellular homeostasis;ATP biosynthetic process;neutrophil degranulation;protein homotetramerization;canonical glycolysis;actin filament organization	GO:000257; GO:000694; GO:000609; GO:000836; GO:000600; GO:000733; GO:003038; GO:004671; GO:000675; GO:004331; GO:005128; GO:006162; GO:000701	nucleus;M band;sperm head;extracellular exosome;cytosol;actin cytoskeleton;secretory granule lumen;membrane;extracellular space;I band;ficolin-1-rich granule lumen;extracellular region;platelet alpha granule lumen;tertiary granule lumen	GO:000563; GO:003143; GO:006182; GO:007006; GO:000582; GO:001562; GO:003477; GO:001602; GO:000561; GO:003167; GO:190481; GO:000557; GO:003109; GO:190472	 Metabolic pathways; Biosynthesis of amino acids; Glycolysis / Gluconeogenesis; HIF-1 signaling pathway; Carbon metabolism; Pentose phosphate pathway; Biosynthesis of antibiotics; Fructose and mannose metabolism	hsa0110; hsa0123; hsa0001; hsa0406; hsa0120; hsa0003; hsa0113; hsa0005	protein binding;identical protein binding;RNA binding;cytoskeletal protein binding;fructose binding;tubulin binding;actin binding;fructose-bisphosphate aldolase activity;cadherin binding	GO:000551; GO:004280; GO:000372; GO:000809; GO:007006; GO:001563; GO:000377; GO:000433; GO:004529
XP_020943678.1;XP_020948940.1;XP_020948938.1;XP_020948934.1;XP_020948933.1;XP_020948928.1;XP_020948925.1;XP_020950998.1;XP_020950993.1;XP_013848440.1;XP_005659658.1;XP_005659656.1;XP_001925326.1	XP_020943678.1	XP_020943678.1 mitogen-activated protein kinase 3 [Sus scrofa]	12	10	10	96788000	158080000	156990000	135610000	93309000	139460000	134000000	154480000	137550000	128050000	120740000	177920000	130560000	151580000	143900000	145140000	124600000	139890000	NA	NA	NA	MAPK3	MAPK3;NA;NA;NA;NA	positive regulation of cytokine secretion involved in immune response;positive regulation of macrophage chemotaxis;regulation of phosphatidylinositol 3-kinase signaling;peptidyl-serine phosphorylation;BMP signaling pathway;lipopolysaccharide-mediated signaling pathway;positive regulation of telomere maintenance via telomerase;positive regulation of histone phosphorylation;intracellular signal transduction;Fc-gamma receptor signaling pathway involved in phagocytosis;regulation of sequence-specific DNA binding transcription factor activity;Bergmann glial cell differentiation;cellular response to tumor necrosis factor;cellular response to dopamine;positive regulation of protein phosphorylation;cellular response to reactive oxygen species;positive regulation of xenophagy;MAPK cascade;axon guidance;aging;response to toxic substance;viral process;regulation of ossification;cellular response to amino acid starvation;thymus development;stress-activated MAPK cascade;face development;positive regulation of ERK1 and ERK2 cascade;negative regulation of apolipoprotein binding;protein phosphorylation;apoptotic process;fibroblast growth factor receptor signaling pathway;regulation of gene expression;positive regulation of gene expression;regulation of cellular pH;positive regulation of cyclase activity;cartilage development;lung morphogenesis;trachea formation;macromolecular complex assembly;interleukin-1-mediated signaling pathway;caveolin-mediated endocytosis;regulation of Golgi inheritance;regulation of early endosome to late endosome transport;activation of MAPK activity;cell cycle;platelet activation;regulation of stress-activated MAPK cascade;response to epidermal growth factor;regulation of cellular response to heat;positive regulation of metallopeptidase activity;phosphorylation;sensory perception of pain;positive regulation of histone acetylation;response to exogenous dsRNA;positive regulation of telomerase activity;cellular response to cadmium ion;cellular response to organic substance;transcription initiation from RNA polymerase I promoter;DNA damage induced protein phosphorylation;arachidonic acid metabolic process;peptidyl-tyrosine autophosphorylation;positive regulation of translation;positive regulation of telomere capping;thyroid gland development;outer ear morphogenesis;positive regulation of transcription from RNA polymerase II promoter;decidualization;regulation of cytoskeleton organization;cardiac neural crest cell development involved in heart development;cellular response to mechanical stimulus	GO:000274; GO:001075; GO:001406; GO:001810; GO:003050; GO:003166; GO:003221; GO:003312; GO:003555; GO:003809; GO:005109; GO:006002; GO:007135; GO:190335; GO:000193; GO:003461; GO:190441; GO:000016; GO:000741; GO:000756; GO:000963; GO:001603; GO:003027; GO:003419; GO:004853; GO:005140; GO:006032; GO:007037; GO:200065; GO:000646; GO:000691; GO:000854; GO:001046; GO:001062; GO:003064; GO:003128; GO:005121; GO:006042; GO:006044; GO:006500; GO:007049; GO:007258; GO:009017; GO:200064; GO:000018; GO:000704; GO:003016; GO:003287; GO:007084; GO:190003; GO:190505; GO:001631; GO:001923; GO:003506; GO:004333; GO:005197; GO:007127; GO:007131; GO:000636; GO:000697; GO:001936; GO:003808; GO:004572; GO:190435; GO:003087; GO:004247; GO:004594; GO:004669; GO:005149; GO:006130; GO:007126	nuclear envelope;nucleoplasm;Golgi apparatus;cytoskeleton;nucleus;plasma membrane;macromolecular complex;cytoplasm;late endosome;cytosol;caveola;pseudopodium;early endosome;focal adhesion	GO:000563; GO:000565; GO:000579; GO:000585; GO:000563; GO:000588; GO:003299; GO:000573; GO:000577; GO:000582; GO:000590; GO:003114; GO:000576; GO:000592	 FoxO signaling pathway; PI3K-Akt signaling pathway; Dorso-ventral axis formation; VEGF signaling pathway; Adherens junction; Platelet activation; Alzheimer's disease; Chagas disease (American trypanosomiasis); Hepatitis C; Colorectal cancer; MAPK signaling pathway; Adrenergic signaling in cardiomyocytes; Focal adhesion; Gap junction; Glutamatergic synapse; Regulation of actin cytoskeleton; Melanogenesis; Shigellosis; Acute myeloid leukemia; cGMP-PKG signaling pathway; Natural killer cell mediated cytotoxicity; Type II diabetes mellitus; Prion diseases; Viral carcinogenesis; Choline metabolism in cancer; HIF-1 signaling pathway; Oocyte meiosis; Osteoclast differentiation; NOD-like receptor signaling pathway; Fc gamma R-mediated phagocytosis; Alcoholism; Sphingolipid signaling pathway; Vascular smooth muscle contraction; Axon guidance; TGF-beta signaling pathway; Signaling pathways regulating pluripotency of stem cells; Long-term depression; Oxytocin signaling pathway; Aldosterone-regulated sodium reabsorption; Circadian entrainment; Tuberculosis	hsa0406; hsa0415; hsa0432; hsa0437; hsa0452; hsa0461; hsa0501; hsa0514; hsa0516; hsa0521; hsa0401; hsa0426; hsa0451; hsa0454; hsa0472; hsa0481; hsa0491; hsa0513; hsa0522; hsa0402; hsa0465; hsa0493; hsa0502; hsa0520; hsa0523; hsa0406; hsa0411; hsa0438; hsa0462; hsa0466; hsa0503; hsa0407; hsa0427; hsa0436; hsa0435; hsa0455; hsa0473; hsa0492; hsa0496; hsa0471; hsa0515	MAP kinase kinase activity;protein serine/threonine kinase activity;identical protein binding;kinase activity;phosphotyrosine binding;MAP kinase activity;scaffold protein binding;protein binding;ATP binding;phosphatase binding	GO:000470; GO:000467; GO:004280; GO:001630; GO:000178; GO:000470; GO:009711; GO:000551; GO:000552; GO:001990
XP_020943688.1;XP_020943687.1	XP_020943688.1;XP_020943687.1	XP_020943688.1 coronin-1A [Sus scrofa];XP_020943687.1 coronin-1A [Sus scrofa]	6	6	6	24086000	22060000	26631000	0	0	0	21889000	18428000	0	0	19226000	0	38886000	18765000	25955000	0	29175000	0	NA	NA	NA	CORO1A	CORO1A;CORO1A;NA;NA;NA	phagolysosome assembly;leukocyte chemotaxis;cell-substrate adhesion;actin filament organization;regulation of cell shape;actin cytoskeleton organization;positive regulation of cell migration;negative regulation of vesicle fusion;T cell homeostasis;uropod organization;negative regulation of neuron apoptotic process;immunological synapse formation;early endosome to recycling endosome transport;natural killer cell degranulation;innate immune response;positive chemotaxis;cellular response to interleukin-4;calcium ion transport;phagocytosis;positive regulation of T cell proliferation;homeostasis of number of cells within a tissue;negative regulation of actin nucleation;regulation of release of sequestered calcium ion into cytosol;regulation of actin cytoskeleton organization;nerve growth factor signaling pathway	GO:000184; GO:003059; GO:003158; GO:000701; GO:000836; GO:003003; GO:003033; GO:003133; GO:004302; GO:003279; GO:004352; GO:000177; GO:006150; GO:004332; GO:004508; GO:005091; GO:007135; GO:000681; GO:000690; GO:004210; GO:004887; GO:005112; GO:005127; GO:003295; GO:003818	immunological synapse;phagocytic cup;cortical actin cytoskeleton;early endosome;cytosol;membrane;axon;actin filament;cell-cell junction;macromolecular complex;phagocytic vesicle;phagocytic vesicle membrane;extracellular exosome;glutamatergic synapse;nucleus;cytoplasm;lamellipodium	GO:000177; GO:000189; GO:003086; GO:000576; GO:000582; GO:001602; GO:003042; GO:000588; GO:000591; GO:003299; GO:004533; GO:003067; GO:007006; GO:009897; GO:000563; GO:000573; GO:003002	 Tuberculosis; Phagosome	hsa0515; hsa0414	RNA binding;actin binding;protein binding;protein C-terminus binding;protein homodimerization activity;cytoskeletal protein binding;actin monomer binding;myosin heavy chain binding;phosphatidylinositol 3-kinase binding;actin filament binding	GO:000372; GO:000377; GO:000551; GO:000802; GO:004280; GO:000809; GO:000378; GO:003203; GO:004354; GO:005101
XP_020943695.1	XP_020943695.1	XP_020943695.1 LOW QUALITY PROTEIN: bolA-like protein 2 [Sus scrofa]	3	3	3	23445000	30955000	33948000	0	38027000	0	32199000	0	37597000	34355000	33895000	45750000	36436000	0	0	29434000	27853000	0	NA	NA	NA	BOLA2B	BOLA2B;NA;NA;NA;NA	[2Fe-2S;protein maturation by iron-sulfur cluster transfer;regulation of transcription from RNA polymerase II promoter;interleukin-12-mediated signaling pathway	GO:004457; GO:009742; GO:000635; GO:003572	cytoplasm;cytosol;nucleus	GO:000573; GO:000582; GO:000563	"NA"	"NA"	protein binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding	GO:000551; GO:000098
XP_020943699.1;XP_020943698.1	XP_020943699.1;XP_020943698.1	XP_020943699.1 eukaryotic translation initiation factor 3 subunit C [Sus scrofa];XP_020943698.1 eukaryotic translation initiation factor 3 subunit C [Sus scrofa]	11	11	11	39626000	67372000	57789000	51176000	54402000	63741000	41721000	45953000	43222000	51358000	46414000	65426000	52721000	74063000	47242000	55953000	45505000	64574000	NA	NA	NA	LOC110260088	LOC110260088;LOC110260088;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020943802.1;XP_020943794.1;XP_020943768.1;XP_020943765.1;XP_020943759.1;XP_020943755.1;XP_020943752.1;XP_020943743.1;XP_020943737.1;XP_020943726.1;XP_020943720.1;XP_020943712.1;XP_020943706.1;XP_020943702.1;XP_020943852.1;XP_020943833.1;XP_020943893.1;XP_020943841.1;XP_020943813.1;XP_020943784.1;XP_020943775.1;XP_020943876.1;XP_020943862.1;XP_020943824.1;XP_020943789.1;XP_020943936.1;XP_020943914.1;XP_020943903.1;XP_020943952.1;XP_020943946.1;XP_020943983.1;XP_020943993.1;XP_020943957.1;XP_020933679.1;XP_020933678.1;XP_005672964.1;XP_005672963.1;XP_020933677.1;XP_005672962.1;XP_020933676.1;XP_020933675.1;XP_020933674.1;XP_005672961.1;XP_020933673.1;XP_020933672.1;XP_001924870.3;XP_013840793.1;XP_005672959.1;XP_013840792.1;XP_005672958.1;XP_005672957.1;XP_020933671.1;XP_020933669.1;XP_020933668.1;XP_020933667.1;XP_005672960.1	XP_020943802.1;XP_020943794.1;XP_020943768.1;XP_020943765.1;XP_020943759.1;XP_020943755.1;XP_020943752.1;XP_020943743.1;XP_020943737.1;XP_020943726.1;XP_020943720.1;XP_020943712.1;XP_020943706.1;XP_020943702.1;XP_020943852.1;XP_020943833.1;XP_020943893.1;XP_020943841.1;XP_020943813.1;XP_020943784.1;XP_020943775.1;XP_020943876.1;XP_020943862.1;XP_020943824.1;XP_020943789.1;XP_020943936.1;XP_020943914.1;XP_020943903.1;XP_020943952.1;XP_020943946.1;XP_020943983.1;XP_020943993.1;XP_020943957.1	XP_020943802.1 band 4.1-like protein 2 isoform X5 [Sus scrofa];XP_020943794.1 band 4.1-like protein 2 isoform X5 [Sus scrofa];XP_020943768.1 band 4.1-like protein 2 isoform X1 [Sus scrofa];XP_020943765.1 band 4.1-like protein 2 isoform X1 [Sus scrofa];XP_0	33	33	3	281480000	650420000	397500000	386970000	264850000	402710000	375840000	400500000	298710000	417700000	292560000	408920000	286790000	427750000	390860000	509670000	350640000	447990000	NA	NA	NA	EPB41L2	EPB41L2;EPB41L2;EPB41L2;EPB41L2;EPB41L2	cell division;cell cycle;positive regulation of protein localization to cell cortex;actomyosin structure organization;cortical actin cytoskeleton organization	GO:005130; GO:000704; GO:190477; GO:003103; GO:003086	cytosol;cell cortex region;nucleoplasm;focal adhesion;plasma membrane;spectrin;COP9 signalosome;nucleus;cell junction;extracellular exosome	GO:000582; GO:009973; GO:000565; GO:000592; GO:000588; GO:000809; GO:000818; GO:000563; GO:003005; GO:007006	 Tight junction	hsa0453	spectrin binding;structural molecule activity;PH domain binding;protein binding;actin binding	GO:003050; GO:000519; GO:004273; GO:000551; GO:000377
XP_020943837.1;XP_020943836.1	XP_020943837.1;XP_020943836.1	XP_020943837.1 constitutive coactivator of PPAR-gamma-like protein 1 isoform X2 [Sus scrofa];XP_020943836.1 constitutive coactivator of PPAR-gamma-like protein 1 isoform X1 [Sus scrofa]	4	4	4	0	0	10704000	0	0	11858000	0	0	0	0	0	0	0	12862000	0	0	0	0	NA	NA	NA	FAM120A	FAM120A;FAM120A;NA;NA;NA	"NA"	"NA"	nucleus;cytosol;membrane;plasma membrane	GO:000563; GO:000582; GO:001602; GO:000588	"NA"	"NA"	RNA binding	GO:000372
XP_020943861.1;XP_020943860.1;XP_020943859.1;XP_020943858.1	XP_020943861.1;XP_020943860.1;XP_020943859.1;XP_020943858.1	XP_020943861.1 catenin alpha-2 isoform X4 [Sus scrofa];XP_020943860.1 catenin alpha-2 isoform X3 [Sus scrofa];XP_020943859.1 catenin alpha-2 isoform X2 [Sus scrofa];XP_020943858.1 catenin alpha-2 isoform X1 [Sus scrofa]	6	1	1	0	9503000	6035100	8737500	8801200	0	0	0	7693800	8614100	0	14251000	7286700	8593700	0	9527900	6700700	8335300	NA	NA	NA	CTNNA2	CTNNA2;CTNNA2;CTNNA2;CTNNA2;NA	modification of postsynaptic actin cytoskeleton;regulation of synapse structural plasticity;cytoskeleton organization;axonogenesis;cell-cell adhesion;radial glia guided migration of Purkinje cell;dendrite morphogenesis;brain morphogenesis;positive regulation of muscle cell differentiation;prepulse inhibition	GO:009888; GO:005182; GO:000701; GO:000740; GO:009860; GO:002194; GO:004881; GO:004885; GO:005114; GO:006013	cell-cell adherens junction;actin cytoskeleton;hippocampal mossy fiber to CA3 synapse;presynaptic active zone cytoplasmic component;basolateral plasma membrane;nucleus;cytoplasm;adherens junction;extrinsic component of postsynaptic membrane;lamellipodium;cytosol;axon;extrinsic component of presynaptic membrane;postsynaptic density, intracellular component	GO:000591; GO:001562; GO:009868; GO:009883; GO:001632; GO:000563; GO:000573; GO:000591; GO:009889; GO:003002; GO:000582; GO:003042; GO:009888; GO:009909	 Endometrial cancer; Tight junction; Pathways in cancer; Leukocyte transendothelial migration; Bacterial invasion of epithelial cells; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Hippo signaling pathway; Adherens junction	hsa0521; hsa0453; hsa0520; hsa0467; hsa0510; hsa0541; hsa0439; hsa0452	identical protein binding;cadherin binding;protein binding;structural constituent of cytoskeleton;actin filament binding	GO:004280; GO:004529; GO:000551; GO:000520; GO:005101
XP_020943872.1;XP_020943866.1;XP_020943925.1;XP_020943884.1;XP_020943873.1;XP_020943889.1	XP_020943872.1;XP_020943866.1;XP_020943925.1;XP_020943884.1;XP_020943873.1;XP_020943889.1	XP_020943872.1 band 4.1-like protein 2 isoform X12 [Sus scrofa];XP_020943866.1 band 4.1-like protein 2 isoform X12 [Sus scrofa];XP_020943925.1 band 4.1-like protein 2 isoform X19 [Sus scrofa];XP_020943884.1 band 4.1-like protein 2 isoform X15 [Sus scrofa];	31	1	1	11385000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EPB41L2	EPB41L2;EPB41L2;EPB41L2;EPB41L2;EPB41L2	cell division;cell cycle;positive regulation of protein localization to cell cortex;actomyosin structure organization;cortical actin cytoskeleton organization	GO:005130; GO:000704; GO:190477; GO:003103; GO:003086	cytosol;cell cortex region;nucleoplasm;focal adhesion;plasma membrane;spectrin;COP9 signalosome;nucleus;cell junction;extracellular exosome	GO:000582; GO:009973; GO:000565; GO:000592; GO:000588; GO:000809; GO:000818; GO:000563; GO:003005; GO:007006	 Tight junction	hsa0453	spectrin binding;structural molecule activity;PH domain binding;protein binding;actin binding	GO:003050; GO:000519; GO:004273; GO:000551; GO:000377
XP_020943881.1;XP_020943880.1;XP_020943879.1;XP_020943878.1;XP_020943877.1;XP_020943882.1;XP_020943883.1;XP_020938432.1;XP_020938431.1;XP_020938430.1;XP_020938429.1;XP_020938428.1	XP_020943881.1;XP_020943880.1;XP_020943879.1;XP_020943878.1;XP_020943877.1;XP_020943882.1;XP_020943883.1	XP_020943881.1 spectrin beta chain, non-erythrocytic 1 isoform X1 [Sus scrofa];XP_020943880.1 spectrin beta chain, non-erythrocytic 1 isoform X1 [Sus scrofa];XP_020943879.1 spectrin beta chain, non-erythrocytic 1 isoform X1 [Sus scrofa];XP_020943878.1 spec	111	111	108	1973300000	3640400000	2501300000	3155900000	2220600000	2665100000	2716700000	3437600000	2163700000	2916600000	2741900000	3498700000	2220100000	3249900000	3043200000	3283800000	2553000000	3063100000	NA	NA	NA	SPTBN1	SPTBN1;SPTBN1;SPTBN1;SPTBN1;SPTBN1	axon guidance;Golgi to plasma membrane protein transport;membrane assembly;positive regulation of protein localization to plasma membrane;MAPK cascade;cytoskeleton organization;regulation of SMAD protein import into nucleus;protein localization to plasma membrane;ER to Golgi vesicle-mediated transport;common-partner SMAD protein phosphorylation;positive regulation of interleukin-2 secretion;mitotic cytokinesis;plasma membrane organization;actin filament capping	GO:000741; GO:004300; GO:007170; GO:190307; GO:000016; GO:000701; GO:006039; GO:007265; GO:000688; GO:000718; GO:190004; GO:000028; GO:000700; GO:005169	nucleolus;cytoplasm;cytosol;cuticular plate;macromolecular complex;spectrin;postsynaptic density;axolemma;extracellular exosome;spectrin-associated cytoskeleton;M band;glutamatergic synapse	GO:000573; GO:000573; GO:000582; GO:003243; GO:003299; GO:000809; GO:001406; GO:003067; GO:007006; GO:001473; GO:003143; GO:009897	"NA"	"NA"	actin binding;structural constituent of cytoskeleton;calmodulin binding;phospholipid binding;ankyrin binding;macromolecular complex binding;Ras guanyl-nucleotide exchange factor activity;cadherin binding;RNA binding;GTPase binding	GO:000377; GO:000520; GO:000551; GO:000554; GO:003050; GO:004487; GO:000508; GO:004529; GO:000372; GO:005102
XP_020944008.1;XP_020944007.1	XP_020944008.1;XP_020944007.1	XP_020944008.1 BRCA1-A complex subunit BRE isoform X2 [Sus scrofa];XP_020944007.1 BRCA1-A complex subunit BRE isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	414230	NA	NA	NA	BABAM2	BABAM2;BABAM2;NA;NA;NA	cell division;double-strand break repair;signal transduction involved in G2 DNA damage checkpoint;signal transduction;apoptotic process;cell cycle;response to ionizing radiation;positive regulation of DNA repair;negative regulation of apoptotic process;chromatin organization;cellular response to DNA damage stimulus;protein K63-linked deubiquitination;protein deubiquitination	GO:005130; GO:000630; GO:007242; GO:000716; GO:000691; GO:000704; GO:001021; GO:004573; GO:004306; GO:000632; GO:000697; GO:007053; GO:001657	BRISC complex;nucleus;nuclear ubiquitin ligase complex;cytoplasm;BRCA1-A complex;nucleoplasm;cytosol	GO:007055; GO:000563; GO:000015; GO:000573; GO:007053; GO:000565; GO:000582	"NA"	"NA"	peroxisome targeting sequence binding;tumor necrosis factor receptor binding;polyubiquitin binding;protein binding	GO:000026; GO:000516; GO:003159; GO:000551
XP_020944070.1	XP_020944070.1	XP_020944070.1 LOW QUALITY PROTEIN: kanadaptin [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	6915700	0	0	0	0	0	0	+	NA	NA	SLC4A1AP	SLC4A1AP;NA;NA;NA;NA	"NA"	"NA"	nucleoplasm;plasma membrane;intracellular membrane-bounded organelle;cytoplasm	GO:000565; GO:000588; GO:004323; GO:000573	"NA"	"NA"	protein binding;mRNA binding	GO:000551; GO:000372
XP_020944096.1;XP_020944092.1;XP_020944089.1;XP_020944087.1;XP_020944086.1;XP_020944085.1	XP_020944096.1;XP_020944092.1;XP_020944089.1;XP_020944087.1;XP_020944086.1;XP_020944085.1	XP_020944096.1 rho GTPase-activating protein 18 isoform X6 [Sus scrofa];XP_020944092.1 rho GTPase-activating protein 18 isoform X5 [Sus scrofa];XP_020944089.1 rho GTPase-activating protein 18 isoform X4 [Sus scrofa];XP_020944087.1 rho GTPase-activating pro	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	13392000	0	0	0	0	NA	NA	NA	ARHGAP18	ARHGAP18;ARHGAP18;ARHGAP18;ARHGAP18;ARHGAP18	regulation of cell shape;regulation of actin filament polymerization;positive regulation of GTPase activity;small GTPase mediated signal transduction;regulation of actin cytoskeleton organization;regulation of cell motility;regulation of small GTPase mediated signal transduction	GO:000836; GO:003083; GO:004354; GO:000726; GO:003295; GO:200014; GO:005105	cytoplasm;cytosol;plasma membrane;nuclear speck	GO:000573; GO:000582; GO:000588; GO:001660	"NA"	"NA"	GTPase activator activity;cadherin binding	GO:000509; GO:004529
XP_020944163.1;XP_020944162.1;NP_001121945.1;NP_001121946.1	XP_020944163.1;XP_020944162.1;NP_001121945.1	XP_020944163.1 interferon-induced guanylate-binding protein 1 isoform X1 [Sus scrofa];XP_020944162.1 interferon-induced guanylate-binding protein 1 isoform X1 [Sus scrofa];NP_001121945.1 interferon-induced guanylate-binding protein 1 [Sus scrofa]	6	6	6	20029000	0	17056000	0	33608000	0	15631000	19465000	15256000	0	19022000	0	16160000	0	13876000	14403000	16518000	14285000	NA	NA	NA	GBP1	GBP1;GBP1;GBP1;NA;NA	regulation of calcium-mediated signaling;negative regulation of T cell receptor signaling pathway;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of ERK1 and ERK2 cascade;cellular response to interleukin-1;protein localization to vacuole;cellular response to tumor necrosis factor;regulation of protein localization to plasma membrane;protein homooligomerization;interferon-gamma-mediated signaling pathway;negative regulation of interleukin-2 secretion;defense response to virus	GO:005084; GO:005086; GO:190002; GO:007037; GO:007134; GO:007266; GO:007135; GO:190307; GO:005126; GO:006033; GO:190004; GO:005160	Golgi apparatus;cytosol;actin cytoskeleton;cytoplasm;vesicle membrane;plasma membrane;Golgi membrane;extracellular region	GO:000579; GO:000582; GO:001562; GO:000573; GO:001250; GO:000588; GO:000013; GO:000557	"NA"	"NA"	GTPase activity;identical protein binding;actin binding;GDP binding;Hsp90 protein binding;protein binding;cytokine binding;spectrin binding;GTP binding;enzyme binding	GO:000392; GO:004280; GO:000377; GO:001900; GO:005187; GO:000551; GO:001995; GO:003050; GO:000552; GO:001989
XP_020944376.1;NP_999414.1;NP_001165224.1;NP_001165012.1;XP_020948935.1;XP_020945235.1;NP_999456.1;XP_005653908.1;XP_020949229.1;XP_020949228.1;XP_020949227.1;XP_020949226.1	XP_020944376.1;NP_999414.1	XP_020944376.1 sodium/potassium-transporting ATPase subunit alpha-1 isoform X1 [Sus scrofa];NP_999414.1 sodium/potassium-transporting ATPase subunit alpha-1 precursor [Sus scrofa]	20	20	20	194710000	243080000	209240000	212500000	146370000	188040000	249710000	184160000	184220000	163050000	233190000	180510000	210670000	194610000	195570000	168810000	262360000	194710000	NA	NA	NA	ATP1A1	ATP1A1;ATP1A1;NA;NA;NA	regulation of blood pressure;sodium ion export from cell;response to drug;cellular response to mechanical stimulus;membrane repolarization;establishment or maintenance of transmembrane electrochemical gradient;cellular response to steroid hormone stimulus;cellular potassium ion homeostasis;potassium ion import across plasma membrane;negative regulation of glucocorticoid biosynthetic process;negative regulation of heart contraction;positive regulation of striated muscle contraction;membrane hyperpolarization;ATP hydrolysis coupled proton transport;regulation of sodium ion transport;cellular sodium ion homeostasis;dephosphorylation;relaxation of cardiac muscle;membrane repolarization during cardiac muscle cell action potential;cell communication by electrical coupling involved in cardiac conduction;response to glycoside	GO:000821; GO:003637; GO:004249; GO:007126; GO:008600; GO:001024; GO:007138; GO:003000; GO:199057; GO:003194; GO:004582; GO:004598; GO:006008; GO:001599; GO:000202; GO:000688; GO:001631; GO:005511; GO:008601; GO:008606; GO:190341	endosome;basolateral plasma membrane;extracellular vesicle;Golgi apparatus;membrane;sarcolemma;intercalated disc;T-tubule;sodium:potassium-exchanging ATPase complex;postsynaptic density;macromolecular complex;endoplasmic reticulum;plasma membrane;extracellular exosome;caveola;melanosome	GO:000576; GO:001632; GO:190356; GO:000579; GO:001602; GO:004238; GO:001470; GO:003031; GO:000589; GO:001406; GO:003299; GO:000578; GO:000588; GO:007006; GO:000590; GO:004247	 cGMP-PKG signaling pathway; Adrenergic signaling in cardiomyocytes; Bile secretion; Proximal tubule bicarbonate reclamation; cAMP signaling pathway; Thyroid hormone synthesis	hsa0402; hsa0426; hsa0497; hsa0496; hsa0402; hsa0491	sodium:potassium-exchanging ATPase activity;ATP binding;chaperone binding;protein binding;protein kinase binding;steroid hormone binding;phosphatase activity;ankyrin binding;sodium ion binding;ADP binding;potassium ion binding;phosphatidylinositol 3-kinase binding	GO:000539; GO:000552; GO:005108; GO:000551; GO:001990; GO:199023; GO:001679; GO:003050; GO:003140; GO:004353; GO:003095; GO:004354
XP_020944517.1;XP_020944516.1;XP_020944515.1;XP_020944518.1;XP_020944509.1;XP_020944514.1;XP_020944513.1;XP_020944511.1;XP_020944510.1;XP_020944507.1;XP_020944506.1;XP_020944505.1;XP_020944504.1;XP_020944508.1;XP_020944502.1;XP_020944501.1;XP_020944503.1;XP_020944499.1;XP_020944498.1;XP_020944497.1;XP_020944495.1;XP_020944494.1;XP_020944493.1;XP_020944492.1;XP_020944500.1;XP_020944491.1;XP_020944490.1;XP_020944496.1;XP_020944489.1;XP_020944512.1;XP_020944488.1;XP_020944487.1;XP_020944486.1;XP_020944485.1;XP_020944484.1;XP_020944483.1;XP_020944482.1;XP_020944481.1;XP_020944480.1;XP_020944479.1	XP_020944517.1;XP_020944516.1;XP_020944515.1;XP_020944518.1;XP_020944509.1;XP_020944514.1;XP_020944513.1;XP_020944511.1;XP_020944510.1;XP_020944507.1;XP_020944506.1;XP_020944505.1;XP_020944504.1;XP_020944508.1;XP_020944502.1;XP_020944501.1;XP_020944503.1;XP_020944499.1;XP_020944498.1;XP_020944497.1;XP_020944495.1;XP_020944494.1;XP_020944493.1;XP_020944492.1;XP_020944500.1;XP_020944491.1;XP_020944490.1;XP_020944496.1;XP_020944489.1;XP_020944512.1;XP_020944488.1;XP_020944487.1;XP_020944486.1;XP_020944485.1;XP_020944484.1;XP_020944483.1;XP_020944482.1;XP_020944481.1;XP_020944480.1;XP_020944479.1	XP_020944517.1 focal adhesion kinase 1 isoform X32 [Sus scrofa];XP_020944516.1 focal adhesion kinase 1 isoform X32 [Sus scrofa];XP_020944515.1 focal adhesion kinase 1 isoform X31 [Sus scrofa];XP_020944518.1 focal adhesion kinase 1 isoform X33 [Sus scrofa];	4	4	4	0	10202000	12494000	0	0	0	0	0	0	8666500	0	0	18755000	12439000	10168000	0	7169900	10436000	NA	NA	NA	PTK2	PTK2;PTK2;PTK2;PTK2;PTK2	positive regulation of protein phosphorylation;axon guidance;establishment of cell polarity;extracellular matrix organization;vasculogenesis;regulation of endothelial cell migration;positive regulation of phosphatidylinositol 3-kinase signaling;peptidyl-tyrosine phosphorylation;negative regulation of cell-cell adhesion;regulation of cell adhesion;netrin-activated signaling pathway;endothelial cell migration;positive regulation of phosphatidylinositol 3-kinase activity;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;neuron migration;epidermal growth factor receptor signaling pathway;regulation of cell shape;positive regulation of cardiac muscle hypertrophy;positive regulation of cell migration;peptidyl-tyrosine autophosphorylation;regulation of GTPase activity;regulation of cytoskeleton organization;positive regulation of protein kinase B signaling;regulation of protein phosphorylation;nuclear migration;positive regulation of cell proliferation;MAPK cascade;placenta development;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of protein kinase activity;negative regulation of axonogenesis;regulation of substrate adhesion-dependent cell spreading;negative regulation of anoikis;negative regulation of autophagy;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;growth hormone receptor signaling pathway;central nervous system neuron axonogenesis;negative regulation of apoptotic process;negative regulation of organ growth;cell motility;negative regulation of synapse assembly;microtubule cytoskeleton organization;angiogenesis;heart morphogenesis;integrin-mediated signaling pathway;regulation of epithelial cell migration;regulation of cell adhesion mediated by integrin;regulation of cell proliferation;regulation of osteoblast differentiation	GO:000193; GO:000741; GO:003001; GO:003019; GO:000157; GO:001059; GO:001406; GO:001810; GO:002240; GO:003015; GO:003800; GO:004354; GO:004355; GO:200006; GO:000176; GO:000717; GO:000836; GO:001061; GO:003033; GO:003808; GO:004308; GO:005149; GO:005189; GO:000193; GO:000709; GO:000828; GO:000016; GO:000189; GO:003809; GO:004586; GO:005077; GO:190002; GO:200081; GO:001050; GO:004677; GO:004801; GO:006039; GO:002195; GO:004306; GO:004662; GO:004887; GO:005196; GO:000022; GO:000152; GO:000300; GO:000722; GO:001063; GO:003362; GO:004212; GO:004566	cytosol;dendritic spine;plasma membrane;cytoplasm;cell cortex;apical plasma membrane;lamellipodium;focal adhesion;stress fiber;cytoskeleton;nucleus;microtubule organizing center	GO:000582; GO:004319; GO:000588; GO:000573; GO:000593; GO:001632; GO:003002; GO:000592; GO:000172; GO:000585; GO:000563; GO:000581	 Bacterial invasion of epithelial cells; Transcriptional misregulation in cancer; VEGF signaling pathway; Leukocyte transendothelial migration; PI3K-Akt signaling pathway; Axon guidance; Focal adhesion; Chemokine signaling pathway; Small cell lung cancer; ErbB signaling pathway; Amoebiasis; Regulation of actin cytoskeleton	hsa0510; hsa0520; hsa0437; hsa0467; hsa0415; hsa0436; hsa0451; hsa0406; hsa0522; hsa0401; hsa0514; hsa0481	Ras guanyl-nucleotide exchange factor activity;protein kinase binding;protein tyrosine kinase activity;protein binding;actin binding;protein kinase activity;JUN kinase binding;ATP binding;SH2 domain binding	GO:000508; GO:001990; GO:000471; GO:000551; GO:000377; GO:000467; GO:000843; GO:000552; GO:004216
XP_020944534.1	XP_020944534.1	XP_020944534.1 protein NDRG1 [Sus scrofa]	2	2	2	0	77697000	42286000	61406000	36861000	61815000	64980000	28994000	35522000	51549000	46719000	0	58667000	59821000	45823000	0	82638000	60660000	NA	NA	NA	NDRG1	NDRG1;NA;NA;NA;NA	signal transduction;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator;mast cell activation;cellular response to hypoxia;negative regulation of cell proliferation;regulation of apoptotic process	GO:000716; GO:003228; GO:001003; GO:003033; GO:004557; GO:007145; GO:000828; GO:004298	cytosol;centrosome;nucleus;microtubule cytoskeleton;recycling endosome membrane;cell-cell adherens junction;extracellular exosome;cytoplasm;glutamatergic synapse;plasma membrane;microtubule;perinuclear region of cytoplasm	GO:000582; GO:000581; GO:000563; GO:001563; GO:005503; GO:000591; GO:007006; GO:000573; GO:009897; GO:000588; GO:000587; GO:004847	"NA"	"NA"	microtubule binding;gamma-tubulin binding;cadherin binding;Rab GTPase binding;protein binding	GO:000801; GO:004301; GO:004529; GO:001713; GO:000551
XP_020944561.1;XP_020944560.1;XP_020944559.1;XP_020944558.1;XP_020944557.1	XP_020944561.1;XP_020944560.1;XP_020944559.1;XP_020944558.1;XP_020944557.1	XP_020944561.1 protein EFR3 homolog A isoform X4 [Sus scrofa];XP_020944560.1 protein EFR3 homolog A isoform X4 [Sus scrofa];XP_020944559.1 protein EFR3 homolog A isoform X3 [Sus scrofa];XP_020944558.1 protein EFR3 homolog A isoform X2 [Sus scrofa];XP_02094	2	2	2	0	0	0	0	0	0	0	0	0	0	3027300	0	0	0	0	0	0	0	NA	NA	NA	EFR3A	EFR3A;EFR3A;EFR3A;EFR3A;EFR3A	protein localization to plasma membrane;phosphatidylinositol phosphorylation	GO:007265; GO:004685	plasma membrane;cytosol	GO:000588; GO:000582	"NA"	"NA"	"NA"	"NA"
XP_020944591.1;XP_020944590.1	XP_020944591.1;XP_020944590.1	XP_020944591.1 WASH complex subunit 5 isoform X2 [Sus scrofa];XP_020944590.1 WASH complex subunit 5 isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1671400	0	NA	NA	NA	WASHC5	WASHC5;WASHC5;NA;NA;NA	oocyte maturation;positive regulation of neuron projection development;protein transport;polar body extrusion after meiotic divisions;spindle assembly involved in meiosis;endosomal transport	GO:000155; GO:001097; GO:001503; GO:004003; GO:009030; GO:001619	WASH complex;neuronal cell body;endoplasmic reticulum;cytosol;early endosome;neuron projection;nucleoplasm	GO:007120; GO:004302; GO:000578; GO:000582; GO:000576; GO:004300; GO:000565	 Endocytosis	hsa0414	protein binding	GO:000551
XP_020944640.1	XP_020944640.1	XP_020944640.1 beta-1-syntrophin [Sus scrofa]	18	18	17	156060000	173280000	128980000	152950000	125410000	93243000	150640000	129570000	134320000	148000000	168000000	223950000	81616000	191110000	139410000	189190000	122990000	144300000	NA	NA	NA	SNTB1	SNTB1;NA;NA;NA;NA	muscle contraction	GO:000693	cytoskeleton;cytoplasm;dystrophin-associated glycoprotein complex;macromolecular complex;focal adhesion;sarcolemma;synapse	GO:000585; GO:000573; GO:001601; GO:003299; GO:000592; GO:004238; GO:004520	"NA"	"NA"	protein binding;calmodulin binding;actin binding;PDZ domain binding;structural molecule activity	GO:000551; GO:000551; GO:000377; GO:003016; GO:000519
XP_020944683.1;XP_020944682.1;XP_020944681.1;XP_020944680.1;XP_020944679.1;XP_020944678.1;XP_020944677.1;XP_020944676.1;XP_020944675.1;XP_020944674.1	XP_020944683.1;XP_020944682.1;XP_020944681.1;XP_020944680.1;XP_020944679.1;XP_020944678.1;XP_020944677.1;XP_020944676.1;XP_020944675.1;XP_020944674.1	XP_020944683.1 ER membrane protein complex subunit 2 isoform X7 [Sus scrofa];XP_020944682.1 ER membrane protein complex subunit 2 isoform X7 [Sus scrofa];XP_020944681.1 ER membrane protein complex subunit 2 isoform X7 [Sus scrofa];XP_020944680.1 ER membran	1	1	1	0	8142400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EMC2	EMC2;EMC2;EMC2;EMC2;EMC2	protein folding in endoplasmic reticulum	GO:003497	ER membrane protein complex;endoplasmic reticulum;cytoplasm;nucleus	GO:007254; GO:000578; GO:000573; GO:000563	"NA"	"NA"	protein binding	GO:000551
XP_020944686.1	XP_020944686.1	XP_020944686.1 eukaryotic translation initiation factor 3 subunit E [Sus scrofa]	7	7	7	27661000	34340000	35977000	35243000	31776000	33685000	35666000	30638000	40814000	32578000	35289000	43836000	39921000	38946000	33265000	44964000	39638000	36645000	NA	NA	NA	EIF3E	EIF3E;NA;NA;NA;NA	formation of cytoplasmic translation initiation complex;positive regulation of mRNA binding;translational initiation;regulation of translational initiation;positive regulation of translation;negative regulation of translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	GO:000173; GO:190241; GO:000641; GO:000644; GO:004572; GO:004594; GO:000018	chromatin;extracellular exosome;nucleoplasm;PML body;nucleus;cytoplasm;cytosol;eukaryotic 43S preinitiation complex;eukaryotic translation initiation factor 3 complex;membrane;eukaryotic 48S preinitiation complex;eukaryotic translation initiation factor 3 complex, eIF3e	GO:000078; GO:007006; GO:000565; GO:001660; GO:000563; GO:000573; GO:000582; GO:001628; GO:000585; GO:001602; GO:003329; GO:007154	 Hepatitis C; RNA transport	hsa0516; hsa0301	protein N-terminus binding;cadherin binding;RNA binding;protein binding;translation initiation factor activity	GO:004748; GO:004529; GO:000372; GO:000551; GO:000374
XP_020944728.1;XP_020944727.1;XP_020944726.1;XP_020944725.1	XP_020944728.1;XP_020944727.1;XP_020944726.1;XP_020944725.1	XP_020944728.1 matrilin-2 isoform X4 [Sus scrofa];XP_020944727.1 matrilin-2 isoform X3 [Sus scrofa];XP_020944726.1 matrilin-2 isoform X2 [Sus scrofa];XP_020944725.1 matrilin-2 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	8233700	0	0	0	0	0	NA	NA	NA	MATN2	MATN2;MATN2;MATN2;MATN2;NA	neuron migration;dendrite regeneration;biological_process;axon guidance;growth plate cartilage chondrocyte morphogenesis;glial cell migration;response to axon injury	GO:000176; GO:003110; GO:000815; GO:000741; GO:000342; GO:000834; GO:004867	extracellular matrix;extracellular space;basement membrane	GO:003101; GO:000561; GO:000560	"NA"	"NA"	extracellular matrix structural constituent;calcium ion binding;protein binding	GO:000520; GO:000550; GO:000551
XP_020944894.1	XP_020944894.1	XP_020944894.1 somatomedin-B and thrombospondin type-1 domain-containing protein [Sus scrofa]	1	1	1	0	10818000	14712000	0	0	26398000	0	9447000	0	11027000	11550000	30141000	0	0	0	8754500	8135800	0	NA	NA	NA	SBSPON	SBSPON;NA;NA;NA;NA	immune response;receptor-mediated endocytosis	GO:000695; GO:000689	"NA"	"NA"	"NA"	"NA"	extracellular matrix structural constituent;scavenger receptor activity;polysaccharide binding	GO:000520; GO:000504; GO:003024
XP_020944990.1;XP_020944988.1;XP_020944987.1;XP_020944986.1;XP_020944985.1;XP_020944982.1;XP_020944977.1;XP_020944975.1;XP_020944992.1;XP_020944991.1;XP_020944989.1;XP_020944984.1;XP_020944983.1;XP_020944981.1;XP_020944980.1;XP_020944979.1;XP_020944978.1;XP_020944976.1;XP_020944974.1;XP_003361154.1;XP_003125661.2	XP_020944990.1;XP_020944988.1;XP_020944987.1;XP_020944986.1;XP_020944985.1;XP_020944982.1;XP_020944977.1;XP_020944975.1;XP_020944992.1;XP_020944991.1;XP_020944989.1;XP_020944984.1;XP_020944983.1;XP_020944981.1;XP_020944980.1;XP_020944979.1;XP_020944978.1;XP_020944976.1;XP_020944974.1	XP_020944990.1 aspartyl/asparaginyl beta-hydroxylase isoform X17 [Sus scrofa];XP_020944988.1 aspartyl/asparaginyl beta-hydroxylase isoform X15 [Sus scrofa];XP_020944987.1 aspartyl/asparaginyl beta-hydroxylase isoform X14 [Sus scrofa];XP_020944986.1 asparty	28	28	28	408770000	346320000	473160000	457110000	507130000	442130000	470700000	502430000	471260000	499040000	450910000	595430000	231740000	469100000	561450000	601700000	457770000	471760000	NA	NA	NA	ASPH	ASPH;ASPH;ASPH;ASPH;ASPH	regulation of protein stability;positive regulation of proteolysis;regulation of cardiac conduction;pattern specification process;limb morphogenesis;activation of cysteine-type endopeptidase activity;regulation of protein depolymerization;peptidyl-aspartic acid hydroxylation;face morphogenesis;muscle contraction;electron transport chain;negative regulation of cell proliferation;ion transmembrane transport;palate development	GO:003164; GO:004586; GO:190377; GO:000738; GO:003510; GO:009720; GO:190187; GO:004226; GO:006032; GO:000693; GO:002290; GO:000828; GO:003422; GO:006002	endoplasmic reticulum membrane;cortical endoplasmic reticulum;plasma membrane;integral component of membrane;endoplasmic reticulum;sarcoplasmic reticulum membrane	GO:000578; GO:003254; GO:000588; GO:001602; GO:000578; GO:003301	"NA"	"NA"	structural molecule activity;protein binding;calcium ion binding;electron carrier activity;peptide-aspartate beta-dioxygenase activity;structural constituent of muscle	GO:000519; GO:000551; GO:000550; GO:000905; GO:000459; GO:000830
XP_020945028.1	XP_020945028.1	XP_020945028.1 acyl-protein thioesterase 1 [Sus scrofa]	5	5	5	170520000	108860000	170460000	88963000	117210000	77777000	152230000	98125000	159610000	108790000	121580000	85148000	81350000	101960000	120630000	108400000	113390000	82172000	NA	NA	NA	LYPLA1	LYPLA1;NA;NA;NA;NA	fatty acid metabolic process;negative regulation of Golgi to plasma membrane protein transport;regulation of nitric-oxide synthase activity;protein depalmitoylation	GO:000663; GO:004299; GO:005099; GO:000208	extracellular exosome;cytoplasm;cytosol	GO:007006; GO:000573; GO:000582	 Glycerophospholipid metabolism; Choline metabolism in cancer	hsa0056; hsa0523	palmitoyl-(protein) hydrolase activity;lysophospholipase activity;carboxylic ester hydrolase activity;lipase activity	GO:000847; GO:000462; GO:005268; GO:001629
XP_020945081.1;XP_020945079.1;XP_020945078.1;XP_020945080.1	XP_020945081.1;XP_020945079.1;XP_020945078.1;XP_020945080.1	XP_020945081.1 DNA-dependent protein kinase catalytic subunit isoform X4 [Sus scrofa];XP_020945079.1 DNA-dependent protein kinase catalytic subunit isoform X2 [Sus scrofa];XP_020945078.1 DNA-dependent protein kinase catalytic subunit isoform X1 [Sus scrofa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10658000	0	NA	NA	NA	PRKDC	PRKDC;PRKDC;PRKDC;PRKDC;NA	cellular protein modification process;protein ubiquitination;positive regulation of apoptotic process;activation of innate immune response;negative regulation of immunoglobulin production;protein phosphorylation;T cell receptor V(D)J recombination;positive regulation of developmental growth;B cell lineage commitment;double-strand break repair via nonhomologous end joining;positive regulation of fibroblast proliferation;rhythmic process;telomere capping;T cell differentiation in thymus;negative regulation of response to gamma radiation;negative regulation of protein phosphorylation;ectopic germ cell programmed cell death;negative regulation of cellular senescence;somitogenesis;T cell lineage commitment;brain development;heart development;positive regulation of type I interferon production;cellular response to insulin stimulus;regulation of circadian rhythm;positive regulation of transcription from RNA polymerase II promoter;spleen development;double-strand break repair via alternative nonhomologous end joining;cellular response to DNA damage stimulus;cell proliferation;protein destabilization;innate immune response;signal transduction involved in mitotic G1 DNA damage checkpoint;telomere maintenance;intrinsic apoptotic signaling pathway in response to DNA damage;response to gamma radiation;response to activity;peptidyl-serine phosphorylation;regulation of smooth muscle cell proliferation	GO:000646; GO:001656; GO:004306; GO:000221; GO:000263; GO:000646; GO:003315; GO:004863; GO:000232; GO:000630; GO:004814; GO:004851; GO:001623; GO:003307; GO:200122; GO:000193; GO:003523; GO:200077; GO:000175; GO:000236; GO:000742; GO:000750; GO:003248; GO:003286; GO:004275; GO:004594; GO:004853; GO:009768; GO:000697; GO:000828; GO:003164; GO:004508; GO:007243; GO:000072; GO:000863; GO:001033; GO:001482; GO:001810; GO:004866	membrane;macromolecular complex;nuclear chromosome, telomeric region;transcription factor complex;cytosol;nucleus;nucleoplasm;nucleolus;DNA-dependent protein kinase-DNA ligase 4 complex;nonhomologous end joining complex	GO:001602; GO:003299; GO:000078; GO:000566; GO:000582; GO:000563; GO:000565; GO:000573; GO:000595; GO:007041	 Non-homologous end-joining; Cell cycle	hsa0345; hsa0411	RNA binding;protein serine/threonine kinase activity;transcription factor binding;protein domain specific binding;protein binding;double-stranded DNA binding;ATP binding;enzyme binding	GO:000372; GO:000467; GO:000813; GO:001990; GO:000551; GO:000369; GO:000552; GO:001989
XP_020945342.1;XP_020945338.1;XP_020945335.1;XP_020945352.1;XP_020945329.1;XP_020945361.1;XP_020945349.1	XP_020945342.1;XP_020945338.1;XP_020945335.1;XP_020945352.1;XP_020945329.1;XP_020945361.1;XP_020945349.1	XP_020945342.1 heterogeneous nuclear ribonucleoprotein Q isoform X3 [Sus scrofa];XP_020945338.1 heterogeneous nuclear ribonucleoprotein Q isoform X2 [Sus scrofa];XP_020945335.1 heterogeneous nuclear ribonucleoprotein Q isoform X2 [Sus scrofa];XP_020945352.	11	11	9	84129000	90511000	86793000	113700000	104090000	92704000	94126000	102290000	78999000	107800000	104300000	120300000	109640000	89095000	102540000	105180000	89799000	114510000	NA	NA	NA	SYNCRIP	SYNCRIP;SYNCRIP;SYNCRIP;SYNCRIP;SYNCRIP	mRNA splicing, via spliceosome;cellular response to interferon-gamma;RNA processing;osteoblast differentiation;RNA splicing;negative regulation of translation;CRD-mediated mRNA stabilization;viral process	GO:000039; GO:007134; GO:000639; GO:000164; GO:000838; GO:001714; GO:007093; GO:001603	GAIT complex;nucleus;nucleoplasm;ribonucleoprotein complex;catalytic step 2 spliceosome;CRD-mediated mRNA stability complex;histone pre-mRNA 3'end processing complex;endoplasmic reticulum;membrane	GO:009745; GO:000563; GO:000565; GO:199090; GO:007101; GO:007093; GO:007120; GO:000578; GO:001602	"NA"	"NA"	poly(A) binding;mRNA binding;protein binding;mRNA 5'-UTR binding	GO:000814; GO:000372; GO:000551; GO:004802
XP_020945400.1;XP_020945399.1;XP_020945398.1	XP_020945400.1;XP_020945399.1;XP_020945398.1	XP_020945400.1 pre-B-cell leukemia transcription factor-interacting protein 1 [Sus scrofa];XP_020945399.1 pre-B-cell leukemia transcription factor-interacting protein 1 [Sus scrofa];XP_020945398.1 pre-B-cell leukemia transcription factor-interacting protei	4	4	4	0	7075500	7934500	0	0	0	12854000	24809000	0	0	8922200	13304000	0	12239000	14428000	10586000	11524000	0	NA	NA	NA	PBXIP1	PBXIP1;PBXIP1;PBXIP1;NA;NA	negative regulation of transcription, DNA-templated;cell differentiation;multicellular organism development	GO:004589; GO:003015; GO:000727	microtubule;nucleus;cytosol	GO:000587; GO:000563; GO:000582	"NA"	"NA"	transcription corepressor activity;protein binding	GO:000371; GO:000551
XP_020945465.1;XP_020921233.1;XP_020918210.1;XP_020946789.1;XP_005660260.1;XP_005660259.1;NP_001231251.1;XP_005660258.1;NP_999270.1;XP_020923507.1;XP_020923508.1;XP_020923506.1	XP_020945465.1	XP_020945465.1 atrial natriuretic peptide receptor 1 [Sus scrofa]	10	10	10	0	22606000	18038000	21401000	18219000	18103000	24795000	20547000	20480000	22113000	24801000	26801000	0	24392000	24647000	27342000	19161000	0	NA	NA	NA	NPR1	NPR1;NA;NA;NA;NA	G-protein coupled receptor signaling pathway;protein phosphorylation;receptor guanylyl cyclase signaling pathway;regulation of blood pressure;positive regulation of renal sodium excretion;cGMP-mediated signaling;regulation of vascular permeability;negative regulation of cell growth;body fluid secretion;dopamine metabolic process;regulation of cardiac conduction;cGMP biosynthetic process;negative regulation of angiogenesis;negative regulation of smooth muscle cell proliferation;positive regulation of cGMP-mediated signaling;regulation of blood vessel diameter	GO:000718; GO:000646; GO:000716; GO:000821; GO:003581; GO:001993; GO:004311; GO:003030; GO:000758; GO:004241; GO:190377; GO:000618; GO:001652; GO:004866; GO:001075; GO:009774	plasma membrane;integral component of membrane;receptor complex	GO:000588; GO:001602; GO:004323	 cGMP-PKG signaling pathway; Oxytocin signaling pathway; Vascular smooth muscle contraction; Purine metabolism; cAMP signaling pathway	hsa0402; hsa0492; hsa0427; hsa0023; hsa0402	G-protein coupled peptide receptor activity;natriuretic peptide receptor activity;guanylate cyclase activity;ATP binding;peptide receptor activity;hormone binding;peptide hormone binding;protein kinase binding;protein kinase activity	GO:000852; GO:001694; GO:000438; GO:000552; GO:000165; GO:004256; GO:001704; GO:001990; GO:000467
XP_020945467.1;XP_020945466.1	XP_020945467.1;XP_020945466.1	XP_020945467.1 protein S100-A1 isoform X2 [Sus scrofa];XP_020945466.1 protein S100-A1 isoform X1 [Sus scrofa]	6	6	6	639480000	605950000	615980000	690600000	1122300000	526330000	583370000	948380000	615490000	752630000	1241600000	770000000	497830000	954780000	1221200000	816600000	957710000	1051700000	NA	NA	NA	S100A1	S100A1;S100A1;NA;NA;NA	positive regulation of nitric-oxide synthase activity;substantia nigra development;negative regulation of transcription from RNA polymerase II promoter;regulation of heart contraction;toll-like receptor signaling pathway;positive regulation of voltage-gated calcium channel activity;intracellular signal transduction;positive regulation of sprouting angiogenesis	GO:005100; GO:002176; GO:000012; GO:000801; GO:000222; GO:190138; GO:003555; GO:190367	nucleus;macromolecular complex;extracellular region;sarcoplasmic reticulum;Z disc;neuron projection;M band	GO:000563; GO:003299; GO:000557; GO:001652; GO:003001; GO:004300; GO:003143	"NA"	"NA"	identical protein binding;protein homodimerization activity;calcium ion binding;calcium-dependent protein binding;protein binding;S100 protein binding;ATPase binding	GO:004280; GO:004280; GO:000550; GO:004830; GO:000551; GO:004454; GO:005111
XP_020945470.1;XP_020945469.1;XP_020945468.1	XP_020945470.1;XP_020945469.1;XP_020945468.1	XP_020945470.1 protein S100-A13 isoform X2 [Sus scrofa];XP_020945469.1 protein S100-A13 isoform X2 [Sus scrofa];XP_020945468.1 protein S100-A13 isoform X1 [Sus scrofa]	3	3	3	53656000	71578000	47493000	63751000	37835000	68636000	62575000	66844000	57089000	60424000	74008000	25050000	82358000	98839000	57570000	71527000	60874000	68100000	NA	NA	NA	S100A13	S100A13;S100A13;S100A13;NA;NA	positive regulation of I-kappaB kinase/NF-kappaB signaling;response to copper ion;cytokine secretion;interleukin-1 alpha secretion;positive regulation of cell proliferation;response to electrical stimulus;regulation of cell shape;mast cell degranulation	GO:004312; GO:004668; GO:005066; GO:005070; GO:000828; GO:005160; GO:000836; GO:004330	extracellular space;nucleus;cytosol;perinuclear region of cytoplasm;cytoplasm;extracellular region;plasma membrane;mast cell granule	GO:000561; GO:000563; GO:000582; GO:004847; GO:000573; GO:000557; GO:000588; GO:004262	"NA"	"NA"	fibroblast growth factor binding;protein binding;lipid binding;protein homodimerization activity;zinc ion binding;RAGE receptor binding;copper ion binding	GO:001713; GO:000551; GO:000828; GO:004280; GO:000827; GO:005078; GO:000550
XP_020945552.1	XP_020945552.1	XP_020945552.1 cathepsin S [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8405400	NA	NA	NA	CTSS	CTSS;NA;NA;NA;NA	immune response;toll-like receptor signaling pathway;extracellular matrix disassembly;antigen processing and presentation of peptide antigen;positive regulation of cation channel activity;antigen processing and presentation;neutrophil degranulation;proteolysis involved in cellular protein catabolic process;proteolysis;response to acidic pH;collagen catabolic process;cellular response to thyroid hormone stimulus;adaptive immune response;protein processing;basement membrane disassembly	GO:000695; GO:000222; GO:002261; GO:004800; GO:200125; GO:001988; GO:004331; GO:005160; GO:000650; GO:001044; GO:003057; GO:009706; GO:000225; GO:001648; GO:003476	extracellular region;ficolin-1-rich granule lumen;endolysosome lumen;intracellular membrane-bounded organelle;tertiary granule lumen;lysosomal lumen;extracellular space;lysosome	GO:000557; GO:190481; GO:003602; GO:004323; GO:190472; GO:004320; GO:000561; GO:000576	 Antigen processing and presentation; Lysosome; Tuberculosis	hsa0461; hsa0414; hsa0515	serine-type endopeptidase activity;collagen binding;laminin binding;cysteine-type endopeptidase activity;proteoglycan binding;fibronectin binding	GO:000425; GO:000551; GO:004323; GO:000419; GO:004339; GO:000196
XP_020945568.1;XP_020945567.1;XP_020945566.1;XP_020945565.1;XP_020945564.1;XP_020945570.1;XP_020945569.1	XP_020945568.1;XP_020945567.1;XP_020945566.1;XP_020945565.1;XP_020945564.1;XP_020945570.1;XP_020945569.1	XP_020945568.1 extracellular matrix protein 1 isoform X5 [Sus scrofa];XP_020945567.1 extracellular matrix protein 1 isoform X4 [Sus scrofa];XP_020945566.1 extracellular matrix protein 1 isoform X3 [Sus scrofa];XP_020945565.1 extracellular matrix protein 1	18	18	18	0	404350000	59889000	452250000	43354000	458870000	92459000	315030000	73273000	224570000	95330000	457250000	96972000	422080000	71938000	237360000	107800000	916320000	NA	NA	NA	ECM1	ECM1;ECM1;ECM1;ECM1;ECM1	angiogenesis;regulation of type 2 immune response;inflammatory response;platelet degranulation;regulation of transcription from RNA polymerase II promoter;ossification;chondrocyte development;biomineral tissue development;endochondral bone growth;positive regulation of angiogenesis;negative regulation of cytokine-mediated signaling pathway;signal transduction;negative regulation of bone mineralization;regulation of T cell migration;positive regulation of endothelial cell proliferation;negative regulation of peptidase activity;positive regulation of I-kappaB kinase/NF-kappaB signaling	GO:000152; GO:000282; GO:000695; GO:000257; GO:000635; GO:000150; GO:000206; GO:003121; GO:000341; GO:004576; GO:000196; GO:000716; GO:003050; GO:200040; GO:000193; GO:001046; GO:004312	extracellular exosome;extracellular matrix;extracellular region;platelet dense granule lumen	GO:007006; GO:003101; GO:000557; GO:003108	"NA"	"NA"	protein binding;protein C-terminus binding;laminin binding;extracellular matrix structural constituent;protease binding;interleukin-2 receptor binding;enzyme binding	GO:000551; GO:000802; GO:004323; GO:000520; GO:000202; GO:000513; GO:001989
XP_020945581.1;XP_020945580.1;XP_020945579.1;XP_020945578.1	XP_020945581.1;XP_020945580.1;XP_020945579.1;XP_020945578.1	XP_020945581.1 acidic leucine-rich nuclear phosphoprotein 32 family member E isoform X3 [Sus scrofa];XP_020945580.1 acidic leucine-rich nuclear phosphoprotein 32 family member E isoform X2 [Sus scrofa];XP_020945579.1 acidic leucine-rich nuclear phosphoprot	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4282700	NA	NA	NA	ANP32E	ANP32E;ANP32E;ANP32E;ANP32E;NA	negative regulation of catalytic activity;histone exchange	GO:004308; GO:004348	nucleus;cytoplasmic vesicle;Swr1 complex	GO:000563; GO:003141; GO:000081	"NA"	"NA"	phosphatase inhibitor activity;histone binding	GO:001921; GO:004239
XP_020945718.1;XP_020945719.1;XP_020945717.1;NP_001231868.1	XP_020945718.1;XP_020945719.1;XP_020945717.1	XP_020945718.1 glutathione S-transferase Mu 1-like isoform X2 [Sus scrofa];XP_020945719.1 glutathione S-transferase Mu 1-like isoform X3 [Sus scrofa];XP_020945717.1 glutathione S-transferase Mu 1-like isoform X1 [Sus scrofa]	10	10	6	365670000	568760000	492700000	598930000	470300000	403380000	603900000	565780000	463470000	431760000	519160000	537750000	411780000	499230000	424640000	509290000	498510000	455270000	NA	NA	NA	LOC110260348	LOC110260348;LOC110260348;LOC110260348;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020945720.1;XP_020925486.1	XP_020945720.1	XP_020945720.1 glutathione S-transferase Mu 1 [Sus scrofa]	10	6	5	34469000	52726000	55960000	41099000	67681000	67658000	38522000	42731000	88721000	79978000	39897000	34670000	23530000	47796000	77054000	96721000	70721000	54420000	NA	NA	NA	LOC106510200	LOC106510200;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020945765.1	XP_020945765.1	XP_020945765.1 syntaxin-binding protein 3 [Sus scrofa]	8	8	8	18500000	20071000	22583000	22783000	19341000	15145000	14929000	0	15545000	18364000	18083000	20129000	15321000	19101000	18693000	20661000	18375000	17927000	NA	NA	NA	STXBP3	STXBP3;NA;NA;NA;NA	response to insulin;cellular response to interferon-gamma;neutrophil degranulation;brain development;protein to membrane docking;negative regulation of glucose import;cellular glucose homeostasis;insulin secretion;platelet aggregation;vesicle docking involved in exocytosis;negative regulation of calcium ion-dependent exocytosis;protein heterooligomerization	GO:003286; GO:007134; GO:004331; GO:000742; GO:002261; GO:004632; GO:000167; GO:003007; GO:007052; GO:000690; GO:004595; GO:005129	cytosol;platelet alpha granule;phagocytic vesicle;apical plasma membrane;specific granule;extracellular exosome;tertiary granule;presynapse;plasma membrane	GO:000582; GO:003109; GO:004533; GO:001632; GO:004258; GO:007006; GO:007082; GO:009879; GO:000588	"NA"	"NA"	syntaxin-1 binding;syntaxin binding;protein binding	GO:001707; GO:001990; GO:000551
XP_020945963.1;XP_020945957.1	XP_020945963.1;XP_020945957.1	XP_020945963.1 ubiquinone biosynthesis O-methyltransferase, mitochondrial isoform X2 [Sus scrofa];XP_020945957.1 ubiquinone biosynthesis O-methyltransferase, mitochondrial isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7120500	0	NA	NA	NA	COQ3	COQ3;COQ3;NA;NA;NA	regulation of ubiquinone biosynthetic process;ubiquinone biosynthetic process;glycerol metabolic process;methylation	GO:001079; GO:000674; GO:000607; GO:003225	extrinsic component of mitochondrial inner membrane;mitochondrial matrix;mitochondrion	GO:003131; GO:000575; GO:000573	 Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways	hsa0013; hsa0110	2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;protein binding;3-demethylubiquinone-9 3-O-methyltransferase activity;decaprenyldihydroxybenzoate methyltransferase activity;O-methyltransferase activity;hexaprenyldihydroxybenzoate methyltransferase activity	GO:000842; GO:000551; GO:000868; GO:004459; GO:000817; GO:000439
XP_020946001.1;XP_020946004.1;XP_020946003.1;XP_013835960.2;XP_020946002.1	XP_020946001.1;XP_020946004.1;XP_020946003.1;XP_013835960.2;XP_020946002.1	XP_020946001.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X1 [Sus scrofa];XP_020946004.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X3 [Sus scrofa];XP_020946003.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform	10	9	9	37485000	151220000	77838000	0	43130000	0	0	0	0	0	0	0	53075000	0	0	0	64957000	0	NA	NA	NA	DDAH1	DDAH1;DDAH1;DDAH1;DDAH1;DDAH1	regulation of nitric-oxide synthase activity;citrulline metabolic process;regulation of systemic arterial blood pressure;arginine catabolic process;nitric oxide mediated signal transduction;negative regulation of cell proliferation;negative regulation of vascular permeability;negative regulation of cellular response to hypoxia;positive regulation of angiogenesis;positive regulation of nitric oxide biosynthetic process	GO:005099; GO:000005; GO:000307; GO:000652; GO:000726; GO:000828; GO:004311; GO:190003; GO:004576; GO:004542	cytosol;extracellular exosome	GO:000582; GO:007006	"NA"	"NA"	catalytic activity;dimethylargininase activity;metal ion binding;amino acid binding	GO:000382; GO:001640; GO:004687; GO:001659
XP_020946052.1;XP_020946051.1;XP_020946050.1;XP_020946049.1;XP_020946048.1;XP_020946047.1;XP_020946046.1;XP_020946045.1;XP_020946044.1;XP_020946037.1;XP_020946043.1;XP_020946035.1;XP_020946042.1;XP_020946041.1;XP_020946040.1;XP_020946034.1;XP_020946039.1;XP_020946033.1;XP_020946038.1;XP_020946036.1;XP_020946024.1;XP_020946023.1;XP_020946022.1;XP_020946032.1;XP_020946031.1;XP_020946030.1;XP_020946029.1;XP_020946028.1;XP_020946027.1;XP_020946026.1	XP_020946052.1;XP_020946051.1;XP_020946050.1;XP_020946049.1;XP_020946048.1;XP_020946047.1;XP_020946046.1;XP_020946045.1;XP_020946044.1;XP_020946037.1;XP_020946043.1;XP_020946035.1;XP_020946042.1;XP_020946041.1;XP_020946040.1;XP_020946034.1;XP_020946039.1;XP_020946033.1;XP_020946038.1;XP_020946036.1;XP_020946024.1;XP_020946023.1;XP_020946022.1;XP_020946032.1;XP_020946031.1;XP_020946030.1;XP_020946029.1;XP_020946028.1;XP_020946027.1;XP_020946026.1	XP_020946052.1 plectin isoform X29 [Sus scrofa];XP_020946051.1 plectin isoform X28 [Sus scrofa];XP_020946050.1 plectin isoform X27 [Sus scrofa];XP_020946049.1 plectin isoform X26 [Sus scrofa];XP_020946048.1 plectin isoform X25 [Sus scrofa];XP_020946047.1 p	163	163	161	638480000	1421500000	1006700000	1195400000	777410000	1602300000	1043300000	1297200000	817530000	1265400000	1238000000	1681700000	1592200000	1207200000	1053100000	1245300000	1363000000	1412400000	NA	NA	NA	PLEC	PLEC;PLEC;PLEC;PLEC;PLEC	wound healing;intermediate filament cytoskeleton organization;hemidesmosome assembly	GO:004206; GO:004510; GO:003158	extracellular exosome;cytosol;sarcoplasm;costamere;cytoplasm;sarcolemma;intermediate filament;brush border;membrane;hemidesmosome;intermediate filament cytoskeleton;perinuclear region of cytoplasm;focal adhesion	GO:007006; GO:000582; GO:001652; GO:004303; GO:000573; GO:004238; GO:000588; GO:000590; GO:001602; GO:003005; GO:004511; GO:004847; GO:000592	"NA"	"NA"	actin binding;protein binding;RNA binding;structural constituent of muscle;ankyrin binding;structural constituent of cytoskeleton;structural molecule activity;cadherin binding	GO:000377; GO:000551; GO:000372; GO:000830; GO:003050; GO:000520; GO:000519; GO:004529
XP_020946053.1	XP_020946053.1	XP_020946053.1 LOW QUALITY PROTEIN: epiplakin [Sus scrofa]	11	9	9	0	0	0	0	14192000	0	23157000	27789000	0	0	20075000	0	14549000	0	19708000	22602000	21901000	0	NA	NA	NA	EPPK1	EPPK1;NA;NA;NA;NA	wound healing;negative regulation of keratinocyte migration;regulation of epithelium regeneration;intermediate filament organization;negative regulation of wound healing;negative regulation of cell migration;negative regulation of epithelial cell proliferation;negative regulation of keratinocyte proliferation;intermediate filament bundle assembly	GO:004206; GO:005154; GO:190504; GO:004510; GO:006104; GO:003033; GO:005068; GO:001083; GO:004511	hemidesmosome;keratin filament;cytoplasm;intermediate filament;apicolateral plasma membrane;cell projection;membrane;cytoskeleton;cell periphery;bicellular tight junction;perinucleolar compartment	GO:003005; GO:004509; GO:000573; GO:000588; GO:001632; GO:004299; GO:001602; GO:000585; GO:007194; GO:000592; GO:009735	"NA"	"NA"	structural molecule activity;RNA binding;intermediate filament binding;cytoskeletal protein binding;keratin filament binding	GO:000519; GO:000372; GO:001921; GO:000809; GO:199025
XP_020946096.1;XP_020946104.1;XP_020946095.1;XP_020946103.1;XP_020946102.1;XP_020946101.1;XP_020946100.1;XP_020946099.1;XP_020946098.1;XP_020946097.1	XP_020946096.1;XP_020946104.1;XP_020946095.1;XP_020946103.1;XP_020946102.1;XP_020946101.1;XP_020946100.1;XP_020946099.1;XP_020946098.1;XP_020946097.1	XP_020946096.1 poly(U)-binding-splicing factor PUF60 isoform X2 [Sus scrofa];XP_020946104.1 poly(U)-binding-splicing factor PUF60 isoform X10 [Sus scrofa];XP_020946095.1 poly(U)-binding-splicing factor PUF60 isoform X1 [Sus scrofa];XP_020946103.1 poly(U)-b	3	3	3	0	0	0	0	0	0	0	0	0	8073600	0	0	0	0	0	0	0	0	NA	NA	NA	PUF60	PUF60;PUF60;PUF60;PUF60;PUF60	apoptotic process;mRNA splicing, via spliceosome	GO:000691; GO:000039	nucleoplasm;cell junction	GO:000565; GO:003005	 Spliceosome	hsa0304	DNA binding;RNA binding;identical protein binding;cadherin binding;protein binding	GO:000367; GO:000372; GO:004280; GO:004529; GO:000551
XP_020946119.1;XP_020946118.1;XP_020946117.1	XP_020946119.1;XP_020946118.1;XP_020946117.1	XP_020946119.1 elongation factor 1-delta isoform X2 [Sus scrofa];XP_020946118.1 elongation factor 1-delta isoform X2 [Sus scrofa];XP_020946117.1 elongation factor 1-delta isoform X1 [Sus scrofa]	7	7	7	223850000	214840000	227330000	157000000	229870000	232560000	216500000	177190000	162920000	173640000	267200000	258720000	251840000	186100000	217690000	196590000	210470000	216120000	NA	NA	NA	EEF1D	EEF1D;EEF1D;EEF1D;NA;NA	translational elongation;positive regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to ionizing radiation	GO:000641; GO:004312; GO:007147	nucleus;eukaryotic translation elongation factor 1 complex;endoplasmic reticulum;cytoplasm;fibrillar center;cytosol	GO:000563; GO:000585; GO:000578; GO:000573; GO:000165; GO:000582	 Herpes simplex infection	hsa0516	protein binding;DNA binding;translation elongation factor activity;translation factor activity, RNA binding;cadherin binding	GO:000551; GO:000367; GO:000374; GO:000813; GO:004529
XP_020946125.1;XP_020946124.1	XP_020946125.1;XP_020946124.1	XP_020946125.1 nicotinate phosphoribosyltransferase isoform X2 [Sus scrofa];XP_020946124.1 nicotinate phosphoribosyltransferase isoform X1 [Sus scrofa]	15	15	15	92600000	95521000	74811000	109400000	95784000	66838000	94849000	103060000	90856000	79456000	108300000	111460000	80490000	91851000	87001000	106720000	106420000	94112000	NA	NA	NA	NAPRT	NAPRT;NAPRT;NA;NA;NA	NAD biosynthetic process;neutrophil degranulation;NAD biosynthesis via nicotinamide riboside salvage pathway;response to oxidative stress;nicotinate nucleotide salvage	GO:000943; GO:004331; GO:003435; GO:000697; GO:001935	azurophil granule lumen;extracellular exosome;cytosol;extracellular region	GO:003557; GO:007006; GO:000582; GO:000557	 Metabolic pathways; Nicotinate and nicotinamide metabolism	hsa0110; hsa0076	nicotinate phosphoribosyltransferase activity;protein binding;nicotinate-nucleotide diphosphorylase (carboxylating) activity;metal ion binding	GO:000451; GO:000551; GO:000451; GO:004687
XP_020946130.1;XP_020946128.1;XP_020946127.1;XP_020946126.1	XP_020946130.1;XP_020946128.1;XP_020946127.1;XP_020946126.1	XP_020946130.1 mitogen-activated protein kinase 15 isoform X4 [Sus scrofa];XP_020946128.1 mitogen-activated protein kinase 15 isoform X3 [Sus scrofa];XP_020946127.1 mitogen-activated protein kinase 15 isoform X2 [Sus scrofa];XP_020946126.1 mitogen-activate	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60786000	NA	NA	NA	MAPK15	MAPK15;MAPK15;MAPK15;MAPK15;NA	MAPK cascade;endoplasmic reticulum organization;regulation of cilium assembly;regulation of gene expression;regulation of autophagy;positive regulation of telomere capping;intracellular signal transduction;positive regulation of telomerase activity;positive regulation of spindle assembly;regulation of COPII vesicle coating;cellular response to DNA damage stimulus;positive regulation of cell proliferation;negative regulation of cell migration;protein autophosphorylation;positive regulation of telomere maintenance via telomerase;protein localization to ciliary transition zone;dopamine uptake;positive regulation of metaphase/anaphase transition of meiosis I	GO:000016; GO:000702; GO:190201; GO:001046; GO:001050; GO:190435; GO:003555; GO:005197; GO:190583; GO:000340; GO:000697; GO:000828; GO:003033; GO:004677; GO:003221; GO:190449; GO:009049; GO:190518	cytoplasm;autophagosome;axoneme;ciliary basal body;extracellular region;centriole;cell-cell junction;nucleus;cytoplasmic vesicle;Golgi apparatus;bicellular tight junction;meiotic spindle	GO:000573; GO:000577; GO:000593; GO:003606; GO:000557; GO:000581; GO:000591; GO:000563; GO:003141; GO:000579; GO:000592; GO:007268	"NA"	"NA"	ATP binding;chromatin binding;protein binding;SH3 domain binding;protein kinase activity;MAP kinase activity;kinase activity	GO:000552; GO:000368; GO:000551; GO:001712; GO:000467; GO:000470; GO:001630
XP_020946189.1;XP_020946188.1;XP_020946186.1;XP_020946190.1;XP_020946187.1	XP_020946189.1;XP_020946188.1;XP_020946186.1;XP_020946190.1;XP_020946187.1	XP_020946189.1 GDP-L-fucose synthase isoform X1 [Sus scrofa];XP_020946188.1 GDP-L-fucose synthase isoform X1 [Sus scrofa];XP_020946186.1 GDP-L-fucose synthase isoform X1 [Sus scrofa];XP_020946190.1 GDP-L-fucose synthase isoform X2 [Sus scrofa];XP_020946187	4	4	4	18588000	17035000	19808000	0	16121000	0	0	17428000	19363000	15834000	16385000	0	0	17069000	0	20215000	0	0	NA	NA	NA	TSTA3	TSTA3;TSTA3;TSTA3;TSTA3;TSTA3	'de novo' GDP-L-fucose biosynthetic process;GDP-mannose metabolic process;T cell mediated cytotoxicity;leukocyte cell-cell adhesion;electron transport chain	GO:004235; GO:001967; GO:000191; GO:000715; GO:002290	extracellular exosome;cytosol	GO:007006; GO:000582	 Amino sugar and nucleotide sugar metabolism; Fructose and mannose metabolism; Metabolic pathways	hsa0052; hsa0005; hsa0110	isomerase activity;identical protein binding;GDP-mannose 3,5-epimerase activity;GDP-4-dehydro-D-rhamnose reductase activity;electron carrier activity;GDP-L-fucose synthase activity;coenzyme binding	GO:001685; GO:004280; GO:004791; GO:004235; GO:000905; GO:005057; GO:005066
XP_020946202.1	XP_020946202.1	XP_020946202.1 pyrroline-5-carboxylate reductase 3 [Sus scrofa]	4	4	4	37858000	44935000	43579000	34385000	40328000	32722000	55157000	37856000	44420000	33571000	55569000	43856000	53435000	57806000	68292000	42777000	54923000	44253000	NA	NA	NA	PYCR3	PYCR3;NA;NA;NA;NA	L-proline biosynthetic process;oxidation-reduction process;cellular amino acid biosynthetic process	GO:005512; GO:005511; GO:000865	cytosol	GO:000582	 Metabolic pathways; Arginine and proline metabolism; Biosynthesis of amino acids; Biosynthesis of antibiotics	hsa0110; hsa0033; hsa0123; hsa0113	pyrroline-5-carboxylate reductase activity;protein binding	GO:000473; GO:000551
XP_020946208.1	XP_020946208.1	XP_020946208.1 maestro heat-like repeat family member 5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	63680000	NA	NA	NA	MROH5	MROH5;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020946444.1;XP_020946445.1	XP_020946444.1;XP_020946445.1	XP_020946444.1 sorting nexin-3 isoform X1 [Sus scrofa];XP_020946445.1 sorting nexin-3 isoform X2 [Sus scrofa]	6	5	5	28986000	61162000	36288000	56112000	40823000	52762000	32559000	50036000	31344000	50911000	34734000	60596000	37550000	44774000	39114000	47391000	34673000	63983000	NA	NA	NA	SNX3	SNX3;SNX3;NA;NA;NA	Wnt signaling pathway;positive regulation of neuron projection development;negative regulation of early endosome to late endosome transport;negative regulation of protein catabolic process;protein transport;protein to membrane docking;intralumenal vesicle formation;membrane invagination;protein deubiquitination;regulation of Wnt signaling pathway;negative regulation of viral entry into host cell;negative regulation of phagocytosis;response to bacterium;negative regulation of protein transport	GO:001605; GO:001097; GO:200064; GO:004217; GO:001503; GO:002261; GO:007067; GO:001032; GO:001657; GO:003011; GO:004659; GO:005076; GO:000961; GO:005122	cytoplasm;retromer complex;early endosome;cytosol;endosome membrane;early endosome membrane;clathrin-coated vesicle;early phagosome;extracellular exosome	GO:000573; GO:003090; GO:000576; GO:000582; GO:001000; GO:003190; GO:003013; GO:003200; GO:007006	 Endocytosis	hsa0414	phosphatidylinositol-3,5-bisphosphate binding;protein binding;protein phosphatase binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol-4-phosphate binding;phosphatidylinositol-5-phosphate binding	GO:008002; GO:000551; GO:001990; GO:003226; GO:007027; GO:001031
XP_020946779.1;XP_020946782.1;XP_020946781.1;XP_020946780.1;NP_999141.1	XP_020946779.1;XP_020946782.1;XP_020946781.1;XP_020946780.1;NP_999141.1	XP_020946779.1 scavenger receptor cysteine-rich type 1 protein M130 isoform X1 [Sus scrofa];XP_020946782.1 scavenger receptor cysteine-rich type 1 protein M130 isoform X4 [Sus scrofa];XP_020946781.1 scavenger receptor cysteine-rich type 1 protein M130 isof	10	10	10	0	32624000	0	26374000	0	35624000	0	30365000	0	0	0	0	35547000	34932000	34089000	31722000	0	37804000	NA	NA	NA	CD163	CD163;CD163;CD163;CD163;CD163	receptor-mediated endocytosis;acute-phase response	GO:000689; GO:000695	plasma membrane;external side of plasma membrane;endocytic vesicle membrane;integral component of plasma membrane;extracellular region	GO:000588; GO:000989; GO:003066; GO:000588; GO:000557	"NA"	"NA"	protein binding;scavenger receptor activity	GO:000551; GO:000504
XP_020946855.1;NP_001233150.1	XP_020946855.1;NP_001233150.1	XP_020946855.1 von Willebrand factor isoform X1 [Sus scrofa];NP_001233150.1 von Willebrand factor precursor [Sus scrofa]	43	43	43	229380000	312720000	230670000	212820000	188660000	282170000	197630000	266960000	218290000	219500000	236060000	325750000	246100000	329720000	234670000	283330000	224620000	230110000	NA	NA	NA	VWF	VWF;VWF;NA;NA;NA	platelet degranulation;blood coagulation;platelet activation;cell-substrate adhesion;extracellular matrix organization;protein homooligomerization;response to wounding;cell adhesion	GO:000257; GO:000759; GO:003016; GO:003158; GO:003019; GO:005126; GO:000961; GO:000715	platelet alpha granule lumen;extracellular region;endoplasmic reticulum;platelet alpha granule;Weibel-Palade body;extracellular exosome	GO:003109; GO:000557; GO:000578; GO:003109; GO:003309; GO:007006	 ECM-receptor interaction; Complement and coagulation cascades; Focal adhesion; PI3K-Akt signaling pathway	hsa0451; hsa0461; hsa0451; hsa0415	protease binding;protein binding;immunoglobulin binding;extracellular matrix structural constituent;protein homodimerization activity;integrin binding;chaperone binding;protein N-terminus binding	GO:000202; GO:000551; GO:001986; GO:000520; GO:004280; GO:000517; GO:005108; GO:004748
XP_020946870.1;XP_020946869.1;XP_020946868.1;XP_020946867.1;XP_020946866.1;XP_020946865.1;XP_020946864.1;NP_001038015.1	XP_020946870.1;XP_020946869.1;XP_020946868.1;XP_020946867.1;XP_020946866.1;XP_020946865.1;XP_020946864.1;NP_001038015.1	XP_020946870.1 ATP-dependent 6-phosphofructokinase, muscle type isoform X3 [Sus scrofa];XP_020946869.1 ATP-dependent 6-phosphofructokinase, muscle type isoform X3 [Sus scrofa];XP_020946868.1 ATP-dependent 6-phosphofructokinase, muscle type isoform X3 [Sus	15	14	14	21393000	18599000	21251000	0	0	8325900	11730000	14462000	0	22649000	14021000	0	24632000	8878500	0	9745500	366770000	14232000	NA	NA	NA	PFKM	PFKM;PFKM;PFKM;PFKM;PFKM	glucose homeostasis;glycolytic process through fructose-6-phosphate;glycogen catabolic process;fructose 6-phosphate metabolic process;fructose 1,6-bisphosphate metabolic process;carbohydrate phosphorylation;glycolysis from storage polysaccharide through glucose-1-phosphate;muscle cell cellular homeostasis;protein oligomerization;glycolytic process;positive regulation of insulin secretion;positive regulation of transcription from RNA polymerase II promoter;canonical glycolysis	GO:004259; GO:006161; GO:000598; GO:000600; GO:003038; GO:004683; GO:009300; GO:004671; GO:005125; GO:000609; GO:003202; GO:004594; GO:006162	cytosol;sperm principal piece;nucleus;apical plasma membrane;6-phosphofructokinase complex	GO:000582; GO:009722; GO:000563; GO:001632; GO:000594	 Biosynthesis of antibiotics; Carbon metabolism; Pentose phosphate pathway; Fructose and mannose metabolism; Biosynthesis of amino acids; AMPK signaling pathway; Metabolic pathways; Glycolysis / Gluconeogenesis; Central carbon metabolism in cancer; RNA degradation	hsa0113; hsa0120; hsa0003; hsa0005; hsa0123; hsa0415; hsa0110; hsa0001; hsa0523; hsa0301	kinase binding;ATP binding;monosaccharide binding;fructose-6-phosphate binding;protein binding;AMP binding;metal ion binding;protein C-terminus binding;6-phosphofructokinase activity;identical protein binding;fructose binding	GO:001990; GO:000552; GO:004802; GO:007009; GO:000551; GO:001620; GO:004687; GO:000802; GO:000387; GO:004280; GO:007006
XP_020946876.1	XP_020946876.1	XP_020946876.1 LOW QUALITY PROTEIN: methyltransferase-like protein 7A [Sus scrofa]	4	4	1	0	0	0	0	44207000	68384000	40166000	0	0	0	41397000	0	31566000	52888000	35321000	0	45852000	40945000	NA	NA	NA	LOC110260568	LOC110260568;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020946892.1	XP_020946892.1	XP_020946892.1 LOW QUALITY PROTEIN: integrin alpha-7 [Sus scrofa]	35	35	35	1069600000	1569900000	1187500000	1472100000	893810000	1029900000	1139800000	1431000000	1010400000	1268300000	1110500000	1588200000	648200000	1420800000	1244700000	1755000000	979340000	1254100000	NA	NA	NA	ITGA7	ITGA7;NA;NA;NA;NA	integrin-mediated signaling pathway;muscle organ development;regulation of cell shape;extracellular matrix organization;heterotypic cell-cell adhesion;endodermal cell differentiation;cell-matrix adhesion	GO:000722; GO:000751; GO:000836; GO:003019; GO:003411; GO:003598; GO:000716	plasma membrane;cell surface;integrin complex	GO:000588; GO:000998; GO:000830	 Focal adhesion; Dilated cardiomyopathy; PI3K-Akt signaling pathway; ECM-receptor interaction; Regulation of actin cytoskeleton	hsa0451; hsa0541; hsa0415; hsa0451; hsa0481	metal ion binding;protein binding	GO:004687; GO:000551
XP_020946919.1	XP_020946919.1	XP_020946919.1 LOW QUALITY PROTEIN: early endosome antigen 1 [Sus scrofa]	7	7	7	0	0	8430600	0	0	0	0	7894800	0	10113000	0	0	9867000	9571000	0	8551800	0	0	NA	NA	NA	EEA1	EEA1;NA;NA;NA;NA	synaptic vesicle to endosome fusion;endocytosis;vesicle fusion;viral RNA genome replication;early endosome to late endosome transport	GO:001618; GO:000689; GO:000690; GO:003969; GO:004502	serine-pyruvate aminotransferase complex;recycling endosome;membrane;extracellular exosome;presynapse;early endosome;cytoplasm;axonal spine;cytosol;extrinsic component of plasma membrane;early endosome membrane	GO:000596; GO:005503; GO:001602; GO:007006; GO:009879; GO:000576; GO:000573; GO:004430; GO:000582; GO:001989; GO:003190	 Tuberculosis; Endocytosis	hsa0515; hsa0414	1-phosphatidylinositol binding;zinc ion binding;GTP-dependent protein binding;nucleic acid binding;protein binding;protein homodimerization activity	GO:000554; GO:000827; GO:003074; GO:000367; GO:000551; GO:004280
XP_020946968.1;XP_020946967.1;XP_020946966.1;XP_020946964.1;XP_020946963.1;XP_020946962.1;XP_020946961.1;XP_020946960.1;XP_020946959.1;XP_020946958.1;XP_020946957.1;XP_020946956.1;XP_020946955.1;XP_020946954.1;XP_020946953.1;XP_020946952.1;XP_020946951.1;XP_020946950.1;XP_020946949.1;XP_020946948.1;XP_020946947.1;XP_020946946.1;XP_020946945.1;XP_020946943.1;XP_020946942.1;XP_020946941.1;XP_020946940.1;XP_020946939.1;XP_020946938.1;XP_020946937.1;XP_020946936.1	XP_020946968.1;XP_020946967.1;XP_020946966.1;XP_020946964.1;XP_020946963.1;XP_020946962.1;XP_020946961.1;XP_020946960.1;XP_020946959.1;XP_020946958.1;XP_020946957.1;XP_020946956.1;XP_020946955.1;XP_020946954.1;XP_020946953.1;XP_020946952.1;XP_020946951.1;XP_020946950.1;XP_020946949.1;XP_020946948.1;XP_020946947.1;XP_020946946.1;XP_020946945.1;XP_020946943.1;XP_020946942.1;XP_020946941.1;XP_020946940.1;XP_020946939.1;XP_020946938.1;XP_020946937.1;XP_020946936.1	XP_020946968.1 plexin-B2 isoform X4 [Sus scrofa];XP_020946967.1 plexin-B2 isoform X4 [Sus scrofa];XP_020946966.1 plexin-B2 isoform X4 [Sus scrofa];XP_020946964.1 plexin-B2 isoform X4 [Sus scrofa];XP_020946963.1 plexin-B2 isoform X4 [Sus scrofa];XP_02094696	6	6	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10292000	0	0	NA	NA	NA	PLXNB2	PLXNB2;PLXNB2;PLXNB2;PLXNB2;PLXNB2	brain development;regulation of GTPase activity;neuroblast proliferation;regulation of cell migration;semaphorin-plexin signaling pathway involved in axon guidance;negative regulation of cell adhesion;semaphorin-plexin signaling pathway;regulation of neuron migration;homophilic cell adhesion via plasma membrane adhesion molecules;neural tube closure;regulation of cell shape;regulation of protein phosphorylation;positive regulation of neuron projection development;positive regulation of axonogenesis	GO:000742; GO:004308; GO:000740; GO:003033; GO:190228; GO:000716; GO:007152; GO:200122; GO:000715; GO:000184; GO:000836; GO:000193; GO:001097; GO:005077	semaphorin receptor complex;extracellular exosome;cell surface;integral component of plasma membrane	GO:000211; GO:007006; GO:000998; GO:000588	 Axon guidance	hsa0436	protein binding;semaphorin receptor activity	GO:000551; GO:001715
XP_020947061.1	XP_020947061.1	XP_020947061.1 LOW QUALITY PROTEIN: beta-parvin [Sus scrofa]	6	5	5	19065000	27413000	0	23521000	0	19035000	0	0	0	33420000	18868000	0	0	27034000	13109000	25970000	0	16270000	NA	NA	NA	PARVB	PARVB;NA;NA;NA;NA	lamellipodium assembly;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity regulating cell shape;establishment or maintenance of cell polarity;cell projection assembly;actin cytoskeleton reorganization	GO:003003; GO:003444; GO:007196; GO:000716; GO:003003; GO:003153	focal adhesion;lamellipodium;Z disc;plasma membrane;cytosol;cytoplasm;actin cytoskeleton	GO:000592; GO:003002; GO:003001; GO:000588; GO:000582; GO:000573; GO:001562	 Focal adhesion	hsa0451	protein binding;actin binding	GO:000551; GO:000377
XP_020947081.1;XP_020947080.1;XP_020947079.1;XP_020947083.1;XP_020947082.1	XP_020947081.1;XP_020947080.1;XP_020947079.1;XP_020947083.1;XP_020947082.1	XP_020947081.1 protein kinase C and casein kinase substrate in neurons protein 2 isoform X1 [Sus scrofa];XP_020947080.1 protein kinase C and casein kinase substrate in neurons protein 2 isoform X1 [Sus scrofa];XP_020947079.1 protein kinase C and casein kin	11	11	11	47151000	64066000	51144000	53087000	56418000	56653000	51351000	56714000	63624000	45910000	62107000	96269000	74523000	52272000	60002000	62842000	60545000	45939000	NA	NA	NA	PACSIN2	PACSIN2;PACSIN2;PACSIN2;PACSIN2;PACSIN2	modulation of synaptic transmission;cytoskeleton organization;protein localization to endosome;cell projection morphogenesis;negative regulation of endocytosis;membrane organization;plasma membrane tubulation;caveola assembly;actin cytoskeleton organization;caveolin-mediated endocytosis	GO:005080; GO:000701; GO:003601; GO:004885; GO:004580; GO:006102; GO:009732; GO:007083; GO:003003; GO:007258	plasma membrane;caveola;focal adhesion;nuclear speck;ruffle membrane;extracellular exosome;intracellular membrane-bounded organelle;cell-cell junction;cytosol;early endosome;glutamatergic synapse;cytoplasm;cytoskeleton;recycling endosome membrane;extrinsic component of membrane;cytoplasmic vesicle membrane	GO:000588; GO:000590; GO:000592; GO:001660; GO:003258; GO:007006; GO:004323; GO:000591; GO:000582; GO:000576; GO:009897; GO:000573; GO:000585; GO:005503; GO:001989; GO:003065	"NA"	"NA"	protein binding;cadherin binding;cytoskeletal protein binding;phospholipid binding;phosphatidic acid binding;identical protein binding;transporter activity	GO:000551; GO:004529; GO:000809; GO:000554; GO:007030; GO:004280; GO:000521
XP_020947120.1	XP_020947120.1	XP_020947120.1 LOW QUALITY PROTEIN: ran GTPase-activating protein 1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RANGAP1	RANGAP1;NA;NA;NA;NA	response to axon injury;negative regulation of protein export from nucleus;activation of GTPase activity;cellular response to vasopressin;signal transduction	GO:004867; GO:004682; GO:009063; GO:190411; GO:000716	condensed chromosome kinetochore;nuclear envelope;dendrite;perinuclear region of cytoplasm;mitotic spindle;cytoplasmic periphery of the nuclear pore complex;nuclear pore cytoplasmic filaments;kinetochore;cytosol;nuclear pore;nuclear membrane;axon cytoplasm;cytoplasm;intracellular membrane-bounded organelle;aggresome;nucleoplasm	GO:000077; GO:000563; GO:003042; GO:004847; GO:007268; GO:199072; GO:004461; GO:000077; GO:000582; GO:000564; GO:003196; GO:190411; GO:000573; GO:004323; GO:001623; GO:000565	 RNA transport	hsa0301	RNA binding;GTPase activator activity;ubiquitin protein ligase binding;protein binding;cadherin binding;Ran GTPase binding	GO:000372; GO:000509; GO:003162; GO:000551; GO:004529; GO:000853
XP_020947146.1;XP_020922421.1;XP_020922420.1;XP_020922419.1;XP_020922417.1	XP_020947146.1	XP_020947146.1 probable ATP-dependent RNA helicase DDX17, partial [Sus scrofa]	13	13	13	48309000	74993000	66310000	71296000	58065000	81507000	64204000	70442000	62420000	65806000	80058000	79070000	85173000	84551000	72563000	67280000	71272000	56167000	NA	NA	NA	DDX17	DDX17;NA;NA;NA;NA	alternative mRNA splicing, via spliceosome;RNA processing;intracellular estrogen receptor signaling pathway;myoblast differentiation;miRNA metabolic process;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription from RNA polymerase II promoter;epithelial to mesenchymal transition;defense response to virus;regulation of alternative mRNA splicing, via spliceosome;gene silencing by RNA;rRNA processing;regulation of skeletal muscle cell differentiation	GO:000038; GO:000639; GO:003052; GO:004544; GO:001058; GO:004594; GO:000635; GO:000183; GO:005160; GO:000038; GO:003104; GO:000636; GO:200101	nuclear speck;nucleoplasm;membrane;cytosol;nucleus;nucleolus	GO:001660; GO:000565; GO:001602; GO:000582; GO:000563; GO:000573	"NA"	"NA"	RNA-dependent ATPase activity;transcription coactivator activity;RNA helicase activity;protein binding;ATP binding	GO:000818; GO:000371; GO:000372; GO:000551; GO:000552
XP_020947160.1	XP_020947160.1	XP_020947160.1 myristoylated alanine-rich C-kinase substrate [Sus scrofa]	4	4	4	15790000	94638000	57544000	85552000	39081000	165830000	48311000	98909000	53291000	73272000	39297000	40707000	68589000	160410000	60613000	61998000	65180000	79673000	NA	NA	NA	MARCKS	MARCKS;NA;NA;NA;NA	actin filament bundle assembly;actin crosslink formation;protein homooligomerization	GO:005101; GO:005176; GO:005126	centrosome;actin cytoskeleton;actin filament bundle;plasma membrane;focal adhesion;cell cortex;germinal vesicle;extracellular exosome	GO:000581; GO:001562; GO:003243; GO:000588; GO:000592; GO:000593; GO:004258; GO:007006	 MicroRNAs in cancer; Fc gamma R-mediated phagocytosis	hsa0520; hsa0466	identical protein binding;protein kinase C binding;calmodulin binding;actin filament binding	GO:004280; GO:000508; GO:000551; GO:005101
XP_020947167.1;XP_020947166.1;XP_020947165.1;XP_020947164.1	XP_020947167.1;XP_020947166.1;XP_020947165.1;XP_020947164.1	XP_020947167.1 ADP-ribosylation factor-binding protein GGA1 isoform X2 [Sus scrofa];XP_020947166.1 ADP-ribosylation factor-binding protein GGA1 isoform X2 [Sus scrofa];XP_020947165.1 ADP-ribosylation factor-binding protein GGA1 isoform X2 [Sus scrofa];XP_0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	2559400	0	0	0	0	0	0	NA	NA	NA	GGA1	GGA1;GGA1;GGA1;GGA1;NA	protein localization to cell surface;toxin transport;positive regulation of protein catabolic process;retrograde transport, endosome to Golgi;Golgi to plasma membrane protein transport;protein localization to ciliary membrane;protein localization;intracellular protein transport;cellular protein metabolic process	GO:003439; GO:190199; GO:004573; GO:004214; GO:004300; GO:190344; GO:000810; GO:000688; GO:004426	membrane;cytosol;macromolecular complex;early endosome membrane;Golgi apparatus;endosome membrane;nucleoplasm;intracellular membrane-bounded organelle;early endosome	GO:001602; GO:000582; GO:003299; GO:003190; GO:000579; GO:001000; GO:000565; GO:004323; GO:000576	 Lysosome	hsa0414	protein binding;protein heterodimerization activity;molecular_function;ADP-ribosylation factor binding	GO:000551; GO:004698; GO:000367; GO:003030
XP_020947197.1;REV__XP_013833673.1;REV__XP_020954903.1;REV__XP_020954902.1;REV__XP_020954901.1;REV__XP_020954900.1;REV__XP_013833674.2	XP_020947197.1	XP_020947197.1 LOW QUALITY PROTEIN: myosin-9 [Sus scrofa]	115	104	94	2167300000	3111700000	2308700000	3195200000	2532800000	3213700000	2070700000	4170700000	2179300000	2547800000	2664700000	3476800000	3623400000	4043900000	2774000000	2858800000	2226700000	3086800000	NA	NA	NA	MYH9	MYH9;NA;NA;NA;NA	in utero embryonic development;myoblast fusion;actomyosin structure organization;leukocyte migration;positive regulation of protein processing in phagocytic vesicle;platelet formation;actin cytoskeleton reorganization;cytokinetic process;regulation of cell shape;actin filament-based movement;protein transport;establishment of meiotic spindle localization;platelet aggregation;negative regulation of actin filament severing;meiotic spindle organization;uropod organization;blood vessel endothelial cell migration;angiogenesis;establishment of T cell polarity;membrane protein ectodomain proteolysis;phagocytosis, engulfment;integrin-mediated signaling pathway	GO:000170; GO:000752; GO:003103; GO:005090; GO:190392; GO:003022; GO:003153; GO:003250; GO:000836; GO:003004; GO:001503; GO:005129; GO:007052; GO:190391; GO:000021; GO:003279; GO:004353; GO:000152; GO:000176; GO:000650; GO:000691; GO:000722	spindle;brush border;COP9 signalosome;extracellular exosome;membrane;actomyosin;myosin II filament;plasma membrane;nucleus;cleavage furrow;ruffle;immunological synapse;cell-cell adherens junction;cytosol;myosin II complex;neuromuscular junction;macromolecular complex;uropod;cytoplasm;cell leading edge;focal adhesion;actin cytoskeleton	GO:000581; GO:000590; GO:000818; GO:007006; GO:001602; GO:004264; GO:009751; GO:000588; GO:000563; GO:003215; GO:000172; GO:000177; GO:000591; GO:000582; GO:001646; GO:003159; GO:003299; GO:000193; GO:000573; GO:003125; GO:000592; GO:001562	 Regulation of actin cytoskeleton; Tight junction; Salmonella infection	hsa0481; hsa0453; hsa0513	protein binding;motor activity;actin filament binding;actin-dependent ATPase activity;protein homodimerization activity;ADP binding;microfilament motor activity;integrin binding;calmodulin binding;ATPase activity;protein anchor;RNA binding;ATP binding;protein domain specific binding;cadherin binding	GO:000551; GO:000377; GO:005101; GO:003089; GO:004280; GO:004353; GO:000014; GO:000517; GO:000551; GO:001688; GO:004349; GO:000372; GO:000552; GO:001990; GO:004529
XP_020947354.1	XP_020947354.1	XP_020947354.1 LOW QUALITY PROTEIN: tensin-2 [Sus scrofa]	7	5	5	0	0	57760000	0	0	0	0	0	63041000	0	0	0	0	0	0	0	0	0	NA	NA	NA	TNS2	TNS2;NA;NA;NA;NA	negative regulation of cell proliferation;multicellular organismal homeostasis;protein dephosphorylation;intracellular signal transduction;response to muscle activity;cellular homeostasis;kidney development;multicellular organism growth;collagen metabolic process	GO:000828; GO:004887; GO:000647; GO:003555; GO:001485; GO:001972; GO:000182; GO:003526; GO:003296	focal adhesion;plasma membrane	GO:000592; GO:000588	"NA"	"NA"	protein binding;phosphoprotein phosphatase activity;kinase binding;metal ion binding	GO:000551; GO:000472; GO:001990; GO:004687
XP_020947363.1;XP_020947362.1;XP_020947361.1;XP_020947360.1;XP_020947359.1;XP_020947366.1;XP_020947365.1;XP_020947364.1;XP_013841140.1;XP_005669383.3;XP_020927153.1	XP_020947363.1;XP_020947362.1;XP_020947361.1;XP_020947360.1;XP_020947359.1;XP_020947366.1;XP_020947365.1;XP_020947364.1;XP_013841140.1	XP_020947363.1 cysteine sulfinic acid decarboxylase isoform X5 [Sus scrofa];XP_020947362.1 cysteine sulfinic acid decarboxylase isoform X4 [Sus scrofa];XP_020947361.1 cysteine sulfinic acid decarboxylase isoform X3 [Sus scrofa];XP_020947360.1 cysteine sulf	15	15	15	153620000	96454000	111880000	92285000	116460000	72555000	117510000	106470000	169630000	98329000	140520000	98781000	87885000	98198000	140120000	144470000	125700000	96044000	NA	NA	NA	CSAD	CSAD;CSAD;CSAD;CSAD;CSAD	taurine biosynthetic process;L-cysteine catabolic process to hypotaurine;L-cysteine catabolic process to taurine	GO:004241; GO:001944; GO:001945	cytoplasm	GO:000573	 Taurine and hypotaurine metabolism; Metabolic pathways	hsa0043; hsa0110	aspartate 1-decarboxylase activity;pyridoxal phosphate binding;sulfinoalanine decarboxylase activity	GO:000406; GO:003017; GO:000478
XP_020947456.1;XP_020947455.1;XP_020947454.1	XP_020947456.1;XP_020947455.1;XP_020947454.1	XP_020947456.1 ras-related protein Rab-5B [Sus scrofa];XP_020947455.1 ras-related protein Rab-5B [Sus scrofa];XP_020947454.1 ras-related protein Rab-5B [Sus scrofa]	8	8	5	195560000	212630000	204070000	232480000	182670000	177370000	206710000	202870000	210470000	208150000	216380000	219940000	190770000	235680000	199140000	231300000	213120000	252120000	NA	NA	NA	RAB5B	RAB5B;RAB5B;RAB5B;NA;NA	Rab protein signal transduction;endocytosis;intracellular protein transport;regulation of endocytosis;endosome organization;antigen processing and presentation;neutrophil degranulation;plasma membrane to endosome transport	GO:003248; GO:000689; GO:000688; GO:003010; GO:000703; GO:001988; GO:004331; GO:004822	endosome;early endosome;intracellular membrane-bounded organelle;secretory granule membrane;melanosome;endocytic vesicle;extracellular exosome;early endosome membrane;plasma membrane;anchored component of synaptic vesicle membrane;membrane	GO:000576; GO:000576; GO:004323; GO:003066; GO:004247; GO:003013; GO:007006; GO:003190; GO:000588; GO:009899; GO:001602	 Ras signaling pathway; Amoebiasis; Tuberculosis; Endocytosis; Vasopressin-regulated water reabsorption	hsa0401; hsa0514; hsa0515; hsa0414; hsa0496	protein binding;GTPase activity;GDP binding;GTP-dependent protein binding;GTP binding	GO:000551; GO:000392; GO:001900; GO:003074; GO:000552
XP_020947485.1	XP_020947485.1	XP_020947485.1 LOW QUALITY PROTEIN: prolow-density lipoprotein receptor-related protein 1 [Sus scrofa]	54	54	54	240140000	417450000	285800000	405950000	254400000	442190000	330640000	354840000	306140000	369460000	341540000	502380000	417000000	428400000	368690000	367660000	343040000	493860000	NA	NA	NA	LRP1	LRP1;NA;NA;NA;NA	astrocyte activation involved in immune response;positive regulation of cell death;positive regulation of endocytosis;positive regulation of axon extension involved in regeneration;positive regulation of protein localization to plasma membrane;negative regulation of platelet-derived growth factor receptor-beta signaling pathway;positive regulation of cholesterol efflux;negative regulation of smooth muscle cell migration;receptor internalization;positive regulation of lipid transport;regulation of phospholipase A2 activity;regulation of actin cytoskeleton organization;cellular lipid catabolic process;positive regulation of phagocytosis;positive regulation of chemokine (C-C motif) ligand 2 secretion;cerebral cortex development;lipoprotein metabolic process;negative regulation of neuron apoptotic process;negative regulation of cytosolic calcium ion concentration;positive regulation of ERK1 and ERK2 cascade;positive regulation of Schwann cell migration;positive regulation of beta-amyloid clearance;cellular response to beta-amyloid;retinoid metabolic process;lipid metabolic process;protein kinase C-activating G-protein coupled receptor signaling pathway;regulation of extracellular matrix disassembly;aorta morphogenesis;phagocytosis;aging;negative regulation of neuron projection development;receptor-mediated endocytosis;transcytosis;negative regulation of Wnt signaling pathway;negative regulation of focal adhesion assembly;beta-amyloid clearance;positive regulation of lysosomal protein catabolic process;positive regulation of insulin secretion involved in cellular response to glucose stimulus;lipoprotein transport;apoptotic cell clearance;chemoattraction of axon;positive regulation of cholesterol import;positive regulation of vascular associated smooth muscle cell migration;cell proliferation;positive regulation of protein binding	GO:000226; GO:001094; GO:004580; GO:004869; GO:190307; GO:200058; GO:001087; GO:001491; GO:003162; GO:003237; GO:003242; GO:003295; GO:004424; GO:005076; GO:190420; GO:002198; GO:004215; GO:004352; GO:005148; GO:007037; GO:190014; GO:190022; GO:190464; GO:000152; GO:000662; GO:000720; GO:001071; GO:003590; GO:000690; GO:000756; GO:001097; GO:000689; GO:004505; GO:003017; GO:005189; GO:009724; GO:190516; GO:003577; GO:004295; GO:004327; GO:006164; GO:190410; GO:190475; GO:000828; GO:003209	focal adhesion;receptor complex;nucleus;lysosomal membrane;insulin-responsive compartment;neuronal cell body;axonal growth cone;plasma membrane protein complex;endocytic vesicle membrane;dendrite;plasma membrane;membrane;basolateral plasma membrane;apical part of cell;clathrin-coated pit;clathrin-coated vesicle	GO:000592; GO:004323; GO:000563; GO:000576; GO:003259; GO:004302; GO:004429; GO:009879; GO:003066; GO:003042; GO:000588; GO:001602; GO:001632; GO:004517; GO:000590; GO:003013	 Malaria; Alzheimer's disease	hsa0514; hsa0501	signaling receptor activity;alpha-2 macroglobulin receptor activity;apolipoprotein binding;beta-amyloid binding;coreceptor activity;lipoprotein transporter activity;macromolecular complex binding;protease binding;clathrin heavy chain binding;protein binding;low-density lipoprotein receptor activity;RNA binding;apolipoprotein receptor activity;cargo receptor activity;lipoprotein particle receptor binding;calcium ion binding;heparan sulfate proteoglycan binding	GO:003802; GO:001696; GO:003418; GO:000154; GO:001502; GO:004295; GO:004487; GO:000202; GO:003205; GO:000551; GO:000504; GO:000372; GO:003022; GO:003802; GO:007032; GO:000550; GO:004339
XP_020947486.1	XP_020947486.1	XP_020947486.1 LOW QUALITY PROTEIN: serine hydroxymethyltransferase, mitochondrial [Sus scrofa]	12	12	11	129010000	85307000	99432000	72304000	128310000	63875000	131150000	110060000	118480000	87530000	102280000	88841000	62776000	82929000	102350000	89435000	78843000	89069000	NA	NA	NA	SHMT2	SHMT2;NA;NA;NA;NA	L-serine biosynthetic process;glycine biosynthetic process from serine;tetrahydrofolate interconversion;glycine metabolic process;response to type I interferon;folic acid metabolic process;regulation of aerobic respiration;L-serine metabolic process;positive regulation of cell proliferation;protein tetramerization;one-carbon metabolic process;regulation of mitochondrial translation;protein K63-linked deubiquitination;cellular response to tetrahydrofolate;regulation of oxidative phosphorylation;protein homotetramerization	GO:000656; GO:001926; GO:003599; GO:000654; GO:003434; GO:004665; GO:190371; GO:000656; GO:000828; GO:005126; GO:000673; GO:007012; GO:007053; GO:190448; GO:000208; GO:005128	mitochondrion;cytoplasm;mitochondrial intermembrane space;nucleus;mitochondrial inner membrane;microtubule cytoskeleton;extracellular exosome;mitochondrial nucleoid;BRISC complex	GO:000573; GO:000573; GO:000575; GO:000563; GO:000574; GO:001563; GO:007006; GO:004264; GO:007055	 One carbon pool by folate; Metabolic pathways; Carbon metabolism; Cyanoamino acid metabolism; Biosynthesis of amino acids; Biosynthesis of antibiotics; Glycine, serine and threonine metabolism; Glyoxylate and dicarboxylate metabolism	hsa0067; hsa0110; hsa0120; hsa0046; hsa0123; hsa0113; hsa0026; hsa0063	protein binding;chromatin binding;L-allo-threonine aldolase activity;amino acid binding;pyridoxal phosphate binding;cobalt ion binding;serine binding;zinc ion binding;identical protein binding;glycine hydroxymethyltransferase activity	GO:000551; GO:000368; GO:000873; GO:001659; GO:003017; GO:005089; GO:007090; GO:000827; GO:004280; GO:000437
XP_020947526.1;XP_020947525.1	XP_020947526.1;XP_020947525.1	XP_020947526.1 methionine--tRNA ligase, cytoplasmic isoform X2 [Sus scrofa];XP_020947525.1 methionine--tRNA ligase, cytoplasmic isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	25257000	0	0	0	0	0	0	0	0	NA	NA	NA	MARS	MARS;MARS;NA;NA;NA	methionyl-tRNA aminoacylation;cellular response to platelet-derived growth factor stimulus;tRNA aminoacylation for protein translation;cellular response to starvation;cellular response to insulin stimulus;rRNA transcription;cellular response to epidermal growth factor stimulus;positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	GO:000643; GO:003612; GO:000641; GO:000926; GO:003286; GO:000930; GO:007136; GO:190183	nucleolus;cytosol;aminoacyl-tRNA synthetase multienzyme complex;extracellular exosome;membrane;cytoplasm	GO:000573; GO:000582; GO:001710; GO:007006; GO:001602; GO:000573	 Selenocompound metabolism; Aminoacyl-tRNA biosynthesis	hsa0045; hsa0097	ATP binding;tRNA binding;methionine-tRNA ligase activity	GO:000552; GO:000004; GO:000482
XP_020947540.1;XP_020947539.1;XP_020947538.1	XP_020947540.1;XP_020947539.1;XP_020947538.1	XP_020947540.1 dynactin subunit 2 isoform X3 [Sus scrofa];XP_020947539.1 dynactin subunit 2 isoform X2 [Sus scrofa];XP_020947538.1 dynactin subunit 2 isoform X1 [Sus scrofa]	14	14	14	259610000	277650000	260470000	207440000	217110000	224940000	250390000	245810000	229180000	219470000	266190000	266350000	277010000	248450000	254370000	219990000	239550000	234020000	NA	NA	NA	DCTN2	DCTN2;DCTN2;DCTN2;NA;NA	protein localization to centrosome;mitotic cell cycle;ER to Golgi vesicle-mediated transport;mitotic spindle organization;melanosome transport;regulation of G2/M transition of mitotic cell cycle;ciliary basal body docking;cell proliferation;G2/M transition of mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class II	GO:007153; GO:000027; GO:000688; GO:000705; GO:003240; GO:001038; GO:009771; GO:000828; GO:000008; GO:001988	membrane;extracellular exosome;centrosome;microtubule;dynein complex;dynactin complex;growth cone;kinetochore;cytosol;cytoplasm;vesicle	GO:001602; GO:007006; GO:000581; GO:000587; GO:003028; GO:000586; GO:003042; GO:000077; GO:000582; GO:000573; GO:003198	 Vasopressin-regulated water reabsorption; Huntington's disease	hsa0496; hsa0501	identical protein binding;protein kinase binding;spectrin binding;protein binding;motor activity	GO:004280; GO:001990; GO:003050; GO:000551; GO:000377
XP_020947557.1	XP_020947557.1	XP_020947557.1 elongation factor Ts, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6933100	0	NA	NA	NA	TSFM	TSFM;NA;NA;NA;NA	translational elongation;regulation of DNA-templated transcription, elongation;mitochondrial translational elongation	GO:000641; GO:003278; GO:007012	mitochondrion;nucleus;mitochondrial matrix	GO:000573; GO:000563; GO:000575	"NA"	"NA"	translation elongation factor activity;RNA binding;protein binding	GO:000374; GO:000372; GO:000551
XP_020947606.1	XP_020947606.1	XP_020947606.1 N-acetylglucosamine-6-sulfatase [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3488100	NA	NA	NA	GNS	GNS;NA;NA;NA;NA	neutrophil degranulation;keratan sulfate catabolic process;glycosaminoglycan catabolic process	GO:004331; GO:004234; GO:000602	lysosome;extracellular region;extracellular exosome;azurophil granule lumen;lysosomal lumen;ficolin-1-rich granule lumen	GO:000576; GO:000557; GO:007006; GO:003557; GO:004320; GO:190481	 Glycosaminoglycan degradation; Metabolic pathways; Lysosome	hsa0053; hsa0110; hsa0414	N-acetylglucosamine-6-sulfatase activity;sulfuric ester hydrolase activity;protein binding;glycosaminoglycan binding;metal ion binding	GO:000844; GO:000848; GO:000551; GO:000553; GO:004687
XP_020947616.1;XP_020947615.1	XP_020947616.1;XP_020947615.1	XP_020947616.1 methionine-R-sulfoxide reductase B3 isoform X2 [Sus scrofa];XP_020947615.1 methionine-R-sulfoxide reductase B3 isoform X2 [Sus scrofa]	3	3	1	0	0	0	0	0	0	0	0	0	0	0	23228000	0	0	0	14508000	0	0	NA	NA	NA	MSRB3	MSRB3;MSRB3;NA;NA;NA	protein repair;cellular response to oxidative stress;oxidation-reduction process	GO:003009; GO:003459; GO:005511	mitochondrion;cytosol;endoplasmic reticulum	GO:000573; GO:000582; GO:000578	"NA"	"NA"	zinc ion binding;L-methionine-(R)-S-oxide reductase activity;protein binding	GO:000827; GO:003374; GO:000551
XP_020947629.1;XP_020947628.1	XP_020947629.1;XP_020947628.1	XP_020947629.1 nuclear pore complex protein Nup107 isoform X2 [Sus scrofa];XP_020947628.1 nuclear pore complex protein Nup107 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17955000	NA	NA	NA	NUP107	NUP107;NUP107;NA;NA;NA	protein import into nucleus;mRNA export from nucleus;female gonad development;nuclear pore complex assembly;posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery;viral process	GO:000660; GO:000640; GO:000858; GO:005129; GO:000097; GO:001603	kinetochore;membrane;nuclear membrane;nuclear pore outer ring;nuclear periphery;condensed chromosome kinetochore;nuclear pore;cytosol;nuclear envelope	GO:000077; GO:001602; GO:003196; GO:003108; GO:003439; GO:000077; GO:000564; GO:000582; GO:000563	 RNA transport	hsa0301	protein binding;structural constituent of nuclear pore	GO:000551; GO:001705
XP_020947723.1;XP_020947722.1;XP_020947721.1;XP_020947720.1;XP_020947719.1;XP_020947717.1;XP_020947716.1;XP_020947715.1	XP_020947723.1;XP_020947722.1;XP_020947721.1;XP_020947720.1;XP_020947719.1;XP_020947717.1;XP_020947716.1;XP_020947715.1	XP_020947723.1 dynamin-1-like protein isoform X8 [Sus scrofa];XP_020947722.1 dynamin-1-like protein isoform X7 [Sus scrofa];XP_020947721.1 dynamin-1-like protein isoform X6 [Sus scrofa];XP_020947720.1 dynamin-1-like protein isoform X5 [Sus scrofa];XP_02094	7	7	7	0	4029700	8836500	0	5046600	0	3604900	0	5884600	3897800	0	0	0	0	0	4493000	0	0	NA	NA	NA	DNM1L	DNM1L;DNM1L;DNM1L;DNM1L;DNM1L	regulation of protein oligomerization;positive regulation of GTPase activity;mitochondrial fragmentation involved in apoptotic process;protein localization to mitochondrion;release of cytochrome c from mitochondria;regulation of mitochondrion organization;cellular response to oxygen-glucose deprivation;positive regulation of intrinsic apoptotic signaling pathway;endoplasmic reticulum organization;membrane fusion;necroptotic process;response to flavonoid;peroxisome fission;intracellular distribution of mitochondria;positive regulation of mitochondrial fission;regulation of ATP metabolic process;cellular response to thapsigargin;dynamin family protein polymerization involved in mitochondrial fission;apoptotic mitochondrial changes;synaptic vesicle recycling via endosome;protein homotetramerization;positive regulation of dendritic spine morphogenesis;positive regulation of synaptic vesicle endocytosis;mitochondrion organization;negative regulation of mitochondrial fusion;synaptic vesicle endocytosis;response to hypobaric hypoxia;positive regulation of synaptic vesicle exocytosis;heart contraction;mitochondrial fission;positive regulation of apoptotic process;positive regulation of protein secretion;protein oligomerization;positive regulation of release of cytochrome c from mitochondria;execution phase of apoptosis;regulation of peroxisome organization;regulation of mitophagy	GO:003245; GO:004354; GO:004365; GO:007058; GO:000183; GO:001082; GO:009065; GO:200124; GO:000702; GO:006102; GO:007026; GO:190539; GO:001655; GO:004831; GO:009014; GO:190357; GO:190457; GO:000337; GO:000863; GO:003646; GO:005128; GO:006100; GO:190024; GO:000700; GO:001063; GO:004848; GO:199091; GO:200030; GO:006004; GO:000026; GO:004306; GO:005071; GO:005125; GO:009020; GO:009719; GO:190006; GO:190314	mitochondrion;peroxisome;mitochondrial outer membrane;Golgi apparatus;macromolecular complex;membrane;microtubule;cytoplasm;endoplasmic reticulum membrane;postsynapse;brush border;mitochondrion-derived vesicle;Golgi membrane;cytosol;synaptic vesicle membrane;perinuclear region of cytoplasm;presynaptic endocytic zone membrane;intracellular membrane-bounded organelle;cell junction;mitochondrial membrane	GO:000573; GO:000577; GO:000574; GO:000579; GO:003299; GO:001602; GO:000587; GO:000573; GO:000578; GO:009879; GO:000590; GO:009907; GO:000013; GO:000582; GO:003067; GO:004847; GO:009883; GO:004323; GO:003005; GO:003196	 TNF signaling pathway	hsa0466	clathrin binding;protein binding;GTPase activity;GTPase activator activity;lipid binding;ubiquitin protein ligase binding;GTP binding;GTP-dependent protein binding;macromolecular complex binding;microtubule binding;protein homodimerization activity;Rab GTPase binding;BH2 domain binding	GO:003027; GO:000551; GO:000392; GO:000509; GO:000828; GO:003162; GO:000552; GO:003074; GO:004487; GO:000801; GO:004280; GO:001713; GO:005143
XP_020948034.1	XP_020948034.1	XP_020948034.1 LOW QUALITY PROTEIN: pregnancy zone protein [Sus scrofa]	48	48	47	2310900000	1070600000	1129600000	1368400000	1939800000	1435300000	2412900000	1180600000	2237400000	1130800000	1549500000	662470000	2094100000	1446400000	2606600000	1028700000	1843500000	735370000	NA	NA	NA	PZP	PZP;NA;NA;NA;NA	female pregnancy;negative regulation of endopeptidase activity	GO:000756; GO:001095	extracellular exosome;extracellular region;blood microparticle	GO:007006; GO:000557; GO:007256	"NA"	"NA"	serine-type endopeptidase inhibitor activity;endopeptidase inhibitor activity	GO:000486; GO:000486
XP_020948055.1;XP_020948054.1	XP_020948055.1;XP_020948054.1	XP_020948055.1 adaptin ear-binding coat-associated protein 1 isoform X2 [Sus scrofa];XP_020948054.1 adaptin ear-binding coat-associated protein 1 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1562900	NA	NA	NA	NECAP1	NECAP1;NECAP1;NA;NA;NA	endocytosis;protein transport;membrane organization	GO:000689; GO:001503; GO:006102	clathrin vesicle coat;clathrin-coated pit;plasma membrane;cytosol	GO:003012; GO:000590; GO:000588; GO:000582	"NA"	"NA"	"NA"	"NA"
XP_020948067.1	XP_020948067.1	XP_020948067.1 complement C1r subcomponent [Sus scrofa]	8	8	8	0	0	0	0	0	10378000	0	0	0	0	0	16098000	0	0	0	0	0	0	NA	NA	NA	C1R	C1R;NA;NA;NA;NA	innate immune response;immune response;regulation of complement activation;zymogen activation	GO:004508; GO:000695; GO:003044; GO:003163	extracellular region;extracellular exosome;blood microparticle;extracellular space	GO:000557; GO:007006; GO:007256; GO:000561	 Phagosome; Systemic lupus erythematosus; Staphylococcus aureus infection; Complement and coagulation cascades; Pertussis	hsa0414; hsa0532; hsa0515; hsa0461; hsa0513	protein binding;serine-type peptidase activity;serine-type endopeptidase activity;calcium ion binding	GO:000551; GO:000823; GO:000425; GO:000550
XP_020948160.1	XP_020948160.1	XP_020948160.1 LOW QUALITY PROTEIN: cat eye syndrome critical region protein 5 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	3857500	0	0	0	0	0	0	0	0	0	NA	NA	NA	HDHD5	HDHD5;NA;NA;NA;NA	glycerophospholipid biosynthetic process	GO:004647	mitochondrion	GO:000573	"NA"	"NA"	"NA"	"NA"
XP_020948284.1	XP_020948284.1	XP_020948284.1 LOW QUALITY PROTEIN: WASH complex subunit 4 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1288500	0	NA	NA	NA	WASHC4	WASHC4;NA;NA;NA;NA	protein transport;endosome organization;endosomal transport	GO:001503; GO:000703; GO:001619	endosome;BLOC-1 complex;WASH complex;nucleoplasm;early endosome	GO:000576; GO:003108; GO:007120; GO:000565; GO:000576	 Endocytosis	hsa0414	"NA"	"NA"
XP_020948368.1;XP_020948359.1;XP_020948351.1;XP_020948344.1	XP_020948368.1;XP_020948359.1;XP_020948351.1;XP_020948344.1	XP_020948368.1 katanin p60 ATPase-containing subunit A-like 2 isoform X4 [Sus scrofa];XP_020948359.1 katanin p60 ATPase-containing subunit A-like 2 isoform X3 [Sus scrofa];XP_020948351.1 katanin p60 ATPase-containing subunit A-like 2 isoform X2 [Sus scrofa	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50993000	0	0	NA	NA	NA	KATNAL2	KATNAL2;KATNAL2;KATNAL2;KATNAL2;NA	cytoplasmic microtubule organization;microtubule severing	GO:003112; GO:005101	nucleus;microtubule;spindle;cytoplasm;spindle pole	GO:000563; GO:000587; GO:000581; GO:000573; GO:000092	"NA"	"NA"	microtubule-severing ATPase activity;isomerase activity;protein binding;ATPase activity;ATP binding;microtubule binding	GO:000856; GO:001685; GO:000551; GO:001688; GO:000552; GO:000801
XP_020948470.1	XP_020948470.1	XP_020948470.1 LOW QUALITY PROTEIN: protein phosphatase 1 regulatory subunit 12A [Sus scrofa]	4	4	3	0	0	93921000	0	0	0	0	189730000	0	0	0	206870000	0	0	0	0	0	0	NA	NA	NA	PPP1R12A	PPP1R12A;NA;NA;NA;NA	negative regulation of catalytic activity;centrosome cycle;regulation of cell adhesion;positive regulation of myosin-light-chain-phosphatase activity;cellular response to drug;regulation of nucleocytoplasmic transport;positive regulation of transcription from RNA polymerase II promoter;regulation of establishment of endothelial barrier;mitotic cell cycle;protein dephosphorylation;signal transduction	GO:004308; GO:000709; GO:003015; GO:003550; GO:003569; GO:004682; GO:004594; GO:190314; GO:000027; GO:000647; GO:000716	contractile fiber;cytoplasm;centrosome;focal adhesion;Z disc;actin cytoskeleton;A band;nucleoplasm;PTW/PP1 phosphatase complex;kinetochore;cytosol	GO:004329; GO:000573; GO:000581; GO:000592; GO:003001; GO:001562; GO:003167; GO:000565; GO:007235; GO:000077; GO:000582	 cGMP-PKG signaling pathway; Proteoglycans in cancer; Oxytocin signaling pathway; Regulation of actin cytoskeleton; Platelet activation; Vascular smooth muscle contraction; Focal adhesion; cAMP signaling pathway	hsa0402; hsa0520; hsa0492; hsa0481; hsa0461; hsa0427; hsa0451; hsa0402	14-3-3 protein binding;protein kinase binding;protein binding;enzyme inhibitor activity;phosphatase regulator activity	GO:007188; GO:001990; GO:000551; GO:000485; GO:001920
XP_020948471.1	XP_020948471.1	XP_020948471.1 LOW QUALITY PROTEIN: PRKC apoptosis WT1 regulator protein [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	PAWR	PAWR;NA;NA;NA;NA	negative regulation of B cell proliferation;positive regulation of apoptotic process;positive regulation of hydrogen peroxide-mediated programmed cell death;negative regulation of transcription from RNA polymerase II promoter;apoptotic signaling pathway;interleukin-2 biosynthetic process;apoptotic process;positive regulation of gene expression;positive regulation of amyloid precursor protein biosynthetic process;negative regulation of fibroblast proliferation;actin filament bundle assembly;negative regulation of T cell proliferation;negative regulation of T cell receptor signaling pathway;positive regulation of cellular senescence	GO:003088; GO:004306; GO:190130; GO:000012; GO:009719; GO:004209; GO:000691; GO:001062; GO:004298; GO:004814; GO:005101; GO:004213; GO:005086; GO:200077	nucleus;nuclear chromatin;actin filament;cytoplasm	GO:000563; GO:000079; GO:000588; GO:000573	"NA"	"NA"	protein binding;actin binding;leucine zipper domain binding;enzyme binding;transcription corepressor activity	GO:000551; GO:000377; GO:004352; GO:001989; GO:000371
XP_020948473.1;XP_020948472.1;XP_003481816.2	XP_020948473.1	XP_020948473.1 cysteine and glycine-rich protein 2 isoform X2 [Sus scrofa]	5	5	5	0	0	58413000	0	0	0	0	0	0	82790000	0	0	304980000	0	0	0	0	0	NA	NA	NA	CSRP2	CSRP2;NA;NA;NA;NA	cell differentiation;multicellular organism development	GO:003015; GO:000727	focal adhesion;nucleus	GO:000592; GO:000563	"NA"	"NA"	protein binding;molecular_function;metal ion binding	GO:000551; GO:000367; GO:004687
XP_020948643.1	XP_020948643.1	XP_020948643.1 LOW QUALITY PROTEIN: interleukin-17 receptor A [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	5466300	0	0	0	0	0	NA	NA	NA	IL17RA	IL17RA;NA;NA;NA;NA	granulocyte chemotaxis;positive regulation of interleukin-5 secretion;positive regulation of interleukin-23 production;fibroblast activation;cell surface receptor signaling pathway;interleukin-17-mediated signaling pathway;defense response to fungus;positive regulation of cytokine production involved in inflammatory response	GO:007162; GO:200066; GO:003274; GO:007253; GO:000716; GO:009740; GO:005083; GO:190001	plasma membrane;extracellular region;integral component of plasma membrane	GO:000588; GO:000557; GO:000588	 Cytokine-cytokine receptor interaction	hsa0406	receptor binding;interleukin-17 receptor activity;protein binding	GO:000510; GO:003036; GO:000551
XP_020948755.1	XP_020948755.1	XP_020948755.1 tubulin--tyrosine ligase-like protein 12 [Sus scrofa]	13	13	13	31114000	33790000	33276000	47542000	49035000	41082000	38290000	34148000	30933000	41280000	41976000	50568000	47686000	38235000	30678000	43681000	44389000	48561000	NA	NA	NA	TTLL12	TTLL12;NA;NA;NA;NA	cellular protein modification process	GO:000646	"NA"	"NA"	"NA"	"NA"	ATP binding	GO:000552
XP_020948951.1;XP_020948944.1	XP_020948951.1;XP_020948944.1	XP_020948951.1 NAD-dependent malic enzyme, mitochondrial [Sus scrofa];XP_020948944.1 NAD-dependent malic enzyme, mitochondrial [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	2883400	0	0	0	0	0	NA	NA	NA	ME2	ME2;ME2;NA;NA;NA	pyruvate metabolic process;tricarboxylic acid cycle;regulation of NADP metabolic process;malate metabolic process;electron transport chain	GO:000609; GO:000609; GO:190203; GO:000610; GO:002290	mitochondrion;mitochondrial matrix	GO:000573; GO:000575	 Pyruvate metabolism; Carbon metabolism	hsa0062; hsa0120	NAD binding;electron carrier activity;malate dehydrogenase (decarboxylating) (NAD+) activity;oxaloacetate decarboxylase activity;metal ion binding	GO:005128; GO:000905; GO:000447; GO:000894; GO:004687
XP_020949000.1;NP_001231011.1	XP_020949000.1;NP_001231011.1	XP_020949000.1 enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X1 [Sus scrofa];NP_001231011.1 trans-2-enoyl-CoA reductase, mitochondrial [Sus scrofa]	3	3	2	0	0	18293000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MECR	MECR;MECR;NA;NA;NA	fatty acid beta-oxidation;fatty acid biosynthetic process	GO:000663; GO:000663	mitochondrion;nucleus;mitochondrial matrix	GO:000573; GO:000563; GO:000575	 Fatty acid elongation; Metabolic pathways; Fatty acid metabolism	hsa0006; hsa0110; hsa0121	trans-2-enoyl-CoA reductase (NADPH) activity	GO:001916
XP_020949081.1;XP_020949080.1;NP_001230546.1;XP_020949083.1;XP_020949082.1	XP_020949081.1;XP_020949080.1;NP_001230546.1;XP_020949083.1;XP_020949082.1	XP_020949081.1 mitochondrial enolase superfamily member 1 isoform X2 [Sus scrofa];XP_020949080.1 mitochondrial enolase superfamily member 1 isoform X1 [Sus scrofa];NP_001230546.1 mitochondrial enolase superfamily member 1 [Sus scrofa];XP_020949083.1 mitoch	9	9	9	52913000	68035000	47575000	72273000	67491000	73192000	60147000	67303000	55135000	67174000	63449000	74347000	40118000	69663000	72191000	87108000	49164000	64072000	NA	NA	NA	ENOSF1	ENOSF1;ENOSF1;ENOSF1;ENOSF1;ENOSF1	cellular carbohydrate catabolic process;cellular amino acid catabolic process	GO:004427; GO:000906	cellular_component;mitochondrion	GO:000557; GO:000573	 Fructose and mannose metabolism	hsa0005	isomerase activity;magnesium ion binding;L-fuconate dehydratase activity	GO:001685; GO:000028; GO:005002
XP_020949157.1;XP_020949156.1;XP_020949154.1;NP_999055.1;XP_020949153.1	XP_020949157.1;XP_020949156.1;XP_020949154.1;NP_999055.1;XP_020949153.1	XP_020949157.1 alcohol dehydrogenase [NADP(+)] isoform X2 [Sus scrofa];XP_020949156.1 alcohol dehydrogenase [NADP(+)] isoform X2 [Sus scrofa];XP_020949154.1 alcohol dehydrogenase [NADP(+)] isoform X2 [Sus scrofa];NP_999055.1 alcohol dehydrogenase [NADP(+)]	19	19	19	352070000	456390000	419220000	507090000	390410000	523520000	490630000	475040000	386730000	442180000	414270000	665180000	661630000	681950000	516020000	489640000	424350000	484820000	NA	NA	NA	AKR1A1	AKR1A1;AKR1A1;AKR1A1;AKR1A1;AKR1A1	glucuronate catabolic process to xylulose 5-phosphate;aldehyde catabolic process;glucose metabolic process;cellular aldehyde metabolic process;D-glucuronate catabolic process;electron transport chain;L-ascorbic acid biosynthetic process;glutathione derivative biosynthetic process	GO:001964; GO:004618; GO:000600; GO:000608; GO:004284; GO:002290; GO:001985; GO:190168	cytosol;apical plasma membrane;extracellular exosome;extracellular space;synapse	GO:000582; GO:001632; GO:007006; GO:000561; GO:004520	 Glycolysis / Gluconeogenesis; Biosynthesis of antibiotics; Glycerolipid metabolism; Pentose and glucuronate interconversions; Metabolic pathways; Degradation of aromatic compounds	hsa0001; hsa0113; hsa0056; hsa0004; hsa0110; hsa0122	alcohol dehydrogenase (NADP+) activity;alditol:NADP+ 1-oxidoreductase activity;electron carrier activity;oxidoreductase activity;protein binding;L-glucuronate reductase activity;glucuronolactone reductase activity	GO:000810; GO:000403; GO:000905; GO:001649; GO:000551; GO:004793; GO:004794
XP_020949202.1;XP_020949201.1;XP_020949200.1	XP_020949202.1;XP_020949201.1;XP_020949200.1	XP_020949202.1 creatine kinase M-type isoform X1 [Sus scrofa];XP_020949201.1 creatine kinase M-type isoform X1 [Sus scrofa];XP_020949200.1 creatine kinase M-type isoform X1 [Sus scrofa]	13	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8105800	0	NA	NA	NA	CKM	CKM;CKM;CKM;NA;NA	phosphocreatine biosynthetic process;creatine metabolic process;phosphorylation	GO:004631; GO:000660; GO:001631	cytosol;extracellular space	GO:000582; GO:000561	 Metabolic pathways; Arginine and proline metabolism	hsa0110; hsa0033	ATP binding;protein binding;creatine kinase activity	GO:000552; GO:000551; GO:000411
XP_020949216.1;XP_020949221.1;XP_020949219.1;XP_020949218.1;XP_020949217.1;XP_020949222.1	XP_020949216.1;XP_020949221.1;XP_020949219.1;XP_020949218.1;XP_020949217.1;XP_020949222.1	XP_020949216.1 liver carboxylesterase isoform X1 [Sus scrofa];XP_020949221.1 liver carboxylesterase isoform X5 [Sus scrofa];XP_020949219.1 liver carboxylesterase isoform X4 [Sus scrofa];XP_020949218.1 liver carboxylesterase isoform X3 [Sus scrofa];XP_02094	22	22	4	1407300000	735270000	1010200000	782510000	1424200000	554730000	2576100000	1401100000	2052200000	1084500000	0	0	953800000	591710000	2007300000	1053900000	0	0	NA	NA	NA	CES1	CES1;CES1;CES1;CES1;CES1	medium-chain fatty acid metabolic process;epithelial cell differentiation;xenobiotic metabolic process;cholesterol ester hydrolysis involved in cholesterol transport;cholesterol biosynthetic process;lipid catabolic process;response to toxic substance	GO:005179; GO:003085; GO:000680; GO:009012; GO:000669; GO:001604; GO:000963	endoplasmic reticulum;extracellular space;endoplasmic reticulum lumen;cytosol	GO:000578; GO:000561; GO:000578; GO:000582	 Drug metabolism - other enzymes; Metabolic pathways	hsa0098; hsa0110	triglyceride lipase activity;carboxylic ester hydrolase activity;methyl indole-3-acetate esterase activity;methylumbelliferyl-acetate deacetylase activity;sterol esterase activity	GO:000480; GO:005268; GO:008003; GO:004737; GO:000477
XP_020949232.1;XP_020949230.1	XP_020949232.1;XP_020949230.1	XP_020949232.1 phosphoglucomutase-1 isoform X2 [Sus scrofa];XP_020949230.1 phosphoglucomutase-1 isoform X1 [Sus scrofa]	27	27	3	795420000	883070000	792060000	806780000	599810000	662820000	757400000	760930000	764440000	743780000	767800000	669950000	541700000	808200000	745960000	713190000	1608000000	703120000	NA	NA	NA	PGM1	PGM1;PGM1;NA;NA;NA	glycogen biosynthetic process;galactose catabolic process;glucose metabolic process;glycogen catabolic process;gluconeogenesis;neutrophil degranulation	GO:000597; GO:001938; GO:000600; GO:000598; GO:000609; GO:004331	actin cytoskeleton;extracellular region;cytosol;ficolin-1-rich granule lumen;tertiary granule lumen;cytoplasm;extracellular exosome	GO:001562; GO:000557; GO:000582; GO:190481; GO:190472; GO:000573; GO:007006	 Metabolic pathways; Pentose phosphate pathway; Galactose metabolism; Purine metabolism; Starch and sucrose metabolism; Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis; Amino sugar and nucleotide sugar metabolism	hsa0110; hsa0003; hsa0005; hsa0023; hsa0050; hsa0113; hsa0001; hsa0052	protein binding;phosphoglucomutase activity;magnesium ion binding	GO:000551; GO:000461; GO:000028
XP_020949233.1;XP_013844056.1;XP_013844055.1;NP_999480.2;XP_013844054.2	XP_020949233.1;XP_013844056.1;XP_013844055.1;NP_999480.2;XP_013844054.2	XP_020949233.1 hormone-sensitive lipase isoform X2 [Sus scrofa];XP_013844056.1 hormone-sensitive lipase isoform X3 [Sus scrofa];XP_013844055.1 hormone-sensitive lipase isoform X3 [Sus scrofa];NP_999480.2 hormone-sensitive lipase [Sus scrofa];XP_013844054.2	39	39	39	1857700000	1220500000	2020000000	1321100000	1640500000	903650000	1476700000	1193600000	1802400000	1126000000	1290900000	1404400000	707240000	1313800000	1709900000	1532000000	1238100000	1021400000	NA	NA	NA	LIPE	LIPE;LIPE;LIPE;LIPE;LIPE	lipid catabolic process;cholesterol metabolic process;protein phosphorylation;triglyceride catabolic process;diacylglycerol catabolic process;long-chain fatty acid catabolic process	GO:001604; GO:000820; GO:000646; GO:001943; GO:004634; GO:004275	lipid particle;cytosol;caveola	GO:000581; GO:000582; GO:000590	 Regulation of lipolysis in adipocytes; AMPK signaling pathway; Aldosterone synthesis and secretion; cAMP signaling pathway; Insulin signaling pathway	hsa0492; hsa0415; hsa0492; hsa0402; hsa0491	protein binding;serine hydrolase activity;protein kinase binding;triglyceride lipase activity;hormone-sensitive lipase activity	GO:000551; GO:001717; GO:001990; GO:000480; GO:003387
XP_020949365.1;XP_020949364.1	XP_020949365.1;XP_020949364.1	XP_020949365.1 cytochrome c oxidase subunit 4 isoform 1, mitochondrial [Sus scrofa];XP_020949364.1 cytochrome c oxidase subunit 4 isoform 1, mitochondrial [Sus scrofa]	6	6	6	211680000	155240000	178920000	121380000	193590000	92971000	245730000	131590000	204010000	114940000	147380000	145950000	0	106230000	199090000	132510000	116380000	105610000	NA	NA	NA	LOC100624067	LOC100624067;LOC100624067;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020949384.1;XP_020949383.1	XP_020949384.1;XP_020949383.1	XP_020949384.1 ubiquitin carboxyl-terminal hydrolase 10 isoform X2 [Sus scrofa];XP_020949383.1 ubiquitin carboxyl-terminal hydrolase 10 isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	200840000	0	0	0	0	0	0	NA	NA	NA	USP10	USP10;USP10;NA;NA;NA	DNA damage response, signal transduction by p53 class mediator;negative regulation of I-kappaB kinase/NF-kappaB signaling;ubiquitin-dependent protein catabolic process;regulation of autophagy;protein deubiquitination;translesion synthesis;autophagy;cellular response to interleukin-1;cellular response to DNA damage stimulus	GO:003033; GO:004312; GO:000651; GO:001050; GO:001657; GO:001998; GO:000691; GO:007134; GO:000697	early endosome;cytosol;cytoplasm;macromolecular complex;nucleus;nucleoplasm	GO:000576; GO:000582; GO:000573; GO:003299; GO:000563; GO:000565	"NA"	"NA"	p53 binding;RNA binding;protein binding;thiol-dependent ubiquitin-specific protease activity;cysteine-type endopeptidase activity;thiol-dependent ubiquitinyl hydrolase activity;ion channel binding	GO:000203; GO:000372; GO:000551; GO:000484; GO:000419; GO:003645; GO:004432
XP_020949443.1	XP_020949443.1	XP_020949443.1 probable D-lactate dehydrogenase, mitochondrial [Sus scrofa]	4	4	4	11627000	0	10218000	0	13838000	0	0	0	11491000	0	0	0	0	0	0	0	0	0	NA	NA	NA	LDHD	LDHD;NA;NA;NA;NA	lactate catabolic process;oxidation-reduction process	GO:190345; GO:005511	mitochondrion;mitochondrial inner membrane	GO:000573; GO:000574	 Pyruvate metabolism	hsa0062	FAD binding;D-lactate dehydrogenase (cytochrome) activity;D-lactate dehydrogenase activity;protein binding;flavin adenine dinucleotide binding	GO:007194; GO:000445; GO:000872; GO:000551; GO:005066
XP_020949450.1	XP_020949450.1	XP_020949450.1 LOW QUALITY PROTEIN: alanine--tRNA ligase, cytoplasmic [Sus scrofa]	11	11	11	0	35774000	33965000	34999000	34254000	39367000	28323000	30218000	32647000	41400000	29313000	43446000	27371000	32899000	29502000	44284000	28896000	36493000	NA	NA	NA	AARS	AARS;NA;NA;NA;NA	neuromuscular process controlling balance;tRNA modification;tRNA processing;tRNA aminoacylation for protein translation;cerebellar Purkinje cell layer development;negative regulation of neuron apoptotic process	GO:005088; GO:000640; GO:000803; GO:000641; GO:002168; GO:004352	cytosol;cytoplasm;extracellular exosome;membrane	GO:000582; GO:000573; GO:007006; GO:001602	 Aminoacyl-tRNA biosynthesis	hsa0097	amino acid binding;translation regulator activity;Ser-tRNA(Ala) hydrolase activity;ATP binding;zinc ion binding;tRNA binding;alanine-tRNA ligase activity;aminoacyl-tRNA editing activity	GO:001659; GO:004518; GO:000219; GO:000552; GO:000827; GO:000004; GO:000481; GO:000216
XP_020949464.1;XP_020949463.1;XP_020949462.1	XP_020949464.1;XP_020949463.1;XP_020949462.1	XP_020949464.1 splicing factor 3B subunit 3 [Sus scrofa];XP_020949463.1 splicing factor 3B subunit 3 [Sus scrofa];XP_020949462.1 splicing factor 3B subunit 3 [Sus scrofa]	7	7	7	0	21538000	18702000	19314000	20275000	27261000	19247000	24537000	0	0	24972000	27418000	21378000	0	0	27336000	21885000	0	NA	NA	NA	SF3B3	SF3B3;SF3B3;SF3B3;NA;NA	mRNA splicing, via spliceosome;negative regulation of protein catabolic process;RNA splicing, via transesterification reactions	GO:000039; GO:004217; GO:000037	nucleolus;U2-type precatalytic spliceosome;nucleus;nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome	GO:000573; GO:007100; GO:000563; GO:000565; GO:000568; GO:007101	 Spliceosome	hsa0304	nucleic acid binding;macromolecular complex binding;protein binding	GO:000367; GO:004487; GO:000551
XP_020949488.1;XP_020949487.1	XP_020949488.1;XP_020949487.1	XP_020949488.1 dihydroorotate dehydrogenase (quinone), mitochondrial isoform X2 [Sus scrofa];XP_020949487.1 dihydroorotate dehydrogenase (quinone), mitochondrial isoform X1 [Sus scrofa]	4	4	4	0	0	0	0	0	0	0	23525000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	DHODH	DHODH;DHODH;NA;NA;NA	oxidation-reduction process;response to caffeine;positive regulation of apoptotic process;pyrimidine ribonucleotide biosynthetic process;response to starvation;'de novo' UMP biosynthetic process;'de novo' pyrimidine nucleobase biosynthetic process;regulation of mitochondrial fission;response to L-arginine;female pregnancy;lactation;pyrimidine nucleoside biosynthetic process	GO:005511; GO:003100; GO:004306; GO:000922; GO:004259; GO:004420; GO:000620; GO:009014; GO:190357; GO:000756; GO:000759; GO:004613	mitochondrial inner membrane;mitochondrion;nucleoplasm;plasma membrane;cytosol;integral component of membrane;neuronal cell body	GO:000574; GO:000573; GO:000565; GO:000588; GO:000582; GO:001602; GO:004302	 Pyrimidine metabolism; Metabolic pathways	hsa0024; hsa0110	drug binding;FMN binding;dihydroorotate dehydrogenase activity;ubiquinone binding	GO:000814; GO:001018; GO:000415; GO:004803
XP_020949513.1;XP_020949509.1;XP_020949508.1;XP_020949512.1;XP_020949511.1;XP_020949510.1	XP_020949513.1;XP_020949509.1;XP_020949508.1;XP_020949512.1;XP_020949511.1;XP_020949510.1	XP_020949513.1 IST1 homolog isoform X1 [Sus scrofa];XP_020949509.1 IST1 homolog isoform X1 [Sus scrofa];XP_020949508.1 IST1 homolog isoform X1 [Sus scrofa];XP_020949512.1 IST1 homolog isoform X3 [Sus scrofa];XP_020949511.1 IST1 homolog isoform X2 [Sus scro	5	5	5	29888000	41606000	44301000	0	34241000	39954000	40303000	37380000	36275000	31846000	32247000	0	38887000	35118000	33464000	33263000	41182000	33229000	NA	NA	NA	IST1	IST1;IST1;IST1;IST1;IST1	protein transport;viral release from host cell;positive regulation of collateral sprouting;ESCRT III complex disassembly;multivesicular body assembly;cytoskeleton-dependent cytokinesis;viral capsid secondary envelopment;cell division;neutrophil degranulation;protein localization;abscission;positive regulation of proteolysis;establishment of protein localization	GO:001503; GO:001907; GO:004867; GO:190490; GO:003625; GO:006164; GO:004674; GO:005130; GO:004331; GO:000810; GO:000983; GO:004586; GO:004518	cytosol;nuclear envelope;midbody;chromatin;intracellular membrane-bounded organelle;azurophil granule lumen;Flemming body;extracellular exosome;extracellular region;centrosome;endoplasmic reticulum-Golgi intermediate compartment	GO:000582; GO:000563; GO:003049; GO:000078; GO:004323; GO:003557; GO:009054; GO:007006; GO:000557; GO:000581; GO:000579	 Endocytosis	hsa0414	cadherin binding;MIT domain binding;protein domain specific binding;protein binding;macromolecular complex binding	GO:004529; GO:009054; GO:001990; GO:000551; GO:004487
XP_020949519.1	XP_020949519.1	XP_020949519.1 26S proteasome non-ATPase regulatory subunit 7 [Sus scrofa]	8	8	8	39463000	34177000	45786000	37477000	36493000	34027000	47134000	30897000	38206000	32102000	29939000	0	44440000	35520000	48060000	38838000	36974000	29735000	NA	NA	NA	PSMD7	PSMD7;NA;NA;NA;NA	neutrophil degranulation;proteasome-mediated ubiquitin-dependent protein catabolic process;protein deubiquitination;post-translational protein modification	GO:004331; GO:004316; GO:001657; GO:004368	extracellular region;nucleoplasm;secretory granule lumen;extracellular exosome;proteasome regulatory particle;proteasome complex;membrane;nucleus;cytosol;ficolin-1-rich granule lumen	GO:000557; GO:000565; GO:003477; GO:007006; GO:000583; GO:000050; GO:001602; GO:000563; GO:000582; GO:190481	 Proteasome; Epstein-Barr virus infection	hsa0305; hsa0516	protein binding;protein homodimerization activity	GO:000551; GO:004280
XP_020949533.1	XP_020949533.1	XP_020949533.1 beta-2-syntrophin [Sus scrofa]	6	5	5	0	20656000	21146000	25444000	0	24573000	21102000	31156000	18317000	26007000	19364000	40533000	24080000	28419000	17181000	29225000	19031000	33394000	NA	NA	NA	SNTB2	SNTB2;NA;NA;NA;NA	"NA"	"NA"	macromolecular complex;cytoplasm;membrane;microtubule;focal adhesion;synapse;dystrophin-associated glycoprotein complex;transport vesicle membrane	GO:003299; GO:000573; GO:001602; GO:000587; GO:000592; GO:004520; GO:001601; GO:003065	"NA"	"NA"	protein binding;calmodulin binding;RNA binding;structural molecule activity;actin binding	GO:000551; GO:000551; GO:000372; GO:000519; GO:000377
XP_020949539.1	XP_020949539.1	XP_020949539.1 peptidyl-prolyl cis-trans isomerase B [Sus scrofa]	12	12	11	251600000	486510000	347840000	440730000	343880000	535940000	290230000	404780000	275310000	384280000	359910000	462840000	284660000	451040000	375880000	433160000	396530000	460400000	NA	NA	NA	PPIB	PPIB;NA;NA;NA;NA	positive regulation by host of viral genome replication;chaperone-mediated protein folding;positive regulation of multicellular organism growth;regulation of post-translational protein modification;protein peptidyl-prolyl isomerization;protein refolding;protein stabilization;positive regulation by host of viral process;bone development	GO:004482; GO:006107; GO:004001; GO:190187; GO:000041; GO:004202; GO:005082; GO:004479; GO:006034	membrane;smooth endoplasmic reticulum;focal adhesion;endoplasmic reticulum chaperone complex;melanosome;perinuclear region of cytoplasm;endoplasmic reticulum;nucleus;extracellular exosome;macromolecular complex	GO:001602; GO:000579; GO:000592; GO:003466; GO:004247; GO:004847; GO:000578; GO:000563; GO:007006; GO:003299	"NA"	"NA"	protein binding;cyclosporin A binding;collagen binding;RNA polymerase binding;unfolded protein binding;RNA binding;peptidyl-prolyl cis-trans isomerase activity	GO:000551; GO:001601; GO:000551; GO:007006; GO:005108; GO:000372; GO:000375
XP_020949569.1	XP_020949569.1	XP_020949569.1 sorting nexin-1 [Sus scrofa]	10	8	8	29025000	51589000	39916000	47407000	33031000	43950000	38649000	42757000	34030000	36025000	0	52951000	37302000	55148000	41856000	50408000	41222000	58450000	NA	NA	NA	SNX1	SNX1;NA;NA;NA;NA	early endosome to Golgi transport;intracellular protein transport;receptor internalization;positive regulation of protein catabolic process;lamellipodium morphogenesis;retrograde transport, endosome to Golgi	GO:003449; GO:000688; GO:003162; GO:004573; GO:007267; GO:004214	endosome membrane;early endosome membrane;retromer, tubulation complex;membrane;macromolecular complex;lysosome;cytosol;intracellular membrane-bounded organelle;lamellipodium;vesicle;cytoplasm;Golgi apparatus	GO:001000; GO:003190; GO:003090; GO:001602; GO:003299; GO:000576; GO:000582; GO:004323; GO:003002; GO:003198; GO:000573; GO:000579	 Endocytosis	hsa0414	protein binding;phosphatidylinositol binding;protein heterodimerization activity;identical protein binding;insulin receptor binding;cadherin binding;transferrin receptor binding;leptin receptor binding	GO:000551; GO:003509; GO:004698; GO:004280; GO:000515; GO:004529; GO:199045; GO:199046
XP_020949689.1	XP_020949689.1	XP_020949689.1 mitotic spindle-associated MMXD complex subunit MIP18 [Sus scrofa]	1	1	1	0	0	0	0	0	2597300	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CIAO2B	CIAO2B;NA;NA;NA;NA	protein maturation by iron-sulfur cluster transfer;chromosome segregation;iron-sulfur cluster assembly	GO:009742; GO:000705; GO:001622	nucleus;cytosol;nucleoplasm;spindle;CIA complex;cytoplasm;MMXD complex	GO:000563; GO:000582; GO:000565; GO:000581; GO:009736; GO:000573; GO:007181	"NA"	"NA"	protein binding	GO:000551
XP_020949710.1;XP_020949709.1;XP_020949708.1;XP_020949707.1;XP_020949706.1	XP_020949710.1;XP_020949709.1;XP_020949708.1;XP_020949707.1;XP_020949706.1	XP_020949710.1 tumor necrosis factor receptor type 1-associated DEATH domain protein [Sus scrofa];XP_020949709.1 tumor necrosis factor receptor type 1-associated DEATH domain protein [Sus scrofa];XP_020949708.1 tumor necrosis factor receptor type 1-associa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	10974000	0	0	0	0	0	NA	NA	NA	TRADD	TRADD;TRADD;TRADD;TRADD;TRADD	signal transduction;regulation of tumor necrosis factor-mediated signaling pathway;protein heterooligomerization;activation of cysteine-type endopeptidase activity involved in apoptotic process;I-kappaB kinase/NF-kappaB signaling;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of inflammatory response;tumor necrosis factor-mediated signaling pathway;regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of NF-kappaB transcription factor activity;extrinsic apoptotic signaling pathway;positive regulation of NIK/NF-kappaB signaling;extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of cell migration;positive regulation of apoptotic process;positive regulation of hair follicle development;cellular response to tumor necrosis factor;death-inducing signaling complex assembly	GO:000716; GO:001080; GO:005129; GO:000691; GO:000724; GO:004312; GO:005072; GO:003320; GO:190204; GO:005109; GO:009719; GO:190122; GO:000862; GO:003033; GO:004306; GO:005179; GO:007135; GO:007155	death-inducing signaling complex;plasma membrane;cytosol;nucleus;receptor complex;cytoplasm;membrane raft;cytoskeleton	GO:003126; GO:000588; GO:000582; GO:000563; GO:004323; GO:000573; GO:004512; GO:000585	 Tuberculosis; Sphingolipid signaling pathway; Apoptosis; Hepatitis C; NF-kappa B signaling pathway; Viral carcinogenesis; RIG-I-like receptor signaling pathway; Adipocytokine signaling pathway; TNF signaling pathway	hsa0515; hsa0407; hsa0421; hsa0516; hsa0406; hsa0520; hsa0462; hsa0492; hsa0466	tumor necrosis factor receptor binding;kinase binding;protein binding;macromolecular complex binding;identical protein binding;binding, bridging;death domain binding	GO:000516; GO:001990; GO:000551; GO:004487; GO:004280; GO:006009; GO:007051
XP_020949905.1	XP_020949905.1	XP_020949905.1 vacuolar protein sorting-associated protein 35 [Sus scrofa]	23	23	23	382380000	397630000	482040000	312050000	325140000	319030000	380140000	321250000	465730000	369150000	288290000	321130000	335030000	347770000	380030000	397930000	359550000	351600000	NA	NA	NA	VPS35	VPS35;NA;NA;NA;NA	neurotransmitter receptor transport, endosome to postsynaptic membrane;negative regulation of lysosomal protein catabolic process;regulation of presynapse assembly;negative regulation of gene expression;protein destabilization;mitochondrial fragmentation involved in apoptotic process;positive regulation of locomotion involved in locomotory behavior;negative regulation of neuron death;synapse assembly;regulation of mitochondrion organization;transcytosis;protein localization to organelle;retrograde transport, endosome to Golgi;negative regulation of inflammatory response;negative regulation of late endosome to lysosome transport;regulation of terminal button organization;regulation of macroautophagy;positive regulation of Wnt protein secretion;positive regulation of cellular protein catabolic process;regulation of cellular protein metabolic process;positive regulation of dopamine biosynthetic process;negative regulation of cellular protein localization;retrograde transport, endosome to plasma membrane;lysosome organization;positive regulation of dopamine receptor signaling pathway;negative regulation of protein homooligomerization;positive regulation of canonical Wnt signaling pathway;mitochondrion to lysosome transport;regulation of dendritic spine maintenance;Wnt signaling pathway;intracellular protein transport;viral process;negative regulation of cell death;neurotransmitter receptor transport, endosome to plasma membrane;voluntary musculoskeletal movement;positive regulation of mitochondrial fission;vesicle-mediated transport in synapse	GO:009888; GO:190516; GO:190560; GO:001062; GO:003164; GO:004365; GO:009032; GO:190121; GO:000741; GO:001082; GO:004505; GO:003336; GO:004214; GO:005072; GO:190282; GO:200033; GO:001624; GO:006135; GO:190336; GO:003226; GO:190318; GO:190382; GO:199012; GO:000704; GO:006016; GO:003246; GO:009026; GO:009907; GO:190295; GO:001605; GO:000688; GO:001603; GO:006054; GO:009963; GO:005088; GO:009014; GO:009900	lysosomal membrane;endosome membrane;endosome;plasma membrane;postsynaptic density;tubular endosome;late endosome;presynapse;mitochondrion;extracellular exosome;neuron projection;neuronal cell body;mitochondrion-derived vesicle;perinuclear region of cytoplasm;cytosol;retromer complex;glutamatergic synapse	GO:000576; GO:001000; GO:000576; GO:000588; GO:001406; GO:009742; GO:000577; GO:009879; GO:000573; GO:007006; GO:004300; GO:004302; GO:009907; GO:004847; GO:000582; GO:003090; GO:009897	 Endocytosis	hsa0414	D1 dopamine receptor binding;protein binding;protein transporter activity	GO:003174; GO:000551; GO:000856
XP_020949912.1;XP_020949911.1;XP_020949910.1;XP_020949909.1	XP_020949912.1;XP_020949911.1;XP_020949910.1;XP_020949909.1	XP_020949912.1 protein C19orf12 homolog [Sus scrofa];XP_020949911.1 protein C19orf12 homolog [Sus scrofa];XP_020949910.1 protein C19orf12 homolog [Sus scrofa];XP_020949909.1 protein C19orf12 homolog [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	47292000	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	C6H19orf12	C6H19orf12;C6H19orf12;C6H19orf12;C6H19orf12;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020949999.1;XP_020949979.1;XP_020949970.1;XP_020949961.1;XP_020949956.1;XP_020949954.1;XP_020949949.1;XP_020949942.1;XP_020949934.1;XP_020949928.1;XP_020949921.1;XP_020949914.1;XP_020949993.1;XP_020949986.1	XP_020949999.1;XP_020949979.1;XP_020949970.1;XP_020949961.1;XP_020949956.1;XP_020949954.1;XP_020949949.1;XP_020949942.1;XP_020949934.1;XP_020949928.1;XP_020949921.1;XP_020949914.1;XP_020949993.1;XP_020949986.1	XP_020949999.1 talin-2 isoform X6 [Sus scrofa];XP_020949979.1 talin-2 isoform X3 [Sus scrofa];XP_020949970.1 talin-2 isoform X2 [Sus scrofa];XP_020949961.1 talin-2 isoform X1 [Sus scrofa];XP_020949956.1 talin-2 isoform X1 [Sus scrofa];XP_020949954.1 talin-	78	66	66	549020000	776760000	638860000	782270000	575220000	592710000	622690000	696860000	547150000	861360000	633360000	906220000	382350000	784190000	670850000	1162600000	594990000	706990000	NA	NA	NA	TLN2	TLN2;TLN2;TLN2;TLN2;TLN2	cell adhesion;cytoskeletal anchoring at plasma membrane;cell-cell junction assembly	GO:000715; GO:000701; GO:000704	focal adhesion;synapse;cytoplasm;plasma membrane;actin cytoskeleton;ruffle	GO:000592; GO:004520; GO:000573; GO:000588; GO:001562; GO:000172	 Rap1 signaling pathway; Focal adhesion; HTLV-I infection; Platelet activation	hsa0401; hsa0451; hsa0516; hsa0461	structural molecule activity;actin filament binding;structural constituent of cytoskeleton;actin binding;protein binding	GO:000519; GO:005101; GO:000520; GO:000377; GO:000551
XP_020950008.1	XP_020950008.1	XP_020950008.1 LOW QUALITY PROTEIN: heterogeneous nuclear ribonucleoprotein L [Sus scrofa]	7	7	7	29929000	35240000	33140000	38460000	25980000	36497000	0	33948000	37010000	35349000	42428000	45688000	49219000	45337000	41491000	31256000	31745000	40224000	NA	NA	NA	HNRNPL	HNRNPL;NA;NA;NA;NA	mRNA splicing, via spliceosome;cellular response to amino acid starvation;positive regulation of translation;RNA metabolic process;regulation of alternative mRNA splicing, via spliceosome;RNA processing;circadian rhythm;positive regulation of mRNA binding;negative regulation of mRNA splicing, via spliceosome;response to peptide	GO:000039; GO:003419; GO:004572; GO:001607; GO:000038; GO:000639; GO:000762; GO:190241; GO:004802; GO:190165	cytosol;membrane;perinuclear region of cytoplasm;ribonucleoprotein complex;pronucleus;nucleoplasm;ribonucleoprotein granule;extracellular exosome;nucleus	GO:000582; GO:001602; GO:004847; GO:199090; GO:004512; GO:000565; GO:003577; GO:007006; GO:000563	"NA"	"NA"	mRNA 3'-UTR binding;RNA binding;mRNA CDS binding;transcription regulatory region DNA binding;protein binding;pre-mRNA intronic binding	GO:000373; GO:000372; GO:199071; GO:004421; GO:000551; GO:009715
XP_020950032.1;XP_020950029.1;XP_020950024.1;XP_020950021.1	XP_020950032.1;XP_020950029.1;XP_020950024.1;XP_020950021.1	XP_020950032.1 vacuolar protein sorting-associated protein 13C isoform X4 [Sus scrofa];XP_020950029.1 vacuolar protein sorting-associated protein 13C isoform X3 [Sus scrofa];XP_020950024.1 vacuolar protein sorting-associated protein 13C isoform X2 [Sus scr	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15711000	0	NA	NA	NA	VPS13C	VPS13C;VPS13C;VPS13C;VPS13C;NA	mitochondrion organization;Golgi to endosome transport;negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;protein targeting to vacuole;protein retention in Golgi apparatus	GO:000700; GO:000689; GO:190509; GO:000662; GO:004505	cytosol;extracellular exosome;extrinsic component of membrane;cytoplasm;mitochondrial outer membrane	GO:000582; GO:007006; GO:001989; GO:000573; GO:000574	"NA"	"NA"	"NA"	"NA"
XP_020950042.1	XP_020950042.1	XP_020950042.1 26S protease regulatory subunit 6B [Sus scrofa]	15	15	15	78985000	85061000	83302000	87118000	82515000	64392000	86780000	97055000	94427000	84562000	80139000	107200000	65376000	90277000	90394000	83878000	84932000	82422000	NA	NA	NA	PSMC4	PSMC4;NA;NA;NA;NA	protein deubiquitination;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;blastocyst development;proteolysis;post-translational protein modification;protein catabolic process;positive regulation of proteasomal protein catabolic process	GO:001657; GO:004589; GO:000182; GO:000650; GO:004368; GO:003016; GO:190180	nucleoplasm;synapse;membrane;cytosol;proteasome regulatory particle, base subcomplex;proteasome accessory complex;cytosolic proteasome complex;proteasome complex;nucleus;inclusion body	GO:000565; GO:004520; GO:001602; GO:000582; GO:000854; GO:002262; GO:003159; GO:000050; GO:000563; GO:001623	 Epstein-Barr virus infection; Proteasome	hsa0516; hsa0305	protein binding;ATP binding;ATPase activity;proteasome-activating ATPase activity	GO:000551; GO:000552; GO:001688; GO:003640
XP_020950058.1	XP_020950058.1	XP_020950058.1 LOW QUALITY PROTEIN: latent-transforming growth factor beta-binding protein 4 [Sus scrofa]	8	8	8	0	0	0	0	0	0	0	0	0	0	27667000	0	86617000	0	0	0	0	0	NA	NA	NA	LTBP4	LTBP4;NA;NA;NA;NA	regulation of cell growth;transforming growth factor beta receptor signaling pathway;multicellular organism development;growth hormone secretion;regulation of cell differentiation;regulation of proteolysis;protein folding;regulation of transforming growth factor beta receptor signaling pathway	GO:000155; GO:000717; GO:000727; GO:003025; GO:004559; GO:003016; GO:000645; GO:001701	extracellular space;extracellular region;extracellular matrix	GO:000561; GO:000557; GO:003101	"NA"	"NA"	extracellular matrix structural constituent;glycosaminoglycan binding;calcium ion binding;integrin binding;transforming growth factor beta binding;transforming growth factor beta-activated receptor activity;protein binding	GO:000520; GO:000553; GO:000550; GO:000517; GO:005043; GO:000502; GO:000551
XP_020950071.1;XP_020950072.1	XP_020950071.1;XP_020950072.1	XP_020950071.1 cytochrome P450 2B4-like isoform X1 [Sus scrofa];XP_020950072.1 cytochrome P450 2B4-like isoform X2 [Sus scrofa]	13	13	1	385770000	237850000	399960000	155880000	341290000	163710000	390830000	266370000	508540000	269180000	376080000	279830000	179250000	172310000	417430000	231320000	353150000	170920000	NA	NA	NA	LOC102165015	LOC102165015;LOC102165015;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020950073.1	XP_020950073.1	XP_020950073.1 cytochrome P450 2S1 [Sus scrofa]	14	14	14	106330000	148990000	116070000	153500000	96201000	116820000	74962000	162540000	66172000	109050000	122240000	233340000	82358000	138780000	136710000	171470000	119800000	117340000	NA	NA	NA	LOC106510546	LOC106510546;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020950075.1	XP_020950075.1	XP_020950075.1 LOW QUALITY PROTEIN: heterogeneous nuclear ribonucleoprotein U-like protein 1 [Sus scrofa]	5	5	5	0	0	16204000	21843000	0	17983000	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	HNRNPUL1	HNRNPUL1;NA;NA;NA;NA	RNA processing;mRNA splicing, via spliceosome;response to virus	GO:000639; GO:000039; GO:000961	nucleoplasm;nucleus	GO:000565; GO:000563	 Influenza A	hsa0516	protein binding;RNA binding;enzyme binding	GO:000551; GO:000372; GO:001989
XP_020950139.1	XP_020950139.1	XP_020950139.1 cell adhesion molecule 4 [Sus scrofa]	5	5	5	0	75717000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	CADM4	CADM4;NA;NA;NA;NA	regulation of cell proliferation;negative regulation of protein phosphorylation;cell adhesion;negative regulation of vascular endothelial growth factor receptor signaling pathway;regulation of Rac protein signal transduction;negative regulation of vascular endothelial growth factor signaling pathway;regulation of cell motility;negative regulation of peptidyl-threonine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;regulation of wound healing	GO:004212; GO:000193; GO:000715; GO:003094; GO:003502; GO:190074; GO:200014; GO:001080; GO:005073; GO:006104	integral component of membrane;cell leading edge;cell-cell contact zone	GO:001602; GO:003125; GO:004429	"NA"	"NA"	vascular endothelial growth factor receptor 2 binding;receptor tyrosine kinase binding;protein phosphatase binding;vascular endothelial growth factor receptor 1 binding	GO:004318; GO:003097; GO:001990; GO:004318
XP_020950223.1;XP_020950222.1;XP_020950221.1;XP_020950220.1;XP_020950226.1;XP_020950225.1;XP_020950224.1;XP_020950219.1;XP_020950218.1	XP_020950223.1;XP_020950222.1;XP_020950221.1;XP_020950220.1;XP_020950226.1;XP_020950225.1;XP_020950224.1;XP_020950219.1;XP_020950218.1	XP_020950223.1 vasodilator-stimulated phosphoprotein isoform X6 [Sus scrofa];XP_020950222.1 vasodilator-stimulated phosphoprotein isoform X5 [Sus scrofa];XP_020950221.1 vasodilator-stimulated phosphoprotein isoform X4 [Sus scrofa];XP_020950220.1 vasodilato	5	5	5	18054000	31150000	32755000	38122000	29324000	37204000	22311000	42840000	30448000	38039000	36342000	38964000	41274000	36716000	32832000	29271000	0	35584000	NA	NA	NA	VASP	VASP;VASP;VASP;VASP;VASP	neural tube closure;cell junction assembly;positive regulation of actin filament polymerization;protein homotetramerization;axon guidance;actin polymerization or depolymerization	GO:000184; GO:003432; GO:003083; GO:005128; GO:000741; GO:000815	extracellular exosome;cytosol;lamellipodium membrane;focal adhesion;filopodium membrane;actin cytoskeleton;plasma membrane	GO:007006; GO:000582; GO:003125; GO:000592; GO:003152; GO:001562; GO:000588	 Leukocyte transendothelial migration; Platelet activation; Rap1 signaling pathway; cGMP-PKG signaling pathway; Focal adhesion; Fc gamma R-mediated phagocytosis	hsa0467; hsa0461; hsa0401; hsa0402; hsa0451; hsa0466	actin binding;protein binding;SH3 domain binding;profilin binding;cadherin binding	GO:000377; GO:000551; GO:001712; GO:000552; GO:004529
XP_020950232.1;XP_020950231.1;XP_020950229.1;XP_020950230.1	XP_020950232.1;XP_020950231.1;XP_020950229.1;XP_020950230.1	XP_020950232.1 echinoderm microtubule-associated protein-like 2 isoform X4 [Sus scrofa];XP_020950231.1 echinoderm microtubule-associated protein-like 2 isoform X3 [Sus scrofa];XP_020950229.1 echinoderm microtubule-associated protein-like 2 isoform X1 [Sus	11	11	11	114970000	104270000	105180000	99963000	102900000	98079000	124420000	108390000	107810000	97234000	131520000	132970000	121650000	120750000	115230000	113400000	120750000	107180000	NA	NA	NA	EML2	EML2;EML2;EML2;EML2;NA	visual perception;negative regulation of microtubule polymerization;sensory perception of sound;regulation of microtubule nucleation	GO:000760; GO:003111; GO:000760; GO:001096	microtubule cytoskeleton;microtubule;mitotic spindle;cytoplasm	GO:001563; GO:000587; GO:007268; GO:000573	"NA"	"NA"	tubulin binding;receptor binding;protein C-terminus binding;protein binding;microtubule binding	GO:001563; GO:000510; GO:000802; GO:000551; GO:000801
XP_020950265.1;XP_020950257.1;XP_020950268.1	XP_020950265.1;XP_020950257.1;XP_020950268.1	XP_020950265.1 retinal dehydrogenase 2 isoform X1 [Sus scrofa];XP_020950257.1 retinal dehydrogenase 2 isoform X1 [Sus scrofa];XP_020950268.1 retinal dehydrogenase 2 isoform X2 [Sus scrofa]	13	12	10	132470000	0	133800000	0	114870000	0	172190000	0	158970000	0	134290000	0	177920000	80429000	127900000	0	264840000	0	NA	NA	NA	ALDH1A2	ALDH1A2;ALDH1A2;ALDH1A2;NA;NA	regulation of endothelial cell proliferation;response to vitamin A;retinol metabolic process;liver development;positive regulation of cell proliferation;hindbrain development;response to cytokine;9-cis-retinoic acid biosynthetic process;cardiac muscle tissue development;cellular response to retinoic acid;retinoic acid receptor signaling pathway involved in somitogenesis;heart morphogenesis;proximal/distal pattern formation;neural crest cell development;morphogenesis of embryonic epithelium;pancreas development;vitamin A metabolic process;neuron differentiation;ureter maturation;positive regulation of apoptotic process;embryonic digestive tract development;oxidation-reduction process;determination of bilateral symmetry;positive regulation of gene expression;neural tube development;pituitary gland development;lung development;embryonic forelimb morphogenesis;midgut development;blood vessel development;kidney development;embryonic camera-type eye development;response to estradiol;face development	GO:000193; GO:003318; GO:004257; GO:000188; GO:000828; GO:003090; GO:003409; GO:004290; GO:004873; GO:007130; GO:009024; GO:000300; GO:000995; GO:001403; GO:001633; GO:003101; GO:000677; GO:003018; GO:003579; GO:004306; GO:004856; GO:005511; GO:000985; GO:001062; GO:002191; GO:002198; GO:003032; GO:003511; GO:000749; GO:000156; GO:000182; GO:003107; GO:003235; GO:006032	perinuclear region of cytoplasm;cytosol;cytoplasm	GO:004847; GO:000582; GO:000573	 Retinol metabolism; Metabolic pathways	hsa0083; hsa0110	retinal dehydrogenase activity;3-chloroallyl aldehyde dehydrogenase activity;retinal binding	GO:000175; GO:000402; GO:001691
XP_020950359.1;XP_020930684.1	XP_020950359.1	XP_020950359.1 60S ribosomal protein L18 [Sus scrofa]	5	5	5	102620000	0	150850000	68320000	91512000	145750000	106540000	34462000	145690000	118160000	110790000	73737000	127950000	109160000	73789000	107020000	161500000	188490000	NA	NA	NA	RPL18	RPL18;NA;NA;NA;NA	translational initiation;SRP-dependent cotranslational protein targeting to membrane;cytoplasmic translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation	GO:000641; GO:000661; GO:000218; GO:000018; GO:000641	membrane;focal adhesion;cytosolic large ribosomal subunit;endoplasmic reticulum;cytosol;nucleus;nucleolus;rough endoplasmic reticulum;polysomal ribosome	GO:001602; GO:000592; GO:002262; GO:000578; GO:000582; GO:000563; GO:000573; GO:000579; GO:004278	 Ribosome	hsa0301	structural constituent of ribosome;RNA binding	GO:000373; GO:000372
XP_020950364.1	XP_020950364.1	XP_020950364.1 17-beta-hydroxysteroid dehydrogenase 14 [Sus scrofa]	12	12	12	74755000	99971000	53136000	188640000	83213000	104680000	31177000	87709000	24996000	41783000	116690000	139380000	74264000	206260000	101700000	124170000	123180000	137860000	NA	NA	NA	HSD17B14	HSD17B14;NA;NA;NA;NA	steroid catabolic process;oxidation-reduction process;estrogen biosynthetic process	GO:000670; GO:005511; GO:000670	cytosol	GO:000582	"NA"	"NA"	identical protein binding;protein binding;estradiol 17-beta-dehydrogenase activity;testosterone 17-beta-dehydrogenase (NADP+) activity	GO:004280; GO:000551; GO:000430; GO:004704
XP_020950419.1;XP_020950417.1	XP_020950419.1;XP_020950417.1	XP_020950419.1 AP-2 complex subunit alpha-1 isoform X2 [Sus scrofa];XP_020950417.1 AP-2 complex subunit alpha-1 isoform X1 [Sus scrofa]	17	12	12	29418000	25420000	26432000	29624000	21857000	23092000	19428000	27902000	22613000	31799000	21336000	34109000	46629000	25166000	24431000	34976000	23753000	28232000	NA	NA	NA	AP2A1	AP2A1;AP2A1;NA;NA;NA	clathrin-dependent endocytosis;intracellular protein transport;positive regulation of neuron projection development;positive regulation of receptor-mediated endocytosis;membrane organization;Wnt signaling pathway, planar cell polarity pathway;Golgi to endosome transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;ephrin receptor signaling pathway;negative regulation of hyaluronan biosynthetic process;low-density lipoprotein particle clearance;regulation of defense response to virus by virus;low-density lipoprotein particle receptor catabolic process	GO:007258; GO:000688; GO:001097; GO:004826; GO:006102; GO:006007; GO:000689; GO:001988; GO:004801; GO:190012; GO:003438; GO:005069; GO:003280	clathrin coat of trans-Golgi network vesicle;filopodium tip;clathrin-coated endocytic vesicle membrane;clathrin-coated endocytic vesicle;apical plasma membrane;plasma membrane;AP-2 adaptor complex;endolysosome membrane;membrane;cytosol	GO:003013; GO:003243; GO:003066; GO:004533; GO:001632; GO:000588; GO:003012; GO:003602; GO:001602; GO:000582	 Endocrine and other factor-regulated calcium reabsorption; Endocytosis; Huntington's disease; Synaptic vesicle cycle	hsa0496; hsa0414; hsa0501; hsa0472	macromolecular complex binding;protein C-terminus binding;clathrin adaptor activity;protein kinase binding;low-density lipoprotein particle receptor binding;protein binding	GO:004487; GO:000802; GO:003561; GO:001990; GO:005075; GO:000551
XP_020950448.1;XP_020950447.1;XP_020950446.1;XP_020950445.1;XP_020950443.1;XP_020950442.1;XP_020950441.1;XP_020950440.1	XP_020950448.1;XP_020950447.1;XP_020950446.1;XP_020950445.1;XP_020950443.1;XP_020950442.1;XP_020950441.1;XP_020950440.1	XP_020950448.1 myosin-14 isoform X6 [Sus scrofa];XP_020950447.1 myosin-14 isoform X5 [Sus scrofa];XP_020950446.1 myosin-14 isoform X5 [Sus scrofa];XP_020950445.1 myosin-14 isoform X4 [Sus scrofa];XP_020950443.1 myosin-14 isoform X4 [Sus scrofa];XP_02095044	36	25	25	48192000	69299000	44757000	61378000	58163000	64927000	49133000	40206000	39386000	52821000	46286000	84610000	41164000	78204000	56249000	84112000	57827000	80385000	NA	NA	NA	MYH14	MYH14;MYH14;MYH14;MYH14;MYH14	sensory perception of sound;vocalization behavior;actin filament-based movement;actomyosin structure organization;regulation of cell shape;neuronal action potential;mitochondrion morphogenesis;skeletal muscle contraction;skeletal muscle tissue development	GO:000760; GO:007162; GO:003004; GO:003103; GO:000836; GO:001922; GO:007058; GO:000300; GO:000751	stress fiber;brush border;myosin II complex;membrane;cytosol;actomyosin;extracellular exosome;myosin II filament;growth cone	GO:000172; GO:000590; GO:001646; GO:001602; GO:000582; GO:004264; GO:007006; GO:009751; GO:003042	 Tight junction; Regulation of actin cytoskeleton; Salmonella infection	hsa0453; hsa0481; hsa0513	calmodulin binding;actin-dependent ATPase activity;actin filament binding;microfilament motor activity;ATP binding;ATPase activity	GO:000551; GO:003089; GO:005101; GO:000014; GO:000552; GO:001688
XP_020950538.1;XP_020950537.1	XP_020950538.1;XP_020950537.1	XP_020950538.1 40S ribosomal protein S9 [Sus scrofa];XP_020950537.1 40S ribosomal protein S9 [Sus scrofa]	10	10	10	260240000	238640000	324200000	213950000	249310000	295440000	234570000	222260000	272600000	250020000	240390000	205010000	250240000	316090000	211700000	297210000	321460000	318790000	NA	NA	NA	RPS9	RPS9;RPS9;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;positive regulation of cell proliferation;rRNA processing;positive regulation of translational fidelity	GO:000661; GO:000018; GO:000641; GO:000828; GO:000636; GO:004590	cytosol;nucleoplasm;nucleolus;synapse;extracellular exosome;nucleus;ribonucleoprotein complex;membrane;focal adhesion;cytosolic small ribosomal subunit;ribosome	GO:000582; GO:000565; GO:000573; GO:004520; GO:007006; GO:000563; GO:199090; GO:001602; GO:000592; GO:002262; GO:000584	 Ribosome	hsa0301	translation regulator activity;structural constituent of ribosome;protein binding;rRNA binding;RNA binding	GO:004518; GO:000373; GO:000551; GO:001984; GO:000372
XP_020950674.1;XP_020950673.1;XP_020950672.1;XP_020950671.1;XP_020950670.1;XP_020950668.1;XP_020950669.1	XP_020950674.1;XP_020950673.1;XP_020950672.1;XP_020950671.1;XP_020950670.1;XP_020950668.1;XP_020950669.1	XP_020950674.1 60S ribosomal protein L28 isoform X1 [Sus scrofa];XP_020950673.1 60S ribosomal protein L28 isoform X1 [Sus scrofa];XP_020950672.1 60S ribosomal protein L28 isoform X1 [Sus scrofa];XP_020950671.1 60S ribosomal protein L28 isoform X1 [Sus scro	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21057000	NA	NA	NA	RPL28	RPL28;RPL28;RPL28;RPL28;RPL28	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;translational initiation	GO:000018; GO:000661; GO:000641	cytosolic large ribosomal subunit;dendrite;extracellular exosome;membrane;cell body;cytoplasmic ribonucleoprotein granule;cytosol	GO:002262; GO:003042; GO:007006; GO:001602; GO:004429; GO:003646; GO:000582	 Ribosome	hsa0301	protein binding;RNA binding;structural constituent of ribosome	GO:000551; GO:000372; GO:000373
XP_020950699.1;XP_020950700.1	XP_020950699.1;XP_020950700.1	XP_020950699.1 isochorismatase domain-containing protein 2 isoform X1 [Sus scrofa];XP_020950700.1 isochorismatase domain-containing protein 2 isoform X2 [Sus scrofa]	3	3	3	32993000	0	24216000	11134000	0	0	0	43471000	0	32165000	25448000	0	0	0	0	22980000	0	20375000	NA	NA	NA	ISOC2	ISOC2;ISOC2;NA;NA;NA	protein destabilization	GO:003164	cytoplasm;nucleus	GO:000573; GO:000563	"NA"	"NA"	protein binding;catalytic activity	GO:000551; GO:000382
XP_020950836.1;XP_020950837.1	XP_020950836.1;XP_020950837.1	XP_020950836.1 agrin isoform X1 [Sus scrofa];XP_020950837.1 agrin isoform X2 [Sus scrofa]	8	8	8	0	0	0	0	0	0	14876000	22890000	0	15968000	0	0	18069000	16064000	0	19621000	0	0	NA	NA	NA	AGRN	AGRN;AGRN;NA;NA;NA	retinoid metabolic process;cytoskeleton organization;synapse organization;extracellular matrix organization;clustering of voltage-gated sodium channels;G-protein coupled acetylcholine receptor signaling pathway;positive regulation of GTPase activity;positive regulation of transcription from RNA polymerase II promoter;signal transduction;receptor clustering;positive regulation of filopodium assembly;glycosaminoglycan biosynthetic process;positive regulation of synaptic growth at neuromuscular junction	GO:000152; GO:000701; GO:005080; GO:003019; GO:004516; GO:000721; GO:004354; GO:004594; GO:000716; GO:004311; GO:005149; GO:000602; GO:004588	basement membrane;cell junction;extracellular exosome;lysosomal lumen;extracellular region;Golgi lumen;plasma membrane;cytosol;integral component of membrane;synapse	GO:000560; GO:003005; GO:007006; GO:004320; GO:000557; GO:000579; GO:000588; GO:000582; GO:001602; GO:004520	 ECM-receptor interaction	hsa0451	dystroglycan binding;extracellular matrix structural constituent;laminin binding;chondroitin sulfate binding;sialic acid binding;heparan sulfate proteoglycan binding;protein binding;calcium ion binding	GO:000216; GO:000520; GO:004323; GO:003537; GO:003369; GO:004339; GO:000551; GO:000550
XP_020950890.1	XP_020950890.1	XP_020950890.1 leucine-rich repeat-containing protein 47 [Sus scrofa]	4	4	4	0	6110100	0	8264200	6637900	0	0	4950700	0	0	0	0	0	6572000	0	12685000	0	0	NA	NA	NA	LRRC47	LRRC47;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	phenylalanine-tRNA ligase activity;RNA binding;protein binding	GO:000482; GO:000372; GO:000551
XP_020950929.1;XP_003358329.1;XP_005653217.1	XP_020950929.1;XP_003358329.1	XP_020950929.1 vesicle-associated membrane protein 3 [Sus scrofa];XP_003358329.1 vesicle-associated membrane protein 2 [Sus scrofa]	6	6	6	269430000	259250000	238580000	213740000	191620000	187780000	273520000	246340000	225100000	278200000	239750000	262790000	205910000	233050000	254360000	201950000	248570000	201140000	NA	NA	NA	VAMP3	VAMP3;VAMP2;NA;NA;NA	substrate adhesion-dependent cell spreading;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;mucus secretion;regulation of histamine secretion by mast cell;SNARE complex assembly;retrograde transport, endosome to Golgi;Golgi to plasma membrane protein transport;macromolecular complex assembly;calcium ion regulated exocytosis;positive regulation of immunoglobulin secretion;membrane organization;cellular response to interferon-gamma;positive regulation of receptor recycling;vesicle docking involved in exocytosis;negative regulation of secretion by cell;vesicle-mediated transport;exocytosis	GO:003444; GO:000247; GO:007025; GO:190359; GO:003549; GO:004214; GO:004300; GO:006500; GO:001715; GO:005102; GO:006102; GO:007134; GO:000192; GO:000690; GO:190353; GO:001619; GO:000688	cell junction;intracellular membrane-bounded organelle;clathrin-coated vesicle membrane;perinuclear region of cytoplasm;integral component of membrane;cytosol;apical plasma membrane;integral component of synaptic vesicle membrane;phagocytic vesicle membrane;trans-Golgi network membrane;recycling endosome;secretory granule;neuron projection;transport vesicle;SNARE complex;plasma membrane;cell surface	GO:003005; GO:004323; GO:003066; GO:004847; GO:001602; GO:000582; GO:001632; GO:003028; GO:003067; GO:003258; GO:005503; GO:003014; GO:004300; GO:003013; GO:003120; GO:000588; GO:000998	 Phagosome; SNARE interactions in vesicular transport	hsa0414; hsa0413	protein binding;syntaxin-1 binding	GO:000551; GO:001707
XP_020950938.1;XP_020950937.1;XP_020950939.1	XP_020950938.1;XP_020950937.1;XP_020950939.1	XP_020950938.1 alpha-enolase isoform X1 [Sus scrofa];XP_020950937.1 alpha-enolase isoform X1 [Sus scrofa];XP_020950939.1 alpha-enolase isoform X2 [Sus scrofa]	29	29	23	4677900000	3866100000	4208200000	4893700000	4205500000	4215400000	3877600000	3548100000	3928100000	4302200000	4240200000	4006900000	3503700000	3920700000	4537400000	4747100000	4896400000	4020600000	NA	NA	NA	ENO1	ENO1;ENO1;ENO1;NA;NA	response to virus;canonical glycolysis;positive regulation of plasminogen activation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;negative regulation of transcription, DNA-templated;negative regulation of cell growth;gluconeogenesis;positive regulation of muscle contraction;positive regulation of ATP biosynthetic process	GO:000961; GO:006162; GO:001075; GO:000012; GO:190329; GO:004589; GO:003030; GO:000609; GO:004593; GO:200117	cytoplasm;cell cortex region;M band;phosphopyruvate hydratase complex;plasma membrane;extracellular exosome;nucleus;cell surface;cytosol;membrane;extracellular space	GO:000573; GO:009973; GO:003143; GO:000001; GO:000588; GO:007006; GO:000563; GO:000998; GO:000582; GO:001602; GO:000561	 Carbon metabolism; Glycolysis / Gluconeogenesis; Biosynthesis of antibiotics; Metabolic pathways; HIF-1 signaling pathway; Biosynthesis of amino acids; RNA degradation	hsa0120; hsa0001; hsa0113; hsa0110; hsa0406; hsa0123; hsa0301	phosphopyruvate hydratase activity;RNA polymerase II regulatory region sequence-specific DNA binding;protein homodimerization activity;magnesium ion binding;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding;RNA binding;cadherin binding;protein binding;GTPase binding	GO:000463; GO:000097; GO:004280; GO:000028; GO:000122; GO:000372; GO:004529; GO:000551; GO:005102
XP_020950947.1;XP_020950946.1;XP_020950945.1;XP_020950944.1	XP_020950947.1;XP_020950946.1;XP_020950945.1;XP_020950944.1	XP_020950947.1 GDH/6PGL endoplasmic bifunctional protein isoform X3 [Sus scrofa];XP_020950946.1 GDH/6PGL endoplasmic bifunctional protein isoform X3 [Sus scrofa];XP_020950945.1 GDH/6PGL endoplasmic bifunctional protein isoform X2 [Sus scrofa];XP_020950944.	10	10	10	0	41636000	32233000	40431000	27616000	38587000	30483000	30665000	46402000	27481000	49770000	35312000	29001000	41310000	35232000	43937000	46854000	25214000	NA	NA	NA	H6PD	H6PD;H6PD;H6PD;H6PD;NA	pentose-phosphate shunt;oxidation-reduction process;glucose metabolic process	GO:000609; GO:005511; GO:000600	endoplasmic reticulum lumen	GO:000578	 Metabolic pathways; Carbon metabolism; Pentose phosphate pathway	hsa0110; hsa0120; hsa0003	6-phosphogluconolactonase activity;glucose-6-phosphate dehydrogenase activity;glucose 1-dehydrogenase [NAD(P);NADP binding	GO:001705; GO:000434; GO:004793; GO:005066
XP_020950968.1	XP_020950968.1	XP_020950968.1 LOW QUALITY PROTEIN: protein LZIC [Sus scrofa]	5	5	5	33875000	43183000	34833000	41819000	34003000	30670000	36509000	50939000	50867000	54166000	29744000	43566000	30211000	36744000	31162000	35940000	27352000	32782000	NA	NA	NA	LZIC	LZIC;NA;NA;NA;NA	response to ionizing radiation	GO:001021	"NA"	"NA"	"NA"	"NA"	beta-catenin binding	GO:000801
XP_020950991.1	XP_020950991.1	XP_020950991.1 TAR DNA-binding protein 43 [Sus scrofa]	4	4	4	0	5520100	6085600	5509200	8913100	6871000	0	8983900	7518000	14441000	0	13931000	0	6547500	0	8438500	5762100	7869100	NA	NA	NA	TARDBP	TARDBP;NA;NA;NA;NA	negative regulation of gene expression;response to endoplasmic reticulum stress;positive regulation of protein import into nucleus;positive regulation of transcription from RNA polymerase II promoter;nuclear inner membrane organization;negative regulation of protein phosphorylation;regulation of apoptotic process;transcription from RNA polymerase II promoter;mRNA processing;RNA splicing;regulation of cell cycle;negative regulation by host of viral transcription;3'-UTR-mediated mRNA stabilization;positive regulation of insulin secretion	GO:001062; GO:003497; GO:004230; GO:004594; GO:007176; GO:000193; GO:004298; GO:000636; GO:000639; GO:000838; GO:005172; GO:004392; GO:007093; GO:003202	nucleus;interchromatin granule;ribonucleoprotein complex;perichromatin fibrils;cytoplasm;nucleoplasm;nuclear speck	GO:000563; GO:003506; GO:199090; GO:000572; GO:000573; GO:000565; GO:001660	"NA"	"NA"	transcription factor activity, sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;double-stranded DNA binding;sequence-specific double-stranded DNA binding;identical protein binding	GO:000370; GO:000372; GO:000373; GO:000551; GO:000369; GO:199083; GO:004280
XP_020951041.1	XP_020951041.1	XP_020951041.1 short-chain dehydrogenase/reductase 3 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7526000	0	NA	NA	NA	DHRS3	DHRS3;NA;NA;NA;NA	bone morphogenesis;retinol metabolic process;regulation of ossification;electron transport chain;negative regulation of retinoic acid receptor signaling pathway;visual perception;outflow tract morphogenesis;palate development;cardiac septum morphogenesis;retinoid metabolic process	GO:006034; GO:004257; GO:003027; GO:002290; GO:004838; GO:000760; GO:000315; GO:006002; GO:006041; GO:000152	integral component of membrane;endoplasmic reticulum membrane;lipid particle;photoreceptor outer segment membrane	GO:001602; GO:000578; GO:000581; GO:004262	 Retinol metabolism; Metabolic pathways	hsa0083; hsa0110	nucleotide binding;NADP-retinol dehydrogenase activity;electron carrier activity;retinol dehydrogenase activity	GO:000016; GO:005265; GO:000905; GO:000474
XP_020951123.1	XP_020951123.1	XP_020951123.1 LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase UBR4 [Sus scrofa]	3	3	3	0	14962000	21802000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	UBR4	UBR4;NA;NA;NA;NA	ubiquitin-dependent protein catabolic process;protein ubiquitination;neutrophil degranulation;viral process	GO:000651; GO:001656; GO:004331; GO:001603	integral component of membrane;centrosome;plasma membrane;specific granule membrane;ficolin-1-rich granule membrane;cytosol;nucleoplasm;membrane;tertiary granule membrane	GO:001602; GO:000581; GO:000588; GO:003557; GO:010100; GO:000582; GO:000565; GO:001602; GO:007082	 Viral carcinogenesis	hsa0520	zinc ion binding;protein binding;ubiquitin-protein transferase activity	GO:000827; GO:000551; GO:000484
XP_020951154.1;XP_020951150.1;XP_020951144.1;XP_020951143.1;XP_020951141.1;XP_020951148.1;XP_020951145.1;XP_020951142.1;XP_020951139.1;XP_020951146.1;XP_020951147.1;XP_020951152.1;XP_020951151.1;XP_020951153.1	XP_020951154.1;XP_020951150.1;XP_020951144.1;XP_020951143.1;XP_020951141.1;XP_020951148.1;XP_020951145.1;XP_020951142.1;XP_020951139.1;XP_020951146.1;XP_020951147.1;XP_020951152.1;XP_020951151.1;XP_020951153.1	XP_020951154.1 basement membrane-specific heparan sulfate proteoglycan core protein isoform X16 [Sus scrofa];XP_020951150.1 basement membrane-specific heparan sulfate proteoglycan core protein isoform X12 [Sus scrofa];XP_020951144.1 basement membrane-speci	144	144	1	6750400000	8507300000	6065300000	8232000000	5486100000	4422400000	6267100000	8680300000	5201100000	6352100000	6914100000	11027000000	4998800000	8726700000	6385500000	8362200000	6091600000	6322000000	NA	NA	NA	HSPG2	HSPG2;HSPG2;HSPG2;HSPG2;HSPG2	receptor-mediated endocytosis;cardiovascular system development;lipid metabolic process;negative regulation of angiogenesis;cell differentiation;cellular protein metabolic process;retinoid metabolic process;extracellular matrix organization;inflammatory response;glycosaminoglycan biosynthetic process;brain development	GO:000689; GO:007235; GO:000662; GO:001652; GO:003015; GO:004426; GO:000152; GO:003019; GO:000695; GO:000602; GO:000742	basement membrane;extracellular space;extracellular exosome;extracellular region;focal adhesion;lysosomal lumen;plasma membrane;Golgi lumen;plasma membrane protein complex	GO:000560; GO:000561; GO:007006; GO:000557; GO:000592; GO:004320; GO:000588; GO:000579; GO:009879	 ECM-receptor interaction; Hepatitis B; Proteoglycans in cancer	hsa0451; hsa0516; hsa0520	protein C-terminus binding;extracellular matrix structural constituent conferring compression resistance;protein binding;calcium ion binding;beta-amyloid binding;low-density lipoprotein particle receptor binding	GO:000802; GO:003002; GO:000551; GO:000550; GO:000154; GO:005075
XP_020951155.1;XP_020951149.1;XP_020951140.1	XP_020951155.1;XP_020951149.1;XP_020951140.1	XP_020951155.1 basement membrane-specific heparan sulfate proteoglycan core protein isoform X17 [Sus scrofa];XP_020951149.1 basement membrane-specific heparan sulfate proteoglycan core protein isoform X11 [Sus scrofa];XP_020951140.1 basement membrane-speci	144	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	6667400	0	0	0	0	NA	NA	NA	HSPG2	HSPG2;HSPG2;HSPG2;NA;NA	receptor-mediated endocytosis;cardiovascular system development;lipid metabolic process;negative regulation of angiogenesis;cell differentiation;cellular protein metabolic process;retinoid metabolic process;extracellular matrix organization;inflammatory response;glycosaminoglycan biosynthetic process;brain development	GO:000689; GO:007235; GO:000662; GO:001652; GO:003015; GO:004426; GO:000152; GO:003019; GO:000695; GO:000602; GO:000742	basement membrane;extracellular space;extracellular exosome;extracellular region;focal adhesion;lysosomal lumen;plasma membrane;Golgi lumen;plasma membrane protein complex	GO:000560; GO:000561; GO:007006; GO:000557; GO:000592; GO:004320; GO:000588; GO:000579; GO:009879	 ECM-receptor interaction; Hepatitis B; Proteoglycans in cancer	hsa0451; hsa0516; hsa0520	protein C-terminus binding;extracellular matrix structural constituent conferring compression resistance;protein binding;calcium ion binding;beta-amyloid binding;low-density lipoprotein particle receptor binding	GO:000802; GO:003002; GO:000551; GO:000550; GO:000154; GO:005075
XP_020951173.1;XP_020951172.1;XP_020951171.1;XP_020951175.1;XP_020951170.1;XP_020951169.1;XP_020951174.1	XP_020951173.1;XP_020951172.1;XP_020951171.1;XP_020951175.1;XP_020951170.1;XP_020951169.1;XP_020951174.1	XP_020951173.1 heterogeneous nuclear ribonucleoprotein R isoform X2 [Sus scrofa];XP_020951172.1 heterogeneous nuclear ribonucleoprotein R isoform X2 [Sus scrofa];XP_020951171.1 heterogeneous nuclear ribonucleoprotein R isoform X2 [Sus scrofa];XP_020951175.	7	5	5	22580000	26109000	18551000	21828000	20158000	14971000	15666000	24046000	14527000	22643000	29928000	0	30387000	26440000	11313000	16063000	20567000	20176000	NA	NA	NA	HNRNPR	HNRNPR;HNRNPR;HNRNPR;HNRNPR;HNRNPR	mRNA destabilization;negative regulation of catalytic activity;mRNA processing;circadian rhythm;mRNA splicing, via spliceosome;RNA metabolic process	GO:006115; GO:004308; GO:000639; GO:000762; GO:000039; GO:001607	nucleolus;dendrite;nucleus;nucleoplasm;ribonucleoprotein complex;endoplasmic reticulum;spliceosomal complex;catalytic step 2 spliceosome;axon terminus	GO:000573; GO:003042; GO:000563; GO:000565; GO:199090; GO:000578; GO:000568; GO:007101; GO:004367	"NA"	"NA"	protein binding;RNA binding;mRNA 3'-UTR binding	GO:000551; GO:000372; GO:000373
XP_020951248.1	XP_020951248.1	XP_020951248.1 chloride intracellular channel protein 4 [Sus scrofa]	10	10	10	128350000	100510000	134190000	154570000	142270000	165450000	158640000	138650000	137890000	161070000	158140000	116750000	266180000	175410000	110610000	129740000	162860000	170560000	NA	NA	NA	CLIC4	CLIC4;NA;NA;NA;NA	establishment or maintenance of apical/basal cell polarity;chloride transmembrane transport;chloride transport;vacuolar acidification;cellular response to calcium ion;retina vasculature morphogenesis in camera-type eye;fertilization;keratinocyte differentiation;regulation of ion transmembrane transport;multicellular organism growth;cell differentiation;angiogenesis;endothelial cell morphogenesis;negative regulation of cell migration;branching morphogenesis of an epithelial tube;regulation of cytoskeleton organization	GO:003508; GO:190247; GO:000682; GO:000703; GO:007127; GO:006129; GO:000956; GO:003021; GO:003476; GO:003526; GO:003015; GO:000152; GO:000188; GO:003033; GO:004875; GO:005149	microtubule cytoskeleton;nuclear matrix;midbody;mitochondrion;cell surface;cytosol;chloride channel complex;perinuclear region of cytoplasm;centrosome;extracellular exosome;apical part of cell;cell-cell junction;nucleus;microvillus;cytoplasmic vesicle membrane;plasma membrane;actin cytoskeleton	GO:001563; GO:001636; GO:003049; GO:000573; GO:000998; GO:000582; GO:003470; GO:004847; GO:000581; GO:007006; GO:004517; GO:000591; GO:000563; GO:000590; GO:003065; GO:000588; GO:001562	"NA"	"NA"	protein binding;voltage-gated ion channel activity;chloride channel activity	GO:000551; GO:000524; GO:000525
XP_020951286.1	XP_020951286.1	XP_020951286.1 SH3 domain-binding glutamic acid-rich-like protein 3 [Sus scrofa]	3	3	3	82851000	97581000	79050000	81716000	78816000	62697000	65713000	81277000	75679000	74758000	76435000	0	146270000	93374000	86370000	75413000	66133000	101060000	NA	NA	NA	SH3BGRL3	SH3BGRL3;NA;NA;NA;NA	cell redox homeostasis;electron transport chain	GO:004545; GO:002290	nuclear body;extracellular exosome;cytoplasm	GO:001660; GO:007006; GO:000573	"NA"	"NA"	electron carrier activity;protein disulfide oxidoreductase activity	GO:000905; GO:001503
XP_020951502.1;XP_020951501.1;XP_020951505.1;XP_020951503.1	XP_020951502.1;XP_020951501.1;XP_020951505.1;XP_020951503.1	XP_020951502.1 adenylate kinase 2, mitochondrial isoform X2 [Sus scrofa];XP_020951501.1 adenylate kinase 2, mitochondrial isoform X1 [Sus scrofa];XP_020951505.1 adenylate kinase 2, mitochondrial isoform X4 [Sus scrofa];XP_020951503.1 adenylate kinase 2, mi	10	10	10	131920000	75605000	129810000	68199000	124410000	50212000	157500000	102970000	136050000	98653000	96957000	49721000	56672000	69674000	135810000	90523000	82110000	58189000	NA	NA	NA	AK2	AK2;AK2;AK2;AK2;NA	nucleobase-containing small molecule interconversion;phosphorylation;ATP metabolic process;ADP biosynthetic process;nucleoside monophosphate phosphorylation	GO:001594; GO:001631; GO:004603; GO:000617; GO:004694	sperm mitochondrial sheath;extracellular exosome;mitochondrial intermembrane space	GO:009722; GO:007006; GO:000575	 Biosynthesis of antibiotics; Purine metabolism; Metabolic pathways	hsa0113; hsa0023; hsa0110	adenylate kinase activity;ATP binding	GO:000401; GO:000552
XP_020951556.1;XP_020951557.1	XP_020951556.1;XP_020951557.1	XP_020951556.1 splicing factor, proline- and glutamine-rich isoform X1 [Sus scrofa];XP_020951557.1 splicing factor, proline- and glutamine-rich isoform X2 [Sus scrofa]	7	7	7	54208000	70118000	56693000	72098000	65223000	79358000	50085000	66286000	51838000	68997000	78745000	83370000	93954000	77042000	91604000	67740000	65177000	67051000	NA	NA	NA	SFPQ	SFPQ;SFPQ;NA;NA;NA	regulation of circadian rhythm;negative regulation of circadian rhythm;negative regulation of transcription from RNA polymerase II promoter;activation of innate immune response;positive regulation of sister chromatid cohesion;positive regulation of transcription from RNA polymerase II promoter;alternative mRNA splicing, via spliceosome;double-strand break repair via homologous recombination;RNA splicing;innate immune response;rhythmic process;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;negative regulation of transcription, DNA-templated;histone H3 deacetylation;mRNA processing;dendritic transport of messenger ribonucleoprotein complex	GO:004275; GO:004275; GO:000012; GO:000221; GO:004587; GO:004594; GO:000038; GO:000072; GO:000838; GO:004508; GO:004851; GO:190217; GO:004589; GO:007093; GO:000639; GO:009896	dendrite cytoplasm;chromatin;nuclear matrix;nucleus;RNA polymerase II transcription factor complex;nuclear speck;nucleoplasm;paraspeckles	GO:003283; GO:000078; GO:001636; GO:000563; GO:009057; GO:001660; GO:000565; GO:004238	"NA"	"NA"	protein binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;chromatin binding;protein homodimerization activity;DNA binding;transcription regulatory region sequence-specific DNA binding;histone deacetylase binding;E-box binding;RNA binding;transcription regulatory region DNA binding	GO:000551; GO:000098; GO:000368; GO:004280; GO:000367; GO:000097; GO:004282; GO:007088; GO:000372; GO:004421
XP_020951579.1	XP_020951579.1	XP_020951579.1 proteasome subunit beta type-2 [Sus scrofa]	7	7	7	60451000	56533000	55245000	53453000	50708000	44482000	53452000	60959000	62602000	43771000	49046000	35880000	58860000	48695000	56895000	56846000	53542000	46389000	NA	NA	NA	PSMB2	PSMB2;NA;NA;NA;NA	proteasomal ubiquitin-independent protein catabolic process;viral process;proteasomal protein catabolic process;response to organic cyclic compound;protein deubiquitination;post-translational protein modification;proteasome-mediated ubiquitin-dependent protein catabolic process;response to organonitrogen compound	GO:001049; GO:001603; GO:001049; GO:001407; GO:001657; GO:004368; GO:004316; GO:001024	proteasome core complex;nucleoplasm;proteasome complex;proteasome core complex, beta-subunit complex;extracellular exosome;cytosol;nucleus;membrane;cytoplasm	GO:000583; GO:000565; GO:000050; GO:001977; GO:007006; GO:000582; GO:000563; GO:001602; GO:000573	 Proteasome	hsa0305	protein binding;threonine-type endopeptidase activity;endopeptidase activity	GO:000551; GO:000429; GO:000417
XP_020951588.1	XP_020951588.1	XP_020951588.1 thyroid hormone receptor-associated protein 3 [Sus scrofa]	3	3	3	0	12537000	9238900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10990000	NA	NA	NA	THRAP3	THRAP3;NA;NA;NA;NA	positive regulation of circadian rhythm;transcription initiation from RNA polymerase II promoter;mRNA processing;androgen receptor signaling pathway;nuclear-transcribed mRNA catabolic process;mRNA stabilization;circadian rhythm;RNA splicing;intracellular steroid hormone receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription, DNA-templated;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome	GO:004275; GO:000636; GO:000639; GO:003052; GO:000095; GO:004825; GO:000762; GO:000838; GO:003051; GO:000038; GO:004589; GO:004594; GO:004802	nucleus;nucleoplasm;exon-exon junction complex;nuclear speck;extracellular exosome;mediator complex	GO:000563; GO:000565; GO:003514; GO:001660; GO:007006; GO:001659	"NA"	"NA"	transcription cofactor activity;vitamin D receptor binding;ligand-dependent nuclear receptor transcription coactivator activity;phosphoprotein binding;protein binding;transcription coactivator activity;ATP binding;thyroid hormone receptor binding;signaling receptor activity;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding	GO:000371; GO:004280; GO:003037; GO:005121; GO:000551; GO:000371; GO:000552; GO:004696; GO:003802; GO:000098; GO:000372
XP_020951661.1;XP_020951660.1;XP_020951659.1;XP_020951658.1;XP_020951668.1;XP_020951667.1;XP_020951666.1	XP_020951661.1;XP_020951660.1;XP_020951659.1;XP_020951658.1;XP_020951668.1;XP_020951667.1;XP_020951666.1	XP_020951661.1 adenylyl cyclase-associated protein 1 isoform X2 [Sus scrofa];XP_020951660.1 adenylyl cyclase-associated protein 1 isoform X2 [Sus scrofa];XP_020951659.1 adenylyl cyclase-associated protein 1 isoform X2 [Sus scrofa];XP_020951658.1 adenylyl c	20	1	1	2990100	2804500	2888500	2056400	3372000	0	0	4283800	3178700	4092600	0	9940900	0	0	0	0	0	2865500	NA	NA	NA	CAP1	CAP1;CAP1;CAP1;CAP1;CAP1	receptor-mediated endocytosis;actin polymerization or depolymerization;cell morphogenesis;activation of adenylate cyclase activity;ameboidal-type cell migration;signal transduction;neutrophil degranulation	GO:000689; GO:000815; GO:000090; GO:000719; GO:000166; GO:000716; GO:004331	extracellular region;focal adhesion;plasma membrane;cortical actin cytoskeleton;azurophil granule lumen;extracellular exosome	GO:000557; GO:000592; GO:000588; GO:003086; GO:003557; GO:007006	"NA"	"NA"	adenylate cyclase binding;actin binding	GO:000817; GO:000377
XP_020951683.1	XP_020951683.1	XP_020951683.1 LOW QUALITY PROTEIN: AFG3-like protein 2 [Sus scrofa]	6	6	6	185260000	140860000	203830000	124840000	260720000	0	241110000	114180000	332430000	122030000	167270000	66516000	0	134290000	180490000	0	212500000	0	NA	NA	NA	AFG3L2	AFG3L2;NA;NA;NA;NA	proteolysis;mitochondrial fusion;myelination;muscle fiber development;mitochondrial calcium uptake;mitochondrial calcium ion homeostasis;axonogenesis;nerve development;mitochondrial calcium ion transport;neuromuscular junction development;protein autoprocessing;mitochondrial protein processing;protein processing;regulation of multicellular organism growth;cristae formation;righting reflex	GO:000650; GO:000805; GO:004255; GO:004874; GO:003644; GO:005156; GO:000740; GO:002167; GO:000685; GO:000752; GO:001654; GO:003498; GO:001648; GO:004001; GO:004240; GO:006001	mitochondrial inner membrane;mitochondrion;m-AAA complex	GO:000574; GO:000573; GO:000574	"NA"	"NA"	protein binding;metalloendopeptidase activity;ATP binding;zinc ion binding;unfolded protein binding;metallopeptidase activity	GO:000551; GO:000422; GO:000552; GO:000827; GO:005108; GO:000823
XP_020951690.1	XP_020951690.1	XP_020951690.1 LOW QUALITY PROTEIN: tubulin beta-6 chain [Sus scrofa]	12	4	4	0	64850000	22669000	23561000	21662000	30279000	20152000	35400000	32190000	35402000	36062000	48929000	56024000	27173000	0	25033000	22374000	58102000	NA	NA	NA	TUBB6	TUBB6;NA;NA;NA;NA	microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process	GO:000022; GO:000027; GO:000701	microtubule;cytoplasm;extracellular exosome;nucleus	GO:000587; GO:000573; GO:007006; GO:000563	 Pathogenic Escherichia coli infection; Phagosome; Gap junction	hsa0513; hsa0414; hsa0454	GTPase activity;molecular_function;structural constituent of cytoskeleton;GTP binding	GO:000392; GO:000367; GO:000520; GO:000552
XP_020951710.1	XP_020951710.1	XP_020951710.1 gamma-soluble NSF attachment protein [Sus scrofa]	6	6	6	0	26533000	25168000	18555000	26073000	21555000	24221000	19525000	20154000	21779000	0	22703000	0	26164000	26301000	26265000	23515000	0	NA	NA	NA	NAPG	NAPG;NA;NA;NA;NA	intracellular protein transport;intra-Golgi vesicle-mediated transport;membrane fusion;macromolecular complex assembly;protein stabilization	GO:000688; GO:000689; GO:006102; GO:006500; GO:005082	mitochondrion;lysosomal membrane;SNARE complex;synapse;vacuolar membrane;extracellular exosome	GO:000573; GO:000576; GO:003120; GO:004520; GO:000577; GO:007006	"NA"	"NA"	soluble NSF attachment protein activity;syntaxin binding;protein binding	GO:000548; GO:001990; GO:000551
XP_020951713.1;XP_020951712.1;XP_020951714.1	XP_020951713.1;XP_020951712.1;XP_020951714.1	XP_020951713.1 vesicle-associated membrane protein-associated protein A isoform X2 [Sus scrofa];XP_020951712.1 vesicle-associated membrane protein-associated protein A isoform X1 [Sus scrofa];XP_020951714.1 vesicle-associated membrane protein-associated pr	6	5	5	29862000	41451000	38789000	0	35659000	44322000	37109000	19212000	23179000	27894000	30746000	52390000	0	34970000	36273000	0	28618000	0	NA	NA	NA	VAPA	VAPA;VAPA;VAPA;NA;NA	endoplasmic reticulum organization;positive regulation by host of viral genome replication;positive regulation of I-kappaB kinase/NF-kappaB signaling;ER to Golgi vesicle-mediated transport;membrane fusion;protein folding in endoplasmic reticulum;COPII-coated vesicle budding;protein localization to endoplasmic reticulum;cell death;sphingolipid biosynthetic process;neuron projection development;neutrophil degranulation;positive regulation by host of viral release from host cell	GO:000702; GO:004482; GO:004312; GO:000688; GO:006102; GO:003497; GO:009011; GO:007097; GO:000821; GO:003014; GO:003117; GO:004331; GO:004479	Golgi membrane;endoplasmic reticulum membrane;microtubule cytoskeleton;vesicle;azurophil granule membrane;perinuclear region of cytoplasm;plasma membrane;bicellular tight junction;endoplasmic reticulum exit site;integral component of membrane;nuclear membrane	GO:000013; GO:000578; GO:001563; GO:003198; GO:003557; GO:004847; GO:000588; GO:000592; GO:007097; GO:001602; GO:003196	 Tight junction	hsa0453	protein binding;protein heterodimerization activity;protein domain specific binding;microtubule binding;cadherin binding;FFAT motif binding	GO:000551; GO:004698; GO:001990; GO:000801; GO:004529; GO:003314
XP_020951716.1	XP_020951716.1	XP_020951716.1 ras-related protein Rab-31 [Sus scrofa]	2	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RAB31	RAB31;NA;NA;NA;NA	intracellular protein transport;phagosome maturation;receptor internalization;Rab protein signal transduction;Golgi to plasma membrane protein transport;positive regulation of phagocytosis, engulfment;neutrophil degranulation;regulated exocytosis;cellular response to insulin stimulus	GO:000688; GO:009038; GO:003162; GO:003248; GO:004300; GO:006010; GO:004331; GO:004505; GO:003286	phagocytic cup;plasma membrane;secretory granule membrane;trans-Golgi network membrane;early phagosome membrane;early endosome;early endosome membrane;cytosol;phagocytic vesicle	GO:000189; GO:000588; GO:003066; GO:003258; GO:003618; GO:000576; GO:003190; GO:000582; GO:004533	 Endocytosis	hsa0414	GTPase activity;protein binding;GDP binding;GTP binding	GO:000392; GO:000551; GO:001900; GO:000552
XP_020951771.1;XP_020951751.1;XP_020951750.1;XP_020951749.1;XP_020951748.1;XP_020951747.1;XP_020951746.1;XP_020951745.1;XP_020951759.1;XP_020951758.1;XP_020951757.1;XP_020951756.1;XP_020951755.1;XP_020951754.1;XP_020951753.1;XP_020951752.1;XP_020951786.1;XP_020951785.1;XP_020951783.1;XP_020951777.1;XP_020951776.1;XP_020951782.1;XP_020951781.1;XP_020951775.1;XP_020951772.1;XP_020951770.1;XP_020951769.1;XP_020951768.1;XP_020951767.1;XP_020951766.1;XP_020951765.1;XP_020951764.1;XP_020951763.1;XP_020951761.1	XP_020951771.1;XP_020951751.1;XP_020951750.1;XP_020951749.1;XP_020951748.1;XP_020951747.1;XP_020951746.1;XP_020951745.1;XP_020951759.1;XP_020951758.1;XP_020951757.1;XP_020951756.1;XP_020951755.1;XP_020951754.1;XP_020951753.1;XP_020951752.1;XP_020951786.1;XP_020951785.1;XP_020951783.1;XP_020951777.1;XP_020951776.1;XP_020951782.1;XP_020951781.1;XP_020951775.1;XP_020951772.1;XP_020951770.1;XP_020951769.1;XP_020951768.1;XP_020951767.1;XP_020951766.1;XP_020951765.1;XP_020951764.1;XP_020951763.1;XP_020951761.1	XP_020951771.1 band 4.1-like protein 3 isoform X22 [Sus scrofa];XP_020951751.1 band 4.1-like protein 3 isoform X7 [Sus scrofa];XP_020951750.1 band 4.1-like protein 3 isoform X6 [Sus scrofa];XP_020951749.1 band 4.1-like protein 3 isoform X5 [Sus scrofa];XP_	17	16	1	65816000	58107000	147380000	16589000	0	0	29801000	0	63210000	28395000	30961000	0	0	0	18527000	19009000	0	18933000	NA	NA	NA	EPB41L3	EPB41L3;EPB41L3;EPB41L3;EPB41L3;EPB41L3	apoptotic process;cytoskeletal anchoring at plasma membrane;protein localization to juxtaparanode region of axon;cortical actin cytoskeleton organization;paranodal junction assembly;regulation of cell growth;protein localization to paranode region of axon;protein localization to plasma membrane;biological_process;actomyosin structure organization;neuron projection morphogenesis;regulation of cell shape;myelin maintenance	GO:000691; GO:000701; GO:007120; GO:003086; GO:003091; GO:000155; GO:000217; GO:007265; GO:000815; GO:003103; GO:004881; GO:000836; GO:004321	plasma membrane;cytosol;cytoskeleton;juxtaparanode region of axon;paranode region of axon;cell-cell junction;postsynaptic density;axolemma	GO:000588; GO:000582; GO:000585; GO:004422; GO:003327; GO:000591; GO:001406; GO:003067	 Tight junction	hsa0453	protein binding;structural constituent of cytoskeleton;actin binding	GO:000551; GO:000520; GO:000377
XP_020951760.1;XP_020951779.1;XP_020951778.1;XP_020951780.1;XP_020951774.1	XP_020951760.1;XP_020951779.1;XP_020951778.1;XP_020951780.1;XP_020951774.1	XP_020951760.1 band 4.1-like protein 3 isoform X12 [Sus scrofa];XP_020951779.1 band 4.1-like protein 3 isoform X29 [Sus scrofa];XP_020951778.1 band 4.1-like protein 3 isoform X28 [Sus scrofa];XP_020951780.1 band 4.1-like protein 3 isoform X24 [Sus scrofa];	17	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	EPB41L3	EPB41L3;EPB41L3;EPB41L3;EPB41L3;EPB41L3	apoptotic process;cytoskeletal anchoring at plasma membrane;protein localization to juxtaparanode region of axon;cortical actin cytoskeleton organization;paranodal junction assembly;regulation of cell growth;protein localization to paranode region of axon;protein localization to plasma membrane;biological_process;actomyosin structure organization;neuron projection morphogenesis;regulation of cell shape;myelin maintenance	GO:000691; GO:000701; GO:007120; GO:003086; GO:003091; GO:000155; GO:000217; GO:007265; GO:000815; GO:003103; GO:004881; GO:000836; GO:004321	plasma membrane;cytosol;cytoskeleton;juxtaparanode region of axon;paranode region of axon;cell-cell junction;postsynaptic density;axolemma	GO:000588; GO:000582; GO:000585; GO:004422; GO:003327; GO:000591; GO:001406; GO:003067	 Tight junction	hsa0453	protein binding;structural constituent of cytoskeleton;actin binding	GO:000551; GO:000520; GO:000377
XP_020951795.1;XP_020951794.1	XP_020951795.1;XP_020951794.1	XP_020951795.1 EMILIN-2 isoform X2 [Sus scrofa];XP_020951794.1 EMILIN-2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6707000	NA	NA	NA	EMILIN2	EMILIN2;EMILIN2;NA;NA;NA	cell adhesion;biological_process;positive regulation of cell-substrate adhesion	GO:000715; GO:000815; GO:001081	collagen trimer;extracellular region;extracellular matrix	GO:000558; GO:000557; GO:003101	"NA"	"NA"	extracellular matrix constituent conferring elasticity;protein binding	GO:003002; GO:000551
XP_020951815.1;XP_020951814.1	XP_020951815.1;XP_020951814.1	XP_020951815.1 collectin-12 isoform X2 [Sus scrofa];XP_020951814.1 collectin-12 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6498400	0	NA	NA	NA	COLEC12	COLEC12;COLEC12;NA;NA;NA	phagocytosis, recognition;toll-like receptor 3 signaling pathway;positive regulation of cell adhesion molecule production;carbohydrate mediated signaling;innate immune response;protein homooligomerization;defense response;receptor-mediated endocytosis;regulation of immune response;cellular response to exogenous dsRNA	GO:000691; GO:003413; GO:006035; GO:000975; GO:004508; GO:005126; GO:000695; GO:000689; GO:005077; GO:007136	plasma membrane;integral component of membrane;collagen trimer;endocytic vesicle membrane;extracellular space;extracellular matrix	GO:000588; GO:001602; GO:000558; GO:003066; GO:000561; GO:003101	 Phagosome	hsa0414	signaling pattern recognition receptor activity;scavenger receptor activity;low-density lipoprotein particle binding;galactose binding;metal ion binding	GO:000832; GO:000504; GO:003016; GO:000553; GO:004687
XP_020951821.1;XP_020951820.1;XP_020951818.1	XP_020951821.1;XP_020951820.1;XP_020951818.1	XP_020951821.1 ubiquitin carboxyl-terminal hydrolase 14 isoform X3 [Sus scrofa];XP_020951820.1 ubiquitin carboxyl-terminal hydrolase 14 isoform X2 [Sus scrofa];XP_020951818.1 ubiquitin carboxyl-terminal hydrolase 14 isoform X1 [Sus scrofa]	4	4	4	24171000	0	28588000	0	0	0	0	0	0	26923000	17917000	22781000	20897000	17310000	21801000	26311000	27448000	18149000	NA	NA	NA	USP14	USP14;USP14;USP14;NA;NA	chemical synaptic transmission;tRNA 5'-end processing;ubiquitin-dependent protein catabolic process;negative regulation of endopeptidase activity;regulation of proteasomal protein catabolic process;protein deubiquitination;regulation of chemotaxis;innate immune response;negative regulation of ER-associated ubiquitin-dependent protein catabolic process	GO:000726; GO:009911; GO:000651; GO:001095; GO:006113; GO:001657; GO:005092; GO:004508; GO:190307	proteasome complex;cell surface;extracellular exosome;plasma membrane;cytoplasmic vesicle;synapse;cytosol	GO:000050; GO:000998; GO:007006; GO:000588; GO:003141; GO:004520; GO:000582	"NA"	"NA"	proteasome binding;thiol-dependent ubiquitin-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity;protein binding;tRNA guanylyltransferase activity;cysteine-type endopeptidase activity;endopeptidase inhibitor activity	GO:007062; GO:000484; GO:003645; GO:000551; GO:000819; GO:000419; GO:000486
XP_020952016.1	XP_020952016.1	XP_020952016.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22506000	NA	NA	NA	GNG5	GNG5;NA;NA;NA;NA	G-protein coupled receptor signaling pathway;positive regulation of secondary heart field cardioblast proliferation;signal transduction;positive regulation of neural precursor cell proliferation	GO:000718; GO:007251; GO:000716; GO:200017	G-protein beta/gamma-subunit complex;heterotrimeric G-protein complex;membrane;extracellular exosome;plasma membrane	GO:003168; GO:000583; GO:001602; GO:007006; GO:000588	 Cholinergic synapse; Pathways in cancer; PI3K-Akt signaling pathway; Circadian entrainment; Morphine addiction; Glutamatergic synapse; Ras signaling pathway; Chemokine signaling pathway	hsa0472; hsa0520; hsa0415; hsa0471; hsa0503; hsa0472; hsa0401; hsa0406	protein binding;GTPase activity;PDZ domain binding	GO:000551; GO:000392; GO:003016
XP_020952022.1;XP_020952029.1;XP_020952028.1;XP_020952027.1;XP_020952026.1;XP_020952025.1;XP_020952024.1;XP_020952023.1;XP_020952020.1	XP_020952022.1;XP_020952029.1;XP_020952028.1;XP_020952027.1;XP_020952026.1;XP_020952025.1;XP_020952024.1;XP_020952023.1;XP_020952020.1	XP_020952022.1 cAMP-dependent protein kinase catalytic subunit beta isoform X2 [Sus scrofa];XP_020952029.1 cAMP-dependent protein kinase catalytic subunit beta isoform X9 [Sus scrofa];XP_020952028.1 cAMP-dependent protein kinase catalytic subunit beta isof	11	4	4	0	13173000	13098000	0	0	0	11604000	17190000	14895000	0	0	21192000	13242000	13683000	14723000	18403000	0	14312000	NA	NA	NA	PRKACB	PRKACB;PRKACB;PRKACB;PRKACB;PRKACB	neural tube closure;signal transduction;stimulatory C-type lectin receptor signaling pathway;negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;renal water homeostasis;protein phosphorylation;activation of protein kinase A activity;regulation of protein processing;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;response to clozapine;high-density lipoprotein particle assembly;cellular response to glucagon stimulus;blood coagulation;negative regulation of meiotic cell cycle	GO:000184; GO:000716; GO:000222; GO:190162; GO:000309; GO:000646; GO:003419; GO:007061; GO:000718; GO:009733; GO:003438; GO:007137; GO:000759; GO:005144	extracellular exosome;ciliary base;plasma membrane;nucleoplasm;intercellular bridge;cytosol;perinuclear region of cytoplasm;centrosome;cAMP-dependent protein kinase complex	GO:007006; GO:009754; GO:000588; GO:000565; GO:004517; GO:000582; GO:004847; GO:000581; GO:000595	 MAPK signaling pathway; Adrenergic signaling in cardiomyocytes; Olfactory transduction; Inflammatory mediator regulation of TRP channels; Ovarian steroidogenesis; Gastric acid secretion; cAMP signaling pathway; Long-term potentiation; Regulation of lipolysis in adipocytes; Parkinson's disease; Pathways in cancer; Dilated cardiomyopathy; Wnt signaling pathway; Prion diseases; Cocaine addiction; Chemokine signaling pathway; Apoptosis; Vascular smooth muscle contraction; Hedgehog signaling pathway; Endocrine and other factor-regulated calcium reabsorption; Oocyte meiosis; Circadian entrainment; Vibrio cholerae infection; Amoebiasis; Ras signaling pathway; Gap junction; Platelet activation; HTLV-I infection	hsa0401; hsa0426; hsa0474; hsa0475; hsa0491; hsa0497; hsa0402; hsa0472; hsa0492; hsa0501; hsa0520; hsa0541; hsa0431; hsa0502; hsa0503; hsa0406; hsa0421; hsa0427; hsa0434; hsa0496; hsa0411; hsa0471; hsa0511; hsa0514; hsa0401; hsa0454; hsa0461; hsa0516	protein serine/threonine kinase activity;ATP binding;cAMP-dependent protein kinase activity;magnesium ion binding;protein binding;ubiquitin protein ligase binding;protein kinase A regulatory subunit binding	GO:000467; GO:000552; GO:000469; GO:000028; GO:000551; GO:003162; GO:003423
XP_020952104.1;XP_020952101.1;XP_020952103.1;XP_020952102.1;XP_005665433.3;XP_020952099.1;XP_020952098.1	XP_020952104.1;XP_020952101.1;XP_020952103.1;XP_020952102.1;XP_005665433.3;XP_020952099.1;XP_020952098.1	XP_020952104.1 nexilin isoform X6 [Sus scrofa];XP_020952101.1 nexilin isoform X3 [Sus scrofa];XP_020952103.1 nexilin isoform X5 [Sus scrofa];XP_020952102.1 nexilin isoform X4 [Sus scrofa];XP_005665433.3 nexilin isoform X2 [Sus scrofa];XP_020952099.1 nexili	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	49943000	0	0	0	0	0	NA	NA	NA	NEXN	NEXN;NEXN;NEXN;NEXN;NEXN	regulation of cell migration;axon guidance;regulation of cytoskeleton organization;dendrite self-avoidance;response to bacterium;homophilic cell adhesion via plasma membrane adhesion molecules	GO:003033; GO:000741; GO:005149; GO:007059; GO:000961; GO:000715	plasma membrane;cytoskeleton;Z disc;focal adhesion;axon	GO:000588; GO:000585; GO:003001; GO:000592; GO:003042	"NA"	"NA"	actin filament binding;protein binding involved in cell-cell adhesion;structural constituent of muscle	GO:005101; GO:009863; GO:000830
XP_020952289.1;XP_020952288.1;XP_020952282.1;XP_020952281.1;XP_020952280.1	XP_020952289.1;XP_020952288.1;XP_020952282.1;XP_020952281.1;XP_020952280.1	XP_020952289.1 enoyl-CoA hydratase domain-containing protein 2, mitochondrial isoform X13 [Sus scrofa];XP_020952288.1 enoyl-CoA hydratase domain-containing protein 2, mitochondrial isoform X12 [Sus scrofa];XP_020952282.1 enoyl-CoA hydratase domain-containi	2	2	2	37710000	23349000	17974000	12211000	29118000	13189000	17303000	17771000	27997000	21194000	27452000	23969000	19998000	21464000	28727000	32099000	19679000	20646000	NA	NA	NA	ECHDC2	ECHDC2;ECHDC2;ECHDC2;ECHDC2;ECHDC2	fatty acid beta-oxidation	GO:000663	mitochondrion	GO:000573	"NA"	"NA"	enoyl-CoA hydratase activity	GO:000430
XP_020952318.1;XP_020952317.1;XP_020952316.1;XP_020952315.1;XP_020952314.1;XP_020952313.1	XP_020952318.1;XP_020952317.1;XP_020952316.1;XP_020952315.1;XP_020952314.1;XP_020952313.1	XP_020952318.1 transcription factor BTF3 homolog 4 isoform X2 [Sus scrofa];XP_020952317.1 transcription factor BTF3 homolog 4 isoform X2 [Sus scrofa];XP_020952316.1 transcription factor BTF3 homolog 4 isoform X2 [Sus scrofa];XP_020952315.1 transcription fa	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6536400	0	0	NA	NA	NA	BTF3L4	BTF3L4;BTF3L4;BTF3L4;BTF3L4;BTF3L4	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	protein binding	GO:000551
XP_020952320.1	XP_020952320.1	XP_020952320.1 thioredoxin domain-containing protein 12 [Sus scrofa]	3	3	3	20844000	24872000	31474000	30362000	26454000	0	22158000	25866000	31682000	24686000	22927000	36913000	20066000	41058000	29022000	34702000	27082000	28973000	NA	NA	NA	TXNDC12	TXNDC12;NA;NA;NA;NA	negative regulation of cell death;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;cell redox homeostasis;oxidation-reduction process	GO:006054; GO:190223; GO:004545; GO:005511	endoplasmic reticulum;endoplasmic reticulum lumen	GO:000578; GO:000578	 Glutathione metabolism	hsa0048	peptide disulfide oxidoreductase activity;protein binding;protein-disulfide reductase (glutathione) activity	GO:001503; GO:000551; GO:001915
XP_020952403.1;XP_020952402.1;XP_020952401.1	XP_020952403.1;XP_020952402.1;XP_020952401.1	XP_020952403.1 peroxiredoxin-1 [Sus scrofa];XP_020952402.1 peroxiredoxin-1 [Sus scrofa];XP_020952401.1 peroxiredoxin-1 [Sus scrofa]	11	11	9	833110000	1019100000	1221600000	957520000	895510000	947030000	1105200000	1003900000	1066800000	1047200000	599730000	517030000	885580000	942950000	778590000	851640000	919020000	782160000	NA	NA	NA	PRDX1	PRDX1;PRDX1;PRDX1;NA;NA	oxidation-reduction process;natural killer cell mediated cytotoxicity;cell proliferation;erythrocyte homeostasis;leukocyte activation;retina homeostasis;hydrogen peroxide catabolic process;cell redox homeostasis;cellular response to oxidative stress;removal of superoxide radicals;skeletal system development;natural killer cell activation;regulation of stress-activated MAPK cascade;response to oxidative stress;regulation of NIK/NF-kappaB signaling	GO:005511; GO:004226; GO:000828; GO:003410; GO:004532; GO:000189; GO:004274; GO:004545; GO:003459; GO:001943; GO:000150; GO:003010; GO:003287; GO:000697; GO:190122	nucleus;cytoplasm;cytosol;extracellular exosome;extracellular space;melanosome	GO:000563; GO:000573; GO:000582; GO:007006; GO:000561; GO:004247	 Peroxisome	hsa0414	thioredoxin peroxidase activity;cadherin binding;peroxidase activity;identical protein binding;protein binding;RNA binding	GO:000837; GO:004529; GO:000460; GO:004280; GO:000551; GO:000372
XP_020952569.1;XP_020952570.1;XP_020952568.1	XP_020952569.1;XP_020952570.1;XP_020952568.1	XP_020952569.1 prolyl 3-hydroxylase 1 isoform X2 [Sus scrofa];XP_020952570.1 prolyl 3-hydroxylase 1 isoform X3 [Sus scrofa];XP_020952568.1 prolyl 3-hydroxylase 1 isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8216500	NA	NA	NA	P3H1	P3H1;P3H1;P3H1;NA;NA	regulation of protein secretion;protein stabilization;protein folding;protein hydroxylation;chaperone-mediated protein folding;peptidyl-proline hydroxylation;collagen metabolic process;oxidation-reduction process;positive regulation of neuron projection development;negative regulation of post-translational protein modification;negative regulation of cell proliferation;bone development	GO:005070; GO:005082; GO:000645; GO:001812; GO:006107; GO:001951; GO:003296; GO:005511; GO:001097; GO:190187; GO:000828; GO:006034	extracellular exosome;endoplasmic reticulum lumen;macromolecular complex;membrane	GO:007006; GO:000578; GO:003299; GO:001602	"NA"	"NA"	collagen binding;iron ion binding;procollagen-proline 3-dioxygenase activity;molecular_function;L-ascorbic acid binding;protein binding	GO:000551; GO:000550; GO:001979; GO:000367; GO:003141; GO:000551
XP_020952616.1;XP_020952605.1;XP_020952598.1;XP_020952590.1;XP_020952585.1;XP_020952580.1;XP_020952574.1	XP_020952616.1;XP_020952605.1;XP_020952598.1;XP_020952590.1;XP_020952585.1;XP_020952580.1;XP_020952574.1	XP_020952616.1 tumor suppressor p53-binding protein 1 isoform X7 [Sus scrofa];XP_020952605.1 tumor suppressor p53-binding protein 1 isoform X6 [Sus scrofa];XP_020952598.1 tumor suppressor p53-binding protein 1 isoform X5 [Sus scrofa];XP_020952590.1 tumor s	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13821000	NA	NA	NA	TP53BP1	TP53BP1;TP53BP1;TP53BP1;TP53BP1;TP53BP1	DNA damage checkpoint;double-strand break repair via nonhomologous end joining;cellular response to DNA damage stimulus;positive regulation of transcription, DNA-templated;positive regulation of isotype switching;positive regulation of transcription from RNA polymerase II promoter;cellular response to X-ray;negative regulation of double-strand break repair via homologous recombination;positive regulation of sequence-specific DNA binding transcription factor activity;protein homooligomerization	GO:000007; GO:000630; GO:000697; GO:004589; GO:004583; GO:004594; GO:007148; GO:200004; GO:005109; GO:005126	site of double-strand break;condensed chromosome kinetochore;cytoplasm;DNA repair complex;chromosome, telomeric region;nucleoplasm;nucleus;nuclear body	GO:003586; GO:000077; GO:000573; GO:199039; GO:000078; GO:000565; GO:000563; GO:001660	"NA"	"NA"	ubiquitinated histone binding;protein binding;damaged DNA binding;histone binding;telomeric DNA binding;RNA polymerase II activating transcription factor binding;transcription cofactor activity;p53 binding;methylated histone binding	GO:006164; GO:000551; GO:000368; GO:004239; GO:004216; GO:000110; GO:000371; GO:000203; GO:003506
XP_020952581.1;XP_003131986.3;XP_020923470.1	XP_020952581.1;XP_003131986.3;XP_020923470.1	XP_020952581.1 LOW QUALITY PROTEIN: nuclease-sensitive element-binding protein 1 [Sus scrofa];XP_003131986.3 Y-box-binding protein 2 isoform X2 [Sus scrofa];XP_020923470.1 Y-box-binding protein 2 isoform X1 [Sus scrofa]	4	4	2	42314000	57740000	58708000	60342000	39186000	64275000	66099000	51310000	48230000	52452000	61208000	0	0	65639000	45242000	55950000	52785000	68245000	NA	NA	NA	YBX1	YBX1;YBX2;YBX2;NA;NA	regulation of transcription, DNA-templated;positive regulation of cell division;positive regulation of transcription from RNA polymerase II promoter;protein localization to cytoplasmic stress granule;mRNA splicing, via spliceosome;transcription from RNA polymerase II promoter;Notch signaling pathway;CRD-mediated mRNA stabilization	GO:000635; GO:005178; GO:004594; GO:190360; GO:000039; GO:000636; GO:000721; GO:007093	nuclear membrane;cytosol;nucleus;U12-type spliceosomal complex;cytoplasmic stress granule;extracellular exosome;extracellular region;nucleoplasm;CRD-mediated mRNA stability complex;histone pre-mRNA 3'end processing complex;cytoplasm;intracellular membrane-bounded organelle;ribonucleoprotein complex	GO:003196; GO:000582; GO:000563; GO:000568; GO:001049; GO:007006; GO:000557; GO:000565; GO:007093; GO:007120; GO:000573; GO:004323; GO:199090	"NA"	"NA"	RNA polymerase II core promoter proximal region sequence-specific DNA binding;GTPase binding;single-stranded DNA binding;protein binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;DNA binding;transcription factor activity, sequence-specific DNA binding;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;RNA binding	GO:000097; GO:005102; GO:000369; GO:000551; GO:000098; GO:000367; GO:000370; GO:000122; GO:000372
XP_020952594.1;XP_020952593.1;XP_020952595.1;XP_020952592.1;XP_020952591.1;XP_020952589.1;XP_020952588.1;XP_020952587.1;XP_020952586.1	XP_020952594.1;XP_020952593.1;XP_020952595.1;XP_020952592.1;XP_020952591.1;XP_020952589.1;XP_020952588.1;XP_020952587.1;XP_020952586.1	XP_020952594.1 forkhead box protein J3 isoform X5 [Sus scrofa];XP_020952593.1 forkhead box protein J3 isoform X4 [Sus scrofa];XP_020952595.1 forkhead box protein J3 isoform X3 [Sus scrofa];XP_020952592.1 forkhead box protein J3 isoform X3 [Sus scrofa];XP_0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10805000	0	0	+	NA	NA	FOXJ3	FOXJ3;FOXJ3;FOXJ3;FOXJ3;FOXJ3	positive regulation of transcription from RNA polymerase II promoter	GO:004594	nucleus	GO:000563	"NA"	"NA"	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding;RNA polymerase II transcription factor activity, sequence-specific DNA binding;sequence-specific DNA binding	GO:000122; GO:000098; GO:004356
XP_020952753.1;XP_020952754.1;XP_020952756.1	XP_020952753.1;XP_020952754.1;XP_020952756.1	XP_020952753.1 guanine nucleotide-binding protein G(o) subunit alpha isoform X1 [Sus scrofa];XP_020952754.1 guanine nucleotide-binding protein G(o) subunit alpha isoform X2 [Sus scrofa];XP_020952756.1 guanine nucleotide-binding protein G(o) subunit alpha i	4	1	1	0	0	0	0	0	0	0	0	0	0	0	0	6397800	0	0	0	0	0	NA	NA	NA	GNAO1	GNAO1;GNAO1;GNAO1;NA;NA	forebrain development;Wnt signaling pathway, calcium modulating pathway;locomotory behavior;regulation of heart contraction;positive regulation of GTPase activity;response to hydrogen peroxide;protein folding;muscle contraction;response to cytokine;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;neuron projection development;odontogenesis of dentin-containing tooth;response to morphine;negative regulation of calcium ion transport;dopamine receptor signaling pathway;aging	GO:003090; GO:000722; GO:000762; GO:000801; GO:004354; GO:004254; GO:000645; GO:000693; GO:003409; GO:000718; GO:003117; GO:004247; GO:004327; GO:005192; GO:000721; GO:000756	cell body;dendrite;myelin sheath;plasma membrane;heterotrimeric G-protein complex	GO:004429; GO:003042; GO:004320; GO:000588; GO:000583	 Cholinergic synapse; Melanogenesis; Retrograde endocannabinoid signaling; Chagas disease (American trypanosomiasis); Rap1 signaling pathway; Long-term depression; Alcoholism; Circadian entrainment; Oxytocin signaling pathway	hsa0472; hsa0491; hsa0472; hsa0514; hsa0401; hsa0473; hsa0503; hsa0471; hsa0492	GTPase activating protein binding;corticotropin-releasing hormone receptor 1 binding;G-protein beta/gamma-subunit complex binding;mu-type opioid receptor binding;metal ion binding;G-protein coupled serotonin receptor binding;G-protein coupled receptor binding;GTPase activity;GTP binding	GO:003279; GO:005143; GO:003168; GO:003185; GO:004687; GO:003182; GO:000166; GO:000392; GO:000552
XP_020952784.1	XP_020952784.1	XP_020952784.1 LOW QUALITY PROTEIN: myelin-associated glycoprotein [Sus scrofa]	3	3	3	0	23921000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	MAG	MAG;NA;NA;NA;NA	negative regulation of axon extension;central nervous system myelination;cellular response to mechanical stimulus;positive regulation of myelination;axon regeneration;negative regulation of axonogenesis;leukocyte migration;cell-cell adhesion via plasma-membrane adhesion molecules;transmission of nerve impulse;positive regulation of astrocyte differentiation;negative regulation of neuron apoptotic process;cell adhesion;negative regulation of neuron projection development	GO:003051; GO:002201; GO:007126; GO:003164; GO:003110; GO:005077; GO:005090; GO:009874; GO:001922; GO:004871; GO:004352; GO:000715; GO:001097	integral component of plasma membrane;mesaxon;myelin sheath;Schmidt-Lanterman incisure;myelin sheath adaxonal region;membrane raft;plasma membrane;cytoplasm;paranode region of axon;compact myelin	GO:000588; GO:009745; GO:004320; GO:004322; GO:003574; GO:004512; GO:000588; GO:000573; GO:003327; GO:004321	 Cell adhesion molecules (CAMs)	hsa0451	protein homodimerization activity;receptor binding;sialic acid binding;carbohydrate binding;protein kinase binding;ganglioside GT1b binding	GO:004280; GO:000510; GO:003369; GO:003024; GO:001990; GO:190557
XP_020953005.1;XP_020953004.1;XP_020953003.1	XP_020953005.1;XP_020953004.1;XP_020953003.1	XP_020953005.1 transcription intermediary factor 1-beta isoform X3 [Sus scrofa];XP_020953004.1 transcription intermediary factor 1-beta isoform X2 [Sus scrofa];XP_020953003.1 transcription intermediary factor 1-beta isoform X1 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	17543000	0	0	0	0	0	NA	NA	NA	TRIM28	TRIM28;TRIM28;TRIM28;NA;NA	Ras protein signal transduction;protein sumoylation;viral process;protein autophosphorylation;regulation of genetic imprinting;positive regulation of methylation-dependent chromatin silencing;negative regulation of transcription from RNA polymerase II promoter;epithelial to mesenchymal transition;embryonic placenta morphogenesis;protein ubiquitination;chromatin organization;transcription initiation from RNA polymerase II promoter;DNA methylation involved in embryo development;positive regulation of DNA binding;DNA repair;positive regulation of transcription, DNA-templated;positive regulation of protein import into nucleus;innate immune response;positive regulation of DNA repair;convergent extension involved in axis elongation;negative regulation of viral release from host cell;embryo implantation;negative regulation of single stranded viral RNA replication via double stranded DNA intermediate;protein oligomerization;negative regulation of DNA demethylation	GO:000726; GO:001692; GO:001603; GO:004677; GO:200065; GO:009030; GO:000012; GO:000183; GO:006066; GO:001656; GO:000632; GO:000636; GO:004304; GO:004338; GO:000628; GO:004589; GO:004230; GO:004508; GO:004573; GO:006002; GO:190218; GO:000756; GO:004586; GO:005125; GO:190153	chromatin;nucleus;nuclear euchromatin;nuclear heterochromatin;nucleoplasm;RNA polymerase II transcription factor complex	GO:000078; GO:000563; GO:000571; GO:000572; GO:000565; GO:009057	"NA"	"NA"	Krueppel-associated box domain binding;DNA binding;chromatin binding;protein kinase activity;promoter-specific chromatin binding;transcription coactivator activity;RNA binding;ubiquitin-protein transferase activity;zinc ion binding;protein binding;SUMO transferase activity;ubiquitin protein ligase binding;sequence-specific DNA binding;chromo shadow domain binding	GO:003585; GO:000367; GO:000368; GO:000467; GO:199084; GO:000371; GO:000372; GO:000484; GO:000827; GO:000551; GO:001978; GO:003162; GO:004356; GO:007008
XP_020953010.1	XP_020953010.1	XP_020953010.1 EH domain-containing protein 4 [Sus scrofa]	24	19	17	286970000	365640000	303560000	330540000	170140000	245120000	254140000	318480000	243790000	367740000	223280000	510770000	232170000	347840000	230240000	350410000	302080000	317790000	NA	NA	NA	EHD4	EHD4;NA;NA;NA;NA	endocytic recycling;regulation of endocytosis;protein homooligomerization;pinocytosis;positive regulation of peptidyl-tyrosine phosphorylation;cellular response to growth factor stimulus	GO:003245; GO:003010; GO:005126; GO:000690; GO:005073; GO:007136	early endosome membrane;recycling endosome membrane;nucleus;endoplasmic reticulum;extracellular exosome;plasma membrane;membrane;perinuclear region of cytoplasm	GO:003190; GO:005503; GO:000563; GO:000578; GO:007006; GO:000588; GO:001602; GO:004847	 Endocytosis	hsa0414	GTP binding;protein binding;calcium ion binding;cadherin binding;nucleic acid binding;ATP binding	GO:000552; GO:000551; GO:000550; GO:004529; GO:000367; GO:000552
XP_020953078.1	XP_020953078.1	XP_020953078.1 NEDD8-conjugating enzyme Ubc12 [Sus scrofa]	4	4	4	0	0	17163000	0	0	13872000	14431000	14025000	0	18498000	15306000	0	0	15527000	20365000	0	16170000	16450000	NA	NA	NA	UBE2M	UBE2M;NA;NA;NA;NA	positive regulation of neuron apoptotic process;protein neddylation;post-translational protein modification;protein ubiquitination;cellular protein modification process	GO:004352; GO:004511; GO:004368; GO:001656; GO:000646	cytosol;nucleoplasm	GO:000582; GO:000565	 Ubiquitin mediated proteolysis	hsa0412	ubiquitin-protein transferase activity;ATP binding;NEDD8 transferase activity;protein binding	GO:000484; GO:000552; GO:001978; GO:000551
XP_020953154.1;XP_020953153.1;XP_020953152.1;XP_020953151.1;XP_020953150.1;XP_020953149.1	XP_020953154.1;XP_020953153.1;XP_020953152.1;XP_020953151.1;XP_020953150.1;XP_020953149.1	XP_020953154.1 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [Sus scrofa];XP_020953153.1 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [Sus scrofa];XP_020953152.1 guanine nucleotide-binding protein G(I)/G(S)/G(T) subun	17	17	12	1064000000	1200400000	1306400000	862310000	956010000	1045500000	1106700000	969150000	988300000	948180000	1017900000	1067700000	871550000	1082600000	1030900000	1010900000	1111100000	971080000	NA	NA	NA	GNB1	GNB1;GNB1;GNB1;GNB1;GNB1	signal transduction;phospholipase C-activating G-protein coupled receptor signaling pathway;cellular response to prostaglandin E stimulus;protein folding;Wnt signaling pathway, calcium modulating pathway;platelet activation;cell proliferation;cardiac muscle cell apoptotic process;rhodopsin mediated signaling pathway;protein heterotrimerization;G-protein coupled receptor signaling pathway;G-protein coupled acetylcholine receptor signaling pathway;sensory perception of taste;Ras protein signal transduction;retina development in camera-type eye;cellular response to hypoxia;adenylate cyclase-activating dopamine receptor signaling pathway;cellular response to catecholamine stimulus	GO:000716; GO:000720; GO:007138; GO:000645; GO:000722; GO:003016; GO:000828; GO:001065; GO:001605; GO:007020; GO:000718; GO:000721; GO:005090; GO:000726; GO:006004; GO:007145; GO:000719; GO:007187	extracellular exosome;lysosomal membrane;cytosol;plasma membrane;membrane;cell body;photoreceptor disc membrane;photoreceptor inner segment;heterotrimeric G-protein complex;dendrite;photoreceptor outer segment membrane;extracellular vesicle	GO:007006; GO:000576; GO:000582; GO:000588; GO:001602; GO:004429; GO:009738; GO:000191; GO:000583; GO:003042; GO:004262; GO:190356	 Pathways in cancer; Circadian entrainment; Cholinergic synapse; Ras signaling pathway; Taste transduction; Alcoholism; Chemokine signaling pathway; PI3K-Akt signaling pathway	hsa0520; hsa0471; hsa0472; hsa0401; hsa0474; hsa0503; hsa0406; hsa0415	spectrin binding;GTPase binding;protein binding;macromolecular complex binding;GTPase activity;alkylglycerophosphoethanolamine phosphodiesterase activity	GO:003050; GO:005102; GO:000551; GO:004487; GO:000392; GO:004739
XP_020953198.1	XP_020953198.1	XP_020953198.1 LOW QUALITY PROTEIN: SUMO-activating enzyme subunit 2 [Sus scrofa]	4	4	4	0	0	0	9895800	0	0	0	0	0	0	0	13800000	0	0	0	11468000	0	0	NA	NA	NA	UBA2	UBA2;NA;NA;NA;NA	positive regulation of catalytic activity;protein modification by small protein conjugation;protein sumoylation	GO:004308; GO:003244; GO:001692	nucleoplasm;cytoplasm;SUMO activating enzyme complex	GO:000565; GO:000573; GO:003151	 Ubiquitin mediated proteolysis	hsa0412	enzyme activator activity;small protein activating enzyme binding;protein heterodimerization activity;magnesium ion binding;transcription factor binding;ubiquitin-like protein conjugating enzyme binding;SUMO binding;protein binding;ATP binding;transferase activity;SUMO activating enzyme activity	GO:000804; GO:004438; GO:004698; GO:000028; GO:000813; GO:004439; GO:003218; GO:000551; GO:000552; GO:001674; GO:001994
XP_020953202.1	XP_020953202.1	XP_020953202.1 LOW QUALITY PROTEIN: mitochondrial import inner membrane translocase subunit TIM50 [Sus scrofa]	3	3	3	0	0	5611800	0	7536400	0	3327300	5046200	6641800	5605100	0	0	0	4246800	7120700	0	0	0	NA	NA	NA	TIMM50	TIMM50;NA;NA;NA;NA	protein import into mitochondrial matrix;release of cytochrome c from mitochondria;protein dephosphorylation;peptidyl-tyrosine dephosphorylation;mitochondrial membrane organization	GO:003015; GO:000183; GO:000647; GO:003533; GO:000700	nuclear speck;integral component of membrane;mitochondrial inner membrane presequence translocase complex;nucleoplasm;mitochondrion	GO:001660; GO:001602; GO:000574; GO:000565; GO:000573	"NA"	"NA"	phosphoprotein phosphatase activity;ribonucleoprotein complex binding;RNA binding;protein binding;protein tyrosine phosphatase activity;interleukin-2 receptor binding	GO:000472; GO:004302; GO:000372; GO:000551; GO:000472; GO:000513
XP_020953257.1	XP_020953257.1	XP_020953257.1 spermatogenesis-associated protein 21 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5410700	+	NA	NA	SPATA21	SPATA21;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	calcium ion binding	GO:000550
XP_020953470.1;XP_020953469.1;XP_020953468.1;XP_020953467.1;XP_020953466.1;XP_020953465.1;XP_020953464.1;XP_020953463.1;XP_020953462.1;XP_020953460.1;XP_020953459.1;XP_020953458.1;XP_020953457.1;XP_020953456.1;XP_020953455.1;XP_020953454.1;XP_020953453.1;XP_020953452.1;XP_020953451.1;XP_020953449.1;XP_020953448.1;XP_020953447.1;XP_020953446.1	XP_020953470.1;XP_020953469.1;XP_020953468.1;XP_020953467.1;XP_020953466.1;XP_020953465.1;XP_020953464.1;XP_020953463.1;XP_020953462.1;XP_020953460.1;XP_020953459.1;XP_020953458.1;XP_020953457.1;XP_020953456.1;XP_020953455.1;XP_020953454.1;XP_020953453.1;XP_020953452.1;XP_020953451.1;XP_020953449.1;XP_020953448.1;XP_020953447.1;XP_020953446.1	XP_020953470.1 FGGY carbohydrate kinase domain-containing protein isoform X15 [Sus scrofa];XP_020953469.1 FGGY carbohydrate kinase domain-containing protein isoform X14 [Sus scrofa];XP_020953468.1 FGGY carbohydrate kinase domain-containing protein isoform	3	3	3	0	0	0	0	0	0	0	0	0	6300400	0	0	0	6405400	0	0	0	0	NA	NA	NA	FGGY	FGGY;FGGY;FGGY;FGGY;FGGY	carbohydrate phosphorylation;neuron cellular homeostasis;pentose metabolic process	GO:004683; GO:007005; GO:001932	cellular_component;cell	GO:000557; GO:000562	"NA"	"NA"	D-ribulokinase activity	GO:001915
XP_020953515.1	XP_020953515.1	XP_020953515.1 complement factor B isoform X1 [Sus scrofa]	25	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61096000	NA	NA	NA	CFB	CFB;NA;NA;NA;NA	complement activation;complement activation, alternative pathway;regulation of complement activation;proteolysis	GO:000695; GO:000695; GO:003044; GO:000650	blood microparticle;plasma membrane;extracellular exosome;extracellular region;extracellular space	GO:007256; GO:000588; GO:007006; GO:000557; GO:000561	 Staphylococcus aureus infection; Complement and coagulation cascades	hsa0515; hsa0461	complement binding;serine-type endopeptidase activity;protein binding	GO:000184; GO:000425; GO:000551
XP_020953871.1;NP_001231576.1	XP_020953871.1;NP_001231576.1	XP_020953871.1 cytosolic 10-formyltetrahydrofolate dehydrogenase isoform X1 [Sus scrofa];NP_001231576.1 cytosolic 10-formyltetrahydrofolate dehydrogenase [Sus scrofa]	47	47	41	1455800000	976150000	986210000	893240000	1538000000	769330000	1251800000	908350000	1077700000	890500000	1569500000	825270000	687530000	1139500000	1355800000	1340800000	1777800000	1114100000	NA	NA	NA	ALDH1L1	ALDH1L1;ALDH1L1;NA;NA;NA	oxidation-reduction process;biosynthetic process;one-carbon metabolic process;10-formyltetrahydrofolate catabolic process;folic acid metabolic process	GO:005511; GO:000905; GO:000673; GO:000925; GO:004665	extracellular exosome;cytosol	GO:007006; GO:000582	 One carbon pool by folate	hsa0067	formyltetrahydrofolate dehydrogenase activity;catalytic activity;hydroxymethyl-, formyl- and related transferase activity;aldehyde dehydrogenase (NAD) activity	GO:001615; GO:000382; GO:001674; GO:000402
XP_020953964.1;XP_020953969.1	XP_020953964.1;XP_020953969.1	XP_020953964.1 gremlin-1 isoform X1 [Sus scrofa];XP_020953969.1 gremlin-1 isoform X2 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	GREM1	GREM1;GREM1;NA;NA;NA	cell morphogenesis;positive regulation of cell proliferation;positive regulation of angiogenesis;positive regulation of NF-kappaB transcription factor activity;activation of transmembrane receptor protein tyrosine kinase activity;negative regulation of chondrocyte differentiation;regulation of stress-activated MAPK cascade;negative regulation of branching involved in ureteric bud morphogenesis;positive regulation of receptor activity;positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;collagen fibril organization;negative regulation of cell growth;positive regulation of transcription from RNA polymerase II promoter;negative regulation of monocyte chemotaxis;embryonic limb morphogenesis;determination of dorsal identity;negative regulation of pathway-restricted SMAD protein phosphorylation;positive regulation of cardiac muscle cell differentiation;branching involved in ureteric bud morphogenesis;positive regulation of receptor internalization;mesenchymal to epithelial transition involved in metanephros morphogenesis;apoptotic process;signal transduction;regulation of focal adhesion assembly;limb development;positive regulation of peptidyl-tyrosine autophosphorylation;proximal/distal pattern formation;regulation of epithelial to mesenchymal transition;negative regulation of transcription, DNA-templated;negative regulation of bone remodeling;positive regulation of telomerase activity;negative regulation of osteoclast proliferation;negative regulation of bone trabecula formation;positive regulation of NIK/NF-kappaB signaling;cell migration involved in sprouting angiogenesis;ureteric bud formation;signal transduction by p53 class mediator;negative regulation of canonical Wnt signaling pathway;cell-cell signaling;negative regulation of apoptotic process;negative regulation of bone mineralization;negative regulation of BMP signaling pathway;negative regulation of osteoblast proliferation;negative regulation of osteoblast differentiation;positive regulation of protein tyrosine kinase activity	GO:000090; GO:000828; GO:004576; GO:005109; GO:000717; GO:003233; GO:003287; GO:009019; GO:200027; GO:000325; GO:003019; GO:003030; GO:004594; GO:009002; GO:003032; GO:004826; GO:006039; GO:200072; GO:000165; GO:000209; GO:000333; GO:000691; GO:000716; GO:005189; GO:006017; GO:190008; GO:000995; GO:001071; GO:004589; GO:004685; GO:005197; GO:009029; GO:190015; GO:190122; GO:000204; GO:006067; GO:007233; GO:009009; GO:000726; GO:004306; GO:003050; GO:003051; GO:003368; GO:004566; GO:006109	extracellular space;cell surface	GO:000561; GO:000998	"NA"	"NA"	receptor agonist activity;vascular endothelial growth factor receptor 2 binding;protein binding;cytokine activity;transmembrane receptor protein tyrosine kinase activator activity;BMP binding;morphogen activity;protein homodimerization activity	GO:004801; GO:004318; GO:000551; GO:000512; GO:003029; GO:003612; GO:001601; GO:004280
XP_020953996.1;XP_020953995.1;XP_020953994.1;XP_020953992.1;XP_020953991.1;XP_020953990.1;XP_020953989.1;XP_020953988.1;XP_020953987.1;XP_020953986.1;XP_020953997.1;XP_020953999.1;XP_020953993.1;XP_020953998.1	XP_020953996.1;XP_020953995.1;XP_020953994.1;XP_020953992.1;XP_020953991.1;XP_020953990.1;XP_020953989.1;XP_020953988.1;XP_020953987.1;XP_020953986.1;XP_020953997.1;XP_020953999.1;XP_020953993.1;XP_020953998.1	XP_020953996.1 tenascin-X isoform X11 [Sus scrofa];XP_020953995.1 tenascin-X isoform X10 [Sus scrofa];XP_020953994.1 tenascin-X isoform X9 [Sus scrofa];XP_020953992.1 tenascin-X isoform X7 [Sus scrofa];XP_020953991.1 tenascin-X isoform X6 [Sus scrofa];XP_0	89	89	5	345720000	767910000	432050000	849470000	382340000	807350000	546870000	539040000	425280000	554910000	711430000	861640000	1177200000	668530000	634730000	651720000	968020000	1286600000	NA	NA	NA	TNXB	TNXB;TNXB;TNXB;TNXB;TNXB	cell adhesion;elastic fiber assembly;actin cytoskeleton organization;collagen metabolic process;collagen fibril organization	GO:000715; GO:004825; GO:003003; GO:003296; GO:003019	extracellular space;extracellular exosome;extracellular matrix;extracellular region	GO:000561; GO:007006; GO:003101; GO:000557	 Focal adhesion; MicroRNAs in cancer; ECM-receptor interaction; PI3K-Akt signaling pathway	hsa0451; hsa0520; hsa0451; hsa0415	collagen fibril binding;integrin binding;protein binding;extracellular matrix structural constituent;heparin binding	GO:009863; GO:000517; GO:000551; GO:000520; GO:000820
XP_020954007.1	XP_020954007.1	XP_020954007.1 LOW QUALITY PROTEIN: synemin [Sus scrofa]	27	27	27	34851000	87920000	122300000	20535000	39010000	129880000	16381000	68330000	52328000	157950000	97924000	175880000	234670000	17484000	18428000	22060000	35394000	15662000	NA	NA	NA	SYNM	SYNM;NA;NA;NA;NA	fast-twitch skeletal muscle fiber contraction;intermediate filament cytoskeleton organization	GO:003144; GO:004510	sarcolemma;intermediate filament;costamere;neurofilament cytoskeleton;adherens junction	GO:004238; GO:000588; GO:004303; GO:006005; GO:000591	"NA"	"NA"	structural constituent of cytoskeleton;protein binding;vinculin binding;structural constituent of muscle;intermediate filament binding	GO:000520; GO:000551; GO:001716; GO:000830; GO:001921
XP_020954119.1;XP_020954118.1;XP_020954117.1	XP_020954119.1;XP_020954118.1;XP_020954117.1	XP_020954119.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 [Sus scrofa];XP_020954118.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 [Sus scrofa];XP_020954117.1 N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 [Sus scrofa]	13	13	12	370890000	752590000	595670000	503720000	400620000	580400000	554630000	634790000	457150000	555500000	502180000	828630000	476500000	650940000	593580000	710940000	488350000	651500000	NA	NA	NA	DDAH2	DDAH2;DDAH2;DDAH2;NA;NA	negative regulation of apoptotic process;nitric oxide biosynthetic process;arginine metabolic process;nitric oxide mediated signal transduction;regulation of nitric-oxide synthase activity;citrulline metabolic process;positive regulation of nitric oxide biosynthetic process	GO:004306; GO:000680; GO:000652; GO:000726; GO:005099; GO:000005; GO:004542	microtubule organizing center;cytosol;extracellular exosome;mitochondrion	GO:000581; GO:000582; GO:007006; GO:000573	"NA"	"NA"	catalytic activity;dimethylargininase activity;protein binding;amino acid binding	GO:000382; GO:001640; GO:000551; GO:001659
XP_020954121.1;XP_020954120.1	XP_020954121.1;XP_020954120.1	XP_020954121.1 chloride intracellular channel protein 1 [Sus scrofa];XP_020954120.1 chloride intracellular channel protein 1 [Sus scrofa]	12	12	12	335070000	356480000	376980000	345880000	323980000	314250000	394620000	334080000	315350000	333870000	398290000	391200000	592700000	355740000	345900000	305360000	520860000	355580000	NA	NA	NA	CLIC1	CLIC1;CLIC1;NA;NA;NA	regulation of mitochondrial membrane potential;platelet aggregation;regulation of ion transmembrane transport;positive regulation of osteoblast differentiation;chloride transport;chloride transmembrane transport;regulation of cell cycle;signal transduction	GO:005188; GO:007052; GO:003476; GO:004566; GO:000682; GO:190247; GO:005172; GO:000716	perinuclear region of cytoplasm;membrane;cytoplasm;extracellular exosome;nuclear envelope;nuclear membrane;blood microparticle;plasma membrane;brush border;extracellular space;vesicle;chloride channel complex	GO:004847; GO:001602; GO:000573; GO:007006; GO:000563; GO:003196; GO:007256; GO:000588; GO:000590; GO:000561; GO:003198; GO:003470	"NA"	"NA"	voltage-gated ion channel activity;chloride channel activity;protein binding;cadherin binding	GO:000524; GO:000525; GO:000551; GO:004529
XP_020954233.1	XP_020954233.1	XP_020954233.1 aldehyde dehydrogenase family 1 member A3 [Sus scrofa]	12	8	8	0	0	0	0	15798000	0	15391000	14964000	11805000	0	0	0	22469000	16153000	0	0	16423000	15481000	NA	NA	NA	ALDH1A3	ALDH1A3;NA;NA;NA;NA	oxidation-reduction process;nucleus accumbens development;retinoic acid biosynthetic process;Harderian gland development;positive regulation of apoptotic process;righting reflex;embryonic eye morphogenesis;locomotory behavior;embryonic camera-type eye development;retinal metabolic process;olfactory pit development;face development;inner ear morphogenesis;neuromuscular process controlling balance;protein homotetramerization;optic cup morphogenesis involved in camera-type eye development	GO:005511; GO:002176; GO:000213; GO:007038; GO:004306; GO:006001; GO:004804; GO:000762; GO:003107; GO:004257; GO:006016; GO:006032; GO:004247; GO:005088; GO:005128; GO:000207	cytosol;cytoplasm;nucleus;extracellular exosome;plasma membrane	GO:000582; GO:000573; GO:000563; GO:007006; GO:000588	 Histidine metabolism; Drug metabolism - cytochrome P450; Glycolysis / Gluconeogenesis; Metabolic pathways; Phenylalanine metabolism; beta-Alanine metabolism; Chemical carcinogenesis; Tyrosine metabolism	hsa0034; hsa0098; hsa0001; hsa0110; hsa0036; hsa0041; hsa0520; hsa0035	aldehyde dehydrogenase [NAD(P)+;thyroid hormone binding;NAD+ binding;retinal dehydrogenase activity;aldehyde dehydrogenase (NAD) activity;protein homodimerization activity	GO:000403; GO:007032; GO:007040; GO:000175; GO:000402; GO:004280
XP_020954305.1;XP_020954304.1	XP_020954305.1;XP_020954304.1	XP_020954305.1 serine/arginine-rich splicing factor 3 [Sus scrofa];XP_020954304.1 serine/arginine-rich splicing factor 3 [Sus scrofa]	3	2	2	19140000	0	0	31539000	0	0	14256000	0	27342000	25917000	19680000	47589000	0	0	0	24029000	0	0	NA	NA	NA	SRSF3	SRSF3;SRSF3;NA;NA;NA	regulation of mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;mRNA 3'-end processing;RNA export from nucleus	GO:004802; GO:004529; GO:000038; GO:000039; GO:003112; GO:000640	nucleus;nucleoplasm;nuclear speck;cytoplasm	GO:000563; GO:000565; GO:001660; GO:000573	 Herpes simplex infection; Spliceosome	hsa0516; hsa0304	protein binding;sequence-specific mRNA binding;RNA binding	GO:000551; GO:199082; GO:000372
XP_020954316.1	XP_020954316.1	XP_020954316.1 LOW QUALITY PROTEIN: dynein heavy chain 8, axonemal [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	21610000	0	0	0	0	0	NA	NA	NA	DNAH8	DNAH8;NA;NA;NA;NA	outer dynein arm assembly;cilium-dependent cell motility;microtubule-based movement	GO:003615; GO:006028; GO:000701	dynein complex;microtubule;outer dynein arm;axonemal dynein complex	GO:003028; GO:000587; GO:003615; GO:000585	 Huntington's disease	hsa0501	ATP-dependent microtubule motor activity, minus-end-directed;dynein light intermediate chain binding;microtubule motor activity;ATP binding;dynein intermediate chain binding	GO:000856; GO:005195; GO:000377; GO:000552; GO:004550
XP_020954491.1;XP_020954490.1	XP_020954491.1;XP_020954490.1	XP_020954491.1 elongation of very long chain fatty acids protein 5 [Sus scrofa];XP_020954490.1 elongation of very long chain fatty acids protein 5 [Sus scrofa]	1	1	1	0	0	8615000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	ELOVL5	ELOVL5;ELOVL5;NA;NA;NA	unsaturated fatty acid biosynthetic process;very long-chain fatty acid biosynthetic process;linoleic acid metabolic process;fatty acid elongation, saturated fatty acid;long-chain fatty-acyl-CoA biosynthetic process;sphingolipid biosynthetic process;fatty acid elongation, monounsaturated fatty acid;alpha-linolenic acid metabolic process;positive regulation of fatty acid biosynthetic process	GO:000663; GO:004276; GO:004365; GO:001936; GO:003533; GO:003014; GO:003462; GO:003610; GO:004572	endoplasmic reticulum;membrane;integral component of endoplasmic reticulum membrane;dendrite;neuronal cell body;dendritic tree;endoplasmic reticulum membrane	GO:000578; GO:001602; GO:003017; GO:003042; GO:004302; GO:009744; GO:000578	 Fatty acid elongation; Biosynthesis of unsaturated fatty acids; Fatty acid metabolism	hsa0006; hsa0104; hsa0121	3-oxo-arachidoyl-CoA synthase activity;3-oxo-cerotoyl-CoA synthase activity;fatty acid elongase activity;protein binding	GO:010233; GO:010233; GO:000992; GO:000551
XP_020954563.1	XP_020954563.1	XP_020954563.1 signal peptidase complex catalytic subunit SEC11A [Sus scrofa]	2	2	2	0	0	0	20387000	0	0	0	18906000	0	0	21797000	25686000	0	0	19432000	0	0	0	NA	NA	NA	SEC11A	SEC11A;NA;NA;NA;NA	signal peptide processing	GO:000646	organelle membrane;endoplasmic reticulum membrane;integral component of membrane	GO:003109; GO:000578; GO:001602	 Protein export	hsa0306	serine-type peptidase activity;peptidase activity	GO:000823; GO:000823
XP_020954569.1;XP_020945330.1;XP_013852411.1	XP_020954569.1	XP_020954569.1 ras GTPase-activating-like protein IQGAP1 [Sus scrofa]	56	56	55	574610000	840440000	771060000	892440000	594990000	873770000	728010000	921600000	673350000	829620000	761800000	916630000	1210000000	1014900000	693640000	868260000	825210000	981710000	NA	NA	NA	IQGAP1	IQGAP1;NA;NA;NA;NA	regulation of cytokine production;negative regulation of dephosphorylation;cellular response to epidermal growth factor stimulus;neuron projection extension;fibroblast growth factor receptor signaling pathway;cell migration;positive regulation of GTPase activity;negative regulation of GTPase activity;positive regulation of MAP kinase activity;positive regulation of focal adhesion assembly;cellular response to calcium ion;positive regulation of peptidyl-tyrosine autophosphorylation;response to angiotensin;positive regulation of vascular associated smooth muscle cell migration;platelet-derived growth factor receptor signaling pathway;signal transduction;epidermal growth factor receptor signaling pathway;glomerular visceral epithelial cell development;positive regulation of dendrite development;positive regulation of cellular protein localization;regulation of mitotic cell cycle;cellular response to platelet-derived growth factor stimulus;neutrophil degranulation;positive regulation of protein kinase activity	GO:000181; GO:003530; GO:007136; GO:199013; GO:000854; GO:001647; GO:004354; GO:003426; GO:004340; GO:005189; GO:007127; GO:190008; GO:199077; GO:190475; GO:004800; GO:000716; GO:000717; GO:007201; GO:190000; GO:190382; GO:000734; GO:003612; GO:004331; GO:004586	microtubule;microtubule cytoskeleton;secretory granule membrane;cytoplasm;focal adhesion;slit diaphragm;plasma membrane;lateral plasma membrane;nucleus;midbody;membrane raft;growth cone;ruffle;cytosol;cytoplasmic ribonucleoprotein granule;actin cytoskeleton;neuron projection;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome	GO:000587; GO:001563; GO:003066; GO:000573; GO:000592; GO:003605; GO:000588; GO:001632; GO:000563; GO:003049; GO:004512; GO:003042; GO:000172; GO:000582; GO:003646; GO:001562; GO:004300; GO:003123; GO:007006	 Regulation of actin cytoskeleton; Adherens junction; Proteoglycans in cancer	hsa0481; hsa0452; hsa0520	protein domain specific binding;cadherin binding;GTPase inhibitor activity;protein phosphatase binding;S100 protein binding;mitogen-activated protein kinase binding;phosphatidylinositol-3,4,5-trisphosphate binding;protein complex scaffold;small GTPase binding;calmodulin binding;Rac GTPase binding;calcium ion binding;protein serine/threonine kinase activator activity;macromolecular complex binding	GO:001990; GO:004529; GO:000509; GO:001990; GO:004454; GO:005101; GO:000554; GO:003294; GO:003126; GO:000551; GO:004836; GO:000550; GO:004353; GO:004487
XP_020954735.1	XP_020954735.1	XP_020954735.1 CD276 antigen [Sus scrofa]	6	6	6	17692000	45280000	22689000	50192000	21347000	46570000	24072000	32297000	25740000	34429000	27127000	43192000	27501000	44309000	33315000	33966000	29922000	40540000	NA	NA	NA	CD276	CD276;NA;NA;NA;NA	immune response;T cell receptor signaling pathway;regulation of immune response;cell proliferation;positive regulation of T cell proliferation;T cell activation;positive regulation of interferon-gamma biosynthetic process	GO:000695; GO:005085; GO:005077; GO:000828; GO:004210; GO:004211; GO:004507	integral component of membrane;external side of plasma membrane	GO:001602; GO:000989	 Cell adhesion molecules (CAMs)	hsa0451	receptor binding;protein binding	GO:000510; GO:000551
XP_020954737.1;XP_020954738.1	XP_020954737.1;XP_020954738.1	XP_020954737.1 neuroplastin isoform X1 [Sus scrofa];XP_020954738.1 neuroplastin isoform X2 [Sus scrofa]	2	2	2	0	40356000	0	42054000	0	42573000	33551000	37738000	0	35417000	34811000	36947000	36193000	47026000	38545000	0	0	52190000	NA	NA	NA	NPTN	NPTN;NPTN;NA;NA;NA	positive regulation of cellular protein localization;positive regulation of protein phosphorylation;positive regulation of cytosolic calcium ion concentration;positive regulation of long-term synaptic potentiation;regulation of receptor localization to synapse;axon guidance;visual learning;dendrite self-avoidance;homophilic cell adhesion via plasma membrane adhesion molecules;positive regulation of fibroblast growth factor receptor signaling pathway;long-term synaptic potentiation;positive regulation of neuron projection development;positive regulation of ERK1 and ERK2 cascade;excitatory synapse assembly;positive regulation of long-term neuronal synaptic plasticity;trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission	GO:190382; GO:000193; GO:000720; GO:190027; GO:190268; GO:000741; GO:000854; GO:007059; GO:000715; GO:004574; GO:006029; GO:001097; GO:007037; GO:190486; GO:004817; GO:009955	glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic density membrane;plasma membrane;presynaptic membrane;inhibitory synapse;dendrite;cell surface;Schaffer collateral - CA1 synapse;integral component of presynaptic active zone membrane	GO:009897; GO:009898; GO:009906; GO:000588; GO:004273; GO:006007; GO:003042; GO:000998; GO:009868; GO:009905	"NA"	"NA"	type 1 fibroblast growth factor receptor binding;ion channel binding;cell adhesion molecule binding;protein binding involved in cell-cell adhesion	GO:000510; GO:004432; GO:005083; GO:009863
XP_020954759.1;XP_020954758.1	XP_020954759.1;XP_020954758.1	XP_020954759.1 ADP-dependent glucokinase isoform X2 [Sus scrofa];XP_020954758.1 ADP-dependent glucokinase isoform X1 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5643500	NA	NA	NA	ADPGK	ADPGK;ADPGK;NA;NA;NA	glucose metabolic process;canonical glycolysis	GO:000600; GO:006162	endoplasmic reticulum membrane;endoplasmic reticulum;membrane;extracellular region	GO:000578; GO:000578; GO:001602; GO:000557	 Biosynthesis of antibiotics; Glycolysis / Gluconeogenesis; Carbon metabolism; Metabolic pathways	hsa0113; hsa0001; hsa0120; hsa0110	metal ion binding;ADP-specific glucokinase activity	GO:004687; GO:004384
XP_020954789.1;XP_020954806.1;XP_013848712.2	XP_020954789.1	XP_020954789.1 prostaglandin reductase 3 isoform X1 [Sus scrofa]	3	3	3	0	0	7168900	0	8432300	0	9119400	0	8180000	0	0	0	0	0	7444500	0	0	0	NA	NA	NA	ZADH2	ZADH2;NA;NA;NA;NA	prostaglandin metabolic process;biological_process;oxidation-reduction process;negative regulation of fat cell differentiation	GO:000669; GO:000815; GO:005511; GO:004559	peroxisome	GO:000577	"NA"	"NA"	zinc ion binding;molecular_function;13-prostaglandin reductase activity;15-oxoprostaglandin 13-oxidase activity	GO:000827; GO:000367; GO:003613; GO:004752
XP_020954894.1;XP_020954893.1;XP_020954892.1	XP_020954894.1;XP_020954893.1;XP_020954892.1	XP_020954894.1 myosin-6 isoform X2 [Sus scrofa];XP_020954893.1 myosin-6 isoform X2 [Sus scrofa];XP_020954892.1 myosin-6 isoform X1 [Sus scrofa]	24	4	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	117420000	0	NA	NA	NA	LOC100736765	LOC100736765;LOC100736765;LOC100736765;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955150.1	XP_020955150.1	XP_020955150.1 papilin [Sus scrofa]	8	8	8	20736000	26991000	26529000	14397000	0	11274000	13840000	18935000	17294000	20884000	19209000	22666000	10640000	17412000	21313000	14987000	15639000	17310000	NA	NA	NA	PAPLN	PAPLN;NA;NA;NA;NA	negative regulation of endopeptidase activity;proteolysis	GO:001095; GO:000650	extracellular region	GO:000557	"NA"	"NA"	serine-type endopeptidase inhibitor activity;peptidase activity	GO:000486; GO:000823
XP_020955153.1;XP_001929075.2;XP_020955154.1	XP_020955153.1	XP_020955153.1 LOW QUALITY PROTEIN: acyl-coenzyme A thioesterase 1-like [Sus scrofa]	16	16	14	352350000	225490000	368080000	236670000	357850000	201010000	384970000	274600000	533250000	319030000	293650000	245320000	198110000	242450000	361640000	311200000	266500000	204100000	NA	NA	NA	LOC110255331	LOC110255331;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955234.1	XP_020955234.1	XP_020955234.1 serpin B5 [Sus scrofa]	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8132100	0	NA	NA	NA	SERPINB5	SERPINB5;NA;NA;NA;NA	morphogenesis of an epithelium;extracellular matrix organization;prostate gland morphogenesis;negative regulation of endopeptidase activity;regulation of epithelial cell proliferation	GO:000200; GO:003019; GO:006051; GO:001095; GO:005067	extracellular space;cytoplasm	GO:000561; GO:000573	 p53 signaling pathway; MicroRNAs in cancer	hsa0411; hsa0520	protein binding;serine-type endopeptidase inhibitor activity	GO:000551; GO:000486
XP_020955261.1;XP_020955258.1;XP_020955252.1	XP_020955261.1;XP_020955258.1;XP_020955252.1	XP_020955261.1 apoptosis regulator Bcl-2 isoform X3 [Sus scrofa];XP_020955258.1 apoptosis regulator Bcl-2 isoform X2 [Sus scrofa];XP_020955252.1 apoptosis regulator Bcl-2 isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4691800	NA	NA	NA	BCL2	BCL2;BCL2;BCL2;NA;NA	lymphoid progenitor cell differentiation;apoptotic process;extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of neuron maturation;positive regulation of B cell proliferation;cellular response to glucose starvation;CD8-positive, alpha-beta T cell lineage commitment;thymus development;positive regulation of skeletal muscle fiber development;extrinsic apoptotic signaling pathway in absence of ligand;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;release of cytochrome c from mitochondria;regulation of nitrogen utilization;cellular response to DNA damage stimulus;response to drug;response to iron ion;cytokine-mediated signaling pathway;positive regulation of cell growth;hair follicle morphogenesis;negative regulation of cellular pH reduction;negative regulation of myeloid cell apoptotic process;T cell differentiation in thymus;digestive tract morphogenesis;transmembrane transport;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;B cell homeostasis;regulation of cell-matrix adhesion;actin filament organization;female pregnancy;response to radiation;response to toxic substance;negative regulation of autophagy;negative regulation of calcium ion transport into cytosol;gland morphogenesis;glomerulus development;positive regulation of multicellular organism growth;positive regulation of melanocyte differentiation;negative regulation of retinal cell programmed cell death;response to glucocorticoid;neuron apoptotic process;regulation of mitochondrial membrane potential;response to ischemia;axonogenesis;regulation of gene expression;positive regulation of smooth muscle cell migration;response to nicotine;pigment granule organization;regulation of calcium ion transport;cell-cell adhesion;negative regulation of intrinsic apoptotic signaling pathway;ossification;metanephros development;B cell lineage commitment;protein dephosphorylation;negative regulation of reactive oxygen species metabolic process;peptidyl-threonine phosphorylation;negative regulation of ossification;axon regeneration;negative regulation of osteoblast proliferation;response to hydrogen peroxide;positive regulation of catalytic activity;regulation of mitochondrial membrane permeability;negative regulation of mitochondrial depolarization;cellular response to hypoxia;negative regulation of anoikis;protein polyubiquitination;melanin metabolic process;humoral immune response;negative regulation of apoptotic process;male gonad development;response to UV-B;melanocyte differentiation;regulation of protein stability;endoplasmic reticulum calcium ion homeostasis;positive regulation of peptidyl-serine phosphorylation;B cell proliferation;T cell homeostasis;focal adhesion assembly;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;ovarian follicle development;renal system process;intrinsic apoptotic signaling pathway in response to DNA damage;regulation of glycoprotein biosynthetic process;regulation of transmembrane transporter activity;negative regulation of cell migration;response to cytokine;organ growth;regulation of protein homodimerization activity;oocyte development;homeostasis of number of cells within a tissue;B cell receptor signaling pathway;defense response to virus;negative regulation of G1/S transition of mitotic cell cycle;negative regulation of apoptotic signaling pathway;behavioral fear response;reactive oxygen species metabolic process;positive regulation of cell proliferation;post-embryonic development;response to gamma radiation;mesenchymal cell development;cochlear nucleus development;negative regulation of neuron apoptotic process;ear development;regulation of viral genome replication	GO:000232; GO:000691; GO:000862; GO:001404; GO:003089; GO:004214; GO:004337; GO:004853; GO:004874; GO:009719; GO:190216; GO:000183; GO:000680; GO:000697; GO:004249; GO:001003; GO:001922; GO:003030; GO:003106; GO:003284; GO:003303; GO:003307; GO:004854; GO:005508; GO:007005; GO:000178; GO:000195; GO:000701; GO:000756; GO:000931; GO:000963; GO:001050; GO:001052; GO:002261; GO:003283; GO:004001; GO:004563; GO:004667; GO:005138; GO:005140; GO:005188; GO:000293; GO:000740; GO:001046; GO:001491; GO:003509; GO:004875; GO:005192; GO:009860; GO:200124; GO:000150; GO:000165; GO:000232; GO:000647; GO:200037; GO:001810; GO:003027; GO:003110; GO:003368; GO:004254; GO:004308; GO:004690; GO:005190; GO:007145; GO:200081; GO:000020; GO:000658; GO:000695; GO:004306; GO:000858; GO:001022; GO:003031; GO:003164; GO:003246; GO:003313; GO:004210; GO:004302; GO:004804; GO:190074; GO:000154; GO:000301; GO:000863; GO:001055; GO:002289; GO:003033; GO:003409; GO:003526; GO:004349; GO:004859; GO:004887; GO:005085; GO:005160; GO:200013; GO:200123; GO:000166; GO:007259; GO:000828; GO:000979; GO:001033; GO:001403; GO:002174; GO:004352; GO:004358; GO:004506	membrane;nuclear membrane;macromolecular complex;nucleus;cytosol;mitochondrial outer membrane;mitochondrion;pore complex;myelin sheath;endoplasmic reticulum;nucleoplasm	GO:001602; GO:003196; GO:003299; GO:000563; GO:000582; GO:000574; GO:000573; GO:004693; GO:004320; GO:000578; GO:000565	 Adrenergic signaling in cardiomyocytes; Focal adhesion; Prostate cancer; Protein processing in endoplasmic reticulum; PI3K-Akt signaling pathway; Tuberculosis; Neurotrophin signaling pathway; Amyotrophic lateral sclerosis (ALS); Toxoplasmosis; Pathways in cancer; NF-kappa B signaling pathway; Apoptosis; Sphingolipid signaling pathway; Epstein-Barr virus infection; Small cell lung cancer	hsa0426; hsa0451; hsa0521; hsa0414; hsa0415; hsa0515; hsa0472; hsa0501; hsa0514; hsa0520; hsa0406; hsa0421; hsa0407; hsa0516; hsa0522	protease binding;transcription factor binding;identical protein binding;protein binding;protein heterodimerization activity;channel activity;BH3 domain binding;sequence-specific DNA binding;protein phosphatase 2A binding;ubiquitin protein ligase binding;channel inhibitor activity	GO:000202; GO:000813; GO:004280; GO:000551; GO:004698; GO:001526; GO:005143; GO:004356; GO:005172; GO:003162; GO:001624
XP_020955329.1	XP_020955329.1	XP_020955329.1 LOW QUALITY PROTEIN: serpin A3-8 [Sus scrofa]	18	10	10	89052000	163380000	292050000	490250000	1706200000	2557200000	243880000	283540000	124840000	68594000	295320000	345330000	340900000	503120000	309880000	263600000	415540000	577220000	NA	NA	NA	LOC106504547	LOC106504547;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955331.1	XP_020955331.1	XP_020955331.1 LOW QUALITY PROTEIN: serpin A3-8 [Sus scrofa]	16	4	4	333140000	358500000	114910000	344680000	1072800000	621680000	222740000	453840000	432810000	461670000	163250000	55252000	194360000	206260000	237780000	201010000	265520000	417370000	NA	NA	NA	LOC106504545	LOC106504545;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955408.1;XP_020955407.1	XP_020955408.1;XP_020955407.1	XP_020955408.1 GDP-mannose 4,6 dehydratase isoform X2 [Sus scrofa];XP_020955407.1 GDP-mannose 4,6 dehydratase isoform X1 [Sus scrofa]	8	8	8	25188000	29734000	30976000	39625000	29077000	24749000	39094000	43252000	40323000	42592000	26178000	33290000	20953000	23897000	34804000	34117000	26545000	24825000	NA	NA	NA	GMDS	GMDS;GMDS;NA;NA;NA	Notch signaling pathway;'de novo' GDP-L-fucose biosynthetic process;GDP-mannose metabolic process	GO:000721; GO:004235; GO:001967	cytosol;cytoplasm;extracellular exosome	GO:000582; GO:000573; GO:007006	 Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Fructose and mannose metabolism	hsa0052; hsa0110; hsa0005	NADP+ binding;GDP-mannose 4,6-dehydratase activity;identical protein binding;protein binding	GO:007040; GO:000844; GO:004280; GO:000551
XP_020955494.1	XP_020955494.1	XP_020955494.1 histone H1.5 [Sus scrofa]	7	7	7	48658000	84081000	81966000	97628000	84038000	84777000	81440000	80979000	104580000	109870000	73666000	61782000	279300000	112490000	118840000	78996000	120650000	90043000	NA	NA	NA	LOC110261661	LOC110261661;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955511.1;XP_020955509.1;XP_020955508.1;XP_020955506.1;XP_020954094.1;XP_020954087.1;XP_020945589.1;XP_005665718.2;XP_020955496.1;XP_020945585.1;XP_013844399.1;NP_001274345.1;NP_001231571.1;XP_020955685.1;XP_020939043.1	XP_020955511.1;XP_020955509.1;XP_020955508.1;XP_020955506.1;XP_020954094.1;XP_020954087.1;XP_020945589.1;XP_005665718.2	XP_020955511.1 LOW QUALITY PROTEIN: uncharacterized protein LOC100525821 [Sus scrofa];XP_020955509.1 histone H4 [Sus scrofa];XP_020955508.1 histone H4 [Sus scrofa];XP_020955506.1 histone H4 [Sus scrofa];XP_020954094.1 histone H4 [Sus scrofa];XP_020954087.1	17	17	12	5856200000	7834100000	8247700000	3997000000	6458400000	13165000000	5717600000	4739700000	7961200000	8971100000	6269100000	8778400000	10500000000	9269300000	4322000000	12932000000	8897700000	10522000000	NA	NA	NA	LOC100525821	LOC100525821;LOC110261675;LOC110261674;LOC110261673;LOC110261487	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955529.1	XP_020955529.1	XP_020955529.1 protein ERGIC-53 [Sus scrofa]	3	3	3	0	0	19647000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	LMAN1	LMAN1;NA;NA;NA;NA	protein folding;endoplasmic reticulum organization;early endosome to Golgi transport;negative regulation of protein targeting to mitochondrion;ER to Golgi vesicle-mediated transport;Golgi organization;COPII vesicle coating;positive regulation of organelle organization;blood coagulation;protein exit from endoplasmic reticulum	GO:000645; GO:000702; GO:003449; GO:190321; GO:000688; GO:000703; GO:004820; GO:001063; GO:000759; GO:003252	endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle;Golgi membrane;membrane;cytosol;host cell perinuclear region of cytoplasm;extracellular exosome;endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;sarcomere	GO:000579; GO:003013; GO:000013; GO:001602; GO:000582; GO:004422; GO:007006; GO:000578; GO:001250; GO:003311; GO:003001	 Protein processing in endoplasmic reticulum	hsa0414	mannose binding;unfolded protein binding;protein binding;metal ion binding	GO:000553; GO:005108; GO:000551; GO:004687
XP_020955552.1;XP_020955551.1;XP_020955548.1;XP_020955547.1;XP_020955546.1;XP_020955544.1;XP_020955549.1;XP_020955545.1;XP_020950276.1;XP_003127284.1;XP_020950275.1;XP_020950274.1	XP_020955552.1;XP_020955551.1;XP_020955548.1;XP_020955547.1;XP_020955546.1;XP_020955544.1;XP_020955549.1;XP_020955545.1	XP_020955552.1 striatin-3 isoform X7 [Sus scrofa];XP_020955551.1 striatin-3 isoform X7 [Sus scrofa];XP_020955548.1 striatin-3 isoform X5 [Sus scrofa];XP_020955547.1 striatin-3 isoform X4 [Sus scrofa];XP_020955546.1 striatin-3 isoform X3 [Sus scrofa];XP_020	3	3	3	0	0	8684900	0	12628000	15812000	13302000	12745000	0	0	0	14677000	0	0	0	0	0	0	NA	NA	NA	STRN3	STRN3;STRN3;STRN3;STRN3;STRN3	negative regulation of transcription, DNA-templated;negative regulation of intracellular estrogen receptor signaling pathway;response to estradiol	GO:004589; GO:003314; GO:003235	macromolecular complex;neuronal cell body;nucleoplasm;plasma membrane;Golgi apparatus;FAR/SIN/STRIPAK complex;dendrite	GO:003299; GO:004302; GO:000565; GO:000588; GO:000579; GO:009044; GO:003042	"NA"	"NA"	macromolecular complex binding;armadillo repeat domain binding;calmodulin binding;Rho GTPase binding;protein phosphatase 2A binding	GO:004487; GO:007001; GO:000551; GO:001704; GO:005172
XP_020955562.1;XP_020955561.1;XP_020955559.1;XP_020955558.1;XP_020955565.1;XP_020955564.1;XP_020955563.1	XP_020955562.1;XP_020955561.1;XP_020955559.1;XP_020955558.1;XP_020955565.1;XP_020955564.1;XP_020955563.1	XP_020955562.1 sec1 family domain-containing protein 1 isoform X4 [Sus scrofa];XP_020955561.1 sec1 family domain-containing protein 1 isoform X3 [Sus scrofa];XP_020955559.1 sec1 family domain-containing protein 1 isoform X2 [Sus scrofa];XP_020955558.1 sec1	7	7	7	22721000	25362000	28886000	29950000	26387000	28073000	32586000	29834000	26565000	29828000	30516000	44658000	25662000	30764000	30224000	33061000	23421000	29809000	NA	NA	NA	SCFD1	SCFD1;SCFD1;SCFD1;SCFD1;SCFD1	response to hypoxia;retrograde vesicle-mediated transport, Golgi to ER;vesicle docking involved in exocytosis;COPII vesicle coating;toxin transport;negative regulation of autophagosome assembly;regulation of protein transport;regulation of ER to Golgi vesicle-mediated transport;response to toxic substance;cell morphogenesis;protein transport	GO:000166; GO:000689; GO:000690; GO:004820; GO:190199; GO:190290; GO:005122; GO:006062; GO:000963; GO:000090; GO:001503	Golgi-associated vesicle;plasma membrane;cis-Golgi network;cytosol;Golgi cisterna membrane;endoplasmic reticulum membrane	GO:000579; GO:000588; GO:000580; GO:000582; GO:003258; GO:000578	"NA"	"NA"	syntaxin binding;protein N-terminus binding;protein binding;macromolecular complex binding	GO:001990; GO:004748; GO:000551; GO:004487
XP_020955776.1;XP_020955774.1;XP_020955773.1;XP_020955778.1;XP_020955777.1	XP_020955776.1;XP_020955774.1;XP_020955773.1;XP_020955778.1;XP_020955777.1	XP_020955776.1 ribosyldihydronicotinamide dehydrogenase [quinone] isoform X1 [Sus scrofa];XP_020955774.1 ribosyldihydronicotinamide dehydrogenase [quinone] isoform X1 [Sus scrofa];XP_020955773.1 ribosyldihydronicotinamide dehydrogenase [quinone] isoform X1	8	8	8	86333000	113640000	85292000	71645000	63810000	87012000	96818000	77093000	76922000	82464000	92046000	90754000	84739000	88584000	94292000	80899000	107670000	72125000	NA	NA	NA	NQO2	NQO2;NQO2;NQO2;NQO2;NQO2	oxidation-reduction process;xenobiotic metabolic process;positive regulation of vascular smooth muscle cell proliferation;memory;positive regulation of reactive oxygen species metabolic process;positive regulation of neuron apoptotic process;positive regulation of ERK1 and ERK2 cascade;electron transport chain	GO:005511; GO:000680; GO:190470; GO:000761; GO:200037; GO:004352; GO:007037; GO:002290	nucleoplasm;extracellular exosome;cytosol	GO:000565; GO:007006; GO:000582	"NA"	"NA"	protein binding;NAD(P)H dehydrogenase (quinone) activity;oxidoreductase activity, acting on other nitrogenous compounds as donors;FAD binding;electron carrier activity;zinc ion binding;dihydronicotinamide riboside quinone reductase activity;protein homodimerization activity;resveratrol binding;oxidoreductase activity;chloride ion binding;melatonin binding	GO:000551; GO:000395; GO:001666; GO:007194; GO:000905; GO:000827; GO:000151; GO:004280; GO:190559; GO:001649; GO:003140; GO:190440
XP_020955779.1;XP_020955656.1	XP_020955779.1	XP_020955779.1 tubulin beta-2A chain [Sus scrofa]	22	5	2	151480000	313350000	135650000	78807000	147520000	75539000	138140000	85991000	188870000	141100000	160980000	155830000	149920000	81966000	88922000	128420000	147380000	87925000	NA	NA	NA	LOC100624785	LOC100624785;NA;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"	"NA"
XP_020955819.1	XP_020955819.1	XP_020955819.1 thioredoxin domain-containing protein 5 [Sus scrofa]	13	13	13	110460000	203900000	178280000	216860000	151830000	245750000	198790000	240310000	145180000	191200000	195870000	253350000	261230000	224310000	181290000	193170000	219310000	285730000	NA	NA	NA	TXNDC5	TXNDC5;NA;NA;NA;NA	cell redox homeostasis;negative regulation of apoptotic process;neutrophil degranulation;apoptotic cell clearance	GO:004545; GO:004306; GO:004331; GO:004327	endoplasmic reticulum lumen;endoplasmic reticulum;lysosomal lumen;extracellular region;azurophil granule lumen;extracellular exosome	GO:000578; GO:000578; GO:004320; GO:000557; GO:003557; GO:007006	 Protein processing in endoplasmic reticulum	hsa0414	isomerase activity;protein binding	GO:001685; GO:000551
XP_020955873.1	XP_020955873.1	XP_020955873.1 adenylyl cyclase-associated protein 2 [Sus scrofa]	4	3	3	0	0	0	0	0	32811000	0	0	0	0	0	0	38899000	0	0	0	0	0	NA	NA	NA	CAP2	CAP2;NA;NA;NA;NA	actin polymerization or depolymerization;signal transduction;activation of adenylate cyclase activity;cell morphogenesis	GO:000815; GO:000716; GO:000719; GO:000090	cortical actin cytoskeleton;plasma membrane;postsynaptic density	GO:003086; GO:000588; GO:001406	"NA"	"NA"	identical protein binding;adenylate cyclase binding;actin binding;protein binding	GO:004280; GO:000817; GO:000377; GO:000551
XP_020956182.1;NP_001072156.1	XP_020956182.1;NP_001072156.1	XP_020956182.1 extracellular superoxide dismutase [Cu-Zn] isoform X1 [Sus scrofa];NP_001072156.1 extracellular superoxide dismutase [Cu-Zn] precursor [Sus scrofa]	6	6	6	912320000	806200000	472730000	786780000	490180000	726240000	1168900000	930010000	631610000	644400000	1100500000	1106900000	541530000	670580000	1241200000	1071300000	753290000	662420000	NA	NA	NA	SOD3	SOD3;SOD3;NA;NA;NA	positive regulation of catalytic activity;removal of superoxide radicals;oxidation-reduction process;response to hypoxia;response to copper ion;cellular response to oxidative stress	GO:004308; GO:001943; GO:005511; GO:000166; GO:004668; GO:003459	extracellular space;extracellular exosome;Golgi lumen;nucleus;extracellular region	GO:000561; GO:007006; GO:000579; GO:000563; GO:000557	"NA"	"NA"	copper ion binding;heparin binding;superoxide dismutase activity;protein binding	GO:000550; GO:000820; GO:000478; GO:000551
XP_020956195.1	XP_020956195.1	XP_020956195.1 LOW QUALITY PROTEIN: signal recognition particle subunit SRP72 [Sus scrofa]	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	7721600	0	0	0	0	NA	NA	NA	SRP72	SRP72;NA;NA;NA;NA	SRP-dependent cotranslational protein targeting to membrane;SRP-dependent cotranslational protein targeting to membrane, translocation;response to drug	GO:000661; GO:000661; GO:004249	cytosol;endoplasmic reticulum;signal recognition particle	GO:000582; GO:000578; GO:004850	 Protein export	hsa0306	RNA binding;7S RNA binding;signal recognition particle binding;protein binding;TPR domain binding;ribosome binding	GO:000372; GO:000831; GO:000504; GO:000551; GO:003091; GO:004302
XP_020956355.1	XP_020956355.1	XP_020956355.1 60S acidic ribosomal protein P1 [Sus scrofa]	3	3	3	90825000	112820000	100670000	128930000	145440000	103850000	133980000	136550000	131410000	134380000	126650000	150690000	146020000	130890000	125580000	109660000	133530000	140790000	NA	NA	NA	RPLP1	RPLP1;NA;NA;NA;NA	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translational elongation;cytoplasmic translation;SRP-dependent cotranslational protein targeting to membrane;activation of protein kinase activity	GO:000018; GO:000641; GO:000218; GO:000661; GO:003214	cytosolic large ribosomal subunit;focal adhesion;cytosol	GO:002262; GO:000592; GO:000582	 Ribosome	hsa0301	protein kinase activator activity;ribonucleoprotein complex binding;protein binding;structural constituent of ribosome	GO:003029; GO:004302; GO:000551; GO:000373
XP_020956357.1;XP_020956358.1	XP_020956357.1;XP_020956358.1	XP_020956357.1 synaptopodin-2 isoform X1 [Sus scrofa];XP_020956358.1 synaptopodin-2 isoform X2 [Sus scrofa]	13	13	13	0	24241000	21920000	0	0	25527000	0	26022000	0	34252000	0	35987000	67001000	0	0	0	0	0	NA	NA	NA	SYNPO2	SYNPO2;SYNPO2;NA;NA;NA	positive regulation of actin filament bundle assembly;chaperone-mediated autophagy;autophagosome assembly	GO:003223; GO:006168; GO:000004	cytosol;Z disc;stress fiber;focal adhesion;actin cytoskeleton;nucleus;intracellular membrane-bounded organelle;tethering complex	GO:000582; GO:003001; GO:000172; GO:000592; GO:001562; GO:000563; GO:004323; GO:009902	"NA"	"NA"	actin binding;protein binding, bridging;filamin binding;14-3-3 protein binding;muscle alpha-actinin binding;alpha-actinin binding;protein binding	GO:000377; GO:003067; GO:003100; GO:007188; GO:005137; GO:005139; GO:000551
XP_020956362.1;XP_005671069.2	XP_020956362.1;XP_005671069.2	XP_020956362.1 LOW QUALITY PROTEIN: ankyrin-2 [Sus scrofa];XP_005671069.2 LOW QUALITY PROTEIN: ankyrin-3 [Sus scrofa]	5	4	4	0	0	0	0	0	0	0	0	0	17964000	0	0	0	0	0	0	0	0	NA	NA	NA	ANK2	ANK2;ANK3;NA;NA;NA	ER to Golgi vesicle-mediated transport;regulation of cardiac muscle contraction by calcium ion signaling;paranodal junction assembly;positive regulation of calcium ion transport;regulation of cardiac muscle contraction;atrial cardiac muscle cell to AV node cell communication;protein transport;regulation of protein stability;regulation of ventricular cardiac muscle cell membrane repolarization;membrane depolarization during SA node cell action potential;sarcoplasmic reticulum calcium ion transport;ventricular cardiac muscle cell action potential;regulation of heart rate;T-tubule organization;protein localization to endoplasmic reticulum;protein localization to plasma membrane;positive regulation of cation channel activity;atrial septum development;cellular calcium ion homeostasis;cellular protein localization;regulation of release of sequestered calcium ion into cytosol;SA node cell to atrial cardiac muscle cell communication;cytoskeleton organization;protein stabilization;protein localization to organelle;protein localization to cell surface;protein localization to M-band;positive regulation of potassium ion transport;regulation of heart rate by cardiac conduction;regulation of atrial cardiac muscle cell action potential;endocytosis;protein localization to T-tubule;response to methylmercury;SA node cell action potential;positive regulation of potassium ion transmembrane transporter activity;positive regulation of gene expression;regulation of SA node cell action potential;positive regulation of calcium ion transmembrane transporter activity	GO:000688; GO:001088; GO:003091; GO:005192; GO:005511; GO:008606; GO:001503; GO:003164; GO:006030; GO:008604; GO:007029; GO:008600; GO:000202; GO:003329; GO:007097; GO:007265; GO:200125; GO:000328; GO:000687; GO:003461; GO:005127; GO:008607; GO:000701; GO:005082; GO:003336; GO:003439; GO:003630; GO:004326; GO:008609; GO:009891; GO:000689; GO:003637; GO:005159; GO:008601; GO:190101; GO:001062; GO:009890; GO:190102	lysosome;early endosome;basolateral plasma membrane;Z disc;A band;sarcolemma;intercalated disc;T-tubule;cytosol;M band;axon initial segment;postsynaptic membrane;membrane;cytoskeleton;recycling endosome;plasma membrane;mitochondrion;costamere;membrane raft	GO:000576; GO:000576; GO:001632; GO:003001; GO:003167; GO:004238; GO:001470; GO:003031; GO:000582; GO:003143; GO:004319; GO:004521; GO:001602; GO:000585; GO:005503; GO:000588; GO:000573; GO:004303; GO:004512	 Proteoglycans in cancer	hsa0520	ATPase binding;enzyme binding;protein kinase binding;protein binding;protein binding, bridging;structural constituent of cytoskeleton;spectrin binding;ion channel binding	GO:005111; GO:001989; GO:001990; GO:000551; GO:003067; GO:000520; GO:003050; GO:004432
XP_020956367.1;XP_020956366.1;XP_020956365.1;XP_020956364.1	XP_020956367.1;XP_020956366.1;XP_020956365.1;XP_020956364.1	XP_020956367.1 elongation of very long chain fatty acids protein 6 isoform X2 [Sus scrofa];XP_020956366.1 elongation of very long chain fatty acids protein 6 isoform X1 [Sus scrofa];XP_020956365.1 elongation of very long chain fatty acids protein 6 isoform	2	2	2	0	10679000	25970000	0	0	0	0	0	0	20528000	0	0	0	0	0	15225000	26625000	0	NA	NA	NA	ELOVL6	ELOVL6;ELOVL6;ELOVL6;ELOVL6;NA	unsaturated fatty acid biosynthetic process;very long-chain fatty acid biosynthetic process;fatty acid elongation, saturated fatty acid;fatty acid elongation, polyunsaturated fatty acid;long-chain fatty-acyl-CoA biosynthetic process;long-chain fatty acid biosynthetic process;regulation of cholesterol biosynthetic process;sphingolipid biosynthetic process	GO:000663; GO:004276; GO:001936; GO:003462; GO:003533; GO:004275; GO:004554; GO:003014	integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane	GO:003017; GO:000578	 Biosynthesis of unsaturated fatty acids; Fatty acid metabolism; Fatty acid elongation	hsa0104; hsa0121; hsa0006	fatty acid elongase activity;3-oxo-cerotoyl-CoA synthase activity;protein binding	GO:000992; GO:010233; GO:000551
XP_020956384.1;XP_020956383.1;XP_020956382.1;XP_020956381.1;XP_020956380.1;XP_020956379.1;XP_020956377.1;XP_020956376.1;XP_020956375.1;XP_020956374.1;XP_020956373.1	XP_020956384.1;XP_020956383.1;XP_020956382.1;XP_020956381.1;XP_020956380.1;XP_020956379.1;XP_020956377.1;XP_020956376.1;XP_020956375.1;XP_020956374.1;XP_020956373.1	XP_020956384.1 centromere-associated protein E isoform X11 [Sus scrofa];XP_020956383.1 centromere-associated protein E isoform X10 [Sus scrofa];XP_020956382.1 centromere-associated protein E isoform X9 [Sus scrofa];XP_020956381.1 centromere-associated prot	2	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16764000	0	NA	NA	NA	CENPE	CENPE;CENPE;CENPE;CENPE;CENPE	antigen processing and presentation of exogenous peptide antigen via MHC class II;positive regulation of protein kinase activity;metaphase plate congression;microtubule-based movement;mitotic chromosome movement towards spindle pole;cell division;retrograde vesicle-mediated transport, Golgi to ER;mitotic cell cycle;kinetochore assembly;mitotic metaphase plate congression;regulation of mitotic metaphase/anaphase transition;chromosome segregation;multicellular organism development;lateral attachment of mitotic spindle microtubules to kinetochore	GO:001988; GO:004586; GO:005131; GO:000701; GO:000707; GO:005130; GO:000689; GO:000027; GO:005138; GO:000708; GO:003007; GO:000705; GO:000727; GO:009960	chromosome, centromeric region;nucleoplasm;microtubule cytoskeleton;condensed chromosome, centromeric region;kinesin complex;chromosome;cytosol;spindle midzone;membrane;mitotic spindle midzone;midbody;nucleus	GO:000077; GO:000565; GO:001563; GO:000077; GO:000587; GO:000569; GO:000582; GO:005123; GO:001602; GO:199002; GO:003049; GO:000563	"NA"	"NA"	ATPase activity;ATP binding;protein binding;kinetochore binding;microtubule motor activity;microtubule binding	GO:001688; GO:000552; GO:000551; GO:004351; GO:000377; GO:000801
XP_020956467.1	XP_020956467.1	XP_020956467.1 LOW QUALITY PROTEIN: wolframin [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4012700	0	NA	NA	NA	WFS1	WFS1;NA;NA;NA;NA	kidney development;ER overload response;ubiquitin-dependent ERAD pathway;endoplasmic reticulum calcium ion homeostasis;negative regulation of ATF6-mediated unfolded protein response;response to endoplasmic reticulum stress;negative regulation of programmed cell death;neurological system process;positive regulation of protein ubiquitination;post-translational protein modification;negative regulation of type B pancreatic cell apoptotic process;visual perception;protein maturation by protein folding;olfactory behavior;positive regulation of growth;positive regulation of protein metabolic process;renal water homeostasis;IRE1-mediated unfolded protein response;glucose homeostasis;negative regulation of neuron apoptotic process;cellular protein metabolic process;protein stabilization;negative regulation of sequence-specific DNA binding transcription factor activity;calcium ion homeostasis;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;negative regulation of transcription from RNA polymerase II promoter;pancreas development;positive regulation of calcium ion transport	GO:000182; GO:000698; GO:003043; GO:003246; GO:190389; GO:003497; GO:004306; GO:005087; GO:003139; GO:004368; GO:200067; GO:000760; GO:002241; GO:004204; GO:004592; GO:005124; GO:000309; GO:003649; GO:004259; GO:004352; GO:004426; GO:005082; GO:004343; GO:005507; GO:190223; GO:000012; GO:003101; GO:005192	integral component of endoplasmic reticulum membrane;endoplasmic reticulum membrane;proteasome complex;dendrite;integral component of synaptic vesicle membrane	GO:003017; GO:000578; GO:000050; GO:003042; GO:003028	 Protein processing in endoplasmic reticulum	hsa0414	calcium-dependent protein binding;activating transcription factor binding;ubiquitin protein ligase binding;protein binding;ATPase binding	GO:004830; GO:003361; GO:003162; GO:000551; GO:005111
XP_020956533.1;XP_020956532.1;XP_020956531.1;XP_020956530.1;XP_020956529.1;XP_020956528.1;XP_020956527.1;XP_020956526.1;XP_020956525.1;XP_020956523.1;XP_020956522.1;XP_020956534.1;XP_020929291.1;XP_020929290.1;XP_020929289.1;XP_020929288.1;XP_020929287.1;XP_020929286.1;XP_003483621.1;XP_013839311.1	XP_020956533.1;XP_020956532.1;XP_020956531.1;XP_020956530.1;XP_020956529.1;XP_020956528.1;XP_020956527.1;XP_020956526.1;XP_020956525.1;XP_020956523.1;XP_020956522.1;XP_020956534.1	XP_020956533.1 C-terminal-binding protein 1 isoform X5 [Sus scrofa];XP_020956532.1 C-terminal-binding protein 1 isoform X4 [Sus scrofa];XP_020956531.1 C-terminal-binding protein 1 isoform X4 [Sus scrofa];XP_020956530.1 C-terminal-binding protein 1 isoform	7	7	7	0	33489000	0	0	0	40502000	0	0	28567000	0	0	43195000	0	0	0	0	0	35870000	NA	NA	NA	CTBP1	CTBP1;CTBP1;CTBP1;CTBP1;CTBP1	protein phosphorylation;positive regulation of histone deacetylation;chromatin silencing;negative regulation of transcription from RNA polymerase II promoter;negative regulation of cell proliferation;negative regulation of transcription, DNA-templated;negative regulation of histone acetylation;regulation of cell cycle;white fat cell differentiation;viral genome replication;negative regulation of histone H4 acetylation;oxidation-reduction process	GO:000646; GO:003106; GO:000634; GO:000012; GO:000828; GO:004589; GO:003506; GO:005172; GO:005087; GO:001907; GO:009024; GO:005511	transcription factor complex;presynaptic active zone cytoplasmic component;GABA-ergic synapse;transcriptional repressor complex;nucleus;nucleoplasm;glutamatergic synapse	GO:000566; GO:009883; GO:009898; GO:001705; GO:000563; GO:000565; GO:009897	 Notch signaling pathway; Pathways in cancer; Chronic myeloid leukemia; Wnt signaling pathway	hsa0433; hsa0520; hsa0522; hsa0431	protein binding;protein domain specific binding;NAD binding;transcription corepressor activity;transcription factor binding;transcription factor activity, sequence-specific DNA binding;protein C-terminus binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;repressing transcription factor binding	GO:000551; GO:001990; GO:005128; GO:000371; GO:000813; GO:000370; GO:000802; GO:001661; GO:007049
XP_020956671.1	XP_020956671.1	XP_020956671.1 WD repeat-containing protein 1 [Sus scrofa]	25	25	25	444710000	679900000	698270000	514740000	397840000	637000000	480970000	602610000	532370000	887760000	478880000	752890000	1014200000	510810000	488940000	562860000	474890000	540180000	NA	NA	NA	WDR1	WDR1;NA;NA;NA;NA	actin filament fragmentation;cortical cytoskeleton organization;neutrophil migration;locomotion;maintenance of epithelial cell apical/basal polarity;sensory perception of sound;neutrophil mediated immunity;regulation of actin filament depolymerization;sarcomere organization;actin filament depolymerization;platelet formation;establishment of planar polarity of follicular epithelium;apical junction assembly;platelet degranulation;regulation of cell shape;regulation of oligodendrocyte differentiation;regulation of ventricular cardiac muscle cell membrane repolarization	GO:003004; GO:003086; GO:199026; GO:004001; GO:004519; GO:000760; GO:000244; GO:003083; GO:004521; GO:003004; GO:003022; GO:004224; GO:004329; GO:000257; GO:000836; GO:004871; GO:006030	cell junction;extracellular exosome;podosome;cytosol;cortical actin cytoskeleton;actomyosin, actin portion;cell projection;extracellular region;plasma membrane;cell-cell junction	GO:003005; GO:007006; GO:000210; GO:000582; GO:003086; GO:004264; GO:004299; GO:000557; GO:000588; GO:000591	"NA"	"NA"	actin filament binding	GO:005101
XP_020956816.1	XP_020956816.1	XP_020956816.1 LOW QUALITY PROTEIN: LIM and calponin homology domains-containing protein 1 [Sus scrofa]	9	9	9	0	38087000	18151000	31479000	0	0	25303000	35531000	0	38534000	0	36532000	0	31528000	0	35289000	0	25842000	NA	NA	NA	LIMCH1	LIMCH1;NA;NA;NA;NA	negative regulation of cell migration;regulation of focal adhesion assembly;actomyosin structure organization;positive regulation of stress fiber assembly;positive regulation of protein phosphorylation	GO:003033; GO:005189; GO:003103; GO:005149; GO:000193	myosin II complex;stress fiber;cytoplasm	GO:001646; GO:000172; GO:000573	"NA"	"NA"	myosin II head/neck binding;metal ion binding;actin binding	GO:003203; GO:004687; GO:000377
XP_020956854.1;XP_020956853.1;XP_020956852.1;XP_020956851.1;XP_020956848.1;XP_020956858.1;XP_020956857.1;XP_020956850.1;XP_020956856.1;XP_020956855.1;XP_020956849.1	XP_020956854.1;XP_020956853.1;XP_020956852.1;XP_020956851.1;XP_020956848.1;XP_020956858.1;XP_020956857.1;XP_020956850.1;XP_020956856.1;XP_020956855.1;XP_020956849.1	XP_020956854.1 OCIA domain-containing protein 1 isoform X1 [Sus scrofa];XP_020956853.1 OCIA domain-containing protein 1 isoform X1 [Sus scrofa];XP_020956852.1 OCIA domain-containing protein 1 isoform X1 [Sus scrofa];XP_020956851.1 OCIA domain-containing pr	4	4	4	0	0	12459000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	OCIAD1	OCIAD1;OCIAD1;OCIAD1;OCIAD1;OCIAD1	regulation of stem cell differentiation	GO:200073	endosome;membrane	GO:000576; GO:001602	"NA"	"NA"	protein binding	GO:000551
XP_020957034.1	XP_020957034.1	XP_020957034.1 LOW QUALITY PROTEIN: multifunctional protein ADE2 [Sus scrofa]	13	13	13	156630000	138370000	139020000	142540000	129710000	109800000	117590000	122210000	143430000	165480000	130400000	162640000	68828000	124590000	85708000	165860000	127450000	135180000	NA	NA	NA	PAICS	PAICS;NA;NA;NA;NA	'de novo' IMP biosynthetic process;purine ribonucleoside monophosphate biosynthetic process;purine nucleobase biosynthetic process	GO:000618; GO:000916; GO:000911	membrane;extracellular exosome;cytoplasm;cytosol	GO:001602; GO:007006; GO:000573; GO:000582	 Purine metabolism; Metabolic pathways; Biosynthesis of antibiotics	hsa0023; hsa0110; hsa0113	phosphoribosylaminoimidazole carboxylase activity;identical protein binding;protein binding;5-amino-4-imidazole carboxylate lyase activity;ATP binding;phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;cadherin binding	GO:000463; GO:004280; GO:000551; GO:004372; GO:000552; GO:000463; GO:004529
XP_020957143.1;XP_020957142.1	XP_020957143.1;XP_020957142.1	XP_020957143.1 fibrinogen alpha chain isoform X2 [Sus scrofa];XP_020957142.1 fibrinogen alpha chain isoform X1 [Sus scrofa]	23	23	22	1218600000	781290000	734940000	829480000	2839200000	3116000000	1109600000	835640000	1472400000	945390000	1369800000	586130000	1197200000	644020000	836670000	640460000	1148900000	941830000	NA	NA	NA	FGA	FGA;FGA;NA;NA;NA	extracellular matrix organization;fibrinolysis;adaptive immune response;plasminogen activation;post-translational protein modification;positive regulation of protein secretion;induction of bacterial agglutination;positive regulation of vasoconstriction;negative regulation of endothelial cell apoptotic process;platelet degranulation;blood coagulation;response to calcium ion;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of exocytosis;platelet aggregation;blood coagulation, common pathway;positive regulation of peptide hormone secretion;cellular protein metabolic process;protein polymerization;macromolecular complex assembly;positive regulation of substrate adhesion-dependent cell spreading;toll-like receptor signaling pathway;cell-matrix adhesion;positive regulation of heterotypic cell-cell adhesion;cellular macromolecular complex assembly;innate immune response;positive regulation of ERK1 and ERK2 cascade	GO:003019; GO:004273; GO:000225; GO:003163; GO:004368; GO:005071; GO:004315; GO:004590; GO:200035; GO:000257; GO:000759; GO:005159; GO:190204; GO:004592; GO:007052; GO:007237; GO:009027; GO:004426; GO:005125; GO:006500; GO:190002; GO:000222; GO:000716; GO:003411; GO:003462; GO:004508; GO:007037	fibrinogen complex;extracellular space;cell cortex;extracellular region;platelet alpha granule lumen;cell surface;synapse;blood microparticle;plasma membrane;external side of plasma membrane;extracellular exosome;extracellular vesicle;endoplasmic reticulum lumen	GO:000557; GO:000561; GO:000593; GO:000557; GO:003109; GO:000998; GO:004520; GO:007256; GO:000588; GO:000989; GO:007006; GO:190356; GO:000578	 Complement and coagulation cascades; Platelet activation	hsa0461; hsa0461	receptor binding;cell adhesion molecule binding;structural molecule activity;metal ion binding;extracellular matrix structural constituent;protein binding	GO:000510; GO:005083; GO:000519; GO:004687; GO:000520; GO:000551
XP_020957374.1;XP_020957373.1;XP_020957372.1	XP_020957374.1;XP_020957373.1;XP_020957372.1	XP_020957374.1 inorganic pyrophosphatase 2, mitochondrial isoform X3 [Sus scrofa];XP_020957373.1 inorganic pyrophosphatase 2, mitochondrial isoform X2 [Sus scrofa];XP_020957372.1 inorganic pyrophosphatase 2, mitochondrial isoform X1 [Sus scrofa]	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5734800	0	NA	NA	NA	PPA2	PPA2;PPA2;PPA2;NA;NA	tRNA aminoacylation for protein translation;phosphate-containing compound metabolic process;protein dephosphorylation;regulation of mitochondrial membrane potential;diphosphate metabolic process	GO:000641; GO:000679; GO:000647; GO:005188; GO:007134	mitochondrial matrix	GO:000575	 Oxidative phosphorylation	hsa0019	protein serine/threonine phosphatase activity;magnesium ion binding;inorganic diphosphatase activity	GO:000472; GO:000028; GO:000442
XP_020957402.1;XP_020957401.1;XP_020957400.1;XP_020957399.1;XP_020957403.1	XP_020957402.1;XP_020957401.1;XP_020957400.1;XP_020957399.1;XP_020957403.1	XP_020957402.1 rap1 GTPase-GDP dissociation stimulator 1 isoform X4 [Sus scrofa];XP_020957401.1 rap1 GTPase-GDP dissociation stimulator 1 isoform X3 [Sus scrofa];XP_020957400.1 rap1 GTPase-GDP dissociation stimulator 1 isoform X2 [Sus scrofa];XP_020957399.	6	6	6	0	16522000	12442000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	RAP1GDS1	RAP1GDS1;RAP1GDS1;RAP1GDS1;RAP1GDS1;RAP1GDS1	positive regulation of mitochondrial calcium ion concentration;myosin filament assembly;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of GTPase activity;vascular smooth muscle contraction	GO:005156; GO:003103; GO:003247; GO:004354; GO:001482	mitochondrion;cytosol;extracellular exosome;endoplasmic reticulum	GO:000573; GO:000582; GO:007006; GO:000578	"NA"	"NA"	GTPase activator activity;protein binding	GO:000509; GO:000551
XP_020957414.1;XP_020957409.1;XP_020957408.1;XP_020957407.1;XP_020957406.1;XP_020957405.1;XP_020957415.1;XP_020957412.1;XP_020957411.1;XP_020957410.1;XP_020957418.1;XP_020957417.1;XP_020957416.1	XP_020957414.1;XP_020957409.1;XP_020957408.1;XP_020957407.1;XP_020957406.1;XP_020957405.1;XP_020957415.1;XP_020957412.1;XP_020957411.1;XP_020957410.1	XP_020957414.1 PDZ and LIM domain protein 5 isoform X8 [Sus scrofa];XP_020957409.1 PDZ and LIM domain protein 5 isoform X4 [Sus scrofa];XP_020957408.1 PDZ and LIM domain protein 5 isoform X4 [Sus scrofa];XP_020957407.1 PDZ and LIM domain protein 5 isoform	12	12	12	0	0	39227000	0	0	35330000	17995000	48406000	0	50646000	33162000	56782000	104340000	32522000	29687000	33784000	47432000	25893000	NA	NA	NA	PDLIM5	PDLIM5;PDLIM5;PDLIM5;PDLIM5;PDLIM5	cell-cell adhesion;regulation of dendritic spine morphogenesis;regulation of synapse assembly;cell growth involved in cardiac muscle cell development	GO:009860; GO:006100; GO:005196; GO:006104	neuron projection;postsynaptic membrane;membrane;cytosol;postsynaptic density;cell-cell adherens junction;actin cytoskeleton	GO:004300; GO:004521; GO:001602; GO:000582; GO:001406; GO:000591; GO:001562	"NA"	"NA"	cadherin binding involved in cell-cell adhesion;actinin binding;protein N-terminus binding;actin binding;protein binding;protein kinase C binding;metal ion binding	GO:009864; GO:004280; GO:004748; GO:000377; GO:000551; GO:000508; GO:004687
XP_020957538.1;XP_020957537.1;XP_020957536.1;XP_020957535.1;XP_020957534.1;XP_020957533.1	XP_020957538.1;XP_020957537.1;XP_020957536.1;XP_020957535.1;XP_020957534.1;XP_020957533.1	XP_020957538.1 heterogeneous nuclear ribonucleoprotein D-like isoform X2 [Sus scrofa];XP_020957537.1 heterogeneous nuclear ribonucleoprotein D-like isoform X2 [Sus scrofa];XP_020957536.1 heterogeneous nuclear ribonucleoprotein D-like isoform X2 [Sus scrofa	4	3	3	0	0	0	0	0	0	18317000	0	21844000	0	0	0	0	0	0	0	21894000	26028000	NA	NA	NA	HNRNPDL	HNRNPDL;HNRNPDL;HNRNPDL;HNRNPDL;HNRNPDL	interleukin-12-mediated signaling pathway	GO:003572	nucleoplasm;cytosol;nucleus;ribonucleoprotein complex	GO:000565; GO:000582; GO:000563; GO:199090	"NA"	"NA"	sequence-specific DNA binding;poly(A) binding;RNA binding;protein binding;sequence-specific double-stranded DNA binding;poly(G) binding	GO:004356; GO:000814; GO:000372; GO:000551; GO:199083; GO:003404
XP_020957544.1;XP_020957543.1;XP_020957542.1;XP_020957541.1;XP_020957540.1;XP_020957539.1	XP_020957544.1;XP_020957543.1;XP_020957542.1;XP_020957541.1;XP_020957540.1;XP_020957539.1	XP_020957544.1 heterogeneous nuclear ribonucleoprotein D0 isoform X4 [Sus scrofa];XP_020957543.1 heterogeneous nuclear ribonucleoprotein D0 isoform X3 [Sus scrofa];XP_020957542.1 heterogeneous nuclear ribonucleoprotein D0 isoform X3 [Sus scrofa];XP_0209575	6	6	5	123600000	127950000	116590000	114890000	114810000	170940000	99300000	108970000	103500000	125070000	141870000	159390000	147470000	120230000	119200000	118630000	117420000	134370000	NA	NA	NA	HNRNPD	HNRNPD;HNRNPD;HNRNPD;HNRNPD;HNRNPD	cerebellum development;regulation of circadian rhythm;response to electrical stimulus;liver development;RNA catabolic process;positive regulation of translation;cellular response to nitric oxide;cellular response to putrescine;mRNA splicing, via spliceosome;regulation of telomere maintenance;positive regulation of telomerase RNA reverse transcriptase activity;circadian regulation of translation;response to sodium phosphate;hepatocyte dedifferentiation;RNA processing;positive regulation of transcription, DNA-templated;cellular response to amino acid stimulus;response to calcium ion;cellular response to estradiol stimulus;positive regulation of telomere capping;regulation of transcription, DNA-templated;RNA metabolic process;regulation of mRNA stability;mRNA stabilization;3'-UTR-mediated mRNA destabilization;response to rapamycin	GO:002154; GO:004275; GO:005160; GO:000188; GO:000640; GO:004572; GO:007173; GO:190458; GO:000039; GO:003220; GO:190566; GO:009716; GO:190438; GO:199082; GO:000639; GO:004589; GO:007123; GO:005159; GO:007139; GO:190435; GO:000635; GO:001607; GO:004348; GO:004825; GO:006115; GO:190135	nucleus;cytosol;nucleoplasm;synapse;ribonucleoprotein complex	GO:000563; GO:000582; GO:000565; GO:004520; GO:199090	"NA"	"NA"	sequence-specific DNA binding;RNA binding;protein binding;AT DNA binding;mRNA 3'-UTR AU-rich region binding;transcription factor binding;histone deacetylase binding;sequence-specific double-stranded DNA binding;telomeric DNA binding	GO:004356; GO:000372; GO:000551; GO:000368; GO:003592; GO:000813; GO:004282; GO:199083; GO:004216
XP_020957559.1;XP_020957555.1;XP_020957552.1;XP_020957546.1	XP_020957559.1;XP_020957555.1;XP_020957552.1;XP_020957546.1	XP_020957559.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [Sus scrofa];XP_020957555.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [Sus scrofa];XP_020957552.1 guanine nucleotide-binding protein G(I)/G(S)/G(O) sub	2	2	2	19508000	0	18358000	0	0	17417000	20343000	28105000	19131000	20457000	0	0	26316000	26469000	24229000	31089000	15004000	20663000	NA	NA	NA	GNG2	GNG2;GNG2;GNG2;GNG2;NA	adenylate cyclase-activating dopamine receptor signaling pathway;cell proliferation;cellular response to prostaglandin E stimulus;cellular response to catecholamine stimulus;protein folding;platelet activation;Wnt signaling pathway, calcium modulating pathway;G-protein coupled receptor signaling pathway	GO:000719; GO:000828; GO:007138; GO:007187; GO:000645; GO:003016; GO:000722; GO:000718	plasma membrane;membrane;heterotrimeric G-protein complex;extracellular exosome	GO:000588; GO:001602; GO:000583; GO:007006	 Glutamatergic synapse; Alcoholism; Dopaminergic synapse; Ras signaling pathway; PI3K-Akt signaling pathway; Pathways in cancer; Circadian entrainment; Chemokine signaling pathway	hsa0472; hsa0503; hsa0472; hsa0401; hsa0415; hsa0520; hsa0471; hsa0406	protein binding;G-protein beta-subunit binding;GTPase activity	GO:000551; GO:003168; GO:000392
XP_020957576.1;XP_020957575.1;XP_020957574.1;XP_020957572.1;XP_020957571.1;XP_020957570.1;XP_020957569.1;XP_020957568.1;XP_020957567.1;XP_020957566.1;XP_020957565.1;XP_020957564.1;NP_001090984.2	XP_020957576.1;XP_020957575.1;XP_020957574.1;XP_020957572.1;XP_020957571.1;XP_020957570.1;XP_020957569.1;XP_020957568.1;XP_020957567.1;XP_020957566.1;XP_020957565.1;XP_020957564.1;NP_001090984.2	XP_020957576.1 serum paraoxonase/arylesterase 1 isoform X2 [Sus scrofa];XP_020957575.1 serum paraoxonase/arylesterase 1 isoform X2 [Sus scrofa];XP_020957574.1 serum paraoxonase/arylesterase 1 isoform X2 [Sus scrofa];XP_020957572.1 serum paraoxonase/arylest	4	4	4	33748000	25737000	14982000	31333000	0	0	35773000	15497000	48266000	34065000	23558000	20111000	15660000	14930000	0	0	20925000	0	NA	NA	NA	PON1	PON1;PON1;PON1;PON1;PON1	positive regulation of cholesterol efflux;aromatic compound catabolic process;organophosphate catabolic process;phosphatidylcholine metabolic process;response to fatty acid;response to toxic substance;dephosphorylation;lipoxygenase pathway;response to fluoride;positive regulation of transporter activity;cholesterol metabolic process;carboxylic acid catabolic process;negative regulation of plasma lipoprotein oxidation;response to nutrient levels;positive regulation of binding	GO:001087; GO:001943; GO:004643; GO:004647; GO:007054; GO:000963; GO:001631; GO:001937; GO:190261; GO:003241; GO:000820; GO:004639; GO:003444; GO:003166; GO:005109	extracellular region;intracellular membrane-bounded organelle;extracellular exosome;extracellular space;high-density lipoprotein particle;blood microparticle	GO:000557; GO:004323; GO:007006; GO:000561; GO:003436; GO:007256	 Metabolic pathways	hsa0110	phospholipid binding;calcium ion binding;aryldialkylphosphatase activity;protein homodimerization activity;acyl-L-homoserine-lactone lactonohydrolase activity	GO:000554; GO:000550; GO:000406; GO:004280; GO:010200
XP_020957573.1;XP_020957580.1;XP_020957589.1	XP_020957573.1;XP_020957580.1;XP_020957589.1	XP_020957573.1 nidogen-2 isoform X1 [Sus scrofa];XP_020957580.1 nidogen-2 isoform X2 [Sus scrofa];XP_020957589.1 nidogen-2 isoform X3 [Sus scrofa]	53	53	52	3314300000	4565200000	3553700000	3566900000	2650500000	2359100000	3554600000	4374500000	2720100000	3087400000	3158000000	4670700000	1782200000	3751600000	3340000000	4317000000	3199500000	3113900000	NA	NA	NA	NID2	NID2;NID2;NID2;NA;NA	cell-matrix adhesion;cell adhesion;extracellular matrix organization;basement membrane organization	GO:000716; GO:000715; GO:003019; GO:007171	extracellular exosome;extracellular region;basement membrane;plasma membrane	GO:007006; GO:000557; GO:000560; GO:000588	"NA"	"NA"	protein binding;collagen binding;calcium ion binding;extracellular matrix structural constituent	GO:000551; GO:000551; GO:000550; GO:000520
XP_020957796.1;XP_020957768.1;XP_020957787.1;XP_020957759.1;XP_020957783.1;XP_020957739.1;XP_020957784.1;XP_020957750.1;XP_020957777.1;XP_020957728.1;XP_020957772.1;XP_020957769.1;XP_020957719.1	XP_020957796.1;XP_020957768.1;XP_020957787.1;XP_020957759.1;XP_020957783.1;XP_020957739.1;XP_020957784.1;XP_020957750.1;XP_020957777.1;XP_020957728.1;XP_020957772.1;XP_020957769.1;XP_020957719.1	XP_020957796.1 fermitin family homolog 2 isoform X6 [Sus scrofa];XP_020957768.1 fermitin family homolog 2 isoform X6 [Sus scrofa];XP_020957787.1 fermitin family homolog 2 isoform X5 [Sus scrofa];XP_020957759.1 fermitin family homolog 2 isoform X5 [Sus scro	27	27	27	517360000	803520000	635350000	763910000	400100000	742660000	481810000	722720000	560690000	881970000	454610000	836760000	420020000	848650000	444410000	883010000	487970000	763800000	NA	NA	NA	FERMT2	FERMT2;FERMT2;FERMT2;FERMT2;FERMT2	integrin-mediated signaling pathway;transforming growth factor beta receptor signaling pathway;protein localization to membrane;cell junction assembly;Wnt signaling pathway;cell-matrix adhesion;regulation of cell shape;integrin activation;substrate adhesion-dependent cell spreading;focal adhesion assembly	GO:000722; GO:000717; GO:007265; GO:003432; GO:001605; GO:000716; GO:000836; GO:003362; GO:003444; GO:004804	nucleus;cell surface;I band;focal adhesion;lamellipodium membrane;stress fiber;cytosol;cytoplasm;nucleoplasm;cell cortex;extrinsic component of cytoplasmic side of plasma membrane	GO:000563; GO:000998; GO:003167; GO:000592; GO:003125; GO:000172; GO:000582; GO:000573; GO:000565; GO:000593; GO:003123	"NA"	"NA"	phosphatidylinositol-3,4,5-trisphosphate binding;protein binding;actin filament binding	GO:000554; GO:000551; GO:005101
XP_020957795.1;XP_020957794.1;XP_020957793.1;XP_020957792.1;NP_001230503.1	XP_020957795.1;XP_020957794.1;XP_020957793.1;XP_020957792.1;NP_001230503.1	XP_020957795.1 isobutyryl-CoA dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020957794.1 isobutyryl-CoA dehydrogenase, mitochondrial isoform X3 [Sus scrofa];XP_020957793.1 isobutyryl-CoA dehydrogenase, mitochondrial isoform X2 [Sus scrofa];XP_0209	5	5	5	36183000	0	38682000	0	35295000	0	40620000	31791000	36864000	29362000	40197000	44662000	23319000	0	25499000	42173000	0	0	NA	NA	NA	ACAD8	ACAD8;ACAD8;ACAD8;ACAD8;ACAD8	oxidation-reduction process;valine catabolic process;branched-chain amino acid catabolic process;lipid metabolic process	GO:005511; GO:000657; GO:000908; GO:000662	mitochondrial matrix	GO:000575	 Valine, leucine and isoleucine degradation; Metabolic pathways	hsa0028; hsa0110	acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding	GO:000399; GO:005066
XP_020957857.1;XP_020957858.1;XP_020957856.1;NP_999053.1	XP_020957857.1;XP_020957858.1;XP_020957856.1	XP_020957857.1 membrane cofactor protein isoform X2 [Sus scrofa];XP_020957858.1 membrane cofactor protein isoform X3 [Sus scrofa];XP_020957856.1 membrane cofactor protein isoform X1 [Sus scrofa]	6	6	6	26548000	52079000	48501000	0	29019000	58338000	32997000	41281000	35589000	37391000	39892000	77938000	43411000	39173000	33187000	30547000	39043000	39779000	NA	NA	NA	CD46	CD46;CD46;CD46;NA;NA	interleukin-10 production;T cell mediated immunity;negative regulation of gene expression;regulation of Notch signaling pathway;viral entry into host cell;positive regulation of interleukin-10 production;innate immune response;sequestering of extracellular ligand from receptor;positive regulation of T cell proliferation;complement activation, classical pathway;single fertilization;regulation of complement activation;positive regulation of memory T cell differentiation;positive regulation of transforming growth factor beta production;adaptive immune response;positive regulation of regulatory T cell differentiation	GO:003261; GO:000245; GO:001062; GO:000859; GO:004671; GO:003273; GO:004508; GO:003558; GO:004210; GO:000695; GO:000733; GO:003044; GO:004338; GO:007163; GO:000225; GO:004559	inner acrosomal membrane;integral component of plasma membrane;focal adhesion;extracellular exosome;cell surface	GO:000207; GO:000588; GO:000592; GO:007006; GO:000998	 Measles; Complement and coagulation cascades	hsa0516; hsa0461	virus receptor activity;protein binding;cadherin binding;signaling receptor activity	GO:000161; GO:000551; GO:004529; GO:003802
XP_020957929.1;XP_020957931.1;NP_001038069.1;XP_020957930.1	XP_020957929.1;XP_020957931.1;NP_001038069.1;XP_020957930.1	XP_020957929.1 serum paraoxonase/lactonase 3 isoform X1 [Sus scrofa];XP_020957931.1 serum paraoxonase/lactonase 3 isoform X3 [Sus scrofa];NP_001038069.1 serum paraoxonase/lactonase 3 precursor [Sus scrofa];XP_020957930.1 serum paraoxonase/lactonase 3 isofo	13	13	13	293570000	313770000	227220000	263360000	328910000	190750000	268670000	243770000	187680000	196780000	182680000	208380000	231960000	460090000	401750000	429540000	518160000	603820000	NA	NA	NA	PON3	PON3;PON3;PON3;PON3;NA	carboxylic acid catabolic process;phenylacetate catabolic process;response to toxic substance;dephosphorylation;negative regulation of superoxide anion generation;aromatic compound catabolic process;coumarin catabolic process;lipoxygenase pathway	GO:004639; GO:001012; GO:000963; GO:001631; GO:003292; GO:001943; GO:004622; GO:001937	extracellular exosome;extracellular space;intracellular membrane-bounded organelle;extracellular region	GO:007006; GO:000561; GO:004323; GO:000557	 Metabolic pathways	hsa0110	protein homodimerization activity;aryldialkylphosphatase activity;acyl-L-homoserine-lactone lactonohydrolase activity;metal ion binding;3,4-dihydrocoumarin hydrolase activity	GO:004280; GO:000406; GO:010200; GO:004687; GO:001873
XP_020958205.1	XP_020958205.1	XP_020958205.1 exocyst complex component 5 [Sus scrofa]	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4650200	0	0	NA	NA	NA	EXOC5	EXOC5;NA;NA;NA;NA	protein transport;post-Golgi vesicle-mediated transport;epithelial cell apoptotic process;protein localization to plasma membrane;exocytosis;establishment of planar polarity;vesicle docking;homeostasis of number of cells within a tissue;non-motile cilium assembly	GO:001503; GO:000689; GO:190401; GO:007265; GO:000688; GO:000173; GO:004827; GO:004887; GO:190551	cytoplasm;midbody;cytosol;exocyst	GO:000573; GO:003049; GO:000582; GO:000014	"NA"	"NA"	protein binding;Ral GTPase binding;protein N-terminus binding	GO:000551; GO:001716; GO:004748
XP_020958258.1	XP_020958258.1	XP_020958258.1 cAMP-dependent protein kinase type II-beta regulatory subunit [Sus scrofa]	11	11	9	226960000	264800000	293670000	244160000	260480000	257680000	328280000	308370000	286440000	231930000	319130000	424480000	161780000	266570000	303960000	354000000	232310000	278370000	NA	NA	NA	PRKAR2B	PRKAR2B;NA;NA;NA;NA	cGMP-mediated signaling;activation of protein kinase A activity;negative regulation of cAMP-dependent protein kinase activity;G2/M transition of mitotic cell cycle;blood coagulation;modulation of synaptic transmission;cellular response to glucagon stimulus;regulation of G2/M transition of mitotic cell cycle;learning;ciliary basal body docking;renal water homeostasis;fatty acid metabolic process;intracellular signal transduction;response to clozapine	GO:001993; GO:003419; GO:200048; GO:000008; GO:000759; GO:005080; GO:007137; GO:001038; GO:000761; GO:009771; GO:000309; GO:000663; GO:003555; GO:009733	glutamatergic synapse;cytosol;centrosome;membrane raft;ciliary base;plasma membrane;cytoplasm;dendritic shaft;cAMP-dependent protein kinase complex;perinuclear region of cytoplasm;extracellular exosome;neuronal cell body	GO:009897; GO:000582; GO:000581; GO:004512; GO:009754; GO:000588; GO:000573; GO:004319; GO:000595; GO:004847; GO:007006; GO:004302	 Insulin signaling pathway; Apoptosis	hsa0491; hsa0421	protein binding;cAMP binding;protein domain specific binding;protein kinase A catalytic subunit binding;3',5'-cyclic-GMP phosphodiesterase activity;cAMP-dependent protein kinase regulator activity;cAMP-dependent protein kinase inhibitor activity;ubiquitin protein ligase binding	GO:000551; GO:003055; GO:001990; GO:003423; GO:004755; GO:000860; GO:000486; GO:003162
XP_020958264.1;XP_020958263.1;XP_020958262.1;XP_020958261.1	XP_020958264.1;XP_020958263.1;XP_020958262.1;XP_020958261.1	XP_020958264.1 B-cell receptor-associated protein 29 [Sus scrofa];XP_020958263.1 B-cell receptor-associated protein 29 [Sus scrofa];XP_020958262.1 B-cell receptor-associated protein 29 [Sus scrofa];XP_020958261.1 B-cell receptor-associated protein 29 [Sus	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9617800	NA	NA	NA	BCAP29	BCAP29;BCAP29;BCAP29;BCAP29;NA	intracellular protein transport;ER to Golgi vesicle-mediated transport;protein localization to endoplasmic reticulum exit site;osteoblast differentiation;apoptotic process	GO:000688; GO:000688; GO:007097; GO:000164; GO:000691	membrane;endoplasmic reticulum membrane;integral component of plasma membrane	GO:001602; GO:000578; GO:000588	"NA"	"NA"	"NA"	"NA"
XP_020958330.1;XP_020958325.1	XP_020958330.1;XP_020958325.1	XP_020958330.1 mitochondrial import inner membrane translocase subunit Tim9 [Sus scrofa];XP_020958325.1 mitochondrial import inner membrane translocase subunit Tim9 [Sus scrofa]	2	2	2	0	0	18716000	0	0	0	24912000	0	0	0	0	0	0	20374000	0	0	0	0	NA	NA	NA	TIMM9	TIMM9;TIMM9;NA;NA;NA	protein targeting to mitochondrion;chaperone-mediated protein transport;sensory perception of sound;protein import into mitochondrial inner membrane	GO:000662; GO:007232; GO:000760; GO:004503	mitochondrial intermembrane space;mitochondrion;mitochondrial intermembrane space protein transporter complex;mitochondrial inner membrane	GO:000575; GO:000573; GO:004271; GO:000574	"NA"	"NA"	protein binding;chaperone binding;zinc ion binding;transporter activity;protein homodimerization activity	GO:000551; GO:005108; GO:000827; GO:000521; GO:004280
XP_020958364.1;XP_020958362.1	XP_020958364.1;XP_020958362.1	XP_020958364.1 trans-3-hydroxy-L-proline dehydratase isoform X2 [Sus scrofa];XP_020958362.1 trans-3-hydroxy-L-proline dehydratase isoform X1 [Sus scrofa]	4	4	4	0	16909000	12921000	0	13054000	12835000	18650000	19412000	19268000	20149000	14356000	20939000	12514000	16450000	0	21549000	16356000	15660000	NA	NA	NA	L3HYPDH	L3HYPDH;L3HYPDH;NA;NA;NA	"NA"	"NA"	"NA"	"NA"	 Arginine and proline metabolism	hsa0033	hydro-lyase activity;proline racemase activity;trans-L-3-hydroxyproline dehydratase activity	GO:001683; GO:001811; GO:005034
